id|nct_id|organization|name|phone|email|extension
22396372|NCT02322125|University of Alberta|Dr. Jaynie Yang|780-492-2894|jaynie.yang@ualberta.ca|
22396373|NCT03427047|Medacta USA|Rena Mandino, Director, Clinical Research|352-359-3581|rmandino@medacta.us.com|
22442333|NCT03718091|Massachusetts Genera Hospital|Gregory M Cote MD PhD|6177244000|gcote@partners.org|
22442334|NCT01043939|Masonic Cancer Center, University of Minnesota|Cindy K. Blair, MPH|612-624-9668|blair016@umn.edu|
22442335|NCT03338959|University of Washington|Lee Cranmer, MD, PhD, Sarcoma Program Director|206-606-7439|ldcranme@fredhutch.org|
22442336|NCT04434846|NIH|Jessica Manning|+85561856557|Jessica.manning@nih.gov|
22442337|NCT00409331|UT MD Anderson Cancer Center|Mark Chambers, DMD / Associate Professor|713-745-2672||
22442338|NCT00281658|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22442339|NCT00730028|San Francisco General Hospital, UCSF|Henry F. Chambers, MD|(415) 206 - 5437|hchambers@medsfgh.ucsf.edu|
22442340|NCT00615901|Memorial Sloan Kettering Cancer Center|Dr. Pamela Drullinksy|516-256-3955|drullinp@mskcc.org|
22396374|NCT03138538|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22396375|NCT04096274|Boise State University|Dr. Nathaniel Williams|2084263145|natewilliams@boisestate.edu|
22396376|NCT05030454|Washington University School of Medicine|Pamela Samson, M.D., MPHS|314-747-1786|psamson@wustl.edu|
22396377|NCT01462435|Iroko Pharmaceuticals, LLC|Daniel Solorio|267-546-3150|dsolorio@iroko.com|
22396378|NCT05092919|Perelman School of Medicine, University of Pennsylvania|Janet Audrain-McGovern, Ph.D. Director, Addictions, Department of Psychiatry|(215) 746-7145|audrain@pennmedicine.upenn.edu|
22396379|NCT01490684|King Abdulaziz Medical City|Dr Hasan Al-Dorzi|966535888632|aldorzih@yahoo.com|
22396380|NCT02709694|Hospital for Special Surgery|Dr. Lisa Mandl|(212) 774-2960|mandll@hss.edu|
22396381|NCT01979159|VA Salt Lake City Health Care System|Dr. Julie Wambaugh|801-582-1565|julie.wambaugh@va.gov|1363
22427034|NCT04059250|University of California San Francisco|Dr. Peter Rechmann|4155143225|Peter.Rechmann@ucsf.edu|
22427035|NCT03631641|The Ohio State University Comprehensive Cancer Center|Dr. John Hays|614-293-6529|John.Hays@osumc.edu|
22427036|NCT01050153|Denver Health Medical Center|Ernest E. Moore|303.602.1820|Ernest.Moore@dhha.org|
22442341|NCT01710137|University of Pennsylvania|Dr. Robert Schnoll|215-746-7143|schnoll@pennmedicine.upenn.edu|
22442342|NCT01734889|Swedish Orphan Biovitrum|Medical Director|+46 8 697 20 00|erik.brouwer@sobi.com|
22442343|NCT01206322|Beth Israel Deaconess Medical Center|Dr. Vera Novak|617-632-8680|vnovak@bidmc.harvard.edu|
22442344|NCT01324518|Orion Global Clinical Operations|Clinical Study Director||jutta.hanninen@orionpharma.com|
22442345|NCT01250496|Rush University Medical Center|Dr. Rami Doukky; Director of Nuclear Cardiology|312-942-4655|rami_doukky@rush.edu|
22442346|NCT00003590|SWOG Statistical Center|Study Statistician|(206)667-4623||
22442347|NCT00802113|Columbia University|Prakash Satwani, MD|(212) 305-0223|ps2087@cumc.columbia.edu|
22442348|NCT01589653|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22442349|NCT01491113|UCB|UCB Clinical Trials Call Center|+1 877 822 9493||
22442350|NCT01425463|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22442351|NCT04620213|Ocuphire Pharma, Inc.|Drey Coleman|8134041993|dcoleman@ocuphire.com|
22442352|NCT01332799|University of Iowa|Dr. Roberto Kalil|319-355-6564|roberto-kalil@uiowa.edu|
22442353|NCT03467152|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22381094|NCT02655692|Yale University|John Krystal|203.785.6396|john.krystal@yale.edu|
22381095|NCT00716079|The George Institute for Global Health|Professor Craig Anderson|+612 9993 4521|canderson@georgeinstitute.org.au|
22381096|NCT04978363|University of Iowa|Molly Pacha|319-290-7596|molly-pacha@uiowa.edu|
22381097|NCT01251614|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
22381098|NCT01032850|University of New Mexico Cancer Center|Dr. Yehuda Patt, MD|505-925-0405|yzpatt@salud.unm.edu|
22381099|NCT01876043|Institut Bergonié|Dr Antoine ITALIANO|+33556333333|a.italiano@bordeaux.unicancer.fr|
22381100|NCT01211665|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
22381101|NCT02685293|Pearl Therapeutics Inc.|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22381102|NCT00498186|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22381103|NCT02022462|University of Southern California|Dr. John Brekke|213-740-0297|brekke@usc.edu|
22381104|NCT03302156|UW School of Medicine and Public Health|Elizabeth Sadowski, MD|608-263-9028|esadowski@uwhealth.org|
22381105|NCT02390557|Massachusetts General Hospital, Mongan Institute for Health Policy|Lisa I. Iezzoni, MD, MSc|6176430657|liezzoni@mgh.harvard.edu|
22381106|NCT01711918|University of Iowa|Dr. Ron Schey|3193849756|ron-schey@uiowa.edu|
22381107|NCT03635112|Theravance Biopharma|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
22381108|NCT02002819|UCLA Mary S. Easton Center for Alzheimer's Disease Research|Dr. Keith Vossel|310-794-3665,|neuroeaston@mednet.ucla.edu|
22381109|NCT03006341|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22381110|NCT00674492|Center for Healthcare Organization and Implementation Research|Jack A. Clark, PhD|781.687.2937|Jack.Clark@va.gov|
22381111|NCT02950545|University of Virginia|Principal Investigator|434-924-8021|djc4f@virginia.edu|
22381112|NCT01950260|Mayo Clinic|Dr. Marius N. Stan|507-284-2463|stan.marius@mayo.edu|
22381113|NCT01882062|Inserm U1127|Dr Fanny MOCHEL|+33 (0)1 5727 46 78|fanny.mochel@upmc.fr|
22381114|NCT03283553|Johns Hopkins University|Research Program Manager|410-614-7910|dechava1@jhu.edu|
22381115|NCT03686683|Dendreon Corporation|Director, Clinical Operations|206-455-2476|clinical@dendreon.com|
22381116|NCT01770860|Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc.|Associate Director, Clinical Research|973-385-7984||
22427037|NCT03159143|University of Pittsburgh|Leonard Appleman, MD|412-648-6538|applemanlj@upmc.edu|
22442354|NCT00945906|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22442355|NCT04583709|Geisinger Heart Institute|Pugazhendhi Vijayaraman|5708085444|pvijayaraman1@geisinger.edu|
22411684|NCT04680052|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22442356|NCT01236547|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22442357|NCT01120782|Johnson & Johnson Vision Care|Ross Franklin, OD|1-904-443-1379|RFrankl1@its.jnj.com|
22442358|NCT04144127|Emory University|Dr. Felipe Lobelo|(770) 488-5737|felipelobelo@emory.edu|
22442359|NCT01767142|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
22442360|NCT03317405|Northwestern University|Seema A. Khan|312-503-4236|s-khan2@northwestern.edu|
22442361|NCT00635219|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
22442362|NCT04093024|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22442363|NCT03145818|Providence VA Medical Center|James Rudolph, MD, Principal Investigator|401-273-7100|James.Rudolph@va.gov|6406
22442364|NCT01541397|The University of Texas Health Science Center at Houston|Heather Saavedra|713-500-7098|Heather.Saavedra@uth.tmc.edu|
22442365|NCT04233918|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22381117|NCT01528709|Lynn Heart and Vascular Institute, Boca Raton Regional Hospital|Dr. Alexander Kulik|5619556300|alex_kulik@yahoo.com|
22381118|NCT05124899|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
22381119|NCT00714233|University of Rochester|Kathleen M Hoeger MD MPH|5852757891|Kathy_hoeger@urmc.rochester.edu|
22381120|NCT03432533|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22381121|NCT00945477|Illinois CancerCare, P.C.|James Knost, M.D.|309-243-3000|jknost@illinoiscancercare.com|
22381122|NCT03587194|Psoriasis Treatment Center of Central New Jersey|Ashley Reed|6094434500|ashley.reed@schweigerderm.com|
22381123|NCT02359058|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22381124|NCT00797225|AbbVie|Global Medical Services|800-633-9110||
22381125|NCT02408965|UCSF|Jennifer Kerns|4152068715|Jennifer.kerns@ucsf.edu|
22381126|NCT02148809|HospitalSS|Dr. Friedrich Boettner|2127742127|boettnerf@HSS.edu|
22381127|NCT01008748|UT MD Anderson Cancer Center - Clinical Research Operations|Dr. Sharon Giordano, MD/Chair, Health Svcs Research-Clinical|713-563-0020|sgiordan@mdanderson.org|
22381128|NCT03008122|Saint Louis University|Sarah George, MD|314-977-9035|sarah.george@health.slu.edu|
22381129|NCT04159896|Karmanos Cancer Institute|Dr. Elisabeth Heath|313.576.8734|heathe@karmanos.org|
22381130|NCT01222247|The George Washington University Biostatistics Center|Elizabeth Thom, Ph.D.|301-881-9260|e_thom@bsc.gwu.edu|
22381131|NCT04529538|PATH|Chris Gast, Ph.D.|206-285-3500|cgast@path.org|
22381132|NCT03669042|Artivion, Inc.|Karen Sylvester|7704193355|karen.sylvester@artivion.com|
22381133|NCT03437668|UCaliforniaLA|Stephen R Marder|3102670221|smarder@mednet.ucla.edu|
22381134|NCT01822821|Cleveland Clinic|Nicole Zimmerman|216-636-9449|zimmern2@ccf.org|
22381135|NCT03298815|University of Utah|Catherine Lee, MD|206-667-4922|Catherine.Lee@hci.utah.edu|
22381136|NCT03251378|HUTCHMED International|William Schelman, MD, PhD|973-306-4490|albertof@hutch-med.com|+1
22381137|NCT04996069|Tufts University School of Dental Medicine|Mabi Singh|6176363931|mabi_l.singh@tufts.edu|
22381138|NCT00935792|Mayo Clinic|Timothy Call, M.D.|5076682050|Call.Timothy@mayo.edu|
22381139|NCT02322775|AstraZeneca Research and Development|Mitchell Goldman, Global Clinical Leader Benralizumab|301 398 0323|Mitchell.Goldman@astrazeneca.com|+1
22381140|NCT05780047|Million Marker Wellness, Inc.|Carol Kwiatkowski, VP of Research|510-305-5690|carol@millionmarker.com|
22396382|NCT03281668|University of North Carolina at Chapel Hill/Thurston Arthritis Research Center|Yvonne Golightly, PhD|919-966-0566|golight@email.unc.edu|
22396383|NCT01543152|Sangamo Therapeutics|Medical Monitor|510-970-6000|clinicaltrials@sangamo.com|
22411685|NCT01557595|UAB|Dr. Rachel Fargason|205-934-5151|rfargason@uab.edu|
22411686|NCT00759148|Alcon Research, Ltd.|Clinical Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22381141|NCT03109015|Duke University|Michael Harrison, MD|919-668-8108|michael.harrison@duke.edu|
22381142|NCT01007552|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|groman@appliedstats.com|847
22381143|NCT02451423|University of California, San Francsico|Dr. Lawrence Fong, MD|(415) 514-3160|lawrence.fong@ucsf.edu|
22381144|NCT04019561|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22381145|NCT05781490|Lument AB|Dr Jan Marsal|+46709822008|jan.marsal@med.lu.se|
22381146|NCT00308061|University of Bamako Faculty of Medicine, Mali|Mahamadou A. Thera, MD MPH|223-222-1809|mthera@mrtcbko.org|
22381147|NCT01521143|Prima BioMed, Ltd.|Marc Voigt|49 173 6771602|marc.voigt@primabiomed.com.au|
22381148|NCT00741273|Repros Therapeutics|Jennifer Wike|2817193402|jwike@reprosrx.com|
22381149|NCT03212365|University of Utah|Christopher Pannucci, MD|801 581 2121|christopher.pannucci@hsc.utah.edu|
22381150|NCT00333138|Novartis pharmaceuticals|Study director|862-778-8300||
22381151|NCT03005288|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22381152|NCT04011033|BeijingYouan Hospital|Lu Jun|+86-010-83997153|lujun98@ccmu.edu.cn|
22381153|NCT01823341|Jaeb Center for Health Research|Judy Sibayan, MPH, CCRP|813-975-8690|jsibayan@jaeb.org|
22381154|NCT01342887|Fred Hutch Cancer Research Center|Roland B. Walter, MD, PhD, MS||rwalter@fredhutch.org|
22381155|NCT00663962|Queen's University|Pregabalin and Post-thoracotomy pain|(613) 548-7827|zamoraj@kgh.kari.net|
22381156|NCT03658629|Novavax Inc.|Novavax Customer Service Center|1-844-Novavax (668-2829)|Clinicaltrials@novavax.com|
22442366|NCT01290796|Bard Medical Division|Jaime Ritter, MPH, CCRP, CIC|770-784-6437|jaime.ritter@crbard.com|
22381157|NCT01125774|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22381158|NCT03323151|ECOG-ACRIN Statistical Center|Opeyemi Jegede, Statistician|617-582-7613|ojegede@ds.dfci.harvard.edu|
22442367|NCT00329797|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22381159|NCT01449929|GlaxoSmithKline|GSK Response Center|866-435-7343||
22381160|NCT03253653|San Diego State University Research Foundation|Dr. Nada Kassem|619-370-7488|Nkassem@sdsu.edu|
22442368|NCT00776919|GlaxoSmithKline|GSK Response Center|866-435-7343||
22396384|NCT02114164|OhioHealth|Dr. Oscar Martinez|(614) 544-8104|oscar.martinez@ohiohealth.com|
22396385|NCT01838616|Grünenthal GmbH|Study Director|+49 241 569|Clinical-Trials@grunenthal.com|3223
22396386|NCT00366275|Division of Hematology, Fondazione IRCCS Policlinico San Matteo, University of Pavia|Luca Arcaini MD|+390382501308|luca.arcaini@unipv.it|
22396387|NCT01227187|George Washington University|Lakhmir Chawla|202-715-4752|lchawla@mfa.gwu.edu|
22396388|NCT01575106|Massachusetts General Hospital|Jian Kong|617-726-7893|JKONG2@mgh.harvard.edu|
22396389|NCT01566773|Pearl Therapeutics Inc|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
22396390|NCT00833053|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||clinicaltrialsdisclosure@merck.com|
22396391|NCT01206062|Wake Forest University Health Sciences|David Reboussin|336-716-6844|drebouss@wakehealth.edu|
22396392|NCT01901575|NYU Langone Medical Center|Avrimin M. Kogan, MD|(212) 263-5072|Avrimin.Kogan@nyumc.org|
22396393|NCT00762892|UT Health Science Center Houston|Tanvir Bell, MD|713-500-6759|Tanvir.K.Bell@uth.tmc.edu|
22396394|NCT02234479|University of Maryland|Elizabeth Nichols, MD|410-328-2324|enichols1@umm.edu|
22396395|NCT01846728|University of Colorado Anschutz Medical Campus|Edward Melanson, PhD|303-724-0935|ed.melanson@cuanschutz.edu|
22396396|NCT02902081|University of Chicago|Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
22396397|NCT01671111|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22396398|NCT04792567|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
22396399|NCT02201420|Navidea Biopharmaceuticals, Inc.|Dr. Frederick O. Cope, Chief Scientific Officer|614-793-7500|fcope@navidea.com|140
22396400|NCT01490814|Medtronic|Ralf Meyer|+49215981490|ralf.meyer@medtronic.com|
22396401|NCT01537198|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
22396402|NCT01127659|University of Buffalo|Paresh Dandona|716) 961-9900|pdandona@kaleidahealth.org|
22396403|NCT00496730|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
22396404|NCT01314963|Stanford Univeristy Medical Center|Craig Levin, PhD; Professor of Radiology (Molecular Imaging Program at Stanford/Nuclear Medicine)|650-736-0449|cslevin@stanford.edu|
22396405|NCT03769246|Columbia University Medical Center|Dr. Anna-Christina Bevelaqua|(212) 342-0085|ab3302@cumc.columbia.edu|
22396406|NCT00113074|University of Iowa|Mark Vander Weg|319-338-0581|mark-vanderweg@uiowa.edu|7717
22396407|NCT03680911|University of Miami|Roy R. Casiano, MD|305-243-5290|rcasiano@med.miami.edu|
22396408|NCT00889226|CMC|Dr. Hoyoung Sohn|82-2-222-2222|abc@snu.ac.kr|3333
22396409|NCT00258011|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22396410|NCT01921751|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22396411|NCT03962738|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22396412|NCT00814671|Johns Hopkins University|Susan Dorman|410-955-1755|dsusan1@jhmi.edu|
22396413|NCT04556136|Madigan Army Medical Center|Dr. Mary McCarthy|253-968-3695|mary.s.mccarthy1.civ@health.mil|
22396414|NCT01507779|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22396415|NCT00935272|Medicis Global Services|Heather M Corey|480-291-5981|hcorey@medicis.com|
22396416|NCT03492554|Apple|Health Technology Clinical Operations|1-866-905-5303|htclinicalquestions@apple.com|
22396417|NCT01478360|Novartis Pharmaceuticals|Study Director|862-778-8300||
22411687|NCT01073020|Joslin Diabetes Center|Mary Elizabeth Patti MD|617 309 1966|mary.elizabeth.patti@joslin.harvard.edu|
22411688|NCT04642950|Nobel Pharma Co. Ltd.|Information Desk|+81-3-6670-3800|taniguchi.masaki@nobelpharma.co.jp|
22427038|NCT02105324|Massachusetts General Hospital|Dr. Steven J. Russell|617.726.1848|sjrussell@partners.org|
22396418|NCT01591317|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22396419|NCT04340557|Sharp HealthCare|Matthew Geriak, PharmD|858-939-3717|matthew.geriak@sharp.com|
22427039|NCT02124824|VAMC SLC|Scott Capps|8015821565|Scott.Capps@hsc.utah.edu|
22427040|NCT03408899|Johns Hopkins University|Craig Hendrix, MD|4109559707|chendrix@jhmi.edu|
22427041|NCT02659501|Loma Linda University, Department of Plastic Surgery|Saba Motakef, Resident Physican|714-925-8932|smotakef@llu.edu|
22427042|NCT01248416|Nemours Children's Clinic|Dr. Nelly Mauras|904-697-3674|nmauras@nemours.org|
22396420|NCT01221727|Amgen Inc.|Study Director|866-572-6436||
22396421|NCT01010633|Bausch & Lomb Incorporated|Tuyen Ong, MD, MRCOphth|(973) 360-6389|tuyen.ong@bausch.com|
22442298|NCT00964171|Institut Bergonié|Dr Marianne Fonck|05.56.33.32.42|m.fonck@bordeaux.unicancer.fr|
22442299|NCT01247272|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22442300|NCT04615832|Fisher & Paykel Healthcare Ltd.|Bhavi Ogra|+64 9 574 0123|bhavi.ogra@fphcare.co.nz|7882
22442301|NCT03179319|Brown University|Katie Biello|401-863-3082|katie_biello@brown.edu|
22442302|NCT00635999|Penn State University|Michelle G. Newman|814-863-1148|mgn1@psu.edu|
22442303|NCT00711477|Orexigen Therapeutics, Inc.|Senior Vice President, Head of Global Development|(858) 875-8600|MedInfo@Orexigen.com|
22442304|NCT02636361|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22442305|NCT02695420|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22442306|NCT02448641|SanBio, Inc.|Bijan Nejadnik M.D.; Chief Medical Officer|650-625-2205|Bijan.Nejadnik@sanbio.com|
22442307|NCT02929407|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
22442308|NCT00916929|St Jude Medical|Tamara Shipman|408 522-6410|tshipman@sjm.com|
22442309|NCT00850421|Park Nicollet Institute|Park Nicollet Institute|952-993-3123||
22442310|NCT03037580|United Therapeutics|Louis Holdstock|919-425-8866|lholdstock@unither.com|
22442311|NCT02036853|Cook Children's Health Care System|Director of Research Operations|682-885-2103|CookChildrensResearch@cookchildrens.org|
22442312|NCT00228553|Cephalon|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
22442313|NCT01309282|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22396422|NCT02941926|Novartis Pharmaceuticals|Study director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22396423|NCT00097773|Seattle Childrens Hospital|Bonnie Ramsey, MD|206-987-5725|bonnie.ramsey@seattlechildrens.org|
22381161|NCT01489176|University of Nebraska Medical Center|Thomas R Porter|402-559-5156|trporter@unmc.edu|
22381162|NCT00079937|Novartis Pharmaceuticals|Study Director|862-778-8300||
22396424|NCT01494350|Institut Pasteur of Tunis|Afif Ben Salah, MD, PhD|011-216-71-792-429|afif.bensalah@pasteur.rns.tn|
22396425|NCT00474708|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22396426|NCT03700320|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
22396427|NCT04305275|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
22396428|NCT03061175|Rutgers Cancer Institute of New Jersey|Dr. Sharon Manne, Associate Director, Population Science|732-235-6759|mannesl@cinj.rutgers.edu|
22396429|NCT00760669|Clinical Research Team, Medical Affairs, Medical Dept. Janssen Korea|Clinical Research Associate|+82-2-2094-4879||
22396430|NCT02456662|University of Rochester|Sarah Betstadt, MD, MPH|585-276-5367|sarah_betstadt@urmc.rochester.edu|
22396431|NCT00504153|The University of Chicago|Dr. Hedy Kindler|(773) 702-0360|hkindler@medicine.bsd.uchicago.edu|
22396432|NCT01771055|University of Louisville|Dr. Jason Smith|502-852-5675|josmit19@louisville.edu|
22396433|NCT04391036|University of Pittsburgh Medical School|Dr. Leslie Meyn|412-641-4233|meynla@mwri.magee.edu|
22396434|NCT01889238|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22396435|NCT04887155|UCLA Semel Institute|Marc Weintraub|3108251300|mjweintraub@mednet.ucla.edu|
22396436|NCT02717754|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22396437|NCT00482703|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22396438|NCT03548285|University of Texas Southwestern Medical Center|David Sher, MD|214-645-8525|david.sher@utsouthwestern.edu|
22396439|NCT00667823|Actelion Pharmaceuticals Ltd|Senior Clinical Leader PH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22396440|NCT04360551|University of Hawaii at Manoa John A Burns School of Medicine|Cecilia M. Shikuma MD|808 692-1328|shikuma@hawaii.edu|
22396441|NCT05338515|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22396442|NCT03496012|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22396443|NCT01524198|King Saud University|Dr. Abdullah Alangari|966506287276|alangari100@gmail.com|
22396444|NCT02232802|Chemi SpA (Part of Italfarmaco Group)|Paolo Bettica, MD|+39 02 64431|p.bettica@italfarmaco.com|
22396445|NCT03650842|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-5817|Joseph.Tobias@nationwidechildrens.org|
22411689|NCT00094302|New England Research Institutes|Brian Harty|617-972-3224|bharty@neriscience.com|
22396446|NCT00634634|Cancer Institute of New Jersey|Dr. Deborah Toppmeyer|732-235-5203|toppmede@cinj.rutgers.edu|
22396447|NCT00885703|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22396448|NCT00346073|GlaxoSmithKline|GSK Response Center|866-435-7343||
22396449|NCT02204150|Mass General Hospital|Gary Tearney|617-724-2979|gtearney@partners.org|
22396450|NCT03600142|University of Utah|Dr. Melissa Watt|8015817201|melissa.watt@hsc.utah.edu|
22396451|NCT03887533|National Institute of Child Health and Human Development (NICHD)|Dr. Forbes Porter|301-435-4432|fdporter@mail.nih.gov|
22396452|NCT04639973|Baylor College of Medicine|Cara Buskmiller, MD|832-824-1000|cara.buskmiller@bcm.edu|
22396453|NCT02053168|BD Interventional - Surgery|Dawn Heimer|401-825-8681|Dawn.Heimer@crbard.com|
22396454|NCT02687542|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22396455|NCT00636675|University of North Carolina Chapel HIll|Ruth A. Anderson|919-966-8785|rutha@email.unc.edu|
22396456|NCT00857532|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22396457|NCT00096785|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22396458|NCT00176605|Rutgers Cancer Institute of New Jersey|Dr. Mark Stein|732-235-8675|steinmn@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
22396459|NCT03785925|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
22411690|NCT03329027|Vibrantgastro|Clinical trials manager|046663322|service@vibrantgastro.com|
22411691|NCT05780541|University of Minnesota|Greg Grandits|651-528-9491|greg-g@ccbr.umn.edu|
22411692|NCT04089982|Duke University|James M. Davis, MD|919-668-5055|james.m.davis@duke.edu|
22411693|NCT02761980|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22411694|NCT00101582|Biovitrum|Hans Olivecrona, MD PhD|+46 8 697 20 00|hans.olivecrona@sobi.com|
22411695|NCT01907087|BioMarin Pharmaceutical Inc.|Peter Slasor/Sr Director, Biostatistics, Global Clinical Sciences|415-506-6765|PSlasor@bmrn.com|
22411696|NCT01919190|Pacira Pharmaceuticals, Inc.|Paci|1-855-793-9727|MedInfo@pacira.com|
22411697|NCT04064229|ivWatch, LLC|Jason Naramore|1-855-489-2824|jason.naramore@ivwatch.com|7019
22411698|NCT01082952|King Saud University|Dr. Rabih Halwani|00966551307134|rhalwani@ksu.edu.sa|
22411699|NCT02337933|INSTITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
22411700|NCT00100165|University of Colorado, Denver|Dr. Robert Freedman|303 724-4940|robert.freedman@ucdenver.edu|
22411701|NCT02850068|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
22411702|NCT01829464|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22411703|NCT03996603|University of Alabama at Birmingham|Kyle Norris, MD Principal Investigator|(205) 934-1704|kyleparkernorris@gmail.com|
22411704|NCT02743702|University of Seville|Dr. Jose J. Jimenez-Rejano|+34667309369|jjjimenez@us.es|
22381163|NCT02857283|UNC Center for Environmental Medicine, Asthma and Lung Biology|Michelle Hernandez, MD|919-843-5383|michelle_hernandez@med.unc.edu|
22381164|NCT00093795|NSABP Foundation, Inc|Director, Department of Regulatory Affairs|412-339-5300|regulatory@nsabp.org|
22381165|NCT00613301|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22442369|NCT02371941|The University of Tennessee Health Science Center|Dr. Jay Lieberman|901-287-7337|jlieber1@uthsc.edu|
22381166|NCT00961805|Federal University of Sao Paulo|Andreia S Baptista, PT|551155764239|deiasalvador1@yahoo.com.br|
22411705|NCT00635778|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22411706|NCT00755326|University of Maryland Center for Integrative Medicine|Brian M. Berman|410706-6181|bberman@som.umaryland.edu|
22411707|NCT03106870|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
22411708|NCT01338636|Brigham and Women's Hospital Heart and Vascular Center|Aaron B. Waxman|617-525-9733|abwaxman@partners.org|
22411709|NCT02385526|Cyberonics, Inc.|Peter Sears, Clinical Project Manager|(281) 228-7597|peter.sears@cyberonics.com|
22411710|NCT00662025|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22427043|NCT04745351|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22442370|NCT01472718|Cardiac Catheterization Laboratory, Cardiothoracic and Vascular Department, Azienda Ospedaliero-Universitaria Pisana,|Marco De Carlo, MD, PHD|+39 050995326|marcodecarlo@gmail.com|
22411711|NCT01689974|New York University School of Medicine|Sylvia Formenti, MD|646.962.4073|formenti@med.cornell.edu|
22411712|NCT01333033|Alliance for Clinical Trials in Oncology|Karyn Goodman, M.D.|(212) 639-3983|goodmank@mskcc.org|
22411713|NCT03588390|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22411714|NCT00384033|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22411715|NCT01544166|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22411716|NCT01842958|Straumann USA, LLC|Kelly Jork|978-747-2533|kelly.jork@straumann.com|
22411717|NCT01829477|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22411718|NCT00897897|Philips Healthcare|Director, Clinical and Regulatory Affairs|425-487-7665|sarah.baxter@philips.com|
22427044|NCT02014272|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22427045|NCT03636256|US Biotest, Inc.|Dr. Gere diZerega|805.595.1300|gere.dizerega@usbiotest.com|
22442371|NCT02093819|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22442372|NCT01469715|University of Virginia|Stacey Anderson, MD||sg4c@virginia.edu|
22442373|NCT01901250|Case Western Reserve University|Dr. Suchitra Nelson|216-368-3469|sxn15@case.edu|
22442374|NCT03091348|Men|Abraham Morgentaler|617-277-5000|research@menshealthboston.com|
22442375|NCT00824733|The Ohio State University Comprehensive Cancer Center|Bhuvaneswari Ramaswamy, MD|614-293-8858|Bhuvaneswari.Ramaswamy@osumc.edu|
22396460|NCT02187471|Daiichi Sankyo, Inc.|Daiichi Sankyo US Contact for Clinical Trial Results|1-908-992-6400|CTRinfo@DSI.com|
22396461|NCT00957528|The University of Texas Medical Branch at Galveston|Randall Urban, M.D., Professor of Medicine|409- 772-1176|rurban@utmb.edu|
22396462|NCT02318667|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22396463|NCT01673919|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22396464|NCT00415857|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes M.D./Professor|713/792-7305|eharrison@mdanderson.org|
22396465|NCT01735279|Department of Psychobiology, Universidade Federal de São Paulo (UNIFESP), Rua Napoleão de Barros, São Paulo , Brazil|Md PhD José Carlos F. Galduróz|+55 11 2149 0000|galduroz@unifesp.br|
22442376|NCT03574181|Boston Medial Center|Dr. Eric Devine|617-638-7888|eric.devine@bmc.org|
22396466|NCT00294060|Medtronic CRDM|P3 Study Team|800-328-2518|medtroniccrmtrials@medtronic.com|
22381167|NCT01684046|Alcon Research, Ltd.|Jessie Lemp, GMA Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22396467|NCT00806195|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22381168|NCT00587288|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22381169|NCT00762463|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22396468|NCT02210065|U.T. MD Anderson Cancer Center|Dr. Betul Oran / Associate Professor, Stem Cell Transplantation|713-745-2820|BOran@mdanderson.org|
22396469|NCT03634397|Penn State College of Medicine|Dr Candice Maenza|7175310003|cmaenza@pennstatehealth.psu.edu|283146
22396470|NCT04748653|University of California San Francisco|Alison El Ayadi, Associate Professor|415-476-5877|alison.elayadi@ucsf.edu|
22396471|NCT03901105|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
22411719|NCT03465891|Memorial Sloan Kettering Cancer Center|Dr. Lia Palomba|646-608-3711|palombam@mskcc.org|
22411720|NCT02737306|CytoDyn|Joseph Meidling Executive Director Clinical Operations|(360) 980-8524|jmeidling@cytodyn.com|
22411721|NCT03361423|Theranica Bio-Electronics Ltd|Dr Dagan Harris. VP Clinical & Regulatory Affairs|+972723909755|daganh@theranica.com|
22411722|NCT00818623|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22411723|NCT00299156|The University of Texas MD Anderson Cancer Center|Hagop Kantarjian, MD /Professor|713-792-7026|eharrison@mdanderson.org|
22411724|NCT01166568|Refocus Group, Inc.|Director of Regulatory & Quality|214-368-0200|lstewart@refocus-group.com|431
22411725|NCT00903383|Lexicon Pharmaceuticals, Inc.|Joel Freiman, MD, MPH|281-863-3070||
22411726|NCT01684410|Grifols Therapeutics Inc.|Henry Li, PhD|919-316-6042|henry.li@grifols.com|
22411727|NCT01195922|University of California San Diego|D. J. Silvio Gutkind|(858) 534 5980|sgutkind@ucsd.edu|
22411728|NCT01934296|University of California San Francisco|Dr. Sarah Wang, Director of Clinical Research|416-353-7885|Sarah.Wang@ucsf.edu|
22411729|NCT00482547|C. R. Bard|Vanessa Dell Clinical Research Scientist|908-277-8094|vanessa.dell@crbard.com|
22411730|NCT02015793|AbbVie|Global Medical Services|800-633-9110||
22411731|NCT00320593|Jaeb Center for Health Research|Raymond Kraker, MSPH|813-875-8690|pedig@jaeb.org|
22396472|NCT01519934|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
22396473|NCT02446314|The University of Reading|Prof Claire Williams|0118 378 7540|claire.williams@reading.ac.uk|
22396474|NCT00326209|Bausch Health Americas, Inc.|Director of Clinical Operations||lindsey.mathew@bauschhealth.com|
22396475|NCT02138617|UNC Lineberger Comprehensive Cancer Center|Melahat Canter|(919) 962-0000|Melahat_Canter@med.unc.edu|
22396476|NCT00529451|Novartis Pharmaceuticals|Study Director|862-778-8300||
22396477|NCT02566577|Emory University|Arshed A. Quyyumi|404-727-3655|aquyyum@emory.edu|
22396478|NCT01009034|Maple Leaf Research|Tony Antoniou|4164657936|tantoniou@smh.toronto.on.ca|
22396479|NCT01022242|Uppsala University Hospital|Monica Wiig||monica.wiig@akademiska.se|
22396480|NCT02243865|Chordate|Dr Jan-Åke Åkesson|+46 8 40015586|info@chordate.com|
22396481|NCT03654976|ALK-Abelló A/S|Senior Director Global Clinical Development|0045 45747576|clinicaltrials@alk.net|
22396482|NCT00117598|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22396483|NCT01235793|Cedars-Sinai Medical Center|Yuliya Linhares, MD|310-423-4646|Yuliya.Linhares@cshs.org|
22396484|NCT02179671|AstraZeneca|Phillip Dennis|1 + 301-398-5549|Phillip.Dennis@astrazeneca.com|
22396485|NCT00545064|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22411732|NCT01076166|Abbott|Global Medical Services|1-800-633-9110||
22411733|NCT02087059|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22411734|NCT03979209|Rush UMC|Bobby Tajudeen, MD|312-942-6100|Bobby_Tajudeen@rush.edu|
22411735|NCT04281485|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22411736|NCT01878656|Chung-Ang University Hospital|Dr. Chong Wha Baek|82-2-6299-2579|nbjhwa@naver.com|
22427046|NCT00879190|Stanford University, Department of Obstetrics & Gynecology|Anna Girsen, Manager of Maternal-Fetal Medicine Research Operations|(650) 725-0499|agirsen@stanford.edu|
22411737|NCT01211769|UNIFESP|José Carlos Fernandes Galduróz|55 11 21490168|galduroz@psicobio.epm.br|
22442377|NCT02969655|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22442378|NCT03753789|Ethicon|Erin Meyers|937-681-0322|eprifog1@its.jnj.com|
22411738|NCT04749524|Intelligent Hearing Systems Corp|Dr. Rafael E. Delgado|305-668-6102|redelgado@ihsys.com|
22411739|NCT01709383|Georgetown University|Elizabeth H. Lacey, PhD, Study Coordinator|202-877-1124|ehl4@georgetown.edu|202
22411740|NCT01193517|UT MD Anderson Cancer Center|Dr. Michael J Overman/ Professor, GI Medical Oncology|713-792-2828|moverman@mdanderson.org|
22411741|NCT01688037|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22411742|NCT02099266|University of Kansas Cancer Center|Dr. Omar Aljitawi|(913) 588-6030|SWILLIAM@kumc.edu|
22411743|NCT01841606|UBC Department of Anesthesia - BC Women's Hospital|Mr. James Taylor|604-875-2424|james.taylor1@phsa.ca|6076
22411744|NCT03065283|Department of Physical Therapy|Prof. Dr. Pedro Lima|558533668091|pedrolima@ufc.br|
22411745|NCT02525029|University of Minnesota, Masonic Cancer Center|Dr. Shernan Holtan, MD|(612) 626-5654|sgholtan@umn.edu|
22411746|NCT02638090|Moffitt Cancer Center|Dr. Jhanelle E. Gray|813-745-7282|Jhanelle.Gray@Moffitt.org|
22411747|NCT03889756|Yale University|Dr. Michael Bloch|203 7374809|michael.bloch@yale.edu|
22411748|NCT02929979|VA Palo Alto Healthcare System|Adrienne Heinz|9196306847|adrienneheinz@gmail.com|
22442379|NCT01012089|University of Oklahoma College of Pharmacy|Teresa Lewis Pharm D|405-271-2859|Teresa-Lewis@ouhsc.edu|
22411749|NCT02958956|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22411750|NCT00747552|University of Utah|Donald Null M.D.|801.588-3865|donald.null@imail.org|
22411751|NCT05590585|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22411752|NCT01673009|Indiana University|Kent Robertson MD PhD|317-944-8784|krobert@iu.edu|
22411753|NCT04161144|Medical University of South Carolina|Dr. Michael Saladin|8437925306|saladinm@musc.edu|
22411754|NCT03617692|University of Colorado Boulder|Angela Bryan, PhD|3034929549|Angela.Bryan@Colorado.EDU|
22411755|NCT02848599|University Hospital Osijek, Croatia|Dr. Gordana Kristek|+385915115746|gordanaldrmed@yahoo.com|
22427047|NCT00723229|University of Washington|Dr. Christine Johnston|206-520-4340|cjohnsto@u.washington.edu|
22427048|NCT02337491|Dana-Farber Cancer Institute|David A. Reardon, MD|617-632-2166|dreardon3@partners.org|
22427049|NCT01432951|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22427050|NCT02900352|Virginia Commonwealth University|Dr. Albert Arias|8048285793|albert.arias@vcuhealth.org|
22442380|NCT00597597|Rush University Medical Center|Ruta Rao|312-942-3324|ruta_d_rao@rush.edu|
22442381|NCT00853567|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
22427051|NCT00960193|Mutual Pharmaceutical Company, Inc.|Medical Drector|215-697-1743|clinicaltrials@urlmutual.com|
22427052|NCT03785028|University of Wisconsin - Madison|Brad Postle, PhD|608-262-4330|postle@wisc.edu|
22427053|NCT00785356|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
22380951|NCT00359619|GlaxoSmithKline|GSK Response Center|866-435-7343||
22396486|NCT01775735|Boston Scientific|Director, Clinical Sciences and Scientific Communication||Roshini.Jain@bsci.com|
22396487|NCT05093322|HUTCHMED Limited|Nick Lawn|+44 7826 422448|nickl@hutch-med.com|
22411756|NCT04828161|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
22411757|NCT03093454|Duke Health|Scott Hollenbeck, MD|919-681-5079|scott.hollenbeck@duke.edu|
22411758|NCT02524379|The Ohio State University|Shelby Miracle|614-366-1648|shelby.miracle@osumc.edu|
22411759|NCT01884025|Central Arkansas Veterans Healthcare System|Dr. Kristen Viverito|501-257-1699|KRISTEN.VIVERITO@VA.GOV|
22442382|NCT02654769|Teva Pharmaceuticals Inc., USA|Senior Director, Clinical R&D|1-888-483-8279|USMedinfo@tevapharm.com|
22380952|NCT04672460|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_inquires@pfizer.com|
22380953|NCT03575962|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22411760|NCT05380635|Soligenix, Inc.|Richard Straube, MD/Chief Medical Officer|609-538-8200|rstraube@soligenix.com|
22411761|NCT02854436|Janssen Research & Development, LLC|EXECUTIVE MEDICAL DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22411762|NCT00506909|UCSD|David Feifel||dfeifel@kadimanp.com|
22411763|NCT03758365|MC2 Therapeutics|Birgitte Vestbjerg|+45 2077 2575|bve@mc2therapeutics.com|
22411764|NCT01700621|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22411765|NCT02985151|Dermatology SLUCare Physician Group|Research Manager/Coordinator|314 977-1794|rhonda.lebbing@health.slu.edu|
22411766|NCT02300025|Genentech|Medical Communications|800-821-8590|genentech@druginfo.com|
22381170|NCT00797862|Novartis Pharmaceuticals|Study Director|862- 778- 8300||
22381171|NCT00531479|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22411767|NCT04992052|Northwell Health System|Nancy Dengler, Clinical Research Nurse|516-496-2637|ndengler@northwell.edu|
22411768|NCT05425966|University of California San Francisco|Lauren Haack, PhD|415-502-8060|lauren.haack@ucsf.edu|
22411769|NCT04756141|Mayo Clinic|Adrian G. Dumitrascu, M.D.|904-956-0081|Dumitrascu.Adrian@mayo.edu|
22411770|NCT00443352|Thomas Jefferson University|William B Young, MD|215-955-2243|william.b.young@jefferson.edu|
22411771|NCT02843074|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
22411772|NCT01564758|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22411773|NCT01186978|Duke University Health System|Assistant Research Practice Manager (ARPM) for Clinical Trials|919-668-5211|Jennifer.Mewshaw@duke.edu|
22411774|NCT01227668|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22427054|NCT01206465|University of Nebraska Medical Center|Jean L Grem|402-559-5166|jgrem@unmc.edu|
22427055|NCT03712280|Mallinckrodt|Medical Information Call Center|800-844-2830|medinfo@mnk.com|
22427056|NCT01245101|University of Miami|Rafael E. Campo|305-689-7030|rcampo@med.miami.edu|
22427057|NCT03093181|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22411775|NCT04317599|Pierre Fabre|Project leader|+33(0)1 49 10 81 84|farida.beghdad@pierre-fabre.com|
22411776|NCT04738279|NorthShore University HealthSystem|Nirav Shah, MD, MPH|(847) 570-1236|nshah2@northshore.org|
22411777|NCT01072331|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22411778|NCT00891878|Mayo Clinic|Aminah Jatoi, M.D|(507) 284-5352|jatoi.aminah@mayo.edu|
22411779|NCT01360450|Johns Hopkins Medical Institution|Estelle B Gauda|4106140151|egauda1@jhmi.edu|
22411780|NCT02115256|Icahn School of Medicine at Mount Sinai|Dr. Yaakov Beilin|212-241-7467|yaakov.beilin@mountsinai.org|
22411781|NCT04616417|University of Illinois at Chiago|Principal Investigor|312-355-3245|Sana.Salih@bsd.uchicago.edu|
22411782|NCT01297257|Clinical Research Director|Frank van Leeuwen, M.D.|+31433566622|frank.van.leeuwen@medtronic.com|
22411783|NCT02427607|Eisai Co., Ltd.|Hidetaka Hiramatsu|+81-3-3817-5245|esi_medinfo@eisai.com|
22411784|NCT03211416|Roswell Park Comprehensive Cancer Center|Kris Attwood|8772757724|Kris.Attwood@roswellpark.org|
22411785|NCT01789320|Clearside Biomedical, Inc.|Thomas Ciulla, MD|(678) 392-2318|thomas.ciulla@clearsidebio.com|
22411786|NCT00494806|MD Anderson Cancer Center|Robert L. Massey, PhD, RN|713-792-3704|rlmassey@mdanderson.org|
22411787|NCT03199274|Thomas Jefferson University|John Eisenbrey, PhD|(215) 503-5188|john.eisenbrey@jefferson.edu|
22411788|NCT06016725|School of Health and Rehabilitation Sciences, College of Medicine, The Ohio State University|Dr. Jessica Krok-Schoen, Associate Professor|8133686470|Jessica.krok@osumc.edu|
22411789|NCT02407756|Regeneron Pharmaceuticals, Inc.|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
22411790|NCT02387814|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22411791|NCT03621085|University of Texas Southwestern Medical Center|Dr. Craig Crandall|2143454623|craigcrandall@texashealth.org|
22411792|NCT04071769|Duke University|Robert M. Tighe, MD|919-684-4894|robert.tighe@duke.edu|
22411793|NCT02743442|Fondation Ophtalmologique A. de Rothschild|Dr Amélie Yavchitz (deputy head of the clinical research unit)|+33148036454|ayavchitz@for.paris|
22411794|NCT00717977|Jaeb Center for Health Research|Roy W. Beck, M.D., Ph.D.|813-975-8690|rbeck@jaeb.org|
22411795|NCT00385541|Columbia University|Dr. Pamela Flood|201-370-3933|pflood@stanford.edu|
22411796|NCT00929708|AstraZeneca|Carin Jorup, MSD||clinicaltrialtransparency@astrazeneca.com|
22411797|NCT02154529|Kadmon Corporation|Associate Vice President, Clinical Operations|833-900-5366|karin.herrera@kadmon.com|
22411798|NCT05440097|AstraZeneca|Clinical project manager|18500554074|jiayu.ye@astrazeneca.com|
22411799|NCT02081599|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22411800|NCT00782431|Alachua Government Services, Inc.|Angie Kimbler|386-418-8751|angie.kimbler@resilience.com|
22411801|NCT01806688|Agriculture and Agri-Food Canada|Dr. Heather Blewett|204 237-2954|hblewett@sbrc.ca|
22427058|NCT04076917|BIOTRONIK, Inc.|Senior Manager, Scientific Affairs|800-547-0394|crystal.miller@biotronik.com|
22411802|NCT02146430|Daiichi Sankyo, Inc.|Daiichi Sankyo US Contact for Clinical Trial Results|+1 (908) 992-6400|CTRinfo@DSI.com|
22411803|NCT03093324|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
22411804|NCT01767597|Service des maladies infectieuses et tropicales - Hôpital Saint-Antoine|Dr. Julie Bottero|+33 1 49 28 04 24|julie.bottero@aphp.fr|
22411805|NCT05342753|Galderma Research & Development, LLC|Sponsor|8179615000|aestheticclinicaltrials@galderma.com|
22411806|NCT00836927|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22411807|NCT02518230|Children's Mercy Hospital|Winston Manimtim|816-234-3000|wmmanimtim@cmh.edu|
22411808|NCT04583579|Lexitas Pharma Services|Dr. Andrew Pucker|9205792900|andrewpucker@hotmail.com|
22381172|NCT05080192|University of Pennsylvania|Seavmeiyin Kun|215-917-0115|seavmeiyin.kun@pennmedicine.upenn.edu|
22411809|NCT02006706|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22427059|NCT02378662|Aevi Genomic Medicine|Garry A. Neil, MD|610-254-4208|garry.neil@aevigenomics.com|
22427060|NCT01159574|Weill Cornell Medical College|Jennifer Hess|6469629440|jmh2004@med.cornell.edu|
22411810|NCT00049036|AIDS Malignancy Consortium|Jeannette Lee|501-526-6712|jylee@uams.edu|
22411811|NCT04700449|Suzhou Connect Biopharmaceuticals, Ltd|John Guo, Director of Clinical Operation|051253577866|jwguo@connectpharm.com|
22411812|NCT06041646|BioXcel Therapeutics|SVP Clinical and Medical Affairs|(203) 530-5000|DKostic@Bioxceltherapeutics.com|
22411813|NCT00356200|Tufts Medical Center|Alice B Gottlieb, MD, PhD|617 636 4802|agottlieb@tuftsmedicalcenter.org|
22411814|NCT03209570|Insight Therapeutics, LLC|H. Edward Davidson, PharmD, MPH|7576246040|EDavidson@inther.com|
22411815|NCT01000337|Aretaieio Hospital, University of Athens|Argyro Fassoulaki|+30210 7286334|fassoula@aretaieio.uoa.gr|
22411816|NCT02173704|GlaxoSmithKline|GSK Response Center|866-435-7343||
22427061|NCT05412134|Duke University|Jason Lang, MD|919-684-3364|jason.lang@duke.edu|
22427062|NCT00072449|Johns Hopkins University|Dr. Stuart A Grossman|410-955-3657|jfisher@jhmi.edu|
22427063|NCT04683640|University of Florida|Yenisel Cruz-Almeida|(352) 294-5845|cryeni@ufl.edu|
22427064|NCT03167242|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22427065|NCT03444584|MedImmune, LLC|Armando Flor|+1-301-398-1955|information.center@astrazeneca.com|
22427066|NCT02886923|Johnson & Johnson Vision|Ross Franklin - PRINCIPAL RESEARCH OPTOMETRIST|904 4431768|RFrankl1@its.jnj.com|
22427067|NCT01077323|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22427068|NCT00372424|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22442383|NCT02055118|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22442384|NCT03098615|UAB|Leslie Roop|2059754917|lmroop@uabmc.edu|
22442385|NCT02281383|Memorial Sloan Kettering Cancer Center|Dr. Harry Herr, MD|646-422-4411|herrh@MSKCC.ORG|
22442386|NCT01324141|National Cancer Institute|Dr. Deborah E. Citrin|301-496-5457|citrind@mail.nih.gov|
22442387|NCT00329524|UAMS Department of Otolaryngology|John Dornhoffer, MD|501-686-7000|dornhofferjohnl@uams.edu|
22442388|NCT01001325|Mount Sinai Hospital|Dr. Brenda Coleman|416-586-4800|bcoleman@mtsinai.on.ca|4161
22411817|NCT03901963|Janssen Research & Development|Director Clinical Research Scientist|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22411818|NCT04956666|Institut de Recherches Internationales Servier (I.R.I.S.)|Clinical Studies Department|+33 1 55 72 60 00|scientificinformation@servier.com|
22411819|NCT02909673|UT Health Houston|Melanie Thiel|713-818-6281|melanie.thiel@uth.tmc.edu|
22411820|NCT02869646|Tibor Rubin VA Medical Center|Michael Hollifield, M.D.|562 826-8000|michael.hollifield@va.gov|4324
22411821|NCT02035137|New Advances in Neuroblastoma Therapy|NANT Medical Director|3233615687|nantops@chla.usc.edu|
22411822|NCT01288859|University of Naples|Prof. Vincenzo Fogliano|+39 0812539356|fogliano@unina.it|
22411823|NCT03349333|Mundipharma(China) Co.,Ltd|clinical study manager|8610-65636856|guodong.lu@mundipharma.com.cn|
22427069|NCT02956382|Seattle Cancer Care Alliance|Chaitra Ujjani, MD|(206) 606-1955|ujjani@uw.edu|
22427070|NCT02439164|Beijing Tiantan Hospital|Dr. Nan Lin|861067096658|linnan127@163.com|
22427071|NCT02343224|Emory University|Dolly Aguilera MD|404-785-3515|Dolly.Aguilera@choa.org|
22427072|NCT03118934|Alcon, A Novartis Division|Head, CDMA Vision Care Franchise|1-888-451-3937|alcon.medinfo@alcon.com|
22427073|NCT04232839|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22427074|NCT02849080|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22427075|NCT02569892|Stanford University School of Medicine|Steven Sanislo, MD|650-723-6995|ssanislo@stanford.edu|
22427076|NCT02155985|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22427077|NCT00732069|Vanderbilt University|Dr. Nancy J. Brown|615-343-8701|nancy.j.brown@vanderbilt.edu|
22427078|NCT02283658|Mayo Clinic|Gerardo Colon-Otero, M.D.|(904) 953-2000|gcolonotero@mayo.edu|
22427079|NCT03608826|Medtronic|Nicole Wood|8006338766|nicole.wood@medtronic.com|
22427080|NCT01733277|ArthroLab Inc.|Dr Jean-Pierre Pelletier|15148908000|dr@jppelletier.ca|26666
22427081|NCT00974363|GlaxoSmithKline|GSK Response Center|866-435-7343||
22427082|NCT03139552|University of Colorado Anschutz Health and Wellness Center|John C. Peters, PhD|303-724-9160|john.c.peters@ucdenver.edu|
22427083|NCT01754519|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22427084|NCT01257347|Columbia University Medical Center|Ian Kronish, MD, MPH|2123421335|ik2293@columbia.edu|
22427085|NCT01768325|Indiana University School of Medicine|John DeWitt, MD|317-944-1113|jodewitt@iu.edu|
22427086|NCT00780975|Pharma Mar, S.A.|Clinical Development Department of PharmaMar´s Oncology,Business Unit.,|+34 918466000|clinicaltrials@pharmamar.com|
22427087|NCT00887484|GlaxoSmithKline|GSK Response Center|888-435-7343||
22427088|NCT01061606|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
22427089|NCT03122171|Rutgers-New Jersey Medical School|Alice Chu, MD|(973) 972-2076|chual@njms.rutgers.edu|
22427090|NCT03044314|Duke University Medical Center|Richard Krasuski|919-681-6195|richard.krasuski@duke.edu|
22427091|NCT01316224|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22427092|NCT00264147|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22427093|NCT03234465|Oragenics, Inc.|Dr. Alan Jolyn|+ 1 813-286-7900|info@oragenics.com|
22427094|NCT02743364|Northwestern University|Seema A. Khan, MD|312-503-4236|s-khan2@northwestern.edu|
22427095|NCT00465530|University of Kansas Medical Center|Dr. Julie Wei|(913) 588-6664|jwei@kumc.edu|
22427096|NCT01274533|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu|
22427097|NCT02563899|GlaxoSmithKline|GSK Response Center|866-435-7343||
22427098|NCT02008526|Friends Research Institute|Dr. Cathy Reback|3234631601|reback@friendsresearch.org|
22427099|NCT01062308|Christian Medical College and Hospital, Ludhiana, Punjab, India|Jeyaraj D Pandian|09915784750|jeyarajpandian@hotmail.com|
22442389|NCT02758184|Duke University|Sergio Mendoza Lattes, M.D.|919-684-2023|sergio.mendoza@duke.edu|
22427100|NCT01305564|Bard Peripheral Vascular|Ryan Melloy|480-350-6074|ryan.melloy@crbard.com|
22427101|NCT01190813|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
22427102|NCT05163392|UCSF|Sylvie Baudart|415-203-4027|sylvie.baudart@ucsf.edu|
22427103|NCT03810456|Michael E. DeBakey VA Medical Center|Dr. Ellen Teng|(713) 578-5513|Ellen.Teng@va.gov|
22427104|NCT00738426|Cosmetic Surgery|Dr. Robert F. Jackson|765-662-8303|rjlipodr@comteck.com|
22427105|NCT03499795|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
22427106|NCT02265510|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22427107|NCT00630916|Sorin Group USA|Director of Clinical and Medical Affairs|512-435-3602|barbara.mathews@sorin.com|
22427108|NCT00324155|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22427109|NCT00390689|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22427110|NCT01253161|Moffitt Cancer Center|Jonathan Strosberg, MD|813-745-6585|Jonathan.Strosberg@moffitt.org|
22427111|NCT03871556|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
22427112|NCT03786380|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22427113|NCT02984982|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22442390|NCT01584440|Avanir Pharmaceuticals, Inc.|Avanir Medical Information|855-572-2722|medinfo@avanir.com|
22442391|NCT00599339|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22442392|NCT00531427|Purdue Pharma|Clinical Leader, Executive Medical Director|800-733-1333||
22442393|NCT05688670|Duke University Medical Center|Lisa Einhorn, M.D.|(919) 668-4000|lisa.einhorn@duke.edu|
22442394|NCT00488683|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22442395|NCT00336856|University of Pittsburgh|Nathan Bahary, MD|412-864-7764|baharyn@upmc.edu|
22442396|NCT03483922|HKG Epitherapeutics|David Cheishvili|5142601972|david.cheishvili@hkgepitherapeutics.com|
22442397|NCT04313647|Ruijin Hospital , Shanghai Jiao Tong University School of Medicine|Dr. Qu|(+86)2164370045|jmqu0906@163.com|
22442398|NCT00843778|UCB|UCB Clinical Trial Call Center|+1 877 822||9493
22442399|NCT02933671|Duke University|W. Michael Bullock, MD, PhD|919-668-2024|william.bullock@duke.edu|
22442400|NCT00830869|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22442401|NCT00507728|UT MD Anderson Cancer Center|Paul M Cinciripini, MD, Chair, Behavioral Science|(713) 745-1868|pcinciri@mdanderson.org|
22381173|NCT01743729|Shire (Note: Lifitegrast was divested to Novartis in 2019)|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22442402|NCT04601454|Medtronic|DTM-LE Clinical Research Study Team|763-514-4000|rs.scsresearch@medtronic.com|
22442403|NCT04140227|Bausch and Lomb|Johnson Varughese VP Clinical Services|908-927-1162|johnson.varughese@bausch.com|
22442404|NCT00538785|MedImmune, LLC|Pamela Griffin, Senior Director, Clinical Development|301 398 0000|griffinp@medimmune.com|
22442405|NCT04022733|Ajou University|Associate professor in Anesthesiology Department|82-31-2195689|beye98@aumc.ac.kr|
22442406|NCT04941443|Boston Medical Center, Department of Anesthesiology|Rachel Achu, MD|(617) 414-2000|rachel.achu@bmc.org|
22442407|NCT01331213|Mayo Clinic|Dr. Michael Camilleri|507-266-2305|camilleri.michael@mayo.edu|
22442408|NCT05315908|University of California San Diego|Dr. Jesse Nodora|(858) 822-3686|jnodora@health.ucsd.edu|
22442409|NCT00280384|Eisai Co., Ltd.|Hiroki Shimizu, Study Director|81-3-3817-5235|h3-shimizu@hhc.eisai.co.jp|
22442410|NCT01128621|GlaxoSmithKline|GSK Response Center|866-435-7343||
22442411|NCT00807560|Icahn School of Medicine at Mount Sinai|Katharine Loeb, PhD|212-659-8724|Katharine.Loeb@mssm.edu|
22442412|NCT00233454|Stanford University Medical Center|Jason R Gotlib, MD, Associate Professor of Medicine (Hematology)|650-867-2823|jason.gotlib@stanford.edu|
22442413|NCT04224688|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22442414|NCT04074161|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22442415|NCT02317744|Yale School of Medicine|Dr. Carlos Grilo|203-785-2792|carlos.grilo@yale.edu|
22442416|NCT03595228|Bavarian Nordic A/S|Bavarian Nordic Call Center|1-844-422|medical.information_us@bavarian-nordic.com|8274
22442417|NCT01639729|AcelRx|Pamela Palmer|650-216-3500|ppalmer@acelrx.com|
22442418|NCT03083990|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+86 13382419112|jessica.yi@innoventbio.com|
22442419|NCT01853839|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22442420|NCT01640314|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22442421|NCT01632267|AssureRx|Joel Winner, MD|513-234-0510|jwinner@assurerxhealth.com|
22442422|NCT02709538|Glenmark Pharmaceuticals Ltd.|Study Director|201-684 8000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
22442423|NCT05099263|Aerin Medical|Anais Laborde, Sr. Director of Clinical Operations|6505189624|alaborde@aerinmedical.com|
22442424|NCT00835211|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22442425|NCT03087617|Imbio, Inc|Director of Engineering|612520360|laurenkeith@imbio.com|2142
22381174|NCT05074498|Truebinding, Inc|Dongxu Sun|650-847-1117|info@truebinding.com|
22396488|NCT00898443|UAB|Marsha Wakefield, M.D.|205-934-4696|mwakefield@uab.edu|
22427114|NCT02144701|Rutgers Cancer Institute of New Jersey|Roger Strair, MD, PhD|732-235-7298|strairrk@cinj.rutgers.edu|
22427115|NCT00467519|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22427116|NCT02314728|Montefiore Medical Center|Kafui A. Demasio, MD, MPH, Maternal Fetal Medicine, Dept of Obstetrics/Gynecology and Women's Health|718-920-2767|kdemasio@montefiore.org|
22442426|NCT02343549|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
22442427|NCT01896206|Nationwide Children's Hospital|Joseph D. Tobias, MD|6147224200|Joseph.Tobias@nationwidechildrens.org|
22442428|NCT02160041|Novartis Pharmaceuticals|Study Director|+1 (800) 778-8300|novartis.email@novartis.com|
22442429|NCT04450381|Masimo Corporation|Vikram Ramakanth|949-297-7000|clincalresearchdept@masimo.com|
22427117|NCT00004547|National Cancer Institute, National Institutes of Health|Marybeth S. Hughes, M.D.|301-594-9341|hughesm@mail.nih.gov|
22442430|NCT03899467|Suzhou Kintor Pharmaceuticals,Inc.|Millie Gu|+8651262639938|PR@kintor.com.cn|
22427118|NCT03902613|Columbia University Irving Medical Center|Dr. Martin Lan|646 774 7610|martin.lan@nyspi.columbia.edu|
22427119|NCT04622969|University of South Carolina|Director, Office of Research Compliance|8037777095|lisaj@mailbox.sc.edu|
22427120|NCT04467515|Precirix|Jonathan Delara, Clinical Trial Manager|+1 (512) 589-2114|jonathan.delara@precirix.com|
22427121|NCT01251042|Wellspect HealthCare|Emma Tällberg, Clinical Research Manager|+46313764000||
22442431|NCT00006409|University of North Carolina - Chapel Hill|June Stevens|919-966-7218|june_stevens@unc.edu|
22442432|NCT00514852|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
22442433|NCT04343235|Wright State University|Sheela Barhan, MD|937-208-2850|sheela.barhan@wright.edu|
22442434|NCT00787267|Duke University Medical Center|Michael Kelley , MD|919-286-0411|kelleym@duke.edu|7326
22442435|NCT01763996|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22442436|NCT00865280|Paratek Pharmaceuticals, Inc.|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
22442437|NCT01396057|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22442438|NCT02428478|Brigham and Women's Hospital|Andrew Wellman, MD, PhD||awellman@rics.bwh.harvard.edu|
22442439|NCT00884741|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22442440|NCT01324401|Harvard Medical School / Massachusetts General Hospital|Wayne Shreffler|617-726-6147|wshreffler@mgh.harvard.edu|
22442441|NCT01578850|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22442442|NCT01567839|The Ohio State University, Division of Endodontics|Dr. John Nusstein|614-292-9412|nusstein.1@osu.edu|
22442443|NCT00601952|San Diego State University/University of California Joint Doctoral Program in Clinical Psychology|Dr. Nader Amir|6192293740|namir@mail.sdsu.edu|
22442444|NCT01818752|Amgen Inc.|Study Director|866-572-6436||
22442445|NCT04629066|Duke Clinical Research Institute|Marjan Cobbaert|919-668-9740|mr157@duke.edu|
22442446|NCT02703337|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22442447|NCT03911102|Revance Therapeutics, Inc.|Todd Gross, PhD, VP, Clinical Development & Data Science|510-742-3400|tgross@revance.com|
22442448|NCT03508908|Aurum Institute|Dr. Eduard Sanders|254723593762|ESanders@auruminstitute.org|
22442449|NCT00282308|Genentech, Inc.|Medical Communications|800 821-8590||
22442450|NCT04237116|Novartis Pharma GmbH|Study Director|(862) 778-8300|novartis.email@novartis.com|
22442451|NCT03212144|Columbia University|Dr. Richard Sloan|6467748947|rps7@columbia.edu|
22442452|NCT00899431|The University of Texas MD Anderson Cancer Center|Dr. Issa F. Khouri, MD/Professor, Stem Cell Transplantation|713- 745-0049|ikhouri@mdanderson.org|
22442453|NCT05225805|Nabriva Therapeutics US, Inc.|Christine Guico-Pabia, MD, MBA, MPH|610-981-2874|christine.guico-pabia@nabriva.com|
22442454|NCT02369172|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
22442455|NCT00661427|Memorial Sloan Kettering Cancer Center|Dr. David Pfister|646-888-4237|pfisterd@mskcc.org|
22442456|NCT01821560|University of Pennsylvania|Dr. Teresa R. Franklin|215-746-1883|teresafr@pennmedicine.upenn.edu|
22442457|NCT01338298|Maryland Psychiatric Research Center|AnnMarie Kearns, MS|4104066854|akearns@som.umaryland.edu|
22381175|NCT04094064|University of Virginia Center for Diabetes Technology|Dr. Meaghan Stumpf|(434) 982-4351|MMS5CF@hscmail.mcc.virginia.edu|
22381176|NCT01306331|Evofem|Clinical Operations|858-550-1900|clinicaloperations@evofem.com|
22381177|NCT03614130|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22381178|NCT03371108|Gan & Lee Pharmaceuticals USA Corp.|Jia Lu, MD, PhD Executive Director of US Clinical Sciences|+1 888-288-5395|Jia.Lu@ganlee.us|
22381179|NCT05805059|Coopervision|Jose A. Vega,OD,MSc,FAAO, PhD|925-621-3761|jvega2@coopervision.com|
22381180|NCT00172185|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22427122|NCT04249427|Duke University|David Jang, MD|919-613-6407|david.jang@duke.edu|
22381181|NCT01677936|Louisville Metabolic and Atherosclerosis Research Center|Kathy Schmitz RN|502.515.5672|kschmitz@lmarc.com|
22381182|NCT04188288|Yale University|Kathleen Garrison, PhD|203-737-6232|kathleen.garrison@yale.edu|
22427123|NCT03886272|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22427124|NCT01091246|MedImmune, LLC|Judy Falloon, MD/ Sr Director Clinical Development|301-398-0000|falloonj@medimmune.com|
22427125|NCT02589145|UT MD Anderson Cancer Center|Dr. Yago Nieto/Professor, Stem Cell Transplantation|713-792-2466|ynieto@mdanderson.org|
22427126|NCT01673178|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22427127|NCT03177148|University of Michigan|Mx. Emerson Delacroix|734-764-2014|emmed@med.umich.edu|
22427128|NCT03724357|University of Maryland, Baltimore|Marcelo Sztein, MD|410-706-5328|msztein@som.umaryland.edu|
22427129|NCT01676012|Radboudumc|Dr. Erik van der Heijden|0031243614579|Erik.vanderHeijden@radboudumc.nl|
22427130|NCT02456194|NSHA|Ross Leighton|1-902-473-4035|Ross.Leighton@nshealth.ca|
22427131|NCT02848664|James Madison University|Dr. Erin Kamarunas|540-568-8846|kamaruee@jmu.edu|
22427132|NCT02408198|King's College London|Dr Amy Hardy|0207 848 0033|amy.hardy@kcl.ac.uk|
22427133|NCT00953290|Cutera Inc.|Ayse Turley, Clinical Development Researcher|415-657-5665|aturley@cutera.com|
22427134|NCT00965237|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22427135|NCT01819727|BioMarin Pharmaceutical Inc.|Principal Scientist I, Clinical Sciences|415-506-6348|dlounsbury@bmrn.com|
22427136|NCT01533116|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22427137|NCT01831895|Vascular Dynamics|VP Clinical Affairs|949-942-1640|clinical@vasculardynamics.com|
22427138|NCT04794751|Johnson & Johnson Vision Care, Inc.|Thomas R. Karkkainen, OD, MS, FAAO|1-800-843-2020|TKarkkai@its.jnj.com|
22427139|NCT02360488|UCLA|Steve Cramer|424-522-7273|sccramer@mednet.ucla.edu|
22442458|NCT02872285|Lycera Corp.|H. Jeffrey Wilkins MD, Chief Medical Officer|484-243-6222|wilkins@lycera.com|
22442459|NCT05477108|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-94 79|information.center@astrazeneca.com|
22442460|NCT01253577|Intersect ENT|James Stambaugh, Vice President Clinical Affairs|650-641-2103|jstambaugh@intersectent.com|
22442461|NCT02970942|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22442462|NCT00508196|University of Dundee|DR Anna Maria Choy|01382 383482|a.choy@dundee.ac.uk|
22442463|NCT01065454|Bayer|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22442464|NCT03374202|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
22381183|NCT02790606|C.R. Bard|Talar Saber, Clinical Project Manager|480-379-2839|talar.saber@crbard.com|
22442465|NCT01604278|Novartis Pharmaceuticals|Study Director|862-778-8300||
22381184|NCT02735915|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22442466|NCT02793856|West China Hospital, Sichuan University|You Lu|+862885423571|283494287@qq.com|
22442467|NCT03630770|Women & Infants Hospital|Dr. Joseph Bliss|4012741100|jbliss@wihri.org|
22442468|NCT03897439|University of Kanas Medical Center|Dr. Nicole Nollen|913-588-3784|nnollen@kumc.edu|
22442469|NCT03124927|Masimo Corporation|Vikram Ramakanth||clinicalresearchdept@masimo.com|
22442470|NCT04586387|Virginia Commonwealth University|Carrie Peterson|804 827 5270|clpeterson@vcu.edu|
22442471|NCT02047344|Golden Biotechnology Corp.|Howard Cheng|+886-2-28086006|howard@goldenbiotech.com|
22381185|NCT05328973|M.D. Anderson Cancer Center|Neil Bailard, MD|713-597-1687|nbailard@mdanderson.org|
22442472|NCT00361634|Amgen Inc.|Study Director|866-572-6436||
22381186|NCT04669249|PRO Health Group|Dr. Steven Proctor|305-814-7762|sproctor@prohealthgroup.net|
22381187|NCT03127358|Albert Einstein College of Medicine|Julia Arnsten, MD|718-920-6641|jarnsten@montefiore.org|
22381188|NCT00409708|Novartis Pharmaceuticals|Study Director|862 778-8300||
22381189|NCT00946114|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22427140|NCT01405898|Queen Mary University London|Professor Amrita Ahluwalia|02078825720|a.ahluwalia@qmul.ac.uk|
22381190|NCT00723294|Weill Cornell Medicine|Rache M. Simmons, MD|(212) 821-0870|rms2002@med.cornell.edu|
22427141|NCT01328964|GlaxoSmithKline|GSK Response Center|866-435-7343||
22427142|NCT00948090|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22427143|NCT02845674|Sun Pharma Advanced Research Company Limited|SPARC|+912266455645|Clinical.Trials@Sparcmail.com|
22427144|NCT00349336|Hoffmann-La Roche|Medical Communications|800-821-8590||
22427145|NCT02139397|Beat Childhood Cancer|Giselle Sholler, MD|7175310003|gsaulniersholler@pennstatehealth.psu.edu|
22427146|NCT00369343|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22427147|NCT01973218|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22427148|NCT02247466|Department of Anaesthesiology, Herlev Hospital, University of Copenhagen|Roar Borregaard Medici, MD, Research Assistant|+4526390068|roar.borregaard.medici.01@regionh.dk|
22427149|NCT01621009|University of Wisconsin Center for Tobacco Research and Intervention|Timothy Baker, PhD, Director of Research|(608) 262-7568|tbb@ctri.wisc.edu|
22427150|NCT02322749|AstraZeneca|Information Centre||Information.centre@astrazeneca.com|
22427151|NCT00073918|Fred Hutchinson Cancer Research Center|Ajay K. Gopal, MD|206-288-2037|agopal@u.washington.edu|
22427152|NCT01409239|The Ohio State University|Kathleen Dungan|614-685-3333|kathleen.dungan@osumc.edu|
22427153|NCT02033759|Mercy Integrative Medicine|Sarah Stolker, MSPT, CLT-LANA|13145402858|sarah@stolker.com|
22427154|NCT01190085|Brown University|Dr. Lorenzo Leggio|401-863-1000|Lorenzo_Leggio@Brown.edu|
22427155|NCT00060606|George Washington University Biostatistics Center|Dr. Elizabeth A Thom|301-881-9260|e_thom@bsc.gwu.edu|8035
22427156|NCT04853043|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
22381191|NCT01257503|University of Washington|James A Taylor|206-616-1206|uncjat@uw.edu|
22381192|NCT00088465|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22381193|NCT04565249|Pliant Therapeutics, Inc.|Éric Lefebvre, M.D., Chief Medical Officer|1-650-481-6779|ELefebvre@pliantrx.com|
22381194|NCT02333630|Nationwide Children's Hospital|David Stukus, MD|614 722-4808|david.stukus@nationwidechildrens.org|
22381195|NCT02359435|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
22381196|NCT00315055|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22381197|NCT01079598|Medtronic|Stephanie Brucato, Principal Clinical Research Specialist|508-261-8000|stephanie.m.brucato@medtronic.com|
22381198|NCT02347943|Acclarent, Inc|Patricia Chen|949-453-6408|pchen126@its.jnj.com|
22427157|NCT02007720|Novartis Pharma AG|Study Director|+41613241111|novartis.email@novartis.com|
22427158|NCT01702909|Western Regional Medical Center|Jessica L. Coats|623-207-3899|jessica.coats@ctca-hope.com|
22427159|NCT00490919|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333||
22427160|NCT01461733|The Ottawa Hospital Research Institute|Salmaan Kanji|613-737-8899|skanji@toh.on.ca|78159
22427161|NCT00545623|Boston University|Bei-Hung Chang|508-856-8959|bhchang@bu.edu|
22381199|NCT01492309|UPenn|Deborah Kim, MD|6107261020|drkim@upenn.edu|
22427162|NCT04265261|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22381200|NCT02596906|Center for BrainHealth, The university of Texas at Dallas|Dr. Namrata Das|9728833266|Namrata.Das@utdallas.edu|
22381201|NCT03613129|Bateman Horne Center|Lucinda Bateman, MD|(801) 359-7400|LBateman@batemanhornecenter.org|
22442473|NCT00505076|Semel Institute at UCLA|Stephen R. Marder|310-268-3647|marder@ucla.edu|
22427163|NCT07116759|University of Pennsylvania|Rodney Wiersma, PhD|773-623-9820|Rodney.Wiersma@pennmedicine.upenn.edu|
22442474|NCT02500056|Tartu University Hospital|Ceith Nikkolo|+37253319082|ceith.nikkolo@kliinikum.ee|
22442475|NCT01988584|The University of Texas Health Science Center at Houston|Charles S. Cox, MD, Professor|713-500-7300|charles.s.cox@uth.tmc.edu|
22442476|NCT03232333|Miromatrix|Head of Clinical Affairs|952.942-6000|mmacenski@miromatrix.com|
22442477|NCT01816945|Yale University|Megan Smith Associate Professor|203 764 8655|megan.smith@yale.edu|
22442478|NCT01155011|UCSD|Jacqueline Kerr|858-534-9305|jkerr@ucsd.edu|
22442479|NCT01087736|University of California, San Francisco|David L. Pennington, PhD (Research Psychologist II)|415-221-4810|david.pennington2@va.gov|4504
22442480|NCT01253811|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22442481|NCT00759564|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22442482|NCT01214057|The University of Texas Health Science Center at Houston|Davide Cattano, MD|(713) 500-6200|Davide.Cattano@uth.tmc.edu|
22442483|NCT01565343|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22427164|NCT02097732|University of Michigan Comprehensive Cancer Center|Dr. Christopher Lao, MD, MPH|(734) 936-4498|clao@med.umich.edu|
22442484|NCT01012674|Guerbet|Dr Pierre Desché, MD - VP Head of Development, Medical and Regulatory Affairs|+33 1 45 91 50 00|pierre.desche@guerbet-group.com|
22381202|NCT02334306|MedImmune, LLC|Gabor Illei|+1 240 558 0038 118|information.center@astrazenea.com|
22381203|NCT01687270|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22381204|NCT00711646|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
22427165|NCT01898078|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22427166|NCT03813108|Radboud university medical center|Matthew McCall, MD, PhD|+3124 3615363|Matthew.mccall@Radboudumc.nl|
22427167|NCT04635839|University of California, Los Angeles|Dr. Thalia Mok|310-794-7274|tmok@mednet.ucla.edu|
22427168|NCT02870868|Vanderbilt University Medical Center|Alfredo Gamboa|(615) 322-5000|alfredo.gamboa@vumc.org|
22427169|NCT01115452|GlaxoSmithKline|GSK Response Center|866-435-7343||
22381205|NCT03441360|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
22381206|NCT00507208|University of Alabama at Birmingham|William Carroll, MD|205-934-9713|wcarroll@uabmc.edu|
22381207|NCT01360840|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22381208|NCT02446223|Cosmetic Laser Dermatology/West Dermatology Research|Clinical Research Coordinator|858 657 1004|IGuiha@CLderm.com|
22381209|NCT00920686|NeurAxon, Inc|Thomas Lategan, PhD|417 673 6697|tlategan@neuraxon.com|
22381210|NCT04337489|Imperial College London|Fahad Iqbal|020 3312 6666|f.iqbal@imperial.ac.uk|
22427170|NCT00499122|UM/Sylvester Comprehensive Cancer Center|Alberto Montero MD|305-243-3771|amontero2@med.miami.edu|
22381211|NCT00688688|Astellas Pharma Global Development, Inc.|Medical Director, Global Medical Sciences||ClinicalTrials.Disclosure@us.astellas.com|
22381212|NCT04296942|National Cancer Institute|Dr. Fatima H. Karzai|301-480-7174|fatima.karzai@nih.gov|
22442485|NCT01962961|Indiana University School of Medicine|Samir K. Gupta|317-274-7926|sgupta1@iu.edu|
22442486|NCT02059291|Novartic Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22442487|NCT00244140|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22442488|NCT02673541|Dartmouth-Hitchcock Medical Center|Dr Jeffrey Adler|603-650-5261|Jeffrey.m.adler@hitchcock.org|
22442489|NCT05408637|Massachusetts General Hospital and Harvard Medical School|Dr. Paolo Cassano|617-643-9622|pcassano@mgh.harvard.edu|
22381213|NCT03255941|FHI 360|Mario Chen|919 544 7040|mchen@fhi360.org|11399
22381214|NCT02865434|Navidea Biopharmaceuticals|Bonnie Abbruzzzese|6147937500|babbruzzese@navidea.com|
22381215|NCT00335153|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22381216|NCT04038099|UT Southwestern Medical Center|Christina Hicks, MS, APRN, WHNP-BC, FAUNA|2146453848|christy.hicks@utsouthwestern.edu|
22381217|NCT01237678|ImmunoGen Inc.|Dr. Richard Bates, Sr. Manager, Publications|781 895 0196|Richard.Bates@immunogen.com|
22381218|NCT02954055|ETOP IBCSG Partners Foundation|Dr. Heidi Roschitzki, PhD|+41 31 511 94 00|heidi.roschitzki@etop.ibcsg.org|
22381219|NCT03194776|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22381220|NCT01939938|Weill Cornell Medical College|Dr. Matthew Ebben|6469629318|mae2001@med.cornell.edu|
22381221|NCT00764868|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22381222|NCT03750656|University of Kansas Medical Center|Dr. David Duchene|(913) 588-8721|dduchene@kumc.edu|
22381223|NCT03713645|Temple University Hospital, Inc.|Adam Diamond, PharmD, BCPS, FAST|215-280-8041|adam.diamond@tuhs.temple.edu|
22381224|NCT03050294|Wake Forest Baptist Health|Steven R. Feldman|336-716-7740|sfeldman@wakehealth.edu|
22381225|NCT04438785|Grupo Hospitalario Quironsalud|Francisco Jesus Gonzalez|0034645014593|fgonzasan@gmail.com|
22381226|NCT04831775|The University of Texas at Austin|Dr. Heather Cuevas|5124226059|hcuevas@mail.nur.utexas.edu|
22381227|NCT02027935|University of Texas MD Anderson Cancer Center|Dr. Adi Diab|(713) 745-7336|adiab@mdanderson.org|
22381228|NCT03115346|VA Hospital|Dr. Mark Eid|502-295-8961|mark.a.eid01@gmail.com|
22427171|NCT00288912|Durham VA HSR&D|Dr. Kelli Allen|919-286-0411|kelli.allen@va.gov|7090
22427172|NCT03312738|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
22427173|NCT01130844|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22381229|NCT00689104|Astellas Pharma Europe B.V.|Director Medical Science||ClinicalTrials.Disclosure@us.astellas.com|
22396489|NCT03880032|Johns Hopkins Bloomberg School of Public Health|Pamela Surkan|4105027396|psurkan@jhu.edu|
22442490|NCT04975438|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22381230|NCT02698436|JNJWorldwide|Lisa Fitzgerald|+1 908-904-6235|lfitzge6@its.jnj.com|
22396490|NCT00407654|Princess Margaret Cancer Centre|Dr. Malcolm Moore|416-945-2263|malcolm.moore@uhn.ca|
22427174|NCT03895801|InflaRx GmbH|Prof. Niels C. Riedemann|+49 3641-508-180|niels.Riedemann@inflarx.de|
22427175|NCT02466399|Peregrine Ophthalmic Pte Ltd|Chief Operating Officer|65 97914382|jchua@peregrineop.com|
22427176|NCT00612235|Beth Israel Deaconess Medical Center|Andrew G. Herzog M.D., M.Sc.|781-431-0277|aherzog@bidmc.harvard.edu|
22427177|NCT00607893|Case Western Reserve University|Reena Mehra|216-445-1698|mehrar@ccf.org|
22427178|NCT02669849|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22427179|NCT00606008|H. Lee Moffitt Cancer Center and Research Institute|Dr. Edward Pan|813-745-3871|edward.pan@moffitt.org|
22427180|NCT03736967|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22427181|NCT02369653|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22427182|NCT01587885|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22427183|NCT01458587|DUSA Pharmaceuticals, Inc.|Anna Houlihan|9147608796|houlihana@dusapharma.com|
22427184|NCT01603602|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@Allergan.com|
22427185|NCT02209064|EpiEP|Pam Bunes CEO & Founder|+1 864 423 2526|pbunes@epiep.com|
22427186|NCT01040819|Baylor College of Medicine|Dr. Yochai Birnbaum|713-798-0273|ybirnbau@bcm.edu|
22427187|NCT04748718|Northern Vermont University|Dr. Eleanor Beltz|802-635-1329|Eleanor.Beltz@NorthernVermont.edu|
22381231|NCT00665561|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22381232|NCT04949399|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22381233|NCT01515319|Imperial College London|Dr Tricia Tan|020 838 38038|t.tan@imperial.ac.uk|
22381234|NCT01354106|cyberDERM|Dr. Gary Grove|610-325-0112|GGrove@cyberderm-inc.com|
22381235|NCT01871285|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22381236|NCT05397470|Fulcrum Therapeutics|Call Center|617-651-8853|clinicaltrials@fulcrumtx.com|
22381237|NCT01919619|M D Anderson Cancer Center|Issa Khouri, MD / Stem Cell Transplantation Department|713-792-8750|ikhouri@mdanderson.org|
22381238|NCT02738840|Abbott|Robyn A Capobianco|+1 512 934 3941|robyn.capobianco@abbott.com|
22381239|NCT01801449|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Montealegre, Gina|+1 301 761 7747|montealegrega@mail.nih.gov|
22381240|NCT02162446|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22381241|NCT01311648|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22381242|NCT02268396|Pearl Therapeutics Inc|Colin Reisner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com|
22381243|NCT01645111|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-4200|Joseph.Tobias@nationwidechildrens.org|
22381244|NCT01565538|Sun Yat-sen University Cancer Center|Dr. Si-Yu Wang|020-87343439|wsysums@163.net|
22381245|NCT03618095|Boston Scientific|Amy Maurer|800-876-9960|amy.maurer@bsci.com|
22381246|NCT01304706|Alimera Sciences, Inc.|Kathleen Billman, Senior Director, Scientific Affairs|678-527-1302|kathleen.billman@alimerasciences.com|
22381247|NCT01171924|Curis, Inc.|Associate Director of Regulatory Affairs|(617) 503-6548|lsaunders@curis.com|
22381248|NCT05526911|TB Alliance|Antonio Lombardi|917.601.0024|antonio.lombardi-consultant@tballiance.org|
22381249|NCT05025449|Emory University|Laura Oh, MD|404-778-1709|laura.oh@emory.edu|
22381250|NCT00887640|Duke University Medical Center|Dr. Andrew Armstrong|919-668-8108|andrew.armstrong@dm.duke.edu|
22427188|NCT00316004|Clinical Trial Center, University of Washington, Seattle, WA|Susanne May, PhD|206-685-1302|sjmay@uw.edu|
22427189|NCT01118299|Abbott|Sripad Bellary|408845814|sripad.bellary@abbott.com|
22427190|NCT02090881|Imperial College Healthcare NHS Trust|Dr Mohammed Aslam|02083831000|m.aslam@imperial.ac.uk|1541
22427191|NCT01935089|The Wistar Institute|Luis J. Montaner|+1 (215) 898-9143|montaner@wistar.org|
22427192|NCT02932943|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
22427193|NCT00250484|Beth Israel Deaconess|Steven D. Freedman, MD Phd|631-667-2132|sfreedma@bidmc.harvard.edu|
22427194|NCT02665117|UT Southwestern Medical Center|Dr. Wanpen Vongpatanasin|214-648-9078|wanpen.vongpatanasin@utsouthwestern.edu|
22427195|NCT04236284|The University of Texas Health Science Center at Houston|Melba Hernandez Tejada, PhD, DHA|7134862729|Melba.A.HernandezTejada@uth.tmc.edu|
22427196|NCT02271451|Cincinnati Children's Hospital|Dr. Gregory Myer|513-636-4366|gregory.myer@cchmc.org|
22427197|NCT00977197|Mayo Clinic|Yuri A. Saito Loftus, M.D.|507-284-2687|saito.yuri@mayo.edu|
22427198|NCT05379920|University at Buffalo|Haley Chizuk|7162043200|haleychi@buffalo.edu|2188
22427199|NCT01267279|Spokane Joint Replacement Center|Principal Investigator|509-466-6393|dfscott@mac.com|
22427200|NCT03530293|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22427201|NCT01997125|The Ohio State University|Marcia Bockbrader MD PhD|6142937604|bockbrader.13@osu.edu|
22427202|NCT02530385|Massachusetts General Hospital Endocrine Unit|Dr. Elaine Yu|617-726-6723|ewyu@mgh.harvard.edu|
22427203|NCT00116142|Dana Farber Cancer Institute|Anthony D'Amico|617.732.6310|ADAMICO@LROC.HARVARD.EDU|
22427204|NCT03482024|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22427205|NCT02295644|University at Buffalo, School of Dental Medicine, Oral Diagnostic Sciences|Dr. Willard D McCall|(716)829-3559|wdmccall@buffalo.edu|
22427206|NCT02147626|Brigham and Women's Hospital|Dr. Janet Rich-Edwards|6175258264|jr33@partners.org|
22381251|NCT03379740|Philip Morris Products S.A.|Christelle Haziza|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
22411824|NCT00783796|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com|
22442314|NCT02087423|AstraZeneca|Phillip Dennis, MD, PhD|+1 301 398-5549|ClinicalTrialTransparency@astrazeneca.com|
22442315|NCT02917122|National Cheng Kung University|Dr. Kao Chin Chen|+886-6-2353535|andchen@mail.ncku.edu.tw|5213
22442316|NCT00499590|OPKO Health, Inc.|Jane Hsiao, PhD, MBA|305-575-6004|jhsiao@opko.com|
22442317|NCT01980485|Penn State University|Jonathan Foulds|717-531-3504|jfoulds@psu.edu|
22442318|NCT00442364|BTG International Inc|David DI Wright MB BS|610-278-1660|david.wright@btgplc.com|
22442319|NCT02633020|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22442320|NCT00934440|University of Kansas Cancer Center|Dr. Peter Van Velduizen|(913) 945-5059|SWILLIAM@kumc.edu|
22381252|NCT02726178|Sainte Justine university hospital center|Dr. Anne Monique Nuyt|514 3454931|anne-monique.nuyt@recherche-ste-justine.qc.ca|3971
22381253|NCT01982760|Case School of Medicine|Dr. Bahman Guyuron|440-461-7999|bguyuron@guyuron.com|
22381254|NCT00530777|University of Washington|Dr. Carey Farquhar|206-543-4278|cfarq@uw.edu|
22381255|NCT03163992|Samsung Medical Center|Jeeyun Lee|8223410-1779|jyunlee@skku.edu|
22381256|NCT01763047|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, OD., M.S., F.A.A.O- Senior Principal Research Optometrist|904-443-3500|TKarkkai@its.jnj.com|3402
22381257|NCT03999944|FRESCA Medical|Vice President, RA/CA/QA|949-542-3535|mlmooney@frescamed.com|
22381258|NCT00884611|Stanford University|Dr. Bruce Buckingham, MD||buckingham@stanford.edu|
22381259|NCT01366196|Hss|Dr. Michael Urban|(212) 606-1000|UrbanM@hss.edu|
22381260|NCT01941316|Cancer Research and Biostatistics|Director of Quality and Regulatory Compliance|206-839-1782|lisau@crab.org|
22381261|NCT02775435|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22381262|NCT00320489|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22381263|NCT02282527|Grifols Therapeutics Inc.|Henry Li|1-919-316-6042|henry.li@grifols.com|
22381264|NCT00941031|Novartis Pharmaceuticals|Study Director|862-778-8300||
22381265|NCT01872611|Alcon Research, Ltd.|Therapeutic Unit Head, Cornea and Inflammation|1-888-451-3937|alcon.medinfo@alcon.com|
22396491|NCT00074581|Fred Hutchinson Cancer Research Center|Dr. Deborah Donnell|2066675661|deborah@scharp.org|
22396492|NCT01770912|University of Florida|Charles G. Widmer, Associate Professor|352-273-5696|widmer@dental.ufl.edu|
22427207|NCT03101020|Faculdade de Ciências Médicas da Santa Casa de São Paulo|Lucas Villalta Santos|+5515998197899|lucasvillalta.s@gmail.com|
22427208|NCT00477685|Grewal Eye Institute|S.P.S Grewal, MD|+91-172-5056969|drgrewal@gmail.com|
22427209|NCT02414698|Montefiore Medical Center|Sayed E Wahezi, MD|7189207246|swahezi@montefiore.org|
22427210|NCT00423046|GlaxoSmithKline|GSK Response Center|866-435-7343||
22427211|NCT01038687|Mayo Clinic|Michael Camilleri, MD|507-266-2305|camilleri.michael@mayo.edu|
22427212|NCT02783911|LomaLindaU|Dr. Jung-Wei Chen, Program director|9095584690|jwchen@llu.edu|85909
22427213|NCT02616783|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22427214|NCT01342354|The University of Chicago|Dr. Stanley Liauw|(773) 702-0817|Stanley.Liauw@uchospitals.edu|
22427215|NCT03080935|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22442491|NCT04973436|Duke University School of Medicine|Tamara Somers, PhD|9194163408|tamara.somers@duke.edu|
22442492|NCT02693132|University of Colorado Denver|Seth Creasy|720-848-6477|seth.creasy@ucdenver.edu|
22442493|NCT01276054|USC Norris Comprehensive Cancer Center|Victoria Soto, Project Specialist, Clinical Investigations Support Office|323-226-6384|victoria.soto@med.usc.edu|
22442494|NCT01168986|University of Florida|Joel Bialosky, PT, PhD|352-273-8636|jbialosky@phhp.ufl.edu|
22442495|NCT05405257|Baylor College of Medicine|Keren Machol|7137987359|machol@bcm.edu|
22381266|NCT04555044|Organization: Baxter Healthcare|Name/Official Title: Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
22381267|NCT01675830|Boston Children's Hospital|Karen Sakakeeny|617-355-6369|Karen.Sakakeeny@childrens.harvard.edu|
22381268|NCT04088188|MD Anderson|Shubham Pant|832-803-5306|spant@mdanderson.org|
22381269|NCT03686384|Laboratorios Salvat, S.A|Medical Director|+34933946400|ejimenez@svt.com|
22381270|NCT01767909|Wake Forest School of Medicine|Suzanne Craft, PhD, Project Director for Clinical Trial|(336) 713-8830|suzcraft@wakehealth.edu|
22381271|NCT04348370|Texas A&M University College of Medicine|Jeffrey D. Cirillo|979-436-0343|jdcirillo@tamu.edu|
22381272|NCT01740557|M D Anderson Cancer Center|Dr. Rodabe Amaria M.D.|(713) 792-2921|rnamaria@mdanderson.org|
22381273|NCT02320253|MGH Diabetes Center|Dr. Deborah J. Wexler|617-726-8767|dwexler@mgh.harvard.edu|
22381274|NCT00615433|Sunovion Pharmacetuicals Inc.|Josephine Cucchiaro, Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com|
22381275|NCT00783692|Millennium Pharmaceuticals Inc|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
22381276|NCT05174065|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22381277|NCT01737268|Astellas Pharma Inc.|Vice-President, Japan-Asia Clinical Development Administration|+81-3-3244-0512|Astellas.resultsdisclosure@astellas.com|
22381278|NCT04873817|Abbott|Devyani Nanduri, Sr. Director, Clinical and Regulatory Affairs|+16698329450|Devyani.Nanduri@abbott.com|
22381279|NCT00216320|Innovative Neurotronics|Director of Clinical Research|512-721-1922|hrogers@ininc.us|
22381280|NCT00593320|Washington University School of Medicine|Jeffrey Bradley, M.D.|314-362-8502|jbradley@radonc.wustl.edu|
22381281|NCT01925781|Creighton University|Director of Clinical Trials|402-280-4961|sandrabyers@creighton.edu|
22381282|NCT02696226|Cleveland Clinic|Dr. Douglas Johnston|216-444-5613|JOHNSTD3@ccf.org|
22381283|NCT02909101|Duke University School of Medicine|Dr. Sheri Towe|919-668-4030|sheri.towe@duke.edu|
22381284|NCT02081365|Maurice H. Kornberg School of Dentistry, Temple University|Marisol Tellez M. BDS, MPH, Ph.D|215-707-1773|marisol@temple.edu|
22381285|NCT00097370|GlaxoSmithKline|GSK Response Center|866-435-7343||
22381286|NCT01394991|Johnson and Johnson PRD|Clinical Development Team Lead|1 908 218 6097||
22381287|NCT01031043|Georgia Regents University|Gregory N. Postma MD|706-721-6100|gpostmat@gru.edu|
22381288|NCT02337361|Public Health Institute/Alcohol Research Group|Madhabika B. Nayak|510-898-5849|mnayak@arg.org|
22381289|NCT03073005|Northwestern University|Dr. Jeffrey H Barsuk|312-926-5924|jbarsuk@nm.org|
22381290|NCT02230579|Medicines for Malaria Venture|Dr Cristina Donini - Associate Director|00 41 22 555 03 12|doninic@mmv.org|
22396493|NCT03613662|Scilex Pharmaceuticals, Inc.|Associate Director Clinical Operations|6503866709|cambrose@scilexpharma.com|
22396494|NCT03250832|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22381291|NCT02427646|LHSC|Dr. Mandar Jog|519-685-8500|mandar.jog@lhsc.on.ca|76708
22427216|NCT01614470|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22427217|NCT01036802|University of North Carolina, Chapel Hill|Kenneth I. Ataga, MD|919-843-7708|kataga@med.unc.edu|
22427218|NCT00069264|Eisai Inc.|Dr. Peter Tarassoff|888-422--4743||
22427219|NCT03014206|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22427220|NCT03974282|Virginia Commonwealth University|David Chester|8048287624|dschester@vcu.edu|
22427221|NCT02895347|GWU Medical Faculty Associates|Dr. Gaby Moawad|202-741-2500|jebert@mfa.gwu.edu|
22427222|NCT00381628|Riley Hospital for Children|Dr. James Chmiel|317-948-7180|jfchmiel@iu.edu|
22427223|NCT00606307|Italfarmaco S.p.A.|Tiziano Oldoni, MD|+39 02 6443|t.oldoni@italfarmaco.com|2540
22442496|NCT02246413|Univeristy of Illinois, Chicago|Nan Lv, PhD, Research Scientist|312-802-1072|lvn2017@uic.edu|
22442497|NCT01788215|University of Rochester|Kathleen Hoeger MD MPH|585-275-7891|kathleen_hoeger@urmc.rochester.edu|
22442498|NCT03116152|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+8613382419112|jessica.yi@innoventbio.com|
22381292|NCT01734811|Inmunotek|Medical Director|916 510 010|mcasanovas@inmunotek.com|
22381293|NCT00062868|Baylor College of Medicine|Dr. Helen E. Heslop|832-824-4662|hheslop@bcm.edu|
22381294|NCT03824236|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22381295|NCT01641861|Khon Kaen University|Dr. Kemporn Kitsahawong|66-910-566-996|kkempo@kku.ac.th|
22381296|NCT01786343|The University of Texas MD Anderson Cancer Center|Farhad Ravandi-Kashani MD/Professor|713-745-0394|fravandi@mdanderson.org|
22381297|NCT01101542|GlaxoSmithKline|GSK Response Center|866-435-7343||
22381298|NCT00701311|William Beaumont Hospital|Kenneth M. Peters, MD|248-551-0387|kmpeters@beaumont.edu|
22381299|NCT04580407|Director|Study|+1-877-825-3327|TrialDisclosures@takeda.com|
22381300|NCT03230006|Center for Anxiety and Related Disorders, Boston University|Dr. Todd Farchione|6173539610|tfarchio@bu.edu|
22381301|NCT00814489|GlaxoSmithKline|GSK Response Center|866-435-7343||
22381302|NCT01974687|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22381303|NCT01712685|National Cancer Institute|Dr. Adam Metwalli|301-435-6237|metwallia@mail.nih.gov|
22381304|NCT04880161|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|17204376500|clinicaltrials@ampiopharma.com|
22381305|NCT00901485|Royal Brompton Hospital|Miss Julia Kelly|+44 2073528121|j.kelly@rbht.nhs.uk|4183
22381306|NCT04207255|Medical University of South Carolina|Alan Brisendine|(843) 792-9007|brisend@musc.edu|
22381307|NCT00256308|University of California, Irvine|Chao Family Comprehensive Cancer Center|(877) 827-8839|UCstudy@uci.edu|
22381308|NCT01419717|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22381309|NCT02165605|UT Southwestern Medical Center|Sarmistha Sen|214-645-1477|Sarmistha.Sen@UTSouthwestern.edu|
22381310|NCT01240356|The University of Texas Health Science Center at Houston|James C. Grotta, MD|+1 (713) 500-7088|james.c.grotta@uth.tmc.edu|
22381311|NCT03766438|Mayo Clnic|Mark Wieland, MD, MPH|507-284-1195|wieland.mark@mayo.edu|
22427224|NCT00628407|Children's Hospital of Philadelphia|Vinay Nadkarni, MD|215-590-7430|nadkarni@email.chop.edu|
22427225|NCT00597272|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|646-888-4162|chapmanp@mskcc.org|
22427226|NCT03781726|University of Pennsylvania|Peter Reese|215-573-8070|Peter.Reese@pennmedicine.upenn.edu|
22427227|NCT03669588|argenx BVBA|Regulatory Manager|+32 93103400|regulatory@argenx.com|
22427228|NCT01035749|GlaxoSmithKline|GSK Response Center|866-435-7343||
22427229|NCT00492726|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22427230|NCT04386902|Neurosteer|Nathan Intrator, Prof.|+1 (401) 837-0351|nathan@neurosteer.com|
22427231|NCT02557399|GlaxoSmithKline|GSK Response Center|866-435-7343||
22427232|NCT00960804|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22427233|NCT02100124|Penn State College of Medicine|Dr. Cynthia Chuang|7175318161|CChuang@psu.edu|
22427234|NCT04350827|The Ohio State University|Dr. Michael Baria|614-293-8196|michael.baria@osumc.edu|
22427235|NCT04166214|NYU Langone Health - Hansjörg Wyss Department of Plastic Surgery|Mary E. Northridge, PhD, MPH, Director of Dental Research|347-377-4342|Mary.Northridge@nyulangone.org|
22427236|NCT00737178|Columbia University|Anne Davis, MD|2123054951|ard4@columbia.edu|
22427237|NCT02034006|Novartis Pharmaceuticals|Study Director|862-778-8300||
22427238|NCT01477567|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22427239|NCT02470741|University of California, San Francisco|Lisa Abinanti, Project Director|415-353-9978|lisa.abinanti@ucsf.edu|
22427240|NCT00485836|Genentech, Inc.|Medical Communications|800-821-8590||
22427241|NCT00750269|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22427242|NCT00161213|UMDNJ|Dr. Susan Goodin (Deputy Director, Associate Director for Clinical Science)|732-235-6783|goodin@umdnj.edu|
22427243|NCT03630393|OhioHealth|Dr. Ryan Hedgepeth|614-788-2870|ryan.hedgepeth@ohiohealth.com|
22427244|NCT02351934|Mayo Clinic|Ilya Danelich, Pharm.D., R.Ph.|507-255-5732|Danelich.Ilya@mayo.edu|
22427245|NCT02305316|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22427246|NCT02426684|Cedars Sinai Medical Center|Dr. Stanley C. Jordan, MD|310-423-2641|sjordan@cshs.org|
22442499|NCT00275340|University of Toronto|Monica Parry, RN, PhD, CCN(C)||parrym@kgh.kari.net|
22442500|NCT02299791|KaiserPermanente Center for Health Research|Rachel Gold|503-528-3902|rachel.gold@kpchr.org|
22442501|NCT00862641|Astellas Pharma Global Development|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com|
22396495|NCT01708291|University of Rochester|Sandra Jee|585-273-4657|sandra_jee@urmc.rochester.edu|
22442502|NCT02365480|Northwestern University|Seema A. Khan, MD|312-503-4236|s-khan2@northwestern.edu|
22411825|NCT00780026|University of Michigan|Subramanian Sathishkumar||ssatish@med.umich.edu|
22381312|NCT04048135|89bio, Inc.|Clinical Director|1-858-261-8838|bio89-100-002@89bio.com|
22427247|NCT01951950|Northwestern University|John F. Bebawy, MD, Principal Investigator|312-695-0061|j-bebawy@northwestern.edu|
22427248|NCT02025075|Massachusetts General Hospital|Marcos Vidal Melo, MD, PhD|617-726-8980|VidalMelo.Marcos@mgh.harvard.edu|
22427249|NCT03073486|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22381313|NCT02466516|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22427250|NCT00095979|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22381314|NCT04358549|FUJIFILM Pharmaceuticals U.S.A., Inc.|Clinical Research Manager|No phone at site|fphucontact@fujifilm.com|
22381315|NCT03712930|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22381316|NCT02909439|Stony Brook Medicine|Ramon Abola, Clinical Associate Professor|631-444-2975|ramon.abola@stonybrookmedicine.edu|
22427251|NCT01483118|Columbia University, Department of OBGYN|Roger A. Lobo M.D.|212-3056337|ral35@columbia.edu|
22427252|NCT02280252|NYU Langone Health|Dr. Nelly Huppert|(212) 731-5003|Nelly.Huppert@nyulangone.org|
22381317|NCT00785772|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22381318|NCT01062126|Abbott (Previously St Jude Medical)|Grant Kim|818-493-3147|grant.kim1@abbott.com|
22381319|NCT03837028|bakirkoy dr sadi konuk training and research hospital|Ismail Alay|+905462375638|dr_ismailalay@hotmail.com|
22381320|NCT00646451|Baylor College of Medicine|Dr. Joseph Jankovic|713-798-6556|josephj@bcm.edu|
22381321|NCT03784963|The University of Chicago|Dr. Ann Nguyen, MD|773-702-9396|anguyen3@medicine.bsd.uchicago.edu|
22381322|NCT00157014|Astellas Pharma Canada, Inc|Associate Director, Scientific Affairs||clinicaltrials@us.astellas.com|
22381323|NCT01362491|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22381324|NCT04867902|Massachusetts General Hospital|Dr. Emily Feig|617-724-9140|efeig@mgh.harvard.edu|
22381325|NCT05355116|University of Winchester|Dr James Belsey|(+44) 07799040556|KneeResearch@pm.me|
22381326|NCT02213900|Indiana University|Babar Khan, MD|317-274-9132|bakhan@iu.edu|
22381327|NCT00448864|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
22381328|NCT01390857|GlaxoSmithKline|GSK Response Center|866-435-7343||
22381329|NCT02485964|University of Arkansas for Medical Sciences|Beth Scanlan|5016868274|bscanlan@uams.edu|
22381330|NCT01474538|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22381331|NCT00367237|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22381332|NCT02501629|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22381333|NCT02004613|Cleveland Clinic Foundation|Dr. Alparslan Turan|216-445-9857|turana@ccf.org|
22381334|NCT00868231|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22381335|NCT03120676|Memorial Sloan Kettering Cancer Center|Dr. Anas Younes, MD|212-639-5059|younesa@mskcc.org|
22381336|NCT02933320|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
22381337|NCT00886613|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22396496|NCT02303704|Ch. Pervaiz Elahi Institute of Cardiology, Multan, Pakistan.|Dr. Muhammad Sher-i-Murtaza|0333-6107570|sherm.cpeic@gmail.com|
22396497|NCT03142438|Fisher & Paykel Healthcare|Hanie Yee|+64 9 574 0123|Hanie.Yee@fphcare.co.nz|7909
22396498|NCT04411628|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22396499|NCT01034540|Biofortis Clinical Research (formerly Provident)|John Marshall, General Manager|630-748-5339|john.marshall@mxns.com|
22396500|NCT02232126|University of Southern California|Dr. Susan Enguidanos|213-740-9822|enguidan@usc.edu|
22396501|NCT01721876|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22396502|NCT03805750|University of California San Diego|F.B. Nahab MD|858-822-6683|fnahab@health.ucsd.edu|
22396503|NCT00493220|Baxter Healthcare Corporation|George Harb, MD, MPH||george_harb@baxter.com|
22396504|NCT00310804|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22396505|NCT00068575|UT MD Anderson Cancer Center|Peter Pisters, MD / Professor||asanmigu@mdanderson.org|
22396506|NCT02844816|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|ctangen@fredhutch.org|
22396507|NCT01292798|California Retina Consultants|Director of Research|8059631648|gabe@californiaretina.com|3034
22396508|NCT04633174|Dartmouth-Hitchcock Medical Center|Dr. Nicholas Daniel, Staff Physician, Emergency Services|(603) 650-7254|Nicholas.Daniel@hitchcock.org|
22396509|NCT01428661|Vanda Pharmaceuticals Inc.|Curt Wolfgang, Ph.D.|202-734-3400|curt.wolfgang@vandapharma.com|
22396510|NCT04631796|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22396511|NCT04376827|Janssen Research & Development, LLC|Senior Director Clinical Research MD|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22396512|NCT04701138|University of North Carolina at Chapel Hill|Saame Shaikh, PhD|919-843-4348|shaikhsa@email.unc.edu|
22427253|NCT02783066|Baylor College of Medicine|Prof.Bijan Najafi|17137987536|bijan.najafi@bcm.edu|
22427254|NCT03248297|University of Alabama at Birmingham|Alan Tita, MD|205-934-5612|atita@uab.edu|
22442321|NCT02152956|MacroGenics, Inc.|Chief Medical Officer|301-251-5172|info@macrogenics.com|
22380954|NCT00049517|ECOG Statistical Office|Statistician|617-632-3012||
22380955|NCT00569946|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22380956|NCT04940390|Satsuma Pharmaceuticals, Inc.|Vice President of Regulatory Affairs and Quality|650-837-0799|clin.inquiries@satsumarx.com|
22380957|NCT02949271|Duke University|Ashraf Habib, M.D.|919-681-4544|ashraf.habib@duke.edu|
22380958|NCT05642000|University of California San Diego|Rebecca Fielding-Miller|8583810603|rfieldingmiller@health.ucsd.edu|
22380959|NCT02357758|London Health Sciences Centre|Dr. Sumit Dave|519.685.8439|Sumit.Dave@lhsc.on.ca|
22380960|NCT01764386|Orexigen Therapeutics, Inc.|Executive Vice President, Head of Global Development|(858) 875-8600|MedInfo@Orexigen.com|
22380961|NCT03738241|Baylor College of Medicine|Hana El Sahly, MD, FIDSA|713-798-2058|hana.elsahly@bcm.edu|
22381338|NCT04878172|Cynosure|Jamie Trimper|9788776342|jamie.trimper@cynosure.com|
22396513|NCT01798589|Dermatology Specialists|Joseph Fowler, MD|502-583-7546|fowlerjoe@msn.com|
22396514|NCT01973777|University of British Columbia|Dr Ellen Wiebe|6047095611|ellenwiebe@gmail.com|
22396515|NCT02722863|Korea Otsuka Pharmaceutical Co.,Ltd.|Huiyeong,Shim/Associate CTM for LPS & ISS|02-3287-9220|hyshim@otsuka.co.kr|
22396516|NCT05745662|UCSF Hypoxia Research Laboratory|Dr. Philip Bickler|1-415-476-1411|philip.bickler@ucsf.edu|
22396517|NCT01490450|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
22396518|NCT00404820|Novartis Pharmaceuticals|Study Director|862 778-8300||
22396519|NCT01101438|Canadian Cancer Trials Group|Professor Bingshu Chen|+16135336000|bechen@ctg.queensu.ca|77703
22427255|NCT01329198|University of Florida Center for Movement Disorders & Neurorestoration|Assistant Director of Clinical Trials|352-294-5000|stacy.merritt@neurology.ufl.edu|
22427256|NCT01004614|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22427257|NCT03044418|University of Pecs|Dr. Timea Bocskai|+36 72 507374|timokeri@gmail.com|
22427258|NCT01569022|VA Western New York|Ali El Solh|716-862-6525|ali.el-solh@va.gov|
22427259|NCT03613493|University of Miami|Dr. Susan Morgan|7654094919|semorgan@miami.edu|
22427260|NCT00644059|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22396520|NCT05335356|Biocon Biologics Limited|Dr Sarika D|080 2808|Sarika.Deodhar@biocon.com|5302
22396521|NCT02289742|Alcon Research, Ltd.|Global Medical Affairs, Brand Lead - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22396522|NCT00709111|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22396523|NCT02865018|Icahn School of Medicine at Mount Sinai, Corrine Goldsmith Dickinson Center for MS|Ilana Katz Sand|212-241-6854|ilana.katzsand@mssm.edu|
22396524|NCT04747834|Regulatory Pathways Group, Inc.|Gretchen Neumann|19494667124|gneumann@regulatorypathways.com|
22427261|NCT02497469|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22396525|NCT00139776|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22396526|NCT00187096|St. Jude Children's Research Hospital|Jeffrey Rubnitz, MD|1-866-278-5833|info@stjude.org|
22396527|NCT04223843|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22396528|NCT01911442|Sunovion|1-866-503-6351|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
22427262|NCT03558516|Department of Anesthesiology, Faculty of medicine, Siriaj hospital, Mahidol University|Assoc. Prof. Manee Raksakietisak|+66814880620|manee95@hotmail.com|
22427263|NCT03144232|Stanford University|Gregory Sahlem|650-724-0444|gsahlem@stanford.edu|
22427264|NCT04081688|Cancer Institute of New Jersey Rutgers|Dr. Jabbour|732-757-9840|jabbousk@cinj.rutgers.edu|
22427265|NCT01462942|AstraZeneca|Esther Garcia||ClinicalTrialTransparency@astrazeneca.com|
22427266|NCT00514618|MemorialCare Health Services LBMC|Lorna Camfield, Research Compliance Analyst|714-377-3227|lcamfield@memorialcare.org|
22427267|NCT04710004|Emory University|Dr. Robert Gross|404-727-2354|rgross@emory.edu|
22427268|NCT02219256|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22427269|NCT02465450|Corbus Pharmaceuticals|Ajay Aggarwal, MD|781-250-9176|aaggarwal@corbuspharma.com|
22427270|NCT00572832|University of Pittsburgh|Richard Zimmerman|412-383-2354|zimmer@pitt.edu|
22427271|NCT04456920|INSTITUT REGIONAL DU CANCER DE MONTPELLIER|Mme Aurore Moussion, Director of Direction of Clinical Research and Innovation|0467613102|drci-icm105@icm.unicancer.fr|+33
22427272|NCT03072186|Ohio State University Wexner Medical Center|Dr. Daniel Prevedello, MD|(614) 293-7190|Daniel.Prevedello@osumc.edu|
22427273|NCT01604785|Oregon Health & Science University|David Sheridan|503 494-8311|sheridda@ohsu.edu|
22427274|NCT05214118|Virginia Commonwealth University|Dr. Caitlin E. Martin|(804) 628-7023|caitlin.martin@vcuhealth.org|
22427275|NCT00931632|Mallinckrodt|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
22427276|NCT01439035|Massachusetts General Hospital|Dr. Gary Tearney PI|617-724-2979|gtearney@partners.org|
22427277|NCT01419314|Texas Woman's University|Roberto Sandoval PT|713-859-9351|rsandoval@mail.twu.edu|
22427278|NCT00449163|UM/Sylvester Comprehensive Cancer Center|Bach Ardalan MD|305-243-4909|bardalan@med.miami.edu|
22427279|NCT00541242|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22396529|NCT00825500|Alexza Pharmaceuticals, Inc|Chief Scientific Officer|650.944.7777|jcassella@alexza.com|
22381339|NCT00672256|Duke University Medical Center|Joseph McClernon|919-668-3987|mccle011@mc.duke.edu|
22396530|NCT00357214|Tufts University|Bess Dawson-Hughes|617 556 3066|bess.dawson-hughes@tufts.edu|6175100519
22381340|NCT02321748|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
22396531|NCT00922480|Boryung Pharmaceuticals|Manager of Clinical Research|+82-2-708-8069|rainbowleo@boryung.co.kr|
22396532|NCT01687179|Brigham and Women's Hospital|Elizabeth P. Henske, MD|857-307-0782|ehenske@bwh.harvard.edu|
22396533|NCT03442036|University of California San Diego|John J. Finneran IV, MD|4083073004|jfinneran@ucsd.edu|
22396534|NCT00330876|Kowa Research Institute|Bill Arana|919 433 1600|barana@kowaus.com|
22396535|NCT00971178|Department of Anaesthesiology, the University of Hong Kong|Clinical Assistant Professor|852-22553303|cheucw@hku.hk|
22396536|NCT02161575|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22396537|NCT00714285|GlaxoSmithKline|GSK Response Center|866-435-7343||
22396538|NCT01970488|Amgen Inc.|Study Director|866-572-6436||
22396539|NCT05525689|Northwestern University|Dr. David Mohr|312-503-1403|d-mohr@northwestern.edu|
22396540|NCT01231659|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22396541|NCT01075412|The University of Iowa|Sarah McGuire, PhD|214-645-7613|Sarah.McGuire@utsouthwestern.edu|
22396542|NCT00509067|Department of Psychiatry Georgetown University Medical School|Dr. Stephen I. Deutsch|757.446.5888|DeutscSI@EVMS.EDU|
22427280|NCT03368807|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22427281|NCT01118052|NRG Oncology|Linda Gedeon for Michael Sill, PhD|716-845-1169|lgedeon@gogstats.org|
22427282|NCT01721447|University of Utah Division of Cardiovascular Medicine|Dr. Brent Wilson|801-585-2341|brent.wilson@hsc.utah.edu|
22427283|NCT00843492|GlaxoSmithKline|GSK Response Center|866-435-7343||
22427284|NCT01339416|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22427285|NCT01677741|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22411826|NCT01215942|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22396543|NCT03716050|Wake Forest Baptist Health|Ivo Pestana|336-716-4171|ipestana@wakehealth.edu|
22427286|NCT00794664|Genzyme Corporation|Genzyme Medical Information|617-252-7832||
22427287|NCT02949947|UT MD Anderson Cancer Center|Saroj Vadhan,Clinical Professor, Cytokine & Supportive Oncology|(713) 792-7966|svadhanr@mdanderson.org|
22427288|NCT00457730|MS Center at Evergreenhealth Care|Theodore R. Brown, MD Principle Investigator|425-899-5350|trbrown@evergreenhealth.com|
22427289|NCT00720499|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22427290|NCT01100502|Seagen Inc.|Chief Medical Officer|(855)473-2436|medinfo@seagen.com|
22427291|NCT01414244|Tulane University|QiQi Zhou|988-7800|qiqi06@gmail.com|
22396544|NCT02132884|Fox Chase Cancer Center|Dr. Hossein Borghaei|215-2141515|Hossein.Borghaei@fccc.edu|
22427292|NCT02121860|Conatus Pharmaceuticals|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com|
22442503|NCT04762719|Mayo Clinic|Madhusudan (Madhu) Grover, M.B.B.S.|507-293-2698|Grover.Madhusudan@mayo.edu|
22442504|NCT01419197|Hoffmann-La Roche|Medical Communications|800 821-8590||
22381341|NCT03255018|National Cancer Institute|Dr. Mark J. Roschewski|240-760-6183|mark.roschewski@nih.gov|
22442505|NCT01099449|Mayo Clinic|Charles Loprinzi, M.D.|(507) 284-3731|cloprinzi@mayo.edu|
22381342|NCT01124162|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22381343|NCT03681691|Wake Forest University Health Science|Christina Hugenschmidt, PhD|336.713.4190|chugensc@wakehealth.edu|
22427293|NCT00525837|Butler Hospital|Noah S. Philip MD|401-455-6258|noah_philip@brown.edu|
22442506|NCT00146848|Clinical Affairs|Kira Stolen|1 800 CARDIAC|cshd@bsci.com|
22381344|NCT02534896|SPARC|Dr Mudgal Kothekar|912266455645|clinical.trials@sparcmail.com|
22427294|NCT00721799|The University of Iowa Department of Radiology|Yusuf Menda, MD|319-356-3214|yusuf-menda@uiowa.edu|
22381345|NCT00465985|Novartis Pharmaceuticals|Study Director|862-778-8300||
22442507|NCT02395172|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22381346|NCT00269399|Bausch Health Americas, Inc.|Director of Clinical Operations|908-927-0873|lindsey.mathew@bauschhealth.com|
22381347|NCT03439124|Basilea Pharmaceutica International Ltd.|Project Physician|+41 79 701 0551|marc.engelhardt@basilea.com|
22381348|NCT04353037|UnitedHealth Group R&D / Optum Labs|Mike Lahm, Director Data Science|302-379-0209|MichaelLahm@uhg.com|
22381349|NCT02749045|University of Pittsburgh Medical Center|Prem Soman, MD, PhD|412 647 3435|somanp@upmc.edu|
22381350|NCT00463151|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22381351|NCT05349084|Washington University School of Medicine|Dr. Pamela K. Woodard|314-362-7100|woodardp@wustl.edu|
22381352|NCT01579578|AstraZeneca|Dr Serban Ghiorghiu||ClinicalTrialTransparency@astrazeneca.com|
22396545|NCT01092143|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22396546|NCT00749476|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22411827|NCT02752776|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22411828|NCT01816477|Mayo Clinic|Dr. Dawn E. Jaroszewski|480-301-7865|Jaroszewski.Dawn@mayo.edu|
22427295|NCT04347408|Queen's University Belfast|Dr Thomas Waterfield|028 9024 5133|t.waterfield@qub.ac.uk|
22427296|NCT01441973|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22427297|NCT04356937|Massachusetts General Hospital|DRAI Director of Clinical Trials|617-726-7938|JHSTONE@mgh.harvard.edu|
22442508|NCT02032238|OD-OS GmbH|Ulrike Weber|+49 332831282|ulrike.weber@od-os.com|100
22442509|NCT00653939|OXiGENE, Inc.|Chief Executive Officer|650-635-7000|info@oxigene.com|
22427298|NCT00807365|Johns Hopkins University|Johns Hopkins ClinicalTrials.gov Program|4105506484|registerclinicaltrials@jhmi.edu|
22442510|NCT00717236|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22442511|NCT01105767|USUHS|LTC Michael Ellis|301-295-2254|Michael.Ellis@usuhs.edu|
22427299|NCT04821830|University of Michigan|Dr. Roger Albin|734-936-9115|ralbin@med.umich.edu|
22427300|NCT03415152|Abbott Laboratories|Irina Solnyshkina|+7 (495) 258-42 80|irina.solnyshkina@abbott.com|
22442512|NCT02413151|University of Lisbon|Maria Helena Santa-Clara Pombo Rodrigues|00351917377277|santaclara@fmh.ulisboa.pt|
22396547|NCT01937598|Div. Diabetology, Med. Dep. I, St. Josef-Hospital (Ruhr-Univeristy Bochum), change of address 01.01.20015|Prof. Dr. M. A. Nauck, Principle Investigator|+49-234-509|michael.nauck@rub.de|6332
22396548|NCT03098836|Duke University Medical Center|Daniel George, MD|(919) 668-8108|daniel.george@duke.edu|
22411829|NCT02162758|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22427301|NCT02934178|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22442513|NCT00029146|University of North Carolina at Chapel HIll|William J. Powers, MD||powersw@neurology.unc.edu|
22442514|NCT02663934|Washington University in St. Louis|Brittany Nelson, Senior Clinical Research Coordinator|314-747-8425|bmnelson@wustl.edu|
22381353|NCT03688542|Community Pharmacy, Center for Primary Care and Public Health (Unisanté), University of Lausanne, Switzerland|Dr Anne Niquille|+41213144845|anne.niquille@unisante.ch|
22411830|NCT04471935|Flint Rehabilitation Devices|Ian Russell|3392232676|irussell@flintrehab.com|
22442515|NCT01146457|BIDMC|Philip Hess|617-667-3353|phess@bidmc.harvard.edu|
22427302|NCT04323592|University of Trieste|Prof. Marco Confalonieri|+393356895168|mconfalonieri@units.it|4667
22442516|NCT02720042|Becton, Dickinson and Company|Sandra van Guldener|+31 6 46900840|sandra.vanguldener@bd.com|
22396549|NCT03986866|University of Arkansas for Medical Sciences|Johnathan Goree, MD|(501) 686-8818|JHGoree@uams.edu|
22396550|NCT01500525|Capital Institute of Pediatrics|Ling Cao，MD,Pulmonologist, Professor|86-13910610319|caoling9919@163.com|
22396551|NCT01660451|Bayer|Therapeutic Area Head|+1-888-8422937|clinical-trials-contact@bayer.com|
22396552|NCT04688775|H. Lundbeck A/S|Email contact via H. Lundbeck A/S|+45 36301311|LundbeckClinicalTrials@Lundbeck.com|
22396553|NCT03407651|Catalyst Biosciences|Howard Levy, Chief Medical Officer|+1.650.266.6871|hlevy@catbio.com|
22411831|NCT02116803|Novartis Pharmaceuticals|Study Director|862-778-8300||
22396554|NCT01380639|Schön Klinik Berchtesgadener Land|Dr. Klaus Kenn|+49 8652 931541|kkenn@schoen-kliniken.de|
22411832|NCT03213210|Sunstar Americas, Inc.|Akane Takemura|8477944276|akane.takemura@us.sunstar.com|
22396555|NCT01536951|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22396556|NCT00351416|Massachusetts General Hospital|Janet Hall|617-877-1112|jehall@partners.org|
22411833|NCT01399736|Maasstad Hospital|Dr.Pieter Smits|+31102913322|SmitsP@maasstadziekenhuis.nl|
22396557|NCT01843972|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22396558|NCT03982342|Nationwide Children's Hospital|Carl Backes, MD|1-614-355-6729|Carl.Backes@nationwidechildrens.org|
22396559|NCT02774616|Biotronik SE & Co.KG|Director Clinical Project Management|+49 30 68905|mathias.freudigmann@biotronik.com|0
22396560|NCT00545402|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22396561|NCT01817751|Virginia Commonwealth University Massey Cancer Center|Massey Cancer Center CTO Operations Managers|877-4627739|ctoclinops@vcu.edu|
22396562|NCT00555477|University of Michigan Comprehensive Cancer Center|Dr. Norah Lynn Henry|734-936-4991|norahh@umich.edu|
22396563|NCT00382018|SWOG|Breast Committee Statistician|2066675712|jmiao@fredhutch.org|
22396564|NCT01984164|Emory University|Dr. Hajjar|404-712-2036|ihabhajjar@emory.edu|
22396565|NCT02219321|University of Texas Southwestern Medical Center|Enas Kandil|214-648|Enas.Kandil@UTSouthwestern.edu|9374
22396566|NCT04743921|University of Alabama at Birmingham Department of Orthopaedic Surgery|Dr. Amit Momaya|205-975-2663|amomaya@uabmc.edu|
22396567|NCT00427349|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
22396568|NCT03057613|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Shlomo Koyfman|1-866-223-8100|TaussigResearch@ccf.org|
22396569|NCT01660321|ParaPro|Director, Quality and Regulatory|317-810-6205|kerrym@parapro.com|
22396570|NCT01590550|Loma Linda University|Rita Sheth, MD|909-558-8242|rsheth@llu.edu|
22396571|NCT00282295|GlaxoSmithKline|GSK Response Center|866-435-7343||
22396572|NCT00290199|UAB|Dr. Alan Tita|205-934-9616|atita@uab.edu|
22396573|NCT03337542|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
22396574|NCT06156215|University of California San Francisco|Dr Melanie Molina|512.294.4366|melanie.molina@ucsf.edu|
22396575|NCT04198623|UCSF Fresno/Community Cancer Institute|Mohammed Sani Bukari MD, Associate clinical professor|3473019055|Mohammed.Bukari@ucsf.edu|
22396576|NCT02481921|Providence VA Medical Center|Dr. Wen-Chih Wu|401-273-7100|wen-chih.wu@va.gov|16237
22396577|NCT04456764|University of Pittsburgh|P. Daniel Patterson|412-647-3078|pdp3@pitt.edu|
22396578|NCT01463670|Memorial Sloan Kettering Cancer Center|Dr. Hani Hassoun MD|646-608-3718|hassounh@mskcc.org|
22396579|NCT03029715|Menoufia Univeristy|Dr Ezzeldin Ibrahim|0021006303178|ezzeldin7@yahoo.com|
22396580|NCT00736255|DukeUMC|Scott Kollins, PhD|9196810014|kolli001@mc.duke.edu|
22396581|NCT00520884|University of Pennsylvania, Department of Medicine, Division of Endocrinology, Diabetes and Metabolism|Anne Cappola, M.D., Sc.M.|215-573-5359|ACappola@mail.med.upen.edu|
22411834|NCT03500484|Yale University / Yale School of Medicine|Ania Jastreboff, MD, PhD|203 737 1932|ania.jastreboff@yale.edu|
22411835|NCT02795104|The Ohio State University Comprehensive Cancer Center|Ryan Baltic|614-293-4121|ryan.baltic@osumc.edu|
22411836|NCT00948675|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22427303|NCT00542308|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com|
22427304|NCT02340676|Dana-Farber Cancer Institute|Dr. John Koreth, MBBS, DPhil|(617) 632-2949|John_Koreth@dfci.harvard.edu|
22427305|NCT03944616|University of California, Irvine|Dr. Andrew Odegaard|949-824-8544|aodegaar@hs.uci.edu|
22427306|NCT01926028|NovaDigm Therapeutics, Inc.|Chief Scientific Officer|2676405189|john_hennessey@novadigm.net|
22427307|NCT04539275|Palo Alto Cooperative Studies Program Coordinating Center|Lisa Zehm, Project Manager|(650)493-5000|lisa.zehm@va.gov|28805
22427308|NCT01799941|Avanir Pharmaceuticals|Nadine Knowles; Executive Director, Research & Development Operations|1-949-268-8972|nknowles@avanir.com|
22411837|NCT00684671|GlaxoSmithKline|GSK Response Center|866-435-7343||
22396582|NCT01140360|Indiana University|Dr. Kent Robertson|317-944-4969|krobert@iu.edu|
22427309|NCT00547339|University of Texas Southwestern Medical Center Dallas|Dr. Robert Timmerman|214-645-8525|Robert.Timmerman@UTSouthwestern.edu|
22427310|NCT03587636|University of Minnesota|James Flaherty|612-625-7675|jflahert@umn.edu|
22427311|NCT04452045|University of California, San Francisco|Lauren Asarnow|(415) 353-2273|lauren.asarnow@ucsf.edu|
22427312|NCT01079780|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22427313|NCT01178294|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22427314|NCT00551369|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22427315|NCT02461693|University of Alabama at Birmingham|Dr. David Allison, PI|205-975-9169|dallison@uab.edu|
22427316|NCT03181308|TRACON Pharmaceuticals Inc|Medical Monitor|8585500780|clinicaltrials@traconpharma.com|
22427317|NCT02051296|VA HCS Palo Alto|Dr Catherine Curtin|650-493-5000|ccurtin@stanford.edu|
22427318|NCT01663623|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22427319|NCT02251275|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
22427320|NCT00667511|NxStage Medical, Inc.|Kristen Sheppard|978-687-4700||
22411838|NCT04128007|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
22442517|NCT03704636|Masimo Corporation|Chelsea Frank|949-297-7000|studies@masimo.com|
22442518|NCT02356900|Duke University Medical School|Richard Moon, MD|919-684-6726|richard.moon@duke.edu|
22442519|NCT00509145|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22411839|NCT06375499|Laboratoires Théa|Corentin LE CAMUS|0033 473989604|Corentin.LECAMUS@theapharma.com|
22442520|NCT03500224|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22442521|NCT00125528|Northwestern Universiyt|Dr. Thomas Schnitzer|312-503-2315|tjs@northwestern.edu|
22381354|NCT01004263|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22381355|NCT01034111|Merck, Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22411840|NCT02755545|Galderma|Director, Medical Affairs and Clinical Development|8179615325|matthew.meckfessel@galderma.com|
22381356|NCT02341534|BIOTRONIK SE & Co. KG|Sascha Mrosk, Senior Clinical Project Manager|15168901308|sascha.mrosk@biotronik.com|0049
22411841|NCT00481247|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22381357|NCT03398356|Wroclaw Medical University|Dr Edyta Sutkowska|+48/503077016|edytasutkowska@yahoo.com|
22411842|NCT01716754|Novartis Pharmaceuticals|Study Director|862-778-8300||
22411843|NCT04371419|Massachusetts Institute of Technology|Pierre-Luc Vautrey|(617) 258-7013|vautrey@mit.edu|
22411844|NCT02931565|Cyclerion Therapeutics, Inc.|Senior Medical Director|1-857-327-8778|info@cyclerion.com|
22411845|NCT02110706|Yale School of Medicine|Dr. Richard Nowak, MD,MS|203-785-4085|richard.nowak@yale.edu|
22381358|NCT00438971|Rush University|Dr. Mark Pollack|312-942-5372|mark_pollack@rush.edu|
22411846|NCT04177810|SKCCC Johns Hopkins Medical Institution|Dung Le, MD|443-287-0002|Dle@jhmi.edu|
22411847|NCT03521999|Ralph H. Johnson VA Medical Center|Research Coordinator|843-301-9917|sarah.szafranski@va.gov|
22411848|NCT01832090|Merz North America, Inc.|Ashlee Duncan|984-222-6040|ashlee.duncan@merz.com|
22411849|NCT04182204|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22411850|NCT03933202|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA,Darmstadt, Germany|Communication Center|6151725200|service@emdgroup.com|+49
22427321|NCT02133508|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22427322|NCT00513799|Washington University|Stephanie Fritz|314-454-6050|fritz_s@kids.wustl.edu|
22427323|NCT01302899|Novartis Pharmaceuticals|Study Director|862-778-8300||
22411851|NCT00947427|Benaroya Research Institute|Carla Greenbaum||cjgreen@benaroyaresearch.org|
22427324|NCT03451071|University of Alabama at Birmingham|Haller Smith|205-934-4986|hjsmith@uabmc.edu|
22411852|NCT05105711|University of North Carolina at Chapel Hill|Melissa Gilkey, PhD|919-966-8650|gilkey@email.unc.edu|
22411853|NCT01348542|Penn State University College of Medicine|Alexandros Vgontzas|717 531-7278|vgontzas@pennstatehealth.psu.edu|
22411854|NCT01569828|Novartis Pharmaceuticals|Study Director|862-778-8300||
22411855|NCT00686036|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22427325|NCT02834975|University of Miami|Abdulrahman Sinno, MD|+1 (305) 2432233|ak.sinno@med.miami.edu|
22411856|NCT01411995|Washington University School of Medicine|Dr Colleen McNicholas|314-747-1331|mcnicholasc@wudosis.wustl.edu|
22411857|NCT05658523|Murdoch Childrens Research Institute|Kathryn Bright|+61 3 99366656|kathryn.bright@mcri.edu.au|
22411858|NCT03212170|UW Carbone Cancer Center|Dr. Amy Fowler, MD, PhD|608-262-9186|afowler@wisc.edu|
22411859|NCT01937364|Essentia Health|Jeffrey E. Lyon, M.D.|218-786-2802|jeffrey.lyon@essentiahealth.org|
22411860|NCT06052202|ISA Associates, Inc.|Samantha Leaf, PhD|7037390883|sleaf@isagroup.com|
22411861|NCT00628212|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22411862|NCT02482571|University of Minnesota|Silvia Mangia, PhD|6126254920|mangia@umn.edu|
22381359|NCT04034121|Elixir Medical|Candace Elek, Executive Vice President, Clinical Research|408-636-2020|celek@elixirmedical.com|
22411863|NCT01533428|Astellas Pharma Global Development|Medical Science Director, Global Medical Science|+31(0)715454002|Astellas.resultsdisclosure@astellas.com|
22411864|NCT02102490|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22411865|NCT00095199|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22411866|NCT03896490|Queen's University Belfast|Dr Oliver Perra|+44289097|o.perra@qub.ac.uk|2313
22411867|NCT01551095|Johns Hopkins University|Mouen Khashab|443-287-1960|mkhasha1@jhmi.edu|
22427326|NCT01856933|Brown University Oncology Research Group (BrUOG)|Heinrich Elinzano, MD|4018633000|kayla_rosati@brown.edu|
22411868|NCT03312530|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22411869|NCT00614055|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22411870|NCT00093964|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22411871|NCT02489318|Aragon Pharmaceuticals, Inc.|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22411872|NCT02261428|"Attikon General University Hospital of Athens"|Mr. Konstantinos Grigoriadis ICU Physical Therapist|00302105832489|grigoriakost@gmail.com|
22411873|NCT03679741|Johnson & Johnson Vision Care|John Buch, O.D., M.S. Sr. Prinicpal Research Optometrist|904 443-1707|JBUCH@its.jnj.com|
22381360|NCT00821236|Durrie Vision|Brigette Ellis|913-491-3330|bellis@durrievision.com|7255
22381361|NCT01582243|Novartis Pharmaceuticals|Study Director|862-778-8300||
22381362|NCT01805323|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22381363|NCT02096003|Icahn School of Medicine at Mount Sinai|Dr. Yaakov Beilin|212-241-7467|yaakov.beilin@mountsinai.org|
22411874|NCT00650936|Abbott|Maren Wagner, Clinical Program Director|7517565585|maren.wagner@abbott.com|
22411875|NCT03305055|Johns Hopkins University|James A. Fauerbach|410-550-0890|jfauerb1@jhmi.edu|
22442522|NCT01994889|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22411876|NCT02540356|Baxalta, now part of Shire|Clinical Trial Registries and Results Disclosure||ClinicalTrialsDisclosure@baxalta.com|
22427327|NCT00217490|Kaiser Permanente Center for Health Research|Victor J. Stevens, PhD|503 335 6751|victor.j.stevens@kpchr.org|
22427328|NCT02714153|Yale School of Medicine|Jude Clancy, MD Associate Professor Term; Director, Lead Management Program|(203) 785-4126|jude.clancy@yale.edu|
22411877|NCT02296775|Dr. Reddy's Laboratories Ltd, Biologics Survey No. 47, Bachupally Village, Bachupally Mandal, Medchal Malkajgiri District Telangana, India - 500 090|Dr. Ankit Ranpura, MD (Associate Director- Clinical Development)|040 4464 4000|ankitr@drreddys.com|
22411878|NCT01654380|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22427329|NCT00686972|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
22411879|NCT03335371|vTv Therapeutics LLC|Study Director|336-841-0300|clinicaltrials@vtvtherapeutics.com|
22411880|NCT01575522|Dana-Farber Cancer Institute|Sara M. Tolaney, MD, MPH|617.632.5743|Sara_Tolaney@dfci.harvard.edu|
22411881|NCT05845645|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22411882|NCT04571242|SGX Medical|VP of Clinical Affairs|818-527-2710|clinical@sgxmedical.com|
22411883|NCT00998881|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22411884|NCT02649231|University of Exeter|Professor Celia Morgan|01392 724649|Celia.Morgan@exeter.ac.uk|
22381364|NCT01112735|Baxter Healthcare Corporation|Clinical Trials Disclosure Group|734-646-8214|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
22381365|NCT00100659|Johns Hopkins University School of Medicine|Kathleen B. Schwarz, M.D.|410-955-8769|kschwarz@jhmi.edu|
22381366|NCT04654351|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22381367|NCT02783950|University of Michigan|Todd Morgan, MD|734-647-8902|tomorgan@med.umich.edu|
22381368|NCT03163511|Vertex Pharmaceuticals, Inc|Gautham Marigowda|617-961-0568|gautham_marigowda@vrtx.com|
22381369|NCT03507309|Imperial College Healthcare NHS Trust|Dr Amit Kaura|020 3312 6666|amit.kaura@nhs.net|
22381370|NCT00209274|Abbott Vascular Structural Heart (formerly Evalve, Inc.)|Chithra Sangli|650-421-6994|chithra.sangli@av.abbott.com|
22381371|NCT01190176|GlaxoSmithKline|GSK Response Center|866-435-7343|pr266560@gsk.com|
22396583|NCT00457015|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22381372|NCT01221181|Columbia University Medical Center|Andrew Bomback, MD, MPH|212-305-0320|asb68@cumc.columbia.edu|
22381373|NCT02584790|Pamela Youde Nethersole Eastern Hospital|Dr Wong Kai Chuen|(852) 64600771|wkc568@ha.org.hk|
22396584|NCT03670953|Impax Laboratories, LLC|Pamela Fitzpatrick, Senior Director, Specialty Regulatory Affairs|631-633-2104|pfitzpatrick@amneal.com|
22396585|NCT04179734|Imperial College London|Professor Waljit S. Dhillo, Principal Investigator|00442075943487|w.dhillo@imperial.ac.uk|
22396586|NCT00937937|SWOG Statistical Center|Melanoma Committee Statistician|2066674623|jmoon@fredhutch.org|
22396587|NCT00054704|NIMH, DIRP, Experimental Therapeutics and Pathophysiology Branch|Dr. Carlos Zarate|3014510861|zaratec@mail.nih.gov|
22381374|NCT01168401|Medical Director|Takeda|+1-877-825-3327|trialdisclosures@takeda.com|
22381375|NCT01260662|MinneapolisMRF|James Miner|612-873-3000|miner015@umn.edu|
22381376|NCT03049111|University of North Carolina at Chapel Hill|Michelle Hernandez, MD|919-843-5383|michelle_hernandez@med.unc.edu|
22381377|NCT00810303|Department of Clinical Pharmacology|Danilo Wegner|+4903834865640|dwegner@uni-greifswald.de|
22396588|NCT02329964|Korea University Anam Hospital|Seolju Park|+82-10-6314-6013|gursla2@naver.com|
22396589|NCT00362414|University of California Irvine|Dr. Steven Cramer|(714) 456-6876|scramer@uci.edu|
22396590|NCT04467424|University Hospital of Split|Dr. Ana Nevescanin Biliskov, pediatric anesthesiologist|00385912508001|anevescanin@gmail.com|
22396591|NCT01114503|GlaxoSmithKline|GSK Response Center|866-435-7343||
22396592|NCT02877693|Abbott|Grant Kim, Director Clinical Programs|818-493-3147|grant.kim1@abbott.com|
22396593|NCT01785160|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22396594|NCT01489670|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22396595|NCT00915772|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22396596|NCT02809131|Vanderbilt University Medical Center|Christopher R. Ellis, MD, FACC, FHRS|(615)-936-2523|Christopher.ellis@vumc.org|
22396597|NCT01365039|Bausch & Lomb Incorporated|Robert Steffen, OD, MS|(585) 338-6399|robert.steffen@bausch.com|
22396598|NCT00867789|Children's Mercy Hospital|Dr. Joan Giovanni|8162343430|gegiovanni@cmh.edu|
22396599|NCT05368961|Cleveland Clinic|Michelle Levay, Nurse Research Manager|216-445-4749|levaym@ccf.org|54749
22396600|NCT00791336|The University of Iowa|John M. Buatti, M.D., Chair, Department of Radiation Oncology|319-356-2699|john-buatti@uiowa.edu|
22396601|NCT05714982|UNC|Principal Investigator|(919) 966-3282|ntb@unc.edu|
22396602|NCT00549939|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22396603|NCT03677596|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22396604|NCT01360554|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22396605|NCT00674583|GlaxoSmithKline|GSK Response Center|866-435-7343||
22411885|NCT02531022|Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh S. Patel|215-898-3367|mpatel@pennmedicine.upenn.edu|
22427330|NCT01901185|Amgen Inc.|Study Director|866-572-6436||
22396606|NCT01621633|Novartis Pharmaceuticals|Study Director|862-778-8300||
22396607|NCT01131676|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
22396608|NCT00125762|BIDMC|Nezam Afdhal|6176321118|nafdhal@bidmc.harvard.edu|
22396609|NCT01816061|DCVAMC|Dr.Joel Scholten|2027458000|joel.scholten@va.gov|55099
22427331|NCT02065557|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22427332|NCT00250588|CCHMC|Michael Seid|5138030083|michael.seid@cchmc.org|
22427333|NCT02737722|Lakewood Amedex|Chief Medical Officer|941 928 7774|poconnor@lakewoodamedex.com|
22427334|NCT02449434|King's College London|Prof David Bartlett|02071887462|david.bartlett@kcl.ac.uk|
22427335|NCT01026493|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22442523|NCT00335764|Adult Brain Tumor Consortium (ABTC)|Mark Gilbert, MD|410-955-3657|jfisher@jhmi.edu|
22396610|NCT00731055|New York State Psychiatric Institute|Dr. Adam Bisaga|646-774-6155|amb107@columbia.edu|
22442524|NCT00929643|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22396611|NCT01286454|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22396612|NCT00702325|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22396613|NCT01898689|UC San Diego|Dr. Brian Ilfeld|(858) 444-5949|bilfeld@ucsd.edu|
22396614|NCT01022502|Chang Gung Memorial Hospital|Yin-Ku Lin, MD. PhD.|886-2-24313131|lin1266@adm.cgmh.org.tw|2127
22396615|NCT00861913|Karmanos Cancer Institute, Wayne State University|Amy M. Weise, D. O.|313-576-8952||
22396616|NCT02101515|George Washington University School of Medicine and Health Sciences|Alexis Gimovsky, MD|2027412603|agimovsk@mfa.gwu.edu|
22396617|NCT01289821|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22396618|NCT02901574|Johns Hopkins University School of Medicine|Rajani Sebastian, PhD|410-502-5012|rsebast3@jhmi.edu|
22396619|NCT01751399|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22396620|NCT03086057|Brown University|Dr. Katie Biello|401-863-3082|katie_biello@brown.edu|
22396621|NCT02887404|Cleveland Clinic Foundation|Dr. Kamal Maheshwari|216-4454311|maheshk@ccf.org|
22396622|NCT02790138|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22396623|NCT03199040|Washington University School of Medicine|Williams Gillanders, M.D.|314-747-0072|gillandersw@wustl.edu|
22396624|NCT01786603|University of Kansas Medical Center|Dr. Richard Barohn|913-945-9944|rbarohn@kumc.edu|
22396625|NCT01226459|Johnson & Johnson Healthcare Products Division of MCNEIL-PPC, Inc.|Study Director|(973) 385-3203||
22396626|NCT03770091|UPMC|John Fowler|412-605-3245|fowlerjr@upmc.edu|
22396627|NCT01854645|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com|
22396628|NCT01908972|Seoul National University College of Medicine|Prof. Tae Hyun Choi|82-10-5595-5829|psthchoi@snu.ac.kr|
22396629|NCT01977820|BioMarin Pharmaceutical Inc.|Medical Information Services|+1-800-983-4587|medinfo@bmrn.com|
22396630|NCT00698997|University California Davis|Dr. Sally Rogers|916-703-0264|sjrogers@ucdavis.edu|
22396631|NCT00475722|University of Michigan|Dr. Zora Djuric|734-615-6210|zoralong@umich.edu|
22396632|NCT03491007|Durham VA Healthcare Center|Susan O'Loughlin|919-286-0411|susan.o'loughlin@va.gov|
22396633|NCT05082376|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
22396634|NCT02568475|Florida Atlantic University|Ruth M. Tappen, Principal Investigator|561-297-2613|rtappen@health.fau.edu|
22396635|NCT02625233|Johson & Johnson Vision Care Inc.|Kristy Canavan, O.D., FAAO Principal Research Optometrist|904 443-1474|KCANAVA2@its.jnj.com|
22396636|NCT02504554|Arizona State University|James Adams|480 965 3316|jim.adams@asu.edu|
22396637|NCT00916279|Lutonix Inc. a subsidiary of C.R. Bard|Chris Barry|763-445-2352|LutonixResearch@crbard.com|
22396638|NCT03023930|Yale University|Dr. Gail D'Onofrio|(203) 785-7059|gail.donofrio@yale.edu|
22396639|NCT03598647|The Miriam Hospital|Jessica Unick, PD (Principal Investigator)|401-793-8966|junick@lifespan.org|
22396640|NCT00290186|Dayton Children's Hospital|Daniel J. Lacey, MD, PhD|937-641-3080|LaceyD@childrensdayton.org|
22396641|NCT01675635|Mundipharma (China) pharmaceutical Co, LTD.|Ms. Dan Zhu, Clinical operation and quality lead of the study|0086-10-65636800|medical.mcpc@mundipharma.com.cn|
22396642|NCT00262522|Abbott|Global Medical Services|800-633-9110||
22396643|NCT01877915|Janssen Research & Development, LLC|SENIOR DIRECTOR, CLINICAL LEADER CV|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22396644|NCT02592018|UCSF Department of Dermatology|Dr. Wilson Liao|415-476-4701|wilson.liao@ucsf.edu|
22396645|NCT00891319|MetroHealth Medical Center|Dr. Jayme Knutson|2169573557|jsk12@case.edu|216
22396646|NCT00798135|IndianaU|Kathy Miller, MD||kathmill@iupui.edu|
22396647|NCT02228720|Intersect ENT|James Stambaugh|6506412103|jstambaugh@intersectent.com|
22396648|NCT01401842|University of South Florida|John M. Mayer, DC, PhD / Study Director|813-974-3818|jmayer2@health.usf.edu|
22411886|NCT00876733|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22411887|NCT01714505|University of Virginia|Boris Kovatchev, PhD|434-924-5592|boris@virginia.edu|
22411888|NCT02611752|Braeburn|Sonnie Kim|1 610 467 8717|sonnie@braeburnrx.com|
22411889|NCT00249821|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22411890|NCT01636297|Cleveland Clinic|Dr. Jay Alberts|216-445-3222|albertj@ccf.org|
22411891|NCT00423800|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22411892|NCT00814320|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22411893|NCT00619385|Repros Therapeutics|Jennifer Wike|2817193402|jwike@reprosrx.com|
22411894|NCT06394973|Laboratoires Théa|Clinical Affairs Director|+33473981436|Corentin.LECAMUS@theapharma.com|
22411895|NCT00656019|StanfordU|Dr. Melinda Telli|650-724-9533|steinhau@stanford.edu|
22411896|NCT01488578|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22411897|NCT01166971|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22427336|NCT03306199|Cardiovascular Institute of the South|Research Team Leader|(985) 873-5613|Deanna.Benoit@cardio.com|
22427337|NCT02662569|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22411898|NCT01483872|UCSD|Saima Aslam|858 657 7463|saslam@ucsd.edu|
22411899|NCT05550532|Janssen Research and Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22396649|NCT03372928|US Army Research Institute of Environmental Medicine|Jess Gwin|508-206-2300|jessica.a.gwin.ctr@mail.mil|
22411900|NCT04234568|University of Kentucky|Dr. Susanne Arnold|859-323-8043|susanne.arnold@uky.edu|
22411901|NCT03071406|Moffitt Cancer Center|Sungjune Kim, MD, PhD|813-745-1898|sungjune.kim@moffitt.org|
22411902|NCT03390504|Janssen Research & Development, LLC|SR DIRECTOR ONCOLOGY CDTL|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22411903|NCT00859469|Columbia University|Joshua Leinwand|212-305-4076|jcl2125@columbia.edu|
22411904|NCT05431686|Children's National Hospital|Dr. Jody Grundman|2024762121|jgrundman@childrensnational.org|
22411905|NCT02286518|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22411906|NCT02938494|Bausch Health|Study Director||anya.loncaric@bauschhealth.com|
22411907|NCT01879800|Baylor College of Medicine|Dr. Lilian Dindo|713-791-1414|lilian.dindo@bcm.edu|10296
22411908|NCT01736553|The Ohio State Unviersity Wexner Medical Center|Dr. Stephen Kolb|614-366-9050|stephen.kolb@osumc.edu|
22411909|NCT01890707|Northwestern University|Shireen Ahmad MD|312-472-3585|sahmad@northwestern.edu|
22411910|NCT00669955|Axcan Pharma Inc.|Monique Giguere, PhD, Programs Director,|1-800-565-3255||2078
22411911|NCT03495869|Virginia Commonwealth University|Lori Keyser-Marcus, PhD|(804) 828-4164|lori.keysermarcus@vcuhealth.org|
22411912|NCT02780661|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22411913|NCT01693484|LSU Health Science Center Shreveport|Dr Todd Jaeblon|318 675 6180|tjaebl@lsuhsc.edu|419
22411914|NCT01691508|GlaxoSmithKline|GSK Response Center|866-435-7343||
22411915|NCT04579926|Klein Buendel, Inc.|Julia Berteletti|3035654321|jberteletti@kleinbuendel.com|
22411916|NCT02918162|Columbia University|Gulam Manji, MD, PhD|212-305-7115|gam2140@cumc.columbia.edu|
22411917|NCT00395226|Essentia Institute of Rural Health|Brian Johnson|218-786-8856|bjohnson3@eirh.org|
22427338|NCT01308619|Galderma Laboratories|Dr. Warren Winkelman|817-961-5494|warren.winkelman@galderma.com|
22427339|NCT03154086|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22427340|NCT01603277|KaloBios Pharmaceuticals Inc.|Nestor Molfino, MD|650-243-3100|nmolfino@kalobios.com|
22427341|NCT03148262|UT Southwestern Medical Center|Dr. Christina Riccio|214-590-7284|Christina.Riccio@UTSouthwestern.edu|
22427342|NCT00305162|The Medicines Company|Meredith Todd|+19732906088|meredith.todd@themedco.com|
22427343|NCT01701245|electroCore LLC|Annelie Andersson|+46 721 803076|annelie.andersson@electrocorellc.com|
22427344|NCT01183923|Johns Hopkins University School of Medicine|Elizabeth Matsui, MD MHS|410-502-3858|ematsui@jhmi.edu|
22427345|NCT01690663|the University of Pennsylvania|Jiabin Liu, MD, PhD|215-573-8208|jiabin.liu@uphs.upenn.edu|
22427346|NCT03555149|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22427347|NCT02965924|Mayo Clinic|Arthur J. Sit, MD|507-284-2787|Sit.Arthur@mayo.edu|
22427348|NCT02785939|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
22427349|NCT04465422|Taipei City Hospital|Shu Chun Lee|+886 2 27263141|A1057@tpech.gov.tw|1004
22427350|NCT02668003|University of Aberdeen|Professor Gary Macfarlane|01224 437 143|g.j.macfarlane@abdn.ac.uk|
22427351|NCT01787552|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22427352|NCT00000575|Johns Hopkins Bloomberg School of Public Health, Dept of Epidemiology|Alice Sternberg|410-955-3752|asternbe@jhsph.edu|
22427353|NCT02443623|Emergent Biosolutions Inc.|Clinical Development Representative|(204) 275-4196|ctgov@ebsi.com|
22427354|NCT01299584|GlaxoSmithKline|GSK Response Center|866-435-7343||
22427355|NCT02679976|Johnson & Johnson Vision Care Inc.|Tom Karkkainen SR. PRINCIPAL RESEARCH OPTOMETRIST|904-443-3500|TKarkkai@its.jnj.com|3402
22442525|NCT01748240|academic group|Groupe Francophone des Myelodysplasies|+ 33 (0)1 71 20 70 59|fatiha.chermat@aphp.fr|
22427356|NCT02709317|University of Pennsylvania|James McKay|215-746-7704|jimrache@upenn.edu|
22427357|NCT01092767|Medtronic, Inc., Aortic and Peripheral Vascular|Laura Regan, MPH - Study Lead|707-591-2743|laura.e.regan@medtronic.com|
22427358|NCT01048424|University of California, San Francisco|Alison Huang, MD|415-353-9751|ahuang@medicine.ucsf.edu|
22427359|NCT01307813|University Hospitals Cleveland Medical Center|Jeffrey Marks, MD - General Surgeon|216-983-4930|Jeffrey.Marks@uhhospitals.org|
22427360|NCT02175121|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22427361|NCT02037893|Pernix Therapeutics|Senior Director, Medical and Scientific Affairs|8007932145|egould@pernixtx.com|
22427362|NCT04798027|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22427363|NCT04054544|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22427364|NCT02147301|University of California, San Francisco|Curt Johanson|415-353-2310|curt.johanson@ucsf.edu|
22427365|NCT02753881|Yale University|Todd Schlachter, MD|(203) 785-5885|todd.schlachter@yale.edu|
22427366|NCT01814007|Zeltiq Aesthetics|Kerrie Jiang, Executive Director Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
22427367|NCT01274351|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22427368|NCT00535613|University of Wisconsin|Cari Meyer|(608) 265-5980|cmeyer@wisc.edu|
22427369|NCT01750502|Department of Cardiology, the Second Affiliated Hospital, Wenzhou Medical University, Zhejiang province, Wenzhou,China|Dr. JiFei Tang|15968766021|jiftang@126.com|
22427370|NCT03861039|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22427371|NCT01113749|University of North Carolina Chapel Hill|Laura C. Hanson, MD, MPH|9199665945|lhanson@med.unc.edu|
22427372|NCT03427892|UTexasSouthwestern|Dr. E. Sherwood Brown|(214) 645-6950|Sherwood.Brown@UTSouthwestern.edu|
22427373|NCT01042795|University of Michigan|Cheryl T. Lee|614-685-6666|cheryl.lee@osumc.edu|
22427374|NCT00997334|Dana-Farber Cancer Institute|David M. Jackman, MD|617.632.3468|David_Jackman@dfci.harvard.edu|
22427375|NCT01586195|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22427376|NCT01258374|Hospital Clinic|Dr. Josep Mallolas Masferrer|00 44 93 227 54 00|mallolas@clinic.cat|3312
22427377|NCT04596293|Bridge Biotherapeutics, Inc.|Clinical Trial Lead|031-8092-3280|clinicaltrials.gov_inquiries@bridgebiorx.com|
22427378|NCT01287936|SanBio, Inc.|Bijan Nejadnik M.D.; Chief Medical Officer|650-625-2205|Bijan.Nejadnik@sanbio.com|
22427379|NCT01855958|Hospital de Clínicas de Porto Alegre|Wolnei Caumo, MD,PhD.|+555133598430|caumo@cpovo.net|
22427380|NCT00296244|Thomas Jefferson University|Carlo Gerardo B Ramirez, MD|215-955-5909|carlo.ramirez@jefferson.edu|
22427381|NCT02863666|University of Buffalo|Brooke Lerner PHD,|716.390.3509|lerner@buffalo.edu|
22427382|NCT01507350|Imperial College|Carel le Roux|07970719453|c.leroux@imperial.ac.uk|
22427383|NCT03946059|University of California San Diego|Dr. Jyoti Mishra|8582322855|jymishra@ucsd.edu|
22442526|NCT02037555|Grifols Therapeutics, LLC|Miquel Barceló, PhD|+34 935.712.368|Miquel.Barcelo@grifols.com|
22427384|NCT00266708|Montefiore Medical Center|Maria Coco, MD|718-920-4136|mcoco@montefiore.org|
22427385|NCT00703534|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22427386|NCT00427934|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22427387|NCT02791269|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22427388|NCT02683109|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22427389|NCT00368251|UCB|UCB Cares|+1877 822||9493
22442527|NCT00145977|The University of Chicago|Tamara Vokes, MD|773-702-1465|tvokes@medicine.bsd.uchicago.edu|
22427390|NCT04596319|Armata Pharmaceuticals, Inc.|Mina Pastagia, MD|(310) 665-2928|mpastagia@armatapharma.com|
22427391|NCT01125930|University of Michigan|Dr. Lisa Maier|734-936-4192|maierl@med.umich.edu|
22427392|NCT02741284|Washington University in St Louis|Dr Nandini Raghuraman|314 362 7300|nraghuraman@wustl.edu|
22427393|NCT00900562|Pharma Mar S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|0034 91846 60 00|clinicaltrials@pharmamar.com|
22427394|NCT02300610|H. Lee Moffitt Cancer Center and Research Institute|Dr. Jingsong Zhang|813-745-3973|jingsong.zhang@moffitt.org|
22427395|NCT02152007|TransDerm, Inc.|Roger Kaspar, PhD|831-420-1684|roger.kaspar@transderminc.com|
22427396|NCT03316105|Mayo Clinic|Michael Camilleri, M.D.|507-284-2687|camilleri.michael@mayo.edu|
22427397|NCT00447083|Wake Forest University Health Sciences|Steve feldman, MD|336-716-3775|sfeldman@wakehealth.edu|
22427398|NCT03363906|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22442528|NCT03435783|Brown University School of Public Health|Tyler Wray|401-863-6659|tyler_wray@brown.edu|
22442529|NCT02645019|Nationwide Children's Hospital|Mineto Kamada|6147224200|mineto.kamata@gmail.com|
22442530|NCT01573052|VA Salt Lake City Medical Center|Dr. Christopher Stock|801-582-1565|christopher.stock@va.gov|1172
22442531|NCT02717832|University of Michigan|Dr. Jeffrey Horowitz|734-647-1076|jeffhoro@umich.edu|
22427399|NCT00676143|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22427400|NCT00929669|University of Pennsylvania|Peter J. Snyder, MD|215-898-0208|pjs@mail.med.upenn.edu|
22427401|NCT00472420|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22427402|NCT01658839|Alcon Research, Ltd.|Theresa Landry, Project Head, Clinical Trial Management|1-888-451-3937|alcon.medinfo@alcon.com|
22442532|NCT01215097|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22442533|NCT00932828|University of North Carolina at Chapel Hill|Dr. Edwin Kim, Director of the UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
22442534|NCT01325337|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22442535|NCT03035487|Exact Imaging|Manager, Clinical Research|905-415-0030|bwodlinger@exactimaging.com|204
22442536|NCT00522925|Ligand Pharmaceuticals, Inc.|Ram Kapil, PhD/ Sr. Director, Clinical Pharmacology|858-550-7603|rkapil@ligand.com|
22442537|NCT02558829|Aeterna Zentaris|Dr. Nicola Ammer|+496942602|nammer@aezsinc.com|3472
22442538|NCT02248688|Dayton Interventional Radiology-Research|Mubin Syed, MD|937-215-0878|mubinsyed@aol.com|
22442539|NCT00576680|Dana-Farber Cancer Institute|Dr. Jennifer Chan|617-632-6315|jang@partners.org|
22442540|NCT00955201|Edward Hines Jr. VA Hospital|Evan Stubbs|708-202-3507|evan.stubbs@va.gov|
22442541|NCT02737891|Saniona A/S|Kim Krogsgaard|20148384|kim.krogsgaard@saniona.com|0045
22442542|NCT02338232|Hackensack Meridian Health|Joshua Zenreich|5519964248|joshua.zenreich@hmhn.org|
22442543|NCT03890666|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
22442544|NCT01105065|Massachusetts Eye and Ear Infirmary|Louis R. Pasquale, MD|617-573-4270|Louis_Pasquale@meei.harvard.edu|
22442545|NCT02331095|The Ohio State University|Dr. Tzu-Fei Wang|614-366-8366|tzufeiwang@gmail.com|
22442546|NCT03495856|University of North Carolina School of Medicine|Carrie Brintz|919-445-6109|carrie_brintz@med.unc.edu|
22442547|NCT02122783|MossRehab|Mukul Talaty|2156636682|mctalaty@einstein.edu|
22442548|NCT00322621|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22442549|NCT04987788|Icahn School of Medicine at Mount Sinai|Sarah Miller|(212) 824-7783|sarah.miller@mssm.edu|
22442550|NCT02010151|Seoul National University Hospital|Dr. Sun Young Lee|+82-10-9269-2376|sy2376@gmail.com|
22442551|NCT01034670|Stanford University|Shai Friedland, MD|(650) 617-2732|shaif@stanford.edu|
22442552|NCT01781299|University of Pittsburgh Plastic Surgery|Kenneth Shestak|412-641-1487|shestakkc@upmc.edu|
22442553|NCT01798849|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
22442554|NCT00612105|Valeant Pharmaceuticals International, Inc.|Associate Director Clinical Operations|919-294-3080|david.lineberry@valeant.com|
22442555|NCT00475982|VA Medical Center Greater Los Angeles Healthcare System|William Aronson, MD|3102683446|waronson@ucla.edu|
22442556|NCT00743106|Cleveland Clinic Foundation|Jerome O'Hara, MD|216-444-8278|oharaj@ccf.org|
22442557|NCT02778113|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22442558|NCT02410343|Teva Branded Pharmaceutical Products|Director of Clinical Trials|215-591-3000|Public_CTD@tevapharm.com|
22442559|NCT00946985|Ortho-McNeil Janssen Scientific Affairs, LLC|Clinical Project Scientist|609-730-3229||
22442560|NCT00271505|UT MD Anderson Cancer Center|Dr. John V Heymach, PHD/ Chair, Thoracic-Head & Neck Med Onc|713-792-6363|jheymach@mdanderson.org|
22427403|NCT04656652|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo_us@daiichisankyo.com|
22442561|NCT04556383|GB004, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.|GB004, Inc. Study Director|1-866-668-4083|ClinicalTrials@gossamerbio.com|
22442562|NCT00539188|Yale University School of Medicine|Christopher Pittenger, MD Ph.D|203-974-7675|christopher.pittenger@yale.edu|
22442563|NCT04784442|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81363617366|CL_OPCJ_RDA_Team@otsuka.jp|
22442564|NCT01955629|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22442565|NCT02259088|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22442566|NCT03060551|Department of Plastic Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea|Suk-Ho Moon|821090803527|nasuko@catholic.ac.kr|
22442567|NCT03562988|Church & Dwight Co., Inc|Dr. Annahita Ghassemi, PhD|609-806-1200|annahita.ghassemi@churchdwight.com|
22442568|NCT02453672|Samsung Bioepis|Director of Clinical Development|+82 31 8061 4534|sbregistry@samsung.com|
22442569|NCT01094522|Stanford University School of Medicine|Dr. Gregory Hammer|6507367359|ham@stanford.edu|
22442570|NCT01214395|PathWest Laboratory Medicine WA|Dr Kerry Carson Trial Manager|+61 8 93464092|kerry.carson@uwa.edu.au|
22442571|NCT04166240|VAORD|Hardeep Singh|713 7948515|hardeep.singh@va.gov|
22442572|NCT03698591|Duke University|Dr. Kevin LaBar, PhD.|(919)668-2424|klabar@duke.edu|
22442573|NCT03009396|Redhill Biopharma|Reza Fathi, Sn. VP Research and Development|972-(0)3-541-3131|reza@redhillbio.com|
22442574|NCT00548652|VANebraska|Cyrus Desouza|4023468800|cyrus.desouza@va.gov|5506
22442575|NCT00610480|UT Southwestern Medical Center|Peter Chen|214-648-3837|peter.chen@utsouthwestern.edu|
22442576|NCT00238355|OHSU Knight Cancer Institute|Dr. Lynne Strasfeld|503-494-1551|strasfel@ohsu.edu|
22442577|NCT02660983|Eisai Co., Ltd.|Inquiry Service||eisai-chiken_hotline@hhc.eisai.co.jp|
22442578|NCT04410133|Blue Earth Diagnostics|Head of Research and Development|+44 (0) 1865 784 186|matthew.miller@blueearthdx.com|
22442579|NCT02902146|HHRI|Audrey Hendrickson|6128737448|audrey.hendrickson@hcmed.org|
22442580|NCT03376295|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22442581|NCT00893815|Henry Jackson Foundation|Infectious Diseases Clinical Research Program||contactus@idcrp.org|
22442582|NCT01165216|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22442583|NCT04947085|Maimonides Medical Center|Sergey Motov|718-283-6000|smotov@maimo.org|
22442584|NCT00167219|University of Minnesota, Masonic Cancer Center|Dr. Margaret MacMillan, MD|+1 612-626-2961|macmi002@umn.edu|
22442585|NCT00243841|Indiana University|Amy Miller Research Manager|317 944 1242|amym@iu.edu|
22442586|NCT00363545|GlaxoSmithKline|GSK Response Center|866-435-7343||
22442587|NCT00721968|Glaukos|Jeff Wells. Sr VP, Clinical, Regulatory, and Quality Affairs|949-367-9600|jwells@glaukos.com|227
22442588|NCT01064947|DermResearch, PLLC|Leon H. Kircik, M.D.|502-451-9000|wedoderm@yahoo.com|
22442589|NCT06221826|Pharmasoft|Meshcherskiy Y.E., Medical director|+7(495)626-47-55|meshcherskiy_y@pharmasoft.ru|140
22442590|NCT04180540|Emory University|Michael lloyd|404-712-4063|mlloyd@emory.edu|
22442591|NCT06457204|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
22442592|NCT01457352|Sun Pharma Advanced Research Company Limited|SPARC|912266455645|Clinical.Trials@Sparcmail.com|
22442593|NCT01601652|UC Davis|Arthur J de Lorimier, Director of Pediatric Gastroenterology|916-734-3112|adelorimier@ucdavis.edu|
22442594|NCT04469998|AxeroVision, Inc.|Dr. Houman Hemmati|+1 (310) 600-4123|houman@axerovision.com|
22442595|NCT03048383|University of Utah|Dr. P. Daniel Ward|801-581-8471|PDanielWard@hsc.utah.edu|
22442596|NCT01909011|Mount Sinai Beth Israel|Igor Galynker MD PhD|212-420-4535|igalynke@chpnet.org|
22442597|NCT00695097|University of California, San Francisco|Flavio Vincenti|415-353-1322|flavio.vincenti@ucsfmedctr.org|
22442598|NCT04614324|Aerin Medical|Anais Laborde Sr. Director of Clinical Affairs|650-518-9624|alaborde@aerinmedical.com|
22442599|NCT00982423|Mayo Clinic|Dr. Horng Chen|507-538-2354|chen.horng@mayo.edu|
22396650|NCT03828292|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22442600|NCT02712047|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22442601|NCT03865316|Masimo Corporation|Cristina Johnson|949-297-7000|ClinicalResearchDept@masimo.com|
22427404|NCT02722967|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development||DT-inquiry@otsuka.jp|
22427405|NCT04142242|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22427406|NCT00773357|Yale School of Medicine|Sherry McKee|2037373529|sherry.mckee@yale.edu|
22442602|NCT03658876|Imperial Healthcare NHS Trust|Dr Damien Ashby||d.ashby@imperial.ac.uk|
22427407|NCT00846053|Washington University|Thomas Ferkol, MD|314 454 6000||
22427408|NCT05597865|Washington University in St. Louis|Rachel Brathwaite|3147282869|rachel.brathwaite@yahoo.com|
22442603|NCT01948193|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22427409|NCT01791595|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
22427410|NCT01776554|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
22442604|NCT01330017|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22442605|NCT04096482|Emory University|Joshua M Levy|(404) 778-3381|joshua.levy2@emory.edu|
22442606|NCT02000154|SymBio Pharmaceuticals|Katsuhisa Goto|+81-3-5472-1127||
22427411|NCT01041859|Janssen Research&Development|Director, Clinical Leader|609-730-6777||
22427412|NCT02027025|Sun Pharma Advanced Research Company Limited|Mudgal Kothekar|912266455645|mudgal.kothekar@sparcmail.com|
22427413|NCT03210714|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22442607|NCT03137069|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22442608|NCT03225859|Minneapolis VA Medical Center|Shannon Kehle-Forbes, PhD|612-467-4772|Shannon.Kehle-Forbes@va.gov|
22442609|NCT01106092|GlaxoSmithKline|GSK Response Center|866-435-7343||
22442610|NCT01371032|Cedars Sinai Medical Center|Dr. Roya Yumul, MD, PhD|310-423-1682|Roya.Yumul@cshs.org|
22381378|NCT01720043|Huntsman Cancer Institute|Kimberlee Taylor|8012135673|Kimberlee.Taylor@hci.utah.edu|
22381379|NCT01688973|City of Hope National Medical Center|Przemyslaw W. Twardowski, MD|626-256-4673|ptwardowski@coh.org|68218
22381380|NCT01702896|Western Regional Medical Center|Jessica L. Coats|623-207-3899|jessica.coats@ctca-hope.com|
22381381|NCT04371536|Baylor College of Medicine|Dr. Jacquelyn Powers|832-824-7330|jmpowers@txch.org|
22381382|NCT02712099|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
22381383|NCT00908947|BD/Bard|Talar Saber, Senior Project Manager, Clinical Affairs|1.480.379.2839|Talar.Saber@crbard.com|
22381384|NCT02796092|GITMI (University of Zaragoza)|Prof. Alicia Laborda|0034 976 76 15 49|alaborda@unizar.es|
22381385|NCT03710564|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22381386|NCT00293462|University of California, San Francisco|Marylin J. Dodd, RN, PhD, FAAN|415-476-2191|Marylin.dodd@ucsf.edu|
22381387|NCT00372060|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22381388|NCT00647348|University of London|Professor Jeremy Chataway, Chief Investigator|07974752295|j.chataway@ucl.ac.uk|
22381389|NCT04880070|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
22381390|NCT01104103|The University of Texas Health Science Center at Houston|Dr. Richard Bradley|713-500-7878|Richard.N.Bradley@uth.tmc.edu|
22381391|NCT03382821|University of Utah, Department of Physical Medicine and Rehabilitation|Dr. Zachary McCormick|801-587-5432|PMR.Research@hsc.utah.edu|
22442611|NCT02434471|Duke University|Mustafa R. Bashir, M.D.|919-684-7366|mustafa.bashir@duke.edu|
22442612|NCT01473368|Beth Israel Deacones Medical Center|Ciaran Kelly, MD|617-667-1272|ckelly2@bidmc.harvard.edu|
22442613|NCT00369629|Northwestern University|Barbara Pro||barbara.pro@nm.org|
22442614|NCT04839562|Massachusetts General Hospital|Dr. Craig Surman|6176808489|csurman@partners.org|
22442615|NCT03381742|Department of Cardiology, the First Affiliated Hospital, Harbin Medical University, Harbin, China|Dr. Yue Li|86-451-85555673|ly99ly@vip.163.com|
22442616|NCT00877773|University of Texas (UT) MD Anderson Cancer Center|Daniel Karp, MD / Professor, Investigational Cancer Therapeutics||CR_Study_Registration@mdanderson.org|
22442617|NCT01145638|Pharmacosmos A/S|Vice President Research & Development Department|+45 59485959|llt@pharmacosmos.com|
22442618|NCT00668733|Graceway Pharmaceuticals|Sharon F. Levy, MD / Sr. VP, Clinical Product Development|267-948-0400|sharon.levy@gracewaypharma.com|
22442619|NCT02908490|University of Pittsburgh|Kimberly P. Liang, MD, MS|412-586-3550|liangkp@upmc.edu|
22442620|NCT01122264|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22442621|NCT00097981|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Medical Director|1 215 325-5329||
22442622|NCT03135119|Penn State College of Medicine|Dr. Brian Allen|7175314100|ballen1@pennstatehealth.psu.edu|
22381392|NCT00282438|Northwestern University|Dr Richard Burt, Chief, Division of Immunotherapy, Department of Medicine|312-695-4960|rburt@northwestern.edu|
22381393|NCT00875641|GlaxoSmithKline|GSK Response Center|866-435-7343||
22381394|NCT04500821|Johnson & Johnson Surgical Vision|Luis Vargas, MD|714-247-8200|LVarga17@ITS.JNJ.com|
22381395|NCT00587132|Mayo Clinic|Dr. Naoki Takahashi|507-284-7249|takahashi.naoki@mayo.edu|
22442623|NCT01836276|University of Kansas Medical Center|Dr. Nicole Nollen|913-588-3784|nnollen@kumc.edu|
22396651|NCT01054742|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22381396|NCT01119703|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22396652|NCT03366298|Imperial College London|Dr Paul Turner|+44 20 3312 7754|p.turner@imperial.ac.uk|
22442624|NCT01707238|Visioncare Research Ltd.|Graeme Young|01252 718719|g.young@visioncare.co.uk|207
22381397|NCT01511250|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22442625|NCT00856414|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22442626|NCT00945295|New Mexico VA Healthcare System|JoAnn Harnar, Research Nurse|505-256-5701|Joann.Harnar@va.gov|
22442627|NCT00583713|Braintree Laboratories, Inc.|Russell Pelham, PhD|781-843-2202|rpelham@braintreelabs.com|
22442628|NCT00796445|GlaxoSmithKline|GSK Response Center|866-435-7343||
22442629|NCT02208063|Cumberland Pharmaceuticals Inc.|Senior Director of Clinical and Regulatory Affairs|615-255-0068|ahaeberle@cumberlandpharma.com|
22442630|NCT00388583|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22442631|NCT00913458|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22381398|NCT04668144|University of Florida College of Medicine Jacksonville|Francesco Franchi, MD|904244206|francesco.franchi@jax.ufl.edu|
22442632|NCT02366091|Johns Hopkins Hospital|Robert G. Weiss, MD|410-955-1703|rweiss@jhmi.edu|
22442633|NCT05194579|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22381399|NCT02095158|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22381400|NCT03441984|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22442634|NCT00700141|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com|
22442635|NCT00638183|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22442636|NCT02350764|Memorial Sloan Kettering Cancer Center|Dr. Adam Schoenfeld, MD|646-608-4042|schoenfa@mskcc.org|
22442637|NCT03180619|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22442638|NCT02743611|Bellicum|Contact for Clinical Trials|(832) 384-1100|clinicaltrials@bellicum.com|
22442639|NCT01433289|Baylor|Supriya Parikh|832-824-2589|supriya.parikh@bcm.edu|
22396653|NCT05050318|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22396654|NCT03116997|Memorial Sloan Kettering Cancer Center|Dr. German Echeverry, MD|212-639-8865|echeverg@mskcc.org|
22396655|NCT00574145|Vanderbilt-Ingram Cancer Center|Nancy Wells, DNSc., R.N|615-322-6184|nancy.wells@vanderbilt.edu|
22396656|NCT03227471|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22442640|NCT00729469|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
22442641|NCT04132804|Massachusetts General Hospital|Dr. Kyle Staller|617-726-5565|kstaller@mgh.harvard.edu|
22442642|NCT02535572|Medical University of South Carolina|Morgan Dancy|843-876-5141|maddoxm@musc.edu|
22381401|NCT00631917|Novartis Pharmaceuticals|Study Director|862-778-8300||
22442643|NCT01989208|Sulfagenix|President and CEO|1-318-349-3851|tgiordano@sulfagenix.com|
22442644|NCT00566696|St. Jude Children's Research Hospital|Brandon Triplett, MD|866-278-5833|referralinfo@stjude.org|
22442645|NCT00706342|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
22411918|NCT02059993|State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College|Zhihong Liu|+86-01088398196|zhihongliufuwai@163.com|
22381402|NCT04001114|University of Maryland|Britta Hahn, Ph.D.|410-402-6112|bhahn@som.umaryland.edu|
22381403|NCT04436029|Cartesian Therapeutics|Chief Medical Officer|(301) 348-8698|trials@cartesiantx.com|
22381404|NCT02696785|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22381405|NCT03486197|University of Washington/Fred Hutch Cancer Center Proton Therapy|Dr. Jing Zeng|2065984110|jzeng13@uw.edu|
22411919|NCT02655237|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22381406|NCT01016353|KCI|Senior Director, Global Clinical Development|(210) 255-5595|jane.hart@kci1.com|
22381407|NCT04863898|RTI International|Laura Nyblade, Fellow|202-728-1961|lnyblade@rti.org|
22411920|NCT02227862|Mylan Inc.|David Gillogly, Head of Global Clinical Operations|+1 (724) 4856581|david.gillogly@mylan.com|
22411921|NCT06331156|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22381408|NCT00614744|Brown University, Women & Infants Hospital of Rhode Island|Abbot Laptook|401-274-1122|alaptook@wihri.org|47421
22381409|NCT03285711|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22381410|NCT00877851|Queen's University, Belfast|Prof Michelle McKinley|+44(0)2890632685|m.mckinley@qub.ac.uk|
22381411|NCT02431533|Pharmabiotix, Inc|Mark Cobb|214-327-4712|cobbcoinc@aol.com|
22381412|NCT02303743|Hospital Germans Trias i Pujol|Dr. Vicente Lorenzo-Zúñiga García|+34-934978866|vlorenzo.germanstrias@gencat.cat|8443
22381413|NCT00770211|Merz Pharmaceuticals GmbH|Dr. Matthias Zerm|0049-69-1503|matthias.zerm@merz.de|865
22381414|NCT02982928|Nationwide Children's Hospital|Ahsan Syed, MD|614-722-4200|Ahsan.Syed@nationwidechildrens.org|
22381415|NCT01446003|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22381416|NCT00318656|GlaxoSmithKline|GSK Response Center|866-435-7343||
22381417|NCT00490555|University of Washington|Dr. Stephanie Page|2066160483|page@u.washington.edu|
22411922|NCT02893267|MetroHealth Medical Center|Dr. Richard Wilson|216-957-3559|rwilson@metrohealth.org|
22396657|NCT04183790|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22396658|NCT01251653|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22396659|NCT00847145|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22396660|NCT02833974|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22427414|NCT04609514|Duke University|Roger Vilardaga Viera, PhD|919-684-3441|roger.vilardaga@duke.edu|
22396661|NCT04419610|Imperial College|Dr David Owen|07575089144|d.owen@imperial.ac.uk|
22396662|NCT00751777|Valneva Austria GmbH|Head Clinical Development|0043120620|info@valneva.com|0
22396663|NCT00675922|University of Texas Medical Branch|Tina Mack-Moshay, ClinicalTrials.gov Administrator|409-266-6917|tlmackmo@utmb.edu|
22396664|NCT00980200|GlaxoSmithKline|GSK Response Center|866-435-7343||
22396665|NCT01617460|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366||
22411923|NCT03748641|Janssen Research & Development, LLC|Executive Medical Director Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22411924|NCT00437281|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22411925|NCT02970669|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22411926|NCT03495986|University of Miami Miller School of Medicine|Dr. Eduard Tiozzo|3052431633|etiozzo@miami.edu|
22396666|NCT00984490|Vanderbilt-Ingram Cancer Center|Ingrid Mayer, MD|615-936-2033|ingrid.mayer@vanderbilt.edu|
22427415|NCT02816723|VA Northern California Health Care System|Juliana Baldo|925-372-4649|Juliana.Baldo@VA.gov|
22427416|NCT00828711|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22381418|NCT01007149|Novartis Pharmaceuticals|Study Director|862-778-8300||
22396667|NCT03197493|Robert W Snyder, MD, PhD, PC|Dr. Robert W. Snyder|5206616516|rsnyder781@gmail.com|
22427417|NCT03883386|University of Michigan Medical School|Professor Kelly Walkovich|734-647-2893|kwalkovi@med.umich.edu|
22427418|NCT01618968|Antares Pharma Inc.|Jonathan Jaffe, MD; Vice President Clinical Development|609-359-3020|jjaffe@antarespharma.com|324
22427419|NCT01326871|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22427420|NCT01004939|GlaxoSmithKline|GSK Response Center|866-435-7343||
22427421|NCT00251758|Takeda Global Research & Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
22427422|NCT01589315|Medical University of South Carolina|Mark S. George, MD|1843876 5142|georgem@musc.edu|
22427423|NCT01712711|Tehran University of Medical Sciences|Professor Raika Jamali|00982163120000|jamalira@tums.ac.ir|411
22427424|NCT01387269|Helsinn Therapeutics (US), Inc.|Richard K. Bourne, Ph.D.|732-603-2852|richard.bourne@helsinn.com|
22427425|NCT01200329|UT MD Anderson Cancer Center|Yago Nieto/Stem Cell Transplantation and Cellular Therapy|713-792-8750|ynieto@mdanderson.org|
22427426|NCT00677898|VA VISN 5 Mental Illness Research, Education and Clinical Center|Julie Kreyenbuhl, Pharm.D., Ph.D.|410-637-1864|Julie.Kreyenbuhl@va.gov|
22442646|NCT00119678|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22442647|NCT03567343|The University of Arizona|Dr Michael Grandner|15206266346|grandner@email.arizona.edu|
22442648|NCT01134705|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22411927|NCT05476679|Raziel Therapeutics|Racheli Gueta, Director of Clinical Trials|972-8-9126941|racheli@raziel-therapy.com|
22442649|NCT00246740|Departments of Pediatrics and Pharmacology, University of Alberta|Dr Richard Schulz|780-492-6581|richard.schulz@ualberta.ca|
22442650|NCT00101452|Massachusetts General Hospital|Maurizio Fava|617-724-2513|mfava@partners.org|
22411928|NCT01214330|Mike O'Callaghan Military Medical Center|Amanda Crawford|702-653-3583|amanda.j.crawford.ctr@health.mil|
22411929|NCT00467584|Mayo Clinic|Dr. Dean M. Wingerchuk|480-301-6328|wingerchuk.dean@mayo.edu|
22411930|NCT00926289|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22442651|NCT01510769|Ardea Biosciences, Inc.|Maple Fung, MD|1-858-652-6671|mfung@ardeabio.com|
22442652|NCT02674204|Cedars-Sinai Medical Center|Marc Goodman, PhD|310-423-6188|Marc.Goodman@cshs.org|
22411931|NCT04104646|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
22442653|NCT02646371|LimmaTech Biologics AG|Director of Clinical Trials|+41 44 733 8585|info@lmtbio.com|
22442654|NCT02466659|Indiana University|Daniel Neely|3172741214|deneely@iupui.edu|
22442655|NCT01536392|UT MD Anderson Cancer Center|Michael Frumovitz, Professor, Gyn Onc & Reproductive Med|(713) 792-9599|mfrumovitz@mdanderson.org|
22396668|NCT01469182|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22396669|NCT02236520|Vanderbilt University Medical Center|Alp Ikizler|(615) 343-7592|alp.ikizler@vumc.org|
22411932|NCT01498484|Atara Biotherapeutics|Study Director|650-278-8930|clinicalstudies@atarabio.com|1
22411933|NCT01199601|Columbia University|Dr. Catherine Todd|212-305-4805|cst2121@columbia.edu|
22411934|NCT00753714|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22411935|NCT03387098|Immunitybio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
22411936|NCT00278512|Northwestern University|Dr Richard Burt|312-695-4960|rburt@northwestern.edu|
22411937|NCT01620177|National Advanced Driving Simulator|Dr. Timothy L. Brown, Co-PI|319-335-4785|timothy-l-brown@uiowa.edu|
22411938|NCT02292238|Weill Cornell Med/ Burke Neurological Institute|Gary E Gibson, Professor of Neuroscience|9145972291|ggibson@med.cornell.edu|
22396670|NCT01033734|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22396671|NCT00111800|GlaxoSmithKline|GSK Response Center|866-435-7343||
22411939|NCT04000009|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261|medicalinformation@acadia-pharm.com|2897
22411940|NCT00756964|University of Florida|A. Ahsan Ejaz, M.D.|3522735328|ejazaa@medicine.ufl.edu|
22396672|NCT00094770|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22396673|NCT02752035|Astellas Pharma Global Development, Inc.|Clinical Transparency|800-888-7704|astellas.resultsdisclosure@astellas.com|
22411941|NCT01754259|Brigham and Women's Hospital|Dr. Marcelo Di Carli|617-732-6291|mdicarli@partners.org|
22442656|NCT02874144|Northwestern|Anju Peters|3126950513|anju.peters@northwestern.edu|
22442657|NCT00574236|University of Wisconsin Carbone Cancer Center|Dr. Anne Traynor|608-262-5092|amt@medicine.wisc.edu|
22396674|NCT03329911|Bio-Thera Solutions Ltd.|Yufeng Zhang|+86 2038251386|yfzhang@bio-thera.com|
22411942|NCT02829918|Moffitt Cancer Center|Richard D. Kim, MD|813-745-1277|Richard.Kim@Moffitt.org|
22396675|NCT02475070|Lund University|Dr Bo Ahrén|+46462220758|Bo.Ahren@med.lu.se|
22396676|NCT03668600|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
22396677|NCT01925573|University of Maryland Medical Center|Caitlin Eggleston|4103287586|caitlineggleston@umm.edu|
22396678|NCT00424749|Mayo Clinic|Dr. Fernando C. Fervenza||fervenza.fernando@mayo.edu|
22396679|NCT01263483|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
22396680|NCT04109222|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22396681|NCT02577406|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22396682|NCT05143489|Maimonides Medical Center|Director of Research Administraton|7182836896|alikourezos@maimo.org|
22396683|NCT01555151|Novartis Pharmaceuticals|Clinical Disclosure Office|+1(862)778-8300||
22442658|NCT00486811|Grünenthal GmbH|Claudia Leinweber|+49 241 569 2509|claudia.leinweber@grunenthal.com|
22442659|NCT02369744|Albert Einstein Medical Center|Kamran Mohiuddin; Director ED Clinical Research|2154562313|MOHIUDDK@EISNTEIN.EDU|
22442660|NCT02975557|Ophthalmology and Visual Sciences, University of Illinois, Chicago, IL|Dr. Sandeep Jain|312-996-4476|jains@uic.edu|
22442661|NCT00852371|Makerere University Kampala|Nankabirwa Joaniter|+256772676429|jnankabirwa@yahoo.co.uk|
22442662|NCT01711216|Abbott|Senior Global Medical Director|+49 160 749 0615|Claire.Pexman-Fieth@abbott.com|
22442663|NCT02228980|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22442664|NCT02744040|Fred Hutchinson Cancer Research Center|Ann C Duerr, MD, PhD, MPH, Member|206-667-7938|aduerr@fredhutch.org|
22442665|NCT00715910|GlaxoSmithKline|GSK Response Center|866-435-7343||
22442666|NCT01185353|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22442667|NCT01030666|JWGUniversity|Prof. Dr. Peter Eickholz|+496963015642|eickholz@med.uni-frankfurt.de|
22442668|NCT03456882|Istituto di Ricerche Farmacologiche Mario Negri IRCCS|Elisabetta Pupillo|+390239014605|elisabetta.pupillo@marionegri.it|
22442669|NCT01144299|GlaxoSmithKline|GSK Response Center|866-435-7343||
22442670|NCT00528541|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22442671|NCT00334113|VA Boston Healthcare System|Dr. DeAnna Mori|857-364-4121|deanna.mori@va.gov|
22442672|NCT02083861|Pain Management Associates|Dr. Ralph Ortiz|(607) 844-9979|rodoc@cnymail.com|
22396684|NCT01961349|CO RI&A TA, R&D|Hideo Negi|+81 6 4803 3533|H.Negi@astrazeneca.com|4716
22442673|NCT02509026|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22442674|NCT04303195|Neurogastrx|Chief Scientific Officer|17817304040|info@neurogastrx.com|
22442675|NCT00773604|University of California, San Francisco|Jill Ostrem|415-353-7885|Jill.Ostrem@ucsf.edu|
22442676|NCT01808092|AstraZeneca|David Wilson, Statistical Team Leader - Infection|+44 1625 517830|David.wilson2@astrazeneca.com|
22411943|NCT03520283|Wake Forest University Health Sciences|Study coordinator|336-716-9055|megreen@wakehealth.edu|
22411944|NCT00491504|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22396685|NCT00702754|Solstice Neurosciences, Inc|Regulatory Affairs Specialist||regulatoryaffairs@usworldmeds.com|
22396686|NCT01353196|VA Medical Center VA Maryland Health Care System, Baltimore, MD|Brajesh K. Lal, MD|410-605-7000|blal@som.umaryland.edu|
22442677|NCT04219085|Yale University|Audrey Merriam|203-785-7813|audrey.merriam@yale.edu|
22442678|NCT01097005|Mylan EPD Japan|Takao Miki, Medical Affairs||takao.miki@mylan.com|
22442679|NCT03425253|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22442680|NCT04174365|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22442681|NCT03472547|Castle Creek Pharmaceuticals, LLC|Dr. Mary Spellman; Chief Medical Officer|862 286 0400|mspellman@castlecreekpharma.com|
22442682|NCT05141448|Johnson & Johnson Vision Care, Inc. (JJVC)|Principal Research Optometrist|614-531-6781|anixon1@its.jnj.com|
22411945|NCT01103505|Notal Vision|Grace Chang, MD, PhD|571-719-6416|Grace.Chang@NotalVision.com|
22442683|NCT04627285|Cares|UCB|+1-844-599-2273|UCBCares@ucb.com|
22442684|NCT02907892|University of Minnesota|Dr. Rachel Vogel|6513345982|isak0023@umn.edu|
22442685|NCT01347580|AstraZeneca|Dr Tomas Andersson MD|00 46 31 77 61966|tomas.lg.andersson@astrazeneca.com|
22442686|NCT01964755|University of Miami|Juan C. Ramos MD|305-243-1326|jramos2@med.miami.edu|
22442687|NCT00918125|Duke University Medical Center|Dr. Kevin Thomas|919-668-7857|kevin.thomas@dm.duke.edu|
22442688|NCT00412373|Ortho McNeil Janssen Scientific Affairs, LLC|Vice President, Medical Affairs, CNS|609-730-2136|jhulihan@its.jnj.com|
22442689|NCT00422513|Hoffman-LaRoche|Medical Communications|800-821-8590||
22442690|NCT01478048|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22442691|NCT02766582|Medical College of Wisconsin|D. Denise Uyar|414-805-6606|duyar@mcw.edu|
22442692|NCT01369329|Janssen Research & Development, LLC|Vice President||ClinicalTrialDisclosure@its.jnj.com|
22442693|NCT03032380|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
22442694|NCT02937584|AstraZeneca|Stephan Stenglein, MD|+46 (0)31 776 1000|stephan.stenglein@astrazeneca.com|
22442695|NCT01883453|Umeå University|Dr Krister Tano|0046705569043|krister.tano@umu.se|
22442696|NCT02238080|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22442697|NCT00701662|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22442698|NCT01566084|University of Colorado Denver|Dr. Kristen Jablonski|303-724-4842|KRISTEN.NOWAK@UCDENVER.EDU|
22442699|NCT02267317|University of Texas Health San Antonio|Hanyu Liang|210-617-5300|liangh0@uthscsa.edu|15197
22396687|NCT01085786|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|886-7-3462121|pihsu@isca.vghks.gov.tw|8233
22396688|NCT02343159|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22396689|NCT00635479|University of Missouri, Department of Orthopaedics|Brett Crist, MD|573-882-6562|cristb@health.missouri.edu|
22411946|NCT02255513|Ironshore Pharmaceuticals and Development, Inc.|Chief Scientific Officer|13457498174|bev@ironshorepharma.com|
22411947|NCT02041702|Abbott (formerly St. Jude Medical)|Clinical Project Leader Asia|0085229967605|lyim@sjm.com|
22411948|NCT00203307|Thomas Jefferson University/ Jefferson Headache Center|Stephen D. Silberstein, M.D.- Principal Investigator|215-955-2243|stephen.silberstein@jefferson.edu|
22396690|NCT02114268|MedImmune, LLC|M. Pamela Griffin, MD, Senior Director|301-398-0000|information.center@astrazeneca.com|
22411949|NCT03730103|The Cleveland Clinic|Lynn Borzi, Research Administrator|216-445-3158|borzil@ccf.org|
22396691|NCT00397033|Ortho McNeil Janssen Scientific Affairs, LLC|Vice President, Medical Affairs, CNS|609-730-2136||
22396692|NCT03519867|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22396693|NCT04702737|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22396694|NCT02064920|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22396695|NCT02109562|Indivior, Inc.|Global Director, Clinical Development|804-379-1090||
22396696|NCT04814823|UCSF Hypoxia Research Laboratory|Dr. Philip Bickler|1-415-476-1411|philip.bickler@ucsf.edu|
22396697|NCT04722042|University of North Carolina at Chapel Hill|Margaret Dillon, AuD, PhD|919-966-5251|mdillon@med.unc.edu|
22396698|NCT02454140|University of California, San Diego|Dr. James D. Murphy|(858) 822-6040|j2murphy@health.ucsd.edu|
22396699|NCT05359679|Kaiser Permanente Washington|Lorella Palazzo PhD|206-287-2900|lorella.g.palazzo@kp.org|
22411950|NCT02789111|University of Virginia Department of Aneshtesiology|Bhiken Naik MD|434-924-2283|BIN4N@hscmail.mcc.virginia.edu|
22411951|NCT02308111|Intercept Pharmaceuticals, Inc.|Medical Information|+1 884-782-4278|medinfo@interceptpharma.com|
22411952|NCT01965561|USAISR|John Kragh, MD|210.539.2210|john.f.kragh.civ@mail.mil|
22411953|NCT03271528|Boston Medical Center|Dr. Eric Devine|617-638-7888|eric.devine@bmc.org|
22411954|NCT00929357|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22411955|NCT03977584|Hoffmann-La Roche|BN40199|888-662-6728 (U.S. Only)|global-roche-genentech-trials@gene.com|
22411956|NCT01042366|University of Pittsburgh|John Kirkwood, MD|(412) 623-7707|KirkwoodJM@upmc.edu|
22411957|NCT02257736|Aragon Pharmaceuticals, Inc.|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22442700|NCT03595618|Galapagos NV|Galapagos Medical Information|+32 15342900|medicalinfo@glpg.com|
22442701|NCT02279407|AstraZeneca|Stefan Carlsson||Stefan.C.Carlsson@astrazeneca.com|
22442702|NCT01410344|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
22442703|NCT01323855|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22442704|NCT03996369|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
22442705|NCT01782469|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
22442706|NCT01038869|DermResearch, PLLC|Leon Kircik, M.D.|502-451-9000|wedoderm@yahoo.com|
22442707|NCT04136444|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22442708|NCT02238067|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22442709|NCT02213133|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
22411958|NCT00745251|Vivus, Inc|Wesley W. Day, PhD|650-934-5200|day@vivus.com|
22411959|NCT01618305|Westat|Lauren Laimon, Project Manager|240-453-2987|laurenlaimon@westat.com|
22442710|NCT01224782|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22442711|NCT01960907|RESTECH srl|Dr. Pasquale Pio Pompilio, R&D manager|+39 02 3659 3690|p.pompilio@restech.it|
22411960|NCT01565083|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22442712|NCT03163017|The University of Texas Health Science Center at Houston|Joshua Gary, MD|713-486-6500|Joshua.L.Gary@uth.tmc.edu|
22442713|NCT00993226|Durect Corporation|Deborah Scott|408-777-1417|deborah.scott@durect.com|
22411961|NCT01118728|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22411962|NCT06454604|Center for Youth Social Emotional Wellness - Graduate School of Applied and Professional Psychology|Dr. Joshua Langberg|(848) 445-2000|jl3079@gsapp.rutgers.edu|
22411963|NCT01309919|Baystate Medical Center|Dr. Katharine White|413-794-5256|katharine.white@bhs.org|
22411964|NCT00455533|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22411965|NCT01896297|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22411966|NCT02415959|Abbott|Suntje Sander-Struckmeier|+49 (0) 511 6750 3254|suntje.sander@abbott.com|
22411967|NCT04555525|Skin Sciences, PLLC|Senen Pena|502-451-9000|spdermresearch@yahoo.com|
22411968|NCT00003782|NSABP Foundation, Inc.|Director, Division of Regulatory Affairs|412-330-4600||
22411969|NCT01323998|GlaxoSmithKline|GSK Response Center|866-435-7343||
22411970|NCT03482713|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-80-672-6372|ClinicalTrialsDisclosure@merck.com|
22411971|NCT01693783|University Health Network - Princess Margaret Cancer Centre|Dr. Amit Oza|416-946-4501|Amit.Oza@uhn.ca|3911
22411972|NCT03626857|University of Michigan|Riann Palmieri-Smith, PhD, ATC|734-615-3154|riannp@umich.edu|
22411973|NCT01301833|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22411974|NCT02178709|IndianaU|Dr. Amikar Sehdev|(317) 274-0339|asehdev@iupui.edu|
22411975|NCT01526538|Johns Hopkins University|Matthew Johnson Ph.D.|4105500056|mwj@jhu.edu|
22411976|NCT01402908|Medigen Biotechnology Corp.|Clinical Research Manager|886-2-77361234|Doyce.Chen@medigen.com.tw|
22411977|NCT01739790|Minneapolis VA Healthcare System|Dennis E. Niewoehner, MD|612-467-4412|niewo001@umn.edu|
22411978|NCT01797471|University of Miami|Jean L. Wright MD|305-243-5965|jwright3@med.miami.edu|
22411979|NCT02192905|University of Massachusetts Medical School|Sherry Pagoto, Professor|508-856-5159|study@umassmed.edu|
22411980|NCT01691859|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22411981|NCT04820842|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22411982|NCT01296932|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22411983|NCT00862979|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
22411984|NCT05568225|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22411985|NCT02405325|UCSD|Loki Natarajan|8588224763|lnatarajan@ucsd.edu|
22411986|NCT01027143|Duke University Medical Center|Jason Lang, MD|919-684-9590|jason.lang@duke.edu|
22411987|NCT03493126|The Ohio State University|Dr. Andrew Hundley|614-293-4647|andrew.hundley@osumc.edu|
22411988|NCT01095003|Institut de Recherche Pierre Fabre|Karim Keddad|+33.5.34.50.61.69|Karim.keddad@pierre-fabre.com|
22411989|NCT02637557|Ironwood Pharmaceuticals, Inc.|IW-3718-202 Study Chair|1 (617) 621-7722|Info@ironwoodpharma.com|
22411990|NCT05218655|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22411991|NCT02228382|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22411992|NCT02337465|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|Dr. Ping Xia|1-866-223-8100|TaussigResearch@ccf.org|
22411993|NCT02396381|Philip Morris Products S.A.|Christelle Haziza|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
22411994|NCT00275002|Pediatric Brain Tumor Consortium|Dana Wallace|901-595-2617|dana.wallace@stjude.org|
22411995|NCT05014204|Endogenex|Chris Sorli, CMO|(763) 251-6820|csorli@endogenex.com|
22411996|NCT02959775|Shanxi Medical University|Suping Wang, PhD|#86-351-4135103|spwang88@163.com|
22411997|NCT00113490|MedImmune|M. Pamela Griffin, MD/ Clinical Development|301-398-0000|clinicaltrialenquiries@medimmune.com|
22411998|NCT00819247|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22411999|NCT02582970|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22442714|NCT00817596|Medasys, Inc.|Clinical Trials Manager|973-426-9229|jarrambide@medasyspumps.com|
22442715|NCT00783198|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22442716|NCT00791817|Procter & Gamble|Peter Thomas|513.622.4838|thomas.pr@pg.com|
22442717|NCT01546623|Takeda|Medical Director, Clinical Science|800-778-2860|trialdisclosures@takeda.com|
22442718|NCT04525885|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22442719|NCT02756806|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
22442720|NCT03158285|Janssen Research & Development, LLC|Head Rheumatology Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22442721|NCT03753113|Tabriz University of Medical Sciences|Dr. Farid Masoud|+989036859062|faridmasoud@gmail.com|
22442722|NCT01642615|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22412000|NCT04652453|Department of Internal Medicine: Yale School of Medicine|Lauren Ferrante, MD, MHS|(203) 785-3207|lauren.ferrante@yale.edu|
22412001|NCT00711464|University of California, Los Angeles|Michael Minzenberg, MD|(310) 825-7642|MMinzenberg@mednet.ucla.edu|
22412002|NCT04033445|Janssen Research & Development, LLC|Medical Director IMM|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22412003|NCT00585780|YALE UNIVERSITY SCHOOL OF MEDICINE|Dr. Rajita Sinha|2038592840|rajita.sinha@yale.edu|
22427427|NCT02230891|Michael E DeBakey Veterans Affairs Hospital|Vijay Nambi|713-794-7300|vijay.nambi@va.gov|
22427428|NCT03400449|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|5034940757|mccrimmo@ohsu.edu|
22427429|NCT03642990|University of Iowa|Donna L. Hammond, Ph.D Professor|319-335-9595|donna-hammond@uiowa.edu|
22427430|NCT03087058|Vifor Pharma, Inc.|EMERALD Clinical Study Team|+41 588 518 000|EMERALD.study@viforpharma.com|
22427431|NCT02858908|AMO Pharma Ltd.|Dr. Mike Snape, Chief Scientific Officer|+44 (0) 7775915639|mike.snape@amo-pharma.com|
22427432|NCT05158140|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22427433|NCT04865588|Icahn School of Medicine at Mount Sinai|Director of The Zena and Michael A. Wiener Cardiovascular Institute|(212) 241-4021|samin.sharma@mountsinai.org|
22427434|NCT01265498|Johns Hopkins Data Coordinating Centers|Mark Van Natta|410-614-1362|mvannat1@jhu.edu|
22427435|NCT01502085|Hackensack Meridian Health|Joshua Zenreich|551-996-4248|joshua.zenreich@hmhn.org|
22427436|NCT00617279|W. L. Gore & Associates, Inc.|Chad Badorek, Clinical Study Manager|928.864.3486|cbadorek@wlgore.com|
22427437|NCT00733278|LA BioMed|Dr. Anita Nelson||anitanelsonwhc@earthlink.net|
22427438|NCT05994963|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22427439|NCT04158219|Hennepin Healthcare|Dr. Andrew Busch|6128736681|andrew.busch@hcmed.org|
22427440|NCT00929838|Medical College of Wisconsin|Jennifer Campbell|414-955-8829|jacampbell@mcw.edu|
22427441|NCT02374320|Ochsner Health System|Ken Bode|504.842.1936|ken.bode@ochsner.org|
22427442|NCT01324947|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22427443|NCT01296412|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22427444|NCT02160626|Aclaris Therapeutics Inc.|Judith Schnyder|+1-484-329-2144|jschnyder@aclaristx.com|
22427445|NCT05471505|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22427446|NCT04239924|BerbeeWalsh Department of Emergency Medicine|Dr. Manish Shah|608-263-9174|mnshah@medicine.wisc.edu|
22427447|NCT05399680|Cordis|Rajesh Nathan|(908) 528-3931|rajesh.nathan@cordis.com|
22427448|NCT02936999|Inova Health Services|Regulatory Research Coordinator|(571) 472-0239|elizabeth.gebregeorgis@inova.org|
22427449|NCT03737994|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22427450|NCT03255187|Department of Environmental Health, School of Public Health, Fudan University|Dr. Haidong Kan|86-21-54237908|kanh@fudan.edu.cn|
22427451|NCT00720278|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2393|WWheeler@medapharma.us|
22427452|NCT01075048|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22427453|NCT01677286|Boston Medical Center|John Berk, MD|617-638-4494|jberk@bu.edu|
22427454|NCT00408499|University of California, Davis|Data Manager|916-734-8381|nmahaffey@ucdavis.edu|
22427455|NCT02420639|Department of Anesthesiology & Intensive Care Medicine, Dnipropetrovsk Medical Academy|Alexander Tsarev|+38 057 701 52 00|tsarev03@rambler.ru|
22427456|NCT04319224|Jounce Therapeutics, Inc.|Stew Kroll, Chief Development Officer|(650) 576-9679|skroll@jouncetx.com|
22427457|NCT03617588|Theragnostics Ltd|Director of Clinical Operations|+44 330 606 7437|archie.hale@theragnostics.com|
22427458|NCT00183339|University of North Carolina|Linmarie Sikich, MD|919 966 8653|Lsikich@med.unc.edu|
22427459|NCT01715831|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22427460|NCT03261401|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22427461|NCT03563222|Fresenius Kabi Germany|Jean-Marc Lohse, PhD|+49 6172|jean-marc.lohse@fresenius-kabi.com|4911
22427462|NCT01516216|Dana-Farber Cancer Institute|Kimmie Ng, MD, MPH|617-632-4150|Kimmie_Ng@dfci.harvard.edu|
22427463|NCT03098979|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22427464|NCT01715298|Novartis Pharmaceuticals|Study Director|862-778-8300||
22427465|NCT02419807|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Stephen Grobmyer|1-866-223-8100|TaussigResearch@ccf.org|
22427466|NCT03860753|The University of Texas Health Science Center at Houston|Jin Ho Yoon, PhD|713-486-2800|jin.ho.yoon@uth.tmc.edu|
22427467|NCT01006629|Abbott|Global Medical Services|800-633-9110||
22427468|NCT01499511|Imperial College London|Professor Peter Sever|02075941100|p.sever@imperial.ac.uk|
22427469|NCT03424304|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
22427470|NCT00998946|Spectrum Pharmaceuticals, Inc|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
22427471|NCT01653418|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
22427472|NCT01065818|Columbia University|K.S. Clifford Chao, MD|212-305-9987|ksc2119@cumc.columbia.edu|
22427473|NCT02202252|Diskapi Training and Research Hospital|Melih Akinci, MD, Associate Prof|90 312 5962080|melihakinci@yahoo.com|
22427474|NCT04459338|Mayo Clinic|Adrian Vella|507-284-3754|vella.adrian@mayo.edu|
22427475|NCT00958074|University of Washington|Dr. Andrei Shustov|206-288-6744|ashustov@uw.edu|
22427476|NCT00784875|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22427477|NCT00915525|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22427478|NCT00470548|University of California Davis|Analyst|916 734 0294|pkaujla@ucdavis.edu|
22427479|NCT00941928|University of Texas MD Anderson Cancer Center|Anna Franklin, MD, Assistant Professor|713-792-3497|rnjackso@mdanderson.org|
22427480|NCT05052580|Duke Clinical Research Institute|Tara Mann, PhD, RN|(919) 668-5111|schoolSETstudy@duke.edu|
22427481|NCT03177395|Pharmacology, Therapeutics and Toxicology Unit, Centre for Cardiovascular Science, University of Edinburgh, UK|Dr James Dear|+44(0)131 242 9214|james.dear@ed.ac.uk|
22427482|NCT00906243|University of Florida|Dr. Johannes Vieweg|352 273-6815|j.vieweg@urology.ufl.edu|
22427483|NCT01604772|Memorial Sloan Kettering Cancer Center|Alan Ho, M.D.||hoa@mskcc.org|
22427484|NCT01381120|Barrie Urology Associates|Dr. Joseph Zadra||joezadra@rogers.com|
22427485|NCT03703895|Center for Clinical and Cosmetic Research|Dr. Mark Nestor|3059336716|nestormd@admcorp.com|
22427486|NCT02732639|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22427487|NCT01668797|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22427488|NCT02515227|University of Virginia|Craig Slingluff, MD|434 924-9311|cls8h@uvahealth.org|
22427489|NCT02111083|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22427490|NCT00827567|Penn State|Allan Lipton, MD|717-531-5960|alipton@psu.edu|
22427491|NCT05998967|VA San Diego HCS|Ariel J Lang, PhD, MPH|(858) 552-8585|ariel.lang@va.gov|
22427492|NCT04418947|University of Pennsylvania|Dr. Anne Cappola|2155735359|acappola@pennmedicine.upenn.edu|
22427493|NCT01259245|Kwong Wah Hospital|Dr Lorna Ng|(852) 23322311|ngl@ha.org.hk|
22427494|NCT03937778|National Center for Complementary and Integrative Health|Chesler, Alexander|+1 301 594 1049|alexander.chesler@nih.gov|
22427495|NCT03261999|Foresee Pharmaceuticals Co., Ltd|John Mao|+886 2-7750-0188|john.mao@foreseepharma.com|
22427496|NCT02318264|SUNY Upstate Medical|Michelle Dolphin, Associate Professor|315 464 6917|dolphinm@upstate.edu|
22427497|NCT01200355|Memorial Sloan Kettering Cancer Center|Dr. Genovefa Papanicolaou MD|212-639-8361|papanicg@mskcc.org|
22427498|NCT02330341|INSTITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
22427499|NCT00706797|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22427500|NCT03502798|Duke University|Dr. Adam Wax|919-660-5143|a.wax@duke.edu|
22381419|NCT05051540|University of Miami|Hadar Lev-Tov, MD|305-243-1953|hlevtov@med.miami.edu|
22381420|NCT01516892|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22381421|NCT02956967|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22381422|NCT02963597|Albert Einstein Healthcare Network|Dr Sunil Sharma|2154566950|sharmasu@einstein.edu|
22381423|NCT00819234|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22381424|NCT01096056|GlaxoSmithKline|GSK Response Center|866-435-7343||
22381425|NCT03568162|Ichnos Sciences SA|Ichnos Sciences Clinical Trials Administrator|315-583-1249|clinicaltrials@ichnossciences.com|
22381426|NCT00337818|GlaxoSmithKline|GSK Response Center|866-435-7343||
22381427|NCT00336232|Tufts University|Sarah Booth, PhD|617-556-3231|sarah.booth@tufts.edu|
22427501|NCT05169905|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22427502|NCT01027845|GlaxoSmithKline|GSK Response Center|866-435-7343||
22427503|NCT01281306|Novartis|Study Director|862-778-8300||
22381428|NCT00938340|Penn State University|Penny Kris-Etherton||pmk3@psu.edu|
22427504|NCT00368550|University of Pennsylvania|Henry R. Kranzler, M.D.|215-222-3200|kranzler_h@mail.trc.upenn.edu|137
22427505|NCT01401322|Stanford University|Bruno C. Medeiros|650-498-6000||
22427506|NCT00890721|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
22427507|NCT03466346|University of California San Francisco|Susan Meffert MD, MPH; Professor of Psychiatry; MPI|4158765455|susan.meffert@ucsf.edu|
22427508|NCT03072550|DeviceFarm|Jeffrey N Roe|925-895-1584|jeffnroe1@devicefarmtech.com|
22427509|NCT02410629|University of California Irvine|Dr An Do|(714) 456-2332|and@uci.edu|
22427510|NCT01670292|Palmer Center for Chiropractic Research|Dr. Ting Xia|563-884-5161|ting.xia@palmer.edu|
22427511|NCT00087178|NRG Oncololgy|Director, Department of Regulatory Affairs|412-339-5300|langerj@nrgoncology.org|
22427512|NCT00243243|US Army Institute of Surgical Research|David G. Baer, PhD, Director Research|210-539-4327|david.g.baer@us.army.mil|
22381429|NCT04783415|City of Hope Medical Center|Dr. Alexey Danilov|626-359-8111|adanilov@coh.org|
22381430|NCT04816526|Cartesian Therapeutics|Dr. Milos Miljkovic, Chief Medical Officer|4436335855|milos@cartesiantx.com|
22381431|NCT00924560|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22427513|NCT02667639|Monitor CRO|Murat Özdemir|902122341260|murato@monitorcro.com|
22427514|NCT01692119|ABDA, Department of Medicine|Dr. Martin Schulz|+49 30 40004-514|arzneimittel@abda.de|
22427515|NCT03451045|Corbus Pharmaceuticals, Inc.|Head of Clinical Operations|6179630100|info@corbuspharma.com|
22427516|NCT00863707|Astellas Pharma Global Development|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com|
22427517|NCT00808340|Vistakon|Tom Karkkainen, OD|904-443-3402||
22427518|NCT03040726|The University of Texas MD Anderson Cancer Center|Dr. David Hui|(713) 792-6258|dhui@mdanderson.org|
22427519|NCT00062166|National Cancer Institute|Dr. Naris Nilubol|301-451-2355|niluboln@nih.gov|
22427520|NCT05063448|Colorado State University|Dr. Stephanie Rayburn|970-988-6306|Stephanie.Rayburn@colostate.edu|
22427521|NCT06119854|CityUNYSPH|Denis Nash|3473316554|denis.nash@sph.cuny.edu|
22381432|NCT01155999|Laboratoires Thea|Pascale Pouliquen (Medical director)|0473963614|p.pouliquen@laboratoires-thea.fr|
22381433|NCT01114620|GlaxoSmithKline|GSK Response Center|866-435-7343||
22381434|NCT02753530|Zevra Denmark A/S|Medical Affairs|+1-888-289-5607|medicalaffairs@zevra.com|
22381435|NCT03590743|Mayo Clinic|Robert D. McBane, II M.D.|507-266-3964|mcbane.robert@mayo.edu|
22381436|NCT00604786|Johns Hopkins University|Sarbjit S. Saini|410-550-2129|ssaini@jhmi.edu|
22381437|NCT03369951|Northwestern University of Feinberg School of Medicine|Richard G. Wunderink, MD|312-695-1878|r-wunderink@northwestern.edu|
22381438|NCT03677375|Masimo|Tala Harake|9492977000|studies@masimo.com|
22381439|NCT02141581|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
22381440|NCT01324882|UConn Health Center|Joseph Anderson|8022959362|joseph.anderson@dartmouth.edu|6003
22381441|NCT00725010|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22381442|NCT01290094|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22381443|NCT01959880|Mentor|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
22381444|NCT01537133|Penn State University|David Mauger|717-531-7178|dtm5@psu.edu|
22381445|NCT00349908|Codman & Shurtleff|J. Thomas Megerian, MD|508.828.8274|jmegerian1@its.jnj.com|
22381446|NCT00496379|Dana-Farber Cancer Institute|Dr. Nancy Lin|617-632-2335|nlin@partners.org|
22381447|NCT00623506|Durham VA Medical Center|Christine E. Marx, MD|919 286-0411|marx0001@mc.duke.edu|7426
22381448|NCT01289119|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22381449|NCT01704846|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22427522|NCT06494761|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
22381450|NCT02912195|Alameda Health System|Andrew Herring|510 437-8356|aherring@alamedahealthsystem.org|
22381451|NCT00530335|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22381452|NCT03647475|Medtronic Coronary/Renal Denervation (C/RDN)|Cecile Mahoney, Sr. Clinical Research Specialist|763-505-1057|cecile.c.mahoney@medtronic.com|
22381453|NCT01244984|GlaxoSmithKline|GSK Response Center|866-435-7343||
22381454|NCT04577183|RedDress Medical|Clinical Trial Manager|1-800-674-9615|alon@reddress.co.il|
22381455|NCT01721564|Royal Prince Alfred Hospital, Sydney, Australia|Prof David Celermajer|+61 2 9515 6519|david.celermajer@email.cs.nsw.gov.au|
22381456|NCT01801930|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22381457|NCT00248612|Center for Anxiety and Related Disorders at Boston University|Todd J. Farchione, PhD|617 353 9610|tfarchio@bu.edu|
22427523|NCT04865289|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22381458|NCT00451698|Medical College of Wisconsin|Dr. Steven Zangwill|414-266-2380|szangwill@chw.org|
22427524|NCT03104374|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22427525|NCT00803179|UMass Medical School|Michael Stalvey, MD, Principal Investigator|508-856-4280|mstalvey@peds.uab.edu|
22427526|NCT00885118|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22427527|NCT02643875|The Hong Kong Polytechnic University|Prof Pauline Cho|(852) 2766-6100|sopaulin@polyu.edu.hk|
22427528|NCT02873975|Dana-Farber Cancer Institute|Geoffrey Shapiro M.D., PhDDana-Farber Cancer Institute|617-632-6594|Geoffrey_Shapiro@dfci.harvard.edu|
22427529|NCT00193375|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|ASKSARAH@scresearch.net|
22427530|NCT03638323|Groupe Hospitalier de la Rochelle Ré Aunis|Marie-Laure Vignaud, neuropsychologist|+33 (0)5 46 45 63 70|marie-laure.vignaud@ght-atlantique17.fr|
22427531|NCT02717195|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
22427532|NCT04194814|University of Sheffield|Dr Simon Danby|0114 2268515|s.danby@sheffield.ac.uk|
22427533|NCT02659865|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22427534|NCT02325414|Northwestern University|Dr. Thomas Schnitzer|312-503-4043|tjs@northwestern.edu|
22427535|NCT04817189|Helsinn|Alessandro Alonzi, Medical Advisor|+41793262091|Alessandro.Alonzi@helsinn.com|
22427536|NCT00959751|NeurAxon, Inc.|Thomas Lategan, PhD|417-673-6697|tlategan@neuraxon.com|
22427537|NCT00761319|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
22427538|NCT01605903|Massachusetts Eye and Ear Infirmar|Gillian Diercks, MD, MPH|617-573-3190|gillian_diercks@meei.harvard.edu|
22427539|NCT03157089|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22427540|NCT00853385|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22427541|NCT00577408|New York State Psychiatric Institute|Edward V. Nunes, MD|646-774-6122|edward.nunes@nyspi.columbia.edu|
22427542|NCT01829347|Vital Therapies, Inc.|Robert Ashley|858-673-6840|rashley@vitaltherapies.com|
22427543|NCT03055013|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22427544|NCT03435055|University of Michigan|Richard Harris|734-998-6996|reharris@umich.edu|
22427545|NCT01951066|Wilmer Eye Institute, Johns Hopkins University School of Medicine|[Peter A. Campochiaro|(410) 955-5106|pcampo@jhmi.edu|
22427546|NCT03817528|New York State Psychiatric Institute|Marlene Carlson, MPH|646-774-5340|marlene.carlson@nyspi.columbia.edu|
22427547|NCT00671749|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5000|elizabeth.nieman@galderma.com|
22427548|NCT00485303|Janssen Research & Development, 10990 Wilshire Blvd, Suite 1200, Los Angeles, California 90024|Senior Director, Clinical Research|(310) 943-8040||2917
22427549|NCT01391611|Stanford University Medical Center|Kristen Ganjoo, MD|650-725-6413|kganjoo@stanford.edu|
22427550|NCT02879032|Bangabandhu Sheikh Mujib Medical University|Dr. Md. Mashiul Alam|+8801724490475|mashiull@gmail.com|
22427551|NCT02423408|Tonix Pharmaceuticals|Judith Gendreau, Senior Medical Director|858-433-5574|judy.gendreau@tonixpharma.com|
22427552|NCT00296335|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
22427553|NCT00830128|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22427554|NCT05892341|ConvaTec Inc.|Cristin Taylor, Senior Director, Medical Affairs, Advanced Wound Care|1-800-422-8811|cristin.taylor@convatec.com|
22427555|NCT00747214|Zalicus|Margaret Lee, PhD|617-301-7142|mlee@zalicus.com|
22427556|NCT01123655|Memphis VAMC|Arnold E. Postlethwaite,MD Principal Investigator|901 448 5774|apostlet@uthsc.edu|
22427557|NCT01894906|Rockwell Medical|Senior Director, Clinical Research & Operations|248-960-9009|rd@rockwellmed.com|
22427558|NCT00595361|Brigham and Women's Hopsital|Elliot Israel, MD|617-732-8110|eisrael@partners.org|
22427559|NCT03329885|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|clinical.trials@bms.com|
22427560|NCT04004000|Fulcrum Therapeutics|Call Center|617-651-8853|clinicaltrials@fulcrumtx.com|
22427561|NCT02121210|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22427562|NCT00943436|Healthy Eating and Activity Laboratory- University of Tenneessee|Emily Jokisch|865-974-0754|ejokisch@utk.edu|
22427563|NCT01232283|Celgene Corporation|Anne McClain|888-260-1599|ClinicalTrialDisclosure@celgene.com|
22427564|NCT01471626|CHU St Pierre|Dr Marie Bruyneel|003225354219|marie_bruyneel@tpierre-bru.be|
22427565|NCT03641508|University of Iowa|Dr. Ericka Lawler|3193563943|ericka-lawler@uiowa.edu|
22427566|NCT00094445|University of Texas (UT) MD Anderson Cancer Center|Vivek Subbiah, MD / Assistant Professor, Investigational Cancer Therapeutics|713-563-0393|CR_Study_Registration@mdanderson.org|
22427567|NCT00855218|BAYER|Therapeutic Area Head||clinical-trial-contact@bayerhealthcare.com|
22427568|NCT02941640|University Clinical Center Tuzla|Samir Delibegovic|+387 61 149 131|delibegovic.samir@gmail.com|
22427569|NCT01773928|Alachua Government Services, Inc.|Angie Kimbler|386-418-8751|angie.kimbler@resilience.com|
22427570|NCT02370511|Mayo Clinic|Dr. Mayra Guerrero|507-255-1267|Guerrero.Mayra@mayo.edu|
22427571|NCT01149655|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22427572|NCT03882918|Ovid Therapeutics Inc|Julia Tsai, PhD|(203) 623-1996|jtsai@ovidrx.com|
22427573|NCT02543840|VA Boston Healthcare System- Center for Healthcare Organization and Implementation Research|Dr. Mark S. Bauer, MD|857-364-6380|mark.bauer@va.gov|
22427574|NCT02775851|SWOG Statistics and Data Management Center|Melanoma Committee Statistician|2066674623|sbellasea@fredhutch.org|
22427575|NCT06125964|University of Southern California|Genevieve Dunton (Principal Investigator)|323-442-8224|dunton@usc.edu|
22427576|NCT03370172|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22427577|NCT02194465|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22427578|NCT01316614|Washington University School of Medicine|Daniel K. Mullady, M.D.|314-362-8546|dmullady@dom.wustl.edu|
22427579|NCT00076570|NIDDK, National Institutes of Health|Dr. Monique Cho|3014355058|moniquec@intra.niddk.nih.gov|
22427580|NCT01373164|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22427581|NCT03979313|Astrazeneca|Global Clinical Lead|+1 877-240-9479|information.center@astrazeneca.com|
22427582|NCT00089648|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22427583|NCT00420745|GlaxoSmithKline|GSK Response Center|866-435-7343||
22427584|NCT00423605|Jazz Pharmaceuticals, Inc.|Grace Wang, MD, Director Clinical Development & Medical Monitor|650-496-3777||
22427585|NCT03183908|Duke University|Dr. Kenneth Schmader|919-660-7572|kenneth.schmader@duke.edu|
22380962|NCT03169361|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22427586|NCT01244477|Michael E DeBakey VAMC|Wright Williams, PhD, ABPP|713-794-7629|wright.williams@va.gov|
22427587|NCT00409825|University of Pittsburgh|Steve N. Caritis, MD|412-641-4874|scaritis@mail.magee.edu|
22427588|NCT02058095|Mayo Clinic|Horng H. Chen, M.D.|507-284-8896|chen.horng@mayo.edu|
22427589|NCT00726453|Medtronic Vascular|K. Bogdanovich||rs.medtroniccardiovascularclinicaltrials@medtronic.com|
22427590|NCT00148798|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22427591|NCT02019069|Stanford University|Rondeep Singh Brar|(650) 498-6000|rbrar@stanford.edu|
22427592|NCT01588509|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22427593|NCT01983930|UCLA|Helen Lavretsky, M.D.|310-794-4619|hlavretsky@mednet.ucla.edu|
22427594|NCT01454284|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22427595|NCT00795340|Division of Medical Oncology, the Ottawa Hospital, Ottawa, Ontario, Canada|Dr. Scott Laurie|1-613-737-7700|slaurie@toh.on.ca|
22427596|NCT00393367|The Children's Hospital of Philadelphia|Cynthia J. Mollen|215-590-4410|mollenc@email.chop.edu|
22427597|NCT03248037|Cornea Research Foundation of America|Marianne Price|3178142990|mprice@cornea.org|
22427598|NCT03720119|Sofar|Dr Laura Patrucco|+39 02909362|laura.patrucco@sofarfarm.it|1
22427599|NCT01944423|Univeristy of Texas at Austin|Dr. Jasper Smits|512-475-8095|smits@utexas.edu|
22427600|NCT02897349|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22427601|NCT01289522|Centre Antoine Lacassagne|Pr. Joël GUIGAY|+33492031000|joel.guigay@nice.unicancer.fr|
22427602|NCT03113955|Zhongda Hospital Southeast University|Dr. Gaojun Teng|13805171500|gjteng@vip.sina.com|+86
22427603|NCT01708603|Bausch Health|Study Director|510-259-5284||
22427604|NCT02765035|Otto Bock Healthcare GmbH|Director of Clinical Research and Services Vienna|+4315233786733|Milana.Mileusnic@Ottobock.com|
22427605|NCT00856180|Dana-Farber Cancer Institute|Ursula A. Matulonis, MD|617-632-2334|umatulonis@partners.org|
22427606|NCT02456896|AIIMS, Bhubaneswar, India|Dr. Rituparna Maiti|9438884191|rituparnamaiti@gmail.com|
22427607|NCT03895086|Maison de la Recherche en Santé|Mr Thomas RULLEAU|6 35 55 03 35|thomas.rulleau@chu-nantes.fr|+33
22427608|NCT01192815|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Panayiotis Savvides, MD|216-844-5946|Panayiotis.Savvides@uhhospitals.org|
22427609|NCT01032928|Ralph H Johnson VA Medical Center|Dr. Bonnie Martin Harris|843-792-0879|Bonnie.Martin-Harris@va.gov|
22427610|NCT01142336|University of Washington|Ge Li, MD, PhD|(206) 764-2485|gli@uw.edu|
22427611|NCT02111200|Baylor|Mahshid Azamian|832-822-1529|azamian@bcm.edu|
22427612|NCT01225055|Northwestern University|Dr. Thomas Schnitzer|312-503-2315|tjs@northwestern.edu|
22427613|NCT04287816|Ohio State University|Dr. Richard Bruno|6142925522|bruno.27@osu.edu|
22427614|NCT03025035|Cedars-Sinai Medical Center|Yuan Yuan, MD, PhD|3108888680|yuan.yuan@cshs.org|
22427615|NCT01218802|Case Western Reserve University|Grace McComsey, MD|2168442739|gam9@case.edu|
22427616|NCT04264208|Stanford University|Andrei Iagaru, MD|(650) 725-4711|aiagaru@stanford.edu|
22427617|NCT04373031|Providence Portland Medical Center|Dr. David Page|503-215-1979|canrsrchstudies@providence.org|
22427618|NCT05469438|University Hospitals Cleveland Medical Center (Case Western Reserve University)|Kylie Phillips (Clinical Research Regulatory Specialist III)|(440)328-7964|kylie.phillips@uhhospitals.org|
22427619|NCT02368132|Corporal Michael J Crescenz VA Medical Center|Dr. Shahrzad Mavandadi|215.823.5211|shahrzad.mavandadi@va.gov|
22427620|NCT02475369|BIDMC|Caitlin Barrett|617-667-8266|cbarret5@bidmc.harvard.edu|
22427621|NCT00471497|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22427622|NCT00982345|Indiana University|Dr. Amit Anand|317-274-7422|aanand@iupui.edu|
22427623|NCT01991795|Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
22427624|NCT02404545|Baptist Health South Florida - Miami Cancer Institute|Murugesan Manoharan MD, FRCS (Eng), FRACS (Urol)|305-595-2141|mmanoharan@baptisthealth.net|
22427625|NCT01141608|UT Southwestern Medical Center|Dr. Madhukar H Trivedi|214-648-0188|madhukar.trivedi@utsouthwestern.edu|
22427626|NCT02078817|University of Minnesota|Katherine Cullen|612-273-9732|rega0026@umn.edu|
22427627|NCT00942786|Department of Anesthesiology and Intensive Care Medicine, Medical University of Graz, Austria|Elisabeth Mahla, MD|++43316385|elisabeth.mahla@medunigraz.at|13027
22427628|NCT00769561|Department of Clinical Psychology and Psychotherapy, Philipps University of Marburg, Germany|Dr. Meike Shedden Mora|+49-6421-282|m.shedden@staff.uni-marburg.de|3657
22381459|NCT02072226|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22427629|NCT00506675|Jaeb Center for Health Research|Raymond Kraker, MSPH|813-975-8690|pedig@jaeb.org|
22427630|NCT03824561|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22427631|NCT03512652|University of Applied Sciences and Arts of Southern Switzerland (SUPSI)|Dr Erich Hohenauer|+41 81 300 01 75|erich.hohenauer@supsi.ch|
22427632|NCT01162733|Christiana Care Health System|Deb Marco|302 733-4130|dmarco@christianacare.org|
22427633|NCT03092752|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22427634|NCT03684408|University of Missouri|Megha Garg MD|573-882-1026|gargmeg@health.missouri.edu|
22427635|NCT00545025|GlaxoSmithKline|GSK Response Center|866-435-7343||
22427636|NCT00921024|Cubist Pharmaceuticals, Inc.|Dr. Obi Umeh, Vice President Global Medical Sciences|781-860-8415|obiamiwe.umeh@cubist.com|
22427637|NCT02764801|Thomas Jefferson University|John Eisenbrey, PhD|(215) 503-5188|John.Eisenbrey@jefferson.edu|
22427638|NCT05462821|Jaeb Center for Health Research - Pediatric Eye Disease Investigator Group|Victoria Woodard, Publications Manager|813-975-8690|pedigpublications@jaeb.org|
22427639|NCT06996301|Doc Lab Inc|Roel Chavez|971 570-4008|roel@doclabinc.com|
22427640|NCT04030598|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
22427641|NCT03658980|Hiroshima University|Zara Khair|+8801715342168|zara.oikee@gmail.com|
22427642|NCT05117060|LEO Pharma A/S|Clinical Disclosure|+45 44945888|disclosure@leo-pharma.com|
22427643|NCT03141359|Atrium Health Levine Cancer|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
22427644|NCT02097823|Prevea Health/St Vincent Hospital|Dr. Catherine Long|9204338670|cathy.long@prevea.com|
22427645|NCT01419535|NIDDK, NIH|Lynnette Nieman MD|301-496-8935|NiemanL@nih.gov|
22427646|NCT03114150|The University of Iowa|Dr. Michelle Voss, Study Principal Investigator|319-335-2057|michelle-voss@uiowa.edu|
22427647|NCT03675308|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22427648|NCT05722522|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22427649|NCT04006457|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22427650|NCT05918055|National Cancer Institute|Dr. Najla El Jurdi|240-992-4033|najla.eljurdi@nih.gov|
22427651|NCT00863122|Johns Hopkins School of Medicine|Jaishri Blakeley|410-955-6827|jblakel3@jhmi.edu|
22427652|NCT00109343|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22427653|NCT04460885|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22427654|NCT04953338|Pfizer Ltd|John Nesnas|01304 616161|john.nesnas@pfizer.com|
22427655|NCT01721798|FHI 360|Catherine Todd|+1-919-544-7040|ctodd@fhi360.org|
22427656|NCT00961064|National Heart Lung and Blood Institute|Bhavisha Patel, MD|301.402.3477|bhavisha.patel@nih.gov|
22427657|NCT01408641|FDA|Bernard Fischer, M.D.|240-402-4511|Bernard.Fischer@fda.hhs.gov|
22427658|NCT02842866|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22427659|NCT01432327|Katholieke Universiteit Leuven|Karen Van Hoye|0032498617141|Karen.Vanhoye@faber.kuleuven.be|
22427660|NCT00204737|University of Wisconsin - Madison|Catherine Johnson|608-280-7084|catherine.johnson2@va.gov|
22427661|NCT05001620|University of Maryland School of Nursing|Dr. Joan G. Carpenter|443-880-1430|joan.carpenter@umaryland.edu|
22427662|NCT00819039|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22427663|NCT04796415|Indiana University School of Nursing|Yvonne Lu, PhD, RN, FGSA, FAAN, Professor, Science of Nursing Care Department|3172782042|yuelu@iu.edu|
22427664|NCT04232137|Vanderbilt University Medical Center|Dr. Tobias Limperg|(615) 343-6710|tobias.limperg@vumc.org|
22427665|NCT00754923|OSU|Miguel Villalona|614-366-5068|miguel.villalona@osumc.edu|
22427666|NCT04009837|University of Delaware|Dr. Gregory Hicks, PT, PhD, FAPTA, FGSA|(302) 831-2690|ghicks@udel.edu|
22427667|NCT04649359|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22427668|NCT06831786|prince of songkla university|Sarunyou Chusri|+66897340446|sarunyouchusri@hotmail.com|
22427669|NCT03307174|University of California San Francisco|Paul Su|415-885-7246|paul.su@Ucsf.edu|
22427670|NCT05911841|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22427671|NCT05595369|Duke University|Kanecia Zimmerman, MD, PhD, MPH|919-668-8651|kanecia.zimmerman@duke.edu|
22427672|NCT00534469|City of Hope Medical Center|Dr. Anthony Stein|626-5375748|AStein@coh.org|
22427673|NCT01641042|GlaxoSmithKline|GSK Response Center|866-435-7343||
22427674|NCT03431584|Centre Hospitalier Departemental Vendée|Dr. Grégoire CORMIER|251446197|gregoire.cormier@ght85.fr|+33
22427675|NCT02592824|Linköping University Hospital|Dr Jonas Holm|+46101034498|jonas.holm@regionostergotland.se|
22427676|NCT02855268|Sanofi-Aventis Recherche & Développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22427677|NCT04002791|Apex Heart Institute|Chairman|011 91 9824030576|theheartworld@gmail.com|
22427678|NCT00465517|Marinus Pharmaceuticals, Inc.|Marinus|(484) 801-4670|clinicaltrials@marinuspharma.com|
22427679|NCT01286129|IUCPQ|Louis-Philippe Boulet, principal investigator|418-656-4747|lpboulet@med.ulaval.ca|
22427680|NCT02326064|Centre Hospitalier Départemental Vendée|Dr. Guillaume DUCARME|0251446161|guillaume.ducarme@ght85.fr|
22427681|NCT00111761|Amgen Inc.|Study Director|866-572-6436||
22427682|NCT00914069|Bard Access Systems, Inc.|Gina Gilbert|407-489-0835|Gina.Gilbert@crbard.com|
22427683|NCT02029417|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22381460|NCT00360126|GlaxoSmithKline|GSK Response Center|866-435-7343||
22427684|NCT00071981|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
22427685|NCT04458922|National Cancer Institute|Alice P. Chen|240-781-3274|chenali@mail.nih.gov|
22381461|NCT02467491|University of Florida|Dr. Vincenzo Valiani|352-2835906|vincio86@gmail.com; v.valiani@ufl.edu|
22442723|NCT00750152|Merz Pharmaceuticals, LLC|Merz Pharmaceuticals, LLC|800-334-0514||
22442724|NCT02057081|VISN 5 Mental Illness Research, Education, and Clinical Center|Dr. Amy Drapalski|410-637-1855|amy.drapalski@va.gov|
22442725|NCT01809639|Spartanburg Regional Healthcare System|John Lucas|423-309-5646|jlucas@srhs.com|
22442726|NCT00978757|Francisco C. Bonofiglio|MD|541149590200|francisco.bonofiglio@hospitalitaliano.org.ar|4949
22442727|NCT01028300|DePuy Synthes Spine|Mark Lotito|508-880-8045|mlotito@its.jnj.com|
22442728|NCT00402740|Abbott Vascular|Ellen Travis, MS, NFP|408 845-1512|Ellen.Travis@av.abbott.com|
22442729|NCT02140593|Herlev and Gentofte Hospital University of Copenhagen|Dr. Matias Vested Madsen|+4538683868|matias.vested.madsen@regionh.dk|
22442730|NCT00946153|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22442731|NCT03353233|Duke University Medical Center|W. Michael Bullock, MD, PhD|919-681-6437|william.bullock@duke.edu|
22442732|NCT00796926|Singapore National Eye Center|Dr Louis Tong|65 62277255|Louis.tong.h.t@snec.com.sg|
22442733|NCT04160975|Harvard University|Dr. Marcella Alsan|617-496-1770|marcella_alsan@hks.harvard.edu|
22442734|NCT04002908|Ariadne Labs|Katherine Semrau|6177805311|ksemrau@ariadnelabs.org|
22442735|NCT01011309|IDRI|Jill Ashman, MSc, Associate Director of Clinical Operations|206-858-6041|jill.ashman@idri.org|
22442736|NCT01085006|Tehran University of Medical Sciences|Dr. Laleh Eslamian|+982184902415|leslamian@tums.ac.ir|
22442737|NCT01254760|Alcon Research, Ltd.|Director of Alcon Clinical|1-800-241-7629||
22442738|NCT00006289|National Institute of Nursing Research|Dr. Leorey Saligan (Principal Investigator, former PI: Dr. Raymond Dioone)|301-451-1685|saliganl@mail.nih.gov|
22442739|NCT02973438|University of Miami|Mark S. Nash, Ph.D.|3052433628|mnash@med.miami.edu|
22442740|NCT02043808|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22442741|NCT00582075|University of Alabama at Birmingham|John Fiveash, MD|205-975-0224|jfiveash@uabmc.edu|
22442742|NCT04359901|VA Boston Healthcare System|Westyn Branch-Elliman, MD, MMSc|857-203-5116|westyn.branch-elliman@va.gov|
22442743|NCT00557856|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22442744|NCT03255083|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22442745|NCT05601544|Johnson & Johnson Vision Care, Inc. (JJVC)|Senior Principal Research Optometrist|904-608-7238|jbuch@its.jnj.com|
22442746|NCT00273793|UTexas_SanAntonio|Dr. RJ Lamb|210-567-5480|lamb@uthscsa.edu|
22442747|NCT02537015|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22442748|NCT03524729|VA|Dr. Sangeorzan|206-516-3261|bruce.sangeorzan@va.gov|
22442749|NCT01548833|Alcon Research, Ltd.|Jami Kern, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
22442750|NCT02626624|CarboFix Orthopedics Ltd.|Dvir Sherpsky, Director of Clinical Trials|+972-54-770-9920|dvir@carbo-fix.com|
22442751|NCT04084561|Center for Asian Health, Temple University|Dr. Grace X. Ma|215-707-6493|grace.ma@temple.edu|
22442752|NCT00678743|Biofortis Research (formerly Provident)|John Marshall, General Manager|630-748-5339|john.marshall@mxns.com|
22442753|NCT02695160|Sangamo Therapeutics|Medical Monitor|+1 510 307 7266|clinicaltrials@sangamo.com|
22442754|NCT02043899|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
22442755|NCT02720107|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22442756|NCT01771809|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22442757|NCT00362180|Kastle Therapeutics, LLC|Christopher Bryant, Ph.D.|8152633913|cbryant@kastletx.com|
22442758|NCT03930264|Nova Laboratories Limited|Dr Hussain Mulla|+44 (0)116 223 0100|hussain.mulla@novalabs.co.uk|
22442759|NCT02600871|University of Texas Health San Antonio|Dr. Adriana Segura Olson|2152649796|adriana.s.olson@gmail.com|
22442760|NCT02930980|Medtronic EMEA RCC|Valentina Amori, Medical Writer|+39 06 32814236|valentina.amori@medtronic.com|
22442761|NCT00911443|R&D Department - Sigma-Tau SpA|Roberto Camerini|+390691393562|roberto.camerini@sigma-tau.it|
22442762|NCT00348933|University of California and Rady Children's Hospital, San Diego|Lynne M. Bird, MD|858-966-5840|Lbird@rchsd.org|
22442763|NCT01489111|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22442764|NCT00762424|WellSpan Health|Barbara Stahlman MS, Clinical Research Associate|717-851-2450|bstahlman@wellspan.org|
22442765|NCT01546402|Post Graduate Institute of Medical Education and Research|Aniruddha Agarwal|+911722756111|aniruddha9@gmail.com|
22442766|NCT01949337|Memorial Sloan-Kettering Cancer Center|Michael J. Morris, MD|646-422-4469|morrism@mskcc.org|
22442767|NCT00003472|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22442768|NCT00874939|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22442769|NCT02870933|National Cardiovascular Center Harapan Kita|Tri Wisesa Soetisna, M.D, MHA, PhD|+62215684093|tricts2000@yahoo.com|
22442770|NCT02168387|Duke University Medical Center|Ira M. Cheifetz, MD, FCCM, FAARC|919-681-4080|ira.cheifetz@dm.duke.edu|
22442771|NCT01659554|Columbia University Medical Center|Reena M. Vattakalam, CCRP|212-342-6895|rmv2110@cumc.columbia.edu|
22442772|NCT00603590|Tehran University of Medical Sciences|Mansoor Rastegarpanah|+989121255960|rastegar@sina.tums.ac.ir|
22442773|NCT00910624|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22381462|NCT00972543|Merck Serono S.A., a division of Merck KGaA|Medical Responsible|+49-6151-75-5200|service@merckgroup.com|
22381463|NCT01466881|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623|hongli@fredhutch.org|
22381464|NCT03101592|David Geffen School of Medicine at UCLA|Dr. Risa Hoffman, MD, MPH; Director of GHP; Associate Professor of Clinical Medicine|310 825-7225|rhoffman@mednet.ucla.edu|
22381465|NCT01970943|Massachusetts General Hospital|Dr David Borsook, study PI|6172817135|david.borsook@childrens.harvard.edu|
22381466|NCT02397889|Icahn School of Medicine at Mount Sinai|Adriana Feder|212-659-9279|adriana.feder@mssm.edu|
22381467|NCT02775617|London School of Hygiene and Tropical Medicine|Dr Michael Marks|02079272566|michael.marks@lshtm.ac.uk|
22381468|NCT03404609|Stanford University|Dr. Carolyn Rodriguez|650-723-6158|cr2163@stanford.edu|
22381469|NCT02219490|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22381470|NCT01454362|Queen Mary University of London|Dr Hayden McRobbie|0207 882 7260|researchamendments@bartsandthelondon.nhs.uk|
22381471|NCT02419521|Medtronic Coronary Structual Heart|Beth Moe, Clinical Study Manager||beth.moe@medtronic.com|
22381472|NCT01928940|GlaxoSmithKline|GSK Response Center|866-435-7343||
22381473|NCT01363479|Helsinn Healthcare SA|Marco Palmas MD, Head of Clinical Development|+41919852121|marco.palmas@helsinn.com|
22381474|NCT01352507|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22381475|NCT03178201|Columbia University|Ana Ignat|212-305-3612|ai2111@cumc.columbia.edu|
22381476|NCT02347917|Sumitomo Dainippon Pharmaceutical|Clinical Research (Oncology)|e-mail only|cc@ds-pharma.co.jp|
22381477|NCT00883350|Pennington Biomedical Research Center|Corby Martin|763-2585|corby.martin@pbrc.edu|
22381478|NCT04639947|Duke Eye Center|Dr. Sanjay Asrani|+1 919 684 8656|sanjay.asrani@duke.edu|
22381479|NCT01018511|Astellas Pharma Europe B.V.|Medical Director, Global Medical Science||Astellas.resultsdisclosure@astellas.com|
22381480|NCT03424239|Massachusetts General Hospital|Dr. Elaine Yu|617-643-6353|ewyu@mgh.harvard.edu|
22381481|NCT01258387|Acorda Therapeutics, Inc.|Anthony Caggiano, MD, PhD|914-347-4300|tcaggiano@acorda.com|5150
22381482|NCT03697460|Mayo Clinic|Aaron R. Mangold, M.D.|480-301-6479|Mangold.Aaron@mayo.edu|
22381483|NCT02414828|Aeras|Ann Ginsberg, Chief Medical Officer|301-547-2912|aginsberg@aeras.org|
22381484|NCT02376933|University of Arizona Cancer Center|Program Coordinator|520-626-0301|aselegue@email.arizona.edu|
22381485|NCT00630864|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22381486|NCT00430677|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22381487|NCT01779375|George Washington University Biostatistics Center|Sharon Edelstein|3018819260|sharone@bsc.gwu.edu|
22381488|NCT01555762|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22381489|NCT00819910|Brooke Army Medical Center|Ahmad Slim, MD|2109164717|ahmad.slim@us.army.mil|
22381490|NCT00112112|MedImmune, LLC|Raburn Mallory|301-398-0000|malloryr@medimmune.com|
22381491|NCT00871429|Northwestern University|Mandy Browning|312-695-6829|mandybrowning2015@u.northwestern.edu|
22381492|NCT01912495|Erasmus MC|B.J.A.Rijnders|0031107034529|b.rijnders@erasmusmc.nl|
22381493|NCT01772719|University of Louisville, James Graham Brown Cancer Center|James Graham Brown Cancer Center, Clinical Trials|502-562-3429|ctobcc@louisville.edu|
22381494|NCT03663101|Ipsen Innovation SAS|Medical Director|see email|clinical.trials@ipsen.com|
22381495|NCT00477412|UT MD Anderson Cancer Center|Michael Wang, Professor, Lymphoma-Myeloma|(713) 792-2860|miwang@mdanderson.org|
22381496|NCT05579886|CooperVision Inc.|José A. Vega OD, MSc, FAAO, PhD|19256213761|javega@coopervision.com|
22381497|NCT00299702|Ortho-McNeil, Inc. N America Pharm CNS/IM|Therapeutic Area Lead|609-730-3693||
22381498|NCT01560949|UT MD Anderson Cancer Center|Dr. Gauri R Varadhachary,Professor, GI Medical Oncology|(713) 792-2828|gvaradha@mdanderson.org|
22381499|NCT03181724|Massachusetts General Hospital|Dr. Neal Chen|617-726-4700|nchen1@mgh.harvard.edu|
22381500|NCT02931396|University of Pittsburgh|Alicia Koontz|4128223700|akoontz@pitt.edu|
22381501|NCT03032159|Seattle Children's|Tumaini R. Coker, MD, MBA|206-884-0559|Tumaini.Coker@seattlechildrens.org|
22381502|NCT05460663|University of New Mexico, College of Nursing|Stephen H. A. Hernandez, PhD, RN, FAAN|505-272-0756|shhernandez@salud.unm.edu|
22381503|NCT00670540|University Hospital Grenoble|Jean-Luc Bosson|33 4 76 76 50 40|jean-luc.bosson@imag.fr|
22381504|NCT00681811|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22381505|NCT02613897|University of Texas Health San Antonio|Yuejuan Qin|210-617-5300|qiny@uthscsa.edu|
22381506|NCT03896230|Hackensack Meridian Health|Gabrielle L. Procopio, Pharm.D., BCPS|551-996-4368|Gabrielle.Procopio@hmhn.org|
22381507|NCT01866917|Montefiore Medical Center|Ja Hyun Shin|718-920-5157|JASHIN@montefiore.org|
22381508|NCT01140347|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22381509|NCT00828919|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22381510|NCT02530151|Northwestern University|Michael Terry, MD|312-472-6488|mterry@nm.org|
22381511|NCT01245413|Lægehuset, Skodsborg Strandvej 125A, 2942 Skodsborg, Denmark|Dr. Claus Hyldahl|4545801331|hyldahl@info.dk|
22381512|NCT01562743|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-6361-7366||
22427686|NCT02075125|Department of Cardiology, College of Medicine, Dong-A University.|Dr. Moo Hyun Kim; Director of Global Clinical Trial Center Dong-A University Hospital.|+82 (51) 240-2976|kimmh@dau.ac.kr|
22427687|NCT05432232|HistoSonics, Inc.|Vice President of Clinical Affairs|(877) 740-0543|clinicaltrials@histosonics.com|
22427688|NCT01981616|Millennium Pharmaceuticals Inc.|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
22427689|NCT01132508|Synthes GmbH|Clinical Research Scientist|+41619656592|clinicalaffairs.emea@synthes.com|
22427690|NCT05079321|Centre for Ocular Research and Education|Lyndon Jones|(519) 888-4567|lwjones@uwaterloo.ca|35030
22381513|NCT05567159|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
22412004|NCT02985957|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1(800) 332-2056|Clinical.Trials@bms.com|
22381514|NCT01374490|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22381515|NCT00662909|Astellas Pharma Global Development, Inc.|Medical Director, Medical Sciences||ClinicalTrials.Disclosure@us.astellas.com|
22381516|NCT02891629|EyeFree Assisting Communication|Or Retzkin, CEO|+972526490093|or@eyecontrol.co.il|
22381517|NCT03396835|Masimo Corporation|Tala Harake|949-297-7137|studies@masimo.com|
22381518|NCT03467724|Venus Concept|Director of Clinical Affairs|1-888-907-0115|mgronski@venusconcept.com|
22381519|NCT01451814|Brown University School of Public Health|Dr. Christopher Kahler|401 863-6651|Christopher_Kahler@brown.edu|
22381520|NCT02049866|Columbia University|Mariana Bucovsky|212-305-7225|mb3523@cumc.columbia.edu|
22381521|NCT03700658|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22381522|NCT00913913|Dartmouth-Hitchcock Medical Center|Dr. Marc Ernstoff|603-650-5534|marc.s.ernstoff@hitchcock.org|
22381523|NCT00918957|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22381524|NCT03107611|Mylan Pharmaceuticals Pvt Ltd|Prasanna C Ganapathi, Clinical Sciences Program Lead|+91 9148448200|PrasannaC.Ganapathi@mylan.in|
22381525|NCT02753413|GlaxoSmithKline|GSK Response Center|866-435-7343||
22381526|NCT01020838|Piramal Imaging|Dr. Juergen Hirschfeld|49 30 461 1246 15|juergen.hirschfeld@piramal.com|
22381527|NCT04176458|Northwestern University|Daniel Ganger, MD|3126954496|daniel.ganger@nm.org|
22381528|NCT00891618|University of Texas MD Anderson Cancer|Michael Wang, MD / Professor, Lymphoma/Myeloma|713-792-2860|CR_Study_Registration@mdanderson.org|
22381529|NCT02145182|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.||clinicaltrials@alexion.com|
22381530|NCT03586167|Alcon Research|CDMA Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22381531|NCT03058783|Bausch Health Americas, Inc|Study Director|19083009920|susan.harris@bauschhealth.com|
22381532|NCT03537651|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22381533|NCT05487703|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22381534|NCT02403323|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22381535|NCT00952718|ChangGungMH|Dr. Liaw MY|+8867317123|myliaw1@yahoo.com.tw|8199
22381536|NCT00197236|GlaxoSmithKline|GSK Response Center|866-435-7343||
22381537|NCT00746330|Novartis Pharmaceuticals|Study Director|862-778-8300||
22381538|NCT01076335|The University of Texas (UT) MD Anderson Cancer Center|Lance Pagliaro, MD|1-877-632-6789|CR_Study_Registration@mdanderson.org|
22381539|NCT02524288|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22381540|NCT03360422|Northeastern University|Robert Leeman|6173736501|r.leeman@northeastern.edu|
22381541|NCT01835899|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22381542|NCT02616263|Washington University in St. Louis, School of Medicine, Program in Physical Therapy|Dr. Mary Hastings, Professor|3142107108|hastingsmk@wustl.edu|
22381543|NCT04807517|Massachusetts General Hospital Lurie Center for Autism|Lurie Center Research Manager|781-860-1711|luriecenterresearch@mgh.org|
22381544|NCT01859195|The Miriam Hospital|Principal Investigator|401-793-4775 or 401-793-8180|scu-uvin@lifespan.org; kate.guthrie@lifespan.org|
22381545|NCT03569813|Emory University|Aaron Siegler, PhD|404-712-9733|asiegle@emory.edu|
22381546|NCT02939183|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22381547|NCT05015478|Icahn School Of Medicine at Mount Sinai|Mariana Figueiro PhD|212-241-6500|Mariana.Figueiro@mountsinai.org|
22381548|NCT04939428|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22381549|NCT05096117|National Institute on Alcohol Abuse and Alcoholism|Dr. Daniel Falk|3014430788|falkde@mail.nih.gov|
22381550|NCT04319094|Mass General Hospital|Dr. Jin hui Joo|410-724-5317|jhjoo@mgh.harvard.edu|
22381551|NCT04081545|Virginia Mason Medical Center|Christine Oryhan|206-223-6980|christine.oryhan@virginiamason.org|
22381552|NCT03057132|Cancer Treatment Centers of America|Joseph Rudolph, BSN, RN, CWOCN, DWC|(215) 537-4678|Joe.Rudolph@ctca-hope.com|
22381553|NCT00654238|Abramson Cancer Center at the University of Pennsylvania|Dr. Marcia Brose|215-746-6344|brosem@mail.med.upenn.edu|
22381554|NCT00658411|Dana-Farber Cancer Institute|Philippe Armand, MD, PhD|617-632-2305|parmand@partners.org|
22381555|NCT03905135|National Cancer Institute|Dr. Kevin C. Conlon|240-858-3570|conlonkc@mail.nih.gov|
22381556|NCT04523181|Golden Biotechnology Corporation|Dr. Howard Cheng|+886228086006|howard@goldenbiotech.com|826
22381557|NCT01481935|University of Maryland School of Medicine|Anthony D. Harris, MD MPH|410-706-0064|aharris@epi.umaryland.edu|
22381558|NCT02042443|SWOG Statistics & Data Management Center|SWOG Statistician|206-667-4408||
22381559|NCT01649427|Novartis Pharmaceuticals|Study Director|(862) 778-8300||
22381560|NCT02735187|Philips Light & Health|Dr. Joerg Liebmann|+ 49-(0)1733715907|joerg.liebmann@philips.com|
22381561|NCT02138916|AstraZeneca|Ulbaldo Martin|1.301.398.0163|ulbaldo.martin@astrazeneca.com|
22381562|NCT01913340|University of California San Francisco|Yvonne Wu, MD MPH||wuy@ucsf.edu|
22381563|NCT05010304|University of Texas Southwestern|Dr Timothy Chow|2144569093|timothy.chow@utsouthwestern.edu|
22381564|NCT05750745|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
22381565|NCT05064761|Galderma Research and Development, LLC (GLLC)|Clinical Project Manager|+1 817-961-5000|aestheticclinicaltrials@galderma.com|
22381566|NCT05096884|Hackensack Meridian Health|Jana Tancredi|5519962353|Jana.Tancredi@hmhn.org|
22381567|NCT02482233|Royal Columbian Hospital / University of British Columbia|Dr. Susan Ming Lee|604-520-4253|susanlee.anesthesia@gmail.com|
22381568|NCT04888585|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22381569|NCT04927975|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22381570|NCT03822351|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22381571|NCT02237079|Tulane University|Dr. Franck Mauvais-Jarvis|504-988-5990|fmauvais@tulane.edu|
22381572|NCT00768066|The EMMES Corporation|Adam Mendizabal, Biostatistician|301-251-1161|amendizabal@emmes.com|221
22381573|NCT05550337|Teva Pharmaceuticals, Inc.|Director, PD/CE Studies|1-888-483-8279|usmedinfo@tevapharm.com|
22381574|NCT02189863|Alcon Research, Ltd.|Global Brand Lead, Global Medical Affairs, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22381575|NCT02178436|Karmanos Cancer Institute|Mohammed Najeeb Al Hallak M.D.|313-576-8718|alhallakm@karmanos.org|
22381576|NCT02266329|VA Puget Sound Health Care System|Hollie Holmes|206-277-6207|Hollie.Holmes@va.gov|
22381577|NCT00813488|Cephalon, Inc.|Sponsor's Medical Expert, Clinical Research|1-800-896-5855||
22381578|NCT00365417|NSABP Foundation, Inc.|Diana Gosik|412-339-5333|diana.gosik@nsabp.org|
22381579|NCT02926937|Lexicon Pharmaceuticals, Inc,|Medical Affairs|338-6064|medical-information@lexpharma.com|(510)
22381580|NCT01559090|AstraZeneca|Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22381581|NCT04985383|Alkahest, Inc.|Head of Communications|(650) 801-0474|sm-Trials-alkahest@grifols.com|
22381582|NCT00126113|National Center for Rehabilitative Auditory Research|Gabrielle Saunder Ph.D.|503-220-8262|gabrielle.saunders@va.gov|56210
22381583|NCT03499600|George Mason University|Dr. Amanda Sanchez|703-993-1354|asanch49@gmu.edu|
22381584|NCT00561574|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22381585|NCT00445692|Fred Hutch Cancer Research Center|Leona A. Holmberg, MD, PhD|206-667-6447|lholmber@fredhutch.org|
22381586|NCT03971357|Price Vision Group|Marianne Price|317-814-2990|mprice@cornea.org|
22381587|NCT01729871|Janssen Scientific Affairs, LLC|Senior Director Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
22381588|NCT01796977|Halyard Health, Inc.|Director of Clinical Affairs|470-448-5352|david.curd@hyh.com|
22381589|NCT01143077|Sunovion Pharmaceuticals|Medical Director, CNS|1-866-503-6351||
22381590|NCT03860077|Brown University|Dr. Rachel Cassidy|4018636621|rachel_cassidy@brown.edu|
22381591|NCT02147990|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
22381592|NCT01333514|Rush University Medical Center|Chung-Kay Koh|8475305230|chungkay@gmail.com|
22381593|NCT04155424|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22381594|NCT03888144|Cleveland Clinic foundation|Dr Sriharan Sivalingam|2162130159|SIVALIS@ccf.org|
22381595|NCT01606124|Mayo Clinic|Frank A. Sinicrope, M.D.|507-284-2511|sinicrope.frank@mayo.edu|
22381596|NCT01091454|Mayo Clinic|Alvaro Moreno-Aspitia MD|507-284-1159|morenoaspitia.alvaro@mayo.edu|
22381597|NCT01510912|Iroko Pharmaceuticals, LLC|Daniel Solorio, Executive Director of Clinical Operations|267-546-3150|dsolorio@iroko.com|
22381598|NCT02030028|University of Pittsburgh|Dr. Dana Ascherman (Principal Investigator)|14123838123|DAscher@pitt.edu|
22381599|NCT00661778|Hoffmann-La Roche|Medical Communications|800 821-8590||
22381600|NCT03557385|Duke Clinical Research Institute|Marjan Cobbaert|9196995638|mr157@duke.edu|
22381601|NCT02236559|McGovern Medical School at The University of Texas Health Science Center at Houston|Dr. Pratik Doshi, MD||pratik.b.doshi@uth.tmc.edu|
22381602|NCT02488317|Arbor Research Collaborative for Health|Dr. Francesca Tentori|7346654108|francesca.tentori@arborresearch.org|
22381603|NCT01149681|Pharma Mar, S.A.|Clinical Development Department of PharmaMar´s Oncology,Business Unit.,|+34 918466000|clinicaltrials@pharmamar.com|
22381604|NCT00817635|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22381605|NCT01259102|Purdue Pharma L.P.|Executive Medical Director, Clinical Pharmacology|800-733-1333||
22381606|NCT01720446|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22381607|NCT01803646|Auris Medical Inc.|Thomas Meyer, CEO|+1 312 396 4150|hear@aurismedical.com|
22381608|NCT02993471|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22381609|NCT00601848|University of Pennsylvania|Keith A Cengel, MD, PhD|(215) 615-5312|cengel@pennmedicine.upenn.edu|
22381610|NCT03999554|FluGen|Pamuk Bilsel, CSO|6084426562|pbilsel@flugen.com|
22381611|NCT02082158|National Center for Occupational Health and Infection Control|Aaron Eagan|352-376-1611|aaron.eagan@va.gov|4973
22381612|NCT02243007|Massachusetts General Hospital|David P. Ryan, MD|6177240245|dpryan@mgh.harvard.edu|
22381613|NCT00742274|W.L. Gore and Associates|Jennifer Gorman|928-864-3381|jgorman@wlgore.com|
22381614|NCT01101165|Purdue Pharma L.P.|Stephen Harris, MD|203-588-7592|Stephen.Harris@Pharma.com|
22381615|NCT01522339|Cincinnati Children's Hospital Medical Center|Jean Tkach|513-636-7166|jean.tkach@cchmc.org|
22381616|NCT00619151|Sorin Group USA, Inc.|Barbara Mathews Director Clinical and Medical Affairs|512-435-3602|Barbara.mathews@sorin.com|
22381617|NCT02060279|Nemours Children's Specialty Care|Dr. Amanda Lochrie|904-697-3698|alochrie@nemours.org|
22381618|NCT04974489|University of North Carolina, Chapel Hill|M. Justin Byron, PhD|(919)966-3292|jbyron@unc.edu|
22381619|NCT05674370|Mayo Clinic|Dr. Matthew Binicker|507-284-3697|binnicker.matthew@mayo.edu|
22381620|NCT02020018|Mayo Clinic|Dr. Hartzell V. Schaff|507-255-7066|schaff.hartzell@mayo.edu|
22381621|NCT05457842|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|8008887704|astellas.resultsdisclosure@astellas.com|
22381622|NCT02280655|Emory University|Dr. John D. Roback|404-712-1774|jroback@emory.edu|
22381623|NCT03124108|Genfit SA|Clinical Head|+33320164000|clinicaltrial@genfit.com|
22381624|NCT02266810|Intersect ENT|James Stambaugh (VP, Clinical Affairs)|650-641-2103|jstambaugh@intersectent.com|
22381625|NCT00578617|Mayo Clinic|Kristi Monahan|507-255-6676|CABANA@mayo.edu|
22381626|NCT01219855|OPKO Health, Inc.|Douglass Laidlaw, PhD, Vice President, Medical Affairs|305-575-4172|dlaidlaw@opko.com|
22381627|NCT01670019|Duke University|John Beyer, M.D.|919-668-0209|john.beyer@dm.duke.edu|
22381628|NCT00683410|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22381629|NCT00295867|UCSF Helen Diller Family Comprehensive Cancer Center|Hope S. Rugo|415-353-7618|hrugo@medicine.ucsf.edu|
22381630|NCT01335932|FHCRC|Dr.Michael Boeckh|206 667-6706|mboeckh@fredhutch.org|
22427691|NCT01081626|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22381631|NCT03582956|Yale University|Michelle Van Name|2037855831|michelle.vanname@yale.edu|
22381632|NCT03885596|Concentric Analgesics|Head of Clinical Operations|14154847921|nancy@concentricanalgesics.com|
22381633|NCT01129778|Stanford University|W. Ray Kim, MD, Chief of Gastroenterology and Hepatology|650-725-6511|wrkim@stanford.edu|
22381634|NCT00517933|Duke Clinical Research Institute|Kevin J Anstrom, PhD|919-668-8902|kevin.anstrom@duke.edu|
22381635|NCT01078246|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22381636|NCT00235495|University of Miami|Dr. Myron D. Ginsberg|305-243-6103|MGinsberg@med.miami.edu|
22381637|NCT01248221|Mayo Clinic|Dr. Adil E. Bharucha|507-284-2687|bharucha.adil@mayo.edu|
22381638|NCT01639443|West Los Angeles VA / Cedars-Sinai Medical Center|Jennifer Talley Soares|(310) 478-3711|jennifer.soares@va.gov|83240
22381639|NCT02806895|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
22381640|NCT01268566|MedImmune, LLC, an affiliate of AstraZeneca|A Phase 2 Study of MEDI-575 in Adult Subjects with Recurrent Glioblastoma Multiforme|1-877-240-9479|information.center@astrazeneca.com|
22381641|NCT00601965|Veterans Medical Research Foundation|Dr. Julie Wetherell|858-552-8585|jwetherell@ucsd.edu|2752
22381642|NCT02784704|La Jolla Pharmaceutical Company|Chief Development Officer|617-715-3600|ljpcregulatory@ljpc.com|
22381643|NCT00603538|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22381644|NCT02387749|Cairo university, faculty of medicine|Dina Mohammed Riad Ebrahim Abdelmagid|+201112052600|drdina_m@hotmail.com|
22381645|NCT04794179|University of Utah Healthcare|Richard Gurgel MD, PI|801-585-1626|Richard.Gurgel@hsc.utah.edu|
22381646|NCT02929069|Yale University|John Pachankis, PhD|(203) 785-3710|john.pachankis@yale.edu|
22381647|NCT01110174|PI has left the institution, all efforts to locate PI have been exhausted.|PI has left the institution, all efforts to locate PI have been exhausted.||steve.martinez@ucdmc.ucdavis.edu|
22381648|NCT03781804|OptiNose|John Messina, PharmD, SVP of Clinical Research & Medical Affairs|267-521-0565|John.Messina@optinose.com|
22381649|NCT04678830|CytoDyn Inc.|Bernie Cunningham, PhD|(360) 980-8524|bcunningham@cytodyn.com|
22381650|NCT06044948|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|8884513937|alcon.medinfo@alcon.com|
22381651|NCT03788291|University of Rochester|Paul Barr, MD|585-273-3258|paul_barr@urmc.rochester.edu|
22381652|NCT01836458|Novartis Pharmaceuticals|Study Director|862-778-8300||
22381653|NCT00429793|Gynecologic Oncology Group Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
22381654|NCT00836810|University of Bristol|Professor John Kirwan|+44 117 342 2904|John.Kirwan@Bristol.ac.uk|
22381655|NCT02639429|The University of Texas Health Science Center at Houston|Mesk Alrais, MD|(713) 566-5735|Mesk.A.Alrais@uth.tmc.edu|
22381656|NCT02040844|Circassia Ltd|VP Clinical Operations|+44 1865 405560|info@circassia.com|
22381657|NCT02014558|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22381658|NCT05273801|Shirley Ryan AbilityLab|Dr. Miriam Rafferty|3122387233|mrafferty@sralab.org|
22381659|NCT03719677|Wayne State University|Heather Fritz|313-664-2627|Heather.fritz@wayne.edu|
22381660|NCT03059992|SCYNEXIS, Inc.|Dr. David Angulo, SCYNEXIS CEO|201-884-5471|david.angulo@scynexis.com|
22381661|NCT04257058|Emory University|Dr. Jordan Marchak|404-727-2293|jgillel@emory.edu|
22381662|NCT03227757|Abbott|Karine Miquel|+32 479 600 107|karine.miquel@abbott.com|
22381663|NCT05570006|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22381664|NCT01144468|University Health Network|Dr. Angela Cheung|416-340-4841|jscher@uhnresearch.ca|
22381665|NCT02960659|NIDDK|Dr. Stephanie Chung|301-402-2122|stephanie.chung@nih.gov|
22381666|NCT04476472|Insulet Corporation|Dr. Trang Ly|9786007628|tly@insulet.com|
22381667|NCT03919955|Brigham and Women's Hospital|Scott Sands|8579280341|scottysands@gmail.com|
22381668|NCT00821184|Lahey Clinic|John T. Stoffel, MD|781-744-5481|John.T.Stoffel@lahey.org|
22381669|NCT04199728|Penn State College of Medicine|Dr. Scott Bunce|215-510-8295|sbunce@pennstatehealth.psu.edu|
22381670|NCT01210820|AMO Development, LLC|Carrie Garufis|714-566-3728|carrie.garufis@amo.abbott.com|
22381671|NCT02703714|University of California, San Francisco|Dr. R. Katie Kelley, MD|(415) 353-9888|katie.kelley@ucsf.edu|
22381672|NCT01875250|National Cancer Institute|Dr. Ravi A. Madan|301-480-7168|m480i@nih.gov|
22381673|NCT05333263|Mayo Clinic|Kenton Kaufman, Ph.D|507-284-2262|Kaufman.Kenton@mayo.edu|
22381674|NCT02749968|University of Cincinnati|Michael Goodman|5135585661|michael.goodman@uc.edu|
22381675|NCT03068468|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
22381676|NCT02555449|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22381677|NCT03895034|RxSight|Jeffrey Ha, Senior Director of Clinical Research|949-521-7870|jha@rxsight.com|
22381678|NCT02085356|University of Miami Miller School of Medicine|Violeta Rodriguez|3052432188|vjrodriguez@med.miami.edu|
22381679|NCT01118377|Hoffmann-La Roche|Medical Communications|800 821-8590||
22381680|NCT00538213|GlaxoSmithKline|GSK Response Center|866-435-7343||
22381681|NCT03140176|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22381682|NCT05365633|University of Oklahoma|Dr. Julia McQuoid|405-271-8001|julia-mcquoid@ouhsc.edu|1
22381683|NCT01331824|Icahn School of Medicine at Mount Sinai|Dr. Matthew D. Galsky|212-241-6756|matthew.galsky@mssm.edu|
22396700|NCT02247245|University of Leeds|Dr Haqeel Jamil|0113 343 3241|haqeel.jamil@nhs.net|
22396701|NCT05678257|NuCana plc|Medical and Scientific Affairs Department|+44 131 357 1111|info@nucana.com|
22396702|NCT01045798|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22396703|NCT01449461|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22396704|NCT05314517|Kinevant|Study Director|(+1) 646-494-6491|kinevant.resolve-lung@kinevant.com|
22396705|NCT01777412|Johns Hopkins University|Michael Levy|443-287-4412|mlevy@jhmi.edu|
22396706|NCT04714073|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22381684|NCT03196167|Yale University|Amit Bardia|2038436469|amit.bardia@yale.edu|
22381685|NCT02234128|Lung Bioengineering Inc.|Michael Roberts, Director Regulatory Affairs|2406502261|mroberts@lungbioengineering.com|
22381686|NCT03179787|Otsuka Pharmaceutical Co., Ltd.|Section Chief of Pharmacovigilance|+81-3-6717-1400|Sugimoto.Yuna@otsuka.jp|
22381687|NCT03181958|Children's Hospital of Chongqing Medical University|Dr.Yuan Shi|+86 23 68757731|shiyuan@hospital.cqmu.edu.cn|
22381688|NCT02695290|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22381689|NCT00427557|MD Anderson Cancer Center|Dr. Partow Kebriaei|713-563-5174|celsaenz@mdanderson.org|
22381690|NCT03106025|Loma Linda University Medical Center|Dr. Stephanie Tseeng|9095584000|ttseeng@llu.edu|
22381691|NCT02786771|Partners Connected Health Innovation|Odeta Dyrmishi - Acting Project Manager|6177243605|odyrmishi@partners.org|
22381692|NCT01063036|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22381693|NCT02702921|Ethicon Endo Surgery|Jason Waggoner, PhD|+1 513.337.8310|jwaggon1@its.jnj.com|
22381694|NCT01107626|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22381695|NCT01977612|Washington University School of Medicine|Lindsay Kuroki, M.D.|314-362-2368|kurokil@wustl.edu|
22381696|NCT04381494|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22381697|NCT01760291|Boston Scientific|Director of Clinical Trials|18002273422|peter.maurer@bsci.com|
22381698|NCT02715258|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
22381699|NCT04310579|U.S. Food and Drug Administration|David Strauss, MD, PhD|301-796-6323|David.Strauss@fda.hhs.gov|
22381700|NCT02052648|Lumos Pharma Corporation|Lumos Pharma, Inc.|515-598-2921|clinical.trials@lumos-pharma.com|
22381701|NCT01325870|Advanced Circulatory|Clinical Research Associate|651-403-5606|nburkhart@advancedcirculatory.com|
22381702|NCT01280591|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22381703|NCT02263508|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22381704|NCT04148937|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22381705|NCT00686517|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22381706|NCT01167426|Teva Pharmaceuticals Medical Affairs|Thomas Smith, MD|816-508-5128|tom.smith@tevapharm.com|
22381707|NCT02047461|Origin Biosciences (affiliate of BridgeBio)|Business Development and Operations|650-391-9740|info@bridgebio.com|
22381708|NCT04044664|Aptinyx|Aptinyx Clinical Development|847-871-0377|clinicalstudies@aptinyx.com|1
22381709|NCT02005666|Cadila Healthcare Limited|Mr Anuj K Saini|02717623666|Anuj.Saini@zyduscadila.com|314
22381710|NCT00001575|National Cancer Institute|Thomas Waldmann M.D.|301-496-6653|waldmann@nih.hhs.gov|
22381711|NCT00478556|UAB Hospital Radiology|Lisa Nelson|205-934-4015|lnelson@uabmc.edu|
22381712|NCT00831792|UT MD Anderson Cancer Center|Corn,Paul,M.D. Ph.D. / Genitourinary Medical Oncology|713-792-7734|PCORN@MDANDERSON.ORG|
22381713|NCT03736785|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22381714|NCT00728845|Cancer Institute of New Jersey|Dr. Joseph Aisner|732-235-8675|aisnerjo@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
22381715|NCT02974010|NeuroRx|Martin Brecher|+1 484 254 6134|mbrecher@neurorxpharma.com|
22381716|NCT03256344|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22381717|NCT00880906|Vanderbilt University|Michael Vaezi, MD, PhD|615-322-3739|michael.vaezi@vanderbilt.edu|
22381718|NCT04163458|Ferring Pharmaceuticals|Global Clinical Compliance|-|DK0-Disclosure@ferring.com|
22381719|NCT03852433|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22381720|NCT02809911|Regenesis Biomedical|Heather Vander Ploeg|602-4287041|Heather.VanderPloeg@regenesisbio.com|
22381721|NCT01113515|NovaLead Pharma Pvt. Ltd.|Supreet Deshpande|+91-866-965-6660|supreet@novaleadpharma.com|12
22381722|NCT02708862|HHRI|Audrey Hendrickson|6128737448|audrey.hendrickson@hcmed.org|
22381723|NCT03717194|Seoul National University Bundang Hospital|Soo Lim|+82-31-787-7035|limsoo@snu.ac.kr|
22381724|NCT03102242|Mayo Clinic|Helen J. Ross, MD|4803018000|Ross.Helen@mayo.edu|
22381725|NCT00389519|King Pharmaceuticals, Inc.|Professional Information Services|1-800-776-3637||
22381726|NCT03425539|Idorsia Pharmaceuticals Ltd|Idorsia Clinical Trial Information|+1 856 661 3721|idorsiaclinicaltrials@idorsia.com|
22381727|NCT00946192|Massachusetts General Hospital and Harvard Medical School|Madhu Misra, MD; Chief, Pediatric Endocrine|6177245602|mmisra@mgh.harvard.edu|
22381728|NCT01080131|Novartis Pharmaceuticals|Study Director|862 778-8300||
22381729|NCT04159506|VA Connecticut Healthcare System|Steve Martino, Ph.D.|203-932-5718|Steve.Martino@va.gov|7418
22381730|NCT02449044|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22381731|NCT00147043|Imperial College London|Professor Nagy Habib|+442033138574|nagy.habib@imperial.ac.uk|
22381732|NCT05968079|Masimo|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
22381733|NCT04057196|Duke University|Katherine Ramos, Ph.D.|919-416-3434|Katherine.Ramos@duke.edu|
22381734|NCT00739102|Cordis Corporation, a Johnson & Johnson company|Patricia Schleckser, Director Medical Affairs|908-541-4564|pschleck@its.jnj.com|
22381735|NCT01144949|Watson Laboratories, Inc.|Gary Hoel, RPh PhD, VP Global Brands Clinical Research|801 588-6641|gary.hoel@watson.com|
22381736|NCT02008292|Yale University|Dr. Kelly Cosgrove|203-737-6969|kelly.cosgrove@yale.edu|
22381737|NCT00149630|Baylor College of Medicine|Thomas R. Kosten, M.D.|(713) 794-7032|kosten@bcm.edu|
22381738|NCT03667547|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22381739|NCT03223883|University of Iowa Carver College of Medicine|Dr. Diana Jalal|319-356-3500|diana-jalal@uiowa.edu|
22381740|NCT05298111|Universiti Sultan Zainal Abidin|Ms Ong Ying Qian|+60142186195|oyq0109@gmail.com|
22381741|NCT04866407|Rutgers RWJMS|Dr Sydney Asselstine|6469403587|sydneyasselstine@gmail.com|
22381742|NCT03079375|OdenseUH|Lene V. Ravn-Nielsen clinical pharmacist|+4523467925|lene.ravn-nielsen@rsyd.dk|
22381743|NCT01335789|Medical University of South Carolina|Aimee McRae-Clark, Pharm.D., BCPP|843-792-5216|mcraeal@musc.edu|
22381744|NCT00991276|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22381745|NCT01268891|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
22381746|NCT03783533|University of Washington|Dr. Jessica Jenness|206-616-7967|jennessj@uw.edu|
22381747|NCT03615001|Laborie|Stephanie Gallone, Clinical Research Manager|9056121170|sgallone@laborie.com|1755
22381748|NCT02001623|Genmab A/S|Clinical Trial Information|70202728|clinicaltrials@genmab.com|
22381749|NCT03669354|Southern California University Of Health Sciences|Anupama Kizhakkeveettil|(562) 475-5158|anu@scuhs.edu|
22381750|NCT00959920|Loyola University Medical Center|Dr. Sarita Massey|708-354-9250|smassey@lumc.edu|
22381751|NCT00109967|Mayo Clinic|Stephen M. Ansell, M.D., Ph.D.||ansell.stephen@mayo.edu|
22381752|NCT02628093|Weill Cornell Medicine|Koianka Trencheva|646-9622342|kivanova@med.cornell.edu|
22381753|NCT04208243|Children's Hospital Colorado|Dr. Jennifer Raybin|720-777-3407|jennifer.raybin@childrenscolorado.org|
22381754|NCT01117480|AbbVie|Global Medical Information|800-633-9110||
22381755|NCT02955069|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
22381756|NCT03721016|Medytox Inc.|Young Ryu|+82-2-6901-5424|aab005@medytox.com|
22381757|NCT04083976|Janssen Research & Development, LLC|Executive Medical Director Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22381758|NCT03357341|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22381759|NCT02175212|Hospital Universitario de la Princesa; Health Research Institute IIS from Hospital Universitario de la Princesa|Dr. Almudena Zapatero|+34 91 520 23 15|almudena.zapatero@salud.madrid.org|
22381760|NCT01524536|National Institute of Allergy and Infectious Diseases|Paneez Khoury|+1 301 402 3773|khouryp@niaid.nih.gov|
22381761|NCT01908634|Illinois Institute of Techology|Britt Burton-Freeman|708-341-0178|bburton@iit.edu|
22381762|NCT01072357|Massachusetts Eye and Ear|Dr. Reza Dana|617-573-4431|Reza_Dana@meei.harvard.edu|4431
22381763|NCT01876511|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dung Le, MD|443-287-0002|dle@jhmi.edu|
22381764|NCT02131324|Dr. Reddy's Lab, Inc|Srinivas Sidgiddi, MD|609-375-9900|srinivassidgiddi@drreddys.com|
22381765|NCT05790408|Northwestern University|Angelo P. Tanna|3129088152|atanna@northwestern.edu|
22381766|NCT01048788|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22381767|NCT01233050|Penn Medicine|Dr. Najjia Mahmoud, MD, Cheif of Colorectal Surgery|(215) 662-2078|najjia.mahmoud@uphs.upenn.edu|
22381768|NCT01771666|Stanford University|Dr. Irene Wapnir|650-724-1953|Wapnir@stanford.edu|
22381769|NCT00812877|Oregon Health & Science University|Dr. Thomas J. Hilton|503.494.8672|hiltont@ohsu.edu|
22381770|NCT01064817|Promedior, Inc.|Elizabeth G. Trehu, MD|781-538-4203|btrehu@promedior.com|
22381771|NCT03533036|UCLA|Dr. Aparna Sridhar, Associate Clinical Professor|3107947274|asridhar@mednet.ucla.edu|
22381772|NCT03102710|Massachusetts General Hospital, Harvard Medical School|Jian Kong, Principal Investigator|617-726-7893|jkong2@mgh.harvard.edu|
22381773|NCT01368406|Programa de Esquizofrenia PROESQ UNIFESP|Cecilia Attux|551155733599|cattux@gmail.com|
22381774|NCT04582877|Zurich Medical|Charles Chan|(612) 889-9412|cchan@zurichmed.com|
22381775|NCT04304534|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22381776|NCT04012853|WJB Dorn VA Medical Center|Dr. X. Michelle Androulakis Chief of Neurology|803-776-4000|xiao.androulakis@va.gov|4077
22381777|NCT01313182|New York University School of Medicine|Dr. Michael Phillips|212 263 4316|michael.phillips@nyumc.org|
22381778|NCT01695317|St. olavs Hospital|Dr. knut Hagen|95401579|knut.hagen@stolav.no|
22381779|NCT00464672|Novartis Vaccines and Diagnostics|Novartis Vaccines and Diagnostics||RegContactVacUS.nvdit@Novartis.com|
22381780|NCT00003656|Weill Cornell Medical College|Sharon Singh|(646) 962-9340|shs4011@med.cornell.edu|
22381781|NCT01134575|The University of Texas MD Anderson Cancer Center|Hagop M. Kantarnian, MD/Chair|713-792-7026|hkantarjian@mdanderson.org|
22381782|NCT01125202|New York University School of Medicine|Mary Ann Sevick, ScD|6465012621|mary.sevick@nyumc.org|646
22381783|NCT01982643|UCLA Integrated Substance Abuse Programs|Walter Ling, MD|310-267-5888|lwalter@ucla.edu|
22381784|NCT01664104|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22381785|NCT04930822|Gaylord Hospital|Dr. Henry Hrdlicka|2032842864|hhrdlicka@gaylord.org|
22381786|NCT00121199|SWOG Statistical Center|Study Statistician|206-667-4623||
22381787|NCT03168438|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22381788|NCT04432974|Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia|Dr. Massimiliano Paltenghi|(+39) 3487046844|massimiliano.paltenghi@spedalicivili.brescia.it|
22381789|NCT01458275|Sunovion|Respiratory Medical Director|1-866-503-6351||
22381790|NCT00751036|Novartis Pharmaceuticals|Study Director|862-778-8300||
22381791|NCT03921528|Scholar Rock|Clinical Trials Coordinator|833-724-7625|clinicaltrials@scholarrock.com|
22381792|NCT03410992|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22381793|NCT02734056|Brigham|Bhavani Kodali|6175258449|kodali@zeus.bwh.harvard.edu|
22381794|NCT04988295|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22381795|NCT00516503|Mayo Clinic|Debra Barton, R.N., Ph.D.||Barton.debra@mayo.edu|
22381796|NCT00943605|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com|
22381797|NCT03284411|Medtronic|SCS Dosing Clinical Research Study Team|800-633-8766|rs.scsdosing@medtronic.com|
22381798|NCT02232178|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
22381799|NCT02162667|Celltrion|Head of Clinical Planning Department|82328505000|contact@celltrion.com|
22396707|NCT02710136|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22396708|NCT02072928|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22381800|NCT01956669|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22381801|NCT01570751|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22381802|NCT00930813|Lutonix Inc. a subsidiary of C.R. Bard|Chris Barry|763-445-2352|LutonixResearch@crbard.com|
22381803|NCT00315120|University of North Texas Health Science Center-The Osteopathic Research Center|John C. Licciardone, DO, MS, MBA|817-735-2028|john.licciardone@unthsc.edu|
22381804|NCT01693614|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22381805|NCT04618471|Boston Scientific Corporation|Sr. Director, Clinical Operations|855-213-9890|BSNClinicalTrials@bsci.com|
22381806|NCT01131494|University Federal of Bahia|Natalie Argolo Ponte|55 31 3274 5579|natyargolo@hotmail.com|
22381807|NCT01196988|GlaxoSmithKline|GSK Response Center|866-435-7343||
22381808|NCT00016913|Department of Medicine, Memorial Sloan-Kettering Cancer Center|Wm. Kevin Kelly, DO||kellyw@mskcc.org|
22381809|NCT05419557|Inova Health System|Dr. Elyssa Wood|5714728649|elyssa.wood@inova.org|
22381810|NCT00588666|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin|646-422-4333|bajorind@mskcc.org|
22381811|NCT02281318|GlaxoSmithKline|GSK Response Center|866-435-7343||
22381812|NCT05257798|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22381813|NCT00703911|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22381814|NCT03055767|"University of California, Irvine | Dept. of Anesthesiology & Perioperative Care"|Shalini Shah, MD|(949) 824-7246|ssshah1@hs.uci.edu|
22381815|NCT02228408|New York University Medical Center|David Charytan|(646) 501-9086|david.charytan@nyulangone.org|
22381816|NCT02759731|National Cancer Institute|Dr. Steven Pavletic|240-760-6174|pavletis@mail.nih.gov|
22381817|NCT00618540|University of Minnesota, Pediatric BMT|Dr. Angela Smith, MD|612-626-2778|smith719@umn.edu|
22381818|NCT04969822|Vitrolife A/S|Mr. Jørgen Berntsen|+4551542005|jberntsen@vitrolife.com|
22381819|NCT00130780|Memorial Sloan Kettering Cancer Center|Dr. Mark Kris, Attending|+1646-888-4205|krism@mskcc.org|
22381820|NCT00957229|Children's Hospital of Oakland Research Institute, Oakland|Ervin H Epstein Jr., MD|510-450-5688|eepstein@chori.org|
22381821|NCT00763282|Center of Innovation for Complex Chronic Health Care|Marylou Guihan, PhD|708-202-2414|marylou.guihan@va.gov|
22381822|NCT00606580|US Army Medical Materiel Development Activity (USAMMDA)|Division of Regulated Activies and Compliance|301-619-0317|usarmy.detrick.medcom-usammda.mbx.usamrmc-regulatory-affairs@mail.mil|
22381823|NCT04580303|Endo Pharmaceuticals|Clinical Operations|1-800-462-3636|ClinicalTrials@Endo.com|
22381824|NCT01444287|Vistakon|Noel Brennan|1 904 4433494|nbrenna2@its.jnj.com|
22381825|NCT01833065|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22381826|NCT00828672|UZ Leuven|Prof. Dr. Eric Van Cutsem|+32 16 34 42 18|Eric.VanCutsem@uzleuven.be|
22381827|NCT04889118|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22381828|NCT00073957|Beth Israel Deaconess Medical Center|Robin Joyce, MD|617-667-9920|rjoyce@bidmc.harvard.edu|
22381829|NCT00601640|University of Arizona/Arizona Cancer Center|Joanne Jeter, MD|520.626.9295|jjeter@azcc.arizona.edu|
22381830|NCT02427737|Hypnalgesics, LLC d/b/a Comfort Talk|Elvira V. Lang, MD (PI of SBIR grant sponsoring site-PIs); CEO|617 734 9087|drevlang@ComfortTalk.com|
22381831|NCT00543725|Janssen Infectious Diseases BVBA|Medical Leader|32 14 641418||
22381832|NCT01250002|Northwestern University|Gildasio De Oliveira, MD|312-926-8373|g-jr@northwestern.edu|
22381833|NCT02317705|On Target Laboratories|Tommy Lee, MSHS, Vice President, Clinical Operations|765-588-4547|Tlee@ontargetlabs.com|
22381834|NCT03095508|Sandoz|Study Director|+41613241111|Sandoz.email@sandoz.com|
22381835|NCT00335556|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22381836|NCT01674569|Tyrogenex, Inc|Sr Vice President, Development|240-403-7153|Dan@tyrogenex.com|
22381837|NCT02430181|Eiger BioPharmaceuticals, Inc|Senior VP, Clinical Development|1-650-618-1621|info@eigerbio.com|
22381838|NCT01599325|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|1-888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22381839|NCT02365298|Johnson & Johnson Vision Care Inc.|Chantal Coles-Brennan|904-443-3449|CColesb@ITS.JNJ.com|
22381840|NCT01878890|Institut Bergonié|Dr Guilhem Roubaud|33 5 56 33 33 33|g.roubaud@bordeaux.unicancer.fr|
22381841|NCT04054661|PATH|Pooja Bansil|206 302 4920|pbansil@path.org|
22381842|NCT00578214|Mayo Clinic|Dr. Clark C. Otley|507-284-3579|otley.clark@mayo.edu|
22381843|NCT01710514|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22381844|NCT02846415|School of Nursing, The Hong Kong Polytechnic University|Dr Daphne Cheung|+852 27664534|cheungdaphne@polyu.edu.hk|
22381845|NCT03404843|Colorado State University|Frank Dinenno|970-491-3203|frank.dinenno@colostate.edu|
22381846|NCT00567164|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22381847|NCT01078233|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22381848|NCT04490148|Penn State College of Medicine|Dr. Andrew Geronimo|717 531 0003|ageronimo@pennstatehealth.psu.edu|282576
22381849|NCT01879371|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22381850|NCT00853827|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22381851|NCT02606734|Osprey Medical|Michele Shepard|952-955-5236|mshepard@ospreymed.com|
22381852|NCT01506362|BioLineRx LTD|Dr. Arnon Aharon|972-2-548-9100|arnona@biolinerx.com|135
22381853|NCT01636206|Shire (Note: Lifitegrast was divested to Novartis in 2019)|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22381854|NCT00580801|Janssen Research & Development, LLC, Titusville, NJ|Clinical Leader|609-730-3174||
22381855|NCT02595398|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
22381856|NCT00502593|GlaxoSmithKline|GSK Response Center|866-435-7343||
22381857|NCT05576051|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22381858|NCT00544440|Clinical Research, Janssen R&D, 10990 Wilshire Blvd, Suite 1200, Los Angeles, CA 90024|Senior Director|310-943-8040||2917
22381859|NCT03601507|University of Arizona Cancer Center|Ricklie Julian, MD|520-694-2873|rickliej@arizona.edu|
22381860|NCT03061513|Weill Cornell Medical College|Claire Henchcliffe|2127462584|clh2007@med.cornell.edu|
22381861|NCT01460342|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22381862|NCT00559949|UNC Lineberger Comprehensive Cancer Center|Dr. David Neil Hayes|919-966-3786|hayes@med.unc.edu|
22381863|NCT01194258|Halozyme Therapeutics|Vice President, Endocrinology Clinical Development|858-794-8889||
22381864|NCT01467700|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22381865|NCT03381274|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22381866|NCT01103973|Boston IVF|Alice D. Domar, PhD|781-434-6500|domar@domarcenter.com|
22381867|NCT04109118|Boston Medical Center and BU School of Medicine|Tae Woo Park, MD|617-414-1906|taewoo.park@bmc.org|
22381868|NCT02824432|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22381869|NCT01348087|Novartis Pharmaceuticals|Study Director|862-778-8300||
22381870|NCT05822440|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22381871|NCT02081391|Grünenthal GmbH|Clinical Trial Helpdesk|+49 241 569|Clinical-Trials@grunenthal.com|3223
22381872|NCT03184428|Eyestylianides ophthalmology center|Christoforos Stylianides|0035725320244|Info@eyestylianides.com|
22381873|NCT03598790|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22381874|NCT03297112|Sidney Kimmel Cancer Center at Thomas Jefferson University|Flemming Forsberg, PhD|215-955-4870|flemming.forsberg@jefferson.edu|
22381875|NCT04018066|Rutgers, The State University of New Jersey|Dr. Diana Roopchand, Study Investigator|8489320248|roopchand@sebs.rutgers.edu|
22381876|NCT03568318|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22381877|NCT05245669|Alkem Laboratories Limited|Dr. Akhilesh Sharma|+91- 9701346369|akhilesh.sharma@alkem.com|
22381878|NCT03518112|The University of Texas MD Anderson Cancer Center|Dr. Elias Joseph Jabbour MD/Professor|713-792-4764|ejabbour@mdanderson.org|
22381879|NCT02657629|HackensackUMC|Nicole Spillane MD|917-446-6656|nspillane@hackensackumc.org|
22381880|NCT05546515|Johns Hopkins School if Medicine|Jennifer Ellis|4105506346|jellis36@jhmi.edu|
22381881|NCT05197049|Janssen-Cilag International NV|Senior Medical Leader IMM|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22381882|NCT00434278|Genentech, Inc.|Medical Communications|800-821-8590||
22381883|NCT00927823|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22381884|NCT02299635|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22381885|NCT00015457|National Institutes of Health|Barbara I Karp, MD|301-496-0150|karpb@ninds.nih.gov|
22381886|NCT01456936|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22381887|NCT00906698|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22381888|NCT03879642|Nemours Children's Health-Jacksonville|Dr. Susana Patton|904-697-2000|susana.patton@nemours.org|
22381889|NCT01744691|Pharmacyclics, Inc.|Dr. Alvina Chu|855-427-8846|medinfo@pcyc.com|
22381890|NCT02701361|Duke University Health System|Christopher Cox|9196817232|christopher.cox@duke.edu|
22381891|NCT00996372|Sprout Pharmaceuticals|VP, Clinical Development|9198820850|clinicaltrials@sproutpharma.com|
22381892|NCT02322216|Alcon, a Novartis Company|Clinical Project Lead, GCRA-Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
22381893|NCT04469218|Lineus Medical|CEO|844-546-3728|vance@lineusmed.com|
22381894|NCT00404079|Oslo University Hospital Ullevaal|Project Manager: Philip Wilkens|004723016140|philip.wilkens@medisin.uio.no|
22381895|NCT01859312|National Institute of Child Health and Human Development (NICHD)|Deborah P. Merke, MD, MS|301-496-0718|DMerke@cc.nih.gov|
22381896|NCT04154943|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22381897|NCT02121418|University of Washington|Dr. Pamela Becker|206-606-7273|pbecker@u.washington.edu|
22381898|NCT02107014|University of Alabama at Birmingham|Dr. Jarred Younger|2059755821|younger@uab.edu|
22381899|NCT00591838|Washington University School of Medicine|Clifford Robinson, M.D.|314-362-4633|clifford.robinson@wustl.edu|
22381900|NCT03761784|Sol-Gel Technologies, Ltd.|Sol-Gel|972-8-9313433|info@sol-gel.com|
22381901|NCT01549652|Stanford University School of Medicine Department of Anesthesiology|Dr. Larry F. Chu|6507236632|lchu@stanford.edu|
22381902|NCT00586339|GlaxoSmithKline|GSK Response Center|866-435-7343||
22381903|NCT02512042|Teva Pharmaceuticals USA, Inc.|Director, CE Studies|1-888-483-8279|USMedinfo@tevapharm.com|
22381904|NCT02001714|Beaumont Health|Ananias C. Diokno, MD||ananias.diokno@beaumont.edu|
22381905|NCT03320096|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
22381906|NCT01097343|St. Vincent Medical Group|Dr. Joseph S. Rossi|765 482 0656|jrossi@thecaregroup.com|
22381907|NCT03495713|Abramson Cancer Center at Penn Medicine|John P. Plastaras, MD, PhD|855-216-0098|PennCancerTrials@emergingmed.com|
22381908|NCT02979899|TRACON Pharmaceuticals Inc|Charles Theuer, Medical Monitor|8585500780|ctheuer@traconpharma.com|
22381909|NCT00964119|University of Wisconsin - Madison|Dermatology Clinical Trials Administrator|608-287-2640|dbock@dermatology.wisc.edu|
22381910|NCT02059980|University of Wisconsin-Milwaukee|Dr. Han Joo Lee|414-229-5858|leehj@uwm.edu|
22381911|NCT01321606|William S. Middleton Memorial Veterans Affairs Medical Center|Dr. Nasia Sardar|608-256-1901|nasia.safdar@va.gov|17800
22381912|NCT01830842|University of Arkansas for Medical Sciences|Merideth Addicott|501-526-8436|MAddicott@uams.edu|501
22381913|NCT03235349|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22381914|NCT03394027|National Cancer Institute|Dr. Stanley Lipkowitz|240-760-6129|lipkowis@navmed.nci.nih.gov|
22381915|NCT05905302|Cleveland Clinic|Jay Alberts, PhD|216-445-3222|albertj@ccf.org|
22396709|NCT02269787|Department of Veterans Affairs|Dr. Christine Timko, Research Career Scientist|6504935000|Christine.Timko@va.gov|23336
22381916|NCT05887323|Abbott|Director of Clinical Research|9725269673|kwangdeok.lee@abbott.com|
22381917|NCT05005429|Fundación GECP|Eva Pereira|+34 934302006|gecp@gecp.org|
22381918|NCT00124982|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22381919|NCT01311713|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22381920|NCT00980538|Janssen Research & Development, LLC|DIRECTOR CLINICAL LEADER EST PRODUCTS|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22381921|NCT05663866|Janssen Research & Development LLC|Senior Medical Director Global Medical Affair Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22381922|NCT02501811|University of Texas-Houston School of Public Health|Shelly Sayre, M.P.H. Project Manager|713-500-9529|Shelly.L.Sayre@uth.tmc.edu|
22381923|NCT04804605|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
22381924|NCT05323630|West End Plastic Surgery|Paul G. Ruff, MD|202-785-4187|drruff@westendplasticsurgery.com|
22381925|NCT03720990|University of Nebraska Medical Center|William Rizzo|402-559-2560|wrizzo@unmc.edu|
22381926|NCT01249092|Cleveland Clinic|Claudia O. Zein, MD|216-444-0421|zeinc@ccf.org|
22381927|NCT00802919|Nathan Kline Institute for Psychiatric Research|Robert C. Smith MD|845-398-6531|rsmith@nki.rfmh.org|
22381928|NCT01541358|David Geffen School of Medicine at UCLA|Andrew Quon, MD|310-983-1419|AQuon@mednet.ucla.edu|
22381929|NCT04033432|Northwestern University|Maha Hussain, MD|312-908-5487|mhussain@northwestern.edu|
22381930|NCT04936035|Alnylam Pharmaceuticals|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
22381931|NCT00286741|Durham VA Medical Center|David Edelman|919-286-6936|dedelman@duke.edu|
22381932|NCT03745794|UT MD Anderson Cancer Center|Dr. Ching-Wei D. Tzeng, MD/Associate Professor, Surgical Oncology|(713) 792-0386|cdtzeng@mdanderson.org|
22381933|NCT05827926|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
22381934|NCT04131933|Ottawa Hospital Research Institute|Dr. Mark Clemons|+1-613-737-7700|mclemons@toh.ca|70170
22381935|NCT00667693|Cleveland Clinic Foundation|Daniel I Sessler, MD|216-445-8396|sesslerd@ccf.org|
22381936|NCT02086708|Massachusetts General Hospital|Dr. Uzma Shah|617-726-1450|USHAH@mgh.harvard.edu|
22381937|NCT01242085|VA Palo Alto HCS|Steven T Woolson, MD|650-493-5000|steven.woolson@va.gov|66101
22381938|NCT00097253|The Ohio State University, Department of Psychiatry|Janice K. Kiecolt-Glaser, PhD|614-292-0033|Kiecolt-Glaser.1@osu.edu|
22381939|NCT02430532|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22381940|NCT04511650|EyePoint Pharmaceuticals, Inc.|Dario Paggiarino, MD|8589670016|dpaggiarino@eyepointpharma.com|
22381941|NCT05650333|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Centre|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22381942|NCT02873754|Duke University School of Medicine|Angela Kirby|919-286-0411|angela.kirby@duke.edu|5526
22381943|NCT01981850|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22381944|NCT00917865|Emory University|David Schuster, MD|404-712-4859|dschust@emory.edu|
22381945|NCT03412747|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22381946|NCT04075266|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22381947|NCT01582945|Massachusetts General Hospital|Dr. Cristina Cusin|6177266421|ccusin@mgh.harvard.edu|
22381948|NCT01726023|AstraZeneca|David Wilson, Statistical Team Leader - Infection|+44 1625 517830|David.Wilson2@astrazeneca.com|
22381949|NCT00816829|Solvay Pharmaceuticals|Sven Voet, Global Communication|+32 (0) 2 509 69 77|sven.voet@solvay.com|
22396710|NCT05470465|U.S. Food and Drug Administration|Jeffry Florian|301-796-4847|Jeffry.Florian@fda.hhs.gov|
22396711|NCT00232583|UT Southwestern Medical Center|Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
22396712|NCT04702451|Volta Medical|Paola Milpied|+33768025499|paola.milpied@volta-medical.com|
22396713|NCT01439282|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22396714|NCT02966509|Stanford University and VA Palo Alto Health Care System|Dr. Manali Patel|650-723-4000|manalip@stanford.edu|
22396715|NCT02982954|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22396716|NCT02603120|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22396717|NCT03370536|Icahn School of Medicine at Mount Sinai|Dr. Vivek Reddy|(212) 241-7114|vivek.reddy@mountsinai.org|
22396718|NCT00916357|Halozyme|Vice President, Endocrinology Clinical Development|858-794-8889||
22396719|NCT04814342|UCSF Hypoxia Research Laboratory|Dr. Philip Bickler|1-415-476-1411|philip.bickler@ucsf.edu|
22396720|NCT05102344|University of California, Irvine|Sabrina E.B. Schuck, Ph.D.|9495335465|sabrina@uci.edu|
22396721|NCT03810781|Syracuse VA Medical Center|Dr. Richard Servatius|315-744-3370|richard.servatius@va.gov|
22396722|NCT05152927|University of California, San Francisco|Dr. Quan-Yang Duh, MD|(415) 221-4810|quan-yang.duh@ucsf.edu|
22396723|NCT03807349|Zimmer Biomet|Ryan Boylan, Clinical Affairs Manager|574-371-9784|ryan.boylan@zimmerbiomet.com|
22381950|NCT03610698|Northwestern University|Project Manager|3125035247|amanda.summers@northwestern.edu|
22381951|NCT04982575|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22381952|NCT05483933|Shattuck Labs|VP, Clinical Operations|919-864-2700|clinicaltrials@shattucklabs.com|
22381953|NCT03038022|Madrigal Pharmaceuticals, Inc.|Thomas Hare|267-268-7800|thare@madrigalpharma.com|
22381954|NCT04798521|Oregon Health & Science University|Dr. P. Todd Korthuis|503-494-8044|korthuis@ohsu.edu|
22381955|NCT01467427|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22381956|NCT04925752|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22381957|NCT04269200|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22381958|NCT04181827|Janssen Research & Development, LLC|Executive Medical Director Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22381959|NCT03887936|Michael E. DeBakey VA Medical Center|Dr, Reina Villareal|314-313-4550|reina.villareal@bcm.edu|
22381960|NCT06269367|University of Michigan|Chandramouli Krishnan|(734) 936-4031|mouli@umich.edu|
22381961|NCT03331250|Massachusetts General Hospital|Gregory Cote, MD, PhD|617-726-8748|GCOTE@mgh.harvard.edu|
22381962|NCT02443792|U of Cape Town|Dr. Justin Shenje|0027788938497|justintshenje@gmail.com|
22381963|NCT01560143|University of Michigan|Manjunath Pai|7346473466|amitpai@med.umich.edu|
22381964|NCT02908620|University of Pennsylvania, School of Dental Medicine|Elliot V Hersh, DMD, Ph.D., Director Clinical Pharmacology Research|215-898-9686|evhersh@pobox.upenn.edu|
22381965|NCT04548622|Yale University Department of Psychiatry|Dr. Philip R. Corlett PhD|(203) 974-7866|philip.corlett@yale.edu|
22381966|NCT01155869|Providence VA Medical Center|Peter Friedmann|401-273-7100|peter.friedmann@va.gov|6240
22381967|NCT01615809|Fundaciò per la Recerca i la Docencia sant Joan de Deu|Rosa Maria morales Palau|936009751|rmorales@fsjd.org|
22381968|NCT00117988|UT MD Anderson Cancer Center|Dr. Anas Younes, MD / Professor||etubbs@mdanderson.org|
22381969|NCT05824351|Duke University|Amy Barto, MD|919-684-1817|amy.barto@duke.edu|
22381970|NCT02137850|Novo Nordisk A/S|Clinical Reporting Office (2834)|866-867-7178|clinicaltrials@novonordisk.com|(+1)
22381971|NCT02912260|Madrigal Pharmaceuticals, Inc.|Thomas Hare|267-268-7800|thare@madrigalpharma.com|
22381972|NCT04549051|Albert Einstein College of Medicine|Sayed Wahezi, M.D.|718-920-7246|swahezi@montefiore.org|
22381973|NCT03878446|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22381974|NCT05803720|RAND|Dr. Lu Dong|3103930411|ldong@rand.org|7494
22381975|NCT03370133|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22381976|NCT06688370|Pierre Fabre Médicament|Aurore Puglisi Mouton|+335679463982|aurore.puglisi.mouton@pierre-fabre.com|
22381977|NCT00567879|Novartis|Study Director|862-778-8300||
22381978|NCT00151996|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22381979|NCT01546155|Massachusetts General Hospital|Dr. Jian Kong|617-726-7893|JKONG2@mgh.harvard.edu|
22381980|NCT02899000|Galderma Laboratories, LP|Dr. Jean Philippe York, Medical Affairs Manager|1-817-961-5468|jp.york@galderma.com|
22381981|NCT02220478|Zimmer Biomet|Hillary Overholser|574-933-4180|hillary.overholser@zimmerbiomet.com|
22381982|NCT01649791|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22381983|NCT02987543|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22381984|NCT03646669|Icahn School of Medicine at Mount Sinai|Maria Peralta|212-274-7571|Maria.peralta@mountsinai.org|
22381985|NCT01227278|MedImmune, LLC.|Rene van der Merwe, MBChB/Senior Director, Clinical Development|301-398-0000|vandermerwer@medimmune.com|
22381986|NCT02156687|Cleveland Clinic|Cecile Ferrando, M.D.|216-444-0642|ferranc2@ccf.org|
22381987|NCT00420316|GlaxoSmithKline|GSK Response Center|866-435-7343||
22381988|NCT00332644|University of Wisconsin|Piper, Megan E|608-265-5472|mep@ctri.medicine.wisc.edu|
22381989|NCT03546907|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22381990|NCT03720210|Mayo Clinic|Marius N. Stan, M.D.|507-266-3769|Stan.Marius@mayo.edu|
22381991|NCT01551056|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
22381992|NCT03110458|Sensorion|Director of Regulatory Affairs|+33 4 67 20 77 30|contact@sensorion-pharma.com|
22381993|NCT02274493|UT MD Anderson Cancer Center|Dr. Jesse C Selber / Professor, Plastic Surgery|713-794-1297|jcselber@mdanderson.org|
22381994|NCT03131206|Dana-Farber Cancer Institute|Mark Awad, MD, PhD|6176323468|mark_awad@dfci.harvard.edu|
22381995|NCT04008836|Ascensia Diabetes Care|Jane Wallace|5748501467|jane.wallace@ascensia.com|
22381996|NCT04588480|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
22381997|NCT01190150|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22381998|NCT02982213|Northwestern University|Feyce Peralta, MD|312-472-3585|feyce.peralta@northwestern.edu|
22381999|NCT01992354|GE Healthcare|John Strohmeyer|+1 609 865 7423|john.strohmeyer@ge.com|
22382000|NCT03523962|University of Maryland, Baltimore|Research Administrator|410-706-6823|ahowe@som.umaryland.edu|
22382001|NCT03247543|Supernus|Joseph Hull, PhD, Associate Director Clinical Research|240-403-5324|jhull@supernus.com|
22382002|NCT01081145|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22382003|NCT01253226|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22382004|NCT03593070|Rush University College of Nursing|Dr. Olimpia Paun|3129426996|olimpia_paun@rush.edu|
22382005|NCT04210024|University of Kentucky|Dr. Brittany Smalls|859-323-4916|brittany.smalls@uky.edu|
22382006|NCT03643211|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22382007|NCT04858425|First Wave BioPharma|VP, Regulatory, QA & Compliance|19194491484|AChandler@FirstWaveBio.com|
22382008|NCT03473743|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22382009|NCT02864992|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22382010|NCT05457491|Mayo Clinic|Saranya P. Wyles, M.D., Ph.D.|507-284-5475|Wyles.Saranya@mayo.edu|
22382011|NCT04536077|Washington University School of Medicine|Roheena Z. Panni, M.D.|314-362-7046|roheenazpanni@wustl.edu|
22382012|NCT04948333|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
22382013|NCT05191797|University of Washington|Rafael Santana-Davila|2066062190|rafaelsd@uw.edu|
22382014|NCT03805295|Massachusetts General Hospital|Dr. Rachel Whooten|6176434585|rwhooten@mgh.harvard.edu|
22382015|NCT00539591|St. Jude Children's Research Hospital|Alberto Pappo, MD|901-595-2322|info@stjude.org|
22382016|NCT04305912|CooperVision, Inc|Jose Vega, OD, MSc, FAAO|9256213761|JVega2@coopervision.com|
22382017|NCT00928200|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
22382018|NCT01843465|Clinique Pasteur, Toulouse, France|Dr Serge Boveda|(33) 5 62 21 16 45|sboveda@clinique-pasteur.com|8819
22382019|NCT00555581|Hospital for Special Surgery|Robert F. Spiera|212-774-2048|spierar@hss.edu|
22382020|NCT05365386|Novoxel Ltd|Dr. Ifat Klein|+972.52-6009860|ifat@novoxel.com|
22382021|NCT04538664|Janssen Research & Development|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22382022|NCT06078774|Virginia Commonwealth University|Sarah Farthing|804-527-4756|sarah.malone@vcuhealth.org|
22382023|NCT03681678|William Beaumont Hospital|Jennifer Giordano|248-551-3517|jennifer.giordano@corewellhealth.org|
22382024|NCT00331162|Wake Forest University Health Sciences|Dr. Alan Farney|336-716-6510|afarney@wakehealth.edu|
22382025|NCT00828945|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22382026|NCT03431350|Janssen Research & Development, LLC|Executive Medical Director Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22382027|NCT04540822|CHD Vendée|Stéphanie BREHU|06 88 39 85 17|stephanie.brehu@ght85.fr|+33
22382028|NCT02141074|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22396724|NCT04630171|Northwestern University|Paul Fitzgerald|312-695-1064|p-fitzgerald2@northwestern.edu|
22396725|NCT01111851|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22382029|NCT03563053|Quince Therapeutics (former Erydel SpA)|Irene Maccabruni, M.Sc.|+39 02 36504470|imaccabruni@quincetx.com|
22396726|NCT05500274|The University of Chicago|Dr. John Schneider|(773) 702-2453|jschnei1@uchicago.edu|
22382030|NCT03536884|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22382031|NCT03722446|University of Michigan - Department of Anesthesiology|Dr. Carlo Pancaro|617-435-5403|cpancaro@med.umich.edu|
22382032|NCT00635817|Abbott|Global Medical Services|800-633-9110||
22382033|NCT01137292|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22382034|NCT00731211|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22412005|NCT00855842|Boston University|Lynn Borgatta, MD|617-414-3440|lynn.borgatta@bmc.org|
22396728|NCT00596947|Hospital of the University of Pennsylvania|Jennifer Trofe-Clark, Clinical Transplant Research Pharmacist|215-614-4274|jennifer.trofe-clark@uphs.upenn.edu|
22382035|NCT04540835|Baskent University|Leyla Kerimova Köse|+905378986689|lkerimova@baskent.edu.tr|
22382036|NCT01838200|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
22396729|NCT03000179|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
22396730|NCT03269435|Montefiore|Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
22382037|NCT03105336|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
22382038|NCT03451851|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22382039|NCT03523702|Albert Einstein College of Medicine|Dr. Nitin Ohri|718-920-7750|nitin.ohri@einsteinmed.edu|
22382040|NCT03944512|The Ohio State University|Maged M. Costantine, MD|614-293-9036|maged.costantine@osumc.edu|
22382041|NCT04969991|Ophirex, Inc.|Tim Platts-Mills, Chief Medical Officer|5592406073|tim@ophirex.com|
22382042|NCT05208359|Loyola University Chicago|Sungha Kang|7735082712|skang@luc.edu|
22382043|NCT03645031|University of Florida|Dr. Barbara K. Smith|352-294-5315|bksmith@ufl.edu|
22382044|NCT04622527|Mayo Clinic|Dr. Ivana Croghan|507-284-2511|gimresearchstudies@mayo.edu|
22382045|NCT01090024|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22382046|NCT04460898|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22382047|NCT00470626|Cook|Scott Snyder|765-463-7537|ssnyder@medinst.com|
22382048|NCT00777556|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22382049|NCT02380742|Loyola University|Brendan Martin, Biostatistician|708-216-8051|bmartin5@luc.edu|
22382050|NCT02689349|Envoy Medical Corp.|Elizabeth Anderson, Ph.D.|(1) 651-788-3017|landerson@envoymedical.com|
22382051|NCT02930343|JIPMER|Dr Pooja Belani|8940482248|drpoojabelani@gmail.com|
22382052|NCT01185522|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22382053|NCT01729819|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22382054|NCT01025843|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22382055|NCT03224299|Becton Dickinson|Erin Zook|224-358-5019|erin.zook@bd.com|
22382056|NCT02378714|Northwestern University|Dr. Brian Hitsman|312-504-5834|b-hitsman@northwestern.edu|
22382057|NCT01281813|Janssen Research & Development, LLC|Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22382058|NCT00558363|GlaxoSmithKline|GSK Response Center|866-435-7343||
22382059|NCT00868192|Washington University School of Medicine|David G. Mutch, M.D.|314-362-2181|mutchd@wudosis.wustl.edu|
22382060|NCT02174562|Thomas Jefferson University|Barry Rovner, MD|215-503-1243|Barry.Rovner@Jefferson.edu|
22382061|NCT03336450|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22382062|NCT00798096|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
22382063|NCT01178762|National Taiwan University Hospital|Yan-Ming Chen / Yu-Chih Hou|886-2-2312-3456|louice1070@gmail.com|62131
22382064|NCT02410291|Sunnybrook Health Sciences Centre|Krista Dawdy, Clinical Educator|416 480 6104|krista.dawdy@sunnybrook.ca|
22382065|NCT03608670|Medtronic Cardiac Rhythm Management|CRM Clinical Research|+1 800 328 2518|rs.medtronicCRMtrials@medtronic.com|
22382066|NCT01651949|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22382067|NCT03636451|University of California, San Diego|Sheila Mody|8583294464|smody@health.ucsd.edu|
22396731|NCT03959332|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22396732|NCT00073528|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22382068|NCT02155829|USUHS|Dr. David M. Benedek|(301) 295-3294|david.benedek@usuhs.edu|
22382069|NCT00678795|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
22382070|NCT01585038|Indiana University School of Medicine|Samir K Gupta, Md, MS|317-274-7926|sgupta1@iu.edu|
22396733|NCT02937194|The University of Hong Kong|Prof Wong, May Chun Mei|852-28590422|mcmwong@hku.hk|
22382071|NCT02750709|Cycle Pharmaceuticals Ltd|James Price|+44 1223 803638|james.price@cyclepharma.com|
22382072|NCT00588965|MetroHealth Medical Center|Dr. Elizabeth Kaufman|216-778-2349|ekaufman@metrohealth.org|
22382073|NCT00771849|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22382074|NCT00290732|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|4432876489|vstearn1@jhmi.edu|
22382075|NCT02087306|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
22382076|NCT02736799|Vibrant LTD|Tal Malina / Clinical trials manager|+972 046663322|tal.m@vibrantgastro.com|
22382077|NCT00843193|GlaxoSmithKline|GSK Response Center|866-435-7343||
22382078|NCT00197015|GlaxoSmithKline|GSK Response Center|866-435-7343||
22382079|NCT00608907|Johnson & Johnson Pharmaceutical Research & Development|Helgi van de Velde, MD, PhD||HVDVELDE@ITS.JNJ.COM|
22382080|NCT05252871|Western University of Health Sciences|Frank Spors|9097063883|fspors@westernu.edu|
22382081|NCT01161563|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|801-588-6641|gary.hoel@watson.com|
22382082|NCT03861169|Sight Sciences|Tommie Rodriguez, Senior Clinical Research Manager|818-687-3310|trodriguez@sightsciences.com|
22382083|NCT02596035|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email|Clinical.Trials@bms.com|
22382084|NCT01559506|Nimbic Systems|Sean Self|281-565-5715|self@nimbicsystems.com|
22382085|NCT00835380|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22382086|NCT03727854|Seoul National University Hospital|Professor|82-2-2072-2217|ymchomd@snu.ac.kr|
22382087|NCT00881335|Shanghai Tenth People's Hospital, Tongji University|Zhang Xiangyu|86-21-66307174|xiangyu62@126.com|
22382088|NCT04164563|Brigham and Women's Hospital|Dr. Jeremy T. Smith|6177325322|jsmith42@bwh.harvard.edu|
22382089|NCT04341298|Avulux|Dr. Charles Posternack, President|833-288-5890|cposternack@avulux.com|
22382090|NCT04487080|Janssen Research & Development|Global Medical Head Onc|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22382091|NCT04415333|North Carolina A&T State University|Marc Cook, PhD|336-285-3547|mdcook@ncat.edu|
22382092|NCT03354390|National Heart Lung and Blood Institute (NHLBI)|Richard Childs, M.D. Principal Investigator|301-451-7128|childsr@nhlbi.nih.gov|
22382093|NCT02126878|West Virginia Universtiy, WVCTSI|Clinical Trials Compliance Coordinator|304-293-0216|ctgovadmin@hsc.wvu.edu|
22382094|NCT00486759|Hoffmann-La Roche|Medical Communications|800 821-8590||
22382095|NCT00377455|Georgetown University|Dr. Virginia Steen|202-444-6200|steenv@georgetown.edu|
22382096|NCT00309452|Yale University|Vinod H. Srihari|2039747816|vinod.srihari@yale.edu|
22382097|NCT00669461|University of Arkansas for Medical Sciences|Muhannad Heif, MD|5016500215|mmheif@gmail.com|
22382098|NCT02962674|seleon gmbh|Annegret Genger|+49 175 934 91 83|Annegret.Genger@seleon.de|
22382099|NCT00771667|Janssen Research and Development, US|Director, Clinical Research|610-651-6554||
22382100|NCT01897233|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22382101|NCT02076919|Alcon Research, Ltd.|Principal Clinical Scientist, CA CSI ID|1-888-451-3937|alcon.medinfo@alcon.com|
22396734|NCT03437564|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22396735|NCT01978535|Mayo Clinic|Dr. Amie Jones|507-284-6063|Jones.Amie@mayo.edu|
22396736|NCT04037748|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22396737|NCT01017003|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22396738|NCT00053703|UNC Chapel Hill|Linmarie Sikich, MD|919-972-9744|lsikich@med.unc.edu|
22396739|NCT03073980|Massachusetts General Hospital|John C. Petrozza, M.D.|617-726-8868|jpetrozza@mgh.harvard.edu|
22396740|NCT04810689|USCalifornia|Darcy Spicer|3238653904|DSPICER@USC.EDU|
22396741|NCT01940471|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22396742|NCT01358760|Endoceutics|Director of Data Analysis|418-653-0033|celine.martel@endoceutics.com|215
22396743|NCT01506960|Massachusetts General Hospital|Iris McNulty|617 726 2612|imcnulty@partners.org|
22396744|NCT00450723|UM/Sylvester Comprehensive Cancer Center|Eli Avisar MD|305-243-4902|eavisar@med.miami.edu|
22412006|NCT02978326|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22442774|NCT00594425|Virginia Clinical Research, Inc|David Pariser MD|757-625-0151|dpariser@pariserderm.com|
22380963|NCT02263885|InSightec|Nadir Alikacem, PhD|214-630-2000|nadira@insightec.com|
22380964|NCT04446975|UNMC|Dr. Karsten Bartels|(402) 559-4081|anesthesiology.research@unmc.edu|
22380965|NCT00112723|The Ohio State University Comprehensive Cancer Center|Jeffrey Jones, MD|614-293-3507|Jeffrey.Jones@osumc.edu|
22380966|NCT04531540|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22380967|NCT02688621|University of Vermont|Doris Ogden|802-656-1960|doris.ogden@uvm.edu|
22380968|NCT01501929|University of Texas Southwestern|Wanpen Vongpatanasin|2146482103|Wanpen.Vongpatanasin@UTSouthwestern.edu|
22380969|NCT02359838|Dana-Farber Cancer Institute|Gregory A. Abel|617-632-2304|gregory_abel@dfci.harvard.edu|
22380970|NCT03239210|NYU Langone Health|Nicolette Recchia|845-398-6563|nicolette.recchia@nyulangone.org|
22380971|NCT01575860|Abramson Cancer Center of the University of Pennsylvania|Jakub Svoboda, MD. Study Principal Investigator|855-216-0098|PennCancerTrials@emergingmed.com|
22380972|NCT01996644|Washington University|Cheri Levinson|5023456483|cherialevinson@wustl.edu|
22380973|NCT04760444|University of Michigan School of Social Work|Dr. Jaclynn Hawkins|(734) 647-4072|jachawk@umich.edu|
22380974|NCT05349864|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22380975|NCT00305760|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Daniel Laheru|410-955-8974|laherda@jhmi.edu|
22380976|NCT00984282|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22380977|NCT02223793|University of Oslo|Karianne Svendsen|+4795026445|karianne.svendsen@medisin.uio.no|
22396745|NCT01846624|Stanford University Medical Center|David Joseph Iberri, MD; Clinical Assistant Professor (Hematology)|650-498-6000|diberri@stanford.edu|
22396746|NCT01806857|Center for Neurological Study|Richard Smith, MD|858-455-5463|cnsonline@ymail.com|
22396747|NCT01721057|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22396748|NCT01020591|CDHA|Wendy Jardine|902 429 6218|wendymjardine@gmail.com|
22396749|NCT03472924|Oregon State University|Marc Norcross, PhD, ATC|541-737-6788|marc.norcross@oregonstate.edu|
22396750|NCT00617539|University of California San Francisco|Michelle Melisko, MD|415-353-7070|Michelle.Melisko@ucsf.edu|
22396751|NCT02546765|Beth Israel Deaconess Medical Center|Dr. Balachundhar Subramaniam|6176320706|bsubrama@bidmc.harvard.edu|6176320706
22396752|NCT02426476|Columbia VA Health Care System, Virginia Commonwealth University, University of South Carolina|James Burch, MS, PhD, Professor|803-404-1552|burch@mailbox.sc.edu|
22396753|NCT04425720|Montefiore Medical Center|Dr. Jonathan Leff|7189204316|jleff@montefiore.org|
22396754|NCT00807742|Brown University|Damaris Rohsenow, Ph.D.|401-863-6648|damaris_rohsenow@brown.edu|
22396755|NCT02044133|Centre hospitalier départemental Vendée|Dr Yves BLEHER|0251446572|yves.bleher@ght85.fr|
22396756|NCT04085523|Ascendis Pharma, Inc.|Aimee D. Shu, MD|+1 650 352 8389|ads@ascendispharma.com|
22396757|NCT04272892|University of Oxford|Dr Melanie Fleming|+441865611461|melanie.fleming@ndcn.ox.ac.uk|
22396758|NCT06557122|Encoll Corp|Dr. Subramanian Gunasekaran, PhD|+1 (510) 396-8581|guna@encoll.com|
22396759|NCT05318937|Sage Therapeutics|Amy Bullock|617-949-5151|amy.bullock@sagerx.com|
22396760|NCT02046096|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
22396761|NCT04969276|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22396762|NCT05599672|University of Utah|Gerald (Jerry) Cochran, PhD|801-213-0654|jerry.cochran@hsc.utah.edu|
22396763|NCT05097144|CooperVision Inc.|José A. Vega OD, MSc, FAAO|9256213761|JVega2@coopervision.com|
22396764|NCT00853749|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22396765|NCT00687440|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22396766|NCT03912376|Memorial Sloan Kettering Cancer Center|Dr. Michelle Bradbury, MD, PhD|917-294-4585|bradburm@MSKCC.ORG|
22396767|NCT00430482|Boston University Charles River Campus|Michael W. Otto, Ph.D.|(617)353-9610|mwotto@bu.edu|
22396768|NCT03996980|Universidad de Sevilla|Dr. Manuel Pabón-Carrasco|954 350 997|mpabon2@us.es|+34
22396769|NCT00583024|University of Iowa/Holden Comprehensive Cancer Center|David Lubaroff, PhD|(319) 335-8423|david-lubaroff@uiowa.edu|
22382102|NCT00628862|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22382103|NCT02814643|AstraZeneca|Mitchell Goldman MD, PhD|+1 610 457 5585|Mitchell.Goldman@astrazeneca.com|
22382104|NCT02504619|Gamida Cell|Kelly Myers|026595631|kelly@gamida-cell.com|
22382105|NCT00531518|Maine Medical Center Research Institute|William R McFarlane, M.D.|207-662-4348|mcfarw@mmc.org|
22382106|NCT01883492|Zimmer Biomet G.K.|Senior Manager of Clinical Affairs|+81-3-6402-6610|takahito.nakai@zimmerbiomet.com|
22396770|NCT04338516|UT Health San Antonio (UTHSA), San Antonio, Texas|Angela Palaiologou-Gallis , DDS., MS|210-450 8736|PalaiologouA@uthscsa.edu|
22396771|NCT04347226|Columbia University|Mark N. Stein, MD|917-658-2771|mns2146@cumc.columbia.edu|
22396772|NCT04259411|Abbott Structural Heart|Janani Aiyer/ Clinical Scientist II|+1(669)287-4507|Janani.aiyer@abbott.com|
22382107|NCT00796068|Fred Hutchinson Cancer Center|Dr. Filippo Milano|206-667-5925|fmilano@fredhutch.org|
22382108|NCT04020718|Massachusetts General Hospital|Dr. Gina Kruse|6177243157|gkruse@mgh.harvard.edu|
22382109|NCT02192606|Brigham and Women's Hospital|Jon I. Einarsson|617-732-5500|jeinarsson@partners.org|
22382110|NCT00549848|St. Jude Children's Research Hospital|Sima Jeha, MD|(901) 595-3901|sima.jeha@stjude.org|
22382111|NCT03673124|The GOG Foundation, Inc.|Brian Slomovitz, MD|1-215-854-0770|bslomovitz@gog.org|
22382112|NCT00957658|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@stryker.com|
22382113|NCT03383887|Brigham and Women's Hospital|Luigi Taranto Montemurro, MD|6177326541|ltarantomontemurro@bwh.harvard.edu|
22382114|NCT00300456|Abbott|Medical Information Specialist|800-633-9110||
22382115|NCT00975806|Celgene Corporation|Anne McClain,Senior Manager|1-888-260-1599|clinicaltrialsdisclosure@celgene.com|
22396773|NCT00095875|Dana Farber Cancer Institute|Robert I Haddad, MD|617-632-3090|rihaddad@partners.org|
22396774|NCT00766038|University of Pennsylvania|Ramon Diaz-Arrastia|215-662-9732|Ramon.Diaz-Arrastia@uphs.upenn.edu|
22396775|NCT00449670|GlaxoSmithKline|GSK Response Center|866-435-7343||
22396776|NCT03743311|AO Servier|Olga Linnik|+7 495 9370700|olga.linnik@servier.com|
22396777|NCT01502709|University of North Carolina|Dr Asma Khan|919 537 3389|asma_khan@dentistry.unc.edu|
22396778|NCT03703882|Astria Therapeutics, Inc|Andrew Nichols, PhD - Chief Scientific Officer|617-349-1971|anichols@astriatx.com|
22396779|NCT02013180|Catalca Ilyas Cokay State Hospital|Dr. Mustafa Zafer Temiz|+90 212 787 19 12|dr_mustafazafertemiz@hotmail.com|1178
22396780|NCT01535573|The University of Texas Health Science Center at Houston|Joy M. Schmitz, PhD, Professor and Director of Center For Neurobehavioral Research On Addictions||Joy.M.Schmitz@uth.tmc.edu|
22396781|NCT00290615|Duke University Medical Center|Brant Hamel|919-68-1861|brant.hamel@duke.edu|
22396782|NCT02611154|Sports Medicine Research & Testing Laboratory|Dr. Geoffry Miller|801-994-9519|gmiller@smrtl.org|
22396783|NCT02263079|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22396784|NCT00840086|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22396785|NCT03332498|Moffitt Cancer Center|Richard D. Kim, MD|813-745-1277|Richard.Kim@moffitt.org|
22396786|NCT01875783|Joslin Diabetes Center|Dr. Jennifer Sun|617-209-2554|jennifer.sun@joslin.harvard.edu|
22382116|NCT02718118|Galderma Laboratories|Jay Mashburn||jay.mashburn@galderma.com|
22382117|NCT01806714|University of Rochester|Dr. Cynthia Rand|585 275-9316|cynthia_rand@urmc.rochester.edu|
22382118|NCT01919697|Synergy Pharmaceuticals Inc.|Dr. Patrick H. Griffin|212-297-0020||
22396787|NCT06098248|VPIX Medical, Inc|Min-Jae Jeong|82425350676|clinical@vpixmedical.com|
22396788|NCT00253643|Oregon Health & Science University|Dr. Jackilen Shannon|503-220-8262|shannoja@ohsu.edu|54868
22396789|NCT04252859|Huntsman Cancer Institute, Center for Quantitative Cancer Imaging|Sam Mitchell|801-213-6110|sam.mitchell@hci.utah.edu|
22382119|NCT01120275|SWOG Statistical Center|Melanoma Committee Statistician|2066674623|jmoon@fredhutch.org|
22382120|NCT00614406|Oregon Health and Sciences University|Allison Edelman, MD, MPH|503-494-5949|edelmana@ohsu.edu|
22396790|NCT05807464|UCSF Hypoxia Research Laboratory|Dr. Philip Bickler|1-415-476-1411|philip.bickler@ucsf.edu|
22396791|NCT04738474|University of Washington|Jill Steiner|2062218240|jills8@uw.edu|
22396792|NCT04451161|University of Washington|Dr. Aaron Lyon|(206) 221-8604|lyona@uw.edu|
22396793|NCT03596866|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22396794|NCT04770532|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22396795|NCT02703090|Boston Children's Hospital|Dr. Barry Kussman|617-355-6225|barry.kussman@childrens.harvard.edu|
22396796|NCT02512809|Nationwide Children's Hospital|Joseph D. Tobias, MD|6147224200|joseph.tobias@nationwidechildrens.org|
22396797|NCT01431274|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22396798|NCT01069172|AMO Development, LLC|Luis Atiles, Manager, Clinical Research|214 537-6784|luis.atiles@amo.abbott.com|
22396799|NCT01396226|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22396800|NCT04206605|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22396801|NCT04580446|UT Southwestern Medical Center|Dr. Dominic Moon|214-645-8525|Dominic.Moon@UTSouthwestern.edu|
22396802|NCT01651351|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22396803|NCT02225080|Integra LifeSciences Corporation|Director, Global Clinical Affairs|609-936-5490|andrew.tummon@integralife.com|
22396804|NCT00003702|NRG Oncology|Angela M. Kuras on behalf of Virginia Filiaci|7168455702|kurasa@nrgoncology.org|
22396805|NCT00843518|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22396806|NCT00827606|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22396807|NCT01748942|Oregon Health and Science University|Daniel Clayburgh, MD PhD|503-494-8510|clayburg@ohsu.edu|
22396808|NCT00243386|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22396809|NCT00133991|Johns Hopkins University|Yvette Kasamon, MD||ykasamon@jhmi.edu|
22396810|NCT01953575|Mayo Clinic|David A. Katzka|507-284-4824|Katzka.David@mayo.edu|
22396811|NCT04995055|Johnson & Johnson Vision Care, Inc. (JJVC)|Thomas R. Karkkainen, OD, MS, FAAO|1-800-843-2020|TKarkkai@its.jnj.com|
22396812|NCT03418129|Duke University|Eric Elbogen, Ph.D.|919-684-9983|eric.elbogen@duke.edu|
22396813|NCT02087956|University of Rochester|Dr. Ellen Poleshuck|585-275-3138|ellen_poleshuck@urmc.rochester.edu|
22396814|NCT01378858|Albert Einstein College of Medicine|Shadi Nahvi, MD, MS|718 920 5379|snahvi@montefiore.org|
22396815|NCT02664272|Smith & Nephew, Inc.|Vice President of Medical Affairs|+41 41 7662222|luca.orlandini@smith-nephew.com|
22396816|NCT04695392|UPENN|Martha A.Q. Curley, RN, PhD|2155739449|curley@nursing.upenn.edu|
22396817|NCT04261504|Arizona State University|Yi-Yuan Tang|4807903577|yiyuan@asu.edu|
22396818|NCT01202279|Reckitt Benckiser|Kim Clark|855.966.5483|ClinicalRequests@rb.com|
22396819|NCT02047253|University of Alabama at Birmingham|Pam Dixon, RN, BSN, OCN|205-975-9875|pamdixon@uab.edu|
22396820|NCT03574753|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
22396821|NCT01034592|Stanford University Medical Center|Jason R Gotlib, MD, Professor of Medicine (Hematology)|650-867-2823|jason.gotlib@stanford.edu|
22396822|NCT01379469|Washington University School of Medicine|David Rudnick MD, PhD- Associate Professor|314-286-2832|rudnick_d@wustl.edu|
22396823|NCT00912002|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22396824|NCT00609986|Medical University of South Carolina|Dr. Kathie Hermayer|843-792-2529|hermayer@musc.edu|
22396825|NCT03159091|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22382121|NCT01534910|Los Angeles Biomedical Research Institute|Dr Matthew Budoff|310-222-4107|mbudoff@labiomed.org|
22382122|NCT01787240|MGH|Dr. Cristina Cusin|617 726 6421|ccusin@partners.org|
22382123|NCT03237936|Santen Inc|R&D Quality Manager|4152689199|evelyn.chikere@santen.com|
22382124|NCT04379713|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22382125|NCT04567888|Twill|Eliane M. Boucher, PhD (Sr Director of Research Strategy)|(800) 264-6428|eliane@twill.health|
22382126|NCT02526680|Wills Eye Hospital Glaucoma Research Center|Dr. L. Jay Katz|215-928-3123|ljkatz@willseye.org|
22382127|NCT00554801|Portland VA Medical Center|Marjorie R. Leek|503-220-8262|Marjorie.Leek@va.gov|54525
22382128|NCT03028363|Eli Lilly and Company.|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22382129|NCT04771273|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22382130|NCT05196737|Medical University of South Carolina|Gretchen Seif, PT, DPT, MHS, OCS, FAAOMPT|(843) 792-9345|seif@musc.edu|
22382131|NCT02357784|Northwestern University|Dr. Margaret Mueller|13124723874|mgmueller@nm.org|
22382132|NCT00462943|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22382133|NCT01944319|Peking University Third Hospital|Dr. Qingtao ZHOU|86-10-82265562|zhouqingtaobysy@sina.com|
22382134|NCT01144182|VA New York Harbor Healthcare System|Sundar Natarajan, MD, M.Sc.|212-951-3395|sundar.natarajan@va.gov|
22382135|NCT02987335|Albert Einstein College of Medicine|Dr Meredith Hawkins|718.430.3186|meredith.hawkins@einsteinmed.org|
22382136|NCT01670110|Mayo Clinic|Marie C. Hogan, M.D., Ph.D.|507-284-3479|Hogan.Marie@mayo.edu|
22382137|NCT03395353|Shionogi|Corporate Communications Department|+81-6-6209-7885|shionogiclintrials-admin@shionogi.co.jp|
22396826|NCT02667418|Hines VA|Dr. Stuart Johnson|708--202-8387|Stuart.Johnson2@va.gov|257772
22382138|NCT03301220|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22382139|NCT03981549|The Emmes Company, LLC|Principal Investigator of the TRUST Data Coordinating Center|301-251-1161|trust@emmes.com|
22396827|NCT03520959|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22412007|NCT02024087|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22396829|NCT05166226|Pennington Biomedical Research Center|Dr. Corby Martin|+1 (225) 763-2585|corby.martin@pbrc.edu|
22396830|NCT00943579|Children's Health Council|Glen R. Elliott, Ph.D., MD|650.688.3649|gelliott@chconline.org|
22382140|NCT05012644|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22396831|NCT00418665|Amgen Inc.|Study Director|866-572-6436||
22396832|NCT02786134|Brigham and Women's Hospital|Dr. Marcelo Di Carli|617-732-6290|mdicarli@bwh.harvard.edu|
22396833|NCT01538628|Boston Scientific Corporation|Director, Clinical Operations|952-930-6000|teresa.takle-flach@bsci.com|
22382141|NCT04845620|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
22382142|NCT00708097|GlaxoSmithKline|GSK Response Center|866-435-7343||
22382143|NCT03425643|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
22382144|NCT04133363|University of Alabama at Birmingham|Nicolaas C. Geurs, DDS, MS, Interim Dean, Principal Investigator|205-9344506|ngeurs@uab.edu|
22382145|NCT05150210|Intuitive|Anna Virk|1 480-676-3938|SP.Thoracic@intusurg.com|
22382146|NCT07214922|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22382147|NCT00726596|Rutgers Cancer Institute of New Jersey|Mark Stein, MD|732-235-5773|steinmn@cinj.rutgers.edu|
22382148|NCT00482729|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22382149|NCT02743078|RTOG Foundation|Wendy Seiferheld|215-574-3208|wseiferheld@acr.org|
22382150|NCT01549314|Massachusetts General Hospital Endocrine Unit|Dr. Melissa Putman|857-218-5017|msputman@partners.org|
22382151|NCT02425449|The University of Toledo|Shashi Bhatt, MD|419-383-3556|Shashi.Bhatt@utoledo.edu|
22382152|NCT00954707|Cordis Corporation, a Johnson & Johnson company|Amy Orlick, Associate Director|908-541-4347|aorlick@its.jnj.com|
22382153|NCT03265210|Weill Cornell Medicine|Dimitris Kiosses, PhD|914-997-4381|dkiosses@med.cornell.edu|
22382154|NCT04002973|Masimo|Chelsea Frank|(949) 297-7000|studies@masimo.com|
22382155|NCT02488980|Penn State Hershey Infectious Diseases|Jose Stoute, MD|800-243-1455|noemail@no.com|
22382156|NCT03768856|Cleveland Clinic, Case Comprehensive Cancer Center|Dr Shlomo Koyfman|1-800-223-2273|TaussigResearch@ccf.org|
22382157|NCT02620761|Medical College of Wisconsin|Jeffrey Segar|14143377702|jsegar@mcw.edu|
22382158|NCT02614560|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
22382159|NCT00738699|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
22382160|NCT05193318|Metrohealth Hospital System (formerly employee of Medical University of South Carolina)|Eric Dobson, MD (principal nvestigator)|513-504-2091|edobson@metrohealth.org|
22382161|NCT03670602|University at Buffalo|Leonard H. Epstein|716-829-3400|lhenet@buffalo.edu|
22382162|NCT03201809|UC Davis|Dr. Granger Wong, Chief and Professor of Plastic Surgery|(916) 734-7289|gwong@ucdavis.edu|
22382163|NCT00246012|Centocor, Inc.|Senior Director|908-927-2116||
22382164|NCT02377362|GLWL Research Inc|Study Director||choruspharma@lists.lilly.com|
22382165|NCT04889664|Icahn School of Medicine at Mount Sinai|Dr. Adriana Feder|212-585-4661|adriana.feder@mssm.edu|
22382166|NCT04181632|Nemours Children's Health System (North Florida/JAX)|Jennifer Pfieffer|904 383 0414|jennifer.pfieffer@nemours.org|
22382167|NCT02699970|Philips Digital Pathology Solutions|Mischa Nelis, Clinical Study Director||dpsclinicaltrials@philips.com|
22382168|NCT02469064|Universidad del Valle|Dr Lina Marcela Sandoval Moreno|316 478 0808|linamarce48@gmail.com|
22382169|NCT04107805|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22382170|NCT00422201|HRA Pharma|Head of Clinical Research|0033140331130|s.durand@hra-pharma.com|
22382171|NCT01234532|University of Maryland, Baltimore|Katherine Tkaczuk, M.D.|410-328-2565|ktkaczuk@umm.edu|
22382172|NCT01191086|Upsher-Smith Laboratories, Inc.|Bob Anders, Sr. Director of Clinical Operations|763-315-2000|bob.anders@upsher-smith.com|
22382173|NCT00964366|GlaxoSmithKline|GSK Response Center|888-435-7343||
22382174|NCT02957539|VA Puget Sound Health Care System|Paul Hebert|2062774165|paul.hebert2@va.gov|
22382175|NCT01833832|National Cancer Institute|Dr. Jeremy Davis|240-760-6229|jeremy.davis@nih.gov|
22382176|NCT01156116|University of Chicago|Esra Tasali|773-702-1497|etasali@medicine.bsd.uchicago.edu|
22382177|NCT02057718|Mirum Pharmaceuticals|Mirum Clinical Trials|650-667-4085|medinfo@mirumpharma.com|
22382178|NCT01320072|Montefiore Medical Center|Dr. Elina Jerschow, attending physician|9173625291|ejerscho@montefiore.org|
22382179|NCT00434018|VACO|Dr. Shirley Groer|202-553-9899|Shirley.Groer@va.gov|
22396834|NCT06689527|Santhera Pharmaceuticals LTD|Shabir Hasham MD, Chief Medical Officer|+41 79 520 95 18|shabir.hasham@santhera.com|
22396835|NCT00402649|University of Maryland Center for Vaccine Development|Ina Stephens, MD|410-706-1123|istephen@medicine.umaryland.edu|
22396836|NCT02628236|DUSA Pharmaceuticals Inc., a Sun Pharma Co.|Anna Houlihan|8452681943|Anna.Houlihan@sunpharma.com|
22396837|NCT01584479|University of Michigan|William Giannobile, Principal Investigator|734-764-1562|wgiannob@umich.edu|
22396838|NCT01761292|Italfarmaco SpA|Paolo Bettica, MD|+39 02 64431|p.bettica@italfarmaco.com|
22396839|NCT03577730|University of Michigan|Phillip Vlisides|734-936-4280|pvliside@umich.edu|
22396840|NCT02538016|Boston Children's Hospital|Alyssia Venna|617-919-6352|Alyssia.Venna@childrens.harvard.edu|
22396841|NCT05611671|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22396842|NCT01368536|Novartis Pharmaceuticals|Study Director|862-778-8300||
22382180|NCT01740817|University of Texas Health Science Center at San Antonio|Dr. Nicolas Musi|200-562-6152|musi@uthscsa.edu|
22382181|NCT00130637|National Eye Institute, NIH|H. Nida Sen, MD, MHS|301-435-5139|senh@nei.nih.gov|
22382182|NCT00139737|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22382183|NCT00217672|University of California, Los Angeles|Sara Hurvitz, M.D.|310-829-5471|shurvitz@mednet.ucla.edu|
22382184|NCT03781336|National Institutes of Health|Psychologist|3014027360|amelir@mail.nih.gov|
22382185|NCT01972152|Xeris Pharmaceuticals, Inc.|Martin J. Cummins, VP, Drug Development|512-498-2675|mcummins@xerispharma.com|
22382186|NCT03068611|Brown University|Christopher Kahler|401 863-6651|christopher_kahler@brown.edu|
22382187|NCT01157182|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22382188|NCT00878722|Topotarget A/S|PRS Admnistrator Gunilla Emanuelson|+45 39 17 83 92|enquiries@topotarget.com|
22382189|NCT00383188|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22382190|NCT00972504|GlaxoSmithKline|GSK Response Center|866-435-7343||
22382191|NCT00319436|Yale University School of Medicine, Department of Psychiatry and Yale Child Study Center|Nancy Suchman, Ph.D., Associate Professor|203-937-3486|nancy.suchman@yale.edu|7430
22382192|NCT01147380|University of Miami|Dr. Seigo Nishida|305-355-5760|snishida@med.miami.edu|
22382193|NCT00639002|Incyte Corporation|Study Director|855 463-3463||
22382194|NCT03098966|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
22382195|NCT05325853|American Genomics, LLC|Dr. Martin Uram|973-885-3447|aschupp@cmcturnkey.com|
22382196|NCT01839877|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
22382197|NCT02509585|Cardinal Health|LaTosha Eligon|913-661-3896|latosha.eligon@cardinalhealth.com|
22382198|NCT01544062|University of Washington|Srdjan Jelacic, MD|(206) 598-3777|sjelacic@uw.edu|
22382199|NCT04979988|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22382200|NCT01323777|Alcon Japan, Ltd.|Group Manager, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22382201|NCT00597519|Memorial Sloan Kettering Cancer Center|Dr. Juliet Barker|212-639-3468|barkerj@mskcc.org|
22382202|NCT00414206|CoMentis, Inc.|Carl Grove|650-869-7600|cgrove@comentis.com|
22382203|NCT01224678|University of Vermont|Marie E. Wood, M.D|802-656-5452|marie.wood@uvm.edu|
22382204|NCT02104765|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22382205|NCT02698241|Medtronic CRHF Clinical Research|Joe Hobbs Clinical Research Specialist|800-633-8766|joe.hobbs@medtronic.com|
22382206|NCT01751724|University of Miami|Eduardo Bancalari M.D., Director Division of Neonatology|3055856408|ebancalari@miami.edu|
22382207|NCT03693742|BC Cancer - Vancouver|Study Manager|(604) 877-6000,|hsaprunoff@bccancer.bc.ca|
22382208|NCT02685033|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22382209|NCT00603447|Amgen, Inc.|Study Director|866-572-6436||
22382210|NCT00798265|National Cancer Institute|Dr. Hoyoung Maeng|240-781-3253|hoyoung.maeng@nih.gov|
22382211|NCT04411082|Imara, Inc.|Rahul Ballal|617-206-2020|rballal@imaratx.com|
22382212|NCT00589667|Memorial Sloan-Kettering Cancer Center|David Pfister, MD|646-888-4232|pfisterd@mskcc.org|
22382213|NCT02804594|University of California San Francisco|Emmanuelle Waubant, MD|415 514 2468|Emmanuelle.Waubant@ucsf.edu|
22382214|NCT03538041|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22382215|NCT00094809|Amgen Inc.|Study Director|866-572-6436||
22382216|NCT03408860|University of Kentucky|Shannon Sauer-Zavala|858-218-4082|ssz@uky.edu|
22382217|NCT01596751|University of California, San Francisco|Dr. Hope Rugo, MD|(415) 353-7070|Hope.Rugo@ucsf.edu|
22382218|NCT03748433|Imperial College London|Professor Nick Oliver|+44 (0)20 7594 1796|nick.oliver@imperial.ac.uk|
22382219|NCT05372094|Sonova US|Director of Research|630-821-5000|phonakaudiologyresearch@gmail.com|
22382220|NCT02046616|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22382221|NCT03760419|Vanderbilt University Medical Center|Derek J. Williams, MD, MPH|615-322-2744|derek.williams@vumc.org|
22382222|NCT01678196|Minneapolis VA Healthcare Service Center|Christopher Erbes, PhD|612-725-2000|christopher.erbes@va.gov|2125
22382223|NCT01563354|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22382224|NCT01377623|UMDNJ-New Jersey Medical School|Alex Bekker|973-972-5007|alex.bekker@nyumc.org|
22382225|NCT05334758|BioTeke USA|Chang Turkmani|202-679-2112|chang@themegaco.com|
22382226|NCT02050308|The University of Kansas Medical Center|Dr. Won S. Choi|(913) 588-4742|wchoi@kumc.edu|
22382227|NCT00906035|Upenn|Emile Mohler, MD|215-573-6606|Emile.Mohler@uphs.upenn.edu|
22382228|NCT01986686|Stony Brook Medicine|Roberto Bergamaschi, MD, PhD|631-638-2215|roberto.bergamaschi@stonybrookmedicine.edu|
22382229|NCT00942149|Duke University Medical Center|Brian Smith|9196688951|brian.smith@duke.edu|
22382230|NCT02925195|University of Washington|Dr. Ian de Boer|206-616-5403|IDeBoer@Nephrology.washington.edu|
22382231|NCT01988233|University of Illinois Chicago|Dr. David X. Marquez|3129961209|marquezd@uic.edu|
22382232|NCT01689519|Hoffmann-La Roche|Medical Communications|800 821-8590||
22382233|NCT01245439|Hoffmannb-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22382234|NCT01050569|University of Minnesota|Dorothy Hatsukami|612 626-2121|hatsu001@umn.edu|
22382235|NCT03525119|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22382236|NCT05046132|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
22382237|NCT01959412|Novartis Pharmaceuticals|Study Director|862-778-8300||
22382238|NCT01186848|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
22382239|NCT03888755|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22382240|NCT00932022|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22382241|NCT02903836|Wockhardt|Dr Manishkumar D Shah|02226534444|manish.shah@wockhardt.com|6893
22382242|NCT01669148|Massachusetts General Hospital|Thomas J. Brady, MD|6177268294|tbrady@mgh.harvard.edu|
22396843|NCT00309465|Beaumont Health System|Tamra Dukatz, CRNA, MSN|248 992-4741 (pager)|tdukatz@beaumont.edu|
22427692|NCT02003144|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22427693|NCT00747916|Titus Regional Medical Center|Dr. Gordon Downie|903-572-9050|downieg@trhta.net|
22427694|NCT02344316|UCSF Pediatric Headache Program|Amy Gelfand, MD|415-885-7832|Amy.Gelfand@ucsf.edu|
22427695|NCT02074514|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22427696|NCT00032591|Palo Alto CSPCC|Bob Edson|(650) 493-5000|Bob.Edson@va.gov|22250
22427697|NCT00666237|University of Miami|Steven Gedde, MD|305-326-6435|sgedde@med.miami.edu|
22396844|NCT00383084|Johns Hopkins University|Kevin Fontaine, PhD|443-449-4314|kfontai1@jhmi.edu|
22396845|NCT02113436|GlaxoSmithKline|GSK Response Center|866-435-7343||
22427698|NCT05366725|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49 06151725200|service@emdgroup.com|
22427699|NCT02839707|NRG Oncology|Christopher Purdy on behalf of Mike Sill, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
22427700|NCT01778413|Hospital Clínic de Barcelona|Dr. Esteban Martinez|932275400|estebanm@clinic.cat|
22396846|NCT01486927|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22427701|NCT04530630|Weill Cornell Medicine|Catherine Small, MD|212-746-9803|cbs9003@med.cornell.edu|
22427702|NCT00850642|GlaxoSmithKline|GSK Response Center|866-435-7343||
22427703|NCT06128954|Orphalan SA|Carla Bennett|07918380893|carla.bennett@orphalan.com|
22427704|NCT05335161|Purdue University|Bruno Tesini Roseguini|7654962612|brosegui@purdue.edu|
22427705|NCT05352763|Cassava Sciences|Project Manager|5125013180|closedstudyinfo@cassavasciences.com|
22427706|NCT01288430|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22427707|NCT05507437|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22427708|NCT06583096|University of Michigan|Adam Horwitz|(734) 764-0231|ahor@med.umich.edu|
22396847|NCT00067028|The University of Texas M. D. Anderson Cancer Center|Hagop M Kantarjian,MD/Chair, Leukemia|(713) 792-7026|hkantarjian@mdanderson.org|
22396848|NCT01148537|Purdue Pharma L.P.|Executive Medical Director|800-733-1333||
22396849|NCT05895552|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22396850|NCT03810911|Richard L. Roudebush Veterans Affairs Medical Center|Dr. Rajiv Agarwal MD MS|(317) 988-2241|ragarwal@iu.edu|
22396851|NCT05374525|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22396852|NCT02445651|Thomas Jefferson University|Andrew Newberg, M.D.|215-503-3423|Andrew.Newberg@jefferson.edu|
22427709|NCT05172609|University of Pennsylvania|Dr. Emily Becker-Haimes|215-573-5614|emily.haimes@pennmedicine.upenn.edu|
22427710|NCT04771754|Chelsea and Westminster Hospital NHS Foundation Trust|Dr Ruth Byrne|02033152560|ruthbyrne@nhs.net|
22427711|NCT05610605|University of Cadiz|Cristina Casals|956016216|cristina.casals@uca.es|
22396853|NCT01349101|Thomas Jefferson University|Dr. John Wagner|215-955-8874|JLW102@jefferson.edu|
22396854|NCT00454857|Amgen Inc.|Study Director|866-572-6436||
22427712|NCT00753519|Department of Neurology, Centre Hospitalier Universitaire Vaudois|David H. Benninger, MD||David.Benninger@chuv.ch|
22396855|NCT00829179|Duke University Medical Center|John S. Sundy M.D. PhD|(919) 668-2169|john.sundy@duke.edu|
22427713|NCT00042289|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
22427714|NCT01950663|Dean McGee Eye Institute / University of Oklahoma Health Sciences Center|Dr. Stephen R. Fransen|405-271-1092|stephen-fransen@dmei.org|
22427715|NCT00498550|Dartmouth Medical School|Christopher OKeefe|603-271-5287|chris.okeefe@hitchcock.org|
22396856|NCT03782402|CUIMC|Diana Martinez|646-774-6160|dm437@cumc.columbia.edu|
22396857|NCT00754832|Oregon Health & Science University|Dr. Michelle Cameron|503-418-1971|cameromi@ohsu.edu|
22396858|NCT02018822|University of Rochester|Hans Malmstrom|585-275-5087|hans_malmstrom@urmc.rochester.edu|
22382243|NCT00982033|Wake Forest School of Medicine|Dalane W. Kitzman, M.D.|336-716-3274|dkitzman@wakehealth.edu|
22382244|NCT01872819|University of Washington|Dr. Pamela Becker|206-288-7273|pbecker@u.washington.edu|
22382245|NCT00158054|Columbia University Medical Center|Karina W Davidson, PhD|212-342-4493|kd2124@cumc.columbia.edu|
22382246|NCT00410124|Novartis Pharmaceuticals|Novartis Pharmaceuticals|862-778-8300||
22382247|NCT04673851|University of North Carolina at Chapel Hill|Bryan Stiles, MA|919-590-5811|stilesb@unc.edu|
22382248|NCT00880048|GlaxoSmithKline|GSK Response Center|866-435-7343||
22382249|NCT02914522|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22382250|NCT03098030|United Therapeutics Corporation|Program Manager, Oncology|919-485-8350|kmaher@unither.com|
22382251|NCT04495634|University of North Carolina at Chapel Hill|Doreen Steed, R.T. (R)(M)|919-966-0188|doreen_steed@med.unc.edu|
22382252|NCT03368001|Vanderbilt University Medical Center|Blythe Corbett, Ph.D.|615-936-0280|blythe.corbett@vumc.org|
22382253|NCT03612804|VA Puget Sound Health Care System|Steven B Zeliadt|206-277-4175|Steven.Zeliadt@va.gov|
22396859|NCT01785459|Carolinas Medical Center|Dr. Sean Fox|704-355-3181|Sean.Fox@atriumhealth.org|
22396860|NCT00271596|University of Iowa; Elks Rehab Hospital|Leigh Beglinger, PhD|319-353-4489|leigh-beglinger@elksrehab.org|
22427716|NCT03150043|UTMB|Katherine Jelliffe|2146635394|katherine.emilie@gmail.com|
22427717|NCT00548327|Clinical Brain Disoders Branch-National Institute of Mental Health (NIMH)-National Institute of Health (NIH)|Jose A. Apud MD, PhD|301 5946561|apudj@mail.nih.gov|
22382254|NCT05484726|Fatima Memorial Hospital Shadman Lahore|Assistant Professor Dr Rafia Gul|00923064620027|docrafiagul@gmail.com|
22382255|NCT04391309|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22382256|NCT02781584|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22396861|NCT04707157|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
22382257|NCT00967369|UT MD Anderson Cancer Center|Dr. Michelle A Fanale / Associate Professor, Lymphoma/Myeloma|713-792-2860|MFANALE@MDANDERSON.ORG|
22382258|NCT00782639|Bracco Diagnostics, Inc|Usha Halemane|609-514-2578|usha.halemane@diag.bracco.com|
22382259|NCT00768651|Faculty of Medicine and Dentistry, University of Alberta|Peter Senior, MD, PhD - Professor of Medicine, Medical Director-Clinical Islet Transplant Program,|780-407-1480|peters@islet.ca|
22382260|NCT00995709|Novartis Pharmaceuticals|Study Director|862-778-8300||
22396862|NCT01063075|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22382261|NCT03328949|Shockwave Medical, Inc.|Beaux Alexander, Vice President of Clinical Affairs|510-279-4262 ext. 145|balexander@shockwavemedical.com|
22396863|NCT04232553|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22396864|NCT02969915|Johns Hopkins University|Gregory M. Lucas|410 614 0560|glucas@jhmi.edu|
22382262|NCT04026620|University of North Carolina at Chapel Hill|Julie Hasken, PhD|704-250-5000|julie_hasken@unc.edu|
22382263|NCT01543685|Iroko Pharmaceuticals, LLC|Daniel Solorio|267-546-3150|dsolorio@iroko.com|
22396865|NCT01329679|DavidGrant|Sachin Shah|707-423-3277|sshah@pacific.edu|
22382264|NCT00604721|UNC Lineberger Comprehensive Cancer Center|Bert. H. O'Neil, Associate Professor, Clinical Research|919-966-4431|bert_oneil@med.unc.edu|
22382265|NCT04776213|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22382266|NCT03392532|Alcon, A Novartis Division|CDMA Project Lead, CDMA Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22382267|NCT00556543|Oregon Health & Science University|John Mayberry, MD|503-494-5300|mayberrj@ohsu.edu|
22382268|NCT01838551|Strongbridge Biopharma|Chief Medical Officer|14845890392|f.cohen@strongbridgebio.com|
22396866|NCT05032612|The University of Texas Health Science Center at Houston|Timothy Kirkpatrick, DDS|713-486-4227|timothy.c.kirkpatrick@uth.tmc.edu|
22382269|NCT00906282|SCRI Development Innovations|Charles Davis, RAC|615-524-4341|charles.davis2@scri-innovations.com|
22382270|NCT00038103|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22382271|NCT01391013|Jan-Cil Italy|Therapeutic Area Medical Manager|39 02 2510589||
22382272|NCT01286402|University of Texas Health Science Center at Houston|Angela Stotts, PhD, PI|713-500-7590|Angela.L.Stotts@uth.tmc.edu|
22396867|NCT03625687|Massachusetts General Hospital|Raymond Chung, MD|6177247562|Chung.Raymond@mgh.harvard.edu|
22382273|NCT02163915|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22396868|NCT00585611|UW-Madison at time of study|Nancy Sweitzer||nancysweitzer@shc.arizona.edu|
22396869|NCT00974675|MedImmune, LLC|Meena Jain, MB BChir/Associate Medical Director|301-398-0000|jainm@medimmune.com|
22382274|NCT02555631|Albert Einstein College of Medicine|Dr. Elizabeth Walker|718-430-3242|elizabeth.walker@einstein.yu.edu|
22396870|NCT04311216|University of Liverpool|Dr Fraser Philp|01517942000|f.philp@liverpool.ac.uk|
22396871|NCT01987960|A/S|H. Lundbeck||LundbeckClinicalTrials@Lundbeck.com|
22382275|NCT03906968|MUSC|Dr. Zachary M. Soler|(843) 792-3531|solerz@musc.edu|
22382276|NCT04181307|NYU Langone Health|Andrea B. Troxel, ScD|646-501-3654|andrea.troxel@nyulangone.org|
22382277|NCT02299336|Retina Consultants of Houston|Dr. Charles C. Wykoff|7135243434|ccwmd@houstonretina.com|
22382278|NCT02251613|Alcon Japan, Ltd.|Hironari Sakaguchi, Phase IV Clinical & Regulatory Affairs, Japan|+81 3 6899 5054|Hironari.Sakaguchi@alcon.com|
22382279|NCT02013037|Cedars Sinai Smidt Heart Institute|Dr. Jignesh Patel|310-248-8300|jignesh.patel@cshs.org|
22382280|NCT02465359|University of South Florida|Tuan H. Vu, MD|813-974-9413|tvu6@usf.edu|
22382281|NCT01304147|Icahn School of Medicine at Mount Sinai|Dr. James W. Murrough|212-241-7574|james.murrough@mssm.edu|
22382282|NCT03141788|3M|Elaine Egging|651-737-0263|eegging@mmm.com|
22382283|NCT01942707|Universidade Federal de São Paulo|Dr. Heraldo Carlos Borges Inforzato|55-13-997112644|heraldo@litoral.com.br|
22382284|NCT02812966|Advocate Aurora Research Institute|Director, Clinical Trials Research Cardiovascular and Multiple Specialties|708-860-7792|laura.wrona@aah.org|
22382285|NCT01066923|University of Pittsburgh|Clifton Callaway|412-647-3078|callawaycw@upmc.edu|
22382286|NCT01070888|Boston Children's Hospital|Wanda Phipatanakul|857-218-5336|wanda.phipatanakul@childrens.harvard.edu|
22382287|NCT02195713|Theranova, LLC|Devyani Nanduri|415-926-8616|dnanduri@theranova.com|
22382288|NCT02577523|NeuroDerm Ltd.|Laurence Salin, MD, Senior Medical Director||laurence@neuroderm.com|
22382289|NCT02787694|University of Alabama at Birmingham|David A. Brown, PT, PhD|205-975-2788|dbrownpt@uab.edu|
22382290|NCT02525796|Brigham and Women's Hospital|Anand Vaidya|16177325666|anandvaidya@bwh.harvard.edu|
22382291|NCT01198275|Department of Experimental and Applied Medicine-Section of Cardiovascular Diseases|Dr. Savina Nodari|00390303996|nodari@med.unibs.it|587
22382292|NCT00391846|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22382293|NCT02477670|Avanir Pharmaceuticals, Inc.|Sanjay Dubé, M.D.|949-389-6700|SDube@avanir.com|
22382294|NCT00970307|GlaxoSmithKline|GSK Response Center|866-435-7343||
22382295|NCT02810080|ZOLL|Nathan Burkhart|763.367.0462|nburkhart@zoll.com|
22382296|NCT03597100|Cala Health|Sr. Director of Clinical Operations|6506515296|vivien@calahealth.com|
22382297|NCT00565110|USC Suzanne Dworak-Peck School of Social Work|Kathleen Ell, DSW, Principle Investigator|760-399-0263|ell@usc.edu|
22382298|NCT00831272|University of Pennsylvania|David Oslin|215 823 5894|oslin@upenn.edu|
22382299|NCT01213706|University of Miami|Adam Wanner, MD|(305) 243-2568|awanner@med.miami.edu|
22396872|NCT00832520|UNM Comprehensive Cancer Center|Valerie Parks, RN|505-925-0390|vparks@salud.unm.edu|
22396873|NCT00789880|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22396874|NCT01177683|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
22396875|NCT06347731|Varian Medical Systems|Sophia Shao|+86-21-23156400|sophia.shao@varian.com|
22396876|NCT00580372|University of Arkansas for Medical Science|Dr. Bart Barlogie|501-526-2873||
22396877|NCT01058070|Torax Medical, Inc.|VP of Clinical Affairs|651-361-8900|aderosier@toraxmedical.com|
22396878|NCT01436084|University of Texas (UT) MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Professor, Leukemia|1-877-MDA-6789|CR_Study_Registration@mdanderson.org|
22427718|NCT01673386|AVEO Pharmaceuticals, Inc.|Chief Medical Officer|857-400-0101|Clinical@aveooncology.com|
22427719|NCT02314546|Bassett Healthcare Network|David A. Ullman, MD, Senior Attending Anesthesiologist|607-547-3153|david.ullman@bassett.org|
22427720|NCT00274456|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22427721|NCT03042546|Harboview|research coordinator|206.744.4406|bagel@uw.edu|
22427722|NCT03588624|Sight Sciences|VP Medical and Clinical Affairs|(877) 266-1144|info@sightsciences.com|
22427723|NCT00336544|Advanced Life Sciences|David Eiznhamer, PhD, Executive Vice President, Clinical Development|630-739-6744|deiznhamer@advancedlifesciences.com|
22427724|NCT00576758|Hoffman-LaRoche|Medical Communications|800-821-8590||
22427725|NCT03427411|National Cancer Institute|Dr. Julius Strauss|240-858-3999|julius.strauss@nih.gov|
22427726|NCT01712178|AbbVie|Global Medical Services|800-633-9110||
22427727|NCT00486044|University of Wisconsin School of Medicine and Public Health|Cynthia M. Carlsson, MD, MS|608-280-7000|cmc@medicine.wisc.edu|
22427728|NCT02701634|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22427729|NCT01206764|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
22427730|NCT04494646|NYU Langone Health|Sripal Bangalore, MD, MHA|(212) 263 3540|Sripal.Bangalore@nyulangone.org|
22427731|NCT00537277|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22427732|NCT05282823|Boston Scientific|Clinical Trial Manager|+6564188833|jamie.kwek@bsci.com|
22427733|NCT00997893|University of Illinois at Chicago|Dr. Pauline Maki|312 996-6941|pmaki1@uic.edu|
22427734|NCT03620162|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22427735|NCT02767531|UT Southwestern Medical Center|Abhimanyu Garg, MD|2146482895|abhimanyu.garg@utsouthwestern.edu|
22427736|NCT00112957|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22427737|NCT02182804|Division of Gastroenterology. Department of Medicine. Faculty of Medicine. Chulalongkorn University.|Dr. Piyapan Prueksapanich|6622564000|mpkus1@gmail.com|81001
22427738|NCT03134768|Danone Nutricia Research|Dr Elena Sandalova|6568309433|elena.sandalova@danone.com|
22427739|NCT05352815|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22427740|NCT01258049|Xidea Solutions Limited|Dr Daryl Bendel||daryl@xideasolutions.com|
22427741|NCT00961415|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22427742|NCT00226655|Celtic Pharma Development Services America Inc|Director Medical Sciences|(212) 616 4016|henk-andre.kroon@dev.celticpharma.com|
22427743|NCT02309359|Ablynx NV|Medical Monitor|+32 (0)9 262 00 00|clinicaltrials@ablynx.com|
22427744|NCT01151436|Galderma|Ma May|+33 4 92 38 67 33|may.ma@galderma.com|
22427745|NCT05144945|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22427746|NCT06290180|Cambridge Health Alliance|Heather Gray|(617) 575-5612|hgray@cha.harvard.edu|
22427747|NCT06129149|The Ohio State University|Christine Kimpel|614-247-1195|kimpel.28@osu.edu|
22382300|NCT01772420|Albert Einstein College of Medicine|Dr. Amit K. Verma|718-430-8761|amit.verma@einsteinmed.edu|
22382301|NCT00753012|Massachusetts General Hospital|Dr. Paul Hammerness|(503)617-1040|phammerness@partners.org|
22382302|NCT01930045|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22382303|NCT00241644|GlaxoSmithKline|GSK Response Center|866-435-7343||
22382304|NCT03557333|Impel NeuroPharma|Karen Craig, PhD (Medical Writer)|206-568-1466|kcraig@impelnp.com|
22382305|NCT00864682|Virginia Mason Medical Center|Joseph M. Neal, MD|206-223-6980|anejmn@vmmc.org|
22382306|NCT05097573|Venus Concept|Director of Clinical Affairs|888-907-0115|mgronski@venusconcept.com|
22382307|NCT00742573|New York State Psychiatric Institute|Mark Olfson, MD, MPH|646-774-6413|mark.olfson@nyspi.columbia.edu|
22382308|NCT00657280|Stanford Hospital and clinics|Dr. Michael Fowler Director of the Heart Failure|650-721-5540|mfowler@stanford.edu|
22382309|NCT02507336|University of Miami|Izidore Lossos MD|+1 (305) 2434785|ilossos@med.miami.edu|
22382310|NCT02506257|AMC Amsterdam|Dr. IJE van Der Muelen|020 - 566 9111|TtT@amc.uva.nl|
22382311|NCT04420195|NYU Langone Health|Tyler C Lewis|646-501-4222|Tyler.lewis@nyulangone.org|
22382312|NCT01183533|University of Texas Health Science Center at Houston|Sean I. Savitz, MD|713-500-7083|sean.i.savitz@uth.tmc.edu|
22382313|NCT04842604|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22382314|NCT03036735|Steward Health Care|Dr Peter Catalano|617-789-5004|peter.catalano@steward.org|5004
22382315|NCT00344019|BIDMC|Director of Clinical Trials|6176678800|dcutlip@bidmc.harvard.edu|
22382316|NCT01193153|Janssen Scientific Affairs, LLC, Titusville, NJ|Director of Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
22382317|NCT02503202|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22382318|NCT01119950|Novartis Pharmaceuticals|Study Director|41 61 324 1111||
22396879|NCT00487396|Given Imaging|Director, Clinical Affairs|+972-4-9097777|Hila.Debby@givenimaging.com|
22382319|NCT04897737|UCLA|Dr. Dvora Joseph Davey, PI|310-701-1526|dvoradavey@ucla.edu|
22382320|NCT00478335|University of Colorado Denver|Melissa Cadnapaphornchai, MD|720776263|melissa.cadnapaphornchai@ucdenver.edu|
22427748|NCT01704261|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22427749|NCT02391337|University of Birmingham|Prof. Dipak Kotecha|+44 (0) 7974 115676|d.kotecha@bham.ac.uk|
22427750|NCT04182958|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22427751|NCT00726609|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22427752|NCT03084237|Shanghai Henlius Biotech|Head of Clinical Development|+86 021-33395800|contact@henlius.com|
22427753|NCT01067586|University of Minnesota|Dorothy Hatsukami, PhD|612-626-2121|hatsu001@umn.edu|
22427754|NCT00746551|Mahidol University, Department of Obstetrics and Gynaecology, Division of Maternal Fetal Medicine, Faculty of Medicine, Siriraj Hospital|Pharuhas Chanprapaph|+66819920053|pharuhasc@gmail.com|
22427755|NCT01451372|Medtronic Minimed|Suiying Huang, Statistician|8184763319|suiying.huang@medtronic.com|
22427756|NCT00843466|Unilever|Jamie Regan|203-381-4448|Jamie.Regan@unilever.com|
22427757|NCT00465179|The University of Texas (UT) MD Anderson Cancer Center|Nizar M Tannir, MD, Professor, Genitourinary Medical Oncology||CR_Study_Registration@mdanderson.org|
22427758|NCT00976339|Columbia University|Dr. Katherine Crew|212-305-1732|kd59@cumc.columbia.edu|
22427759|NCT01434511|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22427760|NCT02867592|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22427761|NCT00909870|Shire Regenerative Medicine|Mollie Carter, MD, Medical Director|(858) 754-5678|mcarter@shire.com|
22427762|NCT03699748|Stanford University|Dr. Manali Patel|6504859462|manalip@stanford.edu|
22427763|NCT03818854|University of California San Francisco|Dr. Michael Matthay|415-476-1079|michael.matthay@ucsf.edu|
22427764|NCT01222299|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
22427765|NCT01420536|Araraquara Dental School -Universidade Estadual Paulista (Sao Paulo State University)|Prof. Marco Antonio Compagnoni|+55-16-3331-6411|compagno@foar.unesp.br|
22427766|NCT02866643|Stanford University|Clinical Research Manager|6507247826|gynresearch@stanford.edu|
22427767|NCT04711005|Duke University School of Medicine|Michelle Mack|919 613 1107|michelle.mack@duke.edu|
22427768|NCT00764790|GlaxoSmithKline|GSK Response Center|866-435-7343||
22427769|NCT03191552|Department of Physical medicine and Rehabilitation, Marmara University School of Medicine, Istanbul,Turkey|Esra Giray|+90216624545|girayesra@hotmail.com|6515
22427770|NCT02634177|Genomind|Chief Medical Officer|267-989-3461|dkrause@genomind.com|
22427771|NCT02555254|CHU Nantes|Jean-Baptiste Lascarrou|+33251446572|jeanbaptiste.lascarrou@chu-nantes.fr|
22427772|NCT00788671|UT MD Anderson Cancer Center|Dr. Shannon N. Westin, MD, Associate Professor, Gyn Onc & Reproductive Med|(713) 794-4314|swestin@mdanderson.org|
22427773|NCT04780659|Karolinska University Hospital|Soo Aleman Sponsor representative|+46 72595 7225|soo.aleman@regionstockholm.se|
22427774|NCT03729362|Amicus Therapeutics, Inc.|Patient advocacy|001 6096622000|clinicaltrials@amicusrx.com|
22427775|NCT03405870|University of Florida College of Medicine|Dr. Faheem Guirgis, MD|352-733-1469|fguirgis@ufl.edu|
22427776|NCT02987868|Pennington Biomedical Research Center|Dr. Frank Greenway, Chief of Outpatient Clinic|225-763-2578|Frank.Greenway@pbrc.edu|
22427777|NCT02807259|Karnataka Health Promotion Trust|Prakash Javalkar|+91 80 4040 0200|prakashj@khpt.org|
22427778|NCT01171534|University of Missouri, Department of Orthopaedic Surgery|Gregory J. Della Rocca, MD, PhD, FACS|573-882-6562|dellaroccag@health.missouri.edu|
22427779|NCT00849056|GlaxoSmithKline|GSK Response Center|866-435-7343||
22427780|NCT04588259|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22427781|NCT02688803|Ottawa Hospital Research Institute|Dr. John Hilton|613-737-7700|jfhilton@toh.ca|70170
22427782|NCT02100631|Emergent BioSolutions Canada Inc.|David Cassie, Scientist, Clinical Research||dcassie@ebsi.com|
22427783|NCT04476043|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22427784|NCT00715208|Millennium Pharmaceuticals|Carol Ann Satler, MD, PhD|617- 551-3729|carol.satler@mpi.com|
22427785|NCT01648764|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22427786|NCT00903968|Dana-Farber Cancer Institute|Irene M. Ghobrial, MD|617-632-4198|Irene_Ghobrial@dfci.harvard.edu|
22427787|NCT01294046|Cleveland Clinic|Kathryn O'Connor||oconnok@ccf.org|
22427788|NCT00396292|Luitpold Pharmaceuticals, Inc.|Marc Tokars|610-650-4200|mtokars@lpicrd.com|
22427789|NCT02156258|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
22427790|NCT03738696|University of Alabama at Birmingham, Department of Orthopaedics|Dr. Amit Momaya|205-930-8339|amomaya@uabmc.edu|
22427791|NCT02631057|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22382321|NCT04059237|Stanford University|Catherine Benedict, PhD|650-498-9111|cbenedict@stanford.edu|
22382322|NCT03058991|Boston University Charles River Campus|Dr. Michael Otto|617-353-9610|mwotto@bu.edu|
22382323|NCT03951649|UAB|Rachel Sinkey|(205) 934-5611|rsinkey@uabmc.edu|
22382324|NCT01591616|Virginia Commonwealth University, School of Dentistry|Tegwyn H. Brickhouse, DDS, PhD|(804) 827-2699|thbrickhouse@vcu.edu|
22382325|NCT00758602|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22382326|NCT03038399|ReveraGen BioPharma Inc.|Dr. Eric Hoffman|301-762-7980|ericphoffman@gmail.com|
22382327|NCT00770965|Novartis|Study Director|862-778-8300||
22382328|NCT00509769|Genentech, Inc.|Medical Communications|800 821-8590||
22382329|NCT02371746|Envisia Therapeutics, Inc.|Kristin Blackwell, Consultant, Regulatory Affairs & Quality Assurance|919-219-6448|kristin.blackwell@envtx.com|
22382330|NCT00414648|Division of Pulmonary, Critical Care and Sleep Medicine, University of Cincinnati|Francis X. McCormack, MD|513-558-4831|mccormfx@ucmail.uc.edu|
22382331|NCT00754936|Weill Cornell Medicine|George S Alexopoulos|914-997-5767|gsalexop@med.cornell.edu|
22427792|NCT03801252|University of Oklahoma Health Sciences Center|Dr. Stephanie Pierce|(405) 271-8787|stephanie-pierce@ouhsc.edu|
22382332|NCT00436644|Mayo Clinic|Dr. Paul Haluska|507-266-2123|haluska.paul@mayo.edu|
22427793|NCT02690727|Algorithme Pharma Inc.|Dr. Eric Sicard|(514) 858-6077|esicard@algopharm.com|
22427794|NCT04757636|Opthea Limited|Chief Officer|+61 (0) 3 9826 0399|info@opthea.com|
22427795|NCT02443077|University of California|Dr. Charalambos Andreadis|415-353-8363|candreadis@medicine.ucsf.edu|
22427796|NCT01732692|Takeda|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
22427797|NCT01027949|United Therapeutics|Louis Holdstock, PhD|919-425-8866|lholdstock@unither.com|
22427798|NCT03315949|College of Medicine, The Catholic University of Korea|Dr. Tae-Geun Gweon|82 32 340 2228|gweontae@naver.com|
22427799|NCT00656617|University of Texas (UT) MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/Professor, Leukemia Department|713-745-3428|CR_Study_Registration@mdanderson.org|
22427800|NCT02030600|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22427801|NCT02805998|UCSF|Dr. Jennifer Felder|415-476-7014|jennifer.felder@ucsf.edu|
22427802|NCT00091819|Theravance, Inc.|Steven Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
22427803|NCT02606253|Lipscomb University College of Pharmacy|Dr. Zachary Cox, Associate Professor|6159667163|zac.cox@lipscomb.edu|
22427804|NCT00701363|Ipsen|Medical Director, Clinical Endocrinology and Metabolism|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22427805|NCT03426878|Kaiser Permanente Center for Health Research|Joanna Bulkley, PhD|5033352400|joanna.e.bulkley@kpchr.org|
22427806|NCT03704064|University of Florida|Dr. Rebecca Pearl, Assistant Professor|352-294-5405|rebecca.pearl@ufl.edu|
22427807|NCT05033041|Northwestern University|Paul C. Fitzgerald,RN,BSN,MS|312-695-1064|p-fitzgerald2@northwestern.edu|
22427808|NCT06469372|Columbia University Irving Medical Center|Timothy J. Poterucha, MD|(212) 932-4537|tp2558@cumc.columbia.edu|
22427809|NCT00262925|ECOG Statistical Office|Study Statistician|617-632-3012||
22427810|NCT04682301|Fred Hutchinson Cancer Center|Madison Snidarich, Clinical Research Coordinator|2066674589|msnidari@fredhutch.org|
22427811|NCT04220021|University of Florida|Laura P.W. Ranum, PhD|(352) 294-5209|ranum@ufl.edu|
22427812|NCT03043053|Massachusetts General Hospital|Elizabeth A. Lawson, MD, MMSc|617-726-3870|ealawson@mgh.harvard.edu|
22427813|NCT04935879|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22427814|NCT01652690|Amgen Inc.|Study Director|866-572-6436||
22427815|NCT03533751|AnaptysBio, Inc.|Clinical Project Leader|858-362-6295|info@anaptysbio.com|
22427816|NCT01899911|University of California, San Francisco (UCSF)|Philip E. Bickler, MD, PhD, Professor of Anesthesia|415-476-1411|Philip.Bickler@UCSF.edu|
22427817|NCT01884597|Retina Consultants of Hawaii, Inc.|Gregg Kokame, MD|(808) 487-8928|retinahi@aol.com|
22427818|NCT05965752|Duke University|Daniel Laskowitz, MD|919-684-0056|daniel.laskowitz@duke.edu|
22427819|NCT05619471|Enspectra Health|President|650 480-6022|clinical@enspectrahealth.com|
22427820|NCT00834041|Novartis Pharmaceuticals|Study Director|862 778-8300||
22427821|NCT02634710|Froedtert and the Medical college of Wisconsin|Ciani Ellison, MD|414-805-4400|cellison@mcw.edu|
22382333|NCT00619645|University of California Davis|Data Manager|916-734-8381|nmahaffey@ucdavis.edu|
22382334|NCT01114945|Department of Anesthesiology at Cedars-Sinai Medical Center in Los Angeles|Roya Yumul, M.D., Ph.D.|310-423-5841|(Roya.Yumul@cshs.org)|
22382335|NCT04364269|Vifor Pharma, Inc.|CSL Vifor|+41 588 518 000|VIT2763-THAL-201.study@viforpharma.com|
22382336|NCT04173572|University of North Carolina at Chapel Hill|Tonya Elliott|919-966-3915|tonya_elliott@med.unc.edu|
22382337|NCT01490580|NICU, CHI Créteil|Dr Xavier Durrmeyer|+33145175433|xavier.durrmeyer@chicreteil.fr|
22382338|NCT04615299|John Dingell VA Medical Center|Dr Padmavathi Patel|313-576 2731|Padmavathi.Patel@va.gov|
22382339|NCT02026258|UConn Health|Flavio Uribe|8606793656|furibe@uchc.edu|
22382340|NCT00761930|Colgate Palmolive Co.|William Devizio|732-878-7901|William_Devizio@colpal.com|
22382341|NCT03478696|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22382342|NCT00117663|Group Health Research Institute|Diana Buist PhD, Principal Investigator|206-287-2931|buist.d@ghc.org|
22382343|NCT01104415|Lexicon Pharmaceuticals, Inc.|Pablo Lapuerta, MD||plapuerta@lexpharma.com|
22382344|NCT04286529|Mayo Clinic|Rajiv Kumar, MD|507-284-0020|rkumar@mayo.edu|
22382345|NCT03105128|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22382346|NCT04550039|Shirley Ryan AbilityLab|Katherine Enzler, Physical Therapist|312-238-2941|kenzler@sralab.org|
22382347|NCT05826431|UW Medicine Multiple Sclerosis Center|Dr. Kevin Alschuler, Director of Rehabilitation Research|206-668-8413|kalschul@uw.edu|
22382348|NCT01199237|University of California, San Francisco|Rachel Eshima McKay|415-502-1715|eshimar@anesthesia.ucsf.edu|
22427822|NCT03454555|RTI International|Dr. Lauren McCormack|919-541-6277|lmac@rti.org|
22427823|NCT05019430|University of Kentucky|William W. Stoops|8592575388|william.stoops@uky.edu|
22427824|NCT05032183|The Univeristy of Texas MD Anderson Cancer Center|Ghayas Issa MD./Associate Professor|713-745-6798|GCIssa@mdanderson.org|
22427825|NCT03834961|Children's Oncology Group|Results Reporting Coordinator|6262411500|resultsreportingcoordinator@childrensoncologygroup.org|
22427826|NCT05493111|Alcon Research, LLC|Scientific Advisor, Clinical Research and Development|1-888-451-3937|alcon.medinfo@alcon.com|
22427827|NCT05539131|Yongin Severance Hospital|Woo Jung Kim|01092827943|woojungkim@yuhs.ac|
22427828|NCT01140906|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
22427829|NCT04889040|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22427830|NCT01107015|University of Maryland, Baltimore|Cindy Geppi|4107062406||
22427831|NCT01155323|Johnson and Johnson K.K.|Wakana Katabami|81-34411-8040|wkatabam@its.jnj.com|22025
22427832|NCT02052635|AstraZeneca AB|Anders Himmelmann, MD PhD|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
22427833|NCT01208051|University of Chicago|Chih-Yi Liao, MD|(773) 702-6241|andyliao@medicine.bsd.uchicago.edu|
22382349|NCT01697319|BioMarin Pharmaceutical Inc.|BioMarin Medical Information Services|800-983-4587|medinfo@bmrn.com|
22427834|NCT02349386|Besins Healthcare Ireland Ltd|Global Chief Medical Officer|+353 87 1039215|clinicaldevelopment@besins-healthcare.com|
22427835|NCT00973973|AbbVie|Global Medical Services|800-633-9110||
22427836|NCT02471339|National Cancer Institute|Staci M. Peron, Ph.D.|240-760-6025|martins@mail.nih.gov|
22427837|NCT06057064|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22427838|NCT02240329|University of Florida|Erin Pearson Ph.D CCC/SLP|352-339-4100|epearson@ufl.edu|
22427839|NCT00851591|Texas Tech University Health Sciences Center|Thomas Hale, PhD.|806-354-5528|thomas.hale@ttuhsc.edu|
22427840|NCT01038765|Radboud University Medical Centre|Anne E.M. Speckens|0031243610449|a.speckens@psy.umcn.nl|
22427841|NCT02736617|Oregon Health and Sciences University, Knight Cancer Institute|Dr. Stephen E. Spurgeon, Associate Professor of Medicine|503-494-8950|spurgeos@ohsu.edu|
22427842|NCT01718691|SymBio Pharmaceuticals|Toshihiko Nagase|+81-3-5472-1125||
22427843|NCT04383132|Şehit Prof. Dr. İlhan Varank Eğitim Ve Araştırma Hastanesi|Dr. Beslen Göksoy|05349530112|beslengoksoy@gmail.com|
22427844|NCT03901300|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|2257632500|amanda.staiano@pbrc.edu|
22427845|NCT00481676|Novartis Pharmaceuticals|Study Director|862 778-8300||
22427846|NCT02911116|National Institutes of Health|H. Nida Sen, MD, MHSc, Principal Investigator, NEI|301-402-3254|senh@nei.nih.gov|
22427847|NCT01240694|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22427848|NCT01513590|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22427849|NCT02110693|Friends Research Institute|Robert Schwartz|410-837-3977|rschwartz@friendsresearch.org|276
22427850|NCT01056276|Sarah Cannon Development Innovations|Charles Davis, RAC||charles.davis2@scri-innovations.com|
22427851|NCT01881425|InnFocus, Inc. (a Santen Company)|Sharon Herbert, Director of Global Clinical Operations|(415) 268-9059|sharon.herbert@santen.com|
22427852|NCT00397579|University of Texas Southwestern Medical Center at Dallas|Clinical Research Office|214-648-7097|studyfinder@utsouthwestern.edu|
22427853|NCT02524119|UT Southwestern Medical Center|Dr. Muhammad Beg|2146484180|Muhammad.Beg@UTSouthwestern.edu|
22427854|NCT02054156|Seattle Children's Hospital|Margaret Kloster|2068847862|margaret.kloster@seattlechildrens.org|
22427855|NCT04154956|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22427856|NCT04424901|UConnHealth|Ellen Ciesielski|860-679-6004|eciesielski@uchc.edu|
22427857|NCT00147238|UT MD Anderson Cancer Center|Haesun Choi, MD / Professor|713-745-4693||
22427858|NCT04810962|AimMax Therapeutics Inc.|Chief Medical Officer|919-797-1146|admin@aimmaxrx.com|
22427859|NCT01348269|University Hospital Wuerzburg - Department of Orthopaedics (Clinical Study Unit)|Dr. Lothar Seefried|+499318033590|l-seefried.klh@uni-wuerzburg.de|
22427860|NCT00805532|VA Portland Health Care System|Amy W. Wagner, Ph.D.|(503) 220-8262|amy.wagner@va.gov|33365
22427861|NCT00920816|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22427862|NCT01180777|Johnson & Johnson Vision Care|Michael S. Mayers, O.D., FAAO|1-904-443-3252|MMayers@its.jnj.com|
22427863|NCT03185208|University of Pittsburgh|Ariel Gildengers, M.D.|412-246-6002|ariel.gildengers@pitt.edu|
22427864|NCT03834350|University of Chicago|Dr. Valerie Press|773-702-5170|vpress@bsd.uchicago.edu|
22427865|NCT02765165|Proximagen, LLC|Chief Medical Officer|952-658-7440|tcmeng@proximagen.com|
22427866|NCT01189266|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22427867|NCT00321763|GlaxoSmithKline|GSK Response Center|866-435-7343||
22427868|NCT00410163|GlaxoSmithKline|GSK Response Center|866-435-7343||
22427869|NCT05824026|Coloplast A/S|Clinical Strategy Project Manager: Johanne Louise Gotfredsen|004549113350|dkjoat@coloplast.com|
22427870|NCT02674659|Harapan Kita National Cardiovascular Center|Bambang Dwiputra, MD, FIHA|0215684093|bambangdwiputra@gmail.com|
22427871|NCT02366871|University of Colorado, Anschutz Medical Campus|Dr. Saketh Guntupalli|303-724-2033|saketh.guntupalli@cuanschutz.edu|
22427872|NCT01572792|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
22427873|NCT03530696|George Washington Cancer Center|Dr. Pavani Chalasani|(202) 741-2277|pavani.chalasani@email.gwu.edu|
22427874|NCT04759131|Bioverativ Therapeutics Inc. (a Sanofi Company)|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
22427875|NCT03692949|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22427876|NCT06309394|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22427877|NCT01090180|Veterans Affairs North Texas Health Care System|Alina Suris|817-715-0625|alina.suris@va.gov|
22427878|NCT00833755|Massachusetts General Hospital|Dr. Jianren Mao|6177246102|mghpainresearch@partners.org|
22427879|NCT04062227|HealthPartners Institute|Bhavani Kashyap, MBBS, PhD|651-495-6363|Bhavani.X.Kashyap@HealthPartners.com|
22427880|NCT00560404|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22427881|NCT06015490|Virginia Polytechnic Institute and State University|Alexandra DiFeliceantonio|540-526-2285|dife@vt.edu|
22427882|NCT02642042|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|jmiao@fredhutch.org|
22427883|NCT04108468|Leeds Teaching Hospital Trust|Professor Helena Marzo-Ortega|+44 (0) 113 392 4848|H.Marzo-Ortega@leeds.ac.uk|
22427884|NCT03260023|Transgene|Director of Medical Affairs|+ 33 3 88 27 91 00|clinical.trials@transgene.fr|
22427885|NCT03506061|Emory University|Eric Sorscher, MD|205-612-1327|esorscher@emory.edu|
22427886|NCT05035407|National Cancer Institute|Dr. Scott Norberg|301-275-9668|scoot.norberg@nih.gov|
22427887|NCT04513366|Swedish Orphan Biovitrum AB (publ)|Blank Clinical Study Physician, MD|+46 8 697 20 00|medical.info@sobi.com|
22427888|NCT04386785|Venclose|Mai-Ly Wilcox|415-254-1930|mwilcox@venclose.com|
22427889|NCT06121609|Department of Anesthesiology and Pain Medicine, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital, Tongji Medical College, Huazhong University of Scien|aijun xu|+8618627784217|ajxu@tjh.tjmu.edu.cn|
22427890|NCT03344757|University of Miami|Dr. Frank Penedo|305-284-4290|fpenedo@miami.edu|
22427891|NCT00269152|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22427892|NCT00848497|Baylor College of Medicine|Mohit Khera, MD|713-798-6593|mkhera@bcm.edu|
22427893|NCT01832766|University of Colorado Denver|Lynn Johnson, Pharm.D.|303 724 6221|lynn.johnson@ucdenver.edu|
22427894|NCT02139540|Washington University|Principal Investigator|7737022544||
22427895|NCT03054428|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
22427896|NCT03880474|Vaccitech Ltd.|Tom Evans, MD|+44 01865 591 445|enquiries@vaccitech.co.uk|
22427897|NCT03225287|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22427898|NCT03036267|Columbia University School of Nursing|Dr. Maureen George|2123051175|mg3656@cumc.columbia.edu|
22427899|NCT06070610|Boehringer Ingelheim, Call Centre|Boehringer Ingelheim|18002430127|clintriage.rdg@boehringer-ingelheim.com|
22427900|NCT01499810|Research Institute of Cradiology, Siberian Branch of Russian Academy of Sciences|Dr. Stanislav Pekarskiy|+73822558122|pekarski@cardio-tomsk.ru|
22427901|NCT01191749|University of Texas (UT) MD Anderson Cancer Center|Tapan Kadia, MD|1-877-632-6789|CR_Study_Registration@mdanderson.org|
22427902|NCT01509105|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22396880|NCT04551677|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22427903|NCT03836053|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22427904|NCT03846479|Icahn School of Medicine at Mount Sinai|Dr. John Levine|212-241-6021|john.levine@mssm.edu|
22427905|NCT02332707|Merck Sharp & Dohme Corp.|Senior VIce President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22427906|NCT01473134|Clinical Affairs Associate Director|Hillary Overholser|574-933-4180|hillary.overholser@zimmerbiomet.com|
22427907|NCT03643848|Florida International University|Dana L. McMakin, PhD, ABPP|305-348-0042|dmcmakin@fiu.edu|
22427908|NCT00375752|Novartis Pharmaceuticals|Study Director|862-778-8300||
22427909|NCT03265964|VA Salt Lake City Health Care System, VISN 19 Rocky Mountain MIRECC for Veteran Suicide Prevention|Dr. Douglas Kondo|801-587-1549|douglas.kondo@va.gov|
22427910|NCT00890162|National Institute of Allergy and Infectious Diseases|Carter, Melody|+1 301 496 8772|mc396j@nih.gov|
22427911|NCT01649765|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22427912|NCT02469233|Department of Psychology, University of California, Berkeley|Professor of Clinical Psychology|5104736490|aharvey@berkeley.edu|
22427913|NCT03837847|Mayo Clinic|Roberto P. Benzo, M.D.|507-284-0561|Benzo.Roberto@mayo.edu|
22427914|NCT03726476|University of New Mexico Health Sciences Center|Cassandra Darley|505-967-8428|cjdarley@salud.unm.edu|
22427915|NCT00855582|Eli Lilly and Company|Chief Medical Office|800-545-5979||
22427916|NCT03813654|Brigham and Women's Hospital|Jeanne F. Duffy, Principal Investigator|617-732-7995|jduffy@bwh.harvard.edu|
22427917|NCT02832037|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22427918|NCT01401166|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22427919|NCT04727749|University of Saskatchewan|Dr. Colleen Dell|306-966-5912|Colleen.Dell@usask.ca|
22427920|NCT02378181|Public Health Management Corporation|Adam C. Brooks, Ph.D.|215-399-0636|abrooks@tri.phmc.org|
22427921|NCT01859741|OncoMed Pharmaceuticals, Inc.|Manager, Regulatory Affairs|6509958322|imran.chaudhry@oncomed.com|
22427922|NCT03988647|Stanford University|Susan J Knox, Associate Professor of Radiation Oncology|650-725-2720|sknox@stanford.edu|
22427923|NCT02412657|MaisonneuveRH|Dr Veronique Brulotte|(514)252-3400|veronique.brulotte@umontreal.ca|
22427924|NCT00154466|National Taiwan University Hospital|Dr. Bai-Chin Lee|0223123456|lebai@ntu.edu.tw|63352
22427925|NCT04167462|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
22427926|NCT02320396|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22427927|NCT02567422|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
22427928|NCT02511717|Lawson Health Institute|Dr Blayne Welk|5196466000|lawson@lawsonsresearch.com|
22427929|NCT02382939|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22427930|NCT00142415|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22427931|NCT04342169|University of Utah School of Medicine Division of Infectious Diseases|Dr. Adam Spivak|8015871964|adam.spivak@hsc.utah.edu|
22427932|NCT02026297|Brigham and Women's Hospital|Dr. Michaela K. Farber|6177591609|mfarber@bwh.harvard.edu|
22427933|NCT01129128|University of Washington|James A Taylor, MD|206-616-1206|uncjat@uw.edu|
22427934|NCT02841046|Guangzhou Panyu central Hospital|Dr. Yang Lin|+8615915721012|salinyangyl@163.com|
22427935|NCT01311661|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22427936|NCT01900314|University of Michigan|Stephan Taylor|734-936-4955|sftaylor@umich.edu|
22427937|NCT02013414|Emory University|Baowei Fei, PhD|972-883-7239|bfei@utdallas.edu|
22427938|NCT04497883|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22427939|NCT03207399|Duke University Medical Center|Dr. Omar Mohamedaly|919-684-4589|omar.mohamedaly@duke.edu|
22427940|NCT04431206|Wake Forest University School of Medicine|Dr. James Eisenach|3367164182|james.eisenach@advocatehealth.org|
22427941|NCT03197129|Hadassah School of Dental Medicine, P.O.Box 12272|Dr. Avia Fux-Noy|+972-2-6776135|fuxavia@gmail.com|
22427942|NCT00289276|Medtronic CRDM Clinical Research|CRDM Core Clinical|800-328-2518|medtroniccrmtrials@medtronic.com|
22427943|NCT00869960|UAB|Jennifer King|205-934-2696|jenking@uab.edu|
22427944|NCT04848480|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22427945|NCT05219162|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22396881|NCT04066491|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22396882|NCT04506086|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22427946|NCT01426581|University of Chicago|Valerie G. Press, MD, MPH|73-702-5170|vpress@medicine.bsd.uchicago.edu|
22427947|NCT02908347|MetrioPharm Deutschland GmbH|Clinical Disclosure Officer|+49303384395|info@metriopharm.com|36
22427948|NCT02783690|Mayo Clinic|Robert Mutter, M.D.|507-284-2511|mutter.robert@mayo.edu|
22427949|NCT05516758|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22427950|NCT01316575|University of Saskatchewan|Dr. William McKay|306-655-1202|william.mckay@saskatoonhealthregion.ca|
22427951|NCT00402831|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22427952|NCT04585893|UNC Lineberger Comprehensive Cancer Center|Matthew S Painschab|919-966-4431|matthew_painschab@med.unc.edu|
22427953|NCT01366092|Dana-Farber Cancer Institute|John Koreth, MBBS, DPhil|617-632-2949|JKoreth@partners.org|
22427954|NCT03540771|Albert Einstein Healthcare Network|Manisha Verma, MD, MPH. Director, Research|2154561026|Manisha.Verma@jefferson.edu|
22427955|NCT02394769|Massachusetts General Hospital|Andrew T. Chan, MD, MPH|(617) 726-3212|achan@partners.org|
22427956|NCT04761822|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22427957|NCT06217380|Masimo|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
22427958|NCT00867932|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.||ClinicalTrials@Alexion.com|
22427959|NCT02394275|St. Joseph's Healthcare Hamilton, ON|Dr. Marek Smieja|905 521 6021|smiejam@mcmaster.ca|
22427960|NCT00248560|Barbara Ann Karmanos Cancer Institute|Ammar Sukari, M.D.|313-576-8751|sukaria@karmanos.org|
22427961|NCT02471183|Actelion Pharmaceuticals Ltd|Global Post approval studies Director||lperchen@its.jnj.com|
22427962|NCT02478671|Terumo Medical Corporation|Robert Gash, Director of Clinical Affairs|732-302-4931|robert.gash@terumomedical.com|
22427963|NCT00614393|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22427964|NCT02612857|Idera|Senior Development Operations Director|877-888-6550|clinicaltrials@iderapharma.com|2
22427965|NCT03556683|University of North Carolina at Chapel Hill|Carole Robinette|919-966-5638|carole_robinette@med.unc.edu|
22427966|NCT02018107|Brigham & Women's Hospital INC|Paul Shyn, MD|6177326304|PSHYN@BWH.HARVARD.EDU|
22427967|NCT03286504|Weill Cornell Medicine|Dr. Daniel Fitzgerald|646-962-8140|dwf2001@med.cornell.edu|
22427968|NCT02730130|Memorial Sloan Kettering Cancer Center|Christopher Barker, MD|212-639-8168|barkerc@mskcc.org|
22427969|NCT00141921|Amgen Inc.|Study Director|866-572-6436||
22396883|NCT05937165|Hebrew SeniorLife, Marcus Institute of Aging, Harvard Medical School|Courtney Millar|6179715531|courtneymillar@hsl.harvard.edu|
22396884|NCT01357577|VA National Center for PTSD|Jessica L. Hamblen, PhD|8022965132|jessica.hamblen@va.gov|
22427970|NCT03320369|Northwestern University|Nirmala Gonsalves|312-695-4054|n-gonzalves@northwestern.edu|
22427971|NCT02721069|Neurelis, Inc.|Cyndi Guerra|9736156258|cguerra@neurelis.com|
22396885|NCT05493280|UT Southwestern|Lead Coordinator|214-645-8907|jennifer.barillas@utsouthwestern.edu|
22396886|NCT04890314|Weill Cornell Medicine|Dr. Jim C. Hu|(646) 962-6363|jch9011@med.cornell.edu|
22396887|NCT00307151|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22396888|NCT00075400|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22396889|NCT01183559|Igor Astsaturov, MD, PhD, Assistant Professor, Medical Oncology|Igor Astsaturov, MD, PhD, Assistant Professor, Medical Oncology|215 728-3135|Igor.Astsaturov@fccc.edu|
22396890|NCT00516048|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22396891|NCT01321710|University of California, San Francisco|Kathryn Lee, RN, PhD|415-476-4442|kathryn.lee@nursing.ucsf.edu|
22396892|NCT02554019|Biotest AG|Dr. Peter Röttgen|+496103801|peter.roettgen@biotest.com|803
22396893|NCT00390546|University of British Columbia|Dr. Shubhayan Sanatani|604-875-2345|ssanatani@cw.bc.ca|7955
22396894|NCT02463409|Vanderbilt University Medical Center|Dr. Ashley Shoemaker|615-343-8816|ashley.h.shoemaker@vanderbilt.edu|615
22396895|NCT01308008|VA GRECC|Neil Alexander MD|734-845-3048|nalexand@umich.edu|
22396896|NCT01444742|The University of Texas MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/Professor|713-745-3428|CR_Study_Registration@mdanderson.org|
22396897|NCT02187172|University of Pennsylvania|Dr. Joel Gelfand|215-662-3514|joel.gelfand@pennmedicine.upenn.edu|
22396898|NCT01523496|University Hospitals Cleveland Medical Center|Dr Grace McComsey|216-844-2739|Grace.McComsey@UHhospitals.org|
22396899|NCT05400213|University of Texas Health Science Center at San Antonio|Brian Mealeey, DDS, MS|210-450-8736|mealey@uthscsa.edu|
22396900|NCT01035099|Weill Cornell Medicine|Rodriq Stubbs|646-962-3276|res2011@med.cornell.edu|
22396901|NCT03179891|Aquestive Therapeutics|Director of Clinical Operations|908-941-1900|clinicaltrials@aquestive.com|
22396902|NCT02605187|Stanford University School of Medicine|Dr. Brendan Carvalho|650-861-8607|bcarvalho@stanford.edu|
22396903|NCT01648790|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22396904|NCT04075721|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22396905|NCT02159729|Allergan, Inc|Beta Bowen|714-246-4446|Bowen_Beta@allergan.com|
22396906|NCT02636582|UT MD Anderson Cancer Center|Dr. Isabelle Bedrosian, MD, Professor, Breast Surgical Oncology|(713) 563-1872|ibedrosian@mdanderson.org|
22396907|NCT00573430|AstraZeneca|Gerard Lynch|+44 7780 956181|aztrial_results_posting@astrazeneca.com|5895
22396908|NCT01278745|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22396909|NCT00896779|Stanford University|Steven Sanislo, MD|650-723-6995|ssanislo@stanford.edu|
22396910|NCT01843842|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Head of department of clinical trials|+74952761575|PutilovskiyMA@materiamedica.ru|302
22396911|NCT01376778|The George Washington University Biostatistics Center|Dr. Rebecca Clifton, MFMU Principal Investigator|301-881-9260|rclifton@bsc.gwu.edu|
22396912|NCT00632099|New York State Psychiatric Institute|Dr. Suzette Evans|646-774-6136|se18@columbia.edu|
22427972|NCT01461551|Ruijin Hospital|Dr. Lijie Jia|13916667704|litery0301@163.com|
22396913|NCT01517529|University of Cincinnati|Dr. Mohamed Tarek M Shata|(513) 558-6110|mohamed.shata@uc.edu|
22427973|NCT02326883|Kaiser Permanente Washington Health Research Institute|Gregory Simon, Investigator|206-287-2979|gregory.e.simon@kp.org|
22427974|NCT05853120|Emory University|Colleen Kelley|404-712-1823|scolleen.kelley@emory.edu|
22427975|NCT00790036|Novartis Pharmaceuticals|Study Director|862-778-8300||
22427976|NCT00706563|GlaxoSmithKline|GSK Response Center|866-435-7343||
22427977|NCT04428151|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22427978|NCT02187783|Novartis Pharmaceuticals|Study Director|1-888-669-6682|Novartis.email@novartis.com|
22427979|NCT00171249|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22427980|NCT00392223|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22427981|NCT05816070|IVIEW Therapeutics Inc.|Bo Liang, PhD|609 773 8580|info@iviewinc.com|
22427982|NCT01498549|Yale University|Dr. Mehmet Sofuoglu, Professor of Psychiatry; Director of VA New England Mental Illness Research, Ed|(203) 937-4809|mehmet.sofuoglu@yale.edu|
22427983|NCT04622345|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
22427984|NCT02792504|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22427985|NCT01535924|The Ohio State University|Dr. Beth Christian|614-293-7807|Beth.Christian@osumc.edu|
22427986|NCT01114724|Medtronic Inc., Aortic and Peripheral Vascular|Celeste Claudy - Study Lead|763-514-0130|celeste.m.claudy@medtronic.com|
22427987|NCT02814526|Alzheimer's Disease Cooperative Study (ADCS)|Clinical Operations|858-246-1333|alzinfo@ucsd.edu|
22427988|NCT02431299|Indiana University Purdue University Indianapolis|Dr. Alan B. McGuire|3179882725|abmcguir@iupui.edu|
22427989|NCT06178991|BioNTech SE|BioNTech clinical trials patient information|+49 6131 90840|patients@biontech.de|
22427990|NCT01526408|House Institute Foundation|Mahta Marefat|(213) 770-1808|mmarefat@hifla.org|
22427991|NCT03415178|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22427992|NCT07000981|Inonu University|Asst. Prof. Gürkan ÖZDEN|+90 505 715 62 65|gurkan.ozden@inonu.edu.tr|
22427993|NCT02485860|Centre Hospitalier Departemental Vendée|Dr. Emeric ABET|02 51 44 61 48|emeric.abet@ght85.fr|+33
22427994|NCT05706610|Cincinnati Children's Hospital Medical Center|Dr. Meghan McGrady|513-803-8044|meghan.mcgrady@cchmc.org|
22427995|NCT02273167|Norgine Ltd|Lucy Clayton|+44-1895-826669|LClayton@norgine.com|
22427996|NCT03082729|University of Pennsylvania|Joel Gelfand, MD, MSCE|215-662-2737|joel.gelfand@pennmedicine.upenn.edu|
22427997|NCT00763360|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22427998|NCT01416571|GlaxoSmithKline|GSK Response Center|866-435-7343||
22427999|NCT03608163|Albert Einstein College of Medicine|Dr. Meredith Hawkins|718-430-2903|meredith.hawkins@einsteinmed.edu|
22428000|NCT03914612|NRG Oncology|Christopher Purdy on behalf of Mike Sill, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
22428001|NCT04320888|Children's Oncology Group|Results Reporting Coordinator|6262411500|resultsreportingcoordinator@childrensoncologygroup.org|
22428002|NCT03353220|Columbia University|Sharon Wardlaw, MD|212-305-3725|sw22@cumc.columbia.edu|
22428003|NCT03586479|University of Kansas|Rebecca Swinburne Romine|7857668612|swin0024@ku.edu|
22428004|NCT01533259|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22428005|NCT06649409|Santhera Pharmaceuticals LTD|Shabir Hasham MD, Chief Medical Officer|+41 79 520 95 18|shabir.hasham@santhera.com|
22428006|NCT03857256|Montreal Heart Institute|Dr Jean-Claude Tardif|514-376-3330|jean-claude.tardif@icm-mhi.org|3612
22428007|NCT00315341|University of California, Los Angeles|Walter Ling, M.D.|(310) 933-8111|lwalter@ucla.edu|
22428008|NCT04240314|Nationwide Children's Hospital|Megan Waldrop, Sponsor-Investigator|614-722-2231|megan.waldrop@nationwidechildrens.org|
22428009|NCT01566370|Yale/VA Connecticut Healthcare system|Albert Arias|2039325711|albert.arias@va.gov|8155
22428010|NCT05423743|Division of Infectious Diseases, University of California Irvine School of Medicine|Dr. Shruti Gohil, MD, MPH|(714) 456-7890|skgohil@hs.uci.edu|
22428011|NCT01799889|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22428012|NCT01431976|GlaxoSmithKline|GSK Response Center|866-435-7343||
22428013|NCT02594111|VA NY Harbor Healthcare System|Dr. Binita Shah|212-686-7500|binita.shah@va.gov|
22428014|NCT01294514|Covidien|Ulf Borg, Director of Clinical Affairs|303 305 2400|ulf.borg@covidien.com|
22428015|NCT01963611|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22428016|NCT04601506|University of Minnesota|Ezra Golberstein|612-626-2572|egolber@umn.edu|
22428017|NCT01126424|Astellas Pharma Europe Ltd.|Associate Medical Director Urology||clinicaltrials@us.astellas.com|
22428018|NCT02127671|Johns Hopkins University School of Medicine|Gail Daumit, MD, MHS|410-614-6460|gdaumit@jhmi.edu|
22428019|NCT00782067|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22428020|NCT02328105|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
22428021|NCT06094647|University of North Carolina at Chapel Hill|Kelsey Ludwig, PhD|919-962-1401|kelsey_ludwig@med.unc.edu|
22428022|NCT01104285|Maimonides Medical Center|Yizhak Kupfer MD|718-283-8380|ykupfer@maimonidesmed.org|
22428023|NCT01013753|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22428024|NCT01890577|Amgen Inc.|Study Director|866-572-6436||
22428025|NCT00621530|Wake Forest School of Medicine|Dr. James C. Eisenach|336-716-4498|jimeisenach@gmail.com|
22428026|NCT03104413|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22428027|NCT00303186|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22428028|NCT01283386|Hoffmann-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22428029|NCT02469857|Atox Bio, Ltd.|Wayne M Dankner, MD, Chief Medical Officer|1-919-219-6377|wayned@atoxbio.com|
22428030|NCT01137786|Bracco Diagnostics Inc.|Maria Luigia Storto, M.D.|609-514-2262|MariaLuigia.Storto@diag.bracco.com|
22428031|NCT01531153|Yale University|Dr. Mehmet Sofuoglu, Professor of Psychiatry; Director of VA New England Mental Illness Research, Ed|(203) 937-4809|mehmet.sofuoglu@yale.edu|
22428032|NCT00297167|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1- 800- 472- 2634||
22428033|NCT03416179|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22428034|NCT01385176|Institut Lorrain du Coeur et des Vaisseaux, CHU de Nancy, France|Principal Investigator of the Study, Prof. Faiez Zannad|+33 3 83 15 73 22|f.zannad@chu-nancy.fr|
22428035|NCT00284856|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22428036|NCT01056536|Travel Clinic, Department of Ambulatory Care and Community Medicine, University Hospital of Lausanne|Dr Serge de Vallière|+41 79 556 43 12|serge.de-valliere@unisante.ch|
22428037|NCT01285518|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22428038|NCT02373865|GWT-TUD GmbH, Study center Prof. Hanefeld|Prof. Dr. Markolf Hanefeld|+49 351 44005|Markolf.Hanefeld@gwtonline.de|82
22428039|NCT01052948|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22428040|NCT00639509|Memorial Sloan-Kettering Cancer Center|Ghassan K. Abou-Alfa, MD|646-888-4184|abou-alg@mskcc.org|
22428041|NCT02921256|NRG Oncology|Director, Department of Regulatory Affairs|412-339-5261|langerj@nrgoncology.org|
22428042|NCT03507790|Cogntion Therapeutics Inc|Dr. Anthony Caggiano|914-221-6730|acaggiano@cogrx.com|
22428043|NCT00157755|Medtronic Neuromodulation|Clinical Program Manager|763-526-8172|medtronicneurotrials@medtronic.com|
22428044|NCT02421939|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22428045|NCT00671788|Gynecologic Oncology Group Statistical and Data Center|Jessalyn Reboy|716-845-7738|reboyj@nrgoncology.org|
22428046|NCT02966834|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22428047|NCT03133676|Calibr, a Division of Scripps Research|Study Director|(858) 242 1000|KA34ph1@scripps.edu|
22428048|NCT01925417|Rebiotix|Sarah Mische PhD, Associate Director of Clinical Research|6512122839|smische@rebiotix.com|
22428049|NCT00655889|Biologics Consulting Group|Dr. Joseph Fratantoni|(301) 340-8432|jfratantoni@bcg-usa.com|
22428050|NCT01093846|Novartis Pharmaceuticals|Study Director|862-778-8300||
22428051|NCT04066374|Cleveland Clinic|Yuki Kuramochi, BSN, RN|216-445-4063|kuramoy@ccf.org|
22428052|NCT02781324|Children's Hospital Colorado|Eun Kim, Spine Research Assistant|720-777-8026|eun.kim@childrenscolorado.org|
22428053|NCT00661388|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22428054|NCT00362232|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22428055|NCT02700841|University of Nebraska Medical Center|IIT Office|402-559-4596|IITOffice@unmc.edu|
22428056|NCT05020015|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22428057|NCT02233413|Massachusetts General Hospital|Dr. Rajiv Gupta|617-726-0369|rgupta1@mgh.harvard.edu|
22428058|NCT00090103|GlaxoSmithKline|GSK Response Center|866-435-7343||
22428059|NCT02515253|University of Portsmouth|Dr Emma Sharland||emma.sharland@port.ac.uk|
22428060|NCT06633965|Center for Diabetes Technology|Dr. Marc Breton|434-982-6484|mb6nt@virginia.edu|
22428061|NCT00320086|University of New Mexico|Aaron Jacobs, MD|(505)272-5551|Ajacobs@salud.unm.edu|
22428062|NCT04213261|Castle Creek Biosciences|Associate VP of Clinical Trials|16506901024|rblumenthal@castlecreekbio.com|
22428063|NCT00947544|Hyperion Therapeutics|Craig James-Associate Director, Clinical Operations|650-745-7840|craig.james@hyperiontx.com|
22428064|NCT01080261|Boston Scientific Corporation|Ruth Starzyk, Ph.D.|508-683-6577|ruth.starzyk@bsci.com|
22428065|NCT02385318|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
22428066|NCT00300053|Caladrius Biosciences|William Sietsema|9495352391|bsietsema@caladrius.com|
22428067|NCT02566005|Mount Sinai Health Systems|Dr. Zainab Al-Ibraheemi||Zainab.Al-ibraheemi@mountsinai.org|
22428068|NCT02472405|University of Miami|Keyvan Nouri MD|305-243-3380|KNouri@med.miami.edu|
22428069|NCT03095287|Grifols Therapeutics LLC|Rhonda Griffin|919-316-6693|rhonda.griffin@grifols.com|
22428070|NCT00055237|National Cancer Institute, National Institutes of Health|Robert Yarchoan, M.D.|301-496-0328|Robert.Yarchoan@nih.gov|
22428071|NCT01134042|GlaxoSmithKline|GSK Response Center|866-435-7343||
22428072|NCT03345004|Diamyd Medical AB|Director of Clinical Development|+46 (0) 8 661 00 26|clinicaltrials@diamyd.com|
22428073|NCT05350423|Icahn School of Medicine at Mount Sinai|Dr. Mantu Gupta|212-241-1272|Mantu.Gupta@mountsinai.org|
22428074|NCT02097277|Bristol-Myers Squibb|Study Director||clinical.trials@bms.com|
22428075|NCT04706221|Zynex Monitoring Solutions|Donald Gregg|(800) 495-6670|dgregg@zynex.com|3802
22428076|NCT00835926|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22428077|NCT01091259|Perlmutter Cancer Center at NYU Lagone|Franco Muggia, MD|212-263-6485|Franco.Muggia@nyumc.org|
22428078|NCT04398966|University of North Carolina at Chapel Hill|Markeela Lipscomb|919-843-3670|markeela_lipscomb@med.unc.edu|
22428079|NCT02081807|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22428080|NCT00984867|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
22428081|NCT00671060|Gynuity Health Projects|Hillary Bracken|2124481230|hbracken@gynuity.org|
22428082|NCT01541748|Coloplast|Cathy Bartz|612-834-3127|uscmba@coloplast.com|
22428083|NCT03340883|Chinook Therapeutics, Inc.|Chinook Therapeutics, Inc. (formerly Aduro Biotech, Inc.)|206-485-7051|clinicaltrials@chinooktx.com|
22428084|NCT01675778|Jacobi Medical Center|Dr. Shujun Xia|718-918-5800|shujun.xia@nbhn.net|
22428085|NCT00626639|Biovitrum|Hans Olivecrona, MD PhD|+46 8 697 20 00|hans.olivecrona@sobi.com|
22428086|NCT01155141|Stanford University|Dr. Richard Lafayette|650-498-6063|czar@stanford.edu|
22428087|NCT03473197|Castle Creek Pharmaceuticals, LLC|Dr. Mary Spellman|862 286 0400|mspellman@castlecreekpharma.com|
22382350|NCT01421654|ResMed|Amy Blase/Clinical Research Manager|858-836-6715|amy.blase@resmed.com|
22382351|NCT04222959|San Diego State University Research Foundation|Elizabeth Reed|508-212-1517|ereed@sdsu.edu|
22382352|NCT03772964|University of Pittsburgh|Dr. Brian Zuckerbraun|(412) 647-3065|zuckerbraunbs@upmc.edu|
22382353|NCT03254394|Washington University in St Louis|Simon Haroutounian, PhD. Associate Professor|3132861715|sharout@wustl.edu|
22382354|NCT00907218|MassGH|Dr. Timothy Wilens|617-724-5226|twilens@partners.org|
22428088|NCT00785629|Denver Nephrologists, P.C.|Geoffrey A. Block, MD|303-364-4775|gablock@denverneph.net|
22382355|NCT04248829|Yuhan Corporation|Dongmin Kim|+82-2-828-0523|clinicaltrials@yuhan.co.kr|
22382356|NCT01910636|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22382357|NCT01867580|KCI, an Acelity Company|Anthony Tate, RN, BSN|210-515-4060|anthony.tate@kci1.com|
22382358|NCT01212757|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22382359|NCT03284957|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22382360|NCT04670822|State University of New York at Buffalo|Dr. Xiaozhong Wen|7168296811|xiaozhon@buffalo.edu|
22382361|NCT01049503|Bauru Dental School/University of São Paulo|Dr. Marília Buzalaf|+55 14 32358346|mbuzalaf@fob.usp.br|
22382362|NCT01072006|VANCHCS|Juliana Baldo|925-372-4649|juliana.baldo@va.gov|
22382363|NCT00580073|University of Wisconsin-Madison|CRA|608-265-4347|smccarthy@medicine.wisc.edu|
22382364|NCT00487578|Clinvest|M.E. Beach|(417) 841-3618|mbeach@clinvest.com|
22382365|NCT01199783|Herz- und Diabeteszentrum NRW|PD Dr. Bernd Stratmann|+495731973768|bstratmann@hdz-nrw.de|
22382366|NCT00726999|Medical College of Wisconsin|Lynn Rusy, MD|414-266-2555|lrusy@chw.org|
22382367|NCT00955825|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com|
22382368|NCT00708032|Johnson & Johnson Vision Care, Inc.|Kathy Osborn, OD|+1 904 443-1032|clinicalstudies@its.jnj.com|
22382369|NCT00150176|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22382370|NCT01904071|Maimonides Medical Center|Dr. Eitan Dickman, Director of EM Ultrasound|718-283-6057|edickman@maimonidesmed.org|
22382371|NCT01012388|Merz Aesthetics, Inc.|Merz Aesthetics, Inc.|650-286-4041|clinicaltrials@merzaesthetics.com|
22382372|NCT03624413|Emory University|Brian C. Zanoni, MD|404-727-0284|brian.christopher.zanoni@emory.edu|
22382373|NCT02729701|University of Kansas Medical Center|Bruce F. Kimler, Ph.D.|913-205-6382|bkimler@kumc.edu|
22382374|NCT02937831|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22382375|NCT01759264|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
22382376|NCT00816751|UC San Diego Health|Jessica M. Kingston, MD|858-249-1204|jkingston@ucsd.edu|
22382377|NCT02107339|NorthShore University HealthSystem|Glenn Murphy|847-570-2760|dgmurphy2@yahoo.com|
22428089|NCT00267670|Northwestern University|Mary E. Rinella, MD|312-503-4592|m-rinella@northwestern.edu|
22382378|NCT01811706|University of Florida|Dr. Guangbin Xia, Assistant Professor|352-273-5550|guangbin.xia@neurology.ufl.edu|
22382379|NCT05174013|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22382380|NCT02034916|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22382381|NCT01370694|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22382382|NCT01852019|The Medicines Company|Jayne Prats, PhD - VP, Global Knowledge Management|888-779-MDCO|jayne.prats@themedco.com|1510
22382383|NCT00208507|DePuy Orthopaedics, Inc|Dave Whalen|574-372-7028|DWhalen@its.jnj.com|
22382384|NCT04089488|Statistical and Data Analysis Center, AIDS Malignancy Consortium|Deukwoo Kwon|(713) 500-7964|deukwoo.kwon@mountsinai.org|
22382385|NCT02148133|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22382386|NCT03808883|Case Western Reserve University|Sarah Fulton, MA, RA, Begun Center, Jack, Joseph and Morton Mandel School of Applied Social Science|216-368-0429|sarah.fulton@case.edu|
22382387|NCT04628572|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22382388|NCT00855465|Bayer|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22382389|NCT02470949|University of Florida|Michelle Cardel, PhD, RD|(352) 273-9703|mcardel@ufl.edu|
22382390|NCT01595854|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22382391|NCT04365400|Afimmune|Study Director|+3532946380|info@afimmune.com|
22382392|NCT00612586|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22382393|NCT02613364|University of Rochester Medical Center|Dr. Karen Mustian, Study PI|585-275-0557|karen_mustian@urmc.rochester.edu|
22382394|NCT01909336|HIMFG|Claudia Montserrat Flores Robles|(52) 5566756686|montseflores@hotmail.com|
22382395|NCT01235949|GlaxoSmithKline|GSK Response Center|866-435-7343||
22382396|NCT03743246|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22382397|NCT00395018|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22428090|NCT02020941|IndianaU|Dr. Attaya Suvannasankha|317-944-0920|asuvanna@iu.edu|
22428091|NCT01114555|Memorial Sloan Kettering Cancer Center|Dr. Shakeel Modak, MD|212-639-7623|modaks@mskcc.org|
22428092|NCT04773795|Nitinotes Ltd.|Ravit Peled- Director of clinical operations|0526145354|ravit@nitinotesurgical.com|
22428093|NCT02107898|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22428094|NCT03329989|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|ClinicalTrials@Endo.com|
22428095|NCT05258721|Arcadia Consumer Healthcare, Inc.|Jai Shewale|504-913-4344|jshewale@arcadiach.com|
22428096|NCT00879658|Novartis Pharmaceuticals|Study Director||Novartis.email@novartis.com|
22382398|NCT04296227|Vital USA Inc.|Mark H Khachaturian, PhD|+1(561)282-6074|mark.khachaturian@vvvital.com|
22428097|NCT01719653|Gastroenterology Services, Ltd|David Gerard, MD|630 969 1167|davidpgerard@comcast.net|
22428098|NCT03836066|Fundación GECP|Eva Pereira|+34 934302006|gecp@gecp.org|
22428099|NCT05881733|Erasmus MC|Dr. Sing-Chien Yap|+31650031551|s.c.yap@erasmusmc.nl|
22382399|NCT02534350|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22382400|NCT00128193|Colorado State University, Department of Microbiology, Immunology and Pathology|Patrick J. Brennan, Ph.D.|970-491-6700|patrick.brennan@colostate.edu|
22382401|NCT00716144|GlaxoSmithKline|GSK Response Center|866-435-7343||
22382402|NCT01568918|Mayo Clinic|Michelle Clarke, M.D.|(507) 284-5317|Clarke.Michelle@mayo.edu|
22382403|NCT04301986|UNC Center for Esophageal Diseases & Swallowing|Ariel E. Watts, Assistant Director of Clinical Trial Operations|919-962-7316|ariel_watts@med.unc.edu|
22382404|NCT01891968|The University of Texas MD Anderson Cancer Center|Guillermo Garcia-Manero, MD|713-745-3428|CR_Study_Registration@mdanderson.org|
22382405|NCT02341625|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22382406|NCT01161498|Amgen, Inc.|Study Director|866-572-6436||
22382407|NCT00739765|New York State Psychiatric Institute|John C. Markowitz, M.D.|646 774-8098|jcm42@cumc.columbia.edu|
22382408|NCT03310983|University of Kansas Medical Center|Dr. Holly Hull|9135881000|hhull@kumc.edu|
22382409|NCT01656304|Barbara Ann Karmanos Cancer Institute|Ulka Vaishampayan, M.D.|(313) 576-8718|vaishamu@karmanos.org|
22382410|NCT00823979|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22382411|NCT03396913|Lumenis|Yair Manor, Clinical Director|+972-52-3763416|yair.manor@lumenis.com|
22382412|NCT03523091|William Beaumont Hospital|Jennifer Giordano|248-551-3517|jennifer.giordano@beaumont.org|
22382413|NCT01093534|Astellas Pharma Europe Ltd.|Director Medical Affairs - Urology||clinicaltrials@us.astellas.com|
22382414|NCT00741988|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22382415|NCT01832506|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22382416|NCT02885311|Northwell Health|Dr. Jonathan Morgenstern|(516) 837-1694|jmorgenste@northwell.edu|
22382417|NCT01001078|Maisonneuve-Rosemont Hospital|Nikola Joly, M.D.|+1 514 252 3426|nikola.joly@umontreal.ca|
22382418|NCT03863834|Inmode Ltd|Maria Shusterman, Clinical Director|9057070975|maria.shusterman@inmodemd.com|
22382419|NCT01624168|Appalachian State University|Dr. Karen Caldwell, Professor|828-262-6045|caldwellkaren@appstate.edu|
22382420|NCT00281918|Hoffmann-LaRoche|Medical Communications|800-821-8590||
22382421|NCT03386929|Worldwide Innovative Network (WIN) Association|Fanny Wunder, Project Manager|0033604090029|fanny.wunder@winconsortium.org|
22382422|NCT03538054|The University of Alabama at Birmingham|Dr. Jarred Younger|2059755821|younger@uab.edu|
22382423|NCT01981356|Center for Innovation to Implementation, VA Palo Alto HCS|Matthew Boden, Ph.d.|650-493-5000|Matthew.Boden@va.gov|27529
22382424|NCT01278862|3M HCBG Clinical Operations|Rolf Halvorson|651-733-3384|rhhalvorson@mmm.com|
22382425|NCT04520165|CHU-Uliege|Dr Florence Schleich|003243667881|fschleich@chuliege.be|
22382426|NCT02952261|Shanghai Pulmonary Hospital affiliated to Tongji university|Dr. Chang Chen|+86 13816869003|chenthoracic@163.com|
22382427|NCT05233085|AstraZeneca Clinical study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
22382428|NCT05147233|OCULIS Operations SàrI|Sharon Klier, M.D., M.S., M.P.H, Chief Development Officer|+41 21 711 3970|info@oculis.com|
22382429|NCT04513522|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22382430|NCT04517864|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22382431|NCT04541303|Univ of Mo|Brianna Castillo MD|813-765-1619|briannacastillo.md@gmail.com|
22382432|NCT04722003|Emory University Vaccine and Treatment Evaluation Unit (VTEU)|Varun K. Phadke, MD|404-712-9046|varun.phadke@emory.edu|
22382433|NCT03351075|KU Leuven|Prof. An De Groef|+32 16 342 171|an.degroef@kuleuven.be|
22382434|NCT01613118|Travere Therapeutics, Inc.|Jula Inrig, MD|1-445-529-6312|Jula.Inrig@travere.com|
22382435|NCT05219253|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22382436|NCT03086369|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22382437|NCT03544515|Columbia University College of Dental Medicine|Philip Y. Kang, DDS|212-342-5244|pyk2104@cumc.columbia.edu|
22382438|NCT03169244|University of North Carolina at Chapel Hill|James C. Garbutt, MD|919-445-0205|jc_garbutt@med.unc.edu|
22382439|NCT00178399|University of Rochester|Michael Milano|585-273-4096|michael_milano@urmc.rochester.edu|
22382440|NCT02631148|Brigham and Women's Hosptial|Dr. Ciaran McMullan|617 732 5500|mcmullcj@gmail.com|
22382441|NCT03686813|Duke University|Richard Moon, M.D.|919-684-8762|richard.moon@duke.edu|
22382442|NCT00357396|Memorial Sloan Kettering Cancer Center|Dr. Susan Prockop|212-639-6715|prockops@mskcc.org|
22382443|NCT04035668|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22382444|NCT02385669|University of Virginia|Craig L. Slingluff, Jr. MD|434-924-9311|cls8h@virginia.edu|
22382445|NCT00004124|SWOG Statistics and Data Management Center|Catherine Tangen, Genitourinary Committee Statistician|(206) 667-4623|ctangen@fredhutch.org|
22382446|NCT02630719|Truman Medical Center|Sean Gratton MD|816-404-5275|sean.gratton@tmemed.org|
22382447|NCT03426228|Fakih IVF|Dr. Ayla Coussa|+971501403866|A.coussa@warwick.ac.uk|
22382448|NCT04218110|Eurofins EVIC|Commercial Manager|+40 213357090|luciachirita@eurofins.com|
22382449|NCT00114244|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22382450|NCT02200523|Cleveland Medical Devices|Sarah Weimer|216-791-6720|sweimer@clevemed.com|
22382451|NCT04763044|Procter & Gamble|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
22382452|NCT01376089|GE Healthcare|Lauren Lim, PharmD|1-626-356-1937|lauren.lim@ge.com|
22382453|NCT03262935|Byondis B.V.|Clinical Development|0031246795101|clinicaltrials@byondis.com|
22382454|NCT03557008|Emory University|Nadine Rouphael, MD|404-712-1435|nroupha@emory.edu|
22428100|NCT04773028|Kartal Kosuyolu Hihg Speciality Training and Research Hospital|Dr.Ahmet Zengin|+905365022173|dr.zenginahmet@gmail.com|
22428101|NCT01035138|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22442775|NCT03005873|Taiwan Liposome Company|Dr. Carl Brown|886-2-2655-7377|tlc_clinicaltrials@tlcbio.com|
22382455|NCT02224924|Memorial Sloan Kettering Cancer Center|Dr. Amgad Moussa MD|212-639-3690|moussaa@mskcc.org|
22382456|NCT00701896|Ohio State University|Dr. Philip Diaz|6142934925|diaz.3@osu.edu|
22382457|NCT01458210|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22382458|NCT03020745|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22382459|NCT01867216|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22382460|NCT00186186|Stanford University|Dr. Terence Ketter, Chief Bipolar Disorder Clinic|650-723-2515|tketter@stanford.edu|
22382461|NCT02513238|Rigshospitalet|Principal Investigator, Mesrix|26276374|c.gronhoj@gmail.com|
22382462|NCT03622580|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22382463|NCT00354640|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|4432876489|vstearn1@jhmi.edu|
22382464|NCT01169311|Covidien|Tam LaFleur|203-821-4744|tam.lafleur@covidien.com|
22382465|NCT00590707|Johns Hopkins|frederick Sieber|410-550-0942|fsieber1@jhmi.edu|
22382466|NCT00943735|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22382467|NCT03959241|The Emmes Company, LLC|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
22382468|NCT00545844|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22382469|NCT01329328|University of Verona|Prof. Carlo Zancanaro|+390458027155|carlo.zancanaro@univr.it|
22382470|NCT02242773|University of Miami|Sanoj Punnen, MD|+1 (305) 2436596|s.punnen@med.miami.edu|
22382471|NCT04439799|University of Miami, Miller School of Medicine - Desai Sethi Urology Institute|Ranjith Ramasamy, MD|305-243-6596|Ramasamy@miami.edu|
22382472|NCT00371566|GlaxoSmithKline|GSK Response Center|866-435-7343||
22382473|NCT05565391|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22382474|NCT00530842|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22382475|NCT00082810|Montefiore Medical Center - New York|NYCC Regulatory Coordinator|718-379-6862|sforde@montefiore.org|
22382476|NCT00177216|University of Pittsburgh|Jean Miewald|412-246-6406|miewaldjm@upmc.edu|
22382477|NCT03399370|The Medicines Company|Vice-President, Regulatory Operations|973-985-0597|frank.bosley@novartis.com|
22382478|NCT05819190|Pharmndev Experts|Dr Bernard Gout Organization|+41798659000|Email:bgout@pharmndev.ch|
22382479|NCT03468920|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
22382480|NCT02685488|University of Arizona|Dr. John J.B. Allen|(520) 621-7448|john.jb.allen@arizona.edu|
22382481|NCT04436120|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22382482|NCT01769391|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22382483|NCT00667745|Bipolar Clinic and Research Program at|Dr. Andrew Nierenberg, Director of the Bipolar Trials Network|617-724-0837|ANIERENBERG@PARTNERS.ORG|
22382484|NCT02351180|Washington University in St. Louis|Ramsey Hachem, MD|3144548766|rhachem@wustl.edu|
22382485|NCT00208767|Emory University School of Medicine|Dr. Arshed Quyyumi|404-727-3655|aquyyum@emory.edu|
22382486|NCT02317016|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
22382487|NCT03545984|Cleveland Clinic|Dr. Maged Argalious|+12164452064|ARGALIM@ccf.org|
22382488|NCT03418324|Cedars-Sinai Medical Center|Edwin Posadas, MD|310-423-7600|Edwin.Posadas@cshs.org|
22382489|NCT01768676|Vivus|Wesley D Day, PhD|650-934-5200||
22382490|NCT00605033|Schering-Plough|Head, Clinical Trials Registry & Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com|
22382491|NCT03121950|The Ohio State University|Deb Kegelmeyer|614-293-0214|kegelmeyer.1@osu.edu|
22382492|NCT02023125|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22382493|NCT03175172|Aduro Biotech, Inc.|Medical Affairs|510.809.2452|MedicalAffairs@aduro.com|
22382494|NCT01124188|UPMC Late Life Depression|Jordan F. Karp, MD|412-246-6048|karpjf@upmc.edu|
22382495|NCT00028769|SWOG Statistical Center|Study Statistician|206-667-4623||
22382496|NCT01645098|Nationwide Children's Hospital|Marco Corridore, MD|614-722-4200|Marco.Corridore@nationwidechildrens.org|
22382497|NCT02496702|Technical University of Denmark, Center for Playware|Jari Due Jessen|+45 45 25 39 29|jdje@elektro.dtu.dk|
22382498|NCT02860286|Epizyme|Kemly Calixte|617-500-0608|kcalixte@epizyme.com|
22382499|NCT02698891|Dana-Farber Cancer Institute|Dr. Nancy Lin|617-632-3800|nlin@partners.org|
22428102|NCT03513952|Fred Hutchinson Cancer Center|Cancer Immunotherapy Trials Network Trial Manager|514-718-2858|citn@fredhutch.org|
22382500|NCT00516386|Massachusetts General Hospital|Madhu Misra, MD|617-724-5602|mmisra@partners.org|
22428103|NCT01101178|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
22428104|NCT01850641|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
22428105|NCT00141817|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22428106|NCT00127803|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22428107|NCT01643213|Boston Scientific|Clinical Research Information|855-213-9890|BSNClinicalTrials@bsci.com|
22428108|NCT02072200|Mundipharma Korea Ltd|Kim Bu Yeon|+82 2 568 5689|BuYeon.Kim@mundipharma.co.kr|
22428109|NCT04739800|NRG Oncology|Christopher Purdy on behalf of Austin Miller, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
22428110|NCT05227677|Nagase Diagnostics Co.,Ltd.|Takuji Kohzuma|09080045463|takuji.kohzuma@nagase.co.jp|
22428111|NCT03573297|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22428112|NCT04084015|Massachusetts General Hospital|Dr. David D'Alessandro|617-726-8841|DADALESSANDRO@MGH.HARVARD.EDU|
22382501|NCT00002842|City of Hope|Jeffrey Longmate, Ph.D.|626-256-4673|jlongmate@coh.org|
22382502|NCT00393848|UAMS|Arny Ferrando|501-526-5711|aferrando@uams.edu|
22382503|NCT04238429|Sun Yat-sen University|Dr. Hongchun Liu|86-13826189071|hongchun_liu@vip.sina.com|
22382504|NCT02694978|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
22382505|NCT03848910|Hearing CRC Melbourne|Professor Robert Cowan|+61 3 9035 5347|r.cowan@unimelb.edu.au|
22382506|NCT03675581|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22382507|NCT02452918|Melinta Therapeutics|Study Director|1-844-633-6568|medinfo@melinta.com|
22382508|NCT00807144|Imperial College Healthcare NHS Trust|Adam McLean|+44 020 8383 5164|adammclean@nhs.net|
22382509|NCT00989937|UCSD|David Feifel||dfeifel@kadimanp.com|
22382510|NCT01713530|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22382511|NCT03939819|Emory University|Dr. Elizabeth Hechenbleikner|404-778-3712|elizabeth.hechenbleikner@emory.edu|
22382512|NCT03987451|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22382513|NCT00949975|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22382514|NCT04347954|Stanford University|Jayakar Nayak, MD, PhD|(650) 723-5281|jnayak@stanford.edu|
22382515|NCT03257813|Laboratorios Sophia|Dr. Ricardo Llamas (clinical safety pharmacologist)|3001 4200|ricardo.llamas@sophia.com.mx|1059
22382516|NCT04246762|R-Pharm|Marina Beloukhova, Scientific advisor|0074959567937|beloukhova@rpharm.ru|2129
22382517|NCT02878330|MedImmune, LLC|M. Pamela Griffin|+1 301-398-4059|information.center@astrazeneca.com|
22382518|NCT03615924|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22382519|NCT01989910|Taipei Veterans General Hospital|Dr. WEN-WEI KU|+886228751997|stephaneku@gmail.com|
22382520|NCT02954848|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22382521|NCT01069341|The University of Medicine and Dentistry of New Jersey|Dr. Neelakshi Bhagat|973-972-2032|bhagatne@umdnj.edu|
22382522|NCT01802632|AstraZeneca|Senior Medical Director, Tagrisso||ClinicalTrialTransparency@astrazeneca.com|
22382523|NCT03299816|Johns Hopkins University School of Medicine|Deidra C. Crews, MD, ScM|410-502-0518|dcrews1@jhmi.edu|
22382524|NCT03368937|University of Virginia|Sue Brown|434-982-0206|sab2f@virginia.edu|
22382525|NCT01184508|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22382526|NCT00790790|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22382527|NCT02969863|MGH|Courtney Balliro, BS RN CDE|617-726-1242|cballiro@partners.org|
22382528|NCT03253913|University of Cincinnati|Nishant Gupta, MD|5135584831|nishant.gupta@uc.edu|
22382529|NCT02194933|Otsuka Data Transparency Organization|Global Clinical Development||DT-inquiry@otsuka.jp|
22382530|NCT02053363|Rady Children's Hospital|Michael P Kelly|858-576-1700|mkelly5@rchsd.org|223750
22382531|NCT00756730|Community Research initiavte|Dr. Daniel Skiest|413 794 5376|Daniel.Skiest@baystatehealth.org|
22382532|NCT00166166|Emory University|Dr. Arshed Quyyumi|404-727-3655|aquyyum@emory.edu|
22382533|NCT05382104|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22382534|NCT00988637|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Dierctor|817-961-5358|ron.gottschalk@galderma.com|
22382535|NCT02336438|Bassett Healthcare Network|Dr. Amy Freeth|607-547-3273|amy.freeth@bassett.org|
22382536|NCT02807493|University of Minnesota|James Gambucci|612-625-7448|gambu001@umn.edu|
22382537|NCT01493778|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22382538|NCT05190419|UNION therapeutics A/S|UNION therapeutics A/S|+4561777435|clinicaltrials@uniontherapeutics.com|
22382539|NCT02020616|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22382540|NCT02124460|Massachusetts General Hospital|Dr. Elsie Taveras|617-726-8555|elsie.taveras@mgh.harard.edu|
22382541|NCT05019729|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
22382542|NCT00392678|Joslin Diabetes Center|Allison B. Goldfine, MD co-investigator|617-309-2643|allison.goldfine@joslin.harvard.edu|
22382543|NCT03008915|Columbia University|Dr. Carrie Pistenmaa|212-342-4162|"cp2346@atcumc.columbia.edu"|
22382544|NCT04318444|Columbia University|Jon T. Giles, MD|212-305-6327|jtg2122@cumc.columbia.edu|
22382545|NCT00712166|Gilead Sciences, Inc.|Mark Bresnik, MD, Director, Clinical Research|(650) 522-5934|mark.bresnik@gilead.com|
22382546|NCT01773122|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22382547|NCT04173962|Icahn School of Medicine at Mount Sinai|Dr. James Murrough|212-585-4640|james.murrough@mssm.edu|
22382548|NCT02289560|Insightec|Nadir Alikacem, SVP Global Regulated Clinical Affairs|214-630-9900|nadira@insightec.com|
22382549|NCT02540213|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22382550|NCT01264718|Medica Research Institute|Dr. Glenn Flores, Distinguished Chair of Health Policy Research|952-992-3367|Glenn.Flores@medica.com|
22382551|NCT02908464|Beth Israel Deaconess Medical Center|Brian O'Gara, MD, MPH|617-754-3189|bpogara@bidmc.harvard.edu|
22382552|NCT01673113|Massachusetts General Hospital|Dr. Lilit Garibyan|617-726-6168|lgaribyan@partners.org|
22382553|NCT01975467|Sonoma Orthopedics|Rick Epstein|8479872516|repstein@sonomaorthopedics.com|
22382554|NCT00536380|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22382555|NCT00387465|SKCCC|John Wrangle, MD|843-792-7789|wrangle@musc.edu|
22382556|NCT00939991|Duke University Medical Center|Katherine Peters, MD, PhD|919-684-3914|katherine.peters@dm.duke.edu|
22382557|NCT02754479|DuPage Medical Group|Kelly Stankiewicz, MD FAAD|(630) 547-5040|kjstanki@gmail.com|
22382558|NCT03183518|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22382559|NCT02132702|Clinic for Spinal Cord Injuries, Rigshospitalet, University of Copenhagen|Carsten Bach Baunsgaard|1111111111|carsten.bach.baunsgaard@regionh.dk|
22382560|NCT01303835|Duke University Medical Center, The Preston Robert Tisch Brain Tumor Center|Katherine B. Peters, MD, PhD|(919) 684-6173|katherine.peters@duke.edu|
22428113|NCT01749956|SCRI Development Innovations|Charles Davis, RAC|615-524-4341|charles.davis2@scri-innovations.com|
22428114|NCT02696798|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22382561|NCT01244828|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22396914|NCT03374189|St. Vincent's Hospital|Dr. Hee Youn Kim|82-31-249-7473|khyoun10589@gmail.com|
22382562|NCT00573833|Memorial Sloan Kettering Cancer Center|Dr. Josh Yoshiya Yamada, Assistant Attending|+1212-639-2950|yamadaj@mskcc.org|
22382563|NCT05052983|Galderma Research & Development|Sponsor|(817) 961-5000|clinical.studies@galderma.com|
22382564|NCT04493242|Direct Biologics, LLC|Dr. Amy Lightner|512-354-7124|alightner@directbiologics.com|
22382565|NCT00849147|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com|
22382566|NCT03215927|University of Pittsburgh|Rohit Aggarwal|4123838123|aggarwalr@upmc.edu|
22382567|NCT03779048|University of Pennsylvania|Dr. Jena Tronieri|2157465045|jena.tronieri@pennmedicine.upenn.edu|
22382568|NCT02694835|Alcon, A Novartis Division|Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22382569|NCT00446550|Patient Advocacy|Amicus Therapeutics|+1-609-662-2000|Clinicaltrials@amicusrx.com|
22382570|NCT02983617|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22382571|NCT02027558|VA Greater Los Angeles Healthcare System|Cathy Alessi, MD|818-891-7711|Cathy.Alessi@va.gov|39311
22382572|NCT02567656|Rhizen Pharmaceuticals S.A.|Prajak Barde MD|+41 32 580 0113|pjb@rhizen.com|
22382573|NCT00203216|Thomas Jefferson University/Jefferson Headache Center|Dr. William Young, Principal Investigator|215-955-2243|William.B.Young@Jefferson.Edu|
22382574|NCT01616654|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
22382575|NCT02057692|Mirum|Study Physician|1 650-667-4085|medinfo@mirumpharma.com|
22382576|NCT03923491|Brown University School of Public Health|Dr. Alison Tovar|401-863-7327|alison_tovar@brown.edu|
22382577|NCT00355914|Pain Management Center of Paducah, Paducah, KY|Laxmaiah Manchikanti, MD|2705548373|drlm@thepainmd.com|100
22428115|NCT04880850|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22382578|NCT02633358|China Medical University Hospital, Taichung, Taiwan|Dr. Da-Long Chen, director of cardiac intensive care unit|0952122027|my686chen@gmail.com|
22382579|NCT03823300|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22382580|NCT00831415|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22382581|NCT00486330|Yale University AIDS Program|R. Douglas Bruce|2037374040|robert.bruce@yale.edu|
22382582|NCT01290224|Mayo Clinic|Dr. Charles L. Loprinzi|507-284-2511|cloprinzi@mayo.edu|
22382583|NCT01027286|The Cleveland Clinic|Wael K Barsoum, MD|216-444-7515|barsouw@ccf.org|
22382584|NCT05694065|Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China|Dr. Fenghua Ding|+00 86 21 64370045|ruijindfh@126.com|
22382585|NCT00813904|ZymoGenetics, a Bristol-Myers Squibb company|John Pribble, Vice President, Medical Affairs; Scot Maxon, Scientific Information|(206) 428-2756; (206) 434-3365|John.Pribble@bms.com; Scot.Maxon@bms.com|
22382586|NCT01087762|Cares|UCB|+1887822||9493
22396915|NCT01517893|University of Massachusetts Medical School|John E. Harris, MD, PhD|508-856-1982|john.harris@umassmed.edu|
22396916|NCT00715026|Zimmer|Director, Clinical Affairs|574-371-8019|erin.osborn@zimmer.com|
22396917|NCT04490863|Masimo Corporation|Vikram Ramakanth|949-297-7000|ClinicalResearchDept@masimo.com|
22396918|NCT02184195|AstraZeneca AB|Global Clinical Leader|1-877-240-9479|information.center@astrazeneca.com|
22396919|NCT00589420|Abramson Cancer Center|Ravi Amaravadi|2156622222|ravi.amaravadi@pennmedicine.upenn.edu|
22396920|NCT00841568|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366||
22396921|NCT03002155|University of Washington (affiliation)|Sara Morgan, PhD|651-229-1719|sjmorgan@uw.edu|
22396922|NCT00685880|Mayo Clinic|Dr. Jeffrey S. Brault|507-284-1643|brault.jeffrey@mayo.edu|
22396923|NCT02662036|Washington University School of Medicine|Terence Myckatyn, M.D.|314-996-8800|myckatyn@wustl.edu|
22396924|NCT01412554|Oslo University Hospital Ullevål, Norway|MD PhD Tonje Amb Aksnes|+22119101|tonjeaksnes@hotmail.com|47
22396925|NCT01131520|Friends Research Institute|Robert Schwartz|410-837-3977|rschwartz@friendsresearch.org|
22396926|NCT04118270|University of Massachusetts Medical School|Alok Kapoor|917-856-4538|alok.kapoor@umassmed.edu|
22396927|NCT03302975|Univeristy of British Columbia|Chris Napier|604-721-1310|chris.napier@ubc.ca|
22396928|NCT03834519|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|Clinicaltrialsdisclosure@msd.com|
22396929|NCT04490018|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22428116|NCT04091451|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22428117|NCT03907488|SWOG|Hongli Li|206-667-6077|hongli@fredhutch.org|
22428118|NCT03456245|Harvard TH Chan School of Public Health|Dr. David Bloom|6174320650|dbloom@hsph.harvard.edu|
22428119|NCT03074500|Marmara University School of Medicine|Gulseren Derya Akyuz|+90 216 657 06 06|girayesra@hotmail.com|1628
22428120|NCT03321721|St. Louis University School of Medicine|Dr. Trevor L. Tredway|314-577-5630|trevor.tredway@health.slu.edu|
22428121|NCT06023563|Indiana University|Dr. Georgia Frey, Faculty, Department of Kinesiology|(812) 855-1262|gfrey@iu.edu|
22428122|NCT00634504|BTG International Inc.|SVP, Clinical Development|610-278-1660|angela.ogden@btgplc.com|
22428123|NCT00937950|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22428124|NCT02210195|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu|
22428125|NCT01928849|Duke University Department of Anesthesiology|Thomas Buchheit, MD Division Chief, Pain Medicine|9196811924|Thomas.Buchheit@duke.edu|
22428126|NCT03483103|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|855-907-3286|Clinical.Trials@bms.com|
22428127|NCT02475213|MacroGenics, Inc.|Chief Medical Officer|301-251-5172|info@macrogenics.com|
22428128|NCT00505921|UT MD Anderson Cancer Center|Issa F. Khouri, MD / Associate Professor|713-792-8848|pmcadams@mdanderson.org|
22396930|NCT01839396|Boston Scientific|Roshini Jain, Director of Clinical Sciences|6619494355|roshini.jain@bsci.com|
22428129|NCT00630292|University of North Carolina|William Irvin, Jr. MD / Co-Principal Investigator|919-966-6735|william_irvin@med.unc.edu|
22382587|NCT02311972|Duke University|Dr. Robin B. Dail|919-684-3786|robin.dail@duke.edu|
22396931|NCT00450242|University of North Carolina, Dept. of Obstetrics and Gynecology|Denniz Zolnoun, MD, MPH|919-966-7764|denniz_zolnoun@med.unc.edu|
22382588|NCT01405924|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22382589|NCT02393716|Medtronic|Kristel Wittebols Sr. Clinical Research Director|31 (0)43-3566566|kristel.wittebols@medtronic.com|
22382590|NCT01924767|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22382591|NCT01648140|GlaxoSmithKline|GSK Response Center|866-435-7343||
22382592|NCT01565928|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22382593|NCT05340244|GE Healthcare|Tracy Grzendzielewski|414-218-6167|tracy.grzendzielewski@ge.com|
22382594|NCT03264248|University of Pittsburgh|Dr. Jonathan Pearlman|412-822-3685|jlp46@pitt.edu|
22382595|NCT03621761|University of Michigan|Tiffany Braley|734-232-1147|tbraley@med.umich.edu|
22382596|NCT00470106|VA Greater Los Angeles|Michael F. Green, PhD|(310)2693376|michael.green6@va.gov|
22382597|NCT01191788|RAND Corporation|Katherine Watkins|(310) 393-0411|kwatkins@rand.org|6509
22382598|NCT02178540|Novartis Pharmaceuticals|Study Director|862-778-8300||
22382599|NCT03673943|RadioMedix Inc|Ebrahim Delpassand|7134999733|edelpassand@radiomedix.com|
22382600|NCT01256034|Chiba University Graduate School of Medicine|Dr. Katsunori Furukawa|+81-43-226-2269|k-furukawa@umin.ac.jp|
22382601|NCT02441036|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
22382602|NCT01183780|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22382603|NCT00001304|National Institute of Child Health and Human Development|WINER, Karen|+1 301 435 6877|winerk@mail.nih.gov|
22382604|NCT00079183|Fred Hutchinson Cancer Research Center|Dr. Paul A. Carpenter|(206) 667-5191|pcarpent@fredhutch.org|
22382605|NCT00762606|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22382606|NCT01505881|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22382607|NCT01147341|michael schiff|Michael schiff|303 773 8429|michael.schiff@me.com|
22382608|NCT01596504|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22382609|NCT02314117|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22382610|NCT02716324|The Children's Hospital of Philadelphia|James Guevara, MD MPH|2155901130|guevara@email.chop.edu|
22382611|NCT00888979|UConn Health|Cheryl Oncken|860-679-3425|oncken@uchc.edu|
22382612|NCT00909363|Weill Cornell Medicine|Dr james B Bussel|917-291-5091|jbussel@med.cornell.edu|
22382613|NCT05641311|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22382614|NCT03280836|Penn State University|Dr. Kathleen Sturgeon|7175314530|kms99@psu.edu|284676
22382615|NCT00922207|HoffmannLa Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22382616|NCT02476890|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22382617|NCT00367991|New York University School of Medicine|Stuart Katz, MD|212-263-3946|stuart.katz@nyumc.org|
22382618|NCT01271452|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22382619|NCT03684265|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22382620|NCT02705586|VA Portland Health Care System|Dr. Amie Hiller|503 721 1091|peterami@ohsu.edu|
22382621|NCT02808338|Philips|Clinical Operations Manager|14125423669|jeremy.powers@philips.com|
22382622|NCT04349150|Massachusetts General Hospital|Daniel C. Chung, MD|6177263544|chung.daniel@mgh.harvard.edu|
22382623|NCT01227707|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22382624|NCT03210402|Medtronic Inc|Mike Bennett, Clinical Study Manger|262-362-1956|mike.s.bennett@medtronic.com|
22382625|NCT00811057|University of Mississippi Medical Center|Dr. Rick Martin|601-815-7035|rmartin@umc.edu|
22382626|NCT00145041|Talon Therapeutics|Chief Medical Officer|650-588-6404|info@talontx.com|
22382627|NCT00430300|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22382628|NCT02205307|Novadaq Technologies|Alicia Wilton|416-949-4992|alicia.wilton@stryker.com|
22382629|NCT02041104|Mlinotest d. d.|Ana Velikonja|0038651321785|anaa.velikonja@gmail.com|
22382630|NCT05328297|Janssen Research & Development|Senior Director Clinical Sciences Neuroscience|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22382631|NCT01286272|Alliance for Clinical Trials in Oncology|Kristie A. Blum, MD|614-293-8858|kristie.blum@osumc.edu|
22382632|NCT02945332|Texas Tech University|Dr. Nikhil Dhurandhar|806 834-6446|nikhil.dhurandhar@ttu.edu|
22382633|NCT03979365|Mayo Clinic|Mark Stegall, M.D.|507-266-4505|stegall.mark@mayo.edu|
22382634|NCT04496960|National Institute of Dental and Craniofacial Research|Dr. Blake Warner|+1 301 500 8063|blake.warner@nih.gov|
22382635|NCT00550394|University of Cincinnati|Melissa DelBello, MD, MS|513-558-2989|delbelmp@uc.edu|
22382636|NCT04668339|Arcturus Therapeutics, Inc.|Arcturus Therapeutics, Inc.|858-900-2660|clinicaltrials@arcturusrx.com|
22382637|NCT02986178|Istari Oncology|Head of Clinical Operations|919-245-7662|info@istarioncology.com|
22382638|NCT03253848|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22382639|NCT06331403|Massachusetts General Hospital|Lucy Finkelstein-Fox, PhD|617-726-6300|lfinkelsteinfox@mgh.harvard.edu|
22382640|NCT05758415|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22382641|NCT03622593|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22382642|NCT01037530|Hull University Teaching Hospitals NHS Trust|Judith Long|01482 311918|judith.long3@nhs.net|
22382643|NCT01393119|Oncternal Therapeutics|Mary Breitmeyer|8582092082|mbreitmeyer@oncternal.com|208
22428130|NCT02411643|Northwestern University|Stephanie Rangel|3125035942|stephanie.rangel@northwestern.edu|
22382644|NCT04860258|CureVac AG|Clinical Trial Information|0049 6976805870|clinicaltrials@curevac.com|
22382645|NCT01266265|United Therapeutics Corporation|Nicole Leedom|919-425-5870|nleedom@unither.com|
22382646|NCT01580293|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22382647|NCT01134562|Amgen, Inc|Study Director|866-572-6436||
22382648|NCT01324453|Minneapolis Heart Institute Foundation|Jane Fox|6128636289|jane.fox@allina.com|
22382649|NCT01499134|Thomas Jefferson University|Danielle Duffy MD|215 955 5050|Danielle.Duffy@jefferson.edu|
22382650|NCT00941655|National Cancer Institute, National Institutes of Health|Dr. Udo Rudloff|301-496-3098|Udo.Rudloff@nih.gov|
22382651|NCT00597038|UCSF Helen Diller Family Comprehensive Cancer Center|Adil Daud, Director, Melanoma Clinical Research|415-353-7392|adaud@medicine.ucsf.edu|
22382652|NCT03245580|Parkview Mirro Research Center|Christina Zelt RN|2602664153|christina.zelt@parkview.com|
22382653|NCT05855655|Brown University|Shufang Sun|401-863-5735|shufang_sun@brown.edu|
22382654|NCT01613716|Cleveland Clinic Foundation|Sunil K. Srivastava, MD|216-636-2286|srivass2@ccf.org|
22382655|NCT01426269|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5130|elizabeth.nieman@galderma.com|
22382656|NCT02550197|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22382657|NCT04580160|Vesper Medical|Joseph C. Griffin, III|4848926340|Jgriffin@vespermedical.com|
22382658|NCT00419094|UCB, Inc.|Study Director|+1 877 822 9493||
22382659|NCT02296424|Novartis Pharmaceuticals|Clinical Disclosure Office|+1 (862) 778-8300|Novartis.email@novartis.com|
22382660|NCT00743444|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22382661|NCT02680457|Instituto de Terapéutica Experimental y Clínica, Universidad de Guadalajara|Dr. Manuel González Ortiz|+52 3310585200|uiec@prodigy.net.mx|34212
22382662|NCT01112670|University of Colorado|Christina Aquilante, Pharm.D.|303-724-6126|christina.aquilante@ucdenver.edu|
22382663|NCT01337635|Medical College of Wisconsin|Yvonne Chiu, MD|414-955-2818|ychiu@mcw.edu|
22382664|NCT03176654|Loma Linda University Health|Everett Lohman, PhD. Professor||elohman@llu.edu|83171
22382665|NCT03287622|University of Michigan|Dr. Terri Voepel-Lewis|734-646-6803|terriv@umich.edu|
22382666|NCT05882812|Medical Pain Consultants|Dr. Ralph Ortiz|607-844-9979|rodoc@cnymail.com|
22382667|NCT00610688|Cincinnati Children's Hospital Medical Center|Dr. Adekunle Dawodu|513-636-1966|Adekunle.Dawodu@cchmc.org|
22382668|NCT01192542|Johnson and Johnson Vision Care|Brian Pall, O.D., M.S. F.A.A.O. Principal Research Optometrist|1 904 443-1290|bpall@its.jnj.com|
22382669|NCT03804918|Imperial College London|Dr Gehan Soosaipillai|+44 20 3312 6666|gsoosaip@ic.ac.uk|7651
22382670|NCT03387319|Emory University|Kimberly R Jacob Arriola, PhD, MPH|404-727-2600|kjacoba@emory.edu|
22382671|NCT03192046|UtexasSouthwestern|Staci Shearin|214-648-6564|staci.shearin@utsouthwestern.edu|
22382672|NCT03557658|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
22382673|NCT01194154|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22382674|NCT00842257|Massachusetts General Hospital|Dr. David Patrick Ryan, Chief, Hem/Onc|617-974-4545|DPRYAN@mgh.harvard.edu|
22382675|NCT01901276|Columbia University Medical Center|Daniel Freedberg, MD, MS|212-305-1021|def2004@cumc.columbia.edu|
22382676|NCT04141917|University of Washington|Dr. Helen Chu|206-685-8702|helenchu@uw.edu|
22382677|NCT03515304|Johns Hopkins University - Baltimore, MD|Dr. Thorsten Leucker|4105020469|tleucke1@jhmi.edu|
22382678|NCT00373269|Temple University|Dr. Nina T. Gentile|215-707-8402|ngentile@temple.edu|
22382679|NCT01269736|Yale University|Professor Marjorie Funk, PhD, RN|(203) 737-2346|marjorie.funk@yale.edu|
22382680|NCT02861937|Krishnadevaraya college of dental sciences|Dr. Rudrakshi C|080-28467083|drrudrakshi@rediffmail.com|
22382681|NCT02045836|GlaxoSmithKline|GSK Response Center|866-435-7343||
22382682|NCT00057837|ECOG Statistical Office|Study Statistician|617-632-3012||
22382683|NCT02000817|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22382684|NCT03383146|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22382685|NCT01317420|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22382686|NCT05686421|Wills Eye Hospital|Joel Schuman, MD FACS|215-928-3197|JSchuman@willseye.org|
22382687|NCT04210180|Rose Research Center|Jed E. Rose, Ph.D.|9193282345|jed.rose@roseresearchcenter.com|
22382688|NCT00367055|GlaxoSmithKline|GSK Response Center|866-435-7343||
22382689|NCT04707313|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22382690|NCT02459899|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22382691|NCT00940992|Solgel|Ofra Levy-Hacham, Ph.D, VP of Quality Assurance|972-8-9313433|ofra.levy-hacham@sol-gel.com|3802
22382692|NCT04663802|University of Pennsylvania|Dr. Meeta Prasad Kerlin (PI)|215-746-0446|prasadm@pennmedicine.upenn.edu|
22382693|NCT03586544|The Ohio State University|Dharini Bhammar|614-866-9467|dharini.bhammar@osumc.edu|
22382694|NCT00539292|The Hospital for Sick Children|Dr Jacob C Langer|416-813-7340|jacob.langer@sickkids.ca|
22382695|NCT02165761|W.L. Gore and Associates, Inc.|Suzy Palmer, CCRP|928-864-3670|supalmer@wlgore.com|
22382696|NCT00176839|University of Minnesota Masonic Cancer Center|Margaret MacMillan, M.D.|612-626-2778|macmi002@umn.edu|
22382697|NCT01063517|AstraZeneca|Anitra Fielding|+44 1625 517178|aztrial_results_posting@astrazeneca.com|
22382698|NCT06269640|National Heart Lung and Blood Institute|Robert Lederman, M.D.|301.402.6769|lederman@nih.gov|
22382699|NCT02974634|University of Pennsylvania|Dr. Robert Krouse|215-615-4573|robert.krouse@pennmedicine.upenn.edu|
22382700|NCT05011396|Vistagen Therapeutics, Inc.|Ester Salman, MPH|650-577-3693|clinicalstudies@vistagen.com|
22382701|NCT01400776|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22382702|NCT01815008|Johns Hopkins School of Medicine|Rehan Qayyum|410-955-7781|rqayyum@jhmi.edu|
22382703|NCT00711958|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|0049 80244760|biopharma.clinicaltrials@sandoz.com|
22382704|NCT01111526|H. Lee Moffitt Cancer Center and Research Institute|Dr. Lia Perez|813-745-3665|lia.perez@moffitt.org|
22382705|NCT04424641|Genmab|Clinical Trial Information|+45 7020 2728|clinicaltrials@genmab.com|
22382706|NCT02015546|Duke University Medical Center|Dr. Ashwin Patkar|919-681-0613|ashwin.patkar@duke.edu|
22382707|NCT01171625|Edwards Lifesciences, LLC|Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Andrey_Nersesov@edwards.com|0225
22382708|NCT03854253|Tyumen Cardiology Research Center, Tomsk National Research Medical Center, Russian Academy of Science, Tomsk, Russia|Dr. Stanislav Sapozhnikov|+79091919191|stas_ss@bk.ru|
22382709|NCT00799396|University of Maryland School of Medicine|Alan R Shuldiner, MD|410-706-1623|ashuldin@medicine.umaryland.edu|
22382710|NCT01113931|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22382711|NCT01307267|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22382712|NCT02568644|Universidade Federal de Minas Gerias|Dr. Antonio Lucio Teixeira||altexr@gmail.com|
22382713|NCT04956575|ModernaTX, Inc|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
22382714|NCT00432458|Mayo Clinic|Dr. Thomas Witzig||witzig@mayo.edu|
22382715|NCT00854906|University of Arkansas for Medical Sciences|Richard Harper|501 526-6000|harperricharda@uams.edu|2616
22382716|NCT05526248|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22382717|NCT05575375|The Miriam Hospital|Emily Gathright|4017938271|emily.gathright@brownhealth.org|
22382718|NCT02425111|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22382719|NCT00585533|Huntsman Cancer Institute/University of Utah|Wallace Akerley, MD|801-585-5986|wallace.akerley@hci.utah.edu|
22382720|NCT01867632|MUHC|Dr. Mirko Gilardino|514.934.1934|Mirko.Gilardino@muhc.mcgill.ca|
22382721|NCT00739141|Memorial Sloan Kettering Cancer Center|Juliet Barker, MBBS|646-608-3756|barkerj@mskcc.org|
22382722|NCT03482011|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22382723|NCT00468052|UMDNJ|Anuradha Patel, MD|973 972-5254|patelan@umdnj.edu|
22382724|NCT02533167|Wake Forest Health Sciences|Ashley Tonidandel, MD|336-718-8278|atonidan@wakehealth.edu|
22382725|NCT04446117|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
22382726|NCT06315907|Pennington Biomedical Research Center|Professor|+1 (225) 763-2585|corby.martin@pbrc.edu|
22382727|NCT05673720|Florida State University|Geraldine Martorella, Hyochol Ahn|850-645-9758|gmartorella@fsu.edu|
22382728|NCT00839540|Michigan State University|Dr. Gary E.Stein, Pharm.D.|517-353-5126|steing@msu.edu|
22382729|NCT00299741|Massachusetts General Hospital|Dr. Dror Michaelson|617-726-1594|dmichaelson1@partners.org|
22382730|NCT02885350|Helsinki University Central hospital/Women's hospital/anaesthesia|Dr Antti Vaananen|358504271850|antti.vaananen@hus.fi|
22382731|NCT00324038|Napp Pharmaceutical Ltd|Dr Paul Schofield, Medical Director|01223424444|info@contact-clinical-trials.com|
22382732|NCT01215695|University Louisville|Rainer Lenhardt, MD|502-228-7517|rainer.lenhardt@louisville.edu|
22382733|NCT01378065|Coloplast Corp|Cathy Bartz|612-834-3127|uscmba@coloplast.com|
22382734|NCT00361283|University of Florida|Reginald F. Frye, PhD, Associate Professor|3522735453|fryerf@ufl.edu|
22382735|NCT01837641|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22382736|NCT02930590|Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergology Charité - Universitätsmedizin Berlin|Dr. Jan Kottner|+49 30 450 518218|jan.kottner@charite.de|
22382737|NCT01123083|GlaxoSmithKline|GSK Response Center|866-435-7343||
22382738|NCT00961636|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22382739|NCT04884737|UCLA School of Nursing|Barbara Bates-Jensen, PhD, RN, FAAN|626-437-8543|batesjen@sonnet.ucla.edu|
22382740|NCT00290706|Northwestern University|Leo Gordon|312-695-4520|l-gordon@northwestern.edu|
22382741|NCT04066738|Oxford University Hospitals NHS Foundation Trust|Prof. Tim Betts|01865 220256|ep.doctors@ouh.nhs.uk|
22382742|NCT01196429|NRG Oncology Statistics and Data Management Center - Buffalo|Linda Gedeon for William Brady PhD|716-845-5702|lgedeon@nrgoncology.org|
22382743|NCT00688519|GlaxoSmithKline|GSK Response Center|866-435-7343||
22382744|NCT03768206|University of South Carolina|Christine Pellegrini|803-777-0911|pellegca@mailbox.sc.edu|
22382745|NCT00329732|Thomas Jefferson University|Kathleen Bradley|215-955-2025|Kathleen.Bradley@jefferson.edu|
22382746|NCT02551055|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22382747|NCT02666742|Kansas City Heart Rhythm Institute|Donita Atkins|913-253-3064|Donita.Atkins@hcahealthcare.com|
22382748|NCT01359371|VA Center for Clinical Management Research Health Services|Sonia A. Duffy, Ph.D., R.N., FAAN|734.395.0613|Sonia.Duffy@va.gov|
22382749|NCT02106442|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22382750|NCT02355158|BDSI|Tim Warneke|919-582-0294|twarneke@bdsi.com|
22382751|NCT03172624|Memorial Sloan Kettering Cancer Center|Dr. Alan Ho, MD, PhD|646-888-4235|hoa@mskcc.org|
22382752|NCT00423098|Novartis Pharmaceuticals|Study Director|862-778-8300||
22382753|NCT02284555|Destiny Pharma|Director of Projects|+44 (0)1273 704440|medinfo@destinypharma.com|
22382754|NCT02064959|The University of Texas Health Science Center at Houston|Georgene W. Hergenroeder, Ph.D., Associate Professor|713-500-6230|lisa.h.schmitt@uth.tmc.edu|
22382755|NCT00534937|Allegheny General Hospital|Dr. Satish Muluk|(412) 359-3714|muluk@usa.net|
22382756|NCT02711839|Taipei Medical University|Dr. Sing-Chung Li|886-2-27361661|sinchung@tmu.edu.tw|6560
22382757|NCT03290248|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
22382758|NCT05674136|Masimo Corporation|Ahmed Alghazi|949-297-7000|studies@masimo.com|
22382759|NCT02383472|Boston Children's Hospital|Dr. William Meehan|781-216-1328|William.Meehan@childrens.harvard.edu|
22382760|NCT02013830|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22428131|NCT00717886|Memorial Sloan Kettering Cancer Center|Dr. Leslie Montgomery|(212) 639-5386|Montgoml@mskcc.org|
22428132|NCT01369433|AVEO Pharmaceuticals, Inc.|Chief Medical Officer|857-400-0101|Clinical@aveooncology.com|
22382761|NCT06119113|Başakşehir Çam Ve Sakura Şehir Hastanesi|Dr.Ayşenur Çalış Özbayram|+905549707052|draysenurcalis@gmail.com|
22382762|NCT00114101|Roswell Park Cancer Institute|Philip McCarthy, MD||philip.mccarthy@roswellpark.org|
22382763|NCT00326924|Ottawa Hospital Research Institute|Dean Fergusson, Senior Scientist|613-737-8480|dafergusson@ohri.ca|
22428133|NCT01553851|Washington University School of Medicine|Dr. Douglas Atkins|314-747-8475|datkins@dom.wustl.edu|
22382764|NCT01786564|Northwestern University|Kristen Knutson|312-503-1526|kristen.knutson@northwestern.edu|
22382765|NCT03034915|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22428134|NCT00797563|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
22428135|NCT00149643|University of Pittsburgh|Jack R. Cornelius, M.D.|412-246-6906|corneliusjr@upmc.edu|
22428136|NCT02196831|Massachusetts General Hospital|Steven Grinspoon, MD|617-724-9109|sgrinspoon@mgh.harvard.edu|
22428137|NCT01654887|Icahn School of Medicine at Mount Sinai|Dr. James Tsung|212-241-6272|james.tsung@mountsinai.org|
22428138|NCT02313155|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22428139|NCT00475332|University of Florida|Bridget Fitzgerald, Clinical trials coordinator|(352) 265-0680|fitzgb@shands.ufl.edu|87829
22428140|NCT01545336|University of Pennsylvania|Dr. Steven M. Kawut|215-573-0258|kawut@upenn.edu|
22428141|NCT03822416|University of Minnesota|Harry Lando, PhD|612-624-1877|lando001@umn.edu|
22428142|NCT04666298|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22428143|NCT00844519|University of California San Francisco|Dr. Priscilla Hsue|415-206-8257|phsue@medsfgh.ucsf.edu|
22428144|NCT01303419|GE Healthcare|Jean-Paul Antonini|+33 130709703|Jean-Paul.antonini@ge.com|
22428145|NCT06438601|CooperVision, Inc.|Jose A. Vega, OD, MSc, PhD|925-621-3761|javega@coopervision.com|
22382766|NCT02138006|Karolinska Institutet Södersjukhuset|Thomas Nyström|+46704325214|thomas.nystrom@sodersjukhuset.se|
22382767|NCT01188499|TetraLogic Pharmaceuticals|Vice President, Clinical Research|610-889-9900|Jeffrey.Skolnik@tetralogicpharma.com|141
22382768|NCT00424762|University of Texas Southwestern Medical Center at Dallas|Dr. Darren K. McGuire|214 645 7520|darren.mcguire@utsouthwestern.edu|
22382769|NCT01122901|Adult Brain Tumor Consortium|David Peereboom, MD|410-955-8837|jfisher@jhmi.edu|
22382770|NCT01733238|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22382771|NCT02203630|Vanderbilt University Medical Center|Raj Keriwala|615-322-3412||
22382772|NCT02570295|Swiss Federal Institute of Sport Magglingen SFISM|Dr. Thomas Wyss|+41 58 467 64 16|thomas.wyss@baspo.admin.ch|
22382773|NCT01135511|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22382774|NCT03608839|State University of Campinas (UNICAMP)|Dr Rodrigo Pessoa Cavalcanti Lira|551935217396|alayf@hotmail.com|7396
22382775|NCT03920215|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
22382776|NCT01576523|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
22382777|NCT03506880|The Pennsylvania State University|Dr. Rob Turrisi|814-865-7808|rturrisi@psu.edu|
22382778|NCT02547922|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22382779|NCT02709655|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
22382780|NCT00102063|Otsuka Pharmaceutical Development & Commercialization, Inc.|Margaretta Nyilas|609-452-5673|Margaretta.nyilas@otsuka-us.com|
22382781|NCT00857649|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
22382782|NCT03687892|Stanford University|Principal Investigator|650-736-2233|nbassano@stanford.edu|
22382783|NCT02739035|Mayo Clinic|Gabriel Schouten - Clinical Research Coordinator|5072665895|schouten.gabriel@mayo.edu|
22382784|NCT01591733|Massachusetts General Hospital|Dr. Theodore Hong|617-726-6050|TSHONG1@mgh.harvard.edu|
22382785|NCT00833365|University of Utah|Dr. Gary Chan|801-587-7508|gary.chan@hsc.utah.edu|
22382786|NCT03165175|Naval Health Research Center|Suzanne Hurtado|619-553-7806|suzanne.l.hurtado.civ@mail.mil|
22382787|NCT04470193|University of Utah|Flory Nkoy, MD, MS, MPH|801-662-3660|flory.nkoy@hsc.utah.edu|
22382788|NCT02517307|Oregon Health & Science University|Melanie Gillingham, PhD|503-494-1682|gillingm@ohsu.edu|
22382789|NCT00843882|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22382790|NCT02248480|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22382791|NCT00630786|Amgen Inc.|Study Director|866-572-6436||
22382792|NCT02770248|Alcon, A Novartis Division|Field Medical, Ophthalmology|1-888-451-3937|alcon.medinfo@alcon.com|
22382793|NCT01579916|MedImmune, LLC|Raburn Mallory, MD/Senior Director Clinical Development|301-398-0000|malloryr@medimmune.com|
22382794|NCT03264456|University of Alabama at Birmingham|Samuel Galgano|2059341388|samuelgalgano@uabmc.edu|
22382795|NCT01597128|University of Kentucky Medical Center|J. Scott Roth, M.D.|859-323-6346|arockich@uky.edu|246
22382796|NCT06001177|Kanyos Bio, Inc.|Study Director|+1-857-320-6607|clinicaltrials@anokion.com|
22382797|NCT03593876|University of Pittsburgh|Dr. Elizabeth Skidmore|(412) 383-6617|skidmore@pitt.edu|
22382798|NCT05309668|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22382799|NCT02696707|Ottawa Hospital Research Institute|Dr. John Hilton|613-737-7700|jfhilton@toh.ca|70170
22382800|NCT00071799|Celgene Corporation|CL Beach||CLBeach@celgene.com|
22382801|NCT00814346|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22382802|NCT05136443|Cornea Research Foundation of America|Marianne Price|317-814-2990|mprice@cornea.org|
22382803|NCT05764161|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22382804|NCT01241435|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22428146|NCT03329001|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22428147|NCT02178956|Sumitomo Dainippon Pharma Oncology|Marilyn Fontaine|617-674-8556|mfontaine@bostonbiomedical.com|
22428148|NCT00622518|University of Washington|James A. Taylor, MD|206-616-1206|uncjat@u.washington.edu|
22382805|NCT02221219|University of Kentucky|Research Protocol Manager/Clinical/UKHC|(859) 257-1000|hong.huang@uky.edu|
22382806|NCT00507689|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22428149|NCT03769493|Brown University|Ethan Moitra, Ph.D.|4014441949|ethan_moitra@brown.edu|
22382807|NCT01241292|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22428150|NCT02709369|Wake Forest School of Medicine|Dr. Charles H. Tegeler|+1 (336) 716-7651|ctegeler@wakehealth.edu|
22382808|NCT03861767|UPMC|Matthew D. Neal, MD FACS|412-647-1158|nealm2@upmc.edu|
22382809|NCT01145885|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22382810|NCT05299606|ETHICON|Erin Meyers|937-681-0322|eprifog1@its.jnj.com|
22382811|NCT00596167|Indiana University School of Medicine|Brian Decker MD, PharmD|317-278-2868|bsdecker@iupui.edu|
22382812|NCT03460756|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
22382813|NCT04333758|Tan Tock Seng Hospital Pte Ltd|Ms Lim Chien Joo|9035249|Chien_Joo_LIM@ttsh.com.sg|
22382814|NCT00723450|GlaxoSmithKline|GSK Response Center|866-435-7343||
22382815|NCT00117286|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
22382816|NCT00189202|University of Michigan|Dr. Akinlolu Ojo, Professor of Medicine|734 9364890|aojo@umich.edu|
22382817|NCT02326649|UCSD|Christopher Davis|8589665855|cdavis@rchsd.org|5668
22382818|NCT02311907|Mayo Clinic|Charles L. Loprinzi M.D.|507/284-1623|cloprinzi@mayo.edu|
22382819|NCT02950558|University of Cincinnati|Jun-Ming Zhang, MD, MSc|5135582427|jun-ming.zhang@uc.edu|
22382820|NCT00717626|The Hospital for Sick Children|Dr. Brian Feldman|416-813-5828|brian.feldman@sickkids.ca|
22382821|NCT02806869|University of Michigan|Dr. Duxin Sun|734-615-8740|duxins@med.umich.edu|
22382822|NCT04001517|EIP Pharma|Dr. John Alam|6176698426|johnjalam@gmail.com|
22382823|NCT02537522|Johnson & Johnson Vision Care Inc.|Andrea Le, OD -Manager Global Medical Affairs|904 4431866|ale3@ITS.JNJ.com|
22382824|NCT01794936|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu|
22382825|NCT03024606|Saint Louis University|Research Nurse|314-977-2090|jathompson@slu.edu|
22382826|NCT01595061|NRG Oncology|Linda Gedeon for Wei Deng|716-845-1169|linda.gedeon@roswellpark.org|
22382827|NCT00356265|University of Michigan|Crystal Gadegbeku||crystal.Gadebeku@tuhs.temple.edu|
22382828|NCT02498769|Duke University Health System|Dr. Joseph P Mathew Professor of Anesthesiology and Chairman Department of Anesthesiology|919-681-6646|joseph.mathew@duke.edu|
22382829|NCT01582269|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22382830|NCT03360396|Boston Scientific Corporation|Jessica Stockwell|612-618-1136|Jessie.Stockwell@bsci.com|
22382831|NCT02486588|Kaiser Permanente Northern California Division of Research|Anjali Gopalan|510-891-3458|Anjali.Gopalan@kp.org|
22382832|NCT00546871|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22382833|NCT01713946|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
22382834|NCT05959655|Bright Uro|Brittany Carter|9492025689|brittany@brighturo.com|
22382835|NCT04036058|Wm. S. Middleton Memorial VA Hospital|Linda McKinley|608-256-1901|linda.mckinley2@va.gov|
22382836|NCT02098343|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
22382837|NCT05515562|Wake Forest University Health Sciences|John Williamson, PharmD|336.713.3431|johnwill@wakehealth.edu|
22382838|NCT02188420|University of Minnesota|Kate Frost|612-626-0637||
22382839|NCT05644444|Reckitt Benckiser Health Limited|Clinical Study Manager|+44 (0)1482 326151|ClinicalRequests@reckitt.com|
22382840|NCT03215095|Memorial Sloan Kettering Cancer Center|Dr. Alan Ho, MD, PhD|646-608-3774|hoa@mskcc.org|
22382841|NCT03941912|Regulatory Insight, Inc.|Elvira Cawthon|6154475150|elvira@reginsight.com|
22382842|NCT03145480|Northwell Health|Jacqueline Barrientos, MD|516-470-4050|jbarrientos@northwell.edu|
22382843|NCT00346333|Harvard Medical School|Eliot L. Berson, M.D.|617-573-3600|marilyn_sullivan@meei.harvard.edu|
22382844|NCT03466788|Centre François Baclesse|Jean-Michel Grellard|0231455002|jm.grellard@baclesse.unicancer.fr|
22382845|NCT02798835|Department of Anesthesia and Perioperative Care, Vancouver General Hospital, Vancouver, BC, Canada.|Dr. Steven Lee|6048754111|steven.lee2@vch.ca|61534
22382846|NCT03320434|Ora, Inc|Caitlin Pearson|978-685-8900|cpearson@oraclinical.com|
22382847|NCT01996917|Columbia University|Christine Rohde, MD|212-342-3707|chr2111@cumc.columbia.edu|
22382848|NCT03189589|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22382849|NCT03194958|Washington University in St. Louis|Matthew Kreuter|314-935-3701|mkreuter@wustl.edu|
22382850|NCT01118338|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
22382851|NCT05019144|Medical University of South Carolina|Dr. Aaron P. Lesher|843-408-6782|leshera@musc.edu|
22382852|NCT05241691|Orthofix srl|Clinical Program Manager|0456719000|danielacangiano@orthofix.it|
22382853|NCT00588770|ECOG-ACRIN Cancer Reserch Group Statistical Office|Study statistician|6176323012|eatrials@jimmy.harvard.edu|
22382854|NCT04697628|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22382855|NCT03388632|National Cancer Institute|Dr. Jiran Ahmed|240-781-4042|jibran.ahmed@nih.gov|
22382856|NCT04177394|Abbott|Melody Dong|4086434617|melody.dong@abbott.com|
22382857|NCT02115282|ECOG-ACRIN Cancer Research Group|Study Statistician|6176323012|eatrials@jimmy.harvard.edu|
22382858|NCT00256243|Chao Family Comprehensive Cancer Center|Dr. Rita Mehta|(714) 456-5153|rsmehta@uci.edu|
22382859|NCT05455476|VA Center of Excellence for Suicide Prevention|Lisham Ashrafioun|585-430-2026|Lisham.ashrafioun@va.gov|
22382860|NCT06218251|ABBVIE CALL CENTER|AbbVie|844-663-3742|abbvieclinicaltrials@abbvie.com|
22382861|NCT00147277|Medtronic Italia S.p.A.|Laura Manotta|003902241371|laura.manotta@medtronic.com|
22382862|NCT00997386|University of Arizona Cancer Center|Program Coordinator|52-626-0301|aselegue@email.arizona.edu|
22382863|NCT03617263|Zydus Therapeutics Inc.|Dr Deven Parmar|7324050886|dparmar@zydustherapeutics.com|
22382864|NCT02763124|Gainesville Eye Associates|Clayton Blehm, MD|7705324444|claytonblehm@gmail.com|
22382865|NCT00762619|Colgate Palmolive Co.|William De Vizio|732-878-7901|William_Devizio@colpal.com|
22382866|NCT03492177|Actelion Pharmaceuticals Ltd|Clinical Scientist|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22382867|NCT00617201|University of Kentucky|Dr. Sharon Walsh|859-257-2684|sharon.walsh@uky.edu|
22382868|NCT05555082|University of Linkoping, Department of Health, Medicine and Care|Peter Johansson|460700896548|peter.b.johansson@liu.se|
22396932|NCT01181076|Oslo University Hospital|Kristin Skaarud|4723070000|kskaarud@ous-hf.no|
22396933|NCT01392677|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
22396934|NCT03996876|University of California, San Francisco|Aoife O'Donovan, Associate Professor of Psychiatry|4152214810|aoife.odonovan@ucsf.edu|x24959
22396935|NCT00121108|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22396936|NCT01380379|Stanford University|Dr. Jennifer Keller|650-724-0070|jkeller@stanford.edu|
22396937|NCT02324075|Stanford University|Prof. Stephen P. Luby, MD|+1-650-723-4129|sluby@stanford.edu|
22396938|NCT06608368|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
22396939|NCT03977974|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22396940|NCT03080883|Mayo Clinic|Dr. Robert McBane|(507)266-3964|mcbane.robert@mayo.edu|
22396941|NCT00388973|AstraZeneca|Medical Science Director, Seroquel||AZTrial_Results_Posting@astrazeneca.com|
22396942|NCT01258504|University of Heidelberg|Prof. Dr. med. Gerd Mikus|4962215639197|gerd.mikus@med.uni-heidelberg.de|
22396943|NCT02530528|MicroBioTest|Dr. MH Bashir|7039250100|muhammad.bashir@microbac.com|
22396944|NCT02701868|Pennington Biomedical Research Center|Abby Altazan|2257632801|Abby.Altazan@pbrc.edu|
22396945|NCT00586261|Mayo Clinic|Dr. Patricia Best|507-284-4441|best.patricia@mayo.edu|
22396946|NCT00666458|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22396947|NCT01999465|University of Michigan|Dr. Lynda Yang|7349365017|bpclinic@umich.edu|
22396948|NCT02325219|Janssen Pharmaceutical K.K., Japan|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22396949|NCT03289650|Northwestern University|Lorenzo Gallon|312 695 4457|l-gallon@northwestern.edu|
22396950|NCT00880399|GlaxoSmithKline|GSK Response Center|866-435-7343||
22396951|NCT02181816|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22396952|NCT00909181|Antares Pharma|Kaushik Dave|609 359 3020|kdave@antarespharma.com|
22396953|NCT02830880|Emory University|David Schuster, MD|(404) 712-4859|dschust@emory.edu|
22396954|NCT02349048|Janssen R&D BE|Associate Director, Medical Department||ClinicalTrialDisclosure@its.jnj.com|
22396955|NCT02219282|DorkuzEU|Semih Kucukguclu|902324125707|semih.kucukguclu@gmail.com|
22396956|NCT00871845|Allegheny Singer Research Institute|Hossam Kandil||Hossam.KANDIL@ahn.org|
22396957|NCT04172714|Emory University|Nima Kokabi, MD|(404) 778-4747|nima.kokabi@emory.edu|
22396958|NCT00530894|Edwards Lifesciences|Tenley Koepnick|949-250-6504|tenley_koepnick@edwards.com|
22396959|NCT02969187|Cleveland Clinic|Dr. Philip R. Schauer|216-444-4794|schauep@ccf.org|
22396960|NCT03923426|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrialsgov_Inquiries@Pfizer.com|
22396961|NCT01761084|University of Waterloo|Dr. Lora Giangregorio|5198884567|lmgiangr@uwaterloo.ca|36357
22396962|NCT01261507|Georgetown University Medical Center|Matthew T. Freedman, MD|4105429680|freedmmt@georgetown.edu|
22396963|NCT02860676|University of California, San Diego|Michael Choi, MD|858-534-1765|mychoi@ucsd.edu|
22396964|NCT02700412|University of Alabama at Birmingham|Dr. Jerzy Szaflarski, MD, PhD|205-934-3866|jszaflarski@uabmc.edu|
22396965|NCT02310776|Northwestern Medicine|Ellen B. Mendelson, MD, FACR, Lee F. Rogers Professor of Medical Education in Radiology, Profess|3124720436|emendels@nm.org|
22396966|NCT04416555|Cleveland Clinic|Dr. Sabry Ayad|216.476.7052|Saayad@ccf.org|
22396967|NCT03462576|Exalenz Bioscience|Avrahm Hershkowitz/ Clinical Trial Manager|972-8-9737513|avrahamh@exalenz.com|
22396968|NCT03201458|Johns Hopkins University|Grants Administrative Manager|4439273568|JHCCCRO@jhmi.edu|
22396969|NCT01496131|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22396970|NCT00750737|University of Texas (UT) MD Anderson Cancer Center|Issam Raad, MD / Chair, Infectious Diseases|713-792-7943|CR_Study_Registration@mdanderson.org|
22396971|NCT04784182|Auburn University|Drew Frugé|3348448433|adf0003@auburn.edu|
22396972|NCT01441037|National Heart Lung and Blood Institute|Young, Neal|+1 301 496 5093|youngns@mail.nih.gov|
22396973|NCT00711425|DENTSPLY Implants|Manager Global Clinical Operations|+46313763500||
22396974|NCT00916149|VA New York Harbor Healthcare System, NYU|Beth Leeman-Markowski, MD|212-686-7500|beth.leeman-markowski@nyumc.org|
22396975|NCT02997735|Children's Hospital of Philadelphia|Brian Jenssen, MD MSHP|215-554-4390|JenssenB@email.chop.edu|
22396976|NCT00545298|Nitric BioTherapeutics Inc|Frank J. McCaney, CEO Sponsor|215-788-6200|fmccaney@nbtherapeutics.com|
22396977|NCT00978029|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22396978|NCT01087775|San Francisco VA Medical Center|Dr. Karen Seal|4152214810|Karen.Seal@va.gov|24852
22396979|NCT01784770|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22396980|NCT01147744|GlaxoSmithKline|GSK Response Center|866-435-7343||
22396981|NCT01439672|University of Virginia|Sue Brown, MD||sab2f@virginia.edu|
22396982|NCT01342484|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22396983|NCT01744665|Novartis Pharmaceuticals|Study Director|888-669-6682|Novartis.email@novartis.com|
22396984|NCT05998148|Lundquist Institute for Biomedical Innovation|Jonathan Wu|6268227769|wu.jonathan.g@gmail.com|
22396985|NCT03497806|Finch Therapeutics|Dr. Shrish Budree|(857) 322-4646|sbudree@finchtherapeutics.com|646
22396986|NCT02090413|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22396987|NCT03473652|Centre François Baclesse|Alexandra LECONTE|0231455002|a.leconte@baclesse.unicancer.fr|
22396988|NCT05248295|MGH IHP|Lauryn Zipse|6176433245|lzipse@mghihp.edu|
22396989|NCT01293968|Qazvin University of Medical Sciences|Dr.Katayun Borhanmojabi|09127841440|ka.mojabi@yahoo.com|
22396990|NCT01133379|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
22396991|NCT00841204|The University of Arizona|H-H. Sherry Chow, Ph.D.|520-626-3358|schow@azcc.arizona.edu|
22428151|NCT01341470|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22428152|NCT04057235|Integrity Implants Inc|Lauren Kamer, Senior Director of Regulatory and Clinical Affairs|+1.561.529.3861|lkamer@integrityimplants.com|
22428153|NCT01136915|Bracco Diagnostics, Inc.|Maria Luigia Storto, M.D.|609-514-2262|MariaLuigia.Storto@diag.bracco.com|
22382869|NCT05672030|Brigham and Women's Hospital, Allergy and Clinical Immunology|Tanya M. Laidlaw, MD, Associate Professor of Medicine|6177329850|tlaidlaw@partners.org|
22382870|NCT03602911|West Virginia University|Rusha Patel, MD|4052717559|Rusha-Patel@ouhsc.edu|
22382871|NCT03723616|Duke University|Isaac Lipkus Reiner, Ph.D.|919-668-2348|isaac.lipkus@duke.edu|
22382872|NCT03142841|North Florida South Georgia Veterans Health System|Dr. Ivette Magaly Freytes|352-376-1611|ivette.freytes@va.gov|102012
22382873|NCT00493649|US Oncology Research, McKesson Specialty Health|Dr. Stephen E Jones|832-381-7580|steve.jones@usoncology.com|
22382874|NCT02639286|NIDDK|Dr. Rebecca Brown|301-594-0609|rebecca.brown@nih.gov|
22382875|NCT00925899|Bispebjerg Hospital|Lise Pedersen|004535312305|lise.pedersen.01@regionh.dk|
22382876|NCT00683696|Biotronik, Inc.|Kelly Mohr|800-547-0394|kelly.mohr@biotronik.com|
22382877|NCT00227994|Washington University School of Medicine|Eric Lenze|314-362-1671|lenzee@wustl.edu|
22382878|NCT03648762|VA Pittsburgh Healthcare System|Daniel E. Forman, MD|(412) 360-2917|Daniel.Forman@va.gov|
22382879|NCT02135679|University of Pennsylvania|Ching Lai|267-250-9244|ching.lai@pennmedicine.upenn.edu|
22382880|NCT04112069|Mass. General Hospital|Courtney Balliro, BS, RN, CDE|617-726-1242|cballiro@partners.org|
22382881|NCT01662336|AbbVie (prior Sponsor Abbott)|Global Medical Services|800-633-9110||
22382882|NCT02189252|AstraZeneca AB|Hong Yang, Study Statistician|+46-(0)317762397|hong.yang1@astrazeneca.com|
22382883|NCT04396860|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
22382884|NCT02139046|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22382885|NCT00818454|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22382886|NCT03573518|Botanix Pharmaceuticals|Head of Development|+1 445 300 3403|trials@botanixpharma.com|
22382887|NCT03454529|Karmanos Cancer Institute|Michael Simon,MD|313. 576-8727|simonm@karmanos.org|
22382888|NCT00779870|Imperial College London|Prof Fan Chung|00442075947954|f.chung@imperial.ac.uk|
22382889|NCT01402531|UCSD|Department of Surgery|(858) 657-5291||
22382890|NCT01040689|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22382891|NCT04147897|University of Washington|Dror Ben-Zeev, Professor|206-685-9655|dbenzeev@uw.edu|
22382892|NCT06129045|Black Hills State University|Ashley Pfeiffer|6053815370|ashley.pfeiffer@bhsu.edu|
22382893|NCT02031471|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22382894|NCT04970342|National Advanced Driving Simulator, University of Iowa|Timothy Brown, Ph.D.|3193354785|timothy-l-brown@uiowa.edu|
22382895|NCT05797155|Oregon Research Behavioral Intervention Strategies Inc.|Dr. Dana Smith|541-484-2123|danas@ori.org|
22382896|NCT01350804|Novartis|Study Director|862-778-8300||
22382897|NCT00026312|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22382898|NCT02611037|Moffit Cancer Center|Bela Kis, MD, PhD|813-745-8425|Bela.Kis@Moffitt.org|
22382899|NCT05793112|Massachusetts General Hospital|Dr. Qian Yuan|6172435466|QYUAN@mgh.harvard.edu|
22382900|NCT05850520|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22382901|NCT05841680|Florida International University|Jeremy Pettit|3053481671|jpettit@fiu.edu|
22382902|NCT01170026|Department of Psychiatry and Human Behavior, The Alpert Medical School of Brown University|Dr. Anthony Spirito|401-369-2435|anthony_spirito@brown.edu|
22382903|NCT03785782|University of North Carolina at Chapel Hill|Director, Clinical Research, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
22382904|NCT03889925|Andrews Research & Education Foundation|Director of Research|8509168570|jessica.truett@andrewsref.org|
22382905|NCT05777785|VIZO Specs|Yael Richter, PhD|972-54-7384809|yaelr@vizo-o.com|
22382906|NCT04817670|CSL Behring|Study Director|+1 610-878-4000|clinicaltrials@cslbehring.com|
22382907|NCT00304031|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
22382908|NCT04951310|University of Pennsylvania|Dr. Katherine Milkman|215-573-9646|bcfg@wharton.upenn.edu|
22382909|NCT01188655|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22382910|NCT00089544|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
22382911|NCT02396316|Bayer|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22382912|NCT01823536|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22382913|NCT05636332|Philips|Tiffani Bowers|724-989-3072|tiffani.bowers@philips.com|
22382914|NCT00566735|Massachusetts General Hospital|Dr. John Matthews|617-724-0847|jmatthews@partners.org|
22382915|NCT04603924|Robert Homolka|Sr. Vice President Clinical Operations|8572991035|bob.homolka@neurobopharma.com|
22382916|NCT01175317|Maastricht University Medical Center|Kostan Reisinger|0031433881494|k.reisinger@maastrichtuniversity.nl|
22382917|NCT03762668|Alcon Research, LLC|Sr. CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22428154|NCT03282097|Indiana University School of Medicine; Indiana University Center for Aging Research; Regenstrief Institute, Inc.|Nicole R. Fowler, PhD, MHSA; Associate Professor of Medicine|317-274-9021|fowlern@iu.edu|
22428155|NCT01732211|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22428156|NCT03916926|Case Western Reserve University|Suchitra Nelson|216-368-3469|suchitra.nelson@case.edu|
22428157|NCT04291131|VA Boston Healthcare System|Marilyn Moy, MD, MSc|857-203-6622|marilyn.moy@va.gov|
22382918|NCT02164240|DFCI|Suzanne George|617-632-5204|Suzanne_George@dfci.harvard.edu|
22382919|NCT00768664|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22382920|NCT02544152|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22382921|NCT00686855|Dana-Farber Cancer Institute|Nathaniel S. Treister, DMD, DMSc|617-632-2806|ntreister@partners.org|
22382922|NCT01731041|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD-Associate Professor of Medicine Director, Cardiovascular Research|+1-904-244-3005|dominick.angiolillo@jax.ufl.edu|
22382923|NCT02731755|University of Reading|Prof Jeremy Spencer|+44(0) 1183788724|j.p.e.spencer@reading.ac.uk|
22382924|NCT02320123|UT Southwestern Medical Center|Dr. Ramona Rhodes|214-648-9012|ramona.rhodes@utsouthwestern.edu|
22382925|NCT04480827|Galmed Pharmaceuticals|Dr. Yossi Gilgun-Sherki|972.3.693.8448|yossigs@galmedpharma.com|
22382926|NCT00465816|GlaxoSmithKline|GSK Response Center|866-435-7343||
22382927|NCT01292252|University of California, San Francisco|Shane Burch, MD|415-353-4487|Shane.Burch@ucsf.edu|
22382928|NCT00773370|VA Medical Center, Baltimore Maryland|Mary Stuart, ScD, VA Research Investigator|410-455-2084|stuart@umbc.edu|
22382929|NCT01765543|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22382930|NCT01185561|Loyola University|Sue Penckofer, Ph.D.|708-216-9303|spencko@luc.edu|
22382931|NCT01296815|Centro de Investigación en. Enfermedades Infecciosas|Gustavo Reyes-Teran|52 55 56667985|gustavo.reyesteran@gmail.com|
22382932|NCT05876949|Alvotech Swiss AG|Clinical Development and Medical Lead|+41 78 659 89 89|alvotech.clinical@alvotech.com|
22382933|NCT02755805|University of Pittsburgh|Elizabeth R. Skidmore, PhD, OTR/L, FAOTA|(412) 383-6617|skidmore@pitt.edu|
22382934|NCT02369484|European Thoracic Oncology Platform (ETOP)|Heidi Roschitzki-Voser, Lead Trial Activities|+41 31 511 94 18|Heidi.Roschitzki@etop-eu.org|
22382935|NCT02178241|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22382936|NCT02334436|Evolus, Inc|Rui L. Avelar, MD|(805)689-8668|rui@evolusinc.com|
22382937|NCT01924975|University of Iowa Hopspital & Clinics|Satoshi Hanada/Clinical Assistant Professor|3193561219|satoshi-hanada@uiowa.edu|
22382938|NCT06258785|Endeavor Health|Dr. Claudia Paya Ten|847-570-4729|claudia.payaten@endeavorhealth.org|
22382939|NCT04483856|Relife Srl|Clinical Trials Coordinator|05556809528|lfabbri@relifecompany.it|
22382940|NCT03718767|National Cancer Institute|Dr. Jing Wu|240-760-6036|jing.wu3@nih.gov|
22382941|NCT00494442|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22382942|NCT00604019|RUSH University Medical Center|Gourang Patel, PharmD|312-942-4258|gourang_p_patel@rush.edu|
22382943|NCT03593213|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22382944|NCT02658240|UT Southwestern Medical Center|Irina Gasanova|4694191997|Irina.Gasanova@UTSouthwestern.edu|
22382945|NCT03184558|BerGenBio ASA|BerGenBio Clinical Team|+47 559 61 159|trialsites@bergenbio.com|
22382946|NCT01254019|GlaxoSmithKline|GSK Response Center|866-435-7343||
22382947|NCT03061474|University of California, Irvine|Dr. Joshua Grill|(949) 824-5905|jgrill@uci.edu|
22382948|NCT03109795|University of Iowa|Professor|319-335-9487|gary-pierce@uiowa.edu|
22382949|NCT01391130|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22382950|NCT04153435|Aarhus University|Lars W. Andersen|+4551781511|lwandersen@clin.au.dk|
22382951|NCT00317226|Luitpold Pharmaceuticals, Inc.|Mark Falone, MD|610-650-4200|mfalone@luitpold.com|
22382952|NCT00566527|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22382953|NCT02348658|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22382954|NCT00818805|Alcon Labs|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22382955|NCT01179334|Bayer|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22382956|NCT00664430|Abbott|Global Medical Services|800-633-9110||
22382957|NCT01152190|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22382958|NCT03070483|Loyola University Chicago|Dr. Holly Kramer|7083279039|hkramer@lumc.edu|
22382959|NCT01123928|Zhongshan Ophthalmic Center|Dr. Nathan Congdon|13925056342|ncongdon1@gmail.com|
22382960|NCT00732381|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22382961|NCT01390402|University of Texas (UT) MD Anderson Cancer Center|Richard E. Champlin, MD/Chair, Stem Cell Transplantation||CR_Study_Registration@mdanderson.org|
22382962|NCT04789330|University of California, San Francisco|Matthieu LEGRAND MD, PhD|415-885-7388|matthieu.legrand@ucsf.edu|
22382963|NCT03995069|Ralph H. Johnson VA Health Care System|Principal Investigator|8434671373|NaJin.Seo@va.gov|
22382964|NCT02582593|University of Florida|Dawn Bowers, Ph.D.|(352) 273-6617|dawnbowers@phhp.ufl.edu|
22382965|NCT02207972|Mount Sinai West|Dr Barbara Orlando MD and PI|2125236915|barbara.orlando@mountsinai.org|
22382966|NCT00414544|Cosmeta, A Gel-Del Technolgies Company|Dr. David B. Masters|651 209-0707|dmasters@gel-del.com|
22382967|NCT01599104|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300||
22382968|NCT00714714|Valeant Pharmaceuticals International, Inc|David Lineberry, Associate Director Clinical Operations|949-973-1153|David.Linberry@valeant.com|
22382969|NCT00019747|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
22382970|NCT02616900|eSight Corporation|Rob Hilkes|613 276-4145|rhilkes@eSightcorp.com|
22382971|NCT04425863|Eurnekian Public Hospital|Dr. Héctor Carvallo|54144800949|hymcarvallo@hotmail.com|
22382972|NCT03691428|Yale|Dr. Joan Monin|203785-2895|joan.monin@yale.edu|
22382973|NCT01460290|University Hospitals of Cleveland|Martha Sajatovic, Professor of Psychiatry|2168442808|martha.sajatovic@uhhospitals.org|
22382974|NCT01831791|GlaxoSmithKline|GSK Response Center|866-435-7343||
22382975|NCT01190007|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22382976|NCT04589689|Stanford University|Jessie Wong, PhD|6507361517|wongjj@stanford.edu|
22382977|NCT03193619|Becton, Dickinson, and Company|Anna Lovas|952-239-0548|anna.lovas@bd.com|
22382978|NCT03963583|Johns Hopkins University School of Nursing|Martha Abshire Saylor|4433406201|mabshir1@jhu.edu|
22382979|NCT00845832|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22382980|NCT01665092|Univeristy of Mississippi Medical Center|Alan Jones|601-384-5586|aejones@umc.edu|
22382981|NCT03520413|Durham Veterans Affairs Medical Center|Matthew Crowley, MD|919-286-0411|matthew.crowley@va.gov|
22382982|NCT00869323|Masonic Cancer Center, University of Minnesota|Dr. Anne Blaes|612-626-8138|blaes004@umn.edu|
22382983|NCT02880241|Medicines for Malaria Venture (MMV)|Dr Stephan Duparc, Chief Medical Officer|+41 22 555 0351|duparcs@mmv.org|
22382984|NCT00638963|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22382985|NCT00971789|National Cancer Institute, National Institutes of Health|Dr. Arun Rajan|301-594-5322|rajana@mail.nih.gov|
22382986|NCT05283395|Alcon Research, LLC|Scientific Advisor, Clinical R&D|1-888-451-3937|alcon.medinfo@alcon.com|
22382987|NCT00712335|Inje University|Dr. Chang-Keun Kim|82-2-950-8832|kimck@paik.ac.kr|
22382988|NCT03401112|Imara Inc.|Imara Clinical Operations|617-206-2020|info@imaratx.com|
22382989|NCT01264679|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
22382990|NCT03475316|Albert Einstein College of Medicine|Dr. Joe Verghese|718-430-3877|joe.verghese@einsteinmed.org|
22382991|NCT02476409|University of North Carolina at Chapel Hill|Amanda Lee|919-843-9936|akg72@med.unc.edu|
22382992|NCT00275392|James H. Quillen VAMC|Courtney D. Hall, PhD|423-926-1171|courtney.hall@va.gov|7518
22382993|NCT00886145|James J. Peters VA Medical Center|William A. Bauman|718-584-9000|william.bauman@va.gov|5428
22382994|NCT02971488|Hospital Universitario Infanta Leonor|Pablo Ryan|0034616832148|pablo.ryan@salud.madrid.org|
22382995|NCT01837966|NYU School of Medicine|Associate Professor ; Res Program Dir/Medical Dir Day Surgery; Vice Chair for Education|212.263.5072|michael.wajda@nyumc.org|
22382996|NCT03293498|Novavax Inc.|Novavax Customer Service Center|1-844-Novavax (668-2829)|Clinicaltrials@novavax.com|
22382997|NCT04975308|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
22382998|NCT00468910|Northwestern University|Dr. Seema Khan|312-503- 4236|skhan@nm.org|
22382999|NCT01909778|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22383000|NCT01943916|Seno Medical Instruments, Inc|Shaan Schaeffer, VP Clinical Operations|2106156501|sschaeffer@senomedical.com|
22383001|NCT00919763|Galderma|Clinical Operations|8179615000|Clinical.Studies@galderma.com|1
22383002|NCT03654768|SWOG Statistics and Data Management Center|Leukemia Committe Statistician|2066674623|amoseley@fredhutch.org|
22383003|NCT05323734|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
22383004|NCT00547118|Maryland Psychiatric Research Center|Dr. Robert W. Buchanan|410-402-7876|rwbuchanan@mprc.umaryland.edu|
22383005|NCT01335542|Hospital for Special Surgery|Dr. Jacques YaDeau|2127742224|yadeauj@hss.edu|
22383006|NCT01595321|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Daniel Laheru, MD|410-955-8974|Laherda@jhmi.edu|
22396992|NCT02726971|Department of Hysteroscopic Center, Fuxing Hospital, Capital Medical University, Beijing, China|Dr. YH Liu|8618301474064|emmagj@126.com|
22396993|NCT02122198|University of Colorado Denver|Kerry Hildreth, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
22396994|NCT04090580|"Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Vasco de Quiroga 15, Belisario Domínguez Secc 16, Tlalpan, 14080, CDMX, Mexico. Department of endocrinology and lipid metabolism"|Miguel Ángel Gómez Sámano|+52 1 55 59939816|miguel.gomezs@incmnsz.mx|
22396995|NCT00597753|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
22396996|NCT04649255|Sirtex Medical|Janet Bell|+ 888-474-7839|jbell@sirtex.com|
22396997|NCT01652885|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22396998|NCT03723707|NYU Langone Health|Mauricio Arcila-Mesa|646-501-4660|Mauricio.arcila-mesa@nyulangone.org|
22396999|NCT00075023|NINR/NIH|Suzanne Wingate|301-827-0982|suzanne.wingate@nih.gov|
22397000|NCT04342871|UNC Lineberger|Eliza Park|919-966-3494|leeza_park@med.unc.edu|
22397001|NCT03382665|Zimmer Biomet|Fabrizio Lucchini, Clinical Jr.Project Lead|0041798575924|Fabrizio.Lucchini@zimmerbiomet.com|
22397002|NCT04682405|Washington University School of Medicine|Keith Stockerl-Goldstein, M.D.|314-747-7859|ksgoldstein@wustl.edu|
22397003|NCT04002037|UMissourri|Vicki L Jones|573-882-7583|jonesvicki@health.missouri.edu|
22397004|NCT01429584|University of Utah Department of Anesthesiology|Dr. Elizabeth Thackeray|(801) 581-6393|elizabeth.thackeray@hsc.utah.edu|
22397005|NCT00750698|Syndax Pharmaceuticals|Syndax Pharmaceuticals|781-419-1400|clinicaltrials@syndax.com|
22397006|NCT05030012|Vapotherm|Katherine Gerich|5854696753|kgerich@vtherm.com|
22397007|NCT01417195|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22397008|NCT03357731|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22397009|NCT04766021|Indiana University|Dr. Blair Johnson|8128558699|bj33@indiana.edu|
22397010|NCT02634151|NeuroBo Pharmaceuticals|Vice President Clinical Operations|+1 (857) 702-9600|info@neurobopharma.com|
22397011|NCT00003535|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22397012|NCT01849874|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22397013|NCT02347098|VA North Texas Health Care System, Dallas, TX and University of Texas Southwestern Medical Center|Dr. Subhash Banerjee|214-857-1608|Subhash.Banerjee@va.gov, Subhash.Banerjee@UTSouthwestern.edu|
22397014|NCT04640272|Ribomic, Inc.|Dr. Yoshikazu Nakamura|81-3-3440-3303|yoshi@ribomic.com|
22397015|NCT04673292|Johns Hopkins School of Medicine; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University School of Nursing|Jacky Jennings,PhD, MPH; Shruti Mehta, PhD, MPH; Jason Farley, PhD, MPH, ANP-BC, FAAN|410-550-4132|jennings@jhmi.edu; smehta@jhu.edu; jfarley1@jhu.edu|
22428158|NCT05850494|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22428159|NCT00957359|NYU Langone Health|Stephen Ross, MD|212-263-7264|Stephen.Ross@nyulangone.org|
22428160|NCT03034967|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22428161|NCT03806296|University of Pittsburgh School of Medicine|Brant Hasler, PhD|412-246-6413|haslerbp@upmc.edu|
22397016|NCT02535715|University of Texas Health San Antonio|Curtis Triplitt, PharmD|210-358-7228|triplitt@uthscsa.edu|
22397017|NCT04353284|Yale School of Medicine|Geoffrey Chupp, MD Professor of Medicine (Pulmonary); Director, Yale Center for Asthma and Airways D|(203) 785-3627|geoffrey.chupp@yale.edu|
22397018|NCT03709654|Naked Biome|Emma Taylor, MD CEO|626-260-1230|emma.t@nakedbiome.com|
22397019|NCT01040351|Cairo university|Usama M.Fouda, M.D, PhD|+20123595106|umfrfouda@yahoo.com|
22397020|NCT06243198|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22397021|NCT01230242|MaineHealth|Clinicaltrials.gov Administrator|207.396.8228|llemire@mmc.org|
22397022|NCT02256540|University of Colorado Anschutz Medical Campus|Dr. Kerrie Moreau|303-724-1914|kerrie.moreau@cuanschutz.edu|
22397023|NCT01438489|MedImmune, LLC|Gabor Illei, MD, Senior Director|301-398-0000|illeig@Medimmune.com|
22397024|NCT00766532|University of Wisconsin|Dr. Karen Hansen|608-263-0517|keh@medicine.wisc.edu|
22397025|NCT03451786|Carl Zeiss|Michael Bonilla|+1 925-557-4100|michael.bonilla@zeiss.com|
22397026|NCT00940589|Neurim Pharmaceuticals (1991) LTD|Amnon Katz|972-3-768-4906|amnonk@neurim.com|
22397027|NCT03719690|Kura Oncology, Inc.|Clinical Operations|617-588-3755|KO-TIP-007@kuraoncology.com|
22397028|NCT03070470|U.S. Food and Drug Administration|Jose Vicente, PhD|301-796-8442|Jose.VicenteRuiz@fda.hhs.gov|
22397029|NCT00842231|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22397030|NCT02953340|Spectrum Pharmaceuticals Inc. Research and Development Office 157 Technology Drive Irvine, CA 92618|Shanta Chawla|(949) 788-6700|shanta.chawla@sppirx.com|
22397031|NCT01977599|UCL|Dr Robert Kerrison, Senior Research Fellow|02076798268|Robert.kerrison.13@ucl.ac.uk|
22397032|NCT00530270|Rho Federal Systems Division|Karen Kesler, PhD|919-408-8000|karen_kesler@rhoworld.com|244
22397033|NCT02006342|The University of Texas Health Science Center at Houston|Dr. Pratik B. Doshi|713-608-6537|Pratik.B.Doshi@uth.tmc.edu|
22397034|NCT01118273|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22397035|NCT01923285|Abbott|Robyn Capobianco|512-286-4274|robyn.capobianco@abbott.com|
22397036|NCT04512040|VA Palo Alto Health Care System|Peter Bayley, PhD|650-493-5000|peter.bayley@va.gov|68653
22397037|NCT01309659|Duke University Medical Center|Harvey J Cohen, MD|919-660-7502|harvey.cohen@dm.duke.edu|
22397038|NCT03962101|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22397039|NCT00761007|Menarini Group- Clinical Research|Angela Capriati MD PhD, Clinical Research Director|+39 055 5680|acapriati@menarini-ricerche.it|9933
22397040|NCT01409213|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22397041|NCT00865904|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22397042|NCT01543828|Novartis Pharmaceuticals|Study Director|862-778-8300||
22397043|NCT00941668|Colgate Palmolive|Willliam DeVizio-DMD|732-878-7901|William_DeVizio@colpal.com|
22397044|NCT03901079|BSC|Chenchen FAN|+861085216427|chenchen.fan@bsci.com|
22397045|NCT04607148|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22397046|NCT01820364|Array BioPharma, Inc.|Study Director|303-381-6604|clinicaltrials@arraybiopharma.com|
22397047|NCT03096730|Tianjin Medical University General Hospita|Dr. Guolin Wang|13002211205|1464322162@qq.com|
22397048|NCT00825162|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
22397049|NCT03455491|PHARMENTERPRISES LLC|CEO Vladimir Nebolsin|+7 (985) 728-75-72|ph@pharmenterprises.ru|
22397050|NCT01391286|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22397051|NCT03113656|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
22397052|NCT02016820|Columbia University|Daniel E. Freedberg, MD, MS||def2004@cumc.columbia.edu|
22397053|NCT00884273|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
22397054|NCT00258674|Baylor Research Institute|Baylor Research Institute|214-820-9991|Elizabeth.Cothran@baylorhealth.edu|
22397055|NCT03710486|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22397056|NCT01279850|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22397057|NCT01555567|University of Michigan|Riann Palmieri-Smith|7346153154|riannp@umich.edu|
22397058|NCT01252745|Acerus Pharmaceuticals Corporation|Vice President|(416) 679-0776|nbryson@aceruspharma.com|
22397059|NCT00432042|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22397060|NCT03497585|Pennine Acute NHS Trust|Dr Deborah Antcliff|0161 7242168|Deborah.Antcliff@pat.nhs.uk|
22397061|NCT00492752|BAYER|Therapeutic Area Head|<not disclosed>|clinical-trials-contact@bayerhealthcare.com|
22397062|NCT02904915|The University of Texas Health Science Center at Houston|Pamela D. Berens, MD|713-500-6471|Pamela.D.Berens@uth.tmc.edu|
22397063|NCT03067571|The University of Texas MD Anderson Cancer Center|Gautam Borthakur MD/Professor|713-563-1586|gborthak@mdanderson.org|
22397064|NCT02321930|UCLA|Veena K. Ranganath|310-825-4321|vranganath@mednet.ucla.edu|
22397065|NCT01484977|UCB Clinical Trial Call Center|Study Director|+1 887 822 9493||
22397066|NCT04857996|Unity Biotechnology, Inc.|Study Director|650-513-0096|UBX1325_medicalmonitor@unitybiotechnology.com|
22397067|NCT01129921|Napa Pain Institute|Eric Grigsby, MD|707-252-9660|egrig@aol.com|
22397068|NCT00255970|RTI Biologics|Clinical Projects, Director|386-418-8888|rparkhurst@rtix.com|
22397069|NCT02580409|Spaulding Rehabilitation Hospital|Dr. Jonathan Bean|617 952 6813|jfbean@mgh.harvard.edu|
22397070|NCT02484911|First Affiliated Hospital of Harbin Medical University|Dr.Zhang|85555068|daxinmay@126.com|
22397071|NCT02222207|BAYER|Therapeutic Area Head||Clinical-Trial-Disclosure@bayer.com|
22397072|NCT01773109|University of Pennsylvania (Abramson Cancer Center)|Dr. Charu Aggarwal|2156624000|charu.aggarwal@pennmedicine.upenn.edu|
22397073|NCT01239342|The University of Texas (UT) MD Anderson Cancer Center|Eric Jonasch, MD/Professor, Genitourinary Medical Oncology|713-792-7734|EJonasch@mdanderson.org|
22383007|NCT02950896|Washington University School of Medicine|Heather McKenzie|3142862628|heather.mckenzie@wustl.edu|
22383008|NCT00834834|NYSPI|Barbara Stanley, Ph.D.|6467747582|stanley@nyspi.columbia.edu|
22383009|NCT00373529|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22383010|NCT04795752|Sight Sciences, Inc|VP, Medical and Clinical Affairs|1-877-266-1144|jdickerson@sightsciences.com|
22383011|NCT00792948|SWOG Statistics and Data Management Center|Leukemia Committee Statistician|(206) 667-4623||
22383012|NCT00800605|Alachua Government Services, Inc.|Angie Kimbler|386-418-8751|angie.kimbler@resilience.com|
22383013|NCT04923724|Washington University School of Medicine|Venessa Riegler|314-362-1721|rieglerv@wustl.edu|
22383014|NCT00748410|GlaxoSmithKline|GSK Response Center|866-435-7343||
22383015|NCT04345913|Washington University in St. Louis School of Medicine|Nusayba Bagegni|3142733022|nbagegni@wustl.edu|
22383016|NCT01585558|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|Shionogiclintrials-admin@shionogi.co.jp|
22383017|NCT02601170|Tri-service general hospital|Dr. Tsung-Ying Li|886-2-87927166|doc31141@gmail.com|
22383018|NCT02994654|AVITA Medical|VP Clinical Research|661-367-9170|USClinicalTrials@avitamedical.com|
22383019|NCT00605904|NIAAA, NIH|Markus Heilig|301.435.9386|mheilig@mail.nih.gov|
22383020|NCT01190566|Seoul National University Hospital|Woo Kyung Moon|82-2-2072-2584|moonwk@snu.ac.kr|
22383021|NCT04178941|Children's Hospital of Philadelphia|Chris Bonafide, MD, MSCE|267-426-2901|bonafide@chop.edu|
22383022|NCT05314634|National Taiwan Normal University|Ruei-Hong Li|+886988163220|rueihongli@gmail.com|
22383023|NCT03439891|University of California, San Francisco|Dr. R. Katie Kelley, MD|(415) 353-9888|katie.kelley@ucsf.edu|
22383024|NCT05470868|Laboratorios Sophia|Alejandra Sanchez-Ríos M.D.|:+52 (33) 3001 4200|alejandra.sanchez@sophia.com.mx|
22383025|NCT00585052|University of Iowa|Raymond Hohl, MD|319-335-6564|rhohl@pennstatehealth.psu.edu|
22383026|NCT00687856|University of Pittsburgh|John Gorcsan MD|4126476570|gorcsanj@upmc.edu|
22383027|NCT02613871|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22383028|NCT02527148|Stryker South Pacific|David Fulker|+61 2 9467 1072|david.fulker@stryker.com|
22383029|NCT02918279|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22383030|NCT00309907|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org|
22383031|NCT00494780|GlaxoSmithKline|GSK Response Center|866-435-7343||
22383032|NCT00869258|Columbia University|Robert Fine, MD|212-305-1168|rlf20@columbia.edu|
22383033|NCT01641198|Université de Montréal|Dr. Aldo-Joseph Camarda|(514) 343-7124|aj.camarda@umontreal.ca|
22383034|NCT01396837|RedDress|Saron Sirota, Clinical Team Leader|+972-54-5800765|sharon@reddress.co.il|
22383035|NCT00980330|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com|
22383036|NCT00346151|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22383037|NCT01075217|Bracco Diagnostics Inc|Usha Halemane|609.514.2578|Usha.Halemane@diag.bracco.com|
22383038|NCT02448446|South Coast Retina Center|Dr. Julie Gasperini|5629847024|jgasperini@gmail.com|
22383039|NCT03260140|VA Puget Sound Health Care Sysem|Margaret P. Collins|206.764.2085|margaret.collins@va.gov|
22383040|NCT00463788|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22383041|NCT00360698|sanofi-aventis|Medical Affairs study director||publicregistryGMA@sanofi-aventis.com|
22383042|NCT01755949|Mayo Clinic|Joseph L. Blackshear, Principal Investigator|904-953-7279|blackshear.joseph@mayo.edu|
22383043|NCT00831675|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22383044|NCT01059877|QuietMind Foundation|Marvin Berman, PhD|610.940.0488|marvinberman@quietmindfdn.org|
22383045|NCT01692938|Stanley M. Truhlsen Eye Institute|Quan Nguyen, MD Director of the Stanley M. Truhlsen Eye Institute|402-559-4276|quan.nguyen@unmc.edu|
22383046|NCT04598321|Brown University Oncology Research Group (BrUOG)|Assistant Director|401-863-3000|BrUOG@brown.edu|
22383047|NCT00640250|Institute of Clinical Research, Department of Dermoto Venerology and Allergy Center|Evy Paulsen, MD|+45 65 41 27 08||
22383048|NCT02957136|Duke University Health System|Christopher Polage|919-668-5008|christopher.polage@duke.edu|
22383049|NCT01667796|Johns Hopkins|Ellen Mowry|4106141522|vitamindtrialms@jhmi.edu|
22383050|NCT01937507|CTCA|Jessica L. Coats|6232073899|jessica.coats@ctca-hope.com|
22383051|NCT02200770|AstraZeneca Clinical study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
22383052|NCT01647438|Northwestern University|Dr. Namratha Kandula, Principal Investigator|312-503-6470|nkandula@nm.org|
22383053|NCT04925765|University of Pittsburgh Medical Center|Dr. Katherine Grace Lim|4126411777|limkg2@upmc.edu|
22383054|NCT00424645|UT MD Anderson Cancer Center|Saroj Vadhan, MD||CR_Study_Registration@mdanderson.org|
22383055|NCT02555215|Biogen|Medical Director, Overall Study Officials|866-633-4636|clinicaltrials@biogen.com|
22383056|NCT00529789|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22383057|NCT02204982|Secura Bio, Inc.|Beth Gregory, PharmD, MBA|1-702-254-0011|bgregory@securabio.com|
22383058|NCT01968226|Cleveland Clinic|Dr. Balaji Tamarappoo|216-444-6765|tamarab@ccf.org|
22383059|NCT00857545|NRG Oncology|Linda Gedeon for Wei Deng PhD|716-845-1169|lgedeon@gogstats.org|
22383060|NCT00457743|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22383061|NCT00959946|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22383062|NCT00841035|University of Alabama at Birmingham|Research Nurse Supervisor of Clinical trials|(205)975-0450|jhrichardson@uabmc.edu|
22383063|NCT00891176|GlaxoSmithKline|GSK Response Center|866-435-7343||
22383064|NCT00433199|Abbott|Global Medical Services|800-633-91110||
22383065|NCT00357097|GlaxoSmithKline|GSK Response Center|866-435-7343||
22383066|NCT00658996|Bausch & Lomb Incorporated|Gerard Cairns, PhD, MCOptom|(585) 338-5170|gerard.cairns@bausch.com|
22397074|NCT01733472|Region Skane|Andreas Harsten|46708870567|andreas.harsten@skane.se|
22428162|NCT03350919|University of Rochester|Steven E. Feldon, MD|585-273-1050|Steven_Feldon@urmc.rochester.edu|
22428163|NCT03136198|Indiana University|Peter S. Pang|317-880-3900|ppang@iu.edu|
22428164|NCT01998360|University of New England|Peter S. Millard, MD, PhD|2078663503|pmillard@mac.com|
22428165|NCT04613453|Yale University|Brooke Rivera|203-974-2241|Brooke.rivera@yale.edu|
22383067|NCT03072953|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
22383068|NCT01625013|University of California, San Francisco|Anthony Luke, MD|4155146120|Anthony.Luke@ucsf.edu|
22383069|NCT00385801|Massachusetts General Hospital - Harvard Medical School|A. Eden Evins, MD, MPH. Director of the MGH-Harvard Center for Addiction Medicine|6176434679|a_eden_evins@hms.harvard.edu|
22383070|NCT03603717|Department of Veterans Affairs, Center of Excellence for Suicide Prevention|Wilfred Pigeon, PhD|(585) 393-7918|wilfred.pigeon2@va.gov|
22383071|NCT03505099|Novartis Gene Therapies EU Limited|EMEA Medical Information|+353 (1) 566-2364|medinfoemea.gtx@novartis.com|
22383072|NCT01810263|Seoul National University Bundang Hospital|Nam-Jong Paik|82-031-787-7731|njpaik@snu.ac.kr|
22383073|NCT00457691|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22383074|NCT04584099|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
22383075|NCT04926181|University of California, San Francisco|Dr. Rahul Aggarwal, MD|(415) 476-1000|Rahul.Aggarwal@ucsf.edu|
22383076|NCT00840177|SWOG Statistical Center|S0919 Statistician|2066674623|amoseley@fredhutch.org|
22383077|NCT00722046|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22383078|NCT01318382|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22383079|NCT01437605|Moffitt Cancer Center|Dr. Nikhil Khushalani|813-745-3437|Nikhil.Khushalani@Moffitt.org|
22383080|NCT01582100|Northwestern University|Christine Ebert Nelson|3126954513|c-ebert@northwestern.edu|
22383081|NCT03795194|Phoenix Children's|Research Coordinator|6029331858|zhunteman@phoenixchildrens.com|
22383082|NCT01647581|VA|Linda Feagins|214-587-1603|linda.feagins@austin.utexas.edu|
22383083|NCT01105117|Actelion Pharmaceuticals, US|Wade Benton, PharmD, Director of Medical Affairs|650-808-6562|wade.benton@actelion.com|
22383084|NCT01078116|Abbott|Global Medical Services|1-800-633-9110||
22383085|NCT02242487|Acorda Therapeutics|Dr. Charles Oh, Senior Vice President - Clinical Development|914-326-5455|coh@acorda.com|
22383086|NCT03644849|Saint Louis University|Dr. Ramona Behshad|314-977-9721|ramona.behshad@health.slu.edu|
22383087|NCT02771899|Columbia University Medical Center|Dr. Lawrence Lenke|2129324410|ll2989@columbia.edu|
22383088|NCT01883908|University of Maryland Baltimore Greenebaum Cancer Center|Michelle Medeiros|410-328-1160|mmedeiros@umm.edu|
22383089|NCT01296191|Bucci Laser Vision|Frank A. Bucci Jr., MD|570-825-5949|buccivision@aol.com|
22383090|NCT03737240|University of Miami Miller School of Medicine|Dr. Rodolfo Galindo|305-243-7707|Rodolfo.galindo@miami.edu|
22383091|NCT00846066|Childrens Mercy Hospital|Nasreen Talib MD, MPH.|816-234-3242|ntalib@cmh.edu|
22383092|NCT02512965|Canadian Cancer Trials Group|Dr. Keyue Ding|16135336430|kding@ctg.queensu.ca|77705
22383093|NCT04303156|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22383094|NCT00588809|The University of Chicago Medicine|Olatoyosi Odenike, MD|(773) 702-6149|todenike@medicine.bsd.uchicago.edu|
22383095|NCT02570711|Acerta Pharma, LLC|Priti Patel, MD, Vice President - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
22383096|NCT05001945|Mineralys Therapeutics|David Rodman, MD Chief Medical Officer|1-888-378-6240|drodman@mineralystx.com|
22383097|NCT01369498|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22383098|NCT00545077|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
22383099|NCT01852071|Orchard Therapeutics (Europe) Ltd|Orchard Medical Information|+44 (0) 203 808 8286|medinfo@orchard-tx.com|
22383100|NCT00376363|University of North Carolina|Donald Budenz|919-843-0297|donald_budenz@med.unc.edu|
22383101|NCT00439569|Westat|René Gonin, PhD (Math. Stats.)|301-251-1500|renegonin@westat.com|
22383102|NCT01444417|Amgen Inc.|Study Director|866-572-6436||
22383103|NCT01836133|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22383104|NCT02755116|Icahn School of Medicine at Mount Sinai|Dr. Jaime B. Hyman|212-241-7473|Jaime.hyman@mountsinai.org|
22383105|NCT02423291|"Institute of Hematology L. e A. Seràgnoli, AOU Policlinico S.Orsola-Malpighi Via Massarenti, 9 - 40138 Bologna Italy"|MD Vittorio Stefoni|+39 0512143680|vittorio.stefoni2@unibo.it|
22383106|NCT04018924|Emoled|Duccio Rossi Degl'Innocenti|+39 0550751981|d.rossi@emoled.com|
22383107|NCT01124734|Penn State Cancer Institute|Joseph Drabick, MD|717 531 5059|jdrabick@pennstatehealth.psu.edu|
22383108|NCT01214824|Abbott Diabetes Care|Director Global Clinical and EMEA Regulatory Affairs|01993863164|joe.bugler@abbott.com|
22383109|NCT02214160|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
22383110|NCT02423798|Medtronic Minimed|Odile O'Sullivan, Clinical Trial Manager|8184763319|odile.osullivan@medtronic.com|
22383111|NCT01063972|University of Kansas Medical Center|Sharon Fitzgerald, MPH|913-588-3488|sfitzgerald@kumc.edu|
22383112|NCT00634621|GE Healthcare|Emilio Moreno Carretero, M.D.|011-34-9166-30970|Emilio.Morenocarretero@ge.com|
22383113|NCT01510717|Alcon Research, Ltd.|Magda Michna, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
22383114|NCT04221828|US Biotest, Inc.|Gere S. diZerega, MD|18055951300|gere.dizerega@usbiotest.com|
22383115|NCT01430611|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22383116|NCT00939510|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Robert Dreicer|216-445-4623|dreicer@ccf.org|
22383117|NCT01202955|University of Pennsylvania|Dr. Caryn Lerman|215-746-7141|clerman@mail.med.upenn.edu|
22428166|NCT02084797|Oakland University|Tamara Hew-Butler|248-364-8686|hew@oakland.edu|
22428167|NCT03116230|Stanford University|Thomas Andriacchi|650-|tandriac@stanford.edu|
22397075|NCT02257372|GlaxoSmithKline|GSK Response Center|866-435-7343||
22397076|NCT04325542|Medical Mission Institute|Dr Christa Kasang||christa.kasang@medmissio.de|
22397077|NCT02104583|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22397078|NCT04203745|Candela Medical|Dr. Konika Patel Schallen|508-358-0357|konikap@candelamedical.com|
22397079|NCT00129766|MedImmune|M. Pamela Griffin, Sr. Director, Clinical Development|301-398-0000|clinicaltrialenquiries@medimmune.com|
22397080|NCT03448068|Mayo Clinic|Dr. Andrew W. Gorlin|480-342-2446|Gorlin.Andrew@mayo.edu|
22397081|NCT01422356|Melbourne Sexual Health Centre, Alfred Health|Associate Professor Marcus Chen|+61 3 9341 6260|mchen@mshc.org.au|
22397082|NCT02833922|Institute for Reproductive Health|Dr. Victoria Jennings|2026871392|Victoria.Jennings@georgetown.edu|
22397083|NCT01476475|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22397084|NCT00676676|Massachusetts General Hospita|Dr. Karen K. Miller|617-726-3870|kkmiller@partners.org|
22397085|NCT00751400|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22397086|NCT01372384|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22397087|NCT03129321|Mylan Inc.|Abhijit Barve, Head of Global Clinical Research||abhijit.barve@mylan.com|
22397088|NCT00441974|GlaxoSmithKline|GSK Response Center|866-435-7343||
22397089|NCT02576444|Yale School of Medicine: Medical Oncology|Joseph Paul Eder, MD|(203) 737-6980|joseph.eder@yale.edu|
22397090|NCT00988143|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22397091|NCT03503877|University of California, San Francisco|Mitchell Rosen|415-353-7475|Mitchell.Rosen@ucsf.edu|
22397092|NCT03370120|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
22397093|NCT03672370|Zimmer Biomet|Clinical Project Lead, Sandra Rosser|+41 (0)58 854 84 09|sandra.rosser@zimmerbiomet.com|
22397094|NCT00928889|Novartis Pharmaceuticals|Study Director|862 778-8300||
22397095|NCT04712110|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22397096|NCT01356407|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22397097|NCT01197521|AstraZeneca|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
22397098|NCT05879107|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22397099|NCT03341975|Children's Mercy Hospitals and Clinics|Melissa Miller MD|8162343430|mmiller@cmh.edu|
22397100|NCT00912028|University of Campinas, Brazil|Carlos E Leite Arieta MD, PhD||ra-visus-clnclstds@its.jnj.com|
22397101|NCT03029143|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22397102|NCT02588976|Triemli City Hospital|Director Clinical Trial|+41 44 416 25 52|christoph.hofer@triemli.stzh.ch|
22397103|NCT04744207|Gesynta Pharma AB|Study Director|+46 73 386 4246|ctg@gesynta.se|
22397104|NCT02230384|University of Pittsburgh|K.N. Roy Chengappa, MD / Principal Investigator|412-246-5006|chengappakn@upmc.edu|412
22397105|NCT00961220|Case Comprehensive Cancer Center|Dr. Kevin Cooper|216-844-3111|kevin.cooper@uhhospitals.org|
22397106|NCT05376215|Phonak Audiology Research Center|Director of Research|630-821-5000|phonakaudiologyresearch@gmail.com|
22397107|NCT01301950|DePuy Synthes|Sam Himden, Clinical Portfolio Leader|574-372-7231|shimden@its.jnj.com|
22397108|NCT00942175|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22397109|NCT02651584|Braeburn Pharmaceuticals|Sonnie Kim|1 610 467 8717|sonnie@braeburnrx.com|
22397110|NCT04041284|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
22397111|NCT00455689|Brigham & Women's Hospital|Hadine Joffe, MD MSc|617-732-4906|hjoffe@bwh.harvard.edu|
22397112|NCT00075088|University of California, San Francisco|Barbara J Drew, PhD|415-476-4302|barbara.drew@nursing.ucsf.edu|
22397113|NCT00353834|Joslin Diabetes Center|Edward S. Horton, MD|6173091995|edward.horton@joslin.harvard.edu|
22397114|NCT02973087|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22397115|NCT00445705|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22397116|NCT02941705|Cedar Sinai|Russell Haber|(310) 967-8322|Russell.Haber@CSHS.org|
22397117|NCT04402970|University of Missouri|Dr. Zach Holliday|5738829072|hollidayz@health.missouri.edu|
22397118|NCT01840579|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22397119|NCT03499509|The University of Alabama at Birmingham|Barbara Gower, PhD|205-934-4087|bgower@uab.edu|
22397120|NCT02437864|University of New Mexico Health Sciences Center (HSC)|Dr. Codruta Soneru|5052722610|csoneru@salud.unm.edu|
22397121|NCT04018794|University of California, San Francisco|Dr. Melissa Dvorsky|4154767167|melissa.dvorsky@ucsf.edu|
22397122|NCT02822885|Benha university|dr khalid M Salama|01225861026|dr.khalid_sleem@yahoo.com|
22397123|NCT00645593|University of Michigan Comprehensive Cancer Center|Dr. Maha Hussain, M.D.|(734) 647-8903|mahahuss@umich.edu|
22397124|NCT01585272|Novartis Pharmaceutical|Study Director|862-778-8300||
22397125|NCT03803059|Crown Laboratories, Inc|Thomas Hitchcock, PhD.|8883723982|THitchcock@crownlaboratories.com|
22397126|NCT04013529|Corporal Michael J. Crescenz VA Medical Center|Manik Chhabra|(215) 823-5800|manik.chhabra@va.gov|
22397127|NCT02988661|Emory University|Cristina Drenkard, MD, PhD|404-251-8901|cdrenka@emory.edu|
22397128|NCT04093843|West Virginia University|Amelia Adcock, MD|304-598-6127|akadcock@hsc.wvu.edu|
22397129|NCT02971631|University of Cambridge|Mr Geoffrey Roberts|01223767176|geoffroberts@cantab.net|
22397130|NCT04050982|Stanford University|Linda Ottoboni|(650) 498-5914|LOttoboni@stanfordhealthcare.org|
22428168|NCT02763566|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22428169|NCT04896385|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22397131|NCT04138017|University of Virginia|Eric McVey, Clinical Research Coordinator|434.243.5382|eric.mcvey@uvahealth.org|
22397132|NCT01292642|McLean Hospital|Kevin P Hill, MD, MHS|617-855-4501|khill@mclean.harvard.edu|
22397133|NCT02562924|University of Vermont Medical Center|Dr. Daniel Gerges|8028474535|daniel.gerges@uvmhealth.org|
22397134|NCT01682135|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22397135|NCT00747643|H. Lee Moffitt Cancer Center and Research Institute|Thomas H. Brandon, Ph.D.|813-745-1750|thomas.brandon@moffitt.org|
22397136|NCT03557281|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22397137|NCT01199042|Bethesda North Hospital|Dr. Shahrokh Javaheri|513-793-7378|shahrokhjavaheri@icloud.com|
22397138|NCT01423162|Food and Nutrition Research Institute|Trinidad P. Trinidad|6328372071|trinidadtp@yahoo.com.ph|2281
22397139|NCT04036708|Michigan State University|Michael J Boivin|1-517-884-0281|boivin@msu.edu|
22397140|NCT02918864|Rush University Medical Center|Dr. Latha Valluripalli Soorya|(312) 942-6238|latha_soorya@rush.edu|
22397141|NCT01656031|Comprehensive Cancer Center of Wake Forest University|Dr. Bayard Powell|336-716-7970|bpowell@wakehealth.edu|
22397142|NCT01230307|University of Michigan|Barry Bleske|734-763-3232|bbleske@umich.edu|
22397143|NCT04773106|Implandata Ophthalmic Products GmbH|Clinical Study Manager|+49 (0) 511 - 2204 2580|clinical@implandata.com|
22397144|NCT02387359|Synergy Pharmaceuticals Inc.|VP Regulatory Affairs & Clinical QA|646-675-7283|ejaeger@synergypharma.com|
22397145|NCT00291447|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22397146|NCT01349465|Janssen Research & Development, LLC|Study Responsible Scientist||ClinicalTrialDisclosure@its.jnj.com|
22397147|NCT05433571|Johnson & Johnson Vision Care (JJVC)|Ross Franklin|1-800-843-2020|RFRANKL1@its.jnj.com|
22397148|NCT04329702|Duke University|Christopher Cox|9196817232|christopher.cox@duke.edu|
22397149|NCT00429403|UT MD Anderson Cancer Center|Naoto Ueno, MD / Professor||CR_Study_Registration@mdanderson.org|
22397150|NCT01918007|National and Kapodistrian University of Athens School of Medicine and Aghia Sophia Children's Hospital, Athens, Greece|Dr. Athanasios Kaditis, Head, Division of Pediatric Pulmonology, First Department of Pediatrics|+302132013000|akaditis@med.uoa.gr|
22397151|NCT01140451|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22397152|NCT04206020|Mitotech S.A.|Chief Operating Officer|+352621692785|info@mitotechpharma.com|
22397153|NCT02888093|University of Iowa Hospitals and Clinics|Dr. Joseph Kowalski|3193561616|joseph-kowalski@uiowa.edu|
22397154|NCT04962022|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22397155|NCT02375724|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22397156|NCT00631020|UCLA Center for Health Promotion and Disease Prevention|Dr. Steven Shoptaw|310-794-0619|sshoptaw@mednet.ucla.edu|225
22397157|NCT02614859|Fox Chase Cancer Center|Dr. Daniel Geynisman|215-728-3889|Daniel.Geynisman@fccc.edu|
22397158|NCT03548935|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22397159|NCT00732303|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
22397160|NCT00397813|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fredhutch.org|
22397161|NCT01074190|Northwerstern University|Paul Fitzgerald|312-695-1064|p-fitzgerald2@northwestern.edu|
22397162|NCT01594515|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22397163|NCT01576549|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22397164|NCT00053417|Acorda Therapeutics|Andrew Blight, PhD|914-347-4300|ablight@acorda.com|102
22397165|NCT00804570|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22397166|NCT00290342|GlaxoSmithKline|GSK Response Center|866-435-7343||
22397167|NCT01056510|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22397168|NCT02285998|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
22397169|NCT01793142|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22397170|NCT02242578|The University of Texas at Austin|Robert J Buchanan, MD|512-324-7991|robertbuchanan@utexas.edu|
22397171|NCT00619255|University of Washington|Doug Zatzick, MD|(206) 744-6701|dzatzick@uw.edu|
22397172|NCT02121262|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22397173|NCT02716987|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22397174|NCT01553188|National Cancer Institute|Dr. Ravi Madan|301-480-7168|madanr@mail.nih.gov|
22397175|NCT02445625|University of Coimbra|Prof. Dr. Miguel Castelo-Branco|+351239790000|mcbranco@fmed.uc.pt|
22397176|NCT02829138|University of Guelph|Dr. David M Mutch|+1-519-824-4120|dmutch@uoguelph.ca|53322
22397177|NCT01394627|Brigham and Women's Hospital|Gail Adler|617-732-5661|gadler@partners.org|
22397178|NCT00974246|Valley Medical Research|Meenakshi Patel, MD|937-208-8298|mpatelmd@ymail.com|
22397179|NCT05289570|Duke University|Ian Welsby, MD|919-681-6752|ian.welsby@duke.edu|
22397180|NCT01617070|USC/Keck School of Medicine|Shoji Yano|323-226-3816|syano@usc.edu|
22397181|NCT02777268|Simbec Research Limited|Dr Girish Sharma|+44 1443 690977||
22397182|NCT00808236|BeneChill, Inc.|Becky Inderbitzen, Vice President of Clincial Affairs|858-695-8118|binderbitzen@benechill.com|
22397183|NCT01066585|Sanofi Topaz|Medical Director||RegistryContactUs@sanofipasteur.com|
22397184|NCT01071538|University of Pittsburgh|Jordan F. Karp, MD|412-246-6048|karpjf@upmc.edu|
22397185|NCT00964743|H. Lee Moffitt Cancer Center and Research Institute|Edward Pan, M.D.|813-745-3871|edward.pan@moffitt.org|
22397186|NCT02086786|Rovi S.A. Laboratorios Farmacéuticos|Jordi Llaudó Garín ( Clinical Development Manager)|+34913756230|jllaudo@rovi.es|
22397187|NCT03317795|Mayo Clinic|Dr. Shannon K. Laughlin-Tommaso|507-538-5783|LaughlinTommaso.Shannon@mayo.edu|
22397188|NCT00886600|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
22397189|NCT00501007|Rutgers, The State University of New Jersey|Marc L. Steinberg, Ph.D.|732-235-4341|marc.steinberg@rutgers.edu|
22397190|NCT00047060|National Heart Lung and Blood Institute|Aue, Georg|+1 301 451 7141|aueg@nhlbi.nih.gov|
22397191|NCT02424253|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22397192|NCT00473343|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22428170|NCT04512924|Medical University of South Carolina|Dr. Brantlee Broome|843-792-3370|broomeb@musc.edu|
22428171|NCT05291689|Morphic Therapeutic Inc.|Head of Clinical Development|781-996-0955|clinicaltrials@morphictx.com|
22383118|NCT00237770|James J Peters VA Medical Center|Dr. Jill M. Wecht, principal Investigator|718 584-9000|jm.wecht@va.gov|3122
22383119|NCT00392054|Population Health Research Institute|Carlos A. Morillo, MD, FRCPC, FACC, FHRS, FESC, FHRS|905-527-4322|Carlos.Morillo@phri.ca|40311
22383120|NCT00159783|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22383121|NCT02115139|MFAR Clinical Research|Pau Doñate||investigacion@mfar.net|
22383122|NCT04740164|The University of Texas MD Anderson Cancer Center|Dr. Katherine Hagan|(713) 794-5945|khagan@mdanderson.org|
22383123|NCT05216510|Tonix Pharmaceuticals|Herb Harris, MD, PhD|(862) 904-0355|herb.harris@tonixpharma.com|
22383124|NCT05444244|University of Wisconsin School of Medicine and Public Health|Andrea Gilmore-Bykovskyi|6082623057|algilmore@wisc.edu|
22383125|NCT00258895|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22383126|NCT00442117|Merck Sharp and Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclcosure@merck.com|
22383127|NCT01568073|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22383128|NCT01243619|Brigham and Women's Hospital / Dana Farber Cancer Institute|Harvey Mamon MD, PhD|617-732-8564|hmamon@lroc.harvard.edu|
22383129|NCT01071993|University of Oklahoma|Mazen Abu-Fadel, MD|405-271-4742|mazen-abufadel@ouhsc.edu|
22383130|NCT00305695|NRG Oncology|Linda Gedeon on behalf of James Kauderer, MA, BS|716-845-1169|linda.gedeon@roswellpark.org|
22383131|NCT01499654|Northwestern University|Edwin Wu, MD|847-535-7270|ed-wu@northwestern.edu|
22383132|NCT01121549|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22383133|NCT03619226|Coloplast A/S|Julie Schnipper, Medical Writer|49111257|dkjuls@coloplast.com|
22383134|NCT04786457|University of Maryland, Baltimore, Center for Vaccine Development and Global Health|Kirsten E. Lyke, MD|410-706-5328|klyke@som.umaryland.edu|
22383135|NCT03073941|Zimmer Biomet|Chiara Griffoni, Clinical Project Senior Lead|+41 79 560 16 28|chiara.griffoni@zimmerbiomet.com|
22383136|NCT04250883|Radboud umc|Dr. Michiel Warle|024-3613808|michielwarle@radboudumc.nl|
22383137|NCT02763319|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22383138|NCT03936660|Duke Clinical Research Institute|Chris Granger, MD|9196688700|christopher.granger@duke.edu|
22383139|NCT00589277|Yale University School of Medicine|Benjamin Toll, Ph.D. Associate Professor of Psychiatry|(203) 974 5767|benjamin.toll@yale.edu|
22383140|NCT00925587|Amgen Inc.|Study Director|866-572-6436||
22383141|NCT00490802|Holland Bloorview Kids Rehabilitation Hospital|Dr. Evdokia Anagnostou|416-753-6005|eanagnostou@hollandbloorview.ca|
22383142|NCT00085436|Dartmouth-Hitchcock Medical Center|Dr. Marc S. Ernstoff|603-650-5534|marc.s.ernstoff@hitchcock.org|
22383143|NCT01668940|The Hospital for Sick Children|Dr Shinya Ito, Principal Investigator|4168135776|shinya.ito@sickkids.ca|205776
22383144|NCT01460446|Hoffmann-La Roche|Medical Communications|800 821-8590||
22383145|NCT00516321|GlaxoSmithKline|GSK Response Center|866-435-7343||
22383146|NCT00373386|Research Institute at Nationwide Children's hospital|Robert P. Hoffman MD|614-722-4425|robert.hoffman@nationwidechildrens.org|
22383147|NCT01556724|University of Pittsburgh|Susan Sandusky|412-383-1036|sis127@pitt.edu|
22383148|NCT01925469|University of Pennsylvania|Dr. Emelia Bachman|443-955-9195|emeliacleo@gmail.com|
22383149|NCT02271854|Novartis Consumer Health a GSK Consumer Healthcare company|Director Clinical Research pain category|+413635528||
22383150|NCT01308567|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22383151|NCT01571596|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
22383152|NCT03344536|Memorial Sloan Kettering Cancer Center|Dr. Komal Jhaveri MD|646-888-5145|jhaverik@mskcc.org|
22383153|NCT02499159|Inova Health System|Devon Collins|703-776-4096|Devon.Collins@inova.org|
22383154|NCT01599793|University of Chicago|Russell Szmulewitz, MD|773-702-7609|rszmulew@medicine.bsd.uchicago.edu|
22383155|NCT02564744|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
22383156|NCT02966275|MGH|Courtney Balliro BS, RN, CDE|617-726-1242|cballiro@partners.org|
22383157|NCT03122236|University of Florida|Dr. David Clark|352-376-1611|davidclark@ufl.edu|105244
22383158|NCT00829036|Atlanta VA Rehab R&D Center of Excellence|David A. Ross|404-321-6111|ross0128@bellsouth.net|6817
22383159|NCT04530149|Maimonides Medical Center|Research Administration Director|7182836896|alikourezos@maimo.org|
22383160|NCT00538759|Minneapolis Heart Institute Foundation|Lisa Tindell, Director of Clinical Operations|6128633816|Lisa.Tindell@allina.com|
22383161|NCT02675244|Icahn School of Medicine at Mount Sinai|Annetine Gelijns|212-659-9567|annetine.gelijns@mountsinai.org|
22383162|NCT04040296|Yale University|Abinet Aklilu|203-737-1787|abinet.aklilu@yale.edu|
22383163|NCT01956032|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22397193|NCT00578136|The Children's Hospital of Philadelphia|Harshad Gurnaney, MBBS, MPH|267-426-5850|gurnaney@email.chop.edu|
22397194|NCT00891982|GlaxoSmithKline|GSK Response Center|866-435-7343||
22397195|NCT05815719|Instituto Bernabeu|Juan Carlos Castillo|+34965154000|jcastillo@institutobernabeu.com|
22397196|NCT05419128|CHESS - University of Wisconsin--Madison|Kasey Thompson|608-590-7821|kfwagner@wisc.edu|
22397197|NCT00517751|Medtronic Spinal and biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
22397198|NCT01671423|Einstein Medical Center|Scott Goldstein|2154561836|goldstes@einstein.edu|
22397199|NCT02958007|VA Maryland Healthcare System|Anjana Muralidharan|443-421-6275|anjana.muralidharan2@va.gov|
22397200|NCT02581202|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22397201|NCT05885737|CSL Behring|Clinical Study Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22397202|NCT00609791|City of Hope|Dr. Mina Sedrak|6263598111|msedrak@coh.org|
22428172|NCT01931098|National Cancer Institute|Dr. Kevin Camphausen|240-760-6205|camphauk@nih.gov|
22397203|NCT04218201|NYU Langone Health|Rebecca Stone|646-754-5322|Rebecca.Stone@nyulangone.org|
22397204|NCT04129528|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22397205|NCT00218491|Medical University of SC|Robert Malcolm, MD|843-792-1901|malcomr@musc.edu|
22397206|NCT00605423|Johns Hopkins University|Peter Campochiaro, M.D.||pcampo@jhmi.edu|
22397207|NCT00490568|GlaxoSmithKline|GSK Response Center|866-435-7343||
22397208|NCT03118232|University of California, Irvine|Dr. Susan Huang|714-456-5047|sshuang@hs.uci.edu|
22397209|NCT03927105|Hoosier Cancer Research Network|Adelai Neal|317-921-2053|aneal@hoosiercancer.org|
22397210|NCT03303950|HCI Research Compliance Office|Data Manager|8015850601|compliance@hci.utah.edu|
22397211|NCT02933034|Stanford University|Phillip C. Yang|(650) 498-8008|phillip@stanford.edu|
22397212|NCT02819635|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22397213|NCT01081912|Zogenix|Kevin Romanko|(510) 550-8323|kromanko@zogenix.com|
22397214|NCT02868242|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22397215|NCT00556452|University of Michigan Cancer Center|Dr. John Magenau|734/936-8785|johnmage@umich.edu|
22397216|NCT02152085|University of Colorado Boulder|Roger Enoka|3034927232|enoka@colorado.edu|
22397217|NCT00783094|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22397218|NCT01324232|Avanir Pharmaceuticals|Avanir Medical Information|855-572-2722|medinfo@avanir.com|
22397219|NCT02513329|Northwestern University|Paul Fitzgerald|312-695-1064|p-fitzgerald2@northwestern.edu|
22397220|NCT05440539|Houston Methodist Hospital|Dr. Emily Rutledge|713-441-5800|erut@me.com|
22397221|NCT01265615|Ural Institute of Cardiology, Ural State Medical Academy|Dr. Alexander Kharlamov|+79638547663|drskharlamov@gmail.com|
22397222|NCT01471015|University of Utah|Dr. Mariana Baserga|801-581-7052|mariana.baserga@hsc.utah.edu|
22397223|NCT01732796|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22397224|NCT05626270|Erchonia Corporation|Travis Sammons|864-531-0064|tsammons@erchonia.com|
22397225|NCT00330382|University of California, Irvine|Dr. Frank Meyskens, Jr.|714-456-6310|flmeyske@uci.edu|
22397226|NCT02684604|Ain Shams Maternity hospital|amr ahmed mahmoud riad|01005347179|amr.riad@med.asu.edu.eg|+2
22397227|NCT03200366|Indiana University|Susan M. Rawl, PhD, RN, FAAHB, FAAN|317-278-2217|srawl@iu.edu|
22397228|NCT00405067|Aegerion Pharmaceuticals|Chief Medical Officer|617-500-7867||
22397229|NCT02055820|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22397230|NCT02285777|GlaxoSmithKline|GSK Response Center|866-435-7343||
22397231|NCT00552175|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22397232|NCT01437852|Stratatech Corporation, a Mallinckrodt Company|Mary Lokuta|608-441-8358|mlokuta@stratatechcorp.com|
22397233|NCT04677959|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
22397234|NCT01399788|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22397235|NCT02919436|Maine Medical Center|Dr. Anand Rughani|207-885-0011|arughani@mmc.org|
22397236|NCT04718974|Infectious Diseases Institute, College of Health Sciences, Makerere University|Dr. Agnes Bwanika Naggirinya|+256752521570|anaggirinya@idi.co.ug|
22397237|NCT01389752|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22397238|NCT02409290|MRC CTU at UCL, University College London, London UK|Dr Ruth Goodall|+44 2076704728|r.goodall@ucl.ac.uk|
22397239|NCT02830776|Formerly - Tulane University Department of Dermatology. Currently - Suzanne Bruce and Associates, PA|Megan Couvillion, MD, FAAD|504-473-2915|megan.couvillion@gmail.com|
22397240|NCT03339206|University of North Carolina at Chapel Hill|Adam O. Goldstein|984-974-0210|adam_goldstein@med.unc.edu|
22397241|NCT02668874|University of Iowa College of Dentistry|Director of Clinical Research|319-467-1398|dentistry-research@uiowa.edu|
22397242|NCT03300674|Montefiore|Benjamin W. Friedman|718-920-6626|befriedm@montefiore.org|
22397243|NCT01024010|Mayo Clinic|Tait D. Shanafelt, M.D.||shanafelt.tait@mayo.edu|
22397244|NCT00841789|Seattle Childrens hospital|Michael A Portman|2069871014|michael.portman@seattlechildrens.org|
22397245|NCT01664559|BWH|Dr. Lynn Ngo, Lead Study Coordinator/investigator|(617)732-8798|llngo@partners.org|
22397246|NCT03631732|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22397247|NCT01439204|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22397248|NCT01251367|Ipsen|Medical Director, Neurology,||clinical.trials@ipsen.com|
22397249|NCT02255409|Seqirus|Clinical Study Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com|
22397250|NCT03917823|University of California San Diego|Brian Ilfeld, MD, MS|858-822-0776|bilfeld@health.ucsd.edu|
22397251|NCT00135668|Duke University Medical Center|Scott Schulman, MD|919-681-4877|schul003@mc.duke.edu|
22397252|NCT01732809|Brazilian Center for Studies in Dermatology|Scientific Coordinator|+55 51 30262633|cientifico@cbed.org.br|
22397253|NCT02008682|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22397254|NCT02290873|PAION UK Ltd|Trial Information|+49 2414453101|reg_paion@paion.com|
22397255|NCT02370615|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22397256|NCT03715153|Institut de Recherches Internationales Servier (I.R.I.S.)|Dr. Pierre-François PENELAUD|+ 33 1 55 72 68 58|pierre-francois.penelaud@servier.com|
22397257|NCT04126083|Mayo Clinic|W. Michael Hooten, M.D.|507-266-9672|Hooten.William@mayo.edu|
22397258|NCT03471975|Ajou University School of Medicine|Jihoon Hwang|+821093103304|kironojh@gmail.com|
22397259|NCT01892163|Moorfields Eye Hospital NHS Foundation Trust|Professor Sobha Sivaprasad|02072533411|sobha.sivaprasad@moorfields.nhs.uk|
22397260|NCT02577146|Washington University School of Medicine|Alana Desai, M.D.|(314) 362-7581|desaia@wustl.edu|
22397261|NCT03116698|Dr. Reddy's Laboratories Inc.|Dr. Srinivas Sidgiddi|6093759910|srinivassidgiddi@drreddys.com|
22397262|NCT02258451|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22397263|NCT01031550|UMDNJ|Yuriy Gubenko, MD|973 972-5007|yuriygubenko@yahoo.com|
22428173|NCT02612155|Duke University|Dr. Kim Fisher, Ph.D., FNP-BC|919-681-4913|kimberley.fisher@duke.edu|
22428174|NCT05233761|Defined Research Institute|Paul Muchowski|415-413-8666|paul.muchowski@definedresearch.org|
22428175|NCT04235374|University of Maryland|Barbara Resnick|410 706 5178|resnick@umaryland.edu|
22383164|NCT02652442|James H Quillen VAMC|Research Health Science Specialist|(423) 926-1171|courtney.hall@va.gov|7518
22383165|NCT02252042|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22383166|NCT01065506|The University of Texas at Austin|Jasper Smits|512-475-8095|smits@utexas.edu|
22383167|NCT02593149|Pursuit Vascular, Inc.|Laurie Lynch, PhD|6124249006|llynch@pursuitvascular.com|
22383168|NCT01571557|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22383169|NCT01177670|Hologic, Inc.|Edward Evantash, MD|508-263-8475|edward.evantash@hologic.com|
22383170|NCT00979992|NRG Oncology Statistics and Data Management Center - Buffalo Office|Angela M. Kuras, Associate Director of Administration and Operations|716-845-5702|kurasa@nrgoncology.org|
22383171|NCT03835819|Dana-Farber Cancer Institute|Dr. Panagiotis Konstantinopoulos|617-632-5269|Panagiotis_Konstantinopoulos@dfci.harvard.edu|
22383172|NCT01140048|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22383173|NCT02888080|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22383174|NCT04283552|Washington University School of Medicine|Richard L. Wahl, M.D.|314-362-7100|rwahl@wustl.edu|
22383175|NCT04530747|Pennington Biomedical Research Center|Prachi Singh|12257633151|prachi.singh@pbrc.edu|
22383176|NCT03292913|RTI International Institute|Megan Lewis|206-268-3613|melewis@rti.org|
22383177|NCT03950622|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22383178|NCT03977935|Changhai Hospital|Investigator of Clinical Trials|15021569528|1372971347@qq.com|
22383179|NCT01224015|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22383180|NCT01047241|Copenhagen University Hospital, Rigshospitalet|Sponsor's contact person Bettina Nygaard Nielsen|+45 35459546|bettina.nygaard.nielsen@regionh.dk|
22383181|NCT03531840|National Cancer Institute|Dr. Raffit Hassan|240-760-6232|raffit_hassan@nih.gov|
22383182|NCT00770757|Washington University School of Medicine|John F. DiPersio, M.D., Ph.D.|314-454-8603|jdipersi@dom.wustl.edu|
22383183|NCT02267824|Shaughnessy Orthodontics|Dr. Timothy Shaughnessy|770-495-9590|staff@straightteethdoc.com|
22383184|NCT02928224|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22383185|NCT02538107|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22383186|NCT01278394|Anacor Pharmaceuticals, Inc.|Sheryl Baldwin, RN/Associate Director|650-223-8597|clinicaltrials@anacor.com|
22383187|NCT02471755|Guang'anmen Hospital of China Academy of Chinese Medical Sciences|Dr.Xiaoxu Liu|+86 10 8800 1124|liuxiaoxu_lxx@163.com|
22383188|NCT03302741|The University of Texas Health Science Center at Houston|Sheng Li, MD, PhD|713-797-7125|sheng.li@uth.tmc.edu|
22383189|NCT00958633|University Of British Columbia|Dr. Lakshmi Yatham|604-822-7310|yatham@mail.ubc.ca|
22383190|NCT01649180|ECOG-ACRIN Biostatistics Center|PrECOG Statistician|617-632-3633|jmanola@jimmy.harvard.edu|
22383191|NCT01576952|InSite Vision|Senior Manager, Clinical Sciences||manjiri.desai@sparcmail.com|
22383192|NCT00094575|VAMC Minneapolis, MN|Dr. Frank A. Lederle|612-725-2158|Frank.Lederle@va.gov|
22383193|NCT00794118|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22383194|NCT00042224|Northshore LIJ Health System|Georgios Petrides, M.D.|718-470-8569|GPetride@NSHS.EDU|
22383195|NCT01597258|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22383196|NCT04789408|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
22383197|NCT04411056|The Guthrie Clinic|Praneet Madabhushi MD|5708874882|praneeth.madabhushi@guthrie.org|
22383198|NCT04623008|Ohio State University College of Nursing|Mei-Wei Chang, PhD|614-247-7211|chang.1572@osu.edu|
22383199|NCT03702842|University of Florida|Emily J Fox, Research Associate Professor|352-273-6085|ejfox@phhp.ufl.edu|
22383200|NCT03568422|Canadian Cancer Trials Group|Pierre-Olivier Gaudreau|6135336430|p-ogaudreau@ctg.queensu.ca|
22383201|NCT02631603|LMU/ Haunersches Kinderspital|Prof. Dr. med. Matthias Griese|+498944000|matthias.griese@med.uni-muenchen.de|57870
22383202|NCT03122886|Mayo Clinic|Aminah Jatoi, MD|507/284-2511|Jatoi.Aminah@mayo.edu|
22383203|NCT02460900|NIH|National Heart, Lung and Blood Institute--Josh Fessel|3018275514|josh.fessel@nih.gov|
22383204|NCT05985044|Johns Hopkins University School of Nursing|Dr.Binu Koirala|707-225-2166|bkoiral1@jhu.edu|
22383205|NCT04888637|University of Arkansas for Medical Sciences (UAMS)|University of Arkansas for Medical Sciences (UAMS)|501-526-6876|ORRAClinicalTrials-govadmin@uams.edu|
22383206|NCT04163328|UAB|Dr. Kelly K. Nichols|205-975-9935|nicholsk@uab.edu|
22383207|NCT02279095|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22383208|NCT05938413|Columbia University|Rebecca Schnall, PhD, MPH, RN|212-342-6886|rb897@cumc.columbia.edu|
22383209|NCT03312907|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22383210|NCT04688450|Massachusetts General Hospital|Dr. Andrew Tomas Reisner|617-726-2241|areisner@mgh.harvard.edu|
22383211|NCT04498052|University of Utah|Kensaku Kawamoto, MD, PhD, MHS / Associate Chief Medical Information Officer|801-581-4080|kensaku.kawamoto@utah.edu|
22383212|NCT02576574|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22383213|NCT03481777|Aarhus University Hospital|Dr. Rolf Blauenfeldt|0045 78450000|rolfblau@rm.dk|
22383214|NCT03189524|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22383215|NCT04879524|Queen Mary University of London|P Chaichanavichkij|020 7882 8752|p.chaichanavichkij@qmul.ac.uk|
22383216|NCT01780298|Philip Morris Products S.A.|Julia HOENG, PhD|+41 (58) 242 2214|clinicaltrials.pmi@pmi.com|
22383217|NCT03718065|Medical University of South Carolina|Dr. Constance Guille|843-792-6489|guille@musc.edu|
22397264|NCT03021499|Aurinia Pharmaceuticals|Rashieda Gluck|1 (250) 744-2487|clinicaltrials@auriniapharma.com|
22397265|NCT00495820|Central Arkansas Veterans Healthcare System|Prasad Padala, MD, MS, Associate Director for Clinical Programs, GRECC|5012572537|prasad.padala@va.gov|
22397266|NCT00820950|Incyte|Incyte Corporation Call Center (US)|1.855.463.3463|medinfo@incyte.com|
22397267|NCT01878526|Khon Kaen University|Dr.Chingching Foocharoen|6643363746|fching@kku.ac.th|
22397268|NCT00789529|Manhattan Vision Associates / Institute for Vision Research|Dr. George Zikos|2126884277|gzikos@mvaivr.com|
22397269|NCT01870401|Becton Dickinson|Lisa Erickson|763-463-2897|Lisa.Erickson@bd.com|
22397270|NCT02289222|University of Maryland Greenebaum Comprehensive Cancer Center|Ashraf Badros M.B.Ch.B|410-328-1230|Abadros@umm.edu|
22397271|NCT01135498|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22397272|NCT01192022|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22397273|NCT01351389|Brown University, Center for Alcohol and Addiction Studies|Dr. Peter Monti|(401) 863-6661|peter_monti@brown.edu|
22397274|NCT04839978|Emory University|Kelli Komro, PhD|404-727-8742|kkomro@emory.edu|
22397275|NCT03045861|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22397276|NCT03551509|Cleveland Clinic|Dr. Gregory Gilot|786 566-9176|gilotg@ccf.org|
22397277|NCT01902966|UT MD Anderson Cancer Center|Lois M. Ramondetta, MD, Professor, Gynecologic Oncology & Reproductive Medicine|713-745-0307|lramonde@mdanderson.org|
22397278|NCT01549275|Kaohsiung Medical University Hospital|Dr. Zu-Yau LIn|886-7-323-4553|linzuyau@yahoo.com.tw|
22397279|NCT00122681|GlaxoSmithKline|GSK Response Center|866-435-7343||
22397280|NCT03078075|UT Southwestern Medical Center|Dr. Madhukar Trivedi|214/648-0188|Madhukar.Trivedi@UTSouthwestern.edu|
22397281|NCT02841397|Masimo Corporation|Cristina Johnson|(949) 297-7000|clinicalresearchdept@masimo.com|
22397282|NCT02324920|BIOTRONIK Italiy|Daniele Giacopelli|+39 3491712305|daniele.giacopelli@biotronik.com|
22397283|NCT01757678|HeartFlow|VP Clinical, Quality & Regulatory Affairs|650-241-1221|clinicalresearch@heartflow.com|
22397284|NCT02004262|Aduro Biotech, Inc.|Corporate Communications|510-848-4400||
22397285|NCT01146873|Columbia University|Louise Kuhn, PhD|212-305-2398|lk24@cumc.columbia.edu|
22397286|NCT03703102|Kyowa Kirin Co., Ltd.|Research & Development Planning Department, Research & Development Division|+81-3-5205-7200|clinical.info.jp@kyowakirin.com|
22397287|NCT00876187|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22397288|NCT01379274|Rush University Medical Center|Dr. Jamile Shammo|312-CANCER-1|jamile_shammo@rush.edu|
22397289|NCT04331795|University of Chicago, Department of Medicine Section of Rheumatology|Dr. Pankti Reid|773-702-6119|pankti.reid@uchospitals.edu|
22397290|NCT01224626|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22397291|NCT05074251|UCLA|Dr. Dvora Joseph Davey|310-701-1526|dvoradavey@ucla.edu|
22397292|NCT03287219|Cosmo Technologies Ltd|R&D Manager||rjones@cosmopharma.com|
22397293|NCT00957008|University of South Carolina|Project director|8037773881|msui@mailbox.sc.edu|
22397294|NCT00811135|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22397295|NCT01118351|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Jorge Garcia|216-444-7774|garciaj4@case.edu|
22397296|NCT00518154|Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán|Dr. Carlos Aguilar Salinas, Director of Ethics in Human Research Committee|5554870900|carlos.aguilars@incmnsz.mx|4524
22397297|NCT03345108|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22397298|NCT02192827|Johns Hopkins all childrens hospital|Meghan Martin|9417373107|mmart163@jhmi.edu|
22397299|NCT05112536|G1 Therapeutics, Inc.|Clinical Trial Info.|919-213-9835|clinicalinfo@g1therapeutics.com|
22397300|NCT03571646|Medtronic|Geraldine Kelly|+353 879840223|geraldine.kelly@medtronic.com|
22397301|NCT03972969|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov|
22397302|NCT00283595|Massachusetts General Hospital|Anne Klibanski, MD|617-726-3870|aklibanski@partners.org|
22397303|NCT02459795|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
22397304|NCT00845728|Novartis Pharmaceuticals|Study Director|862-778-8300||
22397305|NCT03259074|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
22397306|NCT04081363|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22397307|NCT01717209|Stanford University|Charles Hill|(650) 725-1930|chill1@stanford.edu|
22397308|NCT01713621|Medicines for Malaria Venture|Dr. Jörg J. Möhrle|+41 22 555 03 00|moehrlej@mmv.org|
22397309|NCT00705783|Otsuka Pharmaceutical Development and Commercialization|Global Medical Affairs|800 562-3974||
22397310|NCT02182687|Lahey Hospital & Medical Center|Julia Roache|781-744-3055|julia.roache@lahey.org|
22397311|NCT02327052|Hospital São Rafael|Dr. Milena Botelho Pereira Soares|+557132816455|milenabpsoares@gmail.com|
22397312|NCT00445484|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Ivan Borrello|(410) 955-4967|iborrell@jhmi.edu|
22397313|NCT04251910|BioXcel Therapeutics|Vice President Head of Clinical Operations|(475) 355 5177|cgommoll@bioxceltherapeutics.com|
22397314|NCT02788097|Antalya IVF|Kevin Coetzee|090 242 345 4700|kevincoetzee61@yahoo.co.nz|
22397315|NCT01722604|Bausch & Lomb|Daniel Donatello|(585) 338-5306|Daniel.Donatello@bausch.com|
22397316|NCT01707043|Wake Forest|Steve Feldman, MD|336-716-3775|sfeldman@wakehalth.edu|
22397317|NCT03831971|Clinical Center|Masur, Henry|+1 301 496 9320|hmasur@cc.nih.gov|
22397318|NCT03451084|ASLAN Pharmaceuticals|Study Director|+65 6222 4235|contact@aslanpharma.com|
22428176|NCT01551173|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22428177|NCT04612400|The University of Arkansas for Medical Sciences|Katie Rose Hisrch, Ph.D.|5015265708|krhirsch@uams.edu|
22397319|NCT00573989|Wake Forest University Health Sciences|Dr. Mercedes Porosnicu|336-716-8664|mporosni@wakehealth.edu|
22428178|NCT01394276|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22428179|NCT04530344|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22383218|NCT05286385|Cochlear Ltd.|PRS Specialist, Clinical Affairs|+61294286555|cltd-prs-admin@cochlear.com|
22383219|NCT04046848|Octapharma|Sigurd Knaub, Senior VP CR&D Haematology|01554512141|Sigurd.Knaub@octapharma.com|
22383220|NCT05930782|MMV Medicines for Malaria Venture|Dr Anne Claire Marrast|+41 22 555 03 00|marrasta@mmv.org|
22383221|NCT03613740|University of Guadalajara|PhD. Karina G. Pérez Rubio|+52 1 3310585200|karina.prubio@academicos.udg.mx|
22383222|NCT01693120|Medtronic AF Solutions|Bob Hokanson, Clinical Research Manager|763.526.2811|robert.hokanson@medtronic.com|
22383223|NCT01741363|Department of Internal Medicine, National Taiwan University Hospita|Han-Mo CHIU|+886-2-23123456|hanmochiu@ntu.edu.tw|63354
22383224|NCT03803605|University of North Carolina at Chapel Hill|Cynthia Gay, MD, MPH|919-966-2537|cynthia_gay@med.unc.edu|
22397320|NCT04544475|NYU Langone Health|Lila Nachtigall|2122636361|Lila.Nachtigall@nyulangone.org|
22397321|NCT01765920|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22397322|NCT03223428|TerSera Therapeutics LLC|Noran Osman, PharmD, MHS, Associate Director, External Research and Medical|+1-224-754-4605|nosman@tersera.com|
22397323|NCT02025907|Janssen Research & Development, LLC|Senior Director, Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
22397324|NCT00777101|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
22397325|NCT02017327|Laboratoires Thea|Director of medical operation|+473985089|J.auger@laboratoires-thea.fr|
22397326|NCT02411539|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22397327|NCT02153528|Institute of Tropical Medicine Antwerp|Clinical Trials Unit ITM|0032 32470778|jbuyze@itg.be|
22397328|NCT02031770|University of Colorado Denver|Dr. Jessica Kendrick|3037244837|Jessica.Kendrick@ucdenver.edu|
22397329|NCT00282334|Dept. of Medical Research, Holstebro Hospital|Line Bille Madsen|+45 99125421|linemads@rm.dk|
22397330|NCT01947816|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22397331|NCT00471705|Universidad de Antioquia - Colombia|Iván Darío Vélez Bernal|574 + 219 6501 - 02|idvelez@pecet-colombia.org|
22397332|NCT01422915|BrighamHospital|Dr. Peter V. Tishler|617-525-2123|repvt@channing.harvard.edu|
22397333|NCT01265797|University of Toledo|Gretchen Tietjen, MD|419-383-3544|gretchen.tietjen@utoledo.edu|
22397334|NCT01298752|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22397335|NCT06290206|University of Utah|Kaila Christini, MsPH, MS|801-587-4565|Kaila.Christini@hci.utah.edu|
22397336|NCT00336973|Genentech, Inc.|Medical Communications Specialist|800-821-8590||
22397337|NCT00583362|GlaxoSmithKline|GSK Response Center|866-435-7343||
22397338|NCT03998046|Northwestern University|Ronald Ackermann, MD, MPH|(312)-503-3232|r.ackermann@northwestern.edu|
22397339|NCT02431572|Massachusetts General Hospital|Dr. Elizabeth Gerstner|617-724-8770|EGERSTNER@mgh.harvard.edu|
22397340|NCT00506883|AR Scientific, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22397341|NCT00455013|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22397342|NCT00078325|Cephalon|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
22397343|NCT01473563|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22397344|NCT01519765|Stanford University|Dr. Linh Tran|925-642-2241|lltran20@gmail.com|
22397345|NCT03610724|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22397346|NCT03054922|Nationwide Children's Hospital|David P. Martin, MD|614-722-4200|david.martin@nationwidechildrens.org|
22397347|NCT01699542|Boston Scientific Corporation|Joyce Peetermans, PhD - Vice President, Global Clinical Programs|508-683-4211|Joyce.Peetermans@bsci.com|
22397348|NCT05513625|AiCuris Anti-infective Cures AG|Information Desk|+4920231763|info@aicuris.com|0
22397349|NCT00754793|University of Washington|Dr. Greg E. Davis, MD MPH|206-543-5230|gedavis@uw.edu|
22397350|NCT02943564|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
22397351|NCT00932360|University of Iowa|Dana Dailey|319-335-7149|dana-dailey@uiowa.edu|
22397352|NCT02536313|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22397353|NCT00917150|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22397354|NCT01080248|Washington University School of Medicine|Joel Picus, M.D.|314-362-5740|jpicus@dom.wustl.edu|
22397355|NCT04143009|University of North Carolina at Chapel Hill|Brian Wells Pence, PhD|+1 919-966-7446|bpence@unc.edu|
22397356|NCT03704142|University of Massachusetts Amherst Dept. of Communication Disorders|Dr. Karen Helfer|413-545-4014|khelfer@comdis.umass.edu|
22397357|NCT01066364|UCSD|Rohit Loomba, MD|858-246-2201|roloomba@ucsd.edu|
22397358|NCT00874120|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22397359|NCT03615183|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22397360|NCT00105443|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22397361|NCT03187769|Alkermes|Global Clinical Services|888-253-8008|clinicaltrials@alkermes.com|
22397362|NCT01623271|Massachusetts General Hospital|Jianren Mao, MD, PhD|617-724-6102|jmao@mgh.harvard.edu|
22397363|NCT03402607|Duke University Health System|Linda Kaltenbach|919-681-6804|Linda.Kaltenbach@duke.edu|
22397364|NCT02037295|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Jonathan Krakoff, M.D.|(602) 200-5217|jkrakoff@mail.nih.gov|
22397365|NCT03077347|University of CA Davis Health|Tiffany T . Norris|916-703-9193|ttnorris@ucdavis.edu|
22397366|NCT01981590|Medtronic Bakken Research Center|Lilian Kornet, Prin.Scientist|+31433566710|lilian.kornet@medtronic.com|
22397367|NCT02770547|Purdue University|Bruno Roseguini, Assistant Professor|(765) 496-2612|brosegui@purdue.edu|
22428180|NCT03279952|Penn State College of Medicine|Raman Baweja, MD|7175318521|rbaweja@pennstatehealth.psu.edu|
22397368|NCT00661531|Georgetown University|Dr. Claudine Isaacs|2024443677|isaacsc@georgetown.edu|
22397369|NCT00060346|ECOG Statistical Office|Study Statistician|617-632-3012||
22397370|NCT03134599|CooperVision|Jose Vega, O.D., MSc., FAAO|9252516213761|javega@coopervision.com|
22397371|NCT00393887|Cook Biotech Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@cookbiotech.com|
22397372|NCT02311153|Vanderbilt University Medical Center|Justin H. Turner, MD, PhD||justin.h.turner@vanderbilt.edu|
22397373|NCT01967628|University of Iowa|Dr. Alicia Gerke|319-356-1869|alicia-gerke@uiowa.edu|
22397374|NCT00838331|Emory University|John Roback, MD PhD|404-712-1774|jroback@emory.edu|
22397375|NCT01445951|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
22397376|NCT04901481|TheraNova, LLC|Director of Clinical|4159268616|clinicalstudy@theranova.com|
22397377|NCT02739620|University of Vermont|Michael J. Toth|802-656-7989|michael.toth@med.uvm.edu|
22397378|NCT00786565|Bausch & Lomb|Jon Hayashida|(585) 338-6370|jon.hayashida@bausch.com|
22397379|NCT00730964|GE Healthcare|Rubin Sheng, MD|1-609-514-6899|Rubin.Sheng@ge.com|
22397380|NCT02218242|University of Kentucky|Angela Mahan|859 257 4488|angela.mahan@uky.edu|
22397381|NCT00993265|Yale University, Child Study Center|Dr. Michael Bloch, MD, MS|203-737-4809|michael.bloch@yale.edu|
22397382|NCT03765138|Columbia University Medical Center/New York State Psychiatric Institute|Dr. Yuval Neria|646-774-8092|Yuval.Neria@nyspi.columbia.edu|
22397383|NCT00781911|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22397384|NCT00219284|Novartis Pharmaceuticals|Study Director|862-778-8300||
22397385|NCT01357655|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22397386|NCT05003622|Pierre Fabre Medicament|Jean Claude Vedovato|+33 609828746|jean.claude.vedovato@pierre-fabre.com|
22397387|NCT01692275|Palmer Center for Chiropractic Research|Dr. Cyndy Long|563-884-5157|LONG_C@palmer.edu|
22397388|NCT03924752|Georgia Institute of Technology|Dr. Aaron Young|404-385-5306|aaron.young@me.gatech.edu|
22397389|NCT02012621|University of Colorado-AMC|Dr. Jose Castillo-Mancilla|303-724-4934|jose.castillo-mancilla@cuanschutz.edu|
22397390|NCT01916928|Medstar Washington Hospital Center|Cecily A. Clark-Ganheart|202-877-3067|ganheartmd@gmail.com|
22397391|NCT01445821|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
22397392|NCT01624662|OptiNose|Vice President Global Clinical Operations & Outsourcing|267-364-3508|jennifer.carothers@optinose.com|
22397393|NCT00361270|Michael E DeBakey VAMC|Wright Williams, Ph.D., ABPP|713-794-7629|wright.williams@va.gov|
22397394|NCT02351505|The Ohio State University Comprehensive Cancer Center|Erin Bertino, MD|614-293-8054|Erin.Bertino@osumc.edu|
22397395|NCT00533442|University of Miami|Dr. George W. Burke, III|305-355-5111|gburke@med.miami.edu|
22397396|NCT03921021|Weill Cornell Medicine|Manish Shah, MD|(646) 962-6200|mas9313@med.cornell.edu|
22397397|NCT04473690|KBio Inc|Katrina Whelan|2706893345|katrinaw@KBio.com|
22397398|NCT00278993|Eisai Call Center|Eisai Inc.|888-422-4743||
22397399|NCT00470054|Wake Forest University|Antonius Miller||aamiller@wfubmc.edu|
22397400|NCT01439555|UMass Medical School|Elizabeth DeGrush, DO|508-334-1000|elizabeth.degrush@umassmemorial.org|
22397401|NCT03310450|Universitas Negeri Semarang|Mahalul Azam|+628122853982|mahalul.azam@mail.unnes.ac.id|
22397402|NCT00396201|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22397403|NCT04194528|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|adarke@fredhutch.org|
22397404|NCT04867473|Stanford University|Peter Bayley, PhD|650-493-5000|peter.bayley@va.gov|68653
22397405|NCT00616122|University of California, San Francisco|Hope S. Rugo|877-827-3222|clinicaltrials@ucsf.edu|
22397406|NCT03921424|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22397407|NCT01143727|Healthpoint, Ltd.|Jaime E. Dickerson, PhD; Sr. Director Clinical Affairs|817-302-3914|jaime.dickerson@healthpoint.com|
22428181|NCT04478266|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22428182|NCT04058717|Penn State College of Medicine|Nicolle Krebs|7175315673|nkrebs@pennstatehealth.psu.edu|
22428183|NCT02799602|Bayer AG|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22428184|NCT06006208|Thomas Jefferson University|Associate Professor|3059784358|moritayoshihisa2016@gmail.com|
22428185|NCT05430204|The University of Texas Health Science Center at Houston|Michal Fishel Bartal, MD|713-500-6421|Michal.F.Bartal@uth.tmc.edu|
22428186|NCT04356833|Royal Free London NHS Foundation Trust|Professor Pratima Chowdary|0207 794 0500|p.chowdary@nhs.net|35921
22428187|NCT04809974|Massachusetts General Hospital|Edmarie Guzmán-Vélez|6176436107|eguzman-velez@mgh.harvard.edu|
22428188|NCT04338581|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22397408|NCT01246583|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22397409|NCT02595450|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22397410|NCT02330978|University São Paulo|Jayter Silva de Paula, MD, PhD|55 16 3602-2499|jspaula@fmrp.usp.br|
22397411|NCT05264740|McMaster University|Dr. Laura Anderson|N/a|ln.anderson@mcmaster.ca|
22397412|NCT02813551|The University of Texas Health Science Center at Houston|Oscar Andres Viteri Molina, MD|(713) 500-6412|Oscar.A.ViteriMolina@uth.tmc.edu|
22397413|NCT00102960|Perinatal HIV Research Unit, Johannesburg and Children's Infectious Diseases Clinical Research Unit, Cape Town all in South Africa|Dr Avy Violari and Prof Mark Cotton|27 11 989 9702/27 21 938 4219|violari@mweb.co.za|9702/4219
22397414|NCT01423851|NS Pharma, Inc.|Medical Affairs|201-986-3860|trialinfo@nspharma.com|+1
22397415|NCT02901925|Dartmouth-Hitchcock|Dr. David Roberts|603-650-|David.W.Roberts@dartmouth.edu|
22397416|NCT01395394|Emory University|Kathryn Coakley|404-778-1286|kcoakle@emory.edu|
22397417|NCT02356562|AbbVie|Global Medical Services|800-633-9110||
22397418|NCT00150592|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22397419|NCT03787472|Johnson & Johnson Vision Care|Thomas R. Karkkainen, OD, MS, FAAO- Sr. Principal Research Optometrist|904-443-3402|TKarkkai@its.jnj.com|
22397420|NCT00412750|Novartis Pharmaceuticals|Study Director|862-778-8300||
22397421|NCT02227693|Eisai Inc.|Eisai Medical Services|1-888-274-2378|esi_medinfo@eisai.com|
22428189|NCT00549055|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22428190|NCT00770809|University of North Carolina - Lineberger Comprehensive Cancer Center|Lisa Carey, M.D.||lisa_carey@med.unc.edu|
22428191|NCT03834168|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Dr. Pankaj Arora|2059754720|parora@uabmc.edu|
22428192|NCT00770367|Medical University of South Carolina|Dana King MD|843-792-8112|kingde@musc.edu|
22428193|NCT00435942|Bolton Medical, Inc.|Annie Weiller|954-838-9699|AWeiller@boltonmedical.com|
22428194|NCT01898130|Northwestern University|Priya Kumthekar, MD|312-503-1818|p-kumthekar@northwestern.edu|
22428195|NCT04115059|Dana-Farber Cancer Institute|Jorge Castillo|617-632-2681|jorgej_castillo@dfci.harvard.edu|
22428196|NCT04491994|Pak Emirates Military Hospital (PEMH) Rawalpindi|Sultan Mehmood Kamran|+923008501100|sultanmajoka79@hotmail.com|
22428197|NCT03589703|Johns Hopkins University|Nada Lukkahatai, PhD, MSN, RN, CNE, FAAN|410-614-5297|nada.lukkahatai@jhu.edu|
22428198|NCT02234180|Memorial Sloan-Kettering Cancer Center|Yelena Y. Janjigian MD|646-888-4186|janjigiy@mskcc.org|
22383225|NCT02300298|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22383226|NCT00774397|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22383227|NCT00749749|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|Innocoll|484-406-5211|ctucker@innocoll.com|
22383228|NCT02663297|UNC Lineberger Comprehensive Cancer Center|Melahat Canter|919-962-0000|Melahat_Canter@med.unc.edu|
22383229|NCT01636687|Novartis Pharmaceuticals|Study Director|+1-862-778-8300|Novartis.email@novartis.com|
22383230|NCT01269749|University of Florida|Dr Scott Rivkees|352-273-9001|srivkees@ufl.edu|
22397422|NCT01823679|Stanford University Medical Center|Alexander Dimitrios Colevas, MD|650-724-9707|colevas@stanford.edu|
22428199|NCT03575364|Inari Medical|Ashleigh Willson|925-330-3446|ashleigh.willson@inarimedical.com|
22428200|NCT02567188|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22428201|NCT01033136|Michael E. DeBakey VA Medical Center|Dr. Ellen Teng|(713) 578-5513|Ellen.Teng@va.gov|
22428202|NCT05383209|EyePoint Pharmaceuticals, Inc.|Ramiro Ribeiro, MD, PhD|908-440-0979|rribeiro@eyepointpharma.com|
22428203|NCT01101100|Valeant Pharmaceuticals International|Lindsey Mathew|908|lindsey.mathew@valeant.com|
22428204|NCT00933933|Abbott Diagnostic Division|Barbara Kaesdorf, Associate Director Clinical Affairs|847-937-8702|barbara.kaesdorf@abbott.com|
22428205|NCT01532089|Duke University|Thomas E. Stinchcombe, M.D.|507/284-4565|thomas.stinchcombe@duke.edu|
22428206|NCT01138046|GlaxoSmithKline|GSK Response Center|866-435-7343||
22428207|NCT03149770|University of Minnesota|Anjali Kumar|612-301-7040|studydiabetes@umn.edu|
22428208|NCT00585182|University of Utah|Dr Robert Pendleton|801 581 7818|robert.pendleton@hsc.utah.edu|
22428209|NCT01104766|Allergan|Medical Director|877-277-8566|IR-CTRegistration@Allergan.com|
22428210|NCT03225482|VA San Diego Healthcare System|Elizabeth Twamley, PhD|858-642-3848|Elizabeth.Twamley@va.gov|
22428211|NCT05452239|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
22428212|NCT03965923|Fred Hutchinson Cancer Center|Daniel Szydlo|2066677451|dszydlo@fredhutch.org|
22428213|NCT02755090|University of New Mexico|Sharla Biefeld Research Coordinator|505-272-9703|hsc-familyplanningresearch@salud.unm.edu|
22428214|NCT00207740|Centocor Research & Development, Inc.|Director Clinical Research|1-800-457-6399||
22428215|NCT05473039|SEID|Ana Gavilán|+34 630928812|agavilan@lab-seid.com|
22428216|NCT04800627|UT MD Anderson Cancer Center|Dr. Michael Overman,MD- Assoc VP, CN Research, SVP, Cancer NW Clin & Acad Dev|(713) 792-2828|moverman@mdanderson.org|
22428217|NCT01402700|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com|
22428218|NCT01933594|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22428219|NCT03314935|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22428220|NCT00168298|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
22428221|NCT05252702|Abbott Medical Devices, Cardiac Rhythm Management|Nicole Harbert, Director of Clinical Research|972-526-4841|nicole.harbert@abbott.com|
22428222|NCT04153864|Sinai Health System (Canada)|Dr. Daisy R Singla|416-535-8501|daisy.singla@utoronto.ca|39423
22428223|NCT06442800|University of North Carolina at Chapel Hill|Marissa Hall, PhD|919-445-1310|mghall@unc.edu|
22428224|NCT03869268|The University of Sheffield|Dr William Parker|01142266159|w.parker@sheffield.ac.uk|
22428225|NCT05457855|Brigham and Women's Hospital|Rishi J Desai, PhD|617-278-0932|rdesai@bwh.harvard.edu|
22428226|NCT03331341|University of Washington|Dr. Ryan Lynch, Associate Professor|206-606-1739|rclynch@uw.edu|
22428227|NCT05352399|Yale School of Medicine|Cameron Gettel|717-228-7759|cameron.gettel@yale.edu|
22428228|NCT06354257|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22428229|NCT02401230|Emory University|Dr. Colleen Kelley|404-712-1823|colleen.kelley@emory.edu|
22428230|NCT02657551|Dana-Farber Cancer Institute|Kartik Seghal|000-000-0000|Kartik_Sehgal@dfci.harvard.edu|
22428231|NCT02251821|Fred Hutchinson Cancer Center|Rachel Salit|206-667-1317|rsalit@fredhutch.org|
22428232|NCT01579214|Massachusetts General Hospital|Dr. Mark Siedner|617-726-4686|msiedner@mgh.harvard.edu|917
22428233|NCT02164916|SWOG Statistics & Data Management Center|SWOG Statistician|206-667-4408|smcdonou@fredhutch.org|
22428234|NCT00296517|GlaxoSmithKline|GSK Response Center|866-435-7343||
22428235|NCT03229499|Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine|Dr. Steven M Kawut, MD, MS|646-352-1654|kawut@upenn.edu|
22428236|NCT00964782|Milton S. Hershey Medical Center|Compliance Specialist|7175310003|clinicaltrials.gov@pennstatehealth.psu.edu|287544
22428237|NCT02630030|Emory University|Dr. Jeffrey Olson|404-778-5770|jolson@emory.edu|
22428238|NCT00596635|Yale University School of Medicine|Manisha Juthani-Mehta, MD|(203)785-4140|manisha.juthanimehta@yale.edu|
22428239|NCT01484340|Johns Hopkins University School of Medicine|Dr. Jonathan E. Golub|443-287-2969|jgolub@jhmi.edu|
22428240|NCT01010763|Zimmer Biomet G.K.|Manager of Clinical Affairs|+81-3-6402-6610|takahito.nakai@zimmerbiomet.com|
22442776|NCT04585009|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22442777|NCT03699475|Bellicum|Contact for Clinical Trial Information|(832) 384-1100|clinicaltrials@bellicum.com|
22442778|NCT02871882|Mayo Clinic|Andres Acosta|15072666931|acosta.andres@mayo.edu|
22442779|NCT00732901|Virginia Commonwealth University|F. Gerard Moeller|804-828-4134|fgmoeller@vcu.edu|
22442780|NCT01514786|UMichigan|Dr. Masahito Jimbo|734-998-7120|mjimbo@med.umich.edu|
22442781|NCT04618770|Stryker|Kevin Barga|2018315073|kevin.barga@stryker.com|
22442782|NCT01733212|New York Methodist Hospital|Sandip Darji|718/780-3779|darji_sandip2005@yahoo.com|
22442783|NCT00422084|Medicines for Malaria Venture (MMV)|Stephan Duparc, MD, Chief Medical Officer|+41 22 555 0300|duparcs@mmv.org|351
22442784|NCT01579812|UPMC Hillman Cancer Center|Dr. Ronald Buckanovich, MD, PhD|412-641-4721|buckanovichrj@mwri.magee.edu|
22442785|NCT00653432|Anika Therapeutics, Inc.|Kara Mezger, Exec Director Clinical Affairs|781.457.9000|kmezger@anika.com|
22442786|NCT00357760|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
22442787|NCT02353143|Menarini Ricerche|Director of Clinical Sciences|003905556809990|acapriati@menarini-ricerche.it|
22442788|NCT00600119|AstraZeneca|Mark Sostek||ClinicalTrialTransparency@astrazeneca.com|
22442789|NCT04740905|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22397423|NCT01157078|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22397424|NCT01611974|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22397425|NCT00522431|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22397426|NCT00665457|University of Nebraska Medical Center|Elizabeth Reed, M.D.|402-559-5388|ereed@unmc.edu|
22397427|NCT00132132|SEMC|Dr. Shirley Gonzalez|617-926-0114|shirley.gonzalez@steward.org|
22397428|NCT02145741|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22397429|NCT03776175|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22397430|NCT01496885|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22397431|NCT03273166|Masimo|Chelsea Frank|(949) 297-7000|studies@masimo.com|
22397432|NCT01294670|Memorial Sloan Kettering Cancer Center|Tanya Trippett, MD|1-833-MSK-KIDS|trippet@mskcc.org|
22397433|NCT03808077|Memorial Sloan Kettering Cancer Center|Dr. Elizabeth Rieth, MD|212-639-5737|riethe@mskcc.org|
22397434|NCT02412787|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22397435|NCT03246958|Dana Farber Cancer Institute (DFCI)|Dr. Kartik Sehgal|617-632-3090|kartik_sehgal@dfci.harvard.edu|
22397436|NCT00354770|University of Chicago|Jon E. Grant|773-834-1325|jongrant@uchicago.edu|
22397437|NCT04086823|Raziel Therapeutics|Racheli Gueta , Director of Clinical trials|97289124670|racheli@raziel-therapy.com|
22397438|NCT01650636|University of Miami|Dr. Michael Antoni|305-284-5466|mantoni@miami.edu|
22397439|NCT01560780|VA North Texas Healthcare System|Shuaib Abdullah|214-857-1458|shuaib.abdullah@va.gov|
22397440|NCT00930761|Instituto de Puericultura e Pediatria Martagão Gesteira - UFRJ|Dr. Arnaldo Prata Barbosa|+55 21 25904891|arnaldoprata@globo.com|
22397441|NCT01598779|University of Buenos Aires|Dr. Laura Fleider|541159508000|laurafleider@hotmail.com|8582
22397442|NCT01970995|Philip Morris Products S.A.|Christelle HAZIZA, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
22397443|NCT03699007|Stanford University Medical School|Dr. Laura Simons|(650) 736-0838|lesimons@stanford.edu|
22397444|NCT00414453|University of Rochester|Robert H Dworkin|275-8214|robert_dworkin@urmc.rochester.edu|
22397445|NCT01709435|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22397446|NCT01157364|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
22397447|NCT00822757|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22397448|NCT01780662|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22397449|NCT01263639|Vanderbilt Medical Center|Dr. Brent J. Morris Orthopaedic Resident|615-835-0699|brent.j.morris@vanderbilt.edu|
22397450|NCT00183274|UPENN|Karl Rickels, M.D.|215-746-6417|krickels@mail.med.upenn.edu|
22428241|NCT00846365|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22428242|NCT00720759|VAHSRD|Stephen E. Nadeau|352-374-6082|stephen.nadeau@va.gov|
22428243|NCT02318940|Universidad de Chile|Dr. Pietro Pietroboni Fuster|+56982261539|pietroboni@gmail.com|
22428244|NCT01047319|Teva Pharmaceutical Industries, Ltd|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22428245|NCT03100747|University of North Carolina at Chapel Hill|Emily Gower, PhD|919-966-1420|egower@unc.edu|
22428246|NCT04376567|University of Arizona|Tze-Woei Tan|3234426835|tze-woei.tan@med.usc.edu; ttan@arizona.edu|
22428247|NCT00658619|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22428248|NCT03261193|UPMC|Nicholas Schott, MD|412-692-4503|schottnj@upmc.edu|
22428249|NCT01277861|University of Texas Southwestern Medical Center at Dallas|Girish P. Joshi, MD|214-590-7259|girish.joshi@utsouthwestern.edu|
22428250|NCT05032196|Wave Life Sciences USA, Inc|Medical Director, MD|+1 617-949-2900|info@wavelifesci.com|
22428251|NCT00857389|UT MD Anderson Cancer Center|Kris M Mahadeo, Associate Professor, Pediatrics - Patient Care|(713) 792-2873|kmmahadeo@mdanderson.org|
22428252|NCT00001305|National Institute of Child Health and Human Development|Marini, Joan|+1 301 594 3418|marinij@mail.nih.gov|
22442790|NCT00561977|UMass Medical School|Barbara Olendzki, RD MPH LDN|508-856-5195|barbara.olendzki@umassmed.edu|
22442791|NCT03077087|Regions Hospital|Joshua S Rosenzweig / Study Coordinator|651-254-3351|joshua.s.rosenzweig@healthpartners.com|
22442792|NCT01989468|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22383231|NCT00636207|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22383232|NCT00568854|Los Angeles County Department of Public Health|Dr. Alicia Chang|213-745-0846|alchang@ph.lacounty.gov|
22442793|NCT00568633|Stanford University|Robert Lowsky, Professor of Medicine (Blood and Marrow Transplantation)|650-725-8950|rlowsky@stanford.edu|
22442794|NCT00065429|ImmunoGen, Inc|CMO, ImmunoGen|781-895-0600|clinicaltrials@immunogen.com|
22442795|NCT00977080|Abbott|Global Medical Services|800-633-9110||
22442796|NCT03048006|Guerbet GmbH|Oliver Heine, MD, Radiology & Scientific Affairs Manager|+49 6196 76250|oliver.heine@guerbet-group.com|
22442797|NCT01534897|Massachusetts General Hospital Cancer Center|Dr. Lori J. Wirth|617 724 4000|lwirth@mgh.harvard.edu|
22442798|NCT01950013|Indiana University, Dept of Speech & Hearing Sci|Larry Humes|812-855-3507|humes@indiana.edu|
22442799|NCT01765218|University of California, Davis|Kristin Hoffman, MD|916-205-2755|krhoffman@ucdavis.edu|
22442800|NCT00313781|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22442801|NCT03148691|Aclaris Therapeutics|Executive Director, Clinical Operations|4843247933|jschnyder@aclaristx.com|
22442802|NCT01590758|Dipexium Pharmaceuticals, Inc|Robert J DeLuccia|+19145226503|delucciarj@gmail.com|
22442803|NCT02929498|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22442804|NCT00096356|Wake Forest University Comprehensive Cancer Center|Dr. Glenn Lesser|(336) 713-5440|glesser@wakehealth.edu|
22442805|NCT01181986|Phoenix VA Health Care System|Dr. Juraj Koska|602-277-5551|juraj.koska@va.gov|7685
22442806|NCT00530504|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com|
22442807|NCT05009979|National Cancer Institute|Dr. Esther Mena Gonzalez|240-760-6111|esther.menagonzalez@nih.gov|
22442808|NCT05286749|UW School of Medicine and Public Health|Tana Chongsuwat, MD, MPH|224-260-1666|tana.chongsuwat@fammed.wisc.edu|
22442809|NCT02957968|Virginia Commonwealth University Massey Cancer Center|Massey CTO Breast Team|804-628-6430|masseyctbrst@vcu.edu|
22442810|NCT00576420|BAXTER INNOVATIONS GmbH|Edith Hantak, Dir, Global Therapeutic Area, BioSurgery||edith_hantak@baxter.com|
22442811|NCT02616146|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22442812|NCT01221272|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22442813|NCT01340872|Shield Therapeutics|Jackie Mitchell MA DPhil|+44 (0) 191 511 8515|jmitchell@shieldtx.com|
22442814|NCT01502332|USaoPaulo|Dr Alcino Costa Leme|55 11 989044014|costaleme@uol.com.br|
22442815|NCT03521102|Montefiore Medical Center|Dr. Benjamin Friedman|718-920-6626|bfriedm@montefiore.org|
22442816|NCT03039621|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22442817|NCT02522624|Washington University's School of Medicine|Mary C. Politi, PhD|314-747-1968|politim@wudosis.wustl.edu|
22442818|NCT03254108|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22442819|NCT02361476|Rigshospitalet|Mogens Ydemann, MD|+45 35455620|mogens@ydemann.dk|
22442820|NCT01142089|Cosmo Technologies Ltd.|Richard Jones|+35318170370|RJones@cosmopharma.com|
22442821|NCT01974765|Memorial Sloan Kettering Cancer Center|Dr. Rachel Grisham, MD|646-888-4653|grishamr@mskcc.org|
22442822|NCT04531462|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22442823|NCT00918931|Organization: The University of Texas M. D. Anderson Cancer Center|Srdan Verstovsek M.D./Associate Professor|713-792-7305|eharriso@mdanderson.org|
22442824|NCT01350544|RAND Corporation|Laura M. Bogart, PhD|(310) 393-0411|lbogart@rand.org|7281
22442825|NCT01444092|Perrigo|Beatriz North|718-960-0163|beatriz.north@perrigo.com|
22442826|NCT02528721|Exalenz Bioscience|VP of Clinical Affairs|972-8-9737502|melinaa@exalenz.com|
22442827|NCT05338671|University of Washington|Avina Paranjpe|206-543-5044|avina@uw.edu|
22442828|NCT03859973|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22442829|NCT00640224|Children's Hospital of Pittsburgh of UPMC|Dr. Silva Arslanian|412-692-6935||
22442830|NCT01252667|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fredhutch.org|
22442831|NCT04644315|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22442832|NCT00294762|Astellas Pharma Global Development|Medical Monitor||clinicaltrials@us.astellas.com|
22442833|NCT01738646|Duke Univeristy Medical Center|Katherine Peters|919 684-3914|katherine.peters.@dm.duke.edu|
22442834|NCT04497038|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
22442835|NCT03642132|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22442836|NCT01839604|AstraZeneca Pharmaceuticals LP|Martin Scott, MD/PhD|Martin.Scott@astrazeneca.com|Martin.Scott@astrazeneca.com|
22442837|NCT04493892|Columbia University|Jasmine A. McDonald|12123053586|jam2319@cumc.columbia.edu|
22442838|NCT02577887|Abbott (previously St Jude Medical)|Grant Kim|818-493-3147|grant.kim@abbott.com|
22442839|NCT00159822|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22442840|NCT00947791|Icahn School of Medicine at Mount Sinai|Dr. James W. Murrough|212-241-6539|james.murrough@mssm.edu|
22442841|NCT00766753|University of Pittsburgh Cancer Institute|Frank Lieberman|(412) 648-6507|liebermanf@upmc.edu|
22442842|NCT00864916|Indiana University School of Medicine|Samir K. Gupta, MD|317-274-7926|sgupta1@iu.edu|
22442843|NCT03816709|North Dakota State University|Kara Gange, Associate Professor|701-231-5777|kara.gange@ndsu.edu|
22383233|NCT00666276|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22383234|NCT01039688|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22383235|NCT02594735|GWU Myositis Center|Dr. Rodolfo Curiel|202-741-2488|rcuriel@gwu.edu|
22383236|NCT04567407|Boston Children's Hospital|Roland Brusseau MD|857-218-4814|roland.brusseau@childrens.harvard.edu|
22397451|NCT02370875|University of Florida|Aparna Wagle Shukla|3522945400|aparna.shukla@neurology.ufl.edu|
22397452|NCT00595556|UCHC|Albert J. Arias, M.D.|8606794423|alarias@uchc.edu|4423
22397453|NCT03975920|The Restful Jaw Company, LLC|Dr. Eric Schiffman|(651)338-3344|schif001@umn.edu|
22397454|NCT00586495|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22397455|NCT02631525|Universidade federal de Minas Gerais|Dr Renato Gomez|553134099760|renatogomez2000@yahoo.com.br|
22397456|NCT03882970|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22397457|NCT02863809|Massachusetts Eye and Ear|Odeta Dyrmishi & Joseph Ciolino|7742745014|Odeta_Dyrmishi@meei.harvard.edu; Joseph_Ciolino@meei.harvard.edu|
22397458|NCT03292809|Novaliq GmbH|Dr. Sonja Kroesser|+49 6221 50259|info@novaliq.com|0
22397459|NCT01046877|Acclarent|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com|
22397460|NCT01081249|University of California, San Diego Medical Center, Department of Psychiatry|Dr. Kai MacDonald|619-203-7393||
22397461|NCT00689572|University of Virginia|Nassima Ait-Daoud Tiouririne, M.D.|(434)243-0570|nat7b@virginia.edu|
22397462|NCT03303794|Montefiore Medical Center|Dr.Singh Nair|7189205932|sinair@montefiore.org|
22397463|NCT02813694|Nabriva Therapeutics US, Inc|Jennifer Schranz, M.D., Chief Medical Officer|610 981 2842|jennifer.schranz@nabriva.com|
22397464|NCT04474795|Washington University In St. Louis School of Medicine|Cynthia Herrick, MD, MPHS|3147470278|herrickc@wustl.edu|
22397465|NCT00814775|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org|
22397466|NCT02980224|Brace Consulting Group Inc.|Jeremy Brace, President|7274582823|jbrace@braceconsultinggroup.com|
22397467|NCT00606320|Otsuka Pharmaceutical Co, Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22397468|NCT02189161|Laser Surgery Care|Dr. Stephen E. Goldstone, MD|212-242-6500|segmd@prodigy.net|
22397469|NCT00939783|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22397470|NCT04839380|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22397471|NCT00713427|Boston Scientific Corporation|Joyce Peetermans, PhD - Vice President, Global Clinical Programs|508-683-4211|Joyce.Peetermans@bsci.com|
22397472|NCT01923129|Cedars Sinai Medical Center|Dr. Phillip Fleshner|(310) 289-9224|Phillip.Fleshner@cshs.org|
22397473|NCT01549002|ColumbiaU|Dr. Daniel Fenster|212-305-9825|dbf2114@columbia.edu|
22397474|NCT00749996|Medtronic Spinal & Biologics|Irène Ayer, Clinical research specialist|+41 21 803 84 27|irene.ayer@medtronic.com|
22397475|NCT00996944|GlaxoSmithKline|GSK Response Center|866-435-7343||
22397476|NCT02189213|RFMH|Amir Levine|646 481 2566|amir.levine@nyspi.columbia.edu|
22397477|NCT03775421|Actelion Pharmaceuticals Ltd|Senior Clinical Leader PH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22397478|NCT02445807|Dr. Reddy's Lab, Inc|Srinivas Sidgiddi, MD|609-375-9900|srinivassidgiddi@drreddys.com|
22397479|NCT01227044|Yale School of Medicine|Dr. Lynn Fiellin|203-737-3347|lynn.fiellin@yale.edu|
22397480|NCT03042715|Massachusetts General Hospital|Areej El-Jawahri|617-724-4000|ael-jawahri@partners.org|
22397481|NCT02250274|Marshfield Clinic Research Foundation|Director of the Center for Clinical Epidemiology & Population Health|715-389-3444|belongia.edward@mcrf.mfldclin.edu|
22397482|NCT04247061|Boston University|Director of Center for Behavioral Science Research|6173583358|belindab@bu.edu|
22397483|NCT00768521|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
22397484|NCT01378104|the Catholic University of Korea|Dr. Kwon|+82322805886|doctorkwon@catholic.ac.kr|
22397485|NCT02287623|University of Minnesota|Dr. Jacob Hutchins|612-624-9990|hutc0079@umn.edu|
22397486|NCT01997411|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22397487|NCT02512224|The University of Tokyo Hospital|Dr. Sumito Ogawa|+81-3-5800-8830|suogawa-tky@umin.ac.jp|
22397488|NCT00205855|Boston Scientific Corporation|Natalie Bloom Lyons|763-228-9040|lyonsn@bsci.com|
22397489|NCT01441570|Brigham and Women's Hospital|Dr. Steven Gabardi|617-732-7658|sgabardi@partners.org|
22428253|NCT07169032|First Affiliated Hospital of Jinan University|LI ZHEN ZHONG|+8613711706774|nicolezlz@foxmail.com|
22397490|NCT02870309|Grifols Therapeutics LLC|Susan Sorrells|919-316-6582|susan.sorrells@grifols.com|
22397491|NCT00063570|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22397492|NCT04341441|Henry Ford Health System|John McKinnon, MD, MSc|313-916-8828|jmckinn3@hfhs.org|
22397493|NCT02039375|Johns Hopkins University School of Medicine|Victor C. Urrutia, MD|4109552228|vurruti1@jhmi.edu|
22397494|NCT01475175|Medtronic CRDM|AdOpt CRT Clinical Research Specialist|800-328-2518|medtronicCRMtrials@medtronic.com|62736
22397495|NCT03891264|Massachusetts General Hospital|Dr. Jodi Gilman|617-643-7293|jgilman1@partners.org|
22397496|NCT01924182|Medtronic Neuromodulation|Mary Markert Sr Prin Clinical Research Specialist|763-526-8162|mary.a.markert@medtronic.com|
22397497|NCT02899689|UTMB|Antonio F Saad|4097720982|afsaad@utmb.edu|
22397498|NCT01290874|Brigham and Women's Hospital|Dr. Elliot Israel|6177328201|eisrael@partners.org|
22397499|NCT03040999|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22397500|NCT05121480|Evelo Biosciences, Inc|Duncan McHale, MBBS, MRCP, PhD|+447500128938|duncan@evelobio.com|
22397501|NCT02366611|University of Michigan, School of Dentistry|Alexandre DaSilva|7346153807|adasilva@umich.edu|
22397502|NCT00938314|Stem Cell Therapeutics Corp.|Chief Scientific Officer|403.245.5495|adavidoff@stemcellthera.com|226
22397503|NCT01964352|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22397504|NCT02831673|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22397505|NCT00001379|National Cancer Institute|Dr. Christopher J. Melani|240-760-6057|christopher.melani@nih.gov|
22397506|NCT00264875|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22397507|NCT01628588|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22397508|NCT01500278|Cares|UCB|+1877 822||9493
22397509|NCT03958552|University of Maryland School of Nursing|Dr. Joan Carpenter|443-880-1430|joan.carpenter@umaryland.edu|
22397510|NCT00143312|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22397511|NCT00607386|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22397512|NCT02671136|Loma Linda University Health|Ahmed Khocht|909 558 4000|akhocht@llu.edu|
22397513|NCT00879645|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22397514|NCT00446511|Novartis Pharmaceuticals|Study Director|862-778-8300||
22397515|NCT02700997|TriHealth Inc.|Rachel Pauls MD|513-463-4300|Rachel_Pauls@trihealth.com|
22397516|NCT01073267|University of Texas (UT) MD Anderson Cancer Center|Bouthaina Dabaja, MD/Associate Professor, Radiation Oncology Department||CR_Study_Registration@mdanderson.org|
22397517|NCT04770389|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
22397518|NCT00794157|Novartis Pharmaceuticals|Study Director|862 778-8300||
22397519|NCT04514523|Yale School of Medicine|Dr. Kasia Lipska|203-737-4853|kasia.lipska@yale.edu|
22397520|NCT03817775|• Department of Anaesthesia and Intensive Care, American Hospital of Paris|Dr Gilles BOCCARA|+33 1 46 41 25 25|gilles.boccara@ahparis.org|
22397521|NCT02970292|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|+1-858-261-2897|medicalinformation@acadia-pharm.com|
22397522|NCT00814892|Mayo Clinic|Dr. Manish Kohli|507-284-2511|kohli.manish@mayo.edu|
22397523|NCT01632995|Bridge HIV, San Francisco Department of Public Health|Dr. Albert Liu, Clinical Research Director|415-437-7408|albert.liu@sfdph.org|
22397524|NCT00531752|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22397525|NCT04486950|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22397526|NCT02821715|Theranexus|Chief medical officer|+33680026779|werner.rein@theranexus.fr|
22397527|NCT00640328|GlaxoSmithKline|GSK Response Center|866-435-7343||
22397528|NCT01027819|Seoul National University Hospital|Dr. Dongwook Kim|821067395311|daljookim@gmail.com|
22397529|NCT02374099|Celgene Corporation|Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22397530|NCT01033825|Sunovion|Respiratory Medical Director|1-866-503-6351||
22397531|NCT04294719|Centre for Addiction and Mental Health|Courtney Brennan|4165358501|courtney.brennan@camh.ca|
22397532|NCT01883635|University of Rochester|Dr. Charles Kamen|585-275-9958|charles_kamen@urmc.rochester.edu|
22397533|NCT02572752|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22397534|NCT01464307|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
22397535|NCT04048616|Tufts University and Tufts Medical Center|Lisa Ceglia, MD MS|(617) 636-8171|lisa.ceglia@tuftsmedicine.org|
22397536|NCT03099187|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22397537|NCT03885089|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22397538|NCT03349099|Cleveland Clinic|Manoj Monga MD|216-445-8678|mongam@ccf.org|
22397539|NCT02701387|UCLA School of Dentistry|Perry R. Klokkevold, DDS, MS, FACD|310-825-1927|pklokkevold@dentistry.ucla.edu|
22397540|NCT00894556|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22397541|NCT04869345|Cornell University|Dr. Anthony Ong|6072559993|anthony.ong@cornell.edu|
22397542|NCT00868348|Aarhus University Hospital|Karen V Andersen|51263173|karenand@rm.dk|0045
22397543|NCT00359138|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22397544|NCT01500759|ResMed Germany Inc|Medical Affairs CRS|089990100|ClinicalResearch&Strategy@ResMed.com|
22397545|NCT00528021|Boston Scientific Corporation|Jessie Stockwell|612-618-1136|jessie.stockwell@bsci.com|
22397546|NCT00867321|Mayo Clinic|Steven R. Alberts, MD MPH|507/284-4918|Alberts.steven@mayo.edu|
22397547|NCT01076049|Irrimax Corporation|Chevy Brown, Clinical Trials Manager|770-807-3355|chevy.brown@irrisept.com|15
22397548|NCT05054114|SPP Pharmaclon Ltd.|Julia Isakova|81079055353311|isakova@pharmaclon.ru|
22397549|NCT01779024|National Institute on Alcohol Abuse and Alcoholism|Leggio, Lorenzo|+1 301 435 9398|lorenzo.leggio@nih.gov|
22397550|NCT00199914|Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand|Manee Rattanachaiyanont|+66-2419-4657|manee.rat@mahidol.ac.th|
22397551|NCT04294901|VA Boston Healthcare System|Amy Linsky, MD, MSc|857-364-2760|amy.linsky@va.gov|
22397552|NCT03077685|NanOlogy, LLC|Mark Mitchell|8179004074|Mark.Mitchell@dfb.com|
22397553|NCT02116777|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22397554|NCT01733628|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
22397555|NCT02589496|Samsung Medical Center|Jeeyun Lee|82234101779|jyunlee@skku.edu|
22397556|NCT01934556|Palmetto Retina Center, LLC|John F. Payne, MD|(803) 931-0077|jpayne@palmettoretina.com|
22397557|NCT03471065|Edwards Lifesciences|Edwards THV Clinical Affairs|949-250-2500|THV_CT.gov@edwards.com|
22397558|NCT03770260|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
22397559|NCT01040052|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22397560|NCT00166205|Worldwide Clinical Operations|Sheryl Helsinger, Director|513-337-3079|shelsing@its.jnj.com|
22397561|NCT00919035|Oncolgy Specialists, SC|Sigrun Hallmeyer, MD|847-268-8200|shallmeyer@oncmed.net|
22397562|NCT00477165|Stanford University|Uri Ladabaum, MD, MS||ladabau@stanford.edu|
22397563|NCT01977781|Massachusetts Eye and Ear Infirmary|Dr. Reza Dana, MD, MPH|617-573-4331|reza_dana@meei.harvard.edu|
22397564|NCT03955133|Swansea University|Professor Sue Jordan|+44 (0) 1792518541|s.e.jordan@swansea.ac.uk|
22397565|NCT02135692|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22397566|NCT00141765|University of Michigan Cancer Center|Dr. John E. Levine, MD|734-936-8456|jelevine@umich.edu|
22397567|NCT01097746|UT MD Anderson Cancer Center|Dr. Anil K. Sood, MD/Professor, Gyn Onc & Reproductive Med|(713) 745-5266|asood@mdanderson.org|
22428254|NCT04817410|Rutgers New Jersey Medical School|Ethan Cowan|917-447-4964|ethan.cowan@rutgers.edu|
22397568|NCT01514682|Maryland Psychiatric Research Center|Robert W. Buchanan, M.D.|410-402-7876|rbuchanan@som.umaryland.edu|
22397569|NCT00769002|Hackensack University Medical Center|Dr. David Schwartz|551-996-2000|DSchwartz@hackensackumc.org|
22397570|NCT00960661|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22397571|NCT02699892|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22397572|NCT00711100|University_of_Minnesota|Dorothy Hatsukami, Ph.D.|612-626-2121|hatsu001@umn.edu|
22397573|NCT03405259|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
22397574|NCT01929408|Fred Hutchinson Cancer Research Center|Mohamed Sorror, MD, MSc|(206) 667-6298|msorror@fredhutch.org|
22397575|NCT04377711|Covis Pharma|Clinical Trial Interest|1-877-374 -4177|CTInterest@covispharma.com|
22397576|NCT02079987|University of Florida|Donna L. Carden, MD, MPH|352-265-5911|dcarden@ufl.edu|
22397577|NCT02613936|University of New Mexico|Dr. Davin Quinn|505-272-2223|dquinn@salud.unm.edu|
22397578|NCT02076997|Baylor College of Medicine|Dr. Jennifer Foster|832-824-4646|jhfoster@texaschildrens.org|
22397579|NCT02533063|University of Wisconsin|Diane Krueger|6082656410|dckruege@wisc.edu|
22397580|NCT00652366|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22397581|NCT03873714|Medtronic Neurovascular|Director, Global Clinical Research|949.837.3700|rs.advance@medtronic.com|
22397582|NCT01970501|Arca biopharma Inc.|Dr. Michael Bristow|7209412100|Michael.Bristow@arcabio.com|
22397583|NCT00708123|GlaxoSmithKline|GSK Response Center|866-435-7343||
22397584|NCT00845650|Emergent Product Development Gaithersburg, Inc.|Study Director||clinicalstudies@ebsi.com|
22428255|NCT03595748|Albert Einstein College of Medicine|Dr. Ladan Golestaneh|718-920-5442|lgolesta@montefiore.org|
22397585|NCT02511730|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
22397586|NCT01811875|Bio Products Laboratory Ltd|European Medical Affairs Lead|+44 20 8957 2200|medinfo@bpl.co.uk|
22397587|NCT00677014|Boston Scientific|Greg Voss, Clinical Director|651-581-3068|gregory.voss@bsci.com|
22397588|NCT03115567|Northwestern University|Dermatology CTU|312-503-5944|NUderm-research@northwestern.edu|
22397589|NCT01326546|Institute of Immunology，PLA|Dr.Wu|02368752230|wuyuzhang@yahoo.com|86
22397590|NCT00755274|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22397591|NCT00350142|Stanford Cancer Center|Dr. Albert Koong|650-498-7703|akoong@stanford.edu|
22397592|NCT00081159|University of Texas (UT) MD Anderson Cancer Center|Shi-Ming Tu, MD|1-877-632-6789|CR_Study_Registration@mdanderson.org|
22397593|NCT01714687|Acclarent, Inc|Patricia Chen|949-453-6408|pchen126@its.jnj.com|
22397594|NCT01548339|University Hospital Lausanne|Prof. N. Demartines||demartines@chuv.ch|
22397595|NCT00923130|National Cancer Institute|Dr. Ravi Madan|301-496-3493|madanr@mail.nih.gov|
22397596|NCT00788372|Janssen Research & Development, L.L.C. USA|Director, Clinical Research|1 609 730-3387||
22397597|NCT03693625|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22397598|NCT00684255|New York Medical College|Dr. Mitchell S. Cairo|914-594-3650|mitchell_cairo@nymc.edu|
22397599|NCT02911922|Weill Cornell Medicine - New York Presbyterian Hospital|Josephine Kang, M.D. Ph.D.|212-746-3607|jok9106@med.cornell.edu|
22397600|NCT00761514|Abbott|Medical Information Specialist|1-800-633-9110||
22397601|NCT02457637|Renji Hospital, Shanghai Jiao Tong University School of Medical|Professor Hai Li , Director of Clinical Trials|+86-13818525494|haili＿17@126.cpm|
22397602|NCT01035905|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22397603|NCT00159861|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22397604|NCT06080451|University of Michigan|Dr. David Flood|734-647-2892|dcflood@umich.edu|
22397605|NCT01210690|UCB|UCB Cares|+1 877 822 9493||
22397606|NCT01979536|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22397607|NCT02408471|Smith+Nephew, Inc.|Belinda Larson, Director, Global Clinical Strategy (Trauma)||belinda.larson@smith-nephew.com|
22397608|NCT01806779|Duke Center for Smoking Cessation|Dr. Jed E. Rose|919-668-5055|jed.rose@duke.edu|
22397609|NCT00805480|Novartis Pharmaceuticals|Study Director|862-778-8300||
22397610|NCT05038020|Alkahest, Inc.|Head of Communications|(650) 801-0474|sm-Trials-alkahest@grifols.com|
22397611|NCT05472012|Masimo|Chelsea Frank|949-297-7000|studies@masimo.com|
22428256|NCT02328014|Acerta Pharma|Global Clinical Lead|1-877-240-9497|information.center@astrazeneca.com|
22442844|NCT03774823|Venus Concept Ltd.|Director, Clinical Affairs|888-907-0115|mgronski@venusconcept.com|
22397612|NCT02909985|University of New Mexico|L. Olivia Hopkins|(505) 925-7769|LHopkins@salud.unm.edu|
22397613|NCT00733954|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
22397614|NCT02663453|Thammasat University|Dr.Wilaiporn Techasatid|66890339442|wilaiporn66@gmail.com|
22397615|NCT03416153|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
22397616|NCT05159648|Mayo Clinic|Dr Robert Anderson|507-284-4341|anderson.robert2@mayo.edu|
22397617|NCT03468855|Aclaris Therapeutics, Inc.|David Gordon|484-540-6296|Clintrials@aclaristx.com|
22397618|NCT01908101|Seattle Cancer Care Alliance|Stefanie Parker|206-889-0917|parkers@seattlecca.org|
22397619|NCT01394939|Sillajen Biotherapeutics Inc.|Kyoung Soo Ha, Head of Clinical Development|+1-415-281-8886|ksha@kr.sillajen.com|
22397620|NCT03379662|Regulatory Insight, Inc.|Elvira Cawthon|6154475150|elvira@reginsight.com|
22397621|NCT02068547|Washington University St. Louis|Wilson Z. Ray, MD|314-362-9959|rayz@wustl.edu|
22397622|NCT03657043|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
22397623|NCT00880893|Sanofi Pasteur|Director||Contact-US@sanofi.com|
22397624|NCT04365465|UPMC Magee-Womens Hospital|Dr. Grace Lim, MD, MSc|412-641-2179|limkg2@upmc.edu|
22397625|NCT01736579|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22397626|NCT01995071|AbbVie|Global Medical Services|800-633-9110||
22442845|NCT00915499|ResMed|June Mendoza|1-800-424-0737|june.mendoza@resmed.com|
22442846|NCT02946931|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22442847|NCT03492840|Raziel Therapeutics|Racheli Gueta|97289126941|racheli@raziel-therapy.com|
22442848|NCT00869778|Institute of Immunology，PLA|Dr.Wu|02368752230|wuyuzhang@yahoo.com|86
22442849|NCT00470834|GlaxoSmithKline|GSK Response Center|866-435-7343||
22442850|NCT03051620|Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Denmark|Anne Sophie Sølling|+45 78 45 54 75|annesoel@rm.dk|
22442851|NCT00393510|Institute of Chinese Medicine, Chinese University of Hong Kong|Prof. Leung Ping Chung|(852)2252 8863|pingcleung@cuhk.edu.hk|
22442852|NCT01534182|Novartis|Study Director|+1 (862) 778-8300||
22442853|NCT02412488|Medtronic, PLC|Lindsay Werder, Senior Clinical Research Specialist|7635268168|lindsay.k.werder@medtronic.com|
22442854|NCT00674154|Aarhus University Hospital|Lars Rolighed|004520677876|larsrolighed@gmail.com|
22442855|NCT00816023|Cubist Pharmaceuticals, Inc.|Alistair Wheeler, MD, MFPM, Senior Director Clinical Research|781-860-8660|awheeler@cubist.com|
22383237|NCT03844269|Akili Interactive Labs, Inc.|Minny Suh|857-254-4444|minny@akiliinteractive.com|
22383238|NCT01316263|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22383239|NCT00475319|Dermatologicals & Ophthalmologicals, Otsuka Pharmaceutical Co., Ltd.|Eiji Murakami|+81-6-6231-6067||
22383240|NCT00101010|UT MD Anderson Cancer Center, Community Clinical Oncology Program Research Base|Alma Rodriguez, MD, Lymphoma||CR_Study_Registration@mdanderson.org|
22383241|NCT03698708|Nemours Children's Health|Dr. Susana Patton|904-697-2000|susana.patton@nemours.org|
22383242|NCT00908830|University of Michigan Health System|Linda Stuckey, Pharm.D|734-936-8129|lindastu@med.umich.edu|
22383243|NCT03897348|University of California, San Francisco/San Francisco VA Health Care System|Steven L. Batki, MD|415-221-4810|steven.batki@ucsf.edu|23671
22383244|NCT04054635|University of Manitoba|Dr. Robert J. Schroth|204-977-7764|robert.schroth@umanitoba.ca|
22383245|NCT00364013|Amgen Inc.|Study Director|866-572-6436||
22383246|NCT00891930|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|866-572-6436|Bobby.Reddy@Immunitybio.com|
22383247|NCT01149512|Royal Alexandra Hospital|Xinzhe Shi|7807356735|xinzhe.shi@ahs.ca|
22383248|NCT03873337|Rutgers Robert Wood Johnson Medical School|Marc L. Steinberg, Ph.D.|732-235-4341|marc.steinberg@rutgers.edu|
22383249|NCT03040661|Inova Heart and Vascular Institute|Vineet Kumar|(703) 289-9400|vineet.kumar@inova.org|
22383250|NCT01574807|Division of Endodontics|Dr. John Nusstein|614-292-3596|nusstein.1@osu.ed|
22383251|NCT00835770|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22383252|NCT01185782|Merck Serono Co., Ltd., Japan, an affiliate of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22383253|NCT02507752|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22383254|NCT00149838|MUSC|Mark S. George, MD, Professor|8438700368|georgem@musc.edu|
22383255|NCT01254188|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22383256|NCT00523237|Stanford University|Philip Grant, MD|650-723-2804|pmgrant@stanford.edu|
22383257|NCT01394510|VA Puget Sound Health Care System|Kristina Utzschneider, MD|206-277-3568|kutzschn@uw.edu|6-3568
22383258|NCT02539108|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22383259|NCT02202499|H. Lee Moffitt Cancer Center and Research Institute|Dr. Thomas Brandon|813-745-1750|thomas.brandon@moffitt.org|
22383260|NCT01240330|Venous Health Systems, Inc.|Director of Quality Assurance & Operations|(650)646-3327|rlaguna@venoushealth.com|104
22383261|NCT00535145|Ortho-McNeil Janssen Scientific Affairs, LLC|Vice President, Medical Affairs, CNS|609-730-2136||
22383262|NCT01691690|Nationwide Children's Hospital|Dr. Arlyne Thung|(614) 722-4200|Arlyne.Thung@NationwideChildrens.org|
22383263|NCT05082935|University of Oregon|Dr. Leslie Leve|541-346-9528|leve@uoregon.edu|
22383264|NCT02122445|Sport and Spine Rehab Clincal Research Foundation|Jena Slaski|301-251-2777|jslaski@ssrehab.com|838
22383265|NCT03133182|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
22383266|NCT02544074|The Ohio State University|Douglas Scharre, MD|614-293-4969|Doug.Scharre@osumc.edu|
22383267|NCT05672667|Wake Forest University School of Medicine|Dr. James Eisenach|336-716-4182|jimeisenach@gmail.com|
22383268|NCT03873779|Zeltiq|Sally Hallas, RN, Director Clinical Development - Body Contouring|209-294-5571|sally.hallas@abbvie.com|
22383269|NCT02581215|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22383270|NCT04270526|Mount Auburn Hospital|William Winkelman|617-354-5452|william.winkelman@mah.harvard.edu|
22383271|NCT04279574|Solventum US LLC|Paula Myhre|6513842714|pemyhre1@solventum.com|
22383272|NCT00233090|Icahn School of Medicine at Mount Sinai|Wayne A Gordon, PhD|212-659-9372|wayne.gordon@mssm.edu|
22383273|NCT02407249|Abbott|Clinical Program Director|6517566717|kristin.ruffner@abbott.com|
22383274|NCT01391832|University of Texas at Dallas|Dr. John Hart, Jr.|972-883-4853|jill.ritter@utdallas.edu|
22383275|NCT01154985|Mochida Pharmaceutical Company Ltd.|Hironori Sato, Director|+81-3-3225-6331|hnsato@mochida.co.jp|
22383276|NCT03345901|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|drcrnet@jaeb.org|
22383277|NCT04252586|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
22383278|NCT00232180|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22383279|NCT02748317|MedStar Health Research Institute|Inger Ljungberg|202-877-1694|inger.h.ljungberg@medstar.net|
22383280|NCT03452189|NYU Langone Health|Dr. Jerome Lowenstein|+1 212 263 5635|Jerome.Lowenstein@nyulangone.org|
22383281|NCT02724592|University of Greifswald|Dr. Mohammad Alkilzy|0049-17623399340|alkilzym@uni-greifswald.de|
22383282|NCT00434304|GlaxoSmithKline|GSK Response Center|866-435-7343||
22383283|NCT05262738|University of Texas at Austin, Dell Medical School|Alexander Saucedo, MD|210-845-7571|alexander.saucedo@ascension.org|
22383284|NCT00639860|University of Michigan School of Dentistry|Dr. William Giannobile, Chair Department of Periodontics and Oral Medicine|734-763-2105|wgiannob@umich.edu|
22383285|NCT00687713|National Institute on Drug Abuse|Ann Anderson, MD|301-827-5916|aanderso@nida.nih.gov|
22383286|NCT01149369|Johns Hopkins Data Coordinating Center|Katherine Yates|443-287-0082|kyates1@jhu.edu|
22383287|NCT01424397|GlaxoSmithKline|GSK Response Center|866-435-7343||
22383288|NCT02767765|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22383289|NCT01951170|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22383290|NCT04676334|pharmaand GmbH|Medical Information Department|+43/1/3560006|medinfo@pharmaand.com|
22383291|NCT03631433|OSU|Dr. Melissa Drum|6142923596|drum.13@osu.edu|
22383292|NCT02355275|Sport & Spine Rehab Clinical Research Foundation|Jena Slaski|301-251-2777|jslaski@gmail.com|838
22383293|NCT00083551|UAMS Myeloma Institute|Bart Barlogie|501-526-6990|barlogiebart@uams.edu|2420
22383294|NCT01972724|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22383295|NCT00277355|Massachusetts General Hospital|Merit Cudkowicz, MD, MSc|617-726-1873|mcudkowicz@partners.org|
22383296|NCT00808405|University of Washington|Connie Celum, MD, MPH|206-520-3824|ccelum@uw.edu|
22383297|NCT00668863|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22383298|NCT01911169|Medical University of South Carolina|Dr. James Oates|843-789-6797|oatesjc@musc.edu|
22383299|NCT01546753|University of Arkansas for Medical Sciences|Dr. Stacie Jones|(501) 364-1060|JonesStacieM@uams.edu|
22383300|NCT00960141|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22383301|NCT02933944|Targovax|Chief Medical Officer|+ 47 21398810|contact@targovax.com|
22383302|NCT03036813|Global Blood Therapeutics|Margaret Tonda, PharmD, Sr. Director, Clinical Science|(650) 741-7761|mtonda@gbt.com|
22383303|NCT01102231|IFCT|Communications Officer|+33156811045|contact@ifct.fr|
22383304|NCT00995904|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
22383305|NCT01236560|Children's Oncology Group|Results Reporting Coordinator|626-446-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22383306|NCT00546754|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22383307|NCT01195883|Cleveland Clinic|Daniel I. Sessler, MD|216-444-4900|DS@OR.org|
22383308|NCT01576484|Regeneron Pharmaceuticals, Inc.|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
22383309|NCT00581854|University of Wisconsin|Brad S Kahl, MD|608-263-1836|bsk@medicine.wisc.edu|
22383310|NCT04470375|University of South Dakota|Dr. Kory Zimney|16056586373|kory.zimney@usd.edu|
22383311|NCT05714696|Florida State University College of Medicine|Dr. Mary Gerend|8506451541|mary.gerend@med.fsu.edu|
22383312|NCT00837616|Nemours Children's Clinic|Dr. Nelly Mauras|(904) 697-3674|nmauras@nemours.org|
22383313|NCT02247063|University of Michigan|Thiago Nascimento|734-615-9390|Nasci@umich.edu|
22383314|NCT04090190|Mass General Brigham|Vatche Minassian, MD, MPH|(617) 732-4838|vminassian@bwh.harvard.edu|
22383315|NCT00940537|Washington University School of Medicine|Gary Skolnick|314-362-5292|gskolnic@wustl.edu|
22383316|NCT03512756|Tyme, Inc.|Study Director|617-674-9069|Maria.Loushin@TymeInc.com|
22383317|NCT03473340|University of Michigan|VIbha Lama|734-936-5010|vlama@med.umich.edu|
22383318|NCT02079844|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22383319|NCT01420549|Aché Laboratórios Farmacêuticos S. A.|Antonio Carlos Amedeo Vattimo|+55 11 26088111|antonio.vattimo@ache.com.br|
22383320|NCT03394885|Duke Cancer Center|Dr. Angeles Alvarez Secord|919-684-3765|angeles.secord@duke.edu|
22383321|NCT00203411|Translational Research in Oncology|Dr. Arash Naeim|310 267-6810|anaeim@mednet.ucla.edu|
22383322|NCT04980755|University of Plymouth|Dr Joseph Lanario|01752 764403|joseph.lanario@plymouth.ac.uk|
22383323|NCT01212991|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22383324|NCT02270645|University of Miami|Keyvan Nouri|3052433380|knouri@med.miami.edu|
22383325|NCT03149991|Massachusetts General Hospital|Dr. Rebecca Hock|617-872-3711|rhock@mgh.harvard.edu|
22383326|NCT00981630|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22383327|NCT04520061|Mass General Hospital|Lisa Morse|617-724-2000|lgmorse@partners.org|
22383328|NCT03314753|Medtronic|Study Project Manager (CSM)|00491742122|petra.kremer@medtronic.com|081
22383329|NCT01285999|Cardiovascular Institute and Fu Wai Hospital|Dr. Runlin Gao|+861068314466|gaorunlin@citmd.com|
22383330|NCT04714320|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionis.com|
22383331|NCT03190174|Sarcoma Oncology Research Center|Erlinda M. Gordon, MD/Principal Investigator|310-552-9999|egordon@sarcomaoncology.com|
22383332|NCT04755660|National Taipei University of Nursing and Health Sciences|Dr. Tingru Lin|886-2-28227101|tingru@ntunhs.edu.tw|3150
22383333|NCT02879162|Canadian Cancer Trials Group|Dr. Janet Dancey|6135336000|jdancey@ctg.queensu.ca|75606
22383334|NCT04524390|Mirum Pharmaceuticals, Inc.|Mirum Clinical Trials|16506674085|medinfo@mirumpharma.com|
22383335|NCT02765100|Weill Cornell Medicine|James H Kocsis, M.D.|212-746-5913|jhk2002@med.cornell.edu|
22383336|NCT02597920|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22383337|NCT01900249|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
22428257|NCT03166709|Center for Suicide Prevention and Recovery, University of Washington|Dr. Katherine Anne Comtois|206-744-1752|uwcspar@uw.edu|
22383338|NCT03733028|Durham VA Health Care System|Angela Kirby|919-824-7729|angela.kirby@va.gov|
22383339|NCT04532528|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22442322|NCT05661851|Johnson & Johnson Vision Care, Inc. (JJVC)|Principal Research Optometrist|(347) 903-5029|njoshi30@its.jnj.com|
22383340|NCT01035658|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22383341|NCT00244855|Fred Hutchinson Cancer Research Center|Dr. David Maloney|206-667-5616|dmaloney@fredhutch.org|
22428258|NCT01120197|Faculty of Health Sciences, Oslo University College, Oslo, Norway|Professor, Ph. D, Researcher. Astrid Bergland.|+4722452507|astrid.bergland@hf.hio.no|
22383342|NCT00665444|University of Pittsburgh|Holly Swartz, MD|412-246-5588|swartzha@upmc.edu|
22383343|NCT01068743|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22383344|NCT00293293|Moffitt Cancer Center|Patricia L. Judson, M.D.|813-745-1600|Patricia.Judson@moffitt.org|
22428259|NCT04175639|Duke University School of Medicine|Tamara Somers, PhD|919-416-3408|tamara.somers@duke.edu|
22428260|NCT04070703|Oregon Research Institute|Fuzhong Li|5414842123|fuzhongl@ori.org|
22428261|NCT03481049|Washington State University|Michael G. McDonell|509-368-6967|mmcdonell@wsu.edu|
22383345|NCT03401190|CalciMedica, Inc.|Sudarshan Hebbar, MD|816-838-7105|sudarshan@calcimedica.com|
22383346|NCT03740009|UNC School of Medicine|Crystal Schiller, PhD|919-966-4810|crystal_schiller@med.unc.edu|
22428262|NCT05028569|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22383347|NCT01061151|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
22383348|NCT02384070|Odessa Heart Institute / Permian Research Foundation|Fernando Boccalandro MD FACC FSCAI|432-3373117|Fboccalandro@echd.org|
22383349|NCT03926039|National Taipei University of Nursing and Health Sciences|Director of Nursing Department|886-2-28712121|tsaejyy@ntunhs.edu.tw|3100
22383350|NCT01406223|Duke University Medical Center|Principal Investigator|919-668-3987|francis.mcclernon@duke.edu|
22383351|NCT03756571|Seattle Children's Research Institute|Kristie Bjornson, PT, PhD|206-884-2066|Kristie.bjornson@seattlechildrens.org|
22383352|NCT02379819|Cochlear|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
22383353|NCT00529516|GlaxoSmithKline|GSK Response Center|866-435-7343||
22428263|NCT04609553|Rutgers University|Manuel Jimenez, MD, MS|732-235-9300|jimenema@rwjms.rutgers.edu|
22428264|NCT01035788|Department of Veterans Affairs|Dr. Louanne Davis|317-988-4523|louanne.davis@va.gov|
22383354|NCT03752151|Medtronic, Plc|Dana Wigert, Sr Prin Clinical Research Specialist|+17635262802|dana.wigert@medtronic.com|
22428265|NCT00410488|UT MD Anderson Cancer Center|Saroj Vadhan-Raj, MD / Professor||CR_Study_Registration@mdanderson.org|
22428266|NCT03829475|Brigham and Women's Hospital|Jessica Allegretti MD MPH|617-525-7322|jallegretti@bwh.harvard.edu|
22383355|NCT04056624|East Carolina University, Department of Public Health|Stephanie Jilcott Pitts|252-744-5572|jilcotts@ecu.edu|
22428267|NCT03841513|TMC|Dr Tsung Mou|6176365890|tmou@tuftsmedicalcenter.org|
22383356|NCT03224390|Duke University|Dr. Eric Green|9196817289|eric.green@duke.edu|
22428268|NCT01733953|University of Minnesota|Cameron Naughton|612-625-3623|naug0009@umn.edu|
22428269|NCT00764517|Knight Cancer Institute, Oregon Health & Science University|Dr. Stephen E. Spurgeon MD|503-494-4606|spurgeos@ohsu.edu|
22383357|NCT00548418|Washington University School of Medicine|David G. Mutch, M.D.|314-362-2181|mutchd@wudosis.wustl.edu|
22428270|NCT01433913|University of Arizona|Dr. Sherry Chow|520-626-3358|schow@azcc.arizona.edu|
22428271|NCT02362451|National Cancer Institute|Dr. Hoyoung Maeng|240-781-3253|hoyoung.maeng@nih.gov|
22383358|NCT00703820|St. Jude Children's Research Hospital|Jeffrey E. Rubnitz, MD, PhD|901-595-2388|jeffrey.rubnitz@stjude.org|
22383359|NCT02639910|MorphoSys AG|Peter Kelemen MD, PhD - Director, Clinical Program Leader|+498989927|peter.kelemen@morphosys.com|26856
22383360|NCT01007396|Samsung Medical Center|Won-Jung Koh|82-2-3410-3429|wjkoh@skku.edu|
22383361|NCT03451721|Zhongshan Hospital|Dr Yangang Su|+86 13788905096|suyangang111@163.com|
22383362|NCT03689920|Boston Scientific|Director of Clinical Sciences|661-949-4350|roshini.jain@bsci.com|
22428272|NCT00460798|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22383363|NCT04762875|Ensoma|Elizabeth Hook|617-766-3917|ehook@ensoma.com|
22383364|NCT02943590|MassGH|Tomas Neilan|617726200|tneilan@partners.org|
22428273|NCT03823131|University of California, San Francisco|Dr Chase Heaton, MD|(415) 502-1889|Chase.Heaton@ucsf.edu|
22383365|NCT05946551|Emory University|Tiffany Walker, MD Assistant Professor|404-778-1621|tiffany.austin.walker@emory.edu|
22383366|NCT05061693|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22383367|NCT03823911|Institute of Human Virology, University of Maryland School of Medicine|Dr. Poonam Mathur|410-706-4745|pmathur@ihv.umaryland.edu|
22383368|NCT01691326|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22383369|NCT00311363|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
22428274|NCT01953237|University of Maryland, Baltimore|Julie Kreyenbuhl|410-637-1864|jkreyenb@som.umaryland.edu|
22428275|NCT03517137|EORTC|Catherine Fortpied|+32 2 774 1681|catherine.fortpied@eortc.org|
22428276|NCT01186770|Bausch Health Americas, Inc|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
22428277|NCT02441283|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22383370|NCT00396084|Case Western Reserve University, Tuberculosis Research Unit|John L. Johnson, M.D.|(216) 368-1949|jlj@case.edu|
22383371|NCT04009577|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22428278|NCT01807455|Q-Med AB|Chief Medical Officer|+ 46 (0) 18 474 90 00|Reception.SEUPP@galderma.com|
22428279|NCT02321527|The University of Texas (UT) MD Anderson Cancer Center|Dr. Basak Dogan/Diagnostic Radiology|713-792-7734|CR_Study_Registration@mdanderson.org|
22428280|NCT02472353|Avera|Stacy Kehoe|605.322.3082|Stacy.Kehoe@avera.org|
22428281|NCT02101294|Finger Relief|Molly Choate Summers|703-517-8951|summers.molly@gmail.com|
22428282|NCT00688597|Patient Advocacy|Amicus Therapeutics|+1-609-662-2000|clinicaltrials@amicusrx.com|
22428283|NCT00689936|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
22383372|NCT01832480|Tulane University School of Public Health and Tropical Medicine|Patricia Kissinger, Ph.D.|504-988-7320|kissing@tulane.edu|
22383373|NCT01600729|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22428284|NCT01995201|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22428285|NCT01234116|Henry Ford Health Sytem|Indira Brar, MD|313-916-2565|ibrar1@hfhs.org|
22383374|NCT02261467|Allergan, Inc|Tanya Brandstetter|714-246-2567|brandstetter_tanya@Allergan.com|
22383375|NCT00233519|University of Rochester Medical Center|Richard T. Moxley, III MD|585-275-5006|RichardT_Moxley@urmc.rochester.edu|
22383376|NCT04305405|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22383377|NCT00206375|Texas Children's Hospital, Baylor College of Medicine|Dr. MJ Redondo (designated by the institution to enter results)|832-822-1019|redondo@bcm.edu|
22383378|NCT00696618|Johns Hopkins School of Medicine|Associate Director, Drug Development Unit|(410)641-8762|ejfuchs@jhmi.edu|
22397627|NCT00616109|University of Michigan|Gregory Kalemkerian, M.D.|(734) 936-4991|kalemker@umich.edu|
22397628|NCT01979523|Memorial Sloan Kettering Cancer Center|Dr. Alexander Shoushtari|646-888-4161|shoushta@mskcc.org|
22397629|NCT04762537|New York Psychiatric Institute|Kenzie Potter|2535920386|kenzie.potter@nyspi.columbia.edu|
22397630|NCT02495844|Cares|UCB|+1844599|UCBCares@ucb.com|2273
22397631|NCT03678402|The Ohio State University Wexner Medical Center|Dr. Tammy Moore|6142937847|tammy.moore@osumc.edu|
22397632|NCT01526902|Indiana University|Pete Kollbaum, OD, PhD, FAAO, FBCLA, Principal Investigator|812-856-0108|kollbaum@indiana.edu|
22397633|NCT03470493|ResMed|Adam Benjafield|+61 466 634 609|adam.benjafield@resmed.com|
22397634|NCT00493870|US Oncology Research|Taqi Mohammad|281-863-6439|taqi.mohammad@mckesson.com|
22397635|NCT00647556|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
22397636|NCT02646982|University of Texas Southwestern|Ihab Hajjar, MD|214-645-9533|ihabhajjar@emory.edu|
22397637|NCT00623480|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22397638|NCT01594853|Kennedy Krieger Institute|Kathleen Zackowski|443-923-2716|zackowski@kennedykrieger.org|
22397639|NCT03124823|Masimo|Tala Harake||studies@masimo.com|
22397640|NCT04677712|Endo Pharmaceuticals|Clinical Operations|1-800-462-3636|ClinicalTrials@Endo.com|
22397641|NCT05396742|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
22397642|NCT00847912|Providence VA mendical Center|Martin Weinstock MD, PhD|401-457-3333|Martin.Weinstock@va.gov; Martin_Weinstock_MD@brown.edu|
22397643|NCT00517595|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
22397644|NCT02083380|Medical University of Vienna, Division of Infectious Diseases and Tropical Medicine|Associate Professor Dr Michael Ramharter|+43140400-44400|michael.ramharter@meduniwien.ac.at|
22397645|NCT05525533|University of California, San Francisco|Jenny Liu|6503800762|jenny.liu2@ucsf.edu|
22397646|NCT01577186|Janssen Research & Development|Medical Director|886 2 23762155||
22397647|NCT01032915|Novartis|Study Director|862-778-8300||
22397648|NCT01897285|Arrowe Park Hospital|Mrs Gwenneth Lawrence|0151 678 5111|gwen.lawrence@nhs.net|8362
22397649|NCT02915523|Syndax Pharmaceuticals, Inc.|Kate Madigan, MD, Chief Medical Officer|858-888-3798|kmadigan@syndax.com|
22428286|NCT02226159|OrthoCarolina Research Institute|Susan Odum|7049457710|susan.odum@orthocarolina.com|
22397650|NCT02797808|University of Minnesota|Dr. Gail Bernstein|612-625-1632|berns001@umn.edu|
22397651|NCT03221751|VA Puget Sound Health Care System|Hollie Holmes|206-277-6207|Hollie.Holmes@va.gov|
22428287|NCT01138735|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
22428288|NCT06001866|Purdue University|Dr. Patricia Deevy, Research Associate|765-496-1821|deevy@purdue.edu|
22428289|NCT04703192|Daiichi Sanyko, Inc|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22428290|NCT04797169|Icahn School of Medicine at Mount Sinai|Thomas B Hildebrandt, Psy.D.|(212) 659-8673|tom.hildebrandt@mssm.edu|
22428291|NCT04725188|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22428292|NCT02236364|University of Toledo|Basil Akpunonu, MD|419-383-4909|Basil.Akpunonu@utoledo.edu|
22428293|NCT00390013|University of Iowa|Colleen Kennedy Stockdale, MD, MS|319-384-6849|colleen-stockdale@uiowa.edu|
22428294|NCT03839641|Pennington Biomedical Research Center|Dr. David McDougal|2257630278|DAVID.MCDOUGAL@PBRC.EDU|
22428295|NCT03981055|Spaulding Rehabilitation Hospital|Felipe Fregni|6179526158|fregni.felipe@mgh.harvard.edu|
22428296|NCT05653843|Boston Scientific|Andrea Burbage, Principal Clinical Trial Manager|7812544679|andrea.burbage@bsci.com|
22428297|NCT04325386|University of Maryland, Baltimore|Dr Deanna L. Kelly, PharmD, BCPP|410-402-6861|dlkelly@som.umaryland.edu|
22428298|NCT00722020|Winthrop University|Jon Roberts, MD|516-663-4600|jroberts@winthrop.org|
22428299|NCT03188822|UR Medicine Otolaryngology|Research Program Manager|5852751186|paul_allen@urmc.rochester.edu|
22428300|NCT04537299|Mayo Clinic|Brandon Verdoorn, M.D.|507-266-6201|Verdoorn.Brandon@mayo.edu|
22428301|NCT00392041|Princeton University|Lesley Allen, Ph.D.|609-924-9213|lesleyaallen@gmail.com|
22428302|NCT04297917|Vaccitech Plc|Tom Evan, MD|+44 01865 591 445|enquiries@vaccitech.co.uk|
22428303|NCT04279483|University of Pennsylvania|Emily Falk|215-573-9901|emilybfalk@falklab.org|
22428304|NCT00876343|Otsuka Pharmaceutical Co., Ld.|Director of Clinical Research and Development|+81-3-6361-7366||
22428305|NCT04926233|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22428306|NCT00924898|The University of North Carolina|Dr. Cynthia Gay|919-843-2726|cynthia_gay@med.unc.edu|
22428307|NCT00230737|University of Pennsylvania|Dr. Nalaka Gooneratne|2674083789|ngoonera@upenn.edu|
22428308|NCT01901562|Montefiore Medical Center|Dr. Sheldon Feldman, Chief Breast Surgery and Breast Surgery Oncology|929-246-6300|sfeldman@montefiore.org|
22428309|NCT00294658|University of Alabama at Birmingham|Dr. Gary Cutter, Professor|205-975-5048|cutter@uab.edu|
22428310|NCT00208975|Emory University|Dr. Christopher Flowers|404-778-3942|crflowe@emory.edu|
22428311|NCT03837704|Philip Morris Products S.A.|Global Head Clinical Development & Operations|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
22397652|NCT04338815|University of Nebraska-Omaha|Philippe Malcolm|617-487-1148|pmalcolm@unomaha.edu|
22397653|NCT00535132|Ortho McNeil Janssen Scientific Affairs, LLC|Vice President, Medical Affairs, CNS|609-730-2136||
22397654|NCT00734799|Durham VAMC|Christi S. Ulmer, PhD|9192860411|christi.ulmer@va.gov|4044
22397655|NCT01751308|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22397656|NCT03524339|Cleveland Clinic|Graham Chapman|440-312-2229|gchapman5@gmail.com|
22397657|NCT02041377|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com|
22397658|NCT01022190|Radboud University Nijmegen Medical Centre|Study director|+31 24 36 13918||
22397659|NCT00708500|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22397660|NCT05051904|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22397661|NCT01242267|Hackensack Meridan Health|Joshua Zenreich|5519964248|Joshua.Zenreich@hmhn.org|
22397662|NCT00371293|UPenn|Julio Chirinos|2158235800|julio.chirinos@uphs.upenn.edu|
22397663|NCT02798536|National Cancer Institute|Dr. Raffit Hassan|240-760-6232|hassanr@mail.nih.gov|
22397664|NCT00794677|Children's Hospital Oakland Research Institute|Ronald M Krauss|510.450.7912|rkrauss@chori.org|
22397665|NCT01029366|Abramson Cancer Center of the University of Pennsylvania|Noelle Frey, MD|215-662-6901|noelle.frey@uphs.upenn.edu|
22397666|NCT03350217|Indiana University|Clinical Research Specialist|317-948-0724|rlahr@iu.edu|
22397667|NCT03362970|University of Calgary|Stephen Freedman|403-955-7740|stephen.freedman@ahs.ca|
22397668|NCT03681119|NYU Langone Health|Abraham Brody, PhD, RN, FAAN|212-992-7341|Abraham.Brody@nyulangone.org|
22397669|NCT00549172|University of Helsinki|Dr. Teppo Järvinen, Head of study chair||teppo.jarvinen@helsinki.fi|
22397670|NCT01236300|University of Chicago Medical Center|Dr. Vani J.A. Konda|773-702-1460|vkonda@medicine.bsd.uchicago.edu|
22397671|NCT01797575|The University of Texas Health Science Center at Houston|Jair C Soares, MD|713-486-2627|jair.c.soares@uth.tmc.edu|
22397672|NCT03761615|Sansum Diabetes Research Institute|Dr. Kristin Castorino|805-682-7638|info@sansum.org|
22397673|NCT02941627|Oticon Medical|Clinical Research Director|+33 4 93 95 18 18|mhoe@oticonmedical.com|
22397674|NCT00563186|University of Calgary|Dr. John Conly|403-944-8090|John.Conly@albertahealthservices.ca|
22397675|NCT02595723|UT Southwestern Medical Center|E. Sherwood Brown, M.D., Ph.D.|214-645-6950|sherwood.brown@utsouthwestern.edu|
22397676|NCT01136655|AstraZeneca|Göran Eckerwall, MSD||ClinicalTrialTransparency@astrazeneca.com|
22397677|NCT01265550|Dallas VA Medical Center|Stuart Spechler||sjspechler@aol.com|
22397678|NCT02692495|MEBO Research|Irene Gabashvili, Scientific Director|(408) 341-9355|irene.gabashvili@meboresearch.org|
22397679|NCT00391222|Janssen Cilag Spain|EMEA Medical Affairs Director|+34 91 7228043||
22397680|NCT02461550|Memorial Sloan Kettering Cancer Center|Dr. Stephen Solomon|212-639-5012|solomons@mskcc.org|
22397681|NCT01181011|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|800-542-6257|clintriage.rdg@boehringer-ingelheim.com|Option 4
22397682|NCT00401375|Bausch Health Americas, Inc|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
22397683|NCT00950664|Seoul National University Hospital|BS Jeon|+82220722876|brain@snu.ac.kr|
22397684|NCT03152019|Hospices Civils de Lyon|Dr Dupuis Girod|427856522|sophie.dupuis-girod@chu-lyon.fr|+33
22397685|NCT04703075|Johns Hopkins University School of Medicine|Maria Beatriz Kohler, Senior Research Nurse|4104048921|bkohler@jhmi.edu|
22397686|NCT01187953|Veloxis Pharmaceuticals|Christina Sylvest|+4520553877|csy@veloxis.com|
22397687|NCT03449095|University of Illinois at Urbana-Champaign|Dr. Catharine Fairbairn|215-300-5850|cfairbai@illinois.edu|
22397688|NCT01197326|Philips Healthcare|Duane A Young-Kershaw RN, BSN, Clinical Researcher|508-817-7001|duane.young-kershaw@philips.com|
22397689|NCT00479154|NINDS/NIH|Fatta Nahab|301-496-9526|nahabf@ninds.nih.gov|
22397690|NCT01783678|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22397691|NCT02404103|University Louisville|Nemr Eid, MD|502-852-3772|n.eid@louisville.edu|
22397692|NCT01408147|Cal Poly|Suzanne Phelan|805 756 2087|sphelan@calpoly.edu|
22397693|NCT00621504|Cerexa, Inc|Vice President, Clinical Sciences|(510) 285-9200|clinicaltrials@cerexa.com|
22397694|NCT00600015|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
22397695|NCT03311711|Emory University|Mi-Kyung Song, PhD|404-727-3134|mi-kyung.song@emory.edu|
22397696|NCT02229552|SUNY Buffalo|Leonard H Epstein|716-826-3400|ckk@buffalo.edu|
22397697|NCT03657368|Cleveland Clinic Foundation|YanYan Han|216-444-2250|HANY3@ccf.org|
22397698|NCT00706134|Novartis Pharmaceuticals|Study Director|862-778-8300||
22397699|NCT02586675|H. Lee Moffitt Cancer Center and Research Institute|Dr. Hatem Soliman|813-745-4933|hatem.soliman@moffitt.org|
22397700|NCT03186677|Catalyst Biosciences|Howard Levy, Chief Medical Officer|+1.650.266.6871|hlevy@catbio.com|
22412008|NCT02365597|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22397702|NCT02730884|The University of Texas MD Anderson Cancer Center|Jorge Cortes, MD/Professor|713-794-5783|jcortes@mdanderson.org|
22397703|NCT03378076|Flexion Therapeutics|Scott Kelley, Chief Medical Officer|781-305-7142|skelley@flexiontherapeutics.com|
22397704|NCT00772954|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22397705|NCT01093027|Mayo Clinic|Virgilio Evidente MD|480-301-8000|evidente.virgilio@mayo.edu|
22397706|NCT03354754|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22397707|NCT01661140|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22397708|NCT01391000|Istituto Ortopedico Rizzoli|Dr Roberta Monesi|0516366694|cristiana.forni@ior.it|0039
22397709|NCT03860961|NRG Oncology|Wendy Seiferheld|(215) 574-3208|seiferheldw@nrgoncology.org|
22397710|NCT02239939|WFSM|Dr. Barbara Nicklas|3367138569|bnicklas@wakehealth.edu|
22397711|NCT01659320|Weill Cornell Medical College|Dr. George Alexopoulos, M.D.|914-997-5767|galexopoulos@med.cornell.edu|
22397712|NCT00590590|KV Pharmaceutical|Jim Joffrion, Sr. Director, Clinical Affairs|314-645-6600|jjoffrion@kvph.com|
22383379|NCT00028093|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Combination of Pegylated Interferon and Ribavirin as Therapy for Patients With Chronic Hepatitis C W|3014961333|hoofnaglej@extra.niddk.nih.gov|
22383380|NCT01685606|Brown University Oncology Research Group (BrUOG)|Dr. Peter Quesenberry|4018633000|kayla_rosati@brown.edu|
22383381|NCT01787760|Vistakon, USA|XU CHENG, PRINCIPAL CLINICAL SCIENTIST|1 904 443-1245|xcheng6@its.jnj.com|
22383382|NCT01353963|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22383383|NCT01351272|Universitätsklinikum Würzburg|Prof. Dr. M. Herrmann|093120176650|Herrmann_m@ukw.de|
22383384|NCT03949335|Johnson & Johnson Surgical Vision|Eugenia Thomas, OD|+1 657 2903260|ethoma39@its.jnj.com|
22383385|NCT01926977|Sierra Eye Associates|Arshad Khanani M.D., Vitreo-Retinal Diseases and Surgery|775-329-0286|arshad.khanani@gmail.com|
22383386|NCT02531113|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email:|Clinical.Trials@bms.com|
22383387|NCT00632424|Organization: Bristol-Myers Squibb|Name/Official Title: BMS Study Director||Clinical.Trials@bms.com|
22383388|NCT00801983|University of Pittsburgh|Dr. Nancy Baker|412 383-6607|nab36@pitt.edu|
22383389|NCT04120454|The Ohio State University Comprehensive Cancer Center|Dr. Asrar Alahmadi|614-293-6786|Asrar.Alahmadi@osumc.edu|
22383390|NCT03632941|Duke University|Michael Morse, M.D.|919-681-3480|michael.morse@duke.edu|
22383391|NCT02237417|Otsuka|Wilt, Timothy|240.683.3095|timothy.wilt@otsuka-us.com|
22383392|NCT04156581|Hospital for Special Surgery|Dr. Justas Lauzadis|212-774-2946|lauzadisj@hss.edu|
22383393|NCT05165485|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
22383394|NCT04928001|Montana State University|Dr. Katey T. Franklin|406-570-6056|katey.franklin@montana.edu|
22383395|NCT04153565|Merck Sharp& Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22383396|NCT03827304|Sheffield Hallam University|Ivan Phelan|+44 114 225 6955|i.phelan@shu.ac.uk|
22383397|NCT02541565|University of Washington|Dr. Stephen Smith|206-606-6546|ssmith50@seattlecca.org|
22383398|NCT03113617|Stanford Medicine at Stanford University|David G Marcellus|650-723-4547|dmarcel2@stanford.edu|
22383399|NCT01950780|Columbia University Dept of Dermatology|Director of Clinical Research Dermatology|2123056953|jc299@cumc.columbia.edu|
22383400|NCT01305252|Stanford University School of Medicine|Roham Zamanian, MD, FCCP|650- 725-5495|zamanian@stanford.edu|
22383401|NCT00804648|Vistakon|Arthur Shedden MD|904-443-1557||
22383402|NCT04723394|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22383403|NCT00446459|University of Washington|Dr. Connie L. Davis|206-598-7162|cdavis@u.washington.edu|
22383404|NCT01965665|Duke University Medical Center|Michael Kerzner, DMP|919-613-4449|michael.kerzner@duke.edu|
22383405|NCT00253890|Butler Hospital|Dr. Michael D. Stein, MD|401-455-6646|mstein@butler.org|
22383406|NCT00858117|Northwestern University|Olga Frankfurt, MD|312 695 6180|o-frankfurt@northwestern.edu|
22383407|NCT02647905|Senseonics|Vice President, Clinical Sciences|3015157260|katherine.tweden@senseonics.com|
22383408|NCT00371787|Centre for Contact Lens Research|Dr. Craig Woods|1-519-888-4567|cawoods@uwaterloo.ca|36547
22383409|NCT00077675|Theravance, Inc|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
22383410|NCT02601820|University of North Carolina at Chapel Hill|Donna Evon, PhD|919-260-4062|donna_evon@med.unc.edu|
22383411|NCT01514149|ConjuChem Biotechnologies Inc.|Associate Director of Regulatory Affairs|310-405-7549|Aleece.Nolasco@nantbio.com|
22383412|NCT00642850|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22383413|NCT01236001|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22383414|NCT02869334|Nathan Kline Institute|Dr. Daniel Javitt|8453986534|javitt@nki.rfmh.org|
22383415|NCT01414738|UT Southwestern Medical Center|Dr. Robert Timmerman|214/645-7637|ROBERT.TIMMERMAN@UTSouthwestern.edu|
22383416|NCT01266122|Behavioral Medicine Service, Massachusetts General Hospital|Dr. Steven Safren|617-724-0817|ssafren@partners.org|
22383417|NCT02283749|Brown University Oncology Research Group (BrUOG)|Kayla Rosati|14018633000|kayla_rosati@brown.edu|
22383418|NCT02092116|Bionor Pharma ASA|Maja Sommerfelt|+4723010960|ms@bionorpharma.com|
22383419|NCT03076515|Theranica Bio-Electronics Ltd|Dagan Harris|+972723909755|daganh@theranica.com|
22383420|NCT00174382|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22383421|NCT03903822|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22383422|NCT00296036|Mayo Clinic|Charles Lawrence Loprinzi, M.D.||cloprinzi@mayo.edu|
22383423|NCT01796236|Ear Nose Throat, University Medical Center Utrecht, Utrecht|Professor Robert Stokroos|0031 8875 56644|R.J.Stokroos@umcutrecht.nl|
22383424|NCT00785512|Forest Laboratories|John Whalen, MD Executive Director of Clinical Development - Cardiovascular and Metabolism|1-201-427-8259|John.Whalen@frx.com|
22383425|NCT01792830|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
22383426|NCT01390818|Merck Serono, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+496151725200|service@merckgroup.com|
22383427|NCT01943799|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22383428|NCT05274217|University of Washington|Teresa Evans-Campbell|206-543-6075|tecamp@uw.edu|
22383429|NCT01697969|Alcon Research, Ltd.|Danyel Crout Carr, MS, CCRA|1-888-451-3937|alcon.medinfo@alcon.com|
22383430|NCT01542229|Charleston VAMC|Dr. Anouk L. Grubaugh|843-789-5853|grubaugh@musc.edu|
22383431|NCT03764475|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
22383432|NCT03994705|Cartesian Therapeutics|Dr. Vera Sarkodie Medical Director,|617-231-8085|vera.sarkodie@cartesiantx.com|
22397713|NCT01667471|Hoffmann-LaRoche or Genentech, Inc|Medical Communications|800-821-8590|genentech@druginfo.com|
22397714|NCT00272038|Oncology Specialists, S.C.|Sigrun Hallmeyer, MD (Director of Research); Chadi Nabhan, MD, FACP (PI)|847-268-8200|shallmeyer@oncmed.net|
22397715|NCT03605680|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22383433|NCT05510245|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22383434|NCT02414204|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Timmy Lee|205-934-3589|txlee@uab.edu|
22428312|NCT06181799|I.M. Sechenov First Moscow State Medical University (Sechenov University)|Basheer Abdullah Marzoog|+7(996) 960 28 20|marzug@mail.ru|
22428313|NCT01771107|Emmes Company|Kimberly Mosby-Griffin|301 251-1161|kmosby@emmes.com|10158
22428314|NCT02141555|University of California, San Diego|Dr. Sheila Mody||smody@ucsd.edu|
22428315|NCT03834688|Dana-Farber Cancer Institute|Opeyemi Jegede, Statistician|(617) 582-7613|ojegede@ds.dfci.harvard.edu|
22428316|NCT04717557|Duke University|Dr. Richard Moon|919-684-8762|richard.moon@duke.edu|9199065651
22428317|NCT01654276|University of Texas Southwestern Medical Center|Naim Maalouf. MD|214-648-2954|naim.maalouf@utsouthwestern.edu|
22428318|NCT04812015|Wayne State University|Danielle Taylor, PhD|6166486793|dtaylo@med.wayne.edu|
22428319|NCT00831844|Children's Oncology Group|Results Reporting Coordinator|626-241-0064|Resultsreportingcoordinator@childrensoncologygroup.org|
22428320|NCT01192178|GlaxoSmithKline|GSK Response Center|866-435-7343||
22428321|NCT01093417|University Hospitals Case Medical Center|Grace McComsey, MD|2168443607|gam9@case.edu|
22428322|NCT01143324|MedtronicSpineECA|Christel Van Dam|+31433566523|christel.van.dam@medtronic.com|
22428323|NCT00858988|Washington University School of Medicine in St. Louis|Dr. Mark Manary|314 454-2178|manary@kids.wustl.edu|
22428324|NCT00944554|Johns Hopkins University|Maxine Stitzer, PhD|410-550-0042|mstitze1@jhmi.edu|
22428325|NCT02525523|Atlantic Pharmaceuticals|Dr Chris Dunk, Director of Clinical Development|+44 1799 513391|chris.dunk@atlantichc.com|
22428326|NCT00976027|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22412009|NCT04309474|AbbVie|ABBVIE CALL CENTER|844-663-3742|abbvieclinicaltrials@abbvie.com|
22428327|NCT03805841|Rain Oncology Inc.|Chief Medical Officer|(510) 953-5559|info@rainoncology.com|
22383435|NCT01373346|Gangnam severance hospital|Seung Ho Choi, M.D., Ph.D.|82-2-2019-3374|choish@yuhs.ac|
22383436|NCT01198028|MD Anderson Cancer Center|Dr. Bonnie Glisson, MD,Professor, Thoracic-Head & Neck Med Onc|(713) 792-6363|bglisson@mdanderson.org|
22383437|NCT01186198|Abbott Medical Devices|Jessie Coe|224 668 5360|Jessie.coe@abbott.com|
22383438|NCT01395758|ArQule, Inc.|Brian Schwartz, MD Chief Medical Officer|781-994-0300|ClinicalTrials@arqule.com|
22383439|NCT04515641|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22383440|NCT01514734|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
22383441|NCT02674750|Curis, Inc.|Reinhard von Roemeling, M.D., Senior Vice President, Clinical Development|617-503-6500|rvonroemeling@curis.com|
22428328|NCT03621592|University of Miami|Hadar Lev-Tov, MD|305-243-4472|hlevtov@med.miami.edu|
22383442|NCT00736853|Neuroscience Department, Clinical Science Division, R&D, JANSSEN PHARMACEUTICAL. K.K.|Medical Director|+81-3-4411-5509||
22383443|NCT01415349|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22383444|NCT02139943|Janssen Research & Development, LLC|Senior Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
22383445|NCT01764464|University of Rochester|John Markman|585-276-3616|john_markman@urmc.rochester.edu|
22383446|NCT00700336|CanBas Co., Ltd.|Takumi Kawabe, MD, PhD|81559543666|takumi@canbas.co.jp|
22383447|NCT04578496|CLINUVEL PHARMACEUTICALS LIMITED|Clinical Operations Manager||mail@clinuvel.com|
22383448|NCT02918071|AstraZeneca|Ubaldo Martin, Global Clinical Lead Benralizumab|+1 301 398 0163|Ubaldo.Martin@astrazeneca.com|
22383449|NCT01616459|GlaxoSmithKline|GSK Response Center|866-435-7343||
22383450|NCT01029587|Johns Hopkins University|Benjamin Philosophe|443-287-7178|bphilosophe@jhmi.edu|
22383451|NCT01401023|Michigan State University|Dr. Gary Stein, Pharm D|517-353-5126|steing@msu.edu|
22383452|NCT00590369|Cleveland Clinic|Nancy M. Albert PhD, RN|216-444-7028|albertn@ccf.org|
22383453|NCT03960463|Baylor College of Medicine|Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
22383454|NCT03237481|Heron Therapeutics, Inc.|Vice President, Clinical Operations|858-251-7232|svisonneau@herontx.com|
22383455|NCT04201834|University of Rochester|Ruth Schneider, MD|585-341-7500|Ruth_schneider@urmc.rochester.edu|
22383456|NCT04941287|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
22383457|NCT01998984|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
22383458|NCT05386238|Rush University Medical Center|Melissa Crane|312-563-0269|melissa_m_crane@rush.edu|
22383459|NCT04907474|Eyenovia, Inc.|Michael Rowe|833-393-6684|mmrowe@eyenovia.com|
22383460|NCT02476695|Wuxi HISKY Medical Technologies Co., Ltd.|Peng Lu|13816688340|yixuebu@fibrotouch.com|
22383461|NCT05055778|University of Virginia|Kara P. Wiseman, MPH, PhD|434-243-8126|kara.wiseman@virginia.edu|
22383462|NCT05857644|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22383463|NCT01353313|University of New Mexico Health Sciences|Kristi Watterberg|505-272-8609|kwatterberg@salud.unm.edu|
22383464|NCT03079024|University of Minnesota|Melissa Fisher|(612) 273-9812|mafisher@umn.edu|
22383465|NCT01631214|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22383466|NCT03575052|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|58-261|medicalinformation@acadia-pharm.com|2897
22383467|NCT03717415|Deciphera Pharmaceuticals, LLC|Clinical Trials|785-830-2100|clinicaltrials@deciphera.com|
22383468|NCT02991807|Boston Children's Hospital|Dr. Mustafa Sahin|617-355-8994|Mustafa.Sahin@childrens.harvard.edu|
22383469|NCT02566902|University of California - San Diego|Mike Gardiner, MD|8589668036|magardiner@ucsd.edu|
22383470|NCT01875848|VACT West Haven HealthCare System|William, Becker M.D|203-932-5711|william.becker4@va.gov|2247
22383471|NCT02411084|ADIENNE S.A|Renata Palmieri|+41.91.210.47.22|renata.palmieri@adienne.com|
22383472|NCT01622868|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22383473|NCT00402896|The University of Texas (UT) MD Anderson Cancer Center|Carlos A. Jimenez, MD/Professor, Pulmonary Medicine||CR_Study_Registration@mdanderson.org|
22383474|NCT03285763|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22397716|NCT03189446|Stephenson Cancer Center|Dr. Kathleen Moore|405-271-8777|Kathleen-Moore@ouhsc.edu|
22397717|NCT05594173|University Health Network|Catriona Steele|4165973422|catriona.steele@uhn.ca|7802
22397718|NCT00883337|sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22397719|NCT00763139|Vanderbilt|Dr. Charles Michael Stein|615-936-3420|mike.stein@vanderbilt.edu|
22397720|NCT05634577|M D Anderson Cancer Center|Mouhammed Habra, MD|713-792-2841|mahabra@mdanderson.org|
22397721|NCT03468309|VA Puget Sound Health Care System|Dr. Amanda E. Wood; Clinical Research Psychologist, VA PSHCS|253-583-1652|amanda.wood@va.gov|71652
22397722|NCT01692964|Rapid Pathogen Screening, Inc.|Robert Sambursky, MD|941-556-1853|rob.sambursky@lumosdiagnostics.com|
22397723|NCT03239574|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
22397724|NCT02181829|Memorial Sloan Kettering Cancer Center|Suzanne Wolden, MD|212-639-5148|woldens@MSKCC.ORG|
22397725|NCT03865706|Columbia University|Daniel E. Freedberg, MD, MS|857-998-9370|def2004@cumc.columbia.edu|
22397726|NCT02095535|UBC Department of Anesthesia - BC Women's Hospital|Tashya De Silva|604-875-2158|tashya.desilva@cw.bc.ca|
22397727|NCT01515787|Memorial Sloan Kettering Cancer Center|Dr.Deborah Schrag|617-416-5194|schragd@mskcc.org|
22397728|NCT02631200|Queen's University Belfast|Dr Peter O'Halloran|02890972490|p.ohalloran@qub.ac.uk|
22397729|NCT03174132|Galderma|Reception|+46184749000|reception.seupp@galderma.com|
22397730|NCT01877187|Yale University|Todd Schlachter, MD|(203) 785-5885|todd.schlachter@yale.edu|
22397731|NCT02340585|Stryker|Stacy Phung|678 469 2428|stacy.phung@stryker.com|
22397732|NCT02669017|ADC Therapeutics|ADC Therapeutics|954-903-7994|clinical.trials@adctherapeutics.com|
22397733|NCT04091087|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22397734|NCT04152161|Gates MRI|Study Director|+1 857 702 2108|clinical.trials@gatesmri.org|
22397735|NCT03621280|Cortendo AB|Valentina Conoscenti, MD|1-877-937-4737|OPTICS@cortendo.com|
22397736|NCT03363321|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22397737|NCT00915681|Meda Pharma GmbH & Co KG (A Viatris company)|Baerbel Fingerhut|+49 6172 888|baerbel.fingerhut@viatris.com|1419
22397738|NCT01685463|Medical University of south Carolina|Dr. Xingbao Li|8437925729|lixi@musc.edu|
22397739|NCT00919100|MMJ Labs|Dr. Amy Baxter|877-805-2899|abaxter@mmjlabs.com|106
22397740|NCT00919503|Fred Hutchinson Cancer Research Center|Dr. Lauri Burroughs|206-667-2396|lburroug@fredhutch.org|
22397741|NCT02590588|Boston Medical Center|Mark Sloan MD|617-638-2367|mark.sloan@bmc.org|
22397742|NCT02918773|Emory University|Andi L Shane MD/MPH/MSc|404-727-9880|ashane@emory.edu|
22397743|NCT00003460|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22397744|NCT01098071|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22397745|NCT03504410|Cornerstone Pharmaceuticals Inc|Sanejev Luther|585-978-1351|sanjeev.luther@cornerstonepharma.com|
22397746|NCT00714792|University of Rochester|Michael K. Flynn, MD|585-273-3232|michael_flynn@urmc.rochester.edu|
22397747|NCT00382993|Glaxo Smith Kline|GSK Response Center|1-866-435-7343||
22397748|NCT02461992|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22397749|NCT05515250|Saint Louis University|Purnima Modi|3149772029|purnima.modi.1@slu.edu|
22397750|NCT05284760|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22383475|NCT03624972|Fox Chase Cancer Center|Dr. Jennifer Reese, Associate Professor|215-214-3223|Jennifer.Reese@fccc.edu|
22383476|NCT03112174|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22383477|NCT04425629|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|8447346643|clinicaltrials@regeneron.com|
22383478|NCT02036424|Raj K. Maturi, MD, PC|Raj K. Maturi, MD|317-817-1414|rmaturi@gmail.com|
22383479|NCT00610649|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22383480|NCT00687167|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22383481|NCT04987021|Cochlear Limited|PRS Specialist, Clinical Affairs|+612 9428 6555|cltd-prs-admin@cochlear.com|
22383482|NCT04259450|Affimed GmbH|Clinical Operations|+49 62216530770|trials@affimed.com|
22383483|NCT03390296|The University of Texas MD Anderson Cancer Center|Naval Daver MD./Associate Professor|713-794-4392|NDaver@mdanderson.org|
22383484|NCT00332241|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@BMS.com|
22383485|NCT00924807|St. Luke's Roosevelt Hospital Center|Seth Cohen, MD|212-523-7289|secohen@chpnet.org|
22383486|NCT00542789|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22383487|NCT01714492|The University of Tennessee|Richard Komistek, Ph. D.|8659744159|rkomiste@utk.edu|
22383488|NCT02584829|Fred Hutchinson Cancer Research Center|Dr. Aude Chapuis|2066674369|achapuis@fredhutch.org|
22383489|NCT02374463|Baltimore VA Medical Center|Leslie Katzel, MD, PhD|410-605-7248|leslie.katzel@va.gov|
22428329|NCT02629159|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22383490|NCT03538717|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22383491|NCT01318967|Wake Forest School of Medicine|Michael Rocco, MD|336-716-4650|mrocco@wfubmc.edu|
22383492|NCT03628885|Indiana University|Dr. Gregory Zimet|3172748812|gzimet@iu.edu|
22383493|NCT01537419|Center for Family Intervention Science, Drexel University|Guy Diamond, Ph.D.|215-571-3420|gd342@drexel.edu|
22383494|NCT00106080|Department of Veterans Affairs, Health Services Research and Development|David H. Au, MD, MS|206-764-2430|david.au@va.gov|
22397751|NCT03015259|KINDEVA DRUG DELIVERY|Lester Harrison, PhD|6122714814|lester.harrison@kindevadd.com|
22397752|NCT01965262|Coopervision|Paul Chamberlain, BSc Honors, Sr. Manager Clinical Research|(925) 730-6754|pchamberlain@coopervision.com|
22383495|NCT01839331|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|720-437-6500|clinicaltrials@ampiopharma.com|
22383496|NCT01625104|University of Michigan|Eva Kline-Rogers MS, RN|734 9985909|evakline@med.umich.edu|
22383497|NCT00761605|Clinical Research Team, Medical Affairs Korea|Senior Clinical Research Associate|82-2-2094-4804||
22383498|NCT03074331|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22383499|NCT00741455|Dartmouth-Hitchcock Medical Center|Darcie Findley|603-650-4595|darcie.l.findley@hitchcock.org|
22383500|NCT00350792|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22383501|NCT04594759|Medical University of South Carolina|Dr. Samantha Karlin|(843)- 714-0146|karlin@musc.edu|
22428330|NCT05722015|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22428331|NCT02685735|Wake Forest University School of Medicine|Dr. James Eisenach|336-716-4182|jimeisenach@gmail.com|
22428332|NCT02512419|Brown University|Dr. Bess Marcus|401-863-9858|bess_marcus@brown.edu|
22428333|NCT04133909|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22428334|NCT05020743|Vigil Neuro|VP, Clinical & Medical Sciences|+18572280538|jchavez@vigilneuro.com|
22428335|NCT02003924|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22428336|NCT02340949|MFAR Clinical Research|Pau Doñate Macian|0034934344412|investigacion@mfar.net|
22428337|NCT03980223|University of California, San Francisco|Anne Luetkemeyer|415-502-5753|annie.luetkemeyer@ucsf.edu|
22428338|NCT00434434|Genentech, Inc.|Medical Communications|800-821-8590||
22428339|NCT02460289|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22428340|NCT01155570|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22428341|NCT01922934|Denver Health|Dr. Daniel H. Bessesen|303-602-5021|daniel.bessesen@ucdenver.edu|
22428342|NCT02916927|Alameda Health Systemt - Highland Hospital|Dr. Andrew Herring|(510) 437-4564|aherring@alamedahealthsystem.org|
22428343|NCT02354118|TriHealth|Rachel Baker, Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
22428344|NCT02774889|University of Wisconsin-Madison|Associate Research Specialist|6082631105|wpalmer3@wisc.edu|
22428345|NCT01020123|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22428346|NCT01349595|Mayo Clinic|Dr. Mark Stegall|507-266-2812|Stegall.Mark@mayo.edu|
22428347|NCT01069939|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22428348|NCT00658528|Eisai Call Center|Eisai Inc.|888-422-4743||
22428349|NCT02587936|UT Southwestern Medical Center|Miguel A Vazquez|214-648-8884|Miguel.Vazquez@UTSouthwestern.edu|
22428350|NCT03654417|Duke University|Dr. Laura Havrilesky|(919) 684-0188|laura.havrilesky@duke.edu|
22428351|NCT05203185|NYU Langone Health|Safiya Richardson, MD, MPH|212-263-8313|Safiya.Richardson@nyulangone.org|
22428352|NCT01706328|GlaxoSmithKline|GSK Response Center|866-435-7343||
22428353|NCT01859091|Zeltiq Aesthetics|Sally Hallas, RN, Director Clinical Development - Body Contouring|209-294-5571|sally.hallas@abbvie.com|
22428354|NCT04603066|Washington University in St Louis|Simon Haroutounian|3132861715|sharout@wustl.edu|
22428355|NCT05759338|Wake Forest University Health Sciences|Amy McMichael|704-355-2000|Amy.Mcmichael@Advocatehealth.org|
22428356|NCT04409002|Massachusetts General Hospital|Theodore Hong, MD|617-726-6050|TSHONG1@mgh.harvard.edu|
22428357|NCT06481579|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22428358|NCT04611126|National Center for Cancer Immune Therapy (CCIT-DK)|MD, PhD Tine Juul Monberg|38682983|tine.monberg@regionh.dk|
22428359|NCT05260008|Allay Therapeutics, Inc|Study Director|669-679-5081|clinicaltrialsinfo@allaytx.com|
22428360|NCT03308669|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22428361|NCT01157845|Virginia Commonwealth University|R. Todd Stravitz|804-828-8514|rstravit@vcu.edu|
22428362|NCT04584788|Masimo Corporation|Cristina Johnson|(949) 297-7576|clinicalresearchdept@masimo.com|
22428363|NCT03311555|Duke University|Andrew Armstrong, MD|919-668-8797|andrew.armstrong@duke.edu|
22428364|NCT00505635|UT MD Anderson Cancer Center|Nicholas E. Papadopoulos, MD / Professor|713-792-2921|CR_Study_Registration@mdanderson.org|
22428365|NCT02546570|National Center for PTSD|Dr. Lauren Sippel|802-295-9363|lauren.m.sippel@dartmouth.edu|6082
22428366|NCT01740206|Nationwide Children's Hospital|Richard Cartabuke, MD|614-722-4200|Richard.Cartabuke@nationwidechildrens.org|
22428367|NCT04284774|Children's Oncology Group|Results Reporting Coordinator|6264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22428368|NCT04390750|New York University|Bei Wu|12129925951|bw75@nyu.edu|
22412010|NCT04670068|UNC Lineberger Comprehensive Cancer Center|Kelly Hoye, MS, CCRP Study coordinator - Clinical Immunotherapy Program|919-445-9676|khoye@email.unc.edu|
22428369|NCT01240746|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22428370|NCT01136954|Eisai Call Center|Eisai Inc.|888-422-4743||
22428371|NCT00674297|Hospital for Special Surgery|Doruk Erkan, MD|212 774-2291|erkand@hss.edu|
22428372|NCT00458835|Covis Pharma|Clinical Trials Interest|1-877-374 -4177|CTInterest@covispharma.com|
22428373|NCT00255177|VGX Pharmaceuticals, LLC|Mary Giffear, Sr. Clinical Scientist|267 440 4220|mgiffear@inovio.com|
22428374|NCT02199496|NIAID - LCIM|Fuss, Ivan|+1 301 496 9663|ifuss@niaid.nih.gov|
22428375|NCT04190225|Brown University|Dr. Shira Dunsiger, Biostatistician|401-863-6747|shira_dunsiger@brown.edu|
22428376|NCT00884065|Catalan Institut of Health - Servei de Rhb Sant Ildefons|Martín Eusebio Barra López||martinbarra@gmail.com|
22428377|NCT01732783|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22428378|NCT04429971|Rutgers New Jersey Medical School|Ethan Cowan, MD, MS, FACEP|917-447-4964|ethan.cowan@rutgers.edu|
22428379|NCT03331562|Translational Genomics Research Institute (TGen) An Affiliate of City of Hope|Derek Cridebring, PhD. Director, Molecular Medicine Division|6023438629|dcridebring@tgen.org|
22428380|NCT01088789|SKCCC Johns Hopkins Medical Institution|Daniel Laheru, MD|410-955-8974|Laherda@jhmi.edu|
22428381|NCT03718000|University of Georgia|Dr. Jamie Cooper, Associate Professor|706-542-4903|jamie.cooper@uga.edu|
22428382|NCT01866592|University of Pennsylvania|Suzette Baez VanderBeek, MPH|2156623514|suzette.baezvanderbeek@uphs.upenn.edu|
22428383|NCT00626236|Supernus Pharmaceuticals|Gianpiera Ceresoli-Borroni Director Clinical Research|3018382521|gceresoliborroni@supernus.com|
22428384|NCT05522751|University of California San Francisco|Khaled Moussawi|415-502-6343|khaled.moussawi@ucsf.edu|
22428385|NCT06487390|University of Alabama at Birmingham|Dr. Lynn Matthews|2059348148|lynnmatthews@uabmc.edu|
22428386|NCT04044690|CSL Behring|Study Director|16108784697|clinicaltrials@cslbehring.com|
22428387|NCT01325441|Sumitomo Pharma Oncology|Tegan Nguyen|6176748745|tegan.nguyen@oncology.sumitomo-pharma.com|
22428388|NCT01582451|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22428389|NCT03318341|MUSC|Na Jin Seo, PhD|8437920084|seon@musc.edu|
22428390|NCT00716417|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22428391|NCT00487188|Hoffman-LaRoche|Medical Communications|800-821-8590||
22428392|NCT03881371|Zambon S.p.A|Valentina Zanin|+39 02 665241|valentina.zanin@zambongroup.com|
22428393|NCT02508389|Galera Therapeutics, Inc.|Kara Terry|610-725-1500|kterry@galeratx.com|
22428394|NCT01869374|New York State Psychiatric Institute|Stefan Rowny, MD|(646) 774-5417|stefan.rowny@nyspi.columbia.edu|
22428395|NCT05376358|University of Pittsburgh|Dr. Ana Radovic|4126927227|anr94@pitt.edu|
22428396|NCT04225832|RAND|Laura Bogart, PhD|3103830411|lbogart@rand.org|7281
22428397|NCT00311168|Abbott|Clay Cohorn - Director, Clinical Research|469-929-7116|clay.cohorn@abbott.com|
22428398|NCT05472142|University of Kentucky|Mary E. Lacy, PhD, Study PI|8595621126|mary.lacy@uky.edu|
22428399|NCT02452190|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22428400|NCT04635345|Barts Health NHS Trust|Jessica Gaddie|020 7480 4737|j.gaddie1@nhs.net|
22428401|NCT06001021|University of Gujrat|Dr. Sameera Shafiq (Lecturer, M. Phil, QAU; Ph.D., UOG)|923345116648|sameera.shafiq@uog.edu.pk|
22428402|NCT04341636|King Abdulaziz University|Dr. Zuhair Natto|9666943899|znatto@kau.edu.sa|
22383502|NCT03811574|Novo Nordisk A/S|Clinical Transparency Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22428403|NCT03112603|Call Center|Incyte Corporation|1.855.463.3463|medinfo@incyte.com|
22428404|NCT04092777|Massachusetts General Hospital|Dr. Margarita Alegria|617-724-1237|malegria@mgh.harvard.edu|
22428405|NCT02278354|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
22428406|NCT00848185|IVI Madrid|Dra Cerrillo|911802900|maria.cerrillo@ivi.es|
22428407|NCT01925794|CeloNova BioSciences Inc.|Mark Barakat, MD|(210) 489-4004|mbarakat@celonova.com|
22428408|NCT03126110|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22428409|NCT00314145|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22383503|NCT03639558|University of Nottingham/Psychiatric Hospital of the Cross|Dr. Joseph Dib|07748668553|joseph.elie.dib@gmail.com|
22383504|NCT03485950|UT MD Anderson Cancer Center|Issam Raad,MD - Chair, Infectious Diseases|(713) 792-7943|iraad@mdanderson.org|
22383505|NCT06243796|Nakhon Phanom hospital|Dr.Kriengkrai Prasert|+6642199222|gpsiam28@gmail.com|1091
22383506|NCT03144674|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22383507|NCT01565148|University of Nebraska|Quan Dong Nguyen|4025592020|quan.nguyen@unmc.edu|
22383508|NCT01759771|Ralph H. Johnson Veterans Affairs Medical Center|Stephen J. Savage, MD, Chief Section of Urology|843 789 7330|savages@musc.edu|
22383509|NCT03631550|Neurolief Ltd.|Michal Kedar-Datel|+972-52-6659806|michal.kedar-datel@neurolief.com|
22383510|NCT00529659|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22383511|NCT01692730|University of Rochester|Scott McIntosh|585-275-0511|scott_mcintosh@urmc.rochester.edu|
22383512|NCT01041417|Emory University School of Medicine|Dr. Arshed Quyyumi|4047273655|aquyyum@emory.edu|
22383513|NCT01429350|Penumbra, Inc.|Michaella Corso|510-995-2079|mcorso@penumbrainc.com|
22383514|NCT03762213|Arkansas Children's Hospital|Dr. Saumya V Joshi|501-364-4619|svjoshi@uams.edu|
22383515|NCT04585191|Division of Research, Kaiser Permanente Northern California|Dr. Richard Grant|5108213969|Richard.W.Grant@kp.org|
22383516|NCT03783026|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22383517|NCT04814186|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22383518|NCT03342027|University of Chicago|Dr. Seth Himelhoch|773-834-4314|seth.himelhoch@bsd.uchicago.edu|
22383519|NCT03602612|National Cancer Institute|Dr. James Kochenderfer|240-760-6062|kochendj@mail.nih.gov|
22383520|NCT06336629|Sun Pharmaceutical Industries Limited|Head-Regulatory Affairs|2266455645|Clinical.Trial@sunpharma.com|5689
22383521|NCT04043455|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
22383522|NCT03422276|University of Washington|Dr. Jeanne Hoffman|(206) 221-6511|jeanneh@uw.edu|
22383523|NCT05194917|University of Wisconsin School of Medicine and Public Health Center for Tobacco Research and Intervention|Dr. Adrienne Johnson|608-262-8673|aljohnson43@ctri.wisc.edu|
22383524|NCT04922021|LEO Pharma A/S|Disclosure Specialist|+4544945888|disclosure@leo-pharma.com|
22383525|NCT05786391|The University of Texas Health Science Center at Houston|Randa J Jalloul, MD|713-566-5749|Randa.J.Jalloul@uth.tmc.edu|
22383526|NCT05686408|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 904-0355|greg.sullivan@tonixpharma.com|
22383527|NCT03817684|Tetra Therapeutics|CEO|616-224-0084|info@tetratherapeutics.com|
22383528|NCT02975505|University of California, San Francisco Division of Nephrology|Dr. Elaine Ku|415-502-7760|elaine.ku@ucsf.edu|
22383529|NCT05233098|Boston Scientific|Jessie Stockwell, Sr. Clinical Trial Specialist|6126181136|jessie.stockwell@bsci.com|
22383530|NCT05540535|New York University|Liraz Arie|3478661117|la1816@nyu.edu|
22428410|NCT05807477|UCSF Hypoxia Research Laboratory|Dr. Philip Bickler|1-415-476-1411|philip.bickler@ucsf.edu|
22383531|NCT04104321|Galmed Pharmaceuticals|Dr. Yossi Gilgun-Sherki|0543314054|yossigs@galmedpharma.com|
22428411|NCT02382380|Loyola University Medical Center|Ari Goldberg, M.D.|708-216-2229|argoldberg@lumc.edu|
22428412|NCT01295944|National Cancer Institute|Dr. Kevin Camphausen|240-760-6205|camphauk@mail.nih.gov|
22428413|NCT03785366|Sebela Women's Health|Elizabeth Gray|760.593.8383|Elizabeth.Gray@sebelapharma.com|
22428414|NCT03240874|Northwestern University|Lynn Yee, MD, MPH|312-472-4685|lynn.yee@northwestern.edu|
22428415|NCT04958707|University of Medicine and Pharmacy at Ho Chi Minh City|Dr. Nguyen Tran To Tran|+84 979635889|nguyentrantotran@ump.edu.vn|
22428416|NCT02489539|W.L. Gore & Associates|Charee Robe|928-864-4048|crobe@wlgore.com|
22428417|NCT05360056|The Ohio State University|Dr. Kathleen Dungan|6146853333|kathleen.dungan@osumc.edu|
22428418|NCT02783274|Johnson & Johnson MedTech|Kirstin Cosgrove|+1 574 4049398|kcosgro1@its.jnj.com|
22428419|NCT05567172|Boston Scientific|Nilou Zilinek|5086836127|nilou.zilinek@bsci.com|
22428420|NCT05484778|IstanbulU|Aysen Elif YILMAZ|+905059466301|aysen.elif4@gmail.com|
22428421|NCT02246777|Alcon, A Novartis Division|Associate, Medical Group 1, Japan|1-888-451-3937|alcon.medinfo@alcon.com|
22428422|NCT00927472|Taro Pharmaceuticals U.S.A.,|Director, Clinical Research|914-345-9001|Natalie.Yantovskiy@Taro.com|
22428423|NCT04707469|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22428424|NCT04115098|The University of Texas Health Science Center at Houston|Mark C. Hwang, MD|(713) 500-6597|Mark.C.Hwang@uth.tmc.edu|
22397753|NCT01479543|Hero Institute for Infant Nutrition|Esther Matencio Hilla|+0034 968 89 89 00|esther.matencio@hero.es|
22397754|NCT00906087|University of Michigan|Sayoko E. Moroi|734-763-3732|smoroi@med.umich.edu|
22397755|NCT00440947|ViiV Healthcare|GSK Response Center|866-435-7343||
22397756|NCT02898259|Clevleland|Dr. Brian Hill|1-866-223-8100|TaussigResearch@ccf.org|
22397757|NCT02681172|Piramal Imaging|Dr. Juergen Hirschfeld, Head of GRA & PV|+49 30461124615|Juergen.Hirschfeld@piramal.com|
22397758|NCT01850485|Medical Center Leeuwarden|Matty Koopmans, MSc|0031582866738|matty.koopmans@znb.nl|
22397759|NCT01991990|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22397760|NCT01834274|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22397761|NCT00967551|Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, Bahia, Brasil|Hugo Costa-Ribeiro||hugocrj@ufba.br|
22397762|NCT01827670|GlaxoSmithKline|GSK Response Center|866-435-7343||
22428425|NCT04635423|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22428426|NCT04431960|University of Connecticut|Ock K. Chun|18604866275|ock.chun@uconn.edu|
22428427|NCT00830765|UMississippi|Dr John Morrison|601-984-5300|jmorrison@umc.edu|
22428428|NCT01811238|Samsung Medical Center|Dr.Sungsoo Chung|82-3410-1226|ssc0385@skku.edu|
22428429|NCT01977846|Foundation Fighting Blindness|Chief Scientific Officer|410-423-0600|info@FightBlindness.org|
22428430|NCT00724945|Vistakon|Thomas Karkkainen OD|904-443-3402|tkarkkai@its.jnj.com|
22428431|NCT05166876|Clear Creek Bio, Inc.|Vikram Sheel Kumar|(617) 765-2252|kumar@clearcreekbio.com|
22428432|NCT04901624|University of Southern California|Dr. Jason Doctor|213.821.8142|jdoctor@usc.edu|
22428433|NCT03479905|UTexasSouthwestern|Christina Riccio|214-590-7284|Christina.Riccio@utsouthwestern.edu|
22428434|NCT01147458|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22428435|NCT01034553|Mayo Clinic|Alexander Keith Stewart, M.B.CH.B|(480)301-4411|stewart.keith@mayo.edu|
22428436|NCT04685811|Weill Cornell Medical College|Dr. Juana Martinez Zuloaga|212-746-6000|jum4005@med.cornell.edu|
22428437|NCT01270659|University of Oklahoma Health Sciences Center Tulsa|Dr. Nasir Mushtaw|918/660-3680|Nasir-Mushtaq@ouhsc.edu|
22428438|NCT02811159|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22428439|NCT00639093|GRAP, Clinique de Psychologie au Travail|Benoît Girard|418-542-2030|g.r.a.p@videotron.ca|
22428440|NCT00143507|Institut de Recherches Internationales Servier (I.R.I.S.)|Therapeutic Innovation Pole|+33155724366|clinicaltrials@servier.com|
22428441|NCT00177671|University of Pittsburgh|Charles F. Reynolds III, MD|412-246-6414|reynoldscf@upmc.edu|
22428442|NCT00690898|Ipsen|Medical Director, Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22428443|NCT00520468|The University of Texas M. D. Anderson Cancer Center|Gautam Borthakur, MBBS / Assistant Professor|713-792-7305|eharriso@mdanderson.org|
22428444|NCT00356590|Amgen Inc.|Study Director|866-572-6436||
22428445|NCT01496456|UMichigan|Dr. Mathilde C Peters||mcpete@umich.edu|
22428446|NCT04919161|Gaylord Hospital Inc.|Dr. Henry C. Hrdlicka, Research Coordinator|203-284-2864|hhrdlicka@gaylord.org|
22397763|NCT00524342|University of Pittsburgh|Dr. Margaret Ragni|412-209-7288|ragni@dom.pitt.edu|
22397764|NCT02223260|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22397765|NCT00769184|NeoStrata Co., Inc.|Barbara Green, RPH, MS|(609) 520-0715|bgreen@neostrata.com|
22397766|NCT00517829|Texas Oncology, Tyler Cancer Center|Dr. Donald Richards|903-579-9800|donald.richards@usoncology.com|
22397767|NCT00385255|GlaxoSmithKline|GSK Response Center|866-435-7343||
22397768|NCT00345176|The EMMES Corporation|Traci Clemons, PhD|301-251-1161|tclemons@emmes.com|212
22397769|NCT00835237|GlaxoSmithKline|GSK Response Center|866-435-7343||
22397770|NCT03339921|MOMH|Amanda Crawford|7026533583|amanda.j.rawford.ctr@health.mil|
22428447|NCT02239328|Washington University|Dr. Benjamin Kozower|314-362-8089|kozower@wustl.edu|
22428448|NCT01989975|Medtronic Minimed|Suiying Huang, Statistician|8184763319|suiying.huang@medtronic.com|
22428449|NCT01838876|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22428450|NCT01682031|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22428451|NCT01932606|Mayo Clinic|Dr. Barry A. Borlaug|507-284-6704|Borlaug.Barry@mayo.edu|
22428452|NCT00963235|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22397771|NCT03436862|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
22428453|NCT01756235|AbbVie|Global Medical Information|800-633-9110||
22428454|NCT05658887|University of Iowa Hospitals and Clinics|Dr. Colin Johnson|3193561616|colin-johnson@uiowa.edu|
22428455|NCT00743093|Denver Heatlh Rocky Mountain Poison and Drug Center|Jody Green, PhD|303-389-1246|jody.green@rmpdc.org|
22428456|NCT02327078|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22428457|NCT04940221|Christiana Care Health System|Heather Bittner Fagan, MD MPH|302 320 4110|hbittner-fagan@christianacare.org|
22428458|NCT05219552|University of California School of Nursing|Dr. Emily Tuthill|2078411983|emily.g.tuthill@gmail.com|
22428459|NCT03330197|Alaunos Therapeutics|Jaymes Holland|650 273-2627|jholland@alaunos.com|
22428460|NCT03765073|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22428461|NCT05561400|University of Minnesota|Sharyl Samargia-Grivette|218-726-8347|samargia@umn.edu|
22428462|NCT02242630|Keesler Medical Center|Matthew B. Carroll|228-376-3629|matthew.carroll.1@us.af.mil|
22428463|NCT01670006|Cochlear|PRS Specialist, Clinical Affairs|+612 9428 6555|cltd-prs-admin@cochlear.com|
22428464|NCT02550795|Gil hospital|Dr. Youn Yi Jo|82324603636|endless37@gilhospital.com|
22428465|NCT02802228|Cumberland Pharmaceuticals|Jerry Fox, DVM|615-255-0068|jfox@cumberlandpharma.com|
22428466|NCT05984030|UNC Institute for Global Health and Infectious Diseases|Sarah Rutstein, MD, PhD|919-966-2537|sarah_rutstein@med.unc.edu|
22428467|NCT00695019|Amarillo Biosciences, Inc.|Martin J. Cummins, Director of Clinical & Regulatory Affairs|806-376-1741|mcummins@amarbio.com|14
22428468|NCT00562328|Mayo Clinic|Timothy G. Call, M.D.|507-266-4671|Call.Timothy@mayo.edu|
22428469|NCT03073759|Johns Hopkins University|Mohammad Khoshnoodi|410-955-5460|mkhoshn1@jhmi.edu|
22428470|NCT01014091|GlaxoSmithKline|GSK Response Center|866-435-7343||
22428471|NCT01564407|University of Pittsburgh|Amy Steele, RN, MSN, CCRC|412-641-3728|steeleam@upmc.edu|
22428472|NCT01601977|GSTT|Gill Arbane, Clinical trials coordinator|02071888070|gill.arbane@gstt.nhs.uk|
22428473|NCT05007925|Shockwave Medical|Denise Winn|410-991-9311|dwinn@its.jnj.com|
22428474|NCT04063163|ShanghaiHenliusBiotech|Fan Zhang|021-33395800*6334|Fan_Zhang2@henlius.com|
22428475|NCT05495997|Yale School of Medicine|Sule Tinaz|203-737-6158|sule.tinaz@yale.edu|
22428476|NCT00580840|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22428477|NCT00261040|The Ottawa Hospital - Ottawa Hospital Research Institute|Dr Paul Kim|613-737-8920|pkim@toh.ca|
22428478|NCT04435626|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22428479|NCT06407375|University Hospital Zurich|Dr. Toni Rabadi|043 254 41 10|radiologie@usz.ch|
22428480|NCT00619528|Northwestern University|Joseph Leventhal MD, PhD|312-695-0427|jleventh@nm.org|
22428481|NCT01160614|Purdue Pharma L.P.|Medical Services|888-726-7535, option 1||
22428482|NCT00984399|Memorial Sloan Kettering Cancer Center|Dr. Shari Goldfarb, MD|646-888-5080|goldfars@mskcc.org|
22428483|NCT05049122|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22428484|NCT04357795|Sun Pharmaceutical Industries Limited|Head-Clinical Development|2266455645|clinical.trial@sunpharma.com|5689
22428485|NCT05248386|Grünenthal GmbH|Grünenthal Clinical-Trials Helpdesk|000|clinical-trials@grunenthal.com|000
22428486|NCT01723774|Washington University School of Medicine|Cynthia X. Ma, M.D., Ph.D.|314-362-9383|cynthiaxma@wustl.edu|
22428487|NCT01910441|Novartis|Study Director|862-778-8200||
22428488|NCT02964182|MD Anderson Cancer Center|Jason Robinson, PhD|713-792-2265|nicotinestudy@mdanderson.org|
22428489|NCT05845619|University of California San Francisco|Pamela Murnane|4155021000|pamela.murnane@ucsf.edu|
22428490|NCT02595892|Dana-Farber Cancer Institute|Panagiotis Konstantinopoulos, MD, PhD|617-632-5269|panagiotis_konstantinopoulos@dfci.harvard.edu|
22428491|NCT01139879|Wolcott and Associates|Randy Wolcott|806-793-8869|lisa@randallwolcott.com|
22428492|NCT03636477|Alaunos Therapeutics|Jaymes Holland|6502732627|jholland@alaunos.com|
22428493|NCT04967222|Icahn School of Medicine at Mount Sinai|Dr. Harold W Koenigsberg|(718) 584-9000|harold.koenigsberg@mssm.edu|
22428494|NCT01149083|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22428495|NCT05168800|Dartmouth College|Glyn Elwyn|(603) 646-5623|glynelwyn@gmail.com|
22428496|NCT04279522|Neurolief Ltd.|Yaron Gruper, Director of Clinical affairs|+972-544330712|Yaron.Gruper@neurolief.com|
22428497|NCT03275168|Johns Hopkins University|Dr Maria Trent|4109552910|mtrent2@jhu.edu|
22428498|NCT04383223|Emory University|Dr. Sophia Hussen|404-727-2446|sophia.ahmed.hussen@emory.edu|
22428499|NCT03036254|Icahn School of Medicine at Mount Sinai|Dr. Mary Sano|(212) 659-8838|mary.sano@mssm.edu|
22428500|NCT00278408|Saarland University Medical School|Dr. Viola Poeschel|+4968411615014|dshnhl@uks.eu|
22428501|NCT05277207|Durham VA Health Care System|Angela Kirby|919-824-7729|angela.kirby@va.gov|
22428502|NCT01802281|RTI International|Marie Gantz|919-541-5110|mgantz@rti.org|
22428503|NCT05556057|The University of Texas Health Science Center at Houston|Radha Korupolu, MD|713-797-5233|Radha.Korupolu@uth.tmc.edu|
22428504|NCT03488524|Amylyx Pharmaceuticals, Inc.|Chief Medical Officer|(877) 374-1208|medinfo@amylyx.com|
22428505|NCT00315445|Purdue Pharma L.P.|Medical Director|800-733-1333||
22428506|NCT02390284|University of Miami|Dr. Vittorio Porciatti|3053266050|vporciatti@med.miami.edu|
22428507|NCT01299909|University of Wisconsin|Stevens S. Smith, Ph.D.|608-262-7563|sss@ctri.wisc.edu|
22428508|NCT03421561|Philips|Nicolas Aguirre|612-297-6655|nicolas.aguirre@philips.com|
22428509|NCT01092923|Austin Health|Dr Phil Peyton|9496 5000|phil.peyton@austinhealth.org.au|5704
22428510|NCT01089595|Fox Chase Cancer Center|Margaret von Mehren, Principal Investigator|215-728-4300|margaret.vonmehren@fccc.edu|
22428511|NCT02293499|University of Rochester School of Nursing|Hyekyun Rhee PhD, RN, FAAN|585-276-3775|Hyekyun_Rhee@urmc.rochester.edu|
22428512|NCT03915067|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22428513|NCT03317496|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22428514|NCT02693418|Evofem Biosciences|Kelly Culwell, MD, MPH, FACOG|858-550-1900|kculwell@evofem.com|225
22428515|NCT01750346|National Institutes of Health|Dr. Codrin Lungu|301-402-0976|lunguci@ninds.nih.gov|
22428516|NCT00704353|Luitpold Pharmaceuticals, Inc.|Mark Falone, MD|610-650-4200|mfalone@luitpold.com|
22428517|NCT02034591|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22428518|NCT00599313|Texas Oncology Cancer Center|Dr. Guru Sonpavde|2813327505|Guru.Sonpavde@USOncology.com|
22428519|NCT02782468|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22428520|NCT00448357|UNC Lineberger Comprehensive Cancer Center|Dr. Thomas Shea|919-966-7746|tom_shea@med.unc.edu|
22428521|NCT00712920|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2393|WWheeler@medapharma.us|
22428522|NCT02489773|Asahi Kasei Pharma Corporation|Takuji Kohzuma PhD|+81-3-3296-3617|kouzuma.tb@om.asahi-kasei.co.jp|
22428523|NCT00584285|University of Iowa|Dr. Christine W. Sindt|319-356-2916|christine-sindt@uiowa.edu|
22428524|NCT00620542|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22428525|NCT03755076|Albert Einstein Healthcare Network|Dr. Shailesh Kantak|562-385-7111|skantak@ranchoresearch.org|
22428526|NCT02879695|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
22428527|NCT02572167|Seagen Inc.|Chief Medical Officer|(855)473-2436|medinfo@seagen.com|
22428528|NCT00005047|University of Southern California|Dr. Susan Groshen|323-865-0375|Susan.Groshen@med.usc.edu|
22428529|NCT02213003|Diabetes Research Institute/University of Miami|Rodolfo Alejandro, MD|305-243-3389|Ralejand@med.miami.edu|
22428530|NCT05523297|Toronto General Hospital|Dr Keyvan Karkouti|(416) 340-8597|keyvan.karkouti@uhn.ca|
22428531|NCT05965427|Research Organization (KC) Ltd|MASH1 Clinical Project Manager|+44 (0) 7494 795 982|mash1@rokcservices.com|
22428532|NCT03168672|DePuy Synthes|Dave Whalen|574-404-9399|dwhalen@its.jnj.com|
22428533|NCT00433537|ECOG Statistical Office|Study Statistician|617-632-3012||
22428534|NCT04556097|McLean Hospital|Dr. Brent Forester|617-855-3622|bforester@mclean.harvard.edu|
22428535|NCT05436613|University of East Lonson|Professor Cynthia Fu|020 8223 4119|c.fu@uel.ac.uk|
22428536|NCT03771716|AdventHealth Research Institute|Dr. Kirk I. Erickson|4125763724|Kirk.Erickson@adventhealth.com|
22428537|NCT05317546|Medical University of South Carolina|Dr. Lindsay Squeglia|843-792-5454|squegli@musc.edu|
22428538|NCT05350202|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22428539|NCT03133156|Joslin Diabetes Center|Laura Simpson|617-735-3924|laura.simpson@joslin.harvard.edu|
22428540|NCT05748626|Northwestern University|Paul C. Fitzgerald, RN, BSN,MS|312-695-1064|p-fitzgerald2@northwestern.edu|
22428541|NCT04364646|Center for Sleep and Circadian Rhythms, AHWFB|Katherine M. Sharkey, MD, PhD|336-716-4657|katherine.sharkey@advocatehealth.org|
22428542|NCT02517658|Nationwide Children's Hospital|Clinical Research Coordinator|6147222997|heather.dellinger@nationwidechildrens.org|
22428543|NCT02290184|University of California San Francisco|Melinda Sarmiento Bender, PhD, RN|415 502 5668|melinda.bender@ucsf.edu|
22428544|NCT02530541|BSL|C. Beausoleil|406-587-5735|cbeausoleil@biosciencelabs.com|
22428545|NCT02353780|University of Pittsburgh|Larry Moreland, MD|412-648-4098|lwm5@pitt.edu|
22428546|NCT02402062|MFAR Clinical Research|Federico Nepote|0034934344412|investigacion@mfar.net|102
22428547|NCT01017250|Duke University Radiation Oncology|John Kirkpatrick, MD, PhD|919 668-7342|robert.clough@dm.duke.edu|
22428548|NCT02555878|Janssen Scientific Affairs, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22428549|NCT00765076|GlaxoSmithKline|GSK Response Center|866-435-7343||
22428550|NCT01164475|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22428551|NCT02335944|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22428552|NCT00832975|Hospital Clínico Universitario Puerta de Hierro|Dr Ignacio Fernández Lozano|913445000|iflozano@secardiologia.es|
22428553|NCT03160170|University of Miami Miller School of Medicine|Ian Cote|305-256-4492|Icote@med.miami.edu|
22428554|NCT01744821|Northwestern University|Assistant Professor|312-472-4684|dcarson@nm.org|
22428555|NCT06081829|Institut de Recherches Internationales Servier (I.R.I.S.)|Clinical Studies Department|+33 1 55 72 60 00|scientificinformation@servier.com|
22428556|NCT04835441|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22428557|NCT05666245|Center for Vaccine Development and Global Health (CVD)|Wilbur Chen, MD, MS|410-706-5328|wilbur.chen@som.umaryland.edu|
22428558|NCT06910332|Acıbadem University, Department of Physiotherapy and Rehabilitation|Ali Ömer ACAR|+90 216 500 44 44|aliomer.acar@acibadem.edu.tr|3578
22383532|NCT03591770|Boston Medical Center|Sharmeel K. Wasan, MD|(617) 638-6116|sharmeel.wasan@bmc.org|
22383533|NCT02652260|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22383534|NCT04300647|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22383535|NCT05056246|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22383536|NCT00978042|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22383537|NCT03029598|University of Washington - Cancer Vaccine Institute|Director of Clinical Operations|2062459258|childj@uw.edu|
22383538|NCT03051165|Emory University|Raj Dedhia, MD, MS|(404) 778-3381|raj.dedhia@emory.edu|
22383539|NCT03283371|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22383540|NCT01290341|Merz Pharmaceuticals, LLC|Stefan Plaum, MD Associate Medical Director|800-334-0514|clinicaltrials@merzusa.com|
22383541|NCT01919450|Cardiovascular Imaging Technologies, LLC|Timothy M. Bateman, MD|816-531-2842|tbateman@cvit.com|
22383542|NCT02561702|University of Rochester|David Herrmann|585-275-4568|david_herrmann@urmc.rochester.edu|
22383543|NCT04086966|University of Alabama at Birmingham|April Riddle|(205)934-6504|ariddle@uabmc.edu|
22383544|NCT03231358|American University|Caroline Kuo, DPhil, MPhil|2028857385|ckuo@american.edu|
22383545|NCT03684044|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22383546|NCT03703336|POLYVAC|Nguyen Thuy Huong, Ph.D, Vice Director|+84 912514309|huong72us@yahoo.com|
22383547|NCT00595413|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22397772|NCT00606086|GlobeImmune, Inc.|Clinical Operations Manager|3036252700|Alicia.Mattson@globeimmune.com|
22442856|NCT02080819|Virginia Commonwealth University|Dr. Liangsuo Ma|8048282871|liangsuo.ma@vcuhealth.org|
22442857|NCT00441116|GlaxoSmithKline|GSK Response Center|866-435-7343||
22442858|NCT02925338|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22442859|NCT01332461|GlaxoSmithKline|GSK Response Center|866-435-7343||
22442860|NCT00636363|Bausch & Lomb|Robert Steffen|(585) 338-6399|robert.steffen@bausch.com|
22442861|NCT00597896|Mount Sinai School of Medicine|Katherine E. Burdick, PhD||katherine.burdick@mssm.edu|
22442862|NCT02465099|Ethicon Inc|Jason Waggoner|(513) 337-8130|jwaggon1@its.jnj.com|
22442863|NCT00835731|Planned Parenthood League of Massachusetts|Principal Investigator|6176161600||
22442864|NCT00348881|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22442865|NCT03602560|CymaBay Therapeutics, Inc.|Elaine Watkins, DO, MSPH, Vice President of Clinical Development|510-293-8800|medinfo@cymabay.com|
22442866|NCT00222131|Texas Tech|Jerzy Sarosiek, MD, PhD, AGAF, FACG|915-215-5255|jerzy.sarosiek@ttuhsc.edu|
22442867|NCT04784065|Baylor College of Medicine|Dr. Grace Lo, Associate Professor of Medicine|713-791-1414|ghlo@bcm.edu|227804
22442868|NCT05092360|Mural Oncology, Inc.|Study Director|+1 (781) 614-0100|clinicaltrials@muraloncology.com|
22442869|NCT01675167|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22442870|NCT00833664|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22442871|NCT03952039|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22442872|NCT01246466|AtriCure|Vice President, Clinical Affairs and Biometrics|1-513-644-8192|nndikintum@atricure.com|
22442873|NCT00789074|Queen Mary University of London|Professor Peter Hajek|+44 207 882 8231|p.hajek@qmul.ac.uk|
22442874|NCT00456807|GlaxoSmithKline|GSK Response Center|866-435-7343||
22397773|NCT01556425|Johns Hopkins University School of Medicine|Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
22412011|NCT02974153|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
22442875|NCT04175509|Aultman Hospital|Dr. Michaela Beynon|2488218826|michaelabeynon@gmail.com|
22442876|NCT02641483|VAORD|Dennis Bourbeau|2167913800|dennis.bourbeau@va.gov|
22442877|NCT02855541|University of Colorado Boulder|James Peterman, PhD|303-735-0358|james.peterman@colorado.edu|
22442878|NCT03085914|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22442879|NCT01910311|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22442880|NCT01847131|Faculty of Medicine Siriraj Hospital, Mahidol University|Torpong Thongngarm, M.D.|66-2-419-8263|torpong.tho@mahidol.ac.th|
22442881|NCT01561898|Janssen Pharm KK Japan|Medical Director|03-4411-5067||
22442882|NCT03874429|Laboratoires Thea|Corentin Le Camus|0680382020|corentin.lecamus@theapharma.com|+33
22442883|NCT00331552|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu|
22442884|NCT01445548|National Eye Institute|Wai T. Wong, MD, PhD|301-496-7566|wongw@nei.nih.gov|
22442885|NCT03560518|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
22442886|NCT02307253|Fondazione Policlino Universitario A Gemelli IRCCS|Dr Alberto Larghi|0630156580|alberto.larghi@yahoo.it|
22442887|NCT00958438|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
22442888|NCT02788279|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22442889|NCT00329849|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22442890|NCT00740376|Corin|Global Regulatory Affairs and Clinical Director|+44 (0)1285 659866||
22442891|NCT00362128|Albert Einstein College of Medicine|Judith Wylie-Rosett|718-430-3345|Judith.Wylie-Rosett@einstein.yu.edu|
22442892|NCT05168501|U.S. Food and Drug Administration|David Strauss, MD, PhD|301-796-6323|David.Strauss@fda.hhs.gov|
22442893|NCT05277337|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22442894|NCT01185301|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22442895|NCT04987944|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22442896|NCT00345332|University of Rochester|Division of Urogynecology|585-273-3232|amy_keller@urmc.rochester.edu|
22442897|NCT04121078|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22442898|NCT00409175|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22442899|NCT00430183|Memorial Sloan-Kettering Cancer Center|James A. Eastham, MD|646-422-4390|easthamj@mskcc.org|
22442900|NCT03339297|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-870-9177|ClinicalTrialDisclosure@JazzPharma.com|
22442901|NCT03726996|Yale University|Yong-Hui Jiang, MD, PhD|203-785-2660|yong-hui.jiang@yale.edu|
22442902|NCT02012582|vasopharm GmbH|Dr. Reinhard Schinzel|+49 931 359099|schinzel@vasopharm.de|115
22442903|NCT03531632|MacroGenics, Inc.|Stephen Eck, M.D., Chief Medical Officer|301 251-5172|ecks@macrogenics.com|
22442904|NCT03207438|University of Saskatchewan|Evyn Peters|13068441312|evyn.peters@usask.ca|
22442905|NCT03241368|Medtronic GIH|Amanda Wenisch, Clinical Resaerch Coordinator / Study Manager|1-206-225-4025|amanda.m.wenisch@medtronic.com|
22442906|NCT01119937|Novartis Pharmaceuticals|Study Director|862-778-8300||
22442907|NCT01566214|Iowa City VA Health Care System|Mark Vander Weg|319-338-0581|mark.vanderweg@va.gov|7717
22442908|NCT02189954|DorkuzEU|Anaesthesiology and Reanimation, Dr. Sule Ozbilgin|0905055252901|ozbilginsule@gmail.com|
22442909|NCT02112045|Washington University School of Medicine|Meagan Jacoby, M.D., Ph.D.|314-454-8304|mjacoby@wustl.edu|
22442910|NCT00627445|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22442911|NCT00324259|Washington University School of Medicine|Dr. Matthew Ellis|314-362-8866|mjellis@bcm.edu|
22442912|NCT03554486|Stanford|Bruce Buckingham|6508040476|buckingham@stanford.edu|
22442913|NCT01462253|GIMEMA|Alfonso Piciocchi|+39 06 70390513|a.piciocchi@gimema.it|
22442914|NCT01518270|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22442915|NCT01616693|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22442916|NCT02252744|Western University of Health Sciences|Jasmine Wong Yumori OD FAAO|(909) 706-3886|jyumori@westernu.edu|
22442917|NCT00321646|Dana-Farber Cancer Institute|Mary-Ellen Taplin, MD|617-582-8313|mary_taplin@dfci.harvard.edu|
22442918|NCT01008423|Bausch Health Companies|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
22442919|NCT02878057|Department of Breast Oncology, Peking University Cancer Hospital and Institute|Dr. Huiping Li|86-10-88196739|huipingli2012@hotmail.com|
22442920|NCT02034409|VA Salt Lake City Health Care System|Daniel Clegg, MD|801-582-1565|daniel.clegg@va.gov|
22442921|NCT02342418|University of Michigan|Manjunath Pai, Associate Professor|7346470006|amitpai@med.umich.edu|
22442922|NCT01699867|Johns Hopkins Medicine|Lisa K. Jacobs, M.D.|410-502-0880|ljacob14@jhmi.edu|
22442923|NCT04255394|Zimmer Biomet|Linda Meijer|+31627933741|linda.meijer@zimmerbiomet.com|
22442924|NCT00183729|Washington University School of Medicine|Eric Lenze|314-362-1671|lenzee@wustl.edu|
22442925|NCT03512457|Northwestern University|Dr. June Robinson|312-503-5941|june-robinson@northwestern.edu|
22442926|NCT01264601|University of Michigan|Matthew Greenhawt, MD, MBA|734/936-5634|mgreenha@umich.edu|
22383548|NCT00807937|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22383549|NCT00533910|Hunter Holmes McGuire VAMC|Jasmohan Bajaj|804 675 5802|jasmohan@gmail.com|
22383550|NCT04629950|Department of Dermatology, Weill Cornell Medicine|Dr. Richard D. Granstein|(646) 962-7546|rdgranst@med.cornell.edu|
22442927|NCT01375075|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22442928|NCT00831493|UT MD Anderson Cancer Center|Sunil Krishnan, MD / Associate Professor||mclemons@mdanderson.org|
22442929|NCT00620503|Repros Therapeutics Inc, an Allergan Affiliate|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
22442930|NCT00129311|Yale Unviersity|Dr. Andrea Weinberger|203-974-7598|andrea.weinberger@yale.edu|
22442931|NCT00645450|Manchester VA Medical Center|Dr. Scott P. Orr|603-624-4366|scott.orr@va.gov|6565
22442932|NCT01525225|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22442933|NCT01182844|Medical University of Graz|Dr. Norbert Tripolt|+43 316 385|norbert.tripolt@medunigraz.at|78038
22442934|NCT01379508|Novartis|Clinical Disclosure Office|862-778-8300||
22442935|NCT02055365|Icahn School of Medicine at Mount Sinai|Brad Rosenberg, MD, PhD||brad.rosenberg@mssm.edu|
22442936|NCT01481129|Centre Léon Bérard (now CHLS)|Dr Hervé Ghesquieres|0426556824|herve.ghesquieres@chu-lyon.fr|
22442937|NCT03050775|Mayo Clinic|Jean M. Guyer, DNP|507-255-5716|guyer.jean@mayo.edu|
22442938|NCT03603509|Mayo Clinic|Richard Kennedy, PhD|507-284-0708|Kennedy.Rick@mayo.edu|
22442939|NCT02248558|UNC Project-China|Weiming Tang|+86-15920567132|weimingtangscience@gmail.com|
22442940|NCT02656680|University of Connecticut|Dr. Sherry Pagoto|8604868979|sherry.pagoto@uconn.edu|
22442941|NCT01258998|The University of Texas (UT) MD Anderson Cancer Center|Christopher R Flowers,Chair, Lymphoma-Myeloma|713- 745-6095|crflowers@mdanderson.org|
22442942|NCT01143389|Cornea Research Foundation of America|Marianne Price, PhD|317-814-2990|mprice@cornea.org|
22442943|NCT04966910|University of Washington|Michael Pullmann|206-685-0408|pullmann@uw.edu|
22442944|NCT00002931|City of Hope|Paul Frankel, Ph.D.|626-359-8111|pfrankel@coh.org|65265
22442945|NCT00830791|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|(800) 672-6372|ClinicalTrialsDisclosure@merck.com|
22442946|NCT00504582|UT MD Anderson Cancer Center|Dr. Paul F Mansfield, Professor, Surgical Oncology|(713) 794-5499|pmansfie@mdanderson.org|
22442947|NCT02716896|University of Texas Health San Antonio|Dharam Kaushik|210-567-5676|kaushik@uthscsa.edu|
22442948|NCT02404532|Otsuka Pharmaceutical Development & Commercialization, Inc|Tim Peters-Strickland|800 562-3974||
22442949|NCT01757691|Novartis|Study Director|862-778-8300||
22442950|NCT02484859|Recep Tayyip Erdoğan Üniversitesi|Dr. Başar Erdivanlı|04642130491|berdivanli@gmail.com|2128
22442951|NCT02054481|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22442952|NCT02564432|Department of Veterans Affairs|James Peter Beck|801-231-6309|james.beck@hsc.utah.edu|
22442953|NCT02415842|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22442954|NCT01713933|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
22442955|NCT00528970|Bausch Health Americas, Inc|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
22442956|NCT02882152|University of São Paulo|Dr. Joaquim Edson Vieira|+55 11 3061 8716|joaquimev@usp.br|
22442957|NCT00791973|University of Chicago|Dr. Robert Naclerio|(773) 702-0080|rnacleri@surgery.bsd.uchicago.edu|
22442958|NCT01104376|Indiana University|Zeruesenay Desta, PhD|317-630-8860|zdesta@iupui.edu|
22442959|NCT00797966|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
22442960|NCT00541190|University of Pittsburgh|Tim Corcoran|412-624-8918|corcorante@upmc.edu|
22442961|NCT01486043|Children's Hospital Los Angeles|Dr. Jamie Wood|323-361-7388|jawood@chla.usc.edu|
22442962|NCT01002820|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
22442963|NCT01673347|William Beaumont Hospital|Erin Baker, PhD|248-551-1816|erin.baker@beaumont.org|
22442964|NCT00813176|University of Iowa|Dr Javier H Campos|3193567208|javier-campos@uiowa.edu|
22442965|NCT01430754|Vanda Pharmaceuticals Inc.|Marlene Dressman, Ph.D.|202-734-3462|marlene.dressman@vandapharma.com|
22383551|NCT03233633|Connecticut Hospice|Jim Prota, Director of Pharmacy|203-848-0660|jprota@hospice.com|
22442966|NCT00895011|Vivus, Inc.|Wesley W Day, PhD|650-934-5200|medaffairs@vivus.com|
22442967|NCT02617901|Sheffield Children's NHS Foundation Trust|Dr Amaka C Offiah|0114 271 7557|a.offiah@sheffield.ac.uk|
22442968|NCT00177047|Masonic Cancer Center, University of Minnesota|Dr.Claudio G. Brunstein MD, PhD|612-625-3918|bruns072@umn.edu|
22442969|NCT00052442|Memorial Sloan-Kettering Cancer Center|Owen A. O'Connor, MD, PhD|212-639-8889|oo2130@columbia.edu|
22442970|NCT02661178|Drugs for Neglected Diseases initiative|Sophie Delhomme|+41229069230|sdelhomme@dndi.org|
22397774|NCT01783080|NY State Psychiatric Institute|David J Hellerstein MD, Professor of Clinical Psychiatry, Columbia|646-774-8000|hellers@nypsi.columbia.edu|
22397775|NCT00550680|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22397776|NCT01848184|Medtronic|Michelle DiSalvo|774 284 6089|michelle.v.disalvo@medtronic.com|
22397777|NCT04874194|The university of Texas MD Anderson Cancer Center|Courtney DiNardo MD, Professor|713-794-1141|cdinardo@mdanderson.org|
22397778|NCT05032157|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22397779|NCT02627495|Spaulding Rehabilitation Hospital|Prof. Felipe Fregni|+1 (617) 935-2743|Fregni.Felipe@mgh.harvard.edu|
22397780|NCT03036293|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22397781|NCT02543528|Johnson & Johnson Vision|Elizabeth Dow -PRINCIPAL RESEARCH OPTOMETRIST|904-443-1061|edow1@its.jnj.com|
22397782|NCT02049944|Memorial Care|Dr. Morgan Swank|5624808460|morganswankmd@gmail.com|
22397783|NCT01042600|Albany Medical Center|Joaquim Pinheiro, MD, MPH|518-262-5421|pinheij@mail.amc.edu|
22397784|NCT00731874|Weill Cornell Medical College/Division of Transplant Surgery|Dr. Meredith J Aull|(212) 746-0727|mea9008@med.cornell.edu|
22397785|NCT00631371|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22397786|NCT01500109|Loma Linda University|Chelan Nour, MD|909-558-8493|cnour@llu.edu|
22397787|NCT03325673|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22397788|NCT01602692|University of Wisconsin - Madison|Dr. Venkat Rao|(608) 263-1223|rao@surgery.wisc.edu|
22397789|NCT01695473|University of California, San Francisco|Dr. Won Kim, MD|877-827-3222|Won.Kim@ucsf.edu|
22397790|NCT02559687|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22397791|NCT01780831|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22397792|NCT02214238|Fisher & Paykel Healthcare|Clinical Research Scientist|+6495740123|cpaptrial@fphcare.co.nz|
22397793|NCT00876993|Johns Hopkins All Children's Hospital|Stacie Stapleton|727-767-4176|stacie.stapleton@jhmi.edu|
22397794|NCT00983983|Massachusetts General Hospital|Dr. Anne-Marie Wills|855-644-6387|awills@partners.org|
22397795|NCT01784861|Washington University School of Medicine|Benjamin Tan, M.D.|314-362-5740|btan@wustl.edu|
22397796|NCT02599961|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
22397797|NCT01857869|GlaxoSmithKline|GSK Response Center|866-435-7343||
22397798|NCT04400474|MFAR|A responsibility person designate by sponsor|934344412|investigacion@mfar.net|
22397799|NCT03341962|Immunic AG|Andreas Muehler, MD|004989|Andreas.Muehler@imux.com|20804770
22397800|NCT01142401|Icahn School of Medicine at Mount Sinai|Joseph Sparano, MD|212-241-3300|joseph.sparano@mssm.edu|
22397801|NCT00283075|The Rogosin Institute|Dr. Barry H. Smith, CEO|212-746-1551|bas2005@nyp.org|
22397802|NCT03016325|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22397803|NCT02728830|Duke Cancer Center|Dr. Angeles Alvarez Secord|919-684-3765|secor002@mc.duke.edu|
22397804|NCT01152021|Department of Anesthesia, Perioperative and Pain Medicine|Rachel Dabek|857-218-5413|rachel.dabek@childrens.harvard.edu|
22397805|NCT01087905|University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|608-262-7563|sss@ctri.medicine.wisc.edu|
22397806|NCT00513500|Boston University|Kojo Yeboah-Antwi|617-414-1275|kyantwi@bu.edu|
22397807|NCT04288154|Mayo Clinic|Amir Lerman, M.D.|507-255-2398|lerman.amir@mayo.edu|
22397808|NCT03711500|New York State Psychiatric Institute|Dr. Joshua Kantrowitz|6467746738|Joshua.Kantrowitz@nyspi.columbia.edu|
22397809|NCT00790907|GlaxoSmithKline|GSK Response Center|866-435-7343||
22397810|NCT01902290|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22397811|NCT00774345|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@BMS.com|
22397812|NCT01297335|The Center for Clinical Research|Medical Director|3367656181|rrauck@ccrpain.com|
22397813|NCT02873936|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22428559|NCT06910202|Fralin Biomedical Research Institute at VTC|Dr. Roberta Freitas Lemos|5405262106|rflemos@vtc.vt.edu|
22428560|NCT05370326|Yale School of Medicine|Melissa B. Weimer, DO, MCR, DFASAM|(203) 859-2962|melissa.weimer@yale.edu|
22383552|NCT02708108|Childrens Hospital Los Angeles|Dr Etan Orgel|13233612121|eorgel@chla.usc.edu|
22383553|NCT03049969|NYU Langone Health|Leigh Charvet, MD|9294555141|Leigh.Charvet@nyulangone.org|
22383554|NCT02568683|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22383555|NCT00891436|Rush University Medical College|James N. Moy, M.D.|312-942-6176|jmoy@rush.edu|
22383556|NCT01561989|Roswell Park Cancer Institute|Dr. Martin Mahoney|716-845-2300|martin.mahoney@roswellpark.org|
22383557|NCT05360901|Brigham and Women's Hospital|Jessica M. Lipschitz|617-732-6548|jlipschitz@bwh.harvard.edu|
22383558|NCT04556981|Gates MRI|Study Director|+1 857 702 2108|clinical.trials@gatesmri.org|
22383559|NCT00580866|Vanderbilt|William Obremskey|6159363630|william.obremskey@Vanderbilt.Edu|
22383560|NCT04110743|University of California Davis|Dr. Lorenzo Nardo|916-731-9004|lnardo@ucdavis.edu|
22383561|NCT05113771|Denovo Biopharma|Julie Doostzadeh, Executive Director|858-799-1021|jdoostzadeh@denovobiopharma.com|709
22383562|NCT02477605|Alcon, A Novartis Division|Brand Lead, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
22383563|NCT02574455|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22383564|NCT02189915|The Brain Institute of the University of Utah|Perry Renshaw, MD, PhD, MBA|801-587-1216|perry.renshaw@hsc.utah.edu|
22383565|NCT00995150|Medicines360|Emily Morris|415.951.8700|emorris@medicines360.org|
22383566|NCT02665988|Houston Methodist Hospital|Dr. Alok Madan|832-930-1662|amadan@houstonmethodist.org|
22397814|NCT01015768|Southern California College of Optometry|Jerry R. Paugh, OD, PhD|714-449-7487|jpaugh@scco.edu|
22397815|NCT01627860|Janssen-Cilag Taiwan|Medical Director|886 2 23762155||
22428561|NCT02880176|Fox Chase Cancer Center|Dr. Marshall Strother|555-555-5555|m12912988@gmail.com|
22428562|NCT02606305|ImmunoGen, Inc|CMO, ImmunoGen|781-895-0600|clinicaltrials@immunogen.com|
22428563|NCT01991314|Barts Health NHS Trust|Prof David Rampton|+442035943500|d.rampton@qmul.ac.uk|7885
22428564|NCT00879359|Cleveland Clinic|Lynn Borzi|2164453158|borzil@ccf.org|
22428565|NCT00970944|Spaulding Rehabilitation Hospital|Joseph T Giacino, PhD|617-573-2757|jgiacino@partners.org|
22397816|NCT01225731|Merck Sharp & Dohme|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22428566|NCT02008370|Maimonides Medical Center|Dr G Trunfio|718-283-6000|gtrunfio@maimonidesmed.org|
22428567|NCT00662259|University of California San Diego|Gregory G. Brown|858-246-0607|gbrown@ucsd.edu|
22428568|NCT00972738|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22428569|NCT00601627|Alliance for Clinical Trials in Oncology|George P. Kim, M.D.|507-284-4918||
22428570|NCT01988415|Abbott Medical Optics|Janice Tarrant|408-273-4163|janice.tarrant@abbott.com|
22428571|NCT01001104|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22428572|NCT00597675|University of North Carolina at Chapel Hill|Dr. Edwin Kim, Director of the UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
22428573|NCT01724190|Nationwide Childrens Hospital|Kathryn Obrynba|6147224425|kathryn.obrynba@nationwidechidrens.org|
22428574|NCT01121926|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
22428575|NCT02175758|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22428576|NCT02636283|University of Minnesota|Otto Sanchez|615-833-9867'|sanc0050@umn.edu|
22428577|NCT02887586|Clinical Cancer Center, Xiyuan Hospital, China Academy of Chinese Medical Sciences|Hebin|13520253895|hebinbj68@163.com|
22428578|NCT01879852|University of Florida|Dr. Terese Chmielewski|(352)273-6104|tchm@ufl.edu|
22428579|NCT02111980|UC San Diego School of Medicine|Dr. Ulrika Birgersdotter-Green|858-657-5310|ubgreen@ucsd.edu|
22428580|NCT02696616|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22428581|NCT01716195|University of California Davis|Dr. Megan Daly|916-734-5428|medaly@ucdavis.edu|
22428582|NCT01625182|Novartis Pharmaceuticals|Study Director|862-778-8300||
22428583|NCT01500083|Lundbeck Canada Inc.|Lundbeck Canada Inc.|+45 36301311|LundbeckClinicalTrials@lundbeck.com|
22428584|NCT00741611|CR Bard|Anne Marie Harcarik|908-277-8051|annemarie.harcarik@crbard.com|
22428585|NCT01970371|Achaogen, Inc.|Clinical Trials Registration Group||clinical-trials@achaogen.com|
22428586|NCT01555931|University of North Carolina School of Medicine|Dr. Gretchen Stuart|919-962-4880|gstuart@med.unc.edu|
22428587|NCT01922011|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22428588|NCT01510756|University of California, San Diego|Thomas Kipps, MD|(858) 534-5400|tkipps@ucsd.edu|
22428589|NCT02145676|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22428590|NCT01063907|Kyowa Hakko Kirin Pharma, Inc.|Senior VP Drug Development|609-919-1100|clinical.info@kyowa-kirin-pharma.com|
22428591|NCT00924482|University of California San Francisco|Arthur Wallace, M.D., Ph.D.|415-750-2069|wallacea@anesthesia.ucsf.edu|3732
22428592|NCT04398134|Assembly Biosciences|Executive Director of Clinical Operations|833-509-4583|Clinicaltrials@assemblybio.com|
22428593|NCT00350220|University of Rochester Medical Center|Jill M. Cholette MD|585-275-0189|Jill_Cholette@urmc.rochester.edu|
22428594|NCT02225587|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22428595|NCT06026813|UT Southwestern Medical Center|Dr. Peter Crisologo|214/648-7284|Peter.Crisologo@UTSouthwestern.edu|
22428596|NCT03483584|The Chinese University of Hong Kong|Prof. Grace Lui|+852 35051716|gracelui@cuhk.edu.hk|
22397817|NCT00577642|Massachusetts General Hospital|Dr Noopur Raje|6177260711|nraje@partners.org|
22428597|NCT04426656|University of North Carolina at Chapel Hill|Chunyan Li, MSc|919-966-6695|chunyli@live.unc.edu|
22428598|NCT03033355|houston methodist Hospital|Dr. Rose Khavari|713-363-9154|rkhavari@houstonmethodist.org|
22428599|NCT03013751|Mezzion Pharmaceuticals, Inc|Director of Clinical Operatons|3128980292|wg.kim@mezzion.com|
22428600|NCT01525589|Pharma Mar S.A.|Pharma Mar S.A.|00 34 91846 60 00|clinicaltrials@pharmamar.com|
22428601|NCT02924376|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22428602|NCT03608033|Omeros|Skylar Liles|206-676-5000|ctinfo@omeros.com|
22428603|NCT01471639|Cleveland Clinic Healthcare System|Sharon Mace MD|216-445-4598|maces@ccf.org|
22428604|NCT05253807|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22428605|NCT04735367|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22428606|NCT02360579|Iovance Biotherapeutics|Rana Fiaz, Executive Medical Director|661-645-3572|rana.fiaz@iovance.com|
22428607|NCT05423756|Division of Infectious Diseases, University of California Irvine School of Medicine|Dr. Shruti Gohil, MD, MPH|(714) 456-7890|skgohil@hs.uci.edu|
22428608|NCT06455111|Boston University School of Medicine Endocrinology, Diabetes, Nutrition & Weight Management|Nicole L Spartano, PhD|315-415-2040|spartano@bu.edu|
22428609|NCT01793935|University of Pittsburgh|Dr. K.N. Roy Chengappa - PI|412-246-5006|chengappakn@upmc.edu|
22428610|NCT01201863|Craig Hospital|Don Gerber, PsyD|303-789-8478|dgerber@craighospital.org|
22428611|NCT01149785|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22397818|NCT02054897|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)||clinicaltrials@novonordisk.com|
22397819|NCT00542269|Novartis Pharmaceuticals|Study Director|862 778-8300||
22397820|NCT02069899|Sobi AG|Radmila Kanceva/Senior Medical Director Immunology|+ 41 22 551 91 63|Radmila.Kanceva@sobi.com|
22428612|NCT03439514|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22428613|NCT00753142|Emory University|Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
22428614|NCT01481779|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22383567|NCT00970359|Memorial Sloan Kettering Cancer Center|Dr. Alan Ho|646-888-4235|hoa@mskcc.org|
22383568|NCT01388361|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22383569|NCT01763970|SKCCC at Johns Hopkins|Matthew Ladra,MD|(202) 537-4788|mladra@jhmi.edu|
22383570|NCT01061034|Assaf Harofeh medical center|Dr. Keren Doenyas-Barak|972-57-7346651|kerendoenyas@gmail.com|
22383571|NCT05330234|Imperial College London|Mr Gianpaolo Fusari|--|g.fusari@imperial.ac.uk|
22383572|NCT02101190|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22383573|NCT01499199|GlaxoSmithKline|GSK Response Center|866-435-7343||
22383574|NCT01199705|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22383575|NCT01239316|St. Jude Children's Research Hospital|Tong Lin (Biostatistician)|9015952048|Tong.Lin@stjude.org|
22383576|NCT01550549|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22383577|NCT06630390|University of Rochester Medical Center|Mark Oldham|585-275-3592|mark_oldham@urmc.rochester.edu|
22383578|NCT02788773|Canadian Cancer Trials Group|Lesley Seymour|6135336430|lseymour@ctg.queensu.ca|
22383579|NCT05505045|University of Missouri|Anna Boone, PhD|573-882-7023|booneae@umsystem.edu|
22383580|NCT01643070|Asan Medical Center|Dr. Tae Won Kim|+82-2-3010-3910|twkimmd@amc.seoul.kr|
22383581|NCT04842500|Vanderbilt University|Dr. Joseph Lambert|615-343-0824|joseph.m.lambert@vanderbilt.edu|
22383582|NCT02980276|University of Galway|Professor Fidelma Dunne|+35391492117|fidelma.f.dunne@universityofgalway.ie|
22383583|NCT04354337|University of Washington|Weichao Yuwen|2536924478|wyuwen@uw.edu|
22383584|NCT04139668|Centre for Addiction and Mental Health|Dr. Bernard Le Foll|416-535-8501|bernard.lefoll@camh.ca|33111
22383585|NCT03657212|University of California, Irvine|Dr Sara Mednick|8589457904|mednicks@uci.edu|
22383586|NCT02824029|Karmanos Cancer Institute|Dr. Dipenkumar Modi, MD|313-576-8782|modid@karmanos.org|
22383587|NCT04440176|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22383588|NCT04188379|argenx BV|Regulatory Manager|+32 9 310 3400|regulatory@argenx.com|
22383589|NCT05288283|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
22383590|NCT01108003|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22383591|NCT01164098|University of Miami|George W. Burke, M.D.|3053555315|gburke@med.miami.edu|
22383592|NCT03990649|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22383593|NCT03050814|National Cancer Institute|Dr. Julius Y. Strauss|240-858-3999|julius.strauss@nih.gov|
22383594|NCT01643616|HELIOS-Kliniken Schwerin, Germany|Dr. Ronald Seidel|0049 385 5204251|ronald.seidel@helios-kliniken.de|
22383595|NCT04512482|Indiana University School of Dentistry, Department of Orthodontics|Kelton T. Stewart, Department Chair|317-278-1087|keltstew@iu.edu|
22383596|NCT05119855|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22383597|NCT02115828|Johns Hopkins University|Emmanuel Antonarakis, MD|410-502-7528|eantona1@jhmi.edu|
22383598|NCT04759833|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22383599|NCT00508924|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22383600|NCT05848817|Mann Eye Institute|Phillip Brunson|1-713-580-2500|brunsonphillip@gmail.com|
22428615|NCT04882800|Sonova US|Principal Investigator|630-821-5000|phonakaudiologyresearch@gmail.com|
22428616|NCT01697579|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22428617|NCT03093844|University of Colorado|Dr. Jonathan Gutman|303-724-9562|JONATHAN.GUTMAN@CUANSCHUTZ.EDU|
22428618|NCT04225039|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
22428619|NCT00975923|Vanderbilt University School of Medicine|Dr. Theodore Speroff|615-636-9476|ted.speroff@vanderbilt.edu|
22428620|NCT01964404|Dartmouth Hitchcock|Dr. Mary F. Brunette|603-646-7019|Mary.F.Brunette@Hitchcock.org|
22428621|NCT04046471|University of Kansas Medical Center|Dr. Joseph Donnelly|785-864-1687|jdonnelly2@kumc.edu|
22428622|NCT00325416|H. Lee Moffitt Cancer Center and Research Institute|Daniel M. Sullivan, M.D.|813-745-3878|dan.sullivan@moffitt.org|
22428623|NCT06239610|Parkview Health System|Jan Powers PhD, RN, CCNS, CCRN, CNRN, NE-BC, FCCM|260-266-7761|jan.powers@parkview.com|
22428624|NCT02916771|Dana-Farber Cancer Institute|Dr. Irene Ghobrial|617-632-4198|Irene_Ghobrial@DFCI.Harvard.edu|
22428625|NCT03884374|University of Florida|Eric Weber|352-273-7802|ebweber@ufl.edu|
22428626|NCT03496129|University of Louisville|Dr. Martha Bickford|502-852-3527|martha.bickford@louisville.edu|
22428627|NCT03682848|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22428628|NCT02872714|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22428629|NCT06717399|Saint Joseph's University|Nabila Enam|2155967348|nenam@sju.edu|
22428630|NCT03043573|Weill Cornell Medicine|Dr. Dimitris Kiosses|914-997-4381|dkiosses@med.cornell.edu|
22428631|NCT02337686|UT MD Anderson Cancer Center|Dr. Vinaykumar Puduvalli, MD-Chair, Neuro-Oncology|(713) 745-2343|vpuduval@mdanderson.org|
22428632|NCT02145390|University of Miami|Adrian Ishkanian MD|305-243-4200|aishkanian@miami.edu|
22428633|NCT06231511|Shirley Ryan Abilitylab|Sara Prokup PT, DPT|312-238-1355|sprokup@sralab.org|
22428634|NCT03580928|Dana-Farber Cancer Institute|Matthew Davids, MD|617-632-6331|matthew_davids@dfci.harvard.edu|
22428635|NCT00479232|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22428636|NCT01680172|Mayo Clinic|Robert Bright, MD|480-301-4853|bright.robert@mayo.edu|
22397821|NCT00490451|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22397822|NCT00619073|Children's Hospital Boston|Alan D. Michelson, M.D.|617-919-2116|alan.michelson@childrens.harvard.edu|
22383601|NCT00630058|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22383602|NCT04977700|Klein Buendel, Inc.|Julia Berteletti|303-565-4321|jberteletti@kleinbuendel.com|
22383603|NCT04079972|Dongguk University|Dr.NaNa Keum|+82 10-6793-6654|nak212@mail.harvard.edu|
22383604|NCT02168400|University of Minnesota|Jazmin Camchong|(612) 625-3330|camch002@umn.edu|
22383605|NCT00391898|Novartis Pharmaceuticals|Study Director|862 778-8300||
22428637|NCT00484159|Johns Hopkins|Steven P. Cohen|410-955-1822|scohen40@jhmi.edu|
22428638|NCT05977868|West Virginia University|Dr. Joy J. Juskowich|304-293-3306|jjuskowi@hsc.wvu.edu|3
22428639|NCT00876395|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22428640|NCT00104234|BioMarin Pharmaceutical Inc.|Medical Information Services|8009834587|medinfo@bmrn.com|
22383606|NCT05489484|Guna S.p.a.|Vincenzo Miranda (Clinical Research Manager); Kamilia Laarej (TSU&CRA)|02 280.18.(358)-(359)|v.miranda@guna.it; k.laarej@guna.it|
22383607|NCT02529995|AstraZeneca|Global Clinical Lead, Yuri Rukazenkov|+44 1625 231825|Yuri.Rukazenkov@astrazeneca.com|
22383608|NCT02706717|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22383609|NCT00444600|Jaeb Center for Health Research|Adam R. Glassman, Director DRCR.net Coordinating Center|813-975-8690|drcrnet@jaeb.org|
22383610|NCT05132478|UW School of Medicine and Public Health|Corrine Voils, PhD|(608) 262-9636|voils@surgery.wisc.edu|
22383611|NCT02549170|Shire|Study Director|+18668425335|ClinicalTransparency@shire.com|
22383612|NCT02988817|Genmab A/S|Clinical Trial Information|+45 7020 2728|clinicaltrials@genmab.com|
22383613|NCT04204993|Imperial College London|Professor Chris Chiu|+44 (0)20 8383 2301|c.chiu@imperial.ac.uk|
22383614|NCT00421889|Topotarget A/S|PRS Administrator Gunilla Emanuelson|+45 39 17 83 92|enquiries@topotarget.com|
22383615|NCT00111813|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22383616|NCT01610297|Novartis|Study Director|862-778-8300||
22383617|NCT00818246|RoseLab Skin Optics Laboratory|Dr Daniel Barolet|(514) 343-4444|daniel.barolet@mcgill.ca|
22383618|NCT00409838|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22383619|NCT04247074|Galderma Research & Development|Galderma Research & Development|8179615000|clinical.studies@galderma.com|
22383620|NCT05368831|NorthSea Therapeutics BV|CLIENT TO PROVIDE|31 035760 65 05|info@northseatherapeutics.com|
22383621|NCT03565315|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Martin Gaudinski, MD|301-451-8715|martin.gaudinski@nih.gov|
22383622|NCT01170962|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22383623|NCT03887650|Hartford Hospital|Dr. Kevin Finkel|860-972-1778|Kevin.Finkel@hhchealth.org|
22383624|NCT01083316|Boston Medical Center|Vaishali Sanchorawala|6176386521|vaishali.sanchorawala@bmc.org|
22383625|NCT04200365|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|SCRI.InnovationsMedical@scri.com|
22383626|NCT03942042|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22383627|NCT02808585|PhaseBio|Dr. John Lee, Chief Medical Officer|6109816500|john.lee@PhaseBio.com|
22383628|NCT00933400|American College of Radiology|Communications Director|215-574-3150|nfredericks@acr.org|
22383629|NCT01849055|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22383630|NCT01199575|University of California, San Diego|Thomas Kipps, MD PhD|858-534-5400|tkipps@ucsd.edu|
22383631|NCT00513526|AMC|Group Statistician|501-526-6712|jylee@uams.edu|
22383632|NCT00223795|VA Greater Los Angeles Healthcare System|Meika A. Fang, MD|310-268-4503|meika.fang@va.gov|
22383633|NCT00475501|Geriatric Research Education and Clinical Center|Stephen Borst, Ph.D|352-374-6114|stephen.borst@va.gov|5033
22383634|NCT01819883|Massachusetts General Hospital|Karen Miller|617-726-3870|KKMiller@MGH.Harvard.edu|
22383635|NCT03799783|University Hospital Padova|Angela Amigoni, MD|339 8333765|Angela.amigoni@aopd.veneto.it|++39
22383636|NCT02409667|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22383637|NCT01925339|University of Michigan|Dr. Hom-Lay Wang|734-763-3383|homlay@umich.edu|
22383638|NCT01827787|Dana-Farber Cancer Institute|Dr. Erica Mayer|617-632-2335|Erica_Mayer@dfci.harvard.edu|
22383639|NCT02769858|University of Michigan|Dr. Leslie Swanson|734-239-2248|LMSwan@med.umich.edu|
22383640|NCT04939246|Miami Cancer Institute at Baptist Health, Inc.|Director, Concept Development & Data Management|(786) 527-9546|mciresearchconceptandprotocoldev@baptisthealth.net|
22397823|NCT01119248|Rutgers/New Jersey Medical School|Anuradha Patel, MD Director of Pediatric Anesthesiology|973 972-1886|patelan@njms.rutgers.edu|
22397824|NCT01967550|Novartis Consumer Health|Clinical Project Leader pain category|+41223633111||
22397825|NCT01550562|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
22397826|NCT00853671|Massachusetts General Hospital|Dr. Brian B. Ghoshhajra|617-726-3745|bghoshhajra@partners.org|
22397827|NCT01273883|Mayo Clinic|Dr. Michael J. Cevette|480-301-7020|mcevette@mayo.edu|
22397828|NCT01553136|Yale University|Stephanie Samples O'Malley, PhD, Professor of Psychiatry|(203) 974-7590|stephanie.omalley@yale.edu|
22397829|NCT02587650|University of California, San Francisco|Dr. Adil Daud|(415) 353-7392|Adil.Daud@ucsf.edu|
22397830|NCT00333359|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
22397831|NCT00939900|SeoulNUBH|Professor|82317877194|khkoo@snu.ac.kr|
22397832|NCT01452152|University of Maryland School of Medicine|Dr. Alan R. Shuldiner|410-706-1623|ashuldin@medicine.umaryland.edu|
22397833|NCT01332357|GlaxoSmithKline|GSK Response Center|866-435-7343||
22397834|NCT04099251|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22397835|NCT04311502|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22397836|NCT03451773|National Cancer Institute|Dr. Udo Rudloff|240-760-6238|rudloffu@mail.nih.gov|
22383641|NCT03554265|University of Texas Medical Branch|Randall Urban, MD|409-772-5476|rurban@utmb.edu|
22442971|NCT02278471|UT southwestern|Dr. Thomas J Wang|6159361717|thomas.wang@UTsouthwestern.edu|
22442972|NCT04391049|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22442973|NCT01242813|Novartis Pharmaceuticals|Study Director|862-778-8300||
22442974|NCT02204761|University of Washington Medical Center|Dr. Jing Zeng|2065984110|jzeng13@uw.edu|
22442975|NCT00275821|Novartis Pharmaceuticals|Study Director|862-778-8300||
22442976|NCT01215916|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22442977|NCT00924040|National Cancer Institute, National Institutes of Health|Robert J. Kreitman, M.D.|301-496-6947|kreitman@mail.nih.gov|
22442978|NCT01133990|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22442979|NCT02683746|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22442980|NCT01213576|University of Liverpool|Professor Neil French|+441517959630|french@liv.ac.uk|
22442981|NCT00606047|The Ottawa Hospital Research Institute|Dr Paul Beaule|613-737-8920|pbeaule@toh.ca|
22442982|NCT02614469|Massachusetts General Hospital|Dr. Michael Schwarzschild|617-764-9611|michaels@helix.mgh.harvard.edu|
22442983|NCT02126748|Vrije Universiteit Brussel|Filip Van Ginderdeuren|+3224763916|filip.vanginderdeuren@uzbrussel.be|
22442984|NCT01844479|University of Michigan|James Wrobel, DPM, MS|734-647-4940|jswrobel@med.umich.edu|
22442985|NCT01976988|Cedars Sinai Medical Center|Phillip Fleshner MD|310-289-9224|pfleshner@aol.com|
22442986|NCT01328444|GlaxoSmithKline|GSK Response Center|866-435-7343||
22442987|NCT03316911|University of Michigan|Michelle Munro-Kramer|734-904-4600|mlmunro@umich.edu|
22442988|NCT01270802|Indiana University School of Medicine|Dr. Samir K. Gupta, Principal Investigator|317-274-7926|sgupta1@iu.edu|
22442989|NCT01023477|Inova Health Care|Kirsten Edmiston, MD|703-850-9555|Kirsten.edmiston@inova.org|
22442990|NCT04620798|Indiana University Bloomington School of Public Health|Molly Rosenberg, MPH, PhD|(812) 856-2509|rosenmol@indiana.edu|
22442991|NCT04821362|Ege University|Dr. Sercan Yalçınlı|+90 505 537 41 01|sercan.yalcinli@ege.edu.tr|
22442992|NCT01640327|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22442993|NCT03222492|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22442994|NCT01054183|Akron Children's Hospital|Michael T. Bigham, MD|330-543-8639|MBigham@chmca.org|
22442995|NCT00968032|pfm medical ag|Christof Schmeer|+49 6873 9011|christof.schmeer@pfmmedical.com|41
22383642|NCT03025789|Drugs for Neglected Diseases initiative (DNDi)|Dr. Olaf Valverde Mordt|+41795431713|ovalverde@dndi.org|
22383643|NCT02723955|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22383644|NCT04999085|University of North Carolina Lineberger Comprehensive Cancer Center|Christopher E. Jensen, MD, MSCR|+1 984-987-1072|cejensen@med.unc.edu|
22383645|NCT05057897|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22383646|NCT04751526|The University of Texas Health Science Center at Houston|Sheng Li, MD, PhD|713-797-7125|sheng.li@uth.tmc.edu|
22383647|NCT03088813|Ipsen Bioscience, Inc.|Medical Director|see email|clinical.trials@ipsen.com|
22383648|NCT02152137|Mayo Clinic|Robert C. Smallridge, M.D.|904-953-2392|smallridge.robert@mayo.edu|
22383649|NCT04878354|ALK-Abelló A/S|Senior Director, Clinical Data Science|+4545747576|clinicaltrials@alk.net|
22383650|NCT03599648|University of Oregon|Dr. Laura Lee McIntyre|541-346-7452|llmcinty@uoregon.edu|
22383651|NCT04656925|Washington State University|Abigail Bowen|(425) 736-1354|abigail.bowen@wsu.edu|
22383652|NCT02217904|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22383653|NCT00977691|National Heart Lung and Blood Institute|Courtney Fitzhugh, MD, Investigator|+1 301 402 6496|courtney.fitzhugh@nih.gov|
22383654|NCT01903811|SWOG Statistical Center|S1304 Statistician|2066674623|rachaels@crab.org|
22383655|NCT04540913|TEOXANE SA|Clinical Research Scientist|+41(0) 22 344 96 36|clinical@teoxane.com|
22383656|NCT05613205|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22383657|NCT03602014|James J Peters VAMC|Dr. Jill Wecht|718-584-9000|jm.wecht@va.gov|3122
22383658|NCT00825630|Sharon Hospital|Dr. Haim Shirin|0097239372231|haims3@clalit.org.il|
22383659|NCT01939899|Millennium Pharmaceuticals, Inc.|Medical Director|+1-844-662-8532|globaloncologymedinfo@takeda.com|
22383660|NCT00265200|James Graham Brown Cancer Center, University of Louisville|Goetz H Kloecker, MD|502-562-4358|ghkloe01@louisville.edu|
22383661|NCT01854385|University of Washington|Dr. Jeanne Hoffman|(206) 221-6511|jeanneh@uw.edu|
22383662|NCT02932579|University of Rochester Eastman Institute for Oral Health|Yanfang Ren, Professor|5852735588|yanfang_ren@urmc.rochester.edu|
22383663|NCT03833661|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22383664|NCT02121002|Amneal Pharmaceuticals|Candis Edwards|631-974-7949|cedwards@amneal.com|
22383665|NCT02590432|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22383666|NCT01319617|UCSD|Felipe Medeiros|858 82245-92|fmedeiros@glaucoma.ucsd.edu|
22383667|NCT04788641|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22383668|NCT01250769|Philips Healthcare, Office of Medical and Health Affairs|Director of Clinical Operations|425 908-1208|wendy.jenkins@philips.com|
22383669|NCT04872738|Massachusetts General Hospital|Associate Director, Lymphedema Research Program|617-724-0127|cbrunelle@mgh.harvard.edu|
22383670|NCT04191499|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22383671|NCT03951805|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22383672|NCT05524454|Varian Medical Systems|Sean Davidson|437-991-8294|sean.davidson@varian.com|
22412012|NCT02521948|Essential Medical, Inc|Director of Operations|610-557-1009|todd@essmedclosure.com|
22442996|NCT02486627|Achaogen, Inc.|Clinical Trials Registration Group||clinical-trials@achaogen.com|
22442997|NCT02775240|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22397837|NCT03936387|BOSTON CHILDREN'S HOSPITAL|ROLAND BRUSSEAU MD|6173557737|roland.brusseau@childrens.harvard.edu|
22397838|NCT01339559|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22383673|NCT05999435|Laurent Pharmaceuticals Inc.|Vice President Clinical Development|514-941-2313|jmhoule@laurentpharma.com|
22383674|NCT03337399|Massachusetts General Hospital/Harvard Medical School|Jennifer Temel|617-724-4000|jtemel@mgh.harvard.edu|
22397839|NCT00971945|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22397840|NCT03354663|Abbott|Steven Madej|651-756-2230|steven.madej@abbott.com|
22397841|NCT03691974|Regeneron Pharmaceuticals, Inc|Study Director|844-734-6643|clinicaltrials@regeneron.com|
22442998|NCT05395091|Alvotech Swiss AG|Clinical Development and Medical Lead|+41 78 659 89 89|alvotech.clinical@alvotech.com|
22442999|NCT02992197|The University of Vermont College of Medicine|Benjamin Lee|8026567748|blee7@uvm.edu|
22443000|NCT03192358|University Health Network|Director, Swallowing Rehabilitation Research Laboratory|416 597 3422|tri-swallowinglab@uhn.ca|7802
22443001|NCT00832624|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22443002|NCT00548184|Baylor College of Medicine|Dr. Mothaffar Rimawi|713-798-1311|rimawi@bcm.edu|
22443003|NCT03467685|UPMC Dermatology|Dr. Rashek Kazi|5167105208|kazir@upmc.edu|
22443004|NCT00796523|University of Toledo|Jonna M. McRury, M.D.|419-389-1118|jmcrury@aol.com|
22443005|NCT01876329|Keesler Medical Center|Matthew B. Carroll, MD|228-376-3629|matthew.carroll.1@us.af.mil|
22443006|NCT02431260|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22443007|NCT00684541|SDSU|Professor Nader Amir|6192293744|namir@mail.sdsu.edu|
22443008|NCT03288142|Northwestern University Feinberg School of Medicine|Stephen D. Persell, MD, MPH, FACP|312-503-6464|spersell@nm.org|
22443009|NCT02270944|GlaxoSmithKline|GSK Response Center|866-435-7343||
22443010|NCT01059929|University of Chicago|John Kress|773-702-6790|jkress@medicine.bsd.uchicago.edu|
22443011|NCT00384111|Spectrum Pharmaceuticals, Inc, Research and Development Office 157 Technology Drive Irvine, CA 92618|Gajanan Bhat|949-743-9219|gajanan.bhat@sppirx.com|
22443012|NCT01551420|Providence VA Medical Center|Linda Resnik, Research Career Scientist|401-273-7100|Linda.Resnik@va.gov|2368
22443013|NCT04463069|Hong Kong Baptist University|Dr. Yang Gao|+852 3411 3082|gaoyang@hkbu.edu.hk|
22443014|NCT00311584|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22443015|NCT03073733|jCyte, Inc.|Robert Beathard|9492430687|rob.beathard@jcyte.com|
22443016|NCT01215929|UAMS|Michael J Mancino MD|501-526-8440|mjmancino@uams.edu|
22443017|NCT02276027|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22443018|NCT02446171|AstraZeneca AB|Ian Wogan|+1 301 398 0670|ClinicalTrialTransparency@astrazeneca.com|
22443019|NCT01264081|National Cancer Institute|Dr. Udo Rudloff'|301-496-3098|rudloff@nih.gov|
22443020|NCT01727700|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22443021|NCT01631656|WakeForest University Health Sciences|Dr Amy McMichael|336-716-3775|amcmicha@wakehealth.edu|
22443022|NCT01909791|Jaeb Center for Health Research|Adam Glassman|8139758690|drcrnet@jaeb.org|
22443023|NCT01009840|Otsuka Pharmaceutical Development and Commercialization|Global Medical Affairs|800 562-3974||
22443024|NCT04240678|UC Davis Medical Center|Eric Chak|916-734-3751|echak@ucdavis.edu|
22443025|NCT03616223|Frequency Therapeutics|Carl LeBel, PhD, CDO|781-315-4600|clinicaltrialsinformation@frequencytx.com|
22443026|NCT01122394|VA New York Harbor Healthcare System|Jennifer Friedberg, Ph.D.|212-951-3314|jennifer.friedberg@va.gov|
22443027|NCT03739242|A. Menarini Industrie Farmaceutiche Riunite SrL|Dr Paolo Fabrizzi Clinical Operation Director|+39 055 5680459|pfabrizzi@menarini.it|
22443028|NCT00039871|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22443029|NCT02446743|GlaxoSmithKline|GSK Response Center|866-435-7343||
22443030|NCT03086967|Atrium Health|Dr. Susan Bliss|(704)562-4860|Susan.Bliss@atriumhealth.org|
22443031|NCT02478398|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22443032|NCT01031420|Fox Chase Cancer Center|Elizabeth Plimack|215-728-3889|Elizabeth.Plimack@fccc.edu|
22383675|NCT01198145|Mayo Clinic|Robert C. Miller, M.D., M.S.||miller.robert@mayo.edu|
22397842|NCT03962439|University of Texas at Dallas|Joseph Hennessee|408-813-4488|joseph.hennessee@utdallas.edu|
22397843|NCT00513409|GlaxoSmithKline|GSK Response Center|866-435-7343||
22397844|NCT01049035|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22397845|NCT00746252|University of Marylland, Baltimore|Gloria M. Reeves, M.D.|410-706-3522|greeves@psych.umaryland.edu|
22397846|NCT01137773|University Louisville|Rainer Lenhardt, MD|502-228-7517|rainer.lenhardt@louisville.edu|
22383676|NCT00603954|CHU de Liège|Dr. Frédéric Baron|003243667201|f.baron@ulg.ac.be|
22383677|NCT04705480|Charleston Area Medical Center|Nancy Duvall|304-388-3653|nancy.duvall@vandaliahealth.org|
22383678|NCT04970654|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22383679|NCT02528188|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22383680|NCT03226899|Ironwood Pharmaceuticals, Inc.|Ironwood Study Chair|(617) 621-7722|Info@ironwoodpharma.com|
22383681|NCT02299375|GlaxoSmithKline|GSK Response Center|866-435-7343||
22397847|NCT00439946|United Therapeutics|Remodulin Program Leader|(919) 485-8350|ClinicalRecordsManagement@unither.com|
22397848|NCT03548051|Hope Clinic of the Emory Vaccine Center|Nadine Rouphael|404-377-3719|nroupha@emory.edu|10
22397849|NCT00082888|Mayo Clinic|Thomas E. Witzig, M.D.|507-266-2040|witzig@mayo.edu|
22397850|NCT03874377|Children's National Medical Center|Dr. Sarah Hornack|202-895-3860|shornack@childrensnational.org|
22383682|NCT02047981|UCSF F.I. Proctor Foundation|Ying Lin|4155144709|ying.lin@ucsf.edu|
22383683|NCT00704184|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22443033|NCT02531971|University of Maryland, Baltimore|Dr. Audra Stinchcomb|410-706-2646|astinchc@rx.umaryland.edu|
22443034|NCT01556347|Tim Icenogle MD PLLC|Timothy B Icenogle MD|509-220-1900|timicenogle@comcast.net|
22443035|NCT02013141|Cumberland Pharmaceuticals Inc|Clinical Scientist|615-255-0068|bgibson@cumberlandpharma.com|229
22443036|NCT01475071|Galderma|Cyril Moulin|+33 4 92 38 30 14|cyril.moulin@galderma.com|
22443037|NCT02230527|Cleveland Clinic|Joseph Campbell, MD|216-444-9836|campbej10@ccf.org|
22443038|NCT01752036|SKCCC|Terrence Caldwell|443-287-1889|caldwte@jhmi.edu|
22443039|NCT01011478|NSABP Foundation|Director, Department of Regulatory Affairs|412-339-5300||
22443040|NCT01020006|Pharmacyclics|Dr. Laurence Elias|855-427-8846|pharmacyclics@medcomsol.com|
22443041|NCT01205581|St. Jude Children's Research Hospital|Jon McCullers, MD|866-278-5833|info@stjude.org|
22443042|NCT03337490|Mayne Pharma LLC|Associate Director, Clinical Operations|9195737948|phoevos.hughes@maynepharma.com|
22443043|NCT00917644|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22443044|NCT03442868|Texas Woman's University|Hui-Ting Goh|2146897723|HGoh1@twu.edu|
22443045|NCT01568528|Emory University|Dr. Erica Duncan|404-321-6111|eduncan@emory.edu|
22443046|NCT00618098|CRMG|Patrick Murphy|4138210022|p.murphy@crmg-usa.com|
22443047|NCT02108262|CSLBehring|Trial Registration Coordinator|610-878-4000|clinicaltrials@cslbehring.com|
22443048|NCT01512667|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22443049|NCT01883856|University of Virginia|Peter A. Netland, MD, PhD|4349821086|pan9c@virginia.edu|
22443050|NCT01967784|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22443051|NCT01238588|Brigham and Women's Hospital|Kambiz Zandi-Nejad|617-732-5500|kzandinejad@partners.org|34769
22443052|NCT01544088|VA Boston Healthcare System|Denise Sloan, Ph.D.|(857) 364-6333|denise.sloan@va.gov|
22443053|NCT00445588|Adult Brain Tumor Consortium|David Peereboom, MD|216-445-6068|peerebd@ccf.org|
22443054|NCT04114617|University Health Network|Director, Swallowing Rehabilitation Research Laboratory|416 597 3422|tri-swallowinglab@uhn.ca|7802
22443055|NCT01915303|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22443056|NCT00637780|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22443057|NCT02509117|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22443058|NCT00568386|Alcon Research|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22443059|NCT01251536|UZ Leuven|Prof Dr Eric Van Cutsem|003216344218|eric.vancutsem@uzleuven.be|
22443060|NCT05396599|Johnson & Johnson Surgical Vision|Luis Vargas, MD|714-247-8200|LVarga17@ITS.JNJ.com|
22443061|NCT00280748|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22443062|NCT01433250|Novartis Pharmaceuticals|Study Director|862-778-8300||
22443063|NCT02576145|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22443064|NCT01227824|GlaxoSmithKline|GSK Response Center|866-435-7343||
22443065|NCT01294098|Washington University School of Medicine|Lauren Westlund|314-454-5345|davislauren@wustl.edu|
22443066|NCT00985829|skin research center|Zohreh Tehranchi-nia, assist. prof|+989121029415|zohreh_tehranchi@yahoo.com|
22443067|NCT00995566|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22443068|NCT02390791|Cincinnati Children's|Dr. William B. Brinkman|513-636-2576|bill.brinkman@cchmc.org|
22443069|NCT00821509|National Institute for Health and Welfare|Tapani Hovi, Project Leader|+358 400 517299|tapani.hovi@thl.fi|
22443070|NCT03612856|Aronora, Inc.|Christina U. Lorentz|503-964-0250|christina.lorentz@aronorabio.com|
22443071|NCT01576159|Middle East Technical University|Ozgur Celik PhD.|+903122104016|ozgur@udel.edu|3663
22443072|NCT01055067|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22443073|NCT01454778|Sanford Health|Dr. Patrick Kelly|605-312-7300|Patrick.Kelly@SanfordHealth.org|
22443074|NCT00575146|Dr. Senckenberg Institute of Neurooncology|Dr. Johannes Rieger|+49 69 6301|johannes.rieger@med.uni-frankfurt.de|87711
22443075|NCT01227629|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22443076|NCT01588470|UT Health Science, San Antonio|Dr. Muhammad Abdul-Ghani, MD|210-567-6691|abdulghani@uthscsa.edu|
22443077|NCT03708393|Seno Medical|Shaan Schaeffer VP of Clinical Operations|610-698-3259|sschaeffer@senomedical.com|
22443078|NCT00636701|Atlanta VA Medical Center|Dr. Andrew Butler|404-413-1415|andrewbutler@gsu.edu|
22443079|NCT03224598|Aclaris Therapeutics|Executive Director Clinical Operations|4843247933|jschnyder@aclaristx.com|
22383684|NCT03276871|Cleveland Clinic|Aldo Fafaj|2162195943|fafaja@ccf.org|
22443080|NCT02197455|Yale Univ School of Medicine|Brett King, MD|2037854092|brett.king@yale.edu|
22443081|NCT01845103|CryoLife, Inc.|Scott Capps, MS/ Vice President, Clinical Research|800-438-8285|clinicaltrialregistration@cryolife.com|
22443082|NCT03328182|Hollister Incorporated|Director Global Clinical Affairs|8476802837|stacy.haddad@hollister.com|
22383685|NCT00716859|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22443083|NCT02320903|Evidence-Based Practice Institute|Linda Dimeff, PhD|206-455-7934|grants@ebpi.org|
22443084|NCT00773383|Hoffman-LaRoche|Medical Communications|800-821-8590||
22443085|NCT03386253|University of Minnesota|Michael Kotlyar|612-625-1160|kotly001@umn.edu|
22443086|NCT01012219|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22443087|NCT03493815|The Pennsylvania State Univ College of Medicine, The Milton S. Hershey Medical Center|Stephanie Estes, M.D.|717-531-8478|sestes@pennstatehealth.psu.edu|
22383686|NCT02178098|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
22383687|NCT02701257|MGH Diabetes Research Center|Courtney Balliro|617-726-1242|cballiro@partners.org|
22383688|NCT01109524|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22383689|NCT00411216|Emory|Susan J Herdman, PT, PhD|4047120612|sherdma@emory.edu|
22383690|NCT01205048|Galderma|Clinical Scientist|+46184749000|reception.seupp@galderma.com|
22383691|NCT00823472|UMC Utrecht|Prof. dr. B.C.J.M. Fauser|+31-88-7557524|b.c.fauser@umcutrecht.nl|
22383692|NCT02515305|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
22383693|NCT00903162|Dana-Farber Cancer Institute|Ann Partridge, MD, MPH|617.632.3800|ann_partridge@dfci.harvard.edu|
22383694|NCT02960204|Histogen Inc.|Mark Hubka, Executive Director, Medical Affairs|858-526-3109|mhubka@histogen.com|
22428641|NCT01239680|Truman Medical Center|Charles W. Van Way, III, M.D.|816.235.2553|vanwayc@umkc.edu|
22428642|NCT00639379|Vistakon|Kurt Moody, OD|904-443-3088||
22428643|NCT04385888|George Washington University|Allison Sylvetsky|202-994-5602|asylvets@gwu.edu|
22428644|NCT01797185|Sun Pharma Advanced Research Company Limited|SPARC|+912266455645|Clinical.Trials@Sparcmail.com|
22428645|NCT01787838|Carilion Clinic|Rebecca Culver Clark|540-588-8184|rcclark@carilionclinic.org|
22428646|NCT00000142|Johns Hopkins Bloomberg School of Public Health|Dr. Curtis Meinert|410-955-8175|cmeinert@jhsph.edu|
22428647|NCT01033942|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
22428648|NCT01115231|Ralph H. Johnson VA Medical Center, Division of Research, Charleston, SC, USA|Baerbel Rohrer, PhD; VA Research Scientist|843-792-5086|rohrer@musc.edu|
22428649|NCT03071744|UCSD|Eric Roeland, MD|(858) 534-7079|eroeland@ucsd.edu|
22428650|NCT01199614|Columbia University|John P. Bilezikian, MD|212-305-6257|jpb2@cumc.columbia.edu|
22428651|NCT01143792|The Ohio State University|Natasha Slesnick|614 247-8469|slesnick.5@osu.edu|
22428652|NCT02260986|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
22428653|NCT01111370|Dexcom, Inc|Andy Balo/Sr. VP|8582000203|abalo@dexcom.com|
22428654|NCT02536794|Northwestern University|Ami Shah, MD|312 503 5488|amishah@northwestern.edu|
22428655|NCT00313170|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
22428656|NCT00817063|GlaxoSmithKline|GSK Response Center|866-435-7343||
22428657|NCT00529035|Dana-Farber Cancer Institute|John Koreth, MBBS, D.Phil|(617) 632-2949|jkoreth@partners.org|
22428658|NCT01521364|University of Groningen, University Medical Center Groningen|Dr. J.W.C. Alffenaar|+31-50-3614070|j.w.c.alffenaar@umcg.nl|40378
22428659|NCT03418675|University of Chicago|Dr. Jon E. Grant|7738341325|jgrant4@bsd.uchicago.edu|
22428660|NCT02115386|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
22428661|NCT02493855|AbbVie|Global Medical Services|800-633-9110||
22428662|NCT03086343|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22428663|NCT04900272|Northwestern University Feinberg School of Medicine|Katherine O'Brien|314-747-5361|obrien.k@wustl.edu|
22428664|NCT01385644|The Prince Chalres Hospital|Assoc Professor Daniel Chambers|+61 7 3139 4000|daniel.chambers@health.qld.gov.au|
22428665|NCT02447029|Stanford University|Principal Investigator|650-497-5175|gynresearch@stanford.edu|
22428666|NCT02299167|Dammam University|Roshdi R. Al-Metwalli|+966 50 289 3485|rmetwalli@iau.edu.sa|
22428667|NCT03600428|Vanderbilt University Medical Center|C. Buddy Creech, MD, MPH|6153430332|buddy.creech@vumc.org|
22428668|NCT03802110|Boston Scientific Cardiac Rhythm Management|Stephen J. Hahn, PhD|1-800-227-3422|stephen.hahn@bsci.com|
22428669|NCT00549328|GlaxoSmithKline|GSK Response Center|866-435-7343||
22428670|NCT02162433|Massachusetts Eye and Ear|Dr. Makara Cayer|617-573-3380|makara_cayer@meei.harvard.edu|
22428671|NCT06420232|University of Texas Medical Branch, Galveston|Heather Celkis, OTR, PPOTD|409-|hdcelkis@UTMB.EDU|
22428672|NCT06540170|National Healthcare Group Polyclinics|Senior Wound Nurse Clinician|64966611|julia_zhu@nhgp.com.sg|
22428673|NCT04868682|VA Greater Los Angeles Healthcare System|Dr. Cathy Alessi|818 891-7711|cathy.alessi@va.gov|39311
22428674|NCT00063622|Virginia Commonwealth University|Arun J. Sanyal||asanyal@mcvh-vcu.edu|
22428675|NCT03880565|University of Minnesota|Demetri Yannopoulos, MD|612-626-2935|yanno001@umn.edu|
22428676|NCT02202616|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22428677|NCT04803279|Oticon Medical|Nicole Amichetti, PhD, MS, Manager of Clinical Affairs|6093660424|nitc@oticonmedical.com|
22428678|NCT04327271|University of Washington|Caryl Feldacker|+1-314-600-6743|cfeld@uw.edu|
22428679|NCT01044498|Hoffmann-La Roche|Medical Communications|800 821-8590||
22428680|NCT00820534|Novartis Consumer Health|Head of Clinical Research|+4122363311||
22428681|NCT02903914|Call Center|Incyte Corporation|1-855-463-3463|medinfo@incyte.com|
22428682|NCT01470170|Department of Thoracic Medicine|Dr. Yu-Lun, Lo|+886-3-3281200|loyulun@hotmail.com|5108
22428683|NCT06480032|Rehman Medical Institute|Dr.Iftikhar qayum|+92 91 5838 333|iftikhar.qayum@rmi.edu.pk|4708
22428684|NCT04336943|Fred Hutchinson Cancer Center|Dr. Michael Schweizer|2066066252|mtschwei@fredhutch.org|
22428685|NCT01683526|Beth Israel Medical center|Michael Silverberg|2124202377|msilverberg2@chpnet.org|
22428686|NCT02406612|Essential Medical|Sam Nardone|6105571009|sam@essmedclosure.com|
22428687|NCT02830087|Wake Forest University Health Sciences|Maxwell Langfit, MD||mlangfit@wakehealth.edu|
22428688|NCT03424148|Cutera|Margout Doucette|415-656-9612|mdoucette@cutera.com|
22428689|NCT01235377|Veterans Health Administration Pharmacy Benefits Management|Madeline McCarren, PhD|7087867987|madeline.mccarren@va.gov|
22428690|NCT03483012|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|617-632-5743|Sara_Tolaney@dfci.harvard.edu|
22383695|NCT03087708|VA Long Beach Health Care System|Dr. Pankaj Gupta|562-826-8000|pankaj.gupta@va.gov|
22383696|NCT03350542|Boston Scientific|Patricia O'Mara|518-744-0046|patricia.omara@bsci.com|
22428691|NCT02900976|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22428692|NCT05708924|Masonic Cancer Center|Dr. Melissa Geller|612-626-3111|gelle005@umn.edu|
22428693|NCT03611946|Johns Hopkins CIR|Dr Anna Durbin|410-955-7283|adurbin1@jhu.edu|
22428694|NCT05177094|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
22428695|NCT02737618|Church & Dwight Co., Inc|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
22428696|NCT05075200|Sunnybrook Health Sciences Centre|Dr. Angela Jerath|416-480-4864|angela.jerath@sunnybrook.ca|
22428697|NCT05142774|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
22428698|NCT04443452|University of Nottingham|Professor Ana Valdes|0115823114|ana.valdes@nottingham.ac.uk|
22428699|NCT03487445|Viatris Innovation GmbH|Viatris Innovation Clinical Trial Information|+41 58 844 07 44|viatrisinnovationclinicaltrials@viatris.com|
22428700|NCT01963234|University of Wisconsin - Madison|Andrew Quanbeck|6082627385|arquanbe@wisc.edu|
22428701|NCT02320175|Boston Children's Hospital|Isabella Liss, Patient and Family Centered I-PASS SCORE Study Coordinator|857-218-3229|isabella.liss@childrens.harvard.edu|
22428702|NCT01695746|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22428703|NCT03954535|Columbia University School of Social Work|Dr. Traci Schwinn|212-851-2280|tms40@columbia.edu|
22428704|NCT00373672|Northwestern University|Herbert Y Meltzer|1 312 503 0309|h-meltzer@northwestern.edu|
22428705|NCT04871074|UW School of Medicine and Public Health|Barbara Bendlin, PhD, MA|(608) 265-2483|bbb@medicine.wisc.edu|
22428706|NCT06011798|Unity Biotechnology, Inc.|Anirvan Ghosh|-|anirvan.ghosh@unitybiotechnology.com|
22428707|NCT04132050|Kissei Pharmaceutical Co., Ltd.|Clinical Development Division|Email olly|rinsyousiken@pharm.kissei.co.jp|
22428708|NCT03506477|Icahn School of Medicine at Mount Sinai|Ingrid Sanabria-Gonzalez|212-523-3812|ingrid.sanabria@mountsinai.org|
22428709|NCT03462680|Charlie Norwood VAMC|Dr. Chandramohan Wakade|706-733-0188|chandramohan.wakade@va.gov|2379
22428710|NCT02516241|AstraZeneca|Medical Science Director|1-877-240-9479|information.center@astrazeneca.com|
22428711|NCT04164979|Chao Family Comprehensive Cancer Center, University of California, Irvine|Chao Family Comprehensive Cancer Center, University of California, Irvine|1-877-UC-STUDY|ucstudy@uci.edu|
22428712|NCT00462462|Orfagen|Clinical Project Manager|+33 5 34 50 64 62|info@orfagen.com|
22428713|NCT01163617|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22428714|NCT02394756|Johnson & Johnson Vision Care Inc.|Chantal Coles-Brennan- PRINCIPAL RESEARCH OPTOMETRIST|1 904 443 3449|CColesb@ITS.JNJ.com|
22428715|NCT03018938|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22428716|NCT00191100|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22428717|NCT01769586|VA Connecticut Healthcare System|Dr. Loren Laine|203-932-5711|loren.laine@yale.edu|
22428718|NCT02013427|Northwestern University|Apkar Vania Apkarian|+1 312 503 0404|a-apkarian@northwestern.edu|
22428719|NCT02141113|Rochester Center for Behavioral Medicine|Joel L. Young, MD|2486088800|jyoung@rcbm.net|
22428720|NCT05635370|Brigham and Women's Hospital|Rishi J Desai, PhD|617-278-0932|rdesai@bwh.harvard.edu|
22428721|NCT00357565|Masonic Cancer Center|Christen Ebens, MD, MPH|(612) 626-2961|ebens012@umn.edu|
22428722|NCT04950686|innovation Research and Training|Tracy Scull, PhD|9194937700|tscull@irtinc.us|
22428723|NCT07021443|UZ Brussel|Prof. dr. Hendrik Reynaert|+32 2 477 68 11|hendrik.reynaert@uzbrussel.be|
22428724|NCT04262219|Fox Chase Cancer Center|Dr. Jennifer Reese, Associate Professor|215-214-3223|Jennifer.Reese@fccc.edu|
22428725|NCT03069989|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22428726|NCT05061888|Pennington Biomedical Research Center|Corby Martin|225-763-2585|corby.martin@pbrc.edu|
22428727|NCT05291975|Erchonia Corporation|Clinical Affairs Manager|8882420571|tsammons@erchonia.com|
22428728|NCT02266576|Stanford University|Jan J. Vasquez|408-858-4457|jan.vasquez@stanford.edu|
22428729|NCT01440920|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22428730|NCT02626611|Stanford|Dr. Kari Nadeau|650-867-4592|knadeau@stanford.edu|
22428731|NCT01192698|Carolinas Medical Center|Dr. Mark W. Russo|704-355-6649|mark.russo@carolinashealthcare.org|
22428732|NCT01127061|University of Michigan School of Medicine|Dr. Sara Saberi, MD, MS|734-764-4500|saberis@med.umich.edu|
22428733|NCT00962598|Icahn School of Medicine at Mount Sinai|Dr. Vilma Gabbay|212-659-1661|vilma.gabbay@mssm.edu|
22428734|NCT03921541|Immedica Pharma AB|Vice President, Head of Global Integrated Evidence / Global Head of Genetic and Metabolic Diseases|+46 8 533 39 500|Clinical@immedica.com|
22428735|NCT00003456|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22428736|NCT02798952|GlaxoSmithKline|GSK Response Center|866-435-7343|eg763112@gsk.com|
22428737|NCT00420407|University of Texas Health Science Center at San Antonio|Stephen Cohn, M.D.|210-567-5724|mccarthyj@uthscsa.edu|
22428738|NCT04928339|University of Wisconsin - Madison|Jeremy Sullivan|6082639976|jasullivan@wisc.edu|
22428739|NCT04633447|Janssen Research & Development, LLC|Manager Clinical Science Translational|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22428740|NCT04333498|New York State Psychiatric Institute/ HIV Center|Research Program Manager|646-774-6904|christopher.ferraris@nyspi.columbia.edu|
22428741|NCT01565694|Astellas Pharma Europe B.V.|Clinical Trial Disclosure|310715455050|astellas.resultsdisclosure@astellas.com|
22428742|NCT03690544|Mayo Clinic|Alison J. Bruce, M.B., Ch.B.|904-953-6402|Bruce.Alison@mayo.edu|
22428743|NCT05399771|Atrium Health Wake Forest Baptist|Nicole Levi|336-716-4171|nlevi@wakehealth.edu|
22428744|NCT05416203|Department of Veteran Affairs|Dr. Nicholas Allan|8502740567|nicholas.allan@va.gov|
22428745|NCT01692015|Imperial College London|professor Claire Shovlin|+44 (0)20 7589 5111|c.shovlin@imperial.ac.uk|
22428746|NCT02906618|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22428747|NCT05463055|Varian Medical Systems|Sophia Shao|+86-21-23156400|sophia.shao@varian.com|
22428748|NCT04766333|Rutgers University|Shawna V. Hudson|848-932-0215|hudsonsh@rutgers.edu|
22428749|NCT03234881|VA Connecticut Healthcare System|Robin Masheb, PhD|203-932-5711|Robin.Masheb@va.gov|3954
22428750|NCT00541229|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22397851|NCT00817531|Baylor College of Medicine|Dr. Mothaffar Rimawi|713-798-1311|rimawi@bcm.edu|
22397852|NCT00812214|MedVadis Research Corporation|Egilius L.H. Spierings, M.D., Ph.D.|617-744-1310|Spierings@MedVadis.com|
22397853|NCT01069562|Post Graduate Institute of Medical Education and Research|Puri GD|91-9914209509|gdpuri007@hotmail.com|
22397854|NCT02684981|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22397855|NCT03598166|VA|Anika Zaman|6464190648|anika.zaman@nyulangone.org|
22397856|NCT00820898|NRG Oncology|Angela Kuras on behalf of James Kauderer|716-845-5702|kurasa@nrgoncology.org|
22397857|NCT01000662|NYU Langone Medical Center|Dr. Silvia Formenti, Chairman, Department of Radiation Oncology|(212) 731-5039|silvia.formenti@nyumc.org|
22397858|NCT00452699|GlaxoSmithKline|GSK Response Center|866-435-7343||
22397859|NCT02921971|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22397860|NCT00326898|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
22397861|NCT03847987|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22397862|NCT00648375|Yale School of Medicine|Margaret Altemus|646-209-6277|margaret.altemus@yale.edu|
22397863|NCT02721355|Immunology Research Institute in Gifu|Dr. Van Sa Nguyen|+819068053288|nguyen@ew-nutrition.co.jp|
22397864|NCT00356278|Emory University|Barbara O. Rothbaum, PhD, ABPP|404-712-8866|brothba@emory.edu|
22397865|NCT01166230|The University of Texas|H. Barton Grossman, MD|713-563-7456|hbgrossman@mdanderson.org|
22397866|NCT00679952|Seoul National University College of Medicine|Clinical instructor|82-2-2072-2817|meejookang@gmail.com|
22397867|NCT01968460|Pharma 2B LTD|Pninit Litman study director|+972 8 9472672|pninit@pharma2b.com|
22397868|NCT01268293|Eisai Co., Ltd.|Tatsuya Sasaki|81-3-3817-5252||5252
22397869|NCT02597855|Yeungnam University College of Medicine|Dr. Min Sagong|82-53-620-4191|msagong@ynu.ac.kr|
22397870|NCT03491384|University of Colorado Boulder|Dr. L. Cinnamon Bidwell|3037355180|CUChange@Colorado.edu|
22397871|NCT00713700|Abbott|Ashish Oza|1-818-493-3648|aoza@sjm.com|
22397872|NCT00781456|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22397873|NCT01484626|Loyola University Medical Center|Scott Smith, M.D., Ph.D.|708-327-3142|ssmith8@lumc.edu|
22397874|NCT01777152|Seagen Inc.|Chief Medical Officer|(855)473-2436|medinfo@seagen.com|
22397875|NCT03548558|University of Southern California|Dr. Jill Luoto|+1-213-764-1581|jluoto@usc.edu|
22397876|NCT04852848|University of Oregon|Anne Marie Mauricio, Research Associate Professor|602-920-7459|amariem@uoregon.edu|
22397877|NCT03446885|Florida International University|Gregory A. Fabiano, Ph.D.|716-359-7823|gfabiano@fiu.edu|
22397878|NCT04283123|Washington University School of Medicine in St. Louis|Susan Stark, PhD, OTR/L, FAOTA|(314)273-4114|sstark@wustl.edu|
22397879|NCT03799458|University of New Mexico Health Sciences Center|Dr. Davin Quinn|505-272-2223|dquinn@salud.unm.edu|
22397880|NCT04175626|Biotronik, Inc|Crystal Miller|1 800-547-0394|crystal.miller@biotronik.com|
22397881|NCT03494881|Mayo Clinic|Jason Sluzevich, M.D.|904-953-6192|sluzevich.jason@mayo.edu|
22397882|NCT01709149|Cytokinetics, Inc.|MD Cytokinetics|650-624-2929|medicalaffairs@cytokinetics.com|
22397883|NCT03509350|Emory University|Jon Sevransky MD, MHS|404-778-5734|jonathan.sevransky@emoryhealthcare.org|
22397884|NCT00763815|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22397885|NCT04951037|Emory University|Fayron Epps, PhD, RN|404-727-6936|fepps@emory.edu|
22397886|NCT05630937|Nerviano Medical Sciences S.r.l.|Alberto Ocana|39 0331 58 1111|DL-Clinicaltrials@nervianoms.com|
22397887|NCT03245450|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22397888|NCT02429414|UT MD Anderson Cancer Center|Jagtar S Heir, Professor, Anesthesiology & PeriOper Med|(713) 745-3793|jsheir@mdanderson.org|
22397889|NCT01849172|Guang'an Men Hospital, China Academy of Chinese Medical Sciences|Dr.Zhishun Liu|+86 01088002331|liuzhishun@aliyun.com|
22397890|NCT04442230|Altimmune, Inc.|Sarah K. Browne, MD/Senior Director, Clinical Development|240-654-1450|sbrowne@altimmune.com|
22397891|NCT01604265|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
22397892|NCT01903837|Alkermes|Director, Corporate and R&D Communications|781-609-7000|Gretchen.Murphy@alkermes.com|
22397893|NCT02706873|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22397894|NCT01857713|Somna Therapeutics, L.L.C.|James Miller|262-345-5553|jmiller@somnatherapeutics.com|102
22397895|NCT03759665|IntraBio Ltd.|Taylor Fields, Chief Product Development Officer|+44 8081|tfields@intrabio.com|641283
22397896|NCT05098041|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22397897|NCT00705939|Protalix Ltd.|Vice President Product Development|+(972) 4-9889488|einata@protalix.com|137
22397898|NCT00618410|The University of Chicago|Dr. Robert M. Naclerio, MD|(773) 702-1865|rnacleri@surgery.bsd.uchicago.edu|
22397899|NCT01515657|PLx Pharma|Ronald Zimmerman|1-713-842-1249|ron.zimmerman@plxpharma.com|205
22397900|NCT00464334|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22397901|NCT00797732|Dana-Farber Cancer Institute|Weidong Lu, PhD, MB, Lic.Ac.|617.632.4350|weidong_lu@dfci.harvard.edu|
22397902|NCT03948178|Orion Corporation|Head of Compliance and UK Study Management, Clinical Operations|+441159487100|clinicaltrials@orionpharma.com|
22397903|NCT01297270|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22397904|NCT02112370|Seoul National University Hospital Department of Surgery|Dr. Kyu Eun Lee|+82)-2-2072-2817|kyueunlee@snu.ac.kr|
22397905|NCT00401752|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22428751|NCT03807843|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22428752|NCT01312129|The Mind Research Network|Kent Hutchison, Ph.D.|720-663-0745|khutchison@mrn.org|
22397906|NCT02432235|ADC Therapeutics SA|Clinical Trials Information|954-903-7994|clinical.trials@adctherapeutics.com|954
22397907|NCT01895322|Otsuka Pharmaceutical Co., Ltd|Director of Clinical Research and Development|+81-3-6361-7366||
22428753|NCT00990288|Hospital for Special Surgery|Mark P. Figgie MD|212-606-1932|figgiem@hss.edu|
22383697|NCT01251354|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22383698|NCT01996605|Wake Forest University School of Medicine|Professor James C. Eisenach, MD|336-716-4182|jimeisenach@gmail.com|
22383699|NCT03546608|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22383700|NCT00130117|BIDMC|Christos Mantzoros|6176678630|cmantzor@bidmc.harvard.edu|
22383701|NCT01853748|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|(877) 442-3324|Sara_Tolaney@dfci.harvard.edu|
22383702|NCT06050083|University of Washington|Dr. Mark Jensen, PhD, Principal Investigator|+1 206 543-3185|mjensen@uw.edu|
22428754|NCT04529980|Children's Health Children's Medical Center|Dr. Mayra Garcia, DNP, APRN, PCNS-BC, EBP-C|12144567990|Mayra.Garcia@childrens.com|
22428755|NCT02734667|Stanford University|Dr. Korey Hood|6504976899|kkhood@stanford.edu|
22428756|NCT03014362|Walter Reed National Military Medical Center|Christopher E Hines, MD|301-319-8122|christopher.e.hines.civ@mail.mil|
22428757|NCT02397837|Brigham and Women's Hospital|Dr. Katherine Burdick|617-732-5789|kburdick1@bwh.harvard.edu|
22428758|NCT03235414|Cincinnati Children's Hospital Medical Center; Department of Radiology|Dr. Andrew Trout|513-803-3004|andrew.trout@cchmc.org|
22428759|NCT04764604|University College London Hospitals NHS Foundation Trust|Brian Saccente-Kennedy, Speech and Language Therapist|+44 20 3456 5180|brian.saccente-kennedy@nhs.net|
22428760|NCT04772547|University of Florida|Dr. Carolina B. Maciel|(352) 273-5550|carolina.maciel@ufl.edu|
22428761|NCT00138294|Baylor College of Medicine|Pedro A Piedra, MD|713-798-5240|ppiedra@bcm.edu|
22428762|NCT00607594|Cross Cancer Institute|Dr. Heather-Jane Au|780-432-8500|heathera@cancerboard.ab.ca|
22428763|NCT05276804|Atrium Health|Gregory T. Scarola|704 355-5379|gregory.scarola@advocatehealth.org|
22428764|NCT02827708|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22428765|NCT02199574|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
22428766|NCT00407511|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22428767|NCT02409901|University of Illinois Chicago|Shyreen Kamal, Director of Clinical Research|2068830173|shyreen@uic.edu|
22428768|NCT05059080|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22428769|NCT00263562|Baylor College of Medicine|Andrea T. Cruz, MD, MPh|832-824-5582|acruz@bcm.edu|
22428770|NCT01047501|Amarin Pharma, Inc.|Alex Giaquinto|+1 908 326 1324|alex.giaquinto@amarincorp.com|
22428771|NCT04602000|Celltrion, Inc|Yun Ju Bae / Head of Clinical Planning 1 Department|+82 32 850 4160|YunJu.Bae@celltrion.com|
22428772|NCT00478036|University of Colorado, Dept. of Ophthalmology|Malik Kahook, MD|720-848-2501|Malik.kahook@ucdenver.edu|
22428773|NCT01566162|Sunovion|Medical Director CNS Clinical Trials|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
22428774|NCT00243061|Juravinski Cancer Centre|Dr. Elaine McWhirter|905-387-9495|elaine.mcwhirter@hrcc.on.ca|67559
22428775|NCT00693303|Shenandoah University|Deborah Marr ScD, OTR/L|540-678-4312|dmarr@su.edu|
22428776|NCT00770484|Vanderbilt University|Italo Biaggioni, MD., Professor of Medicine and Pharmacology|(615) 936-3420|italo.biaggioni@vanderbilt.edu|
22428777|NCT00195429|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22428778|NCT00367458|National Cancer Institute|Frank Maldarelli|301-435-8019|fmalli@mail.nih.gov|
22428779|NCT02556788|Galderma S.A.|Anne Fulton|+1 817-961-5203|anne.fulton@galderma.com|
22428780|NCT03683901|MetroHealth Rehabilitation Institute|Dr. Victoria Whitehair|216-778-4414|vwhitehair@metrohealth.org|
22428781|NCT05696847|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22428782|NCT01716156|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22428783|NCT04837521|Duke University|Dr. Andrada Neacsiu|+1 919 684 6714|andrada.neacsiu@duke.edu|
22428784|NCT05513950|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
22428785|NCT05221866|University of Nebraska Medical Center|Karsten Bartels|402-559-4081|anesthesiology.research@unmc.edu|
22428786|NCT05561140|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22428787|NCT05955378|Shirley Ryan AbilityLab|Arun Jayaraman|312-238-6875|ajayaraman@sralab.org|
22428788|NCT01188447|Ottawa Hospital Research Institute|Dr. Christian Vaillancourt|613-798-5555|cvaillancourt@ohri.ca|17012
22428789|NCT00221104|Translational Research Informatics Center, Kobe, Hyogo|Director of Medical Statistics Division|+81-78-303-9108|kagimura@tri-kobe.org|
22428790|NCT02989389|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22428791|NCT01666652|WRAIR|Robin Nielsen, RN|301-319-9063|trials.clinical@amedd.army.mil|
22428792|NCT00088153|Massachusetts General Hospital|Anne Klibanski|617-726-3870|aklibanski@partners.org|
22428793|NCT01132755|Memorial Sloan Kettering Cancer Center|Dr. Peter Kingham MD|212-639-5260|kinghamt@mskcc.org|
22428794|NCT01757847|VA San Diego Healthcare System|Niloofar Afari, PhD|858-642-3387|niloofar.afari@va.gov|
22428795|NCT04057365|Massachusetts General Hospital|Joseph Franses, MD, PhD|617-724-4000|JFRANSES@MGH.HARVARD.EDU|
22428796|NCT01063114|Massachusetts General, Hospital|Torunn Yock, MD|6177262000|tyock@mgh.harvard.edu|
22428797|NCT03409367|Oregon Health & Science University|Director of Clinical Trials|503-764-8544|michaell@ohsu.edu|
22428798|NCT04598828|Atrium Health Wake Forest Baptist|Project Manager|336-713-8793|richarlette.hightower@advocatehealth.org|
22428799|NCT02676973|RTI International|Marie Gantz|919-541-5110|mgantz@rti.org|
22428800|NCT02580604|University of Colorado Anschutz Medical Campus|Dr. Sarah Wherry|303-724-1927|sarah.wherry@cuanschutz.edu|
22428801|NCT01078662|AstraZeneca|Anitra Fielding|+44 1625 517178|aztrial_results_posting@astrazeneca.com|
22428802|NCT01563081|GlaxoSmithKline|GSK Response Center|866-435-7343||
22428803|NCT03279458|University of Mississippi Medical Center|Dr. Madhankumar Sathyamoorthy, Principal Investigator|6018157066|msathyamoorthy@umc.edu|
22428804|NCT01428245|University of Virginia|Clinical Research Coordinator|434-243-6911|pcos@virginia.edu|
22443088|NCT03811093|Vidantis Technologies, Inc|Thomas A. Namynanik - Consultant to invisa-RED Technologies|404 915-5938|andyn997@vidantis.com|
22443089|NCT00178503|University of Texas Medical School at Houston|Deborah A. Pearson, Ph.D.|713-486-2588|Deborah.A.Pearson@uth.tmc.edu|
22443090|NCT01095094|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|David Peereboom, MD|216-445-6068|peerebd@ccf.org|
22443091|NCT01561703|University of Missouri - Department of Otolaryngology - Head and Neck Surgery|Research Coordinator|5738822549|schneiderri@health.missouri.edu|
22443092|NCT00464490|University of California San Francisco|Julin F. Tang, MD, MS|415-206-5274|tangj@anesthesia.ucsf.edu|
22443093|NCT02396160|University of Queensland|Dr Niikee Schoendorfer|0413122076|n.schoendorfer@uq.edu.au|
22443094|NCT03188042|NYU Langone Health|Joel Schuman, MD, FACS|929-455-5030|Joel.Schuman@nyu.edu|
22443095|NCT00925938|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22443096|NCT01328366|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
22443097|NCT01634256|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Sang-Wook Kim, MD|82-63-276-8284|clickm@jbnu.ac.kr|
22443098|NCT00874614|Progenics Pharmaceuticals, Inc|Jessica D Jensen, MPH|646-975-2513|jjensen@progenics.com|
22443099|NCT00137839|Dana-Farber Cancer Institute|David Jackman, MD|617-632-6049|DJACKMAN@PARTNERS.ORG|
22443100|NCT01440543|Digestive Diseases Center, Vitkovice Hospital, Ostrava, Czech Republic|Premysl Falt MD|+420602689561|faltprem@centrum.cz|
22443101|NCT03860935|Eidos Therapeutics, Inc., a BridgeBio Company|VP, Clinical Operations|415-887-1471|info@bridgebio.com|
22443102|NCT00266851|Wisconsin Resaerch & Education Network|Dr. David Hahn|608-234-3212|dlhahn@wisc.edu|
22443103|NCT03361176|Maryland Laser Skin and Vein|Robert A. Weiss, MD|4106662839|cmyers@mdlsv.com|
22443104|NCT01408329|Stanford University|Anne L Friedlander|650-725-7531|afriedlanderCW@gmail.com|
22443105|NCT01437995|Johns Hopkins University|Alexis Rea|4432878496|area5@jhu.edu|
22443106|NCT04456673|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
22443107|NCT02160002|Wayne State University|Seetha Shankaran|(313) 745-1436|sshankar@med.wayne.edu|
22443108|NCT04418661|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22443109|NCT01689532|Janssen Pharmaceutical K.K.|Senior Manager||ClinicalTrialDisclosure@its.jnj.com|
22443110|NCT01363349|BioLineRx LTD|Dr. Arnon Aharon|972-2-548-9100|arnona@biolinerx.com|135
22443111|NCT02280122|JWGUniversity|Prof. Dr. Peter Eickholz|+49696301|eickholz@med.uni-frankfurt.de|5642
22443112|NCT03271983|University of Maryland, Baltimore|Dr. Audra Stinchcomb|410-706-2646|astinchc@rx.umaryland.edu|
22443113|NCT02921061|Fred Hutchinson Cancer Research Center|Roland B. Walter|1-206-667-3599|rwalter@fredhutch.org|
22443114|NCT02599051|Cleveland Clinic Florida|G W Davila|9546595559|davilag@ccf.org|
22443115|NCT02596750|UC Davis Department of Dermatology|Raja Sivamani MD|916-703-5145|dermstudies@ucdavis.edu|
22443116|NCT02700334|INSTITUTO DE TERAPUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
22443117|NCT04449029|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22443118|NCT02312882|Stanford University|Anthony E Oro, M.D., Ph.D.||oro@stanford.edu|
22443119|NCT01073462|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22443120|NCT01126671|Boston Children's Hospital|Dr. Sarah Pitts|617-355-3732|sarah.pitts@childrens.harvard.edu|
22443121|NCT00247611|Center for Health, Intervention & Prevention|Dr. Jeffrey Fisher, Principal Investigator|(860) 486-4940|jeffrey.fisher@uconn.edu|
22443122|NCT00834080|Alkermes, Inc.|Bernard L. Silverman, MD|781-609-6000|Bernard.Silverman@alkermes.com|
22443123|NCT03396952|University of California, San Francisco|Dr. Adil Daud, MD|(415) 353-7392|Adil.Daud@ucsf.edu|
22443124|NCT04345367|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22443125|NCT01037192|Fraser Health Authority|Anna Yuen, BSc. Pharm|604-520-4005|anna.yuen@fraserhealth.ca|
22412013|NCT00310427|NIH/National Institute on Alcohol Abuse and Alcoholism|Markus A. Heilig, M.D., Ph.D.|301-435-9386|mheilig@mail.nih.gov|
22443126|NCT01522937|University of Michigan Comprehensive Cancer Center|Dr. Kyle Cuneo, M.D.|734-936-4300|kcuneo@umich.edu|
22443127|NCT00439738|Novartis Pharmaceuticals|Study Director|1-862-778-8300||
22443128|NCT03774719|Washington University in Saint Louis|Gonzalo Matzumura|3143627211|g.matzumuraumemoto@wustl.edu|
22443129|NCT00400803|Masonic Cancer Center, University of Minnesota|Arkadiusz Dudek, M.D.|612-624-0123|dudek002@umn.edu|
22443130|NCT00781885|Lung Biotechnology PBC|Lung Biotechnology PBC Study Director|301-608-9292||
22443131|NCT01755026|west virginia university|michael stitely|304-293-5631|mstitely@hsc.wvu.edu|
22443132|NCT03836001|Stanford University|Albert Chiou|(650) 721-8418|achiou@stanford.edu|
22443133|NCT00875589|Daroff-Dell'Osso Ocular Motility Laboratory|Jonathan Jacobs, PhD|216-791-3800|jxj24@case.edu|2947
22443134|NCT00392379|Mayo Clinic|Jon O. Ebbert, MD|507-266-1944|nicotineresearch@mayo.edu|
22443135|NCT02184624|GlaxoSmithKline|GSK Response Center|866-435-7343||
22443136|NCT01700387|Clinvest/A Division of Banyan Group Inc.|Dr. Roger Cady|417-883-7889|rcady@banyangroupinc.com|
22443137|NCT01295879|Brigham and Women's Hospital|David E. Leaf, M.D., Renal Fellow|617-732-5951|DELEAF@partners.org|
22443138|NCT03417713|Hamilton General Hospital|Dr. Theodore Rapanos|905-521-2100|rapanost@mcmaster.ca|44652
22443139|NCT02730793|Virginia Commonwealth University|Bruce K. Rubin MEngr, MD, MBA, FRCPC|804 828 9604|bruce.rubin@vcuhealth.org|
22443140|NCT02365233|University of Texas Medical Branch|Nicola Abate, MD - Professor and Director of Endocrinology Division|409 772 1922|niabate@utmb.edu|
22443141|NCT00934843|Medical University of South Carolina|Dr. Eric Graham|843-792-8704|grahamem@musc.edu|
22383703|NCT00780416|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22383704|NCT02916706|Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please e-mail|cti-inq-ml.JP@ml.tanabe-pharma.com|
22383705|NCT03845829|Department of Vascular Surgery, Shanghai Ninth People's Hospital|Kaichuang Ye|+86-021-2327166|ykaichuang@163.com|
22428805|NCT02875080|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22428806|NCT00182637|UC Irvine|Dr. Lauren Pinter-Brown|(714) 456-5153|lpinterb@uci.edu|
22428807|NCT02068794|Mayo Clinic|Evanthia Galanis MD|(507) 284-2511|galanis.evanthia@mayo.edu|
22428808|NCT00898807|Johns Hopkins|Anne Casper|410-955-8183|ashankl1@jhu.edu|
22428809|NCT03928327|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
22428810|NCT01482221|AstraZeneca|Sanjeev Pathak||ClinicalTrialTransparency@astrazeneca.com|
22428811|NCT05607043|Rutgers School of Dental Medicine, Newark, New Jersey, United States|Gayathri Subramanian, PhD, DMD|732 824 7241|subramga@sdm.rutgers.edu|
22428812|NCT01846871|Massachusetts General Hospital|Dr. Elizabeth Gerstner|617-724-8770|EGERSTNER@mgh.harvard.edu|
22428813|NCT00731198|Changhai Hospital, Second Military Medical University, Shanghai, China|Zhaoshen Li M.D.|86-21-81873271|zhaoshenlismmu@gmail.com|
22428814|NCT05427916|Icahn School of Medicine at Mount Sinai|John C Lantis II|(212) 523-4797|John.Lantis@mountsinai.org|
22428815|NCT04757584|Weill Cornell Medicine|Maryam Hyder|646-962-5904|mah4022@med.cornell.edu|
22428816|NCT01257542|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22428817|NCT00081458|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22428818|NCT03562507|University of Michigan Rogel Cancer Center|ClinicalTrials.gov Cancer Center Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
22428819|NCT02132468|Mateon Therapeutics|Clinical Operations|6506357000|ca@mateon.com|
22428820|NCT03097315|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
22428821|NCT03384966|Viatris Innovation GmbH|Viatris Innovation Clinical Trial Information|+41 58 844 07 44|viatrisinnovationclinicaltrials@viatris.com|
22428822|NCT04790201|University of North Carolina at Chapel Hill|Bradley Gaynes, MD, MPH|(919) 445-0214|bradley_gaynes@med.unc.edu|
22428823|NCT01334515|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org|
22428824|NCT03637374|Johns Hopkins University|Dr. James H. Black, III|(410) 955-5165|jhblack@jhmi.edu|
22428825|NCT00776997|Torax Medical|Amy Derosier, VP of Clinical Affairs|651-361-8900|aderosier@toraxmedical.com|
22428826|NCT02948400|University of Alabama at Birmingham|David Schwebel|205-934-8745|schwebel@uab.edu|
22428827|NCT03925220|Tufts University|Dr. Margie Skeer|8579191262|margie.skeer@tufts.edu|
22428828|NCT05774977|University of Pennsylvania Perelman School of Medicine|Dr. Mathias Basner, MD, PhD, MScEpi|215-573-5866|basner@pennmedicine.upenn.edu|
22428829|NCT00374868|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22428830|NCT04470427|ModernaTX, Inc|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
22428831|NCT01018979|TaiGen Biotechnology Co., Ltd.|Chen-En Tsai, M.D., Ph.D.|+886-2-8177-7072|cetsai@taigenbiotech.com|1211
22428832|NCT00248547|Oregon Health & Science University, Knight Cancer Institute|Joseph Bubalo, PharmD|503-494-1054|bubaloj@ohsu.edu|
22428833|NCT02324153|Johns Hopkins University School of Medicine|Karin Neufeld MD MPH: PI of Trial|410-550-0197|kneufel2@jhmi.edu|
22428834|NCT01937299|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com|
22428835|NCT01913353|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
22428836|NCT00385840|GlaxoSmithKline|GSK Response Center|866-435-7343||
22428837|NCT00700635|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22428838|NCT01260948|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22428839|NCT00306488|National Eye Institute|Wai Wong, MD, PhD|301-496-7566|wongw@mail.nih.gov|
22383706|NCT03363854|LEO Pharma A/S|Disclosure|+45 44 94 58 88|disclosure@leo-pharma.com|
22383707|NCT02118961|Tanabe Pharma Corporation / The Research Foundation for Microbial Diseases of Osaka University|Clinical Trials, Information Desk / Clinical Development counter||cti-inq-ml.JP@ml.tanabe-pharma.com/clinicaldevelopment@mail.biken.or.jp|
22383708|NCT03103321|Mayo Clinic|Jon C. Tilburt, MD|5072661105|tilburt.jon@mayo.edu|
22383709|NCT03043599|H Lee Moffitt Cancer Center & Research Institute|Bradford Perez, MD|813-745-8234|Bradford.Perez@moffitt.org|
22383710|NCT05332340|Biozeus Biopharmaceutical S.A.|Joaquim Herzog de Oliveira Knox|+55 (21) 25239089|joaquim.knox@biozeus.com.br|
22383711|NCT05406258|Shirley Ryan AbilityLab|Dr. Megan O'Brien, PhD|312-238-2289|mobrien02@sralab.org|
22383712|NCT03885037|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22383713|NCT01492686|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22383714|NCT05428332|Stanford University|Allen Seo|9254939732|allenseo@stanford.edu|
22383715|NCT03314987|University of Louisville|Dr. Timothy O'Toole Associate Professor|15024190808|tim.otoole@louisville.edu|
22383716|NCT02992925|Tanabe Pharma Corporation / The Research Foundation for Microbial Diseases of Osaka University|Clinical Trials, Information Desk|Please email|cti-inq-ml.JP@ml.tanabe-pharma.com, clinicaldevelopment@mail.biken.or.jp|
22383717|NCT05678998|Werewolf Therapeutics|Werewolf Study Director|617-675-1865|clinicaltrials@werewolftx.com|
22383718|NCT06511076|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22383719|NCT05773313|Mayo Clinic|Nathan Delafield, M.D.|480-574-1920|Delafield.Nathan@mayo.edu|
22383720|NCT05137236|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
22383721|NCT01534494|New York University Grossman School of Medicine|Michael Bogenschutz|5059999325|Michael.Bogenschutz@nyulangone.org|
22383722|NCT00802464|GlaxoSmithKline|GSK Response Center|866-435-7343||
22383723|NCT00402246|Medtronic, Inc|CONNECT Clinical Trial Specialist||medtronicCRMtrials@medtronic.com|
22383724|NCT02880137|Mayo Clinic|Dr. Jonathan Johnson|507-255-7013|johnson.jonathan@mayo.edu|
22383725|NCT00431834|Medtronic, Inc.|Kristin Lawman|763-514-9809|kristin.j.lawman@medtronic.com|
22397908|NCT03196076|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
22443142|NCT00160667|Cares|UCB|+1844599|UCBCares@ucb.com|2273
22443143|NCT01779219|Wroclaw University Hospital, Department of Neurosurgery|Dr. Marcin Czyz|+48 734-34-00|mt.czyz@gmail.com|
22443144|NCT00428584|EMD Serono, Inc.|Fernando Dangond, MD|781-681-2348|fernando.dangond@emdserono.com|
22443145|NCT03259620|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
22443146|NCT00336583|Asan Medical Center|Cheolwon Suh|82 2 3010 3209|csuh@amc.seoul.kr|
22443147|NCT00003830|NSABP Foundation, Inc|Director, Department of Regulatory Affairs|412-339-5300|regulatory@nsabp.org|
22443148|NCT00883688|The University of Texas (UT) MD Anderson Cancer Center|MD Anderson Multicenter coordinating for Collaborative Ependymoma Research Network Study (CERN)||CR_Study_Registration@mdanderson.org|
22443149|NCT04461600|Ayala Pharmaceuticals|Chief Medical Officer|+1-857-444-0553|info@ayalapharma.com|
22443150|NCT01661088|University of Michigan Rogel Cancer Center|Mark Zalupski, M.D.|734-647-8902|zalupski@med.umich.edu|
22443151|NCT00704522|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22443152|NCT00636220|Chembio Diagnostic Systems, Inc.|Javan Esfandiari|(631) 924-1135|jesfandiari@chembio.com|112
22443153|NCT04896229|Oregon Research Behavior Intervention Strategies, Inc. dba Influents Innovations|David Smith|541-484-2123|david.smith@influetnsin.com|
22443154|NCT04395001|Wake Forest School of Medicine|Dennis C. Ang|3367058701|dang@wakehealth.edu|
22443155|NCT00635024|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
22443156|NCT01958489|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22443157|NCT00992589|Janssen R&D US|PORTFOLIO/CDT LEADER|1 609 730-2548||
22443158|NCT00045942|Novartis|Study Director|862-778-8300||
22443159|NCT05508074|InFlectis Bioscience|Beatrice Lejeune|+33 668919060|beatricelejeune@inflectisbioscience.com|
22443160|NCT02142387|Laboratory of Emergency Medical Services, Seoul National University Hospital Biomedical Research Institute|Dr. Gwan Jin Park|82-10-7477-3293|pkj83531@naver.com|
22443161|NCT01101308|Purdue Pharma L.P.|Stephen Harris, MD|203-588-7592|Stephen.Harris@Pharma.com|
22443162|NCT02984943|David Grant Medical Center, Travis Air Force Base|Dr. Michelle Sit|707-423-3875|michelle.t.sit.mil@mail.mil|
22443163|NCT00799773|New England Research Institutes, Inc.|Susan F. Assmann, PhD|617-923-7747|sassmann@neriscience.com|548
22443164|NCT02282345|UT MD Anderson Cancer Center|Dr. Jennifer Litton,VP, Clinical Research, VP Clinical Research|(713) 792-2817|jlitton@mdanderson.org|
22443165|NCT02296138|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22443166|NCT00711516|Cephalon, Inc.|Sponsor's Medical Expert, Clinical Research|1-800-896-5855||
22443167|NCT04575597|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22443168|NCT01280201|Group for Neuroendocrine Tumors (GETNE)|Dr. Enrique Grande (Hospital Universitario Ramón y Cajal)|931780742|getne@getne.org|201
22443169|NCT02095132|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22443170|NCT01981057|Medical University of Vienna|Nadja Haiden M.D.|+4314040032320|nadja.haiden@meduniwien.ac.at|
22443171|NCT04905498|University of Kansas Medical Center|Amanda S. Bruce|4014990576|abruce2@kumc.edu|
22443172|NCT01029405|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22443173|NCT01268579|Memorial Sloan Kettering Cancer Center|Dr. David Pfister MD|646-888-4237|pfisterd@MSKCC.ORG|
22443174|NCT03312751|Swedish Orphan Biovitrum AG|Radmila Kanceva, MD, Medicine Development Lead|+41 793048899|Radmila.Kanceva@sobi.com|
22443175|NCT02692651|University of Michigan|Krishna Rao|734 615-9730|krirao@med.umich.edu|
22443176|NCT03490981|VA Center for Integrated Healthcare|Dr. Gregory P. Beehler, Associate Director of Research|716-862-7934|gregory.beehler@va.gov|
22443177|NCT02324543|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University|Dung Le, MD|443-287-0002|dle@jhmi.edu|
22443178|NCT02480712|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22443179|NCT01860846|AbbVie|Global Medical Services|800-633-9110||
22443180|NCT00466687|Vanderbilt-Ingram Cancer Center|Jeffrey Sosman, M.D.||jeff.sosman@vanderbilt.edu|
22443181|NCT02586506|GlaxoSmithKline|GSK Response Center|866-435-7343||
22443182|NCT00770146|Genzyme Corporation|Genzyme Medical Information|617-252-7832||
22443183|NCT01525901|Icahn School of Medicine at Mount Sinai|Alexander Kolevzon, MD|(212) 659-9134|alexander.kolevzon@mssm.edu|
22443184|NCT01509053|Otsuka Pharmaceutical Development & Commercialization, Inc.|Medical Affairs|800-562-3974||
22443185|NCT03208985|HRA Pharma|Christine VENARD|+33184139244|c.venard@hra-pharma.com|
22443186|NCT01284491|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com|
22443187|NCT01978938|La Jolla Pharmaceutical Company|Chief Development Officer|617-715-3600|ljpcregulatory@ljpc.com|
22443188|NCT02694757|11 Health|Michael Seres|+16572660570|michael@11health.com|
22443189|NCT02650921|Galderma Research & Development, LLC|Assoc Director of Clinical Operations|817-961-5000|courtney.maguire@galderma.com|
22443190|NCT00783302|GE Healthcare|Paul Gordon, PhD|011-47-2318-5822|paul.gordon@ge.com|
22412014|NCT00717756|BrUOG|Howard Safran, MD|4018633000|Hsafran@lifespan.org|
22428840|NCT04298853|Indiana University School of Medicine|Anna Thomas, MD|317-944-9392|aeschwar@iu.edu|
22428841|NCT04550936|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22428842|NCT03301714|Kornber School of Dentistry|Dr. Marisol Tellez Merchan|2177071773|marisol@temple.edu|
22428843|NCT03188185|Alkermes|Eva Stroynowski|781-609-7000|eva.stroynowski@alkermes.com|
22428844|NCT02965456|Bausch Health Americas, Inc.|Clinical Operations Director|1-510-259-5284|aloncaric@bauschhealth.com|
22428845|NCT05073315|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22428846|NCT01529268|Johns Hopkins Data Coordinating Center|Laura Wilson|410-955-0719|lwilson9@jhu.edu|
22428847|NCT00303953|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623|mleblanc@fhcrc.org|
22443191|NCT01087788|Cares|UCB|+1877 822||9493
22428848|NCT04465955|NGM Biopharmaceuticals|VP, Clinical Operations|(650)243-5555|ngm282@ngmbio.com|
22443192|NCT01806662|Rockefeller University|James Krueger|2123278333|gilleap@mail.rockefeller.edu|
22443193|NCT00043550|Adelphi University, The Derner Institute of Advanced Psychological Studies|Jacques P.Barber, PhD, Dean and Professor|516.877.4807|jbarber@adelphi.edu|
22443194|NCT01917656|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22443195|NCT02285062|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22443196|NCT00436501|UT MD Anderson Cancer Center, Office of Multicenter Clinical Research|Robert Coleman, MD / Professor||RColeman@mdanderson.org|
22443197|NCT00714571|VA Ann Arbor Healthcare System|Dr. Benjamin M. Hampstead|734-763-9259|Benjamin.Hampstead@va.gov|
22443198|NCT01872325|Ottawa Hospital Research Institute|Dr. Christian Vaillancourt|613-798-5555|cvaillancourt@ohri.ca|17012
22443199|NCT01390064|University of Arkansas for Medical Sciences|Dr. Laura Hutchins|5016868274|hutchinslauraf@uams.edu|
22443200|NCT04850781|Johns Hopkins University|Kali Thomas|(410) 955-4766|kali.thomas@jhu.edu|
22443201|NCT03011892|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22443202|NCT00608569|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22443203|NCT00562315|Emory University|David M. Schuster, MD|404-712-4859|dschust@emory.edu|
22443204|NCT03381729|Novartis Gene Therapies EU Limited|EMEA Medical Information|+353 (1) 566-2364|medinfoemea.gtx@novartis.com|
22443205|NCT04456153|UT Southwestern Medical Center|Dr. Mamta K. Jain|2140648-9914|mamta.jain@utsouthwestern.edu|
22443206|NCT03758755|Inova Health System|Dr. Edward Chang|571-472-0464|edward.chang@inova.org|
22443207|NCT03848871|Skin Sciences, PLLC|Maureen McAllister|5024519000|mmdermresearch@yahoo.com|
22443208|NCT02000908|University of Minnesota|Peter Argenta MD|612-626-3111|argenta@umn.edu|
22443209|NCT02312687|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
22443210|NCT00878436|NYU Langone Medical Center|Fraustina Hsu|646 754 712|fraustina.hsu@nyumc.org|
22443211|NCT00906971|Universidade Federal de Pernambuco|Carlos André Gomes Silva|+55 83 9913-4949|carlosandrejpa@hotmail.com|
22443212|NCT00545129|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22443213|NCT03678870|Vanderbilt University Medical Center|Sarah Osmundson, Assistant Professor of Obstetrics and Gynecology|(615) 343-7869‬|sarah.osmundson@vumc.org|
22443214|NCT03127098|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22443215|NCT03104816|USCalifornia|Eugenia Ayrian|8186363161|eayrian@med.usc.edu|
22443216|NCT01426789|Novartis Pharmaceuticals|Study Director|862-778-8300||
22443217|NCT01629771|Northwestern University|Clinical Trials Unit Coordinator|312-695-6829|j-bae@northwestern.edu|
22443218|NCT01895361|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22443219|NCT02677324|DFCI|Jorge J. Castillo|617-632-2681|jorgej_Castillo@dfci.harvard.edu|
22443220|NCT00282464|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22443221|NCT00475423|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22443222|NCT05463198|Zynex Monitoring Solutions|ZMS Clinical|800-495-6670|clinical@zynexmonitoring.com|
22443223|NCT01214174|Icon Bioscience, Inc.|Wendy Murahashi, MD|650-369-4049|wendymurahashi@iconbioscience.com|
22443224|NCT01856764|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22383726|NCT04071756|Dana-Farber Cancer Institute|Nicole LeBoeuf, MD, MPH|617-632-6571|nicole_leboeuf@dfci.harvard.edu|
22383727|NCT03567252|University of Kentucky|Ann Koempel|(859) 257-3800|ann.koempel@uky.edu|
22383728|NCT02622568|University of Texas Southwestern|Dr. Nnenna Agim|2144561631|Nnenna.Agim@childrens.com|
22443225|NCT02239120|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22383729|NCT00324350|University of California, San Francisco|Dr. Ann Schwartz|415-514-8000|aschwartz@psg.ucsf.edu|
22383730|NCT00439413|National Institute on Drug Abuse|Liza Zeinert|301-443-1138|liza.zeinert@nih.gov|
22383731|NCT02015520|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
22383732|NCT03285542|Cleveland Clinic|Viktor Krebs|216-445-3843|krebsv@ccf.org|
22383733|NCT04059042|University of Kansas Medical Center|Dr. Rebecca Lepping|913-588-0287|rlepping@kumc.edu|
22383734|NCT00335036|Children's National|Charles Berul, MD|202-476-5710|cberul@childrensnational.org|
22383735|NCT00415519|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22428849|NCT02393755|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
22428850|NCT05324371|Boston Scientific|Nilou Zilinek|508-683-6127|nilou.zilinek@bsci.com|
22428851|NCT04822194|Rice University|Bryan Denny|713-348-8257|bryan.denny@rice.edu|
22428852|NCT05182125|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
22428853|NCT04057768|Venus Concept|Clinical Research Manager|888-907-0115|rmays@venusconcept.com|
22383736|NCT04163718|Moffitt Cancer Center|Javier Pinilla, MD, PhD|813-745-8212|javier.pinilla@moffitt.org|
22383737|NCT05608564|School Of Dental Medicine, University Of Belgrade, Department of Periodontology and Oral Medicine|Assistant Professor Dr. Iva Milinkovic|+381642041811|iva.milinkovic@gmail.com|
22383738|NCT01985334|Novartis Pharmaceuticals|Study Director|862-778-8300||
22383739|NCT05529979|quantum surgical|MESSNER Laetitia, Chief Clinical officer|0448194050|clinical.department@quantumsurgical.com|
22383740|NCT00093015|Amgen Inc.|Study Director|866-572-6436||
22383741|NCT00895531|University Louisville|Nancy Alsip|502-852-2905|nlalsi01@exchange.louisville.edu|
22383742|NCT03403413|Loui9s Stokes Cleveland VAMC|Dr. Stephen Selkirk|440-552-0493|stephen.selkirk@va.gov|
22383743|NCT02924064|Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please e-mail|cti-inq-ml.JP@ml.tanabe-pharma.com|
22383744|NCT03501264|University of Pittsburgh, Graduate School of Public Health|James Egan|412-624-2255|jee48@pitt.edu|
22383745|NCT00529100|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22383746|NCT02253537|QIAGEN Sciences|Clinical Study Coordinator|301-944-7094|andrew.schumacher@qiagen.com|
22383747|NCT05082116|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22383748|NCT01468584|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22383749|NCT04982315|Kaiser Permanente Washington|Andrea Cook, PhD - Principal Investigator|206-287-4257|andrea.j.cook@kp.org|
22383750|NCT03811535|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22383751|NCT00957242|University of Chicago Hospital|Imre Noth, MD, Associate Professor of Medicine|773-834-1832|inoth@medicine.bsd.uchicago.edu|
22383752|NCT05364684|Massachusetts General Hospital|Dr. Laura E. Dichtel|6177263870|ldichtel@mgh.harvard.edu|
22383753|NCT00781274|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22383754|NCT05675046|Sonex Health, Inc.|Amy Stegner, Vice President Clinical Affairs|(888) 518-8780|astegner@sonexhealth.com|
22383755|NCT02346526|Massachusetts General Hospital|Philip Saylor, MD|617-724-5197|psaylor@mgh.harvard.edu|
22383756|NCT01381406|GlaxoSmithKline|GSK Response Center|866-435-7343||
22383757|NCT00194896|University of Washington|Jerry P. Palmer, MD|206-764-2495|jpp@u.washington.edu|
22383758|NCT00861692|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22383759|NCT06429163|Saint-Petersburg State University|Nikita S. Kharlov|+7 926 283-93-77|nikita.kharlov@gmail.com|
22383760|NCT01626885|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22383761|NCT05914519|faculty of medicine sohag university|Ahmed Sabri mahmoud|201061691091|sabriahmed188@gmail.com|
22383762|NCT01466192|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22383763|NCT00856739|Stanford University, Palo Alto Veterans Hospital|Dr. Thomas P. Andriacchi, Ph.D.|650-723-8024|tandriac@stanford.edu|
22383764|NCT02321514|Abbott|Karine Miquel, PhD|+32 479 600 107|karine.miquel@abbott.com|
22383765|NCT00591214|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22383766|NCT03359889|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22383767|NCT03671811|City of Hope|Paul Frankel, Ph.D.|6262185265|pfrankel@coh.org|
22383768|NCT04992390|P1vital Products Ltd|Dr Amy Beckenstrom|+44(0)1865 522 030|abeckenstrom@p1vital.com|
22383769|NCT06938230|University of Miami|Dr. Lisa Gwynn|305-243-3440|LGwynn@med.miami.edu|
22383770|NCT05096819|Oxford University Hospitals|Dr Elizabeth Orchard|01865 741166|elizabeth.orchard@ouh.nhs.uk|
22383771|NCT03324984|Montefiore Medical Center|Dr. Elilary Montilla Medrano|929-263-3302|emontill@montefiore.org|
22383772|NCT04541043|Calliditas Therapeutics|Clinical Program Leader|0737456451|kristin.onnestam@calliditas.com|
22383773|NCT03358875|BeiGene|Study Director|1-877-828-5568|Clinicaltrials@beigene.com|
22383774|NCT01563341|Mayo Clinic|Ryan J. Uitti, MD|904-953-2000|uitti.ryan@mayo.edu|
22383775|NCT04337372|University of Florida|Lisa Scott|352-273-2125|lscott@ufl.edu|
22383776|NCT03494504|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
22383777|NCT04832360|University of Georgia|Dr. Michelle vanDellen|706-542-8991|mvd@uga.edu|
22383778|NCT06375421|Vanderbilt University Medical Center|Dr. Emily Morrow|6153228392|emily.morrow@vumc.org|
22428854|NCT01257438|Bard Peripheral Vascular|Josh Smale, Associate Director Clinical Affairs|(480) 603-8140|Josh.Smale@crbard.com|
22383779|NCT05273723|Northwell Health|Karina Davidson|(516) 562-3467|kdavidson2@northwell.edu|
22443226|NCT01499862|Department of Physical Therapy and Rehabilitation, University of California San Francisco|Dr. Nancy N. Byl|415-514-4816|byln@ptrehab.ucsf.edu|
22383780|NCT03584516|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22428855|NCT02965833|Alcon, A Novartis Division|Head, CDMA Vision Care Franchise|1-888-451-3937|alcon.medinfo@alcon.com|
22428856|NCT02085551|Penumbra, Inc.|Michaella Corso|+1 510-995-2079|mcorso@penumbrainc.com|
22428857|NCT03370302|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22428858|NCT00118287|Fred Hutchinson Cancer Research Center|Bart Scott|206-667-1990|bscott@fredhutch.org|
22428859|NCT04738487|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22428860|NCT03976375|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22428861|NCT04818112|University of Arizona|Dr. Aleeca Bell|5206260575|aleecab@arizona.edu|
22428862|NCT03091439|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22428863|NCT03122106|Washington University School of Medicine|William Gillanders, M.D.|314-747-0072|gillandersw@wustl.edu|
22428864|NCT04017962|Memorial Sloan Kettering Cancer Center|Dr. Genovefa Papanicolaou, MD|212-639-6483|papanicg@mskcc.org|
22428865|NCT05172570|Indiana Univeristy School of Medicine|Randomized prospective study comparing variable Gabapentin dosages for postoperative analgesia follo|317-274-0275|yyeap@iupui.edu|
22428866|NCT00640289|Children's Hospital of Orange County|Clinical Trial Coordinator||KBirschbach@choc.org|
22428867|NCT04507321|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22428868|NCT03550209|Nationwide Children's Hospital|Dr. Sarah Keim|1-800-792-8401|sarah.keim@nationwidechildrens.org|52849
22428869|NCT00768053|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22428870|NCT01590875|Medical College of Wisconsin|Marcie Berger, MD|414-955-6806|mgberger@mcw.edu|
22428871|NCT01202591|Astrazeneca|Richard Mather|+44 1763 263593|ClinicalTrialTransparency@astrazeneca.com|
22428872|NCT04882709|Sonova Canada Inc.|Dr. Jinyu Qian|6472624826|jinyu.qian@sonova.com|
22428873|NCT06048068|Columbia University Irving Medical Center|Dr. Sachin Agarwal, MD MPH|212-305-7236|sa2512@cumc.columbia.edu|
22428874|NCT00632359|The University of Texas (UT) MD Anderson Cancer Center|Alessandra Ferrajoli, Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
22428875|NCT04253626|Stanford University|Deirdre J. Lyell, MD|(650) 498-4069|dlyell@stanford.edu|
22428876|NCT03599713|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22428877|NCT05578872|Anaveon AG|Medical Director, MD|+41615218383|anaveonclinicaltrials@anaveon.com|
22428878|NCT05643794|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22428879|NCT04941898|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22428880|NCT03641924|Corporal Michael J. Crescenz VAMC|Dr. James Cobb Scott|2158235800|James.Scott2de50a@va.gov|207138
22428881|NCT00587457|MedImmune, LLC.|Mark C Lanasa|301-398-0000|clinicaltrialenquiries@medimmune.com|
22428882|NCT01022580|University of California, San Francisco|Roberta A Ballard, MD|415-476-4193|roberta.ballard@ucsf.edu|
22428883|NCT03439839|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22428884|NCT03720847|University of North Carolina at Chapel Hill|Tory Eisenlohr-Moul|859-317-0503|moul@med.unc.edu|
22428885|NCT01500096|Johns Hokpins University|Adriana Andrade|410-955-7287|aandrade@jhmi.edu|
22428886|NCT05124184|W. L. Gore & Associates|Austin Phillips|+1 928 864 3641|agphilli@wlgore.com|
22428887|NCT03033901|James A. Haley Veterans' Hospital|Risa Richardson, PhD|813-972-2000|Risa.Richardson@va.gov|5309
22428888|NCT03096353|National Center for Complementary and Integrative Health|Catherine Bushnell|+1 301 496 2222|mary.bushnell@nih.gov|
22428889|NCT00924651|University of Rochester Medical Center|Karen M. Mustian, PhD, MPH, Associate Professor|585-273-1796|Karen_Mustian@urmc.rochester.edu|
22428890|NCT00723944|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
22428891|NCT00835978|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22428892|NCT02927145|University of Oxford|Dr Angela Minassian|0044 01865611425|angela.minassian@ndm.ox.ac.uk|
22428893|NCT03298061|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22428894|NCT05027282|Bausch Health Americas, Inc|Study Director|19083009920|susan.harris@bauschhealth.com|
22428895|NCT02506036|Johns Hopkins University School of Medicine|Dr. Argye Hillis|410-614-2381|argye@jhmi.edu|
22428896|NCT04119336|Massachusetts General Hospital|Andrew Yee, MD|617-724-4000|AYEE1@mgh.harvard.edu|
22428897|NCT01410604|Hospital Regional de Alta Especialidad del Bajio|M.D. Maria L. Evia-Viscarra|+52 (477) 267-2000|evialola@hotmail.com|1405
22428898|NCT01733888|DMG Dental Material Gesellschaft|Manager Clinical Research|+494084006|clinicalresearch@mtcompanies.com|0
22428899|NCT02383173|Birmingham VA Medical Center|Kathryn L. Burgio, PhD|205-558-7064|kburgio@uabmc.edu|
22428900|NCT00886236|Medical University of South Carolina|Larry Field|843-876-5744|field@musc.edu|
22428901|NCT00800540|Alcon Research, Ltd.|Director, Global Medical Affairs|1-888-451-3937||
22428902|NCT00429299|GlaxoSmithKline|GSK Response Center|866-435-7343||
22428903|NCT04871113|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22428904|NCT01239745|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22428905|NCT01565551|University of California, San Francisco|Geoffrey Manley, MD, PhD|415-206-8300|manleyg@neurosurg.ucsf.edu|
22428906|NCT00315822|Cleveland Clinic|Daniel Sessler, MD|216-444-4900|sessled@ccf.org|
22428907|NCT02143778|Exalenz Bisocience|Clinical Trial Manager|97289737500|avrahamh@exalenz.com|
22428908|NCT05630755|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22428909|NCT02969018|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22428910|NCT04502524|Fred Hutchinson Cancer Center|Jaimee Heffner, Ph.D., Associate Professor|206.667.7314|jheffner@fredhutch.org|
22428911|NCT00363168|Johns Hopkins University|Neil M. Bressler|410-955-8342|nbressler@jhmi.edu|
22383781|NCT04500301|Wake Forest|Danielle M Boselli|2017903385|Danielle.Boselli@AtriumHealth.org|
22397909|NCT02424526|Sacramento State|Katrin Mattern-Baxter, PT, DPT|19162785766|kbaxter@csus.edu|
22443227|NCT01535976|Northwestern University|Gildasio De Oliveira MD|312-472-3573|g-jr@northwestern.edu|
22443228|NCT00420641|GlaxoSmithKline|GSK Response Center|866-435-7343||
22443229|NCT01653028|Memorial Sloan Kettering Cancer Center|Mark Andrew Dickson M.D.|6468884164|dicksonm@mskcc.org|
22443230|NCT00181623|Massachusetts General Hospital|Corrine Welt, MD|617-716-8437|cwelt@partners.org|
22443231|NCT00684047|Grifols Biologicals Inc.|Paul Pinciaro|443-375-8825|Paul.Pinciaro@grifols.com|
22443232|NCT01361854|CHU St Pierre|Dr Marie Bruyneel|003225354219|Marie_BRUYNEEL@stpierre-bru.be|
22443233|NCT02815280|Foamix Pharmaceuticals, Inc.|Iain Stuart, PhD.|1 800-775-7936|Iain.Stuart@foamix.com|
22443234|NCT01367080|Dong Wha Pharm. Co. Ltd.|Cheol-Hee Lim. Clinical Research Manager (CRM)|+82-2-2021-9300|cheolhee.lim@dong-wha.co.kr|551
22443235|NCT00603642|Amgen Inc.|Study Director|866-572-6436||
22443236|NCT00040846|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org|
22443237|NCT00654147|University of Miami School of Medicine|Director AIDS Clinical Research Unit|305-243-3838|mfischl@med.miami.edu|
22443238|NCT00853996|University of Kansas Mecical Center|Bruce F. Kimler Ph.D|913-588-4523|bkimler@kumc.edu|
22443239|NCT01607203|AZ JAN PALFIJN|dr.Decleer Wim|+32 9 325 92 20|wim.decleer@janpalfijngent.be|092248851
22443240|NCT01944839|Ophthotech|Denise Teuber||denise.teuber@ophthotech.com|
22443241|NCT00609362|University of Aarhus|Torben Harsløf, MD|+4589497681|torbhars@rm.dk|
22443242|NCT05093790|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22443243|NCT00548405|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22443244|NCT01229462|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22443245|NCT01476202|GlaxoSmithKline|GSK Response Center|866-435-7343||
22443246|NCT01624870|Medtronic Bakken Research Center|Maarten Hollander|+31620534428|maarten.hollander@medtronic.com|
22443247|NCT00641316|University of Alabama at Birmingham|Nicolaas Geurs, DDS,MS|2059344506|ngeurs@uab.edu|
22443248|NCT05027971|Boston Scientific|Winnie Chen|952-930-6000|FlexivaPulseRegistry@bsci.com|
22443249|NCT02025556|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22443250|NCT00081861|U.T. M.D. Anderson Cancer Center|Barbara Pro, MD / Associate Professor||CR_Study_Registration@mdanderson.org|
22443251|NCT02582684|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22443252|NCT01878149|Baxano Surgical®|Sr. Director of Clinical Affairs|919.899.9760|teresa.schroeder@baxsurg.com|
22443253|NCT02548728|University of North Carolina at Chapel Hill|Cort Pedersen, MD|919-923-3284|cort_pedersen@med.unc.edu|
22443254|NCT04672252|NYU Langone Health|Michael J. Alaia, MD|(646) 501-7223|Michael.Alaia@nyulangone.org|
22443255|NCT01587898|GlaxoSmithKline|GSK Response Center|866-435-7343||
22443256|NCT00796991|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22443257|NCT01764919|Biomed valley discoveries|Dr. Michelle Zhang, Executive Director|7815339412|mzhang@biomed-valley.com|
22443258|NCT02199717|Hospital for Sick Children|Vanessa Bouskill NP|4168135871|vanessa.bouskill@sickkids.ca|
22443259|NCT02437110|National Institutes of Health|Dr. Avi Nath|301-496-1561|natha@mail.nih.gov|
22443260|NCT00171834|Novartis Pharmaceuticals|Study Director|862-778-8300||
22443261|NCT01261780|University of Wisconsin Carbone Cancer Center|Toby Campbell|608-263-3962|tcc@medicine.wisc.edu|
22443262|NCT01239732|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22443263|NCT00927940|Medtronic Japan Co.,Ltd|Hiroko Okubo|+81-3-6430-7017|rs.medtroniccardiovascularclinicaltrials@medtronic.com|
22443264|NCT03007888|Impax Laboratories, LLC|Pamela Fitzpatrick, Director, Specialty Regulatory Affairs|631-633-2104|pfitzpatrick@amneal.com|
22443265|NCT03493932|Emory University|Edjah K. Nduom, MD, FAANS|404-778-5770|edjah.k.nduom@emory.edu|
22443266|NCT04658940|Acutus Medical|Karen Stephens, Director Clinical Affairs|442-232-6080|karen.stephens@acutus.com|
22443267|NCT01479426|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Jong-Kwan Park, MD|82-63-276-8284|rain@chonbuk.ac.kr|
22443268|NCT03471624|Stanford University|Mindie H Nguyen, Professor of Medicine, GI & Hepatology, Liver Transplant|650-498-6084|mindiehn@stanford.edu|
22443269|NCT00827931|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22443270|NCT02015221|Tactile Medical|Director of Clinical Research|6123555121|shoy@tactilemedical.com|
22443271|NCT03579602|Blaze Bioscience|Dr. Kristi Harrington|206-535-8144|Clinical.trials@blazebioscience.com|
22443272|NCT01306929|Prilenia|Prilenia|+972 775558|info@prilenia.com|482
22443273|NCT01870076|Shriners Hosptials for Children|Laura Fowler/Clinical Research Coordinator|513-872-6000|lfowler@shrinenet.org|6249
22383782|NCT03702725|Dana Farber Cancer Institute|Dr. Jacob P. Laubach|617-632-4218|jacobp_laubach@dfci.harvard.edu|
22443274|NCT03041129|University of Colorado|Melanie Cree-Green, PI|720-777-5743|melanie.green@childrenscolorado.org|
22443275|NCT03608150|Luminopia, Inc.|VP of Clinical Development|9788067080|endri@luminopia.com|
22443276|NCT04355728|University of Miami|Camillo Ricordi|305-243-6913|ricordi@miami.edu|
22443277|NCT00483756|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22443278|NCT01453387|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22383783|NCT06839378|Tsinghua Changgung Hospital|Yan Li, Director of the Department of Peritoneal Oncology|+86 18612709123|lya03816@btch.edu.cn|
22383784|NCT05760313|AbbVie|ABBVIE CALL CENTER|844-663-3742|abbvieclinicaltrials@abbvie.com|
22383785|NCT00956007|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
22443279|NCT00729846|California Retina Consultants|Director of Research|8059631648|gabe@californiaretina.com|3034
22443280|NCT00807573|Memorial Sloan Kettering Cancer Center|Dr. Maria Pietanza, Assistant Attending|+1646-888-4203|PietanzM@mskcc.org|
22443281|NCT04545944|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-PHAT (7428)|medicalinformation@phathompharma.com|
22443282|NCT00223236|The University of Texas Southwestern Medical Center|E. Sherwood Brown, M.D., Ph.D., Professor|214-645-6950|sherwood.brown@utsouthwestern.edu|
22443283|NCT01007253|The University of Chicago|Dr. Robert M. Naclerio, MD|(773) 702-1865|rnacleri@surgery.bsd.uchicago.edu|
22443284|NCT00123643|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu|
22443285|NCT01159431|UCLA|Dr. Christopher DeGiorgio|310-206-3753|cmd@mednet.ucla.edu|
22443286|NCT03976648|Galapagos NV|Galapagos Medical Information|+32 15 342900|medicalinfo@glpg.com|
22443287|NCT03645434|AstraZeneca AB|AstraZeneca AB|1-877-400-4656|clinicaltrialtransparency@astrazeneca.com|
22443288|NCT00881868|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
22443289|NCT02076425|Early Emotional Development Program at Washington University School of Medicine|Dr. Joan Luby|3142862730|lubyj@wustl.edu|
22443290|NCT02880956|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22443291|NCT02081859|Cleveland Clinic|Lynn Borzi (Research Administrator)|216-445-3158|BORZIL@ccf.org|
22383786|NCT05228470|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22383787|NCT05552963|Janssen Research and Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22383788|NCT01471691|Thomas Hanscom AMC|Thomas O'Hearn MD|310-829-3303|tohearn@gmail.com|
22383789|NCT01808339|GlaxoSmithKline|GSK Response Center|866-435-7343||
22383790|NCT02131597|The University of Texas MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/ Professor|713-745-3428|ggarciam@mdanderson.org|
22383791|NCT05054725|Revolution Medicines|Vice-President Clinical Operations|650-779-2300|RMC-4630-01@revmed.com|
22383792|NCT03674411|University of Minnesota, Masonic Cancer Center|Dr. Margaret MacMillan|(612) 626-5654|macmi002@umn.edu|
22383793|NCT00780910|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22383794|NCT01753557|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22383795|NCT05018910|University of New Mexico|Jessie Maxwell, MD, MBA|505-272-3967|JRMaxwell@salud.unm.edu|
22383796|NCT04929483|89bio, Inc.|Clinical Director|1-858-261-8838|bio89-100-122@89bio.com|
22383797|NCT04395222|Weill Cornell Medicine|Alexandra Gomez Arteaga, MD|646-962-7950|alg9117@med.cornell.edu|
22383798|NCT04083781|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22383799|NCT01143337|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22383800|NCT04661410|The WELL Center|Dr. Adrienne Juarascio|443-801-8093|asj32@drexel.edu|
22383801|NCT05600283|Mayo Clinic|Dr. Kathy MacLaughlin|507-266-4648|maclaughlin.kathy@mayo.edu|
22383802|NCT00068601|SWOG Statistics and Data Management Center|Cancer Survivorship Committee Statistician|206-667-4623||
22383803|NCT01061671|University of Minnesota|Sarah Lindberg|612-626-9011|sharnden@ccbr.umn.edu|
22383804|NCT02468128|Lumosa Theapeutics|Director of clinical Division|+886 2 26557918|June_Kuo@lumosa.com.tw|5702
22383805|NCT00440011|Allergan, Inc.|Vice President Medical Affairs|(714)246-4500|clinicaltrials@allergan.com|
22383806|NCT01503749|Seoul National University Hospital|Pf. Jung-Hwan Yoon|82-2-2072-2228|yoonjh@snu.ac.kr|
22383807|NCT01172418|University of Miami|George W. Burke, M.D.|305-355-5315|gburke@med.miami.edu|
22383808|NCT00419341|CSL Behring|Clinical Trial Disclosure Manager|Use email contact.|clinicaltrials@cslbehring.com|
22383809|NCT00331136|Medicines for Malaria Venture|Stephan Duparc, MD|+41 22 555 0300|duparcs@mmv.org|
22383810|NCT00621296|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22383811|NCT04166058|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22383812|NCT02998528|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22383813|NCT02692417|University of Michigan|Dr. Tim Bruns|(734) 647-8727|bruns@umich.edu|
22383814|NCT00282971|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22383815|NCT00629850|Texas State Respiratory Care Department|Chris Russian, Associate Professor|512-245-3794|cr23@txstate.edu|
22383816|NCT01753570|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22383817|NCT05308316|Masonic Cancer Center|Dr. Irina Stepanov|612-624-4998|stepa011@umn.edu|
22383818|NCT00475241|VA Ann Arbor Healthcare System|Dr. Sheila A.M. Rauch|734-845-3545|sherauch@med.umich.edu|
22383819|NCT03188692|Tanabe Pharma Corporation / The Research Foundation for Microbial Diseases of Osaka University|Clinical Trials, Information Desk|Please email|cti-inq-ml.JP@ml.tanabe-pharma.com, clinicaldevelopment@mail.biken.or.jp|
22383820|NCT03997916|University Hospitals Cleveland Medical Center|Eric Yeh, MD|216-844-1867|eric.yeh@uhhospitals.org|
22383821|NCT04220229|City of Hope|Lee Cranmer, MD, PhD|626-256-4673|lcranmer@coh.org|
22383822|NCT04917588|CROMA - PHARMA|Head of Clinical Operations|+43 0226268468|clinical.studies@croma.at|
22383823|NCT04919590|Truth Initiative|Dr. Amanda Graham|202-525-6473‬|vapestudy@truthinitiative.org|
22383824|NCT04192747|Elixir Medical Corporation|Tina Cordaro, Sr. Director, Clinical Trials|585-360-7270|tcordaro@ElixirMedical.com|
22383825|NCT04310735|The Pennsylvania State University|Stephen Wilson|8148656219|sjw42@psu.edu|
22383826|NCT03012841|Medtronic|Mary Sauline, Clinical Research Specialist|440-596-3529|mary.k.sauline@medtronic.com|
22383827|NCT05696080|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22383828|NCT03398200|University of Rochester|Omar Aljitawi, MD|(585) 275-4099|Omar_Aljitawi@URMC.Rochester.edu|
22383829|NCT04065048|Case Western Reserve University|Abigail Raffner Basson, Principal Investigator & Study Coordinator|2163276003|axb860@case.edu|
22383830|NCT03397108|The Hospital for Sick Children|Dr. Shinya Ito|4168135776|shinya.ito@sickkids.ca|
22383831|NCT00880425|Thomas Jefferson University|Jessica Ailani, MD/ Headache Fellow|631-807-8194|Jessica.Ailani@gmail.com|
22383832|NCT04607044|Stryker|Monica Fleeman|251-465-5969|monica.fleeman@stryker.com|
22412015|NCT00673790|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22443292|NCT00884377|Walter Reed Army Medical Center|Dr. Naomi Aronson, Principal Investigator|202-782-8691|naronson@usuhs.mil|
22443293|NCT05347147|Executive Director Invex Australia|Tom Duthy|+61 (08) 6382 0137|tduthy@invextherapeutics.com|
22412016|NCT01873859|Cardiovascular research center, Shahid Beheshti University of Medical Sciences|Dr. Saeed Alipour Parsa, director of clinical trial|+9821 2208 3106|s_alipour@sbmu.ac.ir|
22443294|NCT01206387|Taro Pharmaceuticals U.S.A., Inc|Director, Clinical Research|914-345-9001|natalie.yantovskiy@taro.com|
22443295|NCT01276197|CHOIR|Dr. Thomas K. Houston|781-687-2884|thomas.houston2@va.gov|
22443296|NCT03718299|Sun Pharmaceutical Industries Limited|Head-Clinical Development|2266455645|clinical.trials@sunpharma.com|5689
22443297|NCT00334074|Baylor University Medical Center|Dr. Edward Agura|214-818-8472|Sandyli@baylorhealth.edu|
22443298|NCT04389970|University of Alabama at Birmingham|Brooks Wingo|2059345982|bcwingo@uab.edu|
22443299|NCT03123185|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22443300|NCT02153476|Allegro Ophthalmics, LLC|Director of Clinical Research|949-444-5722|lkarageozian@allegroeye.com|
22443301|NCT03702244|Heartflow Inc|Director, Clinical Operations|877-478-3569|whuey@heartflow.com|
22443302|NCT00253708|Beth Israel Deaconess Medical Center|Russell S. Phillips, MD|6174322222|Russell_phillips@hms.harvard.edu|
22443303|NCT00625703|University of Texas Southwestern Medical Center|Lus Stella Muniz, MD|214-648-3111|irb@utsouthwestern.edu|
22443304|NCT06400251|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22443305|NCT02217527|Univ of Pittsburgh|Dr. Kenneth A. Perkins, Prof of Psychiatry|412-246-5395|perkinska@upmc.edu|
22443306|NCT00787904|Emory University|Vin Tangpricha|404-727-7254|vin.tangpricha@emory.edu|
22443307|NCT05478681|The University of Texas Health Science Center at Houston|Kendra M Anderson, PhD|713-486-0513|Kendra.M.Anderson@uth.tmc.edu|
22443308|NCT01431300|Duke University Medical Center|Charles Kim|919-684-7284|charles.kim@duke.edu|
22443309|NCT06390839|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22443310|NCT01495676|INSTITUT REGIONAL DU CANCER DE MONTPELLIER|Mme Aurore Moussion, Director of Direction of Clinical Research and Innovation|0467613102|drci-icm105@icm.unicancer.fr|+33
22443311|NCT06054269|CDC|Perrine Marcenac|6782830242|pmarcenac@cdc.gov|
22443312|NCT01738477|GlaxoSmithKline|GSK Response Center|866-435-7343||
22443313|NCT00502203|UT MD Anderson Cancer Center|Lois M. Ramondetta, MD / Professor||CR_Study_Registration@mdanderson.org|
22443314|NCT02720094|HPTN Statistical & Data Management Center|HPTN Statistical Manager|206-667-4004|HPTN-Data-Access@scharp.org|
22443315|NCT02055638|Azevan Pharmaceuticals, Inc.|Dr. Neal Simon, CEO|(610) 419-1057|ngsimon@azevan.com|
22443316|NCT01911910|Queen Mary University London/ Barts Health NHS Trsut|Dr Mohammed Khanji|020 7363 8079|m.khanji@qmul.ac.uk|
22443317|NCT03735238|Baylor College of Medicine|Jasvinder Singh, MD, MPH; Senior Faculty and Chief of Immunology, Allergy, and Rheumatology|713.798.1365|jasvinder.md@gmail.com|
22443318|NCT02660138|Ipsen|Medical Director|See email|clinical.trials@ipsen.com|
22443319|NCT02971033|Edward Hines Jr. Veterans Administration Hospital|Susan L. Uprichard|(336) 402-1086|susan.uprichard@va.gov|
22443320|NCT00308581|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22443321|NCT02438475|Medstar Health Research Institute|Megan Rowland|202-877-2959|megan.e.rowland@medstar.net|
22443322|NCT00899353|Marshall University Joan C. Edwards School of Medicine|Dr. W. Elaine Hardman|304-696-3721|hardmanw@marshall.edu|
22443323|NCT04475198|SiteOne Therapeutics|John Mulcahy|+1 (650) 392-0419|john.mulcahy@site1therapeutics.com|
22443324|NCT01247298|University of Alabama at Birmingham (UAB)|Rojymon Jacob, MD|205-975-9704|rjacob@uabmc.edu|
22443325|NCT02489422|Wake Forest University Health Sciences|Study coordinator|336-716-9055|megreen@wakehealth.edu|
22443326|NCT00095147|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22443327|NCT02395302|Tactile Medical|Clinical Research Manager|(612)355-5123|mbroich@tactilemedical.com|
22443328|NCT04604132|Basilea Pharmaceutica International Ltd, Allschwil|Manuel Häckl, MD|+41 76 302 53 10|manuel.haeckl@basilea.com|
22443329|NCT00952380|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22443330|NCT03400956|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
22443331|NCT03235180|Mayo Clinic|Shigao Chen, Ph.D.|507-284-3703|Chen.Shigao@mayo.edu|
22443332|NCT02048241|New York State Psychiatric Institute|Stephen J. Donovan, MD|646-774-8078|sd45@columbia.edu|
22443333|NCT00534313|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22443334|NCT00402233|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22443335|NCT00300430|Abbott|Medical Information Specialist|800-633-9110||
22443336|NCT00492063|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22443337|NCT00495040|UT MD Anderson Cancer Center|Chang,Joe Y.,M.D. / Radiation Oncology|713-563-2337|jychang@mdanderson.org|
22443338|NCT01816451|University of Trás-os-Montes and Alto Douro|Ph.D. Laura Castro de Garay|+55 21 22275084|laura@virtualsoftware.com.br|
22443339|NCT01829243|Duke University Medical Center|Ashwin A. Patkar, MD|919-668-3626|ashwin.patkar@duke.edu|
22443340|NCT04157673|University at Buffalo|Leonard H. Epstein, PhD|7168293400|lhenet@buffalo.edu|
22443341|NCT02452931|Tolmar, Inc.|Vice President of Clinical Development|970-212-4500|info@tolmar.com|
22443342|NCT02282293|UCSF|Dr. Grant Dorsey|415-206-4680|grant.dorsey@ucsf.edu|
22443343|NCT00053898|NSABP Foundation, Inc|Director, Department of Regulatory Affairs|412-339-5300|regulatory@nsabp.org|
22443344|NCT03705273|Vanderbilt University School of Medicine|Donald H. Arnold, MD, MPH|16155790516|don.arnold@vumc.org|
22443345|NCT00830076|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22443346|NCT03985878|Sarepta Therapeutics, Inc.|Medical Director|1-888-SAREPTA (1-888-727-3782)|SareptAlly@sarepta.com|
22443347|NCT01894568|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22443348|NCT00599131|University of Michigan Comprehensive Cancer Center|Dr. Francis Worden|734-936-0453|fworden@umich.edu|
22443349|NCT01089361|Beth Israel Deaconess Medical Center|Dr. Daniel Talmor|617-754-2675|dtalmor@bidmc.harvard.edu|
22443350|NCT01514370|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22443351|NCT00169442|GlaxoSmithKline|GSK Response Center|866-435-7343||
22443352|NCT01439815|Ora|Caitlin Pearson|978-685-8900|cpearson@oraclinical.com|
22443353|NCT03353740|University of California, San Francisco|Dr. Thomas Hope, MD|(415) 221-4810|thomas.hope@ucsf.edu|
22443354|NCT01484288|CVRx|Vice President, Global Clinical Research|763-416-2876|egalle@cvrx.com|
22443355|NCT02232880|Vanderbilt University|David Harrison||david.g.harrison@Vanderbilt.Edu|
22443356|NCT03207035|Cork University Hospital|Dr Anil Ranganath||drmrak.2@gmail.com|
22443357|NCT00156936|Alkermes, Inc.|Bernard L. Silverman / VP, Clinical Development|781-609-6000|bernard.silverman@alkermes.com|
22443358|NCT02491359|H. Lee Moffitt Cancer Center|Dr. Joseph Pidala|813-745-2556|joseph.pidala@moffitt.org|
22443359|NCT02519855|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22443360|NCT01545843|University of Michigan|Dr. J. Todd Arnedt|734-764-1234|tarnedt@med.umich.edu|
22443361|NCT00640835|Reckitt Benckiser Pharmaceuticals, Inc.|Rolley E. Johnson, PharmD, Vice President, Clinical, Scientific and Regulatory Affairs|804-379-1090|ed.johnson@reckittbenckiser.com|7089
22443362|NCT03390842|Tricida, Inc.|Medical Information|415-429-7800|medinfo@tricida.com|
22443363|NCT01203644|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
22443364|NCT05954143|Bolt Biotherapeutics, Inc.|Director of Clinical Development Operations|1-650-434-8640|clinicaltrials@boltbio.com|
22443365|NCT00713310|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22443366|NCT00686634|Charles R. Drew University of Medicine and Science|Stanley H. Hsia, MD|323-357-3633|stanleyhsia@cdrewu.edu|
22443367|NCT00880464|Mass General Brigham|Beth Overmoyer|617 632 3800|Beth_Overmoyer@DFCI.HARVARD.EDU|
22443368|NCT04369924|University of Miami|Amanda Jensen-Doss|3052848332|ajensendoss@miami.edu|
22383833|NCT05403801|Dana Farber Cancer Institute|Desiree Azizoddin|(617) 632-3000|desiree_azizoddin@dfci.harvard.edu|
22443369|NCT01431209|University of Nebraska Medical Center|Dr. Julie M. Vose|402-559-3848|jmvose@unmc.edu|
22443370|NCT01653132|Beth Israel Deaconess Medical center|Dr. Pushpa Narayanaswami|617-667-8130|pnarayan@bidmc.harvard.edu|
22443371|NCT03828370|Klein Buendel Inc.-|Dr. W. Gill Woodall, Ph. D.|5053829796|gwoodall@kleinbuendel.com|
22443372|NCT01209832|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22443373|NCT00761150|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22443374|NCT01925989|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22428912|NCT01365611|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com|828
22428913|NCT01479530|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
22428914|NCT02836769|Sunnybrook Research Institute|Dr. Sara McEwen|416-226-6780|sara.mcewen@sunnybrook.ca|7957
22428915|NCT04339972|Medical University of South Carolina|Dr. Mark George or Dr. Bashar Badran|843-792-6076|georgem@musc.edu|
22428916|NCT01186406|Duke University Medical Center|Annick Desjardins, MD, FRCPC|9196846173|annick.desjardins@duke.edu|
22428917|NCT00376506|James Madison University|Christy L. Ludlow, PhD|540-568-3876|ludlowcx@jmu.edu|
22428918|NCT03780387|University of North Carolina at Chapel Hill|Michelle Hernandez, MD|919-843-5383|michelle_hernandez@med.unc.edu|
22428919|NCT00933166|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22428920|NCT00565864|Oregon Health & Science University|Dr. Mary Samuels|5034945242|samuelsm@ohsu.edu|
22428921|NCT06069609|Bausch & Lomb|Jeffery Schafer, OD, MS Director, Clinical Research|585-338-5664|jeffery.schafer@bausch.com|
22428922|NCT02403271|Pharmacyclics LLC, An AbbVie Company|Thorsten Graef|(408) 215-3127|tgraef@pcyc.com|
22428923|NCT02522845|Imperial College London|Mr Roshan Bootun|+442033117335|r.bootun@imperial.ac.uk|
22428924|NCT02112552|Albert Einstein College of Medicine - Montefiore Medical center|Dr. Jessica Atrio, Professor, Department of Obstetrics & Gynecology and Women's Health|917-721-6155|jatrio@montefiore.org|
22428925|NCT00774748|UNC Chapel Hill School of Medicine Dept. Hematology|Clinical Research Coordinator|919-966-2359|catherine_soriano@med.unc.edu|
22428926|NCT04285411|Vital USA Inc.|Mark H Khachaturian, PhD|+1(561)282-6074|mark.khachaturian@vvvital.com|
22428927|NCT02317549|Leading BioSciences|Tom Hallam, PhD, MBA|631-739-3088|tom.hallam@leadingbiosciences.com|
22428928|NCT03349515|Medical University of South Carolina|Dr. Michelle Rovner|843-792-2322|rovner@musc.edu|
22428929|NCT04055519|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22428930|NCT01403584|Universitätsklinik, Essen|Prof. Helmut Teschler|0201 433 4001|teschlerh@t-online.de|
22428931|NCT02232698|Abbott Diabetes Care|Snr Director, Clinical Development & Regulatory Affairs|01993 863164|joe.bugler@abbott.com|
22428932|NCT00729807|University of Maryland Greenebaum Cancer Center|Edward A. Sausville, M.D., Ph.D.|410-328-7394|esausville@umm.edu|
22428933|NCT00317369|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22443375|NCT04964193|Pharma Metric Labs, Indonesia|Pharma Metric Labs|+62 21 4265310|nabila.sutanto@pharmametriclabs.com|
22383834|NCT04898023|University of Missouri Healthcare|Ryan Camden|(575) 882-4141|camdenr@health.missouri.edu|
22428934|NCT03491917|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
22397910|NCT01347554|Yonsei University Wonju College of Medicine|Dr. Seung-Hwan Lee|+82-33-741-0920|carshlee@yonsei.ac.kr|
22428935|NCT01684592|Battelle|Dr. Victoria Coleman-Cowger|4103722748|colemancowger@battelle.org|
22428936|NCT04069520|Emory University|Dr. Kim Barber Foss|404-544-1306|kim.barberfoss@emory.edu|
22428937|NCT04615507|Johnson & Johns Vision Care Inc.|Thomas Karkkainen- Sr. Research Principal Optometrist|1-800-843-2020|tkarkkai@its.jnj.com|
22397911|NCT02500628|Woodinville Psychiatric Associates|Jon Berner MD PhD|425-481-0429|jonbernermd@gmail.com|
22397912|NCT01471457|University of New Mexico|Kate Meriwether|5052495967|meriwet2@salud.unm.edu|
22397913|NCT04352439|Duke University|Dr. Brittany Davidson|+1 919 684 0188|brittany.davidson@duke.edu|
22397914|NCT02228590|Sunovion Pharmaceuticals Inc.|CNS Medical Director|866-503-6351|clinicaltrialdisclosure@sunovion.com|
22397915|NCT02500121|Hoosier Cancer Research Network|Clinical Trials Results Coordinator|317-634-5842|aneal@hoosiercancer.org|21
22397916|NCT01295216|Institute of Nutrition of Central America and Panama|Manuel Ramirez-Zea|+502 24719913|mramirez@incap.int|
22397917|NCT02380716|W. L. Gore & Associates|Greg Miller|623-234-5910|gmiller@wlgore.com|
22397918|NCT02867995|Boston Medical Center|Dr. Manishi Desai|671-414-8806|Manishi.Desai@bmc.org|
22397919|NCT01534533|Peking University|Dr. Zhiyong Zou|+8610-13581525193|harveyzou2002@bjmu.edu.cn|
22397920|NCT03315871|National Cancer Institute|Dr. Ravi A. Madan|301-480-7168|m480i@nih.gov|
22397921|NCT00328627|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22397922|NCT02532231|The University of Texas MD Anderson Cancer Center|Tapan Mahendra Kadia, MD/Professor|713-563-3534|tkadia@mdanderson.org|
22397923|NCT00691483|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22397924|NCT04999267|Duke University - Duke Human Vaccine Institute|Chip Walter|919 620 5346|chip.walter@duke.edu|
22397925|NCT04623242|Washington University|Administrative Director|(314) 221-8344|DIAN-TUDataRequest@wustl.edu|
22397926|NCT03300466|Q-Med AB|Clinical Project Manager|+46184749000|reception.seupp@galderma.com|
22397927|NCT02105454|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22397928|NCT05131204|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22397929|NCT04373369|Washington University School of Medicine|Daniel Morgensztern, M.D.|314-362-5817|danielmorgensztern@wustl.edu|
22397930|NCT02469090|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunovion.com|
22397931|NCT01485627|UNIVERSITY OF ROCHESTER DEPARTMENT OF FAMILY MEDICINE|Ronald Epstein MD|5855069484|ronald_epstein@urmc.rochester.edu|
22397932|NCT01425203|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22397933|NCT06117319|Topmed|Edith Martin|418 683-2104|emartin@topmed.ca|1302
22397934|NCT00290433|The University of Texas (UT) MD Anderson Cancer Center|Christopher Flowers/Chair, Lymphoma-Myeloma|713-745-6095|crflowers@mdanderson.org|
22397935|NCT03001674|Tufts Medical Center|Dr. Navin Kapur|617 636 0720|nkapur@tuftsmedicalcenter.org|
22397936|NCT01968135|University of Colorado Denver|Chanel Mansfield|303-724-6501|chanel.mansfield@ucdenver.edu|
22397937|NCT03824808|University of Missouri|Dr Boris Mraovic|5738822568|mraovicb@health.missouri.edu|
22397938|NCT02275338|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22397939|NCT02465073|Southwest Regional Wound Care Center|Randall Wolcott|806-793-8869|randy@randallwolcott.com|
22397940|NCT01232829|University of Colorado Cancer Center|Dr. Wells Messersmith|303-724-3808|wells.messersmith@ucdenver.edu|
22397941|NCT03603496|Massachusetts General Hospital|Nancy Rigotti, MD|617-724-3548|nrigotti@partners.org|
22428938|NCT03407482|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22428939|NCT01648959|Toronto Western Hospital/UHN|Emad Al Azazi|416-603-8500|emad.alazazi@uhnresearch.ca|6237
22428940|NCT03290768|Savvysherpa, LLC|Jared Jones|763-549-3540|JaredJones@savvysherpa.com|8116
22428941|NCT04050605|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
22428942|NCT02207608|University of Rome Tor Vergata|Prof. Enrico Finazzi Agro|+393296152920|efinazzi@tin.it|
22428943|NCT02850406|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22428944|NCT01653262|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22428945|NCT01112267|Janssen Korea/ Seoul|Therapeutic area Scientist|+82-2-2094-4802||
22428946|NCT01312519|Vidacare Corporation|Senior Director of Science and Clinical|210-375-8500|thomas.philbeck@vidacare.com|
22428947|NCT01373229|Duke University Medical Center|Danielle Brander, MD|919-286-6897|danielle.brander@duke.edu|
22428948|NCT02421211|Janssen Research & Development|Trial Physician, Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
22428949|NCT00726557|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22428950|NCT02810327|Medical University of South Carolina|Kimberly Brown Foil|843-792-6474|foilk@musc.edu|
22428951|NCT01946802|Seoul National University Hospital|Pf. Gil Joon Suh|82-2-2072-2196|suhgil@snu.ac.kr|
22428952|NCT00153920|Dana-Farber Cancer Institute|Paul G. Richardson|617.632.2104|Paul_Richardson@dfci.harvard.edu|
22428953|NCT02541903|UAB|Dr. Lisle Nabell, MD, Professor|(205) 934-3061|lnabell@uabmc.edu|
22428954|NCT00827242|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22428955|NCT05762679|Johns Hopkins school of medicine|Dr. Preeti Raghavan|9174889626|praghavan@jhmi.edu|
22428956|NCT04795323|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
22428957|NCT01944774|TaiGen Biotechnology Co., Ltd.|Chen-En Tsai, M.D., Ph.D.|+886-2-8177-7072|cetsai@taigenbiotech.com|1211
22428958|NCT02503865|Republican Scientific Center for Emergency care at Nazarbayev University|Dr. Kuat Oshakbayev|+77013999141|okp.kuat@mail.ru|
22428959|NCT00021255|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22383835|NCT01704079|OPKO Health, Inc.|Douglass Laidlaw, PhD, Vice President, Medical Affairs|305-575-4172|dlaidlaw@opko.com|
22383836|NCT05846646|ImmuneSensor Therapeutics, Inc.|Patrick Widhelm, Senior Director Clinical Operations and Project Management|830-730-8176|pwidhelm@immunesensor.com|
22383837|NCT00003042|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22383838|NCT02014129|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22383839|NCT01443845|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22383840|NCT02461628|Duke University|Wendy O'Meara, PhD|16099103091|wpo@duke.edu|
22383841|NCT01929759|Boston Medical Center, Boston University School of Medicine|Dr. Nina Lin|617-414-5242|nina.lin@bmc.org|
22383842|NCT03399604|Liquidia Technologies|Chief Medical Offier|919-328-4400|safety@liquidia.com|
22383843|NCT02462759|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
22383844|NCT00570700|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
22383845|NCT02410018|IMBiotechnologies Ltd|President|780-945-6609|mstewart@tbwifi.ca|
22383846|NCT00520546|German Federal Armed Forces Hospital, Ulm|Major Medical Corps Dr. Markus Hartenbach|0049 731 1710 1851|markushartenbach@bundeswehr.org|
22383847|NCT05052996|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22383848|NCT01695954|NYU School of Medicine|Carlos Malvestutto, MD, MPH|212-263-3570|carlos.malvestutto@nyumc.org|
22383849|NCT02088853|Göteborgs University|Professor Lars Fandriks|+46313424123|lars.fandriks@gastro.gu.se|
22383850|NCT03351699|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22383851|NCT04704284|Mayo Clinic|Julie Guerin, M.D.|507-293-3698|Guerin.Julie@mayo.edu|
22397942|NCT02248727|Optometry Research Group (GIO) University of Valencia|Robert Montes-Mico, O.D., PhD|34-9635-44764|robert.montes@uv.es|
22383852|NCT05644730|Ideal Medical Technologies|Dr. Leon DeJournett/Chief Medical Officer|8283379960|leondej@idealmedtech.com|
22383853|NCT02290613|Thoraxklinik Heidelberg gGmbH at Heidelberg University Hospital|Prof. Dr. med. E. Grünig|+49 6221 396|ekkehard.gruenig@med.uni-heidelberg.de|8053
22383854|NCT01248936|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22383855|NCT03930420|University of Washington|Margaret Hannon, PhD|206-616-7859|peggyh@uw.edu|
22383856|NCT05609032|Columbia University|Rebecca Schnall, PhD, MPH, RN-BC, FAAN, FACMI|212-342-6886|rb897@cumc.columbia.edu|
22383857|NCT00609336|University of Washington|Andrew Coveler, MD|206-288-7509|acoveler@uw.edu|
22383858|NCT00567489|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
22383859|NCT02570022|Henry Ford Hospital|Dr. Kelechi Okoroha|8324239895|krokoroha@gmail.com|
22383860|NCT03635151|University of Cincinnati College of Nursing|Tamilyn Bakas|513-558-2254|tamilyn.bakas@uc.edu|
22383861|NCT00262730|Adult Brain Tumor Consortium Central Office- Johns Hopkins|Director of Adult Brain Tumor Consortium|410-955-3657|jfisher@jhmi.edu|
22383862|NCT02020252|University of Chicago Medicine|Toni M Cipriano|574-339-0652|tcipriano@uchicago.edu|
22383863|NCT02793154|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22383864|NCT01215344|Vanderbilt-Ingram Cancer Center|Madan Jagasa, M.D.|(6150 936-8422|madan.jagasia@vanderbilt.edu|
22383865|NCT04426500|Icahn School of Medicine at Mount Sinai|Dr. Reza Mehrazin|(212) 241-4812|reza.mehrazin@mountsinai.org|
22383866|NCT02372253|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Anath Shalev, MD|205-996-4777|shalev@uab.edu|
22397943|NCT04639583|University of New Mexico|Jessie Maxwell, MD, MBA|505-272-3967|JRMaxwell@salud.unm.edu|
22397944|NCT00004259|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22428960|NCT00927082|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22428961|NCT02723331|University of Colorado Hospital|Wells Messersmith, MD|303-724-0747|wells.messersmith@cuanschutz.edu|
22428962|NCT02513563|Moffitt Cancer Center|Jhanelle E. Gray, MD|813-745-2677|Jhanelle.Gray@moffitt.org|
22428963|NCT01068912|MediVector, Inc., managing member MDVI, LLC|Dr. Carol Epstein, Chief Medical Officer|617-439-4500|cepstein@medivector.com|
22428964|NCT00825175|University of Michigan|Julia Looper|253 534 8499|jlooper@umich.edu|
22428965|NCT06086340|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22428966|NCT05128942|Spruce BioSciences Inc.|Spruce CMO, MD|415-655-4169|clinicaltrials@sprucebio.com|
22428967|NCT01767415|Weill Cornell Medicine|Anita Ou|646-962-8188|ano2014@med.cornell.edu|
22428968|NCT03998462|North Florida/South Georgia VA Healthcare System|Dr. Dawn Schiehser, Ph.D.|352-376-1611|Dawn.Schiehser@va.gov|107538
22428969|NCT05710224|Instituto Butantan|Fernanda Castro Boulos - Diretoria Médica, Centro de Ensaios Clínicos e Farmacovigilância|+55 11 3723-6797|fernanda.boulos@fundacaobutantan.org.br|
22428970|NCT05893823|IRCCS Istituto Ortopedico Rizzoli|Francesco Castagnini|0516366418|francescocastagnini@hotmail.it|+39
22428971|NCT03369223|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22428972|NCT00627978|Weill Cornell Medicine|Linda Vahdat, MD|646-962-9888|ltv2001@med.cornell.edu|
22428973|NCT05838664|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov.Inquiries@pfizer.com|
22428974|NCT03010501|Laboratory for the Study of Human Ingestive Behavior, The Pennsylvania State University|Dr. Barbara J. Rolls|814-863-8481|bjr4@psu.edu|
22428975|NCT00942851|Office of the Clinical Director, NINDS, NIH|Codrin Lungu, MD|301-496-5295|lunguci@ninds.nih.gov|
22428976|NCT02347787|University of Pennsylvania School of Medicine|Lindsey Norton|215-573-9961|lindsey.turr@uphs.upenn.edu|
22428977|NCT01917773|Riley Hospital for Children, Indiana University|Joseph Croffie|317-944-3774|jcroffie@iupui.edu|
22428978|NCT02260622|Ottawa Hospital Research Institute|Penny Phillips|613-737-8899|pphillips@ohri.ca|
22428979|NCT00544882|Teva Branded Pharmaceutical Products R&D|Director of Clinical Research|610-786-7047|clinicaltrialsdisclosure@tevapharm.com|
22443376|NCT00046891|Mayo Clinic|Debra L. Barton, R.N., Ph.D.|507-266-6247|barton.debra@mayo.edu|
22443377|NCT01982968|University of California, San Francisco|Harold Collard, MD|415 4761000|Harold.Collard@ucsf.edu|
22443378|NCT05072470|Sonova USCS|Research Audiologist|630-821-5000|phonakaudiologyresearch@gmail.com|
22443379|NCT02496676|National Institute of Allergy and Infectious Diseases|Ravell Aumaitre, Juan|+1 301 761 6669|juan.ravell@nih.gov|
22443380|NCT01009281|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22443381|NCT00924170|National Cancer Institute|Dr. Robert Kreitman|301-496-6947|Robert_Kreitman@nih.gov|
22443382|NCT00579436|University of Kentucky|Phillip Kern|859 323 4933|pake2222@uky.edu|
22443383|NCT03901456|University of Minnesota|Joseph Gaugler, PhD|612-626-2485|gaug0015@umn.edu|
22443384|NCT05318183|The Ohio State University|Richard Bruno|614.292.5522|bruno.27@osu.edu|
22443385|NCT04098224|ART MEDICAL|Mrs. Shirly Steinlauf|972-54-5804242|Shirly@artmedical.com|
22443386|NCT02181517|Allergan, Inc|Clinical Trials Registry Team|1-800-347-4500|IR-CTRegistration@allergan.com|
22443387|NCT01203852|University of Florida|Dr. Julie A. Johnson|(352) 273-6309|johnson@cop.ufl.edu|
22443388|NCT00899392|Children's Hospital of Philadelphia/OHSU/Doernbecher Children's Hospital|Joel A Friedlander|503-494-1078|friedlan@ohsu.edu|
22443389|NCT01431638|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22443390|NCT01381562|GlaxoSmithKline|GSK Response Center|866-435-7343||
22443391|NCT04876690|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22443392|NCT02589600|University of Pittsburgh|Susan Greenspan|4126922477|greenspn@pitt.edu|
22443393|NCT01905423|Washington University in St Louis Medical School|Peter Fischer|+1 (314) 747-5198|pufischer@wustl.edu|
22443394|NCT03709576|Penn State Cancer Institute|Michelle Stojanovic|7175310003|mstojanovic1@pennstatehealth.psu.edu|287412
22443395|NCT01947855|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22443396|NCT00710762|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22443397|NCT00592774|Eisai Call Center|Eisai Inc.|888-422-4743||
22443398|NCT01892384|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22443399|NCT01700439|Edwards Lifesciences, LLC|Jennifer Currin, Senior VP of Medical and Clinical Affairs, Surgical Structural Heart|949-250-2500|Jennifer_Currin@edwards.com|
22443400|NCT00621621|Medtronic- AF Solutions|Adam Cline, MD, MSc.- Sr. Clinical Research Specialist|763-526-9601|adam.cline@medtronic.com|
22443401|NCT03445156|The Ohio State University|Dr. Brad Bushman|614-688-8779|bushman.20@osu.edu|
22397945|NCT03594227|Aclaris Therapeutics, Inc.|Marco Cardillo, Clinical Trial Manager|484-540-6299|mcardillo@aclaristx.com|
22443402|NCT02889562|Sanford Health|Todd Chapin PharmD|701-417-2351|todd.chapin@sanfordhealth.org|
22443403|NCT01943474|C. R. Bard|Gina Gilbert|407-489-0835|gina.gilbert@crbard.com|
22443404|NCT02162576|Propeller Health|Dr. Meredith Barrett|415-409-9258|meredith.barrett@propellerhealth.com|
22443405|NCT04054947|White River Junction VA Medical Center|Dr. Brian Shiner|802-295-9363|brian.shiner@va.gov|6070
22443406|NCT01606878|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22443407|NCT03720652|University of North Carolina at Chapel Hill|Philip D. Sloane, MD, MPH|+1 (919) 966-4439|philip_sloane@med.unc.edu|
22443408|NCT03068091|University of Missouri|Talissa Altes|573 882 1026|ALTEST@HEALTH.MISSOURI.EDU|
22443409|NCT01543581|Loma Linda University Health, Department of Dermatology|Dr. Abel Torres, PI|(909) 558-2055|atorres@llu.edu|
22443410|NCT01155167|UCSF|Andrew Boyle MD|4153533817|aboyle@medicne.ucsf.edu|
22443411|NCT00167778|Dept. of Veterans Affairs, Rehabilitation Research & Development Service|Glenn K. Klute, PhD|206-277-6724|Glenn.Klute@va.gov|
22397946|NCT03389854|Mayo Clinic|Dr. Landon Trost|507-284-3728|Trost.Landon@mayo.edu|
22397947|NCT00907101|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5000|elizabeth.nieman@galderma.com|
22397948|NCT00109707|NovartisPharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22397949|NCT00586209|Emmaus Medical, Inc.|Yutaka Niihara, MD, MPH|310-214-0065|yniihara@emmausmedical.com|
22397950|NCT02018627|Massachusetts General Hospital|Courtney Balliro, BS, RN, CDE|617-726-1242|cballiro@partners.org|
22397951|NCT02111993|UC San Diego School of Medicine|Ulrika Birgersdotter-Green, MD|858-657-5310|ubgreen@ucsd.edu|
22397952|NCT00440505|Columbia University|Pamela Flood, MD|212-305-2008|pdf3@columbia.edu|
22397953|NCT04074928|Seqirus|Seqirus Clinical Trial Manager|1-855-358-8966|seqirus.clinicaltrials@Seqirus.com|
22397954|NCT05182554|MIT|LISA HO|5106505455|lisaho@mit.edu|
22397955|NCT01400451|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22397956|NCT02185404|University of South Florida|Kyle B. Reed|813-974-2385|kylereed@usf.edu|
22397957|NCT01505634|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22397958|NCT00960843|Ethicon Endo-Surgery Inc.|Michael Schwiers Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
22397959|NCT01967537|Principal Investigator|Dr. Naris Nilubol|301-451-2355|niluboln@nih.gov|
22397960|NCT00610987|University of Missouri, Department of Orthopaedics|Dr. Brett Crist|573-882-6562|cristb@health.missouri.edu|
22397961|NCT00254501|University of Florida|Dale Kraemer||Dale.Kraemer@jax.ufl.edu|
22397962|NCT00317109|GlaxoSmithKline|GSK Response Center|866-435-7343||
22397963|NCT03124771|Masimo|Tala Harake||studies@masimo.com|
22397964|NCT04249687|Galderma Research & Development|Galderma Research & Development|8179615000|clinical.studies@galderma.com|
22443412|NCT02654717|Dr. Reddy's Laboratories Inc.|Dr. Srinivas Sidgiddi|6093759900|srinivassidgiddi@drreddys.com|
22443413|NCT00960570|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22397965|NCT01508702|Ardea Biosciences, Inc.|Nihar Bhakta, MD|1-858-652-6671|nbhakta@ardeabio.com|
22397966|NCT04472429|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22443414|NCT00853970|ISTA Pharmaceuticals, Inc.|Tim McNamara, Vice President, Clinical Research & Medical Affairs|949-788-6000|tmcnamara@istavision.com|
22443415|NCT04085367|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
22383867|NCT01803555|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22383868|NCT03201562|Presbyopia Therapies, LLC|Jerry Horn, MD|(847)-772-8885|visionxcl@icloud.com|
22383869|NCT03294499|Imperial College Healthcare NHS Trust|Dr Farai Nyatsanza|n/a|farai.nyatsanza@nhs.net|
22383870|NCT01381471|GlaxoSmithKline|GSK Response Center|866-435-7343||
22383871|NCT00780234|Rocky Mountain Regional VA Medical Center|Robert L. Keith, MD|720-857-5120|robert.keith@ucdenver.edu|
22383872|NCT03892564|MC2 Therapeutics|Birgitte Vestbjerg|+45 2077 2575|bve@mc2therapeutics.com|
22383873|NCT04019444|The Hope Clinic of the Emory Vaccine Center|Varun K. Phadke, MD|404-712-9046|vphadke@emory.edu|
22383874|NCT04578106|Hospital Clínic de Barcelona|Dr. Tomas Pascual|932275400|topascual@clinic.cat|
22383875|NCT06678178|Johns Hopkins Bloomberg School of Public Health|Julia Wolfson|213-359-2915|jwolfso7@jhu.edu|
22383876|NCT04690556|Lupin|Study Director: Lupin|020-66749100|chiragshah@lupin.com|49068
22383877|NCT00497198|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22383878|NCT06729073|AMZELL BV|Delpy|+31235560460|amzell-disclosure@amzell.com|
22383879|NCT03891758|Tanabe Pharma Corporation / The Research Foundation for Microbial Diseases of Osaka University|Clinical Trials, Information Desk|Please email|cti-inq-ml.JP@ml.tanabe-pharma.com, clinicaldevelopment@mail.biken.or.jp|
22383880|NCT07074171|The University of Texas Health Science Center at Houston|Belinda M Reininger, DrPH|956-755-0654|Belinda.M.Reininger@uth.tmc.edu|
22383881|NCT04434729|Boston Children's Hospital|Dr. Darren Orbach|617-355-5012|darren.orbach@childrens.harvard.edu|
22383882|NCT00975819|Children's Hospital of Philadelphia|Denise M. Adams, M.D.|2674253010|adamsdm@chop.edu|
22383883|NCT01968109|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22383884|NCT04474314|Imara, Inc.|Rahul Ballal|617-206-2020|rballal@imaratx.com|
22383885|NCT06954883|Assuit university|Ahmed Kamel Abdel Naser|01061553007|a.k.soliman@hotmail.com|
22383886|NCT04316676|Emory University|Carlo De Cecco, MD, PhD|404-712-7968|carlo.dececco@emory.edu|
22383887|NCT03899792|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22383888|NCT00330681|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22383889|NCT03954184|University of Wisconsin - Madison|Todd Molfenter, PhD|608-262-1685|todd.molfenter@wisc.edu|
22383890|NCT05307783|Merit Medical|Vicky Brunk|(385) 766-9152|vicky.brunk@merit.com|
22383891|NCT04883645|Medical University of South Carolina|Dr. Angela J. Yoon|8437924496|yoona@musc.edu|
22383892|NCT06382064|The Ohio State University College of Optometry|Dr. Jennifer Fogt|614-292-0882|fogt.78@osu.edu|
22383893|NCT03460236|Stanford University|Christine Hoang, Clinical Research Coordinator|650-721-7630|c1hoang@stanford.edu|
22383894|NCT06194214|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22383895|NCT04869982|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22383896|NCT04608045|University of Kansas Medical Center|Dr. John A Taylor|9135888170|jtaylor27@kumc.edu|
22383897|NCT05833789|Vanderbilt University Medical Center|Michael McGill|615-322-0128|michael.g.mcgill@vumc.org|
22383898|NCT02473250|Columbia University Irving Medical Center|Martin Lan MD PhD|646 774 7610|martin.lan@nyspi.columbia.edu|
22383899|NCT05215847|Aardvark Therapeutics|Manasi Jaiman MD, MPH, Chief Medical Officer|(858) 225-7696|MJaiman@aardvarktherapeutics.com|
22383900|NCT04847999|University of British Columbia|Dr Jonathan Little|2508786893|jonathan.little@ubc.ca|
22383901|NCT03830177|Northwestern University|Lucy Bilaver, PhD|312-503-5618|l-bilaver@northwestern.edu|
22383902|NCT02960230|University of California, San Francisco|Dr. Sabine Mueller, MD PhD|(415) 502-1600|Sabine.Mueller@ucsf.edu|
22383903|NCT03401853|University of Washington|Stephen Smith, MD|(206) 606-6546|ssmith50@fredhutch.org|
22428980|NCT00308685|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
22383904|NCT03625323|Immutep|Immutep CMO|+ 49 30 88716843|regulatoryaffairs@immutep.com|
22383905|NCT02488863|University o fFlorida|Eric Weber|352-273-7802|ebweber@ufl.edu|
22383906|NCT04300231|Indiana University Department of Anesthesiology|Yar Luan Yeap, MD|317-274-0275|yyeap@iupui.edu|
22383907|NCT06023082|Citruslabs|Patrick Renner|(805) 292-0714|hello@citruslabs.com|
22383908|NCT05986565|Mt. Hope Family Center, University of Rochester|Christie L. M. Petrenko, Ph.D.|5852752991|christie_petrenko@urmc.rochester.edu|
22383909|NCT00448240|Henry Ford Health System|Tiffany Pearce, Director of Clinical Trials|313-575-8046|tpearce1@hfhs.org|
22383910|NCT04431050|Imperial|Joan Nanan|+44 (0)20 7594 9000|j.nanan@imperial.ac.uk|
22383911|NCT00670046|UTHSCSA|Ron Rodriguez, MD, PhD|2105675643|rodriguezr32@uthscsa.edu|
22383912|NCT03504423|Cornerstone Pharmaceuticals Inc.|Sanjeev Luther|585-978-1351|sanjeev.luther@cornerstonepharma.com|
22383913|NCT00574834|University of Maryland Baltimore|Stephen N. Davis, MBBS- Principal Investigator|410-328-2488|sdavis@medicine.umaryland.edu|
22383914|NCT03128359|City of Hope Medical Center|Dr. Monzr M.Al Malki, MD|6263598111|malmalki@coh.org|
22383915|NCT02006758|Abbott|Rebecca Maslow, MA, Clinical Project Manager|+1 651-756-5564|rebecca.maslow@abbott.com|
22412017|NCT01364870|University of Iowa College of Nursing|Barbara Rakel, PhD, RN, FAAN|319-335-7036|barbara-rakel@uiowa.edu|
22428981|NCT01121575|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22428982|NCT02583269|Wake Forest University Health Sciences|Study Nurse|336-713-7748|saverill@wakehealth.edu|
22428983|NCT03656133|Moffitt Cancer Center|Jimmy Caudell, MD, PhD|813-745-8226|jimmy.caudell@moffitt.org|
22428984|NCT03244189|Duke University|Charles D. Scales Jr, MD MSHS FACS|919-684-1999|chuck.scales@duke.edu|
22428985|NCT06170827|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@GSK.com|
22428986|NCT03393013|Kezar Life Sciences, Inc|Regulatory Affairs|650-822-5600|clinicaltrials@kezarbio.com|
22428987|NCT03860584|Ohio State University|Richard Bruno|8603358494|bruno.27@osu.edu|
22428988|NCT03579771|Robert H. Lurie Comprehensive Cancer Center of Northwestern University Clinical Cancer Center|Shishir Maithel, MD|312-908-5250|shishir.maithel@nm.org|
22383916|NCT00914589|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22383917|NCT01261052|Legacy Health System|Dr. W Kenneth Ward|503-413-5171|kenward503@msn.com|
22383918|NCT02101281|Dompé|Flavio Mantelli, MD, PhD|+39 513138|info@dompe.it|
22383919|NCT05575076|Cassava Sciences|Study Director|737-910-1045|ClinicalTrials.gov@cassavasciences.com|
22383920|NCT00510887|Duke University Medical Center|Dr. David Rizzieri|919-668-1000|rizzi003@mc.duke.edu|
22383921|NCT02214550|NorthShore University HealthSystem|Dr. Frank Tu|8475702520|ftu@northshore.org|
22383922|NCT01736215|Janssen Cilag Thailand|Medical Affairs Director|+6627927232||
22383923|NCT03447249|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22383924|NCT02376790|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22383925|NCT00988858|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22383926|NCT02238483|AstraZeneca|Ziad Taib|+46 708 46 73 56|ziad.taib@astrazeneca.com|
22383927|NCT02538341|University of Alabama at Birmingham|Dr. Jeffrey R. Curtis|205-975-2176|jrcurtis@uabmc.edu|
22383928|NCT00194610|University of Washington|Claire Yang, MD|206-744-6384|cyang@uw.edu|
22383929|NCT01551355|Icahn School of Medicine at Mount Sinai|Dr. Valentin Fuster|212-241-3852|valentin.fuster@mssm.edu|
22383930|NCT00031694|Montefiore Medical Center-New York cancer Consortium|Joseph Sparano|718-405-8404|jsparano@montefiore.org|
22383931|NCT01538719|Boston University School of Medicine|Eric A Stratton, Sr. Clinical Research Manager|6174142507|eas@bu.edu|
22383932|NCT03010631|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22383933|NCT01985542|Helsinki University Hospital|Dr. Sanna Salmi|+358505431421|sanna.salmi@helsinki.fi|
22383934|NCT01255670|Helsinki University Central Hospital|Dr. Karin Blomgren|+358504271579|karin.blomgren@hus.fi|
22383935|NCT03664960|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
22383936|NCT03640949|Aarhus University|Lars W. Andersen|+4551781511|lwandersen@clin.au.dk|
22383937|NCT03807778|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22383938|NCT01207492|Dana-Farber Cancer Institute|Andrew Wagner, MD, PhD|617.632.5204|andrew_wagner@dfci.harvard.edu|
22383939|NCT03582722|Emory University|Michele Marcus, PhD, MPH|404-727-8010|mmarcus@emory.edu|
22383940|NCT00424463|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22383941|NCT04242940|Oticon Medical|Manager of Clinical Affairs|609-366-0424|studyinfo@oticonmedical.com|
22383942|NCT03570892|Novartis Pharmaceuticals|Study Director|862-778-3000|novartis.email@novartis.com|
22383943|NCT05028582|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
22383944|NCT01701986|University of Texas MD Anderson Cancer Center|Dr. Yago Nieto, MD, PhD/ Stem Cell Transplantation Department|713-792-8750|ynieto@mdanderson.org|
22383945|NCT02576509|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22383946|NCT04527146|UPenn|Rachel Paul, Genetic Counselor|215-490-5816|rachel.paul3@pennmedicine.upenn.edu|
22383947|NCT05510232|Hospital for Special Surgery|Dr. Peter Fabricant|(212) 606-1996|fabricantstaff@hss.edu|
22383948|NCT02721381|Michigan State University|Dr. Brooke Ingersoll|517-930-2275|ingers19@msu.edu|
22383949|NCT05166135|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22383950|NCT05687903|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22383951|NCT04468776|CPMCRI|Dr. Katie Stone|(510) 427-4562|katie.Stone@ucsf.edu|
22383952|NCT03890913|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|225.763.2500|amanda.staiano@pbrc.edu|
22383953|NCT04840199|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22383954|NCT03433339|Lindner Center of HOPE/ University of Cincinnati Department of Psychiatry and Behavioral Neurosciences|Dr. Francisco Romo-Nava|513-536-0725|romofo@ucmail.uc.edu|
22383955|NCT04970407|Ipsen Innovation|Laurent Pons/Clinical Pharmacology Director|see email|clinical.trials@ipsen.com|
22383956|NCT01898494|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22383957|NCT05540002|Brigham and Women's Hospital|Robert Jamison|617-732-9046|rjamison@bwh.harvard.edu|
22383958|NCT02819843|Memorial Sloan Kettering Cancer Center|Dr. Christopher Barker, MD|212-639-8168|barkerc@mskcc.org|
22383959|NCT04732494|BeiGene, Ltd.|Study Director|1 877-828-5568|clinicaltrials@beigene.com|
22383960|NCT03055858|Abbott Laboratories|Ebony Kargbo|612-209-8185|Ebony.Kargbo@abbott.com|
22383961|NCT02728557|University of Haifa|Prof. Sigal Zilcha-Mano|972-4-8249047|sigalzil@gmail.com|
22383962|NCT03416010|The Ohio State University|Dr. Bernadette Melnyk|6142924844|melnyk.15@osu.edu|
22383963|NCT03948763|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22383964|NCT06629454|University of Pennsylvania|Doraid Jarrar|2156627878|doraid.jarrar@pennmedicine.upenn.edu|
22383965|NCT05136404|Eli Lilly and Company|Chief Medical Officer|8005955979|ClinicalTrials.gov@lilly.com|
22383966|NCT05568004|Ege University Faculty of Medicine Sport Medicine Department|Dr. Yunus Emre Meydanal|905068046512|yemremeydanal@gmail.com|
22428989|NCT02369458|Washington University School of Medicine|Peter Oppelt, M.D.|636-916-9922|poppelt@wustl.edu|
22428990|NCT03853798|Agios Pharmaceuticals, Inc.|Agios Medical Affairs|833-228-8474|medinfo@agios.com|
22428991|NCT02743494|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22428992|NCT06904404|Wolfe Eye Clinic|Edward Hu|(319) 362-8032|ehu@wolfe.com|
22428993|NCT06400914|CooperVision, Inc.|Jose A. Vega, OD, MSc, FAAO|925-621-3761|javega@coopervision.com|
22428994|NCT06937346|Karaganda Medical University|Amirbekova Mariyam Sayatovna|+77472224951|Amirbekova31081998@gmail.com|
22383967|NCT06146374|DynPort Vaccine Company, a GDIT Company|George A. Saviolakis, MD, PhD|301-835-4101|George.Saviolakis@gdit.com|
22397967|NCT01180660|Northwestern University|Gildasio De Oliveira MD|312-472-3573|g-jr@northwestern.edu|
22397968|NCT00250835|University of New Mexico|Fa-Chyi Lee, MD|5059250405|flee@salud.unm.edu|
22397969|NCT03461757|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
22397970|NCT02425826|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|1-800-260-1599|ClinicalTrialDisclosure@celgene.com|
22397971|NCT03861559|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22397972|NCT02997904|Piedmont Pharmaceuticals|Dr. Kathy Palma|336 544 0320|kpalma@piedmontpharma.com|202
22397973|NCT00879697|University of São Paulo|Raphael Dias|55 81 9728 6878|raphaelritti@gmail.com|
22397974|NCT03730116|Sevier|Mrdical manager - Yuriy Burtsev|8-495-93707-00|Yuriy.Burtsev@servier.com|1389
22397975|NCT00106171|Johns Hopkins University|Dr. Joseph Margolick|410-955-1436|jmargoli@jhsph.edu|
22397976|NCT01836783|University of Alabama at Birmingham|Maninder Kaur, BDS, MPH, MS, Principal Investigator|205-9344506|maninder@uab.edu|
22397977|NCT04011280|Pacific Treatment and Research Center|Dr. Benjamin McKenna|858-534-8817|bmckenna@health.ucsd.edu|
22397978|NCT04942925|Alcon Research, LLC|Sr. Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22397979|NCT03649061|UZLeuven|Prof. Dr. Patrick Verschueren|+3216342541|patrick.verschueren@uzleuven.be|
22397980|NCT03221738|Massachusetts General Hospital|Anna Schwartzberg|617-724-7161|aschwartzberg@mgh.harvard.edu|
22397981|NCT02124564|Cares|UCB|+1844599|UCBCares@ucb.comTokyo|2273
22397982|NCT01100437|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22397983|NCT04489888|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22397984|NCT01003275|University of Washington|Ian H. de Boer, MD, MS, Associate Professor of Medicine|2066165403|deboer@u.washington.edu|
22443416|NCT04133064|Pivot Health Technologies Inc.|VP of Clinical and Medical Affairs|415-757-7696|marler@pivot.co|
22443417|NCT00910247|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
22443418|NCT00625742|University of Texas (UT) MD Anderson Cancer Center|Rony Dev, DO/Associate Professor, Palliative Care Med||CR_Study_Registration@mdanderson.org|
22397985|NCT00254462|University of Nebraska Medical Center|Christopher J. Kratochvil|402-552-6005|ckratoch@unmc.ed|
22397986|NCT00631748|VA Puget Sound Health Care System|Andre Tapp, MD|253-589-4176|andre.tapp@va.gov|
22397987|NCT00400881|Texas Tech University|Juan Figueroa-Casas|915 5456626|juan.figueroa@ttuhsc.edu|235
22397988|NCT00456989|University of Louisville, James Graham Brown Cancer Center|University of Louisville, James Graham Brown Cancer Center Clinical Trials|502-562-3429|ctobcc@louisville.edu|
22397989|NCT03829657|Theravance Biopharma Ireland Limited|Medical Monitor|855 633 8479|medinfo@theravance.com|+1
22397990|NCT06706245|Brown University Health|Joshua Kemp, Assistant Professor|4014321466|joshua_kemp@brown.edu|
22397991|NCT04527185|Yale School of Medicine|Terril Verplaetse|203-737-6496|terril.verplaetse@yale.edu|
22397992|NCT03368170|Integrative Research Laboratories AB|Joakim Tedroff/Chief Medical Officer|+ 46 707 601691|joakim.tedroff@irlab.se|
22397993|NCT02643004|CooperVision Inc.|Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com|
22397994|NCT03445000|ETOP IBCSG Partners Foundation|Heidi Roschitzki-Voser|+41 31 511 94 00|ALERT-lung@etop.ibcsg.org|
22397995|NCT02605642|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22397996|NCT02762513|University of Michigan Rogel Cancer Center|Paul Swiecicki, M.D.|734-647-1017|pswiecic@med.umich.edu|
22397997|NCT02165384|Preceptis Medical|CEO|6123274795|steve@preceptismedical.com|
22397998|NCT02111564|Janssen Research & Development, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22397999|NCT00687362|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22398000|NCT03438045|NYU Grossman School of Medicine|Mary E. Northridge, PhD, MPH, Director of Dental Research|(347) 377-4342|Mary.Northridge@nyulangone.org|
22398001|NCT05362526|University of Florida|Ashleigh Wehy, MD|9042449440|amweyh@gmail.com|
22398002|NCT01707472|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22398003|NCT03522324|University of Colorado Boulder|Dr. L. Cinnamon Bidwell|3037355180|lcb@colorado.edu|
22398004|NCT03704194|Washington university in St.louis|Brittany Minor|314-273-4118|bminor@wustl.edu|
22398005|NCT00925015|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22398006|NCT02396732|University of Miami|Kenneth Proctor|305-585-1178|kproctor@med.miami.edu|
22398007|NCT04986202|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22398008|NCT03340610|Southeast Retina Center|Dr. Dennis Marcus|706650061|dmarcus@southeastretina.com|
22398009|NCT05526833|New York State Psychiatric Institute|Michael Avissar|(646) 774-5431|MichaelAvissarMDPhD@gmail.com|
22398010|NCT00586573|Massachusetts General Hospital|Craig Surman, MD|617-503-1424|csurman@partners.org|
22398011|NCT03806127|Urovant Sciences|Information, Clinical Trial Results|949-226-6029|info@urovant.com|
22398012|NCT02163434|University at Buffalo|Dr. Thomas Guttuso, Jr.|7169326080|tguttuso@gmail.com|
22398013|NCT01390259|University of Virginia|Marc Breton, Ph.D.|434-982-6484|mb6nt@virginia.edu|
22398014|NCT00539695|Texas Children's Hospital|Dr. Rayne Rouce|832-824-4716|rouce@bcm.edu|
22398015|NCT03823391|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22398016|NCT00522795|BrUOG|Kayla Rosati|401-863-3000|Kayla_Rosati@brown.edu|
22398017|NCT01833130|Allergan, Inc|Medical Director,||clinicaltrials@allergan.com|
22443419|NCT03387150|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22443420|NCT04006119|Alaunos Therapeutics, Inc|Jaymes Holland, Clinical Consultant|6502732627|jholland@alaunos.com|
22443421|NCT02919969|Dana Farber Cancer Institute|James Cleary|617-632-6073|james_cleary@dfci.harvard.edu|
22443422|NCT01842633|GlaxoSmithKline|GSK Response Center|866-435-7343||
22443423|NCT04179409|Abigail Wexner Research Institute, Nationwide Children's Hospital|Dr. Kevin Flanigan, Center for Gene Therapy Director|614-722-5615|kevin.flanigan@nationwidechildrens.org|
22443424|NCT02093351|AstraZeneca Pharmaceuticals|Dr Carsten Goessl, Indication Lead||clinicaltrialtransparency@astrazeneca.com|
22443425|NCT03565367|Stanford University|Lawrence Recht, MD|(650) 725-8630|lrecht@stanford.edu|
22443426|NCT02057042|VA Center for Clinical Managment Research|Paul Pfeiffer|7348453649|paul.pfeiffer@va.gov|
22443427|NCT01099709|Purdue Pharma LP|Stephen C. Harris, MD|203-588-7592|Stephen.Harris@pharma.com|
22443428|NCT00706849|Genzyme Corporation|Genzyme Medical Information|617-252-7832||
22443429|NCT02873585|University of North Carolina at Chapel Hill|Angela Broome, DDS, MS|9195373160|abroome@unc.edu|
22443430|NCT01611454|Baptist Health South Florida|Raul Herrera, MD. Director Miami Cardiac and Vascular Institute|786-596-3505|raulh@baptisthealth.net|
22443431|NCT00920907|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22443432|NCT02616601|Teva Pharmaceuticals Inc. USA|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
22443433|NCT01275339|Washington University School of Medicine|Brian R. Lindman, MD|615-936-5949|brlindman@wustl.edu|
22443434|NCT01555957|University of Rochester|Sanjiv Amin|585-273-2696|sanjiv_amin@urmc.rochester.edu|
22443435|NCT00923364|National Cancer Institute|Dr. Dennis Hickstein|301-594-1718|hicksted@mail.nih.gov|
22443436|NCT04352127|Mayo Clinic|J. Ross Renew, M.D.|904-956-3328|Renew.J@mayo.edu|
22443437|NCT01198158|Georgetown University Hospital|George Philips MBBS, MD, MPH, FACP|202-444-2198|George.K.Philips@gunet.georgetown.edu|
22443438|NCT03023046|University of Washington|Ryan Cassaday, MD|2066061202|cassaday@seattlecca.org|
22443439|NCT05478174|Haisco-USA Pharmaceuticals, Inc.|Yu-Ling Lai|858-263-4239|yuling.lai@haisco-usa.com|
22443440|NCT01249118|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22443441|NCT00880685|University of Chicago|Dr. Jon Grant|773-834-1326|jongrant@uchicago.edu|
22443442|NCT04179890|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22443443|NCT01063712|"Cardiology Medical Center Kardiozentrum"|Alexandra Heath MD Ph.D|005912 2785037|draheath@gmail.com|
22443444|NCT04535167|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22443445|NCT00978432|Duke University Medical Center|Anne Beaven, MD|919-684-8964|anne.beaven@duke.edu|
22443446|NCT02352922|Center for Advanced Gynecology, PLLC|Dr. Kenneth I Barron|5088876896|kenneth.barron.md@gmail.com|
22443447|NCT04656275|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22443448|NCT00329901|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22443449|NCT05028361|Duke Human Vaccine Institute|Emmanuel Walter|919 620 5346|chip.walter@duke.edu|
22443450|NCT01993836|Duke University|Miles Berger, MD, PhD|919-684-8679|miles.berger@duke.edu|
22443451|NCT02195687|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22443452|NCT00779259|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22443453|NCT02288377|FFCD|Karine Le Malicot|+ 33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
22443454|NCT00924781|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22443455|NCT05765227|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22443456|NCT01887743|Children's Mercy Kansas City|Valentina Shakhnovich, MD|816-302-3068|vshakhnovich@cmh.edu|
22443457|NCT03459690|Beth Israel Deaconess Medical Center|Balachundhar Subramaniam|617-634- 2721|bsubrama@bidmc.harvard.edu|
22443458|NCT02963831|Ludwig Institute for Cancer Research|Jonathan Skipper|12124501539|jskipper@lcr.org|
22443459|NCT01230177|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22443460|NCT02538783|UPenn|Catherine Reale|215-746-4009|catherine.reale@uphs.upenn.edu|
22443461|NCT02830438|AlbertEHN|Mario Naranjo-Tovar|2157965542|mario.edu6@hotmail.com|
22443462|NCT02536404|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
22443463|NCT02514473|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22443464|NCT02158364|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22443465|NCT04381988|Memorial Sloan Kettering Cancer Center|Dr. Nancy Lee, MD|212-639-3341|leen2@MSKCC.ORG|
22443466|NCT02106923|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22443467|NCT03485495|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22443468|NCT03915860|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22443469|NCT01178827|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22443470|NCT01107379|Acclarent, Inc.|Clinical Director|650-687-5888|lenglan1@its.jnj.com|
22443471|NCT04559529|Vanderbilt University Medical Center|Stephan Heckers, MD; Principal Investigator|6153222665|stephan.heckers@vumc.org|
22443472|NCT01325792|W. L. Gore & Associates, Inc., Sponsor|Lori Norton, PhD|800-437-8181|lnorton@wlgore.com|
22443473|NCT03734705|Stanford University|Katie Fracalanza, PhD|408-769-0589|kfracalanza@stanford.edu|
22443474|NCT00732940|GlaxoSmithKline|GSK Response Center|866-435-7343||
22443475|NCT01642732|University of Michigan Hospital|Dr. Daniel Hamstra, Associate Professor of Radiation Oncology|734-936-4300|dhamm@umich.edu|
22443476|NCT02805504|Loma Linda University Health|Duane Baldwin, MD Director of Urologic Research|909 558 4196|dbaldwin@llu.edu|
22398018|NCT05726318|University of Pittsburgh|Megan Bradley, MD|412-641-3189|bradleym4@upmc.edu|
22398019|NCT05882318|Valencia Technologies|Dylan Beyer|+1 (661) 775-1414|dbeyer@valenciatechnologies.com|
22398020|NCT05030311|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22398021|NCT03042468|Weill Cornell Medicine|Dr. Scott Tagawa|646-962-2027|stt2007@med.cornell.edu|
22398022|NCT02264990|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22398023|NCT04749459|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22398024|NCT03031301|Vibrantgastro|clinical trial manager|046663322|service@vibrantgastro.com|
22398025|NCT00267748|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22398026|NCT01294800|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22398027|NCT03326843|Dova Pharmaceuticals|Associate Director, Clinical Operations|919-338-7864|clinical@dova.com|
22398028|NCT01662895|Beth Israel Deaconess Medical Center|Magdy Selim, MD, PhD|617-63208913|mselim@bidmc.harvard.edu|
22398029|NCT00493038|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22398030|NCT01100944|National Cancer Institute|Dr. Arun Rajan|301-594-5322|rajana@mail.nih.gov|
22398031|NCT01665807|Mount Sinai Hospital, IDERU|Brenda L. Coleman, PhD,|416-586-4800|bcoleman@mtsinai.on.ca|4538
22398032|NCT01618214|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22398033|NCT01179009|Washington University|Michael Yingling|5735791412|yinglinm@wustl.edu|
22398034|NCT00623428|Hoffman-LaRoche|Medical Communications|800-821-8590||
22398035|NCT02937818|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22398036|NCT01692301|Novartis Pharmaceuticals|Study Directors|862-778-8300|trialandresults.registries@novartis.com|
22398037|NCT01142726|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22398038|NCT01568593|Laboratoires Thea|Dr Pascale POULIQUEN|0473981436|p.pouliquen@laboratoires-thea.fr|
22398039|NCT02109484|Chris Hani Baragwanath Academic Hospital|Michelle J. Groome, MD, PhD|+27 11 983 4283|groomem@rmpru.co.za|
22398040|NCT00796315|Procter & Gamble|Guhan Balan|513.622.2657|balan.g@pg.com|
22398041|NCT00574275|Sanofi|International Clinical Development Study Director||Contact-Us@sanofi.com|
22398042|NCT02249143|OHSU|Cindy McEvoy, MD|503-494-0223|mcevoyc@ohsu.edu|
22398043|NCT00889265|Zimmer Dental|Dr Hai Bo Wen, Director of Research|760-929-4312|haibo.wen@zimmer.com|
22398044|NCT03028870|Purdue Pharma L.P.|Clinical Leader|1-800-733-1333|steven.ripa@pharma.com|
22398045|NCT01618942|Huazhong University of Science&Technology|Xianwei Zhang|027 83662853|ourpain@163.com|
22398046|NCT01294579|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22398047|NCT02788747|Stealth BioTherapeutics Inc.|Jim Carr PharmD Chief Clinical Development Officer|617-600-6888|jim.carr@stealthbt.com|
22443477|NCT01230125|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22398048|NCT01223703|Department of Experimental and Applied Medicine-Section of Cardiovascular Diseases|Dr Savina Nodari|00390303996|nodari@med.unibs.it|587
22398049|NCT00562354|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22398050|NCT00784654|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22398051|NCT02864368|Duke University Medical Center|Principal Investigator|(919) 684-5301|dukebrain1@duke.edu|
22443478|NCT01589770|Vanderbilt University Medical Center|Dr. C. M. Stein|615-936-3420|michael.stein@vanderbilt.edu|
22398052|NCT03676010|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Dr Carine Bellera|+33 (0)5 56 33 33 33|c.bellera@bordeaux.unicancer.fr|4495
22443479|NCT00270842|James A. Haley VA|Dr. Patricia A. Quigley|8135583912|patricia.quigley@va.gov|
22443480|NCT01143701|Cincinnati Children's Hospital Medical Center|Jeff Epstein, Ph.D.|5136368296|jeff.epstein@cchmc.org|
22443481|NCT00368290|University of Pennsylvania|Dr. Kyle Kampman|215-222-3200|kampman@mail.med.upenn.edu|109
22398053|NCT00802204|Vanderbilt University|Julia Dunn, MD|615-343-8389|julia.dunn@va.gov|
22398054|NCT04205409|University of Washington|Dr. Andrew Cowan|2066067348|ajcowan@fredhutch.org|
22398055|NCT01014689|Galderma|Florence Paliargues / CPM|+33492952957|florence.paliargues@galderma.com|
22398056|NCT02159703|University of Pennsylvania|Alexander Lin, MD|(215) 662-3198|alexander.lin@uphs.upenn.edu|
22398057|NCT04418076|Associate Director Domestic Projects|Natalie Kil|203.737.2883|natalie.kil@yale.edu|
22398058|NCT02549209|Hoosier Cancer Research Network|Fauzia Sharmin|(317) 634-5842|fsharmin@hoosiercancer.org|75
22398059|NCT01344876|Otsuka Pharmaceutical Co., Ltd|"Leader of Department of Small Global Clinical Development"|+81-3-6361-7366||
22398060|NCT05107765|The University of Texas Health Science Center of Houston|Jin H Yoon, PhD|713-486-2800|jin.ho.yoon@uth.tmc.edu|
22398061|NCT00562588|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22398062|NCT03473145|UC San Diego|Sheri Hartman|(858) 534-9235|sjhartman@health.ucsd.edu|
22398063|NCT04417699|OHSU Knight-Legacy Health Cancer Collaborative|Dr. Hagen Kennecke|971-262-9600|kennecke@ohsu.edu|
22398064|NCT03047980|Kennedy Krieger Institute|Research Assistant|443-923-9569|vedmurthyp@kennedykrieger.org|3-9569
22398065|NCT02164981|Massachusetts General Hospital|Maurizio Fava, MD|617-724-2513|MFAVA@mgh.harvard.edu|
22398066|NCT02240654|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22398067|NCT01761266|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22398068|NCT01662440|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
22398069|NCT00112905|ECOG Statistical Office|Study Statistician|617-632-3012||
22443482|NCT01402427|State Health Center, Hungary|Istvan Hizoh, MD, PhD / Senior Consultant|+36 1 4651800|ihizoh@web.de|71773
22398070|NCT01765673|James Madison University|Christy Ludlow|540-937-3007|ludlowcx@jmu.edu|
22398071|NCT02600507|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646-440-9333|ITCIClinicalTrials@itci-inc.com|
22398072|NCT01975922|Vanderbilt University|Ann Kaiser|615-322-8163|ann.kaiser@vanderbilt.edu|
22398073|NCT04541004|ALK-Abelló A/S|David Hal Mollerup, Senior Director|+45 45747576|ClinicalTrials@alk.net|
22443483|NCT00890045|Houston Methodist Hospital|George M. Nassar M.D.|713-790-1963|georgemnassar@gmail.com|
22443484|NCT00510653|The University of Texas (UT) MD Anderson Cancer Center|David Gershenson, MD / Professor||CR_Study_Registration@mdanderson.org|
22443485|NCT00481507|GEORGETOWN UNIVERSITY|Daniel Merenstein, MD|202-687-2745|djm23@georgetown.edu|
22443486|NCT00819793|Abbott|Poornima Sood||psood@sjm.com|
22443487|NCT01077375|Forest Research Institute|Allan Spera, Director, Clinical Development|(201) 427-8399|Allan.Spera@frx.com|
22428995|NCT02813447|Duke University Medical Center|Neil MacIntyre|919 681 2720|macin001@mc.duke.edu|
22443488|NCT02581839|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Paula Silverman|1-800-641-2422|CTUreferral@UHhospitals.org|
22443489|NCT04711837|Haisco USA Pharmaceutical Inc.|Yu-Ling Lai Senior Director Clinical Operations|1 732-26-4759|Yuling.lai@Haisco-usa.com|
22443490|NCT03021564|Groupe Hospitalier de la Rochelle Ré Aunis|Dr Maxime Leloup|+33 (0)5 46 45 66 09|maxime.leloup@ght-atlantique17.fr|
22443491|NCT00056498|Maryland Psychiatric Research Center|Robert W. Buchanan, MD|410-402-7876|rwbuchanan@mprc.umaryland.edu|
22443492|NCT02520089|Universidad Autonoma de Nuevo Leon|Dr. Carlos Alberto Acosta-Olivo|+528183476698|dr.carlosacosta@gmail.com|
22443493|NCT01634191|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22443494|NCT01981551|National Cancer Institute|Dr. Geraldine H O'Sullivan Coyne|240-781-3371|osullivancoyngh@nci.nih.gov|
22443495|NCT05486416|Haisco-USA Pharmaceuticals, Inc.|Yu-Ling Lai|858-263-4239|yuling.lai@haisco-usa.com|
22443496|NCT01451437|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22443497|NCT01252732|Melinta Therapeutics, Inc.|Karen Fusaro|6098270956|kfusaro@melinta.com|
22443498|NCT03274999|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22443499|NCT00130442|Progen Pharmaceuticals Ltd|Director of Regulatory Affairs and Clinical Development|+61 (0)7 38423333|darrynb@progen-pharma.com|
22443500|NCT00814333|University of Kansas Medical Center|Kevin Sykes, PhD|913-588-7154|ksykes@kumc.edu|
22443501|NCT02233946|Boston Children's Hospital|Dr. Sion Kim Harris|8572184304|sion.harris@childrens.harvard.edu|
22443502|NCT01527357|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22443503|NCT02927067|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22443504|NCT02292784|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22443505|NCT00622739|Baylor College of Medicine|Kirti Saxena|832-822-4065|kxsaxen1@texaschildrens.org|
22443506|NCT00134784|Institute for Neurodegenerative Disorders|Principal Investigator|203 401 4300|kmarek@indd.org|
22443507|NCT03384693|University of California, San Francisco|Dr. Christine Higham|415-476-2188|christine.higham@ucsf.edu|
22443508|NCT03621475|University of Vermont|Renee Stapleton, MD, PhD|(802) 656-7975|renee.stapleton@med.uvm.edu|
22443509|NCT00371761|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22443510|NCT02713256|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
22443511|NCT00718081|AcelRx|Dr. Pamela Palmer|650-216-3500|ppalmer@acelrx.com|
22443512|NCT01397825|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22443513|NCT00357032|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22443514|NCT01931670|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22443515|NCT01689909|Medical College of Georgia; Augusta University|William Vaughn McCall|706-721-6719|WMCCALL@augusta.edu|
22443516|NCT03042702|Innovation Pharmaceuticals|Arthur P. Bertolino MD, PhD, MBA|9789214125|abertolino@IPharmInc.com|
22443517|NCT00976508|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22443518|NCT01992159|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22443519|NCT00470158|AHRQ|Stephanie Chang|301 427-1490|stephanie.chang@ahrq.hhs.gov|
22443520|NCT00997438|VA Portland Health Care System|Dr. Sonemany Salinthone|5032208262|salintho@ohsu.edu|54394
22443521|NCT01236118|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22443522|NCT00095238|Britol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22443523|NCT02579928|Yale University|Dr. Michael H. Bloch|2037374539|michael.bloch@yale.edu|
22443524|NCT04300751|University of Kentucky|Director for the Center on Drug and Alcohol Research|859-257-6485|Sharon.Walsh@uky.edu|
22443525|NCT05033002|Duke University School of Nursing|Michael Relf, Ph.D.|919-684-9219|michael.relf@duke.edu|
22443526|NCT03754972|Medical Metrics, Inc|Trevor Grieco|713-850-7500|tgrieco@medicalmetrics.com|247
22398074|NCT05048719|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22428996|NCT04167670|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|Please email|medicalinformation@phathompharma.com|
22428997|NCT05399485|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22428998|NCT02955394|University of Colorado Hospital|Anthony Elias|720-848-0300|anthony.elias@cuasnchutz.edi|
22428999|NCT03554473|National Cancer Institute|Dr. Anish Thomas|2407607343|anish.thomas@nih.gov|
22429000|NCT01363076|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com|
22429001|NCT02014103|University of Cincinnati|Rita Alloway|513.558.1568|rita.alloway@uc.edu|
22429002|NCT04439175|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22429003|NCT03128086|HOSPITAL UNIVERSITARIO GENERAL DE CASTELLÓN, SPAIN. CONSELLERIA SANITAT|DR. ALBERTO BELENGUER-MUNCHARAZ|964 72 50 00|belengueralberto8@gmail.com|
22429004|NCT05417113|Icahn School of Medicine at Mount Sinai|Dr. Christina Jeng|212-241-4743|christina.jeng@Mountsinai.org|
22429005|NCT01847209|Brigham and Women's Hospital|Dr. Raphael Bueno|617-732-8148|rbueno@partners.org|
22443527|NCT02311582|Washington University School of Medicine|Milan G. Chheda, M.D.|314-747-2712|mchheda@wustl.edu|
22429006|NCT00729586|NRG Oncology|Angela Kuras on behalf of Virginia Filiaci|716-845-5702|kurasa@nrgoncology.org|
22429007|NCT01631188|Rutgers University|Enrique Pantin, MD|7328900640|pantinej@rwmjs.rutgers.edu|
22429008|NCT01870596|Sidney Kimmel Comprehensive Cancer Center|B. Douglas Smith|(410) 287-2935|bdsmith@JHMI.edu|
22429009|NCT05416515|Mayo Clinic|Peter Amadio, M.D.|507-538-1296|pamadio@mayo.edu|
22429010|NCT01858948|University of Cincinnati|Dr. Robert McNamara|513-558-5601|robert.mcnamara@uc.edu|
22429011|NCT02513199|Icahn School of Medicine at Mount Sinai|Michael Buckstein|212-241-7502|michael.buckstein@mountsinai.org|
22398075|NCT00605085|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar-kastner@intercell.com|1175
22398076|NCT03257267|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22429012|NCT03712852|Università degli studi G. D'ANNUNZIO|Prof. Michele Paolantonio|3395204073|mpaolantonio@unich.it|
22429013|NCT02582632|AbbVie|Global Medical Services|800-633-9110||
22429014|NCT01956942|Ophthalmology Department The George Washington University|Dr. David Belyea|2027412800|dbelyea@mfa.gwu.edu|
22429015|NCT04307394|Butler Hospital|Brandon Gaudiano, Ph.D.|401-455-6457|brandon_gaudiano@brown.edu|
22429016|NCT02323334|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22429017|NCT00818272|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22429018|NCT01617967|Alnylam Pharmaceuticals, Inc.|Chief Medical Officer|1-877-256-9526|medinfo@alnylam.com|
22429019|NCT02453048|ILIAD Biotechnologies|Ken Solovay|9543360777|ken@iliadbio.com|
22429020|NCT02346916|Bassett Healthcare Network Research Institute|Melissa B Scribani|6075477635|melissa.scribani@bassett.org|
22429021|NCT00447278|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22429022|NCT03677401|Menlo Therapeutics, Inc.|Iain Stuart|1-800-775-7936|Iain.Stuart@foamix.com|
22429023|NCT06262607|Clexio Biosciences Ltd|Regulatory Affairs Lead|972-733318704|myriam.belahcen@clexio.com|
22429024|NCT00574951|NRG Oncology|Angela Kuras on behalf of Mike Sill, PhD|716-845-5702|kurasa@nrgoncology.org|
22429025|NCT05161936|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
22429026|NCT01692756|Univerisity of Kentucky|Cale Jacobs, ATC, PhD|8592183065|Kycartilagedoc@gmail.com|
22429027|NCT01017497|Duke University Medical Center|John Kirkpatrick MD|919 6687342|john.kirkpatrick@dm.duke.edu|
22429028|NCT03759184|National Cancer Institute|Dr. Kevin Conlon|240-858-3570|conlonkc@mail.nih.gov|
22429029|NCT01431846|Eastern Colorado Health Care System|Dr. Michael Ho|720-857-5115|michael.ho@va.gov|
22429030|NCT01119222|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22429031|NCT00585650|Wake Forest Baptist Health, Department of Dermatology|Steven Feldman, MD, PhD|336-716-3775|sfeldman@wakehealth.edu|
22429032|NCT04925934|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22429033|NCT03144635|Kyushu University Hospital|Dr. Eiichi Ogawa / Assistant Professor|81926425909|eogawa@gim.med.kyushu-u.ac.jp|
22429034|NCT04425018|Dana-Farber Cancer Institute|Adrienne G. Waks, MD|617-632-3800|adrienne_waks@dfci.harvard.edu|
22429035|NCT04913636|Procter & Gamble|Clinical Trial Manager|513-622-4601|conde.e.1@pg.com|
22429036|NCT01163656|The Children's Hospital of Philadelphia|John Fiadjoe, MD|215-590-3916|fiadjoej@email.chop.edu|
22429037|NCT02337946|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22429038|NCT01327703|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
22429039|NCT00728923|New York State Psychiatric Institute|Dr. Carolyn Rodriguez|212-543-5637|cr2163@columbia.edu|
22429040|NCT01131585|Novartis Pharmaceuticals|Study Director|41 61 324 1111||
22429041|NCT00812097|Mentor|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
22429042|NCT01786109|Mayo Clinic|Dr. Michael Camilleri|507-266-2306|camilleri.michael@mayo.edu|
22429043|NCT02641834|Department of Experimental and Clinical Medicine, University of Florence, Italy|Prof. Francesco Sofi|+390557949429|francescosofi@gmail.com|
22429044|NCT00781950|St. Boniface Hospital Research Centre|Dr. Grant Pierce|(204) 235-3414|GPierce@sbrc.ca|
22429045|NCT02949934|University of Colorado School of Medicine|Joseph P. Schacht, Ph.D.|(303) 724-3773|joseph.schacht@cuanschutz.edu|
22429046|NCT00657605|University of Miami|Richard Bookman|305-243-0494|y.p.davis@med.miami.edu|
22429047|NCT00849472|GlaxoSmithKline|GSK Response Center|866-435-7343||
22429048|NCT04536038|Hospital of the University of Pennsylvania|Alexander C. Fanaroff, MD, MHS|2156157674|alexander.fanaroff@pennmedicine.upenn.edu|
22429049|NCT05887401|University of North Carolina at Chapel Hill|Dr. Erin Coffman|9195254677|erin.coffman@advocatehealth.org|
22429050|NCT04530526|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
22429051|NCT05942040|Rutgers University|Dr. Elizabeth Luth, Principal Investigator|6465120670|eluth@rwjms.rutgers.edu|
22429052|NCT03442569|University of North Carolina Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
22429053|NCT06461455|Alcon Research, LLC|Sr. Principal, Clinical Project Management, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22429054|NCT06142383|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22429055|NCT05800145|Wake Forest University Health Sciences|Deepak Palakshappa, MD|3367161795|dpalaksh@wakehealth.edu|
22429056|NCT04827446|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
22429057|NCT04706403|UMass Chan Medical School|Dr. Kimberly Fisher|(508)8561975|Kimberly.Fisher@umassmemorial.org|
22429058|NCT02642679|Brigham and Women's Hospital|Indranil Sinha, MD|617-732-5282|isinha@bwh.harvard.edu|
22429059|NCT05206604|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22429060|NCT03735498|Massachusetts General Hospital|Dr. Deborah Forst|617-724-8770|dforst@partners.org|
22429061|NCT00371631|Michael E. DeBakey Veterans Affairs|Dr. Barbara Trautner, MD, PhD|713-440-4438|barbara.trautner@va.gov|
22429062|NCT00160615|Cares|UCB|+1844 599||2273
22398077|NCT01982292|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22398078|NCT03409744|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22398079|NCT04872101|LEO Pharma A/S|Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
22398080|NCT05804877|Chung Shan Medical University|Dr. Yun-Ling Chen|+886958226869|yunling.annie@gmail.com|
22398081|NCT00879229|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22398082|NCT00264004|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22398083|NCT02475681|Acerta Clinical Trials|Study Director|18882929613|acertamc@dlss.com|
22398084|NCT02323698|Spaulding Rehabilitation Hospital|Dr. Randy D Trumbower, PI|(617) 952-6953|randy.trumbower@mgh.harvard.edu|
22398085|NCT01262365|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22398086|NCT00494091|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22398087|NCT01265459|Q-Med AB|Head of Medical Affairs|+46 (0) 18 4749000|reception.SEUPP@galderma.com|
22398088|NCT00527605|GlaxoSmithKline|GSK Response Center|866-435-7343||
22398089|NCT01480297|The University of Michigan|Rodica Pop-Busui, MD, PhD|734-763-3056|rpbusui@umich.edu|
22398090|NCT03126760|Mallinckrodt|Medical Information Call Center|800-844-2830|medinfo@mnk.com|
22398091|NCT01535365|Stony Brook U|Adam Singer|631-444-7856|adam.singer@stonybrook.edu|
22398092|NCT04312009|University of Minnesota|Christopher Tignanelli|612-626-1968|ctignane@umn.edu|
22398093|NCT01363986|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22398094|NCT01869647|Yale Emergency Medicine|Dr. Chris L. Moore|(203)737-3313|chris.moore@yale.edu|
22398095|NCT01390909|GlaxoSmithKline|GSK Response Center|866-435-7343||
22398096|NCT02354703|University of Maryland School of Medicine|Dr. David Gorelick|410-408-6806|dgorelick@som.umaryland.edu|
22398097|NCT02848079|Yale University|Dr. Jeremy Kortmansky|1 (203) 407-8002|jeremy.kortmansky@yale.edu|
22398098|NCT00699348|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22398099|NCT00122135|Center for Innovations in Quality, Effectiveness, and Safety (IQuESt), MEDVAMC, Houston, TX|Dr. Ursula Braun|832 687 1645|ubraun@bcm.edu; ursula.braun@va.gov|
22398100|NCT03269344|Henry Ford Cancer Institute|Dr. Andrew Cook|3135568400|acook11@hfhs.org|
22398101|NCT01099202|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes M.D./Professor|713/794-5783|eharriso@mdanderson.org|
22429063|NCT05638737|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22429064|NCT06059066|Houston Methodist Hospital|Julu Benoy|(713) 441-6455|jbenoy@houstonmethodist.org|
22429065|NCT05225727|The University of Texas Health Science Center at Houston|Melissa Peskin, PhD|713-500-9759|melissa.f.peskin@uth.tmc.edu|
22429066|NCT03928704|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22429067|NCT00580398|Massachusetts General Hospital|Elyse Park, Ph.D., MPH|617-724-6836|epark@partners.org|
22429068|NCT00327171|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
22429069|NCT01363440|Regeneron|Clinical Trial Management|914 847 7000|clinicaltrials@regeneron.com|
22429070|NCT00992836|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|919-405-1429|mallen@fhi360.org|
22429071|NCT00266812|Merck, Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22429072|NCT03695094|Cares|UCB|+1844 599|clinicaltrials@ucb.com|2273
22429073|NCT00530075|Nippon Kayaku Co., Ltd.|Pharmaceuticals Group|+81-3-6731-5200||
22429074|NCT04764539|iTherapy, LLC|Lois Brady, CEO|9258120037|lois@itherapyllc.com|
22429075|NCT00416949|SKCCC|George Sgouros|4106140116|gsgouros@jhmi.edu|
22429076|NCT01166945|University of Wisconsin School of Medicine and Public Health|Ellen Wald, MD|608-263-8558|erwald@pediatrics.wisc.edu|
22429077|NCT03228914|The University of Texas Health Science Center at Houston|William C. Yao, MD|713-500-5410|william.c.yao@uth.tmc.edu|
22429078|NCT00977184|Department of Neurology, Centre Hospitalier Universitaire Vaudois|David H. Benninger, MD||David.Benninger@chuv.ch|
22429079|NCT03520569|University of Virginia|Eugene Barrett|434-924-1263|EJB8X@VIRGINIA.EDU|
22429080|NCT01178411|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22429081|NCT00784927|Mayo Clinic Arizona|Craig B. Reeder, MD||Reeder.Craig@mayo.edu|
22429082|NCT00714272|eXcorLab GmbH|Dr. Horst-Dieter Lemke|+49-6022-812648|horstdieter.lemke@excorlab.de|
22429083|NCT01471574|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22429084|NCT01795937|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22429085|NCT01137812|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
22429086|NCT03380572|Imperial College London|Mr R Aggarwal|02033126840|r.aggarwal@ic.ac.uk|
22429087|NCT00357162|Washington University|Amanda Cashen, M.D.||acashen@im.wustl.edu|
22429088|NCT03927157|AstraZeneca|Global Clinical Head|1-877-240-9479|information.center@astrazeneca.com|
22429089|NCT02965716|SWOG Data Management Center|Melanoma Committee Statistician|206-667-4623|jmoon@fredhutch.org|
22429090|NCT04368910|Medicines for Malaria Venture|Stephan Duparc, MD|+41 22 555 0300|duparcs@mmv.org|
22429091|NCT02265744|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22429092|NCT00923702|International Agency for Research on Cancer|Dr Partha Basu|+3347273|basup@iarc.fr|8167
22429093|NCT01086475|Christian Sarkine Autism Treatment Center|Dr. Minshawi|317-944-8162|nminshaw@iupui.edu|
22429094|NCT02249793|Upenn|Dr. Carsten Skarke|215-573-0673|cskarke@pennmedicine.upenn.edu|
22443528|NCT05822531|Penn State College of Medicine|Ian Paul|(717) 531-8006|ipaul@pennstatehealth.psu.edu|
22398102|NCT04478708|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22398103|NCT01869114|Thomas Jefferson University|Margaret T Kasner, MD|215-955-3202|Margaret.Kasner@jefferson.edu|
22429095|NCT05950906|Calibr-Skaggs|Director of Clinical Operations|(858) 242-1000|abrooks@scripps.edu|
22443529|NCT03404960|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
22443530|NCT03544775|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
22443531|NCT05204381|University of North Carollina at Chapel Hill|Zachary Stewart|919-966-9929|zachary_stewart@med.unc.edu|
22443532|NCT06312462|Jiangsu Institute of Parasitic Diseases|Dr. Huang Yuzheng|19941716698|huangyuzheng@jipd.com|
22443533|NCT05171816|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22443534|NCT00300742|UVA Center for Addiction Research and Education|Dr. Nassima Ait-Daoud|434-243-0541|uvacare@virginia.edu|
22443535|NCT04902326|University of Michigan Medical School|Jeffrey Kullgren|734-845-3613|jkullgre@med.umich.edu|
22443536|NCT03513848|University of California, Irvine|Alyson Zalta|949-824-3409|azalta@uci.edu|
22443537|NCT01857310|NICHD|Dr. Enrique Schisterman|3014356893|schistee@mail.nih.gov|
22443538|NCT02360605|LSUShreveport|Dr. Connie Arnold|318-675-4324|carnol@lsuhsc.edu|
22443539|NCT00290407|James Graham Brown Cancer Center|Roger H Herzig, MD|502/396-3119|rhherz01@louisville.edu|
22443540|NCT01076296|GE Healthcare|Anita Johnson|262-548-2825|Anita.Johnson@ge.com|
22443541|NCT02757950|GlaxoSmithKline|GSK Clinical Trials|877-379-3718|GSKClinicalSupportHD@gsk.com|
22443542|NCT00868517|Department of Veterans Affairs|Michelle Kennedy Prisco|202-745-8000|michelle.prisco@va.gov|56235
22443543|NCT01721577|Rush University Medical Center|Crista Brawley|312-563-2312|crista_brawley@rush.edu|
22443544|NCT05442775|Cytokinetics|Cytokinetics MD|650-624-2929|medicalaffairs@cytokinetics.com|
22443545|NCT03723603|Medline Industries, Inc|Stephanie Martynenko|2242163822|smartynenko@medline.com|
22443546|NCT01055496|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22443547|NCT00584740|Novartis|Study Director|862-778-8300||
22443548|NCT03681288|PROVIDENCE VAMC/ BROWN UNIVERSITY|Erica Eaton, Ph.D.|14012737100|erica_eaton@brown.edu|13428
22443549|NCT00969280|Korea Institute of Oriental Medicine|Tae-Hun Kim, Researcher|82-10-6532-5524|rockandmineral@gmail.com|
22443550|NCT00821327|US Oncology Research, McKesson Specialty Health|Dr. Matthew D. Galsky|212-659-5412|matthew.galsky@mssm.edu|
22443551|NCT00217464|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22443552|NCT00459979|CCCC|Dr. Brian Rini|216-444-9567|rinib2@ccf.org|
22443553|NCT00278915|AstraZeneca Clinical study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
22443554|NCT05214573|Mayo Clinic|Rozalina McCoy, M.D., M.S.|507-538-7955|mccoy.rozalina@mayo.edu|
22443555|NCT00814801|Janssen Pharm KK Japan|Director|81-3-4411-5717||
22443556|NCT04148872|University of Wisconsin - Madison|Scott Chaiet, MD|608-263-0192|chaiet@surgery.wisc.edu|
22443557|NCT02103153|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22443558|NCT02081248|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
22443559|NCT01037088|UCaliforniaDavis|Dr. Barth Wilsey, MD|916-843-9082|blwilsey@ucdavis.edu|
22443560|NCT02216812|Massachusetts General Hospital|Dr. Neal Chen|617-726-4700|nchen1@mgh.harvard.edu|
22443561|NCT01986933|Chugai Pharmaceutical|Clinical trials information||clinical-trials@chugai-pharm.co.jp|
22443562|NCT01077154|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22443563|NCT00604214|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22443564|NCT00534599|AstraZeneca|Gerard Lynch||AZtrial_results_posting@astrazeneca.com|
22443565|NCT07123272|University of Michigan|Anna Kratz|734-647-5982|alkratz@med.umich.edu|
22443566|NCT06447688|Medicalpark Hospital|Sefa SURAL|+90 532 565 0160|sesural@hotmail.com|
22443567|NCT01752712|Maryland Psychiatric Research Center|Robert W. Buchanan, M.D.|410-402-7876|rwbuchanan@mprc.umaryland.edu|
22443568|NCT04285580|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22443569|NCT01879579|New York University School of Medicine|Dr. Natalie Levy|2122638924|Natalie.Levy@nyumc.org|
22443570|NCT01695668|University of Michigan|Dr Shahzad Mian|734-647-8397|smian@med.umich.edu|
22443571|NCT02935543|Univ. of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
22443572|NCT04948866|University of North Carolina at Chapel Hill|Kathryn Wessell, MPH|919-966-2939|kwessell@email.unc.edu|
22443573|NCT02155946|VA Ann Arbor|Dr. Benjamin Hampstead|734-763-9259|bhampste@med.umich.edu|
22443574|NCT00815516|Astellas Pharma Global Development, Inc. (APGD)|Senior Medical Director, Global Medical Science||Astellas.resultsdisclosure@astellas.com|
22443575|NCT00244842|Aurinia Pharmaceuticals Inc.|Robert Huizinga|250-708-4322|rhuizinga@auriniapharma.com|
22443576|NCT06460493|Verona Pharma|Clinical Development|844-341-9901|clinicaltrials@veronapharma.com|
22443577|NCT02607514|Massachusetts General Hospital|Maren Nyer|6072796290|mnyer@partners.org|
22443578|NCT02642744|University of Pennsylvania|Laura Stein|215-662-6214|laura.stein@pennmedicine.upenn.edu|
22443579|NCT00075270|GlaxoSmithKline|GSK Response Center|866-435-7343||
22443580|NCT00246571|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22443581|NCT00775203|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
22443582|NCT02987660|Alcon, A Novartis Division|Sr. Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22443583|NCT03422627|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22443584|NCT05247398|University of Minnesota|Corey McGee|612-626-5645|mcge0062@umn.edu|
22443585|NCT04251156|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22443586|NCT02937571|Memorial Sloan Kettering Cancer Center|Dr. Neha Korde, MD|646-608-3708|korden@mskcc.org|
22412018|NCT04471428|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22443587|NCT03675321|Medical College of Wisconsin|Clinical Research Manager|4142666131|ksiegel@mcw.edu|
22443588|NCT05293392|Nemours Children's Health|Thao-Ly Phan, MD, MPH|302-331-7342|thaoly.phan@nemours.org|
22443589|NCT02397564|University of Louisville|W. James Tidwell|5025831749|wjamestidwell@gmail.com|
22443590|NCT04656899|Washington State University Elson S. Floyd College of Medicine, Analytics and PsychoPharmacology Laboratory (APPL)|Dr. Crystal Smith (backup: Dr. Sterling M. McPherson)|(509) 368-6876|crystal.lederhos@wsu.edu|
22443591|NCT00934648|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22443592|NCT01848782|Assistance publique hopitaux de paris|Isabelle Boutron|+33 1 42 34 78 33|isabelle.boutron@htd.aphp.fr|
22443593|NCT00461331|Tulane University Health Sciences Center|Tina K. Thethi, MD, MPH|504-988-5044|tthethi@tulane.edu|
22443594|NCT01155479|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22443595|NCT00689091|University of Michigan|Dr. George A Mashour|734-936-4280|gmashour@med.umich.edu|
22443596|NCT01933789|University of Washington|Dr. J. Randall Curtis|206-744-3356|jrc@uw.edu|
22443597|NCT03398278|Mundipharma(China) Pharmaceutical. Co. Ltd|Rongna. A|86 10 65636885|rongna.a@mundipharma.com.cn|
22443598|NCT04739865|COMPASS Pathways|Chief Medical Officer|07443136539|info@compasspathways.com|
22443599|NCT01966432|Duke University, Dept. of Psychiatry and Behavioral Sciences|Dr. Li-Tzy Wu, Professor in Psychiatry|(919) 889-9369|litzy.wu@duke.edu|
22443600|NCT01698710|Massachusetts General Hospital|Dr. William Brugge|6173083532|Brugge.William@mgh.harvard.edu|
22443601|NCT03102190|Massachusetts Eye and Ear Infirmary|Project Manager, Clinical Trials|617-573-6981|elizabeth_grimm@meei.harvard.edu|
22443602|NCT03562767|Emory University|Dr. Ambar Kulshreshtha|(404) 686-2410|akulshr@emory.edu|
22443603|NCT02004288|Sestre milosrdnice University Hospital Center Vinogradska 29, Zagreb, Croatia|Orjena Žaja, MD MSc PhD primarius Ass Prof Pediatrics, Pediatric gastroenterologist|P:+38513787342 M:+3859937872|Orjena Žaja <orjenazf@yahoo.com>|
22443604|NCT02518464|Columbia University Medical Center|Robert Sommer, MD|212-305-7060|rs2463@cumc.columbia.edu|
22443605|NCT01120067|VA Boston Healthcare System|John Otis|857-364-5740|john.otis@va.gov|
22443606|NCT03761797|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22443607|NCT00266877|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
22443608|NCT03720392|Massachusetts General Hospital|Zachariah DeFilipp, MD|617-643-3944|ZDEFILIPP@MGH.HARVARD.EDU|
22443609|NCT00495079|Talon Therapeutics|Chief Medical Officer|650-588-6404|info@talontx.com|
22443610|NCT00527488|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22443611|NCT03036800|University of Leicester|Prof Melanie Davies|0116 258 6481|melanie.davies@uhl-tr.nhs.uk|
22443612|NCT04030026|Trevi Therapeutics, Inc.|Thomas Sciascia, MD, Chief Scientific Officer|203-304-2499|info@trevitherapeutics.com|
22398104|NCT00179309|National Cancer Institute, National Institutes of Health|Dr. James Gulley, M.D., Ph.D.|301-435-2956|gulleyj@mail.nih.gov|
22398105|NCT02698735|University of Southern California Department of Dermatology|Dr. David Woodley|(323)442-0084|dwoodley@med.usc.edu|
22398106|NCT01289015|Merz Pharmaceuticals, LLC|Stefan Plaum, MD Associate Medical Director|800-334-0514|clinicaltrials@merzusa.com|
22398107|NCT04302727|University of North Carolina at Chapel Hill|Thomas Keyserling, MD|984-974-4462|thomas_keyserling@med.unc.edu|
22398108|NCT05980299|Miami University|Dr. Katherine Abbott|513-529-0869|abbottkm@miamioh.edu|
22398109|NCT02246062|Faculdade de ciências médicas da Santa Casa de São Paulo|Dr Débora de Oliveira Cumino|+55 11 33617333|comissaocientifica@fcmsantacasasp.edu.br|
22398110|NCT00793650|Emory University|Dr. Sagar Lonial|404-727-5572|sloni01@emory.edu|
22398111|NCT02128230|University of Arkansas for Medical Sciences|Frits Van Rhee, MD|501-526-2873|vanrheefrits@uams.edu|
22398112|NCT05048342|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22398113|NCT01441063|National Cancer Institute|Dr. Robert Yarchoan|240-760-6075|robert.yarchoan@nih.gov|
22398114|NCT04418765|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
22398115|NCT02164422|Yale School of Medicine|Dr. Sherry McKee|2037373529|sherry.mckee@yale.edu|
22398116|NCT01558661|Memorial Sloan Kettering Cancer Center|Dr. Alan Ho, MD, PhD|646-888-4235|hoa@mskcc.org|
22398117|NCT03345472|Medtronic Restorative Therapies Group, Spinal Cord Stimulation|Stacie Hallaway/Senior Clinical Research Specialist|763-526-3844|RS.VectorsPM@medtronic.com|
22398118|NCT01926782|Regeneron Pharmaceuticals, Inc|Clinical Trial Management||clinicaltrials@regeneron.com|
22398119|NCT02154386|UT Health Science Center San Antonio (School of Dentistry)|Dr. Brian Mealey|210-567-3567|mealey@uthscsa.edu|
22398120|NCT04607733|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22398121|NCT02482675|The Ohio State University|Richard Bruno, PhD, RD|6142925522|bruno.27@osu.edu|
22398122|NCT04668352|Adicet Bio|Nick Harvey|857-315-5528|nharvey@adicetbio.com|
22398123|NCT01639833|Covidien|Michael Rohan|781-839-1757|Michael.Rohan@Covidien.com|
22398124|NCT03504397|Astellas Pharma Global Development, Inc|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
22398125|NCT00070941|NYU Parkinson and Movement Disorders Center|Dr. Alessandro Di Rocco|212-263-4838|Alessandro.Dirocco@nyumc.org|
22398126|NCT01888640|University of Iowa|Dr. Kathleen A. Sluka|319-335-9791|kathleen-sluka@uiowa.edu|
22398127|NCT02199080|Groupe Hospitalier de la Rochelle Ré Aunis|Dr Antoine Milhem|+33546455050|antoine.milhem@ch-larochelle.fr|
22398128|NCT02443883|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
22398129|NCT01277549|Terumo BCT|Jerome R Bill, M.D.|303-231-4729|jerry.bill@terumobct.com|
22398130|NCT00999908|Novartis Pharmaceuticals|Study Director|862 778-8300||
22398131|NCT00684788|Hopkins School of Medicine: Department of Psychiatry|Dr. Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
22398132|NCT01097863|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22398133|NCT00419380|University of Colorado School of Medicine - Department of Pediatric Otolaryngology|Kenny H. Chan, MD|7207774776|kenny.chan@childrenscolorado.org|
22398134|NCT03099707|Brigham and Women's Hospital|Ingrid T. Katz|617-525-8194|ikatz2@bwh.harvard.edu|
22398135|NCT03167073|Washington University of St Louis (where research was conducted). Now at Brown University|Dr. Adam Lewkowitz|401-274-1122|alewkowitz@kentri.org|47447
22383968|NCT01820260|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com|
22383969|NCT05444192|University of Central Lancashire|Dr Graham Chapman|01772894949|gchapman2@uclan.ac.uk|
22383970|NCT01285635|University of Michigan Cancer Center|Dr. Francis Worden, M.D.|734-936-0453|fworden@umich.edu|
22383971|NCT00505934|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22383972|NCT01046136|Reckitt Benckiser|Kim Clark|855.966.5483|ClinicalRequests@rb.com|
22383973|NCT02058108|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22383974|NCT01154192|UC San Diego School of Medicine|Dr. R. Jeffrey Chang|858-534-8930|rjchang@ucsd.edu|
22383975|NCT01376700|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22383976|NCT00727909|VA TVHS|Gene W. Bratt, Ph.D.|615-873-6068|gene.bratt@va.gov|
22429096|NCT02448043|Department of Ophthalmology, Northwestern University Feinberg School of Medicine|Dr. David J. Palmer|3126958150|dpalmermd@comcast.net|
22383977|NCT01696773|The Ohio State University|Steven J. Schwartz|614-292-2934|schwartz.177@osu.edu|
22383978|NCT05623345|Acelyrin Inc.|Clinical Trials Information Desk|+18054564393|clinicaltrials@acelyrin.com|
22383979|NCT06027229|UW School of Medicine and Public Health|Dr. Freddy Caldera, DO, PhD, MS|(608) 263-1995|fcaldera@medicine.wisc.edu|
22383980|NCT04630301|Johns Hopkins University|Dr. Jeffrey Thiboutot|410-502-2533|jthibou1@jhmi.edu|
22383981|NCT06459401|Boston University|Ashlyn Aiello|617-500-3645|ajma@bu.edu|
22383982|NCT01121991|EMD Serono Canada Inc., an affiliate of Merck KGaA, Darmstadt, Germany|Medical Responsible|+1-888-737-6668|david.sciberras@emdserono.com|5248
22383983|NCT02740231|Bone Therapeutics|Dr Olivier Godeaux Medical Officer|+32 71 12 10 00|jta.koa1@bonetherapeutics.com|
22383984|NCT00243503|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22383985|NCT04110054|Shionogi USA|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
22383986|NCT03693937|Sensus Healthcare|Isabelle Raymond|561-922-5808|iraymond@sensushealthcare.com|
22383987|NCT01000480|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22383988|NCT03988023|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|7204376500|clinicaltrials@ampiopharma.com|
22383989|NCT03655262|UCLA|Michelle Craske, Ph. D|(310) 825 8403|mcraske@mednet.ucla.edu|
22383990|NCT03733119|University of Wisconsin Carbone Cancer Center|Kari Wisinski, MD|608-262-2876|kbwisinski@medicine.wisc.edu|
22383991|NCT01188369|Aarhus University Hospital|Dr. Peter Juhl-Olsen|+4578451199|peter.juhl-olsen@ki.au.dk|
22429097|NCT03576846|Karolinska Institutet|Ass professor Iben Axén|+46704400618|iben.axen@ki.se|
22429098|NCT03325439|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22429099|NCT02635035|NYU Langone Health|Terry Leon|1 646 754 4841|Terry.Leon@nyulangone.org|
22429100|NCT02315625|National Cancer Institute|Dr. Naris Nilubol|240-760-6154|niluboln@nih.gov|
22383992|NCT02554786|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22383993|NCT01828554|University of Madison Carbone Cancer Center|Kari B. Wisinski|(608) 262-2876|kbwisinski@medicine.wisc.edu|
22383994|NCT02395978|BioLite, Inc.|Hsien-Ming Wu|+886-6579631|sonnywu@bioliteinc.com|
22383995|NCT03032406|University of Pennsylvania|Dr Angela DeMichele|2156624000|angela.demichele@pennmedicine.upenn.edu|
22383996|NCT04583423|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22383997|NCT03330795|DAIT/NIAID|Director, Clinical Research Operations Program|240-669-5064|DAITClinicalTrialsGov@niaid.nih.gov|
22383998|NCT00393484|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22383999|NCT00132964|Hospital for Sick Children|Kathy Boutis|4168138982|kathy.boutis@sickkids.ca|
22384000|NCT02382744|Department of Anesthesia, St. Paul's Hospital/Providence Health Care|Dr. Stephan Schwarz, Director of Research|(604) 806-8337|stephan.schwarz@ubc.ca|
22384001|NCT01923480|Baxter Healthcare|Aparna Valluru, Clinical Project Manager|224.270.6063|Aparna_Valluru@baxter.com|
22384002|NCT01976312|Novartis|Study Director|862-778-8300||
22384003|NCT02556138|Mayo Clinic|Dr. Kymberly Watt|507-266-1686|Watt.Kymberly@mayo.edu|
22384004|NCT03939312|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22384005|NCT04881175|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
22384006|NCT01609218|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22384007|NCT02807779|University of California, San Francisco|Warren Gasper, MD|415-353-4366|warren.gasper@ucsf.edu|
22384008|NCT05873062|Autifony Therapeutics Ltd|Head of Clinical Project Management|+447909228562|Alice.Sharman@autifony.com|
22384009|NCT06546657|University of Stirling|Julie Johnson|07815893076|julie.johnson1@stir.ac.uk|
22412019|NCT03504852|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22429101|NCT05399355|University of California San Diego|Brian Ilfeld, MD, MS|(858) 220-5714|baabdullah@health.ucsd.edu|
22429102|NCT06132386|Johns Hopkins University|Grant Principal Investigator|410-375-4418|chendrix@jhmi.edu|
22429103|NCT00153842|Dartmouth-Hitchcock Medical Center|James Rigas, MD|603-650-6344|Cancer.Research.Nurse@Dartmouth.edu|
22429104|NCT03734809|The Chinese University of Hong Kong|Dr. Edwin Pun HUI|3505 2145|p_hui@clo.cuhk.edu.hk|
22429105|NCT01853215|Vidacare Corporation|Larry J. Miller, MD|210-375-8500|larry.miller@vidacare.com|
22429106|NCT03514017|Moffitt Cancer Center|Julio Chavez, MD, MS|813-745-4294|julio.c.chavez@moffitt.org|
22384010|NCT01216176|University of Miami|Joyce Slingerland MD PhD FCRP(C)|305-243-7265|jslingerland@med.miami.edu|
22384011|NCT04847479|University of Pennsylvania|Robert Gross|215-898-2437|grossr@pennmedicine.upenn.edu|
22384012|NCT03725722|LEO Pharma A/S|Clinical disclosure|+45 4494 5888|disclosure@leo-pharma.com|
22384013|NCT01600014|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
22384014|NCT04592198|Xiamen LP Pharmaceutical Co.,Ltd|Matthew H Nieder|(415) 516-9498|matthew@lppharma.com|
22384015|NCT03481660|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@Novartis.com|
22384016|NCT04278586|Cambridge Health Alliance|Dr. Zev Schuman-Olivier|617-591-6056|zschuman@cha.harvard.edu|
22443613|NCT02545543|Seqirus|Seqirus Clinical Trial Disclosure Lead|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
22443614|NCT01278927|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com|
22443615|NCT00811642|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22398136|NCT00758745|Alcon Research, Ltd.|Director of Clinical Research|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22398137|NCT00763750|BrUOG|Howard Safran, MD|4018633000|Hsafran@lifespan.org|
22398138|NCT03496428|Implantology Institute|Prof. Dr. Duarte Marques|+351217 210 980|d.marques@institutoimplantologia.com|
22398139|NCT01890642|Medical College of Wisconsin|Maren Lunoe|414-266-2625|mlunoe@mcw.edu|
22398140|NCT01079182|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22398141|NCT01026831|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22398142|NCT02866279|Montefiore Medical Center|Erika Levi|7184058200|elevi@montefiore.org|
22398143|NCT01430455|Depression Evaluation Service (New York State Psychiatric Institute)|Jonathan W. Stewart|646-774-8070|jws6@nyspi.columbia.edu|
22398144|NCT05061719|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646 440-9333|ITCIClinicalTrials@itci-inc.com|
22398145|NCT02025426|Duke University, School of Medicine, Department of Anesthesiology|Dr. Ashraf Habib|(919) 681-4544|ashraf.habib@duke.edu|
22398146|NCT01578980|University of Virginia|Boris Kovatchev, PhD|434-924-5592|bpk2u@virginia.edu|
22398147|NCT01652287|Georgetown University Medical Center, Department of Family Medicine|Director of Research Programs|202-687-1600|FamilyMedResearch@georgetown.edu|
22398148|NCT01592760|Universtiy of Wisconsin School of Medicine and Public Health|Richard E. Galgon, MD, MS|608-263-8100|galgon@wisc.edu|
22398149|NCT01008280|VISN 22 Network Office|Peter Hauser, MD, VISN 22 Mental Health Services Lead|562 826 8000|peter.hauser2@va.gov|2629
22398150|NCT01637142|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22398151|NCT00532480|Indiana University|Dr. Amit Anand|317-944-7422|aanand@iupui.edu|
22398152|NCT00984204|St. Jude Medical|Nabil Kanaan|949-769-5000|nkanaan@sjm.com|
22398153|NCT00559507|Memorial Sloan-Kettering Cancer Center|Clifford Hudis, MD|646-888-4551|hudisc@mskcc.org|
22398154|NCT04681170|Amryt Pharmaceuticals DAC|Head of Clinical Operations|+35315180200|janet.boylan@amrytpharma.com|
22398155|NCT06414512|University of Minnesota|David Boulware|612-624-9996|idim@umn.edu|
22398156|NCT01394081|Tuscaloosa VA Medical Center|Lori L. Davis, MD|205-554-2000|Lori.Davis@va.gov|3819
22398157|NCT01407926|McMaster University|Maureen Markle-Reid, Associate Professor and Canada Research Chair, School of Nursing|905-525-9140|mreid@mcmaster.ca|22306
22429107|NCT06901544|Ain Shams University, Faculty of Medicine|Osama Khalil|01010000903|Osama.Ahmed.Ahmed.Salem.Khalil@med.asu.edu.eg|
22429108|NCT03971422|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22429109|NCT03083379|University of Virginia Health System|Daniel D. Rowley, MSc, RRT-ACCS, FAARC|434-465-7235|ddr8a@virginia.edu|
22429110|NCT04575324|Chestnut Health Systems|Dr. Dennis Watson|312-274-5316|dpwatson@chestnut.org|
22429111|NCT01105130|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
22429112|NCT00943904|University of California, Riverside|Dr. Karen Noblett|(951) 827-7581|karen.noblett@ucr.edu|
22429113|NCT01779362|George Washington University Biostatistics Center|Sharon Edelstein, Lead Research Scientist|301-881-9260|sharone@bsc.gwu.edu|
22429114|NCT02985710|Massachusetts General Hospital|PI|6177260580|akaraa@mgh.harvard.edu|
22429115|NCT01028053|GE Healthcare|Paul Sherwin M.D.|16095146820|Paul.Sherwin@ge.com|
22429116|NCT01177410|Salix Pharmaceuticals, Inc.|Vice President of Clinical Operations|919-862-1000|enoch.bortey@salix.com|
22429117|NCT00471354|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22429118|NCT01336972|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22429119|NCT02313272|Moffitt Cancer Center|Peter Forsyth, MD|813-745-3063|peter.forsyth@moffitt.org|
22429120|NCT03446573|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22429121|NCT02639559|Washington University School of Medicine|Geoffrey Uy, M.D.|314-454-8304|guy@wustl.edu|
22429122|NCT04022694|University of Pennsylvania|Deputy Director of PEACH Lab|2158987093|thepeachlab@gmail.com|
22429123|NCT01197898|Healthpoint, Ltd.|Jaime E. Dickerson, PhD; Sr. Director Clinical Affairs|817-302-3914|jaime.dickerson@healthpoint.com|
22429124|NCT02691663|Campbell University|Snezana Petrovic, MD, PhD, FASN|(910) 893-1751|spetrovic@campbell.edu|
22443616|NCT00721253|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22443617|NCT05744258|UZ Brussel|prof. dr. Sebastien Kindt|+32 2 477 60 11|sebastien.kindt@uzbrussel.be|
22443618|NCT06372782|Q-Med AB|Clinical Scientist|+46184749000|reception.seupp@galderma.com|
22443619|NCT06432088|Levita Magnetics|Vivian Soto|+56958360507|VSoto@Levita.com|
22443620|NCT06661954|University of Alabama at Birmingham|Rachel Cowan, PhD|205-934-5034|recowan@uabmc.edu|
22443621|NCT01395784|New York State Psychiatric Institute|Jermaine Jones, PhD|646 774-6113|jonesje@nyspi.columbia.edu|
22443622|NCT05772702|Pulvinar Neuro|Dr. Christopher Walker|8043173403|chris.walker@pulvinarneuro.com|
22443623|NCT04268823|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22443624|NCT00562627|Baerum Hospital|Ulrich Johannes Spreng|004798499184|ulispreng@hotmail.com|
22443625|NCT01107418|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22443626|NCT05710185|Brigham and Women's Hospital|Director of Clinical Trials, Brigham and Women's Hospital Department of Dermatology|617-732-5500|amostaghimi@mgb.org|
22429125|NCT03142750|Children's Hospital Colorado|Pediatric Surgery Research Fellow|720-777-5371|youngmeeyoungmee@gmail.com|
22429126|NCT02120079|Tufts Medical Center|Dr. Pedram Hamrah|617-636-5321|phamrah@tuftsmedicalcenter.org|
22443627|NCT02316548|NRG Oncology|Wendy Seiferheld, M.S.|215-574-3208|seiferheldw@nrgoncology.org|
22443628|NCT03269552|University of Washington|Dr. Stephen Smith|206-606-6546|ssmith50@seattlecca.org|
22443629|NCT01343823|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22443630|NCT02415855|University of Alberta|Dr. Kenneth Butcher|780-407-4366|ken.butcher@ualberta.ca|
22443631|NCT01285947|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
22443632|NCT03468543|Lyndra|Andrew Bellinger, MD, PhD|857-302-7878|abellinger@lyndra.com|
22398158|NCT02468648|NIDDK|Marc Ghany, MD, MHSc|301-402-5115|marcg@intra.niddk.nih.gov|
22398159|NCT02118792|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22398160|NCT03963544|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trial Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
22398161|NCT04232696|Neuspera Clinical Research|Mark Vollmer|612-281-4875|mark.vollmer@neuspera.com|
22398162|NCT00488982|University of California, San Francisco|Dr. Rahul Aggarwal|(415) 353-9278|Rahul.Aggarwal@ucsf.edu|
22398163|NCT01368835|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
22398164|NCT01678144|Medtentia International Ltd Oy|Olli Keränen / CEO|+358 50 3567090|ok@medtentia.com|
22398165|NCT02754726|HonorHealth Research Institute|Erkut Borazanci, MD MS|4803231350|clinicaltrials@honorhealth.com|
22398166|NCT01676714|University of California Davis|Analyst|916 734 0294|pkaujla@ucdavis.edu|
22398167|NCT01272999|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22398168|NCT02952222|Boston Children's Hospital|Dr. Keira Mason|(617) 355-7737|keira.mason@childrens.harvard.edu|
22398169|NCT04852120|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DK0-Disclosure@ferring.com|
22398170|NCT05801809|Spaulding Rehabilitation Hospital|Felipe Fregni, PI|6179526158|fregni.felipe@mgh.harvard.edu|
22398171|NCT05289830|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Jordan Winter|216-844-5777|Jordan.winter@uhhospitals.org|
22398172|NCT01046825|St. Jude Children's Research Hospital|Raul Ribeiro, MD|901-595-3694|raul.ribeiro@stjude.org|
22398173|NCT05215600|Zimmer Biomet|Carina Hafner|+41797073093|carina.hafner@zimmerbiomet.com|
22398174|NCT03461445|UC Davis Health|Associate Professor of Medicine|916-734-5141|lxchen@ucdavis.edu|
22398175|NCT02872311|Marshfield Clinic Research Institute|Project Manager|715-389-5088|king.jennifer@marshfieldresearch.org|
22398176|NCT05617911|Gaylord Hospital|John Corbett|203-294-3224|jcorbett@gaylord.org|
22398177|NCT03557359|Columbia University|Fabio Iwamoto|212-342-0571|fi2146@cumc.columbia.edu|
22398178|NCT04868903|The University of Chicago|David Meltzer, MD, PhD|7737020836|dmeltzer@bsd.uchicago.edu|
22398179|NCT03975647|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
22398180|NCT03735667|Boston Scientific|Sarah Zanon|+41 79 840 7006|sarah.zanon@bsci.com|
22398181|NCT03092726|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22398182|NCT02523040|Dana-Farber Cancer Institute|Eric Jacobsen, MD|857-215-1405|eric_jacobsen@dfci.harvard.edu|
22398183|NCT00428974|Can-Fite BioPharma Ltd|Pnina Fishman, PhD|011972 3 924 1114|pnina@canfite.co.il|
22398184|NCT01084265|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22398185|NCT03382847|NYU LANGONE TRANSPLANT INSTITUTE|Dr. Bonnie Lonze|2122638365|Bonnie.Lonze@nyumc.org|
22398186|NCT02296242|BioMed Valley Discoveries|Dean Welsch, PhD|8163898831|dwelsch@biomed-valley.com|
22398187|NCT02501265|Duke University School of Medicine|Dr. James Davis|919-668-5055|james.m.davis@duke.edu|
22398188|NCT02365714|Medstar Georgetown University Hospital|Sonali Rudra, M.D.|202-444-3320|sonali.rudra@gunet.georgetown.edu|
22398189|NCT01290692|Saint Lukes Hospital KC, Missouri and Washington University School of Medicine, St.Louis Missouri|Michael E. Salacz,MD and David Tran,MD, PH.D|9134922221|gwood@tvaxbiomedical.com|
22398190|NCT02780648|IndianaU|Dr. Robert Miller|317-944-1317|millro@iu.edu|
22398191|NCT00265538|Iowa City VA Health Care System|Dr. Peter Kaboli|319-338-0581|Peter.kaboli@va.gov|
22398192|NCT03557892|University of Florence Medical School and AOU Careggi|Dr Ilaria Dicembrini|+393387861041|Ilaria.dicembrini@unifi.it|
22398193|NCT01097304|University of Arizona|Dr. Sherry Chow|520-626-3358|schow@azcc.arizona.edu|
22398194|NCT04036968|Johns Hopkins University School of Medicine|Kelly Dunn, Professor|410-550-2254|kdunn9@jhmi.edu|
22398195|NCT01110200|GlaxoSmithKline|GSK Response Center|866-435-7343||
22398196|NCT00903175|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22398197|NCT01785134|Karolinska Institutet|Dr Erik Näslund|+46812355017|Erik.Naslund@ki.se|
22398198|NCT03074474|TELA Bio|Neal Overbeck|484-802-9570|noverbeck@telabio.com|
22398199|NCT02189850|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
22398200|NCT00371865|VA San Diego Healthcare System|Dr. Julie Wetherell, PI|858-552-8585|Julie.Wetherell@va.gov|2752
22398201|NCT03441178|Ethicon Endo-Surgery|Jason Waggoner, PhD|+1 513.337.8310|jwaggon1@its.jnj.com|
22398202|NCT04817111|Children's Hospital of Philadelphia|Dr. Shana McCormack|215-590-3174|mccormacks1@email.chop.edu|
22398203|NCT00713583|The University of Texas Health Science Center at Houston|Joy M. Schmitz, PhD|(713) 486-2867|Joy.M.Schmitz@uth.tmc.edu|
22398204|NCT05073458|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22443633|NCT04972630|Medical University of South Carolina|Dr. Suparna Qanungo|(843) 876-1125|qanungo@musc.edu|
22443634|NCT02651714|Vanda Pharmaceuticals Inc.|Vanda Pharmaceuticals Inc.|202-734-3400|clinicaltrials@vandapharma.com|
22443635|NCT04214288|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22443636|NCT03469570|Edwards Lifesciences|Edwards Critical Care Clinical Affairs|(949) 250-7169|afmidestudy@edwards.com|
22443637|NCT02455557|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
22443638|NCT02278341|Astellas Pharma Europe B.V.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|5473
22398205|NCT01545700|NorthShore University HealthSystem|Glenn S. Murphy, MD|847-570-2760|dgmurphy2@yahoo.com|
22398206|NCT01227551|Viralytics|Mark Grose|1 647 821 7673|Mark.Grose@Viralytics.com|
22398207|NCT05913232|D. Western Therapeutics Institute, Inc.|Shigenobu Nakazora|+81-52-218-8785|shinakazora@dwti.co.jp|
22398208|NCT05103332|Alnylam Pharmaceuticals|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
22398209|NCT04428476|Capricor, Inc.|Mark Awadalla|858-727-1755|clinicaltrialsgov@capricor.com|
22398210|NCT02043548|University of Pittsburgh|Chester Oddis, MD|412-383-8861|cvo5@pitt.edu|
22398211|NCT01425008|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22398212|NCT04179175|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
22398213|NCT01696435|Massachusetts General Hospital|Dr. Olivia Okereke/Study Principal Investigator|(617) 726-2000|olivia.okereke@mgh.harvard.edu|
22398214|NCT03215030|Takeda (Note: This product was divested to Teva Pharmaceuticals in 2025)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22398215|NCT01745146|Moss Rehabilitation Research Institute|Dr. Tessa Hart, PhD|215-663-6153|thart@einstein.edu|
22398216|NCT00130832|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22398217|NCT03195517|University of Perugia - Italy|Dr. Rita Lombardini|+39 075 578 4027|rita.lombardini@unipg.it|
22398218|NCT02770326|Memorial Sloan Kettering Cancer Center|Dr. Robin Mendelsohn, MD|212-639-8286|mendelsr@mskcc.org|
22398219|NCT01885000|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
22398220|NCT02792842|Asahi Kasei Pharma Corporation|Contact for Clinical Trial Information|+81-3-6699-3600|ct-info@om.asahi-kasei.co.jp|
22398221|NCT03716869|MS Hershey MC|Deepa Sekhar, Associate Professor of Pediatrics, Executive Director Penn State PRO Wellness|7175310003|dsekhar@pennstatehealth.psu.edu|281334
22398222|NCT02363686|University of Colorado|Carrie Higgins|7205603037|carrie.higgins@cuanschutz.edu|
22429127|NCT04268979|Moffitt Cancer Center|Margaret Byrne, Ph.D.|813-745-5569|Margaret.Byrne@moffitt.org|
22429128|NCT00303628|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012||
22429129|NCT03158688|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22429130|NCT00471107|NIH/NINDS|Eric Wassermann|301-496-0151|wassermanne@ninds.nih.gov|
22429131|NCT02942407|Duke Universitey|Christopher Granger, MD|919-668-8900|christopher.granger@duke.edu|
22429132|NCT05887908|Clinical Development Department|Meiji Seika Pharma Clinical Trial Administrator|(+81) 3-3273-3745|clinical-trials@meiji.com|
22429133|NCT06413797|University of North Carolina at Chapel Hill, School of Medicine, Department of Family Medicine, and Lineberger Comprehensive Cancer Center|Leah Ranney, PhD, MA, Research Professor and Director of the Tobacco Prevention and Evaluation Progr|984-974-4888|leah_ranney@unc.edu|
22429134|NCT03928743|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22429135|NCT03914703|Zimmer Biomet|Jarrod Hunnicutt, Clinical Affairs Manager|574-453-7834|jarrod.hunnicutt@zimmerbiomet.com|
22429136|NCT04828486|Mayo Clinic|Nguyen H Tran MD MPH|507-284-2511|Tran.Nguyen@mayo.edu|
22429137|NCT06204887|Recep Tayyip Erdogan University|Dr. Ahter Şanal Çıkman|05069293341|ahter.sanalcikman@erdogan.edu.tr|
22429138|NCT04056468|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22429139|NCT02762604|Albert Einstein College of Medicine|Dr. Helena Blumen|7184303810|helena.blumen@einsteinmed.edu|
22443639|NCT01129024|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
22443640|NCT02409914|USherbrooke|Stephen Cunnane|1-819-780-2220|Stephen.Cunnane@USherbrooke.ca|45670
22443641|NCT02361580|Massachusetts Generla Hospital|Taylor Pong, Research Coordinator||tpong1@partners.org|
22443642|NCT02047318|Mirum Pharmaceuticals|Mirum Clinical Trials|650-667-4085|medinfo@mirumpharma.com|
22443643|NCT01487577|Children's Hospital of Pittsburgh of UPMC|Randy M. Windreich, MD|412-692-5225|randy.windreich@chp.edu|
22384017|NCT02791230|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22384018|NCT04076293|Hanmi Pharmaceutical Co., Ltd.|Jiyeon Kang|8224100377|jiyeon.kang@hanmi.co.kr|
22384019|NCT05769595|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22384020|NCT04605198|University of California, Los Angeles|Dr. Dana Rose Garfin, Associate Professor|415-407-9498|dgarfin@ucla.edu|
22384021|NCT05307978|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22384022|NCT05075408|Galderma Research & Development, LLC|Sponsor|8179615000|aestheticclinicaltrials@galderma.com|
22384023|NCT03651895|Imperial College|Farne Hugo|+44 (0)20 7589 5111|h.farne@imperial.ac.uk|
22384024|NCT02380612|AVITA Medical|VP Clinical Research|661-367-9170|clinicaltrial@avitamedical.com|
22384025|NCT04855760|Relmada Therapeutics|Marco Pappagallo, MD|786-638-7384|info@relmada.com|
22398223|NCT03756038|University of Pittsburgh|Dr. Maria Pacella|412-647-3183|pacellam@upmc.edu|
22398224|NCT01789814|Tufts Medical Center|Carey Kimmelstiel, MD Director of the Adult Cardiac Catheterization Laboratory|617-636-4504|Ckimmelstiel@tuftsmedicalcenter.org|
22384026|NCT02879448|Abbott Medical|Jordan Anderson, Clinical Scientist|651 756 3360|ClinicalTrials.gov_SH_Inquiries@abbott.com|
22384027|NCT01718743|University of Texas M D Anderson Cancer Center|Dr. Krina Patel|(713) 792-6662|kpatel1@mdanderson.org|
22384028|NCT05145257|Citruslabs|Patrick Renner|4242450284|hello@citruslabs.com|
22384029|NCT04995484|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22398225|NCT02507011|University of Minnesota|Thenappan Thenappan, MD|612-625-2191|cvheart@umn.edu|
22398226|NCT00577993|UT MD Anderson Cancer Center|Nathan Fowler,MD, Clinical Professor, Lymphoma-Myeloma|(832) 671-3018|nfowler@mdanderson.org|
22398227|NCT02217566|Janssen Research & Development, LLC|Regional Medical Affairs Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22398228|NCT01077973|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22398229|NCT02679469|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366||
22443644|NCT01479985|Washington University in St. Louis|Dr. Tessa Madden, MD, MPH|314-747-6495|maddent@wudosis.wustl.edu|
22398230|NCT02064387|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22398231|NCT03099486|Fox Chase Cancer Center|Dr. Namrata Vijayvergia|215-214-4283|Namrata.Vijayvergia@fccc.edu|
22384030|NCT05178810|Ferrer|Clinical Operations Head|+34 649 442 389|nalbareda@ferrer.com|
22384031|NCT06072404|University of Palermo|Prof. Olga Di Fede|00393294030298|olga.difede@unipa.it|
22384032|NCT04868110|University of Kansas Medical Center|Dr. Holly Hull|9135881000|hhull@kumc.edu|
22398232|NCT03950973|University of Michigan School of Public Health, Department of Health Behavior & Health Education|Minal R. Patel, Ph.D, M.P.H|(734) 763-0087|minalrp@umch.edu|
22384033|NCT02793687|Pharmasoft|Meshcherskiy Y.E., Medical director|+ 7 (495) 626-47- 55|meshcherskiy_y@pharmasoft.ru|140
22384034|NCT02553642|Memorial Sloan Kettering Cancer Center|Dr. Samuel Funt, MD|646-888-4718|funts@mskcc.org|
22384035|NCT03755141|Korea university Guro hospital|In Hae Park|+82-2-2626-3172|parkih@korea.ac.kr|
22384036|NCT04522713|Karolinska Institutet|Dr. Erland Axelsson|0706171039|erland.axelsson@ki.se|+46
22398233|NCT02436876|Microbion Corporation|Brett Baker, President and Chief Innovation Officer|4065991190|bbaker@microbioncorp.com|
22443645|NCT00708201|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
22443646|NCT00761748|Coloplast A/S|Director of Medical Outcome||dkbir@coloplast.com|
22443647|NCT02554279|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22443648|NCT00812487|Ohio State University|Kathleen Dungan, MD, MPH|614-685-3333|kathleen.dungan@osumc.edu|
22443649|NCT00998764|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22443650|NCT01995045|Emory University|Dr. Timothy Olsen|404-778-4996|tolsen@emory.edu|
22443651|NCT04761627|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22443652|NCT01634178|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22443653|NCT01117792|Boston Scientific|Tom Stoltz, Clinical Trial Manager|1-800-227-3422|thomas.stoltz@bsci.com|
22443654|NCT05867342|Stanford University|Peter H. Hwang, MD|(650) 725-6500|hwangph@stanford.edu|
22443655|NCT00723203|City of Hope National Medical Center|Paul Frankel, Ph.D.|(626)359-8111|pfrankel@coh.org|65265
22443656|NCT00997113|Minneapolis Medical Reseach Foundation|James Miner|6128738791|miner015@umn.edu|
22443657|NCT01254942|The University Of British Columbia|Associate Professor MC Ashe|604-675-2574|maureen.ashe@ubc.ca|
22443658|NCT01150474|Mayo Clinic|Dr. Kristina A. Butler|480-301-5934|butler.kristina@mayo.edu|
22443659|NCT04231981|MedSIR|Alicia Garcia|+34 611261467|alicia.garcia@medsir.org|
22443660|NCT02581943|Wake Forest Baptist Comprehensive Cancer Center|Assistant Director of Clinical Research Operations|336-713-6913|mebrown@wakehealth.edu|
22443661|NCT01470989|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22443662|NCT01233687|University of Pittsburgh|Ahmad Tarhini, MD|(412) 648-6578|tarhiniaa@upmc.edu|
22443663|NCT00432601|VA HSRD|Dr. Angela Fagerlin|801-587-1694|angie.fagerlin@hsc.utah.edu|
22443664|NCT02197234|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
22443665|NCT03783702|Stanford University School of Medicine|Noel Ayoub|3109407055|nfa@stanford.edu|
22443666|NCT02119676|Incyte Corporation|Study Director|855 463-3463||
22443667|NCT00219544|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22384037|NCT04848974|The University of Texas MD Anderson Cancer Center|Tapan Kadia MD/Professor|713-563-3534|tkadia@mdanderson.org|
22384038|NCT04424927|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22398234|NCT00075504|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
22398235|NCT02685709|Amryt|Asi Haviv, VP Clinical development|972 8 9393888|Asi@amrytpharma.com|
22398236|NCT03127384|Q-Med AB|Clinical Project Manager|+46184749000|reception.seupp@galderma.com|
22398237|NCT00689871|Allergan Medical|Medical Monitor|(805) 961-5000|devicetrials@allergan.com|
22398238|NCT02171611|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22398239|NCT02340338|Biomedizinische Forschungsgesellschaft mbH|Dr. Martha M. Eibl|+43-1-4081091|martha.eibl@meduniwien.ac.at|
22398240|NCT04906980|Janssen Research & Development, LLC|GLOBAL MEDICAL LEADER RESPIRATORY INFEC|+12153252489|ClinicalTrialDisclosure@its.jnj.com|
22398241|NCT01951820|University of Michigan School of Dentistry|Dr. Carlos Gonzalez|734-763-3391|carlosgc@umich.edu|
22398242|NCT00137111|St. Jude Children's Research Hospital|Ching-Hon Pui|1-866-278-5833|info@stjude.org|
22398243|NCT04417894|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22398244|NCT00262873|University of Rochester|Jane Liesveld, M.D.|585-275-4099|Jane_Liesveld@urmc.rochester.edu|
22398245|NCT00844753|University of Pittsburgh|Ben Handen|412-235-5452|HandenBL@upmc.edu|
22398246|NCT02987621|Colorado State University|Manager of Research Operations|9704912242|Laurie.Biela@colostate.edu|
22398247|NCT02508194|MedImmune, LLC|Judith Falloon, MD|301-398-0000|clinicaltrialenquiries@medimmune.com|
22398248|NCT01031914|Philips|Dr. David P. White|724 387 4554|Dr.DavidWhite@philips.com|
22398249|NCT03892746|Cleveland Clinic|Ela Plow, Associate Professor|216-445-4589|plowe2@ccf.org|
22398250|NCT03977467|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|SCRI.InnovationsMedical@scri.com|
22398251|NCT05721482|The Ohio State University College of Nursing|Dr. Kathy Wright|614-292-0309|wright.2104@osu.edu|
22398252|NCT03485820|Washington University in St. Louis|Susy Stark|3142734114|sstark@wustl.edu|
22398253|NCT02289950|Eisai Inc.|Eisai Medical Information|888-274-2378|esi_oncmedinfo@eisai.com|+1
22398254|NCT01471782|Amgen, Inc|Study Director|866-572-6436||
22398255|NCT00936208|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22398256|NCT04428424|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22398257|NCT03359759|Institut Bergonié|Simone Mathoulin-Pélissier, Director of Clinical Trials|+33556333333|s.mathoulin@bordeaux.unicancer.fr|
22443668|NCT00989573|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22443669|NCT05038904|Johns Hopkins University School of Medicine|Melanie C. Dispenza, MD, PhD|410-550-2301|mdispen1@jhmi.edu|
22443670|NCT03473548|Washington University|Dr. David Leonard|314-454-6162|dsleonard@wustl.edu|
22443671|NCT03351101|Bausch Health|Study Director|+1 (585) 338-6399|Robert.Steffen@bausch.com|
22384039|NCT03727061|Roswell Park Compressive Cancer Center|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|adrienne.groman@roswellpark.org|
22384040|NCT01296646|University of North Carolina at Chapel Hill|James C. Garbutt, M.D., Professor of Psychiatry|919-966-4652|jc_garbutt@med.unc.edu|
22384041|NCT02134951|New York State Psychiatric Institute|Marlene Carlson|646-774-8436|mc157@columbia.edu|
22384042|NCT02386553|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22384043|NCT00595790|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar-kastner@intercell.com|0
22384044|NCT00194714|University of Washington - Cancer Vaccine Institute|Director of Clinical Operations|2062459258|childj@uw.edu|
22384045|NCT02885636|Mayo Clinic|Dr. Barry Borlaug|507-284-8846|borlaug.barry@mayo.edu|
22384046|NCT03921866|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22384047|NCT01363492|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22384048|NCT03794024|Cleveland Clinic|Robert Bolash|216-444-3134|bolashr@ccf.org|
22384049|NCT04149002|Duke University|Sarahn M. Wheeler, MD|(919) 684-6327|sarahn.wheeler@duke.edu|
22384050|NCT05187442|National Taiwan University|PIAO-YI CHIOU, doctoral|+886-2-23123456|piaoyi@ntu.edu.tw|288427
22429140|NCT03833167|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22429141|NCT06428591|Tandem Diabetes Care|Manager, Clinical Affairs|8583666900|clinicalaffairs@tandemdiabetes.com|
22443672|NCT00873873|National Jewish Health|Head, Pediatric Clinical Pharmacology|303-398-1193|szeflers@njhealth.org|
22443673|NCT02207946|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
22443674|NCT02829944|Duke University Medical Center|Emily Barney|9709031869|ezb2@duke.edu|
22443675|NCT05856760|Travere Therapeutics, Inc.|Travere Therapeutics Call Center|1-877-659-5518|medinfo@travere.com|
22443676|NCT04675151|Ocuphire Pharma, Inc.|Drey Coleman|8134041993|dcoleman@ocuphire.com|
22443677|NCT04035486|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22443678|NCT01730937|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
22443679|NCT03947684|UT southwestern medical center|Dr. Yasin Dhaher|2146450064|yasin.dhaher@utsouthwestern.edu|
22443680|NCT05313009|Medical University of South Carolina|Alan Brisendine|843-792-9007|brisend@musc.edu|
22443681|NCT02186301|Clovis Oncology|Vi Nguyen|+1 415 915 9982|vnguyen@clovisoncology.com|
22443682|NCT00749580|USF Health|Charurut Somboonwit, MD|813 3078067|csomboon@health.usf.edu|
22443683|NCT05128929|Stanford University School of Medicine|Roham Zamanian, MD|650-725-5495|zamanian@stanford.edu|
22443684|NCT03553836|Merck Sharp & Dohme LLC.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22443685|NCT00274924|ECOG Statistical Office|Study Statistician|617-632-3012||
22443686|NCT02524977|University of Cincinnati Health|VP Research UC Health|513-558-6937|christopher.lindsell@uc.edu|
22443687|NCT01903525|Scottish Rite for Children|Dr. Shane Miller|469-515-7222|shane.miller@tsrh.org|
22443688|NCT04365257|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Chetan Bettegowda|4109558620|cbetteg1@jhmi.edu|
22443689|NCT03935399|Wake Forest Health Sciences|Dr. James Eisenach|3367164182|eisenach@wakehealth.edu|
22443690|NCT01112683|University of Colorado School of Medicine|Dr. Alberto Costa|303-724-6007|Alberto.Costa@ucdenver.edu|
22443691|NCT02129777|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22443692|NCT03103061|Medical University of South Carolina|Hunter Gray, Program Coordinator|843-876-3185|grayhu@musc.edu|
22443693|NCT02915874|University of Iowa|Jess G Fiedorowicz, MD, PhD|319-384-9267|jess-fiedorowicz@uiowa.edu|
22443694|NCT02301611|Lumabridge, LLC|Marsha Greene|(484) 319-1117|mgreene@lumabridge.com|
22443695|NCT00781508|MetroHealth Medical Center|Robert C. Bahler, MD|216 778-2431|rbahler@metrohealth.org|
22443696|NCT01609478|Novartis Pharmaceuticals|Clinical Disclosure Office|+1(862)778-8300||
22443697|NCT04973137|Prothena Biosciences Limited|Katelyn Diffin|650-837-8550|AFFIRM-ALClinicalTrials@prothena.com|
22443698|NCT01351896|The Ohio State University Comprehensive Cancer Center|Dr. Kerry Rogers|614-293-3873|Kerry.Rogers@osumc.edu|
22443699|NCT04391569|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
22443700|NCT04641221|Butler Hospital|Lisa Uebelacker, PhD|401-455-6381|luebelacker@butler.org|
22443701|NCT01903252|Tillotts Pharma AG|Dr. Robert Hofmann, MD PhD|+4161 935 27 14|robert.hofmann@tillotts.com|
22384051|NCT06061081|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22398258|NCT04818593|NYU Langone Health|Rani Fritz, DO, PhD, FACOG|718-935-9766|rani.fritz@nyulangone.org|
22429142|NCT04544267|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22429143|NCT02227199|University of Washington|Dr. Ajay Gopal|26-606-2037|agopal@uw.edu|
22429144|NCT03003962|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22429145|NCT05179603|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22429146|NCT05937373|Wake Forest University Health Sciences|Susan R. Vishneski, MD|336-306-0778|svishnes@wakehealth.edu|
22429147|NCT06061952|University Hospitals Cleveland Medical Center|Martha Sajatovic, MD|216-844-2808|martha.sajatovic@UHHospitals.org|
22429148|NCT01405911|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22429149|NCT02239289|Université du Québec à Trois-Rivières|Martin Descarreaux|1-819-376-5011|martin.descarreaux@uqtr.ca|3791
22443702|NCT02067975|Maryland Psychiatric Research Center|Sam Kane-Gerard|410-402-6120|SGerard@som.umaryland.edu|
22443703|NCT01138917|AVITA Medical|Director of Clinical Research|661-367-9170|clinicaltrial@avitamedical.com|
22398259|NCT03809611|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22443704|NCT02819908|Eye Center of N Florida|Christina Menck|8507843937|eyenerdgyrl1@gmail.com|1124
22384052|NCT05782231|Massachusetts General Hospital|Ana-Maria Vranceanu, PhD|617-724-4977|avranceanu@mgh.harvard.edu|
22384053|NCT02252172|Janssen Research & Development, LLC|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22384054|NCT03830866|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22384055|NCT01426412|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22384056|NCT03014453|Shengjing Hospital of China Medical University|Dr. Shucheng Zhang|862496615|zhangshucheng76@126.com|57911
22384057|NCT00041938|Columbia University|Dr. J.L.P. (Seamus) Thompson|212-342-1252|jlt12@columbia.edu|
22398260|NCT02600494|Intra-Cellular Therapies, Inc.|Vice President, Clinical Development|646-440-9333|ITCIClinicalTrials@itci-inc.com|
22398261|NCT04671615|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22398262|NCT03124563|Brandeis University|Dr. Margie E. Lachman|7817363255|lachman@brandeis.edu|
22398263|NCT02452528|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
22429150|NCT01685437|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22429151|NCT01059851|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22429152|NCT03770455|Tulane University School of Medicine|Jodi L. Layton, MD|504-988-6121|jlayton@tulane.edu|
22429153|NCT04937387|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22429154|NCT01039675|GlaxoSmithKline|GSK Response Center|866-435-7343||
22429155|NCT03686488|Moffitt Cancer Center|Dae Won Kim, MD|813-745-1277|daewon.kim@moffitt.org|
22429156|NCT00567580|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22429157|NCT01658878|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22429158|NCT02787291|Abbott CAHF CRM|Dr. Adam Cline- Clinical Scientist|818-493-2025|adam.cline@abbott.com|
22429159|NCT00134719|GlaxoSmithKline|GSK Response Center|866-435-7343||
22429160|NCT01807520|Novartis Pharmaceuticals|Study Director|862-778-8300||
22429161|NCT01258855|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22429162|NCT00620035|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22429163|NCT02405208|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
22429164|NCT03600350|University of Wisconsin Carbone Cancer Center|Douglas McNeel, MD, PhD|(608) 263-4198|dm3@medicine.wisc.edu|
22429165|NCT02400736|Tuscaloosa VA Medical Center|Lori L. Davis, M.D.|205-554-2000|Lori.Davis@va.gov|1-3819
22429166|NCT01771913|Faculdade de Medicina - Universidade de Sao Paulo|Dr. Luiz Alexandre Lorico Tissiani|55-11-981798707|latissiani@gmail.com|
22429167|NCT04621760|University of California, San-Francisco|Dr. Dominika Seidman|(415) 353-2119|Dominika.Seidman@ucsf.edu|
22429168|NCT02029443|Acerta Pharma BV|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22429169|NCT00366535|Symptoms Biology Unit, DIR, NINR, NIH|Leorey Saligan, Chief|301-451-1685|saliganl@mail.nih.gov|
22429170|NCT00106535|Hoffmann-La Roche|Medical Communications|800-821-8590||
22429171|NCT06042855|Duke University|Susanna Naggie, MD|919-684-2584|susanna.naggie@duke.edu|
22429172|NCT05901467|Massachusetts General Hospital|Stephanie Seminara|617-726-1309|MGHKisspeptinResearch@partners.org|
22429173|NCT01769365|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@isca.vghks.gov.tw|8233
22429174|NCT01428128|The University of Texas Health Science Center at San Antonio, Department of Radiation Oncology|Chul S. Ha, MD, Professor and Chair|210-450-1109|hac@uthscsa.edu|
22429175|NCT00371449|Mountain Home VA Medical Center|Sherri L. Smith|423.926.1171|sherri.smith@va.gov|7569
22429176|NCT06100250|University of Michigan|Dr. Akshay Sharma|734-647-0151|akshaydr@umich.edu|
22429177|NCT01750073|University of Nebraska Medical Center|Amulya C Yellala|402-559-5388|amulya.yellala@unmc.edu|
22429178|NCT05259033|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22429179|NCT05537571|Silence Therapeutics plc|Global Regulatory|+442034576900|global-regulatory@silence-therapeutics.com|
22429180|NCT06375655|University Hospitals Cleveland Medical Center|Dr. Furman|216-844-3971|Lydia.Furman@UHhospitals.org|
22429181|NCT02943213|Cycle Pharmaceuticals Ltd|James Price|+44 1223 803638|james.price@cyclepharma.com|
22429182|NCT00283959|Medical Affairs|Amicus Therapeutics|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
22429183|NCT05865886|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22429184|NCT06394323|University of North Carolina at Chapel Hill|Lauren Hill, PhD|919-966-5771|hilllm@ad.unc.edu|
22429185|NCT01552889|Washington University School of Medicine|Dr. Robert Carney|314-286-1313|carneyr@wustl.edu|
22429186|NCT01292265|UCB, Inc.|Study Director|+1 887 822 9493||
22429187|NCT01778985|University of Texas Southwestern Medical Center|David D. Rahn, M.D.|214-648-6430|david.rahn@utsouthwestern.edu|
22429188|NCT01002105|Shaar Menashe Mental Health Center|Prof. Alexander Grinshpoon|+972-4-6278719|alexander.grinshpoon@sm.health.gov.il|
22429189|NCT00552058|UCB|Study Director|+1 877 822 9493||
22429190|NCT05788328|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22429191|NCT00845182|UTexas_SanAntonio|Devjit Tripathy|2105676691|tripathy@uthscsa.edu|
22429192|NCT01875237|UT MD Anderson Cancer Center|Champlin,Richard,M.D. / Stem Cell Transplantation|713-792-8750|rchampli@mdanderson.org|
22429193|NCT05558410|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22429194|NCT05141357|HUYABIO International|Chief Medical Officer|(858) 798-8800|Glee@huyabio.com|
22429195|NCT01028560|Jacobi Medical Center / Albert Einstein College of Medicine|Gabriele de Vos, M.D.|7184152809|gabriele.de-vos@einstein.yu.edu|
22429196|NCT01033227|Children's Hospital Los Angeles|Dr. Thomas Coates|323 361 3841|TCoates@chla.usc.edu|
22429197|NCT01960842|AbbVie|Global Medical Information|1-800-633-9110||
22429198|NCT00593645|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
22443705|NCT00645788|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22443706|NCT01924429|Icahn School of Medicine at Mount Sinai|Dr. Jeffrey Newcorn|212-659-8775|Jeffrey.newcorn@mssm.edu|
22443707|NCT06165627|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22443708|NCT00327470|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22443709|NCT00829985|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22443710|NCT03910387|Emory University|Dr. Olumide Gbolahan|404-778-1900|ogbolah@emory.edu|
22443711|NCT03122301|Northwestern Medicine|David Walega, MD|13129271345|d-walega@northwestern.edu|
22443712|NCT04466228|University of California, San Francisco|Wan-Yu Hsu|+14153531140|wanyuhsu3@gmail.com|
22443713|NCT01445886|Department of Traditional Chinese Medicine, Chang Gung Memorial Hospital at Keelung, Taiwan|Yin-Ku Lin|886-2-2431-3131|lin1266@adm.cgmh.org.tw|2127
22398264|NCT04745689|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22384058|NCT00262301|Pharming Technologies BV|Medical Affairs Department|+31715247400|medicalinfo@pharming.com|
22398265|NCT07071129|Stanford University|Jeffrey Goldberg, MD, PhD|(650) 723-6137|eye-chair-office@stanford.edu|
22398266|NCT05429073|Regulus Therapeutics|Kristen Gillotti, Senior Director Clinical Operations|203-313-8185|kgillotti@regulusrx.com|
22398267|NCT02896595|Virginia Commonwealth University Health Department of Anesthesiology|Praveen Prasanna|804-828-2207|praveen.prasanna@vcuhealth.org|
22384059|NCT01017146|GlaxoSmithKline|GSK Response Center|866-435-7343||
22384060|NCT01877343|University of Florida|Dr. Curt DeGroff|352-273-7770|degroffc@peds.ufl.edu|
22398268|NCT04316585|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22384061|NCT01256840|UCLA Department of Psychology|Dr. A. Janet Tomiyama|3102066875|tomiyama@psych.ucla.edu|
22384062|NCT00976495|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
22398269|NCT03118297|WashingtonU|Intervention To End Recurrent Unscheduled bleeding Trial (INTERRUPT): A randomized-controlled trial|3143228697|rachelezig@gmail.com|
22384063|NCT01136486|North Shore LIJ|Dr. Rosemarie Basile|718 226-6501|rbasile1@siuh.edu|
22384064|NCT00001277|NIDDK|Dr. Smita Jha|301-827-1930|smita.jha@nih.gov|
22398270|NCT01121393|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22412020|NCT03290079|Moffitt Cancer Center|Jonathan Strosberg, MD|813-745-5553|jonathan.strosberg@moffitt.org|
22412021|NCT03850509|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22443714|NCT01163032|Vanda Pharmaceuticals Inc.|Marlene Dressman, Ph.D.|202-734-3462|marlene.dressman@vandapharma.com|
22429199|NCT02441114|Seoul National University Hospital|Clinical Pharmacology and Therapeutics|82-2-2072-4081|rheesjin@gmail.com|
22429200|NCT05278065|Brown University|Alexander Sokolovsky|401-863-6629|alexander_sokolovsky@brown.edu|
22429201|NCT01793909|University of Colorado|Dr. Judy Regensteiner|303-724-2247|judy.regensteiner@ucdenver.edu|
22429202|NCT01279187|University of Michigan|Jill Bashutski||jillbashutski@gmail.com|
22429203|NCT02070991|Actelion Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 61 565 6565|clinical-trials-disclosure@its.jnj.com|
22429204|NCT04999020|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22443715|NCT06340763|Abbott|Vinuta Rau|(408)845-0864|vinuta.rau@abbott.com|
22429205|NCT03123588|Incyte Corporation|Call Center|1.855.463.3463|medinfo@incyte.com|
22443716|NCT03615508|Denver Health|Dr. Ifantides|303-602-0156|cristos.ifantides@dhha.org|
22443717|NCT01947907|Ascendis Pharma A/S|VP Clinical Development|+49 172 155 2596|mb@ascendispharma.com|
22443718|NCT03624517|Medical University of South Carolina|Dr. Don Rockey|(843) 792-6982|rockey@musc.edu|
22443719|NCT04155567|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
22443720|NCT03764033|San Francisco VA Health Care System|Shira Maguen, PhD|415-221-4810|Shira.Maguen@va.gov|22511
22443721|NCT04594369|Insmed Incorporated|Insmed Medical Information|1-844-446-7633|medicalinformation@Insmed.com|
22443722|NCT01006603|AstraZeneca|Boaz Hirshberg , MSD||ClinicalTrialTransparency@astrazeneca.com|
22443723|NCT02964078|Moffitt Cancer Center|Jad Chahoud MD, MPH|813-745-6926|Jad.Chahoud@moffitt.org|
22443724|NCT03875235|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22443725|NCT05592223|Fred Hutchinson Cancer Center|Dr. Elizabeth Chandler Church|2066676982|cchurch2@fredhutch.org|
22429206|NCT04740567|Vanderbilt University Medical Center|Jin H. Han|615-936-0253|jin.h.han@vumc.org|
22429207|NCT02063724|H. Lee Moffitt Cancer Center and Research Institute|Dr. Brian Czerniecki|813-745-7575|brian.czerniecki@moffitt.org|
22429208|NCT02697422|VA Puget Sound Health Care System|Dr. Karin Nelson|(206)277-4507|karin.nelson@va.gov|
22429209|NCT02991521|Medical City Arlington, 3301 Matlock Rd, Arlington, TX 76015|Danielle A Pigneri, MD, FACS|(502) 387-3117|dpigneri@gmail.com|
22429210|NCT02068599|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22429211|NCT03019588|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22429212|NCT02958527|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22429213|NCT03573700|St. Jude Children's Research Hospital|Aimee Talleur, MD|8662785833|referralinfo@stjude.org|
22429214|NCT00699751|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22429215|NCT01947933|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22443726|NCT02003365|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
22384065|NCT03161327|Saint Louis University|Dr. Keith Pereira|314-268-5782|keith.pereira@health.slu.edu|
22384066|NCT01411592|University of Kiel|Dr. Martin Sasse, D.M.D., Assistant Professor|+494315972874|sekretariat@proth.uni-kiel.de|
22384067|NCT02539225|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22443727|NCT03070444|Folktandvården Gävleborg AB|Anke Krämer|+4625155680|anke.kramer@regiongavleborg.se|
22443728|NCT01373489|Medical College of Wisconsin|Jennifer Campbell|4149558829|jacampbell@mcw.edu|
22443729|NCT02582255|FIDEC|Ricardo Rüttimann|+13058540075|rruttimann@fidec-online.org|
22443730|NCT01709578|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22443731|NCT04050371|UCSF|Robert Grant|415-323-6658|robert.grant@ucsf.edu|
22443732|NCT00597701|Essentia Health|Charles E Gessert, MD, MPH|218-786-8176|cgessert@eirh.org|
22443733|NCT04247620|Baylor College of Medicine|Dr. Marisa Hilliard|8328247209|mehillia@bcm.edu|
22443734|NCT02670343|Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center|Christina Wang, MDAssociate Director UCLA Clinical and Translational Science Institute|1-310-222-1888|wang@labiomed.org|
22443735|NCT04078178|MGH|Kayla McEachern|617-643-5265|kmceachern2@mgh.harvard.edu|
22443736|NCT04617795|Insulet Corporation|Dr. Trang Ly|9786007628|tly@insulet.com|
22443737|NCT04850313|University of Arkansas for Medical Sciences|Dr. David Warner|501-686-5822|DBwarner@uams.edu|
22443738|NCT04999982|Ann & Robert H. Lurie Children's Hospital of Chicago|Dr. Andrea Spencer|3122273402|aspencer@luriechildrens.org|
22443739|NCT01680549|Texas Tech University Health Sciences Center|Nancy Swinford|806-743-2569|nancy.swinford@ttuhsc.edu|
22443740|NCT03505671|Wake Forest Baptist Comprehensive Cancer Center|Nancy Avis, PhD|336-713-5440|navis@wakehealth.edu|
22443741|NCT02038829|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
22443742|NCT04393298|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22443743|NCT05381454|University of Texas Southwestern Medical Center|Theodoros Kelesidis|2146488979|Theodoros.Kelesidis@UTSouthwestern.edu|
22443744|NCT04633460|Hospital of the University of Pennsylvania|Payman Zamani|(215) 662-4000|payman.zamani@pennmedicine.upenn.edu|
22443745|NCT05283928|The University of Texas Health Science Center at Houston|Popi Stylianou, DDS,MS|713-486-4048|Popi.Stylianou@uth.tmc.edu|
22443746|NCT04911426|Texas Christian University Institute of Behavioral Research|Dr.Jennifer Pankow|8172577226|j.pankow@tcu.edu|6475
22443747|NCT00807027|GREEN CROSS CELL|CRA of Clinical Trial|82-2-2101-0665|a1pole@greencrosscell.com|665
22443748|NCT02339376|Beth Israel Deaconess Medical Center|Bernard S. Chang, M.D.|617-632-8930|bchang@bidmc.harvard.edu|
22443749|NCT05660850|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22443750|NCT02604017|AbbVie|Global Medical Services|800-633-9110||
22443751|NCT05820997|Mayo Clinic|Dr. John Stauffer|904-953-2000|stauffer.john@mayo.edu|
22443752|NCT05048082|OncoNano Medicine, Inc|Vice President, Clinical Operations|(682) 285-1411|trials@onconanomed.com|
22443753|NCT00634270|The Univ of Alabama at Birmingham|Bruce Korf, MD, PhD|205.934.5140|kcole@uab.edu|
22443754|NCT01653782|Karolinska Institute|Dr. Irene Jensen|+46852483218|irene.jensen@ki.se|
22443755|NCT02777749|Columbia University Medical Center|Dr. Matthew Grosso|2123058193|mgrosso13@gmail.com|
22443756|NCT01315236|Insmed Incorporated|Kevin Mange (Senior VP, Clinical Development)|908-947-2651|kevin.mange@insmed.com|
22443757|NCT00926588|VA HSRD|Dr. Kurt Kroenke|317-988-3476|kkroenke@regenstrief.org|
22443758|NCT02497976|IC Study LLC|Philip C. Bosch, MD|760 743-3135|pboschmd@gmail.com|
22443759|NCT01410552|LivaNova|Scientific Communication manager|33146013082|Anne.rousseauplasse@sorin.com|
22443760|NCT01277081|GlaxoSmithKline|GSK Response Center|866-435-7343||
22443761|NCT00058539|Hoffmann-LaRoche|Medical Communications|: 800-821-8590|genentech@druginfo.com|
22443762|NCT00963677|The Second Xiangya Hospital of Central South University|Ru-Ping Dai, B.Sc(Med), PhD, Associate Professor|86-731-85295970|Ruping_dai@yahoo.com.cn|
22443763|NCT01514162|St Jude Medical|Jennifer Johnson|6517566803|jjohnson101@sjm.com|
22443764|NCT01673282|UCB Cares|UCB (Study Director)|+1 887 822 9493||
22443765|NCT02483533|Neothetics|Director of Clinical Trials|8585501900||
22443766|NCT01323920|Dana Farber Cancer Institute|Dr. John Koreth|617-632-2949|John_Koreth@dfci.harvard.edu|
22443767|NCT00768469|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
22443768|NCT05040971|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22443769|NCT05622604|Pray.com|Breanne Laird, PhD|9095574002|breanne.laird@pray.com|
22443770|NCT01293799|Dept. of Nephrology, Sahlgrenska University Hospital, Gothenburg, Sweden|Susanne Ljungman prof. emer. Director of the study|+46-(0)31-3421000|susanne.ljungman@vgregion.se|28579
22443771|NCT03964337|Duke University|Michael Harrison, M.D.|919-668-8108|michael.harrison@duke.edu|
22443772|NCT02891603|Moffitt Cancer Center|Joseph Pidala, MD, PhD|813-745-2556|Joseph.Pidala@moffitt.org|
22443773|NCT03160859|Veterans Administration Greater Los Angeles Healthcare System|Felix W. Leung, M.D, Staff Gastroenterologist|818-891-7711|felix.leung@va.gov|32520
22443774|NCT04702802|Laboratorios Sophia|Alejandra Sanchez-Ríos M.D.|:+52 (33) 3001 4200|alejandra.sanchez@sophia.com.mx|
22443775|NCT06066697|University of Pittsburgh|Ana Radovic MD, MSc|412 692 7227|anr94@pitt.edu|
22398271|NCT02615743|Children's Hospital of Philadelphia|Dr. Chen Kenyon, Faculty PolicyLab and Assistant Professor University of Pennsylvania|267-426-6339|kenyonc@email.chop.edu|
22398272|NCT03988335|Aristea Therapeutics|Aristea Therapeutics|858-465-6142|info@aristeatx.com|
22398273|NCT00119158|The Children's Hospital of Philadelphia|Jonathan Spergel|215 590 1000|spergel@email.chop.edu|
22398274|NCT00608985|Actelion Pharmaceuticals Ltd|Ouali Berkani/Clinical Trial Leader|+41 61 565 5342||
22398275|NCT00661271|Johns Hopkins School of Medicine|Erica Sibinga|410-550-4134|esibinga@jhmi.edu|
22398276|NCT00953758|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22398277|NCT03987854|University of Michigan|Laura Saslow|(734) 764-7836|saslowl@umich.edu|
22398278|NCT00706030|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
22443776|NCT00938886|Brown University|Christopher Kahler|401 863-6651|christopher_kahler@brown.edu|
22443777|NCT02283177|Arog Pharmaceuticals|Edward McDonald|214-593-0500|emcdonald@arogpharma.com|
22443778|NCT01101191|Purdue Pharma L.P.|Stephen Harris, MD|203-588-7592|Stephen.Harris@Pharma.com|
22398279|NCT05779072|Coopervision|Paul Chamberlain|9257306754|pchamberlain@coopervision.com|
22398280|NCT03870555|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22443779|NCT03044574|Pirogov Russian National Researching Medical University|Dr. Kirill Lobastov, Associated professor at the Department of General Surgery and Radiology|+7-985-211-63-31|lobastov_kv@hotmail.com|
22443780|NCT01146860|ENT practice|Dr. Rainer Jund, Specialist in Otorhinolaryngology|+49 89 804880|RainerJund@gmx.de|
22443781|NCT04779216|Massachusetts General Hospital|Karen Miller, MD|6177263870|kkmiller@mgh.harvard.edu|
22443782|NCT00133978|Clinical Evaluation Research Unit|Dr. Daren Heyland|613-549-6666|dkh2@queensu.ca|4847
22443783|NCT01233518|Heartflow, Inc.|Whitney Huey|650.257.6697|whuey@heartflow.com|
22443784|NCT02674854|Aerie Pharmaceuticals, Inc|Theresa GH Heah, MD, MBA|908-947-3844|theah@aeriepharma.com|
22443785|NCT02635646|University of Guanajuato|Dr. Rodolfo Guardado-Mendoza||guardamen@gmail.com|
22443786|NCT02995369|Montefiore Medical Center|Nuntiya Kakanantadilok|718-405-8057|nkakanan@montefiore.org|
22443787|NCT02387476|FRESCA Medical|Robert Lahaderne|949-542-3535|rlahaderne@frescamed.com|
22398281|NCT00293579|Ohio State University Comprehensive Cancer Center|Anterpreet Neki|614-257-2900|Anterpreet.Neki@osumc.edu|
22443788|NCT00879879|SunCoast CCOP Research Base|Dr. Jeffrey Krischer, Principal Investigator|813-396-9245|ccop@epi.usf.edu|
22443789|NCT03769376|"University of Colorado Denver | Anschutz"|Kerri Font, DDS, MS|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
22443790|NCT00745615|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22443791|NCT00570232|University of Alabama at Birmingham|Eben Rosenthal,MD|2059349713|erosenthal@uabmc.edu|
22443792|NCT01076075|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22443793|NCT02751931|Astellas Pharma Europe B.V.|Clinical Trial Disclosure|+44 (0)20 3379 8000|Astellas.resultsdisclosure@astellas.com|
22443794|NCT04090411|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22443795|NCT02233478|Center for Human Nutrition, Department of Medicine, UCLA David Geffen School of Medicine|Zhaoping Li, Professor|310-206-1987|zli@mednet.ucla.edu|61987
22443796|NCT02477696|Acerta Pharma BV|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22443797|NCT02104739|The University of Texas Health Science Center at Houston|Absalon D Gutierrez, MD|(713) 500-6641|Absalon.D.Gutierrez@uth.tmc.edu|
22443798|NCT05618782|Levicept|Iwona Bombelka|0000000000|info@levicept.com|
22443799|NCT04770753|Agios Pharmaceuticals, Inc .|Agios Medical Affairs|833-228-8474|medinfo@agios.com|
22443800|NCT05281510|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22443801|NCT05859698|Neurocrine Biosciences|Neurocrine Medical Information|+1 877-641-3461|medinfo@neurocrine.com|
22443802|NCT05900999|Marquette University|Robert A. Scheidt, PhD|414-288-6124|robert.scheidt@marquette.edu|
22443803|NCT06415305|Sun Pharmaceutical Industries Limited|Head-Regulatory Affairs|2266455645|Clinical.Trial@sunpharma.com|5689
22443804|NCT04527549|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22443805|NCT04103346|University of Michigan|Geoff Barnes|734-763-0047|gbarnes@med.umich.edu|
22443806|NCT05380180|University of Illinois Urbana-Champaign|Wendy Rogers|2173001470|wendyr@illinois.edu|
22443807|NCT05411367|Seikagaku Corporation|General Manager, Clinical Development Department|+81-3-5220-8593|reply@seikagaku.co.jp|
22443808|NCT02032823|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22443809|NCT02411448|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22443810|NCT03096418|University of Wisconsin Carbone Cancer Center|Cancer Connect|800-622-8922|clinicaltrials@cancer.wisc.edu|
22443811|NCT02616562|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22443812|NCT03114059|Dietrich-Bonhoeffer-Klinikum|Ahmed Medra|+49 395 775 13483|a.medra@live.com|
22443813|NCT05470036|University of California, San Diego|Rana McKay, MD|(858) 822-5354|CancerCTO@health.ucsd.edu|
22443814|NCT01464723|University of California San Diego Shiley Eye Center|Dr. Stuart Brown|(858) 822-2585858-246-0814|sibrown@ucsd.edu|
22443815|NCT01683825|Brigham and Women's Hospital|Sharmila Dorbala, Director Nuclear Cardiology|617-732-6290|sdorbala@bwh.harvard.edu|
22443816|NCT05700747|MGH Institute of Health Professions|Kathleen Lyons|617-643-5372|klyons2@mghihp.edu|
22443817|NCT03326206|Brigham and Women's Hospital|Dr. Sonya Shin|617-872-0310|sshin@bwh.harvard.edu|
22443818|NCT01958827|AbbVie|Global Medical Information|800-633-9110||
22443819|NCT04770779|Agios Pharmaceuticals, Inc.|Agios Medical Affairs|833-228-8474|medinfo@agios.com|
22443820|NCT03692052|Agios Pharmaceuticals, Inc.|Medical Affairs|833-228-8474|medinfo@agios.com|
22443821|NCT01163318|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
22443822|NCT03587727|University of Colorado|Yesenia Garcia Reyes|720-777-6984|Yesenia.GarciaReyes@childrenscolorado.org|
22443823|NCT05987709|University of Arizona|Gloria D. Coronado, PhD - Professor, Associate Director Population Sciences, Cancer Center|520-626-0023|gdcoronado@arizona.edu|
22443824|NCT05797974|University of Florida|Dr. Jana Sacco|904-244-7418|Jana.Sacco@jax.ufl.edu|
22443825|NCT06359314|Northwestern University Feinberg School of Medicine|Elizabeth L. Addington, PhD|3125033808|elizabeth.addington@northwestern.edu|
22443826|NCT04562480|Mayo Clinic|Safia K. Ahmed, MD|507-284-2511|ahmed.safia@mayo.edu|
22443827|NCT05905250|The George Washington University|Carla Berg|202-994-0168|carlaberg@gwu.edu|
22443828|NCT04001829|ECOG-ACRIN Biostatistics Center|Study statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22443829|NCT05388058|Mayo Clinic|Dr. Stacy D. D'Andre|507-284-2511|dandre.stacy@mayo.edu|
22443830|NCT03807661|LimFlow SA|Kristi McCaffrey|+1 559 970-1012|kristi.mccaffrey@stryker.com|
22443831|NCT03064152|Brigham and Women's Hospital|Dr. Michaela K. Farber|6177591609|mfarber@bwh.harvard.edu|
22443832|NCT04831216|University of Arkansas for Medical Sciences|Krista Langston|479-713-8000|KNLangston@uams.edu|
22398282|NCT03215771|Northwestern University|Dr. Stefania Fatone, Principle Investigator|3125035717|s-fatone@northwestern.edu|
22443833|NCT02969837|University of Chicago|Member of the Biostatistics Lab|773.702.2453|slee@health.bsd.uchicago.edu|
22443834|NCT03470441|Faraday Pharmaceuticals, Inc|Clinical Trials Manager|206-492-5310|info@faradaypharma.com|
22443835|NCT02656706|Brown University Oncology Research Group|Maria Constantinou, MD|401-863-300|BrUOG@BROWN.EDU|
22443836|NCT05076266|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22443837|NCT05169567|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22443838|NCT05545735|University of Miami|Dr. Jonathan Meizoso|305-585-1178|jpmeizoso@med.miami.edu|
22443839|NCT04576455|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22443840|NCT04449055|The University of Iowa College of Public Health|Dr. Ryan Carnahan|3193841556|ryan-carnahan@uiowa.edu|
22443841|NCT06596005|Hangzhou PhecdaMed Co., Ltd.|Director of Clinical Trials|+86 18626868383|dong.liu@phecdamed.com|
22443842|NCT02445391|ECOG-ACRIN Cancer Research Group|Study Statistician|16176323012|eatrials@jimmy.harvard.edu|
22443843|NCT03516942|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22443844|NCT02275910|Eisai Co., Ltd.|Eisai Inquiry Service.||eisai-chiken_hotline@hhc.eisai.co.jp|
22443845|NCT03961555|Synermore Biologics Co., Ltd.|Ariel Chuang / Director|+886 22659 0988|achuang@synermore.com|
22443846|NCT06837116|Prince of Songkla university|Tawin Khaimook|+66846912946|tawin.khaimook@gmail.com|
22443847|NCT05222555|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22443848|NCT06560632|Repare Therapeutics Inc|Repare Therapeutics Medical Monitor|1 (857) 340-5402|clininfo@reparerx.com|
22443849|NCT06472869|Massachusetts General Hospital|Nancy Rigotti, Study PI|6177243548|nrigotti@mgh.harvard.edu|
22443850|NCT04509739|University of Washington|Christina Zhao|206-221-6415|zhaotc@uw.edu|
22443851|NCT00076024|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22443852|NCT00902161|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22443853|NCT00988325|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22443854|NCT01155219|Laboratoires Thea|Dr Pascale Pouliquen|0473981436|p.pouliquen@laboratoires-thea.fr|
22443855|NCT03052764|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22443856|NCT01314911|Leidos Biomedical Research, Inc. is support to the National Institute of Allergy and Infectious Diseases (NIAID)|John Beigel, M.D|301-451-9881|jbeigel@niaid.nih.gov|
22443857|NCT00306202|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22443858|NCT03150485|Johnson & Johnson Vision|Thomas Karkkainen - SR PRINCIPAL RESEARCH OPTOMETRIST|904 443-3402|TKarkkai@its.jnj.com|
22443859|NCT02097537|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group||clinical@santen.co.jp|
22443860|NCT01695005|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22443861|NCT04478123|Memorial Sloan Kettering Cancer Center|Dr. Michael Scordo, MD|646-608-3771|scordom@mskcc.org|
22443862|NCT00478881|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22443863|NCT05959200|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22443864|NCT05803603|University of Maryland School of Social Work|Jay Unick|410-706-3735|junick@ssw.umaryland.edu|
22384068|NCT00212134|Stanford University School of Medicine|Scott R Lambert, MD, Study Chairman|650-498-4242|lambert7@stanford.edu|
22384069|NCT03101371|University of Colorado, Anshcutz Medical Campus|Saketh Guntupalli, MD|303-724-2033|saketh.guntupalli@cuanschutz.edu|
22384070|NCT01553058|University of Pennsylvania|Suzette Baez VanderBeek, MPH|215-662-3514|suzettev@upenn.edu|
22384071|NCT01094184|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22384072|NCT02318134|First Affiliated Hospital of Nanchang University|Dr. Ling Ding|15279196058|2495802456@qq.com|
22384073|NCT03988842|Cedars-Sinai Medical Center|Victor Tapson|919-971-6441|Victor.Tapson@cshs.org|
22384074|NCT04766034|NYU Langone Health|Pasquale Rummo, MPH, PhD|914-316-5907|Pasquale.rummo@nyulangone.org|
22384075|NCT03398148|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22384076|NCT01259401|VA Greater Los Angeles Healthcare System|Dr. Jennifer Martin|818 891-7711|Jennifer.Martin@va.gov|9173
22384077|NCT00212355|Nobelpharama|Department director of clinical development department 1|+81-3-5651-1177|murakami@nobelpharma.co.jp|
22384078|NCT06241794|Hitit University faculty of medicine|Guvenc Dogan|06342193000|guvencdogan@gmail.com|
22384079|NCT00186992|St. Jude Children's Research Hospital|Matthew Krasin, MD|(901) 595-3226|matthew.krasin@stjude.org|
22384080|NCT01489813|Emory University|Omer Kucuk|404-778-4729|okucuk@emory.edu|
22384081|NCT05644002|Rutgers, the State University of New Jersey|Dr. Teresa Leyro|848-445-2090|tml124@psych.rutgers.edu|
22384082|NCT04499950|SKCCC|Jennifer Sheng|410-614-0762|jsheng7@jhmi.edu|
22384083|NCT06180967|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22384084|NCT05756075|Radboudumc|Drs. D. de Graaf|+31243613450|debbie.degraaf@radboudumc.nl|
22384085|NCT03821844|Brown University|Ellen McCreedy, PhD|401-863-7345|Ellen_McCreedy@brown.edu|
22384086|NCT03416023|OstomyCure AS|Johan Järte|+46 706 524 532|jjaerte@ostomycure.com|
22384087|NCT02837510|University of Pennsylvaina|James Loughead PhD|215-746-6827|loughead@pennmedicine.upenn.edu|
22384088|NCT01727518|Ludwig Boltzmann Institute for Lung Health|Dr Robab Breyer-Kohansal|+436505398439|Robab.Breyer-Kohansal@lunghealth.lbg.ac.at|
22384089|NCT05419505|Endo Pharmaceuticals|Clinical Operations|800-462-3636|clinicaltrials@endo.com|
22384090|NCT05683392|Tandem Diabetes Care, Inc|Supervisor, Clinical Affairs|(877) 801-6901|clinicalaffairs@tandemdiabetes.com|
22384091|NCT02780388|Viela Bio|Viela Bio Clinical Operations|+1 240-558-0038|ClinicalTrials@VielaBio.com|
22384092|NCT04881162|Silk Road Medical|Heather Smith|763-335-5160|hsmith@silkroadmed.com|
22384093|NCT03857620|University of Texas MD Anderson Cancer Center|George J. Chang, MD, MS|713-563-1875|gchang@mdanderson.org|
22398283|NCT02703311|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
22443865|NCT04950608|Dana-Farber Cancer Institute|Dr. Yvan Beaussant|617-582-9318|patresearch@dfci.harvard.edu|
22443866|NCT04104438|University of California Los Angeles|Dr. Fady Kaldas|310-825-1037|fkaldas@mednet.ucla.edu|
22443867|NCT05001347|I-Mab Biopharma|VP of Clinical Development|240-745-6330|us.info@imabbio.com|
22443868|NCT01282203|AbbVie (prior sponsor Abbott)|Global Medical Services|1-800-633-9110||
22443869|NCT03977454|Yale School of Medicine: Anesthesiology|Jinlei Li, MD, PhD|(203) 785-2802|jinlei.li@yale.edu|
22443870|NCT00930982|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22443871|NCT00518973|UCSD Eating Disorders Treatment and Research Center|Walter H. Kaye|858-534-3951|wkaye@ucsd.edu|
22398284|NCT00343889|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22443872|NCT00582816|University of Wisconsin Carbone Cancer Center|Dr. Ken DeSantes|608-263-8563|kbdesantes@pediatrics.wisc.edu|
22398285|NCT00088374|National Cancer Institute, National Institutes of Health|William M. Linehan, M.D.|301-496-6353|linehanm@mail.nih.gov|
22443873|NCT01923168|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22443874|NCT04193410|Maastricht University|Marla Hahnraths, MSc|3882184|mth.hahnraths@maastrichtuniversity.nl|0031
22443875|NCT03896659|University of Texas Southwestern Medical Center|Dr. E. Sherwood Brown|214-645-6950|sherwood.brown@utsouthwestern.edu|
22398286|NCT00852995|Smith & Nephew|Jamie E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
22398287|NCT02692209|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
22443876|NCT02241889|Oregon Health and Science University|Dr. Jessica Castle|503-494-7072|castleje@ohsu.edu|
22443877|NCT00773838|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22443878|NCT02421198|University of Arizona|Dr. Melanie D Hingle|520-621-3087|hinglem@email.arizona.edu|
22398288|NCT00866307|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22443879|NCT00459056|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu|
22443880|NCT02522871|TransMedics|Laura Damme|978-552-0910|LDamme@TransMedics.com|
22443881|NCT01715129|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22443882|NCT03149848|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22398289|NCT02759172|Michigan State University|Dr. Jennifer Johnson|810-730-6121|jjohns@msu.edu|
22443883|NCT01486810|New York Psychiatric Institute|Dr. John Mariani|646-774-8181|John.mariani@nyspi.columbia.edu|
22443884|NCT00330161|University of Michigan Comprehensive Cancer Center|Erin Sargent|(734) 936-3348|esargent@umich.edu|
22443885|NCT00378079|Friends Research Institute|Dr. Timothy Kinlock|(410) 837-3977|tkinlock@friendsresearch.org|224
22443886|NCT02274038|University of Pennsylvania Perelman School of Medicine|Dr. Sharyn Katz, Principal Investigator|215-662-4000|sharyn.katz@pennmedicine.upenn.edu|
22443887|NCT04856865|Alladapt Immunotherapeutics|Chief Medical Officer|650-420-3900|info@alladapt.com|
22443888|NCT05458648|CathVision ApS|Clinical Research Manager|0702097102|kpf@cathvision.com|
22398290|NCT02573155|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
22443889|NCT03666676|University of Rochester|Dr. Laurel H. Carney|585-276-3948|Laurel_Carney@URMC.Rochester.edu|
22443890|NCT03610555|University of Texas - Medical Branch|Ajay Israni, MD, MS - Division Chief - Transplant & General Nephrology|409 772 2473|akisrani@utmb.edu|
22443891|NCT01892722|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22398291|NCT01681433|Hoosier Cancer Research Network|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
22443892|NCT05217927|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22443893|NCT00588952|Yale University|Ismene Petrakis|203-932-5711|Ismene.petrakis@yale.edu|2244
22443894|NCT01490723|U.T. MD Anderson Cancer Center|Issa F. Khouri, M.D., Stem Cell Transplantation|(713) 745-0049|ikhouri@mdanderson.org|
22443895|NCT03560739|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22443896|NCT01362595|Feinstein Institutes for Medical Research|Dr. Adrianna Vlachos|516-562-1504|avlachos@northwell.edu|
22398292|NCT00903929|University of Rochester|Jane L. Liesveld|585-275-5823|jane_liesveld@urmc.rochester.edu|
22398293|NCT01141595|Arkansas Children's Hospital Reseach Insitute|Richard Frye|501-364-5465|REFrye@uams.edu|
22443897|NCT00959374|Covidien|Amy Pollack M.D. Vice President Medical Affairs, STI|203-821-4719|amy.pollack@covidien.com|
22398294|NCT06245551|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22443898|NCT02448680|LFB USA, Inc.|Kerry Biron, Director US Clinical Operations|508-370-5166|kerry.biron@lfb-usa.com|
22443899|NCT01739400|Actelion Pharmaceuticals Ltd.|Clinical Trial Disclosure Desk|+41 61 565 6565|clinical-trials-disclosure@its.jnj.com|
22443900|NCT01736657|Terumo BCT, Inc.|Ray Goodrich, Phd, VP Scientifc and Clinical Affairs|303-205-2680||
22443901|NCT03350984|University of Guanajuato|Dra. Paulina Crespo Morfin|+52 4431300112|pb.crespomorfin@outlook.es|
22443902|NCT04198818|Haihe Biopharma Co., Ltd|Medical Officer|86-(021)-20568888|fugen.li@haihepharma.com|8988
22443903|NCT00642473|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22443904|NCT04533880|NYU Langone Health|Larry Chen|(646) 501-7200|Larry.Chen@nyulangone.org|
22443905|NCT04243421|Medical University of Białystok|Małgorzata Pietruska|+48606461092|mpietruska@wp.pl|
22443906|NCT02284178|University of Central Florida|Mary Lou Sole|407-823-5496|mary.sole@ucf.edu|
22443907|NCT01741012|Wayne State University School of Medicine|Dr. J. Patricia Dhar, MD, Principal Investigator|313-577-6011|pdhar@med.wayne.edu|
22398295|NCT00626093|St. Jude Medical|Ashish Oza|818-493-3648|aoza@sjm.com|
22398296|NCT00511355|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22398297|NCT01632566|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22398298|NCT00454805|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22443908|NCT04123665|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22429216|NCT00294398|CHOP|Esther Sampayo MD MPH|215-590-1944|sampayo@email.chop.edu|
22429217|NCT02475837|Stanford University|Ken Mahaffey MD|650.723.3096|kmahaf@stanford.edu|
22429218|NCT02939781|Great Ormond Street Hospital NHS Trust|Dr Samiran Ray|4420274059200|samiran.ray@gosh.nhs.uk|8213
22429219|NCT04136366|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
22429220|NCT03159195|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22429221|NCT04337021|Cprl. Michael J. Crescenz VA Medical Center|Dr. Amy Helstrom|215-823-4164|amy.helstrom@va.gov|
22429222|NCT03677206|University of Arizona|Dr. Mohab Ibrahim|(520) 626-7221|mohab@arizona.edu|
22429223|NCT02593864|Stanford University|Constance Chu, MD|650-723-5643|chucr@stanford.edu|
22429224|NCT01181479|Agile Therapeutics|Joseph Chiodo III, Senior Medical Director|609-683-1880|jachiodo@agiletherapeutics.com|
22429225|NCT06991803|Recep Tayyip Erdoğan University, Faculty of Dentistry, Department of Endodontics|Medine Çiçek|5442745525|medinecicekk@hotmail.com|+90
22429226|NCT06875115|Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation|Ying-Hsu Juan, M.D. Principal Investigator|+886-5-2648000|ddjjaa@tcts.seed.net.tw|
22429227|NCT06922760|University of Michigan|Njira Lugogo|734-647-6477|nlugogo@med.umich.edu|
22429228|NCT06923033|Moffitt Cancer Center|Dr. Christine Vinci, Ph.D.|813-745-5421|Christine.Vinci@Moffitt.org|
22429229|NCT02564978|National Institutes of Health|Tiarnan Keenan, MD, PhD, Principal Investigator, NEI|301-451-6330|tiarnan.keenan@nih.gov|
22429230|NCT05136430|Brown University|Cara M. Murphy, Ph.D.|4018636519|murphybrownlab@brown.edu|
22429231|NCT01501513|Braintree Laboratories, Inc.|Head of R&D, GI|781-843-2202|studydirector@sebelapharma.com|
22429232|NCT02740582|University of California, San Franciso|Jennifer Mitchell, PhD|510-985-3522|jennifer.mitchell@ucsf.edu|
22429233|NCT05675020|Florida State University|Rachel Sharp|850-865-4443|rls14c@fsu.edu|
22429234|NCT03787212|Johnson & Johnson Vision Care Inc.|Chantal Coles-Brennan, OD - Principal Research Optometrist|904 443 3449|CColesb@its.jnj.com|
22429235|NCT00142597|University of Michigan|Richard E. Harris|734-998-6996|reharris@med.umich.edu|
22429236|NCT02316613|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22429237|NCT02545127|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DK0-Disclosure@ferring.com|
22429238|NCT01952678|GE Healthcare|Jose M Zubeldia, M.D.|011-44-1494-543137|jose.zubeldia@ge.com|
22429239|NCT03309605|Eloxx Pharmaceuticals|Executive Director Clinical Trials|1-781-577-5300|CTI@eloxxpharma.com|
22429240|NCT02082483|Kidney Transplant Research|Dr. John Gill|6046822344|jgill@providencehealth.bc.ca|64706
22429241|NCT00422461|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22429242|NCT02181621|Smith & Nephew, Inc.|Matthew Christensen|+1-303-249-5812|Matthew.Christensen@smith-nephew.com|
22429243|NCT00145327|Novartis Pharmaceuticals|Study Director|862-778-8300||
22429244|NCT00908388|W.L. Gore & Associates|Abe Letter|928-864-3113|aletter@wlgore.com|
22429245|NCT00960856|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clincialtrials@urlmutual.com|
22429246|NCT04027946|National Cancer Institute|Dr. Azam Ghafoor|240-858-3289|azam.ghafoor@nih.gov|
22429247|NCT02197104|Rush University Medical Center|Dr. Deborah A Hall|312-563-2900|Movementdisorder@rush.edu|
22429248|NCT05938010|Scripps Optometric Group|Dr Jay Mashouf|1-858-530-2800|jaymashouf@gmail.com|
22429249|NCT00985192|UCLA GI Oncology Program, David Geffen School of Medicine at UCLA|Dr. Zev Wainberg|310 794-6500|zwainberg@mednet.ucla.edu|
22429250|NCT01454063|Omeros Corporation|Chief Medical Officer|(206) 676-5000|swhitaker@omeros.com|
22429251|NCT00069329|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Goldbach-Mansky, Raphaela|+1 301 435 6243|goldbacr@mail.nih.gov|
22429252|NCT02707744|Imperial College|Yura Mareev|+79166364410|mareev84@gmail.com|
22429253|NCT01562444|GlaxoSmithKline|GSK Response Center|866-435-7343||
22429254|NCT02331407|Columbia University|Dr. Tomoko Kitago|212-305-8389|tk2229@columbia.edu|
22429255|NCT01286324|University of Michigan|Suzanna M Zick|734-998-9553|szick@umich.edu|
22429256|NCT00743262|Netherlands Cancer Institute|Prof. Dr. F.J.M. Hilgers|+31-20-5252550|f.hilgers@nki.nl|
22429257|NCT03055195|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22429258|NCT01908842|University of Virginia|Dr. Erik Gunderson, MD, FASAM|(434) 202-8612|EWG2N@hscmail.mcc.virginia.edu|
22429259|NCT00038610|The University of Texas (UT) MD Anderson Cancer Center|Naval Daver, MD/Leukemia||CR_Study_Registration@mdanderson.org|
22429260|NCT00790933|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22429261|NCT04017910|Sonavex|Katy Feeny|443-862-2024|kfeeny@sonavex.com|
22429262|NCT00245570|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22429263|NCT01901588|NYU School of Medicine|Assistant Professor, Department of Anesthesiology, Perioperative Care, and Pain Medicine|212.263.5072|wanda.chin@nyumc.org|
22429264|NCT00875329|Tampa VAMC|Rodney Vanderploeg, Ph.D|(813) 972-2000|Rodney.Vanderploeg@va.gov|6728
22429265|NCT05706701|Yale University|Stephen R Baldassarri, M.D.|203-785-3627|stephen.baldassarri@yale.edu|
22429266|NCT02822287|GlaxoSmithKline|GSK Response Center|866-435-7343||
22429267|NCT00634972|University of South Alabama|Fabien Eyal, MD|251-415-1055|feyal@health.southalabama.edu|
22429268|NCT00837447|Ewha Womans University School of Medicine|Young-Hoo Kim, MD|822-26505900|younghookim@ewha.ac.kr|
22429269|NCT00866320|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Brian Rini|216-444-9567|rinib2@ccf.org|
22429270|NCT00896233|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22429271|NCT05507450|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22429272|NCT05436288|Kiora Pharmaceuticals, Inc.|Eric Daniels|858-353-0469|edaniels@kiorapharma.com|
22429273|NCT03948386|Thomas Jefferson University|Eric S Schwenk, MD|215-955-6161|eric.schwenk@jefferson.edu|
22429274|NCT00464464|Rutgers- Robert Wood Johnson Medical School|Dr. Roseanne Dobkin|732-235-4051|dobkinro@rutgers.edu|
22398299|NCT00217087|Mayo Clinic|Kenneth Wang MD|507-255-7495|wang.kenneth@mayo.edu|
22398300|NCT00802685|University of Miami|Ilene R. S. Sosenko, M.D.|305-585-6408|isosenko@miami.edu|
22398301|NCT02772432|Mass General Hospital|Elyse Park|6177246836|epark@mgh.harvard.edu|
22398302|NCT03208231|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
22398303|NCT03205995|Omeros Corporation|Dr. Andreas Grauer|206-676-5000|ctinfo@omeros.com|
22398304|NCT03321097|Chang Gung Memorial Hospital-Kaohsiung Medical Center, Kaohsiung, Taiwan|Jen-Wen Hung, MD|+886975056689|hung0702@cgmh.org.tw|
22412022|NCT02666430|Director Global Clinical Operations, General Medicine|Keri L Vaughan|+1 267.980.5015|keri.vaughan@mylan.com|
22398305|NCT04947800|Dartmouth-Hitchcock|james stahl|6036502000|james.e.stahl@hitchcock.org|
22398306|NCT02158091|Dana-Farber Cancer Institute|Matthew Davids, MD|617-632-6331|matthew_davids@dfci.harvard.edu|
22398307|NCT01328951|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22443909|NCT02547714|Novartis Pharmaceuticals|Study Director|862-778-8300||
22443910|NCT04396496|University of Arkansas for Medical Sciences|Beth Scanlan|5016868274|bscanlan@uams.edu|
22443911|NCT01711879|University of Colorado School of Medicine|Rachel Gerle|720-848-2020|rachel.gerle@ucdenver.edu|
22443912|NCT02260531|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|617-632-3800|Sara_Tolaney@dfci.harvard.edu|
22443913|NCT00958789|Stryker Orthopaedics|Ellen Axelson, Director, Clinical Operations|201-831-5401|ellen.axelson@stryker.com|
22443914|NCT00586729|Maricopa Integrated Health System|Karen Richey, RN|602-344-5125|karen.richey@mihs.org|
22443915|NCT02464917|Memorial Health Systems|Michael Nageotte, MD|562-933-2748|mnageotte@memorialcare.org|
22443916|NCT03183778|NYU Langone Health|David Goldfarb, MD|212-263-0744|David.Goldfarb@nyulangone.org|
22443917|NCT01466179|Amgen Inc.|Study Director|866-572-6436||
22443918|NCT03410823|University of Maryland School of Medicine|Denise Orwig|410-706-2406|dorwig@som.umaryland.edu|
22443919|NCT01515540|Northwestern University|Javeria Ali Hashmi|3125037991|j-hashmi@northwestern.edu|
22443920|NCT03707184|Huntsman Cancer Institute, Center for Quantitative Cancer Imaging|Sam Mitchell|8012136110|sam.mitchell@hci.utah.edu|
22443921|NCT04704154|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22443922|NCT03220438|University of Maryland Baltimore|Dr Laura Rowland|410-402-6073|lrowland@som.umaryland.edu|
22443923|NCT04062123|University of Pittsburgh|Keith Vogt, MD, PhD|4126473147|vogtkm@upmc.edu|
22443924|NCT04190680|Maastricht University|Marla Hahnraths, MSc|433882184|mth.hahnraths@maastrichtuniversity.nl|0031
22443925|NCT03780400|University of North Carolina at Chapel Hill|Kelli D. Allen, PhD|919-966-0558|kdallen@email.unc.edu|
22443926|NCT01850602|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
22443927|NCT03115580|Icahn School of Medicine at Mount Sinai|Annapoorna S. Kini, MD|212-241-4181|annapoorna.kini@mountsinai.org|
22443928|NCT00740051|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22443929|NCT03452527|Iconic Therapeutics|Gabriela Burian, M.D.|6504371000|gburian@iconictherapeutics.com|
22443930|NCT01001299|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22443931|NCT01565499|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
22443932|NCT00476047|Fred Hutchinson Cancer Research Ctr|Mazyar Shadman, MD|2066675467|mshadman@fredhutch.org|
22443933|NCT02502006|University of Pennsylvania|Katherine N. Theken, PharmD, PhD|2158987470|ktheken@upenn.edu|
22443934|NCT02398227|University of Akron|Dawn M Johnson, Ph.d|3309722505|johnsod@uakron.edu|
22443935|NCT02793622|University of California, San Francisco|Grant Dorsey, MD|628-206-4680|grant.dorsey@ucsf.edu|
22443936|NCT04738318|Vanderbilt University Medical Center|Dr. Jed Maslow|615-936-7846|jed.i.maslow@vumc.org|
22443937|NCT00453388|Fred Hutchinson Cancer Research Center|Dr. Hans-Peter Kiem|206-667-4425|hkiem@fredhutch.org|
22443938|NCT00586664|ISTA Pharmaceuticals, Inc.|Vice President, Clinical Research & Medical Affairs|949-788-6000|tmcnamara@istavision.com|
22443939|NCT01585584|University of Calgary|Dr. Samuel Lee|403-220-8457|samlee@ucalgary.ca|
22443940|NCT04151667|Moffitt Cancer Center|Dr. Rachid Baz|813-745-3163|Rachid.Baz@moffitt.org|
22443941|NCT01602666|Children's Oncology Group|Results Reporting Coordinator|626 447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22443942|NCT04445792|Duke Clinical Research Institute|Kady-Ann Steen-Burrell, Ph.D.|919-668-8300|kady.ann.steen.burrell@duke.edu|
22443943|NCT03375788|Massachusetts General Hospital|Dr. Takara Stanley|617-724-9109|tstanley@mgh.harvard.edu|
22443944|NCT05443594|Boston Scientific|Thomas Stoltz|651-582-4000|Thomas.Stoltz@bsci.com|
22443945|NCT04369053|Freenome|Director of Clinical Development|(650)446-6630|medicalaffairs@freenome.com|
22443946|NCT01394718|Children's Hospital of Philadelphia|Athena Zuppa, MD, MSCE|267-426-7359|zuppa@email.chop.edu|
22443947|NCT00472459|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22443948|NCT02395016|Biotech Pharmaceutical Co., Ltd.|Director of Clinical Trials|010-51571020|lucy_he@biotechplc.com|8753
22443949|NCT01547780|National Institute of Mental Health|Robert Innis|+1 301 594 1368|innisr@mail.nih.gov|
22443950|NCT02195414|The General Hospital of Shenyang Military Region|Yaling Han, Study Chair of Clinical Trials|+86-024-28856123|hanyaling@263.net|
22443951|NCT00814879|Yale University School of Medicine: Internal Medicine: Infectious Diseases: AIDS Care Program / Viral Hepatitis Program|Dr. Michael J. Kozal|(203)737-4040|michael.kozal@yale.edu|
22443952|NCT01461057|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22443953|NCT01288976|Abbott Vascular|Jeffrey T Ellis||jeffrey.ellis@av.abbott.com|
22443954|NCT05386823|HighField BioPharmaceuticals Corporation|Dr. Yuhong Xu|+86-571-86961869|yhxu@hf-biopharm.com|
22443955|NCT03007407|NSABP Foundation|Director, Department of Site and Study Management|1-800-270-3165|industrytrials@nsabp.org|
22398308|NCT00970853|Children's Hospital of Philadelphia|Dr. Jerilynn Radcliffe|215-590-7446|radcliffe@email.chop.edu|
22443956|NCT03228420|Nevro Corp.|Donald Middlebrook|(650) 433-2218|don.middlebrook@nevro.com|
22398309|NCT01627899|LifeScan Scotland|Mike Grady|+44 01463 721000|MGRADY@its.jnj.com|
22398310|NCT03627403|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
22398311|NCT06232317|Department of Surgery, Houston Methodist Hospital|Dr. Hina Faisal|713-714-4973|hfaisal@houstonmethodist.org|
22398312|NCT04289116|Florida State University|Sylvie Naar, PhD; Distinguished Endowed Professor|18506442334|sylvie.naar@med.fsu.edu|
22398313|NCT01358864|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22398314|NCT04042103|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
22398315|NCT04209855|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22398316|NCT00507559|Medtronic Endovascular|Kristin Schwartz|(763) 514-4000|kristin.schwartz@medtronic.com|
22412023|NCT03922477|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22412024|NCT05202093|Sun Yat-sen University|Dr. Hongchun Liu|86-13826189071|hongchun_liu@vip.sina.com|
22398317|NCT00271817|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22412025|NCT01960816|Aerin Medical, Inc.|Scott Wolf, M.D., President and Chief Medical Officer|650-434-3247|scott@aerinmedical.com|
22398318|NCT00858858|VA|Stuart Spechler|214-857-1603|Stuart.Spechler@va.gov|
22398319|NCT03711578|Rhizen Pharmaceuticals|Prajak Barde MD|+41325800175|pjb@rhizen.com|
22412026|NCT06611410|CooperVision|Lee Hall|+19256604365|LHall@coopervision.com|
22398320|NCT02553512|Proteus Digital Health|Lorenzo DiCarlo MD, Vice-President of Clinical and Medical Affairs|+1 650 637 6199|ldicarlo@proteus.com|
22429275|NCT03767894|Columbia University|Dr. Joel Stein|(212) 305-4818|js1165@columbia.edu|
22429276|NCT00387127|GlaxoSmithKline|GSK Response Center|866-435-7343||
22429277|NCT03296345|Valley Children's Hospital|Jonathan Bryan Cooper-Sood, MD|559-353-3000|coopersoodj@usacs.com|
22429278|NCT02487485|Yale School of Medicine|Chadi Abdallah|347-987-0717|chadi.abdallah@yale.edu|
22429279|NCT04149353|North Carolina State University|David Lalush|919-513-7671|dslalush@ncsu.edu|
22429280|NCT01871727|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22429281|NCT01263028|Kaiser Permanente|John J. Sim, MD||john.j.sim@kp.org|
22429282|NCT06038643|McGill University|Maiya R. Geddes|514-398-8751|maiya.geddes@mcgill.ca|
22429283|NCT03573882|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22429284|NCT02691572|Department of Anesthesia and Surgical Intensive Care, Mansoura University Hospitals, Mansoura, Egypt.|Dr. Mohamed Mohamed Tawfik|1001183400|m2tawfik@mans.edu.eg|0020
22429285|NCT00250718|University of New Mexico|Dulcinea Quintana, MD|505-272-4661|dcandelaria@salud.unm.edu|
22443957|NCT01083173|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
22443958|NCT02090075|Los Angeles Biomedical Research Institute at Harbo|Dr Matthew Budoff|3102224107|mbudoff@labiomed.org|
22443959|NCT00792077|UT MD Anderson Cancer Center|Sriram Yennu, MD- Professor, Palliative Care Med|(713) 792-3938|syennu@mdanderson.org|
22443960|NCT05454657|Massachusetts General Hospital / Harvard Medical School|Dr. David Eddie|6176439194|deddie@mgh.harvard.edu|
22443961|NCT04626310|University of Massachusetts Amherst|Katherine Dixon-Gordon, PhD|413-545-0226|katiedg@umass.edu|
22443962|NCT00740246|Luitpold Pharmaceuticals, Inc.|Mark A Falone|610-650-4200|mfalone@americanregent.com|844
22443963|NCT01041495|SUNY Upstate MEdical Univ|thomas schwartz|3154643166|schwartt@upstate.edu|
22443964|NCT03584373|Montefiore Medical Center|Dr. Kara Watts, Associate Professor, Department of Urology|718-920-4531|kwatts@montefiore.org|
22443965|NCT01060345|University of Chicago|Nora Jaskowiak, MD|773-702-2048|njaskowi@surgery.bsd.uchicago.edu|
22443966|NCT00662532|OraPharma|Ms. Bindu Patel, Senior Scientist, Regulatory Affairs and Quality Assurance|215-420-4064|bpatel@orapharma.com|
22443967|NCT03239665|Rutgers University Center for Health Outcomes, Policy, & Economics|Laura T. Pizzi, PharmD, MPH|8484456825|laura.pizzi@rutgers.edu|
22443968|NCT01931709|University of Washington|Jennifer Specht, MD|206-288-6889|jspecht@uw.edu|
22443969|NCT01853618|National Cancer Institute|Dr. Tim F. Greten|(301) 451-4723|tim.greten@nih.gov|
22443970|NCT01658813|Western Regional Medical Center|Jessica L. Coats|623-207-3899|jessica.coats@ctca-hope.com|
22398321|NCT00264238|Stanford University School of Medicine, Dept of Psychiatry|Dr John Barry, Professor|(650) 725-5588|jbarry@stanford.edu|
22398322|NCT00861744|GlaxoSmithKline|GSK Response Center|866-435-7343||
22398323|NCT01411085|Geisel School of Medicine at Dartmouth|Alan I Green, MD|603-650-7549|alan.i.green@dartmouth.edu|
22398324|NCT05568888|CSL Behring|Study Director|16108784000|clinicaltrials@cslbehring.com|
22398325|NCT01564862|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22398326|NCT00313209|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22398327|NCT02193074|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22398328|NCT01844986|AstraZeneca|Elizabeth Lowe|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22398329|NCT07170488|University of Pittsburgh|Martina Anto-Ocrah|4123352862|maa509@pitt.edu|
22398330|NCT04381650|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22398331|NCT05416138|University of Minnesota|Alexander Opitz|612-624-1094|aopitz@umn.edu|
22398332|NCT04705051|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22398333|NCT03686397|Laboratorios Salvat, S.A|Medical Director|+34933946400|ejimenez@svt.com|
22398334|NCT03075085|University of Arkansas for Medical Sciences|Dr. Taren Swindle|870-236-0997|tswindle@uams.edu|
22398335|NCT00542997|CSL Behring|Program Director, Clinical R&D|Use email contact|clinicaltrials@cslbehring.com|
22398336|NCT00598975|Nektar Therapeutics|Study Director||medicalaffairs@nektar.com|
22412027|NCT04849988|AEON Biopharma, Inc.|Dana Testa, PharmD|949-354-6499|dt@aeonbiopharma.com|
22412028|NCT01893905|Complejo Hospitalario de La Coruña (CHUAC)|Dr Francisco Blanco, study coordinator|981 17 80 00|fblagar@sergas.es|
22443971|NCT00558571|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22443972|NCT01092832|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22443973|NCT04777331|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22443974|NCT01401959|Sarah Cannon Development Innovations|Senior Director, Regulatory Science|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
22443975|NCT00400153|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|800-542-6257 Option 4|clintriage.rdg@boehringer-ingelheim.com|
22443976|NCT01423604|Incyte Corporation|Study Director|1-855-463-3463||
22443977|NCT03020446|University of Toledo|Munier Nazzal, MD|419-383-3576|Munier.Nazzal@utoledo.edu|
22443978|NCT02300727|Aurora Health Care - Bay Area Medical Center|Dhimant Patel, MD|920-288-4123|dhimant.patel@aurora.org|
22443979|NCT05494632|Washington University School of Medicine|Jill B Firszt, PhD|314-362-4760|firsztj@wustl.edu|
22443980|NCT06982937|Jerzy Kukuczka Academy of Physical Education|Katarzyna Sadowska|32 207 5189|komisjabioetyczna@awf.katowice.pl|
22443981|NCT07086378|Cedars Sinai Medical Center|Dr. Robert Wong|3104231682|Robert.Wong@cshs.org|
22443982|NCT06785857|Xiamen Tongan District Xiangping Street Community Health Service Center|Miaoqian Huang|15880248915|hmiaoqian@163.com|
22443983|NCT02621398|Cancer Institute of New Jersey|Salma Jabbour, MD|732-235-8675|jabbousk@cinj.rutgers.edu|
22443984|NCT05952401|Washington University School of Medicine|Li-Shiun Chen, M.D., MPH, ScD|314-362-3932|li-shiun@wustl.edu|
22443985|NCT00543855|Eisai Co., Ltd.|Masaki Nakagawa, Study Director|+81-3-3817-5245||
22443986|NCT00847171|Johns Hopkins University|Dr. Leisha Emens||emensle@jhmi.edu|
22443987|NCT01981759|NYU Langone Health|Principal Investigator|646-754-4843|donald.goff@nyumc.org|
22443988|NCT01994590|UT MD Anderson Cancer Center|Corn,Paul,M.D. Ph.D. / Genitourinary Medical Oncology|713-792-2830|PCorn@mdanderson.org|
22443989|NCT00255801|Memorial Sloan Kettering Cancer Center|Dr. David Straus|212-639-8365|strausd@mskcc.org|
22384094|NCT04118452|University of California, Los Angeles & Kaiser Permanente School of Medicine|Dr. Paul Chung, Professor and Principal Investigator|626-710-0389|paul.j.chung@kp.org|
22443990|NCT00403403|Genentech, Inc.|Medical Communications|800-821-8590||
22443991|NCT00096954|Hoffman-LaRoche|Medical Communications|800-821-8590||
22443992|NCT00719264|Novartis Pharmaceuticals|Study Director|862-778-8300||
22443993|NCT01277042|GlaxoSmithKline|GSK Response Center|866-435-7343||
22443994|NCT01966692|Unversity of Florida|Dr Yuanyuan Jiao|(407) 313-7014|yyjiao@cop.ufl.edu|
22443995|NCT01823510|Icahn School of Medicine at Mount Sinai|Dr. Juan Badimon|212-241-8484|juan.badimon@mssm.edu|
22443996|NCT03581786|Shanghai Junshi Bioscience Co., Ltd.|Xiaojun Wang|86-021-50796193|xiaojun_wang@junshipharma.com|
22443997|NCT02469038|University of Chicago|Melanie Norstrom|773-702-1991|mnorstrom@medicine.bsd.uchicago.edu|
22384095|NCT04586920|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22384096|NCT04761302|University of Puerto Rico: Department of Orthopedic Surgery|Dr. Hans Hess|787-365-5755|hans.hess1@upr.edu|
22384097|NCT00753987|SickKids|Felix Ratjen|4168137500|felix.ratjen@sickkids.ca|
22384098|NCT05271903|University of Utah|Melissa Watt|801-587-2100|melissa.watt@hsc.utah.edu|
22384099|NCT00894543|University of Pennsylvania School of Medicine|Dr. Ellen W. Freeman|215-349-5521|freemane@mail.med.upenn.edu|
22384100|NCT03446157|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat Canter|919-445-4208|Melahat_Canter@med.unc.edu|
22384101|NCT04752163|The University of MD Anderson Cancer Center|Naval Daver MD./Professor|713-794-4392|NDaver@mdanderson.org|
22384102|NCT05384730|University of Southampton|Dr Samantha Meredith|0238120|s.j.meredith@soton.ac.uk|4656
22384103|NCT00411151|Interdisciplinary Center for Clinical Trials (IZKS Mainz)|M. Kabisch|++49 (0)6131-179922|kabisch@izks-mainz.de|
22384104|NCT05050682|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22384105|NCT02664558|Eiger BioPharmaceuticals, Inc.|Senior VP, Clinical Development|1-650-618-1621|info@eigerbio.com|
22384106|NCT01619410|University of Pennsylvania|Michael Z. David/Assistant Professor|215-662-6932|michdav@pennmedicine.upenn.edu|
22384107|NCT03405714|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22384108|NCT04452318|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|8447346643|clinicaltrials@regeneron.com|
22384109|NCT03771352|RxSight|Jeffrey Ha, Senior Director of Clinical Research|949-521-7870|jha@rxsight.com|
22384110|NCT02376530|SUNYBuffalo|Leonard H. Epstein|716-829-3400|lhenet@buffalo.edu|
22384111|NCT03380390|Aclaris Therapeutics|Dr. David Gordon|484-540-6273|dgordon@aclaristx.com|
22384112|NCT06647238|Atrium Health|Lyndsi Roland|828-434-5434|lyndsi.roland@advocatehealth.org|
22384113|NCT05494788|Cardiol Therapeutics Inc.|Andrea B. Parker, MSc., PhD, Senior Director of Clinical Operations|+1 289 9100862|andrea.parker@cardiolrx.com|
22384114|NCT01771731|University of California San Francisco|Donald I. Abrams, MD|415-476-4082|Donald.Abrams@ucsf.edu|444
22384115|NCT00087139|ECOG Statistical Office|Study Statistician|617-632-3012||
22384116|NCT00073749|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22384117|NCT02272816|Centre for Experimental Cancer Medicine, Barts Cancer Institute, QMUL|Project Lead|02078828277|bci-carpet@qmul.ac.uk|
22384118|NCT01748916|University of Hohenheim|Dr. Ralf Schweiggert|0049-711-459-22995|ralf.schweiggert@uni-hohenheim.de|
22384119|NCT04154384|Emory University|Mara L. Schenker|404-778-1550|mara.schenker@emory.edu|
22384120|NCT04095104|University of Colorado School of Medicine|Jaime Moore, MD MPH|303-724-8419|jaime.moore@cuanschutz.edu|
22443998|NCT03435640|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
22443999|NCT01347307|Mercy Research|Lead Regulatory Coordinator - Investigator Initiated Trials|314-251-8827|michelle.mcfarland@mercy.net|
22444000|NCT01483690|Therapeutic Advancements of Childhood Leukemia and Lymphoma|Clinical Research Coordinator, Consortia|323-361-5312|rleong@chla.usc.edu|
22444001|NCT02239224|aTyR Pharma|Gennyne Walker|858 731 8389|clinicaltrials@atyrpharma.com|
22444002|NCT00073073|Georgetown University|Dr. Claudine Isaacs|(202)444-3677|isaacsc@georgetown.edu|
22398337|NCT02388568|The University of Pennsylvania's Center for Weight and Eating Disorders|Dr. Jena Shaw Tronieri|215-746-5045|jena.tronieri@pennmedicine.upenn.edu|
22398338|NCT01178138|University of Arkansas for Medical Sciences|W. Brooks Gentry, MD|501 686 6119|gentrywilliamb@uams.edu|
22398339|NCT03160560|Center for Dental Research, Loma Linda University|Yiming Li, DDS, MSD, PhD, Professor and Associate Dean for Research|909-558-8069||
22398340|NCT00403260|Medicines for Malaria Venture|Stephan Duparc, MD|+41 22 555 0300|duparcs@mmv.org|
22398341|NCT03676257|Institut Bergonié|Carine Bellera|+33556330495|C.Bellera@bordeaux.unicancer.FR|
22398342|NCT04699539|Changhai Hos|Xiaofei Zhu|86-021-31162222|zhuxiaofei_zxf@163.com|
22398343|NCT01241708|Hackensack Meridian Health|Joshua Zenreich|5519964248|joshua.zenreich@hmhn.org|
22398344|NCT05159557|University of California, Berkeley|Robert W. Levenson|510-643-8952|boblev@berkeley.edu|
22398345|NCT04137887|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22398346|NCT02040298|UCSF|Tracy Tran, BA|415-353-2707|tracy.tran@ucsf.edu|
22398347|NCT01790503|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
22398348|NCT04183335|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22398349|NCT00049673|Canadian Cancer Trials Group|Director of Clinical Trials|613-533-6340|jdancey@ctg.queensu.ca|
22398350|NCT01535729|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22398351|NCT00748579|Cytokinetics, Inc.|Medical Director|(650) 624-3011||
22398352|NCT03733392|Abbott|Emily Jesser, Ph.D.|763-954-1350|emily.jesser@abbott.com|
22398353|NCT02740478|ResMed|Paul Phillips|+44 7789633508|paul.phillips@resmed.com|
22398354|NCT03312517|Henry Ford Sleep Research Center|Christopher Drake, PhD|248-344-6672|cdrake1@hfhs.org|
22398355|NCT01934140|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22398356|NCT02168686|Adverum Biotechnology, Inc.|Chief Development Officer|650-649-1413|sseyedkazemi@adverum.com|
22398357|NCT01461044|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22398358|NCT00618748|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22398359|NCT00200850|UW Madison|Gina Crisafi|608-262-5240|gmc@medicine.wisc.edu|
22398360|NCT02392013|Washington University in St. Louis|Dr. Susy Stark|3142734114|sstark@wustl.edu|
22398361|NCT03790683|Sidney Kimmel Medical College, Thomas Jefferson University and Hospitals|Marc C. Torjman, Ph.D.|(215) 955-5275|Marc.Torjman@Jefferson.edu|
22398362|NCT01629797|Northwestern University|Hae Bae|312-695-6829|j-bae@northwestern.edu|
22398363|NCT02814565|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22398364|NCT01414257|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22398365|NCT01978093|GlaxoSmithKline|GSK Response Center|866-435-7343||
22398366|NCT05979207|Medicines for Malaria Venture|Director, Program Leadership and Strategy|+41 22 555 03 00|info@mmv.org|
22398367|NCT00825565|Northwestern University|Stephanie Rangel|312-503-5942|stephanie.rangel@northwestern.edu|
22398368|NCT03033745|CSL Behring|Trial Registration Coordinator|610 878-4000|clinicaltrials@cslbehring.com|
22398369|NCT00703664|Massey Cancer Center, Virginia Commonwealth University|Dr. Beata Holkova|804-628-2581|bholkova@mcvh-vcu.edu|
22398370|NCT03728309|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22398371|NCT03403205|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22398372|NCT03847610|Imperial College London|Richard Wilson|02033132732|richard.wilson@imperial.ac.uk|
22398373|NCT02004873|Medtronic Cardiac Rhythm and Heart Failure|Micra Clinical Team|800-328-2518|MedtronicCRMtrials@medtronic.com|
22398374|NCT01337076|Mayo Clinic, Rochester|Dr. Colin Driscoll|507 266 1965|driscoll.colin@mayo.edu|
22398375|NCT01445769|Incyte Corporation|Study Director|855 463-3463||
22398376|NCT01276236|University of California, San Francisco|Dr. Toby Maurer, MD|(628) 206-8680|Toby.Maurer@ucsf.edu|
22398377|NCT00044512|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22398378|NCT02799069|Biofrontera Bioscience GmbH|Dr. Beate Schmitz|+49 214 876 32|b.schmitz@biofrontera.com|41
22398379|NCT00558870|University of Texas (UT) MD Anderson Cancer Center|Sriram Yennurajalingam, Palliative Care & Rehabilitation Medicine||CR_Study_Registration@mdanderson.org|
22398380|NCT01539590|Yale University Medical Center|Dr. Joesph Brennan|(203) 483-8300|Brennan.Joesph@yale.edu|
22398381|NCT03440814|Soleno Therapeutics, Inc.|C601 Project Manager|650-353-2051|C601ProjectManager@soleno.life|
22398382|NCT02695628|Stanford University|Rajesh Shah|650-723-0728|rajshah@stanford.edu|
22398383|NCT02678390|Research Centre on Aging|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
22398384|NCT03499028|Cleveland Clinic|Anabelle Visperas|216-444-2416|vispera@ccf.org|
22429286|NCT04439123|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22398385|NCT01437397|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22398386|NCT02656485|AOBIOME|Masha Gaber|617-475-1605|mgaber@aobiome.com|
22398387|NCT03194373|University of Michigan Rogel Cancer Center|Paul Swiecicki, M.D.|734-647-1017|pswiecic@med.umich.edu|
22398388|NCT04518462|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9729|MedInfo@Pacira.com|
22398389|NCT01003210|University of Washington|Dr. James Taylor|206-6165-1206|uncjat@uw.edu|
22398390|NCT00931359|Miramar Labs|Kathy O'Shaughnessy, PhD|408-940-8700|kathyo@miramarlabs.com|
22398391|NCT03784079|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22398392|NCT05036083|M.D. Anderson Cancer Center|Olena Weaver|713-471-3613|ooweaver@mdanderson.org|
22398393|NCT02396589|Washington University in St. Louis School of Medicine|Dr. Susan Stark|3142734114|sstark@wustl.edu|
22398394|NCT03963531|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
22398395|NCT05593016|Duke University School of Medicine|Caroline Dorfman, PhD|919-416-3473|caroline.dorfman@duke.edu|
22444003|NCT01885871|Cutera, Inc|Clinical Research Department|1-888-428-8372|gweiss@cutera.com|
22398396|NCT02326805|University of Arizona|Sherry Chow, PhD|520-626-3358|schow@azcc.arizona.edu|
22398397|NCT03591380|University of Wisconsin - Madison|David Foley, MD|608-263-2527|foley@surgery.wisc.edu|
22412029|NCT00992407|R&D Clinical Research, Seoul KOREA|Clinical Research Director|+82 2 2094 -4518||
22398398|NCT02615990|University of Kentucky|Lisa Fryman|859 323 2060|lisa.fryman@uky.edu|
22412030|NCT00761592|Allergan, Inc.|Vice President Medical Affairs|(714)246-4500|clinicaltrials@allergan.com|
22398399|NCT00808444|GlaxoSmithKline|GSK Response Center|866-435-7343||
22398400|NCT04401267|St. Jude Children's Research Hospital|Seth Karol, MD|(901) 595-1716|seth.karol@stjude.org|
22398401|NCT02066792|Institute for Mental Health Research and Department of Psychology, The University of Texas at Austin|Dr. Jasper Smits|512-475-8095|smits@utexas.edu|
22398402|NCT01846455|RECKITT BENCKISER PHARMACEUTICALS, INC.|Reckitt Benckiser Pharmaceuticals, Inc.|804-379-1090||
22398403|NCT01449708|Coastal Anesthesiology|Patrick Ziemann-Gimmel, MD|904-819-4478|pziemann@yahoo.com|
22412031|NCT03738332|University of Pennsylvania|Dr. Jie Deng|215-573-2393|jiedeng@nursing.upenn.edu|
22412032|NCT01521559|Regeneron|Clinical Trials Administrator|914 847 5385|clinicaltrials@regeneron.com|
22398404|NCT02889796|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22398405|NCT04294459|Sanofi Aventis Recherche & Développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22412033|NCT02336737|Endomag|Clinical Develoment Director|+44 7851 247439|mwomack@endomag.com|
22412034|NCT03197064|Stanford University|Dr. Mark Burbridge|(650) 353-8484|markburb@stanford.edu|
22412035|NCT00576381|The Children's Hospital of Philadelphia|Dr Athena Zuppa|267-426-5753|zuppa@email.chop.edu|
22412036|NCT01747850|CAMH|Dr. Jose Trigo|416.535.8501|jose.trigo@camh.ca|30021
22412037|NCT00287118|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22398406|NCT02787863|Samara State Medical University, Institute of Sera and Vaccines RAS|Professor Andrei Dmitrievich Protasov, Professor Mikhail Petrovich Kostinov|+79277444126|crosss82@mail.ru|
22412038|NCT01631864|Novartis Pharmaceuticals|Study Director|862-778-8300||
22398407|NCT02479802|Grifols Bioscience Industrial Group|Miquel Barcelo, PhD|+34 935.712.368|Miquel.Barcelo@Grifols.com|
22412039|NCT00757601|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22412040|NCT04543136|Coloplast A/S|Vice President, Medical Affairs|+4549111111|clinical-studies@coloplast.com|
22412041|NCT00546390|University of Alb erta|Dr B Finegan|7809701302|bfinegan@ualberta.ca|780
22412042|NCT00638157|Cubist Pharmaceuticals|Ed Campanaro / Vice President, Clinical Operations|781-860-8318|ed.campanaro@cubist.com|
22412043|NCT04684524|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
22412044|NCT05120570|Masonic Cancer Center|Punita Grover, MBBS|(612) 273-8383|groverp@umn.edu|
22412045|NCT00601354|Stanford University|Dr. Debra L Safer|650-723-7928|dlsafer@stanford.edu|
22412046|NCT05876091|Roswell Park Comprehensive Cancer Center|Brian Fix|716-845-2300|Brian.Fix@roswellpark.org|
22412047|NCT03402893|Skin Sciences, PLLC|M. McAllister|5024519000|mmdermresearch@yahoo.com|
22412048|NCT03466411|J&J Innovative Medicine|Senior Medical Leader PEDIATRICS IMM|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22412049|NCT03462719|Janssen Research & Development, LLC|EXECUTIVE MEDICAL DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22412050|NCT04799158|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-PHAT|medicalinformation@phathompharma.com|7426
22412051|NCT00319956|University of Kentucky Medical Center|Dr. Hubert O. Ballard|859-323-1496|hoball2@uky.edu|
22412052|NCT02607800|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22412053|NCT01185288|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22412054|NCT01202747|TearScience, Inc. (formerly Kolis Scientific)|Christy Stevens, OD|919-459-4815|cstevens@tearscience.com|
22412055|NCT01446913|Yale University School of medicine|Henry Klar Yaggi, MD (PI)|203-785-4163|henry.yaggi@yale.edu|
22412056|NCT04041609|Lyra Therapeutics|Lyra Clinical|617-393-4600|lyraclinical@lyratx.com|
22412057|NCT01576588|Vilnius University Hospital Santaros Klinikos|Regina Pileckyte, investigator|+370 5 2501384|regina.pileckyte@santa.lt|
22412058|NCT00601484|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22398408|NCT02421887|NICHD|Esther Eisenberg, NICHD Project Scientist|301-496-6516|esther.eisenberg@nih.gov|
22412059|NCT02928848|University of Pennsylvania|Dr. H. Branch Coslett|2156623606|hbc@pennmedicine.upenn.edu|
22412060|NCT00969332|UCLA|Dr. Kara L. Calkins|310-825-9330|KCalkins@mednet.ucla.edu|
22412061|NCT03828461|Stanford University|Carolyn Rodriguez, MD, PhD|650-723-4095|cr2163@stanford.edu|
22412062|NCT04523142|Novaliq GmbH|Sonja Krösser|+49 6221 50259|info@novaliq.com|0
22412063|NCT00663871|University of Pittsburgh, Heart and Vascular Institute|Matthew F. Muldoon, MD, MPH|412-624-8798|mfm10@pitt.edu|
22412064|NCT00582309|UNM|Gary Iwamoto|505-272-4751|giwamoto@salud.unm.edu|
22412065|NCT03123822|UAB|Katherine Weise|2059752020|kweise@uab.edu|
22412066|NCT03095352|University of California, San Francisco|Dr. Laura Huppert, MD|(415) 476-1000|Laura.Huppert@ucsf.edu|
22412067|NCT02779855|Moffitt Cancer Center|Hatem Soliman, MD|813-745-4985|hatem.soliman@moffitt.org|
22412068|NCT06310005|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22412069|NCT01050231|University of California Irvine|Dr David Reinkensmeyer|(949) 824-5218|dreinken@uci.edu|
22412070|NCT00319449|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22429287|NCT00424008|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22429288|NCT01276652|University of Iowa|Brian Gehlbach, MD|319-356-3603|brian-gehlbach@uiowa.edu|
22429289|NCT02213575|University of Florida|Dr. Carl J. Pepine|(352) 339-0696|carl.pepine@medicine.ufl.edu|
22429290|NCT02530242|UCSF Benioff's Children's Hospital Oakland|Ashutosh Lal, MD||Ashutosh.Lal@ucsf.edu|
22384121|NCT01136876|Bracco Diagnostics Inc.|Maria Luigia Storto, M.D.|609-514-2262|MariaLuigia.Storto@diag.bracco.com|
22384122|NCT00536341|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22384123|NCT04732338|Hackensack Meridian Health|Alphonsa Thomas, DO|7328364504|Alphonsa.Thomas@hmhn.org|
22444004|NCT03028350|Cumberland Pharmaceuticals|Senior Clinical Scientist|6154257644|bgibson@cumberlandpharma.com|
22384124|NCT00065260|NIH NHLBI|Dr. Bhavisha Patel|301.402.3477|bhavisha.patel@nih.gov|
22384125|NCT04484935|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22384126|NCT03750968|University of Utah John A. Moran Eye Center|Paul Bernstein, MD, PhD|801-581-4069|Paul.Bernstein@hsc.utah.edu|
22384127|NCT04767698|Johns Hopkins University, School of Medicine|Dimitrios Ladakis|410-614-1522|dladaki1@jhmi.edu|
22384128|NCT00088413|National Cancer Institute|Dr. James Gulley|301-480-8870|james_gulley@nih.gov|
22384129|NCT02759016|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22384130|NCT05123742|Rutgers School of Dental Medicine|Cecile A. Feldman, DMD, MBA|9739724634|feldman@sdm.rutgers.edu|
22384131|NCT00972439|USC/Norris Comprehensive Cancer Center|Celeste Pearce, Ph.D.|323 865 0437|cpearce@usc.edu|
22384132|NCT01522924|University of Louisville|Dr. Jacqueline Singleton|502-852-2611|jasing02@louisville.edu|
22384133|NCT02891915|Vanderbilt Vaccine Research Program|Dr. C. Buddy Creech|615-343-0332|buddy.creech@vanderbilt.edu|
22384134|NCT04048382|San Diego State University|Dr. Aaron J. Blashill|6195942245|ajblashill@sdsu.edu|
22384135|NCT00490100|National Institute of Allergy and Infectious Diseases|De Ravin, SukSee|+1 301 496 6772|sderavin@mail.nih.gov|
22384136|NCT00352976|Masonic Cancer Center, University of Minnesota|Margaret L. MacMillan, M.D.|612-626-2961|macmi002@umn.edu|
22384137|NCT03498196|Baylor College of Medicine|Jennifer M. Taylor, MD, MPH|713-797-7670|Jennifer.Taylor@bcm.edu|
22384138|NCT01967836|Ascension Wisconsin|Dr Maureen Greene|414-447-2716|maureen.greene@ascension.org|
22384139|NCT02119650|Incyte Corporation|Study Director|855 463-3463||
22384140|NCT03481816|National Cancer Institute|Dr. Marijo Bilusic|240-760-6064|marijo.bilusic@nih.gov|
22384141|NCT02269475|CO RIA TA, R&D|Hideo Negi|+81 6 4803 3533|H.Negi@astrazeneca.com|4716
22384142|NCT02730871|Alcon, A Novartis Division|WW Brand Medical Director Ophtha, GMA Ophthalmics|1-888-451-3937|alcon.medinfo@alcon.com|
22384143|NCT05368558|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22384144|NCT01303445|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22384145|NCT01304277|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22384146|NCT03757949|SWOG|Danika Lew|206-667-2272|dlew@fredhutch.org|
22384147|NCT05094141|UT Southwestern Medical Center|Dr. Sarah Rebstock|214-456-8106|sarah.rebstock@utsouthwestern.edu|
22384148|NCT05134337|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22384149|NCT04923347|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22384150|NCT03661359|University of Toledo|Heather Klepacz, M.D, Principle Investigator|419-383-6754|heather.klepacz@utoledo.edu|
22384151|NCT03089125|Massachusetts General Hospital|Joseph A. Greer, Ph.D.|617-643-2143|jgreer2@mgh.harvard.edu|
22384152|NCT03683069|Brigham and Women's Hospital|Gordon H. Williams, Professor of Medicine|617-223-1611|gwilliams@bwh.harvard.edu|
22384153|NCT04799197|University of Michigan|Kristi Gamarel|7346473178|kgamarel@umich.edu|
22384154|NCT02605837|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22384155|NCT05104697|Emma Pendleton Bradley Hospital|Dr. Kristen Benito|401-432-1054|kbenito@lifespan.org|
22384156|NCT03845465|Vanderbilt University Medical Center|Sarah Jaser, PhD|6153436775|sarah.jaser@vumc.org|
22384157|NCT03913195|TaiMed Biologics|Dr. Kuei-Ling Kuo|+886-2-26580058|kkuo@taimedbio.com|118
22384158|NCT03899961|Oslo University Hospital|Leiv Arne Rosseland|92204274|lrossela@ous-hf.no|+47
22384159|NCT05107401|Columbia University|Dr. Alissa Davis|212-851-2224|ad3324@columbia.edu|
22384160|NCT02349412|Massachusetts General Hospital Cancer Center|Jennifer Temel, MD|(617) 724-0453|jtemel@partners.org|
22384161|NCT03569176|Stanford University|Dr. Dennis P. Wall|650-497-9214|dpwall@stanford.edu|
22384162|NCT03229811|Fresenius Medical Care|Dr. Amaka Eneanya|267-769-5455|amakaeneanya@gmail.com|
22384163|NCT04093362|Taiho Oncology, Inc|Taiho|609-250-7336|clinicaltrialinfo@taihooncology.com|
22384164|NCT05265312|Johns Hopkins University School of Medicine|Dr. Eva Tseng|410-583-2774|etseng3@jhmi.edu|
22384165|NCT03535727|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dung Le, M.D.|443-287-0002|Dle@jhmi.edu|
22384166|NCT03055377|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
22384167|NCT05952076|Gates MRI|Study Director|+1 857 702 2108|clinical.trials@gatesmri.org|
22384168|NCT04143061|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22384169|NCT04905407|Syros Pharmaceuticals|Tiffany Crowell|617-674-9069|info@syros.com|
22384170|NCT04899115|University of Michigan|Patricia Bloom, MD|734-647-5944|ppbloom@med.umich.edu|
22384171|NCT00150813|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22384172|NCT02155010|Haeundae paik hospital, Inje University|Ki Hwa Lee|82-51-797-0421|tedy3333@naver.com|
22384173|NCT04048681|Beth Israel Deaconess Medical Center|Dr. Olivia Farr|6176678636|ofarr@bidmc.harvard.edu|
22384174|NCT03928522|Washington University|Venessa Riegler|314-362-1721|rieglerv@wustl.edu|
22384175|NCT00448669|National Institutes of Health|Dr. Michael Thigpen|1-240-669-2877|michael.thigpen@nih.gov|
22444005|NCT04565236|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22384176|NCT04287985|Visterra, Inc.|Mohit Mathur, MD|+1-617-498-1070|mmathur@visterrainc.com|
22384177|NCT02638337|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
22384178|NCT01340066|Beech Tree Labs, Inc.|Dr. John McMichael|518-872-1144||
22384179|NCT02789020|University of Florida|David Vaillancourt|3522941770|vcourt@ufl.edu|
22384180|NCT01691079|University of California, San Francisco|Mona Luke-Zeitoun, MD||lukezeitounm@peds.ucsf.edu|
22412071|NCT00955747|University of Kentucky|Robert Lodder|859-955-0845|lodder@uky.edu|
22412072|NCT00365352|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
22412073|NCT03708211|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22412074|NCT00097695|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22412075|NCT00824460|Vifor Pharma|Medical Information|41 58 851 8222|medinfo@viforpharma.com|
22444006|NCT00366340|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22444007|NCT00367770|Actelion Pharmaceuticals Ltd.|Loïc Perchenet, Head of Global Post-Approval Studies|+41 61 565 64 57|loic.perchenet@actelion.com|
22444008|NCT01778179|Brazilian Center for Studies in Dermatology|Dr. Doris Hexsel|+55 51 30262633|doris@hexsel.com.br|
22444009|NCT04163822|CHCMU|no sponsor, PI: Yuan Shi|13508320283|shiyuan@hospital.cqmu.edu.cn|
22444010|NCT03282565|University of Michigan|Dr. Riann Palmieri-Smith|734-615-3154|riannp@umich.edu|
22444011|NCT01082380|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22444012|NCT02011893|St. Jude Medical|Roni Diaz, Director Clinical Studies|972-309-8601|RDiaz@sjm.com|
22444013|NCT00991952|Memorial Sloan-Kettering Cancer Center|Dr. Yelena Janjigian|646-888-4186|janjigiy@mskcc.org|
22444014|NCT03116347|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22444015|NCT01255787|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22444016|NCT04966741|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
22384181|NCT05512962|Oxular Limited|Friedrich Asmus, MD|'+1 631 292 1207|friedrich.asmus@oxular.com|
22384182|NCT00136435|Dana Farber Cancer Institute|Dr. Dan DeAngelo|617-582-8410|Daniel_Deangelo@dfci.harvard.edu|
22384183|NCT03148496|The University of Texas Health Science Center at Houston|Julie Holihan, MD|713-500-7188|Julie.L.Holihan@uth.tmc.edu|
22384184|NCT00390299|Mayo Clinic|Evanthia Galanis, M.D.|+1 (507) 266-0584|Galanis.Evanthia@mayo.edu|
22384185|NCT00593866|University of Michigan Comprehensive Cancer Center|Dr. Mark Zalupski|734-615-3969|zalupski@umich.edu|
22384186|NCT02965846|Allergan, Inc.|Therapeutic Area Head|877-277-8566|clinicaltrials@allergan.com|
22384187|NCT00539734|Prince of Songkla University|Patama Bhurayanontachai|66-74-451380|tpatama@hotmail.com|
22384188|NCT02794480|GlaxoSmithKline|GSK Response Center|866-435-7343||
22384189|NCT01070069|Endologix|Elisa Hebb|949-598-4628|ehebb@endologix.com|
22384190|NCT03101930|Vanderbilt University Medical Center|Dr. James M. Luther, MD MSCI (Principal Investigator)|(615) 936-3420|james.luther@vumc.org|
22384191|NCT02814838|Dompé Farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22384192|NCT01747486|Abramson Cancer Center of the University of Pennsylvania|Noelle Frey, MD|215-662-6901|noelle.frey@uphs.upenn.edu|
22384193|NCT00632749|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22384194|NCT00611559|GlaxoSmithKline|GSK Response Center|866-435-7343||
22384195|NCT00879333|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22384196|NCT00215787|Head and Neck Surgery Associates|Scott Phillips|317-926-1056|sphillips@hnsaonline.com|
22384197|NCT02672033|Jonsson Comprehensieve Cancer Center|Dr. Percy Lee|310 825-9771|percylee@mednet.ucla.edu|
22384198|NCT05321069|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
22384199|NCT03547999|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22384200|NCT05048186|Massachusetts General Hospital|Dr. Karen R. Sepucha|617-724-3350|KSEPUCHA@mgh.havard.edu|
22384201|NCT02412748|Rush University College of Nursing|Dr. Wrenetha Julion, Professor|3129426272|Wrenetha_A_Julion@rush.edu|
22384202|NCT00839241|Astra Tech AB|Head of Clinical Research Area Health Care|+46317761000||
22384203|NCT04218266|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22384204|NCT00533546|University of Rochester|Curtis Benesch, M.D., M.P.H.|585 275-2530|curtis_benesch@urmc.rochester.edu|
22384205|NCT00879060|Tufts Medical Center|Martin Maron, MD|(617) 636-8066|mmaron@tuftsmedicalcenter.org|
22384206|NCT04011631|SMART Clinical Products|Ellie Coumans|+31 (0)6 53 82 70 16|e.coumans@smartclinicalproducts.com|
22384207|NCT04820686|Assembly BioSciences Inc.|Director of Clinical Operations|415-366-5172|psalstrand@assemblybio.com|
22384208|NCT01424670|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
22384209|NCT00761189|Clinical Research Team, Medical Affairs Korea|Senior Clinical Research Associate|82-2094-4804||
22384210|NCT01494922|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22384211|NCT04377308|The University of Toledo Department of Psychiatry|Cheryl McCullumsmith, M.D., Ph.D.|419-383-5669|cheryl.mccullumsmith@utoledo.edu|
22384212|NCT02150967|QED Therapeutics, Inc.|David van Veenhuyzen, Vice President, Clinical Development|1 650 391-9740|david.vanveenhuyzen@bridgebio.com|103
22384213|NCT00709098|Actelion Pharmaceuticals Ltd|Laila Rouault, MD/International Clinical Leader|+ 41 61 565 8128||
22384214|NCT01037985|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22384215|NCT01704196|National Institute on Drug Abuse|Liza Zeinert|301-443-1138|liza.zeinert@nih.gov|
22384216|NCT05239182|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP, Clinical Research Manager|4126475554|stadtermanbm@upmc.edu|
22384217|NCT00774852|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22412076|NCT00462982|Memorial Sloan Kettering Cancer Center|Dr. Robert Motzer|646-422-4312|motzerr@mskcc.org|
22429291|NCT03837938|Dompé Farmaceutici SpA|Mauro P Ferrari, Pharm D|+39 02 583831|clinical.trials@dompe.com|
22429292|NCT02665455|Abbott Diabetes Care|Jolyon Bugler, Snr Director Clinical Development & Regulatory Affairs|+44 1993 863094|joe.bugler@abbott.com|
22429293|NCT00223821|Birmingham VA Medical Center|Kathryn L. Burgio, PhD|205-558-7064|kburgio@uabmc.edu|
22429294|NCT06818708|University of California San Diego|Baharin Abdullah|+1 858-220-5714|baabdullah@health.ucsd.edu|
22429295|NCT01671059|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22429296|NCT01729091|The University of Texas MD Anderson Cancer Center|Samer Srour, MD / Stem Cell Transplantation|713-794-4354|SSrour@mdanderson.org|
22429297|NCT04971837|Colorado State University|Dr. Christopher Bell, Director, Laboratory of Integrative Physiology|(970) 491-7522|Christopher.Bell@colostate.edu|
22429298|NCT03166631|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22429299|NCT03022630|Vanderbilt University Medical Center|Dr. Cheryl Gatto|6153432252|cheryl.l.gatto.1@vumc.org|
22429300|NCT00382070|NRG Oncology|Director, Department of Regulatory Affairs|412-339-5300|langerj@nrgoncology.org|
22429301|NCT04289298|Weill Cornell Medical College|Dr. Patricia Marino, PhD|914-997-8691|pam2029@med.cornell.edu|
22429302|NCT01734928|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22429303|NCT00504231|University of Washington|Ru-Chien Chi B.S., M.D., M.S.|206 768-5217|rchi@u.washington.edu|
22429304|NCT01629563|PregLem|Dr Pablo Arriagada|0041228840355|info@preglem.com|
22429305|NCT04290676|EyePoint Pharmaceuticals|Dario Paggiarino, MD|(617) 610-3411|dpaggiarino@eyepointpharma.com|
22429306|NCT00088881|ECOG Statistical Office|Study Statistician|617-632-3012||
22429307|NCT03761914|Sellas Life Sciences|Dr Dragan Cicic, Chief Development Officer|646-200-5278|info@sellaslife.com|
22444017|NCT03835728|UT Southwestern, Dept of Neurology|Dr. Steven Vernino|214-645-8800|steven.vernino@utsouthwestern.edu|
22444018|NCT05764265|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22444019|NCT00509262|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22444020|NCT00725842|Merck Sharp & Dohme|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22444021|NCT00947505|Lexington International, LLC|David Michaels|561-417-0200|dm@hairmax.com|
22444022|NCT00618839|Stratatech Corporation|Mary Lokuta|608-441-8358|mlokuta@stratatechcorp.com|
22444023|NCT02009384|University of Louisville|Jason Chesney|502-562-3429||
22444024|NCT01075191|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22444025|NCT02051816|LSU School of Medicine New Orleans|David Janz, MD, MSc|504-568-3167|djanz@lsuhsc.edu|
22444026|NCT01244490|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22444027|NCT00971620|National Cancer Institute|Dr. Edward Cowen|301-496-4299|cowene@mail.nih.gov|
22444028|NCT02829983|Universidade Estadual Paulista Júlio de Mesquita Filho|Mauro Pedrine Santamaria|3947-9033|mauro.santamaria@ict.unesp.br|
22444029|NCT02414139|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
22444030|NCT01226121|Indiana Hand to Shoulder Center|F. Thomas D. Kaplan|3178759105|tdk@hand.md|
22444031|NCT03324581|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22444032|NCT04473482|University of Michigan|Jessica Mellinger|734-232-0284|jmelling@umich.edu|
22444033|NCT01120834|Weill Cornell Medicine|Peter Martin, MD|646.962.2064|amr2017@med.cornell.edu|
22444034|NCT00266864|James J. Peters VA Medical Center|William A. Bauman, M.D.|718-584-9000|william.bauman@va.gov|5428
22444035|NCT00727532|Northwestern University|Results Entry Administrator|312-695-1301|croqualityassurance@northwestern.edu|
22444036|NCT00829933|Daiichi Sankyo.,LTD|So Yoshino, Manager|81-90-8024-0742|yoshino.so.ej@daiichisankyo.co.jp|
22444037|NCT04647890|Certa Therapeutics Pty Ltd|Prof Darren Kelly, CEO|+61 3 9657 0700|dkelly@certatherapeutics.com|
22444038|NCT03687970|Washington University|Simon Haroutounian, PhD. Assistant Professor,|314-286-1715|simon.haroutounian@wustl.edu|
22444039|NCT00686998|Astrazeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22444040|NCT01848041|RVL Pharmaceuticals|Sr. Director, Clinical Development|908-809-1423|mvelasco@osmotica.com|
22444041|NCT06374394|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22444042|NCT00356122|Sanofi-Aventis|Trial Transparency Team||Contact-Us@sanofi.com|
22444043|NCT02625389|Guerbet|Jing Hao, MD, Global Head of Medical Affairs & Clinical Development|+33 (0) 1 45 91 50 00|jing.hao@guerbet.com|
22444044|NCT00636987|St Jude Medical|Sr. Clinical Manager|6517566803|jjohnson101@sjm.com|
22444045|NCT01955980|PARI Pharma|Friedrich Gruber|+4989742846|friedrich.gruber@pari.com|10
22384218|NCT04428112|UCSF|Dr. Veronica Yank|415-476-9654|veronica.yank@ucsf.edu|
22429308|NCT01309880|Bausch & Lomb|Dr. Robert Steffen|585 338 6399|robert.steffen@bausch.com|
22429309|NCT02370394|Butler Hospital/Women and Infants Hospital|Caron Zlotnick, Ph.D.|(401) 455-6529|CZlotnick@Butler.org|
22429310|NCT03017261|Think Surgical|Valentina Campanelli|510-249-2314|vcampanelli@thinksurgical.com|
22429311|NCT00456612|Beth Israel Deaconess Medical Center|Anand Mahadevan, MD|617-667-2345|amahadev@bidmc.harvard.edu|
22429312|NCT04132466|Kestra Medical Technologies, Inc.|Laura Gustavson|14255264759|laura.gustavson@kestramedical.com|
22444046|NCT00509392|VNUS Medical Technologies / Covidien (sponsor)|Eppie Chang, MS; Director Clinical Research|408-360-7200|eppie.chang@covidien.com|
22444047|NCT03954041|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22384219|NCT05158153|University of California, San Francisco|Dr. Ian McCoy|415-476-2172|ian.mccoy@ucsf.edu|
22444048|NCT01896479|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
22444049|NCT05403866|Lumosa Therapeutics Co., Ltd.|Sabrina Yeh|+886 2 26557918|sabrina_yeh@lumosa.com.tw|5735
22444050|NCT00057681|Washington University in St. Louis|Barbara Geller, M.D.|314-747-3657|gellerb@wustl.edu|
22429313|NCT03395990|Duke University Medical Center|Jeff Gadsden|919-681-6437|jeff.gadsden@duke.edu|
22444051|NCT00442468|GlaxoSmithKline|GSK Response Center|866-435-7343||
22444052|NCT00589784|Memorial Sloan Kettering Cancer Center|Dr. Thomas Kaley|212-639-5122|KaleyT@mskcc.org|
22429314|NCT00720083|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.com|
22444053|NCT03127956|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22429315|NCT00894647|Graceway Pharmaceuticals|Vice President Medical Affairs|267-948-0400|Sharon.levy@gracewaypharma.com|
22429316|NCT03050489|First State Pavlov Medical University|Nikolay Bunenkov|+7-950-028-17-40|bunenkov2006@gmail.com|
22429317|NCT04565288|Brown University|Dr. Robert Miranda Jr.|401-863-6658|Robert_Miranda_Jr@brown.edu|
22429318|NCT01913470|Emory University|Miriam Vos, MD, MSPH|404-727-9930|mvos@emory.edu|
22429319|NCT01524705|University of Washington|Jeffrey L Probstfield, MD|206-616-0292|jeffprob@uw.edu|
22429320|NCT00727337|Department of Veterans Affairs|Rachel McArdle|727-398-6661|Rachel.mcardle@va.gov|17479
22444054|NCT00287079|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22429321|NCT00412451|ThromboGenics NV|Petra Kozma-Wiebe, MD|+32 16751310|petra.kozma@thrombogenics.com|
22429322|NCT02573467|Novartis Pharmaceuticals|Study Director|862-778-8300||
22429323|NCT04285684|Ketamine Research Foundation|Philip E Wolfson, MD|415-550-1700|ketamine.research@gmail.com|
22429324|NCT00103506|Janssen R&D UK|Project Physician||ClinicalTrialDisclosure@its.jnj.com|
22429325|NCT01404260|Shanghai Chest Hospital|Shun LU|86-2162821990|shun_lu11@163.com|
22429326|NCT00710970|Baylor College of Medicine|Seth P. Lerner, M.D., F. A. C. S.|713-798-6841|slerner@bcm.edu|
22429327|NCT02153827|University of St. Augustine|Eric Chaconas|904-826-0084|echaconas@usa.edu|1275
22429328|NCT02296801|NSABP Foundation Inc|Director, Department of Site and Study Management|1-800-270-3165|industrytrials@nsabp.org|
22429329|NCT04233580|University of Texas Southwestern Medical Center|Tara Kristof|214-648-8602|tara.kristof@utsouthwestern.edu|
22429330|NCT00625378|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22429331|NCT01371565|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
22429332|NCT02565186|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22429333|NCT00617903|Bayer|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22429334|NCT04676646|AstraZeneca|Global Clinical Lead|18772409479|information.center@astrazeneca.com|
22429335|NCT05156125|Oppilan Pharma Ltd|Clinical Trial Contact|+1(888)-411-5176|clinicaltrials@ventyxbio.com|108
22429336|NCT04018001|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22429337|NCT02609633|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22429338|NCT02320292|Mayo Clinic|Dr. Thomas E Witzig|507-266-4994|witzig.thomas@mayo.edu|
22429339|NCT03670628|University of Miami, Miller School of Medicine - Desai Sethi Urology Institute|Ranjith Ramasamy, MD|305-243-4562|ramasamy@miami.edu|
22429340|NCT00393380|The EMMES Corporation|Adam Mendizabal, Statistician|301-251-1161|amendizabal@emmes.com|221
22429341|NCT02993302|Dr. Cipto Mangunkusumo Hospital|Dyah Purnamasari|62213907703|dyah_p_irawan@yahoo.com|
22429342|NCT00997126|MinneapolisMRF|James Miner|6128732493|miner015@umn.edu|
22429343|NCT02287025|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22429344|NCT00899847|Stanford University School of Med|Wen-Kai Weng, MD; Associate Professor of Medicine|650-723-7689|wkweng@stanford.edu|
22429345|NCT01769443|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22429346|NCT04996264|Ophirex, Inc.|Tim Platts-Mills, Chief Medical Officer|5592406073|tim@ophirex.com|
22429347|NCT00685698|TaiGen Biotechnology Co., Ltd.|Chen-En Tsai, M.D., Ph.D.|+886-2-8177-7072|cetsai@taigenbiotech.com|1211
22444055|NCT01770652|ApoPharma Inc.|Fernando Tricta, MD|Phone: 416-401-7332|ftricta@apopharma.com|
22444056|NCT02953509|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22444057|NCT05780268|University of Minnesota|Birgit Grund|612- 626-8622|birgit@ccbr.umn.edu|
22444058|NCT00573287|Geisel School of Medicine at Dartmouth|Alan I. Green, M.D.|6036507549|alan.i.green@dartmouth.edu|
22444059|NCT02325791|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
22444060|NCT00722371|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22444061|NCT00718237|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22444062|NCT00555425|Yale University|Dr. David Fiellin|203-688-2471|david.fiellin@yale.edu|
22444063|NCT01185834|Alcon Research, Ltd.|Sameena Haque-Khan, PhD, BSc(Hons)Optom, MCOptom, FAAO|1-800-241-7629||
22444064|NCT02128100|University of Louisville|Dr. Neal Dunlap|502-561-2700|neal.dunlap@louisville.edu|
22444065|NCT02694718|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22444066|NCT00002975|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22444067|NCT00322153|Forest Research Institute|Stephen M Graham, PhD|201-427-8156|Stephen.Graham@frx.com|
22444068|NCT01115582|Retrophin, Inc.|Retrophin Medical Information|1-877-659|medinfo@retrophin.com|5518
22444069|NCT03523000|University Hospitals Cleveland Medical Center|Dr. Salim Hayek|216-844-2685|salim.hayek@uhhospitals.org|
22444070|NCT00772070|Sanofi Pasteur Inc|Medical Director||RegistryContactUs@sanofipasteur.com|
22444071|NCT01520454|Beth Israel Deaconess Medical Center|Dr. Christos Manztoros|617-667-8630|cmantzor@bidmc.harvard.edu|
22384220|NCT03638427|Stanford University|Paul Blumenthal, MD|(650) 725-6035|gynresearch@stanford.edu|
22384221|NCT04402294|University of Pennsylvania|Dr. Desmond Oathes, Principal Investigator|215-573-9390|oathes@pennmedicine.upenn.edu|
22384222|NCT04708509|The Ottawa Hospital|Dr. Andrew Seely|613-737-8899|aseely@toh.ca|74052
22429348|NCT02583477|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22429349|NCT05254210|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
22444072|NCT03993379|CytomX Therapeutics|Lawrence Lu|(650) 515-3185|clinicaltrials@cytomx.com|
22444073|NCT02380690|VA ORD|Robert O'Brien|2024435741|Robert.O'Brien2@va.gov|
22444074|NCT02361346|Molecular Templates, Inc.|Study Director|512 930-0304|trials@mtem.com|
22444075|NCT04461509|Cedars-Sinai Medical Center|Laura Sarmiento|310-423-4295|Laura.sarmiento@cshs.org|
22444076|NCT01094561|Columbia University|Elizabeth Hecht, MD|(212)305-6510|eh2560@cumc.columbia.edu|
22444077|NCT02483429|Johns Hopkins University|David E. Newman-Toker|443-287-9593|toker@jhu.edu|
22444078|NCT03576274|Johns Hopkins School of Nursing|Dr.Nada Lukkahatai,|410-614-5297|nada.lukkahatai@jhu.edu|
22444079|NCT04854642|Dompé farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22384223|NCT04870645|M D Anderson Cancer Center|Jason Johnson, MD|713-792-8443|jasonjohnson@mdanderson.org|
22384224|NCT04459416|Memorial Sloan Kettering Cancer Center|Dr. Gary Deng, MD, PhD|646-608-8556|dengg@MSKCC.ORG|
22384225|NCT04924062|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22384226|NCT05768373|Solventum|Helen Han|6517856568|mhan3@solventum.com|
22384227|NCT05478525|Glyscend Therapeutics|Ashish Nimgaonkar, MD|6175483513|ashish.nimgaonkar@gmail.com|
22384228|NCT01649271|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22384229|NCT01991977|Mayo Clinic|Nadia N. Laack, MD|507/284-2511|Laack.Nadia@mayo.edu|
22384230|NCT03433469|University of California, San Francisco|Dr. Collin M. Blakely, MD, PhD|(415) 502-6959|collin.blakely@ucsf.edu|
22384231|NCT04038957|Sumitomo Pharma America Inc|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunovion.com|
22384232|NCT04491968|Rutgers Robert Wood Johnson Medical School|Dr. Nina Cooperman, Associate Professor|7322358569|cooperna@rwjms.rutgers.edu|
22384233|NCT02428192|DFCI|Dr. Suzanne George|617-632-5204|Suzanne_George@dfci.harvard.edu|
22384234|NCT05656911|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22384235|NCT03547908|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22384236|NCT01536886|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
22384237|NCT03236441|UT Southwestern Medical Center|Oladipupo Olafiranye, MD, MS|2148572923|oladipupo.olafiranye@utsouthwestern.edu|
22384238|NCT04059354|University of Wisconsin - Madison, Waisman Center|Houri K. Vorperian, PhD, Senior Scientist Emerita|608-213-3257|vorperian@waisman.wisc.edu|
22384239|NCT00567398|Vantive|Clinical Trials Disclosure Group|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
22384240|NCT03517553|University of Iowa|Dr Bradley S. Dixon|319-356-1626|bradley-dixon@uiowa.edu|
22384241|NCT03271151|Anesthesiology Critical Care & Pain Management|Dr. Jacques Yadeau|2127742224|Yadeauj@hss.edu|
22384242|NCT02201108|Genzyme, a Sanofi Company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22384243|NCT05387447|University of Nebraska Medical Center|Marcia Shade|402-559-6641|marcia.shade@unmc.edu|
22429350|NCT00567112|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22429351|NCT03753542|Institute of Nursing Dow University of Health Sciences, Karachi/Sindh Nurses Examination Board, Karachi|Nomi Waqas Gul, Student MSN DUHS ION and Asst. Controller Sindh Nurses Examination Board, Karachi|0345-2506790|nomiwg@gmail.com|
22429352|NCT00002874|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22429353|NCT04249778|Emory University|Dr. Guillermo E. Umpierrez|(404) 778-1663|geumpie@emory.edu|
22429354|NCT03233217|Sanofi Pasteur|Medical Director|800-633-1610|Contact-US@sanofi.com|1#
22429355|NCT02114684|CAPRISA|Mrs Nonhlanhla Yende-Zuma|0027312604392|Nonhlanhla.Yende@caprisa.org|
22429356|NCT04625972|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22429357|NCT05591755|Bausch & Lomb|Daniel Donatello|5853385306|Daniel.Donatello@bausch.com|
22429358|NCT01346683|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
22429359|NCT00500890|UT MD Anderson Cancer Center|Dr. Richard Gorlick, MD/Division Head, Pediatrics Administration|713- 563-2516|rgorlick@mdanderson.org|
22429360|NCT01789775|Galderma R&D|Galderma CPM|00 33 4 93 95 70 70|clinicaltrials@galderma.com|
22429361|NCT03828383|University of California, Berkeley|Robert W. Levenson|510-643-8952|boblev@berkeley.edu|
22429362|NCT00504309|Penn State University|Ann Skulas-Ray|814-863-0856|aus164@psu.edu|
22429363|NCT02643199|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
22429364|NCT03345095|EORTC|Dr. Thierry Gorlia|+32 2 7741652|thierry.gorlia@eortc.org|
22429365|NCT03630354|Oregon Health & Science University|Dr. Kerri Winters-Stone|503-494-0813|wintersk@ohsu.edu|
22429366|NCT00983957|Bristol-Myers Squibb International Corporation|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
22429367|NCT05894564|Duke University|Susanna Naggie, MD, MHS, FIDSA|919-684-2584|susanna.naggie@duke.edu|
22429368|NCT00884949|BioMarin Pharmaceutical Inc.|BioMarin Medical Information Services|800-983-4587|medinfo@bmrn.com|
22429369|NCT01834261|Stony Brook University|Lilianne Mujica Parodi, PhD / Study Principal Investigator|631-632-1008|lilianne.strey@stonybrook.edu|
22429370|NCT01108796|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22429371|NCT00442689|Northwestern University|Dr. Laura Torchen|312-227-6492|ltorchen@luriechildrens.org|
22429372|NCT02313597|Services Institute of Medical Sciences|Dr, Shabbar Hussain Changazi|923059700111|shabbarchangazi246@gmail.com|
22444080|NCT01785095|IBSA Institut Biochimique SA|IBSA Clinical Research Manager|+41583601000|rd@ibsa.com|
22444081|NCT02294773|Midwest Fertility Specialists or St. Vincent Women's Hospital|Dr. Matt Will or Dr. Lauren Messinger|317-415-7528|laurenmessinger@gmail.com|
22444082|NCT01865084|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22444083|NCT03442764|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22444084|NCT01801072|University of Michigan|Dr. Aditya Pandey, Chair, Department of Neurosurgery|734-936-7010|adityap@umich.edu|
22444085|NCT03693170|Pierre Fabre Medicament|Isabelle Klauck, MD|+33149108018|isabelle.klauck@pierre-fabre.com|
22444086|NCT04444895|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22444087|NCT03034200|Cleveland Clinic Pediatric and Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Peter Anderson|216-308-2706|andersp@ccf.org|
22444088|NCT00510874|GlaxoSmithKline|GSK Response Center|866-435-7343||
22444089|NCT01251146|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22444090|NCT02876640|University of Wisconsin - Madison|Lisa Barroilhet, MD, MS|608-264-3204|barroilhet@wisc.edu|
22444091|NCT00053365|Gynecologic Oncology Group|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
22444092|NCT01583543|Massachusetts General Hospital|Dr. Edwin Choy|617-724-4000|echoy@mgh.harvard.edu|
22444093|NCT04534465|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
22444094|NCT00905827|Department of Veteran Affairs|Kathryn Magruder|843-789-7280|Kathryn.Magruder@va.gov|
22444095|NCT03347188|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22444096|NCT03139604|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22444097|NCT04148911|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22444098|NCT02477423|Neonatology, Department of Pediatrics, University of Chicago|Dr. Christina S. Kim|773-702-6210|christinakim13@gmail.com|
22444099|NCT00521001|Mayo Clinic|Svetomir Markovic, MD, PhD|507/284-1370|markovic.svetomir@mayo.edu|
22444100|NCT00470184|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22384244|NCT01673984|Ipsen|Medical Director, Uro-Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22384245|NCT01974245|Federal University of São Paulo|Dr. Lilian Cuppari|+551159048499|lcuppari@uol.com.br|
22384246|NCT05919082|LEO Pharma|Clinical Disclosure|+45 44945888|disclosure@leo-pharma.com|
22384247|NCT03854578|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22384248|NCT02287311|Baylor College of Medicine|Dr. Rayne Rouce|832-824-4647|rouce@bcm.edu|
22384249|NCT03896516|National Institute on Drug Abuse (NIDA)|Dr Lorenzo Leggio, M.D., Ph.D.|1-667-312-5188|lorenzo.leggio@nih.gov|
22384250|NCT05461131|ILiAD Biotechnologies|Chief Medical Officer|800-603-3525|contact@iliadbiotech.com|
22384251|NCT03739450|UT Southwestern Medical Center|Dr. Shannon Juengst|8328480674|Shannon.Juengst@UTSouthwestern.edu|
22384252|NCT05968495|Pearl Plastic Surgery|Christopher Nichols, MD|360-878-9300|cnichols@pearlplasticsurgery.com|
22384253|NCT03737058|Stanford University School of Medicine|Manali I Patel, MD MPH MS|650-723-4000|manalip@stanford.edu|
22384254|NCT05535257|Mayo Clinic Florida|Suzanne Langley OTR/L|9044724288|langley.suzanne@mayo.edu|
22384255|NCT04469036|UC Davis Health|Raynald Dizon|9167344736|rodizon@ucdavis.edu|
22384256|NCT03606642|HonorHealth Research Institute|Joanne Saczynski, MSN, RN, ACRP-CP|480-323-1046|jsaczynski@honorhealth.com|
22384257|NCT04437433|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22384258|NCT02991534|VA Greater Los Angeles Healthcare System|Dr. Bevanne Bean-Mayberry|818-891-7711|bevanne.bean-mayberry@va.gov|36009
22384259|NCT04579250|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
22384260|NCT02919449|Vyriad|Alice Bexon MD Chief Medical Officer|+1-617-417-7300|alice.bexon@bexonclinical.com|
22384261|NCT01549899|University of Arizona|Daniel J. Taylor, Ph.D.|5206219289|danieljtaylor@arizona.edu|
22384262|NCT04711135|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
22384263|NCT02191085|University of Calgary|Dr. Sachin Pendharkar|403-210-8617|sachin.pendharkar@ucalgary.ca|
22384264|NCT03578536|Minneapolis VA Health Care System|Andrew Hansen, PhD|612-467-2910|Andrew.Hansen2@va.gov|
22384265|NCT01881412|Rhode Island Hospital and Brown University|Dr. Aris Garro|401-480-8682|arisgarro1@gmail.com|
22384266|NCT02538900|Northwestern University|Mary McDermott MD|312-503-6419|mdm608@northwestern.edu|
22384267|NCT03732820|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22384268|NCT03144518|University of Nottingham|Dr Kieran Ayling|+44 1158466908|kieran.ayling@nottingham.ac.uk|
22384269|NCT02374307|OsloMet - Oslo Metropolitan University|Maria Bjerk|+4767236683|maria.bjerk@oslomet.no|
22384270|NCT01989455|ApoPharma Inc.|Caroline Fradette, PhD|416-401-7543|cfradett@apopharma.com|
22384271|NCT00632203|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22384272|NCT00999167|Horizon Therapeutics, Inc.|Julia Egofske||clinicaltrials@horizonpharma.com|
22384273|NCT04238247|Ann & Robert H. Lurie Children's Hospital of Chicago|Dr. Michelle Macy|312-227-6676|mmacy@luriechildrens.org|
22384274|NCT04950127|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22384275|NCT01711632|Memorial Sloan Kettering Cancer Center|Dr. Jae Park, MD|646-608-3743|parkj6@mskcc.org|
22384276|NCT04315181|University of Kentucky|Director for the Center on Drug and Alcohol Research|859-257-6485|Sharon.Walsh@uky.edu|
22384277|NCT01948661|E.O. Ospedali Galliera|Andrea DeCensi|010563|andrea.decensi@galliera.it|4501
22384278|NCT03517969|Dana Farber Cancer Institute|Dr. Atish D Choudhury|617-6326328|atish_choudhury@dfci.harvard.edu|
22384279|NCT03271489|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22429373|NCT01263379|Abeona Therapeutics|Chief Medical Officer|(216) 282-8150|clinicalresults@abeonatherapeutics.com|
22429374|NCT05890586|Duke University|Susanna Naggie, MD, MHS, FIDSA|919-684-2584|susanna.naggie@duke.edu|
22429375|NCT03202550|Johns Hopkins University|Katrina Thaler|410-550-8506|kstouff3@jhmi.edu|
22429376|NCT00358579|Singapore General Hospital|A/Prof Marcus Ong Eng Hock|+6563213590|marcus.ong.e.h@sgh.com.sg|
22429377|NCT01129284|Columbia University Medical Center|Dr. Andrew S. Bomback, MD, MPH|212-305-0320|asb68@columbia.edu|
22429378|NCT00771602|UT MD Anderson Cancer Center|Stefan Faderl, MD / Professor|713-745-4613||
22429379|NCT01629862|University of Pittsburgh|Sanjay Patel|412-692-2035|patelsr2@upmc.edu|
22444101|NCT03727373|Department of Radiation Oncology, University of Lübeck, Germany|Prof. Dr. med. Dirk Rades|0049 451 500|dirk.rades@uksh.de|45401
22444102|NCT03577171|Assembly Biosciences|Linda Baher, Sr. Director, Clinical Operations|415-521-3808|clinicaltrials@assemblybio.com|
22444103|NCT03190369|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22444104|NCT01056328|St. Jude Medical|Nicole Glowacki, Clinical Project Manager|651-756-3432|NGlowacki@sjm.com|
22444105|NCT01606254|Janssen Pharm KK Japan|Medical Director|81-3-4411||5509
22444106|NCT04543409|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22444107|NCT01052844|Faculdade de Medicina do ABC|Felipe Melo Cruz|+55+11+27595914|felipemcruz@yahoo.com.br|
22444108|NCT02093026|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22444109|NCT04499599|L-Nutra, Inc.|Dr. Min Wei|323.791.2426|mwei@l-nutra.com|
22444110|NCT00121173|Johns Hopkins University|Cornelia L. Trimble, MD|410-502-0512|ctrimbl@jhmi.edu|
22444111|NCT01754909|Baltimore VAMC|Dr Eric Cohen|410 605 7000|eric.cohen@va.gov|5/7182
22444112|NCT02195011|Sarah Cannon Development Innovations|Senior Director, Regulatory Science|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
22444113|NCT00977808|University of Virginia|Boris Kovatchev, Ph.D./Principal Investigator|434-982-6479|pcm9b@virginia.edu|
22444114|NCT00174291|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22444115|NCT01466595|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22444116|NCT02313454|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22444117|NCT00450112|Seikagaku Corporation|Clinical Development Dept.|81-3-5220-8950|hiroyuki.hosokawa@seikagaku.co.jp|
22444118|NCT03418571|Ablynx NV|Medical Monitor|+32 9 262 00 00|clinicaltrials@ablynx.com|
22444119|NCT00559754|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22444120|NCT00586326|Hologic, Inc.|Nancy Chenette, Director, Clinical Affairs|508-263-8770|nancy.chenette@hologic.com|
22444121|NCT01439347|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@appirx.com|
22444122|NCT03595774|Indiana University Purdue University Indianapolis|Dr. Andrew R. Coggan|3172740656|acoggan@iu.edu|
22444123|NCT03882008|University of Washington|Bobby Kwanghoon Han|206-685-9950|hank4@uw.edu|
22444124|NCT04831788|University of Novi Sad, Faculty of Medicine|Prof. Vladimir Petrovic|+381648028800|vladimir.petrovic@izjzv.org.rs|
22444125|NCT04115644|UT Southwestern Medical Center|Dr. Michael Khazzam|214/645-8917|michael.khazzam@utsouthwestern.edu|
22444126|NCT03519386|Glaukos|Study Manager|949-481-8076|ldoan@glaukos.com|
22444127|NCT02783469|University of Dundee|Professor Blair H. Smith|01382383795|b.h.smith@dundee.ac.uk|
22444128|NCT01582854|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22444129|NCT03101267|Astellas Pharma Inc.|Clinical Trial Disclosure|+81-3-3244-6500 Japanese only|astellas.resultsdisclosure@astellas.com|
22444130|NCT04068896|NGM Biopharmaceuticals|VP Clinical Operations|(650)243-5555|ngm120@ngmbio.com|
22444131|NCT00484185|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22444132|NCT01222403|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22444133|NCT03442400|Cleveland Clinic|Samir Kapadia, MD|216-444-6735|kapadis@ccf.org|
22444134|NCT02068768|Zimmer Biomet Spine|Clinical Affairs|303-501-8571|tammy.stinson2@zimmerbiomet.com|
22444135|NCT00913692|National Institute of Allergy and Infectious Diseases, Laboratory of Infectious Diseases|Jeffrey I. Cohen, MD|(301) 496-5265|jcohen@niaid.nih.gov|
22444136|NCT04644783|University of Michigan|Mohamad El Zaatari|734-647-2954|mohamade@med.umich.edu|
22444137|NCT02290431|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22444138|NCT00321893|University of Texas MD Anderson|Powel H. Brown, MD, PhD/Professor of Medicine and Cancer Prevention||CR_Study_Registration@mdanderson.org|
22444139|NCT03455764|Dana-Farber Cancer Institute|Dr. Elizabeth Buchbinder|6176325055|elizabeth_buchbinder@dfci.harvard.edu|
22384280|NCT02860130|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
22384281|NCT02886286|University Hospitals Cleveland Medical Center|Salim M. Hayek, MD, PhD|2168442685|salim.hayek@uhhospitals.org|
22384282|NCT01127373|Memorial Sloan Kettering Cancer Center|Dr. Simon Powell, MD|212-639-3639|powells@mskcc.org|
22384283|NCT02633267|University of Michigan|Dr. Joseph Himle|(734) 615-0611|himlej@umich.edu|
22444140|NCT04721067|Indiana University|Dr. Samir K. Gupta|3172747926|sgupta1@iu.edu|
22444141|NCT02125604|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22444142|NCT01030783|AVEO Pharmaceuticals, Inc.|Chief Medical Officer|617-588-1960|Clinical@aveooncology.com|
22444143|NCT00782795|University of Michigan|Matthew DiMagno||mdimagno@umich.edu|
22444144|NCT04894916|Vanderbilt University Medical Center|William Martinez, MD|(615) 936-1010|william.martinez@vumc.org|
22444145|NCT02314364|Massachusetts General Hospital|Henning Willers, MD|617-726-5184|hwillers@mgh.harvard.edu|
22444146|NCT05161689|Mahidol University Faculty of Social Sciences and Humanities|Chair of the Institutional Review Board|+662-441-9180|mussirb310@gmail.com|
22444147|NCT01683019|NeoSync, Inc.|Dr. Bill Phillips|949-333-2906|bill@neosync.com|
22444148|NCT03437512|University of Michigan|Emily O. Garnett, PhD, CCC-SLP|734-232-3371|emilyog@med.umich.edu|
22444149|NCT00301821|Mayo Clinic|Ivana N. M. Micallef, M.D.|507-284-4642|micallef.ivana@mayo.edu|
22444150|NCT03332771|Lexicon Pharmaceuticals, Inc.|Medical Affairs|510-338-6064|medical-information@lexpharma.com|
22384284|NCT00522951|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22444151|NCT03718871|Weill Cornell Medicine|Dr. Radhika Sundararajan|(646) 962-4654|ras9199@med.cornell.edu|
22444152|NCT00737464|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22384285|NCT02713126|Mayo Clinic|Dr. Barry Borlaug|507-255-1051|borlaug.barry@mayo.edu|
22444153|NCT02423109|CooperVision|Myhanh Nguyen, OD|9257306716|mnguyen@coopervision.com|
22444154|NCT02266914|The Ohio State University Wexner Medical Center|Tamara McMath, MPH|614-293-8082|tamara.mcmath@osumc.edu|
22444155|NCT04177355|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
22444156|NCT02742246|Yale University School of Medicine|Dr. Brian Kiluk, Associate Professor of Psychiatry|203-737-1544|Brian.kiluk@yale.edu|
22444157|NCT03489551|University of Iowa|Michelle Weckmann|319-384-7538|michelle-weckmann@uiowa.edu|
22444158|NCT00054717|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22444159|NCT00585559|Vanderbilt University Medical Center|Dr. Matthew Fusco|615-322-1054|matthew.r.fusco@vumc.org|
22444160|NCT04111939|RTI International|Charles Knott|9195416294|cknott@rti.org|
22444161|NCT04218123|Department of Otolaryngology - Head and Neck Surgery, Medical University of South Carolina|Habib Rizk, MD, MSc|8438760112|rizkh@musc.edu|
22444162|NCT01654861|Eastern Regional Medical Center|Eiko Klimant, MD|215-537-7400|eiko.klimant@ctca-hope.com|
22444163|NCT01082640|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22444164|NCT00413478|University of Texas (UT) MD Anderson Cancer Center|Zeev Estrov, MD/Professor, Leukemia|713-794-1675|CR_Study_Registration@mdanderson.org|
22444165|NCT03823378|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22444166|NCT01289782|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com|
22444167|NCT03742440|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
22444168|NCT03436810|Mahidol University|Sunee Bovonsunthonchai|024415450|sunee.bov@mahidol.edu|
22444169|NCT04081233|The University of Texas Health Science Center at Houston|David E. Meyer, MD, MS, FACS|713-500-7244|David.E.Meyer@uth.tmc.edu|
22444170|NCT01264016|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
22444171|NCT01056380|Romark Laboratories, L.C.|Marc Ayers|813-282-8544|Marc.Ayers@romark.com|
22444172|NCT01629706|Alcon Research, Ltd.|Alan Landers, Project Head, Vision Care R&D|1-888-451-3937|alcon.medinfo@alcon.com|
22444173|NCT00048061|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22444174|NCT03583073|Brown U|Anthony Spirito|4013692435|anthony_spirito@brown.edu|
22444175|NCT05714644|Massachusetts General Hospital|Jennifer Haas, MD|6176434266|jennifer.haas@mgh.harvard.edu|
22444176|NCT00957593|Lehigh Valley Health Netword|Joanne N. Quinones MD MSCE|6104021221|joanne_n.quinones@lvhn.org|
22444177|NCT01262352|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22444178|NCT01298193|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
22444179|NCT01975831|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
22444180|NCT02925793|DS Biopharma|Study Director|+35312933590|regulatory.dsbiopharma@dsbiopharma.com|
22444181|NCT03794882|University of Wisconsin-Madison|Dr Kristin Bevil|6082638100|kbevil@wisc.edu|
22444182|NCT00393042|Dept. of Psychiatry, University of Washington|Dr. Mark Stein|206-987-1161|mstein42@uw.edu|
22444183|NCT03475875|Johnson & Johnson Vision|John Buch - Senior Principal Research Optometrist|904-443-1707|JBUCH@its.jnj.com|
22444184|NCT00824070|Bausch & Lomb Inc|Tuyen Ong, MD|(973) 360-6389|tuyen.ong@bausch.com|
22444185|NCT02045303|Texas Health Resources Presbyterian Hospital of Dallas|Lisley Viana, Physical Therapist|214-345-4334|lisleyviana@texashealth.org|
22444186|NCT01642407|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22444187|NCT00256282|University of California, Irvine|Dr. John P. Fruehauf|714-456-5153|jfruehau@uci.edu|
22444188|NCT02431247|Janssen Sciences Ireland UC|Clinical Registry Group|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22444189|NCT00667446|AbbVie, (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22444190|NCT03631355|NYU Langone Health Orthopedic Hospital|Dr. Michael J. Alaia|6465017223|michael.alaia@nyulangone.org|
22444191|NCT02810340|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22444192|NCT03945175|NYU Langone Health|Terry Leon|646 754 4837|terry.leon@nyulangone.org|
22444193|NCT01723696|OHSU|Cindy McEvoy, MD|503-494-0223|mcevoyc@ohsu.edu|
22444194|NCT00922701|University G. D'Annunzio|Mario Bonomini, M.D.|+39 0871 540120|m.bonomini@nephro.unich.it|
22444195|NCT00236951|Luitpold Pharmaceuticals|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|844
22444196|NCT01306877|Covidien|Tam LaFleur, Clinical Project Manager|203-821-4744|tam.lafleur@covidien.com|
22444197|NCT00939952|Albany College of Pharmacy and Health Sciences|Katie Cardone|518-694-7875|katie.cardone@acphs.edu|
22444198|NCT05074173|Tulane University School of Medicine|Keith Ferdinand|504-988-5492|kferdina@tulane.edu|
22444199|NCT01388920|Theratechnologies|Senior Medical Advisor|514-336-7800|jmamputu@theratech.com|
22444200|NCT01307020|Menarini Ricerche S.p.A.|Dr Angela Capriati, Corporate Clinical Research Director|+39 055 5680 9933|acapriati@menarini-ricerche.it|
22384286|NCT01066026|Brazilian Center for Studies in Dermatology|Dr. Doris Hexsel|55 51 30262633|cientifico@cbed.org.br|
22384287|NCT02140645|Boehringer Ingelheim (BI)|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22384288|NCT05450458|RodillaActiva Medical Center|Dr. Julio Carlos Vélez de Lachica|5215518338063|activeknee@gmail.com|
22384289|NCT02371395|CDC|Alexandre Macedo de Oliveira|404 718 4751|acq7@cdc.gov|
22384290|NCT01101451|NRG Oncology|Helen Huang on behalf of Wei Deng Ph.D.|7168452318|huangh@nrgoncology.org|
22384291|NCT02467166|University of California, San Diego Health System|Gregory K. Feld, MD, Director CCEP|(858) 246-2972|gfeld@health.ucsd.edu|
22384292|NCT01044303|East Carolina University|Dr. Paul Bolin|252-744-3773|bolinp@ecu.edu|
22384293|NCT01227265|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22384294|NCT02910713|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22429380|NCT03197935|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22429381|NCT02357485|UCLA Medical Center|Peter Fodor, MD|3102039818|pbfodor@centurysurgery.com|
22429382|NCT03593629|Jomo Kenyatta University of Agriculture and Technology and University of Washington|Kenneth Ngure|+254722362219|kngure@uw.edu|
22429383|NCT03315689|Aclaris Therapeutics, Inc.|Marco Cardillo, Clinical Trial Manager|484-540-6299|mcardillo@aclaristx.com|
22429384|NCT00864513|Georgetown University|Dr. Jimmy Hwang|202-444-2198|jh96@gunet.georgetown.edu|
22429385|NCT00762788|Vistakon|Kathy Osborn, OD, MS, FAAO, FBCLA Senior Principal Research Optometrist|1 904 443-1032|kosborn@its.jnj.com|
22429386|NCT03073109|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22429387|NCT00421733|Abbott|Global Medical Services|800-633-9110||
22429388|NCT00120250|Massachusetts General Hospital|Dr. Mark Pollack|312-942-5372|mark_pollack@rush.edu|
22429389|NCT01967277|Capillus LLC|Patricia Schnoor|7868881874|pschnoor@capillus.com|
22429390|NCT01829165|Stanford University|Amit Etkin, MD, PhD|(650) 725-5736|aetkin@stanford.edu|
22429391|NCT03300336|HSRD ADAPT|S. Nicole Hastings|919-286-6936|susan.hastings@va.gov|
22429392|NCT00397930|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu|
22429393|NCT01158404|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22429394|NCT02056288|Baylor College of Medicine|Chris D. Glover, MD, MBA, Principal Investigator|832-824-5800|cdglover@texaschildrens.org|
22429395|NCT00505362|Stanford University|Anna Girsen, Manager of Research Operations|6507250499|agirsen@stanford.edu|
22444201|NCT02359851|Vanderbilt-Ingram Cancer Center|Principal Investigator|615-936-7423|douglas.b.johnson@vanderbilt.edu|
22444202|NCT00491556|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
22444203|NCT04480424|Scientific Innovation Office (SIO) Clinical Program Leader/Director Bioscience Clinical & Pharmacovigilance|Rhonda Griffin|+1 919 316 6693|Rhonda.griffin@grifols.com|
22444204|NCT00993044|Children's Hospital Los Angeles|Rajkumar Venkatramani|3233615504|rvenkatramani@chla.usc.edu|
22444205|NCT00734747|Medigus Ltd|Aviel Roy-Shapira, MD|+972 8646 6880|avrish@gmail.com|
22444206|NCT01897714|Oncopeptides AB|Eva Nordström|+4686152040|trials@oncopeptides.com|
22444207|NCT04233034|Jaeb Center for Health Research|Colleen Bauza|813-975-8690|cbauza@jaeb.org|
22444208|NCT02417844|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22444209|NCT05828095|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
22444210|NCT03206073|National Cancer Institute|Dr. Tim F. Greten|240-760-6114|tim.greten@nih.gov|
22444211|NCT05523323|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22444212|NCT05654441|University of North Carolina at Chapel Hill|Keely Muscatell, PhD|919-843-5467|kmuscatell@unc.edu|
22444213|NCT00872027|University of Minnesota|Craig Weinert MD|612-624-0999|weine006@umn.edu|
22444214|NCT02428608|Evolus, Inc|Rui L. Avelar, MD|(805)689-8668|rui@evolusinc.com|
22412077|NCT00905125|Medicine and Molecular Virology & Microbiology, Baylor College of Medicine|Shital M. Patel, M.D.|713-798-3793|shitalp@bcm.edu|
22412078|NCT05328375|Columbia University Irving Medical Center|Dr. Andrea T. Duran, Assistant Professor of Medical Sciences|212.342.4491|atd2127@cumc.columbia.edu|
22412079|NCT05856123|Mayo Clinic|Deanna Covelli|480-342-5284|covelli.deanna@mayo.edu|
22412080|NCT04849845|MannKind Corporation|Johanna Ulloa|818-661-5000|contact@mannkindcorp.com|
22412081|NCT05514119|Mayo Clinic|Channa Jayasekera, M.D.|480-342-1095|jayasekera.channa@mayo.edu|
22412082|NCT02946385|GlaxoSmithKline|GSK Response Center|866-435-7343|anand.n.harpalani@gsk.com|
22412083|NCT03185065|Johns Hopkins University|Dr. Bardia Nourbakhsh|4106141522|bnourba1@jhmi.edu|
22412084|NCT00590395|Cedars Sinai Medical Center|Alan Waxman, M.D.|310-423-8000|Alan.Waxman@cshs.org|
22412085|NCT02708290|ImagiRation LLC|Dr. Andrey Vyshedskiy, Founder|6174338577|vysha@bu.edu|
22412086|NCT03229252|Spyryx Biosciences|Dr. Rob Tarran|919-966-7052|rtarran@spyryxbio.com|
22412087|NCT00278200|Johns Hopkins University|Richard Ambinder, MD, PhD|4109558839|rambind1@jhmi.edu|
22412088|NCT00974493|Oxford University Hospitals NHS Trust|Matthew Scarborough|07872436461|matthew.scarborough@ouh.nhs.uk|
22412089|NCT00976664|National University of Health Sciences|Dr. Jerrilyn Cambron|630-889-6536|jcambron@nuhs.edu|
22412090|NCT00132002|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22412091|NCT02688400|Arthrolab inc.|Dr.Jean-Pierre Pelletier|+1 (514) 992-4939|dr@jppelletier.ca|
22412092|NCT02767388|University of Nebraska Medical Center|David Anderson|402-559-6870|david.anderson@unmc.edu|
22412093|NCT03467477|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
22412094|NCT03068273|Scripps Health|Athena Philis-Tsimikas|858-678-7077|philis-tsimikas.athena@scrippshealth.org|
22412095|NCT03901573|NeoImmuneTech,INC|Alex Oh|301-337-2283|aho@neoimmunetech.com|
22412096|NCT03519256|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22412097|NCT02207231|Janssen Research & Development, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
22412098|NCT00421174|The EMMES Corporation|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|221
22412099|NCT04637997|University Hospital Erlangen, Vascular Surgery|Dr. med. Antje Mükke|+4991318532968|antje.muekke@uk-erlangen.de|
22412100|NCT01290263|Dana-Farber Cancer Institute|David A. Reardon, MD|617-632-2166|dreardon3@partners.org|
22412101|NCT02309099|University of North Carolina at Chapel Hill|Dr. Meredith Rooth|919-966-5251|meredith_rooth@med.unc.edu|
22429396|NCT02384460|Amicus Therapeutics, Inc.|Patient Advocacy|+1-609-662-2000|clinicaltrials@amicusrx.com|
22412102|NCT01545076|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22412103|NCT02624843|South Florida Family Health & Research|Elisabeth Rivera|3053870051|elisabeth@sffhrc.com|
22412104|NCT00797108|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22444215|NCT03868124|Glaukos|Study Manager|949-481-8076|ldoan@glaukos.com|
22444216|NCT00397943|GlaxoSmithKline|GSK Response Center|866-435-7343||
22444217|NCT05007717|University of Washington|Data Analyst|7347809402|wenwenj@uw.edu|
22444218|NCT01117051|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22444219|NCT03535571|KGK Science Inc.|Dr. Mal Evans|519-438-9374|mevans@kgkscience.com|
22444220|NCT00206076|Drexel University College of Medicine|David Reich, MD|215-762-7143|David.Reich@DrexelMed.edu|
22444221|NCT00427960|Astrazeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
22444222|NCT01142128|University of Florida|Phillip Toskes, M.D.|352-273-9493|phillip.toskes@medicine.ufl.edu|
22444223|NCT03355664|Mahidol Oxford Tropical Medicine Research Unit (MORU)|Thomas Peto|(+66) 802 187 460|tom@tropmedres.ac|
22444224|NCT02145507|Haemonetics (trial sponsor)|Adrian Orr, Clinical Research Director|781.356.9647|aorr@haemonetics.com|
22444225|NCT01960387|University of Pittsburgh Cancer Institute|Michael Boyiadzis, MD|412-623-0040|boyiadzism@upmc.edu|
22444226|NCT02821910|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22444227|NCT00423670|Merck, Sharp and Dohme|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22444228|NCT00900601|Oslo University Hospital|Thomas Kibsgård|99030831|kibsgard@gmail.com|+47
22444229|NCT02131532|University of Edinburgh|Dr Simiao Wu|0044-131-242-6371|simiao.wu@ed.ac.uk|26371
22444230|NCT01856023|Clinigen|Head of Medical Affairs|8323263256|nancy.gregory@clinigengroup.com|
22444231|NCT00829283|Yale School of Medicine|Dr. Carlos Grilo|203-785-2792|carlos.grilo@yale.edu|
22444232|NCT00424255|GlaxoSmithKline|GSK Response Center|866-435-7343||
22444233|NCT03004248|Revance Therapeutics, Inc.|Todd Gross, PhD, VP Data Science, Interim Head of Clinical Development|510-742-3400|tgross@revance.com|
22444234|NCT00591578|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22444235|NCT01412918|Medical College of Wisconsion|Dr. David Friedland|414-805-|dfriedland@mcw.edu|
22444236|NCT00870233|Memorial Sloan Kettering Cancer Center|Dr. Dennis Chi ME|212-639-5016|chid@mskcc.org|
22444237|NCT01369485|Ethicon Surgical Care|John Lombard, Manager Clinical Research|908 218 2877|Jlombar8@its.jnj.com|
22444238|NCT02942576|Contact for Clinical Trial Information|Daiichi Sankyo|1-908-992-6400|CTRinfo@dsi.com|
22444239|NCT00769483|UT MD Anderson Cancer Center|Milind Javle, MD/Professor, GI Medical Oncology|713-792-2828|mjavle@mdanderson.org|
22444240|NCT00006389|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22444241|NCT01958112|Dana-Farber Cancer Institute|Dr. Ursula Matulonis|617-632-2334|ursula_matulonis@dfci.harvard.edu|
22444242|NCT01781169|Shenzhen Center for Chronic Disease Control|Dr. Ji-Chang Zhou|86-755-25503842|jichangzhou@gmail.com|
22444243|NCT02096575|U of New Mexico - Dept of OBGYN/Family Planning|Michel Paves, HS Research Specialist|505-272-9703|MDaliva@salud.unm.edu|
22444244|NCT01285960|InSightec|Nadir Alikacem|214-630-2000|nadira@insightec.com|
22444245|NCT01309308|Baskent University|Ayse Parlakgumus|00903224586868|ayseparlakgumus@yahoo.de|2102
22444246|NCT00473746|Janssen R&D US|Sr. Director, Clinical Research|(310)914-2917||
22444247|NCT00586196|BIDMC|Edward R Marcantonio|617-754-1405|emarcant@bidmc.harvard.edu|
22444248|NCT01017575|Bristol-Myers Squibb International Corporation|BristolMyers Squibb Study Director||clinical.trials@bms.com|
22444249|NCT01962922|Veloxis Pharmaceutical|Leslie Callahan|732-321-3221|lca@veloxis.com|
22444250|NCT00970736|University of Florida|Karen Hegland|352 359-1830|kwheeler@ufl.edu|
22444251|NCT03014492|Cincinanti Childrens Hospital|Kim Foss|5136365971|kim.foss@cchmc.org|
22444252|NCT04705363|Mayo Clinic of Jacksonville|Dr. Janice Krieger|904-953-6160|krieger.janice@mayo.edu|
22444253|NCT00976573|Mayo Clinic|Robert R. McWilliams, MD|507/284-8432|mcwilliams.robert@mayo.edu|
22444254|NCT02730208|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22444255|NCT04490239|University of Mississippi|Dr. Joshua Sharp|662-915-1758|jsharp@olemiss.edu|
22444256|NCT00413166|The University of Texas (UT) MD Anderson Cancer Center|Dr. Farhad Ravandi-Kashani, Professor, Leukemia|7137927734|fravandi@mdanderson.org|
22444257|NCT00995865|GE Healthcare- Life Sciences|Amanda Culliton|1-508-683-2232|Amanda.Culliton@ge.com|
22444258|NCT00439465|Dartmouth-Hitchcock Medical Center|Kenneth Meehan, MD|603-650-6432|Kenneth.R.Meehan@hitchcock.org|
22444259|NCT00245219|Carnegie Mellon University|Michael F. Scheier, PhD|412-268-3791|Scheier@cmu.edu|
22444260|NCT02750215|Massachusetts General Hospital|Rebecca Suk Heist, MD|617-726-8033|RHEIST@PARTNERS.ORG|
22444261|NCT02021656|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22384295|NCT04430634|Nerudia|Paul Morris|+44 7508 708 917|paul.morris@nerudia.com|
22384296|NCT05928624|Columbia University|Giuseppe Cullaro, MD MAS|8454067438|gc2576@cumc.columbia.edu|
22384297|NCT03744312|Columbia University|Patrick J. Lao, PhD|212-305-9079|pjl2133@cumc.columbia.edu|
22384298|NCT03152786|Wake Forest School of Medicine|Ashok Hemal, MD|336-716-5694|ahemal@wakehealth.edu|
22384299|NCT04955717|USC|Dr. Jeffrey D. Klausner|415-876-8901|jdklausner@med.usc.edu|
22384300|NCT03888989|Stanford University|Philip Grant|650-521-3540|pmgrant@stanford.edu|
22384301|NCT03611153|Mayo Clinic|Dr. Barry A. Borlaug|507-255-2200|borlaug.barry@mayo.edu|
22384302|NCT00979576|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22384303|NCT05338086|mAbxience Research S.L.|Susana Millan , PhD|(+34) 917.711.500|Susana.Millan@mabxience.com|
22444262|NCT01827358|University of Maryland Medical Center|Karen Kotloff, MD|410-706-5328|kkotloff@medicine.umaryland.edu|
22384304|NCT03805594|University of California, San Francisco|Dr. Rahul Aggarwal, MD|(415) 353-7171|Rahul.Aggarwal@ucsf.edu|
22444263|NCT02338336|Norwarta|Peggy Hagerty|267-240-4010|hagertymws@comcast.net|
22444264|NCT00048893|National Cancer Institute (NCI), National Institutes of Health (NIH)|Claude Sportes, M.D.|301-435-5280|csportes@mail.nih.gov|
22444265|NCT01952470|Alfred Health|Benjamin James Tarrant|+61404455658|b.tarrant@alfred.org.au|
22384305|NCT03424811|University of Pennsylvania|Tanja Kral|(215) 573-7512|tkral@nursing.upenn.edu|
22384306|NCT05931861|Laboratoires Théa|Clinical Affairs Director|0473981436|Corentin.LECAMUS@theapharma.com|
22384307|NCT01939275|City of Hope|Paul Frankel, Ph.D.|626-812-5265|pfrankel@coh.org|
22384308|NCT02597946|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22384309|NCT04690673|Helsinki and Uusimaa Hospital District, Pain clinic|Dr Johanna Kujala|+358400780411|johanna.kujala@helsinki.fi|
22384310|NCT03379168|University of New Mexico Health Sciences Center|Dustin Richter, MD; Vice Chair of Research|505-272-4107|DLRichter@salud.unm.edu|
22384311|NCT05485922|Coloplast, Clinical strategies|Medical Writer|+4549112057|dkmhla@coloplast.com|
22384312|NCT04823611|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22384313|NCT05038566|Liberating Technologies, Inc.|Dr. Todd Farrell|774-233-0873|todd.farrell@liberatingtech.com|
22384314|NCT05535062|Neuronetics|Neha Goyal|763-528-1599|neha.goyal@neurostar.com|
22384315|NCT02226341|Columbia University|Anca Askanase MD, MPH|212 305 0856|ada20@cumc.columbia.edu|
22384316|NCT05194969|University of North Carolina at Chapel Hill|Christopher J. Sayed, MD|984-974-3900|christopher_sayed@med.unc.edu|
22384317|NCT05996744|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22384318|NCT04850807|Brown University|Ellen McCreedy, PhD|401-863-7345|Ellen_McCreedy@brown.edu|
22384319|NCT03739996|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|ACTG Network Coordinating Cent|ACTGCT.gov@fstrf.org|
22384320|NCT05141903|Prolacta Bioscience|Dr. David Rechtman VP, Medical Affairs|8887765228|drechtman@prolacta.com|
22384321|NCT03467542|Terumo Neuro|Robert Gash|714-247-8000|robert.gash@microvention.com|
22384322|NCT04178733|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22384323|NCT03679611|Department of Anesthesiology and Pain Medicine, Toronto Western Hospital, University Health Network|Dr. Jean Wong, MD, FRCPC.|416-603-5800|tojean.wong@uhn.ca|3635
22384324|NCT05126862|University of Virginia School of Nursing|Jessie Gibson, PhD, RN|434-924-0107|js6zn@virginia.edu|
22384325|NCT03655132|VA Bedford Healthcare System|Dr. Erin D. Reilly|781-724-4191|Erin.Reilly@va.gov|
22384326|NCT04119284|Nemours Hospital for Children|Suken Shah, MD, Orthopedics Department Chair|3025472557|suken.shah@nemours.org|
22384327|NCT02651324|Albany medical center|Farzana Afroze|518-262-4300|afrozef@amc.edu|
22384328|NCT05439603|Ancora Bio, Inc dba EmbarkNeuro|Chief Medical Officer|610 871-4891|info@embarkneuro.com|
22384329|NCT05783219|University of Louisville Medical Center|Rodger Rothenberger|(502) 588-7660|Rodger.rothenberger@louisville.edu|
22384330|NCT03984695|KUMCRI|Jaime Caldwell|913-588-1261|spa@kumc.edu|
22384331|NCT04549168|Eisai Co., Ltd.|Eisai Inquiry Service|none|eisai-chiken_hotline@hhc.eisai.co.jp|
22384332|NCT05519228|ZimmerBio|Andrea Singer|(0)79 318 06 55|andrea.singer@zimmerbiomet.com|+41
22384333|NCT05653856|Curium|Darcy Denner|314-506-3511|Solar@curiumpharma.com|
22384334|NCT04864912|Cochlear|PRS Specialist|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
22384335|NCT06320964|University of California, San Francisco|Nadia Diamond-Smith, PhD, MS|(415) 502-5800|nadia.diamond-smith@ucsf.edu|
22384336|NCT04737772|RVO Health|Helena Berlin|702-620-4965|hberlin@rvohealth.com|
22384337|NCT02549339|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
22384338|NCT05415410|VectivBio AG|Clinical Trial Information Desk|617.621.7722|ClinicalTrialEnquiries@ironwoodpharma.com|
22384339|NCT02365766|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22384340|NCT05166811|University of Utah|Dr. Michael D. Johnson|(801) 935-0503|mike.johnson@hsc.utah.edu|
22384341|NCT04058626|Imperial College London/ Imperial College Healthcare NHS Trust|Mr Pasha Normahani|020 3312 6666|p.normahani@imperial.ac.uk|switch
22384342|NCT02724956|UT MD Anderson Cancer Center|Carin Hagberg, MD/Chief Academic Officer, CAO Office|713-792-5888|chagberg@mdanderson.org|
22384343|NCT02808676|Lawson Health Research Institute|Dr. Manuel Montero-Odasso|519-685-4292|manuel.monteroodasso@sjhc.london.on.ca|42179
22384344|NCT04600752|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22384345|NCT04436107|BeiGene|Study Director|1 877-828-5568|clinicaltrials@beigene.com|
22384346|NCT04004325|FORMA Therapeutics, Inc.|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22384347|NCT02641912|GlaxoSmithKline|GSK Response Center|866-435-7343||
22384348|NCT05751785|The Geneva Foundation|Ms. Elizabeth Metzger, Senior Scientific Program Manager|253-383-1398|emetzger@genevausa.org|
22384349|NCT00604669|Emory University|Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
22384350|NCT00011986|Gynecologic Oncology Group Statistical and Data Center|Linda Gedeon, BS, CCRP|716-845-1169|lgedeon@gogstats.org|
22384351|NCT00274469|AstraZeneca|Jasmine Lichfield|07585404954|jasmine.lichfield@astrazeneca.com|
22384352|NCT00445315|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22384353|NCT03338816|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
22384354|NCT04999592|MaineHealth Maine Medical Center - Portland|David J. Gagnon, PharmD - Principal Investigator|207-662-0111|dgagnon@mmc.org|
22384355|NCT02671435|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
22384356|NCT01241916|Massachusetts General Hospital|Dr. David Ring|617-724-3953|dring@partners.org|
22384357|NCT04128319|Xenikos|Eric van Hooren, Chief Development Officer|+31 6 109 345 84|e.vanhooren@xenikos.com|
22384358|NCT00976937|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22444266|NCT00596362|Memorial Sloan Kettering Cancer Center|Dr. David Abramson|212-639-7232|abramsod@mskcc.org|
22444267|NCT00817479|The University of Chicago, Department of Medicine|Dr. Gini Fleming, MD|(773) 702-6149|gfleming@medicine.bsd.uchicago.edu|
22444268|NCT02043379|UAB Pediatric Cardiac Critical Care Medicine|Jeffrey Alten, MD|(205) 975-3123|jalten@peds.uab.edu|
22444269|NCT05985980|Istanbul Medeniyet University|Mehmet Agirbasli MD|+902166065200|agirbasli@gmail.com|
22444270|NCT00523367|University of Florida|Juan Munoz, MD|904-633-0089|juan.munoz@jax.ufl.edu|
22444271|NCT02793128|UroGen Pharma Ltd.|Madlen Malinowski|6467689533|madlen.malinowski@urogen.com|
22444272|NCT02355977|Zhejiang University|Dr. Ying Wang|86-571-87217437|wyi1006@sina.com|
22444273|NCT00055471|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22444274|NCT01854944|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22444275|NCT05419999|University of Texas Health Science Center at San Antonio|Casey Straud|210-562-6700|straud@uthscsa.edu|
22444276|NCT00282347|Genentech, Inc.|Medical Communications|800-821-8590||
22444277|NCT02101112|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22444278|NCT04340063|Edward Hines Jr. VA|Dr. Keith Gordon|(312) 503-3339|keith.gordon2@va.gov|
22444279|NCT01847001|Columbia University Medical Center|Dr. Kevin Kalinsky|212-305-1925|cancerclinicaltrials@cumc.columbia.edu|
22444280|NCT00572897|Univeristy of Illinois Hospital & Health Sciences System|Dr. Damiano Rondelli|312-996-6179|drond@uic.edu|
22444281|NCT00606944|Seoul National University Bundang Hospital|Sung-Bum Kang|+82-31-787-7093|kangsb@snubh.org|
22444282|NCT00775944|University of Nottingham|Graeme Docherty|01158321380|graeme.docherty@nottingham.ac.uk|
22444283|NCT00920829|Medical University of South Carolina|Dr. Raymond Anton|843-792-1226|antonr@musc.edu|
22444284|NCT03875118|National Taipei University of Nursing Health and Sciences|Director of Nursing Department|886-2-28227101|tsaejyy@ntunhs.edu.tw|3118
22444285|NCT02237911|University of Pittsburgh|Dr. Sara Piva|(412) 383-6712|spiva@pitt.edu|
22444286|NCT00721123|Hoffmann-La Roche|Medical Communications|800 821-8590||
22444287|NCT03468985|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22444288|NCT03981822|Verrica Pharmaceuticals|Susan Cutler, VP, Medical Affairs|484-773-0898|scutler@verrica.com|
22444289|NCT02519387|Mundipharma Pharmaceuticals Sdn Bhd|Elayne Chan|+60 122162170|Elayne.Chan@mundipharma.com.my|
22444290|NCT04521777|UT MD Anderson Cancer Center|An T Ngo-Huang, Assistant Professor, Rehabilitation Medicine|(713) 745-2327|ango2@mdanderson.org|
22444291|NCT06053463|The Ohio State University College of Optometry|Jennifer Fogt|614-292-0882|fogt.78@osu.edu|
22444292|NCT01617148|Cleveland Clinic Foundation|Dr. Rishi Singh|330-888-4000|singhr@ccf.org|
22444293|NCT01278303|Johns Hopkins Hospital|Dr. Richard E. Ringel|410-614-6745|rringel@jhmi.edu|
22444294|NCT01143207|FHI 360|Vera Halpern, MD|919-54-7040|vhalpern@fhi360.org|11390
22444295|NCT02960997|Stanford University|Joyce Teng, MD, PhD|(650) 724-9627|jteng3@stanford.edu|
22444296|NCT03416374|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22444297|NCT03463031|Glenmark Pharmaceuticals Ltd|Study Director|201-684 8000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
22444298|NCT01241240|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22444299|NCT01025154|The University of Texas MD Anderson Cancer Center|Stefan Faderl, MD / Associate Professor|713-745-4613|eharriso@mdanderson.org|
22444300|NCT00055224|National Institute of Mental Health|Dr Maryland Pao|(301) 435 5770|paom@mail.nih.gov|
22444301|NCT01677312|Center for Interventional Endoscopy, Florida Hospital|Dr. Shyam Varadarajulu, MD|407-303-2570|svaradarajulu@yahoo.com|
22444302|NCT04291001|University of Utah|Lori Gawron, MD|801-213-4989|lori.gawron@hsc.utah.edu|
22444303|NCT02376829|Align Technology Inc|Sherri Wilson-Lopes|408-470-1032|swilson@aligntech.com|
22444304|NCT00057954|ECOG Statistical Office|Study Statistician|617-632-3012||
22444305|NCT01251744|GlaxoSmithKline|GSK Response Center|866-435-7343||
22444306|NCT02147184|Baylor College of Medicine|Dr. Chadi Calarge|832-824-4764|chadi.calarge@bcm.edu|
22444307|NCT02117414|Medtronic, Inc|Evera MRI Clinical Research Specialist|800-328-2518|medtronicCRMtrials@medtronic.com|62813
22444308|NCT00701376|Cleveland Clinic|Brian Parker, MD|216-444-9950|parkerb1@ccf.org|
22444309|NCT02663687|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22444310|NCT00417482|New York State Psychiatric Institute|Davangere P. Devanand, MD|212-543-5612|dpd3@columbia.edu|
22444311|NCT01323946|GlaxoSmithKline|GSK Response Center|866-435-7343||
22444312|NCT05078138|USARIEM|Dr. Lee Margolis|508-206-2335|lee.m.margolis.civ@health.mil|
22444313|NCT03189381|Indiana University (IU)|Dr. Kevin Shiue|317 944 2524|kshiue@iupui.edu|
22444314|NCT00251004|Novartis Pharmaceuticals|Study Director|862-778-8300||
22444315|NCT00887744|Medtronic Spinal & Biologics Europe and Central Asia|E. Wülfert, Medical Affairs & Clinical Operations Director||inca.studyregistration@medtronic.com|
22444316|NCT01569464|UCB Clinical Trial Call Center|Study Director|+1 887 822 9493||
22444317|NCT01376557|Lexicon Pharmaceuticals, Inc.|Dr. Paul Strumph|(281) 863-3302|pstrumph@lexpharma.com|
22444318|NCT04025710|BIOTRONIK SE & Co.KG|Senior Director Clinical Project Management|+49 30 68905|mathias.freudigmann@biotronik.com|0
22444319|NCT00755911|University of Michigan|Darnell Kaigler|734-998-1468|dkaigler@umich.edu|
22444320|NCT01343901|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22444321|NCT01562873|Dana-Farber Cancer Institute|Nancy Lin, MD|617.632.2335|Nancy_Lin@dfci.harvard.edu|
22444322|NCT03221764|University of Louisville|Dr. Victor van Berkel|502-588-7600|victor.vanberkel@ulp.org|
22444323|NCT00633867|NHS Grampian|W Brampton||william.brampton@nhs.net|
22444324|NCT05308290|Stanford University|Charles Brown, MD PhD|6504983512|chbrown@stanford.edu|
22398409|NCT01882907|Pusan National University Hospital|In Joo Kim|+82-51-240-7224|injkim@pusan.ac.kr|
22444325|NCT02117427|Aevi Genomic Medicine|Garry A Neil|610-254-4208|garry.neil@aevigenomics.com|
22444326|NCT00410202|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22444327|NCT01352468|Cincinnati Children's Hospital Medical Center|Dr. Jeff Epstein|5136368296|jeff.epstein@cchmc.org|
22444328|NCT01178073|GlaxoSmithKline|GSK Response Center|866-435-7343||
22444329|NCT01674634|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22444330|NCT00937391|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22444331|NCT04533685|UCLA|Principal Investigator|310-206-6328|pszilagyi@mednet.ucla.edu|
22444332|NCT01226043|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22384359|NCT01637246|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22384360|NCT03859869|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22384361|NCT04442126|Numab Therapeutics AG|Josephine Adams|00447712295851|j.adams@numab.com|
22384362|NCT06450405|University of California, San Diego|Antoni Duleba|858-657-7000|aduleba@health.ucsd.edu|
22384363|NCT03767517|University of Alabama at Birmingham|Dr. Ronit Elk|205-996-1702|relk@uabmc.edu|
22384364|NCT06377358|University of Malaga|José Rioja Villodres|(+34) 952 137 278|jose.rioja@uma.es|
22384365|NCT04994509|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22384366|NCT02396199|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
22384367|NCT05794763|Stanford University|Dr. Eric Stice|6507237885|estice@stanford.edu|
22384368|NCT03217565|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22384369|NCT06066541|Brigham and Women's Hospital|Niteesh Choudhry, MD, PhD|617-278-0930|nkchoudhry@bwh.harvard.edu|
22384370|NCT04533022|Vicore Pharma AB|Chief medical officer Bertil Lindmark|+46 707661505|info@vicorepharma.com|
22384371|NCT02163447|UCSF|Dr. Grant Dorsey|415-206-4680|grant.dorsey@ucsf.edu|
22384372|NCT03897686|RCBIOFORM|Julia Melentyeva Commercial Director|+7 (495) 223-70-95|md@bioform.ru|
22384373|NCT05415436|The University of Toledo Medical Center|Kristi Baker BSN, RN|4193836223|kristi.baker@utoledo.edu|
22384374|NCT04030130|Medical University of South Carolina|Evan Graboyes, MD, MPH|843-792-0719|graboyes@musc.edu|
22384375|NCT04505774|University of Pittsburgh|Dr. Stephen Wisniewski|412-383-4696|stevewis@pitt.edu|
22384376|NCT05386355|University of Arkansas for Medical Sciences|Songthip Ounpraseuth|501-686-7233|stounpraseuth@uams.edu|
22384377|NCT04788537|University of Pennsylvania|Edward S Brodkin, MD|1-215-746-0118|ebrodkin@pennmedicine.upenn.edu|
22384378|NCT03157167|Navidea Biopharmaceuticals|Michael Blue, MD|6145714313|mblue@navidea.com|
22384379|NCT02643667|Washington University School of Medicine|Dr. Russell K. Pachynski|314-286-2341|rkpachynski@wustl.edu|
22384380|NCT03263026|DeNovo Biopharma|Gracielli Hage-Kautz, Associate Director Clinical Operations|858-799-1021|gkautz@denovobiopharma.com|746
22384381|NCT05161715|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
22384382|NCT03775109|Imperial College, London|Professor Mark Thursz|+44 (0) 203 3126454|m.thursz@imperial.ac.uk|
22429397|NCT02400580|University of Pittsburgh Medical Center|Dr. Noah Rindos|(412) 641-8769|rindosnb@upmc.edu|
22429398|NCT00949078|Johns Hopkins University School of Medicine|Professor Robert Wood, M.D.|rwood@jhmi.edu|rwood@jhmi.edu|
22429399|NCT00965094|Novartis Pharmaceuticals|Study Director|862-778-8300||
22429400|NCT01060111|Medical Affairs / Janssen-Cil Korea|Clinical Research Associate|82-2-2094-4837||
22429401|NCT01433978|Eisai Call Center|Eisai Inc.|888-422-4743||
22429402|NCT01004393|Seirei Hamamatsu General Hospital|Masanori Mori, MD|81-53-474-2222|Masanori.Mori@sis.seirei.or.jp|
22429403|NCT03281538|Cara Therapeutics|Frédérique Menzaghi, PhD|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
22429404|NCT01773889|The Cancer and Therapy Center at The University of Texas Health Science Center San Antonio|Tyler Curiel, MD|210-562-5287|CURIELT@UTHSCSA.EDU|
22429405|NCT02301429|Medtronic Regional Clinical Center|Clinical Study manager|0039(0)22 241371|laura.manotta@medtronic.com|
22429406|NCT03954938|University of Kentucky|William W. Stoops|8592575388|william.stoops@uky.edu|
22429407|NCT03270241|Johns Hopkins Medicine Dermatology Cutaneous Translational Research Program|Ruizhi Wang|4105027546|rwang@jhmi.edu|
22429408|NCT00976391|GlaxoSmithKline|GSK Response Center|866-435-7343||
22429409|NCT04270760|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22429410|NCT00887588|Novartis Pharmaceuticals|Study Director|862-778-8300||
22429411|NCT00762177|Colgate Palmolive Co.|William De Vizio|732-878-7901|William_Devizio@colpal.com|
22429412|NCT04514458|Yale University|Tariq Ahmad|203-843-1667|tariq.ahmad@yale.edu|
22429413|NCT04185246|Trust Biosonics, Inc.|Charly Kang|+886-3-668-4965|charlykang@trust-biosonics.com|211
22429414|NCT04180696|Medtronic, Bakken Research Center B.V.|Lidwien Vainer|+31610419653|lidwien.vainer@medtronic.com|
22429415|NCT05866367|HealthPartners Institute Neuroscience Research|Clinical Research Coordinator|651-495-6363|ClinicalTrials@HealthPartners.com|
22429416|NCT05877586|Duke University|Cristina C. Hendrix, DNS, GNP, FAAN|919-684-9358|cristina.hendrix@duke.edu|
22429417|NCT04210375|Salubris Biotherapeutics, Inc|SVP, Clinical Development|16176459160|amanda.mcewen@salubrisbio.com|
22429418|NCT04906421|Sagimet Biosciences, Inc.|Study Director|650-561-8675|sitecontact@sagimet.com|
22429419|NCT05752487|Biosense Webster, Inc.|Director Medical Affairs|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22429420|NCT03585543|Medical University of South Carolina College of Nursing|Shannon Phillips, PhD, RN, Associate Professor|843-792-9379|phillipss@musc.edu|
22429421|NCT04124965|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22429422|NCT02405962|The Hong Kong Polytechnic University|Dr. Yim Wah Mak|(852) 2766-6421|yw.mak@polyu.edu.hk|
22429423|NCT00990769|Duke University Medical Center|Dr. Heather Frederick|919-812-6204|heather.frederick@duke.edu|
22429424|NCT01214720|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22429425|NCT01980888|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22429426|NCT00433290|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22429427|NCT03969420|Sumitomo Pharma Oncology, Inc|Reyna Bishop|512-363-8755|reyna.bishop@oncology.Sumitomo-Pharma.com|
22429428|NCT01397747|Exact Sciences|Director of Clinical Operations|608-284-5700|tvaughn@exactsciences.com|
22444333|NCT00392821|Sarah Cannon Research Institute|John D Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
22444334|NCT01232205|Dept Obstetrics Gynecology Indonesia University|Yuditiya Purwosunu|+44 753 870 6897|yudi@med.showa-u.ac.jp|
22444335|NCT02945787|Moffitt Cancer Center|Thomas H. Brandon PhD|813 745-1750|Thomas.Brandon@moffitt.org|
22444336|NCT00510952|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22444337|NCT02782923|NYU Langone Madison Avenue Orthopaedics|Yong H. Kim, MD|212-427-3986|Yong.Kim@nyulangone.org|
22444338|NCT02418156|Aziyo Biolgics, Inc.|Clinical Director|470-514-4085|clinical@aziyo.com|
22444339|NCT03368118|Abivax|Vice President Clinical Operations|01 53 83 08 41|paul.gineste@abivax.com|
22444340|NCT01445626|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22444341|NCT05824741|Penn State College of Medicine|Ian Paul|(717) 531-8006|ipaul@pennstatehealth.psu.edu|
22444342|NCT00911742|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
22444343|NCT03642327|University of Maryland School of Medicine|Howard Dubowitz, MD, Professor of Pediatrics|4107066144|hdubowitz@som.umaryland.edu|
22444344|NCT05063318|Pharma Mar S.A.|Clinical Developtment, Department of PharmaMar's Oncology, Business Unit|0034918466000|clinicaltrials@pharmamar.com|
22444345|NCT03287635|Toyos Clinic|Dr.|9137064408|mtoyos@toyosclinic.com|
22444346|NCT04088656|University of Washingtion|Carmen Hazim|4042451459|chazim@uw.edu|
22444347|NCT02247531|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22444348|NCT03092024|Lady Davis Institute|Dr. Brett Thombs|514-340-8222|brett.thombs@mcgill.ca|25112
22444349|NCT04879225|Wake Forest University School of Medicine|Emily Harwood|8284067599|eaharwoo@wakehealth.edu|
22444350|NCT03436563|M D Anderson Cancer Center|Dr. Van Morris|713-792-2828|vkmorris@mdanderson.org|
22444351|NCT02882074|Cleveland Clinic|Dr. Marta Kelava|2162133218|kelavam@ccf.org|
22444352|NCT03682809|The University of Alabama at Birmingham|Dr. Andrew Pucker|920-579-2900|apucker@uab.edu|
22444353|NCT01751802|Psyadon Pharmaceuticals|President/CEO|301-919-2020|info@psyadonrx.com|
22444354|NCT00608543|UT Southwestern Medical Center|Dr.Prabha Sunderajan|214-648-0156|prabha.sunderajan@utsouthwestern.edu|
22444355|NCT01869725|University of Iowa|M. Sue O'Dorisio, MD, PhD|319-335-7234|sue-odorisio@uiowa.edu|
22444356|NCT01813110|Pennsylvania State University|Dr. Penny Kris-Etherton|814-863-2923|pmk3@psu.edu|
22444357|NCT01068652|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22444358|NCT00214500|Medical Affairs|Amicus Therapeutics|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
22444359|NCT03170232|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22444360|NCT00147251|MedStar Research Institute|Barbara V Howard|301-560-7305|barbara.v.howard@medstar.net|
22444361|NCT02537574|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
22444362|NCT01151098|Purdue Pharma L.P.|Clinical Leader, Executive Medical Director|800-733-1333 OR 800-745-7445||
22444363|NCT00107952|Theravance Biopharma Antibiotics, Inc.|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
22444364|NCT03533686|University of Miami|Dr. Hillary Snapp|305-243-4611|hsnapp@med.miami.edu|
22444365|NCT02632838|School of Nursing, Rutgers, the State University of New Jersey|Dr. Peijia Zha|7327637412|peijiaz@sn.rutgers.edu|
22444366|NCT02797054|University of Colorado|Julie A Maertens|303-724-7319|julie.maertens@ucdenver.edu|
22444367|NCT02721979|University of Washington|Dr. Michael Schweizer|(206) 606-6252|schweize@uw.edu|
22444368|NCT02398409|VHA|Dr. Virginia (Daggett) Wilder|307-675-3659|virginia.wilder@va.gov|
22444369|NCT03370289|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22444370|NCT00708071|Baxter Innovations, GmbH|Edith Hantak, DVM, Dir, Global Therapeutic Area, BioSurgery||edith_hantak@baxter.com|
22444371|NCT02140775|New York State Psychiatric Institute|Dr. Martin McElhiney|646.774.8035|mcelhin@nyspi.columbia.edu|
22444372|NCT03696927|Abilitech Medical|Director of Clinical and Product Management|833.225.3123|info@abilitechmedical.com|
22444373|NCT00938964|Duke University Health System|Joseph Mathew, M.D|919-681-6646|joseph.mathew@duke.edu|
22444374|NCT01858636|St. Jude Medical|Andrew Campbell|+1.651.756.5538|acampbell2@sjm.com|
22444375|NCT01765803|University of New Mexico|Stuart Winter, MD|505-272-4461|SWinter@salud.unm.edu|
22444376|NCT01085500|Mayo Clinic|Benjamin Zendejas, MD|507-538-5413|zendejas.benjamin@mayo.edu|
22444377|NCT01227564|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22444378|NCT01057901|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com|
22444379|NCT04812080|University of California Davis|Dr. Moon Chen|916-734-1191|mschenjr@ucdavis.edu|
22444380|NCT06309407|Oregon Health and Science University|Dr. Sandy Christiansen|2038092318|chrissan@ohsu.edu|
22444381|NCT04811573|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
22444382|NCT00999921|Medical College and Hospital Kolkata|Md Tanveer Adil|0091-9830154566|tanveer.cmc@gmail.com|
22444383|NCT04650854|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22444384|NCT01987401|Department of Veterans Affairs, Office of Research and Development|Dr. Nicholas L. Smith, Director of Seattle Cooperative Studies Program|2067642773|nicholas.smith@va.gov|
22444385|NCT04859114|Medical College of Wisconsin|Mir A Basir|4142666820|mbasir@mcw.edu|
22444386|NCT02376283|The Royal Wolverhampton NHS Trust|Prof James Cotton|01902307999|jamescotton@nhs.net|
22444387|NCT02378025|Veterans Affairs Palo Alto Healthcare System|Dr. Peter Bayley|650 493-5000|peter.bayley@va.gov|
22384383|NCT03743636|Northwestern University|Mary M. McDermott, MD|312-503-6419|mdm608@northwestern.edu|
22384384|NCT05691452|Vanderbilt University School of Nursing|Dr. Chorong Park|6153436075|chorong.park@vanderbilt.edu|
22384385|NCT04712994|University of Washington|Anjuli Wagner|9784602331|anjuliw@uw.edu|
22444388|NCT00704808|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22444389|NCT02495103|National Cancer Institute|Dr. Ramaprasad Srinivasan|240-760-6251|ramasrin@mail.nih.gov|
22429429|NCT00086307|NIMH|Dr. Carlos A. Zarate|301-451-0861|zaratec@mail.nih.gov|
22429430|NCT03694652|University of New Mexico|Dr. Tracie Collins|505-272-4979|tccollins@salud.unm.edu|
22429431|NCT03158311|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22429432|NCT01018953|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22429433|NCT00724503|Sirtex Medical|Janet Bell, M.B.A.|+ 888-474-7839|jbell@sirtex.com|710
22429434|NCT01184118|UW Madison|Mihaela Teodorescu, MD|608-256-1901|mt3@medicine.wisc.edu|
22429435|NCT01186419|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22429436|NCT05067270|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22429437|NCT03812328|Tetherex Pharmaceuticals|Jonathan Stocker, Ph.D.|855-222-0722|jstocker@tetherex.com|
22429438|NCT01560416|Dana-Farber Cancer Institute|Nancy Lin|617-632-2335|Nancy_Lin@dfci.harvard.edu|
22429439|NCT01033071|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22429440|NCT00727064|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22429441|NCT04073407|Axcella Health, Inc|Margaret Koziel, MD|8573202200|clinicaltrials@axcellahealth.com|
22429442|NCT07085845|Medical College of Wisconsin|Alan Nyitray, PhD|414-955-7701|anyitray@mcw.edu|
22429443|NCT02169401|Abbott|Robyn Capobianco|512-286-4274|robyn.capobianco@abbott.com|
22429444|NCT03150797|UCSF|Dr. Amy Gelfand|415-502-1914|amy.gelfand@ucsf.edu|
22429445|NCT04229381|The Ohio State University Comprehensive Cancer Center|Dr. Carolyn Presley|614-293-9424|Carolyn.Presley@osumc.edu|
22429446|NCT03684057|Brown University|Dr. Judson Brewer|401-863-2826|judson.brewer@brown.edu|
22429447|NCT00758043|Vertex Pharmaceuticals Incorporated|Robert Kauffman, MD, PhD|617-444-6158|Robert_Kauffman@vrtx.com|
22429448|NCT03989570|Minia university|Dr. Hassan Elshorbagy|1204427271|Hassan.Hetta@mu.edu.eg|0020
22429449|NCT03422718|University of Michigan|Principal Investigator|734-615-2766|mdome@umich.edu|
22429450|NCT02083263|Karolinska University Hospital|Maria Cecilia Rodriguez Hortal|0046709558699|cecilia.rodriguez-hortal@karolinska.se|
22429451|NCT00669331|Pharmaxis Ltd|Dr Brett Charlton, Medical Director|+61 2 94547210|brett.charlton@pharmaxis.com.au|
22429452|NCT03387046|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22429453|NCT00509600|UT MD Anderson Cancer Center|Robert J. Wells, MD / Professor|713-792-6620||
22429454|NCT00986232|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22429455|NCT02568423|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22429456|NCT03794544|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22429457|NCT02550210|Dartmouth Hitchcock Medical Center|Dr. Richard J. Barth Jr.|(603) 650-9479|Richard.J.Barth.Jr@hitchcock.org|
22429458|NCT02979054|Laboratoires Théa|Clinical Development Director|+33(0)473981414|Corentin.LECAMUS@theapharma.com|
22429459|NCT01676350|WellSpan York Hospital|Brent Becker|717-851-2223|bbecker2@wellspan.org|
22429460|NCT00382928|Atlanta Research and Education Foundation|Dr. A. Maziar Zafari|404-321-6111|azafari@emory.edu|4019
22429461|NCT00585585|University of Cincinnati|Erik Nelson, MD|513-558-5115|erik.nelson@uc.edu|
22429462|NCT00299221|Newark Beth Israel Medical Center|David Baran MD|973-926-7205|dbaran@barnabashealth.org|
22429463|NCT01964560|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22444390|NCT01654796|Massachusetts General Hospital|Dr. Maurizio Fava|617-724-2513|MFAVA@mgh.harvard.edu|
22444391|NCT04867434|Raziel Therapeutics|Dr. Racheli Gueta, Director of Clinical Trials|97289124670|racheli@raziel-therapy.com|
22444392|NCT01982331|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22444393|NCT03500679|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22444394|NCT04186481|Smith+Nephew, Inc.|Alison Walker, Regional Operation Manager ANZ|+61 466 322 200|Alison.walker@smith-nephew.com|
22444395|NCT00744471|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22444396|NCT01525173|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22444397|NCT04706416|Valley Baptist Medical Center|Dr. Ameer Hassan|973-303-8146|ameerehassan@gmail.com|
22444398|NCT01280955|Duke University Medical Center|Mitchell Horwitz, MD|919-668-1045|mitchel.horwitz@duke.edu|
22444399|NCT01484054|Johnson & Johnson Vision Care|Michael Mayers, OD, FAAO|904-443-3252|mmayers@its.jnj.com|
22444400|NCT01616082|Translational Research Institute for Metabolism and Diabetes|Dr. Steven R. Smith|407-303-7115|steven.r.smith.md@flhosp.org|
22444401|NCT05281601|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22444402|NCT01234207|UCaliforniaBerkeley|Andrew D. Graham|510-643-9252|agraham@berkeley.edu|
22444403|NCT00901927|The University of Texas (UT) MD Anderson Cancer Center|Nathan Fowler/Clinical Professor, Lymphoma-Myeloma|(832) 671-3018|nfowler@mdanderson.org|
22444404|NCT03737851|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22444405|NCT01860573|Women & Infants Hospital|Dr. Joseph Bliss|4012741100|jbliss@wihri.org|
22444406|NCT03496571|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
22444407|NCT05223335|Mayo Clinic|Mandeep Singh, M.D.|507-255-2398|Singh.Mandeep@mayo.edu|
22444408|NCT04638673|Medical University of South Carolina|Dr. Mark S. George|843-876-5142|georgem@musc.edu|
22444409|NCT03119701|Faron Pharmaceuticals Ltd|Chief Medical Officer|+3584005529411|medical@faron.com|
22444410|NCT02691962|Becton Dickinson and Company|Dawn Heimer|+1-401-825-8681|Dawn.Heimer@bd.com|
22412105|NCT02324465|Vanderbilt University Medical Center|Doug Hester|6153439419|doug.hester@vanderbilt.edu|
22429464|NCT01567020|VA Portland Health Care System|Dr. Frederick Gallun|5032208262|Frederick.Gallun@va.gov|57472
22429465|NCT03676725|AlkaliDx|Lynn Feldman|16178791670|lynn@alkalidx.com|
22429466|NCT05696158|Mahana Therapeutics|Kathryn Jenkins|17742666693|kathryn@mahanatherapeutics.com|
22444411|NCT01594385|St. Luke's University Health Network|Stanislaw P. Stawicki, M.D.|484-526-4426|stanislaw.stawicki@sluhn.org|
22444412|NCT00285467|Indiana University School of Medicine|Sharon Moe, MD|317-278-2868|smoe@iupui.edu|
22444413|NCT00406718|UT_SanAntonio UTHSCSA|Dr. Dawn Velligan|210-567-5508|velligand@uthscsa.edu|
22444414|NCT01604109|ThammasatU|Thanya Sitthisettapong|6629869213|thanyasang@yahoo.com|7150
22444415|NCT01888003|University of Alabama at Birmingham Department of Anesthesiology and Perioperative Medicine|Dr. Thomas Vetter|205.934.6501|tvetter@uab.edu|
22444416|NCT03187756|Perlmutter Cancer Center, NYU Langone Health|David Kaminetzky, MD|212-731-5855|David.Kaminetzky@nyulangone.org|
22444417|NCT00396032|Genentech, Inc.|Medical Communications|800-821-8590||
22444418|NCT00323869|Stanford University Medical Center|Heather A Wakelee, MD, Associate Professor of Medicine (Oncology)|650-498-6000|hwakelee@stanford.edu|
22444419|NCT03172910|Apollo Investment Management|Scientific Advisor|+352 2088 1301|rchari@kaiperheathcare.com|
22444420|NCT01397201|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22444421|NCT02285283|The University of Texas Health Science Center at Houston|Amber U. Luong, MD, PhD|713-486-5000|Amber.U.Luong@uth.tmc.edu|
22444422|NCT02661711|Moorfields Eye Hospital|Tumelo Kaminskas|02072533411|moorfields.resadmin@nhs.net|2036
22444423|NCT01337687|Montefiore Medical Center, Albert Einstein College of Medicine|Casara Jean Ferretti|3472499694|cferrett@montefiore.org|
22444424|NCT01229397|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
22444425|NCT04457973|University of Arizona|Dr. Hyochol Ahn|520-626-1769|hbrian@arizona.edu|
22444426|NCT01810432|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22444427|NCT01593722|Laboratory of Parasitic Diseases, NIAID, NIH|Dr. Amy Klion|301-435-8903|aklion@niaid.nih.gov|
22444428|NCT03343067|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22444429|NCT00542451|Dana Farber Cancer Institute|SARA TOLANEY, MD, MPH|617-632-3800|Sara_Tolaney@dfci.harvard.edu|
22444430|NCT01287078|National Heart Lung and Blood Institute|Dr Richard Childs|301-451-7128|childsr@nhlbi.nih.gov|
22444431|NCT00116168|MedImmune|Don Raible, MD|301-398-0000|raibleD@medimmune.com|
22444432|NCT03739840|Cares|UCB|+1-844-599-2273|UCBCares@ucb.com|
22444433|NCT05153473|CHU de Poitiers|Dr Louis Etienne GAYET|+33(0)5.49.44.44.92|Louis-Etienne.GAYET@chu-poitiers.fr|
22444434|NCT02788474|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22444435|NCT03555435|National Center for PTSD|Eve Carlson|6504935000|eve.carlson@va.gov|24058
22444436|NCT01828515|UT Southwestern Medical Center|Dr. E. Sherwood Brown|214-645-6950|sherwood.brown@utsouthwestern.edu|
22444437|NCT00992927|Seoul National University Hospital|Sun Gun Chung/Professer|+82-2-2072-3954|suncg@snu.ac.kr|
22444438|NCT04489732|University of Wisconsin Carbone Cancer Center|Randy Kimple, MD, PhD, FASTRO|608-263-5361|rkimple@humonc.wisc.edu|
22444439|NCT01243671|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22444440|NCT02962765|Octapharma|Sigurd Knaub, Senior VP CR&D Haematology|01554512141|Sigurd.Knaub@octapharma.com|
22444441|NCT02340715|Medical College of Wisconsin|Ergun Ahunbay|4148057898|eahunbay@mcw.edu|
22444442|NCT05014490|"PrJSC Pharmaceutical Firm Darnytsia"|Andrii Doroshenko, PhD, MD|+38 044 207 73 53|a.doroshenko@darnytsia.ua|
22444443|NCT00245583|Icahn School of Medicine at Mount Sinai|Dr. Heather Berlin|212-241-4761|heather.berlin@mssm.edu|
22444444|NCT01309893|Bausch & Lomb|Dr. Robert Steffen|585 338-6399|robert.steffen@bausch.com|
22444445|NCT02017171|Joslin Diabetes Center|Dr. Alessandro Doria (Sponsor and PI of the study)|617-319-0970|alessandro.doria@joslin.harvard.edu|
22444446|NCT02220998|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22444447|NCT00873860|MedImmune, LLC|Meena Jain, MB BChir/Associate Medical Director|301-398-0000|jainm@medimmune.com|
22444448|NCT01484938|Alcon Research, Ltd.|Jami Kern, Ph.D., Global Medical Affairs|800-862-5266||
22444449|NCT00945854|Federico II University|Riccardi Gabriele|+390817462117|riccardi@unina.it|
22444450|NCT02139800|Children's Hospital of Philadelphia (CHOP)|Dr. Haresh Kirpalani|215-590-2455|kirpalanih@email.chop.edu|
22444451|NCT01172275|Yale University|Dr. Michael H. Bloch|203-737-4809|michael.bloch@yale.edu|
22444452|NCT02862600|Heart Metabolics, Ltd.|Mark G. Midei, MD, Executive Director and Head of Cardiology|4103715357|markgmidei@gmail.com|410
22384386|NCT01938547|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
22384387|NCT03564600|University of Pittsburgh School of Medicine|Professor Debra K. Weiner, M.D.|4124016811|dweiner@pitt.edu|
22384388|NCT06190678|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
22384389|NCT05320432|Stanford University|Principal Investigator|650-497-5175|gynresearch@stanford.edu|
22384390|NCT04286282|University of Minnesota|Sarah Lofgren|612-624-9996|Lofg0020@umn.edu|
22384391|NCT01226979|SKCCC at Johns Hopkinis|Amol Narang, MD|(410) 955-7390|anarang2@jhmi.edu|
22384392|NCT01894061|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. David Peereboom|1-866-223-8100|TaussigResearch@ccf.org|
22384393|NCT02728076|Froedtert and the Medical college of Wisconsin|Adam Currey, MD|414-805-4462|acurrey@mcw.edu|
22384394|NCT05054374|Memorial Sloan Kettering Cancer Center|Dr. Ezra Rosen, MD, PhD|646-888-6955|rosene1@mskcc.org|
22384395|NCT04791709|University of Miami|Dr. Daniel Jimenez|305-243-2776|dej18@miami.edu|
22384396|NCT01532388|Karolinska Institutet|Dr Kristina Sinadinovic|+46812345735|kristina.sinadinovic@socialstyrelsen.se|
22384397|NCT03385629|Case Western Reserve University|Dr. Suchitra Nelson|216-368-3469|suchitra.nelson@case.edu|
22384398|NCT03926819|Hillhurst Bio|President and CEO|858 232 9495|admin@hillhurstbio.com|
22384399|NCT04431726|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22384400|NCT01095796|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22384401|NCT04349072|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22398410|NCT03371225|Spaulding Rehabilitation Hospital|Felipe Fregni|6179526154|fregni.felipe@mgh.harvard.edu|
22444453|NCT00194675|VA Puget Sound Health Care System|Alvin M. Matsumoto, MD|(206) 764-2760|alvin.matsumoto@med.va.gov|
22444454|NCT01194427|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|4432876489|vstearn1@jhmi.edu|
22444455|NCT00832390|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22444456|NCT00667420|MassGH|David P. Ryan|617-724-0245|dpryan@partners.org|
22444457|NCT04437368|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22444458|NCT00095628|London Regional Cancer Centre|Dr. Eric Winquist|519-685-8600|eric.winquist@lhsc.on.ca|53243
22429467|NCT02194088|Brigham and Women's Hospital|Edwards Robert|617-732-9486|rredwards@partners.org|
22444459|NCT04271280|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22444460|NCT00495131|National Taiwan University Hospital|Chen-Hua Liu, MD|886223123456|jacque_liu@mail2000.com.tw|63572
22444461|NCT03224546|University of Kentucky|William W. Stoops|859-257-5383|william.stoops@uky.edu|
22444462|NCT02034422|Salt Lake City VAMC|Joel Trinity, PhD|801-582-1565|joel.trinity@va.gov|1794
22444463|NCT01539317|Oregon Health and Science University|Dr. Martha Goetsch|503-494-3666|whru@ohsu.edu|
22444464|NCT04223232|MedDay Pharmaceuticals|Dr Frédéric SEDEL, Chief Scientific Officer and Co-founder|+33 1 80 40 14 40|frederic.sedel@medday-pharma.com|
22384402|NCT00100698|Massachusetts General Hospital|Janet Lo|617-724-9109|jlo@partners.org|
22384403|NCT05480943|VA Sierra Nevada Healthcare System|Elisabeth Mates, MD,PhD, Principal investigator|775-786-7200|Elisabeth.Mates@va.gov|5273
22429468|NCT02217982|Rocky Mountain MS Research Group|Tammy Hoyt|8014085711|thoyt@rmmsc.com|
22429469|NCT01755637|GlaxoSmithKline|GSK Response Center|866-435-7343||
22429470|NCT00668564|Masonic Cancer Center, University of Minnesota|Paul Orchard, M.D.|612-626-2313|orcha001@umn.edu|
22429471|NCT02933476|Stanford School of Medicine|Raumin Neuville|6507236709|raumin@stanford.edu|
22429472|NCT03338023|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22429473|NCT03896217|UCL Institute of Neurology|Prof. Richard Nicholas|0208 383 0675|richard.nicholas3@nhs.net|
22429474|NCT02213107|University of Rochester|Chunkit Fung, MD|585 - 275 - 5823|chunkit_fung@urmc.rochester.edu|
22429475|NCT02030418|Abbott Cardiac Rhythm Management|Nicole Harbert, Director Clinical Research|972-526-4841|nicole.harbert@abbott.com|
22429476|NCT00724893|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22429477|NCT03362957|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
22429478|NCT01279200|University of Michigan|Senait Fisseha, MD, JD|734-763-4323|sfisseha@med.umich.edu|
22429479|NCT01399099|Neodyne Biosciences|Sr. Director of R&D|510-456-4128|jjackson@neodynebio.com|128
22429480|NCT01179516|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22429481|NCT01668537|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
22429482|NCT01149538|University of Minnesota|Jeffrey R. Wozniak, Ph.D.|612-273-9741|jwozniak@umn.edu|
22429483|NCT02122952|AveXis, Inc.|Doug Feltner, MD|833-828-3947|medinfo@avexis.com|
22429484|NCT03412890|Myovant Sciences GmbH|Clinical Trials at Myovant|+1 650 238 0250|clinicaltrials@myovant.com|
22429485|NCT02336503|Botanix Pharmaceuticals|Vice President, Head of Development|+1 (445) 300-3403|trials@botanixpharma.com|
22429486|NCT01436500|Cumberland Pharmaceuticals Inc|Jerry Fox, DVM|615-255-0068|jfox@cumberlandpharma.com|
22429487|NCT00625729|Masonic Cancer Center, University of Minnesota|Veronika Bachanova, M.D.|612-625-5469|bach0173@umn.edu|
22429488|NCT03838874|Mayo Clinic|Dr. Matthew Abdel|507-538-1296|Abdel.Matthew@mayo.edu|
22429489|NCT02021318|Astellas Pharma Europe B.V.|Clinical Trial Disclosure|+44 (0)20 3379 8000|Astellas.resultsdisclosure@astellas.com|
22429490|NCT01068249|UT MD Anderson Cancer Center|Dr. Pamela Soliman,Professor, Gyn Onc & Reproductive Med|(713) 745-2352|psoliman@mdanderson.org|
22429491|NCT01740427|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22429492|NCT00963508|Taro Pharmaceuticals U.S.A., Inc.|Director, Clinical Research|914 -345-9001|natalie.yantovskiy@taro.com|
22429493|NCT02184156|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|7204376500|clinicaltrials@ampiopharma.com|
22429494|NCT00759096|Alcon Research, Ltd.|Benny Li, PhD|+86 21 6375 8762|Benny.Li@Alconlabs.com|
22429495|NCT00165698|Eisai Co., Ltd.|Takao Ishii, Asia regulatory affaires|81-3-3817-3914||
22429496|NCT01483651|Legacy Health System|Kenneth Ward|971-570-2632|kenward503@msn.com|
22429497|NCT02547935|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22429498|NCT01398475|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22429499|NCT01937117|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Jenna Canzoniero, MD|410-955-8983|jcanzon1@jhmi.edu|
22429500|NCT01455519|Rehabilitation Institute of Chicago|Center for Pain Studies|312.238.5654|centerforpainstudies@ric.org|
22429501|NCT01271855|Northwestern University|Kimberly Kenton MD, MS|312-472-3874|kkenton@nm.org|
22384404|NCT03069313|Cleveland Clinic Florida|Zeina Nahleh, MD (previoulsy PI at Texas Tech university HSC-EP)|9546595840|nahlehz@ccf.org|
22384405|NCT03912831|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
22384406|NCT03242148|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 09 574 0123|CPAP.trial@fphcare.co.nz|7044
22384407|NCT04623775|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
22384408|NCT06024174|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22429502|NCT00314106|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
22444465|NCT00364130|Children's Hospital of Philadelphia|Mary Leonard, MD, MSCE|215-590-0874|leonard@email.chop.edu|
22444466|NCT04616027|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22444467|NCT01158703|BROOKE ARMY MEDICAL CENTER|AHMAD M. SLIM, MD, LTC, MC|210-916-4717|AHMAD.SLIM@US.ARMY.MIL|
22444468|NCT00586846|Memorial Sloan Kettering Cancer Center|Dr. Paul Meyers|212-639-5952|meyersp@mskcc.org|
22444469|NCT02239627|West Virginia Universtiy, WVCTSI|Clinical Trials Compliance Coordinator|304-293-0216|ctgovadmin@hsc.wvu.edu|
22444470|NCT00484718|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22444471|NCT01702571|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22444472|NCT03004443|Emory University|Andrew H. Miller, MD|404-727-8260|amill02@emory.edu|
22444473|NCT00828854|Syndax Pharmaceuticals, Inc.|Michael Meyers, MD, PhD, Chief Medical Officer|+1-646-690-7620|mmeyers@syndax.com|
22444474|NCT04221230|Neumora Therapeutics, Inc.|Study Contact|+1- (857) 760-0900|clinicaltrials@neumoratx.com|
22444475|NCT00915356|AstraZeneca|Gerard Lynch||clinicalTrialTransparency@astrazeneca.com|
22444476|NCT03425019|The University of Texas Health Science Center at Houston|Hyochol Ahn|(713) 500-2179|hahn@fsu.edu|
22444477|NCT00191646|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22444478|NCT00723931|Merck Sharp and Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22444479|NCT04350606|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22444480|NCT01753739|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
22444481|NCT05211284|Zydus Therapeutics Inc.|Dr Deven Parmar|7324050886|dparmar@zydustherapeutics.com|
22444482|NCT00252629|Northport, VAMC|Mohammad M. Amin, MD|6312614400|mohammad.amin2@va.gov|2469
22444483|NCT00972088|bikur holim hospital|samuel n adler md, director of clinical trial|972 2 6464206|nasnadler@gmail.com|
22444484|NCT04090957|Estetra SRL|Clinical Study Leader|+3243254451|clinical.trials@estetra.com|
22444485|NCT01909453|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22444486|NCT00309738|Kowa Research Institute|Bill Arana|919 433 1600|barana@kowaus.com|
22444487|NCT04070144|Injeq|Chief Scientific Officer|+358405805944‬|info@injeq.com|
22444488|NCT00970073|Cleveland Clinic|Bijan Eghtesad|2164029954|eghtesb@ccf.org|
22444489|NCT00122278|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|(718)920-6266|befriedm@montefiore.org|
22444490|NCT01002482|CH Chartres|Dr. Pierre Kalfon|003323730303073|pkalfon@ch-chartres.fr|
22444491|NCT03861611|Montefiore Medical Center|Eddie Irizarry, MD|718-904-2104|eddiriza@montefiore.org|
22444492|NCT02598960|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22444493|NCT00398411|University of Cologne|Prof. Dr. Oliver A. Cornely|+49 221 478 88794|oliver.cornely@zks-koeln.de|
22444494|NCT00401531|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22444495|NCT01557894|Babes-Bolyai University|Bogdan Tudor Tulbure|+40745753061|btulbure@gmail.com|
22444496|NCT03402659|EIP Pharma|Jennifer Conway, Associate Director of Clinical Development|(617) 744-4400|jconway@eippharma.com|
22444497|NCT01614600|Alcon Research, Ltd.|Jami Kern, MBA, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
22444498|NCT03403374|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22444499|NCT02128828|University of Hawaii|Dr. Cecilia Shikuma|808 692-1328|shikuma@hawaii.edu|
22444500|NCT03257696|Groupe Hospitalier de la Rochelle Ré Aunis|Dr. Camille Bonnin|+0546455050|camille.bonnin@ght-atlantique17.fr|
22444501|NCT00090051|Hoffmann-La Roche|Medical Communications||global.clinical_trial_registry@roche.com|
22444502|NCT00736957|Neuroscience Department, Clinical Science Division, R&D, JANSSEN PHARMACEUTICAL. K.K. 5-2, Nishi-kanda 3-chome, Cyiyoda-ku, Tokyo 101-0065 JAPAN|Medical Director|+81-3-4411-5509||
22444503|NCT02395666|Beat Childhood Cancer|Dr. Giselle Sholler|704-381-9900|Giselle.Saulniersholler@atriumhealth.org|
22444504|NCT03646643|University of Pennsylvania|Dr. Saman Nazarian|215-615-5220|Saman.Nazarian@pennmedicine.upenn.edu|
22444505|NCT02806973|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22429503|NCT01695772|Hoffmann-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22429504|NCT00254072|UC Irvine Medical Center|Ninh T. Nguyen, M.D.|714-456-8580|ninhn@uci.edu|
22429505|NCT00126737|Edward Hines, Jr. VA Hospital|Elly Budiman-Mak, MS MPH MD|708-202-2414|elly.mak@va.gov|
22429506|NCT01567085|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc. (Sponsor)||clinicaltrials@alexion.com|
22429507|NCT04193176|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22429508|NCT00324857|VA|Said A. Ibrahim, MD, MPH|215 823 5800|Said.Ibrahim2@va.gov|7163
22429509|NCT00944645|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22429510|NCT05715346|Levation Pharma|Houman Hemmati, M.D., Ph.D.|424 274 2642|info@levationpharma.com|
22429511|NCT03537729|Grand Valley State University|Dr. Rebecca Davis|616.331.3079|davirebe@gvsu.edu|
22429512|NCT03404167|DynPort Vaccine Company LLC, a GDIT Company|George A. Saviolakis, MD, PhD, Medical Director|1-240-651-8116|George.Saviolakis@gdit.com|
22429513|NCT01148420|Harbor - UCLA Medical Center|Anita Nelson|310-222-3871|anitanelsonwhc@earthlink.net|
22429514|NCT00284934|Novartis Pharmaceuticals|Study Director|862-778-8300||
22429515|NCT01389284|Bayer HealthCare LLC, Consumer Care|Head Medical Affairs||clinical-trials-contact@bayerhealthcare.com|
22429516|NCT02504775|GlaxoSmithKline|GSK Response Center|866-435-7343||
22429517|NCT01783015|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22429518|NCT01348698|National Cancer Institute|Dr. Naris Nilubol|301-451-2355|niluboln@nih.gov|
22429519|NCT00666978|University of Kansas Medical Center|Lisa Sanderson Cox|913-588-2643|lcox@kumc.edu|
22398411|NCT03124784|Masimo Corporation|Tala Harake|949-297-7000|studies@masimo.com|
22444506|NCT02840240|Cleveland Clinic|Fabio Rodriguez|216444-9950|rodrigf3@ccf.org|
22444507|NCT04209426|Medextens SARL|Frederic C Daoud, M.D., M.Sc., Epidemiologist-Biostatistician|+33964281703|fcdaoud@medextens.com|
22444508|NCT04060862|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22444509|NCT03051646|Columbia University Medical Center|Victoria M. Leavitt|212 342 1351|vl2337@cumc.columbia.edu|
22444510|NCT04824365|Emphycorp/Cellular Sciences, inc.|Dr. Alain Martin|9082371561|dr.martin@erols.com|
22444511|NCT01031381|UPMC Cancer Centers|Rita Johnson, Associate Director of Clinical Research Services|412-647-8571|johnsonr1@upmc.edu|
22444512|NCT02694523|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22444513|NCT01058265|Mayo Clinic in Arizona|Larry Bergstrom, MD|480-301-7108|bergstrom.larry@mayo.edu|
22444514|NCT02169284|University of Wisconsin Carbone Cancer Center|Dr. Tracy Downs|608-263-9534|downs@urology.wisc.edu|
22444515|NCT01367119|Mayo Clinic|Dr. Keith G. Rassmussen|507-284-2933|rasmussen.keith@mayo.edu|
22444516|NCT01257802|University of Michigan|W Joseph McCune MD Professor of Rheuntic Diseases University of Michigan|734 936 5560|jmccune@med.umich.edu|
22444517|NCT02964507|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22444518|NCT04341662|University of Birmingham|Dr Adam Devall|+447971823452|a.j.devall@bham.ac.uk|
22444519|NCT02675231|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22444520|NCT00064298|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
22444521|NCT03309046|MemphisVAMC|Dr. Linda Olivia Nichols|901 523-8990|linda.nichols@va.gov|5082
22444522|NCT02764190|Seattle Children's Research Institute|Cari McCarty|206-884-8243|Carolyn.McCarty@seattlechildrens.org|
22444523|NCT00591266|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22444524|NCT03488927|University of Nebraska-Lincoln|Katie Edwards|402-472-2223|katie.edwards@unl.edu|
22444525|NCT03497676|Family Health International (FHI 360)|IMPAACT ClinicalTrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
22444526|NCT01782833|KoreaOtsukaPharma|Jeong, Hyo-Won||jhw0159@otsuka.co.kr|
22444527|NCT02595996|Columbia University Irving Medical Center|June K. Wu, MD|212-342-3704|jw92@cumc.columbia.edu|
22444528|NCT00880165|Philadelphia VA Medical Center|Samuel T. Kuna, MD|215-823-4400|Samuel.Kuna@va.gov|
22444529|NCT00395538|Rho, Inc|Robert James|(919) 595-6468|robert_james@rhoworld.com|
22412106|NCT01031537|Division of Occupational Health and Safety, NIH|Dr. James M. Schmitt|301-496-4411|james_schmitt@nih.gov|
22444530|NCT01074047|Celgene|Anne McClain, Senior Manager Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
22444531|NCT02211638|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22444532|NCT02658097|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Nathan Pennell|1-866-223 8100|TaussigResearch@ccf.org|
22444533|NCT05140382|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22444534|NCT05419908|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22444535|NCT01659658|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22412107|NCT00928954|Case Western Reserve University|R. John Leigh, M.D.|216-844-3190|rjl4@case.edu|
22412108|NCT03238677|Syracuse University|Jonathan Preston|3154433143|jopresto@syr.edu|
22412109|NCT00561730|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com|
22429520|NCT02502383|University of New Mexico Health Sciences|Alberta Kong|505-272-5551|AKong@salud.unm.edu|
22429521|NCT01428713|Baylor College of Medicine/TCH|Dr. Lakshmi Srivaths|832-822-1514|lvsrivat@txch.org|
22429522|NCT00875667|Celgene Corporationi|Anne McClain, Senior Manager, Clinical Trial Disclosure|8882601599|ClinicalTrialDisclosure@Celgene.com|
22429523|NCT02016885|Dermira Inc.|Eugene A. Bauer, MD, Chief Medical Officer|650-421-7202|eugene.bauer@dermira.com|
22429524|NCT00489268|Mayo Clinic, Arizona|David E. Fleischer, M.D.|(480) 301-4461|fleischer.david@mayo.edu|
22429525|NCT01579305|Allergan, Inc.|Medical Monitor|805 961 5000|devicetrials@allergan.com|
22429526|NCT01441414|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22429527|NCT03791060|Beth Israel Deaconess Medical Center|Co-Director Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS)|6176675834|mporter3@bidmc.harvard.edu|
22429528|NCT01011283|Eisai Inc.|Erhan Berrack, M.D.|888-422-4743||
22429529|NCT01717859|UCLA|Veena K. Ranganath|310-825-4321|vranganath@mednet.ucla.edu|
22429530|NCT01814332|San Francisco VA Medical Center|Jennifer Hlavin|415-221-4810|jennifer.hlavin@va.gov|26624
22429531|NCT04389671|Windtree Therapeutics, Inc.|Executive Director of Biostatistics & Data Management|215-488-9300|psimmons@windtreetx.com|
22429532|NCT05987540|Scion NeuroStim, Inc|Robert Black|919-260-5528|bacllc@earthlink.net|
22429533|NCT00122187|VAHSRD|Linda Humphrey|503-220-8262|linda.humphrey@va.gov|57176
22429534|NCT02734147|Christiana Care Health Services|Jamie Rosini, Pharm D|302-733-6364|jrosini@christianacare.org|
22429535|NCT01584388|MGH Rheumatology|John H Stone|617-726-7938|jhstone@partners.org|
22429536|NCT01290731|Janssen Pharmaceutical K.K., Japan|Manager|81 3 44115639||
22429537|NCT01835756|Regulatory Insight, Inc.|Clinical Consultant|615-712-9743|elvira@reginsight.com|
22429538|NCT04246476|Washington University in St. LOuis|Gammon Earhart|3142861407|earhartg@wustl.edu|
22429539|NCT04308694|Duke University|William John, Ph.D.|919-681-7291|william.john@duke.edu|
22429540|NCT02181738|Bristol Myers Squibb|Bristol Myers Squibb Study Director|855-907-3286|Clinical.Trials@bms.com|
22429541|NCT01968317|Obstetrics and Gynecology Hospital of Fudan University|Xiaojun Chen|33189900|xiaojunchen2013@sina.com|
22429542|NCT02216851|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
22444536|NCT01927341|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22429543|NCT00888849|Ethicon Endo Surgery, Inc|Sheryl Helsinger/Clinical Affairs Director|513-337-3079|shelsing@its.jnj.com|
22384409|NCT05005221|University of Michigan|Manjunath Pai|734/647-0006|amitpai@med.umich.edu|
22429544|NCT05064800|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22444537|NCT00674973|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22384410|NCT02525692|Chimerix, Inc.|Chief Medical Officer|919-806-1074|clinicaltrials@chimerix.com|101
22384411|NCT04112316|University of Pennsylvania|Theresa M Scattergood, MSN|215-898-5664|theresa.scattergood@pennmedicine.upenn.edu|
22384412|NCT04455035|The University of Texas Health Science Center at Houston|Brett Chiquet, DDS, PhD, Associate Professor|7135008220|Brett.T.Chiquet@uth.tmc.edu|
22384413|NCT04247542|Acurx Pharmaceuticals, Inc.|Robert J DeLuccia|914-949-3898|rjdeluccia@acurxpharma.com|
22384414|NCT03438188|Perlman School of Medicine, University of Pennsylvania|James Loughead, Ph.D.|215-205-1876|loughead@pennmedicine.upenn.edu|
22384415|NCT05058391|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22384416|NCT02790931|University of Sao Paulo|Isabel de Camargo Neves Sacco|+551130918426|icnsacco@usp.br|
22384417|NCT03697070|Division of Infectious Diseases, University of California Irvine School of Medicine|Dr. Shruti Gohil, MD, MPH|(714) 456-7890|skgohil@hs.uci.edu|
22384418|NCT03833245|University of Utah|Gerald Cochran, PhD|801-213-0799|jerry.cochran@hsc.utah.edu|
22384419|NCT03347383|iD3 Medical|Clinical Research Professional|+32 (0)52252745|office@iD3medical.com|
22384420|NCT04030169|Lykos Therapeutics|Berra Yazar-Klosinski, PhD / Chief Scientific Officer|877-627-7722|trialdata@lykospbc.com|
22384421|NCT04842643|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22384422|NCT03484702|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22384423|NCT02840474|Vaccine Research Center, NIAID, NIH|Martin Gaudinski, MD|(301) 451-8715|martin.gaudinski@nih.gov|
22429545|NCT00629239|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22429546|NCT02508207|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22384424|NCT02278562|VA TN Valley Healthcare System|Alp Ikizler MD|615-322-5000|alp.ikizler@vanderbilt.edu|
22429547|NCT01851369|National Cancer Institute|Dr. Alice P.Chen|2407813320|chenali@mail.nih.gov|
22429548|NCT00183391|Icahn School of Medicine at Mount Sinai|Dr. Jeffrey H Newcorn|212-659-8705|jeffrey.newcorn@mssm.edu|
22429549|NCT00395512|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22429550|NCT01936974|CTCA|Jessica Coats, RN|6232073899|jessica.coats@ctca-hope.com|
22429551|NCT04584554|Duke University School of Nursing|Tolu Oyesanya, PI of study|919-684-5292|tolu.oyesanya@duke.edu|
22429552|NCT00063999|NRG Oncology|Linda Gedeon for Virginia Filiaci, PhD.|716-545-8321|lgedeon@gogstats.org|
22429553|NCT01853085|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22429554|NCT02904356|Baylor College of Medicine|Sameer Sheth, MD, PhD|713-798-4696|sasheth@bcm.edu|
22429555|NCT02497755|University of Washington|Dr. Amy Bauer|206.221.8385|abauer1@uw.edu|
22429556|NCT01895647|Mackay Memorial Hospital|Dr. Kuang-Hua Cheng|886-975837711|jeff01@mmh.org.tw|
22429557|NCT01659541|MetroHealth Medical Center|Anthony F. DiMarco, MD|216-778-3906|afd3@case.edu|
22429558|NCT01222351|Columbia University|Yaakov Stern|212-342-1350|ys11@columbia.edu|
22429559|NCT01482286|Pennington Biomedical Research Center|Dr. Joshua R. Sparks|2257632928|joshua.sparks@pbrc.edu|
22429560|NCT05610267|Integra LifeSciences|Dr. Dennis Adam Young|443 766 2569|dennis.young@integralife.com|
22429561|NCT03983109|Flat Medical Co., Ltd|LI YU LIN|+886 25672959|liyulin@flatmedical.com|16
22429562|NCT05085405|University of Michigan|Dr. Jacob E Kurlander, MD, MS|734-647-9252|jkurland@umich.edu|
22429563|NCT01860404|Children's Hospital of Philadelphia|Dr. Daniel Corwin|215-327-2306|corwind@chop.edu|
22429564|NCT02641353|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22429565|NCT01799278|Weill Cornell Medical College|Dr. Himisha Beltran|(646) 962-2072|GUONC@med.cornell.edu|
22429566|NCT03461861|Medical College of Wisconsin|Dr. Yang Wang|4149555473|yangwang@mcw.edu|
22429567|NCT01928771|AstraZeneca|Mitchell Goldman , Medical Science Director|+1 301 398 0323|Mitchell.Goldman@astrazeneca.com|
22429568|NCT01030900|National Cancer Institute|Dr. Wyndham Wilson|(240) 760-6092|wilsonw@mail.nih.gov|
22429569|NCT00441896|Marinus Pharmaceuticals, Inc.|Marinus|484-801-4670|clinicaltrials@marinuspharma.com|
22429570|NCT01301092|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22429571|NCT03334175|UCSF|Meghana Gadgil|4153537922|meghana.gadgil@ucsf.edu|
22429572|NCT03018730|Protalix Ltd.|Sari Alon|+972-4-9028100|sari@protalix.com|215
22429573|NCT03277274|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
22429574|NCT00004859|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
22429575|NCT03651609|Institute of Clinical Neurophysiology, Division of Neurology, University Medical Centre Ljubljana, Slovenia|Gregor|+38631226546|gregor.omejec@kclj.si|
22429576|NCT03882801|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22429577|NCT03532490|Johns Hopkins University|Gem Roy|4432875796|groy2@jhu.edu|
22429578|NCT03548415|Ionis Pharmaceuticals, Inc|Ionis Pharmaceuticals, Inc|800-679-4747|patients@ionisph.com|
22429579|NCT04605588|Rutgers, The State University of New Jersey|Jeffrey L Carson, MD|732-235-7122|Jeffrey.Carson@Rutgers.edu|
22429580|NCT01230814|University of Arkansas for Medical Sciences|Shelly Lensing, MS|501-686-8203|sylensing@uams.edu|
22429581|NCT01297244|AVEO Pharmaceuticals, Inc.|Chief Medical Officer|857-400-0101|Clinical@aveooncology.com|
22429582|NCT02595749|USC Dept. of Preventive Medicine|Matthew Kirkpatrick|3234428221|mgkirkpa@usc.edu|
22429583|NCT01803737|University of Arizona|David O. Garcia, PhD|520-626-4641|davidogarcia@email.arizona.edu|
22429584|NCT00546273|UTE. Fund. Inst. Germans Trias i Pujol|Cristina Vilaplana, MD|+34 93 497 86 81|cvilaplana@gmail.com|
22429585|NCT00504556|Daiichi Sankyo Inc.|William Maxwell, Assoc. Director|732-590-5000|wmaxwell@dsi.com|
22429586|NCT03558672|Tactile Medical|Director of Clinical Research|612.540.5267|astone@tactilemedical.com|
22429587|NCT03607695|University of Washington|Valerie E. Kelly, PT, PhD|206-598-5350|vekelly@uw.edu|
22429588|NCT01027416|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22429589|NCT02741193|NYU Langone Health|Anli Liu|9294552340|Anli.Liu@nyulangone.org|
22398412|NCT02162732|Penn State Health Children's Hospital|Giselle Sholler, MD|7175310003|gsaulniersholler@pennstatehealth.psu.edu|
22398413|NCT01784965|Stanford Universtiy|Gerald Reaven, Professor Emeritus|650-724-3416|greaven@stanford.edu|
22398414|NCT04580290|Xiros Ltd|Tracey Oxley|07810337555|Tracey.Oxley@xiros.co.uk|
22398415|NCT03757988|University of North Carolina at Chapel Hill|Tonya Elliott|919-966-3915|tonya_elliott@med.unc.edu|
22398416|NCT01087541|Jordi Gol i Gurina Foundation|Cecilia Borau|34 934824617|cborau@idiapjgol.org|
22398417|NCT02450487|Bauru School of Dentistry University of Sao Paulo|Dr. Adriana Calvo|+551432358200|birinjela@yahoo.com.br|
22412110|NCT03194464|VA Northern California Health Care System|Dr. Carolynn Patten (Principal Investigator)|916.724.5029|carolynn.patten@va.gov|
22412111|NCT03803943|Northwestern University|Megan Roberts|(847) 491-3066|megan.y.roberts@northwestern.edu|
22412112|NCT00995410|POZEN|John Fort, MD / Chief Medical Officer|919-913-1030|jfort@pozen.com|
22429590|NCT02320825|Memorial Sloan Kettering Cancer Center|Dr. Ilya Laufer, MD|212-639-2368|lauferi@mskcc.org|
22429591|NCT01045265|Maple Leaf Research|Tony Antoniou|4164657936|tantoniou@smh.toronto.on.ca|
22429592|NCT00676052|GlaxoSmithKline|GSK Response Center|866-435-7343||
22429593|NCT01215240|University of Alberta|Dr. Lindsay Ryerson|780 407 3396|ryerson@ualberta.ca|780
22429594|NCT03926598|Research Scientist|Jiten Chhabra|4048942000|jiten@imtc.gatech.edu|
22429595|NCT02002208|Atopix Therapeutics Limited|Chief Medical Officer|+44 1235 841 522|atopix@atopixtherapeutics.co.uk|
22429596|NCT04366583|Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan|Dr. Huay-Min Wang|+886-7-3422121|hmwang@vghks.gov.tw|2075
22429597|NCT02365064|Sleep and Human Health Institute|Dr. Barry Krakow|(505) 9987204|bkrakow@sleeptreatment.com|
22429598|NCT01282138|Alcon Research|Head, Global Medical Affairs|1-800-862-5266|medinfo@alconlabs.com|
22429599|NCT03737032|University of Pittsburgh Medical Center, Department of Psychiatry|Dr. Erika Forbes|412-383-5438|forbese@upmc.edu|
22429600|NCT00500110|MD Anderson Cancer Center|Quality Assurance Specialist|713-563-1602|caperez@mdanderson.org|
22429601|NCT00605657|NIAID|V. Koneti Rao, MD|301-496-6502|korao@niaid.nih.gov|
22429602|NCT02284854|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22444538|NCT00451451|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
22444539|NCT00763048|Colgate Palmolive Co.|William Devizio|732-878-7901|William_Devizio@colpal.com|
22444540|NCT00084838|Dana-Farber Cancer Institute|Mark Kieran|(617) 632-4907|mark_kieran@dfci.harvard.edu|
22444541|NCT00518687|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22444542|NCT00695578|Wake Forest University Health Sciences|Steve Feldman MD|336-716-3775|sfeldman@wakehealth.edu|
22444543|NCT01442038|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22444544|NCT00089284|Northwestern University|Clinical Research Office Administrator|312-695-1301|cancertrials@northwestern.edu|
22444545|NCT00137631|Department of Human Development, State University of New York at Binghamton|Leo Wilton, PhD|607-777-9215|lwilton@binghamton.edu|
22444546|NCT02611960|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22444547|NCT01092507|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22444548|NCT04839146|Radboudumc|Benjamin Mordmüller (Principal investigator)|+31 (0)24 3619499|benjamin.mordmueller@radboudumc.nl|
22384425|NCT05114460|New York State Psychiatric Institute|Jermaine Jones PhD: Research Scientist/Associate Professor|646 774-6113|jermaine.jones@nyspi.columbia.edu|
22384426|NCT04638998|University of Alabama at Birmingham|Dr. Jarred Younger|205-975-5821|youngerlab@uab.edu|
22384427|NCT03262779|Yale School of Medicine|Scott Gettinger, MD|(203) 200-5864|scott.gettinger@yale.edu|
22384428|NCT03713086|CureVac|CureVac SE|+49 (0) 697680587-0|clinicaltrials@curevac.com|
22384429|NCT02784509|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|225.763.2500|amanda.staiano@pbrc.edu|
22384430|NCT05374837|Rutgers School of Public Health|Shauna Downs|973-972-7212|sd1081@sph.rutgers.edu|
22384431|NCT03841669|AdventHealth Research Institute|Dr. Kirk I. Erickson|4125763724|Kirk.Erickson@adventhealth.com|
22384432|NCT05406921|AMGA|Elizabeth Ciemins, PhD, SVP Research|4062813275|eciemins@amga.org|
22384433|NCT04299009|Pittsburgh VA Healthcare System|Isabella Soreca|412 3606815|Isabella.Soreca@va.gov|
22384434|NCT04831281|Athira Pharma|Dr. Javier San Martin, CMO|1-866-725-0930|clinicaltrials@athira.com|
22384435|NCT02249949|Georgetown University|Michael J. Pishvaian, MD, PhD|202-444-2144|pishvaim@georgetown.edu|
22384436|NCT04414644|University of Pennsylvania|Kelly Allison, PhD|215-898-2823|kca@pennmedicine.upenn.edu|
22384437|NCT02097420|Abbott|Vinny Podichetty, Clinical Program Director|+1 779-209-9425|vinny.podichetty@abbott.com|
22384438|NCT05059262|Deciphera Pharmaceuticals, LLC|Clinical Trials|785-830-2100|clinicaltrials@deciphera.com|
22384439|NCT02312960|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22384440|NCT05106257|Rush University Medical Center|Amanda R. Mathew, PhD|(312 563-1273|amanda_mathew@rush.edu|
22384441|NCT05691309|Children's Hospital of Philadelphia|Dr. Kevin Downes|215-590-4024|downeskj@chop.edu|
22384442|NCT03131648|LEO Pharma A/S|Disclosure|+45 44945888|disclosure@leo-pharma.com|
22384443|NCT01707030|Department of Veterans Affairs|Dr. Micheal Cucciare|501-257-1068|Michael.Cucciare@va.gov|
22384444|NCT02724878|Dana-Farber Cancer Institute|Toni Choueiri|617-632-5456|toni_choueiri@dfci.harvard.edu|
22384445|NCT04301778|Sidney Kimmel Cancer Center at Johns Hopkins|Lei Zheng, MD PhD|646-239-3110|Lzheng6@jhmi.edu|
22384446|NCT04263311|NYU Langone Health|Jennifer Zanowiak|(646) 501-3502|Jennifer.Zanowiak@nyulangone.org|
22384447|NCT04838613|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
22384448|NCT04757610|Opthea Limited|Chief Officer|+61 (0) 3 9826 0399|info@opthea.com|
22384449|NCT03113422|Dana-Farber Cancer Institute|Mr Opeyemi Jegede|(617) 582-7613|ojegede@jimmy.harvard.edu|
22384450|NCT06207058|Tricore|Medical Director|505-938-8461|michael.crossey@tricore.org|
22384451|NCT00951379|University of Texas (UT) MD Anderson Cancer Center|University of Texas MD Anderson Phase I/II Prevention Consortium||CR_Study_Registration@mdanderson.org|
22384452|NCT03432858|WellSpan Health|Clinical Research Associate|(717) 851-7634|cbush@wellspan.org|
22384453|NCT04277936|Vanderbilt University Medical Center|Stephan Heckers|6159222665|stephan.heckers@vumc.org|
22384454|NCT03169894|Avalo Therapeutics, Inc.|Garry Neil, MD|908-720-2691|gneil@avalotx.com|
22384455|NCT03580369|Novartis Pharmaceuticals|Study Director|1 (862) 778-8300|novartis.email@novartis.com|
22384456|NCT00084552|Fox Chase Cancer Center|Eric Horwitz|215-728-2995|Eric.Horwitz@fccc.edu|
22384457|NCT03448458|Emory University|Mehmet Asim Bilen, MD|404-778-1900|mehmet.a.bilen@emory.edu|
22384458|NCT05239039|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22384459|NCT03690206|Zealand Pharma A/S|Head of clinical operations|+45 8877 3600|info@zealandpharma.com|
22384460|NCT04774380|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22384461|NCT05511467|Medical University of South Carolina|Principal Investigator|(843) 792-3435|heisek@musc.edu|
22384462|NCT03819686|Emory University|Dr. Kimberly Jacob Arriola|404)-727-2600|kjacoba@emory.edu|
22384463|NCT06143670|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
22384464|NCT04563793|Boston Scientific Corporation|Sr. Director, Clinical Operations|855-213-9890|BSNClinicalTrials@bsci.com|
22384465|NCT00837369|University of Nebraska Medical Center|Thomas Porter|402-559-5151|trporter@unmc.edu|
22384466|NCT03625882|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22384467|NCT05343390|University of North Carolina at Chapel Hill|Nora E. Rosenberg, PhD|(919) 966-3761|nrosenbe@email.unc.edu|
22384468|NCT05806788|UT Health San Antonio|Dr. Lisa Smith Kilpela|210-450-8121|kilpela@uthscsa.edu|
22384469|NCT00739648|Horizon Pharma USA, Inc.|Jeffery Nieves, PharmD, Senior Director||clinicaltrials@horizonpharma.com|
22384470|NCT05110495|University of Oxford|Dr Simon Lord|01865 227212|simon.lord@oncology.ox.ac.uk|
22384471|NCT04173663|Vanderbilt University Medical Center|Julie Lounds Taylor, PhD, principal investigator|615-343-5659|julie.l.taylor@vumc.org|
22384472|NCT03604263|Medtronic CRHF|Krestyn Thomas|6123236613|krestyn.j.thomas@medtronic.com|
22384473|NCT03931291|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
22384474|NCT04847544|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
22384475|NCT04716634|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22384476|NCT04833777|University of Saskatchewan|Dr. David Sauder|306-955-9800|sauderdave@gmail.com|
22384477|NCT03636503|Dana-Farber Cancer Institute|Caron Jacobson, MD|617-632-6404|caron_jacobson@dfci.harvard.edu|
22384478|NCT03089398|Icahn School of Medicine at Mount Sinai|Dr. Emilia Bagiella|212-659-9580|emilia.bagiella@mountsinai.org|
22384479|NCT00579124|Children's Hospital of Philadelphia|Patricia Hankins|215 590 5168|hankinsp@chop.edu|
22384480|NCT03818191|Mayo Clinic|Victor Karpyak, MD, PhD|(507)284-8891|karpyak.victor@mayo.edu|
22384481|NCT04820855|University of New Mexico Health Sciences Center|Dr. Angela Dao|5059678428|angela.dao@gmail.com|
22384482|NCT04838262|The University of Texas at Arlington|Dr. Jody Greaney|8172727891|jody.greaney@uta.edu|
22384483|NCT02927769|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22384484|NCT04179149|Ponce Research Institute, Ponce Health Sciences University|Dr. Idhaliz Flores|787-840-2575|iflores@psm.edu|2206
22384485|NCT01253824|Nobelpharama|Department director of clinical development department 1|+81-23-5651-1177|murakami@nobelpharma.co.jp|
22384486|NCT05524233|Baylor College of Medicine|Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
22384487|NCT05272852|BostonScientific|Karin Froidcourt|+0032471636566|Karin.Froidcourt@bsci.com|
22384488|NCT02307565|James J Peters VAMC|Dr. Jill Wecht|718-584-9000|jm.wecht@va.gov|3122
22384489|NCT00650104|GlaxoSmithKline|GSK Response Center|866-435-7343||
22384490|NCT03436745|National Cancer Institute|William D. Figg, Pharm.D.|240-760-6179|figgw@mail.nih.gov|
22384491|NCT03661840|University of Colorado Hospital|Elissa Kolva, MD|7208488090|elissa.kolva@va.gov|
22384492|NCT00792636|GlaxoSmithKline|GSK Response Center|866-435-7343||
22384493|NCT05849051|UNC Lineberger Comprehensive Cancer Center|Adam O Goldstein|919-270-6491|AOG@med.unc.edu|
22384494|NCT05873751|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22384495|NCT06064916|Berkeley Eye Center|Tetiana Huff|713-620-7640|tetiana.huff@berkeleyeye.com|
22384496|NCT01772472|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22384497|NCT02697136|Abionyx Pharma|Constance Peyrottes|+33673045380|cpeyrottes@abionyx.com|
22384498|NCT03295734|UAB|Thomas W. Buford, PhD|205-996-3008|twbuford@gmail.com|
22384499|NCT04391894|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
22384500|NCT01889199|University of California, Los Angeles|Daniel A. Dumesic, MD|310-794-5542|DDumesic@mednet.ucla.edu|
22398418|NCT04269395|Galderma|Clinical Operations|8179615000|Clinical.Studies@galderma.com|1
22398419|NCT05587296|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22398420|NCT03560752|City of Hope|Dr. Ryotaro Nakamura|626-359-8111|rnakamura@coh.org|
22398421|NCT02847624|Pharmacovigilance Department Otsuka Pharmaceutical Co., Ltd|Investigator in charge|+81-6-6943-7722|komaniwa.satoshi@otsuka.jp|
22398422|NCT04735653|University of Michigan Medical School|Dr. Paula Anne Newman-Casey|734-763-6967|panewman@med.umich.edu|
22398423|NCT03142321|Washington University School of Medicine GI Division|Dr. Parakkal Deepak|3143623201|nixd@wustl.edu|
22398424|NCT04589988|Washington University in St. Louis|Dr. Susy Stark|3142734114|sstark@wustl.edu|
22398425|NCT01202656|Center for Human Reproduction|Dr. David Barad|212 994-4400|dbarad@theCHR.com|
22398426|NCT04161495|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
22398427|NCT01262846|University of Pennsylvania|Pablo Tebas|215-6626932|pablo.tebas@uphs.upenn.edu|
22398428|NCT00252057|Boston Medical Center|Brian Jack PI|617-414-44675|brian.jack@bmc.org|
22398429|NCT02926209|GI View Ltd.|CEO, Dr. Tal Simchony|+97235753199|tal@giview.com|
22398430|NCT00429858|University of California, San Francisco|Dr. Andrew Ko, MD|(415) 353-7286|Andrew.Ko@ucsf.edu|
22398431|NCT01587079|Pearl Therapeutics, Inc|Colin Resiner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com|
22398432|NCT01764633|Amgen Inc.|Study Director|866-572-6436||
22398433|NCT02268058|McMaster Children's Hospital|Dr. Tina Petrelli|905-521-2100|petrelli@hhsc.ca|75162
22398434|NCT04142983|GCAM / Biomat USA - Grifols|Center Medical Director|956-729-7677|laredomedical@gcamplasma.com|
22398435|NCT04781816|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22398436|NCT02123485|Department of Affective Disorder, Aarhus University Hospital, Denmark|Dr Poul Erik Buchholtz|21474299|Buchholtz.Hansen@ps.rm.dk|
22398437|NCT03545906|University of Rochester|Dr. Jill Halterman|5852755798|jill_halterman@urmc.rochester.edu|
22398438|NCT04372927|University of Washington School of Medicine|Dr. Jing Zeng|206-598-4115|jzeng13@uw.edu|
22398439|NCT03423342|University of Washington|Dr. Kevin O'Brien, Study PI|206-529-7802|cardiac@uw.edu|
22412113|NCT03594123|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22444549|NCT00351000|Massachusetts General Hospital Schizophrenia Research Program|Dr. David Henderson|(617) 912-7800|dchenderson@partners.org|
22444550|NCT00085709|SWOG Statistical Office|SWOG Leukemia Statistician|206-667-4408||
22444551|NCT04131556|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22444552|NCT01229371|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
22444553|NCT04622735|Unither Pharmaceuticals|Non Clinical & Clinical Project Manager|+33 (0)1 44 63 51 78|clinicaltrials@unither-pharma.com|
22384501|NCT02323321|TransMedics Inc.|Laura Damme|9785520900|ldamme@transmedics.com|
22384502|NCT00446225|Fundación GECP|Eva Pereira|+34934302006|epereira@gecp.org|
22384503|NCT05633407|argenx BV|Regulatory Manager|+32 93103400|regulatory@argenx.com|
22384504|NCT05741489|Emory University|Dr. Guillermo E. Umpierrez|(404) 778-1663|geumpie@emory.edu|
22384505|NCT02500758|Universidad Complutense de Madrid|Dr. Ricardo Becerro de Bengoa Vallejo|914590409|ribebeva@enf.ucm.es|
22444554|NCT05314478|Liverpool University Hospitals NHS Foundation Trust|Dr Tristan Payne|01517064553|tristan.payne@liverpoolft.nhs.uk|
22444555|NCT03288454|Apollo Investment Management|Scientific Advisor|+352 2088 1301|rchari@kaiperheathcare.com|
22444556|NCT00145600|St. Jude Children's Research Hospital|Jamie Flerlage, MD|1-866-278-5833|info@stjude.org|
22444557|NCT00842764|Department of Otolaryngology/UCI|Brian J Wong, MD, PhD|7144565753|bjwong@uci.edu|
22444558|NCT01742936|Nationwide Children's Hospital|Vidya Raman, MD|614-722-4200|Vidya.Raman@nationwidechildrens.org|
22444559|NCT00736879|Clinical Trial Transparency|AstraZeneca||Clinical.Trial.Transparency@astrazeneca.com|
22444560|NCT03090412|Roswell Park Comprehensive Cancer Center|Katy Wang|716-845-6269|Chong.Wang@roswellpark.org|
22444561|NCT00718302|Boston Medical Center|Paul Tornetta, III, MD|617-414-6295|tornetta@bu.edu|
22444562|NCT01684020|DeNova Research|Steven Dayan, MD|3123352070|sdayan@drdayan.com|
22444563|NCT03583164|F2G Ltd|Daniela Zinzi|43 664 3582281|dzinzi@f2g.com|
22444564|NCT01952600|Arbor Research Collaborative for Health|Dr. Francesca Tentori|7346654108|francesca.tentori@arborresearch.org|
22444565|NCT01880047|Weill Cornell Medicine|Sujit Sheth|2126463400|shethsu@med.cornell.edu|
22444566|NCT02869438|AstraZeneca|Ubaldo Martin, Global Clinical Lead Benralizumab|+1 301 398 0163|Ubaldo.Martin@astrazeneca.com|
22444567|NCT01601431|Baylor College of Medicine|Mohamed Othman, M.D.|713 798 0947|mohamed.othman@bcm.edu|
22444568|NCT02343081|FLENI- mrc (FLENI Multi-specialty Research Center)|Dr. Alejandro Muggeri (Principal Investigator)|54-11-5777 3200|alemuggeri@hotmail.com.ar|2020
22444569|NCT01680887|Perelman School of Medicine|Kyle Kampman|215 746 2764|kampman@pennmedicine.upenn.edu|
22444570|NCT00573248|University of California, Irvine|Jean Gehricke, Ph.D.|949-824-1834|jgehrick@uci.edu|
22444571|NCT05323656|Calliditas Therapeutics AB|Head of Clinical Operations|+4684113005|info@calliditas.com|
22444572|NCT03880461|Kaiser Permanente Northern California|Monique Hedderson, Ph.D.|925-520-0785|monique.m.hedderson@kp.org|
22444573|NCT04847622|Research Organisation King's Cross (KC) Ltd.|Toni Sobande, Clinical Project Manager|447494 795 982|toni.sobande@rokcservices.com|
22444574|NCT03953183|Philip Morris Products S.A.|Christelle Haziza|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
22444575|NCT03839082|University of California Los Angeles|Monica Tincopa|310 825-2631|mtincopa@mednet.ucla.edu|
22444576|NCT00645710|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22444577|NCT03367247|Dana-Farber Cancer Institute|Dr. Alexi Wright|617-632-2334|alexi_wright@dfci.harard.edu|
22444578|NCT01115803|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22444579|NCT03063203|Washington University School of Medicine|John Welch, M.D., Ph.D.|314-362-2626|jwelch@wustl.edu|
22444580|NCT04718103|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22444581|NCT02273739|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22444582|NCT01879540|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22444583|NCT02280473|Allergan plc|Michael Robinson|1-714-246-6415|Robinson_Michael@Allergan.com|
22444584|NCT02393690|Academic and Community Cancer Research United (ACCRU)|Alan Ho, M.D.|212-639-7202|hoa@mskcc.org|
22444585|NCT05298306|Lateral Pharma|Dr Stuart Mudge|+61424588904|sm@lateral-pharma.com|
22444586|NCT01482351|George Mason University|Dr. Kathy C. Richards|(703) 946-3725|kricha11@gmu.edu|
22444587|NCT05080660|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
22444588|NCT00237185|Novartis|Study Director|862-778-8300||
22444589|NCT02204007|Cleveland Clinic Foundation|Dr. Carlos A Higuera, MD|2166361136|higuerc@ccf.org|
22444590|NCT03194490|Loma Linda University|Dr. Everett Lohman III|(909) 558-4632|elohman@llu.edu|83171
22444591|NCT03911843|Azienda Ospedaliero-Universitaria di Novara, Italy|Dr. Francesco Cadario, Head of the Pediatric Diabetology service|+39 347 226 6507|francesco.cadario@gmail.com|
22444592|NCT02865343|Harvard Medical School|Dr J. Andrew Taylor|6177585503|jandrew_taylor@hms.harvard.edu|
22444593|NCT02059005|Treatment Research Institute|Adam Brooks, PhD|215-399-0980|abrooks@tresearch.org|128
22444594|NCT02153710|University of Washington|Diane Kendall|2066160537|dkendall@uw.edu|
22444595|NCT02750943|GlaxoSmithKline|GSK Response Center|866-435-7343||
22444596|NCT00171054|Novartis Pharmaceuticals|Study Director|862-778-8300||
22444597|NCT04597918|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22444598|NCT00990938|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
22444599|NCT01069185|Pablo Tobon Uribe Hospital|Dr.Jorge Donado Research Unit Chief|+574459753|jdonado@hptu.org.co|
22444600|NCT04382755|UZ Gent|Anja Delporte|+3293320228|anja.delporte@uzgent.be|
22444601|NCT02900560|Translational Research In Oncology (TRIO)|Director, Project Management|33 158 10 09 09|026@trioncology.org|
22384506|NCT00220740|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
22444602|NCT04041700|Cochlear|Johan Blechert|+46766498632|jblechert@cochlear.com|
22444603|NCT03120624|Mayo Clinic|Jamie N Bakkum-Gamez MD|507-284-2511|bakkum.jamie@mayo.edu|
22444604|NCT06120777|Masimo Corporation|Ahmed Alghazi|949-297-7000|studies@masimo.com|
22444605|NCT01711372|CogCubed|Dr Monika Roots, Chief Medical Officer|6173082009|monika@cogcubed.com|
22444606|NCT01104701|Clinical Trial Transparency|AstraZeneca||ClinicalTrialTrasparency@astrazeneca.com|
22444607|NCT00891462|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22444608|NCT00423722|UT MD Anderson Cancer Center|Dr. Eduardo Bruera, MD / Professor|713-792-6085|ebruera@mdanderson.org|
22384507|NCT01057433|Kowa Research Institute, Inc.|Roger Morgan, MD, FACS|919-433-1600|RMorgan@KowaUS.com|
22384508|NCT02345720|Johnson & Johnson Vision Care Inc.|Tom Karkkainen, OD, MS, FAAO|904-443-3500|TKarkkai@its.jnj.com|3402
22384509|NCT01762059|Massachusetts General Hospital|Dr. Steven J. Russell|617-726-1848|sjrussell@mgh.harvard.edu|
22384510|NCT04854096|NS Pharma, Inc.|Medical Affairs|+1-201-986-3860|trialinfo@nspharma.com|
22384511|NCT06155721|Badalona Serveis Assistencials|Jose Ferrer Costa|+34 937407482|jfcosta@bsa.cat|
22398440|NCT00883246|Medtronic|Clinical Program Manager|763-398-7000|michael.p.swierzewski@medtronic.com|
22398441|NCT01847885|SPR Therapeutics|Clinical Affairs|216-378-9108|support@SPRTherapeutics.com|
22398442|NCT03104725|National Institutes of Health/NINDS|Dr. David Goldstein|301-496-2103|goldsteind@ninds.nih.gov|
22398443|NCT00470600|Cumberland Pharmaceuticals|Amy Rock, Ph.D.|615-255-0068|arock@cumberlandpharma.com|
22398444|NCT05130463|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
22398445|NCT02065154|UAB|Omer Jamy|205-934-9294|omerjamy@uabmc.edu|
22398446|NCT03652662|MUSC|Sarah Miller, PhD, RN|8427921692|millesar@musc.edu|
22444609|NCT00215683|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
22444610|NCT00414271|Johns Hopkins Singapore|Prof Alex Chang|+65 68802220|alexchang@imc.jhmi.edu|
22444611|NCT02437513|Protip Medical|Linda Nicolini CEO|0033388103068|l.nicolini@protipmedical.com|
22444612|NCT00595465|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar-kastner@intercell.com|1175
22444613|NCT00107783|NHGRI|William Gahl, MD/Clinical Director|301-402-2739|gahlw@mail.nih.gov|
22444614|NCT01298531|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22444615|NCT00422097|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22444616|NCT02360995|Loma Linda University School of Dentistry|Yiming Li, DDS|909-558-8069|yli@llu.edu|
22444617|NCT02476422|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22444618|NCT00994318|Vifor Pharma|Medical Information|41 58 851 8222|medinfo@viforpharma.com|
22444619|NCT04157621|MUSC|Vanessa Hinson|843-876-0829|hinsonvk@musc.edu|
22444620|NCT03960554|Columbia University Irving Medical Center|Thomas L. Nickolas MD|212-305-5020|tln2001@cumc.columbia.edu|
22444621|NCT02545075|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22444622|NCT00093782|Princess Margaret Cancer Centre|Dr. Lillian Siu|416-946-2911|lillian.siu@uhn.ca|
22444623|NCT02563990|University of Miami|Andres Missair|3055857037|amissair@miami.edu|
22444624|NCT02751788|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|225.763.2500|amanda.staiano@pbrc.edu|
22444625|NCT00735254|Arizona Dermatology and Cosmetic|Edward Galiczynski, MD|(602) 277-1449|egaliczynski@arizonaderm.com|
22444626|NCT06400979|University of California, Davis Medical Center|Carolyn Mofidi, RN-BC, BSN, MS-L|(916) 734-3333|cmofidi@ucdavis.edu|
22444627|NCT04865640|"Medical Products Group | Analog Devices Inc."|Tony Akl|781-937-1665|tony.akl@analog.com|
22444628|NCT00559936|Massachusetts Eye and Ear Infirmary|Dr. Reza Dana|617-573-3313|cornea_research@meei.harvard.edu|
22444629|NCT01417936|Symphogen A/S|Chief Scientific Officer|+45 8838 2600|info@symphogen.com|
22444630|NCT00925990|Conatus Pharmaceuticals Inc.|Vice President, Clinical Development|858-457-7227|mhuyghe@conatuspharma.com|
22444631|NCT06207435|University of Pennsylvania|Dr. Farouk Dako|2673091241|farouk.dako@pennmedicine.upenn.edu|
22444632|NCT00750880|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22444633|NCT00835159|NYU Langone Medical Center|ALEXANDER ZASLAVSKY|212-263-5569|michael.haile@nyumc.org|
22444634|NCT00277446|Northwestern University|Lewis J. Smith|312-503-0501|ljsmith@northwestern.edu|
22444635|NCT01336296|UCincinnati|Research Associate Professor|5135852145|adele.rike@uc.edu|
22444636|NCT00249288|Schizophrenia Program, Massachusetts General Hospital|Michelle Hill|617-912-7846|michelehill1@gmail.com|
22444637|NCT03091777|Gage Development Company|Gage Development Company|1-847-999-0600|clinicalinfo@capstonedevservices.com|
22444638|NCT02536833|Samumed|Christopher Swearingen, PhD, VP of Clinical Outcomes and Analytics|858.926.2952|chris@samumed.com|
22444639|NCT00089674|Amgen Inc.|Study Director|866-572-6436||
22444640|NCT01437878|Actelion Pharmaceutical Ltd|Maziar Assadi Gehr|+41 61 565 5525|maziar.assadi-gehr@actelion.com|
22444641|NCT01490788|Tonix Pharmaceuticals, Inc.|Greg Sullivan, MD||greg.sullivan@tonixpharma.com|
22444642|NCT01476644|Wills Eye Hospital, Glaucoma Research Center|George L. Spaeth, MD|215-928-3123|gspaeth@willseye.org|
22444643|NCT04105543|University of Wisconsin Carbone Cancer Center|Justine Bruce, MD|(608) 262-4961|jybruce@medicine.wisc.edu|
22444644|NCT01462227|Yale University|Robert Stanley Sherwin, MD|203 737 1932|robert.sherwin@yale.edu|
22444645|NCT00979069|Atlanta VAMC|Dr. Joe Nocera|404 321 6111|joe.nocera2@va.gov|6354
22444646|NCT00586066|Massachusetts General Hospital|Andrew Nierenberg, Principal Investigator|6177240837|anierenberg@partners.org|
22444647|NCT00144027|Central Arkansas Veterans Healthcare System|Jeff Pyne|501-257-1083|jeffrey.pyne@va.gov|
22444648|NCT00910988|Washington University|Julie Schweiger/Michael Yingling|3143623153/5735791412|schweigj@psychiatry.wustl.edu/yinglinm@psychiatry.wustl.edu|
22444649|NCT01977937|OHSU|Dr Elizabeth Pedigo|5039705211|pedigo@ohsu.edu|
22444650|NCT00322101|Fred Hutchinson Cancer Research Center|Bart Lee Scott|206-667-1990|bscott@fhcrc.org|
22444651|NCT02819518|Merck Sharp & Dohme LLC.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22444652|NCT02766465|The Emmes Company, LLC|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
22384512|NCT00593489|Lawson Research Institute|Dr. Stewart Harris|519 858-5028|sharris1@uwo.ca|
22384513|NCT00715884|Cordis|Amy Orlick, Associate Director Clinical Research|908-541-4347|AOrlick@its.jnj.com|
22384514|NCT03930342|Washington State University|Michael McDonell|509 368-6967|mmcdonell@wsu.edu|
22384515|NCT02742519|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22384516|NCT00620698|Beth Israel Deaconess Medical Center|Seward Rutkove|617-667-8130|srutkove@bidmc.harvard.edu|
22384517|NCT01011946|University of Chicago|Dr. Daniel Appelbaum|(773) 834-2012|dappelbaum@radiology.bsd.uchicago.edu|
22384518|NCT02057939|Duke University|Andrew Armstrong, MD ScM|919-668-4615|andrew.armstrong@duke.edu|
22384519|NCT03527160|Cincinnati Children's Hospital Medical Center|Dr. Stuart Goldstein|513-636-2209|stuart.goldstein@cchmc.org|
22384520|NCT00766649|National Eye Institute|Wai T. Wong|(301) 905-7301|wongw@nei.nih.gov|
22384521|NCT01721291|Imperial College London|Dr Omar Usmani|+440(0) 207351 8051|o.usmani@imperial.ac.uk|
22444653|NCT01505647|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22444654|NCT01907100|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22444655|NCT01758289|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22444656|NCT01574079|University of Mississippi Medical Center|Principle investigator|601-984-6369|lbarnes@umc.edu|
22444657|NCT00908011|St. Paul's Hospital/University of B.C.|Dr. Greg Bondy|604-806-8192|gbondy@providencehealth.bc.ca|
22444658|NCT00843726|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|7168451300|adrienne.groman@roswellpark.org|
22444659|NCT00667602|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22444660|NCT03374631|The University of Texas at Dallas|Dr. Amy Pinkham|(972) 883-4462|amy.pinkham@utdallas.edu|
22444661|NCT04808999|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MSCCR, CCRP, Clinical Research Manager|4126475554|stadtermanbm@upmc.edu|
22444662|NCT03640559|Pharmasyntez|Mikhail Shurygin|+7 3952 550 355|m.shurygin@pharmasyntez.com|189
22444663|NCT01436162|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22444664|NCT02567552|IVI Barcelona|Evelin Lara Molina|+34 93 531 63 00|Evelin.Lara@ivi.es|27503
22444665|NCT02745210|Loma LInda University Medical Center|Brenda Bartnik Olson|1-909-558-4000|BBartnik@llu.edu|85216
22444666|NCT05032859|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
22444667|NCT04669535|UMass Chan Medical School|Dr. Terence Flotte|508-856-8992|terry.flotte@umassmed.edu|
22444668|NCT01876810|Centre for Addiction and Mental Health|Bernard LeFoll|416-535-8501|bernard.lefoll@camh.ca|34772
22444669|NCT01298544|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22384522|NCT01091168|INSTITUT DE RECHERCHE PIERRE FABRE|Dr Karim Keddad|+33 5 34 50 61 69|karim.keddad@pierre-fabre.com|
22384523|NCT03978637|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22384524|NCT01959698|Roswell Park Comprehensive Cancer Center|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
22384525|NCT05792423|MGH|Anthony Samir|6176432009|asamir@mgh.harvard.edu|
22384526|NCT03747484|Fred Hutchinson Cancer Center|Joshua Veatch|206.667.5108|jveatch@fredhutch.org|
22384527|NCT05549726|UCSF|Tamara Clark|415-517-3444|tamara.clark@ucsf.edu|
22384528|NCT02387853|LEO Pharma A/S|Clinical Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
22384529|NCT03744936|Mayo Clinic|Dr. Victor Montori|507-284-1920|montori.victor@gmail.com|
22384530|NCT04272619|Fox Chase Cancer Center|Kristen Sorice|215-214-1433|kristen.sorice@fccc.edu|
22384531|NCT05418296|Mentia|Dr Mandy Salomon|4156326872|mandy@mentia.me|
22384532|NCT03101904|Bangor Univeristy|Dr Jamie Hugo Macdonald|+44 1248 38|j.h.macdonald@bangor.ac.uk|3272
22384533|NCT04538417|University of Utah Orthopaedic Center/ Physical Medicine & Rehabilitation|Zachary McCormick, MD|801-587-1493|u6014808@umail.utah.edu|
22384534|NCT05693610|Northwestern University|Varsha Rallapalli|847-467-0897|varsha8904@gmail.com|
22384535|NCT04703322|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22384536|NCT01180634|Horizon Pharma USA, Inc.|Medical Monitor|1-866-479-6742|medicalinformation@horizontherapeutics.com|
22384537|NCT04419168|University of Pittsburgh|Dr. Charles Jonassaint|412-586-9850|cjonassaint@pitt.edu|
22384538|NCT05595629|Women & Infants Hospital of Rhode Island|Adam Lewkowitz|401-274-1122|alewkowitz@kentri.org|
22384539|NCT04640961|Anika Therapeutics|Kara Mezger, Executive Director Clinical Affairs|781.457.9000|kmezger@anika.com|
22429603|NCT00662038|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22429604|NCT00397046|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
22429605|NCT01368185|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22429606|NCT01975285|Department of Anesthesiology at Cedars-Sinai Medical Center in Los Angeles|Roya Yumul, M.D., Ph.D.|310-423-5841|(Roya.Yumul@cshs.org)|
22429607|NCT04535362|Yale School of Medicine|Mehmet Sofuoglu, MD, PhD: Professor of Psychiatry; Director of VA New England Mental Illness Researc|(203) 937-4809|mehmet.sofuoglu@yale.edu|
22429608|NCT04863807|Imperial College Healthcare NHS Trust|Dr Alex Wickham|+4420233121248|alex.wickham@nhs.net|
22444670|NCT03173534|Cleveland Clinic|Samir Kapadia, MD Chairman Cardiovascular Medicine|216 444-6735|KAPADIS@ccf.org|
22444671|NCT02037607|Indiana University|Heather Cero, Research Nurse Manager|317-396-1298|hcero@iupui.edu|
22398447|NCT00487539|Janssen Research & Development|Senior Director|215-793-7540||
22398448|NCT02751502|NYU Langone Health|Renat Sukhov, MD|347-377-5138|Renat.Sukhov@nyulangone.org|
22398449|NCT02925156|Loyola University Chicago|Amy Luke, Ph.D.|(464) 220-9243|aluke@luc.edu|
22398450|NCT01844895|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22398451|NCT01318109|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
22398452|NCT06485479|UNC|Principal Investigator|(919) 966-3282|ntb@unc.edu|
22398453|NCT06142643|Kylane Laboratoires|Basste Hadjab, Sponsor|0225889611|compliance@kylane.com|
22398454|NCT04982250|Fred Hutchinson Cancer Center|Katrina F Ortblad, ScD, MPH|2066677267|kortblad@fredhutch.org|
22398455|NCT04685876|University of Texas, Houston|Dr. Alparslan Turan|713-500-6279|Mehmet.A.Turan@uth.tmc.edu|
22398456|NCT04338009|University of Pennsylvania|Dr. Jordana Cohen|215-662-4000|jco@pennmedicine.upenn.edu|
22398457|NCT03963011|Children's Mercy Hospital|Erin Opfer, DO|816-324-3273|ekopfer@cmh.edu|
22398458|NCT02926950|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
22398459|NCT03845582|Alkeus Pharmaceuticals, Inc.|Meena Venugopal|877-255-7476|mvenugopal@alkeus.com|
22398460|NCT02028455|Seattle Children's Therapeutics|Dr. Colleen Annesley|206-987-7122|ICC-PLAT@seattlechildrens.org|
22398461|NCT07099521|South China Normal University|Dr. Yuanyuan Wang|+86 13076729124|angelayuanyuanwang@gmail.com|
22398462|NCT02392429|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22444672|NCT00458536|Beth Israel Deaconess Medical Center|David Avigan, MD|617-667-9920|davigan@bidmc.harvard.edu|
22444673|NCT00285207|TigrisPharmaceuticals|Chief Medical Officer||info@tigrispharma.com|
22444674|NCT02160782|Mirum Pharmaceuticals|Mirum Clinical Trials|1 650-667-4085|medinfo@mirumpharma.com|
22444675|NCT00729924|Vanderbilt University|David W. Haas, MD|615-936-8594|david.w.haas@vanderbilt.edu|
22444676|NCT00413400|Massachusetts General Hospital|Steven K. Grinspoon|617-724-9109|sgrinspoon@partners.org|
22444677|NCT04382391|Allegheny Health Network (AHN)|Tariq Cheema, MD, Vice President and Medical Director AHN Research Institute|412-321-3344|tariq.cheema@ahn.org|
22444678|NCT01083485|Mundipharma Research|Maggie Wilson|+ 4401223 424444||2303
22444679|NCT02171065|Lund University|Principal Investigator: David Erlinge, MD, PhD|+46-733746165|david.erlinge@gmail.com|
22444680|NCT00683085|Research Hospital, The Institute of Medical Science, The University of Tokyo|Hitomi Nagayama, M.D., Ph.D. / Project Lecturer|+81-3-3443-8111|zephyrus@ims.u-tokyo.ac.jp|
22444681|NCT00851630|Duke University Medical Center|Dr. Nathan Thielman|919-6687174|n.thielman@duke.edu|
22444682|NCT01956435|University of Texas at Austin Medical School and Seton Family of Hospitals|Ammar Ahmed, MD|512-504-0855|amahmed@seton.org|
22444683|NCT00931879|Eastern Virginia Medical School|Dr. Henri Parson|(757)446-7976|parsonhk@evms.edu|
22444684|NCT03906461|Abbott|Clinical Research Scientist|16517563101|laura.zitellaverbick@abbott.com|
22444685|NCT01948310|Duke Medical Center|Leslie Willis|9196606782|leslie.willis@duke.edu|
22444686|NCT04925271|Thomas Jefferson University|Anand Kumar, Associate Professor of Medicine|215-955-8900|anand.kumar@jefferson.edu|
22429609|NCT03611062|University of Massachusetts Lowell|Dr. Jiabin Shen|978-934-3965|jiabin_shen@uml.edu|
22444687|NCT01795638|University of Cincinnati Medical Center|Barbara Isemann|513-584-5060|barbara.isemann@uchealth.com|
22444688|NCT03061097|Microbiome Health Research Institute|Majdi Osman, MD, MPH|617-575-2201|majdi@openbiome.org|
22444689|NCT01043146|Corimmun, GmbH|Gary Peters, MD, Managing Director|001-215 628-5257|gpeters7@its.jnj.com|
22444690|NCT03956056|Washington University School of Medicine|William Gillanders, M.D.|314-747-0072|gillandersw@wustl.edu|
22444691|NCT02231918|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22384540|NCT05009251|Geisinger|Gail Rosenbaum|800-275-6401|grosenbaum@geisinger.edu|
22384541|NCT04204278|Anika Therapeutics|Kara Mezger, Executive Director Clinical Affairs|781.457.9000|kmezger@anika.com|
22384542|NCT01582711|CDC|Andrey Borisov, MD, MPH, Study Director|(404) 639-3311|pha5@cdc.gov|
22384543|NCT02662062|ANZUP|Dr Anthony Uccellini - ANZUP Research fellow|61 2 9046 8954|trials@anzup.org.au|
22384544|NCT00676715|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22384545|NCT04356027|Abbott|Tarn Teraphongphom, Principal Clinical Research Scientist|+1 (408) 931-0504|tarn.teraphongphom@abbott.com|
22384546|NCT05249439|Imperial College London|Professor Tricia Tan|44 207 594 9048|t.tan@imperial.ac.uk|
22384547|NCT00616967|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|443-287-6489|vstearn1@jhmi.edu|
22384548|NCT02910583|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22384549|NCT04453592|FIFA|Dr Andreas Serner|+41796253899|andreas.serner@fifa.org|
22398463|NCT03266016|Children's Hospital Los Angeles|Dr. Robinder Khemani, MD. Medical Staff/USC Faculty|3233612376|rkhemani@chla.usc.edu|
22429610|NCT02018887|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22429611|NCT04053452|Duke University|Natalia Gonzalez, MD|919-684-5422|natalia.gonzalez@duke.edu|
22429612|NCT01421134|Sunovion|1-866-503-6351|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
22429613|NCT02959892|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22429614|NCT00580294|Icahn School of Medicine at Mount Sinai|Marco Pappagallo, MD|212-241-7749|dionne.bobb@mountsinai.org|
22429615|NCT03099863|MetroHealth Medical Center|Dr. Jeffrey Mangel|2167784444|jmangel@metrohealth.org|
22429616|NCT02061592|Johnson & Johnson Vision Care, Inc|Brian Pall, OD, MS, FAAO - Senior Principal Research Optometrist|904-443-3500|BPALL@its.jnj.com|1290
22429617|NCT04433975|University of Michigan Medical School|Dr. Mark Ilgen|734-845-3646|marki@med.umich.edu|
22384550|NCT01331005|Jaeb Center for Health Research|Adam Glassman|813-975-8690|drcrnet@jaeb.org|
22398464|NCT00768898|Alcon Research, Ltd.|Alison Ramsey, O.D., Manager|817-551-6986|Alison.ramsey@alconlabs.com|
22398465|NCT02257580|Hospital for Special Surgery|Colson Zucker, Research Coordinator|6467146029|zuckerc@hss.edu|
22398466|NCT01777763|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22398467|NCT01664793|University of Pittsburgh|Richard K. Zimmerman|412-383-2355|zimmer@pitt.edu|
22398468|NCT05036681|The University of Texas MD Anderson Cancer Center|Dr. Siqing Fu|(713) 792-4318|siqingfu@mdanderson.org|
22398469|NCT00898222|Brigham and Women's Hospital|Dr. Shamsah Kazani|617-732-8201|skazani@partners.org|
22398470|NCT02787850|Zeltiq Aesthetics|Kerrie Jiang, Sr. Director of Clinical, Regulatory and Medical Affairs|(925) 621-7462|Kerrie.Jiang@allergan.com|
22398471|NCT03718143|NYU Langone Health - PCC CTO|Rachael Keller, Sr. Regulatory Specialist|929-455-2453|Rachael.Keller@nyulangone.org|
22398472|NCT04415073|Syndax Pharmaceuticals, Inc.|Kate Madigan, MD|+1-781-419-1400|kmadigan@syndax.com|
22398473|NCT01191697|Dana-Farber Cancer Institute|Peter C. Enzinger, MD|(877) 442-3342|peter_enzinger@dfci.harvard.edu|
22429618|NCT04882215|University of Glasgow|Professor Jonathan Evans|0141 330 3299|Jonathan.Evans@glasgow.ac.uk|
22398474|NCT01411345|University of Miami|Matthew Abramowitz MD|305-243-4200|mabramowitz@med.miami.edu|
22398475|NCT05702515|Duke University|Deborah Hutch Allen|919-681-4719|hutch.allen@duke.edu|
22398476|NCT01396005|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6327|ClinicalTrialsDisclosure@merck.com|
22398477|NCT01415427|BioMarin Pharmaceutical Inc.|Peter Slasor/Sr Director, Biostatistics, Global Clinical Sciences|415-506-6765|pslasor@bmrn.com|
22398478|NCT01789970|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22398479|NCT02475655|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22398480|NCT00643994|Accuray, Inc.|Director of Clinical Affairs|608-824-3421|sgodbold@accuray.com|
22444692|NCT00547196|City of Hope|Dr. Anna Pawlowska, MD|626-359-8111|apawlowska@coh.org|
22444693|NCT00293215|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
22444694|NCT01409434|University of Florida|Dr. Rhonda Cooper-DeHoff|352-273-6184|dehoff@cop.ufl.edu|
22444695|NCT04882501|InovaHCS|Principal Investigator Inova Fair Oaks Hospital|703 391-4892|Laura.McNicholl@inova.org|
22412114|NCT01766921|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
22444696|NCT05015530|BG ClinicalS|Dr Bernard Gout|+33 (0)561 531 944|b.gout@bgclinicals.com|
22444697|NCT04629508|1-855-463-3463|Study Director|1-855-463-3463|medinfo@incyte.com|
22444698|NCT04735536|Cogntion Therapeutics Inc|Chief Medical Officer, Head of R&D|914-221-6730|acaggiano@cogrx.com|
22444699|NCT04073368|Axcella Health, Inc|Margaret Koziel, MD|8573202200|clinicaltrials@axcellahealth.com|
22444700|NCT03026088|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22444701|NCT00761579|Clinical Research Team, Medical Affairs Korea|Senior Clinical Research Associate|82-2094-4804||
22444702|NCT00950911|Amgen Inc.|Study Director|866-572-6436||
22444703|NCT02063880|University of Washington|Grace John-Stewart|206 5434278|gjohn@uw.edu|
22398481|NCT01895127|Brigham and Women's Hospital|Anil Chandraker|617-732-7412|achandraker@bwh.harvard.edu|
22398482|NCT01568606|Ahmanson-UCLA Cardiomyopathy Center|Tamara Horwich, MD, MS|310-825-8816|thorwich@mednet.ucla.edu|
22398483|NCT00584480|UCSF|Robert L. Hendren, D.O.|415-476-7198|Robert.Hendren@ucsf.edu|
22398484|NCT00662792|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22398485|NCT02499029|MUSC|Sudie Back, PhD|843-792-9383|backs@musc.edu|
22398486|NCT01999582|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22398487|NCT02347176|MedImmune, LLC|Rene van der Merwe|301-398-4095|information.center@astrazeneca.com|
22398488|NCT01014741|Icahn School of Medicine at Mount Sinai|Dr. Vivek Reddy|212-241-7114|vivek.reddy@mountsinai.org|
22398489|NCT00411554|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22398490|NCT00236977|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
22398491|NCT02462473|Janssen R&D US|DIRECTOR CLINICAL RESEARCH||ClinicalTrialDisclosure@its.jnj.com|
22398492|NCT01243320|University of Utah|Mark A. Munger, Pharm.D.|8015816165|mmunger@hsc.utah.edu|
22398493|NCT01536860|RSSL|Rungano Munyuki|+44 118 918 4166|rungano.munyuki@rssl.com|
22398494|NCT01707693|University of Arkansas for Medical Sciences|Leanne L. Lefler, PhD, APN, RN Principal Investigator|5012961939|LeflerLeanne@uams.edu|
22398495|NCT01212302|Cardiology Dep, Ruhr-University Bochum|Dr Horst Neubauer|+49-234-509-2326|Horst.Neubauer@rub.de|
22398496|NCT02342015|University of Padova|Marcello Rattazzi|+300498211867|marcello.rattazzi@unipd.it|
22398497|NCT04336995|VUMC|Ken Monahan|6153222318|ken.monahan@vanderbilt.edu|
22398498|NCT00927095|University of North Carolina at Chapel Hill|Dr. Susan Girdler|919-966-2179|susan_girdler@med.unc.edu|
22398499|NCT01662583|Columbia University|Melissa Stockwell, MD MPH|212-342-5372|mss2112@columbia.edu|
22398500|NCT01849770|University of Washington|Michael D. Weiss, MD|206-598-7688|mdweiss@uw.edu|
22412115|NCT00998023|University of Florida|J Mocco, M.D.|352-273-9000|jmocco@neurosurgery.ufl.edu|
22412116|NCT02026453|Cedars-Sinai Medical Center|Dr. Joshua M. Pevnick|310-423-6976|Joshua.Pevnick@cshs.org|
22429619|NCT06083493|University of Michigan|Zirui Huang|734-615-2875|huangzu@med.umich.edu|
22429620|NCT03911687|Columbia University|Sarah Collins Rossetti, PhD|2123056605|sac2125@cumc.columbia.edu|
22429621|NCT04392635|Stanford University|Study Team|650-723-6189|smeyer27@stanford.edu|
22429622|NCT04402957|Arch Biopartners Inc.|Richard Muruve|647-428-7031|rm@archbiopartners.com|
22429623|NCT03034928|Alcon, A Novartis Division|Sr CDMA Project Lead, GCRA - Vision Care|1-888-451-3937|Alcon.medinfo@alcon.com|
22429624|NCT01810952|Baylor College of Medicine|Professor of Medicine|713-660-9902|glennc@bcm.edu|
22429625|NCT04219774|Duke University|David Hasan, MD, MSc|919-684-7777|david.hasan@duke.edu|
22384551|NCT02193958|FUJIFILM Pharmaceuticals U.S.A, Inc.|Vice President of Clinical Operations|(617) 945-3763|fphucontact@fujifilm.com|
22384552|NCT05061095|Lineberger Comprehensive Cancer Center|Dr. Daniel Richardson|(919) 966-4432|daniel_richardson@med.unc.edu|
22384553|NCT03414814|Seoul National University Hospital|Ji-Sook Kim|821025866440|kbj3075814@snu.ac.kr|
22384554|NCT03161379|Sidney Kimmel Cancer Center at Johns Hopkins|Daniel Laheru, MD|410-955-8974|laherda@jhmi.edu|
22384555|NCT05021640|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22384556|NCT02207062|University of Washington|Dr. Ajay Gopal, Professor|206-606-2037|agopal@uw.edu|
22384557|NCT03779204|Unity Health Toronto|Dr. Naomi Thulien|647-460-0781|naomi.thulien@unityhealth.to|
22384558|NCT03315754|Memorial Sloan Kettering Cancer Center, New York, NY, USA|Jonathan Coleman, MD|+1-646-422-4432|colemanj@mskcc.org|
22384559|NCT02954341|CHU de Lille - Institut Coeur Poumon|Dr Pascal De Groote|33 (0)3 20 44 50 38|Pascal.DEGROOTE@chu-lille.fr|
22384560|NCT05227209|Sumitomo Pharma America Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@suniovion.com|
22384561|NCT05633953|Recordati AG|Mario Maldonado|+41798030344|maldonado.m@recordati.com|
22384562|NCT02384317|ChemoCentryx|Study Director|650-210-2900|medinfo@amgen.com|
22384563|NCT04245501|University of Denver|Michelle Rozenman, Ph.D., Director, BRAVE Lab & Associate Professor, Department of Psychology|303-871-6448|michelle.rozenman@du.edu|
22384564|NCT04140708|Vanderbilt University Medical Center|Dr. Daniel Claassen|615-322-6103|daniel.claassen@vumc.org|
22384565|NCT05327101|Abbott Medical Devices|Stephanie Delgado|818-493-3285|stephanie.delgado1@abbott.com|
22384566|NCT04638309|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
22384567|NCT05337748|University of Pretoria|Professor De Wet Swanepoel|+27827824009|dewet.swanepoel@up.ac.za|
22384568|NCT02506959|The University of Texas MD Anderson Cancer Center|Yago Nieto, MD / Stem Cell Transplantation Department|713-792-8750|ynieto@mdanderosn.org|
22384569|NCT03610490|M D Anderson Cancer Center|Amir A Jazaeri, MD|713-792-8578|aajazaeri@mdanderson.org|
22384570|NCT04541706|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22384571|NCT05974046|Clinical Development|Global Director|(804) 594-4488|trialdisclosure@indivior.com|
22384572|NCT03940963|Axogen|Stacy Arnold, VP of Product Development and Clinical Research|770-833-2570|sarnold@axogeninc.com|
22384573|NCT02790502|Department of Agriculture, Environmental and Development Economics, Ohio State University|Brian Roe|614-688-5777|roe.30@osu.edu|
22384574|NCT04812535|InflaRx GmbH|Dr. Camilla Chong, CMO|+49 3641-508-180|camilla.chong@inflarx.com|
22384575|NCT04401800|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22384576|NCT04927065|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
22384577|NCT04621266|The University of Hong Kong|Dr Kris Lok|39176690|krislok@hku.hk|
22384578|NCT05767437|University of Valencia|Jose casaña Granell|677361782|jose.casana@uv.es|
22384579|NCT02085421|University of Minnesota|Caroline Demro|(612) 625-3330|schi0599@umn.edu|
22384580|NCT04021602|University of Kansas Medical Center|Lisette T. Jacobson, Ph.D., MPA, M.A., Associate Professor, Obstetrics and Gynecology|316-293-3484|ljacobson@kumc.edu|
22384581|NCT02689284|TerSera Therapeutics LLC|VP, Scientific Communications|1-844-334-4035|tersera@medinfodept.com|
22384582|NCT05592418|AIM ImmunoTech Inc.|Diane Young|352-448-7797|diane.young@aimimmuno.com|
22384583|NCT03822845|University of Iowa Health Care|Dr. Michael Graham|319-356-4302|michael-graham@uiowa.edu|
22384584|NCT05481320|UC Davis|Ladson Hinton, MD|9167343485|lwhinton@ucdavis.edu|
22384585|NCT02923180|Johns Hopkins Sidney Kimmel Comprehensive Cancer Center|Dr. Emmanuel Antonarakis|410-502-8341|eantona1@jhmi.edu|
22384586|NCT05198310|Kiniksa Pharmaceuticals, Ltd.|Clinical Operations Study Director|1-781-431-9100|studyinfo@kiniksa.com|
22384587|NCT04116736|Johnson & Johnson Vision Care (JJVC)|Graeme Young|+44(0) 1252 718719|g.young@visioncare.co.uk|
22384588|NCT00731341|Galil Medical|Joy Benson, CRA|651-287-5112|joy.benson@galilmedical.com|
22384589|NCT03526354|UMass Chan Medical School|Dr. Xiaoduo Fan|5088566463|xiaoduo.fan@umassmed.edu|
22384590|NCT06041139|Berkeley Eye Center|Tetiana Huff|713-620-7640|tetiana.huff@berkeleyeye.com|
22384591|NCT00738023|Emory University|Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
22384592|NCT01872078|AstraZeneca Pharmaceuticals LP|Martin L. Scott, MD/PhD|781-472-5130|martin.scott@astrazeneca.com|
22412117|NCT02901899|Northwestern University|Daniela Matei, MD|312.472.4684|daniela.matei@northwestern.edu|
22384594|NCT00753090|Zimmer Biomet|Lisette Smid|0623956378|lisette.smid@zimmerbiomet.com|
22384595|NCT06240091|Woebot Health|Tim Campellone, PhD|(415) 209-5642|research@digitaltherapeutic.io|
22384596|NCT04052516|NorthSea Therapeutics BV|Chief Scientific Officer|31 035760 65 05|info@northseatherapeutics.com|
22384597|NCT05574426|University of British Columbia|Dr. Jonathan Little|250-807-9876|jonathan.little@ubc.ca|
22384598|NCT04521478|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22384599|NCT04578912|University of Minnesota|Christine Conelea|(612) 261-3127|cconelea@umn.edu|
22384600|NCT05062265|Atlantic Orthopaedic|Dr. Ashley Suttmiller|7573213300|suttmilera@atlanticortho.com|6283
22384601|NCT04172441|Zealand Pharma A/S|Charlotte Teglman Schiøler|+45 5060 3722|cschioler@zealandpharma.com|
22384602|NCT04236856|Corindus|Clinical Scientist|6173012445|hamid.rai@siemens-healthineers.com|
22384603|NCT06311084|Imperial College London|Dr Martina Di Simplicio|0208 383 4162|m.di-simplicio@imperial.ac.uk|
22384604|NCT04725240|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
22384605|NCT04600323|University of Colorado Denver|Dr. Jessica Kendrick|3037244837|jessica.kendrick@cuanschutz.edu|
22384606|NCT03222128|Edwards Lifesciences|Director of Research|949-250-2500|THV_CT.gov@Edwards.com|
22384607|NCT02829814|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 799-8599|greg.sullivan@tonixpharma.com|
22384608|NCT03393975|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22398501|NCT01543087|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22444704|NCT02600351|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22444705|NCT02521766|Alcon Research, LLC|Sr. Clinical Trial Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22444706|NCT00567593|University of Pennsylvania|James D. Lewis, MD, MSCE|215-573-5137|lewisjd@mail.med.upenn.edu|
22444707|NCT02106910|University of North Carolina at Chapel Hill|Nicholas J. Shaheen, MD|919-966-7655|nicholas_shaheen@med.unc.edu|
22444708|NCT04087213|DEKA Research|Clinical Research Manager|(603) 669-5139|clinical@dekaresearch.com|
22444709|NCT03126370|University of Colorado Anschutz Medical Campus|Jennifer Kiser, PharmD, PhD|3037246131|jennifer.kiser@cuanschutz.edu|
22444710|NCT01272284|Coloplast Corp|Clinical Trials Manager|612-302-4990|usdibe@coloplast.com|
22444711|NCT01272661|UHospitalsCleveland; Rainbow Babies and CHildren's Hospital|Lydia Furman MD, PI|216-844-8260|Lydia.Furman@uhhospitals.org|
22444712|NCT01086423|GlaxoSmithKline|GSK Response Center|866-435-7343||
22444713|NCT02057393|Penn State Hershey Medical Center|Colette Pameijer, Associate Professor of Surgery|717-531-5272|cpameijer@pennstatehealth.psu.edu|
22444714|NCT02652767|GenSight Biologics|Magali Taiel CMO|1 76 21 72 26|mtaiel@gensight-biologics.com|0033
22444715|NCT01130103|Research Foundation for Mental Hygiene|Franklin Schneier MD|212-543-5368|frs1@columbia.edu|
22444716|NCT01028378|Clinical Research Consultants, Inc.|Barbara S. Fant, Pharm.D.|513-961-8200|bsfant@crc-regulatory.com|
22444717|NCT00450385|University of Miami|Izidore Lossos MD|305-243-4785|ilossos@med.miami.edu|
22444718|NCT00471146|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22444719|NCT01267656|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22444720|NCT00467610|Rush university medical center|Jamile shammo|312-942-5157|jamile_shammo@rush.edu|
22444721|NCT02676466|University of Florida|ENRGISE Coordinating Center Project Manager|352-294-5800|ENGISEACC@aging.ufl.edu|
22444722|NCT01016561|University of Pennsylvania|Lilie Lin, MD|215-662-6515|lin@xrt.upenn.edu|
22444723|NCT02001181|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22444724|NCT00706810|Huntsman Cancer Institute|Dr. Randy Jensen|801-581-6908|randy.jensen@hci.utah.edu|
22444725|NCT02436681|Miromatrix|Head of Clinical Affairs|952.942-6000|mmacenski@miromatrix.com|
22444726|NCT00739596|Novartis Pharmaceuticals|Study Director|862-778-8300||
22444727|NCT02103218|UNC Greensboro|Lisa Goble Director Office of Research Integrity|336-256-1173|lagoble@uncg.edu|
22444728|NCT02520661|UW School of Medicine and Public Health|Manish N. Shah, MD, MPH|608-263-6690|mnshah@medicine.wisc.edu|
22444729|NCT02325856|Department of Nephrology, Tungs' Taichung MetroHarbor Hospital, Taichung, Taiwan|Lim Paik-Seong|886-4-26581919|jamespslim@gmail.com|
22444730|NCT02443519|Yeshiva University & Albert Einstein College of Medicine|Dr. Elizabeth Seng|646-592-4368|elizabeth.seng@yu.edu|
22444731|NCT06352060|Kansas City Heart Rhythm Institute|Dhanunjaya Lakkireddy|913-934-4300|dlakkireddy@gmail.com|
22444732|NCT04192370|Brigham and Women's Hospital|Joji Suzuki, MD|617-455-7981|Jsuzuki2@bwh.harvard.edu|
22444733|NCT01414608|NRG Oncology|Linda Gedeon for Wei Deng|716-845-1169|gedeonl@nrgoncology.org|
22444734|NCT02176343|Alcon Research, Ltd.|Clinical Project Lead, GCRA, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22444735|NCT00760084|Eisai Inc.|Yufang Lu, MD, PhD|888-422-4743||
22444736|NCT02301988|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22444737|NCT02891161|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
22444738|NCT03309150|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22444739|NCT01535664|Acorda Therapeutics, Inc.|Gustavo Suarez, MD|(914) 326-5394|gsuarez@acorda.com|
22444740|NCT01931202|New York State Psychiatric Institute|Bret R. Rutherford|6467748660|bret.rutherford@nyspi.columbia.edu|
22444741|NCT03861702|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22444742|NCT01857583|Daiichi Sankyo.,LTD|Masayuki Fukuzawa, Associate Director|81-90-5584-2197|fukuzawa.masayuki.gn@daiichisankyo.co.jp|
22444743|NCT00859027|University of Connecticut Health Center|Pamela Taxel MD|860-679-4743|taxel@nso.uchc.edu|
22444744|NCT01510457|Rehabilitation Institute of Chicago Center for Pain Studies|Dr. R. Norman Harden|312.238.5654|centerforpainstudies@ric.org|
22444745|NCT02775903|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22444746|NCT04468321|Yale University|Joseph Ross, MD, MHS|2037852987|joseph.ross@yale.edu|
22444747|NCT03237871|Johns Hopkins Bloomberg School of Public Health|Principal Investigator|410-955-3537|ljennin6@jhu.edu|
22444748|NCT03552965|University of Arkansas for Medical Sciences|Rashad Perry|501-686-8274|Rperry3@uams.edu|
22444749|NCT03670836|Columbia University Medical center|Rachana Gavara|914-356-2730|rg2460@cumc.columbia.edu|
22444750|NCT02981940|Dana-Farber Cancer Institute|Eudocia Q Lee, MD MPH|617.632.2166|eudocia_lee@dfci.harvard.edu|
22444751|NCT05108922|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22444752|NCT05036369|VibrantGastro|Clinical trials manager|+972 046663322|service@vibrantgastro.com|
22444753|NCT01846104|Department of Clinical Research Division of Medicine USAMRIID|Matthew Chambers, MD|301-619-6731|matthew.s.chambers@mail.mil|
22444754|NCT01564914|TRACON Pharmaceuticals|Medical Monitor|8585500780|ctheuer@traconpharma.com|
22444755|NCT02793921|University of Pittsburgh|Dr. Catherine Bender, Principal Investigator|412-624-3594|cbe100@pitt.edu|
22444756|NCT01854658|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com|
22398502|NCT00143455|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22398503|NCT02682901|Eastern Virginia Medical School|Henri Parson|7574467976|parsonhk@evms.edu|
22398504|NCT01639872|Psychopharmacology Research Group|Dr. Mary Brunette|603-271-5054|mary.f.brunette@hitchcock.org|
22398505|NCT03850912|Dana-Farber Cancer Institute|Michael Hassett|617-726-5200|michael_hassett@dfci.harvard.edu|
22412118|NCT02129348|New York State Psychiatric Institute|Davangere Devanand, MD|646.774.8656|dpd3@cumc.columbia.edu|
22412119|NCT02019940|Yale School of Medicine|Chadi Abdallah|347-987-0717|chadi.abdallah@yale.edu|
22412120|NCT02597543|UCSD|Paul Kim, MD|3104907217|pjk017@ucsd.edu|
22412121|NCT01862328|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22412122|NCT03276975|Duke University Medical Center|Timothy J. Amrhein, MD|9196841909|timothy.amrhein@duke.edu|
22412123|NCT00679783|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22412124|NCT01485536|The University of Texas (UT) MD Anderson Cancer Center|Yasuhiro Oki, Associate Professor, Lymphoma/Myeloma|713-792-7734|CR_Study_Registration@mdanderson.org|
22412125|NCT02626949|Icahn School of Medicine at Mount Sinai|Jeffrey Weiss, PhD, MS|212-824-7575|Jeffrey.Weiss@mountsinai.org|
22412126|NCT00576199|Hoffmann-La Roche|Medical Communications|800 821-8590||
22412127|NCT01463683|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22412128|NCT03111147|William Beaumont Hospitals|Pamela Sloan, Clinical Research Manager|248-551-6059|pamela.sloan@corewellhealth.org|
22412129|NCT01058421|University of Colorado|Dr. Marc Moss|303-724-6079|marc.moss@ucdenver.edu|
22412130|NCT01497938|Medtronic|Thomas Troub|(818) 576-3142|thomas.troub@medtronic.com|
22412131|NCT05665595|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22412132|NCT02581345|Momenta|Jim Jin|+16173954905|jjin@momentapharma.com|
22412133|NCT02122796|Allina Health|Director of Integrative Health Reseach Center|612-262-2354|jeffery.dusek@allina.com|
22412134|NCT01768858|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22412135|NCT03471078|Dova|VP of Global Drug Development|9193387864|clinical@dova.com|
22412136|NCT01544361|MedImmune, LLC.|Joseph M. Parker, Director, Clinical Development|301-398-0000|parkerj@medimmune.com|
22412137|NCT01568008|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22412138|NCT02258256|Rice 360: Institute for Global Health|Dr. Rebecca Richards-Kortum|713-348-3823|rkortum@rice.edu|
22412139|NCT03392974|BioMarin Pharmaceutical Inc.|Medical Manager, Clinical Science|415-996-2917|divya.reddy@bmrn.com|
22444757|NCT03714620|Trinity Health, Loyola University Medical Center, Stritch School of Medicine|Shannon Lovett, MD, Associate Professor of Emergency Medicine|7082168705|slovett@lumc.edu|
22444758|NCT00331864|Novartis Pharmaceuticals|Study Director|862-778-8300||
22444759|NCT00994929|The University of Pittsburgh|Margaret V. Ragni, MD, MPH|412-209-7288|ragni@pitt.edu|
22444760|NCT02213042|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22444761|NCT02007512|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22444762|NCT00920231|Baltimore VA MC|Dr Cha-Min Tang|410 706-2347|ctang@som.umaryland.edu|
22444763|NCT02360111|Memorial Sloan Kettering Cancer Center|Dr. Ann Jakubowski, Ph.D., MD|212-639-5013|jakubowa@mskcc.org|
22444764|NCT00611533|University of Pennsylvania|Cynthia Neill Epperson, M.D.|215-573-8871|cepp@mail.med.upenn.edu|
22444765|NCT01933217|Children's Hospital Medical Center, Cincinnati|Brad Kurowski, MD, MS|513-803-3655|brad.kurowski@cchmc.org|
22444766|NCT01669096|GlaxoSmithKline|GSK Response Center|866-435-7343||
22444767|NCT02861131|Oregon Health & Science University|Brandon Togioka|5034944572|togioka@ohsu.edu|
22444768|NCT03923738|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22444769|NCT05246397|University of Washington|Andrew Bowdle MD, PhD, FASE|206-979-0477|bowdle@u.washington.edu|
22444770|NCT01146275|Q-Med AB|Head of Medical Affairs|+46 (0) 18 4749000|reception.SEUPP@galderma.com|
22444771|NCT03875768|Duke University|Gary G. Bennett, PhD|919-684-4510|gary.bennett@duke.edu|
22444772|NCT01925274|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22444773|NCT00922233|FHI360|Dr. Vera Halpern|9195447040|vhalpern@fhi360.org|
22444774|NCT04327674|Department of Respiratory Diseases and Allergy. Aarhus University Hospital. Denmark.|Søren Helbo Skaarup|28911869|soeska@rm.dk|
22444775|NCT00315146|Wake Forest Universtiy Baptist Medical Center|Stephen Kritchevsky|336-713-8548|skritche@wakehealth.edu|
22444776|NCT00723398|Milton S. Hershey Medical Center|Dr. Andrea Manni|717-531-8395|amanni@pennstatehealth.psu.edu|
22444777|NCT00267189|Novartis Pharmaceuticals|Study Director|862-778-8300||
22444778|NCT00751621|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22444779|NCT05402020|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22444780|NCT01225887|NRG Oncology|Linda Gedeon for Michael Sill, PhD|716-845-1169|lgedeon@gogstats.org|
22444781|NCT05619523|University of Maryland, College Park|Dr. Melanie Killen|(301) 405-3176|mkillen@umd.edu|
22444782|NCT04505540|University of Vermont|Dr. Scott Mackey, PhD|8028478767|msmackey@uvm.edu|
22444783|NCT03686514|Emory University|Nadine Rouphael, MD|404-712-1435|nroupha@emory.edu|
22444784|NCT05342532|Icahn School of Medicine at Mount Sinai|Gres Karim|212-241-2499|gres.karim@mountsinai.org|
22444785|NCT02808871|Baylor College of Medicine|Ivan O. Rosas, MD|617-510-9910|Ivan.Rosas@bcm.edu|
22444786|NCT00805948|Medtronic, Inc|Michael McGuffey, Clinical Research Director|707-591-7126|michael.mcguffey@medtronic.com|
22444787|NCT01123850|Zimmer|Laura Herdrich|952-830-6224|laura.herdrich@zimmer.com|
22444788|NCT03180684|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
22444789|NCT04007198|Equillium|Clinical Operations|8582401200|clinicaltrials@equilliumbio.com|
22384609|NCT02592330|Massachusetts Eye and Ear|Michael Cheung, MS, CCRP (Clinical Research Project Manager)|617-573-6981|mcheung0@meei.harvard.edu|
22412140|NCT02675543|University of Brescia|Francesco Semeraro|+30 030 3995308|francesco.semeraro@unibs.it|
22412141|NCT03012477|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|(877) 442-3324|Sara_Tolaney@dfci.harvard.edu|
22444790|NCT02495233|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22444791|NCT00672204|University of Minnesota|Bernhard J. Hering, M.D.|612-626-5735|bhering@umn.edu|
22384610|NCT03090152|Hospital for Special Surgery|Dr. Kethy Jules-Elysee|2126061036|JulesElyseeK@HSS.EDU|
22384611|NCT03958955|LEO Pharma A/S|Clinical Disclosure|+45 4494 5888|disclosure@leo-pharma.com|
22384612|NCT04673929|The Royal Marsden Hospital|Professor Vinidh Paleri|02078082732|vinidh.paleri@rmh.nhs.uk|
22384613|NCT04638829|Sobi,Inc.|Medicine Development Leader|1-781-786-7370|medinfo.us@sobi.com|
22384614|NCT05150860|San Diego State University|Assistant Vice President for Research Support Services|(619) 594-5938|rgulizia@sdsu.edu|
22384615|NCT02807636|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22384616|NCT05082909|Imperial College London|Dr Timothy Rawson|07891750151|antibiotic.research@imperial.ac.uk|
22384617|NCT04088630|Wake Forest University School of Medicine|Carol Kittel, Senior Biostatistician|336-399-3832|c.kittel@wakehealth.edu|
22384618|NCT04539574|M.D. Anderson Cancer Center|Max Wintermark, MD|713-792-0845|mwintermark@mdanderson.org|
22444792|NCT03660488|University of Southern California|Jeffrey D Klausner MD MPH, Clinical Professor of Population and Public Health Sciences|4158768901|jdklausner@med.usc.edu|
22444793|NCT01638819|Sutter Health|Michael Chez, MD|(916) 773-8711|ChezM@sutterhealth.org|
22444794|NCT00923936|National Cancer Institute|Dr. Robert Yarchoan|301-496-0328|yarchoanr@pop.nci.nih.gov|
22444795|NCT04263454|University of Alabama at Birmingham|Jarred Younger|205-975-5821|youngerlab@uab.edu|
22444796|NCT01231347|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
22444797|NCT01460368|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22444798|NCT02047227|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22444799|NCT01212107|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22444800|NCT01385371|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22444801|NCT04181320|Mölnlycke|Vice President Corporate Clinical & Medical Affairs CMO & RQA|+46317223045|jane.clark@molnlycke.com|
22444802|NCT01090973|H. Lee Moffitt Cancer Center and Research Institute|Celeste Bello, M.D.|813-745-8623|celeste.bello@moffitt.org|
22444803|NCT05466448|Raziel Therapeutics|Racheli Gueta|97289126941|racheli@raziel-therapy.com|
22444804|NCT03112590|Moffitt Cancer Center|Hyo S. Han, MD|813-745-4933|Hyo.Han@moffitt.org|
22444805|NCT03635788|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22444806|NCT05595382|Rutgers University Associate Professor|Dr. Lauren Daniel|856-225-6535|lauren.daniel@rutgers.edu|
22444807|NCT03722173|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22444808|NCT04571515|MEDA Pharma GmbH & Co. KG (A Viatris Company)|Susanne Vogt|+49 (0) 172 19 20 321|susanne.vogt@viatris.com|
22444809|NCT04128579|Equillium, Inc.|Clinical Trial Manager|8582401200|clinicaltrials@equilliumbio.com|
22444810|NCT06624449|University of Cincinnati|Fahad Alanezi|5138845844|alanezfz@mail.uc.edu|
22444811|NCT05098938|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22444812|NCT00942448|IBSA Institut Biochimique|Barbara Gugliotta|+41 58 360 1000|barbara.gugliotta@ibsa.ch|
22444813|NCT02570074|University of Illinois at Chicago|Keith A. Rodvold, PharmD, FCCP, FIDSA|312-996-3341|kar@uic.edu|
22444814|NCT01859143|MedImmune, LLC|Raburn Mallory, MD/Senior Director, Clinical Development|301-398-0000|malloryr@medimmune.com|
22444815|NCT00760214|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22444816|NCT00700570|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22444817|NCT01134315|AbbVie|Global Medical Services|800-633-9110||
22444818|NCT04587271|University of Kentucky|Dr. Suzanna Attia|859-323-6211|suzanna.attia@uky.edu|
22444819|NCT03719586|NIAID/NIH|Dr. Richard T. Davey, Jr., M.D., U.S. study PI|301-496-8029|rdavey@niaid.nih.gov|
22444820|NCT02791594|Abramson Cancer Center|Dr. Michael Farwell|215-662-7750|michael.farwell@pennmedicine.upenn.edu|
22444821|NCT02310321|Astellas Pharma Inc.|Clinical Transparency|800-888-7704|astellas.resultsdisclosure@astellas.com|
22429626|NCT00114777|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22444822|NCT04950166|OncoNano Medicine, Inc|Vice President, Clinical Operations|(682) 285-1411|trials@onconanomed.com|
22444823|NCT01698905|Novartis|Study Director|862-778-8300|novartis.email@novartis.com|
22444824|NCT05896748|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22444825|NCT03207555|The University of Texas MD Anderson|Jan Burger, MD/Professor|713-563-1487|jaburger@mdanderson.org|
22444826|NCT06138145|University of Pennsylvania|Dr. Kevin B. Johnson|215-573-5885|Kevin.Johnson1@Pennmedicine.upenn.edu|
22444827|NCT01729247|Aerocrine, Inc.|Nancy Herje, BSN, RN, MBA|919-449-8873|Nancy.Herje@aerocrine.com|
22444828|NCT03862040|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
22444829|NCT00857415|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22444830|NCT04508140|Highlight Therapeutics S.L.|Marisol Quintero|+34 961 10 99 55|mquintero@highlighttherapeutics.com|
22444831|NCT01822678|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com|
22444832|NCT00764504|DJO Surgical|Manager of Clinical Affairs|512-832-9500|jane.jacob@djosurgical.com|6323
22384619|NCT05695989|Levita Magnetics|Vivian Soto|+56958360507|VSoto@Levita.com|
22384620|NCT05493787|Geisinger|Gail Rosenbaum|570-243-1199|grosenbaum@geisinger.edu|
22429627|NCT01181128|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22429628|NCT02371252|Mahidol University|Dr. Aasis Unnanuntana|+66836871159|uaasis@gmail.com|
22429629|NCT04477486|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22429630|NCT02636322|University of Texas M D Anderson Cancer Center|Dr. Jason Westin|(713) 792-3750|jwestin@mdanderson.org|
22429631|NCT02502071|University of Colorado School of Medicine|Dr. Petter Bjornstad, Assistant Professor|7207774659|petter.bjornstad@childrenscolorado.org|
22444833|NCT01200862|Mereo BioPharma|Dr. Jackie Parkin|+44 333 0237300|enquiries@mereobiopharma.com|
22444834|NCT02456103|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22444835|NCT01465191|Columbia University|Richard Smiley, MD|212-342-2742|rms7@cumc.columbia.edu|
22444836|NCT03614975|University of Pittsburgh, Department of Family Medicine|Richard Zimmerman, MD|412-383-2354|zimmrk@upmc.edu|
22444837|NCT01390220|Proximagen, LLC|David Sequeira|952-658-7438|dsequeira@proximagen.com|
22429632|NCT02460380|Maimonides Medical Center|Mohamad Irani|3472862167|mohamad.irani@hotmail.com|
22444838|NCT00943124|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22444839|NCT03059446|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22429633|NCT02618187|Seres Therapeutics|Dr. Michele Trucksis, Chief Medical Officer|617-945-9626|mtrucksis@serestherapeutics.com|
22429634|NCT03335267|Weill Cornell Medical College|Dr. Ellen K. Ritchie|646-962-2700|ritchie@med.cornell.edu|
22429635|NCT05938816|Oregon Health and Science University|Josh Kaplan, PhD|503) 494-8311|kaplajos@ohsu.edu|
22429636|NCT01254877|JohnHopkinsU|Mary E McCaul|410-955-9526|mmccaul1@jhmi.edu|
22429637|NCT00514917|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
22429638|NCT02280499|Smith & Nephew|Evita Leiber, Clinical Study Manager|+41 41 766 2205|evita.leiber@smith-nephew.com|
22444840|NCT02992132|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2897|medicalinformation@acadia-pharm.com|
22444841|NCT02448810|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22444842|NCT00136604|GlaxoSmithKline|GSK Response Center|866-435-7343||
22398506|NCT00720109|Children's Oncology Group|Results Reporting Coordinator|626-241-1546|resultsreportingcoordinator@childrensoncologygroup.org|
22398507|NCT02665286|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|(718)920-6266|befriedm@montefiore.org|
22398508|NCT00915343|Shire|Study Physician|1866-842-5335|clinicaltransparency@shire.com|
22398509|NCT00393874|University of Pittsburgh|Dr. Anne Germain|412-383-2150|GERMAX@upmc.edu|
22398510|NCT03861143|NImmune Biopharma, Inc.|Clinical Development|(540) 218-2262|info@nimmunebio.com|
22398511|NCT02177201|Adnan Menders University, Anesthesiology and Reanimation Department|Dr. Sinan Yılmaz|+905055954374|dr_snnylmz@hotmail.com|
22398512|NCT05853380|Mindset Medical|Jeremy Markovich|8583055323|jeremy@mindsetmedical.com|
22398513|NCT04153188|Candela Corporation|Medical Director|+1 904 6549629|konikap@candelamedical.com|
22398514|NCT01489527|H. Lee Moffitt Cancer Center and Research Institute|Anna R. Giuliano, Ph.D.|813-745-6820|anna.giuliano@moffitt.org|
22398515|NCT04899232|University of Miami|Enrique Ginzburg, MD|305-585-1178|eginzbur@med.miami.edu|
22398516|NCT00700271|Novartis Pharmaceuticals|Study Director|862-778-8300||
22398517|NCT02406781|Institut Bergonie|Pr Antoine Italiano|0524071947|a.italiano@bordeaux.unicancer.fr|
22398518|NCT02553460|Lucile Packard Children's Hospital|Tanja A. Gruber, MD, PhD|(650) 723-5535|tagruber@stanford.edu|
22398519|NCT00482014|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22398520|NCT01636466|Emory University|Dr. Ashtar Chami|404-712-7735|ashtar.chami@emory.edu|
22398521|NCT01284114|Division of Nephrology, Department of Internal Medicine, Jichi Medical University|Dr. Yoshiyuki Morishita|81-285-58-7346|ymori@jichi.ac.jp|
22398522|NCT00544869|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7314||
22398523|NCT02322710|Mylan Medical SAS|Rafik NAMANE MD.|0033146258607|rafik.namane@mylan.com|
22398524|NCT04161131|Stanford University|Molly Tanenbaum|650-725-3955|mollyt@stanford.edu|
22398525|NCT05064059|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22398526|NCT03905863|Serena Group Inc|Dr Thomas Serena|671-945-5225|serena@serenagroups.com|
22398527|NCT02944448|Cara Therapeutics|Frédérique Menzaghi, PhD|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
22398528|NCT01294384|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22398529|NCT00804687|Janssen Research and Development|Senior Medical Director|858-784-3111||
22398530|NCT02803164|Mayo Clinic|Dr. Mathew Thomas|904-953-2000|thomas.mathew@mayo.edu|
22398531|NCT03037281|University of Leicester|Dr Christopher Hebbes|0116 252 2522|christopher.hebbes@le.ac.uk|
22398532|NCT01029730|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22398533|NCT00805740|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22398534|NCT01282073|Kyungpook National University Hospital|Sun-Hee Park|+82532005547|sh-park@knu.ac.kr|
22398535|NCT04288570|UMissouri|Vicki L Jones|573-882-7583|jonesvicki@health.missouri.edu|
22398536|NCT05227690|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22398537|NCT00975156|Mischer Neuroscience Institute, Memorial Hermann-TMC|Elizabeth Noser||elizabeth.noser@memorialhermann.org|
22398538|NCT02634580|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22398539|NCT00540579|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22398540|NCT03521505|Chang-Gung Memorial Hospital|Dr Ting-Yu Lin|886 3281200|yuebaoyuebao@gmail.com|8467
22398541|NCT02653768|Center to Accelerate Discovery and Practice Transformation, Durham VA|Kelli Allen, Associate Director|919-286-0411|kelli.allen@va.gov|177090
22398542|NCT00424827|Universiy of MA Medical School|Bilal Piperdi, MD|508-426-0442|UMMScommunications@umassmed.edu|
22398543|NCT02170662|Duke University Medical Center|Dr. Elise Olsen|919-668-5613|elise.olsen@dm.duke.edu|
22398544|NCT02397473|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22398545|NCT01467492|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22398546|NCT00491179|National Taiwan University Hospital|Chen-Hua Liu|886223123456|jacque_liu@mail2000.com.tw|63572
22398547|NCT02298933|National Heart Lung and Blood Institute|Aue, Georg|+1 301 451 7141|aueg@nhlbi.nih.gov|
22398548|NCT02009878|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22429639|NCT02826551|Cedars-Sinai|Josh Page|3104233198|josh.page@cshs.org|
22412142|NCT02819362|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
22412143|NCT05456529|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22412144|NCT02710123|SUNY Buffalo|John Leddy MD|7162043200|leddy@buffalo.edu|
22412145|NCT05381948|EyePoint Pharmaceuticals, Inc.|Ramiro Ribeiro, MD, PhD|908-440-0979|rribeiro@eyepointpharma.com|
22412146|NCT04471207|Medical University of South Carolina|Stacey Sellers|843-792-5807|sellersst@musc.edu|
22412147|NCT06046482|The University of Texas MD Anderson Cancer Center|Renata Ferrarotto, MD|(713) 745-6774|rferrarotto@mdanderson.org|
22412148|NCT02433665|Duke University Medical Center|Dr. Daniele Marin|919.684.7709|daniele.marin@duke.edu|
22412149|NCT02456532|Henry Ford Health System|Timothy Roehrs|13138026681|troehrs1@hfhs.org|
22412150|NCT02750761|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22429640|NCT03055507|University of Washington, Department of Otolaryngology - Head & Neck Surgery|Dr. Greg Davis, Director of Rhinology and Skull Base|(206) 598-4022|GEDavis@uw.edu|B
22429641|NCT01270867|Concentric Medical / Stryker Neurovascular Inc|Paula Schmidt, Clinical Project Manager|510-413-2271|paula.schmidt@stryker.com|
22429642|NCT04560309|Nationcal Cardiovascular Center Harapan Kita|I Made Adi Parmana, M.D.|+62 812-4601-212|adiparmana13@gmail.com|
22429643|NCT01106950|Masonic Cancer Center, University of Minnesota|Jeffrey S. Miller, M.D.|612-625-7409|mille011@umn.edu|
22429644|NCT00356421|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22429645|NCT04689009|EMOLED SRL|Dr. Rossi Degl'Innocenti Duccio, Clinical Affairs Manager|+390550751960|d.rossi@emoled.com|
22429646|NCT02187055|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22429647|NCT04159480|University of Colorado, Anschutz Medical Campus|Lisa Brenner|7208481980|lisa.2.brenner@cuanschutz.edu|
22429648|NCT00985790|GlaxoSmithKline|GSK Response Center|866-435-7343||
22429649|NCT02512445|UCSD|Dr. Sonya Norman|858-518-8266|snorman@ucsd.edu|
22429650|NCT02082288|al-azhar university|wael mohamed hamed|002-01001556162|wael79hamed@yahoo.com|
22429651|NCT03462563|Ethicon SARL|Richard Kocharian|+1 609 6423787|rkochar1@its.jnj.com|
22429652|NCT05089357|Q-Med AB|Clinical Scientist|+46184749000|reception.seupp@galderma.com|
22429653|NCT00689052|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22429654|NCT03020888|Endomag|Dr Matthew Womack|+44 7851 247439|mwomack@endomag.com|
22429655|NCT01407367|University of Maryland Baltimore|Jeffrey C. Fink MD, MS; Principal Investigator|410-382-4822|jfink@som.umaryland.edu|
22429656|NCT01793129|RTI International|Dr. Abhik Das|301-770-8214|adas@rti.org|
22429657|NCT04128215|University of Florida|Dr. Demetra Christou|3522941715|ddchristou@ufl.edu|
22429658|NCT00800345|Vector Oncology|Vice President of Scientific Affairs|901.435.5570|mwalker@vectoroncology.com|1759
22429659|NCT06358144|Wake Forest University Health Sciences|Beth Reboussin, PhD|336-713-5213|brebouss@wakehealth.edu|
22429660|NCT02469961|Maimonides Medical Center|Piyush Gupta, Director of clinical affairs|718-283-7189|pgupta@maimonidesmed.org|
22412151|NCT01860976|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22412152|NCT03256799|UAB|Steven M. Rowe|205-975-9776|smrowe@uab.edu|
22412153|NCT02153398|Biometrics Department, Science Affairs Division, R&D, AstraZeneca Japan|Masahiro Nii||Masahiro.Nii@astrazeneca.com|
22412154|NCT01134081|University of Michigan|Dr. William Giannobile|734 763 2105|wgiannob@umich.edu|
22412155|NCT02204371|GlaxoSmithKline|GSK Response Center|866-435-7343||
22412156|NCT00810368|Georgetown University Medical Center|Dr. James N Baraniuk|202-687-8231|baraniuklab@gmail.com|
22412157|NCT01506947|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
22412158|NCT02362594|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22412159|NCT02922868|Wake Forest|Dr Gopal Badlani|3367165928|gbadlani@wakehealth.edu|
22412160|NCT01781286|University of Missouri|Dr. Heather Leidy|(573) 882-4288|leidyh@health.missouri.edu|
22412161|NCT03365375|Indiana University|Paul Musey|317-880-3900|pmusey@iu.edu|
22412162|NCT02187042|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22412163|NCT05343156|Oculis SA|Bastian Dehmel, Chief Development Officer|0041 21 711 39 70|bastian.dehmel@culis.com|
22412164|NCT01060592|Crospon|John O'Dea PhD|+353-91-519880|jodea@crospon.com|
22412165|NCT01807871|University of Vermont|Dr. John Hughes|802-656-1640|John.Hughes@med.uvm.edu|
22412166|NCT01659567|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22412167|NCT02983448|University of Oklahoma Health Sciences Center|Dr. Stavros Stavrakis|405-271-4742|stavros-stavrakis@ouhsc.edu|37507
22412168|NCT01179919|University of Michigan|Manjunath Pai|7346473466|amitpai@med.umich.edu|
22412169|NCT04582396|Columbia University|Dr. Sachin Agarwal|2123421335|sa2512@cumc.columbia.edu|
22412170|NCT01650324|Taipei Medical University - Wanfang Hospital|Dr. Yi-Jen Chen|886-2-2930-7930|yjchen@tmu.edu.tw|2543
22412171|NCT01586741|Karolinska University Hospital|D. Peter Emanuelsson|+46851770000|peter.emanuelsson@sll.se|
22412172|NCT01915732|GlaxoSmithKline|GSK Response Center|866-435-7343||
22412173|NCT01325207|Northwestern University|Jeffrey Raizer, MD||Jeffrey.Raizer@nm.org|
22412174|NCT00698685|University of Arizona, Arizona Cancer Center|Andrew M. Yeager, MD|520-626-0662|ayeager@azcc.arizona.edu|
22412175|NCT00337571|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22412176|NCT01890915|James J. Peters VA Medical Center|Dr. John P. Handrakis|718-584-9000|john.handrakis@va.gov|5439
22412177|NCT00638365|KaloBios Pharmaceuticals, Inc.|Nestor A. Molfino, MD., MSc|650-243-3103|nmolfino@kalobios.com|
22412178|NCT01491620|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
22412179|NCT01569451|University of Colorado|Stefan Sillau|303-724-8657|stefan.sillau@ucdenver.edu|
22412180|NCT01974895|GlaxoSmithKline|GSK Response Center|866-435-7343||
22412181|NCT01513148|Shenandoah University|Dr. Todd Telemeco|540-545-7398|ttelemec@su.edu|
22412182|NCT03552757|Novo Nordisk A/S|Clinical Transparency Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22412183|NCT00571428|Sunovion|Brovana Medical Director|1-866-503-6351||
22412184|NCT02192099|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
22444843|NCT04795622|Merz Aesthetics|Public Disclosure Manager|+49 69 1503|Aesthetic.Trials@merz.com|1
22412185|NCT00386009|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22412186|NCT00536575|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22412187|NCT02334059|Penn State Health Anesthesiology and Perioperative Medicine|Sanjib D Adhikary|717-531-6597|sadhikary1@pennstatehealth.psu.edu|
22412188|NCT01598701|University of Texas Health Science Center at Houston|Carlos Artime, MD|713-500-6200|Carlos.Artime@uth.tmc.edu|
22412189|NCT02549495|Brigham and Women's Hospital|Daniel Palazuelos, MD, MPH|617-521-3381|dpalazuelos@bwh.harvard.edu|
22412190|NCT00936975|ECOG-ACRIN Cancer Research Group|Results Reporting Statistician|401-863-9188|bherman@stat.brown.edu|
22412191|NCT00440596|Kent State University|Joel Hughes|330-672-7721|jhughes1@kent.edu|
22412192|NCT01592799|GlaxoSmithKline|GSK Response Center|866-435-7343||
22412193|NCT01656889|Smith & Nephew|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
22412194|NCT02486796|Midwestern Regional Medical Center, Inc.|Director of ClinicalResearch|847-731-1648|Bruce.Steinert@CTCA-Hope.com|
22412195|NCT02114307|Imperial College London|Dr Tristan Lane|02033117317|tristan.lane@imperial.ac.uk|
22412196|NCT00306384|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22444844|NCT00470847|Dana-Farber Cancer Institute|Nancy Lin, MD|617-632-2335|nlin@partners.org|
22412197|NCT02275364|GlaxoSmithKline|GSK Response Center|866-435-7343||
22444845|NCT02354482|University of Kentucky|Jessica Clouser|8593230284|jess.clouser@uky.edu|
22444846|NCT03963401|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22444847|NCT01916967|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22444848|NCT00337350|Massachusetts General Hospital Schizophrenia Research Program|Dr. David Henderson|(617) 912-7800|dchenderson@partners.org|
22444849|NCT00846287|UMass Medical School|Dr. Mitchell Albert|(807) 684-7270|albertmi@tbh.net|
22444850|NCT01070043|Novartis Pharmaceuticals|Study Director|862 - 778- 8300||
22444851|NCT00390234|Princess Margaret Hospital|Dr. Amit Oza|416-946-2818|amit.oza@uhn.ca|
22444852|NCT01231230|University of Miami|Adam Wanner, MD|(305)243-2568|awanner@med.miami.edu|
22444853|NCT01610271|Baylor College of Medicine|Rabih Darouiche, MD|713.799.5088|sdself@gmail.com|
22444854|NCT02038452|Keele University|Dr Edward Roddy|01782 734715|e.roddy@keele.ac.uk|
22444855|NCT01369615|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
22444856|NCT02337738|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22444857|NCT00986479|AstraZeneca|Clinical Trial Transparency||ClinicalTrialTransparency@astrazeneca.com|
22444858|NCT01721070|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
22444859|NCT02035475|OhioHealth|Dr. Ronney Abaza|614-544-8104|ronney.abaza@ohiohealth.com|
22444860|NCT01302379|University of San Diego, California|Ruth Patterson|8585349235|repatterson@ucsd.edu|
22444861|NCT04398316|Hennepin County Medical Center, Department of Emergency Medicine|Elliott Chinn, DO|612-873-3508|elliott.chinn@hcmed.org|
22429661|NCT00454142|National Cancer Centre Singapore|Dr. Wan Teck LIM|65-64368174|dmolwt@nccs.com.sg|
22384621|NCT01600222|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
22384622|NCT03526861|LEO Pharma A/S|Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
22429662|NCT00520572|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22429663|NCT03254147|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22429664|NCT01723839|John Theurer Cancer Center at Hackensack Meridian Health|Joshua Zenreich|551-996-4248|joshua.zenreich@hmhn.org|
22429665|NCT02527265|MannKind Corporation|Clinical Development|844.323.7399|mapp@mannkindcorp.com|
22429666|NCT01748552|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22429667|NCT01386645|VA Puget Sound Hlthcare System|Kristina Utzschneider|206-277-3568|kutzschn@uw.edu|6-3568
22429668|NCT02930941|University of California, Davis Medical Center|Aimee Moulin, MD|916-703-6110|akmoulin@ucdavis.edu|
22429669|NCT00289978|Novartis Pharmaceuticals|Study Director|862 778-8300||
22429670|NCT00903344|University of Kansas Medical Center|Dr. Leigh Eck|913-588-6022|leck2@kumc.edu|
22429671|NCT00585169|Yale Unviersity|Marc N. Potenza, M.D., Ph.D.|203-737-3553|marc.potenza@yale.edu|
22444862|NCT01842815|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22444863|NCT01626495|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
22412198|NCT00630565|University of Minnesota, Masonic Cancer Center|Dr. Daniel Weisdorf, MD|+1 612-624-3101|weisd001@umn.edu|
22412199|NCT00669578|Mayo Clinic|Ayalew Tefferi, M.D.||tefferi.ayalew@mayo.edu|
22412200|NCT03384745|Avillion LLP|Chief Medical Officer|+44 (0)203 764 9530|avillion@avillionllp.com|
22412201|NCT02984683|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|option 6
22412202|NCT03131999|Medical University of South Carolina|Charlton Strange, MD|843-792-3174|strangec@musc.edu|
22412203|NCT02260492|Oriel Therapeutics, a Novartis Company|Malinda Longphre PhD, Director Clinical Reserach|9193131290|mlongphre@orieltherapeutics.com|114
22412204|NCT04634409|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22412205|NCT02683187|Duke University Medical Center|Dr. David D'Alessio|919-684-5778|david.d'alessio@duke.edu|
22412206|NCT02785913|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
22412207|NCT03717064|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22412208|NCT01298570|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22412209|NCT01929109|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22412210|NCT00076102|National Cancer Institute (NCI), National Institutes of Health (NIH)|Brigitte C. Widemann, M.D.|301-496-7387|widemanb@mail.nih.gov|
22412211|NCT01052116|ALA - ACRC|Robert A. Wise|(410) 550-0545|rwise@jhmi.edu|
22412212|NCT03724149|Perelman School of Medicine|Dr. Peter Reese|215-900-3782|amussell@upenn.edu|
22412213|NCT02180711|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22412214|NCT00444145|Vanderbilt University|Dr. Michael Vaezi|615-322-3739|tina.higginbotham@vanderbilt.edu|
22412215|NCT01619800|Icahn School of Medicine at Mount Sinai|Vivek Reddy|212-241-7114|vivek.reddy@mountsinai.org|
22412216|NCT01581970|Masonic Cancer Center, University of Minnesota|Dr. Gautam Jha|612-624-5373|jhaxx014@umn.edu|
22412217|NCT00927992|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22412218|NCT00234078|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22412219|NCT00502775|GlaxoSmithKline|GSK Response Center|866-435-7343||
22412220|NCT02518113|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22412221|NCT00520741|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22412222|NCT03702621|Indiana University|Dr. Yar Luan Yeap|317-274-0275|yyeap@iupui.edu|
22412223|NCT00419926|Novartis Pharmaceuticals|Study Director|862-778-8300||
22412224|NCT02374918|University of Arizona|"Dr. William Scott Killgore"|(520) 621-0605|killgore@psychiatry.arizona.edu|
22412225|NCT02402166|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22412226|NCT00623103|Novartis Pharmaceuticals|Study Director|862-778-8300||
22412227|NCT00376948|Barbara Ann Karmanos Cancer Institute|Almhanna Khaldoun, M.D.|313-576-8746|almhanna@karmanos.org|
22412228|NCT01141725|FHCRC/UWMC|Elihu Estey, MD, Director of AML Program|206-288-7176|eestey@uw.edu|
22412229|NCT02433678|University at Buffalo|Dr. Paresh Dandona|716-535-1850|dandona@buffalo.edu|
22412230|NCT01024738|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
22412231|NCT01424722|Abbott Medical Devices|Clinical Program Director|972-309-8087|clay.cohorn@abbott.com|
22412232|NCT02483975|GlaxoSmithKline|GSK Response Center|866-435-7343||
22412233|NCT00818883|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22412234|NCT02166697|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22412235|NCT00939653|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
22412236|NCT01556009|Children's Hospital of Oakland Research Institute, Oakland|Ervin H Epstein Jr., MD|510-450-5688|eepstein@chori.org|
22412237|NCT02684578|University of California, San Francisco|Dr. Jay Stewart|628-206-3123|jay.stewart@ucsf.edu|
22412238|NCT01505530|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22412239|NCT03622658|Kinevant Sciences Inc. on behalf of Kinevant Science GmbH|Dr. Simon Lowry, Chief Medical Officer|646-495-5368|simon.lowry@roivant.com|
22412240|NCT00625807|Massachusetts General Hospital|Sara Lazar|617-724-2256|slazar@mgh.harvard.edu|
22412241|NCT01966042|Federal University of Sao Paulo (UNIFESP)|Dr. Nelson Americo Hossne Junior|+55 11 5571-2719|nelson.hossne@gmail.com|
22412242|NCT01802879|Novartis Pharmaceuticals|Study Director|888-669-6682|Novartis.email@novartis.com|
22412243|NCT00266409|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22412244|NCT01933295|Henry Ford Health|Christopher Drake|(248) 344-6672|cdrake1@hfhs.org|
22412245|NCT01105650|Masonic Cancer Center, University of Minnesota|Dr. Melissa Geller|612-626-3111|gelle005@umn.edu|
22429672|NCT03794323|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22429673|NCT01084759|SKCCC at Johns Hopkins|Dr. Samuel Denmeade|410-955-8875|denmesa@jhmi.edu|
22429674|NCT00527748|University of Missouri|Dr. Saul G Trevino|573/884-8840|trevinos@health.missouri.edu|
22444864|NCT00445978|BioMarin Pharmaceutical Inc.|Joshua Lilienstein/Medical Director, Global Medical Affairs|651.523.0310|MEDINFO@bmrn.com|
22412246|NCT00108732|ECOG Statistical Office|Study Statistician|617-632-3012||
22412247|NCT00670956|University of California San Francisco|Hanmin Lee, MD|415-476-4086|hanmin.lee@ucsf.edu|
22412248|NCT01946165|UT MD Anderson Cancer Center|Christopher J. Logothetis M.D. / Genitourinary Medical Oncology|713-792-2830|clogothe@mdanderson.org|
22412249|NCT01901055|University of Pittsburgh|Eileen R. Chasens, PhD, Professor of Nursing|412-624-9380|chasense@pitt.edu|
22412250|NCT03019965|CISMexico|Dr. Yazmín Fuentes|55276900|yazmin_fuentes@hotmail.com|22462
22429675|NCT03055221|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
22429676|NCT01243424|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22429677|NCT01093885|University of Pennsylvania Health System|Dr. Chris Derk|215-662-2792|chris.derk@uphs.upenn.edu|
22412251|NCT00708422|Alcon Research, Ltd.|Director of Medical Affairs|1-800-862-5266|medinfo@alconlabs.com|
22412252|NCT01254409|Promedior, Inc.|Dr. Bernt van den Blink|781-538-4203|bvandenblink@promedior.com|
22412253|NCT03309449|SUNY Upstate Medical University|William Eggleston|315-464-8906|egglestw@upstate.edu|
22412254|NCT01654107|Rutgers Robert Wood Johnson Medical School|Marc L. Steinberg, Ph.D.|7322354341|marc.steinberg@rutgers.edu|
22412255|NCT02356471|Wake Forest University Health Sciences|Dr. Clancy Clark|336-716-7207|cjclark@wakehealth.edu|
22412256|NCT00635154|Mayo Clinic|Dr. John Lust||lust.john@mayo.edu|
22412257|NCT02114697|Emory University|John Oshinski PhD|404-727-5894|jnoshin@emory.edu|
22412258|NCT03312257|Ohio State University|Jeffrey Walline|614-247-6840|walline.1@osu.edu|
22412259|NCT04558554|Fred Hutchinson Cancer Center|Katrina Ortblad|206.667.7267|kortblad@fredhutch.org|
22412260|NCT02660242|Jaeb Center for Health Research|Stephanie DuBose|813.975.8690|sdubose@jaeb.org|
22412261|NCT00982553|Imperial College|Dr Alan Winston|+44 (0)20 3312 1603|a.winston@imperial.ac.uk|
22412262|NCT04087395|TEOXANE SA|Clinical Project Manager|+41(0) 22 344 96 36|clinical@teoxane.com|
22412263|NCT02796664|Asan Medical Center|Dr. Dae Chul Suh|+82-2-3010-4366|dcsuh@amc.seoul.kr|
22444865|NCT00304239|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22412264|NCT01626079|Abbott|Sripad Bellary|4088458114|sripad.bellary@abbott.com|
22412265|NCT01709032|Children's Hospital of Philadelphia|Janet Kwiatkowski, MD|215-590-3437|kwiatkowski@email.chop.edu|
22444866|NCT02979197|Kitov Pharma Ltd.|J. Paul Waymack, M.D., Chief Medical Officer|(202) 965-2215|paul@kitovpharma.com|
22444867|NCT02949700|Baylor College of Medicine|Dr. Vlad Sandulache|713-798-7218|Vlad.Sandulache@bcm.edu|
22412266|NCT02430870|Takeda|Medical Director Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22444868|NCT01532973|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22412267|NCT02566135|Medical College, Baroda.|Dr Aditi Amrutlal Dhimar|09825334605|dhimaraditi@yahoo.in|
22412268|NCT00865709|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22412269|NCT00429923|Sirion Therapeutics, Inc.|Jeremy Brace|813-496-7325|jbrace@siriontherapeutics.com|343
22412270|NCT01265784|La Jolla Pharmaceutical Company|Chief Development Officer|+1.617.715.3600|ljpcregulatory@ljpc.com|
22412271|NCT03644095|Reckitt Benckiser Inc.|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
22412272|NCT03740165|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22412273|NCT03049618|University of Southern California|Victoria Soto|323-865-3441|victoria.soto@med.usc.edu|
22412274|NCT01055223|GlaxoSmithKline|GSK Response Center|866-435-7343||
22412275|NCT03387033|Duke University|Nirmish Shah, MD|919-668-5178|nirmish.shah@duke.edu|
22412276|NCT00788125|City of Hope National Medical Center|Dr. Judith Sato|626-218-5430|jsato@coh.org|
22412277|NCT03165058|GI Clinical Research Enterprise|Tina Higginbotham|615-322-4643|tina.higginbotham@vumc.org|
22412278|NCT00414466|Medtronic Neuromodulation|Robert Spencer, Clinical Research Manager|(763) 514-0253|robert.j.spencer@medtronic.com|
22412279|NCT03480425|University of Saskatchewan|Dr. William P. McKay|306 250 5344|bill.mckay@usask.ca|
22412280|NCT05920161|Yale School of Medicine|Elizabeth Goldfarb, PhD|203-737-6365|elizabeth.goldfarb@yale.edu|
22412281|NCT02742090|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
22412282|NCT01771965|MUSC|Tracy Stecker, PhD|843.792.7287|stecker@musc.edu|
22412283|NCT02753842|Emory University|Aaron Siegler|404-712-9733|asiegle@emory.edu|
22412284|NCT02303548|Asan Medical Center|Director of Clinical Trials|8230103350|wonpia73@naver.com|
22412285|NCT05216081|Yale University|Fuad Abujarad|+1 (203) 737-5088|fuad.abujarad@yale.edu|
22412286|NCT02473640|Synthetic Biologics Inc.|Michael Kaleko, M.D.|(240) 238-3862|mkaleko@syntheticbiologics.com|
22412287|NCT04720664|Georgetown University|Nadia Ashai, MD|202-444-2223|nadia.ashai@medstar.net|
22444869|NCT05430022|University of Southern California|Dr. Jessica Schwartzman, Assistant Professor|3232075910|jstrendlab@gmail.com|
22412288|NCT01315145|Vertos Medical|VP of Clinical Affairs|9493490008|kdavis@vertosmed.com|
22412289|NCT00655642|Vanderbilt University|Dr. Tyler Barrett|6159360253|tyler.barrett@vanderbilt.edu|
22412290|NCT02016300|Stanford University|Jason Dragoo, MD|650-721-3430|jdragoo@stanford.edu|
22412291|NCT05301751|Allgenesis Biotherapeutics Inc.|Tan Nguyen, Vice President of R&D|+886-2-87871232|tan.nguyen@allgenesis.com|105
22412292|NCT04815863|Renji Hospital, Shanghai Jiaotong University School of Medicine|Dr. Meng Jiang|+86 13788912766|jiangmeng0919@163.com|
22412293|NCT06165744|Alcon Research, LLC|Sr. Principal Clinical Project Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22412294|NCT01546987|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22444870|NCT05521906|University of Nebraska-Lincoln, Department of Educational Psychology/Interpersonal Violence Research Laboratory|Katie M Edwards, PhD|402-472-2448|katie.edwards@unl.edu|
22444871|NCT01828320|University of California, Berkeley|Professor of Clinical Psychology|5104736490|aharvey@berkeley.edu|
22444872|NCT01262131|Pico-Tesla Magnetic Therapies, LLC|Allen S. Braswell CEO|303 795-3222|abraswell@pico-tesla.com|
22444873|NCT00866788|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22444874|NCT02260440|UPMC Hillman Cancer Center|Anuradha Krishnamurthy, MD|412-623-3283|krishnamurthya2@upmc.edu|
22444875|NCT02349061|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22444876|NCT02095223|University of Miami|Christopher Kuenze|5174325018|kuenzech@msu.edu|
22444877|NCT01397162|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22412295|NCT02270736|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
22412296|NCT00262600|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22412297|NCT02134756|University of South Florida|Marcus Kilpatrick|(813) 362-6696|mkilpatrick@usf.edu|
22429678|NCT00710554|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
22398549|NCT01583894|Boston Scientific Corporation|Nitzan Mekel-Bobrov, Director of Scientific Communications|6619494537|nitzan.mekel-bobrov@bsci.com|
22429679|NCT04621786|University of New Mexico|Dr. Chris Abbott|5052720406|cabbott@salud.unm.edu|
22429680|NCT01030575|RTI International|Dr. Abhik Das|301-770-8214|adas@rti.org|
22429681|NCT00292370|Ralph H. Johnson VA Medical Center|Mark Hamner, MD|843-789-7799|Mark.Hamner@va.gov|
22429682|NCT01301001|University of Tennessee Health Science Center|Dr. Candace Brown|9014124341|CSBROWN@TENNESSEE.EDU|
22429683|NCT01560988|Brigham and Women's Hospital|Dr. Joshua Boyce|617-525-1261|jboyce@partners.org|
22398550|NCT01790048|Washington University School of Medicine in St. Louis|Dr. Mark Manary|314 454 2178|manarymj@wustl.edu|
22429684|NCT01346709|European Society of anaesthesiology|Brigitte Leva, Research Team Leader|+3222109414|research@esahq.org|
22429685|NCT04821245|Benaroya Research Institute|Joseph M. Neal, MD|206-223-6980|Joseph.Neal@virginiamason.org|
22429686|NCT01840163|University of Michigan|Dr. Sarah Hawley|734-936-8816|sarahawl@med.umich.edu|
22429687|NCT00383565|MD Anderson Cancer Center|Dr. Luis E. Fayad / Associate Professor|713-792-2860|jmdennison@mdanderson.org|
22429688|NCT03992482|University of Illinois Chicago|Dr. Sandeep Jain|312-996-4476|jains@uic.edu|
22398551|NCT01970176|Mayo Clinic|Horng H. Chen, M.D.|507-284-8896|chen.horng@mayo.edu|
22398552|NCT01491178|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22398553|NCT05159596|University of California, Berkeley|Robert W. Levenson|510-643-8952|boblev@berkeley.edu|
22398554|NCT05689047|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22398555|NCT01604512|Memorial Sloan Kettering Cancer Center|Dr. Robert Young, MD|212-639-8196|youngr@mskcc.org|
22398556|NCT03132636|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22398557|NCT03470129|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
22398558|NCT01415752|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22398559|NCT03083886|Brigham and Women's Hospital|Niteesh Choudhry, MD, PhD|617-278-0930|nkchoudhry@bwh.harvard.edu|
22398560|NCT01391507|Janssen Research & Development, LLC|Associate Director Biostatistics||ClinicalTrialDisclosure@its.jnj.com|
22398561|NCT01453855|Alcon Research, Ltd.|Theresa A Landry, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
22398562|NCT00857727|Mount Sinai St. Luke's|Dr. Jinu Kim|212-523-6121|JiKim@chpnet.org|
22398563|NCT01562548|GlaxoSmithKline|GSK Response Center|866-435-7343||
22398564|NCT01285908|National Institute of Neurological Disorders & Stroke|Dr. David S. Goldstein||david.goldstein1@nih.gov|
22398565|NCT03655756|Morphogenesis, Inc|James Bianco, MD - Chief Executive Officer|8138756600|jbianco@morphogenesis-inc.com|104
22398566|NCT03529773|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22398567|NCT03066102|National Yang Ming University|Dr. Yi-Fen Shih|+886-2-28267340|yfshih@ym.edu.tw|
22398568|NCT01496066|RxSight, Inc.|Maureen O'Connell Vice President, Regulator and Clinical Affairs|978-207-12415|moconnell@rxsight.com|
22398569|NCT01340209|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22398570|NCT00253630|City of Hope|Paul Frankel, Ph.D.|626-359-8111|pfrankel@coh.org|65265
22398571|NCT03237065|Pharmacosmos A/S|Clinical trial disclosure desk|+45 5948 5935|trial@pharmacosmos.com|
22398572|NCT00209339|Abbott Vascular|Jeffrey T Ellis||jeffrey.ellis@av.abbott.com|
22398573|NCT01239160|Tactile Medical|Director of Clinical Research|612-540-5267|astone@tactilemedical.com|
22398574|NCT00328770|Liver Transplant Program, University of Alberta Hospitals|Dr. Norman Kneteman|780-407-6168|norm.kneteman@albertahealthservices.ca|
22398575|NCT02062658|Stanford University|Dr. Carolyn Rodriguez, Assistant Professor|6507236158|carolynrodriguez@stanford.edu|
22429689|NCT02421510|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22429690|NCT03203512|University of Reading|Professor Parveen Yaqoob|+443787113|p.yaqoob@reading.ac.uk|
22429691|NCT01058005|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
22429692|NCT01698008|University of Nebraska Medical Center|Whitney Goldner|402-559-3579|wgoldner@unmc.edu|
22429693|NCT02053584|Wolfson Medical Center|Dr. Julio Weinstein|972-3-5028371|vainstein@wolfson.health.gov.il|
22429694|NCT00508300|lausanne university hospital|martin hübner|+41795561506|martin.hubner@chuv.ch|
22429695|NCT01623752|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22429696|NCT00981175|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22429697|NCT02619812|Mayo Clinic|Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
22429698|NCT02728726|Mayo Clinic|J. Ross Renew, M.D.|904-956-3328|Renew.J@mayo.edu|
22429699|NCT02203786|Centre for Addiction and Mental Health|Dr. Daniela Lobo, Qualified Investigator for Study, Clinician-Scientist|416-535-8501|Daniela.Lobo@camh.ca|36568
22429700|NCT00793611|University of New Mexico Health Sciences Center and CTSC|Yuko Komesu MD|505-925-4395|ykomesu@salud.unm.edu|
22429701|NCT00673114|Duke University Medical Center|Dr. Joanne Kurtzberg|919-668-1100|kurtz001@mc.duke.edu|
22429702|NCT01433081|Northwestern University|Gildasio De Oliveira MD|312-472-3573|g-jr@northwestern.edu|
22429703|NCT00271570|University of California, San Diego|Jane Burns, MD, Professor|858-246-0155|jcburns@ucsd.edu|
22429704|NCT04865978|Inova Schar Heart and Vascular|Dr. Palak Shah|703-776-2213|palak.shah@inova.org|
22429705|NCT04263532|Philips|Chuck Cain|412-657-1814|chuck.cain@philips.com|
22429706|NCT04098302|UConn Health|Jonathan Covault Study PI|860-679-7560|jocovault@uchc.edu|
22429707|NCT05061706|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646 440-9333|ITCIClinicalTrials@itci-inc.com|
22429708|NCT00191152|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22429709|NCT01543503|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22444878|NCT02339285|University of North Carolina at Chapel Hill|Dr. Flavio Frohlich|(919) 966-4584|flavio_frohlich@med.unc.edu|
22412298|NCT00583700|West Virginia University|Geraldine Jacobson, MD, MBA, MPH, FACR|(304) 293-7227|GMJACOBSON@hsc.wvu.edu|
22444879|NCT02053051|Imperial College London|Prof Nick Oliver|02075941862|nick.oliver@imerial.ac.uk|
22444880|NCT01507298|Imperial College London|Dr. Richard Mark Kwasnicki|07851759471|rmk107@ic.ac.uk|
22444881|NCT01920555|Massachusetts General Hospital|Maurizio Fava, MD|617-724-2513|MFAVA@mgh.harvard.edu|
22444882|NCT00426231|Johns Hopkins University|Dhananjay Vaidya|410-6142307|dvaidya1@jhmi.edu|
22444883|NCT00108433|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22444884|NCT01193660|CHA Bundang Medical Center, CHA University|Minyoung Kim, MD, PhD|82-31-780-1872|kmin@cha.ac.kr|
22412299|NCT06132919|MC2 Therapeutics|Chief Medical Officer|+45 2018 1111|info@mc2therapeutics.com|
22412300|NCT02132247|IBSA Pharma Inc.|Christopher Jones, Ph.D.|(202) 753-6475|chris.jones@ibsapharma.com|7005
22412301|NCT00724568|University of Michigan Comprehensive Cancer Center|Dr. Moshe Talpaz|734-764-8195|mtalpaz@umich.edu|
22412302|NCT04908748|Teikoku Seiyaku Co.,Ltd.|Hirofumi Fujiwara|+81362649123|hirofumi-fujiwara@teiyaku.co.jp|
22412303|NCT04373434|Emory University|Michelle C. Kegler, MPH, DrPH|404-712-9957|mkegler@emory.edu|
22412304|NCT00527423|Regeneron Pharmaceuticals|Clinical Trials Administrator||clinicaltrials@regeneron.com|
22412305|NCT03103100|University of Alabama at Birmingham|Dr. Mark Powell|205-975-3328|mfpowell@uabmc.edu|
22412306|NCT00231868|Montefiore Medical Center|Dr. Dennis Yi-Shin Kuo|718-405-8082|DYKUO@montefiore.org|
22412307|NCT02354586|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22412308|NCT00436007|GlaxoSmithKline|GSK Response Center|866-435-7343||
22412309|NCT00721409|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22412310|NCT01957488|Coloplast|Medical Director|+45 4911 1395|dkbir@coloplast.com|
22412311|NCT03879239|Vibrant LTD|Tal Malina / Clinical trials manager|+972 046663322|tal.m@vibrantgastro.com|
22412312|NCT00973700|Novartis Vaccines and Diagnostics|Posting Director||RegContactVacUS.nvdit@Novartis.com|
22412313|NCT03179345|Depomed|Clinical Operations|510-744-8000|clinicaltrials@depomed.com|
22412314|NCT02585700|Clinical Center of Serbia-Clinic for Infectious and Tropical Diseases|Dr. Goran Stevanovic|+381 64 1703059|goran_ste@yahoo.com|
22412315|NCT03104205|Dartmouth-Hitchcock|John A. Batsis|6036505000|john.a.batsis@hitchcock.org|
22412316|NCT01618266|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22412317|NCT00290745|Duke University and Duke Cancer Institute|Dr. E. Shelly Hwang, MD, MPH|(919) 684-6849|shelley.hwang@duke.edu|
22412318|NCT00626925|University of Pennsylvania Perelman School of Medicine|Henry R. Kranzler, M.D.|215-386-6662|kranzler@mail.med.upenn.edu|
22412319|NCT02511236|University of Miami Miller School of Medicine|David J. Lee|305-243-9680|dlee@med.miami.edu|
22412320|NCT03267264|Becton Dickinson|Michael Gibney|201-847-6170|michael_gibney@bd.com|
22412321|NCT02224391|UT MD Anderson Cancer Center|Dr. Jason Robinson, PHD- Associate Professor, Behavioral Science|(713) 792-0919|jdrobinson@mdanderson.org|
22412322|NCT02492958|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22412323|NCT03522948|Boston University|Tibor Palfai|617-353-9345|palfai@bu.edu|
22412324|NCT03718455|Mayo Clinic|Genevieve A. Woodard, M.D., Ph.D.|507-538-3945|Woodard.Genevieve@mayo.edu|
22412325|NCT02236130|University of Mississippi Medical Center|Madhankumar Sathyamoorthy|6018157066|msathyamoorthy@umc.edu|
22412326|NCT01948505|Pacific Neuroscience Institute|Dr. Walavan Sivakumar|424-212-5361|walavan.sivakumar@gmail.com|
22412327|NCT00424489|Northwestern University|Dr. Richard Burt|312-695-4960|rburt@northwestern.edu|
22412328|NCT01984242|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22412329|NCT01346852|GlaxoSmithKline|GSK Response Center|866-435-7343||
22412330|NCT00449150|AEterna Zentaris|Daniel Croteau, Medical Manager|418-652-7669|DCroteau@aezsinc.com|272
22412331|NCT00770510|Eisai Co., Ltd.|Atsushi Kamijo, Study Director|+81-3-3817-5245|a-kamijo@hhc.eisai.co.jp|
22412332|NCT02348385|Yale|Kelly Cosgrove|203-737-6969|kelly.cosgrove@yale.edu|
22412333|NCT02246478|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.||toiawase@taiho.co.jp|
22412334|NCT01189123|Vanderbilt University Medical Center|Dr. Keipp Talbot|6153222035|keipp.talbot@vanderbilt.edu|
22412335|NCT02115646|MGH Wellman Center|Kachiu Lee, MD|4018303128|klee52@partners.org|
22412336|NCT01089647|University of Cincinnati|Dr. Ann Romaker|513-475-7500|romakean@ucmail.uc.edu|
22412337|NCT00006156|National Institute of Child Health and Human Development|Nelson, Lawrence Merle|+1 301 402 6608|nelsonl@mail.nih.gov|
22412338|NCT00198029|Hospital for Special Surgery|Dr. Lisa Mandl|212-774-2555|MandlL@hss.edu|
22412339|NCT02001558|University of Alabama at Birmingham|Yuying Chen, MD, PhD|205-934-3329|yuyingchen@uabmc.edu|
22412340|NCT04117607|ICON CRU|Dr. Dennis Ruff, Senior Medical Director|210-283-4572|Dennis.Ruff@iconplc.com|
22412341|NCT02327195|The Ohio State University Wexner Medical Center|Nicoleta Stoicea|614-293-3559|nicoleta.stoicea@osumc.edu|
22412342|NCT04026126|University of Kansas Medical Center|Paige Geiger, PhD|913-588-7408|pgeiger@kumc.edu|
22412343|NCT01457053|University of Cincinnati Medical Center|Dr. Myron C. Gerson/Professor of Medicine|5135583074|myron.gerson@uc.edu|
22429710|NCT01986751|University of Alabama Birmingham|Dr. Promil Kukreja|205-996-7025|pkukreja@uabmc.edu|
22429711|NCT03712618|National Institutes of Health, Clinical Center (NIH CC)|Dr. Willy Flegel|+1 301 594 7401|bill.flegel@nih.gov|
22429712|NCT04957082|Michigan State University|Dr. Todd Lucas|810-600-5629|lucastod@msu.edu|
22429713|NCT00052715|North American Brain Tumor Consortium|Michael Prados, MD|410-955-8837|jfisher@jhmi.edu|
22429714|NCT01078545|Abbott|Global Medical Services|1-800-633-9110||
22429715|NCT02864914|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
22429716|NCT01774370|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22384623|NCT04969419|Momentum Data Ltd|Dr Andrew McGovern|+44 7531221970|andy.mcgovern@momentumdata.co.uk|
22429717|NCT01118091|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
22429718|NCT04243837|PureTech Health, Inc|Director of Clinical Trials|6034982261|ckorth@puretechhealth.com|
22429719|NCT01708525|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
22429720|NCT02555098|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
22384624|NCT04089371|Stryker|Monica Fleeman|251-465-5969|monica.fleeman@stryker.com|
22429721|NCT03501277|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
22429722|NCT04097223|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22384625|NCT03453619|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
22429723|NCT01489358|Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Dr Julie E Ledgerwood||ledgerwood@mail.nih.gov|
22429724|NCT01873833|USC Norris Comprehensive Cancer Center|Victoria Soto, Regulatory Administrator|323-865-0432|Victoria.Soto@med.usc.edu|
22384626|NCT04237298|NUMalaysia|Dr Asma Ashari, Orthodontist and Senior Lecturer, Principal Investigator|+60192228440|asmaashari@ukm.edu.my|
22429725|NCT01109381|Synergy Pharmaceuticals Pte Ltd|Medical Director|+64 9 522 4278|damian@pethica.net|
22429726|NCT00098293|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22429727|NCT01968785|Medstar Health Research Institute|Megan Rowland|2028772959|megan.e.rowland@medstar.net|
22429728|NCT03343886|Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Madrid, Spain.|José Luis Ayuso Mateos||joseluis.ayuso@uam.es|
22429729|NCT03193307|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22384627|NCT04950192|Philips IGTD|Rashmi Ram, Director of Clinical Development|719-464-6326|rashmi.ram@philips.com|
22429730|NCT02018809|University of Pennsylvania|Dr. Peter P. Reese|215-898-6086|peter.reese@uphs.upenn.edu|
22429731|NCT01666314|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22429732|NCT04739709|AimMax Therapeutics Inc.|Chief Medical Officer|919-797-1146|admin@aimmaxrx.com|
22429733|NCT03927716|Novan|Cathy White, Vice President, Drug Development Operations|919-485-8080|clinical@novan.com|
22444885|NCT00195273|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22444886|NCT01886716|Miami University|Dr. Elise Clerkin|513-529-2483|clerkiem@miamioh.edu|
22444887|NCT02367131|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22444888|NCT01012167|Maryland Psychiatric Research Center|William Carpenter, Jr.|410-402-7101|wcarpent@mprc.umaryland.edu|
22444889|NCT00161473|VA Puget Sound Healthcare System|Lucy Y. Wang, M.D.|206-277-5089|wanglucy@u.washington.edu|
22444890|NCT02841189|Indiana University|Nicole Horn MD|317-944-9981|nhorn@iupui.edu|
22444891|NCT01051466|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22444892|NCT00810108|University of California San Diego|Dr. Brookie M. Best, Associate Professor|858-822-5550|brookie@ucsd.edu|
22444893|NCT03326726|Medline Industries|Sr. Regulatory Affairs Specialist|847-643-3515|aminarcik@medline.com|
22444894|NCT01006369|Rutgers Cancer Institute of New Jersey|Elizabeth Poplin MD|732-235-7620|poplinea@cinj.rutgers.edu|
22444895|NCT04806503|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22444896|NCT03589469|ADC Therapeutics SA|Clinical Trials Information|954-903-7994|clinical.trials@adctherapeutics.com|954
22444897|NCT02754557|Emory University|Negar Fani, PhD|404-712-0354|nfani@emory.edu|
22444898|NCT00841971|University of Pittsburgh|Dr Nina Singh|412 360-1688|nis5@pitt.edu|
22444899|NCT04465162|UT MD Anderson Cancer Center|Dr. Bouthaina S Dabaja, MD-Professor, Radiation Oncology Department|(713) 563-2406|bdabaja@mdanderson.org|
22444900|NCT00504985|UT MD Anderson Cancer Center|Xin Shelley Wang, MD, MPH / Associate Professor|713-745-3504||
22444901|NCT01288027|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22444902|NCT01550471|Allegheny Health Network|Deborah Gentile, Principal Investigator|412-359-4099|dgentile@wpahs.org|
22444903|NCT02556203|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
22444904|NCT00739999|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22444905|NCT01431131|University of Louisville|Dr. Henry Greenwell, Principal Investigator|502-852-6928|henry.greenwell@louisville.edu|
22444906|NCT02180165|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22444907|NCT01359007|University of Oklahoma|Ingrid Block - CTO Directo|405-271-8777|ingrid-block@ouhsc.edu|
22444908|NCT02943460|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22444909|NCT00369122|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
22444910|NCT04171765|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22444911|NCT03633617|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22444912|NCT02540226|Hospital for Special Surgery|Dr. Kethy Jules-Elysee|212-606-1206|JulesElyseeK@HSS.EDU|
22444913|NCT00809354|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22444914|NCT04396665|University of Oviedo|Vicerrectorado de investigación|+34985104190|viceinvestigacion@uniovi.es|
22444915|NCT04137224|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
22444916|NCT02315989|Linkou Chang Gung Memorial Hospital|Hong, Ji-Hong M.D.|03-3281200|jihong@cgmh.org.tw|2600
22444917|NCT02148107|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22444918|NCT04137627|Universitas Indonesia|Dr. dr. Diani Kartini, Sp.B-K(Onk)|+628122684919|d.kartini@gmail.com|
22384628|NCT05285618|University of California, Santa Barbara|Michael Beyeler|(805) 893-4321|mbeyeler@ucsb.edu|
22384629|NCT04251299|University of New Mexico|Dr. Cindy Blair|15059257907|CiBlair@salud.unm.edu|
22444919|NCT02234986|CASI Pharmaceuticals, Inc.|Dr. Alexander Zukiwski|+1 240 864 2888|alexz@casipharmaceuticals.com|
22444920|NCT01199731|ViiV Healthcare|GSK Response Center|866-435-7343||
22444921|NCT04010539|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22444922|NCT02028871|University of Illinois at Chicago|Dr. Ajna Hamidovic|312-355-1713|ahamidov@uic.edu|
22444923|NCT05708586|University of Michigan|Dr. Noelle Whyte|734 936-5780|whyteno@umich.edu|
22444924|NCT02314143|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22444925|NCT01289457|The University of Texas M D Anderson Cancer Center|Jabbour,Elias Joseph, M.D./Associate Professor|713-792-4764|CR_Study_Registration@mdanderson.org|
22444926|NCT00179127|Vanderbilt University Medical Center|Sheila McMorrow|615-343-8332||
22444927|NCT03194503|The Children's Hospital of Philadelphia|Dr. Akira Nishisaki|267-426-0665|NISHISAKI@email.chop.edu|
22444928|NCT00457366|USC|Dr George Simpson|7604687106|gsimpson@usc.edu|
22444929|NCT04231318|Anika Therapeutics|Kara Mezger, Executive Director Clinical Affairs|781.457.9000|kmezger@anika.com|
22444930|NCT01528215|DENTSPLY Implants|Manager Global Clinical Affairs|+46313763500|ClinicalResearchMolndal@dentsplysirona.com|
22444931|NCT02322021|Eisai Medical Information|Eisai Ltd.|+1-888-274-2378|esi_medinfo@eisai.com|
22444932|NCT01934972|The Ohio State University|Nicholas Breitborde, PhD|614-685-6052|nicholas.breitborde@osumc.edu|
22444933|NCT01278160|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22444934|NCT00560885|AtriCure, Inc.|Jim Lucky|1-513-755-4101|jlucky@atricure.com|
22444935|NCT03148275|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
22444936|NCT00814788|University of California Davis|Analyst|916 734 0294|pkaujla@ucdavis.edu|
22444937|NCT03803683|Columbia University|Rebecca Schnall, PhD, MPH, RN-BC, FAAN, FACMI|212-342-6886|rb897@cumc.columbia.edu|
22444938|NCT04493333|University of Arkansas for Medical Sciences|I-Shin Wen|5016868274|iwen@uams.edu|24024
22444939|NCT02925923|University of Alabama at Birmingham|Leah Pogwizd|(205) 996-4410|leahpogwizd@uabmc.edu|
22444940|NCT00697073|Santhera|Dr Thomas Meier|+41 61 906 8964|thomas.meier@santhera.com|
22444941|NCT03911713|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22444942|NCT00145704|Upstate Orthopedics|Timothy A. Damron|315-464-8602|damront@upstate.edu|
22444943|NCT01845818|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22444944|NCT02595970|Novartis Pharmaceuticals|Study Director|+1(862)778-8300|Novartis.email@novartis.com|
22444945|NCT02219438|UCSD|Dr Brian Ilfeld|(619) 543-5560|bilfeld@ucsd.edu|
22444946|NCT05061966|University of Pensylvania|Dr. Jose Bauermeister|215-898-9993|bjose@upenn.edu|
22444947|NCT03793556|Sofar Spa|Dr Francesca Baldan|0039 02 909362|francesca.baldan@sofarfarm.it|1
22444948|NCT02923427|DorkuzEU|Anaesthesiology and Intensive Care, Sule Ozbilgin|905055252901|ozbilginsule@gmail.com|
22444949|NCT01325623|Cyberonics Europe BVBA|Wim Van Grunderbeek, Clinical Operations Manager Cyberonics Europe|+32 2 720 95 93|wim.vangrunderbeek@cyberonics.com|312
22444950|NCT01420653|AFT Pharmaceuticals Ltd.|Jennifer Zhang|+ 64 9 488 0232|jenniferz@aftpharm.com|710
22444951|NCT01539642|AcelRx Pharmaceuticals, Inc|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
22444952|NCT00598702|Mallinckrodt Pharmaceuticals|Lawrence Hill, VP Clinical Development|908-238-6370|lawrence.hill@mallinckrodt.com|
22444953|NCT00438451|Interdisciplinary Center for Clinical Trials (IZKS Mainz)|C. Ruckes|+49 (0) 6131 17|ruckes@izks-mainz.de|9919
22444954|NCT02413372|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22444955|NCT03584100|Stanford University|Jeffrey Yao|650-723-5643|jyao@stanford.edu|
22444956|NCT01480089|Loyola University|Elizabeth Mueller, M.D.|708-216-2180|emuelle@lumc.edu|
22444957|NCT00783965|ChildrensHRCOakland|Raj Prasad|510-450-7602|rprasad@chori.org|7602
22444958|NCT02781779|Kansas City Heart Rhythm Institute|Donita Atkins|816-651-1969|donita.atkins@hcahealthcare.com|
22444959|NCT00745940|Lakehead University|Dr. Michel Bédard|807-343-8630|mbedard@lakeheadu.ca|
22444960|NCT03053271|Millendo Therapeutics|Clinical Trial Information|+1 734 845-9000|millendo@millendo.com|
22444961|NCT00580970|Virginia Commonwealth University/Massey Cancer Center|Mitchell S. Anscher, M.D. Professor and chairman|804-828-7238|mitchell.anscher@vcuhealth.org|
22444962|NCT02654314|Yale Center for Analytical Sciences|Jesse S Reynolds|(203) 785-5445|jesse.reynolds@yale.edu|
22444963|NCT03161093|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22444964|NCT00570765|Intercept Pharmaceuticals, Inc.|Medical Information|844-782-4278|medinfo@interceptpharma.com|
22444965|NCT01031706|University of North Carolina at Chapel Hill|Dr. Scott H. Donaldson|919-966-9198|scott_donaldson@med.unc.edu|
22444966|NCT02124161|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22444967|NCT02657538|Department of Preventive, Restorative and Pediatric Dentistry, University of Bern|PD Dr. Klaus Neuhaus|+41 (0)31 632 49 74|klaus.neuhaus@zmk.unibe.ch|
22444968|NCT01669928|Imperial College London|Professor Neil Poulter|+44 20 7594 3446|n.poulter@imperial.ac.uk|
22444969|NCT02439879|Universidad Popular Autonoma del Estado de Puebla|Dr. Hector Garcia Alcala|+522222299400|hector.garcia@upaep.mx|7466
22444970|NCT01954342|Pennington Biomedical Research Center|Dr. Leanne Redman|2257630947|Leanne.Redman@pbrc.edu|
22444971|NCT02437383|University of North Carolina at Chapel Hill|Dr. Inna E. Tchivileva|1 919 537 3291|inna_tchivileva@unc.edu|
22444972|NCT00984568|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22384630|NCT04556656|Prilenia|Prilenia|+972 775558|info@prilenia.com|
22444973|NCT05085730|UT Southwestern|Research Coordinator|214-645-8907|jennifer.barillas@utsouthwestern.edu|
22444974|NCT01649804|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22384631|NCT05536440|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22444975|NCT03845543|iD3 Medical|Clinical Research Professional|+32 (0)52252745|office@iD3medical.com|
22444976|NCT01400815|22nd Century Group, Inc.|Karen Delaney|716-270-1523|kdelaney@xxiicentury.com|
22444977|NCT04242173|Moffitt Cancer Center|Christine Chung|1-813-745-5061|Christine.Chung@moffitt.org|
22444978|NCT03789214|The Johns Hopkins University School of Medicine|Andrew S. Huhn, Ph.D.|410-550-1971|ahuhn1@jhu.edu|
22444979|NCT01687036|Medical University Innsbruck, Department of Internal Medicine III, Cardiology|Markus Stühlinger, MD|+43 512 504|markus.stuehlinger@uki.at|81 320
22444980|NCT01912963|Dana-Farber Cancer Institute|Rachel Freeman MD|617.632.3000|Rachel_Freedman@dfci.harvard.edu|
22444981|NCT03139318|University of Arkansas for Medical Sciences|Beth Scanlan|5016868274|bscanlan@uams.edu|
22444982|NCT03530800|University of Chicago|Dr. Jon E. Grant|7738341325|jgrant4@bsd.uchicago.edu|
22444983|NCT01336569|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Medical Affairs Leader, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com|
22444984|NCT00406354|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22444985|NCT00273910|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
22444986|NCT01721473|VA San Diego Healthcare System|Arthur Brody|8585528585|arthur.brody@va.gov|
22444987|NCT02080637|Duke University|Kevin Hill, M.D.|919-668-8305|kevin.hill@duke.edu|
22444988|NCT01483807|VA SALT LAKE CITY HEALTHCARE SYSTEM|Dr. Julie Wambaugh|8015821565|julie.wambaugh@health.utah.eduj|1363
22444989|NCT03438383|Department of Vascular Surgery, Korgialeneio-Benakeio Hellenic Red Cross Hospital, Athens, Greece|Dr. Konstantinos Roditis, Study Chair|+306976686951|roditis.k@gmail.com|
22444990|NCT02435069|Nemours Children's Clinic|Kimberly S. Jarczyk, PhD, C-PNP|9044611730|jarczykks@gmail.com|
22444991|NCT00590889|St.Jude Medical|Heidi Hinrichs, VP of Clinical Study Management, St. Jude Medical||hhinrichs@sjm.com|
22444992|NCT01498601|Fraser Health|Trudy Robertson RN, MSN, CNN(c)|604-520-4715|Trudy.Robertson@fraserhealth.ca|
22444993|NCT02030938|Sofregen|Clinical Project Manager|4029991564|fjawed@sofregen.com|
22444994|NCT01599832|University of Chicago Comprehensive Cancer Center|Walter Stadler|(773) 702-4150|wstadler@medicine.bsd.uchicago.edu|
22444995|NCT03954132|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
22444996|NCT03170856|Boston Children's Hospital|Dr. William Meehan|781-216-1328|william.meehan@childrens.harvard.edu|
22444997|NCT00932737|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22444998|NCT02401022|National Institute on Drug Abuse|Liza Zeinert|301-443-1138|liza.zeinert@nih.gov|
22444999|NCT05156073|Johns Hopkins University School of Medicine|Dr. Ariel Green|(410) 550-6733|ariel@jhmi.edu|
22445000|NCT00973349|Novartis Vaccines and Diagnostics|Posting Director||RegContactVacUS.nvdit@Novartis.com|
22445001|NCT02780609|Moffitt Cancer Center|Taiga Nishihori, MD|813-745-1856|Taiga.Nishihori@moffitt.org|
22445002|NCT02898116|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22445003|NCT02130024|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22445004|NCT03763318|Equillium|Clinical Operations|858-240-1200|clinicaltrials@equilliumbio.com|
22445005|NCT05597020|Idorsia Pharmaceuticals Ltd|Idorsia Clinical Trial Information|+1 856 661 3721|idorsiaclinicaltrials@idorsia.com|
22445006|NCT05736224|Yale University Department of Dermatology|Kacie Carlson, Physician Assistant|203 785 7432|Kacie.carlson@yale.edu|
22445007|NCT01015131|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22445008|NCT04526509|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22445009|NCT02422940|Acorda Therapeutics|Holy Roberts, Executive Medical Director - Medical Affairs|914-326-5224|hroberts@acorda.com|
22445010|NCT02791399|VA Portland Health Care System|Benjamin Morasco, PhD|5032208262|benjamin.morasco@va.gov|
22445011|NCT00704912|Penn State College of Medicine, Penn State Milton S. Hershey Medical Center|Richard S. Legro, M.D.|717-531-8478|rsl1@psu.edu|
22445012|NCT02206048|UT MD Anderson Cancer Center|Dr. Kathleen M. Schmeler, MD|713-745-3518|kschmele@mdanderson.org|
22445013|NCT00282412|Northwestern University|Dr Richard Burt|312-695-4960|rburt@northwestern.edu|
22445014|NCT00509041|University of Minnesota Masonic Cancer Center|Arkadiusz Dudek, MD, PhD||dudek002@umn.edu|
22445015|NCT02203071|University of Missouri|Research Project Analyst|573-882-7583|jonesvicki@health.missouri.edu|
22445016|NCT02572388|University of Oxford|Adrian V Hill, DPhil FRCP|+44 1865 617610|adrian.hill@ndm.ox.ac.uk|
22445017|NCT00082342|NINDS, NIH|Mark Hallett, MD, Chief|301-496-9526|hallettm@ninds.nih.gov|
22445018|NCT02202837|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22445019|NCT01871142|Colorado State University|Christopher Bell, Ph.D.|(970) 491-7522|christopher.bell@colostate.edu|
22445020|NCT03485391|Ralph H. Johnson VA Health Care System|Stephanie Hart|843-577-5011|Stephanie.Hart4@va.gov|205103
22445021|NCT02006888|IconBioscience|Howard Franklin|2153961332|hfranklin@iconbioscience.com|215
22445022|NCT01137396|Yale University|Peter Morgan|203-974-7560|peter.morgan@yale.edu|
22445023|NCT03089320|Yale University|Dr. David Fiellin|203-737-3347|david.fiellin@yale.edu|
22429734|NCT01452347|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22429735|NCT05762744|University of Maryland School of Medicine|Simeon Taylor, MD, PhD (Professor of Medicine0|4107066439|staylor2@som.umaryland.edu|
22429736|NCT02724644|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquires@endo.com|
22429737|NCT01882829|Icahn School of Medicine at Mount Sinai|Dr. James W Murrough|212-241-7574|james.murrough@mssm.edu|
22429738|NCT03312114|University of Texas Southwestern Medical Center|Phase II trial of Concurrent Anti-PD-L1 and SAbR for Patients with Persistent or Recurrent Epithelia|(214) 645-7296|kevin.albuquerque@utsouthwestern.edu|
22429739|NCT04668599|The MetroHealth|Vidya Krishnan|2167784527|vkrishnan@metrohealth.org|
22429740|NCT03403517|Rigshospitalet|Kristin steinthorsdottir|004531666112|kjs@dadlnet.dk|
22429741|NCT04634903|Stony Brook University|Dr. Jessica Schleider|917-439-1872|jessica.schleider@stonybrook.edu|
22445024|NCT00231842|Montefiore Medical Center|Mark Einstein, MD, MS|718-405-8082|meinstei@montefiore.org|
22445025|NCT02422303|University of Texas Health Science Center San Antonio|Bonnie Gillis|210-567-4500|gillis@uthscsa.edu|
22445026|NCT03481907|George Washington University|Dr. Adam Friedman|214 235 7381|ajfriedman@mfa.gwu.edu|
22445027|NCT00428792|Novartis Pharmaceuticals|Study Director|862 778-8300||
22445028|NCT00850343|Astellas Pharma Inc.|Medical Director, Global Medical Sciences||ClinicalTrials.Disclosure@astellas.com|
22445029|NCT02468232|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
22445030|NCT01973569|Contact for Clinical Trial Information|Daiichi Sanyko|+81 362251111 (M-F 9-5 JST)|dsclinicaltrial@daiichisankyo.co.jp|
22445031|NCT00371826|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22445032|NCT02436304|Alcon, A Novartis Division|Clinical Scientific Director, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
22445033|NCT01237821|Penn State Hershey Medical Center|Diane Thiboutot|717-531-1513|dthiboutot@pennstatehealth.psu.edu|
22445034|NCT03423641|Kaiser Permanente|Elizabeth McGlynn, Ph.D.|6265643807|Elizabeth.A.Mcglynn@kp.org|
22445035|NCT04540497|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22445036|NCT02710396|Columbia University Herbert Irving Comprehensive Cancer Center|Catherine Shu|212 305 3997|cas2145@cumc.columbia.edu|
22445037|NCT05274815|AstraZeneca|Global Clinical Lead|8772409479|information.center@astrazeneca.com|
22445038|NCT03914326|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22445039|NCT04612790|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22445040|NCT00785928|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22445041|NCT04644003|STALICLA SA|Eric Painbeni, PhD - Head of Clinical Operations|+41 (0)79 918 33 16|clinical@stalicla.com|
22445042|NCT05027464|Veterans Affairs San Francisco HCS|Nicole McCamish|415-221-4810|nicole.mccamish@va.gov|24284
22445043|NCT03764007|University of California, San Francisco|Dr. Thomas A. Hope, MD|(415) 221-4810|Thomas.Hope@ucsf.edu|
22445044|NCT03611010|Cumberland Pharmaceuticals Inc.|Senior Manager, Clinical Development|6155642188|imaciasperez@cumberlandpharma.com|
22445045|NCT01675427|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22445046|NCT01924988|Georgetown University Medical Center|James B. Spies MD MPH|202-444-3450|spiesj@gunet.georgetown.edu|
22445047|NCT03572244|University of Iowa|Dr. Chris Barwacz|3193843002|chris-barwacz@uiowa.edu|
22445048|NCT05021081|Johnson & Johnson Vision Care, Inc. (JJVC)|John R. Buch, O.D., M.S., F.A.A.O.|1-800-843-2020|jbuch@its.jnj.com|
22445049|NCT02059902|Health Partners|Dr. William J Mohr|(651)454-5304|William.J.Mohr@healthpartners.com|
22445050|NCT03028103|Epizyme|Kemly Calixte|617-500-0608|kcalixte@epizyme.com|
22445051|NCT03257371|University of Missouri|Dr. James Cook|573-882-7189|cookjl@health.missouri.edu|
22445052|NCT03387683|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22445053|NCT01631110|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
22445054|NCT00566501|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22445055|NCT05095454|Mayo Clinic|Tyson Scrabeck|507-538-1016|scrabeck.tyson@mayo.edu|
22445056|NCT00057876|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
22445057|NCT01368432|Johns Hopkins University & school of Medicine|Vani Rao|410-550-2288|vrao@jhmi.edu|
22445058|NCT02758171|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22384632|NCT01566695|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22384633|NCT04882449|Bodyport Inc.|Dorothy Kwok, Head of Clinical Operations|669-240-3077|dorothy@bodyport.com|
22384634|NCT01416831|Earle A. Chiles Research Institute, Providence Cancer Institute|Brendan Curti, M.D.|503-215-6588|brendan.curti@providence.org|
22384635|NCT05470400|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
22384636|NCT05956002|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22384637|NCT04784559|PharmaMar|Clinical Development Virology Business Unit|+34 918466000|virologytrials@pharmamar.com|
22384638|NCT05323084|Pennington Biomedical Research Institute|Prachi Singh|15072068331|prachi.singh@pbrc.edu|
22384639|NCT01261312|Astex Pharmaceuticals, Inc.|Dr. Harold Keer|925-560-2913|harold.keer@astx.com|
22384640|NCT04294225|Mayo Clinic|Tufia C Haddad MD|507/284-2511|Haddad.Tufia@mayo.edu|
22384641|NCT01198366|Aeras|Product Director|301-547-2919|blandry@aeras.org|
22384642|NCT03336333|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
22384643|NCT02589275|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 904-0355|greg.sullivan@tonixpharma.com|
22384644|NCT05751382|Dentsply Sirona Implants and Consumables|AnnaKarin Lungren Dr.|0046 702 666 492|annakarin.lundgren@dentsplysirona.com|
22384645|NCT05671029|AiCuris Anti-infective Cures GmbH|Information Desk|+4920231763|info@aicuris.com|0
22384646|NCT03846505|Medical University of South Carolina - Institute of Psychiatry|Stacey Sellers, Lab Manager|8437925807|sellersst@musc.edu|
22384647|NCT03665597|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22398576|NCT01877564|University of Arkansas for Medical Sciences|Beth Scanlan|5016868274|BScanlan@uams.edu|
22398577|NCT00353418|Hoffmann-La Roche|Medical Communications|800-821-8590||
22398578|NCT01347034|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D.|813-745-3050|alberto.chiappori@moffitt.org|
22398579|NCT00257010|Janssen-Ortho LLC|Vice President, Medical Affairs||ClinicalTrialDisclosure@its.jnj.com|
22398580|NCT04016311|The University of Texas at Austin, School of Nursing|Gayle M. Timmerman PhD, Professor|5124719087|gtimmerman@mail.utexas.edu|
22384648|NCT05516147|Hopeful Aging|Michael Skrajner|440-477-7881|mike@hopefulaging.com|
22445059|NCT00853073|Wills Eye Hospital|Marlene R. Moster, MD|215-928-3123|marlenemoster@gmail.com|
22445060|NCT01999114|Purdue Pharma L.P.|Clinical Leader|800-733-1333|stephen.harris@pharma.com|
22384649|NCT02386371|INSTITUT REGIONAL DU CANCER DE MONTPELLIER Cancer de Montpellier|Mme Aurore Moussion, Director of Direction of Clinical Research and Innovation|0467613102|drci-icm105@icm.unicancer.fr|+33
22445061|NCT03840174|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22445062|NCT01008150|NSABP Foundation, Inc|Director, Department of Regulatory Affairs|412-339-5300|judy.langer@nsabp.org|
22445063|NCT01649609|Columbia University Medical Center|Sumit Mohan, MD|2123053273|sm2206@cumc.columbia.edu|
22445064|NCT03420625|Karolinska University Hospital|Dr. Paul Ackermann|+46 8 517 700 00|paul.ackermann@sll.se|717 34
22445065|NCT02617888|Ft. Belvoir Community Hospital|Michael K. Cheezum, MD|571-231-2159|Michael.k.cheezum.mil@mail.mil|
22445066|NCT00762216|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22445067|NCT00178633|University of Texas Medical School at Houston|Heinrich Taegtmeyer, MD, DPhil, Principal Investigator|713 500-6569|heinrich.taegtmeyer@uth.tmc.edu|
22445068|NCT05012657|Point Designs|Director of Clinical Research|7206004753|research@pointdesigns.com|
22445069|NCT04810481|Medtronic|Keith Holloman|6126707136|keith.holloman@medtronic.com|
22445070|NCT01318642|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|866-572-6436|Bobby.Reddy@Immunitybio.com|
22445071|NCT03649867|NHS Tayside - Dundee Adult Psychological Therapies Service|Dr Lucie Bartoskova|00441382346556|lucie.bartoskova@nhs.net|
22445072|NCT01810588|Weill Cornell Medicine|Alexandra Gomez Arteaga, MD|646-962-7950|alg9117@med.cornell.edu|
22445073|NCT00381381|Eisai Korea Inc.|Jihee Mun, Pharmacist, Medical team manager|+82-2-3451-5531|jihee_mun@eisaikorea.com|
22445074|NCT00568685|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22445075|NCT02787551|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22445076|NCT03799211|NYU Langone Health|Mia Minen, MD, MPH|212-263-7744|Mia.Minen@nyulangone.org|
22445077|NCT00764491|Spineology|Rose Griffith, Sr. Director, Clinical Affairs|651-256-8503|Rgriffith@spineology.com|
22445078|NCT00542971|The University of MD Anderson Cancer Center|Farhad Ravandi-Kashani, M.D./Associate Professor|713-745-0394|fravandi@mdanderson.org|
22384650|NCT04450342|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
22384651|NCT02874534|University of North Carolina at Chapel Hill|Gabriel S. Dichter, PhD|9194450132|dichter@med.unc.edu|
22384652|NCT02926911|Duke university|Dr. Shelley Hwang|919-668-6688|shelley.hwang@duke.edu|
22384653|NCT02317783|Huntsman Cancer Institute, Center for Quantitative Cancer Imaging|Sam Mitchell|801-213-6110|sam.mitchell@hci.utah|
22384654|NCT03941860|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22384655|NCT04093752|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22384656|NCT05386069|Prisma Health|Manager OBGYN Research|864-455-1510|patti.parker@prismahealth.org|
22384657|NCT02318901|WRMC|Jessica L. Coats|623-207-3899|jessica.coats@ctca-hope.com|
22384658|NCT03811366|Hospital das clínicas- Faculdade de Medicina da Universidade São Paulo|Dra Joyce Hisae Yamamoto|41988263757|vmsakata@yahoo.com.br|
22384659|NCT04774237|Visus Therapeutics, Inc.|Visus Therapeutics|800-281-4536|trials.info@visustx.com|
22384660|NCT02520063|UAB|Erica Stringer-Reasor|2059759375|esreasor@uabmc.edu|
22384661|NCT03264131|UNC Lineberger Comprehensive Cancer Center|Melahat Garipagaoglu Canter|919-962-0000|Melahat_Canter@med.unc.edu|
22384662|NCT02485834|Weill Medical College of Cornell University|Manish A. Shah MD|646-962-6200|mas9313@med.cornell.edu|
22384663|NCT05121740|PharmaMar, S.A.|Clinical Development Virology Business Unit PharmaMar|91 846 60 00|virologytrials@pharmamar.com; clinicaltrials@pharmamar.com|
22384664|NCT06391177|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-7428|medicalinformation@phathompharma.com|
22384665|NCT04311996|University of Minnesota|Bonny Donzella|6126244351|donzella@umn.edu|
22384666|NCT02630823|Washington University School of Medicine|Premal Thaker, M.D., MSc.|314-362-1740|thakerp@wustl.edu|
22384667|NCT05159583|University of California, Berekeley|Robert W. Levenson|510-643-8952|boblev@berkeley.edu|
22384668|NCT03676582|Sheffield Teaching Hospitals NHS Trust|Lise Sproson|07753827428|Lise.Sproson@nihr.ac.uk|
22384669|NCT03328702|University of California, Davis|Dr. Peter Belafsky|8582053366|pcbelafsky@ucdavis.edu|
22384670|NCT05993078|Tianjin Medical University General Hospital|Jiayue Ding|18518347837|sjnkzz2@163.com|
22384671|NCT04674358|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
22384672|NCT03158805|Lindner Center of HOPE|Susan McElroy|5135360700|susan.mcelroy@lindnercenter.org|
22384673|NCT03703700|Center for Reproductive Medicine, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University|Dr. Dongzi Yang|8602081332233|yangdz@mail.sysu.edu.cn|
22384674|NCT02682316|Memorial Sloan Kettering Cancer Center|Dr. Mario Leitao, MD|212-639-3987|leitaom@mskcc.org|
22384675|NCT03394846|University of South Carolina|Robert Glenn Weaver|8037775605|weaverrg@mailbox.sc.edu|
22384676|NCT05543746|University of North Carolina at Chapel Hill|Rachel Kozik|919-590-0813|rachel_kozik@med.unc.edu|
22384677|NCT04975880|Quanta Dialysis Technologies|Dr. Paul Komenda|(204) 510-5219|paul.komenda@quantadt.com|
22384678|NCT04049747|Imperial College London|Ms Puja Jadav|020 7594 7773|p.jadav@imperial.ac.uk|
22384679|NCT04092387|University of Vermont|Stephen T. Higgins, PhD|802-735-6267|stephen.higgins@uvm.edu|
22384680|NCT03205800|University of Maryland, Baltimore|Se-Lim Oh|4107063708|soh@umaryland.edu|
22384681|NCT05449795|Ascensia Diabetes Care|Jane Wallace|5748501467|jane.wallace@ascensia.com|
22384682|NCT04501861|Cleveland Clinic Foundation|Dr. Mariya Geube|216-444-2779|Geubem@ccf.org|
22384683|NCT04234698|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22384684|NCT01007591|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
22384685|NCT04083235|Ipsen Pharma|Medical Director|see email|clinical.trials@ipsen.com|
22384686|NCT03016169|Abbott|Karine Miquel, Associate Director of Project Management|+32 479 600 107|karine.miquel@abbott.com|
22384687|NCT04060355|Emory University, School of Nursing|Kenneth Hepburn, PhD|404-712-9286|khepbur@emory.edu|
22412344|NCT02532010|Weill Cornell Medicine|Dr. Sangmin Lee|646-962-2700|sal9053@med.cornell.edu|
22412345|NCT04333095|Baylor Scott & White Research Institute|Sarah Hale, Project Manager|469-814-4845|Sarah.Hale@BSWHealth.org|
22412346|NCT02364557|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22412347|NCT04347239|CytoDyn Inc.|Bernie Cunningham, PhD, MRPharmS; VP Operations|5164060197|bcunningham@cytodyn.com|
22412348|NCT04582539|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22412349|NCT01004770|GE Healthcare|Rubin Sheng, MD|1-609-514-6899|rubin.sheng@ge.com|
22412350|NCT00788957|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22412351|NCT00662129|Mayo Clinic|Donald W. Northfelt, MD, FACP|507/284-1159|northfelt.donald@mayo.edu|
22412352|NCT00767507|The Medicines Company|Meredith Todd - Sr. Director Program Management|+1.973.290.6088|meredith.todd@themedco.com|
22412353|NCT00966953|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
22412354|NCT00796510|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22412355|NCT03072459|Smith & Nephew, Inc.|Salima Reddy|817-916-2233|salima.reddy@smith-nephew.com|
22412356|NCT02841709|Idorsia Pharmaceuticals Ltd|Clinical Trials Disclosure Desk|+41 588 441977|clinical-trials-disclosure@idorsia.com|
22412357|NCT01210001|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22412358|NCT02051309|Yale School of Medicine|Sherry McKee PhD|2037373529|sherry.mckee@yale.edu|
22412359|NCT01669538|University of Pennsylvania|Rebecca Ashare|2157465789|rlashare@pennmedicine.upenn.edu|
22412360|NCT03581448|Florida Atlantic University|Dr. Erik Engeberg|5612970530|eengeberg@fau.edu|
22412361|NCT01076972|Abbott|Global Medical Services|800-633-9110||
22412362|NCT03900624|Johns Hopkins All Children's Hospital|Dr. Anthony Sochet|7277672912|Anthony.Sochet@jhmi.edu|
22412363|NCT03252964|Savvysherpa, Inc.|Jared Jones, PhD|7635493540|JaredJones@savvysherpa.com|8116
22412364|NCT00872079|University of Louisville|Michael Brier|502-852-0246|mbrier@louisville.edu|
22412365|NCT04526210|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22412366|NCT01781637|Boston Children's Hospital|Lynda Schneider|617-355-6180|lynda.schneider@childrens.harvard.edu|
22412367|NCT02637232|Galderma|Stéphanie Leclerc|+33492386706|stephanie.leclerc@galderma.com|
22429742|NCT00476788|Greenville Hospital System|Elaine Moreland MD|8644545661|emoreland@ghs.org|
22429743|NCT01245751|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22429744|NCT01034527|Mayo Clinic|Dr. Timothy Hewett|513-636-5971|hewett.timothy@mayo.edu|
22429745|NCT02011464|Maimonides Medical Center|Dr. Piyush M Gupta|7182837189|pgupta@maimonidesmed.org|
22429746|NCT02164721|University of Rochester|Valentina Kutyifa MD, PhD|585-275-2676|valentina.kutyifa@heart.rochester.edu|
22429747|NCT02391584|Entellus Medical|Clinical Affairs Manager|7634631595|rschacherer@entellusmedical.com|
22429748|NCT03636269|Cara Therapeutics|Frédérique Menzaghi, PhD|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
22429749|NCT04250363|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22429750|NCT01507103|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22429751|NCT01291160|Ogenix|S.Sarangapani|7817026732|ssarangapani@ogenix.com|
22429752|NCT02852434|Stanford University Division of Family Planning Services and Research|Stanford University, Department of OB/GYN|6507211562|familyplanningresearch@stanford.edu|
22429753|NCT05075772|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22429754|NCT03188705|University of Maryland School of Medicine|Joshua P. Lewis, PhD|410-706-5087|jlewis2@som.umaryland.edu|
22429755|NCT03774810|University of Pennsylvania|Michael L. Perlis, PHD|215-746-3577|mperlis@upenn.edu|
22429756|NCT02212977|Duke University Medical Center|Dr. Charles Kim|9196847424|charles.kim@duke.edu|
22429757|NCT01145222|PAION UK Ltd|Trial Information||reg_paion@paion.com|
22429758|NCT00927186|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22429759|NCT00604383|Chromaderm|info@chroma-derm.com||info@chroma-derm.com|
22429760|NCT00201773|The Ohio State University Comprehensive Cancer Center|Steven Provoski, MD|614-293-8700|Stephen.Povoski@osumc.edu|
22429761|NCT04985682|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22429762|NCT01694186|Eyepoint Pharmacueticals|Clinical Affairs|6179726204|fleonin@eyepointpharma.com|
22429763|NCT03016403|Latino Research and Policy Center, University of Colorado Denver|Evelinn Borrayo, Associate Director|303-724-0884|Evelinn.Borrayo@cuanschutz.edu|
22429764|NCT00799864|Janssen R&D BE|Director 1 Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22429765|NCT00576407|Duke University Medical Center|M. Louise Markert, MD, PhD Professor of Pediatrics and Immunology|919-684-6263|marke001@mc.duke.edu|
22429766|NCT00621322|GlaxoSmithKline|GSK Response Center|866-435-7343||
22429767|NCT00225758|Dartmouth-Hitchcock Medical Center|Gary N. Schwartz, MD|(603) 653-6181|gary.n.schwartz@hitchcock.org|
22429768|NCT04641975|Astellas Pharma Global Development Inc|Clinical Trial Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
22429769|NCT04299425|Vanderbilt University Medical Center|Dr. Carmen C Solorzano|615-343-2735|carmen.solorzano@vumc.org|
22429770|NCT01431573|NYSPI|David Hellerstein|646-774-8069|david.hellerstein@nyspi.columbia.edu|
22429771|NCT00063362|University Hospitals Case Medical Center|Dr. Keming Gao|216-844-2865|keming.gao@UHhospitals.org|
22429772|NCT05587998|AstraZeneca|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
22429773|NCT05574764|Duke University|Emily M. D'Agostino, DPH, MS, MEd, MA|646-853-1223|emily.m.dagostino@duke.edu|
22429774|NCT03528577|SPIL|Clinical Trials|912266455645|clinical.trials@sparcmail.com|
22445079|NCT00240227|VA Puget Sound Health Care System|Andrew J. Saxon, M.D.|206-764-2782|andrew.saxon@va.gov|
22412368|NCT02999178|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22429775|NCT00601107|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22429776|NCT03892915|RAND Corporation|Glenn Wagner|310-393-0411|gwagner@rand.org|7695
22429777|NCT03364686|University of Pittsburgh|Darrell J. Triulzi, MD|412-209-7304|triudj@upmc.edu|
22429778|NCT01520714|The Heart Hospital Baylor Plano|Research Manager|469-814-4712|natalie.settele@baylorhealth.edu|
22429779|NCT00483509|Molmed S.p.A|Clinical Operations|003902212771|clinical.operations@molmed.com|
22429780|NCT00682838|VA San Diego Healthcare System|Carl J. Stepnowsky, PhD|858-642-1240|Carl.Stepnowsky@va.gov|
22429781|NCT02201628|King's College Hospital NHS Foundation Trust|Dr Emily Haberman|07890549924|emilysaffer@gmail.com|
22429782|NCT00449007|Perelman School of Medicine, University of Pennsylvania|Maria A. Oquendo, M.D., Ph.D.|215-662-2818|moquendo@pennmedicine.upenn.edu|
22429783|NCT01478087|Mayo Clinic|Jeffrey Lawrence Winters, MD|507-538-1707|winters.jeffrey@mayo.edu|
22429784|NCT03095976|Indiana University School of Dentistry|Dr. Yusuke Hamada|317-274-5121|yuhamada@iupui.edu|
22429785|NCT02614768|Medical University of Graz|Mader, Julia, Assoz. Dr.med.univ.|0043316385|julia.mader@medunigraz.at|12383
22429786|NCT03518203|Cincinnati Children's Hospital Medical Center|Sonata Jodele, MD|(513) 636-5917|Sonata.Jodele@cchmc.org|
22429787|NCT01457430|MGH Allergy Associates|Dr. Aleena Banerji|617-726-3850|abanerji@mgh.harvard.edu|
22429788|NCT04146909|Yale School of Medicine|Renata Belfort De Aguiar, MD, PhD|(203) 785-5331|renata.aguiar@yale.edu|
22429789|NCT00345592|S. Anna Hospital|Giovanni Luca Botto|0315851|gluca.botto@gmail.com|+39
22429790|NCT01509807|University of South Florida|Jorge Marcet, MD|813-844-4545|jmarcet@health.usf.edu|
22412369|NCT00090857|Dana-Farber Cancer Institute|Judy E. Garber, MD, MPH|617.632.2282|Judy_Garber@dfci.harvard.edu|
22429791|NCT06171399|Wake Forest University School of Medicine|Dr. Beth Reboussin|336-713-5213|brebouss@wakehealth.edu|
22429792|NCT02821793|Institut Bergonié|Pr Simone Mathoulin-Pelissier|0556333333|S.Mathoulin@bordeaux.unicancer.fr|
22429793|NCT03336866|InterveXion Therapeutics|Chief Operating Officer|5015542377|misty.stevens@intervexion.com|
22429794|NCT00032487|Hines CSPCC|Project Manager|708-202-5785|tamara.paine@va.gov|
22429795|NCT04796207|University of Arizona|Floyd H. Chilton|520-621-5327|fchilton@arizona.edu|
22429796|NCT01860989|Novartis Pharmaceuticals|Study Director|862-778-8300||
22429797|NCT02759458|Rush University Medical Center|Nikhil Verma, MD|(312) 563-2214|nikhil.verma@rushortho.com|
22429798|NCT04203056|University of California, Los Angeles|Kenneth Subotnik, PhD|3108250334|ksubotnik@mednet.ucla.edu|
22445080|NCT03139279|Department of Anesthesiology, SUNY Downstate Medical Center|Dennis Dimaculangan, MD|718-270-3765|dennis.dimaculangan@downstate.edu|
22445081|NCT01224665|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|ctangen@fredhutch.org|
22445082|NCT02027376|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
22445083|NCT01565642|University of North Carolina at Chapel Hill|Laura C. Hanson, MD, MPH|919-843-4096|lhanson@med.unc.edu|
22445084|NCT03171051|Venus Concept Ltd|Yoni Iger|888-907-0115|yoni@venusconcept.com|
22445085|NCT01945112|Stanford Department of Emergency Medicine|Grant Lipman|415-290-9286|gslipman@stanford.edu|
22445086|NCT01528033|Witten/Herdecke University|Dörthe Seidel|00492219895731|Doerthe.Seidel@uni-wh.de|
22445087|NCT02856698|Hospital Universitario de Canarias|Alberto Dominguez Rodriguez. MD, PhD, FESC|+34 922678000|adrvdg@hotmail.com|
22445088|NCT03029702|University of Pittsburgh|Maisa Feghali|412 641 1000|feghalim@upmc.edu|
22445089|NCT02452697|Duke University|Cristina Gasparetto, MD|919-668-1000|cristina.gasparetto@duke.edu|
22445090|NCT01554397|UCSD Moores Cancer Center|Dr. Loren Mell|858-246-4071|lmell@health.ucsd.edu|
22445091|NCT04246372|Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz|Joaquin Espinosa|303-724-7389|joaquin.espinosa@cuanschutz.edu|
22445092|NCT04339140|Beth Israel Deaconess Medical Center|Dr. Rushad Patell|617-667-7000|rpatell@bidmc.harvard.edu|
22445093|NCT00257608|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22445094|NCT03673046|Massachusetts General Hospital, Department of Psychiatry|Director, Center for OCD and Related Disorders|617-724-6146|swilhelm@mgh.harvard.edu|
22445095|NCT03817879|Ambu A/S|Anna Charlotte Lundgaard|+4529643748|aclu@ambu.com|
22445096|NCT01896050|University of Michigan Comprehensive Cancer Center|Norah Lynn Henry, MD|734-936-4991|norahh@med.umich.edu|
22445097|NCT02614092|VISN 21 MIRECC, VA Palo Alto Health Care System|Dr. Kaci Fairchild|6504935000|jenniferkaci.fairchild@va.gov|63432
22445098|NCT00392015|United States Military Malaria Vaccine Program Naval Medical Research Center|Dr. Judith Epstein|301-252-9026|judith.epstein@med.navy.mil|
22445099|NCT03693300|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22412370|NCT00458848|GIMEMA|Alfonso Piciocchi|+39 06 70390513|a.piciocchi@gimema.it|
22412371|NCT05097326|Stanford University|Principal Investigator|(650) 497-5175|gynresearch@stanford.edu|
22412372|NCT01483352|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22412373|NCT01244126|Baylor College of Medicine, Department of Anesthesiology|Dr. Helena Karlberg Hippard|832-824-5800|hxkarlbe@texaschildrens.org; karlberg@bcm.edu|
22412374|NCT00630305|Johnson & Johnson Vision Care, Inc.|Kurt Moody, OD|1-904-443-3088|kmoody1@its.jnj.com|
22412375|NCT01085045|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
22412376|NCT00863746|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22412377|NCT02924038|University of California, San Francisco|Dr. Nicholas Butowski, MD|415-353-7500|Nicholas.Butowski@ucsf.edu|
22412378|NCT02395822|University of Minnesota Masonic Cancer Center|Yumna Akhtar - Ct.gov Manager|612-624-6313|akhta012@umn.edu|
22412379|NCT03292653|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
22412380|NCT02841774|Northwestern University|Dr. Matthew Feinstein|3126643278|matthewjfeinstein@northwestern.edu|
22429799|NCT00421993|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
22429800|NCT01751685|University of California, San Francisco|Wendy Katzman, PT|415-353-7598|Wendy.Katzman@ucsf.edu|
22445100|NCT02742441|Therapeutics, Inc.|Clinical Research, Therapeutics, Inc.|858-571-1800|clinicalresearch@therapeuticsinc.com|
22445101|NCT03265665|University of Illinois at Chicago|Dr. Sharmilee Nyenhuis|3124131655|snyenhui@uic.edu|
22445102|NCT01858376|The Ohio State University|Chandan K. Sen|6142477786|chandan.sen@osumc.edu|
22445103|NCT03150160|Novartis Pharmaceuticals|Study Director|1-862-778-8300|novartis.email@novartis.com|
22445104|NCT01680965|Moffitt Cancer Center|Joseph Pidala, M.D., PhD|813-745-2069|Joseph.Pidala@moffitt.org|
22445105|NCT01854242|University of Florida|David A. Weinstein, MD, MMSc|3522650855|weinsda@peds.ufl.edu|
22445106|NCT02910362|Arizona Eye Consultants|Sean McCafferty, MD|(520) 791-7401|sjmccafferty66@hotmail.com|
22445107|NCT01182610|Accelerated Community Oncology Research Network, Inc.|Vice Presidnet of Scientific Affairs||mwalker@acorncro.com|
22445108|NCT00809848|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22445109|NCT02160990|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
22445110|NCT02486302|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22445111|NCT03789396|University of Colorado|Adit Ginde, MD, MPH|720-848-6777|ADIT.GINDE@CUANSCHUTZ.EDU|
22445112|NCT00734474|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22445113|NCT01601860|University of São Paulo|Dra. Alessandra Cristina Marcolin|+55(16)36022813|dralemar@uol.com.br|
22384688|NCT01140880|Friends Research Institute, Inc.|Dr. Cathy J. Reback|323-463-1601|reback@friendsresearch.org|
22384689|NCT02496780|University of Minnesota|Antoinette Moran|612-624-5409|moran001@umn.edu|
22384690|NCT04421378|Karyopharm Therapeutics Inc|Karyopharm Medical Information|(888) 209-9326|clinicaltrials@karyopharm.com|
22384691|NCT04258709|University of Pittsburgh|Dr. Jill Demirci|412-648-9236|JVR5@pitt.edu|
22384692|NCT03175029|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.|+81-3-3293-2455|toiawase@taiho.co.jp|
22384693|NCT03164980|NOGGO e.V.|Jasmin Yamamoto|+49 30 4036865 32|jasmin.yamamoto@noggo.de|
22384694|NCT03381261|Weill Cornell Medicine|Dr. Lisa Gfrerer|646.962.4250|lig4013@med.cornell.edu|
22384695|NCT05634226|Children's Hospital of Pittsburgh|Dr. Tarek Alsaied|5136521226|tarek.alsaied84@gmail.com|
22384696|NCT02729311|University of California, San Francisco|Deborah Barnes, PhD|415-221-4810|Deborah.Barnes@ucsf.edu|4221
22384697|NCT05324124|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22384698|NCT05034952|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22384699|NCT02287610|Horizon Pharma Ireland, Ltd.|Mike Marshall, PharmD|224-383-3000|clinicaltrials@horizonpharma.com|
22384700|NCT04950660|Children's Mercy Kansas City|Anne Stuedemann MSN, RN, CPNP|8162343693|astuedemann@cmh.edu|
22384701|NCT03761537|LEO Pharma A/S|Disclosure|44 94 58 88|disclosure@leo-pharma.com|+45
22384702|NCT04783935|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22384703|NCT05275842|Medical University of South Carolina|Cristina Lopez|843-792-2945|lopezcm@musc.edu|
22384704|NCT05273749|Tonix Pharmaceuticals|Gregory Sullivan, MD|8629040355|greg.sullivan@tonixpharma.com|
22384705|NCT04382898|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
22384706|NCT05229120|Henry Ford Health|Julia Felton, PhD|704-995-7832|jfelton4@hfhs.org|
22384707|NCT05134350|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22384708|NCT03932682|Seqirus|Clinical Trial Disclosure Manager|+1 855 358 8966|seqirus.clinicaltrials@seqirus.com|
22384709|NCT04321031|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22384710|NCT03094663|Hospital for Special Surgery, Anesthesiology|Dr. David Kim|2126061036|kimd@hss.edu|
22384711|NCT03420833|Mayo Clinic|Dr. Yong-Mei Cha|507-255-0774|ycha@mayo.edu|
22384712|NCT05687916|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22384713|NCT00931710|Novartis Pharmaceuticals|Study Director|862-778-8300||
22384714|NCT03338790|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22398581|NCT04311086|Medtronic|Sara Dinkins SPYRAL DYSTAL Global Study Manager|303-840-4034|rs.spyraldystal@medtronic.com|
22384715|NCT02380885|Bar-Ilan University|Prof. Ilanit Hasson-Ohayon|+972-3-5317673|ilanithasson@gmail.com|
22384716|NCT04588298|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22384717|NCT03892616|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22384718|NCT03924986|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
22384719|NCT04922502|Baylor College of Medicine|Dr. Eric Storch|(713) 798-3579|eric.storch@bcm.edu|
22384720|NCT05147155|University of Thessaly|Research Committee - Special Account for Research Grants University of Thessaly|+306971894688|raniakotsiou@gmail.com|
22384721|NCT02907099|The University of Texas MD Anderson Cancer Center|Brandon Smaglo, MD|(713) 745-8763|bgsmaglo@mdanderson.org|
22384722|NCT05569252|Daiichi Sankyo|Contact for Clinical Trial Information|9089926400|CTRinfo_us@daiichisankyo.com|
22384723|NCT02949362|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22384724|NCT05268302|University of Maryland, Baltimore Center for Vaccine Development and Global Health (CVD)|Kirsten E. Lyke, MD|410-706-5328|klyke@som.umaryland.edu|
22384725|NCT02811679|Massachusetts General Hospital|Jeffrey Barnes, MD, PhD|6177244000|JABARNES@mgh.harvard.edu|
22384726|NCT06365086|University of Texas at Austin|Sara Hussain, PhD|5122322686|sara.hussain@austin.utexas.edu|
22398582|NCT04029519|Prollenium Medical Technologies|Director Clinical Affairs|1-905-508-1469|, clinicaltrials@prolleniumus.com|
22445114|NCT02104752|VA Greater Los Angeles Healthcare System/UCLA|Jonathan K. Wynn, Ph.D.|(310) 478-3711|jkwynn@ucla.edu|44957
22445115|NCT02899299|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22384727|NCT05611073|Berkeley Eye Center|Tetiana Huff|713-620-7640|tetiana.huff@berkeleyeye.com|
22384728|NCT05319860|University of Miami|Dr. Debbie Anglade|305-284-2388|d.anglade@miami.edu|
22384729|NCT04314895|NanOlogy, LLC|Mark Mitchell|8179004074|mark.mitchell@dfb.com|
22445116|NCT00313300|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22445117|NCT00726375|University of Michigan Comprehensive Cancer Center|Dr. Sung Choi|734-615-5707|sungchoi@umich.edu|
22445118|NCT02022020|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22445119|NCT00639678|GlaxoSmithKline|GSK Response Center|866-435-7343||
22445120|NCT01926015|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22445121|NCT01364649|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22445122|NCT01826604|Saint Louis University|Dr. Katherine M. Scolari Childress|314-977-2090|scolarik@slu.edu|
22445123|NCT04416633|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22445124|NCT03323502|Indiana University School of Nursing|Dr. Susan Hickman|317-274-0032|hickman@iu.edu|
22445125|NCT01348607|SunCoast CCOP Research Base|Cristina Burroughs, Clinical Research Administrator|(813) 396-9237|Cristina.Burroughs@epi.usf.edu|
22445126|NCT02239354|ViaCyte|Corporate Communications|858-207-0500|info@viacyte.com|
22445127|NCT01892267|Johns Hopkins Hospital|Dr. Mouen Khashab|443-287-1960|mkhasha1@jhmi.edu|
22445128|NCT04172623|Yale School of Medicine|Krysten Bold, PhD|2039747603|krysten.bold@yale.edu|
22445129|NCT04066647|Cedars Sinai Medical Center|Kacey Haptonstall|424-315-4489|kacey.haptonstall@cshs.org|
22445130|NCT00902668|Virginia Commonwealth University|Laurie W. Cuttino, MD|804-828-7232|LCuttino@mcvh-vcu.edu|
22445131|NCT01914757|AstraZeneca|Mitchell Goldman, Medical Science Director|+1 301 398 0323|Mitchell.Goldman@astrazeneca.com|
22445132|NCT01967433|University of Oklahoma Health Sciences Center and VAMC, Oklahoma City|Salman Nusrat|4052715428|salman-nusrat@ouhsc.edu|
22445133|NCT01072669|Cleveland Clinic|Dr. Soumya Chatterjee|216-444-9945|chattes@ccf.org|
22445134|NCT00408629|Abbott|Global Medical Services|800-633-9110||
22445135|NCT01461980|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22445136|NCT00122109|VA Pacific Islands Healthcare System|Leslie A. Morland, PsyD, Principal Investigator|(808) 566-1934|leslie.morland@va.gov|
22445137|NCT01890746|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
22445138|NCT00100178|Barbara Davis Center for Childhood Diabetes, Health Sciences Center, University of Colorado|Peter Gottleib, MD|303-724-6714|Peter.Gottleib@uchsc.edu|
22445139|NCT00631696|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22445140|NCT01784848|HCor|Dr Carlos Schiavon|1130536611|schiavon.ca@gmail.com|8201
22445141|NCT03198078|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22445142|NCT01676727|Medtronic Bakken Research Center|Maarten Hollander|+31620534428|Maarten.Hollander@medtronic.com|
22445143|NCT01578330|Novartis|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22445144|NCT03140254|Becton Dickinson|Erin Zook|201-847-5351|erin.zook@bd.com|
22445145|NCT02517866|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22445146|NCT03114488|University of Minnesota|Elias Boroda|763-498-4176|borod002@umn.edu|
22445147|NCT01436006|Università di Palermo|Sergio Salerno|00390916552315|sergio.salerno@unipa.it|2315
22445148|NCT03711266|Michigan Medicine|Rebecca Sripada|734-222-7432|rekaufma@med.umich.edu|
22445149|NCT02175628|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|9199664997|rad_research@med.unc.edu|
22445150|NCT01646073|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22445151|NCT04558281|University of California San Diego|Brian Ilfeld, MD, MS|(858) 822-0776|bilfeld@health.ucsd.edu|
22445152|NCT00679055|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22445153|NCT00629772|Innovaderm Research|Annie Levesque|514 521 4285|alevesque@innovaderm.ca|222
22445154|NCT00749515|St. Jude Children's Research Hospital|Ellis Neufeld, MD, PhD|901-595-7509|ellis.neufeld@stjude.org|
22445155|NCT01393301|Massachusetts General Hospital|Dr. Conall O'Cleirigh, PI|(617) 643-0385|cocleirigh@mgh.harvard.edu|
22445156|NCT01270542|Doheny Eye Institute/USC/University of Iowa|Dr. Elliott Sohn|319-356-3185|elliott-sohn@uiowa.edu|
22445157|NCT03342963|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22445158|NCT02409810|The Ohio State University|Judy Opalek Director, Research Administration|6147789696|judy.opalek@osumc.edu|
22445159|NCT01309165|Sunnybrook Research Institute|Dr. Sara McEwen|4162266780|sara.mcewen@sunnybrook.ca|7957
22445160|NCT01497275|Duke University Medical Center|Anne Beaven, MD|919-668-1211|anne.beaven@duke.edu|
22445161|NCT01484132|New England Research Institutes|Felicia Trachtenberg, Principal Research Scientist|617-972-3120|ftrachtenberg@neriscience.com|
22445162|NCT03538431|Massachusetts General Hospital|Dr. Joseph Biederman|6177261743|biederman@helix.mgh.harvard.edu|
22445163|NCT00620464|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22445164|NCT05394350|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22445165|NCT02024555|Vanderbilt University Medical Center|Wonder Drake, MD|(615) 322-2035|wonder.drake@vumc.org|
22445166|NCT02887859|Humacyte Inc.|Dr. Shamik Parikh, MD, CMO|919-313-9633|sparikh@humacyte.com|
22384730|NCT03361748|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
22384731|NCT01084707|J&J Consumer and Personal Products Worldwide|Joyce Hauze, Sr. Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
22384732|NCT00901901|BAYER|Therapeutic Area Head|(+)1-888-84-22937|clinical-trials-contact@bayer.com|
22384733|NCT03748342|UT Southwestern Medical Center|Dr. Tiffany Moon|469/419-5790|Tiffany.Moon@UTSouthwestern.edu|
22384734|NCT02815813|Dartmouth-Hitchcock|Dr. Kelly Aschbrenner|603-440-7722|kelly.a.aschbrenner@dartmouth.edu|
22384735|NCT05902793|The Second Affiliated Hospital of Zhejiang University School of Medicine|Dr. Zhijun Pan|0571-87783777|zepzj@163.com|
22445167|NCT00492050|UT MD Anderson Cancer Center|Sheeba Thomas, MD-Professor, Lymphoma-Myeloma|(713) 792-2860|sthomas@mdanderson.org|
22445168|NCT04063384|University of Texas at Austin|Dr. Elizabeth Lippard|512-495-5216|elizabeth.lippard@austin.utexas.edu|
22445169|NCT00537238|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22445170|NCT03538678|University of Pittsburgh|Kar-Hai Chu|412-692-2578|chuk@pitt.edu|
22445171|NCT01743131|Boston Children's Hospital|Dr. Leslie Kean|404-376-0187|leslie.kean@childrens.harvard.edu|
22445172|NCT01824342|Amgen Inc.|Study Director|866-572-6436||
22445173|NCT06132659|University of Michigan|Dr. Stefanie Russman Block|734-232-0373|srblo@umich.edu|
22445174|NCT03615326|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22445175|NCT03794583|United Therapeutics|United Therapeutics Global Medical Information|1-240-821-1881|305PerfectOLEStudy@lungbiotechnology.com|
22445176|NCT02497612|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22445177|NCT02651467|GlaxoSmithKline|GSK Response Center|866-435-7343||
22445178|NCT03153956|NYU Langone Health|Dennis A. Cardone, DO|+1 646 501 7223|Dennis.Cardone@nyulangone.org|
22445179|NCT02477839|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22445180|NCT02268955|Maricopa Integrated Health System|Dan Quan, DO|602-344-5058|dany_quan@dmgaz.org|
22445181|NCT00365144|UCaliforniaSF|Andrew Ko, MD|415-353-9888|andrewko@medicine.ucsf.edu|
22445182|NCT01439568|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22445183|NCT02607930|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22445184|NCT01134731|UAB|Dr. Richard Shelton|205-934-2484|rshelton@uab.edu|
22445185|NCT01050543|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22445186|NCT00149734|University of Colorado Denver|Director, Clinical Research Administration|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
22445187|NCT01950169|Department of Geriatric Medicine, Karolinska University Hospital, Stockholm, Sweden|Dr. Lena Flodin|Mobile: 0701910300|lena.flodin@sll.se|
22445188|NCT00437320|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22445189|NCT01938573|University of Washington|Dr. Bruce Montgomery|206-598-0860|rbmontgo@uw.edu|
22445190|NCT00737438|Memorial Sloan Kettering Cancer Center|Dr. David Ilson|646-888-4183|ilsond@mskcc.org|
22445191|NCT02410551|UT MD Anderson Cancer Center|Popat,Uday,M.D. / Stem Cell Transplantation|713-792-8750|upopat@mdanderson.org|
22445192|NCT01739309|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22445193|NCT05469113|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22445194|NCT05447897|General Internal Medicine, University of Colorado School of|Dr. Gina Kruse, PI|303-724-4811|gina.kruse@cuanschutz.edu|
22445195|NCT04553679|University of Southern California|Marika Demers, PhD, OT, post-doctoral research fellow|13234421196|demers@pt.usc.edu|
22445196|NCT04926077|Philips|Bill Hardy|412-874-2710|bill.hardy@philips.com|
22445197|NCT01230710|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22445198|NCT02905149|Instituto de Investigación Sanitaria La Fe|Maria Cortell|961246611|investigacion_clinica@iislafe.es|
22445199|NCT00747812|Boston Scientific|Lyn Pimentel, Clinical Project Manager|(661) 949-4174|Lyn.Pimentel@bsci.com|
22445200|NCT02907268|ICLS|Shantel Demay|905-842-2262|s.demay@icls.ca|
22445201|NCT01708161|Novartis Pharmaceuticals|Study Director|1-888-669-6682|Novartis.email@novartis.com|
22445202|NCT01349231|Yale University, Connecticut Mental Health Center|Dr. Michael Bloch, MD, MS|203-737-4809|michael.bloch@yale.edu|
22445203|NCT01986140|Baylor College of Medicine|Tao Wang|7137985388|taow@bcm.edu|
22445204|NCT02759354|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22445205|NCT00975637|Valeant Pharmaceuticals|Director of Clinical Trials|908|binu.alexander@valeant.com|
22445206|NCT03616171|Emory University|Ashley Coombe, PhD|404-712-9313|ashley.coombe@emory.edu|
22445207|NCT01833546|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22445208|NCT01069627|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22445209|NCT02963935|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22445210|NCT00464269|UCB|Clinical Trial Call Center|+1 877 822 9493||
22445211|NCT03911154|University of Pennsylvania|Dr. David Dinges|215-898-9665|dinges@pennmedicine.upenn.edu|
22445212|NCT00299182|University of Texas (UT) MD Anderson Cancer Center|Saroj Vadhan-Raj, MD/Professor, Sarcoma Medical Oncology|713-792-7966|CR_Study_Registration@mdanderson.org|
22445213|NCT00725504|Stanford University|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@pain.stanford.edu|
22445214|NCT00292318|Greater Los Angeles VA Medical Center|Felix W. Leung, MD|818-891-7711|felix.leung@va.gov|9403
22445215|NCT00771316|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22445216|NCT01822496|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22445217|NCT01631812|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22380978|NCT00106431|Celgene Corporation|Elizabeth Faust, PhD, Vice President, Clinical Research Services|617/583-1300|EFaust@Celgene.com|
22380979|NCT00278564|Northwestern University|Dr. Richard Burt|312-695-4960|rburt@northwestern.edu|
22380980|NCT01515956|BioMarin Pharmaceutical Inc.|Peter Slasor/Sr Director, Biostatistics, Global Clinical Sciences|415-506-6765|PSlasor@bmrn.com|
22380981|NCT03606460|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22380982|NCT00003377|Gynecologic Oncology Group Statistical & Data Center|Melissa Leventhal|(716)845-5702|mleventhal@gogstats.org|
22380983|NCT02783482|Green Cross Corporation|Clinical Project Manager|82 31 260 9472|sungsil.lee@gccorp.com|
22380984|NCT01341080|Rush University Medical Center|Deborah A Hall MD PhD|312-563-2900|Deborah_A_Hall@rush.edu|
22445218|NCT00543543|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22445219|NCT00945555|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22445220|NCT04502979|University of North Carolina at Chapel Hill|Eric A Hodges, PhD, FNC-BC, FAAN|919-966-0534|eahodges@email.unc.edu|
22445221|NCT01881373|University of Hawaii|Rachel Novotny|808-956-3848|novotny@hawaii.edu|
22445222|NCT00586625|ISTA Pharmaceuticals, Inc.|Vice President, Clinical Research & Medical Affairs|949-788-6000|tmcnamara@istavision.com|
22445223|NCT01366417|CareFusion|Jennifer Raeder-Devens|847-454-4939|jennifer.raeder-devens@carefusion.com|
22445224|NCT02906332|Hackensack Meridian Health|Joshua Zenreich|15519964248|joshua.zenreich@hmhn.org|
22445225|NCT00165984|Emory University|Paul Kirshbom|404-785-6330|pkirshb@emory.edu|
22445226|NCT02046902|Saint Luke's Mid America Heart Institute|Carole Decker|(816) 932-5440|c1decker@saint-lukes.org|
22445227|NCT01686828|University of Washington|Dr. Katya Rubinow|206-7543-3470|rubinow@uw.edu|
22445228|NCT02734433|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22445229|NCT03882788|Research Office|Clinical Trials Manager|650-724-1720|clinicaltrials-gov@stanford.edu|
22445230|NCT03698331|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22445231|NCT06033521|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22445232|NCT04916769|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22445233|NCT04941456|Gaylord Hospital, Inc.|Dr. Henry Hrdlicka|203-284-2864|hhrdlicka@gaylord.org|
22445234|NCT03894046|Entasis Therapeutics|Dr. David Altarac - Chief Medical Officer|+1 781 810 0120|david.altarac@entasistx.com|
22445235|NCT03270644|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22445236|NCT00333801|Tuscaloosa VA Medical Center|Lori Davis, MD|205-554-3819|lori.davis@va.gov|
22445237|NCT02476201|Abbott Medical|Pilar Santamaria|+34 917 278 964|pilar.santamaria@abbott.com|
22445238|NCT00777205|Veterans Affairs Healthcare System|Marcia Valenstein, MD|734-845-3649|marcia.valenstein@va.gov|
22445239|NCT04046055|University of Iowa|Dr. Craig D. Workman|319-467-0746|craig-workman@uiowa.edu|
22445240|NCT02480920|Department of Cardiology, Afyonkarahisar State Hospital, Afyonkarahisar, Turkey|Volkan Emren||vemren@hotmail.com|
22445241|NCT00303901|Barbara Ann Karmanos Cancer Institute|Peter Littrup, M.D.|313-576-8758|littrupp@karmanos.org|
22445242|NCT05055128|Cinclus Pharma Holding AB|Kajsa Larsson, MD, PhD|+46 70 675 01 28|kajsa.larsson@cincluspharma.com|
22445243|NCT00747461|CSA Medical|Ann Murphy Legg, Director of Clinical Research|781-538-4732|alegg@csamedical.com|
22384736|NCT02187003|Biossil Inc.|Head of Regulatory|978-245-7397|debora@biossil.ai|
22412381|NCT02446132|Otsuka Pharmaceutical Development & Commercialization, Inc.|Clinical Transparency|08446878522|clinicaltransparency@otsuka-us.com|
22445244|NCT02149875|Shanghai Sixth People's Hospital|Dr. Hao Chen|02164369181|chenhao_316@aliyun.com|8405
22445245|NCT05055453|Sonova|Jean Anne Schnittker, Research Audiologist|+41 58 928 01 01|jeananne.schnittker@sonova.com|
22445246|NCT04102956|Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.|Xiaoyun Liu PhD|+8613191887318|audrey-l@163.com|
22445247|NCT03643159|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
22445248|NCT03467048|Cleveland Clinic|Dr. Kurt Ruetzler|216-445-8105|ruetzlk@ccf.org|
22445249|NCT04308304|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22445250|NCT02840721|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22445251|NCT00834678|The Ohio State University Comprehensive Cancer Center|Rachel Layman, MD|614-366-8541|Rachel.Layman@osumc.edu|
22445252|NCT05535972|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22445253|NCT03318900|M D Anderson Cancer Center|Amir A. Jazaeri, MD|713-792-2921|aajazaeri@mdanderson.org|
22445254|NCT00772304|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22445255|NCT03945266|Pennsylvania State University|Dr. Abigail Pauley|814-863-7354|amp34@psu.edu|
22445256|NCT03750461|Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH Geisel School of Medicine, Hanover, NH|Matthew Z. Wilson, MD MSc FACS FASCRS|(603) 650-8113|Matthew.Z.Wilson@hitchcock.org|
22445257|NCT03242824|Mayo Clinic|Nadia N. Laack, MD, MS|507/284-2511|Laack.Nadia@mayo.edu|
22412382|NCT03444038|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22429801|NCT02193152|Washington University School of Medicine|Daniel Morgensztern, M.D.|314-362-5737|danielmorgensztern@wustl.edu|
22429802|NCT01107457|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22445258|NCT04432272|Beaumont Hospitals|Matthew Sims, MD|248-551-0027|matthew.sims@beaumont.org|
22445259|NCT03772678|Arch Biopartners Inc.|Richard Muruve|(647) 428-7031|info@archbiopartners.com|
22445260|NCT03805646|University of California Los Angeles|Dr. Catherine Juillard|310-267-9609|cjuillard@mednet.ucla.edu|
22445261|NCT02682420|BD Peripheral Intervention|Courtney Rothwell, Clinical Project Manager|602-830-5544|courtney.rothwell@bd.com|
22384737|NCT04280445|Trent Doctorate in Clinical Psychology Programme, University of Nottingham, UK|Dr Daniell De Boos|+44 (0)115 84 67523|danielle.deboos@nottingham.ac.uk|
22384738|NCT01525966|City of Hope Medical Center|Dr. Yuan Yuan|626-359-8111|Yuyuan@coh.org|
22384739|NCT03648840|Indiana University - Indianapolis|Dr. Martin H. Plawecki, MD, PhD|317 944 8164|mplaweck@iu.edu|
22384740|NCT05382936|Stemline|Carlos Garay, M.D.|877-332-7967|clinicaltrials@menarinistemline.com|
22384741|NCT05063994|Diurnal Limited|Clinical Trials Information|+44 (0) 292 068 2069|info@diurnal.co.uk|
22384742|NCT04630262|DePuy Synthes|Kelly Francher, Staff Clinical Research Scientist|574-241-6581|kfranche@its.jnj.com|
22384743|NCT01195831|Leo Pharma|Malin Jaernkrants|+4544945888|malin.jaernkrants@leo-pharma.com|
22384744|NCT03692676|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22384745|NCT03692611|University of Pittsburgh|Dr. Jessica Merlin|(412) 383-0617|merlinjs@upmc.edu|
22384746|NCT04868227|University of Edinburgh|Professor Malcolm Dunlop|+44 (0) 131 651 8602|malcolm.dunlop@ed.ac.uk|
22384747|NCT03988634|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22384748|NCT02995434|University of British Columbia|Dr. Bernie Garrett|604 822 7443|bernie.garrett@ubc.ca|
22384749|NCT05680675|Huntsman Cancer Institute, Center for Quantitative Cancer Imaging|Sam Mitchell|801-213-6110|sam.mitchell@hci.utah.edu|
22384750|NCT03400059|Chordate Medical AB|Dr Jan Hermansson|+46 8 400 115 86|jan.hermansson@chordate.com|
22384751|NCT04150718|University of Pennsylvania|Dr. Jennifer Goldschmied|215-573-2774|jrgolds2@pennmedicine.upenn.edu|
22384752|NCT03047928|CCIT-DK|Prof. MD, Inge Marie Svane|38683868|inge.marie.svane@regionh.dk|+45
22384753|NCT02437318|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22384754|NCT05086016|Renata Medical|Dali Alarian|8553184988|dali@renatamedical.com|6
22429803|NCT03601052|Viridian Therapeutics (formerly miRagen Therapeutics)|Regulatory Affairs|720-722-5917|clinicaltrials@viridiantherapeutics.com|
22429804|NCT01767285|Duke University|Dr. Beverly Gray|919-684-8111|beverly.gray@dm.duke.edu|
22429805|NCT03888274|Tivic Health Systems|Blake Gurfein|5615737652|blake.gurfein@tivichealth.com|
22429806|NCT01727154|Dendreon|Shabnam Vaziri|206.455.2323|svaziri@Dendreon.com|
22429807|NCT00003474|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22429808|NCT04115228|Nine Continents Medical, Inc.|Peter Jacobson|6128105810|PETERJACOBSON777@YAHOO.COM|
22429809|NCT01198548|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22429810|NCT02269488|MedImmune, LLC, a wholly-owned subsidiary of AstraZeneca PLC|Raburn Mallory|+1 301-398-5799|malloryr@medimmune.com|
22429811|NCT02186171|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22429812|NCT01245062|GlaxoSmithKline|GSK Response Center|866-435-7343||
22429813|NCT00574353|Memorial Sloan Kettering Cancer Center|Dr. John Humm, PhD|212-639-7367|hummj@MSKCC.ORG|
22429814|NCT02015104|National Cancer Institute|Dr. Raju Chelluri|240-858-3700|raju.chelluri@nih.gov|
22429815|NCT06025695|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22429816|NCT03011372|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22429817|NCT03572218|Perelman School of Medicine at the University of Pennsylvania|Dr. Rebecca Pearl|215-746-5129|rpearl@pennmedicine.upenn.edu|
22429818|NCT02507284|Azevan Pharmaceuticals, Inc.|Neal Simon, PhD|(610) 419-1057|ngsimon@azevan.com|
22429819|NCT01350973|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22429820|NCT00853047|Lexicon Pharmaceuticals, Inc.|Pablo Lapuerta, MD||plapuerta@lexpharma.com|
22429821|NCT02638493|University of North Carolina at Chapel Hill|Julie B. Dumond, PharmD, MS, BCPS, AAHIVP|919-966-5017|jdumond@unc.edu|
22445262|NCT04452344|Rutgers University School of Dental Medicine|Cecile A. Feldman, DMD|973-972-4634|feldman@rutgers.edu|
22445263|NCT05171777|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22445264|NCT02364713|Mayo Clinic|Evanthia Galanis|507-266-0584|galanis.evanthia@mayo.edu|
22445265|NCT03806491|University of Missouri|Dr. Mary Beth Miller|573-882-1813|millmary@health.missouri.edu|
22445266|NCT04686786|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22445267|NCT03950791|Stanford University School of Medicine|Maisa Ziadni, PhD|(650) 724-9143|mzaidni@stanford.edu|
22445268|NCT05628103|Otsuka Pharmaceutical Development & Commercialization, Inc.|Clinical Transparency|1-800-441-6763|smb_clinicaltranspa@otsuka-us.com|
22445269|NCT04840888|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22445270|NCT03448653|Centre Hospitalier Départemental Vendée|Dr. Vincent MACE|0251446572|vincent.mace@ght85.fr|+33
22445271|NCT04191187|Moffitt Cancer Center|Dr. Nelli Bejanyan|813-745-6008|Nelli.Bejanyan@moffitt.org|
22445272|NCT04340193|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22445273|NCT03924869|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22445274|NCT01470859|Department of Neurology, Huashan Hospital affiliated to Fudan University.|Dr. Jian Wang|+86-13321934789|wangjian336@hotmail.com|
22445275|NCT03001882|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22445276|NCT02718300|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22445277|NCT03708770|Becton Dickinson (BPV)|Courtney Rothwell|480.350.6037|courtney.rothwell@bd.com|
22445278|NCT05268055|UMass Chan Medical School|Melissa L. Anderson, PhD|508-856-5820|melissa.anderson@umassmed.edu|
22445279|NCT03507400|Practice for Neurology and Ludwigs-Maximilians-Universitiy Munich|Dr. Monika Empl|+4989500598710|dr.empl@dr-empl-neurologie.de|
22445280|NCT01555983|UC Davis (currently at UC San Diego)|Barth Wilsey MD|916-402-2270|bwilsey@ucsd.edu|
22445281|NCT04905082|City of Hope|Stacy W. Gray, MD. AM.|626-715-4425|stagray@coh.org|
22445282|NCT04026711|University of Vermont|Anne Dixon, Professor of Medicine|802 847 0000|anne.dixon@uvmhealth.org|
22445283|NCT02353754|Pacira Pharmaceuticals Inc.|James B. Jones, MD, PharmD|(973) 254-3560|jim.jones@pacira.com|
22445284|NCT02475031|Indiana University School of Medicine - Anesthesia Division|Dr. Yar Yeap|317-274-0275|yyeap@iupui.edu|
22445285|NCT05985395|University of Nebraska Medical Center|Windy Alonso|814-577-2941|windy.alonso@unmc.edu|
22445286|NCT05741528|Otsuka Pharmaceutical Development & Commercialization, Inc.|Clinical Transparency|1-800-441-6763|SMB_ClinicalTranspa@otsuka-us.com|
22445287|NCT04823650|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22445288|NCT02875132|The Chinese University of Hong Kong|Dr. Herbert Ho Fung LOONG|35052166|h_loong@clo.cuhk.edu.hk|
22445289|NCT06350474|Seattle Children's|Margaret Kloster|206-884-7862|margaret.kloster@seattlechildrens.org|
22445290|NCT00546104|Duke University Health System|Kimberly Blackwell, MD|919-668-1478|kimberly.blackwell@duke.edu|
22445291|NCT01191333|Director, VISN21 MIRECC, Department of Veterans Affairs|Jerome Yesavage, MD|650-852-3287|Jerome.Yesavage@va.gov|
22445292|NCT02699697|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|3367135440|Doris.R.Brown@advocatehealth.org|
22445293|NCT02362035|Acerta Pharma|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22445294|NCT00004635|National Cancer Institute, National Institutes of Health|William L. Dahut, M.D.|301-435-8183|dahutw@mail.nih.gov|
22445295|NCT00354614|ResMed|VP Medical Affairs|858 836 6782|ResmedScienceCenter@resmed.com.au|
22445296|NCT00191906|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22445297|NCT00573937|Mayo Clinic|Donald Northfelt, MD|480-301-8335|northfelt.donald@mayo.edu|
22445298|NCT02585843|Columbia University|A. Reshad Garan|(917) 374-3346|arg2024@cumc.columbia.edu|
22445299|NCT01188421|Johns Hopkins University, School of Medicine|Eric C. Strain, MD|410-550-1191|estrain1@jhmi.edu|
22445300|NCT01797731|Hospital for Special Surgery|David Mayman|2127742024|maymand@hss.edu|
22445301|NCT01604408|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22445302|NCT03711318|NYS Psychiatric Institute|Dr. Adam Bisaga, study PI|646-774-6155|adam.bisaga@nyspi.columbia.edu|
22445303|NCT03534362|Saint Louis University|Joe D Brunworth, MD|314-577-8884|joe.brunworth@health.slu.edu|
22445304|NCT02509481|Colorado State University|Dr. Brian D. Foy, Professor|970-491-3470|Brian.Foy@colostate.edu|
22445305|NCT00722423|VA San Diego Healthcare System|Dr. Samuel B. Ho|8586423280|Samuel.Ho2@va.gov|
22445306|NCT04040244|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-716-4760|jkettler@wakehealth.edu|
22445307|NCT01189604|Astrazeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22445308|NCT03945214|University of California San Francisco|Dr. Rachel Radin|845-641-9569|rachel.radin@ucsf.edu|
22445309|NCT02640716|Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China|Dr. Yi Tang|+86 10 83199456|tangyi@xwhosp.org|
22445310|NCT02664610|University of Michigan|Lesli Skolarus|734-936-9075|lerusche@umich.edu|
22445311|NCT04429243|WL Gore|Charee Robe|9288644048|crobe@wlgore.com|
22445312|NCT04102098|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22445313|NCT06448078|Ege University|Gizem Kececi Ozgur|+90 506 678 71 28|gizem.kececi.1991@gmail.com|
22445314|NCT03150173|Montefiore Medical Center|Dr. Aaron D. Fox, Professor, General Internal Medicine|718-920-7173|adfox@montefiore.org|
22445315|NCT00799812|BD|Erin Zook|847-362-9047|erin.zook@bd.com|
22445316|NCT01756053|Center for Interdisciplinary Research on Nicotine Addiction|Benjamin Albelda (Project Manager)|2157467173|albeldab@mail.med.upenn.edu|
22445317|NCT03277690|Cortendo AB|Xeris Medical Director|+1 610-254-9200|LOGICS@cortendo.com|
22445318|NCT03109847|Thomas Jefferson University|Joseph Curry, MD|215-503-6828|joseph.curry@jefferson.edu|
22445319|NCT02633501|Guerbet|Jing Hao, MD, Global Head of Medical Affairs & Clinical Development|+33 (0) 1 45 91 50 00|jing.hao@guerbet.com|
22398583|NCT02706730|Otonomy, Inc.|Otonomy Medical Information Center|1-844-686-4636|medinfo@otonomy.com|
22445320|NCT00590460|BAYLOR|Malcolm Brenner, MD|832-824-4663|mbrenner@bcm.edu|
22398584|NCT00794560|Pharmaceutical Care Research Group, University of Basle, Switzerland|Dr. Seraina Mengiardi|061 267 15 29|seraina.mengiardi@unibas.ch|0041
22398585|NCT04823949|The Medical University of South Carolina|Dr. Matthew Finneran|(843) 792-4500|finneram@musc.edu|
22445321|NCT01104155|Eisai Inc.|Eisai Medical Information|1-888-422-4743|esi_oncmedinfo@eisai.com|
22445322|NCT01672736|University Health Network - Princess Margaret Cancer Centre|Dr. Suzanne Trudel|416-946-4501|Suzanne.Trudel@uhn.ca|4566
22445323|NCT02396251|Galderma|Reception|+46184749000|reception.seupp@galderma.com|
22445324|NCT02927262|Astellas Pharma Global Development, Inc|Clinical trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22445325|NCT02617784|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22445326|NCT02853344|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|18006726372|ClinicalTrialsDisclosure@merck.com|
22445327|NCT02913612|Duke Clinical Research Institute|Kanecia Zimmerman, MD, PhD, MPH|919-668-8651|kanecia.zimmerman@duke.edu|
22445328|NCT04251273|Truth Initiative|Amanda L. Graham, PhD, Principal Investigator|(202) 525-6473‬|vapestudy@truthinitiative.org|
22445329|NCT04402060|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
22445330|NCT04836312|University of Pennsylvania|Alexander Fanaroff, MD|215-615-7674|alexander.fanaroff@pennmedicine.upenn.edu|
22398586|NCT00756938|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22398587|NCT00094055|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22398588|NCT00441545|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22398589|NCT03326141|University of Minnesota|Siobhan McMahon|612-625-3225|skmcmaho@umn.edu|
22398590|NCT00939692|Gateway Medical Research, Inc.|Walter A Parham|(314) 663-4550||
22398591|NCT01891331|Viamet Pharmaceuticals Inc|Neil Moore||nmoore@viamet.com|
22398592|NCT00699907|University of Arizona|Dr. Setsuko K. Chambers|520-626-0950|schamber@uacc.arizona.edu|
22429822|NCT06765889|A*STAR|Alessandro Sparacio|80728247|Alessandro_Sparacio@sics.a-star.edu.sg|
22398593|NCT01081795|Janssen Pharmaceutical KK Japan|Group Manager|+81-3-4411-5072||
22429823|NCT01569763|Minerva Surgical, Inc.|Dr. Eugene Skalnyi, VP Medical Affairs|(1) 650-284-3500|Eugenes@minervasurgical.com|
22429824|NCT01926509|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22429825|NCT02730169|Mereo BioPharma Group|Jackie Parkin|+44 (0) 333 023 7300|enquiries@mereobiopharma.com|
22429826|NCT03004183|Houston Methodist Cancer Center|Jenny C Chang, MD|713-441-0629|ccresearch@houstonmethodist.org|
22429827|NCT03885206|Landsforeningen for hjerte- og lungesyke|Senior Consultant|0047 95706313|irene.steinsvik@lhl.no|
22429828|NCT03076164|Memorial Sloan Kettering Cancer Center|Dr. Helene Yu, MD|646-608-3912|YuH@mskcc.org|
22429829|NCT02698787|Cochlear|Naomi Croghan|+13032642131|ncroghan@cochlear.com|
22429830|NCT00594308|Indiana University School of Medicine|Robert Nelson, MD|317-278-6871|ronelson@iupui.edu|
22429831|NCT02935036|Taro Pharmaceuticals U.S.A., Inc.|Manager, Clinical Research|9143459001|Businessdevelopment@taro.com|
22429832|NCT01260324|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22429833|NCT02533674|Pharma Mar, S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|+34 918466000|clinicaltrials@pharmamar.com|
22429834|NCT02799290|Tampere University Hospital|Ilkka Kaartinen|505687096|ilkka.kaartinen@pshp.fi|
22429835|NCT01160744|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22412383|NCT02606500|University medical centre Ljubljana|Professor Eda Vrtacnik Bokal|+38615226060|eda.bokal@guest.arnes.si|
22412384|NCT02773836|European Network for Smoking and Tobacco Prevention|Dr Constantine Vardavas|+306937281680|vardavas@tobcontrol.eu|
22412385|NCT00825227|Cephalon, Inc.|Vice President, Clinical Research|1-800-896-5855||
22412386|NCT01449266|Guerbet|Dr. Pierre Desché, MD - VP Development, Medical and Regulatory Affairs|+33 1 45 91 50 00|pierre.desche@guerbet-group.com|
22412387|NCT02720510|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22412388|NCT01153984|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22412389|NCT02460159|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22412390|NCT04763876|William Beaumont Army Medical Center Department of Emergency Medicine|Nathaniel James Turner|915-742-6228|nathaniel.j.turner3.mil@mail.mil|
22412391|NCT02226796|University of Minnesota Duluth|Sharyl Samargia-Grivette|218-726-8347|samargia@d.umn.edu|
22412392|NCT00084084|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22412393|NCT02106065|VA Palo Alto Health Care System|Dr. Kaci Fairchild|6504935000|jenniferkaci.fairchild@va.gov|63432
22412394|NCT01531205|H. Lee Moffitt Cancer Center and Research Institute|Julio Pow-Sang, M.D.|813-745-2226|julio.powsang@moffitt.org|
22412395|NCT02465567|Pearl Therapeutics Inc|Pearl Therapeutics Inc|1-877-240-9479|information.center@astrazeneca.com|
22429836|NCT01990352|George Washington Cancer Center|Dr. Pavani Chalasani|(202)-741-2277|pavani.chalasani@email.gwu.edu|
22445331|NCT03860597|University of California, San Diego|Neal Swerdlow, M.D., Ph.D.|(619) 543-6270|nswerdlow@ucsd.edu|
22445332|NCT03648827|PTC Therapeutics, Inc.|Medical Information|1-866-562-4620|medinfo@ptcbio.com|
22445333|NCT00936611|Dana-Farber Cancer Institute|Irene Ghobrial|6176324101|irene_ghobrial@dfci.harvard.edu|
22384755|NCT06074523|Lehigh University|Nancy Carlisle|610-758-5122|nbc415@lehigh.edu|
22445334|NCT02955797|Sanofi Pasteur Inc.|Medical Director|800-633-1610|Contact-US@sanofi.com|1#
22445335|NCT01783054|Medical University of South Carolina|Eric Kimchi, MD|842-792-4271|kimchi@musc.edu|
22445336|NCT03131453|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22445337|NCT02081183|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22445338|NCT00989157|NRIFargo|Dr. James Roerig|701 365 4919|jroerig@nrifargo.com|
22445339|NCT01021306|Palmer Center for Chiropractic Research, Palmer College of Chiropractic|Dr. James DeVocht|563.884.5150|james.devocht@palmer.edu|
22445340|NCT02282358|Memorial Sloan Kettering Cancer Center|Dr. Andrew Zelenetz, MD, PhD|646-608-3728|zeleneta@mskcc.org|
22445341|NCT01898208|Mayo Clinic|Ritu Banerjee, M.D., Ph.D.|507-284-6904|banerjee.ritu@mayo.edu|
22445342|NCT04043728|Rush University Medical Center|Dr. Amanda Mathew|13125631273|amanda_mathew@rush.edu|
22445343|NCT00675259|The Ohio State University|Ewa Mrozek, MD|614-293-0066|Ewa.mrozek@osumc.edu|
22445344|NCT03780543|Assembly BioSciences Inc.|Chief Development Officer|415-855-3006|manderson@assemblybio.com|
22445345|NCT01739361|LSU Health Sciences Center New Orleans|Dr. David R Janz, MD, MSc, Assistant Professor of Medicine|504-568-3167|djanz@lsuhsc.edu|
22445346|NCT02649894|Becton Dickinson|Dawn Heimer|2018476800|dawn.heimer@bd.com|
22384756|NCT02167867|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com|
22384757|NCT02897531|Department of Surgery, Seoul National University College of Medicine, Seoul National University Bundang Hospital|Sung-Bum Kang, MD, PhD|+82-031-787-7093|kangsb@snubh.org|
22384758|NCT03662607|Spectrum Health|Dr. Ryan Madder|6163916660|stephen.orey@corewellhealth.org|
22384759|NCT05868772|Cataract & Laser Institute|Dr Justin Spaulding|541-779-2020|justinophtho@gmail.com|
22384760|NCT03406871|NationalCCHE,JAPAN|Dr.Kohei Shitara|+81-4-7133-1111|regonivo_core@east.ncc.go.jp|
22384761|NCT05102591|University of Calgary/Alberta Health Services|Dr. Serena Orr|403-955-7728|serena.orr@albertahealthservices.ca|
22384762|NCT02281955|University of North Carolina at Chapel Hill|Dr. Colette Shen|984-974-0400|cjshen@email.unc.edu|
22384763|NCT04177823|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22384764|NCT03683719|LEO Pharma A/S|Clinical disclosure|+45 4494 5888|disclosure@leo-pharma.com|
22384765|NCT05081583|Washington State University|Dr. Mary Paine|5093587759|mary.paine@wsu.edu|
22384766|NCT00601900|Memorial Sloan-Kettering Cancer Center|Maura Dickler, M.D.||dicklerm@mskcc.org|
22384767|NCT03699709|University of Washington School of Public Health Department of Epidemiology|Dr. Amanda Fretts|2065431065|amfretts@uw.edu|
22384768|NCT03519581|University of California, Davis Eye Center|Clinical Research Supervisor|916 734-6303|dcmacias@ucdavis.edu|
22384769|NCT05694286|University of Pennsylvania|Ivona Percec, MD, PhD|215-662-7300|ivona.percec@pennmedicine.upenn.edu|
22384770|NCT05371652|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22429837|NCT01502072|UT MD Anderson Cancer Center|Roy F. Chemaly, MD,MPH- Professor, Infectious Diseases|(713) 745-1116|rfchemaly@mdanderson.org|
22429838|NCT01531803|Kedrion S.p.A|Dr. Mirella Calcinai, MD, Clinical Research Director|+393486559761|m.calcinai@kedrion.com|
22429839|NCT03646188|Medicus Pharma|Dr. Huma Qamar, MD., Chief Scientific Officer|610- 540-7515|hqamar@medicuspharma.com|106
22429840|NCT02773537|Medical University of South Carolina|Dr. Eric Bolin|843-792-2322|bolin@musc.edu|
22429841|NCT03606213|University of California, San Francisco (UCSF)|Professor of Medicine|14154761000|Steven.Deeks@ucsf.edu|
22429842|NCT01749293|University of Illinois|Dr. Pritesh Patel|312-996-5762|prpatel8@uic.edu|
22429843|NCT03008213|UCSD|Eric Roeland, MD|858- 534-7079|eroeland@ucsd.edu|
22429844|NCT01908699|Lung Biotechnology PBC|Lung Biotechnology PBC Study Director|301-608-9292|info@lungbiotechnology.com|
22429845|NCT01697501|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22429846|NCT02242903|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22429847|NCT02105012|Pearl Therapeutics Inc.|Paul Dorinsky, MD, FCCP|650-305-2600|pdorinsky@pearltherapeutics.com|
22398594|NCT02161211|University of Minnesota|Matt Kushner, Ph.D.|612-625-7546|kushn001@umn.edu|
22398595|NCT03115151|UT Southwestern Medical Center|Dr. Enas Kandil|214/648-9374|Enas.Kandil@UTSouthwestern.edu|
22398596|NCT04600895|Appili Therapeutics Inc|Prasann Bavaniya, MS-BioTech|902-442-4655|pbavaniya@appilitherapeutics.com|5
22398597|NCT03713944|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
22445347|NCT01736124|James J. Peters Veterans Affairs Medical Center|Dr. Jeremy Silverman|718-584-9000|jeremy.silverman@va.gov; jeremy.silverman@mssm.edu|1700
22445348|NCT01467583|Harper University Hospital|Krista Wahby, Critical Care Pharmacist in the Medical ICU|313-745-2711|kwahby@dmc.org|
22445349|NCT03727425|Auris Health, Inc.|Scott Rehage|9256832590|scott.rehage@aurishealth.com|
22445350|NCT05274165|Sonova USCS|Senior Research Audiologist|630-821-5000|phonakaudiologyresearch@gmail.com|
22398598|NCT02902120|Institute of Human Virology, University of Maryland School of Medicine|Lydia Tang|410-706-6567|LydiaTang@ihv.umaryland.edu|
22398599|NCT04926779|Quality Research and Invention LLC|Zanetta Malanowska-Stega|6462718593|jstega@optonline.net|
22398600|NCT01353703|GlaxoSmithKline|GSK Response Center|866-435-7343||
22398601|NCT03298022|AltruBio|Vice President of Clinical Operations|17142150224|simona.reed@altrubio.com|
22398602|NCT01787916|CHU de Quebec|Weisnagel|4185254444|john.weisnagel@crchul.ulaval.ca|47035
22398603|NCT00730639|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22445351|NCT02127723|Q-Med AB|Q-Med AB|+46 18 474 9000|medicalinfo.q-med@alderma.com|
22445352|NCT02719327|Madison Veterans Affairs Geriatrics Research, Education & Clinical Center (GRECC)|Cynthia Carlsson, MD, MS; Professor of Medicine (Geriatrics)|608-280-7000|cynthia.carlsson@va.gov|
22398604|NCT04397094|Faculty of Dentistry Ain Shams University|Dr. Mariem Wassel|+2 0064871416|mariem.wassel@dent.asu.edu.eg|
22398605|NCT00361595|Cleveland Clinic|Chad Deal|216-444-6575|dealc@ccf.org|
22398606|NCT00848354|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22445353|NCT03428932|Nemours Children's Health|Nelly Mauras, MD|904-697-3674|Nelly.Mauras@nemours.org|
22445354|NCT00717093|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22445355|NCT00217620|SWOG Statistical Center|Study Statistician|206-667-4623||
22445356|NCT03948698|Elizabeth Glaser Pediatric AIDS Foundation|Shirin Kakayeva|2404377929|skakayeva@pedaids.org|
22445357|NCT00418015|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|3129269015|r-mccarthy@northwestern.edu|
22445358|NCT00089414|Behavioral Endocrinology Branch/National Institute of Mental Health/NIH|Pedro E. Martinez, M.D., Principal Investigator|301-402-0615|martinep@mail.nih.gov|
22445359|NCT01805440|Department of Psychiatry|Douglas Kondo, MD|801-583-2500|doug.kondo@hsc.utah.edu|
22445360|NCT02903355|Southern Illinois University School of Medicine|Gary Fifer, MSHI|217-545-7823|gfifer@siumed.edu|
22445361|NCT01517074|National Institutes of Health|H. Nida Sen, MD, MHSc, Principal Investigator, NEI|301-402-3254|senh@nei.nih.gov|
22445362|NCT04176497|UNC Lineberger Comprehensive Cancer Center|Melahat Canter|919-966-4432|Melahat_Canter@med.unc.edu|
22445363|NCT01314703|CareFusion|Jennifer Raeder-Devens|847-454-4939|jennifer.raeder-devens@carefusion.com|
22445364|NCT04667481|University of Washington|Dr. Kerryn Reding, Study Principal Investigator|206-221-1571|kreding@uw.edu|
22445365|NCT04195906|Sanifit Therapeutics S. A.|Peter Szecsödy|+41588529079|clinicaltrials@cslbehring.com|
22445366|NCT03708562|Becton Dickinson (BPV)|Courtney Rothwell|480-350-6037|courtney.rothwell@bd.com|
22445367|NCT01823146|University of Florida|Dr. Natalie Ebner|203 691 0371|natalie.ebner@ufl.edu|
22445368|NCT01426438|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22445369|NCT02122458|VA Pittsburgh Healthcare System|Sheila R. Pratt, Ph.D.|412-979-3157|Sheila.Pratt@va.gov|
22445370|NCT00412542|UT MD Anderson Cancer Center|Vinay Puduvalli, MD / Associate Professor|713-745-5769|kuhunter@mdanderson.org|
22445371|NCT02833350|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22445372|NCT02765269|Xinhua Translational Institute for Cancer Pain, Shanghai|Gang Ding|021-69691540||
22445373|NCT00131508|St Jude Children's Research Hospital|Winfred Wang|1-866-278-5833|info@stjude.org|
22445374|NCT05143541|Kantonsspital St. Gallen|Dr. André E. Dutly|071 494 9944|andre.dutly@kssg.ch|
22445375|NCT01495975|MGH Diabetes Center|Nancy Wei, MD|617-724-7597|ncwei@mgh.partners.org|
22445376|NCT01954160|Duke Clinical Research Institute|Kathy Moore|919-668-8065|kathy.moore@dm.duke.edu|
22445377|NCT00808483|University of Oslo|Professor Anne Marit Mengshoel|004790036933|a.m.mengshoel@medisin.uio.no|
22445378|NCT02038881|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
22445379|NCT00333840|Novartis Pharmaceuticals|Study Director|862-778-8300||
22445380|NCT02357979|University of California at San Francisco|Dr. Peter Rechmann|415 514 3225|Peter.Rechmann@ucsf.edu|
22445381|NCT01453725|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22445382|NCT00392860|Human Engineering Research Laboratories|Michael L Boninger|412-822-3700|boninger@upmc.edu|
22445383|NCT01955564|Newron Pharmaceuticals S.p.A.|Dr. Ravi Anand|+39 026103461|ravi@anand.ch|
22445384|NCT03449901|Washington University School of Medicine|Mia Weiss, M.D.|314-362-5737|m.c.weiss@wustl.edu|
22445385|NCT03594435|University of California Los Angeles|Dr. Lara Ray|310-206-6756|lararay@psych.ucla.edu|
22445386|NCT03755791|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
22445387|NCT01296360|Valneva Austria GmbH|Senior Manager Clinical Research|+43 1 206 20|katrin.dubischar-kastner@valneva.com|1175
22445388|NCT03599635|University of Minnesota|Jason Habeck|612-624-9990|habe0073@umn.edu|
22445389|NCT02394548|Massachusetts General Hospital|Dr. Henning Willers|617-726-5184|hwillers@mgh.harvard.edu|
22445390|NCT03605212|Menarini Group|Angela Capriati, MD PhD - Corporate Director Clinical Sciences|+39 055 5680|acapriati@menarini-ricerche.it|9990
22445391|NCT01254292|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22445392|NCT02083081|Mayo Clinic|Christi Patten PhD|507-538-7370|patten.christi@mayo.edu|
22445393|NCT00285818|Stanford University|Dr. Hugh Brent Solvason|650 776 4793|solvason@stanford.edu|
22445394|NCT01191411|University of Texas Southwestern Medical Center|Keith E. Argenbright, MD|817-288-9898|keith.argenbright@utsouthwestern.edu|
22445395|NCT01259596|Wake Forest School of Medicine|Gretchen A. Brenes, Ph.D.|336-716-4551|gbrenes@wakehealth.edu|
22445396|NCT02263131|The Catholic University of Korea, Seoul St. Mary's Hospital|Dr. Kang Jin Han|+82-10-4251-8375|kjhan@catholic.ac.kr|
22445397|NCT01268150|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
22445398|NCT04209348|The University of Tennessee, Knoxville|Dr. Samantha Ehrlich|510 299 8747|sehrlic1@utk.edu|
22445399|NCT01209923|University of Southern California|Edward Schroeder|323-442-2498|eschroed@usc.edu|
22445400|NCT02507973|The R Adams Cowley Shock Trauma Center|Dr Deborah Stein|410-328-3495|dstein@umm.edu|
22445401|NCT02497300|University of Alabama at Birmingham|Eric Judd|205 934-9509|ejudd@uab.edu|
22445402|NCT01033851|Massachusetts General Hospital|Dr. Elizabeth Hoge|6177240859|ehoge@partners.org|
22445403|NCT04068610|AstraZeneca Clinical study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
22445404|NCT00072176|Princess Margaret Hospital, Toronto, Canada|Dr. Amit M. Oza|416 946 4501|amit.oza@uhn.ca|2818
22445405|NCT02586064|Providence VA Medical Center|Dr. Tracie Shea|401-273-7100|MaryTracie.Shea@va.gov|6248
22445406|NCT02158975|University of Michigan Comprehensive Cancer Center|Dr. Ryan Wilcox, M.D.|734-615-1482|rywilcox@umich.edu|
22445407|NCT02000180|St. Michael's|Dr. Samir C. Grover|4168645628|samir.grover@utoronto.ca|
22445408|NCT02728596|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|karnold@fredhutch.org|
22398607|NCT03790280|University of California, Los Angeles (UCLA)|Angela Martinez, Research Manager|310-206-7630|angelamartinez@mednet.ucla.edu|
22398608|NCT03505021|Orion Corporation|Director, Clinical Operations|358104261|clinicaltrials@orionpharma.com|
22429848|NCT00493285|MedImmune, LLC|Elissa Malkin, DO, MPH|301-398-0000|malkine@medimmune.com|
22445409|NCT04590963|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22445410|NCT04430738|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22445411|NCT06007664|University of Michigan|Noah J. Webster|734-936-3075|njwebs@umich.edu|
22445412|NCT04176705|Wake Forest University Health Sciences|John Bailey, MD|(336) 716-8002|jkbailey@wakehealth.edu|
22445413|NCT02628769|Imperial College London|Louise Donnelly|+44 02075947895|l.donnelly@imperial.ac.uk|
22445414|NCT00289718|GlaxoSmithKline|GSK Response Center|866-435-7343||
22445415|NCT04102189|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22445416|NCT03319173|Bristlecone Health, Inc.|Dr. Kelly J. Gibas|763-913-4600|kelly-gibas@bethel.edu|
22445417|NCT00721500|Vistakon|Kurt Moody OD FAOO / Director|904-443-3088||
22445418|NCT01543698|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22445419|NCT00316719|GlaxoSmithKline|GSK Response Center|866-435-7343||
22445420|NCT01863953|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22445421|NCT00573183|Univerity of Washington Alcohol & Drug Abuse Institute|Dr. Dennis Donovan|206-543-0937|ddonovan@u.washington.edu|
22445422|NCT05439941|Evelo Biosciences, Inc|Duncan McHale, MBBS, MRCP, PhD|+447500128938|duncan@evelobio.com|
22445423|NCT01126801|Brigham & Women's Hospital|Dr. Hadine Joffe|617-732-4906|hjoffe@partners.org|
22445424|NCT02336373|Baylor College of Medicine|Vivien Sheehan, MD, PhD|(832) 824-4459|vxsheeha@txch.org|
22445425|NCT03095885|Allena Pharmaceuticals, Inc|Allena Medical Affairs|6174674577|AllenaMedInfo@allenapharma.com|
22445426|NCT02160535|University of Washington|Dr. Sylvia Lucas, MD, PhD|206-598-9260|lucass@uw.edu|
22445427|NCT04798781|Cedars-Sinai Medical Center|Andrew Hendifar, MD, MPH|3104232217|andrew.hendifar@cshs.org|
22445428|NCT00752102|Joslin Diabetes Center|Dr. Sylvia Rosas|617-309-2477|sylvia.rosas@joslin.harvard.edu|
22445429|NCT00615108|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22445430|NCT02024529|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|7204376500|clinicaltrials@ampiopharma.com|
22445431|NCT00691301|Gynecologic Oncology Group|Linda Gedeon for Mark Brady, PhD|716-845-1169|lgedeon@gogstats.org|
22445432|NCT02642029|McLean Hospital|Ann Shinn, MD|617-855-3053|akshinn@partners.org|
22445433|NCT00463580|Emory University|Andrew H. Miller, MD|404-727-8260|amill02@emory.edu|
22445434|NCT00676338|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22445435|NCT01788046|Amgen Inc.|Study Director|866-572-6436||
22445436|NCT00075218|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22445437|NCT03643575|Reckitt Benckiser, Inc|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
22445438|NCT00875979|Hoffmann-La Roche|Medical Communications|800 821-8590||
22445439|NCT00843531|University of California, San Francisco|Emily Bergsland, MD|(415) 514-6520|Emily.Bergsland@ucsf.edu|
22445440|NCT01696695|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22445441|NCT04081324|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22445442|NCT01076231|University of Pennsylvania|Dr. Jacob Shabason|215-662-3998|susan.mazzoni@uphs.upenn.edu|
22445443|NCT00739050|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22445444|NCT01904058|Mirum|Study Physician|1-650-667-4085|medinfo@mirumpharma.com|
22445445|NCT01464996|University of North Carolina at Chapel Hill School of Dentistry|Dr. Andre Ritter, Professor and Chair|919-537-3987|andre_ritter@unc.edu|
22445446|NCT04041375|Michael E. DeBakey VAMC|Dr. Natalie E. Hundt|713-791-1414|natalie.hundt@va.gov|10315
22445447|NCT01967342|University of Alabama|Beverly E. Thorn, Ph.D.|(205) 348-8024|bthorn@ua.edu|
22445448|NCT01986946|Duke University Hospital|Dr. Erin Manning|919-681-3551|erin.manning@duke.edu|
22445449|NCT02404220|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22445450|NCT00395733|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22445451|NCT05835323|Johnson & Johnson MedTech Surgery|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
22398609|NCT03087955|Drugs for Neglected Diseases|Sandra Rembry, PharmD|+41229077734|srembry@dndi.org|
22429849|NCT03021005|Johns Hopkins University|Dr. Yu-Hsiang Hsieh|410-735-6413|yhsieh1@jhmi.edu|
22429850|NCT03917901|University of Houston|Brooke Kauffman|(713) 743-8056|bkauffma@central.uh.edu|
22429851|NCT00943202|Division of Infectious Diseases and Immunology, Saint Louis University Medical School|Sharon E. Frey, M.D.|314-977-5500|freyse@slu.edu|
22429852|NCT03994120|National Institutes of Health/NINDS|Dr. Eric Wasserman|301-495-0151|wassermanne@ninds.nih.gov|
22429853|NCT00215553|Discovery Laboratories, Inc.|Robert Segal, MD|215-488-9300|rsegal@discoverylabs.com|
22429854|NCT01111292|Northwestern University|Dr. Seema Khan|(312) 503-4236|SKhan@nm.org|
22429855|NCT01429623|Bar Ilan University|Jonathan Rabinowitz, PhD|+972544643889|Jonathan.Rabinowitz@biu.ac.il|
22429856|NCT03156621|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844 734 6643|clinicaltrials@regeneron.com|
22429857|NCT02350998|Otonomy, Inc.|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
22429858|NCT01259024|Washington University|Patricia Nieters, RN, BSN, Clinical Research Specialist|314-362-3371|nietersp@wustl.edu|
22445452|NCT04981392|UMass Chan Medical School|Kimberly Fisher, MD|5088561975|kimberly.fisher2@umassmed.edu|
22445453|NCT04856891|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
22445454|NCT01147172|Anika Therapeutics|Adrian Orr, Director Clinical Affairs|781.457.9000|aorr@anikatherapeutics.com|
22398610|NCT04484285|University of Florida|Eric Porges, Associate Profressor|(352) 294-5838|eporges@ufl.edu|
22445455|NCT01697358|Medtronic Restorative Therapies Group - Pain Stim|Restorative Therapies Group Clinical Trials||medtronicneurotrials@medtronic.com|
22412396|NCT01085344|The Hospital for Sick Children|Dr. Brian Feldman|416-813-5828|brian.feldman@sickkids.ca|
22412397|NCT01807637|University of Arkansas for Medical Sciences|Mark Mennemeier, PhD|15015267773|msmennemeier@uams.edu|
22412398|NCT00337077|ECOG Statistical Office|Study Statistician|617-632-3012||
22445456|NCT02387710|Brigham and women's Hospital|Andrew Wellman, MD, PhD||awellman@rics.bwh.harvard.edu|
22445457|NCT02711345|Novartis Pharma AG|Study Director|862 778-8300|Novartis.email@novartis.com|
22445458|NCT00961649|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22445459|NCT02155881|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22445460|NCT04357782|Central Virginia VA Health Care System|Dr. Brian Davis|804-675-5000|Brian.Davis5@va.gov|
22445461|NCT01786148|Emory University|Marcia McDonnell Holstad|404-727-1307|nurmmcd@emory.edu|
22445462|NCT00338104|Northwestern University|Mark E. Molitch, M.D.|312 503-4130|molitch@northwestern.edu|
22445463|NCT00968890|GlaxoSmithKline|GSK Response Center|866-435-7343||
22445464|NCT02362269|University of Wisconsin|Dr. Corinne D. Engleman|(608) 265-5491|cengelman@wisc.edu|
22445465|NCT02349542|OrthoCarolina Research Institute|Senior Research Scientist|704-323-2260|susan.odum@orthocarolina.com|
22445466|NCT00200161|Memorial Sloan Kettering Cancer Center|Dr. Lisa Deangelis|212-639-7997|deangell@mskcc.org|
22445467|NCT03841448|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
22445468|NCT03896165|Ohio State University College of Nursing|Assistant Professor|614-292-5684|thrane.2@osu.edu|
22445469|NCT01163266|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22445470|NCT02919696|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979|ClinicalTrials.gov@lilly.com|
22445471|NCT03181893|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22445472|NCT04128371|National Institute of Allergy and Infectious Diseases|Dr. Paneez Khoury|+1 301 402 3673|paneez.khoury@nih.gov|
22445473|NCT01706822|Covidien|Julie Doyle|781-839-1729|Julie.Doyle@Covidien.com|
22445474|NCT04815031|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22445475|NCT02308189|Ohio University|Brian Clark, PhD|740-593-2354|clarkb2@ohio.edu|
22445476|NCT01361568|Cara Therapeutics|Frédérique Menzaghi, PhD; Vice President, Research & Development|203-567-1502|fmenzaghi@caratherapeutics.com|
22445477|NCT00484094|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22445478|NCT03594994|Washington University|Joseph Beals|314-362-8199|bealsjw@wustl.edu|
22445479|NCT00193258|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22445480|NCT03308786|Case Western Reserve University|Michael M. Lederman MD|2168448786|MXL6@CASE.EDU|
22445481|NCT00761631|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22445482|NCT00309985|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
22445483|NCT03672643|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22445484|NCT01950390|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22445485|NCT06462014|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov.Inquiries@pfizer.com|
22445486|NCT02975336|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22445487|NCT02495831|CROSS REsearch SA|Dr. Milko Radicioni|+41.91.63.00|clinic@croalliance.com|510
22445488|NCT02008318|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22445489|NCT02281773|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22445490|NCT00385762|Weill Cornell Medical College|Peter N Schlegel, MD|2127465491|pnschleg@med.cornell.edu|
22445491|NCT04021771|Thomas Jefferson University|Dr. Kristin Rising|215-503-5507|Kristin.Rising@jefferson.edu|
22445492|NCT03019575|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22445493|NCT03792191|Mansoura University|Dr. Mohamed Mohamed Tawfik|1001183400|m2tawfik@mans.edu.eg|0020
22445494|NCT02234570|University of Iowa|Patricia Winokur, MD|319-384-1735|patricia-winokur@uiowa.edu|
22445495|NCT02056639|University of Pennsylvania|Bridget Nolan|2156623324|bridget.nolan@uphs.upenn.edu|
22445496|NCT03509883|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22445497|NCT01147640|Cubist Pharmaceuticals, Inc.|Dr. Obi Umeh, Vice President Global Medical Sciences|781-860-8415|obiamiwe.umeh@cubist.com|
22445498|NCT02927327|GE Healthcare|John Strohmeyer|609-865-7423|john.strohmeyer@ge.com|
22445499|NCT01856907|Woman's Hospital|Dr Karen Elkind-Hirsch|225-231-5278|karen.elkind-hirsch@womans.org|
22445500|NCT00091442|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Director Medical Leader|908 218 7361||
22445501|NCT04517500|Mayo Clinic|Roberto P. Benzo, M.D.|507-284-0561|Benzo.Roberto@mayo.edu|
22445502|NCT00986830|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
22445503|NCT00845858|Evoke Pharma|Marilyn R. Carlson|858-345-1494|mcarlson@evokepharma.com|
22445504|NCT01436396|Sanofi Pasteur|Director||Contact-US@sanofi.com|
22412399|NCT02073643|Rush University Medical Center|Brad Appelhans, PhD|312-942-3477|brad_appelhans@rush.edu|
22429859|NCT01657500|Case Western Reserve Univ and University Hospitals Case Medical Center|Jonathan Lass MD|2168445893|jonathan.lass@uhhospitals.org|
22429860|NCT00756444|Amgen Inc.|Study Director|866-572-6436||
22445505|NCT01479127|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
22445506|NCT04674644|Suleyman Demirel University|Dr Esra Oz|05326788040|esrakaraagac@sdu.edu.tr|
22445507|NCT03469934|AnaptysBio, Inc|Clinical Project Leader|858-362-6295|info@anaptysbio.com|
22445508|NCT05280782|Washington University School of Medicine|Dr. Pamela K. Woodard|314-362-7100|woodardp@wustl.edu|
22412400|NCT05723822|RxFunction|Clinical Research Specialist|612-358-2141|Yvonne.Rumsey@rxfunction.com|
22398611|NCT06272370|DARTNet Institute|Wilson Pace, MD|800-434-0278|Wilson.pace@dartnet.info|12
22398612|NCT05280756|University of Pittsburgh Medical Center|Dr. Alexandre Paim Diaz|(412) 624-1000|paimdiaza@upmc.edu|
22398613|NCT00939198|George Washington University|Dr. David Diemert|2029942909|ddiemert@gwu.edu|
22398614|NCT01299766|Thomas Jefferson University|Robin Casten|215-503-1250|robin.casten@jefferson.edu|
22398615|NCT04002310|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|18002430127|clintriage.rdg@boehringer-ingelheim.com|
22398616|NCT00352534|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22398617|NCT00619502|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22398618|NCT02303431|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22398619|NCT01354028|University of Arkansas for Medical Sciences|Dr Richard W Hall MD, Professor of Neonatology|501-680-7894|HallRichardW@uams.edu|
22398620|NCT01641939|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22398621|NCT02894840|Mahidol university|Prof.Punnee Pitisuttithum|662 6435599|punnee.pit@mahidol.ac.th|
22398622|NCT01072344|Memorial Sloan Kettering Cancer Center|Dr. Jun Mao|646-888-0866|maoj@mskcc.org|
22398623|NCT00716976|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22398624|NCT05499559|Arthro Therapeutics/Joint Academy|Study Director|+46708971677|leif@jointacademy.com|
22398625|NCT05022641|University of Michigan|Dr. Paul Gauger|734-936-0231|pgauger@med.umich.edu|
22398626|NCT03881007|Institute of Tropical Medicine Antwerp|Dr. Chris Kenyon|+32(0)32470786|ckenyon@itg.be|
22398627|NCT00847587|UUtah|Kirtly Parker Jones|801-581-3834|kirtly.jones@hsc.utah.edu|
22445509|NCT01024231|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22445510|NCT01419639|NYU Langone Medical Center|Matthias A. Karajannis|212 263 9959|matthias.karajannis@nyumc.org|
22445511|NCT02761733|Felton Institute & Palo Alto University|Joyce Chu (Principal Investigator)|650-814-8376|jchu@paloaltou.edu|
22445512|NCT00669396|University of Utah|David Turok, MD|801-581-7647|david.turok@hsc.utah.edu|
22445513|NCT01262573|Brigham and Women's Hospital|Dr. Jon Einarsson|617-525-8582|jeinarsson@partners.org|
22398628|NCT03472560|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22412401|NCT00984295|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22445514|NCT02256072|Northwestern University Feinberg School of Medicine|Dr. Lee A. Lindquist|312-503-3916|LAL425@md.northwestern.edu|
22445515|NCT00810693|Bayer|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22398629|NCT01946178|Mirabilis Medica, Inc.|Director of Clinical Affairs|425-486-8230|patrick@mirabilismedica.com|
22445516|NCT01297920|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22445517|NCT02572609|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22445518|NCT04295772|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22445519|NCT00331422|Masonic Cancer Center, University of Minnesota|Melissa Geller, MD|612-626-3111|gelle005@umn.edu|
22445520|NCT02345226|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22445521|NCT04141046|University of North Carolina at Chapel Hill|Saira Sheikh, MD|919-966-0545|szsheikh@email.unc.edu|
22445522|NCT01848704|Assistance publique hopitaux de paris|Isabelle Boutron|+33 1 42 34 78 33|isabelle.boutron@htd.aphp.fr|
22445523|NCT01710046|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22445524|NCT02503410|Spaulding Rehabilitation Hospital|Paolo Bonato|617-952-6319|pbonato@partners.org|
22445525|NCT03386474|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22445526|NCT01498978|OHSU Knight Cancer Institute|Kristi Eilers|503-494-2897|eilersk@ohsu.edu|
22445527|NCT00066729|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22445528|NCT03488355|Memorial University of Newfoundland|Dr. Peter Daley|7097772089|pkd336@mun.ca|
22445529|NCT02215096|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22445530|NCT03021304|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22445531|NCT00370071|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22445532|NCT02717273|University of Virginia|Robert Sawyer|4349821632|rws2k@virginia.edu|
22445533|NCT04294277|EAU Research Foundation|Dr. Wim Witjes|31263890677|w.witjes@uroweb.org|
22445534|NCT03350620|Vyluma, Inc|VP of Clinical Development|9083677400|info@vyluma.com|
22445535|NCT00566111|Yale University Department of Psychiatry|Dr. Gerard Sanacora|(203) 974-7535|gerard.sanacora@yale.edu|
22445536|NCT03366012|Columbia University|Julian Abrams, MD, MPH|212-305-1909|ja660@cumc.columbia.edu|
22445537|NCT03401489|San Francisco VA Medical Center|Bruce Ovbiagele|415-750-2047|bruce.ovbiagele@va.gov|
22445538|NCT03774082|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novatis.email@novartis.com|
22445539|NCT05938920|InSilico Medicine Hong Kong Limited|Yujin Tian|+86-21-50831718|Insilico-Clinicaltrial@insilico.ai|
22445540|NCT01251861|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22445541|NCT02027883|Wellmont CVA Heart Institute|Terrie Walker, Director of Clinical Research|423-230-5643|twalker@mycva.com|
22445542|NCT00531934|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22445543|NCT00150709|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22445544|NCT04092582|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22445545|NCT03689114|Istituto di Ricerche Farmacologiche Mario Negri IRCCS|Giorgia Giussani|0239014604|giorgia.giussani@marionegri.it|
22445546|NCT03423082|University of Pittsburgh|Nghi C. Nguyen, MD, PhD|412-647-0104|nguyennc@upmc.edu|
22445547|NCT01816074|Dept of Psychiatry, University of Washington|Dr. Mark Stein|206-987-1161|mstein42@uw.edu|
22445548|NCT03643796|University of Arkansas for Medical Sciences|Mohamed Abdeldayem|2244279747|Maabdeldayem@uams.edu|
22445549|NCT00270790|University of Maryland School of Medicine|Mohan Suntharalingam|410-328-2328|msuntha@umm.edu|
22445550|NCT03355365|Tisch MS Research Center of New York|Saud Sadiq|212-265-8070|ssadiq@tischms.org|
22445551|NCT00320931|University of Maryland, Baltimore|Vasken Dilsizian, MD|410-328-6890|vdilsizian@umm.edu|
22445552|NCT05203289|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22445553|NCT01303861|Duke University Medical Center - Duke Center for Smoking Cessation|Dr. Jed E. Rose|919-668-5055|jed.rose@dm.duke.edu|
22384771|NCT04410042|St. Jude Children's Research Hospital|Michael D. Neel, MD|901-259-1600|mneel@orthosouth.org|
22384772|NCT03898986|Stanford University|Philip Grant, MD|6507239001|pmgrant@stanford.edu|
22429861|NCT01530997|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22384774|NCT04322643|Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center|Dr. Moshe Ornstein|866-223-8100|TaussigResearch@ccf.org|
22384775|NCT05329493|Massachusetts General Hospital|Dr. Dieter Manstein|617-726-4893|dmanstein@mgh.harvard.edu|
22384776|NCT05486078|Guna S.p.a|Dr. Vincenzo Miranda, Clinical Research & Scientific Service Manager|02 280.18.(358)|v.miranda@guna.it|
22384777|NCT03302494|Coherex Medical, Inc.|Senior Director Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22384778|NCT05134233|Fralin Biomedical Research Institute at VTC|Jessica Florig|540-526-2261|jnw@vtc.vt.edu|
22384779|NCT03978871|University of Illinois, Urbana-Champaign|Dr. Karen Rudolph|217-333-8624|krudolph@illinois.edu|
22384780|NCT05710107|Medical University of South Carolina|Ellen Johnson|843-792-2322|hayell@musc.edu|
22384781|NCT04166773|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22384782|NCT04072822|Indiana University School of Medicine|Samer Gawrieh, MD|(317) 278-9326|sgawrieh@iu.edu|
22384783|NCT03033576|SWOG Statistics and Data Management Center|Melanoma Committee Statistician|2066674623|sbellasea@fredhutch.org|
22384784|NCT03719443|Parexel International|Principal Investigator|(781) 487-9900|info@parexel.com|
22384785|NCT02132936|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
22398630|NCT04669678|University of Alabama at Birmingham|Rena C Patel|2059348145|renapatel@uabmc.edu|
22398631|NCT01534676|Columbia University Medical Center|Eldad Hod, MD|212-342-5648|eh2217@cumc.columbia.edu|
22398632|NCT02908880|Essential Medical, Inc.|Sam Nardone|6105571009|sam@essmedclosure.com|
22398633|NCT00374803|University of Cincinnati|Rita Alloway, PharmD|5135581568|rita.alloway@uc.edu|
22398634|NCT01001702|Otsuka Pharmaceutical Development and Commercialization|Global Medical Affair|800 562-3974||
22398635|NCT00997516|University of California, San Francisco|Jonathan T. Carter, MD, FACS|415-476-0974|jonathan.carter@ucsfmedctr.org|
22398636|NCT00584233|University of California Davis|Dr. John Boone|(916) 849-3580|jmboone@ucdavis.edu|
22398637|NCT02494596|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22398638|NCT02222714|Cedars-Sinai Medical Center|Patrick Lyden, MD, FAAN, FAHA|(310) 423-5166|Patrick.Lyden@cshs.org|
22398639|NCT00159432|USC Norris Comprehensive Cancer Center|Victoria Soto, Project Specialist|323-226-6384|victoria.soto@med.usc.edu|
22398640|NCT03286842|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22398641|NCT02261727|The George Institute for Global Health|Prof Christine Jenkins|+61280524300|christine.jenkins@sydney.edu.au|
22398642|NCT03178487|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22398643|NCT01445028|MidAtlantic Retina|Richard Kaiser, MD|215-928-3092|research@midatlanticretina.com|
22398644|NCT06219577|Scripps Optometric Group|Dr Jay Mashouf|18585302800|jaymashouf@gmail.com|
22398645|NCT00883675|Maestro|Michael Mann, MD|650-380-9579|michael.mann@ucsfmedctr.org|
22398646|NCT05325775|Acer Therapeutics Inc ( a wholly owned subsidiary of Zevra Therapeutics Inc|Chief Medical Officer|844-902-6100|aquartel@zevra.com|
22398647|NCT00197054|Kombewa Clinic, US Army Medical Research Unit, Kisumo Kenya|LTC Mark Polhemus MD, MC|877-379-3788|GSKClinicalSupportHD@gsk.com|
22398648|NCT02574637|AstraZeneca|Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22398649|NCT00355394|CHOP|Dr. Nicholas Abend|215-590-1719|abend@email.chop.edu|
22398650|NCT02582957|University of Colorado|Dr. Richard Albert|303-602-5011|RICHARD.ALBERT@cuanschutz.edu|
22398651|NCT03021642|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22398652|NCT01192347|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22398653|NCT00090545|National Cancer Institute, National Institues of Health|William Dahut, M.D.|301-435-8183|dahutw@mail.nih.gov|
22398654|NCT01175902|Seoul St. Mary's Hospital|Chan Kee Park|82222586208|ckpark@catholic.ac.kr|
22398655|NCT03452371|Boston Medical Center/ Boston University Schools of Medicine and Public Health|Karen Lasser|617-414-6688|karen.lasser@bmc.org|
22398656|NCT04317274|Massachusetts General Hospital|Dr. Karen R. Sepucha|617-724-3350|KSEPUCHA@mgh.havard.edu|
22398657|NCT01307930|TTUHSC|Ronald Hall|2143589009|ronald.hall@ttuhsc.edu|
22398658|NCT01164722|AIDS Malignancy Consortium|Group Statistician|1-501-526-6712|jylee@uams.edu|
22398659|NCT01675960|Children's of Minnesota|Scott Schwantes|(612)813-7888|sschwantes@gillettechildrens.com|
22398660|NCT03138876|Mayo Clinic|Dr. William O. Tatum|904-953-2498|tatum.william@mayo.edu|
22398661|NCT03889639|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22398662|NCT01703858|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22398663|NCT02556255|Eximo Medical|Oshrat Cohen|97286307639|oshratc@eximomedical.com|
22398664|NCT04173429|Qilu Hospital of Shandong University|Professor Gao Yanjing|18560086087|gaoyanjing@sdu.edu.cn|
22398665|NCT00993031|University of California, San Francisco|Diane V Havlir, MD|01-415-476-4082|dhavlir@php.ucsf.edu|400
22398666|NCT00465595|Johns Hopkins University School of Medicine|Roland R. Griffiths, Ph.D., Principal Investigator|4105500034|rgriff@jhmi.edu|
22429862|NCT02298491|UMaryland|Horea Rus|410-706-3170|hrus@som.umaryland.edu|
22429863|NCT02318277|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
22445554|NCT00659360|Cross Cancer Institute|Dr. Margaret Von Mehren|215-214-1663|margaret.vonmehren@fccc.edu|
22445555|NCT00333177|University of California, Los Angeles|Keith H. Nuechterlein, Ph.D., Principal Investigator|(310) 825-0036|keithn@ucla.edu|
22445556|NCT03650556|Abbott Medical|Amber Miller|(612) 413-7236|amber.miller@abbott.com|
22445557|NCT00398918|Boston University|Ofra Sarid-Segal, MD|617-414-1990|ofra.segal@bmc.org|
22445558|NCT00723580|Child Psychopharmacology Institute|Bill J. Duke, Ph.D.|701-241-9281|bduke@ChildPsychopharmacologyInstitute.org|2
22445559|NCT03917459|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22445560|NCT00354887|UT MD Anderson Cancer Center|Robert Wolff, MD / Professor|713-792-2828|mjlim@mdanderson.org|
22445561|NCT00567307|Wake Forest School of Medicine, Winston Salem, NC|Dr. Elsayed Z Soliman, Director of the Epidemiological Cardiology Research Center|336-716-8632|esoliman@wakehealth.edu|
22445562|NCT01500031|Boston Scientific|Director Clinical Trials|708-771-4737|Pamela.Grady@bsci.com|
22445563|NCT00917501|University of Cincinnati|Dr. Robert McNamara|513-558-5601|robert.mcnamara@uc.edu|
22445564|NCT03656107|University of Leicester|Dr Lucy Beishon|0116252|lb330@le.ac.uk|3134
22445565|NCT00850070|The Children's Health Council|Glen R. Elliott, Ph.D., M.D.|650.688.3649|gelliott@chconline.org|
22445566|NCT02391701|Hospital Clínico Universitario de Santiago|Dr. María del Mar Calvo Malvar|34 981950395|mariadelmar.calvo.malvar@sergas.es|
22445567|NCT01102270|Brigham and Women's Hospital|Atul Malhotra|6177326488|amalhotra1@partners.org|
22445568|NCT01573260|McGill University|Dr.Ronald B Postuma|514-934-8026|ron.postuma@mcgill.ca|
22445569|NCT01522248|Johns Hopkins University|Kawsar Talaat|410-502-9627|ktalaat@jhu.edu|
22445570|NCT01360593|UPMC Hillman Cancer Center|Barbara Stadterman, Regulatory Supervisor, MPH, CCRP|412-647-5554|stadtermanbm@upmc.edu|
22445571|NCT02191137|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22445572|NCT01332331|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22445573|NCT00538291|City of Hope National Medical Center|Paul Frankel, Ph.D.|(626)359-8111|pfrankel@coh.org|65265
22445574|NCT00694707|Allergan|Willie R. Earley, MD Associate Vice President Clinical Development-CNS|714-246-4500|IR-CTRegistration@allergan.com|
22445575|NCT03417804|Centro Hospitalar do Porto|Dr. Simão Esteves|+351222077549|simao.esteves@me.com|
22445576|NCT03096483|GE Healthcare|Beth Heckel|2623127269|beth.heckel@ge.com|
22445577|NCT00369707|Northwestern University|Leo Gordon, MD|312-695-4520|l-gordon@northwestern.edu|
22445578|NCT05224141|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22445579|NCT02046733|European Thoracic Oncology Platform (ETOP)|Heidi Roschitzki-Voser|+41 31 511 94 18|STIMULI@etop-eu.org|
22445580|NCT04562792|Children's Mercy|Dr. Alan Gamis|816-302-6808|agamis@cmh.edu|
22445581|NCT02956070|Universidade Federal Fluminense|Dr. Luiz Augusto Poubel|55 21 981113344|luizpoubel@id.uff.br|
22445582|NCT02390908|Hunter College|Dr. Tyrel J. Starks|212-772-5550|tstarks@hunter.cuny.edu|
22445583|NCT00515177|University of Minnesota|Cynthia Gross PhD|612-624-8676|gross002@umn.edu|
22445584|NCT04515394|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22445585|NCT00199875|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
22445586|NCT01869439|WoundVision LLC|Dr. James G. Spahn, M.D.|(317) 775-6080|brett@woundvision.com|
22445587|NCT01691898|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22445588|NCT01013350|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22445589|NCT02019277|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22445590|NCT03725852|Galapagos NV|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
22445591|NCT03557853|MSD Pharmaceuticals LLC|Vladimir Achikyan|+74959167100|vladimir.achikyan@merck.com|
22445592|NCT04048122|Washington University School of Medicine|Dr. Erin Foster|314-286-1638|erfoster@wustl.edu|
22445593|NCT01787331|University of California, San Francisco|Rahul Aggarwal, MD|877-827-3222|cancertrials@ucsf.edu|
22445594|NCT01999868|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22445595|NCT00310401|Vanderbilt University|Lorraine B. Ware M.D.|615 322 8614|lorraine.ware@vanderbilt.edu|
22445596|NCT00289016|Amgen, Inc.|Study Director|866-572-6436||
22445597|NCT00667875|Medical University of South Carolina|Raymond F. Anton, MD|843-792-1226|antonr@musc.edu|
22445598|NCT00450255|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22445599|NCT00579137|Baylor|Robert Krance, MD|832-824-4661|rkrance@bcm.edu|
22445600|NCT03553927|Imperial College London|Channa Jayasena|02083833242|c.jayasena@imperial.ac.uk|
22445601|NCT01134276|Seoul National University College of Medicine|Sun-Whe Kim|+82-2-2072-2315|sunkim@plaza.snu.ac.kr|
22445602|NCT03019185|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22445603|NCT03930680|University of Arkansas for Medical Sciences|Hui-Ming Chang, MD, MPH|501-686-7575|hchang@uams.edu|
22445604|NCT02764333|Memorial Sloan Kettering Cancer Center|Dr. Jason Konner, MD|848-225-6530|konnerj@MSKCC.ORG|
22445605|NCT04075279|Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health|Dr. Tyler Quinn|412-386-4450|yhh7@cdc.gov|
22445606|NCT00608972|Rutgers Cancer Institute of New Jersey|Deborah L Toppmeyer, M.D.|732-235-6789|toppmede@cinj.rutgers.edu|
22398667|NCT03506295|Vanderbilt University Medical Center|Dr. Fabien Maldonado|615-322-3412|fabien.maldonado@vumc.org|
22398668|NCT01834729|Mayo Clinic|Dr. Adil E. Bharucha|507-284-2687|bharucha.adil@mayo.edu|
22398669|NCT00288080|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22398670|NCT03403192|Wake Forest Health Science|Benjamin Morris, MD|336.716.6533|bmorris@wakehealth.edu|
22445607|NCT01200524|AstraZeneca|Heather Bryson||clinicaltrialtransparency@astrazeneca.com|
22412402|NCT06052566|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22412403|NCT03978403|Zosano Pharma Corporation|Dr. Don Kellerman, Sr. VP, Clinical Development and Medical Affairs|+1 (510) 745-4004|dkellerman@zosanopharma.com|
22412404|NCT05030753|Univeristy of Virginia|Jamie Zoellner|434-962-4488|jz9q@virginia.edu|
22412405|NCT03277183|NFSGVA|Dr. Mark Segal|3523761611|mark.segal@va.gov|104496
22412406|NCT00809809|Integrative Medicine Institute|David Riley, MD|505 690-0688|dsriley@integrativemed.org|
22412407|NCT00329602|GlaxoSmithKline|GSK Response Center|866-435-7343||
22412408|NCT02579096|Boston CSP Coordinating Center|Ryan E. Ferguson, ScD, MPH, Director|1-857-364-4201|Ryan.Ferguson@va.gov|
22412409|NCT03177603|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22412410|NCT02097121|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22412411|NCT00510510|Novartis Pharmaceuticals|Study Director|862-778-8300||
22412412|NCT03595657|CStone Pharmaceuticals|Zhang Wenyun|+86 021-60333416|CstoneRA@cstonepharma.com|
22412413|NCT01066052|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center,|496151725200|service@merckgroup.com|
22412414|NCT03184441|Boston Children's Hospital|Michele DeGrazia|617-919-1222|michele.degrazia@childrens.harvard.edu|
22412415|NCT01200394|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22412416|NCT04107493|ResMed|maureen crocker|+1 8588366653|maureen.crocker@resmed.com|
22412417|NCT02729896|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22412418|NCT02199509|National Institutes of Health|Dr. Mark Hallett||hallettm@ninds.nih.gov|
22412419|NCT04094870|University of North Carolina at Chapel Hill|Elizabeth Stringer, MD, MSc|919-966-1601|elizabeth_stringer@med.unc.edu|
22412420|NCT00918671|NTNU|Professor Knut Hagen|+4772575080|knut.hagen@ntnu.no|
22412421|NCT02708277|The First Affiliated Hospital of Sun Yat-sen University|Yuqing Chen|+86 020-87755766-8341|fangchenyq@163.com|
22412422|NCT02742181|University Hospitals Cleveland Medical Center|Sharon Stein|(216)844-2873|Sharon.Stein@UHhospitals.org|
22412423|NCT02739984|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22412424|NCT02785172|Bausch Health|Study Director||anya.loncaric@bauschhealth.com|
22412425|NCT01048333|Astra Zeneca|Gerard Lynch|+44 1509 645895|ClinicalTrialTransparency@astrazeneca.com|
22412426|NCT02042911|SymBio Pharmaceuticals|Toshihiko Nagase|+81-3-5472-1127||
22412427|NCT04947579|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22412428|NCT00634179|Emory University|Christopher R. Flowers, MD, MS|404-778-3935|crflowe@emory.edu|
22412429|NCT00767325|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22412430|NCT03538756|RxFunction, Inc.|Lars Oddsson, PhD|612-358-2140|loddsson@rxfunction.com|
22412431|NCT00996736|F.I. Proctor Foundation, University of Califonia, San Francisco|Dr. Thomas Lietman|415-502-2662|tom.lietman@ucsf.edu|
22412432|NCT02346201|Johns Hopkins School of Public Health|Jennifer Jones, Research Coordinator|44377086812|jejones@jhu.edu|
22412433|NCT03363581|Imperial College London|Prof Carel le Roux|07970719453|carel.leroux@nhs.net|
22412434|NCT00409578|Novartis Pharmaceuticals|Study Director|862 778-8300||
22412435|NCT05200858|Baylor College of Medicine|Prof. Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
22429864|NCT02957123|Institute of Fundamental and Clinical Immunology|Alexander A Ostanin, MD, PhD|+7 (383) 236-03-29|ostanin62@mail.ru|
22429865|NCT03566550|University of Nottingham|Professor Alan Smyth|01158230612|alan.smyth@nottingham.ac.uk|
22429866|NCT00986583|Cleveland Clinic|Alparslan Turan, M.D.|216-444-4000|turana@ccf.org|9857
22429867|NCT02829957|Indiana University|Dr. Jeffrey Kline|317-880-3869|jefkline@iu.edu|
22429868|NCT03511066|Celltrion|Clinical Planning Department Leader|82328505000|contact@celltrion.com|
22429869|NCT00137280|Greater Los Angeles Veterans Healthcare Center|Dr. Alexander S. Young|310-268-3416|alexander.young@va.gov|
22429870|NCT05001165|VA Greater Los Angeles|Boback Ziaeian|310-478-3711|boback.ziaeian@va.gov|
22429871|NCT03113136|OhioSUCCC|Dr. Theodore L. Wagener|614-366-4265|Theodore.Wagener@osumc.edu|
22429872|NCT03587857|UCSF|Dr. Parya Saberi|415-502-1000 ext. 17171|parya.saberi@ucsf.edu|
22429873|NCT02675452|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22429874|NCT03467945|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22429875|NCT00977561|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22429876|NCT02218268|University of Florida|Michael Haller|352-265-0111|hallemj@peds.ufl.edu|
22429877|NCT03651336|Implandata Ophthalmic Products|Clinical Study Manager|+49 (0) 511 - 2204 2580|clinical@implandata.com|
22429878|NCT01341990|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
22429879|NCT03378336|University of Pennsylvania|Dr. Alexis Ogdie-Beatty|215-614-2454|alexis.ogdie@pennmedicine.upenn.edu|
22429880|NCT01125748|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22429881|NCT01028391|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development|1-800-672-6372||
22429882|NCT00694161|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22429883|NCT00837330|Southeast Retina Center, P.C.|Dr. Dennis M Marcus Principal Investigator|706-650-0061|dmarcus@southeastretina.com|
22429884|NCT01227395|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22429885|NCT02774278|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22429886|NCT05181657|University of California, San Diego|Dr. Steffanie Strathdee|858-822-1952|sstrathdee@health.ucsd.edu|
22412436|NCT02109133|Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine,Severance Hospital, Yonsei University Health System|Dr. Sun-Jun, Bae|+82-02-2228-4438|SJBAI1@yuhs.ac|
22412437|NCT02448771|Dana-Farber Cancer Institute|Rinath Jeselsohn|617.632.6887|rinath_jeselsohn@dfci.harvard.edu|
22412438|NCT03457909|Department of Gastroenterology|Changhai Hospital|86-21-31161004|liaozhuan@smmu.edu.cn|86-21-6549
22384786|NCT01214616|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22384787|NCT03447470|Redx Pharma Limited|Craig Tilston|+44 (0)7787 983 638|c.tilston@redxpharma.com|
22384788|NCT05328648|University of North Carolina at Chapel Hill|Emilia Goland, MMSc|919-966-2017|emilia_goland@unc.edu|
22445608|NCT01868503|Stanford University|Dr. Kathleen Horst|6507360921|kateh@stanford.edu|
22445609|NCT00736944|Washington University School of Medicine|Dr. Douglas R. Adkins|314-362-5654|dadkins@dom.wustl.edu|
22445610|NCT00491764|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22445611|NCT00894166|Duke University Medical Center|Jed E. Rose, Ph.D.|919-668-5055|jed.rose@duke.edu|
22445612|NCT01601132|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22384789|NCT01361711|Northwestern University|Shuo Ma, MD, PhD|312-908-5250|shuo-ma@northwestern.edu|
22445613|NCT02110238|Seikagaku|Junko Takamura||junko.takamura@seikagaku.co.jp|
22445614|NCT03273543|DeNova Research|Steven Dayan, MD|3123352070|sdayan@drdayan.com|
22445615|NCT00815698|Herlev Hospital, dept. of Surgery|Jacob Rosenberg|+45 26237323|jacob.rosenberg@regionh.dk|
22445616|NCT03228433|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22384790|NCT02596126|Centro Nacional de Investigaciones Cardiovasculares Carlos III F.S.P (CNIC)|Antonio J Quesada, PhD|+34 914531200|aquesada@cnic.es|(#1163)
22384791|NCT04889755|Boston University|Associate Professor|(617) 358-4296|kalong@bu.edu|
22384792|NCT02471638|Endologix|Tammy Stiver|5136731452|tstiver@endologix.com|
22384793|NCT01328262|Haukeland University Hospital|Elin Opheim Netland|+4755976050|elin.opheim.netland@helse-bergen.no|
22384794|NCT05529966|Stanford University|Robert T. Chang, MD|650-725-5743|christyr@stanford.edu|
22384795|NCT05113966|G1 Therapeutics, Inc.|Clinical Trial Info.|919-213-9835|clinicalinfo@g1therapeutics.com|
22384796|NCT04490915|Neurocrine Biosciences|Neurocrine Medical Information Call Center|877-641-3461|medinfo@neurocrine.com|
22384797|NCT03149315|Johns Hopkins University School of Medicine|Melanie Dispenza, MD, PhD|410-550-1815|mdispen1@jhmi.edu|
22384798|NCT00667251|Novartis Pharmaceuticals|Clinical Disclosure Office|1-862-778-8300|Novartis.email@novartis.com|
22384799|NCT03376321|Janssen Research & Development, LLC|Senior Director Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22384800|NCT01426425|Medtronic|Jo Krueger, Senior Clinical Research Specialist|7635261551|jo.krueger@medtronic.com|
22398671|NCT01665118|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
22398672|NCT01269710|The University of North Carolina at Chapel Hill|Linmarie Sikich, M.D.|(919) 972-7499|lsikich@med.unc.edu|
22384801|NCT06093659|Imperial Brands PLC|Tasnim Abusalem|+44 (0) 117 332 2343|tasnim.abusalem@impbrands.com|
22398673|NCT04673786|CELLTRION, Inc.|Head of Clinical Planning|+82-32-850-4160|YunJu.Bae@celltrion.com|
22398674|NCT01325428|Boehringer Ingelheim (BI)|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22445617|NCT03055156|Stanford University|Dr. Seiji Nishino|650-725-8602|nishino@stanford.edu|
22429887|NCT00694122|Massachusetts General Hospital|David M. Nathan, MD|617-726-1848|dnathan@partners.org|
22384802|NCT03281291|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22445618|NCT03626168|The University of Alabama|Dr. Amy Ellis, principal investigator|205-348-8128|aellis@ches.ua.edu|
22445619|NCT00216476|Janssen Cilag European Medical Affairs|EMEA Medical Affairs Director Psychiatry|+34 91 7228043||
22445620|NCT02737397|Clinilabs, Inc|Magdy Shenouda, MD|201-417-7765|Jackie@sen-jam.com|
22445621|NCT03569033|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22445622|NCT00624234|Vanderbilt University|Dr. Laurie Cutting|615-875-1054|Laurie.Cutting@Vanderbilt.Edu|
22445623|NCT04738734|Pulse Biosciences, Inc.|William A. Knape, VP Clinical, Regulatory, and Quality Affairs|510-906-4649|bknape@pulsebiosciences.com|
22445624|NCT02808650|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22445625|NCT03072732|ZOLL|Project Manager|14127216444|moszm@yahoo.com|
22445626|NCT04093414|Beaumont Hospitals|Diedre Brunk|248-898-5580|Diedre.Brunk@beaumont.org|
22445627|NCT04889222|Masimo Corporation|Ahmed Alghazi|949-297-7437|aalghazi@masimo.com|
22445628|NCT01180647|NYU School of Medicine|Joshua D. Lee|212-263-4242|joshua.lee@nyumc.org|
22445629|NCT01044706|Kremers Urban Development Company|Bang Qian Xu, Ph.D., Director of Biopharmaceutics|812-523-5453|Bang.xu@ucb.com|
22445630|NCT01485393|MGH|Dr. Johnson-Akeju|6177247200|ojohnsonakeju@partners.org|
22445631|NCT01561378|Montefiore Medical Center|Daniel Ceusters|718-920-2956|dceuster@montefiore.org|
22445632|NCT00071396|The University of Texas M. D. Anderson Cancer Center|Alessandra Ferrajoli, MD, BS / Assistant Professor|713-745-4613|eharriso@mdanderson.org|
22445633|NCT04545554|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22445634|NCT02639546|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22445635|NCT02478372|Golden Jubilee National Hospital|David McDonald|07914861078|david.mcdonald@nhs.net|
22445636|NCT00116428|Biosense Webster|Melissa Schultz, Project Manager, Regulatory Affairs|800-729-9010|mschult1@its.jnj.com|8787
22445637|NCT01032174|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22445638|NCT00113087|New England Research Institute|Lynn Sleeper|617-972-3235|lsleeper@neriscience.com|
22445639|NCT03452228|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22445640|NCT03212690|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22445641|NCT03998566|Boston Scientific|Jeya Satheesh|6124490870|jeya.satheesh@bsci.com|
22445642|NCT03208127|Massachusetts General Hospital|Raymond Chung, MD|617-724-7562|chung.raymond@mgh.harvard.edu|
22445643|NCT01713608|Medicines for Malaria Venture|Dr Fiona Macintyre|+41 22 799 4078|macintyref@mmv.org|
22445644|NCT01254331|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22445645|NCT01011738|Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22445646|NCT00287365|University of North Carolina at Chapel Hill|David B. Peden, MD, MS|919-966-0768|dpeden@med.unc.edu|
22384803|NCT00512070|VA Puget Sound Health Care System|Amanda Wood, PhD|253-583-1652|amanda.wood@va.gov|
22384804|NCT04956861|University of Colorado|Christopher DeSouza Ph.D.|303-492-2988|desouzac@colorado.edu|
22398675|NCT04849780|Johnson & Johnson Vision Care, Inc.|John R. Buch, OD, MS, FAAO|1-800-846-2020|jbuch@its.jnj.com|
22398676|NCT00725075|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22398677|NCT01298492|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22398678|NCT02340663|University of Michigan|Dr. Geoffrey Gerstner|734-763-7717|geger@umich.edu|
22398679|NCT00087646|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22398680|NCT01331304|Massachusetts General Hospital|Dr. Andrew Nierenberg|617-724-0837|anierenberg@mgh.harvard.edu|
22398681|NCT03694925|Cleveland Clinic Arthroplasty Research Group|Alison Klika|4123017914|klikaa@ccf.org|
22398682|NCT01422239|Yale University School of Medicine|Andrea Weinberger, Ph.D.|203-974-7598|andrea.weinberger@yale.edu|
22398683|NCT06488157|Weill Cornell Medicine|Dr. Veerawat Phongtankuel|212-746-7000|vep9012@med.cornell.edu|
22398684|NCT01459705|DCoE|Gregory A. Gahm, PhD|253-320-5772|gregory.a.gahm.civ@mail.mil|
22398685|NCT03033875|Emory University|Dr. Kenneth Hepburn|404-712-9286|khepbur@emory.edu|
22398686|NCT04116112|University of Cincinnati|Dr. Eva A. Mistry|513-558-1291|mistryea@ucmail.uc.edu|
22398687|NCT00911989|Ethicon-Endo Surgery|Director of Clinical Operations|1.513.337.3079|SHelsing@its.jnj.com|
22398688|NCT03434977|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22398689|NCT01145066|Wake Forest University Health Sciences|Dr. Michael Seeds|3367169811|mseeds@wakehealth.edu|
22398690|NCT02192931|University of Utah|Danielle Boxer|801-587-1549|danielle.boxer@utah.edu|
22429888|NCT00105508|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|496151725200|service@merckgroup.com|
22429889|NCT00683384|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22384805|NCT00961571|Georgetown University, Department of Medicine and Oncology|Dr. Aiwu Ruth He|202-444-8642|arh29@georgetown.edu|
22384806|NCT03818659|University of California, San Francisco|Dr. Mark Pletcher|415-514-8008|mark.pletcher@ucsf.edu|
22384807|NCT02900924|Veryan Medical|Nick Yeo|+441403258984|nick.yeo@veryanmed.com|
22384808|NCT03143153|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
22384809|NCT05448651|Upstream Bio|Sumathi Sivapalasingam, Vice President of Clinical Development|917-499-0789|sumathi.sivapalasingam@upstreambio.com|
22384810|NCT02736409|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22398691|NCT06523491|RCBIOFORM|Julia Melentyeva Commercial Director|84952237095|md@bioform.ru|
22445647|NCT00968864|PRA Health Sciences|Dr. Andrew Gilman|704-615-2744|gilmanandy@prahs.com|
22445648|NCT01967173|Penn State University|David Mauger|717-531-7178|dmauger@psu.edu|
22429890|NCT00063232|National Institute of Diabetes and Digestive and Kidney Diseases|Jay Hoofnagle, M.D.|3014961333|hoofnaglej@extra.niddk.nih.gov|
22412439|NCT00770315|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22412440|NCT05771428|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22412441|NCT04025229|UNC Lineberger Comprehensive Cancer Center|Luz Andrea Cuaboy|1-919-843-1177|luz_cuaboy@med.unc.edu|
22412442|NCT03815942|University of Oxford|Dr Mark Tuthil|01865 227042|mark.tuthill@oncology.ox.ac.uk|
22412443|NCT01374919|Auerbach Hematology Oncology Assoc|Dr. Michael Auerbach|410-780-4050|mauerbachmd@abhemonc.com|
22412444|NCT00366899|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22429891|NCT00809146|University of Michigan|Robert Silbergleit MD, Principal Investigator|734-232-2142|robie@umich.edu|
22429892|NCT03632720|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22412445|NCT00153803|Dartmouth-Hitchcock Medical Center|Clinical Research Office||Cancer.Research.Nurse@Dartmouth.edu|
22412446|NCT05343715|Biosidus S.A.U.|Director of Clinical Trials|+541149098044|v.berstein@biosidus.com.ar|
22412447|NCT04347291|Vanderbilt University Medical Center|Dr. Lindsay Mayberry|615-875-5821|lindsay.mayberry@vumc.org|
22412448|NCT03311646|Medical University of South Carolina|Dr. Tracy Smith|843-792-5164|smithtra@musc.edu|
22412449|NCT00067236|Procter & Gamble|Peter Thomas|513.622.4838|thomas.pr@pg.com|
22412450|NCT00531206|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22412451|NCT01385033|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22412452|NCT05227820|The Regenesis Project|Chief Research Coordinator|(989) 245-9205|jharoon@theneuroassociates.com|
22412453|NCT02892500|Sanford Health|Christie Ellison|605-312-6030|christie.ellison@sanfordhealth.org|
22412454|NCT03104322|patientMpower|Chief Scientific Officer|+353872599131|colin@patientmpower.com|
22412455|NCT01439165|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22412456|NCT03331042|Sequential Medicine Ltd|Thomas Dahl|617-818-2735|tadahl@outlook.com|
22412457|NCT01880073|Center for Reproductive Medicine|Dr. Steven Spandorfer|646-962-3638|sdspando@med.cornell.edu|
22412458|NCT00755196|Pfizer,Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22412459|NCT02388763|Alcon, A Novartis Division|GMA Franchise Head - Vision Care, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
22412460|NCT01604850|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22412461|NCT01703832|Biologische Heilmittel Heel GmbH|Christine Frank, PhD|+49 7221 501 3188|christine.frank@heel.com|
22412462|NCT00243932|Columbia University|Hiroshi Mitsumoto, MD|2123052940|hm264@cumc.columbia.edu|
22412463|NCT01931033|Massachusetts General Hospital|Gagan Joshi, MD|617-726-1541|gjoshi@mgh.harvard.edu|
22412464|NCT01362998|University Hospitals of Cleveland|Evan Goodman, principal investigator|2168445300|evan.goodman@uhhospitals.org|
22412465|NCT01458405|Capricor, Inc.|Vice President of Clinical Research and Development Operations|858-727-1755|clinicaltrialsgov@capricor.com|
22429893|NCT01300065|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
22429894|NCT01049828|Washington University in St. Louis|Dr. Andre Wineland|314-362-5296|winelanda@ent.wustl.edu|
22429895|NCT00290238|RS Medical|Clinical Research Manager|360-891-7299||
22429896|NCT01179399|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22429897|NCT03738215|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22442146|NCT02597478|UT MD Anderson Cancer Center|David Hui, MD/ Associate Professor, Palliative Care Medicine|(713) 792-6258|dhui@mdanderson.org|
22442147|NCT02747433|MGH Institute of Health Professions|Susan Fasoli, ScD OTR/L, Associate Professor|617-643-4777|sfasoli@mghihp.edu|
22442148|NCT01305577|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
22442149|NCT00796978|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Cynthia Owusu|+1 216-844-7670|cynthia.owusu@uhhospitals.org|
22442150|NCT01256190|Mallinckrodt|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
22442151|NCT02834793|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22442152|NCT02364336|NIDDK|Dr. Marc Ghany|301-402-5115|mg228m@nih.gov|
22442153|NCT01731938|Grifols Therapeutics, Inc.|Henry Li, PhD, RAC|1-919-316-6042|Henry.Li@Grifols.com|
22442154|NCT03319745|The University of Texas MD Anderson Cancer Center|Dr. Neema Navai|(713) 792-3250|nnavai@mdanderson.org|
22442155|NCT00870103|Alcon Research Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22442156|NCT03179202|SPR Therapeutics|Clinical Affairs|216-378-9106|support@sprtherapeutics.com|
22442157|NCT03255629|Joslin Diabetes Center|Mary Elizabeth Patti, MD|(617) 309-2635|MaryElizabeth.Patti@joslin.harvard.edu|
22442158|NCT04540198|Baylor Scott & White Health Research Institute|Dr. Alan Stevens|254-215-9885|alan.stevens@bswhealth.org|
22442159|NCT02779556|University of Arkansas for Medical Sciences|Kristie Hadden, PhD/Associate Professor|501-993-3178|KBHADDEN@uams.edu|
22445649|NCT01346969|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22445650|NCT02096679|AstraZeneca|Dr Mireille Cantarini||ClinicalTrialTransparency@astrazeneca.com|
22445651|NCT03666624|University of Washington|Karen Fredriksen Goldsen|206-543-5722|fredrikk@uw.edu|
22445652|NCT03225599|Northwell Health|Administrative Director, Clinical Research|(516) 881-7064|dcannone1@northwell.edu|
22445653|NCT05213481|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22445654|NCT01811680|Tan Tock Seng Hospital|Dr Karen Chua|65 68894580|karen_chua@ttsh.com.sg|
22445655|NCT00447005|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22412466|NCT03499964|Urotronic, Inc|Vice President of Clinical Affairs|763-285-7489|info@urotronic.com|
22442160|NCT03236662|UC Davis Health|Dr. Craig McDonald, Professor and Chair|(916) 734-4293|cmmcdonald@ucdavis.edu|
22398692|NCT02527707|Eiger BioPharmaceuticals, Inc.|SVP Clinical Development|1-650-272-6138|info@eigerbio.com|
22398693|NCT01916980|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22398694|NCT02090855|GE Healthcare|Paul Sherwin, M.D.|1-609-514-6489|Paul.Sherwin@ge.com|
22398695|NCT03695913|University of Michigan|Spring Stonebraker|734-649-0219|sprstone@med.umich.edu|
22398696|NCT03968419|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
22445656|NCT00397215|GlaxoSmithKline|GSK Response Center|866-435-7343||
22445657|NCT00423514|Memorial Sloan Kettering Cancer Center|Dr. Farid Boulad, MD|1-833-MSK-KIDS|bouladf@MSKCC.ORG|
22445658|NCT02128932|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22445659|NCT01433731|TetraLogic Pharmaceuticals|Vice President, Clinical Research|610-889-9900|jeffrey.skolnik@tetralogicpharma.com|
22445660|NCT03685123|University of Virginia|Damon Swift|(434) 924-1436|dls3s@virginia.edu|
22445661|NCT02959983|Allergan, Inc|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
22445662|NCT01254630|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22445663|NCT03221270|University of North Carolina at Chapel Hill|Rachel Force, PhD|984-974-6239|rachel_force@med.unc.edu|
22445664|NCT03439657|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22445665|NCT03353246|Duke University Medical Center|Michael Haglund, M.D., Ph.D.|919-684-6936|haglu001@mc.duke.edu|
22445666|NCT02925117|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22445667|NCT04032652|NorthShore University HealthSystem|Asst Director Research Compliance|2243647975|rpulido@northshore.org|
22445668|NCT02663908|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
22445669|NCT02004522|Secura Bio, Inc.|Beth Gregory, PharmD, MBA|1-702-254-0011|bgregory@securabio.com|
22445670|NCT03175978|IGF Oncology, LLC|Hugh McTavish|651-207-8270|hmctavish@igfoncology.com|
22445671|NCT00502944|Massachusetts General Hospital|Rochelle P. Walensky, MD, MPH|(617) 724-8445|rwalensky@partners.org|
22445672|NCT00319501|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22445673|NCT00561457|Bard Peripheral Vascular|Director of Clinical Affairs|480-303-2644|John.Reviere@crbard.com|
22445674|NCT02764697|Tampa Bay Uveitis Center, LLC|Dr. Grace Levy Clarke|855 798 8393|grace@tampabayuveitis.com|
22445675|NCT01892865|Michael E. DeBakey VAMC|Panos Kougias MD MSc|713.794.7700|panagiotis.kougias@va.gov|
22445676|NCT00302107|Tuscaloosa VA Medical Center|Lori Davis, MD|205-554-2000|lori.davis@va.gov|
22445677|NCT00437983|Sourazky Tel-Aviv Medical Center|Prof. A. Korczyn|972-3-6974229|amosk@tasmc.health.gov.il|
22445678|NCT02612129|Zevra Denmark A/S|Medical Affairs|+1-888-289-5607|medicalaffairs@zevra.com|
22445679|NCT02557295|Celltrion Inc|JiWoong Lim|82-32-850-5702|jiwoong.lim@celltrion.com|
22445680|NCT01798004|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22445681|NCT03320057|University of California San Francisco|Shelly Kaller|510-986-8945|shelly.kaller@ucsf.edu|
22445682|NCT06956170|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22445683|NCT02323113|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22445684|NCT00690274|University of Texas Southwestern Medical Center|Carol A. Tamminga, MD|214-645-2789|carol.tamminga@utsouthwestern.edu|
22445685|NCT01696084|Jazz Pharmaceuticals|Associate Director, Clinical Trial Disclosure & Transparency|2158709177|tom.chmielewski@jazzpharma.com|
22445686|NCT02280304|Michael E. DeBakey VA Medical Center|Dr. Mary Newsome|713-791-1414|mary.newsome@va.gov|25947
22445687|NCT04805541|Akdeniz University|Prof.Dr. Ahmet Burak Bilgin|5465473336|gozdrburakbilgin@gmail.com|
22445688|NCT00928395|Uroplasty, Inc|Clinical Study Manager|952-426-6153|megan.otoole@uroplasty.com|
22445689|NCT01935791|Imperial College London|Dr Chioma Izzi-Engbeaya|02075942454|c.izzi@imperial.ac.uk|
22445690|NCT00713323|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
22445691|NCT04015336|National Cancer Institute|Dr. Scott Norberg, D.O.|301-275-9668|scott.norberg@nih.gov|
22445692|NCT00246753|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22445693|NCT05154578|MinervaX|Cornelia Oostvogels/Chief Medical Officer (CMO)|00491515092821|lio@minervax.com|
22445694|NCT01419626|Johnson & Johnson Consumer and Personal Products Worldwide|DIRECTOR ORAL HEALTH, MEDICAL AFFAIR & CLINICAL RESEARCH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22445695|NCT01146912|Columbia University|Melissa Stockwell, MD MPH|212-342-5372|mss2112@columbia.edu|
22445696|NCT02980783|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22445697|NCT00880542|University of Calicornia Los Angeles (UCLA)|William Tap, MD|888-798-0719|wtap@mednet.ucla.edu|
22445698|NCT05047770|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22445699|NCT01772160|GlaxoSmithKline|GSK Response Center|866-435-7343||
22445700|NCT02202980|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22445701|NCT01952145|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22445702|NCT03441269|Maimonides Medical Center|Sergey Motov, MD|718-283-8693|alikourezos@maimonidesmed.org|
22412467|NCT02497781|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22412468|NCT01193608|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22412469|NCT01047345|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22412470|NCT00712010|Clinical Development Unit / Metabolic Unit|Dr Maurice Beaumont|+41217858054|maurice.beaumont@rdls.nestle.com|
22412471|NCT00995553|Minneapolis VA Health Care System|Dr. Tasha Nienow|612-467-1004|Tasha.Nienow@va.gov|
22412472|NCT00950807|GlaxoSmithKline|GSK Response Center|866-435-7343||
22412473|NCT01434121|Virginia Commonweath University|Alpha A. Fowler, III, MD|804-628-5710|afowler@mcvh-vcu.edu|
22412474|NCT01492400|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22412475|NCT00659607|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22412476|NCT04894994|RAPT Therapeutics|William Ho|650-489-9037|bill.ho@RAPT.com|
22412477|NCT01822548|Azienda ospedaliero-universitaria di Parma|Prof.ssa Ivana Zavaroni|+390521033306|ivana.zavaroni@unipr.it|
22412478|NCT02153736|Virginia Commonwealth University|Stacey Dusing, PT, PhD, PCS, Director Motor Development Lab|804-628-3632|scdusing@vcu.edu|
22412479|NCT02568384|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com|
22412480|NCT01734772|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22412481|NCT03641742|Columbia University Irving Medical Center|Dr. Christine Kim Garcia|2123058203|ckg2116@cumc.columbia.edu|
22412482|NCT00720122|Massachusetts General Hospital|Madhusmita Misra, M.D., Associate Professor in Pediatrics, Assistant Pediatrician|617-724-5602|mmisra@partners.org|
22412483|NCT00661999|Mayo Clinic Rochester|Dr. Charles L. Loprinzi|507-284-8666|cloprinzi@mayo.edu|
22412484|NCT03066999|PUR Clinic|Dr Sijo Parekattil|3525368761|sijo@orlandohealth.com|
22412485|NCT04068142|UAMS|Dr Michael Wilson|501-686-7000|MPWilson@uams.edu|
22412486|NCT01139164|Medical University of South Carolina|Dr. Robert K Stuart|843-792-4271|stuartrk@musc.edu|
22412487|NCT01790568|University of Michigan Comprehensive Cancer Center|Dr. Pavan Reddy, M.D.|734-936-8785|reddypr@umich.edu|
22412488|NCT01361126|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22412489|NCT00264810|NeuroPace, Inc.|Dr. Martha Morrell, Chief Medical Officer|650-237-2776|mmorrell@neuropace.com|
22412490|NCT02994056|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22412491|NCT02969499|University of British Columbia|Dr. Simon Woo|604-520-4662|simon.woo@fraserhealth.ca|
22412492|NCT00205049|University of Wisconsin|Research Program Manager - Kelly Richie|608-262-5404|kr2@medicine.wisc.edu|
22412493|NCT01835145|Alliance for Clinical Trials in Oncology|Jason J. Luke, M.D.||jluke@medicine.bsd.uchicago.edu|
22412494|NCT00483496|Orfagen|Clinical project manager|0033534506462|caroline.miklaszewski@orfagen.com|
22412495|NCT01924390|UTHSCSA Periodontics|Brian L. Mealey|210-567-3589|mealey@uthscsa.edu|
22412496|NCT01658943|SWOG Statistical Center|SWOG Statistician|206-667-4408||
22412497|NCT01592370|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22412498|NCT02625545|NeoTract/Teleflex|Emily Hergenreter, Sr. Director of Clinical Affairs|650-793-5570|Emily.Hergenreter@Teleflex.com|
22412499|NCT01346410|Mercy|Dr Kathy Baglan|3144345886|kathy.baglan@mercy.net|
22412500|NCT00979628|EUSOM|Guillermo Umpierrez|4047781665|geumpie@emory.edu|
22412501|NCT05905783|Acelyrin Inc.|Clinical Trials Information Desk|(650) 231 6625|info@alumis.com|
22412502|NCT00911859|Janssen R&D BE|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
22412503|NCT01396044|Northwestern University|Dr. Curtis Weiss|(312) 695-6439|curtisweiss@northwestern.edu|
22412504|NCT02739542|UT Southwestern Medical Center|Darin T. Okuda, M.D.|214-645-8800|darin.okuda@utsouthwestern.edu|
22412505|NCT03008460|Ipsen|Ipsen Medical Director|use email|clinical.trials@ipsen.com|
22412506|NCT01880099|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu|
22412507|NCT00539539|Resusciatation Outcomes Consortium, University of Washington|Susanne May, Ph.D.|206-685-1302|sjmay@uw.edu|
22412508|NCT04272801|University of Virginia|Dr. Shayna Showalter|434-956-8032|snl2t@uvahealth.org|
22412509|NCT00752856|UCSD|Sheldon Morris|8583364088|shmorris@ucsd.edu|
22412510|NCT02688608|Stanford Medicine at Stanford University|Saad A Khan, MD|650-507-5624|Saad.A.Khan@stanford.edu|
22412511|NCT02456909|Medical College of Wisconsin|Keri R. Hainsworth, PhD|414-266-6306|khainswo@mcw.edu|
22412512|NCT02130466|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22412513|NCT00764309|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22412514|NCT04529109|Johnson & Johnson Vision Care|Meredith Bishop, OD, MS, FAAO-Sr. Principal Research Optometrist|904-443-1783|mbishop4@its.jnj.com|
22412515|NCT01179490|Symbio Pharmaceuticals|Toshihiko Nagase|81-3-5472-1127|tnagase.331@symbiopharma.com|
22412516|NCT01508936|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22445703|NCT01540838|University of Helsinki, Children´s Hospital, Helsinki University Hospital|Dr. Okko Savonius, PhD candidate|+358456731185|okko.savonius@helsinki.fi|
22445704|NCT02130570|Brigham and Women's Hospital|Dr. Jeffrey L Schnipper, MD, MPH, FHM|617-732-7063|jschnipper@partners.org|
22445705|NCT05294640|Moyes Eye Center|Meleha Ahmad|401-523-5911|meleha.ahmad@gmail.com|
22412517|NCT00679367|Boston Medical Center|Vaishali Sanchorawala|617-638-8265|vaishali.sanchorawala@bmc.org|
22412518|NCT01611090|Janssen Research & Development, LLC|Medical Director Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22412519|NCT00922779|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22412520|NCT03968224|UIM Enfermedades Endocrinas. Hospital de Especialidades Centro Médico Nacional Siglo XXI|Aldo Ferreira Hermosillo|+(52)15556276900|aferreira@endocrinologia.org.mx|21913
22384811|NCT01415154|Neuronetics|Director of Clinical Operations|16123067393|steve.erickson@neurostar.com|
22384812|NCT02038569|LEO Pharma A/S|Clinical Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
22384813|NCT02891096|Swiss Paraplegic Research|Dr Gabi Mueller|+41419395563|gabi.mueller@paraplegie.ch|
22384814|NCT03972813|University of Michigan|Abram Wagner|7347632330|awag@umich.edu|
22384815|NCT04382404|University of Pittsburgh|Dr. Catherine Chappell|412-641-1403|chappelca@upmc.edu|
22384816|NCT05102409|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
22429898|NCT00394472|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22384817|NCT05134636|University of Pennsylvania|Ronac Mamtani|215-662-7606|ronac.mamtani@pennmedicine.upenn.edu|
22429899|NCT03211858|Trial Transparency Team|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22445706|NCT05981391|The University of Texas Health Science Center at San Antonio|Dr. John Moring|210-562-6716|moringj@uthscsa.edu|
22445707|NCT04460937|The Ohio State University Comprehensive Cancer Center|Dr. Eric Miller|614-293-8595|eric.miller@osumc.edu|
22445708|NCT03225573|AIn Shams University|Professor Ali Gamal Zohni|+2 01004931448|zohniali@gmail.com|
22445709|NCT01065597|Department of Psychiatry, University of Maryland School of Medicine|William T. Regenold, MDCM|410-328-6511|wregenol@psych.umaryland.edu|
22445710|NCT02484287|University of Oklahoma Health Science Center|Blair Apple|4052714658|Blair-Apple@ouhsc.edu|1
22445711|NCT00386607|Novartis Pharmaceuticals|Study Director|862-778-8300||
22445712|NCT02713204|Regeneron Pharmaceuticals|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
22445713|NCT01222884|Pharmacosmos A/S|Vice President Research & Development Department|+45 59485959|llt@pharmacosmos.com|
22445714|NCT02350569|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22445715|NCT00474760|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22445716|NCT04569253|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
22445717|NCT01927627|Case Comprehensive Cancer Cent|Jorge Garcia MD|216-444-7774|garciaj4@ccf.org|
22445718|NCT02635776|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
22445719|NCT00660673|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22445720|NCT00579098|Mayo Clinic|Paul A. Friedman, MD|507-255-2398|friedman.paul@mayo.edu|
22445721|NCT03505190|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22445722|NCT03476278|Derince Eğitim Ve Araştırma Hastanesi|Dr. Hande Aytuluk|5336515650|handegrbz@gmail.com|
22445723|NCT00633750|Vanderbilt-Ingram Cancer Center|Carlos Arteaga, M.D.|(615) 936-1919||
22445724|NCT01903031|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22445725|NCT01811225|University of Minnesota|Dr. Sharon Allen|612-624-2446|allen001@umn.edu|
22445726|NCT03000569|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22445727|NCT02298023|, Seoul National University Hospital|Dr. Sun G. Chung|+82-2-2072-2560|chung60611@gmail.com|
22445728|NCT04010695|PATH|Pooja Bansil|206 302 4920|pbansil@path.org|
22445729|NCT02002832|Sumitomo Pharma (Suzhou) Co., Ltd.|Chief Medical Officer|+86-10-57322070|luo@dsmpharm.com.cn|
22445730|NCT03329508|Pharma 2B LTD|Pninit Litman study director|+972 8 9472672|pninit@pharma2b.com|
22445731|NCT00492531|Professor of Medicine: Chief, Pulmonary, Allergy and Critical Care Medicine: Director, Hemostasis and Vascular Biology Research Institute; University of Pittsburgh School of Medicine|Mark Gladwin|412-692-2117|gladwinmt@upmc.edu|
22445732|NCT03022435|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker.|650-724-4437|cdekker@stanford.edu|
22445733|NCT04122534|Montana State University|Dr. Kelly E. Knight|303-819-6997|kelly.knight3@montana.edu|
22445734|NCT01790932|Dana-Farber Cancer Institute|Nancy Lin, MD|617.632.2335|nlin@partners.org|
22445735|NCT03572972|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22445736|NCT01441180|NIAID/NIH|Dr. Shyam Kottilil|301-435-0936|skottilil@niaid.nih.gov|
22445737|NCT01267045|VA Puget Sound Health Care System|David J. Kearney, MD|206-277-1445|David.Kearney@VA.gov|
22445738|NCT01558739|Novartis Pharmaceuticals|Study Director|862-778-8300||
22398697|NCT02109159|London School of Hygiene and Tropical Medicine|Dr Junko Kiriya|+442076368636|junko.kiriya@lshtm.ac.uk|
22398698|NCT02968810|Northwestern University|Dr. Seema A. Khan|312-503-4236|s-khan2@northwestern.edu|
22398699|NCT03179085|University of New Mexico Health Sciences Center|Vallabh Shah, PhD. Principal Investigator|505-272-9615|VShah@salud.unm.edu|
22398700|NCT03660878|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
22398701|NCT02971202|Vanderbilt University Medical Center|Justin M. Gregory MD MSCI|615-875-9669|justin.m.gregory.1@vumc.org|
22398702|NCT03193398|BlackThorn Therapeutics, Inc.|Jane Tiller, MD; Study Director|(415) 548-5313|jane.tiller@blackthornrx.com|
22398703|NCT05425563|Dartmouth College|Dr. Tor Wager, professor|603-646-2196|tor@dartmouth.edu|
22398704|NCT04537208|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22398705|NCT03005054|Mallinckrodt|Medical Information Call Center|800-844-2830|clinicaltrials@mnk.com|5
22398706|NCT02263833|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22398707|NCT01537211|Rehabilitation Institute of Chicago|Arun Jayaraman, PT, PhD; Director of Max Nader Lab for Rehabilitation Technologies and Outcomes|3122386875|ajayaraman@ricres.org|
22398708|NCT00704964|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22398709|NCT00653861|Allergan Medical|Therapeutic Area Head|(805) 961-5500|devicetrials@allergan.com|
22398710|NCT02161562|Novartis Pharmaceuticals|Study Director|862-778-8300||
22398711|NCT01394705|Boston Children's Hospial|Tracy Curran|617355-5445|tracy.curran@cardio.chboston.org|
22398712|NCT01573273|MUSC|Lisa Nunn|843-792-0476|jenkinli@musc.edu|
22398713|NCT00929071|Susan H. Weinkle, MD|Susan H. Weinkle, MD|941-794-5432|sweinkle@aol.com|
22398714|NCT03856255|NYU Langone Health|Mark Pochapin, MD|212-263-9177|Mark.Pochapin@nyulangone.org|
22398715|NCT01757717|Memorial Sloan Kettering Cancer Center|Josh Yamada, MD|212-639-2950|yamadaj@mskcc.org|
22398716|NCT02624492|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22398717|NCT01163786|Northwestern University|Clinical Trials at Northwestern University|312-695-6180|cancertrials@northwestern.edu|
22398718|NCT02272686|UT MD Anderson Cancer Center|Issa F. Khouri, MD, Professor, Stem Cell Transplantation|713-745-0049|ikhouri@mdanderson.org|
22398719|NCT00510809|University of Kansas Medical Center|James Backes, PharmD|(913) 588-5324|JBACKES@kumc.edu|
22398720|NCT02474082|Novartis Pharmaceuticals|Study Director|862 -778- 8300||
22412521|NCT03601637|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22412522|NCT00038675|University of Texas (UT) MD Anderson Cancer Center|Hagop M Kantarjian,MD/Chair, Leukemia|(713) 792-7026|hkantarjian@mdanderson.org|
22412523|NCT02322047|Veterans Affairs Puget Sound Health Care System|Tracy Simpson, PhD|206-277-3337|tracy.simpson@va.gov|
22412524|NCT01699607|Yale|Dr. Kelly Cosgrove, Ph.D.|203-737-6969|kelly.cosgrove@yale.edu|
22412525|NCT00920140|GlaxoSmithKline|GSK Response Center|866-435-7343||
22429900|NCT00004228|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22429901|NCT01529112|Eisai Call Center|Eisai Inc.|888-422-4743||
22398721|NCT00430508|Daiichi Sankyo|James McCarthy / Director Regulatory Operations|732-590-3430|jmccarthy@dsus.com|
22429902|NCT00107614|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990|pettynathanm@uams.edu|2461
22398722|NCT01727895|Radboud UMC|Drs. Jenneke Leentjens|0031-243668420|Jenneke.Leentjens@radboudumc.nl|
22398723|NCT03365778|Wills Eye Hospital|Clinical Research Coordinator|215-928-3213|jtran@willseye.org|
22398724|NCT03595553|Summit Therapeutics|Katie Tran|408 677 6503|Katie.Tran@Summitplc.com|
22398725|NCT03467958|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22398726|NCT02286947|Sarepta Therapeutics, Inc.|Medical Director|+1-888-727-3782|clinicaltrials@sarepta.com|
22398727|NCT01687712|Fertility Biotech AG|Executive VP of Regulatory Affairs||maria.vazquez@fertilitybiotech.com|
22398728|NCT01128829|Washington University School of Medicine|M. Yanina Pepino|3143628113|ypepino@dom.wustl.edu|
22398729|NCT01060059|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22398730|NCT04520113|Johns Hopkins Bloomberg School of Public Health|Dr. Colleen Hanrahan|410-502-9289|chanrah1@jhu.edu|
22398731|NCT00516737|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22398732|NCT01816243|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-792-7200||
22398733|NCT00512798|Vanderbilt-Ingram Cancer Center|Jeffrey Sosman, M.D.||jeff.sosman@vanderbilt.edu|
22398734|NCT01920711|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22398735|NCT00425386|OHSU Knight Cancer Institute|Dr. Christopher Ryan|5034946197|ryanc@ohsu.edu|
22398736|NCT02317562|LFB|Clinical Information Desk|0033169827010|supportqcm@lfb.fr|
22398737|NCT03551743|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
22398738|NCT03891901|Emory University|Dr. Cynthia Giver|404-778-5806|cgiver@emory.edu|
22429903|NCT01013870|Baylor College of Medicine|Claudia Robertson, MD|713-873-2792|claudiar@bcm.edu|
22429904|NCT01934231|GlaxoSmithKline|GSK Response Center|866-435-7343||
22429905|NCT02457546|Ethicon, Inc.|Richard Kocharian, MD, PhD|1-908-218-2013|rkochar1@its.jnj.com|
22445739|NCT04721171|Medical College of Wisconsin|Thangam Venkatesan|262-226-9632|tvenkate22@gmail.com|
22445740|NCT01771952|University of Virginia, Kinesiology|Joe Hart|4349246187|jmh3zf@virginia.edu|
22445741|NCT01402011|University of British Columbia Department of family practice|Dr. Helene Bertrand, M.D., CCFP, LM|604-985-5381|dr.hbertrand@gmail.com|
22445742|NCT01066000|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22445743|NCT01386008|Clinical Research Center (CRC) UC Berkeley School of Optometry|Meng Lin, OD, PhD|(510) 642-9731||
22445744|NCT01067976|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22445745|NCT04449861|Jilin Cancer Hospital|Ying Cheng, MD|NA|jl.cheng@163.com|
22445746|NCT00976677|ECOG Statistical Office|Study Statistician|617-632-3012||
22445747|NCT00485433|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
22445748|NCT06238362|SleepRes|Bernard Hete|+1 615-921-2406|bhete@sleepres.com|
22445749|NCT02637622|Johns Hopkins Bloomberg School of Public Health|John FP Bridges|614-685-2543|john.bridges@osumc.edu|
22445750|NCT01925534|Tufts Medical Center|Dr. Nicholas Hill|(617) 636-6377|nhill@tuftsmedicalcenter.org|
22445751|NCT01313858|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22445752|NCT03642457|Icahn School of Medicine at Mount Sinai|Poonam Pai|347-569-4816|poonam.paibantwalhebbalasankatte@mountsinai.org|
22445753|NCT02609204|Wills Eye Hospital, Glaucoma Research Center|Dr. L. Jay Katz|215-928-3123|ljkatz@willseye.org|
22445754|NCT03689530|University of Michigan|Michele Heisler|(734) 845-3504|mheisler@med.umich.edu|
22445755|NCT01392443|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22445756|NCT01895062|5i Sciences|Dr. Richard Rose|858-759-2205|rrose@5isciences.com|
22445757|NCT01977794|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22445758|NCT00533897|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22445759|NCT02515825|AUM Cardiovascular|Marie Johnson, PhD|612.799.2511|mariej@aumcv.com|
22445760|NCT01546207|Icahn School of Medicine at Mount Sinai|Dr. Vivek Y. Reddy|212-241-7114|vivek.reddy@mountsinai.org|
22445761|NCT01626456|Alkermes, Inc.|ARISTADA Medical Information|866-274-7823|usmedinfo@alkermes.com|
22445762|NCT00506662|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22445763|NCT01925677|University of Maryland, Baltimore|Dr. Rolf Barth|4103286020|rnbarth@som.umaryland.edu|4103286020
22445764|NCT00491075|U.T. MD Anderson Cancer Center|Quality Assurance Specialist|713-792-2830|guclinicaltrials@mdanderson.org|
22445765|NCT01603355|Oregon Health & Science University|Dr. Eric Suhler|503-494-5023|suhlere@ohsu.edu|
22445766|NCT03921073|Moffitt Cancer Center|Dr. John Mullinax|813-745-1867|John.Mullinax@moffitt.org|
22398739|NCT03920670|Mayo Clinic|J. Ross Renew, M.D.|904-956-3328|Renew.J@mayo.edu|
22398740|NCT03436615|Novan|Cathy White, Vice President, Drug Development Operations|9194858080|clinical@novan.com|
22429906|NCT04315961|Johns Hopkins University School of Medicine|Dustin Lee|410-550-4035|dlee214@jhmi.edu|
22445767|NCT00545766|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22445768|NCT03750955|University of Washington|Dr. Diane Daubert|206-685-3766|ddaubert@uw.edu|
22445769|NCT01479478|Stanford University|Dr. Natali Aziz, MD|650-725-5720|mfmresearch@stanford.edu|
22445770|NCT00697788|Mass General Hospital for Children|Erik Shank, MD|6177242250|eshank@partners.org|
22445771|NCT00142935|The Miriam Hospital/Brown University|Josiah D. Rich, MD, MPH|401-793-4770|jrich@lifespan.org|
22445772|NCT00689078|ORA|Paul Gomes|9786858900|pgomes@oraclinical.com|
22445773|NCT01180985|Johnson & Johnson Vision Care|John Buch, OD, MS, FAAO|1 904 443-1707|jbuch@its.jnj.com|
22445774|NCT00705289|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22445775|NCT00304746|McLean Hospital|Harrison G Pope Jr., M.D.|617-855-2911|hpope@mcLean.harvard.edu|
22445776|NCT01431989|GlaxoSmithKline|GSK Response Center|866-435-7343||
22398741|NCT00281879|OHSU Knight Cancer Institute|Dr. Richard Maziarz|503-494-1551|maziarzr@ohsu.edu|
22398742|NCT04820309|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
22398743|NCT06033079|Vanderbilt University Medical Center|Derek J. Williams, MD, MPH|615-322-2744|derek.williams@vumc.org|
22398744|NCT04202679|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22398745|NCT01250379|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22398746|NCT03864653|Friends Research Institute, Inc.|Jesse B. Fletcher, Ph.D. [Research Scientist]|(323) 463-1601|jfletcher@friendsresearch.org|126
22398747|NCT02531646|Carestream Health, Inc.|Susan Pate, RN, MS, RAC, Senior Clinical Manager|585-627-6557|susan.pate@carestream.com|
22398748|NCT00429585|Boston Medical Center|Paul Tornetta, MD|617-414-6295|paul.tornetta@bmc.org|
22398749|NCT01582308|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22398750|NCT03376477|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Syed Abbas Ali, MD- Assistant Professor- Division of Hematologic Malignancies|4432877104|sali35@jhmi.edu|
22398751|NCT00772668|UM/Sylvester Comprehensive Cancer|Denise Pereira MD|305-243-9127|dpereira2@med.miami.edu|
22398752|NCT01182428|Abbott Vascular|Ellen Travis, Clinical Science|408-845-3000|Ellen.Travis@av.abbott.com|
22398753|NCT01227902|GlaxoSmithKline|GSK Response Center|866-435-7343||
22398754|NCT00836355|New York University Langone Medical Center|Saran Jonas|212 263 7591|Saran.Jonas@nyumc.org|
22398755|NCT02363478|"Academic Department of Gastroenterology, LAIKON General Hospital"|Dr. George P. Karamanolis|+30.213.2061307|georgekaramanolis@yahoo.co.uk|
22398756|NCT00930059|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22398757|NCT01966770|Clinical Research Center-UC berkely|Meng C. Lin O.D., PhD, FAAO|510-643-9252|mlin@berkeley.edu|
22398758|NCT03303911|Achieve Life Sciences|Daniel Cain, Vice President, Clinical Research|425.686.1546|dcain@achievelifesciences.com|
22398759|NCT00546364|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22398760|NCT03064763|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22398761|NCT00388947|Whitinsville Medical Center|Dr Samuel Zylstra|508-243-6260|samuelzylstra@milreg.org|
22398762|NCT02594644|UC Davis Department of Dermatology|Tatyana Petukhova MD||tpetukhova@ucdavis.edu|
22398763|NCT00935883|University of Miami Miller School of Medicine|Philip J Rosenfeld|305-326-6148|prosenfeld@med.miami.edu|
22398764|NCT04660643|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22398765|NCT00741156|The Hospital for Sick Children|Dr. Kyong-Jin Lee|416-813-7326|kyong-jin.lee@sickkids.ca|
22429907|NCT03939494|Cincinnati Children's Hospital|Mary Banks|513-636-2147|mary.banks@cchmc.org|
22398767|NCT01815229|Washington University School of Medicine|Dr. Carlos Puyo|314-747-1709|cpuyo@wustl.edu|
22398768|NCT01220414|University of Wisconsin-Madison|Kelli F. Koltyn|608 262-4234|kelli.koltyn@wisc.edu|
22398769|NCT00623831|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22398770|NCT01276821|Department of Child Health, Tribhuvan University Teaching Hospital, Institute of Medicine.|Dr. Aayush Khanal|977-1-4421532|aayush_khanal@yahoo.com|
22398771|NCT00066690|ETOP IBCSG Partners Foundation|Dr. Heidi Roschitzki-Voser, Head Trial Activities/Deputy Director|+41 31 511 94 00|heidi.roschitzki@etop.ibcsg.org|
22398772|NCT00223496|UTHSCSA|Dr. Charles Bowden|210-567-5479|Bowdenc@uthscsa.edu|
22398773|NCT00305578|Indiana University|Dr. Amit Anand||aanand@iupui.edu|
22398774|NCT02939131|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
22398775|NCT04033367|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22398776|NCT02723201|Medical Director|Takeda|+1-877-825-3327|trialdisclosures@takeda.com|
22398777|NCT02415712|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22398778|NCT00343512|Vanderbilt-Ingram Cancer Center|Bapsi Chak, M.D.|615-322-2555||
22398779|NCT01262976|GlaxoSmithKline|GSK Response Center|866-435-7343||
22398780|NCT03433781|NYU Langone|Perla Arriola|347-630-0311|perla.arriola@nyulangone.org|
22398781|NCT02809833|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22398782|NCT00492973|Lexington Clinic|Cale Jacobs, PhD|859-258-8238|cjaco@lexclin.com|
22398783|NCT03439033|Weill Cornell Medical College|Dr. Kritika Subramanian|212-746-6000|krs9089@nyp.org|
22398784|NCT02971670|Biomedizinische Forschungsgesellschaft mbH|Dr. Martha M. Eibl|+43-1-4081091|martha.eibl@meduniwien.ac.at|
22398785|NCT00379795|Genentech|Genentech||ctg-post-d@gene.com|
22398786|NCT01127165|Eisai Korea Inc.|Jihee Mun, Pharmacist, Medical Department manager|+82-2-3451-5531|jihee_mun@eisaikorea.com|
22398787|NCT00763321|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22398788|NCT02486757|Massachusetts General Hospital|Dr. Natalie Shaw||natalie.shaw@nih.gov|
22445777|NCT02653872|AstraZeneca AB|AZD7986 Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
22398789|NCT02793232|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22398790|NCT04438174|University of Utah|Dr. Giavonni Lewis|801-581-3050|giavonni.lewis@hsc.utah.edu|
22445778|NCT00619177|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22445779|NCT04873700|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22445780|NCT01281137|International Breast Cancer Study Group (IBCSG)|Head Trial Activities and Deputy Director: Dr. Heidi Roschitzki-Voser|+41 31 511 94 00|heidi.roschitzki@ibcsg.org|
22445781|NCT00788073|Seaside Therapeutics|Dr. Paul Wang, Vice President of Clinical and Medical Affairs|617-374-9009|pwang@seasidetherapeutics.com|1015
22445782|NCT03608254|The University of Alabama|Dr. Amy Ellis|2053488128|aellis@ches.ua.edu|
22445783|NCT00910273|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22445784|NCT03540030|OrthoCarolina Research Institute|Susan Odum|7049457710|susan.odum@orthocarolina.com|
22445785|NCT00569270|Arthur F Gelb MD|Arthur F Gelb MD Principal Investigator|562-633-2204|afgelb@msn.com|
22445786|NCT01469234|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22445787|NCT03451578|Duke Eye Center|Dr. Sharon Fekrat|919-681-3937|sharon.fekrat@duke.edu|
22445788|NCT04729621|Teva Pharmaceuticals|US Medical Affairs|1-888-483-8279|usmedinfo@tevapharm.com|
22445789|NCT03943160|Cardiovascular Systems Inc.|Clinical Trials Manager|651.259.2500|clinicaltrials_csi@csi360.com|
22445790|NCT00347360|GlaxoSmithKline|GSK Response Center|866-435-7343||
22445791|NCT05004077|University of Kentucky|Dr. Kevin Hatton|859-218-0365|kevin.hatton@uky.edu|
22445792|NCT01387789|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22398791|NCT02387580|Medicines for Malaria Venture (MMV)|Fiona Macintyre PhD|+41 22 555 0319|Macintyref@mv.org|
22398792|NCT01064167|Cardiovascular Institute & Fuwai Hospital|Guyan Wang|86-10-88398377|guyanwang2006@163.com|
22398793|NCT01983787|Aarhus University Hospital, Department of infectious diseases|Kristina Öbrink-Hansen|+4578452845|krisoebr@rm.dk|
22398794|NCT03984305|Global Kinetics Corporation|Director of Clinical Affairs|612.240.2437|karen.krygier@globalkineticscorp.com|
22398795|NCT02883244|Sunstar Americas, Inc.|Senior Manager of R&D|8477944276|akane.takemura@us.sunstar.com|
22398796|NCT02082678|UT Southwestern|E. Sherwood Brown. MD, PhD, MBA|(214) 645-6950|Sherwood.Brown@UTSouthwestern.edu|
22398797|NCT01099969|The University of Texas Health Science Center at Houston|Dr. Davide Cattano|713.500.6235|davide.cattano@uth.tmc.edu|
22398798|NCT02882633|University of Pennsylvania|Ignacio Badiola|215-893-7251|Ignacio.Badiola@uphs.upenn.edu|
22398799|NCT03650192|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
22398800|NCT00630955|Yale University|Dr. Suchitra Krishnan-Sarin, Associate Professor of Psychiatry|203-974-7595|suchitra.krishnan-sarin@yale.edu|
22398801|NCT03726164|University College London|Prof Derek Hausenloy|+6584053767|d.hausenloy@ucl.ac.uk|
22398802|NCT03979274|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22398803|NCT02301403|Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|6082627563|sss@ctri.wisc.edu|
22398804|NCT02302963|University of Virginia Center for Diabetes Technology|Director|434-924-5592|bpk2u@virginia.edu|
22398805|NCT03528512|William Beaumont Hospitals|Dr. Margaret Menoch|2489897289|margaret.menoch@beaumont.edu|
22398806|NCT01614093|Morgan State University|Kimberly R. Warren, Ph.D.|443-885-3492|kimberly.warren@gmail.com|
22398807|NCT00603915|Univerisity Health Network|Dr. Lillian Siu|416-946-2911|lillian.siu@uhn.on.ca|
22398808|NCT03064841|Boehringer Ingelheim|Boehringer Ingelheim Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22398809|NCT00573794|AbbVie|Global Medical Services|800-633-9110||
22398810|NCT00723788|Children's National Health System|Pranav Vyas, MD|2024760186|PVyas@childrensnational.org|
22398811|NCT00632853|Mayo Clinic|Dr. Steven Schild|480-301-9692|sschild@mayo.edu|
22398812|NCT01658657|UNC Chapel Hil|Anthony Viera|919-966-0758|viera@med.unc.edu|
22398813|NCT01407094|University of Texas Southwestern Medical Center|Dr. Madhukar H. Trivedi|214-648-0188|madhukar.trivedi@UTSouthwestern.edu|
22398814|NCT01724528|Menarini Ricerche S.p.A.|Dr. Angela Capriati, Corporate Clinical Research Director|+39 055 5680|acapriati@menarini-ricerche.it|9933
22398815|NCT00466310|DUMC|Rima Kaddurah-Douk, Associate Professor|919-684-2611|rima.kaddurah-daouk@duke.edu|
22398816|NCT02183519|University of Florida Communicative Disorders|Karen Hegland, PhD|352-273-3710|kwheeler@ufl.edu|
22398817|NCT01493180|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22398818|NCT00289107|DePuy Orthopaedics|Tammy O'Dell, EMT, CCRA|574-372-7104|TOdell2@its.jnj.com|
22398819|NCT04556617|Opna Bio|Kerry Inokuchi|650-204-4065|info@opnabio.com|
22398820|NCT04949841|LEO Pharma|Clinical Disclosure|+4544945888|disclosure@leo-pharma.com|
22398821|NCT03430921|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
22398822|NCT01984268|Dartmouth-Hitchcock Medical Center|Director, Office of Research Operations|(603) 650-6340|Barbara.A.Moskalenko@hitchcock.org|
22398823|NCT01314716|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22398824|NCT00898560|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22398825|NCT01327157|Master-Pos graduação em Otorrinolaringologia|Dra Rosana de Queiroz Costa|55___11___98579-8799|rosanaqueiroz@msn.com|
22398826|NCT01928381|AstraZeneca Pharmaceuticals LP, Neuroscience Innovative Medicine Unit|Joel Posener, MD - Head Early Clinical Development||CinicalTrialTransparency@astrazeneca.net|
22398827|NCT02017574|Baltimore Veterans Affairs|Jeremy Rietschel, PhD|410-605-7000|jeremy.rietschel@va.gov|3233
22398828|NCT01355705|Stanford University|Michaela Liedtke, MD|650-498-6000|mliedtke@stanford.edu|
22398829|NCT03631706|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22398830|NCT03196180|University of Arizona|Sherry Chow, PhD|520-626-3358|schow@azcc.arizona.edu|
22398831|NCT02554929|The Hospital for Sick Children|Dr. Suneeta Monga|416-813-8954|suneeta.monga@sickkids.ca|
22445793|NCT00913380|Seoul National University Bundang Hospital|Kyoung Ho Lee|82-31-787-7607|kholeemail@gmail.com|
22384818|NCT01580488|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com|
22384819|NCT01969539|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22384820|NCT03792256|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22384821|NCT02203552|The Ohio State University Comprehensive Cancer Center|Dr. Bhuvaneswari Ramaswamy|614-293-7484|Bhuvaneswari.Ramaswamy@osumc.edu|
22384822|NCT03562377|LEO Pharma A/S|Disclosure|+45|disclosure@leo-pharma.com|44945888
22384823|NCT04562649|Columbia University|Rebecca Schnall, PhD, MPH, RN|212-342-6886|rb897@cumc.columbia.edu|
22384824|NCT05368103|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22384825|NCT05817708|Senhwa Biosciences, Inc.|Gina Huang|+886-2-89119856|ginahuang@senhwabio.com|111
22384826|NCT04650087|Duke University Medical Center|Dr. Thomas Ortel|919-684-5350|thomas.ortel@duke.edu|3
22398832|NCT04187092|University of Virginia|Joe M Hart|434.243.0256|jmh3zf@virginia.edu|
22398833|NCT01276171|University of Iowa Hospitals and Clinics|Dr. Kenichi Ueda|319-356-2633|kenichi-ueda@uiowa.edu|48517
22398834|NCT05162066|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
22398835|NCT00445887|NRG Oncology|Linda Gedeon for James Kauderer, MA|716-845-1169|lgedeon@gogstats.org|
22398836|NCT00669617|Novartis Pharmaceuticals|Study Director|862-778-8300||
22398837|NCT03720899|University of Alabama at Birmingham|Karen Cropsey|(205) 975-7809|kcropsey@uab.edu|
22398838|NCT05130008|Massachusetts General Hospital|Dr. Jocelyn Carter|617 724 9000|jcarter0@mgh.harvard.edu|
22398839|NCT03569202|Finnsusp Ltd.|Dr. Jarmo Laihia, Manager of Clinical & Formulation Development|358 50 377 1212|jarmo.laihia@piiloset.fi|
22398840|NCT00454779|Amgen Inc.|Study Director|866-572-6436||
22398841|NCT01418001|Memorial Sloan Kettering Cancer Center|Dr. William Tap|646-888-4163|tapw@mskcc.org|
22398842|NCT00323557|UT MD Anderson Cancer Center|Amar Safdar, MD/Professor||CR_Study_Registration@mdanderson.org|
22398843|NCT00684515|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22398844|NCT02450578|Medicines for Malaria Venture|Jörg Möhrle|+41 22 555 0330|moehrlej@mmv.org|
22398845|NCT01076348|Medtronic, Inc.|Stefanie Lorinser, Sr. Clinical Research Specialist|763-526-2742|stefanie.lorinser@medtronic.com|
22445794|NCT02187744|Pfizer, Inc.|Pfizer CT.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22445795|NCT01788228|GlaxoSmithKline|GSK Response Center|866-435-7343||
22445796|NCT00134030|MRC Clinical Trials Unit at UCL|Prof Matt Sydes||mrcctu.euramos@ucl.ac.uk|
22445797|NCT01972568|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22445798|NCT02358681|Columbia University|Daniel Tsze MD MPH|212-317-0997|dst2141@cumc.columbia.edu|
22445799|NCT00601198|University of Cincinnati|Alison Kastl, Director of Clinical Trials|813-584-0436|kastla@ucmail.uc.edu|
22445800|NCT02059408|University of California, San Francisco|Carmen Peralta, Professor of Medicine|415-221-4810|carmenalicia.peralta@ucsf.edu|23678
22445801|NCT00828412|Promius Pharma|Joanne Fraser|908 429-4504|joannefraser@promiuspharma.com|
22445802|NCT00775346|Covidien|Manager, Clinical Affairs|303 305 2591|Norma.Prince@Covidien.com|
22445803|NCT00144391|Charles R. Drew University of Medicine and Science|Dr. Theodore Friedman|310-668-5197|theodorefriedman@cdrewu.edu|
22445804|NCT04223973|Medtrum France|Mrs Melanie MARMOUNIER-WILHLEM- Commercial DIrector|+33620591224|melanie.marmounier@medtrum.com|
22445805|NCT00594659|Geisel School of Medicine at Dartmouth College|Alan J. Budney, PhD Principal Investigator|855-290-2822|Alan.J.Budney@dartmouth.edu|
22445806|NCT04266769|LightForce Orthodontics|Kelsey Fafara|7329775646|kelsey@lightforceortho.com|
22445807|NCT00142298|Novartis Pharmaceuticals|Study Director|862-778-8300||
22445808|NCT03630042|Oxford University Hospital NHS Trust|Jaimal Kothari|NA|Jaimal.Kothari@ouh.nhs.uk|
22445809|NCT00394147|University of Maryland|Dr. Ranee Mehra|410-328-7904|rmehra@umd.edu|
22445810|NCT02423772|Queen's University of Belfast|Kevin Vowles|+44 (0)28 9097 5445|k.vowles@qub.ac.uk|
22445811|NCT01193842|AIDS Malignancy Consortium|AMC Statistical Center|501-526-6712|jylee@uams.edu|
22445812|NCT00894127|bioAffinity|Maria Zannes|505-400-9747|mz@bioaffinitytech.com|
22445813|NCT03487549|Verrica Pharmaceuticals|Susan Cutler, VP, Medical Affairs|484-773-0898|scutler@verrica.com|
22445814|NCT04638400|Division of Endocrinology, Diabetes and Metabolism, State University of New York at Buffalo, 462 Grider St, Buffalo, NY 14215, USA|Dr. Paresh Dandona|7169574325|pdandona@kaleidahealth.org|
22445815|NCT01484041|Georgetown University|Dr. Claudine Isaacs|2024443677|isaacsc@georgetown.edu|
22445816|NCT01995825|U of Maryland|James Polli|410-706-8292|jpolli@rx.umaryland.edu|
22445817|NCT03243071|NYU Langoen Health|Girardin Jean-Louis, PhD|646-501-3431|Girardin.Jean-Louis@nyulangone.org|
22445818|NCT00354744|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22445819|NCT00541931|Stanford University|Dr. Anne Chang, MD|(650)721-7151|alschang@stanford.edu|
22445820|NCT03094169|Formation Biologics|Sandra Sinclair|8326221699|sandra@forbius.com|
22398846|NCT02167945|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22398847|NCT00132730|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22398848|NCT00094757|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22445821|NCT00617851|Novartis Vaccines and Diagnostics|Posting Director||RegContactVacUS.nvdit@Novartis.com|
22445822|NCT02758132|University of Hawaii Cancer Center|Stacy Mercado|8084404561|smercado@cc.hawaii.edu|
22445823|NCT05350410|Alzheimer's Disease Cooperative Study|Sara Moukarzel, PhD, Program Manager|(858) 432-8828|smoukarzel@health.ucsd.edu|
22445824|NCT00944671|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
22398849|NCT02623335|University of Wisconsin, Madison|Gretchen Lee Schwarze, MD, MPP, FACS|(608) 265-2358|schwarze@surgery.wisc.edu|
22398850|NCT01463098|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22398851|NCT00395967|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22398852|NCT01528787|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
22398853|NCT03534427|The University of Nebraska at Omaha|Dr. Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
22398854|NCT04409873|University of California San Francisco|Dr. Stuart A. Gansky and Dr. Sepideh Banava|415-502-8094; 415-630-0094|stuart.gansky@ucsf.edu ; sepideh.banava@ucsf.edu|
22429908|NCT00779909|Boston University School of Dental Medicine|Raul I Garcia, DMD|617-638-6385|rig@bu.edu|
22445825|NCT02050841|Octapharma|Michael Eppolito|2016041155|michael.eppolito@octapharma.com|
22445826|NCT01024335|NYS Psychiatric Institute|Adam Bisaga|646-774-6155|amb107@columbia.edu|
22445827|NCT02432742|Q-Med AB|Clinical Project Manager|+46184749000|reception.seupp@galderma.com|
22445828|NCT01030536|MedImmune LLC, Milstein Building, Granta Park, Cambridge, CB21 6GH, United Kingdom|Edward Bradley, MD|+44 (0)1223 895997||
22445829|NCT03345914|Regeneron Pharmaceuticals, Inc.|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
22445830|NCT01550731|Veterans Administration|Dr. Rebecca Sudore|(415) 221-4810|Rebecca.Sudore@va.gov|23475
22445831|NCT02601027|Stanford University|Gordon Kwanlyp Lee, Professor of Surgery (Plastic and Reconstructive Surgery)|650-723-5824|glee@stanford.edu|
22445832|NCT01330030|Stanford University|Dr Joel D Killen|650-723-5895|jkillen@stanford.edu|
22445833|NCT01365052|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22445834|NCT02577549|Wake Forest University|Dr. Stephen Messier|336-758-5849|messier@wfu.edu|
22445835|NCT02248701|North Florida/South Georgia Veterans Health System|Joshua Yarrow, MS, PhD|(352) 548-6477|Joshua.Yarrow@va.gov|
22445836|NCT02218320|University of North Carolina at Chapel Hill|Dr. Angela Kashuba|919 966-9998|akashuba@unc.edu|
22445837|NCT00885846|Bastyr University|Guan-Cheng Sun, PhD|425-602-3389|gsun@bastyr.edu|
22445838|NCT00074984|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22445839|NCT03758443|Theravance Biopharma|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
22445840|NCT03080454|Feinstein Institute for Medical Research at Northwell Health|Bruce Volpe|516-562-3384|bvolpe1@northwell.edu|
22445841|NCT02747875|Children's National Hospital|Dr. Andrew Waberski, Assistant Professor|2024762025|awabersk@childrensnational.org|
22445842|NCT03863197|KU Leuven|Dr. Britta Hanssen|+3216341295|britta.hanssen@kuleuven.be|
22445843|NCT01781975|University of South Florida|Melissa Parker|8133969378|MELISSA.PARKER@EPI.USF.EDU|
22445844|NCT01622231|GlaxoSmithKline|GSK Response Center|866-435-7343||
22445845|NCT01058655|Dana-Farber Cancer Institute|Brian M. Wolpin|617.632.6942||
22445846|NCT04545060|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
22445847|NCT02939079|Isfahan University of Medical Sciences|Dr. Vahid Shaygannejad|+98 913 313 3550|shaygannejad@med.mui.ac.ir|
22445848|NCT00973674|University of Washington|Scott Emerson, PhD|206-616-6678|semerson@uw.edu|
22445849|NCT01440452|Johns Hopkins Hospital|Daniel Becker|4108284629|db@inirehab.com|
22445850|NCT02068027|BDSI|Vice President Clinical Operations|919-582-0294|twarneke@bdsi.com|
22445851|NCT03783975|University of Maryland Baltimore|Dr. Amber Beitelshees|410-706-0118|abeitels@som.umaryland.edu|
22445852|NCT01581710|CHA UNIVERSITY|Dr. HAN, MAN YONG|82-31-780-6262|drmesh@gmail.com|
22445853|NCT02846324|Global Blood Therapeutics|Nick Vlahakis|1 650 8228756|nvlahakis@gbt.com|
22445854|NCT04206800|Boston IVF|Kristin Rooney|781-434-6470|krooney@bostonivf.com|
22445855|NCT02605304|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22445856|NCT01216748|University of Miami|Matthias Salathe, MD|(305)243-2568|msalathe@med.miami.edu|
22445857|NCT03638622|Massachusetts General Hospital, Boston|Tayyaba Hasan|617-726-6996|thasan@mgh.harvard.edu|
22445858|NCT00516074|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22445859|NCT00098956|The Ottawa Hospital|Dr. Glenwood Goss|613-737-7700|ggoss@ottawahospital.on.ca|56708
22445860|NCT00810355|Richard L. Roudebush VA Medical Center|Dr. Paul Lysaker|317-988-2546|paul.lysaker@va.gov|
22445861|NCT00644189|Massachusetts General Hospital Cancer Center|Jeremy Abramson, MD|617-724-4000|jabramson@mgh.harvard.edu|
22445862|NCT00579878|University of Nebraska Medical Center|James O'Dell|402 559-7288|jrodell@unmc.edu|
22445863|NCT04154930|Galderma|Clinical Project Manager|817-961-5655|aestheticclinicaltrials@galderma.com|
22445864|NCT00657358|UAB|Dr. Michael Froelich|205-975-0145|froelich@uab.edu|
22445865|NCT00515411|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian, MD|646-888-4186|janjigiy@mskcc.org|
22445866|NCT00400764|Hoffman-LaRoche|Medical Communications|800-821-8590||
22445867|NCT02850601|BWH|Dr. Herve Sroussi|617 5256864|hsroussi@bwh.harvard.edu|
22445868|NCT02564497|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22445869|NCT01449539|University of Arkansas for Medical Science-MIRT|Sarah Waheed, MD|501-686-8230|mirt@uams.edu|
22445870|NCT03113071|Fox Chase Cancer Center|Dr. Henry Fung|215-728-2674|Henry.Fung@tuhs.temple.edu|
22445871|NCT02012283|Center for Human Nutrition, Department of Medicine, UCLA David Geffen School of Medicine|Zhaoping Li, Professor|310-206-1987|zli@mednet.ucla.edu|
22445872|NCT02369016|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22445873|NCT01187433|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22445874|NCT04203797|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22445875|NCT00621959|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22445876|NCT00242216|The University of Texas Health Science Center at Houston|Dr. Roberto C. Arduino, Professor of Medicine|713-500-6731|roberto.c.arduino@uth.tmc.edu|
22445877|NCT02484690|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22445878|NCT03360747|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
22445879|NCT01759511|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22445880|NCT03105479|Actelion Pharmaceuticals Ltd|clinical trial disclosure desk|0041615656565|clinical-trials-disclosure@its.jnj.com|
22445881|NCT02569671|Institut Straumann|Mustapha El Amrani|0041619651741|mustapha.elamrani@straumann.com|
22445882|NCT01757535|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinica.Trials@bms.com|
22384827|NCT05784662|University at Buffalo, School of Social Work|Patricia Logan-Greene|7166451533|pblogang@buffalo.edu|
22384828|NCT03001414|Northern Therapeutics, Inc.|Duncan Stewart, Clinical Trial Medical Consultant|613-737-8899|djstewart@toh.ca|76686
22445883|NCT00589290|National Institutes of Health (NIH), National Cancer Institute (NCI)|Arun Rajan, M.D.|301-594-5322|rajana@mail.nih.gov|
22445884|NCT04508335|Reia, LLC|Chief Medical Officer|603 715-7017|paul@reiahealth.com|
22384829|NCT03272373|Zimmer Biomet|Director of Clinical Operations|800-613-6131|clinicaloperations@zimmerbiomet.com|
22384830|NCT04663087|University of Alabama at Birmingham|Dr. Jan Jansen|205-975-3030|jjansen@uabmc.edu|
22384831|NCT02913872|University of Leicester|Dr Erol Gaillard|+44116 252 3261|eag15@le.ac.uk|
22398855|NCT02400255|Arog Pharmaceuticals|Edward McDonald|214-593-0500|emcdonald@arogpharma.com|
22398856|NCT02568046|Symphogen A/S|Chief Scientific Officer|+45 8838 2600|info@symphogen.com|
22398857|NCT00408694|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
22398858|NCT00523991|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22398859|NCT00193063|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
22398860|NCT03261531|Mayo Clinic|Michael Camilleri, M.D.|507-284-2687|camilleri.michael@mayo.edu|
22398861|NCT01700192|Merck Sharp & Dohme Corp.|Senior Vice President, Global Corporate Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22398862|NCT01158521|Cleveland Clinic|Dr. Brian Rini|(216) 444-9567|rinib2@ccf.org|
22398863|NCT00363038|Northwestern University Department of Dermatology|Murad Alam, MD|312-695-6785|m-alam@northwestern.edu|
22398864|NCT00744874|Medtronic AF Solutions|Linda Nelson, RN, BSN, MBA- AF Solutions Clinical Operations Director|(763)526-2891|linda.k.nelson@medtronic.com|
22398865|NCT00566930|UQTR|Martin Descarreaux|819 376-5011|martin.descarreaux@uqtr.ca|3077
22398866|NCT03285243|Baylor college of Medicine|Adam Adler|832-8245800|Adam.adler@bcm.edu|
22398867|NCT02435849|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22398868|NCT03175549|The Scripps Research Institute|Barbara J. Mason, Ph.D.|858-784-7328|mason@scripps.edu|
22398869|NCT01017952|GlaxoSmithKline|GSK Response Center|866-435-7343||
22398870|NCT02194439|IndianaU|Sophie Paczesny|317-278-5487|sophpacz@iu.edu|
22398871|NCT00352105|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. David Adelstein|216-444-9310|adelstd@ccf.org|
22398872|NCT03076983|Drägerwerk AG & Co. KGaA|Mr. Robin Hüwel|+49 451 882 6830|ClinicalAffairs@draeger.com|
22398873|NCT02979431|Ablynx NV|Medical Monitor|+32 (0)9262 00 00|clinicaltrials@ablynx.com|
22398874|NCT01656434|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22398875|NCT02435914|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22398876|NCT03522441|Catawba|Zaidoon A. Al-Zubaidy|1-980-242-3977|Zaidoon@catawbaresearch.com|
22398877|NCT00693160|Wake Forest School of Medicine|James C. Eisenach, M.D.|336-716-4498|jimeisenach@gmail.com|
22398878|NCT00868101|Universidade de Sao Paulo|Marcos Alves Pavione|55 79 9199 9576|mapavione@hotmail.com|
22398879|NCT00130286|Weill Cornell Medical College|Dr. Marshall J. Glesby|212-746-4177|mag2005@med.cornell.edu|
22398880|NCT04063371|The Ohio State University|Dr. Douglas Scharre|614-293-4969|Doug.Scharre@osumc.edu|
22398881|NCT02642094|University of Texas Health Science Center|LUZHE SUN, Ph.D.|210-567-5746|sunl@uthscsa.edu|
22384832|NCT03818711|Vanderbilt University Medical Center|Senior ClinicalTrials.gov Administrator|615-322-3581|natalie.dilts@vumc.org|
22398882|NCT01818726|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22398883|NCT00357500|Dana-Farber Cancer Institute|Mark Kieran|(617) 632-4907|mark_kieran@dfci.harvard.edu|
22398884|NCT00993928|Mayo Clinic|Charles Lawrence Loprinzi, M.D.||cloprinzi@mayo.edu|
22398885|NCT03550066|Kaiser Permanente Northern California|Dr. Susan D. Brown|5108913544|susan.d.brown@kp.org|
22398886|NCT02154087|Smith & Nephew, Inc|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
22398887|NCT00604968|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22398888|NCT05574062|MedtronicD|Fabio Di Piazza|+393456172157|fabio.di.piazza@medtronic.com|
22398889|NCT03042936|UTHSC|Joan Han|9012876408|jhan14@uthsc.edu|
22398890|NCT05702736|Ege University|Dr. Merve UGURYOL UNAL|+902323115545|merve.uguryol.unal@ege.edu.tr|
22398891|NCT01172652|VA Palo Alto Health Care System|Dr. Trisha Suppes, MD PhD|(650) 493-5000|tsuppes@va.gov|67576
22398892|NCT05165654|BIDMC|Dr. Paulo Lizano|202-776-6708|lizanopl@gmail.com|
22398893|NCT03502993|Imperial College London|Dr J Herberg|0207 594 3900|j.herberg@imperial.ac.uk|
22398894|NCT01119456|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22398895|NCT02288273|AstraZeneca, PLL|Sergey Zhuplatov MD, PhD|215-542-3222|Sergey.Zhuplatov@astrazeneca.com|
22398896|NCT03512418|Brigham and Women's Hospital|Peter Chai|617-732-5640|pchai@bwh.harvard.edu|
22412526|NCT01400425|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22384833|NCT04739956|Imperial College Healthcare NHS Trust|Dr Margaret Pikovsky|+447870276373|m.pikovsky@nhs.net|
22384834|NCT03920111|University of Liverpool|Dr Lance Turtle|01517957554|lance.turtle@liverpool.ac.uk|
22384835|NCT02386722|Cantonal Hospital Baselland|Dr. Claudia Gregoriano|+41619253765|claudia.gregoriano@ksbl.ch|
22384836|NCT05177848|Fralin Biomedical Research Institute at VTC|Dr. Roberta Freitas-Lemos|(540)526-2106|rflemos@vtc.vt.edu|
22384837|NCT06414213|Appalachian State University|Dr. Jared Skinner|828-262-2512|skinnerjw@appstate.edu|
22384838|NCT03110315|EvergreenHealth Research|Theodore Brown|4258995385|trbrown@evergreenhealthcare.org|
22412527|NCT03239522|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22398897|NCT05902364|Alcon Research, LLC|Clinical Project Lead, Dry Eye|1-888-451-3937|alcon.medinfo@alcon.com|
22398898|NCT02270242|Icahn School of Medicine at Mount Sinai|Dr. Roxana Mehran|212-659-9691|roxana.mehran@mountsinai.org|
22412528|NCT00720096|H. Lee Moffitt Cancer Center and Research Institute|Robert Wenham, M.D., via Moffitt Cancer Center|813-745-4933|robert.wenham@moffitt.org|
22412529|NCT04557124|VA Connecticut Healthcare System|Joanna Fiszdon, Principal Investigator|203-932-5711|Joanna.fiszdon@va.gov|
22412530|NCT00442936|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22412531|NCT02428699|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22412532|NCT03127137|Northwestern University|Paul C. Fitzgerald RN, BSN, MS|312-695-1064|p-fitzgerald2@northwestern.edu|
22412533|NCT04424407|Stanford University|Andrea Goldstein-Piekarski, PhD|650-721-4780|agoldpie@stanford.edu|
22412534|NCT00264797|Univ of Colorado Denver; Univ of Cincinnati|Dr. Paula Riggs; Dr. Theresa Winhusen|303-724-2235; 513-487-7800|paula.riggs@ucdenver.edu; winhusen@carc.uc.edu|
22412535|NCT03992196|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22412536|NCT02003053|University of Kentucky|Dr. Peter Morris|8593235045|peter.morris@uky.edu|
22412537|NCT01249664|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22412538|NCT00454636|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22412539|NCT00806156|Nektar Therapeutics|Study Director||medicalaffairs@nektar.com|
22412540|NCT01095510|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22412541|NCT01025037|Tornier, Inc.|Manager of Clinical Operations|952-426-7674|serickson@tornier.com|
22412542|NCT02674334|West Virginia University Department of Orthopaedics|Dr. George K Bal|304-293-1310|gbal@hsc.wvu.edu|
22412543|NCT00600925|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
22412544|NCT01307098|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22412545|NCT03977051|Imperial College London|Dawn Goodall|+44 (0) 203 313 4268|dawn.goodall1@nhs.net|
22412546|NCT00235456|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org|
22412547|NCT01652001|University of Granada|Dr. Gómez-Moreno|+34000000000|ggomez@ugr.es|
22412548|NCT00860405|Fresenius Kabi Aktiengesellschaft, Else-Kröner-Str. 1, 61352 Bad Homburg, Germany|Professor Dr. Martin Westphal, Chief Medical Officer|+49 6172 686 7280|martin.westphal@fresenius-kabi.com|
22412549|NCT00864097|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22412550|NCT04457310|Yale University|John Krystal, MD|203-785-6396|john.krystal@yale.edu|
22412551|NCT00927810|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22412552|NCT02349893|Olympus Europa SE & Co. KG|Dr Samuel Faran|0049 1607168798|samuel.faran@olympus.com|
22412553|NCT00320112|VA HSRD|Fatima Makki|734 845 3623|Fatima.Makki@va.gov|
22412554|NCT02899338|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22412555|NCT06179108|LB Pharmaceuticals Inc|Leslie Callahan, Head, Clinical Operations|9086556884|leslie@lbpharma.us|
22412556|NCT05233163|Columbia University Irving Medical Center|Ani Nalbandian, MD|646-906-2255|an2558@cumc.columbia.edu|
22412557|NCT00814463|Duke University Medical Center|Denise Lally-Goss, NP|919-684-3862|denise.lallygoss@dm.duke.edu|
22412558|NCT01370408|Blood and Marrow Transplant Group of Georgia|Dr. Scott Solomon|404-255-1930|ssolomon@bmtga.com|
22412559|NCT02120443|ivWatch, LLC|Garret T. Bonnema|1.855.489.2824|garret.bonnema@ivwatch.com|7018
22412560|NCT02665143|Yale School of Medicine|Thomas Prebet, MD, PhD|(203) 200-4363|thomas.prebet@yale.edu|
22412561|NCT02780687|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22412562|NCT00979732|Illinois Institute of Techology|Britt Burton-Freeman|708-341-0178|bburton@iit.edu|
22412563|NCT05014412|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22429909|NCT03074643|Wake Forest University School of Medicine|Dr. Denise Houston|336-713-8558|dhouston@wakehealth.edu|
22429910|NCT01174459|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22429911|NCT00290758|NorthwesternU|Seema Khan, MD|312-695-0288|skhan@nmh.org|
22445885|NCT03730012|Astellas Pharma Global Development, Inc|Clinical trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22429912|NCT01556100|Chang Gung Memorial Hospital|Dr. kun-Ju Lin|033281200|lin4857@adm.cgmh.org.tw|2632
22429913|NCT00474968|CytoCore, Inc.|Richard Domanik, Ph.D.|312-222-9550|rdomanik@cytocoreinc.com|
22429914|NCT04914000|Moffitt Cancer Center|Dr. Ursula Martinez|813-745-1754|Ursula.Martinez@moffitt.org|
22429915|NCT01834651|Cedars-Sinai Medical Center|Dr. Edwin Posadas|310-423-7600|Edwin.Posadas@cshs.org|
22429916|NCT01096186|Impax Laboratories, Inc.|Daven Mody, PharmD, MBA, Director, Regulatory Affairs|510-240-6073|dmody@impaxlabs.com|
22429917|NCT00079781|NeuroPace, Inc.|Dr. Martha Morrell, Chief Medical Officer|650-237-2776|mmorrell@neuropace.com|
22429918|NCT00564070|Behavioral Medicine Service, Massachusetts General Hospital|Dr. Steven Safren|(305) 284-2818|ssafren@miami.edu|
22429919|NCT03142334|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22429920|NCT01217047|Kennedy Krieger Institute|Daniel Becker, M.D.|888-923-9222|dbecke13@jhu.edu|
22429921|NCT03835117|Autism Discovery & Treatment Foundation|Richard E Frye|844-ADTF-Research|DrFrye@AutismDiscovery.org|1
22429922|NCT04072432|Renibus Therapeutics|Stacey Ruiz, PhD / VP, Drug Development|424-209-2734|sruiz@renibus.com|
22429923|NCT03225989|Lokon Pharma|Angelica Loskog CEO|+46 18-50 74 44|angelica.loskog@lokonpharma.com|
22429924|NCT02043847|University of Illinois at Chicago|Dr. Rondelli|312-996-6179|drond@uic.edu|
22445886|NCT01367002|Yale School of Medicine|Alessandro Santin, MD|(203) 200-4176|alessandro.santin@yale.edu|
22445887|NCT00403234|Purdue Pharma L.P.|Clinical Leader, Director of Clinical Research|800-733-1333||
22412564|NCT03356821|UMC Utrecht, The Netherlands|Prof. M.J.N.L. Benders, MD, PhD, neonatologist|+31 88 755 5555|m.benders@umcutrecht.nl|
22412565|NCT00414765|Novartis Pharmaceuticals|Study Director|18627788300|Novartis.email@novartis.com|
22412566|NCT04354012|Wake Forest|Research Administrative Coordinator|336-716-2903|irichard@wakehealth.edu|
22429925|NCT03093870|ASLAN Pharmaceuticals|Study Director|+65 6222 4235|contact@aslanpharma.com|
22445888|NCT03811028|Sobi|Global Communication|+4686972000|info@sobi.com|
22445889|NCT00560105|VA WNY Health Care System|Dr. S. Sethy|716-862-7875|ssethi@buffalo.edu|
22445890|NCT01550289|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22445891|NCT03539081|University of Iowa|Marshall Holland, MD|205-934-2654|mtholland@uabmc.edu|
22445892|NCT03695250|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
22445893|NCT00990236|Oregon Health & Science University|Samantha Underwood, Research Manager|503-494-8481|traumare@ohsu.edu|
22445894|NCT02840097|University of California, Davis|Daniel Nishijima, Study Co-PI|916.734.3884|dnishijima@ucdavis.edu|
22445895|NCT02555683|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22445896|NCT03554746|National Yang Ming University|Dr. Yi-Fen Shih|+886-2-28267340|yfshih@ym.edu.tw|
22445897|NCT00899574|NYU Cancer Institute|Sylvia Adams, MD|212-263-6485|sylvia.adams@nyumc.org|
22445898|NCT04622306|Sagami|Mr Grant R Burt|+33 607 54 52 41|grantburt@sagami-europe.com|
22445899|NCT03289858|University of Massachusetts, Worcester|Eric Swart|503-880-7125|eric.swart@umassmemorial.org|
22445900|NCT04269707|American Regent, Inc.|Mark A. Falone, MD|631.772.3544|mfalone@americanregent.com|
22445901|NCT01896102|bluebird bio, Inc|Study Medical Director|339-499-9300|medinfo@bluebirdbio.com|
22445902|NCT02673138|Yale Pediatric Diabetes|Neha S. Patel, DO|203-764-6747|neha.patel@yale.edu|
22445903|NCT03719612|Lantheus Medical Imaging, Inc|Istvan Molnar|978-671-8686|istvan.molnar@lantheus.com|
22445904|NCT01216761|University of Michigan Health System|Laraine Washer, MD|734-936-5205|laraine@med.umich.edu|
22445905|NCT00696800|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22445906|NCT01101880|University of Washington|Pamela Becker, MD, PhD|206-288-7273|pbecker@uw.edu|
22445907|NCT00762385|Vistakon|Kurt Moody, OD FAAO|904-443-3088||
22445908|NCT04424888|Pendulum Therapeutics|James Bullard, PhD, Chief Technical Officer|(844) 912-2256|james.bullard@pendulum.co|
22445909|NCT00591344|Northwestern University|Daniel Corcos, PhD|708-214-5454|daniel.corcos@northwestern.edu|
22445910|NCT00493025|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Rosalyn Juergens, MD.|410-908-7829|rjuerge1@jhmi.edu|
22445911|NCT03779711|Mayo Clinic|Clint Hagen|(507) 577-1764|hagen.clint@mayo.edu|
22445912|NCT01457573|Houston Methodist Hosptial System|Timothy Boone, MD, PhD, Principal Investigator|713-441-6455|tboone3@houstonmethodist.org|
22445913|NCT03881670|IU School of Optometry|Pete Kollbaum|812-856-0108|kollbaum@iu.edu|
22445914|NCT00914485|Southeast Louisiana Veterans Health Care System|P. Adam Kelly, PhD, MBA|504-988-6630|peter.kelly@va.gov|
22445915|NCT01609231|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22445916|NCT00494299|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22445917|NCT01216631|University of Leeds|Professor Philip Conaghan|+44 113 3924884|p.conaghan@leeds.ac.uk|
22445918|NCT03273270|Medical University of South Carolina|Gonzalo Revuelta|7927262|revuelta@musc.edu|
22445919|NCT03822182|AHNI Orthopedics|Brian Badman|3178328800|bbadman@gmail.com|
22445920|NCT01484275|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22445921|NCT04584970|University of North Carolina at Chapel Hill|Jacob Nelson|704-677-3801|jacob14@live.unc.edu|
22445922|NCT03113916|Kaiser Permanente Center for Health Research|Nangel Lindberg|503 528 3961|Nangel.M.Lindberg@kpchr.org|
22445923|NCT00241358|Washington University School of Medicine|John F. DiPersio, M.D., Ph.D.|314-454-8603|jdipersi@wustl.edu|
22445924|NCT00737243|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22445925|NCT01893203|Helsinki university hospital|Noora Neittaanmäki-Perttu|+358407190362|noora.neittaanmaki@fimnet.fi|
22445926|NCT01758523|University of Connecticut School of Medicine|Dr. Jonathan Covault|860-679-7560|jocovault@uchc.edu|
22445927|NCT00722800|MGH|Alexandra B. Kimball, MD|617-726-5066|harvardskinstudies@partners.org|
22445928|NCT00590135|Cleveland Clinic|Brian Griffin MD|216-444-6812|Griffib@ccf.org|
22445929|NCT01533077|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22445930|NCT02130297|Icahn School of Medicine at Mount Sinai|Dr. Hooman Khorasani|347-574-8500|hooman.khorasani@mountsinai.org|
22445931|NCT01219673|University of Texas (UT) MD Anderson Cancer Center|Dr. David Rosenthal Professor, Radiation Oncology Department|713-792-7734|CR_Study_Registration@mdanderson.org|
22445932|NCT00508755|Malcom Randall VA Medical Center, Gainesville Florida|Janis Daly, Ph.D., M.S.; Director, Brain Rehabilitation Research Center of Excellence|(352) 376-1611|janis.daly@neurology.ufl.edu|5223
22445933|NCT00957580|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22445934|NCT00945893|MedImmune, LLC|Raburn Mallory, MD Senior Director Clinical Development|301-398-0000|malloryr@medimmune.com|
22445935|NCT01611155|Mayo Clinic|Charles L. Loprinzi, MD|507-284-3731|cloprinzi@mayo.edu|
22445936|NCT01435603|Northwestern University|Research Project Manager|312-503-3359|emily.anderson1@northwestern.edu|
22445937|NCT01602120|Hoffmann-La Roche|Medical Communications|800 821 - 8590|genentech@druginfo.com|
22445938|NCT04502433|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
22445939|NCT01682954|Ohio State University|Dr. Carla Miller|614-292-1391|miller.4453@osu.edu|
22445940|NCT01681472|Isofol Medical|Anders Rabbe|+46 (0)707 64 65 00|anders.rabbe@isofolmedical.com|
22445941|NCT00795145|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22445942|NCT02556554|Regents of the University of Colorado|Sarit Polsky, MD, MPH|3037248575|sarit.polsky@ucdenver.edu|
22445943|NCT01696071|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22445944|NCT00880997|Baylor College of Medicine|Thomas Kosten, MD|713-794-7032|kosten@bcm.edu|
22445945|NCT00678080|UT Health|Dr. Jerrie Refuerzo, M.D.|713-500-6416|jerrie.s.refuerzo@uth.tmc.edu|
22398899|NCT02321436|Ipsen|Medical Affairs Director, Neurology||clinical.trials@ipsen.com|
22398900|NCT03355300|Radius Pharmaceuticals, Inc.|Tarek El Akkad, Head of Clinical Development|6175514000|telakkad@radiuspharm.com|
22398901|NCT00546052|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22398902|NCT00502216|Yale University School of Medicine|Benjamin Toll, Ph.D.|203-974-5767|benjamin.toll@yale.edu|
22398903|NCT01031446|Vanderbilt-Ingram Cancer Center|Ingrid A. Mayer, MD|615-936-2033|ingrid.mayer@vanderbilt.edu|
22398904|NCT01877083|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22398905|NCT02851173|University of Texas at Austin|Andreana Haley|512-232-0863|haley@austin.utexas.edu|
22398906|NCT01841333|University of Colorado|Dr. Daniel Pollyea|720-848-8084|DANIEL.POLLYEA@cuanschutz.edu|
22398907|NCT05442853|Malcom Randall VA Medical Center|Andrew J. Franck|3523761611|Andrew.Franck@va.gov|105771
22398908|NCT01641120|Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital|Lindsay Tuttle, MPH|860-714-2149|LTuttle@stfranciscare.org|
22398909|NCT02324270|Teva Pharmaceuticals USA, Inc|Senior Director, Global Gx Clinical R&D- PD/CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
22398910|NCT03521791|Laboratorios Sophia|PhD. Ricardo Llamas|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
22398911|NCT04024501|AstraZeneca|AstraZeneca information Centre|1-877-240-9479|information.center@astrazeneca.com|
22398912|NCT00680836|George E. Wahlen V.A. Medical Center, Salt Lake City, UT|Ashok Tuteja, M.D.|801-582-1565|ashok.tuteja@va.gov|4019
22398913|NCT03786432|William Beaumont University Hospital|Grace San Agustin|248 551 6679|grace.sanagustin@beaumont.org|
22398914|NCT03038308|Columbia University|Gabrielle Page-Wilson, MD|212-305-3725|gp2287@cumc.columbia.edu|
22398915|NCT00278876|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
22398916|NCT01475734|GlaxoSmithKline|GSK Response Center|866-435-7343||
22398917|NCT00771472|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22398918|NCT00845195|Alcon Research Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22398919|NCT04793399|ZERO LMC|Valentín García|91 336 86 86|jvalentingg@gmail.com|
22398920|NCT03054363|University of Colorado Hospital|Elena Shagisultanova, MD, PhD|7208480300|elena.shagisultanova@cuanschutz.edu|
22398921|NCT00667576|Abbott Japan Co., Ltd.|Global Medical Services|800-633-9110||
22398922|NCT01734655|Pennington Biomedical Research Center|Dr. Corby K. Martin|225-763-2585|corby.martin@pbrc.edu|
22398923|NCT04866290|Merit Medical Systems, Inc.|Vicky Brunk RN, Vice President, Medical Affairs, Merit Medical|+1 (717) 873-3309|vicky.brunk@merit.com|
22398924|NCT01322022|Children's Hospital of Pittsburgh/University of Pittsburgh|Dr. Cynthia Johnson|412-692-8404|cynthia.rheney.johnson@gmail.com|
22398925|NCT01231555|ViiV Healthcare|GSK Response Center|866-435-7343||
22398926|NCT03793439|Oregon Health & Science University|Dr. Marcia Friedman|5034948637|friedmam@ohsu.edu|
22398927|NCT02707770|Imperial college healthcare NHS trust|vijay padmanaban|02033122349|vijay.padmanaban@nhs.net|
22398928|NCT01748071|Huazhong University of Science&Technology|Xianwei Zhang|027 83662853|ourpain@163.com|
22398929|NCT03068325|New York State Psychiatric Institute|Yuval Neria|646-774-8092|ny126@cumc.columbia.edu|
22398930|NCT00700180|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22398931|NCT03588741|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22398932|NCT01445535|National Cancer Institute|Dr. Wyndham Wilson|240-760-6092|wyndham_wilson@nih.gov|
22398933|NCT03216382|Ryerson University|Dr. Naomi Koerner|416-979-5000|naomi.koerner@ryerson.ca|ext. 5521
22398934|NCT02408692|Oregon Health & Science University|Dr. Alison Edelman|503-494-3666|whru@ohsu.edu|
22398935|NCT00420511|Leadership Sinai Centre for Diabetes, Mount Sinai Hospital|Dr. Ravi Retnakaran|416-586-4800|rretnakaran@mtsinai.on.ca|3941
22398936|NCT01668654|GlaxoSmithKline|GSK Response Center|866-435-7343||
22398937|NCT01337973|VA Ann Arbor|Stephen Chermack, Ph.D.|734 845-5046|chermack@umich.edu|
22398938|NCT03634800|Weill Cornell Medicine|Dr. Himanshu Nagar|212-746-3704|hnagar@med.cornell.edu|
22398939|NCT01114529|Novartis Pharmaceuticals|Study Director|+1(862)778-8300|trialandresults.registries@novartis.com|
22398940|NCT03244033|University of Illinois at Chicago|Dr. Saul Weiner|312-355-1700|sweiner@uic.edu|
22398941|NCT04428411|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22398942|NCT00634569|Grifols|Paul J. Pinciaro, PhD|410-814-7617|paul.pinciaro@grifols.com|
22398943|NCT02918019|Hoffmann-La Roche|Medical Comunications|1-800-821-8590|genentech@druginfo.com|
22398944|NCT01212185|UNC_ChapelHill|Dr. Cort Pedersen|919-966-4447|cort_pedersen@med.unc.edu|
22398945|NCT03555266|University of Pittsburgh Medical Center Department of Anesthesiology and Perioperative Medicine|Jacques E. Chelly, MD, PhD, MBA|412-623-6382|chelje@anes.upmc.edu|
22398946|NCT03370770|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22398947|NCT01699087|Alcon, A Novartis Division|Expert Clinical Project Lead, GCRA, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22398948|NCT03419078|Imperial College Healthcare NHS Trust|Julie Beckerson|02033131922|julie.beckerson@nhs.net|
22398949|NCT01420146|Institut Jules Bordet|Dr Géraldine Gebhart|025413095|geraldine.gebhart@bordet.be|+32
22412567|NCT04559854|Oregon State University|Jessica Gorman|541-737-2323|Jessica.Gorman@oregonstate.edu|
22398950|NCT00797823|Legacy Health System|W Kenneth Ward MD|503-413-5171|wardk@ohsu.edu|
22412568|NCT05694013|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22412569|NCT04817891|University of Michigan|Dr. Benjamin Hampstead|734-936-6185|bhampste@med.umich.edu|
22412570|NCT03982433|Boston University|Tibor Palfai, PhD|6173539345|palfai@bu.edu|
22412571|NCT00368277|Novaris Phamaceuticals|Study Director|862-778-8300||
22412572|NCT03076255|Thomas Jefferson University|Voichita Bar-Ad, MD|215-955-6702|Voichita.BarAd@jefferson.edu|
22412573|NCT04552704|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
22412574|NCT03845933|Evergreen General Hospital|Dr Chi-Liang Cheng|0919768058|chiliang.cheng@gmail.com|
22412575|NCT00696449|Wake Forest University Health Sciences|Steven Feldman|3367167740|sfeldman@wakehealth.edu|
22412576|NCT00475020|UT MD Anderson Cancer Center|Popat,Uday,M.D. / Stem Cell Transplantation|713-745-3055|UPOPAT@MDANDERSON.ORG|
22445946|NCT03569618|University of California, San Francisco|Riley Bove, MD MSc|415.502.7209|riley.bove@ucsf.edu|
22412577|NCT01575054|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22412578|NCT03481309|University of North Carolina at Chapel Hill|Dr. Sangtae Ahn|9195233127|sangtae_ahn@med.unc.edu|
22445947|NCT04439201|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22445948|NCT05136690|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22412579|NCT03309956|Columbia University|Leonardo Liberman, MD|212-305-8509|ll202@cumc.columbia.edu|
22429926|NCT02006654|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
22445949|NCT02020577|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22445950|NCT01453361|Gradalis, Inc.|Director of Clinical Trials|2144428124|info@gradalisinc.com|
22445951|NCT01752985|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
22445952|NCT01516437|GlaxoSmithKline|GSK Response Center|866-435-7343||
22445953|NCT02025621|Duke Clinical Research Institute|Rajendra Mehta, MD Study Principal Investigator|919-668-8971|raj.mehta@dm.duke.edu|
22445954|NCT00739674|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22445955|NCT02373852|Gardia Medical Ltd|Dr Vardit Segal|972-52-4579178|vardit@gardiamedical.com|
22445956|NCT01897454|NYU Langone|Dr. Jennifer Chuy|646-501-0194|jennifer.chuy@nyulangone.org|
22445957|NCT02958293|TriHealth Inc.|Dr. Rachel Pauls|513-463-4300|Rachel_Pauls@trihealth.com|
22445958|NCT02195583|GlaxoSmithKline|GSK Response Center|866-435-7343||
22445959|NCT01560403|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22445960|NCT00539656|Johns Hopkins University School of Medicine|Allen Chen, MD,PhD,MHS|410-614-4434|chenal@jhmi.edu|
22445961|NCT00983437|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22445962|NCT04019288|M.D. Anderson Cancer Center|Amir A Jazaeri|713-745-1613|aajazaeri@mdanderson.org|
22445963|NCT00094172|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22445964|NCT04538430|University of Utah|Shellie Cunningham|801-587-5488|shellie.cunningham@hsc.utah.edu|
22445965|NCT01112358|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center,|496151725200|service@merckgroup.com|
22445966|NCT01519271|University of Pennsylvania|Daniel Weintraub, MD|215-349-8207|Daniel.Weintraub@UPHS.UPENN.EDU|
22445967|NCT00993200|University of Utah|Robert Pendleton|801 581 7818|robert.pendleton@hsc.utah.edu|
22445968|NCT00289133|DePuy Orthopaedics, Inc.|Clinical Portfolio Leader|574-372-7231|shimden@its.jnj.com|
22445969|NCT01691339|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22445970|NCT03372096|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
22445971|NCT00040365|National Cancer Institute (NCI), National Institutes of Health (NIH)|Kevin A. Camphausen|301-496-5457|camphauk@mail.nih.gov|
22445972|NCT03513328|University of Florida|Biljana Horn, MD|352-273-9121|biljana.horn@ufl.edu|
22445973|NCT01803204|USP|Cristina Sousa|+5511996017972|crissousa@usp.br|
22445974|NCT01548651|Baylor College of Medicine|Mandeep Bajaj|713-798-1712|bajaj@bcm.edu|
22445975|NCT01397890|AstraZeneca|Nongluk Yimsuan|66 2 7397400|ClinicalTrialTransparency@astrazeneca.com|429
22445976|NCT03260881|University of Miami Miller School of Medicine|Dr Gianluca Iacobellis MD PhD Professor of Medicine|3052433636|giacobellis@med.miami.edu|
22445977|NCT04755790|Point Designs|Director of Clinical Research|7206004753|research@pointdesignsllc.com|
22445978|NCT02763462|INA-RESPOND|Publication Division|+62214208693|inapublikasi@ina-respond.net|
22445979|NCT00129272|The University of Tennessee|Uma Rao, MD|615-794-3351|urao@utk.edu|
22445980|NCT03473171|The University of Texas Health Science Center at Houston|James M. Stark, MD|713-500-5650|James.M.Stark@uth.tmc.edu|
22445981|NCT00675948|GW Pharma LTD.|Mr Richard Potts, Clinical Operations Director|00 44 1223 266 800|rp@gwpharm.com|
22445982|NCT02100514|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22445983|NCT00319553|Sanofi Pasteur Inc.|Medical Director||RegistryContactUS@sanofipasteur.com|
22445984|NCT01145625|Johnson & Johnson Healthcare Products Division of MCNEIL-PPC, Inc.|Study Director|(973) 385-3203||
22445985|NCT01751178|GlaxoSmithKline|GSK Response Center|866-435-7343||
22445986|NCT04289623|Geisinger Clinic|Amir Goren, PhD|5702144395|agoren@geisinger.edu|
22445987|NCT05091047|Erchonia Corporation|Clinical Affairs Manager|888.242.0571|tsammons@erchonia.com|
22445988|NCT01496248|Krea University College of Medicine|Young-Hoon Ko|+82-31-412-5140|korean@chol.com|
22445989|NCT04138810|University of Pennsylvania, Department of Urogynecology|Dr. Lily Arya|215-662-4147|larya@pennmedicine.upenn.edu|
22445990|NCT03019783|Brigham and Women's Hospital|Dr. Joshua Beckman|617-732-5500|joshua.a.beckman@vanderbilt.edu|
22412580|NCT01566409|Pediatric Department, Hospital Lillebaelt, Kolding|Dr. Line Modin|0045 61386349|line.modin@rsyd.dk|
22429927|NCT04193527|GE Healthcare Ltd.|Yongqing Tang, MD, PhD|21 38774044|Yongqing.Tang@ge.com|+86
22412581|NCT02768298|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@@novartis.com|
22412582|NCT04533646|University of Pittsburgh Medical Center|Associate Professor of Medicine|4125869700|ullalj@upmc.edu|
22412583|NCT04256421|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22412584|NCT02445456|Oxford University Hospitals NHS Foundation Trust|Miss Helen Jones|01865 235657|helen.jones3@ouh.nhs.uk|
22412585|NCT00419770|Los Angeles Biomedical Research Institute|Brad Spellberg|310-781-3680|bspellberg@dhs.lacounty.gov|
22412586|NCT02446626|National Institute of Allergy and Infectious Diseases|Marques, Adriana|+1 301 435 7668|amarques@niaid.nih.gov|
22412587|NCT02696070|Regenesis Biomedical|Heather Vander Ploeg|602-428-7041|heather.vanderploeg@regenesisbio.com|
22412588|NCT02424188|Johns Hopkins University School of Medicine|Gail Daumit, MD, MHS|410-614-6460|gdaumit@jhmi.edu|
22412589|NCT01701024|Exec Dir Clinical Dir|Johnson Varughese|908-927-1162|johnson.varughese@valeant.com|
22412590|NCT02472522|Tata Main Hospital, Jamshedpur, India|Specialist, Anaesthesia & Critical Care|91-9431166582|debsanjay@gmail.com|
22412591|NCT00453362|Hoffman-LaRoche|Medical Communications|800-821-8590||
22412592|NCT04885296|Johnson & Johnson Vision Care, Inc.|John R. Buch, O.D., M.S., F.A.A.O.|904-608-7238|jbuch@its.jnj.com|
22412593|NCT00433147|Patient Advocacy|Amicus Therapeutics|+1-609-662-2000|Clinicaltrials@Alexion.com|
22412594|NCT02683083|Camel-IDS|Tony Lahoutte|0032 24799360|tony.lahoutte@camel-ids.com|
22412595|NCT00248638|Emory University|Thomas R. Ziegler M.D.|4047277354|Tzieg01@emory.edu|
22412596|NCT01059500|indiana university school of medicine|jeffrey kline|317 880 3869|jefkline@iu.edu|
22412597|NCT01124149|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22412598|NCT01644500|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22412599|NCT03272139|Department of Anesthesiology, Critical Care & Pain Management|Dr. David Kim|212-606-1206|kimd@hss.edu|
22412600|NCT00001849|NIDDK, NIH|Lynnette Nieman MD|301-496-8935|NiemanL@nih.gov|
22412601|NCT05518487|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22412602|NCT00543309|Ann & Robert H. Lurie Children's Hospital of Chicago|John M. Costello, M.D., M.P.H.|312 227 1551|jmcostello@luriechildrens.org|
22412603|NCT04084483|Kowa Research Institute, Inc.|Director, Clinical Operations|919-433-1600|CTGResults@KowaUS.com|
22445991|NCT03641339|National Institutes of Health|Matthew J. Memoli, MD, MS|301-443-5971|memolim@niaid.nih.gov|
22445992|NCT02329080|International Extranodal Lymphoma Study Group (IELSG)|Scientific and Medical Director|+41 58 666|ielsg@ior.usi.ch|7321
22445993|NCT03285984|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22445994|NCT00413244|Icahn School of Medicine at Mount Sinai|Dr. Mary Ann McLaughlin|(212) 241-3340|maryann.mclaughlin@mountsinai.org|
22445995|NCT02509767|Planned Parenthood Federation of America|Julia Kohn|2122614636|julia.kohn@ppfa.org|
22445996|NCT02319837|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22445997|NCT02435147|HealthEast Care System|Amy Fehrer|651-232-5363|afehrer@healtheast.org|
22445998|NCT02100579|Northwestern University, Feinberg School of Medicine|Antoun Nader|312-695-3045|a-nader2@northwestern.edu|
22445999|NCT00839852|Allergan|Willie R. Earley, MD Associate Vice President Clinical Development-CNS|714-246-4500|IR-CTRegistration@allergan.com|
22446000|NCT03082261|Abbott|Robyn Capobianco|+15129343941|robyn.capobianco@abbott.com|
22446001|NCT01704521|University of Cincinnati|Kenneth E. Sherman, MD. PhD|513-558-3918|kenneth.sherman@uc.edu|
22446002|NCT01961362|National Jewish Health|Dr. Jeffrey J. Swigris|303-398-1621|swigrisj@njhealth.org|
22446003|NCT01313312|Ipsen Innovation|Medical Director, Neurology.||clinical.trials@ipsen.com|
22446004|NCT00147212|MGH Cancer Center|M. Dror Michaelson, MD PhD|6177261594|dmichaelson1@partners.org|
22446005|NCT01761175|CHU de Québec, Département d'Anesthésie-Réanimation de l'Hôpital de l'Enfant-Jésus|Dre Marie-Josée Nadeau|418 649-5807|marie-josee.nadeau@fmed.ulaval.ca|
22446006|NCT00784641|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
22446007|NCT02640573|Baylor College of Medicine|Vivien Sheehan|832 824 4459|vsheehan@bcm.edu|
22446008|NCT01206166|CERU Queen's University|Dr.Daren Heyland|403-915-5573|dkh2@queensu.ca|
22446009|NCT02716805|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
22446010|NCT00066365|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22446011|NCT04288752|J3 Bioscience, Inc|R. Tyler McCabe, Ph.D.|801-550-9956|tmccabe@j3bio.com|
22446012|NCT00467857|Kimberly-Clark Health Care|Dr. Shu-Ping Yang|770-587-7267|Shu-Ping.Yang@kcc.com|
22446013|NCT00787761|Blood and Marrow Transplant Group of Georgia|Asad Bashey, MD, PhD, Principal Investigator|404-255-1930|abashey@bmtga.com|
22446014|NCT03576495|Brigham and Women's Hospital|Dr. Douglas S. Smink|617-983-7260|dsmink@bwh.harvard.edu|
22446015|NCT02867150|Optimal Health and Weight Center|Dr. Ellyn Levine M.D.|(619) 567-6914|dr.levine@teamtsfl.com|
22446016|NCT05306977|University of Pennsylvania|Nicholas Balderston|2157463058|nicholas.balderston@pennmedicine.upenn.edu|
22446017|NCT02628938|Riyadh Colleges of Dentistry and Pharmacy|Dr. Mohammad Rayyan|00966508821318|mohammadrayyan1979@gmail.com|
22446018|NCT02058693|Collaborative Behavioral Health|Michael Topel PsyD|847-922-3253|michaeltopel@gmail.com|
22446019|NCT03558087|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22446020|NCT03855228|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22446021|NCT02993757|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22446022|NCT00190671|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22446023|NCT00087607|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22446024|NCT02699593|Johnson & Johnson Vision Care Inc.|Brian Pall, OD, MS, FAAO -Sr. Principal Research Optometrist|904 443-1290|BPALL@its.jnj.com|
22412604|NCT02194998|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22412605|NCT01400113|St. Joseph's Hospital Health Center|Michael Pratts, MD|315-726-8610|michael.pratts@sjhsyr.org|
22412606|NCT00282256|Astellas Pharma Global Development, Inc.|Vice President, Therapeutic Area Head, Transplantation||ClinicalTrials.Disclosure@us.astellas.com|
22412607|NCT01632709|Rehabilitation Institute of Chicago|Center for Pain Studies|312.238.5654|centerforpainstudies@ric.org|
22412608|NCT02636907|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22412609|NCT00762086|A. Stein Regulatory Affairs Consulting|Shmulik Adler|972-9-767-0002|shmulik@asteinrac.com|
22412610|NCT02576249|Mayo Clinic|Dr. Jacob Sellon|507-255-1141|sellon.jacob@mayo.edu|
22412611|NCT00784849|LSU Dept of Surgery|Dr. Eugene Woltering|504 464-8500|ewolte@lsuhsc.edu|
22429928|NCT03808909|University of New Mexico, Health Sciences Center|Pilar Sanjuan|505/272-7055|psanjuan@salud.unm.edu|
22429929|NCT01608308|The University of Texas Health Science Center at Houston|Davide Cattano|(713) 500-6200|Davide.Cattano@uth.tmc.edu|
22429930|NCT03677180|Henry Ford Hospital|Dr. Mir Babar Basir|313-916-2896|mbasir1@hfhs.org|
22429931|NCT04786600|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
22429932|NCT02362412|Astellas Pharma Inc.|Vice-President, Japan-Asia Clinical Development Administration||Astellas.resultsdisclosure@astellas.com|
22429933|NCT01266083|Sellas Life Sciences|Dragan Cicic|646-200-5278|info@sellaslife.com|
22429934|NCT00545948|Duke University Medical Center|Neal Ready, PhD, MD|919-681-6932|neal.ready@duke.edu|
22429935|NCT04595370|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22429936|NCT03520387|VA Puget Sound Health Care System Seattle Division, Seattle, WA|Pradeep Suri, MD|206-764-2673|Pradeep.Suri@va.gov|
22429937|NCT00541775|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22429938|NCT01945242|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22429939|NCT04267328|HealthPartners Institute - Neuroscience|Clinical Research Coodinator|651-495-6360|clincialtrials@HealthPartners.com|
22429940|NCT04913675|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
22429941|NCT04501445|Rush University Medical Center|Jared A Greenberg|312-942-6744|jared_greenberg@rush.edu|
22429942|NCT01064284|"Centro Emofilia e Trombosi Angelo Bianchi Bonomi, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico di Milano"|Prof. Flora Peyvandi|0039 0255035414|flora.peyvandi@unimi.it|
22429943|NCT01541254|MicroVention, Inc.|Mary Schmitz|714-247-8025|mary.schmitz@microvention.com|
22429944|NCT05660538|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22429945|NCT04648241|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22429946|NCT02970812|Family Medicine Clinic, Pusan National University Yangsan Hospital|Sang Yeoup Lee|3601442|saylee@pnu.edu|55
22429947|NCT02489045|Thomas Jefferson University|Flemming Forsberg, PhD|215-955-4870|flemming.forsberg@jefferson.edu|
22429948|NCT01940146|SPARC|Shravanti Bhowmik, MD||shravanti.bhowmik@sparcmail.com|
22429949|NCT00120874|NYU Langone Medical Center|Barry Reisberg|121-263-8550|barry.reisberg@nyumc.org|
22429950|NCT01108055|Stanford University|Sandy Srinivas, MD|650 498 6000|sandysri@stanford.edu|
22429951|NCT00845000|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22429952|NCT03339453|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22429953|NCT02903381|Dana-Farber Cancer Institute|Dr. Irene Ghobrial|617-632-4198|irene_ghobrial@dfci.harvard.edu|
22429954|NCT01348490|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22429955|NCT00300495|Houston Methodist Hospital|Min Kim|7134415177|mpkim@houstonmethodist.org|
22429956|NCT04002557|Imperial College London|Ms Ann-Eneli Allas|07508775892|anastassija@hotmail.com|
22429957|NCT02278237|University of Chicago|Valerie G. Press, MD, MPH|773-702-5170|vpress@medicine.bsd.uchicago.edu|
22429958|NCT00908687|Valneva Austria GmbH|Head Clinical Development|0043120620|info@valneva.com|0
22429959|NCT03834883|Purdue University|James E. Tisdale, PharmD|317-880-5418|jtisdale@purdue.edu|
22429960|NCT06173648|State Univeristy of Paulista Júlio de Mesquita Filho, School of Dentistry at Araraquara|Dr. Renato de Toledo Leonardo|+55-16-3301-6391|rleonard@foar.unesp.br|
22429961|NCT02487199|AbbVie|Global Medical Services|800-633-9110||
22429962|NCT00286455|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22429963|NCT04826731|Ankara Sanatoryum Training and Research Hospital|Dr. Kerem Ensarioğlu|905426142727|kerem.ensarioglu@gmail.com|
22429964|NCT01213251|Medtronic plc|PRomPT Clinical Team|+1 800-328-2518|MedtronicCRMtrials@medtronic.com|
22429965|NCT02933151|Dialysis Clinic, Inc. /Tufts Medical Center|Dr. Daniel Weiner|6176365070|dweiner@tuftsmedicalcenter.org|
22429966|NCT04250675|Purdue University|Bruno Roseguini|7654906284|brosegui@purdue.edu|
22429967|NCT00862277|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22429968|NCT02168439|Children's Hospital of Pittsburgh of UPMC|Desiree Neville|4126927692|desiree.neville@chp.edu|
22429969|NCT02004275|Levine Cancer Institute|Peter Voorhees|980-442-5219|peter.voorhees@carolinashealthcare.org|
22429970|NCT03408808|NHS Grampian|Miss Katharine Hamlin|0845 456 6000|katharine.hamlin@nhs.scot|56755
22429971|NCT04432298|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1346|jcharpentier@fibrogen.com|
22429972|NCT00678574|University of Pennsylvania|Cynthia Neill Epperson, M.D.|215-573-8871|cepp@mail.med.upenn.edu|
22429973|NCT01423084|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
22429974|NCT02551809|United Neuroscience|Responsible Medical Officer|+(353) 1 524 0397|info@unitedneuroscience.com|
22429975|NCT01682603|Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University|Dr. Hann-Chorng Kuo|886-3-8561825|hck@tzuchi.com.tw|2113
22429976|NCT02462057|Kaiser Permanente Northern California Division of Research|Anjali Gopalan|510-891-3458|Anjali.Gopalan@kp.org|
22412612|NCT03629925|Innovent Biologics (Suzhou) Co., Ltd|YiBo|+86 13382419112|jessica.yi@innoventbio.com|
22446025|NCT02015754|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu|
22384839|NCT01781468|Mayo Clinic Arizona|Alyx B. Porter Umphrey, M.D.|480-301-4062|Porter.alyx@mayo.edu|
22384840|NCT05256706|Emory University|Dr. Arshed Quyyumi|404-712-2741|aquyyum@emory.edu|
22384841|NCT05009004|Environment and Health Group|Patricia Weitzman|6174555976|pat.weitzman@ehgcambridge.com|
22384842|NCT03720795|Baylor College of Medicine|Dr. Eric Storch|(713) 798-3579|eric.storch@bcm.edu|
22384843|NCT05386758|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22384844|NCT01573442|Mayo Clinic|Charles L. Loprinzi, M.D.|507/284-4565|cloprinzi@mayo.edu|
22384845|NCT03649659|University of Michigan|Dr. Margherita Fontana|734-763-3988|mfontan@umich.edu|
22384846|NCT04510974|James J Peters VA Medical Center|Dr. Caitlyn Peters|9733243588|cpeters@kesslerfoundation.org|
22384847|NCT04763265|Croma Pharma GmbH|Clinical Development - Head of Clinical Operations|+43 2262 684680|clinical.studies@croma.at|
22384848|NCT04418466|Delpor, Inc.|Eesha Gupta|415-289-1770|eesha.gupta@delpor.com|
22384849|NCT05908344|The Pennsylvania State University|Dr. Anne-Marie Chang|814-863-5226|amchang@psu.edu|
22384850|NCT05590312|Düzce University Faculty of Medicine|Assistant Professor Özlem Ersoy Karka|+905337293978|drozlemersoy@gmail.com|
22384851|NCT03269136|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22384852|NCT05308004|University of Maryland School of Nursing|Dr. Joan Carpenter|443-880-1430|joan.carpenter@umaryland.edu|
22384853|NCT04267172|Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences (NDORMS), University of Oxford.|Professor Jonathan Rees|01865737540|jonathan.rees@ndorms.ox.ac.uk|
22446026|NCT02229383|AstraZeneca|Global Clinical Leader|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22384854|NCT04552223|University of Miami|Jose Lutzky MD|+1 (305) 6896500|jose.lutzky@med.miami.edu|
22384855|NCT04856163|RAND|Dr. Lori Uscher-Pines|703-413-1100|luscherp@rand.org|
22384856|NCT04799704|UZ Leuven|Heleen Delbeke, MD|003216342229|heleen.delbeke@uzleuven.be|
22384857|NCT03983018|Örebro University|Prof Susanne Bejerot|+46701655102|susanne.bejerot@oru.se|
22384858|NCT02515773|University of Cincinnati|Casey Moore|513-558-6307|casey.moore@uc.edu|
22384859|NCT04918823|BostonSight|Dr. Daniel Brocks|7817267337|dbrocks@bostonsight.org|
22384860|NCT04072380|Suven Life Sciences|Ramakrishna Nirogi, PhD|+9140 2319 3956|nvsrk@suven.com|
22384861|NCT01552473|The University of Texas at Dallas, Center for BrainHealth|Dr. Daniel Krawczyk, Primary Investigator|214-905-3007|dck061000@utdallas.edu|
22384862|NCT04406441|Geisinger Health System|Dr. Lisa Bailey-Davis|570-214-9625|ldbaileydavis@geisinger.edu|
22446027|NCT00672932|UCSF|Richard W. Price, M.D.|415-206-4487|rwprice@sfgh.ucsf.edu|
22384864|NCT03526874|Children's Hospital of Philadelphia|Dr. Christina Szperka|12155901719|szperka@chop.edu|
22384865|NCT03717506|Gage Development Company|Gage Development Clinical Trials|1-847-999-0600|clinicalinfo@capstonedevservices.com|
22384866|NCT05816551|Institute for Exercise and Environmental Medicine|Craig Crandall, PhD, Primary Investigator|214-345-4623|craigcrandall@texashealth.org|
22384867|NCT04353661|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22384868|NCT03973320|Hospital for Special Surgery, Anesthesiology|Dr. Jiabin Liu|2126061036|liuji@hss.edu|
22384869|NCT04024813|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22384870|NCT04034251|National Cancer Institute|Dr. Andrew Blakely|240-760-7647|blakelyam@nih.gov|
22384871|NCT04419389|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
22384872|NCT05493423|Hemotek Medical Inc|Chief Scientific Officer|7074942895|patrick@hemotekmedical.com|
22384873|NCT00920621|Brigham and Women's Hospital|Scott T. Weiss, MD, MS|617-525-2278|scott.weiss@channing.harvard.edu|
22384874|NCT03070184|The University of Alabama at Birmingham|Nehal Vekariya, MS - Clinical Research Coordinator III|2059347173|nvekariya@uabmc.edu|
22384875|NCT05097430|Centre for Addiction and Mental Health (CAMH)|Dr. Paul Shuper|416-535-8501|paul.shuper@camh.ca|34097
22384876|NCT05862870|UConn Health|Mark D. Litt, PhD|860-679-4680|Litt@uchc.edu|
22384877|NCT04080531|Emory University|Craig C. Hofmeister, MD, MPH|404-778-0519|craig.hofmeister@emory.edu|
22384878|NCT04363515|Hennepin Healthcare Research Institute|Dr. Allyson Hart|612-873-6998|allyson.hart@hcmed.org|
22384879|NCT02543281|Cleveland Clinic, Lerner Research Institute|Larisa Tereshchenko|2164442445|tereshl@ccf.org|
22384880|NCT02530671|University Kiel|Dr. Sonja Sälzer|00494315972810|saelzer@konspar.uni-kiel.de|
22384881|NCT05247489|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22384882|NCT03126019|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22384883|NCT05551195|Woebot Health|Kate Martin|(415) 209-5642|kate@woebothealth.com|
22384884|NCT00170573|Charite Campus Vichow Klinikum|Prof. Dr. Jalid Sehouli|+49 30-450564052|jalid.sehouli@charite.de|
22384885|NCT05722704|Gulf Medical University|Dr. Rania Zaarour|+971 6 7431333|dr.rania@gmu.ac.ae|4184
22446028|NCT01234831|Massachusetts General Hospital|Dr. Erica S. Shenoy|617-726-2036|eshenoy@partners.org|
22446029|NCT00074269|UCSD|Dr. Edward Ball, Director BMT Program|858-822-6600|tball@ucsd.edu|
22446030|NCT00873015|University of Virginia Medical Center|Dr. Edward Oldfield|(434) 982-0059|EHO4U@hscmail.mcc.virginia.edu|
22446031|NCT01542125|Alberta Health Services|Research Coordinator|780-492-2398|manu.saraswat@albertahealthservices.ca|
22446032|NCT02400333|AstraZeneca AB|Brilinta Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
22384886|NCT06069713|Wake Forest University Health Sciences|Olivia Horton MSW, MPH|000.000.0000|ohorton@wakehealth.edu|
22384887|NCT03498651|University of Virginia Department of Psychology|Dr. Bethany Teachman|434-924-0676|bethanyteachman@gmail.com|
22384888|NCT04323137|Geisinger Health|Amir Goren, PhD|570-214-4395|agoren@geisinger.edu|
22384889|NCT05563246|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22384890|NCT03763708|Medtronic Neuromodulation|SCS Research Study Team|800-633-8766|rs.scsresearch@medtronic.com|
22384891|NCT05200247|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22384892|NCT04951492|Fred Hutchinson Cancer Center|Dr. Michael Schweizer|2066066252|mtschwei@fredhutch.org|
22384893|NCT03332017|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22384894|NCT05165108|IndianaU|Thomas Nowak, MD|3179484272|tvnowak@iu.edu|
22384895|NCT02682342|Medical College of Wisconsin|Michael E. Widlansky, MD|414-955-6708|mwidlans@mcw.edu|
22384896|NCT04005716|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
22384897|NCT02783300|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22384898|NCT04302493|Johns Hopkins School of Medicine|Elisabeth B. Marsh, MD|410-550-8703|ebmarsh@jhmi.edu|
22384899|NCT00378105|Dana-Farber Cancer Institute|Dr. Richardson|617-632-2104|Paul_Richardson@dfci.harvard.edu|
22384900|NCT04511286|Karolinska Institutet|Dr. Erland Axelsson|0706171039|erland.axelsson@ki.se|+46
22384901|NCT02243709|Brown University|Prof. Carolina Haass-Koffler|4155191385|carolina_haass-koffler@brown.edu|
22384902|NCT03378570|University of Iowa Hospitals & Clinics|Dr. Nicholas Trapp|(319) 467-8188|nicholas-trapp@uiowa.edu|
22384903|NCT03843151|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22384904|NCT01787383|LEO Pharma A/S|Clinical trial disclosure manager|00 45 44 94 58 88|ctr.disclosure@leopharma.com|
22384905|NCT03443323|Children's Hospital of Philadelphia|Dr. Thomas J. Power|215-590-7447|power@chop.edu|
22446033|NCT00956020|NYEEI Department of Otolaryngology|Anthony Sclafani, MD|212-979-4200|asclafani@nyee.edu|
22384906|NCT03151616|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
22384907|NCT05391893|SpectrumLakeland|Rachelle Pichot; Clinical Research Specialist|(240)389-7340|rachelle.pichot@corewellhealth.org|
22384908|NCT04750473|Emory University/Winship Cancer Institute|Dr. David Schuster|404-712-4859|dschust@emory.edu|
22384909|NCT05178316|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
22384910|NCT04347161|University of Pennsylvania|Katharine A Rendle, PhD,MSW,MPH|215-349-5442|Katharine.Rendle@pennmedicine.upenn.edu|
22384911|NCT04169373|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22384912|NCT04610892|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22384913|NCT01413100|Fred Hutchinson Cancer Center|Dr. Leona Holmberg|206-667-6447|lholmb@fredhutch.org|
22384914|NCT05369403|Chief Medical Officer|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
22384915|NCT04760678|Insitute of Tropical Medicine|Carolien Hoof|0470102562|choof@itg.be|
22384916|NCT05570175|Chang Gung University of Science and Technology|Su-Hui Chen|886-3-2118999|sophee@mail.cgust.edu.tw|3216
22384917|NCT01458782|University Hospital North Norway|Dr.Ann Kristin Hansen|+4777669763|ann.kristin.hansen@unn.no|
22384918|NCT01748448|UZLeuven|Prof. Dr. M. Garmyn|0032 16 33 79 50|marjan.garmyn@uzleuven.be|
22384919|NCT02226276|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22446034|NCT01650844|University of Rochester|Dr. Jill Halterman|585-275-5798|jill_halterman@urmc.rochester.edu|
22446035|NCT01687998|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22446036|NCT01337739|Northwestern University|Paul Fitzgerald|312-472-3539|p-fitzgerald2@northwestern.edu|
22446037|NCT01663532|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22446038|NCT02785432|UT Southwestern|Jason Zafereo|146481002|jason.zafereo@utsouthwestern.edu|146481002
22446039|NCT02432729|Philip Morris Products S.A.|Christelle Haziza, Director Health Science and Biostatistics|+41 58 242 11 11|christelle.haziza@pmi.com|
22446040|NCT03663816|University of Florica|Sharareh Sharififar|352-273-7410|sharareh75@phhp.ufl.edu|
22446041|NCT00871260|The University of Chicago|Dr. Amit Patel|773-702-9461|apatel2@medicine.bsd.uchicago.edu|
22446042|NCT01871532|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22446043|NCT00283400|Baylor College of Medicine|Jose I Suarez, MD, Professor of Neurology|713-798-8472|jisuarez@bcm.edu|
22446044|NCT00289471|Durham VAMC|John W. Williams|919-286-6963|jw.williams@duke.edu|
22446045|NCT02048891|Rambam health Care campus|Shahar Kol Director IVF Unit|97247773232|skol@rambam.health.gov.il|
22446046|NCT00934089|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22446047|NCT01020981|VHA HSR&D|Marcia Valenstein, MD|7349453649|marcia.valenstein@va.gov|
22446048|NCT01337700|Montefiore Medical Center, Albert Eins|Eric Hollander, MD|7189204287|eholland@montefiore.org|
22446049|NCT00814970|Medtronic Aortic and Peripheral Vascular|Arslan Malik - Senior Clinical Research Manager|(707) 541-3256|arslan.malik@medtronic.com|
22446050|NCT00680017|AstraZeneca|Gerard Lynch|+44 1509 645 895|aztrial_results_posting@astrazeneca.com|
22446051|NCT01434667|Brigham and Women's Hospital|Kurt Christensen, PhD|(617) 264-5883|kchristensen@bwh.harvard.edu|
22446052|NCT02034110|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22446053|NCT00064337|SWOG Statistical Center|Study Statistician|206-667-4623||
22446054|NCT02279420|USGI Medical|Senior Director of Clinical Research|9493693890|samlung@usgimedical.com|
22446055|NCT01948947|VA San Diego Healthcare System|Valerie Metzger Smith, Study Coordinator|858-750-0274|valerie.metzgersmith@va.gov|
22446056|NCT03535844|National University of Singapore|Dr. Kim Jung Eun|+6565161136|fstkje@nus.edu.sg|
22446057|NCT00612040|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22446058|NCT00297830|Columbia University|Dr. Elizabeth Shane|2123056289|es54@columbia.edu|
22446059|NCT02835820|University of Alabama at Birmingham|Shannon Morrison|12059967841|samorris@uab.edu|
22446060|NCT00827502|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22446061|NCT05096221|Sarepta Therapeutics Inc.|Sarepta Therapeutics Inc.|1-888-727-3782|SareptAlly@sarepta.com|
22446062|NCT02061774|TTUHSC CRI|Cathy Lovett|806-743-4222|cathy.lovett@ttuhsc.edu|
22398951|NCT01405053|Eisai Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22384920|NCT04864691|Interventional Neuroradiology, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.|Feng Gao|13581936066|gaofengletter@sina.com|
22384921|NCT03675282|Weill Cornell Medicine|Carly Skudin; Research Program Manager|212-746-2003|cas4010@med.cornell.edu|
22398952|NCT02817087|Houston Methodist Neurological Institute|David Chiu, M.D.|713-441-5801|dmccane@houstonmethodist.org|
22384922|NCT03232138|University of Pittsburgh Cancer Institute|Jian-Min Yuan M.D., Ph.D.|412-864-7889|yuanj@upmc.edu|
22384923|NCT03992339|Antengene Corporation|Yumei Tang|18301318100|yumei.tang@antengene.com|
22384924|NCT03853746|Johns Hopkins Universtiy|Bardia Nourbakhsh|410-614-1522|bnourba1@jhmi.edu|
22384925|NCT03555448|Washington University|R. Delos Santos|3143628351|delossantos@wustl.edu|
22384926|NCT05326776|UC San Diego|Dr. Laura Case|858-246-4968|lcase@health.ucsd.edu|
22398953|NCT04871711|LEO Pharma A/S|Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
22398954|NCT01665144|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22398955|NCT02420873|The University of Texas MD Anderson Cancer Center|Naval Daver, MD/ Associate Professor|713-794-4392|ndaver@mdanderson.org|
22398956|NCT03382574|UT MD Anderson Cancer Center|Dr. Powel Brown, Chair, Clinical Cancer Prevention|(713) 745-3672|phbrown@mdanderson.org|
22398957|NCT04811716|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22398958|NCT02320487|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22398959|NCT03344003|Octapharma AG|Dr. Sigurd Knaub, Senior VP CR&D Haematology|01554512141|Sigurd.Knaub@octapharma.com|
22398960|NCT05027932|Clinical Studies Unit, Laboratory of Infectious Diseases, NIAID, NIH|Luca Giurgea|301-538-5235|Luca.giurgea@nih.gov|
22398961|NCT00684957|Columbia University|Pamela Freda, MD|212-305-3725|puf1@columbia.edu|
22384927|NCT04952909|Pi-Cardia|Hadas Givon, VP CA/RA|+972-8-9484800|hadas@pi-cardia.net|
22384928|NCT00881621|Georgetown University|Dr. Aiwu Ruth He|202-444-8642|arh29@georgetown.edu|
22384929|NCT04359108|Johns Hopkins Applied Physics Laboratory|Seth Billings|240-228-7462|seth.billings@jhuapl.edu|
22384930|NCT06393088|IR Technology LLC|Consulting Director of Clinical Trials|404 915-5938|andyn@invisaredtech.com|
22384931|NCT04176965|BVI medical|Rebecca McQuaid|+353871212615|RMcQuaid@bvimedical.com|
22384932|NCT03903146|University of Kentucky|Dr. Ana Maria Linares, PI|8593234726|am.linares@uky.edu|
22384933|NCT05026320|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22384934|NCT05093478|The University of Texas Health Science Center at Houston|Kunal R Shetty, MD|713-486-5000|Kunal.R.Shetty@uth.tmc.edu|
22384935|NCT03197662|Montefiore Medical Center|Dr. Eric Hollander|718-839-7516|eholland@montefiore.org|
22384936|NCT03721952|University of Washington|Dr. Ruth Engelberg|206-744-9523|rengel@uw.edu|
22446063|NCT02614586|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22446064|NCT03417219|VA Palo Alto Health Care System|Dr. Blake Scanlon|6504935000|blake.scanlon@va.gov|65316
22446065|NCT02581787|Stanford University|Maximilian Diehn, MD, PhD|(650) 721-1550|diehn@stanford.edu|
22446066|NCT00408460|University of Washington|Renato G Martins, MD|206-288-2048|rgmart@uw.edu|
22446067|NCT02264639|Apellis Pharmaceuticals, Inc.|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
22446068|NCT02727842|Cochlear Americas|Kimberly Nix, Clinical Project Manager|303-264-2340|knix@cochlear.com|
22446069|NCT01252147|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22446070|NCT01589978|Boston Scientific|Peter Maurer, Director Clinical Trials|508-683-6678|Peter.Maurer@bsci.com|
22446071|NCT00369824|GlaxoSmithKline|GSK Response Center|866-435-7343||
22384937|NCT04624633|Dana-Farber Cancer Institute|Jennifer R Brown MD PhD|617-632-4894|Jennifer_Brown@dfci.harvard.edu|
22384938|NCT05565092|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
22384939|NCT01902173|SWOG|Melanoma Statistician|2066674623|jmoon@fredhutch.org|
22384940|NCT05480124|University of Michigan|Stephan Taylor|(734) 936-4955|sftaylor@med.umich.edu|
22384941|NCT04550468|University of British Columbia|Dr. Jonathan Little|250-807-9876|jonathan.little@ubc.ca|
22384942|NCT03640312|Washington University in St. Louis|Guhan Iyer|3147479487|guhaniyer@wustl.edu|
22384943|NCT03536754|ChemoCentryx|Study Director|650-210-2900|clinicaltrials@chemocentryx.com|
22384944|NCT04891224|Advocate Health Care|Ramona Donovan, Research Project Manager|847-723-5792|ramona.donovan@aah.org|
22384945|NCT03382652|Zimmer Biomet|Esther Foo|+41787183202|esther.foo@zimmerbiomet.com|
22384946|NCT05455086|OhioSUCCC|Dr. Theodore L. Wagener|614-366-4265|Theodore.Wagener@osumc.edu|
22384947|NCT04876118|Zeltiq Aesthetics|Sally Hallas, RN, Director Clinical Development - Body Contouring|209-294-5571|sally.hallas@abbvie.com|
22384948|NCT03964350|University of Chicago|Dr. Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
22384949|NCT02379156|James J. Peters VA Medical Center|John P. Handrakis|718-584-9000|John.Handrakis@va.gov|3129
22384950|NCT04593472|Johns Hopkins Bloomberg School of Public Heath|Dr. Jennifer Wolff|4105020458|jwolff2@jhu.edu|
22384951|NCT05098795|Henry Ford Health|Dr. Julia Felton|313-598-0841|jfelton4@hfhs.org|
22384952|NCT05264376|Stanford University|Dr. Eric Stice|650-723-7885|estice@stanford.edu|
22384953|NCT04927637|Dartmouth Health Orthopaedics|Dr. Ida Leah Gitajn|(603) 650-5133|Ida.Leah.Gitajn@hitchcock.org|
22384954|NCT02754882|Samsung Bioepis Co., Ltd|Director of Clinical Trials|031-8061-1096|sbregistry@samsung.com|
22384955|NCT02111798|Johns Hopkins University School of Medicine|Dr. Kelly Dunn, Ph.D., MBA|410-550-2254|kdunn9@jhmi.edu|
22384956|NCT04806594|Relife Srl|Clinical Trial Coordinator|055 56809345|sdipalma@relifecompany.it|
22384957|NCT04390048|University of Miami|Brian Arwari|305-284-5418|b.arwari@umiami.edu|
22384958|NCT05215314|University of Wisconsin-Madison|Daniel Grupe|608-263-7572|grupe@wisc.edu|
22384959|NCT04179500|TB Alliance|Antonio Lombardi|917-601-0024|Antonio.Lombardi-Consultant@tballiance.org|
22384960|NCT03138512|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22384961|NCT04682106|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
22384962|NCT05470517|Johns Hopkins All Children's Hospital|Nicole M. Chandler, MD|727-767-4170|nicole.chandler@jhmi.edu|
22384963|NCT04106583|Penumbra, Inc.|Brooke Lawson|+15109952183|blawson@penumbrainc.com|
22412613|NCT01074554|Vanderbilt University School of Medicine|Dr. Wonder Drake|615-322-2035|wonder.drake@vanderbilt.edu|
22446072|NCT01443078|Memorial Sloan Kettering Cancer Center|Chaft, Jamie, MD|646-888-4545|ChaftJ@mskcc.org|
22446073|NCT01390649|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22446074|NCT00415168|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22446075|NCT01749631|AbbVie|Global Medical Information|800-633-9110||
22446076|NCT01612858|Tufts Medical Center|Rakhi Kohli MD MS|617-636-4709|rkohli@tuftsmedicalcenter.org|
22446077|NCT00003487|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22384964|NCT03992274|Columbia University|Kathrine Meyers, DrPH, MPP, MSc|2123046110|kam2157@cumc.columbia.edu|
22384965|NCT06064955|Ohio State University|Karen O. Moss|(614) 688-3100|Moss.391@osu.edu|
22446078|NCT02197273|OhioHealth|Deborah Napier|614-566-5575|Deborah.Napier@ohiohealth.com|
22384966|NCT03792555|Crinetics Pharmaceuticals Inc.|Crinetics Clinical Trials|+1 858-450-6464|clinicaltrials@crinetics.com|
22384967|NCT05593510|UT Southwestern Medical Center|Kelseanna Hollis-Hansen|214-645-7676|kelseanna.hollis-hansen@utsouthwestern.edu|
22384968|NCT04485039|SIGA Technologies|Emily Blum, Director of Clinical Development|541-224-1305|eblum@siga.com|
22384969|NCT05481216|Research Organization (KC) Ltd|HIV COCO Project Manager|+44 (0) 7494 795 982|hivcoco@rokcservices.com|
22384970|NCT03535272|Centers for Disease Control and Prevention|Kristina Angelo|404-718-4876|kangelo@cdc.gov|
22446079|NCT00005044|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22446080|NCT00843856|Imperial College NHS Trust|Dr Megan Griffith|02083835272|megan.griffith1@nhs.net|
22412614|NCT00497796|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22412615|NCT01351506|Chiang Mai University|Dr.Kaweesak Chittawatanarat|+66815951259|kchittaw@gmail.com|
22412616|NCT01856309|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Associate Director, Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22412617|NCT00220337|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22412618|NCT00832377|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22412619|NCT00944697|Mundipharma Research GmbH|Director of Medical Operations|44 01223424900|info@contact-clinical-trials.com|
22412620|NCT03661528|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
22412621|NCT00765648|Cleveland Clinic|Frank Peacock MD|(216) 445-4557|peacocw@ccf.org|
22412622|NCT02353169|British Columbia Children's Hospital Research Institute|Simon D. Whyte|604-875-2711|swhyte@cw.bc.ca|
22412623|NCT00486837|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
22412624|NCT05295953|University of Kentucky, Lexington|Gopalkumar Rakesh MD|859-257-9402|gopalkumar.rakesh@uky.edu|
22429977|NCT01791205|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22429978|NCT05345405|University of Washington|Principal Investigator|206-503-3287|edworkin@uw.edu|
22429979|NCT01896986|MCRI|Dr. Nigel Crawford|9345 4772|nigel.crawford@rch.org.au|
22429980|NCT01750281|AstraZeneca|Dr Gabriella Mariani|+44 (0)207 6048000|ClinicalTrialTransparency@astrazeneca.com|
22429981|NCT04189588|TerSera Therapeutics Inc.|Executive Director Clinical Development|888 600 8116|jnorth@tersera.com|
22429982|NCT00948935|Abramson Cancer Center|Bruce Giantonio|(215) 615-5858|bruce.giantonio@uphs.upenn.edu|
22429983|NCT04032327|Walter Reed National Military Medical Center|Katherine L Dengler, MD|301-400-2468|katherine.l.dengler.mil@mail.mil|
22446081|NCT03104543|Fred Hutchinson Cancer Center|Dr. Eric Chow|206-667-7724|ericchow@uw.edu|
22446082|NCT03698409|SUNY Upstate medical University|Assistant Profressor|3154644243|zidan@upstate.edu|
22446083|NCT01468675|Brigham and Women's Hospital|Jennifer Haas, M.D.|617-525-6652|jhaas@partners.org|
22446084|NCT01540266|University Hospital Basel|Dr. med. Roland Bingisser|+41 61 265 58 30|roland.bingisser@usb.ch|
22446085|NCT00345839|Amgen Inc.|Study Director|866-572-6436||
22446086|NCT03928353|SFJ Pharmaceuticals, Inc.|Michele LaRussa SVP, Chief Regulatory Officer|925-223-6233|Bentracimab.General@SFJ-Pharma.com|
22446087|NCT01960400|Université de Sherbrooke|Dr Yannick Tousignant-Laflamme|819-821-8000|Yannick.Tousignant-Laflamme@USherbrooke.ca|72912
22446088|NCT04547712|Medtronic Neuromodulation|Helen Berrier|763-526-8178|helen.berrier@medtronic.com|
22446089|NCT02989714|University of Michigan Rogel Cancer Center|Ajjai Alva, MD|734-936-0091|ajjai@umich.edu|
22446090|NCT03298867|Horizon Pharma USA, Inc.|Suzy Hammel|866-479-6742|clinicaltrials@horizontherapeutics.com|
22446091|NCT00300274|Novartis Pharmaceuticals|Study Director|862-778-8300||
22446092|NCT02963649|Medtronic|Giulia Gatta, Clinical Study Manager|+310629467793|giulia.gatta@medtronic.com|
22446093|NCT05263895|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22446094|NCT05764408|Prisma Health|Dr. Melissa Wise|8644551600|melissa.wise2@prismahealth.org|
22446095|NCT04659928|The University of Texas Health Science Center at Houston|Claudia Ruiz Brisuela, DDS|713-486-4138|Claudia.RuizBrisuela@uth.tmc.edu|
22429984|NCT01658735|University of Utah School of Medicine|Matthew A Hughes, MD, MPH|8015814800|matthew.hughes@hsc.utah.edu|
22429985|NCT03757715|UAB|Dr. Jessica W. Grayson|205-801-7801|jgrayson@uabmc.edu|
22429986|NCT00281580|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22429987|NCT01234714|University of Zurich|Dr Dimitri Aristotle Raptis, Principal Investigator|+41442553300|dimitri.raptis@usz.ch|
22429988|NCT03302936|Icahn School of Medicine at Mount Sinai|Annacecilia Peacher-Holderied|2104887216|apeacher4@gmail.com|
22429989|NCT01379937|GlaxoSmithKline|GSK Response Center|866-435-7343||
22429990|NCT01122680|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22429991|NCT03374956|Mayo Clinic|Andres Acosta|507-266-6931|acosta.andres@mayo.edu|
22429992|NCT02264821|CHU Brugmann|Dr Madeleine Wilwerth|003224773996|madeleine.wilwerth@chu-brugmann.be|
22429993|NCT00983801|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22429994|NCT00619242|The University of Chicago|Ezra Cohen, MD|773/702-4137|ecohen@medicine.bsd.uchicago.edu|
22429995|NCT02067156|University of California, San Diego Moores Cancer Center|Dr. David Piccioni|858-657-7000|dpiccioni@ucsd.edu|
22429996|NCT01853280|Massachusetts General Hospital|Dr. Craig Surman|617-726-8422|csurman@partners.org|
22429997|NCT01655069|Astellas Pharma Europe B.V.|Medical Director|+31 (0) 71 5455 050|Astellas.resultsdisclosure@astellas.com|
22429998|NCT00104884|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
22429999|NCT03473301|Duke University|Jesse D. Troy, PhD, MPH|919-668-1102|cordbloodtherapyinfo@dm.duke.edu|
22446096|NCT06934993|Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine|Dr. Abdulgani Orhun YENİGÜN|+90 05346214600|orhunyenigun@gmail.com|
22446097|NCT01218113|GlaxoSmithKline|GSK Response Center|866-435-7343||
22398962|NCT04341948|SPR|Clinical Affairs|216-378-9106|support@SPRPainRelief.com|
22398963|NCT03406897|University of Miami, Diabetes Research Institute|Dr. David Baidal|305-243-7740|dbaidal@med.miami.edu|
22398964|NCT05900115|innovation Research & Training|Tracy Scull, PhD|9194937700|tscull@irtinc.us|
22398965|NCT02949128|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22398966|NCT01602341|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|001-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22398967|NCT02152345|Columbia University Irving Medical Center|Dr. Mark A. Hardy|(212) 305-5502|mah1@cumc.columbia.edu|
22398968|NCT01903265|Tonix Pharmaceuticals|Gregory M. Sullivan, MD, Chief Medical Officer|212 980 9155|Gregory.Sullivan@TonixPharma.com|117
22398969|NCT03242954|Indiana University School of Nursing|Amy Knopf|206-356-9430|asknopf@iu.edu|
22430000|NCT05529173|Rutgers - NJ Medical School|Dr. Dennis Grech|973 972-5007|grechde@njms.rutgers.edu|
22430001|NCT05965323|University of Washington|Linda K Ko, PhD, Principal Investigator|2062568261|lindako@uw.edu|
22430002|NCT00835042|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22430003|NCT03760081|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22430004|NCT04034056|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22430005|NCT04635280|Air Liquide|Marie-Danielle MILCENT / Clinical Project Manager|+33 (0)1 84 76 42 39|fralsi-ctpublication@airliquide.com|
22430006|NCT04135352|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22430007|NCT02453191|University of Iowa, Holden Comprehensive Cancer Cente|Varun Monga, MD|319-384-9497|varun-monga@uiowa.edu|
22430008|NCT02571244|Federal University of Juiz de Fora/Brazil|Dr. Erica Cruvinel|55-32-99174-8855|ericacruvinel@gmail.com|
22430009|NCT00185900|Stanford University|Dr. Anna Girsen|(650) 725-5720|agirsen@stanford.edu|
22446098|NCT02823431|Duke Biomedical Engineering|Warren Grill PhD|(919) 660-5276|warren.grill@duke.edu|
22412625|NCT01199861|Novartis Pharmaceuticals|Study Director|862-778-8300||
22412626|NCT04981912|UCSD|Michael Choi|8585341765|mychoi@ucsd.edu|
22412627|NCT00365261|University of California, San Diego|Joel Dimsdale, M.D., Principal Investigator|619 543-5592|jdimsdale@ucsd.edu|
22446099|NCT00544466|City of Hope Medical Center|Dr. Jeffrey Wong, MD|6263598111|JWong@coh.org|
22446100|NCT01385566|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22446101|NCT00967668|VA Center for Clinical Management Research|Laura Damschroder|734-845-3603|laura.damschroder@va.gov|
22446102|NCT00825682|Sheba Medical Center|Dr Dorit Gamus|+972-3-5303956|dorit.gamus@sheba.health.gov.il|
22384971|NCT01744782|Horizon Pharma USA, Inc.|Evelyn Olson, Director|224-383-3000|clinicaltrials@horizonpharma.com|
22384972|NCT01747863|Research Institute of the McGill University Health Center|Dr. Guilherme Sant'Anna|(514) 412-4400|guilherme.santanna@mcgill.ca|23489
22384973|NCT02120456|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
22384974|NCT05192200|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22384975|NCT03623321|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261|medicalinformation@acadia-pharm.com|2897
22384976|NCT04241068|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22412628|NCT05630547|Sanofi aventis recherche & développement|Trial Transparency Team|8006331610|Contact-US@sanofi.com|6#
22412629|NCT05049460|University of Kentucky, Lexington|Gopalkumar Rakesh MD|859-257-9402|gopalkumar.rakesh@uky.edu|
22412630|NCT03441581|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
22412631|NCT00117949|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22412632|NCT01974141|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22412633|NCT03580343|Washington University in St. Louis|Lynn Hassman, Assistant Professor and Study PI|3142730341|lhassman@wustl.edu|
22412634|NCT02099461|Amgen Inc.|Study Director|866-572-6436||
22412635|NCT01867242|University of Minnesota|Dorothy Hatsukami, PhD|612-626-2121|hatsu001@umn.edu|
22412636|NCT00406848|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22412637|NCT04803357|university of Washington Diabetes Institute|Dr, Nicole Ehrhardt|2404479566|nehrhard@uw.edu|
22412638|NCT05932654|Biosion, Inc.|Kathy Zhang|+86 18801904945|kathy.zhang@biosion.com|
22412639|NCT02879643|Therapeutic Advances in Childhood Leukemia and Lymphoma|Ellynore Florendo, CCRP|323-361-3022|eflorendo@chla.usc.edu|
22412640|NCT00182091|Massachusetts General Hospital|Dr. Anne Klibanski|617-726-3870||
22412641|NCT01046253|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22412642|NCT02339909|Imperial College London|Colin Bicknell|02078866666|colin.bicknell@imperial.ac.uk|6072
22412643|NCT00860028|Yale School of Medicine|Dr. Stephanie O'Malley|203-974-7590|stephanie.omalley@yale.edu|
22412644|NCT02576990|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22412645|NCT00936390|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22412646|NCT02093689|Omeros Corporation|Medical Monitor|206-676-5000|info@omeros.com|
22384977|NCT04492007|University of North Carolina Lineberger Comprehensive Cancer Center|Xianming Tan PhD|919-966-8450|xianming@email.unc.edu|
22384978|NCT03463824|Virginia Commonwealth University|Dr. James Thomas|740-591-1563|jthomas32@vcu.edu|
22384979|NCT04229992|Vanderbilt University Medical Center|Dr. Martha Shrubsole, Dr. Qi Dai|(615)936-0707|Martha.shrubsole@vanderbilt.edu, qi.dai@vanderbilt.edu|
22384980|NCT03770273|National Institute of Allergy and Infectious Diseases|Hirsh Komarow|+1 301 594 2197|komarowh@niaid.nih.gov|
22384981|NCT00418886|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22384982|NCT00277394|Leo Pharma|Torsten Skov, Senior Medical Advisor|+45 72263990|tosdk@leo-pharma.com|
22384983|NCT03907397|Icahn School of Medicine at Mount Sinai|Dr. Scott Sicherer|212-241-5548|scott.sicherer@mssm.edu|
22384984|NCT05521308|Sonova|Bilal Sheikh - Research Audiologist|2268083260|bilal.sheikh@sonova.com|
22412647|NCT03365947|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400|info@arrowheadpharma.com|
22446103|NCT02468674|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22446104|NCT03281577|Takeda|Medical Director|+1-877-825-3327|takedadisclosures@takeda.com|
22446105|NCT01332500|GlaxoSmithKline|GSK Response Center|866-435-7343||
22446106|NCT01644565|Enteric Diseases Department, Naval Medical Research Center|Ramiro L. Gutierrez, MD, MPH|301-319-3193|ramiro.gutierrez@med.navy.mil|
22412648|NCT02518685|BAROnova, Inc|Lian Cunningham, MD, PhD|650.638.9796|lcunningham@baronova.com|22
22446107|NCT00443261|University of Kansas Cancer Center|Dr. Stephen Williamson|9139455059|swilliam@kumc.edu|
22412649|NCT01922349|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22430010|NCT01696214|University of California San Diego|Dr. Joe Ramsdell|619-543-7241|jramsdell@ucsd.edu|
22384985|NCT05337943|University of Pennsylvania|Dr. Lea Ann Matura|2157468819|matura@nursing.upenn.edu|
22384986|NCT04406857|University of Kentucky|Dr. Charles Kunos|859-323-6486|Charles.Kunos@uky.edu|
22384987|NCT05948670|Woebot Health|Tim Campellone, PhD|(415) 209-5642|research@digitaltherapeutic.io|
22384988|NCT00390793|The University of Texas MD Anderson Cancer Center|Farhad Ravandi-Kashani, MD./ Professor|713-745-0394|fravandi@mdanderson.org|
22384989|NCT03056040|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22384990|NCT03427580|Bar-Ilan University|Prof. Ilanit Hasson-Ohayon|+972-3-5317673|ilanithasson@gmail.com|
22384991|NCT00845481|LEO Pharma|Torsten Skov, Senior Medical Advisor|+45 20 73 62 94|torsten.skov@leo-pharma.com|
22384992|NCT04142788|University of Glasgow|Prof John Cleland|0141 330 7774|john.cleland@glasgow.ac.uk|
22384993|NCT02035787|University of North Carolina Lineberger Comprehensive Cancer Center|Lauren Higgins|919- 966-4432|lqhiggin@ad.unc.edu|
22384994|NCT05392192|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
22384995|NCT05028634|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22384996|NCT03850678|University of Nebraska-Lincoln|Marc Brennan|4024723132|marc.brennan@unl.edu|
22384997|NCT04487145|University of Califronia San Francisco|Liusheng Huang(Co-Investigator and Drug Research Unit Co-Director)|415-502-2594|liusheng.huang@ucsf.edu|
22384998|NCT02933970|University at Buffalo|Andrew Talal|7168884737|AHTALAL@BUFFALO.EDU|
22384999|NCT03300648|Michigan State University|Terrie E. Taylor|5178988467|ttmalawi@msu.edu|
22385000|NCT02724631|Children's Hospital of Philadelphia|Sharon Y Irving|215 590-1000|irvings@chop.edu|
22385001|NCT05076708|Perelman School of Medicine, University of Pennsylvania|Janet Audrain-McGovern, Ph.D. Director, Addictions, Department of Psychiatry|(215) 746-7145|audrain@pennmedicine.upenn.edu|
22385002|NCT02908477|Mayo Clinic|Katharine Price M.D.|507-284-6139|Price.Katharine@mayo.edu|
22385003|NCT03095274|MFAR|A responsibility person designate by sponsor|934344412|investigacion@mfar.net|
22385004|NCT04115540|Stanford University|Michael Eisenberg MD|650-723-3391|meisenb@stanford.edu|
22385005|NCT05590403|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22385006|NCT05305235|University of North Carolina at Chapel Hill|Nicole Short, PhD|702-895-3305|nicole.short@unlv.edu|
22385007|NCT04717492|UAB Lung Health Center|Mark Dransfield|205-934-5425|mdransfield@uabmc.edu|
22385008|NCT03766009|University of Wisconsin School of Medicine and Public Health|Heather B. Neuman, MD, MS|608-265-5852|neuman@surgery.wisc.edu|
22385009|NCT05071807|Penn State University|DCH Lab|8148638056|dchlab@psu.edu|
22385010|NCT03729999|Nationwide Children's Hospital|Dr. Alok Moharir|614-722-4200|alok.moharir@nationwidechildrens.org|
22385011|NCT05434078|Baylor College of Medicine|Dr. Bijan Najafi|+1 (424) 467-7127|bijan.najafi@bcm.edu|
22385012|NCT03652688|PIRE|Dr. Brenda A. Miller|5105205889|BMiller@prev.org|
22385013|NCT05179837|Washington University School of Medicine|Vladimir Kushnir, M.D.|314-362-3685|vkushnir@wustl.edu|
22385014|NCT00554788|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22385015|NCT03557697|NYU Langone Health|Lu Hu|646 501 3438|lu.hu@nyulangone.org|
22385016|NCT03547869|UTDallas|Sven Vanneste|n/a|sven.vanneste@utdallas.edu|
22385017|NCT05409183|Tufts Medical Center|James Udelson, MD|(617) 636-8066|James.Udelson@tuftsmedicine.org|
22385018|NCT02274662|Sumitomo Pharma America, Inc.|Director Clinical Operations|+1 (508) 481-6700|ravi.grewal@us.sumitomo-pharma.com|
22385019|NCT05191472|University of California, San Francisco|Dr. Alfred Chung, MD|(415) 476-1000|Alfred.Chung@ucsf.edu|
22385020|NCT03364647|University of Kentucky|Brian Noehren|859-323-1100|b.noehren@uky.edu|
22385021|NCT03476460|Hospital Universitario Ramón y Cajal, IRYCIS|Coordinator of Research Support Unit, Internal Medicine Dept.|0034913369082|martin.fabregate@salud.madrid.org|
22385022|NCT05332366|Leo Pharma|Clinical Disclosure|+4544945888|disclosure@leo-pharma.com|
22385023|NCT02432404|University of Washington|Christine Johnston|206-520-4340|cjohnsto@uw.edu|
22385024|NCT05538754|STAAR Surgical|Joanne Egamino|626-303-7902|jegamino@staar.com|2905
22385025|NCT04810650|University of California, San Francisco|Douglas Black|4158063016|douglas.black@ucsf.edu|
22385026|NCT05492318|Italfarmaco SpA|Dr. Paolo Bettica, MD|+39 02 64431 (centralino)|p.bettica@italfarmacogroup.com|
22385027|NCT05008835|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261|medicalinformation@acadia-pharm.com|2897
22385028|NCT05194514|Cedars-Sinai|Fardad Esmailian|310-248-7132|fardad.esmailian@cshs.org|
22385029|NCT03270956|ProKidney|to be determined|n/a|info@prokidney.com|
22385030|NCT01212029|National Institute of Child Health and Human Development|Dr. Amir Gandjbakhche|2402742949|gandjbaa@mail.nih.gov|
22446108|NCT00787891|Janssen R&D US|PORTFOLIO/CDT LEADER|1 609 730-2548||
22446109|NCT01594281|Novartis Pharmaceuticals|Study Director|1-862-778-8300|Novartis.email@novartis.com|
22446110|NCT03542474|Northwestern University|Dr. Daniel Corcos|312-908-6792|daniel.corcos@northwestern.edu|
22446111|NCT01431170|NJMS, Rutgers University|Suqin Guo, MD|973-972-2031|guos1@njms.rutgers.edu|
22446112|NCT01193530|The University of Texas (UT) MD Anderson Cancer Center|Rony Dev, DO/Associate Professor, Palliative Care Medicine|713-792-6085|rdev@mdanderson.org|
22446113|NCT01890473|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22446114|NCT01945281|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22446115|NCT02577978|Northwestern Medicine|David W Manning|3124726023|David.Manning@nm.org|
22385031|NCT02671903|Imperial College London|Dr Zachary I Whinnett|+44 (0)20 7594 5735|z.whinnett@imperial.ac.uk|
22385032|NCT03673111|Imperial College London|Professor Tricia Tan|020 8383 8038|t.tan@imperial.ac.uk|
22446116|NCT01819831|Loma Linda University Health|Gary Yang, Professor, Chair of Radiation Medicine|909 558 4444|gyang@llu.edu|
22446117|NCT02647203|University of Talca|Dr. Rodrigo Giacaman|+56712201546|giacaman@utalca.cl|2654
22446118|NCT05074667|Stanford University|Sejal Shah, MD|650-498-7351|sshah2@stanford.edu|
22446119|NCT02911857|Novartis Pharmaceuticals|Study Director|862-778-1873|Novartis.email@novartis.com|
22446120|NCT00779701|Temple University Hospital|Dr. Nina Gentile|215-707-2000|ngentile@temple.edu|8402
22398970|NCT00880750|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22398971|NCT04690699|Istari Oncology|Head of Clinical Operations|919-245-7662|info@istarioncology.com|
22398972|NCT02265913|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
22398973|NCT00483327|Perlmutter Cancer Center at NYU Langone|Stephanie Blank, MD|212-731-5705|stephanie.blank@nyumc.org|
22398974|NCT04391959|Azura Ophthalmics|Chief Medical Officer|17145598435|charles.bosworth@azuraophthalmics.com|
22398975|NCT00568555|Stanford University School of Medicine|Jarred Younger, PhD|650-724-2795|jyounger@stanford.edu|
22398976|NCT01705691|NSABP Foundation, Inc.|Diana Gosik|412-339-5333|diana.gosik@nsabp.org|
22398977|NCT03106779|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
22398978|NCT04233229|Air Liquide Santé International|Marie-Danielle MILCENT / Clinical Project Manager|+33 (0)1 84 76 42 39|fralsi-ctpublication@airliquide.com|
22398979|NCT02288247|Astellas Pharma Europe Ltd. (APEL)|Clinical Trial Disclosure|+44 (0) 20 3379 8000|astellas.resultsdisclosure@astellas.com|
22398980|NCT04652804|Johns Hopkins Bloomberg School of Public Health|Shruti H. Mehta|443-287-3837|smehta@jhu.edu|
22398981|NCT04093531|University of Rochester|Ummara Shah, MD|585-275-1643|ummara_shah@urmc.rochester.edu|
22398982|NCT01580397|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22398983|NCT00820755|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22398984|NCT01486199|University of Pittsburgh|Tim Corcoran|412-624-8918|corcorante@upmc.edu|
22398985|NCT02063035|Massachusetts General Hospital, Boston, MA, USA|Dr. Kirkham B. Wood|617-726-2000|kbwood@stanford.edu|+1
22398986|NCT01893567|Galderma Laboratories, L.P.|Senior Clinical Project Manager|817-961-5000|jay.mashburn@galderma.com|
22398987|NCT03604445|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
22398988|NCT02154425|Cares|UCB|+1877 822||9493
22398989|NCT05787847|University of Vermont|Dr. Richard Rawson|‭+1 (310) 951-9091‬|richard.rawson@uvm.edu|
22398990|NCT06468059|Kennesaw State University|Mark Geil|(470) 578-4805|mgeil@kennesaw.edu|
22398991|NCT00480857|University of Michigan Comprehensive Cancer Center|Dr. Daniel Hamstra|(734) 936-4300|dhamm@umich.edu|
22398992|NCT00611247|Stanford University Medical Center|Bruno C Medeiros, MD|650-498-6000|bruno.medeiros@stanford.edu|
22398993|NCT02199197|Huntsman Cancer Institute Research Compliance Office|Data Manager|801-585-0601|compliance@hci.utah.edu|
22398994|NCT02551159|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22398995|NCT00243659|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22398996|NCT06098729|Yale University|Garrett Ash|2034443079|garrett.ash@yale.edu|
22398997|NCT02129660|Dermira, Inc.|Eugene A. Bauer, MD, Chief Medical Officer|650-421-7202|eugene.bauer@dermira.com|
22398998|NCT01890421|Bayer|Therapeutic Area Head|+1 888-8422937|clinical-trials-contact@bayer.com|
22398999|NCT00956254|Insys Therapeutics, Inc.|Larry Dillaha, M.D., Chief Medical Officer|602 910-2617|ldillaha@insysrx.com|
22399000|NCT02180893|NYU Langone Medical Center|Peter Neuberger|212 263 5821|Peter.Neuburger@nyumc.org|
22399001|NCT01478854|Johns Hopkins University School of Medicine|Kristin Redmond, MD|410-955-6980|kjanson3@jhmi.edu|
22399002|NCT02067039|CDC|Robin MacGowan|404-639-1920|rmacgowan@cdc.gov|
22399003|NCT01972074|Massachusetts General Hospital|Gagan Joshi, MD|(617) 724-1541|joshi.gagan@mgh.harvard.edu|
22399004|NCT02319044|AstraZeneca LP|Jean Fan, MD, Global Clinical Lead|1-301-398-5080|jean.fan@astrazeneca.com|
22399005|NCT02105415|Mayo Clinic|Dr. Nathan Smischney|507-255-4305|smischney.nathan@mayo.edu|
22399006|NCT00742469|Valeant Pharmaceuticals|Valeant Pharmaceuticals|(866) 246-8245||
22399007|NCT02558374|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director of Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
22399008|NCT02026063|Lexicon Pharmaceuticals, Inc.|Pablo Lapuerta, MD|281-863-3000|plapuerta@lexpharma.com|
22399009|NCT03687502|Children's Mercy Hospital|Dr. Tolulope Oyetunji|816-234-3575|taoyetunji@cmh.edu|
22399010|NCT00486278|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22399011|NCT00931489|University of California Davis, Department of Ophthalmology & Vision Science|Lawrence S. Morse, MD, PhD|916 734 6074|lsmorse@ucdavis.edu|
22399012|NCT01777581|Duke University Medical Center|David Marks, MD|919 668-2859|d.marks@duke.edu|
22399013|NCT01211600|Geisinger|Dr. A. Dhanya Mackeen|570-714-1099|admackeen@geisinger.edu|
22399014|NCT02887521|Mayo Clinic|Roberto Benzo, MD, MSc|(507) 284-0561|benzo.roberto@mayo.edu|
22399015|NCT00695565|Arcion Therapeutics, Inc.|Dr. James Campbell|(410) 522-8701|jcampbell@arciontherapeutics.com|
22399016|NCT01462266|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22399017|NCT01106846|Northwestern University|Shireen Ahmad, M.D.|321-472-3585|sah704@northwestern.edu|
22399018|NCT03110900|University of Arkansas for Medical Sciences|Michael Wilson, M.D.|(501) 686-5515|mpwilso1@outlook.com|
22399019|NCT00644787|Janssen Research & Development, L.L.C. USA|Director, Clinical Research|1 609 730-3387||
22399020|NCT01680900|University of Pennsylvania|Dr. Ellen Freeman|215-662-3329|freemane@mail.med.upenn.edu|
22399021|NCT03048422|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
22399022|NCT02549755|Indiana University School of Medicine|Justin Sims, M.D.|317 948-6340|simsjb@iupui.edu|
22446121|NCT02478632|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22446122|NCT01867424|National Cancer Institute|Dr. Ismail Baris Turkbey|301-443-2315|turkbey@nih.gov|
22412650|NCT05109234|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22412651|NCT03533946|Huntsman Cancer Institute/University of Utah|Clinicaltrials.gov and CTRP Specialist|8012136215|IITDataManagement@hci.utah.edu|
22412652|NCT05067504|Merz Aesthetics|Public Disclosure Manager|+1 984-301-3095|Aesthetic.Trials@merz.com|
22412653|NCT03805438|Duke University|Riley Landreth, DO|919-684-8111|riley.landreth@duke.edu|
22412654|NCT02684344|University of Rochester|Edward Messing|585 - 275 - 0998|edward_messing@urmc.rochester.edu|
22412655|NCT03469297|MicroOptx|VP of Clinical|888-591-2784|info@microoptx.com|
22412656|NCT02086188|EvergreenHealth|Theodore Brown, MD|4258995350|TRBrown@evergreenhealthcare.org|
22412657|NCT01494506|Merrimack Pharmaceuticals, Inc.|Dr. Eliel Bayever|6174411000|EBayever@merrimack.com|7676
22412658|NCT02248597|Wake Forest Baptist Comprehensive Cancer Center|Study Nurse|336-716-4761|krike@wakehealth.edu|
22412659|NCT02777528|WL Gore|Meier Hsu|928-864-3338|mhsu@wlgore.com|
22412660|NCT02127281|Cleveland Clinic|Alison K. Klika, MS, Research Manager, Department of Orthopaedic Surgery|(216) 444-4954|klikaa@ccf.org|
22412661|NCT03718234|University of Minnesota|Kyriakie Sarafoglou|6126245965|saraf010@umn.edu|
22412662|NCT01882647|Therapeutics, Inc.|Clinical Research, Therapeutics Inc.|585-571-1800|clinicalreseach@therapeuticsinc.com|
22412663|NCT01108094|Stanford University Medical Center|Jean Tang MD PhD, Associate Professor of Dermatology|650-723-6316|tangy@stanford.edu|
22412664|NCT01759277|University of California San Diego|Brian Ilfeld|858-822-2171|bilfeld@ucsd.edu|
22412665|NCT05037097|Arcturus Therapeutics, Inc.|Arcturus Therapeutics, Inc.|858-900-2660|clinicaltrials@arcturusrx.com|
22412666|NCT02918877|Beth Israel Deaconess Medical Center|Dr. Brian P. O'Gara|617-549-2974|bpogara@bidmc.harvard.edu|
22412667|NCT04510857|Barron Associates, Inc.|Richard Adams|4348253435|adams@bainet.com|
22412668|NCT05346055|Weill Cornell Medical College|Jo Anne Sirey|914-997-4333|jsirey@med.cornell.edu|
22412669|NCT00376220|Johns Hopkins University School of Medicine|Jennifer L. Payne M.D.|410-502-0050|jpayne5@jhmi.edu|
22412670|NCT02564263|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22412671|NCT02906709|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22412672|NCT00977106|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22412673|NCT02419313|Yale-Department of Neurology|Bahman Jabbari M.D , Professor Emeritus- Neurology|914-482-8542|bahman.jabbari@yale.edu|
22412674|NCT01347788|Massachusetts General Hospital|Matthew R Smith, MDPhD|617-763-3748|smith.matthew@mgh.harvard.edu|
22412675|NCT00683020|University of California, San Francisco|Dean Schillinger, MD/Study Principal Investigator|415-206-8940|dschillinger@medsfgh.ucsf.edu|
22412676|NCT03204526|UC Davis Health|Kiarash Shahlaie, MD, PhD, FAANS, Bronte Professor of Neurological Surgery|916-734-6342|krshahlaie@ucdavis.edu|
22412677|NCT00322491|Genzyme Corporation|Genzyme Medical Information||medinfo@genzyme.com|
22412678|NCT00688064|Galderma|Jean-Charles Dhuin, Clinical Project Manager|+33 4 92 95 29 21|jean-charles.dhuin@galderma.com|
22412679|NCT01626664|Kyowa Kirin Inc|Fiona Herr, Associate Director, Medical Communications|1 (908) 234-1096|medinfo-US@kyowakirin.com|
22412680|NCT00524459|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22412681|NCT00728949|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22412682|NCT02747615|Ain-Shams University Hospitals|Dr. Ibrahim Mamdouh Esmat|01001241928|ibrahim_mamdouh@med.asu.edu.eg|
22412683|NCT03209882|University of Texas at Arlington|Fenghua Tian|8178075271|fenghua.tian@gmail.com|
22412684|NCT02319148|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22412685|NCT01574248|Vanderbilt University Medical Center|Nancy J. Brown, M.D.|6153438701|nancy.j.brown@vanderbilt.edu|
22412686|NCT00290147|Naval Medical Research Center, Viral Diseases Department|Charmagne Beckett, LCDR, MC, USNR|301-295-6400|charmagne.beckett@med.navy.mil|
22412687|NCT00048048|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22412688|NCT00733330|DePuy International|Kimberly Dwyer||kdwyer2@its.jnj.com|
22412689|NCT00771537|Indiana University|Gregory D Zimet|317-274-8812|gzimet@iupui.edu|
22412690|NCT01345019|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22412691|NCT05194839|Aristea Therapeutics|Aristea Therapeutics|858-465-6142|info@aristeatx.com|
22412692|NCT03433430|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
22412693|NCT03249584|MedtronicNeuro|Eric Grovender|763-514-4000|eric.a.grovender@medtronic.com|
22412694|NCT03124966|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
22412695|NCT00147030|National Perinatal Epidemiology Unit, University of Oxford|Director of NPEU Clinical Trials Unit|01865 289700|ctu@npeu.ox.ac.uk|89728
22412696|NCT03130699|Scripps Health|Athena Philis-Tsimikas, MD, Co-Principal Investigator|858-678-7045|philis-tsimikas.athena@scrippshealth.org|
22412697|NCT04534283|IndianaU|Dr. Anita Turk|(317) 274-0335|aaturk@iu.edu|
22412698|NCT00661505|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22412699|NCT05956665|Vanderbilt University School of Nursing|Jennifer Kim, DNP, GNP-BC|615-936-0739|jennifer.kim@vanderbilt.edu|
22446123|NCT04645953|Alexza Pharmaceuticals Inc.|Dan Myers, PhD, VP Product & R&D|(650) 210-6164|dmyers@alexza.com|
22446124|NCT04613375|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22446125|NCT03783949|UZLeuven|Ellen Reynders, SC|+3216342996|ellen.reynders@uzleuven.be|
22446126|NCT00434954|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22446127|NCT00002651|SWOG Statistical Center|Study Statistician|206-667-4623||
22446128|NCT01705730|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22446129|NCT01921387|Seattle Cancer Care Alliance|Ajay Kumar Gopal, MD, Director of Clinical Research|(206) 606-2037|agopal@uw.edu.org|
22412700|NCT00977470|Mass General Hospital Cancer Center|Maria Kempner|508-533-4132|mkempner@partners.org|
22412701|NCT05065502|VA Ann Arbor Health Care System|Jeremy Sussman, MD, MS, Corresponding Principal Investigator|N/A|Jeremy.Sussman@va.gov|
22412702|NCT03257462|Spruce Biosciences, Inc.|Spruce Clinical Trials|415-655-4169|clinicaltrials@sprucebio.com|
22412703|NCT00796822|Indiana University School of Medicine|Dr. Samir K. Gupta|317-274-7926|sgupta1@iu.edu|
22412704|NCT02096718|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22412705|NCT03682900|Oregon Research Behavioral Intervention Strategies, Inc.|Judy A. Andrews, Senior Scientist|541-484-2123|Judy.Andrews@Influentsin.com|
22412706|NCT06354270|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
22412707|NCT05097989|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1-855-752-2356|clinicaltrials@alexion.com|
22412708|NCT02809183|Tricida, Inc.|Medical Information|415-429-7800|medinfo@tricida.com|
22412709|NCT02933866|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
22412710|NCT00918567|SUNY Buffalo|James Waxmonsky M.D.|305 348 3258|jwaxmons@fiu.edu|
22412711|NCT02698800|Columbia University Medical Center|Dr. Ari Shechter, Principal Investigator|212-342-4487|as4874@cumc.columbia.edu|
22412712|NCT03283709|University of Kentucky|Hiroko Nagaoka|859-257-2101|h.nagaoka@uky.edu|
22412713|NCT05275998|TaiMed Biologics|Dr. Kuei-Ling Kuo|+886-2-26580058|kkuo@taimedbio.com|118
22412714|NCT00534703|Imperial College London|Dr Alexander Lyon|+442075943409|a.lyon@imperial.ac.uk|
22430011|NCT02134028|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22430012|NCT01210443|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22430013|NCT02719366|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
22430014|NCT02807181|Sirtex|Director, Clinical Research Operations|+1-888-474-7839|info-us@sirtex.com|
22430015|NCT02777190|Penn State Milton S. Hershey Medical Center|Dr. Jaimey Pauli|717-531-8142|jpauli@pennstatehealth.psu.edu|5
22430016|NCT01309100|Bausch & Lomb|Dr. Robert Steffen|585 338 6399|robert.steffen@bausch.com|
22430017|NCT03722030|University of Wisconsin - Madison|Dr. Lisa Cadmus-Bertram|608-262-1167|lisa.bertram@wisc.edu|
22430018|NCT00400205|Emory University Winship Cancer Institute|Nabil Saba, MD|1-888-946-7447|nfsaba@emory.edu|
22430019|NCT01663987|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22430020|NCT01829503|University of Pittsburgh Cancer Institute|Dr. Annie P. Im|412-623-2393|imap@upmc.edu|
22430021|NCT00468546|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22430022|NCT01783236|Weill Cornell Medicine|Hugh Hemmings, MD, PhD|212-746-2953|hchemmi@med.cornell.edu|
22430023|NCT04000724|Friends Research Institute, Inc.|Cathy Reback|3234631601|reback@friendsresearch.org|
22430024|NCT00455455|CCLR|Dr Craig A Woods|519 888 4567|cawoods@uwaterloo.ca|36547
22430025|NCT00472641|Stanford University School of Medicine|Dr. Po W. Wang|650-723-2483|wangp0@stanford.edu|
22430026|NCT00632970|Medical Faculty Associates|Gary Simon|202 741-2234|Gsimon@mfa.gwu.edu|
22430027|NCT00676689|Edwards Lifesciences|Sharanjeet Dhanjal|949-250-2083|sharanjeet_dhanjal@edwards.com|
22430028|NCT01827943|Institut Bergonie|Dr Nadine Houede, oncologist|05.56.33.33.33|nadine.HOUEDE@chu-nimes.fr|
22430029|NCT00501085|Apollo Endosurgery, Inc.|Laura Eaton, R.N., BSN, CCRN-R|949-468-9301|laura.eaton@apolloendo.com|
22430030|NCT01487161|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
22430031|NCT01084135|Duke University Medical Center|Jane Ann Baker,MS, CGC|919-668-4576|janeann.mckillop@duke.edu|
22430032|NCT00663351|Smith & Nephew, Inc.|Rachael Winter, Director, Global Clinical Operations|+44 1482 673475|rachael.winter@smith-nephew.com|
22430033|NCT02366130|UT MD Anderson Cancer Center|Dr. Naoto T Ueno, Professor, Breast Medical Oncology|(713) 792-8754|nueno@mdanderson.org|
22430034|NCT01065766|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-888-577-8839|ClinicalTrialsDisclosure@merck.com|
22430035|NCT00712075|VA San Diego Healthcare System, San Diego|Eric Granholm, PhD|858-552-8585|egranholm@ucsd.edu|7768
22430036|NCT04518410|ACTG Network Coordinating Center, DLH|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22430037|NCT05737745|Virginia Tech Carilion Clinic|Shannon Armbruster MD, MPH|540-581-0160|sdarmbruster@carilionclinic.org|
22430038|NCT02569242|Ono Pharmaceutical Co. Ltd|Medical Information Center|ー|clinical_trial@ono.co.jp|
22430039|NCT02057666|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22430040|NCT05661734|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22446130|NCT01773733|"FEDERAL STATE BUDGETARY INSTITUTION ENDOCRINOLOGY RESEARCH CENTRE MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION"|Prof. Ivan I . Dedov, Director of the Endocrinology Research Centre|+7 499 124 4300|dedov@endocrincentr.ru|
22446131|NCT01315665|Riley Hospital for Children|James Chmiel|317-948-7180|jfchmiel@iu.edu|
22446132|NCT00762229|Bronx VA Medical Center|Dr. Lawrence Baruch|718-584-9000|lawrence.baruch@va.gov|6776
22446133|NCT02096731|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22446134|NCT01439633|Massachusetts General Hospital|Gary Tearney, PI|617-724-2979|gtearney@partners.org|
22446135|NCT01081678|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22446136|NCT00727636|Children's Hospital Boston|Dr. Athos Bousvaros|617-355-2962|athos.bousvaros@childrens.harvard.edu|
22446137|NCT01619423|PledPharma AB|Stefan Carlsson, MD, PhD, Chief Medical Officer|+46 8 679 72 10|stefan.carlsson@pledpharma.se|
22412715|NCT00582400|University of Texas Medical Branch at Galveston|Dr. Avi B. Markowitz|4097721164|abmarkow@utmb.edu|
22412716|NCT01936948|White River Junction VA Medical Center|Heiko Pohl|802-295-9363|heiko.pohl@va.gov|5591
22399023|NCT02482129|Alcon, A Novartis Division|Ophthalmology & Medical Lead, Translational Medicine, NIBR|1-888-451-3937|alcon.medinfo@alcon.com|
22399024|NCT04247425|Oregon Health & Science University|Lara Davis, MD|5034948423|davisla@ohsu.edu|
22399025|NCT02247193|The University of Texas Health Science Center at Houston|Matthew R. Greives, MD|713-500-7275|Matthew.R.Greives@uth.tmc.edu|
22399026|NCT00762515|Colgate Palmolive Co.|William Devizio|732-878-7901|William_Devizio@colpal.com|
22399027|NCT00692211|New Mexico VA Health Care System|Richard Hoffman, MD|505-265-1711|richard.hoffman2@va.gov|5318
22399028|NCT01879345|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22412717|NCT01988922|Washington University in St. Louis School of Medicine|Dr. Lesley K Rao|3143690683|raol@wustl.edu|
22412718|NCT02327130|Isomark, LLC|Dr. Daniel Butz, Chief Scientific Officer|(608) 561-1895|daniel.butz@isomark.com|
22412719|NCT00493831|University of Nebraska Medical Center|Stephen Rennard|402-559-7313|srennard@unmc.edu|
22412720|NCT04028843|Pennington Biomedical Research Center|Dr. Leanne Redman|2257630947|Leanne.Redman@pbrc.edu|
22412721|NCT01347710|Lantheus Medical Imaging|CMO|978-671-8544|c.orlandi@lantheus.com|
22412722|NCT01600495|University of São Paulo.|Prof. Alessandra Cristina Marcolin|Tel.: (16) 36022587|dralemar@uol.com.br|55 +
22412723|NCT00615784|abramsoncc, University of Pennsylvania|Harjeet Sembhi, research program director|215-220-9688|harjeet.sembhi@pennmedicine.upenn.edu|
22412724|NCT01434342|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
22412725|NCT03676803|UCLA Center for Human Nutrition|Zhaoping Li, MD, PhD|310-206-1987|zli@medent.ucla.edu|
22412726|NCT02003183|UCLA Semel Institute for Neuroscience and Human Behavior|Dr. Gary Small|3108250291|gsmall@mednet.ucla.edu|
22430041|NCT03259308|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22412727|NCT00841100|University of Miami|Judy Schaechter|305-243-3993|JSchaech@med.miami.edu|
22412728|NCT03338972|Fred Hutchinson Cancer Center|Dr. Damian Green|2066675398|dgreen@fredhutch.org|
22412729|NCT01355081|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22412730|NCT02589171|The University of Texas Health Science Center at Houston|Associate Professor|(713) 500-7277|Shinil.K.Shah@uth.tmc.edu|
22412731|NCT02719522|Medtronic Neurovascular|Claudia Campo|0039 0224137325|claudia.campo@medtronic.com|
22412732|NCT01868009|GlaxoSmithKline|GSK Response Center|866-435-7343||
22412733|NCT02352298|Barbara Davis Center for Childhood Diabetes|Dr. Satish K. Garg|303-724-6761|satish.garg@ucdenver.edu|
22412734|NCT01451762|Northwestern University|Gildasio De Oliveira MD|312-472-3573|g-jr@northwestern.edu|
22412735|NCT03348423|Baudax Bio, Inc.|Development|484-395-2440|info@baudaxbio.com|
22412736|NCT00373217|University of Virginia|Craig Slingluff MD, Professor of Surgery|4349249311|cls8h@virginia.edu|
22412737|NCT00934934|CERU Queens University|Dr.Daren Heyland|403-915-5573|dkh2@queensu.ca|
22412738|NCT04349917|University of North Carolina at Chapel Hill|Jessica R. Cohen, PhD|(919) 843-3753|jrcohen@unc.edu|
22412739|NCT00633399|Massachusetts General Hospital CNTI|George I Papakostas, M.D. - Scientific Director|6177266697|gpapakostas@partners.org|
22412740|NCT01137539|Michigan Institute of Women's Health|Salil Khandwala/Medical Director|313-982-0200||
22412741|NCT00441467|Eleison Pharmaceuticals|VP Clinical Development|6097211227|matthew.parris@eleison-pharma.com|
22412742|NCT03290326|BIDMC|Principal Investigator - Emiliano Santarnecchi|617-667-0326|esantarn@bidmc.harvard.edu|
22412743|NCT01042522|NRG Oncology|Christopher Purdy on behalf of Austin Miller PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
22412744|NCT01458561|CryoLife, Inc.|Scott B. Capps, Vice President, Clinical Research|770-419-3355|capps.scott@cryolife.com|
22412745|NCT04486066|VA Puget Sound|Dr. Tracy Simpson|(206) 277-3337|tracy.simpson@va.gov|
22412746|NCT00726739|Masonic Cancer Center, University of Minnesota|Arkadiusz Dudek, M.D.|612-624-0123|dudek002@umn.edu|
22412747|NCT00088829|Georgetown University Medical Center|Claudine Isaacs, MD|202-444-3677|isaacsc@georgetown.edu|
22412748|NCT02252562|Dartmouth-Hitchcock Medical Center|Matthew D. Koff, MD Staff Physician, Anesthesiology|(603) 650-5922|Matthew.D.Koff@hitchcock.org|
22412749|NCT02735174|Cincinnati Children's Hospital Medical Center|Theresa Guilbert, MD, MS|(513) 636-6771|Theresa.Guilbert@cchmc.org|
22412750|NCT02148302|SerenaGroup|Thomas E. Serena, MD|617-945-5225|serena@serenagroups.com|
22412751|NCT00525590|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22412752|NCT00708019|University of California, San Francisco|Christine Miaskowski|415-476-9407|chris.miaskowski@nursing.ucsf.edu|
22412753|NCT00369590|Adult Brain Tumor Consortium|Stuart A Grossman, MD Director of ABTC|410-955-8837|grossman@jhmi.edu|
22412754|NCT03830164|UT MD Anderson Cancer Center|Dr. Chad Tang, Associate Professor, Radiation Oncology Department|(713) 745-7179|ctang1@mdanderson.org|
22430042|NCT00066937|Johns Hopkins University|Jennifer Haythornthwaite|410-550-7985|jhaytho1@jhmi.edu|
22412755|NCT04099888|PCI Biotech AS|Chief Executive Officer|(+47) 67 11 54 00|post@pcibiotech.no|
22430043|NCT01807104|VOA Research Foundation|Dr. William P. Barrett, MD|425-656-5060|wpbarrett@comcast.net|3063
22446138|NCT04159571|Wake Forest University School of Medicine|Merideth Addicott, PhD|336-716-7792|maddicot@wakehealth.edu|
22446139|NCT01281865|Memorial Sloan-Kettering Cancer Center|Dr. Mary Keohan|646-888-4160|keohanm@mskcc.org|
22446140|NCT05673889|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22446141|NCT03478657|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22446142|NCT04891978|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22446143|NCT01776840|Janssen Research & Development, LLC|EXECUTIVE MEDICAL DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22446144|NCT05338216|Northeastern University|Dr. Erin Meier|1 (617) 373-7438|e.meier@northeastern.edu|
22446145|NCT01004705|Ferrer Internacional S.A.|Natalia Oudovenko|+34 93 509 32 82|noudovenko-research@ferrergrupo.com|
22385033|NCT04768569|Washington University in St. Louis|Dr. Craig Buchman, Lindburg Professor & Chair, Department of Otolaryngology-Head & Neck Surgery|314-362-2914|buchmanc@wustl.edu|
22446146|NCT02589405|Galderma R&D|Stephanie Leclerc|492386706|stephanie.leclerc@galderma.com|+33
22446147|NCT02693119|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-(617) 600-6888|jim.carr@stealthbt.com|
22446148|NCT01719783|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22446149|NCT01350492|William S. Middleton Memorial Veterans Hospital|Aaron J. Stegner, Ph.D.|608-262-1290|aaron.stegner@va.gov|
22446150|NCT00753766|VA Boston Healthcare System|Paul R. Conlin, M.D.|8572035111|paul.conlin@va.gov|
22385034|NCT05473234|UCSF FI Proctor|Dr. Catherine E. Oldenburg|415-502-8843|catherine.oldenburg@ucsf.edu|
22446151|NCT00120523|MEDA Pharma GmbH & Co. KG|Clinical Research|+49 6172 888|clinical.research@medapharma.de|01
22446152|NCT03800173|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
22385035|NCT03457142|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-2300|Kris.Attwood@roswellpark.org|
22446153|NCT02149719|Imperial College London|Dr Paul Turner|+44 20 3312 7754|p.turner@imperial.ac.uk|
22446154|NCT00932126|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22446155|NCT02127710|AstraZeneca|Senior Medical Director, Savolitinib||ClinicalTrialTransparency@astrazeneca.com|
22446156|NCT04718961|Mirum Pharmaceuticals|Mirum Clinical Trials|650-667-4085|medinfo@mirumpharma.com|
22446157|NCT02121522|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22446158|NCT01235689|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
22446159|NCT00806351|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22446160|NCT03763175|MAST Program|Director of Clinical Trials|(310) 423-0617|GroupMedicineMAST@cshs.org|
22446161|NCT00672646|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22446162|NCT00289783|GlaxoSmithKline|GSK Response Center|866-435-7343||
22385036|NCT04060654|Indivior Inc|Sunita Shinde|804 379-1090|sunita.shinde@indivior.com|
22385037|NCT03707951|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
22430044|NCT01251965|The University of Texas (UT) MD Anderson Cancer Center|Srdan Verstovsek, Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
22430045|NCT01027754|Albert Einstein College of Medicine/Montefiore Medical Center|Dr. Shadi Nahvi|718 920 5379|SNAHVI@montefiore.org|
22385038|NCT04294290|Duke University|Joanne Kurtzberg, MD|919-668-1119|joanne.kurtzberg@duke.edu|
22385039|NCT01999075|CHEO Research Institute|Dr. Sherri Katz (Principal Investigator)|613-737-7600|skatz@cheo.on.ca|2956
22446163|NCT05248867|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22446164|NCT03704467|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22446165|NCT03128411|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22446166|NCT05544734|Weill Cornell Medicine|Dr Shari Lipner|6469623376|shl9032@med.cornell.edu|
22446167|NCT03749447|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22446168|NCT04096963|Boston Scientific Corperation|Associate Clinical Trial Manager|+861085742971|yifan.zhao@bsci.com|
22446169|NCT01673867|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22446170|NCT02550106|Novartis Pharmaceuticals|Study Director|(862) 778-8300||
22446171|NCT01543958|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22446172|NCT00926328|Colgate Palmolive|William De Vizio, DMD|732-878-7901|William_Devizio@colpal.com|
22446173|NCT00726986|Case Comprehensive Cancer Center|Afshin Dowlati MD|216-844-1228|afshin.dowlati@uhhospitals.org|
22446174|NCT00681083|Fisher & Paykel Healthcare|Hansinie Laing|+64 9 574 0123|CPAP.TRIAL@fphcare.co.nz|8601
22446175|NCT01513343|Baylor College of Medicine|Dr. Sheryl O. Hughes, Associate Professor|713-798-7017|shughes@bcm.edu|
22446176|NCT00599924|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22446177|NCT02587234|University of Kentucky|Lumy Sawaki, MD, PhD||lumy.sawaki@uky.edu|
22446178|NCT02165215|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22446179|NCT01877265|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22446180|NCT01947582|University of Texas Southwestern Medical Center|Karen McCain, PT, DPT, NCS, Principal Investigator|214-648-1559|karen.mccain@utsouthwestern.edu|
22446181|NCT00592384|University of Washington|Dr. Jesse R. Fann|206 6854280|fann@uw.edu|
22446182|NCT01468012|New York State Psychiatric Institute|Adam Bisaga|646-774-6155|bisagaa@nyspi.columbia.edu|
22446183|NCT01153347|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22385040|NCT04750525|The University of Texas Health Science Center at Houston|Sheng Li, MD, PhD|713-797-7125|sheng.li@uth.tmc.edu|
22446184|NCT01539694|Bausch Health|Study Director||robert.steffen@bausch.com|
22446185|NCT04401423|Columbia University Irving Medical Center|Dr. Jeanine D'Armiento / Principal Investigator|212-305-3745|jmd12@cumc.columbia.edu|
22446186|NCT00003473|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22446187|NCT04678661|University of Pittsburgh|Dr. Linda Siminerio|412-559-0359|similx@upmc.edu|
22446188|NCT02643381|UT-Southwestern Medical Center|Gerald Matchett|214-648-6400|gerald.matchett@utsouthwestern.edu|
22385041|NCT04606069|University of Maryland Medical Center|Dr. Christine Lau, MD, MBA, Department of Surgery, Surgeon-in-Chief|410-328-8407|CLLau@som.umaryland.edu|
22446189|NCT03039283|Cochlear|Nicole Neben|+4951154277220|nneben@cochlear.com|
22446190|NCT01086033|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22446191|NCT02193867|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22446192|NCT03639935|University of Michigan Rogel Cancer Center|ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
22446193|NCT02924571|NYU Langone Health|Themistocles Protopsaltis|646-501-7200|themistocles.protopsaltis@nyulangone.org|
22446194|NCT00864721|Ocala Oncology, Ocala, FL, USA|Dr. Craig Reynolds|352-732-4032|Craig.Reynolds@USOncology.com|
22446195|NCT00187200|St. Jude Medical|Ashish Oza|(818) 493-3648|aoza@sjm.com|
22385042|NCT04896476|Sonavex|Katy Feeny, Director of Clinical Affairs|443-862-2024|KFEENY@SONAVEX.COM|
22385043|NCT03662698|University of Colorado Hospital|Jamie Studts|303-724-2284|jamie.studts@cuanschutz.edu|
22446196|NCT00261807|U. of Maryland Medical Systems, R Adams Cowley Shock Trauma Center|Dr. Manjari Joshi|410-328-3656|mjoshi@som.umaryland.edu|
22446197|NCT03992014|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22446198|NCT03416946|Orthopaedic Innovation Centre|Trevor Gascoyne|204-926-1235|tgascoyne@orthoinno.com|
22446199|NCT00900237|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22446200|NCT01610570|National Cancer Institute|Dr. Brigitte Widemann|301-496-7387|widemanb@mail.nih.gov|
22446201|NCT02590003|Yale University|Rogerio C. Lilenbaum, MD, Professor of Medicine (Medical Oncology); Chief Medical Officer of Smilow|(203) 200-5864|rogerio.lilenbaum@yale.edu|
22446202|NCT03733470|University of Iowa|Eric Hoffman, PhD|319-365-1381|eric-hoffman@uiowa.edu|
22446203|NCT02983825|University of Pennsylvania|Nicolas Bamat, MD MSCE|2155904010|bamatn@email.chop.edu|
22446204|NCT02989545|Shaare Zedek Medical Center|Dr. Dan Livovsky|+972525622398|danlivo@szmc.org.il|
22446205|NCT04457336|Spruce Biosciences|Dina Ayala-Jones, Associate Director, Clinical Development Operations|424.558.1211|djones@sprucebio.com|
22385044|NCT05260684|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22446206|NCT01554683|Beth Israel Deaconess Medical Center|Dr. Daniel Press|617-667-4074|dpress@bidmc.harvard.edu|
22385045|NCT05268393|Children's National Hospital|Dr. Eleanor Mackey|202-476-5307|emackey@childrensnational.org|
22446207|NCT04208997|Vanderbilt University Medical Center|Dr Giovanni Davogustto|6159361720|giovanni.e.davogustto@vumc.org|
22385046|NCT01728857|Zeltiq Aesthetics|Sally Hallas, RN, Director Clinical Development - Body Contouring|209-294-5571|sally.hallas@abbvie.com|
22446208|NCT00446251|University of Washington|Dr. Connie L. Davis|206-598-6079|cdavis@u.washington.edu|
22446209|NCT02506465|Medi-Tate / Olympus|Sivan Baker|+97247701839|sivan.baker@olympus.com|
22446210|NCT00381550|Sidney Kimmel Comprehensive Cancer Center|Michael McDevitt, MD PhD|410-955-9175|mmcdev1@jhmi.edu|
22446211|NCT01416272|Bausch & Lomb / Valeant Pharmaceuticals|Robert Steffen, OD, MS|585-338-6399|robert.steffen@bausch.com|
22385047|NCT00999804|Baylor College of Medicine|Dr. Mothaffar Rimawi|7137981311|rimawi@bcm.edu|
22446212|NCT00702689|National Institute of Arthritis and Musculoskeletal and Skin Diseases|Edward Cowen, M.D.|301-827-2328|cowene@mail.nih.gov|
22399029|NCT00670007|CSL Behring|Clinical Trial Disclosure Manager|Use Email contact|clinicaltrials@cslbehring.com|
22446213|NCT01833988|Massachusetts General Hospital Diabetes Research Center|Dr. Steven J. Russell|617.726.1848|sjrussell@partners.org|
22399030|NCT00618722|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
22446214|NCT01986907|Novartis Pharmaceuticals|Study Director|+41613241111|trialandresults.registries@novartis.com|
22399031|NCT00925600|Amgen Inc.|Study Director|866-572-6436||
22446215|NCT03993132|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
22446216|NCT00239590|Imperial College London|Dr Carolyn Webb|03301288860|c.webb@imperial.ac.uk|
22399032|NCT00624221|Cornea Research Foundation of America|Marianne O. Price, PhD|317-814-2990|mprice@cornea.org|
22446217|NCT02169479|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22446218|NCT00892047|University of Pittsburgh|Charles F. Reynolds III, MD|412-246-6414|reynoldscf@upmc.edu|
22446219|NCT02217878|Collegium Medicum, Nicolaus Copernicus University|Prof. Jacek Kubica|+485854023|jkubica@cm.umk.pl|
22446220|NCT03407625|University of Texas Southwestern Medical Center|Emily Adhikari, MD|214-648-7825|emily.adhikari@utsouthwestern.edu|
22446221|NCT00259610|University of Alabama at Birmingham|Dr. Jeffrey R. Curtis,|205-934-7733|jcurtis@uab.edu|
22446222|NCT02028754|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22446223|NCT03351933|Grifols Therapeutics LLC|Rhonda Griffin|919-316-6693|rhonda.griffin@grifols.com|
22446224|NCT01201785|University of Florida-Jacksonville|Dominick J. Angiolillo, MD, PhD|904-244-3933|dominick.angiolillo@jax.ufl.edu|
22446225|NCT02151110|MedImmune LLC|David Howe, MBChB, MD, MRCOG|+44 (0) 1223 895980|information.center@astrazenea.com|
22446226|NCT01999179|Versiti|Dr Lisa Baumann Kreuziger|414-937-6826|lisakreuziger@versiti.org|
22446227|NCT01146665|University of Alberta|Dr. Amanda Newton|780-248-5581|an6@ualberta.ca|
22446228|NCT01586065|Nemours Children's Health|Larry A Fox, MD|9046973600|larry.fox@nemours.org|
22446229|NCT02538029|Cleveland Clinic|Dr. Jay Alberts|216 445-3222|albertj@ccf.org|
22446230|NCT02403986|Q-Med AB|Cecilia Skoglund, Manager Study strategy and publications|46 18 474 9000|cecilia.skoglund@galderma.com|
22446231|NCT01064310|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22446232|NCT00001880|National Heart Lung and Blood Institute (NHLBI)|Richard Childs, M.D. Principal Investigator, NIH, NHLBI|301.451.7128|childsr@nhlbi.nih.gov|
22446233|NCT02639065|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
22446234|NCT02383498|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22446235|NCT00660699|Washington University School of Medicine|Benjamin Tan, M.D.|314-362-5740|btan@dom.wustl.edu|
22446236|NCT05147428|UMass Chan Medical School|Jerry H. Gurwitz, MD|508-856-3085|jerry.gurwitz@umassmed.edu|
22446237|NCT03128047|Hackensack Meridian Health|Jeanette Haugh|5519963457|Jeanette.haugh@hmhn.org|
22446238|NCT05996718|Georgia State University|Candace L. Kemp|404-413-5216|ckemp@gsu.edu|
22446239|NCT01713686|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
22446240|NCT02385045|Imperial College London|Professor Julian Teare|02033126666|j.teare@ic.ac.uk|
22446241|NCT00115739|University of Michigan Comprehensive Cancer Center|Frances Worden, M.D.|(734) 615-6633|fworden@umich.edu|
22446242|NCT01637935|Takeda|Head, Pharmacoepidemiology|+1-877-825-3327|trialdisclosures@takeda.com|
22446243|NCT00595530|Connecticut Children's Medical Center|Dr. William T. Zempsky|860-837-5207|wzempsk@ConnecticutChildrens.org|
22446244|NCT02200211|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
22446245|NCT00381485|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@spcorp.com|
22446246|NCT01235351|TIMI Study Group|Jessica L. Mega, MD, MPH|6172780145|jmega@partners.org|
22446247|NCT00745823|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1- 800-672-6372|ClinicalTrialsDisclosure@merck.com|
22446248|NCT00651794|University of Texas HSC-Houston|Dr. Eric Thomas|713-500-7958|Eric.Thomas@uth.tmc.edu|
22446249|NCT01206660|Taro Pharmaceuticals U.S.A., Inc.|Director, Clinical Research|914-345-9001|natalie.yantovskiy@taro.com|
22446250|NCT01633853|Peking University Internetional Hospital|Dr. Zhang Dongliang|+86-10-69006561|zhangdongliang@pkuih.edu.cn|
22446251|NCT01661621|Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University|Dr. Hann-Chorng Kuo|886-3-8561825|hck@tzuchi.com.tw|2113
22446252|NCT01258582|Massachusetts General Hospital|Rochelle P. Walensky, MD, MPH|(617) 724-8445|rwalensky@partners.org|
22446253|NCT02980601|Wake Forest Baptist Health|Joseph Molnar|336-716-4171|jmolnar@wakehealth.edu|
22446254|NCT01575769|Hoffmann-LaRoche or Genentech, Inc|Medical Communications|800 821-8590|genentech@druginfo.com|
22446255|NCT00290888|Pan Am Clinic|Dr. Peter MacDonald|204-925-7480|pmacdonald@panamclinic.com|
22446256|NCT02501473|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22446257|NCT01473836|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22446258|NCT01709513|Regeneron Pharmaceuticals, Inc|Clinical Trial Administrator||clinicaltrials@regeneron.com|
22446259|NCT02954237|Abbott|Jordan Anderson, Clinical Scientist|651-756-3360|ClinicalTrials.gov_SH_Inquiries@abbott.com|
22446260|NCT01034631|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
22446261|NCT04218695|BIDMC|Dr. Zachary Fricker|6176321070|zfricker@bidmc.harvard.edu|
22446262|NCT03166735|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22446263|NCT00799383|Baylor College of Medicine|Chadi Calarge, MD|832-824-4764|chadi.calarge@bcm.edu|
22446264|NCT01292746|Regulatory Insight, Inc.|Clinical Consultant|615-712-9743|elvira@reginsight.com|
22446265|NCT01259128|Serenity Pharmaceuticals|Chief Medical Officer|8456396760|sfein@serenitypharma.com|17
22446266|NCT03119831|Department of Periodontology, School of Dentistry, National and Kapodistrian University of Athens, Greece|Dr. Anastasios M. Gkatzonis|6976486314|gkatzonis.tasos@gmail.com|0030
22446267|NCT01227434|University of California San Francisco|Michael Prados, MD|4154767217|pradosm@neurosurg.ucsf.edu|
22446268|NCT02767843|California Center for Sleep Disorders|Jerrold Kram, MD|510.263.3300|info@californiasleepcenters.com|
22446269|NCT03486223|Vanderbilt University Medical Center|Dr. James M Luther|6153223353|james.luther@vumc.org|
22446270|NCT01023620|UT Southwestern Medical Center|Dr. Michael Limerick|214-590-0611|Michael.Limerick@UTSouthwestern.edu|
22446271|NCT05166824|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22446272|NCT01144286|Privatni gynekologicka ambulance|Vladimir Dvorak|+420 542 221 661|ssgcr@ti.cz|
22446273|NCT03068130|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22446274|NCT00590720|MedImmune|Joseph Parker, MD|301-398-0000|parkerj@medimmune.com|
22446275|NCT00905151|Tufts Medical Center|Associate Professor|617-636-2569|linker@tuftsmedicalcenter.org|
22446276|NCT01966159|Shenyang Northern Hospital (The General Hospital of Shenyang Military Region)|Dr. Hanyaling|024-28897310|hanyl@medmail.com.cn|
22446277|NCT00528788|Duke University Medical Center|Jula Inrig, MD|919-660-6882|Jula.Inrig@duke.edu|
22446278|NCT03741062|University of Manitoba|Dr. Brian Wiens|613-809-4501|wiensb3@myumanitoba.ca|
22446279|NCT02527161|Stryker SP|David Fulker|+61 2 9467 1072|david.fulker@stryker.com|
22446280|NCT02609828|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22446281|NCT01517711|University of Cincinnati College of Medicine|Dr. Thomas Geracioti, Principle Investigator|513-748-9825|thomas.geracioti@uc.edu|
22446282|NCT01786668|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22446283|NCT01979445|The Medicines Company|Global Health Science Center, The Medicines Company|1-888-977-6326|medical.information@themedco.com|
22446284|NCT03068455|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22446285|NCT05379231|National Centre for Audiology|Dr. Susan Scollie|519 661-2111|scollie@nca.uwo.ca|88948
22446286|NCT01496807|H. Lee Moffitt Cancer Center and Research Institute|Dr. Andrew Brohl|813-745-3242|andrew.brohl@moffitt.org|
22446287|NCT00692341|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|ClinicalTrials.gov_Inquiries@pfizer.com|
22446288|NCT04600375|University of Arkansas for Medical Sciences|Dr. Vivian Shi|5015266994|VYShi@uams.edu|
22446289|NCT03330288|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22446290|NCT01117948|JSW-Lifesciences|Director of Clinical Trials|0043316 258111|office@jsw-lifesciences.com|310
22446291|NCT01172522|ConnecticutSC|Edward M. Lane|2033720009|EMLMD@msn.com|
22446292|NCT02805972|University of California San Francisco|Ashley Mason, PhD|415 514 6820|ashley.mason@ucsf.edu|
22446293|NCT00644657|University of Oklahoma Health Sciences Center|Eliot Schechter, MD|405-456-5378|eliot-schechter@ouhsc.edu|
22446294|NCT00939640|University of Michigan|Dr. Scott Hummel|734-998-7991|scothumm@med.umich.edu|
22446295|NCT01809106|Mario Negri Institution|Dr. Oscar Corli|+390239014564|oscar.corli@marionegri.it|
22446296|NCT01706978|The Ottawa Hospital Research Institute|Dr. Peter Lapner|613-737-8899|plapner@toh.ca|78377
22446297|NCT00389597|LDR Spine|Noah Bartsch, VP, Clinical,Regulatory,Quality|512-344-3319|noah.bartsch@ldrspine.com|
22446298|NCT00334958|Eisai Medical Services|Eisai Inc.|1-888-422-4743|esi_medinfo@eisai.com|
22446299|NCT00306189|Amgen Inc.|Study Director|866-572-6436||
22446300|NCT01548287|AstraZeneca Pharmaceuticals LP, Neuroscience iMed|Joel Posener, MD||clinicaltrialtransparency@astrazeneca.net|
22446301|NCT01957930|Karolinska Institutet Södersjukhuset|Thomas Nyström|+46704325214|thomas.nystrom@sodersjukhuset.se|
22446302|NCT00353795|NIH|David Bluemke|301 402 1854|bluemked@nih.gov|
22446303|NCT02762578|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22446304|NCT02083965|Bioverativ|Bioverativ Study Medical Director||clinicaltrials@bioverativ.com|
22446305|NCT00282984|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22446306|NCT00674362|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22446307|NCT02653183|Universitair Ziekenhuis Gent|Prof. Dr. Hilde Beele|+32 9 332 21 11|Hilde.Beele@uzgent.be|
22446308|NCT00939770|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22446309|NCT04665856|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22446310|NCT03386448|The Taub Group|Neal Taub MD|7044429805|nealtaub@gmail.com|
22446311|NCT02564796|UC San Diego|Dr. David Werho|(858) 966-5855|dwerho@rchsd.org|
22446312|NCT00114530|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22446313|NCT02450591|Memorial Sloan Kettering Cancer Center|Dr. Helena Yu, MD|646-888-4274|YuH@mskcc.org|
22446314|NCT01466153|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazenca.com|
22446315|NCT03483740|University of Toronto|Andrew Eaton|4169788895|andrew.eaton@utoronto.ca|
22446316|NCT00688753|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22446317|NCT04147221|Center for Anti Infective Research and Development|Dr. Joseph L. Kuti|860-972-3612|joseph.kuti@hhchealth.org|
22446318|NCT02342327|University of Minnesota|Michael Kotlyar|612-625-1160|kotly001@umn.edu|
22446319|NCT01700725|University of Wisconsin - Madison|David Rabago, MD|608-843-0850|david.rabago@fammed.wisc.edu|
22446320|NCT00666029|University Hospital Southampton|Professor Christopher Byrne|+44 238120 5006|cdtb@soton.ac.uk|
22446321|NCT03192462|Baylor College of Medicine|Dr. Benjamin Musher|(713)798-3750|blmusher@bcm.edu|
22446322|NCT00809276|SKCCC|Leo Luznik, MD|410-502-7732|lluznik2@jhmi.edu|
22446323|NCT03187197|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22446324|NCT04840615|National Cancer Institute|Dr. Raffit Hassan|240760-6232|rh276q@nih.gov|
22446325|NCT00259649|University of Pittsburgh|Dawn marcus|412-953-4797|marcusd@upmc.edu|
22446326|NCT00982137|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22446327|NCT00126191|DFCI|Ann LaCasce, MD|617-632-5959|ALACASCE@PARTNERS.ORG|
22446328|NCT02140372|NYU School of Medicine|Binita Shah|212-263-4235|binita.shah@nyumc.org|
22446329|NCT02519036|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
22446330|NCT03576976|New York State Psychiatric Institute|Dr. Alice Medalia|646-774-8482|am2938@cumc.columbia.edu|
22446331|NCT00300391|UPittsburgh|Barb Early, RN, BSN, CCRC|(412) 647-9745|earlybj@upmc.edu|
22446332|NCT00674700|Stallergenes|Michel Roux, Medical Director|+33 1 55 59 2970|mroux@stallergenes.com|
22446333|NCT00842608|Regenstrief Institute, Inc.|Dr. Malaz Boustani|(317) 274-9235|mboustan@iu.edu|
22446334|NCT01335191|Thymon LLC|Dr. Gideon Goldstein|(973) 467-9558|gidgold@gmail.com|
22446335|NCT02417831|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22446336|NCT00621985|Children's Hospital Boston|Joseph Majzoub|617-355-7476|joseph.majzoub@childrens.harvard.edu|
22446337|NCT01806298|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22446338|NCT01738321|Nationwide Children's Hospital|Senthil Krishna, MD|614-722-4200|Senthil.Krishna@nationwidechildrens.org|
22446339|NCT01001377|Amgen Inc.|Study Director|866-572-6436||
22446340|NCT04343261|Saint Francis Hospital and Medical Center|Latha Dulipsingh, MD|860-714-4402|Latha.Dulipsingh@trinityhealthofne.org|
22446341|NCT02849678|University of Pittsburgh Medical Center Department of Anesthesiology|Jacques E. Chelly, MD, PhD, MBA|412-623-6382|chelje@anes.upmc.edu|
22446342|NCT00289991|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22446343|NCT04447794|University of Alaska Anchorage|Dr. Patrick Dulin|(907) 786-1653|pldulin@alaska.edu|
22446344|NCT00205881|Advanced Bionics, LLC|Kenneth Ripley|(661) 362-4572|Kenneth.Ripley@advancedbionics.com|
22446345|NCT03463512|Abbott|Suntje Sander|+495116750|suntje.sander@abbott.com|3254
22399033|NCT04785612|hVIVO|Alex Mann|+44(0)7738321671|a.mann@hvivo.com|
22446346|NCT01202565|AbbVie|Global Medical Services|800-633-9110||
22399034|NCT00127127|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22399035|NCT00200057|Medtronic Neuromodulation|Chad Giese|763-377-5955|chad.giese@medtronic.com|
22399036|NCT03652909|Ascending Hearing Technologies, LLC|Christina Runge|2623523478|chrunge@mcw.edu|
22399037|NCT01059448|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22446347|NCT01090492|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22399038|NCT01390389|McLean Hospital|Cara McCabe|617-855-2410|cfmccabe@partners.org|
22399039|NCT00778830|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22399040|NCT05512949|St. Louis University|Sharon E. Frey, M.D.|314-977-5500|sharon.frey@health.slu.edu|
22399041|NCT03593915|Sumitomo Oncology|Holly Beever|210-365-9014|holly.beever@oncology.sumitomo-pharma.com|
22399042|NCT01583179|University of Wisconsin-Madison|Melanie Donnelly|720-848-0000|melanie.donnelly@ucdenver.edu|
22399043|NCT01246206|Barbara Ann Karmanos Cancer Institute|Dr. Zaid Al-Kadhimi|800-527-6266|zalkadh@emory.edu|
22399044|NCT02002975|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22399045|NCT03988907|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22399046|NCT02810964|Sheppard Pratt|Dr. Faith Dickerson|410-938-4359|fdickerson@sheppardpratt.org|
22399047|NCT03523351|Memorial Sloan Kettering Cancer Center|Dr. Divya Yerramilli, MD|646-449-1931|yerramid@mskcc.org|
22446348|NCT00929383|Stryker Neurovascular|David Hess, Manager Clinical Affairs|1-510-413-2642|david.hess@stryker.com|
22446349|NCT02718157|GenePOC|Dr Keith Chiasson, PhD|418-650-3535|keith.chiasson@genepoc.ca|322
22446350|NCT00868608|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22446351|NCT00911547|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22446352|NCT00457301|Lung transplant program, University of Alberta Hospital|Maria Jose Santana|780-441-1661|msantana@ualberta.ca|
22446353|NCT00191269|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22446354|NCT00941005|University of Wisconsin - Madison|Jeffrey Larson, MD|(608) 417-6175|larsonjef@surgery.wisc.edu|
22446355|NCT03583697|BioMarin Pharmaceutical Inc.|Alice Huntsman Labed|+44 792-756-5104|alice.huntsmanlabed@bmrn.com|
22446356|NCT00365508|University of Pennsylvania|Robert Schnoll|215-746-7143|schnoll@mail.med.upenn.edu|
22446357|NCT02929667|University of Iowa|Dr. Rup Sainju|319-356-4337|rup-sainju@uiowa.edu|
22446358|NCT00404235|Mayo Clinic|Svetomir N. Markovic, MD, Ph.D|(507) 284-1370|markovic.svetomir@mayo.edu|
22446359|NCT00679432|Santarus, Inc.|Michael Huang, MD, Senior Medical Director, Clinical Research|8583145700|mhuang@santarus.com|
22399048|NCT03609619|Aevi Genomic Medicine|Garry A. Neil, MD|610-254-4208|garry.neil@aevigenomics.com|
22399049|NCT00688909|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22399050|NCT03065179|UT Southwestern Medical Center|Dr. Hans Hammers|214/645-7445|Hans.Hammers@UTSouthwestern.edu|
22399051|NCT02472847|University of Illinois at Chicago|Dr. K. Luan Phan|312-355-5954|klphan@psych.uic.edu|
22399052|NCT04656990|University of South Carolina|Director, USC Office of Research Compliance|803 777-6670|lisaj@mailbox.sc.edu|
22399053|NCT03244059|University of Alabama at Birmingham|Mark Dransfield MD|205-934-5425|mdransfield@uabmc.edu|
22399054|NCT00806221|Oregon Health & Science University|Eric Simpson, MD, MCR|503-494-2121|simpsone@ohsu.edu|
22399055|NCT03657459|Cleveland Clinic|Nancy M. Albert PhD, CCNS, CHFN, CCRN, NE-BC, FAHA, FCCM, FHFSA, FAAN|216-444-7028|albertn@ccf.org|47028
22399056|NCT05499520|University of Pennsylvania|Andy Tan|2157466546|andy.tan@asc.upenn.edu|
22399057|NCT01613326|Novartis Pharmaceuticals|Study Director|4 161 324 1111||
22399058|NCT00793793|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22399059|NCT00840827|Weill Cornell Medicine|Clinical Trials Administrator|212-746-0284|ray2013@med.cornell.edu|
22399060|NCT01940484|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22399061|NCT00358657|Fred Hutchinson Cancer Research Center|Dr. Kanwaldeep Mallhi|206-667-2014|kmallhi@fredhutch.org|
22399062|NCT01044966|Medical University of South Carolina|Dr. Bruce Frankel|8437922052|frankel@musc.edu|
22399063|NCT02658448|Oncternal|Mary Breitmeyer|858-434-1113|MBreitmeyer@oncternal.com|
22399064|NCT00584194|USAMRIID Medical Division|Janice Rusnak, MD|301-619-4156|janice.rusnak@amedd.army.mil|
22399065|NCT00331409|Oregon Health and Science University|Christopher W. Ryan|503-494-1951|ryanc@ohsu.edu|
22399066|NCT01482910|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22399067|NCT02614079|University of Toledo Medical Center|Joseph Atallah, MD|419-383-6699|joseph.atallah@utoledo.edu|
22399068|NCT01961544|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
22399069|NCT00923117|National Cancer Institute, National Institutes of Health|Dr. Teri Kreisl|301-402-3423|kreislt@mail.nih.gov|
22399070|NCT03665285|NextCure, Inc.|Chief Medical Officer|(240) 399-4900|NCClin@nextcure.com|
22399071|NCT03157531|Eximo Medical|Oshrat Cohen|97286307639|oshratc@eximomedical.com|
22399072|NCT03450083|Johns Hopkins University School of Medicine|Jody Tversky, MD|410-550-8017|hoddin1@jhmi.edu|
22399073|NCT01235962|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22399074|NCT03543410|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
22399075|NCT01727258|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
22399076|NCT03640832|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22399077|NCT01318122|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
22399078|NCT02542761|Mayo Clinic|Kenton Kaufman, Ph.D.|507-266-0136|Kaufman.Kenton@mayo.edu|
22430046|NCT02529488|Alcon, A Novartis Division|Sr. Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22430047|NCT05033561|FIDEC Corporation|Ricardo Rüttimann|+5491161188536|rruttimann@fidec-online.org|
22430048|NCT00295503|UT Southwestern|Jonathan Dowell|214-648-4180|jonathan.dowell@utsouthwestern.edu|
22430049|NCT03453515|North Carolina State University|Dr. Laura Widman|919-513-2546|lmwidman@ncsu.edu|
22430050|NCT01557244|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22430051|NCT01313676|GlaxoSmithKline|GSK Response Center|866-435-7343||
22430052|NCT01654250|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22430053|NCT02596893|Celgene Corporation|Anne Mcclain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22430054|NCT03280615|Institute of Nutrition and Food Technology University of Chile|Dr. Francisco Perez Bravo, Director|+5629781411|fperez@inta.uchile.cl|
22430055|NCT00090402|Oregon Health & Science University|Lynne Shinto, ND, MPH|503-494-5035|shintol@ohsu.edu|
22430056|NCT01530256|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
22430057|NCT04334681|Principal investigator|Dr. Alpaslan Şahin|0332310500|drasahin@gmail.com|50510
22430058|NCT02327143|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22430059|NCT02123511|Mayo Clinic|Michele Halyard, M.D.; Robert Foote, M.D.|480-301-4567|mhalyard@mayo.edu; foote.robert@mayo.edu|
22430060|NCT02180672|The Children's Hospital of Philadelphia|Ignacio Tapia, MD, Principal Investigator, Associate Professor|(267) 426-5842|tapia@chop.edu|
22430061|NCT01133977|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22430062|NCT04498273|University of Pittsburgh|Dr. Frank Sciurba|412-648-6494|sciurbafc@upmc.edu|
22430063|NCT03615534|Al-Kindy College of Medicine, ////university of Baghdad|Lewai Sharki Abdulaziz|750 659 0024|lewaisharki@kmc.uobaghdad.edu.iq|+964
22430064|NCT05688657|CooperVision|Jose A. Vega, OD, MSc, FAAO|925-621-3761|jvega2@coopervision.com|
22446360|NCT00824720|Vistakon|Brian Schwam MD/Director Clinical Affairs & Ocular Sciences|904-443-1482||
22446361|NCT01289080|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22399079|NCT01738971|University of Edinburgh|Dr Lucy Michie|0131 5361542|michieluc@yahoo.co.uk|
22446362|NCT01558271|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22399080|NCT03219866|Wake Forest Health Science|Jill Ohar, MD|336-716-1210|johar@wakehealth.edu|
22446363|NCT02610725|Massachusetts General Hospital|Louisa G. Sylvia, Ph.D.|617-643-4804|lsylvia2@mgh.harvard.edu|
22446364|NCT04094883|University of North Carolina at Chapel Hill|Joseph Duncan, MD, PhD|919-966-2536|joseph_duncan@med.unc.edu|
22446365|NCT00743483|Swedish Orphan Biovitrum|Maria Öhman, TA Clinical Head Neonatology|+46 70 694 81 61|maria.ohman@sobi.com|
22446366|NCT01084083|ECOG-ACRIN Statistical Office|ECOG-ACRIN statistician|617-632-3012||
22446367|NCT02914119|Herlev Hospital, research unit, anesthesia|Dr. JLD Thomsen|004538633863|prs@demants.dk|
22446368|NCT00873912|MedImmune, LLC|Elissa Malkin, DO|301-398-0000|malkine@medimmune.com|
22446369|NCT03100500|Novartis Pharmaceuticals|Director|862-778-8300|novartis.email@novartis.com|
22446370|NCT02352974|4Pharma AB|Åsa Carlsheimer|+4672244516|asa.carlsheimer@4pharma.com|
22399081|NCT00578305|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22399082|NCT04698629|University of Washington|Dr. Judith Tsui|206-744-1835|tsuij@uw.edu|
22399083|NCT01821300|The Children's Hopsital of Philadelphia|Dr. Andrea Kelly|215590-3174|kellya@email.chop.edu|
22399084|NCT04663945|University of Colorado Denver|Dr. Jennifer Stevens-Lapsley|303.724.9170|PT.studies@cuanschutz.edu|
22399085|NCT06228586|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22399086|NCT02065453|Saint Louis University|M. Brigid Holloran-Schwartz, MD|314-781-8605|holloran@slu.edu|1
22399087|NCT03267004|University of Tennessee|Hollie Raynor|865-974-6259|hraynor@utk.edu|
22399088|NCT02490293|SeoulStmary's hospital|Tae-ho Hong|010-5206-5266|gshth@catholic.ac.kr|
22399089|NCT05556525|Mayo Clinic|Dr. Sebastian Fernandez-Bussy|904-953-6320|Fernandez-Bussy.Sebastian@mayo.edu|
22399090|NCT03694392|Kaiser Permanente Vaccine Study Center|Amber Hsiao Hyman, Senior Research Project Manger|510-267-7517|Amber.Hyman@kp.org|
22399091|NCT00865020|Novartis Pharmaceuticals|Study Director|862-778-8300||
22399092|NCT00947531|EVERNeuro Pharma|Head of R&D|+43 7665 20555|stefan.winter@everpharma.com|0
22399093|NCT03856944|Gainesville Eye Associates|Clayton Blehm, MD|770-532-4444|claytonblehm@gmail.com|
22399094|NCT02327260|University of Missouri, Kansas City|Dr. Kym Bennett|816-235-6370|bennettkk@umkc.edu|
22399095|NCT03502330|Harvey and Kate Cushing Professor of Medicine (Oncology) and of Dermatology; Director, Yale SPORE in Skin Cancer, Yale Cancer Center|Harriet Kluger, MD|(203) 200-6622|harriet.kluger@yale.edu|
22399096|NCT01936389|NYGRI|Jessica Jasien, MEn|2124777540|jjasien.ganyresearch@gmail.com|371
22399097|NCT01496157|Johns Hopkins University|Steven Rowe, M.D, Ph.D|4105021520|srowe8@jhmi.edu|
22399098|NCT01400932|GlaxoSmithKline|GSK Response Center|866-435-7343||
22399099|NCT01072409|University of Michigan|Teresa Zwolan, Ph.D.|(313) 618-9669|zwolan@umich.edu|
22399100|NCT03980938|EIP Pharma, Inc|Jennifer Conway|(617) 744-4400|jconway@eippharma.com|
22399101|NCT03580616|Dartmouth-Hitchcock Medical Center|Dr. Elijah Stommel|6036505104|elijah.w.stommel@hitchcock.org|
22399102|NCT03706365|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22399103|NCT00605267|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22399104|NCT00006227|NRG Oncology|Christopher Purdy on behalf of Mark Brady PhD|(716)845-1300|purdyc@nrgoncology.org|2296
22399105|NCT04557384|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22399106|NCT02932787|Sheffield Hallam University|Martin Lamb|01142552782|m.lamb@shu.ac.uk|
22430065|NCT02944461|Skin Sciences, PLLC|M. McAllister|5024519000|mmdermresearch@yahoo.com|
22430066|NCT02193347|Duke University|Katy Peters, M.D., Ph.D.|919-684-6173|katherine.peters@duke.edu|
22399107|NCT01175005|Phoenixchildrens|Amanda Kasem|6025461910|akasem@phoenixchildrens.com|
22385048|NCT05229146|Henry Ford Health|Dr. Julia Felton|313-598-0841|jfelton4@hfhs.org|
22385049|NCT01997840|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22446371|NCT01088997|Children's Hospital of Philadelphia|Haresh Kirpalani, MD, MSc|215-590-2455|kirpalanih@email.chop.edu|
22446372|NCT01703039|Brigham and Women's Hospital|Dr. Jessica Harder|617-525-7919|jaharder@bwh.harvard.edu|
22446373|NCT05570500|Ain Shams University|Dr. Omar Alaa Taqa|01001454416|o.a.taqa@hotmail.com|
22446374|NCT01095731|Columbia University Irving Medical Center|E. Sander Connolly Jr., MD|212-305-0376|esc5@cumc.columbia.edu|
22446375|NCT00147446|Northwestern University|David C. Mohr|312-503-3128|m.lisetteluistro@northwestern.edu|
22446376|NCT02302807|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22446377|NCT03000283|Allina Health|Dr. Jesse Corry|651-241-6550|Jesse.Corry@allina.com|
22446378|NCT03802227|Nektar Therapeutics|Study Director|415-482-5416|medicalaffairs@nektar.com|
22446379|NCT04731363|Cleveland Clinic Foundation|Dr. Stanley Hazen, MD|216-444-9426|hazens@ccf.org|
22446380|NCT01511315|UCSF Psoriasis Center|Mio Nakamura, MD|4154764701|mio.nakamura@ucsf.edu|
22446381|NCT01135420|Department of Veterans Afairs|Christine Timko|650-493-5000|Christine.Timko@va.gov|
22446382|NCT01182675|UCSF|Christopher C. Dvorak, MD|415-476-2188|dvorakc@peds.ucsf.edu|
22446383|NCT00717197|University of Florida|Erin M. Dunbar, MD|(352) 273-9000|edunbar@neurosurgery.ufl.edu|
22446384|NCT01811654|NYU Langone Health|Dennis Cardone, DO|212-460-0176|ariel.aponte@nyumc.org|
22446385|NCT01898806|Columbia University|Grace Ulerio|212-305-6953|gu2102@cumc.columbia.edu|
22446386|NCT03003390|Yale University|Dr. E. Vincent S Faustino|203-785-4651|vince.faustino@yale.edu|
22446387|NCT01648101|GlaxoSmithKline|GSK Response Center|866-435-7343||
22446388|NCT00940225|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
22446389|NCT02469298|GlaxoSmithKline|GSK Response Center|866-435-7343||
22446390|NCT00307294|University of Pittsburgh|Rita Johnson RN BSN CCRC|412-647-8571|johnsonr1@upmc.edu|
22446391|NCT03311724|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22446392|NCT01433991|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22446393|NCT02955602|CymaBay Therapeutics, Inc.|Elaine Watkins, DO, MSPH, Vice President of Clinical Development|510-293-8800|medinfo@cymabay.com|
22446394|NCT00872534|PLx Pharma|Ronald Zimmerman, CEO & President|1-713-842-1249|ron.zimmerman@plxpharma.com|205
22446395|NCT01581931|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22446396|NCT02734940|Virginia Commonwealth University|Dr. Jessica Potter|(804) 828-2755|jessica.potter@vcuhealth.org|
22446397|NCT02551757|University of Washington|Dr. Sandeep Khot|206-744-3251|skhot@uw.edu|
22446398|NCT04666051|Menoufia Univeristy|M. Ashraf BAlbaa|+20482224216|mohamed.balbaa@med.menofia.edu.eg|
22446399|NCT00395304|Penn State Hershey College of Medicine|Vernon M. Chinchilli|717-531-4262|vchinchi@psu.edu|
22446400|NCT01270516|University of Kentucky|Emily Bradford, Clinical Trial Compliance Administrator|859) 323-2973|emily.bradford@uky.edu|
22446401|NCT03229278|Cancer Institute of New Jersey Rutgers|Dr. Biren Saraiya - Associate Professor of Medicine Medical Director, Office of Human Research Servi|732-235-5773|saraiybi@cinj.rutgers.edu|
22446402|NCT00980057|Medtronic, Inc|Adaptive CRT Clinical Research Specialist|800-328-2518|medtronicCRMtrials@medtronic.com|
22446403|NCT02732119|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
22446404|NCT00964860|Procter and Gamble|Holly Eynon|513-622-2920|eynon.ha@pg.com|
22446405|NCT02585960|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22446406|NCT02683161|Johns Hopkins University|Kelly Dunn|410-550-2254|kdunn9@jhmi.edu|
22380985|NCT00582790|University of Wisconsin Carbone Cancer Center|Study coordinator|(608) 263-7107|uwcccgu@medicine.wisc.edu|
22385050|NCT04640298|Anika Therapeutics|Kara Mezger, Executive Director Clinical Affairs|781.457.9000|kmezger@anika.com|
22385051|NCT05523154|Mayo Clinic|Dr. Marina Walther-Antonio|(507) - 284-2282|waltherantonio.marina@mayo.edu|
22385052|NCT05311384|University of Alabama at Birmingham|Sarah dos Anjos|205.934.7323|smanjos@uab.edu|
22385053|NCT05079789|University Hospital Tuebingen|Dr. Anja Schork|+49 707129 83172|Anja.Schork@med.uni-tuebingen.de|
22385054|NCT03891667|Lyme Research Center New York State Psychiatric Institute, New York, New York, United States, 10032|Dr. Brian A. Fallon|646-774-8052|baf1@cumc.columbia.edu|
22385055|NCT01106209|University of Utah - Pediatrics|Christian Con Yost, MD|801-518-7052|christian.yost@u2m2.utah.edu|
22385056|NCT02487056|Cardiovascular Academy Society|Dr. Mehdi Zoghi|3904001|mehdi_zoghi@hotmail.com|
22385057|NCT06213194|Ibn Haldun University|Dr. Dilruba Sönmez|905365646640|dilrubasonmez@gmail.com|
22446407|NCT06333613|Johnson & Johnson Vision Care|Johnson & Johnson Vision Care Study Contact|1-800-843-2020|osova@its.jnj.com|
22380986|NCT03570255|Masimo|Vikram Ramakanth|949-297-7416|clinicalresearchdept@masimo.com|
22380987|NCT00790062|University of Alabama at Birmingham|Alan T. N. Tita, MD|(205) 934-9616|atit@uab.edu|
22380988|NCT02680756|Shield Therapeutics|Jackie Mitchell MA DPhil|0044 752 565 6885|jmitchell@shieldtx.com|
22380989|NCT00480441|Treatment Research Center|Dr. Marina Goldman, Principle Study Investigator|215 222 3200|marinag@mail.med.upenn.edu|104
22380990|NCT02374957|Wake Forest University Health Sciences|Dr. Matthew Edwards|336-716-9343|medwards@wakehealth.edu|
22380991|NCT01417000|Aduro Biotech, Inc.|Corporate Communications|510-848-4400||
22380992|NCT01657682|Arog Pharmaceuticals|Edward McDonald|214-593-0500|emcdonald@arogpharma.com|
22385058|NCT02100813|LEO Pharma A/S|Clinical Trial Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
22385059|NCT01963793|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
22385060|NCT03575897|University of Alabama at Birmingham|Dr. Ariel Salas|205-934-4680|asalas@peds.uab.edu|
22385061|NCT03762915|University of Minnesota|Michelle Arnette|6126243457|marnett@umn.edu|
22385062|NCT05369533|University of California, Los Angeles|Steven Cramer|424-522-7874|SCCramer@mednet.ucla.edu|
22446408|NCT01847274|GSK|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22446409|NCT00541593|Baystate Medical Center|Dr. John R. Romanelli|(413) 794-3175|john.romanelli@bhs.org|
22446410|NCT02059395|The Ottawa Hospital|Dr. Sylvain Boet|6137985555|sboet@toh.on.ca|14775
22385063|NCT03150810|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22446411|NCT00134082|Johns Hopkins University|Richard Ambinder, MD|4109558839|rambind1@jhmi.edu|
22446412|NCT02569658|Rush University Medical Center|Yale Fillingham|3095310220|yale.fillingham@gmail.com|
22446413|NCT00724932|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22446414|NCT02021331|University of Michigan|Dr. Robert Eber|734-647-4023|reber@umich.edu|
22446415|NCT01488370|Loma Linda University Department of Anesthesiology|Elizabeth Ghazal, MD|909-558-4475|EGhazal@llu.edu|
22385064|NCT04526704|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22412756|NCT00023309|National Institute of Diabetes and Digestive and Kidney Diseases, NIH|Marc G. Ghany, M.D|3014961721|marcg@mail.nih.gov|
22412757|NCT01661114|University of Michigan Comprehensive Cancer Center|Dr. Mark Zalupski, M.D.|734-615-3969|zalupski@umich.edu|
22412758|NCT01050647|Stanford University|Dr. Anna Girsen|6507255720|agirsen@stanford.edu|
22412759|NCT01273181|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
22412760|NCT04276883|Bioxcel Therapeutics|Vice President Head of Clinical Operations|(475) 355 5177|cgommoll@bioxceltherapeutics.com|
22412761|NCT01929642|Boling Center for Developmental Disabilities|Dr. Tanjala Gipson|901-448-6512|sbarden@uthsc.edu|
22412762|NCT02458469|JOHN D DINGELL VA MEDICAL CENTER|Dr. Abdulghani Sankari Principal Investigator|13135761000|abdulghani.sankari@va.gov|63105
22412763|NCT01430741|Bedford VA|Dr. David Smelson, Professor|781-570-1903|david.smelson@va.gov|
22412764|NCT02603952|MedImmune, LLC|Raburn Mallory|301-398-4095|information.center@astrazeneca.com|
22412765|NCT05215951|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22412766|NCT02789033|Universidad de Guadalajara|PhD. Leonel García Benavides|+52 (33) 20 00 23 00|drleonelgb@hotmail.com|64096
22412767|NCT02070237|Memorial Care|Dr. Jennifer McNulty|562-933-2730|jjmcnulty@sbcglobal.net|
22412768|NCT00958243|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
22412769|NCT00143819|UMDNJ-Robert Wood Johnson Medical School|Dr M Magliocco||maglioma@yahoo.com|
22412770|NCT03587207|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22412771|NCT03339349|University of Utah|Daniel Jones|801-581-2121|daniel.jones2@gmail.com|
22412772|NCT04591626|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22412773|NCT02494713|The University of Texas Health Science Center at Houston|Marka Lyons, Research Manager|713-500-6919|Marka.Lyons@uth.tmc.edu|
22412774|NCT02672553|Edwards Lifesciences, LLC|Mary Edwards, VP Clinical and Regulatory Affairs, HVT|949-250-2500|mary_edwards@edwards.com|1536
22412775|NCT01004172|Dana-Farber Cancer Institure|Nancy Lin, MD|617.632.2335|nlin@partners.org|
22412776|NCT00950872|Covidien|Noreen Fahey, Director, Clinical Program Management|203-821-4716|noreen.fahey@covidien.com|
22412777|NCT00970281|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22412778|NCT03104738|The Ohio State University|Ana Mavarez-Martinez, PostDoctoral Reseacher|614-293-3559|ana.mavarezmartinez@osumc.edu|
22412779|NCT01661270|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22385065|NCT03158714|Auburn University|Francesca Adler-Baeder|334-844-4151|adlerfr@auburn.edu|
22385066|NCT02737436|University of Iowa|Dr Lane Strathearn|2193849464|lane-strathearn@uiowa.edu|
22385067|NCT03936322|UNIVERSITY OF MIAMI|Rodrigo Ruano MD PhD|(305) 585-5610|rodrigoruano@hotmail.com|
22385068|NCT01160211|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22385069|NCT05551637|National Institute of Nutrient|Dr. Nguyen Song Tu|0912322602|nguyensongtu@gmail.com|
22385070|NCT04721912|University of New Mexico|Katrina Nardini, CNM, WHNP-BC, MPH|505-205-4118|hsc-familyplanningresearch@salud.unm.edu|
22385071|NCT02734290|Providence Portland Medical Center|Dr. David B. Page|5032156588|david.page2@providence.org|
22385072|NCT01814501|The Ohio State University Comprehensive Cancer Center|Dr. John Hays|614-293-3873|John.Hays@osumc.edu|
22385073|NCT03829410|Cardiff Oncology|Nancy Sherman, Head of Clinical Operations|858-952-7570|clinops@cardiffoncology.com|
22385074|NCT04924660|Vanderbilt University Medical Center|Sean P. Collins, MD|615-343-8010|vcc@vumc.org|
22385075|NCT02105766|National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)|Matthew Hsieh M.D.|301.402.7687|matthewhs@nhlbi.nih.gov|
22385076|NCT02235909|Azurity Pharmaceuticals, Inc.|David Sequeira|(913) 389-7961|david.sequeira@azurity.com|
22385077|NCT02936752|Yale School of Medicine|Amer Zeidan, MBBS|(203) 200-4363|amer.zeidan@yale.edu|
22385078|NCT05894577|Duke University|Susanna Naggie, MD|919-684-2584|susanna.naggie@duke.edu|
22385079|NCT03241459|Surmodics|Kimberly Hawkinson|952-500-7563|khawkinson@surmodics.com|
22385080|NCT05805865|Loma Linda University Health|Professor, Director of Student Research|909 558 5118|sorankwon@llu.edu|
22385081|NCT03793972|UAntwerpen|Stefan Morreel|003232658721|stefan.morreel@uantwerpen.be|
22385082|NCT05582746|University of Kansas Medical Center|Dr. Jason E Glenn|9135880076|jglenn4@kumc.edu|
22385083|NCT03443388|University of Pennsylvania|Michael Gelfand, MD, PhD|215 662 3606|epilepsytrials@pennmedicine.upenn.edu|
22385084|NCT04495894|Emory University|Viraj Master, MD, PhD|404-778-4898|vmaster@emory.edu|
22385085|NCT04064164|University of Kansas School of Nursing|Kristine Williams|7859797879|kwilliams1@kumc.edu|
22385086|NCT01000961|Horizon Pharma USA, Inc.|Evelyn Olson, Director|224-383-3000|clinicaltrials@horizonpharma.com|
22385087|NCT06165146|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22412780|NCT06096168|SERF|Sponsor|0472056010|clinical@serf.fr|
22412781|NCT04183231|Advantage Silver Dental Arrest, LLC|Dr. Peter Milgrom|206-2516831|drmilgrom@silverarrest.com|
22385088|NCT05746455|Columbia University|Dr. Alice Saperstein|646-774-8464|ams2334@cumc.columbia.edu|
22430067|NCT03760640|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22430068|NCT00087672|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes, M.D./ Professor|713-794-5783|eharriso@mdanderson.org|
22446416|NCT00469274|Vanderbilt University Medical Center|Dr. Thomas R. Talbot|615-322-2789|tom.talbot@vanderbilt.edu|
22446417|NCT00695409|City of Hope National Medical Center|Dr. Amrita Krishnan|626-256-4673|AKrishnan@coh.org|82405
22446418|NCT00961233|University of North Carolina School of Medicine|Evan S. Dellon, MD MPH|919-966-2511|edellon@med.unc.edu|
22446419|NCT01529502|Massachusetts General Hospital|Dr. Lorenzo Berra|617 724 1901|LBERRA@MGH.HARVARD.EDU|
22446420|NCT01158157|Cangene Corporation|Christine Hall, Ph.D. Director Clinical|204-275-4248|chall@ebsi.com|
22446421|NCT02340975|MedImmune, LLC|Shahram Rahimian|+1-800-236-9933|information.center@astrazeneca.com|
22446422|NCT04003012|CAMC Institute of Academic Medicine|Dr. Stephanie Thompson|304-388-9911|stethompson@camc.org|
22446423|NCT01007812|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22446424|NCT01091974|University of Rochester Medical Center|Joseph A. Roscoe Ph.D.|(585) 275-9962|Joseph_Roscoe@URMC.Rochester.edu|
22446425|NCT03948581|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22446426|NCT01876420|Medtronic|Terry Noel|763-526-0309||
22446427|NCT03173313|ZOLL Circulation, Inc.|Vice President of Clinical Affairs|(408) 541-2140|jcreech@zoll.com|
22430069|NCT02662582|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22430070|NCT00428077|University of Utah Huntsman Cancer Institute|Michael Deininger, MD, PhD|801-585-3229|michael.deininger@hci.utah.edu|
22430071|NCT00609973|University of North Carolina|Hans Herfarth|9199666806|hherf@med.unc.edu|
22430072|NCT00965991|University of New Mexico|Lisa Moore|5052727028|hkhawaja@salud.unm.edu|
22430073|NCT01392495|Novartis Pharmaceuticals|Study Director|862-778-8300||
22430074|NCT00806026|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22430075|NCT00930787|LifeCell|Dr Michael Franz|908094701100|mfranz@lifecell.com|
22430076|NCT03063164|Stanford University School of Medicine|Edward E. Manche|6507255765|edward.manche@stanford.edu|
22430077|NCT01452789|Thomas Jefferson University|Walter Kraft|215 955 9077|walter.kraft@jefferson.edu|
22430078|NCT03733483|University of Colorado, Anschutz Medical Campus|Christine Swanson, MD, MCR, Assistant Professor|(303)724-0073|christine.swanson@cuanschutz.edu|
22430079|NCT01928576|Johns Hopkins|Amber Michalik|667-306-8336|amichal2@jhmi.edu|
22430080|NCT01927861|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22430081|NCT00987935|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22430082|NCT01089543|Eisai Inc.|Yoshiumi Okubo, Study Director|+81-3-3817-3908|y4-okubo@hhc.eisai.co.jp|
22430083|NCT02222181|Unesp|Fernanda Mariana de Oliveira|+551636640217|femoliveira12@gmail.com|
22430084|NCT00754559|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22430085|NCT01248468|Novartis Consumer Health|Clinical Project Leader|973-503-8000||
22430086|NCT01370538|AstraZeneca|Gerard Lynch|1625 518062|aztrial_results_posting@astrazeneca.com|+44
22430087|NCT00728182|NoNO Inc.|Roberta Anderson, Vice President of Clinical Development|613 833-1020|randerson@nonoinc.ca|
22430088|NCT03856177|University of New Mexico|Dr. James F. Cavanagh|4158670303|jcavanagh@unm.edu|
22430089|NCT01898091|Medical University of South Carolina|Susan G. Reed, DDS, MPH, DrPH|843 792-1577|reedsg@musc.edu|
22430090|NCT00309244|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
22430091|NCT01905267|University of Illinois at Chicago|Rachel Jacobs|3124139178|rjacobs@psych.uic.edu|312
22430092|NCT03438656|University of Washington|Assistant Professor|414-331-4871|jennessj@uw.edu|
22446428|NCT04461210|University at Buffalo|Director of the Clinical and Translational Science Institute|7168884850|vmbarnab@buffalo.edu|
22446429|NCT02498132|University of Kansas|Professor Carl Lejuez|240-535-0467|clejuez@ku.edu|
22446430|NCT00730405|GlaxoSmithKline|GSK Response Center|866-435-7343||
22446431|NCT00963937|GlaxoSmithKline|GSK Response Center|866-435-7343||
22446432|NCT04203498|Jazz Pharmaceuticals Inc.|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
22446433|NCT02106975|Virginia Commonwealth University School of Medicine|Alpha A Fowler, III, MD|804-828-9071|alpha.fowler@vcuhealth.org|
22446434|NCT00622401|Beth Israel Deaconess Medical Center|David Avigan, MD|617-667-9920|davigan@bidmc.harvard.edu|
22446435|NCT03546062|"Università degli studi della Campania luigi Vanvitelli"|Raffaele Marfella|+390815665110|raffaele.marfella@unicampania.it|
22446436|NCT00181155|Johns Hopkins University|Robert G. Weiss, MD|410-955-1703|rweiss@jhmi.edu|
22446437|NCT02572401|University of Pennsylvania|Dr. John B. Jemmott III|215-573-9366|jjemmott@asc.upenn.edu|
22446438|NCT01323959|GlaxoSmithKline|GSK Response Center|866-435-7343||
22446439|NCT00223262|University of Texas Southwestern Medical Center|E. Sherwood Brown, MD, PhD|2146456950|sherwood.brown@utsouthwestern.edu|
22446440|NCT01768286|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22446441|NCT02243696|BIOTRONIK, Inc.|Clinical Studies Engineer Manager|1-800-547-0394|crystal.miller@biotronik.com|
22446442|NCT00622284|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22446443|NCT02935842|University Hospital Basel|Prof. Peter Fuhr|0041 61 265|peter.fuhr@usb.ch|41 66
22446444|NCT02774954|USCalifornia|Ricky Bluthenthal|3234428236|rbluthen@usc.edu|
22446445|NCT01201850|Children's Hospital Colorado|Margaret Macy, MD|720-777-5877|margaret.macy@childrenscolorado.org|
22446446|NCT04066023|Zosano Pharma Corporation|Don Kellerman, Sr. VP, Clinical Development and Medical Affairs|+1 (510) 745-4004|dkellerman@zosanopharma.com|
22446447|NCT01552694|Washington University School of Medicine|Kevin Yarasheski, PhD|3143628173|key@wustl.edu|
22446448|NCT03338010|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22385089|NCT02023866|Horizon Pharma USA, Inc.|Evelyn Olson, Director|224- 383-3000|clinicaltrials@horizonpharma.com|
22446449|NCT00758836|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22446450|NCT00293033|Meda Pharmaceuticals Inc.|Larry Gever, PharmD, Director, Medical Affairs|732-564-2400|larry.gever@meda.us|
22385090|NCT03307343|West Virginia University|Bethany Barone Gibbs|304-581-1779|bethany.gibbs@hsc.wvu.edu|
22446451|NCT03261973|Massachusetts General Hospital|Grace Ha|617-643-1697|gha2@mgh.harvard.edu|
22385091|NCT03477968|Diagnostica STAGO S.A.S|Nathalie THUILLIER|+33 146 882 167|nathalie.thuillier@stago.com|
22385092|NCT06190340|TenNor Therapeutics (Suzhou) Limited.|TenNor|0512-86861990|info@tennorx.com|
22446452|NCT01980940|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22385093|NCT06469138|BerGenBio ASA|BerGenBio Clinical Team|+47 559 61 159|registry.postings@bergenbio.com|
22446453|NCT00837811|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22385094|NCT01120223|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com|
22385095|NCT05184192|Washington University, Department of Otolaryngology - Head and Neck Surgery|Jay F. Piccirillo|314-362-8641|piccirj@wustl.edu|
22385096|NCT04114877|Yale School of Medicine|Ariadna Forray|2037648620|ariadna.forray@yale.edu|
22385097|NCT04471038|SAB Biotherapeutics|Senior Director Clinical Operations|8326221699|ssinclair@sab.bio|
22385098|NCT03703492|UW School of Medicine and Public Health|Amy Fowler, MD, PhD|608-262-2122|afowler@uwhealth.org|
22385099|NCT04709783|University of Florida|Chiung-ju (CJ) Liu|352-273-6496|c.liu1@phhp.ufl.edu|
22385100|NCT05609760|Universidad de concepción|Rosa Figueroa I, Associate Professor|+56412204247|rosa.figueroa@biomedica.udec.cl|
22385101|NCT05089734|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22385102|NCT05179395|James A Haley Veterans' Hospital and Clinics|Dr. Jeffrey Heckman|813.972.2000|jeffrey.t.heckman@va.gov|7506
22399108|NCT01505894|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22430093|NCT03335566|GE Healthcare|Francois Tranquart, M.D, PhD|011-44-1494-543037|francois.tranquart@ge.com|
22446454|NCT03835780|Centre for Musculoskeletal Research|Maya H Buch|+441613066000|maya.buch@manchester.ac.uk|
22446455|NCT01874132|University of Trás-os-Montes e Alto Douro|Professor Nelson Sousa|259350756|nelsons@utad.pt|+351
22446456|NCT00691015|Barbara Ann Karmanos Institute|Zaid Al-Kadhimi, M. D.|(404) 778-1900|zalkadh@emory.edu|
22446457|NCT01397084|AstraZeneca|James Armbrust||aztrial_results_posting@astrazeneca.com|
22380993|NCT01911221|Novartis Vaccines and Diagnostics|Posting Director||RegistryCpontactVaccinesUS@novartis.com|
22380994|NCT02284464|Hospital Regional Universitario de Málaga|Dr. Domingo Hernandez|951291174|domingohernandez@gmail.com|
22380995|NCT00755755|PregLem S.A.|Dr Elke Bestel|+41 22 884 03 40|medical@preglem.com|
22380996|NCT04653051|Zimmer Biomet|Georgia Tsapara|+41 79 94 54936|georgia.tsapara@zimmerbiomet.com|
22380997|NCT03748771|University of California San Diego|Dr. Rakesh Bhattacharjee|858-966-5846|rlbhattacharjee@ucsd.edu|
22380998|NCT01318811|Vanderbilt_Univeristy MC|Dr. Thomas Golper|615-322-5914|thomas.golper@vumc.org|
22380999|NCT00811187|Montefiore Medical Center|Research Program Administrator|718-405-8526|fheitor@montefiore.org|
22381000|NCT02825043|University of Oklahoma Health Sciences Center Dept. of Medicine|Clinical Trials Manager|(405)271-6651|research@ouhsc.edu|
22381001|NCT00131911|Mayo Clinic Cancer Center|Timothy J. Hobday M.D.||Hobday.timothy@mayo.edu|
22381002|NCT00083174|Canadian Cancer Trials Group|Senior Biostatistician|613-533-6430|dtu@ctg.queensu.ca|
22381003|NCT00329303|Cares|UCB|+1844599|UCBCares@ucb.com|2273
22381004|NCT02444143|University of Illinois at Chicago|Dr. Patricia West-Thielke|312-996-5695|pwest@uic.edu|
22381005|NCT03582137|University of Colorado|Maureen Leehey, MD|3037248288|maureen.leehey@cuanschutz.edu|
22381006|NCT03704298|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
22381007|NCT04582045|HealthPartners Institute|Linda M. Loes|952-967-7862|linda.m.loes@healthpartners.com|
22381008|NCT00558753|Rush University Medical Center|Asokumar Buvanendran, M.D.|(312) 942-3685|asokumar@aol.com|
22381009|NCT01167023|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22381010|NCT02405390|Nicklaus Children's Hospital|Jose M. Vargas Loayza, M.D.|786-624-3588|jose.vargas-loayza@mch.com|
22381011|NCT04794062|Good Samaritan Hospital, TriHealth|Leonid Khokhlov, MD|5138858974|leonkhokhlov@gmail.com|
22381012|NCT04515797|Massachusetts General Hospital|Dr. Raymond Chung|6177247562|Chung.Raymond@mgh.harvard.edu|
22381013|NCT02820051|UANL|Dr. Julio E. González-Aguirre|82204444|jeglza111@gmail.com|229
22381014|NCT02774213|Tools4Patient|Stephanie Alvarez|+32 71 14|stephanie.alvarez@tools4patient.com|02 00
22381015|NCT04883346|Section on Growth and Obesity, NICHD, NIH|Jack A. Yanovski, MD, PhD|301-496-0858|yanovskj@mail.nih.gov|
22381016|NCT00114959|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22381017|NCT02788656|Brigham and Women's Hospital|Akshay Desai|617-732-7046|adesai@bwh.harvard.edu|
22381018|NCT01819415|Maisonneuve-Rosemont Hospital|Dr. Flavio Rezende|514-867-2990|frezendef@hotmail.com|
22381019|NCT03929302|UT Southwestern Medical center|Namrata Das|2146082836|Namrata.Das@utsouthwestern.edu|
22381020|NCT04454567|Assembly Biosciences|Executive Director of Clinical Operations|833-509-4583|Clinicaltrials@assemblybio.com|
22381021|NCT03815916|Clene Nanomedicine|Jeremy Evan, PA-C|5419086335|jeremy@clene.com|
22381022|NCT03748264|Philips|Jeff Jasko|4125423651|Jeff.Jasko@philips.com|
22381023|NCT02757885|Emory University|Professor of Pediatrics, Dr. Suhag H. Parikh|4047853240|suhag.parikh@emory.edu|
22381024|NCT00664521|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22381025|NCT02459964|UT MD Anderson Cancer Center|Sai-Ching J. Yeung, MD, Professor, Emergency Medicine|(713) 745-9911|syeung@mdanderson.org|
22430094|NCT04223687|University of North Carolina at Chapel Hill|Marissa Hall, PhD|(919) 445-1310|mghall@unc.edu|
22446458|NCT02139228|Novartis Vaccines and Diagnostics Srl|Posting Director||RegistryContactVaccinesUS@novartis.com|
22446459|NCT04160195|National Cancer Institute|Dr. James N. Kochenderfer|240-760-6062|kochendj@mail.nih.gov|
22446460|NCT00706823|University of Texas Medical School at Houston|Carin A. Hagberg, MD|713-500-6222|carin.a.hagberg@uth.tmc.edu|
22446461|NCT03130257|Kaiser Permanente Washington Health Research Institute|Beverly B. Green, MD, MPH|206-287-2997|Bev.B.Green@kp.org|
22446462|NCT03766581|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22446463|NCT03716024|Paratek Pharmaceuticals, Inc.|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
22446464|NCT00867568|NMTRC|Giselle Sholler, MD|6162670335|giselle.sholler@helendevoschildrens.org|
22446465|NCT01056653|University of Calgary, Faculty of Nursing|Dr. Karen Benzies|403-220-2294|benzies@ucalgary.ca|
22446466|NCT05275400|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22446467|NCT04566302|Massachusetts General Hospital|Guillermo Tearney, MD, PhD|617-724-2979|gtearney@mgb.org|
22446468|NCT01651039|Icahn School of Medicine at Mount Sinai|Dr. Ajai Chari|212-241-7873|ajai.chari@mountsinai.org|
22446469|NCT03727230|Guangzhou Blood Center|Director of Clinical Trials|+86-20 83595049|fuyongshui1969@yahoo.com|
22446470|NCT03600818|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22446471|NCT01706146|Northwestern University|Adin-Cristian Andrei, Ph.D.|312-694-0509|Adin-Cristian.Andrei@nm.org|
22446472|NCT02124083|National Institute of Child Health and Human Development|Porter, Forbes|+1 301 435 4432|fdporter@mail.nih.gov|
22446473|NCT02837328|University of Minnesota|Pamela Lutsey, PhD MPH|612-624-5812|lutsey@umn.edu|
22446474|NCT02582983|Hoffmann-La Roche|Medical Communications|800-821-8590||
22446475|NCT04930965|Tulane University|Erin Peacock|504-988-1075|epeacoc@tulane.edu|
22446476|NCT04377620|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22446477|NCT05209360|The University of Iowa|Jason M Wilken, PT, PhD|319-335-6857|jason-wilken@uiowa.edu|
22446478|NCT03355820|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22446479|NCT04189081|Procter & Gamble|Clinical Trial Manager|5136225362|combs.cs@pg.com|
22446480|NCT00044083|Office of the Clinical Director-NIMH-NIH-HHS|Jose A. Apud|3015946561|apudj@mail.nih.gov|
22446481|NCT02114216|Seoul National University Hospital|Dr. Jinjoo Kim|82-10-6261-6483|jjkim0727@gmail.com|
22446482|NCT00288054|SWOG Statistical Center|Lung Committee Statistician|206-667-4623||
22446483|NCT02249585|Seoul National University Hospital|Dr Kook Hyun Lee, MD, PhD|82-2-2072-2467|leekh@snu.ac.kr|
22446484|NCT02197247|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
22446485|NCT00444912|Genzyme|Medical Information||medinfo@genzyme.com|
22446486|NCT03758066|Dimagi, Inc.|Y. Xian Ho|617-649-2214|yho@dimagi.com|63
22446487|NCT00977860|UPMC Hillman Cancer Center|Barbara M Stadterman, MPH, MCCR|412-647-5554|stadtermanbm@upmc.edu|
22446488|NCT00332163|Amgen Inc.|Study Director|866-572-6436||
22430095|NCT04217057|Washington University School of Medicine|Dr. Farrokh Dehdashti|314-362-1474|dehdashtif@wustl.edu|
22430096|NCT02945046|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22430097|NCT02468700|Ocular Therapeutix|Jamie L. Metzinger, Medical Affairs|781-357-4000|jmetzinger@ocutx.com|
22430098|NCT03907579|Dartmouth-Hitchcock Norris Cotton Cancer Center|Director of Community Education and Prevention|603-653-9960|nccc.community.outreach@dartmouth.edu|
22430099|NCT00567229|Memorial Sloan Kettering Cancer Center|Dr. Hani Hassoun|212-639-3228|hassounh@mskcc.org|
22430100|NCT03319654|Antwerp University Hospital, Belgium|Dr. Alessa Sugihara|00328213684|alessa.sugihara@uza.be|
22430101|NCT04679818|Cleveland Clinic|Kurt Ruetzler|216 636-0561|ruetzlk@ccf.org|
22430102|NCT00362609|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22430103|NCT02205359|CRM|Janelle van Wel|+3166 273 886 62|janelle.van.wel@medtronic.com|
22430104|NCT00236197|Eisai Medical Research Inc.|Yufang Lu, MD, PhD, Study Director|201-403-2500||
22430105|NCT00480025|GlaxoSmithKline|GSK Response Center|866-435-7343||
22430106|NCT03389750|New York State Psychiatric Institute|Jermaine Jones|646 774-6113|jermaine.jones@nyspi.columbia.edu|
22430107|NCT04902144|University of Washington|Dr. Marianne Dubard-Gault|206-606-6990|mdg2019@uw.edu|
22430108|NCT03361072|Helsinki University Hospital|Dr Paula Kauppi|+358504286802|paula.kauppi@hus.fi|
22430109|NCT06868667|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22430110|NCT04857281|Mayo Clinic Arizona|Dr. Jay Pasricha|(480)301-4279|pasricha.jay@mayo.edu|
22430111|NCT01699685|Novartis Pharmaceuticals|Study Director|862-778-8300||
22430112|NCT02821000|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22430113|NCT00326495|National Cancer Institute|Dr. Alice Chen|240-276-6565|chenali@mail.nih.gov|
22430114|NCT05058456|Shockwave Medical|Kavita Arjungi|1-510-279-4262|karjungi@shockwavemedical.com|
22430115|NCT03931785|Ironwood Pharmaceuticals, Inc.|Wilmin Bartolini, Ph.D.|617.621.8314|wbartolini@ironwoodpharma.com|
22430116|NCT03052257|Durham VA Medical Center, Durham, NC|Dr. Kelly Muir|919-286-0411|Kelly.Muir@va.gov|174035
22446489|NCT01152697|University Hospitals of Cleveland|Martha Sajatovic, Professor of Psychiatry|2168442808|martha.sajatovic@uhhospitals.org|
22446490|NCT02000583|University of Kansas Medical Center|Jeffrey M. Burns MD|913-588-0555|jburns2@kumc.edu|
22446491|NCT03706079|AstraZeneca|Global Clinical Head|+1 302 885 1180|information.center@astrazeneca.com|
22446492|NCT00329238|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22446493|NCT02158273|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu|
22385103|NCT06132867|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22385104|NCT04222660|Iowa City VA Healthcare System|Dr. Mark Yorek|13193380581|mark.yorek@va.gov|637696
22385105|NCT03509116|Guy's & St Thomas' NHS Foundation Trust|Dr Alastair Duncan|02071882010|alastair.duncan@gstt.nhs.uk|
22385106|NCT05228730|Murdoch Children's Research Institute|Ms Kathryn Bright|+61 3 99366656|kathrynbright@mcri.edu.au|
22385107|NCT04318548|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22385108|NCT06283173|Covalon Technologies Inc.|Director of Regulatory Affairs|888-236-4944|customerservice@covalon.com|
22385109|NCT02651428|CorMedix Inc.|Head of Clinical Operations|908-517-9500|lmasson@cormedix.com|
22385110|NCT03366649|Emory University|Dr. Robert Guyton|404 686-4499|rguyton@emory.edu|
22385111|NCT04873401|New York State Psychiatric Institute|Dr. Katherine Elkington|16467746965|ke2143@cumc.columbia.edu|
22385112|NCT04887129|University of Rochester|John Foxe, Phd|585 - 275 - 2591|John_foxe@urmc.rochester.edu|
22385113|NCT04533347|Fast-Track Drugs and Biologics, LLC|Bernadette Tock|240-401-8634|btock@fasttrackresearch.com|
22385114|NCT05520190|University of Rochester|Aileen Aldalur|(585) 371-6125|aileen_aldalur@urmc.rochester.edu|
22385115|NCT04059770|Universidade Federal de Ciências da Saúde de Porto Alegre|Professor Alessandro C. Pasqualotto|5551999951614|pasqualotto@ufcspa.edu.br|
22385116|NCT03476187|ZOLL|Nicole Bianco|4129683333|NBianco@zoll.com|14410
22385117|NCT03445988|Stanford University|Beth Darnall, PhD|N/A|bdarnall@stanford.edu|
22412782|NCT02519322|M D Anderson Cancer Center|Dr. Rodabe Amaria|(713) 792-2921|rnamaria@mdanderson.org|
22412783|NCT04603937|Kodiak Sciences Inc|Pablo Velazquez-Martin|1 (650) 281-0850|ClinOps@kodiak.com|
22412784|NCT00993616|Gynecologic Oncology Group Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
22385118|NCT02921230|Boston Scientific|Andrew Campbell|763-494-2722|Andrew.Campbell@bsci.com|
22385119|NCT04977947|University of Cincinnati|Cathleen Stough, Ph.D.|513-556-5589|odarcc@ucmail.uc.edu|
22385120|NCT05875142|We The Village, Inc.|Jane Macky, PI/CEO|91768344267|jane@wethevillage.co|
22385121|NCT03436290|Vanderbilt University Medical Center|Myrick Shinall, principal investigator|615-343-5613|ricky.shinall@vumc.org|
22385122|NCT00583349|Columiba University Medical Center|Dr. James McKiernan, John K. Lattimer Professor and Chair of Department of Urology|212-342-3976|jmm23@cumc.columbia.edu|
22385123|NCT04274764|University of Michigan|Paula Anne Newman-Casey|734 763-6967|panewman@med.umich.edu|
22385124|NCT05424549|Aldeyra Therapeutics, Inc.|Bill Cavanagh|781-257-3063|bcavanagh@aldeyra.com|
22385125|NCT03396926|University of California, San Francisco|Dr.Chloe Atreya, MD, PhD|(415) 353-9888|chloe.atreya@ucsf.edu|
22385126|NCT01396278|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22385127|NCT00450658|Horizon Pharma, Inc.|Amy Grahn, MS Senior Vice President, Clinical Development and Operations|224-383-3012|agrahn@horizonpharma.com|
22385128|NCT01083758|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com|
22385129|NCT04727554|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22385130|NCT05763823|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22385131|NCT03778112|Rush University Medical Center|Dian Wang, MD|(708) 660-3476|Dian_Wang@rush.edu|
22385132|NCT01264406|Pennington Biomedical Research Center|Corby Martin|763-2585|corby.martin@pbrc.edu|
22385133|NCT05659537|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22385134|NCT04971395|Xentria, Inc.|Tom Matthews, Director of Clinical Research|224.443.4615|tmatthews@xentria.com|
22385135|NCT04456517|Vanderbilt University Medical Center|Michael McGill|615-322-4643|michael.g.mcgill@vumc.org|
22385136|NCT04682587|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22385137|NCT05087693|UNiversity of BRitish COlumbia|Michael Koehle|8229331|michael.koehle@ubc.ca|
22385138|NCT02884011|Rush University Medical Center|Joshua DeMott|312-947-0226|joshua_demott@rush.edu|
22385139|NCT00506519|LEO Pharma A/S|Disclosure|+45 44 94 58 88|disclosure@leo-pharma.com|
22385140|NCT01186367|Memorial Sloan Kettering Cancer Center|Dr. Jessica Scott, PhD|646-888-8093|scottj1@mskcc.org|
22385141|NCT02975882|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22385142|NCT05116787|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
22385143|NCT05275231|Emory University|Dr. Megha K. Shah|404-778-6944|mkshah@emory.edu|
22385144|NCT03158129|MD Anderson Cancer Center|Tina Cascone, MD|713-792-6363|tcascone@mdanderson.org|
22385145|NCT05051124|NYU Langone Health|Jessica Gjonaj|646-501-3663|Jessica.gjonaj@nyulangone.org|
22385146|NCT04782973|Massachusetts General Hospital|Kaavya Paruchuri, MD|617-726-1843|kparuchuri@mgh.harvard.edu|
22385147|NCT06181006|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22385148|NCT03867500|Mayo Clinic|Michael D. Jensen, M.D.|507-255-6515|jensen@mayo.edu|
22385149|NCT06205407|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22385150|NCT03611491|CROMA - PHARMA|Head of Clinical Operations|+43 2262 68468|clinical.studies@croma.at|
22385151|NCT04676022|Boston Scientific Corporation|Sr. Director, Clinical Operations|855-213-9890|BSNClinicalTrials@bsci.com|
22385152|NCT05746494|University of Texas at Dallas|Dr. Linlin Fan|+(853) 8822 4226|linlin.fan@utdallas.edu; linlinfan@um.edu.mo|
22385153|NCT03153410|SKCCC Johns Hopkins Medical Institution|Ana De Jesus-Acosta, MD|443-287-0411|adejesu1@jhmi.edu|
22385154|NCT03408340|Emory University|Justin B. Long, MD, Associate Professor|404-785-6670|justin.bradley.long@emory.edu|
22385155|NCT04806451|Neurocrine Biosciences|Neurocrine Medical Information Call Center|877-641-3461|medinfo@neurocrine.com|
22385156|NCT03274310|Columbia University Vagelos College of Physicians and Surgeons|Dr. Melissa Stockwell|2123425732|mss2112@cumc.columbia.edu|
22385157|NCT05891353|University of Central Florida|Abigail Anderson|4078231026|Abigail.Wilson@ucf.edu|
22385158|NCT03134196|NYU Langone Health|Elisabeth Cohen, MD|9294552412|Elisabeth.Cohen@nyulangone.org|
22385159|NCT00875277|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
22385160|NCT03800108|Cleveland Clinic|Dr. Darlene Floden|216-444-1298|flodend@ccf.org|
22385161|NCT04541147|Duke University|Eileen M. Raynor, MD|919-613-4573|eileen.raynor@duke.edu|
22385162|NCT05916664|RSV Opco 5, Inc. (dba Kinto)|Joseph T Chung|(857) 600-2273|joe@kinto.care|
22385163|NCT05184894|Mayo Clinic|Erin Barreto, PharmD, MS|507-284-2511|barreto.erin@mayo.edu|
22385164|NCT02222155|ChemoCentryx|Study Director|650-210-2900||
22385165|NCT04683744|Indiana University|Dr. Peter H. Schwartz|317-278-4037|phschwar@iu.edu|
22385166|NCT01798498|Croma Pharma|Head of Clinical Operations|+43 2262 68468|clinical.studies@croma.at|
22385167|NCT05136417|Mayo Clinic|Dr. Mohamad Alkhouli|507-255-2502|Alkhouli.Mohamad@mayo.edu|
22385168|NCT04026555|Icahn School of Medicine at Mount Sinai|Dr. Matthew Levin|212-241-8382|matthew.levin@mssm.edu|
22385169|NCT04150900|University of Maryland, Baltimore|Dr. Ranee Mehra|410-328-4059|umgccregulatory@umm.edu|
22385170|NCT04592549|Resilience Government Services|Angie Kimbler|386-418-8751|angie.kimbler@resilience.com|
22385171|NCT06429319|RCBIOFORM|Julia Melentyeva Commercial Director|84952237095|md@bioform.ru|
22385172|NCT02919306|Janssen Vaccines and Prevention BV|CLINICAL FRANCHISE LEADER|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22385173|NCT04293055|The Miriam Hospital|Dr. Jacqueline Hayes|401-793-8917|jhayes3@lifespan.org|
22385174|NCT02649842|Johnson & Johnson Surgical Vision|Devi Priya Janakiraman, OD, FAAO|1+ 714-247-8429|djanaki1@its.jnj.com|
22385175|NCT04625283|Vanderbilt University Medical Center|Dr. Britany Martin|+1 (615)322-8476|britany.l.raymond@vumc.org|
22385176|NCT01824394|Biosense Webster, Inc.|Megan Holden|(949) 923-4700|mholden8@its.jnj.com|
22385177|NCT05364671|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22385178|NCT05794243|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22385179|NCT05733975|Duke Univerisity Medical Center|Dr. Monica Lemmon|919-668-0477|monica.lemmon@duke.edu|
22385180|NCT03637660|University of Alabama at Birmingham|Edward W. Hook, III|205-932-4204|ehooks@uabmc.edu|
22385181|NCT05093829|University of Maryland School of Medicine|Wilbur H. Chen, M.D., M.S., FACP, FIDSA|410-706-5328|wchen@som.umaryland.edu|
22385182|NCT04648033|University of Oxford|Professor Geoff Higgins|01865 617311|geoffrey.higgins@oncology.ox.ac.uk|
22385183|NCT01785719|Cornell University|Marla Lujan, PhD|(607) 255-3153|mel245@cornell.edu|
22385184|NCT05417009|Queen Mary University of London|Professor Gareth Ackland|02035940348|g.ackland@qmul.ac.uk|
22385185|NCT01333969|Hospital for Special Surgery|Dr. Stavros Memtsoudis|646-797-8522|MemtsoudisS@hss.edu|8522
22385186|NCT06020534|Erasmus Medical Center|Drs. Yitian Fang|+31 645680154|y.fang.1@erasmusmc.nl|
22385187|NCT04029688|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22385188|NCT05065658|Medical University of Graz|Dr. Juergen Prattes|004331638530046|juergen.prattes@medunigraz.at|
22385189|NCT01926496|LEO Pharma A/S|Disclosure|+45 44945888|disclosure@leo-pharma.com|
22385190|NCT05441579|Nationwide Children's Hospital|Dr. Vanessa Olbrecht|614-722-4200|vanessa.olbrecht@nationwidechildrens.org|
22385191|NCT02143726|Memorial Sloan-Kettering Cancer Center|Eric J. Sherman, M.D.|646-888-4234|shermane@mskcc.org|
22385192|NCT02924272|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22385193|NCT02919683|Dana-Farber Cancer Institute|Jonathan Schoenfeld, M.D. M.P.H.|617-632-3591|jonathan_schoenfeld@dfci.harvard.edu|
22385194|NCT06491433|Department of Cardiology at Gangnam Severance hospital|Byoung Kwon Lee|+82-10-2721-8813|CARDIOBK@yuhs.ac|
22385195|NCT04572399|Cedars-Sinai|Melissa Hampton|3104230617|Melissa.Hampton@cshs.org|
22385196|NCT04749615|Hospital for Special Surgery|Justas Lauzadis, PhD|212-774-2946|lauzadisj@hss.edu|
22385197|NCT05796583|University of California San Diego|Professor of Anesthesiology|(858) 220-5714|bilfeld@health.ucsd.edu|
22385198|NCT05292365|University of Wisconsin School of Medicine and Public Health|Dr. Ryan Coller|608-263-9408|rcoller@pediatrics.wisc.edu|
22385199|NCT05282173|University of Maryland, College Park|Dr. Jessica Magidson|301-405-5095|jmagidso@umd.edu|
22385200|NCT06398886|Istanbul Nisantasi Universitesi|Metin Çınaroğlu|009053247320|metincinaroglu@gmail.com|
22385201|NCT01463423|Stanford University|Maximilian Diehn, MD, PhD|650-725-4783|diehn@stanford.edu|
22385202|NCT04295798|Hebrew SeniorLife|Junhong Zhou|617-971-5346|JunhongZhou@hsl.harvard.edu|
22385203|NCT03524118|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22385204|NCT03483610|University of Rochester|Research Administrator|585-274-1509|peter_macdowell@urmc.rochester.edu|
22385205|NCT04650269|University of Miami Miller School of Medicine|Hansel Tookes|3056897030|hetookes@miami.edu|
22385206|NCT01437709|Memorial Sloan Kettering Cancer Center|Dr. Paul Hamlin, MD|646-608-1667|hamlinp@mskcc.org|
22385207|NCT04091750|Georgetown University|Geoffrey T. Gibney, MD|202-444-2223|Geoffrey.T.Gibney@gunet.georgetown.edu|
22385208|NCT02619838|Duke University|Mark Easley, M.D.|919-660-5066|mark.e.easley@duke.edu|
22385209|NCT01715285|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22412785|NCT02585258|Amsterdam UMC, Vrije Universiteit|Prof Maarten Boers|+3120-4444474|eb@amsterdamumc.nl|
22412786|NCT05125952|Duke University School of Medicine|Elias Pratt|919-684-8111|elias.pratt@duke.edu|
22412787|NCT03946449|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|1 (626) 304-3400|info@arrowheadpharma.com|
22412788|NCT02848326|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22412789|NCT01269801|AboutSkin|Joel L. Cohen, MD|303-756-7546|research@aboutskinderm.com|
22412790|NCT00890981|Amgen Inc.|Study Director|866-572-6436||
22412791|NCT00479258|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22412792|NCT02087514|Columbia University Medical Center|Dr. Eldad Hod|(212) 342-5648|eh2217@cumc.columbia.edu|
22412793|NCT05086835|McLean Hospital|Dr. Roger Weiss|617-855-2242|rweiss@mclean.harvard.edu|
22412794|NCT01978743|Boston University School of Medicine|Dr. Nina Lin|617-414-5242|nina.lin@bmc.org|
22412795|NCT00745420|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
22412796|NCT01532141|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22412797|NCT00594685|New England Research Institutes|Susan Assmann|617-923-7747|sassmann@neriscience.com|548
22412798|NCT01367275|University of Texas (UT) MD Anderson Cancer Center|Dr. Michael Overman, Associate Professor, GI Medical Oncology|713-792-2828|CR_Study_Registration@mdanderson.org|
22412799|NCT02532764|ProQR Therapeutics|Medical Monitor|+31 6 20 183 437|clinical@proqr.com|
22412800|NCT02215161|University of California, San Francisco|Charles Ryan, MD|877-827-3222|clinicaltrials@ucsf.edu|
22412801|NCT02774798|University Hospital of South Manchester|Nick Heywood|+447739002473|nheywood@doctors.org.uk|
22412802|NCT03765502|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22412803|NCT00048568|Bristol Myers-Squibb|BMS Study Director||clinical.trials@bms.com|
22412804|NCT01717976|Durham VA HSR&D|Susan N. Hastings|919-286-0411|susan.hastings@va.gov|4033
22412805|NCT03831048|TransMedics, Inc.|Laura Damme|9785520900|ldamme@transmedics.com|
22412806|NCT01365650|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com|828
22412807|NCT01346085|Ospedale San Raffaele|Dr Lorenzo Piemonti|+390226432706|piemonti.lorenzo@hsr.it|
22412808|NCT01996033|Abbott|Steven Madej|651-756-2230|steven.madej@abbott.com|
22412809|NCT04818242|Emory University|Dr. Guillermo E. Umpierrez|(404) 778-1663|geumpie@emory.edu|
22412810|NCT02896361|Abbott Neuromodulation|Filippo Agnesi, PhD|972-526-4860|filippo.agnesi@abbott.com|
22412811|NCT03831451|University of Michigan|Dr. Lesli Skolarus|734-936-9075|lerusche@umich.edu|
22412812|NCT01767064|USCalifornia|Jason Doctor|213.821.8142|jdoctor@usc.edu|
22412813|NCT02143102|Elucid Bioimaging|Andrew J. Buckler|978-468-0508|andrew.buckler@elucidbio.com|
22412814|NCT03027661|University of Tennessee Health and Science Center|Elaine Todd, Director of Sponsored Programs - Contracts and research agreements|9014483303|ElaineTodd@uthsc.edu|
22412815|NCT03164772|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22385210|NCT05020249|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22385211|NCT04015167|Stryker|Monica Fleeman|251-465-5969|monica.fleeman@stryker.com|
22385212|NCT03916042|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
22385213|NCT03798093|Sharp Healthcare|Dr. Anup Katheria|8589394170|Anup.Katheria@sharp.com|
22385214|NCT04376502|Miami Cancer Institute at Baptist Health, Inc.|Director, Research Concept & Protocol Development|(786) 527-9546|MCIResearchConceptAndProtocolDev@baptisthealth.net|
22385215|NCT04111536|University of Pennsylvania|Theresa M Scattergood, MSN|215-898-5664|theresa.scattergood@pennmedicine.upenn.edu|
22385216|NCT04547920|Avation Medical|Clinical Operations Project Manager|(614) 591-4201|customercare@avation.com|
22385217|NCT06037369|Chang Gung University, Taiwan|Yen-Fan Chin|032118800|yenfan@mail.cgu.edu.tw|5189
22385218|NCT04209465|Black Diamond Therapeutics, Inc.|Medical Monitor|617-401-8444|ClinicalTrials@bdtx.com|
22385219|NCT05603143|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22385220|NCT05647304|REGEnLIFE|Guillaume Blivet|+33434481535|gblivet@regenlife.com|
22385221|NCT04171999|University of Chicago|Emily Abramsohn|7738344832|eabramsohn@bsd.uchicago.edu|
22385222|NCT03993509|University of Pennsylvania|Nicholas Balderston|2157463058|nicholas.balderston@pennmedicine.upenn.edu|
22385223|NCT04505904|University of Arizona|Brian Arizmendi|9168473623|arizmendi@email.arizona.edu|
22385224|NCT03629990|Medical University of South Carolina|Brian Sherman, Ph.D.|843-792-8174|shermanb@musc.edu|
22385225|NCT04277442|The Ohio State University|Dr. Alice Mims|(614) 293-3196|Alice.Mims@osumc.edu|
22385226|NCT03092518|National Cancer Institute|Dr. Jeremy Davis|2408583731|jeremy.davis@nih.gov|
22385227|NCT02301910|SuperGene LLC|Markin Sergey|(495) 287-98-07|info@supergene.ru|+7
22385228|NCT02547987|Baylor College of Medicine|Mothaffar Rimawi, M.D.|713-798-1311|rimawi@bcm.edu|
22385229|NCT04282148|Abbott|Ikuko Kishimoto, Principal Research Scientist|480-482-8279|ikuko.kishimoto@abbott.com|
22385230|NCT03808818|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22385231|NCT04518917|Washington University in St. LOuis|Gammon Earhart|314-286-1407|earhartg@wustl.edu|
22385232|NCT03865498|Columbia University|Sunmoo Yoon|+1 212 300 7081|sy2102@cumc.columbia.edu|
22385233|NCT05084508|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22385234|NCT04137289|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22385235|NCT04531280|Brigham and Women's Hospital|Dr. David Levine|6177328925|dmlevine@bwh.harvard.edu|
22412816|NCT01076452|Hines Veterans Affairs Hospital Center for Management of Complex Chronic Care|Frances M. Weaver, Ph.D|708-202-8387|frances.weaver@va.gov|25866
22412817|NCT00324168|F.I. Proctor Foundation, University of Califonia, San Francisco|Dr. Thomas Lietman|415-502-2662|tom.lietman@ucsf.edu|
22385236|NCT03994653|Imperial College London|Dr James Flanagan|44 2075942127|j.flanagan@imperial.ac.uk|
22385237|NCT03931174|Northwestern University|Sara Becker|312-503-4203|sara.becker@northwestern.edu|
22385238|NCT05386030|Croma Pharma|Clinical Development - Head of Clinical Operations|+432262684680|clinical.studies@croma.at|
22385239|NCT05228457|University of Pennsylvania|Walid Makhoul|215-573-2409|walid.makhoul@pennmedicine.upenn.edu|
22430117|NCT03137407|Revance Therapeutics, Inc.|Todd Gross, PhD, VP, Clinical Development & Data Science|510-742-3400|tgross@revance.com|
22412818|NCT01203878|Tennessee Clinical Research Center|Medical Director|615-383-2400|jbiron@tnclinicalresearch.com|
22430118|NCT01267136|Children's Hospitals and Clinics of Minnesota|Andrea Postier/Clinical Research Program Manager|612-813-6409|andrea.postier@childrensmn.org|
22430119|NCT01897896|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22430120|NCT01489826|e-Therapeutics plc|Clinical Operations Manager|+44 1993 880000|contact@etherapeutics.co.uk|
22430121|NCT02451007|Pharma Mar, S.A.|Clinical Development Department of PharmaMar's Oncology Business Unit|+34 91 846 60 00|clinicaltrials@pharmamar.com|
22430122|NCT01716559|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22430123|NCT00348374|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22430124|NCT00548691|Luitpold Pharmaceuticals, Inc.|Mark Falone, MD|610-650-4200|mfalone@luitpold.com|
22430125|NCT01631929|HOSPITAL GENERAL DE NIÑOS PEDRO DE ELIZALDE|Ferreira Juan Pablo MD|+5491136085959|ferreirajuanpablo@hotmail.com|
22446494|NCT00959764|Tarsa Theapeutics, Inc.|Dr. David Krause, Chief Medical Officer|1-267-273-7940|dkrause@tarsatherapeutics.com|
22446495|NCT02284516|Shire (Note: Lifitegrast was divested to Novartis in 2019)|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22446496|NCT00864383|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|(212) 227-7540|Dan.Everitt@tballiance.org|
22446497|NCT01306942|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
22446498|NCT03988088|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22446499|NCT00113022|Experimental Therapeutics and Pathophysiology Branch, NIMH|Dr. Carlos Zarate|301-451-0861|zaratec@mail.nih.gov|
22446500|NCT01546883|University of Utah|Clinical Research Manager|8015873889|christina.pacchia@hsc.utah.edu|
22446501|NCT03344796|Northwestern Univ|Dr. June Robinson|312-503-5941|june-robinson@northwestern.edu|
22446502|NCT00915278|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22446503|NCT02412618|VCU Medical Center|Dr. Frances Casey|804-828-7877|frances.casey@vcuhealth.org|
22446504|NCT01253408|Mayo Clinic|Dr. Michael Camilleri|507-266-2306|camilleri.michael@mayo.edu|
22446505|NCT03408483|UAB|Adam Sturdivant|205-934-4042|Adamsturdivant@uabmc.edu|
22446506|NCT02516046|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
22446507|NCT01199965|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
22446508|NCT00923156|Novartis Pharmaceuticals|Study Director|862-778-8300||
22446509|NCT03137537|Dana Farber Cancer Institute|Dr. Anju Nohria|6175257052|anohria@partners.org|
22446510|NCT00672243|The Preston Robert Tisch Brain Tumor Center at Duke|David A. Reardon, MD|(919) 668-1409|reard003@mc.duke.edu|
22446511|NCT01211730|Northwestern University Feinberg School of Medicine|Mark E. Molitch, M.D.|312 503-4130|molitch@northwestern.edu|
22446512|NCT02465515|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22446513|NCT00816595|Mayo Clinic|Tait Shanafelt, M.D.||shanafelt.tait@mayo.edu|
22446514|NCT00629707|University of California, Davis|Dr. Nicole Glaser|916-734-7098|nsglaser@ucdavis.edu|
22446515|NCT00453063|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22446516|NCT01577108|China Medical University Hospital|Ming Ho, MD|886422052121|mi.ho@msa.hinet.net|2063
22446517|NCT02885012|Medical University of South Carolina|John Terrill Huggins|(843) 792-2296|hugginjt@musc.edu|
22446518|NCT01055171|Medical University of South Carolina|Dr. Michael Saladin|843-792-5306|saladinm@musc.edu|
22446519|NCT01918774|Richard L. Roudebush VA Medical Center|Marina Kukla|317-988-3330|marina.kukla2@va.gov|
22446520|NCT01619982|Stanford University|Chandra Ramamoothy|650-723-5728|chandrar@stanford.edu|
22446521|NCT03000439|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22446522|NCT01308060|Q-Med AB|Clinical Project Manager|+46184749000|reception.seupp@galderma.com|
22446523|NCT01389817|Medical College of Wisconsin|Harry T. Whelan M.D.|414-266-3466|hwhelan@mcw.edu|
22446524|NCT01749137|Rhythm Pharmaceuticals, Inc|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
22446525|NCT01244724|Weill Cornell Medical College|James H. Kocsis, M.D.|212-746-5913|jhk2002@med.cornell.edu|
22446526|NCT04980040|Takeda|Medical Director|+1 877-825-3327|trialdisclosures@takeda.com|
22446527|NCT01508650|Wake Forest School of Medicine|Dr. Dalane Kitzman|336-716-2227|dkitzman@wakehealth.edu|
22446528|NCT02064894|CHU Ste-Justine Hospital|Dr. Sylvie Le May|514-343-6384|sylvie.lemay@umontreal.ca|
22446529|NCT01976338|Novartis|Study Director|862-778-8300||
22446530|NCT01373242|University of North Carolina at Chapel Hill|Edwin Kim, MD; Director UNC Food Allergy Initiative|919-537-3193|edwinkim@email.unc.edu|
22446531|NCT01471171|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22446532|NCT02864498|DS Biopharma|Study Director|+353 1 2933590|regulatory.dsbiopharma@DSBiopharma.com|
22446533|NCT01112865|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22385240|NCT04382664|Ultimovacs ASA|Øivind Foss, Head of Clinical Operation|97008357|oivind.foss@ultimovacs.com|
22385241|NCT04528173|The Children's Hospital of Philadelphia|Tori Nicole Sutherland MD MPH|443-631-5032|sutherlant@chop.edu|
22430126|NCT02062008|University of California San Francisco|miguel hernandez pampaloni|4153531886|miguel.pampaloni@ucsf.edu|
22412819|NCT01682083|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22412820|NCT02731157|Duke University|Ian Welsby, M.D.|919-681-6752|ian.welsby@duke.edu|
22412821|NCT01014728|University of Chicago|Dr. Robert Naclerio|773-702-0080|rnacleri@surgery.bsd.uchicago.edu|
22412822|NCT03657160|Takeda|Study Director|+1-877-825-3327|medinfoUS@takeda.com|
22412823|NCT00488865|Rex Medical|James Bressler|610-940-0665|ebressler@rexmedical.com|
22412824|NCT02732210|Amgen Inc.|Study Director|866-572-6436||
22412825|NCT00686959|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22412826|NCT01876706|NeoTract|Monica Ransom Director of Clinical Operations|4159648770|Monica.Ransom@Teleflex.com|
22412827|NCT00604500|Merck Sharp and Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsresultsdisclosure@merck.com|
22412828|NCT02191891|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22412829|NCT02339233|University of Lousiville|Dr. Susan Harkema|502-581-8675|susan.harkema@louisville.edu|
22412830|NCT03099538|Mayo Clinic|Aaron R. Mangold, MD|480-301-4256|mangold.aaron@mayo.edu|
22412831|NCT01448057|Novartis consumer Health a GSK Consumer Healtcare company|Director Clinical research Respiratory|(1) 5512065988|anna.x.grinienko@gsk.com|
22412832|NCT02724800|VA Pittsburgh Healthcare System|Adam Bramoweth, PhD|412-360-2806|Adam.Bramoweth@va.gov|
22412833|NCT02468778|Abbott Vascular|Sandeep Pingle, Principal Clinical Scientist|408-845-2111|Sandeep.pingle1@abbott.com|
22412834|NCT00924326|National Cancer Institute|Steven Rosenberg, M.D., Ph.D.|240-858.3080|sar@nih.gov|
22412835|NCT00262964|Washington University School of Medicine|Elisa Fabbrini, MD|314-362-8156|efabbrini@dom.wustl.edu|
22412836|NCT03912337|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22412837|NCT01041781|Fox Chase Cancer Center|Martin J. Edelman, M.D.|(215) 728-4790|martin.edelman@fccc.edu|
22412838|NCT03561883|Ironwood Pharmaceuticals, Inc.|Ironwood Study Chair|(617) 621-7722|Info@ironwoodpharma.com|
22412839|NCT03978624|UNC Lineberger Comprehensive Cancer Center|Melahat Canter|919-962-0000|Melahat_Canter@med.unc.edu|
22412840|NCT03118466|Massachusetts General Hospital|Andrew Brunner MD|6177241124|abrunner@mgh.harvard.edu|
22430127|NCT00782379|Blood and Marrow Transplant Group of Georgia|Dr. Scott Solomon|404-255-1930|ssolomon@bmtga.com|
22430128|NCT01585207|Icahn School of Medicine at Mount Sinai|Dr. Barbara J. Coffey|212-659-1663|Barbara.coffey@mssm.edu|
22430129|NCT00458705|Memorial Sloan Kettering Cancer Center|Dr. Heather Landau|212-639-8808|landauh@mskcc.org|
22430130|NCT02695771|Corewell Health|Dr. Brian Lane|616-267-7333|brian.lane@corewellhealth.org|
22430131|NCT03574389|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22430132|NCT00378560|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22430133|NCT03023683|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
22446534|NCT00705484|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22446535|NCT01606007|AstraZeneca Pharmaceuticals|Boaz Hirshberg||ClinicalTrialTransparency@astrazeneca.com|
22446536|NCT00851747|Loyola Medical Center|Rebecca Tung, MD|(708) 216-4962|rtung@loyolamedical.org|
22446537|NCT04353271|University of South Alabama|Office of Research Complaince|2514607573|swhite@southalabama.edu|
22446538|NCT02499783|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22446539|NCT02228460|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22446540|NCT01243892|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22446541|NCT03675477|ReistoneBiopharma|Roger Liu, Medical Director|+8613917512446|roger.liu@reistonebio.com|
22446542|NCT00119106|CDC|Dr. Michael Martin|662 580 0669|ZND9@CDC.GOV|
22446543|NCT01866293|Memorial Sloan Kettering Cancer Center|Sergio Giralt, MD|212-639-6009|GiraltS@mskcc.org|
22446544|NCT01010061|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22446545|NCT03066804|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22446546|NCT00740831|PregLem SA|Dr Elke Bestel|+41 22 884 03 40|medical@preglem.com|
22446547|NCT03050554|UC San Diego Moores Cancer Center|Dr. Andrew Sharabi|858-534-4808|ansharabi@health.ucsd.edu|
22446548|NCT00730132|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22446549|NCT03982368|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22446550|NCT03570697|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22446551|NCT00518284|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22446552|NCT01849783|University of Iowa|Margarida Magalhaes-Silverman, MD|319-384-9156|margarida-silverman@uiowa.edu|
22446553|NCT02571777|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22446554|NCT00801632|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22446555|NCT03652012|University of Arizona|Dr Ying-hui Chou|5206217447|yinghuichou@arizona.edu|
22446556|NCT01288235|Massachusetts General, Hospital|Torunn I. Yock, MD|6177262000|tyock@mgh.harvard.edu|
22446557|NCT05393895|Orasis Pharmaceuticals, Ltd.|Head of Regulatory Affairs|+972-9-8877745|iris.meisner@orasis-pharma.com|
22446558|NCT02478775|University of Colorado School of Medicine|Dr. Alex Polotsky|303-704-8221|ALEX.POLOTSKY@CUANSCHUTZ.EDU|
22446559|NCT03851705|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22446560|NCT03617185|University of Michigan|Brian Callaghan, MD|7349367183|Bcallagh@med.umich.edu|
22412841|NCT04646109|Afyonkarahisar Health Sciences University|Prof. Dr. Nurullah Okumuş|+90 532 4372406|drnuri@hotmail.com|
22412842|NCT06176768|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22430134|NCT02070380|Bracco Diagnostics, Inc.|Gianpaolo Pirovano, MD|609-514-2226|gianpaolo.pirovano@diag.bracco.com|
22446561|NCT04672993|Coloplast|Senior Scientific Manager Marianne Raff Dambæk|004549112562|dkmr@coloplast.com|
22446562|NCT01964430|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22446563|NCT02591290|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22446564|NCT02571075|Womack Army Medical Center|Anthony Plunkett|910-643-2324|anthony.r.plunkett.civ@mail.mil|
22446565|NCT04092439|Pennington Biomedical Research Center|Tim Allerton, Ph.D.|225-763-2940|timothy.allerton@pbrc.edu|
22446566|NCT00913497|Corewell Health|Esther Peariso|6164860358|esther.peariso@corewellhealth.org|
22446567|NCT03190915|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22446568|NCT02713373|Roswell Park Comprehensive Cancer Center|Katy Wang|716-845-1300|Chong.Wang@RoswellPark.org|
22446569|NCT04789499|Washington University in Saint Louis|Research Statistician|3143621077|kallogjerid@wustl.edu|
22446570|NCT01194466|Mount Mercy University/The University of Iowa|Dr. Jen Lee|3193231623|jlee@mtmercy.edu|
22446571|NCT02933606|Bionomics Limited|VP Clinical Development|+61 8 8150 7400|BNC210clinicalstudies@bionomics.com.au|
22446572|NCT00183677|Massachusetts General Hospital|Dan Iosifescu, MD, MSc||diosifescu@partners.org|
22446573|NCT02021773|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22446574|NCT01745133|DermResearch PLLC|leon kircik|5023965310|wedoderm@yahoo.com|
22446575|NCT00478231|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22385242|NCT03213691|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22385243|NCT02862210|Brown University|Edward Huey, MD|401-455-6403|edward_huey@brown.edu|
22385244|NCT03161028|VA Portland Medical Center|Dr. Rebecca Spain|503-346-0768|rebecca.spain@va.gov|
22446576|NCT01899261|Montefiore Medical Center and Albert Einstein College of Medicine|Dr. Nitin Ohri|718-920-7750|nohri@montefiore.org|
22446577|NCT00084383|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Daniel Laheru|410-955-8974|laherda@jhmi.edu|
22446578|NCT00191139|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22446579|NCT01817530|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22446580|NCT00072566|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22446581|NCT00566995|National Cancer Institute|Dr. W. Marston Linehan|301-496-6353|linehanm@mail.nih.gov|
22446582|NCT02657369|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22446583|NCT00481078|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22446584|NCT00074152|International Breast Cancer Study Goup|Barbara Ruepp|+4131 3899222|barbara.ruepp@ibcsg.org|
22446585|NCT00228384|W. L. Gore & Associates, Inc.|Chad Badorek|800/437-8181|cbadorek@wlgore.com|
22446586|NCT01785069|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22446587|NCT03288129|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22446588|NCT05853185|Liaquat University of Medical and Health Sciences|Dr. Sarang Suresh|03154044802|hotchandanisarang@gmail.com|
22446589|NCT01744197|Evergreen Hematology and Oncology|Melanie Matson, RN, BSN|5094642873|mmatson@evergreen4cure.com|
22430135|NCT03850431|Center to Improve Veteran Involvement in Care (CIVIC), HSR&D Center of Innovation, VA Portland Health Care System|Dr. Alan Teo|5032208262|alan.teo@va.gov|52461
22446590|NCT04543838|UPMC|Parthasarathy Thirumala, MD|412-648-4208|thirumalapd@upmc.edu|
22446591|NCT02761252|Menarini International Operations Luxembourg SA|Medical Director|+352 2649761|aconte@menarini.lu|
22446592|NCT03305575|Tufts Medical Center|Alaa Basura, MD|6176365000|abasura@tuftsmedicalcenter.org|6208
22446593|NCT01758432|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
22385245|NCT03492216|University of California, San Francisco (UCSF)|Dr. Gabriel Chamie|415-476-4082|gabriel.chamie@ucsf.edu|445
22385246|NCT00736723|University|Prof. Dr. Manfred Weiss|#49 731 500 60226|manfred.weiss@uni-ulm.de|
22385247|NCT02587403|RTI Surgical|Jennifer Johnson, Senior Clinical Manager|386-418-8888|jljohnson@rtix.com|
22385248|NCT01799265|Bluebird Consulting|Melinda Swanson|6123084500|melinda@bluebirddevice.com|
22385249|NCT03134092|University of Pennsylvania Perelman School of Medicine|Dr. Zachary Meisel|215-746-5618|zfm@pennmedicine.upenn.edu|
22446594|NCT02871297|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
22446595|NCT01509950|Stanford University|Research Operations Manager|6507255720|agirsen@stanford.edu|
22446596|NCT02966028|Sanifit|SVP Clinical Development Operations|18582815976|Claire.Padgett@sanifit.com|
22446597|NCT04115839|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22446598|NCT01304316|University of Pennsylvania|Dr. Elliot V. Hersh|215-898-9686|evhersh@pobox.upenn.edu|
22446599|NCT02820753|Northwestern University|Stephanie Batio|312-503-4684|stephanie.batio@northwestern.edu|
22446600|NCT01408485|St. Jude Medical|Nancy Ouch, Senior Clinical Project Manager|949-769-5000|NOuch@sjm.com|
22446601|NCT01652703|Amgen Inc.|Study Director|866-572-6436||
22446602|NCT02151591|YALE UNIVERSITY SCHOOL OF MEDICINE|Dr. Lisa Fucito|203-200-1470|Lisa.fucito@yale.edu|
22446603|NCT02380677|NewLink Genetics Corporation|Manager, Clinical Operations|515-598-5020|csmith@linkp.com|2624
22446604|NCT01342796|Novartis Vaccines and Diagnostics|Posting Director||Novartis.email@novartis.com|
22446605|NCT01751867|Janssen R&D US|SR DIR COMPD DEV TM LDR|1 908 704-5197||
22446606|NCT01396148|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22446607|NCT02536040|Advantage Silver Dental Arrest, LLC|Peter Milgrom|2062516831|drmilgrom@silverarrest.com|
22446608|NCT01089062|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
22446609|NCT00224042|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com|
22446610|NCT00840450|NYU Cancer Institute|Franco Muggia, MD|212-263-6485|franco.muggia@nyumc.org|
22446611|NCT03095066|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22446612|NCT00844714|University of California, San Francisco|Priscilla Hsue, MD|415-206-8257|phsue@medsfgh.ucsf.edu|
22446613|NCT05988619|Pomona College|Dr. Benjamin Rosenberg|408-458-5375|benjamin.rosenberg@pomona.edu|
22446614|NCT04538261|AdventHealth Orlando|D. Ashley Hill, MD|407-303-1444|Ashley.Hill.MD@AdventHealth.com|
22446615|NCT00726232|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22446616|NCT00790985|Primus Pharmaceuticals|Robert Levy, MD., Director of Clinical Development|480-483-1410|Rlevy@primusrx.com|
22446617|NCT01203098|Daiichi Sankyo.,LTD|Masayuki Fukuzawa, Associate Director|81-90-5584-2197|fukuzawa.masayuki.gn@daiichisankyo.co.jp|
22446618|NCT02650856|Universidad Autonoma de Nuevo Leon|FELIX VILCHEZ CAVAZOS|8183476698|vilchez.doctor@gmail.com|
22446619|NCT00244010|St. Jude Children's Research Hospital|Kimberly Kasow, DO|901-595-3300|kimberly_kasow@med.unc.edu|
22430136|NCT00337194|The Ohio State University|Dr. Kristie Blum||kristie.blum@osumc.edu|
22446620|NCT03095612|University of Texas Southwestern Medical Center|Dr. David Gerber|214-648-4180|david.gerber@utsouthwestern.edu|
22446621|NCT00621582|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22446622|NCT01042678|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22446623|NCT01387932|Merit Medical Systems, Inc.|Vicky Brunk RN, Vice President, Medical Affairs, Merit Medical|+1 (717) 873-3309|vicky.brunk@merit.com|
22446624|NCT00000371|Freedom Clinic Trail, Massachusetts General Hospital|Dr. Donald Goff|617-921-7899|goff@psych.mgh.harvard.edu|
22446625|NCT02197520|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22446626|NCT03208244|Massachusetts General Hospital|Raymond Chung, MD|617-724-7562|Chung.Raymond@mgh.harvard.edu|
22446627|NCT00578383|McLean Hospital|Dr. Michael Rohan|617-855-3127|mrohan@mclean.harvard.edu|
22446628|NCT04431453|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22446629|NCT03385564|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22446630|NCT01146834|Weill Cornell Medicine|Ruben Niesvizky, MD|646-962-9376|run9001@med.cornell.edu|
22446631|NCT01481376|Surgical Department of the Protestant Hospital|Docteur Dieter BIRK|06332 422120||
22446632|NCT01702961|Baylor College of Medicine|George Carrum, MD||GCarrum@houstonmethodist.org|
22446633|NCT01804465|University of California, San Francisco|Dr. Lawrence Fong, MD|(415) 514-3160|Lawrence.Fong@ucsf.edu|
22446634|NCT04338074|University of Alabama at Birmingham|Dr. Timothy J Ness|205-975-9643|tness@uabmc.edu|
22446635|NCT00727220|IndianaU|Linda A DiMeglio|317-944-3889|dimeglio@iu.edu|
22446636|NCT02405780|Fujifilm Kyowa Kirin Biologics Co., Ltd., EU Branch|Clinical Trial Information|0044 1896 668 173|Clinical-Trials@fk-b.com|
22446637|NCT00668707|The Centre for Health Innovation|Mark Legacy, Clinical Trial Coordinator|613-792-1222|mlegacy@thechi.ca|1
22446638|NCT02494297|Center for Epidemiology and Health Research, Germany|Dr. Klaas Heinemann|0049 (0) 30 945 101 20|k.heinemann@zeg-berlin.de|
22446639|NCT00834171|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22446640|NCT03724032|University of Michigan|Jacqueline Dobson|734-763-8469|contactHOPE@umich.edu|
22446641|NCT00751933|Haukeland University Hospital|Gunnar Nysæter or Solomon Tefera or Jan Hatlebakk|+47 55972900|jhat@helse-bergen.no|
22446642|NCT00981370|Childrens Hospital Los Angeles|Thomas Coates, MD|323-361-2352|tcoates@chla.usc.edu|
22446643|NCT03846804|Indiana University School of Medicine|James Wood, MD|317-944-7260|woodjb@iu.edu|
22446644|NCT00361569|Duramed Research|Duramed Research Protocol Chair|215-293-7279|medicalaffairs@barrlabs.com|
22446645|NCT02605824|UCSF Airway Clinical Research Center|Fahy Research Manager|415-514-1539|ariana.baum@ucsf.edu|
22446646|NCT04875195|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@msd.com|
22446647|NCT02339584|Enter Alcon, A Novartis Division|Clinical Scientific Associate Director, GCRA, GDD|1-888-451-3937|alcon.medinfo@alcon.com|
22446648|NCT00826943|Vanderbilt University|Douglas Tzanetos|615-942-7971|dtzanetos@hotmail.com|
22446649|NCT03715530|University of Iowa|Dr. Mark Santillan|319-356-3180|mark-santillan@uiowa.edu|
22446650|NCT01594762|Dipexium Pharmaceuticals, Inc|Robert J DeLuccia|+19145226503|delucciarj@gmail.com|
22446651|NCT02151383|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22446652|NCT03338998|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22446653|NCT01213329|Northwestern University|Dr. Lorenzo Gallon|312-695-8900|l-gallon@northwestern.edu|
22446654|NCT04706091|Massachusetts General Hospital|John W Winkelman, MD PhD|617-724-7426|jwwinkelman@mgh.harvard.edu|
22446655|NCT03329573|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22446656|NCT00650260|University of South Florida Dept of Surgery/Anesthesiology|Enrico Camporesi MD|813-844-7170|ecampore@health.usf.edu|
22446657|NCT02777333|University of Oxford|Mr P Garfjeld Roberts|01865 227374|patrick.garfjeldroberts@ndorms.ox.ac.uk|
22446658|NCT05405309|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
22446659|NCT05695209|Indiana University|Principal Investigator|317-278-3154|mmatthia@iu.edu|
22446660|NCT05438888|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22446661|NCT03069378|Memorial Sloan Kettering Cancer Center|Dr. Ciara Kelly, MD|646-888-4312|Kellyc1@mskcc.org|
22446662|NCT02993146|Johns Hopkins University|Grants Administrative Manager|4439273568|JHCCCRO@jhmi.edu|
22446663|NCT01397708|Alaunos Therapeutics, Inc|Jaymes Holland Clinical Consultant|6502732627|jholland@alaunos.com|
22446664|NCT04997304|University of Michigan|Njira Lugogo|734-647-6477|nlugogo@med.umich.edu|
22446665|NCT05231954|Indiana University|Katrina Coppedge|317-278-1602|kcoppedg@iu.edu|
22446666|NCT05947643|Washington University, Department of Otolaryngology - Head and Neck Surgery|Dorina Kallogjeri, Assoc.Professor of Otolaryngology|314-362-1077|kallgjerid@wustl.edu|
22412843|NCT03571048|University of Colorado School of Medicine|Elizabeth Thomas, MD|303-724-9083|elizabeth.thomas@cuanschutz.edu|
22412844|NCT03006978|Sight Sciences|Jaime Dickerson|(877) 266-1144|jdickerson@sightsciences.com|
22412845|NCT01606306|Penn State University Dept of Public Health Sciences|David Mauger, PhD|717.573.0336|dmauger@psu.edu|
22412846|NCT00159965|Rhode Island Hospital|W. Curt LaFrance, Jr., MD, MPH|401-444-3534|William_LaFrance_Jr@Brown.edu|
22412847|NCT01759290|Abbott Vascular|Kunal Sampat|408-845-0746|kunal.sampat@av.abbott.com|
22412848|NCT01333527|Research Associate|Anelise Silveira|780-492-2398|anelise.silveira@ahs.ca|
22412849|NCT01993875|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22412850|NCT01264952|Institute of Oncology Ljubljana|Gregor Sersa, PhD|+386 1 5879 434|gsersa@onko-i.si|
22412851|NCT01766778|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22446667|NCT01606800|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22412852|NCT03218592|University of North Carolina at Chapel Hill|Dr. Angela Kashuba|9199969998|akashuba@unc.edu|
22412853|NCT02098993|University of Pittsburgh|Craig Seaman, MD|412-209-7308|seamanc@upmc.edu|
22446668|NCT01340885|Oregon Health & Science University|Diana Dimitrova|503-494-7269|dimitrov@ohsu.edu|
22446669|NCT04249583|Galderma Research & Development|Galderma Research & Development|8179615000|clinical.studies@galderma.com|
22446670|NCT00612690|University of Illinois at Chicago|Marc S. Atkins, Ph.D.|312-413-1048|atkins@uic.edu|
22446671|NCT00634166|Mylan Pharmaceuticals Inc.|Eric Davis, M.D.|304.554.6503|eric.davis@mylan.com|
22446672|NCT02370160|Masonic Cancer Center at University of Minnesota|Dr. Veronika Bachanova|612-625-8287|pham0179@umn.edu|
22446673|NCT04487730|Weill Cornell Medicine|Dr. Nili Solomonov|212-746-5886|nis2051@med.cornell.edu|
22446674|NCT00907777|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22446675|NCT03291808|Johns Hopkins University|Gem Roy|4432875796|groy2@jhu.edu|
22446676|NCT00638378|Incyte Corporation|Study Director|1-855-463-3463||
22446677|NCT03364023|Medtronic Neurovascular Clinical Affairs|Medtronic Neurovascular Clinical Affairs|9498373700|rs.nvclinicalprospr-sea@medtronic.com|
22446678|NCT02891850|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22446679|NCT02957305|Dep. of Obstetrics and Gynecology, Universidade Federal do Rio Grande do Sul, Porto Alegre - RS - Brazil|Ricardo Francalacci Savaris|+5551997781966|rsavaris@hpca.edu.br|
22446680|NCT03797014|Institute of Human Virology, University of Maryland Baltimore|Dr. Joel Chua|14107065704|jchua@ihv.umaryland.edu|
22446681|NCT01970397|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22446682|NCT03903874|University of Alabama at Birmingham|Dr. Dori Pekmezi|205-975-8061|dpekmezi@uab.edu|
22446683|NCT02356575|Memorial Sloan Kettering Cancer Center|Dr. Jun Mao, MD, MSCE|646-888-0866|maoj@mskcc.org|
22446684|NCT00105469|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22446685|NCT00056316|University of Missouri-St. Louis|Ann M. Steffen, PhD, Associate Professor|314-516-5382|ann_steffen@umsl.edu|
22446686|NCT02381288|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22446687|NCT02471430|Massachusetts General Hospital|Mathias Lichterfeld|617-726-2000|mlichterfeld@mgh.harvard.edu|
22446688|NCT00573469|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22446689|NCT02468414|Aevi Genomic Medicine|Garry A. Neil, MD|610-254-4208|garry.neil@aevigenomics.com|
22446690|NCT00004978|Division of Biostatistics, University of Minnesota|James Neaton, PhD|612-626-9040|jim@ccbr.umn.edu|
22446691|NCT01044862|Yale University|Heping Zhang, PhD|203-785-5185|heping.zhang@yale.edu|
22446692|NCT03719885|Penn Medicine|Research Coordinator|215-662-9393|jonathan.lilley@pennmedicine.upenn.edu|
22446693|NCT02155608|University of California, Los Angeles|James McGough, M.D.|310-794-7841|jmcgough@mednet.ucla.edu|
22446694|NCT03555591|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22446695|NCT00869349|Brigham and Women's Hospital|Nancy A. Shadick|617-732-5266|nshadick@partners.org|
22446696|NCT01532414|Repros Therapeutics Inc.|Jennifer L Wike, Director of Regulatory Affairs|281-719-3402|jwike@reprosrx.com|
22446697|NCT02728050|University of Washington|Anna Halpern, MD|206-606-1978|halpern2@uw.edu|
22446698|NCT05035550|Michigan State University|Dr. Jason Moser|517-355-2159|jmoser@msu.edu|
22446699|NCT02577510|CF|Gaurav Gupta|6139451601|gaurav00gupta@gmail.com|
22446700|NCT00160693|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22446701|NCT00617123|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22446702|NCT03052725|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22446703|NCT01354990|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22446704|NCT00777608|Merck Sharp and Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22446705|NCT04213079|Icahn School of Medicine at Mount Sinai|Sergei Yakushin|212-241-9349|sergei.yakushin@mssm.edu|
22446706|NCT00520936|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22446707|NCT02123121|University of Florida|Dr. Stephen Anton|(352) 273-7514|santon@ufl.edu|
22446708|NCT00587054|Memorial Sloan-Kettering Cancer Center|Dr. Ann Jakubowski|212-639-5013|jakubowa@mskcc.org|
22446709|NCT03858309|Oregon Health & Science University (OHSU)|Selda Yildiz, PhD|(503) 494-7219|yildiz@ohsu.edu|
22446710|NCT01812174|Artivion, INC|Erica Troup , Clinical Project Manager|706-409-5974|erica.troup@artivion.com|
22446711|NCT00553644|Veterans Affairs Medical Center/University of Minnesota|Vicki Morrison, M.D.||morri002@umn.edu|
22446712|NCT02621060|Institute of Experimental and Clinical Therapeutics|Dra. Esperanza Martínez Abundis|+52-33-10-58-52-00|esperanzamartnezabundi@yahoo.com|34211
22430137|NCT04046952|Long Beach VA Healthcare System|Dr. Arnold Seto|562-826-8000|arnold.seto@va.gov|12876
22412854|NCT02888171|University of Alabama at Birmingham|Orlando M. Gutierrez, MD|205-996-2736|ogutierrez@uabmc.edu|
22412855|NCT02937701|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22412856|NCT01507051|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22412857|NCT01101022|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22412858|NCT03075761|The University of Texas Southwestern Medical Center|Ayesha Zia, MD|214-456-7000|Ayesha.Zia@UTSouthwestern.edu|
22385250|NCT05704543|Indivior Inc.|Global Director Clinical Development|(804) 594-4488|trialdisclosure@indivior.com|
22430138|NCT01132690|Protalix Biotherapeutics|Senior VP Development|+972-4-902-8100|einat@protalix.com|
22412859|NCT01139047|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
22412860|NCT00581139|University of California, Irvine|Dr. Zeev Kain|714-480-0039|zkain@uci.edu|
22412861|NCT00420303|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22412862|NCT01941095|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22412863|NCT01721681|Bio Products Laboratory Ltd|Head of Medical Affairs|+44 20 8957 2200|medinfo@bpl.co.uk|
22412864|NCT04455633|Lexicon Pharmaceuticals, Inc.|Medical Affairs|510-338-6064|medical-information@lexpharma.com|
22412865|NCT01648166|University of Kentucky|Dr. Susanne Arnold|8592579568|smarno0@uky.edu|
22412866|NCT00883090|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22412867|NCT03527745|Swiss Tropical and Public Health Institute|Jennifer Keiser, PhD|+41 (61) 284 8218|jennifer.keiser@swisstph.ch|
22412868|NCT03344510|Perelman School of Medicine at the University of Pennsylvania|Dr. Joseph Sobanko|215.360.0909|joseph.sobanko@uphs.upenn.edu|
22412869|NCT04083859|Wake Forest University School of Medicine|Dr. David P. Miller, Jr|336-713-5218|dmiller@wakehealth.edu|
22412870|NCT00560235|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22412871|NCT04015232|Lambda Therapeutic Research Ltd.|Dr. Adarsh Kumar Garg, M.B.B.S. Principal Investigator|+91-79-40202020|adarshgarg@lambda-cro.com|
22412872|NCT01027780|University of Rochester|Dr. Jan Moynihan|585-275-4648|jan_moynihan@urmc.rochester.edu|
22412873|NCT01087970|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22412874|NCT03655106|William Beaumont Hospitals|Amit Bahl, MD|2488982245|amit.bahl@beaumont.edu|
22412875|NCT00365300|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22412876|NCT01029353|Vanderbilt University Medical Center|Martin L Blakely, MD|615-936-7211|martin.blakely@vumc.org|
22412877|NCT01453075|VA ORD|Mary Jane Burton|6013624471|mary.burton2@va.gov|1251
22412878|NCT04538170|Department of Anaesthesiology and Intensive Care Medicine, Eberhard-Karls-University,Tuebingen, Germany|Dr. Barbara Schlisio|+4970712985535|barbara.schlisio@med.uni-tuebingen.de|
22412879|NCT00637299|Fondazione Salvatore Maugeri|Ercole Zanotti|39 385 247|ercole.zanotti@fsm.it|324
22412880|NCT00274937|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22412881|NCT03002597|Children's Hospital of Pittsburgh UPMC|Dr. Kanwal Nischal|4126928940|nischalkk@upmc.edu|
22412882|NCT02932878|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
22412883|NCT03503578|Massachusetts General Hospital DACCPM|Dr. Oluwaseun Johnson-Akeju|617-724-7200|oluwaseun.akeju@mgh.harvard.edu|
22430139|NCT00159874|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22430140|NCT01104870|United Therapeutics, Corp.|Kevin Laliberte, PharmD|919-425-8176|KLaliberte@unither.com|
22430141|NCT00501943|UCSF|Dr Emmanuelle Waubant, MD|415- 514 2468|Emmanuelle.Waubant@ucsf.edu|
22430142|NCT05463705|Brigham and Women's Hospital|Nancy Haff, MD, MPH|857-307-3826|nhaff@mgb.org|
22430143|NCT02771145|Alcon, A Novartis Division|Sr. Clinical Project Lead, GCRA, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22430144|NCT00276380|Ipsen|Medical Director||clinical.trials@ipsen.com|
22430145|NCT03596983|NYU Langone Health|Susan Malone, PhD, RN|212 992-7047|Susan.Malone@nyulangone.org|
22430146|NCT03071965|Neurotech Pharmaceuticals, LLC|CMO|401-333-3880|neurotech@neurotechusa.com|
22430147|NCT02346370|Halozyme, Inc.|Halozyme Study Information|1-844-855-4256|medinfo@halozyme.com|
22430148|NCT03654326|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22430149|NCT04601493|University of Minnesota|Ezra Golberstein|612-626-2572|egolber@umn.edu|
22430150|NCT01362270|Oregon Health & Science University|Samantha Underwood, Research Manager|503-494-8481|underwos@ohsu.edu|
22430151|NCT01691482|GlaxoSmithKline|GSK Response Center|866-435-7343||
22430152|NCT01953354|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22430153|NCT00819832|UT MD Anderson Cancer Center|Dawid Schellingerhout, MD/Asst. Professor||CR_Study_Registration@mdanderson.org|
22430154|NCT01063881|Janssen Research & Development, LLC|Sr. Director CDTL, RA CVM Urology|1 908 704-4648||
22430155|NCT00066170|Jazz Pharmaceuticals, Inc|Grace Wang, MD Director of Clinical Development & Medical Monitor|650-496-3777||
22430156|NCT02540434|Weill Cornell Medicine|Michele Steinkamp|2127462953|mls9004@med.cornell.edu|
22430157|NCT01370642|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22430158|NCT01796470|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22430159|NCT00147537|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22430160|NCT02191397|GlaxoSmithKline|GSK Response Center|866-435-7343||
22430161|NCT03124602|Masimo|Tala Harake|9492977459|studies@masimo.com|
22430162|NCT01933425|Herlev Hospital, University of Copenhagen, Department of Anesthesiology|Dr. Matias Vested Madsen|+4538689058|matias.vested.madsen@regionh.dk|
22430163|NCT03888482|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22430164|NCT02294019|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22430165|NCT00846482|Montefiore Medical Center|Dr. Sanjay Goel|718-405-8404|sgoel@montefiore.org|
22430166|NCT01189227|NSABP Foundation, Inc.|Director, Division of Regulatory Affairs|412-330-4600||
22430167|NCT04818086|Virginia Commonwealth University|Dr. Frederick Gerald Moeller|804-828-4134|fgmoeller@vcu.edu|
22430168|NCT02882178|Institut Bergonié|Pr Simone Mathoulin-Pélissier|0556333333|s.mathoulin@bordeaux.unicancer.fr|
22430169|NCT04128228|Department of Psychiatry, Yale University School of Medicine|Dongju Seo|475-441-3457|dongju.seo@yale.edu|
22430170|NCT01016015|Memorial Sloan Kettering Cancer Center|Dr. William Tap|646-888-4163|tapw@mskcc.org|
22430171|NCT02402036|Levine Cancer Institute-Concord|Mohamed Salem, MD|704-403-1370|mohamed.salem@lcic.edu|
22412884|NCT01918397|Boston University School of Public Health|Charles R Horsburgh, MD|617-414-1282|rhorsbu@bu.edu|
22412885|NCT01423760|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22412886|NCT00959660|Wake Forest School of Medicine|Dalane W. Kitzman, M.D.|336-716-3274|dkitzman@wakehealth.edu|
22446713|NCT01336764|National Center for PTSD|Steven H. Woodward, PhD|650-493-5000|steve.woodward@va.gov|22111
22446714|NCT01051323|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22446715|NCT01626391|TauRx Therapeutics Ltd|Dr. Jiri Hardlund|+44 (0)1224438550|JHH@taurx.com|
22385251|NCT02938377|University of Alabama at Birmingham|Karen Cropsey, Psy.D|(205) 975-4204|kcropsey@uab.edu|
22385252|NCT05297864|University of Oklahoma Health Sciences Center|James Battiste, MD|405-271-8777|James-Battiste@ouhsc.edu|
22385253|NCT05351554|Kinevant|Study Director|Please email|kinevant.resolve-heart@kinevant.com|
22385254|NCT05030233|The Ohio State University College of Nursing|Marliese D. Nist|614-247-5781|nist.10@osu.edu|
22385255|NCT02727699|Actinogen Medical Limited|Director of Drug Development & Strategy|+61289647401|info@actinogen.com.au|
22385256|NCT05251909|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22385257|NCT02677298|Croma Pharma|Clinical Development - Head of Clinical Operations|+432262684680|clinical.studies@croma.at|
22385258|NCT03210272|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22385259|NCT03611621|Hansa Biopharma AB|Study Director|+46 46 16 56 70|clinicalstudyinfo@hansabiopharma.com|
22385260|NCT03064217|University of Maryland, Baltimore|Se-Lim Oh|4107063708|soh@umaryland.edu|
22385261|NCT03812679|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
22385262|NCT05653427|Janssen Research & Development, LLC|Global Medical Head Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22385263|NCT04671446|Queen Mary University of London|Dr Myles Lewis, Dr Paul Pfeffer|+4420 7882 5555|myles.lewis@qmul.ac.uk; p.pfeffer@qmul.ac.uk|
22385264|NCT04145466|Department of Health and Sport Sciences, TUM School of Medicine and Health, Technical University of Munich|Christoph Hoechsmann|+49 (89) 289 - 24492|christoph.hoechsmann@tum.de|
22385265|NCT04574024|Rutgers, The State University of New Jersey|Suhayl Dhib-Jalbut|732-235-7335|jalbutsu@rwjms.rutgers.edu|
22385266|NCT03016754|ZOLL|Nicole Bianco|4129683333|nbianco@zoll.com|14410
22385267|NCT04185298|Saint John's Cancer Institute|Dr. Jennifer Bramen|310-525-0865|jennifer.bramen@providence.org|
22412887|NCT00849901|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22446716|NCT00370032|GlaxoSmithKline|GSK Response Center|866-435-7343||
22446717|NCT05683249|Neurocentria Inc.|Clinical Development|925-954-4868|info@neurocentria.com|
22446718|NCT05469178|BerGenBio ASA|BerGenBio Clinical Team|+47 559 61 159|registry.postings@bergenbio.com|
22446719|NCT00968513|Stanford University|Judith Prochaska|6507243608|jodi.prochaska@stanford.edu|
22446720|NCT01521546|The Ohio State University|Subha V. Raman, MD|(614)293-8963|raman.1@osu.edu|
22446721|NCT03292562|The University of Texas Health Science Center at Houston|Amir Khan, MD|713-500-5519|Amir.M.Khan@uth.tmc.edu|
22446722|NCT00764738|Retina Macula Institute|Dr. Ron Gallemore||rongallemoremd@gmail.com|
22446723|NCT05466682|NYU Langone Health|Mia T Minen, MD|212-263-7744|mia.minen@nyulangone.org|
22446724|NCT02801396|Johnson & Johnson Vision|Meredith Bishop, OD, MS, FAAO|904-443-1396|MBishop4@its.jnj.com|
22446725|NCT02423993|Endocrinology Research Centre, Moscow|Dr. Lyudmila Ibragimova|+7 9266180811|doc_mila@mail.ru|
22446726|NCT02856035|Department of Veterans Affairs, N Fl/S Georgia VA Medical Center|Dr. Janis J Daly|216 402 8940|jjd17@case.edu|
22446727|NCT02846714|Huntsman Cancer Institute University of Utah|Dr. Yelena Wu|8012135653|yelena.wu@utah.edu|
22446728|NCT03087643|University of Verona|Dr. Massimo Venturelli|00390458415114|massimo.venturelli@univr.it|
22381026|NCT01175707|Cubist Pharmaceuticals|Vice President, Clinical Research|781-860-8318||
22381027|NCT01456780|Massachusetts Eye and Ear|Dr. Reza Dana|617-573-4431|Reza_Dana@meei.harvard.edu|4431
22381028|NCT00350532|Wake Forest University School of Medicine|Dr. James Eisenach|336-716-4498|jimeisenach@gmail.com|
22381029|NCT04170764|TriHealth|Dr. Emily Aldrich|513-463-4300|Emily_Aldrich@trihealth.com|
22381030|NCT01598025|Memorial Sloan Kettering Cancer Center|Dr. Richard O'Reilly, MD|646-888-2157|oreillyr@mskcc.org|
22381031|NCT02321540|UT MD Anderson Cancer Center|Dr. John V. Heymach, Chair, Thoracic-Head & Neck Med Onc|(713) 792-6363|jheymach@mdanderson.org|
22381032|NCT00427973|Massachusetts General Hospital Cancer Center|Andrew X. Zhu, MD|617-643-3415|azhu@partners.org|
22381033|NCT05142228|University of Maryland, School of Dentistry|Dr. Marcela Romero Reyes|4107067168|mromero@umaryland.edu|
22381034|NCT04541186|89bio, Inc.|Entrigue Study Team|1-415-432-9270|Ct.gov_SHTG@89bio.com|
22381035|NCT01873287|Children's Hospital of Eastern Ontario|Dr. Roger Zemek|613-737-7600|rzemek@cheo.on.ca|
22381036|NCT00303303|Carolinas Medical Center|William Kerns II MD Program Directorm Medical Toxicology|704-355-5297|rkerns@carolinas.org|
22385268|NCT04316871|Assiut University|Dr Muhammad Shawqi|01100671067|m.shawqi@med.au.edu.eg|+20
22381037|NCT03085017|Loma Linda University Health Care|David G. Rabkin, MD FACS|909-558-4354|drabkin@llu.edu|
22385269|NCT01842542|Neuronetics|Director of Clinical Operations|16123067393|steve.erickson@neurostar.com|
22385270|NCT02262728|Janssen Research & Development, a division of Janssen Pharmaceutica NV|Medical Leader Hepatitis C, GCO ED&CP||ClinicalTrialDisclosure@its.jnj.com|
22385271|NCT05505292|SUNY College of Optometry|Danielle Iacono|2129385936|diacono@sunyopt.edu|
22385272|NCT02100891|Fred Hutchinson Cancer Center|Monica Thakar, MD - Professor of Pediatrics|206-667-5000|isioc@fredhutch.org|
22385273|NCT01389856|Actelion Pharmaceuticals Ltd|Pegah Nowbakht/Senior Clinical Trial Scientist|+41 61 565 68 41|pegah.nowbakht@actelion.com|
22385274|NCT03959696|Massachusetts General Hospital|Karen Sepucha|617-724-3350|ksepucha@mgh.harvard.edu|
22385275|NCT03452579|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|David Peereboom, MD|1-866-223-8100|TaussigResearch@ccf.org|
22385276|NCT03474679|Janssen Pharmaceutical K.K.|EXECUTIVE MEDICAL DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22385277|NCT05490459|Element Science, Inc.|Chief Medical Officer|4158726500|zubin@elementsci.com|
22385278|NCT05604508|RAND|William Shadel|4126832300|shadel@rand.org|4489
22385279|NCT05337306|GogyUp|Ned Zimmerman-Bence, Co-Founder|6124605358|ned.zb@gogyup.com|
22385280|NCT04858321|University of Portsmouth|Dr Anthony Shepherd|02392845289|ant.shepherd@port.ac.uk|
22385281|NCT01539083|Janssen R&D|Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
22399109|NCT00254566|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22399110|NCT03222427|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22399111|NCT01989221|TempleU|Dr. Henry Parkman|2157072498|henry.parkman@temple.edu|
22399112|NCT00059202|Mayo Clinic|Dr. Keith Lindor|507-284-2511||
22399113|NCT03378479|UZ Leuven|Prof. Dr. Joost Wauters - Intensivist|016344275|joost.wauters@uzleuven.be|
22399114|NCT04088409|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22412888|NCT03828734|University of North Carolina at Chapel Hill|Justin Riddle, PhD|919-966-4755|justin_riddle@med.unc.edu|
22399116|NCT00841763|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22399117|NCT00400400|Novartis Pharmaceuticals|Study Director|862-778-8300||
22399118|NCT00648167|Keryx Biopharmaceuticals Inc|Medical Information|1-844-44-KERYX (1-844-445-3799|medicalinfo@keryx.com|
22399119|NCT01688050|Cook Research Incorporated|Alan Saunders,MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
22399120|NCT00927368|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org|
22399121|NCT03473561|Abbott Laboratories|Suntje Sander, PhD|0049 - 511 - 6750 3254|suntje.sander@abbott.com|
22399122|NCT02876887|Northwestern University|Mary McDermott, MD, Jeremiah Stamler Professor|1 312 503 6419|mdm608@northwester.edu|6419
22399123|NCT03887299|University of Texas Medical Branch Galveston|Antonio F Saad|4097476646|afsaad@utmb.edu|
22399124|NCT00191451|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22399125|NCT00964431|Iroko Pharmaceuticals, LLC|Steven Jensen|267-546-3003|sjensen@iroko.com|
22399126|NCT00592475|Astellas Pharma Global Development|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com|
22399127|NCT00356031|Massachusetts General Hospital|Dr. Sam S. Yoon, Principal Investigator|617 643-9475|syoon@partners.org|
22399128|NCT00272987|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22399129|NCT04137783|Children's Hospital of Chongqing Medical University|Dr. Jianhui Wang|13678428167|wangjh@cqmu.edu.cn|
22399130|NCT03222349|Aquestive Therapeutics|Director of Clinical Operations|908-941-1887|denis.scheper@aquestive.com|
22399131|NCT01058096|Allergan, Inc.|Therapeutic Area Head|714-246-4500||
22399132|NCT04451330|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22399133|NCT05099640|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22399134|NCT00179959|Children's Memorial Hospital|Amy Paller, MD|312-695-6829|apaller@nmff.org|
22381038|NCT00058058|American College of Radiology Imaging Network|Senior Director of Protocol Management||Donna Hartfeil <dhartfeil@acr.org>|
22381039|NCT00748969|LA Biomed at Harbor-UCLA Medical Center|Dr. Lynda Polgreen|310-222-1972|lpolgreen@labiomed.org|
22381040|NCT03532178|UCaliforniaSF|Dr. Chanhung Lee|4154762131|chanhung.lee@ucsf.edu|
22381041|NCT01608971|Heart and Diabetes Center NRW|Andreas Koster|0043 5731 3284|akoster@hdz-nrw.de|
22381042|NCT01113463|University of Texas MD Anderson Cancer Center|Charles A. Conrad, MD / Professor, Neuro Oncology|713-792-2883|CR_Study_Registration@mdanderson.org|
22381043|NCT02724787|James A. Haley Veterans' Hospital|Dr. Shannon Miles|813-972-2000|shannon.miles@va.gov|6728
22381044|NCT00372528|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22381045|NCT00562965|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22381046|NCT00761774|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22381047|NCT01648283|Washington University School of Medicine|Evan D. Kharasch, MD, PhD|314-362-8796|kharasch@wustl.edu|
22381048|NCT01124617|Neuroscience department, clinical science department, R&D in Janssen Japan, Chiyodaku, Tokyo 101-0065 Japan|Manager|+81-3-4411-5509||
22381049|NCT00372970|Temple University|Frank Friedenberg|215-707-9900|frank.friedenberg@temple.edu|
22381050|NCT02402764|H. Lee Moffitt Cancer Center and Research Institute|Dr. Hyo Sook Han|813-745-8960|hyo.han@moffitt.org|
22381051|NCT01354938|Abbott|Esther Oppermann, Clinical Trial Manager|49 511 6750 3954||
22381052|NCT01253200|Boston Scientific|Timothy Meyer; Director of Clinical Trials|651 581 3425|Timothy.meyer@bsci.com|
22381053|NCT02049437|University Hospitals Cleveland Medical Center|Marijke Frederix, PhD|(216) 844-0383|marijke.frederix@UHhospitals.org|
22381054|NCT02706626|Criterium, Inc.|Tom Stinchcombe|9196819509|Thomas.stinchcombe@duke.edu|
22381055|NCT01055782|Specialist Doctors Rolighedsvej|Lene Hendel MD|+4545819090|lene@hendel.dk|
22446729|NCT02083783|Tris Pharma, Inc.|Antonio Pardo MD|732-823-4755|apardo@trispharma.com|
22446730|NCT02256631|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22446731|NCT04528732|Washington University in St. Louis|Dr. Proscovia Nabunya|3149359087|nabunyap@wustl.edu|
22446732|NCT02051686|University of Missouri, Department of Orthopaedics|Brett Crist, MD|573-882-6562|cristb@health.missouri.edu|
22446733|NCT00335478|OHSU Knight Cancer Institute|Joseph Bubalo, PharmD, BCPS, BCOP|503-494-1080|bubaloj@ohsu.edu|
22412889|NCT00262223|The City College of New York|Denise A. Hien, Ph.D.|(212) 650-5666|dhien@ccny.cuny.edu|
22412890|NCT00437658|AbbVie|Global Medical Services|800-633-9110||
22412891|NCT03952143|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22412892|NCT02152566|Fisher & Paykel Healthcare|Dr Rachel Vicars|09 574 0123|rachel.vicars@fphcare.co.nz|7759
22412893|NCT01866319|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22412894|NCT00496964|Virginia Commonwealth University|Dr. Sheryl Finucane|804-628-3639|sfinucan@vcu.edu|
22412895|NCT02942264|National Cancer Institute|Dr. Jing Wu|240-760-6036|jing.wu3@nih.gov|
22412896|NCT01328093|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22412897|NCT04421508|Bellerophon Therapeutics|Bobae Kim|(917) 675-2254|bobae.kim@bellerophon.com|
22412898|NCT03980483|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22412899|NCT05150964|Sonova USCS|Director of Clinical Research|630-821-5000|phonakaudiologyresearch@gmail.com|
22412900|NCT02005536|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22412901|NCT02597998|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22412902|NCT02506309|Brno University Hospital|dr. Martin Huser|+420532233843|huser.martin@fnbrno.cz|
22412903|NCT01062256|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com|
22412904|NCT00208026|The Children's Hospital of Philadelphia|Albert C. Yan, M.D.|(215) 590-2158|Yana@email.chop.edu|
22412905|NCT02921737|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
22412906|NCT02649387|Mayo Clinic|Asher Alban Chanan Khan|904-953-0450|Chanan-Khan.Asher@mayo.edu|
22412907|NCT03883906|Cincinnati Children's Hospital Medical Center|Michael Grimley, MD|513-803-3218|Michael.Grimley@cchmc.org|
22412908|NCT01334827|The Miriam Hospital|Dr Kate Guthrie, Co-Investigator, Project MIST Lead Investigator|401-793-8180|kate.guthrie@lifespan.org|
22412909|NCT02412228|Brown University Oncology Research Group|John Reagan, MD|401-863-3000|BrUOG@Brown.edu|
22412910|NCT01629381|University of Padua|Dr. Giuseppe Camporese|049 8212882|giuseppe.camporese@aopd.veneto.it|+39
22412911|NCT02385097|Sintetica SA|Dr.Elisabetta Donati, Corporate Director Scientific Affairs|+41.91.640.42.50|edonati@sintetica.com|
22412912|NCT02942966|Philips Image Guided Therapy|Nicolas Aguirre|(612) 297-6655|nicolas.aguirre@philips.com|
22412913|NCT00745095|JJPVAMC National Center of Excellence for the Medical Consequeunces of Spinal Cord Injury|Dr. Mark A. Korsten, Chief of Gastroenterology|718-584-9000|mark.korsten@va.gov|6753
22412914|NCT00162123|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22412915|NCT01318499|Alcon Research|Dana Sager, Clinical Manager Group Leader|1-817-551-8603|dana.sager@alconlabs.com|
22412916|NCT01395030|The Queen's Medical Center|Program Director for PET Research|808-691-5466|skwee@queens.org|
22412917|NCT03629249|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22412918|NCT02134522|Yale University|Nicola Santoro|2037376356|nicola.santoro@yale.edu|
22412919|NCT02534493|Pressure Profile Systems|Jae Son|3106418100|jaeson@pressureprofile.com|
22412920|NCT01478620|"Kiev regional City Hospital"|Ivanov, Dmitry|+38 (039) 247 12 36|ivanovdd@i.kiev.ua|
22412921|NCT00911898|South Texas Accelerated Research Therapeutics|Dr. Muralibhar Beeram|210-593-5921|murali.beeram@stoh.com|
22412922|NCT02817841|Estetra SPRL|Mithra Pharmaceuticals SA Pharma Department|+3243492822|clinical.trials@mithra.com|
22412923|NCT04188106|Rose Research Center|Perry Willette, MD|919.908.0945|perry.willette@roseresearchcenter.com|
22412924|NCT00705536|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|(858) 794-8889||
22412925|NCT02289963|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22412926|NCT03514420|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
22412927|NCT01746017|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22412928|NCT04742283|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
22412929|NCT00397488|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin|646-422-4333|bajorind@mskcc.org|
22412930|NCT02424097|UCSF - School of Dentistry|Dr. Peter Rechmann|415 514 3225|Peter.Rechmann@ucsf.edu|
22412931|NCT01675622|Mundipharma (China) phamaceutical CO. LTD|Director of R&D|0086-10-65636800||
22412932|NCT04032977|Prollenium Medical Technologies|Director Clinical Affairs|1-905-508-1469|clinicaltrials@prolleniumus.com|
22412933|NCT02158572|Agile Therapeutics|Michelle Previtera, Associate Director of Clinical Development|609-683-1880|mprevitera@agiletherapeutics.com|
22412934|NCT02880761|Continuous Quality Improvement Experts Congress of Changping District|Director of Continuous Quality Improvement Experts Congress of Changping District|+861069006549|zhangdongliang@pkuih.edu.cn|1069006789
22412935|NCT01519661|Novartis Pharmaceuticals|Study Director|862-778-8300||
22412936|NCT02106156|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22412937|NCT02606708|New York University School of Medicine|Carmen Perez, MD|212 731 5003|carmen.perez@nyumc.org|
22412938|NCT00840632|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22412939|NCT05017480|Suzhou Connect Biopharmaceuticals, Ltd|John Guo, Director of Clinical Operation|051253577866|jwguo@connectpharm.com|
22412940|NCT01136382|AstraZeneca|Geoff Gilmartin||ClinicalTrialTransparency@astrazeneca.com|
22446734|NCT01654536|Sunovion|Respiratory Medical Director|1-866-503-6351||
22446735|NCT01996852|Case Comprehensive Cancer Center|Dr. Amy Zhang|+1 216-368-0968|amy.zhang@case.edu|
22385282|NCT03885518|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|225.763.2500|amanda.staiano@pbrc.edu|
22385283|NCT05533359|University of Utah|Dr. Guilherme Del Fiol|801-581-4080|guilherme.delfiol@utah.edu|
22385284|NCT01422434|LEO Pharma A/S|Clinical trial disclosure manager|00 45 44 94 58 88|ctr.disclosure@leo-pharma.com|
22385285|NCT05328362|Dartmouth College|Catherine Stanger|603-646-7023|catherine.stanger@dartmouth.edu|
22385286|NCT02573493|Washington University School of Medicine|Douglas R. Adkins, M.D.|314-747-8475|dadkins@wustl.edu|
22385287|NCT02761057|SWOG Statistics and Data Management Center|Genitourinary Committee Statistician|2066674623|mplets@fredhutch.org|
22385288|NCT04971681|Indiana University|Dr. Martin H. Plawecki, MD, PhD|3179486550|mplaweck@iu.edu|
22385289|NCT00686335|Horizon Pharma|Senior Vice President, Clinical Development & Operations|224-383-3012|agrahn@horizonpharma.com|
22385290|NCT04863378|Oregon Heatlh & Science University|Raina Croff, PhD Study investigator/ KL2 trainee|503-494-2367|croff@ohsu.edu|
22385291|NCT03629678|The Ohio State University|Dr Robert Cronin|6146889220|robert.cronin@osumc.edu|
22385292|NCT06215430|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22385293|NCT02433613|Medtronic GmbH|Dr. Ralf Meyer|01755810431|ralf.meyer@medtronic.com|
22385294|NCT04632992|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22385295|NCT02677805|Croma Pharma GmbH|Clinical Development - Head of Clinical Operations|+432262684680|clinical.studies@croma.at|
22385296|NCT02291302|Boston Children's Hospital|Wanda Phipatanakul, MD. MS.|617-355-6117|wanda.phipatanakul@childrens.harvard.edu|
22385297|NCT04350463|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22385298|NCT04652700|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22385299|NCT04187833|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|James Isaacs, MD|1-866-223-8100|TaussigResearch@ccf.org|
22385300|NCT01898754|University of Washington|Professor Lisa Frenkel|+1 206 987-5140|lfrenkel@uw.edu|
22385301|NCT03097549|Umeå University|Towe Wadensten|0046907865000|towe.wadensten@umu.se|
22385302|NCT01824537|McGill University|Eduardo L Franco|514-398-6032|eduardo.franco@mcgill.ca|
22385303|NCT02146378|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22385304|NCT01743807|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
22385305|NCT06215521|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22385306|NCT04096040|ZOLL Medical|Director of Scientific Affairs|4129683333|nbianco@zoll.com|14410
22385307|NCT04044768|Adaptimmune|Clinical Trials Management|+1 (215) 825 9260|clinicaltrials@adaptimmune.com|
22385308|NCT01814813|Mayo Clinic|Ian Parney, MD, PhD|507-284-8167|Parney.Ian@mayo.edu|
22385309|NCT05089019|Eli Lilly and Company|Chief Medical Officer|8005955979|ClinicalTrials.gov@lilly.com|
22385310|NCT04925986|Yale School of Medicine|Sarah Goldberg, MD, MPH: Associate Professor of Internal Medicine (Medical Oncology)|(203) 200-5864|sarah.goldberg@yale.edu|
22385311|NCT03858634|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
22385312|NCT06181760|Island Pharmaceuticals|David Foster, CEO|510-393-6523|dfoster@islandpharmaceuticals.com|
22385313|NCT05838313|University of South Florida Morsani College of Medicine, Department of Obstetrics and Gynecology|Anjali Kaimal, MD, MAS|(813) 259-8680|akaimal@usf.edu|
22385314|NCT05415722|Terns, Inc.|Study Director|+1 650-525-5535|clinicaltrials@ternspharma.com|101
22385315|NCT03524612|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22385316|NCT04537715|Epizyme, Inc.|Medical Lead or Designee|(855) 500-1011|clinicaltrials@epizyme.com|
22385317|NCT01414400|Stanford University School of Medicine|Subhas Banerjee|650-723-2623|sbanerje@stanford.edu|
22385318|NCT05457647|Studio Italiano di Oftalmologia|Dr. Marco Lombardo, Study Director|+393313438300|studiolombardo@visioeng.it|
22385319|NCT04938492|University of Rochester|Dr. Lisham Ashrafioun|585-430-2026|lisham_ashrafioun@urmc.rochester.edu|
22385320|NCT04623671|Capricor, Inc.|Mark Awadalla|858-727-1755|clinicaltrialsgov@capricor.com|
22385321|NCT03448107|NYU Dentistry|Richard Niederman|917-280-5920|r.niederman@nyu.edu|
22385322|NCT04025554|National Institutes of Health|Dr. Daniel S. Reich|301-496-1801|reichds@ninds.nih.gov|
22385323|NCT01802788|Abbott|Vinny Podichetty, Clinical Program Director|779-209-9425|vinny.podichetty@abbott.com|
22385324|NCT03509402|"University of Campania Luigi Vanvitelli"|Prof. Marco Annunziata|0815665515|marco.annunziata@unicampania.it|0039
22385325|NCT01648023|University of Louisville|Robert Martin, MD, PhD|502-629-3355|robert.martin@louisville.edu|
22385326|NCT01986712|St. Luke's University Health Network|Neil Belman|484-503-4673|neil.belman@sluhn.org|
22385327|NCT04158804|Massachusetts General Hospital|Michael K. Mansour, MD, Ph.D.|617-726-6726|mkmansour@mgb.org|
22430172|NCT01312675|B. Braun Medical Inc.|Dr. Diana Velencia, Associate Director of Clinical Affairs|610-596-2875|diana.valencia@bbraunusa.com|
22430173|NCT01117350|sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22430174|NCT02931539|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22446736|NCT01352546|Plastic Surgery Professional Association|Peter T. Pacik, MD, FACS|603 387 7735|ptpacik@verizon.net|
22446737|NCT04698187|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22446738|NCT04362072|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22446739|NCT04524689|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22446740|NCT01133522|Amgen Inc.|Study Director|866-572-6436||
22446741|NCT03128424|Endologix|Mohamed Moawad|949-595-7244|mmoawad@endologix.com|
22446742|NCT01354977|Albert Einstein College of Medicine|Dr. Meredith Hawkins|7184302903|meredith.hawkins@einstein.yu.edu|2903
22446743|NCT01664533|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22446744|NCT04869644|Northwell Health|Joan Duer-Hefele, RN, MA|646-766-7153|jduerhefele@northwell.edu|
22446745|NCT00844831|University of Louisville|John M. Wo, MD|502-852-6991|johnwogi@gmail.com|
22446746|NCT05255068|The University of Iowa|Wen Liu|3193557104|wen-liu-1@uiowa.edu|
22446747|NCT00680862|VHA|Henry Anaya|310-478-3711|henry.anaya@va.gov|48488
22446748|NCT03156543|University of Michigan Medical School|Bethany Ruffino|734 615-0768|bruffino@med.umich.edu|
22446749|NCT03875885|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-713-0677|radellin@wakehealth.edu|
22446750|NCT02397278|Stanford University|Michael Fadell II|3037241111|mfadell@stanford.edu|
22446751|NCT03444961|Cleveland Clinic|Dr. Aleksandra Rachitskaya|216-445-9519|rachita@ccf.org|
22446752|NCT02601469|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
22446753|NCT02161731|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22446754|NCT01315678|Insmed Incorporated|Kevin Mange (Senior VP, Clinical Development and Medical Affairs)|908-947-2651|kevin.mange@insmed.com|
22446755|NCT00790023|Sunovion|Respiratory Medical Director|1-866-503-6351||
22446756|NCT01338792|USC Norris Comprehensive Cancer Center|Jacek Pinski, MD|323-865-3900|pinski_j@ccnt.usc.edu|
22446757|NCT00062374|Memorial Sloan-Kettering Cancer Center|Dr. David P. Kelsen|646-888-4179|kelsend@mskcc.org|
22446758|NCT03644212|Maimonides Medical Center|Sara Meeder|7182837253|smeeder@maimonidesmed.org|
22446759|NCT03633695|AcuFocus, Inc.|Magda Michna, PhD., Chief Global Clinical, Medical and Regulatory Affairs Officer|(949) 585-9511|mmichna@acufocus.com|
22430175|NCT02059642|Alcobra|Dr. Jonathan Rubin|610-940-1631|jrubin@alcobra-pharma.com|
22446760|NCT00684593|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22446761|NCT05426902|Duke University|Amanda Eudy, MSPH, Ph.D.|919-681-1811|amanda.eudy@duke.edu|
22446762|NCT02584673|The Cooper Health System|Irwin Gratz|856-968-8527|gratz-irwin@cooperhealth.edu|
22446763|NCT02599129|Icahn School of Medicine at Mount Sinai|Dr. Mark Lebwohl|2122413288|giselle.singer@mssm.edu|
22446764|NCT00617773|Recepta Biopharma|Dr. Oren Smaletz, M.D., Medical Director|55 11 3709-2140|oren.smaletz@receptabiopharma.com.br|
22446765|NCT01029795|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22446766|NCT03217175|MGH Diabetes Research Center|Courtney Balliro, BS, RN, CDE|617-726-1242|cballiro@partners.org|
22446767|NCT01223001|The Rehabilitation Hospital of Indiana|Dr. Lance Trexler|(317)879-8940|lance.trexler@rhin.com|
22446768|NCT01896544|Massachusetts General hospital|Tiffany M.N. Otero|4074950753|totero@partners.org|
22446769|NCT03487276|InflaRx N.V.|Dr. Korinna Pilz, MD, MSc|+49 89 414 189 78 00|Korinna.Pilz@InflaRx.de|
22446770|NCT00429273|University of California, Los Angeles|James T. McCracken, M.D.|310-825-0470|jmccracken@mednet.ucla.edu|
22446771|NCT00461045|Triphase Accelerator|Associate Director of Clinical and Regulatory Operations|858-295-4337|jennifer.ki@triphaseco.com|
22446772|NCT01246401|Yale University|Dr. Sandra Springer||sandra.springer@yale.edu|
22446773|NCT00038857|MDAnderson Cancer Center|Dr. Richard E. Champlin|713-792-8750|celsaenz@mdanderson.org|
22446774|NCT01218204|GlaxoSmithKline|GSK Response Center|866-435-7343||
22430176|NCT06097273|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
22399135|NCT02516670|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Channing Paller Associate Professor Urologic Oncology|4109558239|cpaller1@jhmi.edu|
22399136|NCT00536172|University of Nebraska|William Burke MD|4025526005|wjburke@Unmc.edu|
22399137|NCT01552681|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22399138|NCT03075163|UC Davis Anesthesiology & Pain Medicine|Neal Fleming, MD, PhD|916 734-5046|nwfleming@ucdavis.edu|
22399139|NCT01299727|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22399140|NCT03882424|Zhejiang Teruisi Pharmaceutical Inc.|Yilin Li, Medical Director|13601247168|yilin.li@teruisipharm.com|
22399141|NCT00236080|Cephalon, Inc.|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
22399142|NCT01214044|Oregon Health & Science University and VA Portland Health Care System|Jonathan Emens, M.D.|503-220-8262|emensj@ohsu.edu|58490
22399143|NCT02395991|Seoul National University Hospital|Professor Jeong Min Lee|82-2-2072-3154|jmsh@snu.ac.kr|
22399144|NCT02772757|Mountain Home VA Medical Center|Sherri L. Smith, Au.D., Ph.D.|423.926.1171|sherri.smith@va.gov|7569
22399145|NCT04698525|Medicine Faculty, Universidad Autónoma de San Luis Potosi|Ildefonso Rodriguez-Leyva MD, PhD|4442043016|ildefonso.rodriguez@uaslp.mx|
22399146|NCT00441792|Advocate Christ Medical Center|Erik Kulstad, MD, MS|7086843889|kulstad@uic.edu|
22399147|NCT01731678|University of Calgary|Frank MacMaster, PI of the project|403-955-2784|fmacmast@ucalgary.ca|
22446775|NCT00975650|Acerus Pharmaceuticals Corporation|Dr. Nathan Bryson, Vice President, Scientific Affairs|1-416-679-0776|nbryson@aceruspharma.com|
22446776|NCT01061177|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registry@novartis.com|
22385328|NCT00764751|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
22385329|NCT01623167|National Heart Lung and Blood Institute (NHLBI)|Neal S. Young, M.D, NIH Principal Investigator|301-496-5093|youngns@nhlbi.nih.gov|
22385330|NCT05296525|Gamida Cell|Associate director, Clinical Operations|+972556660324|aurelie@gamida-cell.com|
22385331|NCT04830800|PATH|Dr. Thang Tran Cong, Medical office|84-913301883|thangtran@path.org|
22385332|NCT04285515|Intra-Cellular Therapies, Inc.|Susan Kozauer, MD|646 440-9333|ITCIClinicalTrials@itci-inc.com|
22385333|NCT03396588|University of Kentucky|Dr. Henrietta Bada|8593231019|henrietta.bada@uky.edu|
22385334|NCT00812461|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
22385335|NCT01388777|UT MD Anderson Cancer Center|Hwang, Rosa, M.D.|713-792-7734|CR_Study_Registration@mdanderson.org|
22385336|NCT03287817|Autolus Ltd|Clinical Project Manager|+44 1483 920748|clinicaltrials@autolus.com|
22446777|NCT03616600|Hong Kong Polytechnic University|Dr. Henry Chan|+85227667937|henryhl.chan@polyu.edu.hk|
22385337|NCT00636077|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
22446778|NCT03984994|University of Maryland|Dr. Steven J. Prior|301-405-2483|sprior@umd.edu|
22446779|NCT05873257|Coloplast A/S|Clinical Strategy Project Manager: Johanne Louise Gotfredsen|004549113350|dkjoat@coloplast.com|
22446780|NCT03010176|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22446781|NCT04220866|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22446782|NCT01903187|St. Jude Medical, Inc.|Steven Madej|651-756-2230|smadej@sjm.com|
22446783|NCT03210376|UT MD Anderson Cancer Center|Dr. Wendell H. Williams III / Anesthesiology & Perioperative Medicine|713-563-0034|WHWilliams@mdanderson.org|
22446784|NCT00709761|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
22446785|NCT03739593|Aerie Pharmaceuticals, Inc|Kevin Kerr, Director of Clinical Development|(949) 526-8701|kkerr@aeriepharma.com|
22446786|NCT03478930|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22446787|NCT04950998|University of Southern California|Dr. Stacey Schepens Niemiec|3234422069|schepens@usc.edu|
22446788|NCT00555971|Cleveland Clinic|David M. Lang|216-444-6933|langd@ccf.org|
22446789|NCT02573311|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22446790|NCT01328431|Yale University|Steven L. Bernstein, MD|203-737-3574|steven.bernstein@yale.edu|
22446791|NCT03834441|MGH|Margaret Samuels-Kalow|617-726-8340|msamuels-kalow@partners.org|
22446792|NCT01427972|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22446793|NCT02094677|Coopervision|Jose A. Vega, OD, Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|jvega@coopervision.com|
22446794|NCT02557555|Rutgers New Jersey Medical School|Assistant Professor|4133869415|ajantoni@gmail.com|
22446795|NCT02168361|Center for Hepatitis C|Dr. Brian Pearlman|4042651044|brianpearlman3@hotmail.com|
22446796|NCT00255125|Kansas City VA Medical Center|Dr. Peter Van Veldhuizen|816-861-4700|peter.vanveldhuizen@va.gov|
22446797|NCT04967443|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22446798|NCT04502693|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|
22446799|NCT02784431|Cerus Endovascular|Lori E Adels, Ph.D.|510-651-4000|lori.adels@cerusendo.com|109
22446800|NCT00279305|Type 1 Diabetes TrialNet|Carla Greenbaum, MD||cjgreen@benaroyaresearch.org|
22446801|NCT04404361|CTI BioPharma Corp.|John Volpone|206-351-7663|jvolpone@ctibiopharma.com|
22446802|NCT00217594|NHLBI, NIH|Chris Hourigan MD|301-451-0257|hourigancs@mail.nih.gov|
22446803|NCT00701675|Ralp H. Johnson VA Medical Center|Olga Brawman-Mintzer, MD|8437242302|mintzero@musc.edu|2834
22446804|NCT01063868|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537||
22446805|NCT01949506|Froedtert and the Medical college of Wisconsin|Meena Bedi, MD|414-805-4400|mbedi@mcw.edu|
22385338|NCT04130438|Stanford University|Jennifer A. Tremmel, MD, MS|(650) 723-0180|nocad_study@stanford.edu|
22385339|NCT03499821|STAAR Surgical|Joanne Egamino|626-303-7902|jegamino@staar.com|
22385340|NCT03338933|VA Portland Health Care System|Dr. William Hoffman|503-220-8262|hoffmaw@ohsu.edu|56214
22385341|NCT01084876|Celltrion|Head of Clinical Planning Department|82328505000|contact@celltrion.com|
22446806|NCT01446289|Novartis vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
22446807|NCT03307967|Yale University|Christina Lazar, Project Director|203-932-5711|christina.lazar@yale.edu|4833
22446808|NCT02915016|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22446809|NCT02578316|Eisai Inc.|Eisai Medical Services|888-||
22446810|NCT02166905|Roswell Park Comprehensive Cancer Center|Katy Wang|716-845-2300|chong.wang@roswellpark.org|
22446811|NCT02617628|University of Pennsylvania Office of Research Services|W. Stuart Watson|215-573-6707|wswatson@upenn.edu|
22446812|NCT02065375|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22446813|NCT03432897|Brown Oncology Research Group|BrUOG|4018633000|BrUOG@Brown.edu|
22446814|NCT03278873|MeiraGTx|Program Manager|0044 (0)20 3866 4320|ocularinfo@meiragtx.com|
22446815|NCT05243641|M D Anderson Cancer Center|Rachel M. Layman, MD|713) 745-8401|rlayman@mdanderson.org|
22446816|NCT04785677|Florida State University|Stephen Tripodi|850-645-1572|stripodi@fsu.edu|
22446817|NCT05169437|Tempus AI, Inc|Virginia Rhodes, MD|(800) 976-5448|support@tempus.com|
22446818|NCT01886794|University of Texas Medical Branch|Kathleen L. Vincent, M.D.|409-772-2610|klvincen@utmb.edu|
22446819|NCT00895232|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|844
22446820|NCT02159560|Beth Israel Deaconess Medical Center|Philip Hess|6176673112|phess@bidmc.harvard.edu|
22446821|NCT05372419|Chief Medical Officer|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
22446822|NCT02801331|University of Pittsburgh School of Medicine|Elisabeth B Salisbury, PhD|14122465378|salisburye2@upmc.edu|
22446823|NCT02443987|Gloucestershire Hospitals NHS Foundation Trust|Dr Sharan Athwal|0300 422 2222|sharan.athwal@glos.nhs.uk|
22446824|NCT00407797|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22446825|NCT02713347|VA|Dr. David Bekelman|7207236388|david.bekelman@va.gov|
22446826|NCT03250845|UZ Leuven|Datamanager|+3216346880|jonas.vanham@uzleuven.be|
22446827|NCT01402492|UCLA Integrated Substance Abuse Programs|Walter Ling, MD|310-267-5888|lwalter@ucla.edu|
22446828|NCT04866225|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22446829|NCT02019693|National Cancer Institute|Dr. Ramaprasad Srinivasan|240-760-6251|ramasrin@mail.nih.gov|
22446830|NCT03822078|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22446831|NCT05973981|RAND|William Shadel|412-683-2300|shadel@rand.org|4489
22446832|NCT05820685|The University of Texas Health Science Center at Houston|John Harvin, MD, FACS|713-500-7244|John.Harvin@uth.tmc.edu|
22446833|NCT00601458|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22446834|NCT00518986|Cephalon, Inc.|Medical monitor|1-800-896-5855||
22446835|NCT03647033|National University Hospital|Dr. David Chen|+6594550281|david_chen@nuhs.edu.sg|
22399148|NCT03715426|University of Michigan|Michelle Munro-Kramer|734-904-4600|mlmunro@umich.edu|
22399149|NCT00888355|Merck & Co., Inc.|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
22399150|NCT00880360|University of Texas Health Science Center at San Antonio|Dr. Tyler Curiel|210-450-1000|curielt@uthscsa.edu|
22399151|NCT01539980|Faculty of Pharmaceutical Sciences, Chulalongkorn University|Professor Pornanong Aramwit, Pharm.D., Ph.D.|+66899217255|aramwit@gmail.com|
22399152|NCT01815645|Federal University of Sao Paulo|Andre Q. C. Miguel|005511 965884111|aqcmiguel@gmail.com|
22399153|NCT02211261|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22399154|NCT01573910|Alcon Research, Ltd.|Firoz Vohra, Project Head, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
22399155|NCT02251912|University of North Carolina at Chapel Hill|Dr. Cort Pedersen|919-923-3284|cort_pedersen@med.unc.edu|
22399156|NCT01286493|Queen Saovabha Memorial Institute|Dr.Suda Sibunruang|+66 2 2520161|sudapunrin@gmail.com|125
22399157|NCT00268242|The Cleveland Clinic|Anjali S. Advani, MD|216-445-5330|advania@ccf.org|
22399158|NCT02175680|CytoDyn Inc.|Joseph Meidling, Sr. Director Clinical Operations|(360) 980-8524|jmeidling@cytodyn.com|
22399159|NCT01913483|Miami Cardiac & Vascular Institute, Baptist Health South Florida|Chief Medical Executive|800-273-2700|MCVI@BaptistHealth.net|
22399160|NCT03969888|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22399161|NCT00535925|University of Campania|Prof. Ferdinando Carlo Sasso. MD, PhD|+39-081-5665010|ferdinandocarlo.sasso@unicampania.it|
22399162|NCT04062214|Yale University|Marc Rosen, MD|2039325711|marc.rosen@yale.edu|12112
22399163|NCT00836433|Durham VA GRECC|Dr. Cathleen Colon-Emeric|9192860411|cathleen.colonemeric@va.gov|6777
22399164|NCT00464178|Hackensack University Medical Center|Dr. David Siegel|551-996-2000|DSiegel@hackensackumc.org|
22399165|NCT02052557|Des Moines University|Grants and Contracts Manager|5152711657|mlyon@dmu.edu|
22399166|NCT04506294|Children's Hospital of Philadelphia|Nancy Kassam-Adams, PhD (Principal Investigator)|215-590-3118|adamsn@chop.edu|
22399167|NCT00874250|W.L. Gore & Associates|Abe Letter|928-864-3113|aletter@wlgore.com|
22399168|NCT02838407|GlaxoSmithKline|GSK Response Center|866-435-7343||
22446836|NCT00603889|Albert B. Sabin Vaccine Institute|Dr. David Diemert, Director of Clinical Trials|202-842-5025|david.diemert@sabin.org|
22446837|NCT04862585|Ohio State University|Mike Berger, PharmD|614-366-0556|michael.berger@osumc.edu|
22385342|NCT04515576|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22385343|NCT01461655|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
22385344|NCT04256941|University of Texas M D Anderson Cancer Center|Dr. Senthil Damodaran|713-792-2817|sdamodaran@mdanderson.org|
22385345|NCT04622943|University of Alabama at Birmingham|Dr. David Schwebel|205-934-8745|schwebel@uab.edu|
22385346|NCT05717907|Mahidol university|Pattamon Leelachaikul|+66863019830|pattamonl@hotmail.com|
22385347|NCT02140554|bluebird bio, Inc|Study Medical Director|339-499-9300|medinfo@bluebirdbio.com|
22385348|NCT02289209|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP|4126475554|stadtermanbm@upmc.edu|
22412941|NCT02311361|National Cancer Institute|Dr. Tim Greten|240-760-6114|tim.greten@nih.gov|
22412942|NCT04927013|Emory University|Yue Guan, PhD|404-712-1671|yue.guan@emory.edu|
22412943|NCT05628675|King's College London/South London and Maudsley NHS|Dr Rebecca Cockburn|02032288800|rebecca.cockburn@kcl.ac.uk|
22412944|NCT00878878|GE Healthcare|Ruben Sheng, M.D.|1-609-514-6899|Rubin.Sheng@ge.com|
22412945|NCT00633594|Sarah Cannon Research Institute|Ian Flinn, MD|1-877-691-7274|asksarah@scresearch.net|
22412946|NCT02028715|Aultman Hospital|Director of Research Programs|330-363-7274|mary.amos@aultman.com|
22412947|NCT01492361|Amarin Pharma, Inc.|Dr. Alexander Giaquinto, Executive Director, Regulatory Affairs|908-326-1324|alex.giaquinto@amarincorp.com|
22412948|NCT01475838|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22412949|NCT01595503|University of Michigan|stephan taylor|7349364955|sftaylor@umich.edu|
22412950|NCT03227445|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22412951|NCT03538587|National Cancer Institute|Staci M. Peron, Ph.D.|240-760-6025|martins@mail.nih.gov|
22412952|NCT01991470|Medtronic Minimed|Suiying Huang, Statistician|818-576-3319|suiying.huang@medtronic.com|
22412953|NCT00874887|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22412954|NCT00760266|Novartis Pharmaceuticals|Study Director|862-778-8300||
22412955|NCT01225146|Retina Consultants of Houston|David M. Brown, MD|713-524-3434|dmbmd@houstonretina.com|
22412956|NCT01239121|James J. Peters VA Medical Center|Kenneth Boockvar|718-584-9000|kenneth.boockvar@va.gov|3807
22412957|NCT00623779|AstraZeneca|Gerard Lynch|+44 1509 645895|aztrial_results_posting@astrazeneca.com|
22412958|NCT03472365|Jiangsu Hengrui Pharmaceuticals Co., Ltd.|Medical Director: Linna Wang|+86-13581990612|linna.wang@hengrui.com|
22412959|NCT00581971|UAB Hospital|Dr. Sharon Spencer Professor of Radiation Oncology|205-934-2762|sspencer@uabmc.edu|
22412960|NCT02158494|University of Wisconsin - Madison|Mitchell Tyler|608-262-5112|metyler1@wisc.edu|
22412961|NCT00906347|University of Texas Southwestern Medical Center|Dr. April Bleich|214-648-2316|april.bleich@gmail.com|
22412962|NCT02688556|Sun Pharma Advanced Research Company Limited|SPARC|+912266455645|clinical.trials@sparcmail.com|
22412963|NCT00472290|Amgen Inc.|Study Director|866-572-6436||
22412964|NCT00777829|UCSD|Dr. Sara C. Mednick|8586423192|mednicks@uci.edu|
22412965|NCT04567342|Cincinnati Children's|Dr. William B. Brinkman|513-636-2576|bill.brinkman@cchmc.org|
22412966|NCT00301756|Princess Margaret Cancer Centre|Dr. Amit Oza|416-946-2818|amit.oza@uhn.ca|
22412967|NCT00577460|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22412968|NCT02016170|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3933|dominick.angiolillo@jax.ufl.edu|
22412969|NCT02365207|University of Texas Health San Antonio|Robert Svatek|210-567-5676|svatek@uthscsa.edu|
22412970|NCT01607645|FHCRC|Derek L. Stirewalt|2066675386|dstirewa@fhcrc.org|
22412971|NCT05214560|Becton, Dickinson and Company|Clinical Project Manager|00393452237718|gloria.viti@bd.com|
22412972|NCT04977336|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22412973|NCT01968382|Virginia Commonwealth University|Stephanie Taylor MSN, RN|804-828-9311|stephanie.taylor@vcuhealth.org|
22412974|NCT00878995|University of Texas Medical Branch|Melinda Sheffield-Moore|409-772-8707|melmoore@utmb.edu|
22412975|NCT01353495|Wright Medical Technology, Inc.|Jonette Hodge, MSN, RN, CCRP, Director, Medical Affairs|8002387188|jonette.hodge@wmt.com|4747
22412976|NCT00352690|Washington University School of Medicine|Ramaswamy Govindan, M.D.|314-362-5737|rgovinda@dom.wustl.edu|
22412977|NCT00448175|Uroplasty, Inc|Clinical Study Manager|952-426-6153|megan.otoole@uroplasty.com|
22412978|NCT03633721|Albert Einstein College of Medicine|Dr. Anjali Sharma|7185152593|anjali.sharma@einsteinmed.edu|
22412979|NCT03054103|Wake Forest University Health Sciences|Dr. Timothy Harwood|3367164498|tharwood@wakehealth.edu|
22430177|NCT03020082|Ascletis Pharmaceticals Co., Ltd|Clinical Trial Disclosures|86057187707910|xin.li@ascletis.com|
22446838|NCT05288062|Mayo Clinic|Wilson I. Gonsalves, MD|507-266-5947|Gonsalves.Wilson@mayo.edu|
22446839|NCT00018031|NIAID/NIH|Dr. Shyam Kottilil|301-435-036|skottilil@niaid.nih.gov|
22446840|NCT02099708|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22446841|NCT01874054|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
22446842|NCT00702923|University of Wisconsin Carbone Cancer Center|Douglas McNeel, M.D., Ph.D.|(608) 263-4198|dm3@medicine.wisc.edu|
22446843|NCT02002091|Algiers' university -1- Benyoucef Benkhedda, Faculty of Medicine Meherzi, Algiers.|Dr Wafia- Nadia Nibouche-Hattab|+213771810932|wani16000@yahoo.fr|
22446844|NCT03953820|Aquestive Therapeutics|Denis Scheper, Director of Portfolio Management and Clinical Operations|(908)941-1887|denis.scheper@aquestive.com|
22446845|NCT02467075|University of Michigan, Department of Radiology|Matthew Davenport, MD|734-232-2095|matdaven@med.umich.edu|
22446846|NCT01233258|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22446847|NCT03685968|The University of Texas Health Science Center at Houston (UTHealth)|Elizabeth M. Gendel|+1 (713) 500-3587|Elizabeth.M.Gendel@uth.tmc.edu|
22446848|NCT00530946|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22446849|NCT01534962|Menarini Ricerche S.p.A|Angela Capriati MD PhD, Head of Corporate Clinical Research|00390555680|acapriati@menarini-ricerche.it|9933
22446850|NCT03965039|Procter and Gamble|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
22446851|NCT00880009|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22446852|NCT02771093|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22412980|NCT01475474|Renew Medical, Inc.|Victoria Mackinnon, Vice President, Regulatory, Clinical & Quality|1-888-987-2929|victoria@renew-medical.com|
22412981|NCT02343120|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
22412982|NCT01765530|Massachusetts General Hospital|Robert M Kacmarek PhD, RRT|617-724-4490|rkacmarek@partners.org|
22399169|NCT02986230|HealthPartners Institute|Dr. Tom Elliott|218-525-7268|elliottt793@gmail.com|
22399170|NCT01469000|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22399171|NCT04033419|University of North Carolina at Chapel Hill, Department of Psychiatry|Zev Nakamura, MD|(984) 974-3829|zev_nakamura@med.unc.edu|
22399172|NCT03618056|Fred Hutchinson Cancer Research Center|Jessica Andriesen|206-667-5812|jandries@fredhutch.org|
22399173|NCT00769119|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22399174|NCT03564626|Virginia Commonwealth University|Dr. Jasmohan Bajaj|(804) 828-4060|jasmohan.bajaj@vcuhealth.org|
22399175|NCT01116544|Oregon Health & Science University|Dr. Paul Cordo|503 418 2520|cordop@ohsu.edu|
22399176|NCT05168267|University of Wisconsin Madison - Incarceration and Mental Health Lab|Michael Koenigs|(608) 263-1679|mrkoenigs@wisc.edu|
22399177|NCT02937350|University of Washington|Dr. Ian de Boer|206-616-5403|IDeBoer@Nephrology.washington.edu|
22430178|NCT03181009|The Sean N. Parker Center for Allergy and Asthma Research at Stanford University|Dr Andres Alvarez Pinzon, Director of Regulatory Affairs and Translational Medicine|650 - 521 - 7237|andresap@stanford.edu|
22399178|NCT02419508|Alcon, A Novartis Division|Brand Medical Director Ophtha, GMA Ophthalmics|1-888-451-3937|alcon.medinfo@alcon.com|
22399179|NCT01332071|GlaxoSmithKline|GSK Response Center|866-435-7343||
22399180|NCT00494143|VA Puget Sound Health Care System|Dr. Joseph Czerniecki|206 277 5188|joseph.czerniecki@va.gov|
22399181|NCT05523973|University of Cincinnati|Dr. Brittany Krekeler, PI|5132272759|krekelby@ucmail.uc.edu|
22399182|NCT01891643|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22399183|NCT01542307|Massachusetts General Hospital|Aneesh Singhal, MD|6177268459|asinghal@partners.org|4
22399184|NCT02010203|Clinical Development|Lori McDermott|9197948950|lmcdermott@heatbio.com|9197948950
22399185|NCT04047797|MD Anderson Cancer Center|Hun J Lee, MD|713-792-2860|hunlee@mdanderson.org|
22399186|NCT01430442|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
22399187|NCT03363633|Duke University Medical Center|Ellen D. Dillavou, MD, FACS||ellen.dillavou@duke.edu|
22399188|NCT00772629|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22430179|NCT03681093|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22430180|NCT03435107|Academic Research Office, Clinical Trial Center, Asan Medical Center|Project manager|82-2-3010-7187|jiyun.an@amc.seoul.kr|
22446853|NCT03322631|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22446854|NCT01646762|Mayo Clinic|Dr. Rafael Fonseca|480-301-4280|fonseca.rafael@mayo.edu|
22446855|NCT01300650|Virginia Commonwealth University|Benjamin Van Tassell|8049820997|bvantassell@vcu.edu|
22446856|NCT00602797|University of Nebraska Medical Center|Apar Ganti|402-559-5622|aganti@unmc.edu|
22446857|NCT03943147|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22446858|NCT01318993|GlaxoSmithKline|GSK Response Center|866-435-7343||
22446859|NCT00418457|Cleveland Clinic|Daniel Sessler, MD|216-444-4900|sessled@ccf.org|
22446860|NCT02267083|Gem Pharmaceuticals, LLC|Elizabeth Moore, Regulatory Affairs Agent|8583532019|elizabethmoore109@comcast.net|
22446861|NCT03736447|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
22446862|NCT02619175|Loewenstein Rehabilitation Hospital|Mrs. Shirley Handelzalts|972-9-7709010|peregshir@gmail.com|
22446863|NCT01434030|University of Virginia|Boris P Kovatchev, Ph.D.|434-924-5592|bpk2u@virginia.edu|
22446864|NCT02644135|UHCMC|Dr. Robert Salata|2168443293|robert.salata@uhhospitals.org|
22446865|NCT02795832|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22446866|NCT02389361|ASTES|Dr. DEFLANDRE Eric|0032477764241|eric.deflandre@gmail.com|
22446867|NCT02695329|Zimmer Biomet G.K.|Clinical Affairs Senior Manager|+81-6402-6777|takahito.nakai@zimmerbiomet.com|
22446868|NCT01382212|AbbVie|Global Medical Information|800-633-9110||
22446869|NCT01273597|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22446870|NCT00393029|National Cancer Institute (NCI), National Institutes of Health (NIH)|Steven Rosenberg, M.D., Ph.D.|301-496-4164|Steven.Rosenberg@nih.gov|
22446871|NCT01003288|University of Bergen|Professor Rebecca Cox|+4755974668|rebecca.cox@uib.no|
22446872|NCT03547583|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
22446873|NCT01846416|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22446874|NCT00382252|Institut Bergonie|Dr Françoise Bonichon||F.Bonichon@bordeaux.unicancer.fr|
22446875|NCT00833794|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
22446876|NCT00565045|MetroHealth Medical Center|Dr. Jayme Knutson|216-778-8364|jsk12@case.edu|
22446877|NCT00039130|Duke University Medical Center|David Rizzieri, M.D.||rizzi003@dm.duke.edu|
22446878|NCT01269463|Rhodes Pharmaceuticals L.P.|Inder Chaudhary, PhD|401-262-9272|inder.chaudhary@rhodespharma.com|
22399189|NCT04051957|The University of Texas Health Science Center at Houston|Jaya Kala, MD|713-500-6868|jaya.kala@uth.tmc.edu|
22399190|NCT01929057|UCSD Dermatology Clinical Trials|Dermatology Clinical Trial Manage|(858)657-8390|dermstudies@ucsd.edu|
22399191|NCT03760484|University of Alberta|Dr. Dina Kao|780-233-6025|dina.kao@ualberta.ca|
22399192|NCT05197803|Sonova AG|Study Manager|519 895 0100|carolina.rubiano@sonova.com|2135
22430181|NCT04566510|UCSF|Dr. Grant Dorsey|628-206-4680|grant.dorsey@ucsf.edu|
22446879|NCT00456014|Stony Brook University School of Medicine|Ramin V. Parsey, MD, PhD|631-444-3084|Ramin.Parsey@stonybrookmedicine.edu|
22446880|NCT02657915|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
22446881|NCT02612727|Minnesota Medical Research Foundation (now Hennepin Healthcare) and University of Minnesota|Tina M. Slusher|612-624-4586|tslusher@umn.edu|
22399193|NCT00132041|American College of Radiology Imaging Network|Donna Harfeil, Director of Protocol Management|215-717-2765|Donna Hartfeil <dhartfeil@acr.org>|
22399194|NCT01171820|Abbott Vascular|Robert Smith Jr, Ph.D., Sr Clinical Research Scientist|408-845-8265|robert.smithjr@av.abbott.com|
22446882|NCT05670236|Cleveland Clinic Foundation|Dr. Patrick Corrigan|216-618-9932|corrigd4@ccf.org|
22446883|NCT04518306|George Medicines Pty Limited|Anthony Rodgers (Principal Investigator)|+44 7983 578 290|arodgers@georgeinstitute.org|
22399195|NCT03969875|Icahn School of Medicine at Mount Sinai|Dr. Poonam Pai|212-523-4000|poonam.paibantwalhebbalasankatte@mountsinai.org|
22399196|NCT00167245|University of Pennsylvania|Dr. Kyle Kampman|2152223200|kampman@mail.med.upenn.edu|109
22399197|NCT01871090|St Jude Medical, Inc.|Todd Stirman, Clinical Manager|(972) 526-9625|Tstirman@sjm.com|
22399198|NCT03057366|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22399199|NCT04201717|FIrst Hospital of Jilin University|Dr. Quan Wang|+86 ‭15843073207‬|wquan@jlu.edu.cn|
22399200|NCT02911688|Center for Environmental Medicine Asthma and Lung Biology|Carole Robinette Assistant Director of Clinical Research|919 966-5638|carole_robinette@med.unc.edu|
22399201|NCT01307033|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22399202|NCT02274688|University of Washington|Douglas Zatzick|2067446701|dzatzick@uw.edu|
22399203|NCT03562663|Moss Rehabilitation Research Institute|Dylan Edwards|(215) 663-6411|EdwardDy@einstein.edu|
22399204|NCT01793792|MicroVention, Inc|Anne Hurley|714-247-8000|anne.hurley@microvention.com|
22399205|NCT01773421|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
22399206|NCT02804763|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22399207|NCT00445302|Genzyme Corporation|Genzyme Medical Information|1-800-745-4447||
22399208|NCT00709826|Tragara Pharmaceuticals|Tracy Parrott|760-208-6919|tparrott@tragarapharma.com|
22399209|NCT00860158|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
22399210|NCT00282243|Astellas Pharma Global Development, Inc.|Vice President, Therapeutic Area Head, Transplantation||ClinicalTrials.Disclosure@us.astellas.com|
22399211|NCT00851903|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi.com|
22399212|NCT00270894|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
22399213|NCT01070329|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22399214|NCT02863848|Universitat Rovira i virgili|Dr. Joaquin Escribano|+ 34 977 759364|joaquin.escribano@urv.cat|
22399215|NCT06062264|UCLA|Principal Investigator|310-206-6328|pszilagyi@mednet.ucla.edu|
22399216|NCT05256888|University of Maryland School of Nursing|Amber Kleckner, PhD|410-706-5961|amber.kleckner@umaryland.edu|
22399217|NCT02088385|Changi General Hospital|Dr Andrew Kwek Boon Eu|6788 8833|andrew_kwek@cgh.com.sg|
22399218|NCT02487108|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22399219|NCT00469612|The Ohio State University|Dr. Don Mutti|614-247-7057|mutti.2@osu.edu|
22399220|NCT00883493|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22399221|NCT01622569|OptiNose|Vice President Global Clinical Operations & Outsourcing|267-364-3508|jennifer.carothers@optinose.com|
22399222|NCT02522767|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22399223|NCT00548548|Hoffman-LaRoche|Medical Communications|800-821-8590||
22399224|NCT01848145|SCRI Development Innovations|Charles Davis, RAC|615-524-4341|Charles.Davis2@scri-innovations.com|
22399225|NCT00364689|University of Miami|Clinical Trial Disclosure Manager|305-243-0494|y.p.davis@med.miami.edu|
22399226|NCT01872338|VA New Jersey Healthcare System|Alejandro Interian, PHD|908-647-0180|alejandro.interian@va.gov|4617
22399227|NCT01284504|Stanford University|Anthony Doufas, MD, PhD|1-650-498-7699|agdoufas@stanford.edu|
22399228|NCT03683394|The University of California, San Francisco|Dr. Kristine Yaffe|(415) 476-7307|kristine.yaffe@ucsf.edu|
22399229|NCT03739528|NTC srl|Alessandro Colombo|+390243850490|alessandro.colombo@ntcpharma.com|
22399230|NCT02239263|cochlear|Lori O'Neill Director of Research|8005235798|loneill@cochlear.com|
22399231|NCT04303000|University of Alabama at Birmingham|Melinda Clarke|205-975-7809|melindaclarke@uabmc.edu|
22399232|NCT05655377|Flint Rehabilitation Devices|Ian Russell|9496670140|irussell@flintrehab.com|
22399233|NCT01110395|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
22399234|NCT00506857|UT MD Anderson Cancer Center|Richard E. Champlin/Professor||ytdinh@mdanderson.org|
22399235|NCT03118947|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2897|medicalinformation@acadia-pharm.com|
22399236|NCT01109940|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22399237|NCT02769624|Cincinnati Children's Hospital Medical Center|Katy Fischesser|513-803-5191|katy.fischesser@cchmc.org|
22399238|NCT02769728|Medical University of Graz|Prof. Harald Sourij|0316 385 81310|ha.sourij@medunigraz.at|
22399239|NCT04139122|Senju Pharmaceutical Co. Ltd.|Director, Clinical Development|+81 078 777 1018|senju-clinicaltrials@senju.co.jp|
22399240|NCT01987908|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22399241|NCT03711604|Rhizen Pharmaceuticals AG|Dr.Prajak Barde|9820503970|pjb@rhizen.com|
22399242|NCT01869348|The University of Texas Medical Branch|Eloisa Martinez|4092669643|esmartin@utmb.edu|
22399243|NCT02789657|BrUOG|Brown University Oncology Research Group|4018633000|BrUOG@Brown.edu|
22412983|NCT02467621|Copenhagen University Hospital Rigshospitalet, Dept. of Intensive Care 4131|Dr. Morten Hylander Møller|22555343|mortenhylander@gmail.com|+45
22412984|NCT02914795|Medical University of Grazt|Assoc. Prof. Dr. Dirk von Lewinski|+43 316 385|dirk.von-lewinski@medunigraz.at|80684
22446884|NCT03268954|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22412985|NCT03086356|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22399244|NCT01728779|Johns Hopkins University|Dana Kaplin|410-614-3950|dkaplin1@jhmi.edu|
22399245|NCT00448708|Angiotech Pharmaceuticals|Dr. Trudy Estridge|604-221-7676|testridge@angio.com|
22399246|NCT01925209|Novartis Pharmaceuticals|Study Director|862-778-8300||
22399247|NCT00384241|Medical College of Georgia, Georgia Regents University|Haidong Zhu MD, PhD, Assistant Professor|706 721 5470|hzhu@gru.edu|
22446885|NCT05358444|Johns Hopkins University Schoo of Medicine|Maya Venkataramani MD, MPH|4109559869|mvenkat2@jh.edu|
22446886|NCT00946478|UCSD Dermatology|Dr. Tissa Hata|858-657-8390|ucsddermstudies@gmail.com|
22446887|NCT00887653|THE MIRIAM HOSPITAL|Aadia Rana|4017934680|arana@lifespan.org|
22446888|NCT03820986|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22446889|NCT02284126|Columbia University Irving Medical Center|Dr. E. Sander Connolly Jr.|2123054118|esc5@cumc.columbia.edu|
22446890|NCT03480646|Constellation, Inc.|Clinical Program Lead|1-844-667-1992|medinfo@morphosys.com|
22446891|NCT01638546|Memorial Sloan Kettering Cancer Center|Dr. Charles Rudin|646-888-4527|rudinc@mskcc.org|
22446892|NCT02513394|Dana-Farber Cancer Institute|Erica L. Mayer, MD, MPH|617-632-3800|emayer@partners.org|
22446893|NCT00540514|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22446894|NCT01651195|Helsinki University Central Hospital|Prof. Anne Pitkäranta|+358406430511|anne.pitkaranta@hus.fi|
22446895|NCT02417974|Boston Medical Center and BU School of Medicine|Alan Moss, MD, PhD|617-638-6116|alan.moss@bmc.org|
22446896|NCT01892293|Adaptimmune|Clinical Trials Management||clinicaltrials@adaptimmune.com|
22446897|NCT04988646|Pharma Metric Labs, Indonesia|Pharma Metric Labs|+62 21 4265310|nabila.sutanto@pharmametriclabs.com|
22446898|NCT03602482|Pennsylvania State University College of Medicine|Dr. Amanda J. Miller|7175317676|aross1@pennstatehealth.psu.edu|
22446899|NCT02543437|Stryker Japan|Yasuyuki Inatsugu, Associate manager of clinical affairs|81 3 6894 8394|yasuyuki.inatsugu@stryker.com|
22446900|NCT02114814|The Ohio State University|Dr. Jie Hu|6146880394|hu.1348@osu.edu|
22446901|NCT00903396|Mayo Clinic|Michele Halyard, M.D.|4803014567|mhalyard@mayo.edu|
22446902|NCT05276401|Lakewood Amedex|Dr. Adam Ruskin|941-225-2514|ARuskin@LakewoodAmedex.com|
22446903|NCT04617509|Gesynta Pharma AB|Charlotte Edenius|+46733864246|charlotte.edenius@gesynta.se|
22446904|NCT00441883|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
22399248|NCT05384041|Climb Technologies, Inc.|Julia Lanoha|(925) 405-5458|julia@climb.care|
22399249|NCT02266108|UCSDMED|Elizabeth Reed, Associate Professor|5082121517|elizared7@gmail.com|
22399250|NCT02086331|Imperial College London|Miss Kate Williams||k.williams@imperial.ac.uk|
22399251|NCT03329378|Icahn School of Medicine at Mount Sinai|Dr. Aarti Bhardwaj|(212) 824-8578|Aarti.Bhardwaj@mountsinai.org|
22399252|NCT00510276|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22399253|NCT04714372|University of Minnesota, Masonic Cancer Center|Dr. Joseph Maakaron|612-624-5109|maaka001@umn.edu|
22399254|NCT04025632|UCB BIOSCIENCES GmbH|Clin Trial Reg & Results Disclosure|Please email|clinicaltrials@ucb.com|
22399255|NCT00376961|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623||
22399256|NCT02216695|Derby Teaching Hospital NHS Trust|Nitin V Kolhe|01332788266|nitin.kolhe@nhs.net|
22399257|NCT02591615|NorthShore Medical Group|Thomas Hensing|847.570.2112|thensing@northshore.org|
22399258|NCT03220412|The Ohio State University|Dr. Brad Bushman|614-688-8779|bushman.20@osu.edu|
22399259|NCT00686127|University of California, San Francisco|Dr. Christine Miaskowski, PI|415-476-9407|chris.miaskowski@nursing.ucsf.edu|
22399260|NCT05195528|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-7428|medicalinformation@phathompharma.com|
22399261|NCT01552902|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22399262|NCT02720757|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22399263|NCT03256045|University of Washington|Dr. Andrew Cowan|206-606-7348|ajcowan@seattlecca.org|
22399264|NCT00168831|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22399265|NCT05210504|VUMC|Dr. Jane Ferguson|6158759896|jane.f.ferguson@vumc.org|
22399266|NCT04173741|Hacettepe University|Dr. Asli Melek|+905376636789|aslimelek121@gmail.com|
22399267|NCT02357420|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22399268|NCT03617705|University of Florida|Dr. Yan Wang|3522945942|ywang48@ufl.edu|
22399269|NCT03502187|University of Tennessee Health Science Center|Dr. Laura Talbot|901-448-3630|ltalbot@uthsc.edu|
22399270|NCT00214461|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22399271|NCT06118385|Benevolent|Judit Molnar, MD, PhD|+44 20 3781 9360|judit.molnar.md@benevolent.ai|
22399272|NCT01554579|Afferent Pharmaceuticals|Clinical Development|650-286-1276|info@afferentpharma.com|
22399273|NCT00234039|SWOG Statistical Center|Study Statistician|206-667-4623||
22399274|NCT01808612|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22399275|NCT03897751|Bausch & Lomb|Johnson Varughese|9089271162|Johnson.Varughese@bauschhealth.com|
22399276|NCT03072160|National Cancer Institute|Dr. Ravi Madan|301-480-7168|rm480i@nih.gov|
22399277|NCT01046695|Mayo Clinic|Deborah J. Engen, OT, CMT|507-255-5504|engen.deborah@mayo.edu|
22399278|NCT04426695|Regeneron Pharmaceuticals, Inc|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
22399279|NCT00559273|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22399280|NCT01016873|Oraya Therapeutics Inc.|Denis O'Shaugnessy, Ph.D.|917-417-3974|doshaughnessy@orayainc.com|
22399281|NCT03653390|University of Washington|Dr. Ivan Molton, PhD|2065433602|imolton@uw.edu|
22399282|NCT01261819|Florida Hospital|Katherine Kratz, M.D.||katiegoodrich@gmail.com|
22399283|NCT00849667|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22399284|NCT00189462|West Penn Allegheny Health System|David Skoner, MD|4123594099|dskoner@wpahs.org|
22399285|NCT00553462|Yale Cancer Center|Rogerio Lilenbaum, M.D.||Rogerio.lilenbaum@yale.edu|
22399286|NCT00553163|Barts Health NHS Trust|Prof D S Rampton|+442035943300|d.rampton@qmul.ac.uk|
22399287|NCT01262625|American College of Radiology|Director Clinical Research Administration|215-574-3150|info@acr.org|
22446905|NCT00618072|New York Medical College|Harriette R. Mogul MD MPH|914-594-2278|Harriette_Mogul@NYMC.edu|
22446906|NCT00684307|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22446907|NCT02170298|UC Davis|Julie B Schweitzer|916-703-0294|jschweitzer@UCDAVIS.EDU|
22446908|NCT05048784|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22446909|NCT01448486|St. Vincent's Hospital, Sydney|Prof. Bruce Brew|61 2 8382 1111|b.brew@unsw.edu.au|4100
22446910|NCT02853604|Advaxis, Inc.|Surya Vangala|609-423-2528|vangala@advaxis.com|
22446911|NCT00727025|Dartmouth-Hitchcock|Dr. Carolyn Kerrigan|603 650-5148|carolyn.l.kerrigan@hitchcock.org|
22446912|NCT02269241|Exeltis|Dr. Enrico Colli, Chief Scientific Officer|+34917711500|enrico.colli@exeltis.com|
22446913|NCT03020160|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22446914|NCT02270957|Oklahoma Medical Research Foundation|Joan T. Merrill, M.D.|405 822 2336|joan-merrill@omrf.org|
22446915|NCT03291054|Northwell|Richard Carvajal, MD|516-734-8900|rcarvajal2@northwell.edu|
22446916|NCT04251169|SOLTI|Sara Cano|34 664 449 862|info@gruposolti.org|
22446917|NCT02535312|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22446918|NCT01539538|AcelRx|Pamela Palmer|650-216-3500|ppalmer@acelrx.com|
22446919|NCT03897465|Lohmann & Rauscher GmbH & Co. KG|Dr Daria Trofimenko, Senior Manager Clinical Regulatory Affairs|+49 (0) 2631 99 6385|Daria.Trofimenko@de.LRMed.com|
22446920|NCT00847379|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22446921|NCT00521014|Memorial Sloan Kettering Cancer Center|Dr. Craig Moskowitz|212-639-7992|moskowic@mskcc.org|
22446922|NCT04390191|Icahn School of Medicine at Mount Sinai|Dr. Neomi Shah|212-241-6286|neomi.shah@mssm.edu|
22446923|NCT01312272|VISN 22 Mental Illness Research, Education, and Clinical Center|Dr. Michael C. Davis|3104783711|mcdavis@mednet.ucla.edu|49234
22446924|NCT03978832|Indivior Inc|PERSERIS Medicines Development Lead and Head Global Clinical Operations and Development|804 379-1090|regan.fong@indivior.com|
22399288|NCT00110994|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22399289|NCT04398732|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22399290|NCT02055404|Alcon Research, Ltd.|Joachim Nick, Dipl. Ing.|1-888-451-3937|alcon.medinfo@alcon.com|
22399291|NCT00947284|UCaliforniaSF|Jon Levine MD, PhD|415-476-5108|jon.levine@ucsf.edu|
22399292|NCT01727089|City of Hope|Jeff Longmate, Ph.D.|626-218-2478|jlongmate@coh.org|
22399293|NCT00464204|Fresenius Kabi Aktiengesellschaft|Professor Dr. Martin Westphal|+49 6172 686|martin.westphal@fresenius-kabi.com|7280
22399294|NCT01500057|Brooklyn Urology Research Group|Ivan Grunberger, M.D. Medical Director|718-230-7788|ivg9002@nyp.org|
22399295|NCT01225341|DeNova Research|Steven Dayan, MD|3123352070|sdayan@drdayan.com|
22399296|NCT02318784|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
22399297|NCT00638937|The Ottawa Hospital Cancer Centre|Dr. Scott Laurie|613-737-7700|slaurie@ottawahospital.on.ca|70175
22399298|NCT01564706|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22399299|NCT00354601|Wake Forest University Health Sciences|Doug Case Biostatistician|336-716-1048|dcase@wfubmc.edu|
22399300|NCT02471716|FivePrime Theraputics|Medical|415-365-5600|nick.mahasuwan@fiveprime.com|
22399301|NCT02981069|University of Texas Health San Antonio|Professor|12103587200|cersosimo@uthscsa.edu|
22399302|NCT01154933|State University of NY at Buffalo|Paresh Dandona|7165351850|dandona@buffalo.edu|
22399303|NCT01558063|Columbia University|J. John Mann, MD|646-774-7553|jjm@columbia.edu|
22399304|NCT03002974|Swedish Orphan Biovitrum|Kineret Clinical Program Leader|+46(8)6972000|info@sobi.com|
22399305|NCT01838044|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22399306|NCT00330187|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
22399307|NCT01751971|Brigham and Women's Hospital|Scott Sands, PhD|6172780911|sasands@bwh.harvard.edu|
22399308|NCT01649947|Rutgers Cancer Institute of New Jersey|Joseph Aisner, MD|732-235-7401|aisnerjo@cinj.rutgers.edu|
22399309|NCT01920802|New York State Psychiatric Institute|Jeffrey A. Lieberman, MD|646-774-8436|jlieberman@columbia.edu|
22399310|NCT01162421|AbbVie|Global Medical Information|800-633-9110||
22399311|NCT01054079|Comprehensive Cancer Center of Wake Forest University|Dr. K.C. Balaji|336-618-2272|kbalaji@wakehealth.edu|
22399312|NCT01750255|Universidad de Antioquia|Pedro Amariles Muñoz|57 4 2195456|pedro.amariles@udea.edu.co|
22399313|NCT02678429|VUMC|Fenna Phibbs|614-936-0060|fenna.phibbs@vumc.org|
22399314|NCT01133171|Department of Veterans Affairs|Dawn M. Bravata, MD|317-988-2676|dawn.bravata2@va.gov|
22399315|NCT02526550|Siriraj Hospital|Prof.Kulkanya Chokephaibulkit|662 4195695|kulkanya.cho@mahidol.ac.th|
22399316|NCT01260454|University of Rochester|R. James White, MD, PhD|585-486-0869|jim_white@urmc.rochester.edu|
22399317|NCT00091832|Amgen Inc.|Study Director|866-572-6436||
22399318|NCT02349178|Medical College of Wisconsin|Michael J Burke, MD|414-955-4170|mmburke@mcw.edu|
22399319|NCT00282841|University of California San Diego|Thilo Hoelscher, MD|619-543-5251|thoelscher@ucsd.edu|
22399320|NCT03434379|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22399321|NCT03122431|Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo|Prof Eloisa Bonfa|551130617490|eloisa.bonfa@hc.fm.usp.br|
22399322|NCT00686647|AngioScore|Gary Gershony, MD/ Chief Medical Officer|510-933-7900|gary@angioscore.com|
22399323|NCT00578643|Baylor College of Medicine|Robert Krance, MD|(832) 824-4661|rakrance@txch.org|
22399324|NCT01725750|Icahn School of Medicine at Mount Sinai|Jacob Greisman|212-241-4886|Jacob.greisman@mountsinai.org|
22399325|NCT02022826|Medtronic|Michal Kedar-Datel|+972-4-9097952|michal.kedar-datel@medtronic.com|
22412986|NCT01054599|VA New York Harbor Healthcare System, NYU|Beth Leeman-Markowski, MD|212-686-7500|beth.leeman-markowski@nyumc.org|
22399326|NCT03179436|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22412987|NCT01104662|Cubist Pharmaceuticals, Inc.|Vice President, Clinical Research|1.781.860.8660||
22399327|NCT01634555|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
22399328|NCT01506882|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22399329|NCT01811147|Cleveland Clinic Foundation|Dr. Amit Anand|216-636-2840|ananda@ccf.org|
22399330|NCT02863068|Albert Einstein College of Medicine|Dr. Caterina Minniti|240-498-8684|bloodconsultant@gmail.com|
22399331|NCT00325078|National Institute of Allergy and Infectious Diseases|De Ravin, SukSee|+1 301 496 6772|sderavin@mail.nih.gov|
22430182|NCT00368849|The University of Iowa|Leigh J. Beglinger, Ph.D.|319-335-8765|leigh-beglinger@uiowa.edu|
22446925|NCT00003499|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22446926|NCT01744574|University of Minnesota|Dr. Sharon Allen|612-624-0446|allen001@umn.edu|
22446927|NCT02042183|Mallinckrodt Pharmaceuticals|Clinical Team Leader|800-844-2830|clinicaltrials@mnk.com|5
22446928|NCT01256008|Wenzhou Medical University|Director of Clinical Trials|+86 0577 55579363|hjc@wmu.edu.cn|
22446929|NCT02244606|SCYNEXIS|Dr. David Angulo|(201) 884 - 5471|david.angulo@scynexis.com|
22446930|NCT02256189|Lund University|Professor Bo Ahrén|+46462220758|Bo.Ahren@med.lu.se|
22446931|NCT00378378|Merck, Sharp & Dohme Corp.|Senior Vice Presiden, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22446932|NCT02348606|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
22446933|NCT02321800|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
22446934|NCT01854710|Alexza Pharmaceuticals, Inc|Chief Scientific Officer|650.944.7777|jcassella@alexza.com|
22446935|NCT03722966|The University of Oklahoma Health Sciences Center|Dr. Darla Kendzor|(405) 271-8001|Darla-Kendzor@ouhsc.edu|
22446936|NCT03132220|University of Colorado School of Medicine|Dr. Meredith Mealer|303-724-6857|Meredith.Mealer@cuanschutz.edu|
22446937|NCT03284398|Fresenius Kabi Deutschland, GmbH|Prof. Dr. med. Martin Westphal|+49 6172 686-7348|martin.westphal@fresenius-kabi.com|
22446938|NCT01193868|The University of Texas MD Anderson Cancer Center|George Blumenschein, MD / Professor|713-792-2734|CR_Study_Registration@mdanderson.org|
22446939|NCT00642460|Hoffman-LaRoche|Medical Communications|800-821-8590||
22446940|NCT02227758|St Jude Medical/Abbott|Clinical Study Director||rdiaz@sjm.com|
22446941|NCT01115101|University of Rostock|Dr. Max Dieterich|+493814401|max.dieterich@uni-rostock.de|4500
22446942|NCT04171531|RTI International|Marie Gantz|919-541-5110|mgantz@rti.org|
22446943|NCT04124757|LUMC|Martijn Boon MD PhD|003171522301|m.boon@lumc.nl|
22446944|NCT05537883|Wake Forest University Health Sciences|Selwan Barbat, MD|704-355-2000|Selwan.Barbat@atriumhealth.org|
22446945|NCT00769392|Lahey Clinic|Gregory Blaha, MD|781-744-2580|christine.gould@lahey.org|
22446946|NCT02296320|MedImmune, LLC|Hasan S. Jafri|301-398-4431|information.center@astrazeneca.com|
22446947|NCT05229406|Center for Healthy Minds, University of Wisconsin - Madison|Simon B. Goldberg, PhD|608-265-8986|sbgoldberg@wisc.edu|
22446948|NCT04026308|UAMS|Michael Wilson|501-686-8729|MPWilson@uams.edu|
22446949|NCT01697566|M.D. Anderson Cancer Center|Karen H. Lu, MD|713-745-8902|khlu@mdanderson.org|
22446950|NCT01930123|Duke University|Brian J. Soher, Ph.D.|919-684-7350|brian.soher@duke.edu|
22446951|NCT01447433|Changhai Hospital|Prof. Donglian Cai|86 21 81873168|nutrition1226@126.com|
22446952|NCT02899793|Yale University School of Medicine|Dr. Alessandro Santin|203-737-4450|alessandro.santin@yale.edu|
22446953|NCT01805154|Abbott|Clay Cohorn, Clinical Program Director|972-309-8087|clay.cohorn@abbott.com|
22446954|NCT00729651|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22446955|NCT03310021|Portola Pharmaceuticals|Head of Clinical Development|6502767153|ClinicalTrials@Portola.com|
22446956|NCT01128842|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
22446957|NCT02378961|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22446958|NCT00390468|UT MD Anderson Cancer Center|Quality Assurance Specialist|713-792-2830|caperez@mdanderson.org|
22446959|NCT01049308|VA Loma Linda Healthcare System|Dr Helme Silvet|9095836097|helme.silvet@va.gov|
22446960|NCT00363883|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22446961|NCT01348165|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22446962|NCT01600638|Zeltiq Aesthetics|Kerrie Jiang, Executive Director Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
22446963|NCT00607815|Cincinnati VA Medical Center|Dr. Kathleen M. Chard|859-572-6741|Kathleen.Chard@va.gov|
22446964|NCT03396367|Hunter College|Dr. Tyrel Starks|212-772-5550|tstarks@hunter.cuny.edu|
22446965|NCT05766423|Northwestern University|Research Assistant Professor|312-503-0274|allison.pack@northwestern.edu|
22446966|NCT00806390|UMaryland|Stephen Gottlieb|410-328-8788|sgottlie@medicine.umaryland.edu|
22446967|NCT00996216|GlaxoSmithKline|GSK Response Center|866-435-7343||
22446968|NCT02129725|Vanderbilt University Medical Center|Nancy J. Brown, M.D.|615-343-8701|nancy.j.brown@vanderbilt.edu|
22446969|NCT03825315|Revance Therapeutics, Inc.|Todd Gross, PhD, VP, Clinical Development & Data Science|510-742-3400|tgross@revance.com|
22446970|NCT01411774|Baylor College of Medicine|Dr. Eric Storch|727-767-8230|eric.storch@bcm.edu|
22446971|NCT03808545|University of Alabama at Birmingham|Brooks Wingo, Associate Professor|2059345982|bcwingo@uab.edu|
22446972|NCT02038023|AUERBACH HEMATOLOGY ONCOLOGY ASSOC|Dr Michael AUERBACH|410-780-4050|MAUERBACHMD@ABHEMONC.COM|
22446973|NCT00583778|MetroHealth Medical Center|Dr. Rita Cydulka|216-778-7800|rcydulka@gmail.com|
22446974|NCT03292588|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22446975|NCT03808493|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22446976|NCT00036738|Fred Hutchinson Cancer Research Center|Dr. George Georges|206-667-6886|ggeorges@fredhutch.org|
22399332|NCT02663895|Stanford University|Dr. Lorinda Chung|(650) 723-6961|shauwei@stanford.edu|
22399333|NCT00809328|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22446977|NCT05526716|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClincalTrialsDisclosure@msd.com|
22430183|NCT01902303|Beech Tree Labs, Inc.|Dr. John McMichael|518-872-1144||
22385349|NCT03953508|University of Oklahoma Health Sciences Center|Amy Cohn, PhD|4052711903|amy-cohn@ouhsc.edu|
22385350|NCT03771417|Louisiana State University|Brian A. Irving, PhD|12255787179|brianairving@lsu.edu|
22385351|NCT05546749|Albert Einstein College of Medicine|Hector Perez|7189205756|heperez@montefiore.org|
22385352|NCT03869866|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22385353|NCT06181227|Aviceda Therapeutics|David Callanan|817-312-9258|dcallanan@avicedarx.com|
22385354|NCT05543915|NYU Langone Health|Guiseppina Pilloni|646-501-9274|giuseppina.pilloni@nyulangone.org|
22385355|NCT02577835|Italian Institute of Telemedicine|Stefano Omboni|00390331984176|stefano.omboni@iitelemed.org|
22385356|NCT04342494|University of Michigan|Amy Bohnert|(734) 936-4280|amybohne@med.umich.edu|
22385357|NCT03736720|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-1300|Kristopher.Attwood@roswellpark.org|
22385358|NCT05119023|MGH-Institute of Health Professions|Sofia Vallila Rohter, Project Principle Investigator|617-724-3824|svallilarohter@mghihp.edu|
22385359|NCT03194217|BenevolentAI|Administrator|+44 20 3781 9360|LondonAdmin@benevolent.ai|
22385360|NCT02962895|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22385361|NCT03659734|Stanford University|Dr. Jennifer Hah|650-723-4000|map_pain_study@stanford.edu|
22385362|NCT05682937|Prince of Songkla University|Anucha Thatrimontrichai|66 74451257|tanucha@medicine.psu.ac.th|
22385363|NCT04719390|Partnership to End Addiction|Dr. Sarah Dauber|212-841-5270|sdauber@toendaddiction.org|
22385364|NCT05130762|Becton, Dickinson and Company|Stephan Hofmann|+49 160 105 3421|Stephan.Hofmann@bd.com|
22385365|NCT04019873|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22385366|NCT05467345|Ascensia Diabetes Care|Jane Wallace|5748501467|jane.wallace@ascensia.com|
22385367|NCT01606215|Imperial College London|Professor Paolo Muraro|02075946670|p.muraro@imperial.ac.uk|
22385368|NCT05851573|University of Central Florida|Dr. Deena Schwen Blackett|407-823-0909|deena.blackett@ucf.edu|
22385369|NCT05087992|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22385370|NCT02839161|George Washington University|David J. Diemert, MD|202-994-2909|ddiemert@gwu.edu|
22385371|NCT04149704|Dana-Farber Cancer Institute|Jennifer Snaman|617632-5548|jennifer_snaman@dfci.harvard.edu|
22385372|NCT05832996|University of Iowa|Douglas Jin, MD|319-356-3185|Douglas-Jin@uiowa.edu|
22385373|NCT00528268|University of Utah|Dr. Kathryn Swoboda|801-585-9717|swoboda@genetics.utah.edu|
22385374|NCT05362487|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22385375|NCT04973254|Boston Medical Center|Laura Fletcher, LCSW MSW MPH|857-225-5183|laura.fletcher@bmc.org|
22385376|NCT04543357|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22385377|NCT03115476|LEO Pharma|Clinical Trial Disclosure|+45 4494 5888|disclosure@leo-pharma.com|
22385378|NCT04980248|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22385379|NCT05257486|Xoft, Inc.|Robert Burnside|14084931533|rob.burnside@elekta.com|
22385380|NCT04542317|University of California, Davis|Ladson Hinton, MD|9167343485|lwhinton@ucdavis.edu|
22385381|NCT04700163|The Rockefeller University|Marina Caskey|2123277396|mcaskey@rockefeller.edu|
22385382|NCT05590962|University of Pennsylvania|Dr. Ravi Parikh|3524224285|ravi.parikh@pennmedicine.upenn.edu|
22385383|NCT03848065|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22385384|NCT03854214|Kennedy Krieger Institute|Ann S. Choe, Ph.D.|443-923-9500|choea@kennedykrieger.org|
22385385|NCT04564742|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22385386|NCT04131686|Boryung|Ji-Yeon Kim|82-2-708-8128|jiyeonkim@boryung.co.kr|
22385387|NCT03313076|University of North Carolina at Chapel Hill|Matt Mauck, MD, PhD|919-966-5136|matt_mauck@med.unc.edu|
22385388|NCT05869383|Sriwijaya University|Nur Riviati|+6281377671384|eviqodir@yahoo.com|
22385389|NCT04473430|University of Miami|Dr. Rodolfo Galindo|305-284-3781|rodolfo.galindo@miami.edu|
22385390|NCT02535338|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22385391|NCT03270501|Department of Rheumatology, Gent University Hospital|Professor Dirk Elewaut|+32 9 332 22 30|reumatologie@uzgent.be|
22399334|NCT00008385|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012||
22399335|NCT00595231|Acorda Therapeutics|Christopher Kenney, Senior Vice President - Medical Affairs|9143265775|ckenney@acorda.com|
22399336|NCT00365989|InSightec|Nadir Alikacem|214-630-2000|nadira@insightec.com|
22399337|NCT00317044|AstraZeneca|ClinicalTrialTransparency||ClinicalTrialTransparency@astrazeneca.com|
22399338|NCT04647110|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22399339|NCT04317690|Massachusetts General Hospital|Dr. Karen R. Sepucha|617-724-3350|KSEPUCHA@mgh.havard.edu|
22399340|NCT02318095|Regulatory Coordinator|Linda Kaltenbach, PhD|(919) 681-6804|Linda.Kaltenbach@duke.edu|
22399341|NCT02064764|Medtronic, Inc.|Vanessa DeBruin|6123607687|vanessa.debruin@medtronic.com|
22399342|NCT00600171|GlaxoSmithKline|GSK Response Center|866-435-7343||
22399343|NCT02367521|Johns Hopkins University School of Medicine|Vani Rao, MD|4105502288|vrao@jhmi.edu|
22399344|NCT00542191|Leo W. Jenkins Cancer Center|Dr. Paul Walker|252-744-1015|walkerp@ecu.edu|
22385392|NCT06264986|Blanquerna Institute - Universitat Ramon Llull|Olivia Coope|+447882461097|oliviacharlottec@blanquerna.url.edu|
22385393|NCT02918890|Columbia University|Dr. Andrew M. Gordon|212.678.3332|ag275@columbia.edu|
22385394|NCT04478643|ASST SPEDALI CIVILI - UNIVERSITY OF BRESCIA|Dr. Magda Mensi|+390303995784|magda.mensi@unibs.it|
22430184|NCT03635996|Milestone Pharmaceuticals Inc.|Cameron Szakacs _PhD_VP Drug Development|1 704-594-4102|cszakacs@milestonepharma.com|
22385395|NCT04349371|Columbia University|Anca Askanase, MD|212-305-0856|ada20@cumc.columbia.edu|
22385396|NCT05270408|UT Southwestern Medical Center|Dr Christian LoBue|2146485265|Christian.LoBue@utsouthwestern.edu|
22385397|NCT04338061|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22385398|NCT03631784|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22385399|NCT04204265|Anika Therapeutics|Kara Mezger, Executive Director Clinical Affairs|781.457.9000|kmezger@anika.com|
22385400|NCT02465268|University of Florida|Duane Mitchell, MD, PhD|352-273-9000|duane.mitchell@neurosurgery.ufl.edu|
22385401|NCT03482557|Beth Israel Deaconess MEdical Center|Marc Mccall|617-418-9216|mmccall1@bidmc.harvard.edu|
22385402|NCT02876588|Columbia University|Dr. Jason Adelman|646-317-4803|adelman.jason@columbia.edu|
22385403|NCT02547363|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
22385404|NCT04364048|Hoosier Cancer Research Network|Andrew Benson|317-921-2050|abenson@hoosiercancer.org|
22385405|NCT03322267|National Taiwan University Hospital|Dr Chih-Hung Hsu|+886-23123456|chihhunghsu@ntu.edu.tw|
22385406|NCT03046251|Jacobs School of Medicine and Biomedical Sciences, University of Buffalo, Buffalo, NY, USA.|Dr. Bianca Weinstock-Guttman|716-829-4415|bw8@buffalo.edu|
22385407|NCT03084536|Washington University School of Medicine|Ryan C. Guffey, M.D.|314-286-2883|rguffey@wustl.edu|
22385408|NCT04836195|Pacylex Pharmaceuticals|VP Operations|1 (888) 580-4483|ryan.heit@pacylex.com|
22385409|NCT05002608|Massachusetts General Hospital|Elyse R. Park|6177246836|epark@mgh.harvard.edu|
22385410|NCT04986501|Sunbio|Min-Jung Ahn|+82-31-423-5467|mjahn@sunbio.com|
22385411|NCT05302596|State University of NY at Buffalo|Husam Ghanim|7168818924|ghanim@buffalo.edu|
22385412|NCT03450980|Schepens Eye Research Institute of Mass Eye & Ear, Harvard Medical School, Boston, MA, USA|Gang Luo|(617) 573-4177|gang_luo@MEEI.HARVARD.EDU|
22385413|NCT06212804|Visterra, Inc.|Mohit Mathur, MD|+1-617-498-1070|mmathur@visterrainc.com|
22385414|NCT03491969|Zhongshan hospital, Fudan University|Dr. Hanchuan Chen|18459111985|chenhanchuan66@126.com|
22385415|NCT05044793|Sight Sciences, Inc.|VP, Medical and Clinical Affairs|1-877-266-1144|jdickerson@sightsciences.com|
22385416|NCT04764448|Dicerna Pharmaceuticals, Inc., a Novo Nordisk company|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22385417|NCT04728347|Arcturus Therapeutics, Inc.|Arcturus Therapeutics, Inc.|858-900-2660|clinicaltrials@arcturusrx.com|
22385418|NCT02702102|Columbia University|William Kreisl, MD|212-305-9194|wck2107@cumc.columbia.edu|
22385419|NCT05835336|VIZO Specs|Yael Richter, PhD|972-54-7384809|yaelr@vizo-o.com|
22385420|NCT04509674|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22385421|NCT00817219|LEO Pharma A/S|Malin Järnkrants|+45 7226 2990|malin.jaernkrants@leo-pharma.com|
22399345|NCT02633371|University of Colorado|Dr. Anna Bruckner|720-777-0955|anna.bruckner@ucdenver.edu|
22399346|NCT03990870|Posit Science Corporation|Dr. Kyu Lee|415-528-7235|kyu.lee@positscience.com|
22399347|NCT00305942|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22399348|NCT00486447|GE Healthcare|Angela N. Johnson, Senior Manager Clinical Affairs Operations|262-226-9495|angela.johnson@ge.com|
22399349|NCT01242644|University of South Alabama|Office of Research Compliance|251-460-7573|swhite@southalabama.edu|
22399350|NCT03603652|ETHICON|Erin Meyers|937-681-0322|eprifog1@its.jnj.com|
22399351|NCT00579813|University of Arkansas for Medical Sciences|Robert E. McGehee Jr., Ph.D.|501-603-1998|rem@uams.edu|
22399352|NCT00109473|Cincinnati Children's Hospital Medical Center|Lee A. Denson|513-636-7575|lee.denson@cchmc.org|
22399353|NCT03213366|Albert Einstein College of Medicine|Dr. Viraj V Patel|718.920-7102|vpatel@montefiore.org|
22399354|NCT01290627|The University of Tennessee|Richard Komistek, Ph. D.|86598744159|rkomiste@utk.edu|
22399355|NCT02532855|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22399356|NCT00666926|Verastem, Inc.|Mitchell Keegan|617-252-9300|mkeegan@verastem.com|
22399357|NCT00756548|Braintree Laboratories, Inc.|John McGowan, Director, Clinical Research|781-843-2202|jmcgowan@braintreelabs.com|
22399358|NCT01960855|AbbVie|Global Medical Services|800-633-9110||
22399359|NCT01879410|GlaxoSmithKline|GSK Response Center|866-435-7343||
22399360|NCT02058147|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22399361|NCT01012492|Emory University School of Medicine|Leslie S Kean|404-376-0187|Leslie.kean@emory.edu|
22399362|NCT02808390|PPM Services|Salvatore Bellinvia|+41916961710|sbellinvia@ppmservices.ch|
22399363|NCT00773279|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22399364|NCT04178772|Johnson & Johnson VIsion Care, Inc.|Thomas Karkkanien - Sr. Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
22399365|NCT01737931|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22399366|NCT04897867|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22399367|NCT00508391|BIOTRONIK, Inc.|Clay Cohorn|503-387-2614|clay.cohorn@biotronik.com|
22399368|NCT00880256|VA Puget Sound Health Care System|Dr. David Kearney|206-764-2285|david.kearney@va.gov|
22399369|NCT01958645|AstraZeneca|Anders Berggren, MD, PhD||clinicaltrialtransparency@astrazeneca.com|
22399370|NCT02041962|University of Michigan|Amy Kilbourne, PhD|734-845-3452|amykilbo@umich.edu|
22399371|NCT01686568|Mayo Clinic|Dr. Ian R. Lanza|507-255-8147|lanza.ian@mayo.edu|
22399372|NCT02928952|VAPHS, Center for Heath Equity Research and Promotion|Monica DiNardo PhD, Primary Investigator|412 360-2262|monica.dinardo@va.gov|
22399373|NCT02601573|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22399374|NCT00974220|Queen's University, Kingston, ON, Canada|Dr. Denis O'Donnell|1-613-548-2339|odonnell@queensu.ca|
22385422|NCT03676764|University of California, San Francisco FI Proctor Foundation|Dr. Thomas Lietman, Director of the UCSF FI Proctor Foundation|415-476-1442|tom.lietman@ucsf.edu|
22385423|NCT04461405|Oregon Health & Science University|Dr. Deborah Cohen|503-781-8795|cohendj@ohsu.edu|
22385424|NCT04660201|University of Maryland School of Medicine|James Campbell, MD|410-706-5328|Jcampbel@som.umaryland.edu|
22385425|NCT06190691|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
22385426|NCT04633122|Zai Lab|Medical Director|+86 4008201022|Medinfo@zailaboratory.com|
22385427|NCT03241745|Memorial Sloan Kettering Cancer Center|Dr. Claire Friedman, MD|646-888-4247|friedmac@mskcc.org|
22385428|NCT02305277|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22385429|NCT02561247|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
22385430|NCT03896789|University of Washington|Dr. Monica S. Vavilala|206-744-7235|vavilala@uw.edu|
22385431|NCT03916510|University of Oxford|CEDAR Trial Manager, Oncology Clinical Trials Office (OCTO)|01865 617085|octo-CEDAR@oncology.ox.ac.uk|
22385432|NCT04473222|University of Oregon|Ariel Williamson|971-352-4004|arielaw@uoregon.edu|
22385433|NCT01098812|Abbott Medical Optics|Kristen Featherstone|714-247-8621|kristen.featherstone@amo.abbott.com|
22385434|NCT04908722|Janssen Vaccines & Prevention B.V.|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22385435|NCT06321809|Hacettepe University|Assoc.Prof. Duygu Ayhan Baser|+90-505-664-5210|dr.duyguayhan@gmail.com|
22385436|NCT03123848|Janssen Pharmaceutical K.K.|Director, IDV Department|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22385437|NCT01369355|Janssen Research & Development, LLC|Vice President|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22385438|NCT02319759|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22385439|NCT02436096|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 904-0355|greg.sullivan@tonixpharma.com|
22385440|NCT03131154|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
22385441|NCT06424236|Washington University|Administrative Director|(314) 221-8344|DIAN-TUDataRequest@wustl.edu|
22385442|NCT04213872|ASU/PVHMC|Dr. Francisco Munoz|909-753-8391|fmunoz007@verizon.net|
22385443|NCT03339713|Janssen Research & Development, LLC|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22385444|NCT01959425|Biosense Webster Inc.|Stephanie Lyke|(949) 285-7966|SLyke@its.jnj.com|
22385445|NCT05403827|Kowa Research Institute, Inc.|Director, Clinical Operations|919-433-1600|CTGResults@KowaUS.com|
22385446|NCT05597085|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22385447|NCT01987895|Actelion Pharmaceuticals Ltd|Clinical Trial disclosure Desk|0041615656565|clinical-trials-disclosure@its.jnj.com|
22385448|NCT02979327|Mayo Clinic|Anna Svatikova, M.D., Ph.D.|507-284-3685|Svatikova.Anna@mayo.edu|
22385449|NCT04002830|Shaare Zedek Medical Center|Majdolen Istaiti|972526659995|joleenist@szmc.org.il|
22385450|NCT03628924|Janssen Research & Development, LLC|Product development portfolio leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22385451|NCT05368402|Dompé Farmaceutici SpA|Clinical Development & Operations|+30 902 583831|clinicaltrials@dompe.com|
22385452|NCT05006872|Health Research Institute of the Balearic Islands|Dra. Rocío Zamanillo Campos|+34 971175883|rocio.zamanillo@ssib.es|
22385453|NCT01753414|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
22385454|NCT03913702|University of Texas Medical Branch Galveston|Dr. Jeremy Somerson|409-747-5701|jesomers@utmb.edu|
22385455|NCT05499377|Virginia Commonwealth University|Augustus Whiet|(804) 828-8892|whiteam25@vcu.edu|
22385456|NCT04332926|Virginia Commonwealth University|Caroline Cobb, PhD, PI|804-828-8687|cobbco@vcu.edu|
22385457|NCT05783102|Case Western Reserve University|Kylie Meyer|216-368-1928|knm77@case.edu|
22385458|NCT06019559|Kallyope Inc|Clinical Director|917-336-3279|contactus@kallyope.com|
22430185|NCT04359680|Romark, L.C.|Sr. Director, Research Operations|8132828544|jessica.fulgencio@romark.com|
22446978|NCT03489720|Vanderbilt University Medical Center|Dr. Uma Shastri|615-936-3198|uma.shastri@vumc.org|
22446979|NCT02552199|Botanix Pharmaceuticals|Anthony Robinson MS CRNP|+1 (445) 300-3403|trials@botanixpharma.com|
22446980|NCT01806545|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22446981|NCT04932096|Oregon Health & Science University|Dr. Cydni Williams|5034945522|willicyd@ohsu.edu|
22446982|NCT01438957|Pfizer|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22446983|NCT00144963|Talon Therapeutics|VP, Regulatory Affairs|650-228-5066|ttarlow@talontx.com|
22446984|NCT00884312|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22446985|NCT00846430|Corewell Health|Dr. Albert Cornelius|616-391-2086|albert.cornelius@helendevoschildrens.org|
22446986|NCT03902574|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22446987|NCT00133952|Chromaderm|info@chroma-derm.com||info@chroma-derm.com|
22446988|NCT04592874|Alector|Alector Medical Information|650-826-2454|medinfo@alector.com|
22446989|NCT03143894|Johns Hopkins University|Tracy Vannorsdall, PhD|410-502-3701|TVannor1@jhmi.edu|
22446990|NCT00314093|University of Texas Southwestern Medical Center|Dr. Ellen Vitetta|214-648-1200|ELLEN.VITETTA@UTSouthwestern.edu|
22446991|NCT03809117|George Washington University|Dr. Andrew Meltzer|202-741-2952|ameltzer@mfa.gwu.edu|
22446992|NCT01603056|ALK-Abelló A/S|Vivian Wang, Sr. Medical Affairs Manager|86 - 10 5166 8198|Vivian.Wang@alk.net|
22446993|NCT02101060|Salem VA Medical Center|Dr. Krisann Oursler|540-982-2463|krisann.oursler@va.gov|4981
22446994|NCT02335294|Trevena, Inc.|Kelly Arscott|6103548840|karscott@trevena.com|
22446995|NCT00545168|ParaPRO LLC|Director, Quality and Regulatory|317-810-6205|kerrym@parapro.com|
22446996|NCT00960778|Medical University of South Carolina|Dr. Karen Hartwell|843-792-8174|hartwelk@musc.edu|
22385459|NCT05986682|Duke University School of Medicine|Dr. Thomas W. LeBlanc|919-668-2115|thomas.leblanc@duke.edu|
22399375|NCT01850615|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22399376|NCT00706628|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22399377|NCT02921425|University of Miami|Dr. Joseph Sharit|305-284-6472|jsharit@miami.edu|
22399378|NCT01227967|Leidos Biomedical Research, Inc. is support to the National Institute of Allergy and Infectious Diseases (NIAID)|John Beigel, M.D.|301-451-9881|jbeigel@niaid.nih.gov|
22446997|NCT03508921|Vanderbilt Medical Center|Melissa Kaufman, MD, PhD Professor of Urology|615-322-3807|melissa.kaufman@vumc.org|
22446998|NCT01833520|UT MD Anderson Cancer Center|Vivek Subbiah,Associate Professor, Invest. Cancer Therapeutics|(713) 563-0393|vsubbiah@mdanderson.org|
22446999|NCT00489541|Boston Scientific|Andrey Nersesov, Clinical Project Manager|508-683-4988|andrey.nersesov@bsci.com|
22447000|NCT03784729|Guang'anmen Hospital, China Academy Chinese Medical Sciences|Zhishun Liu|+86 010 88002331|liuzhishun@aliyun.com|
22447001|NCT00426855|Kantonsspital Aarau|Dr. Peter Moosmann|+41 62 838 60 51|peter.moosmann@ksa.ch|
22447002|NCT00003479|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22447003|NCT01484197|Novartis Pharmaceuticals|Study Director|862-778-8300||
22447004|NCT01727297|Medtronic, Inc.|Medtronic Cardiac Rhythm and Heart Failure clinical trial manager|763-505-6000|medtronicCRMtrials@medtronic.com|
22447005|NCT01192516|Veterans Affairs--Ann Arbor Health Care System|Research Health Science Specialist|734-936-2123|sumurphy@umich.edu|
22447006|NCT03012165|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
22447007|NCT00982878|Imperial College London|Professor Alan Winston|+44 (0)20 3312 1603|a.winston@imperial.ac.uk|
22447008|NCT04605484|AlloVir, Inc.|Richard Riese|617-433-2605|rriese@allovir.com|
22447009|NCT02454296|University of Hawaii|Reni Soon, MD|808-203-6548|rsoon@hawaii.edu|
22447010|NCT03366337|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22447011|NCT03282682|Comenius University in Bratislava|Doc. Mgr. Milan Sedliak, PhD.|+421918340671|milan.sedliak@uniba.sk|
22447012|NCT01191398|University of Texas Southwestern Dallas Medical Center|Craig J. Huang, MD|214-456-6371|craig.huang@utsouthwestern.edu|
22447013|NCT01578187|Syneron Beauty|Doran Rozen, Director of Clinical Affairs|+972-54-7800260|Doran.Rozen@syneron.com|
22447014|NCT04518293|George Medicines Pty Limited|Anthony Rogers (Principal Investigator)|+44-7983 578 290|arodgers@georgeinstitute.org|
22447015|NCT02516163|Stryker SP|Holly Solomon|+61 2 9467 1072|Holly.Solomon@stryker.com|
22447016|NCT01217814|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22447017|NCT02446483|GlaxoSmithKline|GSK Response Center|866-435-7343||
22447018|NCT01658072|Hospital for Special Surgery|Kethy Jules-Elysee, MD|2126061206|juleselyseek@hss.edu|
22447019|NCT00040664|GlaxoSmithKline|GSK Response Center|866-435-7343||
22447020|NCT01709162|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22447021|NCT04087096|Massachusetts General Hospital|Dr. Elaine Yu|617-643-6353|EWYU@mgh.harvard.edu|
22447022|NCT02334358|LG Chem|Study Leader|82-2-6987-4148|sodam@lgchem.com|
22447023|NCT00823095|Loma Linda University Medical Center|Deborah Dodge|(909) 558-4000|ddodge@llu.edu|48500
22447024|NCT01525563|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com|
22447025|NCT01086761|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22447026|NCT01637272|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22447027|NCT01844518|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22447028|NCT05399641|Scynexis|David Angulo|201-884-5471|david.angulo@scynexis.com|
22447029|NCT01146418|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22447030|NCT02457260|University of Pittsburgh|Daniel E. Forman - Chief of a section of Geriatrics Cardiology|412-864-2507|formand@pitt.edu|
22447031|NCT04523220|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22447032|NCT00779285|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22447033|NCT00256750|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22447034|NCT02517567|Alcon, A Novartis Division|Sr Global Brand Medical Affairs Lead, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
22447035|NCT04659161|Karuna Therapeutics, Inc.|Inder Kaul, VP Clinical Development|1-888-783-0380|medinfo@karunatx.com|
22447036|NCT01929343|UT Southwestern Medical Center|Josh Becker|2146485277|joshua.becker@utsouthwestern.edu|
22447037|NCT00901316|Texas Children's Hospital|Sheldon L. Kaplan, MD|832-824-4330|skaplan@bcm.edu|
22447038|NCT02197130|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22447039|NCT02615145|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22447040|NCT02320669|Seattle Childrens hospital|Michael A Portman|206-987-1014|michael.portman@seattlechildrens.org|
22447041|NCT00592943|Massachusetts General Hospital; Harvard Medical School|Thomas J. Spencer, MD|(617) 726-1731|tspencer@partners.org|
22447042|NCT00006237|SWOG statistical office|SWOG Melanoma Statistician|206-667-4408||
22447043|NCT01257087|Imperial College|Carel le Roux|07970719453|c.leroux@imperial.ac.uk|
22447044|NCT00680706|Baystate Medical Center|Howard Smithline|413-794-3433|howard.smithline@baystatehealth.org|
22447045|NCT03648983|Montefiore Medical Center|Lisa Wiechmann||lwiechma@montefiore.org|
22447046|NCT00750815|H. Lee Moffitt Cancer Center and Research Institute|Melissa Alsina, M.D.|813-745-6886|melissa.alsina@moffitt.org|
22447047|NCT01943292|Verastem|Lou Vaickus, MD, FACP/Chief Medical Officer|781-292-4200|lvaickus@verastem.com|
22447048|NCT00911820|Dana-Farber Cancer Insitute|Peter Enzinger, MD|617-632-6855|Peter_Enzinger@dfci.harvard.edu|
22447049|NCT05519540|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22447050|NCT02674529|University of Pittsburgh|Project Research Coordinator|412-376-3913|neppacham@upmc.edu|
22447051|NCT02066740|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com|
22399379|NCT03403400|Advent Health|Amie Jasper|407-303-8626|amiemarie.jasper@adventhealth.com|42
22399380|NCT00989989|Novartis Pharmaceuticals|Study Director|41 61 324 1111||
22447052|NCT02141282|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22447053|NCT02566083|Johnson & Johnson Surgical Vision|Devi Priya Janakiraman, OD, FAAO|+1 714 247- 8628|djanaki1@its.jnj.com|
22399381|NCT01107444|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22399382|NCT02284165|Duke Clinical Resarch Institute|Janet Prvu Bettger, ScD|617-901-0277|janet.bettger@duke.edu|
22399383|NCT02266433|New York University School of Medicine - Division of Hand Surgery|Anthony Sapienza, MD / Assistant Professor|212 737 3301|Anthony.Sapienza@nyulangone.org|
22399384|NCT03709602|Duke University|Dr. Lisa Mansfield|919-681-9198|lisa.mansfield@duke.edu|
22399385|NCT00737529|Celgene Corporation|Senior Manager, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialsdisclosure@celgene.com|
22399386|NCT01948830|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22447054|NCT00963547|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22447055|NCT00331682|Memorial Sloan-Kettering Cancer Center|Dr. Eileen O'Reilly|646-888-4182|oreillye@mskcc.org|
22447056|NCT03761277|Medtronic Neuromodulation Clinical Research|Pain Therapies Clinical Research Director|763-514-4000|rs.embracetdd@medtronic.com|
22447057|NCT00187486|University of California San Francisco|Michael Prados, MD|415 353 2076|PradosM@neurosurg.ucsf.edu|
22447058|NCT00759031|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
22447059|NCT00543140|Ethicon Endo-Surgery|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
22447060|NCT04532164|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22447061|NCT02483520|University of Kansas School of Nursing|Kristine Williams, RN, PhD, FNP-BC, FGSA, FAAN, E. Jean Hill Professor|913 588-1673|Kwilliams1@kumc.edu|
22447062|NCT02515058|UT Health Science Center at San Antonio|Dr. Brian Mealey|210-567-3567|mealey@uthscsa.edu|
22447063|NCT01104493|MedImmune, LLC|Dr. Robert Gasser|301-398-0000|gasserr@medimmune.com|
22447064|NCT02033694|Infraredx, A Nipro Company|Priti Shah|781-345-9646|pshah@infraredx.com|646
22447065|NCT01148940|Albert Einstein College of Medicine|Dr. Henny Billett|718-430-2186|hbillett@montefiore.org|
22447066|NCT02442869|University of Nevada, Reno|Dr. Jacqueline Pistorello|775-784-4648|pistorel@unr.edu|
22447067|NCT03521934|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
22447068|NCT00284050|Novartis Pharmaceuticals|Study Director|862 778-8300||
22447069|NCT01391559|Dartmouth-Hitchcock|Donald A. Mahler, M.D.|603 650-5533|Donald.a.mahler@hitchcock.org|
22447070|NCT02010840|The Hog Kong Polytechnic University|Vivian Ngai|2766|vivian.ngai@polyu.edu.hk|6775
22447071|NCT00859053|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22447072|NCT04028700|University of North Carollina at Chapel Hill|Matthew S. Karafin MD MS|984-974-1583|matthew.karafin@unchealth.unc.edu|
22447073|NCT04182763|Oregon Health & Science University|Allison Gregory, MS CGC, Project Manager|503-494-4344|gregorya@ohsu.edu|
22447074|NCT03348956|Dartmouth Hitchcock Medical Center|Victoria Lawson|(603) 650-5104|victoria.h.lawson@hitchcock.org|
22447075|NCT02551731|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com|
22447076|NCT03680105|Reven Pharmaceuticals|Head, Global Clinical Affairs|13036691336|kristina.cabala@reven.com|
22447077|NCT03814356|Massachusetts General Hospital|Brian L. Edlow, M.D.|617-724-6352|bedlow@mgh.harvard.edu|
22447078|NCT01774604|Penn State Hershey Medical Center/Dartmouth-Hitchcock Medical Center|John M. Levenick|603-667-1332|jlevenick@hmc.psu.edu|
22447079|NCT02248103|Faculty of Oral and Dental Medicine Cairo University|Ass. Prof. Dr. Noha Ghallab|+201005263365|noha.ghallab@dentistry.cu.edu.eg|
22447080|NCT01238471|Rambam Medical Center|Professor Imad Makhoul|972-4-8542219|makhoul@rambam.health.gov.il|
22447081|NCT05228132|Becton Dickinson|Joshua Black, Clinical Project Manager|520-599-6124|joshua.black@bd.com|
22447082|NCT02627144|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22447083|NCT01044771|Metropolis Medical|Dr. Fritz Bredeek|415 292 5477|fritz@doctor.com|
22447084|NCT00265798|University of Chicago|Dr. Hedy L. Kindler|773-702-0360|hkindler@medicine.bsd.uchicago.edu|
22447085|NCT01401582|Geman Centr for Neurodegenerative Diseases (DZN)|PD Dr. JR Thyrian|+49383486|rene.thyrian@dzne.de|7592
22447086|NCT04545385|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
22447087|NCT04891874|Shanghai Eastern Hepatobiliary Surgery Hospital|Dr. SHI Changying|+86-021-81887735|nona-peach@hotmail.com|
22447088|NCT01919606|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
22447089|NCT01217801|Par Pharmaceutical|Medical Affairs|800-828-9393|DrugInfo@strativapharma.com|
22447090|NCT04456959|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22447091|NCT00291577|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22447092|NCT04584645|Evidation Health|Director, Enterprise Research Design|650-389-9550|results@evidation.com|
22447093|NCT00830362|Medical University of South Carolina|Dr. Michael Saladin|843-792-5306|saladinm@musc.edu|
22447094|NCT03473977|Cincinnati Children's Hospital Medical Center|Marc E. Rothenberg, MD, PhD|513-636-7177|marc.rothenberg@cchmc.org|
22447095|NCT00545662|Columbia University|Dr. William Friedewald|212-305-3017|wtf1@columbia.edu|
22447096|NCT03845985|UMass Chan Medical School|Melissa L. Anderson, Associate Professor of Psychiatry|508-856-5820|melissa.anderson@umassmed.edu|
22447097|NCT02756013|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Peter Rose|+1 216-444-6601|ROSEP@ccf.org|
22447098|NCT03926169|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22447099|NCT03334539|Hanall Biopharma|Project Manager|82-222041763|parksm@hanall.co.kr|
22447100|NCT00968201|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22447101|NCT04974697|Johnson & Johnson Vision Care (JJVC)|Ross Franklin, BAppSc-Optom|1-800-843-2020|RFRANKL1@its.jnj.com|
22447102|NCT03706456|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22447103|NCT03889444|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22399387|NCT01145560|AstraZeneca|Justin Lindemann||ClinicalTrialTransparency@astrazeneca.com|
22447104|NCT03302234|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22447105|NCT04112784|Masimo Corporation|Ahmed Alghazi|949-297-7000|aalghazi@masimo.com|
22447106|NCT00221403|Ohio State Medical Center/Nationwide Children's Hospital|Robert Kowatch, MD, PhD|(614) 355-2872|Robert.Kowatch@nationwidechildrens.org|
22447107|NCT02439138|Dana-Farber Cancer Institute|Jorge J. Castillo|617-632-6045|jorgej_castillo@dfci.harvard.edu|
22447108|NCT00787852|BrUOG|Howard Safran, MD|4018633000|kayla_rosati@brown.edu|
22399388|NCT00712348|Protalix Ltd.|VP Medical Affairs|+972-4-9028100|raul@protalix.com|
22399389|NCT00928421|BTG International Inc|David Wright MB FRCS|610-943-3513|david.wright@btgplc.com|
22399390|NCT03310970|University of Iowa|Nicole Brogden, Associate Professor|319-335-8752|nicole-brogden@uiowa.ed|
22399391|NCT03875950|University of Washington|Pamela Kohler|206.221.5746|pkohler2@uw.edu|
22399392|NCT02604940|West Virginia University|Pavithra Ranganathan Ellison, MD|304-598-4929|pavithra.ellison@wvumedicine.org|
22399393|NCT01446419|Relievant Medsystems, Inc.|V.P. of Clinical & Regulatory Affairs|650-261-2259|lhook@relievant.com|
22399394|NCT01557166|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22399395|NCT00946309|Fred Hutchinson Cancer Research Center|Dr. Daniel Lin|206-221-0797|dwlin@uw.edu|
22399396|NCT01465659|Northwestern University|Sheetal Kircher, MD|312-695-0990|sheetal.kircher@nm.org|
22399397|NCT01698528|Joslin Diabetes Center|Dr William Hsu|617-309-5803|william.hsu@joslin.harvard.edu|
22399398|NCT02411747|Copenhagen Academy for Medical Education and Simulation, Rigshospitalet, Copenhagen University Hospital|Dr. Sarah Bube, director of the CYSTOSIM project|+4561339183|sarahbube@gmail.com|
22399399|NCT02149810|London Health Sciences Centre|Dr. Akshya Vasudev|519-685-8500|akshya.vasudev@lhsc.on.ca|75504
22399400|NCT00428597|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22399401|NCT00675597|Memorial Sloan Kettering Cancer Center|Dr. Mark G. Kris|646-888-4205|Krism@mskcc.org|
22399402|NCT00622895|Fred Hutchinson Cancer Research Center|George E. Georges MD|206-667-6886|ggeorges@fredhutch.org|
22399403|NCT00560755|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22399404|NCT02385279|European Cardiovascular Research Institute|Dr. E. Spitzer|+31102062828|E.Spitzer@ECRI-Trials.com|
22399405|NCT03828487|Masimo Corporation|Vikram Ramakanth|949-297-7416|clinicalresearchdept@masimo.com|
22399406|NCT01285427|Life Technologies|Deanna Vella, Staff Regulatory Engineer|760-918-3000|deanna.vella@lifetech.com|
22399407|NCT03404648|Mayo Clinic|Dr. Ming Yang|480-342-0988|Yang.Ming@mayo.edu|
22399408|NCT01784796|Edward Hines VA Hospital|Karen Saban, PhD|708-202-5264|Karen.Saban@va.gov|
22399409|NCT02474329|Radboudumc|Marjan Meinders|+00000000|Marjan.Meinders@radboudumc.nl|
22399410|NCT01356589|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22399411|NCT02447848|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
22399412|NCT04320407|Cochlear|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
22399413|NCT03219164|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22399414|NCT04585763|Shockwave Medical|Birgit Greschner|650-575-6199|bgreschner@shockwavemedical.com|
22399415|NCT02561897|Electrophysiology Research Foundation|Sanjeev Saksena|7323029990|eprf@aol.com|
22399416|NCT03021577|Columbia University Irving Medical Center|Ziad A. Ali, MD Assistant Professor of Medicine|212-305-7060|zaa2112@cumc.columbia.edu|
22399417|NCT03932799|University of Washington|Andrea Elmore|206-685-7194|aelmore@uw.edu|
22399418|NCT01097629|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22399419|NCT00956943|University of Pennsylvania|Robert A. Schnoll, Ph.D.|215-746-7143|schnoll@mail.med.upenn.edu|
22399420|NCT02613208|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22399421|NCT01524991|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317-643-5842|jsmith@hoosiercancer.org|41
22399422|NCT01678976|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|francisco.rocha@bial.com|
22399423|NCT04574999|Italfarmaco|Dr. Concepción Nieto|+34 91 657 23 23|cnieto@itfsp.com|
22399424|NCT03631927|Tata Memorial Hospital|Dr. Jigeeshu Divatia|+919869077435|jdivatia@yahoo.com|
22399425|NCT00206726|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22399426|NCT05148884|Neurolixis|Adrian Newman-Tancredi, PhD, DSc, CEO|(+33) 605 14 09 64|contact@neurolixis.com|
22430186|NCT02802865|University of Iowa|Dr. Rachel Mejia|319-356-3143|rachel-mejia@uiowa.edu|
22447109|NCT02216591|Duke University School of Medicine|Dr. Sheri Towe|919-668-4030|sheri.towe@duke.edu|
22447110|NCT01372462|Clinical Research Consulting|Richard J. Morishige, MS, RRT|510-606-0375|rjmorishige@gmail.com|
22447111|NCT01950741|Pusan National University Hospital|Ji Eun Lee, Assoicated professor|+82-51-240-7957|jlee@pusan.ac.kr|
22447112|NCT03129178|University of Portsmouth|Dr Anthony Shepherd|02392 84|ant.shepherd@port.ac.uk|5289
22447113|NCT00558558|UT MD Anderson Cancer Center|Ying Guo, MD - Associate Professor|713-745-2327|jaallo@mdanderson.org|
22447114|NCT01125605|Pascoe pharmazeutische Praeparate GmbH|Director of Clinical Trials|0049 641 7960100|klinische.forschung@pascoe.de|
22447115|NCT02549937|HUTCHMED Limited|Martin Benes|+1.973.306|martinb@hutch-med.com|4490
22447116|NCT01893632|NYSPI|john mariani, md|646-774-6140|john.mariani@nyspi.columbia.edu|
22447117|NCT02144012|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22447118|NCT00317356|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22447119|NCT04342897|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22447120|NCT00903695|UOklahoma Health Sciences Center|Marilee Monnot, PhD|405-456-5773|marilee-monnot@ouhsc.edu|5773
22447121|NCT01599234|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
22447122|NCT03848650|Columbia University|Manish Parikh, MD|212-326-8532|map2224@cumc.columbia.edu|
22399427|NCT01341457|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22399428|NCT00999830|HOPITAL DE PURPAN Service Hematologie|Dr Michel ATTAL|+33 (0)5.61.77.77.84|attal.m@chu-toulouse.fr|
22399429|NCT00832819|Eisai Co., Ltd.|Wataru Yusa|+81 3-3817-5252||5252
22399430|NCT01717638|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22399431|NCT01719757|Suyoun Yang|CR head|82-2-527-9219|suyoun.yang@mundipharma.co.kr|
22399432|NCT02626338|AROG Pharmaceuticals Inc.|Edward McDonald|214-593-0500|emcdonald@arogpharma.com|
22399433|NCT01099111|KFMC|Dr. Ahmed Al Omair|+96612889999|aalomair@kfmc.med.sa|8771
22399434|NCT03312218|McGill University|Dr. Roland Grad|514-947-3718|roland.grad@mcgill.ca|
22399435|NCT01901224|Brigham and Women's Hospital|Mark A. Creager, MD|603-650-8283|mark.a.creager@hitchcock.org|
22399436|NCT06441877|Topmed|Edith Martin|418 683-2104|emartin@topmed.ca|1302
22399437|NCT05742984|Cinclus Pharma|Cinclus Pharma Holding AB|+46 8 13 33 10|gosta.hiller@cincluspharma.com|
22399438|NCT02162862|University of Pittsburgh Medical Center|Dr. Eva Szigethy|412-802-6696|szigethye@upmc.edu|
22399439|NCT03116113|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22399440|NCT02159807|Icahn School of Medicine at Mount Sinai|Dr. Barbara Orlando|917-496-7490|barbara.orlando@mountsinai.org|
22399441|NCT00950170|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22399442|NCT01910792|Vitamin D, Skin, and Bone Research Laboratory|Dr. Michael F Holick|6176384546|mfholick@bu.edu|
22399443|NCT01254669|Boston Medical Center|Dr. Natalie Joseph|1-617-414-5202|napierre@bu.edu|
22399444|NCT02104414|Mount Sinai St. Luke's|Dr. Ali Shariat|914-409-5023|alishariatmd@gmail.com|
22399445|NCT00103012|National Institutes of Health, Clinical Center, Department of Pharmacy|Scott Penzak|301-496-2997|spenzak@cc.nih.gov|
22399446|NCT03051633|Colorado State University|Dr. Meghan Crabtree|2105875584|meghan.crabtree@colostate.edu|
22399447|NCT01834235|Precision Biologics Inc.|Dr. Philip Arlen President and CEO|3015008646|philip.arlen@precision-biologics.com|
22399448|NCT00393718|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22399449|NCT01790490|NYSPI|Elias Dakwar, MD|(646) 774-8728|dakware@nyspi.columbia.edu|
22399450|NCT04271761|Cochlear|Ruth English|0386633105|REnglish@cochlear.com|3105
22399451|NCT01084551|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22399452|NCT03902080|Urovant Sciences|Information, Clinical Trial Results|949-226-6029|info@urovant.com|
22399453|NCT01703000|Boston Scientific|Peter Maurer, Director Clinical Trials|508-683-6678|Peter.Maurer@bsci.com|
22399454|NCT00289913|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com|
22399455|NCT03822884|Biosidus S.A.|Clinical Trial Manager - Dr. Roberto A. Diez|+5411 4909 8000|r.diez@biosidus.com.ar|
22399456|NCT02620904|Montefiore Einstein|Jessica Maria Atrio|7184058260|jatrio@montefiore.org|
22399457|NCT00434967|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
22399458|NCT01279057|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22399459|NCT00626743|INJE University Pusan Paik Hospital|Jae Gook Shin, MD,PhD|+82-51-890-8954|phshinjg@paik.ac.kr|
22399460|NCT01014585|Forest Research Institute, Inc., a subsidiary of Forest Laboratories, Inc.|Joel Trugman, MD|201-427-8681|joel.trugman@frx.com|
22399461|NCT00165958|Emory University|Dr. Suephy Chen|4047783084|schen2@emory.edu|
22399462|NCT01481896|Anderson Orthopaedic Research Institute|Robert H. Hopper, Jr., PhD|(703) 619-4411|research@aori.org|
22399463|NCT03543085|China Medical University Hospital (in Taiwan)|Dr. Yeong-Ray Wen (Department of Anaesthesia)|+886 4 2205-2121|yray.wen@gmail.com|
22399464|NCT00364182|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22399465|NCT03336502|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22399466|NCT04244370|BD|Heather Vander Ploeg|602-751-3268|heather.vander.ploeg@bd.com|
22399467|NCT03497845|BARDA|Silvija Tresnjak-Smith, Regulatory Operations Branch Chief, Regulatory and Quality Affairs Division|202-557-1993|Silvija.Tresnjak-Smith@hhs.gov|
22399468|NCT01831960|Cassiopea, SpA|Cassiopea R&D|+39 02 868 911 24|r&d@cassiopea.com|
22399469|NCT05032950|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22399470|NCT02959814|Skejby University Hospital, Denmark|Niels Ramsing Holm, MD|004526849066|Niels.holm@clin.au.dk|
22399471|NCT05243628|Mannkind Corporation|Jennifer Pleitez, Director of Clinical Operations|818-661-5032|endocrineresearch@mannkindcorp.com|
22399472|NCT04343651|CytoDyn Inc.|Dr. Scott Kelly, Chief Medical Officer|(360) 980-8524|skelly@cytodyn.com|
22399473|NCT01943565|Brigham and Women's Hospital|Dirk J Varelmann, MD|617-732-8280|dvarelmann@partners.org|
22399474|NCT01583374|Celgene Corporation|Anne McClain, Senior Study Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22399475|NCT01265524|Sorbent Therapeutics|Howard Dittrich, MD FACC|858-405-1429|hdittrich@sorbent.com|
22399476|NCT01292057|Medical University of South Carolina|Joseph Schacht, Ph.D.|(843) 792-7497|schacht@musc.edu|
22399477|NCT02307370|Spectranetics, LLC now a part of Philips Image Guided Therapy Devices|Nicolas Aguirre, Senior Manager, Clinical Operations|612-297-6655|nicolas.aguirre@philips.com|
22399478|NCT04451707|Groupe Hospitalier La Rochelle Ré Aunis|Dr Florence Hoefler|+330546455050|florence.hoefler@ch-troyes.fr|
22399479|NCT02281591|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22399480|NCT02732951|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22399481|NCT01805180|Terumo BCT|Raymond P. Goodrich, PhD / VP, Scientific and Clinical Affairs; Chief Science Officer-BBT|303.205.2680|Ray.Goodrich@terumobct.com|
22430187|NCT01862029|National Institute of Health, NHLBI, Laboratory of Obesity and Aging Research|Jay H. Chung, Ph.D, MD|301-496-3075|chungj@nhlbi.nih.gov|
22385460|NCT05170009|Weill Cornell Medicine|Dr. Mirella Salvatore|(646) 318-8506|mis2053@med.cornell.edu|
22385461|NCT04629716|Florida State University|Nicole Ennis, PhD|850-644-2334|nicole.ennis@med.fsu.edu|
22385462|NCT02724449|North Shore University Hospital|Mary Brennan, Assist Director WOCN|516-562-8252|mbrennan@northwell.edu|
22385463|NCT00670358|Mayo Clinic|Dr. Grzegorz Nowakowski|507-284-5096|Nowakowski.Grzegorz@mayo.edu|
22385464|NCT00613106|Horizon Pharma, Inc.|Amy Grahn, MS Senior Vice President, Clinical Development and Operations|224-383-3012|agrahn@horizonpharma.com|
22385465|NCT03496168|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
22385466|NCT02396134|City of Hope|Dr. Ryotaro Nakamura|626-359-8111|rnakamura@coh.org|
22385467|NCT05543629|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@BMS.com|
22385468|NCT04568603|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22385469|NCT05194540|Leo Pharma|Clinical Disclosure|+45 44945888|disclosure@leo-pharma.com|
22385470|NCT04573517|University of Texas Medical Branch|Dr. Marissa Berry|402-772-4099|majberry@utmb.edu|
22385471|NCT04137367|University of Oslo|Nils Inge Landrø|+4795038479|n.i.landro@psykologi.uio.no|
22385472|NCT05144009|ADC Therapeutics|Contact ADC Therapeutics|954-903-7994|clinical.trials@adctherapeutics.com|
22385473|NCT03374787|Oticon Medical|Director of Clinical Affairs|0046-31-7486100|studyinfo@oticonmedical.com|
22385474|NCT04492722|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22385475|NCT04074759|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22385476|NCT03752203|Children's Hospital Colorado|Dr. Todd Hankinson|7207776100|todd.hankinson@childrenscolorado.org|
22385477|NCT06180954|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22385478|NCT05329220|Bavarian Nordic A/S|Bavarian Nordic Call Center|1-844-422-8274|medical.information_us@bavarian-nordic.com|
22385479|NCT05651308|Weill Cornell Medicine|Lisa M. Kern, MD, MPH|646-962-5889|lmk2003@med.cornell.edu|
22385480|NCT00986856|LEO Pharma|Anders Rhod Larsen, Scientific advisor|+45 72262990|anders.larsen@leo-pharma.com|
22385481|NCT05445427|Mayo Clinic|Dr. Ryan T. Hurt, MD, PhD|507-284-4461|hurt.ryan@mayo.edu|
22385482|NCT04313972|Endeavor Health|Urogynecology Research Coordinator|847-570-4729|JLee5@northshore.org|
22385483|NCT00967447|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22385484|NCT04447469|Kiniksa Pharmaceuticals, Ltd.|Clinical Operations Study Director|1-781-431-9100|studyinfo@kiniksa.com|
22385485|NCT05201079|Mikrobiomik Healthcare Company S.L.|Olaia Aurtenetxe Saez|+34 944 540 166|ensayosclinicos@mikrobiomik.net|
22385486|NCT03569631|Shionogi|Shionogi Clinical Trials Administrator Clinical Support Help Line|1-800-849-9707|Shionogiclintrials-admin@shionogi.co.jp|
22385487|NCT05746299|University of Pennsylvania|Anna Schapiro|215-898-0482|aschapir@sas.upenn.edu|
22385488|NCT04719832|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|
22385489|NCT05239455|Terumo BCT, Inc|Erin Goodhue, DO, MPH, Director, Clinical Affairs|614-400-4638|Erin.Goodhue@TerumoBCT.com|
22385490|NCT03701763|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22385491|NCT04489771|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22385492|NCT04711447|University of Manitoba|Dr. Trisha Scribbans|(204) 272-1699|trisha.scribbans@umanitoba.ca|
22385493|NCT05292872|Intercept Pharmaceuticals, Inc.|Medical Information|844-782-4278|medinfo@interceptpharma.com|
22385494|NCT02561585|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
22385495|NCT03059030|Northwestern University|Riad Salem MD|312-695-6371|rsalem1@nm.org|
22385496|NCT06516705|National Tainan Junior College of Nursing|Mei-Chuan Huang|886-0956646992|mayhuang@ntin.edu.tw|
22385497|NCT05579899|Evommune|Eugene Bauer, M.D., Chief Medical Officer|310-721-3364|eugene.bauer@evommune.com|
22385498|NCT05373862|Biosense Webster, Inc.|Senior Director Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22385499|NCT04059484|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22385500|NCT04292223|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|+1-858-261|medicalinformation@acadia-pharm.com|2897
22385501|NCT00753545|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22385502|NCT05453773|Ohio State University Comprehensive Cancer Center|Marielle Brinkman|614-688-3226|brinkman.224@osu.edu|
22385503|NCT00391365|Center For Limb Loss Prevention and Prosthetic Engineering, VA Puget Sound Health Care System|Alan Wesley, Program Manager|206 277 1079|alan.wesley@va.gov|
22385504|NCT02485938|Capricor, Inc.|Vice President of Clinical Research and Development Operations|858-727-1755|clinicaltrialsgov@capricor.com|
22385505|NCT03839940|Mayo Clinic|Dr. Kathryn J. Ruddy|507-293-1732|ruddy.kathryn@mayo.edu|
22385506|NCT00470704|Dana-Farber Cancer Institute|Nancy Lin|6176322335|Nancy_Lin@dfci.harvard.edu|
22385507|NCT04963270|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22385508|NCT05540665|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22385509|NCT03462030|Johns Hopkins University|Dr. Robert Wood|410-955-5883|rwood@jhmi.edu|
22399482|NCT04226469|University of Illinois Chicago|Phimon Atsawasuwan|3124132651|patsawas@uic.edu|
22399483|NCT01196442|Virginia Commonwealth University|Dr. Craig W. Swainey|804-828-9723|cswainey@mcvh-vcu.edu|
22399484|NCT01427309|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22399485|NCT00542620|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22399486|NCT00928070|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22399487|NCT00849017|GlaxoSmithKline|GSK Response Center|866-435-7343||
22399488|NCT02913313|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22399489|NCT01061008|UWalesBangor|Dr. Jamie Macdonald|+441248383272|j.h.macdonald@bangor.ac.uk|
22399490|NCT01492673|Memorial Sloan Kettering Cancer Center|Dr. Tanya Trippett, MD|212-639-8267|trippet1@mskcc.org|
22399491|NCT01841619|UC Irvine Dermatology Research Center|Sergei A. Grando|949 824 7103|sgrando@uci.edu|
22399492|NCT02908100|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22399493|NCT02024971|Takeda Pharmaceuticals Company Limited|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22399494|NCT00544830|City of Hope|Dr. Cy Stein|626-359-8111||
22399495|NCT04933123|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
22399496|NCT05254418|Vanderbilt University Medical Center|Dr. Talat Alp Ikizler|6159366646|alp.ikizler@vumc.org|
22399497|NCT04130646|Medical University of South Carolina|Associate Professor-Faculty|(843) 792-6076|badran@musc.edu|
22399498|NCT02631538|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22399499|NCT03118596|University Hospitals Coventry & Warwickshire NHS Trust|Dr Cyprian Mendonca|02476964000|cyprian.mendonca@hotmail.com|25871
22399500|NCT00440726|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
22399501|NCT04067518|Institut de Recherches Internationales Servier|Clinical Studies Department|+33 1 55 72 43 66|scientificinformation@servier.com|
22399502|NCT00110019|ECOG Statistical Office|Study Statistician|617-632-3012||
22399503|NCT00822107|Oregon Health & Science University|Dr. David H. Ellison|5034944465|ellisond@ohsu.edu|
22399504|NCT01577238|Starpharma|Dr Jeremy Paull||jeremy.paull@starpharma.com|
22399505|NCT04276207|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22399506|NCT01256177|AstraZeneca|Dhaval Desai (MSD, Seroquel)|+13028857643|aztrial_results_posting@astrazeneca.com|
22399507|NCT02690194|Boston Children's Hospital|Greggory Kobelski|7812161093|Greggory.Kobelski@childrens.harvard.edu|
22399508|NCT03624946|Emergent BioSolutions Canada Inc.|Jason Richardson, Senior Scientist, Clinical Research|204-275-4266|jrichardson@ebsi.com|
22399509|NCT03501966|Jaeb Center for Health Research|Colleen Bauza|813-975-8690|cbauza@jaeb.org|
22399510|NCT00862251|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22399511|NCT00624520|Department of Veterans Affairs|Dr Douglas C Russell|608-256-1901|Dcrussel@facstaff.wisc.edu|
22399512|NCT02796755|Emory University|Andrew H Miller, MD|404-727-8260|amill02@emory.edu|
22399513|NCT00675025|Eisai Inc|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22399514|NCT02002702|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
22399515|NCT00556426|C.R. Bard|John Reviere, Director of Clinical Affairs|480-303-2644|john.reviere@crbard.com|
22399516|NCT01589484|University of Sao Paulo Medical School|Dr. Fabio Torricelli|+55 11 94308951|fabio_torri@yahoo.com.br|
22399517|NCT00944034|Novartis Vaccines|Posting Director|+39 0577 245863|anh.phung@novartis.com|
22399518|NCT01596257|Memorial Sloan Kettering Cancer Center|Dr. Sergio Giralt, MD|646-608-3731|GiraltS@mskcc.org|
22399519|NCT00602355|Women and Infants Hospital|Caron Zlotnick|401-455-6529|czlotnick@butler.org|
22399520|NCT01570244|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22399521|NCT03176316|Loyola University Medical Center|Russell Nockels, M.D.|847-618-9565|neurocare@nch.org|
22399522|NCT01349140|University California San Diego|Brian Ilfeld, MD, MS|1-858-444-5949|bilfeld@ucsd.edu|
22399523|NCT00531960|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22399524|NCT03062657|Medtronic|Rhys Jones, PhD; Senior Clinical Research Specialist|+44 7826874430|rhys.j.jones@medtronic.com|
22399525|NCT04258579|Weill Cornell Medical College|Dr. Jo Anne Sirey|914-997-4333|jsirey@med.cornell.edu|
22399526|NCT04007159|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22399527|NCT01510327|Boston Scientific|Ruth Starzyk, PhD|508-683-6577|ruth.starzyk@bsci.com|
22399528|NCT00331006|New England Research Institutes, Inc.|Susan F. Assmann, PhD|617-972-3048|sassmann@neriscience.com|
22399529|NCT03804684|Wills Eye Hospital|M. Reza Razeghinejad, MD|12159283197|reza@willseye.org|
22399530|NCT00238264|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22399531|NCT00713219|Memorial Sloan Kettering Cancer Center|Dr. Matthew Fury|646-888-4233|furym@mskcc.org|
22399532|NCT03183128|Seres Therapeutics|Lisa von Moltke, MD, Chief Medical Officer|617-945-9626|clinicalstudies@serestherapeutics.com|
22399533|NCT02978222|Marker Therapeutics|Gerald Garrett|713.400.6400|ggarrett@markertherapeutics.com|
22399534|NCT03258814|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22399535|NCT01413958|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22399536|NCT02908516|Yale School of Medicine, Department of Orthopaedics and Rehabilitation|Dr. Michael P. Leslie|(203) 737-6358|michael.leslie@yale.edu|
22399537|NCT03382509|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22399538|NCT01225562|AstraZeneca AB|Anders Himmelmann, MD PhD|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
22399539|NCT00348140|GlaxoSmithKline|GSK Response Center|866-435-7343||
22399540|NCT01375764|Amgen Inc.|Study Director|866-572-6436||
22399541|NCT03887130|Pierre Fabre|Gustavo Villanova M.D|+33149108265|gustavo.villanova@pierre-fabre.com|
22399542|NCT00484315|Boston Scientific|Andrey Nersesov, Clinical Project Manager|508-683-4988|andrey.nersesov@bsci.com|
22399543|NCT01990261|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22399544|NCT01552343|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22399545|NCT01078805|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22399546|NCT01609842|VHA Eastern Colorado Health Care System|Marina McCreight|720-857-2785|marina.mccreight@va.gov|
22430188|NCT01832038|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22399547|NCT04722991|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22399548|NCT03186989|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionis.com|
22399549|NCT03057795|City of Hope Medical Center|Dr. Alex Herrera|626-359-8111|aherrera@coh.org|
22399550|NCT01370460|Henry Ford Health System|Andrew Georgiadis, MD|313-916-7520|ageorgi1@hfhs.org|
22399551|NCT02246621|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
22399552|NCT00821678|VA HSR&D|John Fortney|206.764.2821|john.fortney@va.gov|
22399553|NCT03641560|Astellas Global Development, Inc. (APGD)|Clinical Transparency|800-888-7704|astellas.resultsdisclosure@astellas.com|
22399554|NCT01542645|NorthShore University HealthSystem|Glenn Murphy, MD|847-570-2760|dgmurphy2@yahoo.com|
22399555|NCT04439279|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22399556|NCT02031679|Johns Hopkins University School of Medicine|Dr. Eric Oliver|410-550-2300|eolive15@jhmi.edu|
22399557|NCT01974817|Michigan State University|Dr Subhashis Mitra|517-353-3128|mitrasub@msu.edu|
22399558|NCT02828267|Duke University Medical Center|Catherine Staton|9196845537|catherine.staton@duke.edu|
22399559|NCT00110305|Janssen-Virco BE|Director|32 14 641418||
22399560|NCT05047523|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
22399561|NCT03658889|ChugaiPF|Isabelle Idier, Rheumatology Medical Leader|+33 (0) 1 56 37 44 89|idier@chugai-pharm.fr|
22399562|NCT02923271|University of Pennsylvania|Dr. M. Kit Delgado|215-746-8256|Mucio.Delgado@uphs.upenn.edu|
22399563|NCT01495819|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-932-5711|mehmet.sofuoglu@yale.edu|4809
22399564|NCT01609933|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22399565|NCT00224016|Watson Laboratories, Inc|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com|
22399566|NCT01252966|University of Pennsylvania (Perelman School of Medicine)|Benjamin Albelda (Project Manager)|2157467173|albeldab@mail.med.upenn.edu|
22399567|NCT03340350|VA Nebraska-Western Iowa Health Care System|Sriram Ramaswamy, MD|402-995-4712|Sriram.Ramaswamy@va.gov|
22399568|NCT03275870|Beth Israel Lahey Health|Dr. Elena Gonzalez Brant, PI|6173191221|emgbrant@gmail.com|
22399569|NCT04188197|Rose Research Center|Dr. Jed E. Rose|9193282345|jed.rose@roseresearchcenter.com|
22399570|NCT01922921|University of Washington|Director of Clinical Operations|2066162305|childj@u.washington.edu|
22399571|NCT00391599|Edith Wolfson Medical Center|Investigator|+972-35028329|lurie@wolfson.health.gov.il|
22399572|NCT03455673|Groupe Hospitalier de la Rochelle Ré Aunis|Caroline Allix-Béguec, manager of clinical trials|+33546455050|caroline.allix-beguec@ght-atlantique17.fr|
22399573|NCT04684420|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49 6151 72 5200|service@emdgroup.com|
22399574|NCT00463476|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22399575|NCT00254410|The University of Texas MD Anderson Cancer Center|Wierda,William G, MD./Professor|713-745-0428|wwierda@mdanderson.org|
22399576|NCT00820573|University of Texas HSC at San Antonio|Eugenio Cersosimo, MD PhD|210 358 7200|Eugenio.cersosimo@uhs-sa.com|
22399577|NCT00754156|University of Kentucky Medical Center|Phillip Chang, M.D. PI or Anna Rockich, Pharm.D. GSRP Director|859-323-6346|arockich@uky.edu|247
22399578|NCT04591054|Penn State Hershey Medical Center|Seth Pantanelli MD|717-531-4696|spantanelli@pennstatehealth.psu.edu|
22399579|NCT00516919|Yale University School of Medicine|Dr. Carlos Grilo|203-785-2792|carlos.grilo@yale.edu|
22399580|NCT03371355|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
22399581|NCT00868790|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22399582|NCT01167608|Rutgers-Robert Wood Johnson Medical School|Dr. Roseanne Dobkin, Associate Professor of Psychiatry|732-235-4051|dobkinro@rutgers.edu|
22399583|NCT03251326|New York State Psychiatric Institute|Margaret Haney, Ph.D.|646-774-6129|meg.haney@nyspi.columbia.edu|
22399584|NCT02909153|Rockwell Medical|clinical project manager|248-960-9009|sgrimberg@rockwellmed.com|
22399585|NCT01273064|Conatus Pharmaceuticals Inc.|MiRa Huyghe, Vice President, Clinical Development|(858) 457-7227|mhuyghe@conatuspharma.com|
22399586|NCT04666038|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22399587|NCT03357393|Region Östergötland|Lena Nilsson|+46 10 103 00 00|lena.nilsson@regionostergotland.se|1838
22399588|NCT01228903|University of Colorado|Diana Jalal|3037244867|diana.jalal@ucdenver.edu|
22399589|NCT02602223|Oregon Health & Sciences University|Dr. Sivaraman Prakasam|503-346-4711|prakasam@ohsu.edu|
22399590|NCT02867761|University of Michigan|Meilan K. Han|734 615-9772|mrking@med.umich.edu|
22399591|NCT03595280|Georgetown University|Darren Mays|2026878937|dmm239@georgetown.edu|
22399592|NCT00374244|Yale University School of Medicine, Dept of Psychiatry|Handan Gunduz-Bruce MD|(203) 932-5711|handan.gunduz-bruce@yale.edu|4130
22399593|NCT02658812|UT MD Anderson Cancer Center|Dr. Naoto T. Ueno, MD-Professor Breast Medical Oncology|713-792-8754|nueno@mdanderson.org|
22399594|NCT03400800|Novartis|Vice-President, Regulatory Operations|973-985-0597|frank.bosley@novartis.com|
22399595|NCT02445586|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22399596|NCT01512264|Universtiy of Alabama at Birmingham|Dr. Jerzy P. Szaflarski|205.975.5587|jszaflarski@uabmc.edu|
22399597|NCT01194440|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|443-287-6489|HopkinsBreastTrials@jhmi.edu|
22399598|NCT00854828|Washington University|Keith H. Bridwell, MD|314-747-2655|bridwellk@wustl.edu|
22399599|NCT01931059|Northwell Health|Dr. Miklos Argyelan|718-470-8175|margyela@northwell.edu|
22399600|NCT01239355|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22399601|NCT02675075|James A. Haley VA Hospital|Dr. Sam Phillips|813 558 3995|samuel.phillips@va.gov|
22399602|NCT02292212|Asahi Kasei Medical Co., Ltd.|Masaharu Aritomi, Ph.D.||aritomi.mb@om.asahi-kasei.co.jp|
22399603|NCT01859247|The University of New Mexico Health Sciences Center|Dr. Sarah Pirio Richardson, MD|505-272-3342|spiriorichardson@salud.unm.edu|
22399604|NCT04957290|Noxopharm|Lorena, Director Clinical Operations|+ 61 2 9144 2223|lorena.figueroa@noxopharm.com|
22399605|NCT01282229|Millenium Dental Technologies, Inc|Dr. David Harris|510-502-3345|dharris@LANAP.com|
22412988|NCT01691248|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22412989|NCT00993187|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372||
22412990|NCT00633256|Yale University|James Poling, Ph.D.|203-937-4830|james.poling@yale.edu|
22412991|NCT00318812|Ottawa Hospital Research Institute|Dr Deborah Zimmerman, principal investigator|613-738-8400|dzimmerman@toh.on.ca|82534
22412992|NCT00549718|Sunovion Pharmaceuticals Inc.|Josephine Cucchiaro|201-592-2050|josephine.cucchiaro@sunovion.com|
22412993|NCT03422653|Cara Therapeutics|Frédérique Menzaghi, PhD|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
22412994|NCT04503603|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22412995|NCT01725529|Janssen R&D US|ASSOCIATE DIRECTOR, MEDICAL DEPARTMENT||ClinicalTrialDisclosure@its.jnj.com|
22412996|NCT02091882|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22412997|NCT01315249|Novartis|Study Director|41 61 324 1111||
22412998|NCT01191320|Repros Therapeutics Inc.|Jennifer L. Wike|281-719-3402|jwike@reprosrx.com|
22412999|NCT02831569|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22413000|NCT00954915|MacroGenics, Inc.|Teplizumab Program Manager||info@macrogenics.com|
22413001|NCT01287013|National Institutes of Health|Bradford Wood, MD|(301) 496-7739|bwood@nih.gov|
22413002|NCT00051025|Eisai Call Center|Eisai Inc|888-422-4743||
22413003|NCT01900730|UT MD Anderson Cancer Center|Dr. Wendy Woodward, PHD/ Professor, Radiation Oncology Department|713-563-8481|wwoodward@mdanderson.org|
22413004|NCT01179048|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22413005|NCT02109042|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22413006|NCT01163760|Vistakon|Kurt Moody OD, FAAO|904-443-3088||
22413007|NCT03203447|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
22413008|NCT02189941|ApoPharma Inc.|Fernando Tricta, MD|416-401-7332|ftricta@apopharma.com|
22413009|NCT00445003|Jaeb Center for Health Research|Adam R. Glassman, Director DRCR.net Coordinating Center|813-975-8690|aglassman@jaeb.org|
22413010|NCT02962934|University of Queensland Center for Clinical Research|Professor Jason Roberts|+61 7 334 65032|j.roberts2@uq.edu.au|
22399606|NCT00896532|Amgen Inc.|Study Director|866-572-6436||
22399607|NCT01176916|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22399608|NCT01014403|UT Southwestern Medical Center|Dr. Herb Phelan|214-648-6841|herb.phelan@utsouthwestern.edu|
22399609|NCT03158220|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22399610|NCT01671280|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22399611|NCT00996203|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22399612|NCT01959165|Biometrics|Nii Masahiro|+81 6 7711 4571|Masahiro.Nii@astrazeneca.com|4571
22399613|NCT03686969|CRMG|Mikaela Raymond|866-337-1868|ctgov@cllinicalresearchmgt.com|
22399614|NCT01144598|Abbott|Global Medical Services|1-800-633-9110||
22399615|NCT00848120|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22399616|NCT02525549|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
22399617|NCT01961115|Fred Hutchinson Cancer Research Center|Dr. Martin A. Cheever|206-667-4141|mcheever@fredhutch.org|
22399618|NCT02497001|Pearl Therapeutics Inc.|Pearl Therapeutics Inc.|1-877-240-9479|information.center@astrazeneca.com|
22399619|NCT00705263|Schering-Plough|Head, Clinical Trials Registry & Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com|
22399620|NCT02899156|University of California Davis Medical Center|Kendra Schomer, PharmD|916-734-2243|kjschomer@ucdavis.edu|
22399621|NCT03135249|UT Southwestern Medical Center|Dr. Olaf Stuve, Principal Investigator|12146484559|olaf.stuve@utsouthwestern.edu|
22399622|NCT01445678|Cubist Pharmaceuticals, Inc.|Dr. Obi Umeh, Vice President Global Medical Sciences|781-860-8415|obiamiwe.umeh@cubist.com|
22399623|NCT01565980|Michigan State University College of Nursing|Rebecca H. Lehto, PhD, Assistant Professor|517-353-4757|rebecca.lehto@hc.msu.edu|
22399624|NCT02078219|Study Information Center AstraZeneca|Fredrik Erlandsson, MD|+1 877-240-9479|information.center@astrazeneca.com|
22399625|NCT03639948|University of Kansas Medical Center|Dr. Priyanka Sharma|913-588-6029|psharma2@kumc.edu|
22399626|NCT03036527|University of Louisville|Charles Hubscher|502-852-3058|charles.hubscher@louisville.edu|
22399627|NCT00891202|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22399628|NCT00460993|Atlanta VA Medical Center|Dr. Patricia C. Griffiths|404-321-6111|Patricia.Griffiths@va.gov|7138
22399629|NCT02924896|Imperial College London|Prof Gary Frost|020 7589 5111|g.frost@imperial.ac.uk|
22399630|NCT04801758|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22399631|NCT05019131|University of California, San Francisco|Dr. Patience Afulani|(415) 476-1000|Patience.Afulani@ucsf.edu|
22399632|NCT02360098|TORONTO WESTERN HOSPITAL/UHN|Emad Al Azazi|416-603-5800|emad.alazazi@uhnresearch.ca|6237
22399633|NCT00412529|Novartis Pharmaceuticals|Study Director|862-778-8300||
22413011|NCT00528606|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22413012|NCT01471093|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22430189|NCT03810365|School of Nursing, University at Buffalo|Dr Suzanne S. Dickerson|716-829-3254|sdickers@buffalo.edu|
22399634|NCT03293654|mAbxience|Susana Millan|+34917711500|susana.millan@mabxience.com|
22399635|NCT01919307|Denver Health and Hospital Authority|Edward Maa|303-602-5099|Edward.Maa@dhha.org|
22430190|NCT01755156|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22385510|NCT03381196|Janssen Research & Development, LLC|Senior Director Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22385511|NCT00227344|Biosense Webster, Inc.|Pat Ticknor, Clinical Operations|909-839-8500|PTicknor@its.jnj.com|
22385512|NCT03371381|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22385513|NCT04098263|Lumen Bioscience|Senior Medical Director|206-899-1904|trials@lumen.bio|
22385514|NCT01073566|Calibra Medical|Vice President Clinical Affairs|650-298-4750|ddreon@calibra.com|
22385515|NCT05780437|University of Minnesota|Greg Grandits|651-528-9491|greg-g@ccbr.umn.edu|
22385516|NCT03309306|Department of Agricultural, Environmental & Development Economics, Ohio State University|Brian Roe|614-688-5777|roe.30@osu.edu|
22399636|NCT03742427|Marmara University|Sinan KARACABEY|+902166254545|karacabeysinan@gmail.com|
22399637|NCT05052723|University of Kentucky|Dr. Joseph Kim|859-257-4490|joseph.kim@uky.edu|
22399638|NCT04526730|Moffitt Cancer Center|Ahmad Tarhini, MD, PhD|813-745-8581|Ahmad.Tarhini@moffitt.org|
22399639|NCT01551979|Beth Israel Deaconess Medical Center|Mark Halko|6176670367|mhalko@bidmc.harvard.edu|
22399640|NCT02771522|Calcivis Ltd|Director of Clinical Research|+44 131 658 5152|mwillins@calcivis.com|
22399641|NCT01111305|NIAID/NIH|Dr. Amy Klion|301-435-8903|aklion@niaid.nih.gov|
22399642|NCT03049449|National Cancer Institute|Dr. James N. Kochenderfer|240-760-6062|kochendj@mail.nih.gov|
22385517|NCT03001713|Kaiser Permanente Center for Health Research|Rachel Gold, PhD MPH|503-335-2400|rachel.gold@kpchr.org|
22399643|NCT00891995|Jaeb Center for Health Research|Katrina Ruedy|8139758690|kruedy@jaeb.org|
22399644|NCT02673333|Memorial Sloan Kettering Cancer Center|Diane Reidy-Lagunes, MD|646-888-4185|reidyd@mskcc.org|
22399645|NCT02054702|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22399646|NCT03486392|Janssen Research & Development, LLC|Senior Director Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22399647|NCT02737163|Johns Hopkins All Children's Hospital|Gerald Tuite, MD|7277678181|gtuite1@jhmi.edu|
22399648|NCT00701714|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|0049 80244760|biopharma.clinicaltrials@sandoz.com|
22399649|NCT01175798|Icahn School of Medicine at Mount Sinai|Anita Mehrotra MD|2122415153|anita.mehrotra@mssm.edu|
22399650|NCT02347631|UT Southwestern Medical Center|Danielle Robertson|214-648-3416|danielle.robertson@utsouthwestern.edu|
22399651|NCT01509625|Hospital Clínico San Cecilio Granada|Dr Isabel Blancas|+34 958023498|blancaslb@hotmail.com|
22399652|NCT01262898|GlaxoSmithKline|GSK Response Center|866-435-7343||
22399653|NCT02304926|FISABIO-University Hospital Dr Peset|Dr Antonio Hernández|961622492|hernandez_antmij@gva.es|
22399654|NCT04354428|University of Washington|Christine Johnston|206-520-4340|cjohnsto@uw.edu|
22399655|NCT01963481|NYU Langone Health|Sylvia Adams|212 731 5795|Sylvia.Adams@nyulangone.org|
22399656|NCT02388295|AstraZeneca Pharmaceuticals LP|Jamie Mullen MD||Clinicaltrialtransparency@astrazeneca.net|
22399657|NCT02076165|VA Greater Los Angeles Healthcare System|Dr. Jennifer Martin|818 891-7711|Jennifer.Martin@va.gov|36080
22399658|NCT01551693|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617.632.5053|Stephen_Hodi@dfci.harvard.edu|
22399659|NCT02429856|UAlberta|Director of NACTRC|780-407-8007|ron.welch@ahs.ca|
22399660|NCT03700047|QMedAB|Clinical Project Manager|(817) 961-500|aestheticclinicaltrials@galderma.com|
22399661|NCT01950819|Novartis Pharma|Study Director|8627788300|Novartis.email@novartis.com|
22399662|NCT04340050|University of Chicago|Leila Yazdanbakhsh|773-834-5087|leila.yazdanbakhsh@bsd.uchicago.edu|
22399663|NCT04134494|BIDMC|Roger Lefevre|6176674070|rlefevre@bidmc.harvard.edu|
22399664|NCT00781365|HealthPartners Institute for Education and Research|Dr. Karen Margolis, MD MPH|952-967-7301|karen.l.margolis@healthpartners.com|
22399665|NCT01360645|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
22399666|NCT03954626|Novartis Pharmaceuticals|Study Director|862 778 8300|Novartis.email@Novartis.com|
22399667|NCT00495157|Penn State Hershey College of Medicine|Vernon M. Chinchilli, PhD|717-531-4262|vchinchi@psu.edu|
22399668|NCT01032629|Janssen- Cilag International NV|Senior Director Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22385518|NCT03544281|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22385519|NCT02547233|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
22385520|NCT05235750|University of Arkansas for Medical Sciences|Dr. Mei Bai|501-603-1900|MBai@uams.edu|
22385521|NCT03603600|Bausch & Lomb|Johnson Varughese|9089271162|Johnson.Varughese@bausch.com|
22385522|NCT03344094|University of Chicago|anthony t reder|773-702-6204|areder@neurology.bsd.uchicago.edu|
22385523|NCT03461276|Araclon Biotech, S.L.|Maria Pascual Lucas|+34976796562|mpascual@araclon.com|
22385524|NCT02310646|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
22385525|NCT05530603|University of South Dakota|Soonhee Roh|6053571593|Soonhee.Roh@usd.edu|
22385526|NCT02619994|Seoul National University|Dr. Prof. JJ Yim|82-02-1588-5700|yimjj@snu.ac.kr|
22385527|NCT02043678|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22385528|NCT04710498|Stanford University|Dr. Vasu Divi|650-725-5968|vdivi@stanford.edu|
22385529|NCT04406623|Shattuck Labs|VP, Clinical Operations|919-864-2700|clinicaltrials@shattucklabs.com|
22385530|NCT05827094|University of Washington School of Nursing|Associate Professor|2068493301|ozasl@uw.edu|
22385531|NCT04307355|Baylor College of Medicine|Prof. Bijan Najafi|7137987536|najafi.bijan@gmail.com|
22385532|NCT04065841|Novartis Pharmaceuticals|Study Director|(862) 778-8300|novartis.email@novartis.com|
22385533|NCT03298477|Endologix LLC|Tammy Stiver, Manager, Clinical Affairs|+15136731452|tstiver@endologix.com|
22385534|NCT02809443|GeneOne Life Science|Senior Clinical Operations Associate|6106576351|dkane@genels.us|
22385535|NCT02690558|University of North Carolina Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
22385536|NCT01420237|Stryker Orthopaedics|Kevin Barga, Senior Manager, Clinical Affairs|201-831-5000|Kevin.Barga@stryker.com|
22385537|NCT05269667|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22385538|NCT05448105|Vanderbilt University Medical Center|William Martinez, MD, MS|615-936-1010|william.martinez@vumc.org|
22385539|NCT03768505|MEI Pharma|Richard Ghalie, MD CMO|858 898 0956|rghalie@meipharma.com|
22385540|NCT05022329|University Health Network|Kevin Yau|416 480 4592|Kevin.Yau@uhn.ca|
22385541|NCT05246280|Navidea Biopharmaceuticals|Michael Blue, MD|6145714313|mblue@navidea.com|
22385542|NCT05331053|Penn State University|Lacy M. Alexander, Ph.D.|8148671781|lma191@psu.edu|
22385543|NCT02815566|University Health Network|Dr. Sharon Walmsley|416-340-3871|sharon.walmsley@uhn.ca|
22430191|NCT03048019|Sinai Center for Thrombosis Research|Director of Clinical Trials|443-244-1497|kbliden@lifebridgehealth.org|
22447123|NCT02511184|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22447124|NCT02111772|University of Virginia|Dr. Peter W. Heymann|434-242-8209|pwh5a@virginia.edu|
22447125|NCT02950025|Washington University School of Medicine|Michael C. Roach, M.D.|314-747-1786|roachm@wustl.edu|
22447126|NCT00869206|Christiana Care Health System|Andrew L. Himelstein, MD|(302) 366-1200|ahimelstein@cbg.org|
22385544|NCT02993159|Northwestern University|Seema A. Khan, MD|312-503-4236|s-khan2@northwestern.edu|
22385545|NCT02231164|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22413013|NCT02475954|Rutgers - Robert Wood Johnson Medical School|Roseanne D. Dobkin|732-235-4051|dobkinro@rutgers.edu|
22385547|NCT02268461|University of Minnesota|Kate Frost|612-626-4913|jahnke.k.131@gmail.com|
22385548|NCT05216315|University of Valencia|Dr Juan C Melendez|+34 963983844|melendez@uv.es|
22385549|NCT05808257|Icahn School of Medicine at Mount Sinai|Dr. Mantu Gupta|212-241-1272|mantu.gupta@mountsinai.org|
22385550|NCT04568486|University of Kentucky|Brittany Smalls|859-323-4916|brittany.smalls@uky.edu|
22385551|NCT04042233|Houston Methodist Hospital|Thomas Sullivan|2817254460|tsullivan@houstonmethodist.org|
22385552|NCT03986931|University of Iowa|Dr. Linnea Polgreen|(319) 384-3024|linnea-polgreen@uiowa.edu|
22385553|NCT04907851|Redx Pharma Limited|Craig Tilston|+44 (0)7787 983 638|c.tilston@redxpharma.com|
22385554|NCT05562401|UColima|Fabian Rojas Larios|3121206804|frojas@ucol.mx|
22385555|NCT05281562|Prisma Health|J. Benjamin Jackson|803-296-9610|benjamin.jackson@prismahealth.org|
22385556|NCT00704262|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
22385557|NCT05312008|Indiana University|Dr. Ann E.K. Kosobud|3172740087|akosobud@iu.edu|
22385558|NCT00324805|ECOG-ACRIN Statistical Center|Study Statistician|617-632-3012||
22385559|NCT05698875|University of Stirling|Julie Johnson|07815893076|julie.johnson1@stir.ac.uk|
22385560|NCT05792085|University of Pennsylvania|Lauren Eberly|2676244449|Lauren.Eberly@pennmedicine.upenn.edu|
22385561|NCT05757453|NXTech|Principal Investigator for Study 31380|7814721140|external+studyinvestigator@nxtech.co|
22385562|NCT01652196|The Ohio State University Comprehensive Cancer Center|Dr. John Hays|614-293-6529|John.hay@osumc.edu|
22385563|NCT04524442|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
22385564|NCT03819153|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22385565|NCT04283149|STAAR Surgical|Joanne Egamino|626-303-7902|jegamino@staar.com|2905
22385566|NCT04324359|Surface Ophthalmics Inc.|VP, Clinical Operations|(925) 494-3660|cbaenziger@surfaceophthalmics.com|18
22385567|NCT05526430|Icahn School of Medicine at Mount Sinai|Jessica L Ables|(212) 241-2774|jessica.ables@mssm.edu|
22385568|NCT03058289|Intensity Therapeutics|Lewis Bender|2032217377|LBender@intensityTherapeutics.com|
22385569|NCT03085810|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22385570|NCT02601313|Kite, A Gilead Company|Medical Information|844-454-5483(1-844-454-KITE)|medinfo@kitepharma.com|
22385571|NCT04731818|Eastern Virginia Medical School|Andrea Thurman MD, Principal Investigator|7574465808|thurmaar@evms.edu|
22385572|NCT02272998|The Ohio State University Comprehensive Cancer Center|Dr. Sameek Roychowdhury|614-685-5842|Sameek.roychowdhury@osumc.edu|
22385573|NCT02618577|Universitätsklinikum Hamburg-Eppendorf|Prof. Dr. Paulus Kirchhof|+49 (0)40 7410-52438|p.kirchhof@uke.de|
22385574|NCT05192109|New York University|Dr. Sudha Arunachalam|212-998-4139|sudha@nyu.edu|
22385575|NCT02975375|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
22385576|NCT05623228|Private practice|Dr. Stavroula Rakitzi|6989766935|srakitzi@gmail.com|
22385577|NCT04752657|Framingham Heart Study, Boston University|Joanne M Murabito, MD ScM|508-935-3461|murabito@bu.edu|
22385578|NCT05456360|The University of Texas MD Anderson Cancer Center|Dr. Vijaya Gottumukkala|(713) 794-1398|vgottumukkala@mdanderson.org|
22385579|NCT05210608|University of Colorado-Boulder|Anahi Collado, Assistant Research Professor|3037354140|anco7407@colorado.edu|
22385580|NCT04802967|Dompé Farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22385581|NCT01857245|Prisma Health|Dr. Claire Stam - Director, Addiction Medicine Center|(864) 979-6749|claire.stam@prismahealth.org|
22385582|NCT03122847|Aarhus University Hospital|Dr. Torben Harsløf|+4578455470|torbhars@rm.dk|
22385583|NCT03560609|NYU Langone Health|Jamika Singleton-Garvin|(212) 263-2573|jamika.singleton-garvin@nyulangone.org|
22385584|NCT04636528|Sword Health Inc|Fernando Dias Correia|+1 (646) 379-6751|fcorreia@swordhealth.com|
22385585|NCT02268253|Stemline Therapeutics, Inc.|Ira Gupta, MD|1-877-332-7967|clinicaltrials@menarinistemline.com|
22385586|NCT05672069|SERF|Sponsor|+33 4.72.05.60.10|clinical@serf.fr|
22385587|NCT03333590|Abigail Wexner Research Institute at Nationwide Children's Hospital|Dr. Kevin Flanigan|614-355-2947|kevin.flanigan@nationwidechildrens.org|
22385588|NCT04016662|Jaeb Center for Health Research|Robert Henderson|(813) 975-8690|Rhenderson@jaeb.org|
22385589|NCT03021096|Hospital for Special Surgery, Anesthesiology|Dr Jacques Yadeau|2126061036|Yadeauj@hss.edu|
22385590|NCT03216057|Hospital Infantil de Mexico Federico Gomez|Blanca Estela Del Rio Navarro|+525552289917|leijamjj@gmail.com|2444
22385591|NCT05126433|Jazz Pharmaceuticals Inc.|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
22385592|NCT03907878|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22385593|NCT02861300|University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. David Bajor|(216) 286-4414|david.bajor@uhhospitals.org|
22385594|NCT04910152|The Ohio State University Comprehensive Cancer Center|Dr. Hannah Choe|614-293-3196|Hannah.choe@osumc.edu|
22385595|NCT05038878|Icahn School of Medicine at Mount Sinai|Dr. Alice C. Levine|(212) 241-3422|alice.levine@mountsinai.org|
22385596|NCT05459857|Imperial Brands PLC|Libby Clarke|+44 (0117) 3320221|libby.clarke@impbrands.com|
22399669|NCT01662648|Janssen China|Regional Medical Franchis Director AP|+86 10 582 187 66||
22385597|NCT03133546|ETOP IBCSG Partners Foundation|Dr. Heidi Roschitzki, PhD|+41 31 511 94 00|heidi.roschitzki@etop.ibcsg.org|
22385598|NCT05034328|Pharmndev Experts|Dr Bernard Gout|+41798659000|bgout@pharmndev.ch|
22385599|NCT05399459|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22385600|NCT04992520|PATH|Patricia Njuguna/Senior Medical Officer|+254 20 3877177|pnjuguna@path.org|
22385601|NCT03625167|Charité - Universitätsmedizin Berlin|Monira El Genedy-Kalyoncu|+49 30 450 529 434|monira.el-genedy@charite.de|
22385602|NCT05583578|University of Florida|Dr. Clayton Swanson|3522735919|clayton.swanson@ufl.edu|
22385603|NCT05877976|NYU Langone Health|Lita Anglin|212-263-2519|Lita.anglin@nyulangone.org|
22385604|NCT00248287|Baylor Sammons Cancer Center|Dr. Joyce O'Shaughnessy|(214) 370 -1796|Joyce.OShaughnessy@usoncology.com|
22385605|NCT05825755|vitalera (FollowHealth SL)|Data Scientist of vitalera|+34644499760|val-hic@humanitcare.com|
22385606|NCT04103580|Washington University|Kyle Pitzer: Study Statistical Data Analyst|314-747-5361|kyleapitzer@wustl.edu|
22385607|NCT04145440|HI-Bio, A Biogen Company|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22385608|NCT02749006|University Of British Columbia|Dr. Lakshmi Yatham|604-822-7310|l.yatham@ubc.ca|
22385609|NCT04752709|Elidah, Inc.|Director of Clinical Trials|978.435.4324|customercare@elitone.com|
22399670|NCT02633540|Fox Chase Cancer Center|Dr. Thomas Galloway|215-728-5536|Thomas.Galloway@fccc.edu|
22399671|NCT00619957|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22399672|NCT00723957|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22399673|NCT01763164|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22399674|NCT01264939|Genentech, Inc.|Medical Communications|800 821-8590||
22399675|NCT04964258|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22399676|NCT02965378|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
22399677|NCT03384329|Institute of Physiology and Basic Medicine|Dr. Lyubomir Aftanas|+7-913-912-2228|liaftanas@gmail.com|
22399678|NCT01384292|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22399679|NCT03670030|Ochsner Medical Center|Robert Ramirez, DO|504-464-8500|awendt@ochsner.org|
22399680|NCT01171612|Corporacion Sanitaria y Universitaria Parc Tauli|Anna Rodriguez-Pont|0034937231010|anna.r.pont@gmail.com|21283
22399681|NCT01285349|Social Intervention Group|Dr. Nabila El-Bassel|212-851-2391|ne5@columbia.edu|
22399682|NCT00565617|Medical University of South Carolina|Gregory Sahlem|843-792-5716|sahlem@musc.edu|
22399683|NCT03040024|Emory University|Dr. Amit Prabhakar|404-686-2747|amit.prabhakar@emory.edu|
22399684|NCT02278783|Huntsman Cancer Institute|Theresa Werner|801-587-3486|theresa.werner@hci.utah.edu|
22399685|NCT01526148|University Hospitals Cleveland Medical Center|Keming Gao, MD, PhD|216-844-2865|keming.gao@UHhospitals.org|
22399686|NCT01173653|Vanderbilt University Emergency Medicine Department|Benjamin Heavrin, MD|615-936-0253-|benjamin.heavrin@vanderbilt.edu|
22399687|NCT00125034|Merck Serono|Inmaculada Ollero/Clinical Trial Manager|+34935655433|iollero@merck.es|
22413014|NCT03656783|Brigham and Women's Hospital|Marcelo Di Carli, MD|6177326290|mdicarli@bwh.harvard.edu|
22447127|NCT01513473|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22447128|NCT04016285|University of Kentucky Department of Orthopaedic Surgery & Sports Medicine|Dr. Stephen Duncan|859-218-3084|stephen.duncan@uky.edu|
22447129|NCT03462082|University of Rochester|Karlo J Lizarraga, MD, MS / Assistant Professor of Neurology|585-341-7500|karlo.lizarraga@gmail.com|
22447130|NCT00919724|Indiana University School of Medicine|Samir K. Gupta, MD, MS|317-274-7926|sgupta1@iu.edu|
22447131|NCT00743340|Gilead Sciences|Clinical Trial Disclosures & Data Transparency|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22447132|NCT00127660|University of Minnesota|Lisa Harnack, DrPH|612-626-9398|harna001@umn.edu|
22447133|NCT01425281|Abbott Vascular International BVBA|Susan Veldhof|+31653428610|susan.veldhof@av.abbott.com|
22447134|NCT01987505|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22447135|NCT01749514|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22447136|NCT02509156|University of Texas-Houston School of Public Health|Shelly Sayre, M.P.H. Project Manager|713-500-9529|Shelly.L.Sayre@uth.tmc.edu|
22447137|NCT05131646|Clearside Biomedical, Inc.|Susan Coultas, PhD|678.270.3639|susan.coultas@clearsidebio.com|
22447138|NCT02128113|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22447139|NCT01750242|Medtronic Neuromodulation|Stephanie Salisbury|763-526-8096|stephanie.salisbury@medtronic.com|
22447140|NCT03765918|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22447141|NCT04202965|Protagonist Therapeutics, Inc|Clinical Study Director|1-888-899-1543|ptgxclintrials@ptgx-inc.com|
22447142|NCT02969369|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltraildisclosure@sunovion.com|
22447143|NCT02254252|Mashhad University of Medical Sciences|Pouya Nezafati|00989151578421|nezafatip871@mums.ac.ir|
22385610|NCT00576979|Department of Hematology and Hematopoietic Cell Transplantation, City of Hope|Anthony Stein, MD, corresponding author|626-256-4673|astein@coh.org|62405
22385611|NCT04248725|University of Washington|Dawn Ehde, PhD|206-591-3780|ehde@uw.edu|
22385612|NCT03697096|Division of Infectious Diseases, University of California Irvine School of Medicine|Dr. Shruti Gohil, MD, MPH|(714) 456-7890|skgohil@hs.uci.edu|
22385613|NCT04893239|Lumen Bioscience|Senior Medical Director|206-899-1904|trials@lumen.bio|
22385614|NCT01210807|University Eye Clinic, Tubingen, Germany|PD Dr. med. Peter Szurman|49-7071-29-84915|peter.szurman@med.uni-tuebingen.de|
22385615|NCT05977530|University of Alabama at Birmingham|Dr. David Schwebel|205-934-8745|schwebel@uab.edu|
22385616|NCT05496231|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22385617|NCT05692960|The University of Tennessee, Knoxville|Noël Arring, DNP, PhD, RN|865-974-1988|narring@utk.edu|
22385618|NCT02675777|Kaiser Permanente Washington Health Research Institute|Katharine Bradley, MD, MPH|206-948-1933|katharine.a.bradley@kp.org|
22385619|NCT00691002|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
22385620|NCT04898673|Cochlear Limited|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
22385621|NCT04797897|Smith+Nephew, Inc|Senior Manager Clinical Compliance|07811407089|datasharing.gcs@smith-nephew.com|
22385622|NCT05966870|Indiana University|Nana Gletsu Miller|812-8557643|ngletsum@indiana.edu|
22385623|NCT05778695|University of Michigan|Nicolaas Bohnen, MD, PhD|734-936-1168|nbohnen@umich.edu|
22385624|NCT03128021|University of Pittsburgh|Rachel Berta|4128607406|goodra@upmc.edu|
22385625|NCT05493072|Imperial College NHS Healthcare Trust|Calandra Feather|07977185577|calandra.feather@nhs.net|
22385626|NCT04971031|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
22385627|NCT04642820|University of Chicago|Harriet de Wit, Principal Investigator|773-702-1234|hdew@uchicago.edu|
22385628|NCT04568434|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionis.com|
22385629|NCT04567238|Duke University School of Medicine|Angela Kirby|9198247729|angela.kirby@duke.edu|
22385630|NCT04164888|CiVi Biopharma, Inc.|Chief, Clinical Development|484-674-5456|chuck.shear@civibiopharma.com|
22385631|NCT04049643|The University of Iowa|Dr. Yu-Hsiang Wu|319-3359758|yu-hsiang-wu@uiowa.edu|
22385632|NCT04081103|Amber Ophthalmics|Director of Clinical Trials|858-539-3418|clinical@Amberophthalmics.com|
22385633|NCT05123118|State University of New York at Buffalo|Dr. Xiaozhong Wen|7168296811|xiaozhon@buffalo.edu|
22385634|NCT03365882|SWOG Statistics and Data Management Center|Gastrointestinal Committee Statistician|2066674623|scolby@fredhutch.org|
22385635|NCT04437615|Olympus Corporation|Jeremy Bolt, Global GI Lead|5085798495|jeremy.bolt@olympus.com|
22385636|NCT04828005|Opiant Pharmaceuticals|Clinical Director|+1 804 379 1090|PatientSafetyNA@Indivior.com|
22385637|NCT03023410|Stryker|Kevin Barga|+12018315073|Kevin.Barga@stryker.com|
22385638|NCT04799899|Massachusetts General Hopsital|Dr. Christina Luberto|617-643-9453|CLUBERTO@mgh.harvard.edu|
22385639|NCT02014649|Aviragen Therapeutics, Inc.|Anna Novotney-Barry|678-221-3356|abarry@aviragentherapeutics.com|
22385640|NCT05459688|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22385641|NCT04475679|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
22385642|NCT03379675|Janssen Research and Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22385643|NCT02817776|Biosense Webster Inc|Kendra McInnis|+1 949 322-8010|kmcinnis@its.jnj.com|
22385644|NCT05349500|University of North Carolina at Chapel Hill|Kelli Allen, PhD|919-966-0558|kdallen@email.unc.edu|
22385645|NCT02675751|Johnson & Johnson Surgical Vision|Sanjeev Kasthurirangan Ph.D.|+1 408-273-4081|skasthur@its.jnj.com|
22385646|NCT02359890|Biosense Webster|Robert Stagg|(800) 729-9010|RStagg@its.jnj.com|
22385647|NCT05260112|University of Pennsylvania|Lily Arya, MD|267-785-8024|larya@pennmedicine.upenn.edu|
22385648|NCT04341896|New York University|Rhiannon Reed|205-999-3360|rjd1125@uab.edu|
22385649|NCT05714761|Icahn School of Medicine at Mount Sinai|Dr. Grenye O'Malley|212-241-7173|omallg01@mssm.edu|
22385650|NCT05213390|Newcastle University|Prof Edward Meinert|191 208 6000|edward.meinert@newcastle.ac.uk|
22385651|NCT06238609|Baylor College of Medicine|Prof. Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
22385652|NCT04997148|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22385653|NCT03031470|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22385654|NCT01593917|Abbott Medical Devices, Structural Heart Divison|Clinical Scientist, Tissue Heart Valves|+1 651-756-2320|Roland.MaudeGriffin@Abbott.com|
22385655|NCT03435614|MUHC-RIMUHC|Marc Perreault|514-343-6111|marc.perreault@umontreal.ca|3788
22385656|NCT02852330|Cochlear|Bernadette Pickering|+61296115909|bpickering@cochlear.com|
22385657|NCT02683447|Sunnybrook Health Sciences Centre|Dr. Fahad Alam|416-480-4864|fahad.alam@sunnybrook.ca|
22385658|NCT04663737|Senhwa Biosciences, Inc.|Kacy Huang, Director of Clinical Department|+886-2-8911-9856|kacyhuang@senhwabio.com|214
22385659|NCT02489903|EpicentRx, Inc|Bryan Oronsky|858-229-1062|mstirn@epicentrx.com|
22385660|NCT04625686|Cincinnati Children's Hospital Medical Center|Rosalie Hemphill LSW|5044940883|rosalie.hemphill@cchmc.org|
22385661|NCT03904147|Abbott|Natalie Richardson, Senior Clinical Project Manager|651-756-3842|natalie.richardson@abbott.com|
22413015|NCT00880568|Merck Sharp & Dohme|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22413016|NCT00620022|Novartis Pharmaceuticals|Study Director|862 778-8300||
22447144|NCT01980992|Icahn School of Medicine at Mount Sinai|Dr. Hugh A. Sampson|212-659-9426|hugh.sampson@mssm.edu|
22385662|NCT04413708|Duke University|Sara LeGrand|919-438-0448|sara.legrand@duke.edu|
22385663|NCT04599062|University of Iowa, Holden Comprehensive Cancer Center|Varun Monga, MD|319-384-9497|varun-monga@uiowa.edu|
22385664|NCT06044090|University of Pittsburgh|Gabriella Alvarez, PhD|412-624-4500|gabyalvarez@pitt.edu|
22430192|NCT01730729|Northwestern University|Cesar Santa-Maria, MD|312-695-6180|cancertrials@northwestern.edu|
22430193|NCT00382863|Paracor Medical, Inc.|Michael Kolber, General Manager, VP of Regulatory Affairs|408-734-6000|info@paracor.com|
22430194|NCT01889563|Federal university of Sao Carlos|Audrey Borghi e Silva|+55 163351-8952|audrey@ufscar.br|
22430195|NCT01292473|Genentech, Inc|Medical Communications|800 821-8590||
22430196|NCT00203242|Thomas Jefferson University/Jefferson Headache Center|Stephen D. Silberstein-Principal Investigator|215-955-9477|Stephen.Silberstein@jefferson.edu|
22430197|NCT00449787|Montefiore Medical Center|Benjamin Friedman|718-920-6626|bwfriedmanmd@gmail.com|
22430198|NCT03777176|Zealand Pharma|Sune Birch|+45 5060 3864|SBirch@zealandpharma.com|
22430199|NCT05084885|Centre for Addiction and Mental Health|Dr. Nigel Turner|416-535-8501|nigel.turner@camh.ca|36063
22430200|NCT02094885|Ethicon, Inc|Jonathan Batiller, Senior Clinical Director|+1 908 218-2492|JBatill2@its.jnj.com|
22430201|NCT01061710|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22430202|NCT01903720|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22430203|NCT02570425|Sydney Medical School, University of Sydney & Woolcock Institute of Medical Research|Assoc Prof Sinthia Bosnic-Anticevich|+61 2 9114 0040|sinthia.bosnic-anticevich@sydney.edu.au|
22430204|NCT04045145|Neurocrine Biosciences|Neurocrine Medical Information Call Center|877-641-3461|medinfo@neurocrine.com|
22430205|NCT02197065|Hospital for Special Surgery|Anne R. Bass, MD|212-774-7043|bassa@hss.edu|
22430206|NCT01018056|Johns Hopkins University|Dr. Harvey S. Singer|410-955-7212|hsinger@jhmi.edu|
22430207|NCT00552279|GlaxoSmithKline|GSK Response Center|866-435-7343||
22430208|NCT02150863|Massachusetts General Hospital|Elizabeth Morehouse, Clinical Research Coordinator|617-724-2168|emorehouse@partners.org|
22430209|NCT04829214|Otonomy, Inc.|Medical Information|+1 844-686-4636|medinfo@otonomy.com|
22430210|NCT05287685|Florida International University|Shayl Griffith, PhD|305-348-9891|shagriff@fiu.edu|
22430211|NCT06399471|Georgia Institute of Technology|Kinsey Herrin, MSPO, C/LPO, FAAOP, Senior Research Scientist|470-578-7600|kinsey.herrin@gatech.edu|
22430212|NCT04008069|Stanford University, School of Medicine, Immunology & Rheumatology|Dr. Matthew C. Baker, Principal Investigator|650- 498-4528|mbake13@stanford.edu|
22430213|NCT00511199|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22430214|NCT04543786|University of Pittsburgh|Lee Fisher|412-383-1329|lef44@pitt.edu|
22430215|NCT02046200|UCLA Department of Psychology|Dr. Lara Ray|310-794-5383|lararay@psych.ucla.edu|
22430216|NCT01837550|Sodra Alvsborg, Hearing Organisation|Milijana Malmberg, PhD student|0046 703 80 36 63|milijana.lundberg.malmberg@vgregion.se|
22430217|NCT01570192|University of Florida, Department of Medicine|Dr. George L. Drusano|407-313-7060|gdrusano@ufl.edu|
22430218|NCT02965976|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-2300|Kris.Attwood@roswellpark.org|
22430219|NCT00407030|Merz Pharmaceuticals GmbH|Angelika Hanschmann|++49-69-1503|angelika.hanschmann@merz.de|538
22430220|NCT01340170|Dentsply Sirona Implants|Manager of Global Clinical Reseach|+46313763500|clinicalresearchmolndal@dentsplysirona.com|
22430221|NCT03878602|Ospedale Buon Consiglio Fatebenefratelli|Dr.Giuseppe De Bernardo|3357441303|pinodebtin@gmail.com|+39
22430222|NCT00736476|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22430223|NCT02633527|Supernus|Joseph Hull, PhD, Director Clinical Research|240-403-5324|jhull@supernus.com|
22430224|NCT00452530|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22430225|NCT06091956|Mayo Clinic|Aaron Mangold, M.D.|480-301-6169|Mangold.Aaron@mayo.edu|
22430226|NCT00742157|University of Nebraska Medical Center|Fedja Rochling, MD|402-559-3652|frochling@unmc.edu|
22430227|NCT00318136|Genentech, Inc.|Medical Communications|800-821-8590||
22430228|NCT02176525|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22430229|NCT01950039|Joslin Diabetes Center|Mary Elizabeth Patti MD|617 309 2635|mary.elizabeth.patti@joslin.harvard.edu|
22430230|NCT02100644|GlaxoSmithKline|GSK Response Center|866-435-7343||
22430231|NCT05370209|Circius Pharma AB|Maria Carlsson|+46 (0) 31-81 84 00|RAQA@circiuspharma.com|
22430232|NCT02236767|Hartford Hospital|Gretchen Diefenbach|860-545-7396|gretchen.diefenbach@hhchealth.org|
22430233|NCT01378273|University of Washington|Sandra Juul MD, PhD|2062216814|sjuul@uw.edu|
22399688|NCT02344225|SUNY Downstate Medical Center|Jacob V. Aranda, MD, PhD, FRCPC, Principal Investigator|718-270-1912|jaranda@downstate.edu|
22399689|NCT02844998|Ankara TRH|Dr. Muhammet Fatih Kilinc|+90 312 595 3700|mdfatihkilinc@yahoo.com|3724
22399690|NCT01578031|University of Pennsylvania|Samuel T. Kuna, MD|215-823-4400|skuna@mail.med.upenn.edu|
22399691|NCT03219073|University of Iowa|Thorsten Rudroff|17205323701|thorsten-rudroff@uiowa.edu|
22399692|NCT01988090|Baylor College of Medicine|Tao Wang|7137985388|taow@bcm.edu|
22399693|NCT02238847|Boston Scientific Corporation|Lina Ginnetti, Clinical Endoscopy Director|508-683-4512|lina.ginnetti@bsci.com|
22399694|NCT03633084|Ribomic USA|Yusuf Ali, Ph.D.|(707) 287-4313|yusuf.ali@ribomic.com|
22399695|NCT01734317|Mölnlycke Health Care|Joan Wilson|+1 706-650-1012|joan.wilson@molnlycke.com|
22430234|NCT00979615|Alcon Research, Ltd.|Maria J. Tort, PhD|(817) 302-5968|Maria.Tort@alconlabs.com|
22430235|NCT02844075|Yonsei University|Byoung Chul Cho|+82 2 2228 4190|cbc1971@yuhs.ac|
22447145|NCT00299975|Hong Kong Baptist University|Prof. Zhao-xiang Bian|(852) 3411 2905|bzxiang@hkbu.edu.hk|
22385665|NCT04520191|University of New Mexico Health Sciences Center|Vallabh Shah, PhD. Principal Investigator|505-272-9615|VShah@salud.unm.edu|
22447146|NCT04380116|Yale University|Dr. Frank Buono|2037795799|frank.buono@yale.edu|
22447147|NCT01746745|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22447148|NCT01169493|Duke University Medical Center|Brett D. Atwater, MD|9196848111|brett.atwater@duke.edu|
22447149|NCT05883449|Affimed GmbH|Clinical Operations|+49 621 560030|trials@affimed.com|
22447150|NCT03018704|Department of Veteran Affairs|David Oslin|215-823-5894|dave.oslin@va.gov|
22447151|NCT00320411|GlaxoSmithKline|GSK Response Center|866-435-7343||
22447152|NCT01110434|Brown University|Dr. Robert Miranda|401.863.6658|Robert_Miranda_Jr@brown.edu|
22447153|NCT04448171|Mayo Clinic|John Occhino, M.D., M.S.|507-538-5883|Occhino.John@mayo.edu|
22447154|NCT02088047|University of Arkansas for Medical Sciences|Betholyn Gentry|(501) 603-1010|bfgenry@uams.edu|
22447155|NCT01667029|Massachusetts General Hospital|Dr. Brian Wainger|617-726-8810|Brian.Wainger@mgh.harvard.edu|
22447156|NCT00211809|Icahn School of Medicine at Mount Sinai|Dr. Andrea Allen|212-241-3176|andrea.allen@mssm.edu|
22447157|NCT01417234|KCI|VP, Global Clinical Development|12102555595|jane.hart@acelity.com|
22447158|NCT00023764|Memorial Sloan-Kettering Cancer Center|Dr. John Gerecitano|212-639-3748|gerecitj@mskcc.org|
22447159|NCT01537393|CaseWestern|Dr. Jonathan Lass|2168448368|Jonathan.Lass@UHhospitals.org|
22447160|NCT01619774|University of Texas (UT) MD Anderson Cancer Center|Michael Davies, Associate Professor, Melanoma Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
22447161|NCT00459953|Stanford University|Joel D Killen|(650) 723-5895|jkillen@stanford.edu|
22447162|NCT04171050|University of California, Los Angeles|Tamara Grisales, MD|310-983-1023|tgrisales@mednet.ucla.edu|
22447163|NCT00036270|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22447164|NCT00496470|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22447165|NCT01370356|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22447166|NCT03170401|University of Washingtion|Dr. Grant E O'Keefe|206-744-8016|gokeefe@uw.edu|
22447167|NCT01891695|University of Virginia|Paul Read, MD|434-924-5191|pwr3u@hscmail.mcc.virginia.edu|
22447168|NCT05451225|Columbia University|Dr. Michael Compton|646-774-8476|mtc2176@cumc.columbia.edu|
22447169|NCT04746963|AsclepiX Therapeutics|Dr A Shojaei|800-572-3545|info@asclepix.com|
22447170|NCT00799422|Alcon Research, Ltd.|Head, Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
22447171|NCT01496612|NIH/NINDS|Dr. William Theodore|301-496-1505|theodorw@ninds.nih.gov|
22385666|NCT03468868|Shepherd Center, Atlanta, GA|Deborah Backus, PT, PhD|404-352-2020|deborah.backus@shepherd.org|
22385667|NCT05135650|Fred Hutch/University of Washington Cancer Consortium|Dr. Alpana Waghmare (Study Principal Investigator)|206-667-7329|awaghmar@fredhutch.org|
22385668|NCT06103188|Jordan University Hospital|Dr Omar Ismail|+962791301329|omar.moh.isml@gmail.com|
22385669|NCT05283304|UT Southwestern Medical Center|Madhukar Trivedi|214-648-0188|madhukar.trivedi@utsouthwestern.edu|
22385670|NCT06074172|Colorado State University Pueblo|Dr. Moussa Diawara|719-549-2813|Moussa.Diawara@csupueblo.edu|
22385671|NCT05038137|Medical University of South Carolina|Dr. Karanchi|(843) 792-2529|karanchi@musc.edu|
22385672|NCT05495555|Cataract & Laser Institute|Dr Justin Spaulding|541-779-2020|justinophtho@gmail.com|
22385673|NCT05534789|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22385674|NCT04436276|Janssen Vaccines & Prevention B.V.|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22385675|NCT03029884|University of California, San Francisco|Prasad Shirvalkar MD, PhD - Principal Investigator|415-885-7246|Prasad.Shirvalkar@ucsf.edu|
22385676|NCT03656510|Janssen Research & Development, LLC|Senior Director Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22385677|NCT05322044|Imperial College London|Dr Louise Fleming|02073528121|l.fleming@imperial.ac.uk|2938
22385678|NCT01710488|Fadoi Foundation|Antonella Valerio|0248005140|antonella.valerio@fadoi.org|
22385679|NCT03728790|Columbia University|Dr. Leslie Moroz|646-532-8208|lm3000@cumc.columbia.edu|
22385680|NCT03852472|Chemocentryx|Study Director|650-210-2900|medinfo@amgen.com|
22385681|NCT06457802|Vanderbilt University School of Nursing|Dr. Shelagh Mulvaney, PhD|6153221198|shelagh.mulvaney@vanderbilt.edu|
22385682|NCT03896867|University of Minnesota|Benjamin Kloesel|612-301-1245|bkleosel@umn.edu|
22385683|NCT00167674|University of Washington|Grace John-Stewart|206 948 9357|gjohn@uw.edu|
22385684|NCT04084288|Hospital for Special Surgery|Dr. Stephanie Cheng|212-606-1206|chengs@hss.edu|
22385685|NCT03974178|Drugs for Neglected Diseases initiative (DNDi)|Dr. Olaf Valverde Mordt|+41229069239/+41795431713|ovalverde@dndi.org|
22385686|NCT04880863|NeoTX Therapeutics Ltd.|Dr. Ilana Lorber, VP of Clinical Operations|+972-3-912-5853|ilanal@neotx.com|213
22385687|NCT03899259|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22385688|NCT01152450|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22385689|NCT05670587|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22385690|NCT03738852|Yale School of Medicine|Renata Belfort De Aguiar, MD, PhD|(203) 785-5331|renata.aguiar@yale.edu|
22385691|NCT01205828|Georgetown University Medical Center|Dr. Aiwu Ruth He|202-444-8642|arh29@georgetown.edu|
22385692|NCT01544114|Horizon Pharma, Inc.|Julie Ball, Executive Director of Clinical Development & Operations||clinicaltrials@horizonpharma.com|
22385693|NCT04649476|Hospital of Stomatology, Wuhan university|Gang Chen, MD|+86 02787686215|geraldchan@whu.edu.cn|
22447172|NCT02518750|St. Jude Children's Research Hospital|Sima Jeha, MD|901-595-3901|sima.jeha@stjude.org|
22447173|NCT03129100|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22447174|NCT03789474|ALL INDIA INSTITUTE OF MEDICAL SCIENCES,RISHIKESH,UTTARAKHAND,INDIA.|Dr M KESARI|7093005219|kesyellow@yahoo.com|
22447175|NCT03708328|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22447176|NCT00571948|Research Institute of Child Nutrition|Dortmund Intervention Trial for Optimization of Infant Nutrition|0049 231 7922100|kersting@fke-do.de|
22447177|NCT00496808|UT MD Anderson Cancer Center|Raphael E Pollock,PHD/Professor Emeritus, Surgical Oncology|(713) 792-6928|CR_Study_Registration@mdanderson.org|
22399696|NCT04870671|Eastern Virginia Medical School|Dr. Terry Jacot|757-446-7056|jacotta@evms.edu|
22399697|NCT01083667|HSS/WCMC|Dale Lange|6467978917|langed@hss.edu|
22399698|NCT00360399|Emory University|Helen Mayberg|404-727-6740|hmayber@emory.edu|
22399699|NCT01439945|Mayo Clinic|Charles Lawrence Loprinzi, M.D.||cloprinzi@mayo.edu|
22399700|NCT04082663|Washington University School of Medicine|Dr. Gammon Earhart|314-286-1407|earhartg@wustl.edu|
22399701|NCT00927563|University of Chicago|Dr. Jon Grant|773-834-1325|jongrant@uchicago.edu|
22399702|NCT02914509|Ocular Therapeutix, Inc.|Clinical Project Manager|781-357-4000|clinicalaffairs@ocutx.com|
22399703|NCT03529409|University of Maryland, College Park|Dr. Jessica Magidson|301-405-5095|jmagidso@umd.edu|
22399704|NCT00777179|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22399705|NCT01497262|Novartis Pharmaceuticals|Study director|862-778-8300||
22399706|NCT05501119|Medical University of South Carolina|Dr. Diana Layne|(843) 792-8515|layne@musc.edu|
22399707|NCT01752023|SKCCC at Johns Hopkins|Ronan Kelly, MD|443-287-0005|rkelly25@jhmi.edu|
22399708|NCT02542072|CooperVision Inc.|Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com|
22447178|NCT01845831|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
22447179|NCT02010775|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22447180|NCT03936985|University of Utah|Gerald (Jerry) Cochran, PhD|801-213-0654|jerry.cochran@hsc.utah.edu|
22447181|NCT02030041|PGIMER|Anil Bhansali|01722756583|ashuendo@gmail.com|
22447182|NCT02006719|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22447183|NCT03123913|University of Rochester Medical Center|Chad Heatwole, MD, MS-CI|585-275-7867|dystrophy_registry@urmc.rochester.edu|
22447184|NCT00663169|Novartis Pharmaceuticals|Study Director|862-778-8300||
22447185|NCT02984709|Vanderbilt University Medical Center|Sarah Jaser|615-343-6775|sarah.jaser@vanderblit.edu|
22447186|NCT00496054|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22447187|NCT01737697|ZS Pharma, Inc.|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22447188|NCT02207244|Janssen Research & Development, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
22447189|NCT01362205|Denver Health Medical Center|Katie Overdier RN|303 602 1479|Katie.Overdier@dhha.org|
22447190|NCT01866930|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|clinical.trials@bms.com|
22447191|NCT02579239|aTyr Pharma|Study Director|858 731 8389|clinicaltrials@atyrpharma.com|
22447192|NCT02288897|Provectus Biopharmaceuticals, Inc.|Eric Wachter, Chief Technology Officer|865-769-4011|wachter@pvct.com|23
22447193|NCT00471328|Novartis Pharmaceuticals|Study Director|862-778-8300||
22447194|NCT02854631|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22447195|NCT03930797|Fox Chase Cancer Center|Dr. Jennifer Reese, Associate Professor|215-214-3223|Jennifer.Reese@fccc.edu|
22447196|NCT01179568|Columbia School of Social Work|M. Katherine Shear, MD|212-851-2176|ks2394@columbia.edu|
22447197|NCT03727347|Aerin Medical, Inc.|Anais Laborde|(650) 518-9624|alaborde@aerinmedical.com|
22447198|NCT04292743|Lombardi Comprehensive Cancer Center|Marcus Noel|202-444-2223|Marcus.S.Noel@gunet.georgetown.edu|
22447199|NCT05330702|University of Iowa|Shaoping Zhang|(319) 335-7386|shaoping-zhang@uiowa.edu|
22447200|NCT02881554|University of Washington|Dr. Smith Apisarnthanarax, Principal Investigator|+1 206 598-4100|apisarn@uw.edu|
22447201|NCT01852110|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22447202|NCT00218465|Center for Addiction Medicine|Sara Carlini|617-643-1990|scarlini@partners.org|
22447203|NCT02298803|Diabetes Centre, Royal Prince Alfred Hospital|Dr Ted Wu|61295155888|ted.wu@sswahs.nsw.gov.au|
22447204|NCT00279591|University of Arkansas for Medical Sciences|Dr. Michael Stroud|501-364-1861|StroudMichaelH@uams.edu|
22447205|NCT01549860|VP Medical Affairs|Pamela Unger|(952) 224-8755|punger@celleration.com|
22447206|NCT04882540|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22447207|NCT01366521|GlaxoSmithKline|GSK Response Center|866-435-7343||
22447208|NCT02430311|Astrazeneca|Gershon Locker|+1 773 868 0184|Gershon.Locker@astrazeneca.com|
22447209|NCT00578812|NuVasive, Inc|Julie Pairamore, Sr. Manager, Clinical Affairs|858-320-5258|jpairamore@nuvasive.com|
22447210|NCT01011634|UCSF|Karen Meckstroth, MD|415 206-8713|meckstrothk@obgyn.ucsf.edu|
22447211|NCT02113592|Kaiser Permanente Washington Health Research Institute|Lynn DeBar, PhD, MPH, Principal Investigator|206-287-2900|lynn.debar@kp.org|
22447212|NCT03684811|Forma Therapeutics, Inc.|Medical Affairs|(617) 679-1970|medicalinformation@formatherapeutics.com|
22447213|NCT00786682|Cancer Institute of New Jersey|Dr. Mark Stein|732-235-8675|steinmn@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
22447214|NCT00166114|University of Miami School of Medicine|Dominique Musselman, MD, MSCR|404-723-8361|dmusselman@med.miami.edu|
22447215|NCT03729960|Danone Asia Pacific Holdings|Digital Project Manager|82281172|jill.wong@danone.com|
22447216|NCT00799604|The Medicines Company|Jason Campagna. MD, PhD|973-290-6199|jason.campagna@themedco.com|
22447217|NCT01929460|Kaiser Permanente, Los Angeles Medical Center|Karl Kwok, MD|800-954-8000|regional-research-committee@kp.org|
22447218|NCT02708121|Department of Health Education and Behavior, College of Health and Human Performance, University of Florida|Dr. Megan McVay|(352)294-7029|megan.mcvay@ufl.edu|
22447219|NCT03266107|Relievant Medsystems Inc.|VP Clinical Affairs|(650) 368-1000|dsahr@relievant.com|280
22399709|NCT00909155|University of Wisconsin|Dr. Michael Peterson|608 265 8130|mpeterson2@wisc.edu|
22399710|NCT03961360|The University of Texas Health Science Center at Houston|Farah Amro, MD|713-500-6421|farah.h.amro@uth.tmc.edu|
22385694|NCT04223505|University of Ottawa Heart Institute|Dr. Benjamin Chow|6136966786|bchow@ottawaheart.ca|
22385695|NCT04508309|PATH|Niranjan Bhat, MD|206 302 4843|nbhat@path.org|
22385696|NCT05482698|MC2 Therapeutics|Chief Medical Officer|+45 2018 1111|info@mc2theraprutics.com|
22385697|NCT01674140|SWOG Statistics and Data Management Center|Breast Committee Statistician|2066674623|jmiao@fredhutch.org|
22385698|NCT02305888|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
22385699|NCT05139810|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionis.com|
22385700|NCT05940194|PATH|Dr. Thang Tran Cong, Medical office|+84913301883|thangtran@path.org|
22385701|NCT06182033|Crane Center for Early Childhood Research and Policy at The Ohio State University|Dr. Laura Justice|614-247-7488|justice.57@osu.edu|
22385702|NCT05576155|University of Iowa|Kelsey Schwartz|319-467-3096|kelsey-schwartz@uiowa.edu|
22385703|NCT04515849|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22385704|NCT03272217|Hoosier Cancer Research Network|Fauzia Sharmin|317-634-5842|fsharmin@hoosiercancer.org|75
22385705|NCT05095779|The University of Oklahoma Health Sciences|Dr. Darla E. Kendzor|(405) 271-7848|Darla-Kendzor@ouhsc.edu|
22385706|NCT04078191|Navidea|Michael Blue, MD|6145714313|mblue@navidea.com|
22385707|NCT05693935|Teva Branded Pharmaceutical Products R&D LLC|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
22399711|NCT02440581|University of Kentucky|Division Administrator|859-218-4943|daniel.ormond@uky.edu|
22447220|NCT01898611|University of Pennsylvania|Anne Cappola, MD|215-573-5359|acappola@mail.med.upenn.edu|
22447221|NCT02548650|University of Florida College of Medicine - Jacksonville|Dominick J Angiolillo|9042443933|dominick.angiolillo@jax.ufl.edu|
22399712|NCT00654498|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22447222|NCT01191801|Sunesis Pharmaceuticals, Inc|Judy Fox, Chief Scientific Officer|(650) 266-3736|jfox@sunesis.com|
22447223|NCT00299104|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
22447224|NCT04394286|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22447225|NCT03167411|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
22447226|NCT02651922|PASCOE Pharmazeutische Präparate GmbH|Dr. Inga Trompetter and Jennifer Lebert|0049-(0)641-7960-955|Jennifer.lebert@pascoe.de|
22447227|NCT01366209|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22447228|NCT00420927|Abbott|Global Medical Services|1-800-633-9110||
22399713|NCT01468987|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22447229|NCT01218243|Guang'an Men Hospotal Affiliated to China Academy of Chinese Medical Sciences|Zhishun Liu, Director of the study|8610-010-88001124|liuzhishun@yahoo.com.cn|
22447230|NCT02701400|Emory University|Dr. Taofeek Owonikoko|404-778-5575|TOWONIK@emory.edu|
22447231|NCT01032837|Hoffman-LaRoche|Medical Communications|800-821-8590||
22447232|NCT01197560|Celgene|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22447233|NCT00585247|University of Ccalifornia, Irvine. Beckman Laser Institute|Dr. Kristen Kelly|949.824.7997|kmkelly@uci.edu|
22447234|NCT00211510|Medtronic, Inc|John Shin, PhD, MBA|818 576 4019|john.shin@medtronic.com|
22447235|NCT01487200|Flexion Therapeutics|Scott Kelley, Chief Medical Officer|781-305-7142|skelley@flexiontherapeutics.com|
22447236|NCT03791489|Stryker ENT|Pr. Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
22447237|NCT00080470|Boston Scientific|Director of Clinical Operations|866-360-4747|Valerie.Lucero-Cimmarust@bsci.com|
22447238|NCT00508716|Griffin Hospital|Dr. Dorothea Wild|203 7327327|dwild@griffinhealth.org|
22447239|NCT02521870|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-665-0414|rjanssen@dynavax.com|
22399714|NCT00787787|Cancer Consortium|Medical Director, Clinical Research Support|206-667-5767|lmendels@fredhutch.org|
22447240|NCT00519831|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22399715|NCT00943683|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22399716|NCT01245673|University of Pennsylvania|Liz Veloso|215|eveloso@pennmedicine.upenn.edu|
22399717|NCT02153099|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22447241|NCT04051008|SUNY Buffalo|Stephanie Anzman-Frasca|17168296692|safrasca@buffalo.edu|
22447242|NCT02862171|International Partnership for Microbicides|Dr John Steytler|+27 21 8602300|jsteytler@ipmglobal.org|
22447243|NCT01962896|University of Texas Southwestern Medical Center|Theodore Laetsch, MD|214-648-5475|ted.laetsch@utsouthwestern.edu|
22447244|NCT00662012|Uniformed Services University of Health Sciences (USUHS)|Naomi Aronson, MD|(301) 295-3621|naomi.e.aronson.civ@mail.mil|
22447245|NCT00844896|Massachusetts General Hospital|Frederick J. Stoddard Jr., M.D.,|(617) 371-4762|fstoddard@partners.org|
22447246|NCT00458211|Bronx Psychiatric Center|Nigel Bark MD|718 862 5429|Nigel.Bark@omh.ny.gov|
22447247|NCT02154243|HSS|Dr. Haskins|(212) 606-1000|HaskinsS@hss.edu|
22447248|NCT00176228|Uillinois|Dr. Mani Pavuluri|312 4130064|mpavuluri@psych.uic.edu|
22447249|NCT00753415|Merck Sharpe & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22447250|NCT00621153|AstraZeneca|Gerard Lynch|+44 1509 64589|aztrial_results_posting@astrazeneca.com|4589
22447251|NCT04212650|Steadman Philippon Research Institute|Suzanne Liv Page, JD|970-401-8770|spage@sprivail.org|
22447252|NCT00838578|KYOWA KIRIN PHARMA|Project Leader|6099191100|clinical.info@kyowa-kirin-pharma.com|
22399718|NCT04152824|Oregon Health & Science University|Dr. Leslie Hammer|503-494-9313|hammerl@ohsu.edu|
22399719|NCT01459614|Sidney Kimmel Comprehensive Cancer Center|Dr. Dung Le|443-287-0002|dle2@jhmi.edu|
22399720|NCT05391438|Children's Hospital Los Angeles|Alaina Vidmar|3236614606|avidmar@chla.usc.edu|
22447253|NCT00598832|Galderma|Michael Graeber MD/ Head of Global Clinical Project Management|609-860-8201|michael.graeber@galderma.com|
22447254|NCT00357968|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22447255|NCT01414010|Beth Israel Deaconess Medical Center|Ciaran Kelly, MD|617-667-1272|ckelly2@bidmc.harvard.edu|
22447256|NCT03919799|Kadmon (A Sanofi Company)|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
22399721|NCT01629615|SOLTI|Scientific Manager|(+34) 93 343 63 02|pamela.celiz@gruposolti.org|
22399722|NCT03283085|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22399723|NCT03812172|Columbia University Irving Medical Center|Mathew Maurer|2123058274|msm10@cumc.columbia.edu|
22399724|NCT06001307|Illinois Institute of Technology|Arryn Guy|312-567-6467|aguy1@iit.edu|
22447257|NCT02970422|McGill University|Emilie Michalovic, Ph.D. Candidate|514-941-6450|emilie.michalovic@mail.mcgill.ca|
22447258|NCT02142959|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22447259|NCT04936256|Gainesville Eye Associates|Clayton Blehm, MD|7705324444|claytonblehm@gmail.com|
22447260|NCT00679302|Southern Illinois University, School of Medicine|Dr. Myto Duong, Pediatric Emergency Medicine Director|217-545-7409|myto_duong@yahoo.com|
22447261|NCT03547687|Oregon Health Science University|Dr. Julia Durrant|503-494-0353|durrantj@ohsu.edu|
22447262|NCT00646776|Bristol-Myers Squibb|BMS Study Director||ClinicalTrials@bms.com|
22447263|NCT04656691|UnitedHealth Group/Optum Labs|Tracy Ziolek , Vice President, Human Research Affairs|215-868-3114|tracy_ziolek@uhg.com|
22399725|NCT02237235|Northwestern University|Herbert Y. meltzer|312-503-0309|h-meltzer@northwestern.edu|
22399726|NCT03532100|CLiMB|Glenn Klute, PhD|206.277.6724|Glenn.Klute@va.gov|
22447264|NCT02959307|Massachusetts General Hospital|Dr. Paolo Cassano|617-643-9622|pcassano@mgh.harvard.edu|
22385708|NCT04216563|The University of MD Anderson Cancer Center|Ghayas Issa MD, Associate Professor|7133205722|GCIssa@mdanderson.org|
22385709|NCT05660018|UTHealth Houston|Dr. Xiaoming Du|4438829717|Xiaoming.Du@uth.tmc.edu|
22385710|NCT05263037|AppliedVR|Vice President of Research|13108901584|tmaddox@appliedvr.io|
22385711|NCT04321395|Washington University in St. Louis|Assistant Professor|314-362-8708|ssfarabi@wustl.edu|
22385712|NCT00085735|Childrens's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreporingcoordinator@childrensoncologygroup.org|
22385713|NCT06504862|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22385714|NCT05949788|ShenzhenBMCHH|Dr. Jun Luo|015818671195|luojun-78@163.com|
22385715|NCT01574274|Dana-Farber Cancer Institute|Dr. Lewis Silverman|16176326191|lewis_silverman@dfci.harvard.edu|
22385716|NCT04881903|Durham VA Health Care System|Angela Kirby|919-824-7729|angela.kirby@va.gov|
22385717|NCT01363388|ChemoCentryx|Study Director|650-210-2900||
22385718|NCT05477095|Vaxxinity, Inc.|Executive Director, Clinical Development|254-244-5739|info@vaxxinity.com|
22385719|NCT02191618|Sequent Medical, Inc|Director, Clinical Operations|714-247-8000|anne.hurley@microvention.com|
22385720|NCT04215146|Oncolytics Biotech Inc.|Chief Medical Officer|(403) 670-7377|info@oncolyticsbiotech.com|
22385721|NCT01943409|Toronto General Hospital|Scientific Associate|4163405159|kschweng@uhnresearch.ca|
22385722|NCT01541553|LEO Pharma A/S|Clinical trial disclosure|00 45 44 94 58 88|ctr.disclosure@leo-pharma.com|
22385723|NCT02969707|Stanford University|Dr. David Spiegel|650-723-6421|dspiegel@stanford.edu|
22385724|NCT03020199|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22385725|NCT04314713|Pharmaron|Paolo DePetrillo|240-673-0500|paolo.depetrillo@pharmaron.com|1731
22385726|NCT02714257|Milton S. Hershey Medical Center|Christopher Sciamanna, MD, MPH|717-531-4417|csciamanna@pennstatehealth.psu.edu|
22385727|NCT04700176|Hackensack Meridian Health|Joshua Zenreich|551-996-4248|joshua.zenreich@hmhn.org|
22385728|NCT04111874|University of Pennsylvania|Dr. Andrew Guzick|215-573-3708|andrew.guzick@pennmedicine.upenn.edu|
22385729|NCT03879863|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
22385730|NCT03800654|VA San Diego Healthcare System|Dr. Matthew Herbert|858-642-1411|Matthew.Herbert2@va.gov|
22385731|NCT03459729|Froedtert and the Medical college of Wisconsin|Stuart Wong, MD|414-805-4600|swong@mcw.edu|
22385732|NCT03576885|AdventHealth|Hussnain Mirza MD|9736263952|Hussnain.Mirza.MD@adventhealth.com|
22385733|NCT04053075|Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Healthcare Institute|Dr. Meghan Baker, MD, ScD|617-867-4946|MBAKER1@BWH.HARVARD.EDU|
22385734|NCT05476328|Cochlear|PRS Specialist|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
22385735|NCT02626533|Hospital for Special Surgery, Anesthesiology|Dr. Meghan Kirksey|2126061036|KirkseyM@hss.edu|
22385736|NCT04068181|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22385737|NCT05658224|USouthDakota|Dr. Kory Zimney|6056586373|kory.zimney@usd.edu|
22385738|NCT03785964|SpringWorks Therapeutics|Head of Clinical Operations|877-279-4870|clinical@springworkstx.com|
22385739|NCT02723591|Astellas Pharma Global Development, Inc. (APGD)|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22385740|NCT05070728|EyePoint Pharmaceuticals, Inc.|Ramiro Ribeiro, MD, PhD|908-440-0979|rribeiro@eyepointpharma.com|
22385741|NCT02151981|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22385742|NCT03847311|University of Arizona|Dr. Mohab Ibrahim|(520) 626-7221|mohab@arizona.edu|
22385743|NCT00597909|Horizon Pharma plc|Bruce Scharschmidt, MD||bscharschmidt@horizonpharma.com|
22385744|NCT01922050|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
22385745|NCT05645757|DynPort Vaccine Company, a GDIT Company|George Saviolakis|301-835-4101|George.Saviolakis@gdit.com|
22385746|NCT03905798|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22385747|NCT03463044|INOTREM SA|Executive VP Research and Medical Sciences, INOTREM SA|30 62 86 51|jjg@inotrem.com|+33 (0)6
22385748|NCT03334630|Medtronic|Katie Flor, Principal Clinical Research Specialist|+1 763 526 9651|katie.j.flor@medtronic.com|
22385749|NCT04498390|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22385750|NCT02068885|Boston Children's Hospital|Cara Ebbeling, PhD, Co-Director, New Balance Foundation Obesity Prevention Center|617-919-3457|Cara.Ebbeling@childrens.harvard.edu|
22447265|NCT00590005|Emory University Department of Pediatrics|Dr. Anne Fitzpatrick, Director, Emory Asthma Clinical Research Program|404-727-9112|anne.fitzpatrick@emory.edu|
22447266|NCT01753856|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22447267|NCT00887978|United Therapeutics Corporation|Kevin Laliberte, PharmD|919-425-8350|klaliberte@unither.com|
22447268|NCT05980182|Virginia Commonwealth University|Dr. Maria Thomson|804-628-2640|mthomson2@vcu.edu|
22447269|NCT02136810|Yale School of Medicine|Dr. Robert Schonberger, PI|203-785-2802|robert.schonberger@yale.edu|
22447270|NCT05284656|Al-Azhar University|Amira Reda Muhammad|0106 822 0389|amira.reda89@hotmail.com|
22447271|NCT04334902|Heuron|Yoomi Kim_Clinical Research Team Leader|01035173212|yoomi_kim@iheuron.com|
22447272|NCT04419714|Wesper/Tatch|Amir Reuvent|5754482824|amir@wesper.co|
22447273|NCT02700815|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22447274|NCT04023526|OncoVerity|Clay Smith, MD Chief Medical Officer|7204981136|csmith@oncoverity.com|
22447275|NCT02470234|Rhodes Pharmaceuticals L.P.|Dr. Akwete Adjei|401-262-9408|akwete.adjei@rhodespharma.com|
22447276|NCT01955733|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22447277|NCT02267811|Biolux Research, Ltd.|Dr. Peter Brawn|6046690674|p.brawn@bioluxresearch.com|
22447278|NCT02239978|Salt Lake City VA|Dr. Daniel Peterson|6028242279|daniel.peterson1@asu.edu|
22447279|NCT00602953|UT Southwestern Medical Center, Dallas, TX|Dr. ILDIKO LINGVAY|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
22447280|NCT04567225|The Cleveland Clinic Foundation|Dr. Mohammed Al-Jaghbeer|216-476-7983|ALJAGHM@ccf.org|
22447281|NCT02324569|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22447282|NCT02016560|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
22447283|NCT03758274|University of Rochester|Kenneth R. Conner|585-275-1211|kenneth_conner@urmc.rochester.edu|
22447284|NCT00793403|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22447285|NCT02422511|Baylor College of Medicine|Jill Robinson|7137985848|jill.robinson@bcm.edu|
22447286|NCT02961751|University of California, Los Angeles|Jeffrey D. Klausner, MD, MPH|310-267-0409|jdklausner@mednet.ucla.edu|
22447287|NCT00842712|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22447288|NCT02144233|University of Santiago de Compostela. A Coruña. SPAIN|Professor Urbano Santana Penín|+34647344093|urbano.santana@usc.es|
22447289|NCT02299479|Boston Children's Hospital|Garry Steil, PhD|617 355-6000|Garry.Steil@childrens.harvard.edu|
22447290|NCT03909295|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22447291|NCT02785354|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22447292|NCT03312933|Brigham and Women's Hospital|Dr. Jeremy T. Smith|(617) 983-7295|jsmith42@bwh.harvard.edu|
22447293|NCT00875212|Federal University of Paraiba|Fabio Correia Sampaio (research leader)|+55 83 3216 7795|fabios@ccs.ufpb.br|
22447294|NCT00848081|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22447295|NCT01752907|Amgen Inc.|Study Director|866-572-6436||
22447296|NCT03098550|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22447297|NCT02804932|University of Iowa|Dr. Darren Casey|13193841009|darren-casey@uiowa.edu|
22447298|NCT01693653|NYU Langone Medical Center, Center for Musculoskeletal Care|Yusuf Yazici|646-501-7400|yusuf.yazici@nyumc.org|
22447299|NCT01204853|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22447300|NCT01384760|ChineseUHK|Dr Susanna S Ng|(852) 98075787|drsssng123@yahoo.com.hk|
22447301|NCT00719134|Beth Israel Deacxoness Medical Center|Rami Burstein|617 735 2832|rburstei@bidmc.harvard.edu|
22447302|NCT00760578|Metabolic Solutions Development Company|Jerry Colca, PhD|269-343-6732|jcolca@msdrx.com|
22447303|NCT00187876|University of Florida|Peter Indelicato, MD|352-273-7017|wernegs@ortho.ufl.edu|
22447304|NCT00471068|Alcon Labs|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22447305|NCT04113304|Wayne State University|"Dr. Kathleen Lucy McGoron"|313.664.2500|Lucy.K.McGoron@wayne.edu|
22447306|NCT00309387|University of Parma|Giovanni Maraini, MD|+39 0521 238527|maraini@unipr.it|
22447307|NCT04159025|Washington University School of Medicine|Alexander Chen, M.D.|314-454-8764|chenac@wustl.edu|
22447308|NCT00208091|Clinical Motor Physiology Laboratory|Dr. Seth Pullman|212-305-3808|sp31@columbia.edu|
22385751|NCT04353258|University of Connecticut|Principal Investigator|8604862834|tricia.leahey@uconn.edu|
22385752|NCT04581564|Assistant Professor. Speech, Language and Hearing|Dr. Yune Lee|972-883-5639|yune.lee@utdallas.edu|
22385753|NCT04721977|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22385754|NCT05544695|MEDA Pharma GmbH & Co. KG (A Viatris Company)|Christine Kolb|+49 6172 888|christine.kolb@viatris.com|2511
22385755|NCT04304820|National Heart, Lung and Blood Institute (NHLBI)|Bhavisha Patel, M.D.|301-402-3477|bhavisha.patel@nih.gov|
22385756|NCT03873818|The University of Texas MD Anderson Cancer Center|Isabella C Glitza, MD,PHD|(713) 792-2921|icglitza@mdanderson.org|
22385757|NCT05171855|Ascendis Pharma|Aimee D. Shu, MD|+1 650-461-4835|ads@ascendispharma.com|
22385758|NCT03946111|Yale School of Medicine|Dr. Carlos M. Grilo|2037857210|carlos.grilo@yale.edu|
22385759|NCT04221490|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
22385760|NCT04987320|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22385761|NCT01824875|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22385762|NCT04195698|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22385763|NCT00433329|Actelion Pharmaceuticals, US, Inc.|Rajiv Patni/Medical Officer|(650) 624-6900||
22385764|NCT01129102|Nobelpharma|Department director of clinical development department 1|+81-5651-1177|murakami@nobelpharma.co.jp|
22447309|NCT02899988|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22413017|NCT04622709|University of North Carolina, Chapel Hill|Jennifer E. Flythe, MD, MPH|(919) 445-2656|jflythe@med.unc.edu|
22447310|NCT02041286|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
22447311|NCT03454581|Federal University of Rio Grande do Sul|PhD Manoela Domingues Martins|55-51-33085011|manomartins@gmail.com|
22447312|NCT00085631|Duke University Medical Center|Dr Mark Dewhirst|919 6683726|joan.cahill@dm.duke.edu|
22447313|NCT00411645|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22447314|NCT01349790|Octapharma USA|Michael Eppolito, Director, Clinical Operations Immunology and ICU Medicine|201 604-1155|michael.eppolito@octapharma.com|
22447315|NCT02289690|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22447316|NCT02376361|Albany Medical College|Loay Salman, MD|518-262-5176|SalmanL@amc.edu|
22447317|NCT04166435|Yale University|Dr. Michael Cecchini|(203) 737-3472|michael.cecchini@yale.edu|
22447318|NCT00571987|UAMS|Dr. Suzanne Klimberg|501-686-6504|klimbergsuzanne@uams.edu|
22447319|NCT00187369|Sunnybrook Health Sciences Center|Dr Jon Barrett||jon.barrett@sunnybrook.ca|
22447320|NCT00814164|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22447321|NCT01053221|University of Wisconsin-Madison|William Burlingham, PhD|6082630119|burlingham@surgery.wisc.edu|
22447322|NCT01025752|VA Connecticut Healthcare System|Dr. Alicia Heapy|203-932-5711|alicia.heapy@va.gov|2299
22447323|NCT00855920|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
22413018|NCT00643578|University of Florida Asthma Research Lab|Dr. Leslie Hendeles|352-273-6027|hendeles@cop.ufl.edu|
22413019|NCT00925769|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22413020|NCT04006171|Near East University|Dr.Ali Cenk Ozay|00905428583248|dr.alicenk@hotmail.com|
22413021|NCT03138330|Danone Nutricia Research|Dr Elena Sandalova|6568309433|elena.sandalova@danone.com|
22413022|NCT03049488|Vaccine Research Center, NIAID, NIH|Martin Gaudinski, MD|(301) 451-8715|martin.gaudinski@nih.gov|
22447324|NCT00843024|GlaxoSmithKline|GSK Response Center|866-435-7343||
22447325|NCT05201703|University of Florida - Jacksonville|Dr. Katherine Zarroli|3025615456|katherine.zarroli@jax.ufl.edu|
22447326|NCT02132130|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22447327|NCT04600921|Department of Internal Medicine, Division of Cardiology, Medical University of Graz|Dr. Dirk von Lewinski|+4331638580684|dirk.von-lewinski@medunigraz.at|
22447328|NCT03734055|University of Rochester|Dr. Edith Williams|5856020802|edith_williams@urmc.rochester.edu|
22447329|NCT00858130|University of North Carolina at Chapel Hill|Dr. Stephan Moll, Professor of Hemology/Oncology|919-966-3311|stephan_moll@med.unc.edu|
22447330|NCT05425745|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
22447331|NCT04221009|James A Haley Veterans' Hospital|Dr. Marc A Silva|813-972-2000|marc.silva1@va.gov|5613
22447332|NCT00793598|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
22447333|NCT02762266|Stanford University|Erqi Pollom, MD|(650) 498-0484|erqiliu@stanford.edu|
22447334|NCT01850550|Penn State Hershey Medical Center|Jennifer Kraschnewski|717-531-8161|jkraschnewski@hmc.psu.edu|
22447335|NCT02255604|Aarhus Universitets Hospital|Hans Jürgen Hoffmann|7845000|Hans.Jurgen.Hoffmann@ki.au.dk|
22447336|NCT00630396|Georgia Health Sciences University|David Hess, MD|706-721-1691|dhess@georgiahealth.edu|
22447337|NCT01479517|Rock Dental Clinic|Christina Sletten, DDS|719-599-9700||
22447338|NCT02990910|the Children's Hospital of Fudan University|Dr.Wang Xuan|18017591058|744734170@qq.com|
22399727|NCT03896581|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22399728|NCT04533711|University of North Carolina at Chapel Hill|Kelli Allen, PhD|919-966-0558|kdallen@email.unc.edu|
22399729|NCT02689492|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22399730|NCT01750918|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22399731|NCT00659295|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22399732|NCT04544566|Coloplast A/S|Head of Scientific Affairs|+45 4911 1111|clinicaltrialsgovSA@coloplast.com|
22399733|NCT00162773|Johns Hopkins University School of Medicine|Clinical Trials Program JHU ICTR|410-550-6484|registerclinicaltrials@jhmi.edu|
22399734|NCT00654927|Acorda Therapeutics, Inc.|Andrew Blight, PhD Chief Scientific Officer|914-347-4300|ablight@acorda.com|4102
22399735|NCT02338843|La Jolla Pharmaceutical Company|George Tidmarsh, MD, PhD|858-207-4264|gtidmarsh@ljpc.com|
22399736|NCT03338556|PrEP Biopharm Limited|Chief Medical Officer|8666207176|info@prepbiopharm.com|0
22399737|NCT04246554|UH Cleveland Medical Center|Dr. Michael Karns|216-844-7200|srmengers@gmail.com|
22399738|NCT02660580|Fresenius Kabi SwissBioSim GmbH|Eugenia Kunina, senior clinical development manager|+41791093376|clinical.development@fresenius-kabi.com|
22399739|NCT05415449|Children's Medical Center|Maria Leal|2144560276|Maria.leal@childrens.com|
22399740|NCT00951821|Brown University|Anthony Spirito|401-444-1929|anthony_spirito@brown.edu|
22399741|NCT02185521|Philips Healthcare|Dr. Szymon Bieganski|978-284-3271|szymon.bieganski@philips.com|
22399742|NCT04646148|Butler Hospital|Dr. Lisa Uebelacker|401-455-6381|luebelacker@butler.org|
22399743|NCT00398112|Mayo Clinic|Tait Shanafelt||shanafelt.tait@mayo.edu|
22399744|NCT00582556|University of Wisconsin Carbone Cancer Center|Dr. Douglas McNeel|608-263-4198|dm3@medicine.wisc.edu|
22399745|NCT01993888|Ethicon, Inc.|Senior Director of Ethicon Clinical R&D|908-218-2492|jbatill2@its.jnj.com|
22399746|NCT04628936|Kezar Life Sciences, Inc|Regulatory Affairs|650-822-5600|clinicaltrials@kezarbio.com|
22399747|NCT01676831|Hospital of the University of Pennsylvania|Study Coordinator|215-662-6722|deborah.leahy@uphs.upenn.edu|
22399748|NCT03124459|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22399749|NCT01028352|University of Michigan Comprehensive Cancer Center|Dr. Norah L. Henry|734-936-4991|norahh@umich.edu|
22399750|NCT01903876|Georgia State University|Dr. Laura Salazar|404-413-1396|lsalazar1@gsu.edu|
22399751|NCT03062917|Imperial College NHS trust|Study PI Simon Nadel|02033126202|s.nadel@imperial.ac.uk|
22399752|NCT00673855|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22399753|NCT04486560|Johns Hopkins University|Dr. Lonny Yarmus|410-502-5224|lyarmus@jhmi.edu|
22399754|NCT02357992|UT MD Anderson Cancer Center|Dr. Jack Roth, MD- Professor, Thoracic & Cardio Surgery-Rsch|(713) 792-7664|jroth@mdanderson.org|
22399755|NCT00826748|Weill Cornell Medicine|Grace Mammen|646-962-2672|gwm2004@med.cornell.edu|
22399756|NCT03802721|Oregon State University|David E. Williams, PhD|541-737-3277|david.williams@oregonstate.edu|
22399757|NCT02300129|Galderma R&D|Galderma CPM|00 33 4 93 95 70 70|clinicaltrials@galderma.com|
22399758|NCT01887912|Sanofi Pasteur|Medical Director|800-633-1610|Contact-US@sanofi.com|1#
22399759|NCT04462536|NoNO Inc.|Michael Tymianski|6472932232|mtymianski@nonoinc.ca|
22399760|NCT02747927|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22399761|NCT04033926|Kezar Life Sciences, Inc|Regulatory Affairs|650-822-5600|clinicaltrials@kezarbio.com|
22399762|NCT00450580|GlaxoSmithKline|GSK Response Center|866-435-7343||
22399763|NCT06331884|4TEEN4 Pharmaceuticals|Kathleen Richter|0049 1784027078|richter@4teen4.de|
22399764|NCT00522392|ECOG Statistical Office|Study Statistician|617-632-3012||
22399765|NCT03932812|University of Iowa|Sato Ashida|319-384-1477|sato-ashida@uiowa.edu|
22399766|NCT00687453|Charles R. Drew University of Medicine and Science|Stanley H. Hsia, MD|323-357-3633|stanleyhsia@cdrewu.edu|
22399767|NCT00430755|Robert-Bosch-Hospital|Prof. Dr. Mark Dominik Alscher|+4971181013496|dominik.alscher@rbk.de|
22399768|NCT00970606|Vanderbilt University Medical Center|Gordon R. Bernard, MD, Associate Vice Chancellor for Research|615-343-0077|gordon.bernard@vanderbilt.edu|
22399769|NCT02472457|The Children's Hospital of Philadelphia|Ronen Stein, MD|215-590-7801|ibdresearch@email.chop.edu|
22399770|NCT01154101|GlaxoSmithKline|GSK Response Center|866-435-7343||
22399771|NCT03575104|Idorsia Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 58 844 00 00|clinical-trials-disclosure@idorsia.com|
22399772|NCT00332709|Novartis Pharmaceuticals|Study Director|862-778-8300||
22399773|NCT00582517|University of Alabama at Birmingham|Taylor Vlack, RN|205-996-6781|tmwebb@uabmc.edu|
22399774|NCT01479348|National Cancer Institute|Dr. Karen Kurdziel|804-897-1207|kurdziek@nih.gov|
22399775|NCT01295125|University Hosptials Cleveland Medical Center|Dr. Michael Rosen|216-396-9937|rosenm@ccf.org|
22399776|NCT00891735|Genentech, Inc.|Medical Communications|800-821-8590||
22399777|NCT01355289|Eisai Call Center|Eisai Inc.|888-422-4743||
22399778|NCT01814787|Indiana University School of Medicine|Aaron E. Carroll, MD, MS|3172789616|aaecarro@iu.edu|
22399779|NCT00802360|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22399780|NCT03773302|QED Therapeutics, Inc.|Acting Chief Medical Officer|1-877-280-5655|PROOF301.ct@qedtx.com|
22399781|NCT01916629|Physicians Institute|Sharon Keene, MD|(520) 290-5555|monican@appliedbiology.com|
22399782|NCT01647737|Georgia Regents University|Dr. Scot DeRossi, Chairman of the ORal Medicine & Diagnostic Sciences Department|706-721-2607|Sderossi@gru.edu|
22399783|NCT03838484|Vanderbilt University Medical Center|Alan S. Lewis, M.D., Ph.D.|615-875-4027|alan.s.lewis@vumc.org|
22399784|NCT01900002|UT MD Anderson Cancer Center|Dr. Ahmed Kaseb, MD, Professor, GI Medical Oncology|(713) 792-2828|akaseb@mdanderson.org|
22399785|NCT01614964|Tulane University|Jeffrey G Shaffer|504-988-1142|jshaffer@tulane.edu|
22399786|NCT03618030|Purdue Pharma L.P.|Clinical Leader|1-800-733-1333|Sailaja.Bhaskar@ImbriumThera.com|
22399787|NCT00860470|JHSPH|Keith P. West, Jr.|4109552061|kwest@jhsph.edu|
22399788|NCT03689192|National Center for Cancer Immune Therapy|Cathrine Lund Lorentzen|004538683868|cathrine.lund.lorentzen@regionh.dk|
22399789|NCT00888238|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22399790|NCT03705481|Corindus, Inc.|John Van Vleet, VP Clinical and Regulatory Affairs|260-615-8892|john.vanvleet@corindus.com|
22399791|NCT00469508|UCLA Center for Behavioral and Addiction Medicine|Steven Shoptaw PhD|310 794 0619|sshoptaw@mednet.ucla.edu|225
22399792|NCT04091347|Johns Hopkins School of Nursing|Janiece Taylor|443-287-4503|jwalke90@jhu.edu|
22430236|NCT03163264|VA New York Harbor Manhattan|Dr. Melanie Jay|212-686-7500|melanie.jay@va.gov|5097
22413023|NCT01735630|Transition Therapeutics Ireland Limited|Aleksandra Pastrak, MD, PhD, Vice President Clinical Development|+1 416 263 1227|apastrak@transitiontherapeutics.com|
22413024|NCT01327963|EndoGastric Solutions|Adrian Lobontiu, Chief Medical Officer|1 650-474-9259|alobontiu@endogastricsolutions.com|
22413025|NCT00891293|GlaxoSmithKline|GSK Response Center|866-435-7343||
22413026|NCT02178722|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22413027|NCT01572948|University of Alabama at Birmingham, Division of Pulmonary, Allergy, and Critical Care Medicine|J. Michael Wells, M.D.|205-934-6047|jmwells@uab.edu|
22413028|NCT00440557|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Sr Director of Clinical Research|908-927-2116||
22413029|NCT00802100|Columbia University|Scott Stroup|(212) 543-5676|stroups@nyspi.columbia.edu|
22413030|NCT00680121|University of Kansas Medical Center|Ann Manzardo, PhD|(913) 588-6473|amanzardo@kumc.edu|
22413031|NCT01939197|AbbVie|Global Medical Services|800-633-9110||
22413032|NCT02849652|University of Pennsylvania|Dr. Robert Schnoll|2157467143|schnoll@pennmedicine.upenn.edu|
22413033|NCT02545998|Oxshott Medical Practice|Dr Sarah Glynne|01372 844000|sarah.glynne@nhs.net|
22413034|NCT01226797|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22413035|NCT01641445|Brown University|Dr. Robert Miranda|401.863.6658|Robert_Miranda_Jr@brown.edu|
22413036|NCT04538040|Gilead Sciences|Lisa Sterman, MD, MPH|415-407-8434|Lisa.Sterman@Gilead.com|
22413037|NCT00408902|Case Comprehensive Cancer Center|Jorge Garcia MD|216-444-7774|garciaj4@ccf.org|
22413038|NCT01106326|University of Rochester|Maria Fagnano|5852758220|maria_fagnano@urmc.rochester.edu|
22413039|NCT02480764|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22413040|NCT03117569|Viral Hepatitis Clinical Research Program Kirby Institute|Clinical Trials Manager|+61 9385 0900|pmarks@kirby.unsw.edu.au|
22413041|NCT02457832|Associate Professor of Medicine Emory University School of Medicine, Department of Medicine, Division of Geriatrics and Gerontology; Research Health Scientist Atlanta VA Health Care System, Center for Visual and Neurocognitive Rehabilitation|Madeleine E. Hackney, Ph.D.|404-315-4100|mehackn@emory.edu, madeleine.hackney@va.gov|373141
22413042|NCT01044732|Avantis Medical Systems|Jack Higgins, MD - Chief Medical Officer|6508239216|jhiggins@avantismedical.com|
22413043|NCT01030965|GlaxoSmithKline|GSK Response Center|866-435-7343||
22413044|NCT02097290|Boston Scientific|Gregory Voss|6515813068|Gregory.Voss@bsci.com|
22413045|NCT02304432|McLean Hospital|Dr. Deborah Levy|617-855-2854|dlevy@mclean.harvard.edu|
22413046|NCT03991494|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22413047|NCT05277389|Arizona State University|Claire Honeycutt, Associate Professor|4809658453|claire.honeycutt@asu.edu|
22413048|NCT03144687|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22413049|NCT02514174|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22413050|NCT00824265|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
22413051|NCT02170688|Duke University Medical Center|Lisa Ho, MD|919-684-7890|lisa.ho@duke.edu|
22413052|NCT01894178|Baylor College of Medicine|Dr. Lee Chang|713-873-4321|lcchang@bcm.edu|
22413053|NCT02079532|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22413054|NCT02920996|Dana-Farber Cancer Institute|Mark Awad, MD, PhD|(617) 632-3468|mark_awad@dfci.harvard.edu|
22413055|NCT01402947|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22413056|NCT00591630|University of Texas MD Anderson Cancer Center|Issa F. Khouri, MD / Stem Cell Transplantation|713-792-8750|ikhouri@mdanderson.org|
22413057|NCT02218164|H. Lee Moffitt Cancer Center and Research Institute|Dr. Christine Chung|813-745-5061|christine.chung@moffitt.org|
22413058|NCT02419690|Denver Health & Hospital Authority|Deborah Rinehart|303-602-2743|deborah.rinehart@dhha.org|
22413059|NCT01471522|NYU Langone Health|Anna Naumova|212.263.6927|Anna.Naumova@nyulangone.org|
22413060|NCT02405195|Västra Götalandsregionen|Lukas Lannemyr|46313428860|lukas.lannemyr@vgregion.se|
22413061|NCT01432171|Dana-Farber Cancer Institute|Dr. Andrew Norden, M.D., M.P.H. - Lead Principal Investigator|617-632-2166|anorden@partners.org|
22413062|NCT02863575|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22413063|NCT01706926|MedImmune, LLC|Marius Albulescu, Associate Medical Director|301-398-0000|albulescum@medimmune.com|
22413064|NCT01248247|UT MD Anderson Cancer Center|Dr. Marcelo Vailati Negrao, MD, Assistant Professor, Thoracic-Head & Neck Med Onc|(713) 614-4938|mvnegrao@mdanderson.org|
22413065|NCT01215981|Masonic Cancer Center, University of Minnesota|Michael Verneris, M.D.|612-626-2961|verneris@umn.edu|
22413066|NCT03597256|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
22413067|NCT02943447|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22413068|NCT00722124|Mayo Clinic|Amit Sood, MD|507-266-1944|nicotineresearch@mayo.edu|
22413069|NCT01907334|University of Florida|Leslie Hendeles, PharmD|352-273-6027|hendeles@cop.ufl.edu|
22430237|NCT03679884|Idorsia Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 58 844 00 00|clinical-trials-disclosure@idorsia.com|
22430238|NCT01026038|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22430239|NCT03274661|Miami Cancer Institute at Baptist Health, Inc.|Dr. John Diaz, Principal Investigator|(786) 527-8284|johnpd@baptisthealth.net|
22430240|NCT01083472|LifeCell|Sandra VanGuldener|310612504695|svanguldener@lifecell.com|
22430241|NCT00667589|Northwestern University|Hae Bae|312-695-6829|j-bae@northwestern.edu|
22430242|NCT02792257|Johns Hopkins University|Dr. Paul Rosenberg|4105509883|prosenb9@jhmi.edu|
22430243|NCT02189629|Galderma S.A.|Anne Fulton|+1 817-961-5203|anne.fulton@galderma.com|
22447339|NCT00113217|University of Texas (UT) MD Anderson Cancer Center|Eric Jonasch, MD / Associate Professor|713-563-7232|ejonasch@mdanderson.org|
22447340|NCT02064868|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22447341|NCT00482612|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22447342|NCT00660023|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22447343|NCT00603993|Abbott|Global Medical Services|1-800-633-9110||
22413070|NCT01794039|Mayo Clinic|Shaji K. Kumar, M.D.|(507) 284-2017|kumar.shaji@mayo.edu|
22413071|NCT00963482|Divsion Substance Use Disorder, Psychiatric Hospital of the Univeristy of Basel|M. Sc. S. Müller (Site-investigator) Prof. G. A. Wiesbeck (PI)|+41 61 325 53 33|sandra.mueller@upkbs.ch|
22413072|NCT02562378|Medica Scientia Innovation Research (MEDSIR)|Scientific director|+34 93 221 41 35|trialsregister.medsir@medsir.org|
22413073|NCT01104025|Cincinnati Children's Hospital Medical Center|Michael Jordan, MD|513-803-9063|Michael.Jordan@cchmc.org|
22413074|NCT02653664|University of Washington|Dr. Mark Jensen|206-543-3185|mjensen@uw.edu|
22413075|NCT04657770|UCLA|Steve Cramer|424-522-7273|SCCramer@mednet.ucla.edu|
22413076|NCT00485472|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22413077|NCT00746798|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22413078|NCT02055963|UT MD Anderson Cancer Center|Dr. Juan P. Cata, MD-Associate Professor, Anesthesiology & PeriOper Med|(713) 792-7452|jcata@mdanderson.org|
22413079|NCT04915755|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22413080|NCT00556049|MGH Cancer Center|Dr. M. Dror Michaelson|617-726-1594|dmichaelson1@partners.org|
22413081|NCT00727571|Amgen Inc.|Study Director|866-572-6436||
22413082|NCT03247556|Supernus|Joseph Hull, PhD, Associate Director Clinical Research|240-403-5324|jhull@supernus.com|
22413083|NCT02031978|USDA Food and Nutrition Service|Courtney Paolicelli|7036054370|Courtney.Paolicelli2@usda.gov|
22430244|NCT03760666|Clear Creek Bio, Inc.|Vice President, Clinical Operations|(617) 765-2252|clinical@clearcreekbio.com|
22430245|NCT02129556|International Breast Cancer Study Group (IBCSG)|Heidi Roschitzki-Voser|+41 31 511 94 18|heidi.roschitzki@ibcsg.org|
22430246|NCT03721367|Baylor College of Medicine|Dr. Lindsay Burrage|832-822-4280|burrage@bcm.edu|
22430247|NCT01800058|Hospital Universitario de La Princesa|Almudena Zapatero, MD PhD|+34 91 520 23 15|almudena.zapatero@salud.madrid.org|
22430248|NCT01064622|University of Chicago|Hedy Kindler, MD|773-702-0360|hkindler@medicine.bsd.uchicago.edu|
22430249|NCT03772340|Vanda Pharmaceuticals Inc.|Vanda Pharmaceuticals Inc.|2027343400|clinicaltrials@vandapharma.com|
22430250|NCT02946996|Medical University of South Carolina|Tricia Bentz CTO Administrative Director|8437921415|adraleta@musc.edu|
22430251|NCT00176254|University of Kentucky|Dr. Emily Van Meter/Assistant Professor, Division of Cancer Biostatistics|859-323-3076|emily.vanmeter@uky.edu|
22430252|NCT04967417|Samsung Medical Center|Myung-Ju Ahn|+82-2-3410-3438|silkahn@skku.edu|
22430253|NCT05330429|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22430254|NCT01537367|Division of HIV/AIDS (Epidemiology Branch), National Center for HIV/Hepatitis/STD/Tuberculosis Prevention, Centers for Disease Control and Prevention|Lytt I. Gardner, Ph.D., CDC Project Officer|(404) 639-6163|lig0@cdc.gov|
22430255|NCT02568254|Johnson & Johnson Vision Care Inc.|Chantal Coles-Brennan BSc, OD, FAAOPrincipal Research Optometrist|904 443 3449|CColesb@ITS.JNJ.com|
22430256|NCT06896734|Eminence Clinical Research, Inc.|Nick Leppo|719-400-7464|nleppo@ecr-inc.com|
22430257|NCT05670756|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-4200|joseph.tobias@nationwidechildrens.org|
22430258|NCT04681885|Sunstar Americas, Inc.|Toru Saito|1-847-794-4271|toru.saito@us.sunstar.com|
22430259|NCT02113878|Dana Farber Cancer Institute|Glenn J. Hanna, MD|617.632.6799|GJHanna@partners.org|
22430260|NCT03142451|Foamix Pharmaceuticals, Inc.|Iain Stuart, PhD.|1 800-775-7936|Iain.Stuart@foamix.com|
22430261|NCT02144337|University of Nottingham (UK)|Helen Quirk|01157484325|ntxhq1@nottingham.ac.uk|
22430262|NCT05333965|CooperVision|Jose A. Vega, OD, MSc, FAAO|9256213761|jvega2@coopervision.com|
22430263|NCT02743312|San Francisco State University|Dr. Diane Allen|4153386837|ddallen@sfsu.edu|
22430264|NCT00871000|GlaxoSmithKline|GSK Response Center|866-435-7343||
22430265|NCT01052428|University of Alabama at Birmingham|Louis J. Dell'Italia, M.D.|205-934-0850|loudell@uab.edu|
22430266|NCT03400787|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
22430267|NCT03912805|Clinical Research Management Group|Patrick Murphy|(866) 337-1868|p.murphy@crmg-usa.com|
22430268|NCT02402907|Icahn School of Medicine at Mount Sinai|Dr. Joanne Stone|212-241-5681|joanne.stone@mssm.edu|
22430269|NCT02685436|Manicure university children hospital|Dr.Ahmed Zaki|0201008335567|drahmedmd17@yahoo.com|
22430270|NCT02595437|Rockwell Medical, Inc|Clinical Project Manager|248-960-9009|sgrimberg@rockwellmed.com|
22430271|NCT02925143|Herlev Hospital|Dr. Jakob Thomsen|004538683868|dr.j@demants.dk|
22430272|NCT02837952|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22430273|NCT01879826|University of California San Francisco|Cynthia Kim|(415)353-1328|cynthia.kim@ucsf.edu|
22430274|NCT03439072|Xeris Pharmaceuticals, Inc.|Martin J. Cummins|312-736-1624|mcummins@xerispharma.com|
22430275|NCT02003898|Medtronic Minimed|Suiying Huang, Statistician|818-576-3319|suiying.huang@medtronic.com|
22430276|NCT01651208|University of Miami|Ana M. Palacio|3052439754|apalacio2@med.miami.edu|
22430277|NCT01391299|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22430278|NCT03492385|SFJ Pharmaceuticals, Inc.|Michele LaRussa SVP, Chief Regulatory Officer|925-223-6233|Bentracimab.General@SFJ-Pharma.com|
22430279|NCT00986102|Jan-Cil Singapore|VP MEDICAL AFFAIRS ASIA PACIFIC|+65 6827 6753||
22430280|NCT02314247|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
22430281|NCT01722734|Harvard School of Public Health|Dr Günther Fink|6174327389|gfink@hsph.harvard.edu|
22430282|NCT02261532|Taiho Pharmaceutical co., ltd.|Clinical Trial Registration Contact|+81-3-3293-2113|toiawase@taiho.co.jp|
22447344|NCT04180488|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
22447345|NCT03506815|The Ottawa Hospital|Dr. Marc Carrier|613-737-8899|mcarrier@toh.ca|73034
22413084|NCT00358449|GlaxoSmithKline|GSK Response Center|866-435-7343||
22430283|NCT01775410|Avinger, Inc.|Director of Clinical Trials|650 241 7030|tlawson@avinger.com|
22413085|NCT01804270|Mayo Clinic|Paul E. Croarkin, D.O., M.S.|507-293-2557|Croarkin.Paul@mayo.edu|
22413086|NCT01469767|Wake Forest University Health Sciences|Steve Feldman MD|336-716=3775|sfeldman@wakehealth.edu|
22385765|NCT04502888|Shattuck Labs|VP, Clinical Operations|919-864-2700|clinicaltrials@shattucklabs.com|
22413087|NCT02334722|University of Florida|Kristine Wynne|352-273-9727|kristine.wynne@neurosurgery.ufl.edu|
22413088|NCT03988803|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22413089|NCT01171690|Mayo Clinic|Marius Stan, MD|507-284-2463|stan.marius@mayo.edu|
22413090|NCT01666730|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. David Bajor|1-800-641-2422|CTUReferral@UHhospitals.org|
22385766|NCT05256017|Drugs for Neglected Disease initiative (DNDi)|Dr Junior Matanglia|+243 970 756 890|jmatangila@dndi.org|
22385767|NCT04500613|Hospital for Special Surgery|Marko Popovic|646-797-8948|popovicm@hss.edu|
22413091|NCT01434693|Coronado Biosciences|Vice President Clinical Operations|781.652.4516|nsilver@coronadobio.com|
22385768|NCT05082025|The University of Texas MD Anderson Cancer Center|Dr. Timothy Yap|(713) 839-5458|tyap@mdanderson.org|
22385769|NCT03032107|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|617-632-3800|Sara_Tolaney@dfci.harvard.edu|
22385770|NCT03854227|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_lnquiries@pfizer.com|
22385771|NCT04192266|The University of Texas Health Science Center at Houston|Mohammed R Milad, PhD|713-486-2754|Mohammed.R.Milad@uth.tmc.edu|
22413092|NCT02087904|AbbVie|Global Medical Services|AbbVie|abbvieclinicaltrials@abbvie.com|
22385772|NCT04948697|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22385773|NCT04870515|Fred Hutch Cancer Center|Marian L. Neuhouser, PhD|206-667-4797|mneuhous@fredhutch.org|
22413093|NCT01973348|Indiana University|Dr. Daniel Neely, PI|3172741214|deneely@iupui.edu|
22385774|NCT04032704|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22413094|NCT01270919|Stryker Orthopedics|Director of Clinical Research|201-831-5401|ellen.axelson@stryker.com|
22385775|NCT01501955|Zimmer Biomet|Linda Meijer|+31786292929|linda.meijer@zimmerbiomet.com|
22413095|NCT00874237|Alexza Pharmaceuticals, Inc|Chief Scientific Officer|650.944.7777|jcassella@alexza.com|
22385776|NCT04298983|University of Alabama at Birmingham (UAB)|Andrew McDonald, MD; Principal Investigator|2059345670|ammcdonald@uabmc.edu|
22413096|NCT01878825|GlaxoSmithKline|GSK Response Center|866-435-7343||
22385777|NCT02927236|National Institute on Drug Abuse (NIDA)|Yihong Yang, PhD|443-740-2648|yihong.yang@nih.gov|
22385778|NCT05477186|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22413097|NCT00877032|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22385779|NCT01767636|Mayo Clinic|Brian Costello MD|507/284-2511|Costello.Brian@mayo.edu|
22413098|NCT04056182|New York State Psychiatric Institute|Frances R Levin, MD|6467746137|frances.levin@nyspi.columbia.edu|
22413099|NCT02107092|ZS Pharma, Inc.|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22385780|NCT01919554|Stallergenes|Michel Roux, Medical Director|+33 (0) 1 55 59 20 00|mroux@stallergenes.com|
22413100|NCT00537030|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22413101|NCT02828917|Medinol|Dina Kofler, VP Clinical Affairs|+97237679032|dinak@medinol.com|
22413102|NCT04213326|Exact Sciences|Adriann Kern|4843563027|akern@exactsciences.com|
22385781|NCT04018053|BrighamHospital|Heather Jacene|617-632-3767|hjacene@bwh.harvard.edu|
22413103|NCT01954264|GlaxoSmithKline|GSK Response Center|866-435-7343||
22413104|NCT01496183|The State University of New York at Buffalo|Dr. Elsa Daurignac, Research Assistant Professor|716-898-4540|ecd3@buffalo.edu|
22385782|NCT03982459|University of California, San Francisco|Dr. Sue Yom, MD|415-353-7175|sue.yom@ucsf.edu|
22413105|NCT03325426|UCSF|Elaine Ku|415-502-7760|elaine.ku@ucsf.edu|
22385783|NCT01733316|Horizon Pharma USA, Inc.|Evelyn Olson, Director|224-383-3000|clinicaltrials@horizonpharma.com|
22385784|NCT05533918|University of Utah|Dr. Guilherme Del Fiol|801-581-4080|guilherme.delfiol@utah.edu|
22385785|NCT02838420|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22413106|NCT01173692|UT MD Anderson Cancer Center|Brandon Gunn, MD/ Associate Professor, Radiation Oncology Department|(713) 563-2562|gbgunn@mdanderson.org|
22385786|NCT03024437|University at Buffalo|Dr. Roberto Pili|(716) 881-8918|rpili@buffalo.edu|
22385787|NCT03621371|Karolinska Institutet|Dr Benjamin Bohman|701713443|benjamin.bohman@ki.se|+46
22385788|NCT03240016|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
22385789|NCT05200403|Boston University School of Medicine|Kevin Thomas, PhD, MBA|617-358-9787|kipthoma@bu.edu|
22385790|NCT05546411|Dana Farber Cancer Institute|Kimberly Perez, MD|617-632-5370|KIMBERLY_PEREZ@DFCI.HARVARD.EDU|
22385791|NCT02606422|Johns Hopkins University School of Medicine|Kyrana Tsapkini|410-614-2646|tsapkini@jhmi.edu|
22385792|NCT04625465|Georgia State University|Dr. Dominic Parrott, Distinguished University Professor of Psychology|+1 (404) 413-6287|parrott@gsu.edu|
22413107|NCT02370407|Johns Hopkins University|Dr. Lauren Thomaier|410-955-6710|lthomai1@jhmi.edu|
22413108|NCT00669864|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22413109|NCT04826809|Mayo Clinic|Dr. Janielle R. Nordell|507-594-4700|Nordell.Janielle@mayo.edu|
22413110|NCT02359305|Nationwide Children's Hospital - Dept. of Anesthesiology & Pain Medicine|Dr. Arlyne Thung|614-722-4200|Arlyne.Thung@nationwidechildrens.org|
22413111|NCT01941030|Cardiovascular Systems, Inc.|Clinical Trials Manager|651.259.2500|clinicaltrials_csi@csi360.com|
22413112|NCT04448678|University of Utah|Anne Kirchhoff|801-587-4084|Anne.Kirchhoff@hci.utah.edu|
22447346|NCT01393704|Brigham and Women's Hospital|Dr. Jon Einarsson|617-525-8582|jeinarsson@partners.org|
22447347|NCT01804296|Mayo Clinic|Paul E. Croarkin, D.O., M.S.|507-293-2557|Croarkin.Paul@mayo.edu|
22385793|NCT04947397|University of California San Francisco|Daniel Abelson|510 428 3000|daniel.abelson@ucsf.edu|
22399793|NCT03480802|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22385794|NCT03584633|Cleveland Clinic|Dr. Wei F. Chen|319-333-6166|chenw6@ccf.org|
22385795|NCT05566639|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
22385796|NCT05166577|Viracta Therapeutics|Dr. Darrel Cohen|858-400-8470|ClinicalTrials@Viracta.com|
22385797|NCT04054193|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22385798|NCT04082143|Virginia Commonwealth University|Lyndon Cooper, Dean|(804) 828-7235|cooperlf@vcu.edu|
22385799|NCT05436262|Johns Hopkins University|Cherie Marvel|410-387-8510|cmarvel1@jhmi.edu|
22385800|NCT05299073|mAbxience Research S.L.U.|Susan Millan PhD|+34 917711500|susana.millan@mabxience.com|
22385801|NCT03952338|University of Calgary|Dr. Dana Lee Olstad|403-210-8673|dana.olstad@ucalgary.ca|
22385802|NCT05934942|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22385803|NCT03924635|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22385804|NCT05469464|UNION therapeutics A/S|UNION therapeutics A/S|+45 61 77 7435|clinicaltrials@uniontherapeutics.com|
22385805|NCT04421989|Cincinnati Children's Hospital Medical Center|Dr. Claire Aarnio-Peterson|5138037459|claire.aarnio-peterson@cchmc.org|
22385806|NCT05374798|Medical University of South Carolina|Stacey sellers|843-792-5807|sellersst@musc.edu|
22385807|NCT04252573|Endologix|Mohamed Moawad|949-595-7244|mmoawad@endologix.com|
22385808|NCT03404115|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
22385809|NCT05487404|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
22385810|NCT04585815|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22385811|NCT01854775|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22385812|NCT04068311|The Ohio State University|Dr. Lauren Southerland, Principal Investigator|919-293-8305|lauren.southerland@osumc.edu|
22385813|NCT03100149|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22385814|NCT02670525|Dana-Farber Cancer Institute|Dr. Yana Pikman|6176324754|yana_pikman@dfci.harvard.edu|
22385815|NCT03474107|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22385816|NCT05041257|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22385817|NCT03067480|East Tennessee State University|Rick Hess|423-439-2075|hessr@etsu.edu|
22385818|NCT05782816|University of Texas Medical Branch|Amanda Wang, MD|4097728666|amanda.mei.wang@gmail.com|
22385819|NCT02442349|AstraZeneca|Global Clinical Lead, Yuri Rukazenkov|+441625231825||
22385820|NCT03936959|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22385821|NCT03748953|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22399794|NCT00988247|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22399795|NCT01409928|UTSW|Olga T. Gupta|(214) 648-8718|olga.gupta@utsouthwestern.edu|
22399796|NCT02661594|Acacia Pharma Ltd|Dr Gabriel Fox|+44-(0)1223-919764|GabrielFox@acaciapharma.com|
22399797|NCT01989130|University of California-Davis|Larissa May, MD|916-736-5010|lsmay@ucdavis.edu|
22399798|NCT02557178|Mayo Clinic|Johanna Hoult|507-293-1989|hoult.johanna@mayo.edu|
22385822|NCT04676763|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22385823|NCT02296125|AstraZeneca AB|Global Clinical Leader|+46 766 346712|ClinicalTrialTransparency@astrazeneca.com|
22385824|NCT05799079|Vanderbilt-Ingram Cancer Center|Sanjay Mohan|615-936-8422|sanjay.mohan@vumc.org|
22385825|NCT04858451|Thirty Respiratory Ltd|Inva Hoti, PhD|+44 (0) 1235 431200|Inva.Hoti@30.technology|
22385826|NCT02998268|Weill Cornell Medicine|Dr. Manish Shah|646-962-6200|mas9313@med.cornell.edu|
22385827|NCT04225273|QMedAB|Clinical Project Manager|18179615000|aestheticclinicaltrials@galderma.com|
22385828|NCT02966873|Medical University of South Carolina|Stacey Sellers|843-792-5807|sellersst@musc.edu|
22385829|NCT05844137|Duke University|Anastasia Alexopoulos|1 919 684 4005|anastasia.alexopoulos@duke.edu|
22385830|NCT00950742|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22385831|NCT06176963|Samsung Bioepis Co., Ltd|Director of Clinical Trials|+82-32-728-0371|sbregistry@samsung.com|
22385832|NCT01456949|Medtronic|Kirsten Rasmussen|763-526-2833|kirsten.l.rasmussen@medtronic.com|
22385833|NCT04753697|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22385834|NCT01658930|Canadian Cancer Trials Group|Lois E. Shepherd|6135336430|LShepherd@ctg.queensu.ca|
22385835|NCT05002088|Abbott|Karine Miquel|+32 479 600 107|karine.miquel@abbott.com|
22385836|NCT05495971|Visioneering Technologies, Inc.|Dr. Douglas P. Benoit|6035459507|dbenoit@vtivision.com|
22385837|NCT04770402|Atrium Health Levine Cancer|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
22385838|NCT03599661|Wake Forest Baptist Comprehensive Cancer Center|Stephanie Bunch|336-716-5180|sbunch@wakeforest.edu|
22385839|NCT04811040|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22385840|NCT05124704|Zhejiang Cancer Hospital|Jiangling Wang|15168373331|wangjl@zjcc.org.cn|
22385841|NCT05446129|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
22385842|NCT05446168|University of Michigan|Nicolaas Bohnen, MD, PhD|734-936-1168|nbohnen@umich.edu|
22385843|NCT03512327|Scripps Clinic|Dr. Gauree Konijeti|8585548880|konijeti.gauree@scrippshealth.org|
22399799|NCT01169779|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22385844|NCT06258174|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
22447348|NCT00616200|UNC Center for Functional GI & Motility Disorders|Stephan R. Weinland, Ph.D.|9198437828|stephan_weinland@med.unc.edu|
22385845|NCT01828099|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@Novartis.com|
22447349|NCT00088985|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@UNC.med.edu|
22447350|NCT00381095|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22447351|NCT02057406|Duke University Medical Center|Dr. Wei Jiang|919-668-0762|jiang001@mc.duke.edu|
22447352|NCT03562481|University of North Carolina at Chapel Hill|Jessica Lee, DDS, MPH, PhD|9195373955|jessica_lee@unc.edu|
22447353|NCT02056782|Cantex|CBertrand|954-315-3660|cbertrand@cantex.com|
22413113|NCT05067647|Ethicon Endo-Surgery, Inc.|MEDICAL DIRECTOR LCM Compliance|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22385846|NCT04162665|Washington University School of Medicine|Hyun Kim, M.D.|314-362-8502|kim.hyun@wustl.edu|
22413114|NCT04166032|Cleveland Clinic|Kimberly Jenkins, Research Administrator|216-445-4791|jenkink@ccf.org|
22385847|NCT05875467|dfusion Inc|Chief Executive Officer|8312225103|tamara.kuhn@dfusioninc.com|
22447354|NCT01401283|Hamburg Eppendorf University Hospital|Daniel A. Reuter, MD|+49-40-7410-0|dreuter@uke.de|
22447355|NCT02433483|St. Jude Children's Research Hospital|Jeffrey E. Rubnitz, MD, PhD|901-595-2388|jeffrey.rubnitz@stjude.org|
22447356|NCT02000973|First Hospital of China Medical University|Jun Wang|8602483283100|wjun2000@hotmail.com|
22447357|NCT00856284|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22447358|NCT01635101|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22413115|NCT02781727|Ascendis Pharma, Inc.|Aimee D Shu, MD|+1 650 352 8389|ADS@ascendispharma.com|
22447359|NCT02569723|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
22447360|NCT01327885|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22447361|NCT03975790|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22447362|NCT03232801|University of Pittsburgh|Holly Thomas|412-586-9836|thomashn@upmc.edu|
22413116|NCT00113425|University of Michigan Dept of Dermatology|Dr. Jeffrey Orringer|734-936-4075|jorringe@umich.edu|
22447363|NCT03824912|Encube Ethicals Pvt Ltd|Dr. Lalatendu Panigrahi, Chief Scientific Officer|+91-22-6264-7002|lalatendu.p@encubeethicals.com|
22385848|NCT06473662|Diabetology Ltd|Roger New|07818068012|rn@diabetology.co.uk|
22385849|NCT02398656|University of Calgary|Dr. Shelagh Coutts|4039444286|scoutts@ucalgary.ca|
22385850|NCT05602220|University of Southern California|Director of Clinical Trials|213-740-9543|nashiro@usc.edu|
22385851|NCT04471246|Ottawa Hospital Research Institute|Krishan Yadav|613-798-5555|kyadav@toh.ca|19489
22385852|NCT04826471|Relife Srl|Clinical Trials Coordinator|05556809528|lfabbri@relifecompany.it|
22385853|NCT05764525|Vivozon, Inc.|Chief Medical Officer|609 269 9140|adminus@vivozon.com|
22447364|NCT04271605|National Taiwan University BioMedical Park Hospital Chu-Tung Campus|Chirn-Bin Chang|0972654906|G03776@hch.gov.tw|
22447365|NCT02485301|GlaxoSmithKline|GSK Response Center|866-435-7343||
22447366|NCT01577329|University of Michigan|Roxane Raffin Chan|7344780170|roxchan@comcast.net|734
22447367|NCT03991715|University of North Carolina at Chapel Hill|Kelly Evenson, PhD|(919) 966-1967|kelly_evenson@unc.edu|
22447368|NCT01059825|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22447369|NCT01824901|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
22447370|NCT00844051|Children's Hospital Los Angeles|Pia Pannaraj, MD, MPH|323-361-2509|ppannaraj@chla.usc.edu|
22447371|NCT00106392|Astellas Pharma Global Development|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com|
22447372|NCT03342690|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22447373|NCT03138889|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
22447374|NCT02634684|UC San Diego|Neal Swerdlow, M.D., Ph.D.|619-543-6270|nswerdlow@health.ucsd.edu|
22447375|NCT03836612|St Thomas' Hospital, London|Dr Peter Irving|020 7188 7188|peter.irving@gstt.nhs.uk|
22447376|NCT02557698|Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergology Charité - Universitätsmedizin Berlin|Dr. Jan Kottner|+49 30 450 518218|jan.kottner@charite.de|
22447377|NCT00549302|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22447378|NCT01414114|Amgen, Inc|Study Director|866-572-6436||
22447379|NCT01737944|Antares Pharma|Jonathan Jaffe, MD; Vice President Clinical Development|1-609-359-3020|jjaffe@antarespharma.com|324
22447380|NCT00105482|Yale School of Medicine, Department of Psychiatry|Stephanie Samples O'Malley PhD, Director, Division of Substance Abuse Research|(203) 974-7590|stephanie.omalley@yale.edu|
22447381|NCT01781403|Asan Medical Center|Dr. Tae Won Kim|+82-2-3010-3910|twkimmd@amc.seoul.kr|
22447382|NCT00597545|Columbia University|Eric J Heyer|212-305-9072|ejh3@cumc.columbia.edu|
22447383|NCT02495168|Teva Pharmaceuticals Inc. USA|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
22447384|NCT00644995|Group Health Cooperative|Jennifer McClure, PhD|206-287-2737|mcclure.j@ghc.org|
22385854|NCT04079218|Albert Einstein College of Medicine|Dr. Kerry Murphy|718-839-7885|kerry.murphy@einsteinmed.edu|
22385855|NCT03743532|The University of Oklahoma Health Sciences|Dr. Darla E. Kendzor|(405) 271-7848|Darla-Kendzor@ouhsc.edu|
22413117|NCT03069937|Medical University of South Carolina|Principal Investigator|843-792-4271|gourdith@musc.edu|
22385856|NCT05705518|University of California Berkeley Clinical Research Center|Andrew D. Graham|510-643-9252|agraham@berkeley.edu|
22385857|NCT03910478|Fred Hutchinson Cancer Research Center|Michael Boeckh, MD|206-667-6706|mboeckh@fredhutch.org|
22413118|NCT00098371|The Ohio State University Comprehensive Cancer Center|John Byrd, MD|614-293-9869|John.Byrd@osumc.edu|
22413119|NCT00981305|SeoulNUH|Myung Jae Jeon|82-2-2072-1916|jeonmj@snu.ac.kr|
22385858|NCT05293171|BioLineRx Ltd|VP Clinical & Medical Affairs|+972-8-6429100|clinicaltrials@biolinerx.com|
22413120|NCT01569152|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinialTrialsDisclosure@merck.com|
22413121|NCT04190693|Imcyse SA|Jean Van Rampelbergh|+3243251100|j.vanrampelbergh@imcyse.com|
22385859|NCT04066205|University of Washington|Teresa Ward, Professor, Department of Pediatrics|206-884-1439|teresa.ward@seattlechildrens.org|
22385860|NCT02052882|Memorial Sloan Kettering Cancer Center|Dr. Cy Wilkins, MD|646-608-3720|wilkinsc@mskcc.org|
22385861|NCT05590728|DynPort Vaccine Company, a GDIT Company|George A. Saviolakis, MD, PhD|301-835-4101|George.Saviolakis@gdit.com|
22385862|NCT03734679|Surmodics|Thu Huyen Ha|952.500.7261|tha@surmodics.com|
22385863|NCT04036253|Biosidus S.A.U.|Director of Clinical Trials|+541149098044|v.berstein@biosidus.com.ar|
22385864|NCT04339101|City of Hope Medical Center|Dr. Ali Haris|626-359-8111|aharis@coh.org|
22413122|NCT01523899|University of California-Davis|Larissa May, MD|9167345000|lsmay@ucdavis.edu|
22385865|NCT06201559|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22385866|NCT05218096|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
22385867|NCT04901078|Kinoxis Therapeutics Pty Ltd|Director of Clinical Operations|+61434360596|tiina.ahveninen@kinoxistherapeutics.com|
22385868|NCT04386057|Dana-Farber Cancer Institute|Dr. Kimberly Perez, MD|617-632-5370|Kimberly_Perez@DFCI.HARVARD.EDU|
22385869|NCT04032847|Achilles Therapeutics UK Limited|Dr Matilde Saggese|0786 9814607|matildesaggese@gmail.com|
22385870|NCT03056573|Abbott|Angelic Roach, Clinical Program Director|+16517563379|angelic.roach@abbott.com|
22385871|NCT03697876|Laboratorios Sophia S.A. de C.V.|Alejandra Sanchez-Ríos|3330014500|alejandra.sanchez@sophia.com.mx|1190
22385872|NCT05321082|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
22385873|NCT07147257|Hopeshine-Minsheng Hospital of Xinzheng|Principal Investigator|(+86) 138-4905-6696|chenjinxi6688@126.com|
22385874|NCT04231149|Coloplast A/S|Medical Affairs Vice President|+45 4911 1111|clinical-studies@coloplast.com|
22385875|NCT03252847|MeiraGTx|Program Manager|+44 (0)20 3866 4320|ocularinfo@meiragtx.com|
22385876|NCT03532282|Stanford University|Rachel Manber, PhD|(650) 498-9111|rmanber@stanford.edu|
22385877|NCT04914676|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
22385878|NCT03235544|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22385879|NCT02433379|Boston Scientific|Paji Vitoff, Manager, Clinical Trials|651-582-5415|Paji.Vitoff@bsci.com|
22385880|NCT04200456|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22385881|NCT00592852|Massachusetts General Hospital|Gagan Joshi, MD|617-503-1084|joshi.gagan@mgh.harvard.edu|
22385882|NCT03725384|Sunnybrook Health Sciences Centre|Dr. Yulia Lin|4164804042|yulia.lin@sunnybrook.ca|
22385883|NCT02505984|Massachusetts General Hospital|Dr. Sharon Dekel|617-726-1352|sdekel@mgh.harvard.edu|
22385884|NCT03709121|Aldeyra Therapeutics, Inc.|VP, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
22385885|NCT04176601|University of Rochester|Dr. Kim Van Orden|585-275-5176|kimberly_vanorden@urmc.rochester.edu|
22385886|NCT02317887|VegaVect, Inc.|Dr. Rob Lin|412-560-9760|r.lin@avistatx.com|
22385887|NCT04299464|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22385888|NCT04019977|University of Maryland School of Social Work|Dr. Lisa Berlin|410 706 6392|lberlin@ssw.umaryland.edu|
22385889|NCT03617679|University of Colorado Denver|Bradley Robert Corr, MD|303-724-2066|bradley.corr@cuanschutz.edu|
22385890|NCT05299242|University of Oxford|Prof. Sally Hopewell|+441865223458|sally.hopewell@csm.ox.ac.uk|
22385891|NCT05907174|University of Maryland, College Park|Dr. Jessica Magidson|301-405-5095|jmagidso@umd.edu|
22385892|NCT04777721|University of Oxford|Professor Helen McShane|01865 617606|helen.mcshane@ndm.ox.ac.uk|
22385893|NCT03916276|The University of Queensland|Dr. Melissa Day, Co-Principal Investigator|+61 7 3365 6421|m.day@uq.edu.au|
22385894|NCT03953417|Stanford University|Principal Investigator|650-736-2233|nbassano@stanford.edu|
22385895|NCT03209973|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22385896|NCT02641639|Mateon Therapeutics Inc|CEO|(650) 635-7000|ir@oncotelic.com|
22385897|NCT06415292|Sun Pharmaceutical Industries Limited|Head-Regulatory Affairs|2266455645|Clinical.Trial@sunpharma.com|5689
22385898|NCT04383496|Minneapolis VA Health Care System|Wei Duan-Porter|6124675845|wei.duanporter@va.gov|
22385899|NCT04800211|Altria|Jeffery Edmiston, Functional Director Clinical Research|8043352366|Jeffery.S.Edmiston@altria.com|
22385900|NCT05170841|A Menarini Industrie Farmaceutiche Riunite SrL|Corporate Medical Affair and Clinical Operation Director|+39 055 5680459|pfabrizzi@menarini.it|
22385901|NCT05233800|MedStar Health Research Institute|Hannah Arem, Scientific Director, Implementation Science|2028932430|hannah.arem@medstar.net|
22385902|NCT05123586|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22385903|NCT03643744|Wright State University|Dr. Jeffrey Travers|(937)-245-7500|Jeffrey.Travers@Wright.edu|
22385904|NCT04487860|Aché Laboratórios Farmacêuticos S.A|Dr. Fabio Ikedo|55 11 26086933|fabio.ikedo@ache.com.br|
22385905|NCT02432261|Health Decisions|Kimberly Myer|9842381297|Kimberly.Myer@premier-research.com|
22385906|NCT00915759|Warfighter Refractive Eye Surgery Program and Research Center at FT Belvoir|Principal Investigator|571-231-1600|dha.belvoir.fbch.mbx.wresp-research@health.mil|
22385907|NCT06085547|Michigan State University|Dr. Todd Lucas|810-600-5629|lucastod@msu.edu|
22385908|NCT05546385|Rehaler A/S|Troels Johansen|004540977313|tj@rehaler.com|
22385909|NCT06122194|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22385910|NCT05841004|Coloplast A/S|Christian Riis Forman, Medical writer|49111756|dkcrif@coloplast.com|
22385911|NCT05193409|Bionomics Limited|SVP Clinical Development|+61 8 8150 7400|BNC210clinicalstudies@bionomics.com.au|
22385912|NCT04726371|The Mongan Institute at Massachusetts General Hospital|Dr. Stephen Bartels|617-726-5213|sjbartels@mgh.harvard.edu|
22385913|NCT03088878|Oncternal Therapeutics|Mary Breitmeyer|760-703-2802|mbreitmeyer@oncternal.com|
22413123|NCT00683293|Kantonsspital Aarau|Dimtri SARLOS|00418384141|la.kots@ksa.ch|
22385914|NCT04506866|Medtronic|Mylène Champs|612-433-0600|mylene.champs@medtronic.com|
22385915|NCT04690582|The Ohio State University College of Medicine|Dr. Craig Bryan, PsyD, ABPP|614-814-8612|craig.bryan@osumc.edu|
22385916|NCT03125070|Fred Hutchinson Cancer Center|Dr. K. Scott Baker|206-667-5594|ksbaker@fredhutch.org|
22447385|NCT00865124|Brigham and Women's Hospital|Gail K. Adler|617-732-5661|gadler@partners.org|
22385917|NCT05104463|CuraSen Therapeutics, Inc|Clinical Trial Information Desk|+1 650 475 2842|clinicaltrials@curasen.com|
22385918|NCT05267470|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22447386|NCT02743520|University of Miami, Miller School of Medicine|Alberto Ramos, MD, MSPH, FAASM|305-243-8393|a.ramos1@med.miami.edu|
22385919|NCT04428203|University of Kentucky|Dr. Zin Myint|8593233964|zin.myint@uky.edu|
22385920|NCT02823145|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22385921|NCT04622046|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22385922|NCT03626766|Columbia University|Dr. Anthony Lin|(917) 628-6522|akl17@cumc.columbia.edu|
22385923|NCT04171141|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22385924|NCT03314454|Northeastern University|Dr. Robert Leeman|6173736501|r.leeman@northeastern.edu|
22385925|NCT04119843|Ascelia Pharma AB|Andreas Norlin|+46 735179119|an@ascelia.com|
22447387|NCT03247530|Supernus|Joseph Hull, PhD, Associate Director Clinical Research|240-403-5324|jhull@supernus.com|
22385926|NCT04418232|University of Kansas Medical Center|Jaime Perales Puchalt|913-588-3716|jperales@kumc.edu|
22385927|NCT01037881|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
22385928|NCT02841579|Catalan Institute of Oncology, Institut d'Investigació en Ciències, de la Salut Germans Trias i Pujol|Dr. Rafael Rosell|+34 935 543 050|rrosell@iconcologia.net|
22385929|NCT04563546|Duke University|Julian T. Hertz, MD|919-681-0196|julian.hertz@duke.edu|
22447388|NCT03042533|harborview medical center|julie agel|206.744.4113|bagel@uw.edu|
22447389|NCT01587001|National Jewish Health|Nabeel Hamzeh|303-270-2613|hamzehn@njhealth.org|
22385930|NCT04233216|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22385931|NCT03652389|NYU Langone Health|Antoinette M. Schoenthaler|646-501-3434|Antoinette.Schoenthaler@nyulangone.org|
22385932|NCT02895464|Karolinska Institutet|Dr Elisabeth Rydwik|+46852488818|elisabeth.rydwik@ki.se|
22385933|NCT04979442|Rain Oncology|Clinical Research|7082323791|clinicalresearch@rainoncology.com|
22385934|NCT04005794|Vanderbilt University|Dr. Sohee Park, Professor of Psychology and the principal investigator|615 322 3435|sohee.park@vanderbilt.edu|
22447390|NCT04786990|Supernus Pharmaceuticals|Joseph T. Hull, PhD|240-403-5324|jhull@supernus.com|
22385935|NCT03287336|GW University|Homa K. Ahmadzia|2027412500|homa.khorrami@gmail.com|
22447391|NCT02233647|University of Kentucky|William W. Stoops, Ph.D.|859-257-5388|william.stoops@uky.edu|
22385936|NCT02116530|Indiana University School of Medicine South Bend|Rudolph M. Navari, MD, PhD, FACP|574-252-7225|rmnavari@gmail.com|
22447392|NCT02812160|Spatz FGIA Inc.|Jeffrey Brooks MD|1-516-303-0613|jeff@spatzmedical.net|
22447393|NCT03305653|Children's Hospital Colorado|Dr. Calies Menard-Katcher|720-777-2318|calies.menard-katcher@childrenscolorado.org|
22447394|NCT03779724|Aksaray University Training and Research Hospital|The principal investigator|905555289493|mlk.aykut@gmail.com|
22447395|NCT00439244|Novartis Pharmaceuticals|Study Director|862-778-8300||
22447396|NCT02846779|Brigham and Women's Hospital|Niteesh K. Choudhry, MD, PhD|617-278-0930|nkchoudhry@bwh.harvard.edu|
22447397|NCT03159624|University of Alabama at Birmingham|Dr. Brad Woodworth|205-801-7858|bwoodworth@uabmc.edu|
22447398|NCT01154764|Asan Medical Center|Hyeong-Seok Lim MD, Ph.D|+82 2 3010 4613|mdihs@amc.seoul.kr|
22385937|NCT03766685|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22385938|NCT04676165|McGill University|Bettina Habib, Research Project Manager|514-396-1156|bettina.habib@mcgill.ca|
22385939|NCT05593900|University of California Davis|Jennifer Rosenthal|9167344719|rosenthal@ucdavis.edu|
22385940|NCT02844465|MedtronicNeuro|Clinical Study Manager|(877) 590-7835|rs.slatestudy@medtronic.com|
22385941|NCT05029622|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22385942|NCT05671653|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22385943|NCT03812549|West China Hospital, Sichuan University|Prof. You Lu|13398179653|radyoulu@hotmail.com|
22385944|NCT01197378|Horizon Pharma USA, Inc.|Evelyn Olson|224-383-3000|clinicaltrials@horizonpharma.com|
22385945|NCT06232590|CooperVision Inc.|José A. Vega|+1 (925) 621-3761|JVega2@coopervision.com|
22385946|NCT02460458|Hematology and Transfusion Medicine, L. Sacco University Hospital, University of Milan, Via G. B. Grassi, 74 20157 Milan, Italy|Prof. Augusto B. Federici|+39-0250319895|augusto.federici@unimi.it|
22385947|NCT03162783|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
22385948|NCT03710603|Stichting European Myeloma Network (EMN)|Sarah Lonergan|+31 10 268 70 65|sarah.lonergan@emn.life|
22385949|NCT00248807|James J Peters VAMC|Dr. Jill M. Wecht; Principal Investigator|718 584-9000|JM.Wecht@va.gov|3122
22385950|NCT04197310|Dana Farber Cancer Institute|Dr. Kimberly Perez|617-632-5960|Kimberly_Perez@DFCI.HARVARD.EDU|
22385951|NCT02589795|Imperial College London|Research Integrity Officer|020 7594 1872|rgit@imperial.ac.uk|
22385952|NCT02322203|National Heart Lung and Blood Institute (NHLBI)|Marcelo J. Amar, M.D. Principal Investigator, NIH, NHLBI|301.402.0521|mamar@nhlbi.nih.gov|
22385953|NCT03691935|Milton S. Hershey Medical Center|Urology Research Operations Manager|717-531-0003|UrologyResearch@pennstatehealth.psu.edu|287502
22447399|NCT05353985|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22447400|NCT00524368|Tibotec Pharmaceuticals, Ireland|Medical Leader|+32 015 461 497||
22447401|NCT00998660|Medtronic, Inc.|Todd Weaver, PhD|763-526-8130|todd.weaver@medtronic.com|
22447402|NCT00040937|SWOG|Robert Z. Orlowski, MD,PhD|(713) 792-2860|rorlowsk@mdanderson.org|
22385954|NCT03511664|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22385955|NCT01946789|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22385956|NCT04076618|Wake Forest University School of Medicine|Kristen Beavers, PhD, MPH, RD|336-758-5855|kbeavers@wakehealth.edu|
22447403|NCT01438424|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22447404|NCT00345345|National Heart Lung and Blood Institute|Stefan F Cordes, Principal Investigator, M.D., Ph.D.|+1 240 383 6460|stefan.cordes@nih.gov|
22385957|NCT01928394|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22447405|NCT01113983|Edwards Lifesciences|Shin Sakai, PhD||shin_sakai@edwards.com|
22385958|NCT01868997|Horizon Pharma USA, Inc.|Julie Ball, Executive Director||clinicaltrials@horizonpharma.com|
22385959|NCT04533737|LEO Pharma A/S|Clinical Disclosure|+45 44 94 58 88|disclosure@leo-pharma.com|
22385960|NCT05093842|West Virginia University|Bethany Barone Gibbs|304-581-1779|behany.gibbs@hsc.wvu.edu|
22385961|NCT04089137|Georgia State University|Dr. Amanda Gilmore|(404) 413-2000|agilmore12@gsu.edu|
22385962|NCT04032041|University of Iowa|Jason M Wilken, PT, PhD|319-335-9791|jason-wilken@uiowa.edu|
22385963|NCT01275677|NRG Oncology|Director, Department of Regulatory Affairs|412-339-5300|langerj@nrgoncology.org|
22385964|NCT05012683|Point Designs|Director of Clinical Research|7206004753|research@pointdesignsllc.com|
22385965|NCT00207636|DFCI, Harvard|Jennifer Allen|617-632-2269||
22385966|NCT03478956|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22385967|NCT04730739|Zimmer Biomet|Octavia Gladden, Clinical Research Speaclist|704.493.0178|octavia.gladden@zimmerbiomet.com|
22385968|NCT03806790|LEO Pharma A/S|Clinical disclosure|+4544945888|disclosure@leo-pharma.com|
22385969|NCT02733159|Cancer Research UK Clincial Trials Unit, University of Birmingham|PePS2 Trial Coordinator|0121 414 8040|peps2@trials.bham.ac.uk|
22447406|NCT02373202|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22447407|NCT00410046|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22447408|NCT03010254|Alcon Research|CDMA Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22447409|NCT02715076|Department of outcomes research Cleveland Ohio|Dr. Daniel I. Sessler||ds@or.org|
22447410|NCT02927080|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22447411|NCT01404325|Novartis Pharmaceuticals|Study Director|8627788300||
22447412|NCT02389088|University of California, San Diego|Dr. R. Jeffrey Chang|858-534-8930|rjchang@ucsd.edu|
22447413|NCT01075204|Abbott|Esther Oppermann, Clinical Trial Manager|49 511 6750 3954|esther.oppermann@abbott.com|
22447414|NCT01411228|Target Health Inc.|Glen Park|212-681-2100|gpark@targethealth.com|
22447415|NCT00945139|University of Vermont CC|Dr. Claire Verschraegen|802-656-5487|claire.verschraegen@vtmednet.org|
22447416|NCT00664742|Novartis Pharmaceuticals|Study Director|862-778-8300||
22447417|NCT02310568|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22447418|NCT01206608|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
22447419|NCT02893514|NYU Langone Health|Jennifer McNeely, MD, MS|(646) 501-3551|Jennifer.McNeely@nyulangone.org|
22447420|NCT02989194|Visterra|Chief Medical Officer|617-498-1070|clinicaltrials@visterrainc.com|
22447421|NCT02670083|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22447422|NCT02825992|Acutus Medical, Inc.|Steve McQuillan, Sr. Vice President Regulatory, Clinical, & Quality Assurance|763-331-4344|steven.mcquillan@acutus.com|
22447423|NCT00711711|HECVSanté|Pr. Claude Pichonnaz|++41213168126|claude.pichonnaz@hesav.ch|
22447424|NCT04160091|Flexion Therapeutics, Inc.|David Golod, Vice President, Clinical Operations|(781) 305-7572|dgolod@flexiontherapeutics.com|
22447425|NCT00609492|GlaxoSmithKline|GSK Response Center|866-435-7343||
22447426|NCT01224431|Phoenix Children's Hospital|Angelique Ferayorni|602-546-1910|aferayorni@phoenixchildrens.com|
22447427|NCT04492618|Mayo Clinic|Aaron R. Mangold, M.D.|480-301-4256|Mangold.Aaron@mayo.edu|
22447428|NCT05620563|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22447429|NCT00779467|Wake Forest School of Medicine|Peter H. Pan, MD, MSEE|336-718-8278|ppan@wakehealth.edu|
22447430|NCT01427504|University of Colorado|Dr. Jennifer Kiser|303-724-6131|jennifer.kiser@ucdenver.edu|
22447431|NCT00460408|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22447432|NCT02573350|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22447433|NCT04648631|University of Miami|Hadar Lev-Tov, MD|305-689-2646|hlevtov@med.miami.edu|
22447434|NCT01573572|Bausch Health|Study Manager|908-242-8287|sandra.narain@bauschhealth.com|
22447435|NCT02461563|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22447436|NCT01111149|University of Minnesota|Dr. S. Hossein Fatemi|612-626-3633|fatem002@umn.edu|
22385970|NCT00291525|Artivion|Clinical Project Manager (Yael Goode)|8454800137|Yael.Goode@Artivion.com|
22385971|NCT05646355|NYU Langone Health|Aasma Shaukat|6465012906|Aasma.Shaukat@nyulangone.org|
22385972|NCT03362476|New York University|Ralph J DiClemente|+1 (212) 992-3709|rjd438@nyu.edu|
22385973|NCT05216406|Nova Southeastern University|Dr. Jose Antonio|(954) 262-8140|Jose.Antonio@nova.edu|
22385974|NCT03617445|University of Wisconsin-Madison|Dr. Nasia Safdar|608-263-1545|ns2@medicine.wisc.edu|
22385975|NCT04270942|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
22385976|NCT04059185|Boston College School of Social Work|Catherine Taylor, PhD, LCSW, MPH|(617) 552-4033|catherine.taylor.2@bc.edu|
22385977|NCT04707326|ErasmusMC|Dr. Casper Rokx|+310107040704|c.rokx@erasmusmc.nl|
22385978|NCT02329262|The Ohio State University Martha S. Pitzer Center for Women, Children and Youth|Principal Investigator|16142924578|smith.5764@osu.edu|
22385979|NCT01009788|Massachusetts General Hospital|Steven Isakoff, MD, PhD|617-835-2285|SISAKOFF@mgh.harvard.edu|
22385980|NCT06180980|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22385981|NCT04741776|Dartmouth-Hitchcock Clinic|Fallon Cluxton-Keller, Ph.D.|603-650-4724|Fallon.P.Cluxton-Keller@dartmouth.edu|
22447437|NCT02221947|Neurotrope BioScience, Inc|Vice President, Regulatory Affairs|973-826-5109|dcrockford@neurotropebioscience.com|
22413124|NCT02126306|HMO|Dr Gadi Lalazar|97226777337|lalazar@hadassah.org.il|
22447438|NCT00006903|NRG Oncology, Statistics and Data Management Center, Buffalo Office|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
22447439|NCT02794883|Northwestern University, Feinberg School of Medicine|Karan Dixit, MD|312-503-4724|karan.dixit@northwestern.edu|
22385982|NCT04622774|ImmunoGen, Inc|CMO, ImmunoGen|781-895-0600|clinicaltrials@immunogen.com|
22447440|NCT00811798|GlaxoSmithKline|GSK Response Center|866-435-7343||
22385983|NCT00957047|Bial - Portela & Cª, S.A.|Head of Clinical Research Section|+ 351 22 986 61 00|clinical.trials@bial.com|
22385984|NCT02852655|Dana-Farber Cancer Institute|Jose R. McFaline Figueroa, MD, PhD|617-632-2166|jose_mcfalinefigueroa@dfci.harvard.edu|
22447441|NCT01906008|UT MD Anderson Cancer Center|Dr. James Yao, MD, Director of GI Medical Oncology|(713) 792-2828|jyao@mdanderson.org|
22385985|NCT05809453|University of Texas at Southwestern|Dr. Craig Crandall|214-345-4623|craigcrandall@texashealth.org|
22447442|NCT01574326|Genzyme Corporation|Trial Transparency Team||Contact-US@sanofi.com|
22447443|NCT00137046|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22447444|NCT00589563|City of Hope Medical Center|Dr. Ryotaro Nakamura|626-256-4673|rnakamura@coh.org|65285
22385986|NCT00462696|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
22385987|NCT03257410|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
22447445|NCT04216017|University of Washington|Dr. Jonah Hebert-Davies|2067443466|jdavies2@uw.edu|
22447446|NCT03223246|Massachusetts General Hospital|Dr. Margaret Samuels-Kalow|6177262000|msamuels-kalow@mgh.harvard.edu|
22385988|NCT03011333|Heron Therapeutics, Inc.|Vice President, Clinical Operations|858-251-7232|svisonneau@herontx.com|
22385989|NCT03663569|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22385990|NCT04183283|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22385991|NCT01002235|Helixmith Co., Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
22385992|NCT04506307|Zeltiq Aesthetics|Sally Hallas, RN, Director Clinical Development - Body Contouring|209-294-5571|sally.hallas@abbvie.com|
22385993|NCT00104676|Unicancer|Deputy Director R&D|(+33)1 44 23 04 19|b-juzyna@unicancer.fr|
22385994|NCT05622812|Q-Med AB|Head of Development|1-817-961-5000|reception.seupp@galderma.com|
22385995|NCT03916185|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
22385996|NCT06214559|Eurofins Dermscan Pharmascan|Project Manager|+33 (0)4 72 82 36 56|manon.laune@cpt.eurofinseu.com|
22385997|NCT05297565|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
22385998|NCT03711734|Hospital for Special Surgery|Dr. Stephanie Cheng|212-606-1206|chengs@hss.edu|1206
22385999|NCT04228042|M D Anderson Cancer Center|Mehrad Adibi, MD|713-563-7458|mllozano@mdanderson.org|
22386000|NCT03828799|Institut régional du Cancer de Montpellier|Representative of sponsor|467612446|aurore.moussion@icm.unicancer.fr|+33
22386001|NCT05196919|Xalud Therapeutics, Inc.|Director of Medical Inquiries|212-301-6673|medical.information@xaludthera.com|
22386002|NCT05299723|Columbia University Irving Medical Center|Ari Shechter|212-342-1335|as4874@cumc.columbia.edu|
22386003|NCT01959607|Philip Morris Products S.A.|Christelle Haziza|+41 58 242 11 11|clinicaltrials.pmi@pmi.com|
22386004|NCT03913442|NYU Langone Health|Michael H Pillinger, MD, FACP|646-501-2722|Michael.Pillinger@nyulangone.org|
22386005|NCT00696111|University of Chicago|Karla Temple, Clinical Research Manager|773-702-3334|katemple@uchicago.edu|
22386006|NCT03744182|Hanmi Pharmaceutical Co., Ltd.|GAEUN PARK|+824108746|gaeun.park@hanmi.co.kr|8746
22386007|NCT03687086|University of California, Los Angeles and VA Greater Los Angeles Healthcare System|Dr. Constance Fung|818 891-7711|Constance.Fung@va.gov|39311
22386008|NCT03859635|Indiana University Department of Anesthesiology|Yar Luan Yeap, MD|3172740275|yyeap@iu.edu|
22386009|NCT04362254|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
22386010|NCT04707625|Wake Forest University Health Sciences|Mark Nelson, MD|336.713.1680|mhnelson@wakehealth.edu|
22386011|NCT00321048|Indiana University|Richard Zellars|3179444505|rzellars@iu.edu|
22386012|NCT01627574|University of Rhode Island|Dr. Lynda Stein, Ph.D.|401-874-2830|lmurphy@uri.edu|
22386013|NCT03528928|Womens Health|Teresa Brousseau|866-432-4400|tbrousseau@isapin.com|
22386014|NCT05089877|AtriCure|Nfii Ndikintum, VP of Clinical Affairs and Biometerics|5136448192|NNdikintum@atricure.com|
22386015|NCT04314778|University of Pennsylvania|S. Ryan Greysen, MD (Principal Investigator)|215-614-0095|Ryan.Greysen@pennmedicine.upenn.edu|
22386016|NCT02240238|NANO MRNA Co.,Ltd.|NANO MRNA Clinical Info Admin|+81 (0)3-6432-4792|clinical.info@nanomrna.co.jp|
22386017|NCT02657005|Oncternal Therapeutics|Mary Breitmeyer|858-434-1113|clinical@oncternal.com|
22386018|NCT05863156|Uskudar Univercity|Tugba YILMAZ ESENCAN|05057084946|tugba.yilmazesencan@uskudar.edu.tr|
22386019|NCT01346540|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22386020|NCT06357169|University of Minnesota|Ronda Farah|(612) 625-8625|rfarah@umn.edu|
22386021|NCT06081309|Wave Neuroscience, Inc.|Bill Phillips|714-883-7890|bill@waveneuro.com|
22386022|NCT05679908|Tonix Pharmaceuticals|Gregory Sullivan|(862) 904-0355|greg.sullivan@tonixpharma.com|
22386023|NCT03625115|Children's Hospital of Philadelphia|Dr. James Guevara|2155901130|guevara@chop.edu|
22386024|NCT04797195|Massachusetts General Hospital Center for Global Health|Katharine Morley, MD|617-726-2000|kemorley@mgh.harvard.edu|
22386025|NCT05868382|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
22386026|NCT03655028|Edward Hines Jr., VA Hospital|Eileen Collins|312-3550118|ecollins@uic.edu|
22386027|NCT03513302|Indiana University Indianapolis|Dr. Andrew Coggan|3172740656|acoggan@iu.edu|
22386028|NCT01236781|American College of Radiology|Director Clinical Research Administration|215-574-3150|info@acr.org|
22447447|NCT01369758|Hologic, Inc|Christina Mastandrea|508-263-8772|Christina.Mastandrea@Hologic.com|
22386029|NCT04577963|HUTCHMED International, Inc.|William Schelman, MD, PhD, Senior Vice President, Clinical Development, US/Europe|+1 9733064490|williams@hutch-med.com|
22447448|NCT02268084|Wave Neuroscience|Meagan Kovacs, Clinical and Regulatory Affairs Manager|9492292869|meagan@waveneuro.com|
22386030|NCT05256654|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22386031|NCT02112526|Acerta Pharma LLC|Study Director|1-888-292-9613|acertamc@dlss.com|
22386032|NCT00866684|Charité Universitätsmedizin Berlin Augustenburger Platz 1 13353 Berlin|Prof. Dr. Petra Reinke|+49 30 450 653 490|petra.reinke@charite.de|
22386033|NCT02709161|University of Pittsburgh|Kymberly Young|4126486179|youngk@pitt.edu|
22386034|NCT03808961|VAORD|Chandramohan Wakade|7067211106|cwakade@augusta.edu|
22386035|NCT05121441|Aardvark Therapeutics, Inc.|Manasi Jaiman MD, MPH, Chief Medical Officer|(858) 225-7696|MJaiman@aardvarktherapeutics.com|
22399800|NCT00893516|Emergent Biosolutions|Clinical Development Representative||ctgov@ebsi.com|
22447449|NCT05227027|University of California, San Francisco|Dr. Justin White, Associate Professor|415-476-8045|justin.white@ucsf.edu|
22447450|NCT03552198|KCL|Dr D D'Antoni|NA|donatella.d'antoni@kcl.ac.uk|
22447451|NCT06149247|Soligenix, Inc.|Richard Straube, MD/Chief Medical Officer|609-538-8200|rstraube@soligenix.com|
22447452|NCT03735433|The Ohio State University|Kara Rood, MD|614-293-8515|Kara.Rood@osumc.edu|
22447453|NCT01767155|Aeterna Zentaris|Dr. Nicola Ammer|+496942602|nammer@aezsinc.com|3472
22447454|NCT00371137|Jazz Pharmaceuticals, Inc.|Grace Wang, MD, Medical Monitor & Director of Clinical Development|650-496-3777||
22447455|NCT03725098|Biom'up|William Spotnitz, MD, MBA|351-514-5009|w.spotnitz@biomup.com|
22447456|NCT01756898|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22447457|NCT01500694|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22447458|NCT02837783|Ironwood Pharmaceuticals, Inc.|Lara Lane|(617) 621-7722|llane@ironwoodpharma.com|
22447459|NCT04774328|Concentric Analgesics|Carrie Khouri, Associate Director of Clinical Operations|1-415-484-7921|ckhouri@concentricanalgesics.com|
22447460|NCT01900704|Serenity Pharmaceuticals|Chief Medical Officer|8456396760|sfein@serenitypharma.com|17
22447461|NCT02465216|IDRI|Dr. Corey Casper|2063810883|corey.casper@idri.org|
22447462|NCT04748120|Cleveland Clinic Foundation|Dr. Clayton Petro|216-444-3501|petroc@ccf.org|
22447463|NCT01112241|Azienda Ospedaliera Universitaria San Martino, Genova, Italy|Dr. Giovanni Barisione, MD|+39 010 5553367|giovanni.barisione@hsanmartino.it|
22447464|NCT02154490|SWOG Statistics & Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
22447465|NCT00936585|National Institute of Allergy and Infectious Diseases|Michael Yao, MD|301-594-0593|yaomic@niaid.nih.gov|
22447466|NCT01442493|Friends Research Institute|Robert Schwartz, M.D.|410-837-3977|rschwartz@friendsresearch.org|276
22447467|NCT00938639|Seqirus|Clinical Trial Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
22447468|NCT02309489|King's College London, UK|Dr Marina Daniele|020 7836 5454|marina.daniele@kcl.ac.uk|
22447469|NCT02547649|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22447470|NCT01354951|Memorial Sloan Kettering Cancer Center|Dr. Michael Zelefsky, MD|212-639-6802|zelefskm@mskcc.org|
22447471|NCT04326231|Cognoa|Senior Director of Clinical Research|4082076659|minda.seal@cognoa.com|
22447472|NCT03303079|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22447473|NCT03454997|Johns Hopkins University School of Medicine|Gail Daumit MD, MHS|410-614-6460|gdaumit@jhmi.edu|
22447474|NCT05259696|Palleon Pharmaceuticals|Palleon Clinical Development|857-285-5900|clinical@palleonpharma.com|
22447475|NCT03857243|UTSW|Timea Hodics, M.D.|(240)-423-2741|Timea.Hodics@UTSouthwestern.edu|
22447476|NCT01909674|Weill Cornell Medical College|Dr. Matthew Ebben|6469629318|mae2001@med.cornell.edu|
22447477|NCT00484874|Dana-Farber Cancer Institute|Heather Jacene, MD|617-632-3767|hjacene@partners.org|
22447478|NCT00586001|Boston University Charles River Campus|Todd Farchione|(617) 353-9610|tfarchio@bu.edu|
22447479|NCT01678911|Rehabilitation Institute of Chicago|Director of the Center for Pain Studies|312.238.5654|centerforpainstudies@ric.org|
22447480|NCT02706691|University of Chicago Comprehensive Cancer Center|Technical Director|773-702-0819|pccc_regulatory@bsd.uchicago.edu|
22447481|NCT05374434|Lumendo|Mark Bispinghoff|+41 44 589 68 02|mark.bispinghoff@lumendo.ch|
22447482|NCT02602496|University of Nebraska Lincoln|Dr. Devin Rose|402-472-2802|drose3@unl.edu|
22447483|NCT01830972|Ultragenyx Pharmaceutical Inc|Kim Mooney, Associate Director, Patient Advocacy Medical Services|408-981-3526|kmooney@ultragenyx.com|
22447484|NCT02117648|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22447485|NCT01815515|Johns Hopkins University|Steven Rowe, M.D, Ph.D|4105021520|srowe8@jhmi.edu|
22447486|NCT00171730|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22447487|NCT05025241|Neuren Pharmaceuticals|Chief Medical Officer|+61 (3) 9092 0480|MedicalInformation@neurenpharma.com|
22447488|NCT02670837|University of Minnesota, Masonic Cancer Center|Dr. Christen Ebens|(612) 626-5654|ebens012@umn.edu|
22447489|NCT01829191|Vistakon, USA|XU CHENG, PRINCIPAL CLINICAL SCIENTIST|1 904 443-1245|xcheng6@its.jnj.com|
22447490|NCT02220205|Beth Israel Deaconess Medical Center|Siripanth Nippita|617-667-4165|snippita@bidmc.harvard.edu|
22447491|NCT03546192|Sanofi Pasteur Inc.|Medical Director|800-633-1610 ext 1#|RegistryContactUs@sanofipasteur.com|
22447492|NCT01276353|Clinical Development. JAC PCU. Eisai Co., Ltd.|Naoki Kubota|+81-3-3817-5245||
22447493|NCT01200602|Mayo Clinic|Vilmarie Rodriguez, MD|507-284-2695|rodriguez.vilmarie@mayo.edu|
22447494|NCT02266225|University of Waterloo|Dr. Lora Giangregorio|519-888-4567|lora.giangregorio@uwaterloo.ca|36357
22447495|NCT00553514|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22447496|NCT02648178|The Koop Institute at Dartmouth, Geisel School of Medicine|Dr James Sargent|603-653-9025|James.D.Sargent@dartmouth.edu|
22447497|NCT03856164|University of Texas Southwestern|Dr. Olutoyosi Ogunkua|2145578873|olutoyosi.ogunkua@utsouthwestern.edu|
22386036|NCT04862416|Radboud university medical center|Dr. Matthew McCall|+31 24 361 43 56|Matthew.McCall@radboudumc.nl|
22386037|NCT04028284|Sunnybrook Health Sciences Centre|Dr. Fahad Alam|416-480-4864|fahad.alam@sunnybrook.ca|
22413125|NCT00743197|Northwestern University|Dr. Martha Gulati, Principal Investigator|312-695-4965|mgulati@nmh.org|
22413126|NCT00672854|Emory University|Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
22413127|NCT02380183|Montefiore Medical Center|Dr. Amaresh Vydynathan|718-920-4316|avydynathan@montefiore.org|
22447498|NCT00660309|Novartis Pharmaceuticals|Study Director|862-778-8300||
22447499|NCT03782272|PATH|Gwen Ambler, Clinical Research Officer|+1-206-285-3500|gambler@path.org|
22447500|NCT05860647|HealthPartners Institute Neuroscience Research Center|Bhavani Kashyap, MBBS, PhD|651-495-6565|bhavani.x.kashyap@healthpartners.com|
22447501|NCT02532972|Massachusetts Eye & Ear Infirmary|Dr. Daniel Lee|6175736981|Daniel_Lee@meei.harvard.edu|
22447502|NCT01018186|GlaxoSmithKline|GSK Response Center|866-435-7343||
22447503|NCT02603419|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22447504|NCT02925494|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22447505|NCT02845453|Boston Medical Center|Amy Yule, MD|617-414-1936|amy.yule@bmc.org|
22447506|NCT02911753|University of Arizona|David O. Garcia, PhD, FACSM|520-626-4641|davidogarcia@email.arizona.edu|
22447507|NCT01666782|Rochester General Hospital|Saad Jamshed, MD|585-922-4020|Saad.Jamshed@rochesterregional.org|
22447508|NCT00923247|National Cancer Institute|Dr. Ravi Madan|301-480-7168|madanr@mail.nih.gov|
22447509|NCT02007109|Baylor College of Medicine|Dr. Mary Felberg|832-824-5800|mafelber@texaschildrens.org|
22447510|NCT01858389|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021||
22447511|NCT03572062|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22447512|NCT01691781|Brigham and Women's Hospital|Anand Vaidya|6175258285|avaidya1@partners.org|
22447513|NCT03978520|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22447514|NCT02760069|Brooke Army Medical Center|Dr. Michael D. April|210-916-0808|Michael.D.April.mil@mail.mil|
22447515|NCT01550302|University of Washington|Srdjan Jelacic|(206) 598-3777|sjelacic@uw.edu|
22447516|NCT00600483|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
22447517|NCT02343627|Taro Pharmaceuticals U.S.A. Inc|Senior Director, Clinical|+1 914-345-900|Natalie.Yantovskiy@Taro.com|
22447518|NCT00705653|Progen Industries|Michael Fitzgerald|919-803-9988|michaelf@progen-pharma.com|
22447519|NCT01684007|Alcon Research, Ltd.|Magda Michna, Expert Clinical Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22447520|NCT03031678|MED-EL Corporation|Allison Racey|1-888-633-3524|research.us@medel.com|
22447521|NCT03694821|UConn Health|Director of Outcomes, Research & Quality|860-679-4932|mcote@uchc.edu|
22447522|NCT02421315|New York State Psychiatric Institute|Dr. Rachel Marsh|646-774-5774|rachel.marsh@nyspi.columbia.edu|
22447523|NCT01317030|Bausch & Lomb Incorporated|Robert Steffen, O.D., M.S.|585-338-6399|Robert.Steffen@bausch.com|
22447524|NCT05109442|Affimed GmbH|Clinical Operations|+49 621 56003-0|trials@affimed.com|
22447525|NCT03898362|VA Pittsburgh Healthcare System|Dr. Brad Dicianno|412-822-3700|brad.dicianno@va.gov|
22447526|NCT05542576|Amydis, Inc.|Matthew Lehman|6463317899|matt.lehman@amydis.com|
22447527|NCT03278613|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
22447528|NCT01405456|Massachusetts General Hospital|Dr. Steven K. Grinspoon|6177249109|sgrinspoon@mgh.harvard.edu|
22447529|NCT02299297|Columbia University Department of Dermatology Clinical Research Unit|Grace Ulerio, CCRC|212-305-6593|gu2102@cumc.columbia.edu|
22447530|NCT05475236|Veterans Health Administration|Dr. Clayton Swanson|3523761611|clayton.swanson@va.gov|107583
22447531|NCT02044393|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22447532|NCT05355805|Acelyrin|Donald Betah|(805) 419-3805|Donald.Betah@acelyrin.com|
22447533|NCT03631472|Gala Therapeutics|James Stambaugh SVP of Clinical Affairs|4087186834|jstambaugh@galatherapeutics.com|
22447534|NCT01129609|Medtronic|Rianna Rapson|763-526-2170|rianna.k.rapson@medtronic.com|
22447535|NCT02692716|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22447536|NCT03709771|Vanderbilt University Medical Center|Emily Shardelow|615-875-8949|emily.m.shardelow@vumc.org|
22447537|NCT00536601|Roswell Park Cancer Institute|Theresa Hahn, PhD|716-845-5819|theresa.hahn@roswellpark.org|
22447538|NCT02904512|Veterans Affairs Medical Center|Dr. Ilias (Elias) Spanakis|(617) 319-9731|ispanakis@som.umaryland.edu|
22447539|NCT03828357|Abbott|Grant Kim, Director Clinical Programs|8184933147|grant.kim1@abbott.com|
22447540|NCT03219294|Maine Medical Center|Research Coordinator|2076622862|richaj3@mmc.org|
22447541|NCT01963403|UC Davis|Dr. Mitchell Creinin|916-734-6670|mdcreinin@ucdavis.edu|
22447542|NCT03585504|Medical University of South Carolina|Dr. Angela Dempsey|843-762-4500|dempsear@musc.edu|
22447543|NCT02564042|GlaxoSmithKline|GSK Response Center|866-435-7343||
22447544|NCT01356966|Emory University|Dr. Jeanie Park|404-727-1386|jeanie.park@emory.edu|
22447545|NCT02743806|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22447546|NCT00660530|University of Illinois College of Pharmacy|Dr. Alan Lau|(312) 996-0894|alanlau@uic.edu|
22447547|NCT00849381|GlaxoSmithKline|GSK Response Center|866-435-7343||
22447548|NCT01170754|Temple University|Frank Friedenberg, MD|215-707-9900|frank.friedenberg@temple.edu|
22447549|NCT01622699|Isala|Dr J Bekhof|0384247492|j.bekhof@isala.nl|+31
22447550|NCT02461355|Burke Neurological Institute|Tomoko Kitago, MD|914-368-3169|tok7002@med.cornell.edu|
22447551|NCT04429061|University of Alabama at Birmingham|Dr Carolyn Bolton|966841034|Carolyn.Bolton@cidrz.org|
22447552|NCT02085785|Department of Veterans Affairs|Dr. Alyson Littman, Research Health Scientist|206-277-4182|alyson.littman@va.gov|
22447553|NCT03590041|University of Colorado Anschutz medical Campus|Dr. Bethany Kwan|303-724-5153|bethany.kwan@cuanschutz.edu|
22399801|NCT00432237|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
22399802|NCT01354132|Beth Israel Deaconess Medical Center|Larry Seidman, PhD|617 754-1238|lseidman@bidmc.harvard.edu|
22399803|NCT00956930|Northwestern University|Riad Salem MD|312-695-6371|rsalem1@nm.org|
22399804|NCT00191854|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22399805|NCT04355013|University Hospital of Salamanca|Dr. José A. Sastre|+34923291100|jasastre@saludcastillayleon.es|55580
22399806|NCT02348099|Gerontology Research Lab|Mr Boris Feldman, Research Associate|16048755115|boris.feldman@vch.ca|
22447554|NCT02692703|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22447555|NCT04118166|Stanford Medicine at Stanford University|Maria Ahern|650-725-6413|mahern@stanford.edu|
22447556|NCT03519932|CooperVision Inc.|Jose A.Vega OD, MSc., FAAO|9256213761|javega@coopervision.com|
22447557|NCT02254486|Norgine Ltd|Lucy Clayton|+44-1895-826669|lclayton@norgine.com|
22447558|NCT01350414|Boston Scientific|Narinder Shargill|408-635-3907|Narinder.Shargill@bsci.com|
22447559|NCT01493570|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22447560|NCT00267046|UT MD Anderson Cancer Center|Saroj Vadhan-Raj, MD/Professor|713-792-7966|xzhou@mdanderson.org|
22447561|NCT00103142|Duke University Medical Center|Dr. Michael Morse|919-684-5705|michael.morse@dm.duke.edu|
22447562|NCT02772081|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
22447563|NCT03267186|Stanford University|Andrew R. Rezvani, MD|650-725-4077|arezvani@stanford.edu|
22447564|NCT01214356|MUSC|Vanessa Diaz, MD MSCR|8438762923|diazva@musc.edu|
22447565|NCT01077856|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22447566|NCT03950167|UFUK UNIVERSITY|DR MÜGE KESKİN|+905333522090|mugekeskin1@hotmail.com|
22447567|NCT02533427|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22447568|NCT01979016|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
22447569|NCT01985867|The Medical University of Warsaw|Katarzyna Wojtyniak|+48 22 317 94 21|wojtyniakkasia@gmail.com|
22447570|NCT01465997|Cares|UCB|+1844 599||2273
22447571|NCT02205814|MENARINI Group|Angela Capriati, MD PhD - Corporate Director Clinical Research|+39 055 5680|acapriati@menarini-ricerche.it|9990
22447572|NCT01426373|Kythera Biopharmaceuticals, Inc.|Clinical Trial Disclosure||clinical_trials@kythera.com|
22447573|NCT02397785|Cleveland Clinic Foundation|Erica Magelky, Principal Investigator|713-628-5357|magelke@ccf.org|
22447574|NCT00726661|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22447575|NCT02756689|UAB|Lorie Harper, MD|205-934-5611|lmharper@uabmc.edu|
22447576|NCT02557646|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22447577|NCT00911053|Oregon Health and Science University|OHSU IRB|5034948849|irb@ohsu.edu|
22447578|NCT00005937|NIH National Heart, Lung and Blood Institute|Neal S. Young MD|301-402-1806|youngns@nhlbi.nih.gov|
22447579|NCT00160251|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22447580|NCT01288469|Sanofi|Trial Transparency Team||Contact --US@sanofi.com|
22447581|NCT01574612|Meda Pharmaceutical|David Ginsberg, DO|732 564 2200|ginsberg.david@gmail.com|
22447582|NCT00582166|University of Wisconsin Carbone Cancer Center|Lymphoma/Myeloma Disease Oriented Team|608-265-3794|barnstable@wisc.edu|
22447583|NCT04488068|VA San Diego Healthcare System|Mahadevan Rajasekaran, Ph.D.|8585528585|Mahadevan.Rajasekaran@VA.gov|7114
22447584|NCT01606436|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22447585|NCT02859454|National Cancer Institute|Scott Norberg, DO|301-275-9668|scott.norberg@nih.gov|
22447586|NCT00110149|BIDMC|Robin Joyce, MD|617-667-9920|rjoyce@bidmc.harvard.edu|
22447587|NCT01911689|Sichuan Key Laboratory of Medical Imaging, Department of Radiology, Affiliated Hospital of North Sichuan Medical College|Dr.XiaoMing Zhang|+86 817 2262218|cjr.zhxm@vip.163.com|
22447588|NCT02245308|Durham VA Health Care System|Angela Kirby|919-286-0411|angela.kirby@va.gov|175526
22447589|NCT02452398|Venus Concept Ltd|Yoni Iger|888-907-0115|yoni@venusconcept.com|
22447590|NCT00748033|Wellspect Health Care|Head of Medical Affairs|+46313763000|mace@wellspect.com|
22447591|NCT03334448|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22447592|NCT02326025|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22447593|NCT01365910|Vanderbilt-Ingram Cancer Center|Dr. Jordan Berlin|615-343-4128|jordan.berlin@vanderbilt.edu|
22447594|NCT02013791|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22447595|NCT03798483|Oxford University hospital foundation trust|Colin Forde|+441865221540|Colin.Forde@ouh.nhs.uk|
22447596|NCT02643082|Pearl Therapeutics, Inc.|Pearl Therapeutics, Inc.|650-305-2600|creisner@pearltherapeutics.com|
22447597|NCT02289417|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22447598|NCT02725710|Duke University|Jeremy M. Weber|919-681-4561|jeremy.m.weber@duke.edu|
22447599|NCT02505867|The Ohio State Unveristy|Rami Khayat|6142477717|rami.khayat@osumc.edu|
22447600|NCT01782222|UCB|UCB Cares|+1 877 822 9493||
22447601|NCT03200860|University Medical Center Groningen - Department of Cardiology|Prof. dr. A.A. Voors|0031503616161|a.a.voors@umcg.nl|
22447602|NCT01605877|Alcon Japan, Ltd.|Hiroshi Kodama, Group Manager|81-3-6899-5000||
22447603|NCT02818569|Massachusetts General Hospital|Dr. Oluwaseun Johnson-Akeju|617-724-7200|ojohnsonakeju@partners.org|
22447604|NCT03844646|Stanford University|Sun H. Kim, MD, MS|650-723-8284|sunhkim@stanford.edu|
22447605|NCT01918085|Coloplast|Henrik Sigaard Knoth|+ 45 4911 3469|dkhsk@coloplast.com|
22447606|NCT03158116|UCSF Benioff Children's Hospital Oakland|Rachna Wadia, MD|844-724-4140|rawadia@mail.cho.org|
22447607|NCT01118221|MVAHS|Robert M Jackson, MD|305-575-3548|robert.jackson4@va.gov|
22447608|NCT02634320|Alkermes, Inc.|ARISTADA Medical Information|866-204-7823|usmedinfo@alkermes.com|
22447609|NCT00687323|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22399807|NCT02354833|West Virginia University|Dr. Manuel C. Vallejo, Chair of Department of Anesthesiology|304-598-4929|mvallejo@wvumediciane.org|
22399808|NCT01933932|AstraZeneca Research and Development|Dr Gabriella Mariani|+44 (0)1763 263801|ClinicalTrialTransparency@astrazeneca.com|
22399809|NCT02601950|Epizyme, Inc.|Medical Lead or Designee|(855) 500-1011|clinicaltrials@epizyme.com|
22399810|NCT02157883|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
22399811|NCT01701258|McLean Hospital|Diego Pizzagalli, Ph.D.|617-855-4230|dap@mclean.harvard.edu|
22399812|NCT01323478|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
22447610|NCT01593215|RegionSkane|Anders Rosengren|+4640391169|anders.rosengren@med.lu.se|
22399813|NCT02371850|University of Maryland School of Pharmacy|Audra Stinchcomb, PharmD|410-706-2646|astinchc@rx.umaryland.edu|
22399814|NCT05617521|Hospital Central Norte PEMEX|Dr. Antonio Marmolejo|+526142231826|dr.marmolejo.ch@gmail.com|
22399815|NCT00934102|University of Waterloo|Craig Woods, PhD, FAAO / Research Manager|1-519-888-4742|cclr2@uwaterloo.ca|
22399816|NCT00792298|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22399817|NCT00670709|UCLA|Jennifer Villalobos|310-825-3351|info@brain.ucla.edu|
22447611|NCT04208698|CinDome Pharma, Inc.|Director of Clinical Trials|844-531-1834|info@cinrx.com|
22447612|NCT03655691|Eirion Therapeutics|Chief Executive Officer|(781) 935-1216|info@eirionthera.com|
22447613|NCT04557371|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22447614|NCT00064844|Yale University School of Medicine|Ned Cooney, PhD|860-594-6339|ned.cooney@yale.edu|
22447615|NCT01428453|GlaxoSmithKline|GSK Response Center|866-435-7343||
22447616|NCT01996709|Alcon Research, Ltd.|Jessie Lemp, DrPH, GMA Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22447617|NCT03918447|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22447618|NCT00477971|Mayo Clinic|Dr. Morie Gertz||gertz.morie@mayo.edu|
22399818|NCT00863551|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22399819|NCT01474590|University of Western Ontario and Windsor Clinical Research Inc., 2224 Walker Rd. Suite 300, Windsor, ON, Canada|Dr. Jerry Tan||jerrytan@bellnet.ca|
22399820|NCT00486603|Adult Brain Tumor Consortium|Director of ABTC|410-955-3657|jfisher@jhmi.edu|
22399821|NCT02649634|University of Calgary|Dr. Kristin von Ranson|403.220.7085|kvonrans@ucalgary.ca|
22399822|NCT00680225|New England Retina Associates|Dr. Peter Liggett|203-288-2020|neretina@msn.com|
22399823|NCT03837184|Novartis Gene Therapies EU Limited|EMEA Medical Information|+353 (1) 566-2364|medinfoemea.gtx@novartis.com|
22399824|NCT01670994|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22399825|NCT00763009|UCHC|Michael Azrin|8606793343|azrin@uchc.edu|
22399826|NCT01111604|Eli Lilly and Compnay|Chief Medical Officer|800-545-5979||
22399827|NCT00758784|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22399828|NCT01231412|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org|
22399829|NCT01360996|Woman's Hospital|Dr Karen Elkind-Hirsch|225-231-5275|karen.elkind-hirsch@womans.org|
22447619|NCT01774968|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22399830|NCT03377634|Wake Forest University School of Medicine|Amber Brooks, MD|336-716-4498|akbrooks@wakehealth.edu|
22399831|NCT01454076|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22447620|NCT00534430|Department of Hematology, City of Hope|Anthony Stein, MD, Clinical Professor|626-537-5748|astein@coh.org|
22447621|NCT02423577|President and Chief Scientific Officer|Russell Wilson, PhD|504-896-2789|rbw@autoimmune.com|
22447622|NCT01986855|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22447623|NCT04317066|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22447624|NCT00333814|Allergan, Inc|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com|
22447625|NCT02014597|Baylor College of Medicine|Dr. Benjamin Frankfort|713-798-3453|benjamin.frankfort@bcm.edu|
22447626|NCT01780636|UC Irvine|Karen Noblett|714-456-6807|knoblett@uci.edu|
22447627|NCT02279173|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22447628|NCT01938378|Octapharma|Michael Eppolito|201-604-1155|michael.eppolito@octapharma.com|
22447629|NCT00754624|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
22447630|NCT01571427|Oregon Health & Science University|Dr. Hiroko Dodge|(503) 494-6695|dodgeh@ohsu.edu|
22447631|NCT02070692|Oregon Health & Science University|Dr. Katharine Simmons|404-718-6619|simmonka@ohsu.edu|
22447632|NCT02368431|VA Connecticut Healthcare System West Haven Campus, West Haven, CT|Dr Albert Arias|804-828-5793|albert.arias@vcuhealth.org|
22447633|NCT03124875|LimFlow Inc.|Cecilia Petrella|(888) 478-7705|cpetrella@limflow.com|101
22447634|NCT00022633|Cleveland Clinic|Dr. Derek Raghavan|216-445-6888|raghavd@cc.ccf.org|
22447635|NCT00982592|Perlmutter Cancer Center at NYU Langone|Deirdre Cohen, MD|212-731-5656|deirdre.cohen@nyumc.org|
22447636|NCT01741701|University of Kansas Medical Center|Dr. Rajesh Pahwa|913-588-6782|rpahwa@kumc.edu|
22447637|NCT04677374|University of North Carolina at Chapel Hill|Mitch Matoga, MD, MS|00265 1 755056|mmatoga@email.unc.edu|
22447638|NCT01669915|Brigham and Women's Hospital;181 Longwood Ave; Boston, MA 02115|Jae Hee Kang|617-525-2022|nhjhk@channing.harvard.edu|
22447639|NCT04247581|Apple|Health Tech Clinical Operations|866-905-5303|htclinicalquestions@apple.com|
22447640|NCT00372112|GlaxoSmithKline|GSK Response Center|866-435-7343||
22447641|NCT04649060|Oncopeptides AB|VP Chief Operating Officer|+46 8 615 20 40|trials@oncopeptides.com|
22447642|NCT03033394|Imperial College London|Richard Wilson|02033132732|richard.wilson@imperial.ac.uk|
22447643|NCT02927431|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22447644|NCT02246660|Northwestern University|Dr. Mary McDermott|312-503-6419|mdm608@northwestern.edu|
22447645|NCT04952402|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22447646|NCT00143403|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22447647|NCT00587639|Mayo Clinic|Dr. Christopher Wall|5072843352|wall.chris@mayo.edu|
22447648|NCT03530098|Stanford University|Safwan S Halabi, MD|(650) 721-2850|safwan.halabi@stanford.edu|
22447649|NCT00533845|Maimonides Medical center|Danny A Sherwinter|7182837952|dsherwinter@maimonidesmed.org|
22447650|NCT01442675|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22447651|NCT01860651|Hvidovre University Hospital|Dr. Katrine Carlsen|26180513|katrinec@gmail.com|0045
22447652|NCT02695498|Atrium Health Wake Forest Baptist|Rebecca Wells, MD, MPH|336-716-2357|rewells@wakehealth.edu|
22447653|NCT04583891|University of Virginia|Philip Chow|9146453458|pic2u@virginia.edu|
22447654|NCT00667368|University of Alabama at Birmingham|Dr. Jane Schwebke|205-975-5665|schwebke@uab.edu|
22447655|NCT03944954|University of Kentucky|Dr. Michael J Wesley|8593230579|michael.wesley@uky.edu|
22399832|NCT00096161|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org|
22447656|NCT05564429|National Institute of Mental Health (NIMH)|Dr Robert Innis|301-594-1368|robert.innis@nih.gov|
22447657|NCT03235154|Community Research Initiative of New England|Amy E. Colson, MD|6175021700|acolson@crine.org|
22447658|NCT02850965|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22447659|NCT00536198|Yale University School of Medicine|Kimberly A. Yonkers, M.D.|203-764-5914|Kimberly.Yonkers@yale.edu|
22447660|NCT00881712|University of Florida Proton Therapy Institute|Bradford Hoppe, M.D.|904-588-1800|bhoppe@floridaproton.org|
22447661|NCT00276744|SKCCC|Dr. Daniel Laheru|410-955-8974|laherda@jhmi.edu|
22447662|NCT01294267|Icahn School of Medicine at Mount Sinai, Helmsley Electrophysiology Center|Vivek Y. Reddy, MD|212-241-7114|vivek.reddy@mountsinai.org|
22447663|NCT01462097|University of Maryland School of Medicine|Stephen Seliger, MD MS|410-605-7000|sseliger@som.umaryland.edu|x55231
22447664|NCT03809052|Galecto BIotech|Dr Bertil Lindmark, Chief Medical Officer|+45 70 70 52 10|info@galecto.com|
22447665|NCT02071914|Celltrion|Head of Clinical Planning Department|82328505000|contact@celltrion.com|
22447666|NCT03178903|Butler Hospital|Ana M. Abrantes, Ph.D.|4014556440|Ana_Abrantes@Brown.edu|
22447667|NCT01307397|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22447668|NCT00230607|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22447669|NCT03672747|Boys Town National Research Hospital|Tony Wilson|531-355-8909|tony.w.wilson@gmail.com|
22447670|NCT00387023|UT MD Anderson Cancer Center|Bita Esmaeli, MD / Professor||CR_Study_Registration@mdanderson.org|
22447671|NCT00790855|The University of MD Anderson Cancer Center|Hagop M. Kantarjian, M.D.|713-792-7026|eharriso@mdanderson.org|
22447672|NCT00965718|Yonsei university|Moonjae Chung, MD|82-2-2228-2274|MJCHUNG@yuhs.ac|
22447673|NCT03667924|University of Minnesota|Joseph Gaugler, PhD|612-626-2485|gaug0015@umn.edu|
22447674|NCT00126568|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Panayiotis Savvides|216-844-5946|Panayiotis.Savvides@uhhospitals.org|
22447675|NCT01244425|BAXTER INNOVATIONS GmbH|Ildiko Szabo, MD, MBA Medical Director, Biosurgery||ildiko_szabo@baxter.com|
22447676|NCT02547454|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22447677|NCT00973739|New York University Langone Medical Center|Matthias Karajannis, MD|212-263-8400|matthias.karajannis@nyumc.org|
22447678|NCT00733408|University of Washington|Jennifer Specht, MD, Associate Professor|(206) 606-1000|jspecht@uw.edu|
22447679|NCT04346537|Boston Scientific|Gena Kantor|1-800-227-3422|gena.kantor@bsci.com|
22447680|NCT01134783|University of North Carolina, Chapel Hill|Dr. Leslie A. Lytle|919-843-8171|llytle@email.unc.edu|
22447681|NCT01148745|Dialysis Clinic, Inc.|Dr. Toros Kapoian, M.D., F.A.C.P.|732-940-8368|Toros.Kapoian@dciinc.org|
22447682|NCT00531232|Genzyme, a Sanofi Company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22447683|NCT04232124|Vanderbilt University Medical Center|David G. Harrison|6158753049|david.g.harrison@vumc.org|
22447684|NCT00264641|Hypoglycaemia Research Group|Prof. Birger Thorsteinsson|+4548294829|Birger.Thorsteinsson@regionh.dk|
22447685|NCT00463346|Yale University School Of Medicine Department of Psychiatry|Elizabeth Ralevski|2039325711|elizabeth.ralevski@yale.edu|4282
22399833|NCT03056443|West Virginia University|Robert Stansbury, MD|304-293-4661|rstansbury@hsc.wvu.edu|
22399834|NCT00291551|Paracor Medical, Inc.|Michael Kolber, General Manager, VP, Regulatory Affairs|408-734-6000|info@paracor.com|
22399835|NCT02452762|Children's Hospital of Eastern Ontario|James Dayre McNally, Principal Investigator and Pediatric Intensivist|613-737-7600|dmcnally@cheo.on.ca|3553
22399836|NCT00584870|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22399837|NCT00631137|Johns Hopkins|Jaishri Blakeley|410-955-8837|jblakel3@jhmi.edu|
22399838|NCT03682120|St Louis University School of Medicine|Sharon Frey, MD|314-997-5500|sharon.frey@health.slu.edu|
22399839|NCT01015833|Memorial Sloan-Kettering Cancer Center|Ghassan Abou-Alfa, MD|646-888-4184|abou-alg@mskcc.org|
22399840|NCT03898063|University of Miami|Nick Carcioppolo|3052845633|n.carcioppolo@miami.edu|
22399841|NCT02730260|Washington University School of Medicine|Dr. Walton Sumner|314-454-8164|wsumner@dom.wustl.edu|
22399842|NCT03430986|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22399843|NCT03257189|MC10 Inc|Chief Medical Officer|8572145600|ACombs@mc10inc.com|
22399844|NCT00299988|Weill Cornell Medical College|Norman Relkin, MD, PhD|212-746-9882|nrelkin@med.cornell.edu|
22399845|NCT01889602|University of Minnesota|Dr. Susan Marino|612-624-2964|marin007@umn.edu|
22399846|NCT00961961|UPenn|Dr. Robert J. DeRubeis|215-573-5804|derubeis@psych.upenn.edu|
22399847|NCT01412957|Amgen Inc.|Study Director|866-572-6436||
22386038|NCT05229822|NJSC KARAGANDA MEDICAL UNIVERSITY|Dr. Yermek Turguov|+77016119655|Turgunov@qmu.kz|
22386039|NCT03571581|The Miriam Hospital|Elena Salmoirago-Blotcher|401-793-8325|Elena_Salmoirago_Blotcher@brown.edu|
22386040|NCT01309672|University of Colorado, School of Medicine|Dr. Thomas W. Flaig, MD||Thomas.Flaig@ucdenver.edu|
22386041|NCT03283722|Medtronic|Jenell Lorenz, Sr. Clinical Research Specialist|651-269-4768|jenell.m.lorenz@medtronic.com|
22386042|NCT02397954|Ophthotech Corp|Keith Westby||Keith.Westby@ophthotech.com|
22386043|NCT04141891|University of Colorado|Dr. Marian Betz|303-550-5669|marian.betz@cuanschutz.edu|
22386044|NCT04737330|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22386045|NCT04884308|Johns Hopkins University|Noah Lechtzin|410-502-7044|nlechtz@jhmi.edu|4102994561
22386046|NCT03295721|Heron Therapeutics, Inc.|Vice President, Clinical Operations|855-251-7232|svisonneau@herontx.com|
22386047|NCT04231331|Asan Medical Center|Professor Duk-Hyun Kang|821030103166|dhkang@amc.seoul.kr|
22386048|NCT04168580|AdventHealth Translational Research Institute|Paul M. coen, PhD., Associate Investigator|765-426-9743|paul.coen@adventhealth.com|
22386049|NCT05098158|Washington State University|Marian Wilson|509-324-7443|marian.wilson@wsu.edu|
22386050|NCT02598388|Janssen Vaccines & Prevention B.V.|MEDICAL LEADER|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22386051|NCT03069924|Medical University of South Carolina|Dr. Benjamin Toll|843-876-1132|toll@musc.edu|
22386052|NCT03668236|Rigshospitalet, University of Copenhagen|Prof. Anders Perner|+45 35458333|anders.perner@regionh.dk|
22386053|NCT06132282|Texas Christian University|Danica Knight|817-257-4391|d.knight@tcu.edu|
22386054|NCT03526887|Fundación GECP|Eva Pereira|+34934302006|gecp@gecp.org|
22386055|NCT04499924|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
22386056|NCT04850898|SAB Biotherapeutics|Senior Director Clinical Operations|8326221699|ssinclair@sabbio.com|
22386057|NCT03374241|HanmiPharma|khseo@hanmi.co.kr|+82 2 410 9042|khseo@hanmi.co.kr|
22386058|NCT04942613|University of Colorado Denver, Anschutz Medical Campus|Dr. Jennifer Stevens-Lapsley|303.724.9170|jennifer.stevens-lapsley@cuanschutz.edu|
22386059|NCT04909801|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22386060|NCT04447040|Johnson & Johnson Consumer, Inc.|Assoc Dir Med Sci Leader US Self Care Pain|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22386061|NCT04433208|Prolacta Bioscience|Dr David Rechtman VP, Medical Affairs|8887765228|drechtman@prolacta.com|
22386062|NCT03208049|VA Palo Alto Health Care System, Palo Alto, CA|Dr. Andrea Goldstein-Piekarski|(650) 493-5000|Andrea.Goldstein2@va.gov|60584
22386063|NCT05485779|AQILION AB|Anneli Tinnerholm|+46 730 88 14 15|anneli.tinnerholm@aqilion.com|
22386064|NCT02038777|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22386065|NCT03138603|University of Chicago Medicine|Peter Nagele, MD, MSc|773-795-3544|pnagele@uchicagomedicine.org|
22386066|NCT02010242|Calliditas Therapeutics|Richard Philipson, MD Chief Medical Officer|+46 556659-9766|richard.philipson@calliditas.com|
22386067|NCT03676192|Celltrion|Head of Clinical Planning Department|82328505000|contact@celltrion.com|
22386068|NCT04731129|Centre hospitalier universitaire de liège|Dr Olivier Bonhomme|003243239580|obonhomme@chuliege.be|
22386069|NCT03386578|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
22413128|NCT01411332|University of Miami|Alan Pollack MD, PhD|305-243-4916|apollack@med.miami.edu|
22386070|NCT03841773|Tonix Pharmaceuticals|Gregory Sullivan, MD|862-904-0355|greg.sullivan@tonixpharma.com|
22386071|NCT02424617|BerGenBio ASA|BerGenBio Clinical Team|+ 47 55961159|registry.postings@bergenbio.com|
22386072|NCT05205460|Tri-service general hospital|Chia-Ying Lai|87923311|pokerface165@gmail.com|13606
22386073|NCT04971109|SIGA Technologies|Emily Blum, Director of Clinical Development|541-224-1305|eblum@siga.com|
22386074|NCT05133739|TEOXANE SA|Clinical Research Scientist|+41(0) 22 344 96 36|clinical@teoxane.com|
22386075|NCT04778397|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22386076|NCT03664700|Oxford University Hospitals|Dr Vassilis Athanassoglou|01865|vassilis.athanassoglou@ouh.nhs.uk|221590
22386077|NCT03987022|Metrohealth System|Dr. Robert Pollard|2167781446|rpollard@metrohealth.org|
22386078|NCT03308877|University of Rochester Medical Center|Marc T. Swogger, Associate Professor, Psychiatry and Medicine|585-301-7738|marc_swogger@urmc.rochester.edu|
22386079|NCT03523572|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22386080|NCT00957684|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com|
22386081|NCT04685135|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22386082|NCT02315703|Janssen Vaccines & Prevention B.V.|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22386083|NCT05987813|Virginia Commonwealth University|Gisela Chelimsky|804-628-5882|gisela.chelimsky@vcuhealth.org|
22386084|NCT04134208|The University of Texas M D Anderson Cancer Center|Dr. Gregory Ravizzini|(713) 518-9866|gravizzini@mdanderson.org|
22386085|NCT02724969|University of Pittsburgh|Jill R. Demirci, PhD, RN, IBCLC|412-648-9236|jvr5@pitt.edu|
22413129|NCT01710657|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22386086|NCT05061069|Ghent University|Prof. Dr. Leen Maes|093324066|leen.maes@ugent.be|+32
22386087|NCT05974501|University of Miami|Dr. Victor H. Hernandez|305-243-4000|vhh1@med.miami.edu|
22413130|NCT03334825|New York City Department of Health and Mental Hygiene|Dr. Ellen Wiewel|347-396-7653|ewiewel@health.nyc.gov|
22413131|NCT03921294|Indiana Hemophilia & Thrombosis Center|Kat Molitor|3178710011|kmolitor@ihtc.org|
22413132|NCT00978822|Albany Medical Center|Panayiotis Varelas|2488739855|varelap@amc.edu|
22386088|NCT04911296|Rani Therapeutics|Sr. Director of Clinical Operations|+1 (408) 457-3700|joshua.myers@ranitherapeutics.com|
22413133|NCT05087524|University of Wisconsin - Madison|Dr. Ellen Wald|(608) 263-8558|erwald@pediatrics.wisc.edu|
22413134|NCT00546897|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
22386089|NCT02497950|Rigshospitalet Copenhagen, Denmark|Prof. Finn Gustafsson|+4535459743|finn.gustafsson@regionh.dk|
22386090|NCT04249362|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22413135|NCT01297348|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22447686|NCT03641651|Zurich University of applied sciences|Prof. Dr. Markus Wirz|+41 58 934|markus.wirz@zhaw.ch|6321
22447687|NCT01430091|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22447688|NCT01991067|Medical University of Vienna, Department of Medicine I, Division of Infectious Diseases|Assoc. Prof. Dr. Christina Bahrs|+4314040044400|christina.a.forstner@meduniwien.ac.at|
22447689|NCT03134989|Cochlear|Ruth English|0386633105|REnglish@cochlear.com|
22447690|NCT00224055|Watson Pharmaceuticals, Inc|Naomi Dahl, PharmD Director, Clinical Affairs||Naomi.dahl@watson.com|
22447691|NCT02771990|Providence Veterans Affairs Medical Center|Benjamin Greenberg|4012737100|benjamin.greenberg@va.gov|
22447692|NCT00127712|Purdue University|James E. Tisdale|317-613-2315|jtisdale@iupui.edu|306
22447693|NCT00407563|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
22447694|NCT03055260|University of Minenesota|Russel Giveans|5042314007|russell.giveans@gmail.com|
22447695|NCT00464087|Medstar Health Research Institute|Ron Waksman, MD|202-877-2812|ron.waksman@medstar.net|
22447696|NCT01164956|Dana-Farber Cancer Institute|Christina K. Ullrich, MD, MPH|617.632.4997|Christina_Ullrich@dfci.harvard.edu|
22447697|NCT00720434|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22447698|NCT00418314|St. Jude Medical|Sr. Director Clinical Studies|(408) 522-6410|tshipman@sjm.com|
22447699|NCT00967798|Emory University|Arlene Stecenko, MD|404-712-2657|astecen@emory.edu|
22447700|NCT02425046|Center for Children's Healthy Lifestyles & Nutrition - Children's Mercy Hospital|Dr. Helena Laroche|(816) 234-9251|hhlaroche@cmh.edu|
22447701|NCT01409564|Seoul National University Hospital|Prof. Jung Seok Choi|82-2-870-3461|choijs@neuroimage.snu.ac.kr|
22447702|NCT02782780|San Francisco VA Health Care System|Dr. Linda Chao|415-221-4810|linda.chao@va.gov|24386
22447703|NCT01413191|UT MD Anderson Cancer Center|Dr. Sapna Patel, MD - Associate Professor, Melanoma Medical Oncology|713-792-2921|SPPatel@mdanderson.org|
22447704|NCT05040386|University of Alabama at Birmingham|Anand Iyer, MD, MSPH|2059341968|aiyer@uabmc.edu|
22447705|NCT03654651|The Pennsylvania State University|Dr. Penny Kris-Etherton|814-863-2923|pmk3@psu.edu|
22447706|NCT03045328|Stanford University|Steven Edward Coutre, Professor of Medicine (Hematology)|650-498-6000|coutre@stanford.edu|
22447707|NCT04615923|Healey Center for ALS at Massachusetts General Hospital|Healey Center for ALS Project Management|833-425-8257 (HALT ALS)|healeyalsplatform@mgh.harvard.edu|
22447708|NCT00592839|Duramed Research|Duramed Research Protocol Chair|215-293-7279|medicalaffairs@barrlabs.com|
22447709|NCT03395886|Zhongshan Hospital, Fundan university|Mr Zhe Luo|64041990|ec@zs-hospital.sh.cn|
22447710|NCT00589914|Johnson & Johnson Pharmaceutical Research & Development LLC|Clinical Leader Psychiatry|1 609 730-2324||
22447711|NCT02781051|UT Southwestern Medical Center|Chad Rethorst, Associate Professor|2146480153|chad.rethorst@utsouthwestern.edu|
22447712|NCT00799487|Ortho-McNeil Janssen Scientific Affairs, LLC|VP Medical Affairs, CNS|609-730-2136||
22447713|NCT02310464|OBI Pharma, Inc.|Chen-En Tsai, MD, PhD|886 2 27866589|chenentsai@obipharma.com|215
22447714|NCT02618434|Supernus Pharmaceuticals|Gianpiera Ceresoli-Borroni Director Clinical Research|3018382521|gceresoliborroni@supernus.com|
22447715|NCT02106728|Toronto General Hospital|Dr. Gina Dimitropoulos|416-340-3749|gdimit@ucalgary.ca|
22447716|NCT01967121|Michigan State University|Tracey Covassin|517-353-2010|covassin@msu.edu|
22447717|NCT02289898|Mereo BioPharma Group Plc.|John, Lewicki, Chief Scientific Officer|+44333023300|John.Lewicki@mereobiopharma.com|
22447718|NCT04626297|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22447719|NCT03434275|Baudax Bio, Inc.|Development|484-395-2440|info@baudaxbio.com|
22447720|NCT00885105|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22447721|NCT02066233|Mayo Clinic|Dr. Prasad G. Iyer|507-284-6469|Iyer.Prasad@mayo.edu|
22447722|NCT02598076|Yale Comprehensive Epilepsy Center, Department of Neurology, Yale Univseristy School of Medicine|Benjamin Tolchin, MD, MS|347-721-8491|benjamin.tolchin@yale.edu|
22447723|NCT02005445|VA Boston Healthcare System|Dr. Daniel Gottlieb|857-203-6375|daniel.gottlieb@va.gov|
22447724|NCT00759954|Actavis Inc.|Meena Venugopal, Director, Clinical R&D|908-659-2885|MVenugopal@actavis.com|
22447725|NCT00010374|Synapse Biomedical, Inc.|Anthony Ignagni|440-774-2488|aignagni@synapsebiomedical.com|110
22386091|NCT03268382|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
22386092|NCT01221948|Bostons Scientific Neuromodulation|Nic Van Dyck, Director International Clinical Operations|+31 43 3568328|vandyckn@bsci.com|
22447726|NCT05989815|Federal University of São Carlos (UFSCar)|Italo Amaral de Oliveira, Principal Investigator|+55 19 99719-0361|italoao@estudante.ufscar.br|
22447727|NCT01250834|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22447728|NCT02407704|University of Pittsburgh|Dr. Kirk Erickson|412-624-4533|kiericks@pitt.edu|
22386093|NCT00746096|Nobelpharma|Department director of clinical development department 1|+81-3-5651-1177|murakami@nobelpharma.co.jp|
22386094|NCT03756662|Implandata Ophthalmic Products|Clinical Study Manager|+49 (0) 511 - 2204 2580|clinical@implandata.com|
22447729|NCT01683383|Stanford University School of Medicine|Krisa P. Van Meurs, M.D.|+1 650 723 5711|vanmeurs@stanford.edu|
22447730|NCT02496611|University of Minnesota|Aaron Kelly PhD|6126253492|kelly105@umn.edu|
22447731|NCT02784275|NovMetaPharma Co., Ltd|Peter Lee|+82 (0)2 538 1893|Peter@NovMeta.com|
22447732|NCT01897402|JN-International Medical Corporation|Regulatory Affairs Director|4028843477|dr_orten@jn-vaccines.org|
22447733|NCT03228537|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|jmoon@fredhutch.org|
22447734|NCT01307007|Luitpold Pharmaceuticals, Inc.|Sumita Chowdhury, MD, MPH, FACC, MBA|610-650-4200|SChowdhury@lpicrd.com|
22447735|NCT00138203|University of Wisconsin Carbone Cancer Center|Dr. Anne Traynor|(608) 262-8158|amt@medicine.wisc.edu|
22447736|NCT00580606|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsgov@niaid.nih.gov|
22447737|NCT00240162|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
22447738|NCT03358290|Akros Pharma Inc.|Kazuhiro Okamiya|609-919-6123|okamiya@akrospharma.com|
22447739|NCT01482884|AstraZeneca|Mark Berner Hansen|+46 31 776 4794|Mark.Berner.Hansen@astrazeneca.com|
22447740|NCT04102020|ABBVIE CALL CENTER|AbbVie|844-663-3742|abbvieclinicaltrials@abbvie.com|
22447741|NCT04853225|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22447742|NCT03789318|Concentric Analgesics|Head of Clinical Operations|14154847921|nancy@concentricanalgesics.com|
22447743|NCT01463878|Eastern Virginia Medical School|Dr Paul Marik|757-446-8910|marikpe@evms.edu|
22447744|NCT02775162|OrganOx Ltd|Robert Bovy, VP of Regulatory Affairs, North America|608-556-4429|robert.bovy@organox.com|
22447745|NCT02051608|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22447746|NCT00142584|Viatris Inc|M. Rachel Kirker, PhD, Director, Clinical Oversight & Inspection Readiness|724-485-6170|rachel.kirker@viatris.com|
22447747|NCT01083576|US Army Medical Materiel Development Activity (USAMMDA)|Director, Division of Regulated Activites and Compliance|301-619-0197|usarmy.detrick.medcom-usammda.mbx.usamrmc-regulatory-affairs@mail.mil|
22447748|NCT01986985|GE Healthcare|Terri Hanlon, Clinical Affairs Project Manager|609-578-0173|terri.hanlon@GE.com|
22447749|NCT00449540|Neuralieve|Cynthia Merrell|408-245-6400|cmerrell@neuralieve.com|
22447750|NCT04577118|iotaMotion, Inc|Laura Chenier|442-325-4171|lchenier@iotamotion.com|
22447751|NCT02036294|Johns Hopkins University|Principle Investigator|410-637-7152|habouma1@jhmi.edu|
22447752|NCT00356369|GlaxoSmithKline|GSK Response Center|866-435-7343||
22447753|NCT01660698|Clinical Development Unit / Metabolic Unit|Dr Maurice Beaumont, Principal Investigator|+41217858054|maurice.beaumont@rdls.nestle.com|
22447754|NCT00673465|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22447755|NCT01285310|Celgene Corporation|Anne McClain|888-260-1599|clinicaltrialdisclosure@celgene.com|
22447756|NCT00514540|University of Texas MD Anderson Cancer Center|Lisa Pruitt, Quality Assurance Specialist|713-792-0411|LPruitt@mdanderson.org|
22447757|NCT04468204|Department of Otolaryngology - Head and Neck Surgery|Director of Clinical Research|(843)792-1356|nguyensh@musc.edu|
22447758|NCT01996982|Ascension Seton|Research Enterprise Staff|512-3247991|ra@seton.org|
22447759|NCT02278250|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22447760|NCT01195415|University of Michigan Comprehensive Cancer Center|Dr. Mark Zalupski, M.D.|734-615-3969|zalupski@umich.edu|
22447761|NCT01919723|University of Alabama at Birmingham|Mehak Goel ,PhD|205-975-4021|mehakgoel@uabmc.edu|
22447762|NCT00555321|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22447763|NCT04294472|Vera Therapeutics Inc.|Isabel Gorham, Director of Clinical Operations|(910)200-0532|isabel.gorham@veratx.com|
22447764|NCT00563381|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22447765|NCT01957644|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22447766|NCT04044716|Atrium Health Wake Forest Baptist|Dr. Carolyn Huffman|336.713.4018|cshuffma@wakehealth.edu|
22447767|NCT01957553|Coloplast|Dr. Birte P.Jakobsen|+45 4911 1395|dkbir@coloplast.com|
22447768|NCT01348347|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22447769|NCT02480439|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22447770|NCT00759811|Instituto de Cardiologia do Rio Grande do Sul|Daniel Medeiros Moreira, MD. MSc.|55 (51) 3219-2802|danielmedeirosmoreira@gmail.com|
22447771|NCT03636061|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
22447772|NCT00996307|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22447773|NCT02788357|University of Kentucky|Dr. Lumy Sawaki||lsawa2@uky.edu|
22447774|NCT00640601|AstraZeneca|Gerard Lynch|441625 518062|aztrial_results_posting@astrazeneca.com|
22447775|NCT03198234|Stanford|Rajni Agarwal, MD|650-725-9250|rajnia@stanford.edu|
22447776|NCT04973826|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22386095|NCT05207982|University at Buffalo, Department of Psychiatry|Daniel Antonius|7168582792|danielan@buffalo.edu|
22386096|NCT02807545|Scottish Rite for Children|Karina Zapata|214-559-7790|karina.zapata@tsrh.org|
22386097|NCT04295512|San Diego State University|Kelsey Dickson|(619) 594-5380|kdickson@sdsu.edu|q
22386098|NCT04089059|UCSF School of Medicine|Liviu Klein|415-476-2143|liviu.klein@ucsf.edu|
22386099|NCT03728608|University of Florida|Leslie Parker|352 273 6384|parkela@ufl.edu|
22399848|NCT03035760|University of Iowa|Patricia Winokur, MD|319-384-1735|patricia-winokur@uiowa.edu|
22447777|NCT00165776|Eisai Co., Ltd.|Hiroki Shimizu, Study Director|+81-3-3817-5245||
22386100|NCT05207956|University of Pennsylvania|Dr. David Mandell|(215) 573 7494|david.mandell@pennmedicine.upenn.edu|
22447778|NCT04285879|Connecticut Children's|Adam P. Weaver, PT, DPT|860-284-0246|Aweaver@connecticutchildrens.org|
22386101|NCT04243070|BIOTRONIK SE & Co. KG|Senior Director Clinical Project Management|+49 30 68905|mathias.freudigmann@biotronik.com|0
22386102|NCT04587453|Leo Pharma A/S|Clinical Disclosure|+45 4494 5888|disclosure@leo-pharma.com|
22386103|NCT02800356|San Raffaele Hospital|Prof. Giuseppe Querques|00390226434004|querques.giuseppe@hsr.it|
22386104|NCT01254864|The University of Texas MD Anderson Cancer Center|Paul Corn, MD|(713) 563-7208|pcorn@mdanderson.org|
22386105|NCT03626220|An Nan Hospital, China Medical University, Tainan, Taiwan|Dr. Chien-Chen Huang|886-6-3553111|chenchinh2013@gmail.com|2231
22386106|NCT02795858|Dana-Farber Cancer Institute|Dr. Jennifer Chan, MD|617-632-6315|jennifer_chan@dfci.harvard.edu|
22386107|NCT02573779|Baylor College of Medicine/Texas Children's Hospital|Dr. Amy B. Hair|832-826-1398|abhair@bcm.tmc.edu|
22386108|NCT03746106|University of California, San Francisco|Dr. Kathleen Giacomini|4155144363|kathy.giacomini@ucsf.edu|
22386109|NCT01651403|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22386110|NCT05090683|University of the Fraser Valley|Dr. Cynthia Thomson|6045047441|cynthia.thomson@ufv.ca|2518
22386111|NCT03213665|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22386112|NCT03325985|NYU Langone Health|Keith Goldfeld|(212) 263-5550|Keith.Goldfeld@nyulangone.org|
22386113|NCT03034356|VA Eastern Colorado Health Care System|Jason Tregellas, PhD|303-724-6232|jason.tregellas@va.gov|
22386114|NCT02684227|MD Anderson Cancer Center|Shannon Westin, MD|713-794-4314|swestin@mdanderson.org|
22386115|NCT04070573|Weill Cornell Medicine|Dr Line Malha|6469622606|lim9120@med.cornell.edu|
22386116|NCT04571619|University of Pennsylvania|Natalie Kuzla|2155732935|nkuzla@pennmedicine.upenn.edu|
22386117|NCT05205486|B. Braun Medical Inc.|Director, Scientific Affairs Operations|610-596-2512|kevin.minnich@bbraunusa.com|
22386118|NCT05210569|Image Plus Laser Eye Centre|Dr James Wiens|1-204-943-6287|jamesjwiens@gmail.com|
22386119|NCT04167553|Hanmi Pharmaceutical Co., Ltd.|Jiyeon Kang|+8224100377|jiyeon.kang@hanmi.co.kr|
22386120|NCT04750538|The University of Texas Health Science Center at Houston|Sheng Li, MD, PhD|713-797-7125|sheng.li@uth.tmc.edu|
22386121|NCT04479761|New York University|Prof. Anat Lubetzky|2129989195|anat@nyu.edu|
22386122|NCT05209152|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22386123|NCT04550221|University of Washington|Susan M. Graham|206-351-0414|grahamsm@uw.edu|
22386124|NCT05274074|University of Rochester|Dr. Benzi M. Kluger|5852754259|benzi_kluger@urmc.rochester.edu|
22386125|NCT04117347|University of Michigan|Dr. Helen Burgess|734-615-8303|bhelen@med.umich.edu|
22386126|NCT05194956|University Hospitals of Derby and Burton NHS Trust|Mrs Trishna Patel|01332340131|trishnaanil.patel@nhs.net|83556
22386127|NCT05452460|Department of Physical Education and Sport Sciences, National Taiwan Normal University|Dr. Yu-Kai Chang|+886277493223|yukaichangnew@gmail.com|
22386128|NCT05050149|Palvella Therapeutics, Inc.|Christine Kampf, Vice President of Regulatory Affairs|484-844-0865|christine.kampf@palvellatx.com|
22386129|NCT02694822|Agenus, Inc.|Clinical Trial Information|1-781-674-4265|clinicaltrialinfo@Agenusbio.com|
22386130|NCT05370040|Immunitybio|Lennie Sender, Chief Operating Officer|855-797-9277|lennie.sender@immunitybio.com|
22413136|NCT02495857|Teva Pharmaceuticals Inc. USA|Senior Director, Clinical R&D|1-888-483-8279|USMedinfo@tevapharm.com|
22386132|NCT04870307|University of Oklahoma Tulsa|Dr. Juell Homco|918-660-3038|juell-homco@ouhsc.edu|
22386133|NCT05906784|University of California, San Francisco|Maria Chao, DrPH, MPA, Principal Investigator|415-353-7749|Maria.Chao@ucsf.edu|
22386134|NCT03397706|Viracta Therapeutics|Medical Director|858-400-8470|ClinicalTrials@Viracta.com|
22386135|NCT04491617|Cleveland Clinic|Cecile Ferrando, M.D.|216-444-0642|ferranc2@ccf.org|
22386136|NCT03249090|University of North Carolina at Chapel Hill|Principal Investigator|9194456223|symptom_study@unc.edu|
22386137|NCT05163496|University of Washington|Anthony Back MD|2066194367|tonyback@uw.edu|
22386138|NCT03476343|Cincinnati Children's Hospital Medical Center|Dr. Beth Kline-Fath|(513) 636-1856|beth.kline-fath@cchmc.org|
22386139|NCT05147116|University of Portsmouth|Dr Anthony Shepherd|02392845289|ant.shepherd@port.ac.uk|
22386140|NCT03672916|Zimmer Biomet|Martina Hersberger, Clinical Project Lead|+41 79 535 90 29|martina.hersberger@zimmerbiomet.com|
22386141|NCT04197336|Johns Hopkins University|Clifford Weiss, MD|410-614-1046|cweiss@jhmi.edu|
22386142|NCT03221309|Institute of Human Virology, University of Maryland School of Medicine|Dr. Elana Rosenthal / Associate Professor|2403674157|erosenthal@ihv.umaryland.edu|
22386143|NCT04083170|Fred Hutchinson Cancer Center|Dr. Filippo Milano|206.667.5925|fmilano@fredhutch.org|
22386144|NCT04625725|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22413137|NCT01367457|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|001
22413138|NCT02006160|UBMD Neurology|Dr. Ralph Benedict|7163230556|benedict@buffalo.edu|
22413139|NCT04257474|Moffitt Cancer Center|Susan T. Vadaparampil, PhD, MPH|813-745-1997|Susan.Vadaparampil@moffitt.org|
22447779|NCT00492583|Georgetown University|Daniel J Merenstein, MD|202-687-2745|djm23@georgetown.edu|
22447780|NCT01835587|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22447781|NCT00824512|Ipsen|Medical Director, Primary Care|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22447782|NCT01209260|University of California San Diego|Jonathan Hsu, MD, MAS|415-476-5706|jonathan.hsu@ucsd.edu|
22447783|NCT01580618|Kaiser Permanente|Hyo-Chun Yoon, MD, PHD|8084327342|Hyo-Chun.Yoon@nsmtp.kp.org|
22447784|NCT03310775|Kyunghee university hospital, Seoul, South Korea|Dr. Miae Oh|82-10-8929-5048|miae612@naver.com|
22447785|NCT01161862|Department of Biomedical Engineering, Boston University, Boston, Massachusetts.|Edward R. Damiano|(617) 353-9493|edamiano@bu.edu|
22447786|NCT01648205|University of Rochester|Wojciech Zareba, MD, PhD|5852755391|wojciech_zareba@urmc.rochester.edu|
22447787|NCT02622321|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22447788|NCT00886899|BridgePoint Medical|VP, Clinical Affairs|763-225-8500|jschultz@bridgepointmedical.com|
22447789|NCT01958008|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
22447790|NCT00241280|Johnson & Johnson Vision Care, Inc.|David C. Turner, Ph.D. GLOBAL PLATFORM SR DIRECTOR, R&D|904-443-3500|DTURNER2@its.jnj.com|3479
22447791|NCT02402127|Alcon Research, Ltd.|Global Medical Affairs Franchise Head, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22447792|NCT02260921|Myoscience|Director of Clinical|5109331541||
22447793|NCT03501069|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22447794|NCT02999854|Kiadis Pharma Netherlands B.V|Klaudia Traudtner, MD. Head of Safety and Pharmacovigilance.|+31 (0)20 240 52 50|k.traudtner@kiadis.com|
22447795|NCT00203996|The University of Chicago|David A. Ehrmann, MD|(773) 702-6138|dehrmann@medicine.bsd.uchicago.edu|
22447796|NCT03064451|Johnson and Johnson Medical NV/SA|Nathalie Macours / Clinical Research Director|+32 2 746 35 27|nmacours1@its.jnj.com|
22447797|NCT00897104|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22447798|NCT00750204|Johns Hopkins University School of Medicine|Roy Brower, M.D.|1 (410) 614-6292|rbrower@jhmi.edu|
22447799|NCT01217840|Stanford University|Sejal Shah MD|6507211811|sshah2@stanford.edu|
22447800|NCT00434330|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
22447801|NCT00850564|Massachusetts General Hospital|Steven Grinspoon, MD|617-724-9109|sgrinspoon@partners.org|
22447802|NCT03032705|Tufts University School of Dental Medicine|Dr Gerard Kugel|(617) 636-0870|Gerard.Kugel@tufts.edu|
22447803|NCT03482440|University of Iowa|Anna Stanhewicz|3194671732|anna-stanhewicz@uiowa.edu|
22447804|NCT02167893|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22447805|NCT04818840|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
22447806|NCT01804075|Eastern Maine Medical Center|Dr. Mark Brown|207-973-9503|mbrown@emh.org|
22447807|NCT01730833|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22447808|NCT04847557|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22447809|NCT01325584|Midwestern Regional Medical Center|Director of Clinical Trials|847-731-1648|Bruce.Steinert@CTCA-Hope.com|
22447810|NCT01853826|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22447811|NCT00397982|University of Virginia|Craig Slingluff|434 924 1730|cls8h@virginia.edu|
22447812|NCT02152696|Yale University|Heping Zhang, PhD|203-785-5185|heping.zhang@yale.edu|
22447813|NCT04812964|VA Greater Los Angeles Healthcare System|Dr. Jonathan Jacobs|310-478-3711|jonathan.jacobs2@va.gov|
22447814|NCT02329730|Shanghai Public Health Clinical Center|Shuihua Lu|021-37990333|tubercle@gmail.com|2582
22447815|NCT00289315|Pennington Biomedical Research Center|Lori Steib|(225) 252-5030|Lori.Steib@pbrc.edu|
22447816|NCT02345850|The Emmes Company|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
22447817|NCT02758899|Washington University|Wilson Z. Ray|314-747-6145|rayz@wustl.edu|
22447818|NCT01909154|Hospital Universitario Puerta de Hierro Majadahonda, Madrid|Dr. Vaquero Crespo|91 191 7760|jesus.vaquero@salud.madrid.org|
22447819|NCT02392247|Virginia Commonwealth University|Dr.Bruce Spiess, Principal Investigator|804-828-2267|bruce.spiess@vcuhealth.org|
22447820|NCT04779489|UT Southwestern Medical Center|Dr. Solomon Woldu|214-648-9558|solomon.woldu@utsouthwestern.edu|
22447821|NCT00951665|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22447822|NCT02801942|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22447823|NCT02450903|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22447824|NCT05126901|Shield TX (UK) Ltd.|Clinical Operations, Shield TX (UK) Ltd.|+44 (0) 191 511 8500|info@shieldtherapeutics.com|
22447825|NCT00254540|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22447826|NCT00710710|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22386145|NCT02945176|Implandata Ophthalmic Products|Clinical Study Manager|+49 (0) 511 - 2204 2580|clinical@implandata.com|
22386146|NCT05244187|MEDIcept Inc|Adelina Paunescu, VP Clinical Affairs|781-526-8152|apaunescu@medicept.com|
22386147|NCT04308681|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22386148|NCT05086796|Cedars-Sinai Medical Center|Itai Danovitch, MD|310-423-2600|itai.danovitch@cshs.org|
22386149|NCT00429364|New England Research Institutes, Inc.|Paul Stark, PhD|617-972-3362|pstark@neriscience.com|
22386150|NCT05873556|University of Washington|Dr. Anne Fairlie|2062215896|afairlie@uw.edu|
22386151|NCT04047602|Indiana University Health|Kevin Shiue, MD|317 944 2524|kshiue@iuhealth.org|
22386152|NCT04689256|UMass Chan Medical School/UMass Memorial Health|Dr. Brian Silver|508-334-5989|Brian.Silver@umassmemorial.org|
22386153|NCT04867278|Emory University|Dr. Adam Boissonneault|(404) 616-1000|adam.boissonneault@emory.edu|
22386154|NCT04862234|Emory University|Georgia Davis, MD|404-251-8957|georgia.marie.davis@emory.edu|
22386155|NCT04484428|Kowa Research Institute, Inc.|Director, Clinical Operations|919-433-1600|CTGResults@KowaUS.com|
22386156|NCT00661141|Horizon Pharma USA, Inc.|Beth Robinson, Executive Director||clinicaltrials@horizonpharma.com|
22386157|NCT05828017|Sonova|Bilal Sheikh - Research Audiologist|2268083260|bilal.sheikh@sonova.com|
22386158|NCT04132518|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
22386159|NCT05425420|Duke University|Kanecia Zimmerman|919-668-8651|kanecia.zimmerman@duke.edu|
22386160|NCT04999111|Janssen R&D US|SENIOR ADVISOR CLINICAL DEVELOPMENT|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22386161|NCT03714815|Actelion Pharmaceuticals Ltd|Clinical Scientific Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22386162|NCT05987072|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22386163|NCT03169972|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22386164|NCT00670241|LEO Pharma|Anders Rhod Larsen, Scientific Advisor|+4572262990|anders.larsen@leo-pharma.com|
22386165|NCT04056611|Janssen Research & Development, LLC|Senior Director Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22386166|NCT02946736|Oregon Health & Science University|Dr. Leslie Hammer, PI|503-494-9313|hammerl@ohsu.edu|
22386167|NCT03213873|Karolinska Institutet|Erika Franzén|08-52488878|erika.franzen@ki.se|
22447827|NCT00715078|Dendreon|Shabnam Vaziri|206-455-2323|Svaziri@Dendreon.com|
22447828|NCT01313767|Clinical Development Team of Medytox Inc.|Medytox Inc.|82-70-8666-6911|hgpark@medytox.com|
22447829|NCT01529346|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22447830|NCT00258882|Sanofi Pasteur Inc|Medical Drector||RegistryContactus@sanofipasteur.com|
22447831|NCT04867850|Abramson Cancer Center|Dr. Samuel Takvorian|267-438-8269|Samuel.takvorian@pennmedicine.upenn.edu|
22447832|NCT02282020|AstraZeneca AB|Global Clinical Leader|1-877-240-9479|ClinicalTrialTransparency@astrazeneca.com|
22447833|NCT00588848|MetroHealth Medical Center|Dr. Dennis Auckley|216-778-7212|dauckley@metrohealth.org|
22447834|NCT00249444|Columbia University|Dr Wilfrid Raby|212-923-3031|rabywil@nyspi.columbia.edu|
22447835|NCT01499667|Novartis Pharnaceuticals|Study Director|862-778-8300||
22447836|NCT02673489|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22447837|NCT00232817|Columbia University|Dr. Pamela Flood|201-370-3933|pamelaflood181@gmail.com|
22447838|NCT01711177|Université de Montreal|Pierre Forcier|514-343-7468|pierre.forcier@umontreal.ca|
22447839|NCT01084174|Johns Hopkins University|Robert A. Wood, MD|410-955-5883|rwood@jhmi.edu|
22447840|NCT04273217|AbViro LLC|Urban Ramstedt|617-818-8112|urban.ramstedt@abviro.com|
22447841|NCT04532099|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22447842|NCT05492942|Boston Medical Center, Internal Medicine|Emily Hurstak, MD MPH|(617) 414 5951|emily.hurstak@bmc.org|
22447843|NCT02506153|SWOG Statistics and Data Management Center|Melanoma Committee Statistician|2066674623|jmoon@fredhutch.org|
22447844|NCT03103919|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22447845|NCT01124422|GlaxoSmithKline|GSK Response Center|866-435-7343||
22447846|NCT01828281|Chinese University of Hong Kong|Prof David SC Hui|2632 3134|dschui@cuhk.edu.hk|
22447847|NCT02959944|Pharmacyclics, LLC|Justin Wahlstrom MD|669-215-7210|jwahlstrom@pcyc.com|
22447848|NCT03454893|AVROBIO, Inc|AVROBIO MedInfo|617-914-8419|medinfo@avrobio.com|
22447849|NCT04876274|School of Pharmacy, Taipei Medical University|Professor Hsiang-Yin Chen|(02)2736-1661|shawn@tmu.edu.tw|6175
22447850|NCT02606604|Stony Brook University|Lori Hochman|631-444-1193|lori.hochman@stonybrook.edu|
22447851|NCT03070782|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
22447852|NCT01830699|Keesler Medical Center|Matthew B. Carroll, MD|228-376-3629|matthew.carroll.1@us.af.mil|
22447853|NCT03527966|Virtua Health Inc.|Jillian Hoopes|856-761-3904|jhoopes@virtua.org|
22447854|NCT01948050|Beth Israel Medical Center|Helena Knotkova, PhD|212-844-8541|hknotkov@chpnet.org|
22447855|NCT02288559|Hoffmann-La Roche|Medical Communications|(+41) 616878333|global.trial_information@roche.com|
22447856|NCT01313936|UCSF Dept of Pediatrics|Steven DuBois, MD|415-476-3831|duboiss@peds.ucsf.ed|
22447857|NCT02709785|Saint Louis University|D. Douglas Miley|314-977-8381|ddouglas.miley@health.slu.edu|
22447858|NCT02135146|University of Colorado|Nick Naughton, Professional Research Assistant|3037200833|nick.naughton@cuanschutz.edu|
22447859|NCT01961323|Icahn School of Medicine at Mount Sinai|Dr. Partho Sengupta|212-659-8847|partho.sengupta@mountsinai.org|
22447860|NCT00810407|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22447861|NCT00449046|GlaxoSmithKline|GSK Response Center|866-435-7343||
22447862|NCT03472469|The University of Texas Health Science Center at Houston|John A. Harvin, MD|(713) 500-7244|John.Harvin@uth.tmc.edu|
22447863|NCT02320149|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22386168|NCT01385189|George Washington University|Dr. David J. Diemert, Associate Professor|202.994.2909|ddiemert@gwu.edu|
22447864|NCT00276159|Masonic Cancer Center, University of Minnesota|Sarah Cooley, MD|612-625-8474|cool0023@umn.edu|
22430284|NCT01260311|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22430285|NCT00478140|The University of Texas (UT) MD Anderson Cancer Center|Dr. Ahmed Kaseb / Associate Professor|713-792-2828|akaseb@mdanderson.org|
22430286|NCT00684554|New York State Psychiatric Institute|Dr. Frances Levin|646-774-6137|frl2@columbia.edu|
22430287|NCT00425854|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22430288|NCT01630811|Sutter Medical Group, Neurology|Michael Chez, MD|(916) 454-6667|ChezM@sutterhealth.org|
22430289|NCT01217411|University of Texas (UT) MD Anderson Cancer Center|Morris D. Groves, MD / Professor|713-792-2573|mgroves@mdanderson.org|
22430290|NCT01725308|Astellas Pharma Inc.|Head of Clinical Development Administration||Astellas.resultsdisclosure@astellas.com|
22430291|NCT05094102|University of Wisconsin School of Medicine and Public Health|Heather Neuman, MD, MS|(608) 262-2025|neuman@surgery.wisc.edu|
22430292|NCT05652140|Department of Physical Education and Sport Sciences, National Taiwan Normal University|Dr. Yu-Kai Chang|+886277493223|yukaichangnew@gmail.com|
22430293|NCT03375164|Sarepta Therapeutics, Inc.|Medical Director|888-727-3782|SareptAlly@sarepta.com|
22430294|NCT02598973|Crescenz VA Medical Center|James Morley|215-823-5934|james.morley@va.gov|
22430295|NCT06048705|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22430296|NCT02614066|Kite, A Gilead Company|Medical Information|844-454-5483(1-844-454-KITE)|medinfo@kitepharma.com|
22430297|NCT04565756|Exonate|Loic Lhuillier|+44 (0)1223 734716|loic.lhuillier@exonate.com|
22430298|NCT04274218|US Department of Veterans Affairs|Matthew Major|3125035731|matthew.major2@va.gov|
22430299|NCT00968968|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22430300|NCT04401293|System Director - Anticoagulation and Clinical Thrombosis Services Northwell Health at Lenox Hill Hospital Affiliation: Northwell Health|Alex Spyropoulos, MD|(212) 434-6776|aspyropoul@northwell.edu|
22430301|NCT01339013|Region Skane, Lund University Hospital, Lund, Sweden|Dr Louise Walther Sturesson|+46 46 171953|louise.waltersturesson@skane.se|
22430302|NCT00308282|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22430303|NCT01783938|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22430304|NCT03782103|Zurex Pharma|Andrew Morgan Exec. VP RA/QA Clinical|16082175239|amorgan1@charter.net|
22430305|NCT00930176|Bio Products Laboratory|Head of Medical Affairs|+44 20 8957 2200|medinfo@bpl.co.uk|
22430306|NCT00964444|Pinnacle Health|David B. Peisner MD|717-231-8472|dpeisner@pinnaclehealth.org|
22430307|NCT01292538|Regulatory Insight, Inc.|Elvira Walls|615-712-9743|elvira@reginsight.com|
22430308|NCT03315559|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22430309|NCT01712074|Pfizer|Pfizer|1-8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22430310|NCT03478787|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22430311|NCT02413346|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22430312|NCT02403778|Univesity Colorado Ansshutz Medical Campus|Martin McCarter|303-724-2728|martin.mccarter@ucdenver.edu|
22430313|NCT02978508|Mayne Pharma LLC|Associate Director, Clinical Operations|919 573 7948|phoevos.hughes@maynepharma.com|
22430314|NCT02766478|Emory University|Dr. Jessica Alvarez|404-727-1390|jessica.alvarez@emory.edu|
22430315|NCT05626686|Coloplast|Zenia Størling, Senior Director of Clinical Strategies|+4549111869|dkzenst@coloplast.com|
22430316|NCT00682435|Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore Medical Center|Andrew Chang, MD, MS|718-920-7464|achang@montefiore.org|
22430317|NCT00089583|ViiV Healthcare|GSK Response Center|866-435-7343||
22430318|NCT03289741|Memorial Sloan Kettering Cancer Center|Dr. Nitya Raj, MD|646-888-4849|rajn@mskcc.org|
22430319|NCT04921800|Northwestern University|Shuai Xu|312-695-3721|stevexu@northwestern.edu|
22447865|NCT04356690|Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center|John Mark Sloan, MD|617-638-7002|mark.sloan@bmc.org|
22447866|NCT00333866|Organization: Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22447867|NCT06073119|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
22447868|NCT00456547|Northwestern University Feinberg School of Medicine|Dr. Robert J McCarthy, Pharm D|312-926-9015|r-mccarthy@northwestern.edu|
22447869|NCT01359449|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22447870|NCT00330564|UT MD Anderson Cancer Center|Quality Assurance Specialist|713-563-1602|caperez@mdanderson.org|
22447871|NCT02408315|Indiana University School of Medicine|Dr. David M. Haas|317-880-3949|dahaas@iu.edu|
22447872|NCT01907815|The University of Texas MD Anderson Cancer Center|Nitin Jain, MD, Assistant Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
22447873|NCT00191789|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22447874|NCT01414855|Genentech, Inc.|Medical Communications|800-821-8590|genetech@druginfo.com|
22447875|NCT03194698|Mayo Clinic|Joanne F. Shen, M.D.|480-301-8085|Shen.Joanne@mayo.edu|
22447876|NCT01937559|Hawkins Foundation|Kyle Adams, Research Coordinator|864-454-7458|kyle.adams@hawkinsfoundation.com|
22447877|NCT03653637|James J. Peters VA Medical Center|Dr. Marianne Goodman|6462457071|mggoodman2001@yahoo.com|
22447878|NCT01346839|Michael E. DeBakey VA Medical Center and Baylor College of Medicine|Dr. Hardeep Singh|713-794-8515|hardeeps@bcm.edu|
22447879|NCT02068443|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22447880|NCT03879655|Mandos, LLC|Executive Vice President, Regulatory Affairs|619-905-0489|jspinella@mandoshealth.com|
22447881|NCT02723084|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22447882|NCT00139399|Imperial College London|Dr Carolyn Webb|03301288860|c.webb@imperial.ac.uk|
22447883|NCT04067544|University of Utah College of Nursing|Lisa Taylor-Swanson|801.585.5486|lisa.taylor-swanson@nurs.utah.edu|
22447884|NCT01320085|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22430320|NCT02318979|Denver Research Institute|Judith Jung, DRI Executive Director|303-501-0540|Judith.Jung@dri-va.org|
22430321|NCT00992394|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22430322|NCT01245049|GlaxoSmithKline|GSK Response Center|866-435-7343||
22430323|NCT00450749|University of Texas MD Anderson Phase I/II Prevention Consortium|Powel H Brown, MD, PhD/Professor of Medicine and Cancer Prevention|713-792-2830|PHBrown@mdanderson.org|
22430324|NCT02151604|Oxford University Hospitals NHS Foundation Trust|Avianna Laws, Clinical Research Operations Manager|01865 (2)26221|avianna.laws@ouh.nhs.uk|
22430325|NCT01395537|Case Comprehensive Cancer Center|David Adelstein MD|216-444-9310|adelstd@ccf.org|
22430326|NCT00537082|Novartis Pharmaceuticals|Study Director|862-778-8300||
22430327|NCT04495478|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22430328|NCT00655746|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22430329|NCT00561821|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22430330|NCT03178942|Encube Ethicals Pvt ltd|GM-Strategy & Commercial|+91-22-6228-8000|Pratik.K@EncubeEthicals.com|8003
22447885|NCT01432886|Eisai Co., Ltd.|Tadashi Nakanishi|81-3-3817-5252||5252
22447886|NCT00225251|NY State Psychiatric Institute|David Hellerstein MD|6467748000|hellers@nyspi.columbia.edu|
22447887|NCT01702454|GlaxoSmithKline|GSK Response Center|866-435-7343||
22430331|NCT03645681|W. L. Gore & Associates|Bre Lester|480-698-6670|blester@wlgore.com|
22430332|NCT03508440|University of Missouri|Rebecca Schneider, Assistant Director of Research|573-882-2549|schneiderri@health.missouri.edu|
22430333|NCT01197300|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22447888|NCT00082355|NIHCC|Dr Richard Chang|301-402-0256|rchang@cc.nih.gov|
22447889|NCT01207765|Tufts Medical Center|Andreas Klein, MD|617-636-8884|aklein2@tuftsmedicalcenter.org|
22430334|NCT04526925|Rush University|Jie Li|3125634643|jie_li@rush.edu|
22430335|NCT05170061|SUNYBuffalo|Joseph Izzo MD|7168985625|jizzo@buffalo.edu|
22430336|NCT03443401|USouthDakota|Kory Zimney, PhD|6056586373|kory.zimney@usd.edu|
22430337|NCT02363283|UT MD Anderson Cancer Center|Dr. Sapna Pradyuman Patel,MD/ Melanoma Medical Oncology|713-792-2921|SPPatel@mdanderson.org|
22399849|NCT02040142|Montefiore Medical Center|Dr. John McAuliffe, Associate Professor Department of Surgery and Department of Pathology|718-379-6865|jomcauli@montefiore.org|
22430338|NCT02257138|The University of Texas MD Anderson Cancer Center|Dr. Farhad Ravandi-Kashani|713-745-0394|fravandi@mdanderson.org|
22430339|NCT00530257|The Children's Hospital of Philadelphia|Dr. Nathan Blum|215-590-6336|blum@email.chop.edu|
22430340|NCT00385515|Mucosal Therapeutics, LLC|Eward G. Fey, PhD|857-228-1100||
22430341|NCT03676270|Institut Bergonié|Pr Antoine Italiano|335 56333333|a.italiano@bordeaux.unicancer.fr|
22430342|NCT04110145|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22430343|NCT05401409|Westmead Hospital and Westmead Institute for Medical Research|Prof Gopala Rangan|8627 3000|g.rangan@sydney.edu.au|
22430344|NCT02562040|Brigham and Women's Hospital|Dr. Susan Redline|(617) 732-5500|sredline@bwh.harvard.edu|
22430345|NCT04804709|Columbia University Irving Medical Center|Cheng-Chia Wu, MD, PhD|646-317-3033|cw2666@cumc.columbia.edu|
22430346|NCT02255279|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
22447890|NCT01411696|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22447891|NCT02233309|University of Nebraska Children's Hospital & Medical Center|Jessica K. Goeller, DO|(402) 955-4303|JGoeller@childrensOmaha.org|
22399850|NCT02797470|Statistical and Data Analysis Center, AIDS Malignancy Consortium|Deukwoo Kwon|(713) 500-7964|deukwoo.kwon@mountsinai.org|
22399851|NCT05142826|Florida International University|Gregory A. Fabiano, Ph.D.|716-359-7823|gfabiano@fiu.edu|
22399852|NCT03120832|Senseibio|Ramzi Melhem MD Medical Director|9168336928|rmelhem@senseibio.com|
22399853|NCT00954109|Harry S Truman Memorial VA Hospital and University of Missouri|John Thyfault, Associate Professor|573-814-6000|thyfaultj@health.missouri.edu|53742
22399854|NCT00667615|Memorial Sloan Kettering Cancer Center|David Straus MD|212-639-8365|strausd@mskcc.org|
22399855|NCT00895830|Acacia Pharma Ltd|Dr Gabriel Fox||gabrielfox@acaciapharma.com|
22399856|NCT00382031|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com|
22399857|NCT00288574|NYSPI|BT Walsh, MD|646-774-8066|edru@nyspi.columbia.edu|
22413140|NCT04407806|William Beaumont Hospital|Dr. Graham Krasan, Pediatric Infectious Disease Specialist|248-551-0046|graham.krasan@beaumont.org|
22413141|NCT03447262|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22413142|NCT01541891|Laboratorios Sophia, SA de CV|Baiza-Duran Leopoldo, Medical Director|+52 (33)30014200|leopoldo.baiza@sophia.com.mx|
22413143|NCT00374335|Children's Mercy Hospitals and Clinics|Dr. Kimberly Horii|816-234-3924|kahorii@cmh.edu|
22413144|NCT01375660|Jesse Brown VA Medical Center|Dr. Barengolts, Attending Endocrinologist, Chief, Section of Endocrinology|312-569-7651|Elena.Barengolts@va.gov|
22413145|NCT02058498|Mayo Clinic Jacksonville|Jennifer Serotta, DNP, ARNP|904-956-3200|serotta.jennifer@mayo.edu|
22413146|NCT04605094|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22413147|NCT02724462|Fred Hutchinson Cancer Research Center|Dr. Jonathan Bricker|206-667-5077|jbricker@fredhutch.org|
22413148|NCT00979303|Children's Hospital Boston|Christina Miyake|832-826-5650|cymiyake@bcm.edu|
22413149|NCT00469417|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22413150|NCT02059070|Wayne State University, School of Medicine|Pranav Patel|313-745-7233|gmckelve@dmc.org|
22413151|NCT02188303|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22413152|NCT02589808|Imperial College|Petros Nihoyannopoulos|020 3311 3311|p.nihoyannopoulos@imperial.ac.uk|
22430347|NCT01161121|St. Louis University|Dr. Michael Lim|314-268-7992|limmj@slu.edu|
22447892|NCT01067456|MGH|Dr. Udo Hoffmann|617-726-1255|uhoffmann@partners.org|
22447893|NCT02328755|University of Michigan|John Magenau|734 936-8785|johnmage@med.umich.edu|
22386169|NCT02631746|Duke University - Duke Cancer Institute LAO|Christy Arrowood|919-613-6130|christy.arrowood@duke.edu|
22386170|NCT04709419|The University of Texas Health Science Center at San Antonio|Lawrence Lavery, DPM|214-399-5381|lavery@uthscsa.edu|
22386171|NCT02056834|Synthes GmbH|Clinical Research Scientist Biomaterials|0041327204465|clinicalaffairs.emea@synthes.com|
22386172|NCT05723575|University of Wisconsin - Madison|Carrie Niziolek, PhD|(608) 262-7583|cniziolek@wisc.edu|
22386173|NCT06397443|IRCCS Istituto Ortopedico Rizzoli|Dr. Manila Boarini|+39 051 63666062|manila.boarini@ior.it|
22386174|NCT03367754|Clinical Center|Kovacs, Joseph|+1 301 496 9907|jkovacs@mail.nih.gov|
22386175|NCT03149822|University of Colorado Hospital|Dr. Elaine Lam|7208480723|elaine.lam@cuanschutz.edu|
22386176|NCT03687762|The University of Queensland|Dr. Melissa Day, Co-Principal Investigator|+61 7 3365 6421|m.day@uq.edu.au|
22386177|NCT04580914|Boston Scientific|Claire Dietzsch, Senior Clinical Trials Specialist|9529306745|Claire.Dietzsch@bsci.com|
22447894|NCT00475176|National Institute of Diabetes and Digestive and Kidney Diseases, National In|Jay H. Hoofnagle, M.D.|301-496-1333|hoofnaglej@mail.nih.gov|
22447895|NCT01484873|Vanderbilt University|Ashley Shoemaker|615-343-8116|ashley.h.shoemaker@vanderbilt.edu|
22447896|NCT01549392|London Health Sciences Hospital|Barbara Fisher|519-685-8650|barbara.fisher@lhsc.on.ca|
22447897|NCT00227903|Yale University|Dr. Kimberly Yonkers|1-203-764-6621|Kimberly.Yonkers@yale.edu|
22447898|NCT01475331|Milton S. Hershey Medical Center|Dr. Matthew T. Moyer|717-531-3694|mmoyer@pennstatehealth.psu.edu|
22386178|NCT00544414|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22447899|NCT00462761|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22386179|NCT02828358|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22386180|NCT03298945|Corporal Michael J. Crescenz Department of Veterans Affairs Medical Center|Yu-Xiao Yang, MD, MSCE|215-823-5800|yuxiao.yang@va.gov|
22447900|NCT02877082|Emory University/Winship Cancer Institute|Zaid Al-Kadhimi, MD|404-778-1900|zalkadh@emory.edu|
22386181|NCT03702270|VANDERBILT UNIVERSITY MEDICAL CENTER|Dr. Cosby A Stone, Jr.|6153223412|Cosby.a.stone@vumc.org|
22447901|NCT01843751|University of Wisconsin|Randall Brown|608-263-6558|rtbrown@wisc.edu|
22386182|NCT05285137|Cidara Therapeutics, Inc.|Chief Medical Officer|858-888-7868|clinicaltrialinfo@cidara.com|
22447902|NCT00311623|Duke University|Andrew Armstrong, MD ScM FACP|(919) 668-8797|andrew.armstrong@duke.edu|
22447903|NCT03998189|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-713-4550|aohlmans@wakehealth.edu|
22447904|NCT04983264|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22447905|NCT05081011|Stanford University|Ashwin K Nayak, MD|(650) 725-5071|aknayak@stanford.edu|
22447906|NCT00558025|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22447907|NCT01506479|University of Pittsburgh|Dr. Charity G. Moore|412-383-6630|cgp22@pitt.edu|
22447908|NCT01980914|Gerontology Research Unit|Boris Feldman|6048755115|boris.feldman@vch.ca|
22447909|NCT05247866|Children's Hospital of Philadelphia|Jonathan Spergel|2155902549|spergel@chop.edu|
22447910|NCT04994522|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22447911|NCT03315208|Massachusetts General Hospital/Harvard Medical School|Dr. Kate Bentley|617-724-7741|kbentley@mgh.harvard.edu|
22447912|NCT02746874|Northwestern University|David Walega, MD|312-695-0061|d-walega@northwestern.edu|
22447913|NCT00473642|Retina Specialists of Michigan|Scott Westhouse, DO|616-954-2020|s.westhouse@gmail.com|
22447914|NCT01156311|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22386183|NCT05309291|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
22386184|NCT02568566|University of Arizona|Sherry Chow, PhD|520-626-3358|schow@azcc.arizona.edu|
22386185|NCT03221426|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22386186|NCT06262477|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22386187|NCT06130410|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22386188|NCT05365958|University of Houston|Dr. Chakema Carmack, Ph.D., Associate Professor|713-743-6231|ccarmack@central.uh.edu|
22386189|NCT03397654|Imperial College London|Dr David Pinato|+44 20 7594 2799|david.pinato@imperial.ac.uk|
22386190|NCT03220035|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22386191|NCT05270876|Cochlear|PRS Specialist|+61294286555|cltd-prs-admin@cochlear.com|
22386192|NCT04432506|The University of Texas MD Anderson Cancer Center|Paolo Strati, MD|(713) 745-1776|pstrati@mdanderson.org|
22386193|NCT04200911|UT Health San Antonio|Mitzi Gonzales, PhD|210-450-9047|Gonzalesm20@uthscsa.edu|
22386194|NCT04024020|University of Pennsylvania|Philip Gehrman|2157463578|philip.gehrman@pennmedicine.upenn.edu|
22386195|NCT05269966|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22399858|NCT01926626|Duke Center for Smoking Cessation|Dr. Jed E. Rose|919-668-5055|jed.rose@duke.edu|
22399859|NCT03636906|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22399860|NCT05070338|RAND Corporation|Katherine E. Watkins|310-393-0411|kwatkins@rand.org|6509
22399861|NCT03431467|The Hospital of the University of Pennsylvania|Dr. Christian Bermudez|2153165151|christian.bermudez@pennmedicine.upenn.edu|
22399862|NCT02292771|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22399863|NCT04596891|New York State Psychiatric Institute|Dr. Yuval Neria|646-774-8092|ny126@cumc.columbia.edu|
22399864|NCT04280081|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22399865|NCT01468311|National Cancer Institute|Dr. Kevin C. Conlon|240-858-3570|gconlonkc@mail.nih.gov|
22399866|NCT00023322|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Theo Heller, M.D.|(301) 402-7147|Theoh@mail.nih.gov|
22447915|NCT06185374|NYU Langone Health|Peter Liang, MD|(212) 686-7500|peter.liang@nyulangone.org|5745
22447916|NCT06133348|University of Alabama at Birmingham Cancer Center|Gabrielle Rocque, MD, MSPH|205-996-9281|grocque@uabmc.edu|
22447917|NCT00003644|NRG Oncology|Linda Gedeon, Christopher Purdy on behalf of Mark Brady, PhD|(716) 845-1169|lgedeon@gogstats.org|
22447918|NCT02393547|Mayo Clinic|Ryan T. Hurt, MD|507-266-1944|nicotineresearch@mayo.edu|
22447919|NCT03545165|Weill Cornell Medicine|Scott Tagawa MD, Principal Investigator|646-962-2072|guonc@med.cornell.edu|
22447920|NCT00429104|University of Texas MD Anderson Cancer Center|Naoto Ueno, MD.PhD./Professor|713-792-8754|CR_Study_Registration@mdanderson.org|
22447921|NCT02493621|MUSC|Sylvia Wilson|8437922322|wilsosh@musc.edu|
22447922|NCT01370174|University of Maryland|Dr. Vicki Gray Principal Investigator|4107063778|vicki.gray@som.umaryland.edu|
22447923|NCT00345254|Edith Wolf son Medical Cemter|Samuel Lurie|+972-35028329|drslurie@hotmail.com|
22447924|NCT06316973|Clear Scientific|Piercen Oliver|617-621-8500|poliver@clearsci.com|
22447925|NCT03078647|Candela Corporation|Director of Clinical Marketing|(949) 599-7646|doranr@candelamedical.com|
22447926|NCT04997161|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22447927|NCT00752232|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22447928|NCT04502589|Virginia Commonwealth University|Albert Arias, M.D.|(804) 828-5793|albert.arias@vcuhealth.org|
22447929|NCT02663232|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22447930|NCT02730455|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
22447931|NCT02733367|Diurnal|Information Line|+44 (0) 2920 682069|info@diurnal.co.uk|
22447932|NCT02532933|University Of Denver|Kevin Shelburne|3039021249|kevin.shelburne@du.edu|
22447933|NCT01922089|Novartis Pharmaceuticals|Study Director|862-778-8300||
22447934|NCT02988843|Masonic Cancer Center, University of Minnesota|Dr. Shilpa Gupta|612 624 0123|guptash@umn.edu|
22447935|NCT05582889|University of New Mexico|Dr. Cindy Blair|5059257907|CiBlair@salud.unm.edu|
22447936|NCT00001723|National Institute of Child Health and Human Development, NIH|Jack A. Yanovski, MD, PhD, Chief SGO, PDEGEN|301-496-4686|yanovskj@mail.nih.gov|
22447937|NCT02170051|Professor of Psychiatry, UC San Diego|Elizabeth W Twamley, PhD|858-642-3848|etwamley@health.ucsd.edu|
22447938|NCT04551092|Quantum Applied Science & Research, QUASAR Inc.|Gayle Guy|858 412 1839|gayle@quasarusa.com|
22447939|NCT01324999|University of North Carolina at Chapel Hill|H. James Ford, MD|(919) 966-2531|hjford@med.unc.edu|
22447940|NCT01712490|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22447941|NCT02423876|University of Wisconsin Carbone Cancer Center|Cancer Connect|800-622-8922|clinicaltrials@cancer.wisc.edu|
22447942|NCT01966900|Imperial College London|Dr Tom Cole|+44(0)2033136198|t.cole@imperial.ac.uk|
22447943|NCT00060008|Children's Hospital of Philadelphia|Dr. Michael Fisher|215 590 2800|fisherm@email.chop.edu|
22447944|NCT03748758|Novus Therapeutics|Clinical Director|949-679-1110|study002@novustherapeutics.com|
22447945|NCT01932112|Seoul St Mary's hospital|Y. Oh, director of clinical trial|82-2-2258-1141|oys@catholic.ac.kr|
22447946|NCT00560859|University of Pennsylvania|Dr. Susan S. Ellenberg|215-573-3904|sellenbe@upenn.edu|
22447947|NCT02503735|Massachusetts General Hospital|Dr. Meghan Sise|617-726-5050|MSise@partners.org|
22447948|NCT01714635|Abbott Medical Optics|Kendra Hileman, Ph.D., Director, Clinical Research & Development|714-247-8613|kendra.hileman@amo.abbott.com|
22447949|NCT02860169|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22447950|NCT01782495|AbbVie|Global Medical Services|800-633-9110||
22447951|NCT03057431|Inselspital, Bern University Hospital, Bern, Switzerland|Prof. Daniel Fuster|++41316323144|daniel.fuster@insel.ch|
22447952|NCT00396591|sanofi-aventis|Trial Transparency Team||Contact-Us@sanofi.com|
22447953|NCT01962207|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22447954|NCT01535053|NRG Oncology|Linda Gedeon for Virginia Filiaci, PhD.|716-845-1169|lgedeon@gogstats.org|
22447955|NCT00512707|Brigham and Women's Hospital|Dr. Shalender Bhasin|617-525-9150|sbhasin@partners.org|
22447956|NCT04309656|TB Alliance|Erica Egizi|917-696-4984|erica.egizi@tballiance.org|
22447957|NCT03720470|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22447958|NCT01988103|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
22447959|NCT00176826|University of Minnesota|Dr. Angela Smith|612-626-2778|smith719@umn.edu|
22447960|NCT01946425|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22447961|NCT02451839|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22447962|NCT05682326|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22447963|NCT01402544|Univeristy of California, San Diego|Dr. Henry Ferreyra|858-822-7982|hferreyra@ucsd.edu|
22447964|NCT01113801|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22447965|NCT00877877|GlaxoSmithKline|GSK Response Center|866-435-7343||
22447966|NCT02734238|Pennington Biomedical Research Center|Jennifer C. Rood|225-763-2524|jennifer.rood@pbrc.edu|
22447967|NCT01949051|GlaxoSmithKline|GSK Response Center|866-435-7343||
22447968|NCT02935088|Abbott Vascular|Tarn Teraphongphom, Sr. Clinical Scientist|408-9310504|tarn.teraphongphom@abbott.com|
22447969|NCT04545866|University of Alabama at Birmingham|Namasivayam Ambalavanan MD|2059344680|nambalav@uabmc.edu|
22447970|NCT02311933|Alliance for Clinical Trials in Oncology|Matthew P. Goetz, MD|: 507-284-2511|goetz.matthew@mayo.edu|
22447971|NCT04463719|University of Florida|Naykky Singh Ospina|(352) 273-8655|naykky.singhospina@medicine.ufl.edu|
22447972|NCT02436356|Vanderbilt University Medical Center|Jeffry S. Nyman, Ph.D.|615-936-6296|jeffry.s.nyman@vumc.org|
22447973|NCT02875860|Baylor College of Medicine|Dr. Michael Belfort|832-826-7375|belfort@bcm.edu|
22447974|NCT03287804|Autolus Ltd|Clinical Project Manager|+44 1483 920748|clinicaltrials@autolus.com|
22447975|NCT01881776|StLukeNY|Dr.Admir Hadzic|212-665-1400|admir@nysora.com|
22447976|NCT00487747|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22447977|NCT04483011|Bioenergy Life Science, Inc.|Alex Xue, Chief Technology Officer|763-746-0032|alex.xue@bioenergyls.com|3924
22447978|NCT01454947|University of Southern California|Jason N. Doctor|213.821.8142|jdoctor@usc.edu|
22447979|NCT01025791|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22447980|NCT02979522|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22447981|NCT02237950|Starpharma|Dr Jeremy Paull||jeremy.paull@starpharma.com|
22447982|NCT01896531|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22447983|NCT05185089|NeRRe Therapeutics Ltd|CMO|+44 (0)1438 906960|info@nerretherapeutics.com|
22447984|NCT00770289|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22447985|NCT02733991|Medtronic Diabetes EMEA|Ohad Cohen M.D., Medical Affairs Director|+972 54 321 1108|ohad.cohen@medtronic.com|
22447986|NCT03483051|University of Pennsylvania|Dr. Julio Chirinos|215-200-7779|juliochi@pennmedicine.upenn.edu|
22447987|NCT02956486|Eisai Ltd.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22447988|NCT01905384|Vanderbilt University Medical Center|Sharee Burkeen, Research Program Manager|(615) 875-7515|sharee.k.burkeen@vumc.org|
22447989|NCT01485770|Jazz Pharmaceuticals|Director, Disclosure & Transparency|(215) 970-7145|ClinicalTrialDisclosure@JazzPharma.com|
22447990|NCT02151253|Duke University Health System|Andrew D. Krystal, MD, MS|919-971-4355|andrew.krystal@duke.edu|
22399867|NCT00142506|MEMORIAL SLOAN KETTERING CANCER CENTER|MICHAEL J ZELEFSKY|+1212-639-6802|zelefskm@MSKCC.ORG|
22399868|NCT00937235|University of Pennsylvania|Dr. Edna Foa|2157463327|foa@mail.med.upenn.edu|
22399869|NCT00961532|Northwestern Medicine|Andrew M Naidech|312-503-3335|a-naidech@northwestern.edu|
22399870|NCT01133639|Mount Auburn|Emily Cook|(617) 354-3131|ecook@mah.harvard.edu|
22399871|NCT02511522|Canadian Cancer Trials Group|Dr. Chris O'Callaghan|6135336430|cocallaghan@ctg.queensu.ca|
22399872|NCT05194345|University of South Florida|Heewon Gray|(813) 974-9881|hlgray@usf.edu|
22399873|NCT03890679|Tufts Medical Center|Dr. Jonathan Davis|6176365322|jdavis@tuftsmedicalcenter.org|
22399874|NCT04854499|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22399875|NCT02612909|IVAC|Le Van Be|(+84 90) 3501529|ivaclevabe@dng.vnn.vn|
22447991|NCT02485574|Chung-Ang University hospital|Kwang-Sup Song|+82-1037616503|ksong70@cau.ac.kr|
22399876|NCT04214080|Marmara University|Assoc. Prof Aysel Yıldız Ozer|5334674433|aysel.yildiz@marmara.edu.tr|+90
22399877|NCT02863263|Mundipharma Singapore Holding Pte. Limited|Valerie Anne Leck|+65 6511 1165|info.rma@mundipharma.com.sg|
22447992|NCT01214811|Molnlycke Health Care|Viktoria Ahlenius Körner|0046 31 7223000|viktoria.ahleniuskorner@molnlycke.com|
22447993|NCT00255047|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22447994|NCT02704975|United States Army|Rob Halle|910-689-8887|robhalle@gmail.com|
22447995|NCT02403154|Indiana University|Krista Brown, Clinical Research Coordinator|317-963-1944|brownkm@indiana.edu|
22447996|NCT01585194|MD Anderson Cancer Center|Dr. Sapna P. Patel/Associate Professor, Melanoma Medical Oncology|713-792-2921|sppatel@mdanderson.org|
22447997|NCT00993291|Vanderbilt University|Fenna Phibbs M.D.|615-936-2025|fenna.phibbs@vanderbilt.edu|
22447998|NCT00003492|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22447999|NCT04446377|AI Therapeutics|Peter R. Young/Chief Scientific Officer|203-458-7100|pyoung@ai-thera.com|
22448000|NCT04152603|Seattle Children's Research Institute|Professor Stephanie Kraft|20688471022068841191|stephanie.kraft@seattlechildrens.org|
22448001|NCT01958320|University of California San Francisco|Ronald Clyman, MD PI|415-443-9305|clymanr@peds.ucsf.edu|
22448002|NCT03049280|Intuitive Surgical|Intuitive Surgical Clinical Affairs|408-523-2100|sylvie.akiel-fu@intusurg.com|
22448003|NCT01867021|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22448004|NCT01516346|University of Pennsylvania|Julio Chirinos, MD, PhD|215-573-6606|julio.chirinos@pennmedicine.upenn.edu|
22448005|NCT01129960|BIAL - Portela & Cª, S.A.|Director R&D|351-22-9866100|clinical.trials@bial.com|
22448006|NCT05740644|Zynex Monitoring Solutions|Clinical Team|888-386-4185|clinical@zynexmonitoring.com|
22448007|NCT02056340|Beth Israel Deaconess Medical Center|Dr Maureeen Chase, Assistant professor of Emergency Medicine|6177542298|mchase1@bidmc.harvard.edu|
22448008|NCT02032810|H. Lee Moffitt Cancer Center and Research Institute|Dr. Nikhil I. Khushalani|813-745-3437|nikhil.khushalani@moffitt.org|
22448009|NCT01927367|QEII Health Sciences Centre, Halifax, Nova Scotia|Dr. Jafna L Cox|(902) 473-7811|jafna.cox@dal.ca|
22448010|NCT00071513|Univeristy of Washington|Elizabeth McCauley, PHD, Principal Investigator|206-987-2579|eliz@uw.edu|
22448011|NCT01634360|Eisai Call Center|Eisai Inc.|888-422-4743||
22448012|NCT02743871|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22448013|NCT01973166|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
22448014|NCT03171415|Raziel Therapeutics|Racheli Gueta - Clinical Trials Manager|972-8-9126941|racheli@raziel-therapy.com|
22448015|NCT02848651|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22448016|NCT00883116|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22448017|NCT04140292|Cleveland Clinic Foundation|Maytin, Edward, V|1-866-223-8100|taussigresearch@ccf.org|
22448018|NCT00667004|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22448019|NCT01988857|GlaxoSmithKline|GSK Response Center|866-435-7343||
22448020|NCT00680043|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
22448021|NCT02484729|AstraZeneca AB|Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
22448022|NCT02480114|Vanderbilt University Medical Center|Derek Smith, DDS, PhD|6159367423|derek.k.smith@vumc.org|
22399878|NCT05067127|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
22448023|NCT01031069|GlaxoSmithKline|GSK Response Center|866-435-7343||
22448024|NCT01317160|Karolinska university Hospital|Dr. Paul W. Ackermann|+46851770000|paul.ackermann@karolinska.se|
22448025|NCT05286281|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22448026|NCT03578367|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
22448027|NCT01705288|Masonic Cancer Center at University of Minnesota|Dr. Peter Argenta|612-626-6283|argenta@umn.edu|
22448028|NCT02835274|Boston Scientific|Director of Clinical Sciences|6619494350|roshini.jain@bsci.com|
22448029|NCT01182493|CHU Caen|Prof. Yves Reznik|+33231064585|reznik-y@chu-caen.fr|
22448030|NCT00670800|University of Michigan|Yolanda Smith|(734) 936-7401|ysmith@umich.edu|
22448031|NCT00587561|VA Connecticut Healthcare System|Dr. Joanna Fiszdon|2039325711|joanna.fiszdon@va.gov|2231
22448032|NCT05661942|Advocate Health|Michael Cirone, MD|7086841710|michael.cirone@aah.org|
22448033|NCT02960776|Columbia University Irving Medical Center|Marie-Pierre St-Onge|212-305-9379|ms2554@cumc.columbia.edu|
22448034|NCT00360828|H. Lee Moffitt Cancer Center and Research Institute|Edward Pan, M.D.|813-745-3871|edward.pan@moffitt.org|
22448035|NCT02081690|Actelion Pharmaeuticals Ltd.|Clinical Trial Disclosure Manager||clinical-trials-disclosure@actelion.com|
22448036|NCT00959842|Professor|Dr. Greg Shearer|814-867-3040|gcs13@psu.edu|
22448037|NCT00982488|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22448038|NCT03204981|Icahn School of Medicine at Mount Sinai|Sam Cammack|212-824-8931|sam.cammack@mountsinai.org|
22448039|NCT04203238|Pennington Biomedical Research Center|Dr. Candida Rebello|2257633159|Candida.Rebello@pbrc.edu|
22448040|NCT01662908|Daiichi Sankyo, Inc.|Senior Director, CVM TA Development|732-590-5000||
22448041|NCT04244786|New York State Psychiatric Institute|Jeffrey Miller|646-774-7613|jeffrey.miller@nyspi.columbia.edu|
22448042|NCT03274687|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22448043|NCT01694641|Kaali Inst. IVF Center|Dr Peter Kovacs|36-1-202-2802|peterkovacs1970@hotmail.com|
22448044|NCT01572909|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
22448045|NCT01199289|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22448046|NCT02636868|Windtree Therapeutics, Inc.|Executive Director of Biostatistics & Data Management|215-488-9477|psimmons@windtreetx.com|
22448047|NCT02635828|The Ohio State Universtiy Wexner Medical Center|Director of Neuroanesthesia|6142933559|sergio.bergese@osumc.edu|
22448048|NCT02290509|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
22448049|NCT00415909|University of Texas MD Anderson Cancer Center|Jorge Cortes, MD / Professor, Leukemia|713-794-5783|CR_Study_Registration@mdanderson.org|
22448050|NCT05024058|Novartis Pharmaceuticals|Study Director|(862) 778-8300|novartis.email@novartis.com|
22448051|NCT00714389|University of Rochester|Gunhilde Buchsbaum, MD|585-273-3232|gunhilde_buchsbaum@urmc.rochester.edu|
22448052|NCT02734810|Anthera Pharmaceuticals|Monica Gangal|510-856-5600|info@anthera.com|
22448053|NCT00528398|City of Hope National Medical Center|Anthony Stein, M.D.|626-256-4673|AStein@coh.org|82405
22448054|NCT03626714|Auritec|Sarjan Shah|9092109715|sshah@auritecpharma.com|
22448055|NCT02127567|Assistance publique hopitaux de paris|Isabelle Boutron|+33 1 42 34 78 33|isabelle.boutron@htd.aphp.fr|
22386196|NCT05575219|The University of Texas Health Science Center at Houston|Andrea Leigh Heifner, MD|407-729-2972|andrea.heifner@stjude.org|
22448056|NCT02507505|University of Pennsylvania Perelman School of Medicine|Mark D. Neuman, MD, MSc (Principal Investigator)|215-746-7468|mark.neuman@uphs.upenn.edu|
22430348|NCT02722330|ENT Department, Royal Hallamshire Hospital, Sheffield|Professor Jaydip Ray|+44 (0)114 271 1900|jaydip.Ray@sth.nhs.uk|
22430349|NCT04392362|University of Pretoria|Dr. Amanda Makhubela|0722746091|neurosurgeon76@gmail.com|
22430350|NCT00432991|Weill Cornell Medicine, Department of Anesthesiology|Michele Steinkamp, Research Nurse Specialist|212-746-2953|mls9004@med.cornell.edu|
22430351|NCT00363467|H. Lee Moffitt Cancer Center|Jeffrey Lancet MD|813-745-6841|Jeffrey.Lancet@moffitt.org|
22430352|NCT02918630|The University of Texas Health Science Center at Houston|Jin Ho Yoon, PhD|(713) 486-2796|Jin.Ho.Yoon@uth.tmc.edu|
22430353|NCT03160573|University Health Resources Group|Sushma Nachnani, MS, PhD|(310) 645-8576|sushnach@yahoo.com|
22430354|NCT01620047|Gulf-to-Bay Anesthesiology Associates LLC|Director of Research|813-844-4413|rkarlnoski@fgtba.com|
22430355|NCT02389738|Johns Hopkins/NIH|Principal Investigator|4109558837|sjacks78@jhmi.edu|
22430356|NCT04565353|Behavior Change for Good initiative|Dr. Joseph Kay|2157466609|jskay@wharton.upenn.edu|
22430357|NCT02715856|UT MD Anderson Cancer Center|Dr. Robert Satcher, Associate Professor, Orthopaedic Oncology|(713) 794-5242|rlsatcher@mdanderson.org|
22430358|NCT00128492|Gilead Sciences, Inc.|Mark Bresnik, Director of Clinical Research|650-522-5934|Mark.Bresnik@gilead.com|
22430359|NCT03436420|Emory University|Miriam Vos, MD|404-727-9930|mvos@emory.edu|
22430360|NCT00756314|IMIP - Instituto Materno Infantil Prof. Fernando Figueira|Ana Laura Carneiro Gomes Ferreira - MD|+558121224779|analaura@imip.org.br|
22430361|NCT02605967|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22430362|NCT03627468|Botanix Pharmaceuticals|Anthony Robinson, MS, MBA, CRNP|+1 (445) 300-3403|trials@botanixpharma.com|
22430363|NCT02134808|University of Utah|Dr. Douglas Kondo|(801) 587-1549|doug.kondo@hsc.utah.edu|
22430364|NCT01475825|Kastle Therapeutics, LLC|Medical Information|1-800-745-4447|medinfo@genzyme.com|
22430365|NCT04157738|Emory University|Dr. Eric Felner|404-727-7651|efelner@emory.edu|
22430366|NCT02244957|UCSD|Dillon Gilbertson|8582452155|dcgilbertson@health.ucsd.edu|
22430367|NCT02090894|Indiana University School of Medicine|Dr. Ally-Khan Somani|317-944-7744|somania@iupui.edu|
22430368|NCT01725282|Astellas Pharma Inc.|Vice President, Clinical Development Administration||clinicaltrials@us.astellas.com|
22430369|NCT05071027|Montefiore Medical Center|Dr. David Altschul, Department of Neurosurgery|718-920-7498|daltschu@montefiore.org|
22430370|NCT04576481|Children's Hospital of Philadelphia|James Guevara, MD MPH|215-590-1130|guevara@chop.edu|
22430371|NCT04463914|Medical University of South Carolina|Dr. Jennifer Dahne|843-876-2280|dahne@musc.edu|
22430372|NCT05463952|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22430373|NCT01397591|OHSU Knight Investigational Cancer Services|Jeff Donovan|503-494-7702|mastersj@ohsu.edu|
22430374|NCT02739828|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22430375|NCT01307618|University of Chicago Comprehensive Cancer Center|Tomas Gajewski|773-702-4601|tgajewsk@medicine.bsd.uchicago.edu|
22448057|NCT00931762|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22448058|NCT03182829|DOASENSE GmbH|Harenberg, Job Prof Dr.|+496221825|j.harenberg@doasense.de|9785
22448059|NCT03316131|AstraZeneca RD, Gothenburg|Fredrik Erlandsson|1-877-240-9479|information.center@astrazeneca.com|
22448060|NCT02664441|Seattle Children's Hospital|Christian L. Roth, MD|206-987-5428|christian.roth@seattlechildrens.org|
22448061|NCT03510884|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22448062|NCT05608005|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22448063|NCT00157950|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22448064|NCT01531374|Medtronic, Inc.|Hatice Bilgic Lim||rs.medtroniccardiovascularclinicaltrials@medtronic.com|
22448065|NCT01287897|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22448066|NCT02892760|The University of Texas Health Science Center at Houston|Gerard Francisco, MD|713-797-7636|Gerard.E.Francisco@uth.tmc.edu|
22448067|NCT00386776|Beth Israel Deaconess Medical Center|Dr. Warner V. slack|617 278 8155|wslack@bidmc.harvard.edu|
22448068|NCT00786487|University of Minnesota|Dr. Lisa Chow|612-625-8934|chow0007@umn.edu|
22448069|NCT01500629|Johnson & Johnson Consumer and Personal Products Worldwide|Daniel Qi, MD, PhD, Director, Clinical Research|973 385-2260|dqi6@its.jnj.com|
22448070|NCT02902965|Pharmacyclics Switzerland GmbH|Dr. Bernhard Hauns, Medical Monitor|+41 52 556 0800|bhauns@pcyc.com|
22448071|NCT00293254|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22448072|NCT02259582|OncoMed Pharmaceuticals, Inc.|Manager, Regulatory Affairs|6509958322|imran.chaudhry@oncomed.com|
22448073|NCT02335489|St. Jude Medical|Roni Diaz|+1 972 309 8601|rdiaz@sjm.com|
22448074|NCT01969240|Mayo Clinic|Dr. Erik Hess|507-284-7221|hess.erik@mayo.edu|
22448075|NCT00759863|Photozig, Inc.|Bruno Kajiyama|650-694-7496|lifezig@photozig.com|3
22448076|NCT02653391|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
22448077|NCT00503308|UCSF, San Francisco General Hospital|Deborah Cohan, MD|415 206 3658|cohand@obgyn.ucsf.edu|
22448078|NCT02452346|Weill Cornell Medicine|Dr. Sangmin Lee, MD|646-962-2700|sal9053@med.cornell.edu|
22448079|NCT00531050|Novartis Pharmaceuticals|Study Director|862-778-8300||
22448080|NCT03263442|University of North Carolina - Chapel Hill|Zev Nakamura|984-974-3829|zev_nakamura@med.unc.edu|
22448081|NCT01594125|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22448082|NCT00708643|Vistakon|Kurt Moody, O.D. FAOO|904-443-3088||
22448083|NCT05584176|MP Biomedicals|Dana Hummel|8008540530|Dana.Hummel@mpbio.com|7019
22448084|NCT03635957|Horizon Therapeutics Ireland DAC|Paul Peloso, MD|866-479-6742|clinicaltrials@horizontherapeutics.com|
22448085|NCT01710033|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22448086|NCT00826020|University of Nebraska Medical Center|David Mercer|402-559-6955|dmercer@unmc.edu|
22448087|NCT01525550|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22448088|NCT02493608|Texas Tech Health Sciences Center|Chadley Copeland|8067434752|chadley.copeland@ttuhsc.edu|
22448089|NCT00460031|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Jorge Garcia|216-444-7774|garciaj4@ccf.org|
22448090|NCT01194479|Department of Internal Medicine and Endocrinology, Yale University School of Medicine, New Haven, CT|Robert Sherwin, MD|(203) 785-3482|robert.sherwin@yale.edu|
22448091|NCT01141907|Johns Hopkins University|Dr. Cheryl Dennison|443-287-4174|cdennis4@jhu.edu|
22448092|NCT04585022|Copenhagen University Hospital Hvidovre, Orthopaedic Department|MD Peter Nyby Hersnaes|+45 40104845|pnhersnaes@gmail.com|
22448093|NCT03045887|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22448094|NCT03414424|Bronx VA Medical Center|Noam Y. Harel|718-584-9000|Noam.harel@va.gov|1742
22448095|NCT01846507|Nationwide Children's Hospital|Sarah O'Brien, MD|614-722-3070|sarah.obrien@nationwidechildrens.org|
22448096|NCT01314443|Ohio State University|Richard Bruno, PhD, RD|614-292-5522|bruno.27@osu.edu|
22448097|NCT01782859|Hospital for Special Surgery|Kethy Jules-Elysee, MD|2126061206|juleselyseek@hss.edu|
22448098|NCT02536196|Keystone Heart|Pauliina Margolis - CMO|813.530.8200|pauliina.margolis@keystoneheart.com|
22448099|NCT00680745|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
22448100|NCT01408914|Harvard Medical School|Carole Mitnick|617-432-6018|Carole_Mitnick@hms.harvard.edu|
22448101|NCT00446290|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
22448102|NCT01733407|Massachusetts General Hospital|Dr. Florian Eichler|617-643-3799|Feichler@partners.org|
22448103|NCT04903626|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22399879|NCT01499173|University of Michigan, Neurology|Dr. Lesli Skolarus|734-936-9075|lerusche@umich.edu|
22448104|NCT02642952|Ramón y Cajal University Hospital|Dr. Andrés Reyes Valdivia|0034 629586239|cauzaza@hotmail.com|
22399880|NCT03615222|CTX VA|Suzannah Creech|254-654-7241|suzannah.creech@va.gov|
22430376|NCT00489359|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22430377|NCT03180138|Johns Hopkins University|Sanjay K Jain|4105028241|sjain5@jhmi.edu|
22430378|NCT03719300|Anchiano Therapeutics, Israel Ltd.1 Kendall Square, Building 1400, Suite 105 Cambridge, MA 02139|David Kerstein, M.D.,Chief Medical Officer|857-259-4626|David.Kerstein@anchiano.com|
22430379|NCT04191733|DePuy Orthopaedics|FRANCHISE MEDICAL DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22430380|NCT02349477|Medical University of South Carolina|Dr. Michaela Hoffman|8437927758|HoffmaMi@musc.edu|
22448105|NCT06112756|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22448106|NCT03060629|Janssen Vaccines & Prevention B.V|CLINICAL FRANCHISE LEADER|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22448107|NCT01862874|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22448108|NCT03681405|Wake Forest Baptist Comprehensive Cancer Center|Meg O'Mara|336-716-9055|megreen@wakehealth.edu|
22448109|NCT00412854|GlaxoSmithKline|GSK Response Center|866-435-7343||
22448110|NCT03518073|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22430381|NCT01903733|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22448111|NCT03045081|University of Washington|Dale J. Langford, PhD; Research Assistant Professor|2066160158|dalejwl@uw.edu|
22448112|NCT03804879|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22430382|NCT02202577|Virginia Commonwealth University Health System|Edward H Springel, MD|804-828-8468|edward.springel@vcuhealth.org|
22448113|NCT02436889|University of California, San Francisco|Alison Huang, MD|415-514-8697|alison.huang@ucsf.edu|
22448114|NCT01034462|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|8124
22448115|NCT00911495|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22448116|NCT02169739|University of California Los Angeles|Latisha Sharma, MD|310-794-6379|lali@mednet.ucla.edu|
22448117|NCT03480750|National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University|Dr. Yu-Fang Huang|886 6 2353535|yufangh@mail.ncku.edu.tw|5221
22448118|NCT03040466|UCSF|Dr. Thomas Chi|415-476-1611|tom.chi@ucsf.edu;manint.usawachintachit@ucsf.edu|
22448119|NCT05584644|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22448120|NCT03683758|Mountain Health and Performance|Dr. Matthew Wentzell|6043566986|drwentzell@mountainhp.ca|
22448121|NCT00723892|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800--672-6372|ClinicalTrialsDisclosure@merck.com|
22448122|NCT02411292|Division of Plastic Surgery, University of Utah|Dr. Christopher J. Pannucci, M.D., M.S.|801-581-7719|christopher.pannucci@hsc.utah.edu|
22448123|NCT00453921|Dartmouth Hitchcock Medical Center|Dr. Laura Flashman|6036505824|Laura.A.Flashman@hitchcock.org|
22448124|NCT00303498|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22448125|NCT00174915|Takeda Global Research & Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22448126|NCT02232425|Ixchelsis Limited|Chief Medical Officer|44(0)1227-832760|ian.osterloh@ixchelsis.com|
22448127|NCT03060447|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22448128|NCT00705081|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22448129|NCT01601626|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22448130|NCT00498602|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22448131|NCT00546637|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22448132|NCT00587483|Mayo Clinic|Dr. William Mauermann|507-255-4240|mauermann.william@mayo.edu|
22448133|NCT01230801|BioMarin Pharmaceutical Inc.|Manager, Clinical Operations|415-455-7448|Slava.Titov@bmrn.com|
22448134|NCT04984993|Futura Medical Development Ltd.|Andrew Graham, Senior Clinical Project Manager|+44 1483 685682|Andy.Graham@futuramedical.com|
22448135|NCT01110707|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22448136|NCT02350881|Casa di Cura VIlla Berica|Dr Stefano Fieschi||stefanofieschi@gmail.com|
22448137|NCT00159250|Imperial College London|Francesco Muntoni|+44 02075941872|f.muntoni@ucl.ac.uk|
22448138|NCT02140788|Duke University Health System|Joseph P. McEvoy|919-819-9295|JMCEVOY@gru.edu|
22448139|NCT01930747|az sint jan brugge|jan mulier|0032486729203|jan.mulier@azsintjan.be|
22448140|NCT03179995|Fox Chase Cancer Center|Protocol Development Coordinator|215-728-4097|ryan.romasko@fccc.edu|
22448141|NCT03108027|Novartis Pharmaceutical|Study Director|862-778-8300|novartis.email@novartis.com|
22448142|NCT02426892|UT MD Anderson Cancer Center|Dr. Renata Ferrarotto,MD, Associate Professor, Thoracic-Head & Neck Med Onc|(713) 745-6774|rferrarotto@mdanderson.org|
22448143|NCT03178773|University of Southern California|Elizabeth Burner|3234096667|eburner@usc.edu|
22448144|NCT01382446|SJHMC|Tracy L. Thomas MSN RN CCRN ACNS-BC|602-406-2567|Tracy.Thomas007@dignityhealth.org|
22448145|NCT00003901|Memorial Sloan Kettering Cancer Center|Valerie Rusch, MD|212-639-5873|ruschv@mskcc.org|
22448146|NCT04458909|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22448147|NCT00268996|GlaxoSmithKline|GSK Response Center|866-435-7343||
22448148|NCT00765375|DeNova Research|Jack Arkins, Data Manager|312-335-2070|jack@drdayan.com|
22430383|NCT01714063|Department of Pediatrics UAMS/COM|Ariel Perlinkski MT||berlinskiariel@uams.edu|
22430384|NCT01646216|Kennedy Krieger Institute|Anthony Gonzalez|4439080074|gonzalezan@kennedykrieger.org|
22448149|NCT02545101|Otsuka Pharmaceutical Europe Ltd.|Medical Department|+44(0)2037475000||
22448150|NCT03325075|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
22448151|NCT00422591|UT MD Anderson Cancer Center|Farhad Ravandi-Kashani, MD|713-792-7734|CR_Study_Registration@mdanderson.org|
22448152|NCT00862745|University of California, San Francisco|Dr. Jeanette Brown|415-353-9751|brownj@obgyn.ucsf.edu|
22448153|NCT02455531|Carelon Research|Dr. Felicia Trachtenberg|Felicia.Trachtenberg@carelon.c|Felicia.Trachtenberg@carelon.com|
22448154|NCT01414075|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441||
22448155|NCT03847233|Boston Scientific Japan K.K.|Yoko Takizawa/Clinical Project Manager|+81-3-6853-7500|Yoko.Takizawa@bsci.com|
22448156|NCT00573534|Columbia University/New York State Psychiatric Instittue|Stephen J. Donovan MD|646 774 8078|sd45@columbia.edu|
22448157|NCT01064713|University of Texas (UT) MD Anderson Cancer Center|Agop Y. Bedikian, MD/Professor||CR_Study_Registration@mdanderson.org|
22448158|NCT03498300|Faculty of Medicine Siriraj Hospital, Mahidol University|Dr. Nalat Sompagdee|+6687-008-7100|pear_nalat@hotmail.com|
22448159|NCT04851314|UC Irvine Health|Dr. Robert Ryan Field|7145065703|fieldr@uci.edu|
22448160|NCT00867009|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22448161|NCT00147199|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
22448162|NCT03266094|Medtronic|Melody LaBeau, Director of Clinical Operations|763.526.2931|melody.a.labeau@medtronic.com|
22448163|NCT01563003|University of South Florida|Eric Storch, Ph.D.|727-767-8230|estorch@health.usf.edu|
22448164|NCT00118365|University of California, Irvine|Dr. Frank Meyskens, Jr.|714-456-6310|flmeyske@uci.edu|
22448165|NCT03241342|Oncternal|Mary Breitmeyer|858-434-1113|MBreitmeyer@oncternal.com|
22448166|NCT00848367|Ottawa Hospital Research Institute|Dr. Giorgio Tasca|1-613-737-8085|gtasca@toh.on.ca|
22448167|NCT01537029|TTUHSC|Ronald Hall|2143589009|ronald.hall@ttuhsc.edu|
22448168|NCT03036072|Maine Medical Center|Alexa Craig, MD|207-396-6920|craiga@mmc.org|
22448169|NCT03334903|Brigham and Women's Hospital|Dr. Wolfgang Fitz|6177325500|wfitz@bwh.harvard.edu|
22399881|NCT00499109|H. Lee Moffitt Cancer Center and Research Institute|Charles C. Williams, M.D., Study Chair|813-745-7282|charles.williams@moffitt.org|
22399882|NCT03304522|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22448170|NCT04202354|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|1 (626) 304-3400|info@arrowheadpharma.com|
22448171|NCT00001596|National Human Genome Research Institute|Dr. William A. Gahl|301-402-2739|gahlw@mail.nih.gov|
22448172|NCT01024296|Stanford University|Bilal M Shafi, MD|(215) 738-0400|bmshafi@stanford.edu|
22448173|NCT03867981|The Miriam Hospital|Principal Investigator|401-793-8966|junick@lifespan.org|
22448174|NCT00429507|University of Texas (UT) MD Anderson Cancer Center|Nato Ueno, MD, PhD/Professor, Breast Medical Oncology||CR_Study_Registration@mdanderson.org|
22448175|NCT00903617|GlaxoSmithKline|GSK Response Center|866-435-7343||
22448176|NCT01104636|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22448177|NCT01706003|UT Southwestern Medical Center|Deborah I. Friedman, MD, MPH, Professor of Neurology and Neurotherapeutics and Ophthalmology|2146483517|Deborah.Friedman@utsouthwestern.edu|
22448178|NCT02560584|Regional Hospitals & Family Health Centers|Dr. J. Stephen Jones|+1-216-442-5060|joness7@cff.org|
22430385|NCT03721107|4D pharma plc|Programme Development Director|+4401138950130|clinicaltrials@4dpharmaplc.com|
22430386|NCT04792970|Duke University Medical Center|Scott Shofer|(919) 668-2402|scott.shofer@duke.edu|
22430387|NCT02369159|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
22430388|NCT02214628|Ophthotech Corp.|Keith Westby|732-824-7474|keith.westby@ophthotech.com|
22430389|NCT00563316|Amgen Inc.|Study Director|866-572-6436||
22430390|NCT03000751|University of California San Francisco|Rebecca Smith-Bindman, MD|415-353-4946|rebecca.smith-bindman@ucsf.edu|
22430391|NCT02991859|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22430392|NCT02268305|MOMH|Amanda Crawford|7026533583|amanda.j.crawford.ctr@health.mil|
22430393|NCT00908908|Eisai Call Center|Eisai Inc.|888-422-4743||
22430394|NCT03888287|Hackensack Meridian Health|Hooman Azmi, MD|201-342-2550|hooman.azmi@hmhn.org|
22430395|NCT01514422|Mood and Anxiety Disorders Program, Icahn School of Medicine at Mount Sinai|Dr. Dan V. Iosifescu|212-241-4480|dan.iosifescu@mssm.edu|
22430396|NCT03511209|VA Greater Los Angeles Healthcare System|Constance H. Fung, MD, MSHS|818-891-7711|Constance.Fung@va.gov|39311
22430397|NCT00562861|Tufts Medical Center|Nassir Ghaemi|6176365735|nghaemi@tuftsmedicalcenter.org|
22430398|NCT00655356|CBR International Corp.|Kevin Hennegan|720-746-1190|khennegan@cbrintl.com|
22430399|NCT02427672|Nanyang Technological University|Dr. Olivia Choy|(65)65921522|oliviachoy@ntu.edu.sg|
22430400|NCT02687165|New York State Psychiatric Institute|Alla Landa PhD|6467746717|AL2898@cumc.columbia.edu|
22430401|NCT01093573|Case Comprehensive Cancer Center|Brenda Cooper MD|(216) 844-3213|Brenda.cooper@uhhospitals.org|
22430402|NCT01623154|Otsuka America Pharmaceutical, Inc|Tao Wang, PhD|240-683-3213|Tao.Wang@otsuka-us.com|
22430403|NCT01412983|Bausch & Lomb|Dr. Robert Steffen|1 585 338 6399|robbert.steffen@bausch.com|
22430404|NCT04349098|Karyopharm Therapeutics Inc|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
22430405|NCT00800384|Population Health Research Institute, McMaster University|Dr. Jeff Healey|001 905 330 6760|jeff.healey@phri.ca|
22430406|NCT02376010|Lundquist Institute|Matthew Budoff|3102224107|mbudoff@lundquist.org|
22430407|NCT01428635|The University of Texas MD Anderson Cancer Center|Gautam Borthakur MD./Professor|713-563-1586|GBorthak@mdanderson.org|
22430408|NCT04280783|Emory University|Dr. Jacob Kariuki|4047272353|jacob.kariuki@emory.edu|
22430409|NCT01394185|Johns Hopkins University|Ryan Vandrey|410-550-4036|rvandrey@jhmi.edu|
22399883|NCT03367871|University of Miami|Abdulrahman Sinno MD|+1 (305) 243-2233|ak.sinno@med.miami.edu|
22430410|NCT02254460|GlaxoSmithKline|GSK Response Center|866-435-7343||
22430411|NCT01050218|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22430412|NCT02336555|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22448179|NCT02261714|Targovax ASA|Chief Medical Officer|004721398810|contact@targovax.com|
22399884|NCT02494570|Aadi Bioscience|Medical Information|1-888-246-2234|MedInfo@aadibio.com|
22399885|NCT02013544|Endoceutics|Director of Data Analysis|418-653-0033|celine.martel@endoceutics.com|215
22448180|NCT01244906|Blood and Marrow Transplant Group of Georgia|Scott R. Solomon, MD|404-255-1930|ssolomon@bmtga.com|
22448181|NCT03889158|University of Illinois at Chicago|Dr. Elizabeth Lefferts|312-996-9607|eschro7@uic.edu|
22448182|NCT02865187|Wright State University|Steven R Lindheim|858-740-1083|doclalalindheim@gmail.com|
22448183|NCT04267133|University of Rochester|Jean-Philippe Couderc, PhD|585-275-1096|heartjpc@heart.rochester.edu|
22448184|NCT03318315|University of Maryland School of Medicine|Kathleen M. Neuzil, MD, MPH|410-706-5328|kneuzil@som.umaryland.edu|
22448185|NCT02968563|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22399886|NCT02036320|Johnson and Johnson Vision Care Inc.|Meredith Jansen,O.D.,M.S., FAAO|904-443-3500|mjanse12@ITS.JNJ.com|1396
22448186|NCT00674661|Avedro, Inc.|Vineeta Belanger, VP of Clinical Affairs|781-768-3459|vbelanger@avedro.com|
22448187|NCT04249310|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22448188|NCT00614315|Bard Peripheral Vascular, Inc.|John Reviere, Director, Clinical Affairs|480-303-2644|John.Reviere@crbard.com|
22448189|NCT05319795|University Health Network|Professor Catriona Steele|4165973422|catriona.steele@uhn.ca|7802
22448190|NCT02617511|University of Manitoba|Dr. Stephen Cornish|204-474-9981|Stephen.Cornish@umanitoba.ca|
22448191|NCT00811473|AstraZeneca|Gerard Lynch||aztrail_results_posting@astrazeneca.com|
22448192|NCT04127331|Nationwide Children's Hospital|Dr. Alok Moharir|614-722-4200|alok.moharir@nationwidechildrens.org|
22448193|NCT01119131|VA Portland Health Care System|Amie Hiller, MD|503.721.1091|peterami@ohsu.edu|
22448194|NCT01909479|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
22448195|NCT01608659|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22448196|NCT01187043|Repros Therapeutics Inc.|Jennifer L. Wike|281-719-3402|jwike@reprosrx.com|
22448197|NCT00923598|University of California San Diego|Dr. Brian Ilfeld, Professor of Anesthesiology, In Residence|(858) 444-5949|bilfeld@ucsd.edu|
22448198|NCT03383198|Prisma Health|Dr. William R. Hand|864.522.3707|William.Hand@prismahealth.org|
22448199|NCT00927784|Mount Sinai School of Medicine|Deborah Ascheim, MD, Principal Investigator, Data Coordinating Center|212-659-9567|deborah.ascheim@mssm.edu|
22448200|NCT02457910|Vanderbilt University Medical Center|Vandana Abramson, MD|(615)936-8422|vandana.abramson@vumc.org|
22448201|NCT00467259|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22448202|NCT02196558|Eisai Co., Ltd.|Inquiry Service.||eisai-chiken_hotline@hhc.eisai.co.jp|
22448203|NCT02947997|Massachusetts General Hospital|Gary Tearney, MD|617-724-2979|gtearney@partners.org|
22448204|NCT02994979|The New Jewish Home|Dr. Kenneth Boockvar|212-870-5062|kenneth.boockvar@mssm.edu|
22448205|NCT01339429|Brigham and Women's Hospital|Dr. Gita Mody|617-921-8221|gmody@partners.org|
22448206|NCT00459667|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22448207|NCT01013701|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
22448208|NCT01267812|City of Hope|Dr. Matthew Mei|626-359-8111|mamei@coh.org|
22448209|NCT00556712|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22448210|NCT03445650|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
22448211|NCT01059799|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22448212|NCT01361464|H. Lee Moffitt Cancer Center and Research Institute|Jeffrey Lancet, M.D.|813-745-6841|jeffrey.lancet@moffitt.org|
22448213|NCT00671502|Meda Pharma US|David Ginsberg, MD Sr Medical Director|732 564 2364|david.ginsberg@meda.us|
22448214|NCT00849810|University of Mississippi Medical Center|Professor of Medicine|601-984-5600|DMinor@umc.edu|
22448215|NCT01722071|University of Michigan|Tiffany Love, PhD|734-219-3674|tiflove@umich.edu|
22448216|NCT01106898|University of Nebraska Medical Center|Elizabeth Reed|402-559-5166|ereed@unmc.edu|
22448217|NCT03021265|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22448218|NCT00818662|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22448219|NCT01338493|Medtronic Spinal & Biologics|Cristina Faria|+41 (0)21 802 70 00|cristina.faria@medtronic.com|
22448220|NCT01846611|Janssen Research & Development, LLC|Senior Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22448221|NCT00541034|Memorial Sloan Kettering Cancer Center|Dr. Renier Brentjens|1212-639-7053|brentjer@mskcc.org|
22448222|NCT01614067|University of California, San Francisco|Mitchell Rosen, MD|415-353-7475||
22448223|NCT00847704|Oregon Health & Science University|Paul J. Cordo|503-418-2520|cordop@ohsu.edu|
22448224|NCT04049123|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@llilly.com|
22448225|NCT00775645|SWOG Statistical Center|Study Statistician|206-667-4623||
22448226|NCT02289079|University of MInnesota|Dr. Jacob Hutchins|6126249990|hutc0079@umn.edu|
22448227|NCT02671422|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22448228|NCT02111850|National Cancer Institute|Dr. Steven A. Rosenberg|240-858-3080|sar@mail.nih.gov|
22448229|NCT03061331|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22448230|NCT02625259|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22448231|NCT00513474|Massachusetts General Hospital|Bimalangshu R. Dey, MD, PhD||bdey@mgh.harvard.edu|
22448232|NCT04772755|Duke University|Emmanuel B Walter, MD, MPH|919-620-5346|chip.walter@duke.edu|
22448233|NCT02192814|UCB Pharma|UCB Clinical Trial Call Center|+1877 822||9493
22448234|NCT00195676|Abbott|Global Medical Services|800-633-9110||
22448235|NCT01189812|Columbia Northwest Pharmaceuticals|Director of Clinical Operations|425.453.0404|jhobus@nwcrc.net|
22448236|NCT03761147|Hebrew Univeristy|Anna Shaphir|+972 50 716 7309|shaphira@hadassah.org.il|
22448237|NCT04080297|Chief Exceutive Officer|Rob Crombie|+61 3 9657 0731|rcrombie@queoncology.com|
22448238|NCT02744391|New York State Psychiatric Institute|Dr. Bret R. Rutherford|646-774-8660|brr8@cumc.columbia.edu|
22448239|NCT05838742|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22448240|NCT02045797|GlaxoSmithKline|GSK Response Center|866-435-7343||
22448241|NCT03851302|Bronx Veterans Medical Research Foundation|Principal Investigator|718-584-9000 x1742|NOAM.HAREL@VA.GOV|
22448242|NCT02703909|University of Missouri - Columbia|Terri G. Monk, MD, Principal Investigator|(573)-882-2568|monkt@health.missouri.edu|
22448243|NCT00501293|Shire Pharmaceutical|Timothy Whitaker, MD||twhitaker@shire.com|
22448244|NCT01188694|University of Washington|Lori Zoellner|206 685-3617|zoellner@u.washington.edu|
22448245|NCT02355691|UNC Orthopaedics|Scott Eskildsen, MD|(919) 966-9166|seskilds@unch.unc.edu|
22448246|NCT04396990|Vance Thompson Vision|Keeley Boever|6053613937|keeley.boever@vancethompsonvision.com|
22448247|NCT02880189|Mayo Clinic|Dr. Barham K. Abu Dayyeh|507-284-1825|AbuDayyeh.Barham@mayo.edu|
22448248|NCT01042236|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22448249|NCT02338960|AMAG Pharmaceuticals|Medical Information|1-877-411-2510||
22448250|NCT01172847|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22448251|NCT00183092|UCaliforniaSF|Michael Geschwind, MD, PhD|415-476-2901|mgeschwind@memory.ucsf.edu|
22448252|NCT02132767|Icahn School of Medicine at Mount Sinai|Annetine C. Gelijns, PhD|212-659-9568|annetine.gelijns@mssm.edu|
22448253|NCT00390858|Novartis Pharmaceuticals|Study Director|862-778-8300||
22448254|NCT00937157|Buffalo Neuroimaging Analysis Center|Robert Zivadinov, MD, PhD|716-859-7040|rzivadinov@bnac.net|
22448255|NCT02141997|AbbVie|Global Medical Information|1-800-633-9110||
22448256|NCT00451321|GlaxoSmithKline|GSK Response Center|866-435-7343||
22448257|NCT00598663|University Children's Hospital Vrazov trg 1 SI-1525 Ljubljana, Slovenia|Tadej Battelino|+386 1 522 50 50|tadej.battelino@mf.uni-lj.si|
22448258|NCT00732615|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22448259|NCT01341964|Population Health Reseach Institute, Hamilton, ON, Canada|Lynda Hill|905-297-3479|Lynda.Hill@phri.ca|40323
22448260|NCT00909389|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22448261|NCT01516424|Shang Hai Mental health center|Dr.HuafangLi|13641625395|lhlh_5@163.com|
22448262|NCT03566823|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22448263|NCT01166763|University of Kansas Medical Center|Bruce F. Kimler, Ph.D.|913-588-4523|bkimler@kumc.edu|
22448264|NCT03557151|Nemours Children's Hospital, Delaware|Melissa A. Alderfer, Ph.D., Center Director & Principal Research Scientist|302-651-6522|melissa.alderfer@nemours.org|
22448265|NCT02810392|Wake Forest School of Medicine|Cheryl Bushnell, MD|336-713-2983|cbushnel@wakehealth.edu|
22448266|NCT01590238|New York Eye & Ear Infirmary|Anthony P Sclafani, MD|212-979-4200|asclafani@nyee.edu|
22448267|NCT03035409|UT MD Anderson Cancer Center|Dr. Sriram Yennu, Professor, Palliative Care Med|(713) 792-3938|syennu@mdanderson.org|
22448268|NCT06079320|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22448269|NCT03428360|Aquestive Therapeutics|Clinical Project Manager|9089411896|cbuan@aquestive.com|
22448270|NCT00734903|VA BOSTON|Lisa Najavits, PhD|617-299-1620|lisa.najavits@va.gov; najavits@bu.edu|
22448271|NCT00830596|Palmer College of Chiropractic|Christine Goertz, DC, PhD, Principal Investigator|(563) 884-5150|christine.goertz@palmer.edu|
22448272|NCT02107482|Tufts Medical Center|Nicole Dumont|617 636 7462|ndonovan1@tuftsmedicalcenter.org|
22448273|NCT04868890|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|17204376500|clinicaltrials@ampiopharma.com|
22399887|NCT00885365|Chiesi Farmaceutici S.p.A.|Chiesi Clinical Trials||clinicaltrials_info@chiesi.com|
22448274|NCT04474704|The Ohio State University|Maged Costantine, MD|614-293-2222|Maged.Costantine@osumc.edu|
22448275|NCT02669433|Axovant Sciences, Inc.|Ilise Lombardo, MD|646-822-8626|ilise.lombardo@axovant.com|
22448276|NCT00576927|Emory University Division of General Medicine and Geriatrics|Dr. Patricia Griffiths|404-321-6111|pcgriff@emory.edu|7138
22448277|NCT03128892|Masimo Corporation|Chelsea Frank|949-297-7000|studies@masimo.com|
22448278|NCT04570150|UCSD|Dr. Rodney Gabriel|6194710670|ragabriel@health.ucsd.edu|
22448279|NCT00379574|Asan Medical Center, Ulsan University College of Medicine|Dr. Cheolwon Suh|+82-2-3010-3209|csuh@amc.seoul.kr|
22448280|NCT01850524|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22448281|NCT02727751|Ardelyx|Chief Development Officer|5107451752|drosenbaum@ardelyx.com|
22448282|NCT00368355|Baylor College of Medicine|Dr. Robert A. Krance|832-824-4661|rakrance@txch.org|
22448283|NCT04899921|Dana-Farber Cancer Institute|Senior Physician|6176326836|ann_silk@dfci.harvard.edu|
22448284|NCT04061915|New York University|S. Raquel Ramos|212-992-5994|TheHOTIEStudy@gmail.com|
22448285|NCT01457521|Gynuity Health Projects|Elizabeth Raymond|2124481230|eraymond@gynuity.org|
22448286|NCT01322360|Roxane Laboratories, Inc|Anton (Tony) Amann, PhD, Executive Director, Drug Regulatory and Medical Affairs|614-272-4785|Tony.Amann@boehringer-ingelheim.com|
22448287|NCT03473808|Medical University of South Carolina|Amanda Vatinno|8437924840|vatinno@musc.edu|
22448288|NCT01706081|Memorial Sloan Kettering Cancer Center|Dr. Ting Bao MD|646-888-0865|baot@mskcc.org|
22448289|NCT02157298|AstraZeneca K.K.|Yuji Ageishi|+81-3-6268-2740|Yuji.Ageishi@astrazeneca.com|
22448290|NCT04059094|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22448291|NCT01085591|Cubist Pharmaceuticals, Inc.|Vice President, Clinical Research|1.781.860.8660||
22448292|NCT03715764|Region Västra Götaland, Närhälsan|PhD-student, Chan-Mei Ho-Henriksson|+46709892821|chan-mei.ho@vgregion.se|
22448293|NCT01551082|Alliance of Cardiac Vascular and Thoracic Surgeons|Jeremy Smith RN|4236245200|jsmith@actvsurgeons.com|
22448294|NCT01980875|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22448295|NCT00662363|Rehabilitation Institute of Chicago|Christina Marciniak|312-238-1000|cmarciniak@ric.org|
22448296|NCT01905657|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22399888|NCT01824979|Fisher and Paykel Healthcare|Clinical Research Scientist|+ 64 09 574 0100|CPAPtrial@fphcare.co.nz|
22399889|NCT02547623|Icon Bioscience, Inc.|Vice President, Quality and Compliance|510-933-8381||
22399890|NCT01221857|Gamida Cell|Kelly Myers|+972-2-659-5631|clinicaltrials@gamida-cell.com|
22399891|NCT00481845|Stanford Cancer Institute, Stanford University|Mark Daniel Pegram; Susy Yuan-Huey Hung Professor|650-723-5801|mpegram@stanford.edu|
22399892|NCT02849639|University of Kentucky|Daniela C Moga MD PhD, Associate Professor|859-323-9682|daniela.moga@uky.edu|
22399893|NCT01756456|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22448297|NCT02123745|ivWatch, LLC|Garret T. Bonnema|1.855.489.2824|garret.bonnema@ivwatch.com|7018
22448298|NCT02059057|Boston Scientific|Kristi Winterfeldt|+1 763-494-1165|kristi.winterfeldt@bsci.com|
22386197|NCT06262347|University of Cincinnati|T. John Winhusen, PhD.|513-585-8292|winhust@ucmail.uc.edu|
22386198|NCT05427253|Vicore Pharma AB|Cecilia Ganslandt, MD, MSc, Global Medical Director|+46 317880560|info@vicorepharma.com|
22386199|NCT04362085|St. Michael's Hospital|Dr. Michelle Sholzberg|4168606060|michelle.sholzberg@unityhealth.to|
22386200|NCT04660539|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22386201|NCT05618587|University at Buffalo|Thomas Guttuso, Jr., MD|716-932-6080|tguttuso@buffalo.edu|
22399894|NCT02706938|Universidad Nacional de Colombia|Dr. Ivan Mauricio Villamil Morales|+573178755369|imvillamilm@unal.edu.co|
22399895|NCT00813995|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22399896|NCT02868892|WRMC|Jessica L. Coats|6233417220|jessica.coats@ctca-hope.com|
22399897|NCT01261559|University of Washington|Dr. Claire Sandstrom|206-744-3561|cks13@uw.edu|
22399898|NCT00661583|University of Colorado Denver|Dr.Malik Kahook|720-848-2020|malik.kahook@ucdenver.edu|
22399899|NCT01508455|Hospira|Dr. Marcelo Garcia da Rocha|224-212-4424|marcelo.rocha@hospira.com|
22399900|NCT01007526|Samsung Medical Center|Won Seog Kim|82234106548|wskimsmc@skku.edu|
22399901|NCT04525703|University of Wisconsin - Madison|Pajarita Charles, PhD|608-263-3834|paja.charles@wisc.edu|
22399902|NCT01656772|Stereotaxis, Inc.|Qun Sha M.D. (Study Director)|314-678-6143|qun.sha@stereotaxis.com|
22399903|NCT04752384|Medical College of Wisconsin|Stuart J. Wong, MD|414-805-4600|swong@mcw.edu|
22399904|NCT04439331|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22399905|NCT04828330|VA Puget Sound Health Care System|Dr. Pradeep Suri|207-762-1010|pradeep.suri@va.gov|
22399906|NCT04370509|University of California, San Francisco|Dr. David Oh, MD, PhD|(415) 476-1000|david.oh@ucsf.edu|
22399907|NCT04743856|University of Pittsburgh|Bonny Rockette-Wagner|4126240188|bjr26@pitt.edu|
22399908|NCT04696861|Duke University School of Nursing|Brandon Knettel|1 919 660 1218|brandon.knettel@duke.edu|
22399909|NCT04439188|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22399910|NCT00413959|Oncology Specialists SC|Sigrun Hallmeyer, MD Director of Research|847-268-8200|shallmeyer@oncmed.net|
22386202|NCT05167864|University of Pennsylvania|Dr. Ivona Percec, PhD, MD|215-662-7300|ivona.percec@pennmedicine.upenn.edu|
22386203|NCT06007781|HilleVax, Inc.|Astrid Borkowski, Chief Medical Officer|+1 (617) 213-6562|aborkowski@hillevax.com|
22386204|NCT03852550|McMaster University|Research Coordinator|9055259140|galuppi@mcmaster.ca|27852
22386205|NCT05204654|University at Buffalo|No Dr. Alexandria Newton|716-829-2845|amnewton@buffalo.edu|
22386206|NCT03314688|Yale School of Medicine|Tara Sanft, MD|(203) 200-2328|tara.sanft@yale.edu|
22386207|NCT00179400|Albert Einstein College of Medicine|Prof. Meredith A. Hawkins|718 430 3186|meredith.hawkins@einsteinmed.edu|
22386208|NCT03895996|Avotres Inc.|Tuochuan Dong, Director, Business & Operations|7169093370|tuochuan.dong@avotres.com|
22386209|NCT01828112|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@Novartis.com|
22386210|NCT01188928|Leo Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
22386211|NCT04410328|Rutgers New Jersey Medical School|Dr. Amit Singla|319-512-3558|as3321@njms.rutgers.edu|
22386212|NCT03911141|Hospital of the University of Pennsylvania|Alexander C. Fanaroff, MD, MHS|2156157674|alexander.fanaroff@pennmedicine.upenn.edu|
22386213|NCT05565820|Alliance Pharmaceuticals|R&D Director|01249 466966|medaffairs@allianceph.com|+44
22386214|NCT02393885|AtriCure, Inc.|Nfii Ndikintum|1-513-755-4100|nndikintum@atricure.com|
22386215|NCT05586490|University of Michigan|Chatkaew Pongmala, PhD|734-936-1168|pchatkae@umich.edu|
22386216|NCT04136912|UNC Lineberger Comprehensive Cancer Center|Desma Jones|(919) 843-9463|desma_jones@med.unc.edu|
22386217|NCT03606408|Recordati AG|Mario Maldonado|+41798030344|maldonado.m@recordati.com|
22386218|NCT03556293|Dartmouth College|Dr. Jeremiah Brown|(603) 646-5409|jeremiah.r.brown@dartmouth.edu|
22386219|NCT03292484|Aimmune Therapeutics, a Nestlé Health Science Company|Jay Patel|(800) 422-2752|jay.patel@uk.nestle.com|
22399911|NCT01438008|Children's Hospital of Eastern Ontario|Dr. Denise Harrison|6137377600|dharrison@cheo.on.ca|6045
22399912|NCT01870739|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22413153|NCT04206332|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
22386220|NCT05419830|University of Pittsburgh|Shachi Tyagi, MD, MS|4126471274|sht55@pitt.edu|
22386221|NCT05012163|Geisinger|Gail Rosenbaum|800-275-6401|grosenbaum@geisinger.edu|
22413154|NCT01644058|Université de Montréal|Elham Emami, DDS, MSc, PhD|514-343-6111|elham.emami@umontreal.ca|6053
22386222|NCT05062330|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
22430413|NCT01959919|Pfizer Clinical Trial.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrails.gov_Inquiries@Pfizer.com|
22430414|NCT02923167|Spaulding Rehabilitation Hospital|Paolo Bonato|617-952-6319|pbonato@mgh.harvard.edu|
22430415|NCT01537432|Novartis Pharmaceuticals|Study Director|862-778-8300||
22430416|NCT03446690|University of Alabama at Birmingham|Chung How Kau|205-934-1289|ckau@uab.edu|
22430417|NCT03682367|UC Davis Health|Arnaud Bewley|9167342704|abewley@ucdavis.edu|
22430418|NCT05166902|CooperVision|Jose A Vega, OD, MSc, FAAO|9256213761|javega2@coopervision.com|
22430419|NCT00612768|SmartPractice|Kathy Shannon|602-225-0595|kshannon@smarthealth.com|7208
22430420|NCT03704922|University of North Carolina at Chapel Hill|Matthew S. Karafin MD MS|984-974-1583|matthew.Karafin@unchealth.unc.edu|
22430421|NCT01079390|Mass General Hospital|Jian Kong|617-726-7893|kongj@nmr.mgh.harvard.edu|
22430422|NCT04019704|Axsome Therapeutics, Inc.|Caroline Streicher, Senior Director, Clinical Operations|212-332-5061|cstreicher@axsome.com|
22430423|NCT01550965|AbbVie|Global Medical Information|800-633-9110||
22430424|NCT03093246|São Paulo State University - Unesp|Dr Mauro Pedrine Santamaria|+5516981937777|mauro.santamaria@unesp.br|
22430425|NCT00160563|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22430426|NCT00309946|The University of Chicago|Dr. Hedy Kindler|(773) 702-0360|hkindler@medicine.bsd.uchicago.edu|
22430427|NCT02118831|California Retina Consultants|Director of Research|8059631648|gabe@californiaretina.com|3034
22430428|NCT01347086|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22430429|NCT03232892|University of California, San Francisco|Dr. Collin Blakely, MD PhD.|(415) 502-6959|Collin.Blakely@ucsf.edu|
22430430|NCT03111108|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22430431|NCT01514357|Mayo Clinic|Dr. John C. Burnett|507-284-7932|burnett.john@mayo.edu|
22430432|NCT04691115|AnaMar AB|Chief Medical Officer|+46 (0)46-275 60 00|info@anamar.com|
22430433|NCT01514279|School of Medicine, Case Western Reserve University|Dr. Elaine Borawski, PhD|216)368-1024|exb11@case.edu|
22430434|NCT00830336|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22430435|NCT00867334|George Mason University|Emanuel Petricoin|571-830-4166|epetrico@gmu.edu|
22430436|NCT01148771|Center for Anti-Infective Research and Development, Hartford Hospital|Joseph L. Kuti, Pharm.D. / Associate Director, Clinical and Economic Studies|860-545-3612|jkuti@harthosp.org|
22430437|NCT00601731|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22430438|NCT01437189|ZhejiangU|Bo Wang|87784711|wangke1121@163.com|
22430439|NCT00347269|University of Washington|Peter Roy-Byrne MD Professor of Psychiatry|206-313-8504|roybyrne@u.washington.edu|
22430440|NCT00835549|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22448299|NCT06092710|CAndreRenard|CEDRIC GARCION|+33661817274|cedric.garcion.osteo@gmail.com|
22448300|NCT05119569|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22448301|NCT03909178|Massachusetts General Hospital|Dr. Scott Martin|(617) 726-7500|sdmartin@partners.org|
22448302|NCT02623439|University of California, San Diego|Michelle Padilla|(858) 822-5354|CancerCTO@health.ucsd.edu|
22448303|NCT01880840|Meda Pharmaceutical|Dr.Nancy Ruiz Chief Medical Officer|732 564 2200|nancy.ruiz@meda.us|2390
22448304|NCT02200445|Brigham and Women's Hospital|Dr. Jessica Allegretti|617-732-5500|jallegretti@bwh.harvard.edu|
22448305|NCT04484142|Daiichi Sanyko, Inc|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22448306|NCT03700671|University of Central Lancashire|Stefan Birkett Lecturer in Exercise Science|01772 893325|sbirkett4@uclan.ac.uk|
22448307|NCT05371509|Mayo Clinic|Umesh Goswami, M.B.B.S., M.D.|480-342-1137|goswami.umesh@mayo.edu|
22448308|NCT01083368|Case Comprehensive Cancer Center|Jorge Garcia MD|216-444-7774|garciaj4@ccf.org|
22448309|NCT06253806|Washington University, Department of Otolaryngology - Head and Neck Surgery|Nyssa Farrell, MD|314-273-2490|nyssafarrell@wustl.edu|
22448310|NCT04405037|Cleveland Clinic Foundation|Dr. Scott Steele|216-444-4715|steeles3@ccf.org|
22448311|NCT04434092|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22448312|NCT02554812|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22448313|NCT02879305|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22448314|NCT03730948|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
22448315|NCT01786629|Braintree Laboratories, Inc.|John McGowan, Director Clinical Research|781-843-2202|jmcgowan@braintreelabs.com|
22448316|NCT00180414|Boston Scientific|Jens Goetzke|+32 2 41|jens.goetzke@bsci.com|67011
22448317|NCT00613938|Johnson & Johnson Pharmaceutical Research & Development|Senior Director, Clinical Leader|609-730-4537||
22448318|NCT00623727|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22448319|NCT01852942|University of Minnesota|Timothy Schacker, MD|612-626-6577|olso7966@umn.edu|
22386223|NCT02567409|City of Hope|Paul Frankel. Ph.D.|626-218-5265|pfrankel@coh.org|
22430441|NCT03268499|The Chinese University of Hong Kong|Simon Chun Ho Yu|+852 35051035|simonyu@cuhk.edu.hk|
22448320|NCT02315755|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22448321|NCT03220217|Ipsen|Ipsen Medical Director|See email|clinical.trials@ipsen.com|
22448322|NCT03025542|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22386224|NCT03092453|University of Pennsylvania|Regulatory Lead|215-573-7101|psom-ind-ide@pobox.upenn.edu|
22386225|NCT05524402|Massachusetts General Hospital|Dr. Jonathan Greenberg|617-643-9402|jgreenberg5@mgh.harvard.edu|
22386226|NCT05976334|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22386227|NCT03381586|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22386228|NCT01130519|National Cancer Institute|Dr. Ramaprasad Srinivasan|240-760-6251|ramasrin@mail.nih.gov|
22386229|NCT03703908|ChemoCentryx|Study Director|650-210-2900|clinicaltrials@chemocentryx.com|
22386230|NCT05280574|Outcomes Research Consortium, Department of Anesthesiology, Cleveland Clinic, Cleveland, Ohio|Daniel I. Sessler MD, Professor and Michael Cudahy Chair|216-870-2620|DS@OR.org|
22386231|NCT04180462|Washington University School of Medicine|Allison King, M.D., Ph.D., MPH|314-454-4291|king_a@wustl.edu|
22386232|NCT03733925|Johnson & Johnson Private Limited|Medical Advisor Immunology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22386233|NCT02361216|LEO Pharma A/S|Clinical Trial Disclosure Manager||disclosure@leo-pharma.com|
22386234|NCT05683340|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81363617366|CL_OPCJ_RDA_Team@otsuka.jp|
22386235|NCT03931408|University of Louisville|Dr. Harkema|502-582-7676|lori.clark2@louisville.edu|
22386236|NCT02224144|Columbia University|Thomas Nickolas MD, MS|2123053273|tln2001@cumc.columbia.edu|
22386237|NCT03505008|Keio University School of Medicine|Prof. Y Kaneko|+81-3-5363-3786|ykaneko@z6.keio.jp|
22386238|NCT02437136|Syndax Pharmaceuticals, Inc.|Kate Madigan, MD, Chief Medical Officer|858-888-3798|kmadigan@syndax.com|
22386239|NCT04117178|Department of Neurology, Zealand University Hospital|Michael Fischer|+4547322800|mihh@regionsjaelland.dk|
22386240|NCT04312841|The Ohio State University Comprehensive Cancer Center|Dr. John Reneau|614-293-3196|John.Reneau@osumc.edu|
22386241|NCT02780700|Boehringer Ingelheim|Boehringer IIngelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22386242|NCT02827838|Wake Forest Baptist Comprehensive Cancer Center|Mercedes Porosnicu|336-716-8664|mporosni@wakehealth.edu|
22386243|NCT03980925|MFAR Clinical Research|Federico Nepote|+34 93 434 44 12|investigacion@mfar.net|
22386244|NCT05130814|Emoled srl|Duccio Rossi Degl'Innocenti|+390550751960|d.rossi@emoled.com|
22448323|NCT04693507|Antev Ltd|Carol MacLean|+447525177617|cmaclean@antev.co.uk|
22448324|NCT00312494|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22448325|NCT00488345|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22448326|NCT04538066|Synaptogenix, Inc.|Chief Medical Officer|973 242-0005|atuchman@synaptogen.com|
22448327|NCT00696696|NYU Cancer Institute|Deirdre Cohen, MD|212-731-5656|deirdre.cohen@nyumc.org|
22448328|NCT02642614|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22448329|NCT01585428|National Cancer Institute|D. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
22448330|NCT01985581|Center for Pediatric Excellence|Dr. Judy van Stralen|613-726-7355|judyvanstralen@bellnet.ca|
22448331|NCT02057198|Duke University Medical Center|Daniel Sexton, M.D.|919-684-4596|sexto002@mc.duke.edu|
22448332|NCT03878745|Becton Dickinson|Michael Gibney|201-847-6170|Michael.gibney@bd.com|
22448333|NCT00065507|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22386245|NCT03824366|Washington University School of Medicine|Hyun Kim, M.D.|314-362-8502|kim.hyun@wustl.edu|
22386246|NCT04068831|Memorial Sloan Kettering Cancer Center|Dr. Ritesh Kotecha, MD|646-422-4791|kotechar@mskcc.org|
22448334|NCT00350636|Watson Laboratories, Inc|Gary Hoel, PhD, Executive Director|801-808-8866|gary.hoel@watson.com|
22386247|NCT00323856|Grifols|Rhonda Griffin|919-316-6693|rhonda.griffin@grifols.com|
22386248|NCT04538378|National Cancer Institute|Dr. Anish Thomas|240-760-7343|anish.thomas@nih.gov|
22386249|NCT04086121|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22386250|NCT03825588|University of Texas Southwestern Medical Center, University of Pittsburgh|Dr. Beth Dohoney Kennard; Dr. David Brent|214.456.4244|beth.kennard@utsouthwestern.edu|
22386251|NCT02834390|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22386252|NCT03118518|Medtronic|Erika Pouliot|17635261270|erika.pouliot@medtronic.com|
22386253|NCT04667468|University of Pittsburgh|Dr. Jason Sperry|412-215-7025|sperryjl@upmc.edu|
22386254|NCT01726257|Endologix|Tammy Stiver|5136731452|tstiver@endologix.com|
22386255|NCT06029452|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22386256|NCT04750941|Columbia University|Jennifer E. Amengual, MD|212-326-5720|jea2149@cumc.columbia.edu|
22386257|NCT04560595|Johns Hopkins University|Dr. Dustin C. Lee|410-550-4035|dlee214@jhmi.edu|
22386258|NCT03106740|Massachusetts General Hospital|Marco Loggia|(617) 643-7267|marco.loggia@mgh.harvard.edu|
22386259|NCT04797858|University of Pennsylvania|Robert Gross|2158982437|grossr@pennmedicine.upenn.edu|
22386260|NCT03426891|Moffitt Cancer Center|Dr. Peter Forsyth|813-745-3063|Peter.Forsyth@moffitt.org|
22386261|NCT01880515|Instituto Nacional de Cancerología de México|Oscar Gerardo Arrieta Rodriguez|+52 1 55 56 28 04 00|ogar@unam.mx|71101
22448335|NCT00100815|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22448336|NCT01214161|Columbia University|Anne Davis, MD|212-305-4951|ard4@cumc.columbia.edu|
22448337|NCT01647282|UNMC College of Dentistry|Dr. Amy C. Killeen|402-202-7848|akilleen@unmc.edu|
22448338|NCT00665353|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22448339|NCT01851720|Johns Hopkins School of Medicine|Alex Coon|410-955-2438|acoon2@jhmi.edu|
22448340|NCT00870363|University of California Davis Medical Center|David M Asmuth|(916) 734-8695|dasmuth@ucdavis.edu|
22386262|NCT05361031|Helixmith, Co., Ltd.|Jinsub Lee, PhD|+82-10-8256-0439|jinsub.lee@helixmith.com|
22386263|NCT02593773|Horizon Pharma Ireland, Ltd, Dublin Ireland|Julie Ball, Executive Director, Clinical Development & Operations|(224) 383-3000|clinicaltrials@horizonpharma.com|
22386264|NCT04304144|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22386265|NCT04101357|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
22386266|NCT04618315|Northwestern University|Sumitrajit Dhar|847 491 8542|s-dhar@northwestern.edu|
22386267|NCT05176093|Helixmith Co., Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
22386268|NCT04871529|SWOG|Melissa Plets|206 667 2707|mplets@fredhutch.org|
22386269|NCT05184452|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
22386270|NCT02584647|Columbia University|Gulam A. Manji|212 305 0592|gam2140@cumc.columbia.edu|
22386271|NCT05290493|Nobias Therapeutics, Inc.|Patrick Dougherty|(215) 821-4698|dougherty@nobiastx.com|
22386272|NCT04003246|University of Texas Southwestern Medical Center|Dr. Yuanyuan Zhang|2146458525|yuanyuan.zhang@utsouthwestern.edu|
22386273|NCT03914742|Johns Hopkins University|Program Manager Adult Brain Tumor Consortium (ABTC) and Brain Cancer Program|410-955-8837|jfisher@jhmi.edu|
22386274|NCT05363163|Eurofins Dermscan Pharmascan|Florence REBER|0472823656|Florence.Reber@cpt.eurofinseu.com|+33
22386275|NCT05735652|Boston Scientific|Taimin.Yue|18911590729|Taimin.yue@bsci.com|
22386276|NCT03673501|Deciphera Pharmaceuticals, LLC|INTRIGUE Clinical Team|781-209-6400|clinicaltrials@deciphera.com|
22386277|NCT05838027|University of Pennsylvania|Eva Fabian|760-791-2633|eva.fabian@pennmedicine.upenn.edu|
22386278|NCT04599634|National Cancer Institute|Dr. Mark J. Roschewski|240-760-6183|mark.roschewski@nih.gov|
22386279|NCT05776875|Yale University|Wei Cheng|203-737-7005|w.cheng@yale.edu|
22386280|NCT06193070|Fred Hutchinson Cancer Center|Dr. Megan Shen, Associate Professor|206-667-4172|mshen2@fredhutch.org|
22386281|NCT04526886|Dartmouth Hitchcock Medical Center|Gabriel Brooks|(603) 650-4344|gabriel.a.brooks@hitchcock.org|
22386282|NCT05046639|Northwestern University|Paul Fitzgerald|312-695-1064|p-fitzgerald2@northwestern.edu|
22386283|NCT03276676|Huntsman Cancer Institute, Center for Quantitative Cancer Imaging|Sam Mitchell|801-213-6110|sam.mitchell@hci.utah.edu|
22386284|NCT04753788|LSHTM|Professor Michael Marks|+44020 7636 8636|michael.marks@lshtm.ac.uk|
22386285|NCT05015751|Rhaeos, Inc.|Anna Somera|855-814-3569|info@rhaeos.com|
22386286|NCT02962076|Mercy Research|Michelle Bryant, MPH|314-251-8827|michelle.bryant@mercy.net|
22386287|NCT05482360|University of Washington|Anjuli Wagner, PI|978 460 2331|anjuliw@uw.edu|
22386288|NCT04723147|Emory University|Dr. Jennifer Felger|404-727-3987|jfelger@emory.edu|
22386289|NCT03580356|Novartis Pharmaceuticals|Study Director|1 (862) 778-8300|novartis.email@novartis.com|
22386290|NCT05715528|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22386291|NCT03331835|LEO Pharma AS|Clinical Disclosure|(+1) 877-557-1168|disclosure@leo-pharma.com|
22386292|NCT03485729|Chimerix, Inc.|Chief Medical Officer|919-806-1074|clinicaltrials@chimerix.com|101
22386293|NCT05035654|Lyra Therapeutics|Senior Vice President, Clinical Affairs|617-393-4600|lyraclinical@lyratx.com|
22386294|NCT05848947|Sirtex Medical|Janet Bell, Director, Clinical Research Operations|978-866-1798|jbell@sirtex.com|
22386295|NCT05533190|The Institute of Cancer Research|Prof Ceire Costelloe|20 3437 6777|ceire.costelloe@icr.ac.uk|
22386296|NCT05552508|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22386297|NCT05814211|Coloplast A/S|Christian Riis Forman, Medical writer|49111756|dkcrif@coloplast.com|
22386298|NCT04451772|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22386299|NCT04311632|ITB-MED LLC|Jesse Scott, MPH|+46 8 410 02 887|KTX@itb-med.com|
22386300|NCT05856435|Cincinnati Children's Hospital Medical Center|Katie Nause|513-803-1506|Katie.Fox@cchmc.org|
22386301|NCT04632225|Helixmith Co, Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
22386302|NCT03812289|OHSU Knight Cancer Institute|Nima Nabavizadeh, MD|503-418-3685|nabaviza@ohsu.edu|
22386303|NCT02484430|Mayo Clinic|Aref Al-Kali, M.D.|(507) 284-2511|alkali.aref@mayo.edu|
22386304|NCT03421340|Boston Scientific|Pooja Goswamy|15086834335|pooja.goswamy@bsci.com|
22386305|NCT05660434|West Virginia University|Dr. Marian Reven, PhD, RN, AHN-BC, CNE, RA|304-293-3399|marian.reven@hsc.wvu.edu|
22386306|NCT00780494|Stanford University|Pamela Kunz|650-725-8738|pkunz@stanford.edu|
22386307|NCT05664958|Duke Unversity School of Medicine|Ashraf Haib|919-668-2024|ashraf.habib@duke.edu|
22386308|NCT01199133|Stallergenes|Michel Roux, Medical Director|+33 (0) 1 55 59 29 70|mroux@stallergenes.com|
22386309|NCT02575950|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
22386310|NCT05080283|Cochlear Ltd.|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
22386311|NCT03993392|Indivior, Inc|Global Director, Clinical Development|804-379-1090|Robert.Dobbins@Indivior.com|
22386312|NCT03100760|University of New Mexico Health Sciences Center|Justin Baca|505-272-5062|jtbaca@salud.unm.edu|
22386313|NCT05292391|Kaiser Permanente Washington Health Research Institute|Lisa A. Jackson, MD, MPH|(206)-442-5216|Lisa.A.Jackson@kp.org|
22386314|NCT00636389|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
22386315|NCT04857723|CooperVision Inc.|Paul Chamberlain|+19257306754|pchamberlain@coopervision.com|
22386316|NCT01064440|Helixmith, Co., Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
22386317|NCT03505710|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo_us@daiichisankyo.com|
22386318|NCT04414722|Dept. of Family Medicine, Georgetown University Medical Center|Dan Merenstein, Director of Research Programs|202-687-1600|djm23@georgetown.edu|
22386319|NCT04766892|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22386320|NCT04359654|University College London|Ms Donna Basire|+44-2031087748|d.basire@ucl.ac.uk|
22386321|NCT04738591|Health Research Institute of the Balearic Islands (IdISBa)|Dr. Rocío Zamanillo Campos|971175897|rocio.zamanillo@ssib.es|
22386322|NCT03711474|West Virginia University|Scott Daffner, MD|304-293-1172|sdaffner@hsc.wvu.edu|
22448341|NCT01870583|Stony Brook Medicine|Dr David Garry|631-444-7650|david.garry@stonybrookmedicine.edu|
22448342|NCT02389998|Boston Children's Hospital|Dr Samuel Nurko|6173556055|samuel.nurko@childrens.harvard.edu|
22448343|NCT01623323|OptiNose|Jennifer Carothers|908-432-3061|jennifer.carothers@optinose.com|
22448344|NCT02632552|U.S. Department of Veterans Affairs, Center for Healthcare Organization and Implementation Research (CHOIR)|Timothy P. Hogan, PhD,|508-244-2303|Timothy.Hogan@VA.gov|
22448345|NCT01516957|Bausch Health|Director of Clinical Trials|310-770-7750|anya.loncaric@bauschhealth.com|
22448346|NCT02074631|University of Minnesota, Masonic Cancer Center|Dr. Kyriakie Sarafoglou|(612) 624-5965|saraf010@umn.edu|
22448347|NCT00450450|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22448348|NCT02402309|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
22448349|NCT02150954|Duke University Medical Center|Chad Grotegut , MD||chad.grotegut@dm.duke.edu|
22448350|NCT02621242|University of Washington|Dr. Joanne Stekler|206-744-8312|jstekler@uw.edu|
22448351|NCT04344314|Becton, Dickinson and Company|Christopher Rini, Associate Director Translational and Clinical Sciences Center of Excellence|+1 984 389 1186|christopher.rini@bd.com|
22448352|NCT00632411|University of Tennessee Health Science Center|Dr. Robert Klesges|901-448-3174|lcolvin1@uthsc.edu|
22448353|NCT00913003|Northwestern University|Paul Fitzgerald|312-695- 1064|p-fitzgerald2@northwestern.edu|
22448354|NCT02377466|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22448355|NCT04210310|NYU Langone Health - Preston Robert Tisch Center for Men's Health|Lawrence Newman, MD|646-754-2000|Lawrence.Newman@nyulangone.org|
22448356|NCT00495170|UT MD Anderson Cancer Center|Dr. Joe Chang / Professor, Radiation Oncology Department|713-563-2337|jychang@mdanderson.org|
22448357|NCT00330616|GlaxoSmithKline|GSK Response Center|866-435-7343||
22448358|NCT00697203|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
22448359|NCT03063476|Vanderbilt University Medical Center|Dr. Jane Ferguson|6158759896|jane.f.ferguson@vanderbilt.edu|
22448360|NCT03254927|Celldex Therapeutics|Chief Medical Officer|844-723-9363|info@celldex.com|
22448361|NCT00597766|MetroHealth Medical Center|Dr. Richard Wilson|216-957-3529|rwilson@metrohealth.org|
22448362|NCT01333059|Cook Children's Medical Center|Javier Gelvez, MD||Javier.Gelvez@cookchildrens.org|
22448363|NCT00676455|Lahey Clinic|Christopher Wald, MD|781-744-8710|Christopher.Wald@lahey.org|
22448364|NCT00737282|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
22448365|NCT02763189|Wake Forest School of Medicine|Dr. Michael A. Olympio|3369182132|molympio@wakehealth.edu|
22448366|NCT00530764|GW Pharma Ltd.|Matthew Hersch, Senior Clinical Project Manager|+44 1353 616600|mhersch@gwpham.com|
22448367|NCT02049957|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22448368|NCT04447755|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22448369|NCT00840294|University of Chicago|Scott Eggener|(773) 702-5195|seggener@surgery.bsd.uchicago.edu|
22448370|NCT05392998|Clínica Rementería|Dr. Inés Contreras|34913083838|contreras@clinicarementeria.es|
22448371|NCT03721276|Yale University|Dr. John Pachankis|6463444060|john.pachankis@yale.edu|
22386323|NCT03085719|Dana-Farber Cancer Institute|Jonathan Schoenfeld, MD, MPH|617-582-8731|Jonathan_Schoenfeld@dfci.harvard.edu|
22386324|NCT06038708|BIOTRONIK Italy|Paola Napoli, Clinical Project Manager|3357369277|paola.napoli@biotronik.com|0039
22386325|NCT03154190|Stanford University School of Medicine|Manali Patel|650-723-4000|manalip@stanford.edu|
22386326|NCT05237284|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22386327|NCT03583333|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22386328|NCT03926130|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22386329|NCT01569659|Northwestern University|Herbert Meltzer, MD|312-503-9096|h-meltzer@northwestern.edu|
22386330|NCT04587024|Johns Hopkins University|Dr. Cozumel S. Pruette|410-955-2467|csouthe1@jhmi.edu|
22386331|NCT05069896|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22386332|NCT05395871|Imperial College London|Amish Acharya|0203312 6666|aa2107@ic.ac.uk|
22386333|NCT04204083|Anika Therapeutics|Kara Mezger, Executive Director Clinical Affairs|781.457.9000|kmezger@anika.com|
22386334|NCT04075318|Vaxxinity, Inc.|Executive Director, Clinical Development|254-244-5739|info@vaxxinity.com|
22386335|NCT04605159|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22386336|NCT05599334|Pierre Fabre Médicament|Medical Director (Jeanne Suissa)|+33149108269|jeanne.suissa@pierre-fabre.com|
22386337|NCT04934072|Fresenius Kabi SwissBioSim GmbH|Clinical Development|+41 793075735|medinfo_biosim@fresenius-kabi.com|
22386338|NCT03631290|Duke University Medical Center|Rasheeda Hall, M.D.|919-660-6861|rasheeda.hall@duke.edu|
22386339|NCT05424380|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22386340|NCT03204825|University of Stirling|Dr Chris Seenan|+441413318151|christopher.seenan@stir.ac.uk|
22386341|NCT03624465|Levita Magnetics|Vivian Soto|+56958360507|VSoto@Levita.com|
22386342|NCT03213678|Children's Oncology Group|Results Reporting Coordinator|6264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22386343|NCT04218851|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22386344|NCT03717935|University of Colorado|Melanie Cree-Green, PI|720-777-5743|melanie.green@childrenscolorado.org|
22386345|NCT04456296|Endo Pharmaceuticals|Clinical Operations|800-462-3636|clinicaltrials@endo.com|
22430442|NCT04526158|Minneapolis VAMC|Dr. Diana Burgess|612-567-1591|diana.burgess@va.gov|
22430443|NCT00677040|Essentia Health|Ken Dornfeld|218 786-1311|kenneth.dornfeld@essentiahealth.org|
22430444|NCT04064567|University of Arkansas for Medical Sciences|Director, Research Programs|501-686-6427|hkhorton@uams.edu|
22430445|NCT03168529|Wayne State University|Phillip Levy, MD|3135771214|plevy@med.wayne.edu|
22430446|NCT03464461|University of Missouri|Dr. Matthew Robinson|573 884-4400|robinsonmt@health.missouri.edu|
22430447|NCT05524948|HALEON|Haleon Response Center|+447880182593|ww.clinical-trial-register@haleon.com|
22430448|NCT05155085|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
22430449|NCT03460704|Zambon S.p.A.|Michela Meroni - Clinical Trial Manager|+39 02 665241|clinicaltrials@zambongroup.com|
22448372|NCT00828347|Department of Nephrology, Kumamoto University Graduate School of Medical Sciences|A study of maintenance therapy after intravenous maxacalcitol for secondary hyperparathyroidism|+81-96-373-5164|m-adachi@gpo.kumamoto-u.ac.jp|
22448373|NCT01405742|University of Pittsburgh|Margaret V. Ragni, MD, MPH|412-209-7288|ragni@pitt.edu|
22386346|NCT05736458|University of Pennsylvania|Dr. Desmond Oathes, Principal Investigator|215-573-9390|oathes@pennmedicine.upenn.edu|
22386347|NCT02990338|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22386348|NCT04011644|Dept of Family Medicine and Community Health, UW-Madison|Dr. Andrew Quanbeck|608-609-7308|andrew.quanbeck@fammed.wisc.edu|
22386349|NCT05493852|Boston Scientific|Dr Xiuyue Jia|+86 15104673346|xiuyue.jia@bsci.com|
22386350|NCT04874948|Klinikum der Universität München (LMU)|Dr. med. vet. Julia Dreisbach|+49 89 4400|julia.dreisbach@med.uni-muenchen.de|59825
22386351|NCT05100628|Noxopharm|Lorena Figueroa, Director Clinical Operations|+ 61 2 9144 2223|lorena.figueroa@noxopharm.com|
22386352|NCT03914469|UT Southwestern Medical Center|Dr. Makris|214 648 3133|una.makris@utsouthwestern.edu|
22386353|NCT03717753|Hospital for Special Surgery|Dr. Jacques YaDeau, MD PhD|212- 606-1206|yadeauj@hss.edu|
22386354|NCT03655080|Washington University School of Medicine|Hiram A. Gay, M.D.|314-362-8516|hiramgay@wustl.edu|
22386355|NCT05408663|Extend Biosciences|Laura Hales PhD|(732) 599-8581|lhales@extendbio.com|
22386356|NCT03334695|Janssen Research & Development, LLC|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22399913|NCT01986062|Arbor Pharmaceuticals|Dr. Steve Caras|(470) 235-2327|scaras@arborpharma.com|
22399914|NCT03538743|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22399915|NCT02587338|Universitätsklinikum Würzburg|Prof. Dr. Martin Herrmann|+4993120176650|Herrmann_m@ukw.de|
22399916|NCT01827384|National Cancer Institute|Dr. Alice P. Chen|240-781-3274|chenali@mail.nih.gov|
22399917|NCT00630331|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22399918|NCT00524537|AbbVie|Global Medical Information|800-633-9110||
22399919|NCT01302808|UT Southwestern Medical Center|David Gerber, MD|2146484180|david.gerber@utsouthwestern.edu|
22399920|NCT01110252|Labcel|João Tadeu Ribeiro Paes|55 18 3302 5800|labcel.tronco@gmail.com|5856
22399921|NCT06120530|Indiana University School of Medicine|Jose Lazaro|7274241947|jlazarow@iu.edu|
22399922|NCT01929135|Universidad de los Andes|Dra. Catherine Andrade|056-972862308|catherine.perio@gmail.com|
22399923|NCT02425098|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22399924|NCT02761967|University of Granada|Dr. Rodríguez-Blanque|+34644322567|rarobla@gmail.com|
22399925|NCT01955707|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22399926|NCT03866200|The University of Texas Health Science Center at Houston|Karen Posey, PhD|713-500-5786|karen.posey@uth.tmc.edu|
22399927|NCT01905956|InQpharm Europe Ltd|Pee-Win Chong|+603 6201 9690|pwchong@inqpharm.com|358
22399928|NCT01817790|GlaxoSmithKline|GSK Response Center|866-435-7343||
22399929|NCT01671345|Jesse Brown VA Medical Center|Howard S. Gordon, MD|312-569-7331|howard.gordon2@va.gov|
22399930|NCT04291560|University of North Carolina at Chapel Hill|Jamie Crandell, PhD|919-966-5803|jcrandell@unc.edu|
22399931|NCT02847598|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22448374|NCT01340898|GlaxoSmithKline|GSK Response Center|866-435-7343||
22448375|NCT04900220|West Virginia University|Dr. Shafic Sraj - Associate Professor|304-293-3007|shafic.sraj@hsc.wvu.edu|
22448376|NCT02028065|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22448377|NCT03457129|University of Arizona, College of Medicine Phoenix|Stephanie Marsh, MPH, CCRC|602-255-7552|slmarsh@arizona.edu|
22448378|NCT03649750|Reckitt Benckiser Inc.|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
22448379|NCT01698801|Celgene Corporation|Senior Manager, Clinical Trials Disclosure|1-888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22448380|NCT00656474|Glycotex|Dr. Reinhard Koenig, CEO|301-670-2825|Reinhard.Koenig@glycotexinc.com|
22448381|NCT02062879|UC Health University of Cincinnati Medical Center|Sheila Takieddine|513-585-6195|Sheila.Takieddine@UCHealth.com|
22448382|NCT03195088|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22448383|NCT00665847|Tibotec Pharmaceuticals, Ireland|Senior Director|32 14 641 265|gdsmedt1@its.jnj.com|
22448384|NCT01754623|Florida Hospital Orlando (Formerly at Moffitt Cancer Center)|Ravi Shridhar, M.D., Ph.D.|407-303-5857|ravi.shridhar.md@flhosp.org|
22448385|NCT06029673|Stanford University|Research Team|(650) 497-5175|gynresearch@stanford.edu|
22448386|NCT00410761|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22448387|NCT02659709|Wills Eye Hospital, Glaucoma Service|Dr. Jonathan S. Myers|215-928-3197|jmyers@willseye.org|
22448388|NCT01277354|University of Pennsylvania|Cynthia Neill Epperson, M.D.|215-573-8871|cepp@mail.med.upenn.edu|
22386357|NCT00721149|Biosense Webster, Inc.|Diana Bordley, Director, Regulatory Affairs|800-729-9010|dbordley@its.jnj.com|8604
22399932|NCT03690869|Regeneron Pharmaceuticals Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22399933|NCT04981223|Stanford University|Dr. Geoffrey Sonn|(650) 498-6000|gsonn@stanford.edu|
22430450|NCT02913326|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22430451|NCT01767857|Janssen Research & Development, LLC|Product Development Portfolio Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22386358|NCT01240122|Abbott Medical Optics|Senior Manager, Clinical Research|714.247.8723|eugenia.kao@amo.abbott.com|
22386359|NCT04614948|Janssen Vaccines & Prevention B.V.|VICE PRESIDENT Medical Affairs IDV|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22386360|NCT04271046|Kaiser Permanente Washington Health Research Institute|Robert Penfold|206-287-2232|robert.b.penfold@kp.org|
22386361|NCT01570361|Johnson & Johnson Medical N.V., Biosense Webster|Liesbeth Vanderlinden|+32 (0) 2 746 3446|lvanderl@its.jnj.com|
22386362|NCT05158504|IstanbulSBU|HKARTAL|05378870982|kartal_hilal@yahoo.com|
22430452|NCT01421459|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22430453|NCT02899754|Philadelphia VA Medical Center (CMCVAMC), Philadelphia, PA|Dr. Marilyn M Schapira, Senior Investigator, Center for Health Equity Research & Promotion (CHERP)|215 898 2022|mschap@pennmedicine.upenn.edu|
22430454|NCT04818229|Connect Biopharma|Dr. Chin Lee, MD Chief Medial Officer|+1 650 676 9617|clee@connectpharm.com|
22430455|NCT04082364|MacroGenics, Inc.|Chief Medical Officer|301-251-5172|info@macrogenics.com|
22430456|NCT03186378|Verrica Pharmaceuticals|Susan Cutler, VP, Medical Affairs|484-773-0898|scutler@verrica.com|
22430457|NCT02592655|Marcus Migura|Marcus Migura|(619) 436-7323|mwmigura@gmail.com|
22430458|NCT02628145|University of Rhode Island|Matthew Delmonico|4018745440|delmonico@uri.edu|
22430459|NCT03247673|Celltrion|Clinical Planning Department Leader|82328505000|contact@celltrion.com|
22386363|NCT03309644|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
22430460|NCT03000166|University of Wisconsin-Milwaukee|Jeanne M. Erickson, PhD, RN|414-229-6920|ericksoj@uwm.edu|
22430461|NCT04409418|William Beaumont Hospitals|Dr. Amit Bahl|248 898-9111|amit.bahl@corewellhealth.org|
22430462|NCT02971137|VA Connecticut Healthcare System|Dr. Lori A. Bastian|203-932-5711|lori.bastian@va.gov|2655
22448389|NCT00478569|Takeda|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
22448390|NCT01829516|University of California, San Francisco|Jennifer Mitchell, PhD|510-985-3921|jennifer.mitchell@ucsf.edu|
22448391|NCT02366845|University of Colorado|Dr. Marc Moss|303-724-6080|marc.moss@cuanschutz.edu|
22448392|NCT04708886|Northwestern University Feinberg School of Medicine|Thomas Schnitzer|3125032315|tjs@northwestern.edu|
22448393|NCT01729754|Sun Pharma Advanced Research Company Limited|Head-Clinical Development|912266455645|clinical.trials@sparcmail.com|
22386364|NCT03606512|Janssen Vaccines & Prevention B.V|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22448394|NCT00936910|Children's Hospital of Pittburgh|Dr. William McGhee, Clinical Pharmacy Specialist, Transplant|412-692-5733|william.mcghee@chp.edu|
22448395|NCT00773292|Imperial College London|Graham P Taylor|0207 594 3910|g.p.taylor@imperial.ac.uk|
22448396|NCT01853046|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22448397|NCT05022784|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22448398|NCT03020407|Department of Emergency Medicine, Faculty of Medicine, Chulalongkorn University|Dr. Khrongwong Musikatavorn|+6626494000|kmusikatavorn@yahoo.com|83058
22448399|NCT00708162|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22448400|NCT02699554|University of Washington|Katherine Steele|206-685-2390|kmsteele@uw.edu|
22448401|NCT00788151|Sanofi Pasteur SA|Director||Contact-US@sanofi.com|
22448402|NCT00503009|GlaxoSmithKline|GSK Response Center|866-435-7343||
22448403|NCT03540147|University of Texas at Austin|Hirofumi Tanaka|5122324801|htanaka@austin.utexas.edu|
22448404|NCT01349803|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com|
22448405|NCT02345811|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
22448406|NCT02522286|Palo Alto Medical Foundation Research Institute|Dr. Ming Tai-Seale|650-853-4779|Tai-SealeM@pamfri.org|
22448407|NCT03633487|Reckitt Benckiser, Inc|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
22448408|NCT00605813|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22448409|NCT00119392|Fred Hutchinson Cancer Research Center|Ajay Gopal|206-288-2037|akgopal@fhcrc.org|
22448410|NCT01163279|Baycrest Health Sciences|Dr. Deirdre Dawson|416-785-2500|ddawson@research.baycrest.org|2136
22448411|NCT02312726|University of New Mexico - Family Planning Research Division|Michel Paves, Research Specialist|505-272-9703|mdaliva@salud.unm.edu|
22448412|NCT01394523|Nationwide Children's Hospital|Tarun Bhalla, MD|6147224200|Tarun.Bhalla@nationwidechildrens.org|
22448413|NCT00594997|Brigham and Women's Hospital|Nancy Shadick|617-732-5266|nshadick@partners.org|
22448414|NCT00583804|MetroHealth Medical Center|Principal Investigator|2169573683|ue.fes.clinicaltrials@gmail.com|
22448415|NCT01290640|The University of Tennessee|Dr. Richard Komistek, Professor|865-974-4159|rkomiste@utk.edu|
22448416|NCT03525574|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22448417|NCT00905554|Valduce Hospital - Como - Italy|Vittorio Terruzzi, MD|+39031324009|vterruzzi@valduce.it|
22448418|NCT04741074|Geisinger|Alexander Chang|570-271-8026|achang@geisinger.edu|
22448419|NCT01770379|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22448420|NCT00778700|Incyte Organization|Study Director|1-855-463-3463|medinfo@incyte.com|
22448421|NCT04155632|Medical University of South Carolina|Dr. Xiaolong Peng|8437928642|pengxi@musc.edu|
22448422|NCT02929823|PPD|Joseph Pollard|+1 910 558 4428|joseph.pollard@ppdi.com|
22448423|NCT03274440|Columbia University/New York State Psychiatric Institute|Dr. Reilly Kayser|6467748118|reilly.kayser@nyspi.columbia.edu|
22448424|NCT02611778|bioeq GmbH|Head of Clinical Development|+498024463330|columbus@bioeq.com|
22448425|NCT00385996|Weill Cornell Medical College|Nasser Altorki, MD|212-746-5156|nkaltork@med.cornell.edu|
22448426|NCT04008030|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22448427|NCT02972554|University of North Carolina at Chapel Hill|Dr. Keely A. Muscatell|919-843-9113|kmuscatell@unc.edu|
22448428|NCT03756688|Mayo Clinic|Dr. Landon Trost|507-202-1995|landontrost@gmail.com|
22448429|NCT02574247|University of Illinois at Urbana-Champaign|Dr. Ian Mertes|217-300-4756|imertes@illinois.edu|
22448430|NCT02268864|Janssen Research and Developement, Belgium|Trial Physician||ClinicalTrialDisclosure@its.jnj.com|
22386365|NCT05513937|A. Menarini Industrie Farmaceutiche Riunite SrL|Clinical Operation Director|055 5680459|pfabrizzi@menarini.it|+39
22386366|NCT02846545|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22448431|NCT06273124|Tandem Diabetes Care|Supervisor, Clinical Operations|(858) 366-6900|clinicalaffairs@tandemdiabetes.com|
22448432|NCT03336853|AOUCareggi|Dr. Riccardo Pace|+390557945608|riccardo.pace@unifi.it|
22386367|NCT06468982|Atatürk University|Dr. Ümit Arslan|05418209007|kvcumit@gmail.com|
22386368|NCT02326974|Dana-Farber Cancer Institute|Project Manager|617-632-3500|ctopm@dfci.harvard.edu|
22386369|NCT04181736|Stanford University|Laura Hack, MD, PhD|650-724-7478|lhack@stanford.edu|
22386370|NCT04924400|Geisinger|Dr. Thomas Morland|703-593-0088|tmorland@geisinger.edu|
22386371|NCT04633538|Oxford University Hospital|Dr Elizabeth Orchard|01865223084|elizabeth.orchard@ouh.nhs.uk|
22386372|NCT04565990|Actelion Pharmaceuticals Ltd|Executive Medical Director CP|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22386373|NCT05507333|Gedea Biotech AB|Annette Säfholm, CEO|0046 708 91 86 81|annette.safholm@gedeabiotech.com|
22448433|NCT01528254|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22448434|NCT00383149|Organization: Bristol-Myers Squibb|Name/Official Title: BMS Study Director||Clinical.Trials@bms.com|
22448435|NCT01150981|University of Massachusetts Medical School|Samir Malkani, MD|5088563800|samir.malkani@umassmemorial.org|
22448436|NCT02418026|Groupe Hospitalier de la Rochelle Ré Aunis|Mrs Sandrine Delavaux|+33 5 46 45 50 50|saniade@msn.com|
22448437|NCT03626623|Integra LifeSciences|Allison Matthews|(443) 766-3869|allison.matthews@integralife.com|
22448438|NCT00416078|VAGLAHS at West Los Angeles|Dr. Theodore Hahn|3102684108|thahn@ucla.edu|
22448439|NCT01190878|InSite Vision|Senior Manager, Clinical Sciences||manjiri.desai@sparcmail.com|
22448440|NCT00989014|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
22448441|NCT02998840|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
22448442|NCT01686633|GlaxoSmithKline|GSK Response Center|866-435-7343||
22448443|NCT02530554|Evic Romania|Dr. R Olsavszky|40 21 335 70 91|evicromania@evic.ro|
22448444|NCT00511667|Merck Sharp & Dohme|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22448445|NCT03564145|Sol-Gel Technologies, Ltd.|Sol-Gel|972-8-9313433|info@sol-gel.com|
22448446|NCT02607033|Baltimore VA Hosptial|Odessa Addison|4106057000|odessa.addison@va.gov|55393
22448447|NCT04219891|Alcon Research, LLC|Clinical Projects Director, Surgical|8884513937|alcon.medinfo@alcon.com|
22448448|NCT03724812|Abbott|Angelic Roach|+1 651 756 3379|angelic.roach@abbott.com|
22448449|NCT03227029|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22448450|NCT01291173|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22448451|NCT05855005|Northwestern University|Kendra Marks|2069991423|kendra.marks@northwestern.edu|
22448452|NCT06119529|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22448453|NCT01074450|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22448454|NCT02728895|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22448455|NCT02769247|Walter Reed National Military Medical Center|Dr. Shana Miles|318 456 6389|shana.m.miles2.mil@mail.mil|
22448456|NCT04788953|Brigham and Women's Hospital|Dr. Kirsi-Marja Zitting|617-525-8339|kzitting@bwh.harvard.edu|
22448457|NCT00469092|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22448458|NCT04473937|Massachusetts General Hospital|Chirayu Patel, MD|617-724-9627|CPATEL@MGH.HARVARD.EDU|
22448459|NCT01462084|Stanford Sleep Medicine|Michelle Cao, DO, FAASM|(650) 723-6601|michellecao2007@gmail.com|
22448460|NCT01086540|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22448461|NCT02278263|Ko Awatea|Dr Marinus Stowers|+64 276 0044|msto062@aucklanduni.ac.nz|2219
22448462|NCT01998737|Bone Index Finland Ltd.|CTO|+358 45 896 2650|janne.karjalainen@boneindex.fi|
22448463|NCT00519818|Diurnal Ltd|Richard JM Ross|0044 114 2712386|r.j.ross@sheffield.ac.uk|
22448464|NCT02092662|University of Haifa|Sharon Israely|972-523-755-091|sharonis@mh.org.il|
22448465|NCT02707991|Johns Hopkins University|Laura Starbird|9787587909|Lstarbi1@jhu.edu|
22448466|NCT02049307|Hennepin Healthcare Research Institute|Jason Baker|612-873-2705|baker@umn.edu|
22448467|NCT02659631|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22448468|NCT05407675|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22448469|NCT00857220|Sunovion|CNS Medical Director|866-503-6357||
22448470|NCT02612428|Vital Therapies, Inc.|Robert Ashley, Chief Technical Officer|001 858-673-6840|rashley@vitaltherapies.com|
22448471|NCT00742001|Terumo BCT|Marty Huntington / Sr Mgr Global Clinical Affairs|+1 (303) 231-4849|Marty.Huntington@terumobct.com|
22448472|NCT03035708|National Institute on Alcohol Abuse and Alcoholism|Health Scientist Administrator|301-443-0788|falkde@mail.nih.gov|
22448473|NCT00137423|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22448474|NCT01928329|C.N.H. Long Professor of Immunobiology and of Medicine (Endocrinology)|Kevan Herold, MD|(203) 785-6507|kevan.herold@yale.edu|
22448475|NCT03187262|Dana-Farber Cancer Institute|Dr. Jorge Castillo|617-632-2681|jorgej_castillo@dfci.harvard.edu|
22448476|NCT03611790|BioMDg, CRO for VITAL Study|Sigi Caron, President and CEO at BioMDg|(831) 346-6970|sigi@biomdg.com|
22448477|NCT01496313|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
22448478|NCT00535990|UCSD|Dr. Jonathan Li|6618603471|jzl023@health.ucsd.edu|
22386374|NCT03963518|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Carine Bellera|+33556333333|c.bellera@bordeaux.unicancer.fr|
22386375|NCT01960452|University of Wisconsin|Meredith Rumble, PhD|608-232-3171|rumble@wisc.edu|
22386376|NCT03981926|University of California, Los Angeles|April W. Armstrong, MD, MPH; Professor and Chief of Dermatology|424-365-4129|skinstudy@mednet.ucla.edu|
22386377|NCT02446236|Hackensack Meridian Health|Joshua Zenreich|551-996-4248|joshua.zenreich@hmhn.org|
22386378|NCT03677141|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22448479|NCT01770483|SIMS|Prof. Faisal Masud|00923004260213|faisalmasud@hotmail.com|
22448480|NCT05167734|Mayo Clinic|Matthew Warner, M.D.|507-422-1714|Warner.Matthew@mayo.edu|
22386379|NCT03018366|Mayo Clinic|Dr. Chrisandra Shufelt|904-953-7224|shufelt.chrisandra@mayo.edu|
22386380|NCT05716763|Unither-Pharmaceuticals|Non-clinical & clinical Project Manager|33 (0)1 44 63 51 78|clinicaltrials@unither-pharma.com|
22386381|NCT04417998|Mayo Clinic|Bradley J. Kemp, Ph.D.|507-284-4399|Kemp.Brad@mayo.edu|
22386382|NCT01866163|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
22386383|NCT01449513|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com|
22386384|NCT04466098|University of Minnesota, Masonic Cancer Center|Dr. David Ingbar|612-624-9452|ingba001@umn.edu|
22386385|NCT04820322|INQUIS Clinical Research|Principal Scientist|4168619177|twolever@inquis.com|
22386386|NCT04209595|National Cancer Institute|Dr. Anish Thomas|240-760-7343|anish.thomas@nih.gov|
22386387|NCT03156465|University of Iowa|Camille Dunn|319-353-8776|camille-dunn@uiowa.edu|
22386388|NCT04200313|Jaeb Center for Health Research|Katrina Ruedy|813-975-8690|kruedy@jaeb.org|
22448481|NCT01510379|The Ohio State University|Kyle A. Perry, MD|614-293-5815|kyle.perry@osumc.edu|
22448482|NCT01050257|Hoffman-LaRoche|Medical Communications|800-821-8590||
22448483|NCT00171223|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22448484|NCT02064166|Brigham & Women's Hospital|Peter Novak, MD PhD|617-732-8896|pnovak2@bwh.harvard.edu|
22448485|NCT03706053|UVA Health|Dr. Alex Kadl|434-243-4851|AK5SC@uvahealth.org|
22448486|NCT04339296|Health Systems Evaluation & Evidence - Alberta Health Services|Research and Evaluation Coordinator|4036489255|armghan.ahmad@albertahealthservices.ca|
22448487|NCT00278655|Northwestern University|Dr Richard Burt|312-908-0059|rburt@northwestern.edu|
22448488|NCT03742037|Viatris Innovation GmbH|Viatris Innovation Clinical Trial Information|+1 908 435 2675|viatrisinnovationclinicaltrials@viatris.com|
22448489|NCT00453544|UC San Diego|Dr. Barton Palmer|858-246-0765|bpalmer@ucsd.edu|
22448490|NCT01558752|The Ottawa Hospital Research Institute|Dr Paul Beaule|613-737-8899|pbeaule@toh.ca|73265
22448491|NCT00969150|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|8124
22448492|NCT00461682|GlaxoSmithKline|GSK Response Center|866-435-7343||
22448493|NCT05020990|CooperVision Inc.|Director Global Clinical Affairs|+19256213761|jvega2@coopervision.com|
22448494|NCT04128267|Vanderbilt-Ingram Cancer Center|Teresa Melton|(615) 936-7423|teresa.melton@vumc.org|
22448495|NCT01183897|Memorial Sloan Kettering Cancer Center|Brian Kushner MD|212-639-6793|kushnerb@mskcc.org|
22448496|NCT01705652|The University of Texas Health Science Center at San Antonio Department of Radiation Oncology|Gregory P. Swanson, MD|210-450-1109|swansong@uthscsa.edu|
22448497|NCT01196923|CardioFocus, Inc.|Burke Barrett, VP, Regulatory & Clinical Affairs|508 658-7200|bbarrett@cardiofocus.com|
22448498|NCT00056407|GlaxoSmithKline|GSK Response Center|866-435-7343||
22448499|NCT00616655|Sunovion|Eszopiclone Medical Director|866-503-7813|clinicaltrialdisclosure@sunovion.com|
22448500|NCT00309842|Masonic Cancer Center, University of Minnesota|Dr.Claudio G. Brunstein MD, PhD|612-625-3918|bruns072@umn.edu|
22448501|NCT01026792|BC Cancer Agency, Vancouver Clinic, Vancouver, BC, Canada|Dr. Anna Tinker|604 877 6217|atinker@bccancer.bc.ca|
22448502|NCT01865539|Canandaigua VA Medical Center|Dr. Paul Dougherty, PI|585-463-2673|paul.dougherty@va.gov|
22448503|NCT02335099|University of Virginia|Emaad Abdel-Rahman, MD|434-924-5820|ea6n@virginia.edu|
22448504|NCT01472081|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22448505|NCT01367158|Novartis Vaccines|Posting Director||RegistryContactVaccineUS@novartis.com|
22448506|NCT04702997|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22448507|NCT03915496|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22448508|NCT02759471|CooperVision|Senior Manager Global Medical Scientific Affairs|1-925-621-3761|javega@coopervision.com|
22448509|NCT01103284|CBR International|Dr. Jeanne Novak|7207461190|jnovak@cbrintl.com|
22448510|NCT03694171|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
22448511|NCT02064907|Takeda Study Registration Call Center|Takeda|+1-877-825-3327|medicalinformation@tpna.com|
22448512|NCT03712904|Thomas Jefferson University|Wenyin Shi, MD, PhD|(215) 955-6702|wenyin.shi@jefferson.edu|
22448513|NCT04568590|Wake Forest University School of Medicine|Elizabeth Halvorson, MD, MS|336-716-4999|ehalvors@wakehealth.edu|
22448514|NCT03745937|MedImmune, LLC|Lars Hansen|+1 301 398 4563|information.center@astrazeneca.com|
22448515|NCT02710890|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22448516|NCT01190254|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22448517|NCT02356783|Hospital for Special Surgery|Robert Griffin, MD, PhD|212-774-2944|griffinr@hss.edu|
22448518|NCT01485640|Sunovion|Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
22448519|NCT05359666|Irrimax Corporation|Director of Clinical Trials|770-807-3355|cs@irrisept.com|
22448520|NCT00202644|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22448521|NCT00602576|University of Pennsylvania|Dr. Ravi Amaravadi|2157965159|ravi.amaravadi@pennmedicine.upenn.edu|
22448522|NCT00772772|The Rockefeller University|Dr. Mansih Ponda|212-327-7631|mponda@rockefeller.edu|
22448523|NCT03232281|Ipsen Pharma|Medical Director|see email|clinical.trials@ipsen.com|
22448524|NCT01403246|GIMEMA|Alfonso Piciocchi|+393203671224|a.piciocchi@gimema.it|
22448525|NCT00861146|Yale University School of Medicine|Ned L. Cooney, PhD|860-594-6339|ned.cooney@yale.edu|
22448526|NCT01372501|GI Dynamics, Inc.|Clinical Affairs Manager|781.357.3261|pkeating@gidynamics.com|
22448527|NCT05333900|University of Minnesota|Alexander Khoruts|612-624-2101|khoru001@umn.edu|
22448528|NCT00573755|Mayo Clinic|Dr. Vivek Roy|507-284-1159|roy.vivek@mayo.edu|
22448529|NCT02024867|University at Buffalo|Dr. Lucy Holmes|716-878-7277|LHolmes@upa.chob.edu|
22448530|NCT03642210|Medicines360|Emily Morris|415.951.8700|emorris@medicines360.org|
22448531|NCT02369341|GlaxoSmithKline|GSK Response Center|866-435-7343||
22448532|NCT03742154|MUSC|Lisa Coles Program Coordinator|843-876-2291|colesl@musc.edu|
22448533|NCT00772707|Alcon Global Medical Affairs|Jami Kern, Ph.D.|1-888-451-3937||
22448534|NCT03777007|Stanford University|Derek F. Amanatullah|(650) 723-2257|dfa@stanford.edu|
22448535|NCT01266460|NRG Oncology|Christopher Purdy on behalf of Austin Miller PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
22413155|NCT05612724|Rutgers School of Dental Medicine, Newark, New Jersey, United States|Gayathri Subramanian, PhD, DMD|732 824 7241|subramga@sdm.rutgers.edu|
22448536|NCT01132547|SunCoast CCOP Research Base at the University of South Florida|Angelina Fink, Research Base Administrator|813-396-9245|angelina.fink@epi.usf.edu|
22448537|NCT05811234|Almirall S.A|Head of Global Clinical Development|+34932913000|gco@almirall.com|
22448538|NCT02710045|University of Tasmania|Katie Flanagan|+61 3 6777 4081|katie.flanagan@ths.tas.gov.au|
22448539|NCT00227305|AstraZeneca|Seroquel Medical Science Director, MD||AZTrial_Results_Posting@astrazeneca.com|
22448540|NCT00870896|University of South Florida|Thomas Truncale|813 974 8952|ttruncal@health.usf.edu|
22386389|NCT05524116|Boston University|Dr. Deepak Kumar|3026901455|kumard@bu.edu|
22386390|NCT04380337|Stanford University|Dr. Erqi Pollom|650-498-0484|erqiliu@stanford.edu|
22386391|NCT03181516|Georgetown University Medical Center|Dr. Daniel Merenstein|2026872745|djm23@georgetown.edu|
22386392|NCT04444518|University of Rochester|Cynthia Rand, PI|5852759316|cynthia_rand@urmc.rochester.edu|
22386393|NCT04544007|University of Alabama at Birmingham|Coretta Thomas, Scientist & Data Manager for NF Consortium|205-975-8629|coretta@uab.edu|
22386394|NCT06197360|Yangzhou University|Yueqi Zhao|13390676131|mz120221975@stu.yzu.edu.cn|
22386395|NCT03489434|Georgia State University|Amanda Gilmore|404-413-2000|agilmore12@gsu.edu|
22386396|NCT05791435|Nemours Children Health System|Tariq Rahman|302 651 6831|trahman@nemours.org|
22386397|NCT02874001|Institut Bergonié|S Mathoulin-Pélissier, Director of Clinical Trials Unit|+33556333333|s.mathoulin@bordeaux.unicancer.fr|
22413156|NCT03112863|UC Davis Dermatology|Iryna Rybak|916-551-2636|irybak@ucdavis.edu|
22448541|NCT00527943|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22386398|NCT02839265|Montefiore Medical Center|Dr. Nitin Ohri|718-920-7750|nitin.ohri@einsteinmed.edu|
22413157|NCT01969747|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22413158|NCT04000815|Dr.Ali Cenk Ozay|Dr.Ali Cenk Ozay|00905428583248|dr.alicenk@hotmail.com|
22413159|NCT00239577|GlaxoSmithKline|GSK Response Center|866-435-7343||
22413160|NCT02631772|Medical University of South Carolina|Dr. Derek Dubay|843-792-3368|dubay@musc.edu|
22413161|NCT01034358|Mayo Clinic|Jeanne Tung, MD|507-266-0114|tung.jeanne@mayo.edu|
22413162|NCT02968992|Johns Hopkins University|Jeremy D. Waltson, MD|410-550-1003|jwalston@jhmi.edu|
22413163|NCT00377260|Children's Hospital of Pittsburgh of UPMC|Efficacy of Antimicrobials in Young children with Acute Otitis Media|412-692-5249|Hoberman@chp.edu|
22413164|NCT01617668|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22413165|NCT02017964|Children's Oncology Group|Results Reporting Coordinator|626-446-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22413166|NCT00193037|Sarah Cannon Research Institute|John D. Hainsworth, MD|615-329-7274|jhainsworth@tnonc.com|
22413167|NCT02300103|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22413168|NCT04091971|NYSPI|Jeffrey Miller, M.D.|646-774-7613|jeffrey.miller@nyspi.columbia.edu|
22413169|NCT01391793|UPMC Children's Hospital of Pittsburgh|Nader Shaikh, MD, MPH|412-692-8111|nader.shaikh@chp.edu|
22413170|NCT01015625|ABCSG (Austrian Breast & Colorectal Cancer Study Group)|Trial Office Director|+43 1 4089230|info@abcsg.at|
22413171|NCT05439252|University of Bath|Dr Oliver Perkin|01225384356|o.j.perkin@bath.ac.uk|
22448542|NCT00278109|Indiana University School of Medicine|Richard Zellars MD|3179444505|rzellars@iu.edu|
22413172|NCT05600322|Photocure ASA|Clinical Director|+4722062210|research@photocure.com|
22413173|NCT00150462|Amgen, Inc.|Study Director|866-572-6436||
22413174|NCT01212874|Loma Linda University Anesthesiology|Patricia Moore|1-909-558-4475|pamoore@llu.edu|
22448543|NCT02580357|Institute of Science and Technology of São José dos Campos (Unesp)|Dr. Mauro P. Santamaria|+55 (16) 981937777|mauro.santamaria@ict.unesp.br|
22413175|NCT03107091|BioVie|Penelope Markham|17035989972|pmarkham@biovieinc.com|
22413176|NCT02332863|University of Colorado - Anschutz Medical Campus|Dr. Sachin Wani|720-848-2786|sachin.wani@cuanschutz.edu|
22413177|NCT00912288|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22448544|NCT03424265|University of Arkansas for Medical Sciences|Scott Schutzler, R.N.|501-526-5734|seschutzler@uams.edu|
22448545|NCT01829230|Vistakon USA|XU CHENG, PRINCIPAL CLINICAL SCIENTIST|1 904 443-1245|xcheng6@its.jnj.com|
22413178|NCT01449630|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22448546|NCT02573857|Medicines for Malaria Venture|Dr Joerg Moehrle|+41 22 555 0330|moehrlej@mmv.org|
22413179|NCT00105196|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22413180|NCT03340727|RTI International|Abhik Das|301-770-8214|adas@rti.org|
22448547|NCT04501666|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22413181|NCT01873586|SeaSpine|Director Clinical Affairs||tish.mikoczi@seaspine.com|
22413182|NCT00615069|W.L. Gore and Associates|Jennifer Gorman|928 864 3381|jgorman@wlgore.com|
22399934|NCT03797001|Virginia Commonwealth University|Benjamin Van Tassell|8048284583|bvantassell@vcu.edu|
22448548|NCT03338855|AstraZeneca|Global Clinical Lead|+1 877-240-9479|information.center@astrazeneca.com|
22413183|NCT02703948|Galderma R&D, LLC|US A&C Clinical Operations|8179615111|courtney.maguire@galderma.com|
22399935|NCT00960076|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22413184|NCT00259012|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22413185|NCT02674477|Johns Hopkins University|Dr. Alexis Hammond|410-550-0045|ahammon9@jhmi.edu|
22413186|NCT01789905|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22413187|NCT02495467|Richmond Pharmacology Limited|Dr Jorg Taubel|020 8664 5200|j.taubel@richmondpharmacology.com|
22413188|NCT00834756|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22413189|NCT04365153|Cleveland Clinic|Paul C. Cremer, MD|216-444-6765|cremerp@ccf.org|
22413190|NCT03287310|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|1
22413191|NCT03611608|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22399936|NCT00500266|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22399937|NCT02029976|George Mason University, College of Health and Human Services|Dr. Martha Y Kubik, Professor and Director School of Nursing|703-993-1971|mkubik@gmu.edu|
22399938|NCT03263806|Beaumont Hospitals|Korana Stakich-Alpirez|248 898 0315|Korana.Stakich-Alpirez@beaumont.org|
22399939|NCT04840667|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22399940|NCT01445171|Edwards Lifesciences, LLC|Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Andrey_Nersesov@edwards.com|0225
22399941|NCT01552057|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22399942|NCT03895203|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22399943|NCT04572633|HistoSonics, Inc.|Vice President of Clinical Affairs|(877) 740-0543|clinicaltrials@histosonics.com|
22399944|NCT03289416|Andrews Research and Education Foundation|Jessica Truett|8509168570|jessica.truett@andrewsref.org|
22399945|NCT03155997|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22399946|NCT00848744|Northwestern University|Dermatology CTU|312-503-5944|NUdermatologyCTU@northwestern.edu|
22399947|NCT03514914|University of California San Diego|Dr. Anita Raj|(858) 246-0066|anitaraj@health.ucsd.edu|
22399948|NCT00004054|NRG Oncology|Wendy Seiferheld||wseiferheld@nrgoncology.org|
22399949|NCT02198833|Baylor College of Medcine|Rabih Darouiche, MD|713-794-8858|rabihd@bcm.edu|
22413192|NCT04625114|University Hospital Ghent|Dr Marie-Angélique De Scheerder|+32 9 33 21349|marie-angelique.descheerder@uzgent.be|
22413193|NCT03205553|University of Arkansas for Medical Sciences|Dr. Patrick Bonasso|(501) 364-2943|PCBonasso@uams.edu|
22413194|NCT02507375|Hoffmann-La Roche|Medical Communications|800-821-8590||
22386399|NCT02323880|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22386400|NCT02787031|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
22386401|NCT06324344|Baylor College of Medicine|Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
22386402|NCT00844415|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22386403|NCT03174275|University of North Carolina Lineberger Comprehensive Cancer Center|Dr. Jared Weiss|+1 919-843-7718|jared_weiss@med.unc.edu|
22386404|NCT02413489|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22448549|NCT03965533|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22448550|NCT03605303|Johnson & Johnson Vision Care Inc.|Brian Pall OD, MS, FAAO - Director of Clinical Sciences|9044431290|BPALL@its.jnj.com|
22448551|NCT00399360|Massachusetts General Hospital|Dr. Steven Grinspoon, Principal Investigator|617-726-3890|sgrinspoon@partners.org|
22448552|NCT01765153|University of Alberta|Dr. Jaynie Yang|780-492-2894|jaynie.yang@ualberta.ca|
22386405|NCT05970861|Asfendiyarov Kazakh National Medical University|Prof. Abdugani Musayev|+77772509406|musaev.dr56@gmail.com|
22386406|NCT04186819|Blue Earth Diagnostics|Head of R&D|+44 (0) 1865 784 186|matthew.miller@blueearthdx.com|
22386407|NCT04588415|University of Ottawa|Dr. James Downar|613 562 6262|jdownar@toh.ca|1502
22386408|NCT03252288|University of South Carolina|Jan Ostermann|+1803-777-8747|jano@mailbox.sc.edu|
22386409|NCT05900154|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22386410|NCT00758862|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
22448553|NCT02663674|Duke Clinical Vaccine Unit|Emmanuel Walter, M.D., M.P.H.|919-620-5346|walte002@mc.duke.edu|
22448554|NCT02811445|Tufts University HNRCA|Michael Lustgarten|617-556-3399|Michael.Lustgarten@tufts.edu|
22448555|NCT01386554|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
22448556|NCT00353262|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22448557|NCT04166513|Medical College of Wisconsin|Sara Pillay|414-955-4482|Sapillay@mcw.edu|
22448558|NCT05286307|NYU Langone Health|Eric J Strauss, MD|646 501-7223|Eric.Strauss@nyulangone.org|
22448559|NCT03676218|Institut Bergonié, Bordeaux Comprehensive Cancer Center|Carine Bellera, PhD|+33 5 56 33 04 95|c.bellera@bordeaux.unicancer.fr|
22448560|NCT05636098|Masimo Corporation|Ahmed Alghazi|949-297-7000|studies@masimo.com|
22448561|NCT00555750|Brigham and Women's Hospital|Dr. John Winkelman, MD, PhD|617-278-0061|jwwinkelman@partners.org|
22448562|NCT02489344|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22448563|NCT01132482|National Jewish Health|Jennifer Taylor-Cousar, Principal Investigator|3032702764|Taylor-CousarJ@NJHealth.org|
22448564|NCT04499781|NYU Langone Health|Ann-Margaret Navarra, PhD, CPNP-PC|631-638-0859|amd363@nyu.edu|
22448565|NCT03019107|Liberate Medical|Angus Mclachlan|+1 (833) 203-4663|info@liberatemedical.com|
22448566|NCT00644280|University of California San Francisco|Shan C. Lin, MD|415-353-2608|lins@vision.ucsf.edu|
22448567|NCT04318990|Baylor Scott and White Resarch Institute|Sarah Hale|469-814-4845|sarah.hale@bswhealth.org|
22448568|NCT01304966|Queen Sirikit Nation Institute of Thailand|Dr.Pavinee Intakorn|06623548333|pintakorn@yahoo.com|2301
22448569|NCT04105998|Wake Forest University School of Medicine|Dr. James Eisenach|336-716-4182|jimeisenach@gmail.com|
22448570|NCT00584558|University of Oklahoma Health Sciences Center|Karen Beckman, MD|405-271-9696|karen-beckman@ouhsc.edu|37536
22448571|NCT04232670|Oregon Health and Science University|Gregory Cote|503-494-4373|coteg@ohsu.edu|
22448572|NCT00613015|MUSC|Dr. McRae-Clark|843-792-5216|mcraeal@musc.edu|
22448573|NCT03632655|Weill Cornell Medicine|Dr. Jim C. Hu|(646) 962-9600|jch9011@med.cornell.edu|
22448574|NCT00071760|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22448575|NCT02073279|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22448576|NCT01994629|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22448577|NCT05074693|University of Houston|Michael Zvolensky, Ph.D.|713-743-8056|mjzvolen@Central.UH.EDU|
22448578|NCT03338062|IndianaU|Dr. Ryan Rhome|(317) 944-1367|rrhome@iu.edu|
22448579|NCT01092559|GeNO, LLC|Director of Clinical Development|321-785-2613|matthew.rush@genollc.com|
22448580|NCT04340362|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22448581|NCT01689701|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Sang-Wook Kim, MD|82-63-276-8284|clickm@jbnu.ac.kr|
22448582|NCT02417701|Memorial Sloan Kettering Cancer Center|Dr. Paul Paik, MD|646-608-3759|paikp@mskcc.org|
22386411|NCT04102111|Janssen Research & Development, LLC|Vice President|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22386412|NCT02542631|Johnson & Johnson Diabetes Companies|Brian Levy, MD-Chief Medical Officer|484 328-6128|BLevy1@its.jnj.com|
22386413|NCT02641730|Janssen Pharmaceutical K.K.|Senior Director, Immunology General|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22386414|NCT05460871|University of Iowa Hospitals and Clinics|Dr. Lee Kral|(319) 384-6593|lee-kral@uiowa.edu|
22386415|NCT02938923|Washington University in St. Louis School of Medicine|Dr. Ellen F. Binder, Professor of Medicine and Occupational Therapy|314-286-2707|ebinder@wustl.edu|
22386416|NCT04984590|OnPoint Vision Inc.|Head of Clinical|949-688-0660|larcher@onpoint-vision.com|
22386417|NCT04129554|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22386418|NCT03663205|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
22386419|NCT05932407|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22386420|NCT05215613|Zimmer Biomet|Andrea Singer|(0)79 318 06 55|andrea.singer@zimmerbiomet.com|+41
22386421|NCT03582033|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
22448583|NCT02375113|The University of Texas at San Antonio|Dr. Meizi He|2104585416|meizi.he@utsa.edu|
22448584|NCT01214629|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22386422|NCT06010836|Johns Hopkins|Associate Professor|4109552611|jsampso4@jhmi.edu|
22386423|NCT03812614|University of Pittsburgh School of Medicine|Ann-Marie Rosland, MD, MS|412-648-5660|roslandam@pitt.edu|
22386424|NCT04817176|Florida State University College of Medicine|Dr. Julia Sheffler|850-644-4199|julia.sheffler@med.fsu.edu|
22386425|NCT03681912|Florida State University|Sylvie Naar, PhD; Distinguished Endowed Professor|850-644-2334|sylvie.naar@med.fsu.edu|
22386426|NCT03372057|Secura Bio, Inc.|Ohad Bentur, MD, MHA, MSc|1-702-254-0011|obentur@securabio.com|
22386427|NCT02518048|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
22386428|NCT04505410|University of Miami Miller School of Medicine|Associate Professor, Director of Translational Studies for the Crohn's and Colitis Center|3057733573|odamas@med.miami.edu|
22386429|NCT05123027|Medical University of South Carolina|Dr. Ralph Ward|843-876-6110|wardrc@musc.edu|
22386430|NCT05654662|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
22386431|NCT04330040|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22386432|NCT04230681|Washington University|Dr. Greg Miller|314-454-6000|g.c.miller@wustl.edu|
22386433|NCT05962814|Bionics Institute|Prof Colette McKay|+61 408698202|cmckay@bionicsinstitute.org|
22386434|NCT03057054|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22386435|NCT00696124|Helixmith Co., Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
22386436|NCT04427007|Liberating Technologies, Inc.|Brianna Rozell|774-233-0876|brianna.rozell@liberatingtech.com|
22386437|NCT04998305|Columbia University|Hiroshi Mitsumoto, MD|212-305-1319|hm264@cumc.columbia.edu|
22386438|NCT05311176|Imugene|Study Director|+61 2 9423 0881|info@imugene.com|
22386439|NCT05247034|Universidad Anáhuac México Norte|Dr. Carlos Alberto Cuéllar Ramos|5556270210|carlos.cuellarra@anahuac.mx|8736
22386440|NCT03489122|VA Bedford Healthcare System|Administrative Officer/R&D|781-687-2903|karen.smith9@va.gov|
22386441|NCT05879991|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22399950|NCT01379625|Oregon Health & Science University|Dr. Melanie Gillingham|503-494-1682|gillingm@ohsu.edu|
22399951|NCT02507349|UPMC Center for High-Value Health Care|Kelly Williams, Program Administrator|412-454-1198|Williamsk17@upmc.edu|
22399952|NCT02700984|Alcon Research|Sr Clinical Project Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22399953|NCT00473876|University of Dundee|Professor Chim C Lang|0044(0)1382 496375|c.c.lang@dundee.ac.uk|
22399954|NCT00727402|Case Western Reserve University Dept Ophthalmology & Visual Sciences|Loretta Szczotka-Flynn OD, PhD|216-844-3609|loretta.szczotka@uhhospitals.org|
22399955|NCT00620061|Sucampo Pharma Americas, LLC|VP, Clinical Development|301-961-3400|info@sucampo.com|
22399956|NCT03094195|Novartis Pharmaceuticals|Study Director|888-669-6682|Novartis.email@novartis.com|
22399957|NCT01651780|The Medicines Company|Global Health Science Center|800-388-1183||
22399958|NCT02949830|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
22399959|NCT00054132|Memorial Sloan Kettering Cancer Center|Dr. Maura Dickler|646-888-4560|dicklerm@mskcc.org|
22399960|NCT01290887|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22399961|NCT01628926|Otsuka Pharmaceutical Co, Lts.|Director of Clinical Research and Development|+81-3-6361-7366||
22399962|NCT03029832|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22399963|NCT04373460|Johns Hopkins University Bloomberg School of Public Health|David J. Sullivan|410-502-2522|dsulliv7@jh.edu|
22399964|NCT01412229|UNC Lineberger|Robin Johnson|(919) 966-1125|Robin_V_Johnson@med.unc.edu|
22399965|NCT00454207|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22399966|NCT01672957|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22399967|NCT03359902|University of Florida|John Williamson|352-548-6920|john.williamson@ufl.edu|
22399968|NCT00323284|Glaukos|Jeff Wells, Sr. VP, Clinical, Regulatory, and Quality Affairs|949-367-9600|jwells@glaukos.com|227
22399969|NCT01795547|Email contact via H. Ludbeck A/S|Study director||LundbeckClinicalTrials@lundbeck.com|
22399970|NCT01557790|University of Pennsylvania|Justin E. Bekelman, MD|(215)662-7292|bekelman@xrt.upenn.edu|
22399971|NCT00642642|Biologics Consulting Group|Dr/ Joseph Fratantoni|(301) 340-8432|jfratantoni@bcg-usa.com|
22399972|NCT02116621|University of California, Davis|Richard Kravitz, MD, MSPH|916-734-1248|rlkravitz@ucdavis.edu|
22448585|NCT03107754|University of Hawaii|Dr. Reni Soon|808-983-6000|rsoon@hawaii.edu|
22399973|NCT00151892|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22399974|NCT01272583|Academic Medical Center|Dr. Josefine E. Schopman|+31 20 5669111|j.e.schopman@amc.uva.nl|
22399975|NCT04223609|Mayo Clinic|Gaurav N. Pradhan, PhD|480-301-5351|Pradhan.Gaurav@mayo.edu|
22399976|NCT03437447|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22399977|NCT02549716|Milton S. Hershey Medical Center|Sprague W. Hazard III, M.D.|717-531-0003|shazard@pennstatehealth.psu.edu|311253
22399978|NCT03440944|Boston University School of Medicine|Joseph Pare, MD|6174144925|Joseph.pare@bmc.org|
22399979|NCT00591734|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22399980|NCT04672083|Navigen, Inc.|Alan L. Mueller, VP Research|801-243-9703|amueller@nvgn.com|
22399981|NCT01551745|Gradalis, Inc.|Director of Clinical Trials|2144428124|info@gradalisinc.com|
22413195|NCT04298918|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22399982|NCT01661790|China PLA General Hospital|Dr. Nan Du|86-13911599657|dunan05@aliyun.com|
22399983|NCT00382148|Genentech, Inc.|Medical Communications Specialist|800-821-8590||
22399984|NCT02764541|Dana-Farber Cancer Institute|Otto Metzger|6176323800|otto_metzger@dfci.harvard.edu|
22399985|NCT02048904|University of Missouri|Principal Investigator|573-882-2273 lastrag@healt|lastrag@health.missouri.edu|
22399986|NCT00888511|Odense University Hospital|Olfred Hansen|+45 2424 1588|olfred.hansen@rsyd.dk|
22399987|NCT01813890|Janssen Research & Development, L.L.C.|Mila Etropolski, Clinical Leader|609-730-4537|MEtropol@its.jnj.com|
22399988|NCT04482647|UT MD Anderson Cancer Center|Santhosshi Narayanan, MD-Assistant Professor, Integrative Medicine Program|(346) 228-6676|snarayanan2@mdanderson.org|
22399989|NCT03952559|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22399990|NCT01997463|University of Arizona|Clara Ehrman|520-621-5439|csehrman@email.arizona.edu|
22399991|NCT04980391|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22399992|NCT04167345|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22399993|NCT03804671|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22399994|NCT02935738|Barz IVF Center for Embryo Research and Infertility Treatment|Dr. Saeeda A. Muhsen-Alanssari|9798201303|barzivfcenter@gmail.com|
22399995|NCT01389245|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
22399996|NCT05540652|Brown University|Shufang Sun|401-863-5735|shufang_sun@brown.edu|
22413196|NCT01066143|McLean|Igor Elman, PI|(800) 333-0338|ielman@partners.org|
22413197|NCT05376319|Mayo Clinic|Ulrich Specks, M.D.|507-284-2494|specks.ulrich@mayo.edu|
22413198|NCT01340495|Massachusetts General Hospital|Shannon MacDonald, MD|617-643-7250|SMACDONALD@mgh.harvard.edu|
22413199|NCT03478397|CEDES|Dr. Silvina Arrossi|541148651007|silviarrossi2020@gmail.com|
22413200|NCT05327491|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22413201|NCT00096447|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22413202|NCT02535611|Mazandaran University of medical sciences|Nasim Tabrizi|+981133343015|nasimtabrizi@gmail.com|
22399997|NCT04454489|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336 -713-5440|mporosnicu@wakehealth.edu|
22399998|NCT02073487|Houston Methodist|Jenny Chang|713-441-0681|jcchang@houstonmethodist.org|
22430463|NCT02757963|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22448586|NCT00877383|Novartis Pharmaceuticals|Study Director|862 778-8300||
22430464|NCT00215657|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
22386442|NCT04267120|Washington University School of Medicine|Joel Picus, M.D.|314-362-9115|jpicus@wustl.edu|
22386443|NCT05464069|Theranica|Dr Dagan Harris, VP Clinical and Regulatory Affairs|+972542220121|daganh@theranica.com|
22386444|NCT05320406|Emory University|Dr. Sagar Patel|404-778-1900|sagar.patel@emory.edu|
22386445|NCT05512650|Tufts University|Nancy Baker, Professor|617 627 5562|nancy.baker@tufts.edu|
22386446|NCT03804788|University of Missouri|Dr. Mary Beth Miller|573-882-1813|millmary@health.missouri.edu|
22386447|NCT04615273|Ascendis Pharma, Inc.|Aimee D. Shu, MD|+1 650-461-4835|ads@ascendispharma.com|
22386448|NCT04197869|UCLA Health|Dr. Alexandra Goodwin|917-969-1654|zangoodwin@gmail.com|
22386449|NCT06106022|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-7428|medicalinformation@phathompharma.com|
22386450|NCT04393207|Yale|Antonio Gonzalez|203.785.2802|antonio.gonzalez-fiol@yale.edu|
22386451|NCT05405985|Galderma|Clinical Operations|08179615000|Clinical.Studies@galderma.com|1
22386452|NCT03314740|Istituto di Ricerche Farmacologiche Mario Negri|Elena Biagioli|+39 0239014650|elena.biagioli@marionegri.it|
22430465|NCT04755231|Alcon Research, LLC|Director, Clinical Projects, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22386453|NCT04227288|University of Alabama at Birmingham|Dr. Boni Elewski|205-502-9960|dermresearch@uabmc.edu|
22413203|NCT00569374|University of Arkansas for Medical Sciences Center for Addiction Research|Dr. Alison Oliveto|501-526-8441|olivetoalison@uams.edu|
22413204|NCT01126736|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22413205|NCT05194722|Washington University School of Medicine|Abby Cheng, MD, PI|314-747-2823|chengal@wustl.edu|
22413206|NCT02202850|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22413207|NCT00669942|Novartis|Study Director|862-778-8300||
22413208|NCT00282048|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22413209|NCT03522675|NeXtGen Biologics, Inc|Dayna Healy|352-215-9961|Dhealy@nextgenbiologics.com|
22413210|NCT00707161|Huntsman Cancer Institute|Dennis Shrieve, MD|801-581-8793|dennis.shrieve@hci.utah.edu|
22413211|NCT04005859|Atrium Health|Dr. Kevin Kasten|704-355-1813|kevin.kasten@atriumhealth.org|
22413212|NCT00819507|Oregon Health & Science University|Eric Simpson|503-494-2121|simpsone@ohsu.edu|
22413213|NCT02336165|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
22413214|NCT00450190|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22413215|NCT03959683|INDIANA UNI SCHOOL OF MEDICINE|Erica Sahm|317-274-3560|esahm@iuhealth.org|
22413216|NCT03002077|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
22413217|NCT00986245|Seoul National University Hospital|BS Jeon|82-2-2072-2876|brain@snu.ac.kr|
22413218|NCT02461771|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
22448587|NCT01953120|UCLA|Dr. Suphamai Bunnapradist|3107948516|bunnapradist@mednet.ucla.edu|
22400000|NCT00442598|Eleison Pharmaceuticals|VP Clinical Development|6097211227|matthew.parris@eleison-pharma.com|
22400001|NCT02886702|Fougera Pharmaceuticals Inc.|Angela C Kaplan|631-659-2256|angela.kaplan@sandoz.com|
22448588|NCT00459108|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22448589|NCT01857232|Acacia Pharma Ltd|Dr Gabriel Fox|+44-(0)1223-875149|GabrielFox@acaciapharma.com|149
22448590|NCT00233103|Icahn School of Medicine at Mount Sinai|Wayne A Gordon, PhD|212-659-9372|wayne.gordon@mssm.edu|
22448591|NCT02733588|Joslin Diabetes Center|Mary-Elizabeth Patti, MD|617-309-2665|mary.elizabeth.patti@joslin.harvard.edu|
22448592|NCT04387435|University of California, Los Angeles|Olujimi Ajijola, MD, Phd|310-206-2235|oajijola@mednet.ucla.edu|
22448593|NCT03305822|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22448594|NCT00391274|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22448595|NCT03087760|University of Pennsylvania|Ching Lai|267-250-9244|ching.lai@pennmedicine.upenn.edu|
22448596|NCT00642941|F. Hoffmann-La Roche AG|Study Director|+41 616878333|global.trial_information@roche.com|
22448597|NCT01991457|University of Alabama at Birmingham|Dr. Omer Jamy|2059349294|omerjamy@uabmc.edu|
22400002|NCT01808560|TearScience, Inc.|Manager of Clinical and Medical Affairs|919-459-4842|LJi4@its.jnj.com|
22400003|NCT00054847|Southern Arizona VA Health Care System|Steven Goldman, MD|(520) 792-1450|Steven.Goldman@va.gov|4624
22400004|NCT02991599|Shanxi Medical University|Suping Wang, PhD|#86-351-4135103|spwang88@163.com|
22400005|NCT01316042|Milton S. Hershey Medical Center|Richard S. Legro, M.D.|717-531-8478|rlegro@hmc.psu.edu|
22400006|NCT02589977|Vanderbilt University Medical Center|Marvin Kronenberg, MD|615-322-2318|marvin.w.kronenberg@vumc.org|
22400007|NCT01025635|Bayer HealthCare Pharmaceuticals, Inc. (formerly Intendis GmbH)|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22400008|NCT02393209|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22400009|NCT03545282|University of Washington|India Ornelas|206-685-8887|iornelas@uw.edu|
22400010|NCT00755079|VAHSRD|Joshua Hobson, MS|(718) 584-9000|joshua.hobson@va.gov|3129
22400011|NCT03751111|Xiangya Hospital, Central South University|Dr. Minxue Shen|86-15973164022|shenmx1988@csu.edu.cn|
22400012|NCT00929240|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22400013|NCT02582671|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22400014|NCT01755169|MUSC|Dr. Amy-Lee Bredlau|843-876-0444|bredlau@musc.edu|
22400015|NCT01287104|National Cancer Institute|Dr. Nirali N. Shah|301-451-0390|shahnn@nih.gov|
22400016|NCT00296322|Asan Medical Center, University of Ulsan College of Medicine|Dr. Yoon-Koo Kang|+82-2-3010-3230|ykkang@amc.seoul.kr|
22400017|NCT01834404|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
22400018|NCT00278525|Northwestern University|Dr. Richard Burt|312-908-0059|rburt@northwestern.edu|
22400019|NCT01276288|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22400020|NCT04552470|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22400021|NCT00629083|Contura International A/S|Ieva Ankorina-Stark, Ph D, Chief Scientific Officer|011 45 8110 0900|ieva.ankorina-stark@contura.com|
22400022|NCT01478958|University of Reading|Professor Julie Lovegrove|+44 (0)118 3786418|j.a.lovegrove@reading.ac.uk|
22400023|NCT01193686|VA Puget Sound Health Care System|Rhonda Williams, Ph.D.|206-277-6290|Rhonda.Williams1@va.gov|
22400024|NCT03401749|University of Alabama at Birmingham|Ashish Shah|205-930-6722|ashishshah@uabmc.edu|
22400025|NCT05003115|Vanderbilt University Medical Center|Dr. Ebele Umeukeje|615-322-3221|ebele.m.umeukeje@vumc.org|
22400026|NCT01147809|GlaxoSmithKline|GSK Response Center|866-435-7343||
22400027|NCT01307423|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22400028|NCT03757039|Alcon Research, LLC|Sr. CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22400029|NCT03406962|Magenta Therapeutics|Medical Director|(857) 242-0170|clinicaltrials@magentatx.com|
22400030|NCT03853694|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
22400031|NCT02209766|CO RIA TA, R&D|Hideo Negi|+81 6 4803 3533|H.Negi@astrazeneca.com|4716
22400032|NCT00805207|Washington University in St Louis|Gordon Smith, PhD|314-362-4375|gsmith@wustl.edu|
22400033|NCT00064701|Astellas Pharma Global Development, Inc.|Vice President, Therapeutic Area Head, Transplantation||ClinicalTrials.Disclosure@us.astellas.com|
22400034|NCT01818297|Medtronic Neuromodulation|Neuro Clinical Trials||medtronicneurotrials@medtronic.com|
22400035|NCT02536248|Laval university|Dr. Patrick Couture MD, PhD, FRCP|418-654-2106|patrick.couture@crchul.ulaval.ca|
22400036|NCT00749190|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22400037|NCT00355121|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22400038|NCT04492566|Sansum Diabetes Research Institute|Dr. Kristin Castorino|805-682-7638|info@sansum.org|
22400039|NCT00784758|University of California, Los Angeles|Dr. Eric Kleerup|310-794-6593|ekleerup@mednet.ucla.edu|
22400040|NCT03726268|Duke University|Evan Kharasch, MD, PhD|919-613-1154|evan.kharasch@duke.edu|
22400041|NCT00490542|Tufts Medical Center|S. Nassir Ghaemi, MD, MPH|617-636-5735|nghaemi@tuftsmedicalcenter.org|
22400042|NCT02875223|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22400043|NCT03136107|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22400044|NCT02921386|Clarus Therapeutics Inc.|Theodore Danoff, MD, PhD|847-562-4300|tdanoff@clarustherapeutics.com|
22400045|NCT01707992|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|info.era-clinical@teva.de|
22413219|NCT00854308|Hoffman-LaRoche|Medical Communications|800-821-8590||
22413220|NCT01390844|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22413221|NCT00610363|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
22413222|NCT02980978|Minneapolis Heart Institute Foundation|Population Health Program Manager|612-863-4222|gbenson@mhif.org|
22413223|NCT03048500|Northwestern University|Young Chae, MD|312-695-1301|young.chae@northwestern.edu|
22413224|NCT03221374|Carnegie Mellon University|Dr. Bin He|412-268-9857|bhe1@andrew.cmu.edu|
22413225|NCT00818337|Creighton University|Kathleen Packard, PharmD|402-280-2668|kpackard@creighton.edu|
22413226|NCT03361228|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22413227|NCT01479439|Cincinnati Children's Hospital Medical Center|Dr. Charles Quinn|5138033086|charles.quinn@cchmc.org|
22413228|NCT00360360|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-MY-1-SCRI|asksarah@scresearch.net|
22413229|NCT00401778|Emory University|Suresh S. Ramalingam, MD|404-778-5378|ssramal@emory.edu|
22413230|NCT02597101|Allegheny Health Network|Dr. Nick Giannoukakis|412-359-6394|nick.giannoukakis@ahn.org|
22413231|NCT01722877|Midwest Cardiovascular Research Foundation|Dr Nicolas W Shammas|5633200263|shammas@mchsi.com|
22430466|NCT03769467|Atara Biotherapeutics|Study Director|650-278-8930|clinicalstudies@atarabio.com|1
22430467|NCT04754399|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
22430468|NCT01331330|Abbott Medical Devices|Devyani Nanduri|+1 510-561-4328|devyani.nanduri@abbott.com|
22430469|NCT05259722|LEO Pharma|Clinical Disclosure|+4544945888|disclosure@leo-pharma.com|
22386454|NCT04951076|Bionomics Limited|SVP Clinical Development|+61 8 8150 7400|BNC210clinicalstudies@bionomics.com.au|
22386455|NCT04601480|University of Minnesota|Ezra Golberstein|612-626-2572|egolber@umn.edu|
22386456|NCT01820611|Zimmer Biomet|Linda Meijer|+31 6 57933741|linda.meijer@zimmerbiomet.com|
22386457|NCT03015532|Heron Therapeutics, Inc.|Vice President, Clinical Operations|858-251-7232|svisonneau@herontx.com|
22386458|NCT03484819|Mayo Clinic|Nora Bennani, M.D.|(507) 284-2511|bennani.nora@mayo.edu|
22386459|NCT00971087|Hologic|Jennifer Bartoshevich, Sr Manager of Clinical Affairs|781-999-7764|jennifer.bartoshevich@hologic.com|
22386460|NCT06435624|Nanjing Mingzhou Rehabilitation Hospital|Jingzhi Zhang|16677137704|170787717@qq.com|86
22386461|NCT05013385|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22386462|NCT00677365|Horizon Pharma USA, Inc.|Jeffery Nieves, PharmD, Senior Director||clinicaltrials@horizonpharma.com|
22386463|NCT03969563|VA Northern California Health Care System|Dr. Jerry Nadler, Chief of Research|9168432776|Jerry.Nadler@va.gov|
22386464|NCT05571267|IVERIC Bio, Inc.|Medical Director|609-474-6755|info@ivericbio.com|
22386465|NCT04424316|Pfizer Inc.|PfizerClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22386466|NCT05070741|University of Kansas Medical Center|Paige Geiger, PhD|913-588-7408|pgeiger@kumc.edu|
22386467|NCT03245840|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22386468|NCT03995979|University of Florida|Dr. Salvatore Scali|(352) 376-1611|salvatore.scali@surgery.ufl.edu|
22386469|NCT04923776|Columbia University|Brian Henick, MD|212-342-5162|bh2682@cumc.columbia.edu|
22400046|NCT00998738|Mayo Clinic|Dr. Charles Loprinzi|507-266-6247|cloprinzi@mayo.edu|
22400047|NCT03498521|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22400048|NCT04977037|The University of Texas Health Sciences Center at Houston|Nuray Yozbatiran, PhD, PT|7137975282|Nuray.Yozbatiran@uth.tmc.edu|
22400049|NCT02963376|NuvOx Pharma|Evan Unger, MD|520-624-6688|eunger@nuvoxpharma.com|
22400050|NCT02848833|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22400051|NCT04375761|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22400052|NCT04840836|Columbia University|Samantha Garbers, PhD, Principal Investigator|212-305-0123|svg2108@cumc.columbia.edu|
22400053|NCT05105243|Cerevance|Michelle Charles, Executive Director Regulatory Affairs|(408) 220-5722|Michelle.Charles@cerevance.com|
22386470|NCT04763772|UH Cleveland Medical Center|Ian Neeland|216-844-5965|ian.neeland@uhhospitals.org|
22448598|NCT03051607|Acorda Therapeutics|Christopher Kenney, Senior Vice President - Medical Affairs|9143265775|ckenney@acorda.com|
22448599|NCT01505868|UT MD Anderson Cancer Center|Paul Corn, MD PHD- Chair Ad Interim, Genitourinary Medical Oncology|(713) 563-7208|pcorn@mdanderson.org|
22448600|NCT00894322|Clinical Trial Transparency|AstraZeneca||Clinical.Trial.Transparency@astrazeneca.com|
22448601|NCT00951808|New England Research Institutes|Hae-Young Kim|617-972-3251|hkim@nerisicence.com|
22448602|NCT01169610|Mayo Clinic|Mark A. Frye, MD|507-255-9391|mfrye@mayo.edu|
22448603|NCT02654483|Stanford University|Irene Bailey, CRC|650-721-7149|baileyhi@stanford.edu|
22448604|NCT01364207|Massachusetts Eye and Ear Infirmary|Dr. Louis R. Pasquale|617-573-4240|aliya_jiwani@meei.harvard.edu|4240
22448605|NCT01710254|University of Utah, Dept. of Radiology Research|Edward DiBella, Ph.D.|801-585-5543|edward.dibella@hsc.utah.edu|
22448606|NCT02626520|Essentia Health|Dr. Bret Friday|218-786-3625|bret.friday@essentiahealth.org|
22448607|NCT00535223|Atlanta VA Medical Center|David J. Ready,Ph.D.|(404) 321-6111|David.Ready@va.gov|7082
22448608|NCT02953314|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22448609|NCT01288287|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22448610|NCT03143569|WASHINGTON UNIVERSITY|Thomas J Graetz|3147474155|graetzt@wustl.edu|
22448611|NCT03831347|Butler Hospital|Dr. Lisa Uebelacker|401-455-6200|LUebelacker@butler.org|
22448612|NCT00841087|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22448613|NCT00238121|University of Chicago Comprehensive Cancer Center|Dr. Gini Fleming|773-702-6712|gfleming@medicine.bsd.uchicago.edu|
22448614|NCT02221284|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22448615|NCT03251508|UNC Food Allergy Initiative|Edwin Kim, MD, MS|919-537-3193|edwinkim@email.unc.edu|
22448616|NCT00101907|Amgen Inc.|Study Director|866-572-6436||
22448617|NCT01556581|Madigan Army Medical Center|Dr. Dan Rhon|253-968-0780|daniel.i.rhon.ctr@mail.mil|
22448618|NCT01474876|AbbVie|Global Medical Information|800-633-9110||
22448619|NCT04035161|Becton Dickinson|Erin Zook, PhD|224-358-5019|erin.zook@bd.com|
22400054|NCT02251743|Ohio State University|Dr. L Eugene Arnold|614-685-6701|L.Arnold@osumc.edu|
22448620|NCT03839212|University of Miami|Daniel E. Jimenez, Ph.D., Associate Professor|3052432776|dej18@miami.edu|
22448621|NCT00733746|Alliance for Clinical Trials in Oncology|Peter Pisters, MD||ppisters@mdanderson.org|
22448622|NCT02113956|Center for Innovative Public Health Research|Dr. Michele Ybarra|877-302-5858|michele@innovativepublichealth.org|801
22400055|NCT00824564|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22400056|NCT00476086|Dana-Farber Cancer Institute|Susana M. Campos, MD, MPH|617-632-5269|susanna_campos@dfci.harvard.edu|
22400057|NCT02900092|Massachusetts General Hospital|Karen K. Miller, MD|617-726-3870|KKMiller@mgh.harvard.edu|
22400058|NCT01287754|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22400059|NCT03464045|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22400060|NCT06161012|Johnson & Johnson Vision Care, Inc. (JJVC)|David Murakami, OD, MPH, FAAO|1-800-843-2020|dmuraka2@its.jnj.com|
22400061|NCT04607408|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|2066675812|hvtn.covpn.sdmc@hvtn.org|
22400062|NCT02148029|Veterans Administration of Baltimore Maryland|Dr. Brajesh K. Lal|410-328-5840|blal@som.umaryland.edu|
22400063|NCT05424276|ABLi Therapeutics|Milton Werner|9174940831|info@ablitherapeutics.com|
22400064|NCT01725165|M D Anderson Cancer Center|Dr, Chad Tang|(713) 745-7179|ctang1@mdanderson.org|
22400065|NCT05039086|Brigham and Women's Hospital|Rishi J Desai, PhD|617-278-0932|rdesai@bwh.harvard.edu|
22400066|NCT05113940|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22400067|NCT05023252|Veterans Health Administration, Greater Los Angeles Veterans Healthcare Center|Alexander Young MD|310-478-3711|alexander.young@va.gov|
22400068|NCT03619213|AstraZeneca AB|AstraZeneca Clinical Study Information Center|877-240-9479|Information.center@astrazeneca.com|+1
22400069|NCT00501228|U.T. M.D. Anderson Cancer Center|Martin Korbling, MD / Professor|713-745-3219||
22400070|NCT01756274|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
22400071|NCT01147926|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22400072|NCT01085682|The Catholic University of Korea|Kun-Ho Yoon, professor|82-2-2258-8281|yoonk@catholic.ac.kr|
22400073|NCT01365156|UT MD Anderson Cancer Center|Michael Frumovitz,Professor, Gyn Onc & Reproductive Med|(713) 792-9599|mfrumovitz@mdanderson.org|
22400074|NCT04485455|University of North Carolina at Chapel Hill|Shahzad Ali, MD|984-974-0033|shali@med.unc.edu|
22400075|NCT03926143|Bayer AG|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
22400076|NCT01110187|University of Alabama at Birmingham|Jerzy P. Szaflarski, MD|205-934-3866|szaflaj@uab.edu|
22400077|NCT00422279|Nobel Biocare|Isabelle Arrighi, Head Clinical Trial Management|+41 43 211 42 00|isabelle.arrighi@nobelbiocare.com|
22400078|NCT02561156|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22400079|NCT01071070|Abbott|Global Medical Services|800-633-9110||
22400080|NCT04579549|University of Wisconsin - Madison|Kristi Hall|608-890-0844|klhall1@wisc.edu|
22400081|NCT00967941|CAMC Health System|Patrick Stone, MD|304-388-8250|pstone0627@yahoo.com|9901
22400082|NCT02639351|GlaxoSmithKline|GSK Response Center|866-435-7343|kt144805@gsk.com|
22400083|NCT02207907|GlaxoSmithKline|GSK Response Center|866-435-7343||
22400084|NCT00158184|Substance Use Research Center|Dr. Sandra D. Comer|212-543-5981|sdc10@columbia.edu|
22400085|NCT03952286|University of Arizona Asthma & Airway Disease Research Center|Dr. Ashley A. Lowe|5206268814|aaray@email.arizona.edu|
22400086|NCT00195650|Abbott|Global Medical Services|800-633-9110||
22400087|NCT00432809|Cleveland Clinic|Dr. Philip Schauer|216-444-4794|schauep@ccf.org|
22400088|NCT01499290|AstraZeneca|Paul Newell, Medical Science Director|+44 1625 515727|paul.newell@astrazeneca.com|
22400089|NCT03308188|University of Cincinnati|T. John Winhusen, PhD.|513-585-8292|winhust@ucmail.uc.edu|
22448623|NCT02472795|Viatris Innovation GmbH|Viatris Innovation Clinical Trial Information|+1 908 435 2675|viatrisinnovationclinicaltrials@viatris.com|
22448624|NCT04616547|Markey Cancer Center|Dr. Zin Myint|866-340-4488|zin.myint@uky.edu|
22448625|NCT04318080|BeiGene|Study Director|1 877-828-5568|clinicaltrials@beigene.com|
22448626|NCT06308822|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22448627|NCT02926924|University of Michigan|Rakesh Patel|734 615-2002|rakeshpa@med.umich.edu|
22448628|NCT01536379|GlaxoSmithKline|GSK Response Center|866-435-7343||
22448629|NCT02410382|University of Arizona|Dr. Sun K. Yi|(520) 694-7236|sunkyi@email.arizona.edu|
22448630|NCT04916600|Wayne State University School of Medicine|Dr. Mark Greenwald, Professor|3139933965|mgreen@med.wayne.edu|
22448631|NCT00708942|Photocure|Bjørn Klem, Project Director|+47 22 06 22 10|bk@photocure.no|
22448632|NCT03055000|National Institute of Allergy and Infectious Diseases|Memoli, Matthew|+1 301 443 5971|mm982v@nih.gov|
22448633|NCT04734652|CAPRISA|Dr Anushka Naidoo|031 655 0668|anushka.naidoo@caprisa.org|0669
22448634|NCT05027438|VA Pittsburgh Healthcare System|Adam Bramoweth, PhD (Principal Investigator)|(412) 360-2806|adam.bramoweth@va.gov|
22448635|NCT03303404|University of Texas at Austin|Brandon Fico|512-471-8594|bfico@utexas.edu|
22448636|NCT04146545|University of Chicago|Emily Abramsohn|7738344832|eabramsohn@bsd.uchicago.edu|
22448637|NCT04729127|University of Pennsylvania|Melanie Pellecchia|215-746-1950|melanie.pellecchia@pennmedicine.upenn.edu|
22448638|NCT01245270|University of Aberdeen Rowett Institute of Nutrition and Health|Dr Nigel Hoggard|[+44] (0) 1224 438700|N.Hoggard@abdn.ac.uk|
22448639|NCT01139450|Fougera Pharmaceuticals Inc.|Angela C. Kaplan|631-659-2256|angela.kaplan@sandoz.com|
22448640|NCT01277523|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22448641|NCT00302042|Northwestern University|Dr. Ronald T. Ackermann|3126036400|r.ackermann@northwestern.edu|
22448642|NCT02807350|Jaeb Center for Health Research|Raymond Kraker, Coordinating Center Director|(813)-975-8690|rkraker@jaeb.org|
22448643|NCT03662542|Janssen Research & Development, LLC|Head of Gastroenterology Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22448644|NCT01217060|UT MD Anderson Cancer Center|Steven H. Lin, Associate Professor, Radiation Oncology Department|(713) 563-8490|shlin@mdanderson.org|
22448645|NCT01854905|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22448646|NCT01959542|Brigham and Women's Hospital/Dana-farber Cancer Institute|Dr. Fiona Fennessy|617 632 4891|ffennessy@bwh.harvard.edu|
22448647|NCT03050619|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22448648|NCT04762680|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22400090|NCT01791855|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22400091|NCT00481065|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22400092|NCT01709331|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22400093|NCT00772447|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22400094|NCT04439344|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22400095|NCT00650858|Johns Hopkins University|Daniel F. Hanley, MD|410-614-6996|dhanley@jhmi.edu|
22400096|NCT02630953|Brown University|Dr. Bess Marcus, Principle Investigator|401-863-6950|bess_marcus@brown.edu|
22400097|NCT03770403|argenx BVBA|Regulatory Manager|+32 93103400|regulatory@argenx.com|
22400098|NCT03896295|Momenta Pharmaceuticals, Inc.|DIRECTOR CLINICAL RESEARCH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22400099|NCT01957137|Pelvic Health and Gastric Therapies|Rachael McNamara / Clinical Research Specialist|763.526.8107|rachael.m.mcnamara@medtronic.com|
22400100|NCT00582894|University of Oklahoma Health Sciences Center|George Selby, MD|405/271-4022|george-selby@ouhsc.edu|
22400101|NCT03185546|Wake Forest School of Medicine|Eric Donny, PhD|336-713-1520|edonny@wakehealth.edu|
22400102|NCT01207466|CIBA VISION|Joe Rappon, OD, MS, FAAO / Head, Clinical Trial Management|1-678-415-3343|joseph.rappon@cibavision.com|
22400103|NCT02553135|University of Miami|Byron Lam , MD|305-326-6021|blam@med.miami.edu|
22400104|NCT00700804|United States Department of Agriculture (USDA) Grand Forks Human Nutrition Reserch Center|Janet Hunt, PhD|701-795-8353|janetrhunt@gmail.com|
22400105|NCT02901431|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22400106|NCT02500537|Medtronic|Michelle DiSalvo|774.284.6089|michelle.v.disalvo@medtronic.com|
22400107|NCT02413203|Univesrity of Pennsylvania|Garret A. FitzGerald|215-898-1185|garret@upenn.edu|
22400108|NCT03832387|HOSPITAL GENERAL UNIVERSITARIO DE CASTELLÓN|Dr. ALBERTO BELENGUER MUNCHARAZ|96472500|belengueralberto8@gmail.com|
22400109|NCT05775289|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22400110|NCT01984515|Center for Integrated Healthcare|Dr. Kyle Possemato|315-425-4400|kyle.possemato@va.gov|53551
22400111|NCT04336397|Alaska Native Tribal Health Consortium|Dr. Diana Redwood|907-729-3959|dredwood@anthc.org|
22400112|NCT02330419|Department of Community Health Systems, University of California at San Francisco|Glenn-Milo Santos, Associate Professor|(628) 2177-6231|glenn-milo.santos@ucsf.edu|
22400113|NCT00046228|Centocor Inc.|Executive Director Clinical Research|1-800-972-9063|EBarnath@ITS.JNJ.COM|6171
22400114|NCT02226965|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22400115|NCT01587989|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22400116|NCT03313050|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22400117|NCT01291017|University of Florida|Priya K Gopalan, MD|352-273-8699|gopalpk@ufl.edu|
22400118|NCT05818124|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22400119|NCT00215150|Duke University Medical Center|Wei Zhang, MD|(919) 684 5645|wei.zhang@duke.edu|
22400120|NCT01871506|Elyse Park|Associate Professor|617-724-6836|epark@mgh.harvard.edu|
22400121|NCT00783289|MedImmune, LLC.|Rene van der Merwe, MBChB/Senior Director, Clinical Development|301-398-0000|vandermerwer@medimmune.com|
22400122|NCT00506389|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22400123|NCT03739619|Emory University|Jonathon Cohen, MD|404-778-2214|jonathon.cohen@emory.edu|
22400124|NCT05224258|Medtronic Diabetes|Thomas Troub, Sr Clinical Research Program Manager|8052089091|thomas.troub@medtronic.com|
22448649|NCT03388138|Johnson & Johnson Vision Care, Inc.|Brian Pall O.D, MS, FAAO|1-800-843-2020|bpall@its.jnj.com|
22448650|NCT01528072|Zimmer Biomet Spine|Clinical Affairs|303-501-8571|spinemedinfo@zimmerbiomet.com|
22448651|NCT03001258|BRAC|Anita Sharif Chowdhury/Research Fellow of BRAC Research and Evaluation Division|+88029846448|anita.sc@brac.net|3719
22448652|NCT02996864|Klein Buendel|Valerie Myers, PhD|3035654343|vmyers@kleinbuendel.com|
22448653|NCT00862186|Seattle Children's Hospital|Catherine Fiona Macpherson, PhD|206-987-2032|catherine.macpherson@seattlechildrens.org|
22448654|NCT02436759|RVL Pharmaceuticals, Inc.|Senior Director of Clinical Operations|9088091423|mvelasco@osmotica.com|
22448655|NCT04014075|Daiichi Sankyo|Contact for Clinical Trial Information|1-908-992-6400|CTRinfo@dsi.com|
22448656|NCT01879228|University of Pennsylvannia|Paola Alvarado|215-746-2081|paola.alvarado@pennmedicine.upenn.edu|
22448657|NCT02584504|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22448658|NCT02432846|Immunicum Aktiebolag (AB)|Chief Medical Officer|+46 (0)8 732 84 00|info@immunicum.com|
22448659|NCT01912287|NYU Langone Health|Naomi Simon|646-754-4507|Naomi.Simon@nyulangone.org|
22448660|NCT00413192|Eisai Ltd. Mosquito Way, Hatfield, Hertfordshire, AL 10 9SN|Gitta Irmer Associate Director, Data Quality & Standards Global Regulatory Operations|+44 (0) 845 676 1618||
22448661|NCT01998633|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
22448662|NCT02631850|University of Massachusetts Lowell|Lynne Gauthier|9789345383|lynne_gauthier@uml.edu|
22448663|NCT04600414|University of Washington|John Fortney, Professor|2066856955|fortneyj@uw.edu|
22448664|NCT00310791|Children's Hospital Boston|Dr. Catherine Gordon|401-444-4712|cgordon1@lifespan.org|
22448665|NCT01166724|Cleveland Clinic|Dr. Stuart Flechner|216 445-5772|FLECHNS@ccf.org|
22448666|NCT01270711|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22448667|NCT01471106|M D Anderson Cancer Center|Dr. Arun K. Banu|(713) 792-2817|barun@mdanderson.org|
22448668|NCT01879332|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22448669|NCT00553150|Mayo Clinic|Jann N. Sarkaria, M.D.|507/284-3559|sarkaria.jann@mayo.edu|
22448670|NCT00112593|Fred Hutchinson Cancer Research Center|Ann Woolfrey, MD|206-667-4453|awoolfre@fredhutch.org|
22448671|NCT00975481|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22448672|NCT01895855|Emergent BioSolutions Canada Inc.|David Cassie, Scientist, Clinical Research|204-275-4589|dcassie@ebsi.com|
22448673|NCT03559257|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22448674|NCT00706407|Weill Cornell Medical College|Dr. Alexis Te|646-962-4811|aet2005@med.cornell.edu|
22448675|NCT03630120|Moffitt Cancer Center|Christine Chung, MD|813-745-5061|Christine.Chung@moffitt.org|
22448676|NCT03251079|Senseonics, Incorporated|Katherine Tweden, PhD|651.335.2205|Katherine.Tweden@senseonics.com|
22448677|NCT01519960|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|61 6878333|global.trial_information@roche.com|
22448678|NCT01387347|ReGenTree, LLC|Won S. Yang, President & CEO|609-734-4328|wonsyang@regentreellc.com|
22448679|NCT02658357|Braeburn|Christine Kampf|6104678728|ckampf@braeburnrx.com|
22448680|NCT00196716|Genzyme Corporation|Genzyme MedInfo|800-745-4447|medinfo@genzyme.com|
22448681|NCT02014844|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22448682|NCT00492115|UCSD|Dr. Sonia Ancoli-Israel|858 822 7710|sancoliisrael@ucsd.edu|
22448683|NCT03194555|Allodynic Therapeutics, Inc.|Dr. Annette Toledano, Sponsor-Investigator|+13058956808|annette.toledano@allodynic.com|
22448684|NCT01831154|James A Haley Veterans Hosptial|Dr. Sierra Gower|(813) 972-2000|sierra.gower@va.gov|5946
22448685|NCT01685996|Johns Hopkins University School of Medicine|Dr. Annie Umbricht, M.D.|410-550-1917|annieumbricht@jhu.edu|
22448686|NCT02515045|Carolina Eyecare Physicians, LLC|Helga P. Sandoval, MD, MSCR. Director of Research|8438813937|helga.sandoval@carolinaeyecare.com|
22448687|NCT03255382|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22448688|NCT00735787|Abbott Laboratories|Global Medical Services|1-800-633-9110||
22448689|NCT00624052|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22448690|NCT00471848|European Group for Blood and Marrow Transplantation|Prof. Judith Marsh|+31 (0)71 5265005|a.j.barrois@lumc.nl|
22448691|NCT01467947|CSL Behring|Program Director, Clinical R&D|Use email contact|clinicaltrials@cslbehring.com|
22448692|NCT02291055|Advaxis, Inc.|Surya Vangala|609-423-2528|vangala@advaxis.com|
22448693|NCT01523886|Herlev Hospital|Mona R Gätke, MD, PH.D.|004538662420|mona.gatke@regionh.dk|
22448694|NCT00631566|Infectious Disease Clinical Research Program, USUHS and HJF|Dr. Brian Agan, Deputy Science Director|301-816-8446|bagan@idcrp.org|
22448695|NCT00679263|Medicinova Inc|Kazuko Matsuda, MD, Vice President Clinical Development|858-373-1500|matsuda@medicinova.com|132
22448696|NCT04640519|Columbia University|Imama Naqvi, MD|646-426-3876|ian2108@cumc.columbia.edu|
22400125|NCT04053387|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
22448697|NCT03479307|Faes Farma|Nieves Fernández, MD, PhD|+34 94 481 83 00|nfernandez@faes.es|
22448698|NCT02467465|Universidad Complutense de Madrid|Miguel Suárez Varela|+34913941518|misuarezvarela@gmail.com|
22430470|NCT01887600|Astellas Pharma Europe B.V. (APEB)|Clinical Trial Disclosure|31 (0) 715455050|astellas.resultsdisclosure@astellas.com|
22430471|NCT00962650|Ethicon Endo-Surgery, Inc.|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
22430472|NCT03688139|Weill Medical College of Cornell University|Dr. Jennifer N. Bress|914-997-8683|jeb2061@med.cornell.edu|
22400126|NCT03095703|Amsterdam UMC, location Academic Medical Center|Prof. dr. Evelien Dekker|+3120-5663534|e.dekker@amsterdamumc.nl|
22400127|NCT03539432|The Mind Research Network|Dr. Eric Claus|5055151556|eclaus@mrn.org|
22400128|NCT01381094|Akebia Therapeutics, Inc.|Akebia Therapeutics, Inc.|+1 617-844-6128|trials@akebia.com|
22400129|NCT03370757|Duke University School of Nursing|Dr. Debra Brandon|919-681-3813|debra.brandon@duke.edu|
22400130|NCT02443402|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
22400131|NCT02241486|Loyola University Medical Center|Dr. Joseph R. Holtman|7082168563|jholtman@luc.edu|
22400132|NCT01934504|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22400133|NCT02665689|Charité University, Berlin|Prof. Dr. Antonia Joussen|+49 30 84452331|antonia.joussen@charite.de|
22400134|NCT03198221|Cleveland Clinic|Dr. Carol Burke|216-444-6864|BurkeC1@ccf.org|
22400135|NCT01035151|University of South Caroina|Jeannette Andrews|803 777 3862|j.andrews@sc.edu|
22400136|NCT04504318|Stanford University|Dr. Arash Momeni|650-723-6189|amomeni@stanford.edu|
22400137|NCT00996840|GlaxoSmithKline|GSK Response Center|866-435-7343||
22400138|NCT00603239|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22400139|NCT02292849|Weill Cornell Medical College|Patrick Raue, Ph.D.|206-543-3807|praue@uw.edu|
22400140|NCT02988856|Massachusetts Eye and Ear|Kevin Houston|617-573-4177|kevin_houston@meei.harvard.edu|
22400141|NCT02210780|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
22400142|NCT01562028|European Thoracic Oncology Platform (ETOP)|Heidi Roschitzki-Voser|+41 31 511 94 18|belief@etop-eu.org|
22400143|NCT04938648|Johns Hopkins University|Dr. Ariel Green|(410) 550-6733|ariel@jhmi.edu|
22400144|NCT00364793|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22400145|NCT02724033|Department of Otolaryngology, Indiana University School of Medicine|Dr. Charles Yates, Primary Investigator|317-278-1286|cwyates@iupui.edu|
22400146|NCT00775021|Vistakon|Kurt Moody, Director Design R&D|904-443-3088||
22400147|NCT00363415|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22400148|NCT04802837|Summit Therapeutics|Katie Tran|4086776503|Katie.Tran@Summitplc.com|
22400149|NCT03193866|Karolinska Institutet|Professor Fredrik Piehl|+46-(0)8-517 798 40|fredrik.piehl@ki.se|
22400150|NCT04439266|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22400151|NCT02516657|Jacobs School of Medicine and Biomedical Sciences, Department of Pediatrics|Lucy D. Mastrandrea|716-323-0170|ldm@buffalo.edu|
22400152|NCT05027802|Ipsen Bioscience Inc.|Medical Director|see email|clinical.trials@ipsen.com|
22400153|NCT00001337|National Cancer Institute|Dr. Mark J. Roschewski|240-760-6183|mark.roschewski@nih.gov|
22400154|NCT03878147|Michigan State University|Michael J. Boivin|+15178840281|boivin@msu.edu|
22400155|NCT00408005|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22400156|NCT05817045|EmitBio|Director of Clinical Trials|919-321-1734|info@emitbio.com|
22400157|NCT01506141|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22400158|NCT04889209|Baylor College of Medicine|Dr. Robert L. Atmar|713-798-6849|ratmar@bcm.edu|
22400159|NCT04586504|Columbia University|Daniel Tsze MD MPH|212-317-0997|dst2141@cumc.columbia.edu|
22400160|NCT03905928|Pennsylvania State University College of Medicine|Andrea Hobkirk|717-531-7279|alh98@psu.edu|
22400161|NCT01464697|University of British Columbia|Dr. Jerilynn C. Prior, Professor|6048755927|jerilynn.prior@ubc.ca|
22400162|NCT00382967|GE Healthcare|Igor Grachev, MD|1-609-514-6857|igor.grachev@ge.com|
22400163|NCT00378326|Rockefeller University|Robert B. Darnell, MD, PhD|212-327-7474|darnelr@rockefeller.edu|
22400164|NCT02731742|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22400165|NCT04026568|Penn State Hershey Medical Center|Kenneth Taylor, MD, Professor of Orthopaedics and Rehabilitation|717-531-2948|ktaylor3@pennstatehealth.psu.edu|
22400166|NCT00331760|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
22400167|NCT00461175|Center for Epidemiology and Health Research, Germany|Dr. Klaas Heinemann|0049 (0) 30 945 101 20|k.heinemann@zeg-berlin.de|
22400168|NCT02514044|University of Texas Health Science Center at Houston (UTHealth)|Dr. Gerard E. Francisco, Chairman and Professor, Physical Medicine and Rehabilitation|713.797.5246|gerard.e.francisco@uth.tmc.edu|
22400169|NCT00833092|USDA Grand Forks Human Nutrition ResearchCenter|Forrest H Nielsen, PhD|701-790-8455|forrest.nielsen@ars.usda.gov|
22400170|NCT02673229|The University of Kansas Health System|Suzanne Mitchell, PhD, ARNP, FNP-BC, CWS|913-588-5000|smitchell3@kumc.edu|6562
22400171|NCT00619229|UCB|UCB Clinical Trial Call Center|+ 1 877 822 9493 (UCB)||
22400172|NCT03417440|University of Southern California Chan Division of OS-OT|Stacey Schepens Niemiec|3234422069|schepens@usc.edu|
22400173|NCT00316264|MedImmune|Pamela Griffin|301 398 0000|clinicaltrialenquiries@medimmune.com|
22400174|NCT00355264|BioMarin Pharmaceutical Inc.|Joshua Lilienstein|651-523-0310|MEDINFO@bmrn.com|
22400175|NCT01451645|Regeneron|Clinical Trials Administrator|914 847 5385|clinicaltrials@regeneron.com|
22400176|NCT03862027|University of North Carolina at Chapel Hill|Amanda Kovacich, MD|919-966-2532|amanda.kovacich@unchealth.unc.edu|
22400177|NCT01053312|GE Healthcare|Paul Sherwin, MD|1-609-514-6820|paulsherwin@ge.com|
22400178|NCT02209506|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22400179|NCT02203149|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22413232|NCT03693430|Novo Nordisk A/S|Clinical Reporting Office (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22413233|NCT02079766|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
22413234|NCT00985257|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
22413235|NCT02930005|The University of Texas Health Science Center at Houston|Dr. Olaoluwa O. Okusaga|(713) 741-3952|Olaoluwa.O.Okusaga@uth.tmc.edu|
22413236|NCT00585689|University of Michigan Comprehensive Cancer Center|Dr. David Smith, M.D.|734-936-6884|dcsmith@umich.edu|
22413237|NCT02373098|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email.@novartis.com|
22413238|NCT03252353|Chiasma|Asi Haviv, VP Clinical development|972-8-939-3888|Asi@chiasmapharma.com|
22413239|NCT01884740|Weill Cornell Medicine|Jeffery Greenfield, MD PhD|212-746-2363|jpgreenf@med.cornell.edu|
22413240|NCT01313416|Georgetown University|Dr. Samir Khleif|(202) 687-0100|snk48@georgetown.edu|
22413241|NCT01918800|Portland VA Medical Center|Cinda Hugos|503-220-8262|hugosc@ohsu.edu|52338
22413242|NCT03018249|NRG Oncology|Linda Gedeon for Virginia Filiaci, PhD|716-845-1169|linda.gedeon@roswellpark.org|
22413243|NCT04881968|The Dartmouth Institute|Dr. Amber Barnato|603-646-5237|amber.barnato@dartmouth.edu|
22413244|NCT00304083|SARC|Research Project Manager|734-930-7600|sarc@sarctrials.org|
22413245|NCT03966365|Laboratorios Sophia|PhD. Ricardo Llamas|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
22413246|NCT01378975|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22413247|NCT00323193|VA VISN 5 Mental Illness Research, Education and Clinical Center|Richard W. Goldberg, Ph.D.|410-637-1851|richard.goldberg@va.gov|
22413248|NCT00319735|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
22413249|NCT03929393|University of Minnesota|Brent Leininger|(612) 626-6477|lein0122@umn.edu|
22413250|NCT01320696|Resilience Inc.|Wael El-Amin, M.D.|(240)885-1221|Wael.el-amin@resilience.com|
22413251|NCT01314742|Vanderbilt University Sch of Medicine|Dr. Beatrice Stefanescu|6159365933|beatrice.stefanescu@Vanderbilt.edu|
22413252|NCT03883607|Genfit SA|Clinical Head|+33320164000|clinicaltrial@genfit.com|
22413253|NCT01023074|Portland VA Medical Center|Robert Folmer, Ph.D.|503-220-8262|Robert.Folmer@va.gov|51868
22413254|NCT00694551|H. Lee Moffitt Cancer Center and Research Institute|Mayer Fishman, M.D., Ph.D.|813-745-4398|mayer.fishman@moffitt.org|
22413255|NCT03929367|Wake Forest Health Sciences|Dr. James Eisenach|3367164182|eisenach@wakehealth.edu|
22413256|NCT00515203|Amgen Inc.|Study Director|866-572-6436||
22413257|NCT01937390|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22413258|NCT01874951|Depression Clinical and Research Program, Massachusetts General Hospital|David Mischoulon, MD, PhD, Director of Research|617-724-5198|dmischoulon@partners.org|
22413259|NCT02216071|Exela Pharma Sciences|Aruna Koganti, VP Clinical Programs|828-758-5474|akoganti@exela.us|
22413260|NCT03544138|Preceptis Medical|Steve Anderson|612-327-4795|steve@preceptismedical.com|
22413261|NCT01706536|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
22413262|NCT00860314|University Hospital Hamburg-Eppendorf, Heart Center|Tim Risius, MD|+49-40-42803|risius@uke.uni-hamburg.de|4142
22413263|NCT04753437|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22413264|NCT01096290|University of South Alabama|Jack DiPalma, MD|251-660-5555|jdipalma@health.southalabama.edu|
22413265|NCT00385684|Tuscaloosa VA Medical Center|Andrea L. Snow|205-554-2000|lynn.snow@va.gov|2260
22413266|NCT00463606|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22413267|NCT02228174|Gynesonics|Taraneh G. Farazi, Ph.D. (Vice President, Clinical Affairs)|650-216-3878|tfarazi@gynesonics.com|
22413268|NCT02682602|University of Tennessee|Richard Komistek, Principal Investigator|8659742093|rkomiste@utk.edu|
22413269|NCT03567174|Johns Hopkins University|Gregory M. Lucas|410 614 0560|glucas@jhmi.edu|
22413270|NCT02140060|Alcon Research, Ltd.|Clinical Project Lead, GCRA, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
22413271|NCT00522457|Fresenius Biotech North America|Manager of Regulatory Affairs|781-699-4652|bao.le@fresenius-biotech.com|
22413272|NCT03497897|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@novartis.com|
22413273|NCT00723528|Janssen Research & Development, LLC|Senior Director, Clinical Development|793-7633||215
22413274|NCT02627924|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22413275|NCT00667862|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22413276|NCT03979079|Institut Bergonié|Dr Carine Bellera|33 0 5 56 33 04 95|c.bellera@bordeaux.unicancer.fr|
22413277|NCT00987948|Hawaii Center for AIDS, University of Hawaii|Dr. Cecilia M Shikuma|8086921328|shikuma@hawaii.edu|
22413278|NCT02440308|Stanford Healthcare|Dr. Andrei Iagaru, Chief of the Division of Nuclear Medicine and Molecular Imaging|650-725-4711|aiagaru@stanford.edu|
22413279|NCT00667095|Mayo Clinic|Dr. Steven P. Petrou|904-953-7330|peterou.steven@mayo.edu|
22413280|NCT01520909|GlaxoSmithKline|GSK Response Center|866-435-7343||
22413281|NCT00654030|University of Kentucky|Dr. Edward Hirschowitz|859-323-5045|eahirs2@uky.edu|
22413282|NCT01435265|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-7740|sfeldman@wakehealth.edu|
22413283|NCT02128997|UPENN|Valerie Riis|2154989099|valerie.armendariz@uphs.upenn.edu|215
22413284|NCT00603187|University of Washington|Dr. John K. Amory|206.616.1727|jamory@u.washington.edu|
22413285|NCT00840099|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22413286|NCT01173211|Baylor College of Medicine|Shital M. Patel, M.D.|713-798-3793|shitalp@bcm.edu|
22413287|NCT00856388|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22413288|NCT05038293|University of Washington Department of Periodontics|Dr. Diane Daubert|206-685-3766|ddaubert@uw.edu|
22413289|NCT02163837|Chu St Pierre|Dr Marie Bruyneel|003225354219|marie_bruyneel@stpierre-bru.be|
22413290|NCT01171989|GlaxoSmithKline|GSK Response Center|866-435-7343||
22413291|NCT00418184|Enzymotec Ltd|Yael Richter Ph.D|+972 74 7177 177|Yaelr@enzymotec.com|144
22413292|NCT02339558|Prince of Wales Hospital|Brigette B.Y. Ma|(852) 26321042|brigette@clo.cuhk.edu.hk|
22430473|NCT00231465|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D.|813-745-2158|alberto.chiappori@moffitt.org|
22430474|NCT02069184|Montefiore Medical Center|Jeffrey Bernstein|718-920-4317|JBernste@montefiore.org|
22430475|NCT00127933|Hoffman-LaRoche|Medical Communications|800-821-8590||
22430476|NCT00498485|Rutgers|Dr Benjamin Natelson|973-2236370|bnatelson@chpnet.org|
22430477|NCT03072875|Evidence-Based Practice Institute|Linda Dimeff, PhD|206-455-7934|research@ebpi.org|83
22430478|NCT01943825|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22430479|NCT00452400|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22430480|NCT00907088|The Hospital for Sick Children|Dr. Patricia Parkin|416-813-7654|patricia.parkin@sickkids.ca|301544
22430481|NCT02474901|University of Colorado|Adriana Weinberg, MD|3037244480|adriana.weinberg@ucdenver.edu|
22430482|NCT03378635|Zealand Pharma A/S|Dr Kim Mark Knudsen|+4550603780|KMKnudsen@zealandpharma.com|
22430483|NCT03377127|Beaumont Health|Dr. Alexandra Halalau|2485513481|alexandra.halalau@beaumont.org|
22430484|NCT01472835|Johns Hopkins|Steven Cohen|410-955-1818|scohen40@jhmi.edu|
22430485|NCT01044693|Vanderbilt University|Italo Biaggioni MD|615-936-3420|italo.biaggioni@vanderbilt.edu|
22430486|NCT01835431|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22430487|NCT01316900|GlaxoSmithKline|GSK Response Center|866-435-7343||
22430488|NCT01684033|Alcon Research, Ltd.|Jessie Lemp, GMA Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22430489|NCT05346640|Cionic|Rebecca Webster, Clinical Operations Manager|9257886649|rebecca@cionic.com|
22430490|NCT03726879|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22430491|NCT02496156|Nemours Children's Health System|Vicky Funanage, PhD, Operational Vice President for Research|302-651-6819|vfunanag@nemours.org|
22430492|NCT00507507|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22430493|NCT00088699|National Institute of Mental Health|Zarate, Carlos|+1 301 451 0861|zaratec@mail.nih.gov|
22430494|NCT02371889|University of Pennsylvania Perelman School of Medicine|Henry R. Kranzler, M.D.|215-746-1943|kranzler@pennmedicine.upenn.edu|
22430495|NCT05130281|Weill Cornell Medicine|Maddy Schier|(646) 289-5271|mas4019@med.cornell.edu|720
22430496|NCT06844812|mazhar osman mental and nervous diseases hospital|Dr. Enes Faruk ALTUNKILIÇ|+905077362191|enesfarukaltunkilic@gmail.com|
22430497|NCT02006836|Huazhong University of Science and Technology|Dr.Yu|862783662883|xfyu188@163.com|
22430498|NCT05520333|RTI International|Nisha Gottfredson O'Shea|9192481826|nishaoshea@rti.org|
22386471|NCT01768013|LEO Pharma A/S|Clinical trial disclosure manager|00 45 44 94 58 88|ctr.disclosure@leo-pharma.com|
22386472|NCT05890105|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22386473|NCT04206787|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22386474|NCT05008055|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22386475|NCT05117008|Medical College of Wisconsin|Meera Mohan MD, MS|414-805-4600|memohan@mcw.edu|
22386476|NCT03003533|Spark Therapeutics|Spark Therapeutics|Please Email|clinicaltrials@sparktx.com|
22386477|NCT00640822|LeoPharma|Torsten Skov|+4520736294|torsten.skov@leo-pharma.com|
22386478|NCT03011034|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22386479|NCT04564209|University of Colorado College of Nursing|Dr. Samantha Stonbraker, Study PI|720-880-8194|Samantha.Stonbraker@CUAnschutz.edu|
22386480|NCT03419052|Indiana University|Daniel Clark, PhD|317-274-9292|daniclar@iu.edu|
22386481|NCT02361658|Toronto Western Hospital, University Health Network|Emad Al Azazi|4166035800|emad.alazazi@uhnresearch.ca|2508
22386482|NCT03735979|Medical University of South Carolina|Jordan J. Elm, PhD|843-876-1605|elmj@musc.edu|
22386483|NCT03417284|The University of Texas MD Anderson Cancer Center|Qaiser Bashir, MD / Stem Cell Transplantation|713-794-4422|QBashir@mdanderson.org|
22386484|NCT03972150|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22386485|NCT02668692|LEO Pharma A/S|Clinical Trial Disclosure Manager||disclosure@leo-pharma.com|
22386486|NCT03442309|New York University|Richard Niederman|917-280-5920|r.niederman@nyu.edu|
22430499|NCT02683954|Ain Shams Maternity hospital|amr ahmed mahmoud riad|01005347179|amr.riad@med.asu.edu.eg|+2
22430500|NCT02410200|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22448699|NCT01499563|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646-440-9333|ITCIClinialTrials@itci-inc.com|
22448700|NCT03658538|Johns Hopkins University|Dr. Nadia Hansel|410-955-3841|nhansel1@jhmi.edu|
22386487|NCT05465239|Barron Associates, Inc.|Jason Burkholder|434-973-1215|burkholder@bainet.com|
22386488|NCT05423730|Beth Israel Deaconess Medical Center|Kenneth J Mukamal|617-754-1401|kmukamal@hsph.harvard.edu|
22386489|NCT04276935|Memorial Sloan Kettering Cancer Center|Dr. Thomas M. Atkinson|646-888-0089|atkinsot@mskcc.org|
22386490|NCT01314105|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22386491|NCT04089865|Hospital for Special Surgery|Stavros G. Memtsoudis, MD, PhD, MBA|(212) 606-1206|memtsoudiss@hss.edu|
22386492|NCT03640286|Neurovalens|Head of Clinical and Regulatory|02890991835|sinead.watson@neurovalens.com|
22386493|NCT04389957|San Francisco Veterans Affairs Medical Center|Dr. Tonya Kaltenbach|(415) 221-4810|tonya.kaltenbach@va.gov|24406
22386494|NCT01540994|Sharp Healthcare|Dr. Geoffrey Weinstein|858-939-5010|geoffrey.weinstein@sharp.com|
22386495|NCT01447719|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22386496|NCT03235440|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|225.763.2500|amanda.staiano@pbrc.edu|
22386497|NCT03318159|Seoul National University Hospital|Dr. Koh|82220727217|go01@snu.ac.kr|
22386498|NCT04574583|National Cancer Institute|Dr. James Gulley|301-480-8870|james.gulley@nih.gov|
22386499|NCT02944968|Johnson and Johnson Medical NV/SA|Nathalie Macours, Clinical Research Director|+32 2 746 35 27|nmacours1@its.jnj.com|
22413293|NCT00620074|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22413294|NCT00645762|Entellus Medical|Entellus Medical|763-463-1599||
22413295|NCT00705003|Massachusetts General Hospital|Maurizio Fava, MD|617-724-2513|mfava@partners.org|
22413296|NCT04466111|SGX Medical|VP of Clinical|818-527-2710|clinical@sgxmedical.com|
22413297|NCT02829268|Washington University School of Medicine, Department of Medicine, Division of Endocrinology|Fumihiko Urano, MD, PhD|314-362-8683|urano@wustl.edu|
22413298|NCT02016612|Bengtson Center|Dr Bradley Bengtson|616 588 8880|drb@bengtsoncenter.com|
22413299|NCT03021538|Cleveland Clinic|Michael Tong, M. D.|216-445-0807|tongz@ccf.org|
22413300|NCT03553823|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22413301|NCT00893464|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22413302|NCT03450070|Johnson & Johnson Consumer Inc.|Heather Smith|908-874-1235|HSmith21@its.jnj.com|
22413303|NCT02910037|The University of California, San Francisco|Dr. Charles Chiu|(415) 514-8219|charles.chiu@ucsf.edu|
22448701|NCT00319644|University of California, San Francisco|Julin Tang, MD|415-206-5274|tangj@anesthesia.ucsf.edu|
22448702|NCT00597012|The Brigham and Women's Hospital|Jeffrey N. Katz, MD, MSc|617-732-5338|jnkatz@bwh.harvard.edu|
22448703|NCT01716013|OptMed|Associate Director of Quality Assurance|(908) 720-2372|nyajnik@optmed.com|
22448704|NCT03839511|Pennington Biomedical Research Center|Dr. David McDougal|2257630278|DAVID.MCDOUGAL@PBRC.EDU|
22448705|NCT01290666|University of California, Irvine|Michael J Stamos, MD|888-532-4123||
22448706|NCT05089682|Mayo Clinic|Dr. Gregory A. Worrell|507-538-4880|Worrell.Gregory@mayo.edu|
22448707|NCT03992781|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22448708|NCT01996826|Mass. Eye and Ear|Reza Dana, M.D., M. Sc, MPH|6175734331|Reza_Dana@meei.harvard.edu|
22448709|NCT00695396|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Head of Hematology and Nephrology||pbowers@its.jnj.com|
22448710|NCT02734979|Stanford University|Dr. Stanley G Rockson, Allan and Tina Neill Professor of Lymphatic Research and Medicine|650-725-7571|rockson@stanford.edu|
22448711|NCT00518323|Johnson & Johnson Pharmaceutical Research & Development|Compound Development Team Leader (CDTL)|609-730-4530||
22448712|NCT03164928|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22448713|NCT01312818|University of Minnesota, Pediatric Hematology Dept.|Dr. Michael Burke, MD|612-672-7422||
22448714|NCT04631029|Johns Hopkins University|Grants Administrative Manager|4439273568|JHCCCRO@jhmi.edu|
22448715|NCT01463644|McMaster University|Dr. Parameswaran Nair|905-522-1155|parames@mcmaster.ca|34934
22448716|NCT00326950|Eisai Call Center|Eisai Inc.|888-422-4743||
22448717|NCT01514760|University of Arkansas for Medical Sciences|Dr. Tamara T. Perry|501-364-3264|perrytamarat@uams.edu|43264
22448718|NCT01275833|Boston Scientific|Elke Sommerijns|+32479767156|elke.sommerijns@bsci.com|
22448719|NCT01192282|Groote Schurr Hospital / University of Cape Town|Dr Shahila Tayib|0060195773376|syarq@yahoo.com|
22448720|NCT02118012|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Christopher Koh, M.D.|(301) 443-9402|kohchris@mail.nih.gov|
22448721|NCT00536107|AstraZeneca|Sharon Chang||aztrial_results_posting@astrazeneca.com|
22448722|NCT03329690|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22448723|NCT02290106|Massachusetts General Hospital|Takara Stanley, MD|6177249109|tstanley@mgh.harvard.edu|
22448724|NCT01422772|Helixmith Co., Ltd.|Jinsub Lee PhD|+82-10-8256-0439|jinsub.lee@helixmith.com|
22448725|NCT00619801|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22448726|NCT02315170|Raj K M|Raj K Maturi MD|3178171414|maturi.md@midwesteye.com|
22448727|NCT01980355|Spectrum Health|G. Paul Wright, MD|6162678540|paul.wright@spectrumhealth.org|
22448728|NCT00450333|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22448729|NCT02172742|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|francisco.rocha@bial.com|
22448730|NCT01519414|The Ohio State University Comprehensive Cancer Center|Paul Monk, MD|(614) 293-6196|Paul.Monk@osumc.edu|
22448731|NCT01347008|Federal University of Sao Paulo|Fernando Villela Andrigueti, MD|+55 11 55764239|fernando.andrigueti@usp.br|
22448732|NCT03855280|Medexus Pharma|Julissa Leon|3125483125|julissa.leon@medexus.com|
22448733|NCT00531817|Hoffmann-La Roche|Medical Communications|800-821-8590||
22448734|NCT02738450|AC Immune|Olivier Sol|+41 21 345 91 21|clinicaltrials@acimmune.com|
22448735|NCT03204305|Johns Hopkins School of Medicine|Dr. Elise M. Weerts, PhD, Professor|443-550-2781|eweerts@jhmi.edu|
22448736|NCT03439670|ReveraGen BioPharma Inc.|Dr. Eric Hoffman|301-762-7980|ericphoffman@gmail.com|
22448737|NCT01165554|GE Healthcare|Dr. Paul Sherwin|1-609-514-6820|paulsherwin@ge.com|
22448738|NCT02951156|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22448739|NCT03388294|University of North Carolina at Chapel Hill|Linda R. Watson, EdD|919-966-1007|lwatson@med.unc.edu|
22448740|NCT01603459|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
22448741|NCT01092182|National Cancer Institute|Dr. Mark J. Roschewski|240-760-6183|roschewskimj@nih.gov|
22448742|NCT01641692|GlaxoSmithKline|GSK Response Center|866-435-7343||
22448743|NCT01166178|Novartis|Study Director|41 61 324 1111||
22448744|NCT04948450|National Geriatric Hospital|Dr Nguyen Xuan Thanh|0983277646|xuanthanhbmlk@hmu.edu.vn|
22448745|NCT03930446|University of Chicago|Dr. Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
22448746|NCT01762631|Pennington Biomedical Research Center|Leanne Redman, PhD|2257630947|leanne.redman@pbrc.edu|
22448747|NCT03141281|Florida State University|Dr. Neil Charness|850-644-6686|charness@psy.fsu.edu|
22448748|NCT00657241|SUNYBuffalo|Joseph L. Izzo Jr. M.D.|716-898-5625|jizzo@buffalo.edu|
22448749|NCT01173718|W. L. Gore & Associates|Debby Pfile, Clinical Research Associate|623-234-5226|dpfile@wlgore.com|
22448750|NCT04262232|Fred Hutchinson Cancer Center|Megan Shen|206-667-4172|mshen2@fredhutch.org|
22448751|NCT02005250|Odense Universitetshospital, afd.M|Prof. Steen Bonnema|+4527339180|steen.bonnema@rsyd.dk|
22400180|NCT02537678|University of South Florida|Alison Salloum|8139741535|asalloum@usf.edu|
22400181|NCT04348851|North Florida/South Georgia Veterans Health System|Dr. Constance Uphold|352-548-6000|connie.uphold@va.gov|106893
22400182|NCT00552110|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22400183|NCT00963807|Washington University in St. Louis|John P Crandall|(314) 747 - 5561|jcrandall@wustl.edu|
22400184|NCT04211337|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22400185|NCT07145541|AION Biosystems|Samara Barend|9079024986|sam@aionbiosystems.com|
22400186|NCT05404776|University of Texas Medical Branch|Meagan Benson, DO|409-772-0982|meaganbenson88@gmail.com|
22400187|NCT05630846|GlaxoSmithKline Biologicals SA|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|
22400188|NCT03697564|University of California, San Diego|Dr. Hitendra Patel|(858) 822-5354|CancerCTO@health.ucsd.edu|
22430501|NCT05069415|Carolina Eyecare Physicians, LLC|Director of Clinical Trials|8438813937|hps@cepmd.com|
22386500|NCT02905331|Janssen Research & Development, LLC|Senior Director, Immunology General|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22386501|NCT05007080|Janssen Vaccines & Prevention B.V.|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22386502|NCT03329937|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22386503|NCT02874742|Janssen Research & Development, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22386504|NCT04442165|Insitute of Tropical Medicine|Brecht Ingelbeen|+32(0)33455787|bingelbeen@itg.be|
22386505|NCT01223352|Actelion Pharmaceuticals Ltd|clinical trial disclosure desk||clinical-trials-disclosure@actelion.com|
22386506|NCT04583280|Janssen Research & Development LLC|Senior Director Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22386507|NCT03691298|Smith+Nephew|Laura Everson|+447718320892|laura.everson@smith-nephew.com|
22386508|NCT02577354|Mainstay Medical|Vice President Clinical Affairs|7637727637|diane.burnside@mainstay-medical.com|
22386509|NCT04173247|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-716-4760|jkettler@wakehealth.edu|
22386510|NCT02561611|Pennington Biomedical Research Center|Corby Martin|225-763-2585|Corby.Martin@pbrc.edu|
22386511|NCT05985382|University of Central Florida|Abigail Anderson|4078231026|Abigail.Wilson@ucf.edu|
22386512|NCT06097494|Pfizer Ltd|Ranjit Nagra|01304 616161|ranjit.nagra@pfizer.com|
22386513|NCT04265807|University of Washington|Graham Nichol|206 521 1784|nichol@uw.edu|
22386514|NCT01116895|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
22400189|NCT01431287|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22400190|NCT03019549|Eli Lilly and Compnay|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22400191|NCT00371267|San Francisco VA Medical Center|Timothy P. Carmody, Ph.D.|415-221-4810|Timothy.Carmody@va.gov|6344
22400192|NCT01412879|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623||
22400193|NCT04030195|Precision BioSciences|Michael Karg, Senior Director, Clinical Operations|919-324-5512|michael.karg@precisionbiosciences.com|1574
22400194|NCT02109029|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22400195|NCT03195894|KontigoCare AB|Markku Hämäläinen, Research Director|0769 47 31 32|markku.hamalainen@kontigocare.com|
22400196|NCT01575912|Centre Hospitalier Esquirol|Dr Murielle Girard|0033555431028|murielle.girard@ch-esquirol-limoges.fr|
22400197|NCT02101437|taipei city hospital|chen yueh-chung|88627093600|chenyuehchung.tw@yahoo.com.tw|3741
22400198|NCT00608465|Vanderbilt University Medical Center|James Muldowney|615-936-1720|james.muldowney@vanderbilt.edu|
22400199|NCT01056107|Mayo Clinic|Dr. Michael Camilleri|507-266-2305|camilleri.michael@mayo.edu|
22400200|NCT03783195|University of North Carolina at Chapel Hill|Saroja Voruganti, PhD|704-250-5009|saroja@unc.edu|
22400201|NCT00377962|Novartis Pharmaceuticals|Study Director|862 778-8300||
22400202|NCT01225263|BIDMC|Catherine Buettner, MD MPH|617-754-9600|cbuettne@bidmc.harvard.edu|
22400203|NCT02240134|University of Montana|Curtis Noonan, PhD|406-243-4957|curtis.noonan@umontana.edu|
22400204|NCT01380899|Facultad de Medicina, Universidad Autonoma de San Luis Potosi|Ildefonso Rodriguez-Leyva|+52 4442043016|ildefonso.rodriguez@uaslp.mx|
22400205|NCT02364778|Icahn School Of Medicine at Mount Sinai|Dr. Annapoorna Kini||annapoorna.kini@mountsinai.org|
22400206|NCT00496366|Rutgers Cancer Institute of New Jersey|Deborah Toppmeyer, MD|732-235-6789|toopmede@cinj.rutgers.edu|
22400207|NCT02718820|Medical University of Vienna|Thorsten Fuereder|+43140400|thorsten.fuereder@meduniwien.ac.at|44450
22400208|NCT00260208|Novartis Pharmaceuticals|Study coordinator|862-778-8300||
22400209|NCT02091440|Osaka University Hospital|Prof. Yoshiki Sawa|+81 668793160|sawa@surg1.med.osaka-u.ac.jp|
22400210|NCT03576144|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22400211|NCT00278629|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
22400212|NCT03323749|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
22400213|NCT01821963|University of Texas (UT) MD Anderson Cancer Center|Harrys A. Torres, MD/Assistant Professor, Infectious Diseases|(713) 792-6503|htorres@mdanderson.org|
22400214|NCT00852644|Boston Medical Center|Minh Tam Truong|617-638-7070|minh-tam.truong@bmc.org|
22400215|NCT03424109|NYU Langone Health|Allison Cuthel|212-263-8631|Allison.Cuthel@nyulangone.org|
22400216|NCT00097539|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22400217|NCT02966314|University of Wisconsin - Madison|Ravi Viswanathan|(608) 263-1081|rviswanathan@medicine.wisc.edu|
22400218|NCT05127486|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
22400219|NCT02582515|Johns Hopkins University School of Medicine|Assistant Professor|443-287-5143|jfmcguire@jhmi.edu|
22400220|NCT02688647|Kadmon Corporation|Karin Herrera, Vice President, Clinical Operations|1-724-778-6134|karin.herrera@kadmon.com|
22400221|NCT02542267|W. L. Gore & Associates|Eric Novak|314-440-2119|enovak@wlgore.com|
22448752|NCT02738151|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22386515|NCT05652010|Coloplast A/S|Senior Scientific Manager|+4549113192|dkmbs@coloplast.com|
22386516|NCT05451693|HealthPartners Institute|Bhavani Kashyap, PhD, MBBS|651-495-6363|Bhavani.x.kashyap@healthpartners.com|
22386517|NCT04099732|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22386518|NCT05958927|Usak University Medical Faculty|Suzan Doğruya|05322270732|sdogruya@hotmail.com|
22386519|NCT00319111|Actelion Pharmaceuticals Ltd|Loïc Perchenet PhD/Clinical Trial Leader|+41 61 565 6457||
22386520|NCT01475786|Helixmith|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
22386521|NCT06229119|Carolina Eyecare Physicians, LLC|Director of Clinical Research|8438813937|hsandoval@cepmd.com|
22400222|NCT03093402|DAIT/NIAID|Director, Clinical Research Operations Program|3015947669|DAITClinicalTrialsGov@niaid.nih.gov|
22400223|NCT01276184|University of Maryland School of Medicine|Dr. J. Kathleen Tracy, PhD|410-706-1205|ktracy@som.umaryland.edu|
22400224|NCT00887458|Johns Hopkins University|Dr. Michael Carducci|410-614-3977|carducci@jhmi.edu|
22400225|NCT01147497|Emory University|Eva Lathrop, MD, MPH|404-778-1379|elathro@emory.edu|
22400226|NCT02197377|DorkuzEU|Anaesthesiology and Reanimation|0905055252901|ozbilginsule@gmail.com|
22400227|NCT01974323|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22400228|NCT00699192|Novartis Pharmaceuticals|Study Director|862 778-8300||
22400229|NCT01773473|Eli Lilly and Company|Medical Officer|800-545-5979||
22400230|NCT00826514|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22400231|NCT03663166|Moffitt Cancer Center|Bradford A. Perez, MD|813-745-4380|bradford.perez@moffitt.org|
22400232|NCT03424161|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
22400233|NCT00707577|Massachusetts General Hospital|Dr. Anne Thorndike|617-724-4608|athorndike@mgh.harvard.edu|
22400234|NCT00190775|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22400235|NCT01794780|Novartis Pharmaceutical|Study Director|862-778-8300||
22400236|NCT02286102|Hospital for Special Surgery|Oheneba Boachie-Adjei, MD|212 606-1723|rosst@hss.edu|
22400237|NCT01967225|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22400238|NCT00327444|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
22400239|NCT02249052|Dr. Zachary E. Gerut|Dr. Zachary E. Gerut, Sponsor/Investigator|516 295-2100|zger@optonline.net|
22400240|NCT01658514|Elcelyx Therapeutics, Inc|Senior Director, Development|858-876-1814|info@elcelyx.com|
22400241|NCT01271686|University of California, San Diego|Dr. John Liu|858 534-7056|joliu@ucsd.edu|
22400242|NCT00144170|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22400243|NCT00981526|UMass Medical School|Dr. Xiaoduo Fan|508-856-3881|xiaoduo.fan@umassmed.edu|
22400244|NCT00332202|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22400245|NCT01392183|UT MD Anderson Cancer Center|Amado J. .Zurita-Saavedra, MD/ Associate Professor, Genitourinary Medical Oncology|713- 563-6966|azurita@mdanderson.org|
22400246|NCT00407355|Wilmer Eye Institute|Peter Campocahiro|: 410-955-5106|pcampo@jhmi.edu|
22400247|NCT01587950|GlaxoSmithKline|GSK Response Center|866-435-7343||
22400248|NCT03128957|University of Michigan|Dr. Paul Picton|734 615 9864|ppicton@med.umich.edu|
22400249|NCT05654714|Baxter|Jessica Gregory|N/A|jessica_gregory@baxter.com|
22400250|NCT00075881|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
22400251|NCT02224664|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22400252|NCT00768222|J&J Medical, China Ltd.|Xiaowei SUN, MD PhD|86 10 5952 3103|xsun5@its.jnj.com|
22400253|NCT01444716|The University of Texas MD Anderson Cancer Center|Allessandra Ferrajoli, MD./Professor|713-792-2063|aferrajo@mdanderson.org|
22400254|NCT03263091|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|082MDSstudy@fibrogen.com|
22400255|NCT03026803|City of Hope|Jeffrey Longmate, Ph.D.|626-256-4673|jlongmate@coh.org|62478
22400256|NCT00265941|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22400257|NCT03109951|International St. Mary's Hospital, Catholic Kwandong University|Myong Ki Baeg|82-10-6391-9010|baegmk@gmail.com|
22400258|NCT04092257|UNC Lineberger Comprehensive Cancer Center|Melahat Garipagaoglu|919-962-0000|Melahat_Canter@med.unc.edu|
22400259|NCT02677779|AOU Careggi|Dr. Matteo Monami, Director Diabetic Foot Unit|00390557946563|matteo.monami@unifi.it|
22400260|NCT01217749|Pharmacyclics, Inc.|Dr. Jutta K. Neuenburg|877-877-3536|medinfo@pcyc.com|
22400261|NCT00810797|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22400262|NCT02432807|Eyevance Pharmaceuticals|Mark Jasek|817-677-6127|mjasek@eyevance.com|
22400263|NCT03976401|Akero Therapeutics, Inc.|Brittany de Temple, Senior Director Clinical Operations|(650) 868-7935|brittany@akerotx.com|
22400264|NCT00089128|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
22400265|NCT04125680|University of Michigan|Emily Feuerherm|810-766-6725|feuerher@umich.edu|
22400266|NCT02872103|Generon|Jianmin Chen|7327100262|jianmin_chen@generonbiomed.com|
22400267|NCT00391976|Novartis Pharmaceuticals|Study Director|862 778-8300||
22400268|NCT00049127|Mayo Clinic|Kurt A. Jaeckle, M.D.|5072841370|jaecle.kurt@mayo.edu|
22400269|NCT00310310|VA San Diego Healthcare System|Carl J. Stepnowsky,PhD|858-642-1240|Carl.Stepnowsky@va.gov|
22400270|NCT03826875|University of Washington|Professor of Neurological Surgery|2067449330|mlevitt@uw.edu|
22400271|NCT02725788|3M|Laura Rutledge|651-733-5394|lfrutledge1@mmm.com|
22400272|NCT00828464|GlaxoSmithKline|GSK Response Center|866-435-7343||
22400273|NCT00474240|Aegerion Pharmaceuticals|Chief Medical Officer|617-500-7867||
22400274|NCT00502840|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22400275|NCT02786901|Bausch Health|Study Manager|(908) 242-8287|sandra.narain@bauschhealth.com|
22400276|NCT00466505|Vanderbilt-Ingram Cancer center|Jordan Berlin, MD|615-343-4128|jordan.berlin@vanderbilt.edu|
22386522|NCT03165955|Athenex Inc.|Regional Project Manager|+886-978365735|lmeiying@athenex.com|
22386523|NCT03745716|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
22386524|NCT04761198|Mereo BioPharma|Mereo BioPharma|Please Email|enquiries@mereobiopharma.com|
22386525|NCT02994927|ChemoCentryx, Inc.|Clinical trial disclosure|650.210.2900|clinicaltrials@chemocentryx.com|
22386526|NCT03875339|University of Kentucky|Dr. Matthew L. Bush, Professor and Chair of Otolaryngology- Head and Neck Surgery|(859)218-2139|matthew.bush@uky.edu|
22386527|NCT03533257|Amylyx Pharmaceuticals, Inc.|Chief Medical Officer|(877) 374-1208|medinfo@amylyx.com|
22386528|NCT06412965|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22386529|NCT04046094|University of Kansas Medical Center|Faith Rahman|913-588-2502|frahman2@kumc.edu|
22386530|NCT02039401|Helixmith, LLC|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
22386531|NCT04479514|DFCI|Jennifer Huang|6173558937|jennifer.huang@childrens.harvard.edu|
22448753|NCT02047747|University of California, San Diego|David Piccioni M.D., Ph.D.|(858) 822-6346|dpiccioni@ucsd.edu|
22386532|NCT06834490|Pharmasoft|Y.E. Meshcherskiy, Medical Director|+ 7 (495) 626-47- 55|meshcherskiy_y@pharmasoft.ru|140
22386533|NCT03550170|Case Western Reserve University|Dr. Matthew Plow|216-368-8969|map208@case.edu|
22386534|NCT05850052|Cleveland Clinic Foundation|YanYan Han|216-444-2250|HANY3@ccf.org|
22386535|NCT04214860|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
22386536|NCT04282980|Zai Lab|Medical Director|+86 4008201022|Medinfo@zailaboratory.com|
22386537|NCT05860114|Italfarmaco SpA|Maurizio Caserini, MD|+39 02 64431|m.caserini@italfarmacogroup.com|
22386538|NCT01917084|New England Research Institutes|Felicia Trachtenberg|617-972-3120|FTrachtenberg@neriscience.com|
22386539|NCT03571386|Vanderbilt University|David Vago|236-516-6530|vago.dave@gmail.com|
22386540|NCT03938246|Sagimet Biosciences Inc.|Study Director|650-561-8675|sitecontact@sagimet.com|
22386541|NCT06037668|Sumitomo Pharma America|Director, Frontier Business Office|1-866-503-6351|gazeleh.vakili@us.sumitomo-pharma.com|
22386542|NCT02473445|Horizon Pharma USA, Inc.|Evelyn Olson, Director|224- 383-3000|clinicaltrials@horizonpharma.com|
22386543|NCT04881461|ALK-Abelló A/S|Senior Director, Clinical Data Science, Global Clinical Development|+4545747576|clinicaltrials@alk.net|
22386544|NCT03988621|University of Pennsylvania|Barbara Riegel, PhD, RN, Professor|2158989927|briegel@nursing.upenn.edu|
22386545|NCT04247802|Oxford University Hospitals NHS Foundation Trust|Mrs Martha Batting|01865|martha.batting@ouh.nhs.uk|737526
22386546|NCT03778801|Aksaray University training and Research Hospital|Principal Investigator|905555289493|mlk.aykut@gmail.com|
22386547|NCT03165786|University of Illinois Chicago|Pamela Martyn-Nemeth, Professor|(312) 996-7903|pmartyn@uic.edu|
22386548|NCT04629339|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22386549|NCT06356285|Imperial College London|Dr Kate Grailey|07912563290|k.grailey18@imperial.ac.uk|
22413304|NCT00999037|University of California at Los Angeles|Katherine Wesseling-Perry|310-206-6987|kwesseling@mednet.ucla.edu|
22413305|NCT04753710|Sintetica SA|Roberta Bianchi|0041 91 640 42 50|rbianchi@sintetica.com|
22413306|NCT00813293|Beth Israel Deasoness Medical Center|Andrea Bullock MD, MPH||abullock@bidmc.harvard.edu|
22413307|NCT02794974|HELIOS Medical Center Schwerin, Germany|Ronald Seidel|+49 385 5204251|ronald.seidel@helios-kliniken.de|
22413308|NCT02870920|Canadian Cancer Trials Group|Chris O'Callaghan|6135336430|cocallaghan@ctg.queensu.ca|
22413309|NCT00533273|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22413310|NCT00454909|GlaxoSmithKline|GSK Response Center|866-435-7343||
22413311|NCT03752528|Indivior, Inc.|Global Director, Clinical Development|804-379-1090|Robert.Dobbins@Indivior.com|
22413312|NCT01981720|Protalix Ltd.|Sari Alon MSc|+972-4-9028100|sari@protalix.com|215
22413313|NCT00425672|University of Washington|Principal Investigator||TrialTVG@medicine.washington.edu|
22413314|NCT02549092|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22413315|NCT00910663|TEVA Pharmaceuticals USA|Associate DIrector, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22413316|NCT01390233|University of Arizona (Investigator has changed institutions - study completed at University of South Carolina)|Meg Hill, MBBS|520 626 6174|meghanhill@obgyn.arizona.edu|
22413317|NCT01772537|The Johns Hopkins University|Dr. Charles Brown|410-955-0994|cbrown@jhmi.edu|
22413318|NCT01376167|GlaxoSmithKline|GSK Response Center|866-435-7343||
22413319|NCT00656305|InSightec|Nadir Alikacem|214-630-2000|nadira@insightec.com|
22413320|NCT02193165|Colgate Palmolive|William Devizio|732-878-7901|william_devizio@colpal.com|
22413321|NCT03115177|Rush University Medical Center|Dr. Allison Rao|608-445-0545|allison.rao@gmail.com|
22413322|NCT00678639|Wake Forest University Baptist Medical Center|Chadwick Miller, MD|336-716-1740|cmiller@wfubmc.edu|
22386550|NCT05265065|Murdoch Children's Research Institute|Kim Mulholland|+61 3 99366656|kim.mulholland@mcri.edu.au|
22413323|NCT02642835|Medway NHS Foundation Trust|Professor Jonaathan Duckett -Consultant Urogynaecologist|01634|jraduckett@hotmail.com|835154
22413324|NCT01546545|Pennington Biomedical Research Center|Jeffrey Gimble, MD, PhD|225-763-3000|doctors@pbrc.edu|
22413325|NCT01214850|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22413326|NCT05615935|National Taiwan University|Dr. Piao-Yi Chiou|02-2312-3456|piaoyi@ntu.edu.tw|288427
22413327|NCT00735904|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22413328|NCT02543554|Washington University in St. Louis|Brian M Fuller|3147475368|fullerb@wustl.edu|
22448754|NCT01975909|Beth Israel Deaconess Medical Center|Brad Manor, Ph.D.|617-971-5332|bmanor@bidmc.harvard.edu|
22386552|NCT04778410|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22386553|NCT03866837|Columbia University|Gary M. Brittenham, M.D.|212 305 7005|gmb31@cumc.columbia.edu|
22413329|NCT00076050|University of Miami|Silvina Levis MD|305-575-3388|slevis@med.miami.edu|
22386554|NCT05308979|UC Irvine Medical Center|Dr. Carly Crowder|7144562911|crowderc@hs.uci.edu|
22413330|NCT02567968|University of Chicago|Aaron Fox, PhD|7737020021|aaronfox@uchicago.edu|
22413331|NCT00048581|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22413332|NCT00487669|Dartmouth-Hitchcock Medical Center|James Rigas, MD|603-650-6344|james.r.rigas@hitchcock.org|
22386555|NCT05422885|Marcus Institute|Courtney Millar|6179715531|courtneymillar@hsl.harvard.edu|
22386556|NCT04084574|Duke University|Crystal Tyson, MD, MHS|919-660-6671|crystal.simpson@duke.edu|
22386557|NCT01121588|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22386558|NCT00942877|National Cancer Institute|Dr. Alice Chen|240-781-3274|chenali@nih.gov|
22386559|NCT02095691|Biosense Webster, EMEA|Liesbeth Vanderlinden, Manager Clinical Research|+32(0)2 7463527|lvanderl@its.JNJ.com|
22386560|NCT04370834|National Cancer Institute|Dr. Richard Little, Principal Investigator|240-276-6093|littler@mail.nih.gov|
22386561|NCT04068792|Janssen Research & Development, LLC|Senior director medical leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22386562|NCT00964392|Biosense Webster, Inc.|Robert Stagg, Clinical Franchise|(800) 729-9010|RStagg@its.jnj.com|
22386563|NCT00631475|Actelion Pharmaceuticals Ltd|Isabelle Leconte, PhD/Data Science Group Leader, Director|+ 41 61 565 64 18|isabelle.leconte@actelion.com|
22386564|NCT01146704|Department of Veterans Affairs, VAGLAHS|Dr. Joseph Pisegna|3104783711|Joseph.Pisegna@va.gov|41664
22386565|NCT04072861|Renibus Therapeutics|Donald J Keyser, Chief Operating Officer|18178756991|jkeyser@renibus.com|
22386566|NCT04801368|Mayo Clinic|Dr. Matthew Ziegelmann|507-266-3982|Ziegelmann.Matthew@mayo.edu|
22386567|NCT04214834|RTI International|Dr. Abhik Das|3017708214|adas@rti.org|
22386568|NCT04947137|Navidea Biopharmaceuticals|Senior Medical Director|6149737555|mblue@navidea.com|
22386569|NCT06609486|Hanyang University Seoul Hospital|Jongshill Lee, Ph.D.|+82-10-6209-4260|netlee@hanyang.ac.kr|
22386570|NCT05683158|Department of Physiotherapy, University of Valencia|PI. Jose Casaña Granell|+34 656-437-371|jose.casana@uv.es|
22386571|NCT04109066|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22386572|NCT04967599|University of Southern California|Susan Luczak, PI of study|2137402203|luczak@usc.edu|
22386573|NCT05864040|Rob Surgical Systems|Jaume Amat, CEO|+34 93 013 08 83|jaume.amat@robsurgical.com|
22386574|NCT04369911|HealthPartners Institute|Amanda Herrmann, PhD|6514956565|amanda.a.herrmann@healthpartners.com|
22386575|NCT05741294|Almirall S.A|Valentina Cappello/Global Medical Operations Manager|+34932913000|valentina.cappello@almirall.com|
22386576|NCT03817983|Addenbrookes Hospital, Cambridge, UK|Dr Deepak Jadon|01223 805000|deepak.jadon@addenbrookes.nhs.uk|
22386577|NCT03744676|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
22386578|NCT02510235|Dompé farmaceutici SpA|Clinical Development & operations|+39583831|clinical.trials@dompe.com|
22386579|NCT00450216|Horizon Pharma, Inc.|Amy Grahn, MS Senior Vice President, Clinical Development and Operations|224-383-3012|agrahn@horizonpharma.com|
22386580|NCT05990335|Kansas State|Study Director|(785) 532-6850|external+studydirector@nxtech.co|
22386581|NCT03418740|The Children's Hospital of Philadelphia|Dr. David Lynch|215-590-2242|lynchd@pennmedicine.upenn.edu|
22386582|NCT05525104|Erasmus Medical center|I.J. de Heer, MD|+31107040704|i.deheer@erasmusmc.nl|
22386583|NCT02865538|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22386584|NCT06149338|Saint Andrew's General Hospital of Patras|Dr. Vasileios Boviatsis|+306982925945|billboviatsis@gmail.com|
22386585|NCT06946888|Kaohsiung Veterans General Hospital|Li-Ying Lin|07-3422121|llylin@vghks.gov.tw|71571
22386586|NCT04244175|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22386587|NCT05505578|225.763.2500 Pennington Biomedical Research Center|Dr. Amanda Staiano|225.763.2500|amanda.staiano@pbrc.edu|
22386588|NCT02585323|University of British Columbia|Dr. Linda Li|604-207-4020|lli@arthritisresearch.ca|
22386589|NCT01130883|Abbott|Global Medical Services|1-800-633-9110||
22386590|NCT00449748|The University of Texas M. D. Anderson Cancer Cent|Srdan Verstovsek M.D./Associate Professor|713-792-7305|eharriso@mdanderson.org|
22386591|NCT04536012|Hospital of the University of Pennsylvania|Alexander C. Fanaroff, MD, MHS|2156157674|alexander.fanaroff@pennmedicine.upenn.edu|
22386592|NCT03364127|University of Illinois Chicago|Judith M. Schlaeger, PhD, CNM, LAc, FAAN|(312) 413-4469|jschlaeg@uic.edu|
22386593|NCT02278211|University of Edinburgh|Professor Dave Newby|0131 242 6515|D.E.Newby@ed.ac.uk|
22386594|NCT05717400|M D Anderson Cancer Center|Harrys A. Torres, MD|(713) 792-6503|htorres@mdanderson.org|
22386595|NCT02909686|University of Alabama at Birmingham|Dr. Jarred Younger|205-975-5821|youngerlab@uab.edu|
22386596|NCT03858517|Stryker|Monica Fleeman|251-465-5969|monica.fleeman@stryker.com|
22386597|NCT05268276|Faculty of nursing /cairo university|Asmaa Abdallah Ahmed Hussein|01006961502|asmaaabdallah.cu@cu.edu.eg|
22386598|NCT04804540|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22386599|NCT05172232|Linköping University|Professor Magnus Falk|+46708106176|magnus.falk@liu.se|
22386600|NCT01828021|TerSera Therapeutics LLC|VP, Scientific Communications|1-844-334-4035|tersera@medinfodept.com|
22386601|NCT04938726|University of Alabama at Birmingham|Dr. Eric P. Plaisance|2057090980|plaisep@uab.edu|
22386602|NCT04502186|University of Michigan School of Social Work|Dr. Addie Weaver|734-615-2122|weaverad@umich.edu|
22386603|NCT01385202|Biosense Webster, Inc.|Robert Stagg, Manager, Clinical Operations|(800) 729-9010|RStagg@its.jnj.com|8611
22386604|NCT03681262|Stanford University|Vafi Salmasi, MD. MS.|6507250246|vsalmasi@stanford.edu|
22413333|NCT03005522|Banner University Medical Center|Dr Noah Tolby|520-694-8888|ntolby@aemrc.arizona.edu|
22413334|NCT03639311|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22448755|NCT03333044|NYU Langone Health|Shinu Mammen|646-501-3484|shinu.mammen@nyulangone.org|
22386605|NCT00887198|Janssen R&D US|SENIOR DIRECTOR CLINICAL RESEARCH||ClinicalTrialDisclosure@its.jnj.com|
22386606|NCT02782676|Abbott Medical Optics, Inc.|Kendra Hileman, Ph.D., Head of Clinical Sciences|714-247-8613|kendra.hileman@abbott.com|
22448756|NCT01892371|The University of Texas MD Anderson Cancer Center|Yesid Alvarado MD./Associate Professor|713-794-4364|yalvarado@mdanderson.org|
22386607|NCT05830799|Vicore Pharma AB|Cecilia Ganslandt, MD, MSc|+46 31788 05 60|info@vicorepharma.com|
22386608|NCT05043064|Aalborg University Hospital|Dr Gennady V Atroshchenko|97 66 46 49|g.atroshchenko@rn.dk|45
22386609|NCT04631016|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
22386610|NCT05205161|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22386611|NCT04704869|The University of Texas Health Science Center at Houston|Bryan A Cotton, MD|713-500-7313|Bryan.A.Cotton@uth.tmc.edu|
22386612|NCT04325815|University College London|Professor Laurence B Lovat|020-7679-9060|l.lovat@ucl.ac.uk|
22386613|NCT04707768|Akebia Therapeutics, Inc.|Akebia Therapeutics, Inc.|6178446128|trials@akebia.com|
22386614|NCT04490109|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
22386615|NCT04163991|Horizon Therapeutics USA, Inc.|Ilias Alevizos, PhD, DMD|866-479-6742|clinicaltrials@horizontherapeutics.com|
22386616|NCT05953740|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22386617|NCT05496140|UCSF|Lauren M. Haack|415-502-8060|lauren.haack@ucsf.edu|
22386618|NCT05541484|Washington University School of Medicine|Janet McGill, Professor Medicine|314-273-3929|jmcgill@wustl.edu|
22386619|NCT05698368|Stanford University|Dr. Melissa Boswell|(650) 725-4009|boswellm@stanford.edu|
22386620|NCT02785991|Medtronic Ibérica|Patricia Pascual|636183869|patricia.pascual@medtronic.com|
22386621|NCT00626795|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
22386622|NCT03998488|Weill Cornell Medicine|Dr. Randy Longman|646-962-6289|ral2006@med.cornell.edu|
22386623|NCT04499521|University of Virginia|Kara Romano, MD|434-982-6278|ked7c@uvahealth.org|
22386624|NCT04108130|Columbia University Medical Center|Dr. Marcos F. Vidal Melo|2123424799|mv2869@cumc.columbia.edu|
22386625|NCT05132400|NYU Langone Health|Marco Campello, PT, PhD|212-255-6690|Marco.campello@nyulangone.org|
22386626|NCT00640978|UT MD Anderson Cancer Center|Milind Javle, MD/Associate Professor|713-792-2828|mjlim@mdanderson.org|
22386627|NCT06024642|Imbrium Therapeutics L.P.|Clinical Leader|1-888-827-0622|Medinfo@imbriumthera.com|
22386628|NCT03636490|Columbia University Irving Medical Center|Daichi Shimbo|‭(646) 317-0305‬|ds2231@cumc.columbia.edu|
22386629|NCT00739908|CeNeRx BioPharma Inc.|Mahnaz Asgharnejad, Pharm.D.; Daniel Burch, M.D.|(919) 655 1435; (919) 674 6041|masgharnejad@cenerx.com; danburch@cenerx.com|
22386630|NCT02299349|TriHealth Hatton Research Institute|Angela N Fellner PhD CCRP|513-862-2330|Angie_Fellner@trihealth.com|
22386631|NCT04734197|Surface Ophthalmics, Inc.|VP, Clinical Operations|(925) 494-3660|cbaenziger@surfaceophthalmics.com|18
22386632|NCT02076009|Janssen R&D US|Director, Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
22386633|NCT04165213|University of Pennsylvania, School of Nursing|Emily Summerhayes, Project Manager|6099233786|esummer@nursing.upenn.edu|
22386634|NCT04464564|Otsuka Pharmaceutical Development & Commercialization, Inc.|Clinical Transparency|08446878522|smb_clinicaltranspa@otsuka-us.com|
22386635|NCT04310423|University of California, Los Angeles|Dr. Lara Ray|310-794-5383|lararay@psych.ucla.edu|
22386636|NCT03786926|HUTCHMED Limited|Chao Pan|(+86)15215192478|chaop@hutch-med.com|
22386637|NCT04012931|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22386638|NCT02997202|Astellas Pharma Global Development, Inc|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
22386639|NCT03967379|Massachusetts General Hospital|Areej El-Jawahri|617-724-4000|ael-jawahri@partners.org|
22386640|NCT04664959|Samsung Bioepis Co., Ltd|Director of Clinical Trials|+82-32-728-0371|sbregistry@samsung.com|
22386641|NCT04332211|University of Maryland School of Medicine, Department of Emergency Medicine|Siamak Moayedi MD|4103288025|Mak.Moayedi@som.umaryland.edu|
22386642|NCT01950234|University of Minnesota|Sarah Hikbert|612-624-7745|hilbe010@umn.edu|
22386643|NCT00303459|Actelion Pharmaceuticals Ltd|Jonathan Tolson|+41 61 565 56 04|jonathon.tolson@actelion.com|
22386644|NCT04055012|The University of Pittsburgh|Study Coordinator|412-692-2084|kesslerl@upmc.edu|
22386645|NCT05960032|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22386646|NCT05633147|Cinclus Pharma Holding AB|Kajsa Larsson, CMO|+46 706750128|kajsa.larsson@cincluspharma.com|
22386647|NCT02492711|TerSera Therapeutics LLC|VP, Scientific Communications|1-844-334-4035|tersera@medinfodept.com|
22386648|NCT01474122|Actelion Pharmaceuticals Ltd|Angelina Marr|+41 61 565 63 69|angelina.marr@actelion.com|
22386649|NCT03652272|Northwestern University|Dr. Michael Wolf|(312) 503-5592|mswolf@northwestern.edu|
22386650|NCT02163694|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22386651|NCT03884101|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22386652|NCT05061017|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP, Clinical Research Manager|4126475554|stadtermanbm@upmc.edu|
22386653|NCT05883345|Konkuk University Medical Center|Sun-Young Lee|82-2-2030-7747|sunyoung1973.lee@gmail.com|7505
22386654|NCT02506673|Hospital for Special Surgey|Danya DeMeo, Research Assistant|2127742678|demeod@hss.edu|
22386655|NCT03880955|Stryker|Monica Fleeman|251-465-5969|monica.fleeman@stryker.com|
22386656|NCT05112900|Huntsman Cancer Institute at the University of Utah|Dr. Yelena Wu|801-213-5653|yelena.wu@utah.edu|
22386657|NCT05386589|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22386658|NCT01438853|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Office|855-797-9277|Bobby.Reddy@Immunitybio.com|
22386659|NCT02919917|Icahn School of Medicine at Mount Sinai|Dr. Jill Wecht|718-584-9000|jm.wecht@va.gov|3122
22386660|NCT04743973|Mayo Clinic|Dr. Ivana T. Croghan|507-284-2511|GIMRESEARCHSTUDIES@mayo.edu|
22386661|NCT01536938|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
22386662|NCT04300127|Mayo Clinic Arizona|Dr. Jay Pasricha|(480)301-4279|pasricha.jay@mayo.edu|
22386663|NCT05412004|Eli Lilly and Company|Chief Medical Officer|800-459-5979|ClinicalTrials.gov@lilly.com|
22400277|NCT00673595|Mayo Clinic|Dr. John H. Eisenach|507-266-8715|eisenach.john@mayo.edu|
22400278|NCT00605826|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22400279|NCT01241786|Hackensack University Medical Center|Dr. Anthony Mato|551-996-2000|AMato@hackensackumc.org|
22400280|NCT03431012|KCL|Dr D D'Antoni||donatella.d'antoni@kcl.ac.uk|
22400281|NCT01748799|Centre for Addiction and Mental Health (CAMH)|Bernard Le Foll|416.535.8501|bernard.lefoll@camh.ca|34772
22400282|NCT02620020|Regeneron Pharmaceuticals|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
22400283|NCT00691665|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22400284|NCT03456115|Johns Hopkins University Hospital|Christopher Razavi, MD|410-955-2307|crazavi1@jhmi.edu|
22400285|NCT02904226|Jounce Therapeutics, Inc.|Stew Kroll, Chief Development Officer|(650) 576-9679|skroll@jouncetx.com|
22400286|NCT03182738|Columbia University School of Nursing|Dr. Rebecca Schnall|212-342-6886|rb897@cumc.columbia.edu|
22400287|NCT00098787|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
22400288|NCT00684814|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22400289|NCT00446030|sanofi-aventis|Trial Transparency Team||Contact-us@sanofi-aventis.com|
22400290|NCT03496701|CooperVision, Inc|Jose A. Vega|925-640-2964|javega2@coopervision.com|
22400291|NCT02886715|Fougera Pharmaceuticals Inc.|Angela C Kaplan|631-659-2256|angela.kaplan@sandoz.com|
22400292|NCT00608140|Duke University|Mary Ann Sellers|919-668-8544|maryann.sellers@duke.edu|
22400293|NCT00503399|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22400294|NCT01676961|NYU Clinical Cancer Center|Amitabha Mazumder, MD|(212) 731-5757|Amitabha.Mazumder@nyumc.org|
22400295|NCT01172067|CRT, Global Clinical Affairs, Cardiac Arrhythmias and Heart Failure, Abbott Medical Devices|Clay Cohorn, Program Director|+1 972 309 8087|clay.cohorn@abbott.com|
22400296|NCT05292755|University of Florida|Dr. Yujia Zhou|3053429166|yzhou1996@ufl.edu|
22400297|NCT02216136|Washington University School of Medicine|Terence M. Myckatyn, M.D.|314-996-3873|myckatyn@wustl.edu|
22400298|NCT04052139|Boston Medical Center|Dr. Jeffrey H. Samet|617-414-7288|jsamet@bu.edu|
22400299|NCT02499952|Hoosier Cancer Research Network|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
22400300|NCT00519077|The University of Chicago|Tanguy Lim-Seiwert|773-702-2452|seiwert@uchicago.edu|
22400301|NCT03333577|Cochlear|George Cire|303 885 5440|gcire@msn.com|
22400302|NCT02120417|Incyte Corporation|Study Director|855 463-3463||
22400303|NCT00927485|University of Puerto Rico Medical Sciences Campus|Dr. Marcia Cruz-Correa|787-758-2525|marcia.cruz1@upr.edu|1722
22400304|NCT01440101|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
22400305|NCT00410891|Stanford|Professor|6504984791|cta@stanford.edu|
22400306|NCT00885079|Otsuka Pharmaceutical Co., Ltd.|Mr. Kyoji Imaoka|-81-6-6943-7722||
22400307|NCT02305563|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22400308|NCT02107755|The Ohio State University Comprehensive Cancer Center|Dr. Jose Bazan|614-688-7040|Jose.Bazan2@osumc.edu|
22400309|NCT01275222|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22400310|NCT00655928|Imperial College LOndon|Mark J Griffiths|+44 (0) 2073518523|m.griffiths@imperial.ac.uk|
22400311|NCT02370121|Institute of Experimental and Clinical Therapeutics|Dra. Esperanza Martínez Abundis|+52-33-10-58-52-00|esperanzamartnezabundi@yahoo.com|34211
22400312|NCT00342355|National Institute of Allergy and Infectious Diseases, Dvision of Clinical Research|Michael A Polis, MD, MPH|301-496-8027|mpolis@niaid.nih.gov|
22400313|NCT04551014|Stanford University|Shai Friedland, MD|650-723-4000|shaif@stanford.edu|
22400314|NCT02654002|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22400315|NCT04108429|Northwestern University|Dr. Emily Lattie|312-503-5509|emily.lattie@northwestern.edu|
22400316|NCT02570672|UT Health San Antonio|Sara Espinoza|210 617 5197|Sara.Espinoza@cshs.org|
22400317|NCT05262764|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
22400318|NCT00275561|Mayo Clinic|Jeffrey A. Alexander, MD, Assistant Professor of Medicine|507-538-2403|alexander.jeffrey14@mayo.edu|
22400319|NCT01769105|Department of ophthalmology, University of Duesseldorf|Dr. David Finis|+49 211 8117320|David.Finis@med.uni-duesseldorf.de|
22400320|NCT01530243|Seyyed-al-Shohada Heart Center, Urmia University of Medical Sciences|Yousef Rezaei|+989126231864|yousefrezaei1986@gmail.com|
22400321|NCT00684177|GlaxoSmithKline|GSK Response Center|866-435-7343||
22400322|NCT02093702|Barrie and Community Family Health Team|Dr. Andrew Wozniak|(705) 728-2618|andrew.wozniak@barriefht.ca|
22400323|NCT03874234|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22400324|NCT01587963|Rutgers RWJMS|Vincente Gracias|732-235-7920|graciavh@rwjms.rutgers.edu|
22400325|NCT00430040|State University of NY at Buffalo|Paresh Dandona|7165351852|dandona@buffalo.edu|
22400326|NCT02983058|New York State Psychiatric Institute|Marlene Carlson, MPH|646-774-8436|marlene.carlson@nyspi.columbia.edu|
22400327|NCT00318292|Mayo Clinic|Michaele Menghini|480-301-6651|menghini.michaele@mayo.edu|
22400328|NCT02770521|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22400329|NCT01217606|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22400330|NCT00809133|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22400331|NCT01057277|Brown University Oncology Research Group (BrUOG)|Howard Safran, MD|4018633000|kayla_rosati@brown.edu|
22400332|NCT03093155|Yale School of Medicine/Yale Cancer Center|Alessandro Santin, MD|(203) 737-4450|alessandro.santin@yale.edu|
22448757|NCT02893878|GlaxoSmithKline|GSK Response Center|866-435-7343||
22400333|NCT01700829|NY State Psychiatric Institute-Columbia University Medical Center|Michael Grunebaum, MD|646-774-7573|michael.grunebaum@nyspi.columbia.edu|
22448758|NCT04007094|The Ohio State University|Shelby Miracle|614-366-1648|shelby.miracle@osumc.edu|
22448759|NCT02653560|UT Southwestern Medical Center|Dr Wanpen Vongpatanasin|2146489078|wanpen.vongpatanasin@utsouthwestern.edu|
22413335|NCT00855738|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22413336|NCT03151057|Northwell Health Cancer Institute|Dr. Douglas Gladstone|(516) 734-8900|msteve35@jhmi.edu|
22386664|NCT03781089|Duke University Medical Center|Dr. John Middleton|919-684-8111|j.p.middleton@duke.edu|
22413337|NCT02287675|Kettering Health Network|Dr. Arash Kardan|937-395-8611|arash.kardan@ketteringhealth.org|
22413338|NCT03486990|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22413339|NCT03187002|Stanford University|Research Manager|6507211567|fpresearch@stanford.edu|
22413340|NCT00154102|Merck Serono|Monika Foerster/Clinical Trial Leader|+496151729517|monika.foerster@merck.de|
22413341|NCT02158936|Novartis Pharma AG|Study Director|862-778-8300||
22413342|NCT01149473|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22386665|NCT04644029|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22413343|NCT01247701|Baylor College of Medicine/Texas Children's Hospital|Caridad A. Martinez|832-824-4692|camartin@texaschildrens.org|4670
22413344|NCT04166630|Emory University|Randi Smith|404-251-8914|randi.smith@emory.edu|
22413345|NCT01838941|McGill University Health Centre|Dr. Nancy Braverman, Associate Professor, Human Genetics and Pediatrics|(514) 934-1934|nancy.braverman@mcgill.ca|23404
22386666|NCT02246127|Grupo Español de Tumores Neuroendocrinos y Endocrinos (GETNE)|GETNE Secretary|0034934344412|getne@getne.org|
22413346|NCT02822235|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22413347|NCT00829530|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22413348|NCT00840866|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22386667|NCT05988398|University of Michigan|Dr. Katie M Edwards|734-647-8812|edkatie@umich.edu|
22386668|NCT05891275|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22386669|NCT03733626|William Beaumont Hospitals|Jad Khalil, MD|(248) 663-1900|jad.khalil@corewellhealth.org|
22386670|NCT05147584|Raydiant Oximetry, Inc.|Laura Kemp|4083751465|laurakemp@raydiantoximetry.com|
22386671|NCT03370913|BioMarin Pharmaceutical Inc.|Tara Robinson, MD, PhD, Senior Medical Director, Clinical Sciences|415-455-7931|tara.robinson@bmrn.com|
22386672|NCT04560179|Stanford University School of Medicine|Erik Jensen, MD, MSCE|267-648-2720|jensene@stanford.edu|
22386673|NCT04078152|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22386674|NCT05292222|HealthPartners Institute|Bhavani Kashyap, MBBS, PhD|651-495-6565|bhavani.x.kashyap@healthpartners.com|
22386675|NCT05966766|Tufts Medical Center|Dan Drzymalski, MD|617-913-8168‬‬‬‬‬‬‬‬‬‬‬‬‬‬|dan.drzymalski@tuftsmedicine.org|
22386676|NCT05257603|State University of New York at Buffalo|Dr. Kathleen Parks|(716) 887-3301|kparks@buffalo.edu|
22448760|NCT02921776|The Ohio State University|Mary Beth Happ, PhD, RN|614-292-8336|happ.3@osu.edu|
22386677|NCT05454514|HIDO TECHNOLOGIES, INC.|Charles Gellman, CEO|5108137224|charles@hidohealth.com|
22386678|NCT04795245|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22386679|NCT04807777|Columbia University|Alexander Wei, MD|212-305-7115|aw3056@cumc.columbia.edu|
22386680|NCT03279978|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22386681|NCT00329836|Doylestown Hospital|Abraham Ashkenazi, M.D./ Prinicpal Investigator|215-625-2894|aashkenazi@yahoo.com|
22386682|NCT02461134|Actelion Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 61 565 6565|clinical-trials-disclosure@its.jnj.com|
22386683|NCT04159519|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22386684|NCT05305560|MedinCell|Head of Clinical Development|6 40 38 93 83|caroline.denot@medincell.com|0033
22386685|NCT03493542|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22386686|NCT01651000|OPKO Health, Inc.|Douglass Laidlaw, PhD, Vice President, Medical Affairs|305-575-4172|dlaidlaw@opko.com|
22386687|NCT02765412|VA Ann Arbor Healthcare System|Angela Larkin|734-845-3612|angela.larkin@va.gov|
22386688|NCT03697408|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
22386689|NCT04595331|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
22386690|NCT05207033|University of Massachusetts Chan Medical School|Elise Stevens, Assistant Professor|(774) 455-6684|elise.stevens@umassmed.edu|56684
22386691|NCT05020353|Li Ka Shing Knowledge Institute, St. Michael's Hospital|Sean B. Rourke|(416) 878-2779|sean.rourke@utoronto.ca|
22386692|NCT02611687|Bioprojet Pharma|Clinical Project Manager|+33 (0)1 47 03 66 23|a.viatte@bioprojet.com|
22386693|NCT03934931|University of California Irvine|Professor Adithya Cattamanchi|415-206-5489|adithya.cattamanchi@uci.edu|
22386694|NCT03952520|University of North Carolina at Chapel Hill|Jane Chen, PhD|919-966-2537|janechen@live.unc.edu|
22386695|NCT03635567|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22386696|NCT05157841|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
22386697|NCT06237686|Medical Consultant|Principal Investigator: Søren Meisner, MD|+4520117378|sm_meisner@hotmail.com|
22386698|NCT02075554|Globus Medical Inc.|Brandon Bucklen|610-930-1800|bbucklen@globusmedical.com|2517
22413349|NCT01038856|University of Oklahoma|Research Regulatory Specialist III|405-271-8777|sharon-ross@ouhsc.edu|48394
22413350|NCT04638153|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22413351|NCT01389102|KV Pharmaceutical Company|Jim Joffrion|314-645-6600|jjoffrion@kvph.com|3410
22413352|NCT00050778|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22386699|NCT00624442|Cytokinetics, Inc.|Medical Director|(650) 624-3011||
22413353|NCT01035060|University of Florida|Dr. Thomas Buford|352-273-5918|tbuford@ufl.edu|
22413354|NCT02770625|ISU ABXIS Co., Ltd.|Taekseung Kim|+82.31.696.4715|kimts@isu.co.kr|
22413355|NCT00625443|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
22386700|NCT04282109|APICES|Juan Luis Sanz (MW)|+34 918166804|juanluis.sanz@apices.es|103
22386701|NCT01167010|Eurofarma Laboratórios S.A|Sandra Rodrigues (Clinical Research)|1150908600|sandra.rodrigues@eurofarma.com.br|8417
22386702|NCT03340428|Johns Hopkins University|Christopher Hoffmann|410-614-4257|choffmann@jhmi.edu|
22386703|NCT04243759|Northeastern University|Robert Leeman|6173736501|r.leeman@northeastern.edu|
22386704|NCT04757753|SEPTODONT|Dr. Farid BENABDALLAH|+33785662179|clinical-operations@septodont.com|
22386705|NCT03944915|University of Chicago|Dr. Ari Rosenberg|855-702-8222|arirosenberg@bsd.uchicago.edu|
22386706|NCT02954809|University at Buffalo|Dr. Carleara Weiss|716-829-2006|carleara@buffalo.edu|
22386707|NCT00942734|University of Texas (UT) MD Anderson Cancer Center|Vali Papadimitrakopoulou, MD||CR_Study_Registration@mdanderson.org|
22386708|NCT00319046|Actelion Pharmaceuticals Ltd|Cécile Luzy, MSc/Clinical Research Scientist|+ 41 61 565 6386||
22400334|NCT01075178|Abbott|Global Medical Services|800-633-9110||
22448761|NCT03628703|Cincinnati Children's Hospital Medical Center|Steve W. Wu, M.D.|513-636-4222|steve.wu@cchmc.org|
22448762|NCT05247229|Department of Medicine, Division of Occupational, Environmental, and Climate Medicine, University of California|Matthew O. Gribble|‭(949) 350-6134‬|matt.gribble@ucsf.edu|
22448763|NCT01928524|Odense University Hospital|Per Pfeiffer|+45-26283844|per.pfeiffer@rsyd.dk|
22448764|NCT04350788|UNC-CH School of Nursing|Biostatistician|919-966-7181|peiran@live.unc.edu|
22448765|NCT04537234|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22448766|NCT00378209|Dana-Farber Cancer Institute|Dr. Paul Richardson|617-632-2104|Paul_Richardson@dfci.harvard.edu|
22448767|NCT02070744|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22448768|NCT03084081|Cleveland Clinic|Miriam Cremer, M.D.|216-213-6460|cremerm@ccf.org|
22448769|NCT01239368|National Cancer Institute|Dr. Steven Pavletic|301-402-4899|steven_pavletic@nih.gov|
22448770|NCT02145039|University of Minnesota Cancer Center|Dr. Claudio Brunstein|612-625-8942|bruns072@umn.edu|
22448771|NCT03181399|Weill Cornell Medicine|Dr. Juan Pascual|(212) 746-3278|jup9003@med.cornell.edu|
22448772|NCT00265473|Schulze Diabetes Institute, University of Minnesota|Melena D. Bellin, MD|612-625-4686|bell0130@umn.edu|
22448773|NCT00939809|Gynecologic Oncology Group Statistical and Data Center|Jessalyn Reboy|716-845-7738|reboyj@nrgoncology.org|
22448774|NCT01921179|San Francisco VA HCS|Dr Tatjana Novakovic-Agopian|415-753-3888|tatjana.novakovic-agopian@va.gov|
22448775|NCT01002755|The University of Texas M D Anderson Cancer Center|Ferrajoli,Alessandra M.D.|713-792-2063|aferrajo@mdanderson.org|
22448776|NCT00858442|coaniquem|M Beatriz Quezada.MD|56-2-28734077|investigacion@coaniquem.cl|
22448777|NCT02016625|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22448778|NCT06145542|Zhejiang University|Dr. Xiao Tan|18651218270|xiao.tan@zju.edu.cn|
22448779|NCT02603809|Idorsia Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 58 844 19 77|clinical-trials-disclosure@idorsia.com|
22448780|NCT02953990|Virginia Commonwealth University School of Nursing|Patricia Kinser, PI|804-828-0724|kinserpa@vcu.edu|
22448781|NCT00380978|Department of Anesthesiology; Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|312-926-9015|r-mccarthy@northwestern.edu|
22448782|NCT01254227|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22448783|NCT02750592|Novartis Pharmaceuticals|Study Director|1-888-669-6682|novartis.email@novartis.com|
22448784|NCT02981342|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22448785|NCT03970733|Valneva Austria GmbH|Director Clinical Strategy|+43120620|office@valneva.com|0
22448786|NCT02341807|Spark Therapeutics|Clinical Director|1-866-647-7275|clinicaltrials@sparktx.com|
22448787|NCT02784821|University of Florida|Dr. Josef Neu|352-733-0111|neuj@peds.ufl.edu|
22448788|NCT02794103|Université de Montréal|Dr. Sylvie Le May, Professor & Researcher|514 345-4931|sylvie.lemay@umontreal.ca|4938
22448789|NCT00112502|The University of Texas (UT) MD Anderson Cancer Center|John F de Groot, Chair Ad Interim, Neuro-Oncology|713-745-3072|jdegroot@mdanderson.org|
22448790|NCT00834210|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22400335|NCT02983604|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22400336|NCT01687790|University of Pittsburgh|Dr. Christiane Hakim|412-641-1965|chakim@magee.edu|
22400337|NCT00607048|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22400338|NCT04336163|University of California, Irvine|Kristen Kelly, MD|949-824-6550|kmkelly@uci.edu|
22400339|NCT04927312|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22400340|NCT02351115|Engage Therapeutics, Inc|Chief Medical Officer||studydirector@engagetherapeutics.com|
22400341|NCT04919564|National Cardiovascular Center Harapan Kita Jakarta|Prieta Adriane, MD|+62 852-2004-0006|prietaadriane@gmail.com|
22400342|NCT03624816|QMedAB|Clinical Project Manager|(817) 961-5000|aestheticclinicaltrials@galderma.com|
22400343|NCT03812510|Aclaris Therapeutics, Inc.|Aclaris Clinical Operations|1-833-225-2747|clinicaloperations@aclaristx.com|
22400344|NCT03168867|Wayne State University|Deborah Ellis, Ph.D.|313-577-1055|dellis@med.wayne.edu|
22400345|NCT01128387|University of Wisconsin Carbone Cancer Center|Dr. Mark Ritter|608-263-8500|ritter@humonc.wisc.edu|
22400346|NCT01021111|Stanford University|Professor Thomas P. Andriacchi|6507238024|tandriac@stanford.edu|
22400347|NCT01535235|Medical College of Wisconsin|Dr. Leslie Cockerham|414-805-0738|lcockerham@mcw.edu|
22400348|NCT00858832|USF Health Department of Obstetrics and Gynecology|Patrick Teefey MD|813-259-8680|ObGynClinicalResearch@health.usf.edu|
22400349|NCT03502746|Hoosier Cancer Research Network|Fauzia Sharmin|(317) 921-2050|fsharmin@hoosiercancer.org|
22413356|NCT02015390|Texas Medical Branch, University of, Galveston|Study PI|409-747-5760|zgugala@utmb.edu|
22413357|NCT03136380|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22413358|NCT01661686|Erasmus University Medical Center|Dr. V.M.C.W. Spaander|0031 10 703 5643|v.spaander@erasmusmc.nl|
22413359|NCT00784823|Hackensack Meridian Health|Joshua Zenreich|551-996-4248|Joshua.Zenreich@hmhn.org|
22413360|NCT01720264|IndianaU|Dr. Sherif Farag|(317) 278-0460|ssfarag@iu.edu|
22413361|NCT02728102|The Emmes Company|Adam Mendizabal, PhD|301-284-1798|amendizabal@emmes.com|
22413362|NCT04869787|Cincinnati Children's Hospital Medical Center|Dr. Stuart L.Goldstein|513-636-4837|stuart.goldstein@cchmc.org|
22413363|NCT03834870|Yale University|Fuad Abujarad|+1 (203) 737-5088|fuad.abujarad@yale.edu|
22413364|NCT00553280|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22413365|NCT01544127|Canandaigu VA Medical Center|Dr. Peter Britton|585-393-7926|peter.britton@va.gov|
22413366|NCT01437501|Johns Hopkins Bloomberg School of Public Health|Thomas W. Kensler, PhD|410-955-1292|tkensler@jhsph.edu|
22413367|NCT02914600|Galapagos NV|Galapagos Medical Information|+3215342900|medicalinfo@glpg.com|
22448791|NCT00265343|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22386709|NCT02765854|Atrium Health Wake Forest Baptist Comprehensive Cancer Center|Leon Bernal-Mizrachi, MD|336-716-9253|lbernalm@wakehealth.edu|
22386710|NCT03816397|F.I. Proctor Foundation, University of California, San Francisco|Nisha Acharya, MD, MS|(415) 476-6687|nisha.acharya@ucsf.edu|
22386711|NCT05757193|Duke University|Senthil Selvaraj, MD|919-660-0730|Senthil.Selvaraj@duke.edu|
22386712|NCT03907982|Barts and London NHS trust|Dr Malcolm Finlay, Principal Investigator|+442037658635|malcolm.finlay1@nhs.net|
22386713|NCT04908930|Wake Forest University Health Sciences|Jillian Urban, PhD|336.716.0947|jurban@wakehealth.edu|
22386714|NCT04679389|Mayo Clinic|Eva Morava-Kozicz, M.D., Ph.D.|507-266-9140|Morava-Kozicz.Eva@mayo.edu|
22386715|NCT02777593|W.L. Gore|Meier Hsu|928-864-3338|mhsu@wlgore.com|
22386716|NCT05954546|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22386717|NCT04198701|Medtronic, Inc.|Clinical Research Specialist|800-328-2518|medtroniccrmtrials@medtronic.com|
22386718|NCT03904576|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22386719|NCT04881110|University of Campania Luigi Vanvitelli|Prof. Katherine Esposito, Head of the Division of Endocrinology and Metabolic Diseases|+390815665031|katherine.esposito@unicampania.it|
22386720|NCT05215054|Eurofins Dermscan Pharmascan|Florence REBER|0472823656|Florence.Reber@cpt.eurofinseu.com|+33
22400350|NCT00659438|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22400351|NCT00201851|International Breast Cancer Research Foundation|Richard R. Love|608-698-7881|richardibcrf@gmail.com|
22448792|NCT02608268|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22448793|NCT02994732|Biomed Valley Discoveries|Associate Director of Translational Sciences|636-887-6429|Dknoerzer@biomed-valley.com|
22448794|NCT03684512|University of Kansas Medical Center|Dr. Lauren Ptomey|913-588-7983|lptomey@kumc.edu|
22448795|NCT03202264|McMaster University|Dr. Dee Mangin|905-525-9140|mangind@mcmaster.ca|21219
22448796|NCT02094716|Mylan Pharmaceuticals Pvt Ltd|Clinical Sciences Program Lead||prasannac.ganapathi@mylan.in|
22448797|NCT02430337|Georgia State University|Shannon Self Brown, PhD|404-413-1283|sselfbrown@gsu.edu|
22448798|NCT01859494|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com|
22400352|NCT02469246|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22448799|NCT01810666|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22448800|NCT02381418|Abbott|Global Clinical Director|+31294477184|serge.vandewitte@abbott.com|
22448801|NCT00775931|Masonic Cancer Center, University of Minnesota|Dr. Paul Orchard|612-626-2313|orcha001@umn.edu|
22448802|NCT00297037|University of Utah|Dr. Christopher Hull|801-581-6465|christopher.hull@hsc.utah.edu|
22448803|NCT01203046|Dr. Silvia M. Pinango L|Dr. Silvia M. Pinango L.|+584169267988|pinangosilvia@yahoo.com|
22448804|NCT03814746|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22448805|NCT02631954|INHA UNIVERSITY HOSPITAL|Sang-Heon Cho, Ph.D.|82-32-890-1122|shcho123@inha.ac.kr|
22448806|NCT01229423|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22448807|NCT01053819|University of Alabama at Birmingham|Boni Elewski, MD|205-502-9960|beelewski@gmail.com|
22448808|NCT00391989|GIMEMA|Dr. Paola Fazy; Dr. Marco Vignetti|+39 06.70390521|gimema@gimema.it|
22448809|NCT00371254|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22448810|NCT01817725|Chang Gung Memorial Hospital, Linkou Branch|Dr. Ming-Wei Lai|886-3-3281200|a22141@adm.cgmh.org.tw|8969
22448811|NCT00909779|Sunovion|Respiratory Medical Director|1-866-503-6351||
22448812|NCT02809677|UT Southwestern Medical Center|Dr. E. Sherwood Brown|24-645-6950|sherwood.brown@utsouthwestern.edu|
22448813|NCT03971188|Washington University in St. Louis|Dr. Charles Goldfarb|(314) 362-3768|goldfarbc@wustl.edu|
22448814|NCT05172544|Najít Technologies, Inc.|Dr. Ian Amanna|9717273569|iamanna@najittech.com|
22448815|NCT04829318|Janssen-Cilag Limited|Director Global Medical Affairs Lead|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22448816|NCT02014363|e-Therapeutics plc|Clinical Operations Manager|+44 1993 880000|contact@etherapeutics.co.uk|
22448817|NCT01601782|University of Michigan|Jon Jacobson, MD|734-936-4365|jjacobsn@umich.edu|
22448818|NCT02084147|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Philipp Frank Graner|+1 216-844-8275|philipp.graner@uhhospitals.org|
22448819|NCT00561080|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22448820|NCT02295995|Durham VA HCS|Dr. Katherine S. Hall|919-286-0411|katherine.hall@duke.edu|6734
22448821|NCT05986019|Medical University of South Carolina|Dr. Bashar Badran|843-792-6076|badran@musc.edu|
22448822|NCT03158051|University of Wisconsin School of Medicine and Public Health|Kara Hoppe, DO|608-417-4224|khoppe2@wisc.edu|
22448823|NCT02588833|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
22448824|NCT04709341|Medical University of South Carolina|Samuel Bidwell- Research Manager|843-792-2305|bidwells@musc.edu|
22448825|NCT03649711|University of Arkansas for Medical Sciences|Dr. Nishank Jain, Associate Professor of Medicine|5016865295|njain2@uams.edu|
22448826|NCT01581307|H. Lee Moffitt Cancer Center and Research Institute|Dr. Sarah Hoffe|813-745-4380|sarah.hoffe@moffitt.org|
22448827|NCT04994444|Brown University|Dr. Patricia Cioe|4018636638|patricia_cioe@brown.edu|
22448828|NCT02117999|Studio Italiano di Oftalmologia|Marco Lombardo|+39 331 34 38 300|mlombardo@visioeng.it|
22448829|NCT07114198|Inonu|Assistant Professor Merve Bilmez Selen|5457673089|merve.selen@inonu.edu.tr|
22400353|NCT00046566|Tulane University|Jiang He, MD, PhD, Chair of Epidemiology|5049885165|jhe@tulane.edu|504
22448830|NCT01331148|Carolinas Healthcare System|Ifeyinwa Osunkwo, MD, MPH, Principal Investigator|980 442 5001|ify.osunkwo@carolinashealthcare.org|
22386721|NCT01897441|Albert Einstein College of Medicine|Dr. Jesus Anampa Mesias|718-405-8505|janampa@montefiore.org|
22400354|NCT03352245|Yale University|Dr. Brett Bade|203 785 6670|Brett.bade@yale.edu|
22400355|NCT02643095|The Ohio State University College of Optometry|Jennifer Fogt|614-292-2020|Fogt.78@osu.edu|
22400356|NCT02690701|Novartis Pharmaceuticals|Study Director|+1 (800) 778-8300|Novartis.email@novartis.com|
22400357|NCT02700451|HospitalSS|Catherine Himo Gang|917-260-4603|gangh@HSS.EDU|
22400358|NCT01578902|Sunnybrook Research Institute|Dr Andrew Loblaw, Director GU Radiation Trials|4164804806|andrew.loblaw@sunnybrook.ca|
22400359|NCT02930174|University of Michigan Health System|Carl Haas|734-936-5234|chaas@med.umich.edu|
22400360|NCT04214652|Bausch Health Americas, Inc|Study Director|7072851528|Varsha.Bhatt@bauschhealth.com|
22448831|NCT01698463|University of Waterloo|Dr. Lora Giangregorio|(519) 888-4567|lmgiangr@uwaterloo.ca|36357
22448832|NCT04709575|Regeneron Pharmaceuticals, Inc|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
22400361|NCT00404092|University of Cologne|Oliver A. Cornely|+49 221 478 6494|Oliver.Cornely@zks-koeln.de|
22400362|NCT03303989|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Jeff Foster|2059966086|pjfoster@uabmc.edu|
22448833|NCT02967692|Novartis Pharmaceuticals|Study Director|862 778 8300|Novartis.email@Novartis.com|
22448834|NCT06063603|Mayo Clinic|Andrea L. Cheville, MD|507-284-2511|cheville.andrea@mayo.edu|
22448835|NCT04447417|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22448836|NCT00702403|Fred Hutchinson Cancer Research Center|Dr. Paul A. Carpenter|(206) 667-5191|pcarpent@fredhutch.org|
22448837|NCT01341600|University of Maryland School of Medicine|Richard Horenstein M.D., Associate Professor of Medicine|410-706-0154|rhorenst@medicine.umaryland.edu|
22448838|NCT00066066|The Forsyth Institute|Ricardo P Teles, DDS, DMSc|617 892-8556|rteles@forsyth.org|
22448839|NCT02155738|University of Pittsburgh|Halina Zyczynski|412-641-1440|hzyczynski@mail.magee.edu|
22448840|NCT01230931|The University of Texas Health Science Center at Houston|Catherine G. Ambrose, PhD||Catherine.G.Ambrose@uth.tmc.edu|
22448841|NCT01466348|GlaxoSmithKline|GSK Response Center|866-435-7343||
22448842|NCT01291056|University of Utah Department of Obstetrics & Gynecology|Dr. Jessica Pittman|801-339-4103|jessica.pittman@hsc.utah.edu|
22448843|NCT02189473|Department of Radiation Oncology, University of Lübeck, Germany|Prof. Dr. Dirk Rades|0049 451 500|dirk.rades@uksh.de|45401
22400363|NCT04325503|Unversity of Michigan|Nicolaas Bohnen|734-998-8400|nbohnen@umich.edu|
22400364|NCT02337387|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22400365|NCT01642212|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22413368|NCT02377947|Abbott|Dr. Shubhangi Desai|+91 22 7175 7408|shubhangi.desai@abbott.com|
22413369|NCT02996682|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22413370|NCT02457520|SPIL|Clinical Trials|912266455645|Clinical.Trials@sparcmail.com|
22413371|NCT02605395|GlaxoSmithKline|GSK Response Center|866-435-7343||
22448844|NCT03928847|University of California at San Francisco|Harold A. Chapman, M.D.|415-514-1210|hal.chapman@ucsf.edu|
22448845|NCT02385266|Northwestern University|Camila Bonin Pinto, PhD|3125033971|camila.pinto@northwestern.edu|
22448846|NCT00914810|Minneapolis VA Health Care System|Ken Kunisaki, M.D.|612-467-4400|kunis001@umn.edu|
22448847|NCT02082210|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22448848|NCT01268111|Mayo Clinic|A J Vinaya Simha|5072664321|simha.aj@mayo.edu|
22448849|NCT03493828|New York Methodist Hospital|Dr Joel Yarmush|(718) 780-3279|joelyarmush@gmail.com|
22448850|NCT02529137|Philips Digital Pathology Solutions|Mischa Nelis, Clinical Study Director||dpsclinicaltrials@philips.com|
22448851|NCT02731729|Parker Institute for Cancer Immunotherapy|Ute Dugan|203-379-6757|udugan@parkerici.org|
22448852|NCT01344447|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22448853|NCT01660711|NorthShore University/University of Chicago|Dr Robert Marsh|847-5702112|rmarsh@northshore.org|
22448854|NCT03460587|UCLA|Steven C. Cramer, MD|424-522-7273|sccramer@mednet.ucla.edu|
22448855|NCT00952341|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22448856|NCT04322396|Gentofte Hospital|Prof. Jens-Ulrik Stæhr Jensen, MD PHD|+4538673057|jens.ulrik.jensen@regionh.dk|
22448857|NCT01686841|Zeltiq Aesthetics|Lori Brandt, Director Clinical Trial Management|(925) 621-7460|lori.brandt@abbvie.com|
22448858|NCT02066467|Boston Scientific|Caroline Beaudoint|+32479904163|Caroline.Beaudoint@bsci.com|
22448859|NCT01442363|Braintree Laboratories, Inc.|Head of R&D, GI|7818432202|studydirector@sebelapharma.com|
22448860|NCT00581776|University of Wisconsin- Madison|Brad S Kahl|608-263-1836|bsk@medicine.wisc.edu|
22386722|NCT02933489|ECOG-ACRIN|Director Clinical Research Administration|800-227-5463|dhartfeil@acr.org|4765
22448861|NCT02357901|Indivior, Inc.|Global Director, Clinical Development|804-379-1090||
22448862|NCT04259762|University of New Mexico Health Sciences Center|Dr. Shiraz Mishra|505-925-6085|smishra@unm.edu|
22448863|NCT03453684|"University of Colorado Denver | Anschutz"|Melissa Brooks-Peterson, MD|30372411111|clinicalresearchsupportcenter@ucdenver.edu|
22448864|NCT01319812|BIOTRONIK|Amy Culley, Director of Vascular Intervention|503-451-8034|amy.culley@biotronik.com|
22448865|NCT02759120|Weill Cornell Medicine|Elizabeth Peters|646-962-2742|elp2018@med.cornell.edu|
22448866|NCT04302389|University of Connecticut|Dr. Sherry Pagoto|860-486-8979|sherry.pagoto@uconn.edu|
22448867|NCT02063516|tianjinMUGH|Dr. Haiyun Wang|008613752211206|wanghy819@hotmail.com|
22448868|NCT04461015|Mayo Clinic|Adrian Vella|507-255-6515|vella.adrian@mayo.edu|
22448869|NCT00706979|Medical University of South Carolina'|Matthew J. Carpenter|843-792-3974|carpente@musc.edu|
22448870|NCT00470574|Memorial Sloan Kettering Cancer Center|Teresa Gilewski, MD|(212) 639-2000|gilewskt@mskcc.org|
22448871|NCT00483379|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22448872|NCT01199744|GlaxoSmithKline|GSK Response Center|866-435-7343||
22448873|NCT02418468|Novartis Pharmaceuticals|Study Director|862-778-8300||
22448874|NCT02914769|UFRN|Draulio Barros de Araujo|+5584991225987|draulio@neuro.ufrn.br|
22448875|NCT02337907|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22448876|NCT01592344|Bioness|Charlene Myers, Contractor|9499101655|cahanderson@msn.com|
22448877|NCT00099437|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22448878|NCT02738333|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22448879|NCT00949325|Johns Hopkins University|David M. Loeb, M.D., Ph.D.|410-502-7247|loebda@jhmi.edu|
22448880|NCT00641862|Harvard T.H. Chan School of Public Health|Dr. Christopher Duggan|617-355-7612|christopher.duggan@childrens.harvard.edu|
22448881|NCT03033511|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22448882|NCT03141242|University of Colorado|Hillary Lum, MD, PhD|3037241911|hillary.lum@cuanschutz.edu|
22448883|NCT02409459|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610.650.4200|mfalone@luitpold.com|844
22448884|NCT03311659|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22448885|NCT01176266|Alexion Pharmaceuticals, Inc.|Director of Clinical Trials|475-230-2596|ClinicalTrials@alexion.com|
22448886|NCT01179477|Abbott|Clay Cohorn, Clinical Program Director|972-309-8087|clay.cohorn@abbott.com|
22448887|NCT00189228|University of New Mexico Health Sciences Center|Dr. Mark Schuyler|5059254197|mschuyler@salud.unm.edu|
22448888|NCT04327388|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22448889|NCT00728130|Simmons Cancer Institute at Southern Illinois University School of Medicine|Director of Clinical Trials|217-545-1946|krobinson@siumed.edu|
22448890|NCT02730299|Gamida Cell|Associate Director, Clinical Operations|+972-073-2064774|aurelie@gamida-cell.com|
22448891|NCT04053023|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22448892|NCT03447990|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22448893|NCT03755414|Washington University School of Medicine|Dr. Ramzi Abboud|314-454-8304|rabboud@wustl.edu|
22448894|NCT02153112|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22448895|NCT00423150|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22448896|NCT00862446|Vanderbilt University Medical Center|William Walsh|615-322-3476|bill.walsh@vumc.org|
22448897|NCT05104567|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
22448898|NCT01464346|Medtronic Diabetes Clinical Research|Pamela Haworth||pamela.c.haworth@medtronic.com|
22448899|NCT03999892|Johns Hopkins|Gail Daumit|410 614 6460|gduamit@jhmi.edu|
22413372|NCT02763865|Medical University of South Carolina|Gonzalo REvuelta|843-792-7262|revuelta@musc.edu|
22413373|NCT00696020|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22413374|NCT00267644|Maimonides Medical Center|Dr. Eitan Dickman, MD; Principal Investigator|718-283-6057|edickman@maimonidesmed.org|
22413375|NCT03687736|Q-Med AB|Clinical Project Manager|(817) 961-5000|aestheticclinicaltrials@galderma.com|
22413376|NCT02511782|Cincinnati Children's Hospital Medical Center|Pooja Khandelwal, MD|513-803-4762|Pooja.Khandelwal@cchmc.org|
22413377|NCT01536574|GlaxoSmithKline|GSK Response Center|866-435-7343||
22413378|NCT02514122|University of Saskatchewan|Dr. William P. McKay|1 306 655 1202|bill.mckay@usask.ca|
22413379|NCT03541941|Cleveland Clinic Foundation|Dr. Michael Rosen|216-445-3441|rosenm@ccf.org|
22413380|NCT01472341|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22413381|NCT00579670|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22413382|NCT00112463|Wake Forest School of Medicine|Dr. Doug Case|336-716-1048|dcase@wakehealth.edu|
22413383|NCT03506386|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22413384|NCT00296647|UW-Center for Tobacco Research and Intervention|Stevens Smith, PhD|608-262-7563|sss@ctri.medicine.wisc.edu|
22413385|NCT01863745|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22413386|NCT01157091|City of Hope|Dr. Sumanta Pal|626-359-8111|SPal@coh.org|
22413387|NCT03865654|Dana-Farber Cancer Institute|Rachel Freedman, M.D., M.P.H.|617-632-3800|rafreedman@partners.org|
22448900|NCT01848756|Esanex Inc|Eric Orlemans, Chief Scientific Officer|919-338-2019|eorlemans@esanexpharma.com|
22448901|NCT01286012|Rockwell Medical|Raymond Pratt, MD CMO|248 960 9009|rd@rockwellmed.com|
22448902|NCT00827983|IBSA Institut biochimique|Clinical trial manager|+41583601000|barbara.cometti@ibsa.ch|
22448903|NCT04056195|Oscotec Inc.|Sungsil Lee/Team Leader of Clinical Development|+82316287624|sslee@oscotec.com|
22448904|NCT01498458|University Hospital Heidelberg|Dr. Andreas Schneeweiss|+49 (0)6221 56 36051|andreas.schneeweiss@med.uni-heidelberg.de|
22448905|NCT02226003|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22448906|NCT01876485|Department of Veterans Affairs|Dr. LeChauncy Woodard|(713) 440-4441|woodard.lechauncy@va.gov|
22448907|NCT05734443|Virginia Tech|Michael Madigan|5402313543|mlm@vt.edu|
22448908|NCT03279692|Massachusetts General Hospital|Priscilla Brastianos, MD|617-724-8770|pbrastianos@partners.org|
22448909|NCT02446990|Institut de Recherches Internationales Servier (I.R.I.S.)|Therapeutic Innovation Pole|+33155724366|clinicaltrials@servier.com|
22448910|NCT01064401|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22448911|NCT04439253|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22448912|NCT01280552|ImmunoCellular Therapeutics Ltd.|Anthony Gringeri, Ph.D. Senior Vice President Strategic Resources|818 264 2300|anthony.gringeri@imuc.com|
22448913|NCT00887354|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22448914|NCT00824044|Massachusetts General Hospital|Dr. Amy Farabaugh|617-726-1629|afarabaugh@partners.org|
22448915|NCT00192504|MedImmune, LLC|Genevieve A. Losonsky, MD/VP Clinical Development|301-398-0000|losonskyG@medimmune.com|
22448916|NCT02974296|Columbia University|DR. Marta Moreno-Ortega|9142187311|mm4355@cumc.columbia.edu|
22448917|NCT00542919|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22448918|NCT01010906|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22448919|NCT05123222|Center for Immunization Research|Anna Durbin|667-306-9772|adurbin1@jhu.edu|
22448920|NCT02535741|Stryker European Operations BV|Doug McGurty|+44(0)1635 500690|doug.mcgurty@stryker.com|
22448921|NCT03927612|Indiana University School of Medicine|Clinical Research Specialist|317-274-8670|vrlab@iupui.edu|
22448922|NCT03020823|Syncore|Dr. Lin|0227603688|JWLin@syncorebio.com|
22448923|NCT03739112|Medicago|Medical Director|+1 418-658-9393|clinicaltrialinquiries@medicago.com|
22448924|NCT03492099|Johns Hopkins University School of Medicine|Dr. Sophie Lanzkron|4105028642|slanzkr@jhmi.edu|
22448925|NCT00588822|Mayo Clinic|Dr. Benn E. Smith|480-301-6711|bsmith@mayo.edu|
22448926|NCT01948739|Rice University|Marcia K. O'Malley, PhD|(713) 348-3545|omalley@rice.edu|
22448927|NCT03054857|King Chulalongkorn Memorial Hospital|Dr.Yada Thongsuk|+66817738629|thongsuk.y@hotmail.com|
22448928|NCT01727141|Novartis Pharmaceuticals|Study Director|862-778-8300||
22448929|NCT01957462|Coloplast|Daniel Carter|+45 49222523|dkdac@coloplast.com|
22448930|NCT04855643|The University of Texas Health Science Center at Houston|Antonio L. Teixeira, MD, PhD, MSc|713-486-2555|Antonio.L.Teixeira@uth.tmc.edu|
22448931|NCT03102918|Beth Israel Deaconess Medical Center|Dr. Kevin Hill|617-667-1504|khill1@bidmc.harvard.edu|
22448932|NCT04765358|Jaeb Center for Health Research|Robin Gal|813-975-8690|rgal@jaeb.org|
22448933|NCT01652664|Alcon Research, Ltd.|Subha Venkataraman, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22448934|NCT01633892|University of Pittsburgh|J. Peter Rubin|412-624-9703|rubipj@upmc.edu|
22448935|NCT00491387|University of Cincinnati|Myron Gerson MD|5135583974|myron.gerson@uc.edu|
22448936|NCT02293655|Cincinnati Children's Hospital Medical Center|Tanya Froehlich, MD|5136361154|tanya.froehlich@cchmc.org|
22448937|NCT02004028|Verastem Oncology|Clinical Trials|+1-781-292-4204|clinicaltrials@verastem.com|
22413388|NCT01171963|GlaxoSmithKline|GSK Response Center|866-435-7343||
22400366|NCT00477087|Stanford University Medical Center|Sandy Srinivas, MD; Professor of Medicine (Oncology)|650-725-2078|sandysri@stanford.edu|
22400367|NCT00957853|UT MD Anderson Cancer Center|Dr. Maura Gillison, PHD/Professor, Thoracic-Head & Neck Med Onc|713-792-6363|mgillison@mdanderson.org|
22400368|NCT00518349|NorwegianDohsa|Dr. Geir Hoff|+4791866762|hofg@online.no|
22400369|NCT03871491|RTI International|Elizabeth McClure|919-316-3773|mcclure@rti.org|
22400370|NCT05202808|RxSight, Inc.|Director, Clinical Trials|9494215463|dgoffredo@rxsight.com|300
22400371|NCT04996797|Merck Sharp and Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22400372|NCT02793544|National Marrow Donor Program/BeTheMatch|Steve Spellman|763-406-8334|sspellma@nmdp.org|
22400373|NCT04174599|Evivebiotech|Catrina Wang|021-61760866|catrina.wang@evivebiotech.com|
22400374|NCT01701622|University of Mississippi Medical Center|Debbie Minor|601-984-6888|DMinor@umc.edu|
22400375|NCT05087030|Gedeon Richter Plc.|Medical Information Scientific Service|+36 1 505 70 32|medinfo@richter.hu|
22400376|NCT02722044|Momenta|Jim Jin|+16173954905|jjin@momentapharma.com|
22400377|NCT04640766|NYU Langone Health|Lenard Adler, MD|212-263-3580|Lenard.Adler@nyulangone.org|
22400378|NCT00609622|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22400379|NCT00825370|Department of Emergency Medicine, Albert Einstein College of Medicine|Andrew Chang, MD, MS|7189207464|achang@montefiore.org|
22400380|NCT01237951|UT MD Anderson Cancer Center|Dr. Nieto, Yago, M.D./Stem Cell Transplantation|713-792-2466|ynieto@mdanderson.org|
22400381|NCT01708057|AstraZeneca|Carin Jorup||aztrial_results_posting@astrazeneca.com|
22400382|NCT00682630|Shin Poong Pharmaceutical Co., Ltd.|Jansik Shin|+82-2-2189-3468|jsshin@shinpoong.co.kr|
22400383|NCT03481270|Stanford University|Marcella Alsan, Associate Professor of Medicine|(650) 721-1352|malsan@stanford.edu|
22400384|NCT02970929|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1 866-503-6351|clinicaltrialdisclosure@sunovion.com|
22400385|NCT00291343|GlaxoSmithKline|GSK Response Center|866-435-7343||
22400386|NCT00666562|University of Wisconsin|Howard H. Bailey|608-263-8624|hhbailey@wisc.edu|
22400387|NCT01946516|SWOG Statistics and Data Management Center|Cancer Care Delivery Committee Statistician|2066674623|karnold@fredhutch.org|
22400388|NCT00000479|Brigham and Women's Hospital|Julie E. Buring|617 732 4965|jburing@rics.bwh.harvard.edu|
22400389|NCT01024244|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22400390|NCT03285529|Cleveland Clinic|Viktor Krebs|216-444-2600|krebsv@ccf.org|
22400391|NCT02811744|Univerisity of Pennsylvania|Erin Schubert|215-573-6569|erin.schubert@pennmedicine.upenn.edu|
22400392|NCT04101890|Children's Research Institute|Elena Gibson|(202) 476-6877|egibson@cnmc.org|
22400393|NCT01896232|Amgen Inc.|Study Director|866-572-6436||
22400394|NCT00686205|Abbott Diagnostics Division|Peggy Moreno|847-937-2044|Peggy.Moreno@abbott.com|
22400395|NCT01697215|Cleveland Clinic Foundation|Adriano Tonelli, MD|216-444-0812|tonella@ccf.org|
22400396|NCT02945657|Medimetriks Pharmaceuticals, Inc.|Director of Clinical Development|973-882-7512|clinicaltrials.gov_inquiries@medimetriks.com|524
22400397|NCT01588821|Massachusetts General Hospital|Rebecca Suk Heist, MD|617-724-4000|rheist@partners.org|
22400398|NCT03932240|Emory University|Laura Downey, MD|404-785-6670|laura.ansley.downey@emory.edu|
22400399|NCT03075839|Yale University|Krysten Bold|203-974-7603|Krysten.bold@yale.edu|
22400400|NCT02696083|Regenesis Biomedical|Clinical Operations Manager|602-428-7041|heather.vanderploeg@regenesisbio.com|
22400401|NCT02700529|Eiger BioPharmaceuticals, Inc.|Senior VP, Clinical Development|1-650-618-1621|info@eigerbio.com|
22400402|NCT05421754|Northwestern University|Shuai Xu|312-695-8106|stevexu@northwestern.edu|
22400403|NCT04433117|University of Kentucky|Dr. Mohanad Al-Sabbagh|859-257-3003|malsa2@email.uky.edu|
22400404|NCT01051739|Iowa City Veterans Administration Medical Center|Michael Wall, M.D.|319-3380581|michael-wall@uiowa.edu|
22400405|NCT00824421|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22400406|NCT02704104|Arch Therapeutics, Inc|Medical/Scientific Affairs|617 431-2313|jprats@archtherapeutics.com|
22400407|NCT03527043|Weill Cornell Medicine|Jonathan Gal|646-962-4811|jog4018@med.cornell.edu|
22400408|NCT02500550|Kiadis Pharma Netherlands B.V.|Andrew Sandler, MD / Chief Medical Officer|+1 206 779 9213|a.sandler@kiadis.com|
22400409|NCT02201940|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22400410|NCT00636818|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22400411|NCT02604264|Fresenius Medical Care North America|Jeffrey L. Hymes, MD|615-567-4821|Jeffrey.HymesMD@fmc-na.com|
22400412|NCT01511445|Amedica Corporation|Sonny Bal, MD|(573) 808-4512|SBal@amedica.com|
22400413|NCT02658461|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22400414|NCT02344576|University of Colorado School of Medicine|Dr. Larry Allen, Principal Investigator|303-724-4713|larry.allen@ucdenver.edu|
22400415|NCT02823457|GV Sonny Montgomery VAMC|Mary Jane Burton|6013624471|mary.burton2@va.gov|
22400416|NCT01243268|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22400417|NCT00397150|Centre for International Health, University of Bergen, Norway|Prof Thorkild Tylleskar|+47 55588562|Thorkild.Tylleskar@cih.uib.no|
22400418|NCT00702143|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22400419|NCT04091217|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22400420|NCT02901314|Cleveland Clinic|Nancy M. Albert, PhD, CCNS, CCHFN, CCRN, NE-BC, FAHA, FCCM, FHFSA, FAAN|216-444-7028|albertn@ccf.org|47028
22400421|NCT02495948|Alcon, A Novartis Division|Global Medical Affairs Brand Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22400422|NCT00100048|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22400423|NCT03878485|Washington University School of Medicine|Dr. Clifford Robinson|314-362-8567|clifford.robinson@wustl.edu|
22400424|NCT01822561|Tufts Medical Center|Andre Witkin|6176367950|awitkin@tuftsmedicalcenter.org|
22400425|NCT01624142|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22448938|NCT02063854|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22448939|NCT02419742|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22448940|NCT01701115|HSS|Dr. Daniel Maalouf|(212) 606-1000|MaaloufD@HSS.EDU|
22448941|NCT03002012|University of Minnesota|David Boulware|612-624-1966|boulw001@umn.edu|
22448942|NCT01413360|Seoul National University Hospital|Jung-Hwan Yoon|+82-2-2072-2228|yoonjh@snu.ac.kr|
22448943|NCT01628601|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22448944|NCT02246673|Study Information Center AstraZeneca|Jesse Hall, MD|+1 877-240-9479|information.center@astrazeneca.com|
22448945|NCT05413369|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22448946|NCT01335230|University of Cincinnati, Associate Prof., PI.|Mohamed Tarek M. shata|(513) 558-6110|mohamed.shata@uc.edu|
22448947|NCT01679002|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22448948|NCT00612924|Terumo|Amanda Isula, Clinical Research Coordinator|800-262-3304|amanda.isula@terumomedical.com|5549
22448949|NCT00730912|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22448950|NCT00545155|University of Rochester|Manish N. Shah|585-463-2920|manish.shah@rochester.edu|
22448951|NCT00525733|Aaron Diamond AIDS Research Center|Martin Markowitz MD|212-448-5020|mmarkowitz@adarc.org|
22448952|NCT02205333|MedImmune, LLC|Victoria Chiou|301-398-4330|chiouv@MedImmune.com|
22448953|NCT00455429|Janssen Research and Development, 3210 Merryfield Row San Diego, CA 92121|William Barchuk, M.D.|858-784-3111||
22448954|NCT04351087|The Ohio State University|Dr. Michael Baria|614-293-8196|michael.baria@osumc.edu|
22448955|NCT03519347|NYU Langone Health|David M Charytan, MD, MSc|646-501-9086|david.charytan@nyulangone.org|
22448956|NCT01412021|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22400426|NCT00667277|Icahn School of Medicine at Mount Sinai|Dr. Ronald Hoffman|(212) 241-2297|ronald.hoffman@mssm.edu|
22400427|NCT02747004|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22400428|NCT04826900|Chang Gung Memorial Hospital-Kaohsiung Medical Center, Kaohsiung, Taiwan|Jen-Wen Hung, MD|+886975056689|hung0702@cgmh.org.tw|
22400429|NCT01363050|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com|828
22400430|NCT03658954|Yale University School of Medicine|Lisa Fucito, PhD|(203) 200-1470|lisa.fucito@yale.edu|
22400431|NCT04885257|Birmingham VA Medical Center|Research Compliance Officer|205-933-8101|latanya.higginbottom@va.gov|336885
22400432|NCT00818259|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22400433|NCT02597062|Canadian Cancer Trials Group|Bingshu Chen|613-533-6000|bechen@ctg.queensu.ca|77703
22400434|NCT02863198|Benha university|dr khalid M Salama|01225861026|dr.khalid_sleem@yahoo.com|
22400435|NCT01053429|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22400436|NCT01697345|Creighton University|Dr. Melissa A Dahir|402-657-2847|melissadahir@creighton.edu|
22400437|NCT01976806|Beth Israel Deaconess Medical Center|Dr. Kenneth Mukamal|617-754-1401|kmukamal@bidmc.harvard.edu|
22400438|NCT04188730|USWM, LLC|Medical Affairs|1-888-900-8796|medinfo@usworldmeds.com|
22400439|NCT03929250|Oregon Health & Science University|Dr. Amala Soumyanath|503-494-6878|soumyana@ohsu.edu|
22400440|NCT01041248|Childrens Hospital of Eastern Ontario|Dr Johannes Roth|6137377600|jroth@cheo.on.ca|1015
22400441|NCT01523873|Guerbet|Corinne Dubourdieu, PharmD, Head of Clinical Projects and Medical Writing|+33 (0) 1 45 91 51 84|corinne.dubourdieu@guerbet-group.com|
22400442|NCT06119191|CooperVision, Inc.|Cameron Postnikoff|925-730-6734|postnikoff@coopervision.com|
22400443|NCT02108457|University of Pennsylvania|Lilie Lin, MD|215-662-6515|lin@xrt.upenn.edu|
22400444|NCT03551028|University of Virginia|Emma Mitchell|4342433962|emm6z@virginia.edu|
22400445|NCT01195025|University Hospital Linköping|Dr. Joachim Zdolsek|+46101030000|joachim.zdolsek@lio.se|
22400446|NCT02468193|Novartis PharmaCeuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22400447|NCT01485614|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22400448|NCT00942409|University of California, San Diego|Januario E Castro, MD|(858) 822-6600|jecastro@ucsd.edu|
22400449|NCT03537664|University of Sao Paulo|Dr. Ericka Pinheiro|551126488293|erickapinheiro@usp.br|
22400450|NCT03617926|Oystershell Laboratories|Frank Eertmans|+3293772485|fe@oystershell.be|
22400451|NCT01503021|Rockwell Medical, Inc|Senior Director, Clinical Research|248-960-9009|rd@rockwellmed.com|
22400452|NCT03941548|Concert Pharmaceuticals, Inc.|Colleen E. Hamilton|781-860-0045|AAclinicaltrial_inquiries@concertpharma.com|
22400453|NCT01012661|Merz Aesthetics, Inc.|Merz Aesthetics, Inc.|650-286-4041|clinicaltrials@merzaesthetics.com|
22400454|NCT01242111|BioMarin Pharmaceutical Inc.|BioMarin Medical Information Services|800-983-4587|medinfo@bmrn.com|
22400455|NCT00870688|Desitin|Lohmueller|0049(0)40-59101|lohmueller@desitin.de|373
22400456|NCT02015819|City of Hope Medical Center|Dr. Jana Portnow|6262189200|jportnow@coh.org|
22400457|NCT00987415|Duke University|Kevin Anstrom|919-668-8902|kevin.anstrom@dm.duke.edu|
22400458|NCT01315574|Massachusetts Eye and Ear Infirmary|Dr. Pedram Hamrah|617-573-6060|ophthalmologyclinicalresearch@meei.harvard.edu|
22400459|NCT01929083|Indiana University|Dr. James E Tisdale|317-880-5418|jtisdale@purdue.edu|
22400460|NCT02599402|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22400461|NCT01591005|University Hospital Ostrava|Prof. David Skoloudik, MD, Ph.D.|+420597375613|skoloudik@hotmail.com|
22400462|NCT01075087|Northwestern University|Gildasio De Oliveira MD,MS|312-472-3573|g-jr@northwestern.edu|
22400463|NCT00087438|Radition Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@gmail.com|
22448957|NCT02448654|Yale University|Elise E. DeVito, Ph.D./ Associate Research Scientist|203-737-4882|elise.devito@yale.edu|
22448958|NCT02155647|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22413389|NCT05093205|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22413390|NCT02519491|University of Ottawa Heart Institute|Dr. Benjamin Hibbert, Cardiologist|613-696-7000|bhibbert@ottawaheart.ca|
22413391|NCT03660839|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22413392|NCT02265783|Medtronic|Michael Luna-Victoria|3033052463|michael.luna-victoria@medtronic.com|
22413393|NCT00268905|Eisai|Prash Krishna, Study Director|888-422-4743||
22413394|NCT04510285|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian,MD|646-888-4186|janjigiy@mskcc.org|
22413395|NCT00870870|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22413396|NCT01406795|Stanford University|Rusty Hofmann|6507366096|lhofmann@stanfordhealthcare.org|
22413397|NCT01709474|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22413398|NCT00822926|Stanford University School of Medicine|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@stanford.edu|
22413399|NCT03897088|Sun Pharmaceutical Industries Limited|Head-Clinical Development|2266455645|clinical.trial@sunpharma.com|5689
22413400|NCT01874756|Indiana University|Dr. Alan Breier|3178808495|abreier@iupui.edu|
22413401|NCT01853553|University of Colorado|Dr. Michel Chonchol|303-724-7796|Michel.Chonchol@ucdenver.edu|
22413402|NCT03097783|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
22413403|NCT04320849|Duke University Medical Center|Dr. Jonathan Piccini|919-668-8049|jonathan.piccini@duke.edu|
22413404|NCT00699491|Washington University School of Medicine|Cynthia Ma, M.D., Ph.D.||cma@im.wustl.edu|
22413405|NCT03135834|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22413406|NCT02268500|University of Minnesota|Orly Vardeny, Associate Professor of Medicine|612.467.4586|ovardeny@umn.edu|
22413407|NCT00119379|University Hospitals Case Medical Center|Dr. Grace McComsey|216-844-2739|mccomsey.grace@clevelandactu.org|
22413408|NCT01312922|ANeuroTech|Dr. E. Buntinx, MD|+32 (0) 473 861 079|erik.buntinx@aneurotech.com|
22413409|NCT03262012|AstraZeneca|Paul M. Dorinsky, MD|1-877-240-9479|information.center@astrazeneca.com|
22413410|NCT01469546|University of Michigan Comprehensive Cancer Center|Dr. Francis Worden, M.D.|734-936-0453|fworden@umich.edu|
22413411|NCT02801877|Northwestern University|Mary Kwasny|312-503-2294|m-kwasny@northwestern.edu|
22413412|NCT02865122|Elgan Pharma Ltd.|Miki Olshansky, Chief Executive Officer|972-4-6098600|Miki@elganpharma.com|
22413413|NCT03325114|University of Rochester|Carrie Dykes|15852750736|carrie_dykes@urmc.rochester.edu|
22413414|NCT05665426|Zhejiang Chhinese Medicial University|Siyi Zheng|+86159 9008 8547|zsy980714@gmail.com|
22413415|NCT03857919|Sight Sciences|Tommie Rodriguez, Senior Clinical Research Manager|18186873310|trodriguez@sightsciences.com|
22413416|NCT04934722|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22413417|NCT06358820|Gaozhou People's Hospital|Shanshan Deng|13927596600|276531255@qq.com|
22413418|NCT01294787|Novartis Pharmaceuticals|Study Director|41 61 324 1111||
22413419|NCT01124175|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22413420|NCT00942968|Pfizer, Inc.|Pfizer ClinicalTrials.gov|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22413421|NCT01948258|SPD Swiss Precision Diagnostics GmbH/SPD Development Company Ltd|Dr Sarah Johnson, Head of Clinical and Regulatory Affairs|01234835486|sarah.johnson@spdspark.com|
22413422|NCT00834535|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22413423|NCT04408586|Mayo Clinic|Andres J. Acosta, M.D., Ph.D.|507-266-6931|Acosta.Andres@mayo.edu|
22413424|NCT00428298|Johns Hopkins UNiversity School of Medicine|Jennifer L. Payne MD|410-502-0050|jpayne5@jhmi.edu|
22413425|NCT03547622|Yale University|Theresa Babuscio Data Manager|203 737 5430|theresa.babuscio@yale.edu|
22413426|NCT00520130|National Cancer Institute|Dr. Steven Z. Pavletic|301- 402-4899|sp326h@nih.gov|
22413427|NCT01045096|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22413428|NCT01900691|Cook Research Incorporated|Alan Saunders, MDR, RAC; Manager, Biostatistics|765-463-7537|alan.saunders@cookmedical.com|321204
22413429|NCT01954394|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22413430|NCT00909610|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22413431|NCT01026623|Memorial Sloan Kettering Cancer Center|Dana Rathkopf|646-422-4379|rathkopd@mskcc.org|
22413432|NCT02422264|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22413433|NCT03021018|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22413434|NCT01032083|Imperial College London|Professor Thomas Barnes||t.r.barnes@imperial.ac.uk|
22413435|NCT00328926|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22413436|NCT02269657|Children's Hospital of Philadelphia|Saba Pasha, PhD|215-590-1815|pashas@email.chop.edu|
22413437|NCT03342157|Advocate Aurora Health|Dr. Bradley Gose|414-385-2590|bradley.gose@aah.org|
22413438|NCT02196766|Coopervision Japan|Taku Muraoka, OD, Director Professional Services Organization|81-3-5449-6619|taku.muraoka@jp.coopervision.com|
22413439|NCT03612960|Pennsylvania State University|Dr. Andrea Hobkirk|7175310003|ahobkirk@pennstatehealth.psu.edu|286415
22413440|NCT00834249|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22413441|NCT00834743|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22413442|NCT01534663|University Hospital Jena|Christian Schulze, MD, PhD|03641-9 32 41 04|christian.schulze@med.uni-jena.de|
22413443|NCT01643707|Medtronic|Sr Clinical Research Program Manager|+1 (651) 308 3608|jennifer.tinsley@medtronic.com|
22413444|NCT04112823|Montefiore Medical Center|Dr. Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
22413445|NCT01693523|UT MD Anderson Cancer Center|Dr. David Fogelman/ Associate Professor, GI Medical Oncology|832-710-7754|dfogelman@mdanderson.org|
22448959|NCT01675128|National Cancer Institute|Dr.Tim Greten|301-451-4723|gretentf@mail.nih.gov|
22448960|NCT04418999|Illinois College of Optometry|Jennifer Harthan|3129497249|JHarthan@ico.edu|
22448961|NCT02461225|Regulatory Insight, Inc.|Elvira Cawthon|6154475150|elvira@reginsight.com|
22448962|NCT03526458|University of Wisconsin, School of Medicine and Public Health, Department of Urology|Shuang Li|6082638336|lis@urology.wisc.edu|
22448963|NCT00484939|Hoffmann-La Roche|Medical Communications|800 821-8590||
22448964|NCT00735878|Dartmouth-Hitchcock Medical Center (DHMC)|Konstantin H. Dragnev, MD|(603) 650-6344|konstantin.h.dragnev@hitchcock.org|
22448965|NCT04404855|UT Health San Antonio|Michael Liss, MD|210-567-5676|liss@uthscsa.edu|
22448966|NCT01786954|Duke Eye Center|Dr Paul Hahn|919-684-5631|paul.s.hahn@duke.edu|
22448967|NCT01522365|Dentsply Sirona Implants|Director Center of Clinical Research, AnnaKarin Lundgren|+46 (0)31 376 30 00|clinicalresearchmolndal@dentsplysirona.com|
22448968|NCT00651755|University of Texas MD Anderson Cancer Center|Saroj Vadhan-Raj, MD / Professor||xzhou@mdanderson.org|
22448969|NCT02404285|Next Science|Matt Myntti PHD, President|9046474161|mmyntti@nextscience.org|
22448970|NCT02466555|University Hospitals Connor Integrative Health Network|Samuel Rodgers-Melnick, MT-BC, music therapist|216-844-7727|Samuel.RodgersMelnick@UHhospitals.org|
22448971|NCT01120756|VA Northern California|Anthony Chen, MD|925-372-2000|anthony.chen@va.gov|
22448972|NCT04026048|Memorial University of Newfoundland|Dr. Sheila Garland|(709) 864-4897|sheila.garland@mun.ca|
22448973|NCT03760146|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22448974|NCT00529542|Milton S. Hershey Medical Center|Richard S. Legro|717-531-8478|rsl1@psu.edu|
22448975|NCT03616899|Kala Pharmaceuticals, Inc|VP, Clinical Development|(781) 996-5252|Results011@kalarx.com|
22448976|NCT00445965|Memorial Sloan Kettering Cancer Center|Dr. Kim Kramer MD|212-639-6410|kramerk@MSKCC.ORG|
22448977|NCT03448185|University of Texas Southwestern Medical Center|Eriko Iwatate|214-648-3680|Eriko.Iwatate@UTSouthwestern.edu|
22448978|NCT02865915|Millendo Therapeutics US, Inc.|Director of Clinical Operations|734-845-9000|millendo@millendo.com|
22448979|NCT03578081|University of Alabama at Birmingham|Dr Rudolph M. Navari|205-975-2833|rnavari@uabmc.edu|
22448980|NCT06002958|University of North Carolina at Chapel Hill|Kelsey Ludwig, PhD|(919) 962-1401|kelsey_ludwig@med.unc.edu|
22448981|NCT05760300|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22448982|NCT00947297|Hyperion Therapeutics|Craig James|650-745 7840|craig.james@hyperiontx.com|
22448983|NCT00699972|Eisai Call Center|Eisai Inc.|888-422-4743||
22448984|NCT01545817|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22448985|NCT03752307|University of New Mexico|Corey Ford, M.D., Ph.D.|505-925-4124|cford@salud.unm.edu|
22448986|NCT05477875|University of Florida Oaks Eye Center|Yujia Zhou|3522652020|yzhou1996@ufl.edu|
22448987|NCT03989440|ReNetX Bio, Inc.|George D. Maynard, Ph.D., Study Director|2032088925|info@renetx.com|
22448988|NCT01955161|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
22448989|NCT04608500|Foamix Pharmaceuticals, Inc.|Iain Stuart, PhD.|1 800-775-7936|Iain.Stuart@foamix.com|
22448990|NCT01925404|RAND|Deborah Cohen|310 3930411|dcohen@rand.org|
22448991|NCT00706641|Hoosier Cancer Research Network, Inc.|Noah Hahn, MD|317-921-2050|jsmith@hoosiercancer.org|
22448992|NCT04782856|Uconn Health|Francesco S. Celi, MD, MHSc.|860-679-2715|celi@uchs.edu|
22448993|NCT01030523|Dentsply Sirona Implants|Manager of Global Clinical Research|+46313763500|ClinicalResearchMolndal@dentsplysirona.com|
22448994|NCT00426283|Cincinnati Children's Hospital Medical Center|Marc E Rothenberg|513-636-7177|rothenberg@cchmc.org|
22448995|NCT04475588|Biocon Biologics India Limited|Dr. Subramanian Loganathan|0802808|subramanian.l101@biocon.com|5466
22448996|NCT01327300|University of Florida|Dr. Baharak Moshiree|(352)273-8393|bmoshiree@med.miami.edu|
22448997|NCT01063764|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22448998|NCT00697515|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22448999|NCT02603432|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22449000|NCT01231581|GlaxoSmithKline|GSK Response Center|866-435-7343||
22449001|NCT05954052|University of Chicago|Karam Radwan, MD|7738346686|radwan@uchicago.edu|
22449002|NCT01649375|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22449003|NCT04939727|HealthPartners Institute|Dr. Rebecca Rossom|952-883-5466|Rebecca.C.Rossom@HealthPartners.com|
22449004|NCT01921829|University of Pittsburgh|Dr. Kelly Liang|507-269-7812|liangk@upmc.edu|
22449005|NCT00613028|Preston Robert Tisch Brain Tumor Center at Duke|David A. Reardon, MD|919-668-1409|reard003@mc.duke.edu|
22449006|NCT05394025|Center to Improve Veteran Involvement in Care (CIVIC), VA Portland Health Care System|Project Manager|503-220-8262|Holly.McCready2@va.gov|51856
22449007|NCT01316276|Insmed Incorporated|Kevin Mange (Senior VP, Clinical Development)|908-947-2651|kevin.mange@insmed.com|
22449008|NCT00605475|Novartis Pharmaceuticals|Study Director|862 778 8300||
22449009|NCT05469100|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22449010|NCT04098107|Children's Hospital of Philadelphia|Elliot Greenberg|215-590-1527|GREENBERGE@chop.edu|
22449011|NCT03538158|Weill Cornell Medicine|Chelsie Burchett|212-746-1417|cob2014@med.cornell.edu|
22449012|NCT03240679|Mayo Clinic|Dr. Kenneth K. Wang|507-284-2691|wang.kenneth@mayo.edu|
22449013|NCT02829463|Third Xiangya Hospital of Central South University|Dr. Jinshen He|8613517470997|jinshen.he@hotmail.com|
22449014|NCT00862810|Duke University Health System|Emmanuel Walter MD, MPH|919-620-5346|walte002@mc.duke.edu|
22449015|NCT04519645|Cares|UCB|+1-844-599-2273|UCBCares@ucb.com|
22449016|NCT02422745|Brigham and Women's Hospital; 900 Commonwealth Ave, 3rd fl.; Boston, MA 02215|COSMOS Study Director|1-800-633-6913|cosmostrial@partners.org|
22449017|NCT01335581|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22449018|NCT01899300|Asian Institute of Gastroenterology|Rajesh Gupta, MD|+91 4023378888|drrajeshgupta98@gmail.com|
22449019|NCT05517382|Yale University|Claudia-Santi Fernandes|203-785-2885|Claudiasanti.fernandes@yale.edu|
22413446|NCT03049215|Vanderbilt University Medical Center|Sharee Burkeen, Research Program Manager|(615) 875-7515|sharee.k.burkeen@vumc.org|
22413447|NCT01440283|St. Jude Children's Research Hospital|Chia-ho Hua, PhD|901-595-3610|chia-ho.hua@stjude.org|
22413448|NCT01196052|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22413449|NCT03603314|Sensorion|Director of Regulatory Affairs|+33467207720|contact@sensorion-pharma.com|
22413450|NCT00436553|Novartis Pharmaceuticals|Study Director|862 778-8300||
22413451|NCT02379247|University of Kansas Medical Center|Dr. Priyanka Sharma|9135886079|psharma2@kumc.edu|
22413452|NCT01382719|Palatin Technologies, Inc.|Jeffrey Edelson, MD, FRCPC|(609) 495-2200|jedelson@palatin.com|
22413453|NCT00064753|University of North Carolina at Chapel Hill|Dr. Myra Carpenter|9199429408|myra_carpenter@unc.edu|
22413454|NCT01346397|Boris Petrovsky research cener od surgery|Dr Michael Kaabak|+74992481344|kaabak@hotmail.com|
22413455|NCT02193880|University of Alabama at Birmingham|Tiffany D Hill|205-996-8023|tiffanydhill@uabmc.edu|
22413456|NCT01361048|UAB|Dr. Jane Schwebke|205-975-5665|schwebke@uab.edu|
22413457|NCT00830232|Dallas VA Medical Center|Dr. Carlos H Timaran|2148570336|carlos.timaran@va.gov|
22413458|NCT00672178|Duke University Medical Center|John Kirkpatrick, MD, PhD|919 668-7342|kirkp001@mc.duke.edu|
22413459|NCT02419937|United States Air Force|Dr. Matthew B. Carroll|228-376-3829|mcar100210@yahoo.com|
22413460|NCT01182415|Massachusetts General Hospital|Dr. Yi-Bin Chen|617-726-0187|YCHEN6@PARTNERS.ORG|
22413461|NCT01256684|Endoceutics|Director of Data Analysis|418-653-0033|celine.martel@endoceutics.com|215
22413462|NCT04121364|RevBio|Dr. Alan Pollack|9145226972|apollack@revbio.com|
22413463|NCT05452798|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22413464|NCT02587962|Medivir AB|Chief Medical Officer|+46854683100|info@medivir.com|
22413465|NCT00184600|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22413466|NCT00624065|GlaxoSmithKline|GSK Response Center|866-435-7343||
22413467|NCT01387022|CAPRISA|Head of Statistics and Data Management|+27 31 260 4392|nonhlanhla.yende@caprisa.org|
22413468|NCT02076022|University of Pittsburgh Plastic Surgery|Patsy Simon|412-648-9207|simopa@upmc.edu|
22413469|NCT01972204|Mirai Iryo Research Center|Tomoko Machida (Director)|81-3-3263-4801|machida@mirai-iryo.com|
22413470|NCT01536405|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22413471|NCT02024646|Bausch Health|Director of Clinical Trials|310-770-7750|anya.loncaric@bauschhealth.com|
22413472|NCT01844375|Faculty of Medicine siriraj Hospital|Dr.Mingkwan Wongyingsinn|6624197995|mingkwan.won@mahidol.ac.th|
22413473|NCT03195491|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22413474|NCT03627091|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22413475|NCT03496623|United Therapeutics|United Therapeutics Global Medical Information|240-821-1881|304perfectstudy@lungbiotechnology.com|
22413476|NCT02543203|The Ohio State University Nisonger Center|Dr. Jill Ann Hollway|614-688-3848|Jill.Hollway@osumc.edu|
22413477|NCT02729714|EvergreenHealth Medical Center|Dr. Daniel Burdick|4258993108|djburdick@evergreenhealthcare.org|
22413478|NCT00626548|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22413479|NCT00385593|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22413480|NCT00998374|Lenox Hill Hospital|Dr. Mitchell Roslin|212-434-3285|MRoslin@NSHS.edu|
22413481|NCT03125200|ADC Therapeutics|ADC Therapeutics|954-903-7994|clinical.trials@adctherapeutics.com|
22413482|NCT00720330|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org|
22413483|NCT02421952|Baylor College of Medicine|Dr. Mary Felberg|832-824-5800|mafelber@texaschildrens.org|
22413484|NCT02227121|Medtronic Cardiac Rhythm and Heart Failure|Griet Wouters|800-328-2518|MedtronicCRMtrials@medtronic.com|
22413485|NCT03041025|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22413486|NCT02963259|Abbott|Erika Ross|+19725268207|Erika.ross@abbott.com|
22413487|NCT02131129|IndianaU|Dr. Michael Francis|317-880-8495|mmfranci@iupui.edu|
22413488|NCT00539071|Northwestern University|Dr. Herbert Meltzer|(312) 503-0309|h-meltzer@northwestern.edu|
22413489|NCT00486863|Warren Alpert Medical School of Brown University, Lifespan Center for International Health Research|Jennifer Friedman, M.D., Ph.D|(401) 444-7449|jennifer_friedman@brown.edu|
22413490|NCT01811953|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22413491|NCT02110277|UConn Health|Dr.Molly Brewer|860-679-2100||
22413492|NCT00517530|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22413493|NCT03585790|IU School of Optometry|Pete Kollbaum|812-856-0108|kollbaum@iu.edu|
22413494|NCT04089735|AimMax Therapeutics Inc.|Chief Medical Officer|919-797-1146|admin@aimmaxrx.com|
22413495|NCT00773422|Yale School of Medicine|Sherry McKee, PhD|2037373529|sherry.mckee@yale.edu|
22413496|NCT00561834|Rocky Mountain Lions Eye Institute, Dept. of Ophthalmology|Dr. Naresh Mandava, M.D.|720-848-2500|Naresh.mandava@ucdenver.edu|
22413497|NCT04123548|Mallinckrodt|Medical Information Call Center|800-844-2830|medinfo@mnk.com|
22413498|NCT02956460|CooperVision|Jose Vega, O.D., MSc., FAAO|925-621-3761|JVega2@coopervision.com|
22413499|NCT00851877|UT Southwestern Medical Center|Director of Clinical Trial||ClinicalTrials@utsouthwestern.edu|
22413500|NCT02440711|University of Washington|Dr. Brian Hafner|206-685-0214|bhafner@uw.edu|
22413501|NCT00573066|Children's Hospital of Philadelphia|Athena Zuppa|267-426-7359|zuppa@email.chop.edu|
22413502|NCT04129346|Northwestern University Feinberg School of Medicine|Siobhan Phillips|312-503-4235|smphillips@northwestern.edu|
22413503|NCT05755282|Medline Industries, LP|Julie Miller|630-418-6891|jamiller@medline.com|
22413504|NCT02473718|University of Texas Southwestern Medical Center|Catherine Chen|214-648-9095|catherine.chen@utsouthwestern.edu|
22386723|NCT01756300|Biosense Webster, EMEA|Liesbeth Vanderlinden, Manager Clinical Research|+32(0)2 7463527|lvanderl@its.JNJ.com|
22413505|NCT00627016|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22413506|NCT04088760|Cincinnati Children's Hospital Medical Center|Rebecca Marsh, MD|(513) 803-1139|Rebecca.Marsh@cchmc.org|
22413507|NCT03025880|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
22413508|NCT01275586|Indiana University|Dr. Melissa Markel|317-944-4969|memarkel@iu.edu|
22386724|NCT04780581|IBSAL|Project manager|+34 923 29 11 00|uicec.coordinacion@ibsal.es|55779
22386725|NCT04678856|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
22413509|NCT01185548|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22386726|NCT03734029|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22413510|NCT00086996|SWOG Statistical Center|Study Statistician|206-667-4623||
22413511|NCT00234286|Birmingham VA Medical Center|Kathryn L. Burgio, PhD|205-558-7064|kburgio@uabmc.edu|
22413512|NCT01422538|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
22413513|NCT02770820|FHCRC|Dr. Aude Chapuis|2066674369|achapuis@fredhutch.org|
22413514|NCT00312663|WRAIR|James Cummings, MD|301-319-9312|james.cummings@us.army.mil|
22413515|NCT00376623|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22386727|NCT04633278|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22413516|NCT00524264|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
22413517|NCT00286754|Department of Veterans Affairs|Sundar Natarajan, MD, Staff Physician|212-686-7500|Sundar.Natarajan@va.gov|3287
22413518|NCT02661295|NYU Langone Health|Candace Grant, MD|516-663-0333|candace.grant@nyulangone.org|9054
22386728|NCT03705793|Washington University in St. Louis|Pawina JIramongkolchai, MD|314-362-5296|pawina@wustl.edu|
22386729|NCT05448014|Umeå University|Inga Dennhag, Associate Professor|+46706217414|inga.dennhag@umu.se|
22386730|NCT00447980|Neurotech USA, Inc.|Patricia Davis, Sr. Director of Clinical Operations|401.333.3880|p.davis@neurotechusa.com|
22386731|NCT02720068|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22386732|NCT02047500|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilson@thresholdpharm.com|
22386733|NCT03094052|University of California, San Francisco|Dr. A. Jo Chien, MD|(415) 885-7577|Jo.Chien@ucsf.edu|
22386734|NCT05002738|University of Colorado Anschutz Medical Campus|Eva Dindinger|3037242019|eva.dindinger@cuanschutz.edu|
22386735|NCT01773993|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22386736|NCT04664881|Mayo Clinic|Joerg Herrmann, M.D.|507-255-1267|Herrmann.Joerg@mayo.edu|
22386737|NCT05643196|NYU Langone Health|Wei Qi|212-961-4492|wei.qi@nyulangone.org|
22386738|NCT04868656|Durham VA Medical Center|Dr. Susan N. Hastings, MD, M.H.Sc|(919) 286-6936|susan.hastings@va.gov|
22386739|NCT01746979|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilson@thresholdpharm.com|
22386740|NCT05441683|Department of Periodontology, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China|Dr. Yan-Min Wu|+86-13757119560|wuyanmin@zju.edu.cn|
22386741|NCT05374538|VITRAC Therapeutics, LLC|Linda Paradiso, DVM, Chief Development Officer|713-898-8965|linda.paradiso@vitractherapeutics.com|
22386742|NCT03901534|Columbia University|Sanja Jelic, MD|212-543-8875|sj366@cumc.columbia.edu|
22386743|NCT06603766|faculty of medicine Benha University|Dr. Heba Morsy Saad El Din El Ganady|+201111211367|Heba.Aljanadi21@fmed.bu.edu.eg|
22386744|NCT04496752|Linus Health|Dr. Sean Tobyne|(617) 433-1777|stobyne@linus.health|
22386745|NCT04214418|Columbia University|Gulam Manji, MD, PhD|212-304-6357|gam2140@cumc.columbia.edu|
22386746|NCT04323397|Prince of Songkla University|Anucha Thatrimontrichai|66 74451257|tanucha@medicine.psu.ac.th|
22386747|NCT05334355|Montclair State University|Dr. Evan Matthews, Associate Professor|9736553948|matthewse@montclair.edu|
22386748|NCT05785130|ChangGung Memorial Hospital|Ya-Ching, Nien|+886 913112012|yaching79@cgmh.org.tw|
22386749|NCT03351998|University of Kansas Medical Center|John P. Thyfault|913-588-1790|jthyfault@kumc.edu|
22386750|NCT04494958|APICES|Juan Luis Sanz|91 816 68 04|juanluis.sanz@apices.es|112
22386751|NCT02624050|Milton S. Hershey Medical Center|Dr. Anthony Bonavia|717-531-6140|abonavia@pennstatehealth.psu.edu|
22386752|NCT03547271|Sanofi Pasteur|Trial Transparency Team|800-633-1610 ext: 6#|Contact-US@sanofi.com|
22386753|NCT04835363|University of Malaga|Garcia-perez, Patricia|+34 675447206|terapiaocupacional.patricia@gmail.com|
22386754|NCT06065735|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22386755|NCT03522298|Kazia|Jeremy Simpson|+61 400 410 974|jeremy.simpson@kaziatherapeutics.com|
22386756|NCT01992913|Corporal Michael J Crescenz VA Medical Center|Steven L. Sayers, Ph.D.|(215) 823-5196|steven.sayers@va.gov|
22386757|NCT05718687|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22386758|NCT05933772|CooperVision|Jose A. Vega,OD,MSc,FAAO|925-621-3761|jvega2@coopervision.com|
22386759|NCT05485935|Coloplast A/S|Malene Hornbak Landauro, Medical writer of Clinical strategies|+4549112057|dkmhla@coloplast.com|
22386760|NCT04093869|Duke University|Stephanie K. Mabe, MS|919-668-3555|stephanie.mabe@duke.edu|
22386761|NCT02325154|Hospital for Special Surgery, Anesthesiology|Dr. Sean Garvin|2126061036|GarvinS@hss.edu|
22386762|NCT03990883|Croma Pharma GmbH|Clinical Development - Head of Clinical Operations|+43 2262 684680|clinical.studies@croma.at|
22386763|NCT03801616|Cedars-Sinai Medical Center|Dr. Alice Chung|3104239331|alice.chung@cshs.org|
22386764|NCT02295891|Johns Hopkins University|Kristen Rodgers- Research Program Manager, Dept, of Thoracic Surgery|410-955-9047|kpelosk1@jhmi.edu|
22386765|NCT05109871|Liverpool University Hospitals NHS Foundation Trust|Richard Norris|0151529 2534|richard.norris2@liverpoolft.nhs.uk|
22386766|NCT04408755|Otsuka Pharmaceutical Development & Commercialization, Inc.|Clinical Transparency|08446878522|smb_clinicaltranspa@otsuka-us.com|
22386767|NCT00308997|Yale University School of Medicine|Ralph Hoffman, MD|203-688-9734|Ralph.Hoffman@yale.edu|
22386768|NCT06655818|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22386769|NCT03662022|Insitute of Tropical Medicine|Carolien Hoof|+32470102562|choof@itg.be|
22386770|NCT05275556|Verily|Dr. Scooter Plowman|650-861-9783|splowman@verily.com|
22386771|NCT05836012|HilleVax, Inc.|Astrid Borkowski, Chief Medical Officer|+1 (617) 213-6562|aborkowski@hillevax.com|
22413519|NCT00301366|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
22386772|NCT03248479|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22386773|NCT06017115|Universitat Internacional de Catalunya|Dr. Jordi Gargallo|+34 935 04 20 00|jgargallo@uic.es|
22386774|NCT03076021|University of Washington|Dr. Mary Hebert|206-616-5016|mhebert@u.washington.edu|
22386775|NCT03771612|UCLA|Naomi Eisenberger|3108494330|neisenbe@ucla.edu|
22413520|NCT01313273|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22413521|NCT01054586|GlaxoSmithKline|GSK Response Center|866-435-7343||
22413522|NCT02726581|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22413523|NCT02841033|Boston Medical Center|Vaishali Sanchorawala, MD|617-638-8213|vaishali.sanchorawala@bmc.org|
22413524|NCT01270503|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22413525|NCT02459951|Albert Einstein Healthcare Network|Nathaniel Mayer MD|215 663 6681|nmayer@einstein.edu|
22413526|NCT04786184|Columbia University|Annamaria Norweg, PhD|212-305-1651|amn2212@cumc.columbia.edu|
22413527|NCT02255097|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22413528|NCT04239872|University of Michigan School of Dentistry|Dr. Livia Tenuta|734-763-3703|litenuta@umich.edu|
22413529|NCT00783367|University of Pennsylvania, Clinical Research Unit, Lymphoma Group|Ellen Napier, CRNP|215.279.1972|Ellen.Napier@pennmedicine.upenn.edu|
22413530|NCT03956862|GB001, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.|GB001, Inc. Study Director|1-866-668-4083|ClinicalTrials@gossamerbio.com|
22413531|NCT01498120|UCB BIOSCIENCES GmbH|Clinical Trial Registries and Results Disclosure|40789+49 2173 48|clinicaltrials@ucb.com|15 15
22413532|NCT02294604|Shuang Ho Hospital, Taipei Medical University|Dr. Ka-Wai Tam|886-2-22490088|kelvintam@h.tmu.edu.tw|8860
22413533|NCT01118312|Johns Hopkins University|Razan Yasin|443-287-5796|ryasin1@jhu.edu|
22413534|NCT01975948|Dalhousie University, Department of Psychiatry|Dr. Bianca Lauria-Horner|902-473-5633|bianca.horner@dal.ca|
22413535|NCT01675765|Aduro Biotech, Inc.|Corporate Communications|510-848-4400|press@aduro.com|
22413536|NCT03965091|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
22413537|NCT02420210|University of Chicago|Theodore Karrison|773-702-9326|tkarrison@health.bsd.uchicago.edu|
22413538|NCT04060147|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22413539|NCT01534520|UPittsburgh|Dionne Best|412-641-5496|dbest@upmc.edu|
22413540|NCT00565448|sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22413541|NCT00193609|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22413542|NCT00302952|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22413543|NCT02979353|Vanderbilt University Medical Center|Sandra F Simmons, PhD, Principle Investigator|615-343-6729|sandra.simmons@vumc.org|
22413544|NCT00857623|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22413545|NCT04185909|Apyx Medical|Kari Larson, MBA, Sr. Director, Clinical Affairs|8012440058|kari.larson@apyxmedical.com|
22413546|NCT03435081|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22413547|NCT02601560|MedImmune, LLC|Richard George, MD, Director, Clinical Development|+1-301-398-5681|information.center@astrazeneca.com|
22413548|NCT02082392|New York State Psychiatric Institute|Bret Rutherford|6467748660|brr8@cumc.columbia.edu|
22413549|NCT00420238|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22413550|NCT04384978|DreamFace Technologies, LLC|President and CEO|7202015694|mmahoor@dreamfacetech.com|
22413551|NCT00214422|National Cancer Institute|Dr. Kevin Camphausen|240-760-6205|camphausen@nih.gov|
22413552|NCT03154658|University of Texas Southwestern|Anthony Machi M.D.|2146486400|anthony.machi@utsouthwestern.edu|
22413553|NCT02629094|National Institute of Allergy and Infectious Diseases|Hadigan, Colleen|+1 301 594 5754|hadiganc@mail.nih.gov|
22413554|NCT01993030|The Second Xiangya Hospital of Central South University|Dr. Li Qian|+86-13958104032|649418291@qq.com|
22413555|NCT03785548|TriHealth Inc.|Tiffanie Tam, Md|513-463-4300|Tiffanie_Tam@trihealth.com|
22413556|NCT01033565|University of Nebraska|Howard Needelman MD|402-559-4097|hneedelm@unmc.edu|
22413557|NCT01819597|Cedars-Sinai Medical Center|Nestor Gonzalez, MD. Professor of Neurosurgery|310 423 0783|nestor.gonzalez@cshs.org|
22413558|NCT00396279|Amgen Inc.|Study Director|866-572-6436||
22413559|NCT01199848|Illinois Institute of Techology|Britt Burton-Freeman|708-341-0178|bburton@iit.edu|
22413560|NCT01882257|University of Michigan Health System|Robert G. Sitrin, M.D.|(734) 936-5201|rsitrin@umich.edu|
22413561|NCT00830206|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22413562|NCT01832259|Huntsman Cancer Institute / University of Utah|Josiah Lyn Hawks|801-585-0601|Josiah.Hawks@hci.utah.edu|
22413563|NCT00487565|DePuy Orthopaedics, Inc.|Tammy O'Dell|574-372-7104|TOdell2@its.jnj.com|
22413564|NCT00905346|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22413565|NCT03351335|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
22413566|NCT02337218|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
22413567|NCT02736721|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22413568|NCT02996591|Hospital for Special Surgery|George Birch|2127747377|birchg@hss.edu|
22413569|NCT01530880|Columbia University|Michael Schmidt|212-305-8745|mjs2134@columbia.edu|
22413570|NCT01439880|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22413571|NCT00875550|Hospira|Marcelo Garcia de Rocha MD, Global Medical Director|224-212-4424|marcelo.rocha@hospira.com|
22413572|NCT00829673|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22413573|NCT00272779|Bristol-Myers Squibb|BMS Study Director||ClinicalTrials@bms.com|
22413574|NCT04089917|Department of Interventional Neuroradiology, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain|Mariano Espinosa de Rueda|+34 968 36 96 42|mm.espinosa@gmail.com|
22400464|NCT01486264|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
22400465|NCT00283387|Mayo Clinic|Dr. Dawn S. Milliner|507-284-7431|milliner.dawn@mayo.edu|
22400466|NCT05340504|Medical University of South Carolina|James J. Prisciandaro, Ph.D.|843-792-1433|priscian@musc.edu|
22400467|NCT03723447|Cedars-Sinai|Dr Karen Zaghiyan|(310) 289-9224|kzaghiyan@yahoo.com|
22400468|NCT01043640|Masonic Cancer Center, University of Minnesota|Dr. Paul Orchard|612-626-2313|orcha001@umn.edu|
22400469|NCT03068715|Stanford University|Dr. Nolan Williams|(650)800-6920|nolanw@stanford.edu|
22400470|NCT00728416|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22400471|NCT00117312|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
22400472|NCT01120626|Stanford University|Allan Reiss, MD|650-498-4538|reiss@stanford.edu|
22400473|NCT00509106|Cerexa, Inc.|Vice President, Clinical Sciences|(510) 285-9200|clinicaltrials@cerexa.com|
22400474|NCT01159262|Hospira|Marcelo Garcia de Rocha MD, Global Medical Director|224-212-4424|marcelo.rocha@hospira.com|
22400475|NCT05089708|Galderma|Clinical Scientist|+46184749000|reception.seupp@galderma.com|
22400476|NCT01697332|Brigham and Women's Hospital|Samuel Patz|6172780616|patz@bwh.harvard.edu|
22400477|NCT00594399|Durham VA Medical Center (GRECC/HSRD)|Miriam C. Morey, Ph.D.|919-286-0411|miriam.morey@va.gov|6776
22400478|NCT03293680|Fundación GECP|Eva Pereira|+34934302006|gecp@gecp.org|
22449020|NCT02591147|University of Iowa College of Dentistry|Dr. Justine Kolker|(319) 335-7583|justine-kolker@uiowa.edu|
22449021|NCT03886220|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22449022|NCT01340144|Colorado Joint Replacement|Raymond Kim, MD|720-524-1367|raymondkim@ccentura.org|
22449023|NCT00967993|Keryx Biopharmaceuticals Inc|Medical Information|1-844-44-KERYX (1-844-445-379|medicalinfo@keryx.com|
22449024|NCT00271947|Northwestern University|Dr Richard Burt|312-908-0059|rburt@northwestern.edu|
22449025|NCT03098173|Tokyo University|Dr. Ryota Niikura|+81-3-3815-5411|niikura-dky@umin.ac.jp|
22449026|NCT00698581|UCB|UCB Cares|+1 877 822 9493||
22449027|NCT00449644|Janssen Infectious Diseases - Diagnostics BVBA|Medical Leader|1 609 730-7768||
22449028|NCT01566461|Medtronic Endovascular Therapies|Arslan Malik, Sr. Clinical Research Manager||arslan.malik@medtronic.com|
22449029|NCT01997515|Rhode Island Hospital|Director of Research|401-444-4933|mark.kendall@lifesapn.org|
22449030|NCT05778786|Johnson & Johnson Vision Care, Inc. (JJVC)|Benjamin Straker|1-800-843-2020|bstraker@its.jnj.com|
22449031|NCT02075658|UCI Health Department of Urology|Clinical Research Coordinator|714-456-8176|yoonrh@uci.edu|
22449032|NCT02124863|vrije universiteit brussel|filip van ginderdeuren|+3224763916|filip.vanginderdeuren@telenet.be|
22449033|NCT02406651|Generon/Evive Biotech|Christina Tay|1-908-540-0816|christina.tay@evivebiotech.com|
22449034|NCT04595513|Cincinnati Children's Hospital Medical Center|Darcy A. Krueger, MD., PhD|513-636-4222|krueger_darcy@cchmc.org|
22449035|NCT01395329|University of Colorado|Dr. Christopher DeSouza|303-492-2988|desouzac@colorado.edu|
22449036|NCT00718328|Johns Hopkins University SOM (former employer during the study)|Neeraj Naval|9042026290|neerajnaval@gmail.com|
22449037|NCT00663052|Wyeth, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22449038|NCT00496756|University of Nebraska Medical Center|Ralph Hauke, MD|402-354-8124|rhauke@nebraskacancer.com|
22449039|NCT02946047|Mayo Clinic|Dr. Nathan Cummins|507-284-3747|Cummins.Nathan@mayo.edu|
22449040|NCT03615105|Memorial Sloan Kettering Cancer Center|Dr. Brian Shaffer, MD|646-608-3737|shaffeb1@mskcc.org|
22449041|NCT05041322|Spaulding Hospital Cambridge|Jason Hamner|6177585501|jhamner@mgb.org|
22449042|NCT01252940|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22449043|NCT01502423|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22449044|NCT04199117|University of Wisconsin School of Medicine and Public Health|Danielle McCarthy, Ph.D.|6082655949|demccarthy@ctri.wisc.edu|
22449045|NCT04383743|University of Washington|Dr. Petros Grivas|2066061943|pgrivas@uw.edu|
22449046|NCT05230693|Medical University of South Carolina|Ennis James, MD|843-792-3769|jamesw@musc.edu|
22449047|NCT04814433|NYU Langone Health|Thomas Calahan|929-455-5826|Thomas.Calahan@nyulangone.org|
22449048|NCT03939897|Washington University in St. Louis School of Medicine|Cynthia X. Ma, M.D., Ph.D.|314-362-9383|cynthiaxma@wustl.edu|
22449049|NCT03482791|Washington University School of Medicine|Gregory Vlacich, M.D., Ph.D.|314-362-8610|gvlacich@wustl.edu|
22449050|NCT01918761|Cecog|MD Christiane Thallinger|+43 1 409 77 25|office@cecog.at|
22449051|NCT01721330|Massachusetts General Hospital|Leah Feinberg|617-726-4651|lkfeinberg@mgh.harvard.edu|
22449052|NCT00296374|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22449053|NCT01816893|Brigham and Women's Hospital|Dr. Gail Kurr Adler|(617) 732-8742|gadler@bwh.harvard.edu|
22449054|NCT02747420|NYU Langone Health|Dr. Benjamin Brucker|+1 646 825 6300|Benjamin.Brucker@nyulangone.org|
22449055|NCT00798369|Novartis Pharmaceuticals|Study Director|862-778-8300||
22449056|NCT04307446|Tufts University|Nancy Baker|617 627 5562|nancy.baker@tufts.edu|
22449057|NCT05620576|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22449058|NCT02622828|University of Manitoba|Dr. Jacquie Ripat|204-789-3303|jacquie.ripat@umanitoba.ca|
22449059|NCT02666183|Case Western Reserve University|Sara L. Douglas, PhD, RN, Professor FPB School of Nursing|216-368-0702|sld4@case.edu|
22449060|NCT00666757|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22449061|NCT02130063|Pharmacosmos|Chief Medical Officer|+45 5948 5959|llt@pharmacosmos.com|
22449062|NCT02510794|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22449063|NCT01856790|Yale University School of Medicine|Dr. Jennifer Sherr|203-785-5831|jennifer.sherr@yale.edu|
22449064|NCT04091646|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
22449065|NCT00912990|Rady Children's Hospital San Diego|Dr. Sandeep Khanna|858-966-5863||
22449066|NCT03168464|Weill Cornell Medicine|Sharanya Chandrasekhar|646-962-3110|shc2043@med.cornell.edu|
22449067|NCT00634088|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22449068|NCT02438722|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|jmiao@fredhutch.org|
22449069|NCT02876900|Noven Pharmaceuticals|George Harb, MD, MPH - Executive Director, Clinical Development|1-551-233-2656|gharb@noven.com|
22449070|NCT04356963|University of Maryland School of Medicine|Dr. Nicholas Morris|410-328-4515|nicholas.morris@som.umaryland.edu|
22449071|NCT02285907|Purdue University|Dr. Heather Leidy|765-496-0184|hleidy@purdue.edu|
22449072|NCT01577758|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22449073|NCT00629499|Sarah Cannon Research Institute|Director, Breast Cancer Research|615-329-7274|asksarah@scresearch.net|
22449074|NCT02410954|University of California, San Francisco|Andrew Krystal, MD|(415) 476-7702|andrew.krystal@ucsf.edu|
22449075|NCT02653456|Ra Medical Systems, Inc.|Vice President of Regulatory Affairs and Quality Assurance|877-635-1800|vchester@ramed.com|207
22449076|NCT00791518|GlaxoSmithKline|GSK Response Center|866-435-7343||
22449077|NCT02488681|Medtronic|Micra CA Study Manager|800-328-2518|rs.micracontinuedaccess@medtronic.com|
22449078|NCT00720057|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22449079|NCT00006101|University of California, Irvine|Dr. Thomas Ahlering|(714) 456-6068|tahlerin@uci.edu|
22449080|NCT04949165|University of Minnesota|Protocol Manager for BLIS|(612)590-2697|telke001@umn.edu|
22400479|NCT01119040|University Hospitals Case Medical Center|Jeffrey Marks, MD/Principal Investigator|216-983-4930|jeffrey.marks@UHhospitals.org|
22449081|NCT04969224|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22449082|NCT02735551|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|5034940757|mccrimmo@ohsu.edu|
22449083|NCT04191382|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22449084|NCT04147455|Emory University|Dr. Kathryn Yount|404-727-8511|kyount@emory.edu|
22449085|NCT02701647|The Hong Kong Polytechnic University|Chloe Chung|2766|chloe.lh.chung@connect.polyu.hk|7092
22449086|NCT03054870|Cyclomedica Australia Pty Ltd|James McBrayer|+61 2 9541 0411|clinicaltrials@cyclomedica.com|
22449087|NCT02009046|PHI|Norman A. Constantine, Ph.D.|925-284-8118|nconstantine@berkeley.edu|
22449088|NCT00620828|Duke UMC|Michael Bolognesi, MD|919-668-4732|bolog002@mc.duke.edu|2
22449089|NCT01096810|Mount Sinai|Dr. Sundar Jagannath|2122417873|sundar.jagannath@mountsinai.org|
22449090|NCT01807897|VA Boston Healthcare System|Dr. Daniel Gottlieb|857-203-6175|daniel.gottlieb@va.gov|
22449091|NCT01172184|Kaohsiung veterans general hospital|Dr. Shih-Hung Hsiao|886-7-3422121|irb@vghks.gov.tw|1518
22449092|NCT00271609|National Cancer Institute, National Institutes of Health|Teri Kreisl, M.D.|301-402-3423|kreislt@mail.nih.gov|
22449093|NCT03341533|Mayo Clinic|Dr. Tatnai Burnett|507-538-5783|burnett.tatnai@mayo.edu|
22449094|NCT00643682|Boston Medical Center|Brian Jacobson, MD, Principal Investigator|6176386563|brian.jacobson@bmc.org|
22449095|NCT04311424|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22449096|NCT04039412|Zagazig University-Faculty of Human Medicine|Dr. Ayman Fathy Elsayed|+201125020593|aymanf28@yahoo.com|
22449097|NCT03168308|University of Texas Southwestern|Tiffany Moon, MD|4694195790|Tiffany.Moon@UTSouthwestern.edu|
22449098|NCT00003641|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012||
22449099|NCT01782664|GlaxoSmithKline|GSK Response Center|866-435-7343||
22449100|NCT04170348|CUIMC|Dr. Margaret T. Lee, Professor of Pediatric|212-305-6290|ml653@cumc.columbia.edu|
22449101|NCT00506155|University of Texas (UT) MD Anderson Cancer Center|Arlene Siefker-Radtke, MD/Associate Professor, Genitourinary Medical Oncology||CR_Study_Registration@mdanderson.org|
22449102|NCT01082965|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22449103|NCT03642717|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22449104|NCT02587065|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
22449105|NCT01559012|Città della Salute e della Scienza Ospedale Sant'Anna. Servizio di Medicina Interna|Dr. Aldo Maina M.D. Obstetric Medicine|0039011313|amaina@cittadellasalute.to.it|5735
22449106|NCT00946712|SWOG Statistics & Data Management Center|Lung Committee Statistican|2066675712|jmiao@fredhutch.org|
22449107|NCT04665050|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22449108|NCT00302458|Massachusetts General Hospital|Dr. Thomas Spencer|617-726-1731|spencer@helix.mgh.harvard.edu|
22449109|NCT00853723|UPittsburgh|Mara J Horwitz|4126922848|horwitz@pitt.edu|
22449110|NCT04248933|University of Maryland, College Park|Dr. Jessica Magidson|301-405-5095|jmagidso@umd.edu|
22449111|NCT02517996|Johns Hopkins University School of Medicine|Dr. Tola Fashokun|410-464-6641|bunmi_omo@hotmail.com|
22449112|NCT02642432|AbbVie|Global Medical Services|800-633-9110||
22449113|NCT02447081|Abbott|Ryan Gage, Senior Scientist|651 756 3334|Ryan.Gage@abbott.com|
22449114|NCT01787175|University of Utah Health Care System|Dr. Jonathan Nebeker|801-582-1565|Jonathan.Nebeker@hsc.utah.edu|2458
22449115|NCT02867709|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22449116|NCT01722240|Division of Endocrinology, Diabetes and Metabolism, State University of New York at Buffalo, 462 Grider St, Buffalo, NY 14215, USA|Dr. Paresh Dandona|7169574325|pdandona@kaleidahealth.org|
22449117|NCT03188094|NYU Langone Health|Jennifer Zanowiak|212 263 0485|Jennifer.Zanowiak@nyulangone.org|
22449118|NCT01894581|University of Colorado Denver|Dr. Alex Polotsky|303-724-2001|alex.polotsky@ucdenver.edu|
22449119|NCT03313804|University of Kentucky|Dr. John Villano|8593234405|jlvillano@uky.edu|
22449120|NCT03795298|Boston Scientific|Anne Cornaille|+1-800-227-3422|anne.cornaille@bsci.com|
22449121|NCT02059928|Health Partners|Dr. Ralph J Frascone|6512545304|ralph.j.frascone@healthpartners.com|
22449122|NCT00571259|Satellite Healthcare, Inc.|Veronica Legg, MS: Director of Research Business|360-607-6892|leggv@satellitehealth.com|
22449123|NCT03971695|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22449124|NCT00156533|University of Rochester|Wilfred Pigeon|585 275-3374|wilfred_pigeon@urmc.rochester.edu|
22449125|NCT01881230|Celgene|Anne McClain, Senior Manager Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
22449126|NCT05129488|Bausch & Lomb|Study Director|15853386399|robert.steffen@bausch.com|
22449127|NCT02515942|Alcon, A Novartis Division|WW Brand Medical Director Ophtha, GMA Ophthalmics|1-888-451-3937|alcon.medinfo@alcon.com|
22449128|NCT03616912|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22449129|NCT01723163|Durham Veterans Affairs Medical Center|Dr. Patrick Calhoun|919-286-0411|patrick.calhoun2@va.gov|7970
22449130|NCT01124604|Neuroscience Department, Clinical Science Department, R&D in Janssen Japan Chiyodaku, Tokyo 101-0065 Japan|Manager|+81-3-4411-5509||
22449131|NCT01859507|Cairo University. Department of Obstetrics and Gynecology|Abdelmaguid Ramzy|+201008606060|amramzy@gmail.com|
22449132|NCT01762943|University of North Carolina at Chapel Hill|Dr. Crystal Schiller|9199664810|crystal_schiller@med.unc.edu|
22449133|NCT00539838|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22449134|NCT01660893|University of Maryland|Dr. Sharon M. Gordon|410-706-1656|sgordon@dental.umaryland.edu|
22449135|NCT03090100|Janssen Research & Development, LLC|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22400480|NCT03322358|University of Pennsylvania|Heather Schofield|617-233-4775|hschof@wharton.upenn.edu|
22386776|NCT02360371|Johns Hopkins University School of Medicine|Dr. Kelly Dunn, Ph.D., MBA|410-550-2254|kdunn9@jhmi.edu|
22386777|NCT04731233|University of Florida|Dr. Charles G. Widmer|352-273-5696|widmer@dental.ufl.edu|
22386778|NCT05129501|University of Nebraska-Lincoln, Nebraska Center for Research on Children, Youth, Families, and Schools/Interpersonal Violence Research Laboratory|Katie M Edwards, PhD|402-472-2448|katie.edwards@unl.edu|
22386779|NCT01499368|Boryung Pharmaceuticals|Manager of Clinical Research|+82-2-708-8069|rainbowleo@boryung.co.kr|
22386780|NCT03092674|SWOG Statistics and Data Management Center|Leukemia Committee Statistician|2066674623|amoseley@fredhutch.org|
22386781|NCT01527188|Stallergenes|Michel Roux, Medical Director|+33 (0) 1 33 55 59 29 70|mroux@stallergenes.com|
22386782|NCT04626427|Becton Dickinson|Simon Lubek, Clinical Program Manager|+33 6 07 56 66 08|simon.lubek@bd.com|
22386783|NCT01553149|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22386784|NCT01265537|St. Paul's Hospital|Dr. Jagbir Gill|6046822344|JAGill@providencehealth.bc.ca|64706
22386785|NCT06202560|Institute of dermatology, Thailand|Chinmanat Lekhavat|+66 95-207-2870|chinmanat@gmail.com|
22386786|NCT04518943|VA Puget Sound Health Care System|Dr. Paul Hebert|(206) 277-4165|paul.hebert2@va.gov|
22386787|NCT03873805|City of Hope Medical Center|Dr. Tanya Dorff|626 218 8231|tdorff@coh.org|
22386788|NCT06408870|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22386789|NCT01144455|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilson@thresholdpharm.com|
22386790|NCT04993677|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22386791|NCT04174170|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
22386792|NCT00324415|AMC|Director, AMC Statistical Center|501-526-6712|jylee@uams.edu|
22386793|NCT04772534|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22386794|NCT04194450|University of British Columbia|Dr. Jonathan Little|(250) 807-9876|jonathan.little@ubc.ca|
22386795|NCT03718130|GenevaUSA.org|Elissa K. Thomas, Associate Director, Corporate Strategy|248-802-6095|ethomas@genevausa.org|
22386796|NCT05265871|Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, The First Affiliated Hospital of Guangzhou Medical University|Kefang Lai|18928868231|klai@vip.163.com|
22386797|NCT05875701|Novavax Inc.|Novavax Customer Service Center|1-844-Novavax (668-2829)|Clinicaltrials@novavax.com|
22386798|NCT02514915|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP, Clinical Research Manager|4126233272|stadtermanbm@upmc.edu|
22386799|NCT03910218|The University of Texas Health Science Center at Houston|Diane Santa Maria, DrPH|713-500-2187|diane.m.santamaria@uth.tmc.edu|
22386800|NCT05769634|Icahn School of Medicine at Mount Sinai|Allison C.Waters|(212) 523-8832|allison.waters@mssm.edu|
22386801|NCT00704769|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22386802|NCT04490356|Duke University Medical Center|Kathryn Starr, Ph.D.|919-660-7571|kathryn.starr@duke.edu|
22386803|NCT06664684|İstanbul Bilgi University|Dr. Tugce Ozlu Karahan|+90 212 311 5042|tugce.karahan@bilgi.edu.tr|
22400481|NCT02853760|University of Innsbruck, Department of Sport Science|Martin Niedermeier||martin.niedermeier@uibk.ac.at|
22386804|NCT00412607|Biosense Webster, Inc.|Karen Cropper, Manager, Clinical Operations|(800) 729-9010|Kcropper@its.jnj.com|8607
22386805|NCT00503971|Fundación GECP|Eva Pereira|+34 934302006|secretaria@gecp.org|
22386806|NCT04675034|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
22386807|NCT03201939|Vanderbilt University Medical Center|C. William Wester|6158750145|william.wester@vumc.org|
22386808|NCT04024059|Johns Hopkins University School of Medicine|Kenneth Silverman, Ph.D.|4436176051|ksilverm@jhmi.edu|
22386809|NCT05886452|Mann Eye Institute|Dr Phillip Brunson|17135802500|Phillip.Brunson@manneye.com|
22386810|NCT04177771|RxSight|Jeffrey Ha, VP Clinical Affairs|949-521-7870|jha@rxsight.com|
22400482|NCT00488631|Janssen Research & Development|Senior Director|215-793-7540||
22400483|NCT05300087|Intech Biopharm Ltd.|Sabina Chien|+886-2-7721-8877|sabina.i198@intechbiopharm.com|631
22400484|NCT01444300|Oregon Health & Science University|Dr. Michelle Cameron|503-218-1971|cameromi@ohsu.edu|
22400485|NCT03372941|Washington University School of Medicine|Stephen Liang|3017470750|syliang@wustl.edu|
22400486|NCT00741819|United Therpaeutics Corporation|Inhaled Treprostinil Program Head|919-485-8350|clinicalrecordsmanagment@unither.com|
22400487|NCT00686543|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22400488|NCT00752986|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22400489|NCT00924703|BioMarin Pharmaceutical Inc.|Debra Lounsbury/Sr Principle Scientist, Clinical Sciences|415-506-6348|Dlounsbury@bmrn.com|
22400490|NCT03040154|Children's Hospital Los Angeles|Joyce R. Javier, MD, MPH, MS|(323)669-2113|jojavier@chla.usc.edu|
22400491|NCT02382133|Barnes-Jewish Hospital|Dr. Marilyn Schallom|314-286-0835|marilyn.schallom@bjc.org|
22400492|NCT04906707|Emory University|Dr. Nadine Matthie|404-712-8449|nadine.matthie@emory.edu|
22400493|NCT01815957|UNewMexico|Bina Ahmed|505-272-7028|hkhawaja@salud.unm.edu|
22400494|NCT01106040|Navidea Biopharmaceuticals|Dr. Frederick Cope|614-793-7500|fcope@navidea.com|140
22400495|NCT01245647|University of Florida|Dr. Bob Cook|352-273-5869|cookrl@ufl.edu|
22400496|NCT03971721|The Ohio State University|Dr. Ulysses Magalang|(614) 293-4925|Ulysses.Magalang@osumc.edu|
22400497|NCT04429022|University at Buffalo|Dr Sarah Andres, PI|7163230631|seandres@buffalo.edu|
22400498|NCT04321343|POXEL|Director, Medical Operations|+33 (0)4 37 37 20 10|carole.thang@poxelpharma.com|
22400499|NCT03430310|The University of Alabama at Birmingham|Barbara Gower, PhD|205-934-4087|bgower@uab.edu|
22400500|NCT04984889|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22400501|NCT00045032|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
22386811|NCT02806726|Johnson & Johnson Surgical Vision, Inc.|Priya Janakiraman|1 714 2478628|djanaki1@its.jnj.com|
22413575|NCT03257722|Augusta University|Asha Nayak, MD|706-721-2505|anayak@augusta.edu|
22386812|NCT05073510|BlueDop Medical, Ltd.|Dr. Patrick Kelly|+1 605 521 9831|patrick@bluedopmedical.co.uk|
22413576|NCT02331394|Jewish General Hospita;|Goulnar Kasymjanova|514-340-8222|gkasymja@jgh.mcgill.ca|24312
22413577|NCT01371786|Sunovion|Respiratory Medical Director|1-866-503-6351||
22413578|NCT02865850|Akebia Therapeutics, Inc.|Clinical Trial Information Desk|+1 617-844-6128|trials@akebia.com|
22413579|NCT00552669|Centro de Estudios en Cardiologia Intervencionista|Alfredo Rodriguez, MD, PHD|541149648721|rodrigueza@sanatorio-otamendi.com.ar|
22449136|NCT03446040|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22449137|NCT00456521|Orexigen Therapeutics, Inc.|Senior Vice President, Head of Global Development|(858) 875-8600|Medinfo@Orexigen.com|
22386813|NCT05372042|University of Washington|Dr. Kristen Lindgren|206-658-8083|kpl9716@uw.edu|
22386814|NCT01612351|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22386815|NCT03512301|Psychology Software Tools, Inc.|Anthony Zuccolotto|412-449-0078|anthony.zuccolotto@pstnet.com|
22386816|NCT03779984|UTexasSouthwestern|David Mercier|214-645-3479|David.Mercier@utsouthwestern.edu|
22386817|NCT03363763|Aucta Pharmaceuticals, Inc.|Dr. Marie Tan|7329129575|Marie.Tan@auctapharma.com|
22386818|NCT05419856|4Moving Biotech|Odile Fleurot|03 20 11 80 30|odile.fleurot@4p-pharma.com|
22386819|NCT04819191|Johns Hopkins Bloomberg School of Public Health|Jennifer Wolff, PhD|(410) 502-0458|jwolff2@jhu.edu|
22386820|NCT04602611|Wake Forest|Danielle M Boselli|2017903385|Danielle.Boselli@AtriumHealth.org|
22386821|NCT04567316|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22386822|NCT02637609|Johns Hopkins Bloomberg School of Public Health|John FP Bridges|614-685-2543|john.bridges@osumc.edu|
22386823|NCT03884439|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22386824|NCT03250676|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22386825|NCT03839446|UPMC Hillman Cancer Center|Barbara M Stadterman, MPH, MSCR, CCRP|412-647-5554|stadtermanbm@upmc.edu|
22386826|NCT04281498|Icahn School of Medicine at Mount Sinai|Dr. John Mascarenhas|212-241-3417|john.mascarenhas@mssm.edu|
22386827|NCT04342260|University of North Carolina Lineberger Comprehensive Cancer Center|Amanda Gentry|(336) 655-7743|agentry@email.unc.edu|
22449138|NCT02596854|GE Healthcare|John Strohmeyer|609-865-7423|john.strohmeyer@ge.com|
22449139|NCT05853250|Cleveland Clinic|Nancy M. Albert, PhD, Associate Chief Nursing Officer|216-444-7028|albertn@ccf.org|47028
22449140|NCT00464568|GlaxoSmithKline|GSK Response Center|866-435-7343||
22449141|NCT00405587|Plexxikon Inc.|Dr. Henry Hsu|510-647-4000|hhsu@plexxikon.com|
22449142|NCT00390325|The Ohio State University Comprehensive Cancer Center|Manisha Shah, MD|614-293-8629|Manisha.Shah@osumc.edu|
22449143|NCT00507442|Millennium Pharmaceuticals, Inc|Dixie-Lee Esseltine, MD|(617) 679-7000||
22449144|NCT00930579|Columbia University|Dawn Hershman, MD|212-305-1945|dlh23@cumc.columbia.edu|
22449145|NCT04434131|University of New Mexico Health Sciences Center|Dr. Michelle Harkins|5052724751|mharkins@salud.unm.edu|
22449146|NCT02255981|Escuela Neijing|Researcher|5744211000|lhgut2001@gmail.com|
22449147|NCT02672423|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22449148|NCT02808130|Ondokuz Mayıs University Dentalfaculty Periodontology Dep.|Assoc Prof Muge Lutfioglu|+905063073738|mugelutfioglu@hotmail.com|
22449149|NCT01232920|Proctor Foundation, University of California San Francisco|Nisha Acharya|415-476-8131|nisha.acharya@ucsf.edu|
22449150|NCT01454570|James J Peters VA Medical Center|Dr. Ann Spungen - PI|718-584-9000|ann.spungen@va.gov|5420
22449151|NCT00885755|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22449152|NCT00325754|Harbo-UCLA Research and Education Institute|Richard Casaburi|310-22-8249|casaburi@ucla.edu|
22449153|NCT01334723|GlaxoSmithKline|GSK Response Center|866-435-7343||
22449154|NCT00151320|Weill Cornell Medicine|John Leonard, MD|646.962.2064|amr2017@med.cornell.edu|
22449155|NCT03836963|Edward Hines Jr. VA Hospital|Sandra Kletzel|708-202-5735|sandra.kletzel@va.gov|
22449156|NCT02625090|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
22449157|NCT04649164|Rush University Medical Center|Dr. Jori Fleisher|3125632900|jori_fleisher@rush.edu|
22449158|NCT02250443|Novartis Pharmaceutical|Study Director|862-778-8300||
22449159|NCT01549964|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22449160|NCT04916795|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22449161|NCT00499096|Department of Veterans Affairs|Dr. Amy M. Kilbourne, PhD, MPH|734-845-3502|Amy.Kilbourne@va.gov|
22449162|NCT02290821|Novartis Consumer Health|Clinical Research Director Pain, CH Clinical Research & Development Lead|+41225672574||
22449163|NCT01052207|CHOA/Emory|Dr. Kiran Hebbar|404-785-6135|khebbar@emory.edu|
22449164|NCT01110421|Janssen R&D US|Therapeutic Areas Director||ClinicalTrialDisclosure@its.jnj.com|
22413580|NCT00176306|University of Kentucky|Aaron Cook|8593239258|amcook0@email.uky.edu|
22449165|NCT02245841|Cleveland Clinic|Anthony Fernandez, MD, PhD|216-445-8776|fernana6@ccf.org|
22449166|NCT03343483|University of Rochester Medical Center|Dr. Kim Van Orden (PI)|585-275-5176|kimberly_vanorden@urmc.rochester.edu|
22449167|NCT01835743|Coughlin Foot and Ankle Clinic|Michael Coughlin, MD|208-367-3330|thefootmd@gmail.com|
22449168|NCT01488097|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|475-230-2596|clinicaltrials@alexion.com|
22449169|NCT00117559|VA Boston Healthcare System|Amy Silberbogen, Ph.D.|857-364-4797|amy.silberbogen@va.gov|
22413581|NCT04459585|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22449170|NCT02726074|Eisai Inc.|Eisai Korea Inc. Medical department|+82-2-3451-5539|h3-park@eisaikorea.com|
22449171|NCT00579826|University of Kansas Medical Center|Bruce F. Kimler, Ph.D.|913-588-4523|bkimler@kumc.edu|
22449172|NCT01748643|Ziekenhuis Oost-Limburg|Dr. Pascal Vanelderen|+3289325298|pascal.vanelderen@gmail.com|
22449173|NCT00454987|GlaxoSmithKline|GSK Response Center|866-435-7343||
22413582|NCT02098876|Northeast Georgia Health System|Habib Samady|770-297-3549|Habib.Samady@nghs.com|
22413583|NCT01263704|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22413584|NCT02566239|Oregon Health & Science University|Dr. Jeffrey Kaye|503 494 6695|kaye@ohsu.edu|
22413585|NCT01061866|National Institute of Neurology and Neurosurgery of Mexico|Julio Sotelo|5255-5652-8285|jsotelo@unam.mx|
22413586|NCT00252720|AstraZeneca|Niklas Berglind, GPS Atacand|+46 31 7766310|ClinicalTrialTransparency@astrazeneca.com|
22413587|NCT01314417|National Institutes of Health|H. Nida Sen, MD, MHSc, Principal Investigator, NEI|301-402-3254|senh@nei.nih.gov|
22413588|NCT01010542|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22413589|NCT01808794|Tufts University|Associate Vice Provost for Research Administration & Development|617-627-7000|tss@tufts.edu|
22413590|NCT01780870|Beth Israel Deaconess Medical Center|Dr. Christos Mantzoros|6176678633|cmantzor@bidmc.harvard.edu|
22449174|NCT02447133|Topcon|Charles Reisman|201-599-5283|CREISMAN@topcon.com|
22449175|NCT02951338|University Health Network|Avril Mansfield|416-597-3422|avril.mansfield@uhn.ca|7831
22413591|NCT03025945|Arizona Eye Consultants|Sean McCafferty, MD|520-327-3487|sjmccafferty66@hotmail.com|
22413592|NCT02819323|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
22430502|NCT00963638|William Beaumont Hospitals|Catherine Coleman, RN, BSN|248-655-5865|cjcoleman@beaumont.edu|
22449176|NCT00973479|Centocor, Inc.|Director Clinical Research|1-800-457-6399||
22449177|NCT05075850|Monteris Medical|Christa Seligman|(952) 463-7747|cseligman@monteris.com|
22449178|NCT04256785|Universidad de Granada|Dr. Elena Pita Calandre|+34 958246291|epita@ugr.es|
22449179|NCT01265849|CEL-SCI Corporation|John Cipriano, Senior VP Regulatory Affairs, Eyal Talor Chief Scientific Officer|(205) 586-6947|jcipriano@cel-sci.com|
22449180|NCT00362115|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22449181|NCT01170091|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22449182|NCT03194321|Cedars Sinai Medical Center|Dr. Stanley C. Jordan, MD|310-423-2641|sjordan@cshs.org|
22449183|NCT02188589|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
22449184|NCT00731770|Penn State University|Erin Banta|717-531-6525|ebanta@hmc.psu.edu|1
22449185|NCT00741039|Memorial Sloan Kettering Cancer Center|Dr. Susan Seo|212-639-3151|seos@mskcc.org|
22449186|NCT00878709|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
22449187|NCT00768300|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22449188|NCT02068222|AbbVie|Global Medical Information|800-633-9110||
22449189|NCT03525210|KU Leuven / UZ Leuven|Head of Leuven University Vaccinology Center|+32 16 321 078|luvac@kuleuven.be|
22449190|NCT03011307|Wake Forest University School of Medicine|Dr. James Eisenach|336-716-4182|eisenach@wakehealth.edu|
22449191|NCT03022292|Stein Eye Institute of UCLA|Dr. David Sarraf|310-825-7836|DSarraf@ucla.edu|
22449192|NCT05198843|University of Texas M D Anderson Cancer Center|Dr. Rachel Layman|(713) 745-8401|RLayman@mdanderson.org|
22449193|NCT00877058|Göteborg University|Professor Synneve Dahlin-Ivanoff (Research leader)|+46317865733|synneve.dahlin-ivanoff@gu.se|
22449194|NCT00567892|Washington University|Dr. Jay F. Piccirillo|314.362.8641|piccirilloj@ent.wustl.edu|
22449195|NCT02556333|National Institutes of Health, National Institute of Allergy and Infectious Diseases|Alice Pau, Pharm.D., Staff Scientist (Clinical)|301-451-3740|apau@niaid.nih.gov|
22381056|NCT01163149|Alexion Pharmaceuticals, Inc.|Director of Clinical Trials|475-230-2596|ClinicalTrials@alexion.com|
22381057|NCT01700530|University of Missouri|John P. Thyfault, PhD|573-874-9728|thyfaultj@missouri.edu|
22381058|NCT00696293|University of Pittsburgh|Jordan F. Karp, MD|412-246-6048|karpjf@upmc.edu|
22430503|NCT00101400|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22381059|NCT00578227|GlaxoSmithKline|GSK Response Center|866-435-7343||
22381060|NCT00980278|University of Michigan School of Dentistry|Dr. William Giannobile, Chair Department of Periodontics and Oral Medicine|734-763-2105|wgiannob@umich.edu|
22449196|NCT02485912|University of Oxford|Adrian V Hill, DPhil FRCP||vaccinetrials@ndm.ox.ac.uk|
22449197|NCT03722017|Tennessee Valley Healthcare System Nashville Campus|Amanda Mixon, MD MSPH MS|(615) 936-3710|amanda.mixon@va.gov|
22449198|NCT03181828|Children's National|Dr. Nicholas Ah Mew|2025452513|nahmew@childrensnational.org|
22449199|NCT01541969|University of Nottingham|Professor Deborah Hall, Professor of Hearing Sciences|+44 (0) 115 823 2600|deborah.hall@nottingham.ac.uk|
22449200|NCT01365507|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22449201|NCT01614990|Geriatric Research, Education and Clinical Center, VA Puget Sound Health Care System|Jose Garcia, MD, PhD|(206) 764-2984|jg77@uw.edu|
22449202|NCT05630274|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22449203|NCT00525174|Jaeb Center for Health Research|Raymond Kraker, MSPH|813-875-8690|pedig@jaeb.org|
22449204|NCT02255500|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
22449205|NCT03340337|Universidad Maimónides - Universidad Nacional Arturo Jauretche - Instituto Universitario de Ciencias de la Salud Fundación H.A. Barceló|Oscar Ronzio|+54-11-4905-1140|ronzio.oscar@maimonides.edu|
22449206|NCT01074164|Northwestern University Department of Dermatology|Mandy Browning|312-695-6829|mandybrowning2015@u.northwestern.edu|
22449207|NCT04254978|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22449208|NCT02449239|Sesen Bio, Inc.|Dr. Rachelle Dillon|204-296-6579|rachelle.dillon@sesenbio.com|
22449209|NCT03257631|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22449210|NCT02310919|UCSF Center for Reproductive Health|Dr. Yanett Anaya, Assistant Professor|832-654-8361|Yanett.anaya2@ucsf.edu|
22449211|NCT03244865|UF Health Department of Anesthesiology|Dr. Tammy Euliano|352-514-7460|teuliano@anest.ufl.edu|
22449212|NCT03509675|University of Washington|Stuart Taylor|206-221-3772|stuartt@uw.edu|
22449213|NCT00277212|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22449214|NCT00902564|H. Lundbeck A/S|Study Director|Email contact via|LundbeckClinicalTrials@lundbeck.com|Lundbeck
22449215|NCT03898349|VA|Vera Yakovchenko|7816873374|vera.yakovchenko@va.gov|
22449216|NCT03239470|DAIT/NIAID|Director, Clinical Research Operations Program|240-669-5064|DAITClinicalTrialsGov@niaid.nih.gov|
22449217|NCT01023581|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22449218|NCT02474199|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22449219|NCT02752191|UCLA|J. Paul Finn|(310) 825-5344|ohrpp@research.ucla.edu|
22449220|NCT04061694|Folktandvården Skåne AB|Björn Gjelvold|+46709467870|bjorn.gjelvold@gmail.com|
22449221|NCT02826681|American Regent, Inc.|Mark Falone|631.772.3544|mfalone@americanregent.com|244
22449222|NCT03314584|VAORD|Dr. Albert Leung|858-552-8585|ayleung@health.ucsd.edu|3331
22449223|NCT06134817|NYU Langone Health|Bedros Taslakian, MD|332-237-9866|Bedros.Taslakian@nyulangone.org|
22449224|NCT04345614|CalciMedica, Inc.|Sudarshan Hebbar, MD|8168387105|sudarshan@calcimedica.com|
22449225|NCT05230082|HealthPartners Institute Neuroscience Research Center|Amanda Herrmann, PhD|651-495-6363|Amanda.A.Herrmann@HealthPartners.com|
22449226|NCT03406858|Wayne State University/Karmanos Cancer Institute|Dr. Abhinav Deol|313-576-8093|deola@karmanos.org|
22449227|NCT06027866|Queen's University Belfast/Western Health & Social Care Trust|Carla McClintock|07706482050|cmcclintock02@qub.ac.uk|
22449228|NCT01378221|Heart and Diabetes Center North Rhine-Westphalia, Germany|Dr. Armin Zittermann|+49 5731 97|azittermann@hdz-nrw.de|1912
22449229|NCT04236804|University of Pittsburgh|Brian O'Connell|3023997506|oconnellb2@upmc.edu|
22449230|NCT04335279|Lady Davis Institute|Dr. Brett Thombs|514-340-8222|brett.thombs@mcgill.ca|25112
22449231|NCT01046682|UHospitalsCleveland|Grace McComsey, MC|216-844-3607|mccomsey.grace@clevelandactu.org|
22449232|NCT01794806|University of Iowa|Gustavo Avila-Ortiz|3193357241|gustavo-avila@uiowa.edu|
22400502|NCT02582658|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22449233|NCT05071183|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22449234|NCT02046148|GlaxoSmithKline|GSK Response Center|866-435-7343||
22449235|NCT06002347|Boise State University|Dr. Aida Midgett|2084261219|aidamidgett@boisestate.edu|
22449236|NCT03506373|Mayo Clinic Jacksonville|Asher Chanan-Khan, MD|904-953-2708|chanan-khan.asher@mayo.edu|
22449237|NCT00076687|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22449238|NCT04196140|Insulet Corporation|Dr. Trang Ly|9786007628|tly@insulet.com|
22449239|NCT00107198|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22449240|NCT02836600|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22449241|NCT01820416|Dept. of Communication Sciences & Disorders, University of Iowa|Shawn S Goodman|319-335-8700|shawn-goodman@uiowa.edu|
22449242|NCT04493060|Mayo Clinic|Dr. Robert R McWilliams|507-284-2511|mcwilliams.robert@mayo.edu|
22449243|NCT02939560|Medical University of South Carolina|McLeod F. Gwynette, MD|843-792-9162|gwynette@musc.edu|
22449244|NCT03340025|University of Alabama at Birmingham|Benjamin Greene, MD|205-801-7855|bjgreene@uabmc.edu|
22449245|NCT02420691|UT MD Anderson Cancer Center|Arvind Dasari,MBBS|713-792-2828|adasari@mdanderson.org|
22449246|NCT01852812|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22449247|NCT02149173|University of Washington|Hannah M Linden|206-606-2053|hmlinden@uw.edu|
22449248|NCT02449174|University of Texas School of Public Health|Dr. Herbert DuPont|713 500 9366|herbert.l.dupont@uth.tmc.edu|
22449249|NCT01293240|Alcon Research|Peter Bergenske|1-800-241-7629||
22400503|NCT02581995|Bayer AG|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22449250|NCT01520363|Hugo W. Moser Research Institute at Kennedy Krieger , Inc.|Dr. Sakkubai Naidu|443 923 2778|naidu@kennedykrieger.org|
22400504|NCT02770807|Quince Therapeutics (former Erydel SpA)|Irene Maccabruni, M.Sc.|+39 02 36504470|imaccabruni@quincetx.com|
22386828|NCT03142009|University of New Mexico College of Population Health|Dr. Nina Wallerstein|404-272-4173|nwallerstein@salud.unm.edu|
22386829|NCT04319887|Saluda Medical|Angela Leitner|651-208-4223|angela.leitner@saludamedical.com|
22386830|NCT03587805|LEO Pharma A/S|Clinical Disclosure|+45 44945888|disclosure@leo-pharma.com|
22386831|NCT03982186|Janssen Sciences Ireland UC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22386832|NCT01607853|Leo Pharma A/S|Clinical Trial Disclosure Manager|00 45 44 94 58 88|ctr.disclosure@leo-pharma.com|
22386833|NCT03008382|Virginia Commonwealth University|Dr. Thomas Chelimsky|(804) 628-4859|Thomas.Chelimsky@vcuhealth.org|
22386834|NCT06637774|University of Pittsburgh|James Coyle|4123836608|jcoyle@pitt.edu|
22386835|NCT05362474|University of Colorado Denver|Jessica Kendrick|303-724-4837|jessica.kendrick@cuanschutz.edu|
22386836|NCT04039113|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22386837|NCT00353496|Ipsen|Medical Director Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22386838|NCT02180867|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22386839|NCT05267639|Liberating Technologies, Inc.|Jen Johansson|774-233-0874|jen.johansson@liberatingtech.com|
22386840|NCT04732871|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22386841|NCT05787054|Catholic University of the Sacred Heart, Fondazione Policlinico Gemelli|Dr Alessandra Familiari|+393285887422|alessandra.familiari@policlinicogemelli.it|
22386842|NCT03109873|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Adam Luginbuhl|215-240-0748|adam.luginbuhl@jefferson.ed|
22386843|NCT00983307|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Maria Werner-Wasik|215 955-6702|maria.werner-wasik@jefferson.edu|
22386844|NCT05180539|Lehigh University|Lucy Napper|610 758 4689|lun214@lehigh.edu|
22386845|NCT00968149|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22386846|NCT02502266|NRG Oncology|Christopher Purdy on behalf of Austin Miller, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
22386847|NCT02719574|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22386848|NCT00113360|UT M. D. Anderson Cancer Center|James Yao, M.D./Associate Professor|713-792-2828|CR_Study_Registration@mdanderson.org|
22386849|NCT00124735|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22386850|NCT02467270|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22386851|NCT02988193|Optima Integrated Health|Gabriela Voskerician|6502233588|gxv4@case.edu|
22386852|NCT06102421|Second Faculty of Medicine, Charles University|Mgr. Jakub Katolicky|+420702088258|jakubkatolicky@gmail.com|
22386853|NCT02945800|Moffitt Cancer Center|Jonathan Metts, MD|813-745-5616|Jonathan.Metts@moffitt.org|
22386854|NCT02231749|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22386855|NCT05377411|University of Florida|Dr. Aprinda Queen|(352) 294-8990|aprinda.indahlas@phhp.ufl.edu|
22386856|NCT05030584|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22386857|NCT00410423|Thomas Jefferson University|Joanne Filicko-O'Hara, MD|215-955-8874|Joanne.Filicko@jefferson.edu|
22386858|NCT04107116|Stanford University School of Medicine|Manali I Patel, MD MPH MS|650-723-4000|manalip@stanford.edu|
22386859|NCT02532621|Phraxis, Inc.|Cindy Setum, PhD|612-801-6730|csetum@phraxis.com|
22386860|NCT05424718|Columbia University|Rebecca Schnall, PhD, MPH, RN-BC, FAAN, FACMI|212-342-6886|rb897@columbia.edu|
22386861|NCT04046549|Horizon Therapeutics USA, Inc.|Todd Wilson, DO|866-479-6742|clinicaltrials@horizontherapeutics.com|
22386862|NCT06059443|Columbia University School of Nursing|Dr. Rebecca Schnall|212-342-6886|rb897@cumc.columbia.edu|
22386863|NCT03520114|Wake Forest University|Sachin Nalin Vyas, MS,PhD|336-713-4098|svyas@wakehealth.edu|
22386864|NCT00709956|Actelion|Laila Rouault, M.D.|+ 41 61 565 8128|laila.rouault@actelion.com|
22449251|NCT03394768|Changi General Hospital|Serene Yeow, Senior Executive, Clinical Trials and Research Unit|+6581258267|serene_yeow@cgh.com.sg|+656426781
22449252|NCT00178841|Vanderbilt University Dermatology|John Zic, MD|615-322-6485|john.zic@vanderbilt.edu|
22449253|NCT02658136|Rigshospitalet|Dr Kiran Mirza|004535451442|KMIR0003@regionh.dk|
22449254|NCT03165110|Ascensia Diabetes|Jane Wallace|(574) 850-1467|jane.wallace@ascensia.com|
22449255|NCT01498952|MedImmune LLC|Mohammed Dar|+301-398-0000|information.center@astrazeneca.com|
22449256|NCT05533632|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22449257|NCT00304356|VA Houston|Daniel Musher|713-794-7386|daniel.musher@va.gov|
22449258|NCT01154218|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22449259|NCT01547000|University of South Florida|Tanya K. Murphy, MD, MS|813-974-2201|tmurphy@health.usf.edu|
22449260|NCT03019939|The University of Texas MD Anderson Cancer Center|Prithviraj Bose MD/Associate Porfessor|713-792-7747|PBose@mdanderson.org|
22449261|NCT01374087|Ipsen|Medical Director|use email|clinical.trials@ipsen.com|
22449262|NCT04690751|SK Life Science, Inc.|Executive Director and Head, Clinical Pharmacology|862-271-2645|vvashi@sklsi.com|
22449263|NCT01344161|Tehran University of Medical Sciences|Dr.Farzad Shidfar|09123082922|f-shidfar@tums.ac.ir|
22449264|NCT04364620|Alethia Biotherapeutics ULC|Dr. Julie Laurin, Vice-President, Drug Development|514-581-8125|julie.laurin@alethiabio.com|
22449265|NCT03336216|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22449266|NCT05005390|The University of Texas Health Science Center at Houston|Travis Markham, MD|713-500-6200|Travis.H.Markham@uth.tmc.edu|
22449267|NCT00922766|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22449268|NCT03856437|University of Maryland, College Park|Xiaoli Nan|301-405-0640|nan@umd.edu|
22449269|NCT00843713|University of California, San Francisco|Priscilla Hsue, MD|415-206-8257|Priscilla.Hsue@ucsf.edu|
22449270|NCT03483935|University of Dundee|Prof Charlotte Proby|+44 1382 383289|c.proby@dundee.ac.uk|
22400505|NCT01841632|University Hospital Regensburg|Prof. Dr. Marc-H. Dahlke, Ph. D.|+49941944|marc.dahlke@ukr.de|6809
22400506|NCT01167712|NRG Oncology|Linda Gedeon for Mark Brady, PhD.|716-845-1169|lgedeon@gogstats.org|
22400507|NCT01084252|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
22400508|NCT04909463|CommonSpiritHealth|Trenton Bradbury|7193730213|trenton_b1@yahoo.com|
22400509|NCT00853632|Edwards Lifesciences|Director of Clinical Affairs|949-250-2500|Aya_Westbrook@edwards.com|
22400510|NCT04364854|Medical University of South Carolina|Principal Investigator|843-876-8311|bonilha@musc.edu|
22400511|NCT04933812|Duke University|Dr. Sarahn Wheeler|919-668-5462|sarahn.wheeler@duke.edu|
22400512|NCT04493619|Opna Bio|Kerry Inokuchi|650-204-4065|info@opnabio.com|
22430504|NCT03701074|University of South Alabama|Ramachandra Bhat|2514151055|rbhat@health.southalabama.edu; rambhat79@gmail.com|
22430505|NCT01644331|Duke Clinical Research Institute|G. Michael Felker, MD|919-668-8919|Michael.Felker@duke.edu|
22430506|NCT03829514|Medical University of South Carolina|Misti Leyva|endo office|leyva@musc.edu|
22430507|NCT01339091|Durata Therapeutics|Michael Zelasky|203-871-4616|mzelasky@duratatherapeutics.com|
22430508|NCT01661595|University of Texas Medical Branch|Melinda Sheffield-Moore|409-772-8707|melmoore@utmb.edu|
22430509|NCT01500135|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22430510|NCT00661687|Bausch & Lomb Incorporated|Gerard Cairns|(585)338 - 5170|gerard.cairns@bausch.com|
22430511|NCT00912509|Cornea Research Foundation of America|Marianne O. Price, PhD|317-814-2990|mprice@cornea.org|
22430512|NCT05538728|Galderma Research and Development, LLC|Clinical Project Manager|817-961-5000|aestheticclinicaltrials@galderma.com|
22430513|NCT02593630|University of New England|Peter S. Millard, MD, Phd|2072992131|pmillard@mac.com|207
22430514|NCT01362530|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22430515|NCT01034657|Novartis|Study Director|862-778-8300||
22449271|NCT02681549|Harvey and Kate Cushing Professor of Medicine (Oncology) and of Dermatology; Director, Yale SPORE in Skin Cancer, Yale Cancer Center|Harriet Kluger, MD|(203) 200-6622|harriet.kluger@yale.edu|
22449272|NCT02658890|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22449273|NCT02404311|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22449274|NCT00159588|St. Olavs Hospital|Professor Knut Hagen|+47 95401579|knut.hagen@stolav.no|
22449275|NCT01797328|UHLinkopeing|Fredrik H Nystrom|+46101037749|fredrik.h.nystrom@liu.se|
22449276|NCT02098161|The University of Texas MD Anderson Cancer Center|Naveen Pemmaraju MD/ Associate Professor|713-792-4956|NPemmaraju@mdanderson.org|
22449277|NCT04896658|University of Maryland, Baltimore|Ashraf Badros, MD|410-328-1230|abadros@umm.edu|
22449278|NCT02864251|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22449279|NCT03970590|VA Bedford Healthcare System Center for Health Organization and Implementation Research|Sarah Cutrona, MD|781-687-2861|sarah.cutrona@va.gov|
22449280|NCT02532647|PAION UK Ltd|Trial Information||reg_paion@paion.com|
22449281|NCT02492269|Nationwide Children's Hosp.|Dr. Aymen Naguib|614-722-4200|Aymen.Naguib@nationwidechildrens.org|
22449282|NCT00755131|University of Naples Federico II|Prof. Carlo Vigorito, Director Cardiac Rehabilitation Unit, Federico II University|+39081746|vigorito@unina.it|2639
22449283|NCT04773158|Indiana University School of Medicine, Pediatrics|William E Bennett, MD|317-944-3774|webjr@iu.edu|
22449284|NCT03897179|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
22449285|NCT01480076|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22449286|NCT02503332|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
22449287|NCT04053101|Institut Bergonié|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33556333333|s.mathoulin@bordeaux.unicancer.fr|
22449288|NCT05694546|University of Maryland Baltimore|Cassidy Claassen|316-727-6185|cclaassen@ihv.umaryland.edu|
22449289|NCT02120950|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22449290|NCT02424383|Becton Dickinson|Sharon Christensen|612-757-0750|Sharon.Christensen@bd.com|
22449291|NCT03559179|HealthPartners Institute|Dr. Rebecca C Rossom|952-883-5466|Rebecca.C.Rossom@HealthPartners.com|
22449292|NCT03412084|University of Wisconsin - Madison|Dr. Kelli F Koltyn|608-263-6746|kelli.koltyn@wisc.edu|
22449293|NCT00177970|UPittsburgh|Dr. George Arnold|4126212334|arnoldgl@upmc.edu|
22449294|NCT02916563|Barbara Davis Center for Childhood Diabetes|Dr. Satish K. Garg|3037246713|satish.garg@ucdenver.edu|
22449295|NCT01928862|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22449296|NCT03869450|Q-Med AB|Clinical Project Manager|+4618 474 9000|reception.seupp@galderma.com|
22449297|NCT01752855|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22449298|NCT00703885|UCSD|Murray B. Stein MD, MPH|858-534-6451|mstein@ucsd.edu|
22449299|NCT01478321|Northwestern University|Karan Dixit, MD|312-695-1301|karan.dixit@northwestern.edu|
22449300|NCT00314574|Hoffman-LaRoche|Medical Communications|800-821-8590||
22449301|NCT02053753|Amgen Inc.|Study Director|866-572-6436||
22449302|NCT02439320|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22449303|NCT01505608|NMTRC|Giselle Sholler, MD|6162670335|genevieve.bergendahl@helendevoschildrens.org|
22449304|NCT03999411|University of Miami|Dr. Taghrid Asfar|305-243-3826|tasfar@med.miami.edu|
22449305|NCT01142310|UT Southwestern Medical Center|Dr. E. Sherwood Brown|214-645-6950|sherwood.brown@utsouthwestern.edu|
22449306|NCT03342742|"University of Colorado Denver | Anschutz"|Kristen Nowak|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
22449307|NCT01272830|Clinic Orthopaedic Center|Thomas Bear, MD|330-375-3906|kovacikm@summahealth.org|
22430516|NCT01517178|Bispebjerg Hospital|Tonny Karlsmark||tkar0002@bbh.regionh.dk|
22449308|NCT01251380|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22449309|NCT00751348|GlaxoSmithKline|GSK Response Center|866-435-7343||
22386865|NCT04079517|Karolinska Institutet|Per Hall|+4670750 2110|per.hall@ki.se|
22386866|NCT04940624|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22386867|NCT04479787|Abbott|Devyani Nanduri, Sr. Director, Clinical and Regulatory Affairs|+16698329450|Udoka.okaro@abbott.com|
22386868|NCT05648890|Thomas Bata Hospital, Zlin, Czech Republic|Dr. Klára Nekvindová|+420 577 552 280|klara.nekvindova@bnzlin.cz|
22386869|NCT05550636|Boehringer Ingelheim, Call Centre|Boehringer Ingelheim|18002430127|clintriage.rdg@boehringer-ingelheim.com|
22449310|NCT04383210|Elevation Oncology|Medical Information|+1-716-371-1125|medinfo@elevationoncology.com|
22449311|NCT03583996|HepQuant LLC|Elyse Handley|3037480524|elyse.handley@hepquant.com|
22449312|NCT02404350|Novartis Pharmaceuticals|Clinical Disclosure Office|+1 (862) 778-8300|Novartis.email@novartis.com|
22449313|NCT05389657|University of California, San Francisco|Erin Accurso|415-476-5139|erin.accurso@ucsf.edu|
22449314|NCT00743652|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22449315|NCT04503564|Capillary BioMedical, Inc.|Director of Clinical Affairs|949-317-1711|alayne.lehman@capillarybio.com|
22449316|NCT05237206|Alloplex Biotherapeutics|Dr. Sharron Gargosky, Chief Development Offier|+1 503-915-1400|sgargosky@alloplexbio.com|
22449317|NCT02457403|The Ohio State University|A James Hanje|614 293 6255|james.hanje@osumc.edu|
22449318|NCT01085097|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22449319|NCT06049043|KDHRC|Andrew Simkus, Research Analyst|7046073567|asimkus@kdhrc.com|
22449320|NCT05365750|Kaiser Permanente Colorado|Ingrid A Binswanger, MD, MPH|720-416-7104|ingrid.a.binswanger@kp.org|
22449321|NCT03089606|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat G. Canter MD MS ACRP-CP, Clinical Trial Analyst|(919) 962-0000|Melahat_Canter@med.unc.edu|
22449322|NCT00335972|Cleveland Clinic|Rafi Avitsian, M.D|(216)-444-9735|avitsir@ccf.org|
22449323|NCT00922883|NHLBI|Cynthia E Dunbar|301-496-5093|dunbarc@nhlbi.nih.gov|
22449324|NCT03965962|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22449325|NCT04017936|Virginia Commonwealth University|Dr. Jordana Kron, MD|804-828-7565|jordana.kron@vcuhealth.org|
22449326|NCT00651573|Cleveland Clinic Foundation|Daniel Sessler, MD|216-4444900|ds@or.org|
22449327|NCT04962009|Mati Therapeutics Inc.|Deepank Utkhede|778-991-3301|dutkhede@matitherapeutics.com|
22449328|NCT00944450|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22449329|NCT02154581|UT Health San Antonio|Research Compliance Coordinator-Senior|210-567-8554|NijlandK@uthscsa.edu|
22449330|NCT00403273|minneapolis VAMC|jasvinder singh|205-504-9559||
22449331|NCT00322335|GlaxoSmithKline|GSK Response Center|866-435-7343||
22449332|NCT02327429|University of Alberta|Catherine Chan|780-492-9939|cbchan@ualberta.ca|
22449333|NCT00589108|Mayo Clinic|Dr. Robert T. Trousdale|507-284-3663|trousdale.robert@mayo.edu|
22449334|NCT03256552|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
22386870|NCT03699163|Imperial College London|Professor George Hanna|02033122124|g.hanna@imperial.ac.uk|
22386871|NCT00630487|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22386872|NCT01976936|Columbia University|Mitchell S.V. Elkind, MD, MS, MPhil|212-305-1710|mse13@cumc.columbia.edu|
22386873|NCT00495677|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22386874|NCT01969916|University of Chicago|Victor Mor-Avi|773-702-7780|vmoravi@bsd.uchicago.edu|
22386875|NCT04632394|St George's University of London|Dr Michael Waight|020 8672 9944|m2110065@citystgeorges.ac.uk|
22386876|NCT05595213|BUCA School of Medicine, Endocrinology|Michael F Holick, PhD MD|(617) 358-6139|mfholick@bu.edu|
22386877|NCT01864538|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilso2112@gmail.com|
22386878|NCT02306161|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22386879|NCT05162586|Merck Healthcare KGaA, DarmstadtGermany, an affiliate of Merck KGaA,Darmstadt, Germany|Communication Center|6151-72-5200|service@emdgroup.com|+49
22386880|NCT04899778|Cedars-Sinai Medical Center|Dr. Melodie Metzger|310-423-7765|Melodie.Metzger@cshs.org|
22386881|NCT00982644|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22413593|NCT01783561|Neonatal Research Institute, Sharp Mary Birch Hospital for Women and Newborns|Anup Katheria, M.D.|858-939-4170|anup.katheria@sharp.com|
22386883|NCT02989662|Johns Hopkins University School of Medicine|Mary E McCaul, Ph.D.|4437225728|mmccaul1@jhmi.edu|
22386884|NCT06393127|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22386885|NCT02446600|NRG Oncology|Linda Gedeon for Austin Miller, PhD.|716-845-1169|Linda.Gedeon@roswellpark.org|
22386886|NCT00328783|Thomas Jefferson University|Rani Anne, MD|215-955-6045|Rani.Anne@jeffersonhospital.org|
22386887|NCT00357682|NICE|Prof Janusz A Z Jankowski|07968 479355|prof.jankowski@outlook.com|
22386888|NCT03660930|University of Washington|Lee Cranmer, MD, PhD|206-606-7439|ldcranme@fredhutch.org|
22386889|NCT03242915|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
22386890|NCT02752685|NYU Langone Health|Sylvia Adams, MD|212-731-5795|Sylvia.Adams@nyulangone.org|
22449335|NCT01012622|Janssen Korea MAF, Korea|Clinical Research Associate|82-2-2094-4837||
22449336|NCT01176292|Anderson Orthopaedic Research Institute|Dr. William Hamilton|703-619-4411|research@aori.org|
22449337|NCT00380393|GlaxoSmithKline|GSK Response Center|866-435-7343||
22449338|NCT01536496|Denver Health Medical Center|Ernest E. Moore|303.602.1817|Ernest.Moore@dhha.org|
22386891|NCT03333915|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22449339|NCT03865329|Mayo Clinic|Dr. Roberto Benzo|(507) 284-0561|Benzo.Roberto@mayo.edu|
22449340|NCT00265616|CHUV Lausanne|Dr Andrea O. Rossetti|+41 21 314 1190|andrea.rosseti@chuv.ch|
22449341|NCT04693585|University of California San Francisco|Nadia Diamond-Smith|415-353-4545|nadia.diamond-smith@ucsf.edu|
22449342|NCT03221595|Denver Health Medical Center|Research Coordinator|303-602-6213|Kiara.Leasia@dhha.org|
22449343|NCT01742338|Rutgers Robert Wood Johnson Medical School|Dr. Jeffrey L. Carson|732-235-7122|jeffrey.carson@rutgers.edu|
22449344|NCT00076011|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22449345|NCT04296006|University of Kentucky|Joshua Lile, Ph.D.|859-323-6034|jalile2@uky.edu|
22449346|NCT02855437|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Jeff Foster|205-996-6086|pjfoster@uabmc.edu|
22449347|NCT00278954|Bio Products Laboratory|Margaret Stratford Bobbitt|+44 20 8258 2288|Margaret.Stratford-Bobbitt@bpl.co.uk|
22449348|NCT00826800|Memorial Sloan Kettering Cancer Center|Dr. Leonard Saltz|646-888-4286|saltzl@mskcc.org|
22449349|NCT03760796|Johns Hopkins University School of Medicine|Dr. Seth Martin|(610) 331 - 3842|smart100@jhmi.edu|
22449350|NCT04343521|Emory University|Gonzalo Vazquez-Prokopec, PhD|404-727-4217|gmvazqu@emory.edu|
22449351|NCT02211131|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22449352|NCT05664490|University of California, San Francisco|Dr. Jennifer Velloza|9173923561|Jennifer.Velloza@ucsf.edu|
22449353|NCT03144180|Texas Tech University Health Sciences Center at El Paso|Associate Director of Ob/Gyn Research|9152155103|christina.bracamontes@ttuhsc.edu|
22449354|NCT03261947|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22449355|NCT03969992|Aerogen Pharma|David Durand, MD|510-928-2111|ddurand@aerogenpharma.com|
22449356|NCT00228917|GlaxoSmithKline|GSK Response Center|866-435-7343||
22449357|NCT03038815|Institute for Biomechanics ETH Zürich|Silvio Lorenzetti|078 608 14 84|sl@ethz.ch|
22449358|NCT02063737|Carolinas HealthCare System|Dr. Daniel Patterson|704-446-0433|Daniel.Patterson@carolinas.org|
22449359|NCT04372602|Washington University School of Medicine|John DiPersio, M.D., Ph.D.|314-454-8491|jdipersi@wustl.edu|
22449360|NCT04120974|Becton, Dickinson and Company|Sandra van Guldener, Director OUS Clinical Affairs|+31646900840|sandra.vanguldener@bd.com|
22449361|NCT00129129|GlaxoSmithKline|GSK Response Center|866-435-7343||
22449362|NCT03190889|The Ohio State University Wexner Medical Center|Nathaniel A. Bates|614-293-9013|nathaniel.bates@osumc.edu|
22449363|NCT00369512|University of Alabama at Birmingham|Eben Rosenthal, MD Department of Surgery Department|(205) 934-9714|erosenthal@uabmc.edu|
22449364|NCT02140567|Imperial College Healthcare NHS Trust in London, United Kingdom|Dr. Phang Boon Lim|+44|p.b.lim@imperial.ac.uk|(0)20 3313
22449365|NCT00867451|Cincinnati Children's Hospital Medical Center|Richard Gilman, Ph.D.|513-636-8172|richard.gilman@cchmc.org|
22449366|NCT02882854|Vanderbilt University Medical Center|Stephen Harvey, MD|(615) 936-3198|stephen.harvey@vumc.org|
22449367|NCT02039674|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22449368|NCT01358357|Sunovion Pharmaceuticlas Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
22400513|NCT01491958|The Ohio State University Comprehensive Cancer Center|Yvonne Efebera, M.D|614-293-3196|Yvonne.Efebera@osumc.edu|
22400514|NCT01385696|Almirall S.A.|Clinical Project Leader and Trial Manager|+34 93 291 3200||
22400515|NCT01695369|University of Houston, College of Optometry, TERTC|Jan Bergmanson, OD,PhD|713-743-1950|jbergmanson@uh.edu|
22400516|NCT03528681|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22400517|NCT00745030|Northwestern University|Angelica Marconi|312-503-1999|a-marconi@northwestern.edu|
22400518|NCT01756976|Haemonetics|Clinical Project Manager|781-356-9595|michael.dioguardi@haemonetics.com|
22400519|NCT02342171|Institute of Tropical Medicine|Prof. Dr. Johan van Griensven|+3232476426|jvangriensven@itg.be|
22400520|NCT02062177|Università Vita-Salute San Raffaele|Professor Testoni Pier Alberto|+390226432756|testoni.pieralberto@hsr.it|
22400521|NCT03518840|Loyola University Chicago|Colleen Fitzgerald, M.D., M.S.|708-216-3380|CFITZGERALD@lumc.edu|
22400522|NCT00920309|Yale University School of Medicine|Dr. Neera Dahl|203-785-4184|neera.dahl@yale.edu|
22400523|NCT00875420|Radius Health, Inc.|Program Director|(617) 551-4700|info@radiuspharm.com|
22400524|NCT01612793|electroCore LLC|Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
22400525|NCT00914628|AGC Biologics S.p.A|Anna Stornaiuolo|00390221277440|astornaiuolo@agcbio.com|
22400526|NCT00374556|Johns Hopkins University School of Medicine|Michael Smith, PhD, Associate Professor of Psychiatry, Director of Behavioral Medicine|410-550-7000|msmith62@jhmi.edu|
22400527|NCT00473694|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22400528|NCT00742781|Pennsylvania State University|Dr. Margherita Cantorna|814-863-2819|mxc69@psu.edu|
22400529|NCT01416181|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22400530|NCT01756157|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22400531|NCT01623466|Agile Therapeutics|Lisa Flood|609-683-1880|lflood@agiletherapeutics.com|
22400532|NCT02799381|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22413594|NCT03204539|UC Davis|Dr. Jonathan Ducore|916-734-3461|jmducore@ucdavis.edu|
22413595|NCT01658228|New York State Psychiatric Institute|Dr. Davangere Devanand|646-774-8658|dpd3@cumc.columbia.edu|
22449369|NCT00368654|Kaiser Permanente (Current), UC Davis (Previous)|Chai Sue Lee||lam.nguyen@ucdmc.ucdavis.edu|
22449370|NCT03774433|Dartmouth College|Dr. Lisa Marsch|603-646-7092|Lisa.A.Marsch@dartmouth.edu|
22449371|NCT00108160|VA Ann Arbor Healthcare System|Suzanne F. Bradley, M.D.|734-845-5820|sbradley@umich.edu|55826
22449372|NCT02081079|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22449373|NCT00768144|Dana-Farber Cancer Institute|Susana M. Campos, MD, MPH|617-632-5269|susana_campos@dfci.harvard.edu|
22449374|NCT01712854|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu|
22449375|NCT01150123|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
22449376|NCT02171260|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22449377|NCT01347541|University of Washington School of Medicine|Dr, Douglas Zatzick|206-744-6701|dzatzick@uw.edu|
22449378|NCT05821842|Sound Health Systems, Inc.|Paramesh Gopi|313-509-8237|pgopi@soundhealth.life|
22449379|NCT00322842|Genzyme Corporation|Genzyme Medical Information||medinfo@genzyme.com|
22449380|NCT00323492|Gilead Sciences|Camille Aubron-Olivier|+33(0)1 42 737130|camille.aubron-olivier@gilead.com|
22449381|NCT03082599|Carolina Eyecare Physicians, LLC|Dr. Helga P Sandoval, Director of Research|8438813937|helga.sandoval@carolinaeyecare.com|
22449382|NCT02486042|UC San Diego Health|Sarah Lazar, clinical research manager|(858) 249-1711|slazar@health.ucsd.edu|
22449383|NCT01466387|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22449384|NCT02530450|UT Health Science Center in San Antonio|Dr. Maria Rayas, Assistant Professor in Pediatric Endocrinology and Diabetes|210-567-5283|rayas@uthscsa.edu|
22449385|NCT01724060|Imperial College|Carel le Roux|07970719453|c.leroux@imperial.ac.uk|
22449386|NCT00832585|Rush University Medical Center - Department of Dermatology|Dr. Michael D. Tharp|312-563-4001|derm@rush.edu|
22449387|NCT00091273|University of Virginia|Craig L. Slingluff, MD|434-924-1730|cls8h@virginia.edu|
22449388|NCT00673179|UT MD Anderson Cancer Center|Peter M. Anderson, MD, PHD / Professor||CR_Study_Registration@mdanderson.org|
22449389|NCT00352846|The University of Texas (UT) MD Anderson Cancer Center|Fredrick Hagemeister, MD/Professor||psanjorjo@mdanderson.org|
22449390|NCT00281684|GlaxoSmithKline|GSK Response Center|866-435-7343||
22449391|NCT01308450|BioBDx|Calvin R. Sumner, MD, CMO, Sr. VP for Clinical Development|978-431-5103|calvin_sumner@biobdx.com|
22449392|NCT03745092|Xuanwu Hospital, Capital Medical University|Pro. Ran Meng|+86-10-83199280|ranmeng2011@pku.org.cn|
22449393|NCT01531387|St. Jude Children's Research Hospital|James M. Boyett, PhD|901-595-4986|james.boyett@stjude.org|
22449394|NCT02586896|NYU School of Medicine|Michael Bogenschutz|646-501-4026|michael.bogenschutz@nyulangone.org|
22449395|NCT00578942|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu|
22449396|NCT01124643|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22449397|NCT04220411|Arjil Pharmaceuticals LLC.|YEH B, WU|+886-3-573-3608|ybw333@arjilbio.com|
22449398|NCT00983281|University of Miami|Kenneth Proctor, PhD|305-243-4694|kproctor@med.miami.edu|
22449399|NCT00502697|Vanderbilt University|Melanie Lutenbacher, PhD, MSN, FAAN|615-343-3314|melanie.lutenbacher@vanderbilt.edu|
22449400|NCT00864474|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22430517|NCT01557569|UAMS|Dr. Alison Oliveto|501-526-8441|olivetoalison@uams.edu|
22449401|NCT00610532|The Ohio State University|Dr. Jim McAuley|614-292-9713|mcauley.5@osu.edu|
22449402|NCT04076644|University of Missouri|Matt Schmidt|573-882-5688|schmidtmw@health.missouri.edu|
22449403|NCT02283814|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22449404|NCT01713868|Boston University|Michael Corwin, MD||mjcorwin@bu.edu|
22449405|NCT00476021|University of Pittsburgh|Principal Investigator|412-641-5496|chenba@upmc.edu|
22449406|NCT02268409|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22449407|NCT03026257|Alcon, A Novartis Division|Senior Clinical Project Lead, GCRA - Clin Dev Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22449408|NCT01398566|The Ohio State University|Lise Worthen-Chaudhari|614-304-1421|liseworthen@gmail.com|
22449409|NCT02181556|FFCD|Mrs Karine Le Malicot, Head of biostatistics|+33 3 80 39.34.79|karine.le-malicot@u-bourgogne.fr|
22449410|NCT00427635|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22449411|NCT02376946|TuftsU|Dr. Archana Viswanath|617-636-3578|Archana.Viswanath@tufts.edu|
22449412|NCT00838201|Amgen Inc.|Study Director|866-572-6436||
22449413|NCT00489853|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22449414|NCT00704535|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22449415|NCT04415281|University of Florida|Eric Weber|3522737802|ebweber@ufl.edu|
22449416|NCT01589445|Ministry of Science and Technology, Government of the People's Republic of Bangladesh|Dr. Masuma Parvin|88 01819141258|acmasuma@gmail.com|
22449417|NCT01100242|University of New Mexico|Richard Lauer, MD|5052725837|rlauer@salud.unm.edu|
22449418|NCT00181207|Johns Hopkins University|Gregory Diette|410-955-3497|gdiette@jhmi.edu|
22449419|NCT02418195|University of Alabama at Birmingham|Samantha White/ Clinical Trials Manager|12059349189|swwhite@uabmc.edu|
22449420|NCT02882321|The University of Texas MD Anderson Cancer Center|Marina Konopleva MD./Professor|713-794-1628|mkonople@mdanderson.org|
22449421|NCT00481195|Cephalon, Inc.|Medical Monitor|1-800-896-5855||
22449422|NCT02932904|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22449423|NCT03095456|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
22449424|NCT04128683|University of California San Diego|Dr. Guido Frank|858-246-2053|gfrank@health.ucsd.edu|
22449425|NCT01476696|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22449426|NCT02918851|Stony Brook Medicine|Dr. Elliott Bennett-Guerrero|6314442979|elliott.bennett-guerrero@stonybrookmedicine.edu|
22386892|NCT04276779|University of Alabama at Birmingham|Dr. Caitlin Clevenger|205-934-7008|cwclev@uab.edu|
22386893|NCT02831283|Columbia University|Patrick Lao|2123421351|PJL2133@CUMC.COLUMBIA.EDU|
22386894|NCT04591080|University at Buffalo|Thikriat Al-Jewair, Program Director|17168296190|thikriat@buffalo.edu|
22386895|NCT04549792|Northwestern University|Principal Investigator|312-503-5944|NUderm-research@northwestern.edu|
22386896|NCT05771467|AkdenizU|Dr. Aslı Cetinkaya Yaprak|+0905069228431|ysf20smt@gmail.com|
22386897|NCT03696433|Vanderbilt University Medical Center|Cassandra Reynolds, BS, CCRC|615-875-9854|cassandra.f.reynolds@vumc.org|
22386898|NCT01220531|Sumitomo Pharma America, Inc.|Director Clinical Operations|+1 (508) 481-6700|ravi.grewal@us.sumitomo-pharma.com|
22386899|NCT05047952|Brain and Cognition Discovery Foundation|Dr. Roger S. McIntyre|416-669-5279|roger.mcintyre@bcdf.org|
22386900|NCT05866926|Ferrer|Clinical Operations Head|649442389|nalbareda@ferrer.com|
22400533|NCT03638011|Maimonides Medical Center|Dr Dennis Feierman|718-283-6000|dfeierman@maimonidesmed.org|7703
22400534|NCT02638012|St. Michael's Hospital|Dr. John Lee|416-864-5306|John.Lee@unityhealth.to|
22400535|NCT00621023|Duke University Medical Center|Dr. Carlos de Castro|919-684-8964|decas003@mc.duke.edu|
22400536|NCT01583647|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22400537|NCT03816995|The Cleveland Clinic|Rita Brienza|216-399-9186|brienzr@ccf.org|
22400538|NCT00486902|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|312-926-9015|r-mccarthy@northwestern.edu|
22400539|NCT04331899|Stanford University|Dr. Prasanna Jagannathan, MD|1-650-724-5343|prasj@stanford.edu|
22400540|NCT01062399|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22400541|NCT00813748|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22400542|NCT01829048|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22400543|NCT00651040|Rheumatology Institute Prague|Rheumatology Institute Prague|+420234075111|vencovsky@revma.cz|
22400544|NCT01854177|Dartmouth-Hitchcock|Donald A. Mahler, M.D.|603 650-5533|Donald.a.mahler@hitchcock.org|
22400545|NCT03584009|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22400546|NCT04112914|Seattle Children's Research Institute|Dr. Emily Kroshus|206-884-5326|Emily.Kroshus@seattlechildrens.org|
22400547|NCT00768560|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22400548|NCT02635204|Dr. Reddy's Lab, Inc|Srinivas Sidgiddi, MD|609-375-9900|srinivassidgiddi@drreddys.com|
22400549|NCT00389207|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22400550|NCT03102411|TriHealth Inc.|Rachel Pauls MD|513-463-4300|Rachel_Pauls@trihealth.com|
22400551|NCT02039947|Novartis Pharmaceutical|Study Director|862-778-8300|novartis.email@novartis.com|
22400552|NCT01772134|GlaxoSmithKline|GSK Response Center|866-435-7343||
22449427|NCT01498640|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22400553|NCT01740362|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22400554|NCT03830281|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22400555|NCT00922935|Straumann|Kristina Espemar Holst, Senior Clinical Trial Manager|+41 61 965 11 11|info@straumann.com|
22400556|NCT01491945|Endologix|Sripad Bellary, Director of Clinical Affairs|9257011628|sbellary@endologix.com|
22400557|NCT00074958|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22400558|NCT03124069|Fisher & Paykel Healthcare|Hanie Yee|+64 9 574 0123|Hanie.Yee@fphcare.co.nz|7909
22400559|NCT01894672|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman MD|646-888-4162|chapmanp@MSKCC.ORG|
22400560|NCT03192904|Ruijin Hospital Shanghai JiaoTong University School of Medicine|Prof. Hecheng Li, Chair of Thoracic Surgery|(86)13917113402|lihecheng2000@hotmail.com|
22400561|NCT00709202|Nathan Kline Institute for Psychiatric Research|Dr. Robert C Principal Investigator. Smith,|845-398-6531|robert.smith@nki.rfmh.org|
22400562|NCT03133767|University of Iowa|Nicholas Mohr|319-384-8285|nicholas-mohr@uiowa.edu|
22413596|NCT00550537|Vanderbilt-Ingram Cancer Center|Dr. Leora Horn, Principal Investigator||leora.horn@vanderbilt.edu|
22430518|NCT01772693|Insightec|Nadir Alikacem, Ph.D., VP Clinical Research|214-630-2000|nadira@insightec.com|
22449428|NCT02590939|CEFALY Technology|Clinical Trials Department director|+32 4 367 67 22|info@cefaly.com|
22449429|NCT02225743|Medical University of South Carolina|Sylvia Wilson, MD|843-792-2322|wilsosh@musc.edu|
22449430|NCT02664909|UConn Health|Vincent Williams, M.D.|(860) 679-8384|vwilliams@uchc.edu|
22449431|NCT03706794|Albert Einstein College of Medicine|Dr. Elizabeth Seng|646-592-4368|Elizabeth.Seng@einsteinmed.edu|
22449432|NCT01319877|Hoffmann-La Roche|Medical Communications|800-821-8590||
22449433|NCT01057017|BrUOG|Howard Safran, MD|4018633000|Hsafran@lifespan.org|
22449434|NCT00566150|Yale University|Dr. Zubin Bhagwagar|203-974-7560|zubin.bhagwagar@yale.edu|
22449435|NCT02347189|Medtronic|Megan Mueller, Clinical Research Manager|612-916-4771|megan.d.mueller@medtronic.com|
22449436|NCT02677987|Northwestern University Feinberg School of Medicine|Lisa M. Wu, Ph.D.|(312) 503-7722|lisa.wu1@northwestern.edu|
22449437|NCT03320564|Wake Forest Baptist Health|Katie Holbrook Bingman|336-713-7765|krholbro@wakehealth.edu|
22449438|NCT01527682|ASST Spedali Civili di Brescia|Prof. Luciano Quaranta|+39 030 3995|luciano.quaranta@unibs.it|847
22430519|NCT00781898|University Of Pennsylvania|Charle P. O'Brien|215-222-3200|obrien@mail.med.upenn.edu|
22449439|NCT01359254|The University of Chicago Medicine|Andrew Artz, MD, MS|(773) 834-8980|aartz@medicine.bsd.uchicago.edu|
22449440|NCT04668950|Washington University in St. Louis|Dr. Eric Lenze|314-362-5154|lenzee@wustl.edu|
22449441|NCT03979638|Bellus Health Inc|Senior Director Clinical Development|833-703-0708|lharvey@bellushealth.com|
22400563|NCT02240706|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22449442|NCT00600938|Novartis Pharnaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22400564|NCT03301857|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22449443|NCT02680639|Philips|Senior Clinical Development Scientist|(724) 733-5835|chuck.cain@philips.com|
22449444|NCT02678676|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22449445|NCT03200899|The University of Texas at Austin|Dr. Alexa Stuifbergen|+1 (512) 471-4100|astuifbergen@mail.utexas.edu|
22449446|NCT04646499|University of California San Francisco|Dr. Theodore Zanto|415-502-7322|theodore.zanto@ucsf.edu|
22449447|NCT00302133|University of Miami Miller School of Medicine|Ihsan Salloum, MD, MPH|305 243-7931|isalloum@med.miami.edu|
22449448|NCT01001442|Biotest AG|Iris Bobenhausen|+49 6103 801|iris.bobenhausen@biotest.com|4832
22449449|NCT02753699|Debiopharm International, S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
22449450|NCT01342510|University of Wisconsin School of Medicine and Public Health, Department of Anesthesiology|Kristopher Schroeder, MD|608-263-8100|kmschro1@wisc.edu|
22449451|NCT01538862|Vanderbilt University|Haydar Frangoul, MD, MS|615-342-7339|Haydar.Frangoul@hcahealthcare.com|
22449452|NCT01400516|Brigham and Women's Hospital|Daniel H Solomon, MD, MPH||dsolomon@partners.org|
22449453|NCT01412866|DArtmouth-Hitchcock|Mary F. Brunette|603-27105747|mary.f.brunette@dartmouth.edu|
22449454|NCT00549562|Indiana University School of Medicine|David D. Dunn MD|317-944-8164|ddunn@iupui.edu|
22449455|NCT00128921|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990|pettynathanm@uams.edu|2461
22449456|NCT00323115|Dartmouth-Hitchcock Medical Center|Dr. Camilo Fadul|603-653-6312|camilo.e.fadul@hitchcock.org|
22449457|NCT02496533|Midwestern Regional Medical Center, Inc.|Jessica Kapustin, RN-C||Jessica.Kapustin@CTCA-Hope.com|
22449458|NCT05756790|University of California San Francisco|Dr. Amy Conroy|303-522-9439|amy.conroy@ucsf.edu|
22449459|NCT05447156|Masonic Cancer Center|Dana Mowls Carroll, Ph.D., M.P.H.|612-624-4511|dcarroll@umn.edu|
22449460|NCT01263301|Mennonite Christian Hospital|Ling-Chih Wu MD|88638241234|lingchihwu@yahoo.com|1810
22449461|NCT03265249|Duke University|Alisha Mavis, M.D.|919-684-5068|alisha.mavis@duke.edu|
22449462|NCT01554891|Geisel School of Medicine at Dartmouth|Laura A. Flashman, Ph.D.|6036505824|flashman@dartmouth.edu|
22449463|NCT03873987|Melinta Therapeutics, Inc.|Vice President Clinical Operations|9086171319|kfusaro@melinta.com|
22449464|NCT01465022|University of New Mexico|Eve Espey MD, MPH, Principal Investigator|505 272 6372|eespey@salud.unm.edu|
22449465|NCT00004888|Eastern Cooperative Oncology Group Statistical Office|Study Statistician|617-632-3012||
22449466|NCT00136084|St. Jude Children's Research Hospital|Jeffrey Rubnitz, M.D|1-866-278-5833|info@stjude.org|
22449467|NCT02579265|Fresenius Kabi Deutschland GmbH|Dr. Jean-Marc Lohse, Director Clinical Operations PN NAM & ELAMA|+49 6172 686|Jean-Marc.Lohse@fresenius-kabi.com|4911
22449468|NCT02174848|Chiesi Canada Corp.|Fernando Tricta, MD|416--558-6342|f.tricta@chiesi.com|
22449469|NCT02229318|The Children's Hospital of Philadelphia|Dr Christina Bergqvist, M.D., Study Principal Investigator|+1 215 590 1719|Bergqvist@Email.CHoP.Edu|
22449470|NCT02520011|Sumitomo Dainippon Pharma Oncology, Inc.|Susan Smith|+1-210-414-7702|Susan.smith@sdponcology.com|
22449471|NCT00644969|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22449472|NCT06076694|Clinical Study Center of the First Hospital of Jilin University|TenNor|0512-86861979|info@tennorx.com|
22449473|NCT00997503|Boston Scientific Corporation|Peter Maurer, Director of Clinical Trials|1-508-683-6678|Peter.Maurer@bsci.com|
22449474|NCT01933048|Uniformed Services University of the Health Sciences|Eugene V. Millar, PhD|301-816-8451|emillar@idcrp.org|
22449475|NCT01364090|Viral Hepatits Clinical Research Program - The Kirby Institute - UNSW Sydney|Dr. Jason Grebely|+61 2938 50957|Jgrebely@kirby.unsw.edu.au|
22449476|NCT02780804|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22449477|NCT02476968|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22449478|NCT01661712|2Guy's and St Thomas' NHS Foundation Trust, Lane Fox Respiratory Unit/Sleep Disorders Centre, London, UK|Dr Joerg Steier|020 7188 3430|joerg.steier@gstt.nhs.uk|
22449479|NCT02155335|Merck Sharp & Dohme|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22449480|NCT01746784|N30 Pharmaceuticals|Dr. Steven Shoemaker|720-945-7700|steven.shoemaker@n30pharma.com|
22449481|NCT04171414|Celltrion Inc.|JiWoong Lim|032-850-5806|jiwoong.lim@celltrion.com|
22449482|NCT01714310|University of California, Los Angeles|James J. McGough, M.D.|310-794-7841|jmcgough@mednet.ucla.edu|
22449483|NCT02487394|UTMB|William Calhoun, M.D.|409-772-1176|wjcalhou@utmb.edu|
22449484|NCT01641367|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22449485|NCT01018420|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22449486|NCT00218296|University of Minnesota|Dorothy Hatsukami, Ph.D.|612-626-2121|hatsu001@umn.edu|
22449487|NCT02623803|Mayo Clinic|Dr. Elird Bojaxhi|904-956-3327|bojaxhi.elrid@mayo.edu|
22449488|NCT01117727|University of Michigan|Jane Huggins|734-936-7177|janeh@umich.edu|
22449489|NCT04452331|University of Illinois Chicago|Dr. Alan Schwartz|3129962070|alansz@uic.edu|
22449490|NCT01420289|Calvary Hospital|Oscar M. Alvarez PhD, Director Center for Curative and Palliative Wound Care|718-518-2577|oalvarez@calvaryhospital.org|
22449491|NCT01969812|Atrium Health|Bradley Hurst, M.D.|704-355-3153|brad.hurst@atriumhealth.org|
22449492|NCT04064294|Portland VA Health Care System|Dr. Kathryn Chung|(503) 721 -1091|Kathryn.Chung@va.gov|
22400565|NCT03664726|University at Buffalo|Leonard H. Epstein|716-829-3400|lhenet@buffalo.edu|
22400566|NCT02319369|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22400567|NCT01856114|UT MD Anderson Cancer Center|Dr. David Hui, MD, Associate Professor, Palliative Care Medicine|713-792-6258|dhui@mdanderson.org|
22400568|NCT03119649|Galapagos NV|Evelyn Fox|0032 15 34 29 00|evelyn.fox@glpg.com|
22400569|NCT03248128|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22400570|NCT01914679|University of Michigan|Daniel Clauw, MD|734-998-6901|dclauw@med.umich.edu|
22413597|NCT02008565|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
22413598|NCT00617305|Gilead Sciences|Ellen Shen, PhD, Senior Manager, Regulatory Affairs|+1 (650) 522-5278|Ellen.Shen@gilead.com|
22413599|NCT01650350|Brown University Oncology Research Group|Maria Constantinou, MD|401-863-3000|Kayla_rosati@brown.edu|
22413600|NCT00537979|Abbott|Global Medical Services|800-633-9110||
22413601|NCT02193178|CooperVision, Inc.|Sr. Manager, Clinical Research|9257306754|pchamberlain@coopervision.com|
22413602|NCT00580138|University of Arkansas for Medical Sciences Medical Center|Gary McCullough|501-852-7886|mcculloughgaryh@uams.edu|
22413603|NCT01059903|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22449493|NCT03137693|Moffitt Cancer Center|Michael Montejo, MD|813-745-8424|Michael.Montejo@moffitt.org|
22449494|NCT01289847|Bio Products Laboratory|Head of Medical Affairs|+44 20 8957 2200|medinfo@bpl.co.uk|
22449495|NCT03441633|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22449496|NCT00006478|University of Nebraska Medical Center Division of Oncology/Hematology|Bryan Ludwig, Regulatory Coordinator|402-559-8071|bmludwig@unmc.edu|
22449497|NCT04534764|Johnson & Johnson Vision Care|Meredith Bishop, OD, MS, FAAO-Sr. Principal Research Optometrist|904-443-1783|mbishop4@its.jnj.com|
22449498|NCT03161483|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22449499|NCT02767427|Columbia University|Dr. Kiehyun Daniel Riew, Professor of Orthopedic Surgery|212-932-4410|kr2637@cumc.columbia.edu|
22449500|NCT03007394|National Institute on Drug Abuse|David McCann, Ph.D.|301-827-5934|dmccann@nida.nih.gov|
22449501|NCT00600756|AstraZeneca|Gerard Lynch||clinicaltrialtransparency@astrazeneca.com|
22449502|NCT04753164|Idorsia Pharmaceuticals Ltd|Idorsia Clinical Trial Information|+18566613721|idorsiaclinicaltrials@idorsia.com|
22449503|NCT00694369|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22449504|NCT00439556|UT MD Anderson Cancer Center|Dr. Khouri,Issa,M.D. / Stem Cell Transplantation|713-792-8750|ikhouri@mdanderson.org|
22449505|NCT02871739|Massachusetts General Hospital Health Decision Sciences Center|Karen Sepucha|617-724-3350|ksepucha@partners.org|
22449506|NCT01642238|Icahn School of Medicine at Mount Sinai|Dr. Juan J. Badimon|(212) 241-8484|Juan.Badimon@mssm.edu|
22449507|NCT01324388|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22449508|NCT01405963|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22449509|NCT03615807|Balgrist University Hospital|Professor Ilker UCKAY|+41 44 386 37 05|ilker.uckay@balgrist.ch|
22449510|NCT03023085|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
22449511|NCT00850395|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22449512|NCT01737047|Imperial College London|Alan Winston|02033121603|a.winston@imperial.ac.uk|1603
22449513|NCT02802592|Johns Hopkins University School of Medicine|Dr. Kenneth Horvath|301-896-3100||
22449514|NCT04007523|Michigan Medicine|Dr. Phillip Vlisides|734-936-4280|pvliside@med.umich.edu|
22449515|NCT01826487|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22449516|NCT01408030|Cure HHT|James R. Gossage, MD, Medical Director of Cure HHT|706-721-6789|jgossage@augusta.edu|
22449517|NCT00363779|National Cancer Institute (NCI), National Institutes of Health (NIH)|Thomas Waldmann, M.D.|301-496-6653|Thomas_Waldmann@nih.gov|
22449518|NCT03608774|University of Washington|Julia C. Dombrowski, MD, MPH|206-744-5640|jdombrow@uw.edu|
22449519|NCT01586819|Loyola University Chicago|Rebecca Tung, M.D.|708-216-8000|rtung@lumc.edu|
22449520|NCT04837131|Mayo Clinic|Michael Pham, M.D.|480-301-8318|Pham.Michael@mayo.edu|
22449521|NCT04439318|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22449522|NCT02151448|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR, Regulatory Supervisor, CRS|412-647-5554|stadtermanbm@upmc.edu|
22449523|NCT04227236|dFusion, Inc.|Regina Firpo-Triplett|831-222-5094|regina.firpo@dfusioninc.com|
22449524|NCT01841151|KIND, KBH, Karolinska Institutet|Prof. Sven Bölte|0046703170105|sven.bolte@ki.se|
22449525|NCT00409617|Abbott|Global Medical Services|800-633-9110||
22449526|NCT00914862|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22449527|NCT03917420|UNC Chapel Hill|Amanda Poliseno|919-962-5344|amanda_poliseno@unc.edu|
22449528|NCT00591942|University of Iowa|Dr. Clark Stanford|319-335-7381|Clark-Stanford@uiowa.edu|
22449529|NCT02319005|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
22449530|NCT00149747|Stanford Prevention Research Center|Abby C. King|6507252826|king@stanford.edu|
22449531|NCT02689258|Heron Therapeutics, Inc.|Clinical Operations|1-800-767-0524|cquaratino-baker@herontx.com|
22449532|NCT03373383|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22449533|NCT03317431|Department of Anesthesia,Xinhua hospital affiliated to Shanghai Jiaotong University School of Medicine|Dr.Lai Jiang|021-25078999|jianglaimz@sina.com|
22449534|NCT02159521|EKOS Corporation|David Hahn|4254153100|David.Hahn@btgplc.com|
22449535|NCT04649775|Duke University|Loretta Que, M.D.|919-681-8551|loretta.que@duke.edu|
22449536|NCT00907374|Charles R. Drew University|Mayer B. Davidson, MD|323 357-3439|mayerdavidson@cdrewu.edu|
22449537|NCT03818516|Emory University|David R. Goldsmith, MD|404-727-3735|drgolds@emory.edu|
22449538|NCT00594464|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22449539|NCT00785486|Mutual Pharmaceutical Company, Inc.|Medical Affairs Director|215-697-1743|clinicaltrials@urlmutual.com|
22449540|NCT00358462|University of Washington|Lisa E. Manhart, PhD - PI|206-744-3646|lmanhart@uw.edu|
22449541|NCT00706836|University of California San Diego|Murray B. Stein MD, MPH|858-534-6400|mstein@ucsd.edu|
22449542|NCT00544076|City of Hope|Laura Crocitto, M.D.|626-218-3708|lcrocitto@coh.org|
22449543|NCT02907359|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
22449544|NCT03892460|University of Vermont College of Medicine|Michael Toth|802-656-7989|michael.toth@med.uvm.edu|
22449545|NCT00746941|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
22400571|NCT01696357|University of Rochester Medical Center|Hyekyun Rhee|5852763775|hyekyun_rhee@urmc.rochester.edu|
22400572|NCT00256295|University of California, Irvine|Nicole Macaranas|714-456-6550|nicole.macaranas@uci.edu|
22400573|NCT01126580|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22400574|NCT04109599|play2PREVENT Lab, Yale Center for Health and Learning Games, Department of Internal Medicine|Tyra Pendergrass Boomer, Deputy Director of Programs and Partnerships|+1 (203) 737-6101|tyra.pendergrass@yale.edu|
22449546|NCT01805024|Santhera Pharmaceuticals|Roxana Drake|+41 61 906 89 29|roxana.drake@santhera.com|
22449547|NCT02508571|Department of Pediatrics, Seoul National University College of Medicine|Dr. Ee-Kyung Kim|82-2-2072-3628|kimek@snu.ac.kr|
22449548|NCT01524692|University of Virginia|Dr. Patrick Dillon|4349821495|pmd5b@virginia.edu|
22449549|NCT01209442|University of Colorado|Douglas Ney, M.D.|303-724-2184|Douglas.Ney@ucdenver.edu|
22449550|NCT01709695|Icahn School of Medicine at Mount Sinai|Department of Psychiatry|212-241-6623||
22449551|NCT00788892|Jazz Pharmaceuticals|Associate Director, Clinical Trial Disclosure & Transparency|215-832-3750||
22449552|NCT03352323|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
22449553|NCT03065244|Dept. of Pediatrics UCSD School of Medicine|Dr. Jane Burns|858-246-0155|jcburns@health.ucsd.edu|
22449554|NCT03717480|Dana-Farber Cancer Institute|Dr. Vincent Ho|617-632-6256|vincent_ho@dfci.harvard.edu|
22449555|NCT01894152|Abbott Vascular|Roy Leong|+65 (6277) 3202|roy.leong@abbott.com|
22449556|NCT02741700|VA ORD: Birmingham VA Medical Center|Dr. Jasvinder Singh|205-934-3235|jasvinder.md@gmail.com|
22449557|NCT05265260|Cochlear|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
22449558|NCT01774786|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22449559|NCT00075582|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22449560|NCT04544293|Savara Inc.|Raymond D Pratt, MD FACP|512 614 1848|ray.pratt@savarapharma.com|
22449561|NCT03556579|Johnson & Johnson Vision Care Inc.|John Buch, O.D. F.A.A.O - Senior Principal Research Optometrist|904-443-1707|JBUCH@its.jnj.com|
22449562|NCT02965703|Northwestern University|Dr. Seema A. Khan|312-503-4236|s-khan2@northwestern.edu|
22449563|NCT00744627|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22449564|NCT02268786|Illumina|Tasha Kalista|858-202-4500|tkalista@illumina.com|
22449565|NCT01035944|HemCon Medical Technolgoies|Dr. Jody Oyama|503.245.0459|jody.oyama@hemcon.com|
22449566|NCT01625455|VANDERBILT UNIVERSITY MEDICAL CENTER|Nancy J. Brown, M.D., Principal Investigator|6153438701|nancy.j.brown@vanderbilt.edu|
22449567|NCT02535845|The University of Chicago|Dr. Jasmin Tiro|773-834-4384|jtiro@bsd.uchicago.edu|
22449568|NCT01062555|University of Minenesota|Arthur Matas|612-625-5151|matas001@umn.edu|
22449569|NCT03560531|Zeno Alpha Inc.|Head of Regulatory Affairs|(858) 263-4333|RegLeads@zentalis.com|
22449570|NCT02968979|CHUGAI PHARMA FRANCE|Dr Luz BOBADILLA, Medical Affairs Director|+33 1 56 37 05 28|bobadilla@chugai-pharm.fr|
22449571|NCT01471379|UNC Chapel Hill|Dr. Spencer Dorn Associate Professor|919-966-0141|sdorn@med.unc.edu|
22449572|NCT00788827|Imperial College London|Professor Charles Pusey|+44 3313 2308|c.pusey@imperial.ac.uk|
22449573|NCT00265512|VA Center for Innovation to Implementation|Todd Wagner|6504935000|todd.wagner@va.gov|22048
22449574|NCT04222712|Tarsier Pharma|COO|+972508371319|zohar@tarsierpharma.com|
22449575|NCT00699556|Yale University|Sherry McKee|(203) 737-3529|sherry.mckee@yale.edu|
22449576|NCT01457885|University of Michigan Comprehensive Cancer Center|Dr. John Magenau, M.D.|734-936-8785|johnmage@umich.edu|
22449577|NCT04993287|NorthShore University HealthSystem|Dr. Nirav Shah|847-657-5959|nshah2@northshore.org|
22449578|NCT04448210|innovation Research & Training|Dr. Alison Parker|919-493-7700|aparker@irtinc.us|
22449579|NCT02818777|University of Colorado|Dr. Maureen Anne Leehey|303-724-2194|maureen.leehey@ucdenver.edu|
22449580|NCT02028988|Dana-Farber Cancer Institute|Glenn Bubley MD|617-735-2062|gbubley@bidmc.harvard.edu|
22449581|NCT02803307|Taiwan Liposome Company|Dr. Carl Brown|886-2-2655-7377|carlb@tlcbio.com|
22449582|NCT00747435|MED-EL Corporation|Sr. Clinical Research Associate||clinicaltrials@medelus.com|
22449583|NCT01324349|Covidien|Vice President, Medical Affairs|203-500-4256|amy.pollack@covidien.com|
22449584|NCT00851799|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22449585|NCT01976442|University of Rochester Medical Center|Neil Blumberg MD|(585) 275-3189|neil_blumberg@urmc.rochester.edu|
22449586|NCT02276612|Gilead Sciences|Clinical Trial Disclosures & Data Transparency|1-833-445-3230|GileadClinicalTrials@gilead.com|
22449587|NCT04365556|Cincinnati Children's Hospital Medical Center|Rachelle Ramsey|513-803-0415|rachelle.ramsey@cchmc.org|
22449588|NCT00254995|Sanofi Pasteur Inc|Medical Drector||RegistryContactus@sanofipasteur.com|
22449589|NCT00614913|Radiation Medicine - Loma Linda University Medical Center|David Bush MD|909-558-4280|dbush@dominion.llumc.edu|
22449590|NCT00302003|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22449591|NCT02042924|Masonic Cancer Center, University of Minnesota|Dr. Susanta Hui|626-218-0556|shui@coh.org|
22449592|NCT04033003|University of Michigan, School of Nursing|Jody R. Lori PhD, Associate Dean for Global Affairs, Director, PAHO/WHO Collaborating Center|734-763-0097|jrlori@med.umich.edu|
22449593|NCT02919670|DFCI|Kelly Masone|6176324167|kmasone@partners.org|
22449594|NCT02256891|Health Partners|Michael Walsh|(952) 831-8742|michael.walsh@tria.com|
22449595|NCT02227485|Shiraz University of Medical Sciences|Dr. Mahsa Rostami-Chijan|+989111960300|mahsa_59_2007@yahoo.com|
22449596|NCT04920123|University of Massachusetts Amherst|Juhyeon Lee|413-404-4732|juhyeonlee@cs.umass.edu|
22449597|NCT00826267|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22449598|NCT03893799|Renibus Therapeutics|Donald J Keyser, Chief Operating Officer|18178756991|jkeyser@renibus.com|
22449599|NCT02212587|Hospital of Sick Children|Dr. Valerie Waters|416-813-1500|valerie.waters@sickkids.ca|
22449600|NCT00134381|UMDNJ-Robert Wood Johnson Medical School|Dr M Magliocco||maglioma@yahoo.com|
22430520|NCT01633112|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22430521|NCT00062764|National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health|Jay H. Hoofnagle, MD|3014961333|hoofnaglej@extra.niddk.nih.gov|
22430522|NCT01225952|Bausch & Lomb Incorporated|Omid Khodai, OD,RAC|(949) 521-7894|omid.khodai@bausch.com|
22449601|NCT02586493|GlaxoSmithKline|GSK Response Center|866-435-7343||
22449602|NCT04066426|Tekirdag Namik Kemal University|Dr. Volkan Kaplan|+90282250000|dr.volkankaplan61@gmail.com|6307
22449603|NCT03249779|Mayo Clinic|Melissa C. Lipford, M.D.|507-255-9230|Lipford.Melissa@mayo.edu|
22449604|NCT02984384|University of Maryland School of Medicine|Robert O'Toole|410-328-6280|rotoole@som.umaryland.edu|
22449605|NCT01604343|Janssen Research & Development, LLC|Associate Director||ClinicalTrialDisclosure@its.jnj.com|
22449606|NCT00436748|Amgen Inc.|Study Director|866-572-6436||
22449607|NCT00850200|University of Florida Proton Therapy Institute|Bradford Hoppe, MD, MPH|904-588-1800|bhoppe@floridaproton.org|
22449608|NCT02711800|Duke University|Nancy Zucker|9196680075|zucke001@mc.duke.edu|
22449609|NCT04133168|Boston Scientific|Stephanie Roelke, Clinical Trial Manager|651-582-4000|Stephanie.Roelke@bsci.com|
22449610|NCT01295515|National Cancer Institute|Dr. Frank Maldarelli|301- 846-5611|frank_maldarelli@nih.gov|
22449611|NCT05442554|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22449612|NCT04938232|Dana-Farber Cancer Institute|Reid Merryman|6176326844|reid_merryman@dfci.harvard.edu|
22449613|NCT02269280|The University of Texas MD Anderson Cancer Center|Guillermo Garcia-Mnaero|713-745-3428|ggarciam@mdanderson.org|
22449614|NCT03754959|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22449615|NCT01990495|VA Palo Alto Health Care System|Dr. Jonathan Myers|6504503440|Drj993@aol.com|
22449616|NCT00097721|Eisai Inc|Eisai Call Center|888-422-4743||
22449617|NCT00449956|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22449618|NCT03167879|RAND Corporation|Dr. Glenn Wagner|310-393-0411|gwagner@rand.org|7698
22449619|NCT01565330|Avid Radiopharmaceuticals|Chief Medical Officer|215-290-0700|clinicaloperations@avidrp.com|
22449620|NCT01067768|Hospital Pablo Tobón Uribe|Dr. María Victoria Restrepo|57-4-4459315|mrestrepo@hptu.org.co|
22449621|NCT02972632|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22449622|NCT02126969|University of Kentucky|Dr. Susanne Arnold|8592579568|smarno0@uky.edu|
22449623|NCT00354172|Masonic Cancer Center, University of Minnesota|Jeffrey Miller, M.D.|612-625-7409|mille011@umn.edu|
22449624|NCT01828034|Memorial Sloan Kettering Cancer Center|Dr. Ghassan Abou-Alfa, MD|646-888-4184|abou-alg@mskcc.org|
22449625|NCT02023151|Johns Hopkins University|Sarbjit Saini|4105502191|ssaini@jhmi.edu|
22449626|NCT03450707|BIDMC|Dr. Michael Donnino|6177542882|mdonnino@bidmc.harvard.edu|
22449627|NCT02871375|Alcon, A Novartis Division|Franchise Head, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22449628|NCT03592121|Applied Biology, Inc.|Dr. Andy Goren|(949) 387-4526|andyg@appliedbiology.com|
22449629|NCT01988571|Wake Forest NCI Community Oncology Research Program Research Base|Lead Biostatistician|336-716-0891|NCORP@wakehealth.edu|
22449630|NCT00004412|Boston University School of Medicine|Douglas V. Faller, Ph.D., M.D., Susan P. Perrine, M.D.|(617) 638-5639|sperrine@bu.edu|
22449631|NCT00337103|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22449632|NCT03387813|Abbott|Fei San Lee, PhD, Sr Clinical Research Scientist|925-694-2109|feisan.lee@abbott.com|
22449633|NCT05876273|Center for Diabetes Technology, University of Virginia School of Medicine|Boris Kovatchev, PhD|434-924-5592|boris@virginia.edu|
22449634|NCT03131440|Northwestern University|Siobhan Phillips|312-503-4235|smphillips@northwestern.edu|
22449635|NCT00176592|Rutgers New Jersey Medical School|Stuart Cook, MD|973-972-2550|cooksd@njms.rutgers.edu|
22449636|NCT03742141|Icahn School of Medicine at Mount Sinai|Dr. David Steinmetz|646-831-5950|dsteinmetz0@gmail.com|
22449637|NCT01566448|West Virginia University Hospitals|Aaron Cumpston|304-598-4000|cumpstona@wvumedicine.org|73350
22449638|NCT02180412|University of Texas Medical Branch, Galveston|Dr. Karl Anderson, MD|409-772-9092|kanderso@utmb.edu|
22449639|NCT04654117|Department of Psychology, Michigan State University|Dr. Brooke Ingersoll, Professor|517-432-8412|ingers19@msu.edu|
22449640|NCT01354496|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22449641|NCT01278485|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22449642|NCT00500292|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22449643|NCT05045144|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22449644|NCT02385084|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22449645|NCT04809220|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22449646|NCT00729183|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22449647|NCT01218555|Emory University|Taofeek K. Owonikoko, MD, PhD, MSCR|404-778-1900|towonik@emory.edu|
22449648|NCT04697693|New York State Psychiatric Institute|Dr. Bret Rutherford|646-774-8660|bret.rutherford@nyspi.columbia.edu|
22449649|NCT01070316|Cincinnati Children's Hospital Medical Center|Elizabeth Hoskins|(513) 803-7263|elizabeth.hoskins@cchmc.org|
22449650|NCT02531321|University of Southern California|Dr. Nicole Bender|3234093416|nicole.bender@med.usc.edu|
22449651|NCT00748215|University of Texas (UT) MD Anderson Cancer Center|Bryan Kee, MD/Assistant Professor, GI Medical Oncology|713-792-2828|bkkee@mdanderson.org|
22449652|NCT02138461|MDbackline, LLC|John A. Hovanesian, MD|949 951 9248|jhovanesian@mdbackline.com|
22449653|NCT01113879|The Ohio State University|Stacy Harnish|614-688-1471|harnish.18@osu.edu|
22449654|NCT04151290|Cognoa|Senior Director Clinical Research|4082076659|minda.seal@cognoa.com|
22449655|NCT02204748|The University of Tennessee|Adrija Sharma, Ph. D.|8659742093|asharma1@utk.edu|
22449656|NCT03007758|Prisma Health|Abby Birrell, Study Coordinator|8645222117|abby.birrell@prismahealth.org|
22449657|NCT00082433|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22400575|NCT01731002|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director of Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
22400576|NCT05369806|University of Washington|Keshet Ronen|2065854363|keshet@uw.edu|
22400577|NCT00765765|Cancer Institute of New Jersey|Dr. Vassiliki Karantza|732-235-8675|karantva@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
22400578|NCT01331161|Emory University|Nadine Rouphael, MD|404-712-1435|nroupha@emory.edu|
22449658|NCT01796197|Dana-Farber Cancer Institute|Beth Overmoyer, MD, FACP|617.632.3800|beth_overmoyer@dfci.harvard.edu|
22449659|NCT04097821|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22449660|NCT00244712|GlaxoSmithKline|GSK Response Center|866-435-7343||
22449661|NCT03299842|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22449662|NCT04380857|Cleveland Eye Clinic|Kathleen Jee, MD|440-526-1974|kjee@midwestvision.com|
22449663|NCT02558790|Massachusetts General Hospital|Craig Surman, MD|617-726-8422|csurman@partners.org|
22449664|NCT05083442|Mayo Clinic Rochester|Dr. Ivana Croghan|507 284-2511|gimresearchstudies@mayo.edu|
22449665|NCT03878316|National Institute on Alcohol Abuse and Alcoholism|Dr. Daniel Falk|301-443-0788|falkde@mail.nih.gov|
22449666|NCT04865354|Alcon Research, LLC|Sr. Project Lead, CDMA Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22449667|NCT03961100|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22449668|NCT02945410|Technical University of Munich|Dr. Karsten Koehler|+49 89 289 24488|karsten.koehler@tum.de|
22449669|NCT00110812|University of Minnesota|Deborah Wentworth|612-726-9005|wentw001@umn.edu|
22449670|NCT04200248|Ribomic, Inc.|Dr. Yoshikazu Nakamura|81-3-3440-3303|yoshi@ribomic.com|
22449671|NCT01454726|Xuan Wu Hospital of Capital Medical University|Dr. Jianping JIA|0086-10-83198899|jiajp@vip.sina.com|8650
22449672|NCT01886833|CIDRZ|Dr. Roma Chilengi|+2609173724935|Roma.Chilengi@cidrz.org|
22449673|NCT04476030|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22449674|NCT02342704|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22449675|NCT01675882|DBV Technologies|Chief Medical Officer|33-1-55-42-78-78|clinicaltrials@dbv-technologies.com|
22449676|NCT03405142|Stanford Medicine at Stanford University|Roan Courtney Raymundo|650-721-4071|rcraymun@stanford.edu|
22449677|NCT01446965|University of California, San Francisco|Jeffrey Olgin, MD|415-476-1000|jeffrey.olgin@ucsf.edu|
22449678|NCT02719158|Otonomy, Inc.|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
22449679|NCT01451775|boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22449680|NCT02016482|AbbVie|Global Medical Services|800-633-9110||
22449681|NCT00606892|Yale University|Mehmet Sofuoglu, M.D., Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu|
22449682|NCT00594061|University of Iowa|Bruce Gantz|319-353-8776|bruce-gantz@uiowa.edu|
22449683|NCT00855309|Comprehensive Cancer Center of Wake Forest University|LeAnne Kenndy, PharmD|336-713-3416|lakenned@wakehealth.edu|
22449684|NCT00829296|University of Chicago|Dr. George Bakris|773-702-7936|gbakris@medicine.bsd.uchicago.edu|
22386901|NCT01105091|Actelion Pharmaceuticals, US|Wade Benton, PharmD, Director of Medical Affairs|650-808-6562|wade.benton@actelion.com|
22386902|NCT05672017|Bournemouth University|Dr Katherine Appleton|01202965985|k.appleton@bournemouth.ac.uk|
22386903|NCT03027128|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22386904|NCT00176800|University of Michigan Comprehensive Cancer Center|Dr. Susan Urba, M.D.|734-615-4762|surba@umich.edu|
22386905|NCT00557492|UPMC CancerCenter|Herbert Zeh, MD|4126922852|zehxhx@upmc.edu|
22386906|NCT04098575|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22400579|NCT05198713|Sonova US Corporate Services, LLC|Director of Research|630-821-5000|phonakaudiologyresearch@gmail.com|
22400580|NCT03277196|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22400581|NCT05738486|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22400582|NCT01419171|Peter Maurer, Director Clinical Trials|Peter Maurer, Director Clinical Trials|508-683-6678|Peter.Maurer@bsci.com|
22386907|NCT00575016|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22386908|NCT01149759|Rockefeller University|Emma Guttman Yassky, MD|212-327-8333|skhattri@rockefeller.edu|
22386909|NCT05186740|ProVerum|"Vice President, Clinical Affairs |"|"+1-720-472-1504|"|diane@proverummedical.com|
22386910|NCT03694262|Medical College of Wisconsin|William Bradley, MD|414-805-6606|wbradley@mcw.edu|
22400583|NCT00597558|University of North Carolina at Chapel Hill|Dr. Edwin Kim, Director|919-843-9087|edwinkim@email.unc.edu|
22400584|NCT04442581|University of Washington|Madeline Jacoby|2026068246|mjacoby@seattlecca.org|
22386911|NCT01925144|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22449685|NCT00537446|Columbia University Irving Medical Center|Robert Basner, MD||rcb42@cumc.columbia.edu|
22449686|NCT01193907|Novartis Vaccines Institute for Global Health|Dr. Audino Podda|+39 0577 243496|audino.podda@novartis.com|
22449687|NCT04960228|Lady Davis Institute for Medical Research|Ben Haward, Research Assistant|514-340-8222|ben.haward@ladydavis.ca|23978
22449688|NCT02547129|Mayo Clinic|Dr. Michael J. Taunton|507-284-7692|Taunton.Michael@mayo.edu|
22449689|NCT00794196|Parc Sanitari Sant Joan de Déu|Dr. Antoni Serrano Blanco|+34936406350|aserrano@pssjd.org|12215
22449690|NCT01640366|Smith & Nephew Inc|Rachael Winter, Director of Clinical Operations|+44 1482 673475|rachael.winter@smith-nephew.com|
22449691|NCT04964128|Medtronic|Roseline Re|+33684520425|roseline.re@medtronic.com|
22449692|NCT00827255|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22449693|NCT00994240|University of Wisconsin-Madison|Clinical Research Administrator|608-287-2640|dbock@dermatology.wisc.edu|
22449694|NCT00446147|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
22449695|NCT01200797|Vanderbilt-Ingram Cancer Center|Marta A. Crispens, M.D.|615-322-8072|marta.crispens@Vanderbilt.Edu|
22449696|NCT02742987|Campus Bio-Medico University|Dr. Fabio Mangiacapra|003906225411612|f.mangiacapra@unicampus.it|
22449697|NCT03745144|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49 6151-72-5200|service@emdgroup.com|
22449698|NCT04681482|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22449699|NCT00642668|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22449700|NCT00896337|Boston Scientific|Angela Schutt|763-494-2166|schutta@bsci.com|
22449701|NCT01177540|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22449702|NCT02323854|Medtronic|Dr. Jaime Kean|303-882-6759|Jaime.m.Kean@medtronic.com|
22449703|NCT02013167|Amgen Inc.|Study Director|866-572-6436||
22449704|NCT03200925|Kettering Health Network|Catherine Caponero, DO|937-723-4124|catherine.caponero@ketteringhealth.org|
22449705|NCT05233566|Washington University School of Medicine|Dr. Bradley Fritz|3142733453|bafritz@wustl.edu|
22449706|NCT01633320|Edouard Herriot hôspital Anaesthesia and intensive care|Dr Emmanuel Boselli|+334711689|emmanuel.boselli@chu-lyon.fr|
22449707|NCT02214277|Claret Medical|Director of Clinical Research|707-528-9300|info@claretmedical.com|
22449708|NCT01519882|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22449709|NCT01077804|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22449710|NCT02776917|University of California, San Diego|Barbara Parker, MD|(858) 657-6100|baparker@health.ucsd.edu|
22449711|NCT02818218|Cleveland Clinic Foundation|YanYan Han|216-444-2250|HANY3@ccf.org|
22449712|NCT05965349|University of Washington|Dr. Linda Ko|2066854978|lindako@uw.edu|
22449713|NCT04476537|Columbia University|Gulam Manji, MD|212-342-5162|gam2140@cumc.columbia.edu|
22449714|NCT02280941|University of Ottawa Heart Institute|Dr. Terrence Ruddy|6136967000|truddy@ottawaheart.ca|7267
22449715|NCT04866771|University Of Illinois At Chicago|PRS Training Lead|(312) 996-4995|awards@uic.edu|
22449716|NCT00560950|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22449717|NCT00483223|Massachusetts General Hospital|Steven Isakoff, MD, PhD|617-726-4920|SISAKOFF@mgh.harvard.edu|
22449718|NCT04328207|University of Alabama at Birmingham|Cynthia Owsley|2053258635|cynthiaowsley@uabmc.edu|
22449719|NCT00574405|Arkansas Children's Hospital Research Institute|Kathryn Thrailkill, MD|501-364-1430|thrailkillkathrynm@uams.edu|
22449720|NCT01336738|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22449721|NCT01083433|Rainbow Babies and Children's Hospital|Sarah A. MacLeish, DO|216-844-3661|sarah.macleish2@uhhospitals.org|
22449722|NCT02383667|The University of Toledo|Saima Karim, DO|419-383-3697|Saima.Karim@utoledo.edu|
22449723|NCT02970968|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
22449724|NCT03003520|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22449725|NCT01332149|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22449726|NCT04982029|Brigham and Women's Hospital|Dr. Joji Suzuki|617-455-7981|jsuzuki2@bwh.harvard.edu|
22400585|NCT02017444|University of Birmingham|Professor Alex Sinclair|+44 121 415 9125|a.b.sinclair@bham.ac.uk|
22400586|NCT01232946|Indiana University|Kieren J. Mather MD|317-278-7826|kmather@iu.edu|
22400587|NCT01614457|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22400588|NCT02698410|Ipsen|Ipsen Medical Director|see email|clinical.trials@ipsen.com|
22400589|NCT03952130|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22400590|NCT01713348|Abbott Diabetes Care|Snr Director, Clinical Development & Regulatory Affairs|01993863164|joe.bugler@abbott.com|
22400591|NCT01712360|Merz North America, Inc.|Ashlee Duncan|984-222-6040|Ashlee.Duncan@merz.com|
22381061|NCT00310362|MInneapolis VA Health Care System|Dr. Joan Griffin|507-538-1490|griffin.joan@mayo.edu|
22400592|NCT04425850|Eurnekian Public Hospital|Dr. Héctor Carvallo|54144800949|hymcarvallo@hotmail.com|
22400593|NCT03199911|University of California, San Francisco|Davin Ashraf MD|415-353-2800|davin.ashraf@ucsf.edu|
22413604|NCT03555305|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22413605|NCT04544787|University of Antwerp|Pierre Van Damme, MD, PhD|+32 3 265 21 30|pierre.vandamme@uantwerpen.be|
22413606|NCT00925054|BioMarin Pharmaceutical Inc.|Medical Director|415-475-5854|ari.gershman@bmrn.com|
22386912|NCT02757898|Emory University|Dr. John Roback|404-712-1774|jroback@emory.edu|
22386913|NCT03744559|Medical University of South Carolina|Dr Michael Saladin|(843) 792-5306|saladinm@musc.edu|
22386914|NCT02567435|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22386915|NCT02166463|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22386916|NCT04726410|University of Pittsburgh|Jason Sperry|4128028270|sperryjl@upmc.edu|
22386917|NCT01318694|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
22386918|NCT03767335|Menarini Ricerche S.p.A.|Clinical Sciences|+39 05556809990|martine.piccart@bordet.be|
22386919|NCT03705390|CRCTU, University of Birmingham|D3B Trial Mangement Team Leader|+44 (0) 121 371 8027|ALS@trials.bham.ac.uk|
22386920|NCT03047213|Yale School of Medicine: Medical Oncology|Joseph Kim, MD, Associate Professor of Internal Medicine|(203) 200-4822|joseph.w.kim@yale.edu|
22386921|NCT05988957|HealthPartners Institute|Holly Willis|952-993-3219|holly.willis@parknicollet.com|
22386922|NCT06139302|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22386923|NCT05394844|uwashington|Dr nicole ehrhardt|2404479566|nehrhard@uw.edu|
22386924|NCT03725332|University of Kentucky|Wendy Hansen, MD|859-218-0765|wendy.hansen@uky.edu|
22386925|NCT04098276|Johns Hopkins University|Bushra Sabri|+1 (410) 955-7105|bsabri1@jhu.edu|
22386926|NCT04599296|University of Washington|Dr. Mia Hagen, Associate Professor|206-598-3404|smia@uw.edu|
22386927|NCT02726386|NeuroDerm Ltd.|Laurence Salin, MD, Senior Medical Director|+33687548073|laurence@neuroderm.com|
22386928|NCT04955431|University of Montana|Dr. John Quindry|406-243-4268|john.quindry@mso.umt.edu|
22386929|NCT06415045|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|001
22386930|NCT02101853|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22386931|NCT02112916|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22386932|NCT06995755|Pro-Change Behavior Systems, Inc.|Sara Johnson, PhD|401.360.2980|sjohnson@prochange.com|
22386933|NCT02823327|Statistical and Data Analysis Center, AIDS Malignancy Consortium|Deukwoo Kwon|(713) 500-7964|deukwoo.kwon@mountsinai.org|
22386934|NCT04712903|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22386935|NCT00391443|Actelion Pharmaceuticals Ltd|Isabelle Leconte,PhD -Data Science Group Leader, Director|+41 61 565 64 18|isabelle.leconte@actelion.com|
22386936|NCT03782116|Elidah, Inc.|Director of Clinical Trials|978.435.4324|customercare@elitone.com|
22386937|NCT04908514|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
22386938|NCT00945724|International Extranodal Lymphoma Study Group (IELSG)|Scientific and Medical Director|+41 58 666|ielsg@ior.usi.ch|7321
22386939|NCT03485287|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
22386940|NCT05039021|Ethicon Endo-Surgery, Inc.|Senior Director Medical Affair-Endomechanical and Trx|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22386941|NCT00994643|Thomas Jefferson University|Dr. Matthew Carabasi|215-955-8874|matthew.carabasi@jefferson.edu|
22386942|NCT02566889|Janssen Scientific Affairs|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22386943|NCT02377700|Xeltis|Eliane Schutte, CEO|+31 40 751 7614|clinical@xeltis.com|
22386944|NCT03971539|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22386945|NCT02454283|Laguna Pharmaceuticals|Chief Medical Officer|858-405-1429|hdittrich@imager.com|
22386946|NCT00825344|Johns Hopkins|Dr. Steven P. Cohen|410-955-1818|scohen40@jhmi.edu|
22386947|NCT03373916|University of Michigan|Paul Pfeiffer, MD|734-845-3645|ppfeiffe@med.umich.edu|
22386948|NCT01964300|Pediatric Brain Tumor Consortium|Catherine Billups|901-595-3709|catherine.billups@stjude.org|
22386949|NCT02524769|Loyola University Chicago|Dr. Elizabeth Mueller|708-216-2180|EMUELLE@lumc.edu|
22386950|NCT03653364|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22386951|NCT06003075|University of Kentucky|Dr. Ralph Zinner|859-562-2864|ralph.zinner@uky.edu|
22386952|NCT03286114|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
22413607|NCT04841317|Stanford University|Paul J. Wang, MD|(650) 723-7111|Paul.J.Wang@stanford.edu|
22449727|NCT03264404|Columbia University|Ruth White, MD, PhD|212-342-5162|raw2168@cumc.columbia.edu|
22449728|NCT02565381|Massachusetts General Hospital|Travis P. Baggett, MD, MPH (Principal Investigator)|617-643-9314|tbaggett@mgh.harvard.edu|
22449729|NCT01558700|Northwestern University|Apkar Vania Apkarian|(312) 503-0404|a-apkarian@northwestern.edu|
22449730|NCT04615949|CardiolRx|Andrea B. Parker, MSc. PhD, Senior Director Clinical Operations|+1 289 9100862|andrea.parker@cardiolRx.com|
22449731|NCT03036566|University of Michigan|Dennis J. Fasbinder, DDS|7346474450|djfas@umich.edu|
22449732|NCT05458856|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22449733|NCT04625803|The First Affiliated Hospital, Zhejiang University School of Medicine|Weijia Fang|+86 87235147|weijiafang@zju.edu.cn|
22449734|NCT05087875|University of Kentucky|Carolyn Lauckner|8595623335|carolyn.lauckner@uky.edu|
22449735|NCT01852292|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22449736|NCT04320940|Hikma Pharmaceuticals|Amy Schutte|440-201-5010|aschutte@Hikma.com|
22449737|NCT00071812|GlaxoSmithKline|GSK Response Center|866-435-7343||
22449738|NCT03661814|Icahn School of Medicine at Mount Sinai|Dr. Joel Bauer|914-715-4242|jjb.msh@gmail.com|
22449739|NCT01940120|Abbott Vascular Structural Heart (formerly Evalve, Inc.)|Chithra Sangli|650-430-1329|chithra.sangli@av.abbott.com|
22449740|NCT01088646|Givenimaging|Hilla Debby/Director of clinical affairs|97249097774|hila.debby@givenimaging.com|7774
22449741|NCT03711162|Galapagos NV|Galapagos Medical Information|+32 15 342900|medicalinfo@glpg.com|
22449742|NCT02431754|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22449743|NCT01275066|BioMarin Pharmaceutical Inc.|BioMarin Medical Information Services|(800) 983-4587|medinfo@bmrn.com|
22449744|NCT03240133|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
22449745|NCT00749463|J&J Consumer and Personal Products Worldwide|Joyce Hauze, Sr Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
22449746|NCT00116831|GlaxoSmithKline|GSK Response Center|866-435-7343||
22449747|NCT04904185|National Center for Cancer Immune Therapy (CCIT-DK)|MD, PhD Tine Juul Monberg|38682983|tine.monberg@regionh.dk|
22449748|NCT02061969|Emory University|Saumeth Cardona MD|404-616-4827|scardon@emory.edu|
22449749|NCT01344369|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22449750|NCT03567850|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-2300|Kristopher.Attwood@roswellpark.org|
22449751|NCT01127503|Valeant Pharmaceuticals|Johnson Varughese|9089271400||
22449752|NCT00333229|Novartis Pharmaceuticals|Study Director|862-778-8300||
22449753|NCT02129075|Fred Hutchinson Cancer Research Center|Dr. Martin A. Cheever|206-667-4141|mcheever@fredhutch.org|
22449754|NCT00935428|OHSU|Dr. John Mayberry|503-494-5300|mayberrj@ohsu.edu|
22449755|NCT00526058|B. Braun Medical Inc.|Kevin Minnich, Manager Clinical Affairs/Safety Officer|610-596-2358|kevin.minnich@bbraun.com|
22449756|NCT01010282|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22449757|NCT00735371|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22449758|NCT01533246|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Jorge Garcia|216-444-7774|garciaj4@ccf.org|
22449759|NCT00422032|The University of Texas M. D. Anderson Cancer Center|Hagop Kantarjian, MD / Professor|713-792-7026|eharriso@mdanderson.org|
22449760|NCT00980395|University of Arizona|Amy Selegue, NCTN Program Coordinator|520-626-0301|aselegue@email.arizona.edu|
22449761|NCT01094548|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22449762|NCT01112293|AbramsonCC|James Robinson|215-662-8758|jamesrobinson2@pennmedicine.upenn.edu|
22449763|NCT00112242|Department of Oncology, Division of Medical Oncology University Hospital Lausanne|Prof Olivier Michielin|+41 21 314 01 85|Olivier.Michielin@chuv.ch|
22449764|NCT03608488|SultanAbdulhamid|Tugba OZsoy-Unubol|+905074583382|tugbaozsoyy@gmail.com|
22449765|NCT02127632|DorkuzEU|Anaesthesiology and Reanimation|90.505.525.29.01|ozbilginsule@gmail.com|
22449766|NCT02901951|GlaxoSmithKline|GSK Response Center|866-435-7343|sk994601@gsk.com|
22449767|NCT01971853|"University of Colorado Denver | Anschutz"|Director, Clinical Research Administration||clinicalresearchsupportcenter@ucdenver.edu|
22449768|NCT06431061|CooperVision Inc.|Jose A Vega, OD,MSc,PhD|925-621-3761|JVega2@coopervision.com|
22449769|NCT04225923|Nobelpharma Co. Ltd.|Research & Development Divion|81-3-6670-3800|watanabe.tatsuya@nobelpharma.co.jp|
22449770|NCT04964453|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22449771|NCT01585766|MedImmune|Armando Flor, MD, Director, Clinical Development|301-398-1955|information.center@astrazeneca.com|
22449772|NCT01364428|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22449773|NCT01987427|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22449774|NCT04630093|University of Florida|Dr. Julio Duarte|352-273-8132|juliod@cop.ufl.edu|
22449775|NCT04590547|GeneOne Life Science|Senior Clinical Operations Associate|6106576351|dkane@genels.us|
22449776|NCT03799484|The University of Texas Health Science Center at Houston|Karina Richani-Reverol, MD|(713) 559-5200|Karina.RichaniReverol@uth.tmc.edu|
22449777|NCT04120610|Medtronic|Janki Shah|732-266-2503|janki.shah@medtronic.com|
22386953|NCT02956642|University of California San Francisco|Dr. Jenise Wong|415-476-3316|jenise.wong@ucsf.edu|
22386954|NCT03983382|Memorial Sloan Kettering Cancer Center|Dr. Anthony Yu, MD|212-639-5154|yua3@mskcc.org|
22386955|NCT03053960|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Lionel Gold|215-955-6215|Lionel.Gold@jefferson.edu|
22386956|NCT02348632|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-970-7145|ClinicalTrialDisclosure@JazzPharma.com|
22386957|NCT01260896|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22386958|NCT01209195|Merrimack Pharmaceuticals, Inc.|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
22386959|NCT02754596|Glaukos|Study Manager|949-481-8076|ldoan@glaukos.com|
22449778|NCT02129803|Virginia Commonwealth University|Bruce K. Rubin MEngr, MD, MBA, FRCPC|804 828 9604|bruce.rubin@vcuhealth.org|
22386960|NCT03601897|Deciphera Pharmaceuticals, LLC|Clinical Trials|785-830-2100|clinicaltrials@deciphera.com|
22386961|NCT03598998|City of Hope Medical Center|Dr. Alex Herrera|6263598111|aherrera@coh.org|
22386962|NCT04227600|JCR Pharmaceuticals|Study Director|+81 797 32 8582|clinical_development@jp.jcrpharm.com|
22386963|NCT04018495|Medical College of Wisconsin|Rose Franco, MD|414-955-7040|rfranco@mcw.edu|
22386964|NCT02879318|Canadian Cancer Trials Group|Chris O'Callaghan|6135336430|cocallaghan@ctg.queensu.ca|
22386965|NCT02382003|University of Virginia Department of Psychology|Dr. Bethany Teachman|434-924-0676|bethanyteachman@gmail.com|
22386966|NCT05934292|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22386967|NCT02890355|SWOG Statistical Center|SWOG Statistician|2066674623|mduong@fredhutch.org|
22386968|NCT02206828|Medtronic|Djamila Bennat|33474089000|djamila.bennat@medtronic.com|1591
22386969|NCT03391466|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
22386970|NCT03140670|Abramson Cancer Center|Pancreas Research Program Manager|2672575567|mazali@pennmedicine.upenn.edu|
22386971|NCT00220805|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
22386972|NCT02325466|Icahn School of Medicine at Mount Sinai|Dr. Robert S. Rosenson|212-241-9101|robert.rosenson@mssm.edu|
22430523|NCT00889005|New York Langone Medical Center Department of Psychiatry|Arieh Y. Shalev, M.D.|6467544782|arieh.shalev@nyumc.org|
22430524|NCT04556006|Kilis 7 Aralık University|Dr. Uğur Doğan|+903488139301|63ugurdogan@gmail.com|
22386973|NCT00692913|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22386974|NCT01637402|University of California, San Francisco|Dr. Terry Friedlander, MD|415-514-6380|Terence.Friedlander@ucsf.edu|
22386975|NCT00351299|BrighamHospital|Dr. Gerald Weinhouse|617-732-5499|gweinhouse@partners.org|
22386976|NCT02285270|University of Pennsylvania|Daniel Pryma|215-349-5272|daniel.pryma@uphs.upenn.edu|
22386977|NCT02111096|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22386978|NCT01143142|University of Colorado|Amanda Dempsey|303-724-6679|amanda.dempsey@ucdenver.edu|
22386979|NCT00439270|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22386980|NCT01268306|Arthur B. Epstein, OD|Dr. Arthur Epstein|424-226-2020|artepstein@yahoo.com|
22386981|NCT04121546|Indiana University School of Medicine|Dr. Michael Bushey|3179637300|mabushey@iu.edu|
22386982|NCT04129164|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22386983|NCT06203990|Washington University in St. Louis|Gammon Earhart|314-286-1407|earhartg@wustl.edu|
22386984|NCT05288348|University of Pittsburgh|Francis X Guyette|412 651 1077|guyettef@upmc.edu|
22386985|NCT00909649|Mansoura university hospital|Elnakeeb Ayman|0106752021|elnakeebayman@yahoo.com|
22386986|NCT00943917|Intarcia Therapeutics, Inc|Michelle Baron MD|510-782-7800|clinicaltrials@intarcia.com|
22386987|NCT01171976|Novartis Pharmaceuticals|Study Director|862-778-8300||
22386988|NCT00003222|University of Virginia|Craig L. Slingluff, MD|434-924-1730|CLS8H@hscmail.mcc.virginia.edu|
22386989|NCT02224729|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Joanne Filicko, O'Hara|215-955-8874|joanne.filicko@jeffersron.edu|
22386990|NCT01313559|Thomas Jefferson University|Jianqing Lin, MD|215-955-8874|Jianqing.Lin@jefferson.edu|
22386991|NCT02466971|NRG Oncology|Christopher Purdy on behalf of Wei Deng, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
22386992|NCT05707351|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22386993|NCT01996436|The University of Texas Health Science Center at Houston|Peng Roc Chen, MD|713-486-8016|Peng.R.Chen@uth.tmc.edu|
22386994|NCT04174560|Cincinnati Children's Hospital|Robert Frenck, Jr., MD|513-636-4463|Robert.Frenck@cchmc.org|
22386995|NCT03872466|Barron Associates, Inc.|Richard Adams|4348253435|adams@bainet.com|
22386996|NCT01778686|Rigshospitalet and University of Copenhagen|Gitte Moos Knudsen|+4535456720|gmk@nru.dk|
22386997|NCT04012567|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
22386998|NCT05856266|Biovitrum|CPL|0795914760|rolf.schlosshauer@sobi.com|
22386999|NCT04261790|Johns Hopkins Universtiy|Bardia Nourbakhsh|410-614-1522|bnourba1@jhmi.edu|
22387000|NCT02586974|Città della Salute e della Scienza di Torino - Ospedale Molinette|Dr. Marco Oderda|+393479383465|marco.oderda@libero.it|
22387001|NCT05714059|Medtronic Diabetes|DZ Dai, Sr Statistician|8185764034|dz.dai@medtronic.com|
22387002|NCT04899674|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22387003|NCT05545280|Cleveland Clinic Foundation|Kurt Ruetzler, MD|216 636-0561|RUETZLK@ccf.org|
22400594|NCT00541307|W. L. Gore & Associates, Inc.|Chad Badorek|928/437-8181|cbadorek@wlgore.com|
22400595|NCT00101361|James J. Peters VA Medical Center|William A. Bauman, M.D.|718-584-9000|william.bauman@va.gov|
22400596|NCT02424539|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22400597|NCT04178590|Department of Periodontology and Oral Medicine, School of Dental Medicine, University of Belgrade|Dr Mila Vuckovic|+381637060694|jovanovic.dr.mila@gmail.com|
22400598|NCT04723537|RedHill Biopharma Ltd.|Gilead Raday, COO|+972-(0)3-541-3131|info@redhillbio.com|
22400599|NCT04329949|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
22400600|NCT01845025|Novartis Pharmaceuticals|Study Director|862-778-8300||
22400601|NCT02513940|Indiana University|Dr. James E Tisdale|317-880-5418|jtisdale@iu.edu|
22400602|NCT03102736|Icahn School of Medicine at Mount Sinai|Dr. James Murrough|212-585-1640|james.murrough@mssm.edu|
22400603|NCT00345605|Baylor College of Medicine|Dr. Sandesh Nagamani||nagamani@bcm.edu|
22400604|NCT00733902|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22400605|NCT01552876|Johnson & Johnson Vision Care|Katherine Osborn OD, MS FAAO|1 904 443-1032|kosborn@its.jnj.com|
22400606|NCT03717922|UCLA Psychiatry & Biobehavioral Sciences|Dr. Taylor P. Kuhn, PhD|‭(310) 829-5968‬|tkuhn@mednet.ucla.edu|
22400607|NCT03126227|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
22400608|NCT01126619|Abbott|Global Medical Services|800-633-9110||
22400609|NCT04876391|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
22449779|NCT02319031|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
22449780|NCT02356692|CooperVision|Donald Siegel, OD|602 485 3414|dsiegel@coopervision.com|
22449781|NCT03712410|University of Pennsylvania|George Demiris|2158988559|gdemiris@upenn.edu|
22449782|NCT01015586|Medical University of South Carolina|Bryan K. Tolliver, MD PhD|843-792-4869|tollive@musc.edu|
22449783|NCT00314236|Piramal Healthcare (Canada) Limited|Alberto Restrepo, MD, Director of Medical and Clinical Affairs|450-686-2437|alberto.restrepo@piramal.com|315
22449784|NCT01465464|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.||toiawase@taiho.co.jp|
22449785|NCT03395314|Yale School of Medicine|Sarah Fineberg, MD, PhD|(203) 974-7265|sarah.fineberg@yale.edu|
22449786|NCT01183975|Ethicon, Inc.|Birgit Temiz|+49 (0) 40 5297 3144|btemiz@its.jnj.com|
22449787|NCT04371380|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22449788|NCT01102413|Pharmacosmos A/S|Vice President Research & Development Department|+45 59485959|llt@pharmacosmos.com|
22449789|NCT02376166|Icahn School of Medicine at Mount Sinai|Dr. Matthew D. Galsky|(212) 659-5599|matthew.galsky@mssm.edu|
22449790|NCT01425879|The Ohio State University|Tanios Bekaii-Saab, MD|614-293-9863|tanios.bekaii-saab@osumc.edu|
22387004|NCT03593356|University of California, Irvine|Greg John Duncan|(949) 824-7831|gduncan@uci.edu|
22387005|NCT04305327|LEO Pharma A/S|Clinical disclosure|+45 4494 5888|disclosure@leo-pharma.com|
22387006|NCT02379351|University of Utah, Department of Obstetrics & Gynecology|Dr. Erin Clark|801-5818425|erin.clark@hsc.utah.edu|
22387007|NCT05517902|Mallinckrodt|Medical Information Call Center|1-800-844-2830|medinfo@mnk.com|
22387008|NCT01162096|Thomas Jefferson University|Neal Flomenberg, MD|215-955-4367|neal.flomenberg@jefferson.edu|
22387009|NCT05864209|NYU Langone Health|Linda G Kahn, PhD, MPH|(917) 439-8069|linda.kahn@nyulangone.org|
22387010|NCT04530487|M D Anderson Cancer Center|Jeremy S Connors, MD|(713) 792-6624|jsconnors@mdanderson.org|
22387011|NCT04977583|Department of Veterans Affairs|Dr. Grant Huang|(202) 443-5700|CSP@va.gov|
22387012|NCT04207736|Aldeyra Therapeutics, Inc.|Bill Cavanagh|781-257-3063|bcavanagh@aldeyra.com|
22387013|NCT00979459|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22387014|NCT04974047|BeiGene|Study Director|1 877-828-5568|clinicaltrials@beigene.com|
22387015|NCT00655499|GERCOR|Regulatory affairs|00331 40 29 85 00|Regulatory.Affairs@gercor.com.fr|
22387016|NCT00753337|Medtronic Aortic and Peripheral Vascular|Arslan Malik - Senior Clinical Research Manager|(707) 541-3256|arslan.malik@medtronic.com|
22387017|NCT00146172|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
22387018|NCT00210106|Digestive Tumours Unit, Institut Bergonie|Pr Serge Evrard|s.evrard@brdeaux.unicancer.fr||
22387019|NCT00786864|University of the Witwatersrand|Gina L Fanucchi|+27 11 616 4400|gfanucs@mweb.co.za|
22387020|NCT02422615|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22387021|NCT01288443|Sanofi|Trial Transparency Team||Contact --US@sanofi.com|
22387022|NCT01596972|Planned Parenthood League of Massachusetts|Director of Clinical Research and Training|617.616.1600|agoldberg@pplm.org|
22387023|NCT04327843|Case Western Reserve University|Kaylee Sarna|(216) 368-3577|kns17@case.edu|
22387024|NCT01639131|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University|Nilofer Azad, MD|410-614-9169|nazad2@jhmi.edu|
22387025|NCT01617369|University of North Carolina Chapel Hill|Dr. Scott Donaldson|919-966-9198|scott_donaldson@med.unc.edu|
22387026|NCT00557284|IMMUNOe International Research Centers|Dr. Isaac Melamed, principle investigator|303-773-9000|melamedi@immunoe.com|
22387027|NCT00945321|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22387028|NCT02438137|UMichigan|Tiffany Braley, M.D., M.S.|734-232-1147|tbraley@med.umich.edu|
22387029|NCT00195403|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22387030|NCT06065501|National Cheng Kung University|Professor Miaofen Yen / Professor of Nursing department|886-6-2353535|miaofen@mail.ncku.edu.tw|5823
22413608|NCT00858845|University of California, Los Angeles (UCLA)|Dr. Holly R. Middlekauff|310-206-6672|hmiddlekauff@mednet.ucla.edu|
22413609|NCT03031847|UPMC Presbyterian Hospital|Eric Pasquantonio|4126478210|pasquantonioej@upmc.edu|
22413610|NCT04916548|University of Pittsburgh|Dr. Rebecca Price|412-383-2150|pricerb@upmc.edu|
22413611|NCT02100228|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22413612|NCT01964092|University of Oslo|Silje Endresen Reme|22845236|s.e.reme@psykologi.uio.no|+47
22413613|NCT00322465|University of Alabama at Birmingham|Jane R. Schwebke, MD|(205) 975-5665|schwebke@uab.edu|
22413614|NCT01073657|Veterans Health Adminstration|Marsha Langer Ellison, Ph.D.|781 687 3401|Marsha.Ellison@va.gov|
22413615|NCT02744352|University of Pennsylvania|Anmol Madaan, Clinical Research Coordinator|2156623778|Anmol.Madaan@Pennmedicine.Upenn.edu|
22413616|NCT00854100|Allergan, Inc|Therapeutic Area Head|877-277-8566|IR-CTRegistration@allergan.com|
22413617|NCT00183794|USC/Norris Cancer Comprehensive Cancer Center|Agustin Garcia, MD|323-865-3900|aagarcia@usc.edu|
22413618|NCT02242201|Mayo Clinic|Dr. Rebecca L. Johnson|507-266-2049|Johnson.Rebecca1@mayo.edu|
22413619|NCT00389064|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
22413620|NCT01379664|Cleveland Clinic Foundation|Daniel Sessler|216-444-4900|DS@OR.org|
22413621|NCT02298322|Zeltiq Aesthetics, Inc. an Allergan Affiliate|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|Kerrie.Jiang@allergan.com|
22413622|NCT01223365|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22413623|NCT03880266|Dermira, Inc|Jordan Adajar|650-421-2919|jordan.adajar@dermira.com|
22413624|NCT05472038|BioNTech clinical trials patient information|BioNTech SE|6131 90840|patients@biontech.de|
22413625|NCT03235739|Cleveland Clinic|Alparslan Turan, MD|216-4459857|turana@ccf.org|
22413626|NCT00467896|Actelion Pharmaceuticals, US, Inc.|Wade Benton, Pharm D / Director, Medical Affairs Veletri and Ventavis|(650) 624-6900|wade.benton@actelion.com|
22413627|NCT02847650|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22413628|NCT03797872|University of Oxford|Professor Laura Coates|+447870257823|laura.coates@ndorms.ox.ac.uk|
22413629|NCT03818581|Massachusetts General Hospital|Dr. John Winkelman|617-643-9101|jwwinkelman@mgh.harvard.edu|
22413630|NCT01686451|Department of Cardiology, the Second Affiliated Hospital, Wenzhou Medical University, Zhejiang province, Wenzhou, 325000, China|Dr. JiFei Tang|+8615968766021|jiftang@126.com|
22413631|NCT00156247|UMDNJ-Robert Wood Johnson Medical School|Melissa Magliocco, MD|(732) 235-5735|maglioma@umdnj.edu|
22413632|NCT01529060|Baylor|Alyssa Tran, BS|832-822-4264|alyssat@bcm.edu|
22413633|NCT02378935|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22413634|NCT01980771|State University of New York, Downstate Medical Center|Tracey Wilson, Principal Investigator|718 270 2105|Tracey.Wilson@downstate.edu|
22413635|NCT03199872|RhoVac ApS|Steven Glazer, MD|+4525674434|sgl@rhovac.com|
22413636|NCT03450057|General Hospital of Athens 'Alexandra', Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine|Prof. Evangelos Terpos|+302102162540|eterpos@med.uoa.gr|
22413637|NCT01163461|VAMC Puget Sound|Dr. Diane Kendall (PI)|206-762-1010|diane.kendall@va.gov|
22413638|NCT03214952|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22413639|NCT00829790|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22413640|NCT03935880|University of Wisconsin - Madison|Andrew Brooks|248-953-9777|abrooks2@uwhealth.org|
22413641|NCT00365365|Sanofi|Trial Transparency Team||Contact_Us@sanofi.com|
22413642|NCT00984022|Maricopa Integrated Health System|David Drachman|602-344-5161|david.drachman@mihs.org|
22413643|NCT01036009|Benioff Children's Hospital at UCSF|Biljana Horn|415 476 2188|hornb@peds.ucsf.edu|
22413644|NCT02924883|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22413645|NCT00004562|New York University School of Medicine|Judith S. Hochman, M.D.|212-263-6927|judith.hochman@nyumc.org|
22413646|NCT00724477|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22413647|NCT02062580|University of Cape Town and University of Washington|Heather Jaspan|+2721 4066823|hbjaspan@gmail.com|
22413648|NCT00102440|Takeda Global Research & Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22413649|NCT04627038|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22413650|NCT02325531|Kaiser Permanente Center for Health Research|Rachel Gold|5033352400|rachel.gold@kpchr.org|
22413651|NCT01792635|Pfizer, Inc.|Pfizer ClnicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22413652|NCT03861845|Florida International University|Dr. Jaclyn Schwartz|305-348-3106|jschwart@fiu.edu|
22413653|NCT00717405|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22413654|NCT01401647|University of Washington, Resuscitation Outcomes Consortium|Dr. Susanne May|206-685-1302|rochelp@uwctc.org|
22413655|NCT00752973|Taro Pharmaceuticals U.S.A., Inc.|Director, Clinical Research|914 345 9001|natalie.yantovskiy@taro.com|
22413656|NCT05428020|Rush University Medical Center|Anne DeBenedetti, Director of Research, Adult Reconstruction|3124322468|anne.debenedetti@rushortho.com|
22430525|NCT04629157|Alder Hey Children's NHS Foundation Trust|Miss Rachel Harwood|0151 228 4811|rachel.harwood@alderhey.nhs.uk|
22430526|NCT02872142|Grifols Bioscience Industrial Group|Michael Woodward|+34 938008784|michael.woodward@grifols.com|
22449791|NCT01113632|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22449792|NCT02045511|Johns Hopkins University School of Medicine Dept. Otolaryngology-HNS|Carrie Nieman|3025368362|cnieman1@jhmi.edu|
22449793|NCT02739269|The University of Hong Kong|Dr. Raymond Li|+852 22554517|raymondli@hku.hk|
22449794|NCT02244580|Biontech Diagnostics GmbH|Dr. Michael Oed|+49 6131/ 6358030|michael.oed@theracode.de|
22449795|NCT01228747|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22449796|NCT01821534|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22449797|NCT02136576|Tufts University School of Dental Medicine|Dr. Britta Magnuson|617-636-3878|britta.magnuson@tufts.edu|
22449798|NCT01708174|Novartis Pharmaceuticals|Study Director|862-778-8300||
22449799|NCT00923559|Dept of Women's and Children's Health, Karolinska Institutet|Björn Salomonsson|+46851777206|bjorn.salomonsson@ki.se|
22449800|NCT02268812|Eisai Europe Ltd.|Eisai Medical Services|+44 (0)20 8600 1400||
22449801|NCT04903249|Dartmouth-Hitchcock Medical Center|Courtney J. Stevens, PhD, Principal Investigator|603-650-9643|courtney.j.stevens@dartmouth.edu|
22449802|NCT01144442|Masonic Cancer Center|Peter Argenta, MD|612-626-3111|argenta@umn.edu|
22449803|NCT01951157|Pharma Mar S.A.|Pharma Mar S.A.|00 34 91846 60 00|clinicaltrials@pharmamar.com|
22449804|NCT05218018|University of Washington|Angela Hanson|206-897-5393|hansonaj@uw.edu|
22449805|NCT00868712|Walter Reed Army Medical Center, Cardiology Service|Todd C. Villines, MD|301-295-7839|todd.villines@us.army.mil|
22449806|NCT04662801|Yale School of Medicine|Dr Valentina Ivezaj, Assistant Professor of Psychiatry|+1 (203) 785-7807|valentina.ivezaj@yale.edu|
22449807|NCT00828191|IBSA Institut Biochimique SA|IBSA U.S. Agent|805 376 00 78|cejtwsxx@verizon.net|
22449808|NCT01883427|Umeå University|MD, PhD Krister Tano|0046705569043|krister.tano@umu.se|
22449809|NCT02620046|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22449810|NCT04041869|University of Iowa|Lucas Carr|319-353-5432|lucas-carr@uiowa.edu|
22449811|NCT01914666|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22449812|NCT01195467|St Stephen's AIDS Trust|Dr Mark Nelson|02033|mark.nelson@chelwest.nhs.uk|155610
22449813|NCT02388737|Takeda|Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
22449814|NCT03252522|Oregon Health & Science University|Jeanette Johnstone, PhD|5034943700|jojeanet@ohsu.edu|
22449815|NCT03018392|Bone and Joint Clinic of Baton Rouge|Research Projects Director|2254218207|aobrien@bjcbr.com|
22449816|NCT04152447|Massachusetts General Hospital|Dr. Marilyn Heng|617-643-0149|mheng@mgh.harvard.edu|
22449817|NCT03240575|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22449818|NCT04482179|Clinical Research Coordinator|Daniela Sacchetti, MS|215-573-4336|danielas@pennmedicine.upenn.edu|
22449819|NCT04718870|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22449820|NCT04127786|Sanofi Pasteur|Trial Transparency Team|8006331610|Contact-US@sanofi.com|6#
22449821|NCT03034954|University of Michigan|Dr. Annalise Rahman-Filipiak|734-763-9259|rahmanam@med.umich.edu|
22449822|NCT02400723|VA Palo Alto Health Care System|Christine Gould, PhD|650-493-5000|Christine.gould@va.gov|68899
22449823|NCT02340299|Charité - Universitätsmedizin Berlin|PD Dr. Christoph Czernik, principal investigator|+49 30 450|christoph.czernik@charite.de|566122
22449824|NCT03568942|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22449825|NCT02904057|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
22430527|NCT05122143|Altamira Medica Ltd.|Thomas Meyer|0041 61 201 13|ra@altamiramedica.com|50
22430528|NCT02317042|University of Western Australia|Prof Nigel McArdle & Prof Peter Eastwood|+61 8 9346 1706|peter.eastwood@health.wa.gov.au|
22430529|NCT00692237|Sapienza University of Rome|Dr Andrea Isidori|+39 0649970540|andrea.isidori@uniroma1.it|
22430530|NCT02579057|Johns Hopkins Hospital|Stuart Russell MD|4109555708|srusse14@jhmi.edu|
22430531|NCT00395447|BIOTRONIK, Inc|Crystal Miller, Clinical Studies Engineer|503-451-8051|crystal.miller@biotronik.com|
22430532|NCT03766906|Oregon Research Behavioral Intervention Strategies, Inc. dba Behavioral Influents Innovations|Jessie Marquez|541-484-2123|jessie.marquez@influentsin.com|
22449826|NCT01381861|TRACON Pharmaceuticals|Charles Theuer, Medical Monitor|8585500780|ctheuer@traconpharma.com|
22449827|NCT00554671|Providence VA Medical Center|Wen-Chih Wu, MD|4012737100|wen-chih.wu@va.gov|6237
22387031|NCT03820544|Sidney Kimmel Cancer Center at Thomas Jefferson University|Thomas Kowalski, MD|215-955-9396|Thomas.Kowalski@jefferson.edu|
22387032|NCT01380743|Patient Advocacy|Amicus Therapeutics|+1-609-662-2000|clinicaltrials@amicusrx.com|
22430533|NCT02624687|University of Pittsburgh|Bethany Barone Gibbs|4123834002|bbarone@pitt.edu|412
22430534|NCT02811419|University of California San Francisco|Trilokesh Kidambi|909-973-0629|tkgastromd@gmail.com|
22430535|NCT00836901|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22400610|NCT00644592|University of Florida|Reginald F. Frye, PhD, Associate Professor|3522735453|fryerf@ufl.edu|
22400611|NCT03981029|Ottawa Hospital Research Institute|Alysha Harvey|613-737-8899|alyharvey@ohri.ca|73838
22400612|NCT01859403|VA San Diego Health Sciences|Amir Zarrinpar, MD, PhD, Assistant Professor of Gastroenterology|858-246-1665|azarrinpar@health.ucsd.edu|
22400613|NCT01157117|Ichan School of Medicine at Mount Sinai|Dr. Hugh A. Sampson|212-659-9426|hugh.sampson@mssm.edu|
22400614|NCT00811252|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
22400615|NCT03014648|UPMC Hillman Cancer Center|Barbara M Stadterman, Regulatory Supervisor, Clinical Research Services|412-647-5554|stadtermanbm@upmc.edu|
22400616|NCT00749606|SUNY Upstate Medical University|Ruth S. Weinstock MD PhD|315-464-5740|weinstor@upstate.edu|
22400617|NCT01931865|Yale University School of Medicine|Bahman Jabbari M.D.|203-737-2464|bahman.jabbari@yale.edu|
22400618|NCT01121406|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22400619|NCT00504257|H. Lee Moffitt Cancer Center and Research Institute|Robert Wenham, Principal Investigator|813-745-8478|robert.wenham@moffitt.org|
22400620|NCT00892437|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22400621|NCT03185130|University Medical Center of Southern Nevada|Tony Zitek, MD|7023837885|zitek10@gmail.com|4
22400622|NCT02286960|NYU Langone Health|Milan Amin|646-754-1206|Milan.Amin@nyulangone.org|
22400623|NCT01860170|Spectrum Health|A. Samer A;-Homsi|616-486-5933|a.samer.al-homsi@spectrumhealth.org|
22400624|NCT00759577|New York University|Dr. Victor Nitti|646 825 6300|Victor.Nitti@NYUMC.org|
22449828|NCT04145895|Beaumont Hospitals|Diane Studzinski|2485512570|diane.studzinski@corewellhealth.org|
22400625|NCT02176486|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22400626|NCT03494647|Children's Hospital Colorado|Emily Sweeney, MD|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
22400627|NCT01882725|Arizona Institute of Footcare Physicians|Kerry Zang, DPM|480-834-8804|kerryzang@aol.com|
22400628|NCT00500071|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22400629|NCT01225354|DeNova Research|Jack Arkins, Data Manager|312-335-2070|jack@drdayan.com|
22400630|NCT05614011|QuantuMDx|Alice Toomey-Smith|4408708031234|alice.toomey-smith@quantumdx.com|
22400631|NCT04283461|Kaiser Permanente Washington|Lisa Jackson, MD, MPH|206-442-5216|lisa.a.jackson@kp.org|
22400632|NCT05490771|ECOG-ACRIN Cancer Research Group|Study Statistician|16176323012|eatrials@jimmy.harvard.edu|
22400633|NCT02481505|Sintetica SA, via Penate 5 Mendrisio|Elisabetta Donati Clinical Project Leader|+41.91.640.42.50|edonati@sintetica.com|
22400634|NCT04898166|Jinnah postgraduate medical centre|Syeda Mahanum Ali|03033901112|mahanumsyed8@gmail.com|
22400635|NCT00424398|ISTA Pharmaceuticals, Inc.|Vice President, Clinical Research & Medical Affairs|949-788-6000|tmcnamara@istavision.com|
22400636|NCT01023789|Abbott Vascular International BVBA|Susan Veldhof|+31653428610|susan.veldhof@av.abbott.com|
22400637|NCT01852084|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22400638|NCT01523821|Fred Hutchinson Cancer Research Center|H. Joachim Deeg, MD|206-667-5985|jdeeg@fredhutch.org|
22400639|NCT02533089|Li Ka Shing knowledge institute|Dr. L M Puchalski Ritchie|416 864 6060|lisa.puchalskiritchie@utoronto.ca|
22400640|NCT00095563|Princess Margaret Cancer Centre|Dr. Lillian Siu|416-946-2911|lillian.siu@uhn.ca|
22400641|NCT02115308|Cardiovascular Imaging Technologies, LLC|Joseph Soltys, PhD|816-531-2842|jsoltys@cvit.com|103
22400642|NCT01309737|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22400643|NCT02335502|St. Jude Medical|Roni Diaz|+19723098601|RDiaz@sjm.com|
22400644|NCT01442181|UF Healthcare|Dr. Thomas Beaver|352-273-5503|thomas.beaver@surgery.ufl.edu|
22400645|NCT02698189|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22400646|NCT00855439|University of Michigan|Rodica Pop-Busui, MD, PhD|734 647-9809|rpbusui@med.umich.edu|
22400647|NCT05502289|Johnson & Johnson Vision Care, Inc. (JJVC) 7500 Centurion|Benjamin Straker|1-800-843-2020|bstraker@its.jnj.com|
22400648|NCT04454411|University of Pennsylvania|James Loughead, Ph.D.|215-205-1876|loughead@pennmedicine.upenn.edu|
22400649|NCT01397851|independent|Richard Sedlmayr|6468412169|richard.sedlmayr@gmail.com|
22400650|NCT02333227|Baylor College of Medicine, Department of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine|Dr. Kjersti Aagaard|7137988467|aagaardt@bcm.edu|
22400651|NCT03459040|Icahn School of Medicine at Mount Sinai|Dr. John Levine|212-241-6021|john.levine@mssm.edu|
22400652|NCT03934684|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22400653|NCT01073943|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22400654|NCT00761215|Cubist Pharmaceuticals, Inc.|Philippe Prokocimer, MD|858-452-0370|philippe.prokocimer@cubist.com|241
22400655|NCT05662332|Eli Lilly and Company|Chief Medical Officer|08004595979|ClinicalTrials.gov@lilly.com|
22400656|NCT00947349|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22400657|NCT00538681|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22400658|NCT00628355|Ribeirao Preto Medical School - University of Sao Paulo|Omero Benedicto Poli Neto|551636023183|polineto@fmrp.usp.br|
22400659|NCT01446809|University of Washington|Dr Darin Davidson|206-543-3690|djdavi@uw.edu|
22400660|NCT03395210|Sanofi aventis recherche & développement|Trial Transparency Team|8006331610|Contact-US@sanofi.com|6#
22449829|NCT00913744|ThromboGenics NV|Dr. Petra Kozma-Wiebe|+32 16 751 310|Petra.kozma@thrombogenics.com|
22449830|NCT00805935|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22400661|NCT03063385|University of Pennsylvania School of Nursing|Dr. Antonia M. Villarruel|2158988283|amvillar@nursing.upenn.edu|
22400662|NCT00886821|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22400663|NCT03716726|Boston Medical Center|Patricia Kavanagh, MD|617-414-3573|Patricia.Kavanagh@bmc.org|
22400664|NCT02579603|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22387033|NCT05858905|Shockwave Medical|Josh Popp|1-510-279-4262|jpopp@shockwavemedical.com|
22413657|NCT00473330|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
22413658|NCT03502148|Privo Technologies|Dr. Manijeh Goldberg|9785872322|mgoldberg@privotechnologies.com|
22413659|NCT02512393|The University of Texas Health Science Center at Houston|Hyochol Ahn, PhD, ARNP|713-500-2179|Hyochol.Ahn@uth.tmc.edu|
22413660|NCT03999684|Dana-Farber Cancer Institute|Dr. Glenn Hanna|6176323090|glenn_hanna@dfci.harvard.edu|
22413661|NCT00336479|Vertex Pharmaceuticals Incorporated|Jeff Chodakewitz, M.D.|617-341-6777|Jeff_Chodakewitz@vrtx.com|
22413662|NCT00846495|Clinvest|Rebecca Browning|417-841-3664|rbrowning@clinvest.com|
22413663|NCT01079988|Merck Serono, a division of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22413664|NCT00468286|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
22449831|NCT00283439|Amgen Inc.|Study Director|866-572-6436||
22449832|NCT01539226|International Partnership for Microbicides|Dr John Steytler||jsteytler@ipmglobal.org|
22449833|NCT01218516|Morphotek (subsidiary of Eisai)|Morphotek (subsidiary of Eisai)|1-888-422-4743|esi_medinfo@eisai.com|
22449834|NCT01632891|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22449835|NCT00240071|University of Alabama at Birmingham|Carla I Falkson|205-975-2691|cfalkson@uab.edu|
22449836|NCT02633956|Intercept Pharmaceuticals, Inc|Medical Information|844-782-4278|medinfo@interceptpharma.com|
22449837|NCT04070833|Brigham and Women's Hospital|Pamela M. Rist|617-278-0835|prist@bwh.harvard.edu|
22449838|NCT04118010|Emory University|Dr. Vin Tangpricha|404-727-7254|vtangpr@emory.edu|
22449839|NCT04206293|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22449840|NCT03863210|University of Split School of Medicine|Dr. Slavica Jurić Petričević||slavica.juric01@gmail.com|
22449841|NCT02378844|electroCore INC|Clinical Affairs|+1 973 355 6683|clinical@electrocore.com|
22449842|NCT03325166|Oregon Health and Science University|Gerda Teglassy, MD|503-494-4526|tothg@ohsu.edu|
22449843|NCT02299050|University of Texas Health San Antonio|Mariam Alatrach|210-358-7220|alatrach@uthscsa.edu|
22449844|NCT03341052|Mayo Clinic|Andres Acosta|15072666931|acosta.andres@mayo.edu|
22449845|NCT00782210|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22449846|NCT02146482|Stanford University|Grant Ognibene|9518343465|grantog@stanford.edu|
22449847|NCT00820612|University of Michigan|B. Joseph Elmunzer, MD.|735 615 6652|badihe@umich.edu|
22449848|NCT01610791|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22449849|NCT01105247|Pharmacyclics|Danelle James|855-427-8846|medinfo@pcyc.com|
22449850|NCT05923229|Washington University School of Medicine|Kerri Rawson|314-273-1053|rawson@wustl.edu|
22449851|NCT04304001|Florida A&M University|Dr. Tanise Jackson, Director of Animal Welfare Research Integrity|850-599-3214|tanise.jackson@famu.edu|
22449852|NCT04164901|Institut de Recherches Internationales Servier (I.R.I.S.)|Clinical Studies Department|+33 1 55 72 60 00|scientificinformation@servier.com|
22449853|NCT02465528|Novartis Pharmaceuticals|Study Director|888-669-6682|Novartis.email@novartis.com|
22449854|NCT05358821|Sage Therapeutics|Amy Bullock|617-949-5151|amy.bullock@sagerx.com|
22449855|NCT01241903|University of Kentucky|Dr. Susan S. Smyth|(859) 323-2274|ssmyt2@uky.edu|
22449856|NCT04627064|Dana-Farber Cancer Institute|Toni Choueiri, M.D|617-6325456|toni_choueiri@dfci.harvard.edu|
22449857|NCT02121483|Boehringer Ingelheim (BI)|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22413665|NCT02352259|Institute of Oncology Ljubljana|Dr Gregor Serša|+38615874343|gsersa@onko-i.si|
22449858|NCT02086110|University of California, Davis Health System|Dr. Kathleen Angkustsiri|916-703-0278|kangkustsiri@ucdavis.edu|
22449859|NCT01869192|University of Colorado|Anthony Elias, MD|17208480347|anthony.elias@ucdenver.edu|
22413666|NCT02196675|Ethicon|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
22413667|NCT01265056|The University of Iowa|Jennifer Lassner|319-335-2123|jennifer-lassner@uiowa.edu|
22413668|NCT01416584|Johns Hopkins University School of Medicine|Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
22413669|NCT01624363|Indiana Universtiy Schol of Medicine|John DeWitt, MD, Director, Endoscopic Ultrasound|317-944-1113|jodewitt@iu.edu|
22413670|NCT02711852|Secura Bio, Inc.|Beth Gregory, PharmD, MBA|1-702-254-0011|bgregory@securabio.com|
22413671|NCT03459807|University of California, San Francisco|Dr. Chi-yuan Hsu|415-476-2172|chi-yuan.hsu@ucsf.edu|
22413672|NCT02431494|Nova Southeastern University|Sue Breno|9542621447|sb1382@nova.edu|
22449860|NCT05583903|Department of Surgery, Houston Methodist Hospital|Dr. Hina Faisal|713-714-4973|hfaisal@houstonmethodist.org|
22449861|NCT02286193|Group Health Research Institute|Clarissa Hsu, PhD|206-287-4276|hsu.c@ghc.org|
22449862|NCT00423891|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22449863|NCT00579111|Baylor|Rammurti Kamble, MD|713-394-6252|rtkamble@tmhs.org|
22449864|NCT02667483|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22449865|NCT01907828|Abbott|Rebecca Maslow, MA, Clinical Project Manager|+1 651-756-5564|rebecca.maslow@abbott.com|
22400665|NCT00469079|University of Minnesota|Dorothy Hatsukami, Ph.D.|612-626-2121|hatsu001@umn.edu|
22400666|NCT00942162|GlaxoSmithKline|GSK Response Center|866-435-7343||
22400667|NCT02833311|Case Western Reserve University|Matthew Plow, Ph.D.|216-368-8969|map208@case.edu|
22400668|NCT01006356|Medical department / Korea|Medical Director|+82-2-2094-4518||
22400669|NCT01670201|Harborview Medical Center / Seattle, Washington|Dr Nicole Gibran|206-744-3140|nicoleg@uw.edu|
22400670|NCT02189382|Procter and Gamble|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
22400671|NCT03368859|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22449866|NCT01073865|AstraZeneca|Global Clinical Lead|+44 1509 645895|clinicaltrialtransparency@astrazeneca.com|
22449867|NCT03925324|Medstar Health Research Institute|Megan Rowland|202-877-2959|megan.e.rowland@medstar.net|
22449868|NCT00259090|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22449869|NCT00696137|BDSI|Tim Warneke|919-582-0294|twarneke@bdsi.com|
22449870|NCT00167934|Washington University School of Medicine|Michael Yingling|573-579-1412|yinglingm@wustl.edu|
22449871|NCT00262509|Atlanta VA Rehabilitation R&D Center of Excellence|David A. Ross|404-321-6111|ross0128@bellsouth.net|6817
22449872|NCT02074995|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22449873|NCT02197806|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22449874|NCT00680901|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22449875|NCT00847288|Medtronic Cardiac Rhythm Disease Management|OptiVol Care Pathway Clinical Team|1-800-328-2518|medtronicCRMtrials@medtronic.com|
22449876|NCT04251221|Yale University|Dr. Ansel Hillmer|203-737-6400|ansel.hillmer@yale.edu|
22449877|NCT03035955|WakeForest|Director of Clinical Trials|336-716-3775||
22449878|NCT02120794|Medtronic Minimed|Suiying Huang, Statistician|8184763319|suiying.huang@medtronic.com|
22449879|NCT01148511|Novartis Pharmaceuticals|Study Director|862 778-8300||
22449880|NCT00589316|Fred Hutchinson Cancer Center|Johnnie Orozco, MD, PhD|(206) 667-4102|jorozco@fredhutch.org|
22449881|NCT00969553|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22449882|NCT04243538|Weill Cornell Medicine|Dr. Veerawat Phongtankuel|212-746-7000|vep9012@med.cornell.edu|
22449883|NCT04536727|University of Illinois at Chicago|Dr. David Marquez|(312) 996-1209|marquezd@uic.edu|
22449884|NCT00500370|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22449885|NCT02381392|Harbor-UCLA Medical Center|Kelly D. Young, MD|310-222-3506|kyoung@emedharbor.edu|
22449886|NCT03369717|Montefiore Medical Center|Nadeem Akbar MD|7189204646|nakbar@montefiore.org|
22449887|NCT05308901|Providence Portland Medical Center|Dr. Matthew Taylor|503-215-1979|canrsrchstudies@providence.org|
22449888|NCT02586012|University of Pittsburgh|Craig Seaman, MD|412-209-7308|seamanc@upmc.edu|
22449889|NCT02453113|UC Irvine|Kristen Kelly|949 824 5515|kmkelly@uci.edu|
22449890|NCT01816139|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22449891|NCT01572038|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22449892|NCT02554656|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22449893|NCT01888497|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22449894|NCT02488785|Joslin Diabetes Center|Sylvia Rosas|6173092486|sylvia.rosas@joslin.harvard.edu|
22449895|NCT01140477|Bausch & Lomb, a division of Valeant Corporation|Johnson Varughese|908-541-2179|Johnson.Varughese@valeant.com|
22449896|NCT04013191|Cares|UCB|+1844 599|clinicaltrials@ucb.com|2273
22449897|NCT05543928|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
22449898|NCT01904604|DAIT/NIAID|Director, Clinical Research Program|(301) 594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22449899|NCT05124665|Yale School of Public Health|Dr. J. Lucian Davis|203-785-3665|lucian.davis@yale.edu|
22449900|NCT04147442|Bernafon AG|Dr Barbara Simon|+41 31 998 1515|bsim@bernafon.com|1684
22449901|NCT04144166|North Shore University Hospital|Director of Clinical Research for Emergency Medicine|(516) 562-1513|TLi2@northwell.edu|
22400672|NCT02396147|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22449902|NCT02809430|University of Washington|Dr. Sandeep Khot|206-744-3251|skhot@uw.edu|
22449903|NCT01236755|The Hong Kong Polytechnic University|Prof Pauline Cho|+852 2766-6100|pauline.cho@polyu.edu.hk|
22449904|NCT01481116|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22449905|NCT03848845|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22449906|NCT02547662|Mayo Clinic|Shaji Kumar MD|507 284 2511|Kumar.Shaji@mayo.edu|
22400673|NCT02559505|University Of Rochester|Dr. Jennifer Nayak|5852767404|Jennifer_Nayak@URMC.Rochester.edu|
22400674|NCT03523585|Daiichi Sankyo|Contact for Clinical Trial Information|1-908-992-6400|CTRinfo@dsi.com|
22449907|NCT02433834|Pearl Therapeutics, Inc.|Paul Dorinsky, MD, FCCP|650-305-2600|pdorinsky@pearltherapeutics.com|
22449908|NCT02821962|University of Ottawa Heart Institute|Dr. Robert Reid|613-696-7393|breid@ottawaheart.ca|
22449909|NCT05847153|Massachusetts General Hospital|Dr. Christine Ritchie|4156721780|csritchie@mgh.harvard.edu|
22449910|NCT04609020|AbbVie|ABBVIE CALL CENTER|844-663-3742|abbvieclinicaltrials@abbvie.com|
22449911|NCT02107599|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22449912|NCT00779103|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|ClinicalTrials@Endo.com|
22430536|NCT01047540|AiCuris Anti-infective Cures GmbH|Information Desk|+4920231763|info@aicuris.com|0
22449913|NCT04098458|Medical University of South Carolina|Evan M. Graboyes, MD, MPH (principal investigator)|843-792-0719|graboyes@musc.edu|
22449914|NCT02462967|Galectin Therapeutics|Vice President of Regulatory Affairs|678-620-3186|horton@galectintherapeutics.com|
22449915|NCT00577512|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990|pettynathanm@uams.edu|2461
22449916|NCT02272413|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22449917|NCT04327999|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
22449918|NCT02872116|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22449919|NCT03552575|University of Glasgow|Professor John McMurray|0141 330 2627|john.mcmurray@glasgow.ac.uk|
22449920|NCT01052545|Michael E. DeBakey VA Medical Center|Barbara Trautner, MD, PhD|713-440-4438|barbar.trautner@va.gov|
22449921|NCT03792672|Takeda|Medical Director|1-877-825-3327|medicalinformation@tpna.com|
22449922|NCT00453999|BioCryst Pharmaceuticals, Inc.|William P. Sheridan, MBBS|919-859-1302||
22449923|NCT01734551|University of Kentucky|Dr. Henrietta S. Bada, Professor and Vice Chair, Academic Affairs|859-323-1019|hbada2@uky.edu|
22449924|NCT04238728|University of Rochester Medical Center|Julie Ryan, MD|585-276-3862|Julie_Ryan@URMC.Rochester.edu|
22449925|NCT00983216|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22449926|NCT04414553|University of Colorado|Lisa Ross DeCamp|3037246499|lisa.decamp@cuanschutz.edu|
22449927|NCT02508636|University of California, San Francisco|Dr. Hao Nguyen|(415) 514-5541|Hao.Nguyen@ucsf.edu|
22449928|NCT00974571|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22449929|NCT01874262|AstraZeneca|Susanna Jerström|+46 8 553 260 00||
22449930|NCT00966238|VaxInnate|Dr. David N. Taylor|609-860-2260|david.taylor@vaxinnate.com|
22449931|NCT03458130|Eidos Therapeutics|Mark McGovern, Vice President of Clinical Operations|415-887-1471|medinfo@eidostx.com|
22449932|NCT03778931|Stemline Therapeutics, Inc.|Carlos A. Garay, MD, Senior Vice President, Clinical Development & Medical Affairs - Solid Tumors|+1-877-332-7967|clinicaltrials@menarinistemline.com|
22449933|NCT01845792|University of Colorado Cancer Center|Elaine Lam, MD|7208480273|elaine.lam@ucdenver.edu|
22449934|NCT04180020|Yale School of Medicine|Sandra Springer, MD|877-554-3578|sandra.springer@yale.edu|
22449935|NCT00738972|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22449936|NCT03216850|University Hospital Hradec Kralove|Dr. David Astapenko|+420495833218|astapenko.d@seznam.cz|
22449937|NCT01519453|Johns Hopkins School of Medicine|Dr. Michelle Eakin|410-550-0487|meakin1@jhmi.edu|
22449938|NCT03554291|University of Washington|Peter Leary|206-685-2484|learyp@uw.edu|
22449939|NCT00537381|Janssen Research & Development, L.L.C.|Senior Director|908-927-2116||
22449940|NCT05544786|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22449941|NCT02357940|Johnson & Johnson Consumer Inc.|Amisha Parikh-Das, PhD/Study Director|973-255-8701 USA EST|AParikh1@its.jnj.com|
22449942|NCT01048723|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Zager, M.D.|813-745-1085|jonathan.zager@moffitt.org|
22449943|NCT01025427|University of California, San Francisco|Hiroyu Hatano|415-476-4082|hhatano@php.ucsf.edu|122
22449944|NCT04258605|Zimmer Biomet|Carina Hafner|+41797073093|carina.hafner@zimmerbiomet.com|
22449945|NCT02910167|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22449946|NCT00181961|Massachusetts General Hospital|Dr. Christina Dording|6177249457|cdording@mgh.harvard.edu|
22449947|NCT05300295|University of Minnesota|Lindsey Weiler, PhD|612-301-9345|lmweiler@umn.edu|
22449948|NCT04944901|Scioto Biosciences|Phoevos Hughes, VP Clinical Operations|866-672-4686|phoevos@sciotobiosciences.com|700
22449949|NCT01951339|University of Colorado|Dr. Judy Regensteiner|303-724-2247|judy.regensteiner@ucdenver.edu|
22449950|NCT00842348|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22449951|NCT00603746|GlaxoSmithKline|GSK Response Center|866-435-7343||
22449952|NCT05516082|CooperVision, Inc.|José A. Vega OD, MSc, FAAO|19256213761|javega@coopervision.com|
22449953|NCT03664752|Bausch Health Americas, Inc|Study Director|19083009920|susan.harris@bauschhealth.com|
22449954|NCT00026793|National Cancer Institute|Dr. Robert Yarchoan|240-760-6075|robert.yarchoan@nih.gov|
22449955|NCT01449526|Bausch & Lomb Incorporated|Robert Steffen, OD, MS|585-338-6399|robert.steffen@bausch.com|
22449956|NCT01132495|St. Jude Medical|Sr. Director, Global Clinical Affairs|651-756-5586|jmifek@sjm.com|
22449957|NCT03913091|NYU Langone Health|Uchenna O. Umeh, MD|(212) 598-6085|Uchenna.Umeh@nyulangone.org|
22449958|NCT00655564|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-3775|sfeldman@wakehealth.edu|
22449959|NCT01581593|Kedrion S.p.A|Dr. Mirella Calcinai, MD, Clinical Research Director|+393486559761|m.calcinai@kedrion.com|
22449960|NCT00653224|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22449961|NCT03756558|Terumo Medical Corporation|Director of Clinical Operations|9085146154|charis.sugden@terumomedical.com|
22449962|NCT02896400|Yale School of Medicine|Steven L. Bernstein, MD|203-737-3574|steven.bernstein@yale.edu|
22449963|NCT02984020|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22449964|NCT00588445|Memorial Sloan Kettering Cancer Center|Dr. Charles Rudin|646-888-4527|rudinc@mskcc.org|
22449965|NCT00358527|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22449966|NCT02674412|Cleveland Clinic|Scott Gabbard, MD|216 444-6523|gabbars@ccf.org|
22449967|NCT00934544|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22449968|NCT02643251|BDSI|Tim Warneke|919-582-0294|twarneke@bdsi.com|
22449969|NCT00348556|Mayo Clinic|Dr. Horng Chen|507-284-8846|chen.horng@mayo.edu|
22449970|NCT00192075|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22413673|NCT01417078|Acorda Therapeutics, Inc.|Executive Medical Director - Clinical Development & Medical Affairs|914-347-4300|dsquillacote@acorda.com|5367
22413674|NCT01234103|University of California, San Francisco|Cherrie B. Boyer, PhD|4154762184|Cherrie.Boyer@ucsf.edu|
22413675|NCT02563808|University of Pennsylvania Hospital|Lee Fleisher|2156623738|lee.fleisher@uphs.upenn.edu|
22413676|NCT02392000|Edith Nourse Rogers Memorial VA Hospital|Karen S. Quigley|781-687-2273|karen.quigley@va.gov|
22413677|NCT00833937|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22413678|NCT01985308|Wave Neuroscience, Inc.|Mazaya Soundra, Clinical Trials Manager|9492292869|mazaya@waveneuro.com|
22413679|NCT02512900|MedImmune, LLC|Rene van der Merwe, Senior Director, Clinical Development, Respiratory, and Inflammation|301-398-0000||
22413680|NCT02612337|Otonomy, Inc.|Otonomy Medical Information Center|1-844-686-4636|medinfo@otonomy.com|
22413681|NCT01697696|Novartis Pharmaceuticals|Study Director|862-778-8300||
22413682|NCT03616106|University of Colorado College of Nursing|Samantha Stonbraker, Assistant Professor|720-880-8194|Samantha.Stonbraker@Cuanschutz.edu|
22413683|NCT01880593|Icahn School of Medicine at Mount Sinai|Dr. James Murrough|212-241-7574|james.murrough@mssm.edu|
22413684|NCT02779543|Weill Cornell Medical College|Dr. Ana Krieger|6469629316|ack2003@med.cornell.edu|
22413685|NCT02372630|State University of NY at Buffalo|Paresh Dandona, B.Sc., M.B. B.S., D.Phil., F.R.C.P|71653518520|dandona@buffalo.edu|
22413686|NCT05275205|Unity Biotechnology, Inc.|Study Director|650-513-0096|UBX1325_medicalmonitor@unitybiotechnology.com|
22413687|NCT03962348|Columbia University Irving Medical Center|Dr. Michael Compton|646-774-8476|mtc2176@cumc.columbia.edu|
22413688|NCT03243630|Yale University|Mehmet Sofuoglu|203-932-5711|mehmet.sofuoglu@yale.edu|4809
22413689|NCT00091260|Boston Medical Center|Vaishali Sanchorawala|6176386521|vaishali.sanchorawala@bmc.org|
22413690|NCT02648880|University of Colorado|Ryan Marker|3037240819|ryan.marker@cuanschutz.edu|
22413691|NCT00939003|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22413692|NCT03707912|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22413693|NCT02934347|Glan Clwyd Hospital, Betsi Cadwaladr University Health Board|Dr Raj Reddy|01745 583910|Rajashekhar.Reddy@wales.nhs.uk|
22413694|NCT02350647|Hawkins Foundation|Kyle Adams, Research Coordinator|864-454-7458|kyle.adams@hawkinsfoundation.com|
22413695|NCT00831428|University of Dundee|Dr Karine Clearie|01382 496440|k.clearie@dundee.ac.uk|
22413696|NCT02186821|Novartis Pharmaceuticals|Study Director|1-888-669-6682|Novartis.email@novartis.com|
22413697|NCT06090461|Currax Pharmaceuticals LLC|SVP, Chief Medical Officer|708.834.8254|mkyle@curraxpharma.com|
22413698|NCT01313780|Seoul Asan Hospital|Taewon Kim|82-2-3010-3910|twkimmd@amc.seoul.kr|
22413699|NCT00355797|BIOTRONIK, Inc.|CLEAR Study CSE|503-451-8051||
22413700|NCT01466166|Horizon Pharma Rheumatology LLC|Jeffery Nieves, PharmD|224-383-3000|clinicaltrials@horizonpharma.com|
22449971|NCT00779675|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22449972|NCT01944059|University Cincinnati Physicians Company|Vincent Martin, MD|513-558-7581|vincent.martin@uc.edu|
22449973|NCT01818804|Aalborg University hospital|Salome Kristensen, MD. PhD|+45 97664015|sakr@rn.dk|
22449974|NCT05028374|Karmanos Cancer Institute|Dr. Jeffery Zonder|313-576-8732|zonderj@karmanos.org|
22449975|NCT02111252|Takeda|Medical Director, Clinical Science|800-778-2860|trialdisclosures@takeda.com|
22449976|NCT00430092|Sirion Therapeutics, Inc.|Jeremy Brace|813-496-7325|jbrace@siriontherapeutics.com|343
22449977|NCT01956110|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
22449978|NCT01857258|The Ohio State University|Richard Bruno, PhD, RD|6142925522|bruno.27@osu.edu|
22449979|NCT01166594|Sunnybrook Health Sciences Centre|Dr Catherine Birt|416 480-5882|catherine.birt@sunnybrook.ca|
22449980|NCT02118428|Terumo BCT Biotechnologies, LLC|Ray Goodrich, PhD|(303) 231-4832|ray.goodrich@terumobct.com|
22449981|NCT04587934|Sharp Healthcare|Dr. Anup Katheria|858-939-4170|Anup.Katheria@sharp.com|
22449982|NCT01633944|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22449983|NCT00463060|Good Samaritan Hospital Medical Center|Dr. Johnny Kao|(631) 376-4444|johhny.kao@chsli.org|
22449984|NCT01400841|Biostable Science and Engineering, Inc.|John Wheeler|512-386-1996|John.wheeler@biostable-s-e.com|
22449985|NCT00701129|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22449986|NCT00910715|UMC Ljubljana, Department of Infectious Diseases|Dr.Dasa Stupica|+386 1 522 2110|cerar.dasa@gmail.com|
22449987|NCT00706966|University of California San Francisco|Mack Roach, MD|415-353-9855|tdiep@radonc.ucsf.edu|
22449988|NCT02884089|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22449989|NCT01631474|Cassiopea, SpA|Cassiopea R&D|+39 02 868 911 24|r&d@cassiopea.com|
22449990|NCT01467076|Wayne State University|Beena Sood, M.D.|313-745-5638|bsood@med.wayne.edu|
22449991|NCT03354429|Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
22449992|NCT00386256|VA Greater Los Angeles Healthcare System|Nancy Harada, PhD|310-268-3632|Nancy.Harada@va.gov|
22449993|NCT01691027|Kansas City VA Medical center|Health Scientist|816-861-4700|George.Timberlake@va.gov|52755
22449994|NCT00654381|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22449995|NCT00542750|Medical University of South Carolina|Kevin M. Gray, M.D.|8437920135|graykm@musc.edu|
22449996|NCT04883632|Croma Pharma|Clinical Development - Head of Clinical Operations|+432262684680|clinical.studies@croma.at|
22449997|NCT02981381|VA Providence|Noah S. Philip MD|401-273-7100|noah.philip@va.gov|12369
22413701|NCT02262377|Boston Medical Center|Paula Gardiner|414-6267|Paula.GardinerMD@gmail.com|617
22413702|NCT00371839|Portland VAMC|Dr. Marjorie R. Leek|(909)825-7084|Marjorie.Leek@va.gov|7293
22449998|NCT05040152|The Ohio State University Comprehensive Cancer Center|Xiaochen Zhang|614-293-9600|xiaochen.zhang@osumc.edu|
22387034|NCT03248492|Daiichi Sankyo|Contact for Clinical Trial Information|1-908-992-6400|CTRinfo_us@daiichisankyo.com|
22449999|NCT00645333|University of Michigan|Anne F. Schott, MD|1-800-865-1125|canceranswerline@umich.edu|
22450000|NCT00006489|University of Pennsylvania|Dr. Edna Foa|215-746-3327|foa@mail.med.upenn.edu|
22450001|NCT00578175|GlaxoSmithKline|GSK Response Center|866-435-7343||
22450002|NCT02153944|National Institute of Mental Health (NIMH)|Dr Maryland Pao|301-435-5770|paom@mail.nih.gov|
22450003|NCT03029624|Valencia Technologies|Stacy Chambliss, Chief of Clinical Trials|661-775-1414|schambliss@valenciatechnologies.com|1002
22450004|NCT01371656|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org|
22450005|NCT03621878|imam abdulrahman bin faisal university|Mohammed Alghamdi|+966556852888|mohdg.ios@gmail.com|
22450006|NCT00748956|Icahn School of Medicine at Mount Sinai|Dr. Adriana Feder|212-659-9145|adriana.feder@mssm.edu|
22450007|NCT04334460|Blade Therapeutics|SVP, Global Regulatory Affairs, Quality, and Safety|(650) 278 4291|dmody@blademed.com|
22450008|NCT00775437|AbbVie|Global Medical Information|800-633-9110||
22450009|NCT00915798|UC Irvine|Dr. Jean Gehricke|949-267-0404|jgehrick@uci.edu|
22450010|NCT04688164|Relmada Therapeutics|Marco Pappagallo, MD|786-638-7384|info@relmada.com|
22387035|NCT04495621|Menarini Ricerche S.p.A.|Clinical Sciences|+39 0555680|martine.piccart@bordet.be|9990
22450011|NCT02442778|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22450012|NCT02482025|VA Greater Los Angeles Healthcare System|Steven R. Simon, MD|310.268.3132|steven.simon2@va.gov|
22450013|NCT02641379|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22450014|NCT01165138|GlaxoSmithKline|GSK Response Center|866-435-7343||
22450015|NCT01751386|National Institute on Alcohol Abuse and Alcoholism|Lorenzo Leggio|+1 301 435 9398|lorenzo.leggio@mail.nih.gov|
22450016|NCT01644175|Sanofi|Trial Transparency Team||Contact -US@sanofi.com|
22450017|NCT01495585|National Insitute of DIabetes and Digestive and Kidney Diseases|Dr. Theo Heller|301-402-7147|hellert@mail.nih.gov|
22450018|NCT01398956|UCB Cares|UCB (Study Director)|+1887822||9493
22450019|NCT00856908|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22450020|NCT01667978|Montefiore|Jessica Atrio|718 405 82 60|jatrio@montefiore.org|
22450021|NCT00799578|Columbia University|Dr. Joel Lavine|212 304 5533|jl3553@columbia.edu|
22450022|NCT01063595|Octapharma USA|Michael Eppolito, Director, Clinical Operations Immunology and ICU Medicine|201 604-1155|michael.eppolito@octapharma.com|
22450023|NCT00451035|Novartis pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22450024|NCT01623596|Novartis Pharmaceuticals|Study Director|(862) 778-8300||
22450025|NCT04059146|University of Iowa|Dr. Ruth Chimenti|319-335-9802|ruth-chimenti@uiowa.edu|
22450026|NCT01886807|UTSouthwestern Medical Center|Dr. Jeffrey Steiner, PI|214-456-0606|jeffrey.steiner@utsouthwestern.edu|
22450027|NCT01965288|CooperVision|Jose A. Vega Sr. Mgr. Global Medical Scientific Affairs|(925) 621-3761|jvega2@coopervision.com|
22450028|NCT01712256|Bionor Pharma ASA|Maja Sommerfelt|+4723010960|ms@bionorpharma.com|
22450029|NCT00543764|BIDMC|Bernard Lee|617-632-7835|blee3@bidmc.harvard.edu|
22450030|NCT00962104|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22450031|NCT03274986|Alcon Research|CDMA Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22450032|NCT02603835|TherOx, Inc.|Jeffrey L. Creech, Ph.D.|(949) 225-6587|jcreech@therox.com|
22450033|NCT01524627|UPenn|Teresa R. Franklin, Ph.D.|215-746-1883|teresafr@mail.med.upenn.edu|
22450034|NCT02679911|Galderma|Farzaneh SIDOU Clinical Project Manager|0493957051|farzaneh.sidou@galderma.com|33
22450035|NCT00638885|Atlanta VAMC|J Douglas Bremner MD|404-712-9569|jdbremn@emory.edu|
22450036|NCT05627518|Cinclus Pharma AB|Kristofer Katkits Nilsson, Global Trial Manager|+46 7064955|kristofer.katkits@cincluspharma.com|
22450037|NCT05535777|UCLA|Principal Investigator|310-206-6328|pszilagyi@mednet.ucla.edu|
22450038|NCT01101841|Noven Therapeutics, LLC|Sailaja Bhaskar, Executive Director, Clinical Research|(212) 287-0798|sbhaskar@noven.com|
22450039|NCT02159547|Akdeniz University|Cenker EKEN|00905321593948|cenkereken@akdeniz.edu.tr|
22450040|NCT00145509|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22450041|NCT03641378|Massachusetts General Hospital|Areej El-Jawahri|617-724-4000|ael-jawahri@mgb.org|
22450042|NCT00697346|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22450043|NCT03569371|Incyte Corporation|Incyte Corporation Call Center, Study Director|1-855-463-3463|medinfo@incyte.com|
22450044|NCT03643562|Mandos, LLC|Executive Vice President, Regulatory Affairs|619-905-0489|jspinella@mandoshealth.com|
22450045|NCT01433107|Novartis|Clinical Project leader|+41223633111||
22450046|NCT01982253|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@takeda.com|
22387036|NCT03228719|University of Delaware|Daniel K. White|3028317607|dkw@udel.edu|
22387037|NCT03774472|M D Anderson Cancer Center|Debasish Tripathy|713-794-4385|dtripathy@mdanderson.org|
22387038|NCT05495945|University of Michigan|Zirui Huang|(734) 615-2875|huangzu@med.umich.edu|
22387039|NCT04059406|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionis.com|
22387040|NCT05155306|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22387041|NCT04121741|Medical College of WI|Principal Investigator: Jacquelyn P Kulinski|414-955-6896|jakulinski@mcw.edu|
22387042|NCT01084863|Celltrion|Head of Clinical Planning Department|82328505000|contact@celltrion.com|
22387043|NCT04056910|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP, Clinical Research Manager|4126475554|stadtermanbm@upmc.edu|
22450047|NCT01489969|Neurim Pharmaceuticals (1991) LTD|Amnon Katz|972-3-768-4906|amnonk@neurim.com|
22450048|NCT02223767|Universitätsklinikum Würzburg|Prof. Dr. M Herrmann|093120176650|Herrmann_m@ukw.de|
22413703|NCT01511939|Arthritis Treatment Center|Manager, Clinical Research Department|301-624-1168|tgillis@arthritistreatmentcenter.com|
22413704|NCT01591785|Icahn School of Medicine at Mount Sinai|Gary Goldenberg, MD|212-241-6500|garygoldenbergmd@gmail.com|
22450049|NCT02789176|University of Michigan|Stephanie Rau|734-232-8474|shatchew@med.umich.edu|
22450050|NCT01200875|Stanford University|Jason Dragoo, Associate Professor|(650) 721-3430|jdragoo@stanford.edu|
22450051|NCT05194020|Midwest Evaluation and Research|Dr. Matthew Shepherd|833-643-9377|matt.shepherd@midwestevaluation.com|
22450052|NCT02224872|Johns Hopkins University|Amy DeZern|4105027208|Adezern1@jhmi.edu|
22450053|NCT03913078|Milton S. Hershey Medical Center|Christopher Sciamanna, MD, MPH|717-531-4417|csciamanna@pennstatehealth.psu.edu|
22450054|NCT00770120|SWOG Statistical Center|Lung Committee Statistician|206-667-6197|jmoon@fredhutch.org|
22450055|NCT02412631|Mayo Clinic|Dr. Ryan Hurt|(507) 284-2511|gimresearchstudies@mayo.edu|
22450056|NCT02822508|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
22450057|NCT03100825|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22450058|NCT00994448|UCLA|Keith Heinzerling MD|310-794-0619|KHeinzerling@mednet.ucla.edu|
22450059|NCT00651482|Stanford University Medical Center|Associate Professor of Medicine (Oncology)|650-725-2078|sandysri@stanford.edu|
22450060|NCT05288556|Cleveland Clinic|Eric Yudelevich Blumrosen, MD|216 445-6914|YUDELEE@ccf.org|56914
22450061|NCT02704364|NGM Biopharmaceuticals, Inc|Clinical Trial Information and Disclosure|650-243-5555|ngm282@ngmbio.com|
22450062|NCT01232296|Novartis Pharmaceuticals|Study Director|862-778-8300||
22450063|NCT02108821|Children's Mercy Hospital, Kansas City|Alka Goyal MD|816-302-3069|agoyal4@stanford.edu|
22450064|NCT01461096|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22450065|NCT02963493|Oncopeptides|Global Clinical Project Lead|866-596-6626|info@oncopeptides.com|
22450066|NCT04889625|Johnson & Johnson Vision Care, Inc.|Thomas R. Karkkainen, OD, MS, FAAO|1-904-254-0152|TKarkkai@its.jnj.com|
22450067|NCT00404352|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22400675|NCT02874794|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22400676|NCT02939300|Massachusetts General Hospital|Priscilla Brastianos, MD|617-724-8770|pbrastianos@partners.org|
22400677|NCT00613314|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22400678|NCT03818815|Novus Therapeutics|Clinical Director|949-679-1110|study006@novustherapeutics.com|
22400679|NCT04419506|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22400680|NCT04645797|Apros Therapeutics|Tom Wu, PhD|+1-858-284-8839|tom_wu@aprostx.com|
22400681|NCT00817414|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22400682|NCT01602731|VA Loma Linda Healthcare System|Dr. Helme Silvet, cardiologist|9095836097|helme.silvet@va.gov|
22400683|NCT02586805|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22400684|NCT01961531|BrUOG- Brown University Oncology Research Group|Jaroslaw Hepel, MD|401-863-3000|BrUOG@brown.edu|
22400685|NCT00327392|Eisai Inc|Eisai Medical Services|1-888-422-4743||
22400686|NCT04249882|University of California Los Angeles|Dr. Lara Ray|310-206-6756|lararay@psych.ucla.edu|
22400687|NCT00215930|Karmanos Cancer Institute (formerly at Moffitt Cancer Center)|Gerald Bepler, M.D., via Moffitt Cancer Center|813-745-4398|beplerg@karmanos.org|
22400688|NCT00472303|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|Clinical-Trials@grunenthal.com|
22400689|NCT03596164|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22400690|NCT03427073|Almac Discovery|Professor Richard Kennedy, Medical Director|+44 28 3833 2200|richard.kennedy@almacgroup.com|
22400691|NCT02955329|University of California, San Francisco|Dr. Gideon St. Helen|628-206-2687|gideon.sthelen@ucsf.edu|
22400692|NCT00759603|The University of Texas (UT) MD Anderson Cancer Center|Alessandra Ferrajoli, MD/Professor, Leukemia||CR_Study_Registration@mdanderson.org|
22400693|NCT02835495|Wake Forest School of Medicine|Mara Z. Vitolins, DrPH, MPH, RDN|(336) 716-2886|mvitolinn@wakehealth.edu|
22400694|NCT02580058|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22400695|NCT00749203|Icahn School of Medicine at Mount Sinai|Dr. Adriana Feder|212-241-1563|adriana.feder@mssm.edu|
22400696|NCT02034123|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22400697|NCT00246259|Janssen Inc., Toronto, ON, Canada|Director Medical Affairs - CNS|+1-416-382-5094||
22400698|NCT01564784|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22400699|NCT02272790|AstraZeneca|Pejvack Motlagh, MD|+44 (0) 7384 799 850|pejvack.motlagh@astrazeneca.com|
22400700|NCT03022461|Abbott|Poornima Sood|+17818528334|poornima.sood@abbott.com|
22400701|NCT01982630|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22400702|NCT01076179|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
22400703|NCT00986349|GI Dynamics, Inc.|Clinical Affairs Manager|781.357.3261|pkeating@gidynamics.com|
22400704|NCT02299934|University of Colorado, Denver|Dr. Samuel Chang|720-848-1875|SAMUEL.CHANG@UCDENVER.EDU|
22400705|NCT00561353|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com|
22400706|NCT01273818|S.B.Ankara Diskapi Yildirim Beyazit Education and Teaching Hospital|Dr.Gaye Seker|+905323360618|gayeebru@superonline.com|
22400707|NCT00463437|GlaxoSmithKline|GSK Response Center|866-435-7343||
22400708|NCT00803114|University of Toronto|Dr. Alison Macarthur|416 586 4800|alison.macarthur@uhn.on.ca|6632
22400709|NCT01696461|National Marrow Donor Program/BeTheMatch|Dr. Steven Devine|7634068239|sdevine2@nmdp.org|
22400710|NCT03072602|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Dr. Pankaj Arora|12059754720|parora@uabmc.edu|
22400711|NCT03912584|Optos|Michael Sinai, PhD|+1 800 854 3039|MSinai@optos.com|1495
22400712|NCT01236391|Pharmacyclics, Inc.|Dr. Darrin Beaupre|855-427-8846|medinfo@pcyc.com|
22400713|NCT01097044|Clinuvel Pharmaceuticals Limited|Dr. Dennis Wright, Acting Chief Scientific Officer|646 527 7310|Dennis.Wright@clinuvel.com|
22400714|NCT01682044|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22400715|NCT02730546|Mayo Clinic|Harry H Yoon MD MHS|507-284-2511|yoon.harry@mayo.edu|
22400716|NCT00843986|Astellas Pharma Global Development|Medical Director||clinicaltrials@us.astellas.com|
22400717|NCT02452359|Venus Concept Ltd|Yoni Iger|888-907-0115|yoni@venusconcept.com|
22400718|NCT03414359|UAMS|Nadir El Sharawi|5016866114|nelsharawi@uams.edu|
22400719|NCT02043574|South Texas Veterans Health Care System|Monica Serra|210-617-5300|monica.serra@va.gov|15313
22450068|NCT00699010|Acura Pharma|Dr. Ron Spivey|847-705-7709|rspivey@acurapharm.com|
22450069|NCT01479621|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000||
22450070|NCT03663283|Mayo Clinic|Steven J. Hattrup, M.D.|480-301-8519|hattrup.steven@mayo.edu|
22450071|NCT02308735|University of Oklahoma Health Sciences Center|Douglas Dannaway|405-271-5215|douglas-dannaway@ouhsc.edu|42048
22450072|NCT01271868|Aptevo Therapeutics|Dr. David Schaaf|206-859-6655|schaafd@apvo.com|
22450073|NCT00802412|VA San Diego|Neal Doran, PhD|8585528585|neal.doran@va.gov|2421
22450074|NCT01632202|Weill Cornell Medicine|Sr. Research Compliance Specialist|646-962-4065|lao2003@med.cornell.edu|
22450075|NCT01417481|Instituto Nacional de Enfermedades Respiratorias|Dr. Mario H. Vargas|(+55)54871771|mhvargasb@yahoo.com.mx|
22450076|NCT02614547|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
22450077|NCT00582933|Memorial Sloan Kettering Cancer Center|Dr. Farid Boulad|212-639-2429|bouladf@mskcc.org|
22450078|NCT02457598|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22450079|NCT00087633|Hoffmann-La Roche|Medical Communications|800-821-8590||
22450080|NCT04707534|University of Oklahoma Health Sciences Center|Manager of Clinical Trials|405-271-6173|Dianne-Belshe@ouhsc.edu|
22450081|NCT02151526|bluebird bio, Inc.|Study Medical Director|339-499-9300|medinfo@bluebirdbio.com|
22450082|NCT03316885|Alcon Research, LLC|Director, Clinical Projects - CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22450083|NCT01820754|Duke University Medical Center|Neal Ready, MD|919 681-6932|neal.ready@duke.edu|
22450084|NCT00627679|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|(650) 386-3100|dkellerman@mappharma.com|
22450085|NCT00409292|Dana-Farber Cancer Institute|Brian Wolpin, MD|617-632-3000|brian_wolpin@dfci.harvard.edu|
22450086|NCT04865432|Boston University Chobanian & Avedisian School of Medicine|Michael F. Holick PhD, MD|617-358-6139|mfholick@bu.edu|
22450087|NCT01736696|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22450088|NCT01116232|Barbara Ann Karmanos Cancer Institute|Zaid Al-Kadhimi, M.D.|404-778-5984|zalkadh@emory.edu|
22450089|NCT00405548|Mayo Clinic|Dr. Horng H. Chen|507-538-2354|chen.horng@mayo.edu|
22450090|NCT02036502|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22450091|NCT04652479|Stanford University|Marilyn Tan, MD, FACE|(650) 721-1300|mjtan@stanford.edu|
22450092|NCT00056563|Center for Management of Complex Chronic Care|Frances M. Weaver, Ph.D, Study Investigator|(708) 202-2414|Frances.Weaver@va.gov|
22450093|NCT00811577|Capstone Therapeutics Corp.|Denise Lamon|602-286-5206|dlamon@capstonethx.com|
22450094|NCT04011410|University of Kentucky College of Medicine|Patrick Hensley|859-562-3223|patrick.hensley@uky.edu|
22450095|NCT01068509|PrimaBioMed, Ltd.|Marc Voigt|49 173 6771602|marc.voigt@primabiomed.com.au|
22450096|NCT01455012|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22450097|NCT01017237|University of North Carolina School of Dentistry|Jay Anderson, DDS, MD|919-966-1126|janderson@aims.unc.edu|
22450098|NCT01418937|GlaxoSmithKline|GSK Response Center|866-435-7343||
22450099|NCT00704028|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
22450100|NCT00656630|The Scripps Research Institute|Barbara J. Mason, Ph.D.-Principal Investigator|858784-7328|mason@scripps.edu|
22450101|NCT03483675|FHCRC|Kate Chilson|206-667-6069|kchilson@fredhutch.org|
22450102|NCT04052542|University of Pittsburgh School of Medicine|Timothy D Girard, MD, MSCI|(412) 383-0582|timothy.girard@pitt.edu|
22450103|NCT06021951|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
22450104|NCT01162382|Washington University School of Medicine|Kathy Pierce|314-362-5626|jenkerson_m@wustl.edu|
22450105|NCT03323658|UT MD Anderson Cancer Center|Priya Thomas,MD-Associate Professor, Clinical Cancer Prevention|(713) 745-1075|psthomas@mdanderson.org|
22450106|NCT00615056|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22450107|NCT00717769|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22450108|NCT01726738|University of North Carolina Lineberger Comprehensive Cancer Center|Robin Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
22450109|NCT03639766|University of Central Florida|Dr. David Weinstein|(407)266-4900|david.weinstein@ucf.edu|
22450110|NCT01380184|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22450111|NCT02469116|Washington University School of Medicine|David G. Mutch, M.D.|314-362-3181|mutchd@wustl.edu|
22450112|NCT01251588|Vericel Corporation|Ann Remmers, Senior Director, Clinical Science|734-428-4526|aremmers@vcel.com|
22450113|NCT00692770|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22450114|NCT04248816|University of Pennsylvania|Dr. Shivan Mehta|215-898-6027|shivan.mehta@pennmedicine.upenn.edu|
22450115|NCT04327986|National Cancer Institute|Dr. Udo Rudloff|240-760-6238|udo.rudloff@nih.gov|
22450116|NCT02769702|Washington University School of Medicine|Richard Brasington MD|314-454-7255|rbrasing@wustl.edu|
22450117|NCT04010266|AppliedVR|Vice President of Research|13108901584|tmaddox@appliedvr.io|
22450118|NCT03350503|Alcon Research|Expert Clinical Project Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22450119|NCT04492891|Baylor College of Medicine|Michelle Almarez: Clinical Research Manager|713-798-3680|malmarez@bcm.edu|
22450120|NCT03829046|Icahn School of Medicine at Mount Sinai|Dr. Qinzhong Chen|212-659-8864|qinzhong.chen@mssm.edu|
22450121|NCT00262067|Genentech, Inc.|Medical Communications|800 821-8590||
22450122|NCT04804813|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22450123|NCT05226104|UT Southwestern|Research Coordinator|214-645-8907|jennifer.barillas@utsouthwestern.edu|
22450124|NCT01012817|Mayo Clinic|Andrea Wahner Hendrickson MD|507-293-0553|WahnerHendrickson.Andrea@mayo.edu|
22450125|NCT00634647|National Cancer Institute, National Institutes of Health|Dr. William Dahut|301-435-8183|dahutw@mail.nih.gov|
22450126|NCT01700179|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22387044|NCT04505722|Janssen R&D US|SENIOR ADVISOR CLINICAL DEVELOPMENT|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22387045|NCT03473223|CSL Behring|Study Director|+1 610-878-4000|clinicaltrials@cslbehring.com|
22387046|NCT04755595|SUNY Downstate Health Sciences University|Jared Jagdeo MD, MS|(718) 270-1229|jared.jagdeo@downstate.edu|
22387047|NCT05501548|Johns Hopkins University|Channing Paller, M.D., principal investigator|410-955-8239|cpaller1@jhmi.edu|
22387048|NCT05365997|University of Pennsylvania|Dr. Ravi Parikh|3524224285|ravi.parikh@pennmedicine.upenn.edu|
22413705|NCT01049334|Reckitt Benckiser Inc.|Gail Solomon, Director, Clinical Development|973-404-2752|gail.solomon@rb.com|
22413706|NCT02071108|Shockwave Medical, Inc.|Gheda Sahyun, Director of Clinical Affairs|510-624-9073|gsahyun@shockwavemedical.com|
22413707|NCT02393417|Nielsen BioSciences Inc.|David Burney, PhD, MBA|858-571-2726|david@nielsenbio.com|
22387049|NCT02549352|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
22387050|NCT01347255|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
22387051|NCT01411137|Impax Laboratories, Inc.|Michelle Landolfi, Senior Director, Regulatory Affairs|(510) 240-6496|Michelle.Landolfi@impaxlabs.com|
22387052|NCT02291913|Sarah Cannon Development Innovations|Senior Director, Regulatory Science|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
22387053|NCT04876417|University of Iowa|Thorsten Rudroff, PhD, Associate Professor|(319) 467-0363|thorsten-rudroff@uiowa.edu|
22387054|NCT04334317|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
22387055|NCT03621735|University of Michigan|Susan Shore|734-647-2116|sushore@umich.edu|
22387056|NCT03614663|Zynerba Pharmaceuticals|Stephen O'Quinn, PharmD|919-271-1339|oquinns@Zynerba.com|
22387057|NCT00605306|Novartis Pharmaceuticals|Study Director|862-778-8300||
22387058|NCT05274321|University of California, San Francisco|Julius Oatts, MD|(415) 353-2800|Julius.Oatts@ucsf.edu|
22387059|NCT03875313|Calithera Biosciences, Inc|Study Director|650-870-1000|clinicaltrials@calithera.com|
22387060|NCT01092416|Cardiovascular Systems, Inc.|Clinical Project Manager|6512591600|clinicaltrials_csi@csi360.com|
22387061|NCT03709706|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22387062|NCT01105975|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22387063|NCT04868617|Coloplast A/S|Pernille Nonboe|+4549113143|dkpen@coloplast.com|
22387064|NCT05441449|Spinal Cord Damage research Center, James J. Peters VA Medical Center|Dr. John Handrakis|(718) 584-9000|john.handrakis@va.gov|5439
22387065|NCT00686595|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22387066|NCT04612244|BSC|Allison Anderson|651-582-5077|allison.anderson@bsci.com|
22387067|NCT01315132|Sidney Kimmel Cancer Center at Thomas Jefferson University|Neal Flomenberg, MD|215-955-4367|Neal.Flomenberg@jefferson.edu|
22387068|NCT03260569|University of Cincinnati|Michael Goodman|5135585661|michael.goodman@uc.edu|
22387069|NCT06199986|University of Chicago|Dr. Ted Skolarus|773 702-0881|tskolarus@bsd.uchicago.edu|
22387070|NCT04158141|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22387071|NCT03850899|Indiana University School of Medicine|Samer Gawrieh|(317) 278-9326|sgawrieh@iu.edu|
22387072|NCT00319696|Actelion Pharmaceuticals Ltd|Andjela Kusic-Pajic, MD/Clinical Project Team Leader|+41 61 565 64 17||
22387073|NCT03777657|BeiGene|Study Director|877-828-5568|Clinicaltrials@beigene.com|
22387074|NCT06284941|Jiangyan District Hospital of traditional Chinese medicine attached to the Nanjing University of Chinese Medicine|Yang Zhang|15861013918|617405180@qq.com|
22387075|NCT04129450|Boston Medical Center|Natalia Morone, MD, MS|617-414-6652|natalia.morone@bmc.org|
22387076|NCT04559698|Yale University School of Public Health|Dr. Zachary Soulliard|646-344-4060|zachary.soulliard@yale.edu|
22387077|NCT01982682|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Dolores Grosso|215-955-0182|dolores.grosso@jefferson.edu|
22387078|NCT02760654|University of Michigan School of Nursing|Robert Knoerl, Doctoral Student|734-536-9369|rjknoerl@umich.edu|
22387079|NCT01574716|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22387080|NCT03183050|Georgetown University|Suzanne O'Neill|202-687-0869|sco4@georgetown.edu|
22387081|NCT00698867|Zimmer Biomet|Kelly Francher, Clinical Affairs Manager|574-371-9783|kelly.francher@zimmerbiomet.com|
22387082|NCT02797132|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22387083|NCT02502526|Alcon, A Novartis Division|Dir Surg Instrumentation, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22387084|NCT03304418|Huntsman Cancer Institute/University of Utah|Clinicaltrials.gov and CTRP Specialist|8012136215|IITDataManagement@hci.utah.edu|
22387085|NCT00610558|University of California, Irvine|Dr. Lydia Su|(949) 824-4925|msu@uci.edu|
22387086|NCT01074294|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22387087|NCT00112359|Gilead Sciences, Inc.|Mark Bresnik, MD, Director, Clinical Research|(650) 522-5934|mark.bresnik@gilead.com|
22387088|NCT01500200|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
22387089|NCT00312208|sanofi-aventis|Medical Affairs study director||publicregistryGMA@sanofi-aventis.com|
22387090|NCT01262339|University of Wisconsin- Madison|Dermatology Clinical Trials Administrator|608-287-2640|dbock@dermatology.wisc.edu|
22387091|NCT01218659|Amicus Therapeutics|Medical Affairs|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
22387092|NCT00588406|North Shore Long Island Jewish Health System|Dr. Robert Silverman|718-470-7501|rsilverman@nshs.edu|
22387093|NCT03066609|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22387094|NCT02284113|Pacira Pharmaceuticals, Inc.|Medical Information||MedInfo@Pacira.com|
22387095|NCT01357512|Oulu University Hospital and Univeristy of Oulu|Chief urologist Markku Vaarala|+3588315|markku.vaarala@oulu.fi|2840
22387096|NCT01324310|Celgene Corporation|Senior Manager|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22387097|NCT03170882|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22387098|NCT03213457|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22413708|NCT01631331|Stanford University|Dr. Gina Kwon|650-724-3859|gkwon@stanford.edu|
22413709|NCT02476994|Baxter Healthcare|Clinical Trials Disclosure Group||joe_archer@baxter.com|
22413710|NCT02246166|GlaxoSmithKline|GSK Response Center|866-435-7343||
22413711|NCT02563561|Spectrum Pharmaceuticals, Inc. Research and Development Office 157 Technology Drive Irvine, CA 92618|Shanta Chawla|(949) 788-6700|shanta.chawla@sppirx.com|
22413712|NCT03769896|Medical University of Innsbruck|Prof. Klaus Seppi|004351250481553|klaus.seppi@tirol-kliniken.at|
22413713|NCT01015703|BTG International Inc.|SVP Clinical Development|610-278-1660|angela.ogden@btgplc.com|
22413714|NCT03122535|University of Utah|Elizabeth Nuttall|8012133461|elizabeth.nuttall@hsc.utah.edu|
22413715|NCT02646124|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|(718)920-6266|befriedm@montefiore.org|
22413716|NCT05025345|Johnson & Johnson Surgical Vision|Luis Vargas, MD|714-247-8200|LVarga17@ITS.JNJ.com|
22413717|NCT00857454|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22413718|NCT03154047|Prothena Biosciences|Wendy Curlin|650 837 8550|clinicaltrials@prothena.com|
22413719|NCT00573443|Avanir Pharmaceuticals|Nadine Knowles; Executive Director, Research & Development Operations|1-949-268-8972|nknowles@avanir.com|
22413720|NCT00200785|Silliker, Inc./Plant Bioactives Research Institute, Inc.|Larry D. Lawson|801-226-3041|larry.lawson@silliker.com|
22413721|NCT00274781|The Cleveland Clinic|Mikkael Sekeres, MD, MS|216-445-9353|sekerem@ccf.org|
22413722|NCT04567186|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, OD, MS, FAAO, Sr. Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
22413723|NCT04247282|National Cancer Institute|Dr. Hoyoung Maeng|240-781-3253|hoyoung.maeng@nih.gov|
22413724|NCT00904345|University of Michigan Rogel Cancer Center|Shruti Jolly, M.D.|734-936-4302|shrutij@med.umich.edu|
22413725|NCT02481830|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1(800) 332-2056|Clinical.Trials@bms.com|
22413726|NCT00772941|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22413727|NCT02294253|NYS Psychiatric Institute|Adam Bisaga MD|646-774-6155|adam.bisaga@nyspi.columbia.edu|
22413728|NCT02714062|VIVUS|Sr. Director, Clinical Research|650-934-5200||
22413729|NCT02682784|Medical University of South Carolina|Lisa Nunn|843-792-0476|jenkinli@musc.edu|
22413730|NCT01702987|Beth Israel Deaconess Medical Center|Jim Wu|617-754-2390|jswu@bidmc.harvard.edu|
22413731|NCT00467363|NICHD|Dr Enrique Schisterman|(301) 435-6893|schistee@mail.nih.gov|
22413732|NCT03181594|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
22413733|NCT02017223|University of Southern California|Donna Spruijt-Metz, MFA PhD|310-577-6248|dmetz@usc.edu|
22413734|NCT02834663|Wonkwang University Hospital|Dr. Seung Joon Lee|010-5004-8165|eunilsa@hanmail.net|
22413735|NCT00365846|Emory University|Stuart Knechtle, MD|404-727-8465|stuart.knechtle@emoryhealthcare.org|
22413736|NCT00904215|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22413737|NCT01010932|Guerbet|Dr Pierre Desché, MD - VP Head of Development, Medical and Regulatory Affairs|+33 1 45 91 50 00|pierre.desche@guerbet-group.com|
22413738|NCT00982397|Medtronic, plc|CRHF Clinical Research|800-328-2518|medtroniccrmtrials@medtronic.com|
22413739|NCT00838630|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22413740|NCT00204373|The University of Alabama at Birmingham|Dr. C. Mel Wilcox|205-934-6060|melw@uab.edu|
22413741|NCT00578552|Mayo Clinic|Amit Sood|507-266-1944|nicotineresearch@mayo.edu|
22413742|NCT02057458|Augusta University|Ryan Harris, PhD|7067215998|ryharris@augusta.edu|
22413743|NCT05244421|Midwest Evaluation and Research|Dr. Matthew Shepherd|8336439377|matt.shepherd@midwestevaluation.com|
22413744|NCT00424619|McMaster University|Dr. Alexandra Papaioannou|905-521-2100|papaioannou@hhsc.ca|77715
22413745|NCT00723710|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22413746|NCT01864174|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22413747|NCT01884519|GlaxoSmithKline|GSK Response Center|866-435-7343||
22413748|NCT02158663|James A. Haley VA Hospital|F. Andrew Kozel|(813) 972-2000|FRANK.KOZEL@VA.GOV|
22413749|NCT00576056|University of Pittsburgh Medical Center|Dr. David Geller|412-692-2001|gellerda@upmc.edu|
22413750|NCT03197883|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22413751|NCT01353664|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22450127|NCT01896895|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
22413752|NCT03273153|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22450128|NCT03277846|University of Pennsylvania|Michael Perlis|215-746-3577|mperlis@upenn.edu|
22450129|NCT01207778|University of Utah|Dr. Robin Ohls|505-400-7644|robin.ohls@hsc.utah.edu|
22450130|NCT04015219|BioTissue|Medical Affairs|8882968858|medicalaffairs@biotissue.com|
22450131|NCT05168475|Cambridge University Hospitals NHS Foundation Trust|Professor David Jayne|01223 336816|dj106@cam.ac.uk|
22450132|NCT01589822|Ethicon|Director of Clinical Development|1 908 218-2492|JBatill2@its.jnj.com|
22450133|NCT00646204|Baylor College of Medicine/Houston Methodist|William G. Ondo, MD|713-363-8930|wondo@houstonmethodist.org|
22450134|NCT02582840|AstraZeneca K.K.|Yu Shimizuishi|81 6 7711 4669|Yu.Shimizuishi@astrazeneca.com|
22450135|NCT03662100|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22450136|NCT00773175|Halozyme Therapeutics|Dimitrios Chondros, M.D., Chief Medical Officer|858-794-8889|dchondros@halozyme.com|
22413753|NCT02409355|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22381062|NCT00916006|LEO Pharma|Dr. Torsten Skov|+4520736294|tosdk@leo-pharma.com|
22413754|NCT01237054|National Cancer Institute|Dr. Peter Choyke|301-402-8409|pchoyke@mail.cc.nih.gov|
22413755|NCT00838539|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
22450137|NCT00503841|Barbara Ann Karmanos Cancer Institute|Dr. Elaina Gartner|313-576-8724|egartner@seagen.com|
22413756|NCT01908205|Holland Bloorview Kids Rehabilitation Hospital|Lisa Genore|416-425-6220|lgenore@hollandbloorview.ca|6443
22413757|NCT05323396|University of North Carolina at Chapel Hill|Melisa Reimer-McAtee, MD|265 175 5056|melissa_reimer-mcatee@med.unc.edu|
22413758|NCT01114893|Alcon Research, Lt.d|Alcon Clinical|888.451.3937|medinfo@alconlabs.com|817.568.67
22413759|NCT03238781|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22413760|NCT04115293|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22413761|NCT02674152|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22413762|NCT03772522|MAP Centre for Urban Health Solutions, Unity Health Toronto|Dr. Naomi Thulien|647-460-0781|ThulienN@mcmaster.ca|
22430537|NCT04250207|Kowa Research Institute, Inc.|Director, Clinical Operations|919-433-1600|CTGResults@KowaUS.com|
22430538|NCT02772302|Massachusetts General Hospital|Brian Edlow|6177246352|bedlow@mgh.harvard.edu|
22430539|NCT03032484|University of Texas Health San Antonio|Andrew Brenner, MD|210-562-4090|brennera@uthscsa.edu|
22430540|NCT01689649|Janssen-Cilag Taiwan|Medical Director|886 2 23762155||
22430541|NCT04893811|Pfizer Inc.|PfizerClinicalTrials.gov Call Center|1-8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22430542|NCT05263791|MacKay Memorial Hospital|Chien-Chung Huang|02-25433535|titanh@gmail.com|3009
22430543|NCT03689179|University of Utah|Rebecca Utz|801 699 5685|rebecca.utz@utah.edu|
22430544|NCT04581629|Calcilytix Therapeutics, Inc., a BridgeBio company|Medical Information|650.600.3610|MedInfo@bridgebio.com|
22430545|NCT00595075|Sentara Neurology Specialists|Daniel Cohen|757-388-6323|dacohen@sentara.com|
22430546|NCT03329131|University of Texas Health Science Center in San Antonio|Virginia Kaklamani, MD|210-450-3838|kaklamani@uthscsa.edu|
22430547|NCT05261490|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22430548|NCT01244412|University of Rochester|David Kleinman, MD||david_kleinman@urmc.rochester.edu|
22430549|NCT04135443|dfusion, Inc|Tamara Kuhn, Vice President and Research Scientist|831-222-5003|tamara.kuhn@dfusioninc.com|
22430550|NCT01335685|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22413763|NCT01921894|University of Pittsburgh|Dr. Juan C. Celedon, Niels K. Jerne Professor of Pediatrics|412-692-8429|juan.celedon@chp.edu|
22413764|NCT00070291|ECOG Statistical Office|Study Statistician|617-632-3012||
22413765|NCT03255733|Guided Therapy Systems|Rich Amodei, RDMS|480-649-8587|r.amodei@guidedtherapy.com|
22413766|NCT00210223|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
22413767|NCT02533258|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22413768|NCT02096211|Johnson & Johnson MedTech|Dave Whalen|574-404-9399|dwhalen@its.jnj.com|
22413769|NCT03649841|University of Washington|Dr. Jing Zeng|2065984110|jzeng13@uw.edu|
22413770|NCT03618147|Kuwait Society of Allergy & Clinical Immunology|Kuwait Society of Allergy & Clinical Immunology|0096524636478|walherz@hsc.edu.kw|
22413771|NCT02883452|Celltrion, Inc.|SungHyun Kim|+82 32 850 5778|sunghyun.kim@celltrion.com|
22413772|NCT01281501|Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital.|Khrongwong Musikatavorn, MD|+662-256-4000|kmusikatavorn@yahoo.com|4553-5
22413773|NCT01153503|University of Texas Southwestern Medical Center|Irina Gasanova, MD, PhD|214-590-0064|Irina.Gasanova@UTSouthwestern.edu|
22413774|NCT00905840|Johannes-Gutenberg-University Mainz|Prof. Dr. Dr Bilal Al-Nawas, Principal Investigator|0049 6131 17|al-nawas@mkg.klinik.uni-mainz.de|3083
22413775|NCT00448019|The University of Texas (UT) MD Anderson Cancer Center|MD Anderson Cancer Center Leukemia Department|713-792-7734|CR_Study_Registration@mdanderson.org|
22413776|NCT03020615|St. Jude Children's Research Hospital|Jeremie Estepp, MD|(901) 595-5703|jeremie.estepp@stjude.org|
22413777|NCT00089661|Amgen Inc.|Study Director|866-572-6436||
22413778|NCT02760368|R-Pharm|Maria Lemak, Scientific Advisor|0074959567937|lemak@rpharm.ru|1408
22413779|NCT00794963|North Shore Long Island Jewish Health System, Zucker Hillside Hospita, Glen Oaks, NY|Peter Manu, MD|718 470-8290 pmanu@nshs.edu||
22413780|NCT01037114|GlaxoSmithKline|GSK Response Center|866-435-7343||
22413781|NCT01602419|Octapharma AG|Sigurd Knaub/SVP CR&D Haematology|+41 55 4512141|Sigurd.Knaub@octapharma.com|
22413782|NCT01565902|Novartis Pharmaceuticals|Study Director|862-778-8300||
22413783|NCT03645785|Albany Medical Center|Vikas Bhatt|5182623341|bhattv@amc.edu|
22413784|NCT03620747|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22430551|NCT02554474|University of British Columbia|Dr. Linda Li|604-207-4020|lli@arthritisresearch.ca|
22430552|NCT02542280|Ain Shams Maternity Hospital|Ahmed Bahaa|+20 1111700556|abahaa0503@yahoo.com|
22430553|NCT03211832|Prevention Research Center, Brown School, Washington University in St. Louis|Ross Brownson|3149350121|rbrownson@wustl.edu|
22430554|NCT02770365|Perrigo|Associate Director|718-960-9900|jonathan.schwartz@perrigo.com|
22430555|NCT03777020|University of Maryland School of Nursing|Dr. Erika Friedmann|410 706 0659|friedmann@umaryland.edu|
22430556|NCT01422382|Kowa Research Institute, Inc|Roger Morgan, MD FACS|919-433-1600|RMorgan@kowaus.com|
22430557|NCT00967499|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22387099|NCT05116774|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
22413785|NCT02129426|University of Louisville|John W. Berkenbosch|502-852-3720|john.berkenbosch@louisville.edu|
22413786|NCT00635492|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22413787|NCT02251886|Herning Hospital|Finn Lauszus|+45 78434614|finlau@rm.dk|
22413788|NCT04533594|JOHNS HOPKINS HOSPITAL|Dulce M. Cruz-Oliver, MD|4109558305|dcruzoli@jhmi.edu|
22413789|NCT02757105|RedHill Biopharma Ltd.|Dr. Terry F. Plasse|972-(0)3-541-3131|terry@redhillbio.com|
22413790|NCT02477202|Memorial Sloan Kettering Cancer Center|Dr. Dennis Chi, MD|212-639-5016|chid@MSKCC.ORG|
22413791|NCT01593852|Catharina Hospital Eindhoven|Lukas Dekker, MD, PhD|+31 40 239 7000|lukas.dekker@catharina_ziekenhuis.nl|
22413792|NCT02699866|Institut Straumann AG|Dr. Michael McCaskey, Team Leader Clinical Research|+41619651741|michael.mccaskey@straumann.com|
22413793|NCT02937870|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22413794|NCT01185821|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22413795|NCT01837654|Assaf Harofhe MC|Dr. Kobi Stav|972-8-9779409|stavkobi@yahoo.com.au|
22413796|NCT04263649|Becton, Dickinson and Company|Clinical Project Manager|00393452237718|gloria.viti@bd.com|
22413797|NCT05169710|Sumitomo Pharma America Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@suniovion.com|
22413798|NCT04107675|Zambon SpA|Ferdinando Ceravolo, MD|02 665241|ferdinando.ceravolo@zambongroup.com|
22413799|NCT01208337|University of Pittsburgh|Dr. Rakesh Sindhi|412-692-6110|rakesh.sindhi@chp.edu|
22413800|NCT02399917|The University of Texas MD Anderson Cancer Center|Naval Daver, MD./Associate Professor|713-794-4392|NDaver@mdanderson.org|
22413801|NCT00836056|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22413802|NCT03226522|Axsome Therapeutics|Study Director|212-332-5061|cstreicher@axsome.com|
22413803|NCT01001208|Amgen Inc.|Study Director|866-572-6436||
22413804|NCT03458871|The University of Texas Health Science Center at Houston|Dr. Argyrios Stampas|713-797-5938|argyrios.stampas@uth.tmc.edu|
22413805|NCT03420300|National Taiwan University Hospital|Dr. Chen-Hua Liu|+886-223123456|jacque_liu@mail2000.com.tw|63572
22413806|NCT01790581|UNC Charlotte|Erik Wikstrom|704-778-5784|ewikstrom@uncc.edu|
22413807|NCT00584922|University of Oklahoma Health Science Center|Sunny Po, MD, PhD|405-271-9696|Sunny-Po@ouhsc.edu|
22413808|NCT01944930|Lahey Hospital and Medical Center|Thomas Schnelldorfer|781-744-5100|thomas.schnelldorfer@lahey.org|
22413809|NCT04234997|The University of Texas Health Science Center at Houston|Robert Suchting, MD|713-486-2521|Robert.Suchting@uth.tmc.edu|
22413810|NCT03500692|Abbott|Sripad Bellary|6503531726|sripad.bellary@abbott.com|
22413811|NCT02305758|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22413812|NCT01051570|Barbara Ann Karmanos Cancer Institute|Elisabeth I. Heath M.D.|313-576-8717|vaishamu@karmanos.org|
22413813|NCT01424644|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22413814|NCT05593965|University of North Carolina at Chapel Hill|Justin Riddle, PhD|(919) 966-4584|justin_riddle@med.unc.edu|
22413815|NCT02272777|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22413816|NCT04732195|Emory University|Dr. Lokesh Guglani|404-712-2324|lokesh.guglani@emory.edu|
22450138|NCT01302964|Massachusetts General Hospital|Christopher J. McDougle, MD|781-860-1783|cmcdougle@mgh.harvard.edu|
22450139|NCT05723770|Bausch & Lomb|Megan Cavet|5852849474|Megan.Cavet@bausch.com|
22450140|NCT01945489|Allergan, Inc|Vice President Medical Affairs|1-877-277-8566|IR-CTRegistration@allergan.com|
22450141|NCT02281851|University of Birmingham|Mathew Soden|07800549318|matthewsoden33@gmail.com|
22450142|NCT00394212|Davol Inc., Subsidiary of C.R. Bard|Dawn Heimer, Clinical Research|401-825-8681|Dawn.Heimer@crbard.com|
22450143|NCT01076985|Abbott|Global Medical Services|800-633-9110||
22450144|NCT00596011|H. Lee Moffitt Cancer Center and Research Institute|Nagi Kumar, Ph.D.|813-745-6885|nagi.kumar@moffitt.org|
22450145|NCT02347527|University of Colorado School of Medicine|Dr. Kristina Legget|3037245809|kristina.legget@cuanschutz.edu|
22450146|NCT01276314|Chang Gung Memorial Hospital, Linko|Drug Hypersensitivity Clinical and Research Center, Laboratory of Dr. Wen-Hung Chung,|886-3-328-1200|kiruamairo@gmail.com|8494
22450147|NCT01466270|Wake Forest School of Medicine|Dr. Doug Case|336-716-1048|dcase@wakehealth.edu|
22450148|NCT03237234|Shepherd Center|Dr. Edelle C. Field-Fote|404-603-4274|edee.field-fote@shepherd.org|
22450149|NCT01569529|University of Illinois at Chicago, Institute for Health Research and Policy|Dr. Robin Mermelstein|312 996-1469|robinm@uic.edu|
22450150|NCT03427658|Bournemouth University|Dr Katherine Appleton|+441202965985|k.appleton@bournemouth.ac.uk|
22450151|NCT00749775|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22450152|NCT01163604|jinling hospital|xinfeng Liu|025-84801861|xfliu2@vip.163.com|
22450153|NCT00742313|Duke University Medical Center|Terry Ainsworth, Director, Clinical Research Operations, Education & Training|919-681-7084|terry.ainsworth@duke.edu|
22450154|NCT03097653|Istituto di Ricerche Farmacologiche Mario Negri IRCCS|Dr. Paola Mosconi and Dr. Anna Roberto|+390239014503|donnainformata-mammografia@marionegri.it; paola.mosconi@marionegri.it|
22450155|NCT01436279|Boston Medical Center|Olivera Vragovic|617 414 7304|Olivera.Vragovic@bmc.org|
22450156|NCT02096458|Takeda Development Center Americas, Inc.|Takeda Study Registration Call Center|800-778-2860|medicalinformation@tpna.com|
22450157|NCT03004534|Translational Research In Oncology (TRIO)|Director, Project Management|33 158 10 09 09|030@trioncology.org|
22450158|NCT03364049|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|18006726372|ClinicalTrialsDisclosure@merck.com|
22450159|NCT01236196|San Francisco VA Medical Center|Dr. Timothy Carmody|415-221-4810|Timothy.Carmody@va.gov|6344
22450160|NCT01340976|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22387100|NCT03150862|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22413817|NCT02066922|Alcon Research, Ltd.|Clinical Lead, Vision Care Development|1-888-451-3937|alcon.medinfo@alcon.com|
22413818|NCT00440297|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22450161|NCT02953821|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
22450162|NCT03064126|Boston Scientific|Cynthia Peterson|763-955-8233|Cynthia.Peterson@bsci.com|
22450163|NCT01978314|University of Alabama, Birmingham|Dana Victor Rizk, M.D.||drizk@uab.edu|
22450164|NCT03907683|The Pennsylvania State University|Dr David E Conroy|814-863-3451|conroy@psu.edu|
22450165|NCT03400332|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22450166|NCT00048542|Abbott|Global Medical Services|800-633-9110||
22450167|NCT01188577|Amphastar Pharmaceuticals, Inc.|Stephen A. Campbell, Esq.|(909) 980-9484|stephenc@amphastar.com|2016
22450168|NCT06138756|Theranica|Dr Dagan Harris|+972-73-3703649|daganh@theranica.com|
22450169|NCT04063761|Attune Medical|Clinical Research Coordinator|888.534.4873|info@attune-medical.com|
22450170|NCT04033159|Dynacure|Dynacure|+33 3 74 95 20 50|info@dynacure.com|
22450171|NCT02027844|Department of Anesthesiology and Pain medicine, Yeungnam University School of Medicine, Deagu, Repulic of Korea|Sun Mee Jung, M.D.|+82-53-620-3368|applejsm@gmail.com|
22450172|NCT00548860|Luitpold Pharmaceuticals, Inc.|Mark Falone, MD|610-650-4200|mfalone@luitpold.com|
22450173|NCT00151814|Daiichi Sankyo|Howard Kessler|732-590-5032|hmkessler@dsi.com|
22450174|NCT01265446|Novartis Consumer Health, Nyon, Switzerland|Clinical Project Leader|+41223633279|Rowland.Furcha@novartis.com|
22450175|NCT04152226|Dermbiont, Inc|Emma Taylor, MD (Chief Medical Officer)|510-607-8155|emma@dermbiont.com|
22450176|NCT01452412|Albert Einstein College of Medicine|Michal Melamed, MD|718-430-2496|michal.melamed@einstein.yu.edu|
22450177|NCT02346136|MGH Biostatistics|Eric Macklin, PhD|617-724-9828|emacklin@mgh.harvard.edu|
22450178|NCT03047135|Johns Hopkins University|Catherine Handy Marshall, MD|410-955-0231|chm@jhmi.edu|
22450179|NCT00323414|Cleveland Clinic Foundation|Srinivasan Dasarathy MD|216-444-2766|dasaras@ccf.org|
22450180|NCT04382911|University of North Carolina at Chapel Hill|Director, Clinical Research, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
22450181|NCT06105528|ProMIS Neurosciences, Inc.|Wendy Luca|617-250-0365|promisclinical@promisneurosciences.com|
22450182|NCT05619692|Sage Therapeutics|Amy Bullock|617-949-5151|amy.bullock@sagerx.com|
22450183|NCT01589302|The Ohio State University Comprehensive Cancer Center|Kami Maddocks, MD|614-293-3507|Kami.Maddocks@osumc.edu|
22450184|NCT02703636|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22450185|NCT02561130|McMaster University|Natalia McInnes|905-521-2100|natalia.mcinnes@mcmaster.ca|
22450186|NCT01764607|University of Florida|Priya K Gopalan|352-273-8699|gopalpk@ufl.edu|
22450187|NCT01224639|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22450188|NCT04656132|NYU Rory Meyers College of Nursing|Margaret M. McCarthy, PhD, RN, FNP-BC|212-992-5796|mmm529@nyu.edu|
22450189|NCT04365699|NYU Langone Health|Stuart Katz, MD|212-263-3946|Stuart.Katz@nyulangone.org|
22450190|NCT03761732|University of Washington|Lori Zoellner|206 685 3617|ContactUWCATS@uw.edu|
22450191|NCT01076504|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22450192|NCT02196324|Menlo Therapeutics Inc. (formerly Tigercat Pharma, Inc.)|Iain Stuart, PhD.|1- 800-775-7936|Iain.Stuart@foamix.com|
22450193|NCT00834912|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
22450194|NCT00816101|Sheftel Associates Dermatology, LLC|Scott Sheftel, MD|520-293-5757|ssheftel@sheftelderm.com|7106
22450195|NCT01399593|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.||clinicaltrials@alexion.com|
22450196|NCT02131402|Optics Department, University of Valencia 46100 Valencia, Spain|Dr. Robert Montés-Mico O.D., MPhil, PhD|34-9635-44764|robert.montes@uv.es|
22450197|NCT00344773|Astrazeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
22450198|NCT04859868|Mayo Clinic|Gaurav N. Pradhan, Ph.D.|480-301-5351|Pradhan.Gaurav@mayo.edu|
22450199|NCT02766244|Texas Tech University Health Sciences Center|Dr. Sharmila Dissanaike|8067435609|sharmila.dissanaike@ttuhsc.edu|
22450200|NCT02849548|Howard University|Ihori Kobayashi|202-865-7185|ihori.kobayashi@gmail.com|
22413819|NCT02024932|Novartis Pharmaceuticals|Study Director|862-778-1873||
22413820|NCT02445339|NYU Langone Health|Ryan P. McCormack, MD|212-562-6561|Ryan.McCormack@nyulangone.org|
22413821|NCT03206177|University of Oklahoma Health Sciences Center, Stephenson Cancer Center|Dr. Kathleen Moore|405-271-8777|Kathleen-Moore@ouhsc.edu|
22413822|NCT03020641|Ramon y Cajal University Hospital|Characterization of changes in peritoneal cells gene expression after standard versus low pressure l|610 312962|aserranor@salud.madrid.org|+34
22413823|NCT00727961|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22413824|NCT03161405|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22413825|NCT01421277|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6327|ClinicalTrialsDisclosure@merck.com|
22413826|NCT02039908|Florida International University|William E. Pelham, Jr., Ph.D.|305-348-0477|wpelham@fiu.edu|
22413827|NCT01597245|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22413828|NCT00731783|Washington University|Stephanie A. Fritz, M.D., M.S.C.I.|314-454-6050|fritz_s@kids.wustl.edu|
22413829|NCT03071575|Centers for Disease Control and Prevention|Dr. Takudzwa SAYI|404-718-3797|prp2@cdc.gov|
22413830|NCT03666026|UCLA|Principal Investigator|(310) 206-6328|pszilagyi@mednet.ucla.edu|
22413831|NCT00218257|University of Minnesota|Dr. Sheila Specker|612-273-9806|speck001@umn.edu|
22450201|NCT00714259|UAB|William Vaughan, MD|20-934-0066|liwilliams@uabmc.edu|
22450202|NCT02357147|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22450203|NCT02177266|Mayo Clinic|Dr. Jae K. Oh|507-284-6055|oh.jae@mayo.edu|
22450204|NCT03019627|Dompé|Valeria Motta, PhD|02583831|info@dompe.it|
22450205|NCT05107128|Sage Therapeutics|Amy Bullock, PhD|617-949-5151|amy.bullock@sagerx.com|
22450206|NCT03761628|Gedea Biotech AB|Annette Säfholm, CEO|0046 708 91 86 81|annette.safholm@gedeabiotech.com|
22450207|NCT01740596|CHF Solutions|Audrey Singh|9523454217|audrey.singh@chf-solutions.com|
22450208|NCT01470469|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22450209|NCT05459129|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22450210|NCT04508725|Stanford University|Dr. Alice Fan|(650) 498-6000|afan@stanford.edu|
22450211|NCT02638298|Medical University of South Carolina|Dr. Leddy|843-876-1119|leddyl@musc.edu|
22450212|NCT03307759|Peter MacCallum Cancer Centre|Clinical Research Development and Operations|+61 3 8559 5000|crdo@petermac.org|
22450213|NCT04649151|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
22450214|NCT03752619|MetroHealth Medical Center|Dr. Richard Wilson|216-957-3623|rwilson@metrohealth.org|
22450215|NCT04476017|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
22450216|NCT03362502|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22450217|NCT03032796|University of California San Francisco|"Joaquin A. Anguera, Associate Professor, Neuroscape | UCSF"|415-502-7322|joaquin.anguera@ucsf.edu|
22387101|NCT05139992|ASH Research Collaborative|Nicole Mortier|866-828-1231|nmortier@ashrc.org|
22450218|NCT03795610|University of California, San Diego|Dr. Assuntina Sacco|(858) 822-6100|agsacco@health.ucsd.edu|
22450219|NCT02775344|Queen Mary Hospital|Dr Manwa Lui|22554647|ellenlui@hku.hk|
22450220|NCT02650986|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-1300|Kris.Attwood@roswellpark.org|
22450221|NCT03817320|TACL|TACL|3233615429|TACL@chla.usc.edu|
22450222|NCT04664998|University of Washington|Dr. Renee Heffron|2065203817|rheffron@uw.edu|
22450223|NCT03909165|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22450224|NCT06034496|Center for Applied Brain and Cognitive Sciences|Research Assistant Professor|617-627-1059|kana.okano@tufts.edu|
22450225|NCT02018458|Baylor Scott and White Health|Dr. Joyce O'Shaughnessy|214-818-8472|joyce.oshaughnessy@usoncology.com|
22450226|NCT02845752|The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center|Dr. Harry Rossiter|3102228200|hrossiter@lundquist.org|
22450227|NCT03909009|Izmir Katip Çelebi University, Faculty of Medicine|Doç.Dr. Ayhan AŞKIN|00902322444444|ayhanaskin@hotmail.com|1529
22450228|NCT02377089|UCLA Semel Insititute|Andrew F. Leuchter|310-825-0207|afl@ucla.edu|
22450229|NCT03277261|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
22450230|NCT03762083|Gedea Biotech AB|Annette Säfholm, CEO|0046 708 91 86 81|annette.safholm@gedeabiotech.com|
22450231|NCT01203072|Daiichi Sankyo.,LTD|Kei Ibusuki, Associate Director|81-90-2732-9505|ibusuki.kei.tx@daiichisankyo.co.jp|
22450232|NCT00235872|Abbott|Global Medical Services|800-633-9110||
22387102|NCT05521516|University of California San Diego|Brian Ilfeld, MD, MS|(858) 220-5714|bilfeld@health.ucsd.edu|
22387103|NCT00747565|Abbott Medical Optics, Inc.|Nicholas Tarantino, O.D., Head, Global Clinical Research & Development|866-427-8477|nicholas.tarantino@amo.abbott.com|8613
22387104|NCT06229106|Carolina Eyecare Physicians, LLC|Director of Clinical Research|8438813937|hsandoval@cepmd.com|
22387105|NCT05709860|Northwestern University|Research Assistant Professor|312-503-0274|allison.pack@northwestern.edu|
22387106|NCT01513122|The Kirby Institute|Prof Sean Emery|+61293850900|semery@kirby.unsw.edu.au|
22387107|NCT03437733|Biosense Webster, Inc.|Franchise Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22387108|NCT00712179|Ralph H Johnson VA Medical Center|Dr. Steven A Kautz|843-792-3867|kautz@musc.edu|
22387109|NCT00290537|U.T. M.D. Anderson Cancer Center|Vali Papadimitrakopoulou, MD / Associate Professor|713-792-6363||
22387110|NCT04017611|Masimo|Chelsea Frank|(949) 297-7000|studies@masimo.com|
22387111|NCT03406325|Hong Kong Sanatorium & Hospital|Prof. Tak Hong Lee|28358430|TakHong.Lee@hksh.com|
22387112|NCT00145587|St. Jude Children's Research Hospital|Kimberly Kasow, DO|901-595-3300|kimberly_kasow@med.unc.edu|
22387113|NCT01128595|GlaxoSmithKline|GSK Response Center|866-435-7343||
22387114|NCT01970410|Providence Health & Services|Director of PBSI /WC Clinical Research Program|(503) 216-1012|Chiayi.Chen@providence.org|
22387115|NCT00702884|The Ohio State University Comprehensive Cancer Center|Tanios Bekaii-Saab|614-293-6529|Tanios.Bekaii-Saab@osumc.edu|
22387116|NCT00366249|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22387117|NCT00246805|Medtronic BRC - Medtronic Italia|Giorgio Corbucci - Sr Principal Scientist|+39 02 241371|giovanna.zucchi@medtronic.com|
22387118|NCT00609869|H. Lee Moffitt Cancer Center and Research Institute|Javier Pinilla-Ibarz|813-745-1387|javier.pinilla@moffitt.org|
22387119|NCT01342367|The University of Chicago|Dr. Stanley Liauw|7737026870|sliauw@radonc.uchicago.edu|
22387120|NCT02964741|University of Michigan|Jacqueline Dobson|734-763-8469|contacthope@umich.edu|
22387121|NCT00640159|Baylor College of Medicine/Houston Methodist|William G. Ondo , MD|713-363-8930|wondo@houstonmethodist.org|
22450233|NCT00116558|University of Kentucky|Edward J. Kasarskis, M.D., Ph.D.|859-218-5061|ejkas@uky.edu|
22450234|NCT00378014|Novartis Pharmaceuticals|Study Director|862-778-8300||
22387122|NCT03355573|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22387123|NCT04191824|Duke University|Hrishikesh Chakraborty, PhD|919-668-1238|hrishikesh.chakraborty@duke.edu|
22387124|NCT01218009|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com|
22387125|NCT03433794|Old Dominion University|Dr. Abby Braitman|757-683-3708|abraitma@odu.edu|
22387126|NCT01371994|Astellas Pharma Global Development, Inc.|Medical Director, Urology||clinicaltrials@us.astellas.com|
22387127|NCT00087685|The University of Texas (UT) MD Anderson Cancer Center|Karen H. Lu, MD, Chair, Gynecologic Oncology & Reproductive Medicine|713-745-8902|CR_Study_Registration@mdanderson.org|
22387128|NCT01830595|Minneapolis Medical Research Foundation|Jason Baker|612-873-2705|baker@umn.edu|
22387129|NCT03875001|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22387130|NCT03857646|Stanford University|Cody Arnold|(650) 723-8772|codya@stanford.edu|
22387131|NCT04529616|RxSight, Inc.|Associate Director, Clinical Trials|9494215463|dgoffredo@rxsight.com|
22387132|NCT03280030|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22387133|NCT05747599|RTIInternational|Yukiko Washio, PhD|9194852794|ywashio@rti.org|
22430558|NCT00257933|The Children's Hospital of Philadelphia|Joseph Zorc, MD|215-590-1944|zorc@email.chop.edu|
22430559|NCT01375140|The University of Texas MD Anderson Cancer Center|Srdan Verstovsek, MD/Professor|713-745-3429|sverstov@mdanderson.org|
22430560|NCT01217515|S.L.A. Pharma UK Ltd|Dr C Jordan, Head of Clinical Operations|44 01923 681001|cjordan@slapharma.com|
22430561|NCT00420056|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22430562|NCT02470377|University of Minnesota|Yoon-Hee Cha|612-301-2738|ycha@umn.edu|
22430563|NCT03111732|National Cancer Institute|Dr. Tim F. Greten|240-760-6114|tim.greten@nih.gov|
22430564|NCT03406975|Mayo Clinic|Dr. Barham Abu Dayyeh|507-266-4347|AbuDayyeh.Barham@mayo.edu|
22430565|NCT00289900|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22430566|NCT01703221|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22430567|NCT01152385|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com|
22430568|NCT03249558|Massachusetts General Hospital|Dr. Jianren Mao|617-724-6102|mghpainresearch@partners.org|
22430569|NCT02656173|Astellas Pharma Inc.|Medical Director|+81-3-3244-0512|astellas.resultsdisclosure@astellas.com|
22430570|NCT04132427|Arizona State University|James B. Adams|480 965-3316|jim.adams@asu.edu|
22430571|NCT05177328|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22430572|NCT03927846|Wake Forest Health Sciences|Dennis Ang, Primary Investigator|336-705-8701|dang@wakehealth.edu|
22430573|NCT03449147|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|18006726372|ClinicalTrialsDisclosure@merck.com|
22430574|NCT00954538|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22430575|NCT02043860|UIC Cancer Center Clinical Trials Office|Annette Kinsella, RN, CCRC, QA Education Specialist|312-996-5931|annettek@uic.edu|
22430576|NCT03338686|University of Alabama at Birmingham|Ramzi Abou-Arraj|2059344506|rva@uab.edu|
22430577|NCT00974233|University of Wisconsin|Julie E. Chang, MD|608-262-3970|jc2@medicine.wisc.edu|
22430578|NCT01657942|Insightec|Nadir Alikacem|214-630-9900|nadira@insightec.com|
22430579|NCT00684138|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22430580|NCT03061214|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22430581|NCT03413995|Johns Hopkins University|Mark Markowski, MD|410-614-0567|mmarko12@jhmi.edu|
22430582|NCT02290574|Samsung Medical Center|Professor|82-2-3410-2612|hee.ro.park@gmail.com|
22430583|NCT01866150|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
22430584|NCT02904265|Mayo Clinic|Dr. Katherine Nickels|5072660774|nickels.katherine@mayo.edu|
22387134|NCT01983683|Actelion Pharmaceuticals Ltd|clinical trial disclosure desk|0041615656565|clinical-trials-disclosure@its.jnj.com|
22387135|NCT03400150|BioProtect|Dafna Carmi Yinon|+972 (9) 7731-929|dafna@bioprotect.com|
22387136|NCT04882917|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22387137|NCT00319020|Actelion Pharmaceuticals Ltd|clinical trial disclosure desk||clinical-trials-disclosure@actelion.com|
22387138|NCT04926740|Lawson Health Research Institute|Kristine Van Aarsen (Research Associate)|5196858500|kristine.vanaarsen@lhsc.on.ca|76089
22387139|NCT04980300|University of Delaware|Daniel White|302-831-7607|dkw@udel.edu|
22387140|NCT04528459|Columbia University|Wakenda K. Tyler, MD, MPH|2123059192|wkt2106@cumc.columbia.edu|
22387141|NCT02278185|University of Colorado School of Medicine|Dr. Elizabeth R Kessler|720-848-0402|elizabeth.kessler@cuanschutz.edu|
22387142|NCT06056310|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22387143|NCT04406272|Dana-Farber Cancer Institute|Patrick Y. Wen, MD|617-632-2166|patrick_wen@dfci.harvard.edu|
22387144|NCT01078909|The Pennsylvania State University|Dr. Penny Kris-Etherton|814-863-2923|pmk3@psu.edu|
22387145|NCT01596231|McLean Hospital|Scott E. Lukas, Ph.D.|617-855-2767|slukas@mclean.harvard.edu|
22387146|NCT00536120|Biogen Idec Inc.|Biogen Idec Medical Director||clinicaltrials@biogenidec.com|
22387147|NCT02722434|Mayo Clinic|Charles L Loprinzi MD|507/284-2511|cloprinzi@mayo.edu|
22387148|NCT06336967|University of Pennsylvania|Dr. Heather Nuske, PI|(215) 746-6041|heather.nuske@pennmedicine.upenn.edu|
22387149|NCT03684590|University of Texas Southwestern|Tiffany Moon, MD|2145345456|tiffany.moon@utsouthwestern.edu|
22387150|NCT01675063|Emory University|James Blum|404-778-3482|jmblum@emory.edu|
22387151|NCT03876457|University Hospitals Cleveland Medical Center|Dr. Amrou Sarraj|(216)844-0474|Amrou.Sarraj@UHhospitals.org|
22387152|NCT01084694|Northside Hospital|Dr. Dawn Speckhart, PhD|404-255-1930|dawn.speckhart@northside.com|
22387153|NCT02414633|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22387154|NCT02432300|EmotEd, LLC|Dawn Neumann|716-713-5048|dneumann73@gmail.com|
22387155|NCT01211106|Cpl Micheal J Crescenz VA Medical Center|David Oslin, MD|215-823-5894|dave.oslin@va.gov|
22387156|NCT02185794|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22387157|NCT00336505|Advanced Life Sciences|David Eiznhamer, PhD, Executive Vice President, Clinical Development|630-739-6744|deiznhamer@advancedlifesciences.com|
22430585|NCT00600704|Larissa University Hospital Dept. of Anesthesiology|Dr Athina Kleitsaki|00306948481865|theoath1@gmail.com|
22413832|NCT00579345|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22413833|NCT01343004|Radius Health, Inc.|Program Director|(617) 551-4700|info@radiuspharm.com|
22430586|NCT01509404|Medical University of South Carolina|James Fleming|843-792-0312|fleminj@musc.edu|
22430587|NCT00185614|Stanford University School of Medicine|Wen-Kai Weng, MD; Associate Professor of Medicine|650-723-7689|wkweng@stanford.edu|
22413834|NCT02517294|Nemours|Dr Katrin Post-Martens|904-330-9942|Katrin.Post-Martens@nemours.org|
22430588|NCT02735642|Yale University School of Nursing|Ann Kurth|N/A|ann.kurth@yale.edu|
22413835|NCT02267187|University of Pittsburgh|Patsy Simon|412-648-9207|simonpa@upmc.edu|
22413836|NCT02392286|Yale|Dr. Loren Laine|203-785-7312|loren.laine@yale.edu|
22430589|NCT04255381|Yale University|Dr. Stuart Weinzimer|203-785-5831|stuart.weinzimer@yale.edu|
22430590|NCT00993473|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi.com|
22430591|NCT01630109|Genesys Regional Medical Center Office of Research|Dr. Steven Brooks|8106067722|Steven.Brooks@genesys.org|
22430592|NCT02790736|NY State Psychiatric Institute|Franklin Schneier MD|6467748041|fschneier@nyspi.columbia.edu|
22413837|NCT04210557|Yale University|Dr. Philip Corlett|203 974 7866|belieflab@yale.edu|
22430593|NCT01085903|University of Arkansas for Medical Sciences|Mark Mennemeier, PhD|501 526 7773|msmennemeier@uams.edu|
22430594|NCT03992872|Bavarian Nordic|Medical Information|1-844-422-8274|medical.information_NA@bavarian-nordic.com|
22413838|NCT00712959|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22413839|NCT00834067|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22413840|NCT00418561|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22413841|NCT01796171|Nordic Nanovector|Head of Clinical Operations|+47 22 18 33 01|mail@nordicnanovector.com|
22413842|NCT00829309|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22413843|NCT00085293|University of Texas MD Anderson Cancer Center|Steven I. Sherman, MD / Professor|713-792-2841|sisherma@mdanderson.org|
22413844|NCT01707420|University of Colorado|Thomas Notides|720-777-6005|thomas.notides@childrenscolorado.org|
22413845|NCT03699020|University of California San Diego|Maile Young Karris|1-619-543-5039|m1young@health.ucsd.edu|
22413846|NCT02678286|Recro Pharma|Randall Mack|484-35-2470|rmack@recropharma.com|2406
22413847|NCT00280904|Codman & Shurtleff|J. Thomas Megerian|1-508-828-8274|jmegeri1@its.jnj.com|
22413848|NCT04860804|Maimonides Medical Center|Dr. Sergey Motov|718-283-8693|smotov@maimonidesmed.org|
22413849|NCT05704426|Hackensack Meridian Health|Sameer Jamal, MD|15519962997|Sameer.Jamal@hmhn.org|
22413850|NCT02077465|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22413851|NCT01246076|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
22430595|NCT00770679|Johns Hopkins University School of Medicine|Harry Silber, M.D., Ph.D. Assistant Professor of Medicine, Division of Cardiology|4105505717|hsilber@jhmi.edu|
22450235|NCT00414661|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22450236|NCT00654069|Acura Pharma|Dr. Ron Spivey|847-705-7709|rspivey@acurapharm.com|
22450237|NCT02852265|University of California, Davis|Dr. Melissa Chen|916-734-6670|mejchen@ucdavis.edu|
22450238|NCT01143090|Sunovion Pharmaceuticals Inc|Medical Director, CNS|1-866-503-6351||
22450239|NCT02432716|HealthPartners Neuroscience Research|Clinical Trial Manager|651-495-6363|maria.x.pyle@healthpartners.com|
22450240|NCT01800916|Coloplast A/S|Marian Sinvani|+45 49112356|dkmards@coloplast.com|
22450241|NCT01054703|Acclarent|Laura England, Manager-Clinical Research|650-687-4466|lenglan1@its.jnj.com|
22450242|NCT00534235|Paradigm Spine|Fran Magee, DVM|212-367-7274|fran.magee@paradigmspine.com|
22450243|NCT00117143|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22450244|NCT00727714|Telemark Hospital|Dr. Anne Kristin M. Fell, MD, PhD|+4735003106|annfel@sthf.no|
22450245|NCT01103934|University of Chicago|Robert M Naclerio, MD|(773) 702-0080|rnacleri@surgery.bsd.uchicago.edu|
22450246|NCT00325234|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22450247|NCT01234467|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22450248|NCT02662387|Loma Linda University Children's Hospital|Dr. Janeth Ejike|9095584000|jejike@llu.edu|44250
22450249|NCT00559962|Aegerion Pharmaceuticals|Mark Sumeray, MD, Chief Medical Officer|617-500-7867||
22450250|NCT05052190|UCLA|Principal Investigator|310-206-6328|pszilagyi@mednet.ucla.edu|
22450251|NCT01639040|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
22450252|NCT04370691|Abbott|Vinuta Rau|+ 1 408-834-0621|vinuta.rau@abbott.com|
22450253|NCT00486265|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22450254|NCT03013543|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
22450255|NCT04087122|Valley Health|Rebekah Smith, RN, BSN|540-536-5547|rsmith3@valleyhealthlink.com|
22450256|NCT02552316|University of Pennsylvania|Junko Takeshita|215-349-5551|Junko.Takeshita@pennmedicine.upenn.edu|
22450257|NCT04521166|Northwestern University|Varsha Rallapalli|847-467-0897|varsha8904@gmail.com|
22450258|NCT00577083|Indiana University|Douglas K Rex, MD|317-948-8741|drex@iu.edu|
22430596|NCT01998477|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22430597|NCT00129974|Tufts Medical Center|Research Administration||mcoughlin@tuftsmedicalcenter.org|
22430598|NCT01220687|OUHSC College of Medicine, Pediatrics, Neonatal-Perinatal Medicine|Krishnamurhty Sekar, MD, Professor of Pediatrics|405-271-5215|kris-sekar@ouhsc.edu|
22450259|NCT04116710|NightHawk Biosciences Inc.|Vice President, Clinical Development|9197948950|barana@nighthawkbio.com|203
22450260|NCT01256593|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22413852|NCT03375463|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22450261|NCT04514991|University of Pennsylvania- Endodontic Department|Dr. Bekir Karabucak|2158984927|bekirk@upenn.edu|
22430599|NCT02800785|University of Washington|Erin Fannon|206-685-9770|ecarney@uw.edu|
22430600|NCT00113373|NRG Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22430601|NCT02395627|University of California, San Francisco|Dr. Pamela Munster, MD|(415) 502-3598|Pamela.Munster@ucsf.edu|
22430602|NCT03253627|New York University Meyers College of Nursing|John Merriman, PhD, RN|212-998-5375|john.merriman@nyu.edu|
22430603|NCT04710303|Immunitybio|Lennie Sender, Chief Operating Officer|855-797-9277|lennie.sender@immunitybio.com|
22430604|NCT04717479|University of Michigan|Sarah Yon|734-763-0412|shlim@umich.edu|
22430605|NCT00979407|GlaxoSmithKline|GSK Response Center|866-435-7343||
22430606|NCT00855166|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
22430607|NCT00489476|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
22430608|NCT03138382|UCSD|Dr Paul McGeoch|858-232-3312|pdmcgeoch@ucsd.edu|
22430609|NCT04003389|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|8008887704|astellas.resultsdisclosure@astellas.com|
22430610|NCT02364271|Chinese University of Hong Kong|Professor Timothy Rainer|00 852 2632 1034|thrainer@cuhk.edu.hk|
22430611|NCT01512251|University of California, San Francisco|Alain Algazi|(415) 353-7552|alain.algazi@ucsf.edu|
22430612|NCT02514746|PATH|Jorge Flores, MD|(202) 822-0033|jeflores@path.org|
22430613|NCT04003142|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22430614|NCT04806373|Memorial Healthcare System|Mark Block, Chief, Division of Thoracic Surgery|9542651125|mblock@mhs.net|
22430615|NCT03382873|Indiana University|Dr. Carla Miller (current affiliation)|812-855-1608|ckm1@iu.edu|
22430616|NCT01450631|KCI USA, Inc.|Jill Twardowski, Director of Clinical Operations|210-515-4166|jill.twardowski@kci1.com|
22430617|NCT02170519|Duke University Medical Center|Neil MacIntyre, MD|919-681-2720|neil.macintyre@dm.duke.edu|
22430618|NCT02214212|University of Washington|Jeanne Hoffman|2062216511|jeanneh@u.washington.edu|
22400720|NCT04865731|University of Texas Health Science Center at San Antonio|Dr. Shraddha Dalwadi|210-567-1203|dalwadi@uthscsa.edu|
22450262|NCT01110915|Medtronic, Inc|Advisa MRI Clinical Research Specialist|800-328-2518|medtronicCRMtrials@medtronic.com|62813
22450263|NCT03985813|University of Pittsburgh|Oliver Lindhiem|4122465909|lindhiemoj@upmc.edu|
22450264|NCT02161718|Alkermes|Director, Corporate and R&D Communications|781-609-7000|Gretchen.Murphy@alkermes.com|
22450265|NCT03463889|University of California, San Francisco|Dr. Robert Flavell, MD PhD|877-827-3222|Robert.Flavell@ucsf.edu|
22450266|NCT00283933|Medical Affairs|Amicus Therapeutics|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
22450267|NCT02948842|University of South Florida|Lucas Wiegand, MD|813-844-5972|lwiegand@usf.edu|
22450268|NCT01537783|Brigham and Women's Hospital|Scott Weiner, MD, MPH|617-732-5640|sweiner@bwh.harvard.edu|
22450269|NCT05124873|Liberating Technologies, Inc.|Brianna Rozell|774-233-0876|brianna.rozell@liberatingtech.com|
22450270|NCT02350309|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22450271|NCT00207142|Bristol-Myers Squibb|Study Director||clinical.trials@bms.com|
22450272|NCT01554618|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22450273|NCT01857063|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22450274|NCT00058825|Baylor College of Medicine|George Carrum, MD||GCarrum@houstonmethodist.org|
22450275|NCT03023488|Marmara University, School of Medicine, Department of Urology|Dr. Tarik Emre Sener|+905337620712|dr.emresener@gmail.com|
22400721|NCT04907045|Kaiser Permanente Washington Health Research Institute|Joseph E Glass, PhD|206-287-4266|joseph.e.glass@kp.org|
22400722|NCT00222105|University of Kansas Medical Center|Cancer Center Clinical Trials Office|(913) 945-5059|SWILLIAM@kumc.edu|
22400723|NCT04068103|NRG Oncology|Director, Department of Regulatory Affairs|412-339-5300|langerj@nrgoncology.org|
22400724|NCT01672892|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22400725|NCT00468715|Memorial Sloan Kettering Cancer Center|Dr. Tiffany Traina|646-888-4558|trainat@mskcc.org|
22400726|NCT00934895|Rutgers Cancer Institute of New Jersey|Deborah L Toppmeyer, M.D.|732-235-6789|toppmede@cinj.rutgers.edu|
22400727|NCT04745832|MEI Pharma|Richard Ghalie, MD CMO|858.898-0956|rghalie@meipharma.om|
22400728|NCT02981472|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22400729|NCT01498991|AMES Technology Inc.|Paul Cordo|15039706129|pcordo@amesdevices.com|
22400730|NCT02907944|Yale School of Medicine|David Fiellin, MD|(203) 688-5555|david.fiellin@yale.edu|
22400731|NCT03451825|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22400732|NCT01473004|Thomas Jefferson University|Takami Sato, MD|215-955-8874|Takami.Sato@jefferson.edu|
22400733|NCT00698516|GlaxoSmithKline|GSK Response Center|866-435-7343||
22400734|NCT05882890|Rahbek FYS|Cathrine Rahbek|0045 30645390|cathrinerahbek@outlook.dk|
22400735|NCT03549520|Children's Hospital of Philadelphia|Misun Hwang|267-425-7129|hwangm@chop.edu|
22400736|NCT03815292|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22400737|NCT01495988|The Emmes Corporation|Damon Collie|301-251-1161|dcollie@emmes.com|
22400738|NCT01584024|University of Michigan|Dr. Mathilde Peters (PI)|734-925-2750|mcpete@umich.edu|
22400739|NCT00753636|Northwestern University|Dr. Tanya Simuni, MD|312-503-2970|tsimuni@nmff.org|
22400740|NCT00702624|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22400741|NCT00719810|Melinta Therapeutics|Eugene Sun, M.D.|203.624.5606|esun@melinta.com|
22400742|NCT03453060|Aronora, Inc.|Norah G. Verbout, Senior Scientist and Project Manager|503-964-0250|norah.verbout@aronorabio.com|
22400743|NCT04106492|Shasqi Inc|Jose M. Mejia Oneto, MD, PhD|415-800-1376|clinicalstudies@shasqi.com|
22400744|NCT00450463|National Cancer Institute|Dr. Ravi Madan|301-480-7168|ravi_madan@nih.gov|
22450276|NCT01205165|GlaxoSmithKline|GSK Response Center|866-435-7343||
22450277|NCT04352140|Mayo Clinic|J. Ross Renew, M.D.|904-956-3325|Renew.J@mayo.edu|
22450278|NCT01429272|Laureate Institute for Brain Research|Jonathan Savitz; Principal Investigator|918 502 5104|jsavitz@laureateinstitute.org|
22450279|NCT00329407|Boston University|Ofra sarid-Segal, MD|617-414-1990|ofra.segal@bmc.org|
22450280|NCT00978068|University of California, San Francisco|Tamara Clark|415-206-8790|tamara.clark@ucsf.edu|
22387158|NCT03478969|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22450281|NCT02275481|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
22450282|NCT01215227|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22450283|NCT01393405|University of North Carolina, Chapel Hill, NC|Dr. Hans Herfarth|9199666806|hherf@med.unc.edu|
22450284|NCT01434290|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22400745|NCT04893265|University of California San Francisco|Janice Tsoh, PhD, Professor/ Principal Investigator|4155028438|janice.tsoh@ucsf.edu|
22387159|NCT01185600|University of Miami|Wenche Jy, PhD, Research Associate Professor, Principal Investigator|305-243-6617|wjy@med.miami.edu|
22450285|NCT02281552|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22450286|NCT01595516|University of Colorado|Dr. Christopher DeSouza|303-492-2988|desouzac@colorado.edu|
22450287|NCT01359592|SWOG Statistics and Data Management Center|Lymphoma Committee Statistician|206-667-4623|lymph@crab.org|
22387160|NCT05405244|University of North Carolina at Chapel Hill|Kyle Burger, PhD, RD, MPH|9198439933|Kyle_burger@unc.edu|
22387161|NCT00739934|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22387162|NCT03455985|The Ohio State University|Kathleen Dungan|6146853333|kathleen.dungan@osumc.edu|
22387163|NCT00754065|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22387164|NCT04497727|University of Florida|Dr. Carl J. Pepine|(352) 339-0696|carl.pepine@medicine.ufl.edu|
22387165|NCT04353492|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22387166|NCT03893318|University of California, San Diego|Michael Kelly, MD|508-410-9567|mpkelly@ucsd.edu|
22387167|NCT01952366|Sykehuset Innlandet|Dr. Tom Borza|+47 91834607|tom.borza@sykehuset-innlandet.no|
22400746|NCT02523586|Oregon Health and Science University|Jeffrey Kirsch|503-494-9000|kirschje@ohsu.edu|
22450288|NCT02365636|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22450289|NCT01454934|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22450290|NCT03912233|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22450291|NCT02583256|Seqirus|Seqirus Clinical Trial Disclosure Manager|Phone: 1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
22450292|NCT00933491|University of Michigan|Tae-Ju Oh|734-647-3320|taejuoh@umich.edu|
22450293|NCT02530294|Dermira, Inc.|Eugene A. Bauer, MD, Chief Medical Officer|650-421-7202|eugene.bauer@dermira.com|
22450294|NCT01948375|Guang'an Men Hospotal Affiliated to China Academy of Chinese Medical Sciences|Zhishun Liu, Director of the study|8610-010-88001124|liuzhishun@aliyun.com.cn|
22450295|NCT01023659|Centre for Addiction and Mental Heatlh|Dr. Peter Selby|416-535-8501|peter.selby@camh.ca|74946
22450296|NCT04537806|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
22450297|NCT01873989|Yale University|Dr. Declan Barry|203-285-2708|declan.barry@yale.edu|
22450298|NCT01802775|Daiichi Sankyo Development Inc.|Clinical Trial Information|+44 1753482800|info@dsd-eu.com|
22450299|NCT00519649|GlaxoSmithKline|GSK Response Center|866-435-7343||
22450300|NCT01465802|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22450301|NCT01067352|Merck Serono S.p.A., Italy, an affiliate of Merck KGaA, Darmstadt, Germany|Medical Responsible|+49-6151-72-5200|service@merckgroup.com|
22450302|NCT02103478|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
22450303|NCT03219333|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
22400747|NCT02465034|Emory University|Dr. Michael Borich|404-712-0612|michael.borich@emory.edu|
22400748|NCT00573131|Boston Scientific Corporation|Jessie Stockwell|1-612-618-1136|jessie.stockwell@bsci.com|
22400749|NCT03033108|Kubota Vision Inc.|Clinical Trials Helpdesk|(206) 805-8310|clinicaltrials@kubotavision.com|
22400750|NCT01142323|University of Miami|Dr. Cynthia Levy|305-243-2147|clevy@med.miami.edu|
22400751|NCT01959204|PPSI|Study Director|8139279302|mgoodhead@pharmaprojectsolutions.com|
22400752|NCT03090191|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22400753|NCT02494141|"University of Colorado Denver | Anschutz"|Kristen Nowak, Ph.D.|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
22400754|NCT01324830|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22413853|NCT01827163|Memorial Sloan Kettering Cancer Center|Dr. Chau Dang, MD|914-367-7181|dangc@mskcc.org|
22413854|NCT03075553|Mayo Clinic|Stephen M Ansell MD PhD|507/284-2511|ansell.stephen@mayo.edu|
22413855|NCT01745120|bluebird bio, Inc.|Study Medical Director|339-499-9300|medinfo@bluebirdbio.com|
22413856|NCT04314362|Azura Ophthalmics|Charles Bosworth|17145598435|charles.bosworth@azuraophthalmics.com|
22430619|NCT00890656|The University of Texas M. D. Anderson Cancer Center|Stefan Fader, M.D./Associate Professor|713/745-4613|eharriso@mdanderson.org|
22450304|NCT00723606|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22450305|NCT02566759|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22450306|NCT01096784|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22450307|NCT00976898|Massachusetts General Hospital|Theodore Sunki Hong, MD|617-724-1159|tshong1@mgh.harvard.edu|
22450308|NCT02082717|Baptist Health South Florida|Diana D'Orazio-Garcia|786-594-9737|DianaDO@baptisthealth.net|
22430620|NCT03926247|University of New Mexico|Dr. Jessica Goodkind|505-277-2501|jgoodkin@unm.edu|
22430621|NCT05226884|Clinical Research Coordinator|Diana Hill|713-526-1600|diana.hill@berkeleyeye.com|
22430622|NCT03624036|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
22430623|NCT00298155|University of Washington|Dr. Bruce Montgomery|206-598-0860|rbmontgo@uw.edu|
22430624|NCT00291226|Yale University School of Medicine|Scott W. Woods, MD|203-974-7038|scott.woods@yale.edu|
22430625|NCT01185366|UT MD Anderson Cancer Center|Amado Zurita-Saavedra,Associate Professor, Genitourinary Medical Oncology|(713) 563-6966|azurita@mdanderson.org|
22430626|NCT01691313|Laguna Pharmaceuticals, Inc.|Howard C. Dittrich|858-405-1429|HDittrich@lagunarx.com|
22413857|NCT01860521|IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy|Dr. Umberto Leone Roberti Maggiore|00393289461340|ulrm@libero.it|
22413858|NCT02214615|VAMC and Yale University|Stephen Waxman|203-937-3802|stephen.waxman@yale.edu|
22413859|NCT02909907|Cleveland Clinic Foundation|Hubert H Fernandez|2164451108|FERNANH@ccf.org|
22413860|NCT01513174|Fundación GECP|Eva Pereira|+34 934302006|gecp@gecp.org|
22413861|NCT00850174|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22413862|NCT02413320|University of Kansas Medical Center|Dr. Priyanka Sharma|913-588-6029|psharma2@kumc.edu|
22413863|NCT01900626|University of Wisconsin School of Medicine and Public Health|Benjamin J. Walker, MD|608/262-8858|bjwalker2@wisc.edu|
22413864|NCT02355886|University of Washington|George Schade|2065986190|grschade@uw.edu|
22413865|NCT01200810|Rutgers Cancer Institute of New Jersey|Mark Stein, MD|(732) 235-8675|steinmn@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu|
22413866|NCT01727180|Far Eastern Memorial Hospital|Hon-Yen Wu, MD, PHD|+886-2-8966-7000|honyenwu@gmail.com|1164
22413867|NCT03500341|Masimo Corporation|Chelsea Frank|949-297-7000|studies@masimo.com|
22413868|NCT01294917|Centre for Contact Lens Research|Clinical Scientist|519-888-4567|marc.schulze@uwaterloo.ca|36590
22413869|NCT03017885|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22413870|NCT04503174|Tandem Diabetes Care|Clinical Affairs|877-801-6901|clinicalaffairs@tandemdiabetes.com|
22430627|NCT01390584|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22430628|NCT00025233|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22450309|NCT04135703|The Oho State University|Natasha Slesnick|6142478469|slesnick.5@osu.edu|
22450310|NCT05132127|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22450311|NCT05220397|Mayo Clinic|Mark Stegall, M.D.|507-266-2812|stegall.mark@mayo.edu|
22450312|NCT02659020|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22450313|NCT01120210|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director Translational Medicine|858.320.3408|wradzisz@its.jnj.com|
22450314|NCT04296396|George Washington University Biostatistics Center|MFMU Principal Investigator|301-881-9260|mfmudatasets@bsc.gwu.edu|
22450315|NCT06219915|University of Michigan|Principle Investigator|734-998-8400|pchatkae@umich.edu|
22450316|NCT05320029|Fengh Medical Co., Ltd.|Jiao Liu|13815132106|jiao.liu@fulbrightmed.com|
22450317|NCT02043015|Emory University|Patrick S Sullivan PhD/DVM|404-727-2038|pssulli@emory.edu|
22450318|NCT01246791|Nobelpharma|Department director of clinical development department 1|+81-3-5651-1177|murakami@nobelpharma.co.jp|
22450319|NCT04049760|Amicus Therapeutics, Inc.|Patient Advocacy|001 609-662-2000|clinicaltrials@amicusrx.com|
22450320|NCT02927457|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22450321|NCT00868621|Cleveland Clinic Florida|Gamal M. Ghoniem, MD, FACS|954-659-5188|ghonieg@ccf.org|
22450322|NCT00393939|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22450323|NCT01494610|GlaxoSmithKline|GSK Response Center|866-435-7343||
22387168|NCT00623194|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22430629|NCT00401830|UCB Clinical Trial Call Center|Study Director|+1 877 822 9493||
22430630|NCT01720602|University of Washington|Hannah Linden, MD|206-288-6989|hmlinden@u.washington.edu|
22430631|NCT02539394|HospitalSS|Catherine Himo Gang|917-260-4603|gangh@hss.edu|
22430632|NCT02301793|Johns Hopkins Medical Institutions|Elliott R Haut M.D, PhD, Associate Professor of Surgery, Anesthesiology &Critical Care Medicine|410-502-3122|ehaut1@jhmi.edu|
22430633|NCT02691494|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22430634|NCT04634331|Cleveland Clinic|Dr. Jay Alberts|216 445-3222|albertj@ccf.org|
22430635|NCT01270555|Massachusetts General Hospital|Timothy Wilens, MD|617-503-1053|twilens@partners.org|
22430636|NCT00761137|NeuroHealing Pharmaceuticals|Daniel Katzman|617-965-0872|info@neurohealing.com|
22430637|NCT01827306|Sport & Spine Rehab Clinical Research Foundation|Jena Slaski|7179915595|jslaski@ssrehab.com|
22430638|NCT00461812|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
22430639|NCT02916433|Western Connecticut Health Network|Joann Petrini|203-739-6882|Joann.Petrini@wchn.org|
22430640|NCT01694771|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22430641|NCT00890097|Alcon Research, Ltd.|Dana Sager, Clinical Manager Group Leader|1-888-451-3937|alcon.medinfo@alcon.com|
22430642|NCT06003829|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22430643|NCT01941628|Dept. of Anaesthesiology and Intensive Medicine, General University Hospital in Prague|Assoc. Prof. Jan Blaha, MD, PhD|+420 224962243|jan.blaha@lf1.cuni.cz|
22430644|NCT03878069|Chiesi Canada Corp.|Anna Rozova, MD, Clinical Program Leader|1-800-854-3534|a.rozova@chiesi.com|7038
22430645|NCT00834587|Teva Pharmaceuticals USA|Manger, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22450324|NCT02385799|UC Davis MIND Institute|Dr. Randi Hagerman|916-703-0247|rjhagerman@ucdavis.edu|
22387169|NCT00857766|GlaxoSmithKline|GSK Response Center|866-435-7343||
22387170|NCT01988402|San Antonio Military Medical Center|Jay B Higgs,|2109160797|jay.b.higgs.civ@mail.mil|
22387171|NCT01961609|Novartis Pharmaceuticals|Study Director|862-778-1873||
22387172|NCT00647400|Abbott|Global Medical Services|800-633-9110||
22387173|NCT01212744|BioMarin Pharmaceutical Inc.|Medical Director|415-475-5854|ari.gershman@bmrn.com|
22387174|NCT02167451|Cincinnati Children's Hospital Medical Center|Pooja Khandelwal, MD|513-803-4762|Pooja.Khandelwal@cchmc.org|
22387175|NCT00571649|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22387176|NCT02555306|Santen Inc|R&D Quality Manager|+1 415 268 9199|evelyn.chikere@santen.com|
22387177|NCT01566890|Medical College of Wisconsin Department of Hematology|Joshua Field, MD|414-937-6896|JField@Versiti.org|
22400755|NCT01973283|New York State Psychiatric Institute|Patrick J Brown|646-774-8666|patrick.brown@nyspi.columbia.edu|
22430646|NCT00879619|University of California, Irvine|Nicole Macaranas, Clinical Research Specialist|714-456-6550|nicole.macaranas@uci.edu|
22430647|NCT02536339|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
22430648|NCT01691092|Yale University - Psychiatry Department|Irina Esterlis, Ph.D.|(203)737-6820|irina.esterlis@yale.edu|
22430649|NCT03727022|Biosplice Therapeutics|Christopher Swearingen, PhD, VP of Biometrics|858.926.2900|info@biosplice.com|
22430650|NCT05550818|Virginia Tech|Dr. Alexandra DiFeliceantonio|540-526-2285|dife@vt.edu|
22387178|NCT02534285|Technical University Dresden, Dept. of Anaesthesiology|Prof. Dr. Matthias Hübler|+4945814002|matthias.huebler@uniklinikum-dresden.de|
22387179|NCT02397096|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22430651|NCT00581100|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22387180|NCT03029286|Georgetown University|Suzanne O'Neill, PhD|202-687-0869|sco4@georgetown.edu|
22430652|NCT00590317|Emory University|Dr. Daniel Wu|(404) 251-8875|dtwu@emory.edu|
22430653|NCT03031912|CIRN|Dr. Joanne Langley - Coordinating Investigator|902-470-8762|joanne.langley@dal.ca|
22430654|NCT04659876|SBU Gazi Yaşargil Training and Research Hospital|Osman Uzundere|+905330206362|osmanuzundere@gmail.com|
22430655|NCT04097743|University of Oklahoma|Dokyoung Sophia You, PhD|9186603923|dokyoung-you@ou.edu|
22430656|NCT05659329|Stryker|Britta von den Brincken|+491638999202|britta.vondenbrincken@stryker.com|
22430657|NCT00353119|Innovaderm Research Inc|Annie Levesque|514-521-4285|alevesque@innovaderm.ca|222
22430658|NCT02310269|Recordati AG|Mario Maldonado|+41798030344|maldonado.m@recordati.com|
22387181|NCT00743951|University of Ottawa, Ottawa Hospital Research Institute|Dawn Stacey|613-737-8899|dstacey@uottawa.ca|73817
22430659|NCT00839930|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22430660|NCT02500836|STATKING Clinical Services|Lori Christman, PhD|513-858-2989|lori@statkingclinical.com|317
22430661|NCT05562934|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22430662|NCT05365217|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22430663|NCT03997383|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
22430664|NCT04103814|Rush University Medical cEnter|Dr E Bailey Terhune|8018249805|bailey.terhune@rushortho.com|
22430665|NCT00069953|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
22430666|NCT02940223|UT MD Anderson Cancer Center|Sriram Yennu,Professor, MD- Palliative Care Med|(713) 792-3938|syennu@mdanderson.org|
22430667|NCT00143845|University of Michigan Comprehensive Cancer Center|Dr. John Levine, M.D.|734-936-8456|jelevine@umich.edu|
22430668|NCT05528510|Janssen Research & Development, LLC|Senior Medical Leader Pediatrics Immunology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22430669|NCT02586857|Acerta Pharma, LLC|Priti Patel, MD, Executive Director - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
22430670|NCT01856478|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22430671|NCT05032820|The Emmes Company, LLC|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|
22430672|NCT04108208|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22430673|NCT04936308|Janssen Research & Development, LLC|Senior Medical Leader PEDIATRICS IMM|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22430674|NCT04770272|Palleos healthcare GmbH|"Palleos | CRO Germany"|+496119501900|info@palleos.com|
22430675|NCT02363946|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|6263043400||
22430676|NCT03189433|Eagle Pharmaceuticals, Inc.|Chief Medical Officer|201-326-5300|medinfo@eagleus.com|
22430677|NCT03769116|Sarepta Therapeutics, Inc.|Medical Director|888-727-3782|SareptAlly@sarepta.com|
22450325|NCT03995953|Implenomics|Sujha Subramanian|(302) 200 8310|sujha.subramanian@implenomics.com|
22450326|NCT02388997|University of Virginia|Peter W. Heymann|434-982-3654|pwh5a@virginia.edu|
22450327|NCT02130765|Abbott|Senior Clinical Research Scientist|6517562885|amber.miller@abbott.com|
22450328|NCT00384813|Emory University School of Medicine|Marianne Celano, PhD, ABPP|404-778-1536|mcelano@emory.edu|
22450329|NCT00006184|National Cancer Institute, National Institutes of Health|Dr, Claude Sportes, M.D.|301-435-5280|csportes@mail.nih.gov|
22450330|NCT04958109|Massachusetts General Hospital|Margaret Lippincott|6177268434|mlippincott@mgh.harvard.edu|
22450331|NCT01256710|Abbott Medical Devices, Structure Heart Valves|Yunlong (Phil) Zhang, MD, MS, Clinical Consultant|669-203-9308|phil.yl.zhang@abbott.com|
22450332|NCT00715793|University of Pittsburgh|Hussein Tawbi, MD, PhD|713-792-6111|HTawbi@mdanderson.org|
22450333|NCT02346240|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22450334|NCT02681302|Hackensack Meridian Health|Joshua Zenreich|551-996-4248|joshua.zenreich@hmhn.org|
22450335|NCT02942017|Sage Therapeutics|Medical Monitor|617-299-8380|info@sagerx.com|
22450336|NCT00477672|ACADIA Pharmaceuticals Inc.|Roger Mills, MD|858-202-7563|rmills@acadia-pharm.com|
22450337|NCT00838565|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22450338|NCT00458484|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Mitchell Machtay MD|216-844-2530|mitchell.machtay@uhhospitals.org|
22450339|NCT01838642|National Cancer Institute|Dr. James Gulley|301-496-4916|gulleyj@mail.nih.gov|
22450340|NCT02253810|Hospital for Special Surgery|Dr. Ernest Sink|2126061279|Sinke@hss.edu|
22450341|NCT01467999|NYSPI|daniel brooks|6467746171|daniel.brooks@nyspi.columbia.edu|
22450342|NCT00291668|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22430678|NCT04743206|University of Florida|Silvia Delgado Villalta|7185684198|silviadelgado@ufl.edu|
22430679|NCT03030261|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8323|rvij@wustl.edu|
22450343|NCT01557400|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22450344|NCT04155008|Montefiore Medical Center|Dr. Justin Tang|718-920-4094|jtang@montefiore.org|
22450345|NCT04019041|Janssen Research & Development, LLC|Director Clinical Research Dermatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22413871|NCT03138967|UT MD Anderson Cancer Center|Dr. Farzin Goravanchi / Anesthesiology & Perioperative Medicine|713-291-1163|fgoravan@mdanderson.org|
22413872|NCT02448862|Gangnam Severance hospital, Seoul, Korea|Dr. Jae Chul Koh, MD|82-01087023931|aneskoh@yuhs.ac|
22413873|NCT00221299|Unversity of California Davis|Nancy E. Lane MD, Director, Center for Musculoskeletal Health|916 734-0753|nancy.lane@ucdmc.ucdavis.edu|
22413874|NCT04604275|University of Miami|Amanda Fifi|305-243-3166|amandacfifi@gmail.com|
22413875|NCT04405570|Ridgeback Biotherapeutics|Dr. Wendy Painter|786-687-2495|EIDD2801@ridgebackbio.com|
22413876|NCT04499963|Duke University|Richard Bedlack, MD, PhD|919-668-2839|richard.bedlack@duke.edu|
22413877|NCT00693628|Department of Orthopedic Surgery & Rehabilitation, Orthotics and Prosthetics Division|Jonathan Day||jonathan-day@ouhsc.edu|
22413878|NCT02107300|Medical University of South Carolina|Chitra Lal|(843) 792-7776|lalch@musc.edu|
22413879|NCT00501345|UT MD Anderson Cancer Center|Jean-Bernard Durand, MD / Professor||CR_Study_Registration@mdanderson.org|
22413880|NCT02648347|Akebia Therapeutics, Inc.|Clinical Trial Information Desk|+1 617-844-6128|trials@akebia.com|
22413881|NCT01639222|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22413882|NCT03546842|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22413883|NCT01723397|University of Chicago|Dr. Robert Naclerio|773-702-0080|rnacleri@surgery.bsd.uchicago.edu|
22413884|NCT02739997|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22413885|NCT01870856|Alcon Research, Ltd.|Anne Brobst, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22413886|NCT03117296|Henry Ford Hospital|Adele Myszenski, PT, DPT|313-916-1334|amyszen1@hfhs.org|
22413887|NCT02601625|AstraZeneca AB|Anifrolumab Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
22413888|NCT00838279|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22413889|NCT04608188|University of South Carolina|Robert Weaver|8037775605|weaverrg@mailbox.sc.edu|
22413890|NCT03380845|MGH|Dr. Sandeep Saluja|6466621084|sandeep.s.saluja@gmail.com|
22413891|NCT04419311|Aksaray University Training and Research Hospital|Dr. Erdem Aras Sezgin|+905057777697|sezginmd@hotmail.com|
22413892|NCT00965185|Massachusetts General Hospital|Dr. Steven K Grinspoon|617-724-9109|sgrinspoon@mgh.harvard.edu|
22413893|NCT01921062|University Medical Center Groningen|Dieuwke Broekstra, PhD; postdoctoral researcher|0031503613531|d.c.broekstra@umcg.nl|
22413894|NCT03686033|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22413895|NCT00925119|University of Maryland|Dr. Amber Beitelshees|410-706-0118|abeitels@medicine.umaryland.edu|
22413896|NCT01302548|University of Florida|Richard F Petrik, MD|352-265-5911|rpetrik@ufl.edu|
22413897|NCT05528588|UT Southwestern Medical Center|Ambarish Pandey, Principal Investigator|2146200286|Ambarish.pandey@utsouthwestern.edu|
22413898|NCT00913627|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22413899|NCT03254420|INSTITUT REGIONAL DU CANCER DE MONTPELLIER Cancer de Montpellier|Mme Aurore Moussion, Director of Direction of Clinical Research and Innovation|0467613102|drci-icm105@icm.unicancer.fr|+33
22413900|NCT02089997|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22413901|NCT00095212|Massachusetts General Hospital|Steven Grinspoon, MD|617 724 9109|sgrinspoon@partners.org|
22413902|NCT00017953|Wake Forest School of Medicine|Dr. Mark Espeland, Principal Investigator|336-922-2072|mespelan@wakehealth.edu|
22413903|NCT02374853|University of Alberta|Dr. John Mullen|780-902-6327|jmullen@ualberta.ca|
22413904|NCT05844553|Imperial College London, National Heart & Lung Institute and RBH|Prof. Omar Usmani|02073518053|o.usmani@imperial.ac.uk|
22413905|NCT03681470|Icahn School of Medicine at Mount Sinai|Ingrid Sanabria-Gonzalez|212-523-3812|ingrid.sanabria@mountsinai.org|
22413906|NCT00762307|Zeltiq Aesthetics|Kerrie Jiang, Director of Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
22413907|NCT02335658|Sumitomo Dainippon Pharmaceutical|Clinical Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
22413908|NCT01594047|Fondazione IRCCS Istituto nazionale dei Tumori|Tognoli Emiliano MD|+39 0223902282|Emiliano.Tognoli@istitutotumori.mi.it|
22413909|NCT04149964|William Beaumont Hospitals|Mitchell Shecter, DO|2487629363|mitchell.shecter@corewellhealth.org|
22413910|NCT02032888|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22450346|NCT03925727|Mimetogen Pharmaceuticals|VP Clinical Development|514 924 7484|karen.meerovitch@mimetogen.com|
22413911|NCT02851992|Zimmer Biomet|Lisette Smid, Clinical Project Lead|+31 62 395 6378|lisette.smid@zimmerbiomet.com|
22413912|NCT00837486|Medtronic Neuromodulation|Eric Williamson, Clinical Evidence Specialist|763-526-7982|medtronicneurotrials@medtronic.com|
22413913|NCT01577381|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22413914|NCT01754597|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
22413915|NCT02571907|Cook Research Incorporated|Alan Saunders, MS, Senior Manager, Biostatistics|765-463-7537|alan.saunders@cookmedical.com|321204
22413916|NCT03447353|National Advanced Driving Simulator, University of Iowa|Timothy Brown|3193354785|timothy-l-brown@uiowa.edu|
22413917|NCT02175095|Asan Medical Center|Yong Sang Hong, M.D., Ph.D.|+82-2-3010-3227|yshong@amc.seoul.kr|
22413918|NCT02635750|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22413919|NCT00089011|Fred Hutch|David G Maloney, MD PhD|(206) 667-5616|dmaloney@fredhutch.org|
22413920|NCT00462345|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22450347|NCT00213148|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22450348|NCT02581384|Dana-Farber Cancer Institute|Karen Marcus MD|16177328783|karen_marcus@dfci.harvard.edu|
22450349|NCT02321462|Ipsen Pharma|Medical Director||clinical.trials@ipsen.com|
22450350|NCT04425746|CLINUVEL PHARMACEUTICALS LTD|Clinical Operations Manager||mail@clinuvel.com|
22413921|NCT04196907|Masimo Corporation|Vikram Ramakanth|949-297-7000|clinicalresearchdept@masimo.com|
22413922|NCT02642653|University of California Davis|Dr. Randi Hagerman|9167030247|rjhagerman@ucdavis.edu|
22413923|NCT03909607|Maimonides Medical Center|Sergey Motov MD|718-283-8693|smotov@maimonidesmed.org|
22413924|NCT02875392|Taipei Municipal Wanfang Hospital|Ming-Shun Wu|+886229307930|vw1017@gmail.com|
22413925|NCT04974684|IKEM Prague|Dr. Zuzana Tucanova|+420 776292211|zuzana.tucanova@ikem.cz|
22413926|NCT00834717|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22413927|NCT01660243|Toray Industries, Inc|Clinical Trials Information Desk||clinical-trials.toray.mb@mail.toray|
22413928|NCT03025087|Duke University|Joseph Mathew, MD|919-681-6646|joseph.mathew@duke.edu|
22413929|NCT04299087|University of Florida|Dr. David Vaillancourt|(352) 294 - 1770|vcourt@ufl.edu|
22413930|NCT00594035|Integra LifeSciences|Director, Medical Affairs|609-275-0500||
22413931|NCT00795821|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22413932|NCT01285713|New York University, Langone Medical Center|Dr. Kari Posner|212-263-7300|kariposner@gmail.com|
22413933|NCT03821675|Baylor College of Medicine|Prof. Bijan Najafi|17137987536|bijan.najafi@bcm.edu|
22413934|NCT00508651|MedImmune, LLC|Judith Falloon, MD|301 398 0000|falloonj@medimmune.com|
22413935|NCT03155425|Jiangsu Hengrui Pharmaceuticals Co., Ltd.|Clinical Operation Director: Chenglei Qiao|+86-18036618600|chenglei.qiao@hengrui.com|
22413936|NCT02713425|Mayo Clinic|Stephen P. Whiteside, PhD, LP|507-284-2933|Whiteside.Stephen@mayo.edu|
22413937|NCT03874715|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22413938|NCT00738049|University of Texas Medical School at Houston|K. Lance Gould, MD|713-500-6611|K.Lance.Gould@uth.tmc.edu|
22413939|NCT00461786|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22413940|NCT00934050|Transition Therapeutics Ireland Limited and Transition Therapeutics USA Inc.|Susan Abushakra, MD, Chief Medical Officer|+1 650 425 6370|susan.abushakra@tthi.us|
22413941|NCT03161158|Fresenius Medical Care Deutschland GmbH|Dr. Jennifer Braun|+49 6172 609 93488|Jennifer.Braun@fmc-ag.com|
22413942|NCT01379222|Medtronic|Thushari Alahapperuma|763.526.8119|thushari.r.alahapperuma@medtronic.com|
22413943|NCT03616535|NYU Grossman School of Medicine and Langone Health|Dr. Mara McAdams DeMarco|1-646-987-1358|mara.mcadamsdemarco@nyulangone.org|
22413944|NCT03591458|University of Utah|Scott Low|801-585-1380|scott.low@hsc.utah.edu|
22413945|NCT01083693|Abbott|Global Medical Services|1-800-633-9110||
22413946|NCT00834418|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22413947|NCT01705574|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22413948|NCT00777023|Depomed|Head of R&D|650-462-5900|msweeney@depomed.com|108
22413949|NCT02472366|Hopital Lariboisiere|Professor Pascale Massin|0149 95 24 74|pascale.massin@lrb.aphp.FR|
22413950|NCT04274686|University of New Mexico|Dr. Neal Gerstein|505-272-2610|ngerstein@salud.unm.edu|
22413951|NCT04111965|Laboratorios Sophia|Alejandra Sanchez-Ríos M.D.|:+52 (33) 3001 4200|alejandra.sanchez@sophia.com.mx|
22413952|NCT01273805|Dana-Farber Cancer Institute|Brian M. Wolpin|617.632.6942|Brian_Wolpin@dfci.harvard.edu|
22413953|NCT02647944|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
22413954|NCT04920929|Access Vascular Inc.|Brian Hanley|1-781-538-6594|bhanley@accessvascularinc.com|101
22450351|NCT01514396|Medline Industries, Inc.|Ed Drower|847-643-3874|edrower@medline.com|
22413955|NCT00904423|Stanford Cancer Institute, Stanford University|Mark D Pegram, MD|650-723-5801|mpegram@stanford.edu|
22413956|NCT03617523|Sanofi Pasteur Inc.|Medical Director|800-633-1610|Contact-US@sanofi.com|1#
22413957|NCT00202722|Sorlandet Hospital HF|Tor Tveit|+4738073608|tor.tveit@sshf.no|
22413958|NCT01010555|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22413959|NCT02576938|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22450352|NCT03044197|UTexasGalveston|Lori Simon|409-772-1978|lasimon@utmb.edu|
22450353|NCT01153581|Yale School of Medicine|Nina Stachenfeld|203-562-9901|nina.stachenfeld@yale.edu|219
22450354|NCT01574352|USouthernDenmark|professor Lars Bo Andersen|+45 60114380|lars.bo.andersen@hvl.no|
22450355|NCT00245765|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22450356|NCT00660348|Sidney Kimmel Comprehensive Cancer Center|Michael Erdek, MD|410-502-7388|merdek1@jhmi.edu|
22450357|NCT02741115|Mezzion Pharmaceuticals, Inc|Director of Clinical Trials|5734342579|kelly.williams@mezzion.com|
22450358|NCT06425458|Unity Health Toronto|Dr. Naomi Thulien|(416) 864-6060|naomi.thulien@unityhealth.to|77476
22450359|NCT05711927|Columbia University Irving Medical Center|Toni Iurcotta, MD|646-532-8196|ti2241@cumc.columbia.edu|
22450360|NCT03945981|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22450361|NCT03750903|Department of Veterans Affairs|Dr. Joe Nocera, PI|404 321 6111|joe.nocera2@va.gov|121662
22450362|NCT00256698|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22450363|NCT03548584|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22450364|NCT04346615|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22450365|NCT02215070|Duke University|Anthony Sung|919-668-1000|anthony.sung@duke.edu|
22450366|NCT02449356|Xiangya Hospital|Jiali Shao|+8684327413|zwyfeng@163.com|
22450367|NCT02096835|Huashan Hospital Fudan University Shanghai, China|Dr.Xiaoyu Yang|086-021-52889999|yangxiaoyu@huashan.org.cn|7693
22450368|NCT01677195|University of Texas Health Science Center at San Antonio / University of California, Davis* current|Dr. Bradley H. Pollock, PI|(530) 752-7250|pbollock@ucdavis.edu|
22450369|NCT04368429|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22413960|NCT00640562|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22450370|NCT03940508|New York University|Dr. Michael A. Lindsey|212-998-5959|michael.lindsey@nyu.edu|
22450371|NCT03633396|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
22450372|NCT00023673|Radiation Therapy Oncology Group|Wendy Seiferheld||wseiferheld@acr.org|
22450373|NCT00110266|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22450374|NCT00218062|The University of Texas Health Science Center at Houston|Dr Joy M. Schmitz|(713) 486-2867|Joy.M.Schmitz@uth.tmc.edu|
22450375|NCT00667342|St. Jude Children's Research Hospital|Michael Bishop, MD|866-278-5833|referralinfo@stjude.org|
22450376|NCT01433263|Novartis Pharmaceuticals|Study Director|862-778-8300||
22430680|NCT01615029|Janssen Research & Development, LLC|Senior Director, Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22450377|NCT00293384|Barbara Ann Karmanos Cancer Institute|Muneer Abidi, M.D.|(313) 576-8713|abidim@karmanos.org|
22450378|NCT04016324|Medtronic|Rianna Rapson (Prin. Clinical Research Specialist)|763-526-2170|rianna.k.rapson@medtronic.com|
22450379|NCT04709237|Coopervision|Paul Chamberlain|925-251-6682|PChamberlain@coopervision.com|
22450380|NCT02610192|Zimmer Biomet|Mr. Cahit Akbas|+31622981737|Cahit.Akbas@zimmerbiomet.com|
22430681|NCT04903093|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22450381|NCT04048460|University of South Florida Department of Communication Sciences & Disorders|Michelle Arnold, AuD, PhD, CCC-A Assistant Professor|(813) 974-1262|mlarnold@usf.edu|
22450382|NCT03285373|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22450383|NCT02881996|Children's Mercy Hospital|Shawn St. Peter|816-234-3000|sspeter@cmh.edu|3575
22450384|NCT00326612|DIvision of Pediatric Emergency Medicine|Maija Holsti, MD, MPH|801-587-7450|maija.holsti@hsc.utah.edu|
22430682|NCT03213405|Pontificia Universidad Católica de Chile|Dr. Alexis Kalergis|+56223541924|akalergis@bio.puc.cl|
22450385|NCT00419562|Benaroya Research Institute|Carla Greenbaum||cjgreen@benaroyaresearch.org|
22387182|NCT03275285|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22430683|NCT03657407|University of Maryland Medical Center|Anna Reinert, MD|6029089960|anna.reinert@gmail.com|
22387183|NCT00115934|New England Research Institutes|Lynn Sleeper, ScD|617-972-3235|lsleeper@neriscience.com|
22387184|NCT03789110|Dana-Farber Cancer Institute|Sara Tolaney|617-632-5743|Sara_Tolaney@dfci.harvard.edu|
22387185|NCT04032106|Ohio State University|Dr. Paul Reiter|614-292-4803|reiter.36@osu.edu|
22387186|NCT03959423|Medtronic Diabetes|DZ Dai, Sr Statistician|8185764034|dz.dai@medtronic.com|
22387187|NCT04959812|University of Texas Southwestern Medical Center|Craig Crandall|214-345-4623|CraigCrandall@texashealth.org|
22387188|NCT00593840|Washington University School of Medicine|Wade Thorstad, M.D.|314-362-8516|thorstad@radonc.wustl.edu|
22430684|NCT00622843|Infectious Disease Clinical Research Program, Uniformed Services University and HJF|Dr. Brian Agan, Deputy Science Director|240-694-2946|bagan@idcrp.org|
22430685|NCT01539525|Yale University School of Medicine|Kimberly A Yonkers|203-764-6621|kimberly.yonkers@yale.edu|
22430686|NCT02268851|Dana-Farber Cancer Institute|Matthew Davids, MD, MMSc|617-632-6331|matthew_davids@dfci.harvard.edu|
22387189|NCT04440228|University of Pennsylvania|Dr. Courtney Wolk|215-746-6099|courtney.wolk@pennmedicine.upenn.edu|
22387190|NCT05747014|Medtronic|Rianna Rapson - Clinical Study Manager|763-526-2170|rianna.k.rapson@medtronic.com|
22387191|NCT02896907|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. James Posey|215-503-6442|James.Posey@jefferson.edu|
22387192|NCT05802173|Technoderma Medicines|Arthur P. Bertolino MD, PhD, MBA Chief Medical Officer|+1.616.928.1145|arthur.bertolino@innovationderm.com|
22430687|NCT01098578|Ottawa Hospital Research Institute|Dr. Shaun Kilty|613-798-5555|skilty@ottawahospital.on.ca|18514
22450386|NCT00640510|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22387193|NCT04503681|Cooper University Health Care|Brian Roberts|856-342-2352|roberts-brian-w@cooperhealth.edu|
22387194|NCT03352713|Center for Technology and Behavioral Health, Dartmouth Geisel School of Medicine|Dr. Shea Lemley|603-646-7040|behavior.change@dartmouth.edu|
22387195|NCT01812759|UT MD Anderson Cancer Center|Kumar Alagappan,Chair, Emergency Medicine|(713) 745-9911|kalagappan@mdanderson.org|
22387196|NCT00360269|Medical University of South Carolina|Aimee McRae-Clark, Pharm.D., BCPP|843-792-5215|mcraeal@musc.edu|
22387197|NCT02351791|Scientific and Regulatory affairs|Sara Gosk|+45 49113568|dksargo@coloplast.com|
22387198|NCT04989816|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22387199|NCT03758638|Washington University in St. Louis|Rachel Tabak|3149350153|rtabak@wustl.edu|
22387200|NCT01184326|Dana-Farber Cancer Institute|Dr. Mark Pomerantz|617-632-4524|mark_pomerantz@dfci.harvard.edu|
22387201|NCT01036724|CTI Clinical Trials and Consulting|Dr. Tina Hunter, Consulting Statistician to Biosense Webster|513-619-5541|tinah@s2stats.com|
22387202|NCT02967458|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Ethan Halpern|215-955-5345|ethan.halpern@jefferson.edu|
22387203|NCT02186509|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Wenyin Shi|215-955-6702|Wenyin.Shi@jefferson.edu|
22387204|NCT03442777|Belgian Healthcare Knowledge Centre|Jillian Harrison|+32 2 287 33 89|jillian.harrison@kce.fgov.be|
22387205|NCT02866942|Imperial College London|Dr Paul Turner|+44 20 3312 7754|p.turner@imperial.ac.uk|
22387206|NCT00372775|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22387207|NCT01750684|Acorda Therapeutics, Inc.|Chief Scientific Officer|914-347-4300|acorda@acorda.com|
22387208|NCT01561300|Unilever R&D Vlaardingen|Dr Theo Mulder|+31 10 460 8315|theo.mulder@unilever.com|
22387209|NCT00777049|Translational Research in Oncology (TRIO)|Valérie Bee-Muntenau, Director of Project Management|+33 1 58 10 09 09|Valerie.Bee@trioncology.org|
22387210|NCT00790569|Butler Hospital|Dr. Michael Stein|401-455-6646|michael_stein@brown.ed|
22387211|NCT01627561|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22387212|NCT00724126|Salix|David Sorscher|919-862-1827|david.sorscher@salix.com|
22387213|NCT01436175|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22450387|NCT00355238|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22400756|NCT02081963|Department of Respiratory Medicine, Qilu Hospital of Shandong University|Dr.Yu Li|13791122770|qlliyu@163.com|
22400757|NCT01521845|Shaheed Beheshti Medical University|Dr.Jamshid Salamzadeh|00982188662334|j.salamzadeh@yahoo.com|
22450388|NCT00480636|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22450389|NCT02506816|Medica Scientia Innovation Research (MedSIR)|Director of Operations|0034 932 214 135|alicia.garcia@medsir.org|
22450390|NCT01288534|University of Michigan Comprehensive Cancer Center|Dr. Daniel Spratt, M.D.|734-936-9630|sprattda@med.umich.edu|
22450391|NCT02744846|Harvard Pilgrim Health Care Institute|Dr. Jason Block|6178674841|jblock1@partners.org|
22450392|NCT00546715|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22450393|NCT00622427|University of Alabama at Birmingham|Rachel Fargason|205-934-5151|mfargason@uab.edu|
22450394|NCT02477020|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22450395|NCT03852316|University of California, San Diego|Sheldon Morris, MD, MPH|619-543-4761|shmorris@ucsd.edu|
22450396|NCT01049919|Zimmer Biomet|Hillary Overholser|574-373-2042|hillary.overholser@zimmerbiomet.com|
22400758|NCT03047005|Yale University|Dr. Carlos Grilo|203 785 7210|carlos.grilo@yale.edu|
22450397|NCT04354831|Medical College of Wisconsin|Mary Beth Graham, MD|414-955-0500|mbgraham@mcw.edu|
22400759|NCT01122927|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22400760|NCT02389881|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22450398|NCT01018264|University of South Florida|Theresa Zesiewicz, MD, Professor of Neurology|813-974-5909|tzesiewi@health.usf.edu|
22450399|NCT02504372|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22450400|NCT02102256|University of Southern California|Dr. Laurie Eisenberg|213-764-2826|laurie.eisenberg@med.usc.edu|
22400761|NCT01244737|Children's Hospital of Philadelphia|Dr. Frederick Grant|267-600-1542|grantf@chop.edu|
22400762|NCT00736229|Saint Luke's Health System|Steven P. Marso, MD|816-932-5773|smarso@saint-lukes.org|
22400763|NCT01415960|Grand Strand Urology Carolina Urology Reseearch Centre|Dr. Neal Shore MD|+1 843 839 1679|nshore@grandstrandurology.com|
22400764|NCT00356915|GlaxoSmithKline|GSK Response Center|866-435-7343||
22400765|NCT03348514|University of Kansas Medical Center|Dr. John A Taylor III|913-588-8170|Jtaylor27@kumc.edu|
22400766|NCT02371629|Novartis Pharmaceuticals|Study Director|862-778-8300||
22400767|NCT01193335|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22400768|NCT00462423|Northern California Medical Center|Lynn E. Spitler, MD|415-435-9861|lynn@drspitler.com|
22400769|NCT03486314|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22400770|NCT01985321|Benu BioPharma, Inc.|Dr. Eric M. Morrel|5082085634|emorrel@benubio.com|
22400771|NCT01773395|Dana-Farber Cancer Institute|Dr. Vincent Ho|617-632-5938|Vincent_Ho@dfci.harvard.edu|
22400772|NCT01364467|Virginia Commonwealth University|Kelley M. Dodson, MD, FACS|804-828-3965|kelley.dodson@vcuhealth.org|
22400773|NCT03577990|The University of North Carolina at Charlotte|Willie M. Abel, Associate Professor of Nursing|704-687-7949|wmabel@uncc.edu|
22400774|NCT02827877|City of Hope Medical Center|Dr. Joanne Mortimer|626-359-8111|jmortimer@coh.org|
22400775|NCT00729430|Brigham and Women's Hospital|Dr. Raymond Y. Kwong, Director of Cardiac Magnetic Resonance Imaging|857-307-1960|rykwong@partners.org|
22400776|NCT00519532|UCB|UCB Clinical Trial Call Center|+18778229493||
22400777|NCT03914300|The Ohio State University Comprehensive Cancer Center|Dr. Bhavana Konda|614-293-9779|bhavana.konda@osumc.edu|
22400778|NCT00814710|GlaxoSmithKline|GSK Response Center|866-435-7343||
22400779|NCT02280811|National Cancer Institute|Dr. Christian Hinrichs|301-435-3027|hinrichs@nih.gov|
22400780|NCT02871479|Santalis Pharmaceuticals|Dr. Paul Castella|2103992316|paulc@satalispharma.com|101
22400781|NCT01212445|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22400782|NCT04090164|Mansoura University|Osama Hussein|00201099815110|osamahussein@mans.edu.eg|
22400783|NCT01075347|Natinal Taiwan University Hospital|We-Li Chen , MD|886-2-2356|chenweili@ntu.edu.tw|5206
22450401|NCT03491150|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22450402|NCT02402452|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22450403|NCT05179421|Wake Forest University School of Medicine|Professor James C. Eisenach, MD|336-716-4182|jimeisenach@gmail.com|
22450404|NCT00792610|National Taiwan University Hospital|Jan, Chyi-Feng|886-2-23562147|jcf036@ntu.edu.tw|
22450405|NCT00813124|University of Texas (UT) MD Anderson Cancer Center|Richard E. Champlin, MD/Chair, Stem Cell Transplantation|713-792-3618|rchampli@mdanderson.org|
22450406|NCT03746522|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
22450407|NCT03323099|University of California San Francisco|Dr. Greg Marcus|4154763393|greg.marcus@ucsf.edu|
22450408|NCT00767676|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
22450409|NCT05422053|Tandem Diabetes Care|Supervisor, Clinical Operations|(858) 366-6900|clinicalaffairs@tandemdiabetes.com|
22450410|NCT02052739|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
22450411|NCT04907032|UAB|Russell Stanley|325-829-8315|russellstanley74@gmail.com|
22450412|NCT00739752|Indiana University|Dr. Gregory Zimet|317-274-8812|gzimet@iu.edu|
22450413|NCT01183169|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
22450414|NCT00249470|Johns Hopkins School of Medicine: Department of Psychiatry|Dr. Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
22450415|NCT00705107|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22400784|NCT03665155|Memorial Sloan Kettering Cancer Center|Jason Lewis, PhD|314-276-1830|lewisj2@mskcc.org|
22400785|NCT01826214|Novartis Pharmaceuticals|Study Director|82-778-8300|trialandresults.registries@novartis.com|
22413961|NCT03749252|Guerbet|Global Head of Medical Affairs & Clinical Development|+33 (0) 1 45 91 50 00|jing.hao@guerbet.com|
22413962|NCT03098394|University of Maryland School of Medicine|Richard Gentry Wilkerson|4103285555|gwilkerson@som.umaryland.edu|
22413963|NCT04408794|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
22413964|NCT01885117|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22413965|NCT00571064|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
22413966|NCT00244764|GlaxoSmithKline|GSK Response Center|866-435-7343||
22413967|NCT02701556|Valeant Pharmaceuticals|Johnson Varughese|908 927-1162|johnson.varughese@bauschhealth.com|
22413968|NCT01518972|VA Puget Sound Health Care System|Tracy L. Simpson, Ph.D.|206-277-3337|tracy.simpson@va.gov|
22413969|NCT02363803|Washington University in St. Louis|Dr. Simon Haroutounian|3143622628|sharout@wustl.edu|
22413970|NCT03140631|Michigan Medicine|Dr. Hakan Oral|734-936-8214|oralh@med.umich.edu|
22413971|NCT02169115|Charité- Dpt. of Dermatology and Allergy|Professor Martin Metz|+49 30 450 518 159|martin.metz@charite.de|
22413972|NCT02159950|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22413973|NCT00003659|Memorial-Sloan Kettering Cancer Center|Dr. David Scheinberg|646-888-2190|scheinbd@mskcc.org|
22413974|NCT00575159|GlaxoSmithKline|GSK Response Center|866-435-7343||
22413975|NCT04022954|Abbott|Principal Scientist Clinical Research|1 202 253 5981|eric.horvath@abbott.com|
22413976|NCT01499147|University of Illinois Cancer Center|Damiano Rondelli, MD|312-996-6179|drond@uic.edu|
22413977|NCT03872128|Yale University|Nia Fogelman|(917)861-9865|nia.fogelman@yale.edu|
22413978|NCT00958334|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
22413979|NCT03702608|Medinol|Dina Kofler, VP Clinical Affairs|+97237679032|dinak@medinol.com|
22413980|NCT03285594|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
22413981|NCT03733444|Galapagos NV|Galapagos Medical Information|+32 15 342900|medicalinfo@glpg.com|
22413982|NCT03637764|Sanofi Aventis Recherche & Développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22413983|NCT02648438|AstraZeneca AB|Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
22413984|NCT03286465|The University of Texas Health Science Center at Houston|Javier Barreda Garcia, MD|713-500-6838|Javier.BarredaGarcia@uth.tmc.edu|
22413985|NCT01854047|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22413986|NCT01045161|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22450416|NCT03962543|SpringWorks Therapeutics, Inc.|Head of Clinical Operations|8772794870|clinical@springworkstx.com|
22450417|NCT02777125|University of Tennessee Health Sciences College of Medicine/Le Bonheur Children's Hospital|Mark Snider DO, Principal Investigator|9012875986|marksnider02@hotmail.com|
22450418|NCT02917031|AstraZeneca R&D|AstraZeneca R&D|+46 766 346712|clinicaltrialtransparency@astrazeneca.com|
22450419|NCT04036500|Medical College of Wisconsin|Jenna Sarvaideo, DO|414-955-7069|jsarvaideo@mcw.edu|7069
22450420|NCT02742103|CSL Behring|Trial Registration Coordinator|6108784000|clinicaltrials@cslbehring.com|
22450421|NCT02533921|University of Colorado|Benzi Kluger, MD, MS, Principal Investigator|303-724-2194|Benzi.kluger@ucdenver.edu|
22450422|NCT00533949|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22450423|NCT00727194|Alexion Pharmaceuticals|Alexion Pharmaceuticals|855-752-2356|clinicaltrials@alexion.com|
22450424|NCT03853707|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22450425|NCT02349711|Food Science and Human Nutrition Department, University of Florida|Dr. Bobbi Langkamp-Henken|352-294-3721|henken@ufl.edu|
22450426|NCT01516268|Tehran University of Medical Sciences|Dr. Laleh Eslamian|0098218490|leslamian@tums.ac.ir|2415
22450427|NCT05036642|Stanford University|Allison Okamura|(650) 723-3148|aokamura@stanford.edu|
22450428|NCT04269161|University of Missouri|Roger Fales|5738841564|falesr@missouri.edu|
22450429|NCT02472756|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22450430|NCT02871128|Chung Shan Medical University|Dr. You-Cheng Shen|+886-4-24730022|youcheng@csmu.edu.tw|12107
22450431|NCT01440322|Alcon Research, Ltd.|Sharon Holden Thomas, Sr. Principal Clinical Scientist|1-888-451-3937|alcon.medinfo@alcon.com|
22450432|NCT02267629|Stanford University|Dr. Carolyn Rodriguez, Assistant Professor, Director of Rodriguez Translational Therapeutics Lab|650-723-6158|cr2163@stanford.edu|
22450433|NCT04300296|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22450434|NCT01962558|MicroTransponder|VP Clinical Affairs|512-371-4160|studies@microtransponder.com|
22450435|NCT05044234|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22450436|NCT02619409|Medical University of South Carolina|Dr. Eric Bolin|8437922322|bolin@musc.edu|
22450437|NCT02995915|Duke University Medical Center|Angela Kirby, MS|(919) 824-7729|angela.kirby@duke.edu|
22450438|NCT00279708|The National Institutes of Health/ The National Heart, Lung, and Blood Institute|Joseph Fontana, MD|301-451-7740|fontanaj@nhlbi.nih.gov|
22450439|NCT02624284|University of Pennsylvania|Mary Falcone, Ph.D.|215-746-3782|mfalc@pennmedicine.upenn.edu|
22450440|NCT02940691|Kirby Institute|Professor Jason Grebely|+61 2 9385 0957|jgrebely@kirby.unsw.edu.au|
22450441|NCT01369875|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
22450442|NCT00812929|GlaxoSmithKline|GSK Response Center|866-435-7343||
22450443|NCT06285981|Orthofix|Clinical Program Manager|0456719077|danielacangiano@orthofix.it|
22413987|NCT02444715|Luxembourg Institute of Science and Technology|Dr. Lübomira Spassova|+352 275 888 1|lubomira.spassova@list.lu|
22413988|NCT00408070|UCHC|Paige Dunion|860-679-6571|pdunion@uchc.edu|
22413989|NCT02281084|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22413990|NCT02957942|University of Minnesota|Mo Chen|612-624-5220|mchen@umn.edu|
22450444|NCT02975934|pharmaand GmbH|Medical Information Department|+43/1/3560006|medinfo@pharmaand.com|
22387214|NCT01664741|Johns Hopkins School of Medicine|Mary E McCaul|410-955-9526|mmccaul1@jhmi.edu|
22387215|NCT03577106|UPMC|Scott Ward|412-683-7105|wards7@upmc.edu|
22387216|NCT01579318|OncoSec Medical Incorporated|Sharron E Gargosky, Chief Clinical Regulatory Officer|+1 858-255-4729|ClinicalTrialsInfo@OncoSec.com|
22387217|NCT00635700|Yale University|Scott W. Woods, M.D.|203-974-7038|scott.woods@yale.edu|
22387218|NCT03601715|Federal University of Santa Catarina|Inaihá Benincá|(+55 48) 3721-6255|inaiha.b@gmail.com|
22387219|NCT01929291|GlaxoSmithKline|GSK Response Center|866-435-7343||
22387220|NCT01478594|AVEO|Medical Director|1.617.588.1960|clinical@aveooncology.com|
22387221|NCT01119755|Hypertension Center, Third Department of Medicine, University of Athens, Greece|George S Stergiou, Associate Professor of Internal Medicine and Hypertension|+302107763117|gstergi@med.uoa.gr|
22387222|NCT01313884|Stanford University Medical Center|Kristen Ganjoo, MD|650-725-6413|kganjoo@stanford.edu|
22387223|NCT01970007|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
22387224|NCT03878979|Johns Hopkins University|Dr. Tanguy Seiwert|443-287-8312|tseiwert@jhmi.edu|
22387225|NCT05230433|Happy Trails Nutrition|Jennifer Meijer|6036505250|jen@htnutrition.com|
22387226|NCT04250194|Vanderbilt University Medical Center|Dr. Fabien Maldonado|615-322-2386|fabien.maldonado@vumc.org|
22387227|NCT00274261|NICHD|Jason Woo, MD, MPH|301-496-1662|woojj@mail.nih.gov|
22430688|NCT03425188|Respicardia, Inc.|Tim Meyer, VP Clinical Affairs|952-540-4479|tmeyer@respicardia.com|
22450445|NCT02075840|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22450446|NCT05429203|Stanford University|Subhas Banerjee, MD|(650) 736-5555|subhas.banerjee@stanford.edu|
22430689|NCT02184442|Edwards Life Sciences|Tenley Koepnick|949-250-6504|Tenley_Koepnick@Edwards.com|
22430690|NCT00787800|Mayo Clinic|Paul A. Friedman, MD, Professor of Medicine|507-284-7661|friedman.paul@mayo.edu|
22430691|NCT03810495|Go Medical Industries, Pty Ltd|Director of Operations|61(8) 9388 1700|ctc@gomedical.com.au|
22430692|NCT04028960|HealthPartners Institute dba International Diabetes Center|Anders Carlson, MD|952-993-1927|Anders.L.Carlson@HealthPartners.Com|
22430693|NCT01905683|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
22430694|NCT01157429|Tulane University|Dr. Michael Scheeringa|5049882167|mscheer@tulane.edu|
22430695|NCT02037984|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22430696|NCT00527878|NIAID, NIH|Alexandra Freeman MD, Staff Clinician, Lead Associate Investigator for Protocol|301-594-9045|freemaal@mail.nih.gov|
22430697|NCT01258985|Tufts Medical Center|chenchen wang|617-636-3251|cwang2@tuftsmedicalcenter.org|
22430698|NCT04924608|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22430699|NCT05415215|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22430700|NCT02797522|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
22450447|NCT02509065|Massachusetts General Hospital|Courtney A Balliro|617-726-1242|cballiro@partners.org|
22450448|NCT02644967|Idera Pharmaceuticals, Inc|Head of Clinical Operations|484-348-1605|lcolfer@iderapharma.com|
22450449|NCT02287896|LFB Biotechnologies|Clinical trial Information desk|33169825656|supportqcm@lfb.fr|
22450450|NCT02097992|University of Miami|Adam Wanner|(305)243-3045|awanner@med.miami.edu|
22450451|NCT01147653|Duke University School of Medicine, Division of Pediatric Blood and Marrow Transplantation|Jesse Troy, PhD||cordbloodtherapyinfo@dm.duke.edu|
22450452|NCT00280566|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22450453|NCT01409291|Creighton University|Kathleen Packard, PharmD, MS, BCPS (AQ Cardiology)|402-481-3915|kathleenpackard@creighton.edu|
22450454|NCT01077960|EMD Serono|EMD Serono Medical Information|1-888-ASK-SERO (275-7376)||
22450455|NCT01702233|Biologische Heilmittel Heel|Dr Istvan Zatik|+497221501(0)|istvan.zatik@heel.com|3192
22450456|NCT03837899|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22450457|NCT01403974|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22450458|NCT01526889|Novartis Pharmaceuticals|Study Director|+1 862-778-8300|Novartis.email@novartis.com|
22450459|NCT01990677|Wills Eye|Mitchell Fineman,MD|215-928-3092|research@midatlanticretina.com|
22450460|NCT03571516|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22450461|NCT02800148|Perrigo|Associate Director|718-960-9900|jonathan.schwartz@perrigo.com|
22450462|NCT00613509|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22450463|NCT03465878|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22450464|NCT02540954|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22450465|NCT01458327|Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corp.|Berra Yazar-Klosinski, PhD / Chief Scientific Officer|(831) 429-6362|trialdata@mapsbcorp.com|
22450466|NCT00624806|Center of Innovation for Complex Chronic Health Care|Marylou Guihan, PhD|708-202-2414|marylou.guihan@va.gov|
22450467|NCT02448875|Alcon Research|Senior Clinical Project Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22450468|NCT01806896|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22450469|NCT02434770|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22450470|NCT01617603|Medical School, Michael White Diabetes Centre, 220-236, Anlaby Road,|Prof. Stephen Atkin, Principal Investigator|+44(0)1482 675312|Stephen.Atkin@hyms.ac.uk|
22450471|NCT04174313|Hospital El Cruce|Nestor Pistillo|054 1142109000|npistillo@yahoo.com.ar|5636
22450472|NCT01282424|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22450473|NCT04399928|Smith & Nephew|Fleur Derdeyn, Clinical Study Manager|+32497602032|fleur.derdeyn@smith-nephew.com|
22450474|NCT03316872|Princess Margaret Cancer Centre|Dr. Jennifer J Knox|+1-416-946-2399|jennifer.knox@uhn.ca|
22450475|NCT04074317|Xeris Pharmaceuticals Inc.|Dawn Harper, VP Clinical Devlopment|(215) 704-7290|dharper@xerispharma.com|
22450476|NCT05677425|Haukeland University Hospital|Øyvind Ulvik|+47 97 50 00|doc.ulvik@online.no|
22450477|NCT01038778|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|7168451300|adrienne.groman@roswellpark.org|
22450478|NCT02283788|BIAL - Portela & Cª, S.A.|Head of Clinical Research|+351 22 9866100|francisco.rocha@bial.com|
22450479|NCT02595567|Washington University School of Medicine|Alexander Chen, Director of Interventional Pulmonology|314-454-8764|achen@dom.wustl.edu|
22450480|NCT01379963|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22450481|NCT01610700|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
22450482|NCT01706952|McGill University Health Centre|Marc A. Tewfik|+15147976673|marc.tewfik@mcgill.ca|
22450483|NCT04031885|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22450484|NCT02896127|Novartis PharmaAG|Study Lead|+41613241111|novartis.email@novartis.com|
22450485|NCT01782313|Northwestern University|Mark Agulnik, MD|312 695 6182|magulnik@nm.org|
22450486|NCT00958776|BioCryst Pharmaceuticals, Inc.|William P. Sheridan, MBBS|919-859-1302||
22450487|NCT00326911|ImClone LLC|Chief Medical Officer||ClinicalTrials@ImClone.com|
22450488|NCT04027218|University|Ms. Leticia Carmen Simón López|+34 680721340|leticia.simon25@gmail.com|
22450489|NCT00494494|University of North Carolina at Chapel Hill|Kennth L. Cohen, MD|919 843-0292|klc@med.unc.edu|
22450490|NCT00418691|UT MD Anderson Cancer Center|Jeffrey Wefel, PHD/ Associate Professor, Neuropsychology|713-563-0514|jwefel@mdanderson.org|
22400786|NCT00955110|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22450491|NCT00501540|University of Wisconsin Carbone Cancer Center|Dr. Noelle LoConte|608-265-5883|ns3@medicine.wisc.edu|
22450492|NCT02331446|Federal Universisty of Pelotas|Msc. Matheus Pintanel Freitas||matheus.pintanel@hotmail.com|
22450493|NCT02984995|Daiichi Sankyo Co., Ltd.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22450494|NCT04182100|PharmaEssentia Japan KK|Hiroaki Kawase|+81-3-6910-5103|hiroaki_kawase@pharmaessentia.com|
22450495|NCT02100007|MEI Pharma Inc|Richard Ghalie, MD, Sr Vice President Clinical Development|858 369-7116|rghalie@meipharma.com|
22450496|NCT00433654|Medtronic, Inc|EnRhythm MRI Clinical Research Specialist|800-328-2518|medtronicCRMtrials@medtronic.com|62813
22450497|NCT02915029|University of New Mexico|Dr Vallabh Shah|505-272-9615|vshah@salud.unm.edu|
22450498|NCT00499603|The University of Texas MD Anderson Cancer Center|Clinical Research Operations, Office of VP Clinical Research|713-792-7734|CR_Study_Registration@mdanderson.org|
22450499|NCT00937547|Instituto de Oncología Dr. Luis Razetti, Caracas Venezuela|Dr. Jorge Sánchez-Lander Corresponding Author|582129870165|animamotrix@live.com|
22450500|NCT04439240|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22450501|NCT02315768|UCSD|Dr. Thomas Kipps|858-534-5400|tkipps@ucsd.edu|
22400787|NCT02128490|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22450502|NCT00079274|North Central Cancer Treatment Group|Dr. Steven Alberts|507-284-8432|alberts.steven@mayo.edu|
22450503|NCT01302392|Amgen, Inc.|Study Director|866-572-6436||
22450504|NCT00670228|sanofi-aventis|Trial Transparency Team||GV-contact-us@sanofi-aventis.com|
22450505|NCT03604692|Syndax Pharmaceuticals|Syndax Pharmaceuticals|781-419-1400|clinicaltrials@syndax.com|
22450506|NCT00637195|GlaxoSmithKline|GSK Response Center|866-435-7343||
22450507|NCT00203203|Texas Heart Institute|Emerson C. Perin, M.D., Ph.D.|832-355-9405|eperin@texasheart.org|
22450508|NCT00547703|Cleveland Clinic Florida|Fernando Castro|954-659-5646|castrof@ccf.org|
22400788|NCT02243176|ASTRAZENECA INVESTMENT (CHINA) CO., LTD.|Xia, Zhang|+86 21 6030 2288|Xia.Zhang@astrazeneca.com|2035
22450509|NCT02471521|Seoul National University Hospital|Jin-Tae Kim|82-2-2072-3661|jintae73@gmail.com|
22450510|NCT00858390|The University of Texas Health Science Center at Houston|G Hergenroeder, Principal Investigator|7135006130|Georgene.W.Hergenroeder@uth.tmc.edu|
22450511|NCT02016963|Human Genome Sciences Inc.|GSK Response Center|866-435-7343||
22450512|NCT01193556|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com|
22450513|NCT01696032|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
22450514|NCT02188576|Boston Childrens Hospital|Dr. Susan Goobie, PI|6173557737|susan.goobie@childrens.harvard.edu|
22450515|NCT00376168|Protalix Ltd.|Einat Almon|972-4-9889488|einata@protalix.com|137
22450516|NCT01020019|New York State Psychiatric Institute|Daniel Brooks|646-774-6171|brooksd@nyspi.columbia.edu|
22450517|NCT05091528|Silverback Therapeutics, Inc.|Chief Scientific Officer|206-456-2900|info@silverbacktx.com|
22450518|NCT00531843|UCSF/SF General Hospital|M. Margaret Knudson, MD|415.205.4623|pknudson@sfghsurg.ucsf.edu|
22450519|NCT02214121|AstraZeneca|Brilinta Global Clinical Lead|+46 31 776 1000|kontakt@astrazeneca.com|
22450520|NCT02375672|Hoosier Cancer Research Network|Fauzia Sharmin|(317) 634-5842|fsharmin@hoosiercancer.org|75
22450521|NCT02203591|3M|Joan Paulson|651-736-6583|jepaulson@mmm.com|
22450522|NCT04115358|Marmara University|Prof. Dr. Ali Mentes|+90 2164140545|alimentes@gmail.com|
22450523|NCT00835497|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22450524|NCT01573624|GlaxoSmithKline|GSK Response Center|866-435-7343||
22413991|NCT03110003|University of Alabama at Birmingham|Dr. Mark Powell|205-975-3328|mfpowell@uabmc.edu|
22413992|NCT02655679|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22413993|NCT03801707|The Ohio State University|Brenda Cuson|614-293-6883|Brenda.Cuson@osumc.edu|
22413994|NCT00819741|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22413995|NCT02222818|Medtronic Cardiac Rhythm and Heart Failure|CRTee Clinical Team|800-328-2518|MedtronicCRMtrials@medtronic.com|
22413996|NCT01376037|Center for Clinical and Cosmetic Research|Mark S. Nestor, M.D., Ph.D|305-933-6716|nestormd@ADMCORP.com|
22413997|NCT02328040|Children's Hospital at Montefiore|Dr. Rubina Heptulla|718-920-7004|rheptull@montefiore.org|
22413998|NCT05244447|Midwest Evaluation and Research|Dr. Matthew Shepherd|833-643-9377|matt.shepherd@midwestevaluation.com|
22413999|NCT00835991|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414000|NCT02149420|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22414001|NCT04278560|Hebrew SeniorLife|On-Yee Lo|6179715331|AmyLo@hsl.harvrd.edu|
22400789|NCT00918723|Fred Hutchinson Cancer Research Center|Dr. Mazyar Shadman|2066675467|mshadman@fredhutch.org|206
22400790|NCT03311126|University of Wisconsin Carbone Cancer Center|Julie Chang, MD|(608) 263-9823|jc2@medicine.wisc.edu|
22400791|NCT03113500|City of Hope Medical Center|Dr. Alex Herrera|626-359-8111|aherrera@coh.org|
22400792|NCT06470087|Adichunchanagiri Institute of Medical Sciences, BG Nagara|Dr Naveen N|9980023372|drnaveenn@bgsaims.edu.in|+91
22400793|NCT02517515|AbbVie|Global Medical Services|800-633-9110||
22400794|NCT04191668|Ectosense|Frederik Massie|+1 786 305 8547|frederik.massie@ectosense.com|
22400795|NCT03839524|TRANSGENE|Director of Medical Affairs|+ 33 3 88 27 91 00|clinical.trials@transgene.fr|
22450525|NCT04399161|JSS Dental College & Hospital, JSS Academy of Higher Education & Research|Dr. Krupa NC|8105064056|kripa_555@yahoo.com|+91
22450526|NCT03417141|Mayo Clinic|Jason C. Sluzevich, M.D.|904-953-6192|Sluzevich.Jason@mayo.edu|
22450527|NCT01420081|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22400796|NCT01568944|Dental College of Georgia|chairman|706-7212442|chcutler@augusta.edu|
22450528|NCT00411619|Cincinnati Children's Hospital Medical Center|Dr. David Franz|513-636-4222|david.franz@cchmc.org|
22450529|NCT01723228|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22450530|NCT01864291|Massachusetts Eye & Ear Infirmary|Dr. Daniel Lee|6175736391|Daniel_Lee@meei.harvard.edu|
22450531|NCT01282216|Johns Hopkins University|Rich Ambinder, MD|4109558839|rambind1@jhmi.edu|
22450532|NCT05093426|Closed Loop Medicine Ltd.|Nihal Noori|07443603405|nihal.noori@closedloopmedicine.com|
22450533|NCT03080961|CLJI WORLDWIDE|Ty Cross, President & CEO|305-397-8880|tycross@cljiworldwide.com|
22450534|NCT00352612|Johns Hopkins University|Aaron Chen|4109556143|achen33@jhmi.edu|
22450535|NCT02219815|St. Boniface Hospital|Dr. Rakesh Arora|2042581078|rarora@sbgh.mb.ca|
22450536|NCT04976530|CytoSorbents Corp|Weihong Fan|732-329-8885|wfan@cytosorbents.com|
22450537|NCT03508219|European Cardiovascular Research Institute (ECRI-10)|Ernest Spitzer, MD|0031102062828|e.spitzer@ecri-trials.com|
22450538|NCT04466891|Jazz Pharmaceuticals Inc.|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
22450539|NCT00445328|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22450540|NCT05114005|The Ohio State University Comprehensive Cancer Center|Dr. Lise Worthen-Chaudhari|614-293-6281|wort08@osumc.edu|
22450541|NCT00590954|Memorial Sloan Kettering Cancer Center|Thomas Kaley, MD|212-639-5122|kaleyt@mskcc.org|
22450542|NCT02239536|Seoul ST. Mary's hospital|Bo-In Lee|821083671055|gidoc4u@gmail.com|
22450543|NCT02143414|SWOG Statistics and Data Management Center|Leukemia Committee Statistician|2066674623|amoseley@fredhutch.org|
22450544|NCT01532362|Jonsson Comprehensive Cancer Center: University of California at Los Angeles|Dr. Jay Moon Lee|(310) 794-7333|jaymoonlee@mednet.ucla.edu|
22450545|NCT02307552|UC Irvine|Thomas Ahlering, MD|714 456-6068|tahlerin@uci.edu|
22450546|NCT00978731|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22450547|NCT03366077|BioGaia AB|Jenny Palming Clinical research Director|+46 738299900|jp@biogaia.se|
22450548|NCT01221441|TissueGene, Inc|R. Ogden Copeland|(301) 921-6000|ocopeland@tissuegene.com|122
22450549|NCT02649972|Memorial Sloan Kettering Cancer Center|Dr. Eli Diamond, MD|212-610-0243|diamone1@mskcc.org|
22450550|NCT03107988|New Approaches to Neuroblastoma Therapy|NANT Medical Director|3233615687|nantops@chla.usc.edu|
22450551|NCT01344057|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22450552|NCT00529386|Dept of Urology, Queen's University|J C Nickel|613 548 2497|jcn@queensu.ca|
22450553|NCT04027686|UCLA Periodontics and Implant Surgery|Dr Perry Klokkevold|3108251927|pklokkevold@dentistry.ucla.edu|
22450554|NCT02939404|Obesity & Diabetes Clinical Research Section, NIDDK|Douglas C. Chang, MD|602.200.5312|Douglas.Chang@nih.gov|
22450555|NCT01428193|University of Virginia|Clinical Research Coordinator|434-243-6911|pcos@virginia.edu|
22450556|NCT03523117|American Regent, Inc.|Mark A. Falone, MD|631.772.3544|mfalone@americanregent.com|
22450557|NCT04452188|The University of Michigan Health System|Dr. Nathaniel Sznycer-Taub|734-936-8993|nsznycer@umich.edu|
22450558|NCT00357370|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
22450559|NCT02665728|Braintree Laboratories, Inc.|Vice President, Clinical Affairs|781-843-2202|john.mcgowan@sebelapharma.com|
22450560|NCT02075437|Duke University|Dr. Nancy Zucker|919-668-0075|nancy.zucker@duke.edu|
22450561|NCT01632800|Weinberg Medical Physics LLC|Irving Weinberg MD PhD|3013467944|inweinberg@gmail.com|
22450562|NCT01830140|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22450563|NCT01502644|Brigham and Women's Hospital|Ajay D. Wasan, M.D., M.Sc.||awasan@partners.org|
22400797|NCT04902885|Jiangsu Simcere Pharmaceutical Co., Ltd.|Study Director|86-025-85566666|simcere@simcere.com|
22450564|NCT05435885|Department of Rehabilitation Medicine, Pusan National University Hospital|Dr. Sanghun Kim|82-51-240-7485|kel5504@gmail.com|
22450565|NCT03306264|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
22450566|NCT00554749|Centre for Child and Adolescent Mental Health, Eastern and Southern Norway|Dr. Hanne Kristensen|+4722586000|hanne.kristensen@r-bup.no|
22450567|NCT00457197|The University of Texas Southwestern Medical Center|E. Sherwood Brown, M.D., Ph.D., Professor|214-645-6950|sherwood.brown@utsouthwestern.edu|
22450568|NCT03078946|Ain-Shams University Hospitals|Dr. Ibrahim Mamdouh Esmat|01001241928|ibrahim_mamdouh@med.asu.edu.eg|
22450569|NCT02722928|The Ohio State University Wexner Medical Center|Juan Fiorda-Diaz Postdoctoral Researcher|6142933559|juan.fiorda@osumc.edu|
22450570|NCT02165111|Johns Hopkins University|Dr. Ricardo J. Bello|4109557566|rbello@jhmi.edu|
22450571|NCT00094653|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22450572|NCT03921411|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22450573|NCT00330551|University of California, Los Angeles|Keith Nuechterlein, PhD|(310) 825-0036|keithn@ucla.edu|
22400798|NCT02401256|Indiana University School of Medicine|Dr. Zeruesenay Desta|3172742823|zdesta@iu.edu|
22400799|NCT01251575|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fredhutch.org|
22400800|NCT00893789|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22400801|NCT02024464|Alcon Research, LLC|Director, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22400802|NCT01479725|Beaumont Hospital, Royal Oak|Dr. Kenneth Peters|248-551-0387|Kenneth.Peters@Beaumont.edu|
22400803|NCT02037919|Family Planning Associates Medical Group , Ltd.|Allison A. Cowett, MD MPH|312-707-8988|aacowett@gmail.com|
22400804|NCT00886938|Washington University|Dr. Jay F Piccirillo|(314) 362-8641|piccirilloj@ent.wustl.edu|
22400805|NCT00917384|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22400806|NCT04586712|University of Florida|Dr. Paul Borsa|352-294-1726|pborsa@ufl.edu|
22414002|NCT01415232|UPittsburgh'|Dr. Manuel Vallejo|4126414260|vallejomc@anes.upmc.edu|
22414003|NCT00440518|UCB Clinical Trial Call Center|Study Director|+1 877 822 9493||
22414004|NCT03570749|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22414005|NCT00561015|Janssen Research & Development, LLC|Clinical Leader|609-730-3174||
22414006|NCT02146105|McMaster University|Dr. Monica Maly|905-525-9140|mmaly@mcmaster.ca|27823
22414007|NCT03086460|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
22430701|NCT04129398|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22387228|NCT03500549|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
22387229|NCT06456723|Imperial College London|Professor Rohini Sharma|0203 313 3720|r.sharma@imperial.ac.uk|
22387230|NCT02016872|Memorial Sloan Kettering Cancer Center|Dr. Jacob Shin, MD|848-225-6436|shinj2@mskcc.org|
22387231|NCT05018143|University of Pennsylvania|Dr. José A. Bauermeister|215-898-3242|bjose@upenn.edu|
22387232|NCT06688357|University of Florida - Norman Fixel Brain Institute|Dawn Bowers, Ph.D.|(352) 273-6617|dawnbowers@phhp.ufl.edu|
22387233|NCT00545545|HiberCell|Michele A. Gargano, MSC/ VP Clin Ops and Prg Mngt|651.675.0300|mgargano@hibercell.com|
22387234|NCT03399500|University of Oklahoma Health Sciences|Michael Businelle|405-271-8001|michael-businelle@ouhsc.edu|50460
22387235|NCT00227266|University of Utah|Sandra Reyna, M.D.|801-581-3551|sreyna@genetics.utah.edu|
22387236|NCT05357989|Annovis Bio, Inc.|Matthew Peterson, PhD|484-875-3192|peterson@annovisbio.com|
22387237|NCT02761187|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22387238|NCT05617300|HealthPartners Neuroscience Research|Leah Hanson, PhD|6514956352|Leah.R.Hanson@HealthPartners.com|
22387239|NCT05140902|University of Alabama at Birmingham|Dr. Harrison Kim|205-996-4088|hyunkikim@uabmc.edu|
22387240|NCT05786612|Coloplast, Clinical strategies|Malene Hornbak Landauro, Medical writer of Clinical strategies|004549112057|dkmhla@coloplast.com|
22387241|NCT05890794|AM-Pharma|AM-Pharma Office|31 (0)30 228 92 22|office@am-pharma.com|
22387242|NCT04538352|The Cleveland Clinic Foundation|Research Administrator|(216) 445-4791|jenkink@ccf.org|
22387243|NCT05704725|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22387244|NCT01470144|Actelion Pharmaceuticals Ltd|Thomas Pfister, PhD||thomas.pfister@actelion.com|
22387245|NCT01663363|Abbott Medical Optics|Ann Murphy, Manager, Clinical Research|619-518-4158|Ann.Murphy@abbott.org|
22387246|NCT03668899|CairoU|Dr. Amira Farouk|01007192834|Amirafarouk77@gmail.com|
22387247|NCT04803370|Son Llàtzer University Hospital|Joan Bargay Lleonart|34871202000|khaoulahelhaji@gmail.com|
22387248|NCT03752684|University of Alabama at Birmingham|John Knight|205-996-2295|johnknight@uabmc.edu|
22387249|NCT02677766|University of Modena and Reggio Emilia|Stefania Costi|+390522522441|stefania.costi@unimore.it|
22387250|NCT00048932|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22387251|NCT01727167|Duke University Medical Center|John J. Freiberger, M.D.|919-684-6726|john.freiberger@duke.edu|
22387252|NCT04213807|Anthos Therapeutics|Debra Freedholm|609-439-8246|Deb.f@anthostherapeutics.com|
22387253|NCT03418922|Eisai Co., Ltd.|Eisai Inquiry Service|none|eisai-chiken_hotline@hhc.eisai.co.jp|
22387254|NCT03451422|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22387255|NCT02347332|Institut de Recherche Pierre Fabre, Toulouse France|Zahida Issiakhem, Clinical Development Physician|+33 5 34 50 61 71|zahida.issiakhem@pierre-fabre.com|
22387256|NCT01816971|University of Chicago Medical Center|Andrzej Jakubowiak, MD, PhD|773-702-4005|ajakubowiak@medicine.bsd.uchicago.edu|
22387257|NCT04384172|University of Michigan|Tim Bruns|734-647-8727|bruns@umich.edu|
22387258|NCT04860505|Emory University|Dr. Colleen Kelley|404-712-1823|colleen.kelley@emory.edu|
22387259|NCT01640951|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22387260|NCT00582972|University of Wisconsin|Dr. Karen Hansen|608-263-3457|keh@medicine.wisc.edu|
22387261|NCT00588471|Mayo Clinic|Dr. Amir Lerman|507-255-7760|lerman.amir@mayo.edu|
22387262|NCT00293397|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu|
22387263|NCT04124432|Johns Hopkins School of Medicine|Dr. Ryan Vandrey|410-550-4036|rvandrey@jhmi.edu|
22387264|NCT00523419|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22387265|NCT00822120|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623||
22387266|NCT01759862|Stanford University|Paul Grimm|6507237903||
22387267|NCT02999763|Syneron Medical|Director of Clinical Affairs|+972-73-2442347|shlomitm@syneron-candela.com|
22387268|NCT04060212|University of Rochester|Matthew Rand|585-275-5459|matthew_rand@urmc.rochester.edu|
22387269|NCT01499849|Tesaro|Martin Huber, M.D., Senior Vice President and Chief Medical Officer|781.257.2536|mhuber@tesarobio.com|
22387270|NCT02646618|University of Connecticut|Dr. Sherry Pagoto|8604868979|Sherry.Pagoto@uconn.edu|
22387271|NCT03885232|University of Colorado at Anschutz Medical Campus|Sean O'Leary, MD, MPH - Principal Investigator|(303)724-1582|sean.oleary@cuanschutz.edu|
22387272|NCT04474496|University of Arkansas for Medical Sciences|Dr. Pearl A. McElfish|479-713-8680|pamcelfish@uams.edu|
22387273|NCT00918203|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22387274|NCT04066075|University of California Los Angeles|Ava K. Bittner, OD, PhD|310-206-9566|researchatvrc@gmail.com|
22414008|NCT00101647|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22414009|NCT02545283|www.roche.com/about_roche/roche_worldwide.htm|Reference Study ID Number: WO29519|888-662-6728 (U.S. Only)|global-roche-genentech-trials@gene.com|
22414010|NCT02436005|CooperVision Inc.|Paul Chamberlain|925 730-6754|PChamberlain@coopervision.com|
22387275|NCT00309166|GlaxoSmithKline|GSK Response Center|866-435-7343||
22387276|NCT06571058|The Ohio State University Comprehensive Cancer Center|Karen Meade|614-366-5060|Karen.Meade@osumc.edu|
22387277|NCT00701701|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22387278|NCT05601882|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22414011|NCT00583453|University of Iowa|Douglas Van Daele|319-353-8162|douglas-van-daele@uiowa.edu|
22430702|NCT02932410|Actelion Pharmaceuticals Ltd|Executive Medical Director CP|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22387279|NCT03834740|Ivy Brain Tumor Center|Dr. Nader Sanai|602-406-8605|research@ivybraintumorcenter.org|
22387280|NCT01208974|University of Miami|Cristiane Takita MD|305-243-4337|ctakita@med.miami.edu|
22387281|NCT03593226|BioLineRx Ltd|VP Clinical & Medical Affairs|+972-8-6429100|clinicaltrials@biolinerx.com|
22387282|NCT02500576|M D Anderson Cancer Center|Dr. Rodabe Amaria|(713) 792-2921|rnamaria@mdanderson.org|
22387283|NCT03691493|Emory University|Dr. Mylin Torres|404-778-1900|matorre@emory.edu|
22387284|NCT05507970|Medicines for Malaria Venture|Project Director|+41 22 555 03 00|info@mmv.org|
22400807|NCT03767738|Regeneron Pharmaceuticals, Inc|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
22400808|NCT01458340|Theravance Biopharma|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
22400809|NCT02417415|Vanderbilt University Medical Center|Italo Biaggioni|(615) 322-2318|italo.biaggioni@vumc.org|
22400810|NCT01575548|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22400811|NCT03806452|THERAVIA|Clinical Operation Manager|+330149709583|laura.thomas-bourgneuf@theravia.com|
22400812|NCT03872180|Emory University Hospital/Winship Cancer Institute|Dr. Jonathon Cohen|4047781900|jonathon.cohen@emory.edu|
22400813|NCT01049776|Illinois CancerCare, P.C.|Sachdev Thomas, M.D.|309-243-3000|sthomas@illinoiscancercare.com|
22400814|NCT00716443|Galderma Laboratories, L.P.|Ron W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
22400815|NCT02750410|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22400816|NCT02504541|Antares Pharma, Inc.|Jonathan Jaffe, MD|609-359-3020|jjaffe@antarespharma.com|
22400817|NCT01531725|ZNA Middelheim Department Interventional Cardiology, Antwerpen, Belgium|Paul Vermeersch, MD, PhD|+32 3 280 3211|paul.vermeersch@zna.be|
22400818|NCT03215277|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22400819|NCT02317510|Lutfiye NBGH|Dr. Turgut Donmez|00905347400967|surgeont73@hotmail.com|
22400820|NCT03228186|Rogel Cancer Center|Gregory Kalemkerian, MD|734-647-8921|kalemker@med.umich.edu|
22400821|NCT03953118|University of California San Francisco CA|Julie Schallhorn, MD|415-514-1922|julie.schallhorn@ucsf.edu|
22400822|NCT03655444|Washington University School of Medicine|Douglas R. Adkins, M.D.|314-747-8475|dadkins@wustl.edu|
22400823|NCT02502864|H. Lee Moffitt Cancer Center and Research Institute|Christine M. Walko, Pharm.D., BCOP|813-745-1519|christine.walko@moffitt.org|
22400824|NCT00931164|University of Utah|Dr. Kathryn Swoboda|801-585-9717|taran@genetics.utah.edu|
22400825|NCT01472276|Queen's University, Belfast|Michelle McKinley, Professor|02890978936|m.mckinley@qub.ac.uk|
22400826|NCT04375878|First Wave BioPharma Inc.|Chief Medical Officer|(561) 589 7020|info@firstwavebio.com|
22400827|NCT00816036|Department of Veterans Affairs|David Katz, MD, MSc|319-338-0581|david-katz@uiowa.edu|7598
22400828|NCT00004980|Yale University School of Medicine|Ralph Hoffman|203-688-9734|ralph.hoffman@yale.edu|
22400829|NCT01624194|Stanford University|Antonio Y. Hardan, MD|(650) 736-1235|hardanay@stanford.edu|
22400830|NCT04322708|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
22400831|NCT03212261|Massachusetts General Hospital/Harvard Medical School|Dr. Giselle K. Perez|617-724-0765|gperez@mgh.harvard.edu|
22400832|NCT01161225|University of Rochester Medical Center|Hyekyun Rhee|5852763775|hyekyun_rhee@urmc.rochester.edu|
22400833|NCT03815175|Abbott|Lijuan Jenn Wang|01-408-8453133|Lijuan.wang1@abbott.com|
22400834|NCT01233726|Intensive Care Unit, Hospital Clínico Universitario|Alfonso Mesejo|961 97 35 00|mesejo_alf@gva.es|
22400835|NCT02256358|Haeundae Paik Hospital, Inje University|Kihwa Lee|82-51-797-0426|tedy333@paik.ac.kr|
22400836|NCT03195140|Tandem Diabetes Care, Inc|Jordan Pinsker, MD|858-366-6900|clinicalaffairs@tandemdiabetes.com|
22400837|NCT01259466|Yale University School of Medicine|Dr. Marney A. White|203-785-4349|marney.white@yale.edu|
22400838|NCT03679494|Taipei MU|MS. Po-Yao Chiu|+886-2-27361661|m437106006@tmu.edu.tw|6311
22400839|NCT02296840|Emory University|Roy Rajan, MD|404-778-2400|royrajan@yahoo.com|
22400840|NCT00551707|Zalicus|Margaret Lee, PhD|617-301-7142|mlee@zalicus.com|
22400841|NCT02485717|ParaPRO, LLC|Kerry W. Mettert, MBA, MT(ASCP)|317-810-6205|kerrym@parapro.com|
22400842|NCT00457639|UT Southwestern Medical Center|Zahid Ahmad, M.D.|214-648-2377|zahid.ahmad@utsouthwestern.edu|
22400843|NCT03885284|Georgetown University|Benjamin Weinberg, MD|202-444-2223|baw12@gunet.georgetown.edu|
22400844|NCT00484354|Wake Forest School of Medicine|Michael Rocco, MD|3367164650|mrocco@wakehealth.edu|
22400845|NCT01450540|Philips|Senior Data Scientist|+14125423651||
22400846|NCT00140855|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22400847|NCT02932267|Galderma|Rajeev Chavda|0033|rajeev.chavda@galderma.com|492382928
22400848|NCT03542682|Yale School of Medicine|Laura Marie Nally, MD|(877) 925-3637|laura.nally@yale.edu|
22400849|NCT01586091|University of Charité Berlin; Dpt. of Dermatology and Allergy|Professor Marcus Maurer|+49 30 450 518 043|marcus.maurer@charite.de|
22400850|NCT02625402|Massachusetts General Hospital|Karen Sepucha|6177243350|ksepucha@partners.org|
22400851|NCT01200433|Clevland Clinic Foundation|Ehab Farag, MD|216-444-9950|farage@ccf.org|
22400852|NCT01887210|Rhode Island Hospital|Dr. Larry Brown|401-793-8808|lkbrown@lifespan.org|
22400853|NCT00840463|UT Southwestern|Kelly Chin|214-645-1825|kelly.chin@utsouthwestern.edu|
22400854|NCT04884243|Cloudbreak Therapeutics LLC|Dr. Rong Yang|9496798408|rong_yang@cloudbreaktherapeutics.com|
22400855|NCT00770861|Forest Laboratories|John Whalen, MD Executive Director of Clinical Development - Cardiovascular and Metabolism|1-201-427-8259|John.Whalen@frx.com|
22414012|NCT00905606|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414013|NCT03635320|Johnson & Johnson Medical (Shanghai) Ltd.|Jie, Zhou|+86 18600551010|JZHOU138@its.jnj.com|
22414014|NCT01558635|Medtronic, Bakken Research Center, Coronary and Structural Heart Disease Management (CSH), Endepolsdomein 5, 6229 GW Maastricht, The Netherlands|Ber Kleijnen, Sr Clinical Research Manager|+31653227763|ber.kleijnen@medtronic.com|
22414015|NCT02322593|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.||toiawase@taiho.co.jp|
22414016|NCT00455312|Masonic Cancer Center, University of Minnesota|Dr. Jakub Tolar, MD||tolar003@umn.edu|
22414017|NCT02659150|Massachusetts General Hospital|Ahmed Tawakol, MD|617-724-3699|atawakol@mgh.harvard.edu|
22414018|NCT01215279|AstraZeneca|Anna Malmgren||ClinicalTrialTransparency@astrazeneca.com|
22430703|NCT04975230|Case Western Reserve University|Stephanie Griggs|404-544-9915|stephanie.griggs2@emory.edu|
22430704|NCT04557735|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22430705|NCT05473767|University of Pittsburgh|Janet M Catov, PhD MS|412-641-6217|catovjm@mwri.magee.edu|
22400856|NCT00662155|University of Pennsylvania|Michael Perlis|(215) 746-3577|mperlis@upenn.edu|
22450574|NCT03697811|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
22450575|NCT03120013|University of Brescia|Prof. Barbara Borroni|+39 0303995631|bborroni@inwind.it|
22450576|NCT05059600|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
22450577|NCT02152995|Memorial Sloan Kettering Cancer Center|Dr. Alan Ho, MD, PhD|646-608-3774|hoa@mskcc.org|
22450578|NCT02098109|Washington University School of Medicine|Camille Abboud, M.D.|314-454-8304|cabboud@wustl.edu|
22450579|NCT01541826|University of Wisconsin-Madison, Department of Food Science|Dr. Bradley Bolling|608-890-0212|bwbolling@wisc.edu|
22450580|NCT01565291|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22450581|NCT02353247|University of Louisville|Professor Andrew Scott LaJoie, PhD, statistician on project|502-852-1879|lajoie@louisville.edu|
22450582|NCT02600637|VA Northern California|Juliana Baldo|925-372-4649|juliana.baldo@va.gov|
22450583|NCT06561217|Emory University School of Medicine|Ravi B. Parikh, MD, MPP|(352) 422-4285|ravi.bharat.parikh@emory.edu|
22450584|NCT02940327|University of Leicester|Clinical Trials Co-ordinator|0116 250 2427|ha200@le.ac.uk|
22450585|NCT04552587|Medical University of South Carolina|Katherine R. Sterba, PhD, MPH|843- 876-2419|sterba@musc.edu|
22450586|NCT01822132|Oregon Health & Science University|Dr. Todd Korthuis|503-494-8044|korthuis@ohsu.edu|
22450587|NCT03072134|Northwestern University|Christina Amidei, PhD|13126959124|christina.amidei@nm.org|
22450588|NCT00854581|University of Miami|Juan Carlos Ramos MD|305-243-4909|jramos2@med.miami.edu|
22450589|NCT00313612|Montefiore Medical Center|Lisa Escobar-Peralta|718-379-6866|lescobar@montefiore.org|
22450590|NCT02705820|Bank Of Cyprus Oncology Centre|Dr. Harris Charalambous|+35722847300|haris.charalambous@bococ.org.cy|450
22450591|NCT03900299|Alexandria university|DR. mostafa elsayed|560566541|m_elsayed2009@yahoo.com|+966
22450592|NCT01833403|University of Minnesota|Lisa Chow MD|612-625-8934|chow0007@umn.edu|
22450593|NCT02702401|Merck Sharp & Dohme LLC.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22450594|NCT00677807|Novartis Pharmaceuticals|Study Director|862-778-8300||
22450595|NCT01924169|The University of Texas MD Anderson Cancer Center|Alessandra Ferrajoli, MD/Professor|713-792-7734|CR_Study_Registration@mdanderson.org|
22450596|NCT01686646|GlaxoSmithKline|GSK Response Center|866-435-7343||
22450597|NCT01393743|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22450598|NCT05409235|Chief Development Officer|D. Scott Edwards, Ph.D.|(339) 234-1333|sedwards@ocuterratx.com|
22450599|NCT00989833|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22450600|NCT01431703|Shanghai Jiaotong university|Dr Ge zhi zheng|86021-34506250|shenyufeng303@gmail.com|
22450601|NCT00678561|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22450602|NCT05645432|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
22450603|NCT03195478|Bristol-Myers Squibb|Bristol-Myers Squibb Study Directo|1-855-907-3286|Clinical.Trials@bms.com|
22450604|NCT05063734|Oxurion|Clinical Department|+32 16 75 13 10|info@oxurion.com|
22450605|NCT02684591|UCSD|Rohit Loomba, MD, MHSc|858-246-2201|roloomba@ucsd.edu|
22450606|NCT04101526|Moffitt Cancer Center|Dr. Brian Gonzalez|813-745-3219|Brian.Gonzalez@moffitt.org|
22450607|NCT02944578|Emory University|Dr. Lisa Flowers|404-251-8931|flowe2@emory.edu|
22387285|NCT05501600|University of Pittsburgh|Keith Vogt|412-647-3147|vogtkm@upmc.edu|
22387286|NCT00650078|Horizon Pharma|Senior Vice President, Clinical Development & Operations|224-383-3012|agrahn@horizonpharma.com|
22387287|NCT03301467|ChemoCentryx, Inc.|Clinical trial disclosure|650.210.2900|clinicaltrials@chemocentryx.com|
22387288|NCT02798471|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22387289|NCT03459196|Johnson and Johnson Medical NV/SA|Nathalie Macours / Clinical Research Director|+32 2 746 35 27|nmacours1@its.jnj.com|
22387290|NCT03367156|UT MD Anderson Cancer Center|Dr. David Hui- Professor, Palliative Care Medicine|(713) 792-6258|dhui@mdanderson.org|
22387291|NCT03762850|Travere Therapeutics, Inc|Travere Therapeutics Call Center|1-877-659-5518|medinfo@travere.com|
22387292|NCT02303392|The Ohio State University Comprehensive Cancer Center|Dr. Jennifer Woyach|614-293-8165|Jennifer.Woyach@osumc.edu|
22387293|NCT00092534|Merck Sharp & Dohme Corp.|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22387294|NCT03083366|University of Utah|Karena McDonald|801-699-9740|karena.mcdonald@hsc.utah.edu|
22387295|NCT05250115|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22387296|NCT04779177|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|6464409333|ITCIClinicalTrials@itci-inc.com|
22387297|NCT03244800|MedImmune Limited|Victoria Parker|+44 747 1357152|information.center@astrazeneca.com|
22387298|NCT02330588|Department of Pediatrics, University of Alberta|Dr. Geoff Ball|780-248-5490|gdball@ualberta.ca|
22387299|NCT00743574|Yale University|Dr. Lubna Pal|203-737-5619|lubna.pal@yale.edu|
22387300|NCT02803749|University of Rochester|Dr. Ruth Schneider|584-341-7500|ruth_schneider@urmc.rochester.edu|
22387301|NCT00890591|Daiichi Sankyo Pharma Development|Howard Kessler|732-590-5032|hmkessler@dsus.com|
22387302|NCT03234374|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
22387303|NCT01214759|The University of Texas Health Science Center at Houston|Dr. Karen Vigil|(713) 500-6703|Karen.J.Vigil@uth.tmc.edu|
22387304|NCT05896267|Masimo Corporation|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
22400857|NCT02515669|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22400858|NCT04278573|Mayo Clinic|Dr. Stephen P. Merry|507-284-5180|merry.stephen@mayo.edu|
22400859|NCT01444391|Acclarent|Director Clinical|650-687-5888|lenglan1@its.jnj.com|
22400860|NCT02985801|Mayo Clinic|Dr. Massimo Raimondo|904-953-6982|Raimondo.Massimo@mayo.edu|
22414019|NCT02902211|University of Nebraskat at Omaha|Sara Myers|402-554-3246|samyers@unomaha.edu|
22450608|NCT03854916|Klein Buendel, Inc.|Dr. David Buller|3035654321|dbuller@kleinbuendel.com|
22387305|NCT02275611|University of North Carolina at Chapel Hill|Dr. Cort A. Pedersen|(919) 966-4447|Cort_Pedersen@med.unc.edu|
22387306|NCT02195232|Beth Israel Deaconess Medical Center, Harvard Medical School|Jeffrey Zwicker, Division of Thrombosis and Haemostasis, Division of Hematology and Oncology|617.667.9299|jzwicker@bidmc.harvard.edu|
22450609|NCT00548808|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22450610|NCT00348205|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
22450611|NCT00424372|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22450612|NCT01299077|Eisai China Inc.|Haibo Song|0086-21-24192864|songhaibo@eisai.com.cn|
22450613|NCT04879745|University of Pittsburgh Medical Center|Dr. Mehret Birru Talabi|412-383-8000|birrums@upmc.edu|
22450614|NCT00120042|The University of Western Australia|Dr Jan Dickinson|61-8-93401330|Jan.Dickinson@uwa.edu.au|
22450615|NCT01860417|CITOSPIN|Dr. Javier García-Sancho,|0034 983184827|jgsancho@uva.es|
22450616|NCT04532112|University of Pennsylvania|Dr. Michael Kohanski|2153495766|michael.kohanski@pennmedicine.upenn.edu|
22450617|NCT03592641|Duke University Medical Center|John Strickler, MD|919-668-1861|john.strickler@duke.edu|
22450618|NCT01403090|BiO2 medical|Luis Angel, MD|2102139778|langel@bio2medical.com|
22450619|NCT00844545|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals Inc||clinicaltrials@alxn.com|
22450620|NCT01126541|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22450621|NCT04589559|Columbia University Irving Medical Center|Dr. Jeffrey Birk|212-342-5503|jlb2287@cumc.columbia.edu|
22450622|NCT02942979|VA Bedford Medical Center|David Smelson|781-687-2845|david.smelson@va.gov|
22450623|NCT05560932|Yale University|Amy C Justice, MD, PhD|203-932-5711|amy.justice2@va.gov|3541
22450624|NCT04456699|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22450625|NCT02114879|Washington University|Emily Lenard|314-747-5706|lenarde@wustl.edu|
22450626|NCT06259331|Supernus|Charlene A. Tucker|(301) 838-2500|ctucker@supernus.com|
22450627|NCT00480779|University of Pittsburgh|M. Kaye Kramer|4123831286|mkk3@pitt.edu|
22450628|NCT01365273|Monlycke Health Care|Joan Wilson, MSN, MHA, RN|706 504 8997|joan.wilson@molnlycke.com|
22450629|NCT04043312|Hospital of the University of Pennsylvania|Dr. Timothy Markman|267-593-0103|timothy.markman@uphs.upenn.edu|
22450630|NCT02445027|Massachusetts General Hospital|Anna Gao RN.|617-643-6092|tearneylabtrials@partners.org|
22450631|NCT04847674|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
22450632|NCT01446731|Center for Cancer ImmuneTherapy|Per Kongsted, M.D.|+45 38689255|per.kongsted@regionh.dk|
22450633|NCT01188603|Sprout Pharmaceuticals|Sprout Pharmaceuticals|1-919-882-0850|clinicaltrials@sproutpharma.com|
22450634|NCT01831232|Fred Hutchinson Cancer Research Ctr|Dr, Mazyar Shadman|206-667-5467|mshadman@fredhutch.org|
22450635|NCT01524770|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22450636|NCT00689481|GlaxoSmithKline|GSK Response Center|866-435-7343||
22450637|NCT03337724|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22450638|NCT00528528|Janssen Research & Development, LLC Titusville, NJ|Clinical Leader|609-730-3174||
22450639|NCT00773097|University Pittsburgh|Robert E. Schoen ME|412-648-9115|rschoen@pitt.edu|
22450640|NCT00466960|Seattle Cancer Care Alliance|Barbara Goff|206-543-3668|bgoff@u.washington.edu|
22450641|NCT02026115|University of Florida|Diana J. Wilkie, PhD, RN, FAAN, Professor, Prairieview Trust - Earl and Margo Powers Endowed Profess|352-273-6401|diwilkie@ufl.edu|
22450642|NCT04602624|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
22450643|NCT04084769|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22450644|NCT00316199|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22450645|NCT04477304|University of Southern California|Jason Doctor|(213) 821-8142|jdoctor@usc.edu|
22450646|NCT04413929|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22450647|NCT02782949|Mayo Clinic|Dr Paul J. Limburg|507-284-2511|limburg.paul@mayo.edu|
22450648|NCT01168024|Osprey Medical|VP Of Clinial Affairs|952-955-8230|mshepard@ospreymed.com|
22450649|NCT03238911|Pharmacosmos A/S|Clinical trial disclosure desk|+45 5948 5935|trial@pharmacosmos.com|
22450650|NCT06893809|Başakşehir Çam and Sakura City Hospital|Dr. Emine Ozcan|05301592856|dr.emine3419@gmail.com|
22450651|NCT06023394|Children's Mercy Kansas City|Dr. Emily Weisberg, pediatric anesthesiologist|9136605813|eweisberg@cmh.edu|
22450652|NCT02373124|New York State Psychiatric Institute|Elias Dakwar, MD|6467748728|elias.dakwar@nyspi.columbia.edu|
22450653|NCT02556710|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|7204376500|clinicaltrials@ampiopharma.com|
22450654|NCT00368940|Weill Cornell Medicine|Dimitris N. Kiosses, Ph.D.|914-997-4381|dkiosses@med.cornell.edu|
22450655|NCT01507493|Huazhong University of Science&Technology|Xianwei Zhang|13037154560|znpain@sina.com|
22450656|NCT03370341|The University of Texas at Dallas|Dr. Amy Pinkham|(972) 883-4462|amy.pinkham@utdallas.edu|
22450657|NCT02805647|Department of Pediatric Orthopedics and Traumatology Medical University of Bialystok|MichałKarpiński|692224714|gufkarp@gmail.com|+48
22450658|NCT01707004|UW Carbone Cancer Center|Aric Hall|608-262-1604|achall@medicine.wisc.edu|
22450659|NCT02616250|GALDERMA|Fabien AUDIBERT, Sr CPM|+33 (0) 4 9238 3034|fabien.audibert@galderma.com|
22450660|NCT04318210|Centers for Disease Control and Prevention|Dr. Allan Taylor|404-639-6120|avt0@cdc.gov|
22450661|NCT02573324|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22450662|NCT01607905|Karyopharm Therapeutics Inc|Jatin Shah|(617) 658-0600|jshah@karyopharm.com|
22414020|NCT01363765|InCo-TB project, Gama Filho University|Anete Trajman|5521-82189194|atrajman@gmail.com|
22430706|NCT01971593|UT Southwestern|Ari Cedars|3149224788|acedars97@gmail.com|
22450663|NCT00941733|Medtronic - CardioVascular|Clinical Research Director|+31433566580|kristel.wittebols@medtronic.com|
22450664|NCT00194012|Johns Hopkins University School of Medicine|Robert Findling, MD, MBA, Director, Child and Adolescent Psychiatry|410-614-3225|rfindli1@jhmi.edu|
22450665|NCT01105533|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22414021|NCT00448591|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22414022|NCT00609674|GlaxoSmithKline|GSK Response Center|866-435-7343||
22414023|NCT00834431|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414024|NCT00746395|University of South Alabama|Jack A. DiPalma, M.D.|251-660-5555|jdipalma@usouthal.edu|
22414025|NCT01312844|Massachusetts General Hospital|Dr. John Matthews|617-643-9095|jmatthews@partners.org|
22414026|NCT00556322|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22450666|NCT03892889|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22450667|NCT02448303|Acerta Pharma, LLC|Priti Patel, MD, Executive Director - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
22450668|NCT00630877|Abbott|Medical Information Specialist|800-633-9110||
22450669|NCT02284828|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22450670|NCT02517580|Lebanese American University|Dr. Sola Aoun Bahous|+961-1-200-800|sola.bahous@lau.edu.lb|
22450671|NCT02873923|Institut Bergonié|Dr Carine Bellera|33 5 56 33 04 95|c.bellera@brodeaux.unicancer.fr|
22450672|NCT02033005|Imperial College London|Dr Chris Gale|+44 (0) 2033153519|christopher.gale@imperial.ac.uk|
22414027|NCT01913405|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22387307|NCT01437319|Johnson &Johnson Vision Care, Inc|Tawnya Wilson, OD Principal Research Optometrist|904-443-3500|TWilson@ITS.JNJ.com|1834
22387308|NCT00983294|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22387309|NCT00622700|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22387310|NCT03611556|AstraZeneca Clinical study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
22387311|NCT04027439|Verona Pharma|Verona Pharma|+44 (0)203 283 4200|info@veronapharma.com|
22387312|NCT01693822|Institute of Cancer Research, Clinical Trials and Statistics Unit (ICR-CTSU)|Professor Judith Bliss (Director of ICR-CTSU)|+44 0208 722 4297|apredict-icrctsu@icr.ac.uk|
22387313|NCT02844439|Kadmon Corporation|Miranda Ross|724-778-6170|Miranda.Ross@kadmon.com|
22387314|NCT04023175|Atrium Health|Dr. Elizabeth Braxton|8032613377|egwbraxton@gmail.com|
22387315|NCT00390884|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22387316|NCT00756574|McMaster University|Dr. Mark Loeb|905-525-9140|loebm@mcmaster.ca|26066
22387317|NCT04035447|Duke University School of Medicine|Caroline Dorfman, PhD|919-416-3473|caroline.dorfman@duke.edu|
22387318|NCT04622332|Sironax|Lisa Fitzgerald, Senior Director Clinical Operation|781-201-3892|Lisa.Fitzgerald@sironax.com|
22387319|NCT05966155|Duke University|Hrishikesh Chakraborty, PhD|919-668-1238|hrishikesh.chakraborty@duke.edu|
22387320|NCT03950817|Maimonides Medical Center|Dr. Sergey Motov (Director of Emergency Medicine Research)|718-283-8693|smotov@maimo.org|
22387321|NCT03304587|Michigan State University College of Nursing|Dr. Horng-Shiuann Wu, Associate Professor|517-884-4643|wuhorngs@msu.edu|
22387322|NCT04122196|University of Missouri|Eliza DeFroda|573-882-4141|elddmc@health.missouri.edu|
22450673|NCT01639001|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22450674|NCT02097134|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22450675|NCT02610868|Solstice Neurosciences|Regulatory Affairs Specialist|502-815-8148|regulatoryaffairs@usworldmeds.com|
22450676|NCT00679341|Genentech, Inc.|Medical Communications|800 821-8590||
22450677|NCT02492451|Zeynep Kamil Research and Teaching Hospital|Selcuk Selcuk|+905321630488|md_sel@hotmail.com|
22450678|NCT00298896|Sunesis Pharmaceuticals, Inc.|Mike Johnston, Senior Director Regulatory Affairs|(650) 266-3727|mjohnston@sunesis.com|
22450679|NCT02880371|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22450680|NCT02665481|Washington University in St. Louis|Dr. Eric Lenze|314-362-5154|lenzee@wustl.edu|
22450681|NCT03285646|Regeneron Pharmaceuticals, Inc.|Study Director|844-734-6643|clinicaltrials@regeneron.com|
22450682|NCT02660359|Ipsen|Medical Director|See email|clinical.trials@ipsen.com|
22450683|NCT02664038|VA Connecticut Healthcare System|Morris Bell, Ph.D., Senior Research Career Scientist|203-932-5711|morris.bell@va.gov|2281
22450684|NCT03758040|University of Nebraska Omaha|Nathaniel Hunt|402-554-4195|nhunt@unomaha.edu|
22450685|NCT03738826|Duke University|Kai Sun, M.D.|919-681-7417|kai.sun@duke.edu|
22450686|NCT04875520|Nationwide Children's Hospital|Jason G. Newland, MD|614-722-3416|Jason.Newland@nationwidechildrens.org|
22450687|NCT03912753|Columbia University|Corina Lelutiu-Weinberger, PhD|212-342-1502|cl4265@cumc.columbia.edu|
22450688|NCT06640829|The University of Kansas Medical Center|Holly Hull|9135881000|hhull@kumc.edu|
22450689|NCT05773287|Duke University|Katherine Collins-Bennett, Ph.D.|919-479-2368|katherine.collins-bennett@duke.edu|
22450690|NCT01468896|The Ohio State University Comprehensive Cancer Center|William Carson, MD|614-293-6306|William.Carson@osumc.edu|
22450691|NCT00673452|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22450692|NCT04936685|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22450693|NCT03049813|University of Michigan|Brittany Ross|(734) 764-2368|rossbrit@umich.edu|
22450694|NCT00179413|BIDMC|Dr. Nezam Afdhal|617632118|nafdhal@bidmc.harvard.edu|
22450695|NCT01813019|Novartis Pharmaceuticals|Study Director|862-778-8300||
22450696|NCT00427804|Emory University|Vin Tangpricha, M.D., Ph.D.|404-727-7254|vin.tangpricha@emory.edu|
22450697|NCT00439140|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22450698|NCT02164396|Johnson & Johnson Vision Care Inc.|Brian Pall, O.D., M.S.- Senior Principal Research Optometrist|904-443-3500|BPALL@its.jnj.com|190
22450699|NCT01458171|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22450700|NCT02270060|University Hospitals Connor Integrative Health Network|Samuel Rodgers-Melnick, MT-BC, music therapist|216-844-7727|Samuel.RodgersMelnick@UHhospitals.org|
22450701|NCT01072682|SeaStar Medical, Inc|Eric Schlorff|8444278100|eric@seastarmed.com|
22450702|NCT00578565|Mayo Clinic|Eric. L. Matteson, M.D.|507-284-8450||
22450703|NCT03025828|Icahn School of Medicine at Mount Sinai|Dr. Kirk Campbell|212-241-6271|kirk.campbell@mssm.edu|
22450704|NCT01192152|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22450705|NCT02143843|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22450706|NCT00005669|National Institute of Child Health and Human Development, NIH|Jack A. Yanovski, MD, PhD, Chief, Unit on Growth and Obesity|301-496-0858|yanovskj@mail.nih.gov|
22450707|NCT02519712|Memorial Sloan Kettering Cancer Center|Brian Shaffer, MD|212-639-2212|shaffeb1@mskcc.org|
22387323|NCT05036278|Bayer AG|Bayer Clinical Trials Contact|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22387324|NCT04187573|Cerus Endovascular, part of Stryker Corporation|Vanessa Sarge|5103292048|vanessa.sarge@stryker.com|
22450708|NCT03029689|Fundació Lluita Contra les Infeccions|Dr. Roger Paredes|(+34) 93 465 7897|rparedes@lluita.org|8209
22450709|NCT03037528|University of Michigan|Laura Saslow|(734) 764-7836|saslowl@umich.edu|
22450710|NCT01339390|Clement J. Zablocki VA Medical Center|Dr. Jeff Whittle|(414) 384-2000|jeffrey.whittle@va.gov|46444
22450711|NCT00378703|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
22450712|NCT06017089|University of Virginia Center for Diabetes Technology|Marc Breton, PhD|434-982-6484|marc.breton@virginia.edu|
22450713|NCT02149342|Helsinki university central hospital|Md, PhD Noora Neittaanmäki-Perttu|+358407190362|noora.neittaanmaki@fimnet.fi|
22450714|NCT03181542|Penn State Hershey Medical Center|Dr Priti Dalal|717-531-6597|pdalal@pennstatehealth.psu.edu|
22450715|NCT01228968|Washington University School of Medicine|Gary Skolnick|3143625292|gskolnic@wustl.edu|
22450716|NCT01462357|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22450717|NCT02908529|Brigham and women's Hospital|Luigi Taranto Montemurro, MD|6177326541|ltarantomontemurro@bwh.harvard.edu|
22450718|NCT04497987|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22450719|NCT04099524|Stanford University|Feng Vankee Lin, PI|6082156005|vankee_lin@stanford.edu|
22450720|NCT04733157|University of Zimbabwe|Dr. Chipo Gwanzura|+263774718381|chipo.gwanzura@gmail.com|
22450721|NCT00501891|The Preston Robert Tisch Brain Tumor Center at Duke|Annick Desjardins, MD|919-684-6173|annick.desjardins@duke.edu|
22450722|NCT04973488|"University of Medicine and Pharmacy Victor Babes Timisoara"|Dr. Novacescu Alexandru|+40745064844|novacescu_alex@yahoo.com|
22450723|NCT04579679|HUTCHMED International Corporation|Nick Lawn|+44 7826 422448|nickl@hutch-med.com|
22450724|NCT01966926|University of Minnesota|Dr. Jennifer Linde|612-624-0065|linde074@umn.edu|
22387325|NCT01458366|Sidney Kimmel Cancer Center at Thomas Jefferson University|Joanna Filicko-O'Hara, MD|215-503-7787|Joanna.Filicko@jefferson.edu|
22387326|NCT04647487|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22387327|NCT02787005|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22387328|NCT04375072|The University of Arizona|Hyochol Brian Ahn|520.626.1769|hbrian@arizona.edu|
22387329|NCT03498612|University of Washington|Ajay Gopal, MD|206-606-2037|agopal@uw.edu|
22387330|NCT01753999|Rutgers Robert Wood Johnson Medical School|Dr. Jag Sunderram|732-235-7038|sunderja@rwjms.rutgers.edu|
22387331|NCT03890289|"Policlinico S.Orsola-Malpighi - Istituto di Ematologia Seragnoli"|Lisa Argnani|051 214 3827|lisa.argnani@unibo.it|
22387332|NCT05440344|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22387333|NCT02867059|Medicines for Malaria Venture|Andrew Slade|+41 22 555 0415|sladea@mmv.org|
22387334|NCT00174252|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22387335|NCT02744066|Magee Womens, UPMC Hamot Hospital|Dr. Michael J. Balsan|814-877-3190|balsanmj@upmc.edu|
22387336|NCT05509816|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22387337|NCT04144868|Affiliated Hospital of Jiujiang University|Zhiying Chen|+86 13767263459|zychenjj@jju.edu.cn|
22387338|NCT05051982|Indiana University School of Medicine (Dept of Anesthesia)|Dr. Timothy Webb|2196893636|ttwebb@iu.edu|
22387339|NCT00979121|ARDS Network|David A. Schoenfeld, PhD ARDSNet CCC PI|617-726-6111|dschoenfeld@mgh.harvard.edu|
22387340|NCT02107261|Icahn School of Medicine at Mount Sinai|David Simpson, M.D.|2122418748|david.simpson@mssm.edu|
22387341|NCT01913314|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22387342|NCT04337931|Pyxis Oncology, Inc.|Pyxis Oncology Clinical Operations|(339) 545 8252|clinicaltrials@pyxisoncology.com|
22387343|NCT02431273|Auritec Pharmaceuticals|Sarjan Shah|909-210-9715|sshah@auritecpharma.com|
22387344|NCT01738438|Dana-Farber Cancer Institute|Sara Tolaney, MD|617.632.2335|Sara_Tolaney@DFCI.HARVARD.EDU|
22387345|NCT00645359|University of Michigan Comprehensive Cancer Center|Dr. Daniel Lebovic, M.D.|734-936-5310|dlebovic@umich.edu|
22387346|NCT02130557|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22387347|NCT01532999|Tuscaloosa VA Medical Center|Lori L. Davis, MD|205-554-2000|lori.davis@va.gov|
22387348|NCT02928172|Cedars Sinai Medical Center|Dr. Ofelia Loani Elvir Lazo, Research Project Advisor|310-423-1682|loani.elvir-lazo@cshs.org|
22387349|NCT02408887|National Cancer Institute|Dr. Naris Nilubol|240-760-6154|niluboln@mail.nih.gov|
22387350|NCT03333109|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22387351|NCT01447706|Merrimack Pharmaceuticals|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
22387352|NCT00589875|Candel Therapeutics|Garrett Nichols (CMO)|617-916-5445|Gnichols@candeltx.com|
22387353|NCT03598907|Department of anesthesiology and intensive care medicine, Charles University and Motol Hospital|prof. Miroslav Durila|+420224435440|miroslav.durila@fnmotol.cz|
22387354|NCT02678689|BioMarin Pharmaceutical Inc|Pascal Reisewitz, Global Medical Director, PhD|1-800-983-4587|medinfo@bmrn.com|
22387355|NCT05019742|Shanghai Pharma Biotherapeutics USA Inc.|CSO|8587755354|kenneth@sphbio.com|
22387356|NCT05071430|HB Biotech|Tomer Seifan|917-685-7351|tomer.seifan@hbbio.com|
22387357|NCT01958021|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22387358|NCT00490139|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22400861|NCT01903148|Hospital de Bellvitge|Dr. Alberto Martínez Castelao|610 459 262|albertomcastelao@gmail.com|
22400862|NCT03191786|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22400863|NCT05847881|Back & Pain Center Clinical Research|Afton L. Hassett, PsyD|734-763-5226|afton@med.umich.edu|
22400864|NCT03439345|Nuffield Department of Population Health, University of Oxford|Associate Professor David Preiss|01865 743 743|lens@ndph.ox.ac.uk|
22400865|NCT05781542|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
22400866|NCT04974307|National Institute of Child Health and Human Development (NICHD)|Dr. An Ngoc Dang Do|301-496-8849|an.dangdo@nih.gov|
22400867|NCT05405166|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
22400868|NCT05110300|Gaylord Specialty Healthcare|John Corbett|2032943224|jcorbett@gaylord.org|
22400869|NCT01386385|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|jmiao@fredhutch.org|
22430707|NCT05159869|Johns Hopkins University|Natalie G. Regier, PhD, FGSA|410-502-6876|nregier1@jhu.edu|
22400870|NCT05768789|University of Pittsburgh, UPMC|Harikesh Subramanian, MBBS, MS, D.ABA, ABPM-CI|412-647-9085|subramanianh4@upmc.edu|
22400871|NCT03746080|Stanford University|Lawrence Recht, MD|(650) 725-8630|lrecht@stanford.edu|
22430708|NCT05451329|VivaVision Biotech, Inc.|Xiao-Yan (Joanne) Li, M.D.|(858) 692-9752|joanne.li@vivavisionbio.com|
22400872|NCT01843374|AstraZeneca|Paul Stockman, MD, PhD|+44 162-523-1815|Paul.Stockman@astrazeneca.com|
22387359|NCT04640974|Anika Therapeutics|Kara Mezger, Executive Director Clinical Affairs|781.457.9000|kmezger@anika.com|
22387360|NCT00754325|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22387361|NCT03738228|NRG Oncology|Linda Gedeon for Wei Deng|716-845-1169|linda.gedeon@roswellpark.org|
22387362|NCT03801148|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22387363|NCT06212752|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22387364|NCT04162210|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22387365|NCT02941549|Afimmune|Study Director|+3532946380|info@afimmune.com|
22387366|NCT00776009|Novartis Pharmaceuticals|Study Director|862 778-8300||
22387367|NCT01567605|Simon Fraser University|Dr Victoria Claydon (Principal Investigator)|7787828513|victoria_claydon@sfu.ca|
22387368|NCT03983434|Indiana University|Dr. Huiping Xu|317-278-6735|huipxu@iu.edu|
22387369|NCT01536093|Seoul National University College of Medicine|Dr. Juyoung Lee|82-31-787-7301|lamb4122@snu.ac.kr|
22387370|NCT02169869|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|5034940757|mccrimmo@ohsu.edu|
22387371|NCT03911271|Rigshospitalet-Glostrup|Niklas Cyril Hansen MD-PhD|+45 31433244|niklas.cyril.hansen@regionh.dk|
22400873|NCT01332435|GlaxoSmithKline|GSK Response Center|866-435-7343||
22400874|NCT03704051|California Polytechnic State University|Dr. Alison Ventura|(805) 756-5693|akventur@calpoly.edu|
22400875|NCT01382186|Center of Innovation on Disability and Rehabilitation Research|Dr. Jolie Haun|813-558-7622|jolie.haun@va.gov|
22400876|NCT03348683|Icahn School of Medicine at Mount Sinai|Dr. Catherine A Bigelow|651-206-9069|cassie.bigelow@gmail.com|
22400877|NCT01709799|University of Florida|Dr. Dawn Bowers|(352) 392-3450|dawnbowers@phhp.ufl.edu|
22400878|NCT04573777|UCaliforniaLA|David Liebeskind|‭(310) 963-5539‬|dliebeskind@mednet.ucla.edu|
22400879|NCT03167619|Duke Clinical Research Institute|Senior Biostatistician|919-668-8052|lilin.she@duke.edu|
22400880|NCT00678496|University of Sheffield|Daniel Hind, Assistant Director, Sheffield CTRU|+441142220707|d.hind@sheffield.ac.uk|
22400881|NCT02927223|Vanderbilt University Medical Center|Dr. Prince Kannankeril|615-322-7447|prince.kannankeril@vumc.org|
22400882|NCT01348919|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22400883|NCT06400238|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22400884|NCT01009463|GlaxoSmithKline|GSK Response Center|866-435-7343||
22400885|NCT04430348|NightHawk Biosciences Inc.|Vice President, Clinical Development|9197948950|info@nighthawkbio.com|
22400886|NCT00728507|Johns Hopkins University|Susan Dorman|410-955-1755|dsusan1@jhmi.edu|
22400887|NCT03847337|Vanderbilt University Medical Center|Zachary Warren|615-875-3085|zachary.e.warren@vumc.org|
22400888|NCT00384956|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
22400889|NCT00427661|University of Pittsburgh-Department of Pediatrics|Nancy Harter-Administrative Director of Research|412-692-7487|harterne@upmc.edu|
22400890|NCT01021007|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
22400891|NCT03669133|Indiana University|Regina Weber|317-278-3584|reginaw@iu.edu|
22400892|NCT00947154|Stanford Medical Center, Department of Psychiatry|Matthew White, M.D., clinical assistant professor|650 725-5598|mpwhite@stanford.edu|
22400893|NCT01330446|University of Texas M D Anderson Cancer Center|Dr. Gary B. Gunn|(713) 563-2562|gbgunn@mdanderson.org|
22400894|NCT03293030|University of California San Francisco|Wilson Liao|415-476-8364|wilson.liao@ucsf.edu|
22400895|NCT04899271|Dompé Farmaceutici SpA|Clinical Development and Operations|+39 (0) 583831|clinical.trials@dompe.com|
22400896|NCT00900796|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22400897|NCT02233842|National Cancer Institute (NCI)|Dr. Stephanie Land|240-276-6946|stephanie.land@nih.gov|
22400898|NCT00881205|Novartis Pharmaceuticals|Study Director|862-778-8300||
22400899|NCT02888626|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
22400900|NCT01667848|LudwigBoltzmannIOL|Dr. Bettina Klugsberger|+43 732 7806 2133|Bettina.Klugsberger@akh.linz.at|
22400901|NCT02318602|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com|
22400902|NCT00693706|GlaxoSmithKline|GSK Response Center|866-435-7343||
22400903|NCT04871815|Emphycorp/Cellular Sciences, inc.|Dr. Alain Martin|9082371561|dr.martin@erols.com|
22400904|NCT01733329|Hospital Universitario José Eleuterio González, Universidad Autónoma de Nuevo León|Dr. Flavio Hernández Castro|8112776459|flaviohernandezc@yahoo.com|
22400905|NCT00730236|Aegerion Pharmaceuticals|Mark Sumeray, MD, Chief Medical Officer|617-500-7867|msumeray@aegerion.com|
22400906|NCT01015443|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22400907|NCT02379858|Medical College of Wisconsin|Matthew Goldblatt, MD|414-955-5751|mgoldbla@mcw.edu|
22414028|NCT04400890|formerly of Mount Carmel Health Systems|Marvin McCreary, MD|614-526-8492|Marvin.McCreary+RCT@gmail.com|
22400908|NCT00609128|University of Wisconsin-Madison|Jim Stahl, PhD|608-263-6177|jlstahl@wisc.edu|
22400909|NCT00498173|Lurie Center for Autism, Massachusetts General Hospital|Christopher John McDougle, M.D.|7818601721|cmcdougle@mgh.harvard.edu|
22400910|NCT03652454|IzmirKCU|dr.dt.mücahid faik şahin|+902323254040|m.faiksahin@hotmail.com|
22400911|NCT00095303|University of Miami Miller School of Medicine|Viviana E. Horigian, MD|305-243-4305|vhorigian@med.miami.edu|
22400912|NCT04312997|Pulmotect, Inc.|Dr. Brenton Scott, President & COO|713-579-9226|bscott@pulmotect.com|
22400913|NCT01634243|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22430709|NCT02731079|William Beaumont Army Medical Center|Eric Ahnfeldt|915-742-4442|eric.p.ahnfeldt.mil@health.mil|
22400914|NCT00258154|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
22400915|NCT03842137|Butler Hospital|Ana M. Abrantes, Ph.D.|401-455-6440|aabrantes@carene.org|
22400916|NCT02814721|Henry Ford Hospital|Dr. Lalathaksha Kumbar|3136271761|lkumbar1@hfhs.org|
22450725|NCT02285504|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
22387372|NCT03631407|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22387373|NCT01378416|Eisai Inc.|Yufang Lu, MD PhD|1-888-422-4743||
22387374|NCT00811941|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
22387375|NCT03496545|Weill Cornell Medicine|Judy Ch'ang, MD|(212) 746-2596|jhc9010@med.cornell.edu|
22387376|NCT03802994|Ralph H. Johnson VA Medical Center|ACOS/R, R. Amanda C. LaRue|843-789-6707|Rutha.LaRue@va.gov|
22387377|NCT01201772|University of Florida|Dominick Angiolillo|904-244-3933|dominick.angiolillo@jax.ufl.edu|
22387378|NCT03938337|O'Neal Comprehensive Cancer Center at University of Alabama at Birmingham|Eddy S. Yang|12059960780|eyang@uab.edu|
22387379|NCT00942266|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22387380|NCT02139436|Spaulding Rehabilitation Hospital|Glen Picard|6177585511|gpicard@partners.org|
22387381|NCT04230941|University of Rochester|Allison Magnuson, (Principal Investigator), Associate Professor of Medicine|585-276-7155|allison_magnuson@urmc.rochester.edu|
22387382|NCT03664011|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22387383|NCT04614454|Massachusetts General Hospital|Michael Levy|6177267565|mlevy11@mgh.harvard.edu|
22387384|NCT06122935|Fresenius Kabi|Jason Friedmann|847-550-2365|jason.friedmann@fresenius-kabi.com|
22387385|NCT04795167|Inari Medical|Ashleigh Willson|925-330-3446|ashleigh.willson@inarimedical.com|
22387386|NCT03660618|University of Iowa Healthcare|Dr. Randy Kardon|319-356-8299|randy-karon@uiowa.edu|
22387387|NCT02029235|Penn State Health Milton S. Hershey Medical Center|Alexander Payatakes, MD|717-531-4805|apayatakes@pennstatehealth.psu.edu|
22387388|NCT01400958|H. Lee Moffitt Cancer Center and Research Institute|Peter A. Forsyth, M.D.|813-745-3063|peter.forsyth@moffitt.org|
22387389|NCT04436289|Johns Hopkins University|Christopher Hoffmann|410-614-4257|choffmann@jhmi.edu|
22387390|NCT00258830|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22387391|NCT03224481|Queen Mary University of London|Professor Padhraig Fleming|02073777397|padhraig.fleming@qmul.ac.uk|
22387392|NCT03357952|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22387393|NCT00972621|Abbott Medical Optics, Inc.|Kendra Hileman, Ph.D., Head, Clinical Research & Development|714-247-8613|kendra.hileman@abbott.com|
22387394|NCT01675492|Abbott Medical Optics|Director, Clinical Operations|714-247-8628|lachelle.arredondo@abbott.com|
22387395|NCT04057820|University of Arkansas for Medical Sciences|Dr. Songthip Ounpraseuth|5016867233|stounpraseuth@uams.edu|
22387396|NCT04517435|Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center|Dr. Deepa Jagadeesh|1-866-223 8100|TaussigResearch@ccf.org|
22387397|NCT03656718|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22387398|NCT06191679|Children's Hospital of Philadelphia|Shannon Hammer|2678878580|bresslers@chop.edu|
22387399|NCT03211247|DBV Technologies|Pharis Mohideen, MD, Chief Medical Officer|908-679-5200|clinicaltrials@dbv-technologies.com|
22387400|NCT02415127|Horizon Pharma Ireland, Ltd. Dublin, Ireland|Julie Ball, Executive Director Clinical Development & Operations||clinicaltrials@horizonpharma.com|
22387401|NCT05827068|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
22387402|NCT05120856|Monash University|Dr Joshua B. B. Garfield|+61 3 8413 8711|joshuag@turningpoint.org.au|
22387403|NCT05464732|Carolina Eyecare Physicians, LLC|Director of Clinical Trials|8438813937|hps@cepmd.com|
22387404|NCT04153890|West Virginia University School of Nursing|Dr. Ubolrat Piamjariyakul, PhD, RN|3042936729|ubolrat.piamjariyakul@hsc.wvu.edu|
22387405|NCT03610581|Janssen Vaccines & Prevention B.V|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22387406|NCT02868970|Canadian Center for Vaccinology, Dalhousie University|Dr. Jennifer Isenor|902-494-2378|jennifer.isenor@dal.ca|
22387407|NCT05637970|UCLA|David Tehrani|8583360666|davidmtehrani@gmail.com|
22387408|NCT05630833|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22387409|NCT04306367|Lombardi Comprehensive Cancer Center|Aiwu Ruth He, MD|202-444-2223|Aiwu.R.He@gunet.georgetown.edu|
22387410|NCT03044158|University of California Irvine|Adithya Cattamanchi|714-456-2959|Adithya.Cattamanchi@uci.edu|
22387411|NCT04660721|Sealantium Medical Ltd.|Prof. Orgad Laub, Chief Executive Officer|+972 0544434387|orgad@sealantium-med.com|
22387412|NCT05483517|Tri-service general hospital|Lai Chia-Ying|87923311|pokerface165@gmail.com|18792
22387413|NCT02751528|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
22387414|NCT05485805|Bayer AG|Bayer Clinical Trials Contact|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22387415|NCT04218357|Brown University|Carolina Haass-Koffler, PharmD, PhD|4155191385|carolina_haass-koffler@brown.edu|
22387416|NCT05349838|Research Organisation (KC) Ltd|Clinical Project Manager|07376618244|WISARD@rokcservices.com|
22387417|NCT05075395|University of Nebraska Medical Center|Breanna Hetland|402-559-5460|breanna.hetland@unmc.edu|
22387418|NCT05048394|Point Designs|Becca Connolly|720-600-4753|becca@pointdesigns.com|
22387419|NCT00085982|NIDDK|Rebecca Brown, MD|301-594-0609|brownrebecca@mail.nih.gov|
22387420|NCT05037513|University of Kentucky|Dr. Hilary Surratt|8595622458|hilary.surratt@uky.edu|
22387421|NCT00872729|Horizon Orphan LLC|Evelyn Olson, Director|224-383-3000|clinicaltrials@horizonpharma.com|
22387422|NCT03664804|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22387423|NCT05529992|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22387424|NCT06140290|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22387425|NCT03850379|Henry Ford Health|Shatha Farhan|3137133910|sfarhan1@hfhs.org|
22387426|NCT02036970|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22387427|NCT02298842|Terumo BCT|Heather Pidcoke, MD, PhD|(303) 231-4805|Heather.Pidcoke@terumobct.com|
22387428|NCT02386098|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22387429|NCT02702843|Cleveland Clinic Florida|Lo Menzo, M.D.,Emanuele|9546595000|lomenze@ccf.org|
22414029|NCT03925532|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|7168451300|adrienne.groman@roswellpark.org|
22414030|NCT02258074|Cleveland Clinic Foundation|Jennifer J. Gassman, PhD|216-444-9938|gassmaj@ccf.org|
22430710|NCT04629521|Alcon Research, LLC|Director, Clinical Projects - CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22414031|NCT05446870|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22414032|NCT03444090|Evergreen General Hospital, Taoyuan, Taiwan|Dr. Chi-Liang Cheng|+886-3-4631230|chiliang.cheng@gmail.com|1510
22414033|NCT01615198|Novartis|Study Director|862-778-8300||
22414034|NCT01686438|Crescenz VA Medical Center|Dr. Samuel T. Kuna|215-823-4400|Samuel.Kuna@va.gov|
22414035|NCT00984126|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22414036|NCT01938066|The Ohio State University|Gayle Gordillo|6142938566|gayle.gordillo@osumc.edu|
22414037|NCT01029340|BAYER|Therapeutic Area Head||clinical-trial-contact@bayerhealthcare.com|
22450726|NCT05648565|The University of Texas Health Science Center at Houston|David Z. Allen|713-500-5427|David.Allen@uth.tmc.edu|
22450727|NCT05346406|Medical College of Wisconsin|Alina G Burek MD|414-337-7050|aburek@mcw.edu|
22430711|NCT03019406|Genzyme, a Sanofi Company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22430712|NCT03163667|Calithera Biosciences, Inc|Study Director|650-870-1000|clinicaltrials@calithera.com|
22430713|NCT02556736|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22430714|NCT04857060|Tufts Medical Center|Dr. Michael Paasche-Orlow|617-636-1029|michael.paasche-orlow@tuftsmedicine.org|
22450728|NCT00646958|Melinta Therapeutics|Eugene Sun, M.D.|203.624.5606|esun@melinta.com|
22450729|NCT02139644|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22450730|NCT00598689|Georgia Regents University|David D. Bogorad, MD, FACS|706-721-1160|dbogorad@gru.edu|
22450731|NCT02453594|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22450732|NCT01845155|Deutsches Zentrum für Musiktherapieforschung (Viktor Dulger Institut) DZM e.V. - German Center for Music Therapy Research|Dr. Heike Argstatter|+49-6221-7963960|heike.argstatter@dzm-heidelberg.de|
22450733|NCT01663272|University of Michigan Comprehensive Cancer Center|Dr. Mark Zalupski, M.D.|734-647-8902|zalupski@med.umich.edu|
22450734|NCT02506114|University of California, San Francisco|Dr. Lawrence Fong, MD|(415) 514-3160|Lawrence.Fong@ucsf.edu|
22450735|NCT01694706|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22450736|NCT00451282|Children's Hospital of Philadelphia|Nancy Kassam-Adams|215-590-3118|nlkaphd@mail.med.upenn.edu|
22450737|NCT01797536|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22450738|NCT00098839|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22450739|NCT00456092|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22450740|NCT04904510|UCLA|Dr. Noah Kojima|(310) 319-4377|nkojima@ucla.edu|
22450741|NCT03058796|The MetroHealth System|Dr. Jayme Knutson|216-957-3557|jsk12@case.edu|
22450742|NCT01358981|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22450743|NCT01332305|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
22450744|NCT01600040|Massachusetts General Hospital|Andrea Russo, MD|617-726-7941|alrusso@mgh.harvard.edu|
22450745|NCT02476565|Vanderbilt University Medical Center|Antonio Hernandez, MD|615 322-4650|antonio.hernandez@vanderbilt.edu|
22450746|NCT01646671|Novartis Pharmaceuticals|Study Director|+1-862-778-8300||
22450747|NCT01401530|Eisai Inc.|Eisai Medical Services Inc.|1-888-422-4743|esi_medinfo@eisai.com|
22450748|NCT03670810|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22450749|NCT00678691|SUNY Upstate Medical University|Thomas Schwartz|3154643166|schwartt@upstate.edu|
22450750|NCT00779766|GlaxoSmithKline|GSK Response Center|866-435-7343||
22450751|NCT01412424|Cedars-Sinai Medical Center|Shlomo Melmed, MD|310 423-4691|melmed@csmc.edu|
22450752|NCT05446909|Arizona State University|Yi-Yuan Tang|4807903577|yiyuan@asu.edu|
22450753|NCT01252290|University of Kansas Medical Center|Carol J. Fabian, MD; Professor|913-588-7791|cfabian@kumc.edu|
22450754|NCT02247349|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|855-907-3286|Clinical.Trials@bms.com|
22450755|NCT02867605|Cleveland Clinic Foundation|Dr. Carol De la Motte|216 444-5374|delamoc@ccf.org|
22450756|NCT00617240|The University of North Carolina at Chapel Hill|Linmarie Sikich, MD|(919) 972-7500|lsikich@med.unc.edu|
22450757|NCT01611259|AGMT|Public contact Daniela Wolkersdorfer|00436626404411|d.wolkersdorfer@agmt.at|
22450758|NCT04646616|Drexel University School of Public Health|Dr. Mariana Lazo|2673596058|ml3629@drexel.edu|
22450759|NCT00382733|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com|
22450760|NCT02144675|Rutgers Cancer Institute of New Jersey|Roger Strair, MD, PhD|732-235-7298|strairrk@cinj.rutgers.edu|
22450761|NCT03075644|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22414038|NCT03335761|Medtronic|Mylène Champs (Sr Clinical Research Specialist)|+17635261627|mylene.champs@medtronic.com|
22430715|NCT01302834|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22430716|NCT05810597|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22430717|NCT05213624|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22430718|NCT01602380|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22430719|NCT01044459|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22430720|NCT00912873|University California San Diego|Brian Ilfeld, MD, MS|(858) 822-0776|bilfeld@health.ucsd.edu|
22430721|NCT04691492|University at Buffalo|Jennifer Read, PhD.|(716) 645-0193|jpread@buffalo.edu|
22430722|NCT03267498|University of California, San Francisco|Dr. Sue Yom, MD PhD, MAS|(415) 353-9893|Sue.Yom@ucsf.edu|
22414039|NCT00214097|University of Wisconsin|Diana Trask|608-263-9528|trask@humonc.wisc.edu|
22430723|NCT03369704|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22414040|NCT02308475|Medical University of South Carolina|Brian Jacobs - Program Assistant|843-876-4922|jacobsbr@musc.edu|
22414041|NCT02009163|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22414042|NCT02453386|Acorda Therapeutics|Christopher Kenney, Senior Vice President - Medical Affairs|914-326-5775|ckenney@acorda.com|
22414043|NCT00359281|Aegerion Pharmaceuticals|Mark Sumeray, MD, Chief Medical Officer|617-500-7867|msumeray@aegerion.com|
22414044|NCT00833586|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414045|NCT01415986|Roswell Park Cancer Institute|Gal Shafirstein, D.Sc.|716-845-4025|Gal.Shafirstein@RoswellPark.org|
22414046|NCT00304187|New York State Psychiatric Institute|Dr. Michael Devlin|212-543-5748|mjd5@columbia.edu|
22414047|NCT01474551|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|646-888-4162|chapmanp@mskcc.org|
22414048|NCT02155465|Memorial Sloan Kettering Cancer Center|Dr. Helena Yu, MD|646-888-4274|YuH@mskcc.org|
22414049|NCT03586726|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22414050|NCT03122457|Icahn School of Medicine at Mount Sinai|Dr. Anjali Vekaria|212-241-3288|anjali.shroff@mssm.edu|
22414051|NCT03373162|University of California, Irvine|Dr. Craig Stark, Professor|949-824-4201|cestark@uci.edu|
22414052|NCT01141374|University of São Paulo|Leonice Fumiko Sato Kurebayashi|55-11-91126023|fumie_ibez@yahoo.com.br|
22387430|NCT02986789|Masimo Corporation|Cristina Johnson|949-297-7000|clinicalresearchdept@masimo.com|
22387431|NCT05029284|University of Minnesota|Dr. Emily Kringle|(612) 624-8994|ekringle@umn.edu|
22387432|NCT01779141|Medtronic Minimed|Suiying Huang, Statistician|818-576-3319|suiying.huang@medtronic.com|
22387433|NCT03002194|Venus Concept Ltd|Yoni Iger|888-907-0115|yoni@venusconcept.com|
22387434|NCT02232737|University of Vermont|Stephen T. Higgins, PhD, Professor|802-735-6267|stephen.higgins@uvm.edu|
22387435|NCT03849937|University of Kansas School of Nursing|Kristine Williams, RN, PhD, FNP-BC, FGSA, FAAN, E. Jean Hill Professor|913 588 1673|kwilliams1@kumc.edu|
22387436|NCT02200705|IceCure Medical|Clinical Trial Manager|+972-4-623-0333|ronitl@icecure-medical.com|
22387437|NCT03987581|Duke University School of Medicine|Angela Kirby|9198247729|angela.caison.kirby@gmail.com|
22387438|NCT03116464|VA New York Harbor Healthcare System|Dr. Cory K. Chen|212-686-7500|cory.chen@va.gov|4002
22387439|NCT02261805|Lombardi Comprehensive Cancer Center|Giuseppe Giaccone|202-687-7072|gg496@georgetown.edu|
22387440|NCT03284359|University of Pennsylvania|Dr. Katherine Courtright|267-978-5083|Katherine.Courtright@pennmedicine.upenn.edu|
22387441|NCT01083732|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
22387442|NCT00065182|GlaxoSmithKline|GSK Response Center|866-435-7343||
22387443|NCT02633215|University of Kentucky|Dr. Lumy Sawaki||lsawa2@uky.edu|
22387444|NCT02568215|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22387445|NCT01641900|Massachusetts General Hospital|Dara S. Manoach, Principal Investigator|617-724-6148|dara.manoach@mgh.harvard.edu|
22387446|NCT00263757|Mayo Clinic|Dr. Sean M. Caples|507-293-1031|Caples.Sean@mayo.edu|
22387447|NCT00713596|Mayo Clinic|Dr. Oren Friedman|507-538-1392||
22387448|NCT03712371|Medical University of South Carolina, Hollings Cancer Center, Clinical Trials|Alan Brisendine, CCRP, Manager, Sponsor-Investigator Support Unit|843-792-9007|brisend@musc.edu|
22387449|NCT05579600|Butler Hospital|Sarah Arias|909-753-9444|sarias@butler.org|
22414053|NCT03769025|Perelman School of Medicine|Kyle M Kampman MD Principal Investigator|215 746 2764|kampman@pennmedicine.upenn.edu|
22414054|NCT03374176|Centro Universitario de Tonalá, Universidad de Guadalajara|Dr. Arieh Roldán Mercado Sesma|+52 (33) 20 00 23 00|arieh.mercado@academicos.udg.mx|6400
22414055|NCT02911701|University of New Mexico, Division of Maternal-Fetal Medicine|Dr. Nathan Blue|505-272-6309|nblue1297@gmail.com|
22387450|NCT04732000|Stanford University|Professor of Anesthesia|650-723-6412|ang@stanford.edu|
22387451|NCT01211184|Södertälje Hospital|Robert Hahn|+46855024670|robert.hahn@sodertaljesjukhus.se|4670
22414056|NCT00852696|Cleveland Clinic Florida|Cecilia Calvo|954-659-5637|calvoc@ccf.org|
22414057|NCT04659603|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22414058|NCT01110005|Milton S. Hershey Medical Center|Richard S. Legro, M.D.|717-531-6210|rsl1@psu.edu|
22387452|NCT01421667|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
22387453|NCT00503906|UM/Sylvester Comprehensive Cancer CEnter|Stefan Gluck MD|305-243-4909|sgluck@med.miami.edu|
22414059|NCT04646213|Virginia Commonwealth University|Dr. Ashlee Loughan|804-828-4178|ashlee.loughan@vcuhealth.org|
22414060|NCT02441309|University of Oxford|Joint Research Office|+441865572245|ctrg@admin.ox.ac.uk|
22414061|NCT02658084|University of Miami|Dr. Reshma Mahtani|954-698-3639|rmahtani@miami.edu|
22414062|NCT03290781|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22414063|NCT04494867|Attune Medical|Erik Kulstad, MD|+1-708-651-0736|ekulstad@gmail.com|
22414064|NCT01077596|GlaxoSmithKline|GSK Response Center|866-435-7343||
22414065|NCT02538523|Regulatory Insight, Inc.|Elvira Cawthon|6154475150|elvira@reginsight.com|
22414066|NCT02820350|SeaStar Medical|Eric Schlorff, CEO|844-427-8100|eric@seastarmed.com|
22414067|NCT03697109|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
22414068|NCT00665470|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
22414069|NCT02301975|GlaxoSmithKline|GSK Response Center|866-435-7343||
22414070|NCT00163657|Baylor University Medical Center|Goran Klintmalm, MD Director|214-820-2050|michelle.acker@baylorhealth.edu|
22414071|NCT01319383|UNC Chapel Hill School of Medicine|Dr. David Margolis|919-966-6388|dmargo@med.unc.edu|
22414072|NCT01867164|Global Clinical Operations Mexico|Clinical Research Director|+52 55 5484 3184||
22414073|NCT01531894|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22414074|NCT04347018|University at Buffalo|Mohammed Al-Zainal|7168292845|malzaina@buffalo.edu|
22414075|NCT03040362|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22414076|NCT01735994|Pennington Biomedical Research Center|Dr. Tiffany Stewart, Director, Behavior Technology Laboratory|2257632554|tiffany.stewart@pbrc.edu|
22414077|NCT01158118|Washington University School of Medicine|Mark Schroeder, M.D.|314-454-8304|markschroeder@wustl.edu|
22414078|NCT04994535|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22414079|NCT00604162|Given Imaging|Hila Debby|+972 4 9097774|Hila.Debby@givenimaging.com|
22414080|NCT04808362|Peptomyc|Dr Niewel|+34932543450|mniewel@peptomyc.com|8684
22414081|NCT04162899|ReistoneBiopharma|Roger Liu, Medical Director|8613917512446|roger.liu@reistonebio.com|
22414082|NCT02246920|Teva Pharmaceuticals USA|Director, PD/CE Studies|1-888-483-8279|usmedinfo@tevapharm.com|
22414083|NCT01450189|University of North Carolina at Chapel Hill|William C Miller|9199669407|bill_miller@unc.edu|
22414084|NCT00960297|Study Chair|David R. Spigel, M.D.|1-877-MY-1-SCRI|David.Spigel@scresearch.net|
22414085|NCT03247972|Sinai Center for Thrombosis Research|Director of Clinical Trials|443-244-1497|kbliden@lifebridgehealth.org|
22414086|NCT00968812|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
22414087|NCT00834340|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414088|NCT00395694|GlaxoSmithKline|GSK Response Center|866-435-7343||
22414089|NCT05956925|University of Nevada, Las Vegas|Dieu-My Tran (PI)|17028953371|dieu-my.tran@unlv.edu|
22414090|NCT02911792|University of Texas Health Science Center at San Antonio|Ralph DeFronzo, MD - Chief Diabetes Division - Medicine|210 567 6706|defronzo@uthscsa.edu|
22414091|NCT01124305|AORI|Knee Project Director|7036194423|nparks@aori.org|
22414092|NCT00620711|Vanderbilt university|William F Walsh|615-322-0545|bill.walsh@vanderbilt.edu|
22414093|NCT02926677|Stanford University|Hilit Kletter|650-723-5511|hkletter@stanford.edu|
22414094|NCT00840073|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414095|NCT04267276|Boehringer Ingelheim|Boehringer Ingelheim|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22414096|NCT03249454|The University of Texas Health Science Center at Houston|Radha Korupolu, MD, MS|713-797-6976|Radha.Korupolu@uth.tmc.edu|
22414097|NCT03987191|University of Colorado Anschutz Medical Campus|Dr. Viral Shah, Principal Investigator|303-724-8186|viral.shah@cuanschutz.edu|
22414098|NCT02689505|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22414099|NCT04108858|University of Texas M D Anderson Cancer Center|Dr. Senthil Damodaran, MD. PhD.|(832) 829-4307|sdamodaran@mdanderson.org|
22414100|NCT03663179|University of Pennsylvania|Leah Bernardo|2157467162|lleah@pennmedicine.upenn.edu|
22414101|NCT01940341|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22414102|NCT01935934|University Health Network - Princess Margaret Cancer Centre|Dr. Neesha Dhani|416-946-4501|neesha.dhani@uhn.ca|2361
22414103|NCT01289262|DrLutfiKirdarTRH|DR CEM TURAN|00905323513423|cemturan@gmail.com|
22414104|NCT03359356|Icahn School of Medicine at Mount Sinai|Dr. Emma Guttman|212-241-9728|emma.guttman@mountsinai.org|
22414105|NCT03792477|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22430724|NCT06401551|Alcon Research, LLC|Director Clinical Trial Management, Surgical IOL|1-888-451-3937|alcon.medinfo@alcon.com|
22430725|NCT04153149|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
22414106|NCT01681745|Pacira Cryotech, Inc.|Kent Jones/ Sr. Director Quality and Medical Affairs|(510)933-1513|kent.jones@pacira.com|
22430726|NCT03759379|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
22400917|NCT00613626|Hoosier Cancer Research Network|Georgia Gould|317-921-2050|ggould@hoosiercancer.org|
22450762|NCT03022617|University of Alabama at Birmingham|Dr. Boni Elewski|205-502-9960|dermresearch@uabmc.edu|
22430727|NCT00833703|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi-aventis.com|
22430728|NCT00003907|ECOG Statistical Office|Study Statistician|617-632-3012||
22430729|NCT00266032|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22430730|NCT03956082|Mercy Hospital St. Louis|David Levine, MD|314-251-7650|DAVID.LEVINE@MERCY.NET|
22430731|NCT00124657|St. Jude Children's Research Hospital|Alberto Broniscer, MD|866-966-5934|info@stjude.org|
22430732|NCT04350866|VA Pittsburgh Healthcare System|Adam Bramoweth, PhD|412-360-2806|adam.bramoweth@va.gov|
22430733|NCT03318393|UT Southwestern Medical Center|Lakshmi Raman|214-456-6222|lakshmi.raman@utsw.edu|
22430734|NCT04693715|Revalesio Corporation|Clinical Operations|253-922-2600|contact@revalesio.com|
22430735|NCT02367885|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22430736|NCT01378195|Photozig, Inc.|Bruno Kajiyama|650-694-7496|info@photozig.com|
22430737|NCT00752219|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22430738|NCT01683812|Boston Children's Hospital|Michele DeGrazia PhD, RN, NNP-BC, FAAN|617-919-1222|Michele.DeGrazia@childrens.harvard.edu|
22430739|NCT03533491|Oregon Research Behavioral Intervention Strategies, Inc.|Dana Smith|541-484-2123|dana.smith@influentsin.com|
22430740|NCT05201495|Element Science, Inc.|Chief Medical Officer|(415) 872-6500|zubin@elementsci.com|
22430741|NCT05702047|Florida State University|Director, Cardiovascular and Applied Physiology Laboratory|8506441828|jwatso@fsu.edu|
22450763|NCT04138615|University of Texas Southwestern Medical Center|Dr Craig Crandall|2143454623|craigcrandall@texashealth.org|
22450764|NCT00247728|Progen Pharmaceuticals Ltd|Director of Regulatory Affairs and Clinical Development|+61 (0)7 38423333|darrynb@progen-pharma.com|
22450765|NCT01106456|The University of Kansas Medical Center|Dr. Won S. Choi|(913) 588-4742|wchoi@kumc.edu|
22450766|NCT01930058|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22450767|NCT03012386|Vanderbilt University Medical Center|Cyndya Shibao MD|6159364584|cyndya.shibao@vumc.org|
22450768|NCT02694315|Ain Shams Maternity hospital|amr ahmed mahmoud riad|01005347179|amr.riad@med.asu.edu.eg|+2
22450769|NCT04292730|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22450770|NCT01527292|University of Louisville, James Graham Brown Cancer Center|Dr. Shiao Woo|502-561-2700|sywoo001@exchange.louisville.edu|
22450771|NCT02549508|Fisher & Paykel Healthcare|Clinical Research Scientist|+64 09 574 0100|CPAPtrial@fphcare.co.nz|7044
22450772|NCT00314366|Texas Heart Institute|Emerson C. Perin, M.D., Ph.D.|832-355-9405|eperin@texasheart.org|
22450773|NCT01482767|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22450774|NCT00556842|The Centre for Evidence-Based Orthopaedics|Paula McKay|905-521-2100|mckayp@mcmaster.ca|44131
22450775|NCT01032135|University of Pennsylvania|James McKay, PhD|215-746-7704|jimrache@mail.med.upenn.edu|
22450776|NCT03400033|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22450777|NCT01346267|Wake Forest University School of Medicine|Thomas W. McLean, MD|336-716-4085|tmclean@wfubmc.edu|
22450778|NCT01247090|Columbia University Medical Center|Anjali Ganda, MD|617-835-3789|ag355@columbia.edu|
22387454|NCT05580003|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22387455|NCT03516812|University of Washington|Michael Schweizer|206-606-6252|schweize@uw.edu|
22387456|NCT03840902|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22387457|NCT02392234|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22387458|NCT02313675|University of Pittsbur|John R Fowler, MD|412-605-3245|fowlerjr@upmc.edu|
22387459|NCT02816398|Avenu Medical - Sponsor|Gene Reu|949 276 2483|greu@avenumedical.com|102
22387460|NCT01387516|University of Rhode Island|Dr. Lynda Stein, Ph.D.|401-874-5562|lynda_stein@uri.edu|
22387461|NCT03582475|UCLA / Department of Radiology|Sara Rodriguez|310-794-2877|SaraRodriguez@mednet.ucla.edu|
22387462|NCT02972424|Hospital for Special Surgery|Dr. Jeri W. Nieves|2126061604|nievesje@hss.edu|
22387463|NCT01273610|City of Hope|Dr. Daneng Li|626-359-8111|danli@coh.org|
22387464|NCT03736564|Mayo Clinic|Dr. Stephen Broski|507-293-6155|broski.stephen@mayo.edu|
22387465|NCT03509909|VA San Diego Healthcare System|Ariel J Lang|858-552-8585|ariel.lang@va.gov|5359
22387466|NCT04041219|Mayo Clinic|Heather P. May, Pharm.D.|507-266-7405|May.Heather@mayo.edu|
22387467|NCT03683576|GB001, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.|Gossamer Study Director|1-866-668-4083|ClinicalTrials@gossamerbio.com|
22387468|NCT01588951|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Margaret Showel, MD|410-614-0675|mshowel1@jhmi.edu|
22387469|NCT02454959|Pearl Therapeutics, Inc.|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
22387470|NCT02350634|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|AVD_Clinical_Ops@lists.lilly.com|
22387471|NCT04205487|Florida International University|Adam W. Carrico, PhD|305-348-7887|acarrico@fiu.edu|
22387472|NCT01939288|Imperial College London|Miss Katherine Williams|020 3311 7335|k.williams@imperial.ac.uk|
22387473|NCT04724759|Massachusetts General Hospital|Jingping Wang - Principal Investigator|617-643-2729|jwang23@mgh.harvard.edu|
22387474|NCT02823028|University of California Irvine|Professor Cornelia Pechmann|3108920619|cpechman@uci.edu|
22430742|NCT06433908|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22430743|NCT05418426|Daré Bioscience, Inc.|Jessica Hatheway, VP of Clinical Operations|858-926-7655|jhatheway@darebioscience.com|
22430744|NCT00607477|University of Chicago|Michael Maitland, MD, PhD|773-702-4400|mmaitlan@medicine.bsd.uchicago.edu|
22400918|NCT01299025|Region Örebro County|Dr Anette Forsberg|+46-19-6025788|anette.forsberg@regionorebrolan.se|
22387475|NCT00859781|Weill Cornell Medicine|Sarah Yuan|6469626040|say7008@med.cornell.edu|
22387476|NCT02307682|Novartis Pharmaceuticals|Study Director|1-862-778-8300|novartis.email@novartis.com|
22387477|NCT01713660|AMO|Carrie Garufis|7145663728|carrie.garufis@amo.abbott.com|
22387478|NCT03997474|Achilles Therapeutics UK Limited|Dr Matilde Saggese|0786 9814607|matildesaggese@gmail.com|
22387479|NCT03905694|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
22387480|NCT03277989|Stryker|Jennifer Seidman, Manager, Clinical Research|9016338616|jennifer.seidman@stryker.com|
22400919|NCT05480514|Johnson & Johnson Vision Care, Inc. (JJVC)|Brian Pall|1-800-843-2020|bpall@its.jnj.com|
22400920|NCT00820040|Medtronic|Heather McManus|2038213323|heather.mcmanus@medtronic.com|
22400921|NCT02527304|Montefiore Medical Center|Dr. Madhur Garg, Clinical Director, Department of Radiation Oncology|718-920-4361|mgarg@montefiore.org|
22400922|NCT00184054|USC Norris Comprehensive Cancer Center|Victoria Soto, Project Specialist, Clinical Investigations Support Office|323-226-6384|victoria.soto@med.usc.edu|
22400923|NCT00002850|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu|
22400924|NCT04037085|UPMC|Grace Lim, MD, MSc|412-641-1110|limkg2@upmc.edu|
22400925|NCT02006576|University of Nebraska Medical Center|Amy Nelson|402-559-5536|amyjnelson@unmc.edu|
22400926|NCT00785577|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22400927|NCT01919411|Massachusetts Eye & Ear Infirmary|Dr. Eric Holbrook|617-573-3209|Eric_Holbrook@meei.harvard.edu|
22400928|NCT00499915|University of Rochester|Dr. Jill Halterman|585-275-5798|jill_halterman@urmc.rochester.edu|
22400929|NCT05175170|Ann & Robert H. Lurie Children's Hospital of Chicago|Dr. Diane Chen|312-227-2939|DiChen@luriechildrens.org|
22400930|NCT00957372|Bial - Portela & Cª, S.A.|Head of Clinical Research Section|+ 351 22 986 61 00|clinical.trials@bial.com|
22400931|NCT03750838|University of North Texas Health Science Center|Dr. Dana Litt|817-735-5453|dana.litt@unthsc.edu|
22400932|NCT02656472|Advocate Children's Hospital|Andrew VanBergen|7086848758|andrew.vanbergen@advocatehealth.com|
22400933|NCT02032875|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22400934|NCT04060277|City of Hope Medical Center|Dr. Ryotaro Nakamura|6263598111|rnakamura@coh.org|
22400935|NCT01093612|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22400936|NCT06046560|Mass General Brigham|Alexander Blood, MD|617-732-7144|ablood3@mgb.org|
22400937|NCT02123329|Qatar University College of Pharmacy|Dr. Maguy El Hajj|0097444035577|maguyh@qu.edu.qa|
22400938|NCT02413398|Global Clinical Leader-Dapagliflozin AstraZeneca|Anna Maria Langkilde, MD PhD|Tel: + 46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
22400939|NCT05408858|Massey University|Dr. Ilana Seager van Dyk|+64 4 979 3625|i.seagervandyk@massey.ac.nz|
22400940|NCT01576471|Coronado Biosciences|Vice President, Clinical Operations|7816524516|nsilver@coronadobio.com|
22400941|NCT01184989|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22400942|NCT00465569|Johns Hopkins University|Robert A. Wood, MD|410-955-5883|rwood@jhmi.edu|
22400943|NCT02362373|Columbia University|Anne Davis, MD|212-305-4951|ard4@cumc.columbia.edu|
22400944|NCT00482001|Sunnybrook Health Sciences Centre|Dr. Mark Rapoport|416-480-4085|Mark.Rapoport@sunnybrook.ca|
22400945|NCT04786210|NYU Langone Health|Nayoung Lee, MD|212-263-7019|nayoung.lee@nyulangone.org|
22400946|NCT03826914|University of Manitoba|Dr. Semone Myrie|(204) 474-7290|semone.myrie@umanitoba.ca|
22400947|NCT04334148|Duke University|Dr. Susanna Naggie|919-684-2584|susanna.naggie@duke.edu|
22400948|NCT05370157|University of Pittsburgh|Dr. Elizabeth McGuier|412-246-5895|millerea3@upmc.edu|
22450779|NCT01226719|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22450780|NCT00006916|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
22450781|NCT01868633|University of Iowa|Dr. Unyime Ituk|3193562633|unyime-ituk@uiowa.edu|
22450782|NCT02353091|UCL Ear Institute|Mr Georgios Stavrinos|07856067517|georgios.stavrinos.13@ucl.ac.uk|
22450783|NCT02457325|University of Sao Paulo / Bauru School of Dentistry|Carlos Ferreira Santos|+551432358200|cfsantos@fob.usp.br|
22450784|NCT02665975|Anglia Ruskin Univeristy|Eldre Beukes|01223698847|eldre.beukes@anglia.ac.uk|2847
22450785|NCT02367599|UCSD|Sheldon Morris|6195438080|shmorris@ucsd.edu|
22450786|NCT01541930|Galderma K.K.|Clinical Project Manager|+81 3 5937 3850|GaldermaKK.ClinDev@galderma.com|
22450787|NCT03385239|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
22450788|NCT01574703|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22450789|NCT00749931|Dune Medical Devices|Clinical Research Manager|+97246178000|shiri@dunemedical.com|
22450790|NCT03993938|Henry Ford Health System|Trevor Szymanski MD|(313) 622-4168|tszyman1@hfhs.org|
22450791|NCT02751983|Rocky Mountain Mental Illness Research, Education, and Clinical Center|Sean Barnes|720-723-6560|Sean.Barnes2@va.gov|
22387481|NCT00371345|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22387482|NCT00705406|BioCryst Pharmaceuticals, Inc.|William P. Sheridan, MBBS|919-859-1302||
22387483|NCT00442104|Marinus Pharmaceuticals, Inc.|Marinus|484-801-4670|clinicaltrials@marinuspharma.com|
22387484|NCT04545619|Biosense Webster, Inc.|Associate Director Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22387485|NCT00975585|Vistakon|Sheila Hickson-Curran, MCOptom/ Director, Medical Affairs|904-443-1754||
22387486|NCT01082575|Covidien|Fran Haury Clinical Program Manager II|303 305-2314|fran.haury@covidien.com|
22387487|NCT00683800|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22387488|NCT04053270|CLINUVEL PHARMACEUTICAL LIMITED|Dr. Dennis Wright|+ 61 3 9660 4900|mail@clinuvel.com|
22387489|NCT00205179|University of Wisconsin|Dr. Carey Gleason|608-280-7000|ceg@medicine.wisc.edu|
22387490|NCT04941703|University of Maryland School of Medicine|Wonder Drake|410-710-1412|WDrake@som.umaryland.edu|
22387491|NCT03542305|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22387492|NCT01619059|AstraZeneca Pharmaceuticals|Eva Johnsson, Clinical Science Lead|+46 31 7762484|Eva.Johnsson@astrazeneca.com|762484
22387493|NCT03578965|Washington University School of Medicine|Mary M. Mullen, M.D.|314-655-8750|marymullen@wustl.edu|
22387494|NCT04949542|University of Washington (affiliate) / University of North Carolina at Chapel Hill|Dr. Benjamin Buck, Associate Professor|(919) 445-4330|buckbe@uw.edu|
22387495|NCT00135200|University of Michigan Comprehensive Cancer Center|Dr. Mark Kaminski, M.D.|(734) 936-5310|mkaminsk@umich.edu|
22430745|NCT04403880|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
22430746|NCT02360085|Toronto Western Hospital/UHN|Emad Al Azazi|416-603-8500|emad.alazazi@uhnresearch.ca|6237
22430747|NCT03255200|Mainstay Medical|Director, Clinical Affairs|877 702-8488|clinical@mainstaymedical.com|
22430748|NCT04138277|Amicus Therapeutics, Inc.|MedInfo|001 609-662-2000|MedInfoUSA@amicusrx.com|
22430749|NCT03768414|SWOG Statistics and Data Management Center|Gastrointestinal Committee Statistician|2066674623|scolby@fredhutch.org|
22430750|NCT04130425|Mayo Clinic|Stephanie Kannas, OTR/L, OTD, CHT|507-284-8841|kannas.stephanie@mayo.edu|
22430751|NCT04522947|University of Nebraska-Lincoln|Timothy Nelson|4024727707|tnelson3@unl.edu|
22450792|NCT02167256|Yale University|Stephen Strittmatter|2037854878|stephen.strittmatter@yale.edu|
22450793|NCT03467425|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22450794|NCT00025883|National Institute of DIabetes and Digestive and Kidney Dseases, National Institutes of Health|Dr. Phillip Gorden|301-402-7340|phillipg@mail.nih.gov|
22450795|NCT02920983|CooperVision Inc.|Jose Vega, O.D., MSc., FAAO|9256213761|jvega2@coopervision.com|
22450796|NCT01451424|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
22450797|NCT00712296|Icahn School of Medicine at Mount Sinai|Xiu-Min Li, MD|212-241-1755|Xiu-min.li@mssm.edu|
22450798|NCT01387607|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22450799|NCT02084628|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22450800|NCT02553421|ivWatch, LLC|Jason Naramore|855-485-2824|jason.naramore@ivwatch.com|7019
22450801|NCT02056171|Weill Cornell Medicine|Chani Traube|212-746-3056|chr9008@med.cornell.edu|
22387496|NCT03021993|Medical University of South Carolina|Alan Brisendine, Sponsor-Investigator Support Unit Manager|843-792-9007|brisend@musc.edu|
22387497|NCT04033315|Ascensia Diabetes Care|Jane Wallace|5748501467|jane.wallace@ascensia.com|
22387498|NCT02101775|University Health Network - Princess Margaret Cancer Centre|Dr. Amit Oza|416-946-4501|Amit.Oza@uhn.ca|3911
22387499|NCT00909324|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22387500|NCT03502447|Sight Sciences, Inc.|VP Medical & Clinical Affairs|877-266-1144|info@sightsciences.com|
22387501|NCT00482911|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-435-7507|sbpso@mail.nih.gov|
22387502|NCT00853606|Vivus, Inc|Wesley W Day PhD|650-934-5200||
22387503|NCT03170648|Dana-Farber Cancer Institute|Weidong Lu, MB, MPH, PhD|617-632-3322|weidong_lu@dfci.harvard.edu|
22387504|NCT02707198|Whiteside Institute for Clinical Research/St. Luke's Hospital Duluth|Lynsie Radovich, PhD|216-726-7940|lradovic@d.umn.edu|
22387505|NCT04241848|James J. Peters VA Medical Center, Spinal Cord Damage Research Center|Dr. Ann Spungen|(718) 584-9000|Ann.Spungen@va.gov|5814
22387506|NCT02499328|Astrazeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22387507|NCT03611075|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
22387508|NCT02972359|Grünenthal GmbH|Clinical Trial Helpdesk|+49 241 569|clinical-trials@grunenthal.com|3223
22387509|NCT03488719|Saniona A/S|Janus Schreiber Larsen|+45 7070 5225|janus.larsen@saniona.com|
22400949|NCT01508676|Massachusetts General Hospital|Dr. Jianren Mao|6177246102|mghpainresearch@partners.org|
22400950|NCT00542828|Genzyme Corporation|Genzyme MedInfo|800-745-4447|medinfo@genzyme.com|
22400951|NCT06129487|University of Connecticut|Zexin Ma, Ph.D.|(860) 486-6871|zexin.ma@uconn.edu|
22400952|NCT05139030|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
22400953|NCT03772327|Weill Cornell Medicine|Dr. Grant Ellsworth|212-746-7204|gre9006@med.cornell.edu|
22400954|NCT04689828|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22400955|NCT01175369|University of Rochester|Dr. Jill Halterman|5852755798|jill_halterman@urmc.rochester.edu|
22400956|NCT04378426|Palo Alto VA|Carolyn Rodriguez, MD, PhD|650-493-5000|carolyn.rodriguez@va.gov|60067
22400957|NCT01416129|University of South Florida|Jason Highsmith|813-974-3806|mhighsmi@health.usf.edu|
22400958|NCT00195351|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22400959|NCT03959189|Expansion Therapeutics, Inc.|Chief Medical Officer|858-764-4290|info@expansionrx.com|
22430752|NCT03109769|Riyadh Colleges of Dentistry and Pharmacy|Omar Alkadhi|966505154754|omar.alkadhi@riyadh.edu.sa|
22450802|NCT03665038|Sage Therapeutics|Medical Monitor|(617) 299-8380|medinfo@sagerx.com|
22450803|NCT03013491|CytomX Therapeutics, Inc.|Head of Clinical Operations|(650) 515-3185|clinicaltrials@cytomx.com|
22450804|NCT05445128|Ensoma|Ensoma head of regulatory or head of clinical research & development|6127191200|ddietz@ensoma.com|
22450805|NCT05559320|University of Connecticut Department of Kinesiology|Dr. Sudha Srinivasan|(860)-486-6192|sudha.srinivasan@uconn.edu|
22400960|NCT04332419|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|Dr. Ram Gurajala, MD|1-866-223-8100|TaussigResearch@ccf.org|
22450806|NCT03890367|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22450807|NCT02851108|Heidelberg University|Prof. Dr. Olaf Müller|+49 6221 56 4904|olaf.mueller@urz.uni-heidelberg.de|
22450808|NCT04524403|Corcept Therapeutics Incorporated|Medical Director|650-327-3270|info@corcept.com|
22450809|NCT00991302|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22450810|NCT01709318|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22450811|NCT00273364|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
22400961|NCT02493751|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22400962|NCT01480180|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22400963|NCT00519623|Altea Therapeutics|Pei-Ling Roerig, Sr. Manager Clinical Research, Altea Therapeutics|404-835-6415|proerig@alteatherapeutics.com|
22400964|NCT01341912|Octapharma|VP of Clinical Research and Development|+41 554512141|sigurd.knaub@octapharma.com|
22400965|NCT01824602|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com|
22400966|NCT02513446|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22400967|NCT04222725|Tarsier Pharma|Zohar Milman|+972-50-8371319|Zohar Milman <zohar@Tarsierpharma.com>|
22400968|NCT03819140|University of California, San Francisco|Heather Huddleston|(415) 353-7475|Heather.Huddleston@ucsf.edu|
22400969|NCT00104871|UT MD Anderson Cancer Center|Steven Sherman, MD / Professor|713-792-2841|sisherma@mdanderson.org|
22400970|NCT00843180|UCSF|Dr. Wolf Mehling, MD|415-353 9506|mehlingw@ocim.ucsf.edu|
22400971|NCT02192359|City of Hope Medical Center|Dr. Jana Portnow|626-546-8293|JPortnow@coh.org|
22400972|NCT05036785|Royal Devon and Exeter NHS Trust|Dr Ellen Richards|01392 411611|ellen.richards6@nhs.net|
22400973|NCT00658333|Novartis Pharmaceuticals|Study Director|862-778-8300||
22400974|NCT04323488|Stanford University|Jason Yeatman, PhD|(650) 321-7553|jyeatman@stanford.edu|
22400975|NCT00828451|Washington University|Aaron Hamvas, MD|314-454-6148|hamvas@kids.wustl.edu|
22400976|NCT03256539|University of California, San Francisco|Dr. Yue Leng|415 502 2949|yue.leng@ucsf.edu|
22400977|NCT03721328|Nor Consult, LLC|Nor Consult|206-607-6861|regulatory@nor-consult.com|
22400978|NCT04045912|University of California, San Francisco|Dr. Jenny Liu|1-415-502-5200|Jenny.Liu2@ucsf.edu|
22400979|NCT05755438|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22400980|NCT03429075|Imperial College London|Dr Robin Carhart-Harris|02075947992|r.carhart-harris@imperial.ac.uk|
22400981|NCT01885689|City of Hope|Dr. Monzi M.Al Malki, MD|626-359-8111|malmalki@coh.org|
22400982|NCT06027593|Children's Hospital of Philadelphia|Kathleen Chiotos|267-426-7729|chiotosk@chop.edu|
22400983|NCT00513344|Clinical Development Unit / Metabolic Unit|Dr Maurice Beaumont, Principal Investigator|+41217858054|maurice.beaumont@rdls.nestle.com|
22400984|NCT01548638|University of Pennsylvania Perelman School of Medicine|Dr. Rebecca Ashare|2157465789|rlashare@mail.med.upenn.edu|
22400985|NCT05917288|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22400986|NCT04333966|University of North Texas Health Science Center|Dr. Dana Litt|817-735-5453|dana.litt@unthsc.edu|
22400987|NCT02117687|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22400988|NCT03291379|Biocompatibles UK Ltd|Sarah Cooper|07805354224|Sarah-Jane.Cooper@bsci.com|
22400989|NCT04002167|Stanford University|Hadi Hosseini|6507235798|hosseiny@stanford.edu|
22400990|NCT00590161|Cleveland Clinic Lerner College of Medicine of Case Western Reserve University|Claudia O. Zein, MD, MSc|216-444-0421|zeinc@ccf.org|
22400991|NCT01687673|University of California, San Francisco|Dr. R. Katie Kelley, MD|(415) 353-9888|Katie.Kelley@ucsf.edu|
22400992|NCT03476239|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22400993|NCT00618956|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|Robert Palmer, MD|201-427-8218|robert.palmer@frx.com|
22400994|NCT03598777|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22400995|NCT03294304|Masonic Cancer Center, University of Minnesota|Dr. Konety Badrinath|612-625-1655|brkonety@umn.edu|
22400996|NCT00630032|Unicancer|Deputy Director R&D|(+33)1 44 23 04 19|b-juzyna@unicancer.fr|
22400997|NCT02798523|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|Dr. Luis Franco|+1 240 220 4366|luis.franco@nih.gov|
22400998|NCT02332915|University of Utah|Julie Wambaugh|8015846164|julie.wambaugh@health.utah.edu|
22400999|NCT01909492|Providence Health & Services|Director of PBSI /WC Clinical Research Program|(503) 216-1012|Chiayi.Chen@providence.org|
22401000|NCT01901328|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
22401001|NCT03232073|Actelion Pharmaceuticals Ltd|Associate Director Clinical Sciences Neuro|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22401002|NCT04358458|Genmab|CLINICAL TRIAL INFORMATION|+45 7020 2728|clinicaltrials@genmab.com|
22401003|NCT02770287|Venus Concept Ltd|Yoni Iger|888-907-0115|yoni@venusconcept.com|
22401004|NCT01981187|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22401005|NCT00812110|Akron Children's Hospital|P. Cooper White, M.D.|330-543-8530|CWhite@chmca.org|
22401006|NCT03440112|University of Michigan|Stiven Roytman|7349988424|stivenr@med.umich.edu|
22450812|NCT02258152|Acorda Therapeutics|Christopher Kenney, Senior Vice President - Medical Affairs|914-326-5775|ckenney@acorda.com|
22450813|NCT00827372|IndianaU|Kathy Miller, MD|317-944-0920|kathmill@iupui.edu|
22450814|NCT03085927|Indiana University School of Nursing|Dr. Sheri Robb, MT-BC|317-274-3152|shrobb@iu.edu|
22450815|NCT02564471|SUNY Upstate Medical University|Dr. Timothy Endy|3154647692|endyt@upstate.edu|
22450816|NCT01312909|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22450817|NCT02200042|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22450818|NCT00854087|SCTI Research Foundation|Dr. Tarek Hassanein|6195220330|thassanein@livercenters.com|
22450819|NCT01777997|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22450820|NCT00306592|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
22450821|NCT01923181|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22450822|NCT00721526|NYU Grossman School of Medicine|Michael Bogenschutz|505-999-9325|Michael.Bogenschutz@nyulangone.org|
22450823|NCT01878604|Central South University|Shuiping Zhao|86-731-85295806|zhaosp@medmail.com.cn|
22450824|NCT02932891|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
22450825|NCT04622254|Merz Aesthetics|Public Disclosure Manager|+1 984-301-3095|Aesthetic.Trials@merz.com|
22450826|NCT02652624|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22450827|NCT00654628|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22450828|NCT00739336|SUNY Upstate Medical University|Clinical Trials Officer|315-464-5476|Rudesj@upstate.edu|
22450829|NCT00912405|Intersect ENT|James Stambaugh|650-641-2103|jstambaugh@intersectent.com|
22450830|NCT00953329|DukeUMC|Shirley Blalock|919-668-0999|shirley.blalock@duke.edu|
22450831|NCT03511521|Northwestern University Feinberg School of Medicine|Dr. Mark Molitch, Principal Investigator|3125034130|molitch@northwestern.edu|
22450832|NCT01434823|University of Pennsylvania|Dr. Meeta P. Kerlin|215.614.0627|meeta.prasad@uphs.upenn.edu|
22450833|NCT01993108|University of Michigan|Chandra Sripada|734 232 0281|sripada@umich.edu|
22450834|NCT01560624|United Therapeutics|Louis Holdstock|919-425-8866|lholdstock@unither.com|
22387510|NCT02962102|Brigham and Women's Hospital|Dr. David Leaf|617-525-7612|deleaf@bwh.harvard.edu|
22387511|NCT05807074|University of California, San Francisco|Dr. Merisa Piper, MD|(415) 353-4320|Merisa.Piper@ucsf.edu|
22387512|NCT03414684|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|617-632-5743|Sara_Tolaney@dfci.harvard.edu|
22387513|NCT04038580|University of Michigan|Dr. Deanna Gates|7346472698|gatesd@umich.edu|
22387514|NCT03477175|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22387515|NCT02078648|Stemline Therapeutics, Inc.|Clinical Development & Medical Affairs - Solid Tumors|1-973-775-2845|clinicaltrials@menarinistemline.com|
22387516|NCT04088227|Andrews Research & Education Foundation|Director of Research|8509168570|jessica.truett@andrewsref.org|
22414107|NCT05239754|Midwest Evaluation and Research|Dr. Matthew Shepherd|8336439377|matt.shepherd@midwestevaluation.com|
22450835|NCT01733368|Hospital Clinico Universitario Virgen de la Victoria|Dr. Javier Alzueta Rodríguez|951 03 20 00|jalzueta@telefonica.net|
22450836|NCT03228680|Ferring Pharmaceuticals|Clinical Development Support|-|DK0-Disclosure@ferring.com|
22450837|NCT02167035|Cornerstone Healthcare|Michael Tepedino, MD|336-802-2255|mtepedino@wakehealth.edu|
22450838|NCT02099721|Medtronic CRHF|Katy Muckala, Sr. Clinical Research Specialist|(763) 526-1767|katy.a.muckala@medtronic.com|
22450839|NCT00796861|Penn State Health|Dr. Leah Cream|717-531-8870|lcream@pennstatehealth.psu.edu|
22450840|NCT02252081|Nashville Campus TVHS|Dr. Adriana Hung|6153274751|adriana.hung@va.goc|6731
22450841|NCT00754247|University of Miami|Dr. Robert Kirsner|305-243-4472|RKirsner@med.miami.edu|
22450842|NCT00403455|Department of Veterans Affairs|Dr. Zhewu Wang|(843) 789-7949|Zhewu.Wang@va.gov|
22450843|NCT04805983|Associate Director of the Yale Alzheimer's Disease Research Unit|Adam Mecca, MD, PhD|(203) 785-4736|adam.mecca@yale.edu|
22450844|NCT03732638|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
22450845|NCT02992899|Emory University|Dr. Douglas Bremner|404-712-9569|doug.bremner@emory.edu|
22450846|NCT02738775|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
22450847|NCT02370888|Univeristy of Florida Health Cancer Center|Archana Narasanna, Project Manager|(352) 273-6772|PMO@cancer.ufl.edu|
22450848|NCT04574362|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22450849|NCT01785524|Victoria University|Jason D. Allen, PhD|61 3 9919 4264|jason.allen@vu.edu.au|
22450850|NCT01060384|University of Nebraska Medical Center|Julie M. Vose|402-559-3848|jmvose@unmc.edu|
22450851|NCT00642304|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22450852|NCT01150838|University of Virginia|George Politis MD|434-924-2283|GDP8A@hscmail.mcc.virginia.edu|
22450853|NCT03192150|Sun Pharma Global FZE|Head, Clinical development|91 2266455645|Clinical.Trials@sparcmail.com|
22450854|NCT00482391|Memorial Sloan Kettering Cancer Center|Dr. Chau Dang|914-367-7181|dangc@mskcc.org|
22450855|NCT01420302|Department and Laboratory of Intensive Care Medicine KULeuven/UZLeuven|Professor Greet Van den Berghe|003216344017|greet.vandenberghe@kuleuven.be|
22450856|NCT03759223|VA Center for Integrated Healthcare|Dr. Paul King, Clinical Research Psychologist|716-862-6038|paul.king2@va.gov|
22450857|NCT02606136|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|FG3019-079DMDStudy@fibrogen.com|
22450858|NCT02713321|Icahn School of Medicine at Mount Sinai|Dr. Victoria Mayer|(212) 659-9194|victoria.mayer@mountsinai.org|
22450859|NCT04694131|National Institutes of Health|Dr. Eric Wassermann|301-496-0151|wassermanne@nih.gov|
22450860|NCT02399085|MorphoSys AG|Lisa Walz|+49 89 89927 26240|Lisa.Walz@morphosys.com|
22450861|NCT02003625|Massachusetts General Hospital|Bimalangshu Dey, MD, PhD|617-724-1124|BDEY@mgh.harvard.edu|
22450862|NCT00075335|NHLBI NIH|Dr. Richard Childs|301-594-8008|childsr@nhlbi.nih.gov|
22450863|NCT02410811|Cincinnati Children's Hospital Medical Center|Dr. Charles T. Quinn|5138033086|charles.quinn@cchmc.org|
22450864|NCT00353366|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22450865|NCT00259857|Medical University of South Carolina|Deborah A Bowlby, MD, Asst.Professor, Pedeiatric Endocrinology|843-792-6807|bowlbyd@musc.edu|
22450866|NCT05267054|BeiGene|Study Director|1 877-828-5568|clinicaltrials@beigene.com|
22450867|NCT00780572|VA SLC HCS|Director HSR&D|801-582-1565|IDEAS@va.gov|
22450868|NCT01552226|St. Joseph Mercy Hospital Ann Arbor|Dr. Robert Cleary|7347128150|Robert.Cleary@trinity-health.org|
22450869|NCT00727857|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22414108|NCT00446563|Novartis Pharmaceuticals|Study Director|862-778-8300||
22414109|NCT01169558|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22414110|NCT00398983|The University of Texas MD Anderson Cancer Center|Farhad Ravandi-Kashani, MD / Associate Professor|713-745-0394|eharrison@mdanderson.org|
22414111|NCT03134222|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22414112|NCT02605928|Department of Medicine, Division of Rheumatology, Helsinki University Central Hospital and University of Helsinki, Finland|PhD MD Ritva Peltomaa||ritva.peltomaa@hus.fi|
22414113|NCT00906165|UCL Eastman Dental lnstitute University College London|Professor N Donos|+4420 3456 1075|n.donos@eastman.ucl.ac.uk|
22414114|NCT03482882|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2897|medicalinformation@acadia-pharm.com|
22414115|NCT00520234|Mycoses Study Group|Luis Ostrosky-Zeichner, MD|(713) 500-6733|Luis.Ostrosky-Zeichner@uth.tmc.edu|
22414116|NCT01085825|Planned Parenthood of NYC|Research Director|212-274-7255|cti@ppnyc.org|
22414117|NCT02124122|Tulane SPHTM|Richard Oberhelman|5049882511|oberhel@tulane.edu|
22414118|NCT05341622|University of Pennsylvania|Shivan Mehta|215-898-9807|shivan.mehta@pennmedicine.upenn.edu|
22414119|NCT04611789|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22414120|NCT06907719|Midwest Evaluation and Research|Dr. Matthew Shepherd|8336439377|matt.shepherd@midwestevaluation.com|
22414121|NCT05152576|AbbVie|ABBVIE CALL CENTER|844-663-3742|abbvieclinicaltrials@abbvie.com|
22414122|NCT00859430|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414123|NCT01952691|Hacettepe University|Gul Oznur Karabicak|+90 505 3569409|guloznur@gmail.com|
22414124|NCT00001703|National Cancer Institute, National Institutes of Health|Samir N. Khleif, M.D.|301-496-0901|khleifs@mail.nih.gov|
22414125|NCT02286739|Stryker|Kevin Barga|201 831 5073|kevin.barga@stryker.com|
22414126|NCT00834795|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414127|NCT01414153|Lpath, Inc.|Susan E. Hazel|858-926-3205|shazel@lpath.com|
22450870|NCT01469065|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22450871|NCT04542070|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22450872|NCT05035017|CooperVision Inc.|Lee Hall BSc PhD MCOptom, FBCLA|925-251-6884|lhall@coopervision.com|
22450873|NCT03511560|Columbia University|Amanda Alonso|212-342-0261|aa2974@cumc.columbia.edu|
22450874|NCT03487913|Centessa Pharmaceuticals|Milena Kanova, MD, Vice President, Clinical Operations|+44 7780 430583|Milena.Kanova@centessa.com|
22450875|NCT02967367|CHU Saint-pierre|Pr. Marie Bruyneel|00325354219|marie_bruyneel@stpierre-bru.be|
22450876|NCT02383758|Emory University|Dr. Nathan Call||nathan.call@choa.org|
22450877|NCT01010984|University of Louisville|Robert Martin, MD, PhD|502-629-3355|robert.martin@louisville.edu|
22450878|NCT00600821|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22450879|NCT02192684|Stanford Universtiy|Dr. Gerald Reaven|650-724-3416|greaven@stanford.edu|
22450880|NCT02602288|Temple University|Dr. Stephen Lepore|215-204-9422|slepore@temple.edu|
22450881|NCT01310413|GlaxoSmithKline|GSK Response Center|866-435-7343||
22450882|NCT01621373|UZ Leuven, NICU|Liesbeth Thewissen, MD, PhD|003216343211|liesbeth.thewissen@uzleuven.be|
22450883|NCT01076400|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22450884|NCT02160873|Florida State University|Dr. Michael J. Ormsbee|(850) 645-5000|mormsbee@fsu.edu|
22450885|NCT01965067|Department of Anesthesiology and Pain Medicine, Hanyang University Hospital|Kyo Sang Kim, MD, PhD|+82-2-2290-8680|kimks@hanyang.ac.kr|
22450886|NCT02066298|Penn State University|David Mauger|717-531-7178|dmauger@psu.edu|
22450887|NCT01643473|NYU School of Medicine|Antoinette Schoenthaler|212-263-4205|antoinette.schoenthaler@nyumc.org|
22450888|NCT02261818|Johns Hopkins University|Dr Jin Hui Joo|4105502282|jjoo1@jhmi.edu|410
22450889|NCT01519518|Liverpool Heart and Chest Hospital|Dr Rod Stables|01512281616|rod.stables@lhch.nhs.uk|1489
22450890|NCT02033889|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22450891|NCT03894449|University of Veterinary & Animal Sciences, Lahore, Pakistan|Dr. Waqas Ahmed|0092-42-99211449|waqas.niaz@uvas.edu.pk|296
22450892|NCT01265953|Oregon Health & Science University|Dr.Jackilen Shannon|503-418-9860|shannoja@ohsu.edu|
22450893|NCT00182689|SWOG Statistical Center|Study Statistician|206-667-4623||
22450894|NCT01640301|Fred Hutchinson Cancer Research Center|Dr. Aude Chapuis|2066674369|achapuis@fredhutch.org|
22450895|NCT00659646|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
22450896|NCT00158379|Charite Campus Vichow Klinikum|Prof. Dr. Jalid Sehouli|+49 30-450564052|jalid.sehouli@charite.de|
22450897|NCT02842060|University of Pennsylvania|Dr. Jose Bauermeister|215-898-9993|bjose@upenn.edu|
22450898|NCT02717949|UT Southwestern Medical Center|Mamta K.Jain, MD|214-648-9914|mamta.jain@utsouthwestern.edu|
22450899|NCT02391948|University of Washington|Sarah Westcott McCoy PT, PhD, FAPTA|206-616-8601|westcs@uw.edu|
22450900|NCT02348489|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
22450901|NCT00201006|University of Florida|Michael G. Perri, PhD|352 273-6214|mperri@ufl.edu|
22450902|NCT00509197|Hôpital du Sacré-Coeur de Montréal|Dr Catherine Lemiere|514 338 2796|catherine.lemiere@umontreal.ca|
22450903|NCT01969838|Sierra Oncology, a GlaxoSmithKline company|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22450904|NCT00408993|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22450905|NCT04193202|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22450906|NCT02488629|Syncore|Dr. Lin|0227603688|JWLin@syncorebio.com|
22450907|NCT00577122|IndianaU|Kathy Miller, MD||kathmill@iupui.edu|
22450908|NCT02148003|Cleveland Clinic|Nagy Mekhail, MD|216 444-9114|mekhain@ccf.org|
22450909|NCT01241734|Hackensack Meridan Health|Joshua Zenreich|5519964248|joshua.zenreich@hmhn.org|
22450910|NCT00436280|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22450911|NCT02039427|Department of Anesthesiology and Pain medicine, Yeungnam University School of Medicine, Daegu, Republic of Korea|Sung Mee Jung, M.D|+82-53-620-3368|applejsm@gmail.com|
22450912|NCT01540370|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22450913|NCT02595684|INSTITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
22450914|NCT03160703|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22450915|NCT00087568|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22450916|NCT00058240|The Ohio State University Comprehensive Cancer Center|John Byrd, MD|614-293-3196|John.Byrd@osumc.edu|
22450917|NCT03728582|Johns Hopkins University|Dr. Argye Hillis|(443) 287-4610|argye@jhmi.edu|
22450918|NCT00047463|Vanderbilt University|Beth Malow/Principal Investigator|615-322-0283|beth.malow@vanderbilt.edu|
22450919|NCT00672438|Stanford University|Dr. Martin Angst, Professor of Anesthesia|650-498-5109|ang@stanford.edu|
22450920|NCT03054909|University of Minnesota, Masonic Cancer Center|Dr. Melissa Geller|+1 612-626-3111|gelle005@umn.edu|
22450921|NCT01132144|University of Sao Paulo|Dr. Wellington P Martins|55162231|wpmartins@gmail.com|
22450922|NCT01274637|Ottawa Hospital Research Institute|Dr. Marc Rodger|6137388899|mrodger@ohri.ca|
22450923|NCT02722668|University of Minnesota, Masonic Cancer Center|Dr. Margaret MacMillan|612-626-2961|macmi002@umn.edu|
22450924|NCT02214147|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22387517|NCT04021862|Janssen Research & Development, LLC|Director Clinical Research Dermatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22387518|NCT01855750|Janssen Research & Development, LLC|Medical Officer|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22387519|NCT05379270|George Washington University|Allison Sylvetsky|202-994-5602|asylvets@gwu.edu|
22414128|NCT02057835|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22450925|NCT03204942|National Cancer Institute|Director of Ethical Committee|+201224276580|drsherryfanous@yahoo.com|
22387520|NCT05025384|Vanderbilt University Medical Center|Krista Vermillion|615-875-1921|krista.k.vermillion@vumc.org|
22387521|NCT03160885|LEO Pharma A/S|Disclosure|+45 44945888|disclosure@leo-pharma.com|
22387522|NCT03425682|Aziyo Biologics, Inc.|Associate Director, Clinical Operations|678-492-4712|srichardson@aziyo.com|
22414129|NCT00665925|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
22387523|NCT03835754|TransMedics, Inc.|Laura Damme|9785520900|ldamme@transmedics.com|
22387524|NCT05810285|Permedicaspa|Lorenzo Banci, study coordinator - clinical affairs|0399514811|lorenzo.banci@permedica.it|
22387525|NCT04257994|St George's, University of London|Dr Angeliki Asimaki|+447484764641|aasimaki@sgul.ac.uk|
22387526|NCT00984815|Horizon Pharma|Amy Y. Grahn, MS|224-383-3012|agrahn@horizonpharma.com|
22387527|NCT01427517|University of Minnesota|Mary Holmay|612-812-5854|holma101@umn.edu|
22387528|NCT00808834|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22387529|NCT00345046|Indiana University|Louis B. Cantor|317-278-2651|lcantor@iupui.edu|
22387530|NCT02683174|NHS Lothian|Dr Matt Reed|+44 131 242 1448|Matthew.Reed@nhslothian.scot.nhs.uk|
22387531|NCT00123409|Philadelphia VAMC|David Oslin|2158235894|dave.oslin@upenn.edu|
22387532|NCT02522104|Addmedica|Medical director|+33 1 72 69 01 86|corinne.duguet@addmedica.com|
22387533|NCT02157116|Duke University|Richard Riedel, MD|919-681-6932|richard.riedel@duke.edu|
22387534|NCT02463448|Beaumont Hospitals|Jennifer Giordano|248-551-3517|jennifer.geiordano@beaumont.org|
22387535|NCT01728324|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22387536|NCT01351376|Rehabilitation Medicine, New York University School of Medicine|Tara Denham, MD|212 263 8240|Tara.Denham@nyumc.org|
22387537|NCT01787032|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22387538|NCT00388726|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22387539|NCT02406092|Hoffman-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22387540|NCT03041233|Abbott|Clinical Scientist|7639541350|emily.jesser@abbott.com|
22387541|NCT05783843|Wake Forest University School of Medicine|Erin L. Sutfin, PhD|336-713-5282|esutfin@wakehealth.edu|
22387542|NCT00853593|Medtronic, Inc|4396 Clinical Research Specialist|800-328-2518|medtronicCRMtrials@medtronic.com|62808
22387543|NCT03805672|Oregon Health & Science University|Samantha Underwood|503-494-8481|underwos@ohsu.edu|
22387544|NCT00641537|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22387545|NCT03229408|University of Illinois at Chicago|Frank González|(312) 413-1984|frgz12@uic.edu|
22387546|NCT06193590|Indiana University Health|Dr. Alissa M Conklin|317.944.8231|alconkli@iu.edu|
22387547|NCT03745313|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
22387548|NCT03304639|University of Pittsburgh Medical Center|Dr. Jason Luke|412-647-2811|lukejj@upmc.edu|
22387549|NCT03292133|Massachusetts General Hospital|Zofia Piotrowska, MD|6176439707|Zofia.Piotrowska@MGH.HARVARD.EDU|
22387550|NCT02052440|Denver Veterans Administration Medical Center|Daniel Heppe MD|303 399 8020|daniel.heppe@ucdenver.edu|3940
22387551|NCT01367236|Imperial College London|Professor Alan Winston|+44 (0)20 3312 1603|a.winston@imperial.ac.uk|
22414130|NCT02798458|Massachusetts General Hospital|Dr. Braden Kuo and Dr. Claire-Zar-Kessler|617-724-6038|bkuo@mgh.harvard.edu, czarkessler@mgh.harvard.edu|
22414131|NCT04035187|University of Maryland Baltimore|Dr. James Polli|410-706-8292|jpolli@rx.umaryland.edu|
22414132|NCT03423654|VA|April Maa|4043216111|april.maa2@va.gov|206817
22414133|NCT04310345|Vanderbilt School of Nursing|Dr. Mary Jo Gilmer|6153430938|maryjo.gilmer@vanderbilt.edu|
22450926|NCT03226652|Imperial College London|Professor M Cowie|+44 (0)207 3518856|m.cowie@imperial.ac.uk|
22450927|NCT01194297|University of Rochester|Dr. Carl D'Angio|585-275-2972|carl_dangio@urmc.rochester.edu|
22450928|NCT01824303|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22450929|NCT05421078|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
22450930|NCT03296696|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22450931|NCT01350128|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
22450932|NCT01333488|Memorial Healthcare System|Dr Greg Zorman|954 265 1840|csareli@mhs.net|
22450933|NCT01859715|University of Colorado|Andrew A Monte, MD||andrew.monte@ucdenver.edu|
22450934|NCT05944250|Stanford University|Dr. Yuri Ikeda|650-647-3485|yurikeda@stanford.edu|
22450935|NCT00086580|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22450936|NCT01495481|University of Pittsburgh|Dr. Gaurav Arora|412-692-6054|gaurav.arora@chp.edu|
22450937|NCT03296163|mAbxience Research SL|Susana Millan|+34917711500|susana.millan@mabxience.com|
22450938|NCT00821626|Infectious Disease Service, and Travel Clinic, University Hospital of Lausanne, Switzerland|Dr Serge de Vallière|+41 79 556 43 12|serge.de-valliere@unisante.ch|
22450939|NCT02978690|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22450940|NCT00806546|NuPathe Inc.|Mark Pierce, MD, PhD|484-567-0130|mpierce@nupathe.com|
22450941|NCT00558103|GlaxoSmithKline|GSK Response Center|866-435-7343||
22450942|NCT01922024|Curetis USA, Inc.|Clinical Operations|800-659-1221|neil.mucci@curetis.com|
22450943|NCT00308711|Cytokine PharmaSciences, Inc.|Barbara L. Powers|610-687-1776|bpowers@cytokinepharmasciences.com|214
22450944|NCT01556204|Cleveland Clinic|Tommaso Falcone, M.D.|216-444-1752|falcont@ccf.org|
22450945|NCT03139916|Massachusetts General Hospital|Elizabeth R. Gerstner, MD|617-724-8770|egerstner@mgh.harvard.edu|
22387552|NCT02235298|University of Miami|Gianluca Iacobellis, MD|305-243-3636|giacobellis@miami.edu|
22387553|NCT01595282|PPLM|Principal Investigator|617-616-1600||
22387554|NCT02227706|ETHICON Inc|Patricia Schleckser|9082182244|pschleck@its.jnj.com|
22387555|NCT02628626|Mayo Clinic|Dr. Adil Bharucha|507-284-2687|bharucha.adil@mayo.edu|
22450946|NCT01957475|Coloplast|Daniel Carter|+45 49112523|dkdac@coloplast.com|
22450947|NCT02469610|CarmelMC|Dr LEVY FABER Dan|97248250289|DANLf@clalit.org.il|
22401007|NCT02082184|Abbott Diabetes Care|Snr Director, Clinical Development & Regulatory Affairs|01993 863164|joe.bugler@abbott.com|
22430753|NCT02528305|University of Striling|Dr Niels Vollaard|+441786466488|n.vollaard@stir.ac.uk|
22401008|NCT00443560|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy, PharmD|312-926-9015|r-mccarthy@northwestern.edu|
22450948|NCT04590495|West Virginia University|Toni Marie Rudisill, MS, PhD|304-293-0687|trudisill@hsc.wvu.edu|
22450949|NCT00414388|Oncology Specialists, S.C.|Sigrun Hallmeyer, MD (Director of Research); Chadi Nabhan, MD (PI)|847-268-8200|shallmeyer@oncmed.net|
22450950|NCT02318693|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22450951|NCT03591575|Chiesi Canada Corp.|Caroline Fradette, PhD|1-(800) 854-3534|c.fradette@chiesi.com|7014
22450952|NCT02915744|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
22450953|NCT00813358|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|alan.saunders@cookmedical.com|321204
22450954|NCT00218543|COLUMBIA UNIVERSITY|Frances R Levin, MD|212-543-5896|FRL2@COLUMBIA.EDU|
22450955|NCT03265119|Aevi Genomic Medicine|Garry A. Neil, MD|610-254-4208|garry.neil@aevigenomics.com|
22401009|NCT04352660|UCSD Shiley Eye Institute|Dr. Jiun Do|8585346290|jiundo@ucsd.edu|
22450956|NCT04740034|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22450957|NCT04011475|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22450958|NCT03738904|Cedars-Sinai Medical Center|Dr. Karen Zaghiyan|310-289-9224|karen.zaghiyan@cshs.org|
22450959|NCT02086591|University of Rochester|Carla Casulo|585-273-3258|carla_casulo@urmc.rochester.edu|
22450960|NCT01326780|Valeant|Johnson Varughese|908 927-1162|johnson.varughese@bauschhealth.com|
22450961|NCT00274716|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22450962|NCT01257204|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22450963|NCT01268644|UT Southwestern Medical Center|Dr. Abhimanyu Garg|2146482895|abhimanyu.garg@utsouthwestern.edu|
22450964|NCT02489981|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22450965|NCT01565993|Hospital Universitario Severo Ochoa|Dra Elvira Quintanilla|34 914818000|elviramquintanilla@hotmail.com|8326
22450966|NCT03779997|University of Washington|Judith I. Tsui|206-744-1835|tsuij@uw.edu|
22450967|NCT04086472|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22450968|NCT03348904|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22450969|NCT01663259|University of Michigan Rogel Cancer Center|Michelle Mierzwa|734-936-7810|mmierzwa@umich.edu|
22450970|NCT05165121|MDHearing|Dr. Sandra Porps|7346572209|slp@mdhearingaid.com|
22450971|NCT01513291|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22450972|NCT01034397|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22450973|NCT01931839|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22450974|NCT01430585|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22450975|NCT01448850|MedImmune, LLC.|Rene van der Merwe, MBChB/Senior Director, Clinical Development|301-398-0000|vandermerwer@medimmune.com|
22450976|NCT00962429|Oregon Health and Science University|Diana Dimitrova|503-494-7269|dimitrov@ohsu.edu|
22450977|NCT03235024|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
22450978|NCT02357576|University of Michigan|Meghan Arnold|734-936-8978|meghanar@umich.edu|
22450979|NCT00261716|VAGLAHS at West Los Angeles|Shirley M. Glynn. Ph.D.|310-268-3939|sglynn@ucla.edu|
22450980|NCT00128180|UNewMexico|Gregory Mertz, MD|5059808601|gmertz@salud.unm.edu|
22401010|NCT01197573|Cleveland Clinic|Bijan Eghtesad, MD|216 444-9898|eghtesb@ccf.org|
22401011|NCT01943539|Akili Interactive Labs|SVP of Medical Devices|617-456-0984|skellogg@akiliinteractive.com|
22401012|NCT01362322|GlaxoSmithKline|GSK Response Center|866-435-7343||
22401013|NCT03187379|Cleveland Clinic Foundation|Dr. Matthew Kroh|12164457410|krohm@ccf.org|
22401014|NCT03215914|University of Pennsylvania|Cornelia V. Dalton Bakes|215-746-2085|corneliv@pennmedicine.upenn.edu|
22401015|NCT03715465|University of Michigan|Leslie Swanson|734-764-2242|lmswan@med.umich.edu|
22401016|NCT05665335|Apyx Medical|Kari Larson, Sr. Director of Clinical Affairs|8012440058|kari.larson@apyxmedical.com|
22401017|NCT00174941|Takeda Global Research & Development Center, Inc.|Sr VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22401018|NCT01532453|Galderma Spirig|Dr. Francine Santoro|+41 62 387 87 87|Francine.santoro@galderma.com|87 20
22450981|NCT00699699|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22450982|NCT02047110|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22450983|NCT00705575|Novartis Pharmaceuticals|Study Director|862 778-8300||
22450984|NCT00354224|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
22450985|NCT01000051|MD Anderson Cancer Center|Dr. Popat, Uday / Professor, Stem Cell Transplantation|713-745-3055|upopat@mdanderson.org|
22450986|NCT02170727|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22450987|NCT01271543|Penn State Milton S. Hershey Medical Center|Sonia Vaida|7175318433|svaida@hmc.psu.edu|
22450988|NCT01959581|University of Delaware|Michele A. Lobo|302-831-8526|malobo@udel.edu|
22450989|NCT05051241|Zhejiang GenFleet Therapeutics Inc.|Yuting Peng|+86 21 6882 1388|ytpeng@genfleet.com|
22450990|NCT03304379|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22450991|NCT03402243|University of Minnesota|Michael Kotlyar|612-625-1160|kotly001@umn.edu|
22450992|NCT00539526|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22450993|NCT03097068|Vitreo-Retinal Associates, P.C.|Louis C. Glazer, MD|1-616-285-1200|glazerlc@vrapc.com|
22450994|NCT02802345|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22450995|NCT00811564|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22387556|NCT01593020|UT MD Anderson Cancer Center|Dr. Valero Vicente, Professor, Breast Medical Oncology|(713) 563-0751|vvalero@mdanderson.org|
22387557|NCT02990858|CytoDyn|Vice President, Clinical Operations|36009808524|jmeidling@cytodyn.com|
22387558|NCT02766517|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
22387559|NCT06211530|GE HealthCare|Principal Engineer|+358 (40) 7755194|100012917@gehealthcare.com|
22450996|NCT03969212|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22387560|NCT04801420|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|0
22387561|NCT05525572|University of Miami, Miller School of Medicine|Thomas A Masterson, III|(305) 243 - 6260|TMasterson@med.miami.edu|
22387562|NCT05116163|Brigham and Women's Hospital|Dr. Candace Feldman|617-525-1035|chfeldman@partners.org|
22387563|NCT00489307|UT MD Anderson Cancer Center|Dr. Sriram Yennu, Professor, Palliative Care Med|(713) 792-3938|syennu@mdanderson.org|
22387564|NCT03436992|Augusta University|Dr. Ryan Harris|706-721-5483|ryharris@augusta.edu|
22387565|NCT03227861|Janssen Scientific Affairs, LLC|Senior director medical leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22387566|NCT05613907|Leeds Vascular Institute|Dr Assad Khan|0113|assad.khan3@nhs.net|
22387567|NCT05080777|University of Connecticut Center on Aging|Dr. Richard Fortinsky|860-679-8069|fortinsky@uchc.edu|
22387568|NCT04705415|NeurobBo|Sr. Vice President Clinical Operations|8572991035|crinfo@neurobopharma.com|
22387569|NCT03789656|Crinetics Pharmaceuticals, Inc|Crinetics Clinical Trials|+1 858-450-6464|clinicaltrials@crinetics.com|
22387570|NCT02473276|Columbia University|Richard Smiley|212 305 5006|rms7@cumc.columbia.edu|
22387571|NCT05256797|Brigham and Women's Hospital|Shirley Wang|617-525-8376|swang1@bwh.harvard.edu|
22387572|NCT04484623|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22387573|NCT05886777|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22387574|NCT03773107|Levine Cancer Institute|Jim Symanowski, PhD|9804422371|james.symanowski@atriumhealth.org|
22387575|NCT05961995|The Ohio State University Hospital|Dr. Thangam Venkatesan|614-293-6255|thangam.venkatesan@osumc.edu|
22387576|NCT07204444|University of Florida|Laura R. Shannonhouse, PhD|352-273-4332|lshannonhouse@coe.ufl.edu|
22387577|NCT04172675|Janssen Research & Development, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22387578|NCT00378898|Vanderbilt University Medical Center|Dr. Michael Vaezi|615-322-3739|michael.vaezi@vanderbilt.edu|
22387579|NCT00551421|Dana-Farber Cancer Institute|Dr. Kimmie Ng|617-632-4150|kimmie_ng@dfci.harvard.edu|
22387580|NCT01429454|University of California San Diego|Dr. Kristin Cadenhead|(619) 543-6445|kcadenhead@ucsd.edu|
22387581|NCT02000752|Fundación Investigación Biomédica Príncipe de Asturas|Beatriz López Garrido (Midwife)|+34 678210013|bealopega@gmail.com|
22387582|NCT02431741|Faculty Hospital Kralovske Czech Republic|Prof. Dr. Petr Arenberger|+420 267 16 11 11|avemedica@email.cz|
22387583|NCT00512252|Washington University School of Medicine|Geoffrey L. Uy, M.D.|314-454-8304|guy@dom.wustl.edu|
22450997|NCT01397695|UCSD|Research Compliance and Integrity|(858) 822-4939|ctgov@ucsd.edu|
22450998|NCT02075320|UNC School of Medicine Department of Radiology|Dr. Yueh Lee|(919) 537-3730|yueh_lee@med.unc.edu|
22450999|NCT03773757|Indiana University|Dr. Greg Sachs|317-278-5570|sachsg@iu.edu|
22451000|NCT00057746|NRG Onoclogy|Wendy Seiferheld||seiferheldw@nrg.oncology.org|
22451001|NCT01109316|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22451002|NCT01936259|Zimmer Biomet, Inc.|Director of Clinical Operations|800-613-6131|clinicaldirector@zimmerbiomet.com|
22451003|NCT02660918|Christiana Care Health System|Dr. Matthew Hoffman Chair Department of OB/GYN|302 733 3350|mhoffman@christianacare.org|
22451004|NCT00245557|McLean Hospital|Brent Forester MD|617-855-3622|bforester@mclean.harvard.edu|
22451005|NCT02985736|Psoriasis Treatment Center of Central New Jersey|Jerry Bagel Director of Clinical Trials|6094434500|dreamacres1@aol.com|
22451006|NCT00550836|Mayo Clinic|Steven R. Alberts, M.D.||alberts.steven@mayo.edu|
22451007|NCT01826825|Brigham and Women's Hospital|Deborah J. Culley, M.D., Principal Investigator|6177327330|dculley@bwh.harvard.edu|
22451008|NCT01858194|Icahn School of Medicine at Mo|Betsy Ellsworth, Research Program Director|212 824 8902|betsy.ellsworth@mountsinai.org|
22451009|NCT00850031|AcuFocus, Inc|Eugenia Thomas, Director Clinical Trials|949/585-9511|nthomas@acufocus.com|129
22451010|NCT02563028|Hospital for Special Surgery|Valeria Rotundo|212-774-7885|rotundov@hss.edu|
22451011|NCT01856543|Memorial Sloan Kettering Cancer Center|Dr. Daphna Gelblum|914-367-7273|gelblumd@mskcc.org|
22451012|NCT04545515|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22451013|NCT01552772|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22451014|NCT00862784|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22451015|NCT01848990|Halozyme Therapeutics|Dimitrios Chondros, M.D., Chief Medical Officer|858-794-8889|dchondros@halozyme.com|
22451016|NCT00700011|Texas Oncology - Amarillo|Dr. Seah Lim|806-358-8654|seah.lim@usoncology.com|
22387584|NCT02357966|XBiotech USA, Inc.|Haritha Pallapotu|512-386-2992|hpallapotu@xbiotech.com|
22387585|NCT01779700|Indiana University|Dr. Alan Breier|317-880-8495|abreier@iupui.edu|
22387586|NCT00019604|National Cancer Institute, National Institutes of Health|Caryn Steakley|301-435-3685|steaklec@mail.nih.gov|
22387587|NCT01410409|Aalborg University Hospital|Dr. Søren T. Skou|+4523708640|sots@rn.dk|
22387588|NCT01026805|Interlace Medical, Inc.|John Vozella, V.P. Clinical & Regulatory Affairs|508-875-1343|john@interlacemedical.com|112
22451017|NCT00004031|SWOG Statistics and Data Management Center|Study Statistician|2066674623||
22451018|NCT00895180|Sidney Kimmel Comprehensive Cancer Center|Dr. Jaishri Blakely|(410) 955-8893||
22451019|NCT03090256|Alcon Research|Expert Clinical Project Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22451020|NCT00512096|UT MD Anderson Cancer Center|Cherie A. Perez||caperez@mdanderson.org|
22451021|NCT02489227|Coherus BioSciences, Inc.|Barbara K. Finck, MD|650-649-3530|bfinck@coherus.com|
22451022|NCT03212963|Sun Pharma Advanced Research Company Ltd.|Head, Clinical Development|912266455645|clinical.trials@sparcmail.com|
22451023|NCT01312766|IBSA Institut Biochimique SA|Dr. Barbara Cometti, Senior Clinical Research Manager, IBSA|+41 58 360 10 00|barbara.cometti@ibsa.ch|
22451024|NCT00298038|Bausch Health Companies|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
22451025|NCT02696096|Butler Hospital|Dr. Michael Stein|401-455-6652|michael_stein@brown.edu|
22451026|NCT01940705|VA RR&D National Center for Rehabilitative Auditory Research|Gabrielle Saunders, PhD|503-220-8262|Gabrielle.Saunders@va.gov|56210
22451027|NCT02447991|Mayo Clnic|Jeffrey Staab, MD|507-293-9438|staab.jeffrey@mayo.edu|
22451028|NCT00829621|University of Missouri, Department of Orthopaedics|Brett Crist, MD|573-882-6562|cristb@health.missouri.edu|
22451029|NCT03551210|R-Pharm|Aleksandr Chernavin, Regional Medical Director|0074959567937|chernavin@rpharm.ru|
22451030|NCT04953442|Baylor College of Medicine|Erica Soltero, PhD|4029100832|soltero@bcm.edu|
22451031|NCT04260191|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22451032|NCT02343458|Pearl Therapeutics Inc.|Pearl Therapeutics Inc.|650-305-2600|creisner@pearltherapeutics.com|
22451033|NCT01913041|Peking Union Medical College Hospital, Anesthesia Department|Dr. Jie Yi|+86 10 69152025|neyil@pumch.cn|
22451034|NCT01513317|Janssen Research & Development|DIRECTOR CLINICAL RESEARCH||ClinicalTrialDisclosure@its.jnj.com|
22451035|NCT02564198|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22451036|NCT03843502|University of Florida|Robyn Nelson|3522945563|r.nelson@ufl.edu|
22451037|NCT02866682|University of California, Los Angeles (UCLA)|Dr. Suphamai Bunnapradist|310-794-8516|bunnapradist@mednet.ucla.edu|
22451038|NCT01750268|San Francisco VA Health Care System/University of California, San Francisco|Steven L. Batki, MD|415-221-4810|steven.batki@ucsf.edu|23671
22451039|NCT01353339|St Paul's Hospital|Dr. John S. Gill|604-806-8970|jgill@providencehealth.bc.ca|
22451040|NCT01529645|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
22451041|NCT03455855|Boston Scientific|Dr Haotian Zhang|+8617621154031|haotian.zhang@bsci.com|
22451042|NCT00924950|UCSF|Tina Bhutani|4154763396|tinabhutanimd@gmail.com|
22451043|NCT01602315|Novartis Pharmaceuticals|Study Director|862-778-8300||
22451044|NCT00593372|UAMS Medical Center|Gary McCullough|501-852-7886|garyhmccullough@uams.edu|
22451045|NCT02212730|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22451046|NCT00961259|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22451047|NCT05711069|Hacetepe University|Ceyda Sofuoğlu M.Sc.|+905338557742|ceyda_sofuoglu@hotmail.com|
22451048|NCT02691455|The University of Texas Health Science Center at Houston|Robert M. Feldman, MD|(713) 559-5239|Robert.M.Feldman@uth.tmc.edu|
22451049|NCT03394391|Babcock University|Dr. Olumide ABIODUN|07038569725|olumiabiodun@gmail.com|7038569725
22451050|NCT00323739|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22451051|NCT02514252|UT MD Anderson Cancer Center|Suresh K. Reddy, MD/Professor, Palliative Care Med|(713) 794-5362|sreddy@mdanderson.org|
22451052|NCT03358576|Iterum Therapeutics|Senior Director, Clinical Development|18606614035|saronin@iterumtx.com|
22451053|NCT00723801|Brigham and Women's Hospital|Mark Creager|617-732-5267|mcreager@partners.org|
22451054|NCT01222494|Washington University|Dr. Ginger Nicol|314-362-2461|nicolg@wustl.edu|
22451055|NCT01174030|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
22451056|NCT05022810|HALEON|Marc Renard|+44 7880 182593|marc.m.renard@haleon.com|
22451057|NCT01532687|OHSU Knight Cancer Institute|Dr. Christopher Ryan|503-494-9000|ryanc@ohsu.edu|
22451058|NCT04116229|Washington University School of Medicine|Sarah Eisenstein, Associate Professor in Psychiatry|3143627107|seisens@wustl.edu|
22451059|NCT02809976|Tufts Medical Center|David Romarin, MD Prinicpal Investigator|617 636 7462|drosmarin@tuftsmedicalcenter.org|
22451060|NCT01734746|MaastrichtUMC|R.F.P.M. Kruitwagen|+31433874767|r.kruitwagen@mumc.nl|
22387589|NCT04608409|University of Kentucky|Dr. Frederick Ueland|859-257-1613|frederick.ueland@uky.edu|
22387590|NCT03819543|University of Manitoba|Dr. Marcus Ng|204-787-2684|marcus.ng@umanitoba.ca|
22387591|NCT03392194|Brigham and Women's Hospital|Dr. Susan Redline|617-732-5859|SREDLINE@BWH.HARVARD.EDU|
22387592|NCT00918333|Mayo Clinic Cancer Center|Shaji Kumar, MD|507-284-2511|Kumar.shaji@mayo.edu|
22387593|NCT01379651|Unit of Pediatrics, Fatebenefratelli Hospital, Benevento, Italy|Dr. Iride Dello Iacono|+39 824 771111|iridedello@hotmail.com|
22387594|NCT04497415|New York State Psychiatric Institute|Yuval Y. Neria|646-774-8092|ny126@cumc.columbia.edu|
22387595|NCT00620854|Tarsa Therapeutics, Inc.|Thomas Wicks, Ph.D., Vice-President Global RA/QA|267 273 7946|twicks@tarsatherapeutics.com|
22387596|NCT01556594|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22387597|NCT03447912|George Washington University|Carla Berg, PhD, MBA, LP|202-994-0168|carlaberg@email.gwu.edu|
22387598|NCT02927249|Dana Farber Cancer Institute|Wendy Chen|617-632-3800|Wendy_chen@dfci.harvard.edu|
22387599|NCT02723929|Spaulding Rehabilitation Hospital|Felipe Fregni|6179526158|Fregni.felipe@mgh.harvard.edu|
22387600|NCT01477177|Mayo Clinic|Herbert C. Wolfsen, M.D.|904-953-6319|Wolfsen.Herbert@mayo.edu|
22401019|NCT03230097|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22387601|NCT04566861|Johns Hopkins Bloomberg School of Public Health|Dr. Pamela Surkan|4105027396|psurkan@jhu.edu|
22401020|NCT05980416|Elevation Oncology|Medical Information|+1-716-371-1125|medinfo@elevationoncology.com|
22401021|NCT05740813|Healey Center for ALS at Massachusetts General Hospital|Healey Center for ALS Project Management|833-425-8257 (HALT ALS)|healeyalsplatform@mgh.harvard.edu|
22401022|NCT04168203|BWH|Physician|6177326984|gpiazza@bwh.harvard.edu|
22401023|NCT00315302|Jaeb Center for Health Research|Raymond Kraker|813-975-8690|pedig@jaeb.org|
22401024|NCT00635102|Yale University School of Medicine|Dr John Krystal|203-785-6396|john.krystal@yale.edu|
22401025|NCT00217438|Fred Hutchinson Cancer Research Center|Dr. William Bensinger|206-667-4933|wbensing@fhcrc.org|
22451061|NCT01163682|Columbia University Irving Medical Center|Dawn Hershman|212-342-5162|dlh23@cumc.columbia.edu|
22451062|NCT02002767|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22451063|NCT00883389|University of Maryland, School of Medicine|Dr. Jeffrey C. Fink, Associate Professor, Nephrology|410-328-5720|jfink@medicine.umaryland.edu|
22451064|NCT00211081|Emory University|Dr. Willam Mahle|404-785-6000|wmahle@emory.edu|
22451065|NCT01263873|University Hospitals of Cleveland|Brian Radesic|3309725175|radesic@uakron.edu|
22451066|NCT00113516|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22451067|NCT03915548|MGH Institute of Health Professions|Dr. Kathleen Lyons|617-643-5372|klyons2@mghihp.edu|
22451068|NCT00982189|Minneapolis Medical Foundation|Dr. Jason Baker|612-873-2705|baker459@umn.edu|
22451069|NCT02074735|UT Southwestern Medical Center|E. Sherwood Brown, MD, PhD|214-645-6950|sherwood.brown@utsouthwestern.edu|
22451070|NCT03217136|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22451071|NCT03755765|Department of Family Medicine, Georgetown University Medical Center|Daniel Merenstein, MD|202-687-2745|djm23@georgetown.edu|
22451072|NCT02104557|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22451073|NCT03091751|Grifols Therapeutics Inc|Henry Li, PhD|+1 919 316 6042|henry.li@grifols.com|
22451074|NCT04455893|Carnegie Mellon University|Gretchen Chapman|412-268-3665|gchapman@andrew.cmu.edu|
22451075|NCT01158222|Case Comprehensive Cancer Center|Dr. Brian Rini|216-444-9567|rinib2@ccf.org|
22451076|NCT01161329|UppsalaU|Karin Hellström|+46184714762|karin.hellstrom@neuro.uu.se|
22451077|NCT00111228|Medtronic Minimed|Suiying Huang, Statistician|818-576-3319|suiying.huang@medtronic.com|
22451078|NCT02579616|Eisai Co.,Ltd.|Inquiry Service.||eisai-chiken_hotline@hhc.eisai.co.jp|
22451079|NCT01490060|University of Texas (UT) MD Anderson Cancer Center|Saroj Vadhan-Raj, MD/Professor, Sarcoma Medical Oncology|(713) 792-7966|CR_Study_Registration@mdanderson.org|
22451080|NCT02464969|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22451081|NCT02863354|Retina Consultants of Houston|Dr. Charles C. Wykoff|713-524-3434|ccwmd@houstonretina.com|
22451082|NCT01591746|Mayo Clinic|Dr. Valerie Lemaine, MD, MPH|507-284-2736|lemaine.valerie17@gmail.com|
22451083|NCT02409615|Nemours/A I duPont Hospital for Children|Karen Sacks, MSN PNP|302-651-5649|ksacks@nemours.org|
22451084|NCT00724451|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22451085|NCT00720876|City of Hope|Paul Frankel, Ph.D.|626-812-5265|pfrankel@coh.org|
22451086|NCT00286949|Michael E. DeBakey VA Medical Center|Laura Marsh, M.D., Principal Investigator|713-794-8907|laura.marsh2@va.gov|
22451087|NCT03495908|The University of Texas Southwestern Medical Center|Dr Pablo F Mora|469-585-0000|pf_mora@yahoo.com|
22451088|NCT04378933|Mayo Clinic|R. Robert Auger, M.D.|507-266-1066|Auger.Raymond1@mayo.edu|
22451089|NCT01559311|St. Jude Medical (Hong Kong) Ltd|Clinical Project Leader Asia|29967605|lyim@sjm.com|
22451090|NCT03027466|National Cancer Institute|William Klein|2402766972|kleinwm@mail.nih.gov|
22451091|NCT03286140|Imperial College London|Professor Alun Davies|+44 (0)20 3311 7309|a.h.davies@imperial.ac.uk|
22451092|NCT02158039|Mayo Clinic|Dr. Mark Topazian|507-284-7602|topazian.mark@mayo.edu|
22451093|NCT00515827|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22451094|NCT02052466|Cleveland Clinic Foundation|Dr. Eric Ricchetti|2164456915|ricchee@ccf.org|
22451095|NCT04356716|Columbia University|Suzanne Daly, RN, BSN|212 305 9535|sd2798@cumc.columbia.edu|
22451096|NCT01856140|Seoul National University College of Medicine|Dr. Sang Yoon Lee|028702673|rehabilee@gmail.com|
22451097|NCT02293005|UT MD Anderson Cancer Center|Dr. Anne Tsao, MD- VP, Academic Affairs, CAO Office|(713) 792-6363|astsao@mdanderson.org|
22451098|NCT02766608|Pearl Therapeutics, a Member of the AstraZeneca Group|Paul M. Dorinsky, MD|650-305-2600|paul.dorinsky1@astrazeneca.com|
22451099|NCT03223298|Weill Cornell Medicine|Dr. Gwendolyn S. Reeve|(212) 746-5175|gsr9001@med.cornell.edu|
22451100|NCT01151553|Emory University|Dr. Heather Bloom|404-321-6111|heather.bloom@emory.edu|6391
22451101|NCT01032694|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22451102|NCT02277626|Stanford University|Carlos Milla, MD|650-723-5193|cmilla@stanford.edu|
22451103|NCT02648698|Department of Hysteroscopic Centre, Fuxing Hospital, the Eighth Clinical Medical College, Capital Medical University, Beijing, China|Dr. Dongmei Song|13651294056|echosdm@163.com|86
22451104|NCT03574129|University of Washington|Dr. Irene Njuguna|2065191275|irenen@uw.edu|
22451105|NCT03143829|University of Central Floroda|Victoria Loerzel|407-823-0762|victoria.loerzel@ucf.edu|
22451106|NCT00672477|Salix|David Sorscher|919-862-1827|david.sorscher@salix.com|
22451107|NCT02181530|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22451108|NCT02837744|Axio Biosolutions Pvt. Ltd.|Shailee Mehta, Clinical Research Manager|9879009940|shailee.m@axiobio.com|
22451109|NCT01383681|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22451110|NCT00938431|UCB|Study Director|+1877 822 9493||
22451111|NCT00423436|UT MD Anderson Cancer Center|Charles S Cleeland, PhD, Professor||asaleeba@mdanderson.org|
22451112|NCT03738865|Xeris Pharmaceuticals, Inc.|Chelsea Boundy|312-517-1466|cboundy@xerispharma.com|
22451113|NCT02057757|National Institute of Allergy and Infectious Diseases (NIAID)|Dr. John Beigel|301-451-9881|jbeigel@niaid.nih.gov|
22451114|NCT00440271|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22451115|NCT01416194|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22451116|NCT00048724|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22451117|NCT03586869|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22387602|NCT00463229|McMaster University|Maureen Markle-Reid|905-525-9140|mreid@mcmaster.ca|22306
22387603|NCT00455650|Massachusetts General Hospital|A. Eden Evins, MD, MPH|617-643-4679|aeevins@mgh.harvard.edu|
22387604|NCT01359150|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22387605|NCT01170208|International Diabetes Center|Dr. Richard Bergenstal|952-993-3796|richard.bergenstal@parknicollet.com|
22387606|NCT03113409|NYS Psychiatric Institute|Adam Bisaga MD|646-774-6155|adam.bisaga@nyspi.columbia.edu|
22387607|NCT02040870|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22387608|NCT02483468|Ralph H. Johnson VA Medical Center, Charleston, SC & Medical University of South Carolina|Jeffrey J Borckardt, PhD|843.792.3295|borckard@musc.edu|
22387609|NCT03552276|Sun Pharmaceutical Industries Limited|Head-Regulatory Affairs|2266455645|Clinical.Trial@sunpharma.com|5689
22387610|NCT00317720|UT MD Anderson Cancer Center|Dr. Francisco Esteva|713-563-0742|CR_Study_Registration@mdanderson.org|
22387611|NCT01706159|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22387612|NCT03371017|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22401026|NCT02437669|Columbia University College of Physicians and Surgeons|Daniel S. Tsze, MD, MPH|212-305-9825|dst2141@columbia.edu|
22401027|NCT01241539|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22451118|NCT00226941|Stanford Cancer Institute, Stanford University|George Albert Fisher, Jr, MD, PhD; Colleen Haas Chair, School of Medicine|650-723-2990|georgeaf@stanford.edu|
22451119|NCT00009737|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22451120|NCT02732847|Memorial University|Reza Tabrizchi|706-864-3381|rtabrizc@mun.ca|
22451121|NCT00003498|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22451122|NCT02821104|Nationwide Children's Hospi|Robert Hoffman|614-722-4425|robert.hoffman@nationwidechildrens.org|
22451123|NCT03835260|Pivot Health Technologies Inc.|Senior Director of Clinical Affairs and Data Science|650-906-4255|craig@pivot.co|
22451124|NCT01260922|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22451125|NCT02248922|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
22451126|NCT03732248|Medical University of South Carolina|Dr. Michael Saladin|843-792-5306|saladinm@musc.edu|
22451127|NCT00414050|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1 800 672 6372|ClinicalTrialsDisclosure@merck.com|
22451128|NCT02873104|Cutera|Lourdes Moldre, NP|415-971-5118|lmoldre@cutera.com|
22451129|NCT02708745|Seattle Children's Hospital|Dr. Doug Opel|206-987-2000|douglas.opel@seattlechildrens.org|
22451130|NCT02604589|William Beaumont Hospital|Rose Callahan|248 551-5147|rose.callahan@beaumont.org|
22451131|NCT01298063|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22451132|NCT00395044|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu|
22451133|NCT01121211|Massachusetts General Hospital|Dr. Anne Klibanski|6177263870|aklibanski@partners.org|
22451134|NCT05013905|Prometheus Biosciences, Inc.|Study Director|858-422-4300|mm@prometheusbiosciences.com|
22451135|NCT04942938|Centura Health|Dr. Courtney Ellerbusch|3039058272|courtneyellerbusch@centura.org|
22451136|NCT01362907|Alcon Research|Joachim Nick, Dipl. Ing. (FH)|+49 6022 240 520|joachim.nick@cibavision.com|
22451137|NCT03383588|Montefiore Medical Center|Dr Catherine Igel|718-405-8200|cigel@montefiore.org|
22451138|NCT04524962|Cartesian Therapeutics, Inc.|Hafsa Kamboh|4127585340|hafsa@cartesiantx.com|
22451139|NCT02550652|Genentech|Medical Communications|800-821-8590|genentech@druginfo.com|
22451140|NCT02486406|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22451141|NCT00627406|Fertility Clinic Regional Hospital Skive|Dr. Peter Humaidan|+45 78 44 57 60|peter.humaidan@viborg.rm.dk|
22451142|NCT01196871|Medical Affairs|Amicus Therapeutics|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
22451143|NCT00333606|Ernst Moritz Arndt University of Greifswald|Taras Usichenko, director of the trial|+493834865828|taras@uni-greifswald.de|
22451144|NCT01037790|University of Pennsylvania|Jennifer Louie, Program Manager|267-414-6179|Jennifer.Louie2@pennmedicine.upenn.edu|
22451145|NCT03509948|Achieve Life Sciences|Daniel Cain, Vice President, Clinical Research|425.686.1546|dcain@achievelifesciences.com|
22451146|NCT02281136|DUSA Pharmaceuticals Inc., a Sun Pharma Co.|Manager of Clinical Research|9147608796|Anna.Houlihan@sunpharma.com|
22451147|NCT03254134|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22451148|NCT00205712|Washington University School of Medicine|John Newcomer, MD|314-362-3153|newcomerj@wustl.edu|
22451149|NCT01009099|Edward Hines Jr., VA Hospital|Eileen Collins|708-202-3525|eileen.collins@va.gov|
22451150|NCT01331694|GlaxoSmithKline|GSK Response Center|866-435-7343||
22451151|NCT00075829|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com|
22451152|NCT02188485|University of Rochester|Kim Van Orden, PhD|585-275-5176|kimberly_vanorden@urmc.rochester.edu|
22451153|NCT00799617|University of Pennsylvania, Perelman School of Medicine|Peter J. Snyder, MD|215-898-0208|pjsnyder@upenn.edu|
22451154|NCT01712984|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22451155|NCT00685932|University of Iowa Hospitals and Clinics|Abbey Hardy-Fairbank, MD|319-356-2291|abbey-hardy-fairbanks@uiowa.edu|
22451156|NCT00096044|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22451157|NCT03149237|Vanderbilt University Medical Center|Dr. Carolyn Audet|615-343-2418|carolyn.m.audet@vumc.org|
22451158|NCT02442830|UMass Medical School|Principal Investigator|(774) 442-4098|David.Cave@umassmemorial.org|
22451159|NCT01910064|Galderma K.K.|Clinical Project Manager|+81 3 5937 3850|GaldermaKK.ClinDev@galderma.com|
22451160|NCT00595582|LSU Health Sciences Center, Shreveport LA|Dr. James Patterson/Professor|318-813-2070|jpatte@lsuhsc.edu|
22451161|NCT03851016|University of Houston|Dr. Theresa C. Chrisman|713-447-3334|tkchrisman@comcast.net|
22451162|NCT03878134|NIH Clinical Center|Dr. Elizabeth Jones Chief, Radiology and Imaging Sciences|3012634853|ejones@cc.nih.gov|
22451163|NCT00586469|GlaxoSmithKline|GSK Response Center|866-435-7343||
22451164|NCT02553746|424 Army General Hospital|Georgios Kotsovolis|+306948182743|gskotsos@gmail.com|
22451165|NCT04055116|Geisinger|Gayatri Malik, MD|15702716355|gmalik1@geisinger.edu|
22451166|NCT02710526|Braeburn Inc|Sonnie Kim|6104678718|sonnie@braeburnrx.com|
22451167|NCT01003418|GlaxoSmithKline|GSK Response Center|866-435-7343||
22451168|NCT01976845|Department of Anesthesiology at Cedars-Sinai Medical Center in Los Angeles|Dr. Ronald H Wender|3104231682|ronald.wender@cshs.org|
22451169|NCT01660412|UAMS|James A Ntambi|5015265062|jantambi@uams.edu|
22451170|NCT01818336|AllerQuest|Dr. Franklin Adkinson Jr., MD-Vice President, Chief Medical Officer|410-550-2051|fadkinson@allerquest.com|
22451171|NCT00320281|Craig Hospital|Dr. Gary Maerz|303-789-8220|adannels@craighospital.org|
22451172|NCT03042312|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22451173|NCT04258839|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22451174|NCT03328897|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22451175|NCT00608829|W.L. Gore and Associates|Abe Letter|928 864 3113|aletter@wlgore.com|
22451176|NCT02283528|Emory University|Dr. Gary Francis Bouloux|404-778-4500|gfboulo@emory.edu|
22414134|NCT00828295|Helsinn Healthcare SA|Salvatore Chessari|+41 91 985 21 21|salvatore.chessari@helsinn.com|
22387613|NCT04057131|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22387614|NCT02830204|Baylor Scott and White Research Institute|Walter Cerqueira|469-814-3393|walter.cerqueira@bswhealth.org|
22414135|NCT01402050|Phoenix Perinatal Associates - Mednax|Ana Braescu|602-614-0488|ana_braescu@mednax.com|
22414136|NCT03581097|Ospedale Regionale di Bellinzona e Valli (ORBV)|Dr. med. Andrea Saporito, Vice-Chair Department of Anesthesia|091/811.91.11|andrea.saporito@eoc.ch|
22414137|NCT03220958|Montefiore|Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
22414138|NCT02255149|University of Michigan|Dr. Hsun-Liang Chan|734-763-3325|hlchan@umich.edu|
22414139|NCT00373256|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22414140|NCT00238615|Stanford University|Dr. Heather Wakelee|650-736-7221|hwakelee@stanford.edu|
22414141|NCT04726345|Columbia University|Ezra J. Margolin, MD|212-305-0114|ejm2182@cumc.columbia.edu|
22414142|NCT03032172|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22414143|NCT02718326|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
22414144|NCT06195579|University of Lincoln|Dr Nima Moghaddam|01522882000|nmoghaddam@lincoln.ac.uk|
22414145|NCT03868891|UPMC Children's Hospital of Pittsburgh|Dr. Amber Shaffer|412-692-6874|shafferad@upmc.edu|
22414146|NCT00761813|University of Minnesota|Principal Investigator|612.273.8000|swion001@umn.edu|
22414147|NCT03049748|Johns Hopkins University (Former Faculty at University of Michigan)|Dr. Jesus Casida|3132047665|jcasida1@jhu.edu|
22414148|NCT01011413|University of New South Wales|Sean Emery|02 9385 0900|semery@kirby.unsw.edu.au|
22414149|NCT01688609|St. Luke's International Hospital|Dr. Teruo Yamauchi|+81-3-3541-5151|tryhi@luke.ac.jp|
22414150|NCT00462228|Department of Physical Medicine and Rehabilitation, University of Missouri|Dr. S. Jon Rupright|573-882-3101|RuprightJ@health.missouri.edu|
22414151|NCT00567320|Yale University|Mehmet Sofuoglu, M.D., Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu|
22414152|NCT01299454|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800-562-3974||
22451177|NCT03189914|Rexahn|Doug Swirsky/ Chief Executive Officer|12402685300|swirskyd@rexahn.com|
22451178|NCT00734305|Merrimack Pharmaceuticals, Inc.|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
22451179|NCT02080091|Alimera Sciences, Ltd.|Andrew Joyson - Associate Director, Clinical Operations Europe|+44 1252 354 026|Andrew.Joyson@alimerasciences.com|
22451180|NCT04331366|Emory University|Jeffery Miller, MD|404-778-7200|jeffrey.miller@emory.edu|
22451181|NCT03019536|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22451182|NCT03422003|Dana-Farber Cancer Institute|Dr. Rinaa Punglia|617-632-3591|rpunglia@mgb.org|
22451183|NCT00317772|UT MD Anderson Cancer Center|Diane C Bodurka,Chief Education & Training Ofc, Education & Training|(713) 745-3358|dcbodurka@mdanderson.org|
22451184|NCT00966940|Alcon Research, Ltd.|Director of Medical Affairs|1-800-862-5266|medinfo@alconlabs.com|
22451185|NCT03151265|dorsaVi Ltd|Sangeeth Wanasinghage|+61 1800 367 728|support@dorsavi.com|
22451186|NCT01040871|Johnson & Johnson Pharmaceutical Research & Development|Dr. Helgi van de Velde||HVDVELDE@ITS.JNJ.COM|
22451187|NCT02886572|Duke University Health System|Joan Cahill BNS OCN CCRP|(919) 668-5211|joan.cahill@duke.edu|
22451188|NCT04175262|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22451189|NCT03087591|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-716-5772|ptriozzi@wakehealth.edu|
22451190|NCT02621606|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22451191|NCT01175824|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22451192|NCT01774903|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-792-7200||
22451193|NCT00982319|Sidney Kimmel Comprehensive Cancer Center|Dr. Kala Visvanathan|410-614-1112|kvisvan1@jhu.edu|
22451194|NCT00767000|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22451195|NCT00127790|Universityy of Rochester|Wilfred Pigeon, PhD|(585) 275-3374|wilfred_pigeon@urmc.rochester.edu|
22451196|NCT00843791|OREGON HEALTH & SCIENCE UNIVERSITY|Dr. Jonathan Q Purnell|5034941056|purnellj@ohsu.edu|
22451197|NCT01252251|Memorial Sloan Kettering Cancer Center|Dr. Michael Postow, MD|646-888-4589|PostowM@mskcc.org|
22451198|NCT01324024|University of Pennsylvania|Cynthia Neill Epperson, M.D.|215-573-8871|cepp@mail.med.upenn.edu|
22451199|NCT00856024|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClincialTrialsDisclosure@merck.com|
22451200|NCT00097591|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22451201|NCT02312310|Columbia University Medical Center|Scott A. Small, MD|212-305-1269|sas68@columbia.edu|
22451202|NCT01743092|Centre for Addiction and Mental Health|Nigel Turner, Ph.D.|416-535-8501|nigel.turner@camh.ca|36063
22451203|NCT03603964|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
22451204|NCT00563797|Yale University School Of Medicine Department of Psychiatry|Elizabeth Ralevski|203-932-5711|elizabeth.ralevski@yale.edu|4282
22451205|NCT03264157|Bio Products Laboratory|Head of Medical Affairs|1-844-4BPLUSA|MedInfo@bpl-us.com|
22451206|NCT00530023|Director, Program Management, Clinical Research|Harold Torunsky|8185765445|harold.torunsky@medtronic.com|
22451207|NCT04188041|Kent Hospital|Daria Szkwarko, PI|401-921-7981|szkwarkd@gmail.com|77981
22451208|NCT00365859|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22451209|NCT01877421|Oral Health Research Institute, Indiana University School of Dentistry|Domenick T. Zero, DDS, MS|240-457-0668|dzero@iu.edu|
22451210|NCT01611571|Columbia University Medical Center|Marcella Walker MD|212-342-5351|mad2037@columbia.edu|
22414153|NCT02197481|The Second Affiliated Hospital of Anhui Medical University|Dr.Jiang-ming Chen|15855518651|chenjm10@126.com|86
22414154|NCT03437265|Norgine|Lucy Clayton|+441895826669|LClayton@norgine.com|
22414155|NCT02157623|Cleveland Clinic|Edward Maytin, MD, PhD|216-445-6676|maytine@ccf.org|
22414156|NCT02362997|Dana-Farber Cancer Institute|Philippe Armand, MD, PhD|617-632-2305|philippe_armand@dfci.harvard.edu|
22414157|NCT03410862|Cleveland Clinic|Jeff Negrey Study Coordinator|2166365504|negreyj2@ccf.org|
22414158|NCT02600403|Wills Eye Hospital|Michael Waisbourd|2159283000|MWaisbourd@willseye.org|
22414159|NCT03302780|University of Texas McGovern Medical School - Houston|Sheng Li, MD, PhD|7137977125|sheng.li@uth.tmc.edu|713
22414160|NCT01667679|Avanir Pharmaceuticals|Nadine Knowles; Executive Director, Research & Development Operations|1-949-268-8972|nknowles@avanir.com|
22414161|NCT01175018|Virginia Commonwealth University|Antonio Abbate|804-828-0513|aabbate@mcvh-vcu.edu|
22387615|NCT05162261|Novoxel Ltd|Dr. Ifat Klein|+972-52-6009860|ifat@novoxel.com|
22387616|NCT02517268|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Harish Lavu|215-955-6888|Harish.Lavu@jefferson.edu|
22387617|NCT03024866|Xoft Inc.|Robert Burnside|14084931533|rob.burnside@elekta.com|
22387618|NCT04686266|University of Pennsylvania|Lauren Massimo, PhD, CRNP|215-349-5863|lmassimo@upenn.edu|
22387619|NCT05579730|Bausch & Lomb|Daniel Donatello|585-338-5306|Daniel.Donatello@bausch.com|
22387620|NCT02401815|Cogent Biosciences, Inc.|VP, Head of Clinical Development Operations|617-945-5576|clinops@cogentbio.com|
22387621|NCT00748709|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22387622|NCT01586104|Ann & Robert H. Lurie Children's Hospital of Chicago|Dr. David Walterhouse|3122274000|d-walterhouse@northwestern.edu|
22387623|NCT05470114|Leo Pharma|Clinical Disclosure|+4544945888|disclosure@leo-pharma.com|
22387624|NCT06214052|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22387625|NCT05325294|Medtronic Diabetes|Fang Niu, Sr Statistician|8185763319|fang.niu@medtronic.com|
22387626|NCT04649047|Ohio State University College of Nursing|Dr. Mei-Wei Chang|614-247-7211|chang.1572@osu.edu|
22387627|NCT02488408|BerGenBio ASA|BerGenBio Clinical Team|+47 559 61 159|trialsites@bergenbio.com|
22387628|NCT00719888|Fred Hutchinson Cancer Center|Dr. Ann Dahlberg|206-667-1959|adahlber@fredhutch.org|
22387629|NCT00491894|Shionogi USA|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
22387630|NCT04837937|Northwestern University- Feinberg School of Medicine- Division of Geriatrics|Vanessa Ramirez-Zohfeld|+1 312 503 3916|vanessa-ramirez-0@northwestern.edu|
22387631|NCT05422339|MapHabit|Matt Golden|9143301776|mgolden@maphabit.com|
22387632|NCT06072170|Altasciences|Senior Regulatory Affairs Associate|450 973 3155|mgalarza@altasciences.com|112084
22387633|NCT01278030|St. Jude Medical|John Gill|818-493-2609|jgill@sjm.com|
22387634|NCT06307457|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22387635|NCT04456413|Hackensack Meridian Health|Joshua Zenreich|551-996-4248|Joshua.Zenreich@hmhn.org|
22387636|NCT03706261|Columbia University|Adam M. Brickman, PhD|212-342-1348|amb2139@cumc.columbia.edu|
22387637|NCT05815342|Insulet Corporation|Dr. Trang Ly|9786007628|Tly@insulet.com|
22387638|NCT01555138|Novartis Pharmaceuticals|Study Director|862-778-8300||
22387639|NCT04612868|AEYE Health Inc.|Zack Dvey-Aharon, PhD|8662627343|info@aeyehealth.com|
22387640|NCT03220724|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22387641|NCT03376659|Georgetown University|Benjamin Weinberg, MD|202-444-2223|benjamin.a.weinberg@gunet.georgetown.edu|
22387642|NCT01613417|Executive Director, MRI|Gianpaolo Pirovano, MD|609-514-2226|gianpaolo.pirovano@diag.bracco.com|
22387643|NCT00047385|Early Detection Research Group, NCI, NIH|Christine D. Berg, M.D.|301-496-8544|bergc@mail.nih.gov|
22387644|NCT03865732|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
22414162|NCT01788423|Indiana University, Department of Speech and Hearing Sci|Larry E. Humes|812-855-3507|humes@indiana.edu|
22414163|NCT00835263|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414164|NCT03856320|William S. Middleton VA Hospital|Dr. Luke Funk|608-256-1901|Luke.Funk@va.gov|17899
22414165|NCT01020474|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22414166|NCT00107991|UPenn|Jennifer Goldfarb|215-662-2540|jennifer.goldfarb@uphs.upenn.edu|
22414167|NCT03669861|Massachusetts General Hospital|DRAI Director of Clinical Trials|6176920668|JHSTONE@mgh.harvard.edu|
22430754|NCT00966446|Perelman School of Medicine, University of Pennsylvania|Ebbing Lautenbach, MD, MPH, MSCE|215-898-6977|ebbing@mail.med.upenn.edu|
22430755|NCT01308788|Indiana University|Alon Harris|3170278-0177|alharris@indiana.edu|
22430756|NCT00322218|Spectrum Pharmaceuticals,Inc.|Gajanan Bhat|949-743-9219|gajanan.bhat@sppirx.com|
22430757|NCT00124306|University of Pennsylvania|J. Richard Landis, PhD|215-5734922|hultman@upenn.edu|
22430758|NCT04136288|Mayo Clinic|Chandler Chapman, DHSc, MPH, Senior Clinical Research Coordinator|9049538681|Chapman.Chandler@mayo.edu|
22430759|NCT02842242|MyoKardia Inc.|Dr. Amy Sehnert|650-741-7798|asehnert@myokardia.com|
22401028|NCT00440401|Medical Scientific Strategy|Medical Responsible|+45 4677 1111|clinicaltrials@nycomed.com|
22430760|NCT01426555|VA Boston Healthcare System|Dr. Antonio Lazzari|857-364-6381|antonio.lazzari@va.gov|
22430761|NCT03596645|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22430762|NCT04725513|Spaulding Rehabilitation Hospital|Adam Tenforde, MD|6179526800|atenforde@mgh.harvard.edu|
22430763|NCT03026777|LSUHSC New Orleans|Dr. David Janz|504-913-5006|djanz@lsuhsc.edu|
22430764|NCT06151418|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22430765|NCT00866775|Sunovion Phamaceuticals Inc.|Eslicarbazepine acetate Medical Director|866-503-7813|clinicaltrialsdisclosure@sunovion.com|
22451211|NCT04165291|Yale University Child Study Center|Carla Stover|12037853486|carla.stover@yale.edu|
22451212|NCT01416805|University of South Florida|Dr. Eric Storch|727-767-8230|Eric.Storch@bcm.edu|
22451213|NCT02418546|Massachusetts General Hospital|Dr. Anne-Marie Wills|6177265532|awills@mgh.harvard.edu|
22451214|NCT04632940|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|FG3019-094DMDStudy@fibrogen.com|
22451215|NCT05580575|The Ohio State University College of Optometry|Dr. Jennifer Fogt, OD, MS|614-292-0882|fogt.78@osu.edu|
22451216|NCT02709395|Wellspect HealthCare|Head of Medical Affairs, Markus Wittebo|+46 31 376 40 00|markus.wittebo@wellspect.com|
22451217|NCT01649856|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22451218|NCT00179647|Celgene Corporation|Robert D. Knight, M.D.|908-673-9749|rknight@celgene.com|
22451219|NCT00622635|Novartis Pharmaceuticals|Study Director|862 778-8300||
22451220|NCT00281840|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Panayiotis Savvides, MD|216-844-5946|Panayiotis.Savvides@uhhospitals.org|
22451221|NCT00835406|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22451222|NCT00733343|Department of Cardiology, Imperial College London, Dovehouse St., London SW3 6LY, United Kingdom|Martin R. Cowie, MD|+44 (0)20 7589 0|m.cowie@imperial.ac.uk|5111
22451223|NCT00832429|M D Anderson Cancer Center|Sara Hull|713-563-4598|sehull@mdanderson.org|
22451224|NCT01849588|Massachusetts General Hospital|Dr. Andrew Zhu|617-724-4000|azhu@partners.org|
22451225|NCT01706250|GlaxoSmithKline|GSK Response Center|866-435-7343||
22451226|NCT01744730|Duke Clinical Research Institute, Duke University School of Medicine|Kevin Watt, MD|919-668-8556|kevin.watt@dm.duke.edu|
22451227|NCT01079234|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22451228|NCT01485601|Medytox Inc.|Young Ryu|+82-2-6901-5890|young.ryu@medytox.com|
22451229|NCT04519658|CinCor Pharma|Yuan-Di Halvorsen|617-675-8126|yhalvorsen@cincor.com|
22451230|NCT01071512|University of Chicago|Dr. Adil Javed|773.834.0558|ajaved@neurology.bsd.uchicago.edu|
22451231|NCT00183872|USC/Norris Comprehensive Cancer Center|Victoria Soto - Project Specialist|(323) 865-0454|Victoria.Soto@med.usc.edu|
22451232|NCT04587193|Virginia Commonwealth University|Brian Berman|800-762-6161|brian.berman@vcuhealth.org|
22451233|NCT00508742|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22451234|NCT02501096|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22401029|NCT01925703|University of Maryland School of Pharmacy, Department of Pharmacy Practice and Science|Dr. Brent N. Reed||breed@rx.umaryland.edu|
22401030|NCT01938625|Janssen Research & Development|Medical Leader||ClinicalTrialDisclosure@its.jnj.com|
22401031|NCT02088034|Northwestern University|Matthew J. O'Brien, MD|312-503-5046|matthew.obrien1@northwestern.edu|
22401032|NCT00308620|University of Minnesota|David Boulware|6126269546|boulw001@umn.edu|
22401033|NCT00091793|Amgen Inc.|Study Director|866-572-6436||
22401034|NCT05780281|University of Minnesota|Greg Grandits|651-528-9491|greg-g@ccbr.umn.edu|
22401035|NCT00058370|Memorial Sloan Kettering Cancer Center|Dr. Ira Dunkel, MD|212-639-2153|dunkeli@mskcc.org|
22401036|NCT02424149|Hartford Hospital|Katie Propst, MD|860-972-4338|katie.propst@hhchealth.org|
22401037|NCT05309083|Washington University School of Medicine|Dr. Kerri Rawson|813-468-8900|rawson@wustl.edu|
22401038|NCT01238120|University of Rochester Medical Center|Michelle C. Janelsins, PhD, MPH|(585) 276-4656|Michelle_Janelsins@urmc.rochester.edu|
22401039|NCT01748227|Richard L. Roudebush VAMC HSR&D|Dr. Marianne Matthias|317-988-4514|marianne.matthias@va.gov|
22401040|NCT02095561|INSTITUTO NACIONAL DEL CÁNCER, ARGENTINA|Silvina Arrossi, Phd|541152390562|silviarrossi2020@gmail.com|
22430766|NCT02553473|Sørlandet hospital HF|Anne Marit Solheim, MD|0047 38 07 39 10|anne.marit.solheim@sshf.no|
22451235|NCT00437034|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
22451236|NCT00594256|Nathan Kline Institute|Joshua Kantrowitz MD|845-398-5503|jkantrowitz@nki.rfmh.org|
22451237|NCT00853658|Novartis Pharmaceuticals|Study Director|862-778-8300||
22451238|NCT02797262|University of California, Los Angeles|Research Scientist|3105917541|statue22@gmail.com|
22451239|NCT02927691|Teachers College, Columbia University|Michelle Troche|212-678-3953|mst2139@tc.columbia.edu|
22451240|NCT01337089|GW Pharmaceuticals Ltd.|Medical Enquiries||medinfo.USA@gwpharm.com|
22451241|NCT01404312|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22401041|NCT02498652|Study Information Center AstraZeneca|Jesse Hall, MD|(877) 240-9479|information.center@astrazeneca.com|
22401042|NCT01078753|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22414168|NCT02760927|Hollister Incorporated|Stacy Haddad, Director Global Clinical Affairs|+1.847.680.2837|stacy.haddad@hollister.com|
22414169|NCT03169062|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
22414170|NCT03256695|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22414171|NCT00064038|SWOG|Robert Z. Orlowski, MD, PhD|(713) 792-2860|rorlowsk@mdanderson.org|
22414172|NCT03359863|University of California at San Francisco|Aida Venado, MD, MAS|4153532577|aida.venado@ucsf.edu|
22414173|NCT03450850|Chao Family Comprehensive Cancer Center, University of California, Irvine|Chao Family Comprehensive Cancer Center, University of California, Irvine|1-877-UC-STUDY|ucstudy@uci.edu|
22414174|NCT02964039|Ralph H. Johnson VAMC / MUSC|Jesse Dean|8437929566|deaje@musc.edu|
22414175|NCT01103713|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22414176|NCT02089685|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22414177|NCT01341730|The Catholic University of Korea|Dr. Eun Ho Choo|82-10-8500-4569|cmcchu@catholic.ac.kr|
22414178|NCT04887415|University of Florida|Emily K. Plowman, Ph.D. CCC-SLP|(352)273-8632|eplowman@ufl.edu|
22414179|NCT00840411|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414180|NCT01424293|Maimonides Medical Center|Danny Sherwinter|7182837952|dsherwinter@maimonidesmed.org|
22414181|NCT01576042|Duke Clinical Research Institute|Sana M. Al-Khatib, MD, MHS|919-668-8649|sana.alkhatib@dm.duke.edu|
22414182|NCT03233724|National Cancer Institute|Dr. David S. Schrump|240-760-6239|david_schrump@nih.gov|
22414183|NCT02252133|Alcon Research, Ltd.|Senior Manager, Clinical Development, Japan|1-888-451-3937|alcon.medinfo@alcon.com|
22414184|NCT00651820|Healthpoint, Ltd.|Herbert B. Slade, M.D., FAAAI|817-900-4000|bert.slade@healthpoint.com|
22414185|NCT01911676|Yale University|Christina Luddy|203-932-5711|christina.luddy@yale.edu|4549
22414186|NCT00773253|University of California San Francisco|Graham A. Glass, MD|415-353-2311|Graham.Glass@ucsf.edu|
22414187|NCT05178927|UF Health Proton Therapy Institute|Dr. Perry Johnson|904-588-1253|PBJohnson@floridaproton.org|
22414188|NCT03670017|Washington University School of Medicine|Grant Bochicchio, Harry Edison Professor of Surgery, Chief of Acute and Critical Care Surgery|314-362-9347|gbochicchio@wustl.edu|
22414189|NCT00657553|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-569-6990|pettynathanm@uams.edu|2461
22414190|NCT03173547|Therapeutics, Inc.|Clinical Project Manager|858-571-1800|ClinicalResearch@therapeuticsinc.com|
22414191|NCT01566721|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
22414192|NCT01462279|Beth Israel Deaconess Medical Center|Dr. Michael W. Donnino|6177542341|mdonnino@bidmc.harvard.edu|
22414193|NCT04044521|University of Wisconsin-Madison|Dr. Andrew Quanbeck|608-609-7308|andrew.quanbeck@fammed.wisc.edu|
22414194|NCT00811655|Duke University Medical Center|Denise Lally-Goss, NP|919-684-3862|denise.lallygoss@dm.duke.edu|
22430767|NCT02943499|Brown University|Dr. Judson Brewer|401-863-2826|judson_brewer@brown.edu|
22451242|NCT02627677|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22451243|NCT02451748|University of Illinois at Chicago|Shiva Shahrara, PhD|312-413-7529|shahrara@uic.edu|
22451244|NCT02391402|Portland VA|Megan Callahan|503-220-8262|megan.callahan@va.gov|50525
22451245|NCT00673049|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22451246|NCT03971617|Stony Brook University Medical Center|Sandra Skinner|631-444-7513|sandra.skinner@stonybrookmedicine.edu|
22451247|NCT03103282|3-D Matrix Europe SAS|Florian REBECA|+33617587769|frebeca@puramatrix.com|
22451248|NCT00975975|IndianaU|Dr. Robert Nelson|317-944-0920|ronelson@iu.edu|
22451249|NCT01863446|Mass General Hospital|Elizabeth Klerman|617-643-2424|ebklerman@hms.harvard.edu|
22451250|NCT02554773|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22414195|NCT01258933|The University of Texas MD Anderson Cancer Center|William Wierda, MD./Professor|713-745-0428|wwierda@mdanderson.org|
22414196|NCT00787254|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22414197|NCT02608177|Kidney Research Institute, University of Washington|Dr. Ian de Boer, Associate Director|2067444029|IDeBoer@Nephrology.washington.edu|
22414198|NCT00119015|University of Chicago|Robert Naclerio|(773) 702-0080|rnacleri@surgery.bsd.uchicago.edu|
22414199|NCT01718301|Infetious disesases|Dr Josep Mallolas Masferrer|932275400|jmallolas@clinic.ub.es|3312
22414200|NCT05780788|UConn Health - Department of Orthodontics|Dr. Flavio Uribe (Study principal investigator)|8606792550|furibe@uchc.edu|
22414201|NCT01279109|Wake Forest School of Medicine|Dr. Sabina B. Gesell|336-713-8738|sgesell@wakehealth.edu|
22414202|NCT05776901|University of California, Irvine|Dr. Melissa Pinto, Associate Professor, Sue & Bill Gross School of Nursing|949-824-9272|mdpinto@uci.edu|
22414203|NCT04517604|Edward Hines Jr., VA Hospital|Dr. Amy Herrold|708-202-5867|amy.herrold@va.gov|
22414204|NCT01440465|Centre François Baclesse|Alexandra LECONTE|0231455002|a.leconte@baclesse.unicancer.fr|
22414205|NCT02225106|University of Pennsylvania|Ramon Diaz-Arrastia|215-662-9732-|Ramon.Diaz-Arrastia@uphs.upenn.edu|
22414206|NCT01958294|Silk Road Medical, Inc.|Ric Ruedy, Exec VP, Clinical Affairs|408-585-2112|ric@silkroadmed.com|
22414207|NCT05265624|University of Utah Moran Eye Center|Paul Bernstein, Principal Investigator|801-585-7231|Paul.Bernstein@hsc.utah.edu|
22414208|NCT02324660|Azienda Ospedaliera Universitaria di Ferrara|Gianluca Campo, PI of the study|0532237079|cmpglc@unife.it|+39
22414209|NCT00526188|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22414210|NCT05700383|Massachusetts General Hospital|Ana-Maria Vranceanu, PhD|617-724-4977|avranceanu@mgh.harvard.edu|
22414211|NCT02925884|Pacific University|Yu-Chi Tai|503-352-2289|ytai@pacificu.edu|
22414212|NCT04516434|Duke University Medical Center|Cindy Amundsen, MD|919-401-1000|cindy.amundsen@duke.edu|
22414213|NCT06144424|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22414214|NCT05292963|Midwest Evaluation and Research|Dr. Matthew Shepherd|8336439377|matt.shepherd@midwestevaluation.com|
22414215|NCT06284525|Northern Arizona University|Principal investigator|928-523-1787|Zachary.Lerner@nau.edu|
22414216|NCT00834522|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414217|NCT03165994|Pyxis Oncology, Inc.|Pyxis Oncology Clinical Operations|(339) 545 8252|clinicaltrials@pyxisoncology.com|
22414218|NCT00519194|St. Jude Medical|Sue Walgren, Manager Sr., Clinical Project|6517563210|swalgren@sjm.com|
22414219|NCT01111461|Eisai, Inc.|Eisai Medical Services|18884224743|esi_medinfo@eisai.com|
22414220|NCT02598089|IVAC|Dr. Le Van Be||ivaclevanbe@gmail.com|
22430768|NCT01904279|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22430769|NCT02267447|Ottawa Hospital Research Institute|Dr. Doug Manuel|613-798-5555|dmanuel@ohri.ca|19108
22430770|NCT03283241|AddBio AB|Ulf Sewerin, CEO|+46708797988|ulf.sewerin@addbio.se|
22430771|NCT00666263|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22430772|NCT02439957|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
22430773|NCT00586157|Massachusetts General Hospital|Timothy Wilens, MD|617-726-1731|twilens@partners.org|
22430774|NCT00414609|Novartis Pharmaceuticals|Study Director|862-778-8300||
22430775|NCT05898178|Maribor University Medical Centr|Borut Kovačič||Borut.KOVACIC@ukc-mb.si|0038631211
22430776|NCT02853136|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22430777|NCT00841815|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22430778|NCT02517918|Institut Bergonié|Pr Simone Mathoulin-Pelissier|0556333333|S.Mathoulin@bordeaux.unicancer.fr|
22430779|NCT02732145|Ginekološka poliklinika Dr. Vesna Harni|Dr. Vesna Harni|0038512923648|vesnaharni@gmail.com|
22451251|NCT00759967|Ottawa Hospital Research Institute|Dr. Deborah Zimmerman|613-738-8400|dzimmerman@ohri.ca|82534
22451252|NCT02652780|GenSight Biologics|Regulatory Affairs|176217220|ipengue@gensight-biologics.com|0033
22430780|NCT01682720|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22451253|NCT02956629|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22451254|NCT04177693|Yale University|Dr. Heping Zhang|2037855185|heping.zhang@yale.edu|
22451255|NCT03224468|Massachusetts General Hospital|Jodi Gilman, PhD|617-643-7293|jgilman1@mgh.harvard.edu|
22451256|NCT04713748|Duke Clinical and Translational Science Institute|Douglas Wixted|919-668-0515|douglas.wixted@duke.edu|
22451257|NCT01557946|McLean Hospital, Biological Psychiatry Laboratory|Dr. Brian Brennan, MD|617-855-2911|bbrennan@partners.org|
22451258|NCT00406029|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22451259|NCT00812812|GlaxoSmithKline|GSK Response Center|866-435-7343||
22451260|NCT02114892|Institute of Experimental andl Clinical Therapeutics|Dr. Manuel González Ortiz|+52-33-10-58-52-00|uiec@prodigy.net.mx|34212
22451261|NCT02061345|Imperial College, London|Prof Pat Price|02075895111|p.price@imperial.ac.uk|
22451262|NCT04023695|Vanderbilt University|Brian Drolet, MD|(615) 322-2350|brian.c.drolet@vumc.org|
22451263|NCT02178475|Amgen Inc.|Study Director|866-572-6436||
22451264|NCT00718042|Abbott Laboratories|Associate Director Clincal Affairs|847-937-8702|barbara.kaesdorf@abbott.com|
22451265|NCT04327934|John B. Pierce Laboratory/Yale School of Medicine|Nina Stachenfeld|203 562 9901|nina.stachenfeld@yale.edu|219
22451266|NCT02443298|AbbVie|Global Medical Services|1-800-633-9110|abbvieclinicaltrials@abbvie.com|
22451267|NCT03095417|Indiana University|Babar Khan, MD, MS|(317) 274-9132|bakhan@iu.edu|
22451268|NCT02571452|San Francisco VA Healthcare System|Dr. Shira Maguen|415-221-4810|Shira.Maguen@va.gov|22511
22451269|NCT03161314|Physical Therapy Faculty, Mahidol University|Asst.Prof.Dr. Sunee Bovonsunthonchai|024415450|sunee.bov@mahidol.edu|20804
22430781|NCT01687595|Agenus Inc.|Agenus, Inc. Clinical Trial Information|781-674-4265|clinicaltrialinfo@Agenusbio.com|
22414221|NCT02303405|Charles R. Drew University of Medicine and Science|Stanley H. Hsia, MD|323-357-3633|stanleyhsia@cdrewu.edu|
22414222|NCT04757298|University of Illinois Urbana Champaign|Dr. Liliane Windsor|217-300-1782|lwindsor@illinois.edu|
22414223|NCT03600805|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22414224|NCT04512781|Vapotherm|Amy Bergeski|570-351-6966|Abergeski@vtherm.com|
22451270|NCT04847050|National Cancer Institute|Dr. James Gulley|301-480-8870|gulleyj@mail.nih.gov|
22451271|NCT03698773|University of New Mexico Anesthesiology Department|Research Officer|505-272-2610|hsc-anesthesiology@salud.unm.edu|
22451272|NCT01158924|DePuy Synthes Spine|Mark Lotito|508-880-8045|mlotito@its.jnj.com|
22451273|NCT01599650|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22451274|NCT01731171|Sheppard Pratt Health System|Dr. Faith Dickerson|410-938-4359|fdickerson@sheppardpratt.org|
22451275|NCT01410110|Yale University School of Medicine|Morris Bell, Ph.D.|203-932-5711|morris.bell@yale.edu|2281
22451276|NCT01700946|St. Jude Children's Research Hospital|Sima Jeha, MD|(901) 595-3901|sima.jeha@stjude.org|
22451277|NCT00684424|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22451278|NCT02138214|University of Wisconsin, Madison|Dr. Rebecca Sippel|608-263-1387|sippel@surgery.wisc.edu|
22451279|NCT02185768|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
22451280|NCT03221257|University of California, Los Angeles|Dr. Michael D. Roth|3102067389|mroth@mednet.ucla.edu|
22451281|NCT01334866|Medtronic, Inc.|Kristin Lawman|763-514-9809|kristin.j.lawman@medtronic.com|
22451282|NCT03367312|Duke University School of Medicine|Dr. Sudarshan Rajagopal|919-684-6237|sudarshan.rajagopal@duke.edu|
22451283|NCT05267171|Universidad de Oviedo|Claudia Leirós Díaz|663571819|claudia_leiros@hotmail.com|
22451284|NCT01971346|University of Michigan|Heather Chubb|734-936-6394|hdchubb@med.umich.edu|
22451285|NCT04187196|Atrium Health|Elijah Beaty, MD, MPH, FACC|704-403-6100|Elijah.Beaty@atriumhealth.org|
22387645|NCT00454194|Roswell Park Cancer Institute|Alex A. Adjei, M.D., Ph.D.|507-284-9265|alex.adjei@roswellpark.org|
22387646|NCT01354145|Bioiberica|Marta Herrero - Clinical R&D Manager|+34934904908|mherrero@bioiberica.com|
22387647|NCT02095145|University of Wisconsin Carbone Cancer Center|David Jarrard|608-262-0759|jarrard@urology.wisc.edu|
22387648|NCT01703598|Oregon Health & Science University|Matthew Brodsky MD|503-494-9054|brodskym@ohsu.edu|
22387649|NCT01542255|Dartmouth-Hitchcock|Marc Ernstoff|603-650-5534|marc.s.ernstoff@hitchcock.org|
22387650|NCT02085941|Brigham & Women's Hospital/Dana-Farber Cancer Institute|Thomas C. Lee, MD|617-732-7260|tchlee@bwh.harvard.edu|
22387651|NCT01890954|University of Virginia|Daniel Chernavvsky|434-243-1395|drc2v@virginia.edu|
22387652|NCT05462912|UC Davis Orthopaedic Surgery|Eric Giza, MD|916-734-6805|egiza@ucdavis.edu|
22387653|NCT00504023|Memorial Sloan Kettering Cancer Center|Dr. Dennis Chi, MD|212-639-5016|chid@mskcc.org|
22387654|NCT02639637|Vanderbilt University Medical Center|Nancy J. Brown, M.D., Principal Investigator|6153644022|nancy.j.brown@vanderbilt.edu|
22387655|NCT00229658|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22387656|NCT00093496|Mayo Clinic Cancer Center|Charles Erlichman, M.D.||erlichman.charles@mayo.edu|
22414225|NCT00033917|Yale University School of Medicine|Dr. Laura Ment|203-785-5708|laura.ment@yale.edu|
22414226|NCT00804856|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22451286|NCT01687166|Boston Scientific|Clinical Trial Manager|617-218-3849|weismanm@bsci.com|
22451287|NCT02755831|Naval Medical Center San Diego|CAPTAIN Dennis Spence, NC, USN, PhD, CRNA|6199161680|dennis.l.spence.mil@mail.mil|
22414227|NCT03343535|TransMedics, Inc.|VP, Clinical Affairs|978-552-0900|ldamme@transmedics.com|
22451288|NCT01600586|Vanderbilt University|Olena Chorna|850-508-5571|olena.chorna@vanderbilt.edu|
22387657|NCT01953224|The University of Texas Medical Branch|Eloisa Martinez|4092669643|esmartin@utmb.edu|
22387658|NCT00586313|Indiana University Hospital|John DeWitt, MD|317-944-1113|jodewitt@iu.edu|
22387659|NCT00229970|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22387660|NCT01979276|Weill Cornell Medical College|Jennifer Hess|646-962-9440|jmh2004@med.cornell.edu|
22387661|NCT03205566|Guy's & St. Thomas' NHS Foundation Trust|Dr Julie Fox|020 7188 7188|julie.fox@gstt.nhs.uk|
22387662|NCT03184987|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22387663|NCT01767467|GlaxoSmithKline|GSK Response Center|866-435-7343||
22387664|NCT00853580|The University of Alabama at Birmingham|Bruce R. Korf|205.934.9411|bkorf@uabmc.edu|
22387665|NCT01700205|Monell Chemical Senses Center|Julia A. Mennella, PhD|267-519-4880|mennella@monell.org|
22387666|NCT01085513|Given Imaging|director of clinical affairs|+972-4-9097774|Hila.debby@givenimaging.com|
22387667|NCT03335488|Horizon Therapeutics, LLC|Horizon Therapeutics, LLC|866-479-6742|clinicaltrials@horizontherapeutics.com|
22387668|NCT04971733|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22387669|NCT01160354|The University of Texas (UT) MD Anderson Cancer Center|Dr. Jan Burger, Associate Professor, Leukemia|7137927734|CR_Study_Registration@mdanderson.org|
22387670|NCT01006538|King's College Hospital, London|Mr Tim Jackson|+44 2032999000|t.jackson1@nhs.net|1297
22387671|NCT03849066|University of Colorado Denver|James Feinstein, MD, MPH, Principal Investigator|303-724-4186|james.feinstein@cuanschutz.edu|
22387672|NCT00600353|University of Kansas Medical Center|Dr. Omar Aljitawi|913-588-6029|oaljitawi@kumc.edu|
22387673|NCT04941482|Hanoi Medical University|Dr. Thao Thi Phuong Nguyen|+84916911897|dr.nguyenthiphuongthao.hmu@gmail.com|
22387674|NCT04200664|Ear Institute, University College London|Dr N Kharytaniuk (Clinical Research Fellow)|02076792000|n.kharytaniuk@ucl.ac.uk|
22387675|NCT00291694|University of Kansas Medical Center|Dr. Carol Fabian|913-588-3666|cfabian@kumc.edu|
22387676|NCT03362190|IVERIC bio, Inc|Hersh Patel, OD / Zimura Medical Director|609-474-6755|clinicaltrials@ivericbio.com|
22387677|NCT00687219|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22387678|NCT02940249|King's College London|Dr Wendy Hall|020 7836 5454|wendy.hall@kcl.ac.uk|
22387679|NCT00873782|University of North Carolina at Chapel HIll|William J. Powers, MD|919 966 8178|powersw@neurology.unc.edu|
22387680|NCT06110546|The University of Texas Health Science Center at Houston|Pascal Kingah, MD,MPH|713-500-6828|Pascal.L.Kingah@uth.tmc.edu|
22387681|NCT01732120|Washington University School of Medicine|Manager of Clinical Trials|3147479781|klima@wustl.edu|
22387682|NCT03102034|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22387683|NCT02628106|West China Hospital of Sichuan University|Mr.Zhi-cheng Li|+86 13795581617|wangcaizi2@163.com|
22387684|NCT00676091|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22387685|NCT03160521|Laboratorios Farmacéuticos Rovi, S.A.|Director of Medical Department|91 375 62 30|departamento.medico@rovi.es|
22387686|NCT00692185|New York State Psychiatric Institute|Evelyn Attia, MD|212-543-5923|ea12@columbia.edu|
22387687|NCT00989196|Octapharma AG|Dr. Sigurd Knaub|+41 554512141|sigurd.knaub@octapharma.com|
22387688|NCT02788019|UT Southwestern Medical Center|Anthony Machi, MD, Assistant Professor|214-648-6400|Anthony.Machi@UTSouthwestern.edu|
22387689|NCT04300023|University of Wisconsin - Madison|Kristen Pickett, PhD|(608) 890-2103|Kristen.pickett@wisc.edu|
22387690|NCT05251363|BIOTRONIK, Inc.|Crystal Miller|(503) 475-4984|crystal.miller@biotronik.com|
22387691|NCT03070392|Immunocore, Ltd|Study Director|1-844-IMMUNO-1|clinicaltrials@immunocore.com|
22387692|NCT02972034|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22387693|NCT03861052|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22387694|NCT03009344|Eisai Co., Ltd.|Inquiry Service||eisai-chiken_hotline@hhc.eisai.co.jp|
22387695|NCT03678688|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22387696|NCT02794428|Vanderbilt-Ingram Cancer Center|Douglas Morgan|615-936-7423|drmorgan@uabmc.edu|
22387697|NCT03560323|University of Texas Health -San Antonio|Yuejuan Qin, Assistant Professor|210-358-7200|qiny@uthscsa.edu|
22387698|NCT02534233|Johns Hopkins Hospital|Dr Marcia Canto, Director of Clinical Research|443-287-8083|mcanto1@jhmi.edu|
22387699|NCT02271906|UT MD Anderson Cancer Center|George Simon, MD|713-792-7734|GSimon@mdanderson.org|
22387700|NCT03136159|Loyola University Medical Center|Dr Jean Goodman|7082165459|Jrgoodman@lumc.edu|
22387701|NCT03823703|Corcept Therapeutics Incorporated|Medical Director|650-327-3270|info@corcept.com|
22387702|NCT00799409|Ortho-McNeil Janssen Scientific Affairs, LLC|VP Medical Affairs, CNS|609-730-2136||
22387703|NCT04323800|The Johns Hopkins University School of Medicine|Shmuel Shoham|410-614-6431|sshoham1@jhmi.edu|
22387704|NCT00489554|GlaxoSmithKline|GSK Response Center|866-435-7343||
22387705|NCT01732757|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22387706|NCT00925548|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22387707|NCT02949297|Endologix, LLC|Manager, Clinical Affairs|864-270-8524|nsmith@endologix.com|
22387708|NCT00731692|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22387709|NCT00458783|Cleveland Clinic|Andra Duncan, MD|216-445-2372|duncana@ccf.org|
22401043|NCT02388776|Weill Cornell Medicine|Christine Lennon, M.D.|212-746-2621|chl9083@med.cornell.edu|
22401044|NCT01754688|Minnesota Medical Research Foundation and University of Minnesota|Tina M. Slusher, MD|612-624-4586|tslusher@umn.edu|
22414228|NCT02557035|Helsinn Healthcare SA|Daniel Voisin|+41 91 985 2121|daniel.voisin@helsinn.com|
22387710|NCT01737398|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
22401045|NCT02796144|University of North Carolina at Chapel Hill|Lars Fredrik Jarskog, MD|919-843-7683|lars_jarskog@med.unc.edu|
22401046|NCT01889810|Queen's University, Belfast|Professor Michelle McKinley|02890978936|m.mckinley@qub.ac.uk|
22401047|NCT06105138|Colorado State University|Dr. Hollis Karoly|970-491-3677|hollis.karoly@colostate.edu|
22401048|NCT00780403|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22401049|NCT00845429|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22401050|NCT01476787|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22401051|NCT00938548|Department of Anaesthesiology and Pain Medicine and Anaesthesia and Pain Research Institute, Department of surgery, Yonsei University College of Medicine|Dr. So Yeon Kim|82-2-2227-3642|kimsy326@hanmail.net|
22401052|NCT03872427|The University of Texas MD Anderson Cancer Center|Dr. Funda Meric-Bernstam|(713) 794-1226|fmeric@mdanderson.org|
22401053|NCT02234622|Roudebush VA Medical Center|Louanne Davis Psy.D.|317-710-1338|louannedavis52@gmail.com|
22401054|NCT00144300|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22401055|NCT01650805|ARIAD Pharmaceuticals, Inc.|Maureen Conlan, Senior Medical Director|1-617-621-2316|Maureen.Conlan@ariad.com|
22401056|NCT02403206|Alcon, A Novartis Division|Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22401057|NCT02628223|Temple University Hospital|Dr. Jeffrey Henderer|267-418-9126|Jeffrey.Henderer@tuhs.temple.edu|
22401058|NCT04070378|The Feinstein Institutes for Medical Research|Marc L Gordon, MD|(516) 562-3492|mlgordon@northwell.edu|
22401059|NCT02462889|Ophthalmic Consultants of Boston|Jeffrey S. Heier, MD|617-314-2694|jsheier@eyeboston.com|
22401060|NCT01497171|Mayo Clinic|Dr. Emanuel C. Trabuco|507-284-7519|trabuco.emanuel@mayo.edu|
22401061|NCT04636177|Stanford University School of Medicine|Laura E Simons|(650) 736-0838|lesimons@stanford.edu|
22401062|NCT04067661|University of Michigan|Kristi Gamarel|7346473178|kgamarel@umich.edu|
22401063|NCT07215806|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22401064|NCT03590457|Rush University|Dr. Brady Scott|3129426389|jonathan_b_scott@rush.edu|
22401065|NCT03412630|ECOG-ACRIN Statistical Office|Study Statistician|4018639181|ecog-acrin@stat.brown.edu|
22401066|NCT05165394|Neurocrine Biosciences|Neurocrine Medical Information Call Center|877-641-3461|medinfo@neurocrine.com|
22401067|NCT03705494|The University of Hong Kong|Dr Kris LOK|39176690|krislok@hku.hk|
22401068|NCT02495077|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22401069|NCT02742649|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22387711|NCT02372799|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
22387712|NCT00089609|National Cancer Institute, National Institutes of Health|Ravi Madan, M.D.|301-480-7168|rm480i@nih.gov|
22387713|NCT00747006|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
22387714|NCT00357994|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22387715|NCT01767688|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22387716|NCT00686257|Tufts Medical Center|Nicholas Hill MD|617-636-4288|nhill@tuftsmedicalcenter.org|
22387717|NCT02132949|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22387718|NCT01655563|Hospital for Sick Children|Dr. Seema Mital|416-813-7418|seema.mital@sickkids.ca|207418
22387719|NCT01354444|Johns Hopkins University|Paul Rosenberg, MD|410-550-9883|prosenb9@jhmi.edu|
22387720|NCT00982072|Imperial College NHS Trust|Dr Megan Griffith|02033137309|m.e.griffith@imperial.ac.uk|
22387721|NCT00745875|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22387722|NCT03559205|Keele University|Jonathan Hill|01782 733900|j.hill@keele.ac.uk|
22387723|NCT01833455|University of Wisconsin|Stephen Wasmund, PhD|801-587-3740|stephen.wasmund@carma.utah.edu|
22387724|NCT01600482|Vasorum Ltd|Dr James Coleman|00 353 1 4035460|jcoleman@vasorum.ie|
22387725|NCT03689946|Cedars-Sinai Medical Center|Daniel Berman|310-423-4224|daniel.berman@cshs.org|
22387726|NCT01335867|University of Pennsylvania Treatment Research Center|Kyle M. Kampman, M.D.|215 746 2764|kampman@pennmedicine.upenn.edu|
22387727|NCT00748982|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22387728|NCT02203799|Baylor College of Medicine|Carla M. Davis, MD|832-824-1319|carlad@bcm.edu|
22387729|NCT02168309|Central Coast Perinatology|Kathryn Sharma|8058980258|katy.jones@gmail.com|
22387730|NCT02384382|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22387731|NCT01953692|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22387732|NCT00176202|University of Illinois at Chicago|Dr Mani Pavuluri|3124130064|mpavuluri@psych.uic.edu|
22387733|NCT00731614|San Francisco VA Medical Center|John R. McQuaid, Ph.D.|415-221-4810|john.mcquaid@va.gov|4106
22387734|NCT05313412|CooperVision|Jose A. Vega, OD, MSc, FAAO|925-621-3761|JVega2@coopervision.com|
22387735|NCT01822756|Incyte Corporation|Study Director|1-855-463-3463||
22387736|NCT01065779|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22387737|NCT02157948|Amgen Inc.|Study Director|866-572-6436||
22387738|NCT01801007|MicroVention, Inc., A TERUMO Group Company|Senior Manager, Clinical Quality Compliance and Clinical Operations|714-247-8000|jennifer.jelf@microvention.com|
22387739|NCT02743819|University of Chicago|Daniel Olson, Clinical Instructor|773-834-4183|daniel.olson2@uchospitals.edu|
22387740|NCT01683409|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22387741|NCT05350501|Enterome|Dr Jan Fagerberg|+33175772785|info@enterome.com|
22387742|NCT04816955|Bournemouth University|Dr Katherine Appleton|01202965985|k.appleton@bournemouth.ac.uk|
22387743|NCT00553332|The Ohio State University Comprehensive Cancer Center-James Cancer Hospital and Solove Research Institute|Tanios Bekaii-Saab, MD|614-293-9863|Tanios.Bekaii-Saab@osumc.edu|
22387744|NCT04119063|Northern Arizona University|Zach Lerner, Associate Professor|928-523-1787|Zachary.Lerner@nau.edu|
22387745|NCT03637296|New York State Psychiatric Institute|Thomas Smith, MD|(646)774-8442|thomas.smith@nyspi.columbia.edu|
22387746|NCT04960813|Columbia University|Kate D. Fitzgerald|646-774-5681|kf2688@cumc.columbia.edu|
22387747|NCT01536366|BIAL - Portela & Cª, S.A.|Head of Clinical Research|+351 22 9866100|jose.rocha@bial.com|
22387748|NCT00145470|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22387749|NCT02063659|Lexicon Pharmaceuticals, Inc.|Pablo Lapuerta, MD||plapuerta@lexpharma.com|
22387750|NCT04762277|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22387751|NCT02556918|Emory University|Dr. Guillermo Umpierrez|404-778-1665|GEUMPIE@emory.edu|
22387752|NCT00768716|Washington State University|Dr Michael H. Court|5093350817|michael.court@wsu.edu|
22387753|NCT06134089|University of Utah|Andy King|801-646-4274|andy.king@utah.edu|
22387754|NCT05643885|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22387755|NCT03954106|Jazz Pharmaceuticals|Director, Clinical Trial Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
22387756|NCT04511702|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22387757|NCT05349721|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22387758|NCT06006455|Erchonia Corporation|Clinical Affairs Manager|8882420571|tsammons@erchonia.com|
22387759|NCT00108355|VA-CT Healthcare System|Guadalupe Garcia-Tsao|203-932-5711|guadalupe.garcia-tsao@yale.edu|2210
22401070|NCT03937986|University of Kentucky|William W. Stoops|859-257-5388|william.stoops@uky.edu|
22401071|NCT02839746|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22387760|NCT01583166|UMass Worcester|Michael Flynn, MD|508-334-9840|michael.flynn@umassmemorial.org|
22387761|NCT03150875|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+86 13382419112|jessica.yi@innoventbio.com|
22387762|NCT04652869|University of Pittsburgh|Dr. Cynthia Conklin|4125869840|conkca@upmc.edu|
22387763|NCT01372085|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22387764|NCT00562094|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com|
22387765|NCT03960645|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22387766|NCT03903692|Medline Industries, LP|Julie Miller|630-418-6891|jamiller@medline.com|
22387767|NCT00790699|Texas Diabetes & Endocrinology|Thomas Blevins,MD|5812.334.3505|blevins@texasdiabetes.com|
22387768|NCT03732807|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22387769|NCT03345979|Alkermes, Inc|Eva Stroynowski|7816097000|eva.stroynowski@alkermes.com|
22387770|NCT04689932|Rockwell Medical|Raymond D Pratt, MD|2489609009|rpratt@rockwellmed.com|
22387771|NCT00734578|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22387772|NCT00999596|Philips Healthcare|Sarah Baxter or Linda Jalbert|425-487-7665 / 978-659-7434|sarah.baxter@philips.com, linda.jalbert@philips.com|
22387773|NCT03883724|UPittsburgh|Shachi Tyagi|4126471274|sht55@pitt.edu|
22387774|NCT02486939|Coherus BioSciences, Inc|Barbara K. Finck, MD Chief Medical Officer|650-649-3529|Bfinck@coherus.com|
22387775|NCT02304757|Tenth People's Hospital of Tongji University|Chao Ma|02125078593|mc_7419@hotmail.com|86
22387776|NCT03389802|PediatricBTC|Catherine Billups|901-595-3370|catherine.billups@stjude.org|
22387777|NCT02426138|University of North Carolina at Chapel Hill|Dr. Seth A. Berkowitz|919-966-2276|seth__berkowitz@med.unc.edu|
22387778|NCT04677738|Morinaga Milk Industry Co., Ltd.|Director of Clinical Trials|+81-46-252-3067|izen-ri138@morinagamilk.co.jp|
22387779|NCT00003459|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22387780|NCT02502461|Dept. of Anesthesia, University of Saskatchewan|Dr. William P. McKay|306 655 1202|bill.mckay@usask.ca|
22387781|NCT03340415|CUHK|Dr Samuel Ling|35052010|samuel-kk-ling@alumni.cuhk.net|
22387782|NCT00467272|University of Texas (UT) MD Anderson Cancer Center|Issam Raad, MD / Chair, Infectious Diseases|713-792-7943|iraad@mdanderson.org|
22387783|NCT00914966|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22387784|NCT01701401|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22387785|NCT03975400|northwell|Michael Birnbaum|718-470-8305|mbirnbaum@northwell.edu|
22387786|NCT02409680|RTI International|Elizabeth McClure|919-316-3773|mcclure@rti.org|
22387787|NCT04827732|Washington University School of Medicine|Dr. Michael Waters|314-747-7236|m.r.waters@wustl.edu|
22387788|NCT05366751|Sage Therapeutics|Carrie Vaudreuil|+1-857-259-4766|carrie.vaudreuil@sagerx.com|
22387789|NCT05785832|Tandem Diabetes Care|Sr. Supervisor of Clinical Operations|18583666900|clinicalaffairs@tandemdiabetes.com|
22387790|NCT02921555|Grupo Español de Trabajo en Enfermedad de Crohn y colitis Ulcerosa|Dr. Eugeni Domènech|635899553|soporte@geteccu.org|
22387791|NCT01690624|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22387792|NCT05885763|CSL Vifor|Milica Enoiu|+41 58 851 82 64|milica.enoiu@viforpharma.com|
22387793|NCT05986617|University of Iowa|Victoria Tappa|3193846136|victoria-tappa@uiowa.edu|
22387794|NCT02842749|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22387795|NCT05293717|University of Rochester|Anna De Benedetto, MD|(585) 275-7546|anna_debenedetto@urmc.rochester.edu|
22387796|NCT05246709|Columbia University|Seon Mi Jeong|646-317-5238|smj9007@nyp.org|
22387797|NCT04202133|University of Pennsylvanai|Dr. Ariana Chao|215-746-7183|arichao@upenn.edu|
22387798|NCT05395351|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22387799|NCT03377049|UW School of Medicine and Public Health|Azam Ahmed, MD, FAANS, FACS|608-263-0485|azam.ahmed@neurosurgery.wisc.edu|
22387800|NCT00568087|Minneapolis VA Health Care System|Gihyun Yoon, MD|612-467-3996|Gihyun.Yoon@va.gov|
22387801|NCT02489357|Johns Hopkins University/Sidney Kimmel Cancer Center|Emmanuel Antonarakis, MD|410-502-7528|eantona1@jhmi.edu|
22387802|NCT04693637|AlloVir, Inc|Michelle Matzko, MD, PhD|617-433-2605|mmatzko@allovir.com|
22387803|NCT03052517|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22387804|NCT00546156|Dana-Farber Cancer Institute|Dr Ian Krop|617-632-2335|ian.krop@dfci.harvard.edu|
22387805|NCT04885998|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22387806|NCT04263714|McMaster University|Dr. Stuart Phillips|9055259140|phillis@mcmaster.ca|24465
22387807|NCT05260437|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22387808|NCT00910962|GlaxoSmithKline|GSK Response Center|866-435-7343||
22387809|NCT00195819|Abbott|Global Medical Services|800-633-9110||
22387810|NCT00787176|Northwerstern University|Paloma Toledo|312-472-3585|p-toledo@northwestern.edu|
22387811|NCT01124045|Alcon Research, Ltd.|Pam Kaur, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
22387812|NCT05794191|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22451289|NCT04160260|Paratek Pharmaceuticals, Inc.|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
22451290|NCT01227512|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22401072|NCT02333331|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
22387813|NCT00884806|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
22387814|NCT03298087|West LA VAMC|Nathanael Kane|3104783711|nathanael.kane@va.gov|46735
22387815|NCT01079806|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email|Clinical.Trials@bms.com|
22387816|NCT02124304|Sport & Spine Rehab Clinical Research Foundation|Jena Slaski|301-251-2777|jslaski@ssrehab.com|838
22401073|NCT01494038|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22451291|NCT04409041|Washington University|Dr. Caroline Mann|(314) 996-8010|cmann@wustl.edu|
22451292|NCT01978184|UPMC Hillman Cancer Center|Barbara Stadterman|412-647-5554|stadtermanbm@upmc.edu|
22451293|NCT00236938|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|844
22451294|NCT02460198|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22451295|NCT01815671|Specialists in Gastroenterology, LLC|Leonard Weinstock, MD|314-997-0554|lw@gidoctor.net|102
22451296|NCT01069289|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22451297|NCT00965848|Medical Affairs, Janssen-Cilag Ltd.,Thailand|Medical Affairs Director|662-792-7200||
22451298|NCT00691210|Columbia University Medical Center|Owen A. O'Connor, MD, Ph.D.|212-326-5720|oo2130@cumc.columbia.edu|
22451299|NCT02707640|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22451300|NCT02517905|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
22451301|NCT00023452|CDC|Dr Elsa Villarino|404-639-5340|mev1@cdc.gov|
22451302|NCT05789875|UCSF|Dr. Parya Saberi|415-502-1000|parya.saberi@ucsf.edu|17171
22451303|NCT01994395|Rehabilitation Institute of Chicago|Arun Jayaraman, PT, PhD; Director of Max Nader Lab for Rehabilitation Technologies and Outcomes|3122386875|ajayaraman@ricres.org|
22451304|NCT02287415|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22451305|NCT04551105|Virginia Tech|Study Director of Clinical Trials|+1 (301) 820-5225|dcben0@gmail.com|
22451306|NCT01693601|Icahn School of Medicine at Mount Sinai|John Mascarenhas|212-241-3417|john.mascarenhas@mssm.edu|
22451307|NCT00459134|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
22451308|NCT02770391|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Moshe Ornstein,|18662238100|taussigresearch@ccf.org|
22451309|NCT03333486|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
22401074|NCT00537940|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22401075|NCT04260607|Naval Medical Center Camp Lejeune|Naval Medical Center Camp Lejeune|317-691-1718|nathan.butler@usmc.mil|
22401076|NCT00623012|Yale University|Dr. Stuart Seropian|203-737-2477|Stuart.Seropian@yale.edu|
22401077|NCT03952546|Northwell Health System|Nancy Dengler, RN, MS Clinical Research Nurse|516-496-2637|ndengler@northwell.edu|
22401078|NCT00416351|Memorial Sloan Kettering Cancer Center|Dr. Steven Horowitz MD|646-608-2680|horwitzs@mskcc.org|
22401079|NCT02138110|InVivo Therapeutics Corporation|Dr. Rich Toselli|(617) 863-5540|rtoselli@invivotherapeutics.com|
22401080|NCT00430781|GlaxoSmithKline|GSK Response Center|866-435-7343||
22401081|NCT00844298|Asan Medical Center, University of Ulsan College of Medicine|Dr. Dae-Young Kim|82230105930|dani@amc.seoul.kr|
22401082|NCT02158533|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
22401083|NCT03851744|USARIEM|Dr. Lee Margolis|508-206-2335|lee.m.margolis.civ@mail.mil|
22401084|NCT01475955|DUSA Pharmaceuticals, Inc|Manager of Clinical Studies||houlihana@dusapharma.com|
22401085|NCT01518530|Hillel Yaffe Medical Center|Dr. Yaron River|972-523-756-446|yaronr@hy.health.gov.il|
22401086|NCT01389128|University of São Paulo|Dr. Silvana Maria Quintana|+55(16)36022813|quintana@fmrp.usp.br|
22451310|NCT03995758|Indiana University School of Medicine|Dr. Marcelino Rivera|3179622485|maeriver@iu.edu|
22451311|NCT02276495|UC Irvine Health Department of Anesthesiology & Perioperative Care|Dr. Joseph Rinehart|714-456-7415|jrinehar@hs.uci.edu|
22451312|NCT01755416|Children's Hospital at Montefiore|Dr. Rubina Heptulla|718-920-7004|rheptull@montefiore.org|
22451313|NCT04176796|Carnegie Mellon University|Gretchen Chapman|412-268-3665|gchapman@andrew.cmu.edu|
22451314|NCT03704376|The University of Texas Health Science Center at Houston|Lane Bailey, PhD, PT|713-704-6794|lane.bailey@uth.tmc.edu|
22451315|NCT03047447|Bristlecone Health, Inc,|Dr. Kelly Gibas, Director or Clinical Trials|(763) 424-2474|kgibas@bristleconefitness.com|
22451316|NCT02805257|University of California, San Francisco|Ying Han, MD, PhD|415-476-3321|ying.han@ucsf.edu|
22451317|NCT00612066|University of California, Los Angeles|Anthony Heaney, M.D. Ph.D|310 267 4980|aheaney@mednet.ucla.edu|
22451318|NCT01946711|Pari Pharma|Friedrich gruber|+4989742846|friedrich.gruber@pari.com|76
22451319|NCT02669329|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|Kerrie.Jiang@allergan.com|
22451320|NCT01043874|Novartis Pharmaceuticals|Study Director|862-778-8300||
22451321|NCT01627249|Jaeb Center for Health Research|Adam Glassman|813-975-8690|drcrstat2@jaeb.org|
22451322|NCT03266588|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
22451323|NCT00736242|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22451324|NCT02487563|Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University|Yaqiong Tang|+86 18896588075|tangyaqiong@suda.edu.cn|
22451325|NCT00071487|GlaxoSmithKline|GSK Response Center|866-435-7343||
22451326|NCT01176591|UPenn|Dr. Jennifer Plebani|215-222-3200|jplebani@upenn.edu|152
22451327|NCT02696850|WashingtonU|Dr. Jay F. Piccirillo, Principal Investigator|(314) 362-8641|piccirij@wustl.edu|
22451328|NCT03041415|Stanford University|Principal Investigator|6507235082|king@stanford.edu|
22451329|NCT02044510|Lawson Research Institute|Mary McKibbon|5196466367|mary.mckibbon@sjhc.london.on.ca|
22451330|NCT03226067|Calliditas Therapeutics|Richard Philipson, MD Chief Medical Officer|Desk: +46 556659-9766|richard.philipson@calliditas.com|
22451331|NCT00875394|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22451332|NCT01933334|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22401087|NCT00756002|Takeda Global Research & Development Center, Inc.|Sr VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22451333|NCT02039505|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22451334|NCT01722331|Sun Pharma Advanced Research Company Limited|Head-Clinical Development|912266455645|clinical.trials@sparcmail.com|
22401088|NCT01451515|St. Jude Children's Research Hospital|Hiroto Inaba, MD, PhD|(901) 595-3144|hiroto.inaba@stjude.org|
22401089|NCT03163342|Altimmune|Stephanie Holland, Clinical Project Manager|240|Sholland@altimmune.com|40
22401090|NCT00290472|University of Chicago Comprehensive Cancer Center|Dr. Sonali M. Smith|7738342895|smsmith@medicine.bsd.uchicago.edu|
22401091|NCT04329923|UPenn|Amelia Anderson|215-509-5690|amelia.anderson@pennmedicine.upenn.edu|
22401092|NCT01272180|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
22451335|NCT00693992|University of Pittsburgh|Mark A. Socinski, M.D.||socinskima@upmc.edu|
22451336|NCT04265755|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22451337|NCT01531959|Beth Israel Deaconess Medical Center|Matthias Eikermann|6176327034|meikerma@bidmc.harvard.edu|
22451338|NCT04067141|CooperVision, Inc.|Jose A. Vega, O.D., MSC., FAAO|9256213761|javega@coopervision.com|
22451339|NCT01219738|University of Miami|Eliana Mendes|(305) 243-2568|e.mendes@miami.edu|
22451340|NCT02639884|Masimo Corporation|Vikram Ramakanth|9492977416|vramakanth@masimo.com|
22451341|NCT02013765|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22451342|NCT02832674|ThermiGen LLC|Toni Fournier, Sr. VP New Products|214-888-0634|TFournier@Thermi.com|
22451343|NCT02822794|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22451344|NCT04788147|RefleXion|Debradenise Brooks|16504828435|dbrooks@reflexion.com|
22451345|NCT02266381|The First Affiliated Hospital of Guangzhou Medical University|Dr. Guohua Zeng|0086-20-34294163|gzgyzgh@vip.sina.com|
22451346|NCT05101252|Johnson & Johnson Vision Care, Inc. (JJVC)|Thomas R. Karkkainen, OD, MS, FAAO|(904)254-0152|TKarkkai@its.jnj.com|
22451347|NCT01504438|Duke University|James Nunley II, M.D.|919-684-4033|james.nunley@duke.edu|
22451348|NCT02737566|The University of Oklahoma Health Sciences Center|Dr. Darla Kendzor|(405) 271-8001|Darla-Kendzor@ouhsc.edu|50478
22451349|NCT02181231|Washington University School of Medicine|Dr. Eric Lenze|314-362-1671|lenzee@wustl.edu|
22451350|NCT02520531|Stryker|Britta von den Brincken, Clinical Study Manager|+491638999202|britta.vondenbrincken@stryker.com|
22451351|NCT01159067|City of Hope National Medical Center|Dr. Vinod Pullarkat|626-256-4673|vpullarkat@coh.org|82405
22451352|NCT03282955|B. Braun Melsungen|Study Manager|05661/71|studies@bbraun.com|0
22401093|NCT03695276|UCSF|Rachel Willard-Grace|415-476-5248|Rachel.Willard@ucsf.edu|
22401094|NCT01702805|Emeritus Professor U Pennsylvania at CHOP and Emeritus Professor McMaster University, Dept Pediatrics|Haresh Kirpalani|267-844-3233|kirpalan@mcmaster.ca|
22401095|NCT03056287|Medical University of South Carolina|Chris Gregory|8437921078|gregoryc@musc.edu|
22401096|NCT00981435|Stanford University|Clinical Research Coordinator|6507236995|mnunez1@stanford.edu|
22401097|NCT00609271|Tulane University|Dr. Lydia Bazzano|5049887323|lbazzano@tulane.edu|
22401098|NCT02439775|Medtronic|Elishea Argent, Sr. Clinical Research Specialist|(763)505-9584|elishea.n.argent@medtronic.com|
22401099|NCT01588197|Medical University of South Carolina|Dr. Jeffrey J. Borckardt|8437923295|borckard@musc.edu|
22401100|NCT03968965|Hospital for Special Surgery|Celeste Abjornson|2127742126|AbjornsonC@HSS.edu|
22401101|NCT01120639|Stanford University|Dr. Scott Soltys (Associate Professor of Radiation Oncology)|650-724-1569|sgsoltys@stanford.edu|
22401102|NCT01844076|Fox Chase Cancer Center|Crystal Denlinger MD, FACP|215-214-1676|Crystal.Denlinger@fccc.edu|
22451353|NCT01129141|NCRAR, VA RR&D|James A. Henry, Ph.D.|503.220.8262|james.henry@va.gov|57466
22451354|NCT00495716|University of Washington Virology Research Clinic|Clinic Director|206-520-4340|vrc@uw.edu|
22451355|NCT02076412|Rigel|Anne-Marie Duliege, MD|6506241100|clinicaltrials@rigel.com|6506241100
22451356|NCT00958880|Southern Methodist University|Jasper Smits, Ph.D.|214-768-4310|jsmits@smu.edu|
22451357|NCT00955266|Brigham & Women's Hospital|Michael Nurok|617-899-5961|mnurok@gmail.com|
22451358|NCT02316717|Immuron|Neta Tobis, Clinical Director|+972549277334|neta@immuron.com|2549277334
22451359|NCT00298831|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22451360|NCT01516879|Amgen Inc.|Study Director|866-572-6436||
22451361|NCT04568122|Stanford University BioEngineering|Manu Prakash, PhD|(650) 725-3731|manup@stanford.edu|
22451362|NCT01613339|Orebro county council|Dr. Anette Forsberg|+46-19-602 5788|anette.forsberg@orebroll.se|
22451363|NCT01228929|University of Rochester|Dr. James V. Aquavella|585-275-8944|james_aquavella@urmc.rochester.edu|
22451364|NCT02460224|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22451365|NCT01916304|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22451366|NCT04150224|Nearmedic Plus|Viсtoria Shcherbakova|+7 (495) 741 49 89|Viktoriya.Shcherbakova@nearmedic.ru|3869
22451367|NCT02774681|Northwestern University|Massimo Cristofanilli, MD|312-503-5488|Massimo.cristofanilli@nm.org|
22451368|NCT03837496|Massachusetts General Hospital|Jamie Jacobs, PhD|617-643-1777|jjacobs@mgh.harvard.edu|
22451369|NCT01394926|GE Healthcare|Paul Sherwin, M.D.|1-609-514-6820|Paulsherwin@ge.com|
22451370|NCT01974050|Columbia University|Melissa S. Stockwell|212-342-5732|mss2112@cumc.columbia.edu|
22451371|NCT03146650|Northwestern University, Feinberg School of Medicine|Young Kwang Chae, MD, MPH, MBA|312-926-4248|YCHAE@nm.org|
22451372|NCT00931307|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22451373|NCT04666441|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22451374|NCT00813761|Vistakon|Kristy Canavan, OD|1-904-443-1474|kcanava2@its.jnj.com|
22451375|NCT01443442|SCCO at MBKU|Jerry R. Paugh, OD, PhD|714-449-7487|jpaugh@ketchum.edu|
22451376|NCT01130740|Center for Health Services Reserach in Primary Care, Durham VAMC|Kelli D. Allen, PhD|919-286-0411|kelli.allen@va.gov|7090
22451377|NCT02047604|Valeant Pharmaceuticals|VP Clinical Services|9089271162|christine.hnatko@valeant.com|
22451378|NCT00983814|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
22451379|NCT01181895|GlaxoSmithKline|GSK Response Center|866-435-7343||
22414229|NCT00834132|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414230|NCT03415308|Duke Center for Research to Advance Healthcare Equity|Alesha Majors|919-660-7545|alesha.majors@duke.edu|
22414231|NCT00835484|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414232|NCT01471353|University of Florida|Dr. Thomas J. George, Jr.|352-273-8008|thom.george@medicine.ufl.edu|
22414233|NCT04383587|Mayo Clinic|Mark A. Parkulo, MD|9049532000|parkulo.mark@mayo.edu|
22387817|NCT04228952|Masonic Cancer Center|Susan Murphy, PhD|612-624-7633|murph062@umn.edu|
22387818|NCT00843050|Piramal Healthcare Limited|Dr. Alan Hatfield|02230275000|alan.hatfield@piramal.com|5002
22387819|NCT03739866|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22387820|NCT00836498|Merck Sharp & Dohme Corp|Vice President of Late Stage Development||ClinicalTrialsDisclosure@merck.com|
22387821|NCT01034306|Can-Fite Biopharma|Pnina Fishman, PhD|011972 39241114|pnina@canfite.co.il|
22387822|NCT03057600|Calithera Biosciences, Inc|Study Director|650-870-1000|clinicaltrials@calithera.com|
22387823|NCT02091752|Novartis|Study Director|862-778-8300||
22387824|NCT01708278|University of Michigan|Fernando Martinez|(734) 763-2540|fmartine@umich.edu|
22387825|NCT01604824|Regeneron Pharmaceuticals|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
22387826|NCT02630966|Takeda|Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
22387827|NCT03758742|University of Alabama at Birmingham|Dr. Courtney M. Peterson|205-934-0122|cpeterso@uab.edu|
22387828|NCT03617835|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22387829|NCT04111510|Yale School of Medicine|Michael Hurwitz, MD, PhD|(877) 925-3637|michael.hurwitz@yale.edu|
22387830|NCT02422524|Duke University|Julius Wilder, MD, PhD|919-668-3063|julius.wilder@duke.edu|
22387831|NCT04205903|The Ohio State University Comprehensive Cancer Center|Dr. Nicole Williams|(614) 293-0066|Nicole.Williams@osumc.edu|
22387832|NCT00544115|City of Hope|Dr. Monzr Al Malki, MD|626359811|malmalki@coh.org|
22387833|NCT03395080|Leap Therapeutics, Inc.|Cynthia Sirard, MD, Chief Medical Officer|+1-617-714-0360|csirard@leaptx.com|
22387834|NCT04233567|The Ohio State University Comprehensive Cancer Center|Dr. Sameek Roychowdhury|614-685-5842|Sameek.Roychowdhury@osumc.edu|
22387835|NCT02060487|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22387836|NCT03387189|HealthPartners|Kamalini Das|651-293-8233|Kamalini.X.Das@HealthPartners.Com|
22387837|NCT03697603|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22387838|NCT04218864|Women & Infants Hospital|Dr. Caron Zlotnick|4014743332|czlotnick@butler.org|
22387839|NCT03683030|Biosense Webster, Inc.|Senior Director Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22387840|NCT04502472|Inova Health Systems|Anne Whitney Brown, MD|7037763067|anne.brown@inova.org|
22387841|NCT02222493|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22387842|NCT03132298|Stony Brook University|Jessica Schleider|631-632-4131|jessica.schleider@stonybrook.edu|
22387843|NCT00933270|Abbott Vascular|Margo Zaugg|408-845-0576|margo.zaugg@av.abbott.com|
22387844|NCT02542943|GlaxoSmithKline|GSK Response Center|866-435-7343||
22387845|NCT02734355|Research Institute for Complex Problems of Cardiovascular Diseases, Russia|Dr. Sergey Mamchur|+73842643308|reception@kemcardio.ru|
22387846|NCT05824559|MEI Pharma|Richard Ghalie, MD CMO|619 990-1153|rghalie@meipharma.com|
22387847|NCT04728711|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
22387848|NCT03110575|Tonix Pharmaceuticals|Gregory Sullivan, MD|862-904-0355|greg.sullivan@tonixpharma.com|
22387849|NCT04701203|Ascendis Pharma, Inc.|Aimee D. Shu, MD|+1 650 352 8389|ADS@ascendispharma.com|
22387850|NCT01804166|Janssen Scientific Affairs, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22387851|NCT05001139|Relife Srl|Prof. Giuseppe Micali|05556809528|lfabbri@relifecompany.it|
22387852|NCT01563185|Horizon Pharma|Julie Ball, Senior Director of Clinical Development & Operations|224-383-3059|jball@horizonpharma.com|
22387853|NCT04577651|Boston Scientific Corporation|Sr. Director, Clinical Operations|855-213-9890|BSNClinicalTrials@bsci.com|
22387854|NCT03427463|Medical University of South Carolina|Katherine Hatter, M.D.|(843) 792-5454|herbertk@musc.edu|
22387855|NCT00647387|Abbott Structural Heart|Ryan Palmer, Director of Clinical Programs|+1 651-202-8362|ryan.palmer@abbott.com|
22387856|NCT03147287|Dana-Farber Cancer Institute|Project Manager|617-632-3800|ctopm@dfci.harvard.edu|
22387857|NCT00302211|Actelion Pharmaceuticals US, Inc.|Gary Palmer SVP, US Medical Affairs|650-624-6900||
22387858|NCT03137459|Yale School of Medicine|Dr. Terri Fried|203-932-5711|terri.fried@yale.edu|5412
22387859|NCT06571695|Loyola University Medical Center|Dr. Dane H. Salazar|773-562-0456|dsalazar@lumc.edu|
22387860|NCT04921358|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
22387861|NCT02278796|Inselspital University Hospital Bern|Thomas Pabst, Prof Dr. med|+41 31 632 84 30|thomas.pabst@insel.ch|
22387862|NCT04926857|Medtronic|Nirav Patel|1 (800) 633-8766|nirav.a.patel@medtronic.com|
22414234|NCT03123094|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22414235|NCT01909713|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5130|elizabeth.nieman@galderma.com|
22414236|NCT04859517|INVIVYD, Inc.|Study Inquiry|17818190080|ClinicalTrials@invivyd.com|
22414237|NCT04238754|Johns Hopkins Univeristy|Cecilia Bergeria|410-550-1979|cberge21@jhmi.edu|
22414238|NCT03517085|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
22451380|NCT00555438|CHU SAINT-ETIENNE|Pr patrick MISMETTI|33(1)477127788|patrick.mismetti@chu-st-etienne.fr|
22451381|NCT00766415|AstraZeneca|Alison Holt||ClinicalTrialTransparency@astrazeneca.com|
22451382|NCT01114516|Northwestern University Feinberg School of Medicine|Dr. Emily Miller|3124724685|emily-miller-1@northwestern.edu|
22387863|NCT03774849|Candela|Dr. Konika Patel Schallen|5083580357|cie.studyinfo@candelamedical.com|
22414239|NCT01444378|Abbott Vascular|Robert McGreevy|408-845-3932|Robert.mcgreevy@abbott.com|
22414240|NCT00705666|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22414241|NCT00374231|University of Cincinnati|E. Steve Woodle, MD|(513) 558-6001|woodlees@uc.edu|
22414242|NCT02645409|Indiana University|Courtney Dhondt, Clinical Research Nurse|317-274-1791|cgerler@iu.edu|
22414243|NCT00741858|university of illinois at chicago|k.v. slavin|312-996-4842|kslavin@uic.edu|
22414244|NCT03552393|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22451383|NCT05419947|Instituto de Investigación Biomédica de Salamanca (IBSAL)|Dr. Luis Muñoz Bellvís|0034 923 29 11 00|luismb@usal.es|
22387864|NCT00670449|Novartis Pharmaceuticals|Study Director|862 778-8300||
22387865|NCT02637063|Oregon Center for Applied Science|Amelia J Birney (PI), Director of Research|541-342-7227|abirney@orcasinc.com|541
22387866|NCT00491400|Boston University|Joseph A. Vita, MD|617-638-8700|jvita@bu.edu|
22387867|NCT00597376|Rush University Medical Center|Raj C. Shah, MD|312-563-2902|Raj_C_Shah@rush.edu|
22387868|NCT01380145|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22387869|NCT02634307|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22387870|NCT02117310|The Ohio State University|Dr. Daniel Prevedello, Associate Professor|(614) 685-1965|daniel.prevedello@osumc.edu|
22387871|NCT01256359|University of Oxford|Professor Mark Middleton|+44 (0)1865 617331|mark.middleton@oncology.ox.ac.uk|
22387872|NCT01005615|Kennedy Krieger institute|Cristina Sadowsky|443-923-9232|sadowsky@kennedykrieger.org|
22387873|NCT01583868|Bausch Health|Study Director||robert.steffen@bausch.com|
22387874|NCT03737110|Kiniksa Pharmaceuticals (UK), Ltd. c/o Kiniksa Pharmaceuticals Corp.|Clinical Operations Study Director|1-781-431-9100|studyinfo@kiniksa.com|
22387875|NCT00639418|MedImmune LLC|Chris Ambrose|301-398-0000|ambrosec@medimmune.com|
22387876|NCT00599196|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22387877|NCT00252382|Sunesis Pharmaceuticals, Inc.|Mike Johnston, Senior Director Regulatory Affairs|(650) 266-3727|mjohnston@sunesis.com|
22387878|NCT01509183|Propeller Health|Research Team at Propeller Health|9545369563|leanne.kaye@propellerhealth.com|
22387879|NCT03783936|Hoosier Cancer Research Network|Fauzia Sharmin|(317) 921-2050|fsharmin@hoosiercancer.org|
22387880|NCT01009645|Northwestern University|Kenzie Cameron, PhD, MPH|312-503-3910|kcameron@northwestern.edu|
22387881|NCT01263132|Merck S.A. de C.V., Mexico, an affiliate of Merck KGaA, Darmstadt, Germany|Medical Responsible|+49-6151-72-5200|service@merckgroup.com|
22387882|NCT04237792|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22387883|NCT01218048|University of Pittsburgh Cancer Institute|Robert Ferris, MD, PhD|412-623-3205|ferrrl@upmc.edu|
22387884|NCT02788981|University of Chicago|Dr. Nan Chen|773-702-6149|nchen@bsd.uchicago.edu|
22387885|NCT05553366|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22387886|NCT00249769|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22451384|NCT01157533|The University of Texas (UT) MD Anderson Cancer Center|Ara Vaporciyan, MD, BS/ Professor||CR_Study_Registration@mdanderson.org|
22451385|NCT03136068|UCSF|Director of Clinical Trials|414-206-8715|abby.sokoloff@ucsf.edu|
22451386|NCT00432380|GlaxoSmithKline|GSK Response Center|866-435-7343||
22451387|NCT01071395|Rush University of Medical Center|Dr. Christopher G. Goetz|312-942-8016|cgoetz@rush.edu|
22451388|NCT04419493|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22451389|NCT00524134|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu|
22451390|NCT03794089|VA Center for Integrated Healthcare|Dr. Robyn L. Shepardson|315-425-4400|Robyn.Shepardson@va.gov|53956
22451391|NCT03985423|Sobi|Radmila Kanceva, MD|+4686972000|radmila.kanceva@sobi.com|
22387887|NCT01505166|Gradalis, Inc.|Director of Clinical Trials|2144428124|info@gradalisinc.com|
22387888|NCT03187678|Actelion Pharmaceuticals Ltd|clinical trial disclosure desk|0041615656565|clinical-trials-disclosure@its.jnj.com|
22387889|NCT02022657|Skaggs School of Pharmacy, University of Colorado Anschutz Medical Campus, Aurora|Dr. Peter Anderson|3037246821|peter.anderson@ucdenver.edu|
22387890|NCT03274076|University of Michigan|Dinesh Khanna|734-763-7182|khannad@med.umich.edu|
22387891|NCT01786876|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22387892|NCT00795184|Mauna Kea Technologies|Christophe Bailleul|+ 33 1 70 08 09 74|christopheb@maunakeatech.com|
22387893|NCT03781375|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22387894|NCT01629589|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22387895|NCT01530334|SPARC CONSULTING SRL|Claudio Iannacone|+39 0243119667|info@sparcconsulting.com|
22387896|NCT00797212|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
22387897|NCT01303510|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
22387898|NCT02079649|Alcon Research, Ltd.|Clinical Project Lead, Pharma, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
22387899|NCT02909959|University of North Carolina at Chapel Hill|Laura Politte, MD|919-350-1726|lpolitte@wakemed.org|
22387900|NCT03760913|OliPass Corporation|OliPass Call Center|82-2-6488-2200|clinicaltrials.inquiries@olipass.com|
22387901|NCT04278755|University of North Carolina at Chapel Hill|Jessica Baker, PhD|984-974-3929|jhbaker@med.unc.edu|
22387902|NCT01932970|Amgen Inc.|Study Director|866-572-6436||
22387903|NCT00822900|Emergency Neurosciences, Emergency Medicine, Emory University|David W. Wright, Associate Professor, Department of Emergency Medicine, Emory University|404-778-1709|david.wright@emory.edu|
22387904|NCT01968967|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22387905|NCT03489369|Symphogen AS|Medical Director|004545265050|info@symphogen.com|
22387906|NCT01868230|UMass Amherst|Dr. Lisa Chasan-Taber, Principal Investigator|4135451664|lct@umass.edu|
22414245|NCT00539110|Shriners Hospitals for Children|Michele Gottschlich PhD|513-872-6298|mgottschlich@shrinenet.org|
22414246|NCT05646251|Geisinger|Dr Pugazhendhi Vijayaraman|5708086020|pvijayaraman1@geisinger.edu|
22414247|NCT00465270|Abbott|Dr. Laura O'Brien||laura.obrien@abbott.com|
22414248|NCT02388191|Planned Parenthood League of Massachusetts|Principal Investigator|6176298603|jfortin@pplm.org|
22414249|NCT02530905|Sarepta Therapeutics, Inc.|Medical Director|1-800-690-2003|clinicaltrials@sarepta.com|
22414250|NCT01136174|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22414251|NCT02233985|Instituto Mexicano del Seguro Social|Dr. Gloria Patricia Sosa-Bustamante|01 52 4777174800|patriciasosab@hotmail.com|31828
22414252|NCT01249651|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22414253|NCT01581658|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22414254|NCT04322500|University of Molise|Prof. Ciro Costagliola|+39 0874 404861/ 0874 404896|ciro.costagliola@unimol.it|
22414255|NCT03873272|Columbia University Irving Medical Center|Melissa Accordino, MD|646-317-4692|mkg2134@cumc.columbia.edu|
22414256|NCT03761173|Inari Medical, Now Part of Stryker|Ashleigh Willson|925-330-3446|Ashleigh.Willson@Stryker.com|
22430782|NCT04204902|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22387907|NCT02022670|University of Colorado Boulder|Dr. Allison DeVan|303-735-6410|allison.devan@colorado.edu|
22387908|NCT02113449|GlaxoSmithKline|GSK Response Center|866-435-7343||
22387909|NCT00109031|Swedish Orphan Biovitrum|Hans Olivecrona, MD PhD|+46 8 697 20 00|hans.olivecrona@sobi.com|
22387910|NCT02208843|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22387911|NCT03067948|Johns Hopkins University SOM (Adjunct)|Anne Monroe MD|202-994-0251|amonroe@gwu.edu|
22387912|NCT00665392|GERCOR|Regulatory Affairs|+33 (0)1 40 29 85 00|regulatory.affairs@gercor.com.fr|
22387913|NCT00243867|American Regent Inc.|Manager Medical Writing|631-772-3555|HRathfon@americanregent.com|
22387914|NCT04399837|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22387915|NCT03088800|Maimonides Medical Center|Sergey Motov, MD|7182836000|smotov@maimonidesmed.org|
22387916|NCT02831816|Zurex Pharma, Inc.|Andrew Morgan|16082039090|amorgan@zurexpharma.com|
22387917|NCT02954432|Spaulding Rehabilitation Hospital|Felipe Fregni|6179526158|Fregni.felipe@mgh.harvard.edu|
22387918|NCT04224272|Jazz Pharmaceuticals Inc.|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
22387919|NCT02609048|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22387920|NCT04445831|AC Immune|Olivier Sol|+41 21 345 91 21|clinicaltrials@acimmune.com|
22414257|NCT03429712|Duke University Medical Center|Daniele Marin|919-684-2711|daniele.marin@duke.edu|
22414258|NCT00316186|GlaxoSmithKline|GSK Response Center|866-435-7343||
22414259|NCT02740413|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22414260|NCT01802320|The University of Texas MD Anderson Cancer Center, Clinical Research Operations|Dr. Scott Kopetz/Associate Professor, GI Medical Oncology|713-792-2828|SKopetz@mdanderson.org|
22414261|NCT00199901|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
22414262|NCT00917735|University of Minnesota|Dr. Mindy Kurzer|612-624-9789|mkurzer@umn.edu|
22414263|NCT04336332|Cancer Institute of New Jersey|Dr. Sabiha Hussain|+1 732-718-3253|hussaisa@rwjms.rutgers.edu|
22414264|NCT01361633|Anxiety Disorders Center, Institute of Living/Hartford Hospital|Gretchen Diefenbach, Ph.D.|860-545-7685|gdiefen@harthosp.org|5-7396
22414265|NCT06137781|Royal United Hospitals Bath NHS Foundation Trust|Alec Snow|07793554479|alec.snow@nhs.net|
22414266|NCT05932134|Linkou Chang Gung Memorial Hospital|M.D|+886-3-3281200|pitiful1984@gmail.com|8467
22414267|NCT04523168|Mayo Clinic|Dr. Amir Lerman|507-255-2446|lerman.amir@mayo.edu|
22414268|NCT05058430|Saliwell Ltd.|Dr. Andy Wolff|+972508801852|awolff@saliwell.com|
22414269|NCT01515891|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22414270|NCT02768701|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat G. Canter MD MS ACRP-CP, Clinical Trial Analyst|(919) 962-0000|Melahat_Canter@med.unc.edu|
22414271|NCT00540995|City of Hope Medical Center|Dr. Anthony Stein|626-359-8111||
22414272|NCT05014828|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22414273|NCT03382925|University of Utah, Department of Physical Medicine and Rehabilitation|Dr. Zachary McCormick|801-587-5432|PMR.Research@hsc.utah.edu|
22414274|NCT02682238|Botanix Pharmaceuticals|Anthony Robinson, MS, CRNP|+1 (445) 300-3403|trials@botanixpharma.com|
22414275|NCT01370317|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22401103|NCT05483127|Alcon Research, LLC|Associate Director, CRD Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22401104|NCT02951273|Rigshospitalet|Niels D. Olesen|004520262459|niels.damkjaer.olesen.01@regionh.dk|
22401105|NCT00121225|Princess Margaret Cancer Centre|Dr. David Hogg|416-946-4501|david.hogg@uhn.ca|4521
22401106|NCT01937312|Alcon Research, Ltd.|Global Brand Leader, Medical Affairs, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com|
22401107|NCT01486238|Valley Retina Institute, PA|Victor Gonzalez, MD|956-631-8875|research@vritx.com|
22401108|NCT03043365|National Heart Lung and Blood Institute (NHLBI)|Marcelo J. Amar, M.D. Principal Investigator, NIH, NHLBI|301-402-0521|mamar@nhlbi.nih.gov|
22430783|NCT05273437|University of California San Diego|Dr. Eric Hekler|8584299370|ehekler@health.ucsd.edu|
22430784|NCT03647137|Department of Veteran Affairs|Dr. Nicolaas Bohnen|7347697100|nicolaas.bohnen@va.gov|
22430785|NCT03900650|Arizona State University|Kelly Cue Davis|602-496-3217|Kelly.Cue.Davis@asu.edu|
22430786|NCT00829868|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22430787|NCT01548885|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
22430788|NCT01603368|University of Linköping|Thomas Abrahamsson, MD PhD|+46.10.1030000|thomas.abrahamsson@liu.se|
22430789|NCT01554904|University of Florida|Richard B Berry, M.D. Principal Investigator|3522621575|Richard.Berry@medicine.ufl.edu|
22430790|NCT01202162|Northwestern University|Gildasio De Oliveira, M.D.|312-926-8371|g-jr@northwestern.edu|
22430791|NCT03829683|Virginia Commonwealth University|Arun J Sanyal, MD|804-828-4060|arun.sanyal@vcuhealth.org|
22430792|NCT01586897|Massachusetts General Hospital|Steven J. Atlas, Director of Massachusetts General Primary Care Practice Based Research Network|617-724-4736|satlas@partners.org|
22430793|NCT01681849|Emory University|Dr. J. Douglas Bremner|404-712-9569|doug.bremner@emory.edu|
22430794|NCT02412982|UC Health - University of Cincinnati Medical Center|Molly Droege, PharmD|513-584-2126|molly.droege@uchealth.com|
22430795|NCT04525183|Dana-Farber Cancer Institute|Dr. Alexi Wright|617-362-2334|alexi_wright@dfci.harvard.edu|
22430796|NCT00803049|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22430797|NCT01272219|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22430798|NCT05305651|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22430799|NCT00214526|Boston Scientific Corporation|Mark G. Grubb|412-749-1423|Mark.Grubb@bsci.com|
22430800|NCT02100826|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22430801|NCT04379271|Immunic AG|Silke Kropp, Specialist Regulatory Operations & Systems|+49|Silke.Kropp@imux.com|1626774453
22430802|NCT05021224|University of Pennsylvania|Dr. Courtney Wolk|215-746-6099|courtney.wolk@pennmedicine.upenn.edu|
22430803|NCT03996395|Baylor College of Medicine|Nancy E. Moran, PhD|713-798-0520|nancy.moran@bcm.edu|
22430804|NCT01924065|Akdeniz Sifa Konyaalti Medical Center|Mehmet Ozaydin|905533354243|mehmetozaydin@hotmail.com|
22430805|NCT05375929|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22430806|NCT03555994|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22430807|NCT03973489|VA Portland Health Care System|William Hoffman|503-220-8262|hoffmanw@ohsu.edu|56491
22430808|NCT03301415|The University of Alabama at Birmingham|David W. Kimberlin, MD|205-934-5316|dkimberlin@peds.uab.edu|
22430809|NCT00392288|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22430810|NCT02544763|GW Research Ltd|Medical Enquiries|+1 833 424 6724|medinfo@gwpharm.com; medinfo@greenwichbiosciences.com|
22430811|NCT02097225|Massachusetts General Hospital|Ryan Sullivan, MD|617-643-3614|RSULLIVAN7@PARTNERS.ORG|
22430812|NCT01444924|University of Wisconsin Hospitals and Clinics|Dr. David Kushner|608-263-0796|dmkushner@facstaff.wisc.edu|
22430813|NCT03404375|UTMB Galveston|Antonio Saad|4097721571|afsaad@utmb.edu|
22430814|NCT07072793|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov.Inquiries@pfizer.com|
22430815|NCT03379870|The Children's Cochlear Implant Center at UNC|Lisa Park, AuD|919-419-1449|lisa_park@med.unc.edu|
22430816|NCT00003645|UT MD Anderson Cancer Center|Dr. Curtis A. Pettaway, M.D.- Professor, Urology|713-792-7734|cpettawa@mdanderson.org|
22430817|NCT04101331|Affimed GmbH|Clinical Operations|+49 621 560030|trials@affimed.com|
22430818|NCT04616196|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
22430819|NCT03502681|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317-921-2050|jsmith@hoosiercancer.org|
22430820|NCT02254291|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)||clinicaltrials@novonordisk.com|
22430821|NCT02078869|TCART|Robert F Casper, PI|416-972-0777|casper@lunenfeld.ca|
22430822|NCT06790303|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22430823|NCT05796245|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22430824|NCT02579759|Pharnext|Susanne Dorn|+33 (0)1 41 09 22 30|contact@pharnext.com|
22430825|NCT03436732|National Cancer Institute|Dr. Raffit Hassan|240-760-6322|rh276q@nih.gov|
22430826|NCT01254214|University of Minnesota|Cynthia Gross PhD|612-624-8676|gross002@umn.edu|
22430827|NCT02014467|GlaxoSmithKline|GSK Response Center|866-435-7343||
22430828|NCT04642976|University of Pennsylvania|Timothy Markman|215-615-4332|timothy.markman@pennmedicine.upenn.edu|
22430829|NCT01217892|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
22401109|NCT02723630|Eisai Inc.|Eisai Medical Services|1-888-247-2378|esi-medinfo@eisai.com|
22401110|NCT03643692|Imperial College London|Nick Oliver|02033111093|nick.oliver@imperial.ac.uk|
22401111|NCT00847613|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22401112|NCT00754390|United States Department of Agriculture (USDA) Grand Forks Human Nutrition Research Center|Brenda Ling|701-795-8300|brenda.ling@ars.usda.gov|
22401113|NCT00213239|The Hospital for Sick Children, Department of Anesthesia and Pain Medicine|Dr. Jason Hayes|416-813-7654|jason.hayes@sickkids.ca|208963
22401114|NCT00587223|Organogenesis Inc.|Director of Clinical Operations||kgiovino@organo.com|
22401115|NCT03519178|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22414276|NCT00075478|Fred Hutchinson Cancer Research Center/|Dr. Brenda Sandmaier|206-667-4961|bsandmai@fhcrc.org|
22414277|NCT04665375|University Health Network|Sharon Walmsley|416-340-5077|sharon.walmsley@uhn.ca|
22414278|NCT03270462|"University of Colorado Denver | Anschutz"|Larry Chan|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
22387921|NCT03268421|Cincinnati Children's Hospital|Susmita Kashikar-Zuck, PhD|513-636-6337|susmita.kashikar-zuck@cchmc.org|
22387922|NCT04912856|Xenon Pharmaceuticals|Dr. Noam Butterfield|604 484 3300|nbutterfield@xenon-pharma.com|
22387923|NCT02434328|Novartis Pharmaceuticals|Study Director|1-862-778-8300|novartis.email@novartis.com|
22387924|NCT03496766|Fundación GECP|Eva Pereira|+34934302006|gecp@gecp.org|
22387925|NCT01850355|Massachusetts General Hospital|Dr. Gagan Joshi|617-724-1541|joshi.gagan@mgh.harvard.edu|
22387926|NCT01276509|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22387927|NCT01534052|Astellas Pharma Europe B.V. (APEB)|Clinical Trial Disclosure|800-888-7704 Ext:5473|astellas.resultsdisclosure@astellas.com|
22387928|NCT00949117|SunCoast CCOP Research Base|Cristina Burroughs, Clinical Research Coordinator|(813) 396-9237|Cristina.Burroughs@epi.usf.edu|
22387929|NCT00985088|GlaxoSmithKline|GSK Response Center|866-435-7343||
22387930|NCT03964974|University of Michigan|Mark Ilgen|734-845-3646|marki@med.umich.edu|
22387931|NCT01550952|Hospital for Special Surgery|Dr. Jacques YaDeau|2127742224|yadeauj@hss.edu|
22387932|NCT01970878|Pearl Therapeutics Inc.|Colin Reisner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com|
22387933|NCT03062488|Nemours Children's Healthcare System|Carlos A. Archilla, MD|4076507646|carlos.archilla@nemours.org|
22387934|NCT02014402|Grifols Therapeutics Inc|Henry Li, PhD|+1 919 316 6042|henry.li@grifols.com|
22387935|NCT00279409|USSF|Laurence Greenhill||larrylgreenhill@gmail.com|
22387936|NCT02542202|UChicago|Rohan Katipally|773-702-0137|Rohan.Katipally@bsd.uchicago.edu|
22387937|NCT04992273|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22387938|NCT01364597|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22387939|NCT03214081|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22387940|NCT02962284|Sun Pharma Global FZE|Harin Mehta|97145520096, 912266455645|clinicaltrials@sparcmail.com, harin.mehta@sparcmail.com|
22387941|NCT03493282|Cogntion Therapeutics Inc|Chief Medical Officer, Head of R&D|914-221-6730|acaggiano@cogrx.com|
22387942|NCT03926026|Nicox Ophthalmics, inc.|Doug Hubatsch|832-360-3022|hubatsch@nicox.com|
22387943|NCT00413283|Amgen Inc.|Study Director|866-572-6436||
22387944|NCT00667017|University of Texas Southwestern Medical Center|Larry Andeson, MD|214-648-7097||
22387945|NCT01823224|Womack Army Medical Center|Anthony R Plunkett, MD|910-907-6000|anthonyrplunkett@gmail.com|
22387946|NCT01467934|Columbia University|Melissa Stockwell|212-342-5732|mss2112@columbia.edu|
22387947|NCT05741450|CooperVision, Inc.|José A. Vega OD, MSc, FAAO|+19256213761|jvega2@coopervision.com|
22387948|NCT01303796|Cyclacel Ltd|Mark H. Kirschbaum MD|+1 908 517 7330|mkirschbaum@cyclacel.com|
22387949|NCT01532648|Bausch Health Americas, Inc|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
22387950|NCT02148705|MediWound|Keren David Zarbiv|972-77-9714103|kerend@mediwound.com|
22414279|NCT00002601|City of Hope|Paul Frankel, Ph.D.|(626)256-4673|pfrankel@och.org|65265
22414280|NCT05763147|BD China|MA manager of Clinical Trial|0086 21 2325 4853|justina.zhu@bd.com|
22414281|NCT00824291|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22414282|NCT01891994|National Heart Lung and Blood Institute|Dunbar, Cynthia|+1 301 827 1164|dunbarc@nhlbi.nih.gov|
22414283|NCT02115347|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22414284|NCT00123734|AGEN Biomedical Ltd|Dr Michael Gerometta|+61 408 885 416|mgerometta@agenix.com|
22414285|NCT00113386|Radiation Therapy Oncology Group|Wendy Seiferheld||wseiferheld@acr.org|
22414286|NCT02849457|University of Alabama at Birmingham|E. Martina Bebin M.D., M.P.A.|205-975-2890|ebebin@uabmc.edu|
22414287|NCT02599558|Mayo Clinic|Jeffrey A. Alexander, M.D.|507+284-0474|Alexander.Jeffrey14@mayo.edu|
22414288|NCT03673670|Verona Pharma plc|Brian Maurer|+19147675037|brian.maurer@veronapharma.com|9147675037
22414289|NCT01058668|Allergan, Inc.|Therapeutic Area Head|714-246-4500||
22414290|NCT00187720|UCSF|Kathy Giacomini, Ph.D|4154761936|Kathy.Giacomini@ucsf.edu|
22414291|NCT01778010|New York State Psychiatric Institute at Columbia University Medical Center|Margaret Haney, Ph.D.|646-774-6153|meg.haney@nyspi.columbia.edu|
22414292|NCT01068821|Mayo Clinic, Florida|Dr. Mary Ellen Wechter|904 412 7351|wechter.mary@mayo.edu|
22414293|NCT05373173|Vanderbilt University Medical Center|Zachary Warren, Ph.D.|615-875-3085|zachary.e.warren@vumc.org|
22414294|NCT02159183|ZMK University of Bern, Clinic of Periodontology|Prof. Dr. med. dent., Dr. h.c., M.S. Anton Sculean|004131 632 25 72|anton.sculean@zmk.unibe.ch|77
22414295|NCT02154672|Yale University School of Medicine|Dr. Preston Sprenkle|2037852815|preston.sprenkle@yale.edu|
22414296|NCT02558491|University of Virginia Center for Diabetes Technology|Daniel R. Chernavvsky, MD|434-982-0602|mc7m@virginia.edu|
22387951|NCT02094534|Orange County Research Center|Joel M. Neutel, M.D., Study Director|714-550-9990|jmneutel@aol.com|
22387952|NCT01737021|Imperial College London|Professor Elena Garralda|+44 (0)20 3312 6085|e.garralda@imperial.ac.uk|
22387953|NCT01673594|Massachusetts General Hospital|Research Regulatory Coordinator|617-726-4651|apulli@mgh.harvard.edu|
22387954|NCT02824198|Sanofi Pasteur|Medical Director|800-633-1610|Contact-US@sanofi.com|ext 1#
22387955|NCT03883828|Montefiore Medical Center|Dr. Beth McLellan|718.862.8840|bmclella@montefiore.org|
22387956|NCT01738698|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22387957|NCT02575365|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22387958|NCT01545583|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22387959|NCT00343083|University of Maryland Baltimore|Ritesh Kataria|410-328-8018|rkataria@umm.edu|
22387960|NCT02736188|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
22387961|NCT01698918|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
22387962|NCT03176407|Ovesco Endoscopy AG|Prof. Dr. T. Gottwald|0049707196528||160
22387963|NCT01482325|GE Healthcare|Global Research Manager|414 721 2423|Jeffrey.Conner@ge.com|
22387964|NCT01428583|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22387965|NCT05197452|Research Manager|Dr. Yolanda Cartwright|224-420-0323|yolanda_cartwright@rush.edu|
22387966|NCT01817491|Cleveland Clinic|Michael Macknin, MD|216 444-5512|macknim@ccf.org|
22387967|NCT00768755|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22387968|NCT00670488|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22387969|NCT00878189|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22387970|NCT02708498|Department of Health Sciences, Lund University|Professor Gerd Ahlström|+46702747767|gerd.ahlstrom@med.lu.se|
22387971|NCT01829711|MedImmune, LLC|Priti Patel|+1-650-264-9079|information.center@astrazeneca.com|
22387972|NCT01480258|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22387973|NCT02108171|Guangzhou First People's Hospital, Affiliated Hospital of Guangzhou Medical College|Dr. Xiangcai Ruan|+8620-81048306|xc_ruan@hotmail.com|
22387974|NCT02785159|Bausch Health|Study Director||anya.loncaric@bauschhealth.com|
22387975|NCT04273672|University of Massachusetts Medical School|Kara Smith, MD|5083342527|kara.smith@umassmed.edu|
22387976|NCT04864834|Sandoz|Clinical Disclosure Representative|+49 8024 / 908 0|sandoz.disclosure@sandoz.com|
22387977|NCT00701415|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22387978|NCT01676298|Spartan Bioscience Inc.|Dr. Chris Harder|613-228-7756|chris.harder@spartanbio.com|778
22387979|NCT02106884|UZ Leuven|Prof. Dr. Eric Van Cutsem|0032 16 344418|eric.vancutsem@uzleuven.be|
22387980|NCT00407888|Medical Oncology University of Washington|Hannah Linden MD FACP|206-288-6989|hmlinden@uw.edu|
22387981|NCT00659373|IBCSG|Rudolph Maibach, Executive Officer for International Trial Activities|+41 31 389 91 96|rudolf.maibach@ibcsg.org|
22387982|NCT01607320|Greenville Health System|Bruce Lessey|864-455-1600|blessey@ghs.org|
22387983|NCT03042767|Emory University|Dr. Miriam Vos|404-727-5383|mvos@emory.edu|
22387984|NCT03784898|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22414297|NCT00796328|IWK Health Centre|Dr. Ron George|470-6627|rbgeorge@dal.ca|
22414298|NCT03259139|The Ohio State University|Dr. Brad Bushman|614-688-8779|bushman.20@osu.edu|
22414299|NCT03406156|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22387985|NCT01543204|Amgen Inc.|Study Director|866-572-6436||
22387986|NCT04638816|QMedAB|Clinical Project Manager|(817) 961-500|aestheticclinicaltrials@galderma.com|
22387987|NCT00087022|Heidelberg Pharma AG (previously Wilex AG)|Head of R&D||info@hdpharma.com|
22414300|NCT02825680|VA Center for Clinical Management Research|Laura Damschroder|734-845-3603|Laura.Damschroder@va.gov|
22414301|NCT05479058|Galapagos N.V.|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
22414302|NCT05630885|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22414303|NCT03419403|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22414304|NCT02068820|Florida Hospital Gynecologic Oncology|Robert W. Holloway|407-303-2400|robhollowaymd@gmail.com|
22414305|NCT02354339|INSTITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uice@prodigy.net.mx|34212
22414306|NCT03084471|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22414307|NCT03435835|Purdue University/Indiana University|Dr. Bruno Roseguini|7654962612|brosegui@purdue.edu|
22414308|NCT00251979|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22414309|NCT00284518|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22414310|NCT01878292|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
22414311|NCT00323882|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22414312|NCT01668602|Emory University|Trisha Kesar, PT, PhD|404-712-5803|trisha.m.kesar@emory.edu|
22414313|NCT00429416|Thomas Jefferson University|John Wagner, MD|215-955-8874|John.Wagner@jefferson.edu|
22414314|NCT00322439|Amgen Inc.|Study Director|866-572-6436||
22414315|NCT02152163|Delray Medical Center|Russell Weisz, MD|561-213-9371|rdweisz@gmail.com|
22414316|NCT06999265|University of Michigan at Ann Arbor|Tim Bruns|(734) 647-8727|bruns@umich.edu|
22414317|NCT01471041|Vital Access|Mark Crawford|8014339390|mcrawford@vital-access.com|
22414318|NCT00730691|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22414319|NCT00813592|Huntsman Cancer institute|Randy Jensen, MD, PhD|801-585-0255|randy.jensen@hci.utah.edu|
22414320|NCT03682653|UCSF FI Proctor|Dr. Thomas Lietman|(414) 476-1442|tom.lietman@ucsf.edu|
22414321|NCT01391273|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22414322|NCT01521780|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22414323|NCT01097577|US Air Force|Julie Meek, Clinical Pharmacist|210-808-2200|julie.m.meek.mil@mail.mil|
22414324|NCT03190005|taipei city hospital|chen yueh-chung|88627093600|chenyuehchung.tw@yahoo.com.tw|3741
22414325|NCT04870606|Suzhou Kintor Pharmaceuticals,Inc.|Millie Gu|+86- 512 6263 9938|PR@kintor.com.cn|
22387988|NCT01328496|St. Jude Children's Research Hospital|Amr Qudeimat, MD|901-595-8342|amr.qudeimat@stjude.org|
22414326|NCT02566850|Ekso Bionics|Katherine Strausser PhD|(510) 529-2529|kstrausser@eksobionics.com|
22414327|NCT04377087|UPMC|Barbara Stadterman, MPH, CCRP|7245532539|stadtermanbm@upmc.edu|
22414328|NCT00682461|GlaxoSmithKline|GSK Response Center|866-435-7343||
22414329|NCT02028221|University of Arizona|Sherry Chow, PhD|5206263358|schow@azcc.arizona.edu|
22414330|NCT01881763|Northwell Health|Georgios Petrides, MD, PI|718-470-8569|gpetride@northwell.edu|
22387989|NCT03960957|QMedAB|Clinical Project Manager|8179615000|aestheticclinicaltrials@galderma.com|
22451392|NCT03119766|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22451393|NCT02562755|SillaJen Biotherapeutics Inc.|Kyoung Soo Ha, Senior Medical Director|+1-415-281-8886|ksha@kr.sillajen.com|
22451394|NCT02034578|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22451395|NCT01045447|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22451396|NCT01577706|McLean Hospital|Dr. J. Eric Jensen|617-855-3366|ejensen@mclean.harvard.edu|
22451397|NCT01782131|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22451398|NCT00796718|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22451399|NCT01073618|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22451400|NCT01519713|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22451401|NCT01800877|Centre de Recherche du CHUS|Marie-Hélène Masse|819-346-1110|marie-helene.masse3@usherbrooke.ca|14173
22451402|NCT02855060|Atrium Health|Rachel Seymour|74-355-6969|rachel.seymour@atriumhealth.org|
22451403|NCT04088097|Yale University|Dr Janet Lydecker|2037374299|janet.lydecker@yale.edu|
22451404|NCT03556761|University of Pennsylvania|Dr Lisa Levine|215-662-6913|lisa.levine@pennmedicine.upenn.edu|
22451405|NCT00353704|Baerum Hospital|Ulrich J Spreng|004798499184|ulispreng@hotmail.com|
22451406|NCT02807948|Abbott|Adam M.Cline, MD, MSc.- Principal Scientist|818-493-2025|adam.cline@abbott.com|
22451407|NCT03727750|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22451408|NCT01154166|GlaxoSmithKline|GSK Response Center|866-435-7343||
22451409|NCT03614793|University of Utah Orthopaedic Center/ Physical Medicine & Rehabilitation|Zachary McCormick, MD|801-587-1493|u6014808@umail.utah.edu|
22451410|NCT02840877|Boston Medical Center|Karen Jacobson, MD MPH|617-414-5213|karen.jacobson@bmc.org|
22451411|NCT04317586|Stryker|Kevin Barga|2018315073|kevin.barga@stryker.com|
22451412|NCT00491244|National Taiwan University Hospital|Dr. Chen-Hua Liu|+886-2-23123456|jacque_liu@mail2000.com.tw|63572
22451413|NCT01276327|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22451414|NCT00807092|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22451415|NCT01794949|Emory University|Henry Liberman, MD|404-686-2503|hliberm@emory.edu|
22387990|NCT02686658|IVERIC Bio, Inc.|Medical Director|609-474-6755|info@ivericbio.com|
22414331|NCT03098485|Washington University in St. Louis School of Medicine|Kimberly Reske, MPH|3147474041|kreske@wustl.edu|
22414332|NCT04200833|Medical University of Graz|PD MD Andrea Skrabl-Baumgartner|+43 316 385|andrea.skrabl-baumgartner@medunigraz.at|111
22451416|NCT03003676|Targovax|Dr. Lone H. Ottesen, Chief Development Officer|+44 7920567911|lone.ottesen@targovax.com|
22414333|NCT06298396|Cochlear Limited|PRS Specialist|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
22414334|NCT00836004|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414335|NCT01528696|University of Michigan|Mark Chames|734 764-1406|mchames@med.umich.edu|
22414336|NCT02718963|Seoul National University Bundang Hospital, Seoul National University College of Medicine|Ju Seok Ryu|82-31-787-7739|jseok337@snu.ac.kr|
22414337|NCT01547286|Massachusetts General Hospital|Dr. Robert Scott Harris, MD|617-726-9429|rsharris@mgh.harvard.edu|
22414338|NCT00836472|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414339|NCT01695239|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22414340|NCT02007863|University of Miami|Martin Andreansky MD|305-243-0850|mandreansky@med.miami.edu|
22414341|NCT03502811|Abbott|Nadia Bouhdi|32-479-94-10-37|nadia.bouhdi@abbott.com|
22414342|NCT03913377|Johnson & Johnson Vision Care|Elizabeth Dow, PRINCIPAL RESEARCH OPTOMETRIST|+1800-843-2020|edow1@its.jnj.com|
22414343|NCT05239195|Vanderbilt University Medical Center|Jonathan D Casey, MD, MSc|615-875-4681|Jonathan.d.Casey@vumc.org|
22414344|NCT00081653|Hoffmann-La Roche|Clinical Trials Study Director|+1 973 235 5000||
22414345|NCT00529191|Children's Hospital of Philadelphia|Steven Willi, MD|215-590-3174|willi@chop.email.edu|
22414346|NCT00736190|Gilead Sciences, Inc.|Eduardo Bruno Martins, MD, DPhil, Sr. Director, Medical Affairs - Hepatitis|650-522-5792|eduardo.martins@gilead.com|
22414347|NCT03246503|BiliCam, LLC|James Taylor|2064194923|uncjat@google.com|
22414348|NCT02197416|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22414349|NCT03689400|Rehabilitation and Exercise Science Laboratory (RESlab), Department of Business Economics, Health and Social Care (DEASS), University of Applied Sciences and Arts of Southern Switzerland (SUPSI), Landquart, Switzerland|Giannina Bianchi|00418 300 01 78|giannina.dias@supsi.ch|
22414350|NCT01204294|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22414351|NCT03128723|JnJ Worldwide|Gboyega Adenaike|908-874-1214|aadenaike@its.jnj.com|
22414352|NCT02075463|GlaxoSmithKline|GSK Response Center|866-435-7343||
22414353|NCT00392665|Massachusetts General Hospital|Lori J. Wirth, MD|617-724-4000|LWIRTH@mgh.harvard.edu|
22414354|NCT00252967|Brown University|Samuel Dudley, MD, PhD|4014443024|samuel_dudley@brown.edu|
22414355|NCT02294786|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22414356|NCT01663233|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300||
22414357|NCT01144494|University of Nebraska Medical Center|Carol Toris|402-559-1852|ctoris@unmc.edu|
22414358|NCT04813354|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22414359|NCT02105272|Otsuka Pharmaceutical Co., Ltd.|Deputy General Manager, Headquarters of Clinical Development|+81-3-6361-7366||
22414360|NCT05454956|Tarsus Pharmaceuticals, Inc.|Kavita Dhamdhere, Vice President of Clinical Development|650-223-4062|kdhamdhere@tarsusrx.com|
22414361|NCT00318461|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22430830|NCT03226691|National Heart Lung and Blood Institute|John Tisdale|+1 301 402 6497|johntis@nhlbi.nih.gov|
22414362|NCT00505622|Eisai Call Center|Eisai Inc.|888-422-4743||
22414363|NCT00796653|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22414364|NCT00868374|University Hospitals Cleveland Medical Center|Dr. Keming Gao|216-844-2865|keming.gao@UHhospitals.org|
22414365|NCT02738086|University of Colorado Denver|Cory L. Christiansen|303-724-9101|cory.christiansen@cuanschutz.edu|
22414366|NCT02414152|Northwell Health|Dr. Andrea Vambutas|718-470-7550|avambuta@northwell.edu|
22414367|NCT01757392|Nielsen Biosciences, Inc|David Burney|858-571-2726|david@nielsenbio.com|
22414368|NCT01218672|Boston Scientific Corporation|Teresa Takle-Flach, Director, Clinical Operations|(952)930-6000|teresa.takle-flach@bsci.com|
22414369|NCT03703791|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
22414370|NCT01552317|University of Oxford|Principal Investigator|+441865287794|chris.ocallaghan@ndm.ox.ac.uk|
22387991|NCT01695291|New York State Psychiatric Institute|Kelsey Hill, Research Coordinator|646-774-5793|Kelsey.Hill@nyspi.columbia.edu|
22430831|NCT00831389|Medtronic Diabetes|Harry Clark|818-576-5653|bud.clark@medtronic.com|
22387992|NCT02581137|University of Arizona|Dr. Sherry Chow|5206263358|schow@azcc.arizona.edu|
22387993|NCT03476798|Stephenson Cancer Center|Dr. Kathleen Moore|405-271-8777|Kathleen-Moore@ouhsc.edu|
22414371|NCT00841698|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414372|NCT00838136|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414373|NCT01149733|Teva Pharmaceuticals USA|Associate Director, Biopharmaceutics|866-384-5525|clinicaltrialqueries@tevausa.com|
22414374|NCT00545506|Dep. Anesthesia And Intensive Care|Helmut Hager|+43 1 40400 4102|helmut.hager@meduniwien.ac.at|
22414375|NCT04078022|University of Maryland, Baltimore Center for Vaccine Development and Global Health (CVD)|Dr. Wilbur Chen|410-706-5328|wchen@som.umaryland.edu|
22414376|NCT01250912|University of Maryland, Baltimore|Dr. Timm-Michael Dickfeld|410-328-7801|tdickfel@som.umaryland.edu|
22414377|NCT00191815|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22414378|NCT01929863|GlaxoSmithKline|GSK Response Center|866-435-7343||
22414379|NCT06185088|University of Michigan|Meghan Arnold|734-936-8978|meghanar@med.umich.edu|
22414380|NCT01304641|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22414381|NCT00099047|Cleveland Clinic|Matt Kalaycio, MD|216-444-3705|kalaycm@ccf.org|
22414382|NCT01348789|Northwestern Memorial Hospital|Dr. Jerome M. Garden|312-280-0891|j-garden@northwestern.edu|
22414383|NCT05168735|University of Pittsburgh|Dr. Rebecca Price|412-383-2150|pricerb@upmc.edu|
22414384|NCT00803686|Tarsa Therapeutics, Inc|Nicholas LaBella, Jr. Vice-President Global RA/QA|267-273-7944|nlabella@tarsatherapeutics.com|
22414385|NCT00415363|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22414386|NCT03123471|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22414387|NCT01641380|Johns Hopkins University School of Medicine|Maria Trent, MD, MPH, Principal Investigator|443-287-8945|mtrent2@jhmi.edu|
22414388|NCT02358538|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
22414389|NCT01686477|ImperialC|Luke Mills|+447989748017|l.mills@imperial.ac.uk|
22414390|NCT01863030|University of Kentucky Medical Center|Scott Roth M.D.|859-323-6346|sroth@uky.edu|240
22414391|NCT02178787|Beth Israel Deaconess Medical Center|Dr. Vera Novak|617-632-8680|vnovak@bidmc.harvard.edu|
22414392|NCT04189848|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22387994|NCT06269003|University of Hawaii Cancer Center|Donghee Nicole Lee, Assistant Professor|8084418184|nlee@cc.hawaii.edu|
22430832|NCT01377402|Stavanger University Hospital|Dennis WT Nilsen, MD, phd, professor|+4795777735|dnilsen1@getmail.no|
22414393|NCT01588236|Jiangsu Kanion Pharmaceutical Co. Ltd|Weiyi Liu, MD|3016533500|liuweiyi65@hotmail.com|
22414394|NCT02430480|National Cancer Institute|Dr. Fatima Karzai|301-480-7174|karzaifh@mail.nih.gov|
22414395|NCT01030133|Medical University of South Carolina|Dr. Jeffery J Borckardt|843.792.3127|borckardt@musc.edu|
22414396|NCT04493684|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22414397|NCT05635019|University of Pennsylvania and Johns Hopkins University|Ariana Chao|443-287-6223|ariana.chao@jhu.edu|
22414398|NCT00128219|University of Pittsburgh School of Medicine|Sharon Hillier, Ph.D.|412-641-6435|hillsl@mwri.magee.edu|
22414399|NCT05710718|Becton, Dickinson and Company|Director Clinical Affairs and Medical Affairs Strategy|551-225-1164|Kirsten.Hammitt@bd.com|
22387995|NCT06677203|Asceneuron S.A.|Asceneuron Clinical Research|+41213538245|clinicaltrials.gov@asceneuron.com|
22387996|NCT02698475|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22387997|NCT02038049|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22387998|NCT01363128|The University of Texas MD Anderson Cancer Center|Elias Joseph Jabbour, MD/ Professor|7137924764|ejabbour@mdanderson.org|
22387999|NCT02660086|Massachusetts General Hospital|Dr. Anne Thorndike, Prinicipal Investigator|6177244608|athorndike@mgh.harvard.edu|
22388000|NCT01377844|Theracos Sub, LLC|Albert Collinson, Ph.D.|(508) 688-4221|acollinson@theracos.com|
22388001|NCT01653509|GlaxoSmithKline|GSK Response Center|866-435-7343||
22388002|NCT00785798|Yale University School of Medicine|Francine Foss, MD||Francine.Foss@yale.edu|
22388003|NCT01214200|Temple University School of Medicine|Mark Weir, MBChB|215-707-5864|mark.weir@tuhs.temple.edu|
22414400|NCT04372238|Brown University School of Public Health|Brandon DL Marshall, PhD|4018636427|brandon_marshall@brown.edu|
22414401|NCT05005442|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22414402|NCT03696160|Research Organisation (KC) Ltd|Project Manager|+44 (0) 7508 439711|LAPTOP@rokcservices.com|
22414403|NCT00334815|SWOG Statistical Center|Lung Committee Statistician|206-667-4623|jmoon@fhcrc.org|
22414404|NCT05604170|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
22414405|NCT05056376|Johns Hopkins University, School of Medicine|Nestoras Mathioudakis, MD MHS|667-306-8085|nmathio1@jhmi.edu|
22414406|NCT04851184|George Washington University|Karen Goodman|202-994-0705|karengoodman@gwu.edu|
22414407|NCT03317899|Thomas Jefferson University|Dolores Grosso|848-256-5751|dag104@jefferson.edu|
22414408|NCT04534010|Stanford University|Arash Momeni, MD, FACS|(650) 723-6189|amomeni@stanford.edu|
22414409|NCT01056484|University of Wisconsin Madison|Aleksandra Zgierska, MD PhD|(608) 263-7882|aleksandra.zgierska@fammed.wisc.edu|
22414410|NCT02776774|Surgical Outcomes Research Center - SORCE|Dr. Amy Cizik - Research Assistant Professor, Ph.D., M.P.H.,|206-744-4631|amorgan2@uw.edu|
22414411|NCT02651272|Bosotn Medical Center|Elizabeth Klings, MD|617-638-7480|elizabeth.klings@bmc.org|
22414412|NCT00446966|Carient Heart and Vascular|Dr Chirag Sandesara|7033358750|csandesara@carient.org|
22414413|NCT01440803|Columbia University|Elizabeth Shane, MD|212-305-7225|es54@cumc.columbia.edu|
22430833|NCT00278161|Johns Hopkins University|Lode Swinnen, MD|4106146398|lswinne1@jhmi.edu|
22388004|NCT00587171|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H.|813-975-8690|pedig@jaeb.org|
22388005|NCT02310581|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com|
22388006|NCT00887224|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22388007|NCT01353274|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22388008|NCT03510195|Universiti Putra Malaysia|Dr. Aneesa Abdul Rashid|03-86092956|aneesa@upm.edu.my|
22388009|NCT00022672|Hoffman-LaRoche|Medical Communications|800-821-8590||
22388010|NCT00403494|BioMarin Pharmaceutical Inc.|Joshua Lilienstein/Medical Director, Global Medical Affairs|651.523.0310|MEDINFO@bmrn.com|
22388011|NCT05005247|MinervaX|CMO|004553883002|LIO@minervax.com|
22388012|NCT03648541|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|18002430127|clintriage.rdg@boehringer-ingelheim.com|
22388013|NCT01271244|VA NEBRASKA WESTERN IOWA VA HEALTHCARE|SRIRAM RAMASWAMY MD|4029954712|SRIRAM.RAMASWAMY@VA.GOV|
22388014|NCT03490032|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22388015|NCT05005351|Swing Therapeutics, Inc.|Clinical Project Manager|1 (415) 662-0415|research@swingtherapeutics.com|
22388016|NCT00487240|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22388017|NCT01858688|Brigham and Women's Hospital/Dana-Farber Cancer Institute|Neil Martin, MD|(617) 632-3000|NEMARTIN@PARTNERS.ORG|
22388018|NCT04248868|Eminence Clinical Research, Inc.|Christopher A. Schultz|9715067552|cschultz@ecr-inc.com|
22388019|NCT03672032|University of Iowa Hospitals and Clinics|Dr. Henning Gerke|319-384-6582|henning-gerke@uiowa.edu|
22401116|NCT03476850|Medical University of South Carolina|Eric Bolin, MD|8437921869|bolin@musc.edu|
22401117|NCT01039207|NRG Oncology|Angela Kuras on behalf of Mike Sill, PhD|716-845-5702|kurasa@nrgoncology.org|
22401118|NCT01477450|University of Cincinnati|Richard Branson||bransord@uc.edu|
22401119|NCT00072189|California Cancer Consortium|DCC Project Administrator|: 626-256-4673|CCCP@coh.org|60094
22401120|NCT04125745|University of California San Francisco|Marc Simon, MD, Director of Pulmonary Vascular Disease and Pulmonary Hypertension Comprehensive Care|415-476-1325|Marc.Simon@ucsf.edu|
22401121|NCT01145391|University of Colorado Denver School of Medicine|Amy Huebschmann|303-724-2268|amy.huebschmann@ucdenver.edu|
22401122|NCT01684826|Philips|Frank Everaerts|+31630728782|frank.everaerts@philips.com|
22401123|NCT00970294|University of Kansas Medical Center|Patricia Kluding PT PhD|913-588-6918|pkluding@kumc.edu|
22401124|NCT01134510|Cedars-Sinai Medical Center|Stanely Jordan, MD|310-428-8186|stan.jordan@cshs.org|
22401125|NCT01877655|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22401126|NCT02562235|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22401127|NCT02089737|Takeda|Medical Director, Clinical Science|800-778-2860|trialdisclosures@takeda.com|
22451417|NCT01229228|Iroko Pharmaceuticals, LLC|Steven Jensen|267-546-3003|sjensen@iroko.com|
22451418|NCT01037309|Prosensa|Fiona Lawrence|+31(0)713322100|f.lawrence@prosensa.nl|
22451419|NCT02530619|Northwestern University, Feinberg School of Medicine|Brady L. Stein, MD|312-695-6832|bstein@nmff.org|
22451420|NCT00786916|Akron Children's Hospital|Michael D. Reed, Pharm.D.|330-543-3193|MReed@chmca.org|
22401128|NCT00744055|Yale University School Of Medicine Department of Psychiatry|Elizabeth Ralevski|2039325711|elizabeth.ralevski@yale.edu|4282
22401129|NCT05248945|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22401130|NCT05525975|University of Iowa Health Care|Brendan Patterson|319 678-8451|brendan-patterson@uiowa.edu|
22401131|NCT01123889|Loma Linda University Orthopaedic Surgery|Liz Clarke|909-558-5592|eaclarke@llu.edu|
22401132|NCT05090423|National Yang Ming Chiao Tung University|Chen Hsin-I, Physical Therapist|+886-982-641-541|hsini0329@gmail.com|
22401133|NCT05733286|Duke University|Michael Devinney, MD, PhD|919-668-6266|michael.devinney@duke.edu|
22401134|NCT00685178|Johns Hopkins University|Dr. Annie Umbricht|410-550-1917|annieumbricht@jhu.edu|
22401135|NCT00249379|Virginia Commonwealth University|Michael Weaver, MD|804-828-1283|mweaver@mcvh-vcu.edu|
22401136|NCT02836886|Columbia University|Larisa Geskin, MD|2123055550|ljg2145@cumc.columbia.edu|
22401137|NCT05134974|Ocuphire|Drey Coleman, VP of Clinical Operations|813-404-1993|dcoleman@ocuphire.com|
22401138|NCT05098015|RAND|Glenn Wagner|310-393-0411|gwagner@rand.org|
22401139|NCT03618641|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR; CRS Regulatory Supervisor|412-647-5554|stadtermanbm@upmc.edu|
22401140|NCT00467844|GTx Inc.|Senior Director, Clinical Operations|901-523-9700|mdesordi@gtxinc.com|
22401141|NCT01538615|University of Minnesota School of Nursing|Dr. Jayne A. Fulkerson|612-624-4823|fulke001@umn.edu|
22401142|NCT03334214|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
22401143|NCT00003820|Stanford University|Ranjana Advani, MD, Professor of Lymphoma|650-725-6456|radvani@stanford.edu|
22401144|NCT04063215|UTHealth, McGovern Medical School at Houston|Carmen Duron|7135007395|maria.carmen.duron@uth.tmc.edu|
22401145|NCT05655832|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22401146|NCT04281537|Amicus Therapeutics, Inc.|Patient Advocacy|001 6096622000|clinicaltrials@amicusrx.com|
22401147|NCT04516967|Sobi Inc.|Medicine Development Leader|1-781-786-7370|medinfo.us@sobi.com|
22401148|NCT05916170|Wake Forest University Health Sciences|Dr. Erin Sutfin|336-713-5282|erin.sutfin@wfusm.edu|
22401149|NCT04576949|Achieve Life Sciences|Daniel Cain, Vice President, Clinical Research|425.686.1546|dcain@achievelifesciences.com|
22401150|NCT06001398|Children's Mercy Kansas City|Dana Bakula, PhD|(816) 302-3069|dmbakula@cmh.edu|
22401151|NCT03556904|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
22401152|NCT05243680|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22401153|NCT03002506|Texas Tech UHSC|Ronald Hall, PharmD, MSCS|214-358-9009|ronald.hall@ttuhsc.edu|
22401154|NCT01025336|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22401155|NCT03794986|Yale University, School of Medicine|Dr. Joan Cook|203-856-2782|joan.cook@yale.edu|
22401156|NCT02162979|Loma Linda University|Tonya Hamilton, reszearch Compliance Auditor|909-558-4908|thamilton@llu.edu|
22401157|NCT01720251|ANERGIS SA|Dr Gilles DELLA CORTE Clinical Development Director|+41 21 651 92 30|gilles.dellacorte@anergis.ch|
22401158|NCT00550238|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2897|medicalinformation@acadia-pharm.com|
22401159|NCT02273115|University of Massachusetts - Baystate|Dr. Corina Schoen|4137543470|Corina.SchoenMD@baystatehealth.org|413
22401160|NCT01660815|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22401161|NCT02255838|University of Louisville|Rainer Lenhardt|5028523122|rainer.lenhardt@louisville.edu|
22401162|NCT04207710|Henry Ford Health|Director of Research, Department of Anesthesiology|313-771-7128|knowak2@hfhs.org|
22401163|NCT01515072|Rutgers-New Jersey Medical School|Baburao Koneru, MD, MPH|(973) 972-9599|koneruba@njms.rutgers.edu|
22401164|NCT00923091|Daiichi Sankyo Europe, GmbH|Bettina Ammentorp|00498978080|bettina.ammentorp@daiichi-sankyo.eu|
22401165|NCT03291197|Physical Medicine and Rehabilitation Ottawa Resident|Dr. Marc Monsour|6137377350|mmonsour051@gmail.com|
22401166|NCT01819922|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22401167|NCT04246047|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22401168|NCT02495779|University of Pittsburgh, Graduate School of Public Health|James Egan|4126242255|jee48@pitt.edu|
22401169|NCT02111369|Emory University|Dr. Michael Johns|323-865-9839||
22401170|NCT05270265|University of Oxford|Dr. Angela M Minassian|1865 611424|angela.minassian@bioch.ox.ac.uk|
22401171|NCT06081283|University of North Carollina at Chapel Hill|Meitra Kazemi|919-914-9579|meitra_kazemi@med.unc.edu|
22401172|NCT00624338|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22401173|NCT02912364|Stanford University|Kimford Meador|650-725-6648|kmeador@stanford.edu|
22401174|NCT04170621|FARAPULSE|Christopher (Kit) Schneider|6176867661|christopher.schneider@bsci.com|
22401175|NCT01294228|Alere San Diego|Director of Clinical Affairs|1-858-805-4808|william.arnold@alere.com|
22401176|NCT01933672|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22401177|NCT00524303|GlaxoSmithKline|GSK Response Center|866-435-7343||
22401178|NCT00095121|Gilead Sciences|John Flaherty, PharmD, Director, Clinical Research|650-522-5592|John.Flaherty@gilead.com|
22401179|NCT02258412|3M Health Care Business|Clinical Research Specialist|651-736-1578|mdavid@mmm.com|
22401180|NCT03497689|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
22401181|NCT03567187|University of Kansas Medical Center|Neil Segal, MD|9135740961|segal-research@kumc.edu|
22401182|NCT02928289|Sight Sciences, Inc.|VP, Medical and Clinical Affairs|877-266-1144|jdickerson@sightsciences.com|
22401183|NCT01225068|Northwestern University Feinberg School of Medicine|Thomas J Schnitzer|3125032315|tjs@northwestern.edu|
22401184|NCT05176847|University of South Carolina|Brie Turner-McGrievy|8037773932|brie@sc.edu|
22401185|NCT05369208|Sobi Inc.|Medicine Development Leader|1-781-786-7370|medinfo.us@sobi.com|
22401186|NCT05441670|Medical University of South Carolina|Cynthia Dodds, PT, PhD|8437925731|doddscb@musc.edu|
22401187|NCT03943667|Institut Paoli Calmettes|Dr Christelle DE LA FOUCHARDIERE|+33(0)491223333|DELAFOUCHARDIEREC@ipc.unicancer.fr|
22401188|NCT03019055|Froedtert Hospital and the Medical College of Wisconsin|Dr. Nirav Shah, MD|414-805-8900|cccto@mcw.edu|
22401189|NCT01092442|CryoLife, Inc.|Scott B. Capps, MS|800-438-8285|clinicaltrialregistration@cryolife.com|
22401190|NCT01059812|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22401191|NCT05299892|Hearts For Hearing|Sara Neumann, AuD|405-548-4300|sara.neumann@heartsforhearing.org|
22401192|NCT00149214|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22401193|NCT05642442|Jazz Pharmaceuticals, Inc.|Director Clinical Trial Disclosure & Transparency|+1 215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
22401194|NCT04448886|DFCI|Se Eun Kim|9196228080|seeunk@ds.dfci.harvard.edu|
22401195|NCT05338268|VA Finger Lakes Healthcare System|Lisham Ashrafioun|585-430-2026|Lisham.ashrafioun@va.gov|
22401196|NCT02296684|Washington University School of Medicine|Douglas R. Adkins, M.D.|314-362-4471|dadkins@wustl.edu|
22401197|NCT05063591|Brown University|Roxanne Wood|401-863-3000|roxanne_wood@brown.edu|
22401198|NCT00254423|The University of Texas MD Anderson Cancer Center|Lucia Masarova MD/Associate Professor|832-750-4211|LMasarova@mdanderson.org|
22401199|NCT05302908|Wake Forest School of Medicine|Scott Rhodes, Ph.D|336-713-5080|srhodes@wakehealth.edu|
22401200|NCT05561673|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22414414|NCT02342535|Northwestern University|Dr. Namratha Kandula|312-503-6470|nkandula@nm.org|
22414415|NCT01492439|Centre for Addiction and Mental Health|Dr. Sean A. Kidd|416-535-8501|sean.kidd@camh.ca|6295
22414416|NCT00673660|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22414417|NCT01527006|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22414418|NCT00933686|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merck.de|
22414419|NCT01383486|Bayer HealthCare LLC, Consumer Care|Head Clinical and Medical Affairs||clinical-trials-contact@bayerhealthcare.com|
22414420|NCT00245063|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22414421|NCT01370369|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22414422|NCT01776190|University of Texas Southwestern Medical Center|Benjamin Chong, MD|214-645-2400|ben.chong@utsouthwestern.edu|
22414423|NCT01839279|Acorda Therapeutics, Inc.|Executive Medical Director|914-437-4300|paupperle@acorda.com|5263
22414424|NCT01907607|Institut Bergonié|Pr Antoine Italiano|33 5 56 33 33 33|a.italiano@bordeaux.unicancer.fr|
22414425|NCT01505933|Penn State Health Milton S. Hershey Medical Center|Dr. Uma R Parekh, MBBS, DNB, FRCA, FFARCSI|717531-4264|uparekh@pennstatehealth.psu.edu|
22414426|NCT05919823|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
22414427|NCT01648582|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22414428|NCT04614168|University of Edinburgh|Prof. Shareen Forbes|0131 242 6740|shareen.forbes@ed.ac.uk|
22414429|NCT02777580|KU Leuven|Prof Frans Van de Werf|003216342111|frans.vandewerf@kuleuven.be|
22414430|NCT02321098|Galderma|Farzaneh Sidou Clinical Project Manager|04 93 95 70 51|farzaneh.sidou@galderma.com|33
22414431|NCT00840476|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414432|NCT00908128|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414433|NCT03261167|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22414434|NCT00835146|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414435|NCT00529464|UT MD Anderson Cancer Center|Helen E. Rhodes, MD / Assistant Professor|713-792-2933|CR_Study_Registration@mdanderson.org|
22414436|NCT03199963|Besins Healthcare Ireland Ltd|Global Chief Medical Officer|+353 87 1039215|clinicaldevelopment@besins-healthcare.com|
22414437|NCT03930732|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22430834|NCT01817777|GlaxoSmithKline|GSK Response Center|866-435-7343||
22451421|NCT01807585|Medtronic Endovascular|Melissa Hasenbank, Clinical Research Director|707-525-0111|melissa.hasenbank@medtronic.com|
22451422|NCT04279925|Plastic Surgery Division of Surgery Department of Cipto Mangunkusumo Hospital Jakarta / Faculty of Medicine Universitas Indonesia|Prasetyanugraheni Kreshanti, MD|08158732424|pras_md@yahoo.com|
22451423|NCT03021759|University of Pennsylvania|Rebecca Pepe|215-360-0951|peper@pennmedicine.upenn.edu|
22451424|NCT00359762|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22451425|NCT01172938|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|clinicaltrialdisclosure@celgene.com|
22451426|NCT04627727|BIDMC|Judy Nee, mD|617-667-2193|jnee@bidmc.harvard.edu|
22451427|NCT00293540|International Breast Cancer Research Foundation|Richard R. Love, MD|608-698-7881|richardibcrf@gmail.com|
22451428|NCT00403546|Massachusetts General Hospital|Donald C. Goff, MD||Donald.Goff@nyumc.org|
22451429|NCT00793910|Carl R. Darnall Army Medical Center|Matthew Kuhnle, DO|216-965-3518|matthew.kuhnle@us.army.mil|
22451430|NCT03634579|Emory University|Sherif Nour|404-778-3800|sherif.nour@emoryhealthcare.org|
22451431|NCT05061446|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22451432|NCT04111497|Fred Hutchinson Cancer Center|Dr. Stephanie Lee|206-667-6190|sjlee@fredhutch.org|
22451433|NCT05468398|University of California, Irvine|Navid Alem, MD / Principal Investigator|(949) 413-4950|alemn@hs.uci.edu|
22451434|NCT01993719|National Cancer Institute|Dr. Stephanie L. Goff|240-760-6214|stephanie.goff@nih.gov|
22451435|NCT02799082|Biofrontera Bioscience GmbH|Dr. Beate Schmitz|+49 214 876 32|b.schmitz@biofrontera.com|41
22451436|NCT03473886|Massachusetts General Hospital|Rachel A. Millstein|617-724-2047|RAMILLSTEIN@mgh.harvard.edu|
22451437|NCT01194674|National Institutes of Health|H. Nida Sen, Principal Investigator, National Eye Institute|301-402-3254|senh@nei.nih.gov|
22451438|NCT02442700|Ramathibodi Hospital, Mahidol University|Asita Wongprikorn, MD|664236949|wongprikorn@yahoo.com|
22451439|NCT01723904|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22451440|NCT00752908|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
22451441|NCT02617589|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22451442|NCT01752933|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
22451443|NCT01591681|Jaeb Center for Health Research|Roy W. Beck, M.D., Ph.D.|813-975-8690|jdrfapp2@jaeb.org|
22451444|NCT03062891|University of Notre Dame|Dan Denis|6178066484|ddenis@nd.edu|
22451445|NCT03678181|University of Pennsylvania|Dr. Jose Bauermeister|215-898-9993|bjose@upenn.edu|
22451446|NCT03077165|IlkosTherapeutic Inc.|Monique Champagne|450-680-3381|mchampagne@ilkostherapeutic.com|2910
22451447|NCT03362515|Thomas Jefferson University|Dr. Mindy Rabinowitz|215-955-6784|mindy.rabinowitz@jefferson.edu|
22451448|NCT01578044|VA Eastern Colorado Health Care System|P. Michael Ho|720-857-2115|michael.ho@va.gov|
22451449|NCT01431508|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22451450|NCT00132769|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22451451|NCT02755935|Cochlear Americas|Ginger Grant, AuD|410-375-0883|ggrant@cochlear.com|
22451452|NCT02758236|INA-RESPOND|Publication Division|+62214208693|inapublikasi@ina-respond.net|
22451453|NCT01612546|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22388020|NCT00603018|UCSD|Walter Kaye, MD/Director, Eating Disorders Program Professor, UCSD Department of Psychiatry|858- 534-8019|wkaye@ucsd.edu|
22388021|NCT02684136|HenryFordHS|Timothy Roehrs PhD Study Investigator|313-916-5177|troehrs1@hfhs.org|
22388022|NCT01989793|Johns Hopkins University|Dr. Jeremy D. Walston, M.D. , Raymond and Anna Lublin Professor of Geriatric Medicine|410-550-1003|jwalston@jhmi.edu|
22388023|NCT01074242|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22414438|NCT05797961|Mahidol University Faculty of Social Sciences and Humanities|Chair of the Institutional Review Board|+662-441-9180|mussirb310@gmail.com|
22414439|NCT01910688|Columbia University Medical Center|Dr. Julian Abrams|(212) 235-1496|ja660@cumc.columbia.edu|
22414440|NCT00835692|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414441|NCT03644550|National Cancer Institute|Dr. Raffit Hassan|240-760-6232|hassanr@mail.nih.gov|
22414442|NCT01218867|National Cancer Institute|Dr. Steven Rosenberg|301- 496-4164|sar@mail.nih.gov|
22414443|NCT02591420|Data Coordinating and Analysis Center, HJF Global Infectious Diseases|Dr. Glenna Schluck|3015003824|gschluck@global-id.org|
22414444|NCT04241458|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22414445|NCT04688658|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP|4126475554|stadtermanbm@upmc.edu|
22414446|NCT04970810|University of Chicago|Jacqueline Kanoon|773-834-3419|kanoon@bsd.uchicago.edu|
22414447|NCT04742491|HPTN Statistical & Data Management Center|HPTN Statistical Manager|206-667-4004|HPTN-Data-Access@scharp.org|
22451454|NCT01016834|Zogenix|Judith Myers, Senior Director Clinical Operations|510-550-8300|jmyers@zogenix.com|
22414448|NCT00716625|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22414449|NCT04349267|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22414450|NCT04618211|Pharvaris Netherlands B.V.|Pharvaris Clinical|31 712036410|clinical@pharvaris.com|
22414451|NCT06107725|Maimonides Medical Center|Dr. QingL Tony Wang|718.283.7670|qwang@maimo.org|
22414452|NCT01244620|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22414453|NCT00848536|Alcon Research, Ltd.|Director Alcon Clinical|888.451.3937 or 817.568.6725||
22414454|NCT01175135|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22414455|NCT00466167|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22414456|NCT04708028|University of North Carolina at Chapel Hill|Laura Jacox, DMD, PhD|919-966-9731|ljacox@live.unc.edu|
22414457|NCT03534193|Hackensack Meridian Health|Steven Ghanny, MD|5519965329|steven.ghanny@hmhn.org|
22414458|NCT04414930|UCSD|Neal R. Swerdlow, M.D., Ph.D.|6194719455|nswerdlow@health.ucsd.edu|
22414459|NCT05470699|City of Hope|Paul Frankel, Ph.D.|6262185265|pfrankel@coh.org|
22414460|NCT03325881|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22414461|NCT03676634|California Department of Public Health|Stephen S. Arnon, M.D., M.P.H., Chief, Infant Botulism Treatment and Prevention Program|510-231-7600|Stephen.Arnon@cdph.ca.gov|
22414462|NCT03279250|UT MD Anderson Cancer Center|Dr. Christopher Logothetis, MD-Professor, Genitourinary Medical Oncology|(713) 563-7210|clogothe@mdanderson.org|
22414463|NCT02913924|New York State Psychiatric Institute|John Mariani MD|646-774-8181|john.mariani@nyspi.columbia.edu|
22414464|NCT00829712|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414465|NCT02294981|UCSF Psoriasis and Skin Treatment Center|Tina Bhutani|4159147618|psoriasis@ucsf.edu|
22414466|NCT04128761|Virginia Tech|Stephen LaConte|5405262008|slaconte@vtc.vt.edu|
22414467|NCT06539676|Dentsply IH AB d.b.a Dentsply Sirona Implants|Clinical Research Manager|+4631 3763191|freja.freedman@dentsplysirona.com|
22414468|NCT04405765|University of Texas Southwestern Medical Center|Tara Kristof - research coordinator|214-648-9007|tara.kristof@utsouthwestern.edu|
22414469|NCT03393208|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22414470|NCT00909038|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22414471|NCT00207090|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22414472|NCT01370811|Quest Research Institute|Aaron L. Ellenbogen, OD, MPH|+1 248 644 7770|aellenbogen@comcast.net|
22414473|NCT01895335|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22414474|NCT03480763|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22430835|NCT00443456|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22451455|NCT00441337|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22451456|NCT03655236|Sun Pharma Advanced Research Company Limited|Head, Clinical Development|912266455645|clinical.trials@sparcmail.com|
22451457|NCT06748040|Duke University|Hrishikesh Chakraborty, PhD|919-668-1238|hrishikesh.chakraborty@duke.edu|
22451458|NCT01159938|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22451459|NCT02744534|Emory University|Baowei Fei, PhD|972-883-7239|bfei@utdallas.edu|
22451460|NCT02105116|Rutgers Cancer Institute of New Jersey|Roger Strair, MD, PhD|732-235-7298|strairrk@cinj.rutgers.edu|
22451461|NCT03821376|Indiana University|Jordan Swensson, MD|317-944-1831|jswensso@iu.edu|
22388024|NCT01957163|GlaxoSmithKline|GSK Response Center|866-435-7343||
22388025|NCT04899999|University of Rochester|Dr. Francisco Cartujano Barrera, M.D|(585) 273-1646|francisco_cartujano@urmc.rochester.edu|
22388026|NCT03822832|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22388027|NCT01668719|SWOG Statistics and Data Management Center|Myeloma Committee Statistician|2066674623|rachaels@crab.org|
22388028|NCT03539055|Vanderbilt Cardiovascular Research Enterprise|Terry Weyand, MS., CCRP|6153229349|terry.l.weyand@vumc.org|
22388029|NCT04939233|Departments of Mechanical Engineering and Electrical and Computer Engineering, Virginia Tech|Dr. Pinhas Ben-Tzvi|NA|bentzvi@vt.edu|
22430836|NCT03242434|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22451462|NCT02318329|Five Prime Therapeutics|Medical Lead|415-365-5600|FPA144@fiveprime.com|
22451463|NCT04837482|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22451464|NCT00581945|Study Director|Novartis Pharmaceuticals|862-778-8300||
22451465|NCT02979535|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22451466|NCT04820673|Almirall S.A.|Head of Global Clinical Development|+34932913000|rd@almirall.com|
22451467|NCT02621983|Atlanta VA Medical Center|Dr. Erica Duncan|404-321-6111|erica.duncan@va.gov|207532
22451468|NCT00587587|Organogenesis Inc.|Director of Clinical Operations|781-575-0775|clinical@organo.com|
22451469|NCT01162005|Seoul National University Children's Hospital|Hee Gyung Kang|+82-2-2072-0658|pedneph@snuh.org|
22451470|NCT02032901|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22451471|NCT00466193|Purdue Pharma LP|Clinical Leader|800-733-1333||
22451472|NCT01126593|Orlando Orthopaedic Center|Dr. Randy Schwartzberg|(407) 254-2500|orlandosportsdoc@yahoo.com|
22414475|NCT01718873|National Cancer Institute, IRCCS, G. Pascale Foundation|Antonio Avallone, Dierctor of Experimental Abdominal Medcial Oncology|+390815903629|a.avallone@istitutotumori.na.it|
22414476|NCT01647828|OncoMed Pharmaceuticals, Inc.|Manager, Regulatory Affairs|6509958322|imran.chaudhry@oncomed.com|
22414477|NCT00115063|PenningtonBRC|Tiffany Prather, RN, CDE|225-763-2979|tiffany.prather@pbrc.edu|
22414478|NCT01169753|University of Texas (UT) MD Anderson Cancer Center|Carmen Escalante, MD / Chair, General Internal Medicine||CR_Study_Registration@mdanderson.org|
22414479|NCT00702377|Alcon Research Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22414480|NCT00185458|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22414481|NCT00830024|Teva Pharmaceuticals USA|Manger, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414482|NCT02554890|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22414483|NCT05980286|University of California, San Francisco|Julene Johnson, Professor|415-476-1106|Julene.Johnson@ucsf.edu|
22414484|NCT00834275|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414485|NCT03649477|Levo Therapeutics|Vice President of Clinical Development|1-847-901-9260|contactus@levotx.com|
22414486|NCT04544410|Spruce Biosciences|Spruce Clinical Trials|415-655-4169|clinicaltrials@sprucebio.com|
22414487|NCT00748072|University of Bari|Dr. Carlo Manno|390805478878|c.manno@nephro.uniba.it|
22414488|NCT03331289|UTexas_SanAntonio|Ralph A DeFronzo|2105676691|defronzo@uthscsa.edu|
22414489|NCT04037969|Centre for Ocular Research and Education|Jill Woods|5198884567|jwoods@uwaterloo.ca|36743
22430837|NCT00944021|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|212 227 7540|Dan.Everitt@tballiance.org|
22430838|NCT01592747|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22430839|NCT03680521|Mirati Therapeutics|Sr. Clinical Operations Trial Manager|858-332-3540|hallinm@mirati.com|
22430840|NCT01935947|Johns Hopkins University|Gary Rosner|410-955-4884|grosner1@jhmi.edu|
22430841|NCT04102514|University of Kansas Medical Center|Lauren Ptomey|913-588-7983|lptomey@kumc.edu|
22430842|NCT00619918|Children's Hospital Los Angeles|Susan Wu|323-361-6177|suwu@chla.usc.edu|
22430843|NCT04169009|University of Colorado Anschutz Medical Campus|Adriana Weinberg MD|303-724-4480|adriana.weinberg@cuanschutz.edu|
22430844|NCT04889950|Novoxel Ltd|Ifat Klein|972-6009860|ifat@novoxel.com|
22430845|NCT02758626|NYU Langone Health, Comprehensive Epilepsy Center|Orrin Devinsky, MD|6465580803|Orrin.Devinsky@nyulangone.org|
22430846|NCT03876808|University of Missouri - Columbia|Dr. Boris Mraovic, Professor of Clinical Anesthesiology|573-882-2568|mraovicb@health.missouri.edu|
22430847|NCT00456365|PKD Research Group, University of Colorado Anschutz Medical Campus|Melissa Cadnapaphornchai, MD|3037241690|pkd@ucdenver.edu|
22381063|NCT03419780|University of Pennsylvania|Dr Rebecca Hamm|215-662-6913|rebecca.feldmanhamm@pennmedicine.upenn.edu|
22381064|NCT01605136|Clinuvel Inc.|Dr. Dennis Wright|646 527 7310|Dennis.Wright@clinuvel.com|170
22381065|NCT01072929|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22401201|NCT01582282|Procter and Gamble|John McRorie, PhD|513-622-1423|mcrorie.jw@pg.com|
22401202|NCT04426630|Yale University School of Medicine|Dr. Jeremy Schwartz|2036801598|jeremy.schwartz@yale.edu|
22401203|NCT02786537|UF Hepatology Research at CTRB|Lauren Morelli|352-273-9508|lauren.morelli@medicine.ufl.edu|
22401204|NCT01466751|Stanford University|Amit Etkin|650-725-5736|amitetkin@stanford.edu|
22401205|NCT02413255|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22401206|NCT00077623|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22401207|NCT00401973|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22401208|NCT02584634|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22401209|NCT04243369|Philips|T.J. Battisti|(425) 205-3515|t.j.battisti@philips.com|
22401210|NCT04075604|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22401211|NCT00708877|University of Utah|Dr. Jason Schwarz|8015852708|jason.schwartz@hsc.utah.edu|
22401212|NCT00320671|Northwell|Delbert Robinson MD|718.470.8195|drobinson@nshs.edu|
22401213|NCT01050062|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22401214|NCT03894540|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22401215|NCT00852930|Vanderbilt University School of Nursing|Sheila H, Ridner, PHD|615-322-0831|Sheila.Ridner@Vanderbilt.edu|
22401216|NCT00537745|PIRE|Patricia Hokanson|505-765-2325|info@bhrcs.org|
22401217|NCT01823653|Solta Medical|Director of Clinical Programs|510-259-5284|aloncaric@solta.com|
22401218|NCT03700892|University of North Carolina at Chapel Hill, Center for Environmental Medicine Asthma and Lung Biology|Assistant Director of Clinical Research|919 966-5638|robinet@med.unc.edu|
22401219|NCT00650585|PIRE|Heddy Clark|919-265-2643|hclark@pire.org|
22401220|NCT02532543|University of North Carolina at Chapel Hill|Gidgetta Kang|919-537-3968|gidgetta_jenkins@unc.edu|
22401221|NCT02640612|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22401222|NCT00849212|Eisai Call Center|Eisai Inc.|888-422-4743||
22401223|NCT05207436|VA San Diego Healthcare System|Leslie Morland|858-226-5765|leslie.morland@va.gov|
22401224|NCT03583424|The Ohio State University Comprehensive Cancer Center|Dr. Kami Maddocks|614-293-9165|Kami.Maddocks@osumc.edu|
22401225|NCT01144637|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
22401226|NCT03472534|Castle Creek Pharmaceuticals|Dr. Mary Spellman/Chief Medical Officer|862-286-0400|mspellman@castlecreekpharma.com|
22401227|NCT02614794|Seattle Genetics, Inc.|Chief Medical Officer|(855)473-2436|medinfo@seagen.com|
22401228|NCT00906789|Georgetown University Medical Center|Matthew T. Freedman|4105429680|MTFreedman@verizon.net|
22430848|NCT00928720|University of Virginia School of Nursing|Ann Gill Taylor, Professor Nursing|434-924-0113|agt@virginia.edu|
22451473|NCT03057119|Florida State University|Katie Kloss|9045716395|katie.kloss@med.fsu.edu|
22388030|NCT01321073|The University of Alabama at Birmingham|Robert Bourge, M.D., Professor of Medicine, Radiology, and Surgery|(205)934-7400|bbourge@uab.edu|
22388031|NCT01638000|Astellas Pharma Europe Ltd|Medical Director||Astellas.resultsdisclosure@astellas.com|
22388032|NCT04248803|TamilNadu MU|Dr Geeth Deepika|9952331820|geethdeepika@gmail.com|
22388033|NCT00485693|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
22388034|NCT02309294|Church & Dwight Co., Inc.|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
22388035|NCT01227421|Romark Laboratories, L.C.|Marc Ayers|813-282-8544|Marc.Ayers@romark.com|
22388036|NCT00758550|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22388037|NCT00684242|UT MD Anderson Cancer Center|Sriram Yennurajalingam, MD / Assistant Professor||CR_Study_Registration@mdanderson.org|
22388038|NCT01000805|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22388039|NCT04162873|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
22388040|NCT03343704|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22388041|NCT03715946|UPMC Hillman Cancer Center|Barbara Stadterman, MPH|4126475554|stadtermanbm@upmc.edu|
22388042|NCT02969356|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22451474|NCT00086346|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22451475|NCT04495374|Universidade Federal de Alfenas|Profa. Dra. Larissa Helena Lobos Torres Pacheco|3537011805|larissa.torres@unifal-mg.edu.br|55
22451476|NCT02473614|University of California at Irvine|Dr. Kelli Sharp|9495107968|ksharp@uci.edu|
22451477|NCT02525133|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
22451478|NCT01343082|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
22451479|NCT01075074|Northwestern University|Gildasio De Oliveira, MD|312-926-8373|g-jr@northwestern.edu|
22451480|NCT01576536|Vanderbilt University Medical Center|Dr. C. M. Stein|615-936-3420|mike.stein@vanderbilt.edu|
22388043|NCT02678455|University of Vermont|Beth Kirkpatrick MD|802-656-5822|beth.kirkpatrick@med.uvm.edu|
22388044|NCT03187223|Department of Medical Oncology, Inselspital, University Hospital and University of Bern, Bern, Switzerland|Prof Dr. Thomas Pabst|+41 31 63 2 84 30|Thomas.Pabst@insel.ch|
22388045|NCT04700904|Pennington Biomedical Research Center|Corby Martin|763-2585|corby.martin@pbrc.edu|
22388046|NCT03508700|Tonix Pharmaceuticals|Gregory Sullivan|(862) 904-0355|greg.sullivan@tonixpharma.com|
22388047|NCT02808468|University of Washington|Dr. Michele Bedard-Gilligan|206-616-4215|mab29@uw.edu|
22388048|NCT04906057|Cleveland Clinic|Donayja Harris|2164454125|harrisD47@ccf.org|
22388049|NCT05432986|Rhaeos, Inc.|Anna Somera|855-814-3569|info@rhaeos.com|
22388050|NCT04493424|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22388051|NCT06149416|Stryker Sustainability Solutions|Senior Principal Regulatory Affairs|5602-410-0204|moira.barton@stryker.com|
22388052|NCT03769090|Avillion LLP|Chief Medical Officer|+44 (0)203 764 9530|avillion@avillionllp.com|
22388053|NCT02470312|Abbott|Kristin Ruffner, Clinical Program Director|+1 651 756 6717|Kristin.Ruffner@abbott.com|
22388054|NCT02786966|Ottawa Hospital Research Institute|Manya Charette|613-798-5555|mancharette@ohri.ca|17758
22388055|NCT02830893|University of California Irvine|Dr. Steven Cramer|(949) 824-8423|SCCramer@mednet.ucla.edu|
22388056|NCT01277302|Genentech, Inc.|Medical Communications|800 821-8590||
22388057|NCT02710669|Vanderbilt University Medical Center|Benjamin Shoemaker, MD|615-322-2318|moore.b.shoemaker@vumc.org|
22388058|NCT01386632|Sanford Clinical Research|Dr. Steven Powell|605-328-8000|patientquestionsSHDCA@sanfordhealth.org|
22388059|NCT01567852|University of NewMexico|Dr. Tony Yen|505-272-2610|tyen@salud.unm.edu|
22388060|NCT03332589|Spirita Oncology, LLC|Chief Development Officer|+1 (713) 898-8965|linda.paradiso@spiritaoncology.com|
22388061|NCT03627299|Johns Hopkins University|Christine Durand, MD|410-955-5684|ChristineDurand@jhmi.edu|
22388062|NCT01190124|Hospital de Santa Maria - Centro Hospitalar Lisboa Norte|Doroana, Maria Manuela, M.D.|351 217938043|manuela.doroana@hsm.min-saude.pt|
22388063|NCT01719172|Covidien|Julie Totten|781-839-1729|Julie.Totten@Covidien.com|
22388064|NCT05062161|Columbia University Medical Center|Marwah Abdalla|212 342 1275|ma2947@cumc.columbia.edu|
22388065|NCT03469258|Beth Israel Deaconess Medical Center|A. James Moser, MD|(617) 632-1032|ajmoser@bidmc.harvard.edu|
22388066|NCT00326196|Roudebush VAMC|Masoor Kamalesh, MD|317-988-2401|masoor.kamalesh@va.gov|
22388067|NCT02005172|University at Buffalo|Deepika Narasimha||deepikan@buffalo.edu|
22388068|NCT01711294|Boston Scientific Corporation|Lina Ginnetti, Clinical Endoscopy Director|508-683-4512|lina.ginnetti@bsci.com|
22388069|NCT02605174|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22388070|NCT00770874|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.||toiawase@taiho.co.jp|
22388071|NCT04250636|The Rockefeller University|Marina Caskey|2123277396|mcaskey@rockefeller.edu|
22388072|NCT01128959|Lundbeck LCC|Lundbeck LLC|+45 36301311|LundbeckClinicalTrials@lundbeck.com|
22388073|NCT01409837|University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu|Dr. Anthony Mbah, Principal investigator|2348051519065|cmd_unth@yahoo.com|
22388074|NCT01682928|Mednax|Ana Braescu|480-969-5999|ana_braescu@mednax.com|
22388075|NCT04938453|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22388076|NCT04053699|Octapharma|Sigurd Knaub, Senior VP CR&D Haematology|01554512141|Sigurd.Knaub@octapharma.com|
22388077|NCT03292406|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22388078|NCT00308308|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
22388079|NCT03068312|Vertex Pharmaceuticals Incorporated|Medical Monitor|+1 617 341 6777|medicalinfo@vrtx.com|
22388080|NCT01852045|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22388081|NCT01951703|Clinical Compliance Manager|Jurandir Araujo|904 443-1379|jaraujo7@jnj.com|
22388082|NCT02827201|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
22388083|NCT00240994|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22388084|NCT01299285|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22388085|NCT02630186|Clovis Oncology, Inc.|Elizabeth Bradley|1-415-409-5495|ebradley@clovisoncology.com|
22388086|NCT00439218|Westat|René Gonin, PhD (Math. Stats.)|301-251-1500|renegonin@westat.com|
22388087|NCT03142932|Johns Hopkins University School of Medicine|Dr. Jonathan E. Golub|(443) 287-2969|jgolub@jhmi.edu|
22388088|NCT02128269|Alexion|Alexion Medical Monitor|617-613-1071|Bert.Yao@alexion.com|
22388089|NCT01021748|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22388090|NCT01482091|Albert Einstein College of Medicine/Children's Hospital at Montefiore|Dr. Daniel Fein|718-920-5312|dfein@montefiore.org|
22388091|NCT01640288|Duke University School of Medicine, Department of Radiology|H. Cecil Charles, Ph.D.|919-684-7921|cecil.charles@duke.edu|
22388092|NCT03775915|University of Oxford|Dr Melanie Fleming, Research Associate|+441865611461|melanie.fleming@ndcn.ox.ac.uk|
22388093|NCT01485887|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22388094|NCT02234141|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22388095|NCT00895245|University of Washington|Dr. Keith Eaton|206-288-2048|kdeaton@uw.edu|
22388096|NCT01972776|Novartis|Study Director|862-778-8300||
22388097|NCT01228734|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22388098|NCT00462072|University of Rochester|Rick Barrett|585-275-1647|rick_barrett@urmc.rochester.edu|
22388099|NCT02382640|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22388100|NCT01220999|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
22388101|NCT01560429|Queen's University|Dr. Vidur Shyam|(613) 548-7827|shyamv@kgh.kari.net|
22388102|NCT02449902|TherapeuticsMD|Shelli Graham, PhD|561-961-1900|Shelli.Graham@TherapeuticsMD.com|
22388103|NCT01365546|Octapharma|Director of Clinical Operations|4152609577|sylvia.werner@octapharma.com|
22430849|NCT02096354|EpicentRx, Inc|Study Director: Bryan Oronsky, Chief Medical Officer|858-229-1062|boronsky@epicentrx.com|
22388104|NCT03326856|Eirion Therapeutics|Chief Executive Officer|(781) 935-1216|info@eirionthera.com|
22430850|NCT03715829|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22430851|NCT03566732|University of Bergen|Professor Dagny F. Haugen|+4747606633|dagny.haugen@uib.no|
22430852|NCT03579719|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22430853|NCT01443026|University of Illinois at Chicago|Dr. Peter Gann|312-355-3723|pgann@uic.edu|
22430854|NCT00802503|Geneva University Hospitals, Division of Intensive Care,Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14/Switzerland|Dr CP Heidegger|+41223827440|claudia-paula.heidegger@hcuge.ch|
22430855|NCT02951481|Fundación de investigación Hospital Universitario 12 de Octubre|MD, PhD José María Aguado García|913908000|jaguadog1@gmail.com|4632
22430856|NCT01051661|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22430857|NCT05007639|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Pr Simone Mathoulin-Pélissier|+33 (0)5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
22430858|NCT02852005|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22430859|NCT05781685|UT Southwestern Medical Center|Chance Ryan Strenth|337-274-7647|chance.strenth@utsouthwestern.edu|
22430860|NCT04079920|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22430861|NCT03760068|Sr. Director Global Clinical Operations, General Medicine|Keri L. Vaughan|+1 267.980.5015|keri.vaughan@mylan.com|
22430862|NCT05014919|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
22430863|NCT00967486|Vascular center of excellence (CAMC medical staff-with admitting privileges)|Ali Fawazi AbuRahma MD|304-388-9973||
22430864|NCT01469156|Southeast Retina Center|Dr. Dennis Marcus|706-650-0061|dmarcus@southeastretina.com|
22430865|NCT01813227|Hackensack Meridian Health|Joshua Zenreich|5519964248|joshua.zenreich@hmhn.org|
22430866|NCT04126174|Gainesville Eye Associates|Clayton Blehm, MD|7705324444|claytonblehm@gmail.com|
22430867|NCT03773562|Mayo Clinic|Dr. Todd Schwedt|480-342-2695|schwedt.todd@mayo.edu|
22430868|NCT01491919|Duke Clinical Research Institute|Uptal Patel, MD|919-668-4601|uptal.patel@duke.edu|
22430869|NCT01854762|Fundação Bahiana de Infectologia / Universidade Federal da Bahia|Dr. Carlos Brites|5571992329552|crbrites@gmail.com|
22430870|NCT03784300|Cassava Sciences|Michael R Marsman, PharmD|5125822173|mmarsman@cassavasciences.com|
22451481|NCT01375049|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22451482|NCT02082522|At the request of Concordia Laboratories Inc.|Dr. Michelle Depot||michelle.depot@advanzpharma.com|
22388105|NCT03162614|GlaxoSmithKline|GSK Response Center|877-379-3718|GSKClinicalSupportHD@gsk.com|
22388106|NCT03861234|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22388107|NCT00621842|Case Western Reserve University|Christopher Bialko|216-286-4362|Christopher.Bialko@UHhospitals.org|
22388108|NCT00783952|Massachusetts General Hospital|Robert M Kacmarek PhD, RRT|617-314-2222|rkacmarek@partners.org|
22388109|NCT02170532|Duke University Medical Center|Neil MacIntyre, MD|(919) 681-2720|macin001@mc.duke.edu|
22388110|NCT05169684|Bristol Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
22451483|NCT00633984|Boston University|Dr. Stefan G. Hofmann|617 353 9233|shofmann@bu.edu|
22451484|NCT02496884|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22451485|NCT01168999|University of Florida|Dr. Joel Bialosky|352-273-8636|bialosky@phhp.ufl.edu|
22451486|NCT03766646|University Hospital Southampton|Dr Patrick Butler|81205662|patrick.butler@uhs.nhs.uk|+44 (0)23
22451487|NCT01282710|Reproductive Research Technologies, LP|Jack McCrary|7136800200|jmc@innovalp.com|
22451488|NCT02504645|ImmuPharma|CEO|+33 6 18 22 16 50|robert.zimmer@immupharma.com|
22451489|NCT01854554|UT MD Anderson Cancer Center|Dr. Caroline Chung, MD- VP, Chief Data Officer, Data Impact & Governance|(713) 745-5422|cchung3@mdanderson.org|
22451490|NCT02819726|Archigen Biotech Ltd|Medical Director|+44(0)20 3749 5000|info@archigenbio.com|
22451491|NCT02829034|University of Pennsylvania|Yuchi Han, PI of the study|215-615-3417|yuchi.han@uphs.upenn.edu|
22451492|NCT00803023|Jazz Pharmaceuticals|Director of Clinical Development|650-496-3777||
22451493|NCT02647658|University of Pittsburgh|Dr. Charity Patterson|412-383-4812|cgp22@pitt.edu|4123834812
22451494|NCT02202135|AstraZeneca-PPD|Yunxia Lu|910-558-4197|Yunxia.Lu@ppdi.com|
22451495|NCT04382326|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22451496|NCT01181921|Jan-Cil Spain|COUNTRY MEDICAL DIRECTOR|+34 91 7228043||
22451497|NCT02461589|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22451498|NCT00995449|KaloBios Pharmaceuticals, Inc.|Nestor A. Molfino, MD., MSc|650-243-3103|nmolfino@kalobios.com|
22451499|NCT01038921|Emory University|Dr. Abinav Goyal|404-727-8758|agoyal4@emory.edu|
22451500|NCT01978119|GlaxoSmithKline|GSK Response Center|866-435-7343||
22451501|NCT04695691|Cutera|Director Clinical Research|415-657-5518|mdoucette@cutera.com|
22451502|NCT00559897|Barbara Ann Karmanos Cancer Institute|Dr. Shirish Gadgeel|313-576-8753|gadgeels@karmanos.org|
22451503|NCT03295201|Marmara University|Dr. Kardelen Gencer Atalay|5324404887|kardelengencer@gmail.com|532
22451504|NCT02519504|Emory University|Judith Fridovich-Keil, PhD|404-727-3924|jfridov@emory.edu|
22451505|NCT02548962|Pharmacyclics Switzerland GmbH|Dr. Bernhard Hauns, Medical Monitor|+41 52 556 0800|bhauns@pcyc.com|
22451506|NCT03963895|Aronora, Inc.|Norah Verbout, Ph.D.|503-964-0250|norah.verbout@aronorabio.com|
22451507|NCT01958918|Novartis Pharma AG|Study Director|+41613241111|Novartis.email@novartis.com|
22388111|NCT05352230|UAB|Orlando Gutierrez|2059962736|ogutierrez@uabmc.edu|
22388112|NCT05414682|University of Kansas Medical Center|Dr. Ashley Shaw|913-945-5023|ashaw10@kumc.edu|
22388113|NCT03212638|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22388114|NCT00875706|Department of Veterans Affairs|Dr. Carol VanDeusen Lukas|857-364-5685|carol.vandeusenlukas@va.gov|
22388115|NCT03775213|Duke University|Dr. Marc D. Ryser|(919) 684 8294|marc.ryser@duke.edu|
22388116|NCT00786188|Noven Therapeutics, LLC|Sailaja Bhaskar, Executive Director, Clinical Research|(212) 287-0798|sbhaskar@noven.com|
22388117|NCT00326183|Merck Sharp & Dohme Corp|Senior Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
22388118|NCT01990794|Cardno|Dr. David Galbraith|415-618-3211|david.galbraith@cardno.com|
22388119|NCT03787628|UCLA David Geffen School of Medicine|Dr. Edythe London|3106142150|elondon@mednet.ucla.edu|
22388120|NCT01827839|GlaxoSmithKline|GSK Response Center|866-435-7343||
22388121|NCT00570505|Apollo Endosurgery|Laura Eaton|949-468-9301|laura.eaton@apolloendo.com|
22388122|NCT00614614|GlaxoSmithKline|GSK Response Center|866-435-7343||
22388123|NCT05426109|Virginia Tech|Dr. Larson-Meyer|540-231-1025|enette@vt.edu|
22388124|NCT05212285|Huadong hospital,Shanghai ,China|Dr.Yinggang Zhu,Dr Ting Zhao|1374321007|robinzyg-zhu@vip.sina.com;vivianzaza@163.com|+86
22388125|NCT01341301|Thomas Jefferson University|Dr. Neal Flomenberg|215-955-8874|neal.flomenberg@jefferson.edu|
22388126|NCT04069247|Chinese University of Hong Kong|Dr. Yun Kwok Wing|+852 39197593|ykwing@cuhk.edu.hk|
22388127|NCT04118894|Stryker|Jennifer Seidman, Manager, Clinical Research|9016338616|jennifer.seidman@stryker.com|
22388128|NCT00604890|Berg LLC|Nathaniel DiTommaso|617-588-1002|nate.ditommaso@berghealth.com|
22401229|NCT03756012|Ohio Pain Clinic|Dr. Amol Soin|937-434-2226|drsoin@ohiopainclinic.com|
22451508|NCT01597687|GlaxoSmithKline|GSK Response Center|866-435-7343||
22451509|NCT00659269|University of New Mexico|Zoneddy Dayao, MD|5059250404|zdayao@salud.unm.edu|
22451510|NCT00908960|Beth Israel Deaconess Medical Center|Jeffrey Zwicker, MD|617-667-9299|jzwicker@bidmc.harvard.edu|
22451511|NCT02401672|Medical University of South Carolina|Xingbao Li, MD|843-792-5729|lixi@musc.edu|
22451512|NCT01736852|Cook Research Incorporated|Alan Saunders,MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
22451513|NCT03653429|Icahn School of Medicine at Mount Sinai|Poonam Pai B. H|212-523-4000|poonam.paibantwalhebbalasankatte@mountsinai.org|
22451514|NCT01814722|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22451515|NCT01168934|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22451516|NCT01070810|BIDMC|Michael W Donnino|617-754-2295|mdonnino@bidmc.harvard.edu|
22451517|NCT05857527|Medical University of South Carolina|Kelly McGloon|8437926443|mcgloon@musc.edu|
22451518|NCT01592708|UNC Chapel Hill|Dr. Jay Anderson, PI|919-966-5136|janderson@aims.unc.edu|
22451519|NCT00059475|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-6375|nciirbadmin@mail.nih.gov|
22451520|NCT02610140|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22451521|NCT00887341|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22451522|NCT02015234|Tonix Pharmaceuticals|Gregory M. Sullivan, Chief Medical Officer|212 980 9155|greg.sullivan@tonixpharma.com|117
22451523|NCT01312961|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22451524|NCT03333746|The Ohio State University Comprehensive Cancer Center|Dr. Yvonne Efebera|614-293-7243|Yvonne.Efebera@osumc.edu|1278
22451525|NCT05402995|UMissouri|Vicki L Jones|573-882-7583|jonesvicki@health.missouri.edu|
22451526|NCT01427296|Valeant Pharmaceuticals|Johnson Varughese|9089271400||
22451527|NCT01337297|Federal University of Espírito Santo|Dr. Ester Miyuki Nakamura-Palacios|+55 27 7775-7337|emnpalacios@gmail.com|
22451528|NCT01800903|Coloplast A/S|Trine Møller Senior Clinical Manager|+45 4911 2174|dktrm@coloplast.com|
22451529|NCT02002494|Toronto Western Hospital/UHN|Emad Al Azazi|416-603-8500|emad.alazazi@uhnresearch.ca|6237
22451530|NCT01306617|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22451531|NCT01767792|The University of Alabama at Birmingham|Bruce Korf, MD, PhD|205.934.4010|bkorf@uabmc.edu|
22451532|NCT01208233|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22451533|NCT01891734|Department of Veterans Affairs San Diego|Kathleen Grubbs|808-383-9757|kathleen.grubbs@va.gov|
22451534|NCT02780349|Gardia Medical|Vardit Segal Ph.D|972-4-6277166|vardit@gardiamedical.com|
22451535|NCT04028388|Modra Pharmaceuticals|M. Keessen|+31202050188|info@modrapharmaceuticals.com|
22451536|NCT02841644|Atrium Health|Vice Chair of Research|7043552000|Rachel.Seymour@atriumhealth.org|
22451537|NCT04114058|Cedar Sinai -Kerlan Jobe|Dr. Michael Banffy|(310) 665-7200|Michael.Banffy@cskerlanjobe.org|
22451538|NCT02430077|UT Southwestern Medical Center|Abhimanyu Garg|2146482895|Abhimanyu.garg@utsouthwestern.edu|
22451539|NCT00129259|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22451540|NCT01609556|ImmunoGen, Inc|CMO, ImmunoGen|781-895-0600|clinicaltrials@immunogen.com|
22451541|NCT00139997|Yale University|Paul Desan, MD, PhD|203 785 2618|paul.desan@yale.edu|
22451542|NCT01632579|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22451543|NCT00162136|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22451544|NCT00019682|Indiana University Health|Dr Douglas Schwartzentruber|317-948-6873|dschwart@iuhealth.org|
22451545|NCT01539291|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22451546|NCT04450264|Icahn School of Medicine at Mount Sinai|Dr. Jamilia Sly|212-824-7813|jamilia.sly@mssm.edu|
22451547|NCT01543256|Boston Scientific|Evelyne Ho|+1 508-683-4140|Evelyne.Ho@bsci.com|
22451548|NCT00074282|ECOG-ACRIN Statistical Office|Study Statistician|617 632 3012|eatrials@jimmy.harvard.edu|
22451549|NCT01319396|ResMed|Paul Phillips|+353 1 716 3755|paul.phillips@resmed.com|
22451550|NCT00822510|University of Arizona College of Nursing|Terry Badger, PhD, PMHCNS-BC, FAAN|520-626-6058|tbadger@email.arizona.edu|
22451551|NCT02055352|Novartis Pharmaceuticals|Study Director|862-778-8300||
22451552|NCT04745169|Baylor College of Medicine|Elizabeth Lorenz, MD|713-798-2694|elizabeth.lorenz@bcm.edu|
22451553|NCT03809182|Pontificia Universidad Católica de Chile|Mauricio Ibacache MD|+56984421425|mibacach@med.puc.cl|
22451554|NCT01763567|Medtronic, Inc.|Julie Sekella|818-576-5000|Julie.Sekella@medtronic.com|
22451555|NCT00129987|Imperial College London|Martyn R Patridge|+44 (0)20 7594 7959|m.patridge@imperial.ac.uk|
22451556|NCT00116805|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22451557|NCT01575561|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
22451558|NCT05209191|REAL Prevention LLC|Dr. Michael L. Hecht|18143601893|HECHTPSU@GMAIL.COM|
22451559|NCT01033747|Novartis Pharmaceuticals|Study Director|862 778-8300||
22451560|NCT02613481|Yardley Dermatology Associates, PC|Director of Clinical Trials|2155796155|rfried@yardleyderm.com|
22451561|NCT00844194|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22451562|NCT00701389|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22451563|NCT01542528|Yale University|Dr. James Leckman|203-785-5880|james.leckman@yale.edu|
22451564|NCT05282004|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22401230|NCT02117050|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22401231|NCT01591330|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22401232|NCT01662999|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22401233|NCT00196937|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22401234|NCT01322815|Ruesch Center at Georgetown Lombardi|John L Marshall|202.444.7064|marshalj@georgetown.edu|
22401235|NCT03368404|Bausch + Lomb|Associate Director, Global Clinical Operations|+49 30 330 93|natasa.orlic-pleyer@bausch.com|318
22388129|NCT02713594|University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|6082627563|sss@ctri.wisc.edu|
22388130|NCT03690219|Rehabilitation Research Laboratory, University of Applied Sciences and Arts of Southern Switzerland (SUPSI)|Dr Ron Clijsen|0041 81 300 01 78|ron.clijsen@supsi.ch|
22388131|NCT01523392|AstraZeneca|Tomas LG Andersson, MD, PhD|1-800-236-9933|ClinicalTrialTransparency@astrazeneca.com|
22388132|NCT02771366|University of Florida|Adam Woods, Ph.D.|352-294-5842|ajwoods@phhp.ufl.edu|
22388133|NCT02068157|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
22388134|NCT02092285|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22388135|NCT01928732|Palo Alto CSPCC|Lisa Zehm|(650) 493-5000|Lisa.Zehm@va.gov|28805
22388136|NCT01185340|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22388137|NCT00087516|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22388138|NCT00246129|imperial College Kidney & Transplant Centre|Dr Adam McLean|+44 (0) 208 383 5164|adam.mclean@imperial.nhs.uk|356164
22388139|NCT01779050|Washington University School of Medicine|Rebecca Aft, M.D., Ph.D.|314-747-0063|aftr@wustl.edu|
22388140|NCT03403036|Icahn School of Medicine at Mount Sinai|Dr. Mark Lebwohl|212-241-9728|mark.lebwohl@mountsinai.org|
22381066|NCT04833855|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22381067|NCT02806336|Baltimore VA Geriatric Research Education and Clinical Center|Dr. Leslie Katzel|4106057248|leslie.katzel@va.gov|
22381068|NCT03682536|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22381069|NCT04824131|HPTN Statistical & Data Management Center|HPTN Statistical Manager|1206-667-4004|HPTN-Data-Access@scharp.org|
22381070|NCT03643965|Calliditas Therapeutics|Clinical Program Leader|0737456451|kristin.onnestam@calliditas.com|
22381071|NCT04536025|University of Colorado|Dr. Chelsey Anderson|12069926861|chelsey.anderson@cuanschutz.edu|
22381072|NCT00610883|Memorial Sloan Kettering Cancer Center|Dr. Tanya Trippett|212-639-8267|trippet1@mskcc.org|
22381073|NCT02338609|Novartis Pharmaceuticals|Study Director|+1 862-778-8300|novartis.email@novartis.com|
22388141|NCT01335061|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22388142|NCT02125292|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22388143|NCT02392507|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
22388144|NCT00273052|GlaxoSmithKline|GSK Response Center|866-435-7343||
22388145|NCT00704340|Integra LifeSciences|Director, Medical Affairs|609-275-0500||
22388146|NCT01487954|Case Comprehensive Cancer Center AND Summa Health System|Dr. Charles A. Kunos, MD, PhD|(330) 375-3557|kunosc@summahealth.org|
22451565|NCT04808609|Columbia University|Dr. Rebecca Schnall, RN, MPH, PhD, Professor of Disease Prevention and Health Promotion (in Nursing)|212-342-6886|rb897@cumc.columbia.edu|
22451566|NCT00562159|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22451567|NCT02256111|Duke University|Michael Harrison, MD|919-668-4615|michael.harrison@duke.edu|
22451568|NCT00659165|Univ NM|Mark Burge|505-272-4658|mburge@salud.unm.edu|
22451569|NCT00618657|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
22451570|NCT02710630|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22451571|NCT01992536|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22451572|NCT01762761|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
22451573|NCT03017508|Yale University|Angeli Landeros|203-737-4809|angeli.landeros@yale.edu|
22451574|NCT02352493|Alnylam Pharmaceuticals, Inc.|Chief Medical Officer|866.330.0326|Clinicaltrials@alnylam.com|
22451575|NCT02162810|UPMC Children's Hospital of Pittsburgh|Karen Kenyon, research coordinator|4126923058|kenyonkl@upmc.edu|
22451576|NCT00389324|Grifols Therapeutics, Inc.|Henry Li, PhD|800-520-2807|henry.li@grifols.com|
22451577|NCT02317575|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22451578|NCT01465334|Dana-Farber Cancer Institute|Jennifer R. Brown, MD, PhD|(617) 632-3316|Jennifer_Brown@dfci.harvard.edu|
22451579|NCT00572572|Hoosier Cancer Research Network|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
22451580|NCT01831089|Pharma Mar, S.A.|Clinical Development Department of PharmaMar´s Oncology Business Unit.|+34 91 846 60 00|clinicaltrials@pharmamar.com|
22451581|NCT00889421|Oregon Health & Science University|Dr. Eric Suhler|503-494-5023|suhlere@ohsu.edu|
22451582|NCT04729803|palo alto university|Dr. Mikael Rubin|650-433-3805|mrubin@paloaltou.edu|
22451583|NCT03936244|Hospital Universitario Fuenlabrada|Dr. Hugo Otaola Arca|+56 9 4108 9452|hugotaolarca@hotmail.com|
22451584|NCT00652457|University of California, San Diego|Jody Corey-Bloom, MD, PhD|858-249-0574|jcoreybloom@ucsd.edu|
22451585|NCT05734846|CooperVision Inc.|Percy Lazon de la Jara BOptom PhD|+1-925-251-6682|PLazon@coopervision.com|
22451586|NCT01134900|The University of Texas Health Science Center at Houston (UTHealth)|Allison B. McCoy, PhD|713-500-6931|allison.b.mccoy@uth.tmc.edu|
22451587|NCT01714024|UNC School of Dentistry|Steven Offenbacher, DDS, PhD, MMSc|919-537-3205|steven_offenbacher@unc.edu|
22451588|NCT04408963|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
22451589|NCT00583492|Henry Ford Health System|Benjamin Movsas|313-516-2319|bmovsas1@hfhs.org|
22451590|NCT02480621|Department of Orthopaedic Surgery, NYU Langone Orthopaedic Hospital|Dr. Adam Driesman|2033315938|Adam.Driesman@nyumc.org|
22451591|NCT01748994|Pennington Biomedical Research Center|Dr. Eric Ravussin|225-763-3186|eric.ravussin@pbrc.edu|
22451592|NCT03105362|Boston Children's Hospital|Dr. Christopher Duggan|617-355-7612|christopher.duggan@childrens.harvard.edu|
22451593|NCT02749903|Memorial Sloan Kettering Cancer Center|Alan Ho, MD, PhD|646-888-4235|hoa@mskcc.org|
22451594|NCT00861341|University of Rochester, Wilmot Cancer Center|Charles Francis, MD|585-275-3761|Charles_Francis@urmc.rochester.edu|
22451595|NCT01440946|Bioverativ|Bioverativ Study Medical Director||clinicaltrials@bioverativ.com|
22451596|NCT01975389|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22451597|NCT00433992|Case Western Reserve University|Dr. Grace McComsey|216-844-2739|mccomsey.grace@clevelandactu.org|
22451598|NCT01122511|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22451599|NCT03735862|Miromatrix|Head of Clinical Affairs|952.942-6000|mmacenski@miromatrix.com|
22451600|NCT01514318|DJO Surgical|Dr. Jane M. Jacob|512-834-6323|jane.jacob@djoglobal.com|
22451601|NCT02296112|Vanderbilt University Medical Center|Douglas Johnson, MD|(615) 936-8422|douglas.b.johnson@vumc.org|
22451602|NCT02778204|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22451603|NCT01720069|Vectura Limited|Gary Burgess, MD|+44(0)1249 667700|clinical.enquiries@vectura.com|
22451604|NCT00360334|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22451605|NCT01898793|Washington University School of Medicine|Amanda Cashen, M.D.|314-434-8323|acashen@wustl.edu|
22451606|NCT01218997|Alkermes, Inc.|Bernard L. Silverman|781-609-6000|bernard.silverman@alkermes.com|
22451607|NCT01222585|Duke Clinical Research Institute|Michael Cohen-Wolkowiez, MD|919668-8812|michael.cohenwolkowiez@dm.duke.edu|
22451608|NCT02239510|TriHealth Hatton Research Institute|Jenni Steinbrunner|513-862-4033|jenni_steinbrunner@trihealth.com|
22451609|NCT00982020|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22451610|NCT03551938|University of Michigan|Dr. Rob Stephenson|734-763-1188|rbsteph@med.umich.edu|
22451611|NCT01925183|Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna|Markus Peck-Radosavljevic (Principal Investigator)|+43 1 40400|markus.peck@meduniwien.ac.at|47440
22451612|NCT01114646|Hartford Hostpial|Arben Ademi, CCRP|860-972-3561|arben.ademi@hhcealth.org|
22451613|NCT01046110|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22451614|NCT01381172|Impulse Dynamics (USA) Inc|Sr. Director, Clinical and Data Operations|8453592389|angelas@impulse-dynamics.com|
22388147|NCT04220983|Weill Cornell Medicine|Sharanya Chandrasekhar|646-962-3110|shc2043@med.cornell.edu|
22388148|NCT02124044|NIH Clinical Center|Masur, Henry|+1 301 496 9320|HMasur@cc.nih.gov|
22388149|NCT01260883|Seattle Children's Hospital|Anne Lynn MD|206 987-2518|anne.lynn@seattlechildrens.org|
22388150|NCT00403845|Novartis Pharmaceuticals|Study Director|862 778-8300||
22388151|NCT03316170|University of Kentucky|Dr. Jessica Burris|+1 859-257-9612|jessica.burris@uky.edu|
22388152|NCT02935673|Janssen Research & Development, LLC|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22388153|NCT01836523|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22388154|NCT02095678|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Vikas Gulani|+1 216-844-3312|Vikas.Gulani@UHhospitals.org|
22388155|NCT03418545|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22388156|NCT04660799|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22388157|NCT02706483|Bausch Health|Matt Markovich|908-541-1341|Matthew.Markovich@bauschhealth.com|
22388158|NCT03131713|Tufts Medical Center|Bichchau Nguyen, Principal Investigato|617-636-1286|bnguyen2@tuftsmedicalcenter.org|
22388159|NCT02764970|Medical University of Graz|Assoc. Prof. Dr. Dirk von Lewinski|31638580684|dirk.von-lewinski@medunigraz.at|316
22388160|NCT02144597|Imperial College London|Prof Gary Frost|07872850308|g.frost@imperial.ac.uk|
22388161|NCT02356198|Mayo Clinic|Dr. Dorin T. Colibaseanu, MD|904-953-2596|colibaseanu.dorin@mayo.edu|
22388162|NCT02397707|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22388163|NCT05484661|UT Health San Antonio|Monica Serra|210-949-9759|serram@Uthscsa.edu|
22388164|NCT01450397|Hospital for Special Surgery|Scott W. Wolfe|212-606-1529|WolfeS@hss.edu|
22388165|NCT04748341|Lahore school of nursing, University of lahore, Pakistan|Ms. Mishal Liaqat (Principal Investigator)|+923441481666|mishee861@gmail.com|
22388166|NCT05250206|Indizen Optical Technologies (Madrid), Universidad Complutense de Madrid|Director of Clinical Trials|+34 (91) 833 37 86|evachamorro@iot.es|
22388167|NCT02334215|Friends Research Institute|Robert P. Schwartz, M.D.|410-837-3977|rschwartz@friendsresearch.org|276
22388168|NCT03016871|City of Hope Medical Center|Dr. Alex Herrera|626-359-8111|aherrera@coh.org|
22388169|NCT05865392|University of Colorado|Dr. Danielle M. Ostendorf|3037249203|danielle.ostendorf@cuanschutz.edu|
22388170|NCT02159989|MD Anderson Cancer Center|Aung Naing|713-563-3885|anaing@mdanderson.org|
22388171|NCT04889989|Ethicon, Inc.|Erin Meyers|937-681-0322|eprifog1@its.jnj.com|
22414490|NCT03599193|Dr. Reddy's Laboratories Inc.|Dr. Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
22451615|NCT00905580|Department of Anaesthesiology and Pain Medicine and Anaesthesia and Pain Research Institute, Department of surgery, Yonsei University College of Medicine|Dr. So Yeon Kim|82-2-2227-3642|kimsy326@hanmail.net|
22451616|NCT01243450|Cu-Tech, LLC|William J. Cunningham, MD|(973) 331-1620|wcunningham@cu-tech.com|
22388173|NCT02485925|Biosense Webster, Inc.|Kendra McInnis|949-450-7783|kmcinnis@its.jnj.com|
22388174|NCT05995977|Karaman Provincial Health Directorate|Handan Altunkan|05367443152|handanaltunkan@gmail.com|
22388175|NCT04181788|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22451617|NCT02753751|Yale University|Francis P. Wilson|2037376095|francis.p.wilson@yale.edu|
22451618|NCT02667912|Tomsk National Research Medical Center of the Russian Academy of Sciences|Dr. Stanislav Pekarskiy|+73822558122|pekarski@cardio-tomsk.ru|
22451619|NCT04443218|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
22451620|NCT01047683|Amarin Pharma, Inc.|Alex Giaquinto|+1 908 326 1324|alex.giaquinto@amarincorp.com|
22451621|NCT03447769|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
22451622|NCT00088218|The University of Texas M. D. Anderson Cancer Center|Stefan Fader, M.D./Associate Professor|713/745-4613|eharriso@mdanderson.org|
22451623|NCT00781326|University of Pittsburgh|Ellen Whyte, MD|412 246 5066|whyteem@upmc.edu|
22388176|NCT04937504|Boston Medical Center, Psychiatry Department|Sarah Valentine, PhD|(617) 414-1989|sarah.valentine@bmc.org|
22388177|NCT04535414|National Cancer Institute|Dr. Andrew Blakely|240-760-7647|andrew.blakely@nih.gov|
22401236|NCT04725682|FDA/CDER/OGD|Wei-Jhe Sun, Ph.D.|301-796-6176|ORSHSR@fda.hhs.gov|
22401237|NCT00964795|Regeneron|Clinical Trials Administrator|9148475385|clinicaltrials@regeneron.com|
22414491|NCT01750294|Indiana University & Richard L Roudebush VA Medical Center|Rajiv Agarwal, MD, FAHA, FASN, FASH|317-988-2241|ragarwal@iu.edu|
22401238|NCT02973815|School of Nursing, University of Minnesota|Dr. Jayne A. Fulkerson|612-624-4823|fulke001@umn.edu|
22401239|NCT03734666|Moffitt Cancer Center|Christine Vinci|813-745-5421|Christine.Vinci@moffitt.org|
22401240|NCT05866185|University of South Florida|Brian Bunnell|8139748607|bbunnell@usf.edu|
22401241|NCT03037905|Cleveland Clinic|Christian N. Burchill, PhD, RN, CEN|216-445-9317|burchic@ccf.org|
22401242|NCT01607892|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
22401243|NCT03983941|Nationwide Children's Hospital|Julie Rice-Weimer, RN|614-355-3142|julie.rice-weimer@nationwidechildren.org|
22401244|NCT03022422|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
22401245|NCT02104180|Mylan Medical SAS|Benoit LA ROCHE|+33 1 46 25 86 76|benoit.la-roche@mylan.com|
22451624|NCT00096941|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
22451625|NCT01166984|AtoxBio, Ltd.|Wayne M Dankner, MD, Chief Medical Officer|1 919-219-6377|wayned@atoxbio.com|
22451626|NCT03029208|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22388178|NCT03662659|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22388179|NCT06922643|Nanogen Biopharmaceutical JSC|Dr. Thuy Phuong Nguyen|+84 903 754 559|phuongthuy@nanogenpharma.com|
22388180|NCT04104022|University of Vermont|Dr. Kelly R. Peck, Ph.D.|8026569610|Kelly.Peck@uvm.edu|
22388181|NCT04369664|NYU Langone Health|Jeffrey Berger, MD|212-263-4004|jeffrey.berger@nyulangone.org|
22388182|NCT03840200|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22388183|NCT00671853|University Hospitals Cleveland Medical Center|Dr. Kemp Gao|216-844-2865|keming.gao@UHhopsitals.org|
22388184|NCT02354417|Fate Therapeutics, Inc.|Chris Storgard, Chief Medical Officer|866-875-1833|chris.storgard@fatetherapeutics.com|
22388185|NCT01848483|Emory University|Marcia McDonnell Holstad|404-727-1307|nurmmcd@emory.edu|
22388186|NCT01093690|Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University|Suthinee Ithimakin, MD|6624197000|aesi105@yahoo.co.th|4489
22388187|NCT02746107|Carol Davila University of Medicine and Pharmacy Bucharest|Professor Cristian Baicus|+40788302355|cbaicus@gmail.com|
22388188|NCT01450007|Mayo Clinic|Dr. David M. Rosenfeld|480-301-7586|Rosenfeld.David@mayo.edu|
22388189|NCT03851094|ResMed|Clinical Research Team|800-424-0737|clinicaltrials@resmed.com.au|
22388190|NCT00484198|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22388191|NCT01536704|GlaxoSmithKline|GSK Response Center|866-435-7343||
22388192|NCT04658784|Ascension Saint Thomas Medical Group|Dr. Amanda Merriman|615-397-6919|amanda.yacko@gmail.com|
22388193|NCT02958553|Ottobock Healthcare|Russ Lundstrom|512-806-2606|russ.lundstrom@ottobock.com|
22388194|NCT01083706|Fred Hutchinson Cancer Research Center|Bart Scott|206-667-1990|bscott@fredhutch.org|
22388195|NCT04311983|Washington University School of Medicine|Matthew Kreuter, Ph.D.|314-935-3701|mkreuter@wustl.edu|
22388196|NCT02007070|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22388197|NCT00703092|Virginia Commonwealth University|Dr. John Nestler|804-828-3389|jnestler@mcvh-vcu.edu|
22388198|NCT04070105|University of Michigan|Dr. Deanna Gates|7346472698|gatesd@umich.edu|
22388199|NCT00749944|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22388200|NCT00624377|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22388201|NCT05228834|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22388202|NCT05012462|Zynex Monitoring Solutions|ZMS Clinical|800-495-6670|clinical@zynexmonitoring.com|
22388203|NCT04884191|CTI BioPharma, Inc.|John Volpone SVP, Strategic Operations|+1 (206) 272-4652|jvolpone@ctibiopharma.com|
22388204|NCT06631313|Becton, Dickinson and Company|Director of Clinical Affairs|551-225-1164|kirsten.hammitt@bd.com|
22388205|NCT00089791|Amgen Inc.|Study Director|866-572-6436||
22388206|NCT02161458|University of Pennsylvania|Yvette Sheline, Principal Investigator|215-746-2637|cndslab@pennmedicine.upenn.edu|
22388207|NCT02941692|Medical University of South Carolina|Dr. Julianne Flanagan|843-792-5569|Hellmuth@musc.edu|
22388208|NCT02527694|Seoul National University Hospital|So Yeon Kong|82220724412|soyeon.kong@gmail.com|
22388209|NCT02070276|Hôpitaux Universitaires de Genève|Dr. med. Samuele Ceruti|0765661181|samuele.ceruti@me.com|
22388210|NCT02362789|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
22388211|NCT02037568|University of Colorado Denver|Mark L. Laudenslager, PhD|303-724-9277|biel@ucdenver.edu|
22388212|NCT00407485|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22388213|NCT00432445|University of Texas (UT) MD Anderson Cancer Center|Dan Gombos, MD/Professor, Ophthalmology|713-792-6920|CR_Study_Registration@mdanderson.org|
22388214|NCT05353296|Columbia University|Carmela Alcantara, PhD|212-851-2187|ca2543@cumc.columbia.edu|
22388215|NCT05074433|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|8447346643|clinicaltrials@regeneron.com|
22388216|NCT04397263|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22388217|NCT01989689|Emory University|Arshed Ali Quyyumi MD/FACC|404-727-3655|aquyyum@emory.edu|
22388218|NCT02066636|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22388219|NCT04806100|The University of Iowa|Jason M Wilken, PT, PhD|319-335-6857|jason-wilken@uiowa.edu|
22388220|NCT00391170|National Heart Lung and Blood Institute|Clara, Joseph|+1 301 402 2399|joseph.clara@nih.gov|
22388221|NCT03567616|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22388222|NCT01235936|Akebia Therapeutics, Inc|Akebia Therapeutics, Inc|617-844-6128|trials@akebia.com|
22388223|NCT00380250|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22388224|NCT01989104|Pennington Biomedical Research Center|Dr. William Johnson|225-763-2932|William.Johnson@pbrc.edu|
22388225|NCT02833948|The Heart Center - Rigshospitalet, Copenhagen, Denmark|Ole De Backer, MD, PhD|+45-35457086|ole.debacker@gmail.com|
22388226|NCT03897699|University of Minnesota|Dr. Kathryn Cullen|612-273-9732|rega0026@umn.edu|
22388227|NCT00680771|University of rochester|Wilfred Pigeon|(585) 275-3374|Wilfred_pigeon@urmc.rochester.edu|
22388228|NCT02691702|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22388229|NCT05613088|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22388230|NCT03796767|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
22388231|NCT04603586|Changhai Hospital|Xiaofei Zhu|86-021-31162222|zhuxiaofei_zxf@163.com|
22401246|NCT03246529|BioLineRx Ltd|VP Clinical & Medical Affairs|+972-8-6429100|clinicaltrials@biolinerx.com|
22388232|NCT02506283|University of Applied Sciences and Arts of Southern Switzerland (SUPSI)|Dr. Erich Hohenauer|+41813000175|erich.hohenauer@supsi.ch|
22388233|NCT03652610|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22388234|NCT05615363|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22388235|NCT03905642|Insmed Incorporated|Kevin Mange (Senior VP, Clinical Development and Medical Affairs)|908-947-2651|kevin.mange@insmed.com|
22388236|NCT04278833|Stanford University|Clinical Research Coordinator|(650) 723-0003|jessn16@stanford.edu|
22388237|NCT04447027|National Cancer Institute|Dr. Mark J. Roschewski|240-760-6183|mark.roschewski@nih.gov|
22388238|NCT05200416|Coloplast A/S|Senior Clinical Strategy Project Manager|+4549111341|dkteaa@coloplast.com|
22388239|NCT06943638|"General Oncology Hospital of Kifissia Agioi Anargyroi"|Christine Mavrogiannopoulou, Physiotherapist and Study coordinator|+30 6941464095|x.mavrogiannopoulou@gmail.com|
22388240|NCT05992350|Children's Mercy Research Institute|Priscilla Connell|8166014543|Endocrine-RisingT1deAlliance@cmh.edu|
22388241|NCT02421679|Tonix Pharmaceuticals|Gregory M. Sullivan, Chief Medical Officer|862-904-0355|greg.sullivan@tonixpharma.com|
22388242|NCT01458015|Universitätsklinikum Schleswig-Holstein, Campus Kiel; Sektion neurologische Schmerzforschung und -therapie|Prof. Ralf Baron|+4943123911|r.baron@neurologie.uni-kiel.de|
22388243|NCT03565640|Atrium Wake Forest Baptist Health|Sachin Vyas|7865564412|svyas@wakehealth.edu|
22388244|NCT03854734|Penn State College of Medicine|Dr. Jennifer Kraschnewski, Professor of Medicine and Public Health Sciences|717-531-8161|jkraschnewski@pennstatehealth.psu.edu|
22388245|NCT02196259|University of Michigan|Dr. Scott Peltier|734-647-8077|spelt@umich.edu|
22388246|NCT00264576|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22388247|NCT04173000|Cincinnati Children's|Dr. William B. Brinkman|513-636-2576|bill.brinkman@cchmc.org|
22388248|NCT01668355|VA|Alexander Young|310-794-7219|alexander.young@va.gov|
22388249|NCT02659059|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22388250|NCT02236611|GlaxoSmithKline|GSK Response Center|866-435-7343||
22388251|NCT03041090|Saint Louis University|Medhat Osman, MD, PhD - Professor of Radiology, Director of Nuclear Medicine and PET/CT|314-577-8047|medhat.osman@health.slu.edu|
22388252|NCT02202317|University of Miami Miller School of Medicine|Dr Jason Salsamendi|305-585-7500|jsalsamendi@miami.edu|
22388253|NCT02338999|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Kaplan, Mariana|+1 301 496 0517|mariana.kaplan@nih.gov|
22388254|NCT02701296|ST. FRANCIS HOSPITAL AND MEDICAL CENTER|Sanjay Sinha, MD||sanjaysinha@comcast.net|
22388255|NCT01332266|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
22388256|NCT03302091|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22388257|NCT01686152|Teva Pharmaceuticals USA|Director, PD/CE Studies|1-888-483-8279|usmedinfo@tevapharm.com|
22388258|NCT01802333|SWOG Statistics and Data Management Center|Leukemia Committee Statistician|206-667-4623|amoseley@fredhutch.org|
22388259|NCT02551224|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22388260|NCT00724009|The University of Chicago|Wendy Stock, MD|773-834-8982|wstock@medicine.bsd.uchicago.edu|
22388261|NCT01947491|Promius Pharma, LLC|Director of Clinical Operations|609-282-1476|kgulbronson@promiuspharma.com|
22388262|NCT02224755|Abbott|Joyce Chuang/Principal scientist|925-353-5817|joyce.chuang@abbott.com|
22388263|NCT02067663|Stanford University School of Medicine|Lisa Goldthwaite|541-515-1825|lgoldthw@stanford.edu|
22388264|NCT01205126|Janssen Research & Development, LLC|Director, Established Products|+1 609 730 3387;||
22388265|NCT00996164|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com|
22388266|NCT01513902|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22388267|NCT00923078|VA Connecticut Healthcare System|Dr Jason K. Johannesen|2039325711|jason.johannesen@va.gov|2224
22451627|NCT03893448|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22451628|NCT01351740|British Columbia Centre for Excellence in HIV/AIDS|Dr Marianne Harris|1-604-806-8771|mharris@cfenet.ubc.ca|
22451629|NCT01525082|Stanford University|Shaheen Shagufta, Clinical Assistant Professor|650-725-6454|sshaheen@stanford.edu|
22451630|NCT03321981|Merus N.V.|Executive Director Clinical Trials|+16174014499|USenquiries@merus.nl|
22451631|NCT00877448|BiondVax Pharmaceuticals Ltd.|Tamar Ben-Yedidia, PhD|972-8-9302529|benyedidia@BiondVax.com|
22451632|NCT01385059|City of Hope Medical Center|Dr. Sumanta Kumar Pal|626-359-8111|SPal@coh.org|
22451633|NCT00022516|IBCSG|Rudolf Maibach, Executive Officer for International Trial Activities|+41 31 389 91 96|rudolf.maibach@ibcsg.org|
22451634|NCT03895853|UT MD Anderson Cancer Center|Joseph L. Nates, Professor, Critical Care& RespiratoryCare|(713) 792-5040|jlnates@mdanderson.org|
22451635|NCT01568047|BIAL - Portela & Cª S.A.|Head of Clinical Research|+351-229866100|clinical.trials@bial.com|
22451636|NCT03783923|PTC Therapeutics, Inc.|Medical Information|1-866-562-4620|medinfo@ptcbio.com|
22451637|NCT00723177|NYSPI/Columbia University|Sandra Comer PhD|646 774-6146|SDC10@columbia.edu|
22451638|NCT02255110|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22451639|NCT02328326|VA Pittsburgh Healthcare System, Center for Health Equity Research and Promotion|Dr. Ann-Marie Rosland|4123602259|Ann-Marie.rosland@va.gov|
22451640|NCT02543346|Kingston General Hospital|Dr. Anne Ellis|6135482336|ellisa@kgh.kari.net|
22451641|NCT04289753|Northwestern University|Stephen D. Persell, MD, MPH, FACP|3125036464|spersell@nm.org|
22451642|NCT02209324|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
22451643|NCT01985126|Janssen Research & Development, LLC|Senior Director Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
22451644|NCT00366626|Medical University of South Carolina|Dr. Raymond F. Anton, Distinguished University Professor|843-792-1226|antonr@musc.edu|
22451645|NCT03433456|University of Alabama at Birmingham|Dr. Gareth Dutton|205.934.6876|gdutton@uabmc.edu|
22451646|NCT01242527|AstraZeneca Pharmaceuticals|Torbjörn Lundström, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22388268|NCT03054506|Massachusetts General Hospital|Dr. Kyle Staller|617-726-3080|kstaller@mgh.harvard.edu|
22388269|NCT01072149|GlaxoSmithKline|GSK Response Center|866-435-7343||
22388270|NCT01768572|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22388271|NCT04264156|Windtree Therapeutics, Inc.|Executive Director of Biostatistics & Data Management|2154889300|psimmons@windtreetx.com|
22388272|NCT04766996|Emory University|Kelly Wiltse Nicely, MD|404-727-6946|kelly.wiltse.nicely@emory.edu|
22388273|NCT01322386|Stanford University|Kenneth L Cox, MD / Principal Investigator|650-723-5070|KCox@stanfordchildrens.org|
22388274|NCT01102426|Pharma Mar, S.A.|Pharma Mar, S.A.|0034918466000|clinicaltrials@pharmamar.com|
22388275|NCT00871494|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22388276|NCT02637999|MYR GmbH|Dr. med. Alexander Alexandrov|+491777168259|alexandrov@myr-pharma.com|
22388277|NCT00564447|Inspire Pharmaceuticals, Inc.|Director of Clinical Research|010-941-9777|kkuhn@inspirepharm.com|
22388278|NCT03265132|Swedish Orphan Biovitrum|Kineret Clinical Program Leader|+46(8)6972000|info@sobi.com|
22430871|NCT05078112|Duke University|Sujay Kansagra, MD|919-668-0477|sujay.kansagra@duke.edu|
22430872|NCT03204812|UT MD Anderson Cancer Center|Dr. Sumit Subudhi, PhD-Associate Professor, Genitourinary Medical Oncology|(713) 792-2830|sksubudhi@mdanderson.org|
22430873|NCT01027351|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22430874|NCT00911157|GlaxoSmithKline|GSK Response Center|866-435-7343||
22430875|NCT01852214|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3933|dominick.angiolillo@jax.ufl.edu|
22430876|NCT04091438|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22430877|NCT00421408|Yale University|Dr. Karl Insogna|203-737-2871|Karl.insogna@yale.edu|
22430878|NCT04105725|Medical University of South Carolina|Dr. Kathryn Gex|(843) 876-2084|soltisk@musc.edu|
22430879|NCT04573881|HistoSonics, Inc.|Vice President of Clinical Affairs|(877) 740-0543|clinicaltrials@histosonics.com|
22430880|NCT03058952|VA Puget Sound|Dr. Tracy Simpson|(206) 277-3337|Tracy.Simpson@va.gov|
22430881|NCT00107575|Brown University|Christopher Kahler|(401) 863-6651|Christopher_Kahler@brown.edu|
22430882|NCT01373281|Sanofi Pasteur Inc.|Medical Director||Contact-US@sanofi.com|
22430883|NCT02296476|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22430884|NCT03369158|Medacta International|Clinical Data Manager|+41 91 696 60 60|bonacina@medacta.ch|
22430885|NCT02947984|Massachusetts General Hospital|Nina Sanford, MD||NSANFORD@PARTNERS.ORG|
22430886|NCT04378153|Seattle Children's|Margaret Kloster|206-884-7862|margaret.kloster@seattlechildrens.org|
22430887|NCT03345550|University of Michigan|Frederick Korley|734 647-0261|korley@med.umich.edu|
22430888|NCT04622267|Icahn School of Medicine at Mount Sinai|Nicola Tavella|212-241-3888|nicola.tavella@mssm.edu|
22430889|NCT01149460|Teva Pharmaceuticals USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22430890|NCT03257657|University of Colorado|Darcy Thompson, Associate Professor|303 724 7471|darcy.thompson@ucdenver.edu|
22430891|NCT02801578|The University of Texas MD Anderson Cancer Center|Prithviraj Bose, MD./Associate Professor|713-792-7747|PBose@mdanderson.org|
22430892|NCT02971839|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22430893|NCT00668642|Northshore University Healthsystem|Dr. Daniel Shevrin|847-570-2515|Dshevrin@northshore.org|
22430894|NCT02272985|University Medical Center Groningen|Dr. C.F.M. Franssen|+0031(0)50 3616161|c.f.m.franssen@umcg.nl|
22430895|NCT01467557|Vistakon|Jurandir Araujo|+1 904 443-1379|jaraujo7@its.jnj.com|
22430896|NCT02489279|Think Now, Inc.|Dr. Gregory V. Simpson|4156016522|greg@think-now.com|
22451647|NCT01198600|Alcon Research|R. Alan Landers, O.D., M.S., F.A.A.O.|1-800-241-7629||
22451648|NCT01785602|Novartis|Study Director|862-778-8300||
22451649|NCT03127228|University of Michigan|Dr. Chin-Wei Wang|734-763-2105|jeffwa@umich.edu|
22451650|NCT04496258|University of Denver|Kateri McRae|3038713632|Kateri.McRae@du.edu|
22451651|NCT02141516|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22451652|NCT03074734|TobaccoFree Research Institute Ireland|Professor Luke Clancy|+353868364337|lclancy@tri.ie|
22451653|NCT02041429|Dana-Farber Cancer Institute|Beth Overmoyer, MD|617.632.380|Beth_Overmoyer@DFCI.HARVARD.EDU|
22451654|NCT03251924|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22451655|NCT01427712|Medical affairs|Medical affairs manager|+81-3-5656-0516|takumi.kanzo@viatris.com|
22451656|NCT03169153|Alcon Research|CDMA Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22451657|NCT00784043|MED-EL Corporation|Jennifer Bulls|1-888-633-3524|research.us@medel.com|
22451658|NCT03424681|Mind Research Network|Dr. Claire Wilcox|5052725028|cwilcox@mrn.org|
22451659|NCT02678039|Dartmouth-Hitchcock|Mark P. Yeager, MD|603-650-5922|mark.p.yeager@hitchcock.org|
22451660|NCT00006411|JCHR|Roy W. Beck, MD, PhD|813-975-8690|cds@jaeb.org|
22451661|NCT02127307|GE Healthcare|Jose M Zubeldia, M.D.|011-44-1494-5431347|jose.zubeldia@ge.com|
22451662|NCT00766376|Palomar Medical Technologies, Inc.|Director of Regulatory Affairs|781-993-2414|stimberlake@palomarmedical.com|
22451663|NCT00235989|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22451664|NCT04796831|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22451665|NCT00178191|University of Rochester|Michael Flynn|585-273-3232|Michaelk_flynn@urmc.rochester.edu|
22451666|NCT00658112|Wake Forest University Health Sciences|Steve Feldman MD|336-716-3775|sfeldman@wakehealth.edu|
22451667|NCT00983580|Mayo Clinic|Frank A. Sinicrope, M.D.||sinicrope.frank@mayo.edu|
22451668|NCT04382612|Edwards Lifesciences, LLC|Sabrina Hundt, Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Sabrina_Hundt@edwards.com|
22451669|NCT03390907|Penn State Milton S. Hershey Medical Center|Dr. John Levenick|717-531-3834|jlevenick@pennstatehealth.psu.edu|
22451670|NCT01328002|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22451671|NCT01578551|Johns Hopkins University|David Ettinger, MD|410-955-8847|ettinda@Jhmi.edu|
22451672|NCT00389818|AMC|Ronald Mitsuyasu, MD|310-557-1803|rmitsuya@mednet.ucla.edu|
22451673|NCT02752048|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.|+81-3-3294-4527|toiawase@taiho.co.jp|
22451674|NCT00061048|National Cancer Institute, National Institutes of Health|Thomas A. Waldmann, M.D.|301-496-6653|Thomas.Waldmann2@nih.gov|
22388279|NCT00681109|Massachusetts Eye and Ear Infirmary|Dr. Reza Dana|(617) 573-4331|Reza_Dana@meei.harvard.edu|
22388280|NCT03259568|Dept of Neurology, Duke University School of Medicine|Simon W Davis|9195991927|simon.davis@duke.edu|
22388281|NCT04347941|National University of Ireland, Galway|Dr Bairbre McNicholas|+35391893063|bmcnicholas@nuigalway.ie|
22388282|NCT03128099|Vanderbilt University|Dr. Sohee Park, Project Director|6153223435|sohee.park@vanderbilt.edu|
22388283|NCT00148122|University of Michigan Comprehensive Cancer Center|Dr. Francis Worden|734-936-0453|fworden@umich.edu|
22388284|NCT00721734|Amgen, Inc.|Study Director|866-572-6436||
22388285|NCT02251652|Icahn School of Medicine at Mount Sinai|Dr. Gary Goldenberg|212-241-9728|garygoldenbergmd@gmail.com|
22388286|NCT04492475|NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
22388287|NCT02494336|Johns Hopkins All Children's Hospital|Nicole Chandler, MD|7277674170|nicole.chandler@jhmi.edu|
22388288|NCT02696200|Cincinnati Childrens Hospital|Kim Foss|513-636-5971|kim.foss@cchmc.org|
22388289|NCT03035942|Pontificia Catholic University of Sao Paulo|Dr. Eduardo Toshiyuki Moro|+5515997728015|edumoro85@gmail.com|
22388290|NCT05270460|Processa Pharmaceuticals Inc.|Dr. Sian Bigora|410-693-6844|sbigora@processapharmaceuticals.com|
22388291|NCT03205488|Northwestern University|Dr. Tanya Simuni|312-503-2970|Tatyana.Simuni@nm.org|
22388292|NCT01742832|University of Chicago|Dr. Jon Grant|773-834-1325|jongrant@uchicago.edu|
22388293|NCT05163353|Merz Aesthetics|Public Disclosure Manager|+1 984-301-3095|Aesthetic.Trials@merz.com|
22388294|NCT02790281|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22388295|NCT06086028|Tulane University|Leia Y. Saltzman Associate Professor|504-247-1452|lsaltzman@tulane.edu|
22388296|NCT00824408|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22388297|NCT00718120|GlaxoSmithKline|GSK Response Center|866-435-7343||
22414492|NCT01624233|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22414493|NCT03256227|Minneapolis VA Health Care System|Laura Meis, PhD|612-467-4516|laura.meis@va.gov|
22414494|NCT03121586|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|844-422-2342|medicalinformation@acadia-pharm.com|
22414495|NCT06381102|University of Miami|Marlon Wong, Associate Professor of Clinical|3052842670|mwong2@miami.edu|
22414496|NCT03119025|Institute of Fundamental and Clinical Immunology|Alexander A Ostanin, MD, PhD Study Principal Investigator|383-236-03-29|ct_lab@mail.ru; ostanin62@mail.ru|+7
22388298|NCT05640167|University of Rhode Island|Dr Christine Clarkin, Principal Investigator|4018742998|chrisclarkin@uri.edu|
22388299|NCT01706666|Mayo Clinic Cancer Center|Craig B Reeder, MD|4803018335|Reeder.Craig@mayo.edu|
22401247|NCT01676116|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22451675|NCT00898677|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22451676|NCT00852397|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22451677|NCT02331992|Fisher & Paykel Healthcare|Clinical Research Scientist|+64 9 5740123|cpaptrial@fphcare.co.nz|
22451678|NCT00234884|Abbott|Global Medical Services|1-800-633-9110||
22451679|NCT00836875|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22451680|NCT02969928|São Paulo State University - Unesp|Dr Mauro Pedrine Santamaria|+5516981937777|mauro.santamaria@unesp.br|
22401248|NCT00793585|1st Affiliated Hospital, Sun Yat-Sen University|Xueqing Yu , M.D. & Ph.D.|8620-87766335|yuxq@mail.sysu.edu.cn|
22401249|NCT01821677|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|720-437-6500|clinicaltrials@ampiopharma.com|
22451681|NCT04286594|McLean Hospital|Dr. Staci Gruber|617-855-2762|gruber@mclean.harvard.edu|
22451682|NCT02143518|George Washington University|David J. Diemert, MD|202-994-2909|ddiemert@gwu.edu|
22401250|NCT01769404|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22451683|NCT00452335|Sucampo Pharma Americas, Inc.|VP, Clinical Development|301-961-3400|info@sucampo.com|
22451684|NCT03964454|RTI International|Yukiko Washio|9194852794|ywashio@rti.org|
22451685|NCT05955560|Becton, Dickinson & Company|Director of Clinical Affairs|551-225-1164|kirsten.hammitt@bd.com|
22451686|NCT04621500|Medical University of South Carolina|Stephen J. Savage, MD|18437925787|savages@musc.edu|
22401251|NCT00538733|Weill Cornell Medical College|Jennifer Hess|6469629440|jmh2004@med.cornell.edu|
22451687|NCT01787604|MeshalkinRI|Dmitry|+79069090505|dmhvan@mail.ru|
22451688|NCT00527566|National Jewish Health|Michael Wechsler|617-285-4987|wechslerm@NJHealth.org|
22451689|NCT00464542|University of Pittsburgh|Thomas Cherpes|412 692 5930|cherpestl@upmc.edu|
22451690|NCT00993447|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22451691|NCT01760954|AbbVie|Global Medical Services|800-633-9110||
22451692|NCT02707055|National Institute on Drug Abuse (NIDA); National Institute on Alcohol Abuse and Alcoholism (NIAAA)|Dr. Lorenzo Leggio, M.D., PhD|+1 443 740 2801|lorenzo.leggio@nih.gov|
22401252|NCT02768129|Butler Hospital|Benjamin Greenberg|(401) 455-6200|bgreenberg@butler.org|
22451693|NCT01880424|AstraZeneca|Peter Zeng|+86 21 6030 1867|peter.zeng@astrazeneca.com|
22401253|NCT03461965|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Margaret Mann, MD|1-800-641-2422|CTUReferral@uhhospitals.org|
22451694|NCT00272168|VA Central Office|Wendy Tenhula, Ph.D.|202-461-4167|Wendy.Tenhula@va.gov|
22451695|NCT02280044|Johns Hopkins Bloomberg School of Public Health|David A Sack|443 287 8795|dsack1@jhu.edu|
22401254|NCT02680301|Seton Family of Hospitals/Ascension|Katherine Sebastian|801-598-2484|krsebastian@ascension.org|
22414497|NCT02832063|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
22451696|NCT05706506|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22451697|NCT01075321|Mayo Clinic|Craig B. Reeder MD|480.301.8000|Reeder.Craig@mayo.edu|
22414498|NCT03733730|Alcon Research, LLC|Sr. Clinical Project Lead, CRD Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22451698|NCT02646423|University of California, San Francisco|Miriam Kupperman, PhD, MPH|415-502-4089|miriam.kupperman@ucsf.edu|
22414499|NCT00772603|Supernus Pharmaceuticals, Inc|Stefan Schwabe, M.D., Ph.D., Chief Medical Officer|301-838-2500|sschwabe@supernus.com|2527
22414500|NCT00835575|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414501|NCT01988376|Far Eastern Memorial Hospital|Hsiao, Sheng-Mou|(02)89667000|smhsiao2@gmail.com|1424
22451699|NCT04564833|Renibus Therapeutics|Stacey Ruiz, PhD / VP, Drug Development|424-209-2734|sruiz@renibus.com|
22451700|NCT02246998|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22451701|NCT03523533|University of New Mexico Health Sciences Center (HSC)|Dr. Tim Petersen|5052722610|timpetersen@salud.unm.edu|
22451702|NCT00440050|Oregon Health and Sciences University/Portland VA Medical Center, Portland, Oregon.|Joseph Quinn, MD|503-494-6976|quinnj@ohsu.edu|
22451703|NCT01303627|Ministry of Health Diskapi Yildirim Beyazit Training and Research Hospital 1. Anesthesiology|Derya Özkan MD|0903125962553|derya_z@yahoo.com|
22451704|NCT00111657|Duke University Medical Center|John S. Sundy, MD, PhD|919-684-2347|john.sundy@duke.edu|
22451705|NCT03489304|Perelman School of Medicine|Dr. Matthew Kayser|215 898 8298|kayser@pennmedicine.upenn.edu|
22451706|NCT00321919|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22451707|NCT02624804|Hackensack Meridian Health|Joshua Zenreich|15519964248|joshua.zenreich@hmhn.org|
22451708|NCT02590354|Institute of Tropical Medicine Antwerp|Dr. Eric Florence|+32 3 247 66 42|eflorence@itg.be|
22451709|NCT00996996|GlaxoSmithKline|GSK Response Center|866-435-7343||
22388300|NCT01263496|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
22451710|NCT01227889|GlaxoSmithKline|GSK Response Center|866-435-7343||
22388301|NCT01218594|Sun Yat-Sen University Cancer Center|Ming Chen|86-20-87343640|chenming@sysucc.org.cn|
22388302|NCT02203032|Janssen Research & Development, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
22388303|NCT01640340|Ohio State University Medical Center|Rachel Layman, MD|614-293-0066|Rachel.Layman@osumc.edu|
22388304|NCT02241785|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22388305|NCT01836445|Northwestern University|Dr. Brian Mustanski|312-503-5421|brian@northwestern.edu|
22388306|NCT05289037|The Hope Clinic of Emory University|Nadine Rouphael, MD|404-712-1435|nroupha@emory.edu|
22388307|NCT04186247|Amsterdam University Medical Center|Johan Van Limbergen, MD, PhD|+31-20 566 9111|j.e.vanlimbergen@amsterdamumc.nl|
22388308|NCT04852978|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|18447346643|clinicaltrials@regeneron.com|
22388309|NCT00535626|Stryker Orthopedics|Director, Clinical Operations|201-831-5401|ellen.axelson@stryker.com|
22388310|NCT04633200|Environment and Health Group|Patricia Flynn Weitzman|617-455-5976|pat.weitzman@gmail.com|
22388311|NCT04809623|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22451711|NCT02203019|Texas Tech University|Dr Kenneth Nugent|18067436847|kenneth.nugent@ttuhsc.edu|
22451712|NCT02165722|University of Pittsburgh|Richard K. Zimmerman, MD, MPH, MA|412-383-2354|zimmer@pitt.edu|
22451713|NCT02377986|Columbia University|Dr. Carolyn Rodriguez|650-723-6158|cr2163@stanford.edu|
22451714|NCT01709227|Stanford University|David Kwiatkowski|650-721-3290|david.kwiatkowski@stanford.edu|
22401255|NCT02677740|University of Minnesota|Silvia Mangia, Associate Professor|6126254920|mangia@umn.edu|
22451715|NCT02159482|Duke University|Dr. Michael Morse|919-681-3480|morse004@mc.duke.edu|
22401256|NCT00538642|University of Texas Health Science Center at San Antonio|Dr. Alexander Miller|210-567-5508|millera@uthscsa.edu|
22451716|NCT04479618|BenskinL|Linda Benskin, PhD, RN, Independent Researcher|+1 (512) 659-0812|lindabenskin@utexas.edu|
22451717|NCT01430130|Neodyne Biosciences|Kristin Prosak|650-543-7129|kprosak@neodynebio.com|126
22451718|NCT00797667|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22451719|NCT01485861|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22451720|NCT02187016|Silverstone Research Group|Pejjmon Amini, DMD|702-901-444||
22451721|NCT01986829|Washington University School of Medicine|Brian Van Tine, M.D.|314-362-5817|bvantine@wustl.edu|
22451722|NCT03795922|Medytox Inc.|Young Ryu|+82-2-6901-5424|aab005@medytox.com|
22451723|NCT00466323|VA VISN 5 Mental Illness Research, Education and Clinical Center|Amy Drapalski, Ph.D.|410-637-1855|amy.drapalski@va.gov|
22451724|NCT00701051|Baltimore VA Medical Center|Steven J. Prior, PhD|410-605-7000|steven.prior@va.gov|4129
22414502|NCT01564394|Huntsman Cancer Institute, University of Utah|Anita Y. Kinney, PhD|801-585-1151|anita.kinney@hci.utah.edu|
22451725|NCT01243944|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
22401258|NCT01928030|Stanford University|Dr. Mark Pegram, Susy Yuan-Huey Hung Professor|650-723-5801|mpegram@stanford.edu|
22451726|NCT01645709|CaloSyn Pharma Inc.|Stephen Snowdy, PhD|404-863-8892|ssnowdy@ansleyvc.com|
22451727|NCT01863017|University of Kansas Medical Center|Merlin G Butler|9135881800|mbutler4@kumc.edu|
22451728|NCT03054844|Columbia University|Dr. Daniel Tsze|212-305-9825|dst2141@columbia.edu|
22451729|NCT02673697|Corcym|Elisa Cerutti|+39 3459182413|elisa.cerutti@corcym.com|
22401259|NCT05278104|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22451730|NCT00437489|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22451731|NCT00289341|Rockefeller University|Mayu Frank|212-327-7443|frankm@rockefeller.edu|
22388312|NCT01808534|IndianaU|Dr. Lawrence H. Einhorn|(317)274-3515|leinhorn@iu.edu|
22388313|NCT02822599|Nicklaus Children's Hospital|Jenny Esteves|786-624-2854|jenny.esteves@nicklaushealth.org|
22388314|NCT00638456|Univeristy of California, San Diego|Dr. Ranjan Dohil|(858) 966-4003|rdohil@ucsd.edu|
22388315|NCT03236779|Head of iPhysio Research Group. Editor-in-Chief Journal of Invasive Techniques in Physical Therapy|Dr. Pablo Herrero Gallego. PT, PhD.|(+34) 646168248|pherrero@usj.es|
22388316|NCT03070548|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_inquiries@pfizer.com|
22388317|NCT00929526|GlaxoSmithKline|GSK Response Center|866-435-7343||
22401260|NCT04957498|Stanford University School of Medicine|Dr. James Lock|(650) 723-6643|jimlock@stanford.edu|
22401261|NCT00001259|National Institute of Mental Health|Schmidt, Peter|+1 301 496 6120|peterschmidt@mail.nih.gov|
22451732|NCT01286818|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22451733|NCT04689737|Fundació de Lluita contra la SIDA, les Malalties Infeccioses i la Promoció de la Salut i La Ciència|Dr. Jose Molto Marhuenda|+34 934657897|jmolto@lluita.org|
22451734|NCT03321019|University of Florida|Dr. Karen Hegland|3522948366|kwheeler@ufl.edu|
22451735|NCT03880578|Klinikum Lüdenscheid|Professor Rolf Larisch, Director|‭+49 2351 46|rolf.larisch@klinikum-luedenscheid.de|3311
22388318|NCT00578344|Baylor College of Medicine/Texas Children's Hospital|Dr. Tami D. John|832-824-4723|tdjohn@texaschildrens.org|
22388319|NCT02169414|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22388320|NCT00321971|Duquesne University School of Nursing|Linda Garand PhD|412-396-6543|garandl@duq.edu|
22388321|NCT03374254|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
22388322|NCT00667953|Penn|Tara C Mitchell|215-662-4000|Tara.Mitchell@pennmedicine.upenn.edu|
22388323|NCT02309515|Mayo Clinic|Tait D. Shanafelt, MD|507.284.2511|shanafelt.tait@mayo.edu|
22388324|NCT02395692|ABTC|Sr. Research Program Manager|410-955-8837|ABTC@jhmi.edu|
22388325|NCT02547974|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22388326|NCT00823966|Pfizer, Inc.|Pfizer ClinicalTraials.gov Call Center|1-800-718-1021|ClinicalTraials.govCallCenter@pfizer.com|
22388327|NCT02784834|UC San Diego|Dr. Michael Choi|(858) 534-1765|mychoi@ucsd.edu|
22388328|NCT02245620|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
22388329|NCT01999335|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22388330|NCT00950235|Kaiser Permanente Center for Health Research|Victor J. Stevens, PhD Principle Investigator|503 335 6751|victor.j.stevens@kpchr.org|
22388331|NCT00949234|UCLA CARE Center|Dr. Raphael Landovitz|310-557-1891|rlandovitz@mednet.ucla.edu|
22388332|NCT00508183|Ottawa Hospital Research Institute|Dr. Peter Lapner|613-737-8899|plapner@toh.ca|74700
22388333|NCT03785756|Reckitt Benckiser (Health) Limited|Clinical Project Manager|+44 1482 326151|clinicaldatacontroller@reckitt.com|
22388334|NCT03879538|Cleveland Clinic|Alparslan Turan|2162172312|turana@ccf.org|
22388335|NCT02988713|Boston Scientific|Director, Clinical Sciences and Scientific Communication|855-213-9890|BSNClinicalTrials@bsci.com|
22388336|NCT02404441|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22388337|NCT00529204|University of California Davis Medical Center|Christopher L. Bowlus, MD|916-734-8986|chris.bowlus@ucdmc.ucdavis.edu|
22388338|NCT00088166|Celtic Pharma Development Services America Inc|Patrick O'Connor, MD, Managing Director Clinical Development|212-616-4050|patrick.oconnor@dev.celticpharma.com|
22388339|NCT02671266|Massachusetts General Hospital/Harvard Medical School|Dr. Angela Fang|617-643-7717|afang@mgh.harvard.edu|
22388340|NCT00666705|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22388341|NCT02065609|Washington University School of Medicine in St. Louis|Dr. Farrokh Dehdashti|314-362-1474|dehdashtif@wustl.edu|
22388342|NCT01976507|Vanderbilt University Medical Center|Christopher Ellis||christopher.ellis@Vanderbilt.Edu|
22388343|NCT00022490|OHSU Knight Cancer Institute|Dr. Brian Druker|(503) 494 5596|drukerb@ohsu.edu|
22388344|NCT01029704|Theracos, Inc.|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
22388345|NCT03845517|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22388346|NCT01109979|Brigham and Women's Hospital|Ellen Seely, MD|617-732-5012|eseely@partners.org|
22388347|NCT02580799|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22388348|NCT00201825|The Ohio State University Comprehensive Cancer Center|Tanios Bekaii-Saab, MD|614-293-6529|Tanios.Saab@osumc.edu|
22388349|NCT03136861|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22388350|NCT03390166|Mahidol|Punnee Pitisuttithum|6626435599|punnee.pit@mahidol.ac.th|
22388351|NCT03125148|Medical College of Wisconsin|Kulwinder Dua, MD|4149556896|kdua@mcw.edu|
22388352|NCT01735214|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22388353|NCT01934452|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22388354|NCT01328756|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22388355|NCT00257309|Centro Nacional de Investigaciones Cardiovasculares|Héctor Bueno|(+34) 914 531 200|hbueno@cnic.es|4110
22388356|NCT00849485|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-3848-5525|clinicaltrialqueries@tevausa.com|
22388357|NCT00186446|Stanford University|aimee-noelle swanson|650-736-4559|aimnoe@stanford.edu|
22388358|NCT02359916|Rush University Medical Center|Brad Appelhans, PhD (PI)|312-942-3477|brad_appelhans@rush.edu|
22388359|NCT00556478|Plethora Solutions|Chief Scientific Officer|+44 (0) 20 3077 5400|mail@plethorasolutions.co.uk|
22388360|NCT03200574|Corcym S.r.l.|Elisa Cerutti|+393459182413|elisa.cerutti@corcym.com|
22388361|NCT02233998|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
22388362|NCT00705159|Bausch & Lomb Incorporated|Tuyen Ong, MD, MRCOphth|(973) 360-6389|tuyen.ong@bausch.com|
22388363|NCT00526994|CDC|Joanne Klevens|770-488-1386|dzk8@cdc.gov|
22388364|NCT03026166|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22388365|NCT02074384|Park Nicollet Institute|Dr. Deborah Mullen|952-993-2070|deborah.mullen@parknicollet.com|
22388366|NCT03292692|University of Miami|Dr. Brian Doss|305-284-1101|bdoss@miami.edu|
22388367|NCT02110381|University of Michigan|Dr. Elizabeth Jackson|734-998-7411|lisjacks@med.umich.edu|
22388368|NCT00266656|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22388369|NCT01915914|GlaxoSmithKline|GSK Response Center|866-435-7343||
22388370|NCT00286325|Duke University Medical Center|Dr. Russell P Hall|919-684-3110|hall0009@mc.duke.edu|
22388371|NCT00667732|Oregon Health and Science University|Dr. Matthew Riddle|503-494-0557|riddlem@ohsu.edu|
22388372|NCT07016568|LLC UkrMedGroup|Yevheniia Poliakova|+380502818399|jenyapolyakova@gmail.com|
22388373|NCT00210236|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Palissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
22388374|NCT04025125|Duke University|Gerald Bloomfield|919-668-8702|gerald.bloomfield@duke.edu|
22388375|NCT03786471|University of California Los Angeles|Jenny Summapund|3233660667|jsummapund@mednet.ucla.edu|
22388376|NCT03346200|KARMA project, Karolinska Institute|PI Professor MD Per Hall|+46 8 524 85000|Per.hall@ki.se|
22388377|NCT04995601|Recovery Force Health, University of Massachusetts Amherst|Jeff Schwegman (PI), Dr. Karen Giuliano (PI, clinical trial subaward)|317-605-4696; 224-725-0270|kschwegman@recoveryforceusa.com; kkgiuliano@umass.edu|
22451736|NCT04934670|Xenikos BV (no longer in business)|Ypke van Oosterhout, custodian of Sponsor|+31 611 0177 611|ypke@me.com|
22401262|NCT00492622|University Louisville|Nancy Alsip|502-852-2905|nancy.alsip@louisville.edu|
22401263|NCT02629393|Origin Biosciences (affiliate of BridgeBio)|Business Development and Operations|650-391-9740|info@bridgebio.com|
22451737|NCT03259035|Canadian Cancer Trials Group|Dr. Chris O'Callaghan|6135336430|cocallaghan@ctg.queensu.ca|
22451738|NCT03056690|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22451739|NCT02661828|Emory University|Boadie Dunlop, MD|404-727-8474|vcruz@emory.edu|
22451740|NCT02921412|CooperVision|Jose Vega, O.D., MSc., FAAO|9256213761|JVega2@coopervision.com|
22451741|NCT01944046|Duke University|Linmarie Sikich, M.D.|919-681-0026|linmarie.sikich@duke.edu|
22451742|NCT01528228|A.T. Still University|Corey Luebbering|660.626.2147|coreyluebbering@atsu.edu|
22401264|NCT01269125|Dept. of Ob/Gyn, Patra University School of Medicine, Greece|Apostolos Kaponis, M.D.|+30-2610999569|kaponisapostolos@hotmail.com|
22451743|NCT00864032|University of California Davis Comprehensive Cancer Center|Dr. Robert J. Canter|916-734-5907|robert.canter@ucdmc.ucdavis.edu|
22451744|NCT00153101|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22451745|NCT00439777|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22401265|NCT00151411|Penn State Hershey|Sandy Eyer|717-531-1540|seyer@hmc.psu.edu|
22451746|NCT00661492|US Oncology|Dr. Mark T. Fleming|757-827-9400|Mark.Fleming@USONCOLOGY.COM|
22451747|NCT00803634|The Medicines Company|Jason Campagna|973-290-6199|jason.campagna@themedco.com|
22451748|NCT01175226|Aviragen Therapeutics, Inc.|Anna Novotney-Barry|678-221-3356|abarry@aviragentherapeutics.com|
22451749|NCT03791398|BrUOG|Brown University Oncology Research Group|401-863-3000|BrUOG@Brown.edu|
22451750|NCT01072201|Colgate Palmolive Co|William De Vizio, DMD|732-878-7901|William_Devizio@colpal.com|
22451751|NCT01092195|National Institutes of Health|Pamela Stratton MD|301-435-4068|strattop@mail.nih.gov|
22451752|NCT00818441|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22451753|NCT04523129|Novaliq GmbH|Dr. Sonja Kroesser|+49 6221 50259|info@novaliq.com|0
22451754|NCT01751022|Medtronic|Shelby Li|+17635262704|shelby.li@medtronic.com|
22451755|NCT00774995|GlaxoSmithKline|GSK Response Center|866-435-7343||
22451756|NCT01343160|W.L. Gore & Associates|Rizwan Afzal|623-234-5408|rafzal@wlgore.com|
22451757|NCT01489579|Kaiser Permanente|Alicia Cymbala|303-972-5384|Alicia.A.Cymbala@kp.org|
22451758|NCT01203189|Saint Louis Univ Hospital|Aibing Mary Guo, M.D., Assistant Professor|3142563430|aguo@slu.edu|
22451759|NCT02062502|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22451760|NCT05349617|Bavarian Nordic A/S|Medical Information|1-844-422-8274|medical.information_na@bavarian-nordic.com|
22451761|NCT00746954|Louis Stokes DVA Medical Center|Kingman P. Strohl MD|216-7913800|kingman.strohl@va.gov|
22451762|NCT03082963|University of Miami|Dr Jeffrey Goldberger|305-243-4356|j-goldberger@miami.edu|
22451763|NCT04401579|NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
22451764|NCT00489970|GlaxoSmithKline|GSK Response Center|866-435-7343||
22451765|NCT02212028|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3933|dominick.angiolillo@jax.ufl.edu|
22451766|NCT00896168|Xian-Janssen Pharmaceutical Ltd|Director of Medical Affairs|(8610) 5821 8359||
22451767|NCT00902304|Novartis Pharmaceuticals|Study Director|862-778-8300||
22451768|NCT01230593|Icahn School of Medicine at Mount Sinai|Albert Wu MD PhD|2125184524|albert.wu@mssm.edu|
22451769|NCT00003457|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22451770|NCT01054729|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22451771|NCT01148810|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22451772|NCT01235910|University of Colorado|Christina Aquilante, Pharm.D.|303-724-6126|christina.aquilante@ucdenver.edu|
22451773|NCT05423509|University of New Mexico Health System|Selina Silva, MD|505-272-4107|ssilva@salud.unm.edu|
22451774|NCT01319318|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22451775|NCT06390098|Asceneuron SA|Asceneuron Clinical Research|+ 41 21 353 8245|clinicaltrials.gov@asceneuron.com|
22451776|NCT02731131|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22451777|NCT02509624|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22451778|NCT03326999|Icahn School of Medicine at Mount Sinai|Dr. Christina Jeng|212-241-6426|christina.jeng@mountsinai.org|
22451779|NCT04831736|NYU Langone Health|Lisa Doan, MD|212-201-1004|Lisa.Doan@nyulangone.org|
22451780|NCT00795600|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22451781|NCT01659021|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22451782|NCT01233817|Department of Physical Medicine and Rehabilitation, School of Medicine, University of Utah|Aga Lewelt MD, Principal Investigator|801-518-4572|aga@genetics.utah.edu|
22451783|NCT01248884|GlaxoSmithKline|GSK Response Center|866-435-7343||
22451784|NCT01173848|Cleveland Clinic|Dr. James Simon|216-445-4891|simonj2@ccf.org|
22451785|NCT00840970|Intersect ENT|Chris Lewis, VP Clinical Affairs|423-598-6681|clewis@intersectent.com|
22451786|NCT00504829|Life Cycle Pharma|H. Eugene Griffin, MS, DVM|646-200-8505|ggr@lcpharma.com|
22451787|NCT03465540|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22451788|NCT01854827|University of Michigan|DCC PI|734-936-3585|mageej@med.umich.edu|
22451789|NCT00736996|University of Colorado|Robert S. Schwartz, M.D.|303-724-1919|robert.schwartz@ucdenver.edu|
22451790|NCT00462384|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22414503|NCT00859521|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414504|NCT01609257|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22414505|NCT02125461|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22414506|NCT02305732|Cerus|Carol Moore, Senior VP Regulatory Affairs & Quality|925-288-6361|cmoore@cerus.com|
22414507|NCT01246258|Imperial Health|Joanne Rimmer|0061402931120|rimmer.joanne@gmail.com|
22414508|NCT02645253|AstraZeneca AB|AZD7594 Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
22414509|NCT03170219|Duke Clinical Research Institute|Rachel Olson, Project Leader|919-668-5590|rachel.e.olson@duke.edu|
22414510|NCT03552484|Rush University Medical Center|Jori Fleisher, MD MSCE|3125632900|jori_fleisher@rush.edu|
22414511|NCT03499353|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22414512|NCT02241551|University of Pittsburgh Cancer Institute|Nathan Bahary, MD|412-864-7764|baharyn@upmc.edu|
22414513|NCT02741687|Emory University|Maya Fayfman, MD|404-778-1664|maya.fayfman@emory.edu|
22414514|NCT00862563|Department of Psychiatry, Boston Univ School of Medicine|Dr. Domenic A Ciraulo, Professor|617-414-1990|dciraulo@bu.edu|
22414515|NCT00469898|Vanderbilt-Ingram Cancer Center|Leora Horn, M.D.|615-322-4967|leora.horn@vanderbilt.edu|
22414516|NCT01426360|Sun Yat-sen University|Dr. Liu Hongchun|86-0-13826189071|hongchun751@sina.com|
22414517|NCT02663349|Minneapolis VA Health Care System|Tasha Nienow, PhD|612-467-1004|tasha.nienow@va.gov|
22414518|NCT02331108|Albert Einstein Healthcare Network|Jonathan Roth, M.D.|2154567979|rothj@einstein.edu|
22414519|NCT01556906|Aegerion Pharmaceutical|Chief Medical Officer|617-500-7867||
22414520|NCT02751424|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22414521|NCT02284867|Ain Shams university (AinShamsU)|Ahmed Mohammed Abass , Ass.lecturer in faculty of medicine|002-01066903903|ahmedmams@hotmail.com|
22414522|NCT02927639|Children's Hospital of Philadelphia|Tara Kaushal, MD|6177322603|tara.kaushal@joslin.harvard.edu|
22414523|NCT02699463|ResMed Ltd|Dr Alison Wimms|+61 8884 1123|alison.wimms@resmed.com|
22414524|NCT02488239|Boston Scientific|Caroline Beaudoint|+32479904163|Caroline.Beaudoint@bsci.com|
22414525|NCT03283982|Cleveland Clinic Foundation|Dr. Ajita Prabhu|2164444790|prabhua@ccf.org|
22414526|NCT05283148|University of California Davis Comprehensive Cancer Center|Oyebimpe Adesina, MD, MS|9167035166|adesina@ucdavis.edu|
22414527|NCT01370733|University of California Los Angeles|Dr. Andrew Leuchter, MD|(310) 825-0207|afl@ucla.edu|
22414528|NCT06682403|University of Pennsylvania|Dr. Mucio Kit Delgado|2157468256|mucio.delgado@pennmedicine.upenn.edu|
22414529|NCT01188681|Emergent BioSolutions|Scott C. Stromatt|206-859-6675|sstromatt@ebsi.com|
22414530|NCT03926052|Yale University School of Medicine|Dr. Carlos Grilo|2037857210|carlos.grilo@yale.edu|
22414531|NCT03466866|Thomas Jefferson University|Barry Rovner,MD|215-503-1243|Barry.Rovner@Jefferson.edu|
22414532|NCT01172145|Brown University|Laura L. Frakey|401-729-3163|lfrakey@gmail.com|
22414533|NCT04134091|Lipocine Inc|Senior Director of Clinical Development|801-994-7383|admin@lipocine.com|
22414534|NCT01848938|Umeå University, Umeå, Sweden|Dr. Eva Samuelsson|+46706966440|eva.samuelsson@umu.se|
22414535|NCT01640197|Northumbria University|Emma Wightman|(+44) 0191 2437253|emma.l.wightman@northumbria.ac.uk|
22414536|NCT00909753|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414537|NCT00835536|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414538|NCT01636661|University of Minnesota|Dr. Bernadette Gillick|612.626.6415|brown029@umn.edu|
22414539|NCT03077451|Statistical and Data Analysis Center, AIDS Malignancy Consortium|Deukwoo Kwon|(713) 500-7964|deukwoo.kwon@mountsinai.org|
22414540|NCT04603495|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
22414541|NCT03275623|The University of Texas Health Science Center at Houston|Jerrie S. Refuerzo, MD|(713) 500-6416|Jerrie.S.Refuerzo@uth.tmc.edu|
22414542|NCT03804983|University of Virginia Center for Diabetes Technology|Marc Breton, PhD|434-982-6484|mb6nt@virginia.edu|
22451791|NCT04000165|The National Institutes of Health / The National Heart, Lung, and Blood Institute|Dr. Swee Lay Thein, Chief of Sickle Cell Branch|301.402.6699|sweelay.thein@nih.gov|
22451792|NCT01984398|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22451793|NCT01751568|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 544-7040|mallen@fhi360.org|11246
22451794|NCT03834194|University of Virginia, School of Medicine|Dr. Rebecca Krukowski|9014482426|wae4mq@virginia.edu|
22451795|NCT02660944|Resolve Therapeutics LLC|James Posada|(208)7277010|jp@resolvebio.com|
22451796|NCT02843568|University of Wisconsin Carbone Cancer Center|Cancer Connect|800-622-8922|clinicaltrials@cancer.wisc.edu|
22451797|NCT03586999|University of Colorado|Brad Haverkos, MD|7208488698|brad.haverkos@cuanschutz.edu|
22451798|NCT04096560|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22414543|NCT03600376|Eagle Pharmaceuticals, Inc.|Chief Medical Officer|201-326-5300|medinfo@eagleus.com|
22451799|NCT01701375|Johns Hopkins University|Ivana Gojo, MD|410-502-7726|Igojo1@jhmi.edu|
22414544|NCT02067611|Techfields|Dr. Chongxi Yu|571 276 5371|chongxiyu@hotmail.com|
22451800|NCT03526900|Fundación GECP|Eva Pereira|+34934302006|gecp@gecp.org|
22388378|NCT05006703|University Hospital Southampton|Professor Graham Roberts|02381 204335|g.c.roberts@soton.ac.uk|
22388379|NCT03924193|Yale University School of Medicine|Dr. Valentina Ivezaj|2037857807|valentina.ivezaj@yale.edu|
22388380|NCT02489799|The Johns Hopkins University School of Medicine|Rebecca Aslakson, M.D., Ph.D.|410-955-9082|raslaks1@jhmi.edu|
22388381|NCT04371471|NumaHealth international|Dr. Kamyar Hedayat|+33660404192|khedayat@numahealth.com|
22388382|NCT00515112|The University of Chicago|Dr. Walter Stadler|773-702-4400|wstadler@medicine.bsd.uchicago.edu|
22388383|NCT05139615|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22388384|NCT03462966|Cedars-Sinai medical center|Mohamad Rashid|310-423-0617|mohamad.rashid@cshs.org|
22388385|NCT02002689|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22388386|NCT02494076|University Colorado School of Medicine, Chidren's Hospital Colorado|Nidhya Navanandan, MD|847-636-0817|nidhya.navanandan@childrenscolorado.org|
22388387|NCT00278395|University of Texas Health Science Center at San Antonio|Dr. John Sarantopoulos|210-450-1000|sarantopoulo@uthscsa.edu|
22388388|NCT01148017|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
22388389|NCT01053897|Garnet BioTherapeutics, Inc.|Gerri Henwood, CEO|484-395-2440|ghenwood@garnetbio.com|
22388390|NCT01212822|Fox Chase Cancer Center|Protocol Development Coordinator|215-728-4097|ryan.romasko@fccc.edu|
22388391|NCT00569166|Mayo Clinic|Dr. Amit Sood|507-538-7623|sood.amit@mayo.edu|8-7623
22388392|NCT01853384|Smith & Nephew, Inc|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
22388393|NCT01759459|Allina Health|David Gurda|612-863-6566|david.gurda@allina.com|
22388394|NCT01019135|University Health Network & York University|Dr. Sherry L Grace|416.736.2100|sgrace@yorku.ca|22364
22388395|NCT00486954|GlaxoSmithKline|GSK Response Center|866-435-7343||
22388396|NCT05124210|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22388397|NCT02753075|GlaxoSmithKline|GSK Response Center|866-435-7343||
22388398|NCT02143713|AbbVie|Global Medical Services|800-633-9110||
22388399|NCT01215253|University of Rochester|Wojciech Zareba|585-275-5391|wojciech.zareba@heart.rochester.edu|
22388400|NCT00080119|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22388401|NCT01062165|Texas Tech UHSC|Ronald Hall|214-654-9404|ronald.hall@ttuhsc.edu|
22388402|NCT00889863|Novartis Pharmaceuticals|Study Director|862-778-8300||
22388403|NCT01090739|University of Michigan, Professor of Obstetrics and Gynecology|Dee Fenner, MD, Study Coordinating Investigator|734-647-5866|deef@med.umich.edu|
22388404|NCT00441168|Jan-Cilag Germany|EMEA Medical Affairs Director Oncology|+49 2137 955-492|rangermu@its.jnj.com|
22388405|NCT00825318|St. Luke's-Roosevelt Hospital Center|James Jones, MD|2125233530|JaJones@chpnet.org|
22388406|NCT04410445|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
22388407|NCT02291861|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22388408|NCT04332991|Mass General Hopsital (PETAL Network Coordinating Center)|B.Taylor Thompson, MD|617-726-8854|TTHOMPSON1@mgh.harvard.edu|
22388409|NCT02005484|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22388410|NCT03082313|University of Southern California|Beth Smith|13234424072|beth.smith@usc.edu|
22388411|NCT02336958|Helios Kliniken Schwerin|Dr. med. Ronald Seidel|0049 (0)385 5204251|ronald.seidel@helios-kliniken.de|
22388412|NCT03547154|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22388413|NCT03909100|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22388414|NCT01762982|GlaxoSmithKline|GSK Response Center|866-435-7343||
22451801|NCT00534352|Tibotec Therapeutics Clinical Affairs, Division of Centocor Ortho Biotech Services, LLC|Vice President, Tibotec Therapeutics Clinical Affairs|877-732-2488||
22451802|NCT03735420|National University of Natural Medicine|Ryan Bradley, ND, MPH|5035521862|rbradley@nunm.edu|
22451803|NCT03264989|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22451804|NCT02807597|UT Southwestern Medical Center|Dr. Samuel Achilefu|314-362-8599|Samuel.Achilefu@UTSouthwestern.edu|
22451805|NCT00833924|Cook Research Incorporated|Scott Snyder, PhD, Director of Clinical Science & Biostatistics|765-463-7537|SSnyder@medinst.com|
22451806|NCT02504866|Clinical Center|Damiano, Diane|+1 301 451 7544|damianod@cc.nih.gov|
22451807|NCT01229436|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22451808|NCT01144338|Astrazaneca Inc.|Peter Ohman|1(301)398-0120|Peter.Ohman@astrazeneca.com|
22451809|NCT01775137|Novartis Pharmaceuticals|Study Director|862-778-8300||
22451810|NCT04796610|RAND Corporation|Laura Bogart|3103930411|lbogart@rand.org|7281
22451811|NCT01459796|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
22451812|NCT00733824|Washington University School of Medicine|Amanda F. Cashen, M.D.|314-454-8304|acashen@wustl.edu|
22451813|NCT01343056|University of Pittsburgh|Linda Siminerio, PhD|412-864-0158|simineriol@upmc.edu|
22451814|NCT02059148|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22451815|NCT03231371|University of Michigan|Bryan Goldstein||Bryan.Goldstein@cchmc.org|
22451816|NCT02073968|Montefiore Medical Center / Albert Einstein College of Medicine|Dr. Nitin Ohri|718-920-7750|nitin.ohri@einsteinmed.edu|
22451817|NCT01384539|University of Colorado|Dr. Jessica Kendrick|303-602-5012|Jessica.Kendrick@ucdenver.edu|
22451818|NCT02658851|Apyx Medical|Kari Larson|8012440058|kari.larson@apyxmedical.com|
22451819|NCT03067441|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
22451820|NCT00856583|H. Lundbeck A/S|H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
22451821|NCT02291718|Duke University Medical Center|Dr. Lynne Koweek|919-684-8111|lynne.koweek@duke.edu|
22388415|NCT01794299|Kiadis Pharma Netherlands B.V.|Andrew Sandler, MD / Chief Medical Officer|+1 206 779 9213|a.sandler@kiadis.com|
22388416|NCT03006393|Emory University|Dr. Michael Treadway|(404) 727-3166|mtreadway@emory.edu|
22388417|NCT03500406|Mayo Clinic|Dr. Landon Trost|507-284-3728|Trost.Landon@mayo.edu|
22388418|NCT00807599|Memorial Sloan Kettering Cancer Center|Dr. Hani Hassoun, MD|212-639-3228|hassounh@mskcc.org|
22388419|NCT01262456|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22388420|NCT03938272|OxThera|Chief Operating Officer|0046 86600223|elisabeth.lindner@oxthera.com|
22388421|NCT03400579|University of North Carolina at Chapel Hill|Mehul Patel, PhD|919-843-7307|mehul_patel@med.unc.edu|
22388422|NCT02102724|Rush University College of Nursing|Barbara Swanson|3129428977|BARBARA_A_SWANSON@RUSH.EDU|
22414545|NCT03527485|Yale School of Medicine|Gustavo A. Angarita, MD, MHS|(203) 974-7536|gustavo.angarita@yale.edu|
22414546|NCT04827394|University of Oklahoma Health Sciences Center|Birju Shah, MD|405-271-5215|birju-shah@ouhsc.edu|42167
22414547|NCT01154231|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22414548|NCT06041256|Aurion Biotech, Inc.|Study director|+1-857-639-4143|clinicalaffairs@aurionbiotech.com|
22388423|NCT04821271|National Institute of Mental Health|Zarate, Carlos|+1 301 451 0861|zaratec@mail.nih.gov|
22414549|NCT03578809|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22414550|NCT00835705|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414551|NCT01116739|University of Colorado Denver|Patricia A. Braun|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
22414552|NCT05090839|University of Miami|Dr. Roger McIntosh|3052435166|r.mcintosh@miami.edu|
22414553|NCT04039022|Axsome Therapeutics, Inc.|Caroline Streicher, Senior Director, Clinical Operations|212-332-5061|cstreicher@axsome.com|
22414554|NCT00365053|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22388424|NCT03241810|Elevation oncology|VP, Clinical Operations|+1-716 371 1125|clinical@elevationoncology.com|
22388425|NCT02521493|Children's Oncology Group|Results Reporting Coordinator|6264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22388426|NCT02008916|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22388427|NCT01880736|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22388428|NCT04063124|UT Health San Antonio|Mitzi Gonzales, PhD|210-450-9047|Gonzalesm20@uthscsa.edu|
22388429|NCT01971255|National Institute of Allergy and Infectious Diseases|Matthew James Memoli|+1 301 443 5971|memolim@niaid.nih.gov|
22388430|NCT00145145|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22388431|NCT00428714|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22388432|NCT03530631|University of Alabama, Birmingham|Karen Cropsey|(205) 975-7809|kcropsey@uabmc.edu|
22388433|NCT00513071|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22388434|NCT01213940|University of South Alabama, Department of Surgery|William O. Richards, MD|251-471-7993|brichards@health.southalabama.edu|
22388435|NCT02106325|New York University School of Medicine|Stephen Ross, MD/ Principal Investigator|212 562 4097|Stephen.Ross@nyumc.org|
22388436|NCT02656199|Albert Einstein Healthcare Network|Roberta Costello; Research Compliance|215-456-7225|bcostell@einstein.edu|
22388437|NCT00452114|University of Massachusetts Medical School|Stephen Krinzman, Principal Investigator|508-856-1975|stephen.krinzman@umassmed.edu|
22388438|NCT03242863|Laboratory for the Study of Human Ingestive Behavior, The Pennsylvania State University|Dr. Barbara J. Rolls|814-863-8481|bjr4@psu.edu|
22388439|NCT05940688|University of Alabama at Birmingham|Dr. Rachel Sinkey|(205) 934-5612|rsinkey@uabmc.edu|
22388440|NCT04602728|Emory University|Soumitri Sil, PhD|404-727-2712|soumitri.sil@emory.edu|
22388441|NCT03365622|University of Rochester Medical Center|Joseph Dooley, MD|5852752141|joseph_dooley@urmc.rochester.edu|
22388442|NCT05376449|HealthPartners Institute Neuroscience Research Center|Amanda Herrmann, PhD|651-495-6363|Amanda.A.Herrmann@HealthPartners.com|
22388443|NCT05338476|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22388444|NCT06716632|Gulab Devi Hospital, Lahore|Dr. Zain Himayoun|03043862033|Zain.1080@gmail.com|
22388445|NCT02831049|National Institute on Drug Abuse (NIDA)|Dr David Epstein|1-667-312-5092|david.epstein@nih.gov|
22388446|NCT00747149|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22388447|NCT01513447|Northwestern University Feinberg School of Medicine|Cynthia A. Wong, M.D.|312-472-3585|c-wong2@northwestern.edu|
22388448|NCT03141177|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22388449|NCT00230009|Wayne State University|Steven J. Ondersma, ,PI|313-577-6680|s.ondersma@wayne.edu|
22388450|NCT00092456|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22388451|NCT00215943|H. Lee Moffitt Cancer Center and Research Institute|Melissa Alsina, M.D.|813-745-6886|melissa.alsina@moffitt.org|
22388452|NCT00443820|Novartis Pharmaceuticals|Study Director|862-778-8300||
22388453|NCT02121808|Laval University|Jean S. Bussières|418 656-8711|jbuss@criucpq.ulaval.ca|
22388454|NCT04721600|Inmode|Maria Shusterman|9057076787|Maria.Shusterman@inmodemd.com|
22414555|NCT01987765|Allergan, Inc|Vice President GSE,|714-246-4500|clinicaltrials@allergan.com|
22388455|NCT01304940|VA ORD|Suzanne Pineles|857-364-5906|suzanne.pineles@va.gov|
22388456|NCT00304278|Southern Illinois University|Dr. Krishna Rao|217-545-7969|krao@siumed.edu|
22388457|NCT01448447|Mercy|Dr. Robert Frazier|314-251-6844|Robert.Frazier@mercy.net|
22388458|NCT02065895|Boston Children's Hospital|Garry M. Steil, PhD|617-355-7504|garry.steil@childrens.harvard.edu|
22388459|NCT03740737|Ferring Pharmaceuticals|Global Clinical Compliance|-|DK0-Disclosure@ferring.com|
22388460|NCT00507429|OXiGENE, Inc.|Peter Langecker, MD, PhD|650 635 7008|plangecker@oxigene.com|
22388461|NCT04205669|CERMEL|Julian Matthewman|00241 07-98-91-91|julianmatthewman@gmail.com|
22414556|NCT00834964|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414557|NCT00443651|Genentech, Inc.|Medical Communications|800-821-8590||
22414558|NCT02826694|The University of North Carolina at Chapel Hill|Dr. Cynthia M. Powell|9199667646|powellcm@med.unc.edu|
22414559|NCT03606174|Mirati Therapeutics|Director, Clinical Operations|858-381-5289|LatvenL@Mirati.com|
22414560|NCT00491738|Genentech, Inc.|Medical Communications Specialist|800-821-8590||
22414561|NCT03264092|Texas Tech University Health Sciences Center|Dr. Antonio Mendoza Ladd|9152154678|antonio.mendoza-ladd@ttuhsc.edu|
22388462|NCT04025762|University of Cambridge|Dr Charlotte Boughton|+441223769066|cb2000@medschl.cam.ac.uk|
22388463|NCT00759798|The University of Texas MD Anderson Cancer Center|William Wierda MD/Professor|713-745-0428|wwierda@mdanderson.org|
22451822|NCT02056301|Baylor College of Medicine|Chris Glover, MD, MBA|832-824-5800|cdglover@bcm.edu|
22451823|NCT03023891|Vanderbilt University Medical Center|Vivian Kawai|(615) 322-3304|vivian.k.kawai@vumc.org|
22401266|NCT00417612|Yale University School of Medicine|Dr. Thomas O. Carpenter|203-785-6526|thomas.carpenter@yale.edu|
22451824|NCT02096055|The University of Texas MD Anderson Cancer Center|Hagop Kantarjian, MD/Chair|713-792-7026|hkantarjian@mdanderson.org|
22401267|NCT01283581|Melinta Therapeutics|Dr. Sue Cammarata|312-724-9401|scammarata@melinta.com|
22451825|NCT00499889|UT MD Anderson Cancer Center|Richard E. Champlin, MD/Professor|713-792-8848|pmcadams@mdanderson.org|
22451826|NCT03299192|Kaiser Permanente|Rene Hawkes, Project Manager|206-287-2073|rene.j.hawkes@kp.org|
22401268|NCT01334125|University of Massachusetts Medical School|Benjamin U. Nwosu, MD|5083347872|Benjamin.Nwosu@umassmemorial.org|
22451827|NCT03291613|Klein Buendel|Valerie Myers, PhD|3035654343|vmyers@kleinbuendel.com|
22451828|NCT01825408|UNC Department of Otolaryngology|Dr. Adam Zanation||adam_zanation@med.unc.edu|
22451829|NCT01418209|Brigham and Women's Hospital|Hadine Joffe, MD, MSc|617-732-4906|hjoffe@partners.org|
22401269|NCT02412644|Psoriasis Treatment Center of Central New Jersey|Jerry Bagel Director of Clinical Trials|6094434500|dreamacres1@aol.com|
22401270|NCT00882713|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22451830|NCT03779841|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22401271|NCT04901026|Faculty of Medicine, Prince of Songkla University|Dr Pittayapon Pitathawatchai|+6674451390|pittayapon.p@psu.ac.th|
22451831|NCT02788175|NIAID|Dr. Michael C. Sneller|301-496-0491|MSNELLER@niaid.nih.gov|
22451832|NCT03117387|LUMC|Maarten Honing|+31715264038|g.h.m.honing@lumc.nl|
22451833|NCT00136955|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22451834|NCT04827576|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22451835|NCT01773226|Zimmer Biomet|Linda Korthout, Scientific Affairs Specialist|+31.610.072.853|Linda.Korthout.external@zimmerbiomet.com|
22401272|NCT05523362|University Hospitals Cleveland Medical Center|Dr. Ian Neeland|(216)844-5965|Ian.Neeland@UHhospitals.org|
22451836|NCT00724282|University of Chicago|Andrea Eiring|773-702-3657|aeiring@bsd.uchicago.edu|
22451837|NCT00970502|Florida Radiation Oncology Group|Dr. Johnny Kao|813-661-6442|johnnykaomd@gmail.com|
22401273|NCT02760602|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
22430897|NCT03440411|Fondazione EMN Italy Onlus|Fondazione EMN Italy Onlus|+39 011 0243236|clinicaltrialoffice@emnitaly.org|
22451838|NCT01438411|Retrophin, Inc.|Retrophin Medical Information|1-877-659|medinfo@retrophin.com|5518
22388464|NCT03137784|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22388465|NCT01773707|Yale University|Dr. Kevan Herold|203-785-6507|Kevan.Herold@Yale.edu|
22388466|NCT04803734|Intech Biopharm Ltd.|Sabina Chien|+886-2-7721-8877|sabina.i198@intechbiopharm.com|631
22388467|NCT00239642|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|601-650-4200|mfalone@luitpold.com|
22388468|NCT03835416|Durham VA Medical Center|Dr. Connie Bales, Assoc. Director, GRECC|919-286-0411|connie.bales@va.gov|6780
22388469|NCT04026256|Massachusetts General Hospital|Benjamin Leder|617-724-2039|bzleder@mgh.harvard.edu|
22388470|NCT00854594|Louis Stokes VA Medical Center|Jeneen Shell-Boyd|(216) 791-2300|Jeneen.shell-boyd@va.gov|5831
22388471|NCT04471805|University of Iowa, Department of Health and Human Physiology|Thorsten Rudroff, PhD|(319)467-0363|thorsten-rudroff@uiowa.edu|
22388472|NCT04540952|Atrium Health|Dr. Paul Marshburn|704-619-2537|Paul.Marshburn@atriumhealth.org|
22388473|NCT01799993|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22388474|NCT01320683|City of Hope|Paul Frankel, Ph.D.|626-256-4673|pfrankel@coh.org|65265
22388475|NCT04361617|Wake Forest University Health Sciences|Lindsay Reynolds, PhD|336.713.1134|lireynol@wakehealth.edu|
22388476|NCT01263223|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22388477|NCT03695185|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22388478|NCT05919732|Nemours|Dr. Gohalem Felema|904-416-5430|gohalem.felema@nemours.org|
22388479|NCT04183491|U.S. Food and Drug Administration|David Strauss, MD, PhD|301-796-6323|David.Strauss@fda.hhs.gov|
22388480|NCT02538094|Johns Hopkins University SOM|Dr. Tracy Vannorsdall|4105023701|TVannor1@jhmi.edu|
22388481|NCT03288506|Queen's University Belfast|Dr Paul Best|0289097|p.best@qub.ac.uk|3256
22388482|NCT03692871|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22388483|NCT00257894|Veterans Affairs Medical Center (VAMC), Providence|Damaris J. Rohsenow, Ph.D.|401-863-6648|damaris.rohsenow@va.gov|
22388484|NCT02852824|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22388485|NCT01316913|GlaxoSmithKline|GSK Response Center|866-435-7343||
22388486|NCT01860079|AcibademU|Prof.Dr.Şevket Görgülü|+902623174444|sevket5@yahoo.com|4123
22388487|NCT01479010|Virginia Commonwealth University|Benjamin Van Tassell, PharmD|8048284583|bvantassell@vcu.edu|
22388488|NCT02114515|University of Illinois at Chicago|Jerry A. Krishnan, MD, PhD|312-413-3291|partner@uic.edu|
22388489|NCT02144285|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22388490|NCT02759575|University of Cincinnati|Vinita Takiar, MD, PhD, Associate Professor|(513)584-8956|Vinita.Takiar@UCHealth.com|
22388491|NCT00711555|University of Illinois|Sandra Cuellar|312-996-6985|scuell1@uic.edu|
22388492|NCT02534129|ProTechSure Scientific Inc.|L. Michael Glode, MD|303-526-9031|mike.glode@ucdenver.edu|
22388493|NCT01298219|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22388494|NCT05522777|Yakult U.S.A. Inc|Hideyuki Shibata|714-434-6500|hideyuki.shibata@yakultusa.com|
22388495|NCT05489770|EKHUFT|Dr Jane Povey- Research Facilitator|01227766877|jane.povey2@nhs.net|
22388496|NCT05487300|University of Utah|Dr. Guillaume Lamotte|801-585-7575|guillaume.lamotte@hsc.utah.edu|
22388497|NCT00112827|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22388498|NCT02507297|University of Michigan|Leslie Swanson|734-764-2242|lmswan@umich.edu|
22388499|NCT01562275|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22388500|NCT01863368|Alcon Research, Ltd.|Global Brand Med Affairs Lead, Pharma, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
22388501|NCT00070707|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22388502|NCT00647699|Avedro, Inc.|Vineeta Belanger, VP of Clinical Affairs|781-768-3459|vbelanger@avedro.com|
22388503|NCT04909593|Boston Scientific Corporation|Sr. Director, Clinical Operations|855-213-9890|BSNClinicalTrials@bsci.com|
22388504|NCT01018992|Emory University|Dr. Boadie Dunlop|404-727-8474|bdunlop@emory.edu|
22388505|NCT01366976|Vanderbilt University School of Medicine|Mias Pretorius|16153220758|mias.pretorius@vanderbilt.edu|
22388506|NCT03029585|US Biotest, Inc.|Gere S. diZerega, MD, Responsible Medical Officer|1-805-595-1300|gere.dizerega@usbiotest.com|
22388507|NCT04669366|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22388508|NCT01241448|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22388509|NCT02400749|Innovaderm Research Inc.|Dr Robert Bissonnette|514-521-4285|rbissonnette@innovaderm.ca|
22388510|NCT01825785|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22388511|NCT01458288|TaiGen Biotechnology Co., Ltd.|Chen-En Tsai, M.D., Ph.D.|+886-2-8177-7072|cetsai@taigenbiotech.com|1211
22388512|NCT02132520|University of Minnesota|Bin He|612-626-1115|binhe@umn.edu|
22388513|NCT03340961|Dr. Reddy's Lab, INC|Dr. Srinivas Sidgiddi, Senior Director|908-458-5362|Srinivassidgiddi@drreddys.com|
22430898|NCT00505687|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22451839|NCT01863680|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22388514|NCT01286311|Northwestern University|Stephen D. Persell, MD MPH|312-503-6464|spersell@nmff.org|
22388515|NCT03034863|James J Peters VAMC|Marianne Goodman, MD|718-584-9000|Marianne.Goodman@va.gov|5188
22388516|NCT01437540|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
22451840|NCT00618514|Image Guided Surgery Associates|Robert Worthington-Kirsch|(610) 327-7236|kirsch@igsapc.com|
22430899|NCT03707821|Johnson & Johnson VIsion|John Buch OD, MS, FAAO Sr. Principal Research Optometrist|9044431707|JBUCH@its.jnj.com|
22388517|NCT03331978|RAND Corporation|Laura Bogart|3103930411|lbogart@rand.org|7281
22388518|NCT01381549|GlaxoSmithKline|GSK Response Center|866-435-7343||
22451841|NCT01615731|Stanford University|Principal Investigator|650-497-5175|gynresearch@stanford.edu|
22451842|NCT01093794|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22451843|NCT00566228|Mayo Clinic|Luis F. Porrata, M.D.|507/284-2511|Porrata.Luis@mayo.edu|
22388519|NCT00630409|University of Pittsburgh|Leonard Appleman, MD, PhD|412-648-6538|applemanlj@upmc.edu|
22388520|NCT02605876|University of North Carolina at Chapel Hill|Troy Blackburn|9198432021|troyb@email.unc.edu|
22388521|NCT02152384|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22388522|NCT02446015|Alcon, A Novartis Division|WW Medical Affairs Director, GMA Ophthalmics|1-888-451-3937|alcon.medinfo@alcon.com|
22388523|NCT01393600|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22388524|NCT00603798|Graceway Pharmaceuticals|Sharon F Levy, MD|267-948-0400|sharon.levy@gracewaypharma.com|
22388525|NCT03800563|Alma Lasers|Dr Meital Grafi-Cohen|+972-523708780|meital.grafi@almalasers.co.il|
22388526|NCT01163214|Mayo Clinic|Mark J. Spangehl, M.D.|480-342-2377|spangehl.mark@mayo.edu|
22451844|NCT02740127|UT MD Anderson Cancer Center|Bobby Bellard, Assistant Professor, Anesthesiology & PeriOper Med|(713) 794-1461|bbellard@mdanderson.org|
22451845|NCT03320070|Mallinckrodt|Medical Information Call Center|1-800-844-2830|medInfo@mnk.com|
22451846|NCT03586648|Johnson & Johnson Vision Care Inc.|Thomas Karkkainen, OD, MS, FAAO- Sr. Principal Research Optometrist|904-443-3402|TKarkkai@its.jnj.com|
22451847|NCT02041195|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
22451848|NCT00414700|TiGenix n.v.|Nel Van Lommel, MSc, Manager Clinical Operations Europe, TiGenix n.v.|+3216396060|nel.vanlommel@tigenix.com|
22451849|NCT02367911|Therapeutics, Inc.|Clinical Research Director|858-571-1800|projectmanager@therapeuticsinc.com|
22451850|NCT00263666|GlaxoSmithKline|GSK Response Center|866-435-7343||
22451851|NCT02492100|Massachusetts General Hospital|Areej El-Jawahri|248-763-3912|ael-jawahri@partners.org|
22451852|NCT03832010|Cutaneous Translational Research Program|Ruizhi Wang|4105027546|rwang@jhmi.edu|
22451853|NCT02348216|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
22451854|NCT01055639|VA San Diego Healthcare System|Dr. Julie Wetherell|858-552-8585|jwetherell@ucsd.edu|2752
22451855|NCT04450823|Global Surgery Amsterdam|Dr Matthijs Botman|0031648073683|matthijsbotman@gmail.com|
22451856|NCT01202773|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22451857|NCT02585895|Amgen Inc.|Study Director|866-572-6436||
22451858|NCT01243333|Huntsman Cancer Institute Research Compliance Officer|Josiah Hawks|8015850601|Josiah.Hawks@hci.utah.edu|
22388527|NCT00988429|Bial - portela & Cª, S.A.|Head of Clinical Research|+351 22 986 6100|clinical.trials@bial.com|
22388528|NCT02964234|University of Illinois at Chicago|Dr. Yamile Molina|312-355-2679|ymolin2@uic.edu|
22388529|NCT01123356|Medical University of South Carolina|Clinical Trials Network Manager|843-792-1753|adraleta@musc.edu|
22388530|NCT03015961|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
22388531|NCT02067000|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 09 574 0123|CPAPtrial@fphcare.co.nz|7044
22388532|NCT02246647|Mayo Clinic|Madhusudan Grover, MBBS|507-253-5384|Grover.Madhusudan@mayo.edu|
22388533|NCT02416973|Regenesis Biomedical Inc.|Heather Vander Ploeg|602-428-7041|Heather.VanderPloeg@regenesisbio.com|
22388534|NCT04387773|Oregon Health & Science University|Dr. Amie Hiller|503-494-7772|peterami@ohsu.edu|
22388535|NCT01113541|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22388536|NCT04405180|University of Pittsburgh|Dr. Daniel Forman|412-864-2507|formand@pitt.edu|
22451859|NCT01169467|Duke University Medical Center|Dr. Keith Dombrowski|(919)|keith.dombrowski@dm.duke.edu|
22451860|NCT03058679|University of Pennsylvania|Dr. James D. Lewis|215-573-5137|lewisjd@pennmedicine.upenn.edu|
22451861|NCT01098006|GlaxoSmithKline|GSK Response Center|866-435-7343||
22451862|NCT04137380|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22451863|NCT02334800|Pfizer Inc.|Pfizer ClinicalTrail.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22451864|NCT02127164|University of Arizona|Andrew Tang, MD|520-626-5056|traumaresearch@arizona.edu|
22451865|NCT00575588|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22451866|NCT02265705|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22451867|NCT02703844|University of Kent|David Wilkinson|+44 (0)1227 824772|d.t.wilkinson@kent.ac.uk|
22451868|NCT04030416|seca gmbh & co. kg|Kristin Klückmann|+49(40)200000|kristin.klueckmann@seca.com|232
22451869|NCT00801684|Alkermes, Inc.|Bernard L. Silverman, MD|781-609-6000|bernard.silverman@alkermes.com|
22451870|NCT02828111|PellePharm, Inc.|Chief Medical Officer|(510) 502-6144|clinical@pellepharm.com|
22451871|NCT00614939|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22451872|NCT03660683|George Washington University Medical Faculty Associates|Dr. Sabyasachi Sen|301-461-6676|ssen1@email.gwu.edu|
22388537|NCT00825734|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22388538|NCT02132676|VA Ann Arbor Healthcare System Center for Clinical Management & Research|Dr. Michele Heisler|734-845-3502|mheisler@umich.edu|
22451873|NCT02079805|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22451874|NCT00383435|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22451875|NCT01753193|MedImmune, LLC|Raj Tummala|+1 301-398-0548|information.center@astrazeneca.com|
22451876|NCT00583557|GlaxoSmithKline|GSK Response Center|866-435-7343||
22451877|NCT02682264|Cassiopea, SPA|Cassiopea R&D|+39 02 868 911 24|r&d@cassiopea.com|
22451878|NCT01131312|National Cancer Institute|Dr. Mark Schiffman|240-276-7259|schiffmm@nih.gov|
22451879|NCT02347761|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
22451880|NCT01255358|EryDel spa|Clinical Study Coordinator|+39 02 36504470|guenter.janhofer@erydel.com|
22451881|NCT03370887|AstraZeneca|Global Clinical LEad|1-877-240-9479|information.center@astrazeneca.com|
22388539|NCT02424968|Stanford University|Robert Lowsky, Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)|650-723-0822|rlowsky@stanford.edu|
22388540|NCT00687297|PrECOG|Study Statistician|617-632-3633|jmanola@jimmy.harvard.edu|
22388541|NCT01567150|Hollister Incorporated|Director, Global Clinical Affairs|8479183996|ginger.salvadalena@hollister.com|
22388542|NCT02525744|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22388543|NCT01182285|National Cancer Institute|Dr. Naris Nilubol|301-451-2355|niluboln@nih.gov|
22388544|NCT02069379|University of Michigan|Alison Berent-Spillson|(734) 936-4400|berent@umich.edu|
22388545|NCT03195127|University of Maryland, Baltimore|Avelino C. Verceles, M.D., M.S.|4103288141|avercele@medicine.umaryland.edu|
22388546|NCT00274287|Oncology Specialists, S.C.|Chadi Nabhan, MD|847-268-8200|cnabhan@oncmed.net|
22388547|NCT04617847|Wave Life Sciences|Medical Director|855-215-4687|clinicaltrials@wavelifesci.com|
22388548|NCT01525875|Icahn School of Medicine at Mount Sinai|Dr. Mark Lebwohl|212-241-9728|mark.lebwohl@mountsinai.org|
22388549|NCT03150758|Cleveland Clinic|Dr. Eric Klein|1-800-223-2273|CancerCenterResearch@ccf.org|
22388550|NCT04144088|Chung Shan Medical University Hospital|Dr. Cheng Chung Wei|+886-4-24739595|wei3228@gmail.com|34718
22388551|NCT00695188|Department of Clinical Pharmacology, Medical University of Vienna|Eva-Luise Hobl|+43 1 40400 2981|eva-luise.hobl@meduniwien.ac.at|
22388552|NCT03031782|Novartis Pharmaceuticals|Study Director|(862) 778-8300|novartis.email@novartis.com|
22388553|NCT03576118|Ajou University Hospital|Dr. Jong Yeop Kim|+82312195574|kjyeop@ajou.ac.kr|
22388554|NCT04867382|HealthPartners Institute|Stephanie Hooker, PhD, MPH, MS, Principal Investigator|(952) 967-5056|Stephanie.A.HookerShowalter@HealthPartners.com|
22388555|NCT05445557|Raziel Therapeutics|Racheli Gueta, Director of Clinical Trials|97289124670|racheli@raziel-therapy.com|
22388556|NCT03803475|University of California, San Francisco|Dr. Thomas Hope, MD|(415) 221-4810|Thomas.Hope@ucsf.edu|
22388557|NCT01323790|AstraZeneca|Mark Sostek||ClinicalTrialTransparency@astrazeneca.com|
22388558|NCT00046475|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22388559|NCT05011292|Emory University|Dr. Jean Welsh|404-375-1165|jwelsh1@emory.edu|
22388560|NCT02915783|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22388561|NCT02950961|VA Greater Los Angeles Healthcare System, West Los Angeles, CA|Alison B Hamilton, PhD MPH|(310) 478-3711|alison.hamilton@va.gov|44157
22388562|NCT02432274|Eisai Ltd.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22388563|NCT00309751|Kowa Research Institute Inc|Bill Arana|919 433 1600|barana@kowaus.com|
22388564|NCT01736475|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22388565|NCT02807857|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22388566|NCT04197713|University of M D Anderson Cancer Center|Dr. Timothy Yap|713) 563-1784|tyap@mdanderson.org|
22388567|NCT01079949|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22388568|NCT01529632|Novartis Pharmaceuticals|Study Director|862-778-8300||
22388569|NCT05184062|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22388570|NCT06164743|VivaVisionBio|Dr. Joanne Li|(86) 021-58598290|joanne.li@vivavisionbio.com|
22388571|NCT04914897|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22388572|NCT02713217|Central Arkansas Veterans Healthcare System|Richard R. Owen, MD|5012574802|richard.owen2@va.gov|
22388573|NCT01921166|AtriumHealth|Bradley Hurst, M.D., Director of Assisted Reproduction|704-355-3149|brad.hurst@atriumhealth.org|
22388574|NCT04555694|Cleveland Eye Clinic|Dr. Thomas Chester, OD|440-526-1974|tchester@midwestvision.com|
22388575|NCT02834624|University of Missouri-Columbia|Dr. Naomi Lauriello|573-882-2272|lauriellon@health.missouri.edu|
22388576|NCT04783389|Connect Biopharma|Dr. Malinda Longphre, PhD, Head of Clinical Operations|+1 510 520 3361|mlongphre@connectpharm.com|
22388577|NCT01250717|BIDMC|Glenn Bubley MD, Director of GU ONC|617-735-2062|gbubley@bidmc.harvard.edu|
22388578|NCT02164578|Medical Clinic III, Universitätsklinikum Carl Gustav Carus, Dresden, Germany|Dr. Frank Pistrosch|0049 351 458|frank.pistrosch@uniklinikum-dresden.de|5955
22388579|NCT04328467|University of Minnesota|Radha Rajasingham, MD|612-626-8171|radha@umn.edu|
22388580|NCT00990184|SIBCR|Steven E. Kahn|206-277-5515|skahn@u.washington.edu|
22388581|NCT01975701|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novatis.com|
22388582|NCT00376259|Novartis Pharmaceuticals|Study Director|862-778-8300||
22388583|NCT03734588|Spark Therapeutics|Tiffany Chang, MD, MAS Clinical Development Lead, Hematology|Please Email|Tiffany.chang@sparktx.com|
22388584|NCT01877720|Seoul National University College of Medicine|Dr. Han-Suk Kim|82-2-2072-1696|kimhans@snu.ac.kr|
22388585|NCT01828476|Rutgers Cancer Institute of New Jersey|Mark Stein, MD|732-235-5773|steinmn@cinj.rutgers.edu|
22388586|NCT00267956|Centocor Research & Development, Inc|Senior Director Clinical Research|1-800-457-6399||
22388587|NCT01393964|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22388588|NCT01918033|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22388589|NCT04679675|Kaiser Permanente Washington Health Research Institute|Dr. Beverly Green|206-220-2997|bev.b.green@kp.org|
22388590|NCT01338506|Medical University of South Carolina|Dr. Sudie Back|843-792-9383|backs@musc.edu|
22388591|NCT02802111|Children's Hospital Los Angeles|Dr. Patrick Ross|323-361-7864|pross@chla.usc.edu|
22388592|NCT01702259|Surgeon's Inc.|Dr. Robert F. Jackson|765-662-8303|rjlipodr@comteck.com|
22388593|NCT01494467|Galderma R&D, LLC|Clinical Science Director|609-409-7701||
22388594|NCT03711279|Jiangsu HengRui Pharmaceuticals Co., Ltd.|Project manager|+86-18036618962|qianna.zhan@hengrui.com|
22388595|NCT04534738|University of Maryland Baltimore|Amber Kleckner, PhD|410-706-5961|amber.kleckner@umaryland.edu|
22401274|NCT03159754|University of Michigan|Steven Bruch, MD|7349368464|sbruch@umich.edu|
22401275|NCT00474253|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22401276|NCT01165229|GlaxoSmithKline|GSK Response Center|866-435-7343||
22401277|NCT01357239|Novartis Pharmaceuticals|Study Director|862-778-8300||
22401278|NCT01542372|Massachusetts|Dr. Devon Hinton|617-620-4522|DHINTON1@mgh.harvard.edu|
22401279|NCT03133481|University of Alabama at Birmingham|Adam Sturdivant|205-934-4042|Adamsturdivant@uabmc.edu|
22401280|NCT02102230|VA Palo Alto Health Care System|Kimberly Babson, PhD|831-325-1540|kimberly.babson@gmail.com|
22401281|NCT00637728|Endo Pharmaceuticals Inc.|M. Todd Kirby, PhD|(484) 216-6491|kirby.todd@endo.com|
22430900|NCT01432444|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22430901|NCT03673176|Stanford University|Joseph Shrager, MD|(650) 721-2086|shrager@stanford.edu|
22430902|NCT02378480|Paratek Pharmaceuticals, Inc.|Dr. Paul McGovern; Vice President, Clinical Affairs|484-751-4935|Paul.Mcgovern@paratekpharma.com|
22430903|NCT01189760|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22430904|NCT01230060|Bausch & Lomb Incorporated|Jon Hayashida|(949) 521-7876|jon.hayashida@bausch.com|
22430905|NCT03802916|Chiesi Canada Corp.|Fernando Tricta, MD|1-416-558-6342|ftricta@chiesi.com|
22430906|NCT01285102|Fox Chase Cancer Center|Dr. Efrat Dotan|215-214-4283|Efrat.Dotan@fccc.edu|
22430907|NCT02157610|Moffitt Cancer Center|Jennifer Vidrine, PhD, MS|813-745-8764|jennifer.vidrine@moffitt.org|
22430908|NCT02327169|Takeda|Takeda Study Registration Call Center|+1-866-835-2233|GlobalOncologyMedinfo@takeda.com|
22430909|NCT03787615|The Pennsylvania State University|Dr. David Conroy|814-863-3451|conroy@psu.edu|
22430910|NCT01704157|Pacira Bioscience, Inc.|Pacira MedInfo|1-855-793-9729|MedInfo@Pacira.com|
22430911|NCT01229111|Case Comprehensive Cancer Center|Dr. Smitha Krishnamurthi|216-844-5234|smitha.krishnamurhti@uhhospitals.org|
22430912|NCT01946880|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22430913|NCT01531335|Pontificia Universidad Javeriana|Dr Saul Rugeles|5715946161|rujeles@javeriana.edu.co|2240
22430914|NCT00721110|Cleveland Clinic|Daniel Sessler, MD|216-444-4200|sesslerd@ccf.org|
22430915|NCT02799043|Abbott|Anne Sarver, PhD|1-651-756-3813|anne.sarver@abbott.com|
22430916|NCT02226653|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22430917|NCT01922895|U.T. Southwestern Medical Center|Mack C. Mitchell, MD|2146485036|mack.mitchell@utsouthwestern.edu|
22430918|NCT01916226|GlaxoSmithKline|GSK Response Center|866-435-7343||
22430919|NCT01257750|Massachusetts Eye and Ear Infirmary|Reza Dana, MD, MPH, MSc|617-573-3313|Cornea_Research@meei.harvard.edu|
22430920|NCT01166646|Therapeutics, Inc.|Clinical Research, Therapeutics Inc.|858-571-1800|clinicalresearch@therapeuticsinc.com|
22430921|NCT05142306|Emergent BioSolutions Canada Inc|Mila Mirceta, PhD, Senior Scientist, Clinical Research|204-275-4074|mircetam@ebsi.com|
22430922|NCT05430919|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22430923|NCT00521352|Columbia University Department of Psychiatry, City University of New York|Dr. Antonio Mantovani|212-650-5417|AMantovani@med.cuny.edu|
22430924|NCT05181085|NorthSea Therapeutics BV|Michelle Yokley|31 035760 65 05|info@northseatherapeutics.com|
22430925|NCT02614248|Genesis Medical Center|Michelle Martin, RN|562-421-7743|MartinMi@genesishealth.com|
22430926|NCT04650893|University of Nebraska Medical Center|Peter Danielson|402-559-1703|peter.danielson@unmc.edu|
22430927|NCT02370693|Northwestern University|Manu Jain, MD|312-503-4242|m-jain@northwestern.edu|
22430928|NCT02481141|SBI Pharmaceuticals Co, Ltd.|Dr. Riyadh Rehani, President of MENA Region|+973 66394100|rrehani@sbigroup.co.jp|
22430929|NCT04309500|University of Michigan|Annalise M. Rahman-Filipiak|734-763-9259|rahmanam@med.umich.edu|
22430930|NCT00553475|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22430931|NCT00913835|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22430932|NCT00773461|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22430933|NCT00637156|Medtronic Spine and biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
22430934|NCT03193437|Georgetown University|Chul Kim, MD|(202) 444-2223|Chul.Kim@gunet.georgetown.edu|
22430935|NCT04976855|Indivior Inc.|Global Director Clinical Development|(804) 594-4488|trialdisclosure@indivior.com|
22430936|NCT02038036|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22430937|NCT04778709|NYU College of Dentistry|Aikaterini Georgantza|212-998-9986|ag4222@nyu.edu|
22430938|NCT02397720|The University of Texas MD Anderson Cancer Center|Naval Daver MD./Professor|713-794-4392|NDaver@mdanderson.org|
22430939|NCT02605616|University of Virginia|Dr. Rita Basu|434-924-5183|rb4vd@virginia.edu|
22430940|NCT00908141|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Robert Dreicer MD|216-445-4623|dreicer@ccf.org|
22430941|NCT02657356|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22430942|NCT03768336|Massachusetts General Hospital/Harvard Medical Schoool|Dr. Giselle K. Perez|617-724-0765|gperez@mgh.harvard.edu|
22430943|NCT02278003|Memorial Sloan Kettering Cancer Center|Dr. Eric Kelhoffer, MD|212-639-8781|kelhoffe@mskcc.org|
22451882|NCT04079933|Altria|Jeffery Edmiston, Functional Director Clinical Research|8043352366|Jeffery.S.Edmiston@altria.com|
22451883|NCT03207750|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22451884|NCT02493361|University of California, San Francisco|Dr. Katy Tsai|(415) 402-5483|katy.tsai@ucsf.edu|
22451885|NCT02785406|The University of Texas Health Science Center at Houston|Scott Lane|713-486-2535|Scott.D.Lane@uth.tmc.edu|
22451886|NCT01761747|Dana-Farber Cancer Institute|Dr. Peter Hammerman|617-632-6335|phammerman@partners.org|
22451887|NCT02937545|Duke University School of Medicine|Susanne B Haga|919-684-0325|susanne.haga@duke.edu|
22451888|NCT02626715|UPMC Children's Hospital of Pittsburgh|Dr. Randy Windreich|412-692-5055|randy.windreich@chp.edu|
22451889|NCT02504294|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1--800--718--1021|ClinicalTrials.gov_Inquiries@Pfizer.com|
22451890|NCT02252211|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22451891|NCT01059760|Intermountain Heart Institute|Benjamin D. Horne|8015074708|benjamin.horne@imail.org|
22451892|NCT00659633|University of Alabama at Birmigham|Dr. Michael Froelich|205-975-3328|mfroelich@uabmc.edu|
22451893|NCT00986999|University of Hawaii|Cecilia M. Shikuma M.D.|808 692-1328|shikuma@hawaii.edu|
22451894|NCT02255175|UNC School of Medicine|Crystal Edler Schiller, PhD|919-966-4810|crystal_schiller@med.unc.edu|
22430944|NCT00980044|University of Kentucky College of Medicine|Michelle Lofwall, MD, Associate Professor|8593239321|michelle.lofwall@uky.edu|
22451895|NCT05799495|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22451896|NCT03373591|Montefiore Medical Center|Diego Camacho, MD|718-920-4800|dicamach@montefiore.org|
22451897|NCT03694548|Emory University|Dr. Nitya Bakshi|404-727-3149|nitya.bakshi@emory.edu|
22451898|NCT04177108|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22451899|NCT00099983|VA Connecticut HCS|John Krystal, MD|203-937-4790|john.krystal@yale.edu|
22451900|NCT00101101|H. Lee Moffitt Cancer Center and Research Institute|Sophie Dessureault, M.D., Ph.D.|813-745-1965|sophie.dessureault@moffitt.org|
22451901|NCT01603875|Queen Saovabha Memorial Institute|Dr. Terapong Tantawichien|66225201614|terapong_tantawichien@hotmail.com|125
22401282|NCT00325572|Milton S. Hershey Medical Center|Jeanette C. Ramer MD|717 531-8414|jramer2@hmc.psu.edu|
22401283|NCT01873950|U.S. Food and Drug Administration|David G Strauss, MD, PhD|301-796-6323|david.strauss@fda.hhs.gov|
22451902|NCT04737538|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|
22401284|NCT01330290|UCB|UCB Clinical Trials Call Center|+1 877 822 9493||
22401285|NCT03000452|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22401286|NCT00593112|Massachusetts General Hospital|Paul Hammerness, M.D.|617-503-1040|phammerness@partners.org|
22430945|NCT00442702|Hoffman-LaRoche|Medical Communications|800-821-8590||
22451903|NCT01652716|AstraZeneca|ClinicalTrialTransparency@astrazeneca.com||ClinicalTrialTransparency@astrazeneca.com|
22451904|NCT01422070|Università degli Studi di Ferrara|Dr Maurizia Capuzzo|+393355932642|cpm@unife.it|
22451905|NCT04122443|Montefiore Medical Center|Dr. Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
22451906|NCT05204134|Tandem Diabetes Care|Supervisor Clinical Operations|+18778016901|clinicalaffairs@tandemdiabetes.com|
22451907|NCT02584309|Washington University School of Medicine|Brian A. Van Tine, M.D., Ph.D.|314-747-8475|bvantine@wustl.edu|
22451908|NCT01312467|University of California, Irvine|Dr. Frank L. Meyskens, Jr.|714-456-6310|flmeyske@uci.edu|
22451909|NCT03283670|Washington University|Ben Palanca, MD PhD|314 273-9076|palancab@wustl.edu|
22451910|NCT01059617|GlaxoSmithKline|GSK Response Center|866-435-7343||
22451911|NCT03861000|National Institute of Mental Health|Dr Robert Innis|+1 301 693 2979|innisr@mail.nih.gov|
22451912|NCT01968434|Clalit HS|Prof. Herman Avner Cohen|00972 3-939-8203|hermanc@clalit.org.il|
22451913|NCT02199691|Sanofi Pasteur|Trial Transparency Team|800-633-1610 ext 1#|Contact-US@sanofi.com|
22451914|NCT03154710|Weprom|Dr Katell LE DU|241682940|k.ledu@cjb72.org|0033
22451915|NCT00612313|UT Southwestern Medical Center|Dr. Graham Emslie and Dr. Betsy Kennard|214-456-5900|beth.kennard@utsouthwestern.edu|
22451916|NCT01736566|Brigham and Women's Hospital|Carrie Blout, Genetic Counselor Project Manager|617-264-5837|carrie.blout@gmail.com|
22451917|NCT00791765|Amgen Inc.|Study Director|866-572-6436||
22451918|NCT04295564|OHSU|Dr. Cindy McEvoy|503-494-0223|mcevoyc@ohsu.edu|
22451919|NCT04537923|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22451920|NCT01261611|Ipsen Innovation|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22451921|NCT02527798|Duke University|Leigh Gosnell|919-668-1280|leigh.gosnell@duke.edu|
22401287|NCT05372315|Iworks Laser and Vision Center|Dr. Patrick L. Spencer|937-226-7870|iworkeye@gmail.com|
22451922|NCT04690855|Hoosier Cancer Research Network|Fauzia Sharmin|(317) 921-2050|fsharmin@hoosiercancer.org|
22451923|NCT03859323|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22401288|NCT01745055|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22401289|NCT01512368|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran|Dr. Daniel Cuevas-Ramos|525554870900|shiverqks@hotmail.com|2407
22451924|NCT01429259|Hartford Hospital|Joseph L. Kuti, Pharm.D.|860-972-3612|joseph.kuti@hhchealth.org|
22451925|NCT01682460|CCLR|Research Manager|519-888-4742|cclr2@sciborg.uwaterloo.ca|
22451926|NCT00639717|University of Michigan Comprehensive Cancer Center|Dr. Gregory Yanik|734-764-3243|jelevine@umich.edu|
22451927|NCT02180646|University of Missouri|Dr Jill Kanaley|573-882-2519|kanaleyj@missouri.edu|
22401290|NCT00328198|Genzyme Corporation|Genzyme Medical Information|1-800-745-4447||
22451928|NCT02053350|UVirginia|Dr. Cirle Warren|(434) 924-5242|CA6T@hscmail.mcc.virginia.edu|
22451929|NCT01275625|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22451930|NCT03009045|Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center|Loren G. Miller|310-222-5623|lgmiller@ucla.edu|
22451931|NCT01585103|Mayo Clinic|Dr. Jeffrey Alexander|507-284-1825|Alexander.Jeffrey14@mayo.edu|
22401291|NCT01570491|Cleveland Clinic|Daniel Sessler, MD|2164444900|sessled@ccf.org|
22451932|NCT03521635|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22451933|NCT01349569|Johns Hopkins University|Ivan Borrello, MD|4109554967|iborrell@jhmi.edu|
22451934|NCT03581305|NIH/CC|Dima Hammoud, Senior investigator|3014023041|hammoudd@cc.nih.gov|
22451935|NCT01747772|Division of Abdominal Imaging and Interventional Radiology, Massachusetts General Hospital|Anthony E. Samir MD||asamir@partners.org|
22451936|NCT02244944|University of Kentucky|Gregory Graf|8592574749|Gregory.Graf@uky.edu|
22451937|NCT00492349|University of Maryland|L. Elliot Hong, M.D.|410-402-6828|ehong@mprc.umaryland.edu|
22451938|NCT01003899|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22451939|NCT04969783|Masonic Cancer Center|Dr. Dorothy Hatsukami|612-626-2121|hatsu001@umn.edu|
22401292|NCT00066781|Mayo Clinic|Matthew Goetz, M.D.|(507) 284-2511|goetz.matthew@mayo.edu|
22451940|NCT02489500|Boston Medical Center|Vaishali Sanchorawala, MD|6176388261|sfenness@bu.edu|
22451941|NCT01138124|GlaxoSmithKline|GSK Response Center|866-435-7343||
22451942|NCT00987467|Johns Hopkins University, Wilmer Eye Institute|Esen Akpek, MD, Associate Professor of Ophthalmology, Wilmer Eye Institute|410-955-5214|esakpek@jhmi.edu|
22451943|NCT00512135|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
22451944|NCT00262834|SKCCC|Vered Stearns|4432876489|vstearn1@jhmi.edu|
22451945|NCT03422250|IRCCS Centro San Giovanni di Dio Fatebenefratelli|Michela Pievani|+39 030 35011|mpievani@fatebenefratelli.eu|
22451946|NCT03812146|VA Center for Integrated Healthcare|Dr. Kyle Possemato|315-425-4400|Kyle.Possemato@va.gov|53551
22451947|NCT00377819|Amgen Inc.|Study Director|866-572-6436||
22451948|NCT02416791|Neurostimulation Laboratory, Hospital das Clínicas/São Paulo University, Brazil|Professor Adriana Bastos Conforto|+55 11 2661-7955|adriana.conforto@hc.fm.usp.br|
22451949|NCT01054820|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22451950|NCT00467870|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22451951|NCT02239679|DUSA Pharmaceuticals Inc., a Sun Pharma Co.|Anna Houlihan|9147608796|Anna.Houlihan@sunpharma.com|
22451952|NCT01917526|Mahidol University|Department of Anesthesiology, Siriraj Hospital|66-2-41979889|manee95@hotmail.com|501
22451953|NCT01206738|University of Aberdeen|Prof Shaun Treweek||streweek@mac.com|
22451954|NCT00760929|F. Hoffmann-La Roche AG|Study Director|+41 616878333|global.trial_information@roche.com|
22451955|NCT02099838|Huazhong University of Science and Technology|Dr. Yu|027-83662883|xfyu188@163.com|
22451956|NCT04121962|Johns Hopkins Bloomberg School of Public Health|Dr. Karin Tobin|4105025368|ktobin2@jhu.edu|
22451957|NCT01175382|University of Alabama at Birmingham|Dr. Kathryn Burgio|205-558-7064|kburgio@uabmc.edu|
22451958|NCT00774787|Rigel Dermatology|Darrell Rigel|212-684-5964|dsrigel@prodigy.net|
22451959|NCT04535037|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22451960|NCT02031276|Boehringer Ingelheim|Boehringer Ingelheim Call Center|+1 800 243 0127|clintriage.rdg@boehringer-ingelheim.com|
22451961|NCT02880852|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22451962|NCT00765245|Vanderbilt-Ingram Cancer Center|Dr. Nishitha Reddy|800-811-8480|nishitha.reddy@vanderbilt.edu|
22451963|NCT01614210|Huntsman Cancer Institute|Josiah Hawks|8015850601|Josiah.Hawks@hci.utah.edu|
22451964|NCT01790750|University of Florida|Curt DeGroff|(352) 273-7831|degroffc@peds.ufl.edu|
22451965|NCT03535649|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
22451966|NCT00317239|Luitpold Pharmaceuticals, Inc.|Mark Falone|610-650-4200|mfalone@luitpold.com|
22451967|NCT04408469|Yale University School of Public Health|Dr. Danielle Chiaramonte|646-429-9407|danielle.chiaramonte@yale.edu|
22451968|NCT04321460|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22451969|NCT04495712|VA Portland Health Care System|Merritt Raitt MD|503-220-8262|merritt.raitt@va.gov|57571
22451970|NCT03669081|University of Utah|Eryberto Martinez|801-581-2563|eddie.martinez@utah.edu|
22451971|NCT00706121|SWOG Statistical Center|SELECT/S0000D Statistician|206-667-4623||
22451972|NCT01308749|Duke University Center for Autism and Brain Development|Linmarie Sikich, MD|9196810026|linmarie.sikich@duke.edu|
22451973|NCT02546544|University of Oxford|Joint Research Office|+441865572245|ctrg@admin.ox.ac.uk|
22451974|NCT02223390|Duke University (Currently at Columbia University)|Kathleen Sikkema, PhD|212-305-8236|ks3364@cumc.columbia.edu|
22451975|NCT01994486|UNIVERSITY OF FLORIDA|Giuseppe (Joseph) Morelli, MD|352-273-9467|GIUSEPPE.MORELLI@MEDICINE.UFL.EDU|
22451976|NCT01301963|CCCC|Hien Duong, MD|216-445-5531|duongh@ccf.org|
22401293|NCT02648230|Columbia University|Ajay Kirtane, MD, SM|212-305-7060|akirtane@columbia.edu|
22401294|NCT02048878|University of Chicago|Eve Van Cauter, PhD|773-702-0169|evcauter@bsd.uchicago.edu|
22451977|NCT01197950|Universty of Skovde|Professor Lena Mårtensson|+46500448000|lena.martensson@his.se|
22451978|NCT02553330|Incyte Organization|Study Director|855-463-3463|medinfo@incyte.com|
22401295|NCT01720667|University of California San Diego, School of Medicine|Dr. Richard Haas|(858) 822-6700|rhaas@ucsd.edu|
22430946|NCT01444781|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22430947|NCT00313560|Sidney Kimmel Comprehensive Cancer Center|Dr. Amol Narang|410-502-3823|anarang2@jhmi.edu|
22430948|NCT00500331|GlaxoSmithKline|GSK Response Center|866-435-7343||
22430949|NCT02085980|The Christ Hospital - Cincinnati, OH|Dr. Mickey Karram|(513) 463-2500|mickey.karram@thechristhospital.com|
22430950|NCT03895476|University of Alabama at Birmingham|Hussein Basma, DDS, MS|2059344506|basma86@uab.edu|
22430951|NCT03014089|ModernaTX, Inc|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
22430952|NCT00321932|Masonic Cancer Center, University of Minnesota|Linda Burns, M.D.|612-624-8144|burns023@umn.edu|
22430953|NCT00734032|GlaxoSmithKline|GSK Response Center|866-435-7343||
22430954|NCT03562156|Mycovia Pharmaceuticals Inc|Clinical Trial Administration|919-467-8539|adminops@mycovia.com|
22430955|NCT03468998|University of Alabama at Birmingham|Ramzi Abou-Arraj|2059341125|rva@uab.edu|
22430956|NCT00137449|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22430957|NCT02296099|TriHealth|Clinical Research Specialist|513-862-2341|ganga_devaiah@trihealth.com|
22430958|NCT01356940|MS Center at Evergreenhealth|Theodore R. Brown, MD|425-899-5350|trbrown@evergreenhealth.com|
22451979|NCT01666002|Stanford University|Jean Tang MD PhD, assistant professor|650-723-6316|tangy@stanford.edu|
22451980|NCT02511431|NIDDK|Christopher Koh, MD|301-443-9402|christopher.koh@nih.gov|
22451981|NCT05053087|Mayo Clinic|Benjamin K. Wilke, M.D.|904-953-2405|Wilke.Benjamin@mayo.edu|
22451982|NCT04171700|University of Pennsylvania|Kim Reiss Binder|1 215 360 0735|Kim.ReissBinder@uphs.upenn.edu|
22451983|NCT01452269|University of Rochester|Dr. Steven Barnett||steven_barnett@urmc.rochester.edu|
22451984|NCT03108924|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22451985|NCT00346034|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22451986|NCT02100072|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22451987|NCT02641080|West Virginia University Department of Orthopaedics|Matthew J. Dietz, MD|304-285-7445|mdietz@hsc.wvu.edu|
22451988|NCT00167544|Nationwide Children's Hospital Clinical Research Institute|Dr. Nehal Parikh|614-355-6657|nehal.parikh@nationwidechildrens.org|
22451989|NCT01757964|University of Washington|David Suskind MD Professor of Pediatrics|206-987-2521|Jani.Klien@seattlechildrens.org|
22451990|NCT06281548|University of North Carolina-Chapel Hill|Adams Sibley|423-227-9198|asibley@live.unc.edu|
22451991|NCT03835533|Parker Institute for Cancer Immunotherapy|Ute Dugan|203-379-6757|udugan@parkerici.org|
22451992|NCT00754845|Canadian Cancer Trials Group|Senior Biostatistician|6135336430|dtu@ctg.queensu.ca|
22451993|NCT03864900|National Taipei University of Nursing and Health Sciences|Director of Nursing Department|886-2-28712121|tsaejyy@ntunhs.edu.tw|3100
22451994|NCT03238001|Digital Cognition Technologies|SVP, Clinical Affairs|6174331777|aholway@digitalcogtech.com|
22451995|NCT03115424|Mayo Clinic|Adrian Vella, M.D.|507-266-1387|vella.adrian@mayo.edu|
22451996|NCT02582905|University of Texas Southwestern Medical Center|E. Sherwood Brown, MD PhD MBA|214-645-6950|sherwood.brown@utsouthwestern.edu|
22451997|NCT01866709|ZS Pharma, Inc|Henrik Rasmussen, MD, PhD|443-699-5230|hrasmussen@zspharma.com|
22451998|NCT05003791|University of Illinois Chicago|Dr. Madison Goodyke|6166446417|mbuurs2@uic.edu|
22451999|NCT02207829|GlaxoSmithKline|GSK Response Center|866-435-7343||
22452000|NCT04292301|SpinTech MRI|Rana El Hachem|2487126789|rana@spintechmri.com|
22452001|NCT01343706|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22452002|NCT03285477|Almirall S.A.|Head of Global Clinical Development|+34932913000|rd@almirall.com|
22452003|NCT00560833|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22452004|NCT01085318|EMD Serono, Inc.|Fernando Dangond, MD FAAN|781-681-2348|fernando.dangond@emdserono.com|
22452005|NCT01307501|Galil Medical, a wholly owned indirect subsidiary of Boston Scientific|Sr. Clinical Trial Specialist|651-287-5000|GalilClinical@bsci.com|
22452006|NCT02116322|Johns Hopkins Hospital|Dr. Mouen Khashab|443-287-1960|mkhasha1@jhmi.edu|
22452007|NCT00724347|VANCHCS|David L. Woods, Ph.D.|925-372-2571|David.Woods@va.gov|
22452008|NCT01688336|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22452009|NCT01209624|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22452010|NCT03564496|NYU Langone|Matthew Lustberg|929 455 5090|matthew.lustberg@nyulangone.org|
22452011|NCT00428610|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22452012|NCT04704375|LECOM|Dr. Santiago Lorenzo|941-782-5974|slorenzo@lecom.edu|
22452013|NCT01432366|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22452014|NCT01808690|University of Colorado Denver/Children's Hospital Colorado|Dr. Kristen J Nadeau|720-777-2855|Kristen.Nadeau@childrenscolorado.org|
22452015|NCT03811912|Concert Pharmaceuticals, Inc.|Colleen E. Hamilton|781-860-0045|AAclinicaltrial_inquiries@concertpharma.com|
22452016|NCT02891187|UNewMexico|Dr. Jennifer Thompson|16366790301|jthompson626@gmail.com|
22452017|NCT02395120|Case Western Reserve University|Dr. Suchitra Nelson|216-368-3469|sxn15@case.edu|
22452018|NCT00674986|Hoffman-LaRoche|Medical Communications|800-821-8590||
22452019|NCT00377234|Hoffmann-LaRoche|Medical Communications|800-821-8590||
22452020|NCT01997398|Barrow Neurlogical Institute / St. Joseph's Hosptial & Medical Center|Francisco A. Ponce, MD|602-406-3242||
22452021|NCT04396834|UNC-Chapel Hill|Christian Hendershot|(919) 962-5565|christian_hendershot@med.unc.edu|
22452022|NCT01787617|Pennington Biomedical Research Center|Dr. Robert Newton|225-763-3034|Robert.Newton@pbrc.edu|
22452023|NCT01024569|University of Illinois at Chicago|Judith A Cook|312-355-3921|jcook@uic.edu|
22452024|NCT04546581|University of Minnesota|James Neaton|612-626-9040|neato001@umn.edu|
22401296|NCT04407507|Investigacion Biomedica para el Desarrollo de Fármacos S.A. de C.V|Carmen de la Rocha|523320028697|carmen.delarocha@investigacionbiomedica.com.mx|306
22401297|NCT02334267|Frenova Renal Research|Brigid Flanagan, MS, RN, CCRC|781-699-2970|Brigid.Flanagan@frenovarenalresearch.com|
22452025|NCT02526693|Wills Eye Hospital|George L. Spaeth, MD|215-928-3123|gspaeth@willseye.org|
22452026|NCT01798927|UT Southwestern Medical Center|Karen McCain, PT, DPT, NCS|214-648-1559|karen.mccain@utsouthwestern.edu|
22452027|NCT00626522|AstraZeneca|Esther Garcia||ClinicalTrialTransparency@astrazeneca.com|
22452028|NCT01159691|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22452029|NCT01928719|Penn State College of Medicine|Nicolle Krebs|717-531-5673|nkrebs@pennstatehealth.psu.edu|
22401298|NCT00234104|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7314||
22452030|NCT01490632|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22452031|NCT02332720|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22452032|NCT05732454|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22452033|NCT03846024|University of Vermont|Ethan Jones|802-656-9437|ethan.d.jones@med.uvm.edu|
22452034|NCT03725982|Institute of Occupational and Social Medicine and Health Services Research|Tessy Luger|004970712984364|Tessy.Luger@med.uni-tuebingen.de|
22452035|NCT05912400|University of Arkansas for Medical Sciences|I-Shin Wen|5016868274|IWen@uams.edu|24024
22452036|NCT03319277|Cleveland Clinic|Emily RW Davidson, M.D.|812-272-2380|dr.emily.rose@gmail.com|
22401299|NCT00546819|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22401300|NCT04045613|Basilea Pharmaceutica International Ltd, Allschwil|Study Director|+41 76 302 53 10|manuel.haeckl@basilea.com|
22452037|NCT02346383|CCAMP|J Kelby Hutcheson MD|8642956399|khutchesonmd@carolinapain.com|
22452038|NCT00838110|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22452039|NCT00352365|SWOG|Study Statistician|206-667-4623||
22401301|NCT02228499|The George Washington University|Dr. Seema Agrawal|202 699 1648|seema300@yahoo.com|
22401302|NCT04276558|Recordati Rare Diseases Sarl|Beatrice Martin, Clinical study Manager|+33 1 47 73 64 58|martin.be@recordati.com|
22401303|NCT01254344|Merck Sharp & Dohme (China) Ltd.|Naimi Missoum|+8621 2211 8546|naimi_missoum@merck.com|
22452040|NCT01262651|GW Pharmaceuticals Ltd.|Medical Enquiries||medinfo.USA@gwpharm.com|
22452041|NCT04743908|The University of Chicago|Dr. John Schneider|(773) 702-2453|jschnei1@uchicago.edu|
22452042|NCT03822533|Region Västra Götaland, Närhälsan|Chan-Mei Ho-Henriksson, PhD-student, RPT|+46709892821|chan-mei.ho@vgregion.se|
22452043|NCT01512225|Sunnybrook Research Institute|Dr. Elizabeth Asztalos|416-480-6100,|elizabeth.asztalos@sunnybrook.ca|87791
22452044|NCT01412944|Novartis|Study Director|862-778-8300||
22452045|NCT01990950|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|alan.saunders@cookmedical.com|321204
22452046|NCT02863926|Indiana University School of Medicine|Kristen Wanczyk / Certified Clinical Research Nurse Coordinator|317-7988-9548|keevans@iu.edu|
22452047|NCT05356221|Oticon Medical|Dr. Nicole Amichetti|+1 609-366-0424|nitc@oticonmedical.com|
22452048|NCT02061384|University of Washington School of Medicine|Dr. John Amory|2066161727|jamory@uw.edu|
22452049|NCT02066857|Emory University|Claude Jarrett, M.D.|404-778-8099|CJarrett@wilmingtonhealth.com|
22452050|NCT02019719|GlaxoSmithKline|GSK Response Center|866-435-7343||
22401304|NCT00467649|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22401305|NCT00807664|Coloplast|Dr Birte Petersen Jacobsen|004549110000|DKBIR@coloplast.com|1395
22452051|NCT02417246|UF|Dr. Larisa H Cavallari|352-273-8245|lcavallari@cop.ufl.edu|
22452052|NCT04483479|Enterin|Dr. Richard Larson, Chief Medical Officer|5054692670|r.larson@enterininc.com|
22452053|NCT03907501|UCSD School of Medicine|Dr. Christine Tara Peterson|7033959377|chpeterson@health.ucsd.edu|
22452054|NCT01921348|University of MS Medical Center|Gailen D. Marshall, Jr., MD, PhD, Director, Division of Clinical Immunology and Allergy|6018155527|gmarshall@umc.edu|
22452055|NCT02824913|Parion Sciences|Jose Boyer|919-313-1182|jboyer@parion.com|
22452056|NCT02896855|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22452057|NCT01205685|Vanderbilt-Ingram Cancer Center|Dr. Ingrid Mayer|615-936-2033|ingrid.mayer@vanderbilt.edu|
22452058|NCT02169674|Vaccine Evaluation Center|Director of Vaccine Evaluation Center|604-845-2422||
22452059|NCT04634604|Jaeb Center for Health Research|Ray Kraker|8139758690|rkraker@jaeb.org|
22452060|NCT03525834|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22452061|NCT01184014|International Diabetes Center|Dr. Richard Bergenstal|952-993-3796|richard.bergenstal@parknicollet.com|
22452062|NCT00941603|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22452063|NCT02942160|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|ClinicalTrials@Endo.com|
22452064|NCT04040985|Smith and Nephew|Michael Howarth|07540268240|michael.howarth@smith-nephew.com|+44
22452065|NCT03879798|Memorial Sloan Kettering Cancer Center|Dr. Charles Rudin|646-888-4527|rudinc@mskcc.org|
22401306|NCT03233048|Mayo Clinic|Dr. Imad Absah|507-266-0114|absah.imad@mayo.edu|
22452066|NCT01343407|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22414562|NCT01205035|Eye Center of Northern Colorado, PC|Dr. Arthur Korotkin, MD|970-221-2222|retina@eyecenternoco.com|
22414563|NCT01896934|Vanderbilt University Medical Center|Dr. Warren D Taylor|615-936-3555|warren.d.taylor@vanderbilt.edu|
22414564|NCT00721162|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22414565|NCT00316277|McLean Hospital/Harvard Medical School|Roger D. Weiss, M.D.|617-855-2242|rweiss@mclean.harvard.edu|
22414566|NCT00927069|Innovaderm Research, Inc.|Annie Levesque|514 521 4285|alevesque@innovaderm.ca|222
22414567|NCT01572662|The University of Texas MD Anderson Cancer Center|Uday Popat, M.D. / Stem Cell Transplantation|713-792-8750|upopat@mdanderson.org|
22414568|NCT03364192|VA Center for Integrated Healthcare|Emily M. Johnson, Ph.D., PI|315-425-4400|Emily.Johnson1@va.gov|53487
22414569|NCT04692155|UAB|Amitkumar Mehta|2059968400|amitkumarmehta@uabmc.edu|
22414570|NCT04547192|KWAME NKRUMAH UNIVERSITY/SCIENCE/TECH|Dr Adam Gyedu|+233248228838|drgyedu@gmail.com|
22414571|NCT01535222|The Medicines Company|Andreas van de Locht|+4989244180862|andreas.locht@themedco.com|
22414572|NCT02479763|Montreal General Hospital|Dr. De QH Tran|514-934-1934|de_tran@hotmail.com|43261
22414573|NCT00935012|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22414574|NCT01442155|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22414575|NCT04626414|Shield Therapeutics|Jackie Mitchell|+44 (0) 191 511 8500|jackie.mitchell@shieldtx.com|
22414576|NCT01590563|Synexus Hungary|Dr. Beata Szoczei, MD|+36 1 436 7330||
22414577|NCT01108445|Duke University Medical Center|Dr. Andrew J Armstrong|919-668-4615|andrew.armstrong@duke.edu|
22414578|NCT01484912|Sinphar Pharmaceutical Co., Ltd. Taiwan|Justine Tang||justine@sinphar.com.tw|
22414579|NCT00911274|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414580|NCT00205777|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22414581|NCT00700739|DePuy Synthes Spine|Mark Lotito|(508) 880-8045|Mlotito@its.jnj.com|
22414582|NCT05604209|University of North Carolina at Chapel Hill|Cynthia Gay, MD, MPH|919-843-2726|cynthia_gay@med.unc.edu|
22414583|NCT01983969|UT MD Anderson Cancer Center|Nieto, Yago / Stem Cell Transplantation and Cellular Therapy|713-792-8750|ynieto@mdanderson.org|
22414584|NCT03719040|Abbott|Dr. Kwangdeok Lee|9725269673|kwangdeok.lee@abbott.com|
22452067|NCT06027216|Schepens Eye Research Institute, Mass Eye and Ear|Eli Peli|617-912-2597|eli_peli@meei.harvard.edu|
22452068|NCT02745626|University of Connecticut Health|Dr. Madhur Upadhyay, Director Orthodontic Clinic, Assistant Professor|860-679-3729|maupadhyay@uchc.edu|
22452069|NCT01732835|Biostable Science and Engineering, Inc.|John Wheeler|512-386-1996|John.wheeler@biostable-s-e.com|
22452070|NCT02388321|Maimonides Medical Center|Sergey Motov, MD (Prinicipal Investigator)|718-283-8693|smotov@maimonidesmed.org|
22452071|NCT01776645|Stanford University|Dr. Sean Mackey|650-724-2795|smackey@pain.stanford.edu|
22452072|NCT00874029|Halt Medical, Inc|Laura Kemp, Sr. VP Clinical Affairs|408-375-1465|lkemp@haltmedical.com|
22452073|NCT01767116|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
22452074|NCT00968669|MedImmune|Joe Parker, MD|301-398-0000|parkerJ@medimmune.com|
22452075|NCT03836287|Botanix Pharmaceuticals|Anthony Robinson MS CRNP|+1 (445) 300-3403|trials@botanixpharma.com|
22452076|NCT04798586|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22452077|NCT03330834|Sun Yat-sen University Cancer Center|Dr.Yuxiang Ma|86 020 87343894|mayx@sysucc.org.cn|
22452078|NCT01669343|Princess Margaret Hospital|Dr. David Cescon|416-946-2000|dave.cescon@uhn.on.ca|
22452079|NCT00968617|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22452080|NCT04433767|Vanderbilt University Medical Cdenter|Warren Taylor, MD, Director of the DIvision of Geriatric Psychiatry|615-322-1073|warren.d.taylor@vumc.org|
22452081|NCT00298233|Oxford University Clinical Research Unit|Dr. Jeremy Farrar|+84 839237954|info@oucru.org|
22452082|NCT02371369|Contact for Clinical Trial Information|Daiichi Sankyo|1-908-992-6400|CTRinfo@dsi.com|
22452083|NCT01024387|Dana-Farber Cancer Institute|Matthew H. Kulke, MD|617.632.5136|Matthew_Kulke@dfci.harvard.edu|
22452084|NCT03855189|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22452085|NCT01143259|Intermountain Healthcare|Matthew Peters RN MS|801-442-3703|matthew.peters@imail.org|
22452086|NCT04307186|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22452087|NCT01618838|Georgetown University Hospital|Dr. Sean Collins|202-444-3062|spc9@gunet.georgetown.edu|
22452088|NCT01434602|National Cancer Institute|Dr. Mark R. Gilbert|240-760-6023|mark.gilbert@nih.gov|
22452089|NCT01108081|VA Boston Healthcare System|Dr. David Sparrow|857-364-6400|david.sparrow@va.gov|
22452090|NCT01587651|Daiichi Sankyo Medical Affairs|Fred Lipkin|973-944-2216|flipkin@dsi.com|
22452091|NCT00358735|Medical Compression Systems|Clifford W Colwell, M.D Scripps Clinic|972-4-6266630|Jbarak@mcsmed.com|412
22452092|NCT00759109|Merck Sharp and Dohme Corp.|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22452093|NCT00780962|Beth Israel Deaconess Medical Center|Nathan I. Shapiro, MD, MPH|617-754-2323|nshapiro@bidmc.harvard.edu|
22452094|NCT02908269|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22452095|NCT04575896|Johns Hopkins University|Niraj Desai, MD|410-614-8297|ndesai13@jhmi.edu|
22452096|NCT00924287|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg|301-496-4164|sar@mail.nih.gov|
22452097|NCT02498483|Columbia University|Jennifer Woo Baidal|212-342-2962|jw3286@cumc.columbia.edu|
22452098|NCT00156065|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22452099|NCT02250612|Sylentis|Clinical Trials Department||info@sylentis.com|
22452100|NCT02241967|Ralph H. Johnson VA Medical Center|Jeffrey Borckardt, Ph.D|843-792-3295|Jeffrey.Borckardt@va.gov|
22452101|NCT00381966|Johns Hopkins University|Daniel Song|401-502-5875|dsong2@jhmi.edu|
22414585|NCT00268203|GlaxoSmithKline|GSK Response Center|866-435-7343||
22452102|NCT04579757|HUTCHMED Limited|Nicky Murray|+44 7738 881999|nicolam@hutch-med.com|
22452103|NCT01153633|B. Braun Medical AG|Medical Scientific Affairs Manager|+41 58 258 55 47||
22452104|NCT00384085|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi-aventis.com|
22452105|NCT01944631|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22452106|NCT01843192|Ethicon, part of Johnson & Johnson|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
22452107|NCT04389762|Professor Lu Neurological Clinic|Professor Lu|+886-3-396-0388|lucs.clinic@gmail.com|
22452108|NCT02692248|MFAR|Responsable person designated by the sponsor|+34934344412|investigacion@mfar.net|
22452109|NCT00328510|Thomas Jefferson University|Maria Werner-Wasik, MD|215-955-7679|Maria.Werner-Wasik@jeffersonhospital.org|
22452110|NCT00455195|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22452111|NCT01286779|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22452112|NCT00304070|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22452113|NCT03421197|Dr Reddy's Laboratories|Srinivas Sidgiddi, Sr Director, Clinical Development|609-375-9910|srinivassidgiddi@drreddys.com|
22452114|NCT04118348|Geisinger Clinic|Amir Goren, PhD|5702144395|agoren@geisinger.edu|
22452115|NCT00779246|Christiana Care Health System|Marci Drees, MD, MS|302-733-5602|mdrees@christianacare.org|
22452116|NCT02844946|Baylor College of Medicine|Dr. Lilian Dindo|713-440-4637|lilian.dindo@bcm.edu|
22452117|NCT02806986|Grifols Therapeutics LLC|Rhonda Griffin|919-316-6693|rhonda.griffin@grifols.com|
22452118|NCT01617421|Clinical Center|Middleton, Kimberly|+1 301 496 9083|middletonk@mail.nih.gov|
22452119|NCT03646513|Smith+Nephew, Inc.|Andrew Copey|+61.490.503.157|andrew.copley@smith-nephew.com|
22452120|NCT02334748|Novartis Pharma AG|Study Director|+1 (862) 778-8300|Novartis.email@novartis.com|
22452121|NCT01046643|The University of Michigan|Dr. Yolanda Smith|(734) 936-7401|ysmith@med.umich.edu|
22452122|NCT00093145|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22452123|NCT01310036|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22452124|NCT01175668|Baystate Medical Center|Rachana Singh, MD|413-794-2400|rachana.singhmd@bhs.org|
22452125|NCT00817089|UPENN|David Oslin|215 823 5894|oslin@upenn.edu|
22452126|NCT02043782|Coloplast A/S|Medical Director|+45 4911 1395|dkbir@coloplast.com|
22452127|NCT00709722|Nippon Kayaku Co., Ltd.|Pharmaceuticals Group|+81-3-6731-5200||
22452128|NCT04667117|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22452129|NCT03359096|University of Pennsylvania|Raj C. Dedhia, MD, MSCR|215-349-5009|Raj.Dedhia@pennmedicine.upenn.edu|
22452130|NCT00283504|CHILDREN'S HOSPITAL OF THE KING'S DAUGHTERS|MARIPAZ MORALES MD|7576688255|MARIPAZ.MORALES@CHKD.ORG|
22452131|NCT00823082|GrifolsTherapeutics Inc.|Michael Ken Woodward, BSc, M.Sc|+1 919-316-6675|michael.woodward@grifols.com|
22452132|NCT03452917|University of Washington|Francis Kim|206-897-5264|fkim@u.washington.edu|
22452133|NCT03198000|Johnson & Johnson Consumer Inc.|Amisha Parikh-Das, PhD, MPH|(973) 255-8701|AParikh1@its.jnj.com|
22452134|NCT02007577|Stanford Universtiy|Dr. Gerald Reaven|650-724-3416|greaven@stanford.edu|
22452135|NCT01953926|Puma Biotechnology, Inc.|Sr Director, Clinical Operations|4242486500|clinicaltrials@pumabiotechnology.com|
22452136|NCT01276587|Columbia University|Margaret Lee, MD|212-305-6290|ml653@cumc.columbia.edu|
22452137|NCT04644328|Massachusetts Institute of Technology|Esther Duflo|617-258-7013|eduflo@mit.edu|
22452138|NCT04102501|Retrotope|Mark G. Midei, MD, VP Medical Affairs|4103715357|mark@retrotope.com|
22452139|NCT03329352|Fisher & Paykel Healthcare|Hanie Yee|+64 9 574 0123|Hanie.Yee@fphcare.co.nz|7909
22452140|NCT02338362|Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada|Dr. Graham Trope|1-416-603-5117|graham.trope@uhn.ca|
22452141|NCT02388633|OregonHSU|Jonathan Lindner, MD|5034949191|lindnerj@ohsu.edu|
22452142|NCT03447782|Boston Children's Hospital|Dr. Alyssa Lebel|7812161960|alyssa.lebel@childrens.harvard.edu|
22452143|NCT03176693|University of California Los Angeles|Masha Livhits, MD|310-206-0585|mlivhits@mednet.ucla.edu|
22452144|NCT03325712|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22452145|NCT02265237|AbbVie|Global Medical Information|800-633-9110||
22452146|NCT00650546|Department of Gastroenterology, San Antonio Uniformed Services Health Consortium|Patrick R Kenney, DO||pat.kenney@us.army.mil|
22452147|NCT01178853|Kowa Research Institute, Inc.|Roger Morgan, MD, FACS|919-433-1600|RMorgan@KowaUS.com|
22452148|NCT03550313|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22452149|NCT00839072|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
22452150|NCT00380068|Gilead Sciences Inc|Martine Allard, PhD; Senior Clinical Research Scientist|650-524-3898|martine.allard@gilead.com|
22452151|NCT01297062|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22452152|NCT03191903|Anika|Carol Pekar, VP Clinical Affairs|781-457-9218|cpekar@anikatherapeutics.com|
22388596|NCT02721147|Fox Chase Cancer Center|Dr. Jennifer Reese, Assistant Professor|215-214-3223|Jennifer.Reese@fccc.edu|
22452153|NCT03149328|University of Alberta|Dr. Kara Schick-Makaroff|1-780-492-9043|kara.schickmakaroff@ualberta.ca|
22452154|NCT02358889|Iconic Therapeutics|Gabriela Burian, M.D.|6504371000|gburian@iconictherapeutics.com|
22452155|NCT00503685|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22452156|NCT01027793|Brazilian Center for Studies in Dermatology|Dr. Doris Hexsel|+55 51 30262633|cientifico@cbed.org.br|
22401307|NCT01856673|CISALVA, Universidad del Valle|Maria Isabel Gutierrez|+57-2-5577206|maria.gutierrez@correounivalle.edu.co|103
22452157|NCT00927927|Novo Nordisk A/S|Public Access to Clinical Trials||RA-RNDUS-ClinTriDisc@ITS.JNJ.com|
22452158|NCT02379585|CTCA|Jessica L. Coats|6232073899|jessica.coats@ctca-hope.com|
22452159|NCT01976416|Indiana University|Dr Chandy John|317-274-8940|chjohn@iu.edu|
22452160|NCT01110239|University Miami|Sebastian Koch|305 243-6733|skoch@med.miami.edu|
22414586|NCT02709018|University of California San Diego|Murray B. Stein MD, MPH|858-534-6451|mstein@health.ucsd.edu|
22414587|NCT04589650|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22414588|NCT02923349|Incyte Corporation Call Centre|Incyte Biosciences International Sàrl|8554633463|RA@incyte.com|
22414589|NCT00950989|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22414590|NCT00796562|Johns Hopkins University|Heather Symons, MD|4105029961|hsymons2@jhmi.edu|
22414591|NCT05655520|Supernus Pharmaceuticals, Inc.|Gianpiera Ceresoli-Borroni PhD|3018382521|gceresoliborroni@supernus.com|
22414592|NCT00424047|Celgene Corporation|Anne McClain, Senior Manager|1-866-260-1599|ClinicalTrialDisclosure@celgene.com|
22414593|NCT02664961|TRACON Pharmaceuticals|Medical Monitor|8585500780|ctheuer@traconpharma.com|
22414594|NCT00815087|Wang tyng|Dr.Wang TG|+886-2-23123456|patty.jt@gmail.com|67587
22414595|NCT01229150|National Cancer Institute|Dr. Arun Rajan|301-594-5322|rajana@mail.nih.gov|
22430959|NCT03412591|Penn State College of Medicine|Dr. Scott Bunce|2155108295|sbunce@pennstatehealth.psu.edu|
22430960|NCT00690339|Allergan, Inc.|Medical Monitor|714-246-4500|clinicaltrials@allergan.com|
22430961|NCT00685295|Harvard/MGH|Stephen Thomas|6177267622|sthomasmd@gmail.com|
22430962|NCT00480532|University of Hawaii (UH)|Bliss Kaneshiro|808-203-6500|bkaneshiro@ucera.org|
22430963|NCT03322566|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
22452161|NCT02897141|Columbia University|Dr. Rebecca Schnall|212-342-6886|rb897@cumc.columbia.edu|
22452162|NCT00080223|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22452163|NCT02936076|The Miriam Hospital|Dr. Jessica Unick|401-793-8966|junick@lifespan.org|
22452164|NCT01127438|Eisai Call Center|Eisai Inc.|888-422-4743||
22452165|NCT04560166|Y-mAbs Therapeutics|Chief Operating Officer|+4570261414|clinicaltrials@ymabs.com|
22452166|NCT02716974|Johns Hopkins University School of Medicine|Kenneth Pienta|410-502-3137|kpienta1@jh.edu|
22452167|NCT02261363|University of Nevada, Reno|Jennifer Pearson|7756825005|jennipearson@unr.edu|
22452168|NCT01517802|Janssen Research & Development, LLC|DIRECTOR CLINICAL RESEARCH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22452169|NCT02605954|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22452170|NCT02301143|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22452171|NCT03774186|Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus|Dr. Sarit Polsky|303-724-8575|sarit.polsky@cuanschutz.edu|
22452172|NCT03214367|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22452173|NCT03740490|Stephenson Cancer Center, University of Oklahoma Health Sciences|Michael Businelle|405-271-8001|michael-businelle@ouhsc.edu|50460
22452174|NCT03268811|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22452175|NCT04726709|University of Idaho|Dr. Rajal Cohen|2088856324|rcohen@uidaho.edu|
22414596|NCT05248204|Solventum US LLC|Paula Myhre|6513948069|pemyhre1@solventum.com|
22452176|NCT00728819|Penn Medicine|Associate Professor of Radiology|2156627892|ITKINMAX@GMAIL.COM|
22414597|NCT03100344|Galderma|Kenny Frazier|817-961-5120|Kenny.frazier@galderma.com|
22414598|NCT01010503|Hoffmann- LaRoche.|Medical Communications|800-821-8590|genentech@druginfo.com|
22414599|NCT00725322|Stanford University School of Medicine|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@stanford.edu|
22414600|NCT05871151|University of Alabama at Birmingham|Alexandra Evancho|(205)975-5221|amelgin@uab.edu|
22414601|NCT01963728|Inova Health Care System|Anne Whitney Brown, MD Principal Investigator|703.776.3067|anne.brown@inova.org|
22414602|NCT04375514|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|1 (626) 304-3400|info@arrowheadpharma.com|
22414603|NCT04406194|Farmagen|Aydin Erenmemisoglu|+90 532 551 0082|a.erenmemisoglu@farmagenarge.com|
22414604|NCT02888756|Erasmus MC|Dr R.A. Gruters|+31 10 7032100|r.gruters@erasmusmc.nl|
22414605|NCT00928057|BD Medical, Medical Affairs|Kenneth Kassler-Taub, MD|201 847 6729|kenneth_kassler-taub@bd.com|
22414606|NCT03206749|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22414607|NCT01165047|Aurora Health Care|Katernie Slotke|414-649-2615|katherine.Slotke@aurora.org|
22414608|NCT03497130|Department of Dermatology at Johns Hopkins University|Dr. Anna Chien|410-502-7546|achien3@jhmi.edu|
22414609|NCT00158925|Boston Scientific|Elke Sommerijns|+32 479 76 71 56|elke.sommerijns@bsci.com|
22414610|NCT02277093|Washington University School of Medicine|Benjamin R. Tan|314-362-9915|btan@wustl.edu|
22414611|NCT04345653|JFK University Medical Center - Hackensack Meridian Health|Dr. Jawad Kirmani|7327745805|jawad.kirmani@hmhn.org|
22414612|NCT03214588|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22414613|NCT00418938|Amgen Inc.|Study Director|866-572-6436||
22414614|NCT04428307|Duke University|Wendy Prudhomme-O'Meara, PhD|919-613-4406|wendy.omeara@duke.edu|
22414615|NCT03734861|Connecticut Children's Medical Center, Asthma Center|Dr. Jessica Hollenbach, PhD|860-837-5333|jhollenbach@connecticutchildrens.org|
22414616|NCT02314403|Massachusetts General Hospital|Tatsuo Kawai, MD PhD|617-726-0289|tkawai@mgh.harvard.edu|
22452177|NCT02117570|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021||
22414617|NCT00003470|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22430964|NCT01602484|Brigham and Women's Hospital|Dr. Eric Bluman|6179837363|ebluman@partners.org|
22401308|NCT00491530|Abbott|Medical Information Specialist|800-633-9110||
22401309|NCT03114969|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22401310|NCT00971321|GlaxoSmithKline|GSK Response Center|866-435-7343||
22401311|NCT02278146|Skyline Urology|Fredrick Wolk, MD|+1 310.602.5005|fred.wolk@skyuro.com|
22401312|NCT02436239|Allergan|Armin Szegedi, MD, PhD, Vice President CNS Clinical Development|714-246-4500|IR-CTRegistration@allergan.com|
22401313|NCT02168946|Rempex Pharmaceuticals, A Wholly Owned Subsidiary of Melinta Therapeutics, Inc.|Global Health Science Center|1-844-633-6568|medinfo@melinta.com|
22401314|NCT01852344|University of Michigan|Dr. Chandra Sripada, MD PhD||csripada@umich.edu|
22401315|NCT00450866|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|David Peereboom, MD|216-445-6068|peerebd@ccf.org|
22401316|NCT02675517|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22401317|NCT02772783|Boston Children's Hospital|Belinda Lennerz|617 355 7476|belinda.lennerz@childrens.harvard.edu|
22401318|NCT03443024|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22401319|NCT02782715|University of Wisconsin School of Medicine and Public Health|Michael Bassetti, MD, PhD|608-263-8500|bassetti@humonc.wisc.edu|
22401320|NCT04429932|Nerudia Ltd|Paul Morris|+44 7508 708 917|paul.morris@nerudia.com|
22401321|NCT01065428|Department of Critical Care Medicine, Nanjing Zhong-Da Hospital, Southeast University School of Medicine, China|Dr. Haibo Qiu; Dr. Christer Sinderby|008613951965301|haiboq2000@yahoo.com.cn|
22401322|NCT00968344|University of Texas Medical Branch|Douglas Paddon-Jones, Professor|409-772-3073|djpaddon@utmb.edu|
22401323|NCT05439928|Columbia University|Magdalena Bogun, MD|2128515494|mmb2263@cumc.columbia.edu|
22401324|NCT03949673|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22430965|NCT03177798|Vanderbilt University Medical Center|Dr. Jorge L. Gamboa|615-343-4176|jorge.gamboa@vumc.org|
22388597|NCT01722097|Herlev Hospital, University of Copenhagen, Department of Anaesthesiology|Dr. Matias Vested Madsen|+45 38683868|matias.vested.madsen@regionh.dk|
22388598|NCT01535261|Novartis|Study Director|862-778-8300||
22388599|NCT01137682|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22388600|NCT02009332|Aadi Bioscience|Berta Grigorian|818-416-8378|bgrigorian@aadibio.com|
22388601|NCT01912599|University of North Carolina|Jean-Claude Mwanza, MD, MPH, PhD|919-843-4917|jean-claude_mwanza@med.unc.edu|
22388602|NCT03798756|Keele University|Mrs Sarah Lawton|01782 734887|s.a.lawton@keele.ac.uk|
22388603|NCT01757288|UT Southwestern Medical Center|Dr. Yuanyuan Zhang|214-648-6764|Yuanyuan.Zhang@UTSouthwestern.edu|
22388604|NCT02825550|Department of Internal Medicine, National Cheng Kung University|Dr. Xi-Zhang Lin|886-6-2353535|linxz@mail.ncku.edu.tw|3624/5603
22388605|NCT03386344|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
22430966|NCT00425555|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22388606|NCT01077284|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22388607|NCT02791308|Teva Pharmaceuticals Inc. USA|Senior Director, CE Studies|1-888-483-8279|USMedinfo@tevapharm.com|
22388608|NCT05188248|NYU Langone|Matthew Lustberg|929-455-5090|matthew.lustberg@nyulangone.org|
22388609|NCT00042939|ECOG Statistical Office|Study Statistician|617-632-3012||
22388610|NCT03349476|Icahn School of Medicine at Mount Sinai|Stephanie Harcum|(212) 824-8927|stephanie.harcum@mountsinai.org|
22388611|NCT00472082|Emory University|Kenneth A. Newell, MD, PhD|404-727-2489|kanewel@emory.edu|
22388612|NCT00674765|University of Pennsylvania|Dr. Kyle Kampman|215-222-3200|kampman@mail.med.upenn.edu|109
22388613|NCT01762345|Procter & Gamble Company Global Clinical Sciences|Mylissa Trowbridge||trowbridge.mm@pg.com|
22388614|NCT00700999|Jesse Brown VA Medical Center|Dr. K Luan Phan|312-569-7161|Kinh.Phan@va.gov|
22388615|NCT02379078|St. Michael's Hospital (Unity Health Toronto)|Dr. Catherine Yu|(416) 360-4000|catherine.yu@unityhealth.to|
22388616|NCT03481725|University of California San Diego|Brian M. Ilfeld, MD, MS|(858) 822-0776|m1medeiros@health.ucsd.edu|
22388617|NCT00244751|GlaxoSmithKline|GSK Response Center|866-435-7343||
22388618|NCT02077374|Conatus Pharmaceuticals Inc.|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com|
22388619|NCT01777932|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22388620|NCT04604652|HighTide Therapeutics|VP Clinical Operations|760-809-3523|cbennett@hightidetx.com|
22388621|NCT03936699|Elira Therapeutics, Inc.|Stephanie Amlung, PhD, RN, Vice President, Clinical Affairs|513.236.6799|samlung@elira.com|
22388622|NCT00068107|Baylor Research Institute|Dr. Raphael Schiffmann|214-820-4533|raphael.schiffmann@baylorhealth.edu|
22388623|NCT03989232|Novo Nordisk A/S|Clinical Transparency and Medical Writing Office (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22388624|NCT01930188|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22388625|NCT02170207|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22388626|NCT00657709|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22388627|NCT03122860|Biosplice Therapeutics, Inc.|Christopher Swearingen, PhD, VP of Biometrics|858.926.2952|chris.swearingen@biosplice.com|
22388628|NCT01138657|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22388629|NCT02574286|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22388630|NCT00869609|University of Pittsburgh|Trevor J Orchard|412-383-1032|tjo@pitt.edu|
22388631|NCT02399449|University of Maryland Baltimore|James Polli|410-465-3466|jpolli@rx.umaryland.edu|
22388632|NCT01020435|Palmer College of Chiropractic|Christine M Goertz, DC, PhD (Study Principal Investigator)|563-884-5150|christine.goertz@palmer.edu|
22388633|NCT00346398|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22388634|NCT02607956|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22452178|NCT02148250|University of Minnesota|Elizabth Seaquist, MD|612-624-9176|seaqu001@umn.edu|
22452179|NCT03403725|Menarini Ricerche SPA|Corporate Director of Clinical Sciences|+39 055 56809933|acapriati@menarini-ricerche.it|
22452180|NCT04447404|DURECT Corporation|Executive Director, Regulatory Affairs|408-777-1417|jill.burns@durect.com|
22388635|NCT02773732|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
22388636|NCT01888484|Clinical Research Management Group|Mikaela Raymond|866-337-1868|ctgov@cllinicalresearchmgt.com|
22401325|NCT01328873|Northside Hospital|H. Kent Holland, MD|404-255-1930|kholland@bmtga.com|
22401326|NCT00153166|Brigham and Women's Hospital|Mark Creager|617-732-5267|mcreager@partners.org|
22401327|NCT00586690|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu|
22401328|NCT02453841|Nationwide Children's Hospital|Richard Cartabuke, MD|614-722-4200|Richard.Cartabuke@nationwidechildrens.org|
22401329|NCT01751646|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
22401330|NCT02190591|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
22401331|NCT00098059|Novartis Pharmaceuticals|Study Director|862-778-8300||
22401332|NCT01151137|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi.com|
22401333|NCT01031095|Bursa Postgraduate Hospital|Dr.Hasan ARI|00902243605050|hasanari03@yahoo.com|1739
22401334|NCT03478683|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22401335|NCT00833859|H. Lee Moffitt Cancer Center and Research Institute|Gregory Springett, M.D., Ph.D., via Moffitt Cancer Center|813-745-6898|gregory.springett@moffitt.org|
22401336|NCT03661541|Squarex LLC|Hugh McTavish|6512078270|hmctavish@squarex-pharma.com|
22401337|NCT04095416|Henry Ford Hospital|Raef Ali Fadel|3139321347|rfadel2@hfhs.org|
22401338|NCT02273973|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22401339|NCT01810757|The Institute of Cancer Research, Clinical Trials and Statistics Unit (ICR-CTSU)|Professor Emma Hall (Co-Director of ICR-CTSU)|+44 (0)208 722|Emma.Hall@icr.ac.uk|4292
22401340|NCT04513158|Norton Healthcare|Joseph M. Flynn, DO, MPH|502-272-5001|joseph.flynn@nortonhealthcare.org|
22401341|NCT02452970|EpicentRx, Inc.|Study Director: Bryan Oronsky, Chief Medical Officer|408-569-3202|boronsky@epicentrx.com|
22401342|NCT02100657|Pharma Mar S.A.|Pharma Mar S.A.|00 34 91846 60 00|clinicaltrials@pharmamar.com|
22388637|NCT00090519|Chromaderm|info@chroma-derm.com||info@chroma-derm.com|
22388638|NCT00960206|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@stryker.com|
22388639|NCT04000399|University of Pittsburgh|Stephanie D. Stepp, PhD|4127155447|steppsd@upmc.edu|
22388640|NCT01240590|National Cancer Institute|Dr. James Gulley|301-480-7164|gulleyj@mail.nih.gov|
22388641|NCT02725372|Bellerophon Therapeutics Inc|Bobae Kim|(917) 675-2254|bobae.kim@bellerophon.com|
22388642|NCT02548585|MedImmune, LLC|Philip Ambery|+44 (0) 1223 895997|information.center@astrazeneca.com|
22388643|NCT01075152|University of Minnesota|Dr. David R Boulware|6126249996|coat.trial@gmail.com|
22388644|NCT01840722|University of Kentucky|Michele Staton, Associate Professor|859-257-2483|mstaton@uky.edu|
22388645|NCT01818063|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Edith Mitchell|215-955-8874|edith.mitchell@jefferson.edu|
22388646|NCT04445337|University of Nebraska Medical Center|Michael Lankhorst|402-559-4081|michael.lankhorst@unmc.edu|
22388647|NCT03659136|Boehringer Ingelheim, Call Centre|Boehringer Ingelheim|018002430127|clintriage.rdg@boehringer-ingelheim.com|
22388648|NCT05066230|Kodiak Sciences Inc|Chief Medical Officer|1 (650) 281-0850|ClinOps@kodiak.com|
22388649|NCT00307489|Gilead Sciences, Inc.|Stephen J. Rossi, PharmD|650-522-4212|stephen.rossi@gilead.com|
22388650|NCT04425252|Clear Creek Bio, Inc.|Vice President Clinical Operations|(617) 765-2252|clinical@clearcreekbio.com|
22388651|NCT02981953|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
22388652|NCT02556606|Michael E. DeBakey VA Medical Center|Marijn Lijffijt, PhD|3618274395|marijn.lijffijt@bcm.edu|
22388653|NCT02165202|PATH|Heather Kelly|650-392-2510|hkelly@path.org|
22388654|NCT01689740|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
22388655|NCT01420328|Division of Endocrinology, Diabetes and Metabolism, State University of New York at Buffalo, 462 Grider St, Buffalo, NY 14215, USA|Dr. Husam Ghanim|7169574325|ghanim@buffalo.edu|
22388656|NCT01655498|Pelvalon|Director of Clinical|650-276-0130||
22388657|NCT01301183|Massachusetts General Hospital|Madhu Misra|6177265790|mmisra@mgh.harvard.edu|
22388658|NCT01714947|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22388659|NCT06182631|SUNY Buffalo|Jill Fenenll|716-323-0220|jillfenn@buffalo.edu|
22388660|NCT01345253|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22388661|NCT00759681|Greenville Memorial Hospital|David Cull, MD|864-455-9825||
22388662|NCT00930644|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22401343|NCT02531035|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22388663|NCT01012999|University of Utah|Robert Stephen, MD|801-587-7653|rlstephen@comcast.net|
22388664|NCT02410278|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
22388665|NCT02584257|Lupin Research Inc|Dr. Mark Lepore|(443) 740-9323|marklepore@lupin.com|
22401344|NCT00403117|New York State Psychiatric Institute|Margaret Haney, PhD|646-774-6153|mh235@cumc.columbia.edu|
22401345|NCT01543490|Sun Pharma Advanced Research Company Limited|Head-Clinical Development|912266455645|clinical.trials@sparcmail.com|
22401346|NCT01383200|Bascom Palmer Eye Institute|Dr. Sonia Yoo|305-243-2020|syoo@med.miami.edu|
22401347|NCT01976819|University Medical Center Groningen and University of Groningen|Prof. Dr. Bernard F.A.M. van der Laan, PhD, MD|0031 (50) 361 27 00|b.f.a.m.van.der.laan@umcg.nl|
22401348|NCT01335971|Johns Hopkins University School of Medicine|Alexis Rea|(443) 287-8496|area5@jhu.edu|
22401349|NCT01260181|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22401350|NCT03351244|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22401351|NCT03063255|Department of Anesthesiology, NF/SG Veterans Health System|Dr. Jose R. Soberon, Jr.|352-413-2317|jsoberon@anest.ufl.edu|
22401352|NCT01499576|Konyang University Hospital|Dr. Kyung Ho SONG, Assistnat Professor of Konyang University||postit2@daum.net, postit@kyuh.ac.kr|
22401353|NCT01731691|Institute for Human Genetics and Biochemistry|Dr. Cynthia L. Bristow|631-444-6238|cynthia.bristow@stonybrook.edu|
22401354|NCT04109443|Boston University School of Public Health|Kimberly M Nelson, PhD|617-358-1482|knel@bu.edu|
22401355|NCT02984878|Prollenium Medical Technologies, Inc.|Ario Khoshbin, President|866-353-3015||
22401356|NCT03396471|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
22401357|NCT01319929|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22401358|NCT03237845|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
22452181|NCT00574080|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990|PettyNathanM@uams.edu|2461
22452182|NCT01221597|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22452183|NCT02504073|Kantonsspital Baselland Standort Bruderholz|Alexandra Bellwald|0041797429755|alexandra.bellwald@ksbl.ch|
22452184|NCT00563784|UT MD Anderson Cancer Center|Dr. Steven H. Lin/Radiation Oncology|713-563-8490|shlin@mdanderson.org|
22452185|NCT04004611|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22452186|NCT00320216|Centocor Research & Development, Inc.|Senior Director Clinical Research|1-800-457-6399||
22452187|NCT00148343|Case Western Reserve University/MetroHealth Medcial Center|Lynne Sheffler, MD|216-957-3570|lsheffler@metrohealth.org|73556
22452188|NCT04153409|Lateral Pharma Pty Ltd|Mr David Kenley|+61400151490|dk@lateral-pharma.com|
22452189|NCT04844281|The Ohio State University College of Optometry|Jennifer Fogt, OD MS|16142928858|OPTEyeStudies@osu.edu|
22452190|NCT00353275|UT Health Science Center at Houston|Dr. Lillian S. Kao|713-566-5095|Lillian.S.Kao@uth.tmc.edu|
22452191|NCT00574587|Montefiore Medical Center|Markenya Mirander|718-862-8840|MMIRANDE@montefiore.org|
22452192|NCT01754714|Abbott|Associate Director Clinical Services|+31 29-44-79-196|taco.baardman@abbott.com|
22452193|NCT02384759|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
22452194|NCT01605617|Mayo Clinic|Dr. Jeffrey L. Cornella|480-342-2867|cornella.jeffrey@mayo.edu|
22452195|NCT00121238|University of Michigan Comprehensive Cancer Center|Maha Hussain, M.D.|(734)936-8906|mahahuss@med.umich.edu|
22452196|NCT01380327|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22452197|NCT03043664|Duke University Medical Center|Michael Morse, MD|919-668-1861|michael.morse@duke.edu|
22452198|NCT01540851|Brigham and Women's Hospital|Elena Losina, PhD|617-732-6928|elosina@partners.org|
22452199|NCT00325468|Amgen Inc.|Study Director|866-572-6436||
22452200|NCT03732209|Fralin Biomedical Research Institute at VTC|Jeffrey Stein|540-526-2124|jstein1@vtc.vt.edu|
22452201|NCT05046795|Viatris|Dik WH Ng, PhD|+44 (0)1304 626895|dik.ng@viatris.com|
22452202|NCT01127178|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22452203|NCT03950739|United Therapeutics Corp.|United Therapeutics Global Medical Information|919-485-8350|clinicaltrials@unither.com|
22452204|NCT03625570|Louisiana State University Health Sciences Center - New Orleans|Dr. Noelle G. Moreau|504-568-4291|nmorea@lsuhsc.edu|
22452205|NCT04139317|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22452206|NCT05857163|TenNor Therapeutics (Suzhou) Limited.|Guozhu Geng|0512-86861990|guozhu.geng@tennorx.com|
22452207|NCT00345579|GlaxoSmithKline|GSK Response Center|866-435-7343||
22452208|NCT00782340|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
22452209|NCT01949480|University of Pittsburgh|Dr. Anna Uskova, Principal Investigator|412) 623-2167|UskoAA@anes.upmc.edu|
22452210|NCT00144339|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22452211|NCT00305058|Montefiore Medical Center|Andrew Chang, MD|718-920-6626|achang3@yahoo.com|
22452212|NCT03538626|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
22452213|NCT00288587|Cleveland Clinic Foundation|Leighann Cesar, RN|216-445-6551|cesar1@ccf.org|
22452214|NCT01156701|GlaxoSmithKline|GSK Response Center|866-435-7343||
22452215|NCT01835626|University of California, San Francisco|Dr. Sue Yom|(415) 353-9893|Sue.Yom@ucsf.edu|
22452216|NCT02232893|Tsumura USA Inc|Yu Tanaka|609-799-2083|Yu Tanaka <tanaka_yuu@mail.tsumura.co.jp>|
22452217|NCT01764945|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22452218|NCT01308918|Institut universitaire de cardiologie et de pneumologie de Quebec|Nathalie Gagne|418 656-8711|nathalie.gagne@criucpq.ulaval.ca|2645
22452219|NCT00648908|Acorda Therapeutics, Inc.|Andrew Blight, PhD Chief Scientific Officer|914-347-4300|ablight@acorda.com|4102
22452220|NCT05077267|Bavarian Nordic A/S|Bavarian Nordic Call Center|+1-844-422-8274|medical.information_us@bavarian-nordic.com|
22452221|NCT02911948|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22452222|NCT04747977|Ocular Therapeutix|Clinical Project Manager|781-357-4000|clinicalaffairs@ocutx.com|
22452223|NCT02854540|Stanford School of Medicine|Dr. Marlyanne Pol-Rodriguez|650-721-7144|mpr@stanford.edu|
22452224|NCT00690521|University of New Mexico Health Sciences|Joe Anderson|505-272-3664|janderson@salud.unm.edu|
22452225|NCT00586105|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22452226|NCT02679690|University of Pittsburgh|Sheryl Ondrejko, DNP||sherylannmarieo@gmail.com|
22452227|NCT02666950|Mayo Clinic|Lisa Sproat, M.D.|480/301-8000|Sproat.Lisa@mayo.edu|
22452228|NCT03819660|Catalyst Pharmaceuticals, Inc.|Gary Ingenito|3054203200|gingenito@catalystpharma.com|
22452229|NCT01136291|Department of Obstetrics and Gynecology - University of Campinas|Fernanda Garanhani de Castro Surita|+551935219304|surita@unicamp.br|
22452230|NCT03965052|Laboratorios Sophia|PhD. Ricardo Llamas|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
22452231|NCT01286259|University of California, San Francisco|Steven G. Deeks|(415) 476-4082|Steven.Deeks@ucsf.edu|
22452232|NCT00127673|Case Western Reserve University|Dr. Norah C Feeny|2163682695|ncf2@case.edu|
22452233|NCT02545907|Leeds Institute of Clinical Trials Research|Alexandra Pitchford|0113 343 9077|medcatal@leeds.ac.uk|
22452234|NCT01573702|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22452235|NCT02308033|Curatek Pharmaceuticals|Vice President|847-806-7680|info@curatek.com|
22401359|NCT01221233|University of Delaware, Department of Physical Therapy|Dr. Jaclyn Megan Sions, PhD, DPT, PT|302-831-7231|megsions@udel.edu|
22401360|NCT04355117|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22401361|NCT03865407|Virginia Commonwealth University|Cristin Kaspar, MD|804-628-3866|cristin.kaspar@vcuhealth.org|
22401362|NCT01645280|Janssen Pharmaceuticals|Senior Director Clin Development||ClinicalTrialDisclosure@its.jnj.com|
22401363|NCT02723162|Medical University of South Carolina|Dr. Kevin Gray|843-792-9162|graykm@musc.edu|
22401364|NCT00175006|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22401365|NCT02052960|Glycotope GmbH|Senior Director Clinical Department|0049309489|contact@glycotope.com|2600
22401366|NCT02460822|University of Michigan|Dr. Lawrence C. An|734-763-6099|lcan@med.umich.edu|
22401367|NCT03849560|NPO Petrovax Pharm, LLC|Nikolay Dodonov, Head of medical department|+7(495) 730-75-45|DodonovNS@petrovax.ru|125
22401368|NCT00748657|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22401369|NCT01243593|Sick Kids Hospital|Dr. Jason Hayes|416-813-7445|jason.hayes@sickkids.ca|
22401370|NCT01633060|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22401371|NCT00883753|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22401372|NCT02859415|National Cancer Institute|Dr. David S. Schrump|240-858-7000|schrumpd@mail.nih.gov|
22401373|NCT00691574|Oregon Health & Science University|Alfred Lewy, MD, PhD|(503) 494-7746|lewy@ohsu.edu|
22401374|NCT01396525|AbbottVascular|David R Rutledge|408-845-3820|david.rutledge@av.abbott.com|
22401375|NCT02282332|MedStar Health Research Institute|Scientific Center Adminstrator|(301) 560-7300|Research@medstar.net|
22401376|NCT00414440|Novartis|Study Director|+1 (862) 778-8300||
22401377|NCT04634162|Division of Cardiology University of Florida College of Medicine - Jacksonville|Francesco Franchi, MD|1-904-244-2060|francesco.franchi@jax.ufl.edu|
22401378|NCT02457897|NIDDK|Dr. Rebecca Brown|301-594-0609|Rebecca.Brown@NIH.gov|
22401379|NCT01743027|Alcon Research, Ltd.|James Wheeler, Unit Head, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
22401380|NCT00138151|Rutgers Cancer Institute of New Jersey|Lorna Rodriguez, MD, PhD|732-235-8675|rodriglo@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
22401381|NCT02624700|Virginia Commonwealth University Massey Cancer Center|Andrew Poklepovic, MD|(804) 828-0450|AskMassey@vcu.edu|
22401382|NCT04925570|Stanford Prevention Research Center, Department of Medicine, Stanford|Judith J. Prochaska, PhD, MPH|650-724-3608|jpro@stanford.edu|
22401383|NCT00754767|HealthPartnersInstitute|Dr. Alice Shapiro|952-993-1704|shapia@parknicollet.com|
22401384|NCT03494725|DuPont Nutrition and Biosciences|Elaine Patterson, Ph. D.|+358-40-4827-626|elaine.patterson@dupont.com|
22401385|NCT02619253|IndianaU|Dr. Nabil Adra|317-278-7728|nadra@iu.edu|
22401386|NCT02111811|Crescenz VA Medical Center|David Oslin, MD|215-823-8594|dave.oslin@va.gov|
22401387|NCT01359982|EpicentRx, Inc|Study Director: Bryan Oronsky, Chief Medical Officer|8582291062|boronsky@epicentrx.com|
22401388|NCT05593432|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22401389|NCT03529214|Ariadne Labs|Dr. Amber Weiseth|206-786-0282|aweiseth@ariadnelabs.org|
22401390|NCT00069121|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22401391|NCT03851510|Philips|Chuck Cain|412-657-1814|chuck.cain@philips.com|
22401392|NCT02426086|Geron Corp.|Study Director|650-473-7700|myf2001-info@geron.com|
22401393|NCT04542291|Washington University School of Medicine|Kian-Huat Lim, M.D.|314-362-6157|kian-huat.lim@wustl.edu|
22401394|NCT01287117|Genentech, Inc.|Medical Communications|800 821-8590||
22401395|NCT01274897|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22401396|NCT02042131|The University of Utah|Craig Bryan|801-587-7978|craig.bryan@utah.edu|
22401397|NCT02862912|Columbia University|Dr. Allison Lee|212-305-6494|al3196@cumc.columbia.edu|
22401398|NCT00035815|Mayo Clinic|Eric J. Sorenson, MD|507 538-1037|sorenson.eric@mayo.edu|
22401399|NCT00003270|Roswell Park Comprehensive Cancer Center|Dr. Theresa Hahn|716-845-5819|theresa.hahn@roswellpark.org|
22401400|NCT02378753|Centers for Disease Control and Prevention|Dr. Barbara Mahon|404-718-1157|bdm3@cdc.gov|
22401401|NCT03572634|Sr. Director Drug Development/Clinical Operations|Susan Smith|210-414-7702|s.smith@toleropharma.com|
22401402|NCT00756977|Braintree Laboratories|John McGowan|781-843-2202|jmcgowan@braintreelabs.com|
22401403|NCT02606877|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22401404|NCT04952389|Mayo Clinic|Janalee K. Stokken, M.D.|507-284-1482|Stokken.Janalee@mayo.edu|
22401405|NCT02293954|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22401406|NCT02277444|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22401407|NCT03165981|Duke University|Dr. Emmanuel B. Walter|919-620-5346|chip.walter@duke.edu|
22401408|NCT06384989|The Ohio State University|Julie Mansfield|614-366-2101|julie.mansfield@osumc.edu|
22401409|NCT05635838|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22401410|NCT05287893|Medicines for Malaria Venture|Joerg Moehrle|+41 22 555 03 00|info@mmv.org|
22401411|NCT02699515|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|+49
22452236|NCT03165045|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22401412|NCT05243550|UroGen Pharma|Head of Clinical Development|+1 855-987-6436|info@urogen.com|
22401413|NCT02858193|Dompé farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22401414|NCT02031146|University of Washington|Christina Marra, MD|206-744-3251|cmarra@uw.edu|
22401415|NCT01486316|Medtronic, Inc|Rachael Rose, Clinical Research Specialist|763-526-2332|rachael.k.rose@medtronic.com|
22401416|NCT00112151|Univeristy of Colorado at Denver|Dr. Robert S. Schwartz, Head, Division of Geriatric Medicine|303-724-1919|robert.schwartz@ucdenver.edu|
22401417|NCT00266110|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22401418|NCT05094154|Vanderbilt University Medical Center|Edward T Qian, MD|615-322-2386|edward.t.qian@vumc.org|
22452237|NCT04773015|GE Healthcare|Paul Sherwin, MD, PhD|609 510 3686|PaulSherwin@ge.com|
22452238|NCT04964089|Kodiak Sciences Inc|Pablo Velazquez-Martin|1 (650) 281-0850|ClinOps@kodiak.com|
22452239|NCT01915563|Althaia Xarxa Assistencial Universitaria de Manresa|Dr Rafael Fernandez|34.8732550|rfernandezf@althaia.cat|3730
22452240|NCT00499369|SWOG|Study Statistician|206-667-4623||
22452241|NCT01898195|Department of Population Health, New York University School of Medicine|Donna Shelley, MD, MPH/ Vice Chair for Research; Associate Professor of Population Health and Medici|646-501-2526|Donna.Shelley@nyumc.org|
22452242|NCT01562756|Palmer College of Chiropractic|Ting Xia, PhD (Principal Investigator)|563-884-5161|Ting.Xia@palmer.edu|
22452243|NCT02536508|Pearl Therapeutics, Inc.|Pearl Therapeutics, Inc.|1-877-240-9479|information.center@astrazeneca.com|
22452244|NCT00803647|NSABP Foundation|Diana Gosik, Director Department of Site and Study Management|412-339-5333|diana.gosik@nsabp.org|
22452245|NCT00434057|Electro-Optical Sciences, Inc.|Joanna Adrian / Director, Clinical Operations and Medical Affairs|(914)591-3783|adrian@eosciences.com|732
22452246|NCT02312739|Division of Family Planning, University of New Mexico|Sunderjeet Kaur|Email|HSC-familyplanningresearch@salud.unm.edu|
22452247|NCT04829344|American Genomics, LLC|Michelle Widmann|919-600-1819|mwidmann@calclinicalsolutions.com|
22452248|NCT00823719|GlaxoSmithKline|GSK Response Center|866-435-7343||
22452249|NCT00373334|Braintree Laboratories, Inc.|Clinical Operations Manager|781-843-2202|jmcgowan@braintreelabs.com|
22452250|NCT00344682|UMass Medical School|Dr. Kristina Deligiannidis|508-856-5928|kristina.deligiannidis@umassmemorial.org|
22452251|NCT02103439|Biocad|Yulia Linkova Medical Director|+7 (495) 992 66 28|linkova@biocad.ru|930
22452252|NCT02370602|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22452253|NCT02606838|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com|
22452254|NCT02962687|Durham VA HSR&D|Susan N Hastings|919-286-6986|susan.hastings@va.gov|
22452255|NCT00599326|UT Southwestern Medical Center at Dallas|Amit Pandya, M.D.|214-645-8300|amit.pandya@utsouthwestern.edu|
22452256|NCT00784810|Napp Pharmaceuticals Ltd|Director of Medical Affairs|01223 424444||
22452257|NCT02995967|UAB|Joseph Malek|2059965466|jmalek@uabmc.edu|
22452258|NCT03305016|Ascendis Pharma, Inc.|Aimee D Shu, MD|+1 650 352 8389|ADS@ascendispharma.com|
22452259|NCT02119416|SUNYBuffalo|Jennifer Temple|716-829-5593|jltemple@buffalo.edu|
22452260|NCT03434119|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22452261|NCT04420689|Alume Biosciences|Chief Medical Officer|858-922-3966|brett.berman@alumebiosciences.com|
22452262|NCT04323852|Shahid Beheshti Medical School|Dr. ََAfshin Zarghi|021-22439781|Mpajouhesh@sbmu.ac.ir|
22452263|NCT04360824|University of Iowa Hospitals & Clinics|Dr. Usha Perepu|1-319-356-2195|usha-perepu@uiowa.edu|
22452264|NCT04022668|Yeditepe University|Emre Aslanger|0216578000|mr_aslanger@hotmail.com|4240
22452265|NCT02278328|Children's Hospital of Philadelphia|Timothy Roberts, Professor|267 426 0307|robertstim@email.chop.edu|
22452266|NCT02365467|Medtronic|Alexa Glandon, Medtronic Clinical Study Manager|12624087021|alexa.a.glandon@medtronic.com|
22452267|NCT01306162|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22452268|NCT01109992|Brigham and Women's Hospital|Sharmila Dorbala|617-732-6215|sdorbala@partners.org|
22452269|NCT00690755|James A. Haley VA Research Department|Robert Farese, MD|813-972-2000|Robert.Farese@va.gov|
22452270|NCT00819182|Indiana University|Janet S Carpenter, PhD, RN, FAAN|317-278-6093|carpentj@iupui.edu|
22452271|NCT04287920|Mayo Clinic|Douglas (Doug) A. Simonetto, M.D.|507-284-4824|Simonetto.Douglas@mayo.edu|
22452272|NCT00958035|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22452273|NCT03085563|Children's Hospital Colorado|Paul Szefler, MD, FAAP|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
22452274|NCT02952924|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22452275|NCT01435577|Grünenthal GmbH|Director of Clinical Trials|+241 569 3223||
22452276|NCT02830594|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22452277|NCT01934218|Seikagaku Corporation|Clinical Development Dept.|(81)3-5220-8948|yuko.shibata@seikagaku.co.jp|
22452278|NCT02955511|Cedars Sinai Medical Center|Dr. Ofelia Loani Elvir Lazo, Research Project Advisor|3104231682|ofelia.elvir-lazo@cshs.org|
22452279|NCT03273946|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22388666|NCT01670877|Washington University School of Medicine|Cynthia Ma, M.D., Ph.D.|314-362-9383|cynthiaxma@wustl.edu|
22388667|NCT00417885|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22388668|NCT02309892|Helix BioPharma Corp.|Brenda Lee, Director, Clinical Operations|416 642 1807|blee@helixbiopharma.com|
22388669|NCT01672242|University of Maryland School of Medicine|Carl Shanholtz, MD|410.328.8141|cshanhol@som.umaryland.edu|
22388670|NCT05376397|Rutgers School of Public Health|Dr. Devin English, Prinicipal Investigator|19739727212|devin.english@rutgers.edu|
22388671|NCT00711022|DENTSPLY Implants|Senior Manager Global Clinical Research|+46313763500|clinicalresearchmolndal@dentsply.com|
22388672|NCT03029156|Tufts Medical Center|Nicholas S. Hill|617-636-0688|nhill@tuftsmedicalcenter.org|
22388673|NCT04812977|Hayatabad Medical Complex, Peshawar|Yousaf Jamal Mahsood|091921714047|yousaf82@hotmail.com|
22388674|NCT00722865|Massachusetts General Hospital Cancer Center|Jeremy Abramson, MD|617-724-4000|jabramson@mgh.harvard.edu|
22388675|NCT00648895|Forest Laboratories|John Whalen, MD Executive Director of Clinical Development - Cardiovascular and Metabolism|1-201-427-8259|John.Whalen@frx.com|
22388676|NCT01516710|Oslo University Hospital|Dr. Aasmund A. Fretland|004723070100|aafret@ous-hf.no|
22388677|NCT01280721|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366||
22388678|NCT01180400|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22388679|NCT00795639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22388680|NCT04626128|Clearside Biomedical, Inc.|Susan Coultas, PhD|678.270.3639|susan.coultas@clearsidebio.com|
22388681|NCT00248794|VA Connecticut Healthcare System|Gary Bryson|860-594-6348|gary.bryson@va.gov|
22388682|NCT03449979|University of North Carolina at Chapel Hill|Justin Riddle, PhD|6617131602|justin_riddle@med.unc.edu|
22388683|NCT01358175|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22388684|NCT04908488|Alcon Research, LLC|Sr. Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22388685|NCT01125436|Case Western Reserve University|Research Compliance Officer|216-368-0134|kav6@case.edu|
22388686|NCT01694199|Regenesis Biomedical, Inc.|Dr. Rick Isenberg|877-970-4970|isenberg@regenesisbio.com|
22388687|NCT03444155|Otto Loewi Research Center, Chair of Physiological Medicine, Medical University of Graz, Austria|Dr. Willibald Wonisch|00436505299540|willibald.wonisch@medunigraz.at|
22388688|NCT02877680|Baylor College of Medicine|Marisa Hilliard, Associate Professor of Pediatrics|832-824-7209|marisa.hilliard@bcm.edu|
22388689|NCT01133678|University of Chicago|Everett Vokes, MD|(773) 702-6227|evokes@medicine.bsd.uchicago.edu|
22388690|NCT02206607|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22388691|NCT03424187|Imperial College London|Gary Frost|+44 20 7594 0959|g.frost@imperial.ac.uk|
22388692|NCT00761267|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22388693|NCT01864200|BTG|Shirley Steiner, Director of Clinical Operations|610 943 3631|shirley.steiner@btgplc.com|
22388694|NCT03398798|University of North Carolina at Chapel Hill|Christian Piers, DDS, MS, MFA|(828) 433-1242|christian.piers@gmail.com|
22388695|NCT01958346|Teamhealth Anesthesia|Devanand Mangar MD|813-844-4434|devanandmangar@teamhealth.com|
22388696|NCT02466958|UCLA|Helen Lavretsky, MD|310-794-4619|HLavretsky@mednet.ucla.edu|
22388697|NCT00963924|Nathan Klein Institute for Psychiatric Research|Dr. Donald C Goff|646-754-4843|donald.goff@nyumc.org|
22388698|NCT00446095|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
22388699|NCT03014726|Urotronic, Inc.|Ian Schorn, Vice President of Clinical Affairs|320.282.6312|schorni@urotronic.com|
22388700|NCT01419184|Cubist Pharmaceuticals|Vice President, Clinical Research|1.781.860.8660||
22388701|NCT01414192|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22388702|NCT04658888|Penn State Health Milton S Hershey Medical Center|Dr. Christina Scartozzi|484-650-0885|Cscartozzi@pennstatehealth.psu.edu|
22388703|NCT02644122|University of California, San Diego|Ezra Cohen, MD|(858)822-5800|ecohen@ucsd.edu|
22388704|NCT01604122|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22388705|NCT00424476|GlaxoSmithKline|GSK Response Center|866-435-7343||
22388706|NCT02514824|Dana-Farber Cancer Institute|Robert Haddad, MD|617.632.3090|Robert_Haddad@dfci.harvard.edu|
22388707|NCT05303324|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
22388708|NCT02159352|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22388709|NCT00529529|Novartis Pharmaceuticals|Study Director|862 778-8300||
22452280|NCT01220557|Forschungsinstitut der Diabetes Akademie Mergentheim|Norbert Hermanns, PhD|+49 7931 594|hermanns@diabetes-zentrum.de|553
22388710|NCT00337610|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
22452281|NCT02944877|University of California, Irvine|Dr. Sean Young|714-413-2347|syoung5@hs.uci.edu|
22452282|NCT04323436|Novartis|Study Director|862-778-8300|Novartis.email@novartis.com|
22452283|NCT02279641|Study Information Center AstraZeneca|Jesse Hall, MD|+1 877-240-9479|information.center@astrazeneca.com|
22452284|NCT01682837|UT Southwestern Medical Center at Dallas|John Poindexter|2146486857|john.poindexter@utsouthwestern.edu|
22452285|NCT01664078|Cordis US Corp|Jennifer Lee|+1-669-699-6851|jennifer.lee02@cordis.com|
22452286|NCT04782323|Seqirus|Seqirus Clinical Trial Manager|1-855-358-8966|seqirus.clinicaltrials@Seqirus.com|
22452287|NCT02877485|Stanford Facial Plastic and Reconstructive Surgery|Sam P. Most MD|650-736-3223|smost@stanford.edu|
22452288|NCT04369469|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22452289|NCT03135522|The Johns Hopkins University School of Medicine|Dr. Robert A. Wise, M.D.|410-905-5688|rwise@jhmi.edu|
22452290|NCT01700816|Massachusetts General Hospital|Carlos Fernandez Robles MD|6176432410|cfernandez-robles@mgh.harvard.edu|
22452291|NCT03832192|care.coach|Principal Investigator|8554374569|pi@care.coach|2
22452292|NCT01337245|University of Arizona|Senior Regulatory Coordinator|520-621-6417|regulatory@arizona.edu|
22452293|NCT04095858|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22452294|NCT01344460|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22452295|NCT02060890|University of California, San Francisco|Nicholas Butowski MD Professor of Neuro-Oncology|414-353-2966|Thelma.Munoz@ucsf.edu|
22452296|NCT02838017|NorthShore University HealthSystem|Lena Braginsky|2245952705|lena.braginsky.mfm@gmail.com|
22452297|NCT01692197|UT MD Anderson Cancer Center|Borthakur,Gautam MD|713-563-1586|CR_Study_Registration@mdanderson.org|
22452298|NCT02120924|Teva Pharmaceuticals USA, Inc.|Director, CE Studies|1-888-483-8279|USMedinfo@tevapharm.com|
22452299|NCT03483623|David Grant Medical Center, Clinical Investigation Facility, Travis AFB, CA|Lt Col Laurie Migliore|707-423-7280|laurie.a.migliore.mil@mail.mil|
22452300|NCT01884350|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22452301|NCT03510481|NIAID/LMIV|Dr. Patrick Duffy|301-761-5089|patrick.duffy@nih.gov|
22452302|NCT02756624|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
22452303|NCT02596451|Glenmark Pharmaceuticals Ltd|Cathy Tyrrell|91 2267720000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
22452304|NCT03151434|Indiana University Department of Anesthesiology|Dr. Yar Luan Yeap|3172740275|yyeap@iupui.edu|
22452305|NCT02730819|Mayo Clinic|Dr. Jason Sluzevich|904-953-9453|Sluzevich.Jason@mayo.edu|
22452306|NCT01308580|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22452307|NCT03403634|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-1300|Kristopher.Attwood@Roswellpark.org|
22452308|NCT00932893|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22452309|NCT01850004|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22452310|NCT03750487|Partnership to End Addiction|Sarah Dauber, Vice President|212-841-5270|sdauber@toendaddiction.org|
22452311|NCT02508311|James J Peters VA Medical Center|Gregory Schilero|7185849000|gregory.schilero@va.gov|6701
22452312|NCT04862143|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
22452313|NCT04955639|Pivot Health Technologies Inc.|Craig Fujii, Sr. Director of Clinical Affairs and Data Science|650-906-4255|craig@pivot.co|
22452314|NCT00413153|Massachusetts General Hospital|Steven K. Grinspoon, MD|617-724-9109|sgrinspoon@partners.org|
22452315|NCT00924885|Vitrolife|Director of clinical investigations|0046708228063|thardarson@vitrolife.com|
22452316|NCT02508480|Boston University|Dr. Zlatka Russinova|617-353-3549|zlatka@bu.edu|
22452317|NCT03966157|Saint Louis University|Dr. Samuel J. Burton|3147500811|s.burton.1818@gmail.com|
22452318|NCT04969250|University of Minnesota|Melissa Skeans, Statistician/Protocol Manager|612-626-9011|tico@insight-trials.org|
22452319|NCT00377676|VeroScience|Richard Scranton|401 816-0525|richard_scranton@veroscience.com|
22452320|NCT01347333|Mercy Research|Michelle McFarland, MPH, CHRC|314-251-8827|michelle.mcfarland@mercy.net|
22452321|NCT02366338|Mugla Sitki Kocman University|Ozcan Basaran|+902522120724|basaran_ozcan@yahoo.com|
22452322|NCT03834779|UT Southwestern Medical Center|Dr. Ank Nijhawan|214-648-2777|ank.nijhawan@utsouthwestern.edu|
22452323|NCT03579459|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22452324|NCT02528214|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22452325|NCT00407537|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22452326|NCT00347308|The New York Eye & Ear Infirmary|Anthony P. Sclafani, MD|212-979-4200|asclafani@nyee.edu|
22452327|NCT03593655|Stellenbosch University, Centre for Medical Ethics and Law|Gonasagrie Nair|27-21-938-7050|gnair@sun.ac.za|
22452328|NCT03526250|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22452329|NCT04420221|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22452330|NCT05348681|Aristea Therapeutics|Aristea Therapeutics|858-465-6142|info@aristeatx.com|
22452331|NCT01040130|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22452332|NCT04174521|Vanderbilt University Medical Center|Bryan Shepherd|615-343-3496|bryan.shepherd@vumc.org|
22388711|NCT03979040|VA Finger Lakes Health Care System|Dr. Nik Allan - Study Statistician|(850) 274-0567|Nicholas.Allan@osumc.edu|
22388712|NCT02354144|Division of Cancer Epidemiology, Department of Oncology, McGill University|Dr. Eduardo Franco|514-398-6032|eduardo.franco@mcgill.ca|
22388713|NCT04012970|Edinburgh Napier Univerisity|Rebecca Hamilton, PhD student|0131 455|rebeccaisabel.hamilton@napier.ac.uk|2350
22414618|NCT04667338|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22401419|NCT00945750|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22414619|NCT01001403|Seoul National University Hospital|CW Jung|82-2-2072-2467|spss@snuh.org|9
22414620|NCT01794845|University of Miami|Matthew C. Abramowitz MD|305-243-4319|MAbramowitz@med.miami.edu|
22414621|NCT01457196|UNC Lineberger Comprehensive Cancer Center|Robin Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
22414622|NCT03498560|Massachusetts General Hospital DACCPM|Dr. Oluwaseun Johnson-Akeju|617-724-7200|oluwaseun.akeju@mgh.harvard.edu|
22414623|NCT00867360|Stanford University|Dr. Alan Schatzberg|650-723-6811|afschatz@stanford.edu|
22452333|NCT03009110|Indiana University School of Medicine|Graham Hogg|317-962-0415|gahogg@iu.edu|
22452334|NCT00553267|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22452335|NCT04389840|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
22452336|NCT01618864|Iluminage|Director of Clinical Affairs|+972 547 800 260|doranr@iluminagebeauty.com|
22452337|NCT03585244|Foundation for Prader-Willi Research|Theresa Strong, PhD - Director of Research Programs|888-322-5487|theresa.strong@fpwr.org|702
22452338|NCT04575428|Duke University|Marat Fudim, MD, MHS|919-684-1284|marat.fudim@duke.edu|
22452339|NCT00430768|UMASS Medical School|Dr. Terry Flotte|(508) 856-2107|Terry.Flotte@umassmed.edu|
22452340|NCT00762320|Phoenix Children's Hospital|Laura Clarke-Steffen, PhD, RN|602-933-0234|lclarke@choenixchildrens.com|
22452341|NCT01090453|GlaxoSmithKline|GSK Response Center|866-435-7343||
22452342|NCT00884585|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22452343|NCT03970109|National Institutes of Health|Dr. Daniel Falk|301-443-0788|falkde@mail.nih.gov|
22452344|NCT00142909|Yale University School of Medicine|Rajita Sinha, Ph.D|203-737-5805|rajita.sinha@yale.edu|
22452345|NCT03971643|InflaRx|Prof. Dr. Niels C. Riedemann|+49-(0) 3641-508 180|niels.riedemann@inflarx.de|
22388714|NCT02978183|Noveome Biotherapeutics, Inc|David Steed, MD|4124029913|dsteed@noveome.com|
22388715|NCT02279732|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22388716|NCT01605435|University of Pennsylvania|Dr. Anne Cappola, PI|215-573-5359|acappola@mail.med.upenn.edu|
22388717|NCT03020914|Hospital for Special Surgery|Marla Sharp, MPH, MA|646-797-8419|sharpm@hss.edu|
22388718|NCT04620733|CymaBay Therapeutics, Inc.|CymaBay Study Director|1-510-293-8800|medinfo@cymabay.com|
22388719|NCT02221934|Neuros Medical, Inc.|Nick Hargus, PhD. Vice President of Clinical and Medical Affairs|440-951-2565|nhargus@neurosmedical.com|
22388720|NCT03976102|Dr. Reddy's Laboratories Ltd.|Head - Clinical Development|91-40-4464-4000|RI-01-006@drreddys.com|
22388721|NCT03624023|Transwell Biotech Co., Ltd.|Dr. Bin-Ru She|+886-3-5670399|binru.she@tw-bio.com|207
22388722|NCT00451906|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22388723|NCT01578278|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
22388724|NCT00506025|University of California Irvine Medical Center|Deborah A. Wing, MD|714-456-5967|dwing@uci.edu|
22388725|NCT02889900|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazenca.com|
22388726|NCT00805792|Mayo Clinic|James F. Meschia, MD|904-953-2903|meschia.james@mayo.edu|
22388727|NCT04351243|Kinevant Sciences, Inc. on behalf of Kinevant Sciences GmbH|Simon Lowry, MD, Chief Medical Officer|(646) 495-5368|simon.lowry@roivant.com|
22388728|NCT01416285|Chang Gung Memorial Hospital|CHAO-HUNG WANG, MD|+886-2-24313131|bearty54@gmail.com|2923
22388729|NCT01690000|Aarhus University|Anne Kristine Amstrup|4578467681|anne_kristine_am@hotmail.com|
22388730|NCT04785794|FluGen|Pamuk Bilsel, CSO|608-442-6562|pbilsel@flugen.com|
22388731|NCT01248715|University Louisville|Dr. Paula Peyrani|502-852-3905|paula.peyrani@louisville.edu|
22388732|NCT00813709|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22388733|NCT01807234|Johns Hopkins University School of Medicine|Dr. B. Lee Peterlin|410-550-9550|hnitchi1@jhmi.edu|
22388734|NCT01540474|Walter Reed Institute of Research|Jason W. Bennett|3013199477|jason.w.bennett.mil@mail.mil|
22388735|NCT00857311|Merck Sharp & Dohme|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22401420|NCT00345371|National Institute on Drug Abuse|Liza Zeinert|301-443-1138|liza.zeinert@nih.gov|
22401421|NCT02400346|H. Lundbeck A/S|Email contact via||LundbeckClinicalTrials@Lundbeck.com|
22401422|NCT02340104|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22401423|NCT01040832|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22401424|NCT00970203|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|7168451300|adrienne.groman@roswellpark.org|
22414624|NCT01004510|Rochester General Hospital|Todd Sheppard, MD|585-922-4409|todd.sheppard@rochestergeneral.org|
22414625|NCT02096692|Biotronik, Inc.|Clinical Studies Engineer|503-451-8049|justin.michalski@biotronik.com|
22452346|NCT01660763|AcelRx Pharmaceuticals, Inc|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
22388736|NCT01587703|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22388737|NCT01129011|POZEN|Senior Vice President, Clinical Research|919-913-1030|eorlemans@pozen.com|
22388738|NCT03209492|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22388739|NCT02432183|KU Leuven|Dominique MA Bullens|3216341338|dominique.bullens@kuleuven.be|
22414626|NCT02911025|Brigham and Women's Hospital|Dr. Milena Pavlova|6174772129|mpavlova@bwh.harvard.edu|
22414627|NCT00436163|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22414628|NCT02597049|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22414629|NCT04050735|Brown University|Dr. Mollie Monnig|401-863-3491|mollie_monnig@brown.edu|
22414630|NCT01910831|Center for Clinical and Cosmetic Research|Andrew Frisina, Clinical Research Coordinator|305 933 6716|A.Frisina@admcorp.com|
22414631|NCT06647173|Emory University|Dr. Aaron Siegler|404-712-9733|asiegle@emory.edu|
22388740|NCT01894620|University of Manitoba|Dr Zahra Moussavi|204 474-7023|Zahra.Moussavi@umanitoba.ca|
22388741|NCT01124916|Loyola University|Elizabeth Mueller, M.D.|708-216-2180|emuelle@lumc.edu|
22388742|NCT00879710|Medical College of Wisconsin|Srividya Kidambi, MD, MS|414-955-4843|skidambi@mcw.edu|
22388743|NCT00753896|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22388744|NCT00952523|Valeant Pharmaceuticals International Inc|David Lineberry, Associate Director, Clinical Operations|949-973-1153|David.Lineberry@valeant.com|
22388745|NCT02707952|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22388746|NCT01141075|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22388747|NCT01326455|UAlberta|Jennifer Fech||jennifer.fech@albertahealthservices.ca|
22388748|NCT03072862|Cochlear|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
22388749|NCT02203513|National Cancer Institute|Dr. Jung-min Lee|240-760-6128|leej6@mail.nih.gov|
22388750|NCT01441596|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22388751|NCT01331408|Galderma Uppsala|Head of Medical Affairs|+46 (0)18 474 9000|receptionen.SEUPP@galderma.com|
22388752|NCT01673256|St. Jude Medical Inc.|Kyle Brunner|651.756.3482|kbrunner02@sjm.com|
22388753|NCT03015220|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22388754|NCT01670526|Hines CSPCC|Tom Sindowski|708-202-5858|tom.sindowski@va.gov|
22388755|NCT03055988|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22388756|NCT00392197|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22388757|NCT02312258|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22388758|NCT01528605|Peking University|Xiaoming Lin|010-82805336|linbjmu@bjmu.edu.cn|
22388759|NCT04182217|Université d'État d'Haïti|Axler JEAN PAUL, Author|+50943776900|jeanpaulaxler@hotmail.com|
22388760|NCT01681511|ICET, Inc.|Dr. Shantha Sarangapani|781-769-6064|Shantha@icetinc.com|
22388761|NCT01156675|Globus Medical|Director, Clinical Affairs|610-930-1800|jmyer@globusmedical.com|1669
22388762|NCT01970527|University of Washington Medical Center|Dr. Ramesh Rengan|206-598-4100|rengan@uw.edu|
22388763|NCT02151994|BIAL-Portela & Ca, S.A.,|Head of Clinical Research|(+351)-22-9866100|clinical.trials@bial.com|
22388764|NCT01974102|YALE UNIVERSITY SCHOOL OF MEDICINE|Dr. Rajita Sinha|2038592840|rajita.sinha@yale.edu|
22388765|NCT00116649|Graceway Pharmaceuticals LLC|Sharon Levy, MD VP Product Development|267-948-0500|sharon.levy@gracewaypharma.com|
22388766|NCT02161146|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22388767|NCT00845520|RxSight, Inc.|Maureen O'Connell Vice President, Regulator and Clinical Affairs|978-207-12415|moconnell@rxsight.com|
22388768|NCT02613403|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22388769|NCT02934932|Duke University|Dr. Steven Szabo|919-681-8742|steven.szabo@duke.edu|
22388770|NCT02067819|Weill Cornell Medicine|Shannon Bennett, PhD|646-962-2820|smb9017@med.cornell.edu|
22388771|NCT00800176|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22388772|NCT00779194|STATE UNIVERSITY OF NEW YORK|Andras Perl|3154644194|perla@upstate.edu|
22388773|NCT02326220|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
22388774|NCT02699099|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22388775|NCT01094106|Kuopio University Hospital|Matti Reinikainen|+358447176681|matti.reinikainen@kuh.fi|
22388776|NCT02659540|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
22388777|NCT00824850|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22388778|NCT00882050|University of Pennsylvania|Kim Lacy, RN BSN|215-893-7234|kim.lacy@uphs.upenn.edu|
22388779|NCT01782209|University of Alabama at Birmingham|Richard J. Whitley, MD|205.638.2530|rwhitley@peds.uab.edu|
22388780|NCT00703391|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22388781|NCT02739100|Rockwell Medical, Inc|Clinical Project Manager|248-960-9009|sgrimberg@rockwellmed.com|
22414632|NCT00363077|GlaxoSmithKline|GSK Response Center|866-435-7343||
22388782|NCT04820491|Virginia Commonwealth University|Jordan Tozer|804-828-5250|jordan.tozer@vcuhealth.org|
22401425|NCT02767570|Stanford University|Julie Kolesar, PhD|614-561-1563|julie14@stanford.edu|
22401426|NCT04510922|University of Cincinnati|Alberto Espay, MD, MSc|5135584050|espayaj@ucmail.uc.edu|
22401427|NCT03774745|University of California, Davis|Dr. Mitchell Creinin|916-734-6670|mdcreinin@ucdavis.edu|
22401428|NCT01712438|Octapharma|Sylvia Werner|415 260-9577|sylvia.werner@octapharma.com|
22401429|NCT01981122|Dendreon|Shabnam Vaziri|206.455.2323|svaziri@Dendreon.com|
22401430|NCT00089843|Massachusetts General Hospital|Anne Klibanski, M.D.|617-726-3870|aklibanski@partners.org|
22401431|NCT01330381|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22401432|NCT03846947|UNC Chapel Hill|Director, Clinical Research, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
22401433|NCT03060577|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22401434|NCT03216265|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22401435|NCT01306058|Principal Investigator|Dr. Tim Greten|301-451-4723|tim.greten@nih.hhs.gov|
22401436|NCT01539837|Imperial College London|David Dexter|+44 (0)20 7594 6665|d.dexter@imperial.ac.uk|
22401437|NCT00849693|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22401438|NCT02889510|Dynamic Science S.L|Anna Royo|+34680603119|a.royo@dynasolutions.com|
22401439|NCT00098345|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22401440|NCT01183858|Hoffmann-La Roche|Medical Communications|800-821-8590|genetech@druginfo.com|
22401441|NCT00553059|University of Texas (UT) MD Anderson Cancer Center|Michael J. Fisch, MD/Department of General Oncology|713-563-9905|mfisch@mdanderson.org|
22401442|NCT00984659|GlaxoSmithKline|GSK Response Center|866-435-7343||
22401443|NCT01966731|Cincinnati Children's Hospital Medical Center|Russell Ware, MD, PhD|(513) 803-1108|russell.ware@cchmc.org|
22401444|NCT00353977|Hematology Branch, NHLBI|Minoo Battiwalla, MD|301 827 0939|battiwam@nhlbi.nih.gov|
22401445|NCT00779038|Janssen-Cilag Belgium|Study Responsible Physician|003214649584||
22401446|NCT01505062|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22401447|NCT02717546|Zimmer Biomet|Ryan Boylan, Clinical Affairs Manager|574.527.7934|ryan.boylan@zimmerbiomet.com|
22401448|NCT00909090|University of Georgia|Dr. Billy Hammond, Principal Investigator|(706) 54204812|bhammond@uga.edu|
22401449|NCT02004990|University of Minnesota|Robert S. Jones DDS PhD|612-626-2900|rsjones@umn.edu|
22401450|NCT02926573|Washington University School of Medicine|Melanie Townsend, M.D.|314-362-4470|townsendm@wustl.edu|
22414633|NCT03250117|Titan Pharmaceuticals, Inc.|Kate Beebe DeVarney, PhD|650-244-4990|medinfo@titanpharm.com|
22414634|NCT04063878|Dentsply IH AB d.b.a Dentsply Sirona Implants|Clinical Research Manager|+46 31 376 44 11|marie.ahlson@dentsplysirona.com|
22414635|NCT02751827|Institut Bergonié|Pr Simone Mathoulin-Pelissier|0556333333|S.Mathoulin@bordeaux.unicancer.fr|
22414636|NCT01248728|Holland Bloorview Kids Rehabilitation Hospital|Dr. Evdokia Anagnostou|416-425-6220|eanagnostou@hollandbloorview.ca|6005
22414637|NCT01841554|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
22452347|NCT00345397|Medical College of Wisconsin and Zablocki VAMC Milwaukee, WI|Mary F. Otterson, MD; Professor of Surgery|414-384-2000|Motterso@mcw.edu|4-1619
22452348|NCT01870843|Xian-Janssen Pharmaceutical Ltd|Associate TA Manager||ClinicalTrialDisclosure@its.jnj.com|
22452349|NCT00952653|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22452350|NCT03980470|University Hospital Zurich|Dr Ronny R. Buechel|+41442551059|ronny.buechel@usz.ch|
22452351|NCT01494051|Oregon Health & Science University|Dr. Melanie Gillingham|503-494-1682|gillingm@ohsu.edu|
22452352|NCT01365494|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22452353|NCT03021187|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22452354|NCT03351049|University of Pittsburgh|David Brienza|412.624.6383|dbrienza@pitt.edu|
22452355|NCT00718718|Janssen Research & Development, LLC|Associate Director||ClinicalTrialDisclosure@its.jnj.com|
22452356|NCT03099382|Jiangsu HengRui Pharmaceuticals Co., Ltd.|Shiwei Sun; Project Manager|+86-18036618554|shiwei.sun@hengrui.com|
22452357|NCT02939105|Zeltiq Aesthetics|Kerrie Jiang, Sr. Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|Kerrie.Jiang@allergan.com|
22452358|NCT02259608|Radboud UMC|Rob Arts|0031 24|rob.jw.arts@radboudumc.nl|36 67206
22452359|NCT01802411|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|Pacira Pharmaceuticals, Inc.|MedInfo@pacira.com|
22452360|NCT01812044|Duke University Medical Center|Laura Enyedi, M.D.|919-684-2038|laura.enyedi@dm.duke.edu|
22452361|NCT05039268|Macquarie University|Richard Gan|+61 2 9812 3739|richard.gan@mq.edu.au|
22452362|NCT03930745|University of Alabama at Birmingham School of Medicine|Jeanne Marrazzo, MD, MPH|205-975-5500|jmarrazzo@uabmc.edu|
22452363|NCT02670629|"Servicio de Ortopedia y Traumatología . Hospital Universitario José Eleuterio González"|Dr. Adriana Hernández|8112901288|adrianahl@gmail.com|
22452364|NCT02715765|University of Minnesota|Kelvin Lim|612-273-9803|kolim@umn.edu|
22452365|NCT03588572|Guangzhou General Hospital of Guangzhou Military Command|Dr.Yan Liu|0086-02088654756|yanliu@139.com|0086
22452366|NCT02267382|Mycovia Pharmaceuticals|Sr Vice President, Clinical Development|(919) 467-8539|info@mycovia.com|
22452367|NCT01165281|Janssen Pharm KK Japan|Medical Director|＋81-3-5509||
22452368|NCT01311102|Harbor-UCLA Medical Center|Dr. Anita Nelson|310-222-3871|anitanelsonwhc@earthlink.net|
22452369|NCT02863991|Chimerix, Inc.|Chief Medical Officer|919-806-1074|clinicaltrials@chimerix.com|101
22452370|NCT03277313|Takeda|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22452371|NCT00364858|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22452372|NCT00363766|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22452373|NCT00558285|Novartis Pharmaceuticals|Study Director|862-778-8300||
22452374|NCT02345512|National Health Service Greater Glasgow & Clyde|Ms Jennifer Crockett|0141 276 4900|jennifer.crockett@ggc.scot.nhs.uk|4912
22452375|NCT01660906|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22452376|NCT02121847|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22452377|NCT01538745|SAUSHEC|Josh Miller|210-916-7111|joshmillersr@gmail.com|
22388783|NCT00452452|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22452378|NCT02142049|Pharmacyclics, LLC|Director of Clinical Operations|408-774-0330|Clinical_Directors@pcyc.com|
22452379|NCT03478891|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Martin Gaudinski, MD|301-451-8715|martin.gaudinski@nih.gov|
22452380|NCT02099006|University of Rochester|Adrienne Bonham MD|(585) 273-3314|adrienne_bonham@urmc.rochester.edu|
22452381|NCT03843788|Rutgers, The State University of New Jersey|Dr. Adrienne Simonds|8565667190|simondad@shp.rutgers.edu|
22452382|NCT03823651|Duke University Medical Center|Dr. Anthony Sung|919-668-1000|anthony.sung@duke.edu|
22452383|NCT05932290|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22452384|NCT03864614|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
22452385|NCT00443547|DePuy Synthes Spine|Mark Lotito|508-880-8045|mlotito@its.jnj.com|
22452386|NCT00910481|King's College London|Professor Divaka Perera|02071887188|divaka.perera@kcl.ac.uk|
22452387|NCT00976599|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22388784|NCT04343716|University of Alabama at Birmingham|Dr. Robert Sorge|2059348563|rsorge@uab.edu|
22388785|NCT02024477|The George Washington University|Dr Saby Sen|202-994-8560|ssen1@gwu.edu|
22388786|NCT03072238|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22388787|NCT01574105|Saskatoon Health Region|Mark Rosin|306-655-2128|mark.rosin@sasktoonhealthregion.ca|
22388788|NCT00608959|Cadence Pharmaceuticals, Inc|Catherine J Hardalo, MD Vice President, Anti-Infectives Clinical Development|858 4361439|chardalo@cadencepharm.com|
22388789|NCT01005602|University of Illinois at Chicago|Dr. Robert J. DiDomenico|(312) 413-4654|rdidom1@uic.edu|
22388790|NCT02416102|University of Miami|Matthias Salathe, MD|913-588-6000|msalathe@kumc.edu|
22388791|NCT02958826|University of Missouri|Dr. Hope Gole|573-882-8030|golehk@health.missouri.edu|
22388792|NCT01919489|Emory University|Dr. Francisco Pasquel|404-778-1695|fpasque@emory.edu|
22388793|NCT03884478|Loyola Marymount University|Dr. Sarah C. Boyle, Senior Research Scientist|3105686681|sarah.boyle@lmu.edu|
22388794|NCT00828139|SWOG Statistical Center|Lung Committee Statistician|2066674623|jmoon@fredhutch.org|
22430967|NCT05763381|The Geneva Foundation|Elizabeth Metzger, Scientific Program Manager|253-383-1398|emetzger@genevausa.org|
22430968|NCT01847014|Actelion Pharmaceuticals US, Inc.|Scott Tsurutani|6508086586|scott.tsurutani@actelion.com|
22430969|NCT02697448|Medical University of South Carolina|George Guldan|(843) 792-2322|guldan@musc.edu|
22430970|NCT05473715|Bayer AG|Therapeutic Area Head|30 300139003|clinical-trials-contact@bayer.com|
22430971|NCT05498870|Medical University of South Carolina|Carey Brewbaker|843-792-2322|brewbake@musc.edu|
22430972|NCT06045273|Johns Hopkins Center for Indigenous Health|Dr. Victoria O'Keefe|410-955-6931|vokeefe3@jhu.edu|
22430973|NCT02592863|University of Missouri|Assistant Director of Research|573-882-2549|schneiderri@health.missouri.edu|
22430974|NCT02743221|Institut de Recherches Internationales Servier (I.R.I.S.)|Dr Patrick Therasse|+33 1 55 72 43 47|patrick.therasse@servier.com|
22430975|NCT04547556|UMC Utrecht|Dr Cristina Prat Aymerich|+31631118128|c.prataymerich-2@umcutrecht.nl|
22430976|NCT02947048|Yamo Pharmaceuticals|Tracy Fischer|8596855862|tfischer@yamopharma.com|
22430977|NCT03658304|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
22430978|NCT02609503|University of North Carolina Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22430979|NCT01969409|University of Alabama at Birmingham|Steven R. Duncan, MD|(205) 934-5017|duncsr19@uab.edu|
22430980|NCT04642079|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22430981|NCT03813121|Wake Forest University School of Medicine|Dr. Merideth Addicott|336-716-7792|maddicot@wakehealth.edu|
22430982|NCT04011241|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22430983|NCT00759395|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22430984|NCT00086515|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22430985|NCT02871440|University of New South Wales|Dr Jacqueline Tan|+61 (02) 9385 6551|jacqueline.tan@unsw.edu.au|
22430986|NCT02420314|University of Iowa|Dr. Muhammad Furqan|319-356-1616|muhammad-furqan@uiowa.edu|
22430987|NCT02251041|UZLeuven|Diethard Monbaliu|+32 16 348727|diethard.monbaliu@uzleuven.be|
22430988|NCT01046669|Spectral Diagnostics Inc.|Debra Foster, VP Clinical Development|4166263233|dfoster@spectraldx.com|2001
22430989|NCT01618708|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22430990|NCT02915601|University of Colorado Anschutz Medical Campus|Dr. Jessica Kendrick|3037244837|Jessica.Kendrick@cuanschutz.edu|
22430991|NCT00680914|GlaxoSmithKline|GSK Response Center|866-435-7343||
22430992|NCT01848457|The Children's Hospital of Philadelphia|Frank Balis, MD|2674265414|balisf@email.chop.edu|
22452388|NCT01641978|Hospital Universitario de Getafe|Susana Arias Rivera|+34916839360|susana.arias@salud.madrid.org|2459
22452389|NCT02358603|Department of Cardiology, Ruijin Hospital Luwan Branch, Shanghai Jiao Tong University School of Medicine|Dr. Zhao, Jianrong||drzjr@126.com|
22452390|NCT03576547|The University of Texas MD Anderson Cancer Center|Farhad Ravandi-Kashani, MD./Professor|713-745-0394|fravandi@mdanderson.org|
22452391|NCT01461668|University of California Irvine|Raveena Singh|949-824-9285|ravsingh@uci.edu|
22452392|NCT01912612|University of Michigan Rogel Cancer Center|Lynn Henry, MD, PhD|734-936-9868|norahh@med.umich.edu|
22452393|NCT01588184|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22452394|NCT01009931|Rutgers Cancer Institute of New Jersey|Tatiana Zelinskaya|(732) 235-9837|zelinsta@cinj.rutgers.edu|
22452395|NCT01760239|HealthPartners Institute|Elyse Kharbanda, MD MPH|952-967-5038|Elyse.O.Kharbanda@healthpartners.com|
22452396|NCT01983293|Abbott|Clay Cohorn|1 972 309 8087|clay.cohorn@abbott.com|
22452397|NCT03147248|Celltrion. Inc.|SungHyun Kim|+82 32 850 5778|SungHyun.Kim@celltrion.com|
22452398|NCT03750552|Theravance Biopharma Inc|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
22452399|NCT02062632|Mayo Clinic|Terence T. Sio, MD, MS|507/284-2511|sio.terence@mayo.edu|
22452400|NCT02156674|Masonic Cancer Center, University of Minnesota|Elizabeth Braunlin MD, PhD|612 626 2755|braun002@umn.edu|
22452401|NCT00581230|UT Medical School at Houston|Carin A. Hagberg|713-500-6222|carin.a.hagberg@uth.tmc.edu|
22452402|NCT00773968|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22452403|NCT04517396|University of Pennsylvania|Katherine Greene|215-662-7580|katherine.greene@pennmedicine.upenn.edu|
22381074|NCT02084082|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22401451|NCT03099369|University of North Carolina at Chapel Hill|David Lee, MD|347-882-8010|dave.lee0530@gmail.com|
22401452|NCT04460027|Stanford Prevention Research Center, Department of Medicine, Stanford University|Judith J. Prochaska, PhD|650-724-3608|jpro@stanford.edu|
22401453|NCT01057121|AIDS Malignancy Consortium|AMC Statistical Center|501-526-6712|jylee@uams.edu|
22401454|NCT03633331|City of Hope Comprehensive Cancer Center|Mina S. Sedrak MD, MS|626-218-4173|msedrak@coh.org|
22401455|NCT01009294|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22401456|NCT03240081|OHSU|Dr. Martha Goetsch|503-494-3666|goetsch@ohsu.edu|
22401457|NCT00949650|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22401458|NCT04601272|Massachusetts General Hospital|Dr. Karen R. Sepucha|617-724-3350|KSEPUCHA@mgh.harvard.edu|
22401459|NCT01678846|London School of Hygiene and Tropical Medicine|Dr Karen Devries|0207958 8164|Karen.Devries@lshtm.ac.uk|8164
22401460|NCT03322657|Cleveland Clinic Foundation|Dr. Ehab Farag|216 444-7550|FARAGE@ccf.org|
22401461|NCT01088412|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22401462|NCT00793104|RI Biologics|Robin Waite , Clinical Projects Director|386-418-8888|rwaite@rtix.com|
22401463|NCT01450137|Department of Rheumatology, Immunology and Allergology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland|Prof Peter M Villiger||peter.villiger@insel.ch|
22401464|NCT01926886|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22401465|NCT02986373|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22401466|NCT04800315|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22401467|NCT00753922|Ethicon Endo-Surgery|Michael L. Schwiers|513-337-1172|mschwier@its.jnj.com|
22401468|NCT02049502|Emory University|Dr. Shaffer|404-778-5033|virginia.o.shaffer@emory.edu|
22401469|NCT01526356|The University of Texas Health Science Center at Houston|Mary Kay Koenig, MD|713-500-7142|mary.k.koenig@uth.tmc.edu|
22401470|NCT02983292|Senior Specialist-Clinical Study Management|Dr. Manvendra Saxena|+61 455 870 175|manvendra.saxena@smith-nephew.com|
22401471|NCT00857246|Perlmutter Cancer Center|Theresa Ryan, MD|212-731-5430|theresa.ryan@nyumc.org|
22401472|NCT01438710|Veloxis Pharmaceuticals|Christina Sylvest|+4520553877|csy@veloxis.com|
22401473|NCT01266148|Novartis Pharmaceuticals|Study director|862-778-8300||
22401474|NCT03026504|Mayo Clinic|Matthew Koster, M.D.|507-284-5800|koster.matthew@mayo.edu|
22401475|NCT04168645|Hartford Hospital|David Tolin|860-545-7685|david.tolin@hhchealth.org|
22401476|NCT02773758|GlaxoSmithKline|GSK Response Center|866-435-7343||
22401477|NCT00502905|UT MD Anderson Cancer Center|Gabriela Rondon, MD / Assistant Professor|713 745-2294|celsaenz@mdanderson.org|
22401478|NCT03454048|Radboud university medical center|Prof. dr. Teun Bousema|+3124 3614306|teun.bousema@radboudumc.nl|
22401479|NCT01978912|Teijin America, Inc.|President|+1-212-308-8744|clinical-trials-safety@teijinpo.com|
22401480|NCT00224107|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com|
22401481|NCT01509586|Medical University of South Carolina|Dr. Matthew J. Carpenter|843-876-2436|carpente@musc.edu|
22401482|NCT01408537|Department of Tropical Pediatrics, Faculty of Tropical Medicine, Mahidol University, Thailand|Dr. Pornthep Chanthavanich|6623549161|tmpct@mahidol.ac.th|
22401483|NCT01878006|National Institute on Alcohol Abuse and Alcoholism|Ramchandani, Vijay|+1 301 402 8527|vijayr@mail.nih.gov|
22401484|NCT00950352|The Brain Institute of the University of Utah|Perry Renshaw, MD, PhD, MBA|801-587-1216|perry.renshaw@hsc.utah.edu|
22401485|NCT01419249|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22401486|NCT01295905|Alcon Research|Director of Alcon Clinical, Atlanta|1-800-241-7629||
22401487|NCT03707977|Harvard T.H. Chan School of Public Health|Molly Pretorius Holme|617-432-4377|mpretori@hsph.harvard.edu|
22401488|NCT03069690|University of Pittsburgh Medical Center|Dr. Michele Levine|(412) 647-0703|levinem@upmc.edu|
22401489|NCT02564120|The University of North Carolina at Chapel Hill|Dr. Ronald Chen|984-974-0400|ronald_chen@med.unc.edu|
22401490|NCT03842709|University of New Mexico-Dept of Neurosciences|ERIN MILLIGAN,|505-272-4411|EMilligan@salud.unm.edu|
22401491|NCT00641147|Johns Hopkins University|Study Coordinator|410-955-3817|lhylind1@jhmi.edu|
22401492|NCT00791128|GI Dynamics, Inc.|Project Manager, Clinical and Regulatory|781.357.3263|kwoessner@gidynamics.com|
22401493|NCT01629667|MedImmune, LLC|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22401494|NCT02757547|Philips|Pat Olsen|(303) 475-3417|pat.olsen@philips.com|
22401495|NCT00592683|Massachusetts General Hospital|Janet Wozniak, MD|617-503-1038|jwozniak@partners.org|
22401496|NCT00201201|University of Connecticut|Patricia J. Neafsey, PhD|860-486-0779|pjneafsey@actualmeds.com|
22401497|NCT00631319|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
22401498|NCT04901897|Bausch & Lomb|Daniel Donatello|5853385306|Daniel.Donatello@bausch.com|
22401499|NCT00891657|Integra LifeSciences|Director, Medical Affairs|609-275-0500||
22401500|NCT00577590|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
22401501|NCT01673061|Albert Einstein Medical Center|Kamran Mohiuddin, Director Clinical Research Emergency Medicine|2154562313|mohiuddk@einstein.edu|
22401502|NCT01625169|USC|LaShonda Spencer|323 226-6437|lspencer@usc.edu|
22452404|NCT02008890|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22452405|NCT02207816|GlaxoSmithKline|GSK Response Center|866-435-7343|cc781166@gsk.com|
22452406|NCT02522494|Jesse Brown VA Medical Center|Howard S. Gordon, MD|(312) 569-7331|howard.gordon2@va.gov|
22452407|NCT03165526|Abbott Medical Device|Courtney Weiler|224 430 4918|ClinicalTrials.gov_SH_Inquiries@abbott.com|
22452408|NCT02349295|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22401503|NCT02267577|Rice 360: Institute for Global Health|Dr. Rebecca Richards-Kortum|713-348-3823|rkortum@rice.edu|
22452409|NCT03240588|Boston Scientific Corporation|Sr. Director, Clinical Operations|855-213-9890|BSNClinicalTrials@bsci.com|
22452410|NCT01449305|isRed Pharma & Biotech Research Corporation|Mirror Hsieh|886-8-7628188|mingrong@bioisred.com|
22452411|NCT03248739|Wake Forest University School of Medicine|Kyle Fargen|336-716-8641|kfargen@wakehealth.edu|
22452412|NCT01259713|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22452413|NCT02091726|University of New England|Peter S. Millard, MD, PhD|2072992131|pmillard@mac.com|
22452414|NCT01780922|Washington State Unviversity|Boon P. Chew|5093351427|boonchew@wsu.edu|
22452415|NCT06111742|Boston Children's Hospital, Harvard Medical School|Harrison Pravder|516-426-8166|hpravder@meei.harvard.edu|
22452416|NCT03461003|The University of Texas Health Science Center at Houston|Joyce P Samuel, MD, MS|713-500-6708|joyce.samuel@uth.tmc.edu|
22452417|NCT01914926|Maimonides Medical Center|Christian Fromm, MD; Director of Research|718-283-6391|cfromm@maimonidesmed.org|
22452418|NCT01227681|Buddhist Tzu Chi General Hospital Hualien|Dr. Chen Shin-Yuan|+886-3-8561825|william.sychen@msa.hinet.net|2151
22452419|NCT01795833|Imperial College London|Nick Oliver|02033111093|nick.oliver@imperial.ac.uk|
22452420|NCT03663231|University of Rochester|Ralph Saunders|585-275-1141|ralph_saunders@urmc.rochester.edu|
22452421|NCT00620750|New York University School of Medicine|Marc Gourevitch, MD, MPH|212-263-8553|marc.gourevitch@nyumc.org|
22452422|NCT04477187|UT Southwestern|Research Coordinator|214-645-8907|jennifer.barillas@utsouthwestern.edu|
22452423|NCT01889420|University of New Mexico|Dulcinea Quintana, MD|505-272-4661|dcandelaria@salud.unm.edu|
22452424|NCT00511862|BTG International Canada Inc.|Director of Clinical Operations|613-801-1880|TheraSphereClinical@btgplc.com|
22452425|NCT00856856|Abbott Vascular International BVBA|Susan Veldhof|31653428610|susan.veldhof@av.abbott.com|
22452426|NCT00085410|Fox Chase Cancer Center|Assistant Professor, Medical Oncology|215-214-1676|crystal.denlinger@fccc.edu|
22452427|NCT03073603|University of Colorado School of Medicine|John R. Corboy, MD|13037242187|john.corboy@cuanschutz.edu|
22452428|NCT02473952|Grifols Therapeutics, LLC|Rhonda Griffin, BSN|919-316-6693|Rhonda.Griffin@Grifols.com|
22452429|NCT00922428|Pascoe pharmazeutische Präparate GmbH|Anja Braschoss|0049 641 7960100|KlinischeForschung@pascoe.de|
22452430|NCT04757649|San Diego State University|Dr. Aaron Blashill|619-594-2245|ajblashill@sdsu.edu|
22452431|NCT02862106|Institute of Immunology，PLA|Dr.Wu|02368752230|wuyuzhang@yahoo.com|86
22452432|NCT01866410|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22452433|NCT02078284|Pugent Sound Blood Center|Sherrill Slichter|206-292-6541|sjslichter@psbc.org|
22452434|NCT00096135|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22452435|NCT01391962|National Cancer Institute|Dr. Alice P. Chen|240-781-3320|chenali@mail.nih.gov|
22452436|NCT04618718|Protembis GmbH|Karl von Mangoldt|+49 241 9903 3621|kvm@protembis.com|
22452437|NCT01947946|AZ-PPD|Steven Fox|441480716682|steven.fox@ppdi.com|
22452438|NCT00833989|GlaxoSmithKline|GSK Response Center|866-435-7343||
22452439|NCT01805297|Dean McGee Eye Institute|Robert E. Leonard, II, MD|405-271-6060|sonny-icks@dmei.org|
22452440|NCT02310750|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22452441|NCT02199028|Stanford University|Dr Bruce Buckingham|(408) 356-0911|buckingham@stanford.edu|
22452442|NCT00867217|University of Kansas Medical Center|Dr. Bruce Kimler|(913) 588-4523|bkimler@kumc.edu|
22452443|NCT01881126|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22452444|NCT05045625|Albany Medical College|Clinical Research Coordinator|518-262-2367|khazeno@amc.edu|
22452445|NCT03867734|University of Washington|Lindley A. Barbee, MD, MPH|206-744-2595|lbarbee@uw.edu|
22452446|NCT01827904|Insightec|Nadir Alikacem, SVP Global Regulated Clinical Affairs|214-360-9900|nadira@insightec.com|
22414638|NCT00147498|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22414639|NCT01838681|H. Lundbeck A/S|Email contact via||LundbeckClinicalTrials@lundbeck.com|
22414640|NCT01278953|Abbott|Lori Rusch, Ph.D.|651-756-2668|lori.rusch@abbott.com|
22414641|NCT01473953|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22414642|NCT00312897|Icahn School of Medicine at Mount Sinai|Dr. Vilma Gabbay|212-659-1661|vilma.gabbay@mssm.edu|
22414643|NCT00902538|Daiichi Sankyo Europe GmbH|Bettina Ammentorp|0049 89 7808 0|bettina.ammentorp@daiichi-sankyo.eu|585
22414644|NCT06336356|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22414645|NCT05350137|Tongji Hospital affiliated Tongji Medical College of Huazhong University of Science and Technology|Dr. Wei Ping|+8613437101581|247046170@qq.com|
22414646|NCT03442322|University of Pittsburgh|Natalie Leland|(412) 383-3405|NEL24@pitt.edu|
22414647|NCT01885949|MGH Cancer Center|Dr. Dror Michaelson|6177244000|dmichaelson1@mgh.harvard.edu|
22414648|NCT03215706|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22414649|NCT02433977|University of Pittsburgh|Stacy Gelhaus Wendell|412-648-1351|gstacy@pitt.edu|
22414650|NCT03114891|University of Pennsylvania|Dr. Desmond Oathes, Principal Investigator|215-573-9390|oathes@pennmedicine.upenn.edu|
22414651|NCT03506633|University of Nebraska at Omaha|Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
22414652|NCT02324335|Innovation Pharmaceuticals Inc.|Arthur P. Bertolino MD, PhD, MBA|978.921.4125|abertolino@IPharmInc.com|
22414653|NCT02973269|Revance Therapeutics, Inc.|Todd Gross, PhD, VP, Clinical Development & Data Science|510-742-3400|tgross@revance.com|
22414654|NCT03247686|Resolve Therapeutics LLC|James Posada|208 727 7010|jp@resolvebio.com|
22414655|NCT02302716|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22414656|NCT00830258|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414657|NCT00798603|Roswell Park Cancer Institute|Grace K. Dy, M.D.|507-284-9265|grace.dy@roswellpark.org|
22414658|NCT01127087|Mayo Clinic|Dr. John C. Lieske|507-266-7960|lieske.john@mayo.edu|
22414659|NCT01002287|Integra LifeSciences|Stefani Battaglia|44 7880 732691|stefani.battaglia@integralife.com|
22388795|NCT04271254|University of North Carolina Lineberger Comprehensive Cancer Center|David Lalush|9195137671|dlalush@email.unc.edu|
22388796|NCT04751929|Dana-Farber Cancer Institute|Atish Choudhury, MD PhD|6176326328|atish_choudhury@dfci.harvard.edu|
22388797|NCT02962609|Istanbul University|Duygu Gözen (Associate Professor)|+902124400000|dgozen@istanbul.edu.tr|27082
22388798|NCT01732419|Maxima Medical Center|Dr. J. Kraal|+31612520944|j.kraal@mmc.nl|
22388799|NCT00473512|Janssen R & D|Senior Director, Clinical Research|(310) 943-8040||2917
22388800|NCT02662023|University of California, San Diego|Brian M. Ilfeld, MD, MS||bilfeld@ucsd.edu|
22388801|NCT01074099|Harvest Technologies|Director of Clinical Operations|508-732-7530|CLI2011communication@harvesttech.com|
22388802|NCT03557307|AstraZeneca|Maria Jison, MD Global Clinical Head, FASENRA, Late-stage R&I|+13013980340|Maria.Jison@astrazeneca.com|
22388803|NCT03745651|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22388804|NCT04175834|Providence Health & Services|Chiayi Chen, Director of WC/PBSI Clinical Research Program|503-216-1012|Chiayi.Chen@providence.org|
22388805|NCT00946088|Stanford University School of Medicine|Deirdre Lyell, MD|(650) 384-5107|deirdre.lyell@stanford.edu|
22388806|NCT03490942|Xeris Pharmaceuticals|B J. Witkin|919-412-6483|bwitkin@xerispharma.com|
22388807|NCT01322347|Rockwell Medical|Senior Director, Clinical Research & Development|248-960-9009|rd@rockwellmed.com|
22388808|NCT01193283|NIH NHLBI|Dr. Danielle Townsley|301-402-3477|townsleydm@nhlbi.nih.gov|
22388809|NCT04239911|Weill Cornell Medicine|Dr. Madeline Sterling|646-962-5029|mrs9012@med.cornell.edu|
22388810|NCT02137785|DUSA Pharmaceuticals Inc., a Sun Pharma Co.|Anna Houlihan|9147608796|anna.houlihan@sunpharma.com|
22388811|NCT03823794|Guy's & St Thomas' NHS Foundation Trust|Carsten Flohr|020 7188 8884|carsten.flohr@kcl.ac.uk|
22388812|NCT03345407|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22388813|NCT01584648|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22388814|NCT00065611|NIDDK, NIH|Jeffrey B Kopp, MD|3015943403|jbkopp@nih.gov|
22388815|NCT03693989|Laboratorios Sophia|Dr. Ricardo Llamas (clinical safety pharmacologist)|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
22388816|NCT01190436|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22388817|NCT03146845|Smith & Nephew, Inc.|Judith Horner|+44 1482 673251|judith.horner@smith-nephew.com|
22388818|NCT03403153|Department of Veterans Affairs|Dr, Suzannah Creech Ph.D|254-297-3025|suzannah.creech@va.gov|
22388819|NCT01052272|University of Alabama at Birmingham|Louis . J. Dell'Italia, M.D|205-934-3969|Dell'Italia@PHYSIOLOGY.UAB.EDU|
22388820|NCT00185692|Stanford University|Robert Lowsky|650-723-0822|rlowsky@stanford.edu|
22388821|NCT00113529|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22388822|NCT02450747|Johnson & Johnson Vision Care Inc.|Tom Karkkainen O.D., M.S., F.A.A.O- Sr. Research Principal Optometrist|904-443-3500|TKarkkai@its.jnj.com|3402
22388823|NCT04184271|Advantage Silver Dental Arrest, LLC|Peter Milgrom|2062516831|drmilgrom@silverarrest.com|
22388824|NCT04417907|Stanford University|Kimford Meador|650-721-5552|kmeador@stanford.edu|
22388825|NCT00841321|Portland VA Medical Center Multiple Sclerosis Center of Excellence|Dennis Bourdette, MD|503-220-8262|dennis.bourdette@va.gov|54594
22388826|NCT02137603|All Children's Hospital Johns Hopkins Medicine|Dr. Nicole Chandler|727-767-4170|Nicole.Chandler@jhmi.edu|
22388827|NCT02632747|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22388828|NCT03651271|Parker Institute for Cancer Immunotherapy|Ute Dugan|203-379-6757|udugan@parkerici.org|
22388829|NCT00821093|Novartis Pharmaceuticals|Study Director|862 778-8300||
22388830|NCT01107912|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22388831|NCT00595959|Spectranetics Inc|Thomas M. Rasmussen V.P. Clinical Affairs|719-447-2471|thomas.rasmussen@spnc.com|
22388832|NCT00886834|University of Utah, Department of Obstetrics and Gynecology|Dr. David Turok|801-581-7647|david.turok@hsc.utah.edu|
22388833|NCT03875729|Sanofi|Clinical and Translational Medicine Lead|1-703-344-2992|laura.knecht@sanofi.com|
22388834|NCT01280656|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22452447|NCT04266028|Desentum Oy|Head of Clinical Operations|+358400224892|Info@desentum.fi|
22452448|NCT01458574|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22452449|NCT02125786|St. Jude Children's Research Hospital|Thomas E. Merchant, DO, PhD|8662785833|referralinfo@stjude.org|
22452450|NCT01117311|Mayo Clinic|Dr. Adrian Vella|507-284-3289|vella.adrian@mayo.edu|
22452451|NCT02663128|Eli Lilly and Company|Chief Medical Officer|800-545-5079||
22452452|NCT05070897|Hôpital Européen Georges Pompidou|Pr Elena Paillaud|0156093310|elena.paillaud@aphp.fr|
22452453|NCT01253343|Cincinnati Children's Hospital Medical Center|Dr. Drew Barzman|513-636-4788|drew.barzman@cchmc.org|
22452454|NCT01617629|PrimaBioMed, Ltd.|Marc Voigt|49 173 6771602|marc.voigt@primabiomed.com.au|
22452455|NCT01663636|Center for Global Health, University of Colorado|Dr. Edwin J. Asturias|3037246282|edwin.asturias@ucdenver.edu|
22452456|NCT03394924|Enanta Pharmaceuticals, Inc.|Nathalie Adda|+1 6176070705|nadda@enanta.com|
22452457|NCT01842789|Acessa Health, Inc.|Laura Kemp, Clinical Affairs Consultant|4083751465|lkemp@acessahealth.com|
22452458|NCT02663817|University of Miami|Dr. Ivaylo Mihaylov|305-243-8223|i.mihaylov@med.miami.edu|
22452459|NCT05350449|University of Nevada Las Vegas|Dr. Nirmala Lekhak|702-895-5983|nirmala.lekhak@unlv.edu|
22452460|NCT01949311|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|1-844-734-6643|clinicaltrials@regeneron.com|
22452461|NCT03272633|Cancer Institute of New Jersey Rutgers|Roger K. Strair, MD|732-235-4523|strairrk@cinj.rutgers.edu|
22452462|NCT01925950|Soligenix, Inc.|Dr. Richard Straube|609-538-8200||
22452463|NCT00852631|AstraZeneca|Gerard Lynch||clinicaltrialtransparency@astrazeneca.com|
22388835|NCT04085614|Philips Medical Systems Nederland B.V.|Peter Eshuis|+31628739280|peter.g.eshuis@philips.com|
22388836|NCT01029925|University of California Los Angeles Jonsson Comprehensive Cancer Center|Edward Garon, MD|310 586 2098|egaron@mednet.ucla.edu|
22388837|NCT05265247|HALEON|Haleon Response Center|+4407880182593|ww.clinical-trial-register@haleon.com|
22388838|NCT00476957|Medtronic Bakken Research Center|Dr. Frank van Leeuwen, Director Clinical Research Coronary and Renal Denervation|+31 43 3566622|frank.van.leeuwen@medtronic.com|
22452464|NCT03508843|University of Alabama at Birmingham|Dr David Schwebel|1-205-934-8745|schwebel@uab.edu|
22388839|NCT02516202|Fred Hutchinson Cancer Research Center|Dr. Katherine A. Guthrie|2066675595|kguthrie@fredhutch.org|
22388840|NCT02841449|University of Bath|Dr Harriet Carroll|+447706548573|hac38@bath.ac.uk|
22388841|NCT01000649|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22388842|NCT01916109|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin|646-422-4333|bajorind@mskcc.org|
22388843|NCT00103857|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22388844|NCT02951702|St. Luke's Hospital|Ryan Medas, Pharm.D.|314-205-6053|ryan.medas@stlukes-stl.com|
22388845|NCT01287832|St. John Hospital and Medical Center|Leonard Johnson MD|3133438823|leonard.johnson@stjohn.org|
22388846|NCT01790659|Instituto Conmemorativo Gorgas de Estudios de la Salud|Nestor Sosa, MD, FACP|507-527-4950|drnsosa@gmail.com|
22388847|NCT03065400|Icahn School of Medicine at Mount Sinai|Mikaela Dougherty|212-241-8839|Mikaela.dougherty@mssm.edu|
22452465|NCT04717596|Abigail Wexner Research Institute|Dr. Elise Berlan|6147222458|elise.berlan@nationwidechildrens.org|
22388848|NCT00632736|GlaxoSmithKline|GSK Response Center|866-435-7343||
22388849|NCT03347396|Bioverativ, a Sanofi company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22388850|NCT00946998|University of Texas Southwestern Medical Center|Susan Hedayati, MD, Professor of Medicine|214-645-6106|susan.hedayati@utsouthwestern.edu|
22452466|NCT00765843|Rosalind Franklin University of Medicine and Science|Ryan Crews|847-578-8437|ryan.crews@rosalindfranklin.edu|
22452467|NCT03555396|Columbia University|Dr. Alissa Davis|212-851-2224|ad3324@columbia.edu|
22452468|NCT04066114|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22452469|NCT02460991|Boston Scientific|Kristi Winterfeldt|763-494-1165|kristi.winterfeldt@bsci.com|
22452470|NCT02564523|Janssen Vaccines & Prevention B.V|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22452471|NCT03814889|Stanford University|Allison Okamura|(650) 723-3148|aokamura@stanford.edu|
22452472|NCT00958919|Dartmouth-Hitchcock|Donald A. Mahler, M.D.|603 650-5533|Donald.a.mahler@hitchcock.org|
22452473|NCT02357836|UT Southwestern Medical Center|Dr. David Gerber|214-648-4180|David.Gerber@UTSouthwestern.edu|
22452474|NCT03701555|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22452475|NCT00448539|Eisai Inc.|Eisai Medical Information|1 8882472378|esi_medinfo@eisai.com|
22452476|NCT03349710|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22452477|NCT00695903|Cubist Pharmaceuticals|Medical Director||ellie.hershberger@cubist.com|
22452478|NCT04256733|University of Montana|Dr. Laurie Slovarp|406-243-2107|laurie.slovarp@umontana.edu|
22452479|NCT01296568|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22452480|NCT04542343|CHARLES R. DREW UNIVERSITY OF MEDICINE AND SCIENCE|DR. MOHSEN BAZARGAN|323-357-3655|mohsenbazargan@cdrewu.edu|
22452481|NCT02539342|Medical College of Wisconsin|Michael J Burke, MD|414-955-4170|mmburke@mcw.edu|
22452482|NCT01369342|Janssen Research & Development, LLC|Vice President||ClinicalTrialDisclosure@its.jnj.com|
22452483|NCT00321854|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22452484|NCT01816594|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22452485|NCT04723576|RAND|Lisa S. Meredith|310.393.0411|seidel@rand.org|7365
22452486|NCT03905655|Romark Laboratories, L.C.|Jessica Fulgencio|813-282-8544|jessica.fulgencio@romark.com|
22452487|NCT02727894|Institution for Clinical and Experimental Medicine|Jan Král|+420605273008|jan.kral@centrum.cz|
22452488|NCT04320069|Insulet Corporation|Dr. Trang Ly|9786007628|tly@insulet.com|
22452489|NCT03204279|Helsinn Healthcare SA|Edwin de Wit - Head of Clinical Development|+41 91 985 2121|info-HHC@helsinn.com|
22452490|NCT01064739|Vanderbilt University|Dr. Emily Garland|615 936 1748|emily.garland@vanderbilt.edu|
22452491|NCT04827212|Northeastern University|Dr. Dinesh John|(801) 230-6320|d.john@northeastern.edu|
22452492|NCT00454051|Novartis Pharmaceuticals|Study Director|862-778-8300||
22452493|NCT04258020|OhioHealth|Dr. Kiran Devulapally|614-566-9143|kiran.devulapally@ohiohealth.com|
22452494|NCT04386096|Cincinnati Children's|Dr. William B. Brinkman|513-636-2576|bill.brinkman@cchmc.org|
22452495|NCT02097472|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22452496|NCT01669629|Vistakon|Kathy Osborn, OD, MS, FAAO, FBCLA Senior Principal Research Optometrist|904 443-1032|kosborn@its.jnj.com|
22452497|NCT05457608|CooperVision|Jose A. Vega,OD,MSc,FAAO|9256213761|jvega2@coopervision.com|
22452498|NCT04402866|Theravance Biopharma|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
22388851|NCT01945593|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22388852|NCT00228813|Emory University|Kuang-Yueh Chiang, MD|404-785-0858|kchian2@emory.edu|
22388853|NCT02232009|GE Healthcare|Yvonne Celestial|+33 130709133|MarieYvonne.CELESTIAL@ge.com|
22388854|NCT00674609|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
22388855|NCT03761849|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22388856|NCT01131325|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22388857|NCT01272388|Washington University School of Medicine|Brian R. Lindman, MD|314-747-3617|brlindman@wustl.edu|
22388858|NCT02213094|UNC at Chapel Hill|Kim Boggess MD Principal Investigator|919-966-1601|kboggess@med.unc.edu|
22388859|NCT00538629|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22388860|NCT00234832|Abbott|Global Medical Services|800-633-9110||
22388861|NCT02163499|ZS Pharma, Inc|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22430993|NCT03131479|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22452499|NCT01292928|Boston Scientific Corporation|Philip Ghizoni, Clinical Trial Manager|763-255-0036|Philip.Ghizoni@bsci.com|
22452500|NCT03317002|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22452501|NCT02040116|Wake Forest Baptist Medical Center|LeAnne Kennedy|336-713-3400|lakenned@wakehealth.edu|
22452502|NCT01592435|Carestream Health, Inc.|Susan Pate, MS, RN, RAC, Senior Manager, Clinical Affairs|585-627-6557|susan.pate@carestream.com|
22452503|NCT03927950|Department of Psychiatry, University of Tartu|Eduard Maron|+3727318812|eduard.maron@kliinikum.ee|
22452504|NCT03263429|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
22388862|NCT01107717|University of Texas Health Science Center at San Antonio|Muhammad Abdul-Ghani, MD|210-557-1157|abdulghani@uthscsa.edu|
22388863|NCT04454125|University of Pittsburgh|Dr. Franziska Rosser|412-692-8429|franziska.rosser2@chp.edu|
22388864|NCT02301299|Northwestern University|Erin Wymore|3125033243|erin.wymore@northwestern.edu|
22430994|NCT04439903|University of Virginia Center for Diabetes Technology|Patricio Colmegna, PhD|434-924-5592|pc2jx@virginia.edu|
22414660|NCT02997176|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22414661|NCT05511935|KDH Research & Communication Inc.|President|4043958711|kholtz@kdhrc.com|
22414662|NCT04523480|University of Miami, Miller School of Medicine - Desai Sethi Urology Institute|Ranjith Ramasamy, MD|3052434562|ramasamy@miami.edu|
22414663|NCT04102345|HealthPartners Neuroscience Research|Bhavani Kashyap, MBBS, PhD|651-495-6358|bhavani.x.kashyap@healthpartners.com|
22414664|NCT02722239|Biocard Research LLC|Nadiya Rizvanova|+74993088278|n.rizvanova@biocard.com|
22414665|NCT01015287|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22414666|NCT01592240|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22414667|NCT01117623|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22414668|NCT04145635|Procyrion, Inc.|Rubi Reyes-Fuentez, Clinical Research Associate II|-|rubi@procyrion.com|
22414669|NCT01662960|Albert Einstein Healthcare Network|Dr. Steven Jax|215-870-0196|stevenandrewjax@gmail.com|
22414670|NCT00433745|Hematology Branch, NHLBI|Minoo Battiwalla, MD|301 827 0939|battiwam@nhlbi.nih.gov|
22414671|NCT02727192|Oslo University Hospital|Professor Lars Gullestad|+4797644772|lars.gullestad@medisin.uio.no|
22414672|NCT02109458|Johns Hopkins University School of Medicine|Dr. Lonny Yarmus|4105025224|lyarmus@jhmi.edu|
22414673|NCT05497557|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22414674|NCT02920476|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
22414675|NCT00488774|Janssen Research & Development|Senior Director|215-793-7540||
22414676|NCT04590027|University of Tuebingen, Department of Anaesthesiology and Intensive Care Medicine|Dr. Barbara Schlisio|+4970712985535|barbara.schlisio@med.uni-tuebingen.de|
22414677|NCT05523895|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2289|medicalinformation@acadia-pharm.com|
22414678|NCT03674892|Tufts Medical Center|Pedram Hamrah, MD|617-636-5720|pedram.hamrah@tuftsmedicine.org|
22414679|NCT05099380|Johnson & Johnson Vision Care, Inc.|John R. Buch-Sr. Principal Research Optometrist|1-800-843-2020|jbuch@its.jnj.com|
22414680|NCT00041392|Duke University|Dr. Mark F. Newman|919-681-6646|newma005@mc.duke.edu|
22430995|NCT03975660|Stanford University School of Medicine|Dr. Brendan Carvalho|(650) 861-8607|bcarvalho@stanford.edu|
22414681|NCT01384591|University of Texas Medical Branch|Melinda Sheffield-Moore|409-772-8126|melmoore@utmb.edu|
22414682|NCT01959672|University of Nebraska Medical Center|Chi Lin|402-552-3844|clin@unmc.edu|
22414683|NCT02392195|Boston Children's Hospital|Michele DeGrazia|617-919-1222|michele.degrazia@childrens.harvard.edu|
22414684|NCT00907907|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22430996|NCT02181413|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22430997|NCT02365688|Duke University Medical Center, Department of Anesthesiology|Timothy Miller MB ChB, FRCA|(+1) 919 6819660|timothy.miller2@duke.edu|
22414685|NCT03605342|VA Connecticut Healthcare System|Dr Ismene Petrakis|203-932-5711|Ismene.Petrakis@va.gov|1-2244
22430998|NCT02298946|National Cancer Institute|Dr. Tim F. Greten|301-451-4723|gretentf@mail.nih.gov|
22430999|NCT00050011|Novartis Pharmaceuticals|Study Director|862-778-8300||
22431000|NCT03034044|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22452505|NCT04530448|West Virginia University|Ankit Sakhuja, MD|304.598.6092|ankit.sakhuja@hsc.wvu.edu|
22452506|NCT01519206|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
22388865|NCT00555620|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22388866|NCT00476151|EpiCept Corporation|Chief Medical Officer|914-606-3500|deverton@epicept.com|
22388867|NCT01286870|Mentor Worldwide, LLC|Laura Vellucci|(805) 879-6000|lvelucci@its.jnj.com|
22388868|NCT02068352|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22388869|NCT02740517|ResMed|Paul Phillips|+44 7789633508|paul.phillips@resmed.com|
22388870|NCT01767376|GlaxoSmithKline|GSK Response Center|866-435-7343||
22388871|NCT04883541|Üsküdar Üniversitesi|Assistant Professor Tuğba YILMAZ ESENCAN|+905057084946|tugba.yilmazesencan@uskudar.edu.tr|
22388872|NCT01369147|Emory University|Thomas Ziegler, MD|404-727-7351|tzieg01@emory.edu|
22388873|NCT03456856|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22388874|NCT02043652|CDC|Alexande Macedo de Oliveira|404 718 4751|acq7@cdc.gov|
22388875|NCT02542696|Sumitomo Pharma America, Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunovion.com|
22388876|NCT03262389|Mayo Clinic|Michael C. Roarke, M.D.|480-342-0988|Roarke.Michael@mayo.edu|
22388877|NCT00547456|North Shore LIJ Health System|Rubin Cohen, MD|516-465-5400|rocohen@nshs.edu|
22388878|NCT02256553|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22388879|NCT02955225|Rush University Medical Center|Dr. Markus Wimmer, Director Motion Analysis Laboratory|(312) 942 2789|markus_a_wimmer@rush.edu|
22388880|NCT04421456|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
22388881|NCT00379210|University of Pennsylvania|Amishi Jha|215-898-8011|apjha@psych.upenn.edu|
22388882|NCT05104242|University Hospitals of Derby & Burton NHS Foundation Trust, Royal Derby Hospital|Catherine Johnson|01332 789354|catherine.johnson16@nhs.net|
22388883|NCT05756647|Washington University, Department of Otolaryngology - Head and Neck Surgery|Jay F. Piccirillo, MD|314-362-8641|piccirj@wustl.edu|
22388884|NCT02469155|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646-440-9333|ITCIClinicalTrials@itci-inc.com|
22452507|NCT02014116|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22388885|NCT02991118|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
22414686|NCT00629122|Weill Cornell Medical College|Meredith J. Aull, Pharm.D.|(212) 746-8720|mea9008@med.cornell.edu|
22414687|NCT02842853|Sanofi Pasteur Inc.|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22414688|NCT04089553|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22414689|NCT01798264|Intarcia|Michelle Braon|510-782-7800||
22414690|NCT02518945|State University of NY at Buffalo|Paresh Dandona|7165351852|dandona@buffalo.edu|
22414691|NCT04723693|Oxford university Hospitals NHS Foundation Trust|Simon Fletcher|01865 225316|simon.fletcher@ouh.nhs.uk|
22414692|NCT04342663|Washington University School of Medicine|Dr. Eric Lenze|314-362-5154|lenzee@wustl.edu|
22414693|NCT03366792|NYU Langone Health - Perlmutter Cancer Center|Samir S. Taneja, MD|(212) 263-6301|Samir.Taneja@nyulangone.org|
22414694|NCT01808651|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22414695|NCT00841542|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414696|NCT00924638|Medtronic, Inc.|Medtronic CRDM clinical trial manager|763-505-6000|medtronicCRMtrials@medtronic.com|
22414697|NCT01316055|Vice President - Clinical Development & Medical Affairs (CDMA)|Herbert Henney, PharmD|(914) 347-4300|hhenney@acorda.com|5138
22414698|NCT02992067|Zhejiang Cancer Hospital|Yu Xingfei|057188122001|yuxf1177@zjcc.org.cn|+86
22414699|NCT02679729|AstraZeneca AB|Global Clinical Leader|+46 766 346712|ClinicalTrialTransparency@astrazeneca.com|
22414700|NCT00075608|Boston Medical Center|Principal Investigator|617-638-8261|sfenness@bu.edu|
22414701|NCT00883233|Galderma|Jean-Charles Dhuin|+33492952921|jean-charles.dhuin@galderma.com|
22414702|NCT01442376|Helsinn Healthcare SA|Spinelli Tulla|+4191985 21 21|tulla.spinelli@helsinn.com|
22414703|NCT04404725|CooperVision, Inc|Jose Vega, OD, MSc, FAAO|9256213761|JVega2@coopervision.com|
22414704|NCT01075516|Department of Cardiology, San Filippo Neri Hospital - Rome|Dr. Renato P. Ricci||renatopietroricci@tin.it|
22414705|NCT00794547|University of Michigan Comprehensive Cancer Center|Dr. Nithya Ramnath|734-647-1417|nithyar@umich.edu|
22414706|NCT00674128|Mayo Clinic|Gregory Altemose MD|480-301-8000|altemose.gregory@mayo.edu|
22414707|NCT04631562|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1-855-752-2356|clinicaltrials@alexion.com|
22414708|NCT02687126|Shahid Gangalal National Heart Centre|Santosh Sharma Parajuli|+9779806532132|santoshparajuli77@hotmail.com|
22414709|NCT03503318|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22414710|NCT02319824|Fred Hutchinson Cancer Research Center|Seth Pollack|206-667-6629|spollack@fhcrc.org|
22414711|NCT02139826|Ixchelsis Limited|Chief Medical Officer|44(0)1227-832760|ian.osterloh@ixchelsis.com|
22414712|NCT01825798|Holland Bloorview Kids Rehabilition Hospital|Dr. Evdokia Anagnostou|416-753-6005|eanagnostou@hollandbloorview.ca|
22414713|NCT04171115|Resilience Government Services|Angie Kimbler|386-418-8751|angie.kimbler@resilience.com|
22431001|NCT02412436|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22431002|NCT01111552|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22388886|NCT02562521|Yale University School of Medicine|Dr. Krysten Bold|2039747603|krysten.bold@yale.edu|
22388887|NCT03400748|Spiration, Inc.|Lauri DeVore|425-636-5464|lauri.devore@olympus.com|
22388888|NCT01469585|University of Hawaii|Investigator|808-203-6500|blissk@hawaii.edu|
22388889|NCT02428595|Pelvalon|Clinical Management|650-276-0130|steve@pelvalon.com|
22388890|NCT02627794|Cedars-Sinai Medical Center|Dr. Martin L. Hopp|310-657-7704|marty@towerent.com|
22388891|NCT02764320|Mayo Clinic|Dr. Todd J. Schwedt|480-301-9443|Schwedt.Todd@mayo.edu|
22388892|NCT04765046|Medtronic|Ami Stuart|8017934800|ami.stuart@medtronic.com|
22388893|NCT01508117|University of Cincinnati|Alison Kastl|513-584-0436|kastla@ucmail.uc.edu|
22388894|NCT03150589|Samsung Bioepis Co., Ltd|Director of Clinical Trials|+82-32-728-0371|sbregistry@samsung.com|
22388895|NCT01405508|UCB Cares|UCB (Study Director)|+1 887 822 9493||
22388896|NCT03529942|Flexion Therapeutics, Inc.|David Golod, Vice President, Clinical Operations|(781) 305-7572|dgolod@flexiontherapeutics.com|
22388897|NCT02314000|Boston Scientific|Roshini Jain, Director of Clinical Sciences|6619494355|roshini.jain@bsci.com|
22388898|NCT00999336|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22388899|NCT01214109|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22388900|NCT00409747|NIH/NIMH/PDN Branch|Dr. Susan Swedo|301-496-5323|swedos@mail.nih.gov|
22388901|NCT03132571|Yale School of Medicine, Department of Psychiatry|Dr. Cenk Tek|(203) 974-7500|cenk.tek@yale.edu|
22388902|NCT01989156|Philip Morris Products S.A.|Christelle Haziza, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
22388903|NCT03839355|Mayo Clinic|Dr. Malini Madhavan|507-255-4152|Madhavan.Malini@mayo.edu|
22388904|NCT01297595|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22388905|NCT01794689|Johns Hopkins University|Dr. Michael T. Smith, PhD|410-550-7000|msmith62@jhmi.edu|
22388906|NCT01697956|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22388907|NCT03060525|University of Rochester|Dr. Steven Barnett|585-273-2548|steven_barnett@urmc.rochester.edu|
22388908|NCT01964547|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
22388909|NCT01115309|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
22388910|NCT04447287|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22388911|NCT05700851|University of Nottingham|Prof. Maarten Taal|01332224618|m.taal@nottingham.ac.uk|
22388912|NCT02147093|Johnson & Johnson Vision Care INC.|Tom Karkkainen, OD, MS, FAAO|904-443-3500|TKarkkai@its.jnj.com|3402
22388913|NCT03246724|Boston Medical Center|Marissa Fiorello, Clinical Research Manager|617-414-8848|Marissa.Fiorello@bmc.org|
22414714|NCT01559363|Kadmon, a Sanofi Company|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
22431003|NCT05135754|Coloplast A/S|Senior Clinical Strategy Project Manager|+4549111341|dkteaa@coloplast.com|
22388914|NCT00655824|GlaxoSmithKline|GSK Response Center|866-435-7343||
22431004|NCT00723632|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22388915|NCT02978716|G1 Therapeutics, Inc|Clinical Trial Info|+1 9192139835|clinicalinfo@g1therapeutics.com|
22388916|NCT00589628|Duke Health Systems|Dr. C. Egla Rabinovich|919-668-0238|egla.rabinovich@duke.edu|
22388917|NCT01922102|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22388918|NCT05203822|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22388919|NCT00365599|H. Lee Moffitt Cancer Center and Research Institute|Susan Minton, D.O.|813-745-3806|susan.minton@moffitt.org|
22388920|NCT04343989|NYU Langone Health|Bonnie Lonze, MD, PhD|212-263-3865|bonnie.lonze@nyulangone.org|
22388921|NCT04077437|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
22388922|NCT01816165|University of Colorado Denver|Irene Schauer, MD|3037241111|clinicaresearchsupportcenter@ucdenver.edu|
22388923|NCT00447499|Ipsen|Bert Bakker, MD, PhD.|+1 650 238 1669|bert.bakker@ipsen.com|
22388924|NCT05087849|UCSF|Ayan Kusari|4153537800|ayan.kusari@ucsf.edu|
22388925|NCT02092909|Idera Pharmaceuticals|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
22388926|NCT02865083|Saint Louis University|Jennifer Goldkamp, MD|314-977-2574|jgolka2@slu.edu|
22388927|NCT00096278|NSABP Foundation, Inc.|Director, Division of Regulatory Affairs|412-330-4600||
22388928|NCT02105688|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22388929|NCT00329771|Doylestown Hospital, Pennsylvania|Abraham A. Ashkenazi, M.D./Principal Investigator|215-625-2894|aashkenzai2001@yahoo.com|
22388930|NCT02010021|Dartmouth-Hitchcock Medical Center and Norris Cotton Cancer Center|Gary N. Schwartz, MD|(603) 653-6181|gary.n.schwartz@hitchcock.org|
22388931|NCT00887471|SUNY Downsate Medical Center|Nira A Goldstein, MD|718-270-1638|ngoldstein@downstate.edu|
22401504|NCT00318708|Penn State Hershey College of Medicine|Vernon M. Chinchilli, PhD|717-531-4262|vchinchi@psu.edu|
22401505|NCT00537823|Washington University School of Medicine|David Linehan, M.D.||David_Linehan@URMC.Rochester.edu|
22401506|NCT03455543|Regenesis Biomedical|Heather Vander Ploeg|602-428-7041|heather.vanderploeg@regenesisbio.com|
22401507|NCT04382651|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22401508|NCT02612077|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22401509|NCT01753518|Mayo Clinic|Dr. Margaret Dow|507-266-8008|dow.margaret@mayo.edu|
22401510|NCT00940342|The University of Texas MD Anderson Cancer Center|Alessandra Ferrajoli, MD/Professor|713-792-7734|CR_Study_Registration@mdanderson.org|
22401511|NCT01950078|Huazhong University of Science and Technology|Dr. Xianwei Zhang|027 83663173|znpin@sina.cn|
22401512|NCT03249350|Oregon Social Learning Center|Dr. Mike McCart|541-485-2711|MikeM@oslc.org|
22401513|NCT01716169|Stanford School of Medicine|Dr. Alfred Lane|650 721 7166|atlane@stanford.edu|
22401514|NCT00553787|Vivus, Inc|Wesley W Day PhD|650-934-5200|day@vivus.com|
22401515|NCT00466752|University of Washington / Seattle Cancer Care Alliance|Evan Yu|206-288-1152|evanyu@u.washington.edu|
22401516|NCT05121103|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22401517|NCT00514449|Western Psychiatric Institute and Clinic|Dr. Konasale Prasad|412-586-9014|prasadkm@upmc.edu|
22401518|NCT04083144|Centre for Addiction and Mental Health|Dr. Bernard Le Foll|4165358501|bernard.lefoll@camh.ca|33111
22401519|NCT02101008|Huntsman Cancer Institute|Kenneth Grossmann|801-587-4289|kenneth.grossmann@hci.utah.edu|
22401520|NCT01363843|BrUOG|William Sikov, MD and Kimberly Perez, MD|4018633000|kayla_rosati@brown.edu|
22452508|NCT01491854|Novartis Pharma AG|Study Director|862-778-8300|novartis.email@novartis.com|
22452509|NCT02212574|Johns Hopkins University|Dr. Kenneth Cohen|(410) 614-5055|kcohen@jhmi.edu|
22381075|NCT02655653|Montefiore Medical Centr|Dr. Jonathan Leff|7189205409|jleff@montefiore.org|
22401521|NCT02830165|University of California at Los Angeles, David Geffin School of Medicine, Radiation Oncology|Nicholas Nickols, MD|310 825-8278|nnickols@mednet.ucla.edu|50472
22401522|NCT02708212|Evergreen General Hospital|Dr. Chiliang Cheng|+886-3-4631230|chiliang.cheng@gmail.com|
22401523|NCT02694029|UT Southwestern Medical Center|Asal Rahimi, MD|214/645-8556|Asal.Rahimi@UTSouthwestern.edu|
22401524|NCT00301067|Northwestern University|Clinical Trials Office|312-695-1301||
22401525|NCT00149825|Stanford University, School of Medicine|Rachel Manber, PhD|650-724-2377|Rmanber@stanford.edu|
22401526|NCT05897853|Hospital of Ludwig Maximilians University, Munich|Prof. Dr. Michael Strupp|+49 894400|Michael.Strupp@med.uni-muenchen.de|76980
22401527|NCT02609399|Johns Hopkins University|Dr. Richard Rothman|410-735-6428|rrothma1@jhmi.edu|
22401528|NCT04458857|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
22401529|NCT01811030|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22401530|NCT00853905|Wills Eye Hospital Glaucoma Research Center|Marlene Moster MD|215-825-4713|jmolineaux@willseye.org|
22401531|NCT01748695|Brigham and Women's Hospital|Dr. Christine N. Sang, Director of Translational Pain Research|617-525-7246|csang@partners.org|
22401532|NCT00847561|The Johns Hopkins University School of Medicine|Dr. Golda Ginsburg|410-955-1544|gginsbu@jhmi.edu|
22401533|NCT01333189|University of Colorado, Denver|Cory L Christiansen, PT, PhD|303-724-9101|cory.christiansen@ucdenver.edu|
22401534|NCT02312986|Washington University in St. Louis|Kimberly Reske, MPH, Research Coordinator|314-747-4041|kreske@wustl.edu|
22401535|NCT01739595|Repros Therapeutics Inc|Jennifer Wike|2817193402|jwike@reprosrx.com|
22401536|NCT01050660|Yale University|Dr. Orly Levit|203-688-2320|orly.levit@yale.edu|
22401537|NCT02088216|Qilu Hospital of Shandong University|Yu Li|13791122770|qlliyu@163.com|
22401538|NCT04661813|University of Washington|Dr. Chris Longenecker|2066161159|ctlongen@uw.edu|
22401539|NCT04285723|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22401540|NCT00778999|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22401541|NCT02032524|Sanofi-Aventis Recherche & Developpement|Trial Transparency Team|800-633-1610|contact-us@sanofi.com|6#
22401542|NCT04224987|UCSF Proctor foundation|Dr Thomas Lietman|4154761442|tom.lietman@ucsf.edu|
22401543|NCT02903511|"University of Colorado Denver | Anschutz"|Godela Brosnahan, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
22401544|NCT00969618|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22401545|NCT01089725|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22401546|NCT03191396|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22401547|NCT01240811|University of Pittsburgh|Sharon Achilles, MD, PhD|412-641-1403|achisx@upmc.edu|
22401548|NCT02898207|Dana-Farber Cancer Institute|Dr. Panagiotis Konstantinopoulos|617-632-5269|Panagiotis_Konstantinopoulos@dfci.harvard.edu|
22401549|NCT03990766|Washington University School of Medicine|Dr. Jake Lee|3143937248|jakejlee@wustl.edu|
22401550|NCT03726671|University of North Carolina at Chapel Hill|Julie M. Stegall, MSW|704-250-5048|julie_stegall@unc.edu|
22401551|NCT04192448|Eastern Michigan University|Elizabeth Neilson|734-487-4988|eneilso1@emich.edu|
22401552|NCT01853228|Janssen Research & Development, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22401553|NCT00435539|ThromboGenics|Petra Kozma-Wiebe, MD|+32 16751310|petra.kozma@thrombogenics.com|
22401554|NCT02114203|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22401555|NCT01518699|Dr. Reddy's Laboratories Inc.|Dr Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
22401556|NCT02110108|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22401557|NCT01300286|Duke University Medical Center|Dr. Ian Welsby|919-668-2699|ian.welsby@duke.edu|
22401558|NCT03635190|Cardio Flow, Inc.|Michael J Kallok, PhD|16512531754|mjkallok@cardioflow.net|
22401559|NCT03692910|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22401560|NCT01997567|Rush University Medical Center Department of Anesthesiology|Sandeep Amin, M.D|312-942-6449|Sandeep_Amin@rush.edu|
22401561|NCT01322607|Baltimore VA Medical Center (VAHMCS)|Research Specilist|410-605-7156|alyssa.stookey@va.gov|
22401562|NCT00486226|Codman&Shurtleff|Arnaud Nicolas|+33 0 155 004 543|anicolas@its.jnj.com|
22401563|NCT01259492|Novartis Pharmaceuticals|Study Director|8627788300||
22401564|NCT01856491|Boston Scientific|Anneleen Viville|0032479983495|anneleen.viville@bsci.com|
22401565|NCT02123017|Cumberland Pharmaceuticals, Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com|
22401566|NCT03042611|Elevar Therapeutics, Inc|Elevar Clinical Trials|(801) 303-7440|info-clinicalstudy@elevartherapeutics.com|
22401567|NCT00474630|Orexigen Therapeutics, Inc.|Senior Vice President, Head of Global Development|(858) 875-8600|MedInfo@Orexigen.com|
22401568|NCT02740153|Children's National Medical Center|Dr. Nicholas Ah Mew|202-476-5863|nahmew@childrensnational.org|
22401569|NCT02397655|Xuanwu hospital, Capital medical university|Dr. Yang Hua|86-10-83198923|dryanghua99@163.com|
22401570|NCT03321617|New York State Psychiatric Institute|Ragy Girgis, MD|646-774-5553|ragy.girgis@nyspi.columbia.edu|
22401571|NCT01048125|University of Missouri-Columbia|Dr. Anand Chockalingam|573/882-2296|chockalingama@health.missouri.edu|
22401572|NCT03735095|Roswell Park Comprehensive Cancer Center|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
22401573|NCT00591227|Rush University Medical Center|David Baldwin MD|312-942-6163|david_baldwin@rush.edu|
22401574|NCT02345369|Bassett Medical Center|clinical research nurse supervisor|6075476965|jennifer.victory@bassett.org|
22401575|NCT03897712|Bausch & Lomb|Johnson Varughese|9089271162|Johnson.Varughese@bauschhealth.com|
22401576|NCT00545818|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
22401577|NCT02623361|UCSF|Matthias Behrends, PI|415 476 3761|matthias.behrends@ucsf.edu|
22401578|NCT00611455|GlaxoSmithKline|GSK Response Center|866-435-7343||
22401579|NCT03671369|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22401580|NCT02732912|Oxford Brookes University|Dr Derick Wade|+447818452133|derick.wade@ntlworld.com|
22401581|NCT02235285|The Department of Plastic Surgery, Winners Clinic|Dr. Cheol Hwan Kim|.+82.2.511.9446|winners511@naver.com|
22401582|NCT03134963|University of Leicester|Dr Lucy Beishon|0116252|lb330@le.ac.uk|3134
22401583|NCT01507545|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22401584|NCT01873742|Modum Bad Research Institute|Dr. Terje Tilden|+4732749869|tilden@modum-bad.no|
22401585|NCT03739983|University of Wisconsin Carbone Cancer Center|Ryan Spencer, MD, MS|608-265-1700|rjspencer2@wisc.edu|
22414715|NCT00112437|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22414716|NCT00659828|University of Miami|Richard Bookman|305-243-0494|y.p.davis@med.miami.edu|
22414717|NCT01824576|Advanced Circulatory|Sr. Clinical Research Associate|651.403.5606|nburkhart@zoll.com|
22414718|NCT03703258|University of Washington School of Medicine|Dr. Emily R. Dworkin|206-221-6932|edworkin@uw.edu|
22414719|NCT00351039|Fox Chase Cancer Center (formerly at H. Lee Moffitt Cancer Center & Research Institute)|George Simon, M.D.|215-728-2509|george.simon@fccc.edu|
22414720|NCT01125163|UTexas_Houston|Dr. Kathleen A. Kennedy|713-500-6708|Kathleen.A.Kennedy@uth.tmc.edu|
22414721|NCT03218787|Abbott|Lijuan Jenn Wang, Advisor, Clinical Affairs|01-408-8453133|Lijuan.wang1@abbott.com|
22414722|NCT02896296|Indivior, Inc.|Global Director, Clinical Development|804-379-1090|Robert.Bauer@Indivior.com|
22414723|NCT02463487|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
22414724|NCT01120028|University of Oxford|Prof Peter Friend|01865223872|ccc@ctsu.ox.ac.uk|
22414725|NCT04633564|Mylan GmbH|Keri Vaughan, Senior Director|+215.280.2846|keri.vaughan@viatris.com|
22414726|NCT01279486|SPD Swiss Precision Diagnostics GmbH/SPD Development Company Ltd|Dr Sarah Johnson, Head of Clinical and Regulatory Affairs|01234835486|sarah.johnson@spdspark.com|
22414727|NCT04198363|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22414728|NCT05344118|Nationwide Children's Hospital|Dr. Joseph D Tobias|614-722-4200|joseph.tobias@nationwidechildrens.org|
22414729|NCT00640341|Bausch & Lomb Incorporated|Gerard Cairns|(585) 338-5170|gerard.cairns@bausch.com|
22414730|NCT01251393|Universidade Federal de São Paulo|PhD José Carlos F. Galduróz||galduroz@unifesp.br|
22414731|NCT01541215|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22414732|NCT03232736|University of Colorado Anschutz Medical Campus|William Cornwell|16142961686|william.cornwell@ucdenver.edu|
22414733|NCT00521586|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22414734|NCT00529763|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22414735|NCT03669250|Cerevance|Michelle Charles, Executive Director Regulatory Affairs|(408) 220-5722|michelle.charles@cerevance.com|
22414736|NCT00828321|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414737|NCT03390257|SF Otolaryngology|Dr. Jacob Johnson|4153625443|jjohnson@sfotomed.com|
22414738|NCT00691704|Duke University Medical Center|Cristina Gasparetto, MD|919-668-1017|cristina.gasparetto@duke.edu|
22414739|NCT01993186|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
22414740|NCT02451696|NYU Langone|Dr. Orrin Devinsky|646-558-0800|od4@nyu.edu|
22414741|NCT00198133|IndianaU|Patrick J. Loehrer, Sr., M.D.|(317)944-0920|ploehrer@iu.edu|
22414742|NCT01557751|University of Pittsburgh Medical Center (UPMC)|Dr. Jacques Chelly, MD, PHD MBA|412-623-6382|chelje@anes.upmc.edu|
22414743|NCT02752074|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
22414744|NCT00840216|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22452510|NCT02162420|Masonic Cancer Center|Christen Ebens, MD, MPH|612-624-4511|ebens012@umn.edu|
22452511|NCT04738643|University of Pennsylvania|Robert Schnoll, PhD|215-746-7143|schnoll@pennmedicine.upenn.edu|
22401586|NCT00790296|University of Connecticut Health Center|Andrew Winokur MD PhD|860-679-6775|awinokur@uchc.edu|
22401587|NCT01971476|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22401588|NCT04901507|Virginia Commonwealth University School of Dentistry|Dr. Caroline Carrico|804-828-8328|ckcarrico@vcu.edu|
22388932|NCT01597856|VA Connecticut/ Yale University|Christina Lazar|203-932-5711|Christina.Lazar@Yale.edu|4833
22388933|NCT02959866|St. Michael's Hospital|Anne Rucchetto, Research Coordinator|416-864-6060|rucchettoa@smh.ca|76155
22388934|NCT04463004|Virginia Commonwealth University|Antonio Abbate, MD, PhD|804-628-1215|antonio.abbate@vcuhealth.org|
22388935|NCT05866887|Dana-Farber Cancer Institute|Maimouna Oumar|617-632-3000|maimouna_sy@dfci.harvard.edu|
22388936|NCT03541369|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22388937|NCT01856569|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22388938|NCT00696241|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22388939|NCT01613599|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22388940|NCT01107795|University of Alabama at Birmingham|Dr. Kirk Withrow|(205) 801-7874|kwithrow@uabmc.edu|
22388941|NCT00762853|Colgate Palmolive Co.|William Devizio|732-878-7901|William_Devizio@colpal.com|
22388942|NCT01894503|Intersect ENT, Inc.|James Stambaugh, Vice President of Clinical & Medical Affairs|650-641-2103|jstambaugh@intersectent.com|
22388943|NCT04749797|University of Pennsylvania|Timothy Lucas|(215) 662-3487|Timothy.Lucas@pennmedicine.upenn.edu|
22388944|NCT02513667|UT Southwestern Medical Center|Dr. Sawsan Rashdan|214-648-4180|Sawsan.Rashdan@UTSouthwestern.edu|
22388945|NCT02429115|Penn State College of Medicine - Penn State Health|Nasrollah Ghahramani|7175318156|nghahramani@pennstatehealth.psu.edu|
22388946|NCT02417376|GCD Indore|Dr Divya Singh Hada|+918720898289|dr_dshada@yahoo.com|
22388947|NCT00871715|University of Southern California|Carolee Winstein, Principal Investigator|3234422903|winstein@usc.edu|
22388948|NCT01047709|University of Michigan|Devin Brown, MD|7349369075|devinb@umich.edu|
22388949|NCT02291549|Intersect ENT, Inc.|James Stambaugh, Vice President of Clinical & Medical Affairs|650-641-2103|jstambaugh@intersectent.com|
22388950|NCT00537914|Sandoz|Clinical Disclosure Representative|+4980249080|sandoz.disclosure@sandoz.com|
22388951|NCT01180959|UT MD Anderson Cancer Center|Dr. Ahmed Kaseb, MD- Professor, GI Medical Oncology|(713) 792-2828|akaseb@mdanderson.org|
22388952|NCT00613405|Medical University of South Carolina|Aimee McRae-Clark, PharmD|843-792-5126|mcraeal@musc.edu|
22388953|NCT01862159|Region Örebro län, Sweden AND Örebro University, Sweden|Dr Erik Stenberg|+46196021000|erik.stenberg@regionorebrolan.se|
22388954|NCT00507767|MD Anderson Cancer Center|Dr. Vassiliki Papadimitrakopoulou, Professor|713-792-6363|vpapadim@mdanderson.org|
22388955|NCT00663819|CMU College of Medicine|Dr. Anthony Senagore|989-790-1001|anthony.senagore@cmich.edu|
22388956|NCT02302157|Lineage|Avi Ben Shabat, MD|+972-509105205|avi@cellcure.co.il|
22388957|NCT01502813|University of Utah, Diagnostic Neuroimaging Lab|Deborah Yurgelun-Todd, Ph.D.|801-587-1538|Deborah.Yurgelun-Todd@hsc.utah.edu|
22431005|NCT00373360|United Therapeutics Corporation|Rex Mauthe; Senior Director, Regulatory Affairs|919-485-8350|rmauthe@unither.com|
22452512|NCT05545072|Emory University|Thomas S Edwards, MD Assistant Professor, Rhinology and Skull Base Surgery Division|4045017710|thomas.edwards@emory.edu|
22452513|NCT02395042|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22452514|NCT03638141|Sidney Kimmel Comprehensive Center|Ana De Jesus-Acosta|4432870411|adejesu1@jh.edu|
22452515|NCT03996473|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22452516|NCT03759873|University of Texas Medical Branch, Division of Cardiovascular Medicine|Dr. Diann Gaalema|409-772-1533|digaalem@utmb.edu|
22452517|NCT05725005|Asceneuron SA|Asceneuron Clinical Research|+ 41 21 353 8245|clinicaltrials.gov@asceneuron.com|
22452518|NCT03579563|The University of Iowa|Dr. Yu-Hsiang Wu|319-3359758|yu-hsiang-wu@uiowa.edu|
22452519|NCT03621696|Washington University School of Medicine|Douglas Adkins, M.D.|314-747-8475|dadkins@wustl.edu|
22452520|NCT01910519|Emory University|Nadine Rouphael MD|404-712-1435|nroupha@emory.edu|
22452521|NCT03006328|NYU Langone Health|Sandra Wittleder, PhD|212-263-4149|sandra.wittleder@nyulangone.org|
22452522|NCT02720484|Northwestern University|Devalingam Mahalingam|312.472.0564|mahalingam@northwestern.edu;|
22452523|NCT00105027|The EMMES Corporation|Paul C. VanVeldhuisen, Ph.D.|301-251-1161|score@emmes.com|
22452524|NCT01778465|Western University|Clinical Trials Program Coordinator|+15196466100|taciano.rocha@sjhc.london.on.ca|61125
22452525|NCT03832946|Galecto Biotech aps|Hans Schambye - Chief Executive Officer|+4526373726|info@galecto.com|
22452526|NCT05244525|The University of Texas Health Science Center at Houston|James M. Gregory, MD|(713) 486-7500|James.M.Gregory@uth.tmc.edu|
22452527|NCT01003249|Wake Forest University Health Sciences|Dr. Gopal Badlani|3367165928|gbadlani@wakehealth.edu|
22401589|NCT03246074|SKCCC at Johns Hopkins|Stephanie Gaillard, MD PhD|410-955-3774|stephanie.gaillard@jhmi.edu|
22452528|NCT02467777|Fox Valley Orthopaedic Institute|Vishal Mehta|6305841400|vmehta@fvortho.com|
22452529|NCT02276482|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22452530|NCT00450424|Fox Chase Cancer Center|Kristen Sorice|215-214-1433|Kristen.Sorice@fccc.edu|
22452531|NCT01154634|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com|
22452532|NCT02005471|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22452533|NCT03431168|UAB|Dr. Jodie Dionne|2059756530|jdionne@uabmc.edu|
22452534|NCT01592643|Stanford University School of Medcine|Edward E. Manche|6507255765|edward.manche@stanford.edu|
22452535|NCT03712917|Ataturk University|Mustafa Ceylan|+905062773216|drmuson16@hotmail.com|
22452536|NCT00110617|Novartis Pharmaceuticals|Study Director|862-778-8300||
22401590|NCT03368898|bakirkoy dr sadi konuk training and research hospital|İsmail Alay|+905462375638|dr_ismailalay@hotmail.com|
22401591|NCT01457339|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22401592|NCT00995371|Coastal Orthopedics & Sports Medicine|Lois A. Davis|941-782-1353|ldavis@coastalorthopedics.com|
22401593|NCT00306891|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22401594|NCT00673673|Yale University|Dr. Jill Lacy|203-737-1600|jill.lacy@yale.edu|
22401595|NCT02514070|National Heart Lung and Blood Institute (NHLBI)|Marcelo J. Amar, M.D. Principal Investigator, NIH, NHLBI|301-402-0521|mamar@nhlbi.nih.gov|
22431006|NCT02679274|University of Texas Medical Branch|Dr. Edgar L. Dillon|409 772 8701|eldillon@utmb.edu|
22452537|NCT02657226|The University of Pittsburgh|Dr. John Kellum|4123834202|kas287@pitt.edu|
22388958|NCT00725959|Colorado School of Public Health|Dr. Sheana Bull|303-724-1238||
22388959|NCT02189759|University of Alabama at Birmingham|Manimaran Ramani|2054731425|mramani@peds.uab.edu|
22388960|NCT03032198|Seno Medical, Inc.|Shaan Schaeffer|6106983259|sschaeffer@senomedical.com|
22388961|NCT02470806|Smith & Nephew, Inc.|Natasha Schappell, CCRP|817-302-3949|natasha.schappell@smith-nephew.com|
22388962|NCT01147471|Virginia Commonwealth University|Ajai K Malhotra, MD|804-827-2409|akmalhot@mcvh-vcu.edu|
22388963|NCT00866619|GlaxoSmithKline|GSK Response Center|866-435-7343||
22388964|NCT02579915|McLean Hospital|Courtney Beard|16178553557|CBEARD@MCLEAN.HARVARD.EDU|
22388965|NCT05062343|Brigham and Women's Hospital|Sarah Little|6174557372|selittle@bwh.harvard.edu|
22388966|NCT01138969|KaohsiungVGH|Dr. Ping-I Hsu|886-7-3462121|pihsu@isca.vghks.gov.tw|8233
22388967|NCT01307800|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22388968|NCT02892019|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22388969|NCT00689351|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com|
22388970|NCT01766206|GlaxoSmithKline|GSK Response Center|866-435-7343|sss42438@gsk.com|
22388971|NCT01662505|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22388972|NCT01313663|GlaxoSmithKline|GSK Response Center|866-435-7343||
22388973|NCT01229176|Novartis Vaccines Institute for Global Health|Dr. Audino Podda|+39 0577 243496|audino.podda@novartis.com|
22388974|NCT03020498|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
22388975|NCT03890484|University of Washington|Dr. Jessica Canning|206.221.4430|jrcannin@uw.edu|
22388976|NCT00780741|Jaeb Center for Health Research|Ray Kraker, Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
22388977|NCT00518206|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22414745|NCT03276754|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22388978|NCT03075878|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22388979|NCT02188459|University of Pennsylvania Perelman School of Medicine|Henry R. Kranzler, M.D.|215-386-6662|kranzler@pennmedicine.upenn.edu|
22388980|NCT04348357|Texas Tech University Health and Science Center El Paso|Dr Steven Radtke|2177254940|dr.radtke@gmail.com|
22388981|NCT00623714|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22388982|NCT02367794|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22388983|NCT01986348|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
22388984|NCT02612285|Esanex Inc|Eric Orlemans PhD||eorlemans@esanexpharma.com|
22388985|NCT02010684|University of California Los Angeles|Dr. Jeanne Miranda|310-794-3710|mirandaj@ucla.edu|
22388986|NCT00805441|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22388987|NCT02399111|Northwell Health System|Dr. Kambhampaty Krishnasastry|516-233-3643|kkrishna@northwell.edu|
22388988|NCT05379400|NYU Langone Health|Sharine Wittkopp|646-501-7733|Sharine.Wittkopp@nyulangone.org|
22388989|NCT05356130|Kaiser Permanente Center for Health Research|Greg Clarke, PhD|503-335-2400|greg.clarke@kpchr.org|
22388990|NCT04851587|University of Florida|Emily Bartley|352-273-8934|EBartley@dental.ufl.edu|
22388991|NCT02680314|Montefiore Medical Center|Peter Bernstein, MD|718-904-2767|pbernste@montefiore.org|
22388992|NCT04820023|Bridge Biotherapeutics, Inc.|Clinical Trial Lead|+82-31-8092-3280|Clinicaltrials.gov_inquiries@bridgebiorx.com|
22388993|NCT01020487|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22388994|NCT02240810|Boston Scientific|Director, Clinical Trials|508-683-6678|peter.maurer@bsci.com|
22388995|NCT02802176|University of California, San Francisco|Marcelle Cedars, MD, Director, Division of Reproductive Endocrinology|(415) 353-7475|Marcelle.Cedars@ucsf.edu|
22388996|NCT04714359|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
22388997|NCT01330953|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22388998|NCT02109172|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
22388999|NCT01279447|Northwestern|Lawrence Hsu, MD|312 9262000|larryphsu@gmail.com|
22389000|NCT03360071|John Hopkins University School of Medicine|Jody Tversky, MD|410-550-2300|hoddin1@jhmi.edu|
22389001|NCT00830284|Boston Children's Hospital|John Kheir|6179194712|john.kheir@childrens.harvard.edu|
22389002|NCT01383616|Hospital for Special Surgery|Brian Rebolledo, MD|212-606-1172|rebolledob@hss.edu|
22389003|NCT00896389|University of Maryland, Baltimore|Dr. Yen Pei Christy Chang|410-706-6737|cchang@som.umaryland.edu|
22389004|NCT01493947|Galderma R&D|Galderma CPM|00 33 4 93 95 70 70|clinicaltrials@galderma.com|
22401596|NCT01462292|GlaxoSmithKline|GSK Response Center|866-435-7343||
22389005|NCT01074437|Seattle childrens research institute|Jonathan Perkins, Prinicipal Investigator|206-987-1927|jonathan.perkins@seattlechildrens.org|
22389006|NCT03184519|IVIValencia|LAURA CARACENA (STUDY COORDINATOR)|034 963050900|laura.caracena@ivirma.com|
22389007|NCT02755948|Imperial College London|Professor Christopher Chiu|(0)20 8383 2301|c.chiu@imperial.ac.uk|
22389008|NCT02823574|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.gov|
22389009|NCT00590759|W. L. Gore and Associates, Inc.|Robert Makowsky|6232345784|rmakowsk@wlgore.com|
22389010|NCT01580306|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22452538|NCT03230916|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22389011|NCT00901459|Duke Center for Nicotine and Smoking Cessation Research|Jed E. Rose, Ph.D.|919-668-5055|jed.rose@mc.duke.edu|
22389012|NCT01532830|electroCore LLC|Clinical Affairs|+1 973 355 6683|clinical@electrocore.com|
22389013|NCT02465632|Glenmark Pharmaceuticals Ltd|Cathy Tyrrell|91 2267720000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
22401597|NCT02333045|Emory University|Anandi Sheth, MD|404-616-6240|ansheth@emory.edu|
22452539|NCT01438541|Molnlycke Health Care AB|Tina Kjellén|+46317223098|tina.kjellen@molnlycke.com|
22452540|NCT02091167|Federal University of Espírito Santo|Dr. Ester Miyuki Nakamura-Palacios, Coordinator of Clinical Trials|+55 27 3335-7337|emnpalacios@gmail.com|
22452541|NCT04198662|University of California, San Diego|Brian M. Ilfeld, MD, MS|(858) 822-0776|bilfeld@health.ucsd.edu|
22452542|NCT02345031|Autifony Therapeutics Ltd|Clinical Project Manager|+44 1438 906860|info@autifony.com|
22452543|NCT02062359|National Cancer Institute|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
22452544|NCT01002872|Northshore University Healthsystem|Dr Stuart Sprague|847-570-1761|ssprague@northshore.org|
22452545|NCT01559844|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22452546|NCT02181803|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22452547|NCT00951041|GlaxoSmithKline|GSK Response Center|866-435-7343||
22452548|NCT05645354|The University of Texas Health Science Center at Houston|Irene Tami-Maury, DMD,MSc,DrPH-NHSN|713-500-9234|Irene.M.Tami-Maury@uth.tmc.edu|
22452549|NCT01578993|Semprus BioSciences|Ulla Wallin, Director of Clinical Research|1-617-577-2205|ulla.wallin@semprusbio.com|
22452550|NCT02388724|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22452551|NCT04786444|Valneva Austria GmbH|Clinical Strategy Manager|+43 1 206 20|office@valneva.com|0
22452552|NCT03166618|Allergan Sales LLC|Therapeutic Area Head|877-277-8566|IR-CTRegistration@allergan.com|
22452553|NCT00798720|University of Wisconsin|Abigail Mapes, Thoracic Oncology Research Program Manager|(608) 262-8158|acmapes@medicine.wisc.edu|
22452554|NCT03137303|University of Illinois at Chicago|Min J. Joo, MD MPH|312-996-8039|joo@uic.edu|
22452555|NCT01217073|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22452556|NCT03561090|Ironwood Pharmaceuticals, Inc.|Ironwood Study Chair|(617) 621-7722|Info@ironwoodpharma.com|
22452557|NCT00373399|New York State Psychiatric Institute|Margaret Haney|646-774-6153|mh235@cumc.columbia.edu|
22452558|NCT00725452|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22452559|NCT00324870|Johns Hopkins University|Michael Carducci, MD|410-614-6337|carducci@jhmi.edu|
22452560|NCT00713648|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22452561|NCT02047045|Guang'anmen Hospital, China Academy Chinese Medical Sciences|Zhishun Liu|+86 010 88002331|liuzhishun@aliyun.com|
22452562|NCT00546728|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu|
22452563|NCT01343368|Masonic Cancer Center, University of Minnesota|Dr. Angela Smith|612-626-8094|smith719@umn.edu|
22452564|NCT02277106|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
22452565|NCT02479412|AstraZeneca AB|Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
22452566|NCT01571362|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22452567|NCT03667053|Zealand Pharma A/S|Dr Kim Mark Knudsen|+4550603780|KMKnudsen@zealandpharma.com|
22452568|NCT01877538|Department of Nuclear Medicine & PET Center, Aarhus University Hospital|Dr. Per Borghammer|+0045 23818581|perborgh@rm.dk|
22452569|NCT00130533|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
22452570|NCT01059565|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22452571|NCT02732938|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22452572|NCT02898974|Colorado State University|Manager of Research Operations|9704912242|Laurie.Biela@colostate.edu|
22452573|NCT02703350|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22452574|NCT01026974|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22452575|NCT00303966|University of Chicago|Dr. Wendy Stock|773-834-8982|wstock@medicine.bsd.uchicago.edu|
22452576|NCT02297308|Terumo Medical Corporation|Robert Gash, Director of Clinical Affairs|732-302-4931|robert.gash@terumomedical.com|
22452577|NCT01631630|National Institute on Alcohol Abuse and Alcoholism|Diazgranados, Nancy|+1 301 435 9386|nancy.diazgranados@nih.gov|
22452578|NCT01981564|Johns Hopkins University School of Medicine, Department of Pediatrics|Dr. Arlene Butz|410-614-5963|abutz@jhmi.edu|
22452579|NCT02864082|Timber Pharmaceuticals|Alan Mendelsohn, MD|2673004249|amendelsohn@timberpharma.com|
22452580|NCT04349553|Prokarium|Kristen Albright|+44 (0) 7375 124 275|kristen.albright@prokarium.com|
22452581|NCT03256162|Trinity College Dublin|Dr Bronagh Gallagher|01 249|bgallag@tcd.ie|3200
22452582|NCT01869491|Reckitt Benckiser|Clinical Data Controller||clinicaldatacontroller@reckitt.com|
22452583|NCT05177770|Coherus BioSciences|Allison Intondi, Vice President, Clinical Operations|800-794-5434|ClinicalTrials@Coherus.com|
22452584|NCT00233493|University Hospitals Cleveland Medical Center Center for Medical Mycology|Dr. Mahmoud Ghannoum|216-844-8580|Mahmoud.Ghannoum@case.edu|
22389014|NCT04791917|University of Florida Department of Clinical and Health Psychology|Jeff Boissoneault, PhD|352-273-6200|jboissoneault@phhp.ufl.edu|
22389015|NCT00910871|Janssen Infectious Diseases - Diagnostics BVBA|Medical Leader|1 609 730-7768||
22389016|NCT00850993|Mallinckrodt Pharmaceuticals|Medical Information Call Center|1-800-844-2830|clinicaltrials@mnk.com|5
22389017|NCT00349713|University of Bamako|Mahamadou A. Thera, MD, MPH, Professor|223-20-22-81-09|mthera@icermaili.org|
22389018|NCT03032965|University of Michigan|Hamid Ghanbari|734-963-7141|ghhamid@med.umich.edu|
22389019|NCT00636168|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22389020|NCT01852175|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD-Associate Professor of Medicine Director, Cardiovascular Research|+1-904-244-3005|dominick.angiolillo@jax.ufl.edu|
22389021|NCT03816202|Integra LifeSciences|Andrew Tummon, Director, Global Clinical Trials|609-936-5490|andrew.tummon@integralife.com|
22389022|NCT04501614|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22389023|NCT04374435|University of California, Irvine|Anand Ganesan, MD, Professor|949-824-0606|aganesan@uci.edu|
22389024|NCT02555397|Henry Ford Health System|Shyam Nyati|734-272-1751|snyati1@hfhs.org|
22389025|NCT01842360|Inmunotek S.L|Miguel Casanovas|34691490175|mcasanovas@inmunotek.com|
22389026|NCT04529941|Cedars-Sinai Medical Center|Dr. Peng-Sheng Chen|310-967-2707|Peng-Sheng.Chen@cshs.org|
22389027|NCT03800602|Emory University|Olumide B. Gbolahan MBBS, MSc|404-778-0032|ogbolah@emory.edu|
22389028|NCT02971683|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22389029|NCT01005914|Oregon Health & Science University|Dr. Brandon Hayes-Lattin|503-494-1551|hayeslat@ohsu.edu|
22389030|NCT04206501|University of Rochester Medical Center|Spencer Z. Rosero, M.D.|5852752756|spencer_rosero@urmc.rochester.edu|
22389031|NCT01240785|Department of Obstetrics and Gynecology, Turku University Central Hospital|Dr Kristiina Tertti|+358 2 3130000|kristiina.tertti@tyks.fi|
22389032|NCT02066389|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22389033|NCT01468597|Medical University of Graz|Elisabeth Mahla, MD|0043 316 385 13027|elisabeth.mahla@medunigraz.at|
22389034|NCT00736502|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22389035|NCT04520321|Trefoil Therapeutics.com|Thomas M Tremblay, RN, BSN|4153053491|ttremblay@trefoiltherapeutics.com|
22389036|NCT02935894|USDA, ARS Western Human Nutrition Research Center|Dr. John W. Newman|530-752-1009|john.newman@ars.usda.gov|
22389037|NCT02033174|IiSGM|Dr Alvarez-Sala|+34 915868287|luisantonio.alvarezsala@salud.madrid.org|
22389038|NCT00853957|Novartis Pharmaceuticals|Study Director|862-778-8300||
22389039|NCT01884571|Emory University|Jonathan Glass, MD|404-727-3507|jglas03@emory.edu|
22389040|NCT01175980|Barbara Ann Karmanos Cancer Institute|Dr. Ulka N. Vaishampayan|313-576-8718|vaishamu@karmanos.org|
22389041|NCT01695044|Progenics Pharmaceuticals, Inc.|Dr. Vincent A. DiPippo|(646) 975-2502|vdipippo@progenics.com|
22389042|NCT01186809|Asst Papa Giovanni XXIII|Prof Alessandro Rambaldi|+390352673681|arambaldi@asst-pg23.it|
22389043|NCT04895085|University of Wisconsin School of Medicine and Public Health|Dr. Ryan Coller|608-263-9408|rcoller@pediatrics.wisc.edu|
22389044|NCT01303744|Cerespir|Richard Margolin|(646) 202-2562|rmargolin@cerespir.com|
22389045|NCT02591056|Regulatory Insight, Inc.|Elvira Cawthon, Clinical Consultant|615-712-9743|elvira@reginsight.com|
22389046|NCT01159600|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22389047|NCT04919499|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22389048|NCT00760877|Novartis|Study Director|862-778-8300||
22389049|NCT01612221|Huntsman Cancer Institute|Kimberlee Taylor|801-213-5673|Kimberlee.Taylor@hci.utah.edu|
22389050|NCT04413149|Peking Union Medical College Hospital|Dr. Shi Juhong|+86-13701178492|Shijh@pumch.cn|
22389051|NCT00676195|Stanford University School of Medicine|Antonio Hardan, MD|650-736-1235|hardanay@stanford.edu|
22389052|NCT01857362|Swedish Orphan Biovitrum|Dr Erik Brouwer, Medical Director|+4686972000|erik.brouwer@sobi.com|
22389053|NCT00090064|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
22389054|NCT03833934|Addario Lung Cancer Medical Institute (ALCMI)|Ericka Izzo, Clinical Project Manager|941-713-1225|eizzo@alcmi.org|
22389055|NCT05878990|Hackensack Meridian Health|Lisa Carter-Bawa, PhD, MPH, APRN, ANP-C, FAAN|2018803443|lisa.carterbawa@hmh-cdi.org|
22389056|NCT03605745|Boston Scientific|Kaitlyn Rainbow, Clinical Research Associate|952-930-6627|kat.rainbow@bsci.com|
22389057|NCT01074229|Northwestern University|Gildasio De Oliveira, MD|312-926-8373|g-jr@northwestern.edu|
22389058|NCT00584909|UAB|J. MIchael Straughn, MD|205-934-4986|Michael.Straughn@ccc.uab.edu|
22389059|NCT03436797|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
22414746|NCT00545792|Dana-Farber Cancer Institute|Akila N. Viswanathan, MD, MPH|617-732-6331|aviswanathan@lroc.harvard.edu|
22414747|NCT02891863|Boston Scientific CRM|Greg Voss|651-581-3068|gregory.voss@bsco.com|
22414748|NCT05041361|University of California, San Francisco|Ashley Mason, PhD|415 514 6820|ashley.mason@ucsf.edu|
22414749|NCT01642277|Loyola University Chicago, Microbiology and Immunology|Dr. Alan J. Wolfe|224-392-4002|awolfe@luc.edu|
22414750|NCT03679598|University of Alabama at Birmingham|Dr. James Wells|2059345555|LungHealth@uabmc.edu|
22414751|NCT01447017|Centre for Clinical Studies in Malmö|Dr. Pekka Koskinen|+46 (0)40 97 12 60|pekka@clsm.se|
22414752|NCT03317444|Tricida, Inc.|Medical Information|415-429-7800|medinfo@tricida.com|
22414753|NCT00918645|University of California, Davis|Data Manager|916-734-8381|nmahaffey@ucdavis.edu|
22414754|NCT05133180|Dompé farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22414755|NCT02157974|University of Colorado Anschutz Medical Campus|Melanie Cree-Green, PI|720-777-5743|melanie.green@childrenscolorado.org|
22414756|NCT04188392|Baylor College of Medicine|Melissa B Jones, MD|713-791-1414|melissa.jones2@bcm.edu|24747
22414757|NCT00216736|Joseph Epstein Centre for Emergency Medicine Research|Prof Anne-Maree Kelly|+61383456666|anne-maree.kelly@wh.org.au|
22414758|NCT02622386|University of Michigan|Johann Gudjonsson|(734) 615-4508|johanng@med.umich.edu|
22414759|NCT01528150|St. Jude Medical|Director Clinical Studies|+1 818 493 3648|aoza@sjm.com|
22414760|NCT00807495|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22414761|NCT05274763|Emory University|Dr. Jennifer Mascaro|404-727-4301|jmascar@emory.edu|
22414762|NCT01631552|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22414763|NCT00463684|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22414764|NCT01906372|University of Pittsburgh, Division of Rheumatology|Rohit Aggarwal, MD|412-647-2840|aggarwalr@upmc.edu|
22414765|NCT03629054|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22414766|NCT03808376|Senseonics|Vice President, Clinical Sciences|301-515-7260|katherine.tweden@senseonics.com|
22414767|NCT02462837|Southern Illinois University School of Medicine|Dr. Danuta Dynda|217-545-7443|ddynda@siumed.edu|
22414768|NCT04029545|Prollenium Medical Technologies|Director Clinical Affairs|19055081469|clinicaltrials@prolleniumus.com|
22414769|NCT00748566|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22414770|NCT00989950|CoxHealth|Arie Ashkenasi, MD|011 972 50 3007477|ashkenasi1@gmail.com|
22414771|NCT01124786|Clovis Oncology, Inc.|VP Clinical Development|415-409-5440|clinicaltrialinfo@clovisoncology.com|
22414772|NCT00624286|Novartis Pharmaceuticals|Study Director|862 778-8300||
22414773|NCT02177617|University of Florida|Aparna Wagle Shukla|3522945400|aparna.shukla@neurology.ufl.edu|
22414774|NCT02845336|Johns Hopkins University|Timothy J McCulley, MD|4105503000|tmccull5@jhmi.edu|
22431007|NCT04548219|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22431008|NCT03514134|University of Michigan|Brittany Ross|(734) 764-2368|rossbrit@umich.edu|
22431009|NCT00834574|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22431010|NCT00462826|Gynecologic Oncology Group Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
22452585|NCT01673802|University of Alabama at Bimringham|John V. Thomas, MD; Principal Investigator|205-996-4132|jvthomas@uabmc.edu|
22452586|NCT00214136|University of Wisconsin Carbone Cancer Center|Dr. Mark A. Ritter|608-263-8500|ritter@humonc.wisc.edu|
22452587|NCT01272934|Novartis Consumer Health|Clinical Project Leader|0041223635228||
22452588|NCT04313634|Mayo Clinic|Sundeep Khosla, M.D.|507-255-6663|khosla.sundeep@mayo.edu|
22452589|NCT05219877|Department of Urology, Faculty of Medicine University of Indonesia - Cipto Mangunkusumo General Hospital|Prof. dr. Harrina Erlianti|+62 816-825-226|harrinaerlianti@gmail.com|
22452590|NCT00319098|GlaxoSmithKline|GSK Response Center|866-435-7343||
22452591|NCT02105948|GlaxoSmithKline|GSK Response Center|866-435-7343||
22452592|NCT03595904|Icahn School of Medicine at Mount Sinai|Dr. Sarah Miller|212-824-7783|Sarah.Miller@mssm.edu|
22452593|NCT00388414|Stanford University|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@stanford.edu|
22452594|NCT01358526|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
22452595|NCT04558346|University of Kansas Medical Center|Dr. Michael Rippee|913-945-7486|mrippee@kumc.edu|
22452596|NCT00724971|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22452597|NCT01962974|Janssen Pharmaceuticals|STRATEGIC LEAD||ClinicalTrialDisclosure@its.jnj.com|
22452598|NCT00801827|Vanderbilt_University|Julia Dunn, MD|615-343-8389|julia.dunn@va.gov|
22452599|NCT00627705|Stanford University School of Medicine|Antonio Hardan, MD|650-736-1235|hardanay@stanford.edu|
22452600|NCT04697758|AsclepiX Therapeutics|Dr A Shojaei|8005723545|ashojaei@asclepix.com|
22452601|NCT01410448|Novartis Pharmaceuticals|Study Director|862-778-8300||
22452602|NCT02535065|Cook Research Incorporated|Manager, Biostatistics|7654637537|Alan.Saunders@CookMedical.com|321204
22452603|NCT04764396|University of Michigan|Eileen Carpenter|734-615-3948|eicarpen@med.umich.edu|
22452604|NCT03708198|UVA Health|William Manson, MD|4349242283|wcm6m@virginia.edu|
22452605|NCT01781572|Pfizer|Study Director|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22452606|NCT01218438|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22452607|NCT00383448|Masonic Cancer Center, University of Minnesota|Dr. Paul Orchard|612-626-2313|orcha001@umn.edu|
22452608|NCT03762473|University of Alabama at Birmingham|Graham Towns, MD|(205)934-1801|gtowns@uabmc.edu|
22452609|NCT01932164|Hospital Sirio Libanes|Dra Daniela Franco Bueno|+5511997900159|dbuenousp@gmail.com|
22452610|NCT00045110|Adult Brain Tumor Consortium|Lauren E Abrey, MD|410-955-8837|jfisher@jhmi.edu|
22452611|NCT02587351|University of Minnesota|John Connett|612-626-9010|john-c@umn.edu|
22452612|NCT01218646|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22401598|NCT02092415|Oregon Health & Science University|Jonathan Lindner MD|503 595-8750|lindnerj@ohsu.edu|
22401599|NCT04538950|Mayo Clinic|John P. Bois, M.D.|507 284-4072|Bois.John@mayo.edu|
22401600|NCT05610969|University of Pennsylvania|Veena Graff MD, MS|(215) 662-8244|veena.graff@pennmedicine.upenn.edu|
22401601|NCT04579393|The National Institutes of Health / The National Heart, Lung, and Blood Institute|Jeffrey Strich, MD|301.496.9320|jeffrey.strich@nih.gov|
22401602|NCT00603044|The University of Chicago Medicine|Fuad Baroody, MD|(773) 702-4790|fbaroody@surgery.bsd.uchicago.edu|
22401603|NCT01282814|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22401604|NCT01535937|NYSPI|Elias Dakwar, MD|646.774.8728|elias.dakwar@nyspi.columbia.edu|
22401605|NCT02519231|University of Washington|Dr. Emily Godfrey|206.685.4895|godfreye@uw.edu|
22401606|NCT02704429|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22401607|NCT00104104|Novatis Pharmaceuticals|Study Director|862-778-8300||
22401608|NCT03557372|Dana Farber Cancer Institute|Dr. Shyam Tanguturi|617-632-0000|stanguturi@partners.org|
22401609|NCT00447421|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22401610|NCT01707147|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22401611|NCT02725177|Cleveland Clinic Foundation|Daniel Culver, DO|216-444-6508|culverd@ccf.org|
22401612|NCT04435769|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22401613|NCT02234011|McLean Hospital, Biological Psychiatry Laboratory|Dr. Brian Brennan, MD|617-855-2911|bbrennan@partners.org|
22401614|NCT01326962|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22401615|NCT02053246|University of Florida|Dr. Julio Duarte|352-273-8132|juliod@cop.ufl.edu|
22401616|NCT02707757|Imperial Healthcare NHS Trust|Dr Damien Ashby||d.ashby@imperial.ac.uk|
22401617|NCT01318902|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22401618|NCT01783522|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Beth Faiman|216-444-3705|faimanb@ccf.org|
22401619|NCT01894516|Galapagos N.V.|Clinical Trial Information Desk|+32 (0)15 342 900|rd@glpg.com|
22401620|NCT02420652|Rutgers Cancer Institute of New Jersey|Biren Saraiya, MD|732-235-3360|saraiybi@cinj.rutgers.edu|
22401621|NCT05652660|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22401622|NCT02605863|University of Rochester|Edward Messing, ND|585-275-0998|edward_messing@urmc.rochester.edu|
22389060|NCT02074709|University of Texas Southwestern Medical Center|Irina Gasanova|214-590-0064|Irina.Gasanova@UTSouthwestern.edu|
22389061|NCT01951105|Northwestern University|Apkar Vania Apkarian|312-503-0404|a-apkarian@northwestern.edu|
22389062|NCT02727998|Yale School of Medicine|Dr. Ilan Harpaz-Rotem|(203) 937-4760|ilan.harpaz-rotem@yale.edu|
22389063|NCT00237718|Vanderbilt University|T. Alp Ikizler, MD||alp.ikizler@vanderbilt.edu|
22389064|NCT05072795|Medical University of South Carolina|Dr. Andreana Benitez|843-876-8479|benitez@musc.edu|
22389065|NCT00834483|Rush University Medical Center|Dr. Brett R. Levine|312-432-2466|brettlevine@gmail.com|
22389066|NCT00422162|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22389067|NCT05274906|Fred Hutchinson Cancer Center|Marian L. Neuhouser, Principal Investigator|206-667-4797|mneuhous@fredhutch.org|
22389068|NCT00963105|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22389069|NCT01622088|Knopp Biosciences|Head of Regulatory|4124881776|greg@knoppbio.com|
22389070|NCT00237809|Yale University|Dr. Deepak Cyril D'Souza|203-932-5711|deepak.dsouza@yale.edu|2594
22389071|NCT02006641|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
22389072|NCT00872339|New England Research Institutes|Felicia Trachtenberg|6179723120|ftrachtenberg@neriscience.com|
22389073|NCT01158716|Cardiovasular RS|Theodoros Zografos|+306956161001|theodoroszografos@gmail.com|
22389074|NCT02132195|Emory University|Dr. Greenbaum|404-712-6374|LGREEN6@emory.edu|
22389075|NCT00321555|National Cancer Institute|Dr. Robert Kreitman|301-648-7375|robert_kreitman@nih.gov|
22389076|NCT02907489|Cairo university|Mohamed Omaia Ahmed|00201224474609|mohamed.omaia@dentistry.cu.edu.eg|
22389077|NCT00912964|Astellas Pharma Global Development, Europe|Medical Director, Global Medical Sciences||ClinicalTrials.Disclosure@us.astellas.com|
22389078|NCT02684435|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
22389079|NCT02561195|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22389080|NCT03905512|Selecta Biosciences, Inc.|Study Director|617-923-1400|ptraber@selectabio.com|
22389081|NCT03293238|Andrews Research & Education Foundation|Dr. Joshua Hackel|850-916-8796|jghackelmd@yahoo.com|
22389082|NCT04990388|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
22389083|NCT00070317|NRG Oncology|Linda Gedeon for Wei Deng, PhD.|716-845-1169|lgedeon@gogstats.org|
22389084|NCT02502019|Biom'Up|Dr. William Spotnitz, Chief Medical Officer|352-514-5009|wspotnitz@gmail.com|
22389085|NCT03987074|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22389086|NCT00508144|The University of Texas (UT) MD Anderson Cancer Center|Ralph Zinner, MD/Thoracic & Head and Neck Medicine|713-792-7734|CR_Study_Registration@mdanderson.org|
22389087|NCT01661972|Duke University Medical Center|John Strickler, M.D.|919-668-1861|john.strickler@duke.edu|
22401623|NCT01777438|UZ Leuven|Dr Hellings|+32 16 332338|peter.hellings@uzleuven.be|
22414775|NCT03488108|Mayo Clinic|Alison J. Bruce, M.B., Ch.B|904-953-6412|Bruce.Alison@mayo.edu|
22414776|NCT01665508|Massachusetts General Hospital|Nandita S. Scott|6177241739|nsscott@partners.org|
22414777|NCT02054715|University of Rochester Medical Center|Gary R. Morrow, PhD, MS; Deans Professor of Oncology|585-275-9961|Gary_Morrow@urmc.rochester.edu|
22414778|NCT02252016|Merck Sharp & Dohme Corp.|Senior Vice President, Glocal Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22414779|NCT02471807|Edwards Lifesciences|Ted Feldman, MD|949-250-2500|Feldman_Info@edwards.com|
22414780|NCT00834873|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414781|NCT05327777|Thomas Jefferson University Hospital|Research Resident|516-547-7676|ryan.lamm@jefferson.edu|
22414782|NCT01653704|The Ottawa Hospital|Dr. Sylvain Boet|6137985555|sboet@toh.on.ca|14775
22414783|NCT01608906|University of Colorado Denver|Director, Clinical Research Administration|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
22414784|NCT03966911|Medtronic Diabetes|Robin Mottackel|8185764886|robin.e.mottackel@medtronic.com|
22414785|NCT00985751|GlaxoSmithKline|GSK Response Center|866-435-7343||
22414786|NCT01960296|Icahn School of Medicine at Mount Sinai|Dr. Celia M. Divino|212-241-5499|celia.divino@mountsinai.org|
22414787|NCT02611323|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22414788|NCT01899053|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22389088|NCT01084772|Smith & Nephew, Inc.|Stuart Pratt|+1 (901) 497-0365|stuart.pratt@smith-nephew.com|
22431011|NCT04976777|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22389089|NCT01294644|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
22389090|NCT01517282|MorphoSys|Roman Korolkiewicz|+49 89 89927 208|roman.korolkiewicz@morphosys.com|
22389091|NCT03444298|University of North Carolina at Chapel Hill|Carole Robinette|919-966-5638|carole_robinette@med.unc.edu|
22389092|NCT02942771|University of Kentucky|Dr. Linda Van Eldik|(859) 257-5566|linda.vaneldik@uky.edu|
22389093|NCT02158806|University of Auckland|Professor Andrew Jull|+64 9 923 4259|a.jull@auckland.ac.nz|
22389094|NCT02383043|University of Kentucky|Joshua A. Lile, Ph.D.|859-420-0503|jalile2@uky.edu|
22389095|NCT01898299|New York State Psychiatric Institute|Joshua Kantrowitz|6467746738|jk3380@cumc.columbia.edu|
22389096|NCT02340806|Northwestern University|Elizabeth Lange, MD|312-472-3585|elizabeth.lange@northwestern.edu|
22389097|NCT04520256|The Miriam Hospital|Dr. J. Graham Thomas|(401) 793-8154|jthomas4@brownhealth.org|
22389098|NCT02878590|InnoMed Healthscience|Javier Collazo|9547739656|jcollazo@innomedhs.com|
22389099|NCT01730118|National Cancer Institute|Dr. Hoyoung Maeng|240-781-3253|hoyoung.maeng@nih.gov|
22389100|NCT03154827|BioLineRx Ltd|VP Clinical & Medical Affairs|+972-8-642-9100|clinicaltrials@biolinerx.com|
22389101|NCT04206397|UC San Diego|Dr. Laura Case|858-246-4968|lcase@health.ucsd.edu|
22389102|NCT05480410|Fundación Universitaria María Cano|Physiotherapy professor|+573206728934|catalinaloperamuneton@fumc.edu.co|
22389103|NCT03978130|NYU Langone Health|John Dodson, MD|6465012714|john.dodson@nyulangone.org|
22389104|NCT03523897|Virtua Health|Dr. Jeremy Reid|8008967326|jreid@reconstructiveortho.com|
22389105|NCT05349123|Mayo Clinic|Roberto P Benzo|507-284-0561|benzo.roberto@mayo.edu|
22389106|NCT03239899|National Institutes of Health|Avindra Nath, MD|301-496-1561|avindra.nath@nih.gov|
22389107|NCT04049578|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22389108|NCT00668746|OraPharma|Ms. Bindu Patel, Senior Scientist, Regulatory Affairs and Quality Assurance|215-420-4064|bpatel@orapharma.com|
22389109|NCT03409276|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22389110|NCT00984334|S.L.A. Pharma UK Ltd|Dr C Jordan, Head of Clinical Operations|44 01923 681001|cjordan@slapharma.com|
22389111|NCT02169089|University Hospitals Cleveland Medical Center|Dr. Sanjay Rajagopalan|216-844-5191|Sanjay.Rajagopalan@uhhospitals.org|
22389112|NCT01309802|Southern Illinois University School of Medicine|Research Administrator|217-545-2531|surgeryresearch@siumed.edu|
22389113|NCT05361304|Johnson & Johnson Vision Care, Inc. (JJVC)|John R. Buch, OD, MS, FAAO|800-843-2020|jbuch@its.jnj.com|
22389114|NCT03320941|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
22389115|NCT01634620|Aerocrine, Inc.|Nancy Herje, BSN, RN, MBA|919-449-8873|Nancy.Herje@aerocrine.com|
22389116|NCT02368691|Oncternal|Mary Breitmeyer|858-434-1113|MBreitmeyer@oncternal.com|
22389117|NCT02069366|Wayne State University|Dr. Christine Rabinak|(313) 577-9875|rabinak@wayne.edu|
22389118|NCT03314233|Childrens Hospital of Philadelphia|Dr. Elizabeth Foglia|215-590-1653|foglia@email.chop.edu|
22414789|NCT04693429|Laboratorios Sophia|Alejandra Sanchez-Ríos M.D.|:+52 (33) 3001 4200|alejandra.sanchez@sophia.com.mx|
22414790|NCT01767103|ApoPharma Inc.|Fernando Tricta, MD|416-401-7332|ftricta@apopharma.com|
22414791|NCT03531827|National Cancer Institute|Dr. Ravi Madan|301.480-7168|madanr@mail.nih.gov|
22414792|NCT00926887|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com|
22414793|NCT02584608|Indiana Univerity School of Medicine|Micheal Econs|317-274-1339|mecons@iu.edu|
22414794|NCT03500094|Amicus Therapeutics|Medical Affairs|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
22414795|NCT01891357|on behalf of Westdeutsche Studiengruppe GmbH|Anja Braschoss, Consultant Clinical Research and Medical Writing|0049-176-82119153|anja.braschoss@wsg-online.com|
22414796|NCT03944057|Antengene Corporation|Shimin Sun|+8613701803117|jasmine.sun@antengene.com|
22414797|NCT03930849|Department of Veterans Affairs|Carolyn Turvey, Ph.D.|319 338 0581|Carolyn.Turvey@va.gov|637714
22414798|NCT02633241|Boston Children's Hospital|Joseph P. Cravero|617-355-4292|Joseph.Cravero@childrens.harvard.edu|
22414799|NCT02906813|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22414800|NCT00557245|University of Washington|Dr. Connie Celum|206-520-3824|ccelum@uw.edu|
22414801|NCT02658019|University of Miami|Lynn G. Feun, MD|305-243-6606|lfeun@med.miami.edu|
22414802|NCT00851409|Pharming Technologies BV|Medical Affairs Department|+31715247400|medicalinfo@pharming.com|
22414803|NCT02316223|Icahn School of Medicine at Mount Sinai|Dr. Alex Federman|212-824-7565|alex.federman@mountsinai.org|
22414804|NCT01275664|NRG Oncology|Linda Gedeon for Helen Huang, MS|716-845-1169|lgedeon@gogstats.org|
22414805|NCT03234907|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22414806|NCT01472432|Second University Naples|Dr Raffaele Marfella|++390815665110|raffaele.marfella@unina2.it|
22414807|NCT02986139|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22414808|NCT02583048|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22414809|NCT02155257|Wake Forest University Health Sciences|Dr. James Eisenach|3367164182|eisenach@wakehealth.edu|
22414810|NCT00414726|Massachusetts General Hospital|Aneesh B. Singhal, MD|617 726 8459|asinghal@partners.org|
22414811|NCT02107196|MENARINI Group|Angela Capriati, MD PhD - Corporate Director Clinical Research|+39 055 5680|acapriati@menarini-ricerche.it|9990
22414812|NCT00516295|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22414813|NCT01851876|Karadeniz Technical University, School of Medicine, Dept Obs and Gyn.|Dr. Suleyman Guven, Director of clinical trial|+904623775869|drsuleymanguven@yahoo.com|
22414814|NCT02985749|Massachusetts General Hospital|Gagan Joshi, MD|617-724-1541|gjoshi@mgh.harvard.edu|
22414815|NCT00660660|AstraZeneca|Clinical Trial Transparency||ClinicalTrialTransparency@astrazeneca.com|
22414816|NCT02651987|Ipsen|Ipsen Medical Director|see email|clinical.trials@ipsen.com|
22414817|NCT01630616|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22389119|NCT01797705|DeVilbiss Healthcare|Jim Froehlich|814-443-7692|Jim.Froehlich@devilbisshc.com|
22389120|NCT01838447|Children's Hospital of Eastern Ontario|Katie O'Hearn, PICU Research Coordinator|613-737-7600|kohearn@cheo.on.ca|4006
22389121|NCT01585597|Emory University|Christopher Horn|404 387 7320|cmhorn@emory.edu|
22389122|NCT02030847|Abramson Cancer Center of the University of Pennsylvania|Noelle Frey, MD|215-662-6901|noelle.frey@uphs.upenn.edu|
22389123|NCT00168805|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22389124|NCT01114217|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
22389125|NCT01837719|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22389126|NCT01703988|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22389127|NCT06247488|Azurity Pharmaceuticals, Inc.|Vice President of Clinical Development|(913) 389-7961|david.sequeira@azurity.com|
22389128|NCT02995733|Brigham and Women's Hospital|Dr. Elliot Israel|617-732-8110|eisrael@bwh.harvard.edu|
22401624|NCT00375934|Xanodyne Pharmaceuticals, Inc.|Steve Boesing|1-877-926-6396|clinical-trials@xanodyne.com|
22401625|NCT01792986|Intermountain Heart Institute|Benjamin D. Horne|8015074708|benjamin.horne@imail.org|
22401626|NCT00893113|Chesapeake Urology Research Associates|Ronald Tutrone, MD|443.471.5742|hthomas@cua.md|
22401627|NCT02133235|NTUH|YJ Cheng|886-2-23123456|chengyj@ntu.edu.tw|62158
22401628|NCT01289392|Associação Fundo de Incentivo à Pesquisa|Dr Teresa Cristina Barros Schutz|55-21-99868033|schutzferraz@gmail.com|
22401629|NCT00500149|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22401630|NCT01157169|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22401631|NCT00663858|Aeterna Zentaris|Herbert Sindermann|+49 69 42602 3429|HSindermann@aezsinc.com|
22401632|NCT02940886|Pharmacosmos A/S|Clinical trial disclosure desk|+45 5948 5935|trial@pharmacosmos.com|
22401633|NCT02778880|Cincinnati Children's Hospital Medical Center|Theresa Frey, MD|513-636-7966|theresa.frey@cchmc.org|
22401634|NCT00950690|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22401635|NCT01713036|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22401636|NCT00092547|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22401637|NCT01166659|Transcend Medical, Inc.|Vice President of Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
22401638|NCT03152136|Cala Health|Paula Chidester|650-273-7436|paula@calahealth.com|
22401639|NCT01096771|Indiana University School of Medicine|Dr. William Carlos|3178807819|wcarlos@iu.edu|
22401640|NCT05099991|Stanford University|Research Team|(650) 497-5175|gynresearch@stanford.edu|
22401641|NCT01954628|Aquinox Pharmaceuticals (Canada) Inc.|Clinical|+1 (604) 629-9223|clinical@aqxpharma.com|
22401642|NCT01148056|Mass General Hospital Cancer Center|Maria Kempner|508.533.4132|mkempner@partners.org|
22401643|NCT00958568|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22401644|NCT00915005|UT MD Anderson Cancer Center|Dr. Zhongxing Liao, MD/Professor, Radiation Oncology Department|(713) 563-2300|zliao@mdanderson.org|
22401645|NCT00471380|Alcon Research, LTD|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22401646|NCT01848821|Massachusetts General Hospital|Dr. Daniel Dante Yeh, Assistant Professor of Surgery|617-724-8604|dyeh2@partners.org|
22401647|NCT00589472|Memorial Sloan Kettering Cancer Center|Dr. Susan Slovin|646-422-4470|slovins@mskcc.org|
22401648|NCT00117338|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22401649|NCT01380093|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22401650|NCT03952650|Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Dr. Dave Cook|240.627.3066|david.cook@nih.gov|
22401651|NCT02367170|University of Florida|PhD in exercise physiology|352 2736105|UFCT-gov@ufl.edu|
22401652|NCT00771030|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22401653|NCT00114114|Massachusetts General Hospital|Dr. Ben Leder|617-726-6723|bzleder@partners.org|
22401654|NCT01022853|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22401655|NCT01651052|Edwards Lifesciences, LLC|Mary Edwards, VP Clinical and Regulatory Affairs, Surgical Structural Heart|949-250-2500|mary_edwards@edwards.com|1536
22401656|NCT03503773|Ablative Solutions Inc|Kate Rumrill, CEO|1 650-688-9743|krumrill@ablativesolutions.com|
22401657|NCT00607828|University of Nebraska Medical Center|Chi Lin|402-552-3844|clin@unmc.edu|
22401658|NCT02498821|Bard Access Systems, Inc.|Gina Gilbert, BSN, RN|407-489-0835|Gina.Gilbert@crbard.com|
22401659|NCT01417286|Cancer Institute of New Jersey Rutgers|Dr. Haffty|732-235-8675|hafftybg@cinj.rutgers.edu|
22401660|NCT05341466|University of Colorado, Boulder|Andrew Q. Tan|303-735-0259|andrew.tan@colorado.edu|
22401661|NCT03511638|Bausch & Lomb|Study Director|510-259-5284|aloncaric@bauschhealth.com|
22401662|NCT04156646|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22401663|NCT01208181|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22401664|NCT00942708|UT Southwestern|Kelly Chin|214-645-5989|kelly.chin@utsouthwestern.edu|
22401665|NCT00477451|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
22401666|NCT02730247|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR; CRS Regulatory Supervisor|412-647-5554|stadtermanbm@upmc.edu|
22401667|NCT01645930|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22401668|NCT02263365|Cedars Sinai Medical Center|Phillip Fleshner, MD|310-289-9224|pfleshner@aol.com|
22401669|NCT01004107|Merz North America|Ashlee Duncan|984-222-6040|ashlee.duncan@merz.com|
22401670|NCT00393458|Novartis Pharmaceuticals|Study Director|862 778-8300||
22401671|NCT02509546|City of Hope Medical Center|Dr. Vinod Pullarkat, MD|626-359-8111|vpullarkat@coh.org|
22414818|NCT02725515|Xencor, Inc.|Vice President, Biometrics|858-480-3414|bburington@xencor.com|
22414819|NCT02015832|European Cardiovascular Research Institute|Dr. Ernest Spitzer|+31102062828|E.Spitzer@ECRI-Trials.com|
22414820|NCT02297230|New York University School of Medicine|Sylvia Formenti|646.962.4073|lao2003@med.cornell.edu|
22414821|NCT00640393|Innovaderm Research Inc|Annie Levesque|514-521-4285|alevesque@innovaderm.ca|222
22414822|NCT01380782|Dana-Farber Cancer Institute|Patrick Y. Wen, MD|6176322166|pwen@partners.org|
22414823|NCT03682601|GTO Pharma|Clinical Trial Coordinator|9175436934|akhmea01@gmail.com|
22389129|NCT02186587|University of Missouri - Department of Orthopaedic Surgery|Sonny B. Bal, MD, PI|573-882-6762|BalB@health.missouri.edu|
22389130|NCT01183013|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22389131|NCT01189370|University of Kansas Cancer Center|Dr. Peter Van Velduizen|913-945-5059|SWILLIAM@kumc.edu|
22389132|NCT04468633|Duke University|Andrew Gross, MD|919-684-8656|andrew.gross@duke.edu|
22389133|NCT01843920|Mid Atlantic Retina|Jason Hsu, MD|215-928-3092|research@midatlanticretina.com|
22389134|NCT00460434|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
22389135|NCT01498445|The University of Texas MD Anderson Cancer Center|Jorge Cortes MD/Professor|713-792-7734|CR_Study_Registration@mdanderson.org|
22389136|NCT04739306|CELLTRION, Inc.|Head of Clinical Planning|+82-32-850-4190|keumyoung.ahn@celltrion.com|
22389137|NCT00641797|Lehigh Valley Health Network|Regina Sacco, DPT, BA, BHSC|610-969-0300|Regina_R.Sacco@lvhn.org|
22389138|NCT02722278|Clarus Therapeutics|Theodore Danoff, MD, PhD|847-562-4300|tdanoff@clarustherapeutics.com|
22389139|NCT02465866|Charleston Laboratories, Inc|Chief Commercial Officer|561-748-2007|cliregulatory@charlestonlabs.com|
22389140|NCT00203502|University of Arkansas for Medical Sciences|Dr. Issam Makhoul|5016868274|MakhoulIssam@uams.edu|
22389141|NCT02023099|AbbVie|Global Medical Services|800-633-9110||
22389142|NCT04175392|Beaumont Hospitals|Kirsten Gage, CRM|947-521-8519|kirsten.gage@beaumont.org|
22389143|NCT01469819|Texas Tech University Health Sciences Center El Paso|Dr. Irene Sarosiek|(915)215-5254|irene.sarosiek@ttuhsc.edu|
22389144|NCT00561678|Icahn School of Medicine at Mount Sinai|Dr. Stacie Deiner|212-241-7749|stacie.deiner@mountsinai.org|
22389145|NCT01103141|Cook Research Incorporated|Scott Snyder, PhD, Director of Clinical Affairs|765-463-7537|Scott.Snyder@CookMedical.com|
22389146|NCT03082196|Advantage Silver Dental Arrest, LLC|Dr. Peter Milgrom|206-251-6831|drmilgrom@silverarrest.com|
22389147|NCT01403805|Department of Dentistry, Yubari Kibounomori, Japan|Dr. Masahiro Hatta|+81-123-52-4339|masahiro.hatta@hotmail.co.jp|
22389148|NCT01695993|University of Rochester Medical Center|Joseph A. Roscoe, PhD Associate Research Professor|585 275-9962|joseph_roscoe@urmc.rochester.edu|
22389149|NCT00472199|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22389150|NCT01540071|Io Therapeutics, Inc.|Martin E. Sanders, M.D.|(650) 219-5973|msanders@io-therapeutics.com|
22389151|NCT00138645|Pennington Biomedical Research Center|Corby K. Martin, Ph.D.; Assistant Professor|225-763-2585|martinck@pbrc.edu|
22389152|NCT01601821|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22389153|NCT00212888|OHRI|Dr. Jonathan B Angel|613-737-8442|JANGEL@toh.ca|
22389154|NCT01901302|Cubist Pharamceuticals|Vice President Clinical Research|1.781.860.8660||
22389155|NCT00815347|University of Connecticut Health Center|MArk Metersky, MD|860-679-3582|metersky@nso.uchc.edu|
22389156|NCT00848198|TearLab, Inc.|Michael Berg, VP of Regulatory|858-795-6887|mberg@TearLab.com|
22389157|NCT03708744|Zosano Pharma Corporation|Dr. Don Kellerman, Sr. VP, Clinical Development and Medical Affairs|+1 (510) 745-4004|dkellerman@zosanopharma.com|
22389158|NCT02062827|The University of Alabama at Birmingham|James Markert, MD|(205) 934-7171|jmarkert@uabmc.edu|
22389159|NCT04930263|National Yang Ming Chiao Tung University|Mrs Cheng-Chen Chou|28267176|chou8278@gmail.com|
22389160|NCT03075449|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22389161|NCT02812706|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22389162|NCT02342275|Sichuan University|Yi jJi|+86 02885423453|jijiyuanyuan@163.com|
22389163|NCT01699178|Clarus Therapeutics|Theodore Danoff, MD, PhD|847-562-4300|tdanoff@clarustherapeutics.com|
22389164|NCT04588207|University of Pittsburgh School of Medicine|Dr. Helbert Rondon Berrios, Professor of Medicine|4126473120|rondonberriosh@upmc.edu|
22389165|NCT02138838|Amgen Inc.|Study Director|866-572-6436||
22389166|NCT00442507|Washington University School of Medicine|Daniel Morgensztern, M.D.|314-362-5740|dmorgens@dom.wustl.edu|
22389167|NCT00860457|Lombardi Comprehensive Cancer Center, Georgetown University Hospital|Dr. Bruce D. Cheson|202-444-7932|bdc4@georgetown.edu|
22389168|NCT01045057|Atos Medical AB|Director of Clinical Affairs|+1 352 870 0872|Corina.van.As@atosmedical.com|
22389169|NCT04433091|Vanderbilt University Medical Center|M.Benjamin Shoemaker,MD MSCI|615-322-2318|moore.b.shoemaker@vumc.org|
22389170|NCT03016091|Davidoff Cancer Center at Rabin Medical Center|Shlomit Yust-Katz MD|92739378002|shlomit2@clalit.org.il|
22389171|NCT02880293|Memorial Sloan Kettering Cancer Center|Dr. Brian Shaffer, MD|646-608-3737|shaffeb1@mskcc.org|
22414824|NCT01403194|Mayo Clinic|Dr. Seema Kumar|507-538-2724|kumar.seema@mayo.edu|
22414825|NCT01701063|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22414826|NCT03428750|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|clinicaltrials@endo.com|
22414827|NCT02944617|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22414828|NCT00274651|Topotarget A/S|PRS Admnistrator Gunilla Emanuelson|+45 39 17 83 92|enquiries@topotarget.com|
22414829|NCT04474405|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
22414830|NCT03446768|University of California, San Diego, La Jolla, CA|Carl Stepnowsky, PhD|858-642-1240|cstepnowsky@health.ucsd.edu|
22414831|NCT02511535|Med Uni Wien, Institut für Spezifische Prophylaxe und Tropenmedizin|Erika Garner-Spitzer, PhD|0043 1 40160|erika.garner-spitzer@meduniwien.ac.at|38255
22414832|NCT01604941|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22414833|NCT01410227|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22414834|NCT00606281|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22414835|NCT00617396|UNC Chapel Hill|Dr. Douglas Drossman|919-966-0141|douglas_drossman@med.unc.edu|
22414836|NCT00540423|GlaxoSmithKline|GSK Response Center|866-435-7343||
22414837|NCT03131895|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22414838|NCT01339247|GlaxoSmithKline|GSK Response Center|866-435-7343||
22414839|NCT03556618|University of California, Los Angeles|Dr. Elizabeth Barnert, Principal Investigator, Associate Professor|(310) 206-1483|ebarnert@mednet.ucla.edu|
22414840|NCT00731939|Coloplast Corp|Clinical Trial Manager|612-302-4990|usdibe@coloplast.com|
22414841|NCT02213263|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22414842|NCT05752721|NYU Langone Health|Pasquale Rummo|646-501-3371|Pasquale.Rummo@nyulangone.org|
22414843|NCT00263588|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22414844|NCT00493805|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22414845|NCT02287480|Geneva University Hospitals|Prof. Claire-Anne Siegrist|0041 22 379 5778|claire-anne.siegrist@unige.ch|
22414846|NCT02960295|Kaiser Permanente Southern California|Steven Jacobsen MD, PhD. Director, Department of Research and Evaluation|626-564-3470|Steven.J.Jacobsen@nsmtp.kp.org|
22414847|NCT01075282|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22414848|NCT00367133|Jaeb Center for Health Research|Adam R. Glassman, Director DRCR.net Coordinating Center|813-975-8690|drcrnet@jaeb.org|
22414849|NCT00847535|Cook MyoSite, Inc.|Ron Jankowski, PhD|412-963-7380|Ron.Jankowski@CookMyosite.com|
22414850|NCT00906399|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
22414851|NCT00685477|Temple University|Alan Maurer, MD|215-707-8269|amaurer@temple.edu|
22414852|NCT00178178|University of Rochester|Dr. Robert Bronstein|585-275-1024|robert_bronstein@urmc.rochester.edu|
22414853|NCT02811003|Smith+Nephew, Inc.|Samantha Andrews|978.971.8990|samantha.andrews@smith-nephew.com|
22414854|NCT02055547|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22414855|NCT01456221|Coordinacion de Investigacion en Salud, Mexico|Dr. Mardia Guadalupe Lopez Alarcon||marsau2@prodigy.net.mx|
22414856|NCT01986647|University of Pittsburgh|Jennifer S. Brach, PhD, PT|412-383-6533|jbrach@pitt.edu|
22414857|NCT02003391|Alcon Research, Ltd.|Global Brand Leader, Medical Affairs, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com|
22414858|NCT00243347|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22414859|NCT01345539|UPMC Hillman Cancer Center|Barbara M. Stadterman, MPH, MSCR|412-647-5554|stadtermanbm@upmc.edu|
22414860|NCT02011945|Bristol-Myers squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@BMS.com|
22414861|NCT00258856|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22414862|NCT00159419|Indiana University School of Medicine|Dr. Linda DiMeglio|317-944-3889||
22414863|NCT02488109|University of California, San Francisco, Department of Pediatrics|Andrea Garber, PhD, RD|415-514-2180|andrea.garber@ucsf.edu|
22414864|NCT05259852|Case Western Reserve University|Jin Kim-Mozeleski|216-368-6793|jin.kim-mozeleski@case.edu|
22414865|NCT03969641|Duke University|Dr. Geeta Swamy|919.681.5220|geeta.swamy@duke.edu|
22414866|NCT05157048|University of Pennsylvania|Victoria Constantine|215-746-4069|vmcl@pennmedicine.upenn.edu|
22414867|NCT01006967|Geisel School of Medicine at Dartmouth|Jon D. Lurie, MD, MS|603 653-3575|jon.d.lurie@dartmouth.edu|
22414868|NCT00754052|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
22414869|NCT02466087|University of Vermont|Emily Tarleton, MS, RD|802-847-4730|emily.tarleton@uvm.edu|
22414870|NCT00697801|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
22414871|NCT01919112|Beth Israel Deaconess Medical Center|Sandeep Kumar, MD|617-632-8917|skumar@bidmc.harvard.edu|
22414872|NCT00835666|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22389172|NCT02101554|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22414873|NCT00635648|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22389173|NCT04385849|ImmunityBio|Lennie Sender, Chief Operating Officer|855-797-9277|lennie.sender@immunitybio.com|
22414874|NCT04194801|CStone Pharmaceuticals|Hua Hu|+86 021-60333416|CstoneRA@cstonepharma.com|
22389174|NCT02011568|University of Ottawa Heart Institute|Dr Michel Le May|613-696-7000|mlemay@ottawaheart.ca|14646
22414875|NCT00294047|GlaxoSmithKline|GSK Response Center|866-435-7343||
22452613|NCT00722761|MGH Curtis|Alexa B. Kimball|617-726-5066|harvardskinstudies@partners.org|
22452614|NCT03680755|Temple University Kornberg School of Dentistry|Associate Dean for Research & Chair Department of Oral Health Sciences|215-707-1773|marisol.tellez.merchan@temple.edu|
22452615|NCT05054816|Sonova Canada|Jinyu Qian, PhD; VP Sonova Innovation Centre Toronto|647-262-4826|jinyu.qian@sonova.com|
22452616|NCT02693665|Children's National Medical Center|Dr. Maureen E. Lyon, PhD, Professor of Pediatrics, Principal Investigator|703-346-2873|mlyon@childrensnational.org|
22452617|NCT03662750|Imperial College London|Prof Roland Veltkamp|020 3311 7296|r.veltkamp@imperial.ac.uk|
22452618|NCT03096782|University of Texas MD Anderson Cancer Center|Amanda Olson, MD / Stem Cell Transplantation|713-745-1505|alolson@mdanderson.org|
22452619|NCT02075593|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22452620|NCT03156023|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22452621|NCT01496352|Dr. Reddy's Laboratories, Inc.|Kent Allenby, MD, VP, Drug Development|609-375-9855|kallenby@drreddys.com|
22452622|NCT05872035|Apple|Rajiv Kumar, MD|8669055303|htclinicalquestions@apple.com|
22452623|NCT02010060|University of Virginia|Damon Swift|(434) 924-1436|dls3s@virginia.edu|
22452624|NCT05819749|Hennepin Healthcare Research Institute|Katherine Diaz Vickery|612-873-6852|katherine.vickery@hcmed.org|
22452625|NCT00660010|Abbott Laboratories|Global Medical Services|800-633-9110||
22452626|NCT00726752|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22452627|NCT01177098|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22452628|NCT00844857|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22452629|NCT00570674|Dana-Farber Cancer Institute|Roy B. Tishler, MD|617.632.5734|RTISHLER@LROC.HARVARD.EDU|
22452630|NCT03069482|Duke University Psychiatry & Behavioral Sciences|Dr. Roger Vilardaga|9196813441|roger.vilardaga@duke.edu|
22452631|NCT03910413|The University of Alabama at Birmingham|Andrew Smith|205-934-4080|andrewdennissmith@uabmc.edu|
22452632|NCT00240487|The Children's Hospital of Philadelphia|Richard Lin|2155905505|linr@email.chop.edu|
22452633|NCT01096992|The University of Texas MD Anderson Cancer Center|William Wierda, MD./Professor|713-745-0428|CR_Study_Registration@mdanderson.org|
22452634|NCT00907153|Penn State Hershey Medical Center|Dr. Nazia Raja-Khan|717-531-8395|nrajakhan@psu.edu|
22452635|NCT04098939|Aarhus University Hospital|Søren Helbo Skaarup|+4528911869|soeska@rm.dk|
22452636|NCT02434692|Implandata Ophthalmic Products|Clinical Study Manager|+49 (0) 511 - 2204 2580|clinical@implandata.com|
22452637|NCT00778648|Institut für Sozialmedizin, Epidemiologie und Gesundheitsökonomie , Charité - Universitätsmedizin Berlin, Germany|Dr. Stephanie Roll|+49 30 450 529023|stephanie.roll@charite.de|
22452638|NCT01911403|Hospital de Sao Joao, E.P.E.|Dr. Paulo Morgado|+351 22 551 2100|vilaresmorgado@iol.pt|
22452639|NCT02338154|Edwards Lifesciences, LLC|Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Andrey_Nersesov@edwards.com|0225
22452640|NCT01092338|Children's Hospital of Philadephia|Virginia Stallings|215-590-1664|stallingsv@email.chop.edu|
22452641|NCT03393000|Diffusion Pharmaceuticals Inc|Vice President of Clinical Operations|434-220-0718|clinicaltrials@diffusionpharma.com|
22452642|NCT01773070|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
22452643|NCT00780208|Medical University of South Carolina|Aimee McRae-Clark, Professor|843-792-5216|mcraeal@musc.edu|
22452644|NCT01552213|Stanford University, School of Medicine|Anna Girsen, Research Operations Manager|(650) 725-5720|agirsen@stanford.edu|
22452645|NCT02696317|Alcon, A Novartis Division|Sr. Brand Lead, Global Medical Affairs, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22452646|NCT00237744|Malcom Randall VA Medical Center, Gainesville Florida|Janis Daly, Ph.D., M.S.; Director, Brain Rehabilitation Research Center|(352) 376-1611|jjd17@case.edu|6603
22452647|NCT02566031|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
22452648|NCT03031938|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22452649|NCT05762835|University of California at Davis|Dr. Jennifer Rosenthal|9167344719|rosenthal@ucdavis.edu|
22452650|NCT02007291|Federal University of Minas Gerais|Luís Felipe José Ravic de Miranda|55-31-3225-2337|ravicmiranda@gmail.com|
22452651|NCT00000392|NIMH|Benedetto Vitiello, MD - Supervisory Medical Officer|301-443-3357|bvitiell@mail.nih.gov|
22452652|NCT03117738|Nature Cell co., ltd|Project Manager|02-545-4137|tin50@stemcellbio.com|
22452653|NCT02015676|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22452654|NCT01426191|xiangbei welman pharmacuticol CO.,LTD|Directer of clinical trials|020-38868707|gap@welman.com.cn|
22452655|NCT00476476|Dana-Farber Cancer Institute|Neil Horowitz MD|617.732.8843|NHOROWITZ@mgh.harvard.edu|
22452656|NCT01189279|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22452657|NCT00971048|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
22452658|NCT04597190|University of Washington|John Fortney|2066856955|fortneyj@uw.edu|
22452659|NCT01715805|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22452660|NCT04936230|Weill Cornell Medicine|Himanshu Nagar, MD|212-746-3704|hnagar@med.cornell.edu|
22452661|NCT02647359|PTC Therapeutics, Inc.|Medical Information|1-866-562-4620|medinfo@ptcbio.com|
22452662|NCT00413413|Novartis Pharmaceuticals|Study Director|862 778-8300||
22414876|NCT00506831|Stanford University|Lorinda Chung|650-493-5000|shauwei@stanford.edu|62042
22414877|NCT02464657|The University of Texas MD Anderson Cancer Center|Dr. Farhad Ravandi-Kashani, MD/Professor|(713)745-0394|fravandi@mdanderson.org|
22414878|NCT00095784|University of Chicago|Olatoyosi Odenike, MD|773-702-3354|todenike@medicine.bsd.uchicago.edu|
22414879|NCT01161420|Inspire Medical Systems|Quan Ni|763-205-7968|quanni@inspiresleep.com|
22414880|NCT00608322|Cooper University Hospital|Stephen Trzeciak, MD, MPH|856-342-3342|trzeciak-stephen@cooperhealth.edu|
22414881|NCT04002648|IRCCSSRaffaele|Prof. Michele De Bonis|+390226437102|debonis.michele@hsr.it|
22414882|NCT04313751|University of North Carolina at Chapel Hill|Yamnia Cortes, PhD, MPH, RN|319-335-1131|yamnia-cortes@uiowa.edu|
22414883|NCT02121067|University of North Carolina|Matthew Zerden, MD, MPH|6179352394|mzerden@gmail.com|
22414884|NCT05780463|University of Minnesota|Greg Grandits|651-528-9491|greg-g@ccbr.umn.edu|
22414885|NCT00835614|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414886|NCT04077645|University of Illinois Urbana Champaign|Dr. Sean P Mullen|217-244-4502|spmullen@illinois.edu|
22414887|NCT02280863|Stanford University|Dr. Bruce Buckingham, MD||buckingham@stanford.edu|
22414888|NCT02903407|Duke University|Angela Lowenstern|919-684-0111|angela.sandelin@duke.edu|
22414889|NCT03158727|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
22414890|NCT00985439|Iroko Pharmaceuticals, LLC|Steven Jensen|267-546-3003|sjensen@iroko.com|
22414891|NCT01174186|Silkeborg Regional Hospital|René Oestgaard|0045 78 41 50 00|ostgard@immunology.au.dk|
22414892|NCT00918684|Weill Cornell Medical College|Dr. George Alexopoulos, M.D.|914-997-5767|galexopoulos@med.cornell.edu|
22414893|NCT00402103|Novartis Pharmaceuticals|Study Director|862-778-8300||
22414894|NCT00484679|University of Minnesota|Maria Hordinsky, MD|612-624-5721|hordi001@umn.edu|
22414895|NCT02351700|Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center|Andrew S. Little, MD|602-406-3181|neuropub@dignityhealth.org|
22414896|NCT00418145|Icahn School of Medicine at Mount Sinai|Dr. Fred Lublin|212-241-6854|fred.lublin@mssm.edu|
22414897|NCT00472212|The Ohio State University College of Optometry|Marjean Kulp|614-688-3336|kulp.6@osu.edu|
22389175|NCT04179799|University of Florida|Emily Fox|352-273-6500|ejfox@phhp.ufl.edu|
22414898|NCT00425308|Novartis Pharmaceuticals|Study Director|862-778-8300||
22414899|NCT05143801|University of New Mexico|Dr. Christine Mermier|5052772664|cmermier@unm.edu|
22414900|NCT01252953|Nuffield Department of Population Health, University of Oxford|Prof Martin Landray|+44 (0)1865 743743|martin.landray@ndph.ox.ac.uk|
22414901|NCT01007994|Northwell|Christine Sethna|7184703423|csethna@northwell.edu|
22414902|NCT00114504|Kurume University|Hisashi Kai|+81-942-31-7562|naikai@med.kurume-u.ac.jp|
22414903|NCT03393754|VBI Vaccines, Inc.|Vlad Popovic|416-418-4713|vpopovic@vbivaccines.com|
22414904|NCT00101439|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22414905|NCT01851772|Xoft, Inc.|Crystal Leonard, CCRP|9375038588|cleonard@icadmed.com|
22414906|NCT04739735|Faculty of dentistry, Alexandria University, Egypt|Dr. Rodaina Helmy|00201100001193|rodaina.helmy@alexu.edu.eg|
22414907|NCT03272685|University of Minnesota|Dorothy Hatsukami|612-626-2121|hatsu001@umn.edu|
22414908|NCT00863330|Aurora Health Care|IIR regulatory specialist|414-219-7886|jackie.blundon@aurora.org|
22414909|NCT00487435|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537||
22414910|NCT01807026|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22414911|NCT01087502|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22414912|NCT01151618|Philips Respironics|Bob Romano, Biomedical Engineer|724-387-7781|bob.romano@philips.com|
22414913|NCT00868998|Columbia University|Robert Fine|212-305-1168|rlf20@columbia.edu|
22414914|NCT02047305|Medtronic MITG-RGI|Senior Director of Clinical Affairs|303-581-7064|Tumordirectedtherapiesclinical@Medtronic.com|
22414915|NCT01483820|NMTRC|Giselle Sholler, MD|6162670335|giselle.sholler@helendevoschildrens.org|
22414916|NCT02701101|Bruin Biometrics|Vignesh Iyer|3102689494|viyer@bruinbiometrics.com|
22414917|NCT01790685|Johns Hopkins|Dr. Peter A. Campochiaro|410-955-5106|pcampo@jhmi.edu|
22414918|NCT00474188|Celgene Corporation|Robert Kinght, M.D.|908-673-9749|rknight@celgene.com|
22414919|NCT05412121|University of Michigan|Anne Murphy|734-936-5566|aemurph@med.umich.edu|
22414920|NCT03541252|Bispebjerg Hospital|Dr. Emily Wenande, MD, PhD|+4540505590|emily.cathrine.wenande@regionh.dk|
22414921|NCT02272803|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22414922|NCT03124758|Masimo|Tala Harake||studies@masimo.com|
22431012|NCT05654181|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22414923|NCT03961204|Merck Healthcare KGaA, Darmstadt, Germany|Communication Center|+49 6151-72-5200|service@emdgroup.com|
22414924|NCT02218216|GE Healthcare|Chief Medical Officer - Head Health Initiative|262-544-3633|Victor.Miranda@ge.com|
22389176|NCT01038128|McLean Hospital|Study Coordinator|617-855-2984|eryan@mclean.harvard.edu|
22389177|NCT05129592|Johns Hopkins Bloomberg School of Public Health|Caitlin Weiger|3017128357|cweiger2@jhmi.edu|
22414925|NCT00787124|Duke University Medical Center|Brian Smith|9196688951|brian.smith@duke.edu|
22414926|NCT02452463|Roswell Park|CTRP/CT.gov Registry Coordnator|716-845-1073|KIM.BROSIUS@ROSWELLPARK.ORG|
22414927|NCT05740098|University of Vermont|Stephen T. Higgins, PhD., P.I.|802-656-9615|stephen.higgins@uvm.edu|
22389178|NCT03344458|Ascendis Pharma, Inc.|Aimee D. Shu, MD|+1 650 352 8389|ads@ascendispharma.com|
22414928|NCT01073631|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22414929|NCT03067987|University of Miami|Ranjith Ramasamy|3052434873|ramasamy@miami.edu|
22414930|NCT03733145|Atrium Health Wake Forest Baptist|Rohesh J. Fernando, MD|336.716.2712|rfernan@wakehealth.edu|
22414931|NCT00829764|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22389179|NCT03512041|Washington University School of Medicine|Catherine E Lang|314-286-1945|langc@wustl.edu|
22414932|NCT01023776|University of Rochester|John Treanor< M.D.|585-275-5871|john_treanor@urmc.rochester.edu|
22414933|NCT03102879|Universidad de los Andes|Claudia Brizuela|56 2 26181166|clau@cibrizuela.com|
22414934|NCT01098851|Covidien|Fran Haury|303 305-2314|fran.haury@covidien.com|
22414935|NCT03087786|Niconovum USA|Dr. Abraham Varghese|336-741-2315|varghea@rjrt.com|
22414936|NCT02244554|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
22414937|NCT00183196|Medical University of South Carolina|Raymond F. Anton, MD|843-792-1226|antonr@musc.edu|
22414938|NCT00385736|Abbott|Global Medical Services|800-633-9110||
22414939|NCT00845130|Univeristy of Kansas Medical Center|In-Young Choi, Ph.D.|913-588-0174|ichoi@kumc.edu|
22414940|NCT02837913|Cedars-Sinai Medical Center|Dr. Mark Zakowski|310-423-5841|mark.zakowski@cshs.org|
22414941|NCT01310855|UCL and CTC Cancer Trials Centre|Mark Phillips|0207 679 9139|ctc.doric@ucl.ac.uk|
22414942|NCT01085539|Covidien|Fran Haury, RRT Research Coordinator|303 305-2314|fran.haury@covidien.com|
22414943|NCT02906917|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22414944|NCT00687739|University of Colorado Anschutz Medical Campus|Wendy M Kohrt, PhD|3037241913|wendy.kohrt@ucdenver.edu|
22414945|NCT02542462|Cincinnati Childrens Hospital Medical Center|Nancy Back RN MPH|513-636-2479|Nancy.Back@cchmc.org|
22414946|NCT06078501|Stanford University|Principal Investigator|650-497-5175|gynresearch@stanford.edu|
22414947|NCT02043132|Beaumont Health|Dr. J. Michael Wiater|248-551-3140|J.Michael.Wiater@beaumont.edu|
22414948|NCT02554877|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22414949|NCT03827395|Emory University|Evan J. Anderson, MD|404-727-1746|evanderson@emory.edu|
22414950|NCT01537887|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22414951|NCT01370083|Toronto Rehabilitation Institute - University Health Network|Prof. Catriona Steele|4165973422|catriona.steele@uhn.ca|7603
22414952|NCT02450539|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22414953|NCT00495222|Ethicon Endo-Surgery|Susan Knippenberg|513 337-3452|sknippen@its.jnj.com|
22414954|NCT01438060|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22414955|NCT01964950|Takeda Pharmaceutical Company Limited|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22414956|NCT03602339|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22414957|NCT00834405|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414958|NCT00840281|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414959|NCT00076622|University of Pennsylvania|Joel Streim||Joel.Streim@uphs.upenn.edu|
22414960|NCT04224753|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
22414961|NCT03209505|University of Houston College of Optometry|Eric Ritchey, OD, PhD|713-743-1933|erritche@central.uh.edu|
22414962|NCT01190865|Smith & Nephew|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
22452663|NCT01470027|Weill Cornell Medicine|Dr. Dikoma C. Shungu, Professor of Physics in Radiology|2127462481|dcs7001@med.cornell.edu|
22452664|NCT01972061|University of Pittsburgh|Dr. Christopher Chermansky|412-6418385|chermanskycj2@upmc.edu|
22452665|NCT02219932|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22452666|NCT00412087|Medical University of South Carolina|Dr. Carol Wagner|18437922112|wagnercl@musc.edu|
22452667|NCT00511004|NIAID|Thomas B. Nutman|301-496-5398|tnutman@niaid.nih.gov|
22452668|NCT04642638|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
22452669|NCT00990652|Northwestern University|Jeffrey Raizer, MD|312-503-4724|jraizer@nmff.org|
22452670|NCT02388386|Scripps Clinic Medical Group|Sanjeev Bhavanni MD|6196601842|bhavnani.sanjeev@scrippshealth.org|
22452671|NCT01672801|Boston IVF|Alan Penzias|781-434-6500|apenzias@bostonivf.com|
22452672|NCT06476366|Department of Dermatology, Emirates Military Hospital|Dr Ahsan Tameez-ud-din|051-9293480|ahsantameezuddinmalik@gmail.com|312
22414963|NCT00326872|Mayo Clinic|Dr. Dusica Babovic-Vuksanovic||dbabovic@mayo.edu|
22452673|NCT03726346|Fisher & Paykel Healthcare Ltd.|Bhavi Ogra|+64 9 574 0123|bhavi.ogra@fphcare.co.nz|7675
22452674|NCT04159688|Yale University|Dr. Ansel Hillmer|203-737-6400|ansel.hillmer@yale.edu|
22452675|NCT00054353|Fred Hutch|Marco Mielcarek, MD||mmielcar@fredhutch.org|
22452676|NCT04313881|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22452677|NCT00727272|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22414964|NCT00829452|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414965|NCT02615249|Allerderm (dba) SmartPractice|Kathryn Shannon|6022250595|kshannon@smartpractice.com|7208
22452678|NCT00651664|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22401672|NCT01056523|Jewish General Hospital|Dr. Assouline|514-340-8222|sarit.assouline@mcgill.ca|8434
22401673|NCT03425656|Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.|Dr. Reza Safaei, M.D|0098-9124548684|safaiino@sina.tums.ac.ir|
22401674|NCT01399827|Massachusetts General Hospital|Craig Surman, MD|617-726-8392|csurman@partners.org|
22401675|NCT02209597|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
22401676|NCT04441931|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22401677|NCT02316470|Valneva Austria GmbH|Manager Clinical Research|+43120620|info@valneva.com|0
22401678|NCT01592851|GlaxoSmithKline|GSK Response Center|866-435-7343||
22389180|NCT00396409|Novartis Pharmaceuticals|Study Director|862-778-8300||
22389181|NCT00331799|Duke University Medical Center Dept of Psychiatry|Wei Zhang MD|919 684 5645|wei.zhang@duke.edu|
22389182|NCT02889809|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22389183|NCT04694300|University of Pennsylvania School of Dental Medicine|Elliot V Hersh DMD, MS, PhD. Professor of Oral Surgery and Pharmacology|215-898-9686|evhersh@upenn.edu|
22389184|NCT03960437|Columbia University|Thomas L.Nickolas, MD, MS|212-305-9847|tln2001@cumc.columbia.edu|
22389185|NCT00113880|MedImmune, LLC|Chris Ambrose, MD, Sr Director, Medical Affairs|301-398-0000|ambrosec@medimmune.com|
22389186|NCT02630147|University of Sherbrooke Hospital Research Center, QC, Canada|Dr Jean-Paul Praud|819-346-1110|jean-paul.praud@usherbrooke.ca|14851
22389187|NCT01537900|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22389188|NCT03785210|National Cancer Institute|Dr. Tim F. Greten|240-760-6114|gretentf@mail.nih.gov|
22389189|NCT02213458|University of California, San Francisco|Dr. Katherine Possin|(415) 476-1889|katherine.possin@ucsf.edu|
22389190|NCT04043806|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22389191|NCT02499497|Brigham and Women's hospital|Dr. Shalender Bhasin, Principal Investigator|617 525 9150|sbhasin@bwh.harvard.edu|
22389192|NCT03166215|Takeda|Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
22389193|NCT01357564|Center of Innovation on Disability and Rehabilitation Research, Department of Veterans Affairs; St. Catherine University, Department of Occupational Therapy|Dr. Paul Arthur|3176881499|pbarthur824@stkate.edu|
22389194|NCT04362176|Vanderbilt University Medical Center|Todd Rice, M.D., MSc|615-343-8010|vcc@vumc.org|
22389195|NCT04985604|Day One Biopharmaceuticals, Inc.|Study Director|1-650-484-0899|clinicaltrials@dayonebio.com|
22389196|NCT04598776|CeraRoot CLINIC|Dr. Josep Oliva-Ochoa. Director of Clinical Trials|+34 935950247|josep.oliva@cerarootclinic.com|
22389197|NCT02282761|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646-440-9333|ITCIClinicalTrials@itci-inc.com|
22389198|NCT00515281|University of Chicago|Michael D. Schreiber, MD|773-702-6205|mschreiber@bsd.uchicago.edu|
22389199|NCT00658632|Eisai Inc.|Eisai Medical Services|888-422-4743||
22389200|NCT06312566|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22389201|NCT02632045|Columbia University|Melissa Accordino, MD|212-342-5162|mkg2134@cumc.columbia.edu|
22389202|NCT04551053|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22389203|NCT03861078|Virginia Commonwealth University|Alison Breland|804 628 2300|abbrelan@vcu.edu|
22389204|NCT03503188|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22389205|NCT04407442|University of California, San Francisco|Dr. Alfred Chung|(415) 353-2421|Alfred.Chung@ucsf.edu|
22389206|NCT00828178|Johns Hopkins University School of Medicine|Dr. Michelle Petri|410-955-9114|mpetri@jhmi.edu|
22389207|NCT01664806|University of Colorado School of Medicine|Dr. Thomas Robinson|303-724-2728|thomas.robinson@Ucdenver.edu|
22389208|NCT03547167|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22389209|NCT00645411|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22389210|NCT00927849|Mansoura university hospital|ayman elnakeeb|0020106752021|elnakeebayman@yahoo.com|
22389211|NCT03100370|Rice University|Marcia O'Malley, PhD|713-348-3545|omalleym@rice.edu|
22389212|NCT02674399|Nature Cell co., ltd|Project Manager|02-545-4137|tin50@stemcellbio.com|
22389213|NCT01867307|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22389214|NCT00835328|The Children's Hospital of Philadelphia|Diva D. Deleon, MD,MSCE|215-590-3420|deleon@email.chop.edu|
22389215|NCT02736175|Ocular Therapeutix|Jamie L. Metzinger, Medical Affairs|781-357-4000|jmetzinger@ocutx.com|
22389216|NCT02168855|University of Arkansas|Dr. Brian Primack|479-575-3208|bprimack@uark.edu|
22401679|NCT01988012|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22401680|NCT01058369|Universitätsklinikum Erlangen, Medizinische Klinik 5|Prof. Dr. med. Stefan Krause||stefan.krause@uk-erlangen.de|
22401681|NCT00117962|Washington University School of Medicine|Dr. Ramaswamy Govindan||rgovinda@dom.wustl.edu|
22401682|NCT01666444|Vice President, Clinical Affairs|Kristi Manjarrez|206-689-2256|kmanjarrez@ventirx.com|
22401683|NCT00352781|Centre for Addiction and Mental Health|Co-Investigator|416-535-8501|laurie_zawertailo@camh.net|7422
22401684|NCT01650779|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22401685|NCT00052429|Memorial Sloan Kettering Cancer Center|Dr. Suzanne Wolden|212-639-5148|woldens@mskcc.org|
22401686|NCT03567291|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22401687|NCT02284399|Mednax. Inc|Kimberly Maurel|714-593-9171|kimberly_maurel@mednax.com|
22401688|NCT01103349|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22401689|NCT00073333|University of Central Florida|Deborah C. Beidel, Ph.D.|407-823-3254|deborah.beidel@ucf.edu|
22401690|NCT01736683|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|800-672-6372|ClinicalTrialsDisclosure@merck.com|
22401691|NCT04021472|VA Bedford Healthcare System|Timothy P. Hogan|781-687-3181|timothy.hogan@va.gov|
22401692|NCT00915967|Oregon Health & Science University|Director of Clinical Trials|503-494-4314|nsgclinicalresearch@ohsu.edu|
22401693|NCT04146272|Bernafon AG|Barbara Simon|+41 31 998 15 15|bsim@bernafon.com|1664
22401694|NCT01591018|University Hospital Ostrava|David Skoloudik|00420597375630|skoloudik@hotmail.com|
22401695|NCT01936649|GE Healthcare|Dr. Jose Zubeldia|011-44-1494-543137|jose.zubeldia@ge.com|
22401696|NCT03904446|University of Iowa|Cynthia A. Wong, MD|13193563868|cynthia-wong@uiowa.edu|
22401697|NCT03554005|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22401698|NCT00631488|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22401699|NCT00103194|"ECOG Statistical Office"|"Study Statistician"|617-632-3012||
22401700|NCT03136705|Northwestern University Feinberg School of Medicine|Doctor|312-503-6921|tamara.isakova@northwestern.edu|
22401701|NCT02855411|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
22401702|NCT01391312|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22401703|NCT01342640|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22401704|NCT04084392|Vanderbilt University Medical Center|Dr. Dave Marcovitz|615-936-3555|david.marcovitz@vumc.org|
22401705|NCT00670111|Boston Scientific|Elke Sommerijns|+32 479 76 71 56|elke.sommerijns@bsci.com|
22401706|NCT03988751|Wake Forest University School of Medicine|Dr. Clancy Clark|335-480-8064|cjclark@wakehealth.edu|
22401707|NCT00844883|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu|
22401708|NCT01938170|UNC Chapel HIll|Ravi Jhaveri MD|919-962-5136|ravi.jhaveri@unc.edu|
22401709|NCT02441803|University of Texas MD Anderson Cancer Center|Dr. Richard Champlin, MD/Stem Cell Transplantation|713-792-3618|rchampli@mdanderson.org|
22401710|NCT01857986|Hospitech Respiration|Clinical Trials Manager|+972-3-9191648|adir@hospitech.co.il|5
22401711|NCT00824538|University of California San Francisco|Hope S Rugo|877-827-3222|clinicaltrials@ucsf.edu|
22401712|NCT02873221|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22401713|NCT01065480|New York State Psychiatric Institute|Edward V. Nunes, MD|646-774-6122|nunesed@nyspi.columbia.edu|
22401714|NCT02240628|The University of Texas Health Science Center at Houston|Dr. Samia Khalil|713-500-6242|Samia.N.Khalil@uth.tmc.edu|
22401715|NCT00850499|Johnson & Johnson Pharmaceutical Research & Development|Andrew Cakana, MD, FRC Path||[ACAKANA@ITS.JNJ.COM|
22401716|NCT00552305|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22401717|NCT01834326|University of Michigan|Stephen E. Feinberg|734 763 5963|sefein@med.umich.edu|
22401718|NCT01749735|Spaulding Rehabilitation Hospital|Dr. Paolo Bonato|617-952-6319|pbonato@partners.org|
22401719|NCT01703819|Biologische Heilmittel Heel GmbH|Christine Frank, PhD|+49 7221 501 3188|christine.frank@heel.com|
22401720|NCT01302041|Astellas Pharma Global Devlopment, Inc.|Clinical Trial Disclosure||Astellas.resultsdisclosure@astellas.com|
22401721|NCT01241513|USARIEM|Charles S Fulco, PI|508 233-4893|charles.fulco@us.army.mil|
22401722|NCT01834144|University of Manitoba|Dr. Jonathan McGavock|204-480-1359|jmcgavock@chrim.ca|
22401723|NCT02234583|Daiichi Sankyo, Inc.|Daiichi Sankyo US Contact for Clinical Trial Results|1-908-992-6400|CTRinfo@DSI.com|
22401724|NCT01849250|The University of Texas MD Anderson Cancer Center|Powel H. Brown, MD/Chair, Clinical Cancer Prevention|713-792-7734|PHBrown@mdanderson.org|
22401725|NCT04504032|Gates MRI|Study Director|+1 857 702 2108|clinical.trials@gatesmri.org|
22401726|NCT01839188|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22401727|NCT01671488|Brown University Oncology Research Group (BrUOG)|Howard Safran, MD|4018633000|kayla_rosati@brown.edu|
22401728|NCT02285010|Mahidol University|Dr.Taniga Kiatchai|+66-2-419-7990|taniga@gmail.com|
22401729|NCT01478347|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22401730|NCT03245814|The University of Arizona|Dr. Maggie O'Haire|520-621-6767|maggieohaire@arizona.edu|
22401731|NCT01164501|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22401732|NCT00946270|The University of Texas MD Anderson Cancer Center|Dr. Srdan Verstovsek, MD./Professor|713-745-3429|sverstov@mdanderson.org|
22401733|NCT01096667|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22401734|NCT00206518|Baylor College of Medicine|Tao Wang|7137985388|taow@bcm.edu|
22401735|NCT02335450|Oakland University|Beth Black|248-364-8694|bblack@oakland.edu|
22401736|NCT01845077|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22401737|NCT02613572|Scheie Eye Institute; Perelman School of Medicine; University of Pennsylvania|Benjamin J. Kim, MD|215-662-8675|benjamin.kim@uphs.upenn.edu|
22414966|NCT02911909|University of Missouri|Ennio Rizzo|573-882-7615|eardvb@health.missouri.edu|
22414967|NCT03053245|Indiana University|Babar Khan, MD, MS|(317) 274-9132|bakhan@iu.edu|
22414968|NCT00932477|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22414969|NCT05098743|Vanderbilt University|Dr. Christa Hartch, PI|203-979-2044|christahartch@me.com|
22414970|NCT04060251|Brigham Health|Dr. Wolfgang Fitz|617-732-9501|wfitz@bwh.harvard.edu|
22414971|NCT01663896|St. Jude Medical|Sr. Manager, Global Clinical Affairs|651-756-5585|mwagner2@sjm.com|
22414972|NCT03349632|Alcon, A Novartis Division|Senior Clinical Project Lead, GCRA - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22414973|NCT00842309|Massachusetts General Hospital|Dr. Hilary Weingarden|617-643-6206|hilary_weingarden@mgh.harvard.edu|
22414974|NCT02670551|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22414975|NCT04476277|National Heart, Lung, and Blood Institute (NHLBI)|Mathew Hsieh, M.D.|301.402.7687|matthewhs@nhlbi.nih.gov|
22414976|NCT01962298|Antwerp University Hospital|Dr Tom Schepens|003238213265|tom.schepens@uza.be|
22414977|NCT01576705|Institut Jérôme Lejeune|Dr Clotilde Mircher|00 33 1 56 58 63 00|clotilde.mircher@institutlejeune.org|
22414978|NCT03727139|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22414979|NCT00566722|Abbott|Global Medical Services|800-633-9110||
22414980|NCT00858403|H. Lee Moffitt Cancer Center and Research Institute|Eric Haura, M.D., via Moffitt Cancer Center|813-745-6827|eric.haura@moffitt.org|
22414981|NCT02264977|W.L. Gore & Associates|Jennifer Gorman|928-863-8483|jgorman@wlgore.com|
22414982|NCT03573544|OBI Pharma, Inc.|Dr. Wayne Saville, Chief Medical Officer|619-537-7821|waynesaville@obipharmausa.com|
22414983|NCT03329209|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
22414984|NCT04364191|University of Pennsylvania|Miranda McPhillips|215-898-8281|mvarr@nursing.upenn.edu|
22414985|NCT03105297|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22414986|NCT00714051|Edward Hines Jr., VA Hospital|Eileen Collins PhD, RN|708-202-3525|eileen.collins@va.gov|
22414987|NCT00227370|Duke Clinical Research Institute|Scott M. Palmer, MD, MHS|919 684 0254|scott.palmer@duke.edu|
22414988|NCT03846193|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22414989|NCT01390948|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22414990|NCT03111381|Yale Urology|Jamil Syed|2037852815|Jamil.syed@yale.edu|
22414991|NCT02589067|The Lundquist Institute at Harbor-UCLA|Dr. Loren G. Miller|310-222-3775|lmiller@lundquist.org|
22414992|NCT00755235|Group Health Research Institute|Gregory Simon, Principal Investigator|206-287-2979|simon.g@ghc.org|
22414993|NCT01131260|The George Washington University Biostatistics Center|Rebecca Clifton, Ph.D.|301-881-9260|rclifton@bsc.gwu.edu|
22414994|NCT03544216|Marshall B. Ketchum University (The Ohio State University during study data collection)|Erin Rueff, OD, PhD|7654145644|em.rueff@gmail.com|
22414995|NCT01935674|Hospital Clinic of Barcelona|Dr. Esteban Martínez|+34 93 227 54 00|estebanm@clinic.cat|
22414996|NCT00849797|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22414997|NCT01494532|GlaxoSmithKline|GSK Response Center|866-435-7343||
22414998|NCT00679081|Organogenesis Inc.|Director of Clinical Operations|781-575-0775|clinicaltrials@organo.com|
22414999|NCT02153645|Osmotica Pharmaceuticals|George Wagner, VP of Regulatory Affairs|908-809-1357|gwagner@osmotica.ccom|
22415000|NCT01675596|Edwards Lifesciences|Tenley Koepnick||tenley.koepnick@edwards.com|
22415001|NCT01139762|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22415002|NCT00860938|University Hospital Basel, Switzerland|Jörg D. Leuppi, MD PhD, principle investigator|+41-61-2654294|jleuppi@uhbs.ch|
22415003|NCT00412464|Children's Hospital Los Angeles|Guy Young|323-361-5507|gyoung@chla.usc.edu|
22415004|NCT01730846|Yale School of Medicine|Sherry McKee, PhD|203-737-3529|sherry.mckee@yale.edu|
22452679|NCT03449030|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22452680|NCT00680316|Genentech, Inc.|Medical Communications|800-821-8590||
22452681|NCT02187991|Sarah Cannon Development Innovations, LLC|Taqi Mohammad|713-870-2175|taqi.mohammad@scri.com|
22452682|NCT01392560|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22452683|NCT01140191|Walter Reed National Military Medical Center (WRNMMC)|COL Glenn W. Wortman|301-295-6400|glenn.wortmann@amedd.army.mil|
22452684|NCT02558010|Medical College of Wisconsin|Keri R. Hainsworth, PhD|414-266-6306|khainswo@mcw.edu|
22452685|NCT00522275|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22452686|NCT00477191|Department of Dermatology, Mass General Hospital|Alexa Boer Kimball, MD MPH|617-726-0149|akimball@partners.org|
22452687|NCT04656847|Sevier|Medical manager - Yuriy Burtsev|8-495-93707-00|Yuriy.Burtsev@servier.com|
22452688|NCT03301051|Medicago|Medical Director|+1 418-658-9393|clinicaltrialinquiries@medicago.com|
22452689|NCT00047879|National Cancer Institute, National Institutes of Health|Howard A. Fine, M.D.|301-402-6383|hfine@mail.nih.gov|
22452690|NCT01196975|GlaxoSmithKline|GSK Response Center|866-435-7343||
22452691|NCT02073331|Aziyo Biologics, Inc.|Clinical Director|510-730-7973|clinical@aziyo.com|
22452692|NCT01359735|Smith & Nephew|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
22452693|NCT01462344|GlaxoSmithKline|GSK Response Center|866-435-7343||
22452694|NCT00360529|Sprout Pharmaceuticals|Sprout Pharmaceuticals|1-919-882-0850|clinicaltrials@sproutpharma.com|
22452695|NCT01629329|EINSTEIN MEDICAL CENTER|Kamran Mohiuddin, Director Clinical Research Emergency Department|2154562313|MOHIUDDK@EINSTEIN.EDU|
22452696|NCT01913600|Medtronic, Coronary & Structural Heart Clinical|Lisa Bousquette, Clinical Research Director|707-591-2967|rs.medtroniccardiovascularclinicaltrials@medtronic.com|
22415005|NCT01018862|Meda Pharmaceuticals Inc|Sr.Director Medical Scientific Affairs|732 564 2200|David.ginsberg@meda.us|
22415006|NCT01222234|University of Kansas Medical Center|Dr. Jason Stubbs|913-588-9252|jstubbs@kumc.edu|
22415007|NCT01968031|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
22415008|NCT00527098|University of Miami|Kenneth Proctor, PhD|305-243-4694|kproctor@med.miami.edu|
22401738|NCT00953121|Preston Robert Tisch Brain Tumor Center at Duke University Medical Center|Dr. Annick Desjardins|919-684-1691|annick.desjardins@duke.edu|
22401739|NCT02342561|The Orthopaedic Research Unit, Department of Orthopaedic Surgery and Trauma, Odense University Hospital, Denmark|Nikolaj Milandt, Undergraduate researcher|26616611|nikolaj.rongsted.milandt@rsyd.dk|0045
22401740|NCT00312377|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22401741|NCT00231478|Hoffman-LaRoche|Medical Communications|800-821-8590||
22401742|NCT04940598|UAB|Gordon Fisher|2059964114|grdnfs@uab.edu|
22401743|NCT05258058|University of Rochester|Dr. Allison Magnuson|585-602-5085|allison_magnuson@urmc.rochester.edu|
22401744|NCT01001494|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22401745|NCT02179398|Geneva University Hospital|Dr. Laurence Lacroix|+41223725082|laurence.lacroix@hcuge.ch|
22452697|NCT01428765|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22452698|NCT01453595|Memorial Sloan Kettering Cancer Center|Dr. Martin Voss|646-422-4631|vossm@mskcc.org|
22452699|NCT01128413|Washington University School of Medicine|Dr. Chris Holthaus|314-747-5994|holthauscv@wustl.edu|
22452700|NCT06167031|Tzu Chi University|Associate professer Mei-Lin Hsieh|886933513291|shaer@gms.tcu.edu.tw|
22452701|NCT01988246|Cole Eye Institute - Cleveland Clinic|Rishi Singh, MD|216-445-9497|singhr@ccf.org|
22452702|NCT02384954|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22401746|NCT01524289|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22401747|NCT03896425|University of Minnesota|Rebecca Kazinka|612-626-6772|kazin003@umn.edu|
22401748|NCT03004846|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22401749|NCT00408681|Fred Hutchinson Cancer Research Center|Paul J. Martin, M.D.|206-667-4798|pmartin@fredhutch.org|
22401750|NCT00649961|Imperial College London|Dr Nazakat Merchant|00447825881907|nazakat.merchant@kcl.ac.uk|
22401751|NCT01787591|The Ohio State University|Richard S. Bruno, PhD, RD|614-292-1698|bruno.27@osu.edu|
22401752|NCT00815308|Shandong Cancer Hospital and Institute|Jinming Yu|86-531-87984729|jn7984729@public.jn.sd.cn|
22401753|NCT03429556|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22401754|NCT00377299|UT Southwestern Medical Center at Dallas|Dr. E. Sherwood Brown, M.D., Ph.D.|214-645-6950|sherwood.brown@utsouthwestern.edu|
22401755|NCT04799782|JOHN D DINGELL VA MEDICAL CENTER|Dr. Abdulghani Sankari Principal Investigator|13135761000|abdulghani.sankari@va.gov|63105
22401756|NCT02029430|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22401757|NCT02050048|NorthShore Univeristy HealthSystem|Dr. Russell Brown|847-657-1900|rbrown@northshore.org|
22401758|NCT03465735|Mayo Clinic|Waldemar E. Wysokinski, M.D., Ph.D.|507-266-6717|Wysokinski.Waldemar@mayo.edu|
22401759|NCT04902950|Reading Hospital|Amir Behnam, MD|610-988-9127|amir.behnam@towerhealth.org|
22401760|NCT01589094|Memorial Sloan Kettering Cancer Center|Dean Bajorin, MD|646-888-4700|bajorind@mskcc.org|
22401761|NCT00907738|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22401762|NCT05363293|Alzamend Inc.|Eve Del Rio, MD, PhD|9736993847|Eve@RioPharma.com|
22401763|NCT04773041|HealthPartners Institute|Bhavani Kashyap, MBBS, PhD|651-495-6363|bhavani.x.kashyap@healthpartners.com|
22401764|NCT02747628|Ain-Shams University Hospitals|Dr. Ibrahim Mamdouh Esmat|01001241928|ibrahim_mamdouh@med.asu.edu.eg|
22401765|NCT04963179|Womed|Director of Clinical Affairs|0785225561|pauline@womedtech.com|+33
22401766|NCT05270694|MaineHealth Institute for Research|Dr. Kathleen Fairfield|207-661-7614|kathleen.fairfield@mainehealth.org|
22401767|NCT03624101|University of Alabama at Birmingham Child Health Research Unit|Heather Hathorne|2055032829|hyhathorne@uabmc.edu|
22401768|NCT04267562|MicroCube, LLC|Dinesh Mody|(510) 651-5000|m@minitouch.us|
22401769|NCT02026908|Northwestern University/Northwestern Memorial Hospital|Samdeep Mouli MD|312-926-5200|s-mouli@northwestern.edu|
22401770|NCT03729869|Medical University of South Carolina|Lisa Nunn, Program Manager|843-792-0476|jenkinli@musc.edu|
22401771|NCT03270085|Mayo Clinic|Michael Camilleri, MD|507-266-2305|camilleri.michael@mayo.edu|
22401772|NCT00733512|Alcon Research, Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22401773|NCT00592358|Massachusetts General Hospital|Janet Wozniak, MD|(617)503-1038|jwozniak@partners.org|
22401774|NCT00084682|Montefiore Medical Center|Lisa Escobar-Peralta|718-379-6866|lescobar@montefiore.org|
22452703|NCT01692340|The Ohio State University|Steven K. Clinton, MD PhD|614-293-2886|steven.clinton@osumc.edu|
22452704|NCT01474681|Novartis Pharmaceuticals|Study Director|862-778-8300||
22452705|NCT01733056|Emory University|Dr. Robert Swerlick|404-727-3669|rswerli@emory.edu|
22452706|NCT01546194|NorthShore University HealthSystem|Glenn Murphy|847-570-2760|dgmurphy2@yahoo.com|
22452707|NCT00836641|Goethe University Childrens Hospital|Prof Markus Rose|0049-696301|Markus.Rose@kgu.de|5754
22452708|NCT02372396|Veterans Medical Research Foundation|Dr. Ariel Lang|858-552-8585|ajlang@ucsd.edu|5359
22452709|NCT01483924|ApoPharma Inc.|Fernando Tricta, MD|Phone: 416-401-7332|ftricta@apopharma.com|
22452710|NCT02890381|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22452711|NCT00003298|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012||
22452712|NCT03543826|University of Washington|Adrienne James|206-744-4634|ajames1@uw.edu|
22452713|NCT01910129|electroCore Inc.|Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
22452714|NCT02571218|IRCCS Policlinico San Donato|Giuseppe Ciconte|+39 02 52 77 42 60|g.ciconte@gmail.com|
22452715|NCT00965523|Eisai|Tatsuo Watanabe, Study Director|+81-3-3817-5252||
22452716|NCT01201629|OKC VA Medical Center|Dr. Meheroz H. Rabadi|405-456-5298|meheroz.rabadi@va.gov|
22452717|NCT02415400|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22452718|NCT01226745|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22401775|NCT02988986|Houston Methodist Hospital|Dr. Jenny Chang, Director of Houston Methodist Cancer Center|713-441-0681|jcchang@houstonmethodist.org|
22401776|NCT02901262|UNIMIB, ASST-MONZA San Gerardo Hospital|Prof. Giuseppe Citerio|0039 039 233 4316|giuseppe.citerio@unimib.it|
22401777|NCT00634543|Janssen Korea / 25F, LS Yongsan Tower, 191 Hankangro 2-Ga, Yongsan-Gu, Seoul 140-702 Korea|Clinical Research Director|82-2-2094-4518||
22401778|NCT01013883|Darlington Memorial Hospital|Dr Rajender singh|01325380100|drrsdogra@yahoo.com|3444
22401779|NCT01371838|AstraZeneca Pharmaceuticals|Melnick, David A / Exec Dir Med Science|+1 302 886 5627|David.Melnick@astrazeneca.com|
22401780|NCT04315363|Northeastern University|Meishan Ai|858-265-7288|ai.me@northeastern.edu|
22401781|NCT02241512|UT Southwestern|Dr. David Troendle|214456-8000|david.troendle@utsouthwestern.edu|
22401782|NCT04013737|Health Protection Research Unit in HCAI and AMR, Imperial College London|Head of Operations|020 3313 2732|head.ops@imperial.ac.uk|
22401783|NCT00641043|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22401784|NCT04275310|Virginia Commonwealth University|Eric Benotsch|804-828-0133|ebenotsch@vcu.edu|
22401785|NCT00972244|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
22401786|NCT04978376|University of Illinois Chicago|Kelsey Gabel|312-413-8911|kdipma2@uic.edu|
22401787|NCT00283712|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22401788|NCT04635735|Memorial Sloan Kettering Cancer Center|Dr. Gunjan Shah, MD|646-608-3734|shahg@mskcc.org|
22401789|NCT00090285|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22401790|NCT02747043|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22401791|NCT02046564|Otsuka Pharmaceutical Co. Ltd.|Director of Clinical Trials|+81-3-6361-7366||
22401792|NCT00907478|Amgen Inc.|Study Director|866-572-6436||
22401793|NCT02238028|Fudan University|Dr. Haidong Kan|+86-021-54237908|kanh@fudan.edu.cn|
22401794|NCT03648476|Indiana University|Dawn Neumann|3173292188|dmneuman@iupui.edu|
22401795|NCT00907881|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22401796|NCT01097616|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22401797|NCT01325493|Children's National Health System|Julia Finkel|2024764867|JFINKEL@childrensnational.org|
22401798|NCT02927171|University of Colorado Denver|Dr. Jennifer Stevens-Lapsley|303.724.9170|jennifer.stevens-lapsley@cuanschutz.edu|
22401799|NCT02677701|Seattle Children's Hospital|Arthur Baines|2068841431|arthur.baines@seattlechildrens.org|
22401800|NCT04530825|Washington University School of Medicine|Maura Kepper, Ph.D.|314-935-0142|kepperm@wustl.edu|
22401801|NCT03870022|Pivot Health Technologies Inc.|VP of Clinical and Medical Affairs|415-757-7696|marler@pivot.co|
22401802|NCT04101422|Moffitt Cancer Center|Christine Vinci|813-745-5421|Christine.Vinci@moffitt.org|
22401803|NCT00718861|Novartis Pharmaceuticals|Study Director|8627788300||
22401804|NCT01530399|TMC|Peter Villiger|+19732906340|peter.villiger@themedco.com|
22401805|NCT04230486|Wake Forest School of Medicine|Huai Jiang, PhD|336-695-6460|jianghuai.ws@gmail.com|
22401806|NCT04983901|The University of M.D. Anderson Cancer Center|Dr. Issam I Raad|713-792-6237|iraad@mdanderson.org|
22401807|NCT01174784|Avinger Inc.|Thomas Lawson, PhD|650.241.7900|tlawson@avinger.com|
22401808|NCT02416908|Washington University School of Medicine|Geoffrey Uy, M.D.|314-747-8439|guy@wustl.edu|
22401809|NCT01985685|Beth Israel Deaconess Medical Center|Dr. Katherine Berg|617-667-5864||
22401810|NCT01214434|Promius Pharma, LLC|Medical Information Center|888 966-8766|product-complaints@promiuspharma.com|
22401811|NCT03100435|Tufts University|Robert Gyurko|6176366531|robert.gyurko@tufts.edu|
22401812|NCT03792750|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22401813|NCT00943878|Division of Infectious Diseases and Immunology, Saint Louis University Medical School|Sharon E. Frey, M.D.|314-977-5500|freyse@slu.edu|
22401814|NCT01832961|Imperial College|Ada Clarice Gastaldi|55 020 7351 8051|ada@fmrp.usp.br|
22401815|NCT03489291|CSL Behring|Study Director|+1 610-878-4000|clinicaltrials@cslbehring.com|
22401816|NCT01879618|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22401817|NCT00394914|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22401818|NCT00392444|The Ottawa Hospital Cancer Centre|Dr. Scott Laurie|613-737-7700|slaurie@toh.on.ca|70175
22401819|NCT00387660|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
22401820|NCT02099799|VA Boston Healthcare System|Marilyn Moy, MD, MSc|857-203-6622|marilyn.moy@va.gov|
22401821|NCT00465738|Merz Pharmaceuticals GmbH|Claus Goebel, MD|+49-69-1503-6461|claus.goebel@merz.de|
22401822|NCT01435512|BVARI|Dr. Casey Taft|857-364-6261|casey.taft@va.gov|
22401823|NCT02489630|Virginia Tech SOM / Carilion Clinic (prior)|Dr Karen J Bowers, co-PI|678-591-7280|bowerskj@gmail.com|
22401824|NCT01596595|Boston Scientific|Paji Vitoff, Manager, Clinical Trials|651-582-5415|Paji.Vitoff@bsci.com|
22401825|NCT02262130|CHU de Reims|Pr Manuelle Viguier|00333 26 78 43 43|mviguier@chu-reims.fr|
22401826|NCT00734929|Duke University Medical Center|Dr. Ashraf Habib|9196686265|habib001@mc.duke.edu|
22401827|NCT02961764|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
22401828|NCT02369510|Icahn School of Medicine at Mount Sinai|Dr. Daniel Katz|212-241-7475|Daniel.Katz@MountSinai.org|
22401829|NCT03118843|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22452719|NCT03825380|Laboratoires Théa|Corentin LE CAMUS|0473981414|Corentin.LECAMUS@theapharma.com|
22401830|NCT03067311|University of North Carolina at Chapel Hill|David Penn, PhD|(919) 843-7514|dpenn@email.unc.edu|
22401831|NCT02160977|Peking University Third Hospital|Dr. Jia-Kuo Yu|86-10-82267392|yujiakuo@126.com|
22401832|NCT03551522|CymaBay Therapeutics, Inc.|Barry Crittenden, Vice President of Clinical Development|510-293-8800|medinfo@cymabay.com|
22452720|NCT00395876|Genentech, Inc.|Medical Communications|800-821-8590||
22389217|NCT03000829|Intermountain Health|Dr. Ithan Peltan|801-507-6556|ithan.peltan@imail.org|
22389218|NCT00091572|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22389219|NCT00267774|Stanford University|William F. Fearon, MD|650 725-2621|wfearon@stanford.edu|
22389220|NCT00083122|Mayo Clinic Cancer Center|Keith C. Bible, M.D, Ph.D.||Bible.Keith@mayo.edu|
22389221|NCT03122548|Aduro Biotech, Inc.|Medical Affairs|510.809.2452|MedicalAffairs@aduro.com|
22389222|NCT01078402|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22389223|NCT03677986|Johns Hopkins University School of Medicine|Kenneth Silverman, Professor|4105502694|ksilverm@jhmi.edu|
22389224|NCT01199302|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22389225|NCT00424502|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22389226|NCT01634165|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22389227|NCT00635609|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22389228|NCT04097535|Imperial College London|Professor Eric Aboagye|02083833759|eric.aboagye@imperial.ac.uk|
22389229|NCT03070301|Memorial Sloan Kettering Cancer Center|Dr. Diane Reidy-Lagunes, MD|646-888-4185|reidyd@mskcc.org|
22389230|NCT03820024|UNC Lineberger|Leslie Clark|919-966-5996|leslie_Clark@med.unc.edu|
22389231|NCT01044901|The University of Chicago|Dr. Amit Patel, MD|773-702-9461|apatel2@medicine.bsd.uchicago.edu|
22389232|NCT03322514|Imperial College London|Prof Gary Frost|+44 (0)20 7594 0959|g.frost@imperial.ac.uk|
22389233|NCT00088452|Cincinnati Children's Hospital Medical Center|Tracy Glauser, MD|513-636-8854|tracy.glauser@cchmc.org|
22389234|NCT02629419|Matinas BioPharma|Theresa Matkovits, PhD|862-812-1436|tmatkovits@matinasbiopharma.com|
22389235|NCT02081196|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
22389236|NCT00961298|Allegheny General Hospital|Alicia Kaplan MD|412-330-4069|akaplan@wpahs.org|
22389237|NCT02515656|Laboratoire Innotech International|Director of Medical Affairs|+33 (0)1 46 15 29 00||
22389238|NCT04044352|University of Maryland School of Medicine|Kathleen M. Neuzil, MD, MPH|410-706-4946|kneuzil@som.umaryland.edu|
22389239|NCT00097708|Jazz Pharmaceuticals, Inc.|Grace Wang, MD Director Clinical Development & Medical Monitor|650 - 496 - 3777||
22389240|NCT00814632|William Beaumont Hospital|Kenneth M. Peters, MD|248-551-0387|kmpeters@beaumont.edu|
22389241|NCT02004132|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22389242|NCT00729053|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
22389243|NCT00282828|Rush University Medical Center|Mark Pollack, M.D.|312-942-5372|mark_pollack@rush.edu|
22389244|NCT02514577|Bausch Health Americas, Inc.|Director of Clinical Operations|1-510-259-5284|aloncaric@bauschhealth.com|
22389245|NCT00489489|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi-aventis.com|
22389246|NCT06091982|National Cardivascular Center Harapan Kita|Prieta Adriane MD|+62 21 5684093|prietaadriane@gmail.com|7406
22389247|NCT02136797|Memorial Sloan Kettering Cancer Center|Dr. Kevin Curran, MD|212-639-5836|currank@mskcc.org|
22389248|NCT04523571|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
22389249|NCT04198428|HealthPartners Institute|Dr. Rebecca Rossom, Co-Principal Investigator|952-883-5466|Rebecca.C.Rossom@HealthPartners.com|
22389250|NCT03473665|Columbia University|Runsheng Wang|212-305-4308|rw2646@cumc.columbia.edu|
22389251|NCT00627523|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22389252|NCT05030467|Brigham and Women's Hospial|Niteesh Choudhry|617-278-0930|nkchoudhry@bwh.harvard.edu|
22389253|NCT01933776|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22389254|NCT04203199|Wake Forest University Health Sciences|Colleen Hanlon, PhD|844-386-7001|DeepTMS@brainsway.com|
22389255|NCT01136733|Eisai Medical Inc.|Eisai Medical Services|1-888-422-4743||
22389256|NCT00113334|University of Texas (UT) MD Anderson Cancer Center|Edward Kim, MD, BS / Assistant Professor|713-792-6363|CR_Study_Registration@mdanderson.org|
22389257|NCT01882088|Federal research Center of Nutrition and Biotechnology|Dr Sergey Morozov, Senior Reseracher, Dpt Gastroenterology and Hepatology|+74996131091|morosoffsv@mail.ru|
22389258|NCT02186015|Loyola University Chicago|Patricia Sheean|708-216-0344|psheean1@luc.edu|
22389259|NCT00125619|VA Brain Rehabilitation Research Center|Dr. Carolynn Patten|352.376.1611|patten@phhp.ufl.edu|4160
22389260|NCT01533181|H. Lee Moffitt Cancer Center and Research Institute|Dr. Alberto Chiappori|813-745-2158|alberto.chiappori@moffitt.org|
22389261|NCT02720198|Duke University Medical Center|Dr. Narei Hong|984-215-8493|narei.hong@duke.edu|
22389262|NCT03897075|Sun Pharmaceutical Industries Limited|Head-Regulatory Affairs|2266455645|Clinical.Trial@sunpharma.com|5689
22389263|NCT02592434|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22389264|NCT00147745|Daiichi Sankyo, Inc|John Raia, Senior Director, Professional Affairs|(973) 944-2683|jraia@dsi.com|
22389265|NCT01757171|Weill Cornell Medical College|Navjot Kaur, GI Program Manager|646-962-9350|nak2028@med.cornell.edu|
22389266|NCT00103116|UKentucky|Edward Hirschowitz|8596081981|eahirs2@uky.edu|
22389267|NCT00105521|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center,|496151725200|service@merckgroup.com|
22389268|NCT00094497|University Hospital of Wuerzburg, Germany|Martin Fassnacht|+49-931-201-39021|fassnacht_m@ukw.de|
22389269|NCT00385697|Provention Bio, Inc|Sharon Rowland|443-987-0797|SRowland@proventionbio.com|
22389270|NCT03912298|University of Pennsylvania|Peggy Compton|2158986679|pcompton@nursing.upenn.edu|
22389271|NCT00427297|University of Washington|Grace John-Stewart|206 5434278|gjohn@uw.edu|
22389272|NCT00510783|Emory|Brittney Copeland|404-616-0301|bcopel3@emory.edu|
22389273|NCT00316121|Advanced Technologies and Regenerative Medicine, LLC|Manny Lazaro, Director, Clinical Affairs|508-828-2741|mlazaro@its.jnj.com|
22389274|NCT01979211|University of Cincinnati Cancer Center|Vinita Takiar, Associate Professor, MD|513-584-4775|vinita.takiar@uc.edu|
22389275|NCT02741297|Boston Scientific|Roshini Jain, Director of Clinical Sciences|6619494350|roshini.jain@bsci.com|
22415009|NCT01404988|VA New York Harbor Healthcare System|Sundar Natarajan, MD, M.Sc.|212-951-3395|sundar.natarajan@va.gov|
22415010|NCT04594252|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22415011|NCT04573309|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22415012|NCT00605150|Carolinas Healthcare System|David Iannitti, MD|704-446-4838|jessica.drummond@carolinashealthcare.org|
22415013|NCT01487499|University of Florida|Michael A. Jantz, MD|352-273-8737|michael.jantz@medicine.ufl.edu|
22415014|NCT01691430|Yale University|Dr. Manisha Juthani-Mehta|(203)785-4140|manisha.juthani@yale.edu|
22415015|NCT01894230|Duke University|Dr. Deepak Voora|919-668-1755|Deepak.vorra@duke.edu|
22415016|NCT01109849|Penn State College of Medicine|James Waxmonsky MD|7175318646|jwaxmonsky@pennstatehealth.psu.edu|
22415017|NCT02756949|World Bank|Ms Marelize Gorgens|0012024730547|mgorgens@worldbank.org|
22415018|NCT02219009|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22415019|NCT02259348|St. Jude Children's Research Hospital|Brandon M. Triplett, MD|901-595-2766|brandon.triplett@stjude.org|
22415020|NCT01622660|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin|646-422-4333|bajorind@mskcc.org|
22415021|NCT01086228|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com|
22415022|NCT02485158|University of Chicago|Dr. Harriet de Wit|773-702-1537|hdew@uchicago.edu|
22415023|NCT02664415|MHRP|Biostatistician|3015003715|spinyakorns@hivresearch.org|
22415024|NCT00642993|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22415025|NCT02034513|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22415026|NCT00960154|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com|
22415027|NCT00757705|Janssen Research & Development|Medical Director|886 2 23762155||
22415028|NCT03544242|University of Alabama at Birmingham|Adam Sturdivant, MPH|205-934-4042|Adamsturdivant@uabmc.edu|
22415029|NCT04408924|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22415030|NCT00486434|Nordic Bioscience A/S|Bente Juel Riis, Medical Director|+4522901317|bjr@nordicbioscience.com|
22415031|NCT02218541|University of North Carolina at Chapel Hill|Gidgetta Jenkins|919-537-3968|gidget_jenkins@unc.edu|
22415032|NCT04661202|National Cheng Kung University|Dr. Kuan-Yin Lin|06-2353535|10802003@gs.ncku.edu.tw|6737
22415033|NCT00856349|Medtronic Cardiac Rhythm Disease Management|Daniel Lexcen, Clinical Research Specialist|763-526-9702|daniel.lexcen@medtronic.com|
22415034|NCT02132910|DVCIPM|Chester Buckenmaier|301-816-4710|cbuckenmaier@dvcipm.org|
22415035|NCT02313558|Guanghua School of Stomatology, Sun Yat-sen University,|Dr. Hongchun Liu|0086-0-13826189071|hongchun751@sina.com|
22415036|NCT01981044|Allergan Medical|Marcio Torre, M.D., M.A., Medical Monitor|805-683-6761|torre_marcio@allergan.com|
22415037|NCT04158687|Concert Pharmaceuticals, Inc.|Colleen E. Hamilton|781-860-0045|AAclinicaltrial_inquiries@concertpharma.com|
22415038|NCT02856594|Massachusetts General Hospital|Dr, Oluwaseun Johson-Akeju|617-724-7200|oluwaseun.akeju@mgh.harvard.edu|
22452721|NCT02270450|SWOG Statistics and Data Management Center|Palliative and End of Life Care Committee Statistician|2066674623|karnold@fredhutch.org|
22415039|NCT00538031|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22415040|NCT00585286|University of California, Irvine|Christopher Zachary, FRCP, MBBS/Prinicipal Investigator|(949) 824-7103|czachary@uci.edu|
22415041|NCT02052895|Mochida Pharmaceutical|Hironori Sato|+81-3-3225-6331|hnsato@mochida.co.jp|
22415042|NCT03060486|AOU Careggi|Riccardo Pace, DMD|00390557945608|riccardo.pace@unifi.it|
22415043|NCT03358147|Pearl Therapeutics, Inc.|Pearl Therapeutics, Inc.|1-877-240-9479|information.center@astrazeneca.com|
22415044|NCT05143047|Vanderbilt University Medical Center|Alison Carroll, MD, MPH|615-875-5025|alison.carroll@vumc.org|
22415045|NCT02072096|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22415046|NCT03236311|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22415047|NCT00669162|University of Kansas Cancer Center|Xinglei Shen, MD|913-588-3600|ctnursenav@kumc.edu|
22415048|NCT02704091|Ipsen Pharma SAS|Medical Director|see email|clinical.trials@ipsen.com|
22415049|NCT02412852|TheraVasc Inc.|Tony Giordano|3183493851|tgiordano@theravasc.com|
22415050|NCT01051349|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
22415051|NCT05485662|UT Health San Antonio|Bennett Amaechi, BDS, MD, PhD|210 567 3185|amaechi@uthscsa.edu|
22415052|NCT01447511|University of Minnesota|Dr. Richard Brundage|612-624-3115|brund001@umn.edu|
22415053|NCT01439620|Massachusetts General Hospital|Gary Tearney, MD|Optical Frequency Domain Imagi|gtearney@partners.org|
22415054|NCT02336074|Imperial College London|Professor Sarah Fidler|004420331|s.fidler@imperial.ac.uk|26790
22415055|NCT03056144|The Hong Kong Polytechnic University|Dr Tamis W Pin|85227666751|tamis.pin@polyu.edu.hk|
22415056|NCT01694563|Atricure Inc.|Nfii K. Ndikintum, PhD, MBA / VP, Clinical Affairs and Biometrics|513-644-8192|NNdikintum@atricure.com|
22415057|NCT05604014|Mt. Hope Family Center, University of Rochester|Christie L. M. Petrenko, Ph.D.|5852752991|christie_petrenko@urmc.rochester.edu|241
22415058|NCT01026402|AstraZeneca|Bryony Harrop|01625 582828|ClinicalTrialTransparency@astrazeneca.com|
22415059|NCT00836758|University of Florida|Richard B. Berry, MD|352-262-1575|sleep_doc@msn.com|
22452722|NCT02363738|University Health Network|Dr. Roger McIntyre|416-603-5279|roger.mcintyre@uhn.ca|
22452723|NCT00601926|The Ohio State University Comprehensive Cancer Center|Paul Monk, MD|614-293-2886|Paul.Monk@osumc.edu|
22452724|NCT03369444|University College London|Pratima Chowdary|+44(0)20 7472 6835|p.chowdary@ucl.ac.uk|
22452725|NCT01968213|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
22452726|NCT01762046|Massachusetts General Hospital|Jose C. Florez, MD, PhD|6176433308|jcflorez@partners.org|
22452727|NCT01581281|Cincinnati Children's Hospital Medical Center|Scott Powers, PhD|513-636-8106|scott.powers@cchmc.org|
22452728|NCT04458948|UNM HSC|Cristina Beato|505-272-1734|CBeato@salud.unm.edu|
22389276|NCT01368874|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
22389277|NCT02100189|OHSU|John Hunter, MD|503-494-4937|hunterj@ohsu.edu|
22415060|NCT01266902|Janssen Research & Development, LLC|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22415061|NCT03616379|McLean Hospital|Dr. R. Kathryn McHugh|617-855-2000|kmchugh@mclean.harvard.edu|
22415062|NCT00840203|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22415063|NCT02121184|Northwestern University|Paul Fitzgerald|312 695 1064|p-fitzgerald2@northwestern.edu|
22415064|NCT03349567|Iowa City VA Health Care System|Daniel Livorsi|319-688-3871|daniel-livorsi@uiowa.edu|
22415065|NCT04567329|Bausch & Lomb|Daniel Donatello|5853385306|Daniel.Donatello@bausch.com|
22415066|NCT02463981|UESTC|Prof. Keith Kendrick|+86028-61830811|k.kendrick.uestc@gmail.com|
22415067|NCT00875524|Sanofi Pasteur SA|Medical Director||Contact-US@sanofi.com|
22415068|NCT03082586|Department of Radiation Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China|Dr tingfeng Chen|86-021-37798364|tingfeng138138@163.com|
22415069|NCT01296841|VA Palo Alto|Roy Soetikno|650-493-5000|soetikno@earthlink.net|64800
22415070|NCT03867838|Stanford University|Cole Simpson|4049077708|cole.simpson@stanford.edu|
22431013|NCT01397253|University of Pittsburgh|Kenneth J Smith, MD, MS|4126474794|smithkj2@upmc.edu|
22431014|NCT00775658|Vanderbilt Medical Center|John Fahrenholz, M.D.|615-936-2727|john.m.fahrenholz@vanderbilt.edu|
22431015|NCT00889330|Johnson & Johnson Vision Care, Inc.|Arthur Shedden, MD|904-443-1557|ashedden@its.jnj.com|
22431016|NCT02956473|Dana-Farber/Brigham Cancer Center|Dr. Tari King|617-582-8292|tking7@bwh.harvard.edu|
22431017|NCT03033784|The University of Toledo|Elissar Andari, PhD|419-383-5227|elissar.andari@Utoledo.edu|
22431018|NCT00267488|GlaxoSmithKline|GSK Response Center|866-435-7343||
22431019|NCT02093520|Vertos Medical|VP of Clinical Affairs|9493490008|kdavis@vertosmed.com|
22431020|NCT00851084|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
22431021|NCT04033640|PATH|Pooja Bansil|206 302 4920|pbansil@path.org|
22431022|NCT01892189|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22431023|NCT01599286|Children's National Hospital|Robert McCarter|202-476-3140|RMcCarte@childrensnational.org|
22431024|NCT02263547|University of South Florida, COM Neurology|Assistant Director of Research|8139746378|aaungst@health.usf.edu|
22431025|NCT00856557|Jesse Brown VA Medical Center|Dr. Saul J. Weiner|3125192697|Saul.Weiner@va.gov|
22431026|NCT02301897|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22431027|NCT00337168|SWOG Statistical Office|SWOG Leukemia Statistician|206-667-4623||
22431028|NCT01382108|Centre for Contact Lens Research|Kathy Dumbleton|519-888-4567|kdumble@uwaterloo.ca|32694
22431029|NCT02684461|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat Canter|(919) 962-0000|gmelahat@med.unc.edu|
22431030|NCT03663582|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22431031|NCT02069847|Mayo Clinic|Michael B. Wallace|507-953-2221|wallace.michael@mayo.edu|
22431032|NCT04189484|U.S. Food and Drug Administration|David Strauss, MD, PhD|3017966323|David.Strauss@fda.hhs.gov|
22431033|NCT00557440|Novartis Pharmaceuticals|Study Director|862-778-8300||
22431034|NCT00814983|Duke University Medical Center|Mitchell Horwitz, MD|919-668-1045|Mitchell.Horwitz@duke.edu|
22431035|NCT04507763|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22431036|NCT06582732|Glaukos Corporation|Study Director|714-478-2287|ldoan@glaukos.com|
22431037|NCT03931330|Medical College of Wisconsin|Gisela Chelimsky, MD|414-266-3690|gchelimsky@mcw.edu|
22431038|NCT03412929|Medline Industries, Inc|Stephanie Martynenko|2242163822|smartynenko@medline.com|
22431039|NCT04330859|University of Virginia Children's Hospital|Santina Zanelli|4349242697|sz5d@virginia.edu|
22431040|NCT04897568|University of Colorado|Dan Mattlock|(303)724-9941|daniel.matlock@cuanschutz.edu|
22431041|NCT01381679|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22431042|NCT01674062|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22431043|NCT04661839|Emergent BioSolutions Canada Inc.|Clinical Development Representative|204-275-4074|ctgov@ebsi.com|
22431044|NCT03895372|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22452729|NCT02087163|Align Technology|Allison Mossing|4084701056|amossing@aligntech.com|
22431045|NCT03685149|University of Rochester|Dr. Wojciech Zareba|585-275-5391|wojciech_zareba@urmc.rochester.edu|
22431046|NCT06301815|University of Winchester|Amelia Shaw|01962 717478|a.shaw2.18@unimail.winchester.ac.uk|
22431047|NCT02951819|Janssen Scientific Affairs|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22452730|NCT02081846|Cincinnati Children's Hospital Medical Center|Dr. Heidi Sucharew (Biostatistician)|513-803-1920|heidi.sucharew@cchmc.org|
22452731|NCT03265600|Cambridge Health Alliance|Dr. Zev Schuman-Olivier|617-591-6132|zschuman@cha.harvard.edu|
22452732|NCT00535730|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22452733|NCT00295750|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
22452734|NCT01650259|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22389278|NCT01648491|Beaumont Hospital - Royal Oak|Kenneth Peters MD|248-551-0387|Kenneth.Peters@Beaumont.org|
22415071|NCT00574847|Duke University Medical Center|Wei Jiang, MD|919-668-0762|jiang001@mc.duke.edu|
22415072|NCT00957021|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@Stryker.com|
22431048|NCT01881932|University of Maryland Baltimore Greenebaum Cancer Center|Michelle Medeiros|410-328-1160|mmedeiros@umm.edu|
22431049|NCT00581919|University of Wisconsin Hospital and Clinics|Dr. Natalie Callander|608-265-8690|nsc@medicine.wisc.edu|
22431050|NCT02034565|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22431051|NCT00823797|University of Washington|Maciej Mrugala, MD, PhD, MPH|206-543-4069|mmrugala@uw.edu|
22401833|NCT05136885|Healey Center for ALS at Massachusetts General Hospital|Healey Center for ALS Project Management|833-425-8257|healeyalsplatform@mgh.harvard.edu|(HALT ALS)
22401834|NCT02653092|University of Colorado School of Medicine|Dr. Nanette Santoro|303-724-2041|Nanette.Santoro@uanschutz.edu|
22401835|NCT00128206|University of California, San Francisco|Mary White|415-476-5213|mary.white@nursing.ucsf.edu|
22401836|NCT03459131|Alcon, A Novartis Division|Sr Clinical Project Lead, GCRA - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22401837|NCT03032068|Cleveland Clinic|Jayson Zadzilka|216-445-8023|zadzilj@ccf.org|
22401838|NCT01597622|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22401839|NCT00408421|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22401840|NCT02772965|University of North Carolina at Chapel Hill|Michael Kappelman, MD, MPH|919-966-1343|michael_kappelman@med.unc.edu|
22401841|NCT00710034|University of Minnesota|Dorothy Hatsukami, Ph.D.|612-626-2121|hatsu001@umn.edu|
22401842|NCT00494871|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22401843|NCT03825042|A.Menarini Industrie Farmaceutiche Riunite Srl|Director of Clinical Operations|0039 055 5680459|pfabrizzi@menarini.it|
22401844|NCT05085392|Montana State University|Dr. Lauren Davis|8287736328|laure.davis6@montana.edu|
22401845|NCT00521339|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22401846|NCT03314519|Mahidol University|Kasana Raksamanee|66967841010|kasana@gmail.com|
22401847|NCT01819935|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22401848|NCT04003155|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22401849|NCT02435173|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22401850|NCT01912872|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22401851|NCT02392208|University of Michigan|Dr. Bruce A. Mueller|734-763-6629|muellerb@med.umich.edu|
22401852|NCT01277289|Erydel|Angelo Andriulli, MD|+39 882 410784|aandriulli@operapadrepio.it|
22401853|NCT00935857|Northwestern University|Rajesh N. Keswani|312-695-5620|raj-keswani@northwestern.edu|
22401854|NCT04760314|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22401855|NCT02657252|UPECLIN|Dr. Matheus Bertanha|+551438116305|matheus.fameca@ig.com.br|
22401856|NCT02024711|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22401857|NCT01215318|University Hospital of Zurich|Irene A Burger|+41 44 255 11 11|irene.burger@usz.ch|
22401858|NCT03132246|University of Maryland School of Medicine|Dr. Aaron Johnson|410-328-1868|ajohnson1@som.umaryland.edu|
22401859|NCT01372878|Given Imaging|"Ravit Peled | Biostatistics and Data Management Manager"|+972 (4) 909-7894|ravit.peled@givenimaging.com|7894
22401860|NCT05057988|Stanford University|Dr. Dokyoung Sophia You|650-724-9320|dsyou@stanford.edu|
22401861|NCT00621933|Allergan, Inc|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22401862|NCT02616029|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22401863|NCT00479466|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22401864|NCT02383719|Convergent Engineering|Study Coordinator|3523784899|carl@conveng.com|113
22401865|NCT02739698|University Hospital Reina Sofia, Cordoba, Spain|Angela Casado-Adam, MD|0034957010439|angeti@hotmail.com|
22401866|NCT03626415|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22401867|NCT01842464|Western Galilee MC|Menahem Neuman|+972546444033|mneuman@netvision.net.il|
22401868|NCT02544984|The University of Texas Health Science Center at Houston|Ricardo A. Mosquera, MD|(713) 500-5650|Ricardo.A.Mosquera@uth.tmc.edu|
22401869|NCT02487745|Johns Hopkins University School of Medicine|Kenneth Silverman|4105502694|ksilverm@jhmi.edu|
22401870|NCT00532883|NHLBI|Harvey Luksenburg|301-435-0050|luksenburgh@mail.nih.gov|
22401871|NCT02075255|AstraZeneca|Mitchell Goldman, Global Clinical Lead Benralizumab|+1 301 398 0323|Mitchell.Goldman@astrazeneca.com|
22401872|NCT01469013|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22401873|NCT05232097|Helsinki University Hospital|Dr. Jari Punkkinen|+358 50 427 9864|jari.punkkinen@hus.fi|
22401874|NCT05748925|mansoura urology and nephrology center|Nourelsabah Mohamed Elbialy , consaltant nephrology|01065619243|nourelsabah@mans.edu.eg|
22401875|NCT02902809|AstraZeneca|Global Clinical Lead|+1 301-398-0582|ClinicalTrialTransparency@astrazeneca.com|
22401876|NCT00532259|CureTech Ltd.|Director Clinical Resaerch|+972-8-9324000|talh@curetechbio.com|
22401877|NCT00871858|Institut Bergonié, Medical Oncology department|Dr. Nathalie Quenel-Tueux|05.56.33.33.33|N.Quenel-Tueux@bordeaux.unicancer.fr|
22401878|NCT01847547|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22401879|NCT04392011|Washington State University|Dr. Mary Paine|509-358-7759|mary.paine@wsu.edu|
22401880|NCT02795767|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22401881|NCT04983940|University of Miami, Miller School of Medicine - Desai Sethi Urology Institute|Dr. Ranjth Ramasamy|305-243-6596|Ramasamy@miami.edu|
22415073|NCT02442687|Duke University|Dr. Manal F. Abdelmalek|919-684-8356|manal.abdelmalek@duke.edu|
22389279|NCT00460577|Novartis Pharmaceuticals|Study Director|862-778-8300||
22389280|NCT02732899|Raj K. Maturi, MD, PC|Raj K. Maturi, MD|317-817-1414|rmaturi@gmail.com|
22389281|NCT02790788|National and Kapodistrian University of Athens|Associate Professor in Intensive Care Medicine|00302132043307|sdmentzelopoulos@yahoo.com|
22389282|NCT05607147|Rutgers School of Dental Medicine, Newark, New Jersey, United States|Gayathri Subramanian, PhD, DMD|7328247241|subramga@sdm.rutgers.edu|
22389283|NCT01721109|Gilead Sciences|Gilead Clinical Study Information Center||GileadClinicalTrials@gilead.com|
22389284|NCT00134056|University of Southern California Norris Comprehensive Cancer Center|Dr. David I Quinn|3238653956|diquinn@med.usc.edu|
22389285|NCT02035345|Massachusetts General Hospital|Dr. Aleena Banerji|6177263850|abanerji@mgh.harvard.edu|
22389286|NCT00742560|AbbVie|Global Medical Services|800-633-9110||
22401882|NCT01748760|Brown University|Shirley Yen, Ph.D.|401-444-1915|Shirley_Yen_PhD@Brown.edu|
22401883|NCT04337138|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22401884|NCT00044044|Sunovion|Josephine Cucchiaro, Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com|
22401885|NCT01004146|University of Texas at Houston Medical School / Dept. of Anesthesiology|Dr. Davide Cattano|713-500-6235|davide.cattano@uth.tmc.edu|
22401886|NCT01269034|Albert Einstein College of Medicine|Roger Hicks, Administrative Director for Research - Department of Pediatrics|718-920-7386|roger.hicks@einsteinmed.org|
22401887|NCT04286867|Kent State University|William Lechner|8144501093|wlechner@kent.edu|
22401888|NCT03863496|Ilizarov centre|Sergey Raybukh|+79226716007|rso_@mail.ru|
22431052|NCT03232567|Altimmune|Stephanie Holland, Clinical Project Manager|240-654-1450|sholland@altimmune.com|40
22431053|NCT02655601|BioMimetix JV, LLC|Sara Penchev|610-308-6640|sara.penchev@bmxpharma.com|
22431054|NCT05837481|Massachusetts General Hospital|Chien Yi Maximilian Png, MD|617-726-5308|cypng@mgh.harvard.edu|
22431055|NCT02014376|Amicus Therapeutics, Inc.|Patient Advocacy|+1-609-662-2000|clinicaltrials@amicusrx.com|
22431056|NCT01833078|University of Pennsylvania|Dr. Anne Cappola, PI|215-573-5359|acappola@mail.med.upenn.edu|
22431057|NCT02135133|Dana-Farber Cancer Institute|Jennifer R. Brown, MD, PhD|(877) 442-3324|Jennifer_Brown@dfci.harvard.edu|
22431058|NCT03408262|Imperial College London|Research Integrity Officer|020 7594 1872|rgit@imperial.ac.uk|
22431059|NCT03607500|University of Michigan|Abhijit Naik|734-763-0990|abhinaik@med.umich.edu|
22431060|NCT03312543|Johnson & Johnson Consumer Inc.|Sidney Hornby|908-874-2756|SHornby@its.jnj.com|
22431061|NCT04507269|Brii Biosciences Limited|Clinical Research|86 10 6299 8808|clinicaltrials@briibio.com|
22431062|NCT05852340|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22431063|NCT02120261|The University of Texas Health Science Center at Houston|Carlos J. Roldan, MD||Carlos.J.Roldan@uth.tmc.edu|
22431064|NCT00071032|Rutgers Robert Wood Johnsom Medical School|Jeffrey L Carson, MD|732-235-7122|Jeffrey.Carson@rutgers.edu|
22431065|NCT04197583|Boston Scientific|Director, Clinical Operations|5133058628|teresa.takle-flach@bsci.com|
22431066|NCT00375713|UCB Pharma|UCB Clinical Trial Call Center|+ 1 877 822 9493||
22401889|NCT03534271|Rush University|Dr. Jonathan Brady Scott|3129426389|jonathan_b_scott@rush.edu|
22401890|NCT01855789|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22401891|NCT01863758|Octapharma|Sylvia Werner|415 260-9577|sylvia.werner@octapharma.com|
22401892|NCT04331730|Alkahest, Inc.|Head of Communications|(650) 801-0474|trials@alkahest.com|
22401893|NCT02975349|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22401894|NCT01663740|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22401895|NCT02658656|James J Peters VA Medical Center|Dr. Ann Spungen, Study Chairperson|7185849000|ann.spungen@va.gov|5814
22401896|NCT02112448|Advocate Children's Hospital|Jamie Penk|7086845580|jamie.penk@advocatehealth.com|
22401897|NCT03625986|Penn State College of Medicine|Dr. Jonathan Foulds|(717) 531-3504|jfoulds@pennstatehealth.psu.edu|
22401898|NCT04359823|MUSC|Gabriella Santa Lucia|724-413-8833|santaluc@musc.edu|
22401899|NCT01850563|Dartmouth-Hitchcock Medical Center|Alan Hartford, MD, PhD, FACR, Professor of Medicine (RadOnc) Director, Radiation Oncology|603-650-6600|Alan.C.Hartford@Hitchcock.org|
22401900|NCT01842061|The University Of British Columbia|Associate Professor MC Ashe|604-675-2574|maureen.ashe@ubc.ca|
22401901|NCT04220489|UPMC|Jacques E. Chelly, MD, PhD, MBA|412-623-6904|chelje@anes.upmc.edu|
22401902|NCT00912158|Chest Department, Faculty of Medicine, Assiut University- EGYPT|Dr. Maha K Ghanem, MD, FCCP|+ 2 0127694434|mahaghanem@hotmail.com|
22401903|NCT02338076|Rockefeller University|Dr. Emma Guttman|212-327-8333|skhattri@rockefeller.edu|
22401904|NCT05047640|University of Miami|Giselle Guerra|3053555803|gguerra@med.miami.edu|
22401905|NCT03132805|Johns Hopkins University|Nicholas S. Ialongo, Principal Investigator|410-493-1252|nialong1@jhu.edu|
22401906|NCT03009539|University of Miami|Guillermo Prado|305-284-2002|gprado@miami.edu|
22401907|NCT04543955|University of Kentucky|Dr. Lowell Anthony|859-323-8043|lowell.anthony@uky.edu|
22401908|NCT03918642|VA Greater Los Angeles Healthcare System|Brandon C. Yarns|310-478-3711|brandon.yarns@va.gov|
22401909|NCT03046472|Maccabi Health services and Wingate college|Neta Vitman|0508955529|vitmanan@gmail.com|
22401910|NCT03823937|Sultan.abdulhamid|Tugbaozsoy|+905074583382|tugbaozsoyy@gmail.com|
22401911|NCT04985799|University of North Carolina at Chapel Hill|Jennifer Wu, MD, MPH, Professor of OBGYN|919-966-0014|jennifer_wu@med.unc.edu|
22452735|NCT00936858|Dana-Farber Cancer Institute|Dr. Glenn Hanna|6176323090|glenn_hanna@dfci.harvard.edu|
22452736|NCT01289912|Boston Children's Hospital|Dr. Mustafa Sahin|617-355-8994|Mustafa.Sahin@childrens.harvard.edu|
22452737|NCT00626431|Abbott|Global Medical Services|800-633-9110||
22452738|NCT00802854|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22452739|NCT01683864|University Clinic of Tübingen|Prof. Alfred Königsrainer|0049 7071 2983290|silvia.wagner@med.uni-tuebingen.de|
22452740|NCT01298128|Mount Sinai Hospital|Dr. Kimberly Liu|416-586-5367|kliu@mtsinai.on.ca|
22452741|NCT00584727|Vistakon|Kurt Moody, OD, FAAO|904-443-3088||
22452742|NCT04072159|Arizona State University, College of Health Solutions|Dr. Alexis Koskan (Assistant Professor)|602-827-2792|alexis.koskan@asu.edu|
22452743|NCT01177904|IVI Madrid|Dr. Graciela Kohls|91 180 29 00|graciela.kohls@ivi.es|
22452744|NCT02293044|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
22452745|NCT00989287|GlaxoSmithKline|GSK Response Center|866-435-7343||
22415074|NCT00819169|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
22452746|NCT00695669|GlaxoSmithKline|GSK Response Center|866-435-7343||
22452747|NCT00092131|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22452748|NCT02341417|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22452749|NCT02512575|AstraZeneca AB|Global Clinical Leader|+46 766 346712|clinicaltrialtransparency@astrazeneca.com|
22452750|NCT01047839|Valneva Austria GmbH|Senior Scientist Clinical Research|+43 1 206 20|katrin.dubischar-kastner@valneva.com|1175
22452751|NCT02726451|DeNova Research|Steven Dayan, MD|3123352070|sdayan@drdayan.com|
22452752|NCT03570619|University of Michigan Rogel Cancer Center|University of Michigan Cancer Center Admin|7349369499|ClinicalTrialsgov_CCAdmin@umich.edu|
22452753|NCT04773587|Arcutis|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
22452754|NCT03858803|Portland State University|Dr. Janet S. St. Lawrence|971-978-7801|janetsstlawrence@gmail.com|
22452755|NCT00955877|Washington University in St. Louis School of Medicine|Diego Morales|3144544688|d.morales@wustl.edu|
22452756|NCT00435370|Baylor College of Medicine|Dr. Thomas R. Kosten|(713) 794-7032|kosten@bcm.edu|
22452757|NCT00746603|Weill Cornell Medicine|Jennifer Levine, MD|212-305-9770|jel9022@med.cornell.edu|
22415075|NCT01822119|The HEARing CRC & Hearworks, Audiology Hearing and Speech Science, Melbourne, Australia|Professor Robert Cowan|+61 3 9035 5346|r.cowan@unimelb.edu.au|
22415076|NCT00431041|Astellas Pharma Global Development|Astellas Medical Monitor||ClinicalTrials@us.astellas.com|
22415077|NCT02637141|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22415078|NCT01991548|Medtronic Diabetes|Clinical Research Manager|818-576-5000||
22415079|NCT03031795|OhioHealth|John O. Elliott PhD, MPH Research Specialist Medical Education|614-566-3643|john.elliott@ohiohealth.com|
22415080|NCT01155531|Theracos, Inc|Monica Tettamanti, MSc|617-643-5696|mtettamanti@ccib.mgh.harvard.edu|
22415081|NCT02705716|GlaxoSmithKline|GSK Response Center|866-435-7343||
22415082|NCT00562718|UT Southwestern Medical Center|ann spangler|(214) 648-3111|ResearchRegistry@utsouthwestern.edu|
22415083|NCT04025021|MetroHealth Medical Center|Stephanie Merlino Barr|216-778-3269|SMERLINO@METROHEALTH.ORG|
22431067|NCT03637348|Cornea Research Foundation of America|Marianne Price, PhD|3178142990|mprice@cornea.org|
22452758|NCT02132611|Cardiovascular Systems, Inc.|Clinical Project Manager|651-259-1600|clinicaltrials_csi@csi360.com|
22452759|NCT00581529|University of Michigan Comprehensive Cancer Center|Dr. Lori Pierce, M.D.|734-764-9922|ljpierce@umich.edu|
22452760|NCT01965834|University of Miami|Denise Pereira MD|305-243-4909|dpereira2@med.miami.edu|
22452761|NCT00158743|BTG International Inc|Suzanne Ward Pharm D|610-278-1660|suzanne.ward@btgplc.com|
22452762|NCT03674177|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22452763|NCT02493127|Massachusetts General Hospital|Taylor Pong, Research Coordinator|617-726-1569|tpong1@partners.org|
22452764|NCT02037347|Yale University|Brett King MD|203-785-4092|brett.king@yale.edu|
22452765|NCT00670774|Mayo Clinic|Dr. Mark D. Stegall|507-284-6275|Stegall.Mark@mayo.edu|
22452766|NCT03143218|London School of Hygiene and Tropical Medicine|Professor Brian Greenwood|+442072994707|brian.greenwood@lshtm.ac.uk|
22389287|NCT02438410|Mayo Clinic|Dr. Darrell Pardi|(507) 538-1827|pardi.darrell@mayo.edu|
22452767|NCT00809757|Sunovion|Respiratory Medical Director|1-866-503-6351||
22452768|NCT00253864|Ottawa Hospital Research Institute|Clinical Research Coordinator|613-737-8899|kmcilquham@ohri.ca|79839
22452769|NCT00659334|OHSU Knight Cancer Institute|Dr. Edward Neuwelt|503-494-5626|neuwelte@ohsu.edu|
22452770|NCT03034577|The University of Melbourne|Prof Colin Royse|+61408467548|Colin.Royse@unimelb.edu.au|
22452771|NCT01174342|Meir Medical Center|Amit Meshi|+972523580222|amitmeshi@gmail.com|
22452772|NCT02625623|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22452773|NCT00744653|Copenhagen University Hospital Herlev|MD Louise Wichmann Matthiessen|+ 45 38 68 98 58|louise.wichmann.matthiessen@gmail.com|
22452774|NCT00374842|GlaxoSmithKline|GSK Response Center|866-435-7343||
22452775|NCT01316926|GlaxoSmithKline|GSK Response Center|866-435-7343||
22452776|NCT03826667|Smith+Nephew, Inc.|Judith Horner|+44 1482 673251|Judith.horner@smith-nephew.com|
22452777|NCT00808808|MedImmune, LLC|Seth Toback, MD|301-398-0000|tobacks@medimmune.com|
22452778|NCT01681589|NYU Langone Health|Prin Amorapanth, MD, PhD|212-263-6037|Prin.Amoropanth@nyulangone.org|
22452779|NCT02298192|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22452780|NCT02649868|Clinical Center|Wood, Bradford|+1 301 496 7739|bwood@mail.cc.nih.gov|
22452781|NCT02352948|AstraZeneca|Medical Science Director|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22452782|NCT01995123|Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health; William S Middleton Memorial Veterans Hospital|Jessica Cook, PhD|608-265-9775|jwcook@ctri.wisc.edu|
22452783|NCT03166761|Vanderbilt University Medical Center|Byron Schneider|(615)936-7708|byron.j.schneider@vumc.org|
22415084|NCT00840879|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22415085|NCT00477594|Genzyme Corporation|Genzyme Medical Information|617-252-7832||
22389288|NCT01536795|Institut Pasteur, Tunisia|Afif Ben Salah, MD|011-216-71-792-429|afif.bensalah@pateur.rns.tn|
22389289|NCT02267746|Teva Pharmaceuticals USA, Inc.|Director, CE Studies|1-888-483-8279|USMedinfo@tevapharm.com|
22389290|NCT05008224|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22389291|NCT00348283|Abbott|Medical Information Specialist|800-633-9110||
22389292|NCT02051972|Abbott Medical|Nicole Harbert|1-972-526-4841|nicole.harbert@abbott.com|
22389293|NCT02091102|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22389294|NCT00596960|VAMC|Eric Dieperink, MD|612-467-3964|eric.dieperink@va.gov|
22389295|NCT04016415|Milton S. Hershey Medical Center, Penn State Hershey College of Medicine|Dr. Nazia T Raja-Khan, M.D., M.S., Associate Prof, Dept of Medicine, Div. of Endocrin & Diabetes|717-531-8395|nrajakhan@pennstatehealth.psu.edu|
22389296|NCT01885559|Mayo Clinic|Dr. Vicente Torres||torres.vicente@mayo.edu|
22389297|NCT05777772|University of Washington|Dr. Elizabeth Phelan|(206) 520-5000|phelane@uw.edu|
22389298|NCT00732498|University of Arizona|NCTN Program Coordinator|520-626-0301|aselegue@email.arizona.edu|
22389299|NCT04295499|Unicon Optical Co., Ltd.|Dr. Jimmy Chou|+88635775586|ra@uniconvision.com.tw|1307
22389300|NCT00308113|University of Pittsburgh|Dr. Paula R. Clemens|412-648-9762|pclemens@pitt.edu|
22389301|NCT01892007|NIHR Nottingham Biomedical Research Centre, University of Nottingham|Dr Helen Henshaw|+44 (0)115 8232606|helen.henshaw@nottingham.ac.uk|
22389302|NCT01613807|Sansum Diabetes Research Institute|Dr. Kristin Castorino|8056827640|kcastorino@sansum.org|256
22389303|NCT00705614|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22389304|NCT02661490|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22389305|NCT01232569|Hoffmann-La Roche|Medical Communications|800 821-8590||
22389306|NCT02388932|Cleveland Clinic, Case Comprehensive Cancer Center|Shlomo Koyfman, MD|216-444-7552|koyfmas@ccf.org|
22389307|NCT04588246|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22389308|NCT05335005|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22389309|NCT05927753|Bruno Vision|Richard E Lippman|301-580-3931|richard.lippman@gmail.com|
22389310|NCT02123797|Baptist Cancer Center|Dr. Raymond Osarogiagbon|901-752-6131|Raymond.Osarogiagbon@bmg.md|
22389311|NCT02132598|UPMC Hillman Cancer Center|Barbara Stadterman, MPH MCCR|412-647-5554|stadtermanbm@upmc.edu|
22389312|NCT01375777|Amgen Inc.|Study Director|866-572-6436||
22389313|NCT00355784|University of Michigan, Ann Arbor, Michigan|Jeffrey F. Horowitz|734-647-1076|jeffhoro@umich.edu|
22389314|NCT01093976|University of Minnesota|Jon E. Grant|612-273-9800|grant045@umn.edu|
22389315|NCT00376935|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22389316|NCT00406276|Emory University|Dr.Suresh Ramalingam, MD|404-778-5378|ssramal@emory.edu|
22389317|NCT03602053|PATH|Dr Niraj Rathi, MD; Senior Medical Officer|+91 11 4064 0000|nrathi@path.org|
22389318|NCT01769352|Johns Hopkins University School of Medicine|Dr. Peter A. Campochiaro|410-955-5106|pcampo@jhmi.edu|
22389319|NCT04203225|Harbor-UCLA Medical Center|Kelly D. Young, MD|424-306-5431|kyoung3@dhs.lacounty.gov|
22389320|NCT03672188|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
22389321|NCT01234675|Cleveland Sleep Research Center|Mansoor Ahmed, MD|4402438044|sleepresearchcenter@yahoo.com|
22389322|NCT03997409|Vanderbilt University Medical Center|Dr. Sara Duffus|+1 (615)322-7427|sara.duffus@vumc.org|
22389323|NCT03696342|Medical Affairs Operations Chief|Dr. Alejandra Sanchez-Rios|33 3001 4200|alejandra.sanchez@sophia.com.mx|1190
22389324|NCT05065918|The University of Arkansas for Medical Sciences|Jocelyn Anderson|501-686-7712|andersonjocelyn@uams.edu|
22389325|NCT02409732|Dartmouth-Hitchcock Medical Center|Dr. Michael Shane Chapman Section Chief of Dermatology|603-650-3106|Michael.Shane.Chapman@hitchcock.org|
22389326|NCT00553800|Hossein.Borghaei@fccc.edu|Hossein Borghaei|215-214-4297|Hossein.Borghaei@fccc.edu|
22389327|NCT01753323|Novartis Pharmaceuticals|Study Director|862-778-8300||
22389328|NCT01870999|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Medical Affairs|800-562-3974||
22389329|NCT01636258|The Cleveland Clinic|Adam M. Bernstein MD|216-448-8538|bernsta2@ccf.org|
22389330|NCT01838499|AstraZeneca|Humphrey Gardner MD FCAP|+1 781 839 4523|Humphrey.Gardner@astrazeneca.com|
22389331|NCT03614923|AnaptysBio, Inc.|Clinical Project Leader|858-362-6295|info@anaptysbio.com|
22389332|NCT03416335|Sumitomo Pharma America|Reyna Bishop|617-674-6800|reyna.bishop@us.sumitomo-pharma.com|
22389333|NCT03034772|Wills Eye Physicians, Mid Atlantic Retina|Jason Hsu, MD|215-928-3092|research@midatlanticretina.com|
22389334|NCT00116584|ULouisville|Dr. In Kim|502-629-7212|in.kim@louisville.edu|
22389335|NCT01745380|University of Pennsylvania School of Dental Medicine|Elliott V. Hersh, Principal Investigator|215-898-9686|evhersh@pobox.upenn.edu|
22389336|NCT02660034|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22389337|NCT02333071|AMAG Pharmaceuticals|Medical Information|1-877-411-2510|amag@druginfo.com|
22389338|NCT03863184|Weill Cornell Medicine|Jia Ruan, MD, PhD|646-962-2064|jruan@med.cornell.edu|
22389339|NCT00828542|Sao Paulo University|Dr. Milena Bastos Brito|551636022814|milenabastos@usp.br|
22389340|NCT01106586|Gilead Sciences, Inc|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22389341|NCT01318356|Radboud university medical center|S.P. Keijmel, MD PhD|0031243611111|stephan.keijmel@radboudumc.nl|
22389342|NCT03045302|Ipsen|Medical Director|Use email address below|clinical.trials@ipsen.com|
22415086|NCT03809000|American College of Radiology|Wendy Seiferheld|2155743208|wseiferheld@acr.org|
22389343|NCT04453709|University of Massachusetts Amherst|Kalpana Poudel-Tandukar, Associate Professor|413-545-5095|kalpana@umass.edu|
22415087|NCT02998541|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22389344|NCT03590847|University of Florida|Dr. Stephen Anton|(352) 273-7514|santon@ufl.edu|
22389345|NCT05878522|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22389346|NCT05263492|Virginia Commonwealth University Massey Cancer Center|Massey IIT Research Operations|804-628-6430|masseyepd@vcu.edu|
22389347|NCT03747575|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22389348|NCT02916745|on behalf of Concordia Laboratories Inc./Advanz Pharma|Kim McDonald-Taylor|647-267-2942|kmcdonald-taylor@rogers.com|
22389349|NCT03953079|Graybug Vision|Executive Director, Biostatistics|650-459-4235|pdinh@graybug.vision|
22389350|NCT00936065|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22389351|NCT00939211|AstraZeneca|Gerard Lynch|+441509645895|clinicaltrialtransparency@astrazeneca.com|
22389352|NCT02228889|The Ohio State University Wexner Medical Center|Dr. Jeffrey Janis|(614) 297-2913|jeffrey.janis@osumc.edu|
22389353|NCT02260154|Abbott|Tatiana V. Vladimirova MD, PhD|+7 495-258-4280|tatiana.vladimirova@abbott.com|
22389354|NCT03560206|University of Kentucky|Misook Chung, PhD|(859) 323-8024|misook.chung@uky.edu|
22415088|NCT03540160|Menlo Therapeutics, Inc.|Iain Stuart, PhD|1-800-775-7936|Iain.Stuart@foamix.com|
22415089|NCT01944722|Becton, Dickinson and Company|Clinical Study Manager|410-316-4000|BDClinicalTrials@bd.com|
22415090|NCT01923740|Abbott Vascular|Siok Hwee Tan|+1 408-845-3581|siokhwee.tan@abbott.com|
22415091|NCT02312154|Konkuk University|Yang Won Lee|8220305172|20130112@kuh.ac.kr|
22415092|NCT03345420|Huntsman Cancer Institute/University of Utah|Clinicaltrials.gov/CTRP Specialist|8012136215|IITDataManagement@hci.utah.edu|
22415093|NCT02890992|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22415094|NCT02674711|Brooke Army Medical Center|Dr Dan Rhon|210-916-3303|daniel.i.rhon.ctr@mail.mil|
22415095|NCT00979147|Minneapolis VAMC|Terence Gioe M.D.|612-467-1780|tjgioe@gmail.com|
22415096|NCT02933060|Cooper University Health System|Dr. Christopher Jones|856-342-2627|jones-christopher@cooperhealth.edu|
22415097|NCT01945580|Boston Scientific|Director, Clinical Operations|952-930-6000|teresa.takle-flach@bsci.com|
22415098|NCT02045108|The Mind Research Network|Dr. Eric Claus|505-272-5028|eclaus@mrn.org|
22415099|NCT00073307|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22389355|NCT01549951|Takeda|Medical Director|+1-866-835-2233|GlobalOncologyMedinfo@takeda.com|
22389356|NCT03266419|Asan Medical Center|Dr. Byung-Moon Choi|82-2-3010-1704|byungmoonchoi7@gmail.com|
22389357|NCT00738400|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22389358|NCT02255474|The Ohio State University|Dr. Jeffrey Walline|614-247-6840|walline.1@osu.edu|
22389359|NCT02394912|Volcano|VP Clinical Trials|858-720-8731|jonathan.batiller@philips.com|
22389360|NCT01127737|Northwestern University|June Robinson, MD|312-695-6624|june-robinson@northwestern.edu|
22389361|NCT02993926|Takeda|Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
22389362|NCT01082159|Vertos Medical|VP Clinical Research|949-349-0008|cmyers@vertosmed.com|216
22389363|NCT01542502|Virginia Commonwealth University|Antonio Abbate|804-828-0513|aabbate@vcu.edu|
22415100|NCT00858780|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22415101|NCT00690495|B.Braun Melsungen AG|Study manager|+49 5661 71|studies@bbraun.com|0
22415102|NCT01024855|Abbott Medical Optics, Inc.|Nick Tarantino, Head, Clinical Research and Development|714-247-8613|nicholas.tarantino@amo.abbott.com|
22415103|NCT00577655|Teval Global Respiratory Research LLC|Teva Study Physician|215-293-6482||
22415104|NCT01003938|NYU Cancer Institute|Franco Muggia, MD|212-263-6485|franco.muggia@nyumc.org|
22415105|NCT04848688|Swiss Tropical and Public Health Institute|Prof Dr Jennifer Keiser|+41 61 284 82 18|jennifer.keiser@swisstph.ch|
22415106|NCT03306277|AveXis, Inc|US Medical Information|833-828-3947|medinfo@avexis.com|
22452784|NCT03969654|Zimmer Biomet, Inc.|Director of Clinical Operations|8006136131|Clinicaloperations@zimmerbiomet.com|
22389364|NCT02009865|AstraZeneca AB|Hong Yang, Study Statistician|+46-(0)317762397|hong.yang1@astrazeneca.com|
22415107|NCT04306952|Northwestern University|Jennifer Mundt PhD|312-503-2846|jennifer.mundt@nm.org|
22452785|NCT00234065|Department of Clinical Research and Development, Otsuka Pharmaceutical Co., Ltd.|Masahiko Abe, Director Cardiovascular Projects|+81-6-6943-7722|abems@otsuka.jp|2545
22452786|NCT01292603|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22452787|NCT03912259|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22452788|NCT00381940|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org|
22452789|NCT03162224|Global Clinical Lead|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22452790|NCT00082173|Johns Hopkins University|Dr. Richard Chaisson|410-955-1755|rchaiss@jhmi.edu|
22452791|NCT01402141|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Baek-Hwan Cho, MD|82-63-250-1579|chobh@jbnu.ac.kr|
22452792|NCT02964416|Aga Khan University|Dr Asma Abdus Salam|+92-21-34864715|asma.salam.azhar@gmail.com|4639
22452793|NCT01043432|Rocky Mountain MIRECC|Lisa A. Brenner|303-399-8020|lisa.brenner@va.gov|2571
22452794|NCT02633137|Memorial Sloan Kettering Cancer Center|Dr. Anita Kumar, MD|646-608-3780|kumara2@mskcc.org|
22452795|NCT04307004|University of Alabama at Birmingham|Emily B. Levitan, Professor and Vice Chair|(205) 975-7680|elevitan@uab.edu|
22452796|NCT02807558|Syros Pharmaceuticals|Tiffany Crowell|617-674-9069|tcrowell@syros.com|
22452797|NCT01972841|Astellas Pharma Europe B.V.|Medical Director|+31 (0) 71 5455 050|astellas.resultsdisclosure@astellas.com|
22452798|NCT01360606|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP, Clinical Research Manager|4126475554|stadtermanbm@upmc.edu|
22452799|NCT04391023|University of Iowa|Dr. Alexandra Courtney Fietsam|N/A|alexandra-fietsam@uiowa.edu|
22452800|NCT03074630|AmsterdamUMC|Erik van Bommel|+31 20 4444444|e.vanbommel@amsterdamumc.nl|
22389365|NCT01760876|Queen Mary Hospital,University of Hong kong|Prof. Stephen Wai-luen LEE|(852) 22555409 or 28181314|prof.stephenlee@gmail.com ; kongsl@hku.hk|
22415108|NCT01370863|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22415109|NCT04431518|Indiana University School of Medicine|Samir K. Gupta|3172747926|sgupta1@iu.edu|
22415110|NCT05004649|University of Pennsylvania|Dr. David Brainard|215-573-7579|brainard@psych.upenn.edu|
22415111|NCT01852799|Shanghai Changzheng Hospital|Jian Hou, PhD|86021-63610109-73221|houjian@medmail.com.cn|
22415112|NCT01926119|Stanford University|Kevin Johnson, PhD RN|(650) 721-1988|johnsk@stanford.edu|
22415113|NCT00645853|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22415114|NCT00406393|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
22415115|NCT03885934|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22415116|NCT02227238|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22415117|NCT00380588|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22415118|NCT02096705|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
22415119|NCT02905435|PolyNovo Biomaterials Pty Ltd|Tim Barker, PhD|+61386814054|tim.b@polynovo.com|
22415120|NCT00595153|University of California, San Francisco|John V. Fahy, MD, MSc|4154769940|john.fahy@ucsf.edu|
22415121|NCT02377349|GlaxoSmithKline|GSK Response Center|866-435-7343|en736091@gsk.com|
22415122|NCT03486938|agenebio|Richard Mohs|317-997-3241|richard.mohs@agenebio.com|
22415123|NCT03504020|Medtronic CRM Clincial Research|CRM Clinical|800-328-2518|medtroniccrmtrials@medtronic.com|
22415124|NCT00838162|Jan-Cil UK|VP Head of Discovery & Early Development|44 1494 553458|ksimmen1@its.jnj.com|
22415125|NCT01507662|University of Iowa|Dr. Fredric Wolinsky|(319) 384-3821|fredric-wolinsky@uiowa.edu|
22415126|NCT04541173|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22415127|NCT03985657|Johns Hopkins University|Mudiaga Sowho|4105506264|msowho1@jhmi.edu|
22415128|NCT01395017|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22415129|NCT01780350|University of Texas Health Science Center San Antonio|David Wampler, PhD|210.567.7598|wamplerd@uthscsa.edu|
22415130|NCT02235870|Obalon Therapeutics, Inc.|Amy VandenBerg, Vice-President, Clinical Affairs and Regulatory Affairs|760.795.6551|avandenberg@obalon.com|
22415131|NCT03366428|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22415132|NCT00804973|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22415133|NCT01046084|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22415134|NCT00999687|Chang Gung Memorial Hospital|Lin Yin-Ku MD.Ph.D.|886-2-24313131|lin1266@adm.cgmh.org.tw|2127
22415135|NCT05248399|The University of Texas Health Science Center at Houston|Maria E Fernandez Esquer, PhD|(713) 500-9657|Maria.E.Fernandez-Esquer@uth.tmc.edu|
22415136|NCT03614728|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22415137|NCT02818894|Emory University|Thomas L. Bradbury, MD|404-759-3912|tombradburymd@gmail.com|
22415138|NCT01533038|NeoTract|Director of Clinical Affairs|925-401-0641|ehergenreter@neotract.com|
22389366|NCT03584282|University of Washington|Dr. Joanne Stekler, Primary Investigator|(206) 744-8312|jstekler@uw.edu|
22389367|NCT03394508|Karolinska Institutet|Jon Konradsen|+46704242058|jon.konradsen@ki.se|
22389368|NCT03556891|Valencia Technologies|Jackie Dister|7604294787|jdister@valenciatechnologies.com|
22389369|NCT03868735|Rush University|Dr. J. Brady Scott|3129426389|jonathan_b_scott@rush.edu|
22389370|NCT01557699|SERUM INSTITUTE OF INDIA LIMITED|Dr Prasad Kulkarni|+912026602384|drpsk@seruminstitute.com|
22389371|NCT01002547|Malcom Randall VA Medical Center|Dr. Kenneth Cusi|352-273-8662|Kenneth.Cusi@va.gov; Kenneth.Cusi@medicine.ufl.edu|
22389372|NCT03273283|Hospital Clínic de Barcelona|Pol Bruguera Soler|628162567|pbruguer@clinic.cat|
22389373|NCT00710814|Columbia University|Judith Korner, M.D., PhD|2123053725|jk181@cumc.columbia.edu|
22389374|NCT01178281|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22389375|NCT01184859|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22389376|NCT02055053|Lahey Clinic|dmitry nepomnayshy MD|781 744 8576|dmitry.nepomnayshy@lahey.org|
22389377|NCT00434577|GlaxoSmithKline|GSK Response Center|866-435-7343||
22389378|NCT01100268|Columbia University Department of Psychiatry|Dr. Carolyn Rodriguez|(646) 774-8061|cr2163@columbia.edu|
22389379|NCT01921114|AngioDynamics|Alicia Conway|774-249-8707|aconway@angiodynamics.com|
22389380|NCT02956122|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22389381|NCT00635570|Department of Obstetrics and Gynecology, The University of Chicago|Melissa Gilliam|773-834-0840|mgilliam@babies.bsd.uchicago.edu|
22389382|NCT02176356|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22389383|NCT02652390|Hässleholm Hospital, Hässleholm, Sweden|Dr. Isam Atroshi|+46443091260|Isam.Atroshi@skane.se|
22389384|NCT00381888|Masonic Cancer Center, University of Minnesota|Levi S. Downs, Jr., M.D.|612-626-6628|downs008@umn.edu|
22389385|NCT01064882|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22389386|NCT01537120|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22389387|NCT00392704|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22389388|NCT01410084|Wake Forest School of Medicine|Dr. Denise Houston|336-713-8558|dhouston@wakehealth.edu|
22415139|NCT01971645|Nationwide Children's Hospital|Giorgio Veneziano, MD|6147224200|Giorgio.Veneziano@nationwidechildrens.org|
22389390|NCT00958711|Baxter Healthcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
22389391|NCT03722485|3M|Sher-ree Beekman|262-409-5112|sbeekman@mmm.com|
22389392|NCT00197119|GlaxoSmithKline|GSK Response Center|866-435-7343||
22389393|NCT00612716|Masonic Cancer Center, University of Minnesota|Dr. Daniel J.Weisdorf, M.D|612 624-3101|weisd001@umn.edu|
22415140|NCT01377441|NYU School of Medicine|Lisa Doan, MD|212.263.5072|lisa.doan@nyumc.org|
22415141|NCT02943096|New York State Psychiatric Institute|Dr. Bret R. Rutherford|646-774-8660|brr8@cumc.columbia.edu|
22415142|NCT02837237|KBP Biosciences Co., Ltd.|Vincent J. Benn|2677996545|vince.benn@kbpbiosciences.com|
22415143|NCT01189747|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22415144|NCT01401062|NYU Langone Medical Center|Nelly Huppert|212-731-5003|Nelly.Huppert@nyumc.org|
22415145|NCT00438750|Orthopaedic Hand and Upper Extremity Service, Massachusetts General Hospital|David Ring, MD, PhD|617-724-3953|dring@partners.org|
22415146|NCT01165450|University of Maryland School of Medicine|Bennie H. Jeng, MD, MS|667-214-1111|bjeng@som.umaryland.edu|
22415147|NCT01717040|Univeristy Hospitals Cleveland Medical Center|Carla Conroy, MPH|216-844-2871|carla.conroy@UHhospitals.org|
22415148|NCT04203823|Medtronic|Clinical Study Manager|8185765849|carrie.corrigan@medtronic.com|
22415149|NCT03684928|CooperVision,Inc.|Jose A. Vega, O.D., MSc., FAAO|925 621 3761|javega@coopervision.com|
22415150|NCT03193021|Cardiva Medical|Terry Alverson, Director of Regulatory and Clinical|650-207-0563|Terry_Alverson@cardivamedical.com|
22415151|NCT02286466|Massachusetts General Hospital Cancer Center|Joseph Greer, PhD|617-643-2143|jgreer2@mgh.harvard.edu|
22415152|NCT00835081|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22415153|NCT00874276|University of Florida|Dr. Peter Stacpoole/Principal Investigator|1-352-273-9023|pws@ufl.edu|
22415154|NCT02300987|Novartis Pharmaceuticals|Study Director|1-888-669-6682|novartis.email@novartis.com|
22415155|NCT04211766|Fred Hutchinson Cancer Center|Dr. Johanna Lampe|(206) 667-6580|JLampe@fredhutch.org|
22415156|NCT03123874|Cornell University|Sarah Reyes|208-921-4967|smr296@cornell.edu|
22415157|NCT02308241|Memorial Sloan Kettering Cancer Center|Dr. David Pfister MD|646-888-4237|pfisterd@MSKCC.ORG|
22415158|NCT03609944|Oregon Health and Science University|Gregory Cote|503-494-4373|coteg@ohsu.edu|
22415159|NCT00659815|Bausch & Lomb Incorporated|Gerard Cairns|(585) 338-5170|gerard.cairns@bausch.com|
22415160|NCT02578641|Tessa Therapeutics|Khong-Bee Kang, Senior Manager Clinical Development|+65 6978 6594|kangkhongbee@tessacell.com|
22415161|NCT05330975|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
22415162|NCT03574363|KBP Biosciences USA, Inc.|Kimberly Miller|4847644862|kimberly.miller@kbpbiosciences.com|
22415163|NCT05267106|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22415164|NCT04165824|Tanabe Pharma America, Inc.|Clinical Trials, Information Desk|Please email|information.US@mb.tanabe-pharma.com|
22415165|NCT04986072|University of Rochester Medical Center|Dr. Paulo Lizano MD, PhD|(201) 776-6708|lizanopl@gmail.com|
22415166|NCT03199885|NRG Oncology|Director, Department of Regulatory Affairs|412-339-5300|langerj@nrgoncology.org|
22415167|NCT03292458|Massachusetts Eye and Ear|Prof. Kristina Simonyan|617-573-6016|kristina_simonyan@meei.harvard.edu|
22415168|NCT01513239|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22415169|NCT02276885|NYU Langone Health|Naamit Gerber, MD|2127316338|Naamit.Gerber@nyulangone.org|
22415170|NCT04569032|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22415171|NCT03837626|University of Missouri|Camila Manrique, MD|573-882-2554|manriquec@missouri.edu|
22415172|NCT03599362|NYU Langone Health|Fraustina Hsu|6467547124|Fraustina.Hsu@nyulangone.org|
22415173|NCT03707587|National Cancer Institute|Dr. Scott Norberg|301-275-9668|scott.norberg@nih.gov|
22415174|NCT01167829|University of Washington, Dept. of Medicine|John Amory, MD|(206) 616-1727|jamory@u.washington.edu|
22415175|NCT00834444|Manager, Biopharmaceutics|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22415176|NCT01044537|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22415177|NCT00726830|University of Texas MD Anderson Cancer Center|Michael J. Fisch, MPH/Clinical Professor, General Oncology|(713) 563-9905|mfisch@mdanderson.org|
22415178|NCT01496118|Sarah Cannon Development Innovations, LLC|Dr. Jesus Berdeja|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
22415179|NCT00841659|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22415180|NCT03810703|University of Chicago|Dave Arndt|7737023560|dewitlab@yoda.bsd.uchicago.edu|
22415181|NCT03499873|Teva Pharmaceuticals USA, Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
22415182|NCT04608448|UT Health San Antonio|Ellen Kraig, PhD|210-567-3818|kraig@uthscsa.edu|
22415183|NCT01297504|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22415184|NCT00654186|Oncology Specialists, SC|Sigrun Hallmeyer, MD|847-268-8200|shallmeyer@oncmed.net|
22415185|NCT00881751|Medical University of South Carolina|Kate Anderton, MPH, CCRP|anderton@musc.edu|anderton@musc.edu|
22415186|NCT00301964|NRG Oncology, Statistics and Data Management Center, Buffalo Office|Jessalyn Reboy|716-845-7738|ReboyJ@nrgoncology.org|
22415187|NCT02385708|Vanderbilt University Medical Center|Steven Klintworth|615-936-3298|steven.klintworth@vumc.org|
22415188|NCT02761915|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
22415189|NCT02436200|Imperial College London|Professor Alun Davies, Professor of Vascular Surgery|+44 (0)20 3311 7309|a.h.davies@imperial.ac.uk|
22389394|NCT00515697|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22401912|NCT02073435|Northwestern University|Donna Woods, MD|312-503-5550|woods@northwestern.edu|
22401913|NCT06001372|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
22401914|NCT03463265|Aadi Bioscience, Inc.|Aadi Medical Information|1-888-246-2234|MedInfo@aadibio.com|
22401915|NCT03515538|EpicentRx, Inc|Bryan Oronsky|858-229-1062|mstirn@epicentrx.com|
22401916|NCT04410783|Washington Univeristy|Brian M Fuller|3147475368|fullerb@wustl.edu|
22401917|NCT02345161|GlaxoSmithKline|GSK Response Center|866-435-7343||
22401918|NCT03088605|Topivert Pharma Ltd|Director of Clinical Trials|+44 203 763 9469|info@topivert.com|
22401919|NCT03323307|Duke University|Dr. Adam Wax|919-660-5143|a.wax@duke.edu|
22401920|NCT02225223|Merit Medical|Casey Holland|1 (617) 842-0251|casey.holland@merit.com|
22401921|NCT03666143|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
22401922|NCT03090620|UColorado|Dr. George Sam Wang|303-724-9967|george.wang@childrenscolorado.org|
22401923|NCT02834052|AUGUSTA UNIVERSITY MEDICAL CENTER|Dr Asha Nayak|7067216748|anayak@augusta.edu|
22401924|NCT02639182|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22401925|NCT02546856|Servicio de Cardiologıa, Hospital Universitario Galdakao-Usansolo, OSI Barrualde-Galdakao-Osakidetza, Servicio Vasco de Salud, Galdakao, Bizkaia, Spain .BIOCRUCES, Instituto de Investigacion Sanitaria, Bizkaia, Spain|Juana Oyanguren, Nursing graduate, Master in Heart Failure, CV Pathology and Thrombosis Specialist|34 656780945|juanaoy@hotmail.com|
22401926|NCT01958606|University of Cincinnati|Pierce Boyne|513-558-7499|Pierce.Boyne@uc.edu|
22401927|NCT00130208|Keryx Biopharmaceuticals|Medical Information|1-844-44-KERYX|medicalinfo@keryx.com|
22401928|NCT04655586|Arca biopharma Inc.|Dr. Michael Bristow|720-940-2100|Michael.Bristow@arcabio.com|
22401929|NCT03268746|Alcon Research|Clinical/Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22401930|NCT00986258|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|clinical-trials@grunenthal.com|
22401931|NCT02296346|Huntsman Cancer Institute, University of Utah|Dr. Daniel Couriel|801-213-3082|dan.couriel@hci.utah.edu|
22401932|NCT01035606|VA Northern California|Anthony Chen, MD|925-372-2000|anthony.chen@ucsf.edu|
22401933|NCT01070303|Abbott|Global Medical Services|800-633-9110||
22401934|NCT02145156|University of Colorado Denver|Julie A. Maertens|303-724-7319|julie.maertens@ucdenver.edu|
22401935|NCT02404155|Maryland Psychiatric Research Center|Dr. Deanna L. Kelly, Pharm.D., BCPP|410-402-6860|dlkelly@som.umaryland.edu|
22401936|NCT02064439|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22401937|NCT02433288|AstraZeneca|Traxler, Barry M|+1 301 398 0657|barry.traxler@astrazeneca.com|
22401938|NCT02615535|Spaulding Rehabilitation Hospital|Dr. Ginger Polich|617 952 5000|ginger.polich@mgh.harvard.edu|
22401939|NCT00858702|Daiichi Sankyo|Howard Kessler|732-590-5032|hmkessler@dsi.com|
22401940|NCT00205504|Virginia Commonwealth University|Kai Cheang, Principal Investigator|804-828-9698|kicheang@vcu.edu|
22401941|NCT01740440|BioMedical Research Ltd|Gary Rainsford|0035391774361|grainsford@bmr.ie|
22401942|NCT01063751|Stryker - Joint Replacement|Filesha Haniff / Clinical Study Manager|1 470.528.9214|filesha.haniff@stryker.com|
22401943|NCT02805907|MurciaSalud|Dr. Rubén Andújar-Espinosa|0034669500052|rubemed@hotmail.com|
22401944|NCT02046135|Cohen Children's Medical Center|Dr. James Schneider|7184703330|jschneide2@northwell.edu|
22401945|NCT01933984|Division of Critical Care Medicine, Department of Medicine, Changhua Christian Hospital|Dr. Shin-Hwar Wu|886-4-7238595|126366@cch.org.tw|3971
22401946|NCT03408873|Case Western Reserve University and University Hospitals Cleveland Medical Center|Joy Yala, MPH|216-368-0783|jxy790@case.edu|
22401947|NCT00062738|UMDNJ - RWJMS|Matthew Menza, MD|732-235-4440|menza@umdnj.edu|
22401948|NCT01600131|Veterans Health Administration|Constance Uphold|352-548-6000|connie.uphold@va.gov|106893
22401949|NCT01264965|University of Chicago|Theodore Karrison|773-702-9326|karr@health.bsd.uchicago.edu|
22401950|NCT02519244|The University of Texas Health Science Center at Houston|Shuo-Hsiu Chang, PT, PhD|713-799-7016|shuo-hsiu.chang@uth.tmc.edu|
22401951|NCT02844582|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
22401952|NCT00425438|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22401953|NCT01327339|GlaxoSmithKline|GSK Response Center|866-435-7343||
22401954|NCT01172288|Yale University- School of Medicine|Associate Professor|(203)737-4809|michael.bloch@yale.edu|
22401955|NCT02134314|Cedars-Sinai Medical Center|Noriko Ammerman, PharmD|310-248-8186|noriko.ammerman@cshs.org|
22401956|NCT03303339|Cardiff Oncology|Nancy Sherman, Head of Clinical Operations|858-952-7570|clinops@cardiffoncology.com|
22401957|NCT00940927|Nemours Children's Clinic|Kathryn Blake, Pharm.D.|904 858 3806|kblake@nemours.org|
22401958|NCT00510692|S.L.A. Pharma (UK) Ltd|Dr Chris Jordan|+44 (0)1923 681001|cjordan@slapharma.com|
22401959|NCT02116972|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
22401960|NCT00784784|Mount Sinai Hospital|Dr. Brenda Coleman|416-586-4800|bcoleman@mtsinai.on.ca|4161
22401961|NCT00872898|Forest Research Institute|Ephraim Katz, PhD / Associate Director|201-427-8000|Ephraim.Katz@frx.com|8169
22401962|NCT02428140|University of Alberta|Dr. Brian Buck|78024819227|bbuck@Ualberta.ca|
22401963|NCT03176966|Vanderbilt University Medical Center|Michael McGill|615-322-4643|michael.g.mcgill@vumc.org|
22401964|NCT02989727|Univeristy of Saskatchewan|Dr. Evyn Peters|13062904493|evyn.peters@usask.ca|
22401965|NCT01903434|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22401966|NCT00404768|GlaxoSmithKline|GSK Response Center|866-435-7343||
22401967|NCT01118143|University of Tromsø|Professor Jan Bergdahl|+4777649122|jan.bergdahl@uit.no|
22401968|NCT03151148|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22431068|NCT03285893|University of Minnesota|Joni Jensen|612-624-5178|jense010@umn.edu|
22431069|NCT04042311|Hull University Teaching Hospitals NHS Trust|Dr Sean Pymer|01482 674643|s.pymer@nhs.net|
22401969|NCT01228071|Endo Pharmaceutical, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22415190|NCT03276559|Weill Cornell Medicine|Hillary Winoker|646-962-7143|hiw4002@med.cornell.edu|
22389395|NCT03087851|Dep. of Endocrinology and Internal Medicine, Aarhus University Hospital|MD Anne Sophie Sølling|78 45 54 75|annesoel@rm.dk|
22415191|NCT00746421|Emory University|Jeffrey Rakofsky, MD|404-712-5083|jrakofs@emory.edu|
22415192|NCT02654145|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22415193|NCT00354835|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22415194|NCT01968551|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22415195|NCT06475729|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22415196|NCT03515044|Bausch Health Americas, Inc|Study Director|19083009920|susan.harris@bauschhealth.com|
22415197|NCT03922750|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22415198|NCT02166606|Boston Scientific|Dipl.-Ing. (FH) Jens Goetzke|+49171|jens.goetzke@bsci.com|5426813
22389396|NCT00644332|Gilead Sciences|Emmanuelle Bellemin, Senior Manager, Regulatory Affairs||emmanuelle.bellemin@gilead.com|
22389397|NCT03782545|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
22389398|NCT00409006|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22389399|NCT03050372|Medical University of South Carolina|Thomas W. Uhde, M.D.|843-792-0028|uhde@musc.edu|
22389400|NCT01502787|University of Texas Southwestern Medical Center|Wanpen Vongpatanasin|2146458000|wanpen.vongpatanasin@utsouthwestern.edu|
22389401|NCT00443755|Mayo Clinic|K. Sreekumaran Nair, MD, Ph.D.|507-255-3605|nair@mayo.edu|
22389402|NCT02775214|Riley Hospital for Children at Indiana University Health|Dr Nicole Horn|3179449981|nhorn@iuhealth.org|
22389403|NCT01896921|University of Maryland|Gregg Brogden|4107061660|gbrogden@ihv.umaryland.edu|
22389404|NCT02706834|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22389405|NCT01862614|The Ohio State University College of Dentistry|Dr. John Nusstein, Professor|614-292-3596|nusstein.1@osu.edu|
22389406|NCT04441996|Emory University|Cheryl Maier MD, PhD|404-712-2795|cheryl.maier@emory.edu|
22389407|NCT00678899|Cochlear Americas|Ginger Grant/Clinical Project Manager|410-375-0883|ggrant@cochlear.com|
22389408|NCT02543294|UT MD Anderson Cancer Center|Dr. Anecita P. Fadol,PHD/Associate Professor, Department of Nursing|713-792-8397|afadol@mdanderson.org|
22389409|NCT03149887|UPittsburgh|Dr. Steven L. Orebaugh|412-877-5832|orebaughsl@anes.upmc.edu|
22415199|NCT01958476|Tufts Medical Center Floating Hospital for Children|Jonathan M. Davis, MD|(617) 636-5322|jdavis@tuftsmedicalcenter.org|
22415200|NCT03790137|Massachusetts General Hospital|Dr. Elizabeth Thiele|6177266540|ethiele@mgh.harvard.edu|
22415201|NCT03868631|Point Loma Nazarene University|Dr. Heidi Lynch|619-806-3306|hlynch@pointloma.edu|
22415202|NCT05203146|University Hospitals of Geneva|Dr Johan N. Siebert|+41795534072|Johan.Siebert@hcuge.ch|
22415203|NCT03867760|University of Washington Bothell|Dr. Linda Eaton|4253523645|lineaton@uw.edu|
22415204|NCT04236596|University of Michigan|Timothy Bruns|(734) 647-8727|bruns@umich.edu|
22415205|NCT05984290|Bausch & Lomb Incorporated|Director, Medical Affairs, Vision Care R&D|585-413-6397|marjorie.rah@bausch.com|
22415206|NCT02588339|Moffitt Cancer Center|Lia E. Perez, MD|813-745-3665|Lia.Perez@moffitt.org|
22415207|NCT02966340|UW Madison|John J. Curtin|608-262-0387|jjcurtin@wisc.edu|
22415208|NCT04768296|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22415209|NCT02664545|Miach Orthopaedics|Rita Paparazzo|1-800-590-6995 x107|rpaparazzo@miachortho.com|
22415210|NCT04965181|Georgia State University|Claire Spears|404-413-9335|cspears@gsu.edu|
22415211|NCT00255346|The University of Texas MD Anderson Cancer Center|Hagop Kantarjian, MD/Department Chair|713-792-7026|hkantarjian@mdanderson.org|
22415212|NCT04758780|Institut de cancérologie de l'Ouest|Dr Caroline ROUSSEAU|+33 240679900|caroline.rousseau@ico.unicancer.fr|
22415213|NCT04402489|Tanabe Pharma America, Inc.|Clinical Trials, Information Desk|Please E-mail|information.US@mb.tanabe-pharma.com|
22415214|NCT03192891|Brigham and Women's Hospital|Raymond Y. Kwong, MD MPH|8573071960|rykwong@bwh.harvard.edu|
22415215|NCT05223868|Janssen Research and Development, LLC|Global Medical Head Dermatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22415216|NCT03395197|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22415217|NCT02560051|The University of Texas Health Science Center at Houston|Marka Lyons, Research Manager|713-500-6919|Marka.Lyons@uth.tmc.edu|
22415218|NCT02889393|University of Miami|Dr. D. Dante Yeh|3055851178|dxy154@med.miami.edu|
22415219|NCT02655224|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22415220|NCT03036930|Northwestern University|Seema A. Khan|312-503-4236|s-khan2@northwestern.edu|
22415221|NCT06102174|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22415222|NCT04227899|Abbott|Karine Ruster|(408) 845-0764|karine.piard-ruster@abbott.com|
22415223|NCT05151471|Tanabe Pharma America, Inc.|Clinical Trials, Information Desk|908-607-1980|information.US@mb.tanabe-pharma.com|
22415224|NCT04230174|Massachusetts General Hospital|Caterina Mainero|6177247746|cmainero@mgh.harvard.edu|
22415225|NCT04998136|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22415226|NCT05280301|Dartmouth-Hitchcock|Dr Nicholas Daniel|603-650-5000|Nicholas.Daniel@hitchcock.org|
22415227|NCT00396162|University of Michigan|Jeffrey E. Terrell|734 936 7633|terrelj@umich.edu|
22415228|NCT02694536|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22415229|NCT01741545|Bristol Myers Squibb|Bristol Myers Squibb Study Director|Please email|clinical.trials@bms.com|
22415230|NCT01911429|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
22415231|NCT03820258|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22431070|NCT04134936|MorphoSys|Medical Information|+1 844 667-1992|medinfo@morphosys.com|
22389410|NCT02115542|Moffitt Cancer Center|Richard Kim, MD|813-745-1432|Richard.Kim@moffitt.org|
22389411|NCT01107353|Roxane Laboratories, Inc.|Anton (Tony) Amann, PhD., Executive Director, DRAMA|614-272-4785|tony.amann@boehringer-ingelheim.com|
22389412|NCT03327051|Stanford University|Aida Habtezion|650-736-5555|aidah@stanford.edu|
22389413|NCT02798861|University of Pittsburgh|Andres Duarte-Rojo|412-647-7922|duarterojoa@pitt.edu|
22389414|NCT02795819|Virginia Commonwealth University Massey Cancer Center|Andrew Poklepovic, MD|877-462-7739|AskMassey@vcu.edu|
22389415|NCT04879823|UPMC Children's Hospital of Pittsburgh|Dr. Amber Shaffer|4126926874|shafferad@upmc.edu|
22389416|NCT00730925|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22389417|NCT02137239|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22389418|NCT04057937|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22389419|NCT02029521|Intermountain Healthcare|Clark Bishop|385 224 7343|clark.bishop@imail.org|
22389420|NCT01072396|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22389421|NCT02446912|AstraZeneca AB|Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
22389422|NCT01268488|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|914-333-6280|carmine.greene@ascensia.com|
22389423|NCT05216952|University of North Carolina at Chapel Hill|Jill Hagey, MD, MPH|919-966-5280|jmhagey1@ad.unc.edu|
22389424|NCT04864236|UCLA Anesthesiology|John Shin MD, Associate Clinical Professor|310-267-6629|JShin@mednet.ucla.edu|
22389425|NCT03680092|University of California, San Diego|Dr. Dimitrios Tzachanis|(858) 822-6600|dtzachanis@health.ucsd.edu|
22389426|NCT02991456|Duke University|James Herndon II, Ph.D.|919-668-8145|james.herndon@duke.edu|
22431071|NCT03518060|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22389427|NCT02058992|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22389428|NCT04604899|jCyte, Inc.|Chief Strategy Officer|9492430687|media@jcyte.com|
22389429|NCT03689452|Icahn School of Medicine at Mount Sinai|Dr. Danielle P. Dubin|212-731-3311|DPDubin121@gmail.com|
22389430|NCT00525915|University of Texas (UT) MD Anderson Cancer Center|Jaffer Ajani, MD / Professor, GI Medical Oncology|713-792-2828|CR_Study_Registration@mdanderson.org|
22389431|NCT04992494|NYU Langone Health|Amanda Shallcross|646-501-3426|Amanda.Shallcross@nyulangone.org|
22389432|NCT00267865|National Cancer Institute|Dr. Robert Yarchoan|240-760-6075|yarchoar@nih.gov|
22389433|NCT03458416|Radius Pharmaceuticals, Inc.|Tarek El Akkad, Head of Clinical Development|6175514000|telakkad@radiuspharm.com|
22389434|NCT01154699|University of California San Diego|Robert L. Owens|8586575258|rowens@ucsd.edu|
22389435|NCT01755598|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22389436|NCT02332889|University of Louisville|Nancy Alsip|5028522905|nancy.alsip@louisville.edu|502
22389437|NCT02135445|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22389438|NCT02819141|Mayo Clinic|Dr. Linda L. Chlan, Professor of Nursing|507-255-7859|chlan.linda@mayo.edu|
22389439|NCT01809691|SWOG Statistics and Data Management Center|Genitourinary Committee Statistician|2066674623|mplets@fredhutch.org|
22389440|NCT03694210|Interscope, Inc.|Alexis James Global Director of Clinical Affairs|508-847-9478|alexis.james@interscopemed.com|
22415232|NCT04179396|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
22415233|NCT01664039|Alcon Research, Ltd|Global Brand Lead, Medical Affairs, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com|
22415234|NCT01853176|Emory University|Albert Losken MD|404-686-8143|alosken@emory.edu|
22415235|NCT05908162|Republican center of Hygiene, Epidemiology and Public Health|Head of laboratory Fomina E.G.|+375173740417|feg1@tut.by|
22452801|NCT01270347|Horizon Pharma USA, Inc|Medical Monitor|1-866-479-6742|medicalinformation@horizontherapeutics.com|
22452802|NCT02085408|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22452803|NCT02486328|Ufuk University Faculty of Medicine|Dr Perihan Ekmekçi|+903122044000|erdogduperi@gmail.com|
22452804|NCT03317977|Wayne State University|Deborah Ellis, Ph.D.|313-577-1055|dellis@med.wayne.edu|
22452805|NCT00688636|Univerisity of Pittsburgh|Research Coordinator|412-648-9173|goldbyreffnerka@upmc.edu|
22452806|NCT01572727|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22452807|NCT04053764|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
22452808|NCT02935062|Federal University of Santa Maria|Márcia Keske-Soares|55 55 999726370|marcia-keske.soares@ufsm.br|
22452809|NCT04732286|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22452810|NCT01386528|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22452811|NCT00335322|Kirby Institute|Sean Emery|9385 0900|semery@kirby.unsw.edu.au|
22452812|NCT01390246|University of Texas Medical Branch|Dr. Tatiana Nanovskaya, PhD|409-772-3908|tnnanovs@utmb.edu|
22452813|NCT02195986|Mylan Inc.|Abhijit Barve, Head of Global Clinical Research||abhijit.barve@mylan.com|
22452814|NCT02834780|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22452815|NCT03150056|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22452816|NCT03335033|Mayo Clinic|Matthew W. Urban|507-284-3703|Urban.Matthew@mayo.edu|
22452817|NCT01939028|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Chad Michener|216-444-6601|michenc@ccf.org|
22452818|NCT00875836|MUSC|Dr. Aimee McRae-Clark|843.792.5216|mcraeal@musc.edu|
22452819|NCT03282227|Zosano Pharma Corporation|Donald Kellerman, PharmD, Sr. VP, Clin Dev and Med Affairs|(510) 745-4004|dkellerman@zosanopharma.com|
22452820|NCT02576678|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22452821|NCT01201057|Starpharma|Dr Jeremy Paull||jeremy.paull@starpharma.com|
22452822|NCT03240692|Stanford University|Dr. Nolan Williams|650-800-6920|nolanw@stanford.edu|
22452823|NCT00683644|University of Iowa|richard tyler|319 356 2471|rich-tyler@uiowa.edu|
22452824|NCT00355082|GlaxoSmithKline|GSK Response Center|866-435-7343||
22452825|NCT02576067|Icahn School of Medicine at Mount Sinai|Zahi Fayad, PhD|212-824-8471|zahi.fayad@mssm.edu|
22452826|NCT02372409|Washington University School of Medicine|Andrew Cluster, M.D.|314-454-6018|acluster@wustl.edu|
22452827|NCT02522715|Oregon Health & Science University|Rachel Slottke, Program Manager|503-494-6117|slottker@ohsu.edu|
22452828|NCT01808313|GlaxoSmithKline|GSK Response Center|866-435-7343||
22452829|NCT01289067|Icahn School of Medicine at Mount Sinai|Dr. Bobby Liaw|(212) 604-6010|bobby.liaw@mountsinai.org|
22452830|NCT04084314|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22452831|NCT00622167|Massachusetts General Hospital|Iris McNulty, RN|617 726 2612|imcnulty@partners.org|
22452832|NCT03736434|The Ohio State University College of Nursing|Dr. Kathy Wright|614-292-0309|wright.2104@osu.edu|
22452833|NCT03738150|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22452834|NCT01548690|University of Texas Southwestern Medical Center|William M. Lee, MD|(214) 645-6110|William.Lee@UTSouthwestern.edu|
22452835|NCT00147966|UCSD|Arthur Kavanaugh|858-657-7040|akavanaugh@ucsd.edu|
22452836|NCT03086447|Johnson & Johnson Vision|Kristy Canavan- SENIOR PRINCIPAL RESEARCH OPTOMETRIST|904 443-1474|KCANAVA2@its.jnj.com|
22452837|NCT03387852|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22415236|NCT05029687|Rutgers University|Sara Heinert, PhD, MPH|732-235-7872|sara.heinert@rutgers.edu|
22415237|NCT00958724|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
22452838|NCT02194621|RBHS-Rutgers School of Dental Medicine, Oral Biology Department|Daniel Fine, DMD|973-972-3728|finedh@sdm.rutgers.edu|
22452839|NCT00714168|University of Pittsburgh|John M. Jakicic, PhD|412-383-4001|jjakicic@pitt.edu|
22452840|NCT00596440|University of Pennsylvania|Dr. Robert Schnoll|215-746-7143|schnoll@mail.med.upenn.edu|
22415238|NCT04442503|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22415239|NCT02484807|Centre for pulmonary hypertension of the Thoraxclinic at the University Hospital Heidelberg|Professor Dr. med. Ekkehard Grünig|+4962213968053|ekkehard.gruenig@med.uni-heidelberg.de|
22452841|NCT01864564|University of Texas at Austin|Lorie M. Harper, MD, MSCI|512-324-7036|lorie.harper@austin.utexas.edu|
22452842|NCT03077724|Vanderbilt University Medical Center|Harvey J Murff|615 936 8319|harvey.j.murff@vanderbilt.edu|
22452843|NCT02269670|Emory University|Dr. Suchita Pakkala|404-686-3496|suchita.pakkala@emoryhealthcare.org|
22452844|NCT00126438|GE Healthcare|Jose Zubeldia, M.D.|011-44-1494-543137|jose.zubeldia@ge.com|
22452845|NCT02313428|University of Pittsburgh|Sashwati Roy|412-648-8297|sar543@pitt.edu|
22452846|NCT05672628|The University of Texas Health Science Center at Houston|Seema S Aggarwal, PhD, APRN, AGNP-C|713-500-9946|Seema.S.Aggarwal@uth.tmc.edu|
22452847|NCT04414696|Kaiser Permanente|Lyndsay Avalos|5108210300|lyndsay.a.avalos@kp.org|
22452848|NCT06660823|Ain Shams University|Dr.Mohammed Abd Al Jawad,Professor of cardiac surgery|+201111219461|mohammed_abdaljawad@med.asu.edu.eg|
22452849|NCT02160314|Procter & Gamble Company Global Clinical Sciences|Mylissa Trowbridge||trowbridge.mm@pg.com|
22452850|NCT00593567|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
22452851|NCT02993445|Temple University Hospital|Dr. Jeffrey Henderer|267-418-9126|Jeffrey.Henderer@tuhs.temple.edu|
22452852|NCT01946542|Duke University Medical Center|William Kraus|919-684-2063|william.kraus@duke.edu|
22452853|NCT00785291|UCSF Comprehensive Cancer Center|Hope Rugo, M.D.||hrugo@medicine.ucsf.edu|
22452854|NCT02119260|GlaxoSmithKline|GSK Response Center|866-435-7343||
22452855|NCT05183022|University of Alabama at Birmingham|Andrew D. Pucker, OD, PhD|1-920-579-2900|apucker@uab.edu|
22452856|NCT01429532|SunYat-senU|Prof. Yizhi Liu|+86-20-87330341|Reviewborad_SYsU@163.com|
22452857|NCT01877408|University of New England|Dr. Peter Millard|2078663503|pmillard@mac.com|
22452858|NCT03282981|VA Northern California Health Care System|Dr. Sara Dahle and Dr. Rosyln Rivkah Isseroff|916-843-7151|sara.dahle@va.gov|
22452859|NCT03870763|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22452860|NCT03224182|Spectrum Pharmaceuticals, Inc, Research and Development Office 157 Technology Drive Irvine, CA 92618|Shanta Chawla|(949) 788-6700|shanta.chawla@sppirx.com|
22452861|NCT04279314|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|+1-858-261|medicalinformation@acadia-pharm.com|2897
22452862|NCT02120027|MENARINI Group|Angela Capriati, MD PhD - Corporate Director Clinical Research|+39 055 5680|acapriati@menarini-ricerche.it|9990
22452863|NCT00692094|Oregon Health and Science University|OHSU Integrity Department|1-877-733-8313|irb@ohsu.edu|
22452864|NCT01698684|Vivus, Inc.|Wesley W Day, PhD|650-934-5200||
22452865|NCT01471054|Oncology Service, Wills Eye Hospital|Arman Mashayekhi, MD|215-928-3105|arman_mash@yahoo.com|
22452866|NCT00686166|SWOG Statistical Center|SWOG Statistician|206-667-4408||
22452867|NCT00985725|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22452868|NCT00993655|Canadian Cancer Trials Group|Senior Biostatistician|6135336430||
22452869|NCT02314624|Evidence Based Practice Institute|Linda Dimeff, PhD|206-384-7371|linda.dimeff@jasprhealth.com|
22452870|NCT03151005|Department of Endocrinology, Xinqiao Hospital, Army Military Medical University|Min Long, MD|023-68763255|longmin_casper@163.com|
22452871|NCT01718028|Alcon Research, Ltd.|Abayomi Ogundele, Pharm.D.|1-888-451-3937|alcon.medinfo@alcon.com|
22452872|NCT00360308|Eisai Call Center|Eisai Inc.|888-422-4743||
22452873|NCT01549613|University of Cincinnati, Dept. of Emergency Medicine|George J. Shaw, MD, PhD|513-558-8098|shawge@ucmail.uc.edu|
22452874|NCT02131272|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22452875|NCT04162769|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
22452876|NCT01733732|Alcon Research, Ltd.|Abayomi Ogundele, Pharm.D, Global Brand Medical Affairs Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22452877|NCT00464815|GlaxoSmithKline|GSK Response Center|866-435-7343||
22452878|NCT02526654|Wills Eye Hospital, Glaucoma Research Center|Dr. L. Jay Katz|215-928-3123|ljkatz@willseye.org|
22415240|NCT05034874|InterveXion Therapeutics, LLC|Chief Operating Officer|501-554-2377|intervexion@gmail.com|
22389441|NCT01742949|Hopital Bichat-Claude Bernard|Dr Marie-Pia D'Ortho|+33140258080|marie-pia.dortho@bch.aphp.fr|
22452879|NCT00515502|GlaxoSmithKline|GSK Response Center|866-435-7343||
22389442|NCT00411463|University of Pittsburgh|Holly Swartz, MD|412-246-5588|swartzha@upmc.edu|
22452880|NCT02436265|Indiana University|Aali shah MD|317-944-9981|ashah9@iuhealth.org|
22389443|NCT00907517|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22389444|NCT04117711|Applied Therapeutics, Inc|Riccardo Perfetti, MD|2122209226|rperfetti@appliedtherapeutics.com|
22389445|NCT02475733|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22389446|NCT02131155|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22389447|NCT01887418|Antares Pharma Inc.|Jonathan Jaffe, MD; Vice President Clinical Development|609-329-3020|jjaffe@antarespharma.com|324
22389448|NCT00724750|University of Chicago|Lawrence Gottlieb|(773) 702-6302|lgottlie@surgery.bsd.uchicago.edu|
22389449|NCT01014013|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22389450|NCT02527083|VA Pittsburgh Healthcare System|James Ibinson, MD, PhD|412-360-1484|james.ibinson@va.gov|
22389451|NCT05319756|Viatris|Dik WH Ng|+44 (0)1304 626895|dik.ng@viatris.com|
22389452|NCT00442559|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22389453|NCT03508830|University of California, San Francisco|Dr. Greg J. Haro|415-353-7502|greg.haro@ucsf.edu|
22401970|NCT04439838|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22401971|NCT04011436|Universidad Nacional de Colombia|Pt. Luisa Prieto|+57 3202082723|lfprietog@unal.edu.co|
22401972|NCT00960440|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22452881|NCT03252587|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22389454|NCT03906240|VISN 17 Center of Excellence for Research on Returning War Veterans|Dr. Adam McGuire|254-297-5173|adam.mcguire@va.gov|
22389455|NCT03575572|University of Utah|Stephanie Goldstein|801 587-7572|stephanie.goldstein@hsc.utah.edu|
22389456|NCT04908800|Kyorin Pharmaceutical Co.,Ltd|Yoji Mimaki|+81-3-3525-4788|ml-kyorin_clinicaltrials.gov@mb.kyorin-pharm.co.jp|
22389457|NCT02162771|CELLTRION, Inc.|Dr. Sung Hyun Kim|+82-32-850-5000|contact@celltrion.com|
22389458|NCT01047306|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22389459|NCT01132378|Heekin Institute for Orthopaedic Research|R. David Heekin MD, FACS|904-634-0640|drheekin@heekinortho.com|
22389460|NCT03647709|St Elizabeth Medical Center|Dr Andrew Wickline|315-735-4496|awickline23@gmail.com|
22389461|NCT05287178|University of Oregon|Yoel Everett|541-346-7054|yeverett@uoregon.edu|
22389462|NCT01426217|Dartmouth-Hitchcock Medical Center|Randy Loftus, MD|(603) 650-6177|Randy.W.Loftus@hitchcock.org|
22389463|NCT01920178|Cambridge Health Alliance|Paul M. Heffernan, D.P.M.|617-665-2556|pheffernan@challiance.org|
22389464|NCT03023878|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22389465|NCT01812837|UC Davis|Dr. Raja Sivamani|9167035145|rksivamani@ucdavis.edu|
22389466|NCT03720717|University of Alabama at Birmingham|Timothy J Ness MD PhD, Professor Emeritus|2059079743|tness@uabmc.edu|
22389467|NCT00288353|Northwestern University|Dr. Herbert Meltzer|(312) 503-0309|h-meltzer@northwestern.edu|
22389468|NCT05234632|Smith & Nephew, Inc.|Dr Rochelle O'Hara|+44 1923 477218|Rochelle.OHara@smith-nephew.com|
22389469|NCT04799587|Northwestern University|Paul Fitzgerald, RN, BSN,MS|312-695-1064|p-fitzgerald2@northwestern.edu|
22389470|NCT00728884|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
22389471|NCT03613363|Philips|Chuck Cain|412-657-1814|chuck.cain@philips.com|
22389472|NCT05216835|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22389473|NCT02849509|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22389474|NCT04930445|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov.Inquiries@pfizer.com|
22389475|NCT00975130|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22389476|NCT00617708|SWOG|Study Statistician|206-667-4623||
22389477|NCT01075815|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22389478|NCT03867396|University of Colorado Anschutz SOM|Dr. Melinda Anderson|303-724-9316|melinda.anderson@cuanschutz.edu|
22389479|NCT01261793|Care|UCB|+1844599|UCBCares@ucb.com|2273
22389480|NCT03941769|The University of Texas MD Anderson Cancer Center|Gheath Al-Atrash, M.D. / Stem Cell Transplantation|713-792-7734|galatras@mdanderson.org|
22389481|NCT00763919|University Hospitals Case Medical Center|Christopher Bialko|216-286-4362|Christopher.Bialko@UHhospitals.org|
22389482|NCT02374476|Icahn School of Medicine at Mount Sinai|Dr. Srinivas R Dukkipati|(212) 241-7114|srinivas.dukkipati@mountsinai.org|
22389483|NCT03010878|Colorado State University|Dr. Arlene Schmid|9704917562|arlene.schmid@colostate.edu|
22389484|NCT05431543|LENZ Therapeutics, Inc.|Marc Odrich, MD|(646) 249-2800|marc@lenz-tx.com|
22389485|NCT02924051|University of Kentucky|Dr. Frances Hardin-Fanning|(859) 257-4866|fdbowe2@uky.edu|
22389486|NCT02784535|Vanderbilt University Medical center|Dr Cyndya Shibao|615-322-2318|cyndya.shibao@vumc.org|
22389487|NCT00914732|Saint Louis University Medical School|Sharon E. Frey, M.D.|314-977-5500|sharon.frey@health.slu.edu|
22389488|NCT02130401|Scion NeuroStim|Dr. Robert Black|(919) 260-5528|bacllc@earthlink.net|
22389489|NCT03005106|Mallinckrodt|Medical Information Call Center|800-844-2830|MedInfo@mnk.com|
22389490|NCT03163472|Cork University Hospital|Dr Anil Ranganath||drmrak.2@gmail.com|
22389491|NCT00321672|NeurogesX|Trudy Vanhove, VP Clinical Development|650-393-7444|tvanhove@neurogesx.com|
22389492|NCT00512902|University of California at Los Angeles|Dr. Daniel Furst, Carl M Pearson Professor of Rheumatology|310-794-9504|defurst@mednet.ucla.edu|
22389493|NCT02389894|Icahn School of Medicine at Mount Sinai|Annetine C. Gelijns, PhD|212-659-9568|annetine.gelijns@mssm.edu|
22389494|NCT00145496|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22389495|NCT06392464|Complejo Hospitalario Universitario de Santiago de Compostela, Spain|Violeta Gonzalez Salvado|+34981955913|vgonzalezsalvado@gmail.com|
22389496|NCT05957198|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22389497|NCT04617574|Holyoke Medical Center Weight Management Program|Bariatric Clinical Administrator|(413) 535 - 4759|davidson_elana@holyokehealth.com|
22389498|NCT01429285|Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore Medical Center|Andrew Chang, MD, MS|718-920-7464|achang@montefiore.org|
22452882|NCT04052204|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials_gov_Inquiries@pfizer.com|
22452883|NCT03647501|The Ohio State University|Shelby Miracle|614-366-1648|shelby.miracle@osumc.edu|
22452884|NCT03945188|Arena Pharmaceuticals, a wholly owned subsidiary of Pfizer|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
22452885|NCT01613248|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22452886|NCT01636882|Viralytics Ltd|Mark Grose|1 647 821 7673|mark.grose@viralytics.com|
22401973|NCT01733069|Gen-Probe Incorporated|Jennifer Reid, Director of Clinical Affairs|858-731-5985|jennifer.reid@hologic.com|
22401974|NCT03332667|New Advances in Neuroblastoma Therapy|NANT Medical Director|3233615687|nantops@chla.usc.edu|
22401975|NCT00546351|UCB Clinical Trial Call Center|UCB (Study Director)|1-887-822-9493||
22401976|NCT04734873|Corvus Pharmaceuticals|Study Director|650-900-4520|clinicaltrials@corvuspharma.com|
22452887|NCT01433354|Novartis Pharmaceuticals|Study Director|862--778--8300||
22452888|NCT05098054|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22452889|NCT01016769|Memorial Sloan Kettering Cancer Center|Dr. David Pfister, MD|646-888-4237|pfisterd@mskcc.org|
22452890|NCT04794803|Dompé Farmaceutici|Dr Maria De Pizzol, BSc|+39 02 583831|clinops@pec.dompe.it|
22452891|NCT04149405|OndokusMU|Feyza Otan Özden|+905322535106|feyza_otan@yahoo.com|
22452892|NCT04124926|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-PHAT (7428)|medicalinformation@phathompharma.com|
22401977|NCT00609609|The University of Texas (UT) MD Anderson Cancer Center|Dr. Amin Majid Alousi, Associate Professor, Stem Cell Transplantation|713-792-7734|CR_Study_Registration@mdanderson.org|
22452893|NCT01250977|Center for Interdisciplinary Research on Nicotine Addiction|Benjamin Albelda (Project Manager)|215-746-7173|albeldab@pennmedicine.upenn.edu|
22452894|NCT02167074|Erasmusm MC University Medical Center Rotterdam|Dr. P. van Riet|0031648237608|p.vanriet@erasmusmc.nl|
22452895|NCT01507220|The Ohio State University|Sergio Bergese, MD|(614) 293-9027|bergese.1@osu.edu|
22452896|NCT03280121|Daniel and Daniel Consulting, LLC|Cynthia Harris, Director of Clinical Trials|775-392-2975|cindy@clinregconsult.com|
22401978|NCT03065530|The First Affiliated Hospital of Nanjing Medical University|Dr. Shijiang Liu, Dr. Mei Gao|+862568303569|liushijiang1983@hotmail.com|
22401979|NCT03811951|University of Illinois at Chicago - College of Pharmacy|Ajna Hamidovic|312-355-1713|ahamidov@uic.edu|
22401980|NCT02385123|Emory University|Rafi Ahmed, PhD|404-727-3571|rahmed@emory.edu|
22401981|NCT04498910|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22401982|NCT01809262|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22401983|NCT03881163|Zambon S.p.A|Valentina Vaja|+390266524497|Valentina.Vaja@ZambonGroup.com|
22401984|NCT02057237|Princess Margaret Cancer Centre|Dr. Anthony Joshua|416-946-4501|anthony.joshua@uhn.ca|2520
22401985|NCT02345434|Columbia University|Adam Sacarny|212 305 7084|ajs2102@columbia.edu|
22401986|NCT03121352|University Hospitals|Joseph Baar|216-844-8683|joseph.baar@uhhospitals.org|
22401987|NCT00859898|Clinical Trial Transparency|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com|
22401988|NCT02191917|BioMarin Pharmacuetical Inc.|Trial Specialist|1-800-983-4587|medinfo@bmrn.com|
22401989|NCT03215264|University of Pennsylvania/ Abramson Cancer Center|Thomas Karasic, MD|2156141858|thomas.karasic@pennmedicine.upenn.edu|
22401990|NCT00367640|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com|
22401991|NCT02417233|University of California San Francisco|Dr. Sheri Lippman|415-476-6319|sheri.lippman@ucsf.edu|
22401992|NCT02409784|Université de Sherbrooke|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
22401993|NCT02688842|Shanghai Microport Medical (Company) Co.,Ltd.|Haotian Zhang|+86-21-38954600|zhanght@microport.com|8552
22401994|NCT00614666|University of Arizona|Dr. John Galgiani|(520) 626-4968|spherule@email.arizona.edu|
22401995|NCT03799718|Brainstorm Cell therapeutics|Chief Medical Officer|201-488-0460|Clinical.Trial@brainstorm-cell.com|
22401996|NCT01188798|St. Jude Children's Research Hospital|Asha Pillai, MD|1-866-278-5833|info@stjude.org|
22401997|NCT01765647|University of Alberta|Dory Sample|780-248-5599|dory.sample@ahs.ca|
22401998|NCT00700752|Vistakon|Kurt Moody OD|904-443-3088||
22401999|NCT03662334|Halozyme Therapeutics|Dimitrios Chondros, M.D., Chief Medical Officer|858-794-8889|dchondros@halozyme.com|
22402000|NCT01097330|Population Health Research Institute|Dr. Carlos Morillo|905-527-4322|Carlos.Morillo@phri.ca|40311
22402001|NCT01024465|ReShape Medical|Director of Clinical Operations|949-429-6680|lfong@reshapemedical.com|
22402002|NCT00733356|University of California Irvine Child Development Center|Kinberley Lakes|949-824-3009|klakes@uci.edu|
22402003|NCT03078608|Kaiser Permanente Northern California|Elaine Kurtovich|510-891-3118|elaine.m.kurtovich@kp.org|
22402004|NCT00723840|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22402005|NCT03036592|University of Murcia|Prof. Marta Garaulet Aza|868884030|garaulet@um.es|
22402006|NCT05848245|King Abdulaziz University|Dr. Zuhair Natto|9666943899|znatto@kau.edu.sa|
22402007|NCT02760407|R-Pharm|Maria Lemak, Scientific Advisor|0074959567937|lemak@rpharm.ru|1408
22402008|NCT02522377|CLEVELAND CLINIC FOUNDATION|MURAT ALTINAY, MD|2164453359|altinam@ccf.org|
22402009|NCT00945191|Daiichi Sankyo|Contact of Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22402010|NCT01858428|Spectranetics|Julie Wolfram Smith|763-955-1072|julie.wolframsmith@spnc.com|
22402011|NCT01206595|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
22402012|NCT01765712|Nicholas Institute of Sports Medicine and Athletic Trauma|Malachy McHugh Director of Research|2124342714|mchugh@nismat.org|
22402013|NCT01921270|Emory University|Dr. Stewart Factor|404-728-4952|sfactor@emory.edu|
22402014|NCT01183546|Human Engineering Research Laboratories|Dr. Alicia Koontz|412-822-3700|alicia.koontz@va.gov|
22402015|NCT00138125|University of California at Los Angeles|Richard J. Pietras, M.D. Ph.D|310 825 9769|rpietras@ucla.edu|
22402016|NCT00863928|Virginia Mason Medical Center|Kathryn Dahl, RN|206-341-0578|kathryn.dahl@vmmc.org|
22402017|NCT03290300|Aerin Medical, Inc.|Scott Wolf, M.D.; Chief Medical Officer|650-597-0111|swolf@aerinmedical.com|
22402018|NCT00864227|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com|
22452897|NCT04650555|Humanetics Corporation|Michael D Kaytor, PhD|952-400-0405|mkaytor@humaneticscorp.com|
22452898|NCT00845663|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22402019|NCT02124798|GlaxoSmithKline|GSK Response Center|866-435-7343||
22431072|NCT00323622|GlaxoSmithKline|GSK Response Center|866-435-7343||
22415241|NCT01867658|C.R. Bard Inc.|Dawn Heimer|401-825-8681|Dawn.Heimer@crbard.com|
22415242|NCT05278858|University Hospitals Cleveland Medical Center|Dr. Sonal Shah, Director of Pediatric Dermatology|216-286-7285|Sonal.Shah@UHhospitals.org|
22415243|NCT00474058|UCB|UCB Clinical Trial Call Center|+1877 822 9493||
22415244|NCT03101358|US Biotest, Inc.|Gere diZerega, MD|805.595.1300|gere.dizerega@usbiotest.com|
22415245|NCT02640235|Baxter Healthcare Corporation|Clinical Trials Disclosure Group|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
22415246|NCT02426918|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
22415247|NCT01322633|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22415248|NCT02420353|Hopsital For Special Surgery and University of Michigan|Dr. Christopher Mendias|212-249-2373|mendiasc@hss.edu|
22415249|NCT00503867|Sirtex Medical|Medical Director|011 61 2 9964 8470|dcade@sirtex.com|
22415250|NCT01149057|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
22415251|NCT05616728|Enanta Pharmaceuticals, Inc.|Justin Aubin|857-760-0591|jaubin@enanta.com|
22415252|NCT00582205|University of Oklahoma|Dr. Joan Walker|405-271-8707|joan-walker@ouhsc.edu|
22415253|NCT02016235|Mayo Clinic|John C. Lieske, M.D.|507-266-7960|Lieske.John@mayo.edu|
22415254|NCT01859637|Sandoz Biopharmaceutical, Hexal AG|Roumen Nakov|+49 8024 4764704|roumen.nakov@sandoz.com|
22415255|NCT03504085|UC San Diego|Erik Groessl, PhD|858-642-6347|egroessl@ucsd.edu|
22415256|NCT04133311|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
22415257|NCT00834561|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22415258|NCT05032807|King's College London|Dr Edward Chesney|+44 (0)20 7848 0728|edward.chesney@kcl.ac.uk|
22415259|NCT00728754|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
22415260|NCT00270634|Isotechnika Pharma Inc.|Robert Huizinga|780 487 1600|robert.huizinga@isotechnika.com|223
22402020|NCT01797432|University of Minnesota|Maria Hordinsky, MD|612-625-6118|hordi001@umn.edu|
22415261|NCT00835588|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22415262|NCT00295490|University of Southampton|Dr Sarah Brien|07870642667|sbb@southampton.ac.uk|
22415263|NCT03255980|Helsinn Healthcare SA|Dr. Fabio Macchi|0041919852121|fabio.macchi@helsinn.com|
22415264|NCT01597791|Northwestern University|Paul Fitzgerald|312-695-1064|p-fitzgerald2@northwestern.eud|
22415265|NCT05468320|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22415266|NCT03921554|Children's Hospital of Philadelphia|Dr. Adeline Vanderver|215-590-1719|vandervera@chop.edu|
22415267|NCT04440592|Tanabe Pharma America, Inc.|Clinical Trials, Information Desk|Please email|information.US@mb.tanabe-pharma.com|
22415268|NCT00919113|Watson Laboratories, Inc.|Gary Hoel, RPh PhD, VP Global Brands Clinical Research|801 588-6641|gary.hoel@watson.com|
22415269|NCT02957331|UCHealth|Thomas J. Schroeppel, MD, MS|719 365 2422|thomas.schroeppel@uchealth.org|
22415270|NCT05568615|Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml.JP@ml.tanabe-pharma.com|
22452899|NCT04460742|University of Rochester|Adam Simning|585-474-9534|adam_simning@urmc.rochester.edu|
22452900|NCT03806270|Yeditepe U|Dr. Ferda F. Kartufan|+902165784000|ferdasozer@gmail.com|4754
22452901|NCT01324271|Acclarent, Inc.|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com|
22452902|NCT06116591|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22452903|NCT05585307|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22452904|NCT04009291|Ascendis Pharma, Inc.|Aimee D. Shu, MD|+1 650 352 8389|ADS@ascendispharma.com|
22402021|NCT02792777|Thomas Jefferson|Kristin L Rising, MD MS|215-503-5507|kristin.rising@jefferson.edu|
22402022|NCT02795156|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
22402023|NCT03320512|University of North Carolina at Chapel Hill|Lisa Hightow-Weidman|919-843-0033|lisa_hightow@med.unc.edu|
22402024|NCT01137435|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22402025|NCT00487279|St. Jude Medical CRMD|Heidi Hinrichs/Sr. Director, Clinical Operations|(818) 493-3297|hhinrichs@sjm.com|
22402026|NCT00501852|Novartis Pharmaceuticals|Study Director|862-778-8300||
22402027|NCT01171521|University of Missouri, Department of Orthopaedics|Brett Crist, MD|573-882-6562|cristb@health.missouri.edu|
22402028|NCT00399802|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22402029|NCT00492921|JHU SKCCC|Dr. Javier Bolanos Meade|410-614-6398|Fbolano2@jhmi.edu|
22402030|NCT00652093|Translational Pain Research, University of Rochester Medical Center|Dr. John D. Markman, MD|585-276-3616|john_markman@urmc.rochester.edu|
22402031|NCT04946344|Wake Forest University|Dr. Stephen Messier|336-758-3969|messier@wfu.edu|
22402032|NCT01520922|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22402033|NCT02213757|MHRI|Dr. Richter|2028776526|Lee.Ann.Richter@medstar.net|
22402034|NCT04076072|Vanderbilt University Medical Center|Marybeth Carter|615-936-1639|Marybeth.l.carter@vumc.org|
22402035|NCT01422304|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22402036|NCT01566838|Cardiac, Vascular, and Thoracic Surgery Associates|Sandeep Khandhar, MD|703-280-5858|SKhandhar@CVTSA.com|
22402037|NCT02722577|State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China|Guodong Niu|+86(10)88398866|guodongniu@fuwai.com|
22402038|NCT03461289|Novartis Gene Therapies EU Limited|EMEA Medical Information|+353 (1) 566-2364|medinfoemea.gtx@novartis.com|
22402039|NCT00564629|Mallinckrodt Pharmaceuticals|Lawrence Hill|(908) 238-6370|lawrence.hill@mallinckrodt.com|
22402040|NCT03241173|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22389499|NCT00410150|Cincinnati Children's Hospital Medical Center|Dr. Derek Wheeler|513-636-4239|derek.wheeler@cchmc.org|
22389500|NCT00990314|Lung Biotechnology PBC|Lung Biotechnology PBC Study Director|301-608-9292||
22389501|NCT04623996|Sumitomo Pharma Oncology|Tegan Nguyen|617-674-8745|tegan.nguyen@oncology.sumitomo-pharma.com|
22389502|NCT02676778|Eisai Co., Ltd.|Inquiry Service.||eisai-chiken_hotline@hhc.eisai.co.jp|
22389503|NCT01430299|SeaSpine|Vice President, Orthobiologics Research & Development|760.216.5138|frank.vizesi@seaspine.com|
22389504|NCT06466655|University of Delaware|Jody Greaney, PhD|3028312193|jgreaney@udel.edu|
22389505|NCT00925288|Johns Hopkins University|Dr. Brandon Brown|949-266-4401|bbrown@jhsph.edu|
22389506|NCT02151643|Shield Therapeutics|Mark Sampson|+44 (0) 207 186 8500|msampson@shieldtx.com|
22389507|NCT04307134|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22389508|NCT01732627|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22415271|NCT00565851|NRG Oncology|Christopher Purdy on behalf of Austin Miller PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
22389510|NCT02305797|Cardinal Health Regulatory Sciences|Director of Regulatory Affairs and Product Development|913.451.3955|david.rhein@cardinalhealth.com|
22389511|NCT02522299|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22389512|NCT02097056|Eisai Korea Inc.|Youngji Pyo|+82-2-3451-5533|y-pyo@eisaikorea.com|
22389513|NCT02391714|Division of Family Planning, University of New Mexico|Sunderjeet Kaur|Email|skaur@salud.unm.edu|
22389514|NCT03751280|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22389515|NCT00296504|ViiV Healthcare|GSK Response Center|866-435-7343||
22389516|NCT00685659|University of Pennsylvania|James R. McKay, Ph.D.|215-746-7704|jimrache@mail.med.upenn.edu|
22389517|NCT01078571|Abbott|Global Medical Services|1-800-633-9110||
22389518|NCT03317288|UT Southwestern Medical Center|Dr. Yi-Ting Tzen|2146481786|Yi-Ting.Tzen@UTSouthwestern.edu|
22389519|NCT01878253|Zimmer Biomet Inc|Clinical Operation Director|574-371-9823|Bill.Bourdeau@zimmerbiomet.com|
22389520|NCT01818245|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22389521|NCT04393779|Edwards Lifesciences, LLC|Sabrina Hundt, Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Sabrina_Hundt@edwards.com|
22389522|NCT03802513|VA RR&D National Center for Rehabilitative Auditory Research|Principal Investigator|503-220-8262|sarah.theodoroff@va.gov|
22389523|NCT05045638|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22389524|NCT01591655|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22389525|NCT01190228|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22389526|NCT02032420|University of New Mexico|Dr. Nicholas Lam|505-272-2610|nlam@salud.unm.edu|
22389527|NCT03869541|Imperial College London|Huw Woodbridge|+44 (0)20 7594 3192|h.woodbridge@imperial.ac.uk|
22389528|NCT01395914|Helsinn Therapeutics (US), Inc.|Richard K. Bourne, Ph.D.|732-603-2852|richard.bourne@helsinn.com|
22389529|NCT01648699|Janssen Philippines|Medical Affairs Manager|+632-8248935||
22389530|NCT06072196|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22389531|NCT01292005|Mayo Clinic|Dr. Santhi Swaroop Vege|507-284-2175|vege.santhi@mayo.edu|
22389532|NCT03219216|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22389533|NCT02423447|Stanford University|Carlos Milla, MD|650-723-5193|cmilla@stanford.edu|
22389534|NCT03305458|Medical University of South Carolina|Dr. Tatiana Davidson|8437921866|davidst@musc.edu|
22389535|NCT03844750|University of California, San Francisco|Dr. Chloe Atreya, MD|(415) 476-1000|Chloe.Atreya@ucsf.edu|
22389536|NCT01229527|Department of Anesthesia and Intensive Care|Dr. Massimo Agostoni|+39.02.2643.2656|agostoni.massimo@hsr.it|
22389537|NCT05615870|University of Arkansas for Medical Sciences|Jing Jin|501-214-2236|JJin@UAMS.edu|
22389538|NCT02214017|Herning Hospital|Finn Lauszus|+45 78434614|finlau@rm.dk|
22389539|NCT03520036|Tanabe Pharma America, Inc.|Clinical Trials, Information Desk|908-607-1980|information.US@mb.tanabe-pharma.com|
22389540|NCT01855399|VA HSRD: CCMR Ann Arbor and University of Michigan Medical School|Dr. Michele Heisler|(734) 845-3614|mheisler@umich.edu|
22389541|NCT03019289|Prilenia|Prilenia|+972 775558|info@prilenia.com|482
22389542|NCT04743999|Henry Ford Health System|Marissa Gilbert|313-556-8422|mgilber6@hfhs.org|
22402041|NCT00515463|Amgen Inc.|Study Director|866-572-6436||
22402042|NCT02269319|MicuRx Pharmaceuticals Inc.|John M. Sall, Global Head of Regulatory|919-670-7803|jsall@micurx.com|
22402043|NCT02211495|Imperial College London|Miss Kate Williams||k.williams@imperial.ac.uk|
22402044|NCT03478878|National Institutes of Health|Emily Chew, MD, Principal Investigator, NEI|3014966583|emily.chew@nih.gov|
22402045|NCT01158534|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Brian Rini|216-444-9567|rinib2@ccf.org|
22402046|NCT01115569|Zogenix|Kevin Romanko|(510) 550-8323|kromanko@zogenix.com|
22415272|NCT05587530|Columbia University|Lisa B. Dixon, MD, MPH|646 774 8420|Lisa.Dixon@nyspi.columbia.edu|
22389543|NCT01721759|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22389544|NCT03926117|Novo Nordisk A/S|Clinical Reporting Office (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22402047|NCT01614769|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22402048|NCT02115815|MedImmune, LLC|Judith Falloon, MD|301-398-5000|falloonj@medimmune.com|
22402049|NCT02819310|Braintree Laboratories, Inc.|VP, Clinical Affairs|781-843-2202|john.mcgowan@sebelapharma.com|
22402050|NCT04688346|University of Washington|Dr. Travis Nelson|206-290-2899|tmnelson@uw.edu|
22402051|NCT01741272|Alberta Health Services|Dr. Robert Balyk|7804395858|rbalyk6@aol.com|
22402052|NCT01254604|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22402053|NCT03074162|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22402054|NCT02778867|Cincinnati Children's Hospital Medical Center|Marc E. Rothenberg, MD, PhD|513-636-7177|marc.rothenberg@cchmc.org|
22402055|NCT02948777|Helsinki University and Helsinki University Hospital|Prof. Marja-Riitta Taskinen|+358-9-47171990|marja-riitta.taskinen@helsinki.fi|
22402056|NCT02311478|University of Utah|Dr. Dave Turok|8015818160|david.turok@hsc.utah.edu|
22402057|NCT01290484|Stanford University|Dr. Alfred Lane|650-721-7170|alfred.lane@stanford.edu|
22402058|NCT03242928|Novartis Pharma AG|Clinical Disclosure Office|613241111|Novartis.email@Novartis.com|
22402059|NCT03276936|Foamix Pharmaceuticals, Inc.|Iain Stuart, PhD.|1 800-775-7936|Iain.Stuart@foamix.com|
22402060|NCT00943319|UChicago|Dr. Andrew Artz|773-834-8980|aartz@medicine.bsd.uchicago.edu|
22402061|NCT02043301|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22402062|NCT03333057|Novaliq GmbH|Dr. Sonja Kroesser|+49 6221 50259|info@novaliq.com|0
22402063|NCT03703375|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|855-907-3286|Clinical.Trials@bms.com|
22402064|NCT03504774|Stanford University School of Medicine|Sayantani B. Sindher, MD|650-521-7237|tina.sindher@stanford.edu|
22402065|NCT02344628|London School of Hygiene and Tropical Medicine|Dr Michael Marks|+447984643424|michael.marks@lshtm.ac.uk|
22402066|NCT00625365|Lantheus Medical Imaging|Dana Washburn, M.D.|978-671-8686|dana.washburn@lantheus.com|
22402067|NCT01781429|BioMed Valley Discoveries|Brent Kreider, PhD|816-960-4644|bkreider@biomed-valley.com|
22402068|NCT03238248|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
22389545|NCT01334606|BD Medical - Diabetes Care|Laurence J. Hirsch. Medical Director|201-847-6513|laurence_hirsch@bd.com|
22389546|NCT02312245|Mayo Clinic|S. John Weroha, M.D., Ph.D.|(507) 284-2511|weroha.saravut@mayo.edu|
22389547|NCT01123200|University of Michigan|Jane Huggins|734-936-7177|janeh@umich.edu|
22389548|NCT00924833|Istituto Auxologico Italiano|Gianfranco Parati, Professor|+3961911|gianfranco.parati@unimib.it|2949
22389549|NCT00604461|H. Lee Moffitt Cancer Center and Research Institute|Tawee Tanvetyanon, M.D.|813-745-3050|tawee.tanvetyanon@moffitt.org|
22389550|NCT01288729|Stanford Childrens Health|Bruce Buckingham|650725-6549|buckingham@stanford.edu|
22389551|NCT03214198|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22389552|NCT03247985|Mayo Clinic|Dr. David R. Farley|507-284-7565|farley.david@mayo.edu|
22389553|NCT02577315|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22389554|NCT03686176|Johns Hopkins University|Therese Canares|4109964711|tcanare1@jhmi.edu|
22389555|NCT00515879|Boston University|Dr. Stefan G. Hofmann, Ph.D., Professor of Psychology|617 353 9233|shofmann@bu.edu|
22389556|NCT01846988|Cincinnati Children's Hospital Medical Center|Dr. Neepa Gurbani, Assistant Professor|(513) 736-1814|Neepa.Gurbani@cchmc.org|
22389557|NCT03530345|Grünenthal GmbH|Director Clinical Trials|+49 241 569|Clinical-Trials@grunenthal.com|3223
22389558|NCT02442622|NYU Langone Health|Steve Vanlew, PhD|646-501-7707|Steve.Vanlew@nyulangone.org|
22402069|NCT00964548|UMASS Medical School|Susanne Muehlschlegel, MD, MPH, Principal Investigator|508-856-4667|susanne.muehlschlegel@umassmemorial.org|
22402070|NCT04179968|UT Southwestern Medical Center|Kelli Key, Ph.D.|214-648-8152|Kelli.Key@UTSouthwestern.edu|
22402071|NCT02045277|Bausch Health|Study Director||anya.loncaric@bauschhealth.com|
22402072|NCT02440178|seoul national university|Pf. Youngil Koh|82-2-2072-7217|go01@snu.ac.kr|
22402073|NCT03864237|Brown University School of Public Health|Kate B. Carey|4018636558|kate_carey@brown.edu|
22402074|NCT06094296|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22402075|NCT04964063|HALEON|Haleon Response Center|+447880182593|ww.clinical-trial-register@haleon.com|
22402076|NCT01397071|UCLA Department of Medicine/Center for Human Nutrition|Zhaoping Li|310-206-1987|zli@mednet.ucla.edu|
22402077|NCT03350750|Johns Hopkins|Jessica Wollett|6673068141|jwollet1@jh.edu|
22402078|NCT02221739|Weill Cornell Medical College|Silvia Formenti, M.D.|646-962-4065|formenti@med.cornell.edu|
22402079|NCT00321984|Takeda Global Research & Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
22402080|NCT01387295|Herlev University Hospital|Dr Dorte Nielsen|+45 38682344|dorte.nielsen.01@regionh.dk|
22402081|NCT02553915|Massachusetts General Hospital|Dr David Mischoulon, Director, Depression Clinical and Research Program, MGH|617-724-5198|dmischoulon@mgh.harvard.edu|
22402082|NCT03964415|Janssen Vaccines & Prevention B.V.|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22402083|NCT01016483|Merck Serono, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+496151725200|service@merckgroup.com|
22402084|NCT01302769|99MDG Regional Clinical Investigation Program|Amanda Crawford|7026533583|amanda.j.crawford.ctr@health.mil|
22402085|NCT00691197|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
22402086|NCT00298610|Walter Reed Army Institute of Research|Shon A. Remich, MD|254-733-628-670|sremich@hotmail.com|
22402087|NCT01734993|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22402088|NCT01426386|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
22402089|NCT01747330|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com|
22402090|NCT00257192|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22415273|NCT05079620|UConn Health|Brandon Oto|18606792000|oto.brandon@gmail.com|3881
22415274|NCT06437626|Pharmasoft|Meshcherskiy Y.E., Medical director|+ 7 (495) 626-47-55|pharmasoft@pharmasoft.ru|140
22415275|NCT03388008|Washington University in St. Louis|Ramsey Hachem, MD|(314) 454-7953|Rhachem@wustl.edu|
22415276|NCT05194202|Children's Mercy Hospital|Dr. Kimberly Randell|816-302-3503|karandell@cmh.edu|
22415277|NCT01520987|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22415278|NCT02005562|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22415279|NCT00660387|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22415280|NCT03086135|Radboud University Medical center, Nijmegen|Professor Emmanuel Mylanus|+31 24 361 49 34|Emmanuel.Mylanus@radboudumc.nl|
22415281|NCT01023061|University of Washington|Bruce Montgomery|206-598-0860|rbmontgo@uw.edu|
22415282|NCT02710214|University of California, San Francisco|Dr. Riley Bove|415-595-2795|riley.bove@ucsf.edu|
22415283|NCT00929981|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22415284|NCT02832167|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22415285|NCT01754376|MGH Cancer Center|Ryan Sullivan|617-724-4000|rsullivan7@mgh.harvard.edu|
22415286|NCT04590781|Xencor, Inc|Benjamin Thompson, MD, PhD|858-480-3133|bthompson@xencor.com|433
22415287|NCT04313296|Pen Bay Medical Center|Caroline Knight|207-301-8959|caroline.knight@mainehealth.org|
22415288|NCT00820599|Edwards Lifesciences|Edwards THV Clinical Affairs|949-250-2500|THV_CT.gov@edwards.com|
22415289|NCT03686215|Lumicell|Jorge Ferrer, PhD|617-571-0592|jmferrer@lumicell.com|
22415290|NCT01863186|USWM, LLC|Medical Affairs|1-888-900-8796|medinfo@usworldmeds.com|
22415291|NCT01456962|University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences|Peter Anderson, Pharm D|303-724-6128|peter.anderson@ucdenver.edu|
22415292|NCT02483416|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22415293|NCT04808908|University of Minnesota|Kevin Escandón|612-626-9344|escan012@umn.edu|
22415294|NCT03387462|Bridge HIV, San Francisco Department of Public Health|Dr. Susan Buchbinder|628-217-7479|susan.buchbinder@sfdph.org|
22415295|NCT01460628|Brigham & Women's Hospital|Dr. Hadine Joffe|617-732-4906|hjoffe@partners.org|
22415296|NCT01095887|Mayo Clinic|Dr. Mark D. Stegall|507-266-2812|stegall.mark@mayo.edu|
22415297|NCT00496860|Altor Bioscience|Hing C. Wong, Chief Clinical Officer|9544438600|hingwong@altorbioscience.com|
22389559|NCT02938520|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22389560|NCT05022472|UCSD|Dr. Britt Skaathun|619-543-5011|bskaathun@health.ucsd.edu|
22389561|NCT00197106|GlaxoSmithKline|GSK Response Center|866-435-7343||
22389562|NCT00111839|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|496151725200|service@merckgroup.com|
22389563|NCT00762723|Zimmer|Laura Herdrich|952-830-6224|laura.herdrich@zimmer.com|
22389564|NCT03287947|Atrium Health/Levine Cancer Institute, Department of Cancer Biostatistics|Danielle M Boselli|12017903385|Danielle.Boselli@AtriumHealth.org|
22389565|NCT03594266|BiotronikUS|Crystal Miller|503-475-4984|crystal.miller@biotronik.com|
22389566|NCT00166361|Mayo Clinic|Dr. Lance A. Mynderse|507-284-1250|mynderse.lance@mayo.edu|
22389567|NCT00472056|UT MD Anderson Cancer Center|Chitra M. Hosing, MD / Associate Professor||mvpacheco@mdanderson.org|
22389568|NCT00449033|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22389569|NCT01109602|Colorado State University, Department of Occupational Therapy|Arlene Schmid, PhD, OTR|970-491-7562|arlene.schmid@colostate.edu|
22389570|NCT04115319|Otsuka|Clinical Transparency|1-800-441-6763|smb_clinicaltranspa@otsuka-us.co,|1
22389571|NCT06029712|Stanford University|Colette DeJong|650-229-2482|cdejong@stanford.edu|
22415298|NCT00210639|Janssen R&D US|Director, Clinical Research|1 609 730-3158||
22389573|NCT00581009|University of California Irvine|Dr. Joseph Wu|7142252212|jcwu@uci.edu|
22389574|NCT02256488|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
22389575|NCT03562117|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22389576|NCT03928821|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22389577|NCT02684942|Chulabhorn hospital|Saengrawee Thanthong|+662-576-6021|saengrawee81@gmail.com|
22389578|NCT03138499|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22389579|NCT01245699|Maricopa Integrated Health System|Bentley J Bobrow, MD|602-364-0580|bentley.bobrow@azdhs.gov|
22389580|NCT01636778|GlaxoSmithKline|GSK Response Center|866-435-7343||
22389581|NCT00990821|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22389582|NCT04150250|PATH|Gwen Ambler|206-285-3500|gambler@path.org|
22389583|NCT01436045|HealthPartners Institute for Education and Research|Michael H Rosenbloom, MD|6512547900|michael.h.rosenbloom@healthpartners.com|
22389584|NCT03282071|The University of Hong Kong|Dr. Yuying Sun|(852)39179144|gyysun@hku.hk|
22389585|NCT01391234|University of Virginia Department of Radiation Oncology|Dr. Paul Read|(434) 924-5191|PWR3U@hscmail.mcc.virginia.edu|
22389586|NCT00170950|Novartis Pharmaceuticals|Study Director|862 778-8300||
22389587|NCT00748098|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
22389588|NCT03537014|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
22389589|NCT01754389|Dana Farber Cancer Institute|Dr. John Koreth|617-632-2949|John_Koreth@dfci.harvard.edu|
22415299|NCT04684485|Sun Pharmaceutical Industries Limited|Head Regulatory Affairs|2266455645|Clinical.Trial@sunpharma.com|5689
22389590|NCT04448561|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22389591|NCT06597747|MED-EL Corporation|Clinical Research Manager|888-633-3524|research.us@medel.com|
22415300|NCT01202253|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22415301|NCT00000136|The Johns Hopkins University|Curtis Meinert, PhD|410-955-8198|cmeinert@jhsph.edu|
22431073|NCT04603560|Brigham and Women's Hospital|Nancy Haff, MD, MPH|617-278-0930|nhaff@mgb.org|
22415302|NCT04230304|Mayo Clinic|Sikander Ailawadhi|904-953-2000|Ailawadhi.Sikander@mayo.edu|
22431074|NCT00934180|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22431075|NCT02613507|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22431076|NCT04732468|Immunitybio|Lennie Sender, Chief Operating Officer|855-797-9277|lennie.sender@immunitybio.com|
22431077|NCT02471144|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22431078|NCT00710944|DENTSPLY Implants|Senior Manager Global Clinical Research|+46313763500|clinicalresearchmolndal@dentsply.com|
22431079|NCT02185183|ENZO|Dr. Elazar Rabbani|2125830100|erabbani@enzo.com|
22431080|NCT03977155|Boston Pharmaceuticals, Inc.|Craig Basson|(617) 655-9681|clinicaltrials@bostonpharmaceuticals.com|
22431081|NCT00936936|University of Texas MD Anderson Cancer Center|Dr. Yago Nieto, PhD. / Stem Cell Transplantation Department|713-792-8750|ynieto@mdanderson.org|
22431082|NCT00499447|Comprehensive Cancer Center of Wake Forest University|Dr. James Urbanic|336-713-3600|jurbanic@wakehealth.edu|
22431083|NCT04073056|Icahn School of Medicine at Mount Sinai|Dr. Ali Shariat|212-523-2500|AliNima.Shariat@mountsinai.org|
22415303|NCT05740371|Tanabe Pharma GmbH|Clinical Trials, Information Desk|Please email|regulatorycontact.DE@mb.tanabe-pharma.com|
22415304|NCT05112809|Mayo Clinic|Michael Cevette, Ph.D.|480-301-4380|mcevette@mayo.edu|
22415305|NCT00874822|University of Nebraska Medical Center|Jason Shiffermiller, MD, MPH|402-559-7299|jshiffermiller@unmc.edu|
22415306|NCT02854800|West Virginia University|Dr. Melissa Blank|304-293-8341|Melissa.Blank@mail.wvu.edu|
22431084|NCT04717258|University of York|Sarah Cockaiyne|01904321736|sarah.cockayne@york.ac.uk|
22431085|NCT03440385|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22431086|NCT00488293|Department of Veterans Affairs|John D. Whited, MD, MHS|919-286-6926|john.whited@va.gov|
22431087|NCT00939185|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22431088|NCT00363298|Stanford University Medical Center, Department of Psychiatry|Lorrin M. Koran, M.D.|650 498-5035|lkoran@stanford.edu|
22431089|NCT02374255|Icahn School of Medicine at Mount Sinai|Radhi Yagnik|212-659-5933|radhi.yagnik@mountsinai.org|
22431090|NCT00730327|Apollo Endosurgery|Laura Eaton, Study Director, RN, BSN, CCRN-R,|949-468-9301|laura.eaton@apolloendo.com|
22431091|NCT00095576|Merck, Sharp & Dohme|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22431092|NCT01943227|UC Davis Medical Center|Neal Fleming, MD, PhD|916-734-5046|nwfleming@ucdavis.edu|
22431093|NCT02332928|Virginia Commonwealth University Massey Cancer Center|Massey Cancer Center Cancer Prevention & Control Team|877-462-7739|masseycpc@vcu.edu|
22431094|NCT01497197|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22431095|NCT01332981|Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22431096|NCT01425814|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
22431097|NCT01052779|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
22431098|NCT03580044|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22431099|NCT03524157|Laboratorios Sophia|PhD. Ricardo Llamas|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
22431100|NCT01358734|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
22431101|NCT01731782|Cleveland Clinic Florida Region|Dr. Conor Delaney|954-659-6001|DELANEC@ccf.org|
22431102|NCT03427619|University of Iowa|Dr. Richard Smith|319-356-2177|richard-smith@uiowa.edu|
22431103|NCT00498628|NIAAA|Dr. Raye Litten|301-443-0636||
22431104|NCT00127439|University of Louisville|Andrea L. Behrman, PhD, PT|502-582-7451|andreabehrman@catholichealth.net|
22431105|NCT00376558|nyspi|Diana Martinez|212-543-6628|dm437@columbia.edu|
22431106|NCT02743962|University of Bradford|Hilary Pape|01274 236228|hpape@bradford.ac.uk|
22431107|NCT04805593|Alcon Research, LLC|Clinical Projects Director, Surgical|18884513937|alcon.medinfo@alcon.com|
22431108|NCT06034340|Emory University|Dr. Eric Felner -Professor of Pediatrics|404-785-0935|efelner@emory.edu|
22389592|NCT01819233|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Nicole Simone|215-955-6702|nicole.simone@jefferson.edu|
22415307|NCT05673005|Mass General Brigham Department of Urology|Martin Kathrins, MD|617-732-6227|mkathrins@bwh.harvard.edu|
22415308|NCT01634139|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22415309|NCT05014438|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22415310|NCT02627963|AVEO Pharmaceuticals, Inc.|AVEO Clinical Trial Office|857-400-0101|Clinical@aveooncology.com|
22415311|NCT01168856|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22415312|NCT05562011|Wake Forest University School of Medicine|Timothy Harwood, M.D.|336.716.8830|tharwood@wakehealth.edu|
22415313|NCT00387153|Myriad Therapeutics, Inc.|Richard Wenstrup, MD, VP Chief Medical Officer|801-584-3009|rwenstru@myriad.com|
22415314|NCT03073798|Johns Hopkins University|Nadia N Hansel, MD MPH|410-550-2935|nhansel@jhmi.edu|
22415315|NCT03068780|Amryt Research Limited|Janet Boylan|+3531518|Janet.boylan@amrytpharma.com|0200
22415316|NCT04540094|University of Edinburgh|Prof Alasdair Gray|0131 242 1340|alasdair.gray@ed.ac.uk|
22415317|NCT04411680|Partner Therapeutics, Inc.|Medical Information|1-888-479-5385|PartnerTx@medcomminc.com|
22415318|NCT00840658|University of California, San Diego|Steffanie Strathdee, PhD|(858) 822-1952|sstrathdee@ucsd.edu|
22415319|NCT02974907|ReGenTree, LLC|Shinwook Kang|609-649-5505|swkang@regentreellc.com|
22415320|NCT05109104|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
22415321|NCT01632423|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22415322|NCT02372006|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22415323|NCT01859598|The George Institute for Global Health at Peking University Health Science Center|Pro. Linong Ji|82800577|jiln@bjmu.edu.cn|
22415324|NCT00009945|NSABP Foundation, Inc.|Director, Department of Regulatory Affairs|412-339-5300|regulatory@nsabp.org|
22415325|NCT00672984|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22415326|NCT00573313|University of California Davis|Dr. Charles H. Halsted|530-752-4054|chhalsted@ucdavis.edu|
22415327|NCT02611362|Rhode Island Hospital|Dr. Larry K. Brown|(401) 793-8808|lkbrown@lifespan.org|
22415328|NCT00354159|Medtronic CRDM|REDUCEhf Clinical Research Specialist|1-800-328-2518|medtronicCRMtrials@medtronic.com|62736
22415329|NCT00458822|Memorial Sloan Kettering Cancer Center|Dr. Heather Landau|212-639-8808|LandauH@mskcc.org|
22415330|NCT02229084|University of Arkansas for Medical Sciences|Sorena Lo|5016868274|SBLo@uams.edu|
22415331|NCT01728116|GI Dynamics, Inc|Brian Callahan|781.357.3302|bcallahan@gidynamics.com|
22415332|NCT05128058|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22415333|NCT03405363|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22415334|NCT00630253|Masonic Cancer Center, University of Minnesota|Margaret L. MacMillan, M.D.|612-273-2800|macmi002@umn.edu|
22415335|NCT00400634|Ceregene, Inc.|Raymond T. Bartus, Executive Vice President and Cheif Scientific Officer|858-458-8823|rtbartus@ceregene.com|
22415336|NCT01559116|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22415337|NCT01868243|Hospital Ana Nery|Andre Rodrigues Duraes|+557191888399|andreduraes@gmail.com|
22415338|NCT01745094|Astellas Pharma Inc.|Medical Director|+81-3-3244-0512 Ext:|motoko.ida@astellas.com|
22415339|NCT04610580|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22415340|NCT01170715|Rockefeller University|James G. Krueger MD, PhD|212-327-7730|kruegej@rockefeller.edu|
22415341|NCT01451541|Sunovion|Respiratory Medical Director|1-866-503-6351||
22415342|NCT02083809|University of Hawaii|Dr.|8082036500|whrc@ucera.org|
22415343|NCT05665387|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
22415344|NCT01824498|USDA, GFHNRC|Susan Raatz, PhD, RD|701-795-8294|susan.raatz@ars.usda.gov|
22415345|NCT00006436|National Cancer Institute|Dr. Max Gordon|240-858-7151|max.gordon@nih.gov|
22415346|NCT00939523|Cedars-Sinai Medical Center|Odelia Cooper|310-423-4774|coopero@cshs.org|
22415347|NCT00924053|Theracos, Inc|Yuan-Di Halvorsen|617 726-4236|yhalvorsen@ccib.mgh.harvard.edu|
22415348|NCT00757172|Washington University School of Medicine|Dr. A. Craig Lockhart|314-454-8306|alockhar@dom.wustl.edu|
22415349|NCT03196284|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22415350|NCT05471349|University of Wisconsin - Madison|Mark Zehner|608-262-7568|mark.zehner@wisc.edu|
22415351|NCT02233751|Antares Pharma, Inc.|Jonathan Jaffe, MD|609-359-3020|jjaffe@antarespharma.com|
22415352|NCT00685334|New York State Psychiatric Institute|Evelyn Attia, MD|212-253-5923|ea12@columbia.edu|
22415353|NCT04577404|Tanabe Pharma America, Inc.|Clinical Trials, Information Desk|908-607-1980|information.US@mb.tanabe-pharma.com|
22415354|NCT04556734|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22415355|NCT00202839|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22415356|NCT00704496|milton s hershey medical center|timothy craig,|717-531-6525|tcraig@psu.edu|1
22415357|NCT01662024|Brigham and Women's Hospital|Christopher C. Thompson, MD, MSc|617-525-8266|ccthompson@bwh.harvard.edu|
22415358|NCT01134198|new york state psychiatric institute|wilfrid raby, md|212-923-3031|wilfrid.raby@nyspi.columbia.edu|
22415359|NCT05353036|Nationwide Children's Hospital|Dr. Joseph D. Tobias|614-722-4200|joseph.tobias@nationwidechildrens.org|
22415360|NCT01490190|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22415361|NCT04707846|Northwell Health|Joan Duer-Hefele, RN, MA|646-766-7153|jduerhefele@northwell.edu|
22415362|NCT01151449|Princess Margaret Cancer Centre|Dr. Srikala Sridhar|416-946-2662|srikala.sridhar@uhn.ca|
22415363|NCT02318550|Lancaster General Health|Project Manager|7175447395|Tawnya.Vernon@pennmedicine.upenn.edu|
22415364|NCT02951195|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22415365|NCT00963430|Group Health Research Institute|Lisa Jackson, MD, MPH|206-442-5216||
22415366|NCT00063258|University of Texas M.D. Anderson Cancer Center|Mellanie Price, B.S.|713-792-4392|mejprice@mdanderson.org|
22415367|NCT03988608|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
22415368|NCT01876992|Johns Hopkins University|Sally Radovick|7322359524|sradovick@jhmi.edu|7733073353
22452905|NCT03842995|Hudson Alpha Institute for Biotechnology|Greg Cooper, PhD|2563279490|gcooper@hudsonalpha.org|
22452906|NCT00492284|QLT Inc.|Medical Information Department|1-800-663-5486|medaff@qltinc.com|
22452907|NCT02734212|VISN 5 MIRECC|Dr. Amy Drapalski|410-637-1855|amy.drapalski@va.gov|
22452908|NCT01404572|Bristol-Myers Squibb (BMS)|BMS Study Director||Clinical.Trials@bms.com|
22452909|NCT03282890|UConn|Dr. Michael Copenhaver|860-208-3632|michael.copenhaver@uconn.edu|
22452910|NCT02937168|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22452911|NCT02154763|The Ottawa Hospital|Dr.Joseph Mamazza|613-798-5555|jmamazza@toh.on.ca|
22452912|NCT00700401|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22452913|NCT02491671|Hospital Universitario de Salamanca|Dr. Marcelo Jiménez|923291100|mfjl@usal.es|
22452914|NCT00682734|Montefiore Medical Center|Benjamin Friedman|718 920 6626|befriedm@montefiore.org|
22431109|NCT01661283|SARC|SARC|(734) 930-7600|sarc@sarctrials.org|
22431110|NCT00492544|GlaxoSmithKline|GSK Response Center|866-435-7343||
22431111|NCT01055028|Stanford University Medical Center|Kristen Ganjoo, MD|650-725-6413|kganjoo@stanford.edu|
22431112|NCT00361712|Rabin Medical Center|Dr Leonid Edilman|972-9376850|leidelman@clalit.org.il|
22431113|NCT04989218|The University of Alabama at Birmingham|Dr. Mehmet Akce, Associate Professor|2059342992|makce@uabmc.edu|
22431114|NCT03528902|Vanderbilt University Medical Center|Research Programs Manager|615-322-4703|ph_research@vumc.org|
22431115|NCT04620668|University of New Brunswick|Luke MacNeill|506-648-5500|luke.macneill@unb.ca|
22431116|NCT03896633|Bausch & Lomb|Daniel Donatello|5853385306|Daniel.Donatello@bausch.com|
22431117|NCT04047355|New York State Institute for Basic Research|J. Helen Yoo, Ph.D.|718-494-5295|jhelen.yoo@opwdd.ny.gov|
22389593|NCT05579769|St. Jude Children's Research Hospital|Dr. Ashok Srinivasan|8662785833|referralinfo@stjude.org|
22415369|NCT01134549|Amgen, Inc|Study Director|866-572-6436||
22415370|NCT01327976|EnteroMedics|Director of Clinical Research|651-634-3209|mbroich@enteromedics.com|
22415371|NCT00217724|OHSU Knight Cancer Institute|Joseph Bublao|503-494-1054|bubaloj@ohsu.edu|
22415372|NCT00969124|Avantis Medical Systems , Inc.|Jack Higgins, MD - Chief Medical Officer|4086367226|jhiggins@avantismedical.com|
22415373|NCT04421625|INSTITUT DE CANCEROLOGIE DE L'OUEST|DR FREDERIC BIGOT|02 41 35 27 00|frederic.bigot@ico.unicancer.fr|+33
22415374|NCT04462198|Pipeline Therapeutics, Inc.|Stephen Huhn, MD|858-333-5280|SHuhn@pipeline-tx.com|
22415375|NCT01897077|Johns Hopkins School of Medicine|Corinne Keet|410-955-5883|ckeet1@jhmi.edu|
22415376|NCT02786953|Vanderbilt University Medical Center|Sarah S Jaser|6153436775|sarah.jaser@vumc.org|
22415377|NCT01250730|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22415378|NCT01186458|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
22415379|NCT04281472|Argenx|Regulatory manager|Please email:|regulatory@argenx.com|
22415380|NCT01328782|Children's Hospital Colorado|Gaia Georgopoulos, MD|720-777-2588|Gaia.Georgopoulos@childrenscolorado.org|
22415381|NCT00994604|Johns Hokpins Medical Institutions|Dr. Robert Brown|410-614-5451|rbrown2@jhmi.edu|
22415382|NCT00325780|Kowa Research Institute|Bill Arana|919 433 1600|barana@kowaus.com|
22415383|NCT02099318|University Hospitals Cleveland Medical Center|Valerie Cwiklinski Clinical Research Nurse|216-983-5144|valerie.cwiklinski1@uhhospitals.org|
22415384|NCT03617419|GE Healthcare|Sr. Clinical Affairs Project Manager|2624095722|kevin.r.siewert@ge.com|
22415385|NCT01528735|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22415386|NCT03555695|Rush University Medical Center|Dr. Jori Fleisher|312-563-2900|jori_fleisher@rush.edu|
22415387|NCT01426854|Alcon (China) Ophthalmic Product Co., Ltd.|Terence Li, Clinical Research Manager, Development & Medical Affairs, China|+86 10 5829 1452|Terence.li@alcon.com|
22415388|NCT02161705|Johns Hopkins University School of Medicine|Dr. Pathik Aravind|4437879385|paravin1@jhmi.edu|
22415389|NCT04116957|University of Missouri|Jung Hyup Kim|5738840354|kijung@missouri.edu|
22415390|NCT01942135|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22415391|NCT01499043|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
22415392|NCT00538863|Insys Therapeutics, Inc.|Larry Dillaha, M.D., Chief Medical Officer|602-910-2617|ldillaha@insysrx.com|
22415393|NCT06588530|Rutgers University|Dr. Robert Laumbach|1-848-445-6084|laumbach@eohsi.rutgers.edu|
22415394|NCT01596127|The University of Texas MD Anderson Cancer Center|Elias Jabbour MD/Associate Professor|713-792-7734|CR_Study_Registration@mdanderson.org|
22415395|NCT01566435|Washington University School of Medicine|Douglas Adkins, M.D.|314-747-7402|dadkins@wustl.edu|
22415396|NCT00438633|Massachusetts General Hospital|Dr. Neal Chen|6177264700|nchen1@partners.org|
22415397|NCT04569084|Tanabe Pharma America, Inc.|Clinical Trials, Information Desk|908-607-1980|information.US@mb.tanabe-pharma.com|
22415398|NCT02860000|Mayo Clinic|Dr Tufia C Haddad|507-284-2511|Haddad.Tufia@mayo.edu|
22431118|NCT01722643|Dartmouth-Hitchcock|Dr. Catherine Stanger|603-646-7023|catherine.stanger@dartmouth.edu|
22452915|NCT02251990|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22452916|NCT02293538|Alcon Research, Ltd.|Global Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22389594|NCT03602859|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22389595|NCT05492786|Geisinger health|Gail Rosenbaum|570-243-1199|grosenbaum@geisinger.edu|
22389596|NCT00383630|Columbia University|Yoshifumi Naka, MD, PhD|(212) 305-0828|yn33@columbia.edu|
22389597|NCT00506922|UT MD Anderson Cancer Center|Marcos de Lima, MD / Professor|713-745-3219|bmcmullin@mdanderson.org|
22389598|NCT01997437|Kuban State Medical University|Dr. Paolo Macchiarini|+7(928)-268-80-00|pmacchiarini@ksma.ru|
22431119|NCT00427700|Hospital de Clínicas de Porto Alege|Dr. Ricardo Francalacci Savaris|51 33598405|rsavaris@hcpa.edu.br|
22389599|NCT00555997|Massachusetts General Hospital|Dr. George Papakostas|617-726-6697|gpapakostas@partners.org|
22389600|NCT04816708|Duke University|Christopher E. Cox, MD|919-681-7232|christopher.cox@duke.edu|
22389601|NCT03596905|Bausch Health|Angela Moore|843-877-2756|angela.moore@bauschhealth.com|
22389602|NCT00508274|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22389603|NCT02640807|Revimmune|Dr Michel Morre, DVM, Chief Scientific Officer|+33(0)603357060|m.morre@revimmune.com|
22389604|NCT02531126|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22389605|NCT00377312|University of Pittsburgh|Mara J Horwitz|412-692-2848|horwitz@pitt.edu|
22389606|NCT01654445|University of Calgary, Department of Clinical Neurosciences|Shelagh B Coutts and Michael D Hill|4039448065|michael.hill@ucalgary.ca|
22389607|NCT00382408|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|info.era-clinical@teva.de|
22389608|NCT02794441|Children's Hospital of Eastern Ontario Research Institute|Dr. Roger Zemek|6137377600|rzemek@cheo.on.ca|3931
22389609|NCT01572493|National Cancer Institute|Dr. Kevin C. Conlon|240-858-3570|conlonkc@mail.nih.gov|
22389610|NCT00609245|Vanderbilt University Medical Center|Bassel Abou-Khalil, MD|615-936-0060|bassel.abou-khalil@vanderbilt.edu|
22389611|NCT02236598|Duke University Health System|Ranee Chatterjee Montgomery, M.D.||ranee.chatterjee@duke.edu|
22389612|NCT03643705|University of Washington|Dr. Chris Longenecker|2066161159|ctlongen@uw.edu|
22389613|NCT01475370|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22389614|NCT03132753|Chestnut Health's Lighthouse Institute; Chicago, Illinois|Dennis Watson|224-534-0114|dpwatson@chestnut.org|
22389615|NCT00084747|UCLA|Dr. Gary Schiller|310-206-5755|gschiller@mednet.ucla.edu|
22389616|NCT03410953|UICEC, Complejo Asistencial Universitario de Salamanca - Instituto de Investigación Biomédica de Salamanca (IBSAL), Plataforma SCReN, Salamanca, Spain|Ricardo López-Pérez, PhD. Study Coordinator and Manager of Clinical Trial|923 291100|ricardo.lopez@scren.es|55779
22389617|NCT00679549|The Ohio State Unveristy|Rami Khayat|6142477717|rami.khayat@osumc.edu|
22389618|NCT01093183|University of Nebraska Medical Center|James Schwarz, MD|402-559-5166|jkschwarz@unmc.edu|
22389619|NCT01614899|Clinical Research, Drug Development Division|Regional Function Head of CNS Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
22389620|NCT01446042|Trimel Pharmaceuticals Corp.|Natalia Tkachenko, MD Director Clinical Affairs|9054641755|ntkachenko@trimelpharmaceuticals.com|
22389621|NCT02724423|Neurelis, Inc.|Sunita Misra, M.D. Medical Director|(832) 257-1975|smisra@neurelis.com|
22389622|NCT00720629|H. Lee Moffitt Cancer Center and Research Institute|Lia Perez, M.D.|813-745-7202|lia.perez@moffitt.org|
22389623|NCT02713698|Centro Hospitalar do Porto|Ana Maria Araujo|22 2077549|amfariaaraujo@gmail.com|1280
22389624|NCT03152409|Brigham and Women's Hospital|Dr. Jessica Harder|6177326753|jaharder@bwh.harvard.edu|
22389625|NCT05714345|Allogene Therapeutics, Inc|Medical Information|(+1) 415-604-5696|clinicaltrials@allogene.com|
22389626|NCT04474691|New York University|Tara McAllister|212-992-9445|tkm214@nyu.edu|
22389627|NCT01323309|Memorial Sloan Kettering Cancer Center|Dr. William Breitbart, MD|646-888-0020|breitbaw@MSKCC.ORG|
22389628|NCT02815709|Trevena, Inc.|Kelly Arscott|6103548840|karscott@trevena.com|
22389629|NCT00310050|Wake Forest University Health Sciences|Dr. William Blackstock|3367136501|ablackst@wakehealth.edu|
22389630|NCT03048058|Wake Forest University Health Sciences|Irma M. RIchardson, MHA;|336-716-2903|irichard@wakehealth.edu|
22389631|NCT04422210|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22389632|NCT01257698|Mid Atlantic Retina|Jason Hsu MD|215-928-3092|jhsu@midatlanticretina.com|
22389633|NCT00538616|Duke University|Dr. Carmelo Graffagnino|919/681-3751|Carmelo.Graffagnino@duke.edu|
22389634|NCT00274846|Masonic Cancer Center, University of Minnesota|Jeffrey Miller, M.D.|612-625-7409|mille011@umn.edu|
22389635|NCT04601857|Taiho Oncology, Inc|Taiho|844-878-2446|medicalinformation@taihooncology.com|
22389636|NCT00980954|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
22389637|NCT04372186|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genetech@druginfo.com|
22389638|NCT04736472|University of Pennsylvania|Sony Tuteja, PI|215-573-7834|Sony.Tuteja@PennMedicine.upenn.edu|
22389639|NCT02268526|Novartis Pharmaceuticals|Study Director|8627788300||
22389640|NCT00739024|Swedish Headache Center|Pat Barrodale, RN|206-215-3502|pat.barrodale@swedish.org|
22389641|NCT02332824|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22389642|NCT00498797|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22389643|NCT02070640|The Ohio State University Wexner Medical Center|Associate Professor|614-293-3230|raaja.narula@osumc.edu|
22389644|NCT01052714|Psychiatry Department at VA Greater Los Angeles Healthcare System|Dr. Donna Ames, Principal Investigator|310-478-3037|donna.ames@va.gov|
22389645|NCT01195584|General Hospital Amstetten|Wolfgang Senker, MD|+43 7472 6040|wolfgang.senker@aon.at|6611
22389646|NCT00417989|Medtronic|Scott Lee, M.D.|8185764204|scott.w.lee@medtronic.com|
22389647|NCT01184755|Rutgers - Robert Wood Johnson Medical School|Lynn Clemow, PhD|732-235-6972|lynn.clemow@rutgers.edu|
22389648|NCT04212299|University of Illinois Chicago|Andrew Sawers|312-996-1427|asawers@uic.edu|
22389649|NCT05379023|Department of Neurology, University of Colorado Anschutz Medical Campus (CU-AMC)|Brianne Bettcher, PhD, ABPP-CN|(303) 724-3941|brianne.bettcher@cuanschutz.edu|
22389650|NCT02924350|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22402091|NCT02062151|USF Pediatrics|Laura Weathers|813/844-3046|lweathers@health.usf.edu|
22402092|NCT01158950|University of California, San Francisco|Dr. Jennifer Mitchell|510-985-3522|jennifer.mitchell@ucsf.edu|
22402093|NCT02137772|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22402094|NCT01844700|Zucker Hillside Hospital, Division of Psychiatry Research|Anil Malhotra, MD|718-470-8281|amalhotra@nshs.edu|
22431120|NCT04581395|IU school of Medicine, Department of Anesthesiology|Dr. Leighan Bye, Assistant Professor of Clinical Anesthesia|317-274-0275|lbye@iu.edu|
22402095|NCT00638846|Vistakon|Kurt Moody OD|904-443-3088||
22431121|NCT03630679|Danone Asia Pacific Holdings|Digital Project Manager|82281172|jill.wong@danone.com|
22431122|NCT03538808|University of Alabama at Birmingham|Samantha Schiavon|9515509388|sschiavon@uabmc.edu|
22431123|NCT03709472|University of Miami|Victoria Mitrani|3052849139|vmitrani@miami.edu|
22431124|NCT03506360|Mayo Clinic|Yi Lin|5072845096|Lin.Yi@mayo.edu|
22402096|NCT03531957|Asana BioSciencxes, LLC|Pablo Jimenez|9086980782|pablo.jimenez@asanabio.com|
22431125|NCT02085720|Chinese University of Hong Kong|Dr Susanna Ng SS|85226322211|drsssng123@yahoo.com.hk|
22431126|NCT00112385|Brigham and Women's Hospital|A Pilot Study of Etanercept in Dermatomyositis|617-732-8046|aamato@partners.org|
22431127|NCT05697380|University of Chicago|Dr. Emily Rogalski|855-824-7887|emily.rogalski@bsd.uchicago.edu|
22431128|NCT05293314|Department of Respiratory and Critical Care Medicine, Shanghai Pulmonary Hospital, School of Medicine, Tongji University，Shanghai, China|Jin-Fu Xu|008621 65115006|jfxu@tongji.edu.cn|
22431129|NCT05572567|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22402097|NCT03809546|University of Chicago|Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
22431130|NCT02620865|Karmanos Cancer Institute|Dr. Anthony Shields|313-576-8735|shieldsa@karmanos.org|
22402098|NCT02746679|The First Affiliated Hospital of Sun Yat-sen University|Yuqing Chen|+86 020-87755766-8341|fangchenyq@163.com|
22431131|NCT01415453|Columbia University Medical Center|Dr Ronald Silverman|2123055484|rs3072@columbia.edu|
22431132|NCT05528445|Neurosteer|Nathan Intrator, Prof.|+1 (401) 837-0351|nathan@neurosteer.com|
22402099|NCT02679066|Johns Hopkins Bayview|Erik Hasenboehler MD|4105504190|ehasenb1@jhmi.edu|
22431133|NCT00959049|Seqirus|Clinical Program Director||Seqirus.ClinicalTrials@Seqirus.com|
22402100|NCT01416610|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22431134|NCT00565747|Origio A/S|Chief Scientific Officer|+45 46790200|sbendz@origio.com|
22402101|NCT01221298|AbbVie|Global Medical Services|800-633-9110||
22431135|NCT04507204|Purdue Pharma L.P.|Jaromir Mikl, PhD MSPH|800-745-7445|jaromir.mikl@pharma.com|7277
22431136|NCT00895921|Veterans Medical Research Foundation|Jonathan M. Meyer, MD|858-964-0777|jmmeyer@ucsd.edu|
22402102|NCT04172831|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 904-0355|greg.sullivan@tonixpharma.com|
22431137|NCT01905540|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22431138|NCT03729609|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22402103|NCT04036136|University of North Carollina at Chapel Hill|Gabriel Dichter, PhD|919-364-4275|dichter@med.unc.edu|
22402104|NCT01696877|Johns Hopkins University|Emmanuel S. Antonarakis, M.D., principal investigator|443-287-0553|eantona1@jhmi.edu|
22402105|NCT00469014|University of Texas MD Anderson Cancer Center|Richard Champlin, MD / Professor, Chair, Stem Cell Transplantation|713-792-3618|CR_Study_Registration@mdanderson.org|
22431139|NCT04700800|Mayo Clinic|Lori Roust|(602) 543-4254|Roust.Lori@mayo.edu|
22431140|NCT02919618|Washington University|Dr. Phillip Cuculich|314-454-7698|pcuculic@wustl.edu|
22431141|NCT04770285|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22431142|NCT03411044|Zimmer Biomet|Esther Foo|+41787183202|esther.foo@zimmerbiomet.com|
22431143|NCT00645658|VA Palo Alto Health Care System|Jonathan Myers|6504503440|drj993@aol.com|
22431144|NCT04258631|Mayo Clinic|Sean C. Dowdy, M.D.|507-266-0225|Dowdy.Sean@mayo.edu|
22431145|NCT04481685|University of Kansas Medical Center|Gregory Gan, MD PhD|913 588 5881|ggan@kumc.edu|
22431146|NCT02527512|Boston Children's Hospital|Lauren Hutchinson, Clinical Research Manager|6179191632|lauren.hutchinson@childrens.harvard.edu|
22431147|NCT00356187|Denver Health and Hospital Authority|Elizabeth Kingsley, Senior Grants Analyst|3036027061|elizabeth.kingsley@dhha.org|
22431148|NCT00189475|Allegheny Singer Research Institute, WPAHS|David Skoner, MD|4123594099|dskoner@wpahs.org|
22431149|NCT00815633|Icahn School of Medicine at Mount Sinai|Dr. Joshua Zeichner||joshzeichner@gmail.com|
22431150|NCT02457065|Dartmouth-Hitchcock Medical Center|Michael S Chapman, MD|(603) 650-5000|Michael.Shane.Chapman@hitchcock.org|
22452917|NCT00322348|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22452918|NCT02439710|Institute for Policy Advancement Ltd|Mark W Skinner|+1-202-253-8342|mskinnerdc@gmail.com|
22452919|NCT01041638|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22452920|NCT03152552|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22452921|NCT04259086|Revance Therapeutics, Inc.|Todd Gross, PhD, VP, Clinical Development & Data Science|510-742-3400|tgross@revance.com|
22452922|NCT01857531|Duke Center for Smoking Cessation|Dr. Jed E. Rose|919-668-5055|jed.rose@duke.edu|
22452923|NCT04631666|Institute of Virology|Prof. Florian Klein|49221478|florian.klein@uk-koeln.de|85800
22452924|NCT00679939|GlaxoSmithKline|GSK Response Center|866-435-7343||
22452925|NCT05374421|Erchonia Corporation|Clinical Affairs Manager|864-531-0064|tsammons@erchonia.com|501
22452926|NCT02763384|Washington University School of Medicine|Geoffrey L. Uy, M.D.|314-747-8439|guy@wustl.edu|
22452927|NCT04657211|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22431151|NCT01362790|National Cancer Institute|Dr. Raffit Hassan|301-451-8742|raffit_hassan@nih.gov|
22402106|NCT03418662|Indiana University|Rachel Lahr|317-948-0724|rlahr@iu.edu|
22415399|NCT03922490|Hospital for Special Surgery|Jessica Rios|212-774-7321|riosj@hss.edu|
22415400|NCT04729101|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-PHAT (7428)|medicalinformation@phathompharma.com|
22415401|NCT00274625|Cook Biotech Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@cookbiotech.com|
22415402|NCT02940522|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
22415403|NCT00762411|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22415404|NCT02959840|Rutgers-Robert Wood Johnson Medical School|Dr. Shaul Cohen, M.D., Professor of Clinical Anesthesiology, Director of Obstetric Anesthesia|732-937-8841|cohensh@rwjms.rutgers.edu|
22415405|NCT00377572|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22415406|NCT02937506|Mount Carmel Health System|Anantha Padmanabhan, MD|614-234-1079|apadmanabhan@mchs.com|
22415407|NCT01813435|Jessa Ziekenhuis, Hasselt, Belgium|Dr. Pascal Vranckx|+32 11 30 9589|pascal.vranckx@jessazh.be|
22415408|NCT01435824|The Hospital for Sick Children|Dr. Shinya Ito|416-813-5776|shinya.ito@sickkids.ca|205776
22415409|NCT03028896|SNUBH|Dr. Bon-wook Koo|+82-10-7227-1379|tendong2@gmail.com|31
22415410|NCT00117806|James A. Haley Veterans' Hospital|Lisa Ottomanelli, PhD|813-558-3917|lisa.ottomanelli@va.gov|
22452928|NCT00003508|Burzynski Research Institute, Inc|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22415411|NCT01765751|Palmer College of Chiropractic|Maruti R. Gudavalli, PhD|563-884-5260|gudavalli_r@palmer.edu|
22452929|NCT00871689|Masonic Cancer Center, University of Minnesota|Michael Verneris, M.D.|612-626-2961|verneris@umn.edu|
22402107|NCT02119104|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22402108|NCT02222129|USAF|Richard Knight, MD|+44 1638 528186|richard_b_knight@yahoo.com|
22402109|NCT00916721|Massachusetts General Hospital|A. Eden Evins, MD, MPH, Director Center for Addiction Medicine|617-643-4679|a_eden_evins@hms.harvard.edu|
22402110|NCT01519427|Vanderbilt-Ingram Cancer Center|Jeff Sosman, MD|615-936-3048|jeff.sosman@vanderbilt.edu|
22402111|NCT03519308|Abramson Cancer Center, University of Pennsylvania|Liudmila Mazaleuskaya/Pancreas Research Program Manager|2674559141|mazali@pennmedicine.upenn.edu|
22402112|NCT03020524|University of Pennsylvania|Regulatory Lead|215.662.4484|psom-ind-ide@pobox.upenn.edu|
22402113|NCT02273323|Unilever R&D Vlaardingen|Theo Mulder|+31 10 460 8315|theo.mulder@unilever.com|
22402114|NCT00121810|Hoffmann-La Roche|Medical Communications|800-821-8590||
22402115|NCT00798967|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22402116|NCT01354691|Bar Ilan University|Jonathan Rabinowitz, PhD||jonathan.rabinowitz@biu.ac.il|
22402117|NCT00633139|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22402118|NCT01452425|UCLouvain|Pr Patrice Forget|3227641821|forgetpatrice@yahoo.fr|
22402119|NCT01507246|Atlanta Colon and Rectal Surgery|Stephen Cohen, MD|770-997-1975|klong@atlantacolon.com|
22402120|NCT04083222|Ionis Pharmaceuticals, Inc|Ionis Pharmaceuticals, Inc|800-679-4747|patients@ionisph.com|
22402121|NCT03340805|The Children's Hospital of Philadelphia|Dr. Scott L. Weiss, study co-PI|215-590-5505|WeissS@email.chop.edu|
22402122|NCT03575468|Consumer Wellness Solutions|Dr. Katrina Vickerman|469-608-4208|katrina.vickerman@optum.com|
22402123|NCT01522651|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22402124|NCT00962065|Lexicon Pharmaceuticals, Inc.|Joel P. Freiman, MD, MPH|281-863-3000||
22402125|NCT01989546|National Cancer Institute|Dr. Alice P. Chen|240-781-3274|chenali@mail.nih.gov|
22402126|NCT03960138|University of Missouri|Dr. Brett Froeliger|5738824785|froeligerb@health.missouri.edu|
22402127|NCT02046265|University of Pennsylvania School of Nursing|Dr. Anne Teitelman|215-898-1910|teitelm@nursing.upenn.edu|
22402128|NCT01793051|UT MD Anderson Cancer Center|Dr. Robert Orlowski, Professor, Lymphoma-Myeloma|(713) 794-3234|rorlowski@mdanderson.org|
22402129|NCT01419275|Stanford University|Dr. Greg Zaharchuk|650-736-6172|susanmir@stanford.edu|
22402130|NCT00059215|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22402131|NCT04494633|Clinical Tools, Inc.|Mary Metcalf, PhD, MPH|(919) 960-8118|metcalf@clinicaltools.com|
22402132|NCT01958671|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22402133|NCT05730829|McMaster University|Dr Lisa Carlesso|2896805640|carlesl@mcmaster.ca|
22402134|NCT05014776|SKCCC Johns Hopkins Medical Institution|Katherine Bever, MD|443-287-0966|kbever1@jhmi.edu|
22402135|NCT01703286|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22402136|NCT00931892|Beth Israel Deaconess Medical Center|Dr. Ciaran Kelly|617-667-1272|ckelly2@bidmc.harvard.edu|
22402137|NCT02207530|AstraZeneca LP|Jean Fan, MD, Global Clinical Lead|1-301-398-5080|jean.fan@astrazeneca.com|
22402138|NCT00719576|Vericel Corporation|Ann Remmers, Senior Director, Clinical Science|734-428-4526|aremmers@vcel.com|
22402139|NCT03952468|VA Providence Health Care system|Dr. Jennifer Primack|(401) 273-7100|Jennifer.Primack@va.gov|16295
22402140|NCT01084499|Asan Medical Center|Principal Investigator||mdlhs@amc.seoul.kr|
22402141|NCT01849848|SymBio Pharmaceuticals|Toshihiko Nagase|+81-3-5472-1127||
22402142|NCT03649321|UT Southwestern Medical Center|Dr. Syed Kazmi|214-648-4180|syed.kazmi@utsouthwestern.edu|
22402143|NCT01702363|GlaxoSmithKline|GSK Response Center|866-435-7343||
22402144|NCT00406315|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22402145|NCT01312428|Stryker Orthopedics|Director of Clinical Research|201-831-5401|ellen.axelson@stryker.com|
22402146|NCT04860713|Maimonides Medical Center|Research Administration Director|718-283-6896|alikourezos@maimonidesmed.org|
22415412|NCT01120899|National Institutes of Health|Catherine Cukras, MD, PhD, Principal Investigator, NEI|301-435-5061|cukrasc@nei.nih.gov|
22402147|NCT02202031|University of California, San Francisco|Alison Huang, MD|415-514-8697|alison.huang@ucsf.edu|
22452930|NCT03576768|Medical University of South Carolina|Colleen Hanlon, PhD|843-792-9888|hanlon@musc.edu|
22402148|NCT04412954|Ohio State Univeristy|Sandy Solove|6142478366|solove.3@osu.edu|
22389651|NCT01904019|Zimmer Biomet|Emilie Rohmer, Clinical Operations Manager|+41 58 85 48210|Emilie.Rohmer@zimmerbiomet.com|
22389652|NCT00509821|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22389653|NCT01816685|Duke University|Andrew Krystal|(919) 668-1212|andrew.krystal@dm.duke.edu|
22389654|NCT01157351|Janssen Research & Development|Director, Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
22389655|NCT02675998|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
22389656|NCT02552810|University of Valencia|Dr. Luigi Canullo|+39 347 6201976|luigicanullo@yahoo.com|
22389657|NCT02097849|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22452931|NCT00590902|Memorial Sloan Kettering Cancer Center|Dr. Mark Kris|646-888-4205|krism@mskcc.org|
22389658|NCT02137499|Imperial College London|Miss Kate Williams||k.williams@imperial.ac.uk|
22389659|NCT02561078|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22452932|NCT02057874|Vanderbilt University Medical Center|Professor of Surgery and Cancer Biology|615-936-2956|lee.gorden@vanderbilt.edu|
22389660|NCT00598871|ReGenTree, LLC|Won S. Yang, President & CEO|609-734-4328|wonsyang@regentreellc.com|
22389661|NCT01194271|The University of Texas (UT) MD Anderson Cancer Center|Padmanee Sharma, Professor, Genitourinary Medical Oncology|713-792-2830|CR_Study_Registration@mdanderson.org|
22452933|NCT02979639|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22452934|NCT00799292|Mt Sinai School of Medicine, Department of Obstetrics and Gynecology|Charles Ascher-Walsh MD, MPH|212-241-2827|charles.ascher-walsh@mssm.edu|
22389662|NCT00443898|Novartis Pharmaceuticals|Study Director|862-778-8300||
22389663|NCT00043186|Amgen Inc.|Study Director|866-572-6436||
22452935|NCT01738984|University of Hawaii, School of Nursing and Dental Hygiene|Cheryl Albright|8089569716|cherylal@hawaii.edu|
22389664|NCT01341444|Medstar Georgetown University Hospital|Dr. Matthew Cooper|202-444-0753|Matthew.Cooper@gunet.georgetown.edu|
22452936|NCT00610116|Department of Cardiology and Rhythmology, Augusta Hospital, Duesseldorf, Germany.|Joachim Winter, MD|+49 (0) 2118|joachim.winter@uniklinik-duesseldorf.de|1173
22389665|NCT04483791|EVP, Clinical Research|Candace Elek, M.S.|408-913-5468|celek@elixirmedical.com|
22452937|NCT01760889|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22452938|NCT02621931|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22389666|NCT04050722|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22452939|NCT00920426|ViiV Healthcare|GSK Response Center|866-435-7343||
22452940|NCT01466985|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22452941|NCT03100617|UCaliforniaDavis|Dr. Ladson Hinton|9167343485|lwhinton@ucdavis.edu|
22389667|NCT03924947|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22389668|NCT01145417|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22389669|NCT03085433|UCSF CRH|Clinical Research Team|4153534305|CRH.Research@ucsf.edu|
22389670|NCT03809039|Tanabe Pharma America, Inc.|Clinical Trials, Information Desk|Please e-mail|information.US@mb.tanabe-pharma.com|
22389671|NCT03451292|Instituto Grifols, S.A.|Mireia Torres|+34 93 5710500|approach_preciosa@grifols.com|
22452942|NCT00955357|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22452943|NCT02943408|Veterans Affairs Rocky Mountain (VISN 19) Mental Illness Research Education and Clinical Center (MIRECC)|Dr. Samantha Hack|720-234-2017|samantha.hack@va.gov|
22452944|NCT01106833|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
22389672|NCT05271552|BioXcel Therapeutics|SVP Clinical and Medical Affairs|(203) 530-5000|DKostic@Bioxceltherapeutics.com|
22452945|NCT01621126|Massachusetts General Hospital|Dr. Jon J.P. Warner, Chief of Shoulder Service MGH, Harvard Professor of Orthopaedics.|617-724-3140|jwarner@mgh.harvard.edu|
22452946|NCT00886340|Yale School of Nursing|Robin Whittemore, PhD|203-737-2351|robin.whittemore@yale.edu|
22452947|NCT02985866|University of Virginia Center for Diabetes Technology|Boris Kovatchev, PhD|434-982-0602|mc7m@virginia.edu|
22389673|NCT00702338|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22389674|NCT00084409|University of Colorado Denver|Robert Keith, M.D.|303-399-8020|robert.keith@ucdenver.edu|3182
22402149|NCT00748826|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22452948|NCT03751631|Eyenovia, Inc.|VP, Development|714-269-8838|gclasby@eyenoviabio.com|
22452949|NCT02481310|Northwestern University|Barbara Pro, MD|312-695-6832|barbara.pro@northwestern.edu|
22452950|NCT04953390|Sonova USCS|Principal Investigator|630-821-5000|phonakaudiologyresearch@gmail.com|
22452951|NCT00643916|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22452952|NCT03035292|Cambridge University Hospitals NHS Trust|Dr Stephen Kelleher, Director of R&D|01223 217418|r&denquiries@addenbrookes.nhs.uk|
22452953|NCT02184611|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22452954|NCT02925455|Case Western Reserve University and MetroHealth System|Michael Fu|215-368-0355|mjf24@case.edu|
22452955|NCT01808950|Galderma Spirig|Dr. Francine Santoro|+41623878720|francine.santoro@galderma.com|
22452956|NCT01514448|Novartis Pharmaceuticals|Study Director|862-778-8300||
22452957|NCT05159622|George Washington University|Uriyoan Colon-Ramos|202994 1899|uriyoan@gwu.edu|
22452958|NCT02723864|National Cancer Institute|Dr. Alice Chen|240-781-3274|chenali@mail.nih.gov|
22452959|NCT03232983|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22452960|NCT00746590|BTG International Ltd.|Claire Daugherty|+1 801 556 8882|claire.daugherty@btgplc.com|
22452961|NCT01030861|Benaroya Research Institute|Carla Greenbaum, MD|206-342-6933|cjgreen@benaroyaresearch.org|
22452962|NCT02836418|aTyr Pharma|Study Director|858 731 8389|clinicaltrials@atyrpharma.com|
22389675|NCT03840993|Tanabe Pharma America, Inc.|Clinical Trials, Information Desk|Please email|information.US@mb.tanabe-pharma.com|
22389676|NCT01090076|Changi General Hospital|Mr Alvin Wong|68504627|alvin_wong@cgh.com.sg|
22452963|NCT00485485|UT MD Anderson Cancer Center|Anne Tsao, M.D. / Associate Professor|713-792-6363|mejprice@mdanderson.org|
22452964|NCT03643952|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22452965|NCT01358968|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22452966|NCT01597050|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
22452967|NCT00483184|Nobel Ilac San ve Tic. A.S.|Hasan Zeytin MD., Ph.D.|+90 216 6336012|hasan.zeytin@nobel.com.tr|6012
22452968|NCT01992380|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
22452969|NCT00209417|GE Healthcare|Paul Gordon, PhD|011-47-2318-5822|Paul.Gordon@ge.com|
22452970|NCT00815295|Duke University Medical Center|Neal Ready, MD|919-668-6688|neal.ready@duke.edu|
22452971|NCT02071173|Boston Scientific|Kelly Aspinwall|1-800-CARDIAC|kelly.aspinwall@bsci.com|
22452972|NCT03430674|Indiana University|Jamie Renbarger, MD|317-944-8784|jarenbar@iu.edu|
22452973|NCT01618162|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22452974|NCT03321396|Department of Internal Medicine, National Cheng Kung University|Dr. Xi-Zhang Lin|886-6-2353535|linxz@mail.ncku.edu.tw|6202
22389677|NCT02176018|Clinvest Research|Jim Sly|4178413673|jsly@clinvest.com|
22452975|NCT02578238|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22389678|NCT01514630|The Brain Institute of the University of Utah|Perry Renshaw, MD, PhD, MBA|801-587-1216|perry.renshaw@hsc.utah.edu|
22389679|NCT03022045|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22389680|NCT03275402|Y-mAbs Therapeutics|Joris Wilms|+4570261414|clinicaltrials@ymabs.com|
22389681|NCT02223871|Idorsia Pharmaceuticals Ltd|Clinical Trial Disclosure desk||clinical-trials-disclosure@idorsia.com|
22389682|NCT02986659|Atrium Health Wake Forest Baptist|Jingzhong Ding, PhD|336-713-8601|jding@wakehealth.edu|
22389683|NCT02253147|Teoxane|Clinical Project Manager|+41 (0) 22 344 96 36|m.chenet@teoxane.com|
22389684|NCT00926952|Innovaderm Research Inc.|Annie Levesque|514-521-4285|alevesque@innovaderm.ca|222
22389685|NCT02469077|Vanderbilt University Medical Center|Stephen Bruehl, Ph.D.|615-936-1821|stephen.bruehl@vumc.org|
22389686|NCT02973477|University of Michigan|Lynn Ang|734-232-8058|angly@med.umich.edu|
22389687|NCT00694564|UC San Diego|Dr. Jeannie Huang|858-576-1700|jshuang@ucsd.edu|7322
22389688|NCT02402465|University of Chicago|Fuad Baroody, MD|773-702-4790|fbaroody@surgery.bsd.uchicago.edu|
22389689|NCT01284634|GW Research Ltd|Medical Enquires||medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
22389690|NCT03807700|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22389691|NCT01059526|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22389692|NCT01732588|MMV|Dr Fiona Macintyre|+41 22 799 4060|macintyref@mmv.org|4078
22415413|NCT00452348|GlaxoSmithKline|GSK Response Center|866-435-7343||
22415414|NCT01390415|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22415415|NCT01243151|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22415416|NCT03119662|GE Healthcare|Francois Tranquart, M.D., Ph.D.|00-44-1494-543037|francois.tranquart@ge.com|
22415417|NCT04956289|NS Pharma, Inc.|Medical Affairs|+1(201) 986-3860|trialinfo@nspharma.com|
22415418|NCT00544167|Sarah Cannon Research Institute|John Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
22415419|NCT00874549|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22415420|NCT02898740|VA Boston Healthcare System|Dr. David Sparrow|857-364-6400|david.sparrow@va.gov|
22415421|NCT01710358|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22415422|NCT00880334|Dana-Farber Cancer Institute|Toni Choueiri, MD|617-632-5456|toni_choueiri@dfci.harvard/edu|
22415423|NCT00076245|Department of Psychology, University of Vermont|Kelly J. Rohan, Ph.D.|802-656-0798|kelly.rohan@uvm.edu|
22415424|NCT00084864|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22415425|NCT01759251|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com|
22415426|NCT00831987|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22415427|NCT03538795|University of Alabama of Birmingham|Gitendra Uswatte|205-975-5089|guswatte@uab.edu|
22389693|NCT02720081|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22389694|NCT01484314|Brigham and Womens Hospital/ Dana Farber Cancer Institute|Dr. Nancy Berliner|617-732-5840|nberliner@parnes.org|
22389695|NCT02143310|FontemVentures|Tanvir Walele|01779337589|tanvir.walele@fontemventures.com|
22389696|NCT05012397|Rain Oncology|Clinical Research|7082323791|clinicalresearch@rainoncology.com|
22389697|NCT00605384|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22389698|NCT03334747|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22389699|NCT01955720|Boehringer Ingelheim pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22389700|NCT00938041|GlaxoSmithKline|GSK Response Center|866-435-7343||
22389701|NCT02504502|Geisinger Health System|Alanna Kulchak Rahm, PhD|570-214-5093|akrahm@geisinger.edu|
22389702|NCT01509040|University of Washington Harborview Center for Pre Hospital Emergency Care|Dr. Graham Nichol|206-521-1728|nichol@uw.edu|
22389703|NCT03042559|Loma Linda University|Dr. Everett Lohman III|9095584632|elohman@llu.edu|83171
22389704|NCT01855997|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22389705|NCT01994538|Minneapolis VA Health Care System|Dimitri Drekonja, MD, MS|612 467 4183|dimitri.drekonja@va.gov|
22389706|NCT01536535|Connecticut Childrens|Dr. Jeffrey Hyams|8605459532|jhyams@connecticutchildrens.org|
22389707|NCT00428441|University of Insubria|Dr. Walter Ageno|+39 0332 278831|agewal@yahoo.com|
22452976|NCT00937924|University of California, Irvine|Dr. Kenneth Chang|714-456-6187|kchang@uci.edu|
22452977|NCT00224874|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
22431152|NCT03038087|SENSE Diagnostics, Inc.|Joe Korfhagen|844-373-6730|jkorfhagen@senseneuro.com|
22431153|NCT00654355|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-3885|sfeldman@wfubmc.edu|
22402150|NCT01596842|Dong-A University|Professor|82-51-240-2811|anws@dau.ac.kr|
22402151|NCT02214186|Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo|M.D. Wallace Andrino da Silva|+551126616787|wallaceandrino@yahoo.com.br|
22389708|NCT04203160|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
22389709|NCT02744898|NYU Langone Health|Franco Muggia, MD|212 263 2172|Franco.Muggia@nyulangone.org|
22389710|NCT00702234|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22389711|NCT04964297|Weill Cornell Medical Center|Dr. Mehraneh Jafari|+1 646 962 2270|mdj9003@med.cornell.edu|
22389712|NCT01911819|Loma Linda University|Prof. Joseph Kan|(909) 558-4980|jkan@llu.edu|
22402152|NCT04929262|Temple University|Margaret Crane|‭(215) 204-7165‬|margaret.crane@temple.edu|
22402153|NCT01525849|Entellus Medical|Ellen O'Malley|763-463-1598|eomalley@entellusmedical.com|
22402154|NCT00816907|Columbia University|Dr. Scott Stroup|212-543-5676|stroups@nyspi.columbia.edu|
22402155|NCT00339183|Amgen Inc.|Study Director|866-572-6436||
22402156|NCT00793819|Watson Pharmaceuticals|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|801-588-6641|gary.hoel@watson.com|
22402157|NCT00002663|Atara Biotherapeutics|Study Director|650-278-8930|clinicalstudies@atarabio.com|1
22402158|NCT01351766|University of Maryland|Laura MacPherson|6198578425|lauramac.phd@gmail.com|
22402159|NCT00446446|Amgen Inc.|Study Director|866-572-6436||
22402160|NCT02142894|QIAGEN Sciences|Clinical Study Coordinator|301-944-7094|andrew.schumacher@qiagen.com|
22402161|NCT01488318|University of Pittsburgh Cancer Institute|Barbara Stadterman, Regulatory Supervisor|414-647-5554|stadtermanbm@upmc.edu|
22402162|NCT02560701|Harvard Pilgrim Health Care Institute|Dr. J. Frank Wharam|(617) 867-4948|jwharam@post.harvard.edu|
22402163|NCT01776268|Vanderbilt University Medical Center|James Wynn MD||james.wynn@peds.ufl.edu|
22402164|NCT00611130|Catalyst Pharmaceutical Partners, Inc.|M Douglas Winship|305-529-2522|dwinship@catalystpharma.com|12
22415428|NCT02460835|University of Michigan Rogel Cancer Center|Dr. Theodore Lawrence|734-647-9955|tsl@umich.edu|
22415429|NCT03334734|Nearmedic Plus|Viсtoria Shcherbakova|+7 (495) 741 49 89|Viktoriya.Shcherbakova@nearmedic.ru|3869
22415430|NCT01545193|NorthShore University HealthSystem|Glenn S. Murphy,MD|847-570-2760|dgmurphy2@yahoo.com|
22415431|NCT05053360|Inova Health System|Jaimee Robinson, Labor and delivery Clinical Nurse Educator|7038586028|jaimee.robinson@inova.org|
22415432|NCT04697173|Virginia Commonwealth University|Nikki Miller Ferguson MD|804-828-4080|nikki.millerferguson@vcuhealth.org|
22415433|NCT01586039|Brigham and Women's Hospital|Dr. Steven W. Lockley|617-732-4977|slockley@hms.harvard.edu|
22415434|NCT04436198|Regional Clinical Investigation Program|Amanda Crawford|7026533583|amanda.j.crawford.ctr@health.mil|
22402165|NCT01564654|ConforMIS|Marc Quartulli, VP Clinical Affairs|781-345-9191|marc.quartulli@conformis.com|
22402166|NCT00717418|Allergan, Inc.|Vice President, GHOSR|714-246-4500|clinicaltrials@allergan.com|
22402167|NCT02836990|University at Buffalo, SUNY|Dr Linda Harris|7168594207|lmharris@buffalo.edu|
22402168|NCT00525148|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22402169|NCT05100199|AbbVie|ABBVIE CALL CENTER|844-663-3742|abbvieclinicaltrials@abbvie.com|
22402170|NCT01455428|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22402171|NCT03425799|Exela Pharma Sciences|Aruna Koganti, VP Clinical Programs|828-758-5474|akoganti@exela.us|
22402172|NCT03694522|Amgen|Study Director|866-572-6436|medinfo@amgen.com|
22402173|NCT04004507|Ophthalmic Consultants Of Long Island|Dr. Marguerite McDonald|7342501718|margueritemcdmd@aol.com|
22402174|NCT01905397|Duke University Medical Center|Dan Blazer III, MD|919-668-1861|trey.blazer@duke.edu|
22415435|NCT05533411|Eli Lilly and Company|Chief Medical Officer|8005955979|ClinicalTrials.gov@lilly.com|
22415436|NCT01753362|University at Buffalo|Dr. Paresh Dandona|716-535-1850|dandona@buffalo.edu|
22415437|NCT01632306|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22415438|NCT01156987|University of MN|Curt Corum|(612) 625-5000|corum003@umn.edu|
22415439|NCT01632215|Federal University of São Paulo|Dr. Rioko K. Sakata|055 11 5084 7463|riokoks.dcir@epm.br|
22415440|NCT03141151|Vanderbilt University Medical Center|William Heerman, MD MPH|615-322-7080|bill.heerman@vumc.org|
22402175|NCT02273310|The Children's Hospital of Philadelphia/Perleman School of Medicine of The University of Pennsylvania|Lamia Barakat, Ph.D.|267-426-8135|barakat@email.chop.edu|
22402176|NCT01927562|Fractyl|Sarah Hackett|617-596-9522|shackett@fractyl.com|
22402177|NCT00642616|Sanofi|Trial Transparency Team||ContactUS@sanofi.com|
22402178|NCT02351037|Pharmacyclics|Priyanka Mandava, Director of Clinical Operations|408-215-3776|psingh@pcyc.com|
22402179|NCT02955186|Yale School of Medicine|Dana Cavallo, Project Coordinator|203-610-9788|dana.cavallo@yale.edu|
22402180|NCT02234115|Foresee Pharmaceuticals co., Ltd.|Dr. John Mao||john.mao@foreseepharma.com|
22402181|NCT01276847|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22402182|NCT04770155|University of Mississippi Medical Center|Director of Clinical Trials|601-815-5000|clinicaltrials@umc.edu|
22402183|NCT02021812|W.L. Gore & Associates|Jennifer Gorman|928-863-8483|jgorman@wlgore.com|
22452978|NCT02355002|Massachusetts General Hospital|Drs. Joan Camprodon and Sabine Wilhelm|6177265340|jcamprodon@mgh.harvard.edu|
22452979|NCT05554237|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22452980|NCT03644186|ETOP IBCSG Partners Foundation|Dr. Heidi Roschitzki|+41 31 511 94 00|TOUCH-monitoring@etop.ibcsg.org|
22452981|NCT04235036|The Blood and Marrow Transplant Group of Georgia|Dr. Scott Solomon|404-255-1930|ssolomon@bmtga.com|
22452982|NCT02192502|Cleveland Clinic|Dr. Andra Duncan|216-538-6944|duncana@ccf.org|
22452983|NCT02921997|Vanderbilt Vaccine Research Program|C. Buddy Creech, MD, MPH|615-343-0332|buddy.creech@vanderbilt.edu|
22452984|NCT04818346|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22452985|NCT05553808|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22452986|NCT02273141|Norgine Ltd|Lucy Clayton|+44-1895-826669|LClayton@norgine.com|
22452987|NCT02046980|Daegu Kyungbook Dizziness society|Dr. Hyun Ah Kim|+82-53-250-7475|kha0206@dsmc.or.kr|
22452988|NCT04575467|Caliway Biopharmaceuticals Pty Ltd|Candra Chou|886226971355|candra.chou@caliway.com|1317
22452989|NCT01328574|National Cancer Institute|Dr. Andrea Apolo|301-451-1984|apoloab@mail.nih.gov|
22389713|NCT01207453|Brigham and Women's Hospital|Yvonne C Lee, MD, MMSc|617-732-8736|ylee9@partners.org|
22389714|NCT02814279|Institute of Science and Technology of São José dos Campos (Unesp)|Dr. Mauro P. Santamaria|+55 (16) 981937777|mauro.santamaria@ict.unesp.br|
22389715|NCT02951052|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22389716|NCT01589523|Cincinnati Children's Hospital Medical Center|Ken Setchell, PhD|5136364548|kenneth.setchell@cchmc.org|
22389717|NCT00332488|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
22389718|NCT00792259|Topcon Medical Systems|Bob Gibson|(201) 599-5121|RGIBSON@TOPCON.COM|
22389719|NCT00371462|Edward Hines Jr., VA Hospital|Associate Chief of Staff for Research|708-202-5689|eileen.collins@va.gov|
22389720|NCT03721978|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
22389721|NCT05244226|Duke University|Lisa Einhorn, MD|919-681-4877|lisa.einhorn@duke.edu|
22389722|NCT01797562|Allerderm(dba) SmartPractice|Kathryn Shannon|602 225 0595|kshannon@smarthealth.com|
22389723|NCT00917462|Memorial Sloan Kettering Cancer Center|Dr. David Ilson, MD, PhD|646-888-4183|ilsond@mskcc.org|
22389724|NCT01441583|Boston Scientific|Clinical Trial Manager|+18002273422|jens.goetzke@bsci.com|
22389725|NCT03341312|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22389726|NCT01103271|Massachusetts General Hospital|Dr. Maurizio Fava|617-724-0838|mfava@partners.org|
22389727|NCT01763346|University or Southern California|Dr. Thomas Buchanan|3234794319|buchanan@usc.edu|
22389728|NCT00744796|University of Texas Southwestern Medical Center|Dr. Vinod Mootha|214-648-3837|peter.chen@utsouthwestern.edu|
22389729|NCT01212952|Mayo Clinic|Martha Q. Lacy, M.D.|(507) 284-8430|lacy.martha@mayo.edu|
22389730|NCT05372913|Woebot Health|Dr. Athena Robinson|(415) 209-5642|athena@woebothealth.com|
22389731|NCT03303521|AstraZeneca|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22389732|NCT00191984|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22389733|NCT01654289|University of Wisconsin|Bruce Barrett MD PhD|608-263-2220|bruce.barrett@fammed.wisc.edu|
22389734|NCT02103816|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22389735|NCT00005908|National Cancer Institute, National Institutes of Health|JoAnne Zujewski, M.D.|301-435-9207|zujewskij@mail.nih.gov|
22389736|NCT04086576|University of Pennsylvania|Jessie Hemmons|215-746-8255|jhemmons@pennmedicine.upenn.edu|
22389737|NCT04748445|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22389738|NCT04736602|Ipsen Pharma|Medical Director|see email|clinical.trials@ipsen.com|
22389739|NCT00578929|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22389740|NCT04362111|University of Alabama at Birmingham|Walter Winn Chatham MD|205-612-7402|wchatham@uabmc.edu|
22415441|NCT01885897|Masonic Cancer Center, University of Minnesota|Dr. Jeffrey Miller|612-626-4024|mille011@umn.edu|
22415442|NCT03277248|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
22415443|NCT01993940|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|1454
22452990|NCT01953081|Theravance Biopharma US, Inc.|Dr. Brett Haumann, SVP, Clinical Development|650-808-6000|BHaumann@theravance.com|
22452991|NCT00729833|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22452992|NCT03421691|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
22389741|NCT02389725|Mayo Clinic|Dr. Tobias Kummer|507-255-4399|kummer.tobias@mayo.edu|
22389742|NCT01485991|Janssen IDV - Janssen Dx|Trial Physician||ClinicalTrialDisclosure@its.jnj.com|
22389743|NCT02538471|Weill Cornell Medicine|Dr. Silvia Formenti|212-746-3608|formenti@med.cornell.edu|
22415444|NCT01949532|Amgen, Inc.|Study Director|866-572-6436||
22452993|NCT01922076|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22452994|NCT00567242|University of Florida|Bruce Crosson, PhD / Professor|352-273-6617|nossorc1@phhp.ufl.edu|
22452995|NCT01181050|Novo Nordisk A/S|Public Access to Clinical Trials||RA-RNDUS-ClinTriDisc@ITS.JNJ.com|
22452996|NCT00572234|University of Nebraska Medical Center|Kathleen Grant|402-995-4347|kathleen.grant2@va.gov|
22452997|NCT03762135|University of Michigan|Dr. Susan Woolford|734-615-8214|swoolfor@med.umich.edu|
22452998|NCT04598152|The Ohio State University College of Medicine|Jay Fournier, PhD|614-293-9600|jay.fournier@osumc.edu|
22452999|NCT02271386|The Children's Hospital of Philadelphia|Alexander Fiks, MD, MSCE|2674262304|fiks@email.chop.edu|
22453000|NCT03346759|University of Michigan|Jason Bell, MD|7342323897|jasonbel@med.umich.edu|
22453001|NCT03943095|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22453002|NCT04988308|Janssen Research & Development, LLC|Director Clinical Research Dermatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22453003|NCT03341910|Dr. Reddy's Laboratories, Inc|Dr. Srinivas Sidgiddi, Sr. Director, Clinical Development|609-375-9910|srinivassidgiddi@drreddys.com|
22453004|NCT00866840|Rutgers Cancer Institute of New Jersey|James Goydos, MD|(732) 235-7593|goydosjs@cinj.rutgers.edu|
22453005|NCT02474927|University of Pittsburgh|John McDyer|(412) 624-8915|mcdyerjf@upmc.edu|
22402184|NCT00081289|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
22402185|NCT03419533|The University of Adelaide|Prof. Helen Marshall|8161 8115|helen.marshall@adelaide.edu.au|
22402186|NCT02239094|Depression Evaluation Service (New York State Psychiatric Institute)|David J. Hellerstein|646-774-8069|david.hellerstein@nyspi.columbia.edu|
22402187|NCT01797029|PATH|Senior Clinical Research Scientist|206-285-3500|klewis@path.org|
22402188|NCT01469052|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22453006|NCT02599194|Stanford University|Andrei H. Iagaru|(650) 725-4711|aiagaru@stanford.edu|
22453007|NCT03919422|Department of Anesthesiology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital|Dr. Junfen Zhang, director of the clinical trial|+8618930173689|zhangjunfeng@sjtu.edu.cn|
22453008|NCT04177758|Rush University Medical Center|Anne DeBenedetti, MSc|312-432-2468|anne.debenedetti@rushortho.com|
22453009|NCT04918784|Acera Surgical, Inc.|Matthew MacEwan|440-477-1890|macewan@acera-surgical.com|
22453010|NCT01712009|Amgen Inc.|Study Director|866-572-6436||
22453011|NCT01253525|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22453012|NCT01111123|Mount Siani School of Medicine Department of Dermatology|Jason Emer, MD|2122413288|jason.emer@mssm.edu|43288
22402189|NCT02508701|Purdue University|Stewart Chang Alexander|765-427-9860|alexan90@purdue.edu|
22402190|NCT03648996|University of Missouri, School of Medicine|Dr. Camila Manrique, MD|(573) 882-2554|manriquec@umsystem.edu|
22402191|NCT01553539|Wake Forest University Health Sciences|Dr. William J. Petty|336-716-3313|wpetty@wakehealth.edu|
22402192|NCT03894904|The University of Texas Health Science Center at Houston|Nischal K. Gautam, MD|(713) 500-6200|Nischal.K.Gautam@uth.tmc.edu|
22402193|NCT04064684|The University of Texas Health Science Center at Houston|Alvaro Jose Coronado Munoz, MD|713-500-5553|Alvaro.J.CoronadoMunoz@uth.tmc.edu|
22402194|NCT00365976|Duke University|Jenny Bridgers, CRC|919-684-0752|jenny.bridgers@duke.edu|
22402195|NCT03090737|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
22402196|NCT03596177|MedImmune, LLC|Victoria Parker|+44 747 1357172|information.center@astrazeneca.com|
22402197|NCT01301742|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22402198|NCT03103750|Yale School of Medicine|Marc Potenza, PhD, MD|(203) 974-7356|marc.potenza@yale.edu|
22402199|NCT03123939|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22402200|NCT03022032|Dana-Farber Cancer Institute|Dr. Alexi Wright|617-632-2334|alexi_wright@dfci.harvard.edu|
22402201|NCT06787781|university of messina|Dr Fiammetta Iannuzzo|327 628 4688|fiannuzzo@unime.it|
22402202|NCT04400318|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22402203|NCT05141435|Children's Hospital of Chongqing Medical University|Prof. Shi Yuan|+86 15084335697|shiyuan@hospital.cqmu.edu.cn|
22402204|NCT00953043|Mayo Clinic|Dr. Michael Camilleri, Professor of Medicine and Physiology, Gastroenterology|507-266-2305|camilleri.michael@mayo.edu|
22402205|NCT03509207|Medical University of Graz|Prof. Edgar Petru|0043 31638581082|edgar.petru@medunigraz.at|
22402206|NCT02078713|University of California, San Francisco|Dr. Christine Dehlendorf, Principal Investigator|415-206-8712|christine.dehlendorf.@ucsf.edu|
22402207|NCT02096861|Celltrion, Inc.|BoYoung Choi / Clinical Operation Team Leader|+82-32-850-6594|BoYoung.Choi@celltrion.com|
22402208|NCT02421120|Hartford Hospital|Dr. Joseph L. Kuti, PharmD|860-972-3612|joseph.kuti@hhchealth.org|
22402209|NCT00372190|Radboud University Medical Center|Dr. M.I.J.Withagen|+31 6 51262468|M.I.J.Withagen@umcutrecht.nl|
22402210|NCT01675531|Seoul ST.Mary's Hospital|Jin-Hyong Kang|82-2-2258-6043|jinkang@catholic.ac.kr|
22402211|NCT00623467|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22402212|NCT02597673|University of Tennessee Health Science Center|Dr. Laura Talbot|901-448-3630|ltalbot@uthsc.edu|
22402213|NCT03691623|Enanta Pharmaceuticals, Inc.|Guy De La Rosa, MD, Senior Medical Director, Infectious Diseases|+1 857 760 0548|gdelarosa@enanta.com|
22402214|NCT02816710|Department of Ophthalmology, Ruijin Hospital Affiliated Shanghai Jiaotong University School of Medicine, 197 Ruijin Er Road, 200025, Shanghai, China.|Dr. Xi Shen|021-64370025|carl_shen2005@126.com|
22402215|NCT00273858|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22402216|NCT02232516|Northwestern University, Feinberg School of Medicine|Dr. Jonathan Moreira|312-695-6180|jonathan.moreira@northwestern.edu|
22402217|NCT01070550|Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22402218|NCT01532700|University Health Network|Dr. Christine Chen|416-946-2827|Christine.Chen@uhn.ca|
22431154|NCT01969214|Analyze & Realize|Felix Alt|+49 30 4000 8194|FAlt@a-r.com|
22389744|NCT01713998|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
22389745|NCT02350127|San Francisco VA|Dr. Deborah Barnes, PI|415-221-4810|deborah.barnes4@va.gov|24221
22389746|NCT00157209|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22389747|NCT01348763|Imperial College London|Alan Winston|+442033121603|a.winston@imperial.ac.uk|21603
22389748|NCT00024102|University of North Carolina|Hyman Muss, MD||hyman.muss@gmail.com|
22389749|NCT02502487|West China Hospital, Department of Anesthesiology|Dr. Guizhi Du, Associate professor|+86 18980602213|du_guizhi@yahoo.com|
22389750|NCT01150500|Study Manager|Hiroko Ookubo|+81-3-6430-7017|hiroko.ookubo@medtronic.com|
22389751|NCT03418701|University of Florida|Dr. Lori Bilello, Project Manager|904-244-9202|Lori.bilello@jax.ufl.edu|
22389752|NCT01247922|Astellas Pharma Global Development, Inc.|Sr. Medical Director||Astellas.resultsdisclosure@astellas.com|
22389753|NCT01876823|Columbia Psychiatry|Dr. Gregory Pelton, MD|(646) 774-8669|ghp4@columbia.edu|
22389754|NCT00577096|University of Arkansas for Medical Sciences|Elizabeth Ann Coleman|501-661-7902|colemanelizabetha@uams.edu|
22389755|NCT04593641|Celltrion Inc.|JiWoong Lim|82-32-850-5806|jiwoong.lim@celltrion.com|
22389756|NCT01370564|Medtronic|Todd Fonseca, VP Clinical|763-526-8151|todd.fonseca@medtronic.com|
22389757|NCT00440037|Kyowa Kirin Co., Ltd.|Research & Development Planning Department , Research & Development Division||clinical.info.jp@kyowakirin.com|
22389758|NCT00794573|Jewish General Hospital / McGill University|Mark Eisenberg, MD MPH|5143408222|mark.eisenberg@ladydavis.ca|
22389759|NCT03740919|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22389760|NCT03479502|Vanderbilt_University MC|Rosemary Sanders, Research Coordinator|16155930171|Rosemary.a.sanders@vumc.org|
22389761|NCT02406859|James J. Peters VAMC|Dr. Mark Korsten|718-741-4675|mark.korsten@va.gov|6753
22389762|NCT01114334|Denver Health and University of Colorado Denver|Dr. Robert D. Keeley|303-602-8270|robert.keeley@dhha.org|
22389763|NCT04374253|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22389764|NCT00998517|Washington University in St. Louis|Indi Trehan|5039284634|itrehan@wustl.edu|
22389765|NCT00448344|VA Connecticut|Dr. Lori Bastian|860-667-6853|lori.bastian@va.gov|
22389766|NCT04313985|Stanford University|Geoffrey Gurtner|(520) 626-2222|gurtner@surgery.arizona.edu|
22389767|NCT02680145|Mayo Clinic|Dr. John A. Occhino|(507) 538-5883|Occhino.John@mayo.edu|
22389768|NCT04382053|Novartis Pharmaceuticals|Study Director|862 778 8300|Novartis.email@novartis.com|
22389769|NCT02704156|Changhai Hospital affiliated to Naval Medical University|Huojun Zhang|86-021-31162207|chyyzhj@163.com|
22389770|NCT01399905|Oregon Health and Science University|John G. Nutt, MD|503-494-9054|nuttj@ohsu.edu|
22402219|NCT01585961|Biosense Webster|Ellen Harris, Project Manager, Clinical Operations|909-839-7376|eharris8@its.jnj.com|
22402220|NCT01258348|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22402221|NCT04465370|Edwards Lifesciences|Cristina Johnson|888.713.1564|CC_Clinical_Affairs@edwards.com|
22402222|NCT01505491|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22402223|NCT02759146|Michigan State University|Dr. Gwen Wyatt|517-353-6672|gwyatt@msu.edu|
22402224|NCT04332640|Johnson & Johnson Surgical Vision|Head of Clinical Science|7142478200|LVarga17@ITS.JNJ.com|
22402225|NCT01120093|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22402226|NCT02631135|UludagU|Hale Aksu Erdost,MD,spesialist|+905323615722|haleaksu78@yahoo.com|
22402227|NCT00385268|University of Pennsylvania|Dr. Helen Pettinati|215-222-3200|helenp@mail.med.upenn.edu|139
22402228|NCT01797783|Alcon Research, Ltd.|Stacie Cummings, O.D.|1-888-451-3937|alcon.medinfo@alcon.com|
22402229|NCT02786355|UBC Department of Anesthesia - BC Women's Hospital|James Taylor|604-875-2424|james.taylor1@phsa.ca|6076
22402230|NCT02184143|Vanderbilt University Medical Center|Kristin Archer|(615) 322-2732|kristin.archer@Vanderbilt.Edu|
22402231|NCT00431847|Philadelphia Veterans Affairs Medical Center|Rollin M Gallagher, MD, MPH|(215) 823-5800|Rollin.Gallagher@va.gov|4907
22402232|NCT00076219|VA Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh, PA|Paul M. Palevsky MD|410-360-3932|paul.palevsky@va.gov|
22402233|NCT00751101|University of California, San Francisco|Dr. Hope Rugo, MD|(415) 353-7618|Hope.Rugo@ucsf.edu|
22402234|NCT02535949|Washington University School of Medicine|Dr. Philip Spinella|314-286-0858|pspinella@wustl.edu|
22402235|NCT00789477|Regeneron|Clinical Trial Management|9148475385|clinicaltrials@regeneron.com|
22402236|NCT00455858|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22402237|NCT02092389|AbbVie|Global Medical Information|1-800-633-9110||
22402238|NCT01242020|Associate Dean for Clinical and Translational Research, College of Physicians and Surgeons|Muredach P. Reilly, MBBCh, MSCE|212-305-9453|mpr2144@cumc.columbia.edu|
22402239|NCT02680847|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22402240|NCT00787332|Canyon Pharmaceuticals|Director of Clinical Trials|888-434-7003|info@canyonpharma.com|
22402241|NCT00693719|University of Arizona Cancer Center|Dr. Robert Livingston|520/626-4175|rlivingston@azcc.arizona.edu|
22453013|NCT01986881|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22453014|NCT04333420|InflaRx GmbH|Prof. Niels C. Riedemann|+49 3641-508-180|niels.Riedemann@inflarx.de|
22453015|NCT00677833|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22453016|NCT02606279|Wake Forest University Health Sciences|Katherine Schafer, Assistant Professor Internal Medicine|13367166342|kschafer@wakehealth.edu|336
22453017|NCT01907191|Saint Francis Hospital and Medical Center|Sanjay Sinha, MD|860-714-6654|ssinha3300@gmail.com|
22453018|NCT01690130|Medical University of South Carolina|TMS in Nicotine Craving|8437925729|lixi@musc.edu|
22453019|NCT02633800|Daiichi Sankyo, Inc.|Global Clinical Leader|9089926400|CTRinfo@DSI.com|
22453020|NCT02013622|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22453021|NCT01763931|SKCCC at Johns Hopkins|Vered Stearns, MD|410-614-1361|HopkinsBreastTrials@jhmi.edu|
22453022|NCT04969198|University of Wisconsin-Madison|Jesse Kaye|608-262-8885|jtkaye@ctri.wisc.edu|
22453023|NCT01640808|Pharmaceutical Division, Clinical Administration Dept.|Administrator of clinical trial information||ctrdinfo@kowa.co.jp|
22453024|NCT02477111|Cordis, A Cardinal Health Company|Jennifer Lee, Clinical Project Manager|669-699-6851|jennifer.lee02@cordis.com|
22453025|NCT01381692|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22453026|NCT02189798|Advanced Bionics|Michelle Caulfield, Senior VP, Global Quality Assurance and Regulatory Affairs|6613621400|clinicalresearch@advancedbionics.com|
22453027|NCT03819491|Consult Med Iasi|Dr. Delia Reurean-Pintilei|+40232233387|drdeliapintilei@gmail.com|
22453028|NCT00529399|Benaroya Research Institute|Carla Greenbaum||cjgreen@benaroyaresearch.org|
22453029|NCT03695172|Duke University Medical Center|Amanda Kumar, MD|919-681-4607|amanda.kumar@duke.edu|
22453030|NCT01506193|GlaxoSmithKline|GSK Response Center|866-435-7343||
22453031|NCT02672111|Braeburn|Sonnie Kim|1 610 467 8717|sonnie@braeburnrx.com|
22453032|NCT01839110|University of Pennsylvania|Dr. Yuchi Han|215-662-2855|yuchi.han@uphs.upenn.edu|
22453033|NCT06242444|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
22453034|NCT02076152|Massachusetts General Hospital|Elizabeth Gerstner, MD|617-724-2887|EGERSTNER@PARTNERS.ORG|
22453035|NCT03206203|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
22453036|NCT01972516|Dana-Farber Cancer Institute|Susana Campos, MD|617-632-5269|susana_campos@dfci.harvard.edu|
22453037|NCT03160027|University of California, San Francisco & San Francisco VA Medical Center|Dr. Linda Chao|14152214810|linda.chao@ucsf.edu|24386
22453038|NCT02045238|Hospital Universitario - Sao Paulo University|Dr. Mateus Deckers Leme|X551130919200|mateusdl@gmail.com|9451
22453039|NCT01454583|Foundation Stiftung Institut fuer Herzinfarktforschung Ludwigshafen, Germany|Professor Dr. Uwe Zeymer|+49 621 503 2813|Uwe.Zeymer@t-online.de|
22453040|NCT04330638|UZ Gent|Anja Delporte|+3293320228|anja.delporte@uzgent.be|
22453041|NCT00856050|Dana-Farber Cancer Institute|Dr. Suzanne George|617-632-5204|sgeorge2@partners.org|
22453042|NCT01410773|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
22453043|NCT01680848|Dental PBRN Japan|Director of the Dental PBRN Japan|+81-93-285-3022|info@dentalpbrn.jp|
22453044|NCT01988779|UR Medicine Otolaryngology|Research Program Manager|5852751186|paul_allen@urmc.rochester.edu|
22453045|NCT02464449|Ann Arbor VA Healthcare System|Dr. John Piette, PhD|734-845-3626|jpiette@umich.edu|
22453046|NCT00377403|Washington University in St Louis|Jane Garbut,MD|314-454-8613|jgarbutt@dom.wustl.edu|
22453047|NCT02275065|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22453048|NCT01284426|Division of Allergy and Immunology, Department of Pediatrics, Siriraj Hospital, Mahidol University|Professor Orathai Jirapongsananuruk, Director of Clinical Trials|024197000|siojr@mahidol.ac.th|
22453049|NCT00417079|sanofi-aventis|International Clinical Development Study Director||GV-Contact-us@sanofi-aventis.com|
22453050|NCT01687257|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22453051|NCT04899349|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
22453052|NCT01027000|Dana Farber Cancer Institute|Edwin P. Alyea, MD||edwin_alyea@dfci.harvard.edu|
22453053|NCT03336619|Romark|Sr. Director, Research Operations|8132828544|jessica.fulgencio@romark.com|
22453054|NCT01300546|Clinvest/A Division of Banyan Group Inc.|Jeanne Tarrasch|417-841-3673|jtarrasch@clinvest.com|
22453055|NCT02820623|Northwestern University|Rinad Beidas, PhD|312-503-0546|rinad.beidas@northwestern.edu|
22453056|NCT05893992|Sonova|Dr. Jonathan Vaisberg|9057456785|jonathan.vaisberg@sonova.com|
22453057|NCT05207813|Boston Scientific Corporation|Sr. Director, Clinical Operations|855-213-9890|BSNClinicalTrials@bsci.com|
22453058|NCT01954017|Leadiant Biosciences, Inc.|Scott Rodgers, MS, CCRA, ACRP-PM / Sr Director of Clinical Operations|301-670-1565|scott.rodgers@leadiant.com|
22453059|NCT01680328|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22453060|NCT00074035|The Ohio State University Medical Center|Sherif S. Farag, M.D., Ph.D.||farag-1@medctr.osu.edu|
22453061|NCT02653482|Saint Luke's Hospital of Kansas City|Program Manager, Cardiometabolic Research|8166957561|DEFINE-HF@saint-lukes.org|
22453062|NCT01669122|GlaxoSmithKline|GSK Response Center|866-435-7343||
22453063|NCT00765193|Department of Dermatology, Medical University of Graz-Austria|Iris Zalaudek, MD|+436763328269|iris.zalaudek@medunigraz.at|
22453064|NCT05132699|University of Texas Health Science Center at San Antonio|Casey Straud|210-562-6742|straud@uthscsa.edu|
22453065|NCT04370054|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22453066|NCT02096900|Loma Linda University|Amgad H. Hanna, MD|909-558-4475|ahanna@llu.edu|
22453067|NCT05557942|Aerovate Therapeutics|Toll Free Number|(888) 373-8110|clinicaltrials@aerovatetx.com|
22453068|NCT03373604|Columbia University|Patrick Lao, PhD|212-342-1399|pjl2133@cumc.columbia.edu|
22453069|NCT00710424|GW Pharm Ltd|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
22415445|NCT00379353|University of Texas M.D. Anderson Cancer Center|Dr. Eduardo Bruera, Professor|713-563-4157|ammarin@mdanderson.org|
22415446|NCT01211262|Immunocore, LLC|Chris Holland, Executive Director Head of Biostatistics|1-267-589-9204|chris.holland2@immunocore.com|
22415447|NCT02248714|6thShanghaiJiaotongU|Dr. Yuqian Bao|(021)64369181|byq522@163.com|
22415448|NCT01277510|Amgen Inc.|Study Director|866-572-6436||
22415449|NCT04049097|Zevra Denmark A/S|Medical Affairs|+1-888-289-5607|medicalaffairs@zevra.com|
22415450|NCT00533507|GlaxoSmithKline|GSK Response Center|866-435-7343||
22415451|NCT01874535|Kaohsiung Chang Gung Memorial Hospital, Taiwan|Dr. Seng-Kee Chuah and Dr. Wei-Chen Tai|886-975056007|chuahsk@seed.net.tw|
22415452|NCT00784095|VA Health Services Research and Development|Dr. Karen Steinhauser|9196682148|karen.steinhauser@va.gov|
22415453|NCT01816230|Gamida Cell|Kelly Myers|026595631|kelly@gamida-cell.com|
22415454|NCT02616380|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22415455|NCT05065619|Medicago|Medical Director|+1 418-658-9393|clinicaltrialinquiries@medicago.com|
22415456|NCT00758758|Zimmer, Inc|Laura Herdrich, Sr. CRA|952-830-6224|laura.herdrich@zimmer.com|
22415457|NCT02119936|UNC Chapel Hill|Holly Krohn|919-445-0218|holly_krohn@med.unc.edu|
22453070|NCT06273774|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22415458|NCT00570128|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22453071|NCT02097108|AGMT|Public contact Daniela Wolkersdorfer|00436626404411|d.wolkersdorfer@agmt.at|
22453072|NCT06675500|Ain Shams University|Dr.Sarah Elghareeb,lecturer of Anesthesia and ICU|+201012434690|Sarahhamdy@med.asu.edu.eg|
22453073|NCT00127608|GlaxoSmithKline|GSK Response Center|866-435-7343||
22453074|NCT06854601|Pharmasoft|Y.E. Meshcherskiy, Medical Director|+ 7 (495) 626-47- 55|meshcherskiy_y@pharmasoft.ru|140
22415459|NCT05315713|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22415460|NCT00421304|AstraZeneca Clinical study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
22415461|NCT00919711|Amgen Inc.|Study Director|866-572-6436||
22415462|NCT00903877|Stanford University|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@stanford.edu|
22415463|NCT03694197|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22415464|NCT03820947|Medtronic|Wendy Moeyersons, Clinical Research Specialist|+32486313172|wendy.moeyersons@medtronic.com|
22415465|NCT01639664|Istituto di Ricerche Farmacologiche Mario Negri IRCCS|Dr. Guido Bertolini|035 4535 313|guido.bertolini@marionegri.it|
22415466|NCT05135273|Laboratory of Malaria Immunology and Vaccinology, NIAID/NIH|Dr. David Cook|240.627.3066|david.cook@nih.gov|
22415467|NCT02497235|Medical Director|Takeda|+1-877-825-3327|trialdisclosures@takeda.com|
22415468|NCT04264819|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22415469|NCT02400463|University of Michigan Rogel Cancer Center|Ryan Wilcox|734-615-1482|rywilcox@umich.edu|
22415470|NCT01680016|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22415471|NCT02569541|Arrevus, Inc.|Carl Kraus, MD (CEO)|9193665503|ckraus@arrevus.com|
22415472|NCT03460990|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22415473|NCT01958060|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22415474|NCT00769314|BioAlliance Pharma|Dr Pierre ATTALI|+33145587600|pierre.attali@bioalliancepharma.com|
22415475|NCT03480685|Avinger, Inc.|Thomas Lawson, PhD|650-241-7030|tlawson@avinger.com|
22415476|NCT02846883|Roudebush VA Medical Center|Michael P. Murphy, MD|317-988-4049|mipmurph@iupui.edu|
22415477|NCT00927251|Medtronic, Bakken Research Center|Model 4296 Left Ventricular (LV) Lead Study Sr. CRS|+31-43-3566602|margriet.kruijshoop@medtronic.com|
22415478|NCT01550367|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR, Regulatory Supervisor, CRS|412-647-5554|stadtermanbm@upmc.edu|
22415479|NCT04492397|Coopervision|Jose A. Vega, O.D., MSc, FAAO|9256213761|JVega2@coopervision.com|
22415480|NCT00442351|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22415481|NCT01427881|Fred Hutchinson Cancer Research Center|Marco Mielcarek, MD|206-667-2827|mmielcar@fredhutch.org|
22453075|NCT00265980|Professor of Pediatrics and Medicine at the Columbia University|Michael Rosenbaum, MD|212-305-9949|mr475@cumc.columbia.edu|
22453076|NCT04050865|Ocular Therapeutix|Clinical Project Manager|781-357-4000|clinicalaffairs@ocutx.com|
22453077|NCT01437124|Wirral NHS Trust|Hussain Kazi|0151 678 6111|hussainkazi@nhs.net|
22453078|NCT02035332|Minerva Surgical, Inc.|Dr. Eugene Skalnyi, VP Medical Affairs|(1) 650-284-3500|eugenes@minervasurgical.com|
22453079|NCT00365391|Wayne State University|Philip A. Philip, M.D., Ph.D., F.R.C.P.||philipp@karmanos.org|
22453080|NCT01258608|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22453081|NCT04205630|Byondis B.V.|Clinical Development|0031246795101|clinicaltrials@byondis.com|
22453082|NCT00676182|James A. Haley Veterans' Hospital|Dr. Kris Siddharthan|813-558-3950|Krishnaswami.Siddharthan@va.gov|
22453083|NCT04250727|Yale School of Medicine|Lisa Fucito, PhD: Associate Professor of Psychiatry; Director, Tobacco Treatment Service, Psychiatry|(203) 688-1878|lisa.fucito@yale.edu|
22453084|NCT01393782|George Washington University Medical Faculty Associates|Clinical Trials Unit, Department of Anesthesiology and Critical Care Medicine|202-715-4750|mseneff@mfa.gwu.edu|
22453085|NCT03078270|George Washington University|Daniel Lieberman, M.D.|202-741-2899|dlieberman@mfa.gwu.edu|
22453086|NCT00440531|Merck Sharp & Dohme Corp|Senior Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
22453087|NCT00447057|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22453088|NCT00512148|Tengion declared bankruptcy in 2014|Tengion declared bankruptcy and there is no results contact|There is no Tengion phone||
22453089|NCT00184548|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22453090|NCT00746122|Imperial College London|Professor Janet Powell|44-2033117312|j.powell@imperial.ac.uk|
22453091|NCT00160680|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22453092|NCT04493216|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22453093|NCT02172755|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|francisco.rocha@bial.com|
22453094|NCT05276830|BioXcel Therapeutics|Vice President Head of Clinical Operations|(475) 355 5177|cgommoll@bioxceltherapeutics.com|
22453095|NCT03595579|Axsome Therapeutics, Inc.|Amanda Jones, PharmD, Senior Vice President of Clinical Development|212-332-3223|ajones@axsome.com|
22453096|NCT05090709|Edinburgh Napier University|Dr Rebecca Hamilton|0131455|rebeccaisabel.hamilton@napier.ac.uk|2350
22453097|NCT03775200|Compass Pathways|Medical Director|07443136539|info@compasspathways.com|
22453098|NCT04605978|Institut de Recherches Internationales Servier (I.R.I.S.)|Clinical Studies Department|+33 1 55 72 60 00|scientificinformation@servier.com|
22453099|NCT02583425|Dr. Reddy's|Director, Clinical Development|609-375-9900||
22453100|NCT01644734|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22453101|NCT02216123|GlaxoSmithKline|GSK Response Center|866-435-7343||
22453102|NCT01922115|UNC Chapel Hill|Dr. Elizabeth Geller|919-966-4717|elizabeth_geller@med.unc.edu|
22453103|NCT04977050|University of New Mexico|Dr. Akshay Sood|505-272-4751|ASood@salud.unm.edu|
22453104|NCT03318523|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22453105|NCT00361374|Massachusetts General Hospital|Dr David Mischoulon, Director of Research, Depression Clinical and Research Program|617-724-5198|dmischoulon@partners.org|
22453106|NCT02858050|Saint Michael's Medical Center|Jihad Slim, MD|9738772663|jsmdsmmc@gmail.com|
22453107|NCT02163733|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
22453108|NCT00464646|NSABP Foundation, Inc.|Director, Department of Site and Study Management|1-800-270-3165|industrytrials@nsabp.org|
22453109|NCT01615328|Seoul National University Bundang Hospital|Jin-Sup Yeom|82-31-787-7190|highcervical@gmail.com|
22453110|NCT02157779|Providence VA Medical Center|M. Tracie Shea, PhD|401-273-7100|MaryTracie.Shea@va.gov|6248
22453111|NCT01738750|University of Utah|Dr. Eric Scaife|801-662-2950|eric.scaife@imail2.org|
22453112|NCT03610464|Tris Pharma, Inc.|Antonio Pardo MD|16107502210|apardo@trispharma.com|
22453113|NCT00487162|UMDNJ-NJMS|J. Jeffrey Freda, MD, MBA|973 972-5007|jjfreda@umdnj.edu|
22453114|NCT00530855|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22453115|NCT02081573|University of Pittsburgh School of Nursing|Judith A. Callan|412-383-5321|callanja@pitt.edu|
22453116|NCT01803074|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22453117|NCT00789438|Institut für Anästhesiologie und Operative Intensivmedizin, Universitätsklinukum Schleswig-Holstein, Campus Kiel|Christoph Ilies M.D.|+49-431-597|christoph.ilies@anaesthesie.uni-kiel.de|2991
22453118|NCT01654549|Tehran University of Medical Sciences|Dr Raika Jamali|982163120000|jamalira@tums.ac.ir|411
22453119|NCT03152526|Miltenyi Biotec|Clinical Project Manager|617-218-0055|lorenb@miltenyibiotec.com|
22453120|NCT05130970|CSL Behring LLC|Trial Registration Coordinator|610 878 4000|clinicaltrials@cslbehring.com|+1
22453121|NCT02701985|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22453122|NCT00989768|Brazilian Center for Studies in Dermatology|Juliana de Souza|+55 51 3026 2633|pesquisa@cebd.org.br|
22453123|NCT01362140|Amgen Inc.|Study Director|866-572-6436||
22453124|NCT01556438|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22453125|NCT01388816|Proprietary Products, Dr. Reddy's Laboratories, Inc.|Kent Allenby, MD|609-375-9855|kallenby@drreddys.com|
22453126|NCT00743366|New York State Psychiatric Institute|Dr. Ziva Cooper|646-774-6129|reslabsurc@gmail.com|
22453127|NCT03998618|Indiana University|Dr. Catherine Mosher|317-274-6769|cemosher@iu.edu|
22453128|NCT02308748|U.S. Food and Drug Administration|David G Strauss, MD, PhD|301-796-6323|david.strauss@fda.hhs.gov|
22453129|NCT01152580|Duquesne University|Dr. Paula Witt-Enderby, Professor of Pharmacology and Toxicology|412-396-4346|wittp@duq.edu|
22453130|NCT00850473|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
22453131|NCT01994954|University of Massachusetts Medical School|Dr. Lawrence Rhein|508-334-6206|Lawrence.Rhein@umassmemorial.org|
22389771|NCT01945086|Janssen Research & Development, LLC.|Senior Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
22389772|NCT00318591|Coloplast|Anna Karina Busch, Intl. Senior Scientific Manager|+45 49112350|dkakb@coloplast.com|
22389773|NCT01524887|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22389774|NCT01808144|Ardea Biosciences, Inc.|Nihar Bhakta, MD|1-858-652-6671|nbhakta@ardeabio.com|
22389775|NCT00383500|Stanford University|Stanley G. Rockson|650-725-7571|rockson@stanford.edu|
22389776|NCT02648282|Sidney Kimmel Cancer Center at Johns Hopkins|Lei Zheng MD, PhD|410-502-6241|lzheng6@jhmi.edu|
22389777|NCT02025647|NCS Pearson|Dr. Paul E Williams, Sr. Research Director|952-681-4553|paul.e.williams@pearson.com|
22389778|NCT02548754|University of Oklahoma Health Sciences Center|Dr. Stavros Stavrakis|4052714742|stavros-stavrakis@ouhsc.edu|
22389779|NCT02093897|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22415482|NCT00500318|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22415483|NCT03023709|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
22415484|NCT04284553|Brigham and Women's Hospital|Niteesh Choudhry, MD, PhD|617-278-0930|nkchoudhry@bwh.harvard.edu|
22415485|NCT00945334|Cedars-Sinai Medical Center|Mark Pimentel|3104233792|chuak@cshs.org|
22415486|NCT00603564|IRCCS Fondazione Po.Ma.Re, Milan, Italy|Roberto Cosentini, MD|00390255033602|roberto.cosentini@policlinico.mi.it|
22415487|NCT01350934|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22415488|NCT01011335|Uniformed Services University of the Health Sciences|David Tribble, MD, DrPH|301-816-8404|dtribble@idcrp.org|
22415489|NCT02435433|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979|ClinicalTrials.gov@Lilly.com|
22415490|NCT02817828|Estetra SPRL|Mithra Pharmaceuticals SA Pharma Department|+3243492822|clinical.trials@mithra.com|
22415491|NCT00072514|Fred Hutchinson Cancer Research Center|Ajay Gopal|206-288-2037|akgopal@fhcrc.org|
22415492|NCT00522041|Allergan plc|Susan Fox, PhD|201-427-8225|susan.fox@allergan.com|
22415493|NCT01579006|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22415494|NCT02383706|Duke University Medical Center|Dr Jennifer Dominguez|(919) 668-2024|jennifer.dominguez@dm.duke.edu|
22415495|NCT02413034|Hospital del Mar|Daniel Pérez-Prieto|0034932483196|dperezprieto@hospitaldelmar.cat|
22415496|NCT00799708|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22415497|NCT03343639|Chief Scientific Officer|Paul Kwon|650-486-1416|pkwon@menlotx.com|
22415498|NCT00859040|Dana-Farber Cancer Institute / Brigham & Women's Hospital|Patrick Y. Wen, MD|617-632-2166|pwen@partners.org|
22415499|NCT00735696|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22415500|NCT01708954|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
22415501|NCT01192776|Wayne State University|Seetha Shankaran|(313) 745-1436|sshankar@med.wayne.edu|
22415502|NCT02587143|Servicio de Urgencias, Hospital de Basurto, Bilbao, España|Dr. Ballesteros-Peña|(+34)946012804|sendoa.ballesteros@ehu.eus|
22415503|NCT01119625|GlaxoSmithKline|GSK Response Center|866-435-7343||
22453132|NCT00449176|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537||
22453133|NCT02472964|Mylan Inc|Clinical Program Manager|412-651-9530|gail.tribble@mylan.com|
22453134|NCT04434560|Duke University|Sarah Sammons, MD|919-684-4563|sarah.sammons@duke.edu|
22453135|NCT01967732|Philip Morris Products S.A.|Christelle HAZIZA, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
22453136|NCT05525494|UCLA|Principal Investigator|310-206-6328|pszilagyi@mednet.ucla.edu|
22453137|NCT00833638|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22453138|NCT01178086|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
22453139|NCT01400503|Janssen Research & Development, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22453140|NCT01261338|University of Cincinnati|Ronald J. Jandacek, PhD, Principal Investigator|513-558-5492|ronald.jandacek@uc.edu|
22453141|NCT01420848|University of São Paulo|Leonice Fumiko Sato Kurebayashi|(5511 991126023)|fumie_ibez@yahoo.com.br|
22453142|NCT05023304|Vance Thompson Vision|Director of Clinical Trials|1-605-371-7075|keeley.boever@vancethompsonvision.com|
22453143|NCT04725890|Endogenex, Inc.|Lian Cunningham, MD, PhD|(763) 251-6820|lcunningham@endogenex.com|
22453144|NCT03377023|Moffitt Cancer Center|Dr. Jhanelle E. Gray|813-745-7282|jhanelle.gray@moffitt.org|
22453145|NCT04480840|Pliant Therapeutics|Pliant Therapeutics Medical Monitor|650-481-6770|clintrials@pliantrx.com|
22453146|NCT02648152|Smith + Nephew plc|Director Clinical Operations - EU|00441923 477100|annelaine.tomlinson@smith-nephew.com|
22453147|NCT03607617|Kaiser Permanente Center for Health Research|Rachel Gold, PhD, MPH|503-528-3902|rachel.gold@kpchr.org|
22453148|NCT03246347|Wake Forest|Danielle Boselli|2017903385|danielle.boselli@atriumhealth.edu|
22453149|NCT03291067|Tanabe Pharma America, Inc.|Clinical Trials, Information Desk|Please e-mail|information.US@mb.tanabe-pharma.com|
22453150|NCT02255435|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22453151|NCT03945773|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22453152|NCT05895461|The Miriam Hospital|Jacqueline Hayes, phD|4017938917|jhayes3@brownhealth.org|
22453153|NCT04165317|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_inquiries@pfizer.com|
22453154|NCT05197335|Orthofix SRL|Clinical Program Manager|+39-045-6719000|danielacangiano@orthofix.it|
22453155|NCT05833035|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22389780|NCT02972242|WRNMMC Cardiology|Hampton Crimm|301-295-4500|hampton.a.crimm.mil@mail.mil|
22415504|NCT03237156|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22453156|NCT03377491|Novocure|Medical Director|1-877-678-8611|clinicaltrials@novocure.com|
22389781|NCT03480919|Hospital for Special Surgery|Jonathan Kirschner|6467146327|kirschnerj@hss.edu|
22415505|NCT01721772|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22389782|NCT04572997|Prof. Dr. Kristian Reich|Prof. Dr. Kristian Reich|+49 1722701941|kreich@jerucon.com|
22389783|NCT03098797|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
22389784|NCT02956278|University of California San Francisco|Kathy Giacomini, PhD|415-514-4363|kathy.giacomini@ucsf.edu|
22389785|NCT01967719|Philip Morris Products S.A.|Christelle HAZIZA, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
22389786|NCT02329223|Novartis|Study Director|862-778-8300||
22389787|NCT00651937|The University of Texas (UT) MD Anderson Cancer Center|Dr. Richard E Champlin,MD/Chair, Stem Cell Transplantation|713- 203-8632|rchampli@mdanderson.org|
22389788|NCT03067610|University of Texas Southwestern Medical Center|Dr. David Sher|214/645-7607|david.sher@utsouthwestern.edu|
22415506|NCT04542694|A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of the Russian Federation|Academician Dmitry Pushkar|+7495-609-67-00|dmitry.pushkar@gmail.com|
22415507|NCT03490916|UMass Medical School|Principal Investigator|4136279111|vincent.kan08@gmail.com|
22415508|NCT04633642|Diabetic Foot Unit, Clínica Universitaria de Podología, Facultad de Enfermería, Fisioterapia y Podología, Universidad Complutense de Madrid, 28040 Madrid, Spain|Dr. Francisco Javier Álvaro Afonso|913-941-502|alvaro@ucm.es|+34
22415509|NCT00611884|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22415510|NCT00981799|Therapeutic Advancements of Childhood Leukemia and Lymphoma|Clinical Research Coordinator, Consortia|323-361-5312|rleong@chla.usc.edu|
22415511|NCT05387408|Washington University|Dr. Ann Marie Dale, Principal Investigator|3144548470|amdale@wustl.edu|
22415512|NCT02181140|Interdisciplinary Endoscopy Department and Clinic University Hospital Hamburg-Eppendorf|Professor Dr. Thomas Rösch|+4940 7410|t.roesch@uke.de|50098
22415513|NCT01207752|Southern California College of Optometry at MBKU|Jerry Paugh, OD, PhD|714-449-7487|jpaugh@ketchum.edu|
22415514|NCT01055834|Eisai Co., Ltd.|Kenya Nakai, Study Director|+81-3-3817-3865|k3-nakai@hhc.eisai.co.jp|
22415515|NCT01943435|University of Pittsburgh|Michael Schneider, PhD, DC - Associate Professor and Principal Investigator|412-383-6640|mjs5@pitt.edu|
22415516|NCT04535986|Verona Pharma plc|Chief Medical Officer|See email|info@veronapharma.com|
22415517|NCT00467597|Portland VA Health Care System (PORVAHCS)|Kathryn Chung, MD|503.220.8262|CHUNGKA@OHSU.EDU|51091
22453157|NCT02878850|Duke University|Miriam Treggiari|9196819933|miriam.treggiari@duke.edu|
22453158|NCT04457297|National Cancer Center Hospital East|Takayuki Yoshino|+81-4-7133-1111|prj-altair_core@eps.co.jp|
22453159|NCT03503344|University of California, San Francisco|Dr. Rahul Aggarwal, MD|(415) 476-1000|Rahul.Aggarwal@ucsf.edu|
22453160|NCT04231669|Washington University in St. Louis|Dr. Ozge Sensoy Bahar|314-935-9403|ozge.sensoybahar@wustl.edu|
22453161|NCT04889638|Johns Hopkins University School of Medicine|Panagis Galiatsatos, MD, MHS|4104934866|pgaliat1@jh.edu|
22453162|NCT04377932|Baylor College of Medicine|David Steffin, MD|(832) 824-4745|dhsteffi@texaschildrens.org|
22453163|NCT04163952|Cancer Institute of New Jersey Rutgers|Dr. Adam Berger|732-235-8675|ab2047@cinj.rutger.edu|
22453164|NCT03729830|Boston Scientific|Susan Hampson, Clinical Trial Manager|508-728-5165|susan.hampson@bsci.com|
22453165|NCT04249596|New York State Psychiatric Instittue|Jonathan A. Javitch, MD, PhD|646-774-8600|jonathan.javitch@nyspi.columbia.edu|
22453166|NCT03289039|Dana-Farber Cancer Institute|Jose Pablo Leone, MD|617-632-3800|josep_leone@dfci.harvard.edu|
22453167|NCT06480981|Richmond Pharmacology|Principal Investigator|020 7042 5800|info@richmondpharmacology.com|
22453168|NCT03563716|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22453169|NCT04692103|UWashington|Hannah Linden, MD|206-606-2053|hmlinden@uw.edu|
22453170|NCT06017102|National Taiwan University Hospital|Dr. Jia-Feng Wu|+886 23123456|wjf@ntu.edu.tw|271718
22453171|NCT04125238|Virginia Tech|Stephen LaConte|5405262008|slaconte@vtc.vt.edu|
22453172|NCT06492226|Xentria, Inc|Vice President, Clinical Developement|2244434615|tmatthews@xentria.com|
22453173|NCT03285321|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22453174|NCT05016960|VA San Diego Healthcare System|Dr. Erin Almklov|858-552-8585|erin.almklov@va.gov|3907
22453175|NCT04825275|Penn State College of Medicine|Alireza Mansouri, MD|717-763-2559|connect@mansourimd.com|
22453176|NCT04993079|Sensome|Clinical Lead|+33185370770|julie@sensome.com|
22453177|NCT03388619|National Cancer Institute|Dr. Deborah E. Citrin|301-496-5457|citrind@mail.nih.gov|
22453178|NCT00659204|Madigan Army Medical Center|Mary McCarthy, Ph.D.|253-968-3695|mary.s.mccarthy1.civ@health.mil|
22453179|NCT06244797|Dr.Lecturer|Dr.Esengul Sen|05549852255|esengulbekar@gop.edu.tr|
22453180|NCT05569174|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|novartis.email@Novartis.com|
22453181|NCT06525727|Marmara University School of Medicine|Dr. Emre Kudu|+902166254545|dr.emre.kudu@gmail.com|
22453182|NCT05788965|University of Minnesota|Amir Moheet|612-624-3209|mohee002@umn.edu|
22453183|NCT02668666|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22453184|NCT00364286|The University of Texas MD Anderson Cancer Center|Susan O'Brien, MD/ Professor|713-792-7543|eharriso@mdanderson.org|
22453185|NCT03794349|Children's Oncology Group|Results Reporting Coordinator|6262411500|resultsreportingcoordinator@childrensoncologygroup.org|
22453186|NCT04872998|University of Utah|Principal Investigator Joel Trinity Associate Professor|801-582-1565|joel.trinity@utah.edu|
22453187|NCT00430989|Bayside health|Professor Paul Myles|+61390762000|p.myles@alfred.org.au|3176
22453188|NCT05755711|Shockwave Medical|Tracy Courtney|1.650.224.7699|TCourtn4@its.jnj.com|
22453189|NCT06547814|University of North Carolina at Chapel Hill|Abby Shackley, MA|828-407-2107|abigail_gamble@email.unc.edu|
22453190|NCT01802099|CHD Vendée|Dr Jean REIGNIER|0251446572|jean.reignier@chd-vendee.fr|+33
22453191|NCT05467397|Brigham and Women's Hospital, Boston, MA|Carmen Priolo, MD PhD|857-307-0783|cpriolo@bwh.harvard.edu|
22453192|NCT04673175|Weill Cornell Medicine|Markus Plate, MD|212-746-7587|map9313@med.cornell.edu|
22453193|NCT05746481|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP|4126475554|stadtermanbm@upmc.edu|
22453194|NCT01494662|Dana-Farber Cancer Institute|Rachel Freedman, MD|617-632-3800|Rachel_Freedman@dfci.harvard.edu|
22453195|NCT05329779|Brigham and Women's Hospital|Director of Research Program Management|617-525-9627|awiley1@bwh.harvard.edu|
22453196|NCT04259632|University of Minnesota|Niki Oldenburg|NA|olden019@umn.edu|
22453197|NCT03361306|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
22453198|NCT05451017|Aelis Farma|Stephanie Monlezun, Chief Operating Officer|0554542327|s.monlezun@aelisfarma.com|
22453199|NCT04530552|University of Arizona|Betsy Wertheim|5207771666|betsy@arizona.edu|
22453200|NCT03468218|Emory University|Dr. Nabil Saba|404-778-1900|nfsaba@emory.edu|
22453201|NCT05746195|University of California, San Francisco|Dr. Erin Van Blarigan, ScD|(415) 476-1000|Erin.VanBlarigan@ucsf.edu|
22453202|NCT05297786|Vanderbilt University Medical Center|Dr. Jorge Gamboa|615-343-4176|jorge.gamboa@vanderbilt.edu|
22389789|NCT02628964|NYU Langone Health|Donna Shelley, MD MPH|917-494-4210|donna.shelley@nyulangone.org|
22389790|NCT03443063|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22389791|NCT00552513|Population Health Research Institute|TIMACS Project Office|19055244322|timacs@phri.ca|
22389792|NCT01101464|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com|
22389793|NCT02720185|University of Wisconsin Carbone Cancer Center|Kari Wisinski|(608) 262-2876|kbwisinski@medicine.wisc.edu|
22389794|NCT04397614|University of Oklahoma Health Sciences Center|Krista Kezbers|405-271-8001|krista-kezbers@ouhsc.edu|45042
22389795|NCT02507687|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22389796|NCT00275301|University of Minnesota|S. Charles Schulz, MD|612-273-9820|scs@umn.edu|
22389797|NCT04357964|Vanderbilt University Medical Center|Alp Ikizler, Catherine McLaughlin Hakim Chair in Vascular Biology, Professor of Medicine|(615) 343-7592|alp.ikizler@vumc.org|
22389798|NCT00733226|Kecioren Education and Training Hospital|Cem Hasan RAZİ|090 312 3659000|cemrazi2@gmail.com|1139
22389799|NCT01540162|National Medical University Odessa|Prof. Mykola L. Aryayev, MD & PhD|+380 48 740 5249|nataly_kononenko@ukr.net|
22389800|NCT01750086|Massachusetts General Hospital|Dr. Joy Tsai|617-726-6723|jntsai@mgh.harvard.edu|
22389801|NCT02288364|Duke University Medical Center|Jay A. Baker, MD|919-684-7645|jay.baker@duke.edu|
22389802|NCT00349622|MGH|Merit Cudkowicz|617-724-1873|mcudkowicz@partners.org|
22389803|NCT03619889|Universidad Complutense de Madrid|Dra. Gema Serrano-Hernanz|669332986|gema.serrano.hernanz@gmail.com, gemase01@ucm.es|
22389804|NCT03296566|University of British Columbia|Dr. Marette Lee|604.875.5608|Marette.Lee@vch.ca|
22389805|NCT03065205|University of Colorado|Heather Hoch MD|720-777-4108|heather.hoch@childrenscolorado.org|
22389806|NCT00821119|Instituto Materno Infantil prof. Fernando Figueira|Jucille Meneses|55 (81) 2122-4100|jmeneses@elogica.com.br|4135
22389807|NCT03511378|Lupin Ltd. (Lupin Research Park), Pune, India|Dr. Chirag Shah, Director|91-20-67917368|chiragshah@lupin.com|
22389808|NCT05012280|Insitute of Tropical Medicine|Carolien Hoof|+32470102562|choof@itg.be|
22389809|NCT01503515|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22389810|NCT01350102|Penn State Milton S. Hershey Medical Center|Nell Blake, DPM|(717) 531-5638|nblake@pennstatehealth.psu.edu|
22389811|NCT00550771|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22389812|NCT01701271|Bio Basic Europe|Prof. Fulvio Marzatico|(39) 0382 - 506390|fulviomk@unipv.it|
22389813|NCT00082641|University of Nebraska|Elizabeth Reed|402-559-5166|ereed@unmc.edu|
22389814|NCT03022578|UT MD Anderson Cancer Center|Dr. Barbara O'Brien, MD/Associate Professor, Neuro-Oncology|(713) 794-4380|bjobrien@mdanderson.org|
22389815|NCT03681353|Duke University Medical Center|Angela Kirby, MS|919-286-0411|angela.kirby@duke.edu|175526
22389816|NCT01189617|Johnson & Johsnon Consumer and Personal Products Worldwide|Joyce Hauze, Sr. Specialist|9285-277-0715|jhauze@its.jnj.com|
22389817|NCT00726388|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22389818|NCT01530477|GE Healthcare|Yi Xia|1 (608) 221-1551|Yi.Xia@ge.com|500-3045
22389819|NCT00871143|Institute of Psychiatry|Dr. David Veale|0203 228 3461|david.veale@kcl.ac.uk|
22389820|NCT03930238|University of Iowa|Jacob Simmering|319-384-1107|jacob-simmering@uiowa.edu|
22389821|NCT01116440|Mereo BioPharma Group Plc.|William Moore|+44333023300|WM@mereobiopharma.com|
22389822|NCT01126879|Northwestern University|William Catalona, MD|312-695-1301|WCatalona@nm.org|
22453203|NCT02503657|Medicinova Inc|Director, Research and Development|8582468680|makhay@medicinova.com|
22453204|NCT04757519|University of Kentucky College of Nursing|Dr. Lovoria Williams|859 323-5579|Lovoria.Williams@uky.edu|
22453205|NCT03829722|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
22453206|NCT05402137|University of California, Los Angeles|A. Janet Tomiyama|310.206.6875|janetto@ucla.edu|
22453207|NCT04933474|Cedars-Sinai Medical Center|Samuel Eberlein|310-423-6721|samuel.eberlein@cshs.org|
22453208|NCT03327649|University of Oklahoma Health Sciences Center|Dr. Stavros Stavrakis|14052714742|stavros-stavrakis@ouhsc.edu|
22453209|NCT03701308|Siteman Cancer Center|Geoffrey Uy|314-454-8304|guy@wustl.edu|
22453210|NCT04504942|CytoDyn|Vice President, Clinical Operations|3609808524|jmeidling@cytodyn.com|
22453211|NCT04924036|University of Utah Dermatology|Stephanie Zone, MD|801-581-6465|dermatology@utah.edu|
22453212|NCT04118088|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22453213|NCT06269484|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22453214|NCT03696225|VA Portland Health Care System|Dr. Maya E. O'Neil, Principal Investigator|503-220-8262|Maya.Oneil@va.gov|54522
22453215|NCT05101564|Stanford University|Dr. Jennifer Lee Caswell-Jin|(650) 498-6000|caswell@stanford.edu|
22453216|NCT05411393|University of Florida|Chiung-ju Liu|352-273-6496|c.liu1@phhp.ufl.edu|
22453217|NCT04035499|University of Rochester Medical Center|Dr. Kah Poh Loh|585-276-4353|kahpoh_loh@urmc.rochester.edu|
22453218|NCT04706624|Hanoi Medical University|Le Minh Giang - Principal Investigator|+84913281842|leminhgiang@hmu.edu.vn|
22453219|NCT05990075|James A. Haley Veterans' Hospital|Vanessa Panaite, PhD|813-768-2193|vanessa.panaite2@va.gov|
22453220|NCT06507566|Alachua Government Services, Inc.|Angie Kimbler|386-418-8751|angie.kimbler@resilience.com|
22389823|NCT03861429|University of Utah|Dr. Gail Towsley|801-585-9085|gail.towsley@nurs.utah.edu|
22389824|NCT02133066|Children's Hospital of Philadelphia|Aaron Chen|2674260383|chena2@email.chop.edu|
22389825|NCT01797822|Baylor College of Medicine|Stephen Pflugfelder|713-798-6100|stevenp@bcm.edu|
22389826|NCT01780545|Hoosier Cancer Research Network|Clinical Data Manager|3176345842|hcrndm@hoosiercancer.org|41
22389827|NCT03441789|Skin Sciences, PLLC|M. McAllister|5024519000|mmdermresearch@yahoo.com|
22389828|NCT04318587|University of Pittsburgh|Naomi Ryssel|412-335-9688|agostinonr@upmc.edu|
22389829|NCT02581189|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22389830|NCT01514864|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22389831|NCT00253019|Emory University|Carrie Cwiak, MD, MPH|404-778-1696|ccwiak@emory.edu|
22389832|NCT05135156|University of Washington|Dr. Kathleen J. Ramos|2065430393|ramoskj@uw.edu|
22389833|NCT00647998|Hospital of the University of Pennsylvania|Steven Messe, MD|2156623363|messe@mail.med.upenn.edu|
22389834|NCT02222337|Lombardi Comprehensive Cancer Center, Georgetown University|Kristi Graves, PhD|202-687-1591|Kristi.Graves@georgetown.edu|
22389835|NCT03746483|First Wave BioPharma Inc.|Chief Medical Officer|(561) 589-7020|info@firstwavebio.com|
22389836|NCT01379521|Novartis Pharmaceuticals|Study Director|862-778-8300||
22389837|NCT00404547|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22389838|NCT00475735|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22389839|NCT01187407|Eli Lilly and Company|Chief Medical Officer|800-545-597||
22389840|NCT01136798|The University of Chicago|Eve Van Cauter, PhD|773-834-4001|evcauter@bsd.uchicago.edu|
22389841|NCT02382406|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
22389842|NCT00125853|Imperial College London|Professor Neil Poulter|+44 2075943445|n.poulter@imperial.ac.uk|
22389843|NCT01078376|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22389844|NCT02488070|Stanford University|Andrei Iagaru, MD|650-725-4711|aiagaru@stanford.edu|
22389845|NCT00050167|UT MD Anderson Cancer Center|Aman Buzdar, M.D./Professor||agmadrig@mail.mdanderson.org|
22389846|NCT01363297|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22389847|NCT02038803|Rush University Medical Center|Dr. Robert Balk|3129426744|Robert_Balk@rush.edu|
22389848|NCT04754594|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
22389849|NCT02116582|Astellas Pharma Europe B.V.|Executive Medical Director|+31 (0) 71 5455 050|Astellas.resultsdisclosure@astellas.com|
22389850|NCT00853021|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Jorge Garcia|216-444-7774|garciaj4@ccf.org|
22389851|NCT02864147|Clinical Research Team Leader, Gynecologic Oncology, Yale Cancer Center|Alessandro Santin, MD|(203) 200-4176|alessandro.santin@yale.edu|
22389852|NCT02269917|Janssen Research & Development|Medical Officer|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22389853|NCT01770509|The Department of Dermatology, Sheba Medical Center|Dr. Shoshana Greenberger|972-3-5302443|shoshana.greenberger@sheba.health.gov.il|
22389854|NCT00832650|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22389855|NCT03356145|Stanford University|Principal Investigator|650-497-5175|gynresearch@stanford.edu|
22389856|NCT04763863|Coloplast AB|Catarina Sternhufvud|+46 (0)705 56 10 97|secast@coloplast.com|
22389857|NCT00991185|duke|brian smith|919668951|brian.smith@duke.edu|
22389858|NCT02418819|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22389859|NCT00672100|William Beaumont Hospital|Craig T. Hartrick, MD|248-964-3440|chartrick@beaumont.edu|
22389860|NCT00513292|University of Texas MD Anderson Cancer Center, Houston, TX, USA|Aman U. Buzdar, MD|713-792-2817|abuzdar@mdanderson.org|
22389861|NCT02135419|University of California, San Francisco|Dr. Joel Palefsky|(415) 476-1574|joel.palefsky@ucsf.edu|
22389862|NCT00714688|Janssen-Cilag Germany|EMEA Medical Affairs Director|+49 2137 955258||
22389863|NCT01786551|Brigham and Women's Hospital|Gail K Adler|617-732-5661|gadler@partners.org|
22389864|NCT03993054|University of Miami|Sara St. George|305-243-0726|s.stgeorge@med.miami.edu|
22389865|NCT04588519|Spark Biomedical, Inc.|Navid Khodaparast, PhD|832-280-4756|navid.khodaparast@sparkbiomedical.com|
22389866|NCT01226485|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22389867|NCT00993798|Durect Corporation|Deborah Scott|408-777-1417|deborah.scott@durect.com|
22389868|NCT00961896|Novartis|Study Director|862-778-8300||
22389869|NCT00848393|Nationwide Children's Hospital|Aymen Naguib, MD|6147220596|Aymen.Naguib@nationwidechildrens.org|
22389870|NCT00575367|Inspire Pharmaceuticals, Inc.|Karen Kuhn/ Director|919 941-9777|kkuhn@inspirepharm.com|
22389871|NCT00755716|UConn Health|Dr. Cheryl Oncken|860-679-3425|oncken@uchc.edu|
22389872|NCT02229396|AstraZeneca|Global Clinical Leader|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22389873|NCT01828593|Entera Health|Senior Director, Clinical Research|515-963-7565|audrey.shaw@enterahealth.com|
22389874|NCT02679079|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22389875|NCT00520403|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22389876|NCT03009019|BioDelivery Sciences (a subsidiary of Collegium Pharmaceutical)|Director, Scientific Communications|913-940-1789|tkunkel@collegiumpharma.com|
22389877|NCT00805285|University of Maryland, Baltimore|Raymond Cross, MD, MS|410-706-3387|rcross@medicine.umaryland.edu|
22389878|NCT03939793|Penn Center for Community Health Workers|Director of Evaluation|267-624-5465|molly.knowles@pennmedicine.upenn.edu|
22389879|NCT00839306|Eisai Inc.|Eisai Medical Services|888-422-4743||
22389880|NCT01812707|Sanofi|Trial Transparency Team||Contact --US@sanofi.com|
22389881|NCT05376787|F2 Labs|Wendy Fuster|3013682586|wfuster@f2labs.com|
22389882|NCT05060237|Biofrontera Bioscience GmbH|Clinical Trial Department|+49 214 876 32|ameluz@biofrontera.com|66
22389883|NCT01066897|Stanford University|Dr. Jennifer Keller|650-724-0070|jkeller@stanford.edu|
22389884|NCT01763645|BIOCAD|Feder Krykov|+7 (812) 380 4933|kryukov@biocad.ru|8552
22389885|NCT01697592|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22389886|NCT02396758|Boston Scientific|Nancy O'Connell|763-494-2706|nancy.oconnell@bsci.com|
22389887|NCT01631825|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22402242|NCT01618656|Yale University School of Medicine|Deepak Cyril D'Souza, MD|203-932-5711|deepak.dsouza@yale.edu|2594
22402243|NCT01899144|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22402244|NCT00751881|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22442323|NCT01014910|Children's Mercy Hospital Kansas City|Dr. Russell McCulloh|816-234-3061|rmcculloh@cmh.edu|
22402245|NCT00866294|GlaxoSmithKline|GSK Response Center|866-435-7343||
22402246|NCT00492401|The Ohio State University Comprehensive Cancer Center|William Blum, MD|614-293-9273|William.Blum@osumc.edu|
22402247|NCT01651260|Hollister Incorporated|Malford Cullum|847-918-3975|malford.cullum@Hollister.com|
22402248|NCT01863563|Children's Hospital of the Kings Daughters|Craig Derkay, MD|757.668. 9327|Craig.Derkay@chkd.org|
22402249|NCT00317941|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22402250|NCT00530712|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com|
22389888|NCT02110225|Dompé farmaceutici s.p.a.|Flavio Mantelli, MD, PhD|+39 02 583831|clinical.trials@dompe.com|
22389889|NCT00265096|Centocor Research and Development, Inc.|Director, Clinical Research|1-800-457-6399||
22389890|NCT00774306|Thomas Jefferson University|Dr. Scott Mintzer|215-955-1222|scott.mintzer@jefferson.edu|
22389891|NCT03436433|Duke Neurosugery|Claudia E. Pamanes, MPH, CCRP|9196680897|claudia.pamanes@duke.edu|
22389892|NCT03568708|CIncinnati Children's Hospital Medical Center|Dr. Halley Wasserman|513-803-3815|halley.wasserman@cchmc.org|
22389893|NCT00666835|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|0049 80244760|biopharma.clinicaltrials@sandoz.com|
22389894|NCT00511147|Grifols Therapeutics Inc|Henry Li, PhD|1 + 919 316 6042|henry.li@grifols.com|
22389895|NCT00899379|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22389896|NCT00809783|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22389897|NCT00126555|University of Texas MD Anderson Cancer Center|Randal S. Weber, MD / Head & Neck Surgery|7137927734|rsweber@mdanderson.org|
22389898|NCT00529555|Sunstar Americas, Inc|Marie Wilson, Clinical Program Manager|773-481-3327|marie.wilson@us.sunstar.com|
22389899|NCT01443546|Weill Cornell Medical College|Ina Cholst, MD|646-962-3025|icholst@med.cornell.edu|
22389900|NCT03229356|Johns Hopkins University|Geetanjali Chander|443-287-2030|gchande1@jhmi.edu|
22389901|NCT01939405|MGH|Dr. Nicolas Oreskovic|6177260593|noreskovic@mgh.harvard.edu|
22389902|NCT01259440|VA San Diego Healthcare System|Carl J. Stepnowsky, PhD|858-642-1240|Carl.Stepnowsky@va.gov|
22389903|NCT01956071|Pennington Biomedical Research Center|Dr. Corby K. Martin|225-763-2585|corby.martin@pbrc.edu|
22389904|NCT02254681|Allina Health|Srinevas K. Reddy|612-863-8716|laura.rockwell@allina.com|
22389905|NCT00396097|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22389906|NCT03461211|Horizon Pharma USA, Inc.|Roxann Becco|866-479-6742|clinicaltrials@horizontherapeutics.com|
22389907|NCT03209050|mmc medical international services|Clinical Research Organization and Trial Manager|9492805700|laura22@mmc-medical.com|
22389908|NCT02316847|SK Bio-pharmaceuticals Co, Ltd|MinJae Lee, Associate Manager||minj.lee@sk.com|
22389909|NCT01370018|Institute for Human Genetics and Biochemistry|Cynthia L. Bristow, MS, PhD|6314446238|cynthia.bristow@alpha1biologics.com|
22389910|NCT01525641|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22389911|NCT02204319|ProHealth Care|Linda LaBorde PT|262-928-5139|linda.laborde@phci.org|
22389912|NCT00383747|Massachusetts General Hospital - Harvard Medical School|A. Eden Evins, MD, MPH. Director of the MGH-Harvard Center for Addiction Medicine|6176434679|a_eden_evins@hms.harvard.edu|
22389913|NCT02959177|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22402251|NCT02749370|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22402252|NCT02101411|taipei city hospital|chen yueh-chung|88627093600|chenyuehchung.tw@yahoo.com.tw|3741
22402253|NCT00279500|Second Sight Medical Products, Inc.|Jessy Dorn, PhD, Director, Clinical and Scientific Research|8188335089|jdorn@secondsight.com|
22402254|NCT03242759|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22402255|NCT03415464|FACULTY OF SPORT|Vedran Hadzic|+38615207700|vedran.hadzic@fsp.uni-lj.si|728
22402256|NCT02186795|MUSC|Sylvia Wilson, MD|843-732-2322|wilsosh@musc.edu|
22402257|NCT00504166|University of California San Francisco|Dr. Thomas M. Link|415-353-2450|Thomas.Link@ucsf.edu|
22402258|NCT00839098|Human Engineering Reserach Laboratories|Clinical Coordinator|412-822-3700|annmarie.kelleher@va.gov|
22402259|NCT01345786|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22402260|NCT02190435|William Beaumont Hospital|Denise Koueiter, MS|248-551-5166|denise.koueiter@beaumont.org|
22402261|NCT02644525|Laboratory of Parasitic Diseases, NIAID/NIH|Elise O'Connell, MD, Principal Investigator|301-661-0172|oconnellem@mail.nih.gov|
22402262|NCT03028025|VALBHS|Dr. Arnold Seto|562-826-8000|arnold.seto@va.gov|
22402263|NCT02986958|Johns Hopkins Bloomberg School of Public Health|Research Program Manager|410-614-7910|dechava1@jhu.edu|
22402264|NCT02399475|University of Pennsylvania|Dr. Anne Cappola|2155375359|acappola@pennmedicine.upenn.edu|
22402265|NCT02260193|Akebia Therapeutics, Inc.|Akebia Therapeutics, Inc.|+1 617-844-6128|trials@akebia.com|
22402266|NCT01963117|Samsung Medical Center|Professor|82-2-3410-2612|hee.ro.park@gmail.com|
22402267|NCT01070784|AstraZeneca|Goran Eckerwall, MSD||ClinicalTrialTransparency@astrazeneca.com|
22402268|NCT01780389|Duke University Medical Center|David Marks, MD|619 668-2859|d.marks@duke.edu|
22402269|NCT00935220|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22402270|NCT01095250|Novartis Pharmaceuticals|Study Director|862-778-8300||
22402271|NCT01000064|Vanderbilt University Medical Center|Dr. Michael G. Tramontana|615-327-7144|Michael.Tramontana@Vanderbilt.Edu|
22442324|NCT00800254|University of Colorado Denver|Jennifer Stevens-Lapsley, PhD|303-724-9170|jennifer.stevens-lapsley@ucdenver.edu|
22402272|NCT02518620|Ablynx NV|Medical Monitor|+32 (0)9 262 00 00|clinicaltrials@ablynx.com|
22402273|NCT03677089|Massachusetts General Hospital - Clinical Coordinating Center|Dr. Karen Kuhlthau|617-724-2842|KKUHLTHAU@PARTNERS.ORG|
22402274|NCT00978445|Cleveland Clinic Foundation|Dr. Heather Gornik|216-445-3689|gornikh@ccf.org|
22402275|NCT01415440|NYSPI|Jonathan Posner, MD|6467745735|jonathan.posner@nyspi.columbia.edu|
22402276|NCT00227877|Boston Children's Hospital - Center for Adolescent Substance Use and Addiction Research|Sion Kim Harris, PhD|857-218-4304|sion.harris@childrens.harvard.edu|
22402277|NCT02517047|Boston Children's Hospital|Dr. Wanda Phipatanakul|6173556117|wanda.phipatanakul@childrens.harvard.edu|
22402278|NCT01810991|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22402279|NCT02522481|Bracco Diagnostics Inc.|Melda S. Dolan, MD, FACC, FASE, Head, Medical Affairs and Cardiac Ultrasound|1-609-514-2506|Melda.Dolan@diag.bracco.com|
22402280|NCT04191967|Univerisity of North Carolina (UNC)|Dr. Chemtai Mungo, MD, MPH|(984) 974-1000|cmungo@email.unc.edu|
22402281|NCT01641835|Heidelberg Engineering GmbH|Gerhard Zinser, PhD|+4962216463|Contact@HeidelbergEngineering.com|0
22402282|NCT01109004|The Emmes Corporation|Adam Mendizabal, PhD||amendizabal@emmes.com|
22402283|NCT03805932|National Cancer Institute|Dr. Robert J. Kreitman|301-480-6187|kreitmar@mail.nih.gov|
22402284|NCT03059810|Johnson & Johnson Vision|Thomas Karkkainen- SR PRINCIPAL RESEARCH OPTOMETRIST|904 443-3402|TKarkkai@its.jnj.com|
22402285|NCT02322892|Beth Israel Deaconess Medical Center|Dr. Lars W. Andersen|6173886343|larswiuffandersen@gmail.com|
22402286|NCT00747617|UCSD School of Medicine|R. Jeffrey Chang, M.D.|858-534-8930|rjchang@ucsd.edu|
22402287|NCT01746732|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22402288|NCT02817555|Eastern Health|Andrea Woodland|7097778146|andrea.woodland@easternhealth.ca|
22402289|NCT02125331|GE Healthcare|Clinical Affairs Project Manager|262-443-7008|stephanie.karwedsky@ge.com|
22402290|NCT00137436|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22402291|NCT01432262|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22402292|NCT00165646|Eisai Co.,Ltd. Eisai Product Creation Systems|Nobuyuki Sugisaki, Study Director|+81-3-3817-3908|n-sugisaki@hhc.eisai.co.jp|
22402293|NCT04657016|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22402294|NCT00701727|Radiant Research|Michael H Davidson, MD FACC|312-494-2220|michaeldavidson@radiantresearch.com|
22402295|NCT05291598|University of Miami Department of Orthopedics|Dr. Victor Hernandez|(305) 689-5195|vhh1@miami.edu|
22402296|NCT03609658|Wake Forest School of Medicine|Jennifer Gabbard, M.D.|336-716-8028|jgabbard@wakehealth.edu|
22402297|NCT05131880|Universidad Europea de Madrid|Alberto Bermejo Franco|+34912115535|alberto.bermejo@universidadeuropea.es|
22402298|NCT02601001|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22402299|NCT00950612|GlaxoSmithKline|GSK Response Center|866-435-7343||
22402300|NCT01356602|Novartis Pharmaceuticals|Study Director|862-778-8300||
22402301|NCT01931462|University of Wisconsin|Director of Clinical Research, Department of Surgery|608-262-0540|clinicalresearch@surgery.wisc.edu|
22402302|NCT01701583|University of Colorado|Jenny Stitt|303-724-7205|jenny.stitt@ucdenver.edu|
22402303|NCT05070429|University of North Carolina, Chapel Hill|Lisa Gravens-Mueller, Biostatistician/Supervisor|919-962-3098|lgravens@email.unc.edu|
22402304|NCT00615290|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22402305|NCT02849990|University of Washington|Dr. Michael Schweizer|2066066252|schweize@uw.edu|
22402306|NCT01252134|Alcon Research, Ltd.|Director of Medical Affairs|888.451.3937|medinfo@alconlabs.com|
22402307|NCT02678741|LumaBridge|Timothy Vreeland, MD|6363465458|tvreeland@lumabridge.com|
22402308|NCT01795898|Janssen Philippines|Medical Affairs Manager|+632-8247901||
22402309|NCT04510194|University of Minnesota|Carolyn Bramante|612-624-0468|jcharles@umn.edu|
22402310|NCT06648161|Kocaeli University|Dr. Resmiye Özdilek|+90 262 303 47 38|resmiyeozdilek@gmail.com|
22402311|NCT02531373|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22402312|NCT01623531|Department of Anesthesia, Dalhousie University, Halifax, Canada|Dr. Myron Kwapisz|+1 902 473 4326|myron.kwapisz@nshealth.ca|
22402313|NCT02834403|Houston Methodist Cancer Center|Polly Niravath, MD|713-441-0629|ccresearch@houstonmethodist.org|
22402314|NCT04705597|BioAge Labs, Inc.|Patrick Martin, M.D.|215-260-5134|patrick@bioagelabs.com|
22402315|NCT00390780|Bioalliance Pharma|Dr Pierre Attali|+33 (0)1 45 58 76 00|pierre.attali@bioalliancepharma.com|
22402316|NCT00305006|Teachers College, Columbia University|Dr. Andrew Gordon|212-678-3326|ag275@columbia.edu|
22402317|NCT02606045|University of Pittsburgh|Margaret V. Ragni, MD, PHD|412-209-7480|ragni@pitt.edu|
22402318|NCT01996319|Novartis Pharmaceuticals|Study Director|862-778-8300||
22402319|NCT02758717|Lombardi Comprehensive Cancer Center|Bruce D. Cheson, M.D.|507-266-0800|bdc4@georgetown.edu|
22415518|NCT04561115|Grifols Therapeutics LLC|Rhonda Griffin|+1 919 757 1744|rhonda.griffin@grifols.com|
22415519|NCT00743145|New York State Psychiatric Institute|Margaret Haney, PhD|646-774-6153|mh235@cumc.columbia.edu|
22402320|NCT01671085|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22402321|NCT00637273|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22402322|NCT00365716|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22415520|NCT02179190|Medtronic Plc|Senior Manager, Clinical Project Management|949-680-1274|darren.j.lacour@medtronic.com|
22415521|NCT01670097|UT MD Anderson Cancer Center|David Hui, MD/ Associate Professor, Palliative Care Medicine|(713) 792-6258|dhui@mdanderson.org|
22415522|NCT02311894|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22415523|NCT00884390|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22415524|NCT01691612|Brigham & Women's Hospital|Elliot Israel, M.D.|617-732-8110|eisrael@partners.org|
22415525|NCT01152112|Hologic, Inc.|Christina Mastandrea / Clinical Research manager|5082638772|christina.mastandrea@hologic.com|
22415526|NCT02623218|AOMA Graduate School of Integrative Medicine|Dr. John Finnell|512-492-3057|jfinnell@aoma.edu|
22431155|NCT01435356|EAU Research Foundation|Wim P.J. Witjes, MD, PhD Scientific and Clinical Research Director|+31 26 389 0677|w.witjes@uroweb.org|
22431156|NCT02796651|AstraZeneca AB|Global Clinical Leader|+46 766 346712|clinicaltrialtransparency@astrazeneca.com|
22431157|NCT00437073|GlaxoSmithKline|GSK Response Center|866-435-7343||
22431158|NCT03485157|MIMEDX|Chief Medical Officer|(770) 651-9100|CTInquiries@mimedx.com|
22431159|NCT04248153|Bracco Diagnostics Inc.|Giordana Marioni, Clinical Trial Assistant|609-514-2282|giordana.marioni@diag.bracco.com|
22431160|NCT04918771|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22431161|NCT01849276|Northwestern University|Dr. Jessica Altman|312-503-1761|J-altman@northwestern.edu|
22431162|NCT02657343|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|(877) 442-3324|Sara_Tolaney@dfci.harvard.edu|
22431163|NCT04104477|University of Florida|Jennifer Nichols, Ph.D.|352-294-8803|jnichols@ufl.edu|
22389914|NCT04970381|Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College|Prof. Yan Liang|+8618801287180|fwyy2803@163.com|
22389915|NCT03544229|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22389916|NCT02460562|Faculty of Dentistry, Thammasat University|Dr. Kritirat Kiatsirirote|662-9869213-5|kkritirat@yahoo.com|7150
22389917|NCT01061775|Children's Hospitals and Clinics of Minnesota|Dr. Jennifer Abuzzahab|651-220-6867|jennifer.abuzzahab@childrensmn.org|
22389918|NCT02642159|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22389919|NCT00588341|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|(646) 888-4162|chapmanp@mskcc.org|
22389920|NCT01954771|Beijing Anzhen Hospital|Dr.Yingsheng Zhou|0086-010-64456185|zys626@aliyun.com|
22389921|NCT02886234|The Miriam Hospital|Dr. Michael Carey|401793-8218|michael_carey@brown.edu|
22389922|NCT00957671|University of Texas Medical Branch|Randall Urban, MD|409-772-1176|rurban@utmb.edu|
22389923|NCT00999141|Baxter Innovations, GmbH|Edith Hantak, DVM, Dir, Global Therapeutic Area, BioSurgery||edith_hantak@baxter.com|
22389924|NCT03866434|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22402323|NCT02853331|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22402324|NCT00844428|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.||clinicaltrials@alxn.com|
22402325|NCT02375698|UCT|Dr. Rodney Dawson|27214066850|rodney.dawson@uct.ac.za|
22402326|NCT01595646|Wake Forest School of Medicine|Suzanne Craft, PhD|3366-713-8830|suzcraft@wakehealth.edu|
22402327|NCT02946229|GE Healthcare|Sean Lucas - Research Manager|1-248-533-5575|sean.lucas@ge.com|
22402328|NCT01161524|Eisai Inc.|Eisai Call Center|888-422-4743||
22402329|NCT01088815|Johns Hopkins SKCCC|Dr. Ana De Jesus Acosta|443-287-0411|adejesu1@jhmi.edu|7-0411
22402330|NCT01319760|Columbia Presbytarian Hospital, NY|Dr. Ajay Kirtane|212-305-7060|akirtane@columbia.edu|
22402331|NCT01952015|Novartis Pharmaceuticals|Study Director|862-778-8300||
22402332|NCT01202110|Cedars-Sinai|Leah Silbert|310 423-3783|Leah.Silbert@cshs.org|
22402333|NCT02167204|University of Washington|Hannah Linden|206-606-2053|hmlinden@uw.edu|
22402334|NCT00651118|Meda Pharmaceutical|David Ginsberg,..|732 564 2364|david.ginsberg@meda.us|
22415527|NCT00759707|Brigham and Women's Hospital|Dr. Joshua Beckman|6175257053|jbeckman@partners.org|
22431164|NCT01287208|Massachusetts General Hospital|Anne Thorndike, MD, MPH|617-724-4608|athorndike@partners.org|
22389925|NCT02033499|University of North Carolina at Chapel Hill|Dr. Katrina Donahue|919-966-5090|Katrina_Donahue@med.unc.edu|
22389926|NCT02865135|Dana Farber Cancer Institute (DFCI)|Kartik Sehgal, MD|617-632-3090|Kartik_Sehgal@dfci.harvard.edu|
22389927|NCT00985621|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22389928|NCT01732406|Massachusetts General Hospital|Dr. Karen Miller|617-726-3870|kkmiller@partners.org|
22389929|NCT04394624|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22389930|NCT00905255|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22389931|NCT01774929|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-792-7200||5888
22389932|NCT01332318|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
22389933|NCT02040532|MGH Center for Women's Mental Health|Dr. Lee Cohen|617-724-0816|lcohen2@partners.org|
22389934|NCT00676663|Syndax Pharmaceuticals, Inc.|Kate Madigan, MD, Chief Medical Officer|+1-858-888-3798|kmadigan@syndax.com|
22389935|NCT02363933|Duke University Medical Center|Katherine Peters, MD, PhD|9196846173|katherine.peters@duke.edu|
22389936|NCT02168153|Palmer Center for Chiropractic Research|Dr. Cyndy Long|563-884-5157|Long_C@palmer.edu|
22389937|NCT01772147|GlaxoSmithKline|GSK Response Center|866-435-7343||
22389938|NCT00796614|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22389939|NCT00740597|City of Hope National Medical Center|Paul Frankel, Ph.D.|(626)359-8111|pfrankel@coh.org|65265
22389940|NCT02983877|Case Western Reserve University|Dr. Jennifer Levin|2168445057|jennifer.levin@uhhospitals.org|
22389941|NCT01983462|University of Iowa|Gary Pierce, PhD|3193359487|gary-pierce@uiowa.edu|
22389942|NCT01902381|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-713-5440|bpowell@wakehealth.edu|
22389943|NCT00791102|University of Chicago|Robert Naclerio, MD|773-702-0080|rnacleri@surgery.bsd.uchicago.edu|
22389944|NCT02762500|Lycera Corp.|H. Jeffrey Wilkins, MD, Chief Medical Officer|484-243-6222|wilkins@lycera.com|
22389945|NCT00730847|GlaxoSmithKline|GSK Response Center|866-435-7343||
22389946|NCT00280683|UCaliforniaDavis|Dr. Nicholas Kenyon|916-734-3564|njkenyon@ucdavis.edu|
22389947|NCT01243411|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22402335|NCT03117049|Ono Pharmaceutical Co. Ltd|Medical Information Center|---|clinical_trial@ono.co.jp|
22389948|NCT00488319|Johnson & Johnson Research & Development, LLC|Director Clinical Research|1-609-730-6771||
22389949|NCT02754310|iLumens|Dr David Drummond|+0033144494848|david.drummond@ilumens.org|6
22389950|NCT01163955|Glinn and Giordano Physical Therapy|W. Brian Monroe, Doctor of Physical Therapy|661-832-9737|tandbmonroe@hotmail.com|
22389951|NCT00784277|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537||
22389952|NCT01093222|SWOG|Study Statistician|206-667-4623||
22389953|NCT04194541|University of Miami|Hadar Lev-Tov, MD|305-243-4472|hlevtov@med.miami.edu|
22389954|NCT02567227|Albert Einstein College of Medicine|Dr. Joe Verghese|718-430-3877|joe.verghese@einsteinmed.org|
22389955|NCT00187135|St. Jude Children's Research Hospital|Doralina Anghelescu, MD|866-278-5833|referralinfo@stjude.org|
22389956|NCT04349124|Duke University|Brenna Hughes, M.D.|919-668-0843|brenna.hughes@duke.edu|
22389957|NCT00475787|Canandaigua VA Medical Center|Paul Dougherty, DC|585-463-2673|paul.dougherty@va.gov|
22389958|NCT01924806|Smith & Nephew|Henry Jaimes|01923-477-164|henry.jaimes@smith-nephew.com|
22389959|NCT00935649|PathoLase|David M Harris, PhD, Research Director|510-502-3345|bmcinc@comcast.net|
22389960|NCT03635775|University of Wisconsin Madison|Bernadette Gillick|612-625-3645|bgillick@wisc.edu|
22389961|NCT01026103|Covidien|Noreen Fahey|203-821-4716|noreen.fahey@covidien.com|
22389962|NCT02498418|Teva Pharmaceuticals Inc. USA|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
22389963|NCT00762502|Johnson & Johnson Vision Care, Inc.|John Buch, OD|1-904-443-1707|RA-Visus-ClnclStds@its.jnj.com|
22389964|NCT05562583|Northwestern University|Judith Tedlie Moskowitz|312-503-7712|judith.moskowitz@northwestern.edu|
22389965|NCT02046941|VANCHCS|Juliana Baldo|925-372-4649|juliana.baldo@va.gov|
22389966|NCT01675050|University of Michigan|Ismaeel Hashemi, M.D. Principal Investigator|6169165566|ismaeel.hashemi@gmail.com|
22389967|NCT00745121|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
22389968|NCT01961921|Alnylam Pharmaceuticals Inc|Chief Medical Officer|1-877-256-9526|Clinicaltrials@alnylam.com|
22389969|NCT03327571|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22389970|NCT03280108|Alcon Research|Expert Clinical Project Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22402336|NCT01096550|Friends Research Institute|Dr. Shannon Gwin Mitchell|410-837-3977|smitchell@friendsresearch.org|238
22389971|NCT02996097|Johns Hopkins School of Medicine|Dr. Ginette Okoye|9142158980|ginette.okoye@howard.edu|
22389972|NCT01820637|Boston Scientific|Lieve Cornelis, Clinical Trial Manager|+ 32 476-840-183|Lieve.Cornelis@bsci.com|
22389973|NCT00264498|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
22389974|NCT03794609|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22389975|NCT03638258|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
22389976|NCT04543942|The Ohio State University|Dr. Jessica Weafer|859-533-9878|jessica.weafer@osumc.edu|
22389977|NCT02205476|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22389978|NCT03840278|Massachusetts General Hospital Diabetes Research Center|Courtney A Balliro, BS, RN, CDE|617-726-1242|cballiro@partners.org|
22402337|NCT00872833|New England Research Institutes, Inc.|Eric Gerstenberger|6179237747|egerstenberger@neriscience.com|
22402338|NCT01555463|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22389979|NCT03805698|Cedars-Sinai Medical Center|David Kulber, MD, PI|3104235900|david.kulber@cshs.org|
22431165|NCT04910165|Saint Luke's University Health Network|Dr. Chinenye Nwachuku|6096101054|chinenye.nwachuku@sluhn.org|
22389980|NCT04405089|Minneapolis VA Medical Center|Dr. Shalamar Sibley, MD, MPH|612-467-1727|Shalamar.Sibley@va.gov|
22389981|NCT00179478|University of California San Diego|Revere P Kinkel MD (PI)|619-543-5295|rkinkel@ucsd.edu|
22389982|NCT00360971|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
22389983|NCT01313299|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22389984|NCT02506881|BIOCAD|Biryulin Andrey|+7812380 49 33|biryulin@biocad.ru|925
22389985|NCT01919398|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22389986|NCT00741468|Repros Therapeutics Inc.|Jennifer Wike|281-719-3402|jwike@reprosrx.com|
22389987|NCT03722836|ServierRussia|Medical Manager-Olga Linnik|8-495-93707-00|olga.linnik@servier.com|1316
22389988|NCT05021757|Shockwave Medical|Randee Randoll|408.577.7856|rrandoll@shockwavemedical.com|
22389989|NCT03799289|The Miriam Hospital|Jessica Unick, PD (Principal Investigator)|401-793-8966|junick@lifespan.org|
22389990|NCT02391545|Secura Bio, Inc.|Beth Gregory, PharmD, MBA|1-702-254-0011|bgregory@securabio.com|
22389991|NCT02016690|AbbVie|Global Medical Services|800-633-9110||
22389992|NCT01222078|GlaxoSmithKline|GSK Response Center|866-435-7343||
22389993|NCT04089332|University of Wisconsin - Madison|Dr. William Schrage|608-262-7715|william.schrage@wisc.edu|
22389994|NCT05756348|Medline Industries, LP|Julie Miller|630-418-6891|jamiller@medline.com|
22389995|NCT05401149|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22389996|NCT02189122|VANDERBILT UNIVERSITY MEDICAL CENTER|Nancy J. Brown, M.D.|6153438701|nancy.j.brown@vanderbilt.edu|
22389997|NCT04281875|Vanderbilt University Medical Center|Dr. Carmen C Solorzano|615-343-2735|carmen.solorzano@vumc.org|
22389998|NCT02656745|Click Therapeutics|Director of Scientific Affairs|646-844-2158|brian@clicktherapeutics.com|
22389999|NCT02588027|University of California, San Francisco|Dr. Jennifer Tangtiphaiboontana|5622095440|Jennifer.Tangtiphaiboontana@ucsf.edu|
22390000|NCT03847389|Hill Dermaceuticals, Inc.|Rosario G Ramirez, MD|4073231887|nini.ramirez@hillderm.com|
22390001|NCT00603278|GlaxoSmithKline|GSK Response Center|866-435-7343||
22390002|NCT00500539|Novartis Pharmaceuticals|Study Director|862-778-8300||
22390003|NCT04853394|University of Illinois Chicago|Mary E. Mackesy-Amiti|312-355-4892|mmamiti@uic.edu|
22390004|NCT04890158|Montefiore Medical Center|Dr. Alecia Thompson-Branch|718-904-4105|alethomp@montefiore.org|
22390005|NCT01123642|VISN 17 Center of Excellence for Research on Returning War Veterans|Sandra B. Morissette, Ph.D.|254-297-5170|sandra.morissette@va.gov|
22390006|NCT04853238|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22390007|NCT04517877|Photozig, Inc.|Bruno Kajiyama|6506947496|info@photozig.com|
22390008|NCT01223963|Q-Med AB|Chief Medical Officer|+46 18 4749000|reception.seupp@galderma.com|
22390009|NCT03245762|University of Florida|Jennifer Miller, MD|352-265-7337|millejl@peds.ufl.edu|
22390010|NCT00637247|AmpliMed Corporation|Robert Dorr|520-626-7892|bdorr@azcc.arizona.edu|
22390011|NCT01982786|Canadian cancer trials group|Dr. Keyue Ding|1-613-533-6000|kding@ctg.queensu.ca|77705
22390012|NCT02312622|Stanford University|Joel W. Neal, MD PhD, Assistant Professor of Medicine (Oncology)|(650) 498-4696|jwneal@stanford.edu|
22390013|NCT01907113|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22390014|NCT00632931|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
22390015|NCT01592396|MedImmune, LLC|Meena Jain, MB BChir/Associate Medical Director|301-398-0000|jainm@medimmune.com|
22390016|NCT01057888|University of Rochester, Deparentment of Pediatrics|Dr. Peter Szilagyi|585 275-5798|peter_szilagyi@urmc.rochester.edu|
22390017|NCT02499835|University of Wisconsin Carbone Cancer Center|Douglas McNeel, MD|608-263-4198|dm3@medicine.wisc.edu|
22390018|NCT01751451|Memorial Sloan Kettering Cancer Center|Dr. Howard Scher, MD|646-888-4878|scherh@MSKCC.ORG|
22431166|NCT01799135|Dana Farber Cancer Institute|Raymond H. Mak|617.632.3591|RMAK@PARTNERS.ORG|
22390019|NCT01906658|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
22402339|NCT04436510|Healey Center for ALS at Massachusetts General Hospital|Healey Center for ALS Project Management|833-425-8257 (HALT ALS)|healeyalsplatform@mgh.harvard.edu|
22402340|NCT03844633|Ohio State University|Maria Gallo|6146882145|gallo.86@osu.edu|
22402341|NCT01377467|University Hospital Zürich|Prof. Rudolf P. Wüthrich|+41 44 255 33 84|rudolf.wuethrich@usz.ch|
22402342|NCT03403491|patientMpower Ltd|Chief Scientific Officer|+353872599131|colin@patientmpower.com|
22453221|NCT05101317|Peking University|Dr. Ruiping Xiao|86-010-62757243|xiaor@pku.edu.cn|
22402343|NCT02588248|UHClevelandMC|L-Menthol Injection as a Novel Technique during Colonoscopy: The MINT-C study|216-844-1000|Richard.wong@UHhospitals.org|6172
22453222|NCT03541200|Tanabe Pharma America, Inc.|Clinical Trials, Information Desk|Please email|information.US@mb.tanabe-pharma.com|
22402344|NCT01355068|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22402345|NCT00336492|Johnson & Johnson Pharmaceutical Research and Development|Senior Director, Clinical Research|610-240-8092||
22453223|NCT04524702|Emory University|Dr. Olatunji Alese|4047781900|olatunji.alese@emory.edu|
22453224|NCT04338893|Zimmer Biomet|Chiara Griffoni, Clinical Project Senior Lead|+41 79 560 16 28|chiara.griffoni@zimmerbiomet.com|
22453225|NCT04570215|UCL Queen Square Institute of Neurology|Prof Alexander Leff|+442076791129|a.leff@ucl.ac.uk|
22453226|NCT06426927|University of North Carolina at Chapel Hill|José Guillem, MD, MPH|717-531-5164|jgguillem41@gmail.com|
22453227|NCT01424150|Alfred Health|Professor Paul Myles|61 3 9076 3176|p.myles@alfred.org.au|
22453228|NCT04189783|The University of Texas MD Anderson Cancer Center|Christopher Scally, MD|(281) 682-3314|cpscally@mdanderson.org|
22453229|NCT03994601|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22453230|NCT04221438|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22453231|NCT05126082|HealthPartners Institute|Dr. Elyse Kharbanda|952-967-5038|Elyse.O.Kharbanda@HealthPartners.com|
22453232|NCT04566666|Sun Pharmaceutical Industries Limited|Head, Regulatory Affairs|9122 66455645|Clinical.Trial@sunpharma.com|
22453233|NCT03841357|Duke University|Laura Schanberg, M.D.|919-684-6575|laura.schanberg@duke.edu|
22453234|NCT01175356|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22453235|NCT02750202|University of Pretoria|Prof G Dreyer|+27123543900|Greta.Dreyer@up.ac.za|
22453236|NCT06379893|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
22453237|NCT03642626|Masonic Cancer Center|Dr. Veronika Bachanova|612-625-5469|bach0173@umn.edu|
22453238|NCT02819752|The Royal Marsden NHS Foundation Trust|PEACH Senior Trial Manager|(+44) 02089156666|peach.trial@rmh.nhs.uk|
22402346|NCT01593748|MUSC|Cameron Coggins|843-792-4743|cogginca@musc.edu|
22402347|NCT04229446|OsloUH|Primary Investigator Dr. Tone Rustøen|+47 22859229|tone.rustoen@medisin.uio.no|
22402348|NCT01781026|Yale University|Harriet Kluger||Harriet.Kluger@yale.edu|
22402349|NCT03141307|University of Utah|Dr. Bob Wong|801-587-9666|bob.wong@nurs.utah.edu|
22402350|NCT03458000|George Washington University|Dr. Andrew Meltzer|202-741-2952|ameltzer@mfa.gwu.edu|
22402351|NCT03569111|Medtronic|Julie Krzykowski|763-202-3325|Julie.Krzykowski@Medtronic.com|
22402352|NCT00328263|Bio-K+ International Inc.|Dr. Serge Carrière|450-978-2465|scarriere@biokplus.com|
22402353|NCT00410280|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22402354|NCT01937130|Conatus Pharmaceuticals|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com|
22402355|NCT01431144|University of Louisville|Henry Greenwell, Principal Investigator|502-852-6928|henry.greenwell@louisville.edu|
22402356|NCT01104558|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22402357|NCT00696657|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)||clinicaltrials@novonordisk.com|
22402358|NCT00738543|University of Guanajuato|Alejandro Macias|52 477 7145859|aaeemmhh@yahoo.com|400
22402359|NCT00523341|Amgen Inc.|Study Director|866-572-6436||
22402360|NCT00912015|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
22402361|NCT01790438|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22402362|NCT02090114|Johns Hopkins University School of Medicine|Samuel Denmeade, M.D.|410-502-8341|denmesa@jhmi.edu|
22402363|NCT01605071|University of Colorado Denver, Anschutz Medical Campus|Kimberly Cox-York||KIMBERLY.COX-YORK@CUANSCHUTZ.EDU|
22402364|NCT03123354|Masimo Corporation|Vikram Ramakanth|1 (949) 297-7416|clinicalresearchdept@masimo.com|
22402365|NCT02856581|Mayo Clinic|Dr. Ivana T. Croghan|507-284-7313|croghan.ivana@mayo.edu|
22402366|NCT03902366|VA Portland Health Care System|Jennifer Loftis, PhD|503-220-8262|jennifer.loftis@va.gov|57155
22402367|NCT01345123|Health Dialog|David R Veroff, MPP, SVP Analytic Development|617-406-5219|dveroff@healthdialog.com|
22402368|NCT01798134|Boston Scientific Corporation|Senior Clinical Program Manager|763-494-2172|hansenj2@bsci.com|
22402369|NCT02653976|Solasia Pharma K.K.|Clinical Development Department|+81358438045|clinicaldev@solasia.co.jp|
22402370|NCT02436577|AstraZeneca AB|Brilinta Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
22402371|NCT00366548|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22402372|NCT03650452|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22402373|NCT02969317|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22402374|NCT02042404|EarLens Corporation|Dr. Suzanne Levy, Director of Clinical Research|650 366 9000|slevy@earlenscorp.com|
22402375|NCT01523808|Erytech Pharmaceuticals|Director of Clinical Trials|+33 4 78 74 44 38|contact@erytech.com|
22402376|NCT04184622|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22402377|NCT01134887|Veterans Administration Health Services Research and Development|Richard M. Frankel Ph.D.|317-988-4000|Richard.Frankel@VA.Gov|
22402378|NCT02795988|Imugene|Study Director|+61 2 9423 0881|info@imugene.com|
22402379|NCT02341014|Memorial Sloan Kettering Cancer Center|Dr. Steve Horwitz, MD|646-608-2680|horwitzs@MSKCC.ORG|
22402380|NCT00726323|GlaxoSmithKline|GSK Response Center|866-435-7343||
22402381|NCT05058664|University of Michigan|Ewa Czyz|734 764-9466|ewac@med.umich.edu|
22402382|NCT01617681|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
22402383|NCT02599766|Swiss TPH|Dr. Karin Hediger|0041795197885|karin.hediger@unibas.ch|
22402384|NCT03480282|Beth Israel Deaconess Medical Center|Mara Schonberg|16177541414|mschonbe@bidmc.harvard.edu|
22402385|NCT03848221|The University of Alabama at Birmingham|Dr. Andrew Pucker|920-579-2900|apucker@uab.edu|
22402386|NCT03685019|University of Oxford|Thomas Hamilton|01865 227374|thomas.hamilton@ndorms.ox.ac.uk|
22402387|NCT00109733|EMD Serono|Sanja Dragnic/Medical Responsible|+7816814017|sanja.dragnic@emdserono.com|
22402388|NCT00669539|Jaeb Center for Health Research|Raymond Kraker, MSPH|813-875-8690|pedig@jaeb.org|
22402389|NCT00376597|The Ohio State University Comprehensive Cancer Center|Electra D. Paskett, PhD|614-293-3917|electra.paskett@osumc.edu|
22453239|NCT02714881|Brigham and Women's Hospital|Katherine P. Liao, MD, MPH|617-732-5000|kliao@bwh.harvard.edu|
22453240|NCT07265245|Ministry of Health Malaysia|Dr. Hanif Omar|+60102169965|thehanifomar@gmail.com|
22453241|NCT03014167|Johns Hopkins University Bloomberg School of Public Health|Judd Walson|2066124571|jwalson1@jh.edu|
22453242|NCT05770895|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22453243|NCT04523714|Kaiser Permanente|Meghan Mayhew|(564) 248-6303|meghan.h.mayhew@kpchr.org|
22453244|NCT04233424|PolyPid|Eyal Shoshani, VP Clinical Affairs|+972-74-7195700|eyal.s@polypid.com|138
22453245|NCT02971748|MD Anderson Cancer Center|Bora Lim, MD|713-745-0689|BLim@mdanderson.org|
22453246|NCT05965778|Laboratoires Thea|Corentin Le Camus|0680382020|corentin.lecamus@theapharma.com|33
22453247|NCT04803214|Mainstay Medical|Jennifer Tinsley, Director of Clinical Affairs|(877) 702-8488|info@mainstaymedical.com|
22453248|NCT02389517|University of Chicago|Andrzej Jakubowiak|855-702-8222|ajakubowiak@medicine.bsd.uchicago.edu|
22453249|NCT04518670|Rapid-Medical|Dr. Walid Haddad- Chief Clinical Officer|+972 72 2503331|walid@rapid-medical.com|
22453250|NCT01208662|Dana-Farber Cancer Institute|Ajantha Nithi|857-215-2829|ajantha_nithi@dfci.harvard.edu|
22453251|NCT06127147|University of Illinois at Chicago|Cemal Ozemek|312-355-3996|ozemek@uic.edu|
22453252|NCT06232018|Hatyai hospital|Pooriwat Lertsurawat|087-6329824|Pooriwat999@gmail.com|
22453253|NCT04657523|Philips Ultrasound LLC.|Rob Johnson|42527572756|rob.johnson_1@philips.com|
22453254|NCT00880594|Washington University School of Medicine|Gregory Sayuk|314-454-8201|gsayuk@wustl.edu|
22453255|NCT05071209|Children's Oncology Group|Results Reporting Coordinator|6262411500|resultsreportingcoordinator@childrensoncologygroup.org|
22453256|NCT04294641|National Cancer Institute|Dr. James Gulley|301-480-8870|gulleyj@mail.nih.gov|
22453257|NCT02411656|The University of Texas MD Anderson Cancer Center|Bora Lim, MD|(713) 745-0689|blim@mdanderson.org|
22453258|NCT05776615|Kütahya Health Sciences University|Canan Sümeyra GÜN|05458125720|canansumeyra.gun@ksbu.edu.tr|
22453259|NCT05932693|Yale University|Suchitra Krishnan-Sarin and Danielle Davis|2039747607|danielle.davis@yale.edu|
22453260|NCT04588428|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
22453261|NCT04050293|Supernus Pharmaceuticals|Gianpiera Ceresoli-Borroni Director Clinical Research|3018382521|gceresoliborroni@supernus.com|
22453262|NCT03575793|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22453263|NCT05339087|Thoraxklinik Heidelberg gGmbH|Prof. Dr. Ekkehard Grünig|+496221396|PH-Studies.THOR@med.uni-heidelberg.de|1230
22453264|NCT04751383|Children's Oncology Group|Results Reporting Coordinator|6262411500|resultsreportingcoordinator@childrensoncologygroup.org|
22453265|NCT03659916|Albireo, An Ipsen Company|Medical Director|see email|clinical.trials@ipsen.com|
22453266|NCT03406884|University of Miami|Joshua M. Hare, MD|305-243-5579|jhare@med.miami.edu|
22453267|NCT04619004|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|9089926400|CTRinfo@dsi.com|
22453268|NCT05763576|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22453269|NCT06187909|Department of Anesthesia, Intensive Care, and Pain Management, Faculty of Medicine, Ain Shams University, Cairo, Egypt|Yasser Mohamed Reyad Ahmed El-Mansoury|01000286206|yassermoahmed0102107@med.asu.edu.eg|
22453270|NCT04798768|Boston Scientific|Julie West|651-582-4721|Julie.West@bsci.com|
22402390|NCT05100316|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22453271|NCT04216329|National Cancer Institute|Dr. Kevin A. Camphausen|240-760-6205|camphauk@mail.nih.gov|
22402391|NCT05628181|University of Michigan|Donovan Maust|734-845-3649|maustd@med.umich.edu|
22402392|NCT01234402|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22402393|NCT03993691|University of North Carolina at Chapel Hill|Director, Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
22415528|NCT04207333|University of North Carolina at Chapel Hill|Lee Stoner, PhD, MPH|919-962-0534|stonerl@unc.edu|
22415529|NCT04736537|Mayo Clinic|Tyson Scrabeck|507-538-1016|scrabeck.tyson@mayo.edu|
22415530|NCT00537095|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22415531|NCT00021541|National Institutes of Health, National Cancer Institute|Brigitte Widemann, M.D.|301-496-7387|widemanb@mail.nih.gov|
22453272|NCT04818671|argenx BV|Regulatory Manager|+32 93103400|regulatory@argenx.com|
22453273|NCT04745676|University of Rochester Medical Center, Wilmot Cancer Institute|Research Project Manager|585 410 5044|cait_fallone@urmc.rochester.edu|
22453274|NCT03543865|Johns Hopkins University|Mary Cwik|(410) 960-9503|mcwik1@jhu.edu|
22453275|NCT04158648|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22453276|NCT04322097|University of Pennsylvania|Raj Dedhia, MD|2158293720|raj.dedhia@pennmedicine.upenn.edu|
22453277|NCT03707834|Temple University|Sharon J. Herring, MD, MPH, Principal Investigator|215-707-2234|herris01@temple.edu|
22453278|NCT05219604|Dent Neurologic Institute|Michelle Rainka, PharmD|716-250-2000|mrainka@dentinstitute.com|
22453279|NCT04625413|University of Rochester Medical Center|Dr. Kah Poh Loh|585-276-4353|kahpoh_loh@urmc.rochester.edu|
22453280|NCT02617563|Medtronic Cranial and Spinal Technologies|Clinical Study Manager|+31433566584|bart.heijnen@medtronic.com|
22453281|NCT03003468|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22453282|NCT03879577|University of Chicago|Theodore Karrison (Research Professor)|(773) 702-2453|tkarrison@health.bsd.uchicago.edu|
22453283|NCT01231906|Children's Oncology Group|Results Reporting Coordinator|6264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22453284|NCT04564339|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1-855-752-2356|clinicaltrials@alexion.com|
22453285|NCT04091945|Lumosa Therapeutics Co., Ltd.|Sabrina Yeh|+886 2 26557918|sabrina_yeh@lumosa.com.tw|5735
22453286|NCT00455156|Premier Research|Kimberly Myer|9842381297|Kimberly.Myer@premier-research.com|
22453287|NCT06286332|Chang Gung University|Principal Investigator|0905126618|k.kathleenwu@gmail.com|
22453288|NCT05272189|Brigham & Women's Hospital|Jeremy M Wolfe, Professor and Principle Investigator|6178511166|jwolfe@bwh.harvard.edu|
22453289|NCT04158739|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22453290|NCT06070987|Chang Gung Memorial Hospital-Kaohsiung Medical Center, Kaohsiung, Taiwan|Jen-Wen Hung, MD|+886975056689|hung0702@cgmh.org.tw|
22453291|NCT02405221|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Stephanie Gaillard, MD, PhD|410-955-8240|HopkinsGynTrials@jhmi.edu|
22453292|NCT03972488|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
22453293|NCT04971590|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22453294|NCT04526665|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22453295|NCT05070247|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22453296|NCT07004010|EspadPharmed|Hamidreza Kafi|989129232594|Kafi.h@orchidpharmed.com|
22453297|NCT04544995|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22453298|NCT06865677|National Cancer Institute|Dr. Stanley Lipkowitz|240-760-6129|lipkowis@navmed.nci.nih.gov|
22453299|NCT03900754|San Francisco VA Medical Center|Dr. Josh Woolley|415-221-4810|joshua.woolley@va.gov|24117
22453300|NCT02086578|Memorial Sloan Kettering Cancer Center|Dr. Daphna Gelblum, MD|914-367-7273|gelblumd@MSKCC.ORG|
22453301|NCT03299166|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
22453302|NCT02408861|Icahn School of Medicine at Mount Sinai|Dr Himanshu Joshi MBBS MPH PhD|2126599635|Himanshu.Joshi@mountsinai.org|
22453303|NCT04814654|Albert Einstein College of Medicine|Dr. Viraj Patel|718-920-5256|viraj.patel@einsteinmed.edu|
22453304|NCT04505553|University of Washington Medical Center - Montlake|Stacey Cohen, MD|2066066405|sshovitz@fredhutch.org|
22453305|NCT04583670|General Practice Department Sorbonne University|Mariela Skendi Study Coordinator|0033613930736|marielaskendi@gmail.com|
22453306|NCT05147662|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
22453307|NCT00826540|Mayo Clinic|Dr. Axel Grothey, M.D.|(507) 284-4430|grothey.axel@mayo.edu|
22453308|NCT06891937|Brigham and Women's Hospital|Bonnie Glanz, PhD|617-525-6574|bglanz@bwh.harvard.edu|
22453309|NCT03091192|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22453310|NCT06680206|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22453311|NCT05309577|University of Pittsburgh|Sarah T. Stahl, PhD|4122466003|sts80@pitt.edu|
22453312|NCT03222609|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22453313|NCT02158507|The University of Alabama at Birmingham|Dr. Erica Stringer-Reasor|2059759375|esreasor@uabmc.edu|
22453314|NCT06602466|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
22453315|NCT03818035|Janssen Research & Development LLC|GUIDE-Study Responsible Physician|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22453316|NCT04098237|Cedars-Sinai Medical Center|Dr. Andrew Hendifar, MD|310-423-2217|andrew.hendifar@cshs.org|
22453317|NCT00336024|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|Resultsreportingcoordinator@childrensoncologygroup.org|
22453318|NCT03505905|University of Texas Southwestern Medical Center|Dr. E. Sherwood Brown|214-645-6950|sherwood.brown@utsouthwestern.edu|
22415532|NCT01929681|McLean Hospital|Dr. Michael Rohan|617-855-3127|mrohan@mclean.harvard.edu|
22453319|NCT03757091|The University of Texas MD Anderson Cancer Center|Dr. Carin Hagberg|(713) 745-4495|chagberg@mdanderson.org|
22453320|NCT05008484|McGuire VA Hospital|Dora E. Ifon|804-675-5455|dora.ifon@va.gov|
22453321|NCT04312945|University of Minnesota|Bonny Donzella|6126244351|donzella@umn.edu|
22453322|NCT00756509|Novartis Pharmaceuticals|Study Director|862 778 8300|Novartis.email@Novartis.com|
22453323|NCT04095689|Houston Methodist Neal Cancer Center|Polly Niravath, M.D.|(713) 441-9948|paniravath@houstonmethodist.org|
22415533|NCT03505151|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22415534|NCT00124618|Mayo Clinic|Aminah Jatoi, M.D.|507/538-0268|jatoi.aminah@mayo.edu|
22415535|NCT04194151|Hospital Central de la Defensa Gomez Ulla|Dr. Paula Agostina VULLO|+34681054151|agosvullo@hotmail.com|
22415536|NCT00087529|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22415537|NCT02535923|Department of Veterans Affairs|Elizabeth A Klingaman PhD|410-259-7810|elizabeth.klingaman@va.gov|
22415538|NCT01723202|The Ohio State University Comprehensive Cancer Center|Dr. Bhavana Konda|614-366-5068|Bhvana.konda@osumc.edu|
22415539|NCT02722616|Johns Hopkins, East Baltimore|Dr. Amol Narang|410-913-3395|anarang2@jhmi.edu|
22415540|NCT01273857|Okayama University Hospital|Prof. Hidemasa Oh|+81-086-235-6506|hidemasa@md.okayama-u.ac.jp|
22415541|NCT01188226|UCLA|Neal Garrett, MD||ngarrett@ucla.edu|
22415542|NCT04980456|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22415543|NCT00122447|Emory University School of Medicine|Mary Rhee, M.D.|404-778-1660|mrhee@emory.edu|
22415544|NCT00578968|Mayo Clinic|Bruce D. Johnson, PhD|507-284-4441|johnson.bruce@mayo.edu|
22415545|NCT02415387|Center for Biostatistics, The Ohio State University|Juan Peng|614-293-5869|juan.peng@osumc.edu|
22415546|NCT03687242|Spruce BioSciences Inc.|Spruce CMO, MD|415-655-4169|clinicaltrials@sprucebio.com|
22415547|NCT01151280|Boston Scientific Corporation|Alexis James, Clinical Project Manager|508-683-4074|jamesa@bsci.com|
22415548|NCT01891812|Columbia University Irving Medical Center|Dr. Daniel Tsze, Professor of Pediatrics|212 305 9825|dst2141@cumc.columbia.edu|
22415549|NCT02733627|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22415550|NCT02246764|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
22415551|NCT05393271|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22415552|NCT02048813|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22415553|NCT05293106|Weill Cornell Medicine|Marianne Nellis, MD|2127463056|man9026@med.cornell.edu|
22415554|NCT03314857|Edwards Lifesciences|Director of Research|949-250-2500|THV_CT.gov@edwards.com|
22415555|NCT02754492|Terumo BCT, Inc.|Heather Pidcoke, MD, PhD|(303) 231-4805|Heather.Pidcoke@terumobct.com|
22415556|NCT01408888|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22415557|NCT01717313|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22415558|NCT01412281|Crucell Switzerland|Medical Affairs Director|+41(0)319806111|info@crucell.com|
22415559|NCT01617096|International Partnership for Microbicides|Dr John Steytler|+27218602300|jsteytler@ipmglobal.org|
22415560|NCT02533466|GlaxoSmithKline|GSK Response Center|866-435-7343||
22415561|NCT01196390|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22415562|NCT01532908|MassBiologics|Director of Clinical Affairs|617-474-3000|Mblclinicaldirector@Umassmed.edu|
22415563|NCT00252564|US Oncology|Allen L. Cohn|303- 388-4876|Allen.Cohn@USOncology.com|
22415564|NCT03480022|Woman's Hospital|Director of Research|12252315278|karen.elkind-hirsch@womans.org|
22415565|NCT00881569|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22415566|NCT04164758|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261|medicalinformation@acadia-pharm.com|2897
22415567|NCT03660787|Pharmasyntez|Mikhail Shurygin|+7 3952 550 355|m.shurygin@pharmasyntez.com|1150
22415568|NCT00697827|Synthes|Ann Marie Simon|610-719-5418|simon.annmarie@synthes.com|
22415569|NCT03259165|Indiana University School of Medicine|Peter S. Pang|317-880-3900|ppang@iu.edu|
22415570|NCT03732833|Medytox Inc.|Young Ryu|+82-2-6901-5424|aab005@medytox.com|
22415571|NCT05068661|Duke University School of Medicine|Dr. Ashraf Habib|9196682024|habib001@mc.duke.edu|
22415572|NCT01567527|Otsuka Pharmaceutical Development & Commercialization, Inc.|Joan Amatniek, Senior Director, Global Clinical Development|(609) 512-4464|joan.amatniek@otsuka-us.com|
22415573|NCT02004691|Sanofi-Aventis Recherche & Développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22415574|NCT01726803|University of Utah|Julie Fritz|801-581-6861|julie.fritz@hsc.utah.edu|
22415575|NCT02805517|Loma Linda University Health|Dr. Duane Baldwin|909-588-4000|dbaldwin@llu.edu|44196
22415576|NCT01970592|Medical University of South Carolina|Chris Gregory|8437921078|gregoryc@musc.edu|
22415577|NCT00499473|The Ohio State University Comprehensive Cancer Center|Robert Cavaliere, MD|614-293-4968|Robert.Cavaliere@osumc.edu|
22415578|NCT03980522|Kiniksa Pharmaceuticals (UK), Ltd. c/o Kiniksa Pharmaceuticals Corp.|Clinical Operations Study Director|1-781-431-9100|studyinfo@kiniksa.com|
22415579|NCT01320722|Brigham and Women's Hospital|John P Forman, MD||jforman@partners.org|
22415580|NCT01091363|University of Massachusetts Medical School|Dr. Sun S Kim|201-388-2656|sun.kim@umb.edu|
22390020|NCT03319719|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
22390021|NCT03193216|Medical University of South Carolina|Dr. Puja Elias, Associate Professor, PI for study|8438764269|eliasps@musc.edu|
22390022|NCT02490878|MD Anderson Cancer Center|Caroline Chung, MD|(713) 745-5422|cchung3@mdanderson.org|
22390023|NCT00922441|Boryung Pharmaceutical|Manager of Clinical Research|+82-2-708-8069|rainbowleo@boryung.co.kr|
22390024|NCT00317603|Mass General Brigham|Beth Overmoyer|617 632 3800|Beth_Overmoyer@DFCI.HARVARD.EDU|
22390025|NCT00991029|Medical University of South Carolina|Dr. Jordan Elm|843-876-1605|elmj@musc.edu|
22390026|NCT00523549|Novartis Pharmaceuticals|Study Director|862-778-8300||
22390027|NCT00439647|Novartis Pharmaceuticals|Novartis Study Director|862-778-8300||
22390028|NCT02005029|Virginia Commonwealth University|Dr. Leslie Cloud|804-662-5304|leslie.cloud@vcuhealth.org|
22415581|NCT00160524|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22415582|NCT04892147|Duke University|Guy G. Potter, PhD|919-668-1269|guy.potter@duke.edu|
22415583|NCT01689155|Sanofi Pasteur Inc|Medical Drector||RegistryContactus@sanofipasteur.com|
22390029|NCT02621047|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22390030|NCT03371485|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
22390031|NCT01264887|Grünenthal GmbH|Director Clinical Trials|+49 241 569|clinical-trials@grunenthal.com|3223
22415584|NCT01215721|UC Irvine|Thomas Ahlering, MD|714-456-6068|tahlerin@uci.edu|
22390032|NCT03389451|University of Iowa Health Care|Dr. Michael Graham|319-356-4302|michael-graham@uiowa.edu|
22390033|NCT01860807|UCLA|Keith Heinzerling MD|310-319-4700|kheinzerling@mednet.ucla.edu|
22390034|NCT00858507|Providence VA Medical Center|Thomas O'Toole, MD|4012737100|thomas.otoole@va.gov|
22390035|NCT02853305|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22415585|NCT00045162|SWOG Statistical Center|Lung Committee Statistician|206-667-4623||
22390036|NCT00349388|Atlantic Health System|Dr. Joel Rosh|973-971-5676|joel.rosh@atlantichealth.org|
22390037|NCT00677092|University of Massachusetts Medical School|Jonathan Kay, MD|508-793-6936|jonathan.kay@umassmemorial.org|
22390038|NCT01947153|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22390039|NCT02381652|Anika|Carol Pekar, VP Clinical Affairs|781.457.9218|cpekar@anikatherapeutics.com|
22390040|NCT04772313|Horizon Therapeutics USA, Inc.|Supra Verma, MD|866-479-6742|clinicaltrials@horizontherapeutics.com|
22415586|NCT01044433|Abramson Cancer Center|Dr. Corey Langer|215-615-5121|Corey.Langer@uphs.upenn.edu|
22415587|NCT05263505|Washington University School of Medicine|Dr. Michael Paley, Director of the Ocular Rheumatology Clinic|314-273-7556|paleym@wustl.edu|
22415588|NCT00826241|National Cancer Institute|Dr. Mark Gilbert|240-760-6023|gilbertmr@nih.gov|
22415589|NCT03407729|Case Western Reserve University|Dr. Michael J. Decker|2163682467|mjd6@case.edu|
22415590|NCT01849458|Tornier Inc.|Marcela Bravo|9526837481|marcela.bravo@tornier.com|
22415591|NCT04387617|Mayo Clinic|Karen L. Stern, M.D.|480-342-3868|Stern.Karen@mayo.edu|
22415592|NCT01050764|Stanford University Medical Center|Everett H Meyer, MD, PhD; Assistant Professor of Medicine|650-725-5816|evmeyer@stanford.edu|
22431167|NCT01813357|Monash University and Alfred Health|Dr Janine Trevillyan|03 90762000|janine.trevillyan@monash.edu|
22390041|NCT01836198|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22390042|NCT03187353|Perlman School of Medicine, University of Pennsylvania|James Loughead, Ph.D.|215-205-1876|loughead@pennmedicine.upenn.edu|
22390043|NCT02215954|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22390044|NCT00139659|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22390045|NCT02943109|Ohio State University College of Medicine|Prof. Ann Scheck McAlearney|614-293-8973|Ann.McAlearney@osumc.edu|
22390046|NCT00924209|National Cancer Institute, National Institutes of Health|Caryn Steakley, Deputy Clinical Director|240-858-3749|steaklec@nih.gov|
22390047|NCT02625922|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22390048|NCT00640042|King Pharmaceuticals, Inc.|Professional Information Services|1-800-776-3637||
22390049|NCT02359552|Cleveland Clinic Lou Ruvo Center for Brain Health|Dr. Aaron Ritter|702-483-6049|rittera@ccf.org|
22390050|NCT01209936|University of Southern California|Dr. David Erceg|(323) 442-2900|erceg@usc.edu|
22415593|NCT03786770|Revance Therapeutics, Inc.|Domenico Vitarella, Sr. Director, Clinical Development|510-742-3400|dvitarella@revance.com|
22390051|NCT02382913|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22402394|NCT02280291|NYU Langone Health|Nirmal Tejwani|212 598 6599|Nirmal.Tejwani@nyulangone.org|
22402395|NCT03508622|Children's Hospital Los Angeles|Brenda Manzanarez|323/361-8245|bmanzanarez@chla.usc.edu|
22402396|NCT05175261|Prolocor, Inc|David J Schneider, MD|8023730071|david.schneider@prolocor.com|
22453324|NCT05985304|Rayner Intraocular Lenses Limited|Senior Clinical Trial Manager|714-398-9988|EricAlegria@rayner.com|
22453325|NCT04497844|Janssen Research and Development, LLC|Executive Director Clinical Prostate|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22453326|NCT05286762|Cingulate Therapeutics, LLC|Kelly R Koehn|913-942-2300|kkoehn@cingulate.com|
22453327|NCT07165366|Indiana University|Bruce A. Matis|3172012089|bmatis@iu.edu|
22453328|NCT04572750|VA Palo Alto Health Care System|Keith Humphreys, PhD|(650) 493-5000|keith.humphreys@va.gov|
22453329|NCT04799145|Össur ehf.|Lisa Tronicke|+4915155367970|ltronicke@ossur.com|
22390052|NCT02391116|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22390053|NCT02109107|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com|
22390054|NCT02520414|Boston Scientific|Meaghan Wilk Clinical Project Manager|5086834113|meaghan.wilk@bsci.com|
22390055|NCT01747629|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com|
22390056|NCT00607789|Lindner Center of HOPE|Susan McElroy, MD|513-536-0718|susan.mcelroy@lindnercenter.org|
22390057|NCT06016127|Albany Saratoga Centers for Pain Management|Kasandra Cliff|518-371-6772|khopkins@northwayspc.com|
22390058|NCT03340766|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22390059|NCT00240097|UAB|Dr. Francisco Robert|205-934-5077|pacorobertuab@cs.com|
22390060|NCT01294358|National Cancer Institute|Dr. Udo Rudloff|301-496-3098|udo_rudloff@nih.gov|
22390061|NCT03613454|University of Alabama at Birmingham|Dr. AJ Gunn|205-975-4850|agunn@uabmc.edu|
22390062|NCT02963922|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22390063|NCT02181400|Sydney Eye Hospital|Maria Willilams|02 9382 7309|maria.williams@sydney.edu.au|
22390064|NCT04374019|University of Kentucky|Susanne Arnold MD|8592579568|smarno0@uky.edu|
22390065|NCT01239056|University of Florida|Dr. Peter V. Draganov|(352) 273-9472|Peter.Draganov@medicine.ufl.edu|
22390066|NCT03873038|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22390067|NCT04222088|Research Institute for Tropical Medicine|Dr. Fe Esperanza Caridad J. Espino|63288072628|fe.espino2019@gmail.com|343
22390068|NCT00595764|Yale University|Dr. David Fiellin|203-737-3347|david.fiellin@yale.edu|
22390069|NCT00141271|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22390070|NCT01544153|Truth Initiative|Amanda L. Graham, PhD|202-454-5938|agraham@truthinitiative.org|
22390071|NCT00390806|GlaxoSmithKline|GSK Response Center|866-435-7343||
22390072|NCT01879735|Dept. of Nuclear Medicine & PET-center, Dept. of Hepatology and Gastroenterolgy. Aarhus University Hospital|Susanne Keiding M.D., Associate professor, D.Sc.|+45 7846 3031|susanne@pet.auh.dk|
22390073|NCT00884793|UCSF|Steven Yukl|415-221-4810|steven.yukl@ucsf.edu|3930
22390074|NCT04783519|University of Washington|Mary Larimer|(206) 543-3513|larimer@uw.edu|
22390075|NCT03169530|Beth Israel Deaconess Medical Center|Kenneth Mukamal, MD, MPH|617 754-1401|kmukamal@bidmc.harvard.edu|
22390076|NCT01032200|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
22390077|NCT00067808|The University of Texas M. D. Anderson Cancer Center|Hagop Kantarjian, MD / Professor|713-792-7026||
22390078|NCT02273180|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22390079|NCT04531813|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22390080|NCT04341584|Hopital Hotel-Dieu (AP-HP)|Dr Raphael Porcher|:+33 (0)1.42.34.89.87|raphael.porcher@aphp.fr|
22390081|NCT00932659|Duke University|Patrick Pun, MD, MHS|919-660-6865|patrick.pun@duke.edu|
22390082|NCT00746785|The Mind Reseach Network|Kent Hutchison, Ph.D.|505-272-5028|khutchison@mrn.org|
22390083|NCT01231464|GlaxoSmithKline|GSK Response Center|866-435-7343||
22390084|NCT00957996|BioCryst Pharmaceuticals, Inc.|William P. Sheridan, MBBS|919-859-1302||
22390085|NCT02503982|Schneider Children's Medical Center of Israel|Dr. Liat Ashkenazi-Hoffnung|972-3-9253681|LiatA3@clalit.org.il|
22390086|NCT00970320|Ostfold Hospital Trust|Dr Hege Hølmo Johannessen|+4799721345|hege.holmo.johannessen@so-hf.no|
22390087|NCT00684203|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22390088|NCT01709123|Louisiana State University Health Science Shreveport|Sushil K. Jain, PhD|318.675.6086|sushil.jain@lsuhs.edu|
22390089|NCT00307164|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22390090|NCT00387959|Memorial Sloan Kettering Cancer Center|Dr. Juliet Barker|212-639-3468|barkerj@mskcc.org|
22390091|NCT03712449|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22390092|NCT05786521|University of Texas Health Science Center San Antonio|TIffany M Cortes, MD|210-450-3333|cortest@uthscsa.edu|
22390093|NCT01369706|Deutsches Herzzentrum München|Prof. Dr. Christof Kolb|+49891218|kolb@dhm.mhn.de|2020
22390094|NCT03972137|Rutgers, The State University of New Jersey|Dr. Teresa Leyro|848-445-2090|tml124@psych.rutgers.edu|
22390095|NCT03226353|CooperVision|Jose A. Vega OD MSc FAAO|(925) 621- 3761|javega@coopervision.com|
22390096|NCT02747121|Helsetilsynet|Dr Einar Hovlid|+4721529900|eho@helsetilsynet.no|
22390097|NCT03168425|Vanderbilt University Medical Center|Sarah Osmundson, MD|+1 (615) 343-5700|sarah.osmundson@vumc.org|
22390098|NCT03029234|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22390099|NCT00498433|Novartis Pharmaceuticals|Study Director|862-778-8300||
22390100|NCT01176435|University of Minnesota|C. Gail Summers, MD|612-625-6469|summe001@umn.edu|
22390101|NCT02685007|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22390102|NCT01887990|University of Cincinnati|Cheryl McCullumsmith|513-5588022|cheryl.mccullumsmith@uc.edu|
22390103|NCT00468858|GSK|Faina Rose, PhD|610-664-8986|faina.v.rose@gsk.com|
22390104|NCT00543101|Community Research Initiative of New England (CRINE)|Clavin Cohen MD|617 502 1700|ccohen@crine.org|
22390105|NCT00797511|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22390106|NCT00843115|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22390107|NCT03690921|M D Anderson Cancer Center|Dr. Emma Holliday|713-563-2340|EBHolliday@mdanderson.org|
22390108|NCT02406495|Coopervision|Jose A. Vega, OD, Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com|
22402397|NCT00506077|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22402398|NCT00316303|Dartmouth-Hitchcock|Stanley Rosenberg, Ph.D.|603-653-0740|Stanley.d.rosenberg@dartmouth.edu|
22402399|NCT02243527|University of British Columbia|Dr. Jordan A. Guenette|604.682.2344|Jordan.guenette@hli.ubc.ca|62129
22402400|NCT01106534|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com|
22402401|NCT04174638|Akdeniz University|Dr Sefika Tugba Yangoz|+905058039716|tugbayangoz@gmail.com|
22390109|NCT03772041|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22390110|NCT05110014|Wake Forest Baptist Health Sciences|Study Coordinator|336-713-3103|eswright@wakehealth.edu|
22381076|NCT03298113|3M Healthcare Business Group|Nancy Klinger, Clinical Manager|651 736|nmklinger@mmm.com|5825
22381077|NCT04736056|Duke University|Hannah Fisher, PhD|919-416-3471|hannah.fisher@duke.edu|
22381078|NCT02223182|DBV Technologies|Pharis Mohideen, MD Chief Medical Officer|908-679-5200|clinicaltrials@dbv-technologies.com|
22381079|NCT05302791|University of Montana|Dustin Slivka|406-243-2389|dustin.slivka@umontana.edu|
22381080|NCT03552978|San Francisco Veterans Affairs Medical Center|Ellen Herbst, MD|415-221-4810|Ellen.Herbst@va.gov|24926
22381081|NCT03663712|Duke University|Dan G. Blazer III, MD|919-668-1861|trey.blazer@duke.edu|
22381082|NCT04956692|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22381083|NCT03541603|Tenax Therapeutics, Inc.|Stuart Rich, MD; Chief Medical Officer|919 855 2100|s.rich@tenaxthera.com|
22381084|NCT02099539|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22381085|NCT05812794|The University of Texas Health Science Center at Houston|Stuart Mason Fraser, MD|713-500-7142|Stuart.M.Fraser@uth.tmc.edu|
22381086|NCT01449721|Christiana Care Health System|Ryan Arnold, MD, Director of Research, Emergency Medicine|302-733-5108|ryarnold@christianacare.org|
22381087|NCT02148718|AbbVie|Global Medical Services|800-633-9110||
22381088|NCT04447820|Kowa Research Institute, Inc.|Director, Clinical Operations|919-433-1600|CTGResults@KowaUS.com|
22381089|NCT01577732|GlaxoSmithKline|GSK Response Center|866-435-7343||
22381090|NCT03888365|Lung Biotechnology PBC|Lung Biotechnology PBC Study Director|301-608-9292|info@lungbiotechnology.com|
22381091|NCT00333788|UCB, Inc|UCB Clinical Trial Call Center|+1 877 822 9493||
22402402|NCT01831934|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
22402403|NCT00570739|Daiichi Sankyo, Inc.|John Raia, Senior Director Professional Affairs|(973) 944-2683|jraia@dsi.com|
22381092|NCT04739423|CuraSen Therapeutics, Inc|Clinical Trial Information Desk|+1 650 475 2842|clinicaltrials@curasen.com|
22402404|NCT02289755|Allena Pharmaceuticals|VP of Clinical Development|617-467-4577|akausz@allenapharma.com|314
22402405|NCT00739297|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22402406|NCT01400971|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22390111|NCT01656486|Carolinas Medical Center|David Iannitti, MD|704-446-2772|david.iannitti@carolinashealthcare.org|
22390112|NCT03927222|Duke University|Mustafa Khasraw, MD|919-684-5301|mustafa.khasraw@duke.edu|
22431168|NCT03135067|University of Pennsylvania|Dr. Harsha Thirumurthy|215-746-0410|hthirumu@upenn.edu|
22390113|NCT03690284|University of Texas Southwestern|Clinical Research Coordinator|3106127741|matthew.oh@utsouthwestern.edu|
22390114|NCT02201771|Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, China|Dr. Yunpeng Zhu|008613816819346|zypB1014@rjh.com.cn|
22390115|NCT00549042|Covidien|Alfredo Bozzini, MD|314-654-2000|Alfredo.Bozzini@covidien.com|
22390116|NCT01287416|University of Manitoba|Shay-Lee Bolton|204-787-5082|sbolton@hsc.mb.ca|
22390117|NCT03697083|University of Pennsylvania|Katherine K. Milkman Ph.D.|215-573-9646|kmilkman@wharton.upenn.edu|
22390118|NCT02694198|Ain Shams Maternity hospital|amr ahmed mahmoud riad|01005347179|amr.riad@med.asu.edu.eg|+2
22390119|NCT00495612|Genentech, Inc.|Medical Communications|800 821-8590||
22390120|NCT00006099|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22431169|NCT03863574|Zydus Therapeutics Inc.|Dr Deven Parmar|7324050886|dparmar@zydustherapeutics.com|
22390121|NCT02264353|University of California, San Diego|Atul Malhotra, MD|(858) 657-6159|amalhotra@ucsd.edu|
22390122|NCT04896502|Arkansas Children's Hospital|Robbie Pesek, MD|501-364-3149|rdpesek@uams.edu|
22390123|NCT02383927|Kura Oncology, Inc.|Clinical Operations|+1 617-588-3755|KO-TIP-001@kuraoncology.com|
22390124|NCT00734851|DukeUMC|Andrew J. Armstrong, MD ScM FACP|(919) 668-8797|andrew.armstrong@duke.edu|
22390125|NCT00818519|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22390126|NCT01518517|Erytech Pharma|Anne-Sophie Clermont|+33 4 78 78 15 70|anne-sophie.clermont@erytech.com|
22390127|NCT00981578|InSightec|Nadir Alikacem|214.360.2000|nadira@insightec.com|
22390128|NCT01393314|Case Western Reserve University|Research Compliance Officer|216-368-0134|kav6@case.edu|
22390129|NCT03427177|Fox Chase Cancer Center|Dr. Linda Fleisher|215-214-3757|Linda.Fleisher@fccc.edu|
22390130|NCT02150109|Ascensia Diabetes Care|Jane Wallace, Deputy Director Clinical Trials|574-257-3063|jane.wallace@ascensia.com|
22390131|NCT01180790|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22390132|NCT00655668|Celgene|Associate Director, Clinical Trial Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22390133|NCT02335242|Stanford University|Jean Teng, MD, PhD|(650) 724-9627|jteng3@stanford.edu|
22390134|NCT04167085|David Geffen School of Medicine at UCLA|Justin P. McWilliams, MD, FSIR|(310) 267-8773|jumcwilliams@mednet.ucla.edu|
22390135|NCT03840148|Venatorx Pharmaceuticals, Inc.|Paul McGovern, MD|484-329-8615|mcgovern@venatorx.com|
22390136|NCT03615404|Duke University Medical Center|Principal Investigator|919-684-0000|pedsneuronc@duke.edu|
22390137|NCT00257556|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22390138|NCT01074034|Boston Scientific|Elke Sommerijns|+32 479 76 71 56|elke.sommerijns@bsci.com|
22390139|NCT03849300|The University of Nebraska at Omaha|Dr. Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
22390140|NCT04839289|Sonova USCS|Lisa Standaert|331-702-0173|lisa.standaert@phonak.com|
22390141|NCT00585910|Massachusetts General Hospital|Kerry Brodziak|617-503-1043|kbrodziak@partners.org|
22390142|NCT00464737|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22390143|NCT01350388|University of Utah|Srinivasan Beddhu, M.D.|801-585-3810|srinivansan.beddhu@hsc.utah.edu|
22390144|NCT00580047|University of Nebraska Medical Center|Lynn Mack|402-559-6208|lmack@unmc.edu|
22390145|NCT01189136|Women & Infants Hospital of Rhode Island|Charles R. Rardin, MD|401 453-7560|crardin@wihri.org|
22390146|NCT01780584|Pediatric Cardiac ICU National Cardiovascular Center Harapan Kita|Dr Eva M Marwali, Principal Investigator|+62215684085|evamarwali@yahoo.com|2807
22390147|NCT02825849|UCSF|Heather Huddleston|415-353-3040|heather.huddleston@ucsf.edu|
22390148|NCT00546884|University of Minnesota|John Song MD MPH MAT|612-624-8936|songx006@umn.edu|
22390149|NCT02127892|Children's Hospital Los Angeles|Neena Kapoor, M.D.|323-361-2546|nkapoor@chla.usc.edu|
22390150|NCT00727259|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22390151|NCT01021683|Clinical Research Team, Medical Affairs, Medical Dept. Janssen Korea|Clinical Research Associate|+82-2-2094-4879||
22390152|NCT01374971|Nathan Wei, MD, PA dba Arthritis Treatment Center|Nathan Wei, MD|301-694-5800|nwei@arthritistreatmentcenter.com|
22390153|NCT04387201|The University of Texas Health Science Center at Houston|Absalon D Gutierrez, MD|713-500-6641|absalon.d.gutierrez@uth.tmc.edu|
22390154|NCT04320602|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22390155|NCT03051984|University of Vermont College of Medicine|Michael Toth|802-656-7989|michael.toth@med.uvm.edu|
22390156|NCT01502306|UCSD|Principal Investigator|8583001056|szhu@ucsd.edu|
22390157|NCT01821729|Massachusetts General Hospital|Dr. Theodore Hong|617-726-6050|TSHONG1@mgh.harvard.edu|
22390158|NCT01845649|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22390159|NCT00381797|St. Jude Children's Research Hospital|Shengjie Wu|(901) 595-2859|shengjie.wu@stjude.org|
22390160|NCT01699698|Kyushu University|Dr. Taketo Matsunaga|092-642-5444|mtaketo@surg1.med.kyushu-u.ac.jp|
22390161|NCT03418493|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22390162|NCT00526097|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22390163|NCT00966979|Stryker Orthopaedics|Stryker JR Clinical Research|201-831-5000|StrykerJRClinical@stryker.com|
22390164|NCT01318317|City of Hope|Dr. Lwaliw Popplewell|626-359-8111|lpopplewell@coh.org|
22390165|NCT01990313|Stanford University|Chioma Anidi|6507236709|chioma.anidi@stanford.edu|
22390166|NCT02412111|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22415594|NCT00360490|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22415595|NCT02289820|MedImmune LLC|Judith Falloon, MD, FACP, FIDSA, Senior Director, Clinical Development|+1-301-398-4010|information.center@astrazeneca.com|
22415596|NCT02005276|Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh Patel||mpatel@upenn.edu|
22415597|NCT02054754|e-Therapeutics Plc|Clinical Operations Manager|+44 1993 880000|contact@etherapeutics.co.uk|
22415598|NCT01688882|Novartis Pharmaceuticals|Study Director|862-778-8300||
22415599|NCT02243579|Fred Hutchinson Cancer Research Center|Asa Davis|206-667-5300|akdavis@fredhutch.org|
22415600|NCT00556673|Novartis Pharmaceuticals|Study Director|862-778-8300||
22415601|NCT01971554|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22415602|NCT00950300|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22415603|NCT03018925|Institut d'Investigació Biomèdica de Girona - Hosp Univ Dr Josep Trueta|MD PhD X Aldeguer|34972940200|xaldeguer.girona.ics@gencat.cat; abahi@idibgi.org|2401
22415604|NCT04388787|Virginia Commonwealth University|Olivier Rolin, MD, PhD|(804) 828-4230|olivier.rolin@vcuhealth.org|
22415605|NCT01800838|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Elma Baron|216-368-4971|elma.baron@uhhospitals.org|
22415606|NCT05186415|Nemours Children's Hospital, Delaware|Shannon Nees, MD|302-651-6600|shannon.nees@nemours.org|
22415607|NCT00851006|University of Utah|Douglas Kondo, M.D.|801-587-1549|doug.kondo@hsc.utah.edu|
22415608|NCT02129062|UT MD Anderson Cancer Center|Jan Burger, MD/ UT MD Anderson Associate Professor, Leukemia|713-794-4329|CR_Study_Registration@mdanderson.org|
22415609|NCT04662710|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22415610|NCT00968019|Johnson and Johnson Medical Iberia|Mayda Lopez-Belmonte, PhD|+34 91 7228481|tlopezbe@its.jnj.com|
22415611|NCT00224484|GlaxoSmithKline|GSK Response Center|866-435-7343||
22415612|NCT04489303|Photozig, Inc.|Bruno Kajiyama|6506947496|info@photozig.com|
22415613|NCT00108628|Philadelphia VA Medical Center|Dr. Richard Ross|(215) 823-4046|Richard.Ross2@va.gov|
22415614|NCT01453153|Halozyme Therapeutics|Dimitrios Chondros, M.D., Chief Medical Officer|858-794-8889|dchondros@halozyme.com|
22415615|NCT01196117|Medical College of Wisconsin|B. Tucker Woodson|414-805-7667|bwoodson@mcw.edu|
22415616|NCT03547635|Integra LifeSciences|Jessica Knowlton, Sr Mgr, Clinical Research & PMCF Strategy|609-325-0111|jessica.knowlton@integralife.com|
22415617|NCT03243396|Duke University|Kathryn Whetten, PhD, MPH|919-613-5313|k.whetten@duke.edu|
22415618|NCT02473393|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22415619|NCT02153723|Montefiore Medical Center|Aleksandra Djukic|718 920 4378|adjukic@montefiore.org|
22415620|NCT01149434|Huntsman Cancer Institute Unversity of Utah|Sunil Sharma, MD|801-585-0255|sunil.sharma@hci.utah.edu|
22415621|NCT02274558|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22415622|NCT01876953|City of Hope Medical Center|Ahmed Aribi|626-359-8111|aaribi@coh.org|
22415623|NCT00964353|University of Chicago|Dr David Meltzer|773-702-0836|dmeltzer@medicine.bsd.uchicago.edu|
22415624|NCT05996198|NYU Langone Health|Heidi Schambra, MD|212-598-6000|Heidi.Schambra@nyulangone.org|
22415625|NCT03542344|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22415626|NCT00059332|UCLA, David Geffen School of Medicine|Dr. Jeffrey Saver|310-794-6379|jsaver@mednet.ucla.edu|
22415627|NCT00287053|Pennington Biomedical Reseach Center|Corby Martin, Ph.D.; Assistant Professor|225-763-2585|martinck@pbrc.edu|
22415628|NCT00487695|Johns Hopkins University School of Medicine Division of Gastroenterology and Hepatology|Dr. Marcia Canto.|410-614-5388|mcanto@jhmi.edu|
22415629|NCT01358877|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22415630|NCT00397254|Clinvest|M.E. Beach|417-841-3618|mbeach@clinvest.com|
22415631|NCT05633862|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
22402407|NCT01729598|University of Kentucky|Dr. Gregory A. Jicha|859-323-5550|gregory.jicha@uky.edu|
22402408|NCT01041573|Valneva Austria GmbH|Senior Manager Clinical Research|+43 1 206 20|katrin.dubischar-kastner@valneva.com|1175
22402409|NCT02138578|University of Michigan Comprehensive Cancer Center|Dr. Daniel Spratt, M.D.|734-936-4300|sprattda@med.umich.edu|
22402410|NCT01632878|Mylan|Patrick Aubonnet / Medical Director||patrick.aubonnet@mylan.com|
22402411|NCT02698423|Geneva University Hospitals|Dr Manuela Viviano|07955 32 272|manuela.viviano@hcuge.ch|
22402412|NCT03634072|Children's Hospital of Philadelphia|Dr Mark Fogel|215-590-7566|fogel@chop.edu|
22402413|NCT01765764|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22402414|NCT00929578|Tufts Medical Center|Alice Gottlieb, MD PhD|617-636-7462|agottlieb@tuftsmedicalcenter.org|
22402415|NCT02307526|James J. Peters VA Medical Center|Jill M. Wecht|7185849000|jm.wecht@va.gov|3122
22402416|NCT00734409|Duke University Health System|DaiWai M Olson, PhD RN|(919) 668-3751|Olson006@mc.duke.edu|
22402417|NCT00064662|New England Research Institutes|Anne M. Stoddard, ScD|617-972-3331|astoddard@neriscience.com|
22402418|NCT03008590|VA Boston Healthcare System|Dr Paul Monach, Chief, Rheumatology Section|857-364-5552|Paul.Monach@va.gov|
22402419|NCT01713400|H. Lee Moffitt Cancer Center and Research Institute|Dr. Joseph Pidala|813-745-2556|joseph.pidala@moffitt.org|
22402420|NCT01165203|GlaxoSmithKline|GSK Response Center|866-435-7343||
22402421|NCT01323673|GlaxoSmithKline|GSK Response Center|866-435-7343||
22402422|NCT04907539|Redx Pharma Limited|Craig Tilston|+44 (0)7787 983 638|c.tilston@redxpharma.com|
22402423|NCT00051558|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22402424|NCT04067765|University of Kansas|Dr. Michael Amlung|785-864-0334|mamlung@ku.edu|
22402425|NCT02163993|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22402426|NCT01808118|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22402427|NCT02369835|Stanford University|Beth Beadle|650-723-6194|bbeadle@stanford.edu|
22402428|NCT00589888|Emory Univ SOM|Guillermo Umpierrez, MD|4047781665|geumpie@emory.edu|
22402429|NCT03041116|Retrophin, Inc.|Clinical Trial Information Desk|+1-877-659-5518|medinfo@retrophin.com|
22402430|NCT03097328|Dana Farber Cancer Institute|Bradley McGregor, MD|617-632-6328|Bradley_McGregor@DFCI.harvard.edu|
22402431|NCT02023164|TerSera Therapeutics LLC|Executive Director, Clinical Development|888 600 8116|jnorth@tersera.com|
22402432|NCT01675011|Boston Scientific|Anastasia Becker - Director of Clinical Trials|763-494-2170|Ana.Becker@bsci.com|
22402433|NCT01815333|UT MD Anderson Cancer Center|Haesun Choi, MD/ Professor, Abdominal Imaging Department|713-745-4693|hchoi@mdanderson.org|
22402434|NCT00750555|Geisinger|Office of Research Compliance|570-214-9628|orc@geisinger.edu|
22402435|NCT02880319|DFCI/BWH|Dr. Tracy Balboni|6177327948|tbalboni@bwh.harvard.edu|
22402436|NCT02983981|Psoriasis Treatment Center of Central New Jersey|Jerry Bagel Director of Clinical Trials|6094434500|dreamacres1@aol.com|
22402437|NCT01984346|AtriCure|Medical Director of Clinical Education|513-560-5974|SGaynor@atricure.com|
22402438|NCT03100942|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22402439|NCT01876732|Staten Island University Hospital|Suzanne El-Sayegh|718-226-6158|uviola@siuh.edu|
22402440|NCT00536731|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22402441|NCT00718419|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22402442|NCT00771407|LifeCell Corporation|Chief Medical Officer|908-947-1104|mfranz@lifecell.com|
22402443|NCT01883440|Umeå University|MD, PhD Krister Tano|0046705569043|krister.tano@umu.se|
22402444|NCT01405313|ResMed|Director Medical Affairs|+6128841000|adamb@resmed.com.au|
22402445|NCT01706549|Tampere University Hospital|MD Satu Pokkinen|+3583311611|Satu.pokkinen@pshp.fi|
22402446|NCT04126603|George Washington University|Sabyasachi Sen|202-994-8560|ssen1@gwu.edu|
22402447|NCT05374408|UNMC|Margaret Emerson|4025596625|margaret.emerson@unmc.edu|
22402448|NCT00879814|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22402449|NCT01005719|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22402450|NCT01753076|GlaxoSmithKline|GSK Response Center|866-435-7343||
22402451|NCT03450369|Naked Biome|Emma Taylor, MD CEO|626-260-1230|emma.t@nakedbiome.com|
22402452|NCT02641236|Dana-Farber Cancer Institute|Dr. Leslie Lehmann|617-632-4882|Leslie_Lehmann@DFCI.HARVARD.EDU|
22402453|NCT02985450|Carla Coffin|Dr.|403-220-7808|cscoffin@ucalgary.ca|
22402454|NCT00069576|GWU Biostatistics Center|Rebecca Clifton, Ph.D.|(301) 881-9260|rclifton@bsc.gwu.edu|
22402455|NCT00905307|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800-562-3924||
22402456|NCT05590793|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22402457|NCT04060667|Massachusetts General Hospital|Adeline Boatin|617 724 61320|adeline_boatin@mgh.harvard.edu|
22402458|NCT03015610|Duke University|Jason Lang, MD|919-684-3364|jason.lang@duke.edu|
22402459|NCT01603641|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22402460|NCT00114972|Boston Scientific|Nic Van Dyck / Senior Program Manager|+ 31 43 356 8328|vandyckn@bsci.com|
22402461|NCT01417780|Atox Bio, Ltd.|Wayne M Dankner, MD, Chief Medical Officer|1 919-219-6377|wayned@atoxbio.com|
22402462|NCT02086565|University of Pennsylvania|Andrea J Apter, MD|215 349-5120|andrea.apter@uphs.upenn.edu|
22402463|NCT01757704|Lunds University|Dr. Bansi Koul|+4646171649|bansi.koul@skane.se|
22415632|NCT00152451|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22402464|NCT00325442|United Therapeutics Corporation|Kevin Laliberte, PharmD; Senior Director, Product Development|919-425-8176|klaliberte@unither.com|
22402465|NCT02890329|Dana Farber Cancer Institute|Dr. Jacqueline Garcia|617-632-1906|Jacqueline_Garcia@dfci.harvard.edu|
22402466|NCT01035255|Novartis Pharmaceuticals|Study Director|862-778-8300||
22402467|NCT00584220|Vistakon|Kurt Moody, OD, FAAO|904-443-3088|kmoody1@its.jnj.com|
22402468|NCT01379534|Novartis|Study Director|862-778-8300||
22390167|NCT01355978|Clinical Research Consuting|Richard J. Morishige, MS, RRT|510-606-0374|rjmorishige@gmail.com|
22390168|NCT00837096|Acelity|VP, Global Clinical Affairs|210-255-5595|jane.hart@acelity.com|
22390169|NCT00721214|Massey Cancer Center|John M. McCarty, MD|804-828-4360|jmccarty@vcu.edu|
22390170|NCT00983905|Mutual Pharmaceutical Company, Inc.|Medical Affairs Director|215-697-1743|clinicaltrials@urlmutual.com|
22390171|NCT01169636|UT MD Anderson Cancer Center|Dr. Christopher Flowers, MD/ Chair, Chair, Lymphoma-Myeloma|713-745-6095|crflowers@mdanderson.org|
22390172|NCT02396953|Ipsen|Medical Director|Use email address below|clinical.trials@ipsen.com|
22390173|NCT00510198|Medtronic CRDM Clinical Research and Reimbursement|Clinical Trial leader|7635262788|ming.duanmu@medtronic.com|
22390174|NCT03018223|Moffitt Cancer Center|Nelli Bejanyan, MD|813-745-7208|Nellie.Bejanyan@moffitt.org|
22390175|NCT00494026|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22390176|NCT02466243|Corbus Pharmaceuticals, Inc.|Head of Clinical Operations|6179630100|info@corbuspharma.com|
22390177|NCT02149524|Samsung Bioepis Co., Ltd.|Director of Clinical Trials||sbregistry@samsung.com|
22390178|NCT00902226|H. Lundbeck A/S|Study Director|email contact via|LundbeckClinicalTrials@lundbeck.com|Lundbeck
22390179|NCT04765553|Swedish Orphan Biovitrum AB|Veronica Asnaghi|+41 61 508 72 13|Veronica.Asnaghi@Sobi.com|
22390180|NCT01885936|Duke University|Dwight Koeberl, M.D., Ph.D.|919-681-9919|dwight.koeberl@duke.edu|
22390181|NCT03214250|Parker Institute for Cancer Immunotherapy|Ute Dugan|203-379-6757|udugan@parkerici.org|
22390182|NCT02487251|Michigan State University|Holly E. Brophy-Herb, PI|517-355-3397|hbrophy@msu.edu|
22390183|NCT00321321|Gentofte Hospital, University of Copenhagen|Dr. Kasper Aaboe|+4539978474|Kasper@dadlnet.dk|
22390184|NCT02845375|Leiden University Medical Center|Dr Albert Dahan|+31715262301|a.dahan@lumc.nl|
22390185|NCT00397020|UCSD Medical Center|Dr. David Feifel|619-543-2485|dfeifel@ucsd.edu|
22390186|NCT02171130|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22390187|NCT01951261|Hospital Puerta de Hierro|Dra Patricia Mínguez Clemente|911916859|drapat3@gmail.com|
22402469|NCT00339079|Brigham and Women's Hospital|Arthur J. Barsky, MD|617-732-5236|abarsky@partners.org|
22402470|NCT01253460|The University of Texas MD Anderson Cancer Center|William G Wierda, MD/Professor|713-745-0428|wwierda@mdanderson.org|
22390188|NCT01372202|SKCCC|Ronan Kelly, MD|443-287-0005|rkelly25@jhmi.edu|
22390189|NCT04098497|University of Wisconsin - Madison|Amy Cochran|(608) 262-0772|cochran4@wisc.edu|
22390190|NCT03455218|Medical College of Wisconsin|Robert Niebler, MD|4142663360|rniebler@mcw.edu|
22402471|NCT00616239|UT Southwestern Medical Center at Dallas|Amit Pandya, M.D.|214-645-8300|amit.pandya@utsouthwestern.edu|
22390191|NCT03723915|Northwestern University, Feinberg School of Medicine|Devalingam Mahalingam MD, PhD Associate Professor, Division of Hematology and Oncology|312-695-6929|mahalingam@nm.org|
22390192|NCT03569475|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22390193|NCT02630706|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22390194|NCT00673127|Beth Israel Deaconess|Steven Balk|617-735-2065|sbalk@bidmc.harvard.edu|
22390195|NCT03039088|Rheumatology department, Cochin Hospital, APHP|Doctor Anna MOLTO|0158412617|anna.molto@aphp.fr|
22390196|NCT01212484|NYU Medical Center|Horacio Kaufmann, MD; director of Dysautonomia Center|212 263 7225|horacio.kaufmann@nyumc.org|
22390197|NCT00702273|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22390198|NCT00789399|Prairie Education and Research Cooperative|Chief Operating Officer|217 492 9104|jchambers@prairieresearch.com|
22390199|NCT02820298|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
22415633|NCT00897676|The Children's Hospital of Philadelphia|Diva DeLeon, MD|267-426-5529|deleon@email.chop.edu|
22415634|NCT00323258|Duke University Medical Center|Sara Calvert, PharmD|919-668-7540|sara.calvert@duke.edu|
22415635|NCT01728636|Northwestern University|Luanne Carabini MD|312-695-0061|l-carabini@northwestern.edu|
22415636|NCT01936662|IndianaU|Nicole Horn, MD|3179449981|ndhorn@hotmail.com|
22415637|NCT04473326|Brigham and Women's Hospital|Julie Lauffenburger, PharmD, PhD|617-525-8865|jlauffenburger@bwh.harvard.edu|
22415638|NCT02046122|Duke University|Anthony Sung, MD|919-668-1002|anthony.sung@duke.edu|
22415639|NCT04090658|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22415640|NCT00106106|NIH/National Institute on Alcohol Abuse and Alcoholism|Markus A. Heilig, M.D., Ph.D.|301-435-9386|mheilig@mail.nih.gov|
22415641|NCT01097694|Brigham and Women's Hopsital|Elliot Israel, MD|617-732-8110|eisrael@partners.org|
22415642|NCT02571634|Womack Army Medical Center|Michael Bartoszek, MD|910-907-6000|michael.w.bartoszek.mil@mail.mil|
22415643|NCT00668395|Indiana University School of Medicine|Zeruesenay Desta, PhD|317-274-2823|zdesta@iu.edu|
22415644|NCT00766493|W. L. Gore & Associates|Bryan Randall|(800) 437-8181|BRandall@WLGore.com|
22415645|NCT00024258|Memorial Sloan Kettering Cancer Center|Dr. Brian Kushner|212-639-6793|kushnerb@mskcc.org|
22415646|NCT01863433|Seqirus|Clinical Trial Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
22415647|NCT03950674|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22415648|NCT00193492|Sarah Cannon Research Institute|John Hainsworth MD|1-877-691-7274|asksarah@scresearch.net|
22415649|NCT00830167|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22390200|NCT01894256|AstraZeneca|Dr Anitra Fielding|+44 1625 582828|anitra.fielding@astrazeneca.com|
22390201|NCT03249272|Duke Cardiovascular Magnetic Resonance Center|Han Kim, MD|9196683539|han.kim@duke.edu|
22390202|NCT01478256|George John MD|George John|5028949757|grjohn777@yahoo.com|
22390203|NCT00645099|Janssen-Cilag Germany|EMEA Therapeutic Area Leader CNS|+492137955153||
22390204|NCT01201915|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
22390205|NCT02154516|Smith and Nephew|Clinical Study Manager|0499905851|stephanie.rufo@smith-nephew.com|+61
22390206|NCT03406507|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|1.855.752.2356|clinicaltrials@alexion.com|
22390207|NCT00663923|Tabriz University of Medical Sciences|Mohammad R sedghipour,MD|+98 411 3306619|sedghipm@yahoo.com|
22390208|NCT00966641|PLx Pharma|Ronald Zimmerman|1-713-842-1249|ron.zimmerman@plxpharma.com|205
22390209|NCT02319304|University of Maryland Medical Center|Caitlin Eggleston|4103287586|caitlineggleston@umm.edu|
22390210|NCT02316171|Viralytics|Mark Grose|+1 905 593 2891|Mark.Grose@viralytics.com|
22390211|NCT03859622|Karl Landsteiner Institute of General Medicine|Dr.med.Gustav Kamenski|+4322832226|kamenski@aon.at|
22390212|NCT01804140|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22390213|NCT01596699|University of California, San Francisco|Dr. Christopher Dvorak, MD|(415) 476-0554|Christopher.Dvorak@ucsf.edu|
22390214|NCT02785900|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
22390215|NCT00547300|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22390216|NCT04435522|Rhode Island Hospital|Philip Chan, M.D.|401-793-4859|philip_chan@brown.edu|
22390217|NCT02270463|Stemline Therapeutics, Inc.|Ira Gupta, MD, Senior Vice President, Clinical Development & Medical Affairs - Hematology|1-877-332-7967|clinicaltrials@menarinistemline.com|
22390218|NCT04990973|Columbia University Irving Medical Center|Dr. Marie-Pierre St-Onge|212-305-9379|ms2554@cumc.columbia.edu|
22390219|NCT00092521|Merck Sharp & Dohme Corp.|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22390220|NCT01878383|University of Alabama at Birmingham|David Kimberlin, MD|205.638.2530|DKimberlin@peds.uab.edu|
22390221|NCT03464383|Wake Forest University School of Medicine|Heidi M. Munger Clary, MD, MPH Associate Professor of Neurology|336-716-7110|hmungerc@wakehealth.edu|
22390222|NCT00560313|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22390223|NCT00605566|Princess Margaret Cancer Centre|Dr. Lillian Siu||lillian.siu@uhn.ca|
22415650|NCT03428945|Yale University|Dr. Kevan Herold|203-785-6507|Kevan.Herold@yale.edu|
22415651|NCT00982228|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22390224|NCT03449134|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22390225|NCT03475056|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
22390226|NCT02542410|BOSTON CHILDREN'S HOSPITAL|DR. AMY DIVASTA|6173556000|amy.divasta@childrens.harvard.edu|
22390227|NCT00113269|Astellas Pharma Global Development|Senior Medical Director||clinicaltrials@us.astellas.com|
22390228|NCT00837590|Indiana University|Dr. Kieren Mather|317-278-2187|kmather@iupui.edu|
22415652|NCT03231345|University Medical Center of Southern Nevada|Dr. Zitek|702-383-7885|zitek10@gmail.com|
22415653|NCT04841967|University of Illinois Chicago|Patricia Hershberger|3129961305|phersh@uic.edu|
22415654|NCT01801917|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22415655|NCT01924364|University of Pittsburgh Plastic Surgery|Danielle Minteer|412-383-4804|minteerdm@upmc.edu|
22415656|NCT00265785|SWOG Statistical Center|Study Statistician|206-667-4623||
22415657|NCT03919695|San Diego State University|Assist. Vice President Research Support Services|619-594-5938|rgulizia@sdsu.edu|
22415658|NCT04750239|Y-mAbs Therapeutics|Joris Wilms|+4570261414|clinicaltrials@ymabs.com|
22415659|NCT01912807|University of Saskatchewan|Andrea Vasquez Camargo|306 7660444|a.vasquez@usask.ca|
22415660|NCT02614196|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22415661|NCT01539239|Ivantis|Richard Hope|949-333-1310|rhope@ivantisinc.com|
22415662|NCT02179788|University of Cincinnati|Dr. Laurie Nommsen-Rivers|513-558-0461|laurie.rivers@uc.edu|
22415663|NCT00633022|GlaxoSmithKline|GSK Response Center|866-435-7343||
22415664|NCT03382041|The University of Alabama at Birmingham (UAB)|Dr. Clay Spitler|205-934-6413|caspitler@uabmc.edu|
22415665|NCT01374451|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22415666|NCT04640194|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22415667|NCT03201003|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
22415668|NCT00834613|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22415669|NCT00663234|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22415670|NCT03646162|Veru|Gary Barnette PhD CSO|9194263611|gbarnette@verupharma.com|
22415671|NCT00840840|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22415672|NCT01253564|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
22415673|NCT06891729|Next Life Sciences|Darlene Walley|415-407-5229|darlene.walley@nextlifesciences.org|
22415674|NCT04584983|The University of Texas Health Science Center at Houston|Lindsay F Holzapfel, MD, MS|713-500-6422|Lindsay.N.Fleig@uth.tmc.edu|
22415675|NCT05377489|Grünenthal GmbH|Grünenthal Clinical-Trials Helpdesk|000|clinical-trials@grunenthal.com|
22415676|NCT02061358|Emergent BioSolutions|Clinical Development Representative||ctgov@ebsi.com|
22415677|NCT00697619|Sun Yat-sen University Cancer Centre|Dr. Li Zhang|86-20-87343458(O)|zhangli6@mail.sysu.edu.cn|
22415678|NCT03093025|Taisho Pharmaceutical R&D Inc.|Taisho Pharmaceutical R&D Inc. Study Director|800-602-0203|ClinicalTrials@taisho-rd.com|
22415679|NCT05590039|Cynosure|Jamie Trimper|(201) 479-9612|jamie.trimper@cynosure.com|
22415680|NCT03403439|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22415681|NCT00559637|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22415682|NCT01109576|VHAPORHCS|Mitchel Turbin, PhD|503-220-8262|Bonnie.Becker@va.gov|
22415683|NCT01705717|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22415684|NCT02031237|University of Michigan Comprehensive Cancer Center|Dr. Yue Cao|(734) 936-8695|yuecao@umich.edu|
22415685|NCT02293460|LFB Biotechnologies|Clinical trial information desk|0033169827010|supportqcm@lfb.fr|
22415686|NCT00706719|Repros Therapeutics, Inc|Ronald Wiehle, PhD|281.719.3406|rwiehle@reprosrx.com|
22415687|NCT04225260|Galderma Research & Development|Galderma Research & Development|817-961-5000|clinical.studies@galderma.com|
22415688|NCT01074008|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
22415689|NCT00673764|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22415690|NCT02805309|Hebrew SeniorLife Marcus Institute for Aging Research|Dr. Dae Hyun Kim, Associate Scientist|617-632-5362|daehyunkim@hsl.harvard.edu|
22415691|NCT01636934|UT MD Anderson Cancer Center|Zhongxing Liao, MD/ Professor, Radiation Oncology Department|(713) 563-2300|zliao@mdanderson.org|
22415692|NCT03239496|FIDEC Corporation|Ricardo Rüttimann|+17863546335|rruttimann@fidec-online.org|
22415693|NCT00275275|University of Kansas Medical Center|Kelly E. Lyons, PhD|913-588-7159|klyons@kumc.edu|
22415694|NCT01474915|The Ohio State University Department of Anesthesiology|Andrew Otey|6142933559|Andrew.otey@osumc.edu|
22415695|NCT02339415|Hennepin Healthcare Research Institute|Jason Baker|612-873-2705|baker@umn.edu|
22415696|NCT01841736|UCSF Helen Diller Family Comprehensive Cancer Center|Emily Bergsland, M.D.|415-353-9888|emily.bergsland@ucsf.edu|
22415697|NCT03035890|WVCTSI|Tara Riddle|304-581-1829|tlr0011@hsc.wvu.edu|
22415698|NCT00003404|Dartmouth Hitchcock Medical Center|Richard J. Barth Jr., MD|(603) 650-9479|Richard.J.Barth.Jr@hitchcock.org|
22390229|NCT00835510|Taro Pharmaceuticals|Medical Director|(914) 345-9001|medical.affairs@taro.com|6427
22390230|NCT03864341|NYU Langone Health|Kelly Doran, MD, MHS|(212) 263-5850|Kelly.doran@nyulangone.org|
22390231|NCT01066936|Smith & Nephew|Tracey Brengola|978-319-2702|tracey.brengola@smith-nephew.com|
22390232|NCT01904136|Samer Srour, MD / Stem Cellular Transplantation Department|UT MD Anderson Cancer Center|713-794-4354|ssrour@mdanderson.org|
22390233|NCT00356993|Addictions Program|Dr. Peter Selby|416-535-8501|peter_selby@camh.net|77432
22390234|NCT01960348|Alnylam Pharmaceuticals, Inc.|Chief Medical Officer|866.330.0326|medinfo@alnylam.com|
22390235|NCT00853372|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22390236|NCT01580995|VAORD|Mary Jane Burton|6013624471|mary.burton2@va.gov|
22390237|NCT01811498|Northwell Health|John Boockvar, MD|212-434-3900|jboockvar@northwell.edu|
22390238|NCT02517528|AbbVie|Global Medical Services|800-633-9110||
22390239|NCT04298099|Baylor College of Medicine|Karla Wyatt-Thompson|8328245800|karla.wyatt@bcm.edu|
22415699|NCT04578132|An organization designated by the Sponsor|A person designated by the Sponsor|+34934344412|investigacion@mfar.net|
22415700|NCT05113563|NYSPI|Diana Martinez|646-771-7774|dm437@cumc.columbia.edu|
22390240|NCT02668198|Mayo Clinic|Dr. Michael B. Wallace|904-953-2221|wallace.michael@mayo.edu|
22415701|NCT05480800|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22415702|NCT04632641|Aurora Health Care|Dr. Mahmoud Ali|(262) 948-6630|mahmoud.ali@aah.org|
22415703|NCT01528293|Georgetown University Medical Center|Paul J. Kim, DPM, Director of Research, MGUH Center for Wound Healing and HBOT|202-444-3059|Paul.J.Kim@gunet.georgetown.edu|
22415704|NCT00377156|Mayo Clinic|Paul Brown, M.D.|507-538-0948|Brown.Paul@mayo.edu|
22415705|NCT00288704|Regeneron Pharmaceuticals|Doug Nadler, MS Statistics|914 345 7905|clinicaltrials@regeneron.com|
22415706|NCT00324896|UMDNJ - RWJMS|Matthew Menza, MD|732-235-4440|menza@umdnj.edu|
22415707|NCT00676650|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22415708|NCT01802216|University of California, San Francisco|Dr. Vanessa Grubbs|415-206-5649|Vanessa.Grubbs@ucsf.edu|
22415709|NCT00292591|Medical University of South Carolina|Dr. Carol Wagner|18437922112|wagnercl@musc.edu|
22415710|NCT02297841|Church & Dwight Co., Inc.|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
22415711|NCT05061992|University of Michigan|Dr. Elliot Tapper|734-647-9252|etapper@med.umich.edu|
22415712|NCT01833754|Amgen Inc.|Study Director|866-572-6436||
22415713|NCT01257581|Massachusetts General Hospital|Nazem Atassi, MD|617-643-1807|natassi@partners.org|
22415714|NCT01157234|University of Florida|Alfonso H. Santos Jr, M,D,|352-273-6374|Alfonso.santos@medicine.ufl.edu|
22415715|NCT03033134|Boston Scientific Japan|Yutaka Gomi|+81.3.6853.7500|Yutaka.Gomi@bsci.com|
22415716|NCT02212106|bioCSL PTY LTD|Clinical Program Director||bioCSL.ClinicalTrials@biocsl.com.au|
22415717|NCT02509260|Cleveland Clinic Foundation|Dr. David Liska|1-216-444-9219|liskad@ccf.org|
22415718|NCT01853371|Ministry of Health|Dr. Nouran Aleyeidi|00966504304577|dr.nouran@live.com|
22415719|NCT02518139|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
22415720|NCT02429583|The Rockefeller University|Aileen O'Connell, Laboratory Manager|212-327-7047|aoconnell@rockefeller.edu|
22415721|NCT01698554|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22415722|NCT02564016|Medical University of South Carolina|Laura L Roberts MD, Assistant Professor|843 792 2322|roberll@musc.edu|
22415723|NCT00751023|Medical University of South Carolina|Bryan K. Tolliver, MD PhD|843-792-4869|tollive@musc.edu|
22415724|NCT01742208|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22415725|NCT01547728|Mayo Clinic Rochester|Dr. William Oliver|507-255-4240|oliver.william@mayo.edu|
22415726|NCT02707276|McLean Hospital|Dr. Michael Rohan|617-855-3127|mrohan@mclean.harvard.edu|
22415727|NCT03448692|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22415728|NCT03711396|University of Colorado School of Medicine|Dr. Hillary D. Lum|303-724-1911|hillary.lum@cuanschutz.edu|
22415729|NCT02786927|GlaxoSmithKline|GSK Response Center|866-435-7343||
22415730|NCT01706263|GlaxoSmithKline|GSK Response Center|866-435-7343||
22415731|NCT02416934|West Virginia University Department of Orthopaedics|Dr. Sanford Emery|304-293-1170|semery@hsc.wvu.edu|
22415732|NCT00494013|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22415733|NCT03061903|Columbia University|Roshan P. Shah, MD|212-305-8193|rs3464@cumc.columbia.edu|
22415734|NCT03490227|Pennington Biomedical Research Center|Dr. Leanne Redman|225-763-0947|leanne.redman@pbrc.edu|
22415735|NCT01562613|Abbott|Taco Baardman||taco.baardman@abbott.com|
22415736|NCT02282722|Dana-Farber Cancer Institute|Dr. Deb Schrag|617-582-8301|deb_schrag@dfci.harvard.edu|
22415737|NCT00987480|Memorial Sloan Kettering Cancer Center|Dr. Farid Boulad|212-639-2429|bouladf@mskcc.org|
22415738|NCT00789776|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fredhutch.org|
22415739|NCT01337596|Eli Lilly Company|Chief Medical Officer|1-800-545-5979||
22415740|NCT02946255|Centre for Addiction and Mental Health|Dr. Sean Kidd|416-535-8501|sean.kidd@camh.ca|36295
22415741|NCT01994980|Denver Health|Dr Fredric Pieracci|303-436-4029|Fredric.Pieracci@dhha.org|
22415742|NCT01709903|Novartis Pharmaceuticals|Study Director|862-778-8300||
22415743|NCT00096460|The EMMES Corporation|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|221
22415744|NCT04771286|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22415745|NCT01751087|Planned Parenthood League of Massachusetts, Inc.|Principal Investigator|617.616.1600||
22415746|NCT00724958|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialDisclosure@merck.com|
22415747|NCT02459418|Fertility Biotech AG|Executive VP of Regulatory Affairs||maria.vazquez@fertilitybiotech.com|
22415748|NCT00653159|The University of Chicago Department of Health Studies, Biostatistics Laboratory|Dr. Sydeaka Watson, PhD|773-834-2378|swatson@health.bsd.uchicago.edu|
22415749|NCT01872715|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5000|elizabeth.nieman@galderma.com|
22415750|NCT03978598|UNM Obstetrics & Gynecology|Family Planning Research Team|505-205-4118|HSC-FamilyPlanningResearch@salud.unm.edu|
22415751|NCT00683592|PGxHealth, LLC|Director of Medical Affairs|203-786-3400||
22415752|NCT02814708|Biomedizinische Forschung & Bio-Produkte AG|Dr. Martha M. Eibl|+43-1-4081091|martha.eibl@meduniwien.ac.at|
22415753|NCT03303417|University of Nottingham|Robin Spiller|0115 823 1090|robin.spiller@nottingham.ac.uk|
22415754|NCT02697617|Indiana University School of Medicine|Dr. Sharon Moe|317 278 2868|smoe@iu.edu|
22415755|NCT02786719|Baylor College of Medicine|Sarah Whittle, MD MS|8328241471|whittle@bcm.edu|
22415756|NCT01578317|NIH|John Tsang|301-496-0304|tsangjs@mail.nih.gov|
22390241|NCT02202109|University of Miami|Dr. Erin Kobetz|3052436185|ekobetz@med.miami.edu|
22390242|NCT00467298|VA Puget Sound Health Care System-Seattle|Cynthia M. Dougherty|206 764 2205|cynthia.dougherty@va.gov|
22390243|NCT01268098|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22390244|NCT00665132|Bioness|Keith McBride, CTO|661-362-4866|Keith.McBride@bioness.com|
22390245|NCT04334668|Cleveland Clinic|Dr. W. H. Wilson Tang|216-444-2121|tangw@ccf.org|
22390246|NCT02416713|University of Pennsylvania|Dr. M. Kit Delgado|215-746-8256|Mucio.Delgado@uphs.upenn.edu|
22390247|NCT04156399|University of Illinois Chicago|Judith Schlaeger, PhD|3124134669|jschlaeg@uic.edu|
22390248|NCT03339271|Mayo Clinic|Dr. Joan Griffin|507-538-1490|griffin.joan@mayo.edu|
22390249|NCT01093599|University of Wisconsin|James M. Davis MD, Assistant Professor, Duke University|608-217-9405|jjamesdavis@hotmail.com|
22390250|NCT01703845|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22390251|NCT01644188|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22390252|NCT03756168|Venus Concept|Director of Clinical Affairs|888-907-0115|mgronski@venusconcept.com|
22390253|NCT01542398|Queen's University, Belfast|Dr Paul O'Callaghan|+44 7501 43 46 32|pocallaghan02@qub.ac.uk|
22390254|NCT04333732|Washington University School of Medicine in Saint Louis|Professor Michael S. Avidan|+1-(314)-273-2456|avidanm@wustl.edu|
22390255|NCT00248534|North American Brain Tumor Consortium|Lauren Abrey, MD|410-955-3657|jfisher@jhmi.edu|
22390256|NCT01222533|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22390257|NCT03834623|Moffitt Cancer Center|Nikhil Khushalani, MD|813-745-3437|Nikhil.Khushalani@moffitt.org|
22415757|NCT01848210|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22415758|NCT00381849|Mayo Clinic|Beverly Tietje, Study Coordinator|507-255-0401|tietje.beverly@mayo.edu|
22390258|NCT01947517|Queen's University|Dr. Stephanie Baxter|613 544 3310|baxters@baxtereyemd.com|
22415759|NCT02824640|Prisma Health|Megan Groome|864-382-1023|megan.groome@primsahealth.org|
22415760|NCT01504711|Barbara Ann Karmanos Cancer Institute|Dr. Philip A. Philip, M.D., Ph.D., F.R.C.P|(313)576-8624|philipp@karmanos.org|
22415761|NCT01765270|Duke Clinical Research Institute|L. Kristin Newby, MD, MHS|919-668-8805|kristin.newby@duke.edu|
22415762|NCT00517192|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22415763|NCT01775722|University of California, Irvine. Beckamn Laser Institute|J Stuart Nelson|9498247997|jsnelson@uci.edu|
22415764|NCT00329160|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22415765|NCT04501094|National Cancer Institute|Dr. Andrea B. Apolo|301-480-0536|andrea.apolo@nih.gov|
22415766|NCT02315261|Faculty of Medicine Siriraj Hospital|Dr.Mingkwan Wongyingsinn|66824197995|minkcheerful@hotmail.com|81
22415767|NCT05661344|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22415768|NCT05212948|Shionogi|Shionogi Clinical Trials Administrator Clinical Support Help Line|1-800-849-9707|Shionogiclintrials-admin@shionogi.co.jp|
22415769|NCT05347693|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22415770|NCT03167606|Columbia University|Dr. Rebecca Schnall, RN, MPH, PhD, Professor of Disease Prevention and Health Promotion (in Nursing)|212-342-6886|rb897@cumc.columbia.edu|
22390259|NCT00719212|Translational Research In Oncology (formerly CIRG)|Matthieu Rupin|+33 (1) 58 10 08 89|matthieu.rupin@trioncology.org|
22390260|NCT02028247|Baylor College of Medicine|Dr. Eric Storch|7137983579|eric.storch@bcm.edu|
22390261|NCT00004146|Adult Brain Tumor Consortium|Stuart A Grossman|410-955-3657|jfisher@jhmi.edu|
22390262|NCT00460564|GlaxoSmithKline|GSK Response Center|866-435-7343||
22390263|NCT01522703|Johns Hopkins University School of Medicine|Elizabeth Matsui, MD MHS|410-502-3858|ematsui@jhmi.edu|
22390264|NCT04140266|Hans Rosling Center for Population Health|Jen Balkus|260 616 6614|jbalkus@uw.edu|
22402472|NCT00878228|Hospital for Special Surgery|Dr. David Kim|212-606-1206|KimD@hss.edu|
22402473|NCT01558089|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22402474|NCT01597193|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22402475|NCT03595215|TheraNova|Clinical Research Associate|415-926-8616|akrajcevska@theranova.com|
22402476|NCT03184701|Albert Einstein Healthcare Netwrok|Manisha Verma|2154561026|vermam@einstein.edu|
22402477|NCT04073823|Tactile Medical|Michelle Wetherby|612.230.4576|mwetherby@tactilemedical.com|
22402478|NCT00590681|University of Chicago|Amanda Spratt|773-834-4031|aspratt@bsd.uchicago.edu|
22390265|NCT00943618|UT MD Anderson Cancer Center|Paul M. Cinciripini, BS,MS,PHD/Chair, Behavioral Science|(713) 745-1868|pcinciri@mdanderson.org|
22390266|NCT06142578|Kylane Laboratoires|Basste Hadjab, Sponsor|0225889611|compliance@kylane.com|
22390267|NCT03713281|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, OD, MS, FAAO- Sr. Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
22390268|NCT02624869|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22390269|NCT00329550|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22390270|NCT02994784|Boston Medical Center and BU School of Medicine|John M Sloan, MD|617-638-7519|mark.sloan@bmc.org|
22390271|NCT04867707|University of Missouri|Dr. Luis Martinez|(573) 882-3244.|martinezlemusl@umsystem.edu|
22390272|NCT03935932|University of Pittsburgh|Tim Corcoran, Associate Professor|4126922210|corcorante@upmc.edu|
22390273|NCT02637856|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22390274|NCT01649557|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22390275|NCT01011049|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22390276|NCT02815735|CooperVision Inc.|Senior Manager Global Medical Scientific Affairs|925 621-3761|javega@coopervision.com|
22390277|NCT00352053|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22390278|NCT02435381|Baylor College of Medicine|Christopher D. Verrico Ph.D.|713-791-1414|Cverrico@bcm.edu|26020
22390279|NCT01490359|University of Pennsylvania|Dr. John B. Jemmott III|215-573-9366|jjemmott@asc.upenn.edu|
22390280|NCT04150341|Theravance Biopharma US, Inc|Nathan Pfeifer|001 (650) 808-3711|npfeifer@theravance.com|
22390281|NCT00875615|University of Miami Sylvester Comprehensive Cancer Center|Lynn Feun MD|305-243-4981|lfeun@med.miami.edu|
22390282|NCT00405912|Mayo Clinic|Dr. Amit Sood|507-266-1944|nicotineresearch@mayo.edu|
22390283|NCT03713073|The University of Texas Health Science Center at Houston|Chun-Teh Lee, DDS, DMSc, MS|713-486-4384|Chun-Teh.Lee@uth.tmc.edu|
22390284|NCT03730662|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22390285|NCT00833898|University of Colorado Denver|Mark L. Laudenslager, PhD|303-724-9279|biel@ucdenver.edu|
22390286|NCT03993457|UTexasSouthwestern|Maria Monastirsky|214-648-0174|maria.monastirsky@utsouthwestern.edu|
22390287|NCT02209610|VAORD|Dr Markus Amann|801-582-1565|markus.amann@hsc.utah.edu|4358
22390288|NCT03082898|Vanderbilt University|Dr. Michael Goldfarb|615 343 6924|michael.goldfarb@vanderbilt.edu|
22390289|NCT02895360|Basilea Pharmaceutica International Ltd.|Thomas Kaindl, MD, Global Medical Director, Oncology|+41615671505|Thomas.Kaindl@basilea.com|
22390290|NCT00666198|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22390291|NCT05153499|Finch Therapeutics|CEO|617-229-6499|info@finchtherapeutics.com|
22390292|NCT04151706|Stanford University|Dr. Robert Lowsky|(650) 723-0822|rlowsky@stanford.edu|
22390293|NCT01960114|McNeil Consumer Healthcare|Rajesh Mishra, MD, PhD/Vice President, Medical/Clinical Affairs, Global OTC|215-273-8569 USA EST|rmishr16@its.jnj.com|
22390294|NCT00427778|Queen's University|Dr Marie-Andree Harvey|613-548-6115|harveym@queensu.ca|
22390295|NCT00225277|Takeda Global Research and Development Center Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
22390296|NCT03432650|Hospital for Special Surgery, Anesthesiology|Dr. Stephen Haskins|212-606-1036|haskinss@hss.edu|
22390297|NCT00735462|Graceway Pharmaceuticals|Robert Babilon, Vice President, Product Development|267-948-0400|robert.babilon@gracewaypharma.com|20428
22390298|NCT00591409|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22390299|NCT01340300|Dana-Farber Cancer Institute|Meyerhardt, Jeffrey,M.D.,M.P.H.|617-632-6855|Jeffrey_Meyerhardt@dfci.harvard.edu|
22390300|NCT01936324|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22390301|NCT05566886|Corsano Health B.V.|Clinical Research Manager|+31 61 640 7778|info@corsano.com|
22390302|NCT03226106|Eastern Colorado VA Medical Center|Cory Christiansen, PT, PhD|303-724-9101|cory.christiansen@cuanschutz.edu|
22390303|NCT04349644|Vanderbilt University Medical Center|Blythe Corbett, Ph.D.|(615) 936-0280|blythe.corbett@vumc.org|
22390304|NCT00702650|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22390305|NCT01309243|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22390306|NCT00661544|U.T. M.D. Anderson Cancer Center|Muzaffar H. Qazilbash, MD / Associate Professor|713-745-3458||
22390307|NCT00943722|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22390308|NCT01772823|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
22390309|NCT02176382|Massachusetts General Hospital|Dr. Joy Tsai|6177266723|jntsai@mgh.harvard.edu|
22390310|NCT01402063|Brown University Oncology Research Group (BrUOG)|Howard Safran, MD|4018633000|kayla_rosati@brown.edu|
22390311|NCT05109117|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
22390312|NCT03897049|dfusion, Inc|Tamara Kuhn, Vice President & Research Scientist|831-222-5003|tamara.kuhn@dfusioninc.com|
22390313|NCT03220776|Medical University of South Carolina|James J. Prisciandaro, Ph.D.|843-792-1433|priscian@musc.edu|
22390314|NCT04491006|Athira Pharma|Hans Moebius, CMO|1-866-725-0930|clinicaltrials@athira.com|
22390315|NCT02166047|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22415771|NCT00413049|Novartis Pharmaceuticals|Study Director|862 778-8300||
22415772|NCT01884844|Department of Psychiatry, Universtity of Massachusetts|Director of the Bipolar Disorders Specialty Clinic|508-334-5052|wendy.marsh@umassmemorial.org|
22415773|NCT00555893|Marshfield Clinic Research Foundation|Edward Belongia, MD|715-389-3783|belongia.edward@mcrf.mfldclin.edu|
22415774|NCT01286805|Hospital for Special Surgery|Dr. Jacques YaDeau|212-606-1206|yadeauj@hss.edu|
22415775|NCT01755975|Memorial Sloan Kettering Cancer Center|Dr. Steven Horwitz, MD|646-608-2680|horwitzs@mskcc.org|
22390316|NCT03192202|Columbia University Irving Medical Center (CUIMC)|Ahmed Sawas, MD|212-305-0591|as4386@cumc.columbia.edu|
22390317|NCT02541942|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22390318|NCT00451555|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22390319|NCT03430050|MUSC|Dr. Sherman|843-792-8174|shermanb@musc.edu|
22390320|NCT01004185|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22390321|NCT01376050|Regulatory Insight, Inc.|Clinical Consultant|615-712-9743|elvira@reginsight.com|
22390322|NCT02154477|SLU|sandeep dhindsa|314-977-4911|dhindsa@slu.edu|
22390323|NCT01388478|University of Kansas Medical Center|Jeffrey Burns, M.D., M.S.|913-588-0555|KUAMP@kumc.edu|
22390324|NCT01037413|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22390325|NCT01990664|Johnson & Johnson Vision Care, Inc.|Jurandir Araujo, Clinical Compliance Manager|9044431379|jaraujo7@its.jnj.com|
22390326|NCT00619983|Wake Forest School of Medicine|Dr. James Eisenach|336-716-4182|jimeisenach@gmail.com|
22390327|NCT01219777|The Ohio State University Comprehensive Cancer Center|Ritu Salani, MD, MBA|614-293-3873|Ritu.Salani@osumc.edu|
22390328|NCT01177137|Center for Clinical Trials and Evidence Synthesis, Johns Hopkins Bloomberg School of Public Health|Roberta W. Scherer, Director Data Coordinating Center|410 502 4636|rschere1@jhu.edu|
22390329|NCT04731675|AmMax Bio, Inc.|Dorothy Nguyen, MD|(650)285-6560|clinical@ammaxbio.com|
22431170|NCT05070819|Petrovsky NRCS|Dr. Artem Gubko|+79684241490|gubko@artvig.ru|
22402479|NCT01259297|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22402480|NCT00933335|GlaxoSmithKline|GSK Response Center|866-435-7343||
22402481|NCT02229864|Abbott Vascular|Latania Chura|503-935-3002|latania.chura@abbott.com|
22402482|NCT00170157|Mayo Clinic|Eugene D. Kwon||kwon.eugene@mayo.edu|
22402483|NCT02650284|Stryker|Alissa Connelly|+61294671000|alissa.connelly@stryker.com|1075
22402484|NCT04525222|Fred Hutchinson Cancer Center|Jaimee Heffner, Ph.D., Associate Professor|206.667.7314|jheffner@fredhutch.org|
22402485|NCT00509873|Allergan, Inc.|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com|
22402486|NCT00374907|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22402487|NCT03395340|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|Dr. Edward W. Cowen|301-827-2328|cowene@mail.nih.gov|
22402488|NCT00797459|Medicis|Ron Staugaard|480-291-5652|rstaugaard@medicis.com|
22402489|NCT01519570|The Ohio State University College of Pharmacy|Stuart Beatty|6146888466|beatty.52@osu.edu|
22402490|NCT04598165|Women and Infants Hospital of Rhode Island|Jennifer Unger, MD, MPH. Associate Professor, Department of Obstetrics and Gynecology|(401) 274-1122|jennifer_unger@brown.edu|48554
22402491|NCT00426751|GlaxoSmithKline|GSK Response Center|866-435-7343||
22402492|NCT01721408|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22402493|NCT04160468|ContraFect|Medical Director|914-207-2300|clinicalstudies@contrafect.com|
22415776|NCT03653026|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22415777|NCT05560555|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22415778|NCT02104817|AstraZeneca|AstraZenenca Information Center|1-877-240-9479|information.center@astrazeneca.com|
22415779|NCT00852917|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
22415780|NCT01312181|ResearchFMH|Dr. Efrat Aharonovich|646-774-7954|efrat.aharonovich@nyspi.columbia.edu|
22415781|NCT01597479|Hospital de la Santa Creu i Sant Pau|Dra. Mireia Rodriguez Prieto|677896054|mrodriguezpr@santpau.cat|
22415782|NCT02167594|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
22415783|NCT02340780|Canadian Cancer Trials Group|Bingshu Chen|613-533-2430|bchen@ctg.queensu.ca|
22415784|NCT03433703|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22415785|NCT03971578|Intelligent Hearing Systems|Dr. Rafael E. Delgado, Director of Research & Development|305-668-6102|redelgado@ihsys.com|
22415786|NCT03422068|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22415787|NCT01405469|University Hospital Hamburg-Eppendorf|Prof. Dr. Thomas Rösch, Principal Investigator|+49 40 7410 50098|t.roesch@uke.de|
22415788|NCT01583530|GlaxoSmithKline|GSK Response Center|866-435-7343||
22415789|NCT02416180|GlaxoSmithKline|GSK Response Center|866-435-7343||
22415790|NCT00640926|Melinta Therapeutics, Inc.|Sue Cammarata, MD|(203) 624-5606|scammarata@melinta.com|
22415791|NCT02985398|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
22415792|NCT01841073|Imperial College London|Prof Gary Frost|+44 (0)20 7594 0959|g.frost@imperial.ac.uk|
22415793|NCT04404907|Northwestern University|Dr. June Robinson|312-503-5941|june-robinson@northwestern.edu|
22415794|NCT02858037|International Partnership for Microbicides|Dr John Steytler|+27 21 860 2300|jsteytler@ipmglobal.org|
22415795|NCT01653405|Rand Corporation|Dr. Adam Rose|617-338-2059|arose@rand.org|8672
22415796|NCT03174158|Massachusetts General Hospital|Dr. Gina Kruse|6177243157|gkruse@partners.org|
22415797|NCT00283842|Wyeth|U.S. Contact Center||clintrialresults@wyeth.com|
22415798|NCT00550147|Indiana University School of Medicine|David W. Dunn, MD|317-944-8162|ddunn@iupui.edu|
22415799|NCT04320745|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22402494|NCT03987620|SCYNEXIS|Dr. David Angulo|(201) 884-5471|david.angulo@scynexis.com|
22442325|NCT00744042|Alexion Pharma GmbH|Alexion Pharma GmbH||ClinicalTrials@alxn.com|
22415800|NCT01282086|Abbott (Ukraine)|Global Medical Services|1-800-633-9110||
22415801|NCT02472639|Cedars Sinai Medical Center|Karen Zaghiyan, MD|310-289-9224|kzaghiyan@yahoo.com|
22415802|NCT00046839|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
22415803|NCT01181596|University of California - San Diego|Jae Kim, MD|619-543-3759|neojae@ucsd.edu|
22415804|NCT02050321|University of Arizona Cancer Center|Dr. Lee Cranmer|520 626-0501|lcranmer@uacc.arizona.edu|
22415805|NCT01176981|Hospital for Sick Children|Dr. Abha Gupta|14168137744|abha.gupta@sickkids.ca|
22415806|NCT04768114|Washington University School of Medicine|Alex T. Ramsey, Ph.D.|314-362-5370|aramsey@wustl.edu|
22415807|NCT02013050|Soligenix, Inc.|Dr. Richard Straube||rstraube@soligenix.com|
22415808|NCT01285076|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22415809|NCT00715676|Deltanoid Pharmaceuticals|Hector F. DeLuca, President and Chief Executive Officer|608-238-7710|info@deltanoid.com|
22415810|NCT03828539|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22415811|NCT02224053|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
22415812|NCT04720547|Wayne State University|Dr. Abdulghani Sankari|313-576-3548|atarbich@med.wayne.edu|
22415813|NCT02585245|ThedaCare|Lori Hartz MS, RDN Manager of Nutrition and Diabetes Education|920 831-5077|lori.hartz@thedacare.org|
22415814|NCT01898598|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22415815|NCT03833427|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22415816|NCT00176891|Masonic Cancer Center, University of Minnesota|Dr. Paul Orchard|(612) 626-2313|orcha001@umn.edu|
22415817|NCT01992874|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22415818|NCT02033317|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com|
22415819|NCT03294317|Medtronic CRM Clinical|Nonye Harcourt|6122421785|nonye.o.harcourt@medtronic.com|
22415820|NCT03847974|LIB Therapeutics|Evan A Stein MD PhD FACC|18596533141|estein@libtherapeutics.com|
22415821|NCT00591760|Federico II University|Prof. Antonio Cittadini|0039(0)817464375|antonio.cittadini@unina.it|
22415822|NCT00608634|Arizona Cancer Center|Steven P. Stratton, PhD|520-626-9295|sstratton@azcc.arizona.edu|
22415823|NCT00593827|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22415824|NCT03718039|Heron Therapeutics, Inc.|Vice President, Clinical Operations|858-251-7232|svisonneau@herontx.com|
22415825|NCT01833169|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22415826|NCT05467540|AORN Cardarelli|Dr. Prof. Mario Muto|+39800019774|mutomar2@gmail.com|
22415827|NCT04315272|UCSF FI Proctor Foundation|Dr Catherine Oldenburg|(415) 502-8843|catherine.oldenburg@ucsf.edu|
22415828|NCT06107036|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
22415829|NCT00804999|University of Iowa|Dr. Christine W. Sindt|319-356-2916|christine-sindt@uiowa.edu|
22415830|NCT04592419|Kodiak Sciences Inc.|Pablo Velazquez-Martin, MD|1 (650) 281-0850|ClinOps@kodiak.com|
22415831|NCT02252445|Keimyung university|Assistant professor|+821028862876|onidori1979@gmail.com|
22415832|NCT00623636|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
22415833|NCT05693805|BUCA School of Medicine, Psychiatry; Boston Veterans Administration|Barbara L Niles, PhD|857-364-4128|barbara.niles@va.gov|
22415834|NCT02943993|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22415835|NCT04254198|University of New Mexico Health Sciences|Janet Page-Reeves|505-272-1694|JPage-Reeves@salud.unm.edu|
22415836|NCT02152982|Mayo Clinic|Jann N. Sarkaria, MD|507-284-8227|Sarkaria.jann@mayo.edu|
22415837|NCT04968925|Johnson & Johnson Vision Care, Inc. (JJVC)|Ross Franklin, BAppSc-Optom|1-800-843-2020|RFRANKL1@its.jnj.com|
22415838|NCT00835796|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22415839|NCT00876265|Merz Aesthetics, Inc.|Merz Aesthetics, Inc.|650-286-4000|clinicaltrials@merzaesthetics.com|
22415840|NCT00264381|University of Oklahoma Health Sciences Center|Suman Rathbun MD,MS|405271-4742|suman-rathbun@ouhsc.edu|44773
22415841|NCT00695110|Clarus Therapeutics, Inc.|Robert E. Dudley, PhD, CEO and President|847-562-4300|rdudley@clarustherapeutics.com|
22415842|NCT03388502|Rush University Medical Center|Dr Philip Louie|2539069256|louie.philip@gmail.com|
22415843|NCT02919111|University of California, San Francisco|Dr. Thomas Hope, MD|(415) 221-4810|Thomas.Hope@ucsf.edu|22648
22415844|NCT02510261|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
22415845|NCT05431777|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22415846|NCT02780167|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22415847|NCT01470196|Dana-Farber Cancer Institute|Steven P. Treon, MD, PhD|617-632-2681|steven_treon@dfci.harvard.edu|
22415848|NCT02315066|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22415849|NCT02003222|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22415850|NCT03760003|ABIVAX|Fabio Cataldi|+33 (0) 1 53 83 08 41|clinicaltrials@abivax.com|
22415851|NCT04941768|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22415852|NCT01737619|M.D. Anderson Cancer Center|Pamela Soliman, MD|713-745-2352|psoliman@mdanderson.org|
22415853|NCT03302078|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22415854|NCT01886872|Ohio State University|Jennifer Woyach, MD|614-685-5667|jennifer.woyach@osumc.edu|
22415855|NCT05148299|Swedish Orphan Biovitrum AB|Medical Director|+4686972000|medical.info@sobi.com|
22415856|NCT02161549|MotusGI|Ravit Peled -Director of Clinical Trial|+972 (0)4 6214447|ravit@motusgi.com|203
22415857|NCT01957150|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22431171|NCT02607722|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
22431172|NCT04347538|Vanderbilt University Medical Center|Justin H. Turner, MD, PhD|615-343-8848|justin.h.turner@vumc.org|
22390330|NCT02367105|Michael E DeBakey VA Medical Center|Dennis T Villareal, MD|713-794-7156|dennis.villareal@va.gov|
22390331|NCT02560389|University of Wisconsin School of Medicine and Public Health, University of Wisconsin, Madison|Josh Cisler|608-263-6100|jcisler2@wisc.edu|
22390332|NCT02716298|CooperVision|Senior Manager Global Medical Scientific Affairs|925-621-3761|javega@coopervision.com|
22390333|NCT00713206|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
22390334|NCT01182103|Kaohsiung Chang Gung Memorial Hospital|Tiao-Lai Huang|886-7-7317123|a540520@adm.cgmh.org.tw|8753
22390335|NCT01114672|Winthrop University Hospital|Mary Schanler, Principal Investigator|5156639028|mschanler@winthrop.org|
22390336|NCT00827775|University of Texas Southwestern Medical Center|Peter Van Buren|214-645-8293|peter.vanburen@utsouthwestern.edu|
22390337|NCT03041701|National Cancer Institute|Dr. Christine Heske|240-760-6197|christine.heske@nih.gov|
22390338|NCT00812838|Baylor College of Medicine|Mohit Khera, MD|713-798-6593|mkhera@bcm.edu|
22390339|NCT01723514|Amgen Inc.|Study Director|866-572-6436||
22390340|NCT00297778|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22390341|NCT01547247|Digestive Diseases Center, Vítkovice Hospital, Ostrava, Czech Republic|Přemysl Falt MD|+420602689561|faltprem@centrum.cz|
22390342|NCT00802438|UW Madison|Gina Crisafi, BS|608-265-4554|gmc@medicine.wisc.edu|
22390343|NCT01281917|University of Wisconsin Carbone Cancer Center|Lymphoma Disease Oriented Team|608-265-5542|neils@wisc.edu|
22390344|NCT00583115|Indiana University|Ronald Mark Payne MD|317-278-6329|rpayne@iu.edu|
22390345|NCT01376297|Helsinn Healthcare SA|Head of Clinical Development|+41 91 9852121|marco.palmas@helsinn.com|
22390346|NCT02569632|Children's Hospital Oakland Research Institute (CHORI)|Dan Granoff, MD (Principal Investigator)|510-428-3000|dgranoff@chori.org|7640
22390347|NCT01678898|Protalix Ltd|Raul Chertkoff|+972-4-9028100|raul@protalix.com|
22390348|NCT00655083|Menarini Group- Clinical Research|Angela Capriati, Clinical research Director|+ 39-055 56809990|acapriati@menarini-ricerche.it|
22390349|NCT03083093|LUMC|F.A. Klok, MD PhD|003171 526 9111|f.a.klok@LUMC.nl|
22390350|NCT03106337|Massachusetts General Hospital|Antonia Stephen, MD||ASTEPHEN@PARTNERS.ORG|
22402495|NCT05128162|University of Michigan|Kevin Boehnke, PhD|734-998-6939|kboehnke@med.umich.edu|
22402496|NCT00370149|Riley Hospital for Children|Elaine G Cox, MD|317-944-7260|elmcox@iu.edu|
22402497|NCT01027910|Massachusetts General Hospital|Dr. Edwin Choy|617-724-4000|echoy@mgh.harvard.edu|
22402498|NCT03538652|National Institute on Drug Abuse (NIDA)|Dr. David Epstein|667-312-5092|david.epstein@nih.gov|
22402499|NCT06018350|Duke University|Kai Sun, M.D.|919-681-7417|kai.sun@duke.edu|
22402500|NCT04920084|Memorial Sloan Kettering Cancer Center|Dr. Urvi Shah, MD, MS|646-608-3713|shahu@mskcc.org|
22402501|NCT01096446|OSF Saint Francis Medical Center|Dr. Kamlesh Macwan|309-624-0611|kamlesh.s.macwan@osfhealthcare.org|
22402502|NCT00620321|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22402503|NCT01113398|Duke University Medical Center|Katherine B. Peters, MD, PhD|919-684-6173|katy.peters@duke.edu|
22402504|NCT02279524|Galmed Research and Development, Ltd.|Medical Director|+972.3.693.8448|clinicaltrial@galmedpharma.com|
22402505|NCT01043185|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22402506|NCT00924352|Vector Oncology (formerly Accelerated Community Oncology Research Network, Inc.)|Vice President of Scientific Affairs|901-435-5570|mwalker@vectoroncology.com|
22402507|NCT05137041|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22402508|NCT02433210|University of Missouri, Department of Medicine, Division of Nephrology|Dr. Madhukar Misra, MD|573 882-7993|misram@health.missouri.edu|
22402509|NCT03488472|University of Alabama at Birmingham (UAB)|Drexell Hunter Boggs, MD; Principal Investigator|(205) 934-3411|dboggs@uabmc.edu|
22402510|NCT02491437|Abbott|Erik van Leeuwen MSc, PMP|+31294479241|erik.vanleeuwen@abbott.com|
22402511|NCT00510224|UCSF|Charles J. Ryan, MD|415-353-9279|ryanc@medicine.ucsf.edu|
22402512|NCT04936724|University of Pennsylvania|Andrew Strasser Ph.D.|215-746-5788|strasse3@pennmedicine.upenn.edu|
22402513|NCT00414310|The University of Texas (UT) MD Anderson Cancer Center|Hagop Kantarjian, MD/Chair, Leukemia Department|713-792-7026|hkantarjian@mdanderson.org|
22402514|NCT03070730|Beth Israel Deaconess Medical Center|Dr. Roy Freeman|617-632-8454|rfreeman@bidmc.harvard.edu|
22402515|NCT01441440|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inuiries@pfizer.com|
22402516|NCT01993329|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22402517|NCT00883558|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|858-794-8889||
22402518|NCT03539458|Abbott Vascular Structural Heart|Reshma Rao, Principal Study Clinical Research Associate|651-756-2542|reshma.rao@abbott.com|
22402519|NCT05936385|Nemours Children's Health|Thao-Ly Phan, Associate Professor of Pediatrics|302-331-7342|tphan@nemours.org|
22402520|NCT02528500|W. L. Gore & Associates|Rimma Zakharyan|928 310 6961|rzakhary@wlgore.com|
22402521|NCT01163162|Indiana University|Dr. Rajiv Agarwal|317 988 2241|ragarwal@iu.edu|
22402522|NCT02750800|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22402523|NCT00643487|Upstate Medical University|Thomas V. Smallman|315-464-8618|smallmat@me.com|
22402524|NCT00972478|SWOG|Study Statistician|206-667-4623||
22402525|NCT04742907|Tsumura USA, Inc.|Yu Tanaka, Ph.D., MBA|609-799-2083|Tanaka_yuu@mail.tsumura.co.jp|
22402526|NCT01259856|Icahn School of Medicine at Mount Sinai|Dr. Ronald Hoffman|212-241-2296|ronald.hoffman@mssm.edu|
22402527|NCT00436969|DePuy Mitek|Aileen Michael|508.828.3337|amichae2@its.jnj.com|
22390351|NCT02551692|Duke University|Anthony DeVito, MD|919-684-1377|anthony.devito@duke.edu|
22390352|NCT02965599|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22402528|NCT03406104|Gensight Biologics|Magali TAIEL Chief Medical Officer|0762891252|mtaiel@gensight-biologics.com|
22402529|NCT00358917|Abbott|Medical Information Specialist|800-633-9110||
22402530|NCT00759473|MUSC|Dr. McRae-Clark|843-792-5216|mcraeal@musc.edu|
22402531|NCT03347617|Oregon Health and Science University|Amy Huddleston|5034942910|huddlesa@ohsu.edu|
22402532|NCT03958201|University of Washington|Research Coordinator|206-744-4634|ajames1@uw.edu|
22402533|NCT00772967|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22402534|NCT01732263|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22402535|NCT00231062|Acclarent|Laura England, Manager-Clinical Affairs|650-687-4466|lenglan1@its.jnj.com|
22402536|NCT00803244|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com|
22402537|NCT03321929|Lumicell|Jorge Ferrer, PhD|617-571-0592|jmferrer@lumicell.com|
22402538|NCT02991820|Nationwide Children's Hospital|Joseph D. Tobias, MD|6147224200|Joseph.Tobias@nationwidechildrens.org|
22402539|NCT00443430|University of Washington and Seattle Children's Hospital|Carol Wallace, MD Principal Investigator|206-987-2057|cwallace@u.washington.edu|
22402540|NCT00053846|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu|
22402541|NCT03880227|The University of Texas at Dallas|Hans Klein|8304562444|hans.klein@utdallas.edu|
22402542|NCT02815397|Northwestern University|Dr. R Karmali|312-695-6832|reem.karmali@northwestern.edu|
22402543|NCT02389946|BIOTRONIK, Inc|Amy Culley, Director of Vascular Intervention Clinical Studies|503-451-8034|amy.culley@biotronik.com|
22402544|NCT00085540|Adult Brain Tumor Consortium (ABTC)|Howard Fine, MD|410-955-8837|jfisher@jhmi.edu|
22390353|NCT00068718|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org|
22390354|NCT00230971|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22390355|NCT01431105|UC San Diego|Adriana Tremoulet|858-246-0012|atremoulet@ucsd.edu|
22402545|NCT01605396|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22402546|NCT01280123|Northwestern University|Tanya Simuni, MD||TSimuni@nm.org|
22402547|NCT00705224|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22402548|NCT03283163|VA Boston Healthcare System|Erica R. Checko (Scioli), PhD|857-364-5696|ericarose.scioli@va.gov|
22402549|NCT00237796|VA San Diego Healthcare System, San Diego|Eric Granholm, PhD|858-552-8585|egranholm@ucsd.edu|7768
22402550|NCT04238663|mAbxience Research SL|Susana Millan|+34917711500|susana.millan@mabxience.com|
22402551|NCT02566525|University of Kentucky College of Medicine|Dr. Joseph Zwischenberger, MD|859-323-6013|jzwis2@uky.edu|
22402552|NCT02149836|Icahn School of Medicine at Mount Sinai|Dr. James W. Murrough|212-241-6539|james.murrough@mssm.edu|
22402553|NCT01745627|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22402554|NCT04430582|Joslin Diabetes Center|Mary Elizabeth Patti, MD|6173091966|MaryElizabeth.Patti@Joslin.Harvard.edu|
22402555|NCT01770353|Ipsen Bioscience, Inc|Medical Director|See email|clinical.trials@ipsen.com|
22390356|NCT00951171|WIHRI|Andrew S Blazar, MD Principal Investigator|401-274-1122|ablazar@WIHRI.org|8461
22390357|NCT04130061|University of Utah|Vikas Sharma, MD|801-581-5311|vikas.sharma@hsc.utah.edu|
22390358|NCT03579680|University of Michigan|Ted Skolarus|Ph: (734) 845-3506|tskolarus@uchicago.edu|
22390359|NCT04267393|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22390360|NCT02917421|Weill Medical College|Dr.Silvia Formenti|212-746-3608|shc2043@med.cornell.edu|
22390361|NCT04396847|UNC-Chapel Hill|Christian Hendershot|(919) 962-5565|christian_hendershot@med.unc.edu|
22390362|NCT01932762|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22390363|NCT03469492|Yale School Of Medicine|Elizabeth Sanchez Rangel, MD|203-737-6067|elizabeth.sanchezrangel@yale.edu|
22390364|NCT01726049|University Hospital Groningen, NL|E.S. Hoendermis, MD, PHD|0031503616161|e.s.hoendermis@umcg.nl|
22390365|NCT02161406|University of Michigan DCC (SABER)|Dr. Cathie Spino|734-615-5469|spino@umich.edu|
22390366|NCT01343251|St John Hospital and Medical Center|Dr. Robert Provenzano|313-886-8787|Rprovenzano@scsp.net|
22390367|NCT06178718|TenNor Therapeutics (Suzhou) Limited.|TenNor|0512-86861990|info@tennorx.com|
22390368|NCT00320398|GlaxoSmithKline|GSK Response Center|866-435-7343||
22390369|NCT00624013|Charles Drew University of Medicine and Science|Diana Echeverry, MD, Principal Investigator|3235634800||
22390370|NCT02179853|UCSD|Dr. Adriana Tremoulet|858-246-0012|atremoulet@health.ucsd.edu|
22390371|NCT02041221|SPARC|Dr Shravanti Bhowmik|+91 22 66455645||
22402556|NCT00376688|The University of Chicago Comprehensive Cancer Center|Dr. Gini F. Fleming|773-702-6712|gfleming@medicine.bsd.uchicago.edu|
22390372|NCT00784147|TaiMed Biologics, Inc.|Stanley T. Lewis, Jr., MD|949-769-6543|stlewis@taimedbiologics.com|108
22390373|NCT03677245|University of Mississippi Medical Center|Dr. Meredith Flowers|662-386-5926|mmflowers@umc.edu|
22402557|NCT00074412|Statistical Center for HIV/AIDS Research and Prevention|Statistical Research Associate|2066677524|cherron@fhcrc.org|
22402558|NCT01847638|Toyos Clinic|Melissa Toyos|6153274015|mtoyos@toyosclinic.com|
22402559|NCT00392171|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22402560|NCT00028002|Radiation Therapy Oncology Group|Wendy Seiferheld||wseiferheld@acr.org|
22402561|NCT00539253|Johns Hopkins Hospital|Ihab R. Kamel, M.D. PhD|410-955-4567|ikamel@jhmi.edu|
22402562|NCT02561000|Tufts Medical Center|Athan Kuliopulos, MD, PhD|617-636-8482|athan.kuliopulos@tufts.edu|
22402563|NCT04889144|Fred Hutchinson Cancer Center|Megan Shen, Associate Professor|206-667-4172|mshen2@fredhutch.org|
22402564|NCT03430245|Candela Corporation|Director of Clinical Marketing|+1 949.246.7983|doranr@candelamedical.com|
22402565|NCT00610727|Alexza Pharmaceuticals, Inc.|Dave Hasegawa, VP, Device Development|650.947.7031|dhasegawa@alexza.com|
22402566|NCT03656926|Zambon S.p.A.|Enrica Bucchioni, M.D., PhD, Global Clinical Development Head|+39 02 665241|clinicaltrials@zambongroup.com|
22402567|NCT01428063|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22402568|NCT02534805|Virginia Commonwealth University|Dr. Jasmohan Bajaj|(804) 828-4060|jasmohan.bajaj@vcuhealth.org|
22402569|NCT02902172|St. Louis University|Dr. Jennifer Goldkamp|3149772200|jen.goldkamp@health.slu.edu|
22390374|NCT03596242|Wake Forest School of Medicine|Claudia L. Campos, MD|ccampos@wakehealth.edu|ccampos@wakehealth.edu|
22390375|NCT04912700|Beaumont Hospitals|Ahmit Bahl, MD|(248) 898-9111|ahmit.bahl@beaumont.edu|
22390376|NCT01508832|University of California San Francisco|Ronald D Miller, MD|415 476-9034|millerr@anesthesia.ucsf.edu|
22390377|NCT02973802|Apitope International|CEO|+44(0)1291 635511|info@apitope.com|
22390378|NCT00706914|AstraZeneca|Esther Garcia||ClinicalTrialTransparency@astrazeneca.com|
22390379|NCT01850823|Teva Pharmaceuticals Inc., USA|Director, PD/CE Studies|1-888-483-8279|usmedinfo@tevapharm.com|
22390380|NCT02601105|UC Davis Department of Dermatology|Raja Sivamani MD|916-703-5145|dermstudies@ucdavis.edu|
22390381|NCT00053352|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22390382|NCT04458181|University of Minnesota|Amy R. Krentzman|612-625-2312|akrentzm@umn.edu|
22390383|NCT00931918|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22390384|NCT00809341|Johns Hopkins Sidney Kimmel Cancer Center|Dr. Lode Swinnen|410-955-8603|lswinne1@jhmi.edu|
22390385|NCT02975297|The University of Texas Health Science Center at Houston|Luba Yammine, PhD, APRN, FNP-C, Associate Professor|(713) 500-2005|Luba.Yammine@uth.tmc.edu|
22390386|NCT03247738|University of Florida College of Medicine, Jacksonville|Dominick J. Angiolillo|9042443933|dominick.angiolillo@jax.ufl.edu|
22390387|NCT04081389|Roswell Park Comprehensive Cancer Center|Kristopher Attwood|716-845-1300|Kristopher.Attwood@roswellpark.org|
22390388|NCT00866918|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22390389|NCT00096681|Desmond Tutu HIV Centre|Prof LG Bekker|+2721 633 6599|Linda-Gail.Bekker@hiv-research.org.za|21
22390390|NCT00527514|Daiichi Sankyo|John Raia|(973) 630-2683|jraia@dsus.com|
22390391|NCT04148521|Atrium Health|Jason Roberge|7043550268|jason.roberge@atriumhealth.org|
22390392|NCT00920699|Johns Hopkins University|Christopher A. Ross M.D. Ph.D.|410-614-0011|caross@jhmi.edu|
22390393|NCT01530659|Neurotech USA, Inc.|Neurotech, Sr. Director of Clinical Operations|629-333-5804|p.davis@neurotechusa.com|
22390394|NCT02287883|University of California, Berkeley|Patricia Ramsay, Project Drector|(510)643-8063|pramsay@berkeley.edu|
22390395|NCT03416621|Duke Cancer Institute|Dr. Kathryn I Pollak|919-681-4757|kathryn.pollak@duke.edu|
22390396|NCT00096109|Barbara Ann Karmanos Cancer Institute|Elaina Gartner, M.D.|(425) 527-4398|egartner@seagen.com|
22390397|NCT04016805|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
22390398|NCT04491084|Albert Einstein College of Medicine|Dr. Nitin Ohri|718-405-8550|nitin.ohri@einsteinmed.edu|
22390399|NCT02101268|Sierra Oncology, a GlaxoSmithKline company|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22390400|NCT00740870|Medtronic|Karla Mezera|612-306-4325|karla.p.mezera@medtronic.com|
22390401|NCT02831998|Zurex Pharma, Inc.|Andrew Morgan|16082039090|amorgan@zurexpharma.com|
22390402|NCT00819013|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22390403|NCT03811834|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22390404|NCT00576823|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
22390405|NCT00839332|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22390406|NCT01200485|UT MD Anderson Cancer Center|Saroj Vadhan, MD/Professor, Cytokine & Supportive Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
22402570|NCT03196505|University of California-San Francisco Fresno|Dr. Pearl Ma|5592614500|pma@fresno.ucsf.edu|
22402571|NCT01773135|Ain Shams University Maternity Hospital|Mohamed Saied Eldein El-Safty, Lecturer of Obstetrics and Gynecology Faculty of Medicine - Ain Shams|01003922211|dr.mai_elshahm@yahoo.com|002
22402572|NCT02575079|Emory University|Elizabeth Stenger|404-785-1272|elizabeth.o'brien.stenger@emory.edu|
22415858|NCT01856192|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22402573|NCT02918266|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22402574|NCT01212172|UC Irvine Dermatology Research Center|Christopher B. Zachary|949 824 7103|czachary@uci.edu|
22402575|NCT00788775|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617.632.5053|Stephen_Hodi@dfci.harvard.edu|
22402576|NCT03796091|Green Counseling Services PLLC|Dr. Melinda Green|5154508913|drgreen@greencounselingservice.com|
22402577|NCT01293032|Virginia Commonwealth University/Massey Cancer Center|Harry D Bear, MD, PhD|804-828-9325|harry.bear@vcuhealth.org|
22402578|NCT01253044|VA San Diego Healthcare System and UCSD|Dr. Ariel Lang|858-246-0631|ajlang@ucsd.edu|
22402579|NCT02262039|Yale University|Dr. Sanjay Kulkarni|203-785-6501|sanjay.kulkarni@yale.edu|
22402580|NCT03116399|Weill Medical College of Cornell University|Sara J. Czaja, PhD|646-962-7141|sjc7004@med.cornell.edu|
22402581|NCT00987623|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22402582|NCT04488822|Daiichi Sankyo, Inc.|Clinical Director|908-992-6400|CTRinfo@dsi.com|
22402583|NCT03838367|CytoDyn|Joseph Meidling - Vice President, Clinical Operations|3609808524|jmeidling@cytodyn.com|
22402584|NCT00962000|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
22402585|NCT01016106|Northwestern University|Mandy Browning|312-695-6829|mandybrowning2015@u.northwestern.edu|
22402586|NCT00148733|University of Bergen|Tor A Strand|90971086|tor.strand@cih.uib.no|
22402587|NCT02005601|Hospital for Special Surgery|Dr. Jacques Yadeau|212-606-1206|yadeauj@hss.edu|
22402588|NCT04111276|University of Tennessee|Dr. Michael LaCour|865-974-7684|mlacour@utk.edu|
22402589|NCT02401555|Bio-Rad Laboratories|David Bhend|425 498 1758|david_bhend@bio-rad.com|
22402590|NCT00195260|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22402591|NCT02749721|Rush University Medical Center|Dr. John Zajecka|312-942-5592|John_Zajecka@rush.edu|
22402592|NCT02691247|Caladrius Biosciences|William Sietsema|9495352391|bsietsema@caladrius.com|
22402593|NCT04590937|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22402594|NCT01635933|Alcon Research, Ltd.|Sharon Holden Thomas, O.D., Sr. Principal Clinical Scientist|1-888-451-3937|alcon.medinfo@alcon.com|
22402595|NCT01544595|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22402596|NCT01929044|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22402597|NCT00554294|Research Institute of Child Nutrition, Dortmund|Dr. Mathilde Kersting|0049 231 79221013|kersting@fke-do.de|
22402598|NCT05022004|Sun Pharmaceutical Industries Limited|Head-Clinical Development|2266455645|clinical.trial@sunpharma.com|5689
22402599|NCT01461863|Dartmouth-Hitchcock|Dr. Charles Fordham von Reyn|6036505000|fvr@dartmouth.edu|8840
22402600|NCT02275026|Icahn School of Medicine at Mount Sinai|Dr. Joshua Mincer|(917) 922-9475|joshua.mincer@mountsinai.org|
22402601|NCT00878072|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22402602|NCT01704781|Bionor Pharma ASA|Maja Sommerfelt|+4723010960|ms@bionorpharma.com|
22402603|NCT02345642|Hospital for Special Surgery|Dr. Geoffrey Westrich|212-606-1510|ortizp@hss.edu|
22402604|NCT01618955|Antares Pharma Inc.|Jonathan Jaffe, MD; Vice President-Clinical Development|609-359-3020|jjaffe@antarespharma.com|324
22402605|NCT01200511|Alcon Research, Ltd.|Brand Lead, Surgical, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
22402606|NCT03288779|DukeUMC|Steven T Szabo|3524540101|steven.szabo@duke.edu|3524540101
22402607|NCT03382899|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979|www.ClinicalTrials.gov@lilly.com|
22402608|NCT00540722|Adult Brain Tumor Consortium (ABTC)|John Fiveash, MD|410-955-8837|jfisher@jhmi.edu|
22402609|NCT02504892|National Cancer Institute|Dr. Ramaprasad Srinivasan|301-451-2298|srinivasanr@mail.nih.gov|
22402610|NCT00524745|PATH|Kathleen Neuzil, Principal Investigator|206-285-3500|kneuzil@path.org|4864
22402611|NCT00576693|Medical University of South Carolina|Marc I. Chimowitz, MBChB|843-792-3020|mchimow@musc.edu|
22402612|NCT01413178|U.T. MD Anderson Cancer Center|Dr. Muzaffar H. Qazilbash / Stem Cell Transplantation and Cellular Therapy|713-745-3219|mqazilba@mdanderson.org|
22402613|NCT00540449|Janssen Infectious Diseases BVBA|Medical Leader||ClinicalTrialDisclosure@its.jnj.com|
22402614|NCT03643432|Oxford University Hospitals NHS FT|Jon Room|01865737526|jonathan.room@ouh.nhs.uk|
22402615|NCT00337467|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22402616|NCT03638947|UIOWA|Randy W. Loftus|6033066475|randy-loftus@uiowa.edu|
22415859|NCT00098475|ECOG Statistical Office|Study Statistician|617-632-3012||
22415860|NCT01194908|Emory University School of Medicine|Ruth O'Regan, MD|404-778-4824|roregan@emory.edu|
22390407|NCT03041298|Guerbet GmbH|Oliver Heine, MD, Radiology & Scientific Affairs Manager|+49 6196 76250|oliver.heine@guerbet-group.com|
22390408|NCT02132117|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22390409|NCT01564953|Aarhus University Hospital|Dr. Sarah Hashim Ali Hussein|0045 42660308|sarsuri@hotmail.com|
22390410|NCT04947436|University of Texas Health San Antonio|Dr. Donna Gardner|210-450-8479|dgardner62001@gmail.com|
22390411|NCT03719378|Colorado Joint Replacement|Rose Johnson, CCRP Research Lead|3032602940|roseannjohnson@centura.org|
22390412|NCT01643902|Johns Hopkins University School of Medicine|Victor C. Urrutia|410-955-2228|vurruti1@jhmi.edu|
22402617|NCT01187901|University of Utah|N. Jewel Samadder|801-213-4211|jewel.samadder@hsc.utah.edu|
22402618|NCT03141086|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22402619|NCT03017924|Cincinnati Childrens Hospital|Kim Foss|5136365971|kim.foss@cchmc.org|
22402620|NCT01128972|GlaxoSmithKline|GSK Response Center|866-435-7343||
22402621|NCT03607682|Vanderbilt University Medical Center|Teresa Melton|6159367423|teresa.melton@vumc.org|
22402622|NCT02574312|DePuy Ortho Joint US|Kirstin Cosgrove|800-827-7003|kcosgro1@its.jnj.com|
22402623|NCT02410902|Curemark|William E. Gannon, Jr MD, Medical Director|914-824-9716|william.gannon@curemark.com|
22390413|NCT01544309|Department of Cardiovascular Medicine, Faculty of Life Sciences, Kumamoto University|Hisao Ogawa, Ph.D; Study Chair|+ 81 963735175|ogawah@kumamoto-u.ac.jp|
22402624|NCT01881620|Institut Bergonié, Medical Imaging Department|Dr. Anne-Laure Cazeaux, Nuclear physician|05.56.33.78.60|A.cazeaux@bordeaux.unicancer.fr|
22402625|NCT01429792|Hoffman-La Roche|Medical Communications|8008218590|genentech@druginfo.com|
22402626|NCT01380106|Boston VA Research Institute, Inc.|Nikhil C. Munshi, M.D.|6176325607|nikhil.munshi@dfci.harvard.edu|
22402627|NCT04149899|Bausch & Lomb Incorporated|Clinical Development|949-416-1194|kevin.kerr@bausch.com|
22402628|NCT02078882|University of California Davis|Christopher L Bowlus|9167348696|clbowlus@ucdavis.edu|
22390414|NCT03078751|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22390415|NCT06135675|TenNor Therapeutics (Suzhou) Limited.|TenNor|0512-86861990|info@tennorx.com|
22390416|NCT02515097|Bausch Health Americas, Inc.|Director of Clinical Operations|1-510-259-5284|aloncaric@bauschhealth.com|
22390417|NCT01196741|University of Glasgow|Prof Iain McNeish, Professor of Gynaecological Oncology|+44 (0)141 330 3968|iain.mcneish@glasgow.ac.uk|
22390418|NCT03030599|Jazz Pharmaceuticals|Director, Clinical Trial Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
22390419|NCT00356759|McMaster University|Dr. Sam Schulman|19055270271|schulms@mcmaster.ca|44810
22390420|NCT01592383|University of Chicago|Hedy Kindler|7737020360|hkindler@medicine.bsd.uchicago.edu|
22390421|NCT04582864|Washington University School of Medicine|Dr. Matthew Christopher|314-273-0286|christopherm@wustl.edu|
22390422|NCT01064856|AbbVie|Global Medical Services|800-633-9110||
22390423|NCT02133131|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
22390424|NCT05329402|Fengh Medical Co., Ltd.|Jiao Liu|13815132106|jiao.liu@fulbrightmed.com|
22390425|NCT01679613|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22390426|NCT03735147|Imperial College London|Dr Paul Turner|+44 20 3312 7754|p.turner@imperial.ac.uk|
22390427|NCT00509925|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22390428|NCT02868788|State University of NY at Buffalo|Paresh Dandona|7165351852|dandona@buffalo.edu|
22390429|NCT02799745|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22390430|NCT02210208|Mölnlycke Health Care|Global Clinical Research Director|+46 31 722 30 00|info@monlycke.com|
22390431|NCT00695136|Pediatrics & Developmental Neuroscience Branch, NIMH|Susan E. Swedo, MD|301-496-5323|swedos@mail.nih.gov|
22390432|NCT01333111|Novo Nordisk A/S|Global Clinical Regstry (GCR, 1452)||clinicaltrials@novonordisk.com|
22390433|NCT01929876|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22390434|NCT01468077|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22390435|NCT05446714|al-azhar university|dr. mohamed shendy|01223303833|Shendy_ortho@azhar.edu.eg|
22390436|NCT03024996|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22390437|NCT02742532|University of California, San Francisco|Jennifer Mitchell, PhD|510-985-3921|jennifer.mitchell@ucsf.edu|
22390438|NCT02418845|Lupin Pharmaceuticals Inc|Gregory Kaufman, MD|908.603.6062|gregorykaufman@lupin.com|
22390439|NCT00478647|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22390440|NCT04333147|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22402629|NCT01457118|Nektar Therapeutics|Study Director|415-482-5300|medicalaffairs@nektar.com|
22390441|NCT00487552|MED Institute, Inc.|Scott Snyder, Ph.D., Manager, Biostatistics and Data Management, Senior Statistician|765-463-7537|ssnyder@medinst.com|
22402630|NCT02324842|University of Texas Health San Antonio|Eugenio Cersosimo, MD|210-358-7220|cersosimo@uthscsa.edu|
22402631|NCT00630812|Pharmaxis|Brett Charlton|02 94547210|Brett.Charlton@pharmaxis.com.au|
22402632|NCT01554956|Kedrion SpA|Clinical Trial Manager|+39 05831969231|a.lotti@kedrion.com|
22402633|NCT05761444|Organon Korea Co. Ltd|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
22402634|NCT05610176|BIOTRONIK SE & Co. KG|Director Clinical Project Management|+49 30 68905|mathias.freudigmann@biotronik.com|0
22402635|NCT00216099|Hoosier Cancer Research Network|Jeff Smith|317-921-2050|jsmith@hoosiercancer.org|
22402636|NCT00850759|UAB|David Schwebel|205-934-8745|schwebel@uab.edu|
22402637|NCT00578864|BAYLOR|Peter Zage, MD|832-824-4615|pezage@txch.org|
22402638|NCT01087528|Givenimaging|Hilla Debby/Director of clinical affairs|972490977740|hila.debby@givenimaging.com|77740
22402639|NCT01226420|Dana-Farber Cancer Institute|Corey S. Cutler, MD, MPH, FRCP(C)|617-632-5946|cscutler@partners.org|
22402640|NCT02868216|Cardiologia (Institute of Cardiology of Rio Grande do Sul/University Foundation of Cardiology|Dra Marcia Moura Schmidt|5551 32333600|mmoura22@terra.com.br|3765
22402641|NCT00938327|GlaxoSmithKline|GSK Response Center|866-435-7343||
22402642|NCT01425190|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22402643|NCT00904826|Mayo Clinic|Dr. Sean J. Pittock|507-284-4741|pittock.sean@mayo.edu|
22402644|NCT02552355|Colorado State University|Manager of Research Operations|9704912242|Laurie.Biela@colostate.edu|
22402645|NCT01519245|University of Saskatchewan|Dr. Kelsey Brose, Primary Investigator|306-655-1483|kelsey.brose@saskcancer.ca|
22402646|NCT05309369|Medical University of South Carolina|Professor|843 367 4260|mintzerj@musc.edu|
22402647|NCT02873715|University at Buffalo|Leonard H. Epstein, PhD, SUNY Distinguished Professor|716-829-3400|lhenet@buffalo.edu|
22402648|NCT00668525|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|Carl Gommoll, MS|201-427-8000|carl.gommoll@frx.com|
22402649|NCT02144220|University of Rochester|Ray Dorsey, MD|585-275-0663|ray.dorsey@chet.rochester.edu|
22402650|NCT01254396|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22402651|NCT00592501|Massachusetts General Hospital|Annie W. Chan, MD|617-726-5184|AWCHAN@PARTNERS.ORG|
22402652|NCT02084134|Washington University School of Medicine|Dr. Julie Silverstein|314-747-7006|jsilverstein@wustl.edu|
22402653|NCT04333433|Santen, Inc.|Edith van Dijkman|+31683667357|edith.vandijkman@santen.com|
22402654|NCT02026271|Alaunos Therapeutics|Jaymes Holland|6502732627|jholland@alaunos.com|
22402655|NCT02807454|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22402656|NCT01585129|WashingtonU|Dr. Anthony Shanks|3179448182|ashanks@iupui.edu|
22402657|NCT05468086|Cedars-Sinai Medical Center|Omer Liran, MD, MSHS|31042333754|omer.liran@cshs.org|
22402658|NCT01108809|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22402659|NCT01293396|Medical University of Graz|Dr. Norbert Tripolt|0316385|norbert.tripolt@medunigraz.at|78038
22402660|NCT04072237|Catalyst Biosciences|Howard Levy, Chief Medical Officer|+1.650.266.6871|hlevy@catbio.com|
22402661|NCT04985773|Infraredx, A Nipro Company|Priti Shah|781-345-9646|pshah@infraredx.com|646
22402662|NCT00001262|National Institute of Child Health and Human Development|Kaler, Stephen G|+1 301 451 6034|kalers@mail.nih.gov|
22402663|NCT00783705|Mayo Clinic Rochester|Paul J. Limburg, M.D., M.P.H.|507-284-2511|limburg.paul@mayo.edu|
22402664|NCT02200458|Christie Medical Holdings, Inc.|Clinical Affairs Manager|901-721-0330|christiemedinfo@christiedigital.com|
22402665|NCT00748540|MED-EL Corporation|Allison Racey, AuD|888-633-3524|allison.racey@medel.com|
22402666|NCT04743635|Revelle Aesthetics, Inc.|Rachel Walsh, Senior Manager of Clinical Affairs|6509634498|rwalsh@revelleax.com|
22402667|NCT02379923|Asahi Intecc USA, Inc.|Robert Ricker|408.429.3749|robertr@asahi-intecc.com|
22402668|NCT00804193|Perrigo|Jonathan Schwartz|718-960-0119|jonathan.schwartz@perrigo.com|
22402669|NCT01193348|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|clinicaltrials@alxn.com|clinicaltrials@alxn.com|
22402670|NCT00968253|The University of Texas (UT) MD Anderson Cancer Center|Marina Konopleva, MD, PHD/Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
22402671|NCT00390364|Sidney Kimmel Comprehensive Cancer Center at JHMI|Manuel Hidalgo, MD (no longer works at Hopkins)|410-502-5328|tbrown55@jhmi.edu|
22402672|NCT02488759|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22402673|NCT03860844|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22402674|NCT04624932|University of British Columbia|Dr. Mariana Brussoni|604-875-3712|mbrussoni@bcchr.ubc.ca|
22402675|NCT01678807|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22402676|NCT05281523|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22402677|NCT04038255|University of Miami|Dr. Taghrid Asfar|+1 (901)-371-7229|tasfar@miami.edu|
22402678|NCT05183867|Center for Healthy Minds|Simon Goldberg|(608) 265-8986|sbgoldberg@wisc.edu|
22402679|NCT05306873|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22402680|NCT01953328|Amgen Inc.|Study Director|866-572-6436||
22402681|NCT03300752|Columbia University School of Nursing|Dr. Maureen George|2123051175|mg3656@cumc.columbia.edu|
22402682|NCT01755195|National Cancer Institute|Dr. Alice Chen|240-781-3274|chenali@mail.nih.gov|
22402683|NCT05113953|Otsuka Pharmaceutical Development & Commercialization, Inc.|Clinical Transparency|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22402684|NCT03499808|SWOG Statistics and Data Management Center|Adam Rosenthal|206-652-9711|adamr@crab.org|
22402685|NCT02340819|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22402686|NCT01328249|Eisai Inc.|Eisai Medical Information|1-888-422-4743|esi_oncmedinfo@eisai.com|
22402687|NCT03331666|Columbia University Irving Medical Center|Dr. Nan Wang|212-342-1761|nw30@cumc.columbia.edu|
22402688|NCT02326467|Boston Children's Hospital|Celeste Chandonnet|781-216-0050|celeste.chandonnet@childrens.harvard.edu|
22402689|NCT00434512|GlaxoSmithKline|GSK Response Center|866-435-7343||
22402690|NCT02405429|University of Iowa|Edward F. Bell, MD|319-356-4006|edward-bell@uiowa.edu|
22402691|NCT04467164|Massachusetts General Hospital, Harvard Medical School|Jill M. Goldstein|617-724-3776|jill_goldstein@hms.harvard.edu|
22402692|NCT01998581|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com|
22402693|NCT00255684|Wake Forest|Gordon L. Phillips|604.875.4111|gophilli@wakehealth.edu|67806
22402694|NCT03463941|Duke School of Nursing|Cherie Conley|2166597128|cherie.conley@duke.edu|
22402695|NCT02273050|AstraZeneca|Eva Johnsson, MD, PhD|46 31 7762484|Eva.Johnsson@astrazeneca.com|
22402696|NCT02273752|Emory University|R. Donald Harvey, PharmD|404-778-1900|donald.harvey@emory.edu|
22402697|NCT00903032|VA ECHCS|P. Michael Ho|720-857-5115|Michael.Ho@va.gov|
22402698|NCT05619172|SOTIO Biotech a.s.|Richard Kapsa|(+420) 2241 74448|kapsa@sotio.com|
22402699|NCT01763905|Amgen Inc.|Study Director|866-572-6436||
22402700|NCT04346628|Stanford University|Yvonne A. Maldonado, MD|(650) 723-5682|bonniem@stanford.edu|
22402701|NCT03165721|National Cancer Institute|Dr. John Glod|240-760-6194|john.glod@nih.gov|
22402702|NCT01263691|Emergent BioSolutions|Dr. Robert Hopkins|(301) 944-0136|hopkinsr@ebsi.com|
22402703|NCT01202227|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22402704|NCT01894477|Fred Hutchinson Cancer Research Center|Eileen J Sickle|206-271-7066|esickle@fredhutch.org|
22402705|NCT02424955|Stanford University|Lucas Kas Vitzthum|(650) 498-6000|ccto-website@stanford.edu|
22402706|NCT01533935|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22402707|NCT02251704|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22402708|NCT00681538|GW Pharma Ltd|Richard Potts, Clinical Operations Director|+44 1353 616600|rp@gwpham.com|
22402709|NCT00069095|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22402710|NCT01434472|Fred Hutchinson Cancer Research Center|Dr. Ajay Gopal|206-606-2037|agopal@uw.edu|
22402711|NCT00818324|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22402712|NCT00138034|Radboud University Medical Center Nijmegen|Professor Doctor F.W.A. Verheugt|+31(0)24-3614533|f.verheugt@cardio.umcn.nl|
22402713|NCT01727713|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
22402714|NCT02389816|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22402715|NCT01842308|Mayo Clinic|Suzanne R. Hayman, M.D|(855) 776-0015|hayman.suzanne@mayo.edu|
22402716|NCT01594476|Oregon Health & Science University|Dr. Maureen Baldwin, MD MPH|(503) 494-9762|schaum@ohsu.edu|
22402717|NCT03161678|University of Maryland, School of Medicine|Joshua P. Lewis, PhD|410-706-5087|jlewis2@som.umaryland.edu|
22402718|NCT00752609|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22402719|NCT05114590|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22402720|NCT00850460|The Rockefeller University Center for Clinical and Translational|Principal Investigator|212 327-8408|trinnamaningatmd@yahoo.com|
22402721|NCT02773914|Göteborg University|Isabelle Andersson Hammar|+4631 786 5719|isabelle.a-h@neuro.gu.se|
22402722|NCT03007953|Department of Veterans Affairs|Dr. Lynn F. Reinke|206-277-4186|Lynn.Reinke1@va.gov|
22402723|NCT01556633|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22402724|NCT02224846|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22402725|NCT02615717|University of Nebraska, Lincoln|Christina Hein, M.A.|7036184722|chein9@gmail.com|
22402726|NCT00872170|New England Research Institutes|Nancy Gee|617-972-3295|ngee@neriscience.com|
22402727|NCT01402284|National Cancer Institute|Dr. Dickran Kazandijian|301-480-8870|kazandijiandg@mail.nih.gov|
22402728|NCT03302416|Univesity of Pittsburgh|Rajesh Narendran|412-647-5176|narendranr@upmc.edu|
22402729|NCT01613014|NIAAA|Megan Ryan, Clinical Program Director|3014434225|mryan1@mail.nih.gov|
22415861|NCT01685008|MorphoSys AG|Medical Information|+1 844 667-1992|medinfo@morphosys.com|
22402730|NCT05319535|Durham VA Medical Center|Courtney H Van Houtven, PhD|919-286-6936|courtney.vanhoutven@va.gov|
22402731|NCT00905021|Baylor College of Medicine|Dr. Mothaffar Rimawi|713-798-1311|rimawi@bcm.edu|
22402732|NCT00786838|Johnson & Johnson Pharmaceutical Research and Development, L.L.C.|Senior Medical Director|1 908 704-5779||
22402733|NCT04937816|Boehringer Ingelheim, Call Center|Boehringer Ingelheim|018002430127|clintriage.rdg@boehringer-ingelheim.com|
22402734|NCT00436215|National Cancer Institute|Dr. Christina Annunziata|301-402-7189|annunzic@mail.nih.gov|
22402735|NCT05513053|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22402736|NCT05299983|UC San Diego|Andrea LaCroix|(858) 822-0627|alacroix@ucsd.edu|
22402737|NCT04491877|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22402738|NCT02614287|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22402739|NCT00418834|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22402740|NCT02429258|AstraZeneca, PLL|Sergey Zhuplatov MD, PhD|215-542-3222|sergey.zhuplatov@astrazeneca.com|
22402741|NCT00554463|NRG Onocology|Wendy Seiferheld||wseiferheld@nrgonology.org|
22402742|NCT00492856|SWOG Statistical Center|SWOG Leukemia Committee Statistician|206-667-4408||
22402743|NCT03987919|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22402744|NCT01915108|assistant professor|Dr. Sangjin Park|82-53-620-3366|apsj0718@naver.com|
22402745|NCT01520324|Cosmo Pharmaceuticals NV|Dr. Richard Jones|+353 18170370|RJones@cosmopharma.com|
22402746|NCT03470922|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22402747|NCT02626819|Manhattan Campus of the VA NY Harbor Healthcare System|Melanie Jay, MD MS|212-686-7500|melanie.jay@va.gov|5097
22402748|NCT01247220|Retina Associates of Florida|Ivan J. Suner, MD|813-875-6373|ivansuner@gmail.com|
22402749|NCT00502307|AVEO Pharmaceuticals, Inc.|Chief Medical Officer|857-400-0101|Clinical@aveooncology.com|
22402750|NCT00748553|Huntsman Cancer Institute|Kimberlee Taylor|8012135673|Kimberlee.Taylor@hci.utah.edu|
22402751|NCT02330549|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22402752|NCT02094872|Yale University|Manuel Avedissian, M.D.|203-737-3669|manuel.avedissian@yale.edu|
22402753|NCT00495495|Indiana University School of Dentistry|Domenick T. Zero, DDS MS Principal Investigator|317-274-8822|dzero@iupui.edu|
22402754|NCT00423085|Novartis Pharmaceuticals|Study Director|862-778-8300||
22402755|NCT04253834|Emory University|Dr. Jeffrey Miller|404-252-6104|jeffrey.miller@emory.edu|
22402756|NCT02750813|Alcon, A Novartis Division|Franchise Head, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22402757|NCT02245568|TauRx Therapeutics Ltd|Dr. Diane Downie|+44 1224440905|info@taurx.com|
22402758|NCT00441441|GlaxoSmithKline|GSK Response Center|866-435-7343||
22402759|NCT02713230|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-397-2467|MedInfo@pacira.com|
22402760|NCT04549597|Ardelyx|David Rosenbaum|6175134929|drosenbaum@ardelyx.com|
22402761|NCT04009096|University of Oxford|Dr. Angela Minassian|01865611425|angela.minassian@ndm.ox.ac.uk|
22402762|NCT00450372|UM/Sylvester Comprehensive Cancer Center|Lynn Feun MD|305-243-4909|lfeun@med.miami.edu|
22402763|NCT00769704|Amgen, Inc.|Study Director|866-572-6436||
22402764|NCT00520676|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22402765|NCT05131451|Johns Hopkins University|Dr. Risa Wolf|4109556463|rwolf@jhu.edu|
22402766|NCT00335504|Mayo Clinic|Dr. Paul Limburg|507-266-9093|limburg.paul@mayo.edu|
22402767|NCT01487668|Department of Veterans Affairs, VA Ann Arbor Healthcare System|Amy M. Kilbourne, PhD, MPH|734-845-3452|amy.kilbourne@va.gov|
22402768|NCT01835496|ApoPharma Inc.|Caroline Fradette, PhD|416-401-7543|cfradett@apopharma.com|
22402769|NCT04426825|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22402770|NCT03000309|Skin Sciences, PLLC|M. McAllister|5024519000|mmdermresearch@yahoo.com|
22402771|NCT02145299|Yale School of Medicine|Dr. Alexandra Lansky|203-737-2142|alexandra.lansky@yale.edu|
22402772|NCT03161938|Rigshospitalet|Kristin steinthorsdottir|31666112|kjs@dadlnet.dk|
22402773|NCT04341675|University of Cincinnati|Nishant Gupta, MD|513-558-4861|Nishant.Gupta@uc.edu|
22402774|NCT03298412|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22402775|NCT03226223|New York State Psychiatric Institute|Dr. Jermaine Jones|6467746113|jermaine.jones@nyspi.columbia.edu|
22402776|NCT03456713|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22402777|NCT00300469|Abbott|Medical Information Specialist|800-633-9110||
22402778|NCT01217190|Par Pharmaceutical|Medical Affairs|1-800-828-9393|DrugInfo@strativapharma.com|
22402779|NCT03196297|Novo Nordisk A/S|Clinical Transparency and Medical Writing (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22415862|NCT01321177|Northwell Health|Patricia Marcy|347-439-8035|pmarcy@northwell.edu|
22415863|NCT03720704|W. L. Gore & Associates|Austin Phillips|+1 928 864 3641|agphilli@wlgore.com|
22415864|NCT01963260|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22415865|NCT02340962|TaiGen Biotechnology Co., Ltd.|Li-Wen Chang|+886-2-8177-7020|lwchang@taigenbiotech.com|1227
22415866|NCT04994431|UMass Memorial Health Care|Feiran Lou|5083348996|feiran.lou@umassmemorial.org|
22402780|NCT01943864|GlaxoSmithKline|GSK Response Center|866-435-7343||
22402781|NCT03230175|TissueTech, Inc.|Nick McCoy, Vice President Clinical Operations|7867340023|nmccoy@tissuetechinc.com|
22402782|NCT02213198|UTHSCSA|Dr. Dawn Velligan|210-567-5508|velligand@uthscsa.edu|
22402783|NCT01954121|UCB Cares|UCB (Study Director)|+1 887 822 9493||
22402784|NCT00601523|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22415867|NCT01837537|Medtronic|Michael Luna-Victoria|303 305 2463|michael.luna-victoria@medtronic.com|
22415868|NCT00936351|Roudebush VA Medical Center|Louanne W. Davis PsyD|317-988-4523|louanne.davis@va.gov|
22415869|NCT01540045|Instituto Nacional de Cancerología de México|Dr. Oscar Arrieta|5628-0400|ogarrieta@gmail.com|832
22415870|NCT01341405|CrystalGenomics, Inc|Sang-Yoon Lee, M.D.|82-31-628-2871|sang-yoon.lee@cgxinc.com|
22390442|NCT03119688|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22390443|NCT00630552|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
22390444|NCT01084239|Massachusetts Genderal Hospital Biostatistics Center|Pearl Zakroysky|617 724 0309|pzakroysky@partners.org|
22390445|NCT05006417|UW School of Medicine and Public Health|Michael Suer, MD|(608) 265-3207|suer@rehab.wisc.edu|
22390446|NCT02705625|Medivir|Linda Basse, Cheif Medical Officer|+46 8 546 831 00|linda.basse@medivir.com|
22390447|NCT00863798|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22390448|NCT04238520|The Ohio State University|Dr. Xi Chen, Associate Professor|614-2920474|chen.13047@osu.edu|
22390449|NCT01470599|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22390450|NCT00195442|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22390451|NCT01917006|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22402785|NCT04415489|University of North Carolina at Chapel Hill|Sarah Moustafa, MD|919-908-0000|sarah_moustafa@med.unc.edu|
22402786|NCT01987986|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquires@endo.com|
22402787|NCT03342469|American University|Dr. Kathleen Holton|(202) 885-3797|holton@american.edu|
22402788|NCT05515601|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22402789|NCT02928406|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22402790|NCT01745393|Temple University|Bradley Collins|215-204-2849|collinsb@temple.edu|
22402791|NCT03929588|EyeQue|VP Science and Technology|5104558168|noam.sapiens@eyeque.com|
22402792|NCT02678780|Kapadi|Start Up Unit|+34961452190|maria.rocasalbas@kapadi.com|
22402793|NCT02100748|Trevena, Inc.|Kelly Arscott|6103548840|karscott@trevena.com|
22402794|NCT01064648|SWOG Statistics & Data Management Center|SWOG statistician|2066674263|jmiao@fredhutch.org|
22402795|NCT05513391|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22402796|NCT02429427|Imperial College London|Prof Charles Coombes|+44 20 7594 2135|c.coombes@imperial.ac.uk|
22402797|NCT00719732|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22402798|NCT01686503|Eastern Virginia Medical School|Dr. Stephanie Troy|757-446-8999|troysb@evms.edu|
22402799|NCT00309777|Kowa Research Europe, Ltd.|Neil Hounslow|01189229004|nhounslow@kowa.co.uk|
22402800|NCT02775760|Boston University Chobanian & Avedisian School of Medicine|Karin Schon, Ph.D.|(617) 358-2118|kschon@bu.edu|
22402801|NCT01760993|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22402802|NCT05138783|Alcon Research, LLC|Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22402803|NCT04710862|Syracuse University|Dr. Soren Lowell|315-443-9615|slowell@syr.edu|
22402804|NCT02361762|Boston Children's Hospital|Dr. Susan Faja|617-919-4108|susan.faja@childrens.harvard.edu|
22402805|NCT03813719|Imperial College London|Dr Diana Marcus|07525133957|d.marcus16@imperial.ac.uk|
22402806|NCT00948818|Forest Research Institute|Paul F.C. Eng Ph.D Director, Clinical Development|201-427-8071|Paul.Eng@frx.com|
22402807|NCT00745368|University of Rochester|Robert DiCenzo|518 694 7228|rob.dicenzo@acphs.edu|
22402808|NCT01156597|University of Miami Miller School of Medicine|Armando J. Mendez, Ph.D.|305-243-5342|a.mendez@miami.edu|
22402809|NCT02364947|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials||CL_OPCJ_RDA_Team@otsuka.jp|
22402810|NCT02702518|University of Illinois Chicago|Dr. Sandeep Jain|312-996-4476|jains@uic.edu|
22402811|NCT00853489|Saint Louis University|Dr. Lisa Kaye Cannada|3145778850|LCannada@slu.edu|7
22402812|NCT01392989|Stanford University|Everett Meyer, Assistant Professor of Medicine (Blood and Marrow Transplantation)|650) 725-5816|evmeyer@stanford.edu|
22402813|NCT01251276|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22402814|NCT02728258|NRG Oncology|Linda Gedeon on behalf of Virginia Filiaci, PhD.|716-845-1169|gedeonl@nrgoncology.org|
22402815|NCT01725152|Marinus Pharmaceuticals, Inc.|Marinus|484-801-4670|clinicaltrials@marinuspharma.com|
22402816|NCT00849121|University of Wisconsin Carbone Cancer Center|Dr. Douglas McNeel|608-265-8131|dm3@medicine.wisc.edu|
22402817|NCT02420223|Medical College of Wisconsin|Dr. Jennifer Knight|866-680-0505|jknight@mcw.edu|
22402818|NCT01826422|IMSS|Dr. Maricela Rodriguez-Cruz|5256276900|maricela.rodriguez.cruz@gmail.com|. 22483
22402819|NCT04263142|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22402820|NCT00812916|Biosense Webster, EMEA|Nathalie Macours|+32 2 7463076|MNathalie@its.jnj.com|
22402821|NCT03010423|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22402822|NCT01351077|Indiana University School of Medicine|Aaron E. Carroll, MD, MS|3172789616|aaecarro@iu.edu|
22402823|NCT03568539|Innovent Biologics (Suzhou) Co., Ltd.|YiBo|+8613382419112|jessica.yi@innoventbio.com|
22402824|NCT03484923|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
22390452|NCT02158247|The Catholic University of Korea|Dr. Oh Saecheol|+88-42-220-9046|oscane0822@gmail.com|
22390453|NCT02190552|Neuravi Limited|Mairsil Claffey|0035391394123|mclaffey@neuravi.com|
22390454|NCT01057251|Forest Research Institute|Manfred Stapff, MD, PhD|201-427-8000|manfred.stapff@frx.com|8686
22390455|NCT02509312|Beth Israel Deaconess Medical Center|John J. Kowalczyk, MD|617-667-3112|jkowalcz@bidmc.harvard.edu|
22390456|NCT04544865|Ethicon Endo-Surgery|SENIOR DIRECTOR OF CLINICAL AFFAIRS|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22390457|NCT03357471|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22402825|NCT03439748|UCLA|Dr. Michelle G. Craske|(310) 825-8403|mcraske@mednet.ucla.edu|
22402826|NCT01856595|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22402827|NCT00458406|CTRC, Children's Hospital of Philadelphia|Paul R. Gallagher, MA|215-590-2739|gallagherp@email.chop.edu|
22402828|NCT01863849|Fluart Innovative Vaccines Ltd|Zsolt Németh|+3620|info@fluart.hu|4197020
22402829|NCT02012608|University of Arkansas for Medical Sciences|Beth Scanlan|501-686-8274|bscanlan@uams.edu|
22402830|NCT04402008|Assertio Holdings|Howard Franklin, MD|224 419 7106|Hfranklin@assertiotx.com|
22402831|NCT00913978|Northwestern University|Meltem Yilmaz, MD|312-695-0061|m-yilmaz@northwestern.edu|
22402832|NCT04716933|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22402833|NCT01327651|Fred Hutchinson Cancer Research Center|Maoji Li (Statistical Research Associate)|2066676035|mli2@fredhutch.org|
22402834|NCT03249792|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22402835|NCT01071044|Rochester Center for Behavioral Medicine|Joel L. Young, MD|248-608-8800|jyoung@rcbm.net|261
22415871|NCT02760433|R-Pharm|Maria Lemak, Scientific Advisor|0074959567937|lemak@rpharm.ru|1408
22415872|NCT02151149|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22390458|NCT01848067|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Jianqing Lin|(215) 955-8874|jianqing.lin@jefferson.edu|
22390459|NCT01202409|UT MD Anderson Cancer Center|Dr. Michael J Overman/ Professor, GI Medical Oncology|713-745-4317|moverman@mdanderson.org|
22390460|NCT01940523|Hospital for Special Surgery|David Mayman MD|212.774.2024|maymand@hss.edu|
22390461|NCT01732926|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22390462|NCT01271036|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, Sr. Specialist|928-277-0715|jhauze@its.jnj.com|
22390463|NCT01649505|Oregon Health and Science University|Dr. Juliana Hansen|503-494-4834|hansenju@ohsu.edu|
22390464|NCT00496626|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22390465|NCT02314104|St. Barnabas Medical Center|Dr. Eric Liberman|917-696-1370|eliberma@montefiore.org|
22390466|NCT02482935|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22390467|NCT03503162|Motus GI|Director of Clinical Operations|954-541-8000|anniec@motusgi.com|
22390468|NCT02835092|Medifast|Linda Arterburn, VP Scientific & Clinical Affairs|443-379-5191|linda.arterburn@medifastinc.com|
22390469|NCT00025506|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22390470|NCT02856490|Joylux|Colette Courtion|206.219.6444|sophia@joylux.com|
22390471|NCT01532635|Thomas Jefferson University|Neal Flomenberg, MD|215-955-8874|Neal.Flomenberg@jefferson.edu|
22390472|NCT00394589|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22390473|NCT04074343|Chao Family Comprehensive Cancer Center, University of California, Irvine|Chao Family Comprehensive Cancer Center, University of California, Irvine|1-877-UC-STUDY|ucstudy@uci.edu|
22390474|NCT01537185|Comprehensive Clinical Development Northwest|Dr. Royce Morrison|206 285 3500|ckeech@path.org|
22390475|NCT04672798|University of Pittsburgh|Dr. Stephanie Stepp|412-715-5447|steppsd@upmc.edu|
22402836|NCT03909763|Peking University People's Hospital|Dr. Xiaohui Zhang, Director of Clinical Trials|86-10-88324577|zhangxh@bjmu.edu.cn|
22415873|NCT00057941|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
22415874|NCT04721145|Johns Hopkins Medicine|Dr. Risa Wolf|410-955-6463|rwolf@jhu.edu|
22415875|NCT03419962|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22415876|NCT05653362|Indiana University School of Medicine|Claire Edelman|3176509107|ceedelma@iu.edu|
22415877|NCT03439085|UT MD Anderson Cancer Center|Dr. Michael Frumovitz, Chief Patient Experience Ofc, Ofc of Chief Operating Officer|(713) 792-9599|mfrumovitz@mdanderson.org|
22415878|NCT01499160|University of Maryland Baltimore Greenebaum Cancer Center|Michelle Medeiros|410-328-1160|mmedeiros@umm.edu|
22415879|NCT02361736|Tianjin Medical University General Hospital|Dr. Yuanyuan Zhang|13821685913|doctorkelly@126.com|
22415880|NCT01438476|UT MD Anderson Cancer Center|Dr. Jean-Nicolas Vauthey,MD/Professor, Surgical Oncology|713- 792-2022|jvauthey@mdanderson.org|
22415881|NCT02911935|Washington University School of Medicine.|Dr. Avraham Beigelman|314-454-2694|beigelmana@wustl.edu|
22415882|NCT00603512|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22415883|NCT04979858|Georgia Institute of Technology|Dr. Sundaresan Jayaraman|404.894.2461|sundaresan.jayaraman@gatech.edu|
22415884|NCT04253236|Immunovant, Inc|Central Study Contact|1-800-797-0414|clinicaltrials@immunovant.com|
22415885|NCT01896505|Karyopharm Therapeutics Inc|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
22415886|NCT03259789|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
22415887|NCT02063217|Washington University School of Medicine|Dr. Brendan Lucey|314-362-4342|luceyb@wustl.edu|
22415888|NCT00889252|Vistakon|Brian Pall OD MS FAAO|904-443-1290||
22415889|NCT04291508|Massachsetts General Hospital|PETAL Network Coordinatine Center PI, B. Taylor Thompson, MD|617 872-2882|tthompson1@mgh.harvard.edu|
22402837|NCT01409031|University of Colorado, Denver|John Kinsella, MD|303-724-2853|John.Kinsella@ucdenver.edu|
22402838|NCT00532948|Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22402839|NCT00995345|ActivX Biosciences|Dr. Diane Plotkin, Sr. Director Clinical Development|858-558-5558|dianep@activx.com|
22402840|NCT02913222|Washington University School of Medicine|Marcie Harris-Hayes, PT, DPT, MSCI, Professor, Physical Therapy and Orthopaedic Surgery|314-286-1435|harrisma@wustl.edu|
22402841|NCT00809458|UNM Cancer Center|Richard Lauer, MD|505-925-0390|rlauer@salud.unm.edu|
22402842|NCT02509598|Cardinal Health 414, LLC|Director, Regulatory & Medical Affairs|6147570226|npsmedicalaffairs@cardinalhealth.com|
22402843|NCT01201798|Alcon Research, Ltd.|Head, Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
22402844|NCT04272216|Clinical Project Manager|Paige Gowen|908-208-3749|paige.gowen@terumomedical.com|
22415890|NCT03566238|Albireo AB|Patrick Horn, MD, PhD|+1 (857) 378- 2035|medinfo@albireopharma.com|
22415891|NCT02710591|EspeRare Fondation|Florence Porte-Thomé|22 794 4004|porte.florence@esperare.org|+41
22415892|NCT04235660|Indiana University School of Medicine|Paul Haste|317-944-5005|phaste@iu.edu|
22415893|NCT01120691|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22415894|NCT00268762|University of Texas Health Science Center at Houston|Andrew D. Barreto, MD|713-500-7002|andrew.d.barreto@uth.tmc.edu|
22415895|NCT00089973|GlaxoSmithKline|GSK Response Center|866-435-7343||
22415896|NCT02627001|San Antonio Military Medical Center|Dr. Michael D. April|(210) 916-0808|Michael.D.April@post.harvard.edu|
22415897|NCT03297541|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|2257632500|amanda.staiano@pbrc.edu|
22415898|NCT02528409|University of Chicago|Dr. Jon E. Grant|773-834-1325|jongrant@uchicago.edu|
22415899|NCT01321697|University of Arkansas for Medical Sciences|Sandy Annis|5016868274|amannis@uams.edu|
22415900|NCT01049581|ChangGungMH|Dr Chia- Ling Chen|886-3-3281200|clingchen@gmail.com|3846
22415901|NCT00493792|Mayo Clinic, Rochester, MN|Emilee Andersen, M.A., Clinical Research Coordinator|507-266-9807|andersen.emilee@mayo.edu|
22415902|NCT00685035|University of Minnesota School of Medicine|Dr. Robert Kempainen|612-873-6413|kempa001@umn.edu|
22415903|NCT02076776|Cleveland Clinic|Dr. Jay Alberts|216 445-3222|albertj@ccf.org|
22415904|NCT02426541|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
22415905|NCT00745134|M D Anderson Cancer Center|Dr. Jillian Gunther|832-710-7864|JGunther@mdanderson.org|
22415906|NCT00784979|Tampa General Hospital|Dr. John Leone|813-844-5666|jpleone@tgh.org|
22415907|NCT01114997|Cedars Sinai Medical Center|Dr. Roya Yumul|310-423-1682|Roya.Yumul@cshs.org|
22415908|NCT00894933|American Medical Systems|Laura Olson, Clinical Project Manager|952-930-6428|laura.olson2@bsci.com|
22415909|NCT04241133|Montana State University|Dr. Carmen Byker Shanks|406-994-1952|cbykershanks@montana.edu|
22402845|NCT03521687|Icahn School of Medicine at Mount Sinai|Ingrid Sanabria-Gonzalez|212-523-3812|ingrid.sanabria@mountsinai.org|
22415910|NCT01503333|Michigan State University College of Nursing|Dr. Lorraine Robbins|517-353-3011|Lorraine.Robbins@hc.msu.edu|
22415911|NCT00468208|Vasculitis Clinical Research Consortium|Carol A Langford, MD MHS|216-445-6056|langfoc@ccf.org|
22415912|NCT00631007|InteKrin Therapeutics|Chief Executive Officer|650-941-5501|Info@intekrin.com|
22415913|NCT02674633|Akili Interactive Labs|Kathryn Jenkins|8572543399|kjenkins@akiliinteractive.com|
22415914|NCT00683787|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22415915|NCT01235715|Hospital for Special Surgery|Dr. Mark P. Figgie|212-606-1932|figgiem@hss.edu|
22415916|NCT02877017|Boston Children's Hospital|Alisa Khan, MD, MPH|6173552565|alisa.khan@childrens.harvard.edu|
22415917|NCT00527475|Texas Retina Associates|David Callanan, MD|817-261-9625|dcallanan@texasretina.com|
22415918|NCT03408730|VBI Vaccines, Inc.|Vlad Popovic|416-418-4713|vpopovic@vbivaccines.com|
22415919|NCT02046863|Great Lakes NeuroTechnologies Inc|Biomedical Research Manager|2163615410|dheldman@glneurotech.com|
22415920|NCT00396630|GlaxoSmithKline|GSK Response Center|866-435-7343||
22415921|NCT02327325|Health Services Research & Development, Durham VA Healthcare System|Kelli Allen, PhD|919-286-0411|kelli.allen@va.gov|7090
22402846|NCT01040208|Sprout Pharmaceuticals|Krista Barbour|9198820850|kbarbour@sproutpharma.com|
22402847|NCT04891770|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22402848|NCT01734512|University of California, San Francisco|Dr. Sabine Mueller, MD, PhD|(415) 502-7301|sabine.mueller@ucsf.edu|
22402849|NCT05692154|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22402850|NCT02154750|UC San Diego Health|Gregory Feld, MD|(858) 246-2972|gfeld@health.ucsd.edu|
22402851|NCT03609359|National Cancer Center Hospital East|Dr.Kohei Shitara|(+81)-4-7133-1111|LenvaPembro_core@east.ncc.go.jp|91520
22402852|NCT01912729|Northwestern University|David C. Mohr, PhD|312-503-1403|d-mohr@northwestern.edu|
22402853|NCT01429987|Synergy Pharmaceuticals Inc.|Dr. Patrick H. Griffin|212-297-0020||
22402854|NCT03860311|UAB|Dr. Stephen Ruffenach|5202707665|stephenruffenach@gmail.com|
22402855|NCT01952834|Medical College of Wisconsin|Dr. Michael Widlansky|414-955-6755|mwidlans@mcw.edu|
22402856|NCT02432287|Albert Einstein College of Medicine|Erika Brutsaert|7188397961|erika.brutsaert@einstein.yu.edu|
22402857|NCT01975272|Maastricht University Medical Centre|Prof. dr. Roy Kruitwagen|0031-3874764|r.kruitwagen@mumc.nl|
22402858|NCT01125176|Weill Cornell Medical College|Richard Furman, MD|646-962-2064|rrfurman@med.cornell.edu|
22402859|NCT04058054|KeraNetics, Inc.|Chris Holder, PhD|336-413-3393|cholder@keranetics.com|
22402860|NCT00740779|Watson Pharmaceuticals|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|801-588-6641|gary.hoel@watson.com|
22402861|NCT03220048|hVIVO|Tim Sharpington|02071480862|t.sharpington@hvivo.com|
22402862|NCT00988559|Johns Hopkins University|Cornelia L. Trimble, MD|410-502-0512|ctrimbl@jhmi.edu|
22402863|NCT01052012|Durect Corporation|Deborah Scott|408-777-1417|deborah.scott@durect.com|
22402864|NCT00923910|National Cancer Institute|Dr. Terry Fry|301-402-0215|fryt@mail.nih.gov|
22402865|NCT00418262|University of Oklahoma Health Sciences Center|Mark Wolraich, M.D.|(405) 271-5700|mark-wolraich@ouhsc.edu|45123
22402866|NCT00829166|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22402867|NCT02538666|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22402868|NCT00843622|Fagerström Consulting AB|Dr Karl Fagerström||karl.fagerstrom@swipnet.se|
22402869|NCT04942483|Imperial College London|Professor Andrew Bush|020 7352 8121|a.bush@imperial.ac.uk|2255
22402870|NCT00320385|GlaxoSmithKline|GSK Response Center|866-435-7343||
22402871|NCT04370028|OOO NPF Materia Medica Holding|Mikhail Putilovskiy, MD, PhD|+74952761575|PutilovskiyMA@materiamedica.ru|302
22402872|NCT02492750|Mayo Clinic|John A Lust MD PhD|507/284-2511|lustj@mayo.edu|
22402873|NCT02965534|University of Applied Sciences Jena|Philipp Hessler|+4916097089677|philipp@hessler.de|
22402874|NCT02582749|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317.921.2050|jsmith@hoosiercancer.org|
22402875|NCT01518192|Department of Infectious Diseases, University Medical Center Ljubljana|Franc Strle|+386 1 522 2610|franc.strle@kclj.si|
22402876|NCT01043523|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22402877|NCT02796924|University of Manitoba|Dr. Mandana Modirrousta|2042372303|mmodirrousta@sbgh.mb.ca|
22402878|NCT00363805|University of Arizona|Dr. Sherry Chow|520-626-3358|schow@azcc.arizona.edu|
22402879|NCT00540436|GlaxoSmithKline|GSK Response Center|866-435-7343||
22415922|NCT01507233|University of Miama/Jackson Memorial Hospital|Keith Candiotti, MD|305-585-5332|info@jhsmiami.org|
22415923|NCT01402128|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Soo-Wan Chae, MD|82-63-276-8284|soowan@jbnu.ac.kr|
22415924|NCT00651183|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22415925|NCT04443569|Massachusetts General Hospital|Christopher Arkfeld|4029803860|carkfeld@mgh.harvard.edu|
22415926|NCT01118026|Alliance for Clinical Trials in Oncology|Ann S. LaCasce, MD|617-632-5959|alacasce@partners.org|
22415927|NCT02575339|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
22415928|NCT04675775|University of Michigan|Elliot Tapper|734-647-9252|etapper@med.umich.edu|
22431173|NCT02259231|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22390476|NCT01710800|Walter Reed National Military Medical Center|Dr. Fouad J. Moawad|(301) 400-1551|Fouad.Moawad@us.army.mil|
22390477|NCT00992719|Department of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine, Duke University School of Medicine|Geeta K. Swamy, M.D.|919-681-5220|geeta.swamy@duke.edu|
22390478|NCT03891641|University of North Carolina at Chapel Hill|Jason R Franz, PhD|919-966-6119|jrfranz@email.unc.edu|
22390479|NCT00156923|Alkermes, Inc.|Bernard L. Silverman / VP, Clinical Development|781-609-6000|bernard.silverman@alkermes.com|
22390480|NCT01585298|Novartis Pharmaceuticals|Study Director|862-778-8300||
22390481|NCT01670188|Mayo Clinic|Dr. Alejandro Rabinstein|507-284-4741|Rabinstein.Alejandro@mayo.edu|
22390482|NCT02212301|Johnson & Johnson Vision Care Inc.|Tawnya Wilson OD|904-443-3500|TWilson@ITS.JNJ.com|1834
22402880|NCT01515306|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22415929|NCT02970552|University of North Carolina at Chapel Hill|Joan Price, MD, MPH|919-962-4717|joni@email.unc.edu|
22415930|NCT00108082|GlaxoSmithKline|GSK Response Center|866-435-7343||
22415931|NCT02419924|Mayo Clinic|Dr. Amy Foxx-Orenstein|480-301-6990|foxx-orenstein.amy@mayo.edu|
22390483|NCT00241969|Cincinnati Children's Hospital Medical Center|Scott Powers, PhD|513-636-8106|scott.powers@cchmc.org|
22415932|NCT00784030|New York University School of Medicine|Dr. Irina Barash|212.263.5851|irina.barash@nyumc.org|
22415933|NCT01091103|Medivation, Inc.|Mohammad Hirmand, MD, VP, Clinical Development|415-829-4126|mohammad.hirmand@medivation.com|
22415934|NCT01270620|Stanford University School of Medicine|Dr. Pedro Tanaka|6507244066|ptanaka@stanford.edu|
22415935|NCT01045707|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22415936|NCT00348816|The University of Texas Health Science Center at San Antonio, Department of Radiation Oncology|Gregory P. Swanson, MD|210-450-1103|swansong@uthscsa.edu|
22415937|NCT04269993|Brown University|Elizabeth Aston, PhD|401-863-6668|elizabeth_aston@brown.edu|
22415938|NCT04886063|Athira Pharma|Dr. Javier San Martin, CMO|1-866-725-0930|clinicaltrials@athira.com|
22415939|NCT02451358|Sanofi Pasteur Inc.|Medical Director|800-633-1610|RegistryContactUs@sanofipasteur.com|1#
22415940|NCT06128525|USC/Norris Comprehensive Cancer Center|Tali Homsey|(323) 865-0451|tali.homsey@med.usc.edu|
22415941|NCT00960414|UCSF Osher Center for Integrative Medicine|Rick Hecht, MD|4153739743|rick.hecht@ucsf.edu|
22415942|NCT01214980|University South Florida|Dr. Lisa Gould|(410) 736-4646|lgould44@hotmail.com|
22415943|NCT03414034|Cardiff Oncology|Nancy Sherman, Head of Clinical Operations|858-952-7570|clinops@cardiffoncology.com|
22415944|NCT01067521|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|001-215-591-3000|info.era-clinical@teva.de|
22415945|NCT02667951|School of Nursing, College of Medicine, Chang Gung University, Taoyuan, Taiwan|Dr. Yea-Ing L. Shyu|+886-3-211 8800|yeaing@mail.cgu.edu.tw|5275
22415946|NCT04142658|Artivion|Melissa Thalin, Director, New Indications|770-419-3355|melissa.thalin@artivion.com|
22415947|NCT01781234|University of Illinois College of Pharmacy|Dr. Ajna Hamidovic|312-355-1713|ahamidov@uic.edu|
22415948|NCT02413008|ITF Research Pharma SLU|Concepción Nieto Magro|0034916572323|concepcion@itfsp.com|
22431174|NCT02871219|The University of Texas MD Anderson Cancer Center|Jason Westin, MD|(713) 792-3750|jwestin@mdanderson.org|
22390484|NCT00413634|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22390485|NCT02427958|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22390486|NCT00578318|Georgetown University Medical Center|Alfiee M. Breland-Noblem Ph.D., MHSc|2026872392|ab2892@georgetown.edu|
22390487|NCT02025985|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
22390488|NCT03628456|International Biophysics Corporation|VP of Engineering and Quality|512-804-0046|quality@biophysicscorp.com|
22390489|NCT00953862|NYU School of Medicine|Dr. Lenard Adler|(212) 263-3580|lenard.adler@nyumc.org|
22390490|NCT00001941|National Cancer Institute, National Institues of Health|Thomas Waldmann, M.D.|301-496-6653|tawald@mail.nih.gov|
22390491|NCT03175198|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22390492|NCT00545571|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22390493|NCT00874497|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22390494|NCT01013740|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22390495|NCT00607997|Sunesis Pharmaceuticals, Inc.|Linda Neuman, Vice President, Clinical Development|(650) 266-3760|lneuman@sunesis.com|
22390496|NCT03029611|UWashington (University of Washington)|Director of Clinical Operations|206-616-2305|childj@u.washington.edu|
22390497|NCT01527500|Novartis Pharmaceuticals|Study Director|862-778-8300||
22390498|NCT00372255|GlaxoSmithKline|GSK Response Center|866-435-7343||
22390499|NCT03790878|Duke University|Katherine (Kibby) McMahon|917-880-1551|Kibby.McMahon@duke.edu|
22390500|NCT00776984|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22390501|NCT00661466|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
22402881|NCT00683475|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22402882|NCT01760941|Virginia Commonwealth University/Massey Cancer Center|Drew Moghanaki, MD, MPH|804-765-5850|Drew.moghanaki@vcuhealth.org|
22402883|NCT03364335|NuSirt Biopharma|Barbara Cannon|6156567898|BCannon@nusirt.com|
22402884|NCT03725202|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22402885|NCT02536170|Emory University|Claudia Morris|404-727-5500|claudia.r.morris@emory.edu|
22402886|NCT00751530|Community Research Initiative|Project Manager|617 502 1700|pmacht@crine.org|
22402887|NCT02658994|Human Development Research Foundation|Siham Sikander|+923330590373|sihamsikander@gmail.com|
22402888|NCT00262080|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22402889|NCT01051986|Seoul National University Hospital|Ki-Bong Kim|+82-2-2072-3482|kimkb@snu.ac.kr|
22402890|NCT02044159|Children's Hospital of Eastern Ontario|Katie O'Hearn, Research Coordinator|613-737-7600|kohearn@cheo.on.ca|4006
22402891|NCT01111539|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22402892|NCT03007485|Northwell Health|Dr. Negin Hajizadeh|516-600-1401|Nhajizadeh@northwell.edu|
22415949|NCT02287636|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Philipp Frank Graner|+1 216-844-8275|philipp.graner@uhhospitals.org|
22415950|NCT03538262|Massachusetts General Hospital|Dr. Michael Schwarzschild|617-724-9611|michaels@helix.mgh.harvard.edu|
22415951|NCT01294449|University of Rochester Heart Research Follow-up Program|Dr. Arthur Moss|585-275-5291|Arthur.Moss@heart.rochester.edu|
22415952|NCT01685216|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22415953|NCT02466386|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22431175|NCT03238196|Vanderbilt-Ingram Cancer Center|Brent Rexer, MD, PhD, Assistant Professor|615-322-4967|brent.rexer@vumc.org|
22415954|NCT05317195|Philip Morris Products S.A.|Christelle Haziza, Global Head Clinical Research and Execution|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
22415955|NCT02922582|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
22415956|NCT04718129|Vanderbilt University|Principal Investigator|615-330-5605|jgarber.vanderbilt@gmail.com|
22415957|NCT02212457|GlaxoSmithKline|GSK Response Center|866-435-7343||
22415958|NCT03346902|Bonti|Wajdie Ahmad|9493796569|wajdie@bonti.com|9493796569
22402893|NCT01848054|PRA International|Lynn R. Webster, MD|801-892-5140|LRWebsterMD@gmail.com|
22402894|NCT03580382|NYU Langone Health - PCC CTO|Rachael Keller, Sr. Regulatory Specialist|929-455-2453|Rachael.Keller@nyulangone.org|
22402895|NCT02808312|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22402896|NCT03628417|Szeged University|Principal Investigator, Assistant Professor|+36-62-545-259|kis.erika.gabriella@med.u-szeged.hu|
22402897|NCT01361009|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22402898|NCT02236546|Vanderbilt-Ingram Cancer Center|Dr. Tom Yankeelov||thomas.yankeelov@utexas.edu|
22402899|NCT03696758|UT Southwestern, Dallas, Texas|Dr. Kara Goss|214-648-6868|kara.goss@utsouthwestern.edu|
22402900|NCT01597557|University at Buffalo|Dr. Anne Curtis|716-859-4828|abcurtis@buffalo.edu|
22402901|NCT03540134|University of Virginia|Dr. Jeff Elias|(434) 924-0451|FUSbrain@virginia.edu|
22402902|NCT00941889|Washington University|Steven Hunt, MD|314-454-7177|hunts@wudosis.wustl.edu|
22402903|NCT02935634|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22402904|NCT03207022|Cork University Hospital|Dr Anil Ranganath||drmrak.2@gmail.com|
22402905|NCT06150573|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
22402906|NCT00210158|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
22402907|NCT03484533|Makerere University Infectious Diseases Institute|Andrew Mujugira|206 520 3800|mujugira@uw.edu|
22402908|NCT02284906|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22402909|NCT00370695|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
22402910|NCT03885726|Vapotherm, Inc.|George C. Dungan, II|(267)347-3305|gdungan@vtherm.com|
22402911|NCT04096326|AbbVie|Global Medical Services|1-800-633-9110|abbvieclinicaltrials@abbvie.com|
22402912|NCT01879176|Medical University of Vienna|Dr. Martin H. Bernardi|004314040041090|martin.bernardi@meduniwien.ac.at|
22402913|NCT02496585|Memorial Sloan Kettering Cancer Center|Dr. Zachary Moore, MD, PhD|929-687-0151|moorez@mskcc.org|
22402914|NCT03248947|Duke University|Dr. Li-Tzy Wu|919-889-9369|litzy.wu@duke.edu|
22402915|NCT04490265|US Department of Veterans Affairs|Lisa McAndrew|862-400-3317|lisa.mcandrew@va.gov|
22402916|NCT01276457|Novartis Pharmaceuticals|Study director|862 778-8300||
22402917|NCT05174039|Theranexus|Chief Medical Officer|0688941976|marie.sebille@theranexus.com|+33
22402918|NCT05122650|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
22402919|NCT00660504|Cancer Hospital of Chinese Academy of Medical Sciences|Dr.Sunyan|86-10-87788519|suny@csco.org.cn|
22402920|NCT03392753|Imperial College London|Mr Roshan Bootun|+442033117335|r.bootun@imperial.ac.uk|
22402921|NCT03280550|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22402922|NCT05896761|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22402923|NCT01318083|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
22402924|NCT00619684|Fred Hutchinson Cancer Research Ctr|Dr. William Bensinger|2066674730|wbensing@fredhutch.org|
22402925|NCT04747808|MediPrint Ophthalmics, Inc.|Chief Operating Officer|(858) 522-0815|clinical@mediprintlens.com|
22402926|NCT02028338|International Partnership for Microbicides|Dr John Steytler||jsteytler@ipmglobal.org|
22402927|NCT00843310|NYU Cancer Institute|Hearn J. Cho, MD|212-263-9274|hearn.jay.cho@med.nyu.edu|
22402928|NCT03552549|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22402929|NCT03403504|Mundipharma(China) Pharmaceutical. Co. Ltd|Rongna. A|86 10 65636885|rongna.a@mundipharma.com.cn|
22402930|NCT01257217|Alcon Research, Ltd.|Brand Lead, Surgical, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
22402931|NCT02094586|Emergent BioSolutions Canada Inc.|David Cassie, Scientist, Clinical Research|204-275-4589|dcassie@ebsi.com|
22402932|NCT02761993|Noveome Biotherapeutics, Inc|David Steed, MD|4124029913|dsteed@noveome.com|
22402933|NCT00041717|Acorda Therapeutics, Inc.|Andrew Blight, Ph.D. Chief Scientific Officer|914-347-4300|ablight@acorda.com|5102
22402934|NCT01231633|Long Island Vitreoretinal Consultants|Vincent A. Deramo, MD|5164660390|vaderamo@gmail.com|222
22402935|NCT00527111|US Oncology Network, McKesson Specialty Health|Dr. David McCollum|214-370-1080|david.mccollum@usoncology.com|
22402936|NCT04072146|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
22402937|NCT01617434|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22402938|NCT02993224|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
22402939|NCT04286412|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22402940|NCT01568905|University of Minnesota Tobacco Research Programs|Dorohty Hatsukami, Ph.D.|612-626-2121|hatsu001@umn.edu|
22402941|NCT00722553|Allos Therapeutics, Inc.|Medical Monitor|303-426-6262|gweems@allos.com|
22402942|NCT02916498|Boston Scientific|Director, Clinical Sciences and Scientific Communication|855-213-9890|BSNClinicalTrials@bsci.com|
22402943|NCT02689219|IndianaU|Dr. Nabil Adra|(317) 944-5349|nadra@iu.edu|
22402944|NCT01515176|The Ohio State University Comprehensive Cancer Center|Jeffrey Jones, MD|614-293-3507|Jeffrey.Jones@osumc.edu|
22402945|NCT01452126|UNM Department of Anesthesiology|Dr Tim Petersen|5052722610|timpetersen@salud.unm.edu|505
22402946|NCT01921257|Circassia Ltd|VP Clinical Operations|+44 1864 405560||
22402947|NCT01081223|TVAX Biomedical, Inc.|Gary Wood PhD|913-961-1327|gwood@tvaxbiomedical.com|
22402948|NCT02426658|Wake Forest University Health Sciences|Study Nurse|336-716-2121|saverill@wakehealth.edu|
22402949|NCT00088634|Sunovion|Josephine Cucchiaro, Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com|
22402950|NCT03050359|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22402951|NCT02020031|Mayo Clinic|Dr. Mark J. Spanghel|480-301-5685|Spangehl.Mark@mayo.edu|
22402952|NCT01136668|Hospital for Sick Children|Dr. Jason Hayes|416-813-7445|jason.hayes@sickkids.ca|
22402953|NCT00755846|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22402954|NCT04047121|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22402955|NCT00810459|Philips|Jeff Jasko|412-542-3651|Jeff.Jasko@philips.com|
22402956|NCT02604810|Grifols Therapeutics LLC|Rhonda Griffin|919-316-6693|rhonda.griffin@grifols.com|
22402957|NCT03754933|GeoVax, Inc.|Kelly T. McKee, Jr., MD, MPH|(678) 384-7220|kmckee@geovax.com|
22402958|NCT02723604|Barbara Ann Karmanos Cancer Institute|Dr. Harold Kim|313-576-9543|kimh@karmanos.org|
22402959|NCT02417870|Brigham and Women's Hospital|Anil Chandraker|617-732-7412|achandraker@bwh.harvard.edu|
22402960|NCT01369849|Mayo Clinic|Wei Ding, MBBS, PhD||ding.wei@mayo.edu|
22402961|NCT00312884|Imperial College london|Professor Cowie|0207 349 7716|m.cowie@imperial.ac.uk|
22402962|NCT00115349|UCL Cancer Institute|John Porter, MD, Principal Investigator|+011 (44) 207 679 6224|j.porter@ucl.ac.uk|
22402963|NCT02780765|Tata Memorial Hospital, Mumbai|Dr Vijaya Patil|+91-2224177000|vijayappatil@yahoo.com|7048
22402964|NCT00208494|DePuy Orthopaedics, Inc.|Jennifer Hoag, MS, Project Leader, Clinical Research|574-372-7399|JHoag2@its.jnj.com|
22402965|NCT01028651|United Therapeutics Corp.|Kevin Laliberte, PharmD|919-425-8176|KLaliberte@unither.com|
22402966|NCT02874404|University of Nebraska Medical Center|Dr. Matthew Lunning, DO, Associate Professor|402-559-7164|mlunning@unmc.edu|
22402967|NCT00390416|Memorial Sloan Kettering Cancer Center|Dr. David Ilson|646-888-4183|ilsond@mskcc.org|
22402968|NCT01592409|Centre for Addiction and Mental Health|Dr. Robert Mann, Senior Scientist|416-535-8501|robert.mann@camh.ca|34496
22402969|NCT01728584|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22402970|NCT01842841|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22402971|NCT05132569|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
22402972|NCT00305643|UT MD Anderson Cancer Center|Scott Kopetz, MD, PHD / Assistant Professor||CR_Study_Registration@mdanderson.org|
22402973|NCT04183179|Michigan State University College of Nursing|Jiying Ling|5173538591|lingjiyi@msu.edu|
22402974|NCT04322994|Stanford University|Dr Thomas Caruso, MD, PhD|6507235728|tjcaruso@stanford.edu|
22402975|NCT00689819|Wayne State University|Phillip Levy, MD|3139938558|plevy@med.wayne.edu|
22402976|NCT02336594|Study Information Center AstraZeneca|Jesse Hall, MD|+1 877-240-9479|information.center@astrazeneca.com|
22402977|NCT00471536|Karmanos Cancer Institute at Wayne State University|Ulka Vaishampayan, M.D.||vaishamu@karmanos.org|
22402978|NCT02403830|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3933|dominick.angiolillo@jax.ufl.edu|
22402979|NCT01188564|Pharming Technologies|Anurag Relan, Vice President Clinical Research and Medical Affairs||a.relan@pharming.com|
22402980|NCT01504854|Alzheimer's Disease Cooperative Study|Michael Rafii, MD, PhD|858-846-1300|mrafii@ucsd.edu|
22402981|NCT01094730|Johnson & Johnson Vision Care|John R. Buch, O.D., M.S., F.A.A.O., Principal Research Optometrist|1-904-443-1707|jbuch@its.jnj.com|
22415959|NCT00772148|Veloxis Pharmaceuticals|Christina Sylvest|+45 20553877|csy@veloxis.com|
22415960|NCT00688844|Emory University|Rani H. Singh|404-448-8519|rsingh@emory.edu|
22402982|NCT04171037|The University of Texas MD Anderson Cancer Center|Gang Zheng, MD|(713) 563-2731|gzheng@mdanderson.org|
22402983|NCT01934894|SCRI Development Innovations|Charles Davis, RAC|615-524-4341|Charles.Davis2@scri-innovations.com|
22402984|NCT01954251|GlaxoSmithKline|GSK Response Center|866-435-7343||
22415961|NCT00857818|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22415962|NCT01745952|UZ Leuven|Prof W Van Paesschen & Dr L Seynaeve|+3216349062|laura.seynaeve@uzleuven.be|
22390502|NCT04414397|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22390503|NCT03640754|MenoGeniX|Debra Duke|303-995-7979|debra.duke@menogenix.com|
22390504|NCT01204775|AstraZeneca AB, S-151 85 Södertälje, Sweden|Eva Johnsson, Clinical Science Lead, GLOBAL_MEDICINES_DEV|+46 31 7762484|Eva.Johnsson@astrazeneca.com|762 484
22390505|NCT00276016|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22390506|NCT04380688|AstraZeneca|Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22390507|NCT02207322|Massachusetts General Hospital|Areej El-Jawahri|617-724-4000|ael-jawahri@partners.org|
22390508|NCT01181609|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22390509|NCT04831047|Bascom Palmer Eye Institute|Wendy W. Lee MD|305-243-6434|wlee@med.miami.edu|
22390510|NCT01339299|Fertility Clinic Regional Hospital Skive|Prof, M.D. Peter Humaidan|+45 78445760|peter.humaidan@viborg.rm.dk|
22415963|NCT02061280|Nemours Children's Specialty Care|Kathryn Blake, Pharm.D.|9046865047|kathryn.blake@nemours.org|904
22415964|NCT01977456|University of Cincinnati|Dr. Opeolu Adeoye|513-558-3117|opeolu.adeoye@uc.edu|
22415965|NCT05718648|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22415966|NCT04814459|Oakland University|Dr. Sara Arena|2483648682|arena@oakland.edu|
22415967|NCT01841060|Institut Bergonie|Pr Simone Mathoulin-Pélissier|33556333333|s.mathoulin@bordeaux.unicancer.fr|
22415968|NCT05258630|Hennepin Healthcare Research Institute|Katherine Diaz Vickery|612-873-6852|katherine.vickery@hcmed.org|
22415969|NCT03431337|Albany Medical College|Dr. Paul Sorum|518-262-7500|sorump@amc.edu|
22415970|NCT02419573|Unviersity of Texas Health Science Center at Houston|Henry E. Wang, MD, MS|713-500-7878|henry.e.wang@uth.tmc.edu|
22415971|NCT05838456|The University of Texas Health Science Center at Houston|Sunil A. Sheth, MD|713-500-7897|Sunil.A.Sheth@uth.tmc.edu|
22415972|NCT00401245|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22415973|NCT02344745|Keck School of Medicine|Begum Ozel, M.D.|323-226-3416|ozel@usc.edu|
22415974|NCT02788513|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22415975|NCT04178096|VA Pittsburgh Healthcare System|Dr. Shari Rogal|412 360 6177|shari.rogal@va.gov|
22415976|NCT03230487|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22415977|NCT00646763|Emory University Winship Cancer Institute|Edmund Waller, MD, PhD|1-888-946-7447|ewaller@emory.edu|
22415978|NCT03211039|Rady Children's Institute for Genomic Medicine|Dr. Stephen F. Kingsmore|816 854 0882|skingsmore@rchsd.org|
22415979|NCT01933919|AbbVie|Global Medical Services|800-633-9110||
22415980|NCT01961882|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22415981|NCT01901848|Durham Veterans Health Care System|Eric Dedert, Ph.D.|919-384-8582|eric.dedert@va.gov|4055
22415982|NCT00684567|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22415983|NCT00809965|Johnson & Johnson Pharmaceutical Research and Development, L.L.C.|Development Head Cardiovascular/Urology|1 215 628-5257||
22415984|NCT05552261|Dompé Farmaceutici S.p.A.|Clinical Development & Operations|+39 02 583831|clinicaltrials@dompe.com|
22415985|NCT00337428|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22415986|NCT02618382|Dignity Health Research Institute|Lisa Arnold, Clinical Research Operations Manager|602-406-9593|lisa.arnold@arrowneuro.org|
22415987|NCT01628549|Allergan|Thearpeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
22415988|NCT03287687|University of Iowa|Dr. Warren Bishop, Professor of Pediatrics|319 356 2977|warren-bishop@uiowa.edu|
22415989|NCT04116658|Enterome|Jan Fagerberg|+33175772785|info@enterome.com|
22415990|NCT00177164|UPMC|K.N. Roy Chengappa|412-246-5006|chengappakn@upmc.edu|
22415991|NCT05584553|Zimmer Biomet|Dr Nesma Bayrich|+41793001484|nesma.bayrich@zimmerbiomet.com|
22415992|NCT00965757|Eisai Co., Ltd.|Kota Nagai|+81-3-3817-5238||
22390511|NCT00664105|Vanderbilt-Ingram Cancer Center|Vicki Keedy, M.D.|(615) 322-4967||
22390512|NCT02185105|CooperVision, Inc|Sr. Manager, Clinical Research|9257306754|pchamberlain@coopervision.com|
22390513|NCT03991988|Emory University|Dr. Ihab Hajjar|4047121763|ihajjar@emory.edu|
22390514|NCT02276638|Nidek|Head, Regulatory Affairs|(800) 223-9044|support@nidek.com|
22390515|NCT02948569|University of Missouri|Dr. Elizabeth Parks|15738825864|parksej@missouri.edu|
22390516|NCT01009762|Statens Serum Institut|Professor Anders Fomsgaard|+45-32683460|afo@ssi.dk|
22390517|NCT02363998|USWM, LLC|Medical Affairs|1-888-900-8796|medinfo@usworldmeds.com|
22390518|NCT00847132|Massachusetts General Hospital|Dr. Jeff Huffman|617-724-2910|jhuffman@partners.org|
22390519|NCT02122549|ZOLL|Vice President of Medical Affairs|412-968-3333|stevens@zoll.com|14400
22390520|NCT01751165|GlaxoSmithKline|GSK Response Center|866-435-7343||
22390521|NCT00988533|Sanofi Topaz|Medical Director||RegistryContactUs@sanofipasteur.com|
22390522|NCT01036165|EMD Serono, Inc.|Fernando Dangond, MD|781-681-2348|Fernando.dangond@emdserono.com|
22390523|NCT01387815|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22415993|NCT03807440|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22415994|NCT01344018|EORTC (European Organisation for Research and Treatment of Cancer)|EORTC HEADQUARTERS|+32 2 774 16 11|eortc@eortc.be|
22415995|NCT02725645|Universidade Fernando Pessoa|Sandra Beatriz Pereira Rodrigues||sandrar@ufp.edu.pt|
22390524|NCT00913523|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Senior Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
22390525|NCT01649297|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22390526|NCT01685047|St Jude Medical|Karolien Timmermans|0032 497 51 39 21|ktimmermans@sjm.com|
22415996|NCT04010227|Indiana University|Dr. Catherine Mosher|3172746769|cemosher@iupui.edu|
22415997|NCT01332968|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22402985|NCT04804033|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22402986|NCT01864018|Mayo Clinic|Shaji Kumar|507-284-2511|Kumar.Shaji@mayo.edu|
22402987|NCT02702193|University of Miami|Victoria Mitrani|305 284-9139|vmitrani@miami.edu|
22402988|NCT04365985|William Beaumont Hospitals|Matthew Sims, MD|248 551-0027|matthew.sims@beaumont.org|
22402989|NCT02439281|U Pittsbutgh, UPMC Children's Hospital|Mihaela Visoiu|4126925260|visoium@upmc.edu|
22402990|NCT03510663|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22402991|NCT03208192|Moscow Clinical Scientific Center|Mikhail Efanov, MD, PhD,|+79161058830|m.efanov@mknc.ru|
22402992|NCT00222729|UPMC Cancer Centers|Rita Johnson, Associate Director of Clinical Research Services|412-647-8571|johnsonr1@upmc.edu|
22402993|NCT01167595|CERU Queen's University|Dr.Daren Heyland|403-915-5573|dkh2@queensu.ca|
22402994|NCT01915849|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22402995|NCT01798706|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22402996|NCT02775864|Columbia University|Dr. Scott Stroup|646-774-8435|Scott.Stroup@nyspi.columbia.edu|
22402997|NCT00256867|GlaxoSmithKline|GSK Response Center|866-435-7343||
22402998|NCT01465178|University of Wisconsin|Neil Binkley|608-265-6410|nbinkley@wisc.edu|
22402999|NCT00668434|Kaiser Permanente, Northern California|Dr. Andrew Avins|510-891-3557|andy.l.avins@kp.org|
22403000|NCT02915367|Massachusetts General Hospital|Jessica Haberer|617-643-9195|jhaberer@partners.org|
22415998|NCT00722436|The Childrens Hospital of Pittsburgh of UPMC|Franklyn Cladis|412-692-5260|cladfp@upmc.edu|
22403001|NCT01930799|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22403002|NCT00875017|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22403003|NCT01477892|Seoul National University Hospital|Pf. Han-suk Kim|+82-2-2072-0647|kimhans@snu.ac.kr|
22403004|NCT02932475|University of North Carolina at Chapel Hill|Kim Boggess, MD|919-966-1601|kboggess@med.unc.edu|
22403005|NCT00364845|Amgen Inc.|Study Director|866-572-6436||
22403006|NCT01912768|Alcon Research, Ltd.|Clinical Project Lead, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
22403007|NCT01423617|Analyze & Realize|Dr Christof Jänicke|+49 30 40 00 83 23|cj@a-r.com|
22403008|NCT03255291|Washington University School of Medicine|Erika Waters, MPH, Ph.D.|314-286-2757|waterse@wustl.edu|
22403009|NCT00634244|ECOG Statistical Office|Study Statistician|617-632-3012||
22403010|NCT02467387|CardioCell, LLC|Sergey Sikora, President and CEO|760-315-0861|SSIKORA@STEMCARDIOCELL.COM|
22403011|NCT02335216|St. Jude Medical|Roni Diaz|+19723098601|rdiaz@sjm.com|
22403012|NCT01672996|GE Healthcare|Rubin Sheng, MD|609-514-6899|Rubin.Sheng@ge.com|
22403013|NCT02330627|University of California, San Diego|Dr. Charles Taylor|8585349446|c1taylor@ucsd.edu|
22403014|NCT04369430|Alkahest, Inc.|Clinical Development|(650) 801-0474|trials@alkahest.com|
22403015|NCT03453151|Duke University|Marat Fudim|(919) 681-5816|marat.fudim@duke.edu|
22403016|NCT01468909|NRG Oncology|Linda Gedeon on behalf of Michael Sill, PhD.|716-845-1169|lgedeon@gogstats.org|
22403017|NCT01204658|GlaxoSmithKline|GSK Response Center|866-435-7343||
22403018|NCT04574297|Changhai Hospital|Dr. Zhuan Liao|86-21-31161004|liaozhuan@smmu.edu.cn|
22403019|NCT04594239|Merz Aesthetics|Public Disclosure Manager|+1 984-301-3095|Aesthetic.Trials@merz.com|
22403020|NCT03229759|Becton Dickinson|Erin Zook|224-358-5019|erin.zook@bd.com|
22403021|NCT05345691|Biocon Biologics Limited|Sarika S Deodhar|0802808|Sarika.Deodhar@biocon.com|5301
22403022|NCT02891798|VA Pittsburgh Health System, and University of Pittsburgh|Brian A. Williams, MD, MBA|412-360-1602|brian.williams6@va.gov|
22403023|NCT00818207|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22403024|NCT02616185|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22403025|NCT01303380|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
22403026|NCT00967226|Childrens Research Institute|Nancy M. Bauman MD, Principle Investigator|2024764270|nbauman@cnmc.org|
22403027|NCT01670656|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22403028|NCT00789958|SWOG|SWOG Statistician|206-667-4408||
22403029|NCT00487084|Northwestern University|Cynthia A. Wong,M.D.|630-472-3555|c-wong2@northwestern.edu|
22403030|NCT00111475|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22403031|NCT03303092|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22403032|NCT01062568|UCSD|Dr. R. Jeffery Chang|858-534-8930|rjchang@ucsd.edu|
22403033|NCT00050986|University of Texas, M. D. Anderson Cancer Center|W.K. Yung,MD/Clinical Professor, Neuro-Oncology|(713) 794-1285|wyung@mdanderson.org|
22403034|NCT01697267|Cambridge University Hospitals NHS Foundation Trust|Prof David Jayne|01223 748062|dj106@cam.ac.uk|
22403035|NCT02543398|UTHSCSA Periodontics|Guy Huynh-Ba|2105673569|huynhba@uthscsa.edu|
22403036|NCT00833248|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
22403037|NCT01830543|Janssen Scientific Affairs, LLC|Senior Director Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
22403038|NCT03496467|Mati Therapeutics|Deepank Utkhede|6046379717|dutkhede@matitherapeutics.com|
22403039|NCT02681055|MediciNova, Inc.|Director, Research and Development|8583444535|makhay@medicinova.com|
22403040|NCT00127530|Acorda Therapeutics, Inc.|Andrew Blight, Chief Scientific Officer|914-347-4300|ablight@acorda.com|102
22403041|NCT01206478|University of Kansas Medical Center|Ann M Davis, PI|913-588-6300|adavis6@kumc.edu|
22403042|NCT00377611|GlaxoSmithKline|GSK Response Center|866-435-7343||
22403043|NCT01030458|University of Leuven|Prof. Dr. Jan A Staessen|+32 16 34 7104|jan.staessen@med.kuleuven.be|
22403044|NCT00884052|University od California San Diego|Sponsor and Principal Investigator|8588226700|rhaas@ucsd.edu|
22403045|NCT00839423|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
22403046|NCT01071096|Clinvest|Jeanne Tarrasch|417-841-3673|jtarrasch@clinvest.com|
22403047|NCT02585999|Boston Medical Center|Dr. Antonella Lavelanet|6174143745|Katharine.White@bmc.org|
22403048|NCT00756886|Surgery - Cardiovascular/Thoracic|Ayesha S. Bryant, MD|(205) 996-7561|abryant@uab.edu|
22403049|NCT03377244|University of Arkansas for Medical Sciences|Dr. Pearl A. McElfish|479-713-8680|pamcelfish@uams.edu|
22403050|NCT00274768|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Antonio Wolff|410-614-6192|awolff@jhmi.edu|
22403051|NCT00871377|UCLA School of Medicine|Christopher M. DeGiorgio, MD|310-206-3753|cmd@mednet.ucla.edu|
22403052|NCT04348656|McMaster University/Hamilton Health Sciences|Dr Donald Arnold|905 525 9140|arnold@mcmaster.ca|28603
22403053|NCT03474406|Department of Anesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University.|Asist. Prof. Suratsawadee Wangnamthip|6624197842|suratsawadee.wan@mahidol.ac.th|
22403054|NCT00922194|Sircar Diabetes Clinic|Dr. Amulya R Sircar|+ 91 (522) 2324747|arsircar@yahoo.com|
22403055|NCT04131517|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22403056|NCT00288860|Nationa Center for PTSD Dissemination & Training Division|Craig S. Rosen|650-493-5000|craig.rosen@va.gov|22812
22403057|NCT05161351|Imperial College London Faculty of Medicine|Agnese Zicari,Quality Assurance Facilitator|+44(0)2075946615|a.zicari08@imperial.ac.uk|
22403058|NCT05142332|University of California San Francsico|Robert Rodriguez|(628) 206-5875|Robert.Rodriguez@ucsf.edu|
22403059|NCT02116660|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22403060|NCT00803010|H. Lee Moffitt Cancer Center|Dr. Joseph Pidala|813-745-4673|Joseph.Pidala@moffitt.org|2556
22403061|NCT01434641|St. Luke's-Roosevelt Hospital|E. Gordon DePuey, M.D.|212-523-3400|edepuey@chpnet.org|
22403062|NCT00411788|Yale University|Abu-Khalaf, Maysa|(203) 785-4095|maysa.abu-khalaf@yale.edu|
22415999|NCT01769222|Stanford University Medical Center|George Albert Fisher, MD|650-725-9057|georgeaf@stanford.edu|
22416000|NCT00721955|Alexza Pharmaceuticals, Inc|Chief Scientific Officer|650.944.7777|:jcassella@alexza.com|
22416001|NCT03702816|Cleveland Clinic|Aaron Ritter, MD|17024836000|rittera@ccf.org|
22416002|NCT04194008|Theranica Bio-Electronics Ltd|Dr Dagan Harris. VP Clinical & Regulatory Affairs|0542220121|daganh@theranica.com|
22416003|NCT01785615|University of Florida College of Medicine Jacksonville|Dr. Gladys Velarde|(904)244-2060|Gladys.Velarde@jax.ufl.edu|
22416004|NCT02522780|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22416005|NCT00926367|GlaxoSmithKline|GSK Response Center|866-435-7343||
22416006|NCT01517867|Johns Hopkins University|Deborah Gross|410-614-5311|debgross@jhu.edu|
22416007|NCT01266603|U T MD Anderson Cancer Center|Dr. Michael A Davies, BA,MD,PHD/Melanoma Medical Oncology|713-792-3454|MDavies@mdanderson.org|
22416008|NCT01041209|Hospital General de Niños Pedro de Elizalde|Dr. Fernando Torres|+54 11 43070140|slaip@intramed.net|
22416009|NCT02725411|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22416010|NCT04307849|NYU Langone Health|Marie Brault, PhD|210-276-9012|Marie.Brault@nyulangone.org|
22416011|NCT00645827|Emory University|G. Randy Smith Jr.|404.686.6730|grsmith@emory.edu|
22416012|NCT02654015|Icahn School of Medicine at Mount Sinai|Samantha St. Elin|(212) 241-1497|samantha.stelin@mountsinai.org|
22416013|NCT02418754|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22416014|NCT00462839|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|(312)926-9015|r-mccarthy@northwestern.edu|
22416015|NCT04784637|University of Virginia|Sue Brown|434-982-0602|sab2f@virginia.edu|
22416016|NCT00761176|Regenesis Biomedical, Inc.|VP of Clinical Research and Regulatory|602-309-2118|mark.davis@regenesisbio.com|
22416017|NCT01139294|Vanderbilt University Medical Center|Thomas Abramo, MD||tjabramo@uams.edu|
22416018|NCT02762994|BIOCAD|Nikiforova Aleksandra|+7(812) 380 49 33|nikiforovaan@biocad.ru|6254
22416019|NCT05103657|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22416020|NCT02020967|Ipsen|Ipsen Medical Director|see email|clinical.trials@ipsen.com|
22403063|NCT00848549|Eisai Call Center|Eisai Inc.|888-422-4743||
22403064|NCT02561299|Cardiovascular Systems Inc.|Clinical Trials Manager|651.259.2500|clintrials_csi@csi360.com|
22403065|NCT05631548|The University of Texas Health Science Center at Houston|Heather Webber, PhD|713-486-2723|Heather.E.Webber@uth.tmc.edu|
22403066|NCT02190747|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22403067|NCT02869854|RegionSkane|Mr Peter Nymberg|0705759810|peter.nymberg@med.lu.se|
22403068|NCT02345252|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22416021|NCT02095340|University of Houston|Andres G Viana, Ph.D., Associate Professor|832-842-0234|agviana@uh.edu|
22431176|NCT05081843|University of Pittsburgh School of Public Health|Dr. Jaime Sidani|412-383-0733|jes107@pitt.edu|
22431177|NCT04938427|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22390527|NCT02544113|Cleveland Clinic|Dr. Bijan Eghtesad|216 444-9898|eghtesb@ccf.org|
22390528|NCT02434523|Boston Medical Center|Dr. Jacob Pieter Noordzij|617-638-8124|Pieter.Noordzij@bmc.org|
22390529|NCT00583050|Massachusetts General Hospital|Matthew Eagleton, M. D.|617-726-8279|MEAGLETON@mgh.harvard.edu|
22390530|NCT02847637|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22390531|NCT01746108|GlaxoSmithKline|GSK Response Center|866-435-7343||
22390532|NCT03036150|AstraZeneca|AstraZeneca Clinical Study Information Center|+1-877-240-9479|Information.center@astrazeneca.com|
22390533|NCT00616577|Loma Linda University|Charles Lee, MD|909-558-9408|thamilton@llu.edu|
22431178|NCT04629196|NYU Langone Health|David Hudesman, MD|646-501-9327|David.Hudesman@nyulangone.org|
22431179|NCT03792737|Johnson & Johnson Medical Shanghai Ltd.|Xiaolei, Wang|+86 21 33378749|xwang183@its.jnj.com|
22431180|NCT00835354|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22431181|NCT04906512|Ruijin Hospital|Dr. Hongping Qu|021-64370045|rjhcrc@126.com|
22431182|NCT02061085|MedSIR|Alicia Garcia|+34 611261467|alicia.garcia@medsir.org|
22431183|NCT05487378|APR Applied Pharma Research s.a.|Chief Scientific Officer|+41.91.6957020|giorgio.reiner@apr.ch|
22431184|NCT05472870|Shanghai Jiaotong University School of Medicine Xinhua Hospital|Fei Li|18930830950|feili@shsmu.edu.cn|
22431185|NCT01385995|Brigham and Women's Hospital|Dr. Susan Redline|857-307-0352|sredline1@rics.bwh.harvard.edu|
22431186|NCT02414841|Proteon Therapeutics, Inc|Steven Burke, MD|781-890-0102|Clinical@ProteonTx.com|
22431187|NCT03053362|Brain and Cognition Discovery Foundation|Dr. Roger McIntyre|(416) 943-6284|rogermcintyre28@gmail.com|
22431188|NCT03918031|University of Houston|Brooke Kauffman|(713) 743-8056|byredmond@central.uh.edu|
22431189|NCT05339659|Kaiser Permanente|Dr. Jennifer McClure|206-287-2737|jennifer.b.mcclure@kp.org|
22431190|NCT03164356|University of Washington|Daniel Ballesteros|206-221-5873|danieb25@uw.edu|
22431191|NCT03648372|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22431192|NCT05964166|Nationwide Children's Hospital|Dr. Joseph Tobias|6147224200|Joseph.Tobias@nationwidechildrens.org|
22390534|NCT01318538|McLean Hospital|Shelly F. Greenfield, MD, MPH|617-855-2241|sgreenfield@mclean.harvard.edu|
22431193|NCT03396445|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22431194|NCT03744637|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22431195|NCT02964377|UC Davis Health|Dr. Craig McDonald, Professor and Chair|(916) 734-4293|cmmcdonald@ucdavis.edu|
22431196|NCT04123704|Baylor College of Medicine, Dan L Duncan Comprehensive Cancer Center|Dr. C. Kent Osborne|713-798-1640|kosborne@bcm.edu|
22431197|NCT03134209|NYU Langone Health|Ran Schwarzkopf, MD|646-356-9405|Ran.Schwarzkopf@nyulangone.org|
22431198|NCT01198691|TriHealth|Donna Lambers, MD|513-862-2828|donna_lambers@trihealth.com|
22431199|NCT03332056|University of Washington|Jonathan Harper|2065988279|jdharper@uw.edu|
22431200|NCT01798225|Medical University of South Carolina|Renata Leite|843-792-3908|leiter@musc.edu|
22431201|NCT03360344|Loma Linda University|Donnamarie Krause|7347642243|donnamarie.krause@gmail.com|
22431202|NCT01145183|Baylor College of Medicine|Thomas Kosten, MD|713 798 8628|kosten@bcm.edu|
22431203|NCT00133705|University of Rochester|Dr. Kevin Fiscella|585-271-1206|kevin_fiscella@urmc.rochester.edu|205
22431204|NCT03840967|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22431205|NCT01765400|University of Nebraska Medical Center|Paul P Dobesh|402-559-3982|pdobesh@unmc.edu|
22431206|NCT04881058|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
22431207|NCT01342666|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (INCMNSZ)|Favorable effect of tomato consumption on HDL-c serum levels|525555133891|shiverqks@hotmail.com|
22431208|NCT05012579|Cala Health|Alex Kent|267-973-4180|alex.kent@calahealth.com|
22431209|NCT00793520|Forest Research Institute|Allan Spera|201-427-8399|allan.spera@frx.com|
22390535|NCT02741713|Wake Forest Baptist Health|Dr.Jon Wells Reynolds|336-715-9695|jreynold@wakehealth.edu|
22390536|NCT00570921|University of Kentucky|Dr. Mara D. Chambers|866-340-4488|mdcham2@email.uky.edu|
22390537|NCT04191148|Medpace|Clinical Trial Manager|513-630-0130|E.Plummer@Medpace.com|
22390538|NCT02447432|GlaxoSmithKline|GSK Response Center|866-435-7343||
22390539|NCT02647788|University of Pennsylvania|Dr. Benjamin Gray|215-294-9650|Benjamin.Gray@uphs.upenn.edu|
22390540|NCT00374088|University of Michigan - Pediatric Cardiology|Ranjit Aiyagari, MD|734-647-8761|ranjita@umich.edu|
22431210|NCT01882816|Memorial Sloan Kettering Cancer Center|Dr. Nancy Lee, MD|212-639-3341|leen2@mskcc.org|
22390541|NCT01274559|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22431211|NCT00688740|sanofi-aventis|International Clinical Development Study Director||Contact-us@sanofi-aventis.com|
22431212|NCT02965781|Squarex LLC|Hugh McTavish|6512078270|hmctavish@squarex-pharma.com|
22403069|NCT02239770|Penn State College of Medicine|Dr. Patricia Sue Grigson|717-531-5772|psg6@psu.edu|
22403070|NCT02864940|Rush University Medical Center|Michael Chen, MD|312-563-2817|Michael_Chen@rush.edu|
22403071|NCT04285346|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
22403072|NCT00610935|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
22403073|NCT04360187|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22403074|NCT02399813|Advaxis, Inc.|Sumitra Sheeri|609-423-2528|sheeri@advaxis.com|
22403075|NCT05372575|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22403076|NCT03115801|Weill Cornell Medicine|Sharanya Chandrasekhar|6469623110|shc2043@med.cornell.edu|
22403077|NCT02203838|Indivior, Inc.|Global Director, Clinical Development|804-379-1090||
22403078|NCT02188121|McLean Hospital|Dr. Dost Ongur|617 855 3922|dongur@partners.org|
22403079|NCT03345836|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22403080|NCT05091060|Erchonia Corporation|Travis Sammons|3214731251|tsammons@erchonia.com|
22403081|NCT02739594|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22403082|NCT01270581|Mount Sinai School of Medicine|Dr. Andrea Weintraub|212-241-6186|andrea.weintraub@mssm.edu|
22403083|NCT00952289|Incyte Corporation|Study Director|855 463-3463||
22403084|NCT03259334|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22403085|NCT03375112|Henry Ford Health System|Dr. Michael Charters|1-800-436-7936|mcharte1@hfhs.org|
22403086|NCT03599141|Indiana University|Heather K. Hardin|317.274.5966|hhardin@iu.edu|
22403087|NCT00777491|NRG Oncology|Wendy Seiferheld, M.S.|215-574-3208|seiferheldw@nrgoncology.org|
22403088|NCT01689207|AstraZeneca|Paul Newell, Medical Science Director|+44 1625 515727|paul.newell@astrazeneca.com|
22403089|NCT03591146|Taiwan Liposome Company|Cynthia Lin|+886 2 2655 7377|cynthia_lin@tlcbio.com|
22403090|NCT04737031|University of Pennsylvania|Robert Schnoll, PhD|215.746.7143|schnoll@pennmedicine.upenn.edu|
22403091|NCT00962039|The Ohio State University|John V. Campo|614-581-5984|john.campo@hsc.wvu.edu|
22403092|NCT00142519|Memorial Sloan Kettering Cancer Center|Dr. Natalia Moryl, MD|646-888-2681|moryln@mskcc.org|
22403093|NCT02592629|Penn State Hershey Medical Center|Robert Gallo, M.D.|7175310003|rgallo@pennstatehershey.psu.edu|289222
22403094|NCT02227329|Mayo Clinic|Dr. Ryan Hurt|507-284-4461|Hurt.Ryan@mayo.edu|
22403095|NCT01511419|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22403096|NCT00937768|Mayo Clinic|Dr. R. Jeffrey Karnes|507 284-4430|Karnes.R@mayo.edu|
22403097|NCT04748783|University of North Carolina at Chapel Hill|Laura Jacox, DMD, PhD, MS|919-537-3424|ljacox@live.unc.edu|
22403098|NCT00762372|Baxter Healthcare|Baxter Clinical Trial Disclosures Call Center|(224)948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
22403099|NCT01194804|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.||clinicaltrials@alexion.com|
22403100|NCT02670915|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22403101|NCT00165841|Eisai Medical Research Inc.|Yufang Lu, Study Director|201-403-2500||
22403102|NCT01000727|GlaxoSmithKline|GSK Response Center|866-435-7343||
22403103|NCT01170117|Columbia Center for Eating Disorders|Dr. Evelyn Attia|646-774-8085|ea12@cumc.columbia.edu|
22403104|NCT01026389|Guerbet|Post M. A. Clinical Unit Manager|+33 1 45 91 50 00|corinne.dubourdieu@guerbet-group.com|
22403105|NCT01995136|Alcon Japan, Ltd.|Senior Manager, Phase IV|1-888-451-3937|alcon.medinfo@alcon.com|
22403106|NCT03222076|MD Anderson Cancer Center|Dr. Ahmed Kaseb|(713) 792-2828|akaseb@mdanderson.org|
22403107|NCT01626352|Sarah Cannon Research Institute|Charles H. Davis|615-524-4341|charles.davis2@scri-innovations.com|
22403108|NCT02059213|University of Michigan Rogel Cancer Center|Phillip Palmbos, M.D., Ph.D.|734-936-3591|ppalmbos@umich.edu|
22403109|NCT01151046|Merrimack Pharmaceuticals|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
22403110|NCT02338492|IlluminOss Medical Inc.|Gene DiPoto|401-714-0008|gdipoto@illuminoss.com|202
22403111|NCT00980785|University of Wisconsin School of Medicine and Public Health|Cynthia M. Carlsson, MD, MS|608-256-1901|cmc@medicine.wisc.edu|11691
22403112|NCT04281030|NYU Langone Health|Mia Minen|9294555130|Mia.Minen@nyulangone.org|
22403113|NCT01395368|Washington University in St. Louis|Dr. Jay F. Piccirillo, Professor|314 362-8641|piccirilloj@ent.wustl.edu|
22403114|NCT00310388|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22403115|NCT00330863|Medical College of Georgia, Georgia Regents University|Peter F. Buckley, MD|706-721-2231|pbuckley@gru.edu|
22403116|NCT05209932|Family Transitions - PTW, LLC|Michele M Porter, PhD - Co-PI/Partner|4802037550|m.marie.porter@gmail.com|
22403117|NCT00882999|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22403118|NCT02082145|Imperial College London|Miss Kate Williams||k.williams@imperial.ac.uk|
22403119|NCT01757405|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22403120|NCT00082758|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22403121|NCT00937560|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22403122|NCT01219959|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
22403123|NCT05906732|Thryv Therapeutics Inc.|VP Clinical Research|514-973-0915|admin@thryvtrx.com|
22403124|NCT00436566|Mayo Clinic|Dr. Edith A. Perez|507-266-0800|perez.edith@mayo.edu|
22403125|NCT02651194|AbbVie|Global Medical Services|800-633-9110||
22403126|NCT01980706|University of North Carolina at Chapel Hill|James C Garbutt, MD|984-974-2201|jc_garbutt@med.unc.edu|
22403127|NCT02546674|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
22416022|NCT00860262|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22403128|NCT02232087|Quotient Clinical Ltd|Pui Leung|44(0)115 974 9000|Pui Leung <Pui.Leung@quotientclinical.com>|
22416023|NCT01183884|Memorial Sloan Kettering Cancer Center|Dr. Brian Kushner, MD|212-639-6793|kushnerb@mskcc.org|
22416024|NCT02169336|Recro Pharma, Inc|Randall Mack|484-395-2400|rmack@recropharma.com|
22403129|NCT02208024|University of Cincinnati Cancer Center|Jordan Kharofa, Associate Professor, Department of Radiation Oncology|(513)-584-4073|kharofjr@ucmail.uc.edu|
22403130|NCT01958125|electroCore Inc.|Director Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
22403131|NCT00004418|Kennedy Krieger Institute|Gerald Raymond|443-923-2750|raymond@kennedykrieger.org|
22403132|NCT02918409|National Jewish Health|Dr. Milene Saavedra|303-270-2333|saavedram@njhealth.org|
22403133|NCT00974051|UColorado|Dr. H Peter Chase|303-724-2323|peter.chase@ucdenver.edu|
22403134|NCT01106625|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1 800 526 7736||
22403135|NCT00803543|University of Alabama at Birmingham|Nicholas Van Wagoner|205-934-2840|nvw@uab.edu|
22403136|NCT01750398|SKCCC at Johns Hopkins|Samuel Denmeade|410-955-8875|denmesa@jhmi.edu|
22403137|NCT04056455|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22416025|NCT01598896|Beth Israel Deaconess Medical Center|Dr. Kevin Hill|617-667-1504|khill1@bidmc.harvard.edu|
22403138|NCT02512068|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22403139|NCT01507584|ucsdmed|Eunice Williams-Steppe|8588221133|emwilliamssteppe@ucsd.edu|
22416026|NCT00420095|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22416027|NCT00393705|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22416028|NCT00642811|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22416029|NCT00938782|Stanford University|Dr. David R Drover|650-725-0364|ddrover@stanford.edu|
22416030|NCT04553406|SperoTherapeutics|Dr. Jon Bruss|(+1) 269-352-3766|jbruss@sperotherapeutics.com|
22416031|NCT03370510|Yale Child Study Center|Dr. Pamela Ventola|(203) 737-4378|ventolalab@yale.edu|
22416032|NCT01525628|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22416033|NCT02614898|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|475-230-2596|clinicaltrials@alexion.com|
22416034|NCT00787605|Novartis Pharmaceuticals|Study Director|862-778-8300||
22416035|NCT00178711|University of Texas Health Science Center|Guy L Clifton|2024224824|guy@guyclifton.com|
22416036|NCT01223027|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registry@novartis.com|
22416037|NCT03493919|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22416038|NCT01195116|University of Rochester|Dr. Suzanne Karan|5852751384|suzanne_karan@urmc.rochester.edu|
22416039|NCT01756885|University of Pennsylvania|Dr. Robert Schnoll|215-746-7143|schnoll@pennmedicine.upenn.edu|
22416040|NCT02367872|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22416041|NCT02812771|Bausch Health Americas, Inc|Study Director|510-259-5284|aloncaric@bauschhealth.com|
22416042|NCT00460109|Mayo Clinic|Stephen M. Ansell, M.D., Ph.D.|507/284-4642|ansell.stephen@mayo.edu|
22416043|NCT04167618|Y-mAbs Therapeutics|Joris Wilms|+4570261414|clinicaltrials@ymabs.com|
22416044|NCT02994394|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22403140|NCT02458690|Indiana University-Purdue University Indianapolis (IUPUI)|Jesse C. Stewart, PhD., Principal Investigator|317-274-6761|jstew@iupui.edu|
22416045|NCT03619876|Columbia University|Laura Geraldino-Pardilla, MD|212-305-4308|lbg2124@cumc.columbia.edu|
22416046|NCT05707403|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22416047|NCT04982445|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22416048|NCT02014441|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22403141|NCT04026412|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22416049|NCT00114231|Memorial Sloan Kettering Cancer Center|Julio Garcia-Aguilar, MD|212-639-5506|garciaaj@mskcc.org|
22403142|NCT00830037|Indiana University School of Medicine & Richard L Roudebush VA Medical Center|Rajiv Agarwal, MD, FAHA, FASN, FASH|317-988-2241|ragarwal@iu.edu|
22403143|NCT01401010|Michigan State University|Gary E Stein|517-353-5126|Gary.Stein@hc.msu.edu|
22416050|NCT02156154|Cleveland Clinic|Alparslan Turan, MD|216-445-0998|turana@ccf.org|
22416051|NCT02051595|University of Florida|Dr. Ettore Crimi|617-697-2861|ettorecrimi@gmail.com|
22416052|NCT01625507|University of Alberta|Dr. Catherine Chan|780-492-9939|cbchan@ualberta.ca|
22416053|NCT03330236|Yale University|Lingzhong Meng, MD|(203) 785-2198|lingzhong.meng@yale.edu|
22403144|NCT00837512|Emory University School of Medicine|Dr. Eric Felner|404-727-7651|efelner@emory.edu|
22403145|NCT02841787|Northwestern University|David C. Mohr, PhD|312-503-1403|d-mohr@northwestern.edu|
22403146|NCT01474746|University of California, Davis, MIND Institute|Dr. Randi Hagerman|916-703-0247|rjhagerman@ucdavis.edu|
22403147|NCT01716468|VA Pittsburgh Healthcare System|Jocelyn Tan, MD|412-360-6178|Jocelyn.Tan@va.gov|
22403148|NCT02110121|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22403149|NCT00524316|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22403150|NCT01199263|NRG Oncology|Linda Gedeon for Michael Sill, PhD|716-845-1169|linda.gedeon@roswellpark.org|
22403151|NCT02963714|Shanxi Medical University|Suping Wang, PhD|#86-351-4135103|spwang88@163.com|
22416054|NCT01191476|Abbott|Global Medical Services|800-633-9110||
22416055|NCT00368316|PDMI, NICHD, NIH|Dr. Rachel Schneerson, Co-Director|301-469-0850|schneerr@mail.nih.gov|
22416056|NCT00763555|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
22416057|NCT01729026|South Texas Veterans Health Care System; University of Texas Health Science Center at San Antonio|Dr. Stephen Stern|210-887-3754|stephen.stern@va.gov; sterns@uthscsa.edu|
22416058|NCT00928226|Stanford University|Scott Soltys, Associate Professor of Radiation Oncology|65072441569|sgsoltys@stanford.edu|
22416059|NCT00493064|PaloAltoMF|Renee Kaneshiro, study coordinator|650-853-4744|kaneshr@pamf.org|
22416060|NCT03765996|Dr. İsmail Atabek Physiotherapy and Rehabilitation Center|Ertan Şahinoğlu|+90 532 647 86 53|ertan.sahinoglu@hotmail.com|
22416061|NCT00955552|Eurofarma Laboratórios|Eurofarma Laboratórios|08007043876||
22416062|NCT02940730|University of Colorado|Dr. Tyree Kiser|3037242883|ty.kiser@ucdenver.edu|
22416063|NCT01522950|University of Minnesota|Jay N. Cohn, M.D., Professor of Medicine|612.625.5646|cohnx001@umn.edu|
22403152|NCT05818527|Cairo university|mohamed atfy abdelmotaleb ( PhD student )|01222798922|atfy2002@yahoo.com|
22403153|NCT01687413|Washington University School of Medicine|Jason Rich, M.D.|314-747-3742|richj@wustl.edu|
22416064|NCT03307564|SKCCC @ Johns Hopkins|Amol Narang. MD|410-955-7390|anarang2@jhmi.edu|
22403154|NCT03047993|The University of Texas MD Anderson Cancer Center|Courtney DiNardo/Professor|713-794-1141|cdinardo@mdanderson.org|
22403155|NCT00091390|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
22403156|NCT02349789|Kennedy Krieger Institute|Anthony Gonzalez|4439080074|gonzalezan@kennedykrieger.org|
22403157|NCT00311181|St Jude Medical|Ashish Oza|818-493-3648|aoza@sjm.com|
22403158|NCT02669862|Aclaris Therapeutics, Inc.|Judy Schnyder, Senior Director of Clinical Operations|484-329-2144|jschnyder@aclaristx.com|
22403159|NCT02294318|ResearchFMH|Dr. Efrat Aharonovich|646-774-7954|efrat.aharonovich@nyspi.columbia.edu|
22403160|NCT00734344|University of Alabama at Bimingham|Principal Investigator|996-2371|heaths@uab.edu|
22403161|NCT00078559|University of Wisconsin - Department of Medicine, Madison, Wisconsin|Arjang Djamali, MD, MS, FASN|608-262-7330|axd@medicine.wisc.edu|
22403162|NCT01116687|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-7257|jonathan.strosberg@moffitt.org|
22390542|NCT03231969|Faes Farma|Nieves Fernández, MD, PhD|+34 94 481 83 00|nfernandez@faes.es|
22390543|NCT00498615|Johns Hopkins University|Gwen Leatherman, R.N.|410-550-8582|gleathe@jhmi.edu|
22416065|NCT00483548|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22416066|NCT04523324|Centers for Disease Control and Prevention|Dr. Ashley Fowlkes|4046394830|afowlkes@cdc.gov|
22416067|NCT02916693|Johns Hopkins University|Dr. Arthur L. Burnett|410-614-3986|aburnet1@jhmi.edu|
22416068|NCT05383170|Cytovation ASA|CEO|+4747718809|contact@cytovation.com|
22416069|NCT00979212|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22416070|NCT00035555|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22416071|NCT03223909|Laboratorios Sophia|Ricardo Alonso Llamas Velázquez (clinical safety pharmacologist)|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
22416072|NCT05932810|Medical University of South Carolina|Dr. Jennifer Dahne|843-876-2280|dahne@musc.edu|
22416073|NCT02046317|The University of Texas Health Science Center at Houston|Carlos J Roldan, MD|713-745-7246|Carlos.J.Roldan@uth.tmc.edu|
22416074|NCT02988882|Ocular Therapeutix|Jamie L. Metzinger, Medical Affairs|781-357-4000|jmetzinger@ocutx.com|
22416075|NCT00974350|Durect Corporation|Deborah Scott|408-777-1417|deborah.scott@durect.com|
22416076|NCT05070754|Medical University of South Carolina|Dr. Lara Wine Lee|(843) 792-3021|winelee@musc.edu|
22416077|NCT01398787|Alcon Research, Ltd.|Sharon Holden Thomas, Sr. Principal Clinical Scientist|1-888-451-3937|alcon.medinfo@alcon.com|
22416078|NCT02351167|Washington University School of Medicine|Li-Shiun Chen, M.D.|314-362-3932|li-shiun@wustl.edu|
22416079|NCT00529217|Columbia University Department of Psychiatry, City University of New York|Dr. Antonio Mantovani|212-650-5417|AMantovani@med.cuny.edu|
22416080|NCT02958319|Servicio de Reumatología del Hospital Universitario|David Vega-Morales MD|52 81 80485210|drdavidvega@yahoo.com.mx|
22416081|NCT00194792|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu|
22416082|NCT02448563|Boston Medical Center|Ashley McCarthy, Clinical Research Manager|617-638-5906|ashley.mccarthy@bmc.org|
22416083|NCT02339038|NIH Clinical Center|Masur, Henry|+1 301 496 9320|HMasur@cc.nih.gov|
22416084|NCT00702507|GlaxoSmithKline|GSK Response Center|866-435-7343||
22416085|NCT02308696|Univ. WI Madison|Amy Amessoudji|608-263-2621|amessoudji@surgery.wisc.edu|
22416086|NCT00113919|University of Arkansas for Medical Sciences|Nathan Petty|501-837-3894|pettynathanm@uams.edu|
22416087|NCT00372996|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22416088|NCT02914457|Medtronic Bakken Research Center|Richard Cornelussen|+31433566651|richard.cornelussen@medtronic.com|
22416089|NCT02092857|University of Alberta|Dr. Tom Clandinin|7804925188|tclandin@ualberta.ca|
22416090|NCT01055886|VA Medical Center|Angela Kirby|919-286-0411|angela.kirby@va.gov|5526
22416091|NCT00781079|Pittsburgh VA|Matthew Chinman|412 360-2438|matthew.chinman@va.gov|
22390544|NCT02561806|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22390545|NCT01859611|ELECTRONIC ENGINEERING EL.EN. SPA|ALESSANDRO BIZZARRI STUDY DIRECTOR|+390558826807|A.BIZZARRI@ELEN.IT|
22390546|NCT01880697|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22390547|NCT00591591|ISS, Inc., Champaign Illinois|Antonios Michalos|217-359-8681|antonios.michalos@iss.com|
22390548|NCT00002597|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22390549|NCT00912223|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
22390550|NCT05324007|University of Chicago|Dr. Hyesung Grace Hwang|(773) 834-9791|hyesung@uchicago.edu|
22390551|NCT01242371|Sheppard Pratt|Dr. Faith Dickerson|410-938-4359|fdickerson@sheppardpratt.org|
22390552|NCT00510146|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22390553|NCT03360110|CooperVision|Myhanh Nguyen, OD, Manager of Clinical Research|19257306716|MNguyen@coopervision.com|
22390554|NCT06080438|University of Miami|Principal investigator|305-326-6434|wlee@med.miami.edu|
22390555|NCT00025662|NHLBI|A. John Barrett|301-402-4170|barrettjj@mail.nih.gov|
22390556|NCT03589300|Zimmer Biomet|Director of Clinical Operations|800-613-6131|clinicaloperations@zimmerbiomet.com|
22390557|NCT02161185|Proximagen, LLC|David Sequeira,|952-658-7437|dsequeira@proximagen.com|
22390558|NCT02573883|Medstar Health Research Institute|Dr. Cheryl Iglesia|202-877-6526|cheryl.iglesia@medstar.net|
22390559|NCT00582114|Professor of Medicine|Dr. Rajiv Agarwal|317-988-2241|ragarwal@iu.edu|
22390560|NCT04289714|Royal Brompton Hospital|Sukeshi Makhecha|0207-3528121|s.makhecha@rbht.nhs.uk|4375
22390561|NCT00953212|Maine Medical Center|Dr. Robert Kramer|207-662-2923|KRAMER@mmc.org|
22390562|NCT00130728|Genentech, Inc.|Medical Communications Specialist|800-821-8590|genentech@druginfo.com|
22390563|NCT02301364|Memorial Sloan Kettering Cancer Center|Christian Grommes, MD|212-639-4058|grommesc@mskcc.org|
22390564|NCT02341599|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22390565|NCT00519285|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
22390566|NCT02970305|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|+1-858-261|medicalinformation@acadia-pharm.com|2897
22390567|NCT02175745|Stanford University|Erik Mittra, MD, PhD|650-736-2859|emittra@stanford.edu|
22416092|NCT04254809|Southeast Louisiana Veterans Health Care System|Joseph Boffa, PhD|504-507-2000|joseph.boffa@va.gov|67372
22416093|NCT02972515|University of Arizona|Judith Gordon|520-626-4970|judithg@email.arizona.edu|
22416094|NCT01928615|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22416095|NCT04531527|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22416096|NCT01272076|TLC Eyecare and Laser Centers|Carmelina Gordon, MD|(517) 7821213|shellie.fuentes@tlcmi.com|
22431213|NCT00366457|Massachusetts General Hospital|Lawrence S. Blaszkowsky, MD|6172191230|LBLASZKOWSKY@mgh.harvard.edu|
22390568|NCT01729923|University of Washington|Dr. Stacey Cohen, Principal Investigator|206-606-6658|shiovitz@uw.edu|
22390569|NCT00808899|St. Jude Children's Research Hospital|Wayne L. Furman|1-866-278-5833|info@stjude.org|
22390570|NCT04088500|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22416097|NCT00569660|The University of Texas M. D. Anderson Cancer Center|Srdan Verstovsek M.D./Associate Professor|713-792-7305|eharriso@mdanderson.org|
22390571|NCT02212197|Camurus AB|Clinical Trial Manager||info@camurus.com|
22390572|NCT01355471|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
22390573|NCT01078584|Abbott|Global Medical Services|800-633-9110||
22416098|NCT03937791|National Cancer Institute|Scott Norberg, D.O.|301-275-9668|scott.norberg@mail.nih.gov|
22390574|NCT01208870|SUNY Buffalo|Leonard H. Epstein, Ph.D.|716-829-3400|lhenet@buffalo.edu|
22416099|NCT01362192|Main Line Center for Laser Surgery|Eric F. Bernstein, M.D., M.S.E.|610-645-5551|dermguy@dermguy.com|
22390575|NCT02979613|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22416100|NCT02608476|Cassiopea, SPA|Cassiopea R&D|+39 02 868 911 24|r&d@cassiopea.com|
22416101|NCT00676494|Pathway Medical Technologies, Inc.|Kevin Peters/Director of Clinical Affairs|425-636-4053|petersk@pathwaymedical.com|
22416102|NCT05862844|School of Medicine, Virginia Commonwealth University|Asmaa Namoos|804-628-4754|Asmaa.Namoos@vcuhealth.org|
22416103|NCT01203917|AstraZeneca|Haiyi Jiang|+86 21 60302408|aztrial_results_posting@astrazeneca.com|
22390576|NCT02946788|Timber Pharmaceuticals|Alan Mendelsohn, MD|12673004249|amendelsohn@timberpharma.com|
22390577|NCT00919061|Memorial Sloan Kettering Cancer Center|Dr. Ghassan Abou-Alfa|646-888-4184|abou-alg@mskcc.org|
22390578|NCT05294328|LENZ Therapeutics, Inc.|Marc Odrich, MD|(646) 249-2800|marc@lenz-tx.com|
22390579|NCT02056873|Univeristy of Florida|Dr. Michael Okun|3522945400|okun@neurology.ufl.edu|
22390580|NCT02388347|MedImmune LLC|Rene van der Merwe||information.center@astrazeneca.com|
22390581|NCT02820597|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
22390582|NCT01475461|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22390583|NCT04051242|University of Pittsburgh|J. Peter Rubin, MD Principal Investigator and Endowed Chair of Plastic Surgery|412-383-8080|rubipj@UPMC.EDU|
22390584|NCT02262364|Zimmer Biomet|Jennifer Woodell-May, PhD||jennifer.woodell-may@zimmerbiomet.com|
22390585|NCT01049984|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22390586|NCT00337285|Shire Pharmaceutical Development, Inc.|Timothy Whitaker||twhitaker@shire.com|
22390587|NCT00553605|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22390588|NCT00997932|University of North Carolina School of Medicine|Dr. G Stuart|919-962-4880|gstuart@med.unc.edu|
22390589|NCT03206476|Universidad de Guadalajara|Dra. Gabriela Macedo Ojeda|(+52) 3310585200|gabriela.macedo@cucs.udg.mx|33900
22390590|NCT01040403|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22390591|NCT05694533|Indivior Inc.|Global Director Clinical Development|(804) 594-4488|trialdisclosure@indivior.com|
22390592|NCT01085812|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|8124
22390593|NCT00594178|Dept of PM&R; University of Arkansas for Medical Sciences|Thomas S. Kiser|501-221-1311|kiserthomass@uams.edu|
22390594|NCT05215418|Vivus LLC|Lan Nguyen|650-934-5246|clinical@vivus.com|
22390595|NCT02005393|FujiFilm Medical Systems USA|Robert Uzenoff: Executive Director of Clinical Science|(203) 602-3664|ruzenoff@fujifilm.com|
22390596|NCT00711997|BioCancell Ltd.|Monique Ben-Am, M.Sc.|+972-2-5486533|monique.ben-am@biocancell.com|
22390597|NCT04582669|Montefiore Medical Center|Haley Heibel, MD|(718) 920-8352|hheibel@montefiore.org|
22390598|NCT01874665|Ariad Pharmaceuticals|Medical Director|+1-844-662-8532|globaloncologymedinfo@takeda.com|
22390599|NCT03201900|Eisai, Inc.|Inquiry Service.|none|eisai-chiken_hotline@hhc.eisai.co.jp|
22390600|NCT01233999|Emory University|Dr. Suephy Chen|404-778-3084|schen2@emory.edu|
22390601|NCT00550446|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22390602|NCT01321723|Unigene Laboratories, Inc.|Nozer Mehta, PhD. Chief Scientific Officer|(973) 265-1100|nmehta@unigene.com|
22390603|NCT02246218|Horizon Therapeutics, LLC|Colleen Canavan, Director|866-479-6742|clinicaltrials@horizonpharma.com|
22390604|NCT00905034|University of Texas (UT) MD Anderson Cancer Center|Gautam Borthakur, MD/Associate Professor, Leukemia|713-563-1586|CR_Study_Registration@mdanderson.org|
22390605|NCT03700372|FARAPULSE, Inc.|Christopher (Kit) Schneider Sr. Director of Clinical & Pre-Clinical Engineering|617-686-7661|cschneider@farapulse.com|
22431214|NCT02829996|Inotek Pharmaceuticals Corp.|Roni Cohen|781-676-2100|rcohen@inotekpharma.com|
22431215|NCT01098747|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22431216|NCT01638507|Medtronic, Coronary Clinical Affairs|Lisa Bousquette, Clinical Research Director|(707) 591-2967|lisa.r.bousquette@medtronic.com|
22416104|NCT03310619|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22416105|NCT00218335|Johns Hopkins Bloomberg School of Public Health|Carl Latkin, PhD||clatkin@jhsph.edu|
22416106|NCT00152516|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22416107|NCT03604549|Penn State Health Milton S. Hershey Medical Center|Richard S. Legro, M.D., Principal Investigator|717-531-6210|rsl1@psu.edu|
22416108|NCT02846233|University of California San Francisco, Fresno Medical Education Program|SOE NAING|5593239236|snaing@fresno.ucsf.edu|
22416109|NCT01104090|The University of Texas Health Science Center at Houston|Davide Cattano, MD, PhD|(713) 500-6200|Davide.Cattano@uth.tmc.edu|
22431217|NCT04484857|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|FG4592-096Study@fibrogen.com|
22390606|NCT03409731|Abbott medical device|Hajime Kusano|+1 408-845-1626|hajime.kusano@abbott.com|
22390607|NCT02591862|Akari Therapeutics plc|Chief Scientific Officer|02080040261|miles.nunn@akaritx.com|
22390608|NCT00505414|Grünenthal GmbH|Director of Clinical Trials|+49 (0)241 569 3223|Clinical-Trials@grunenthal.com|
22390609|NCT04358068|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22390610|NCT01193218|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22390611|NCT00948610|UCLA|Michael R. Irwin|3108258281|mirwin1@ucla.edu|
22390612|NCT00665223|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22390613|NCT00363649|Johns Hopkins University|Doug Smith, MD|4102872935|smithdo@jhmi.edu|
22390614|NCT01349036|Daiichi Sankyo Inc.|Study Director|908-992-6400|CTRinfo@dsi.com|
22390615|NCT03796208|University of Kentucky|Kristin Ashford, PhD, Study MPI|859-257-9333|khashf0@uky.edu|
22390616|NCT01161628|Blood and Marrow Transplant Group of Georgia|Scott R. Solomon, MD (Principal Investigator)|404-255-1930|ssolomon@bmtga.com|
22390617|NCT05127018|Peking University School of Stomatology|Xi Gong|15201304426|gongx31480528@163.com|
22390618|NCT01125566|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22390619|NCT01560585|University Hospitals Cleveland Medical Center - Cleveland, OH|Alan J Lerner,MD|1 216 464 6449|alan.lerner@uhhospitals.org|
22390620|NCT03028012|University of Utah Physical Medicine and Rehabilitation Orthopedics|Dr. Daniel Cushman|8015852373|heidi.hansen@hsc.utah.edu|
22390621|NCT01726517|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22390622|NCT02624375|University of Washington|Dr. Christine Johnston, Associate Professor|206 520 4340|cjohnsto@uw.edu|
22390623|NCT00569010|The University of MD Anderson Cancer Center|Jean-Pierre Issa, M.D./Professor|713-745-2260|eharriso@mdanderson.org|
22390624|NCT00770588|AstraZeneca|Gerard Lynch|52564555|aztrial_results_posting@astrazeneca.com|86 21
22390625|NCT01424189|Alcon Research, Ltd.|Expert Clinical Project Lead, GCRA, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22390626|NCT01203956|Sleep Medicine Associates of Texas|Leon Rosenthal, MD|214-750-7776|LRosenthal@sleepmed.com|
22390627|NCT00513461|University of California, Irvine|Dr. Timothy R. Morgan|562-826-5756|timothy.morgan@va.gov|
22390628|NCT02230306|University of Pittsburgh Cancer Institute|Melissa Burgess, MD|412-623-7277|burgessma@upmc.edu|
22390629|NCT00312845|Johnson & Johnson Pharmaceutical Research & Development|Yusri A. Elsayed, M.D., M.H.Sc., Ph.D.||YElsaye1@ITS.JNJ.COM|
22390630|NCT00574171|UW Carbone Cancer Center|Dr. William Schelman|608-265-4347|wrs@medicine.wisc.edu|
22390631|NCT04206384|CAO Group|VP, Quality & Regulatory|801-256-9282|info@caogroup.com|
22390632|NCT01121185|MassBiologics|Director Clinical Affairs|617-474-3000|MBLclinicaldirector@umassmed.edu|
22390633|NCT01688895|Icahn School of Medicine at Mount Sinai|Dr. Hetanshi Naik|212-241-7699|hetanshi.naik@mssm.edu|
22390634|NCT01260142|Eisai Call Center|Eisai Inc.|888-422-4743||
22390635|NCT01123512|Benvenue Medical, Inc.|Barbara S. Lindsay, Vice President Clinical & Regulatory Affairs|408-454-9300|blindsay@benvenuemedical.com|
22390636|NCT00618917|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR, Regulatory Supervisor, CRS|412-647-5554|stadtermanbm@upmc.edu|
22390637|NCT00621946|The University of Texas Southwestern Medical Center|E. Sherwood Brown, MD, PhD|214-645-6950|Sherwood.Brown@UTSouthwestern.edu|
22390638|NCT00496834|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22390639|NCT01503164|Johns Hopkins University|Naresh Punjabi|410-550-6384|npunjabi@jhmi.edu|
22390640|NCT01227928|GlaxoSmithKline|GSK Response Center|866-435-7343||
22390641|NCT01042145|Washington University School of Medicine|Dr. Jane Garbutt|314-454-8613|jgarbutt@dom.wustl.edu|
22390642|NCT04088136|Georgia Institute of Technology|Dr. Christopher Hertzog|404-894-6774|ch18@gatech.edu|
22390643|NCT01494298|Mercer University College of Pharmacy|Gina Ryan Clinical Professor|678.547.6222|ryan_gj@mercer.edu|
22390644|NCT04159805|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22390645|NCT02930837|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22390646|NCT01393613|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22390647|NCT01618227|Massachusetts General Hospital|Neal Chen|617-726-4700|nchen1@partners.org|
22390648|NCT04236245|Venclose, Inc.|Mai-Ly Wilcox|415-254-1930|mwilcox@venclose.com|
22390649|NCT02998918|University of South Carolina|Mark Sarzynski|8037779510|sarz@mailbox.sc.edu|
22390650|NCT01071317|Montefiore Health|Benjamin W. Friedman, MD|718-920-6626|befriedm@montefiore.org|
22390651|NCT02592486|Department of Pulmonary Medicine, Kameda Medical Center|Kei Nakashima, Associate Chief|81-4-7092-2211|kei.7.nakashima@gmail.com|8614
22390652|NCT05041439|Massachusetts General Hospital|Dr. Julie H Levison|(617) 724-4698|jlevison@mgb.org|
22390653|NCT00676897|Beth Israel Deaconess Medical Center|Dr. Michael W. Donnino|6177542341|mdonnino@bidmc.harvard.edu|
22390654|NCT00497874|Pro-Change Behavior Systems, Inc.|Deborah A. Levesque, Ph.D.|(401) 360-2975|dlevesque@prochange.com|
22390655|NCT01101334|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22381093|NCT02538679|Cedars Sinai Medical center|Dr. Karen Zaghiyan|310-289-9224|karen.zaghiyan@cshs.org|
22390656|NCT00612352|Yale University|Ismene Petrakis||ismene.petrakis@yale.edu|
22390657|NCT00263211|Department of Medicine Div. of Oncology, Washington University School of Medicine St. Louis MO|Katherine Weilbacher, M.D,|Fax: 314-454-8973|kweiblac@dom.wustl.edu|
22390658|NCT00384865|Penn|Steven Kawut|215-573-0258|kawut@upenn.edu|
22390659|NCT01053247|Fougera Pharmaceuticals Inc|Angela C. Kaplan|631-659-2256|angela.kaplan@sandoz.com|
22390660|NCT03458728|Bayer AG|Therapeutic Area Head|30 300139003|clinical-trials-contact@bayer.com|
22390661|NCT01572298|UTHSCSA Periodontics|Dr. Brian Mealey|210-567-3589|mealey@uthscsa.edu|
22390662|NCT00908349|Supernus Pharmaceuticals, Inc|Janet K. Johnson, PhD|301-838-2623|jjohnson@supernus.com|
22390663|NCT04606199|University of California San Francisco|Dr. Stefanie Mayer|7345450698|Stefanie.mayer@ucsf.edu|
22390664|NCT00408928|Thomas Jefferson University|John Wagner, MD|215-955-8874|John.Wagner@jefferson.edu|
22390665|NCT05145439|Vibrato Medical|Vice President of Clinical Affairs|2139215088|bisrat@vibratomedical.com|
22390666|NCT01114139|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
22390667|NCT01951378|Seton Family of Hospital|Director Pediatric Fellowship|512-324-9999|a.a@abc.com|
22390668|NCT05252845|Mahidol-Oxford Tropical Medicine Research Unit (MORU)|Professor Lorenz von Seidlein|+66-(0)2-3549170|Lorenz@tropmedres.ac|
22390669|NCT03468179|Vanderbilt University|Sean S. Davies|6153225049|sean.davies@vanderbilt.edu|
22390670|NCT03752242|BioMimetix|Director of Clinical Operations|303-862-7268|contact@bmxpharma.com|
22390671|NCT02512861|Children's Hospitals and Clinics of Minnesota|Mark Lo Galbo, MPH, CCRP|(612)-813-7828|mark.logalbo@childrensmn.org|
22390672|NCT01774019|Boston Scientific|Andrea Burbage|15086834387|Andrea.Burbage@bsci.com|
22390673|NCT00292981|CSL Behring|Clinical Program Director|Use email contact|clinicaltrials@cslbehring.com|
22390674|NCT01983553|Sanofi Pasteur SA|Director||Contact-US@sanofi.com|
22390675|NCT01035047|Wake Forest Baptist Medical Center|Erin Harper|336-716-2059|erharper@wakehealth.edu|
22390676|NCT04731142|Imperial College London|Dr Jack Halligan|+447742161980|j.halligan@imperial.ac.uk|
22390677|NCT02840916|Kaohsiung Chang Gung Memorial Hospital|Dr. Wen-Long Hu|+886-7-731-7123|oolonghu@gmail.com|2334
22390678|NCT02090998|Rutgers/RWJMS|william grubb md|7322357827|grubbwr@rwjms.rutgers.edu|
22390679|NCT02832284|Boston Scientific Corporation|G Mark Grubb, RN, CCRA|412 749 1423|grubbm@bsci.com|
22390680|NCT03245619|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22390681|NCT03470545|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22390682|NCT04752033|Mayo Clinic|Dr. Joseph Pleticha|5073588378|Pleticha.joseph@mayo.edu|
22390683|NCT00776659|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22390684|NCT02971228|Zealand Pharma A/S|Kim Mark Knudsen|+45 5060 3780|KMKnudsen@zealandpharma.com|
22390685|NCT01664923|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22390686|NCT00726713|Pamlab Inc.|Page Young, Clinical Project Manager|985-867-5788|pyoung@pamlab.com|
22390687|NCT01167192|Washington University School of Medicine|Rebecca Aft, M.D., Ph.D.|314-747-0063|aftr@wustl.edu|
22390688|NCT01336205|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22390689|NCT00129649|Imperial College London|Prof Martyn R Patridge|+44 (0)20 7594 7959|m.patridge@imperial.ac.uk|
22390690|NCT04952701|CooperVision|Jose Vega|9256402964|JVega2@coopervision.com|
22390691|NCT02547441|Clinical Development Dept.|Maruho Co., Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
22390692|NCT01322009|University of Pittsburgh|Robert Clark|412-692-7260|clarkrs@ccm.upmc.edu|
22390693|NCT01657877|GlaxoSmithKline|GSK Response Center|866-435-7343||
22390694|NCT04545476|Vanderbilt University Medical Center|Karen Arnaud|615-322-6485|karen.arnaud@vumc.org|
22390695|NCT01262118|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22390696|NCT01980524|Medical University of Vienna|Dr. Peter Wolf|004314040043110|peter.wolf@meduniwien.ac.at|
22390697|NCT00937521|Novartis Vaccines|Novartis Vaccines||RegistryContactVaccinesUS@novartis.com|
22390698|NCT01978236|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22390699|NCT04035577|Northwestern University|Dr. Emily Lattie|3125033741|emily.lattie@northwestern.edu|
22390700|NCT02906696|The University of Texas MD Anderson Cancer Center|Philip Thompson, MD/Assistant Professor|713-792-7430|PAThompson2@mdanderson.org|
22403163|NCT01694420|Duke University Medical Center|Mehri McKeller, MD|919-668-0242|kara.mcgee@duke.edu|
22403164|NCT02168933|University of Utah, Derpartment of Dermatology|Kristina Callis-Duffin|8015816465||
22403165|NCT03497429|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22403166|NCT00506948|University of Texas (UT) MD Anderson Cancer Center|Amin Alousi, MD /Professor, Stem Cell Transplantation|713-745-8613|aalousi@mdanderson.org|
22403167|NCT02395653|The Medicines Company|Global Health Science Center|1-888-977-6326|medical.information@themedco.com|
22403168|NCT02494778|Prilenia|Prilenia|+972 775558|info@prilenia.com|482
22403169|NCT03621943|Sharp Healthcare|Dr. Anup Katheria|8589394170|Anup.Katheria@sharp.com|
22403170|NCT02174861|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22403171|NCT01215734|Vanderbilt University|Natasha Halasa, Associate Professor of Pediatrics|615-322-3346|natasha.halasa@vanderbilt.edu|
22403172|NCT00315705|Genzyme Corporation|Genzyme Medical Information|1-800-745-4447||
22403173|NCT01346371|Minnesota Eye Consultants, P.A.|Ahmad Fahmy, OD|612-813-3665|amfahmy@mneye.com|
22403174|NCT01716533|GlaxoSmithKline|GSK Response Center|866-435-7343||
22403175|NCT03309787|Dartmouth-Hitchcock|John A. Batsis, MD|603-650-5000|john.batsis@gmail.com|
22403176|NCT02320695|Johnson & Johnson Consumer and Personal Products Worldwide|Christopher Nunez, PhD|973-385-7984|cnunez1@its.jnj.com|
22403177|NCT01393171|Kaiser Permanente|Dr John Nguyen|562-657-2642|john.n.nguyen@kp.org|
22431218|NCT03901430|University of New Mexico|Julia Hess|5052724462|jmhess@unm.edu|
22390701|NCT00846768|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22416110|NCT02387762|Acerta Pharma|Ahmed Hamdy, MD, VP of Early Development|650-591-2800|a.hamdy@acerta-pharma.com|145
22416111|NCT04203667|Interscope, Inc.|Alexis James, Global Director of Clinical Affairs|508-847-9478|alexis.james@interscopemed.com|
22416112|NCT01160640|University of Pittsburgh|Dr. Harold Wiesenfeld|412-641-1403|wieshc@mail.magee.edu|
22416113|NCT02132650|Malcom Randall VA Medical Center|Dr. David Clark|352-376-1611|davidclark@ufl.edu|105244
22416114|NCT04428645|Oregon Health and Science University|Jessica Castle|503-494-7072|castleje@ohsu.edu|
22416115|NCT01834027|Penn State Milton S. Hershey Medical Center|Sonia Vaida|7175318433|svaida@hmc.psu.edu|
22416116|NCT03168906|Tufts Medical Center|Jaime Chisholm|617-636-5409|jchisholm1@tuftsmedicalcenter.org|
22416117|NCT00243152|Boston Children's Hospital|Dr. David Borsook|617-281-7135|david.borsook@childrens.harvard.edu|
22416118|NCT03840382|Rhode Island Hospital|Dr. Larry Brown|+1 (401) 793-8808|lkbrown@lifespan.org|
22416119|NCT00434590|Novartis Pharmaceuticals|Study Director|862-778-8300||
22416120|NCT02710240|University of Pennsylvania|Marie Kerr, Project Manager|215-829-6720|marie.kerr@pennmedicine.upenn.edu|
22416121|NCT01621906|Memorial Sloan Kettering Cancer Center|Dr. Andrew Seidman, MD|646-888-4559|seidmana@MSKCC.ORG|
22416122|NCT04231409|Boston Scientific|Roshini Jain, Sr. Director Clinical Sciences|16619494350|roshini.jain@bsci.com|
22416123|NCT02839798|Butler Hospital|Dr. Linda Carpenter|401-455-6349|Linda_Carpenter_MD@brown.edu|
22416124|NCT00571194|Arkansas Children's Hospital|Dr. Eileen Ellis|501-364-1847|elliseileenn@uams.edu|
22416125|NCT04129944|Unity Biotechnology, Inc.|Chief Medical Officer|650-416-1192|Clinicaltrials@unitybiotechnology.com|
22416126|NCT01560819|Helen DeVos Children's Hospital of Spectrum Health Hospitals|Dr. Sachin Kunde|616-267-2100|sachin.kunde@helendevoschildrens.org|
22416127|NCT00951093|Clinica Gastrobese|Carlos AS Madalosso, Director of Department of Metabolic and Bariatric Surgery|+55(54)3045-4070|madalosso@gastrobese.com.br|
22416128|NCT00996437|Diabetic Retinopathy Clinical Research Network|Adam R. Glassman|813-975-8761|drcrstat4@jaeb.org|
22416129|NCT02576717|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22416130|NCT01363011|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22416131|NCT00407745|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22416132|NCT02960438|Eisai Co., Ltd.|Inquiry Service||eisai-chiken_hotline@hhc.eisai.co.jp|
22416133|NCT01795079|Spaulding Rehabilitation Hospital|Felipe Fregni|6179526158|fregni.felipe@mhg.harvard.edu|
22416134|NCT03519282|CooperVision|Myhanh Nguyen, Sr. Optometrist|925-730-6716|MNguyen@coopervision.com|
22416135|NCT00298740|Johns Hopkins University|Johns Hopkins ClinicalTrials.gov Program|410-550-6484|registerclinicaltrials@jhmi.edu|
22416136|NCT03449199|Teijin America, Inc.|President|1-415-887-9742|clinical-trials-contact@teijinpo.com|
22416137|NCT03136406|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
22416138|NCT01201759|UNIVERSITY OF MIAMI- The Miami Project to Cure Paralysis|Dr. Mark S. Nash|(305) 243-3628|MNash@med.miami.edu|
22416139|NCT00906373|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22416140|NCT00848042|Nanospectra Biosciences, Inc.|Robin Dickson|7138422720|rdickson@nanospectra.com|216
22416141|NCT02744755|Hexal AG/Sandoz Inc.|Sandoz Biopharma Clinical Development - Strategic Planning|0049(0)80244760|biopharma.clinicaltrials@sandoz.com|
22416142|NCT01652729|AstraZeneca|ClinicalTrialTransparency@astrazeneca.com||ClinicalTrialTransparency@astrazeneca.com|
22416143|NCT02667821|Canadian Memorial Chiropractic College|Dr. Nicholas Moser|416-482-2340|nmoser@cmcc.ca|319
22416144|NCT04364737|NYU Langone Health|Mila B. Ortigoza, MD, PhD|646-634-7803|Mila.Ortigoza@nyulangone.org|
22416145|NCT01220609|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22416146|NCT00112294|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22416147|NCT03440424|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22416148|NCT01190930|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22416149|NCT02418455|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
22416150|NCT02445287|Carestream Health, Inc.|Susan Pate, RN, MS, RAC|585-627-6557|susan.pate@carestream.com|
22416151|NCT02001051|National Cancer Institute|Dr. Dhaval Patel|301-827-4989|pateldt@nih.gov|
22416152|NCT02407171|Yale School of Medicine|Allison Campbell, MD/PhD: Assistant Professor of Clinical Therapeutic Radiology|(203) 863-3700|allison.campbell@yale.edu|
22416153|NCT00115869|Fred Hutchinson Cancer Research Center|Arthur V. Peterson, Jr. PhD|206-667-5131|avpeters@fhcrc.org|
22416154|NCT01148524|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22416155|NCT04205162|Centre for Ocular Research and Education|Jill Woods|5198884567|jwoods@uwaterloo.ca|36743
22416156|NCT01999894|Forest Research Institute|Ephraim Katz, PhD / Associate Director|201-427-8000|Ephraim.Katz@frx.com|8169
22390702|NCT03367910|Washington University in St. Louis School of Medicine|Kimberly Reske, Research Coordinator|3147474041|kreske@wustl.edu|
22403178|NCT02295735|Charité Universitätsmedizin Berlin, Department of Dermatology and Allergy|PD Dr. Jan Kottner|+4930450518218|jan.kottner@charite.de|
22403179|NCT02622724|Faron Pharmaceuticals|Chief Medical Officer|+3584005529411|medical@faron.com|
22403180|NCT00254293|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22403181|NCT01575197|PATH|Senior Clinical Research Scientist|206-285-3500|klewis@path.org|
22403182|NCT03196193|Zimmer Biomet G.K.|Senior Manager of Clinical Affairs|+81-3-6402-6610|takahito.nakai@zimmerbiomet.com|
22403183|NCT01290445|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22403184|NCT02709083|Emory University|William Blum, MD|404-778-1900|william.g.blum@emory.edu|
22403185|NCT03544268|University of North Carolina at Chapel Hill|Director, Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
22403186|NCT03583372|Urovant Sciences|Information, Clinical Trial Results|949-226-6029|info@urovant.com|
22403187|NCT02796391|Moffitt Cancer Center|Dr. Vani Simmons|813-745-4816|Vani.Simmons@moffitt.org|
22403188|NCT02695524|University of São Paulo|Anamaria Siriani de Oliveira|+551633154415|siriani@fmrp.usp.br|
22403189|NCT02935699|TerSera Therapeutics|Medical Affairs|844-334-4035|tersera@medinfodept.com|
22403190|NCT03913221|University of North Carolina at Chapel Hill|Wesley Jackson, MD, MPH|984-215-3449|wesley.jackson@unc.edu|
22403191|NCT05439460|Stanford University|Chandra Ramamoorthy, MD|(650) 723-5728|chandrar@stanford.edu|
22403192|NCT03446651|Yale School of Medicine|Jeffrey Testani, MD, MTR|(203) 785-7191|jeffrey.testani@yale.edu|
22403193|NCT00343291|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22403194|NCT04831515|Coopervision|Jose A. Vega, O.D., MSc, FAAO|9256213761|JVega2@coopervision.com|
22403195|NCT03712345|InflaRx GmbH|Prof. Niels C. Riedemann|+49 3641-508-180|niels.Riedemann@inflarx.de|
22403196|NCT05250830|The Ohio State University|Kara Rood|440-321-0264|Kara.Rood@osumc.edu|
22403197|NCT00960934|Merck Sharp and Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
22403198|NCT00748085|CSA Medical|Ann Murphy Legg, Director of Clinical Research|781-538-4732|alegg@csamedical.com|
22403199|NCT03837353|NYU Langone Health|David Wise, MD, PhD|(212) 731-5405|David.Wise@nyulangone.org|
22403200|NCT01332019|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22403201|NCT00174785|sanofi-aventis|International Clinical Development (ICD), Clinical Study Director||GV-Contact-us@sanofi-aventis.com|
22403202|NCT00120289|Axio Research, LLC|Ruth McBride|206-577-0212|ruthm@axioresearch.com|
22403203|NCT01590394|Mayo Clinic|Christopher J. Gostout|507-284-7647|gostout.christopher@mayo.edu|
22403204|NCT00401622|LifeScan Scotland|Mike Grady|(44) 01463 721889|mgrady@its.jnj.com|
22403205|NCT00782418|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22403206|NCT01718509|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22403207|NCT00238303|Mayo Clinic|Evanthia Galanis, M.D.|(507) 284-3902|galanis.evanthia@mayo.edu|
22403208|NCT01833741|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22403209|NCT01248130|Massachusetts General Hospital|Gagan Joshi, MD|617-726-4651|lkfeinberg@mgh.harvard.edu|
22403210|NCT02052778|Taiho Oncology, Inc.|Taiho|+1 844-878-2446|medicalinformation@taihooncology.com|
22416157|NCT05181800|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DK0-Disclosure@ferring.com|
22390703|NCT00634920|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22390704|NCT00644878|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22390705|NCT04353817|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22390706|NCT00979745|CLINUVEL PHARMACEUTICALS LTD|Clinical Operations Manager||mail@clinuvel.com|
22390707|NCT03245463|Hospital for Special Surgery|Dr. James Wyss|2126061731|wyssj@hss.edu|
22390708|NCT00878553|Somnus Therapeutics, Inc|Dr. Christine Blumhardt, Chief Regulatory Officer|617-710-0928|cblumhardt@somnusthera.com|
22390709|NCT02143063|UConn Health|Sheila Alessi, PhD|860-679-1849|salessi@uchc.edu|
22390710|NCT03517111|Arizona State University|Dr. Sonia Vega-López|602-496-3350|sonia.vega.lopez@asu.edu|
22390711|NCT00909532|Vertex|Medical Monitor|617-444-6777|medicalinfo@vrtx.com|
22390712|NCT01305473|C.R. Bard: Davol, Inc.|Dawn Heimer/Director, Clinical Affairs|401-825-8681|dawn.heimer@crbard.com|
22390713|NCT03188536|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22390714|NCT00859976|Zimmer Biomet|Clinical Project Lead||Maggie.Shen@zimmerbiomet.com|
22390715|NCT02062645|Novartis Pharmaceuticals|Study Director|862-778-8300||
22390716|NCT03352882|University of Pennsylvania|Kimberly A. Forde, MD, PhD - Principal Investigator|(215) 349-8222|kforde@pennmedicine.upenn.edu|
22390717|NCT02864342|AstraZeneca|Medical Director|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22390718|NCT00193596|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22390719|NCT00118703|GlaxoSmithKline|GSK Response Center|866-435-7343||
22390720|NCT00461123|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22390721|NCT00927901|Novartis Pharmaceuticals|Study Director|862 778-8300||
22403211|NCT04168593|USaoPauloGH|Andre Wan Wen Tsai|5511981456449|tsai.andre@gmail.com|
22390722|NCT02344173|Abbott|Principal Clinical Research Scientist|6517564067|eric.grovender@abbott.com|
22390723|NCT02383407|George Washington University|Dr. Mohamad Koubeissi|202-741-2533|mkoubeissi@mfa.gwu.edu|
22403212|NCT04087343|The University of Texas Health Science Center at Houston|Jessica Lee, MD, MS, Assistant Professor|713-500-5457|Jessica.Lee@uth.tmc.edu|
22416158|NCT01546519|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22390724|NCT00984698|University of Arizona|Dr. Patricia Haynes, Assistant Professor|5206261855|thaynes@email.arizona.edu|
22390725|NCT00746356|St. Jude Medical|Ashish Oza, Clinical Studies Director|818 362 6822|aoza@sjm.com|3648
22390726|NCT01263925|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22403213|NCT01994226|Keele University|Sponsor|01782|research.governance@keele.ac.uk|734882
22431219|NCT01697709|NYSPI|john mariani. MD|212-923-3031|John.mariani@nyspi.columbia.edu|
22390727|NCT01449747|The Catholic University of Korea|Dr. Ji Hyun Kim|82-2-961-4534|kjhyun@catholic.ac.kr|
22390728|NCT02196168|London Health Sciences centre|Dr.Eric Winquist|519-685-8500|Winquist@lhsc.on.ca|
22390729|NCT03376555|Penn State University|Professor Lacy Alexander|8148671781|lma191@psu.edu|
22390730|NCT00477464|GlaxoSmithKline|GSK Response Center|866-435-7343||
22390731|NCT03568812|Tropical and Infectious Disease Division, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia-Cipto Mangunkusumo Hospital, Indonesia|Dr dr. Erni Juwita Nelwan, Ph.D, Sp.PD-KPTI|+62811961229|ejnelwan@yahoo.com|
22390732|NCT00429143|Thomas Jefferson University|Neal Flomenberg, MD|215-955-4367|neal.flomenberg@jefferson.edu|
22390733|NCT00639769|Vanderbilt-Ingram Cancer Center|Barbara Murphy, M.D.||barbara.murphy@vanderbilt.edu|
22390734|NCT00634842|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22390735|NCT04067843|University Hospital Zurich|Dr. Yvonne Achermann|+41442553402|yvonne.achermann@usz.ch|
22390736|NCT01316887|GlaxoSmithKline|GSK Response Center|866-435-7343||
22390737|NCT00832000|University of Kansas Medical Center|Richard J. Barohn, MD|913-588-6095|rbarohn@kumc.edu|
22390738|NCT03974100|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22390739|NCT03318783|Oregon Health and Science University|Ross Martini|4013386803|martinir@ohsu.edu|
22390740|NCT03856047|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22390741|NCT03398421|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22390742|NCT01419977|Duke University Medical Center|Nirmish Shah, MD|919-684-5350|nirmish.shah@duke.edu|
22390743|NCT01426113|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22390744|NCT00338949|UCSD/VA San Diego|Jonathan Meyer MD|8589640777|jmmeyer@ucsd.edu|
22390745|NCT01494545|Alcon Research, Ltd|Jami Kern, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
22390746|NCT03579433|Alcon Research, LLC|Sr. CDMA Project Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22390747|NCT00436956|National Cancer Institute|William L. Dahut, M.D.|301-435-8183|dahutw@mail.nih.gov|
22390748|NCT02271230|Brigham and Women's Hospital|Dr. Luc Djousse|617-525-7591|ldjousse@rics.bwh.harvard.edu|
22390749|NCT01283022|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22390750|NCT02719743|GlaxoSmithKline|GSK Response Center|866-435-7343|ct427449@gsk.com|
22390751|NCT01930214|Cardiovascular Systems Inc.|Clinical Project Manager|6512591600|clinicaltrials_csi@csi360.com|
22390752|NCT02601209|Memorial Sloan-Kettering Cancer Center|William D. Tap, MD|646-888-4156|tapw@mskcc.org|
22390753|NCT02111863|National Cancer Institute|Dr. Steven A. Rosenberg|301-496-4164|steven-rosenberg@nih.gov|
22390754|NCT02024750|University of Wisconsin School of Medicine and Public Health|Elizabeth Cox|608-263-9104|ecox@wisc.edu|
22390755|NCT02261285|Ono Pharmaceutical Co., Ltd.|Medical Information Center||clinical_trial@ono-pharma.com|
22390756|NCT01215032|Mass General Hospital Cancer Center|Maria Kempner|508.533.4132|mkempner@partners.org|
22390757|NCT01020747|Massachusetts General Hospital|Monica Tettamanti|617-643-5696|mtettamanti@ccib.mgh.harvard.edu|
22390758|NCT00983892|Ann Arbor Veterans Administration|Maria J. Silveira MD MA MPH|734-763-4550|mariajs@med.umich.edu|
22390759|NCT03181282|Washington University in St. Louis|Ryan Duncan|314-273-1052|duncanr@wustl.edu|
22390760|NCT04525456|NUS|Study administrator|+65 6601 7766|lsixtc@nus.edu.sg|
22390761|NCT02484547|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
22390762|NCT03765164|QURE Healthcare|Director of Clinical Trials|415-321-3388|qureadmin@qurehealthcare.com|
22390763|NCT03448536|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22390764|NCT01813305|Charsire Biotechnology Corp.|R&D associate|+886-6-702-0817|cs42@charsire.com|
22390765|NCT01665599|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22390766|NCT03120949|R-Pharm|Sergey Grishin, Head of Scientific Affairs Department|0074959567937|sa.grishin@rpharm.ru|1506
22390767|NCT01705145|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22390768|NCT00988117|UCaliforniaSF|Dr. Bruce Miller|415-476-5569|bmiller@memory.ucsf.edu; kpossin@memory.ucsf.edu|
22390769|NCT05400226|Vergent Bio|Maggie Neptune|+1-510-410-9124|mneptune@vergentbio.com|
22390770|NCT03015181|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Martin Gaudinski, MD|301-451-8715|martin.gaudinski@nih.gov|
22390771|NCT01077622|GlaxoSmithKline|GSK Response Center|866-435-7343||
22390772|NCT00424177|GlaxoSmithKline|GSK Response Center|866-435-7343||
22390773|NCT03927742|University of Minnesota|Rachel Vogel|612-624-6928|isak0023@umn.edu|
22390774|NCT03822377|Cardiology Clinic, Sassari University Hospital, Sassari, Italy|Prof. Guido Parodi|0039|parodiguido@gmail.com|792830626
22390775|NCT02356484|Lausanne University Hospital|Pr. Nicolas Demartines|0041213142424|demartines@chuv.ch|
22390776|NCT01091519|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22390777|NCT00557349|University of Missouri|Archana Ramaswamy, MD|573-884-4003|ramaswamya@health.missouri.edu|
22390778|NCT01817712|VA Cooperative Studies Program|Tassos C. Kyriakides, Ph.D, Biostatistician|203-932-5711|tassos.kyriakides@va.gov|3771
22390779|NCT01177228|Millennium Pharmaceuticals Inc|Medical Director|1-800-778-2860|clinicaltrialregistry@tpna.com|
22390780|NCT01251887|NIAAA/NIA|Ramsden, Christopher|+1 410 558 8369|ramsdence@mail.nih.gov|
22403214|NCT02488551|Central Arkansas Veterans Health Care System|Michael Cucciare|501-526-8179|michael.cucciare@va.gov|
22403215|NCT01860534|University of Texas medical Branch, Galveston|Dr. Cara Geary|409-772-2815|cageary@utmb.edu|
22403216|NCT02520518|COLORADO STATE UNIVERSITY|Manager of Research Operations|970-491-2242|Laurie.Biela@colostate.edu|
22403217|NCT00301028|UT MD Anderson Cancer Center|Merrill S. Kies, MD / Professor||CR_Study_Registration@mdanderson.org|
22403218|NCT03364673|Dana-Farber Cancer Institute|Alexi Wright, MD, MPH|617-632-2334|alexi_wright@dfci.harvard.edu|
22403219|NCT00779324|Indiana University School of Medicine|Flora Hammond, MD|3173292106|flora.hammond@rhin.com|
22403220|NCT02207556|Medical College of Wisconsin|Dr. Anita D'Souza|414-805-0637|dsouza@mcw.edu|
22403221|NCT03558555|Icahn School of Medicine at Mount Sinai|Dr. Alopi Patel|(212) 523-6357|Alopi.patel@mountsinai.org|
22403222|NCT00194025|Case Western Reserve University and Unversity Hospitals Case Medical Center|Martha Sajatovic MD|216-844-2808|martha.sajatovic@uhhospitals.org|
22403223|NCT01202721|Population Health Research Institute|Dr. Tara McCready, Program Director||tara.mccready@phri.ca|
22403224|NCT02740504|ResMed|Paul Phillips|+447789633508|paul.phillips@resmed.com|
22403225|NCT03741725|University of North Carolina, Project-China|Dr. Weiming Tang|+86-15920567132|weiming_tang@med.unc.edu|
22403226|NCT01199055|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22403227|NCT00511342|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22403228|NCT02432040|University of the Philippines - Philippine General Hospital Section of Dermatology|Dr. Sharlene Chua|2418118|sharlene_chua@yahoo.com|
22403229|NCT00369668|University of Florida, Motor Behavior Laboratory|James Cauraugh, Ph.D., PI|352-294-1623|jcaura@hhp.ufl.edu|
22403230|NCT04158908|Weill Cornell Medicine|Sophia Kakarala|(646) 962-5650|sok4004@med.cornell.edu|
22403231|NCT00303108|New York Oncology Hematology, Albany Medical Center|Dr. Rufus Collea|518-262-6696|rufus.collea@usoncology.com|
22403232|NCT03855137|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22403233|NCT02427477|Johnson & Johnson Vision Care Inc.|John R. Buch, O.D., M.S., F.A.A.O.|904-443-3500|JBUCH@its.jnj.com|1707
22403234|NCT02435277|NuSirt Biopharma|Barbara Cannon|615-656-7898|BCannon@nusirt.com|
22403235|NCT00444626|Genzyme|Genzyme Medical Information (MedInfo)||medinfo@genzyme.com|
22403236|NCT00462020|Children's Mercy Hospital|Shawn D. St. Peter, MD|816-983-6479|sspeter@cmh.edu|
22403237|NCT00008138|SWOG Statistical Center|GYN Committee Statistician|206-667-4623||
22403238|NCT03213626|IndianaU|Dr. Patrick Loehrer|(317) 278-7418|ploehrer@iu.edu|
22403239|NCT01005732|University of Washington|Loren Engrav|206-744-3209|engrav@u.washington.edu|
22403240|NCT03302793|UTHealth|Dr. Sheng Li|713-797-7125|Sheng.Li@uth.tmc.edu|
22403241|NCT02198651|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22403242|NCT03522350|Weill Cornell Medical College|Nikica Zaninovic, PhD|212-746-5790|nizanin@med.cornell.edu|
22403243|NCT02389712|Mayo Clinic|Mark A. Frye, M.D.|507-255-7164|MFrye@mayo.edu|
22403244|NCT00786032|Hines Coordinating Center|Project Manager|708-202-5785|tamara.paine@va.gov|
22403245|NCT02922634|BWH|Dr. Gregory Crosby|617-732-7330|gcrosby@bwh.harvard.edu|
22403246|NCT02625324|Medtronic|Rianna Rapson - Clinical Study Manager|763-526.2170|rianna.k.rapson@medtronic.com|
22403247|NCT02457182|University of New Mexico|Gregg Kanter, MD|818-599-3456|greggkanter@gmail.com|
22403248|NCT00304265|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22403249|NCT00352755|Washington University School of Medicine|Dr. James Fleshman|314-747-4610|James.Fleshman@BSWHealth.org|
22403250|NCT03534063|University of Florida|Dr. Larisa Cavallari|(352) 273-8245|LCavallari@cop.ufl.edu|
22403251|NCT02397694|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22403252|NCT00424528|Sepracor Inc|Respiratory Medical Affairs Director|866-503-6351||
22403253|NCT02115113|Novartis Pharmaceuticals|Study Director|862-778-8300||
22403254|NCT01313520|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com|
22403255|NCT01009983|Wake Forest University Health Sciences|Dr. Susan Melin|336-716-2839|smelin@wakehealth.edu|
22403256|NCT02560493|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|2257632869|amanda.staiano@pbrc.edu|
22403257|NCT03137121|Univ Alabama Birmingham|Rudolph M Navari|574-261-8385|rmnavari@gmail.com|
22403258|NCT04410198|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|FG4592-097Study@fibrogen.com|
22403259|NCT02871401|Vanderbilt University Medical Center|Jonathan Kropski MD|615-322-3412|jon.kropski@vumc.org|
22403260|NCT02282982|AbbVie|Global Medical Services|800-633-9110||
22403261|NCT02006667|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22403262|NCT02939937|assistant|dr.alireza gholizade|989112550646|a.gholizade13@yahoo.com|
22403263|NCT02152670|Yale University|Gustavo Angarita, MD, Assistant Professor of Clinical Psychiatry|(203) 974-7536|gustavo.angarita@yale.edu|
22403264|NCT00568958|Yale University School of Medicine|Dr. Stephanie S. O'Malley|203-974-7590|stephanie.omalley@yale.edu|
22403265|NCT02607254|Johns Hopkins University|Dr. Mohammad Khoshnoodi|410-955-5406|mkhoshn1@jhmi.edu|
22403266|NCT00798655|University of Pittsburgh|Robert Ferris, MD|412-647-4654|ferrrl@UPMC.EDU|
22403267|NCT02943265|University of Kansas Medical Center|Simon Lee|(913) 588-2689|slee21@kumc.edu|
22403268|NCT02179515|National Cancer Institute|Dr. James Gulley|301-480-8870|James_Gulley@nih.gov|
22403269|NCT01774344|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22403270|NCT03664193|Weill Cornell Medicine|Josephine Kang|212-746-3607|jok9106@med.cornell.edu|
22403271|NCT01157416|Tulane University School of Medicine|Dr. Michael Scheeringa|5046692322|mscheer@tulane.edu|
22403272|NCT01515995|UT Southwestern Medical Center|Mohamed Badawy, MD|2144567106|mohamed.badawy@utsouthwestern.edu|
22416159|NCT02180230|Nobel Biocare|Head of Clinical Trial Management|+41 43 211 42 00|isabelle.arrighi@nobelbiocare.com|
22416160|NCT01589601|Duke University Medical Center|Joseph G. Rogers, MD|919-681-1370|joseph.rogers@duke.edu|
22431220|NCT01206517|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22431221|NCT00725985|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22431222|NCT02546323|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22431223|NCT04476784|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22431224|NCT02134184|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
22431225|NCT02997085|Baylor Scott & White Research Institute|Dr. Mark Powers|2148652409|Mark.Powers1@bswhealth.org|
22416161|NCT04155840|University of Washington|Dr. Ryan Lynch|206-606-1739|rclynch@uw.edu|
22416162|NCT01819064|Women and Children's Hospital of Buffalo, State University of New York at Buffalo|Dr. Jerrold Lerman|7168787701|jlerman@buffalo.edu|
22416163|NCT01077258|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22416164|NCT00434837|Rhode Island Hospital|Dr. Braden C. Fleming|401-316-4737|braden_fleming@brown.edu|
22416165|NCT00142116|Dana Farber Cancer Institute|Steven P. Treon MD, PhD|617-632-2681|steven_treon@dfci.harvard.edu|
22416166|NCT00726895|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22416167|NCT04079452|Hospital de Bellvitge|Clinical Project Manager|+34675335888|anavarroa@bellvitgehospital.cat|
22416168|NCT00345033|Massachusetts General Hospital|David C. Henderson|(617) 912-7800|dchenderson@partners.org|
22416169|NCT01881737|Stanford University School of Medicine|Antonio Hardan, MD|(650) 736-1235|hardanay@stanford.edu|
22416170|NCT02102932|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
22416171|NCT01450800|Duke University Medical Center|Dr. Alexis Dieter|919-401-1006|alexis.dieter@duke.edu|
22416172|NCT03023137|Hospital Federal dos Servidores do Estado|Dr. Silvia Hoirisch-Clapauch|5521999737500|sclapauch@gmail.com|
22416173|NCT03496298|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22416174|NCT01658995|Mayo Clinic|Petra M. Casey, M.D.|507-266-9873|Casey.Petra@mayo.edu|
22416175|NCT02058160|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22416176|NCT02260635|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22416177|NCT04106817|WCCT Global|Associate Director of Regulatory Affairs|7207713080|erin.flynn@wcct.com|
22416178|NCT04660032|University of Michigan|Dr. Jourdan Triebwasser|734-764-1406|jtriebwa@med.umich.edu|
22416179|NCT00090753|Hoffmann-La Roche|Medical Communications|800-821-8590||
22416180|NCT02767947|Bausch Health Americas, Inc|Director of Clinical Operations||aloncaric@bauschhealth.com|
22416181|NCT03224520|University of Massachusetts Medical School|Rajani Sadasivam|508-856-8923|rajani.sadasivam@umassmed.edu|
22416182|NCT01812473|Universitaire Ziekenhuizen Leuven|Kim Vanstraelen, PharmD|0032 16 342339|kim_vanstraelen@hotmail.com|
22431226|NCT00863304|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22431227|NCT00952692|Duke University|Dr. Michael Morse|919-681-3480|morse004@mc.duke.edu|
22431228|NCT01182350|Dana-Farber Cancer Institute|Karen Wright|617.632.6740|KarenD_Wright@dfci.harvard.edu|
22431229|NCT04023487|University of Southern California|Beth Pyatak|323-442-2615|beth.pyatak@chan.usc.edu|
22431230|NCT00605189|KCI, an Acelity Company|Senior Director, Global Clinical Development|210-255-5595|jane.hart@kci1.com|
22431231|NCT03898180|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22431232|NCT04503616|NYU Langone Health|Kelli Cole, NP|646-501-4848|Kelli.Cole@NYULangone.org|
22390781|NCT00654615|Wake Forest University Health Sciences|Zhongyu Li, MD, PhD, Professor - Department of Orthopaedic Surgery|336-716-9520|zli@wakehealth.edu|
22390782|NCT00316589|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
22390783|NCT03594045|Massachusetts General Hospital|Dr. Rachel Rosovsky|617-724-4000|RPROSOVSKY@mgh.harvard.edu|
22390784|NCT01283971|Hoffman-LaRoche|Medical Communications|800-821-8590||
22390785|NCT02617667|Novaliq GmbH|Dr Sonja Krösser, VP Preclinical and Clinical Development|+49 6221 50259-0||
22390786|NCT03777553|Durham Veterans Affairs Medical Center|Elizabeth Van Voorhees|919-886-5542|elizabeth.vanvoorhees@va.gov|
22390787|NCT00562484|Seqirus|Clinical Study Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com|
22390788|NCT01554371|University of California, San Francisco|Dr. Hope Rugo, MD|(415) 353-7618|Hope.Rugo@ucsf.edu|
22390789|NCT02598934|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22390790|NCT02811302|Medtronic - MITG, RGI|Melanie Crystal, Sr. Clinical Program Manager|720-435-5737|melanie.crystal@medtronic.com|
22390791|NCT00702520|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22390792|NCT02154347|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
22390793|NCT02481934|Hospital universitario 12 de octubre|Alejandra Leivas PhD|+34917792612|alejandraleial@gmail.com|4612
22390794|NCT02473913|University of Chicago|Stephanie Valle|773-834-3778|svalle@yoda.bsd.uchicago.edu|
22390795|NCT04013932|University of North Carolina at Chapel Hill|Joy Noel Baumgartner|919.923.8534|joy.baumgartner@unc.edu|
22390796|NCT05399082|Mayo Clinic|Ryan M. Kern, M.D.|507-266-3958|Kern.Ryan@mayo.edu|
22390797|NCT00960505|University of Illinois Chicago|Krista Varady, PhD, Associate Professor|3129967897|varady@uic.edu|
22390798|NCT02250183|Allegheny Health Network-West Penn Hospital Burn Center|Ariel M. Aballay, MD|412-578-1836|Ariel.Aballay@AHN.org|
22390799|NCT03282799|University of Pittsburgh|Dr. Catherine Chappell|412-641-1403|chappelca@upmc.edu|
22390800|NCT01879085|UPMC Hillman Cancer Center|Barbara M Stadterman, MPH, MCCR, Clinical Trials Administrator|412-647-5554|stadtermanbm@upmc.edu|
22390801|NCT03749616|UMissouri|Vicki L Jones|573-882-7583|jonesvicki@health.missouri.edu|
22416183|NCT00756717|Loyola University Medical Center|Dr. Kathy Albain|708-327-3102|KALBAIN@lumc.edu|
22416184|NCT00250705|The University of Iowa|An Open Label Trial of Aripiprazole in the Treatment of Conduct Disorder in Adolescents.|319-356-1482|Samuel-Kuperman@uiowa.edu|
22390802|NCT03302559|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22390803|NCT00771238|Nebraska Medical Center|Joyce Black, PhD, RN|402-559-6573|JBlack@unmc.edu|
22390804|NCT03390933|MetroHealth System|Dr. Ashwini Sehgal|216-778-8484|axs81@case.edu|
22390805|NCT03371706|University of Chicago|Dr. Emily Rogalski|855-824-7887|emily.rogalski@bsd.uchicago.edu|
22390806|NCT02080403|Dexcel Pharma|Clinical Trial Department Manager|972-4-6364000|sigalit.melcer@dexcel.com|467
22390807|NCT01999972|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22390808|NCT01171183|University of Arkansas for Medical Sciences|Alison Oliveto, PhD|501-526-8441|olivetoalison@uams.edu|
22390809|NCT04260464|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22390810|NCT01004029|Covis Pharma|Clinical Trial Interest|1-877-374-4177|CTInterest@covispharma.com|
22390811|NCT02826798|VBI|Bebi Yassin-Rajkumar|613-749-4200|byassin-rajkumar@vbivaccines.com|151
22390812|NCT02531867|Alexion|Medical Director|(781) 357-9900|clinicaltrials@alexion.com|
22390813|NCT02806505|Hoffmann-La Roche|Medical Communications|800-821-8590|global.trial_information@roche.com|
22390814|NCT00803777|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
22390815|NCT03440047|Mayo Clinic|Dr. Nayantara Coelho-Prabhu|(507)284-2407|CoelhoPrabhu.Nayantara@mayo.edu|
22390816|NCT01722045|Regeneron Pharmaceuticals, Inc.|Clinical Trial Administrator||clinicaltrials@regeneron.com|
22390817|NCT03379545|NYU Langone Health|Joseph Zuckerman, MD|212-598-6674|Joseph.Zuckerman@nyulangone.org|
22390818|NCT03898700|Thomas Jefferson University|Dr. MJ Mulcahey|215-503-2888|maryjane.mulcahey@jefferson.edu|
22390819|NCT01788475|Lahey Medical Center|Christine Gould PAC, MS|9785384412|christine.gould@lahey.org|
22390820|NCT00701909|University of California, San Francisco|Dr. Kathleen Puntillo, RN, PhD|415 819 2655|kathleen.puntillo@ucsf.edu|
22390821|NCT01789840|Merit Medical|Casey Holland|1 (617) 842-0251|casey.holland@merit.com|
22390822|NCT00971997|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22390823|NCT03006185|Bispebjerg Hospital|Emily Wenande|+4540505590|emilycathrinew@hotmail.com|
22390824|NCT03984513|Cincinnati Children's Hospital|Dr. Amie Duncan|513-803-2416|Amie.Duncan@cchmc.org|
22390825|NCT04843579|Weill Cornell Medicine|Multiple Myeloma Program Manager|646-962-9376|hyk4001@med.cornell.edu|
22390826|NCT04009629|University of Kansas Medical Center|Dr. Eric Vidoni|913-588-0555|kuamp@kumc.edu|
22390827|NCT01937195|Evangelical Community Hospital|Norman R. Anderson|570-222-2000|nanderson@evanhospital.com|
22390828|NCT01928693|Cornea Consultants of Nashville|Ira Shivitz MD|615-320-7200|jhatley@corneaconsultants.net|
22390829|NCT00761956|Zimmer, Inc|Kacy Arnold, Associate Director, Clinical Affairs|574-371-8336|kacy.arnold@zimmer.com|
22390830|NCT02022111|Emory University|Mohammed Kumail Ali, MD|404-727-9776|mkali@emory.edu|
22390831|NCT04398368|Mayo Clinic|Stephen A. Boorjian, M.D.|507 422-5516|Boorjian.Stephen@mayo.edu|
22390832|NCT03602586|NRG Oncology|Christopher Purdy on behalf of Danielle Enserro, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
22390833|NCT01479270|MetroHealth Medical Center|Robert Pollard|216-778-4444|rpollard@metrohealth.org|
22390834|NCT01755546|BIODELIVERY|Vice President, Operations|919-582-0294|twarneke@bdsi.com|
22390835|NCT04702893|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22390836|NCT03294941|HepQuant, LLC|Elyse Handley|303-923-2109|elyse.handley@hepquant.com|
22390837|NCT04629443|Institut de Recherches Internationales Servier (I.R.I.S.)|Clinical Studies Department|+33 1 55 72 60 00|scientificinformation@servier.com|
22390838|NCT03954223|Children's Hospital Los Angeles|Alaina Vidmar, MD|323-361-3385|avidmar@chla.usc.edu|
22390839|NCT01172639|University Hospitals Leuven|Prof. Dr. Patrick Verschueren|+32 16 34 25 41|patrick.verschueren@uzleuven.be|
22390840|NCT02172950|CSL Behring|Clinical Trial Disclosure Manager|use email contact|clinicaltrials@cslbehring.com|
22390841|NCT00469456|Forest Research Institute, a subsidiary of Forest Laboratories Inc.|Stephen Graham, PhD|201-427-8156|stephen.graham@frx.com|
22390842|NCT01743521|Kirby Institute|A/Prof Gail Matthews|+61 (0)2 9385 0900|gmatthews@kirby.unsw.edu.au|
22390843|NCT00704171|Covidien|Jennifer L. Doyle, Global Director of Clinical Affairs|781-839-1770|jennifer.doyle@covidien.com|
22390844|NCT00078728|The Johns Hopkins University School of Medicine|Golda Ginsburg, PhD,Professor|410-955-1544|gginnsbu@jhmi.edu|
22390845|NCT00913068|Capital District Health Authority|Dr. Ricardo A. Rendon|9024736604|rrendon@dal.ca|
22390846|NCT00813098|Lexicon Pharmaceuticals, Inc.|Clinical Project Manager|281-863-3000||
22390847|NCT04269434|Instituut van Tropische Geneeskunde Antwerpen|Dr. Chris Kenyon|+3232470786|ckenyon@itg.be|
22390848|NCT01196819|Shanghai Microport Medical (Group) Co.,Ltd.|Kefei Li|+86-21-38954600×6700|kfli@microport.com|
22390849|NCT01086384|GlaxoSmithKline|GSK Response Center|866-435-7343||
22390850|NCT03854019|The University of Texas Health Science Center at Houston|Erin Furr Stimming, MD|713-500-7033|Erin.E.Furr@uth.tmc.edu|
22390851|NCT02586415|Stanford University/School of Medicine|Dr. Gregory Albers|650-723-4448|albers@stanford.edu|
22390852|NCT01690923|ResMed Ltd|Xueling Zhu, Clinical Consultant|61288842265|xueling.zhu@resmed.com.au|
22390853|NCT02023905|University of California, San Francisco|Dr. Jennifer Clarke, MD MPH|(415) 353-2167|Jennifer.Clarke@ucsf.edu|
22390854|NCT00263575|Strakan Pharmaceuticals Ltd|Fiona Miller|01896 66868|fiona.miller@prostrakan.com|
22390855|NCT05674292|Erchonia Corporation|Clinical Affairs Manager|8882420571|tsammons@erchonia.com|501
22390856|NCT01841112|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22416185|NCT00587431|Memorial Sloan-Kettering Cancer Center|Dr. Dana Rathkopf|646-422-4379|rathkopd@mskcc.org|
22416186|NCT05467982|Dartmouth-Hitchcock|Sarah Pratt, PhD-Contact PI|603-496-2665|sarah.i.pratt@dartmouth.edu|
22416187|NCT03185741|Northwestern University|Dr. Michael Wolf|(312) 503-5592|mswolf@northwestern.edu|
22416188|NCT00749658|University of Minnesota|Marc Mooney PhD||moon0078@umn.edu|
22416189|NCT03573336|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
22416190|NCT03108820|University of Wisconsin School of Medicine and Public Health|Dr. Ben Zarzaur|(608) 265-9574|zarzaur@surgery.wisc.edu|
22416191|NCT03298880|University of Exeter, Royal Devon and Exeter Hospital|Dr Andrew Appelboam, Isabel FitzGerald|07515688294|andy.appelboam@nhs.net ; if223@exeter.ac.uk|
22416192|NCT02299869|CooperVision|Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com|
22431233|NCT05030766|University of Miami|Dr. Taghrid Asfar|+1 (901) 371-7229|tasfar@miami.edu|
22390857|NCT03467698|UT Dallas|UT Dallas IRB DIrector|972-883-4506|amanda.boone@utdallas.edu|
22390858|NCT02669615|Medical College of Wisconsin|Parameswaran Hari|4148054600|phari@mcw.edu|
22390859|NCT01612767|BIOTRONIK|Amy Culley, Director of Vascular Intervention|503-451-8034|amy.culley@biotronik.com|
22390860|NCT01209286|Amgen Inc.|Study Director|866-572-6436||
22390861|NCT01891890|Emory University|David Loring, PhD|404-778-5943|dloring@emory.edu|
22390862|NCT03029819|Georgia State University School of Public Health|Claire Spears|4044139335|cspears@gsu.edu|
22390863|NCT00806598|The University of Texas MD Anderson Cancer Center|Tapan Kadia, MD/Assistant Professor|713-563-3534|eharriso@mdanderson.org|
22390864|NCT03605368|Children's Hospital of Philadelphia|Julia Parish-Morris|267-426-7540|parishmorrisj@chop.edu|
22390865|NCT01149876|MGH|Dr. Molly Wanner|617-726-2914|harvardskinstudies@partners.org|
22390866|NCT02881047|Hospital of the University of Pennsylvania|Study Coordinator|215-662-6722|leahyd@uphs.upenn.edu|
22390867|NCT02736955|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22390868|NCT05288504|Avalo Therapeutics, Inc.|Garry Neil, MD|610.254.4201|gneil@avalotx.com|
22390869|NCT01329419|GlaxoSmithKline|GSK Response Center|866-435-7343||
22390870|NCT02920021|AnaptysBio, Inc.|Clinical Project Leader|858-362-6295|info@anaptysbio.com|
22390871|NCT05250960|TriHealth|Rachel Baker|513-569-6191|Rachel_Baker2@trihealth.com|
22416193|NCT01488448|Children's Hospital at Montefiore/Albert Einstein College of Medicine|Dr. Alyssa Silver|718-741-2304|alysilve@montefiore.org|
22390872|NCT00514813|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22390873|NCT00749671|Baystate|James R. Cook MD|413-794-4492|james.cook@bhs.org|
22390874|NCT01075100|US Oncology Research, McKesson Specialty Health|Dr. Cynthia Osborne|214-370-1057|Cynthia.Osborne@usoncology.com|
22390875|NCT00731588|University of Iowa|John A. Widness, M.D.|319-356-8102|john-widness@uiowa.edu|
22390876|NCT00966264|Helsinki University|Ritva Hurskainen|+23845872267|ritva.hurskainen@hus.fi|
22390877|NCT03614676|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22390878|NCT02263040|Mount Sinai Hospital, Toronto|Dr. Allison McGeer|416-586-3118|allison.mcgeer@sinaihealthsystem.ca|
22390879|NCT00416598|The Ohio State University|William Blum, M.D.||William.Blum@osumc.edu|
22390880|NCT00511836|Alkermes, Inc.|Bernard L. Silverman|781-609-6000|bernard.silverman@alkermes.com|
22390881|NCT00030823|Memorial Sloan Kettering Cancer Center|Dr. Teresa Gilewski|646-888-4557|gilewskt@mskcc.org|
22390882|NCT01083199|American Medical Systems|Laura Olson, Clinical Project Manager|952-930-6428|laura.olson2@bsci.com|
22390883|NCT01226732|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22390884|NCT00848510|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22390885|NCT00891046|Novartis Pharmaceuticals|Study Director|862--778--8300||
22390886|NCT02166476|The Medicines Company|Global Health Science Center|888-977-6326|medical.information@themedco.com|
22390887|NCT05155566|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22390888|NCT00362375|SisterLove, Inc.|Dazon Dixon-Diallo, Executive Director|404-505-7777|ddiallo@sisterlove.org|
22390889|NCT02106195|Kadmon Corporation, LLC|Associate VP, Clinical Operations|833-900-5366|karin.herrera@kadmon.com|
22390890|NCT04984239|University of Pittsburgh|William Evans|412-383-6943|will.evans@pitt.edu|
22390891|NCT02034019|Ocular Therapeutix, Inc.|Director, Clinical Affairs|781-357-4000|dmulani@ocutx.com|
22390892|NCT04523207|Janssen Research & Development, LLC|Group Medical Director Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22390893|NCT03113383|Vanderbilt University Medical Center|Thomas C Naslund, MD|5-322-2343|thomas.naslund@vumc.org|
22390894|NCT02438371|The University of Texas Health Science Center at Houston|Jerrie S. Refuerzo, MD|(713) 500-6416|Jerrie.S.Refuerzo@uth.tmc.edu|
22390895|NCT03065933|McLean Hospital|Elizabeth S. Liebson, M.D.|617-855-2284|eliebson@partners.org|
22390896|NCT01513330|Coloplast A/S|Director of Clinical Trials|+45 4911 3595|dkbir@coloplast.com|
22390897|NCT02431455|Lahey Hospital and Medical Center|Haddon Pantel|3013566674|Haddon.Pantel@Lahey.org|
22390898|NCT00916305|London School of Hygiene & Tropical Medicine|Clare Gilbert|+44 207 958 8332|clare.gilbert@lshtm.ac.uk|
22390899|NCT01379703|Abbott|Global Medical Services|1-800-633-9110||
22390900|NCT03481556|Oncopeptides AB|VP Chief Operating Officer|+46 8 615 20 40|trials@oncopeptides.com|
22390901|NCT03463577|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22390902|NCT00236184|Eisai Medical Research Inc.|Yufang Lu, MD, PhD, Study Director|201-403-2500||
22390903|NCT01101997|Zeltiq Aesthetics|Kerrie Jiang, Executive Director Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
22390904|NCT01841697|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22416194|NCT00654641|West Viginia University|Michael L. Stitely, MD|304-293-1566|mstitely@hsc.wvu.edu|
22416195|NCT01475487|Department of Anesthesia and Pain Management, Mount Sinai Hospital Toronto, Canada|Dr Naveed Siddiqui|4165864800|naveed.siddiqui@uhn.ca|5270
22416196|NCT01992094|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22416197|NCT01214239|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22416198|NCT00810602|University of Michigan Comprehensive Cancer Center|Dr. Sung Choi|734-764-8630|sungchoi@med.umich.edu|
22416199|NCT01142661|Eisai Inc.|Prash Gopalakrishna|888-422-4743||
22416200|NCT03180528|Stanford University|Kavita Yang Sarin|(650) 723-6316|ksarin@stanford.edu|
22416201|NCT02447887|Fox Chase Cancer Center|Dr. Daniel M. Geynisman|215-728-3889|daniel.geynisman@fccc.edu|
22416202|NCT03429049|Centrexion Therapeutics, Inc.|Director of Clinical Operations|617-837-6911|info@centrexion.com|
22416203|NCT04703855|Abbott|Carlo Gazzola|+3227746811|carlo.gazzola@abbott.com|
22416204|NCT02717078|University of Minnesota|Anne Bantle|612-625-8673|endofixer@umn.edu|
22416205|NCT02012452|VA Boston healthcare system|Sandra Japuntich|6082398018|sjjapuntich@gmail.com|
22416206|NCT04403399|U of Michigan|Dr. Cathie Spino, Research Professor of Biostatistics|7346155469|spino@umich.edu|
22416207|NCT00399893|Duke University Medical Center|Michael Freemark, MD|919-684-5091|andrea.haqq@albertahealthservices.ca|
22416208|NCT04412057|Avalo Therapeutics, Inc.|Scott White, MD|484-763-3080|swhite@avalotx.com|
22416209|NCT02137382|Abbott|Suntje Sander - Struckmeier|+49 (0) 511 6750 3254|suntje.sander-struckmeier@abbott.com|
22416210|NCT00831233|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
22416211|NCT02457819|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
22416212|NCT06217796|Eyenovia|Greg M. Bennett, VP, Clinical Program Strategy and Development|833-393-6684|gbennett@eyenovia.com|5
22416213|NCT01064531|Smith & Nephew, Inc|Tracey Brengola, MS|978-749-1491|Tracey.brengola@smith-nephew.com|
22416214|NCT02740920|Canadian Cancer Trials Group|Janet Dancey|613-533-2430|jdancey@ctg.queensu.ca|
22416215|NCT00513617|Rho Federal Systems Division|Karen Kesler, PhD|919-408-8000|karen_kesler@rhoworld.com|244
22416216|NCT00573170|GlaxoSmithKline|GSK Response Center|866-435-7343||
22416217|NCT03346850|The University of Texas Health Science Center at Houston|Raymond Parlar-Chun, MD|713-500-5666|Raymond.L.Chun@uth.tmc.edu|
22416218|NCT00779402|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@Dendreon.com|
22416219|NCT01519947|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22416220|NCT00693225|Mayo Clinic|Dr. Yvonne Romero|507-266-9156|romero.yvonne@mayo.edu|
22416221|NCT01992016|University of Colorado Cancer Center|Elaine Lam, MD|7208480273|elaine.lam@ucdenver.edu|
22416222|NCT01186016|University of Nebraska Medical Center|Julia F Houfek|402-660-4046|jhoufek@unmc.edu|
22416223|NCT00890916|Louis Stokes Cleveland VAMC|Dr. Kevin Kilgore|216-9573657|klk4@case.edu|
22416224|NCT03750695|Duke University|Dr. William Todd Cade|919-660-9825|todd.cade@duke.edu|
22416225|NCT03173560|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22416226|NCT00216060|Hoosier Oncology Group|Christopher Sweeney, M.B., B.S.|(617) 632 4524|christopher_sweeney@dfci.harvard.edu|
22416227|NCT02174276|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22416228|NCT02661022|Stemline Therapeutics, Inc.|Ira Gupta, MD, Senior Vice President, Clinical Development & Medical Affairs - Hematology|877-332-7967|clinicaltrials@menarinistemline.com|
22416229|NCT02525263|CTI|Dr William S Aronstein|5135989290|baronstein@ctifacts.com|
22403273|NCT00502320|Lehigh Valley Hospital|Edward R. Norris, MD|610-402-5766|Edward.Norris@lvh.com|
22403274|NCT00543569|Astellas Pharma Global Development, Inc. (APGD)|Global Head Global Medical Sciences--Transplant and Immunology/Inflammation||Astellas.resultsdisclosure@astellas.com|
22403275|NCT04019275|University of Pittsburgh|Elizabeth Skidmore|412-383-6620|skidmore@pitt.edu|
22403276|NCT00862849|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|858-794-8889||
22403277|NCT00617409|H. Lee Moffitt Cancer Center and Research Institute|Dr. Scott Antonia|813-745-3883|scott.antonia@moffitt.org|
22403278|NCT02344407|Division of Biostatistics, University of Minnesota|Greg Grandits|612-626-9033|grand001@umn.edu|
22403279|NCT04124536|University of North Carolina at Chapel Hill|Benjamin Chi, MD, MSc|919-445-4174|bchi@med.unc.edu|
22403280|NCT02124707|UNC Lineberger Comprehensive Cancer Center|Robin Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
22403281|NCT00677690|Fondazione Salvatore Maugeri, IRCCS, Pavia, Italy|Ercole Zanotti|39 385 247|ercole.zanotti@fsm.it|324
22403282|NCT01363713|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
22403283|NCT00718666|GlaxoSmithKline|GSK Response Center|866-435-7343||
22403284|NCT02196038|Wake Forest School of Medicine|Dr. Dalane Kitzman|336-716-3274|dkitzman@wakehealth.edu|
22403285|NCT01580592|Charité - University of Berlin; Dpt. of Dermatology and Allergy|Professor Dr. Martin Metz|+49 30 450 518 159|martin.metz@charite.de|
22403286|NCT00360243|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com|
22403287|NCT00590018|Baylor College of Medicine|Dr. Heather Dickerson|832-826-5637|had@bcm.edu|
22403288|NCT00853333|University of Alabama at Birmigham|Michael Froelich|(205)975-0145|froelich@uab.edu|
22403289|NCT01766336|Transition Therapeutics Ireland Limited|Aleksandar Pastrak, MD, PhD, Vice President Clinical Development|+1 416 263 1227|apastrak@transitiontherapeutics.com|
22416230|NCT00725764|GlaxoSmithKline|GSK Response Center|866-435-7343||
22416231|NCT04480307|GeNeuro SA|David Leppert, Study director|225524800|dl@geneuro.com|+41
22403290|NCT03029650|University of Iowa|Nicole Brogden|319-335-8752|nicole-brogden@uiowa.edu|
22403291|NCT04544709|University of Utah Orthopaedics Center|Heather Littell, Regulatory Coordinator|801-587-5432|u6041929@utah.edu|
22403292|NCT03135028|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22403293|NCT00496873|University of Texas (UT) MD Anderson Cancer Center|Felipe Samaniego, MD/Associate Professor, Lymphoma/Myeloma||CR_Study_Registration@mdanderson.org|
22403294|NCT02065869|Bellicum Pharmaceuticals|Rivogenlecleucel Study Team|(832) 384 1100|clinicaltrials@bellicum.com|
22403295|NCT01842620|GlaxoSmithKline|GSK Response Center|866-435-7343||
22403296|NCT01442129|Mount Sinai|Deborah D. Ascheim, MD, Associate Professor, Clinical Director of Research, InCHOIR|212-659-9567|deborah.ascheim@mountsinai.org|
22403297|NCT01814800|ADMA Biologics|Jimmy Mond, M.D., Ph.D|201-478-5552|jmond@admabio.com|
22403298|NCT02402218|Johns Hopkins School of Medicine|Dr. Mark Sulkowski|443-997-1900|msulkowski@jhmi.edu|
22403299|NCT03827473|Huntsman Cancer Institute Research Compliance Office|Data Manager|8015850601|compliance@hci.utah.edu|
22403300|NCT04436822|Medtronic Diabetes|Robin Mottackel|8185764886|robin.e.mottackel@medtronic.com|
22403301|NCT03807739|Genentech, Inc|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22403302|NCT02371759|University of Belgrade, Faculty of Dental Medicine|DDS PhD Professor Dragica Stojic, DDS PhD Professor Bozidar Brkovic, DDS PhD Marija Milic|+ 381 11 2685 280|brkovic73@yahoo.com|244
22403303|NCT00430625|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22403304|NCT02774226|Augusta University|Dr. Ryan Harris|706-721-5483|ryharris@augusta.edu|
22403305|NCT03136185|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22403306|NCT00125658|VA Brain Rehabilitation Research Center|Dr. Carolynn Patten|352.376.1611|carolynn.patten@va.gov|4160
22403307|NCT02876055|Mayo Clinic|Dr. Jason K. Panchamia|507-284-9698|panchamia.jason@mayo.edu|
22403308|NCT03705962|University of Virginia|Eric McVey|434.243.5382|edm9u@hscmail.mcc.virginia.edu|
22403309|NCT03744780|McGill University|Mallory Frayn, PhD(c)|N/A|mallory.frayn@mail.mcgill.ca|
22403310|NCT05118386|Gates Medical Research Institute|Study Director|+1 857 702 2108|clinical.trials@gatesmri.org|
22403311|NCT00488033|Intermountain Heart Institute|J.Brent Muhlestein|8015074702|jbrent.muhlestein@imail.org|
22403312|NCT00894413|Johns Hopkins University School of Medicine|Zubair Khan, MD|410-955-3157|zkhan@jhmi.edu|
22403313|NCT04019093|University of Florida|Jeff Boissoneault, PhD|352-273-6147|jboissoneault@phhp.ufl.edu|
22403314|NCT03054077|Virginia Commonwealth University|Debra Shockey|804-828-3744|dpshockey@vcu.edu|
22403315|NCT02635737|UHSM|Mr James Harvey|01612914436|james.harvey@uhsm.nhs.uk|
22403316|NCT01552928|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22403317|NCT03566108|University of Alabama at Birmingham|Dr. Maria Geisinger, PI, Professor, Director of Advanced Education in Periodontology|205-934-4984|miagdds@uab.edu|
22403318|NCT03492463|Duke University|Jed E. Rose, Ph.D.|919-668-5055|jed.rose@duke.edu|
22403319|NCT00406640|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22403320|NCT00488618|Allergan, Inc.|Therapeutic Area Head|714-246-4500||
22403321|NCT02278640|Ethicon Endo-Surgery|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
22416232|NCT00609154|Albert Einstein College of Medicine|Dr. Daniel Stein|718-430-2237|daniel.stein@einsteinmed.edu|
22416233|NCT02907073|Mayo Clinic|Dr. Timothy R. DeGrado|507-293-3793|DeGrado.Timothy@mayo.edu|
22416234|NCT03316976|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22416235|NCT01186562|University of Minnesota|Melena D. Bellin|612-624-5409|bell0130@umn.edu|
22416236|NCT00732160|Vanderbilt University Medical Center|James M. Luther|(615) 936-3420|James.Luther@Vanderbilt.edu|
22416237|NCT00108550|VA San Diego Healthcare System|J. H. Atkinson MD|858-642-3775|joseph.atkinson@va.gov|
22416238|NCT02427399|Fenway Health|Dr. Jennifer Potter|617-416-0986|jpotter@bidmc.harvard.edu|
22416239|NCT00176930|Masonic Cancer Center, University of Minnesota|Dr. Daniel J.Weisdorf, M.D|612 624-3101|weisd001@umn.edu|
22403322|NCT00789191|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22403323|NCT03736629|University of Chicago|Theodore Karrison (Research Professor)|773-702-9326|tkarrison@health.bsd.uchicago.edu|
22403324|NCT02860845|Laboratorios Ordesa|Roser De Castellar|+34 902105243|Roser.DeCastellar@ordesa.es|
22403325|NCT01819311|Florida International University|Jeremy W. Pettit (PI)|305-348-1671|jpettit@fiu.edu|
22403326|NCT02343276|Instituto de Cardiologia de Santa Catarina|Roberto Léo da Silva|55 48 32719077|robertoleo@hotmail.com|
22416240|NCT03507686|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22416241|NCT00585312|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22416242|NCT00129116|GlaxoSmithKline|GSK Response Center|866-435-7343||
22416243|NCT00337987|Yale University School of Medicine|Francine Foss, MD|203-737-5312|francine.foss@yale.edu|
22416244|NCT02539368|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22416245|NCT02203578|Rutgers Cancer Institute of New Jersey|Roger Strair, MD, PhD|732-235-7298|strairrk@cinj.rutgers.edu|
22416246|NCT03558139|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22416247|NCT02752802|Osprey Medical, Inc|Michele Shepard, Vice President of Clinical Affairs|952-955-8236|mshepard@ospreymed.com|
22416248|NCT00251316|NIDDK, NIH|Dr. Monica Skarulis|301-496-6087|monicas@intra.niddk.nih.gov|
22416249|NCT00398073|Memorial Sloan Kettering Cancer Center|Jedd Wolchok, MD, Chief Attending|+1646-888-2315|wolchokj@MSKCC.ORG|
22416250|NCT01263561|Department of Ophthalmology and Vision Sciences, University of Toronto|Dr Yvonne Buys|416-603-5682|y.buys@utoronto.ca|
22416251|NCT00879684|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22416252|NCT00708682|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com|
22416253|NCT04728620|Vanderbilt University Medical Center|William Martinez, MD|(615) 936-1010|william.martinez@vumc.org|
22416254|NCT03689894|Dartmouth Hitchcock Medical Center|Director of Clinical Research|2167129120|sean.hobson@hitchcock.org|
22416255|NCT00569777|Vistakon|Brian Pall OD MS FAAO|904-443-1290||
22416256|NCT04084990|Washington University in St. Louis|Alexander Hincker, Associate Professor of Anesthesiology|3143231312|hinckera@wustl.edu|
22416257|NCT00681473|Massachusetts General Hospital|Helen A. Shih, MD|617-724-9627|HSHIH@Partners.org|
22416258|NCT01839695|Medtronic Vascular|Taryn Dellaripa, Principal Clinical Research Specialist|541-301-3181|taryn.dellaripa@medtronic.com|
22416259|NCT02056652|University of Pennsylvania|Bridget Nolan|2156623324|bridget.nolan@uphs.upenn.edu|
22416260|NCT04511208|CCF|Daniel Sessler, MD|216-444-4900|sseslerd@ccf.org|
22416261|NCT02625298|Faculty of Dentistry, University of Belgrade|Dr. Dejan Markovic, professor at Clinic for Pediatric and Preventive Dentistry|+381600203041|dejan.markovic@stomf.bg.ac.rs|
22416262|NCT00965731|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22416263|NCT04773600|Arcutis|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
22416264|NCT04974736|Massachusetts General Hospital|Jonathan P. WInickoff|(617) 726-2728|jwinickoff@mgh.harvard.edu|
22416265|NCT03581188|The University of Sydney, Australia|Associate Professor Katy Bell|+61 415 764 321|katy.bell@sydney.edu.au|
22416266|NCT00760526|Jaeb Center for Health Research|Katrina Ruedy|813-975-8690|direcnet@jaeb.org|
22416267|NCT01923311|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22416268|NCT02304406|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22416269|NCT00991510|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22416270|NCT03710590|Virginia Commonwealth University|Dr. Alison Breland|804 628 2300|abbrelan@vcu.edu|
22416271|NCT02488824|VAORD|Dr John Handrakis|(718) 584-9000|John.Handrakis@va.gov|5439
22416272|NCT01976728|Ferring Pharmaceuticals|Clinical Development Support|+1 833-548-1402|DK0-Disclosure@ferring.com|
22416273|NCT02356211|TVHS GRECC, Nashville TN|James S. Powers MD, Clinical Associate Director, GRECC|615-873-8032|james.powers2@va.gov|
22416274|NCT01185028|NIAID/NIH|Dr. Shyam Kottilil|301-435-0936|skottilil@niaid.nih.gov|
22416275|NCT01563237|InnFocus, Inc.|Sharon Herbert, Associate Director of Clinical Operations|(415) 268-9059|sharon.herbert@santen.com|
22416276|NCT02211014|Acerta Pharma B.V.|Acerta Clinical Trials|1-888-292-9613|acertamc@dlss.com|
22416277|NCT03036839|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22416278|NCT01316419|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22416279|NCT00412737|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22416280|NCT01701037|Vanderbilt-Ingram Cancer Center|Mark C. Kelley|615-936-7423|mark.kelley@vanderbilt.edu|
22416281|NCT04057248|Diabetes and Endocrinology Consultants of Pennsylvania, LLC (Decpa LLC)|Dr. Alan Schorr|2157501691|abs@sugardoc.com|
22416282|NCT00983918|Baylor College of Medicine|Jaime Ortiz, MD|713-873-2860|jaimeo@bcm.edu|
22416283|NCT03244475|VA San Diego Health System|Dr. Mingxiong Huang|858-534-1254|mingxiong.huang@va.gov|
22416284|NCT02548312|BMJ|Dr Sara Schroter|02073836744|sschroter@bmj.com|
22416285|NCT03170388|Bausch Health Americas, Inc|Study Director|5102595284|aloncaric@bauschhealth.com|
22416286|NCT02285634|Mayo Clinic|Dr. Tobias Kummer|507 255 4732|vanmeter.derek@mayo.edu|
22416287|NCT03764735|Mitotech S.A.|Chief Operating Officer|+352621692785|info@mitotechpharma.com|
22416288|NCT01345318|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22416289|NCT01685073|Johns Hopkins University|Ryan Vandrey, PhD|410-550-4036|rvandrey@jhmi.edu|
22416290|NCT00556491|St Louis University|Tarek El-Achkar|317 278 6822|telachka@iu.edu|
22416291|NCT03180801|SEEK|Dr Olga Pleguezuelos|+44 020 7153 6601|olga.pleguezuelos@seekacure.com|
22416292|NCT01049412|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22416293|NCT04735068|University of Pennsylvania|Melissa Volpe|215-220-9703|melissa.volpe@Pennmedicine.upenn.edu|
22416294|NCT03173170|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22416295|NCT05966090|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22416296|NCT00804141|Bausch Health Americas, Inc|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
22390905|NCT01777490|HSR&D/COIN, Durham VAHCS|Courtney Van Houtven|(919)286-6936|Courtney.VanHoutven@va.gov|
22403327|NCT03623334|UT Southwestern Medical Center|Sarah Hardee|214-648-1836|sarah.hardee@utsouthwestern.edu|
22403328|NCT01902953|Maimonides|Danny Sherwinter|7182837952|dsherwinter@maimonidesmed.org|
22403329|NCT01911845|AbbVie|Global Medical Information|800-633-9110||
22403330|NCT03546413|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22403331|NCT04866303|University of Washington|Clinical Trial Manager|2066169195|cgregor2@uw.edu|
22403332|NCT04507867|Universidad Anáhuac México Norte|Dr. Fernando Leal Martínez|+52 5521094339|ferman5@hotmail.com|
22403333|NCT02175771|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com|
22403334|NCT02504268|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22403335|NCT02835677|VA Medical Center|Dr. Linda Nichols, Co-Director Caregiver Center|901 523-8990|linda.nichols@va.gov|5082
22403336|NCT04732819|Hebrew SeniorLife|Sarah Berry, MD|617-971-5355|sarahberry@hsl.harvard.edu|
22403337|NCT00734734|Novartis Vaccines and Diagnostics S.r.l|Posting Director||RegistryContactVaccinesUS@novartis.com|
22403338|NCT01094717|University of Utah, Derpartment of Dermatology|Kristina Callis-Duffin|8015816465|Kristina.Duffin@hsc.utah.edu|
22403339|NCT00555048|Fred Hutchinson Cancer Research Center|Ann Woolfrey, MD|206-667-4453|awoolfre@fredhutch.org|
22403340|NCT00503880|University of Nebraska Medical Center|Lori Maness-Harris, MD|402-559-3848|lmaness@unmc.edu|
22403341|NCT03198754|Icahn School of Medicine at Mount Sinai|Heiðdís B. Valdimarsdottir|(212) 659-5678|heiddis.valdimarsdottir@mssm.edu|
22416297|NCT01142908|Veterans Administration HSRD, Durham COIN|Hayden B. Bosworth, PhD, Assoc Dir, Durham HSR&D COIN|919-286-0411|hayden.bosworth@va.gov|6936
22416298|NCT01601691|Oulu University Hospital|Dr. Markku Vaarala|+3588315|markku.h.vaarala@ppshp.fi|2840
22416299|NCT03235479|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
22416300|NCT00367016|University of California-Davis, Department of Dermatology|Fu-Tong Liu, M.D., Ph.D.|916-734-6556|fliu@ucdavis.edu|
22416301|NCT04090879|Brown University|Jennifer W. Tidey|4018636418|jennifer_tidey@brown.edu|
22416302|NCT00232479|UMiami|Judith Hurley|305-243-6698|jhurley@miami.edu|
22416303|NCT01734694|Augusta University|Jose Vazquez|(706) 723-0105|JVAZQUEZ@augusta.edu|
22416304|NCT01303068|University of New Mexico|Hengameh Raissy|5052725484|hraissy@salud.unm.edu|
22416305|NCT03585959|Medtronic|Katie Bayliss|(763) 647-5547|katie.j.bayliss@medtronic.com|
22416306|NCT01077817|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22416307|NCT01098539|GlaxoSmithKline|GSK Response Center|866-435-7343||
22416308|NCT03843125|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22416309|NCT01386125|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22416310|NCT01292837|UCB|UCB Clinical Trial Call Center|++1 877 822 9493||
22416311|NCT02359864|William Beaumont Hospital|Dr. James Fontanesi, Professor of Neurosurgery, Director of Radiation Oncology|947-521-8121|james.fontanesi@beaumont.org|
22416312|NCT03460899|Medical University of Graz|Assoc.-Prof. Harald Sourij, MD|0043 316 385|ha.sourij@medunigraz.at|81310
22416313|NCT01889797|ECOG-ACRIN Biostatistics Center|PrECOG Statistician|617-632-3627|jmanola@jimmy.harvard.edu|
22416314|NCT00515216|Washington University School of Medicine|A. Craig Lockhart, M.D.|314-362-5740|alockhar@dom.wustl.edu|
22416315|NCT01562132|Yale University|Dr. Ana-Claire Meyer|203-737-8372|ana-claire.meyer@yale.edu|
22416316|NCT01160445|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
22416317|NCT00605176|Graceway Pharmaceuticals LLC|Sharon F. Levy, MD|267-948-0400|sharon.levy@gracewaypharma.com|
22416318|NCT01086969|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22416319|NCT03904550|UT Southwestern Medical Center|Tiffany Moon, MD|(214) 648-6400|tiffany.moon@utsouthwestern.edu|
22416320|NCT03401918|Stanford University|Ruth Bunker Lathi|(650) 498-7911|clinicaltrials-gov@stanford.edu|
22416321|NCT01609582|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22416322|NCT00685750|GlaxoSmithKline|GSK Response Center|866-435-7343||
22416323|NCT03222037|Johnson & Johnson Vision Care, INC.|Chantal Coles-Brennan -PRINCIPAL RESEARCH OPTOMETRIST|1-904-443-3449|CColesb@its.jnj.com|
22416324|NCT04974580|Ohio State University College of Public Health|Dr. Elizabeth G. Klein|614-292-5424|klein.232@osu.edu|
22416325|NCT04381481|University of North Carolina at Chapel Hill|Marissa Hall, PhD|919-962-5907|mghall@unc.edu|
22416326|NCT00220727|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
22416327|NCT02508116|University of Pennsylvania School of Medicine|Sony Tuteja, PharmD, MS|215-573-7834|sonyt@pennmedicine.upenn.edu|
22416328|NCT00109850|SWOG Statistical Center|Study Statistician|206-667-4623||
22416329|NCT01237080|Department of Anaesthesiology, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark|Mogens Ydemann|+4531155995|clinicaltrials@ydemann.dk|
22416330|NCT00709306|Fox Chase Cancer Center|Carolyn Heckman, PhD|215-214-3962|carolyn.heckman@fccc.edu|
22416331|NCT00239005|Novartis Pharmaceuticals|Study Director|862-778-8300||
22416332|NCT04547036|Dept. Ophthalmology at Paracelsus Medical University Salzburg|PD Dr. Markus Lenzhofer PhD FEBO|+43 57255|m.lenzhofer@salk.at|24201
22416333|NCT00987831|Oklahoma Medical Research Foundation|Joan T Merrill, M.D|405-271-7805|JTMmail@aol.com|
22416334|NCT03253094|SCYNEXIS|Dr. David Angulo|(201) 884 - 5471|david.angulo@scynexis.com|
22416335|NCT00824369|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22416336|NCT02413294|University of Michigan|Dr. Amanda Leggett|734-232-0538|leggetta@med.umich.edu|
22416337|NCT02625974|Bayer AG|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22416338|NCT03941834|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22416339|NCT00357955|Providence VA Medical Center|Wen-Chih Wu, MD; Principal Investigator|4012737100|wen-chih.wu@va.gov|6237
22416340|NCT00802178|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22416341|NCT01606228|Janssen China|Medical Affairs Director, CNS, Asia Pacific|8610 5821 8766||
22416342|NCT01115855|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22416343|NCT04100096|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Medical Affairs|800 562-3974|clinicaltransparency@otsuka-us.com|
22416344|NCT01684215|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22416345|NCT00784134|Johns Hopkins University Division of Brain Injury Outcomes|Dr. Daniel F. Hanley|4106146996|dhanley@jhmi.edu|
22416346|NCT03785145|Medytox Inc.|Young Ryu|+82-2-6901-5424|aab005@medytox.com|
22416347|NCT01119807|Mecklenburg EMS Agency|Jonathan R Studnek PhD|7049436046|jonst@medic911.com|
22416348|NCT01124695|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22416349|NCT00097786|Novartis Pharmaceuticals|Study Director|862 778-8300||
22416350|NCT02668822|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22416351|NCT01922219|NYSPI|Jeffrey Miller, M.D.|646-774-7613|jm2233@cumc.columbia.edu|
22416352|NCT02265341|Mayo Clinic|Mitesh J. Borad, MD|480/301-8335|Borad.Mitesh@mayo.edu|
22416353|NCT01647711|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22416354|NCT00271739|Columbia University|Walter Palmas, M.D.|212-305-3163|wp56@columbia.edu|
22416355|NCT01796964|Alcon Research, Ltd.|Clinical Project Group Lead, GCRA, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
22416356|NCT04025684|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22416357|NCT00868296|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22416358|NCT03110380|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22416359|NCT00452543|Massachusetts General Hospital|Dr. Janet Witte|617-726-5104|jwitte@partners.org|
22416360|NCT01206439|University of Cincinnati|Jack Rubinstein|513-558-3062|rubinsjk@ucmail.uc.edu|
22416361|NCT03417739|Dana Farber Cancer Institute|Elizabeth Buchbinder, MD|617-632-5055|Elizabeth_buchbinder@dfci.harvard.edu|
22416362|NCT05889039|LECOM|Dr. Santiago Lorenzo|941-782-5974|slorenzo@lecom.edu|
22416363|NCT02795676|Protalix Ltd.|Sari Alon, MSc|+972-4-9028100|sari@protalix.com|215
22416364|NCT01201486|StavangerUH|Torbjørn Moe Eggebø, phd|004792699433|tme@lyse.net|
22416365|NCT00680524|VA Puget Sound Health Care System|Bradford Felker, MD|(206)277-1191|Bradford.Felker@VA.GOV|
22416366|NCT01115933|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com|
22416367|NCT00819767|Novartis Pharmaceuticals|Study Director|862 778-8300||
22416368|NCT02994290|Yale University|Dr. Sangini Sheth|203-785-5545|Sangini.Sheth@yale.edu|
22416369|NCT00496262|CSL Behring|Program Director, Clinical R&D|Use email contact.|clinicaltrials@cslbehring.com|
22416370|NCT00260689|NHLBI, NIH|Danielle Townsley MD|301-402-3477|townsleydm@nhlbi.nih.gov|
22403342|NCT03247413|Johns Hopkins University School of Medicine|Akhil Chhatre|443-997-5476|achhatr1@jh.edu|
22403343|NCT00668200|Novartis Pharmaceuticals|Study Director|8627788300||
22403344|NCT00642746|OHSU Knight Cancer Institute|Charles Lopez, MD|503-494-8534|lopezc@ohsu.edu|
22403345|NCT01362686|Regenstrief Insitute|Dr. Noll Campbell|317-274-9051|cambenl@regenstrief.org|
22403346|NCT00424294|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22403347|NCT01496430|Takeda|Medical Director; Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22403348|NCT01100307|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22403349|NCT02108951|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22403350|NCT00997321|MinneapolisMRF|James Miner|612-873-3000|miner015@umn.edu|
22403351|NCT00932152|University of Pittsburgh|Ahmad Tarhini, MD|(412) 648-6578|tarhiniaa@upmc.edu|
22403352|NCT02569411|St. Michael's Hospital|Dr. Areti Angeliki Veroniki|416-360-4000|averonik@cc.uoi.gr|
22403353|NCT02528097|NYU Langone Medical Center|The Office of Clinical Trials|646.754.7431|clinicaltrials@nyumc.org|
22403354|NCT01962714|VA Puget Sound Health Care System|David Kearney, MD|206-277-1445|david.kearney@va.gov|
22403355|NCT01151579|Genesys Regional Medical Center|Dr. Fahim Khorfan|810-606-7722|kbarber@genesys.org|
22403356|NCT00608530|VA San Diego Healthcare System|Joseph H. Atkinson MD, Principal Investigator|858 642 3775|joseph.atkinson@va.gov|
22403357|NCT00077610|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22403358|NCT00790738|The Zucker Hillside Hospital|Raphael J. Braga, MD|718-4708060|rbraga@nshs.edu|
22403359|NCT01204255|Virginia Commonwealth University|Thomas J. Smith, MD|804-828-9723|tsmith5@mcvh-vcu.edu|
22403360|NCT01357915|GlaxoSmithKline|GSK Response Center|866-435-7343||
22403361|NCT02991937|NYU Langone Health|Jason Fisher, MD|212-263-7391|Jason.Fisher@nyulangone.org|
22403362|NCT00305253|University of California San Francisco (UCSF)|Suellen Miller|415 597 9394|smiller@globalhealth.ucsf.edu , suellenmiller@gmail.com|
22403363|NCT01098461|GlaxoSmithKline|GSK Response Center|866-435-7343||
22403364|NCT02662985|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22403365|NCT03633227|Intercept Pharmaceuticals, Inc.|Medical Information|+1 844-782-4278|medinfo@interceptpharma.com|
22403366|NCT00400829|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22403367|NCT04836455|University of North Carolina at Chapel Hill|Dr. Seth M. Noar|9192607269|noar@unc.edu|
22431234|NCT03093415|Oregon Health and Sciences University|Andrew Seaman, MD|1 (971) 271 - 6102|seaman@ohsu.edu|
22416371|NCT02913131|University of California, San Francisco|Dr. Rahul Aggarwal, MD|(415) 353-9278|Rahul.Aggarwal@ucsf.edu|
22416372|NCT02997722|University of Mississippi Medical Center|Allen Richert, MD|(601) 984-4820|arichert@umc.edu|
22416373|NCT02010996|changhai hospital|Bi-Hongda|86-13918233009|bihongda0411@yahoo.com.cn|
22416374|NCT01493596|Catalyst Pharmaceutical Partners, Inc.|Douglas Winship, Vice President of Regulatory Operations|305 529-2522|dwinship@catalystpharma.com|12
22416375|NCT04234464|Avillion LLP|Chief Medical Officer|+44 (0)203 764 9530|avillion@avillionllp.com|
22416376|NCT00476593|Department of Ophthalmology, St. Olavs Hospital, Trondheim Norway|Dr Alexandra Wexler|99716763|a.wexler@online.no|0074
22416377|NCT03430011|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
22416378|NCT01334957|Cumberland Pharmaceuticals Inc.|Dr. Amy Rock|615-255-0068|arock@cumberlandpharma.com|
22416379|NCT00559364|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
22416380|NCT04126343|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22416381|NCT01235442|Amgen Inc.|Study Director|866-572-6436||
22416382|NCT00136760|Brown University|Jennifer Tidey, Ph.D.|401-863-6418|Jennifer_Tidey@brown.edu|
22416383|NCT01857973|Medtronic Minimed|Suiying Huang, Statistician|818-576-3319|suiying.huang@medtronic.com|
22416384|NCT00908882|Eastern Colorado Health Care System|Catherine Battaglia PhD RN|720-857-5099|catherine.battaglia@va.gov|
22416385|NCT01701973|Vanderbilt University Medical Center|Dr. Jessica Devin|6159361665|jessica.devin@vanderbilt.edu|
22416386|NCT02663882|Yeshiva University|Dr. Andrea Weinberger|(646) 592-4474|andrea.weinberger@yu.edu|
22416387|NCT03712124|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22416388|NCT01332721|TRACON Pharmaceuticals|Dr Charles Theuer|8585500780|ctheuer@traconpharma.com|233
22416389|NCT00602537|University of Pennsylvania|Dr. Jay Amsterdam|(215) 662-3462|jamsterd@mail.med.upenn.edu|
22416390|NCT01290237|Boston Children's Hospital|Dr. Alicia Demirjian||alicia.demirjian@post.harvard.edu|
22416391|NCT00388037|Cancer Centre of Southeastern Ontario at Kingston|Dr. James Biagi|(613) 544-2630|jim.biagi@krcc.on.ca|
22416392|NCT02941523|Noxopharm Limited|Clinical Manager|+61 499005049|marinella.messina@noxopharm.com|
22416393|NCT04330157|University hospital Osijek|Nenad Neskovic|+385996787250|nneskov@gmail.com|
22416394|NCT04314843|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
22416395|NCT00869440|PAION UK Ltd|Trial Information||reg_paion@paion.com|
22416396|NCT00931996|Ullinois|Dr. Jeffrey Bishop|312-413-3495|jbishop@uic.edu|
22416397|NCT01899326|Albert Einstein College of Medicine|Dr. Amit Verma|718-430-4091|amit.verma@einsteinmed.edu|
22416398|NCT00104247|BioMarin Pharmaceutical Inc.|Medical Information Services|1-800-983-4587|medinfo@bmrn.com|
22416399|NCT01378962|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22416400|NCT01588548|AstraZeneca|Karen Keating|+1 781 839 4182|karen.keating@astrazeneca.com|
22416401|NCT03257254|Boston Scientific|Timothy Keo|425-599-3814|Timothy.Keo@bsci.com|
22403368|NCT03976531|Institut Bergonié|Pr S Mathoulin-Pélissier|33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
22416402|NCT00548431|Rigshospitalet, Juliane Marie Centret|Thomas Frandsen|+45 35458364|thomas.leth.frandsen@rh.regionh.dk|
22416403|NCT03169816|New York State Psychiatric Institute|Frances R Levin, MD|6467746137|frl2@columbia.edu|
22416404|NCT04149535|Boston Scientific|Sarah Zanon - Director Clinical Trials, Interventional Cardiology|+41798407006|sarah.zanon@bsci.com|
22416405|NCT00109837|SWOG Statistical Office|SWOG Leukemia Statistician|206-667-4408||
22416406|NCT01989676|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22416407|NCT01619579|VA Medical Center & UCSD Center for Pain Medicine|Tobias Moeller-Bertram, MD|858-552-8585|tmoellerbertram@ucsd.edu|3123
22416408|NCT03907241|CRMG|Mikaela Raymond|866-337-1868|ctgov@clinicalresearchmgt.com|
22416409|NCT02688387|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22416410|NCT02190279|National Cancer Institute|Dr. Maria Liza Lindenberg|240-760-6109|liza.lindenberg@nih.gov|
22416411|NCT02938442|University of Arkansas for Medical Sciences|Sorena Lo|5016868274|SBLo@uams.edu|
22416412|NCT00480324|GlaxoSmithKline|GSK Response Center|866-435-7343||
22416413|NCT00966381|UNC Greensboro|Cheryl Lovelady|336 256-0310|cheryl_lovelady@uncg.edu|
22416414|NCT01915940|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22416415|NCT03686150|University of Arkansas for Medical Sciences|Songthip Ounpraseuth|501-686-7233|stounpraseuth@uams.edu|
22416416|NCT02443324|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22416417|NCT01344616|PHCC LP|James G. Christian|7195468633|jim@phcclp.com|
22416418|NCT03346070|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22416419|NCT03404401|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
22416420|NCT02948257|Cardiva Medical|Terry Alverson, Director of Regulatory and Clinical|408-470-7119|Terry_Alverson@cardivamedical.com|
22416421|NCT00988208|Celgene Corporation|Senior Manager , Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22416422|NCT03008837|VAORD|Dr. Anna Woodbury|404-321-6111|anna.woodbury@va.gov|
22416423|NCT04894084|Coloplast A/S|Medical Affairs Project Manager|+4549111341|dkteaa@coloplast.com|
22416424|NCT01573533|Mayo Clinic|Fernando C. Fervenza, M.D., Ph.D.|507-266-1045|Fervenza.Fernando@mayo.edu|
22416425|NCT02551679|Hemostemix|Dr. Fraser Henderson|2022978858|fhenderson@hemostemix.com|
22416426|NCT01613378|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22416427|NCT00317642|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22416428|NCT00880087|University of Utah|Dr. Rich Holubkov, Professor of Pediatrics|807-587-3326|richard.holubkov@hsc.utah.edu|
22416429|NCT01002794|Oslo University Hospital|Professor May Arna Risberg|+4741312776|marisb@ous-hf.no|
22416430|NCT01239472|Hospital e Maternidade Marieta Konder Bornhausen|Dr Andre Barreto Pereira|+55 47 984482826|andrebarper@yahoo.com.br|
22403369|NCT02322320|The Emmes Company|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
22416431|NCT03662308|SPINAL CORD DAMAGE RESEARCH CENTER|Dr. John Handrakis|718.584.9000|john.handrakis@va.gov|3129
22416432|NCT00418522|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22416433|NCT02695719|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22416434|NCT01163084|UT MD Anderson Cancer Center|Logothetis, Christopher, M.D. / Genitourinary Medical Oncology|7137922830|clogothe@mdanderson.org|
22416435|NCT01005329|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@gmail.com|
22416436|NCT01714739|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email:|Clinical.Trials@bms.com|
22416437|NCT02250651|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22416438|NCT01903564|University of Wisconsin-Madison|Ronald Wakai, Ph.D.|6082654988|rtwakai@wisc.edu|
22416439|NCT01557920|Massachusetts General Hospital|Dr. Matthias Eikermann|6176434408|meikermann@partners.org|
22416440|NCT01514513|Tec Laboratories, Inc.|Wendy Langley|5419264577|wendy@teclabsinc.com|338
22416441|NCT01466036|Dana-Farber Cancer Institute|Dr. Jennifer Chan|617-632-6315|jang@partners.org|
22416442|NCT00981227|Bial-Portela & Cª, S.A.|Head of Clinical Research Section|+351 22 986 6100|clinical.trials@bial.com|
22416443|NCT01808248|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22416444|NCT02690935|ECSOR|Dr. Stephane Heijmans|3267444093|Jacques.Bruhwyler@ecsor.com|
22416445|NCT01175473|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22416446|NCT02630316|United Therapeutics|United Therapeutics Global Medical Information|919-485-8350|clinicaltrials@unither.com|
22416447|NCT01216410|Duke University Medical Center|Ashraf Habib|919 668 6266|habib001@dm.duke.edu|
22416448|NCT03635983|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22403370|NCT01067508|UCLA Center for Human Nutrition|Zhaoping Li|310-206-1987|zli@mednet.ucla.edu|
22403371|NCT00958308|Bio-K+ International. Inc.|Dr. Serge Carrière|450-978-2465|scarriere@biokplus.com|
22403372|NCT04030104|Seno Medical Instruments, Inc.|Vice President of Clinical Operations|210-615-6501|sschaeffer@senomedical.com|
22403373|NCT00632463|ADMA Biologics|Chief Medical Officer|201-478-5552|agrossman@admabio.com|
22403374|NCT02065622|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22403375|NCT01249872|University Hospital Of Patras, Greece|Dr Anastasia Zotou|0026130603341|anzotou@hotmail.com|
22403376|NCT02366663|City of Hope National Medical Center|Dr. Amrita Krishnan|626-256-4673|AKrishnan@coh.org|82405
22403377|NCT04973228|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
22403378|NCT04237207|Advanced Bionics, LLC|Ankur Kaushal, VP of Global Regulatory Affairs|661 362 1400|clinicalresearch@advancedbionics.com|
22416449|NCT03604432|Corewell Health|Dr. Charles Willekes|616-459-7258|Charles.Willekes@corewellhealth.org|
22416450|NCT02578745|Washington University|Methodius Tuuli|6785582874|methodiustuuli@yahoo.com|
22416451|NCT00330460|Amgen Inc.|Study Director|866-572-6436||
22403379|NCT04357379|Medical University of South Carolina|Dr. Tracy Smith|8437925164|smithtra@musc.edu|
22403380|NCT00306917|DePuy Orthopaedics, Inc|Barry Sisson|574-372-7156|BSisson@its.jnj.com|
22403381|NCT03073213|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22403382|NCT00961662|University of Kentucky|Robert Lodder|859-955-0845|lodder@uky.edu|
22403383|NCT00849251|University of Washington|Dr. Pamela Becker|206-616-1589|pbecker@uw.edu|
22403384|NCT01042613|St. Jude Children's Research Hospital|Luis Trujillo Huaccho, MD|1-866-278-5833|info@stjude.org|
22403385|NCT00074724|MedStar Health Research Institute|Scientific Center Administrator|301-560-7300|Research@medstar.net|
22403386|NCT00296725|New York State Psychiatric Institute|Jonathan W. Stewart, M.D., Principle Investigator|646-774-8070|jws6@cumc.columbia.edu|
22403387|NCT00356863|The Gertner Institute for Epidemiology and Health Service Research|Rachel S Dankner, MD, MPH|972-3-5305390|RachelD@gertner.health.gov.il|
22403388|NCT04863417|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22403389|NCT01648452|National Eye Institute|Paul A Sieving, MD, PhD|301-496-2234|ps261o@nih.gov|
22403390|NCT00797797|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|Robert Palmer, MD|1-201-427-8218|robert.palmer@frx.com|
22403391|NCT02207478|Shanghai Chest hospital|Dr. Jiayuan Sun|+86 18017321598|jysun1976@163.com|
22403392|NCT02568345|Central Hospital, Irmandade da Santa Casa de Misericórdia (ISCM)|Mauro Prado da Silva|+55 11 2176 7000|comissaocientifica@fcmsantacasasp.edu.br|
22403393|NCT00836277|University of Pittsburgh Cancer Institute|Weijing Sun, MD|412-864-7764|sunw@upmc.edu|
22403394|NCT00333619|VA Greater Los Angeles Healthcare System|Dr. Cathy Alessi|818 895-9311|cathy.alessi@va.gov|
22403395|NCT00280150|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22403396|NCT03209440|University of Florida|Dr. Diana Wilkie|352-273-6401|diwilkie@ufl.edu|
22403397|NCT03303040|University of Florida|Dr. Barbara K. Smith|352-294-5315|bksmith@ufl.edu|
22403398|NCT03379506|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22403399|NCT03006471|INSITITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
22403400|NCT05283863|Case Western Reserve University|Jennifer Sweet, MD|216-844-3192|Jennifer.Sweet@UHhospitals.org|
22403401|NCT01120379|Abbott Vascular|Robert Smith Jr, Ph.D., Sr Clinical Research Scientist|408-845-8265|robert.smithjr@av.abbott.com|
22403402|NCT03162055|AstraZeneca|Vice President, Inhalation and Oral Respiratory|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22403403|NCT04031404|University of North Carolina at Chapel Hill|Rachel B. Force, PhD|9199669929|rachel_force@med.unc.edu|
22403404|NCT02581865|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22403405|NCT01993615|Madigan Army Medical Center|Daniel Rhon|253-968-0780|daniel.i.rhon.ctr@mail.mil|
22403406|NCT02621619|Albany Medical Center|Dr. Andrew Chang|518-262-0042|changa1@amc.edu|
22403407|NCT02064205|TNO|W.J. Pasman, PhD|+31888665129|wilrike.pasman@tno.nl|
22403408|NCT00509496|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
22403409|NCT01709136|Children's Hospital of Pittsburgh|Dr. Rakesh Sindhi, MD|412-692-6110|rakesh.sindhi@chp.edu|
22403410|NCT01354353|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22403411|NCT05674344|Masimo Corporation|Chelsea Frank|(949) 297-7000|clinicalresearchdept@masimo.com|
22403412|NCT00111917|National Jewish Health|Lisa Maier, MD|303-398-1983|maierl@njhealth.org|
22403413|NCT01640925|Houston Methodist Hospital|Dr. Joshua Swan|713-441-0165|jtswan@houstonmethodist.org|
22403414|NCT02156492|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22403415|NCT02363270|Maimonides Medical Center|Dr. Sergey Motov|718-283-8693|smotov@maimonidesmed.org|
22403416|NCT00442013|Johns Hopkins University|Janet Holbrook|443-287-3170|ala-acrc@jhsph.edu|
22403417|NCT05254613|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22403418|NCT02574858|University of Michigan|Dr. D. Kim Turgeon|734-764-6860|kturgeon@med.umich.edu|
22403419|NCT00882102|The University of Texas MD Anderson Cancer Center|Gautam Borthakur, MD/Associate Professor|713-563-1586|eharriso@mdanderson.org|
22403420|NCT01944969|H. Lundbeck A/S|H. Lundbeck A/S|+45 36301311|LundbeckClinicalTrials@lundbeck.com|
22403421|NCT02600325|Erasmus MC|Dr. B. J. A. Rijnders|0|b.rijnders@erasmusmc.nl|
22403422|NCT01104584|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22403423|NCT02370498|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22403424|NCT01453569|Shanghai Greenvalley Pharmaceutical Co., Ltd.|Dr. Xianliang Xin|86 21-50504988|xinxianliang@hotmail.com|1370
22403425|NCT02387372|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22403426|NCT03225716|DFCI|Steven Treon|617-632-2681|steven_treon@dfci.harvard.edu|
22403427|NCT00848250|Vanderbilt University Medical Center|Mias Pretorius|615-8757402|mias.pretorius@vanderbilt.edu|
22403428|NCT02883049|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22403429|NCT03421964|Virginia Commonwealth University|Nancy Hsu, PsyD, PI|804-327-1166|nancy.hsu@vcuhealth.org|
22403430|NCT01576016|Abbott|Grant Kim, Program Director - Traditional Cardiac Rhythm Management|818-493-3147|grant.kim1@abbott.com|
22403431|NCT02581111|Washington University in St. Louis School of Medicine|Dr. Rajat Dhar|3143622999|dharr@neuro.wustl.edu|
22403432|NCT03654755|Libertas BioSciences|Niranjan Rao|908-872-1133|niranjan@libertasbiosciences.com|
22403433|NCT01153763|GlaxoSmithKline|GSK Response Center|866-435-7343||
22403434|NCT01277341|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
22403435|NCT05373706|University of Washington|Dr. Anne Fairlie|(206) 221-5896|afairlie@uw.edu|
22403436|NCT01486784|Abramson Cancer Center at the University of Pennsylvania|Dr. Noelle Frey||noelle.frey@pennmedicine.upenn.edu|
22403437|NCT03491553|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22403438|NCT01479374|Alcon Research, Ltd.|Abhijit Narvekar, MS, MBBS|1-888-451-3937|alcon.medinfo@alcon.com|
22403439|NCT00039195|Memorial Slaon Kettering|Dr. Craig Moskowitz|212-639-7992|moskowic@mskcc.org|
22403440|NCT01606761|Janssen Research & Development, LLC|Associate Director||ClinicalTrialDisclosure@its.jnj.com|
22403441|NCT05086289|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22403442|NCT03150108|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22403443|NCT00145249|University of Alabama at Birmingham|Peter G. Pappas, MD|205-934-9951|pappas@uab.edu|
22403444|NCT01996748|Laboratorios SALVAT|Enrique Jimenez, Medical Director|+34933946470|ejimenezv@salvatbiotech.com|
22403445|NCT03628508|The Hong Kong Polytechnic University|Dr Amy Fu|8522766 6726|amy.fu@polyu.edu.hk|
22403446|NCT03238235|Italfarmaco SpA|Maurizio Caserini, MD|+ 39 02 64431|m.caserini@italfarmacogroup.com|
22403447|NCT00540969|Mayo Clinic|Matthew Callstrom, M.D., Ph.D.|5072664532|callstrom.matthew@mayo.edu|
22403448|NCT01975935|University of Michigan|Dr. Elif Oral|7346157271|eliforal@med.umich.edu|
22403449|NCT02742077|Corindus, Inc.|Clinical Research Manager|(757) 910-4818|tina.ridgeway@corindus.com|
22403450|NCT00243230|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22403451|NCT03011840|Tata Memorial Hospital, Mumbai|Dr. Sumitra Bakshi|+912224177058|sumitrabakshi@yahoo.com|
22403452|NCT00086957|City of Hope|Paul Frankel, Ph.D.|626-359-8111|pfrankel@coh.org|65265
22403453|NCT00321100|Fox Chase Cancer Center|Dr. Steven Cohen|215-214-1676|steven.cohen@fccc.edu|
22403454|NCT03201198|University of Michigan School of Nursing|Dr. Janet Larson|7346470126|janetlar@med.umich.edu|
22403455|NCT00471445|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu|
22403456|NCT04715230|InterveXion Therapeutics|Chief Operating Officer|5015542377|misty.stevens@intervexion.com|
22403457|NCT03645408|Boston Medical Center/Boston University School of Medicine|Dr. Eric Devine|617-414-1990|eric.devine@bmc.org|
22403458|NCT00500045|Palo Alto Medical Foundation|Renee Kaneshiro|650-853-4744|kaneshr@pamf.org|
22403459|NCT01927744|M.D. Anderson Cancer Center|Xiuning Le, MD|713-792-6363|xle1@mdanderson.org|
22403460|NCT00369967|VCUHS|Nicole Karjane|804-828-8614|nkarjane@mcvh-vcu.edu|
22403461|NCT03713957|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
22403462|NCT00369746|New York State Psychiatric Institute|Patrick J. McGrath, M.D.|646-774-8076|mcgrath@nyspi.columbia.edu|
22403463|NCT00605722|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22403464|NCT03235817|Anesthesiology|T. Wesley Templeton, MD|336-716-4498|ttemplet@wakehealth.edu|
22403465|NCT02311309|CHU de Caen|Dr Jean-Luc Hanouz|2 31 06 47 36|hanouz-jl@chu-caen.fr|33
22403466|NCT00485589|F. Hoffmann-La Roche AG|Medical Communications|41 616878333|global.trial_information@roche.com|
22403467|NCT00131677|Centers for Disease Control and Prevention (CDC)|Taraz Samandari|404-639-1676|tts0@cdc.gov|
22403468|NCT05340322|Duke University|Nimmi Ramanujam, PhD|9196605307|nimmi@duke.edu|
22403469|NCT00868959|Sunovion|Medical Director, CNS|1-866-503-6351||
22416452|NCT04458467|UC San Diego|John Finneran|(619) 543-2202|jfinneran@health.ucsd.edu|
22403470|NCT04017442|Icahn School of Medicine at Mount Sinai|Dr. Daniel Katz|212-241-7475|daniel.katz@mountsinai.org|
22403471|NCT01122030|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
22403472|NCT01205451|GlaxoSmithKline|GSK Response Center|866-435-7343||
22403473|NCT01236742|The Hong Kong Polytechnic University|Prof Pauline Cho|+852 2766 6100|pauline.cho@polyu.edu.hk|
22416453|NCT02808819|AstraZeneca|AstraZeneca Information Center|+1 8002369933|information.center@astrazeneca.com|
22416454|NCT03297294|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22416455|NCT01435031|Abbott Vascular|Jennifer M Jones-McMeans, PhD (Associate Director Clinical Research)|408-845-1459|jennifer.jones@av.abbott.com|
22416456|NCT00133679|University of California, San Francisco|Roberta Keller, MD|(415) 476-1888|roberta.keller@ucsf.edu|
22416457|NCT00925756|UCSD|Sheldon Morris|6195438080|shmorris@ucsd.edu|
22416458|NCT03718117|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22416459|NCT01917968|Boston Scientific Corporation|Director, Clinical Operations|952-930-6000|teresa.takle-flach@bsci.com|
22416460|NCT03623035|Wake Forest Baptist Health|Christopher Edwards|3367168222|chedward@wakehealth.edu|
22403474|NCT02226146|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22403475|NCT05464836|MD Anderson Cancer Center|Miriam Garcia, DO|(713) 745-4312|mbgarcia@mdanderson.org|
22403476|NCT01522976|SWOG Statistical Center|Leukemia Committee Statistician|206-667-6597|amoseley@fredhutch.org|
22403477|NCT03575884|Seattle Children's Research Institute|Jason Mendoza, MD, MPH|206.884.1261|Jay.Mendoza@seattlechildrens.org|
22403478|NCT02938585|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22403479|NCT03075176|University of Utah John A. Moran Eye Center|Mark Mifflin, MD|801-213-4152|Mark.Mifflin@hsc.utah.edu|
22403480|NCT01850745|Liver Section. Hospital del Mar|Professor Ricard Sola|0034932483200|35783@parcdesalutmar.cat|
22403481|NCT02106455|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22403482|NCT00213980|University of Wisconsin Carbone Cancer Center|Dr. Daniel Mulkerin|608-265-8090|dm2@medicine.wisc.edu|
22403483|NCT03607838|Seikagaku Corporation|General Manager, Clinical Development Department|(81)3-5220-8593|reply@seikagaku.co.jp|
22403484|NCT00576251|Alcon Research, Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22403485|NCT00116857|Washington University School of Medicine|Robert M. Carney, Ph.D.|314-286-1313|carneyr@bmc.wustl.edu|
22403486|NCT01952730|Massachusetts General Hospital|Cristina R. Ferrone, MD|617-643-6189|CFERRONE@PARTNERS.ORG|
22403487|NCT02076321|University of Missouri, Department of Orthopaedics|Dr. Daniel Hoernschemeyer|(573)882-1351|hoernschemeyerd@health.missouri.edu|
22403488|NCT01785810|Abramson Cancer Center|Michael Gardo|215-615-2232|michael.gardo@uphs.upenn.edu|
22403489|NCT00757484|University of Rochester Medical Center|Dr. Erin Duecy|585-275-4004|erin_duecy@urmc.rochester.edu|
22403490|NCT04895605|Regulatory Insight, Inc.|Elvira Cawthon|6154475150|elvira@reginsight.com|
22403491|NCT01514188|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22403492|NCT03615469|Indiana University|Dr. Christine Haedtke|317-274-5358|chaedtke@iu.edu|
22403493|NCT03442829|Bournemouth University|Prof. Katherine Appleton|01202965985|k.appleton@bournemouth.ac.uk|
22403494|NCT02724774|University of Washington|Carol Rhodes, Director of Sponsored Programs|206 543-2139|carhodes@uw.edu|
22403495|NCT02605447|Boston Scientific Corp.|Peter Maurer, Director Clinical Trials|+1 (508) 683|Peter.Maurer@bsci.com|6678
22403496|NCT02237157|RenovoRx|Charles Li|(650) 284-4433|charles@renovorx.com|
22403497|NCT01062074|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22403498|NCT04533815|University of Alabama|Dr. Lynn Snow|205-201-0312|LSNOW@ua.edu|
22403499|NCT02045212|Regenera Pharma Ltd|Dr Konstantin Adamsky|+972 8 9316306|kostia@Regenerapharma.com|
22403500|NCT00488592|Hematology Branch, NHLBI|Minoo Battiwalla, MD|301 827 0939|battiwam@nhlbi.nih.gov|
22403501|NCT00441103|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22403502|NCT05836818|University of California San Francisco|Robert Rodriguez|925-457-2145|robert.rodriguez@ucsf.edu|
22403503|NCT03738566|Mayo Clinic|Dr. Jeffrey A. Alexander|507-538-0474|Alexander.Jeffrey14@mayo.edu|
22403504|NCT03992768|Hamamatsu Photonics, K.K.|MCG Manager|+81-53-435-1560|fujisaka@sys.hpk.co.jp|
22403505|NCT04539249|Federal Medical Centre, Yenagoa|Dr. Olakunle I. Makinde|08032136315|olakunleife@gmail.com|
22403506|NCT00218036|The University of Texas Health Science Center at Houston|Joy M Schmitz, PhD|(713) 486-2867|Joy.M.Schmitz@uth.tmc.edu|
22403507|NCT03126539|Johns Hopkins University|Dr. Anna Chien|410-502-7546|CTReP@jhmi.edu|
22403508|NCT01627067|UT MD Anderson Cancer Center|Dr. Vicente Valero, MD/ Professor, Breast Medical Oncology|713- 563-0751|vvalero@mdanderson.org|
22403509|NCT00926796|University of Arkansas for Medical Sciences|Shelly Lensing|501-686-8203|sylensing@uams.edu|
22403510|NCT00654511|Children's National Medical Center|Julia Finkel, MD|202-476-4867|jfinkel@cnmc.org|4867
22403511|NCT02410707|Einstein Healthcare Network|Joseph Herres, DO, Director of Research|215-456-6666|herresjo@einstein.edu|
22403512|NCT02596711|UT MD Anderson Cancer Center|Dr. Marcel A. de Dios / Health Disparities Research|713-792-7734|CR_Study_Registration@mdanderson.org|
22403513|NCT00586924|MedImmune, LLC|Nai Shun Yao, MD|1-301-398-5936|information.center@astrazenea.com|
22416461|NCT02030535|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22416462|NCT01435928|Sunovion|Medical Director, CNS|1-866-503-6351||
22416463|NCT01634854|Vanderbilt University Medical Center|Angela Wilson-Liverman CNM||angela.wilson-liverman@vanderbilt.edu|
22416464|NCT03365791|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22416465|NCT00739973|Novartis Pharmaceuticals|Study Director|862 778-8300||
22416466|NCT02219308|University of California, San Diego|Dr. Sheila Mody|858-249-1205|smody@ucsd.edu|
22403514|NCT03185455|UPenn|Dr. Adi Hirshberg|917-553-9643|adi.hirshberg@uphs.upenn.edu|
22403515|NCT01331239|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22403516|NCT02010216|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22403517|NCT01767194|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22403518|NCT02223455|CADRE - Iowa City VAHCS|Heather Reisinger|319-338-0581|heather.reisinger@va.gov|7715
22403519|NCT04191577|Cerevance|Michelle Charles, Executive Director Regulatory Affairs|(408) 220-5722|michelle.charles@cerevance.com|
22403520|NCT06704178|Citruslabs|Patrick Renner|+1 805-876-4484|hello@citruslabs.com|
22403521|NCT00992446|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
22403522|NCT00659724|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
22403523|NCT01274338|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22403524|NCT02411201|Guerbet|Corinne Dubourdieu, PharmD, Head of Clinical Projects and Medical Writing|+33 (0) 1 45 91 50 00|corinne.dubourdieu@guerbet-group.com|
22403525|NCT01260467|University of Rochester Medical Center|Jennifer Serventi Research Associate|585-276-3971|jennifer_serventi@urmc.rochester.edu|
22403526|NCT00798694|Wills Eye Hospital|Principal Investigator|215-928-3197|ljaykatz@gmail.com|
22403527|NCT05117229|Mayo Clinic|Rafael J. Sierra, M.D.|507-284-2226|Sierra.Rafael@mayo.edu|
22403528|NCT03709810|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22403529|NCT03364608|Pearl Therapeutics, Inc, a Member of the AstraZeneca Group|Colin Reisner, MD FCCP, FAAAAI|9739750321|Colin.Reisner@astrazeneca.com|
22403530|NCT02351258|Johns Hopkins University|Dr. Aaron Milstone|443-287-8932|amilsto1@jhmi.edu|
22403531|NCT01163253|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22403532|NCT02665364|Neovacs|Head of Regulatory Affairs|+33153109300|info@neovacs.com|
22403533|NCT03888391|University of California, Los Angeles|James McGough, M.D.|310-794-7841|jmcgough@mednet.ucla.edu|
22403534|NCT00439673|GIMEMA|Alfonso Piciocchi|+39 06.70390521|a.piciocchi@gimema.it|
22403535|NCT00654784|Santhera|Thomas Meier|+4161 906 8964|thomas.meier@santhera.com|
22403536|NCT01722487|Pharmacyclics LLC|Dr. Lori Styles, Medical Monitor|+1 (408) 215-3770|lstyles@pcyc.com|
22403537|NCT03025217|Massachusetts General Hospital|Dr. Michelle Dossett|617-643-6034|mdossett@mgh.harvard.edu|
22403538|NCT02173392|Valeant Pharmaceuticals|Director of Clinical Trials|908|lindsey.mathew@valeant.com|
22403539|NCT00838006|Central Arkansas Veterans Healthcare System|Jeff Pyne, MD|501-257-1083|jeffrey.pyne@va.gov|
22403540|NCT02130427|University of Pennsylvania|Dr. Wei Zou|800-789-7366|Wei.Zou@pennmedicine.upenn.edu|
22403541|NCT01735617|Diurnal Ltd.|CEO|+44 (0) 871 716 8848|info@diurnal.co.uk|
22403542|NCT04032171|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22403543|NCT00992784|GlaxoSmithKline|GSK Response Center|866-435-7343||
22403544|NCT00781599|University of Kansas Medical Center|Dr. Nikki Nollen|(913) 588-3784|NNOLLEN@kumc.edu|
22403545|NCT01088438|University of Illinois at Chicago|Dr. Alan Schwartz|312-996-2070|alansz@uic.edu|
22403546|NCT00089479|Hoffman-LaRoche|Medical Communications|800-821-8590||
22403547|NCT00913133|Canyon Pharmaceuticals|Director of Clinical Trials|888-434-7003|info@canyonpharma.com|
22403548|NCT03337152|PATH|Gonzalo Domingo|206-285-3500|gdomingo@path.org|
22403549|NCT00421343|Hebrew SeiorLife|Sarah Berry|617-971-5355|sarahberry@hrca.harvard.edu|
22403550|NCT00678587|GlaxoSmithKline|GSK Response Center|866-435-7343||
22403551|NCT00976950|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22403552|NCT01019486|University of Colorado, Denver|Robert A. Quaife M.D.|720-848-6562|robert.quaife@ucdenver.edu|
22403553|NCT02932332|UT MD Anderson Cancer Center|David Hui, MD, Associate Professor/Palliative Care Med|713-792-6258|dhui@mdanderson.org|
22403554|NCT03134313|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
22403555|NCT01069523|University of Texas Health Science Center at San Antonio|Steven R.Pliszka MD|210-567-5475|pliszka@uthscsa.edu|
22403556|NCT01875367|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
22403557|NCT00473837|Medical Research Council Unit, The Gambia|Mrs Vivat Thomas-Njie|+220-4495442/6|vthomas@mrc.gm|2204
22403558|NCT01016691|Vistakon|Brian Schwam MD|1-904-443-1482|bschwam@its.jnj.com|
22403559|NCT00515008|tufts medical center|chenchen wang|617-636-3251|cwang2@tuftsmedicalcenter.org|
22403560|NCT02951988|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
22403561|NCT00516269|UT MD Anderson Cancer Center|Carmen Escalante, MD / Professor||RABaker@mdanderson.org|
22403562|NCT00626912|Centre de Recherches du Centre Hospitalier de l'Université de Montréal|Ruby Klink, coordinator|(514) 890 8000|ruby.klink@crchum.qc.ca|25245
22403563|NCT04570657|AstraZeneca AB|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22403564|NCT01079962|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22403565|NCT01072539|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22403566|NCT00946530|Stanford University|Jerome A. Yesavage, MD|650-493-5000|yesavage@stanford.edu|x64330
22403567|NCT04167306|Addiction BIology Unit - Clinical Trials, Inst Neuroecience and Physiology, Gotheburg University/ Dep of Addictions and Dependency, Sahlgrenska University Hostpital|Andrea de Bejczy|+46313424724|andrea.debejczy@neuro.gu.se|
22403568|NCT00621855|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22403569|NCT03731364|Concentric Analgesics|Nancy Wu|(415) 484-7921|nancy@concentricanalgesics.com|
22403570|NCT02112994|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22403571|NCT04387136|University of Minnesota|Aaron Berg|612-625-7675|bergx831@umn.edu|
22403572|NCT00417976|The Ohio State University|Tanios Bekaii-Saab|614-293-9863|Tanios.saab@osumc.edu|
22403573|NCT02358369|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22403574|NCT03655717|Massachusetts General Hospital|Dr. Jodi Gilman|617-643-7293|jgilman1@mgh.harvard.edu|
22403575|NCT01185249|Central DuPage Hospital|Dr. Alice Siehoff, Nurse Scientist|1-630-858-0260|asiehoffrn@msn.com|
22403576|NCT01973452|Memorial Sloan Kettering Cancer Center|Dr. Alessia Pedoto, MD|212-639-6840|pedotoa@mskcc.org|
22403577|NCT02193815|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22403578|NCT00064350|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
22403579|NCT00115765|Amgen Inc.|Study Director|866-572-6436||
22403580|NCT03019744|Fondazione Don Carlo Gnocchi|Dr Maurizio Ferrarin|+390240308305|mferrarin@dongnocchi.it|
22403581|NCT01683071|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
22403582|NCT03707158|Boston University|Donna Pincus|(617) 353-9610|dpincus@bu.edu|
22403583|NCT01454401|Reapplix Blokken 45 3460 Birkerød Denmark|MD, PhD Senior Consultant Magnus Löndahl||magnus.londahl@med.lu.se|
22403584|NCT04614545|The Cleveland Clinic Foundation|Dr. Marcio Griebeler|216.444.6568|jenkink@ccf.org|
22403585|NCT04211155|University of Minnesota|Bonny Donzella|6126244351|donzella@umn.edu|
22403586|NCT01968187|Ferring Pharmaceuticals|Global Clinical Compliance|+1 862-286-5200|Disclosure@ferring.com|
22403587|NCT00831441|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22403588|NCT01319110|Beth Israel Deaconess Medical Center|Dr. Michael Cocchi||mcocchi@bidmc.harvard.edu|
22403589|NCT03508661|Lady Davis Institute|Dr. Brett Thombs|514-340-8222|brett.thombs@mcgill.ca|25112
22403590|NCT02924688|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22403591|NCT03072719|GlaxoSmithKline|GSK Response Center|866-435-7343||
22403592|NCT02586233|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22403593|NCT02373241|University of Alabama at Birmingham|Jeffrey Lebensbugrer|2056389285|jlebensburger@uabmc.edu|
22403594|NCT01708941|ECOG-ACRIN Statistical Office|Study Statistician|(617) 632-3012|eatrials@jimmy.harvard.edu|
22403595|NCT00229203|PharmaMar USA Inc|Claudia Silvia Corrado M.D.|1 212 201 6770|cscorrado@pharmamar.com|
22403596|NCT03457103|NYU Langone|Dr. Anna Norweg|646-501-7777|AnnaMaria.Norweg@nyulangone.org|
22403597|NCT03004469|Polichem S.A.|Francesco Scarci|+41 091 9864 005|francesco.scarci@almirall.com|
22403598|NCT01397552|Upstate Medical University|William Lavelle|315-464-4472|lavellew@upstate.edu|
22403599|NCT00423735|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
22403600|NCT00579501|PharmaMar SA, Av de los Reyes 1 Mine Industrial Estate, 28770 Colmenar Viejo, Madrid, Spain|Medical Specialist, Clinical Oncology|+34 91 646-6087||
22403601|NCT00190983|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22403602|NCT02287402|Japan Development Center, Pharmaceutical Development Division, Takeda Pharmaceutical Company Limited|Hitoshi Onouchi|+81-6-6204-5116|hitoshi.onouchi@takeda.com|
22403603|NCT04247815|Aclaris Therapeutics, Inc.|Ajay Aggarwal|484-540-6296|Clintrials@aclaristx.com|
22403604|NCT02394808|Johnson & Johnson Vision Care Inc.|Tawnya Wilson O.D. SR. MANAGER GLOBAL CLINICAL SALES EDU|443-1834|TWilson@ITS.JNJ.com|
22403605|NCT03934710|University of Chicago|Dr. Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
22403606|NCT02108600|University of California, San Francisco|Sindhu Chandran|4153538374|sindhu.chandran@ucsf.edu|
22403607|NCT01621672|University of Arkansas for Medical Sciences|Bart Barlogie|526-6990|barlogiebart@uams.edu|2420
22403608|NCT03150095|Mayo Clinic|Dr. Cassie Kennedy|507-266-3958|kennedy.cassie@mayo.edu|
22403609|NCT01295580|Bioventus, LLC|Director, Regulatory and Clinical Affairs|1-800-396-4325||
22403610|NCT04570332|Highlight Therapeutics Ltd.|M. Quintero, CEO|+34686219355|mquintero@highlighttherapeutics.com|
22403611|NCT03822871|Cancer Targeted Technology|Dr. Beatrice Langton-Webster, CEO|(206) 617-0699|bealw@cancertargetedtechnology.com|
22403612|NCT03943953|Oxford University Hospitals NHS Foundation Trust|Dr Matthew Hotton|01865 234714|matthew.hotton@ouh.nhs.uk|
22403613|NCT01102218|Fresenius Medical Care North America|Christina Kahn, Senior Manager of Clinical Trials|615-345-5542|christina.meng@fmc-na.com|
22403614|NCT00289185|GlaxoSmithKline|GSK Response Center|866-435-7343||
22403615|NCT01742078|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22403616|NCT01811355|Mayo Clinic, Jacksonville|Dr. Bjorn Oskarsson|9049536896|oskarsson.bjorn@mayo.edu|
22403617|NCT05025787|MGH|Allison Campbell|617-595-8372|acampbell17@mgh.harvard.edu|
22403618|NCT03471767|Duke University|James Davis, MD|919-668-5055|james.m.davis@duke.edu|
22403619|NCT01081873|Abbott|Global Medical Services|800-633-9110||
22403620|NCT02491073|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351||
22390906|NCT01772563|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22390907|NCT02767609|Loma Linda University medical Center|Brenda Bartnik Olson|909-558-4000|bbartnik@llu.edu|85216
22390908|NCT03045809|University of Liverpool|Prof. Janneke van de Wijgert, Chief Investigator|+447557195108|j.vandewijgert@liverpool.ac.uk|
22390909|NCT00255944|University of Colorado|Dr. Sheana Bull|3037241238|sheana.bull@ucdenver.edu|303
22390910|NCT03671239|University of Pennsylvania|Jose A. Bauermeister, PhD|215-898-9993|bjose@nursing.upenn.edu|
22390911|NCT00935259|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22403621|NCT00711269|Clinical Research, Drug Development Division|Regional Function Head of CNS Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
22403622|NCT01628016|Hunan Normal University|Dr. Wenhui Yang|+86 731 8873076|yangwh110@163.com|
22403623|NCT03689504|Wuqu' Kawoq|Peter Rohloff, Chief Medical Officer|011-502-4958-1253|peter@wuqukawoq.org|
22390912|NCT01009138|Research Institute of the Diabetes Academy Mergentheim|Dr. Bernhard Kulzer|+49 7931|kulzer@diabetes-zentrum.de|594151
22390913|NCT02980705|Sun Pharma Advanced Research Company Limited|Dr Mudgal Kothekar|912266455645|clinical.trials@sparcmail.com|
22403624|NCT00403559|Dermatology Specialists, PSC|Joseph F. Fowler, Jr., M.D.|502-583-7546|fowlerjoe@msn.com|184
22403625|NCT02768194|GlaxoSmithKline|GSK Response Center|866-435-7343||
22403626|NCT05291949|Henry Ford Health|Director of Research, Department of Anesthesiology|313-771-7128|knowak2@hfhs.org|
22403627|NCT01982773|National Center for Telehealth and Technology|Nigel E. Bush, PhD|253-968-4153|nigel.e.bush.civ@mail.mil|
22403628|NCT02278289|Department of Physical Medicine and Rehabilitation, Taipei Tzuchi Hospital, Buddhist Tzuchi Medical Foundation, New Taipei City, Taiwan, ROC|Dr. Yi-Shiung Horng|+886-2-66289779|d97841001@ntu.edu.tw|64515
22403629|NCT01029886|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22403630|NCT03294681|Cochlear|Nicole Neben|+4951154277220|nneben@cochlear.com|
22403631|NCT01553916|Washington University School of Medicine|Clifford Robinson, M.D.|314-362-4653|clifford.robinson@wustl.edu|
22403632|NCT03089216|Federal University of Goias|Dr. Terezinha de Jesus Esteves Barata|+55 62 3209-6325|terezinhabarata@yahoo.com.br|
22403633|NCT00242385|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22403634|NCT02720016|VHASDC|Dr. Leslie A. Morland|858-552-4324|Leslie.Morland@va.gov|
22403635|NCT04501679|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22403636|NCT01032993|BIDMC|Catherine Buettner, MD MPH, Assistant Professor of Medicine|617-754-9600|cbuettne@bidmc.harvard.edu|
22403637|NCT04846348|Mayo Clinic|Dr. Joseph Butterfield|507-284-3783|butterfield.joseph@mayo.edu|
22403638|NCT02121756|University of Pittsburgh Department of Medicine|Sharon Riddler, MD|412-383-1675|riddler@pitt.edu|
22403639|NCT05319080|New York State Psychiatric Institute|Michael Avissar|(646) 774-5431|MichaelAvissarMDPhD@gmail.com|
22390914|NCT01721746|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22390915|NCT03121612|Arnolda Consulting|Dr Gaston Arnolda|+61 2 8068 4963|gaston.arnolda@gmail.com|
22390916|NCT01880437|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22390917|NCT01209598|Memorial Sloan Kettering Cancer Center|Mark Dickson, MD|646-888-4164|dicksonm@mskcc.org|
22390918|NCT01438840|Eisai Call Center|Eisai Inc.|888-422-4743||
22390919|NCT01062269|Louisville Metabolic and Atherosclerosis Research Center (L-MARC)|Harold E. Bays, MD|502-515-5672|HBaysMD@aol.com|
22390920|NCT00085566|Memorial Sloan Kettering Cancer Center|Dr. Howard Scher|646-422-4323|scherh@mskcc.org|
22390921|NCT01748045|Tufts Medical Center|Dr. Christiane Dammann|617-636-8738|cdammann@tuftsmedicalcenter.org|
22390922|NCT02604342|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22390923|NCT01702519|GlaxoSmithKline|GSK Response Center|866-435-7343||
22390924|NCT01143883|University of South Florida|Jorge E. Marcet, M.D.|813-844-4545|jmateka@health.usf.edu|
22390925|NCT04688086|NIRAMAI Health Analytix Private Limited|Dr Sathiakar Collison|+919810823838|sathiakar.collison@niramai.com|
22390926|NCT01669720|Brown University Oncology Research Group (BrUOG)|Howard Safran, MD|4018633000|kayla_rosati@brown.edu|
22390927|NCT01473745|ChangGungMH|Dr. Yi Hsuan Chen|+886227135211|acantehr@gmail.com|3533
22390928|NCT02330276|Va San Diego Healthcare System|Robert R. Henry, MD|8585528585|rrhenry@outlook.com|3648
22390929|NCT02034162|Janssen R&D US|DIRECTOR CLINICAL LEAD||ClinicalTrialDisclosure@its.jnj.com|
22390930|NCT00760513|University Hospital Southampton|Professor CD Byrne|02381205006|c.d.byrne@soton.ac.uk|
22390931|NCT00158197|Friends Research Institute|Joy Chudzynski|323-333-8122|joychud@ucla.edu|
22390932|NCT02808975|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22390933|NCT04469465|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22390934|NCT02641587|Philip Morris Products S.A.|Christelle Haziza|+41 58 242 11 11|christelle.haziza@pmi.com|
22390935|NCT01296763|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Thomas Brown|410-502-5328|tbrown55@jhmi.edu|
22390936|NCT01150045|Alliance for Clinical Trials in Oncology|Jeffrey A. Meyerhardt, MD, MPH|617-632-6855|jmeyerhardt@partners.org|
22390937|NCT03194867|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22390938|NCT00464945|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22403640|NCT05027516|Institute of Tropical Medicine Antwerp|Dr. Chris Kenyon|+32(0)32470786|ckenyon@itg.be|
22403641|NCT00448916|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22403642|NCT03521193|Centro Cardiologico Monzino, IRCCS|Clinical Trials' Office Chief|+390258002|alessandra.terragni@ccfm.it|675
22403643|NCT00838916|GlaxoSmithKline|GSK Response Center|866-435-7343||
22403644|NCT01328158|AbbVie (prior sponsor, Abbott)|AbbVie Japan PMOS Desk|+81-3-4577-1125|abvj-pmos@abbvie.com|
22403645|NCT01743963|Eastern Colorado Health Care System, VA|Liron Caplan, Primary Investigator|7208575103|liron.caplan@ucdenver.edu|
22403646|NCT00430521|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22403647|NCT03675737|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22403648|NCT03052842|Armata Pharmaceuticals, Inc.|Clinical Operations|3106652928|info@armatapharma.com|
22403649|NCT03422133|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
22403650|NCT02180724|Acerta Pharma|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22403651|NCT01146951|Eisai Call Center|Eisai Inc.|888-422-4743||
22403652|NCT01586026|Bard Access Systems, Inc.|Christopher DiMatteo|801-522-5000|chris.dimatteo@crbard.com|
22403653|NCT01517412|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22403654|NCT01253187|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22403655|NCT04124692|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
22390939|NCT03831854|Cleveland Clinic|Dr Kamal Maheshwari|216-318-7235|maheshk@ccf.org|
22403656|NCT05168813|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
22403657|NCT01010854|University of California, San Francisco|Pamela Munster, MD|877-827-3222|clinicaltrials@ucsf.edu|
22403658|NCT02492997|Venus Concept Ltd.|Dr. Yoni Iger|888-907-0115|yoni@venusconcpet.com|
22403659|NCT01089582|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22403660|NCT02500602|Medical University of South Carolina|Sudie Back|843-792-9383|backs@musc.edu|
22390940|NCT03124693|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
22390941|NCT02094898|Mayo Clinic|William V. Bobo, M.D.|507-538-9041|Bobo.William@mayo.edu|
22390942|NCT03520075|Taiho Oncology, Inc|Taiho|609-250-7336|clinicaltrialinfo@taihooncology.com|
22390943|NCT01439854|University of Texas Health San Antonio|Muhammad Abdul-Ghani|210-557-1157|abdulghani@uthscsa.edu|
22390944|NCT01432626|University of Pittsburgh|Dr. Prem Soman|412 647 3435|somanp@upmc.edu|
22390945|NCT03305809|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22390946|NCT05146206|Community and Patient Preference Research (CaPPRe)|Dr Lili Toh|+61 452551409|lili.toh@cappre.com.au|
22390947|NCT00816556|Mayo Clinic|Maire Brid MacBride MB BCh|507-538-2271|MacBride.Maire@mayo.edu|
22390948|NCT01642147|Huashan Hospital Fudan University|Xiao-Yu Yang|086-021-52889999|xiaoyuyangfudan@gmail.com|7693
22390949|NCT01852032|UC Davis|John Brock Staff Research Associate|916-734-3101|jmbrock@ucdavis.edu|
22390950|NCT02536742|International Breast Cancer Study Group|Head Trial Activities and Deputy Director: Dr. Heidi Roschitzki-Voser|+41 31 511 94 00|heidi.roschitzki@ibcsg.org|
22390951|NCT01010204|Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center|K.N. Roy Chengappa, Md|412-246-5006|chengappakn@upmc.edu|
22390952|NCT01519778|Cubist Pharmaceuticals|Carisa De Anda, Phd, Vice President Clinical Research|8583522639|carisa.deanda@cubist.com|
22390953|NCT02693704|EPFL|Gilles Courtois|0041216932631|gilles.courtois@epfl.ch|
22390954|NCT02007200|University of Michigan Comprehensive Cancer Center|Gregory T. Wolf, M.D.|800-865-1125|gregwolf@umich.edu|
22390955|NCT01547117|Vanderbilt University Medical Center|Alfredo Gamboa, MD|6158751003|alfredo.gamboa@vumc.org|
22390956|NCT01844726|Northwestern University|Dr. James Reilly|312-503-4809|james.reilly@northwestern.edu|
22390957|NCT02229578|University of Florida|Brenda Fahy, MD|859-402-4360|bfahy@anest.ufl.edu|
22390958|NCT01288209|Janssen Pharmaceutical K.K., Japan|Manager|81 3 44115639||
22390959|NCT01496365|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22390960|NCT01015677|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22390961|NCT01660256|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22390962|NCT01184885|Thomas Jefferson University|Margaret Kasner, MD|215-955-8874|Margaret.Kasner@jefferson.edu|
22403661|NCT01124448|Complutense University Madrid|Dr. Juan M Rodríguez|34 91 3943837|jmrodrig@vet.ucm.es|
22403662|NCT01940510|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22416467|NCT02175368|Ivoclar Vivadent AG|Dr. Erik Braziulis||erik.braziulis@ivoclarvivadent.com|
22416468|NCT02875028|Medical University of Vienna|Bernd Jilma|+4314040029910|bernd.jilma@meduniwien.ac.at|
22403663|NCT00986310|University of California, Davis|Lisa Bateman, MD, FRCPC||lb2863@cumc.columbia.edu|
22403664|NCT00564954|Novartis Pharmaceuticals|Study Director|862-778-8300||
22403665|NCT05600309|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22403666|NCT02130258|Massachusetts General Hospital|Dr. Yi Zhang|617-724-6102|yzhang20@partners.org|
22403667|NCT00807846|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22403668|NCT03977727|Texas Diabetes & Endocrinology|Thomas Blevins, MD|512-334-3505|blevins@texasdiabetes.com|1
22403669|NCT01419665|Hexal AG / Novartis Pharmaceuticals|Study Director|+41613241111|novartis.email@novartis.com|
22403670|NCT03448718|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22403671|NCT01655823|Wex Pharmaceuticals|Mehran Kavoosi|6046767900|mehrank@wexpharma.com|
22403672|NCT01700517|Madre Teresa´s Hospital|Dr Lucio Honorio de Carvalho Júnior|+55 31 33398000|luciohcj@gmail.com|
22416469|NCT05068284|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22416470|NCT01844531|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22416471|NCT01546922|University Medical Center Groningen|A. P. van Beek, MD PhD|00315036110388|a.p.van.beek@umcg.nl|
22416472|NCT03325972|NYU Langone Health|Lisa Doan, MD|212.201.1004|Lisa.Doan@nyulangone.org|
22416473|NCT03122587|University of North Carolina at Chapel Hill|Stacey Daughters, PhD|9199629924|daughter@unc.edu|
22416474|NCT02000531|HoffmannLa Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22416475|NCT00792623|GlaxoSmithKline|GSK Response Center|866-435-7343||
22416476|NCT01602471|Certus International, Inc.|Edward M. Aten, M.D.|603.627.1212|eaten@certusintl.com|
22416477|NCT02504723|Kaohsiung Veterans General Hospital|Dr. Wen-Chi Chen|886-7-3422121|wcchen@vghks.gov.tw|2139
22416478|NCT00892281|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
22416479|NCT01280617|Lahey Hospital & Medical Ctr|Mary Ann Simpson, Ph.D|781-744-2500|Mary.a.Simpson@Lahey.org|
22416480|NCT00986570|Biolab Sanus Farmacêutica Ltda.|Priscilla Padilha, MD|55(11)35736335|ppadilha@biolabfarma.com.br|
22416481|NCT02225665|Sangamo Therapeutics|Medical Monitor|510-970-6000|clinicaltrials@sangamo.com|
22416482|NCT01311557|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22416483|NCT00608517|Vanderbilt-Ingram Cancer Center|Brian Engelhardt, M.D.|615-936-1803||
22416484|NCT00572039|Thomas Jefferson University|Barry W. Rovner, MD|2155031254|Barry.Rovner@jefferson.edu|
22416485|NCT03852524|Ohio State University|Shelby Miracle|614-366-1648|shelby.miracle@osumc.edu|
22416486|NCT05045469|CGMH|Dr. HuanHsuan Hsu|0978839349|10356017a@cgmh.org.tw|
22416487|NCT01845116|Atrium Health Levine Children's Hospital|Ricardo A. Caicedo, MD|704-381-8840|ricardo.caicedo@atriumhealth.org|
22416488|NCT01098110|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22416489|NCT02147587|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22416490|NCT01355302|Eisai Inc.|Eisai Medical Services|888-422-4743||
22416491|NCT03068949|University of Rochester|Dr. Angela Branche|5852750526|angela_branche@urmc.rochester.edu|
22416492|NCT01315028|University of Glasgow|Professor Andrew Gumley|0044 141 211 3927|andrew.gumley@glasgow.ac.uk|
22416493|NCT02531594|Cincinnati Children's Hospital Medical Center|Dr. Melinda Mahabee-Gittens|513-636-7966|melinda.mahabee-gittens@cchmc.org|
22416494|NCT03636386|Universidad Andrés Bello|Professor Hernán Andrés de la Barra Ortiz|+56984706322|quiropraxiayequilibrio@gmail.com|
22416495|NCT01430819|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22416496|NCT01218984|Alkermes, Inc.|Bernard L. Silverman, VP, Clinical Development|781-609-6000|bernard.silverman@alkermes.com|
22416497|NCT03476317|Children's Hospital of Philadelphia|Lindsey Albenberg, DO|267-426-0139|albenbergl@chop.edu|
22416498|NCT03649412|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22416499|NCT00865514|University of Florida|Dr. Peter W. Stacpoole|(352) 273-9023|pws@ufl.edu|
22416500|NCT02865395|George Washington University|Dr. Patrick Mufarrij|2027154000|pmufarrij@gmail.com|
22416501|NCT04364763|Renibus Therapeutics|Stacey Ruiz|682-285-1711|sruiz@renibus.com|
22416502|NCT02255487|Irrimax Corporation|Chevy Brown, Clinical Trials Manager|770-807-3355|chevy.brown@irrisept.com|15
22416503|NCT01264835|Ethicon Endo-Surgery|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
22416504|NCT01256060|Holland Bloorview Kids Rehabilitation Hospital|Dr. Evdokia Anagnostou|416-753-6005|eanagnostou@hollandbloorview.ca|
22416505|NCT02684396|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22416506|NCT00436917|Mayo Clinic Jacksonville|Stephanie L. Hines, M.D.|507-266-0800|hines.stephanie@mayo.edu|
22416507|NCT03170869|University of Colorado|Dr. Thor Johnson|720-848-1765|thor.johnson@ucdenver.edu|
22416508|NCT02438540|Nanjing university of TCM|Dr. Amir Firouzjaei|+989125397047|amirfi@yahoo.com|
22416509|NCT00983528|UC San Diego|MCC Clinical Trials Office|(858) 534-5417|tkipps@ucsd.edu|
22416510|NCT04763278|Point Designs|Director of Clinical Research|7206004753|research@pointdesigns.com|
22416511|NCT00373425|Astellas Pharma Global Development, Inc.|Senior Medical Director, Medical Oncology||clinicaltrial.disclosure@us.astellas.com|
22403673|NCT03352414|University of California, San Diego|Raymond Diep, Clinical Research Coordinator|(858) 822-5352|rhdiep@health.ucsd.edu|
22403674|NCT02632110|DUSA Pharmaceuticals Inc., a Sun Pharma Co.|Anna Houlihan|9147608796|anna.houlihan@sunpharma.com|
22403675|NCT03483506|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22403676|NCT00115804|University of Cincinnati|Dr. Lesley Arnold|513-475-8110|lesley.arnold@uc.edu|
22403677|NCT00547378|Pelvic Health & Gastric Therapies|Shenita Bolstrom|763-526-8254|shenita.bolstrom@medtronic.com|
22403678|NCT01449682|Retina Macula Institute|Ron P. Gallemore, M.D., Ph. D.|310) 944-9393|rongallemoremd@gmail.com|
22416512|NCT03073811|Durham VA Health Care System|Kathryn Starr, PhD, RD; Research Health Scientist|919-660-7571|kathryn.starr2@va.gov|
22416513|NCT00551616|HRA Pharma|Henri Mathé|+33140331130|medical2914@hra-pharma.com|
22403679|NCT00426517|National Institute of Allergy and Infectious Diseases|Kang, Elizabeth|+1 301 402 7567|ekang@niaid.nih.gov|
22403680|NCT04633473|Oregon Research Behavioral Intervention Strategies|Jessie Marquez|541-484-2123|jessie.marquez@influentsin.com|
22403681|NCT01822691|H. Lee Moffitt Cancer Center and Research Institute|Dr. Rami Komrokji|813-745-4692|rami.komrokji@moffitt.org|
22403682|NCT00751114|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi.com|
22403683|NCT03095521|Sandoz|Study Director|+41613241111|Sandoz.email@sandoz.com|
22403684|NCT03259490|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22403685|NCT00723073|Brigham and Women's Hospital|David Kubiak, Principle Investigator|617-525-8417|dwkubiak@partners.org|
22403686|NCT01536119|University of Toronto|Jennifer Abbass Dick||jennifer.abbass@mail.utoronto.ca|
22403687|NCT02365584|Ipsen SpA|Medical Director|see email|clinical.trials@ipsen.com|
22403688|NCT00819585|Novartis Pharmaceuticals|Study Director|862-778-8300||
22403689|NCT01927419|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22403690|NCT04597619|Maine Medical Center|David Sobel, MD|207-773-1728|david.sobel@mainehealth.org|
22403691|NCT01935336|U of Colorado, Division of Medical Oncology. Anschutz Medical Campus|Dr. Ross Camidge|7208480300|ross.camidge@cuanschutz.edu|
22403692|NCT02773238|University of Washington|Dr. Jing Zeng|206-598-4110|jzeng13@uw.edu|
22403693|NCT03260205|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22403694|NCT01877382|Daiichi Sankyo, Inc.|Clinical Director|908-992-6400|CTRinfo@dsi.com|
22403695|NCT03423979|Urotronic, Inc|Sr. Clinical Project Manager|612-245-6434|jmoland@laborie.com|
22403696|NCT05149040|Helse Bergen|Dr. G.L. Schwarz|0047-55976850|gabriele.leonie.schwarz@helse-bergen.no|
22403697|NCT00808249|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22403698|NCT04552535|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22403699|NCT05366413|Dana-Farber Cancer Institute|Andrea Enzinger, MD|617-582-7335|andrea_enzinger@dfci.harvard.edu|
22403700|NCT05108805|Vanderbilt University Medical Center|Dr. Olalekan Oluwole|(615) 936-8422|olalekan.oluwole@vumc.org|
22403701|NCT04095286|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22403702|NCT00479557|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22403703|NCT01594294|Alcon Research, Ltd.|Renee Garofalo, OD, FAAO|1-888-451-3937|alcon.medinfo@alcon.com|
22403704|NCT02509494|Janssen Vaccines & Prevention B.V.|Senior Director Clinical Franchise Lead|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22403705|NCT01511107|Children's Hospital of Pittsburgh of UPMC|Dr. Alejandro Hoberman|412-692-5249|hobermana@upmc.edu|
22403706|NCT05371912|Christiana Care|Mitra Assadi, MD|3026233017|mitra.assadi@christianacare.org|
22403707|NCT04752189|Wayne State University|Dr. Andria Eisman, Principal Investigator|313-649-7477|aeisman@wayne.edu|
22403708|NCT00975195|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22403709|NCT03003403|Duke University|Gary G. Bennett, PhD|919-808-7821|gary.bennett@duke.edu|
22403710|NCT01255306|"University Hospital Sestre milosrdnice"|Mia Zoric Geber, MD|+385 1 3787 354|mia.zoric-geber@zg.t-com.hr|
22403711|NCT05195359|Resmed Germany Inc|Susanne Fischer / Sr. Manager Clinical Research|+491707854257|susanne.fischer@resmed.de|
22403712|NCT00847938|Clinique Jules Verne|Dr Florent CAPRON|0251171775|florent.capron@mla.fr|33
22403713|NCT03342937|Duke University|Dr. Hope Uronis|919-668-1861|hope.uronis@duke.edu|
22403714|NCT01677624|Eisai Co., Ltd.|Shin Maeda|+81-3-3817-5252||
22403715|NCT01747811|University of Arizona|William Killgore|520-621-0605|killgore@psychiatry.arizona.edu|
22403716|NCT01299610|GlaxoSmithKline|GSK Response Center|866-435-7343||
22403717|NCT01617655|Sanofi|Trial Transparency Team||Contact--US@sanofi.com|
22403718|NCT01175213|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22403719|NCT03224585|VCU Health|Antonio Abbate, MD, PhD|804-828-0513|antonio.abbate@vcuhealth.org|
22403720|NCT01921634|The Pennsylvania State University, Hershey Medical Center|Andrea Benton, MD|717-531-5394|abenton@pennstatehealth.psu.edu|
22403721|NCT00751179|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22403722|NCT03569449|Boston Medical Center, Boston University School of Public Health|Emily Feinberg, ScD, CPNP|617-414-1425|emfeinbe@bu.edu|
22403723|NCT02325687|Hospital for Special Surgery, Anesthesiology Department|Kethy Jules-Elysee|212-606-1206|juleselyseek@hss.edu|
22403724|NCT03027388|National Cancer Institute|Dr. Eric Burton|240-760-6436|eric.burton@nih.gov|
22403725|NCT03746808|University of North Texas Health Sciece Center|Scott Walters|817-735-2365|scott.walters@unthsc.edu|
22403726|NCT00671723|University of Oklahoma Health Sciences Center|Dr. Houssein Youness|405-271-6173|houssein-youness@ouhsc.edu|
22431235|NCT03559530|Unversidade de Sao Paulo|Dr Priscila Rosalba Domingos de Oliveira|551126616900|priscila.rosalba@hc.fm.usp.br|
22403727|NCT02263014|The University of Texas (UT) MD Anderson Cancer Center|Dr. Abenaa Brewster, Professor, Clinical Cancer Prevention|713-792-7734|abrewster@mdanderson.org|
22403728|NCT05279898|Beth Israel Deaconess Medical Center|Balachundhar Subramaniam|617-278-8000|bsubrama@bidmc.harvard.edu|
22403729|NCT05136170|Dompé farmaceutici S.p.A.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22403730|NCT04393038|Abivax|Study Director|+33 1 53 83 09 63|info@abivax.com|
22403731|NCT04069156|Abbott|Nourdine Chakouri, PhD|(925) 989-5982|nourdine.chakouri@abbott.com|
22403732|NCT00258427|Masonic Cancer Center, University of Minnesota|Margaret L. MacMillan, M.D.|612-273-2800|macmi002@umn.edu|
22403733|NCT04580394|Apnimed, Inc.|Clinical Trials|6175008880|clinicaltrials@apnimed.com|
22403734|NCT03806179|Nordic Nanovector|Head of Clinical Operations|+47 22 18 33 01|mail@nordicnanovector.com|
22403735|NCT05822830|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22403736|NCT04124042|Xalud Therapeutics, Inc.|Director of Medical Inquiries|212-301-6673|medical.information@xaludthera.com|
22403737|NCT05388656|University of North Carolina at Chapel Hill|Elizabeth Andersen, PhD|(970) 420-4944|elizabeth_andersen@med.unc.edu|
22403738|NCT03201965|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22403739|NCT03368664|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22403740|NCT05441592|University of Michigan|Edwin Wilkins|734-936-6680|ewilkins@med.umich.edu|
22403741|NCT01021852|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22403742|NCT02408796|Otonomy, Inc.|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
22416514|NCT02692482|Istituto Ortopedico Rizzoli|Cristiana Forni|0516366694|cristiana.forni@ior.it|0039
22416515|NCT01841216|Sport & Spine Rehab Clinical Research Foundation|Jena Etnoyer, Clinical Research Coordinator|240-766-0300|jetnoyer@ssrehab.com|838
22416516|NCT00105157|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22416517|NCT03314662|Seqirus|Seqirus Clinical Trial Disclosure Manager|Phone: 1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
22416518|NCT01393457|The University of Texas Health Science Center at Houston|Charles Green, PhD|713-500-6402|charles.green@uth.tmc.edu|
22416519|NCT01117766|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22416520|NCT04405739|Ridgeback Biotherapeutics|Wendy Painter, MD, MPH|786-687-2495|EIDD2801@ridgebackbio.com|
22416521|NCT05766787|Alcon Research, LLC|Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22416522|NCT00438659|Mayo Clinic|Robert C. Miller, M.D.||miller.robert@mayo.edu|
22416523|NCT01867606|Mayo Clinic|Aminah Jatoi, M.D.|(507) 284-4918|jatoi.aminah@mayo.edu|
22416524|NCT00206102|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
22416525|NCT03922139|UW School of Medicine and Public Health|Michael Suer, MD|608-265-3207|suer@rehab.wisc.edu|
22416526|NCT00834236|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
22416527|NCT02248662|Dana-Farber Cancer Institute|Rinaa Punglia, MD|617-582-8759|rinaa_punglia@dfci.harvard.edu|
22416528|NCT01835548|Neos Tx|Carolyn Sikes, PhD|972-408-1300|csikes@neostx.com|1255
22416529|NCT02490800|Basilea Pharmaceutica International Ltd, Allschwil|Thomas Kaindl, MD|+41 61 567 15 24|thomas.kaindl@basilea.com|
22416530|NCT01169038|Vanderbilt University|Wonder Drake|615-322-2035|wonder.drake@vanderbilt.edu|
22416531|NCT00576303|F. Hoffmann-La Roche AG|Name/Official Title:Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22416532|NCT00101413|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22416533|NCT00858013|Ajou University|Kwan Woo Lee|82-31-219-4526|lkw65@ajou.ac.kr|
22416534|NCT02843659|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22416535|NCT03203642|Kadmon, a Sanofi Company|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
22416536|NCT02966184|Norton Healthcare|Tristan Murray, PharmD|5026295571|tristan.murray@nortonhealthcare.org|
22416537|NCT02121041|UNC Chapel Hill|Dr. Anthony Viera|984-974-4636|viera@med.unc.edu|
22416538|NCT03632135|Cordgenics|Pier Paolo Claudio, MD, Chief Scientific Officer|6064657226|claudio@cordgenics.com|
22416539|NCT02234752|George Washington University, Washington, DC|Maju Koola|678-200-8613|majumkoola@gmail.com|
22416540|NCT02760264|ReveraGen Biopharma Inc.|Dr. Eric P. Hoffman|240-672-0295|ericphoffman@gmail.com|
22416541|NCT05918822|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22416542|NCT02451150|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22416543|NCT03250299|Basilea Pharmaceutica International Ltd (Basilea)|Thomas Kaindl, MD, Global Medical Director|+41615671505|thomas.kaindl@basilea.com|
22416544|NCT00977548|H. Lee Moffitt Cancer Center and Research Institute|Rami Komrokji, Principal Investigator|813-745-4692|rami.komrokji@moffitt.org|
22390963|NCT01646385|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22390964|NCT04883060|University of Iowa|Matthew Howard III|(319) 356-8468|matthew-howard@uiowa.edu|
22390965|NCT04184349|The University of Texas Health Science Center at Houston|Olga Pewelek, MD|713-500-6227|Olga.I.Lyuksyutova@uth.tmc.edu|
22390966|NCT03603639|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22390967|NCT02440334|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. John Eisenbrey|(215) 503-5188|john.eisenbrey@jefferson.edu|
22390968|NCT04585737|Orlando Immunology Center|Wendy Wert, Clinical Research manager|4076473960|wwert@oicorlando.com|
22390969|NCT00858247|Mayo Clinic|Seema Kumar, MD|507-284-3300|kumar.seema@mayo.edu|
22390970|NCT04205955|SWOG Statistics and Data Management Center|Palliative and End of Life Care Committee Statistician|2066677685|karnold@fredhutch.org|
22390971|NCT02165397|Pharmacyclics LLC, An AbbVie Company|Lori Styles|(408) 215-3770|lstyles@pcyc.com|
22390972|NCT03898960|CERENOVUS|Senior Director Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22390973|NCT02988349|Sichuan University|Dr. Xin Xu|86-28-85503494|xin.xu@scu.edu.cn|
22390974|NCT01898442|University of Florida - Jacksonville|Dominick J. Angiolillo, MD, PhD|9042443933|dominick.angiolillo@jax.ufl.edu|
22390975|NCT00751634|Northwestern University|Dr. Andrew Naidech|312-503-3335|a-naidech@northwestern.edu|
22403743|NCT01025817|Novartis|Study Director|+1 (862) 778-8300||
22416545|NCT00794417|Regeneron Pharmaceuticals, Inc.|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
22416546|NCT02956616|Montefiore Medical Center|Peter S. Bernstein, MD, MPH|718-904-2767|pbernste@montefiore.org|
22416547|NCT01546142|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
22416548|NCT01213836|Astra Zeneca|Gerard Lynch||ClinicalTrailTransparency@astrazeneca.com|
22416549|NCT00450983|Fred Hutchinson Cancer Research Center|Ann Woolfrey, MD|206-667-4453|awoolfre@fredhutch.org|
22431236|NCT01472185|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22416550|NCT00255151|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
22416551|NCT00521989|Zalicus|Margaret Lee, PhD|617-301-7142|mlee@zalicus.com|
22416552|NCT00934596|Cardiothoracic Surgery, Skåne University Hospital Lund|Dr. Bansi Koul MD, PhD, Principal Investigator|+46 46 171649|bansi.koul@skane.se|
22416553|NCT00743509|University of Michigan|Scott Schuetze|734-647-8925|scotschu@umich.edu|
22416554|NCT01534078|Massachusetts General Hospital|Jeremy Abramson, MD|617-724-4000|JABRAMSON@mgh.harvard.edu|
22416555|NCT04975321|University of Washington|Mariella Garcia|2065431740|mgarciaf@uw.edu|
22416556|NCT01470417|University of Florida|Thomas J. George, Jr., MD|(352) 273-8008|thom.george@medicine.ufl.edu|
22416557|NCT03488030|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22416558|NCT02973321|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|
22416559|NCT00263887|Talecris Biotherapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
22416560|NCT00493454|The University of Texas (UT) MD Anderson Cancer Center|Felipe Samaniego, MD / Associate Professor||CR_Study_Registration@mdanderson.org|
22416561|NCT01028911|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22416562|NCT02274948|Faculty of Medicine, University of Colombo|Prof V Pujitha Wickramasinghe|+94112688748|pujithaw@yahoo.com|170
22416563|NCT00707434|UT MD Anderson Cancer Center|Clinical Research Operations, Office of VP Clinical Research|713-792-7734|CR_Study_Registration@mdanderson.org|
22416564|NCT05212883|Duke University|Saira Siddiqui, M.P.H.|919-688-8464|saira.siddiqui@duke.edu|
22416565|NCT02502734|GlaxoSmithKline|GSK Response Center|866-435-7343||
22416566|NCT00614822|Christiana Care Health System|Dr. Michael Guarino|302 366 1200|mguarino@cbg.org|
22403744|NCT00441558|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com|
22403745|NCT01165021|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22403746|NCT04799405|Hebrew SeniorLife|Dr. Pascual-Leone|6179715372|apleone@hsl.harvard.edu|
22403747|NCT00603980|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
22403748|NCT01029002|Albert Einstein College of Medicine|Dr. Michal Melamed|718-430-2304|michal.melamed@einsteinmed.edu|
22403749|NCT02683525|IndianaU|Dr. Sherif Farag|(317) 278-0460|ssfarag@iu.edu|
22403750|NCT01577160|Janssen Research & Development|Medical Director|886 2 23762155||
22403751|NCT01341652|University of Wisconsin Carbone Cancer Center|Douglas McNeel|608-263-4198|dm3@medicine.wisc.edu|
22403752|NCT02618928|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22403753|NCT04593940|Washington University in St. Louis|William G. Powderly MD|314-454-8276|wpowderly@wustl.edu|
22403754|NCT01096849|Achaogen, Inc.|Clinical Trials Posting Group||clinical-trials@achaogen.com|
22403755|NCT00118482|University of Calgary|Dr. Robert S. Sheldon|403-2208191|sheldon@ucalgary.ca|
22403756|NCT01008995|Janssen R&D US|Director, Clinical Research|1 215-793-7646||
22403757|NCT00127062|Imperial College London|Professor Fan Chung|+44 (0)20 7594 7954|f.chung@imperial.ac.uk|
22403758|NCT02856269|University Hospitals Cleveland Medical Center|Dr. Grace McComsey|216-8442739|Grace.McComsey@UHhospitals.org|
22403759|NCT04146467|Apyx Medical|Kari Larson, MBA, Sr. Director, Clinical Affairs|8012440058|kari.larson@apyxmedical.com|
22403760|NCT01269372|Givenimaging|Hilla Debby/ Director of Clinical Affairs|97299077740|hila.debby@medtronic.com|77740
22403761|NCT03927508|Clinical Reserach Specialist|Pamela Dicamillo|719-400-7463|pdicamillo@ecr-inc.com|
22403762|NCT02128763|University of Pennsylvania|Maureen G. Maguire, PhD|215-615-1501|maguirem@pennmedicine.upenn.edu|
22403763|NCT02953782|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22403764|NCT00665288|Ottawa Hospital Research Institute|Manya Charette|613-798-5555|mancharette@ohri.ca|17758
22403765|NCT01934192|GlaxoSmithKline|GSK Response Center|866-435-7343||
22403766|NCT01737840|Akdeniz University|Cenker Eken|00905321593948|cenkereken@akdeniz.edu.tr|
22403767|NCT01189435|Memorial Sloan Kettering Cancer Center|Dr. Gregory Riely|646-888-4199|rielyg@mskcc.org|
22403768|NCT02118610|Maryland Psychiatric Research Center|Ann Kearns, MS|4104066854|akearns@som.umaryland.edu|
22403769|NCT02357849|Northwell Health|Dr. Christoph Correll|718-470|ccorrell@northwell.edu|7000
22403770|NCT03637699|Brigham and Women's Hospital|Bonnie Glanz, PhD|617-525-6574|bglanz@bwh.harvard.edu|
22403771|NCT03105700|Dartmouth Hitchcock Medical Center|Krzysztof Bujarski, MD|6036505000|krzysztof.a.bujarski@hitchcock.org|
22403772|NCT01253421|McLean Hospital|Diego Pizzagalli, Ph.D.|617-855-4230|dap@mclean.harvard.edu|
22403773|NCT01525927|North Shore LIJ Cancer Institute|Jeffrey Revello Sr. Administrative Manager|516 734 7629|jrevello@nshs.edu|
22403774|NCT04105244|Frances Payne Bolton School of Nursing, Case Western Reserve University|Valerie Boebel Toly, PhD, RN, CPNP-PC, FAAN|216-534-5844|vab@case.edu|
22403775|NCT04863014|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|8447346643|clinicaltrials@regeneron.com|
22403776|NCT01608724|Astrazeneca Investment (China) Co., Ltd.|Anya Huang, Brand Physician|+86 21 6030 2032|anya.huang@astrazeneca.com|
22403777|NCT00099359|Westat|Margaret Camarca, Project Director|301-517-4128|margaretcamarca@westat.com|
22403778|NCT00717366|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22403779|NCT01022567|Turku University Hospital|Paulina Salminen|+358 2 313 0542|paulina.salminen@tyks.fi|
22403780|NCT02104804|AstraZeneca|Eva Johnsson, MD, PhD, Global Clinical Lead||Eva.Johnsson@astrazeneca.com|
22403781|NCT00645567|James A Haley VA, Tampa|John Lloyd|813-624-8986|john.lloyd2@va.gov|
22403782|NCT05092971|National Institute of Mental Health (NIMH)|Dr. Maryland Pao|301-435-5770|paom@mail.nih.gov|
22403783|NCT01208038|Chelsea and Westminster NHS Trust|Dr Kate Maclaran|020 3315 3000|kate.maclaran@nhs.net|
22403784|NCT02487901|Seoul National Unversity College of Medicine|Chun Kee Chung|+82-2-2072-2357|chungc@snu.ac.kr|
22403785|NCT05084053|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22403786|NCT03906227|University of North Carolina at Chapel Hill|Anne Froment|919-445-2622|anne_froment@med.unc.edu|
22403787|NCT01179347|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22403788|NCT04092816|University of North Carolina at Chapel Hill|Zev Nakamura, MD|984-974-3829|zev_nakamura@med.unc.edu|
22403789|NCT03833817|Fred Hutchinson Cancer Center|Megan Shen|206-667-4172|mshen2@fredhutch.org|
22403790|NCT02097485|Dr. Reddy's Laboratories Inc.|Dr. Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
22403791|NCT04172701|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22416567|NCT03095118|Mayo Clinic|Dr. Fernando C. Fervenza|507-266-1045|Fervenza.Fernando@mayo.edu|
22416568|NCT00530348|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22416569|NCT00448227|Novartis Pharmaceuticals|Study Director|862-778-8300||
22416570|NCT01839838|Hospital of the University of Pennsylvania|Gary Freedman, MD|215-615-6767|Gary.freedman@pennmedicine.upenn.edu|
22416571|NCT00985231|Bausch & Lomb Incorporated|William Reindel, OD, MS|(585) 338-8129|william.t.reindel@bausch.com|
22416572|NCT00089076|Mayo Clinic|Dr. Stephen Ansell|507-284-0923|ansell.stephen@mayo.edu|
22416573|NCT00808509|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22416574|NCT00931463|The Kirby Institute|Prof Sean Emery|+61293850900|semery@kirby.unsw.edu.au|
22416575|NCT05633082|CooperVision Inc.|José A. Vega OD, MSc, FAAO|+19256213761|jvega2@coopervision.com|
22416576|NCT02169791|Northside Hospital|Scott R. Solomon, MD|404-255-1930|ssolomon@bmtga.com|
22416577|NCT04936594|University of Kentucky|Dr. Gopalkumar Rakesh|859-562-2348|gopalkumar.rakesh@uky.edu|
22416578|NCT01966809|Medical College of Wisconsin|Dr. Harry T. Whelan|414-266-7516|hwhelan@mcw.edu|
22416579|NCT01501110|Hospital de Clínicas de Porto Alegre|Josi Vidart|+55 51 98472520|josividart@gmail.com|
22416580|NCT02221817|West Virginia Universtiy, WVCTSI|Clinical Trials Compliance Coordinator|304-293-0216|ctgovadmin@hsc.wvu.edu|
22416581|NCT02681406|University of Pennsylvania|James McKay|215-746-7704|jimrache@upenn.edu|
22416582|NCT00575380|Inspire|Mike Schiewe|919-941-9777|mschiewe@inspirepharm.com|
22416583|NCT05070390|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22416584|NCT00003531|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22416585|NCT00346164|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordintator@childrensoncologygroup.org|
22416586|NCT02927834|Loma Linda University|Dr. Kristin Seiberling|9095582002|kseiberling@llu.edu|
22416587|NCT04925713|Morphogenesis, Inc|James Bianco, MD - Chief Executive Officer|8138756600|jbianco@morphogenesis-inc.com|104
22416588|NCT03812991|UMissouri - Missouri Orthopaedic Institute|Vicki L Jones|573-882-7583|jonesvicki@health.missouri.edu|
22416589|NCT00127166|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22416590|NCT01396421|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
22416591|NCT01148225|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22416592|NCT00611325|Duke University Medical Center|Dr. Katherine B. Peters|(919) 684-6173|katherine.peters@duke.edu|
22416593|NCT03496987|Yale University School of Medicine|Jonathan Puchalski, MD|2037375699|jonathan.puchalski@yale.edu|
22416594|NCT04798482|Boston Children's Hospital|Keira Mason MD|617-355-5775|keira.mason@childrens.harvard.edu|
22416595|NCT01506908|GlaxoSmithKline|GSK Response Center|866-435-7343||
22416596|NCT01610063|Mayo Clinic|Dr. Daniel K. Hall-Flavin|507-255-4151|flavin.daniel@mayo.edu|
22416597|NCT01818518|Mednax. Inc|Kimberly Maurel|714-593-9171|kimberly_maurel@mednax.com|
22416598|NCT02919826|Queen's University|Dr. Muhammad Ayub|613-549-7944|ma84@queensu.ca|
22416599|NCT04232540|UNC Chapel Hill|Amanda Poliseno|919-962-5344|amanda_poliseno@unc.edu|
22416600|NCT00537017|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22416601|NCT00948792|University of Oklahoma Health Sciences Center|Doug Dannaway|4052715215|douglas-dannaway@ouhsc.edu|42048
22416602|NCT01662362|Abbott|Barbara Kaesdorf, Associate Director Clinical Affairs|847-937-8702|barbara.kaesdorf@abbott.com|
22416603|NCT02339090|Aravive, Inc.|Chief Operating Officer|(936) 355-1910|clinicaltrials@aravive.com|
22416604|NCT00442546|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22416605|NCT00392782|Masonic Cancer Center, University of Minnesota|Daniel Weisdorf, M.D.|612-624-0123|weisd001@umn.edu|
22416606|NCT01253317|Boston Children's Hospital|Walter E. Kaufmann, MD|617-355-5230|rettresearch@childrens.harvard.edu|
22416607|NCT03183141|Seres Therapeutics|Lisa von Moltke, MD, Chief Medical Officer|617-945-9626|clinicalstudies@serestherapeutics.com|
22416608|NCT04052698|Octapharma|Dr. Sigurd Knaub, Senior VP CR&D Haematology|01554512141|Sigurd.Knaub@octapharma.com|
22416609|NCT06442410|Medtronic|Thanh Tran|7278082652|thanh.tran2@medtronic.com|
22416610|NCT01507090|Children's Mercy Hospital|Principal Investigator|816-234-3059|srahman@cmh.edu|
22416611|NCT02449473|AstraZeneca|Global Clinical Lead|+1 301-398-0582|ClinicalTrialTransparency@astrazeneca.com|
22416612|NCT03535857|University of Pittsburgh|Dr, Gnankang Sarah Napoe|412-641-7850|napoegs@upmc.edu|
22416613|NCT02928536|Istituto di Ricerche Farmacologiche Mario Negri|Silvano Gallus, head of the Laboratory of Lifestyle Epidemiology|0039023901|silvano.gallus@marionegri.it|4657
22416614|NCT00546910|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22416615|NCT01301482|Mike O'Callaghan Military Medical Center|Amanda Crawford|7026533583|amanda.j.crawford.ctr@health.mil|
22416616|NCT01682642|Fertility Center AZ Jan Palfijn|dr. Wim Decleer, PI|0032 9 325 92 20|wim.decleer@janpalfijngent.be|09/2248851
22416617|NCT03326986|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22416618|NCT04039919|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22416619|NCT00706095|Eisai Call Center|Eisai Inc.|888-422-4743||
22416620|NCT03460158|University of Pennsylvania|Ivona Percec, MD, PhD|215-662-7300|ivona.percec@pennmedicine.upenn.edu|
22416621|NCT01011556|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22416622|NCT03920280|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22416623|NCT01009515|University of New Mexico|Montaser Shaheen, MD, PhD|505-925-0404|MoShaheen@salud.unm.edu|
22416624|NCT01321437|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
22416625|NCT02075606|Ipsen|Medical Director|00441753627777|clinical.trials@ipsen.com|
22416626|NCT03420768|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22416627|NCT00983476|VA Greater Los Angeles Healthcare System, Los Angeles, CA|Dr. Alexander S. Young|310-794-7219|alexander.young@va.gov|
22416628|NCT02969876|Massachusetts General Hospital|Dr. Andrew Nierenberg|6175122641|anierenberg@mgh.harvard.edu|
22416629|NCT01439724|Instituto Nacional de Cancer|Dr. Heliton Spindola Antunes|55 21 32076597|hspindola@inca.gov.br|
22416630|NCT01997723|UIllinois|Bharati Prasad|3129968433|bpradsad@uic.edu|
22416631|NCT01857206|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22431237|NCT02958865|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22431238|NCT01309230|Gradalis, Inc.|Clinical and Regulatory Operations|214-442-8100|info@gradalisinc.com|
22431239|NCT02661815|Dana-Farber Cancer Insitute|Dr. Joyce Liu|617-632-5269|joyce_liu@dfci.harvard.edu|
22431240|NCT00209131|Emory University|Dr. Kenneth Ogan|404-778-4898|kogan@emory.edu|
22431241|NCT05360784|Bausch and Lomb|Johnson Varughese|908-927-1162|johnson.varughese@bausch.com|
22431242|NCT04875533|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_lnquiries@pfizer.com|
22431243|NCT02971163|Mount Sinai Medical Center|Dr. Marc A. Probst|212-824-8094|marc.probst@mssm.edu|
22431244|NCT02702999|The University of Texas Health Science Center at Houston|Olaide Azizat Ashimi Balogun, MD|(713) 500-6412|Olaide.A.Ashimi@uth.tmc.edu|
22431245|NCT01299961|UCLA|Veena K. Ranganath, MD, MS Assistant Clinical Professor|310-825-3061|vranganath@mednet.ucla.edu|
22431246|NCT02904096|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
22431247|NCT02678377|Northwestern University|Dr. Kimberly Kenton|3124723874|kkenton@nm.org|
22431248|NCT00526799|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
22390976|NCT00702546|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22416632|NCT01483625|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22416633|NCT00084799|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22416634|NCT04019054|UCLA Psychiatry|Dr. Michael K. Leuchter|3108906943|mkleuchter@mednet.ucla.edu|
22416635|NCT00574067|Friends Research Institute|Dr. Michael Gordon|410-837-3977|mgordon@friendsresearch.org|251
22416636|NCT01261624|Italfarmaco S.p.A.|Clinical R&D Director|026443|p.bettica@italfarmaco.com|2584
22416637|NCT01040793|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22416638|NCT02094261|AstraZeneca|Senior Medical Director, Tagrisso||ClinicalTrialTransparency@astrazeneca.com|
22416639|NCT00597428|Sucampo Pharma Americas, LLC|VP, Clinical Development|301-961-3400|info@sucampo.com|
22416640|NCT02412722|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22416641|NCT01083680|AbbVie|Global Medical Information|800-633-9110||
22416642|NCT03877926|Emergent BioSolutions Inc.|Bojan Drobic, Director, Clinical Research|204 275 4196|bdrobic@ebsi.com|
22416643|NCT02240186|Mayo Clinic|Dr. Kenton Kaufman, Principal Investigator|507-284-2262|kaufman.kenton@mayo.edu|
22431249|NCT01441492|Baylor College of Medicine|Amy McElhany, Clinical Research Manager|7137981016|pancreas@bcm.edu|
22431250|NCT03633058|Vanderbilt University Medical Center|Jeffrey L. Neul, MD, PhD, Principal Investigator|615-322-8242|jeffrey.l.neul@vumc.org|
22403792|NCT02757092|Chang Gung Memorial Hospital|Respiratory therapist Nai-Ying Kuo|+886077317123|ellen0605@gmail.com|2648
22403793|NCT03363919|Mayo Clinic|Paul E. Croarkin, D.O., M.S.|507-293-2557|Croarkin.Paul@mayo.edu|
22403794|NCT01975246|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22403795|NCT00574119|Vanderbilt University School of Medicine|Marvin W. Kronenberg,M.D.|615 936-7437|marvin.w.kronenberg@vumc.org|
22403796|NCT03287245|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22403797|NCT02862548|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22403798|NCT00880763|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22403799|NCT02500368|CooperVision Inc.|Sr. Manager Clinical Research|(925) 730-6754|PChamberlain@coopervision.com|
22403800|NCT03353753|Deciphera Pharmaceuticals, LLC|INVICTUS Clinical Team|7812096400|clinicaltrials@deciphera.com|
22403801|NCT00600028|Johns Hopkins University School of Medicine|Maureen R. Horton|410-955-4176|mhorton2@jhmi.edu|
22403802|NCT01830816|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22403803|NCT01753830|Q-Med AB|Clinical Project Manager|+46 18 4749000|reception.seupp@galderma.com|
22403804|NCT00232505|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22403805|NCT03624478|Mayo Clinic|Dr. Carlos Vargas|480-342-1267|Vargas.Carlos@mayo.edu|
22403806|NCT01754922|VA NJ Health Care System|Dr. Michael Falvo|973-676-1000|Michael.Falvo@va.gov|2423
22403807|NCT03263117|The University of Texas Health Science Center at Houston|Peng Roc Chen, MD|713-486-8016|peng.r.chen@uth.tmc.edu|
22403808|NCT01885078|Eli Lilly & Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22403809|NCT02680587|Johns Hopkins University|Dr. Phuoc T. Tran|4106143880|ptran12@jhmi.edu|
22403810|NCT02275767|Univ of Texas Health Sci Ctr San Antonjio, Dept of Periodontics|Brian L. Mealey DDS, MS|210-567-3567|mealey@uthscsa.edu|
22403811|NCT00571688|University of Alabama at Birmingham|Tracy Manley|205-975-3442|tlmanley@uabmc.edu|
22403812|NCT00259740|Amgen Inc.|Study Director|866-572-6436||
22403813|NCT05848323|University of Washington|Lindsey Knowles|2067449640|lmknow@uw.edu|
22403814|NCT01367301|Albert Einstein College of Medicine - Montefiore Medical center|Dr. Jessica Atrio, Professor, Department of Obstetrics & Gynecology and Women's Health|917-721-6155|jatrio@montefiore.org|
22403815|NCT01844830|Loma Linda University|Yiming Li, DDS|909-558-4600|kkellingsworth@llu.edu|
22403816|NCT02170649|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|clinical.trials@bial.com|
22403817|NCT01309867|Bausch Health|Study Director|585-338-6399|robert.steffen@bausch.com|
22403818|NCT04735393|Aldeyra Therapeutics, Inc.|Director of Clinical Trials|781-257-3063|bcavanagh@aldeyra.com|
22403819|NCT00209170|University of Miami School of Medicine|Dominique Musselman, MD|404-723-8361|dmusselman@med.miami.edu|
22403820|NCT00432094|Masonic Cancer Center, University of Minnesota|Dr. Najla El Jurdi|612-625-8942|neljurdi@umn.edu|
22403821|NCT02769351|Fresenius Medical Care Deutschland GmbH|Dr. Jennifer Braun|+49617260893488|jennifer.braun@fmc-ag.com|
22403822|NCT03224104|UniversitaetsSpital Zurich - Neurology Clinic|Dr Emilie Le Rhun|+41 762847518|emilie.lerhun@usz.ch|
22403823|NCT04397718|Department of Veterans Affairs GLA|Dr. Matthew Rettig|310-478-3711|matthew.rettig@va.gov|44761
22403824|NCT01371981|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22403825|NCT02493426|University of Minnesota|Suma Jacob, MD, PhD|612-624-0018|sjacob@umn.edu|
22403826|NCT01153893|GlaxoSmithKline|GSK Response Center|866-435-7343||
22403827|NCT00906074|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22403828|NCT02998554|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22403829|NCT01778127|St. Jude Children's Research Hospital|Kirsten K. Ness, PT, PhD|901-595-5157|kiri.ness@stjude.org|
22403830|NCT01003080|Montefiore Medical Center|Dr. Sun Jin Kim|718-920-2060|sukim@montefiore.org|
22403831|NCT01317667|US Army Medical Research Institute of Infectious Diseases (USAMRIID)|Denise P Clizbe, RN, CCRC|301.619.6869|denise.p.clizbe.civ@mail.mil|
22403832|NCT01348425|Cook|Scott Snyder, PhD, Director of Clinical Science and Biostatistics|765-463-7537|ssnyder@medinst.com|
22431251|NCT01950520|NIDDK|Kong Chen, PhD, MSCI|301-451-1636|chenkong@niddk.nih.gov|
22431252|NCT01107496|Supernus Pharmaceuticals, Inc.|Jonathan Rubin, MD, Senior Vice President and Chief Medical Officer|240-403-5710|jrubin@supernus.com|
22431253|NCT03559556|University of Texas Southwestern Medical Center|Dr. Robert Timmerman|214-645-7637|robert.timmerman@utsouthwestern.edu|
22403833|NCT02049749|Children's Hospital of Philadelphia|Dr. Joanne Wood, PI|267-426-3107|woodjo@email.chop.edu|
22403834|NCT03497026|Auris Health|Scott Rehage|925 6832590|srehage@its.jnj.com|
22403835|NCT03615911|University Medical Center Hamburg-Eppendorf|Prof. Marylyn M. Addo|+49 40 7410|m.addo@uke.de|51102
22403836|NCT04511026|Stanford University|Amer Karam, MD|650-498-6004|amkaram@stanford.edu|
22403837|NCT01968954|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22403838|NCT01423773|Alcon Research|Head, Clinical Trial Management|1-800-241-7629||
22403839|NCT00547638|Ethicon, Inc.|John Lombard, Clinical Research Manager|908 218 2877|jlombar8@its.jnj.com|
22403840|NCT00622544|University of MN|Clifford E. Kashtan|646 692 9309|cassi044@umn.edu|
22403841|NCT00255086|VA Palo Alto Health Care System|Wes Ashford, PhD, MD|650-493-5000|wes.ashford@va.gov|
22403842|NCT01963208|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
22403843|NCT00438399|Galderma|Farzaneh SIDOU Clinical Project Manager|00 33 4 93 95 70 70|farzaneh.sidou@galderma.com|70 51
22403844|NCT01364233|Medline Industries, Inc.|Ed Drower|847-643-3874|edrower@medline.com|
22403845|NCT05522673|National Institute of Mental Health (NIMH)|Dr. Robert Innis|301-594-1368|robert.innis@nih.gov|
22403846|NCT00406783|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22403847|NCT02034474|NYSPI|Ragy Girgis,MD|6467745553|ragy.girgis@nyspi.columbia.edu|
22403848|NCT01391819|GlaxoSmithKline|GSK Response Center|866-435-7343||
22403849|NCT01262755|Temple University|Frank Friedenberg, MD|215-707-9900|frank.friedenberg@temple.edu|
22403850|NCT00995670|Zablocki VA Medical Center|Thomas J. Ebert, MD, PhD|414-384-2000|thomas.ebert@va.gov|42429
22403851|NCT00675103|Savient Pharmaceuticals, Inc.|Chief Medical Officer|732-418-9300||
22403852|NCT02006264|Albert Einstein College of Medicine|Marla Keller, MD, Principal Investigator|718-430-3240|marla.keller@einstein.yu.edu|
22403853|NCT01810042|Pusan National University Hospital|Ji Eun Lee|+82-51-240-7957|jlee@pusan.ac.kr|
22403854|NCT01337167|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22403855|NCT02126670|Promius Pharma, LLC|Director of Clinical Operations|609-282-1476|kgulbronson@promiuspharma.com|
22403856|NCT01646398|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22403857|NCT00424346|Novartis Pharmaceuticals|Study Director|862-778-8300||
22403858|NCT01827319|CryoLife, Inc.|Scott Capps|800-438-8285|brown.carolyn@cryolife.com|
22403859|NCT00571519|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22403860|NCT00989612|GlaxoSmithKline|GSK Response Center|866-435-7343||
22403861|NCT01746940|STATKING Clinical Services|Lori Christman, PhD|513-858-2989|lori@statkingclinical.com|317
22403862|NCT03057951|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22403863|NCT03434418|Duke University|Thomas Stinchcombe, MD|919-681-9509|thomas.stinchcombe@duke.edu|
22403864|NCT05343585|Pennington Biomedical Research Center|Chloe Panizza Lozano|(225) 763-2500|cpanizza@hawaii.edu|
22403865|NCT00696436|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22403866|NCT00944216|Wright State University School of Medicine, Dept of Dermatology|Amy Chen, MD|927-224-3345|amy.chen@wright.edu|
22403867|NCT03039738|Medtronic|Anne Kinney|+1-303-876-8904|anne.r.kinney@medtronic.com|
22403868|NCT04241146|Children's Hospital of Nevada at UMC|Prashant Jha|702-383-2420|prashant.jha@umcsn.com|
22403869|NCT05158179|University of California San Francisco|Yue Ma|415-885-7700|yue.ma@ucsf.edu|
22403870|NCT01293006|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22403871|NCT01494987|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22416644|NCT03554317|Johns Hopkins Sidney Kimmel Comprehensive Cancer Center|Dr. Mark Markowski|410-614-0567|mmarko12@jhmi.edu|
22416645|NCT03546647|University of Houston|Kathryn Richdale OD, PhD|713-743-1974|richdale@central.uh.edu|
22416646|NCT04061577|UCLA|Dr. Mersedeh Bahr Hosseini|3107941195|MBahrHosseini@mednet.ucla.edu|
22403872|NCT04807101|Northwestern University|Greg Cohen, MD|312-695-4452|gregcohen@northwestern.edu|
22403873|NCT06170866|University of Connecticut|Dr. Cristina Colon-Semenza, Assistant Professor|8604860019|cristina.colon-semenza@uconn.edu|
22403874|NCT02092441|Brooke Army Medical Center|Dr. Michael D. April|210-916-6129|Michael.D.April@post.harvard.edu|
22403875|NCT02716194|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22403876|NCT00363051|Novartis Pharmaceuticals|Novartis Study Director|(862 778-8300||
22403877|NCT02293993|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22403878|NCT00205699|Florida Atlantic University|John W. Newcomer|(561) 297-0252|jnewcomer@health.fau.edu|
22403879|NCT03587584|University of Minnesota|Aaron Berg|612-625-7675|bergx831@umn.edu|
22403880|NCT02928380|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22416647|NCT02400476|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|1-424-248-6500|clinicaltrials@pumabiotechnology.com|
22403881|NCT01207388|Amgen Inc.|Study Director|866-572-6436||
22403882|NCT01677507|University of Michigan|Dr. Sayoko Moroi|734-763-3732|smoroi@med.umich.edu|
22403883|NCT00469209|University of Texas M.D. Anderson Cancer Center|Muzaffar H. Qazilbash, MD/Professor, Stem Cell Transplantation|713-745-3458|mqazilba@mdanderson.org|
22416648|NCT00124462|Boston Univeristy|ClinicalTrials.gov Administrator|617 638 8862|damusk@bu.edu|617
22403884|NCT00961441|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22403885|NCT01194869|Emory University|Elisavet Paplomata, MD|404-778-1900|elisavet.paplomata@emory.edu|
22403886|NCT03739853|University of Oxford, NDORMS|Laura Coates|+441865737838|laura.coates@ndorms.ox.ac.uk|
22403887|NCT06087328|Medical University of South Carolina|Amanda M. Palmer, PhD|843-792-1413|palmeram@musc.edu|
22403888|NCT03589326|Director|Medical|+1-877-825-3327|trialdisclosures@takeda.com|
22403889|NCT00156910|Allergan, Inc.|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com|
22403890|NCT04465396|Takeda|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22403891|NCT00434122|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
22403892|NCT00379197|University of Minnesota, Dept. Medicine|Dr. Douglas Yee, MD|612-273-5700|yeexx006@umn.edu|
22403893|NCT00349752|UCB Clinical Trial Call Center|Study Director|+1 877 822 9493||
22403894|NCT05294211|Marani Health, Inc.|Vice President, Clinical Affairs|612-718-9699|mindy@maranihealth.com|
22403895|NCT03334396|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22403896|NCT00601796|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D.|813-745-2158|alberto.chiappori@moffitt.org|
22403897|NCT01842607|GlaxoSmithKline|GSK Response Center|866-435-7343||
22403898|NCT00012012|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
22416649|NCT02487082|Stony Brook Medicine Dept. of Neurology|Ruth A. Reinsel Ph.D., Clinical Research Associate II|(631) 638-2087|ruth.reinsel@stonybrookmedicine.edu|
22416650|NCT00588731|Yale University|Mohini Ranganathan, M.D.|203-932-5711|mohini.ranganathan@yale.edu|2546
22416651|NCT02621463|University of Utah|Dr. Kai Kuck, PhD|8012051010|kai.kuck@hsc.utah.edu|
22416652|NCT01067716|Abbott Medical Optics|Amelia Saliba|408-273-4158|amelia.saliba@amo.abbott.com|
22416653|NCT00268892|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
22416654|NCT00680186|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22416655|NCT00606138|Rush University Medical Center|Mathew MacCumber, MD, PhD|312-563-4032|denise_voskuil-marre@rush.edu|
22416656|NCT01684878|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22416657|NCT00810888|Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center|Dr Jane Khoury, Professor of Pediatrics|513-636-2690|jane.khoury@cchmc.org|
22416658|NCT04647383|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22416659|NCT02087176|SCRI Development Innovations|Charles H. Davis|+615-524-4341|charles.davis2@scri-innovations.com|
22416660|NCT03746002|University of Maryland School of Pharmacy|Brent Reed|410-706-1452|breed@rx.umaryland.edu|
22416661|NCT00304707|University of Massachusetts Medical School|David Kalman, PhD|9785782371|kalmand@comcast.net|
22416662|NCT00479388|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22416663|NCT03942211|Janssen Cilag International NV|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22416664|NCT02938013|Johns Hopkins University School of Medicine|Dr. Mark Sulkowski|443-997-1900|msulkowski@jhmi.edu|
22416665|NCT00777855|UCSF|Leslie Benet|(415) 476-3853|leslie.benet@ucsf.edu|
22416666|NCT01876368|Novartis Pharmaceuticals|Study Director|862-778-8300||
22416667|NCT01955044|NorthShore University HealthSystem|Brandy L Frost|847-570-2033|bfrost@northshore.org|
22416668|NCT01644149|PharmaJet, Inc.|Marilyn Dysart, Clinical Affairs Manager|720-214-9399|marilyn.dysart@pharmajet.com|
22416669|NCT00690482|AstraZeneca|Alison Holt||ClinicalTrialTransparency@astrazeneca.com|
22416670|NCT01886937|New York State Psychiatric Institute|Dr. Laurel Mayer|646-774-8067|lsm16@cumc.columbia.edu|646
22416671|NCT00605917|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22416672|NCT00925301|Amicus Therapeutics|Medical Affairs|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
22416673|NCT03043560|Icahn School of Medicine at Mount Sinai|Dr, James Murrough|212-585-4640|james.murrough@mssm.edu|
22416674|NCT00292227|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22416675|NCT00862537|Pico-Tesla Magnetic Therapies, LLC|Allen S. Braswell CEO|303 795-3222|abraswell@pico-tesla.com|
22416676|NCT01114581|Reckitt Benckiser Inc.|Gail Solomon, Director, Clinical Development|973-404-2752|gail.solomon@rb.com|
22416677|NCT03234608|Portland State University|Dr. Christina Nicolaidis|503-725-9603|nicol22@pdx.edu|
22416678|NCT02329431|UNC Chapel Hill|Kathleen Thomas|919-966-3387|kathleen_thomas@unc.edu|
22416679|NCT02105701|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22416680|NCT01362296|GlaxoSmithKline|GSK Response Center|866-435-7343||
22416681|NCT02774850|Children's Hospital of Philadelphia|Dr. Richard Aplenc|267-426-7252|aplenc@email.chop.edu|
22416682|NCT00248170|Novartis|Study Director|862-778-8300||
22416683|NCT01557582|VentriPoint, Inc.|Jim bodtke, Vice President Clinical Affairs and Development|206-283-0221|jbodtke@ventripoint.com|
22416684|NCT05427045|UArkansas|Dr. Santos-Horta|507-250-5880|ESantoshorta@uams.edu|
22416685|NCT02521181|Cleveland Clinic Foundation|Jennifer J. Gassman, PhD|(216) 444-9938|gassmaj@ccf.org|
22416686|NCT02664987|Mundipharma Pte Ltd|Valerie Leck|+65 6511 1165|info.rma@mundipharma.com.sg|
22403899|NCT02159469|Antares Pharma, Inc.|Jonathan Jaffe, MD|609-359-3020|jjaffe@antarespharma.com|
22403900|NCT01519284|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22403901|NCT03629041|Innoture Ltd|Jemma Burridge, Clinical Project Manager|+44 (0)7799 902476|jburridge@innoture.co|
22403902|NCT03488251|Molecular Templates, Inc.|Study Director|512 930-0304|trials@mtem.com|
22403903|NCT03730194|University of Nebraska Medical Center|Alyson E Hanish|402-559-6731|alyson.hanish@unmc.edu|
22403904|NCT04427917|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22403905|NCT01766817|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
22403906|NCT03600714|NIDDK|Dr. Christopher Koh|301-443-9402|kohchris@mail.nih.gov|
22403907|NCT03814590|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22403908|NCT03011450|Kowa Research Institute, Inc.|Director, Clinical Operations|919-433-1600|CTGResults@KowaUS.com|
22403909|NCT01568424|St. Jude Medical|Poornima Sood|+1.781.852.8334|psood@sjm.com|
22403910|NCT00592553|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22403911|NCT04914377|Novatek Pharmaceuticals|Ahmed Kaseb MD|877-662-8351|akaseb@novatekpharmaceuticals.com|
22403912|NCT01244191|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22403913|NCT01752842|Washington University School of Medicine|Jean E. Schaffer, MD|314-362-8717|jschaff@wustl.edu|
22416687|NCT02280226|University of Bonn|Dr. Jonas Doerner|017632817006|jonas.doerner@ukb.uni-bonn.de|
22416688|NCT01598545|Emory University|Dr. Grant Lynde|404-778-3900|glynde@emory.edu|
22416689|NCT00096122|UT MD Anderson Cancer Center|Jorge Cortes, MD / Professor|713-745-5783|eharrison@mdanderson.org|
22416690|NCT04947150|Drexel University|Dr. Meghan Butryn|215-553-7108|mlb34@drexel.edu|
22416691|NCT02953678|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22416692|NCT00932282|University of North Carolina at Chapel Hill|Edwin Kim, Director UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
22416693|NCT04034355|Egetis Therapeutics AB|Kristina Sjoblom Nygren|+46 732344698|kristina.sjoblom@egetis.com|
22416694|NCT03064438|Accuitis, Inc.|Chief Science Officer|678-812-1492|info@accuitis.com|
22416695|NCT01937351|Avinger|Thomas Lawson|650.241.7030|tlawson@avinger.com|
22416696|NCT04373551|University of Alabama at Birmingham|Dr. Mirjam-Colette Kempf|205-934-9333|MKempf@uab.edu|
22416697|NCT02070757|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22416698|NCT04086641|University of Washington|Conrad Slater|5409318478|conslate13@gmail.com|
22416699|NCT02429375|Memorial Sloan Kettering Cancer Center|Dr. Alison Moskowitz, MD|\646-608-3726|moskowia@mskcc.org|
22416700|NCT00385788|UT MD Anderson Cancer Center|Clinical Research Operations Team, Office of VP Clinical Research|713-792-7734|CR_Study_Registration@mdanderson.org|
22416701|NCT02597582|Taichung Veterans General Hospital|Shih-An Liu|+886-4-23592525|saliu@vghtc.gov.tw|5409
22416702|NCT01322971|Stanford University|Ruth Lathi||rlathi@stanford.edu|
22416703|NCT00126126|Miami VAHS & University of Miami, Department of PT|Robert Gailey, PhD, PT|305-284-4535|rgailey@miami.edu|
22416704|NCT01048502|UPenn|Muredach Reilly|215-573-1214|muredach@mail.med.upenn.edu|
22416705|NCT04136951|Columbia University|Maxim Topaz, PhD, Elizabeth Standish Gill Associate Professor of Nursing|6462760460|mt3315@cumc.columbia.edu|
22416706|NCT01333072|MUSouthCarolina|C. Lindsay DeVane, Pharm.D.|8432701818|devaneL@musc.edu|
22416707|NCT02457611|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22416708|NCT01463982|HanmiPharma|Director of clinical research team|8224109038|jajung@hanmi.co.kr|
22416709|NCT02423317|Govt. Medical College, Haldwani.|Dr. Bikramjit Das|8937963828|bikramjit.anesth@gmail.com|
22416710|NCT00838981|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu|
22416711|NCT04220775|M D Anderson Cancer Center|Dr. Renata Ferrarotto|(713) 745-6774|rferrarotto@mdanderson.org|
22416712|NCT01679054|The Chinese University of Hong Kong|Vivian Lee|+85239438012|vivianlee@cuhk.edu.hk|
22416713|NCT00271024|University of Chicago|Dr. Andrea King|7737026181|aking@bsdad.uchicago.edu|
22416714|NCT00807209|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
22416715|NCT04668274|Marshall A. Hayward, Ph.D., Jupiter Orphan Therapeutics Inc.|David Wyatt|305-547-5857|david.wyatt@syneoshealth.com|
22416716|NCT03767062|Ataturk University|Mustafa Ceylan|+905062773216|drmuson16@hotmail.com|
22416717|NCT04449341|Carl R Darnall Army Medical Center|Matthew Perdue|(254) 553-4653|matthewperdue94@gmail.com|
22416718|NCT04499482|Pennington Biomedical Research Center|Dr. Candida Rebello|2252882411|Candida.Rebello@pbrc.edu|
22416719|NCT00843830|University of Michigan Comprehensive Cancer Center|Mark Zalupski, M.D.|734-615-3969|zalupski@umich.edu|
22416720|NCT01020526|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22416721|NCT02363439|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
22416722|NCT01913795|Boston Children's Hospital|Dr. Wanda Phipatanakul|617-355-6117|Wanda.Phipatanakul@childrens.harvard.edu|
22416723|NCT03573817|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
22416724|NCT02010255|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22416725|NCT01143649|Laboratory of Neuromodulation and Center of Clinical Research Training. Spaulding Rehabilitation Hospital.|Dr. Felipe Fregni|617.952.6153|info@neuromodulationlab.org|
22390977|NCT02725008|New York Presbyterian - Brooklyn Methodist Hospital|Christopher P Kelly|718.780.5040|chk9064@nyp.org|
22390978|NCT03783546|Dana-Farber Cancer Institute|Weidong Lu, MB, MPh, PhD|617-632-3322|weidong_lu@dfci.harvard.edu|
22416726|NCT00707447|FIDAM|Norbert Hermanns|0049 7931 594|hermanns@diabetes-zentrum.de|553
22416727|NCT00508027|Children's Hospital & Research Center Oakland|Dr. Carolyn Hoppe, Principal Investigator|(510)428-3193|choppe@mail.cho.org|
22416728|NCT01719562|Wake Forest University|Project Manager|+1(336) 758-3728|jvolpini@wakehealth.edu|
22416729|NCT02013531|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22416730|NCT04155073|Medical University of South Carolina|Dr. Jennifer Dahne|843-876-2280|dahne@musc.edu|
22416731|NCT00444821|Medtronic|Kristel Wittebols|707-591-3275|kristel.wittebols@medtronic.com|
22416732|NCT00537199|UT MD Anderson Cancer Center|Mark Chambers, MS, DMD / Professor|713-792-6510||
22416733|NCT00467831|NHGRI/NIH|Dr. Thomas Markello|301-451-1305|markellot@mail.nih.gov|
22416734|NCT00612677|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D., via Moffitt Cancer Center|813-745-3050|alberto.chiappori@moffitt.org|
22416735|NCT03139240|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|5034940757|mccrimmo@ohsu.edu|
22416736|NCT01491633|Dana-Farber Cancer Institute|Dr. Peter Hammerman|617-632-3000|phammerman@partners.org|
22416737|NCT00860743|Wayne State University and John D. Dingell VA Medical Center|Jason H. Mateika|313-576-4481|jmateika@med.wayne.edu|
22416738|NCT00467987|State University of NY at Buffalo|Paresh Dandona|17165351852|dandona@buffalo.edu|
22416739|NCT00823199|Bronx Psychiatric Center|Nigel Bark MD|7188625429|Nigel.Bark@omh.ny.gov|
22416740|NCT02776553|University of Arkansas for Medical Sciences|Arny A. Ferrando, Ph.D.|501-526-5711|aferrando@uams.edu|
22416741|NCT00941720|CCCC|Dr. Ronald Sobecks|216-444-6833|sobeckr@ccf.org|
22416742|NCT00171340|Novartis Pharmaceuticals|Study Director|862- 778 8300||
22416743|NCT03827018|Kiniksa Pharmaceuticals (UK), Ltd. c/o Kiniksa Pharmaceuticals Corp.|Clinical Operations Study Director|1-781-431-9100|studyinfo@kiniksa.com|
22416744|NCT01998243|Hospital severo ochoa|Dr Luis Ramon Rabago Torre|34914818000|lrabagot@gmail.com|8326
22416745|NCT02898103|University California San Diego|Brian Ilfeld, MD, MS|858-822-0776|bilfeld@ucsd.edu|
22416746|NCT05197829|University of Massachusetts Chan Medical School|Mark O'Connor|508-334-1000|mark.oconnor2@umassmed.edu|
22416747|NCT01566526|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22416748|NCT05022563|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22416749|NCT02646917|Crown Laboratories, Inc.|Thomas Hitchcock, PhD|8883723982|THitchcock@crownlaboratories.com|
22416750|NCT04569786|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22416751|NCT01640184|Peking University International Hospital|Dr. Zhang Dongliang|+86-10-69006561|zhangdongliang@pkuih.edu.cn|
22416752|NCT01351350|Takeda|Medical Director, Clinical Science|+1-866-835-2233|trialdisclosures@takeda.com|
22416753|NCT02376257|Boston UCRC|Michael Otto, PhD|617-353-9610|mwotto@bu.edu|
22416754|NCT02260258|BIDMC|Mike Donnino|6177542882|mdonnino@bidmc.harvard.edu|
22416755|NCT01930175|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22416756|NCT02820740|Monteris Medical|Clinical Program Manager|763-401-1727|medicalaffairs@monteris.com|
22416757|NCT00890552|Stanford University School of Medicine|Brenda Hann, RN, MBA, CCRC|650-723-0966|bhann@stanford.edu|
22416758|NCT04965389|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
22416759|NCT01436643|Novartis Pharmaceuticals|Study Director|862-778-8300||
22416760|NCT03693950|BIOCAD|Yulia Linkova Medical Director|+7 (495) 992 66 28 ext. 930|linkova@biocad.ru|
22416761|NCT04230876|Amptify|Chris Cardinal|3143999940|Chris@amptify.com|
22416762|NCT01181531|Amgen Inc.|Study Director|866-572-6436||
22416763|NCT04350008|BIOTRONIK SE & Co.KG|Director Clinical Project Management|+49 30 68905|mathias.freudigmann@biotronik.com|0
22416764|NCT00545688|Hoffmannb-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22416765|NCT01168687|Ernest Gallo Clinic and Research Center, UCSF|Jennifer Mitchell, Clinical Project Director|510-985-3100|jmitchell@gallo.ucsf.edu|
22416766|NCT02737592|Church & Dwight Co., Inc|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
22416767|NCT04243096|Boston University|Deepak Kumar, PT, PhD|617-358-3037|kumard@bu.edu|
22416768|NCT02792218|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22416769|NCT03123783|Pyxis Oncology, Inc.|Pyxis Oncology Clinical Operations|(339) 545 8252|clinicaltrials@pyxisoncology.com|
22416770|NCT02408445|University of Colorado|Dr. Shanlee Davis|720-777-6073|shanlee.davis@childrenscolorado.org|
22416771|NCT00503113|Hoffman-LaRoche|Medical Communications|800-821-8590||
22416772|NCT00749411|GlaxoSmithKline|GSK Response Center|866-435-7343||
22403914|NCT02164513|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22403915|NCT05301322|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22403916|NCT04971785|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22403917|NCT03829332|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22403918|NCT01283997|UT MD Anderson Cancer Center|Dr. Sheeba Thomas,Professor, Lymphoma-Myeloma|(713) 792-2860|sthomas@mdanderson.org|
22403919|NCT02109744|University of Rochester|Jane Liesveld|585 - 275 - 5823|Jane_Liesveld@urmc.rochester.edu|
22403920|NCT00168324|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
22403921|NCT04095442|Indiana University Indianapolis|Andrew R. Coggan|3172740656|acoggan@iu.edu|
22403922|NCT02223429|Emory University|Dr. James Rilling|404-727-3062|jrillin@emory.edu|
22403923|NCT00884221|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
22403924|NCT00255034|Merck, Sharp & Dohme Corp.|Senior Vice Predsident, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22403925|NCT01263093|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22403926|NCT01109069|Pharmacyclics|James Dean|669-224-1880|jdean@pcyc.com|
22403927|NCT03947255|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
22403928|NCT02499575|Orthopedic Foot and Ankle Center|Dr. Christopher Hyer|614-895-8747|hyerofac@gmail.com|
22403929|NCT04857593|King's College London|Professor Carmine Pariante|020 78480807|carmine.pariante@kcl.ac.uk|
22403930|NCT02690207|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22403931|NCT01353144|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
22403932|NCT04656418|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
22403933|NCT02586077|OrthoCarolina Research Institute|Susan Odum|7049457710|susan.odum@orthocarolina.com|
22403934|NCT02701192|Carolinas Healthcare System|Rachel Seymour, PhD|704-355-2000|Rachel.Seymour@carolinas.org|
22403935|NCT02267226|Octapharma USA|Director of Clinical Operations|201 604-1149|sylvia.werner@octapharma.com|
22403936|NCT01245764|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22403937|NCT00003476|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22403938|NCT02667457|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22403939|NCT02475850|Yale University|Erich Greene PhD|203-737-3636|erich.greene@yale.edu|
22403940|NCT00912340|Emory University|Elisavet Paplomata, Principal Investigator|404-778-1900|elisavet.paplomata@emory.edu|
22403941|NCT00915538|Western Sky Medical Research|Lyndon Mansfield MD|915-544-2557|immunman@westernskymed.com|
22403942|NCT00436982|Stryker EU Operations B.V. Herikerbergweg 110 1101 CM Amsterdam The Netherlands|Eric Garling, PhD, Snr. Director Medical & Scientific Affairs Europe|+31 20 219 2660|Eric.Garling@stryker.com|
22403943|NCT00953225|Ralph H. Johnson VA Medical Center|Sebastiano Gattoni-Celli, M.D.|843-876-5103|gatttonis@musc.edu|
22403944|NCT03864536|UAB|Pariya Wheeler|2052423924|plfazeli@uab.edu|
22403945|NCT02254551|Sarah Cannon Development Innovations|Charles Davis, Sr Mgr Regulatory Strategy & Operations|615-524-4341|charles.davis2@scri-innovations.com|
22403946|NCT04058158|Samsung Bioepis Co., Ltd|Director of Clinical Trials|+82-32-728-0371|sbregistry@samsung.com|
22403947|NCT02215616|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22403948|NCT01634113|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22403949|NCT01598207|Temple University|Dr. Ron Schey|215-707-9900|Ron.schey@tuhs.temple.edu|
22403950|NCT00520299|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22403951|NCT01352845|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22403952|NCT02062463|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22403953|NCT01743872|Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center|Dr. Vikram S. Kashyap|216-844-1631|vikram.kashyap@uhhospitals.org|
22403954|NCT01509872|Queen's University Belfast|Dr Paul O'Callaghan|+44 7501 43 46 32|pocallaghan02@qub.ac.uk|
22403955|NCT00707655|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com|
22403956|NCT02858154|Cincinnati Children's Hospital Medical Center|Dr. Neepa Gurbani|513-736-1814|Neepa.Gurbani@cchmc.org|
22403957|NCT02979301|Mayo Clinic|Dr. Carrie Hruska|507-293-4719|hruska.carrie@mayo.edu|
22403958|NCT01956240|Methodist University of Piracicaba|Ms Dayana Patricia Rosa|+55 16 3306-6696|dad_rosa@hotmail.com|
22403959|NCT00218426|University of Pennsylvania|Dr. George E Woody|215-746-7702|woodg@pennmedicine.upenn.edu|
22403960|NCT03172481|Purdue Pharma L.P.|Clinical Leader|1-800-733-1333|steven.ripa@pharma.com|
22403961|NCT05197140|University of Arkansas for Medical Sciences|Robert Wolfe|501-526-5769|rwolfe2@uams.edu|
22403962|NCT02759562|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22403963|NCT01957709|Fred Hutchinson Cancer Research Center|Seth Pollack, MD|206-667-6629|spollack@fredhutch.org|
22403964|NCT00830115|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com|
22403965|NCT03050216|Masonic Cancer Center, University of Minnesota|Dr.Claudio G. Brunstein MD, PhD|612 625 3918|bruns072@umn.edu|
22403966|NCT01061736|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22403967|NCT01925612|Seattle Genetics, Inc.|Chief Medical Officer|(855)473-2436|medinfo@seagen.com|
22403968|NCT00397878|University of Texas MD Anderson Cancer Center|Cathy Eng, MD / Professor|713-792-2828|ceng@mdanderson.org|
22403969|NCT01107405|Bausch & Lomb Incorporated|Tuyen Ong, MD MRCOphth|(973) 360-6389|tuyen.ong@bausch.com|
22403970|NCT01827930|Institut Bergonié|Pr Simone Mathoulin-Pelissier|05 56 33 33 33|S.Mathoulin@bordeaux.unicancer.fr|
22403971|NCT00418964|The Chinese University of Hong Kong|Pauline Lui|852 2632 3072|pauline@ort.cuhk.edu.hk|
22403972|NCT01895452|Alkermes, Inc.|ARISTADA Medical Information|866-204-7823|usmedinfo@alkermes.com|
22416773|NCT03694808|University Hospitals Cleveland Medical Center|Dr. David Canaday|216-368-5537|dxc44@case.edu|
22390979|NCT01837797|Study Director|Email contact via H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
22390980|NCT04562896|The University of Iowa|Jason M. Wilken, PT, PhD|319-335-6857|jason-wilken@uiowa.edu|
22390981|NCT06124131|Tulane University|Laura Perry|504-988-8906|lperry5@tulane.edu|
22390982|NCT03797989|University of Oxford|Dr. Angela Minassian|07973684040|angela.minassian@bioch.ox.ac.uk|
22390983|NCT01664897|The University of Texas MD Anderson Cancer Center|Jorge Cortes MD./Professor|713-794-5783|jcortes@mdanderson.org|
22390984|NCT04052997|ADC Therapeutics SA|Clinical Trials Information|954-903-7994|clinical.trials@adctherapeutics.com|954
22390985|NCT04522778|UPMC|Ryan St. Pierre-Hetz|3154369898|stpierrehetzre@upmc.edu|
22390986|NCT00069277|Eisai Inc|Eisai Call Center|888-422-4743||
22390987|NCT04594733|MUSC|Research Coordinator|843-792-1869|nitchie@musc.edu|
22416774|NCT00614926|Columbia University|Judith Rabkin, PhD|212 543 5762|jgr1@columbia.edu|
22403973|NCT00980343|Adult Brain Tumor Consortium (ABTC)|Charles J Nock, MD|410-955-8837|jfisher@jhmi.edu|
22403974|NCT00765128|Mayo Clinic|Mitchell R. Humphreys MD|480-301-8000|humphreys.mitchell@mayo.edu|
22403975|NCT03060083|University of Vermont|Elias M Klemperer|8026561641|elias.klemperer@med.uvm.edu|
22403976|NCT01188538|Galderma|Farzaneh SIDOU|00 33 4 93 95 70 51|farzaneh.sidou@galderma.com|
22403977|NCT01583985|Minneapolis VA Health Care System|Erin Krebs, MD|612-725-2000|erin.krebs@va.gov|
22403978|NCT01170702|Northwestern University Feinberg School of Medicine|Edward Yaghmour|312-695-0693|edward.yaghmour@nm.org|
22390988|NCT02657954|VA San Diego Healthcare System|Dr Elizabeth Twamley|858-642-3848|elizabeth.twamley@va.gov|
22390989|NCT00953199|Penn State Hershey Medical center|Abraham Mathew MD|717 531 3834|amathew@hmc.psu.edu|
22390990|NCT02083679|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22390991|NCT01024036|Janssen R&D US|DIRECTOR CLINICAL RESEARCH||ClinicalTrialDisclosure@its.jnj.com|
22390992|NCT00361842|Jazz Pharmaceuticals|Director, Clinical Trial Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
22390993|NCT03512288|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22390994|NCT00097669|VITATOPS|Clinical Trial Coordinator|+61892247004|julia.o'dea@health.wa.gov.au|
22403979|NCT04999969|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22403980|NCT06964165|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22403981|NCT01551758|GlaxoSmithKline|GSK Response Center|866-435-7343||
22403982|NCT04460690|University of Wisconsin - Madison|Kristi Hall|608-890-0844|klhall1@wisc.edu|
22403983|NCT01586156|Cleveland Clinic|Dr. Serpil Erzurum|216-445-6624|erzurus@ccf.org|
22403984|NCT04363437|Maimonides Medical Center|Dr. Felix Yang|7182836000|fyang@maimonidesmed.org|
22403985|NCT03519516|Laboratorios Sophia|Ricardo Alonso Llamas Velázquez (clinical safety pharmacologist)|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
22403986|NCT00810719|University of California Davis|Analyst|916 734 0294|pkaujla@ucdavis.edu|
22403987|NCT05584202|ModernaTX, Inc.|Moderna WeCare Team|866-663-3762|WeCareClinicalTrials@modernatx.com|
22403988|NCT05294341|Hershey Medical Center|Dr. Halina Yee; Primary Resident Investigator|7175313503|hyee@pennstatehealth.psu.edu|
22403989|NCT00646113|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
22403990|NCT05458011|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
22403991|NCT05076370|Yale University, Department of Psychiatry|Joao De Aquino, M.D.|203-932-5711|joao.deaquinolima@yale.edu|12916
22403992|NCT03794752|UT Southwestern Medical Center|Peter Chen|12146283837|peter.chen@utsouthwestern.edu|
22403993|NCT01206452|University of Kansas Medical Center|Donita Atkins, RN, CCRC|(913) 588-9714|datkins2@kumc.edu|
22403994|NCT03292952|KemPharm|Gerald Orehostky|321-250-3699|gorehostky@kempharm.com|
22403995|NCT03330041|University of California, Davis, Department of Dermatology|Daniel Eisen, M.D.|916-734-6479|dbeisen@ucdavis.edu|
22403996|NCT03097614|Allergan Sales LLC|Therapeutic Area Head|877-277-8566|IR-CTRegistration@allergan.com|
22403997|NCT03297216|University of North Carolina at Chapel Hill|Joan Price, MD, MPH|919-962-4717|joan_price@med.unc.edu|
22403998|NCT00680953|Daiichi Sankyo Co., Ltd.|H. Takami|+81 3 5740 3445|takami.hideo.hs@daiichisankyo.co.jp|
22403999|NCT00603733|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22404000|NCT00605696|Albert Einstein College of Medicine of Yeshiva University|Michelle Ng Gong, MD, MS|718 920 5464|mgong@montefiore.org|
22404001|NCT01057134|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
22404002|NCT02527187|Inmunotek|Dr. Miguel Casanovas/ Medical Director|91 6510010|mcasanovas@inmunotek.com|
22404003|NCT01093755|Mayo Clinic|Prasad Iyer, MD|507-284-0970|Iyer.Prasad@mayo.edu|
22404004|NCT03115112|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
22404005|NCT01610076|Mayo Clinic|Kianoush Kashani; Principal Investigator|5072667093|kashani.kianoush@mayo.edu|
22404006|NCT02093234|GW Medical Faculty Associates|Richard Katz, MD|202-741-2323|RKatz@mfa.gwu.edu|
22404007|NCT02168803|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22404008|NCT01396239|Sarepta Therapeutics, Inc.|Edward M. Kaye MD, Interim CEO, SVP & Chief Medical Officer|+1-888-727-3782|clinicaltrials@sarepta.com|
22404009|NCT00421603|NYSPI|Daniel Brooks|212-740-3205|brooksd@nyspi.columbia.edu|
22404010|NCT01608490|Boston Scientific|Kristi Winterfeldt|+1 763-494-1165|Kristi.Winterfeldt@bsci.com|
22404011|NCT00284739|Kaiser Permanente|Hyo-Chun Yoon, MD,PHD|8084327342|Hyo-Chun.Yoon@nsmtp.kp.org|
22404012|NCT02310906|Sarepta Therapeutics, Inc.|Medical Director|1-800-690-2003|clinicaltrials@sarepta.com|
22404013|NCT00433446|SWOG Statistical Center|Study Statistician|206-667-4623||
22404014|NCT02899377|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|1
22404015|NCT01231607|GlaxoSmithKline|GSK Response Center|866-435-7343||
22404016|NCT03007719|University of California, San Francisco|Dr. Lawrence Fong|(415) 353-2051|Lawrence.Fong@ucsf.edu|
22404017|NCT01709786|University of Cincinnati|Betty Tsuei, MD|513-558-5661|Betty.Tsuei@uc.edu|
22404018|NCT04026178|Chiesi|Metreleptin Clinical Program Lead|+3905212791|clinicaltrials_info@chiesi.com|
22404019|NCT04321252|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22404020|NCT06245044|University of Michigan|Dr. Corey Lester|734-647-8849|lesterca@umich.edu|
22404021|NCT00611897|Yale School of Medicine, Department of Psychiatry|Handan Gunduz-Bruce, MD|(203) 785-2117|handan.gunduz-bruce@yale.edu|
22404022|NCT01082367|Novartis|Study Director|862-778-8300||
22404023|NCT00664755|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
22404024|NCT00098020|National Institutes of Diabetes, Digestive, and Kidney Disorders|Dr. Jeffery Kopp|301-594-3403|koppj@mail.nih.gov|
22404025|NCT02823600|University of North Carolina at Chapel Hill|Seema Garg, MD, PhD|919-966-5296|sgarg@med.unc.edu, ashton.madison@alumni.duke.edu|
22404026|NCT02307838|Novartis Pharmaceuticals|Study Director|862-778-8300||
22404027|NCT00943488|Carver College of Medicine, University of Iowa|Patricia Winokur, MD|319-384-1735|patricia-winokur@uiowa.edu|
22404028|NCT00085917|RCHSPB|John Tierney|301-451-5136|john.tierney@nih.gov|
22404029|NCT00865189|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22404030|NCT02484898|Medtronic CRHF|Medtronic SEEQ Performance Clinical Trial Leader|1-800-328-2518|medtronicCRMtrials@medtronic.com|
22404031|NCT01658579|Sanofi|Trial Transparency Team||Contact--US@sanofi.com|
22404032|NCT01464788|McGovern Medical School UTHealth - Houston|Dr. Andrew Barreto|713-500-7002|andrew.d.barreto@uth.tmc.edu|
22404033|NCT02513784|Columbia University Medical Center|Julian A Abrams, MD|2123059541|ja660@cumc.columbia.edu|
22404034|NCT00418379|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com|
22404035|NCT00843843|Rush University Medical Center|Dr. Helen Burgess|3125634785|Helen_J_Burgess@rush.edu|
22404036|NCT00565058|Aptose Biosciences Inc.|Peter Murray, Director Clinical Development|647-479-9812|pmurray@aptose.com|
22404037|NCT05127044|University of Arkansas for Medical Sciences|Rebecca P Sartini, DNP|5015261580|rpsartini@uams.edu|
22404038|NCT05612581|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
22404039|NCT02754830|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22404040|NCT00400712|Queen's University|Brenda Brouwer|613-533-6079|brouwerb@queensu.ca|
22404041|NCT02670330|Amicus Therapeutics, Inc.|Patient Advocacy|+1-609-662-2000|clinicaltrials@amicusrx.com|
22404042|NCT00634114|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22404043|NCT05080179|University of Pennsylvania, Perelman School of Medicine|Dr. Erica Dixon|215-573-9987|erica.dixon@pennmedicine.upenn.edu|
22404044|NCT03670641|University of Pittsburgh Medical Center (UPMC)|David Rometo, MD|412-586-9700|rometoda@upmc.edu|
22404045|NCT01662297|Yale University/West Haven VAMC|Dr. Albert Arias|2039325711|albert.arias@va.gov|8155
22404046|NCT00538980|Weill Cornell Medicine|Richard T. Silver, MD|646-962-2273|rtsilve@med.cornell.edu|
22404047|NCT01981967|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22404048|NCT00916370|Abbott Vascular|Robert Smith Jr, Ph.D., Sr Clinical Research Scientist|408-845-8265|robert.smithjr@av.abbott.com|
22404049|NCT03172520|Mayo Clinic|Eric J. Moore, M.D.|507-284-3853|Moore.Eric@mayo.edu|
22404050|NCT00264849|Novartis Pharmaceuticals|Study Director|862-778-8300||
22416775|NCT02322788|AstraZeneca R&D Gothenburg, SE-431 83 Mölndal, Sweden|Göran Eckerwall, MD, PhD|+46 708467664|goran.eckerwall@astrazeneca.com|
22404051|NCT03041909|Global Blood Therapeutics|Margaret Tonda, Sr. Director, Clinical Science|650-741-7761|mtonda@gbt.com|
22404052|NCT00383721|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22404053|NCT03722472|Access to Advanced Health Institute (AAHI)|Christopher Fox PhD|(206) 381-0883|Christopher.Fox@aahi.org|
22404054|NCT00781963|VA Greater Los Angeles Healthcare System|Dr. Cathy Alessi|818 895-9311|Cathy.Alessi@va.gov|
22404055|NCT02700919|Mereo BioPharma Group|Ian Hodgson, Head of Clinical Operations|+44 3330237300|enquiries@mereobiopharma.com|
22404056|NCT01842646|H. Lee Moffitt Cancer Center and Research Institute|Dr. Jeffrey Lancet|813-745-1387|jeffrey.lancet@moffitt.org|
22404057|NCT01383109|Shin Poong Pharmaceutical Co., Ltd.|Jansik Shin|+82-2-2189-3468|jsshin@shinpoong.co.kr|
22404058|NCT00132314|VA New England Mental Illness, Research, Education and Clinical Center|Robert Rosenheck, MD|(203) 932-5711|Robert.Rosenheck@va.gov|3723
22404059|NCT01009918|University of South Florida|Maya Guglin, MD, PhD|813-259-0600|mguglin@health.usf.edu|
22404060|NCT01271413|Johns Hopkins University School of Medicine|Dr. Miriam Mintzer|410 550-0529|mmintzer@jhmi.edu|
22404061|NCT01589263|Baylor College of Medicine|Christopher Smith|713-798-4001|cps@bcm.edu|
22404062|NCT03955055|UMass Chan Medical School|Anne Foley, Senior Clinical Research Coordinator|774-442-4098|anne.foley@umassmed.edu|
22416776|NCT00455962|Massachusetts General Hospital|Janet E. Hall, MD|617-877-1112|jehall@partners.org|
22404063|NCT00756093|Alcon Research Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22404064|NCT01653158|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22404065|NCT00698035|University of California, San Francisco|Michelle Melisko, MD|415-353-7070|mmelisko@medicine.ucsf.edu|
22404066|NCT03819218|MC2 Therapeutics|Irene Sandholdt|+45 2015 7033|isa@mc2therapeutics.com|
22404067|NCT00654953|UAMS|Alison Oliveto, Ph.D.|501-526-8441|olivetoalison@uams.edu|
22404068|NCT04116073|Sidney Kimmel Comprehensive Center at Johns Hopkins|Nilo Azad|410-614-9169|nilo.azad@jhu.edu|
22404069|NCT02892201|Yale School of Medicine|Barbara Burtness, MD|(203) 200-4622|arbara.burtness@yale.edu|
22404070|NCT05814471|Topmed|Edith Martin|418 683-2104|emartin@topmed.ca|1302
22404071|NCT03779334|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22404072|NCT06533475|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22404073|NCT01840228|Ohio State University|Dr. Heather Frey|614-688-6798|Heather.Frey@osumc.edu|
22404074|NCT02476357|Lausanne University Hospita! and University of Lausanne|Prof. Dr Med. Maurice MATTER|795561071|maurice.matter@chuv.ch|0041
22404075|NCT02022033|Brown University Oncology Research Group|Howard Safran, MD|401-863-3000|BrUOG@BROWN.EDU|
22404076|NCT01413542|Department of Medicine Vanderbilt University Medical Center|Dr. Nancy J. Brown|615-343-8701|nancy.j.brown@vanderbilt.edu|
22404077|NCT01148563|Louisiana State Univeristy Health Care Services Division|Dr. Ron Horswell|225-763-2983|rhorsw@lsuhsc.edu|
22404078|NCT00947752|Teva Neuroscience, Inc.|Thomas Smith, MD, VP, Medical Affairs|816-508-5000|tom.smith@tevapharm.com|
22404079|NCT05590767|Tri-Service General Hospital, National Defense Medical Center|Dr. Lu Yi-Hsiung|+886933429559|luyihsiung@gmail.com|
22404080|NCT03641547|OCTO, University of Oxford|Dr Ruth Harman, Trial Manager|01865 617018|octo-CHARIOT@oncology.ox.ac.uk|
22404081|NCT02767856|State University of New York College of Optometry|Dr. Jingyun Wang|212-938-5759|jwang@sunyopt.edu|
22404082|NCT01392053|Universidade de São Paulo|Prof Silvana Quintana|55 16 3602-2813|quintana@fmrp.usp.br|
22404083|NCT00304915|Central Arkansas Veterans Healthcare System|Dr. Jeff Pyne|501-257-1083|jmpyne@uams.edu|
22404084|NCT02029638|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22404085|NCT02792049|Brooke Army Medical Center|Dr. Michael D. April|(210) 916 - 0808|Michael.D.April@post.harvard.edu|
22404086|NCT05489081|Children's Hospital of Philadelphia|Dr. Gwendolyn Lawson|2674266612|lawsong@chop.edu|
22404087|NCT03886701|Thomas Jefferson University|Dr. Walter K. Kraft|215 955-9077|walter.kraft@jefferson.edu|
22404088|NCT01887587|Medical College of Wisconsin|Ehab Atallah, MD|414-805-8900|eatallah@mcw.edu|
22404089|NCT00973921|Columbia University Medical Center|Giora Weisz MD|212-305 7060|gw2128@mail.cumc.columbia.edu|
22404090|NCT00125190|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22404091|NCT00414960|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22404092|NCT01318512|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22404093|NCT00363246|James A. Haley Veterans' Hospital|Andrea M. Spehar, DVM, MPH, JD|813-558-3947|Andrea.Spehar@va.gov|
22404094|NCT00669916|Novartis|Study Director|862-778-8300||
22404095|NCT01788306|University of Washington|Dr. Caleb Banta-Green|206-543-0937|calebbg@uw.edu|
22404096|NCT02756650|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22404097|NCT00230100|McLean Hospital|Shelly F. Greenfield, MD, MPH|617-855-2241|sgreenfield@mclean.harvard.edu|
22404098|NCT04348591|Duke University|Dr. Andrada D. Neacsiu|919-684-6714|andrada.neacsiu@duke.edu|
22404099|NCT03371160|ENvizion Medical (Nutriseal)|Clinical Director|+972-72-2288240|anath@envizionmed.com|
22404100|NCT00622869|Novartis Pharmaceuticals|Study Director|862 778-8300||
22404101|NCT03722784|CooperVision, Inc.|Martine Robie|9256604477|mrobie@coopervision.com|
22404102|NCT00186056|Stanford University|Brent Solvason|650-723-8331|solvason@stanford.edu|
22404103|NCT01317615|Novartis|Study Director|862-778-8300||
22404104|NCT01322646|University at Buffalo|Gregory A. Fabiano, Ph.D.|7166451130|fabiano@buffalo.edu|
22404105|NCT02821455|University of Edinburgh|E Alexandra Page|7938645122|s1305565@sms.ed.ac.uk|
22404106|NCT02648724|Symphogen AS|Medical Director|0045 45265050|info@symphogen.com|
22404107|NCT00302718|VA HSR&D Center for Innovations in Quality, Effectiveness & Safety (IQuESt)|Dr. Laura A. Petersen|713-794-8623|Laura.Petersen@va.gov|
22404108|NCT00738374|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22404109|NCT00632541|Hoosier Cancer Research Network|Jeff Smith|317-634-5842|jsmith@hoosiercancer.org|41
22404110|NCT04398199|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-713-5440|mfarris@wakehealth.edu|
22404111|NCT02927873|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22404112|NCT00393913|NYU School o Medicine|Indu Ayappa, PhD|2125628437|indu.ayappa@nyumc.org|
22404113|NCT01518244|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
22404114|NCT02902913|University of California, Davis|Roberta R Holt|530-752-4950|rrholt@ucdavis.edu|
22404115|NCT04900038|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22404116|NCT00258206|Johns Hopkins University|Dr. Carol Ann Huff|410-955-8842|chuff1@jhmi.edu|
22404117|NCT02300077|Department of Anesthesiology Washington University in St. Louis|Helga Komen|3148527622|komenh@anest.wustl.edu|
22404118|NCT00077376|ECOG Statistical Office|Study Statistician|617-632-3012||
22404119|NCT02017899|GSK Vaccines Institute for Global Health S.r.l.|Dr. Audino Podda|+39 0577 243496|audino.p.podda@gsk.com|
22404120|NCT01985971|University of Pennsylvania|Lilie Lin, MD|215-662-7267|lin@xrt.upenn.edu|
22404121|NCT02843178|Stanford University|Mandy Murphy Carroll, Study Coordinator|(650) 509-0004|mandyiam@stanford.edu|
22404122|NCT00591240|VA Palo Alto Health Care System|Dr. Joseph Liao|650-493-5000|joseph.liao@va.gov|65581
22404123|NCT02762799|Biocad|Yulia Linkova Medical Director|+7 (495) 992 66 28|linkova@biocad.ru|930
22404124|NCT02420795|UT MD Anderson Cancer Center|Michael Wang, MD, Professor, Lymphoma-Myeloma|(713) 792-2860|miwang@mdanderson.org|
22404125|NCT01362946|Penn State Hershey Medical Center|Dr. Dan Waschbusch|7175318514|dwaschbusch@hmc.psu.edu|
22404126|NCT00949910|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22404127|NCT02034552|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
22404128|NCT00074802|Temple University|Richard G. Heimberg, Ph.D.|215.204.7489|heimberg@temple.edu|
22404129|NCT02501902|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22404130|NCT02267278|The University of Texas MD Anderson Cancer Center|Srdan Verstovsek, MD/Professor|713-745-3429|sverstov@mdanderson.org|
22404131|NCT02513771|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22404132|NCT00650091|Duke Clinical Research Institute|Kevin J Anstrom|919-668-8902|kevin.anstrom@duke.edu|
22416777|NCT01432574|H. Lee Moffitt Cancer Center and Research Institute|Anna Giuliano, Ph.D.|813-745-6820|anna.giuliano@moffitt.org|
22416778|NCT03135899|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22416779|NCT01042535|H. Lee Moffitt Cancer Center and Research Institute|Hatem Soliman, M.D.|813-745-4933|hatem.soliman@moffitt.org|
22416780|NCT01679197|University of Michigan|Dr. Elif Oral|7346157271|eliforal@med.umich.edu|
22416781|NCT01332578|GlaxoSmithKline|GSK Response Center|866-435-7343||
22416782|NCT01680783|University of Chicago|John P. Kress|7737026790|jkress@medicine.bsd.uchicago.edu|
22416783|NCT02129647|NYU Langone|Theodore Nicolaides|212-263-9959|Theodore.Nicolaides@nyualangone.org|
22431254|NCT02496000|Orange County Research Center|Joel M. Neutel, M. D.|714-541-5591|jmneutel@aol.com|
22431255|NCT01877278|University of Messina|Gianfilippo Bagnato|00390902212502|gianbagnato@gmail.com|
22431256|NCT01969058|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22431257|NCT04090749|Johns Hopkins University School of Nursing|Martha Abshire Saylor|4433406201|mabshir1@jhu.edu|
22431258|NCT03510715|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22431259|NCT04262479|NTNU|Ingrid K Hals|+47 73412207|ingrid.hals@ntnu.no|
22431260|NCT01972659|Kocaeli University Medical Faculty|Assistant Professor Dr Z Ipek ARSLAN AYDIN|00905325011339|zehraipek48@gmail.com|
22431261|NCT02399228|University of Texas Health Science Center at San Antonio|Dr. Ying Li, M.D., Ph.D.|210-450-1719|liy8@uthscsa.edu|
22431262|NCT02457793|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22431263|NCT04316143|BIAL - Portela & Ca, SA|Responsible of Clinical Research & Operations|+351229866100|clinical.trials@bial.com|
22431264|NCT00791648|Vanderbilt University|Frederic Billings|615-343-6268|frederic.t.billings@vanderbilt.edu|
22431265|NCT00836706|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22431266|NCT02989857|Servier Pharmaceuticals LLC|Medical Affairs|888-788-1735|clinical.trial.management@servier.com|
22431267|NCT01992757|University of Pennsylvania Hospital|Rupa Chowdary|215-615-4105|rupa.chowdary@uphs.upenn.edu|
22431268|NCT02682056|Emory University|Eric Felner MD|404-727-7651|efelner@emory.edu|
22431269|NCT02541591|ZOL Genk|Koen Ameloot|0485685969|koen.ameloot@zol.be|
22431270|NCT01344356|Mercy Research|Mercy Research Manager - Regulatory Operations|314-251-8827|michelle.bryant@mercy.net|
22431271|NCT05157360|Department of Surgery, University of Kansas School of Medicine-Wichita|Dr. Thomas Resch|316-268-5990|tresch@wsspa.com|
22431272|NCT00123630|University of Utah|Dr. John Fang|801-581-7802|john.fang@hsc.utah.edu|
22431273|NCT02390076|Minneapolis VA Health Care System|Seth Disner|3105605990|disne014@umn.edu|
22431274|NCT00600340|CECOG|MD. Christiane Thallinger|+43 1 409 77 25|office@cecog.at|
22431275|NCT02095106|Orthopaedic Institute for Children|Dr. Mauricio Silva|213-742-1109|msilva@mednet.ucla.edu|
22431276|NCT05296824|SacEP Research|Arash Aryana, MD, PhD|916-453-2684|a_aryana@outlook.com|
22431277|NCT00103844|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22431278|NCT00635050|UAB|John Carpenter, M.D.|205-910-8886 or 205-934-2084|jtc4321@bellsouth.net|
22431279|NCT03038620|UT Southwestern Medical Center|Dr. Parag Joshi|2146458000|parag.joshi@utsouthwestern.edu|
22431280|NCT01648322|Generon (shanghai) corporation|Chief Medical Officer|8621-61760866|tangt@generonbiomed.com|
22431281|NCT04380142|AbbVie|Global Medical Services|1-800-633-9110|abbvieclinicaltrials@abbvie.com|
22431282|NCT04992065|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22431283|NCT00539500|University of Texas MD Anderson Cancer Center|Laura L. Worth, MD / Professor, Pediatrics|713-792-6620|CR_Study_Registration@mdanderson.org|
22431284|NCT00811850|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22431285|NCT02011542|University of Utah, Dept. of Gastroenterology|Dr. Ashok Tuteja|801-581-5679|ashok.tuteja@hsc.utah.edu|
22431286|NCT03261505|Massachusetts General Hospital|Prof. Jian Kong|16179620978|kongj@nmr.mgh.harvard.edu|
22431287|NCT03988205|Froedtert and the Medical college of Wisconsin|Laura Michaelis, MD|414-805-6700|lmichaelis@mcw.edu|
22431288|NCT00663260|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
22431289|NCT00980798|Janssen-Cilag Ireland|EMEA Medical Affairs Director Analgesia|0035 878 339174||
22404133|NCT04295356|CELLTRION, Inc.|Sung Hyun Kim, Head of Clinical Planning Department|+82 32 850 5778|SungHyun.Kim@celltrion.com|
22404134|NCT01280266|Seoul National University|Dr. Eun Bong Lee|+82 2 2072-3944|leb7616@snu.ac.kr|
22404135|NCT01784588|Boston Scientific|Teresa Takle-Flach|952-930-6000|Teresa.Takle-Flach@bsci.com|
22404136|NCT02084069|Seyyed-al-Shohada Heart Center, Urmia University of Medical Sciences|Yousef Rezaei|+989126231864|yousefrezaei1986@gmail.com|
22404137|NCT04655703|Northwell Health System|Eugene S. Krauss|516-496-2637|ekrauss@northwell.edu|
22404138|NCT04904614|Tufts Medical Center|Dr. Jennifer Chow|617-636-5244|jennifer.chow@tuftsmedicine.org|
22404139|NCT04268004|Nationwide Children's Hospital|Leena Nahata|6147224502|leena.nahata@nationwidechildrens.org|
22404140|NCT01453998|GlaxoSmithKline|GSK Response Center|866-435-7343||
22404141|NCT05137730|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22404142|NCT00712933|GlaxoSmithKline|GSK Response Center|866-435-7343||
22404143|NCT01222572|Dana-Farber Cancer Institute/Brigham and Women's Hospital|Raymond Mak, MD|6177328651|rmak@partners.org|
22404144|NCT01429077|Rehabilitation Institute of Chicago|Leora R. Cherney, PhD|312-238-1117|Lcherney@ric.org|
22404145|NCT00280241|University of Pittsburgh|Michael Boyiadzis, MD|412-623-0040|boyiadzism@upmc.edu|
22404146|NCT01879319|Amgen Inc.|Study Director|866-572-6436||
22404147|NCT01360762|Institute of Tropical Medicine Antwerp|Johan Van Griensven|+32(0)32476426|jvangriensven@itg.be|
22404148|NCT04724733|Washington State University College of Nursing|Julie Postma, Professor, Associate Dean for Research|509-324-7287|jpostma@wsu.edu|
22404149|NCT03067129|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22404150|NCT03372603|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22404151|NCT03341923|Alcon Japan, Ltd.|Group Manager, Vision Care|+81.3.6899.5061|alcon.medinfo@alcon.com|
22404152|NCT03986190|University of Miami Miller School of Medicine|Dr. Sara St George|305-243-0726|s.stgeorge@med.miami.edu|
22404153|NCT02806947|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
22404154|NCT04511819|Fulcrum Therapeutics|Call Center|617-651-8853|clinicaltrials@fulcrumtx.com|
22404155|NCT04929613|West Virginia University|Keith Zullig, PhD|304-293-1091|kzullig@hsc.wvu.edu|
22404156|NCT00289744|GlaxoSmithKline|GSK Response Center|866-435-7343||
22404157|NCT01256983|University Hospital Zürich|Mrs. Hanna Burkahlter|0041 76 371 12 35|hanna.burkhalter@usz.ch|
22404158|NCT00084929|ACRIN|Donna Harfeil, Director of Protocol Management|215-717-2765|dhartfeil@acr.org|
22404159|NCT03930641|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22404160|NCT00844649|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22404161|NCT00664209|UCaliforniaLA|Jeff Bronstein MD, PhD|310 206-9799|jbronste@mednet.ucla.edu|
22404162|NCT00091026|University of Chicago|Hedy Kindler, MD|(773) 702-0360|hkindler@medicine.bsd.uchicago.edu|
22404163|NCT00065442|Dendreon Corporation|Kathleen Picha|206-274-6762|kpicha@dendreon.com|
22404164|NCT01797965|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
22404165|NCT01764256|PATH|Jorge Flores|2028220033|jeflores@path.org|
22404166|NCT01153841|GlaxoSmithKline|GSK Response Center|866-435-7343||
22404167|NCT03373110|Massachusetts General Hospital|Dr. Andrew Nierenberg|617-512-2641|anierenberg@mgh.harvard.edu|
22404168|NCT01647464|OHSU|Jonathan Lindner|5034948750|lindnerj@ohsu.edu|
22404169|NCT03329599|Northern California Institute for Research & Education|Bruce Ovbiagele|415-750-2047|bruce.ovbiagele@va.gov|
22404170|NCT00712322|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22404171|NCT04404010|Precision OS Technology|Dr. Danny P Goel|604-345-0401|danny@precisionostech.com|
22404172|NCT04368455|Cincinnati Children's Hospital Medical Center|Dr. Francis Real|5136364200|francis.real@cchmc.org|
22404173|NCT01599754|SFJ Pharmaceuticals|Stewart Hallett|19252011003|stewart.hallett@sfj-pharma.com|
22404174|NCT00242580|Novartis Pharmaceuticals|Study Director|862 778-8300||
22404175|NCT00753935|Vanderbilt_University MC|John A. Oates, MD|615 4343 4847|john.oates@vanderbilt.edu|
22404176|NCT03666858|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22404177|NCT03282357|Merz Pharmaceuticals GmbH.|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
22404178|NCT03550131|University of Washington|Dr. Karen Fredriksen-Goldsen|206-543-5722|fredrikk@uw.edu|
22404179|NCT01948388|Arthritis & Rheumatic Disease Specialties|Joanne Sagliani|3059324162|drnbg@rheum-care.com|
22404180|NCT02038218|DEKK-TEC, Inc.|Dr. Lee Roy Morgan|504-583-6135|lrm1579@aol.com|
22404181|NCT00910429|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22404182|NCT00594204|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22404183|NCT01740388|Valeant Pharmaceuticals|Johnson Varughese|908-541-2179|Johnson.Varughese@valeant.com|
22404184|NCT01369212|University of Pittsburgh|Dr. Abdus Wahed|412-624-3053|wahed@pitt.edu|
22404185|NCT05757427|MVG Industries SAS|Luc Duchesne|+33 (0) 6 70 33 91 20|luc.duchesne91@gmail.com|
22404186|NCT04860752|Edwards Lifesciences|Edwards THV Clinical Affairs|949-250-2500|THV_CT.gov@Edwards.com|
22404187|NCT06795204|Haisco-USA Pharmaceuticals, Inc.|Yu-Ling Lai|856-263-4239|yuling.lai@haisco-usa.com|
22404188|NCT03927911|Pacira Pharmaceuticals|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
22404189|NCT02658968|Nordic Nanovector|Head of Clinical Operations|+47 22 18 33 01|mail@nordicnanovector.com|
22431290|NCT00522379|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22431291|NCT03213509|Ariadne Labs|Dr. Katherine Semrau|617-384-6555|betterbirth@ariadnelabs.org|
22431292|NCT04562090|Astellas Pharma China, Inc.|Clinical Transparency|+86-(0)10-85216666|astellas.resultsdisclosure@astellas.com|
22431293|NCT00847730|KCI|VP, Global Clinical Affairs|2102555595|jane.hart@kci1.com|
22431294|NCT00432965|Acelity|Sr Director, Global Clinical Development|210-255-5595|jane.hart@kci1.com|
22431295|NCT01889251|Alcon Japan, Ltd.|Group Manager, Clinical Development|+81368995277||
22431296|NCT01903863|Duke University Hospital|Dr. Caroline Ozment|919-681-2554||
22431297|NCT05196776|Temple University Hospital|Ryan Gibbons|2157075522|ryan.gibbons@tuhs.temple.edu|
22431298|NCT00553969|University of Minnesota Medical School|Jay N. Cohn, M.D.|612.625.5646|cohnx001@umn.edu|
22431299|NCT01344226|Discover Vision Centers|Melissa Morrison Toyos|8164781230|mtoyos@discovervision.com|
22431300|NCT05677347|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22431301|NCT01350479|VA Maryland Healthcare System|Mary-Claire Roghmann|410-706-0062|mroghman@epi.umaryland.edu|
22404190|NCT00971425|GlaxoSmithKline|GSK Response Center|866-435-7343||
22404191|NCT04578015|The Ohio State University|Kartik Venkatesh, MD, PhD|614-293-2222|kartik.venkatesh@osumc.edu|
22404192|NCT02528253|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22404193|NCT00505752|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22404194|NCT01624506|Ethicon|Janet DeMarchi|612-867-8727|jdemarch@its.jnj.com|
22404195|NCT01149343|GlaxoSmithKline|GSK Response Center|866-435-7343||
22404196|NCT01016678|Premiere Research Institute|Paul Winner, DO|561-845-0500|pwinner777@aol.com|102
22404197|NCT00700063|Leo Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com|
22404198|NCT03472040|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
22431302|NCT03909971|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22404199|NCT02769832|University of Iowa, Holden Comprehensive Cancer Center|Muhammad Furqan, MD|319-356-1527|muhammad-furqan@uiowa.edu|
22404200|NCT01546285|GE Healthcare|Jeffrey Conner - Global Research Manager|414.721.2423|Jeffrey.Conner@ge.com|
22404201|NCT00225147|Pharming Technologies BV|Medical Affairs Department|+31715247400|medicalinfo@pharming.com|
22404202|NCT04019795|Revian, Inc.|John Oakley|919-321-1726|joakley@knowbiollc.com|
22404203|NCT03625141|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22404204|NCT03250377|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22404205|NCT01114373|Emory University|Frederic Rahbari-Oskoui, Associate Professor of Medicine|404-727-3425|frahbar@emory.edu|
22416784|NCT00918463|Weill Cornell Medicine|Dr. Peter Martin||pem9019@med.cornell.edu|
22416785|NCT02834806|Medinol|Dina Kofler, VP Clinical Affairs|+97237679032|dinak@medinol.com|
22416786|NCT01045993|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22416787|NCT01659736|The Institute of Living|Gretchen J. Diefenbach, Ph.D|860-545-7685|Gretchen.Diefenbach@hhchealth.org|
22416788|NCT01004042|Brazilian Center for Studies in Dermatology|Dr. Doris Hexsel|+55 51 30262633|cientifico@cbed.org.br|
22416789|NCT00474851|Boston Children's Hospital|Dr. Amy D. DiVasta|617-355-3792|Amy.DiVasta@childrens.harvard.edu|
22416790|NCT04862156|OrganOx|Katerina de Metz|19713442167|katerina.demetz@organox.com|
22416791|NCT01570283|Center for Cell and Gene Therapy|Dr. Helen Heslop|832-824-4662|heheslop@txch.org|
22416792|NCT01833533|AbbVie|Global Medical Information|800-633-9110||
22416793|NCT02017860|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22416794|NCT02772562|Medical University of South Carolina|Dr. Michael Lilly|843-792-4271|lillym@musc.edu|
22431303|NCT03140969|Sepul Bio|Zuhal Butuner - Chief Medical Officer|(905) 599 7887|contact@sepulbio.com|
22431304|NCT04727151|Triumvira Immunologics|Maria Apostolopoulou, Clinical Scientist|518-892-8426|mapostolopoulou@triumvira.com|
22404206|NCT03444870|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22416795|NCT03478865|National Institutes of Health|Emily Chew, MD, Principal Investigator, NEI|3014966583|emily.chew@nih.gov|
22404207|NCT02197897|Baylor College of Medicine|Dr. Guilherme Godoy|713-798-4001|godoy@bcm.edu|
22416796|NCT00256776|EBMT|Clinical Study Unit|+31(0)715265005|ebmtcsu@lumc.nl|
22404208|NCT00550277|Sarah Cannon Research Institute|John D. Hainsworth, MD|615-329-7274|jhainsworth@tnonc.com|
22404209|NCT01147406|N30 Pharmaceuticals Inc.|Janice M Troha|720-945-7714|janice.troha@n30pharma.com|
22404210|NCT03807245|MinervaX ApS|Dr Per Fischer|+45 20 25 20 38|pbf@minervax.com|
22404211|NCT03495453|NYU Langone Health|Anvar Babaev, MD, PhD|212-263-5656|Anvar.Babaev@nyulangone.org|
22404212|NCT01668030|University of Louisville School of Nursing|Dr. Carlee Lehna, Associate Professor|502-852-3913|carlee.lehna@louisville.edu|
22404213|NCT01103778|Rogosin Institute|Dr. Choli Hartono|212-746-1578|chh2001@nyp.org|
22404214|NCT03084718|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
22404215|NCT01978509|Mayo Clinic|Dr. Francisco Ramirez|(480) 301-6990|Ramirez.Francisco@mayo.edu|
22404216|NCT00082329|NHLBI NIH|Dr. Richard Childs|301-594-8008|childsr@nhlbi.nih.gov|
22404217|NCT01594333|Brigham & Women's Hospital|Dr. Paul Ridker and Dr. Robert Glynn|617-732-4965|pridker@bwh.harvard.edu|
22404218|NCT00589979|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator|Use e-mail contact|clinicalsite.inquiries@endo.com|
22404219|NCT00779311|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
22404220|NCT03428997|Johnson & Johnson Consumer Inc.|Heather Smith|(908) 874-1235|HSmith21@its.jnj.com|
22404221|NCT05506969|Dynavax Technologies|Ouzama Henry, MD|617-686-4796|ohenry@dynavax.com|
22404222|NCT00510068|Novartis Pharmaceuticals|Study Director|862-778-8300||
22404223|NCT02120157|Johns Hopkins University|Heather Symons, MD|410-502-9961|hsymons2@jhmi.edu|
22404224|NCT02553317|Ablynx|Medical Monitor|+32 (9) 262 00 00|clinicaltrials@ablynx.com|
22404225|NCT00769808|Bausch & Lomb Incorporated|Study Director|9083009926|susan.harris@bauschhealth.com|
22404226|NCT01354431|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22404227|NCT03176277|Ono Pharmaceutical Co., Ltd.|Medical Information Center|Please see email|trials.uk-eu@ono-pharma.com|
22404228|NCT00702052|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22404229|NCT03691610|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22404230|NCT02921919|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22404231|NCT01848899|NYU Langone Medical Center|Binita Shah|212-263-4235|binita.shah@nyumc.org|
22404232|NCT01401465|Sunovion|Respiratory Medical Director|1-866-503-6351||
22404233|NCT01115738|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22404234|NCT04009213|Advanced Medical Solutions|Tina Warburton, Senior Clinical Research Associate|07791742957|tina.warburton@admedsol.com|
22404235|NCT02921763|Mylan EPD G.K.|Takumi Kanzo|+81-3-5656-0516|takumi.kanzo@viatris.com|
22404236|NCT04142216|Demiroglu bilim University|Assistant Professor Nurten Ozen|+905334509382|ozenurten@yahoo.com.tr|
22404237|NCT01582971|Michigan State University|Dr. Gwen Wyatt|517-432-5511|gwyatt@msu.edu|
22404238|NCT03095053|Antalya IVF|Kevin Coetzee|090 530 764 3135|kevincoetzee61@yahoo.co.nz|
22404239|NCT02659605|The University of Texas Health Science Center at Houston|Dr. Pamela D. Berens|(713) 500-6471|Pamela.D.Berens@uth.tmc.edu|
22404240|NCT01054976|Jan-Cil Korea|Business Unit Director|82 2 2094-4537||
22404241|NCT01641991|Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center|David Bernstein, MD, MA|513-636-7625|david.bernstein@cchmc.org|
22404242|NCT01559064|Allergan, Inc.|Medical Monitor|714-246-4500|clinicaltrials@allergan.com|
22404243|NCT00475540|MedStar Health Research Institute|Allie Moses, Manager, Clinical Research Systems and Recruitment Center|301-560-7353|Allison.E.Moses@MedStar.net|
22404244|NCT02618343|UT Health San Antonio|David Wampler, PhD, LP|210-414-9548|wamplerd@uthscsa.edu|
22404245|NCT02394795|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22404246|NCT05202223|University of Kentucky|Dr. Elizabeth Rhodus|859-257-5562|elizabeth.rhodus@uky.edu|
22404247|NCT03245723|UT Southwestern Medical Center, Dallas, Texas|Dr. Kara Goss|214-648-6868|kara.goss@utsouthwestern.edu|
22404248|NCT01628250|Ruijin Hospital, Shanghai Jiao Tong University School of Medicine|Dr. Bo Feng|021-64458887|fengbo2022@163.com|
22404249|NCT03784027|University of Cambridge|Prof Roman Hovorka|+44 1223 762 862|rh347@cam.ac.uk|
22404250|NCT03637842|New York State Psychiatric Institute|Christina Brezing, MD|6467748181|christina.brezing@nyspi.columbia.edu|
22404251|NCT01512108|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22404252|NCT02373371|CHU de Limoges|Project Manager|0555058616|abdeslam.bentaleb@chu-limoges.fr|+33
22404253|NCT01539811|Greenville Health System|Dr. David Cull|8644548295|dcull@ghs.org|
22404254|NCT03287869|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22404255|NCT04847141|Sr Manager, Clinical Research, Scientific Innovation Office (SIO)|Mireia Torres|+34 93 5710500|mireia.torres@grifols.com|
22404256|NCT00324740|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
22404257|NCT01052831|University of Pennsylvania|Dr. Daniel Weintraub|12153498389|Daniel.Weintraub@uphs.upenn.edu|
22404258|NCT02427750|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
22404259|NCT01357980|Ipsen|Medical Director Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22404260|NCT04507776|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22404261|NCT01705964|University of Louisville|Dr. Kerry Caperell|502-629-7212|k0cape01@louisville.edu|
22404262|NCT00393068|Sarah Cannon Research Institute|Johanna C. Bendell, MD|615-329-7274|jbendell@tnonc.com|
22404263|NCT00094835|Amgen Inc.|Study Director|866-572-6436||
22404264|NCT00387348|Massachusetts General Hospital|William F Pirl, MD|617-724-9151|wpirl@partners.org|
22404265|NCT03628599|Alcon Research|CDMA Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22404266|NCT00278863|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
22404267|NCT01766219|Wake Forest University Health Sciences|Caio Max Rocha Lima|336-703-4246|crochali@wakehealth.edu|
22404268|NCT03064568|UTHSCSA|Sally Kabro|210-567-4950|kabro@uthscsa.edu|
22404269|NCT05905601|University of Washington / University of North Carolina at Chapel Hill|Benjamin Buck, Ph.D.|(919) 445-4330|ben.buck@med.unc.edu|
22404270|NCT03024255|Botanix Pharmaceuticals|Anthony Robinson, MS CRNP|+1 (445) 300-3403|trials@botanixpharma.com|
22404271|NCT03532776|Dermax|Chauvel Virginie|+32 488 07 04 18|chauvelvirginie07@gmail.com|
22404272|NCT00868166|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22404273|NCT00240539|GlaxoSmithKline|GSK Response Center|866-435-7343||
22404274|NCT01754207|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22404275|NCT01797445|Gilead Sciences|Gilead Clinical Study Information Center||GileadClinicalTrials@gilead.com|
22404276|NCT00168064|Yaupon Therapeutics|H. Jeffrey Wilkins, MD|4843247935|hjwilkins@yaupontherapeutics.com|935
22404277|NCT00776555|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22404278|NCT03452891|University of Nebraska Medical Center|Amy C Killeen|402-479-6205|akilleen@unmc.edu|
22404279|NCT03482141|University of California, San Francisco|Mary Norton|(415) 467 4080|mary.norton@ucsf.edu|
22404280|NCT03483116|Murdoch Children's Research Institute|Professor Julie Bines|+61 3 9345 5522|julie.bines@mcri.edu.au|
22404281|NCT01181102|Daiichi Sankyo.,LTD|Kei Ibusuki, Associate Director|81-90-2732-9505|ibusuki.kei.tx@daiichisankyo.co.jp|
22404282|NCT01315002|University Hospital Bonn, Department of Psychiatry and Psychotherapy|Prof. Dr. Michael Wagner|004922828716377|michael.wagner@uni-bonn.de|
22404283|NCT00400439|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
22404284|NCT00239837|University of Oregon|Dr Leslie Leve|541-346-9528|leve@uoregon.edu|
22404285|NCT01838590|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22404286|NCT04685499|Weill Cornell Medicine|Meyer Cancer Center GI Program Manager|646-962-8189|cdo4001@med.cornell.edu|
22404287|NCT02802878|University of Kansas Medical Center|Dr. Neil Segal|913-945-8985|segal-research@kumc.edu|
22404288|NCT00101192|Gynecologic Oncology Group Statistical and Data Center|Melissa Leventhal|716-341-3408|mleventhal@gogstats.org|
22404289|NCT00536978|UT MD Anderson Cancer Center|Issa F. Khouri, MD / Professor, Stem Cell Transplantation|713-745-0049|ikhouri@mdanderson.org|
22404290|NCT01232894|Novartis|Study Director|41 61 324 1111||
22404291|NCT03970395|Azienda Ospedaliera Città della Salute e della scienza di Torino _ Italy|Dr Claudio G Priolo|0039 3471403064|claudiog.priolo@gmail.com|
22404292|NCT01996904|CM Chungmu Hospital|Sang-Hoon Lhee|+82(2)2068/4525|cmirb@naver.com|
22404293|NCT02055430|Cairo University|dr Mohammed Said ElSheemy|01006117755|mohammedshemy@yahoo.com|
22404294|NCT02938052|Massachusetts General Hospital|Dr. Christopher Celano|617-726-6485|ccelano@partners.org|
22404295|NCT00929734|University of Oslo|Professor Torbjørn Omland|+47 40107050|torbjorn.omland@medisin.uio.no|
22404296|NCT00980980|University of California, Irvine|Dr. Susan Huang|949-824-5073|sshuang@uci.edu|
22404297|NCT00121992|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
22404298|NCT04664855|Montana State University|Dr. Lauren Davis|8287736328|lauren.davis6@montana.edu|
22404299|NCT03076190|Stanford University|Dr. Beth Darnall|6507365494|bdarnall@stanford.edu|
22404300|NCT01441115|National Cancer Institute|Dr. Deborah E. Citrin|301-496-5457|citrind@mail.nih.gov|
22404301|NCT01906866|Neurim Pharmaceuticals|Dr. Tali Nir|972-7684902|talin@neurim.com|
22416797|NCT00754442|University of Maryland School of Medicine|Elizabeth A Streeten, MD|410-328-6219|estreete@medicine.umaryland.edu|
22416798|NCT00384293|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22416799|NCT02296853|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22404302|NCT02235987|Strongbridge Biopharma|Fredric Cohen, MD|610-254-9200|f.cohen@strongbridgebio.com|
22404303|NCT03180489|Colorado State University|Christopher Bell|9704917522|christopher.bell@colostate.edu|
22404304|NCT01086150|Albany Medical College|Charles E. Argoff, MD|518 262-0034|argoffc@mail.amc.edu|
22404305|NCT01770691|ConTIPI LTD.|Dr. Elan Ziv|972-4-627-6066|eziv@contipi.com|
22404306|NCT00870818|Provention Bio, Inc|Sharon Rowland|443-987-0797|SRowland@proventionbio.com|
22404307|NCT00178464|St. Christopher's Hospital for Children|Dr. Norma B. Lerner|215 427-5261|norma.lerner@drexelmed.edu|
22404308|NCT00094887|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22404309|NCT02260648|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22404310|NCT04093258|Johnson & Johnson Vision Care|Thomas R. Karkkainen, OD, MS, FAAO|1-800-843-2020|tkarkkai@its.jnj.com|
22431305|NCT01587196|University of Pennsylvania|Daniel Langleben, MD|215-760-7067|langlebe@pennmedicine.upenn.edu|
22404311|NCT01890512|Guidant Europe SA/NV A Boston Scientific Company|Giovanni Raciti|+39 02 26983213|giovanni.raciti@bsci.com|
22404312|NCT01529385|Center for Lower Extremity Ambulatory Research|Ryan Crews, Clinical Scientist|847-578-8437|ryan.crews@rosalindfranklin.edu|
22404313|NCT00805545|University of Florida|Patrick Duff, M.D.|352 273 7673|duffp@ufl.edu|
22404314|NCT03543358|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22404315|NCT00986427|Columbia University Dept of Dermatology|Julian Mackay-Wiggan, MD|212-305-6953|jc299@columbia.edu|
22404316|NCT00413335|Yale University School of Medicine|Dr. Sonia Caprio, Principal Investigator|203-785-5692|Sonia.Caprio@yale.edu|
22404317|NCT02379390|Sanofi|Trial Transparency Team|800-633-1610|Us@sanofipasteur.com|1
22404318|NCT00575094|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22416800|NCT00703976|University of Pittsburgh|Julie Bauman, MD|412-623-7833|baumanje@upmc.edu|
22416801|NCT01352182|Cincinnati Children's Hospital Medical Center|Jennifer Kaplan|513-636-4259|jennifer.kaplan@cchmc.org|
22404319|NCT05128682|Beaumont Hosptials|Jennifer Giordano CRM|248-551-3517|jennifer.giordano@corewellhealth.org|
22404320|NCT00643604|United Therapeutics Corporation|Remodulin Program Leader|919-485-8350|clinicalrecordsmanagement@unither.com|
22404321|NCT02763072|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
22404322|NCT02702011|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22416802|NCT02326363|Medical University of South Carolina|Nathaniel L Baker|843-792-5028|bakern@musc.edu|
22416803|NCT01832402|UT MD Anderson Cancer Center|David Hui, MD/ Associate Professor, Palliative Care Medicine|713-792-6258|dhui@mdanderson.org|
22404323|NCT02995330|Johns Hopkins University|"Dr. Samuel R. Denmeade Professor of Oncology| Director Genitourinary Oncology"|410-502-8341|DENMESA@jhmi.edu|
22404324|NCT02721251|VA|David Thompson|602-496-0242|david.thompson4@va.gov|
22404325|NCT01709981|NYU Langone Health|Dr. Binita Shah|212-263-6631|Binita.Shah@nyulangone.org|
22404326|NCT04390568|Boehringer Ingelheimv|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22431306|NCT00642759|Massachusetts General Hospital|Dr. Rebecca Heist|6177244000|rheist@partners.org|
22431307|NCT03546439|Saint Luke's Hospital of Kansas City|Sanjaya Gupta, MD|8169311883|sgupta@saint-lukes.org|
22431308|NCT03612570|Pulse Biosciences, Inc.|William A. Knape|(510) 906-4649|bill.knape@pulsebiosciences.com|
22431309|NCT02476448|Cleveland Clinic Florida|Dr. Eric Hurtado|954-659-5559|hurtade@ccf.org|
22431310|NCT05318287|Oregon Research Behavior Intervention Strategies, Inc. dba Influents Innovations|David Smith|541-484-2123|david.smith@influetnsin.com|
22431311|NCT05185453|University of Pittsburgh|Dr. Alison Culyba|412-692-6056|alison.culyba@chp.edu|
22431312|NCT03537508|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22431313|NCT02516813|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22431314|NCT04652765|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Cathy Handy Marshall|4109550231|chm@jhmi.edu|
22431315|NCT00391716|The Scripps Research Institute|Dr. Barbara J. Mason|858-784-7324|mason@scripps.edu|
22431316|NCT05251805|UZ Brussel|Head of the anesthesiology department|024776001|anesthesiology.clinicaltrials@uzbrussel.be|+32
22431317|NCT03814044|Smith + Nephew, Inc.|Judith Horner|+44 1482 673251|Judith.Horner@smith-nephew.com|
22431318|NCT02757768|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22431319|NCT05218434|Simbec Orion|Dr Annelize Koch|01443694313|gabrielle.brill@simbecorion.com|
22431320|NCT00835367|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22431321|NCT00835172|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22431322|NCT02495883|UCSD|Fatta Nahab, MD|858-822-5871|fnahab@health.ucsd.edu|
22431323|NCT04632030|RAND|William G. Shadel|412-683-2300|shadel@rand.org|4489
22431324|NCT00964678|Virginia Commonwealth University Health System|Dan Grinnan, MD|804-828-9000|daniel.grinnan@vcuhealth.org|
22431325|NCT03552029|Daiichi Sankyo|Contact for Clinical Trial Disclosure Information|908-992-6400|CTRinfo@dsi.com|
22431326|NCT04490278|Washington University|Chris Palmer|314-215-7384|cmpalmer@wustl.edu|
22404327|NCT06076148|Topmed|Edith Martin|418 683-2104|emartin@topmed.ca|1302
22404328|NCT06025396|Tempero Bio|Director, Clinical Operations|510-250-4750|TMP-301-HNV-101@Temperobio.com|
22404329|NCT06422377|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22404330|NCT00453180|Cincinnati Childrens Hospital|Craig Erickson|513-636-6258|craig.erickson@cchmc.org|
22404331|NCT03380026|Rochester Skin Lymphoma Medical Group|Clinical Research Coordinator|(585)364-1188|scarroll@roclymphoma.com|
22404332|NCT03326869|Eye Center of N Florida|Christina Menck|8507843937|eyenerdgyrl1@gmail.com|1124
22404333|NCT01874119|Saint Louis University|Dr. John Richart|314-577-8854|richartj@slu.edu|
22404334|NCT01002742|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
22404335|NCT00562640|Memorial Sloan Kettering Cancer Center|Dr. Roisin O'Cearbhaill, MD|646-888-4227|ocearbhr@mskcc.org|
22404336|NCT05263921|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22404337|NCT04327518|Johnson & Johnson Surgical Vision|Director of Clinical Science, Ophthalmic Implants|7142478200|EThoma39@its.jnj.com|
22404338|NCT01666145|Carolinas Healthcare System|Principal Investigator|704-446-2772|john.martinie@carolinashealthcare.org|
22404339|NCT01297309|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22404340|NCT02591238|Peking Union Medical College Hospital.|Prof. Changwei Liu. Director of vascular surgery.|+86 1069152509|aresbill@outlook.com|
22404341|NCT01184456|AIDS Healthcare Foundation - Public Health Division|Adam Sukhija-Cohen|(323) 436-8900|adam.cohen@aidshealth.org|
22404342|NCT00640146|Bausch Health Americas, Inc|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
22404343|NCT00525785|The University of Texas (UT) MD Anderson Cancer Center|Dr. Jaffer Ajani, MD / Professor, GI Medical Oncology|713-792-2828|jajani@mdanderson.org|
22404344|NCT03728504|Libertas BioSciences|Niranjan Rao|908-872-1133|niranjan@libertasbiosciences.com|
22404345|NCT01204697|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22404346|NCT02119026|Medical University Vienna, Internal Med. I, Dep. of Oncology|Werner Scheithauer, MD|+43 1 40400|werner.scheithauer@meduniwien.ac.at|54620
22404347|NCT00109005|National Cancer Institute, National Institutes of Health|Caryn Steakley|301-435-3685|steaklec@mail.nih.gov|
22404348|NCT01143714|Healthpoint, Ltd.|Jaime E. Dickerson, PhD; Sr. Director Clinical Affairs|817-302-3914|jaime.dickerson@healthpoint.com|
22404349|NCT02849184|Jichi Medical University School of Medicine|Professor Kazuomi Kario|+81-285-58-7538|kkario@jichi.ac.jp|
22404350|NCT01803854|Department of Veterans Affiairs, Office of Research and Development|Dr. Christina D. Williams, Acting Director of Cooperative Studies Program Epidemiology Center Durham|919-286-0411|christina.williams4@va.gov|175464
22404351|NCT03939637|Baylor College of Medicine/ Texas Children's Hospital|Amanda Grimes|832-822-4217|abgrimes@texaschildrens.org|
22404352|NCT03783442|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
22404353|NCT04190186|University of Rochester|David Huang, MD|585 275 5391|david_huang@urmc.rochester.edu|
22404354|NCT01381718|Children's Hospital Boston/Harvard Medical School|Nicole J. Ullrich, MD, PhD|617-355-3193|Nicole.Ullrich@childrens.harvard.edu|
22404355|NCT00365768|Columbia University Medical Center|Julia Glade-Bender, MD|212-305-3379|jg589@cumc.columbia.edu|
22404356|NCT03017846|Albert Einstein College of Medicine|Anthony Guzman, MD|7189208352|anguzman@montefiore.org|
22404357|NCT02505542|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22404358|NCT04150562|National Cancer Institute|Dr. Kevin C. Conlon|240-858-3570|conlonkc@mail.nih.gov|
22404359|NCT00992186|Centocor Research & Development, Inc., PA, USA|Senior Director, Early Clinical Development Global Leader|+1-908-927-3159||
22404360|NCT00707343|Huntsman Cancer Institute|Mark Wade, Ph.D. - Compliance Officer|801-213-5746|mark.wade@hci.utah.edu|
22404361|NCT02451202|Department of Anesthesiology, King Chulalongkorn Memorial Hospital|Dr. Prok Laosuwan|+66 2256 4295|plaospir@yahoo.com|
22404362|NCT02666508|UIC College of Dentistry|Kimberly Fasula RDH, MS, MPH|(312) 996-5513|kfasul1@uic.edu|
22404363|NCT00830804|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22404364|NCT01438307|UAB|Francisco Robert, MD|205-934-5077|paco@uab.edu|
22404365|NCT00171314|Novartis Pharamaceuticals|Novartis Pharmaceuticals|862-778-8300||
22404366|NCT02378883|Medtronic Neurovascular|Darren Lacour, Sr. Manager, Clinical Project Management|949-680-1274|darren.j.lacour@medtronic.com|
22404367|NCT00318565|Biosense Webster|Christine Liu|9098398608|cliu10@its.jnj.com|8608
22404368|NCT01588353|XIA Project, Pharmaceuticals Sales Division, Asahi Kasei Pharma Corporation|Norihiro Tateishi, Manager|+81-3-3296-3641|xia_project@om.asahi-kasei.co.jp|
22404369|NCT00493467|University of Texas (UT) MD Anderson Cancer Center|Felipe Samaniego, MD/Associate Professor, Lymphoma/Myeloma|713-563-1509|fsamaniego@mdanderson.org|
22404370|NCT00835003|Aarhus University Hospital, Dep. Obstetrics and Gynecology, Aarhus, Denmark|MD, PhD Julie Glavind|+4578450000|julie.glavind@dadlnet.dk|
22404371|NCT02242994|Children's National|Dr. Axel Krieger|2024761284|akrieger@childrensnational.org|
22404372|NCT01397448|Eisai Co., Ltd.|Nobuyuki Sugisaki|+81-3-3817-3908||3908
22404373|NCT01804036|University of Utah|Yoshio Nakamura, PhD|801-585-7690|yn5@utah.edu|
22404374|NCT01409993|Vanderbilt University Medical Center|Nancy J. Brown, M.D., Principal Investigator|6153438701|nancy.j.brown@vanderbilt.edu|
22404375|NCT00570531|University of Michigan Comprehensive Cancer Center|Susan Urba, M.D.|734-615-4762|surba@umich.edu|
22404376|NCT00425477|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|B. Douglas Smith|410-614-5068|smithdo@jhmi.edu|
22404377|NCT02466412|Philip Morris Products S.A.|Steffen Fredersdorf|+41 (58) 242 2182|Steffen.Fredersdorf@pmi.com|
22404378|NCT01868776|The Ohio State University|Dr. Melissa Drum|6142923596|drum.13@osu.edu|
22404379|NCT00830960|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22416804|NCT01198873|Sanofi|Trial Transparency Team||Contact_US@sanofi.com|
22416805|NCT01396382|Vanderbilt-Ingram Cancer Center|Dr. Ronald Walker|615-343-8516|ronald.walker@vanderbilt.edu|
22404380|NCT02180217|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22404381|NCT00134017|Johns Hopkins University|Leo Luznik, MD|4105027732|luznile@jhmi.edu|
22404382|NCT01504971|ChinaPLAGH|Dr. Weifeng Wang|0086-13911952018|wangwf301@hotmail.com|
22404383|NCT02703987|Danone Nutricia Research|Danone Nutricia Research||register.clinicalresearchnutricia@danone.com|
22404384|NCT01309841|AstraZeneca|Mark Sostek||ClinicalTrialTransparency@astrazeneca.com|
22404385|NCT02475395|Sandstone Diagnostics|Cheif Science Officer|9253157246|gsommer@sandstonedx.com|925
22404386|NCT01681576|Novartis|Study Director|862-778-8300||
22404387|NCT01606735|Icon Bioscience, Inc|Wendy Murahashi, MD|6503694049|wendymurahashi@iconbioscience.com|
22404388|NCT03448224|University of Kentucky|Dr. Jerod Stapleton|859.562.2802|jerod.stapleton@uky.edu|
22404389|NCT03103906|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22404390|NCT00764478|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22404391|NCT05515952|University of Arizona|Lisbeth Haaheim|520-626-7755|lhaaheim@arizona.edu|
22404392|NCT03450915|BiondVax Pharmaceuticals ltd.|Chief Scientific Officer & Clinical Management|+97289302529|benyedidia@BiondVax.com|5103
22404393|NCT00862121|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
22404394|NCT02007954|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu|
22404395|NCT01929473|IROM CS Co., Ltd.|Tsutomu Takeda|+81-92-738-0500|tsutomu-takeda@irom-cs.co.jp|
22404396|NCT01195363|UTHSCSA|Charles L Bowden, MD|210-567-5393|BowdenC@uthscsa.edu|
22404397|NCT01589510|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22404398|NCT01164865|Alcon Global Medical Affairs|Jami Kern, Ph.D.|1-888-451-3937||
22404399|NCT00750165|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 9 574 0123|cpaptrial@fphcare.co.nz|7044
22404400|NCT00377429|Fresenius Biotech|Anne Kuan|781 699 4618|anne.kuan@fresenius-biotech.com|
22404401|NCT05691829|NYU Langone Health|Fraustina Hsu|646-754-7124|Fraustina.Hsu@nyulangone.org|
22404402|NCT00804843|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22404403|NCT00547898|Valeant Pharmaceuticals|Johnson Varughese|9089271162|christine.hnatko@valeant.com|
22404404|NCT01966263|Sint Maartenskliniek Nijmegen|Dr Maaike Fenten|31243659111|m.fenten@maartenskliniek.nl|2941
22404405|NCT02670928|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22416806|NCT01748955|New York State Psychiatric Institute|Michael F. Grunebaum, MD|6467747573|mgruneb@nyspi.columbia.edu|646
22416807|NCT02080507|Emory University|Dr. William McDonald|404-712-6945|wmcdona@emory.edu|
22416808|NCT00775528|Solvay Pharmaceuticals|Sven Voet - Global Communication|+32 (0)2 509 69 77|sven.voet@solvay.com|
22416809|NCT02492841|UNIVERSIDAD DE LOS ANDES|Dra. CLAUDIA BRIZUELA CORDERO|562226181166|clau@cibrizuela.com|
22416810|NCT03851588|University of Cape Town|Prof Gary Maartens|214066008|gary.maartens@uct.ac.za|+27
22416811|NCT00613730|Amgen Inc.|Study Director|866-572-6436||
22416812|NCT00712244|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22416813|NCT00895037|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22404406|NCT02678312|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22404407|NCT01804257|Zucker Hillside Hospital, Glen Oaks, NY|John M. Kane MD|(718) 470-8141|psychiatry@nshs.edu|
22404408|NCT01807091|University of Washington|Elihu Estey, MD|206-606-6744|eestey@seattlecca.org|
22416814|NCT02063087|Mayo Clinic|Dr. Erik Hess|507-255-6501|hess.erik@mayo.edu|
22404409|NCT04624672|Geisinger Medical Center|Project Manager|570-214-2245|kcunningham1@geisinger.edu|
22404410|NCT00834886|University of Bergen|Dr. Bjørn Bjorvatn|55586130|bjorn.bjorvatn@igs.uib.no|
22404411|NCT00010803|University of Virginia|Steven T. DeKosky MD|434-924-5118|SD3ZC@hscmail.mcc.virginia.edu|
22404412|NCT01415908|Medtronic Spinal and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
22404413|NCT04169113|Northwestern University|Melissa Shauver; Research Project Manager|3124726024|melissa.shauver1@nm.org|
22404414|NCT00193219|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|ASKSARAH@scresearch.net|
22404415|NCT01779648|SMG-SNU Boramae Medical Center|Principal Investigator|+82-10-9988-2691|turejsreal@hanmail.net|
22404416|NCT01878097|University of Kentucky|Dr. Ann Coker|859-323-6758|ann.coker@uky.edu|
22404417|NCT01595438|AstraZeneca/ PPD|Gayan Makumburage|9105588682|gayan.makumburage@ppdi.com|
22404418|NCT00756678|Allergan, Inc|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22404419|NCT02236273|Columbia University|Melissa Stockwell|2123425732|mss2112@cumc.columbia.edu|
22404420|NCT01373918|University of California, Los Angeles|Dr. Kara L. Calkins|310 825-9330|KCalkins@mednet.ucla.edu|
22404421|NCT05859971|University of Wisconsin School of Medicine and Public Health|Heather Neuman, MD, MS, FACS|(608) 262-9060|neuman@surgery.wisc.edu|
22404422|NCT02786836|UT Southwestern Medical Center at Dallas|William M. Lee, MD|(214) 645-6110|William.Lee@UTSouthwestern.edu|
22404423|NCT03617913|Mayo Clinic|Parminder Singh, MD|5072555123|Singh.Parminder@mayo.edu|
22404424|NCT04426890|Celltrion. Inc|Yunju Bae/Head of Clinical Planning 1 Department|+82 32 850 4160|Yunju.bae@celltrion.com|
22404425|NCT02016898|Duke University Health System|Michael Quist, MD|718-490-7657|michael.quist@duke.edu|
22404426|NCT03859960|Fatih Sultan Mehmet Education and Research Hospital|MD. Arzu Atici|+905335621208|arzususinatici@gmail.com|
22404427|NCT03074149|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22404428|NCT02855450|Dompè|Flavio Mantelli, MD, PhD|+39 02583831|info@dompe.com|
22404429|NCT01803711|UConn Health Center|Jayesh Kamath MD PhD|8606796727|jkamath@uchc.edu|
22404430|NCT03438578|St Olavs Hospital|Erlend Johan Skraastad|0047 79829184|Erlend.Johan.Skraastad@stolav.no|
22404431|NCT01519063|Yale University|Dana Cavallo, Assistant Professor|203974-7607|dana.cavallo@yale.edu|
22404432|NCT01376245|GlaxoSmithKline|GSK Response Center|866-435-7343||
22404433|NCT05159362|Q2i, LLC|Steven Jenkins, CEO Q2i|646-660-2151|sjenkins@q2i-group.com|
22404434|NCT01357889|GlaxoSmithKline|GSK Response Center|866-435-7343||
22404435|NCT01335698|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22404436|NCT01170221|Cubist Pharmaceuticals, Inc.|Philippe Prokocimer, MD|858-452-0370|Philippe.Prokocimer@cubist.com|241
22404437|NCT02693691|Abbott|Dr. Marie-Elena Brett|7815283613|marieelena.brett@abbott.com|
22404438|NCT02727660|Pearl Therapeutics, a Member of the AstraZeneca Group|Paul M. Dorinsky, MD|650-305-2600|paul.dorinsky1@astrazeneca.com|
22404439|NCT00050960|Eisai Call Center|Eisai, Inc.|888-422-4743||
22404440|NCT02171819|IVAC|Dr. Le Van Be||ivaclevanbe@gmail.com|
22404441|NCT01567891|Adaptimmune|Clinical Trials Management|215-825-9302|clinicaltrials@adaptimmune.com|6302
22404442|NCT00764946|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22404443|NCT01162304|University of Rochester|Joel Kent, MD|585-273-2972|joel_kent@urmc.rochester.edu|
22404444|NCT01315847|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22404445|NCT02940626|X4 Pharmaceuticals (merged with Arsanis)|Vice President, Clinical Operations|(857) 529-8300|rnd@x4pharma.com|
22404446|NCT00756496|Siemens Medical Solutions USA, Inc.|Milind Dhamankar|+1 (610) 448-6467|milind.dhamankar@siemens-healthineers.com|
22404447|NCT00585923|Biomet|Jacquelyn Hughes|973-299-9300|jacquelyn.hughes@biomet.com|3075
22404448|NCT01324622|DePuy Synthes|Allyson Morris|610-719-5298|amorris5@its.jnj.com|
22404449|NCT00878215|Washington University School of Medicine|William C. Chapman, M.D.|314-362-7792|chapmanw@wustl.edu|
22404450|NCT00138424|Collaborative Antiviral Study Group|Penelope Jester, BSN,MPH,CCRC|(205) 877-975-7280|PJester@peds.uab.edu|
22404451|NCT01802554|University of California San Diego|Brent T Mausbach, PhD|858-822-7529|BMausbach@ucsd.edu|
22404452|NCT01912716|Indiana University|Dr. Evan Fogel|317-944-2816|efogel@iu.edu|
22404453|NCT02391350|University of Utah|Dr. Julie Fritz|8015872237|julie.fritz@utah.edu|
22404454|NCT00413062|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22404455|NCT02176291|University of Pittsburgh|Dr. Jordan F. Karp|412-246-6048|karpjf@upmc.edu|
22404456|NCT02815293|Allergan, Inc.|Therapeutic Area Head|877-277-8566|clinicaltrials@allergan.com|
22404457|NCT00006604|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22404458|NCT02431468|Neurotrope BioScience, Inc.|David Crockford, Vice President, Regulatory Affairs|(973)242-0005|dcrockford@neurotropebioscience.com|
22404459|NCT01056341|Pierre Fabre Dermatologie|Dr. Jean-Jacques VOISARD - General Manager -|+33 5 63 58 88 00|jean.jacques.voisard@pierre-fabre.com|
22404460|NCT01361919|St. Michael's Hospital|Dr. Paul Dorian|416-864-5104|dorianp@smh.ca|
22404461|NCT03454412|International Clinic of Rehabilitation|Oleh Kachmar|+380324765200|okachmar@ic.reha.lviv.ua|
22404462|NCT03001843|University of Florida|Joshua Sappenfield, MD|352-273-5259|jsappenfield@anest.ufl.edu|
22404463|NCT01167582|Rutgers University|Jeffrey Carson|732-235-7122|jeffrey.carson@rutgers.edu|
22404464|NCT03956225|Alcon Research, LLC|Sr. CDMA Project Lead, Ocular Health|1-888-451-3937|alcon.medinfo@alcon.com|
22404465|NCT00567541|Bioness|Keith McBride, CTO|661-362-4866|Keith.McBride@bioness.com|
22404466|NCT01583452|ITESM - Pediatrics Division|Gabriela López Jaimez|+527211476044|gabylopez7@gmail.com|
22404467|NCT02157506|Bristol-Myers Squibb International Corporation|EU Study Start-Up Unit||clinical.trials@bms.com|
22404468|NCT01182337|DePuy Synthes Spine|Mark Lotito|508-880-8045|Mlotito@its.jnj.com|
22404469|NCT00868452|Sunovion|Medical Director, CNS|1-866-503-6351||
22404470|NCT04169061|Mallinckrodt|Medical Information Call Center|800-844-2830|MedInfo@mnk.com|
22404471|NCT00895193|University of Kansas Medical Center|Julie-Ann Dutton, MS, RD|(913) 588-4064|jdutton@kumc.edu|
22404472|NCT00656084|New York Oncology Hematology|Dr. Lawrence E. Garbo|(518) 489-0044|Lawrence.Garbo@usoncology.com|
22404473|NCT00609804|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22404474|NCT04055467|Johns Hopkins School of Medicine|Dr. Elise Weerts, Professor|410-550-2781|eweerts@jhmi.edu|
22404475|NCT02455388|Virginia Tech|Dr. Brenda Davy|540-231-6784|bdavy@vt.edu|
22404476|NCT01136746|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22404477|NCT03154294|Avera Cancer Institute|Dr. Casey Williams|605-322-3588|Casey.Williams@avera.org|
22404478|NCT00092677|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22404479|NCT00873288|Northwestern University|Bonnie Spring|312-908-2293|bspring@northwestern.edu|
22404480|NCT03874351|MJHS Institute for Innovation in Palliative Care, New York, NY|Helena Knotkova, PhD, PhilD|646-784-2262|HKnotkov@mjhs.org|
22404481|NCT00081328|TODAY Coordinating Center at George Washington University Biostatistics Center|Dr. Kathryn Hirst, Coordinating Center PI|301-881-9260|khirst@bsc.gwu.edu|8025
22404482|NCT02814448|Cleveland Clinic|Dr. Miriam Cremer|216-312-0618|cremerm@ccf.org|
22404483|NCT00093470|ECOG-ACRIN Statistical Office|Study statistician|617-632-6012||
22404484|NCT01019252|Massachusetts General Hospital|Susan Sprich, Ph.D.|617-726-5991|ssprich@mgh.harvard.edu|
22404485|NCT02514772|Sandoz|Global Program Medical Director|+49 8024 476|biopharma.clinicaltrials@sandoz.com|0
22404486|NCT00877006|Teva Pharmaceuticals USA|Manager|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22404487|NCT04671342|Philips|Bill Hardy|412-874-2710|bill.hardy@philips.com|
22404488|NCT03583606|Cincinnati Children's Hospital|Paul Spearman, MD|513-636-4509|paul.spearman@cchmc.org|
22404489|NCT02685995|University of Pennsylvania|Gregory Nadolski, MD|(215) 662-7892|gregory.nadolski@pennmedicine.upenn.edu|
22404490|NCT00817206|Veloxis Pharmaceuticals A/S|Christina Sylvest|+45 20553877|csy@veloxis.com|
22404491|NCT00793182|Guerbet|Corinne Dubourdieu, PharmD, Head of Clinical Projects and Medical Writing|33 (0) 1 45 91 50 00|corinne.dubourdieu@guerbet-group.com|
22404492|NCT01188096|Atrium Health|Donald L. Durden, MD, PhD|980-442-2048|donald.durden@atriumhealth.org|
22404493|NCT02273037|The Hospital for Sick Children|Dr. Diego G. Bassani|+14168137654|diego.bassani@sickkids.ca|303033
22404494|NCT00851253|Boston Medical Center|Dr. Minh Tam Truong|617-638-7070|Minh-Tam.Truong@bmc.org|
22404495|NCT02384395|University of North Carolina at Chapel Hill|Cynthia Gay, MD, MPH|919-966-6712|cynthia_gay@med.unc.edu|
22404496|NCT03485222|Icahn School of Medicine at Mount Sinai|Dr. Juan Badimon|(212) 241-8484|juan.badimon@mssm.edu|
22404497|NCT03657810|Charleston Laboratories, Inc.|Bernard P. Schachtel, MD, Chief Scientific Officer|561.379.8726|bschachtel@charlestonlabs.com|
22404498|NCT00688545|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22404499|NCT00985738|University of Colorado Hospital|Dr. Al Baha Barqawi|303-724-2722|AL.BARQAWI@UCDENVER.EDU|
22404500|NCT02487277|University of California, San Francisco|Dr. Andrew Ko|(415) 353-7286|Andrew.Ko@ucsf.edu|
22404501|NCT00812604|University of Hong Kong|Dr. Ricky Wing Kit Wong, Associate professor in orthodontics|852-2859 0554|fyoung@hkucc.hku.hk|
22404502|NCT00340834|Novartis Pharmaceuticals|Study Director|862-778-8300||
22404503|NCT00291499|IBSA Institut biochimique|Project Leader|0041 58360100|rd@ibsa.ch|
22404504|NCT01457924|GlaxoSmithKline|GSK Response Center|866-435-7343||
22404505|NCT00936117|University of Texas (UT) MD Anderson Cancer Center|Jorge Cortes, MD/Professor, Leukemia Department|713-745-2723|CR_Study_Registration@mdanderson.org|
22404506|NCT04581863|University of Pennsylvania|Mucio Delgado, MD, Principal Investigator|215-746-8256|mucio.delgado@pennmedicine.upenn.edu|
22404507|NCT05053126|Viatris|Dik WH Ng|+44 (0)1304 626895|dik.ng@viatris.com|
22404508|NCT04024072|Padagis LLC|Jonathan Schwartz|929-502-7291|jonathan.schwartz@padagis.com|
22404509|NCT00225212|Stanford University Medical Center|Neal Birkett, MS, RAC|650-723-6456|nbirkett@stanford.edu|
22404510|NCT01632735|Azusa Pacific University|Dr. Rachel Gonzales Castaneda|6268156000|rcastaneda@apu.edu|2744
22404511|NCT00574496|Memorial Sloan Kettering Cancer Center|Dr. Miguel-Angel Perales, MD|646-608-3757|peralesm@mskcc.org|
22404512|NCT02486952|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22404513|NCT03589885|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22404514|NCT04111107|Tulane University|Stefan Grant, MD|504-988-5800|sgrant6@tulane.edu|
22404515|NCT01928485|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Lee Ponsky|+1 216-844-4831|lee.ponsky@uhhospitals.org|
22404516|NCT01825655|Virginia Commonwealth University|Santhosh Kumar, MD|804-628-1605|santhosh.kumar@vcuhealth.org|
22404517|NCT00039741|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22404518|NCT00946881|STEBA Biotech|Bertrand Gaillac International Project Leader|+ 33 974197905|b.gaillac@stebabiotech.com|
22404519|NCT00293423|University of California, Davis|Dr. Orin Bloch||obloch@ucdavis.edu|
22404520|NCT00321269|Iowa City VA Health Care System|Carolyn Turvey|319 338 0581|Carolyn-Turvey@uiowa.edu|7714
22404521|NCT04428359|BP Koirala Institute of Health Sciences|Dr. Bibisha Baaniya|9841744777|cul.bibisha@gmail.com|+977
22404522|NCT03571256|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22404523|NCT02270684|University of Southern California|Dr Christopher Powers|3234422900|powers@usc.edu|
22404524|NCT02247401|AbbVie|Global Medical Services|800-633-9110||
22404525|NCT02029495|Valeant Pharmaceuticals|Director of Clinical Trials|908|binu.alexander@valeant.com|
22404526|NCT03498287|Pressure Profile Systems|Clinical Trials Manager|310.641.8100|research@wrist-aid.com|
22404527|NCT02486211|University of Pittsburgh|Dr. Jon Rittenberger|4126479489|rittjc@upmc.edu|
22404528|NCT02807363|Enteris Biopharma Inc.|Paul Shields, Ph.D|9734533520|pshields@enterisbiopharma.com|
22404529|NCT02188719|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22404530|NCT01948141|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22404531|NCT01763866|Amgen Inc.|Study Director|866-572-6436||
22404532|NCT02396342|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
22404533|NCT05055570|Department of Anesthesiology, Beijing Anzhen Hospital, Capital Medical University|Dr. Jun Ma|13370103671|majun@mail.ccmu.edu.cn|
22404534|NCT00192036|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22404535|NCT03371732|Institute Bergonie|Dr. Marion Barrault Couchouron, Coordinating Investigator|0556337805|m.barrault@bordeaux.unicancer.fr|
22404536|NCT01861054|Dompé Farmaceutici|Pier Adelchi Ruffini, MD|+39 (0)2 583831|info@dompe.it|
22404537|NCT00599027|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22404538|NCT04962503|CLINUVEL PHARMACEUTICALS LIMITED|Clinical Operations Manager|Tel: +61 3 9660 4900|mail@clinuvel.com|
22404539|NCT00476996|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22404540|NCT04218799|University of Maryland School of Medicine|Dr. Mary-Claire Roghmann|410 706 0062|mroghmann@som.umaryland.edu|
22404541|NCT02939599|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
22404542|NCT01669811|Clinical Statistics & Programming Department, Clinical Science Division, R&D, AstraZeneca Japan|Masahiro Nii||Masahiro.Nii@astrazeneca.com|
22404543|NCT01214317|Isfahan University of medical sciences|Director of clinical trial|+983136202020|etemadifar.m@gmail.com|
22404544|NCT00587769|Mayo Clinic|Jon O. Ebbert|507-284-2511|ebbert.jon@mayo.edu|
22404545|NCT05351710|Florida State University|Dr. Jesse Cougle|8506458729|cougle@psy.fsu.edu|
22404546|NCT00505895|University of Texas MD Anderson Cancer Center|Muzaffar Qazilbash, MD / Professor, Stem Cell Transplantation|713-745-4371|CR_Study_Registration@mdanderson.org|
22404547|NCT00676793|LSU Health, Shreveport|Dr. Jerry w. McLarty, Ph.D.|(318)813-1446|jmclar@lsuhsc.edu|
22404548|NCT02133742|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22404549|NCT03479216|Derince Training and Research Hospital|Dr. Hande Aytuluk|00905336515650|handegrbz@gmail.com|
22404550|NCT02031432|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|Clinical-Trials@grunenthal.com|
22404551|NCT02148211|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22404552|NCT01425229|University of Heidelberg|Prof. Gerd Mikus|4962215639197|gerd.mikus@med.uni-heidelberg.de|
22390995|NCT00934700|Imperial College London|Research Integrity Officer|+44 020 7594 1872|jrco@imperial.ac.uk|
22390996|NCT01831726|Novartis Pharmaceuticals|Study Director|862-778-8300||
22390997|NCT03821064|Medical University of South Carolina|Evan Graboyes (PI)|843-792-0719|graboyes@musc.edu|
22390998|NCT01314014|James P. Wilmot Cancer Center, University of Rochester|Paul M. Barr, MD|585-273-3258|Paul_Barr@urmc.rochester.edu|
22390999|NCT00474383|Clinical Research, Janssen R&D, 10990 Wilshire Blvd, Suite 1200, Los Angeles, CA 90024.|Senior Director|310-943-8040||2917
22391000|NCT01482819|Johnson & Johnson Vision Care|Daria Wicks, Senior Clinical Research Manager|904-443-1391|RA-ClnclStds@its.jnj.com|
22391001|NCT02364609|UC Davis Comprehensive Cancer Center|Leslie Garcia, Data Research Supervisor|916-734-0156|lesgarcia@ucdavis.edu|
22391002|NCT02672514|Herzzentrum Coswig|Dr. Jessica Vogler|+491749740710|j_vo@web.de|
22391003|NCT00942188|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22391004|NCT01568021|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22391005|NCT04811339|University of Cincinnati|Dr. Bruce Yacyshyn|513-633-8715|yacyshbr@ucmail.uc.edu|
22391006|NCT00143598|Centre for Clinical Epidemiology, Jewish General Hospital|Dr. Susan R Kahn|514-340-8222|susan.kahn@mcgill.ca|7587
22391007|NCT04944784|Cytokinetics|Cytokinetics MD|6506242929|medicalaffairs@cytokinetics.com|
22391008|NCT03900715|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22391009|NCT04510948|Department of Medicine, Yale School of Medicine|Mary Tinetti, MD|203-688-5238|MARY.TINETTI@yale.edu|
22391010|NCT03752177|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22391011|NCT04367480|University of Rochester NCORP Research Base|Jennifer Gewandter, PhD|585-275-2141|Jennifer_Gewandter@urmc.rochester.edu|
22391012|NCT03382561|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22391013|NCT01131104|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22391014|NCT01076244|Center for Pain Relief|Timothy Deer|(304) 347-6144|Diana.tolentino@stfh.net|
22391015|NCT02370251|University of Oklahoma|Kimberly Ernst, MD|405-271-5215|kimberly-ernst@ouhsc.edu|42039
22391016|NCT04120376|Children's Hospital of Philadelphia|Dr. Cynthia Mollen|2153701217|mollenc@chop.edu|
22391017|NCT01165177|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22391018|NCT05499130|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
22391019|NCT03427060|Akari Therapeutics|Chief Scientific Officer|+44 208 004 0261|miles.nunn@akaritx.com|
22391020|NCT00781937|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22391021|NCT00013611|University of Minnesota|Gary Collins, M.S.|612-626-9006|gary-c@ccbr.umn.edu|
22391022|NCT01663506|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22391023|NCT00810342|University of Hawaii, School of Nursing|Cheryl Albright|8089569716|cherylal@hawaii.edu|
22391024|NCT02330562|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22391025|NCT00258362|Masonic Cancer Center, University of Minnesota|Melissa Geller, M.D.|612-626-3111|gelle005@umn.edu|
22391026|NCT01657799|AbbVie|Global Medical Services|800-633-9110||
22391027|NCT00675792|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22391028|NCT00541671|Christiana Care Health System|Deb Marco|302-733-4130|DMarco@christianacare.org|
22391029|NCT04599855|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22404553|NCT01617187|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22404554|NCT01265420|Indiana Hand to Shoulder Center|F. Thomas D. Kaplan|317-875-9105|tdk@hand.md|
22404555|NCT00538824|Weill Cornell Medical College|Jennifer Hess|6469629440|jmh2004@med.cornell.edu|
22404556|NCT03828149|Novus Therapeutics|Clinical Director|949-679-1110|study001@novustherapeutics.com|
22404557|NCT03337139|Drexel University|Dr. Meghan Butryn|215-553-7108|mlb34@drexel.edu|
22404558|NCT02664532|Tata Main Hospital|Dr.Deb Sanjay Nag|+91-7763807101|debsanjay@gmail.com|
22404559|NCT04430283|Faraday Pharmaceuticals, Inc.|Clinical Trial Manager|206-492-5310|info@faradaypharma.com|
22404560|NCT02554253|Mayo Clinic|Erica Wittwer|5072559814|wittwer.erica@mayo.edu|
22404561|NCT03558191|Jiangsu HengRui Pharmaceuticals Co., Ltd.|Project manager|0518-82342973|linan.wang@hengrui.com|
22404562|NCT03288493|Poseida Therapeutics|Rajesh Belani, MD, Vice President Clinical Development|858-779-3100|rbelani@poseida.com|
22404563|NCT02559206|Ironwood Pharmaceuticals, Inc.|Nick Omniewski, MPH|(617) 621-8454|nomniewski@ironwoodpharma.com|
22404564|NCT01561560|Alcon Research, Ltd.|Jami Kern, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
22404565|NCT03862131|Washington University School of Medicine|Dr. Joshua Mitchell|314-362-1291|jdmitchell@wustl.edu|
22404566|NCT02024204|NYU Langone|Joan Reibman, MD|212-263-6479|joan.reibman@nyumc.org|
22404567|NCT01871896|University of California San Francisco|Matthew Lin|415 353 2161|Matthew.Lin@ucsf.edu|
22404568|NCT02415439|ReveraGen BioPharma, Inc.|Eric P. Hoffman, PhD|301-962-1578|eric.hoffman@reveragen.com|
22431327|NCT01999530|Centre for Addiction and Mental Health|Bernard Le Foll|416-535-8501|bernard.lefoll@camh.ca|34772
22391030|NCT01624298|Johns Hopkins University|Stephanie Skavenski|+260966674841|sskavenski@yahoo.com|
22404569|NCT00597935|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
22404570|NCT01064076|Cameron Health, Inc. a subsidiary of Boston Scientific|Michael Husby, Clinical Studies Manager|312-402-1877|michael.husby@bsci.com|
22404571|NCT03127852|Centre for Global eHealth Innovation|Dr. Patrick Ware|1 (416) 340 4800|Patrick.Ware@uhn.ca|4765
22404572|NCT03382262|Flexion Therapeutics|Scott Kelley MD, Chief Medical Officer|781-305-7142|skelley@flexiontherapeutics.com|
22404573|NCT03518034|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22404574|NCT00126581|Dana-Farber Cancer Institute|Pasi Janne, MD, PhD||pjanne@partners.org|
22404575|NCT03728140|Reproductive medcine of Jinan central hospatil|Dr. bin wu|+86 053185695203|wb0538@163.com|
22404576|NCT00546429|DePuy Orthopaedics, Inc.|Sam Himden|574-372-7231|SHimden@its.jnj.com|
22404577|NCT03154307|Miami Neuroscience Institute|Clinical Research Administrator|17865961825|starlieb@baptisthealth.net|
22404578|NCT04547998|AVITA|SVP Global Clinical Research|1-833-462-8482|ekirshner@avitamedical.com|
22404579|NCT03554850|Stryker Neurovascular|Fei Qin|+8613524821775|fei.qin@stryker.com|
22404580|NCT02007252|Novartis Pharmaceuticals|Study Director|862-778-8300||
22404581|NCT03325556|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-|medicalinformation@acadia-pharm.com|2897
22404582|NCT01705587|University of Pittsburgh|Susan Greenspan, MD|412-692-2477|greenspn@pitt.edu|
22404583|NCT00762268|McLean Hospital|Beth Murphy MD|617-855-2297|BMurphy5@partners.org|
22404584|NCT04526067|University of Texas Health Science Center in San Antonio|Dawn Velligan, PhD|210-567-5508|velligand@uthscsa.edu|
22404585|NCT05034614|Mayo Clinic|Danielle J. O'Laughlin, P.A.-C., M.S.|507-284-5164|OLaughlin.Danielle@mayo.edu|
22404586|NCT01324128|Vifor Pharma|Medical Information|41 58 851 8222|medinfo@viforpharma.com|
22404587|NCT03892707|Woerwag Pharma LLC|Anna Shagako, Clinical Trials Manager/ Authorized Person of Pharmacovigilance|+7 (495) 382 85 56|anna.shagako@woerwagpharma.ru|
22404588|NCT03646760|Henry Ford Health|Steven Keteyian, PhD|313-972-1920|sketeyian1@hfhs.org|
22404589|NCT05224076|University of Kansas School of Nursing|Dr. Barbara Polivka|6142049915|bpolivka@kumc.edu|
22404590|NCT04263363|UCLA|Dr. Eilon Gabel, MD|310-267-8693|EGabel@mednet.ucla.edu|
22404591|NCT01807949|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22404592|NCT03819764|The Cleveland Clinic Foundation|Dr. Susan Linder, PT, DPT, PhD|216-445-9815|linders@ccf.org|
22431328|NCT03359161|St. Elizabeth's Medical Center|Dr. Lana Tsao|617-789-3036|lana.tsao@steward.org|
22391031|NCT01588366|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22391032|NCT04962698|Georgia Institute of Technology|Prof. Minoru Shinohara|404-894-1030|shinohara@gatech.edu|
22391033|NCT00853229|Cleveland Clinic|Lynn Borzi (Research Administrator)|216-445-3158|BORZIL@ccf.org|
22391034|NCT03634306|Mercy Hospital St. Louis|David Levine, MD|314-251-7650|David.Levine@Mercy.net|
22391035|NCT00585975|ISTA Pharmaceuticals, Inc.|Tim McNamara, PharmD|949-788-6000|tmcnamara@istavision.com|
22391036|NCT04915131|Bloom Technologies NV|Managing Director|+14156038067|julien@bloomlife.com|
22391037|NCT00364377|Mayo Clinic|Adrian Vella|507-284-3754|vella.adrian@mayo.edu|
22391038|NCT00336817|Upittsburgh|Dr. Roberto Lopez-Solis|412-647-5173|lopezrc@upmc.edu|
22391039|NCT03414047|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22391040|NCT04068051|Axsome Therapeutics, Inc.|Caroline Streicher, Vice President, Clinical Operations|212-332-5061|cstreicher@axsome.com|
22404593|NCT04325906|Rush University|Jie Li, PI|3125634643|jie_li@rush.edu|
22404594|NCT00881361|Mayo Clinic|Judy C. Boughey, MD|507-284-3629|boughey.judy@mayo.edu|
22404595|NCT02141217|GlaxoSmithKline|GSK Response Center|866-435-7343||
22404596|NCT03515213|University of California, Irvine|Leslie Thompson|9498243990|lmthomps@hs.uci.edu|
22404597|NCT01978600|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com|
22404598|NCT01628393|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22404599|NCT01226706|Gynecology, Regina Qu'Appelle Health Region|Dr. Corrine Jabs|(306) 586-3120|corrinejabs@hotmail.com|
22404600|NCT04015440|Walter Reed Army Institute of Research|Jeffrey M Osgood, Ph.D. Associate Director of Military Psychiatry Branch|301-319-7475|jeffrey.m.osgood.mil@mail.mil|
22404601|NCT04603391|University of Florida|John S. Markowitz, Pharm.D.|(352) 273-6262|jmarkowitz@cop.ufl.edu|
22404602|NCT01899677|Zeynep Kamil Maternity and Children's Education Training Hospital|Ozge Serce (Investigator, MD)|+905323270375|ozge_serce@hotmail.com|
22431329|NCT00183248|University of Miami|George W. Burke III, M.D.|(305) 355-5060|Gburke@med.miami.edu|
22416815|NCT01043926|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22416816|NCT01931527|Washington University School of Medicine|Elisa Fabbrini, MD, PhD|314-362-8156|efabbrini@dom.wustl.edu|
22416817|NCT02210052|Mayo Clinic|Dr. Tim J. Lamer, M.D.|507 778-8760|lamer.tim@mayo.edu|
22416818|NCT03903159|University of Minnesota|Amy Krentzman|612-625-2312|akrentzm@umn.edu|
22416819|NCT02732691|JenaValve Technologies Inc.|Vinny Podichetty, Vice President: Clinical & Med Affairs|949-767-2110|podichetty@jenavalve.com|1050
22416820|NCT03770078|Coloplast|Head of Medical Writing and Biostatistics|49113143|dkpen@coloplast.com|+45
22416821|NCT01382251|Department of Anesthesiology, The Ottawa Hospital|Dr. Gregory L Bryson|613.761.4169|glbryson@ottawahospital.on.ca|
22416822|NCT01117987|Novartis Pharmaceuticals|Study Director|862-778-8300|Trialandresults.registries@novartis.com|
22416823|NCT01246713|BIDMC|Michael Ganetsky, MD|6177542323|mganetsk@bidmc.harvard.edu|
22416824|NCT02568007|Medical College of Wisconsin|Praveen Goday|4142663690|pgoday@mcw.edu|
22416825|NCT00702208|CUNY School of Public Health, Hunter College|Heidi Jones|212-396-7750|hjon@hunter.cuny.edu|
22416826|NCT00562120|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22391041|NCT00736125|Duke University Medical Center|Dr. Terri Monk|919-286-6938|terri.monk@duke.edu|
22391042|NCT03124550|Brandeis University|Dr. Margie E. Lachman|7817363255|lachman@brandeis.edu|
22391043|NCT01129115|University of Kansas Medical Center|Dr. Jeffrey Burns|913-588-0555|kuamp@kumc.edu|
22391044|NCT04626271|Healthy.io|Dr. Danielle Jeddah (Director of Clinical Development) OR Jennifer Kachel Acobas (Director of RA)|0543111050, 0528345562|danielle.jeddah@healthy.io, jennifer.acobas@healthy.io|
22391045|NCT01747837|Icahn School of Medicine at Mount Sinai|Sam Commack|212-824-8931|sam.cammack@mountsinai.org|
22391046|NCT01121913|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
22391047|NCT00690378|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22391048|NCT00014222|Canadian Cancer Trials Group|Bingshu Chen|613-533-6000|bechen@ctg.queensu.ca|77703
22391049|NCT02019641|Clinical Center|Leighton Chan|+1 301 496 4733|chanle@mail.nih.gov|
22391050|NCT01246050|VA Medical Center Nashville|Henry Ooi|615-8736373|henry.ooi@va.gov|
22391051|NCT03990298|Hospital of the University of Pennsylvania, Dept of Otorhinolaryngology, Head & Neck Surgery|Erica Thaler, MD|215-662-4533|erica.thaler@pennmedicine.upenn.edu|
22404603|NCT02759861|University of Nebraska Medical Center|Mark Mailliard|402-559-8126|mark.mailliard@unmc.edu|
22404604|NCT02151682|Grünenthal GmbH|Clinical Trial Helpdesk|+49-(0)241-569|clinical-trials@grunenthal.com|3223
22404605|NCT02988219|Warsaw Medical University|Dr. Karolina Dobronska|48 22 502 17 21|karolinapladzyk@gmail.com|
22404606|NCT01306032|National Cancer Institute|Dr. Alice Chen|301-435-0517|chenali@mail.nih.gov|
22404607|NCT01213264|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22404608|NCT02186457|Indiana University School of Medicine|Dr. Michael House|3179440113|michouse@iupui.edu|
22404609|NCT01522443|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
22404610|NCT03260894|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
22404611|NCT01700985|Therapeutics Inc.|Clinical Research, Therapeutics Inc.|858-571-1800|clinicalresearch@therapeuticsinc.com|
22404612|NCT02677220|Cochlear|Director of Clinical Research|3032647180|loneill@cochlear.com|
22404613|NCT00067470|BioMarin Pharmaceutical Inc.|Medical Information Services|800-983-4587|medinfo@bmrn.com|
22416827|NCT02148445|Department of Preventive Medicine & Public Health|Edward F. Ellerbeck, MD, MPH, Chair|913-588-2829|eellerbe@kumc.edu|
22416828|NCT03450629|Sun Pharma Advanced Research Company Limited|Head, Clinical Developmnt|912266455645|clinical.trials@sparcmail.com|
22416829|NCT03366194|Esthetic Education LLC|Study Coordinator|(480) 656-2251|Support@skinstylus.com|
22416830|NCT02093923|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22416831|NCT03438006|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22416832|NCT00955721|University of Miami|Peter J. Hosein MD|3052433462|phosein@miami.edu|
22416833|NCT01631682|Massachusetts General Hospital|Scott P. Orr, Ph.D.|617-643-7269|scott_orr@hms.harvard.edu|
22416834|NCT03512002|Atrium Wake Forest Baptist Health School of Medicine|Charles Tegeler, MD|336-716-9447|BBRP@wakehealth.edu|
22416835|NCT04678817|University of Utah|Lori Gawron, MD|801-213-4989|lori.gawron@hsc.utah.edu|
22416836|NCT00380757|Ottawa Hospital Research Institute|Manya Charette|613-798-5555|mancharette@ohri.ca|17758
22416837|NCT01961687|Becton Dickinson|Dawn Heimer / Sr. Director Medical Affairs|401-479-1253|dawn.heimer@bd.com|
22416838|NCT04815850|University of Leicester|Dr Matthew Graham-Brown|01162588043|mgb23@le.ac.uk|
22416839|NCT01552369|University of Pittsburgh - Medicine - Infectious Diseases|Nina Singh, MD|412-360-1688|nis5@pitt.edu|
22416840|NCT03707041|Medicines for Malaria Venture|Andrew Slade|+41 22 555 0415|sladea@mmv.org|
22416841|NCT02999984|Orchard Therapeutics (Europe) Ltd|Orchard Medical Information|+44 (0) 203 808 8286|medinfo@orchard-tx.com|
22416842|NCT02631837|Imelda ziekenhuis Bonheiden|Dr Jan Baekelandt|+ 32 15 505208|jan.baekelandt@imelda.be|
22404614|NCT01148693|Tehran medical university of science|Dr. Rasoul sotoudehmanesh|(+98 21) 82414000|r.sotudemanesh@gmail.com|82415000
22404615|NCT03688685|Cadent Therapeutics (A Novartis Company)|Cadent Therapeutics (A Novartis Company)|1-888-669-6682|Novartis.email@novartis.com|
22404616|NCT01074658|Medronic Bakken Research Center|Hanne Gonnissen|+3143356|hanne.gonnissen@medtronic.com|6734
22404617|NCT00050622|Florida International University|William E. Pelham, Jr.|305-348-3002|wpelham@fiu.edu|
22404618|NCT01342952|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22404619|NCT00426556|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22404620|NCT02584868|Centre Hospitalier Universitaire Brugmann|Philippe Van der Linden, MD, PhD|+32 2 477 23 30|philippe.vanderlinden@chu-brugmann.be|
22404621|NCT02494440|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
22404622|NCT03970824|CELLTRION, Inc.|SungHyun Kim|+82 32 850 5778|SungHyun.Kim@celltrion.com|
22404623|NCT00416312|Johns Hopkins University, School of Medicine|George Sgouros, Ph.D.|410 614 0116|gsgouros@jhmi.edu|
22404624|NCT01200160|Abbott Laboratories de México|Carlos A Gonzalez MD, PhD|(5255) 5809-|carlos.gonzalez@abbott.com|7576
22404625|NCT02146248|OHSU|Jeffrey T. Jensen|503-629-4058|jensenje@ohsu.edu|
22404626|NCT00425100|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22404627|NCT03086317|Emory University|Dr. Wissam Jaber, Assistant Professor|4046861000|wissam.jaber@emory.edu|
22404628|NCT01969799|Cardeas Pharma|Bruce Montgomery, MD|2069713756|bruce.montgomery@cardeaspharma.com|
22404629|NCT00736580|West Virginia University|Michael Stitely, MD|304-293-1566|mstitely@hsc.wvu.edu|
22404630|NCT02227108|MedImmune LLC|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazenea.com|
22404631|NCT01714817|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22404632|NCT01374217|Carolinas HealthCare System|Nilanjan Ghosh, MD|9804422000||
22404633|NCT02555657|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22404634|NCT02372097|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22404635|NCT02608229|Washington University School of Medicine|Kian-Huat Lim, M.D., Ph.D.|314-362-6157|kian-huat.lim@wustl.edu|
22404636|NCT00904995|The University of Texas MD Anderson Cancer Center|Jorge Cortes, MD / Professor|713-745-5783|eharrison@mdanderson.org|
22404637|NCT00675558|Columbia University Medical Center|Paul D. Berk, MD|2120-305-4491|pb2158@columbia.edu|
22404638|NCT04152642|Procter & Gamble|Clinical Trial Manager|5136225362|combs.cs@pg.com|
22404639|NCT02443571|Blue Earth Diagnostics Ltd.|Chief Medical Officer|+44 (0) 1865 784 186|contact@blueearthdx.com|
22404640|NCT02790463|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Jeff Foster|205-996-6086|pjfoster@uabmc.edu|
22404641|NCT00798577|Alcon Labs|Alcon Clinical|1.888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22404642|NCT00800865|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22404643|NCT01738737|University of Sao Paulo|Sarah Rubia Ferreira de Meneses|+55(11)470898-71|sarah.meneses@usp.br|
22404644|NCT01770145|US WorldMeds|Regulatory Associate, Clinical Operations|5028158130|rgerlach@usworldmeds.com|
22404645|NCT01102140|University of Michigan|Dr. Jennifer Cowger|7345464911|jennifercowger@gmail.com|
22404646|NCT05406440|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22404647|NCT02979444|Northwestern University Feinberg School of Medicine|Darius Tandon, PhD|410-852-0399|dtandon@northwestern.edu|
22404648|NCT01412151|Massachusetts General Hospital|Steven M. Hersch, MD, PhD|617-726-1254|hersch@helix.mgh.harvard.edu|
22404649|NCT00713284|California Pacific Medical Center|Dr. V. Ram Peddi|415-600-1000|peddir@sutterhealth.org|
22404650|NCT00741104|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22404651|NCT03621189|Chang Gung Memorial Hospital|Dr. Hsing Chang Ni|886975365663|alanni0918@yahoo.com.tw|
22404652|NCT02150213|Novartis|Study Director|862-778-8300||
22404653|NCT04134728|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22404654|NCT01175590|Bausch & Lomb Inc.|Tuyen Ong, MD, MRCOphth|(973) 360-6389|tuyen.ong@bausch.com|
22404655|NCT01090102|University of California, San Francisco|Dr. Ma Somsouk|415-206-6480|somsoukma@medsfgh.ucsf.edu|
22404656|NCT00749268|Covidien|Jessica Carlson, Clinical Project Manager|(203) 821-4734|jessica.carlson@covidien.com|
22404657|NCT02062398|BlueWind Medical|Amit Korner, VP Clinical Research|+972.74.7218905|amit.korner@bluewindmedical.com|
22404658|NCT01527110|GlaxoSmithKline|GSK Response Center|866-435-7343||
22404659|NCT00367341|Emory University School of Medicine|Helen Mayberg, MD|404-727-6740|hmayber@emory.edu|
22404660|NCT01387074|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22404661|NCT00150345|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22404662|NCT01392742|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22431330|NCT03801525|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
22431331|NCT03309202|Pfizer,Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22431332|NCT04734210|Surface Ophthalmics, Inc.|VP, Clinical Operations|(925) 494-3660|cbaenziger@surfaceophthalmics.com|18
22404663|NCT01998958|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22404664|NCT02432703|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22404665|NCT02373163|PREVENCION|Josefina Medina-Lezama|+5154251269|jmedinal2911@gmail.com|
22404666|NCT02137837|SWOG Statistics and Data Management Center|Breast Committee Statistician|2066674623|dlew@fredhutch.org|
22404667|NCT01329341|James A Haley Veterans Hospital|Stephanie McGovern|813-558-3964|stephanie.mcgovern@va.gov|
22404668|NCT00448760|UM/Sylvester Comprehensive Cancer Center|Bach Ardalan MD, Professor|305-243-4909|bardalan@med.miami.edu|
22391052|NCT03269695|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22404669|NCT00561340|University of Nebraska Medical Center|Christopher Kratochvil|402-552-6005|ckratoch@unmc.edu|
22404670|NCT01789346|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
22404671|NCT00618995|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22404672|NCT02375984|Saint John's Cancer Institute (formerly John Wayne Cancer Institute)|Lisa van Kreuningen|3105827053|lisa.vankreuningen@providence.org|
22404673|NCT00290589|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|(718)920-6266|befriedm@montefiore.org|
22416843|NCT00784524|Masonic Cancer Center, University of Minnesota|Dr. Douglas Yee|612-626-8487|yeexx006@umn.edu|
22416844|NCT00754013|Eisai inc.|Eisai Medical Services|1-888-422-4743||
22416845|NCT02310789|Stanford University|Jeff Wine, PhD|650-725-2462|wine@stanford.edu|
22416846|NCT02277704|Tonix Pharmaceuticals|Gregory M. Sullivan, Chief Medical Officer|862-904-0355|greg.sullivan@tonixpharma.com|
22416847|NCT01197417|Medical College of Wisconsin|David Brousseau MD, MS|414-266-2625|dbrousse@mcw.edu|
22416848|NCT01252719|Melinta Therapeutics, LLC|Medical Information|1-844-633-6568|medinfo@melinta.com|
22416849|NCT01202071|Eisai Co., Ltd.|Masaharu Yokoyama, Director|+81-3-3817-3908|m-yokoyama@hhc.eisai.co.jp|
22416850|NCT02813421|Children's Hospital Los Angeles|Dr. Jessica Ferris|323-361-4606|jeferris@chla.usc.edu|
22416851|NCT02914236|Aerin Medical, Inc.|Scott Wolf, M.D., Chief Medical Officer|650-597-0111|swolf@aerinmedical.com|
22416852|NCT00441350|Menarini Group|Angela Capriati, MD PhD - Global Director Clinical Sciences|+39 055 5680|acapriati@menarini-ricerche.it|9990
22416853|NCT01221090|Scott & White Hospital|Dr. Samuel N. Forjuoh|(254) 771-7695|SFORJUOH@sw.org|
22416854|NCT03438539|University of Kentucky|Craig Rush, Ph.D.|859-257-5388|crush2@uky.edu|
22416855|NCT03050697|Alcon Research, LLC|Sr. Clinical Trial Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22416856|NCT00440466|J&J PRD|Peter Bowers|908-927-2116||
22416857|NCT00423683|North Shore LIJ Health System|Valerie Blake|516-562-0100|vblake@nshs.edu|
22416858|NCT03614494|The University of Hong Kong|Dr Raymond Li|+852 22554517|raymondli@hku.hk|
22416859|NCT02997657|Brown University School of Public Health|Christopher Kahler|401 863-6651|christopher_kahler@brown.edu|
22416860|NCT00655850|University of Alabama at Birmingham|Francisco Robert, MD|205-934-5077|pacorobertuab@cs.com|
22416861|NCT01223235|Memorial Sloan Kettering Cancer Center|Dr. Paul Sabbatini, MD|212-639-4016|sabbatip@mskcc.org|
22416862|NCT00811434|Riley Hospital|Girish Subbarao|317-944-3774|gsrao@iupui.edu|
22416863|NCT01715896|MedImmune, LLC|Marius Albulescu, Associate Medical Director|301-398-0000|albulescum@medimmune.com|
22416864|NCT03756883|Teva Pharmaceuticals, USA|Director, PD/CE Studies|1-888-483-8279|usmedinfo@tevapharm.com|
22416865|NCT00685802|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22416866|NCT03336242|Radius Pharmaceuticals, Inc.|Tarek El Akkad, Head of Clinical Development|6175514000|telakkad@radiuspharm.com|
22416867|NCT03005067|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22416868|NCT03233958|University of Toronto|Barna Konkoly-Thege|+1 (705) 549 3181|konkoly.thege.barna@gmail.com|2614
22416869|NCT02593396|UNIVERSITY MALAYA|Dr. Anne Yee|+60379492068|annyee17@um.edu.my|
22416870|NCT03093272|Dana-Farber Cancer Institute|Lauren Harshman, MD|617-632-2429|laurenc_harshman@dfci.harvard.edu|
22416871|NCT00103038|Oregon Health and Science University|Gerda Teglassy, MD|5034945626|tothg@ohsu.edu|
22416872|NCT00845975|McDonald hearing Aid Centers|Louis A Looper, MA, CCC-A|916-218-4100|llooper@hearingmed.com|
22416873|NCT05445843|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
22416874|NCT03453840|University of California San Francisco|Liusheng Huang (Co-Investigator and Drug Research Unit Co-Director)|415-502-2594|liusheng.huang@ucsf.edu|
22416875|NCT05307679|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22416876|NCT03581214|Washington University in St Louis|Nandini Raghuraman|3144548181|nraghuraman@wustl.edu|
22416877|NCT01740791|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22416878|NCT02674386|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22391053|NCT01017263|Duke UMC|Scott Kollins, PhD|9196810014|scott.kollins@dm.duke.edu|
22391054|NCT05043883|CathVision|Mads Matthiesen|+4531470730|mem@cathvision.com|
22391055|NCT03849768|Jiangsu Hansoh Pharmaceutical Group Co., Ltd.|Alison Li|86-21-51211850|Alison.li@hspharm.com|
22391056|NCT02447718|IWK Health Centre|Dr. Karina Top|902-470-6343|karina.top@dal.ca|
22391057|NCT00239681|AstraZeneca|Torbjorn Lundstrom||ClinicalTrialTransparency@astrazeneca.com|
22391058|NCT02420041|Naval Medical Center San Diego|LCDR Ian M Fowler, MD|619-532-8954|ian.m.fowler.mil@mail.mil|
22391059|NCT03599622|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22391060|NCT01818427|University of Pittsburgh|Dr. Jason Sperry|412 6922850|sperryjl@upmc.edu|
22391061|NCT00905359|Medtronic Spinal and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
22391062|NCT00468130|Rutgers University|Sherie Novotny, MD|7322354119|novotnsl@ubhc.rutgers.edu|
22416879|NCT02462486|Allergan, Inc|Clinical Trials Registry Team|1-800-347-4500|IR-CTRegistration@allergan.com|
22416880|NCT02039063|EA Pharma Co., Ltd|Corporate Communication Dept.|+81-(0)3-6280-9600|contact_ea@eapharma.co.jp|
22391063|NCT02485899|BioMarin Pharmaceutical, Inc.|Trial Specialist|1-800-983-4587|medinfo@bmrn.com|
22391064|NCT03713320|Viridian Therapeutics (formerly miRagen Therapeutics)|Regulatory Affairs|720-722-5917|clinicaltrials@viridiantherapeutics.com|
22391065|NCT02725528|McMaster University|Dr. Achilles Thoma|905-523-0019|athoma@mcmaster.ca|
22391066|NCT02706847|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22404674|NCT00973622|University of Arkansas for Medical Sciences|Christine Sheffer, PhD|212 650 6860|csheffer@med.cuny.edu|
22404675|NCT00555568|CHOIR (Center for Healthcare Organization & Implementation Research|Susan V. Eisen|781-687-2858|susan.eisen@va.gov|
22404676|NCT06000501|NYU Langone Health|Lenard Adler, MD|212-263-3580|Lenard.Adler@nyulangone.org|
22404677|NCT06444165|Eli Lilly and Company|Chief Medical Officer|08004595979|ClinicalTrials.gov@lilly.com|
22404678|NCT03814005|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22404679|NCT00965146|Stryker Orthopaedics®|Director of Clinical Research|201-831-5401|ellen.axelson@stryker.com|
22404680|NCT05067452|University of California San Francisco|Dr. Kartika Palar|415-502-8492|kartika.palar@ucsf.edu|
22404681|NCT01135017|Sanofi|Trial Transparency Team||Contact_US@sanofi.com|
22404682|NCT00432562|Adventrx Pharmaceuticals|Chief Executive Officer|858-768-6325|culley@adventrx.com|
22404683|NCT00739960|UIC|Nadera J Sweiss, MD|312-996-5723|nsweiss@uic.edu|
22404684|NCT00763243|Indiana University School of Medicine|William Kronenberger, Ph.D.|317-944-8162|wkronenb@iupui.edu|
22404685|NCT04569799|Penn State Health College of Medicine|Kathryn McGillen, M.D.|717-531-0003|kmcgillen@pennstatehealth.psu.edu|
22416881|NCT02740179|Massachusetts General Hospital|Dr. Steven K. Grinspoon|617-724-9109|sgrinspoon@mgh.harvard.edu|
22416882|NCT01192399|Alexion Pharmaceuticals, Inc|Alexion Pharmaceuticals, Inc||clinicaltrials@alexion.com|
22391067|NCT01174264|University of Chicago|Theodore Karrison|773-702-9326|tkarrison@health.bsd.uchicago.edu|
22391068|NCT03432390|Anesthesiology Unit, Teaching Hospital of the Federal University of Pernambuco, Recife, Pernambuco, Brazil|Dr. Jayme Marques dos Santos Neto|5581996212977|jaymemed@yahoo.com.br|
22391069|NCT05702541|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22391070|NCT01774305|Yonsei Univ. Health System, Gangnam Severance Hospital|Dr. Jeongsoo Lee|+82-2-2019-6092|ration99@yuhs.ac|
22391071|NCT03850275|Clarkson University|Ali Boolani|3152681663|aboolani@clarkson.edu|
22391072|NCT03772613|Mayo Clinic|Dr. Shahyar M. Gharacholou|904-956-8400|Gharacholou.Shahyar@mayo.edu|
22391073|NCT03536702|MS Hershey Medical Center|Monika Joshi, MD, MRCP|717-531-8678|muj14@psu.edu|
22391074|NCT01185171|University of Chicago Medicine and Biological Sciences|Dr Everett Vokes, MD|855-702-8222|evokes@medicine.bsd.uchicago.edu|
22391075|NCT03559829|Associate Professor of Neurology and Neurological Sciences|Maarten G. Lansberg, MD PhD|(650) 723-4448|lansberg@stanford.edu|
22391076|NCT01482429|Federal University of Uberlândia|Liliane Barbosa da Silva Passos|553432182150|lilibsp@yahoo.com.br|
22391077|NCT03506347|Mayo Clinic|Dr. Mark Spangehl|480-342-2948|Spangehl.Mark@mayo.edu|
22391078|NCT05275023|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22391079|NCT01437488|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Jean Hoffman-Censits|215 955-8874|jean.hoffman-censits@jefferson.edu|
22391080|NCT03110692|Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh S. Patel|215-898-3367|mpatel@pennmedicine.upenn.edu|
22391081|NCT01502371|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22391082|NCT03325608|NYU Langone Health|Joshua Chodosh, MD, MSHS, FACP|212-263-6768|Joshua.Chodosh@nyumc.org|
22391083|NCT00420147|University of Delaware|Todd Royer|302-831-4351|royer@udel.edu|
22391084|NCT01177956|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22391085|NCT01639742|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22391086|NCT01986114|Sumitomo Dainippon Pharmaceutical|Clinical Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
22391087|NCT04411186|Medical University of South Carolina|Dr. David Gutman, M.D., MBA, Associate Professor of Anesthesiology|843-792-5454|gutman@musc.edu|
22391088|NCT02172911|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
22391089|NCT01589926|Children's Hospital at Montefiore|Kerry Morrone, MD, Asst Prof of Pediatrics|718-741-2342|kmorrone@montefiore.org|
22391090|NCT00575042|University of Miami|Dr. Cynthia Levy|305-243-2330|clevy@med.miami.edu|
22391091|NCT00566813|University of Illinois at Chicago|Jose Oberholzer, MD|312-996-6771|jober@uic.edu|
22391092|NCT04795336|NYU Langone Health|Joshua C Rozell, MD|212-598-6000|Joshua.rozell@nyulangone.org|
22391093|NCT01266018|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22391094|NCT03167151|Oxford University Hospitals NHS Foundation Trust|Dr Andrew S Protheroe|01865 253275|andrew.protheroe@oncology.ox.ac.uk|
22391095|NCT01458522|Duke University|Aatif M. Husain, M.D.|919-668-8700|aatif.husain@duke.edu|
22391096|NCT00516139|GlaxoSmithKline|GSK Response Center|866-435-7343||
22391097|NCT00589303|Mayo Clinic|Dr. Win K. Shen|480-342-0348|wshen@mayo.edu|
22391098|NCT00730015|Ironwood Pharmaceuticals|Doug Levine, MD|617.374.3906|dlevine@ironwoodpharma.com|
22391099|NCT02122172|University of Chicago|Dr. Peter O'Donnell|(773) 702-7564|podonnel@bsd.uchicago.edu|
22391100|NCT03062449|Dartmouth Health|Aleksandra C. Stark|(603) 650-5104|Aleksandra.C.Stark@hitchcock.org|
22391101|NCT03765398|University of Illinois at Chicago|Tanvi Bhatt|3123554443|tbhatt6@uic.edu|
22391102|NCT02053610|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22391103|NCT00543062|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
22391104|NCT02431052|Eli Lilly and Company.|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22404686|NCT01192204|The Ohio State University|Susan R, Mallery DDS, PhD|614 292-5892|mallery.1@osu.edu|
22391105|NCT00328562|Thomas Jefferson University|Maria Werner-Wasik, MD|215-955-6702|Maria.Werner-Wasik@jeffersonhospital.org|
22404687|NCT00979017|Duke University Medical Center, The Preston Robert Tisch Brain Tumor Center|Katherine B. Peters, MD, PhD|(919) 684-6173|katherine.peters@duke.edu|
22404688|NCT03699631|Froedtert and the Medical College of Wisconsin|William Drobyski, MD|414-805-6700|wdrobyski@mcw.edu|
22404689|NCT02219087|OhioHealth|Sara Jordan Clinical Pharmacist for Surgery Services|614-461-8174|sara.jordan@ohiohealth.com|
22404690|NCT05127421|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22404691|NCT00618449|University of California, San Francisco|Julius Schachter, PhD / Emeritus Professor of Laboratory Medicine|+1 (415) 824-5115|Julius.Schachter@ucsf.edu|
22404692|NCT00964158|GlaxoSmithKline|GSK Response Center|866-435-7343||
22404693|NCT02407041|Galectin Therapeutics|Vice President of Regulatory Affairs|678-620-3186|horton@galectintherapeutics.com|
22404694|NCT03418051|University of North Carolina at Chapel Hill|Erik Wikstrom|9199622260|wikstrom@unc.edu|
22404695|NCT03695393|Boston Medical Center and BU School of Medicine|Karsten Lunze, MD|617-638-6933|lunze@bu.edu|
22404696|NCT04585451|PainQx|VP R&D|6179817753|bd@painqx.com|
22404697|NCT03700970|Vanderbilt university medical center|Dr. Galen Perdikis|+1 (615) 936-0198|galen.perdikis@vumc.org|
22404698|NCT01578785|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22404699|NCT00966693|UT MD Anderson Cancer Center|Weber,Donna M.,M.D. / Lymphoma/Myeloma|713-792-2860|dmweber@mdanderson.org|
22404700|NCT02581982|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-713-5440|mgoodman@wakehealth.edu|
22404701|NCT00405821|NIAID|Steven Reynolds|256-772-220-087|sjreynolds@niaid.nih.gov|
22404702|NCT01769469|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
22404703|NCT01476748|BWH|Dr. JI Einarsson|617-525-8582|jeinarsson@partners.org|
22404704|NCT02750267|Center for Diabetes Technology|Dr. Daniel R. Chernavvsky|4342431395|drc2v@virginia.edu|
22404705|NCT02714504|Univ Fed Rio de Janeiro|Dr Marcio Nucci|552139382463|mnucci@hucff.ufrj.br|
22404706|NCT02392494|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22404707|NCT02713789|Urovant Sciences GmbH|JP Nicandro, PharmD|833-219-5557|clinicaltrials@urovant.com|
22404708|NCT01664858|University of Leeds|Professor John P Greenwood|+44 (0)113 3925481|j.greenwood@leeds.ac.uk|
22404709|NCT01011218|Stanford University Medical Center|Oxana RG Palesh, MD, PhD; Assistant Professor of Psychiatry and Behavioral Sciences|650-725-7011|oxana.palesh@stanford.edu|
22404710|NCT00888615|NRG Oncology|Christopher Purdy on behalf of James Kauderer|(716)845-1300|purdyc@nrgoncology.org|2296
22404711|NCT00141037|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22404712|NCT00861380|GlaxoSmithKline|GSK Response Center|866-435-7343||
22404713|NCT04186663|University of California San Francisco|Dr. Hellene Ellenikiotis|408-313-0166|hellene.ellenikiotis@ucsf.edu|
22404714|NCT01375647|University of Vermont|Dorothy M Dickson, MSc|802 656 9296|dorothy.dickson@med.uvm.edu|
22404715|NCT02354092|Oregon Health & Science University|Ob/Gyn Regulatory Specialist, Women's Health Research Unit|503-494-3666|whru@ohsu.edu|
22404716|NCT03788967|Senior Vice President Clinical Development|Angela Talley|857-242-1575|atalley@sperotherapeutics.com|
22404717|NCT01824693|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22404718|NCT03488238|Masimo Corporation|Cristina Johnson|949-297-7000|clincalresearchdept@masimo.com|
22404719|NCT05711862|The University of Texas Health Science Center at Houston|Heather Webber, PhD|713-486-2723|Heather.E.Webber@uth.tmc.edu|
22404720|NCT01316939|GlaxoSmithKline|GSK Response Center|866-435-7343||
22404721|NCT01432457|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22404722|NCT02715804|Halozyme Therapeutics|VP, Medical, Regulatory and Drug Safety|858-794-8889|medinfo@halozyme.com|
22404723|NCT01089751|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22404724|NCT03300258|University of Wisconsin, Madison|Peter Adamczyk|(608) 263-3231|peter.adamczyk@wisc.edu|
22404725|NCT00801892|University of Pittsburgh|E. Chasens, PhD|412-624-9380|chasense@pitt.edu|
22404726|NCT00905268|The National Hospital, University College London|Prof. Nicholas William Wood|020 7837 3611|n.wood@ucl.ac.uk|
22404727|NCT01281189|Knopp Biosciences|Head of Regulatory|4124881776|greg@knoppbio.com|
22404728|NCT00662389|Apsara Medical Corporation|Eve Conner, Ph.D. Consultant|510 566-2495|eaconner@sbcglobal.net|
22404729|NCT02966353|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22404730|NCT03351478|Lexicon Pharmaceuticals, Inc|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
22404731|NCT01618422|Chinese University of Hong Kong|Prof David SC Hui|2632 3134|dschui@cuhk.edu.hk|
22416883|NCT00789113|University of Minnesota College of Pharmacy|Dr. Rory P. Remmel|6126240472|remme001@umn.edu|
22416884|NCT03060759|Massachusetts General Hospital|Farrah J. Mateen, MD, PhD, Associate Professor of Neurology|617-724-8653|fmateen@mgh.harvard.edu|
22416885|NCT00384176|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22416886|NCT01425528|University of utah|Kathryn Swoboda MD|801-585-9717|Swoboda@genetics.utah.edu|
22416887|NCT02697773|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22416888|NCT00613834|The Ohio State University|Dr. Michelle Isley|614-293-4203|Michelle.Isley@osumc.edu|
22416889|NCT00842530|Sanofi Pasteur|Medical Director||Contact-US@sanofi.com|
22404732|NCT03911869|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22404733|NCT00527072|Janssen Biotech, Inc.|Sr. Director, Clinical Research - Medical Affairs|215-325-5711||
22404734|NCT02657434|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22404735|NCT00608881|Massachusetts General Hospital|Dr. Merit Cudkowicz|617-726-0813|mcudkowicz@partners.org|
22404736|NCT01619488|Nemours Childrens Health Delaware|Kirk W Reichard, MD, MBA, Surgical Director|302-651-5999|kreichar@nemours.org|
22404737|NCT00510484|Solvay Pharmaceuticals|Sven Voet - Global Communication|+32 (0)2 509 69 77|sven.voet@solvay.com|
22404738|NCT01590212|University of Glasgow|Prof. Phil Wilson|+44 (0)1463 255892|p.wilson@abdn.ac.uk|
22404739|NCT02533401|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22404740|NCT02451488|Mayo Clinic|Dr. James Jakub|507-284-3629|Jakub.James@mayo.edu|
22404741|NCT01106391|Cordis Corp.|Brandy Maschhaupt, Clinical Project Manager|847-887-5744|brandy.maschhaupt@cardinalhealth.com|
22404742|NCT01858597|The first Affiliated Hospital of Sun-Yat Sen University|Director of Clinical Trials|86-020-28823388|zsyyyb@mail.sysu.edu.cn|
22404743|NCT04897594|Terns, Inc.|Study Director|+1 650-525-5535|clinicaltrials@ternspharma.com|101
22404744|NCT02698566|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22404745|NCT02147691|DermResearch, PLLC|Leon H. Kircik, M.D.|502-451-9000|wedoderm@yahoo.com|
22404746|NCT04866823|Wake Forest School of Medicine|Morgana Mongraw-Chaffin|13367133108|mmongraw@wakehealth.edu|
22404747|NCT01181141|Daiichi Sankyo.,LTD|Kenichi Sakakura, Manager|81-90-1885-0271|sakakura.kenichi.ef@daiichisankyo.co.jp|
22404748|NCT00118911|Massachusetts General Hospital|Susan Sprich, Ph.D.|617-726-5991|ssprich@partners.org|
22416890|NCT02939950|Bausch Health Americas, Inc.|Director of Clinical Operations|(585) 338-5306|Daniel.Donatello@bausch.com|
22416891|NCT02243293|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22416892|NCT02244424|Michigan State University, College of Nursing|Dr. Mildred A. Horodynski|(517) 355-6744|millie@msu.edu; silkk@msu.edu|
22416893|NCT02377063|UCLA Center for Human Nutrition|Zhaoping Li, MD, PhD - Principal Investigator|310-206-1987|zli@mednet.ucla.edu|
22416894|NCT01524913|Emory University|Gary Bouloux, MD, DDS|404-778-4500|gfboulo@emory.edu|
22416895|NCT02723773|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22416896|NCT05168774|Children's Hospital of Philadelphia|Dr. David Lynch|215-590-2242|lynch@chop.edu|
22391106|NCT04014790|REGiMMUNE|Chief Executive Officer|+81-80-7022-7536|kenzo@regimmune.com|
22391107|NCT03546816|Menlo Therapeutics Inc.|Iain Stuart, PhD|1- 800-775-7936|Iain.Stuart@foamix.com|
22391108|NCT01161446|University of Washington|Dr. David Katz|206-744-5877|dkatz7@u.washington.edu|
22404749|NCT05014542|Family Medicine Practice Svijetlana Perculija Durdevic, MD, Ninska 10, Sesvete|Svijetlana Perculija Durdevic, MD, family medicine specialist, acupuncturist|00385913302507|svijetlana.perculija.durdevic@outlook.com|
22404750|NCT03496662|Washington University School of Medicine|Kian-Huat Lim, M.D., Ph.D.|314-362-6157|kian-huat.lim@wustl.edu|
22404751|NCT01467661|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22404752|NCT01707368|LEO Pharma GmbH|Tobias Anger, Medical Advisor|+49 610 220 1258|TANDE@leo-pharma.com|
22404753|NCT00691093|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22404754|NCT03123055|Rainier Therapeutics|Chief Medical Officer|510-878-2486|Sabella@RainierRx.com|
22404755|NCT03395223|Provepharm SAS|Emilie HUYGHUES|+33 6 20 58 28 27|emilie.huyghues@provepharm.com|
22404756|NCT00810810|Bloodworks Northwest (formerly Puget Sound Blood Center)|Karen Nelson, PhD., Vice President Laboratories|206-689-6549|knelson@bloodworksnw.org|
22404757|NCT01896856|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Nilofer Azad|410-614-9169|nazad2@jhmi.edu|
22404758|NCT01156532|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22404759|NCT04446299|Braintree Laboratories, Inc.|Head of R&D, GI|7819646710|studydirector@sebelapharma.com|
22416897|NCT05368012|Hospital for Special Surgery|MIDCAB (Mid-Calf Block) for foot surgery: A pilot study|646-797-8948|popovicm@hss.edu|
22416898|NCT02124902|Washington University School of Medicine|Foluso Ademuyiwa, M.D., MPH|314-362-7201|bisiademuyiwa@wustl.edu|
22416899|NCT01314118|Janssen Services, LLC|Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22416900|NCT01794572|Institut de Cancérologie de l'Ouest|Pr Stéphane SUPIOT|(+33) 2406799 00|stephane.supiot@ico.unicancer.fr|
22416901|NCT02658487|Vanderbilt University Medical Center|Stephen Strickland, MD|(615) 936-8422|stephen.strickland@vumc.org|
22416902|NCT01467479|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22416903|NCT03815240|Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergology Charité - Universitätsmedizin Berlin|Dr. Jan Kottner|+49 30 450 518218|jan.kottner@charite.de|
22416904|NCT02284347|Medtronic Xomed|Director of Clinical Trials|904-296-9600|dl.nuventstudy@medtronic.com|
22404760|NCT02563925|Memorial Sloan Kettering Cancer Center|Dr. Shanu Modi, MD|646-888-5243|modis@MSKCC.ORG|
22404761|NCT03819478|Wake Forest University Health Sciences|Ashley Weaver, PhD|336-716-0944|asweaver@wakehealth.edu|
22416905|NCT01730040|Regeneron Pharmaceuticals, Inc|Clinical Trial Management||clinicaltrials@regeneron.com|
22416906|NCT03185182|Lund University|Professor Håkan Axelson|+46 046 2226434|hakan.axelson@med.lu.se|
22416907|NCT03407612|Jameson Crane Sports Medicine Institute|Maria Munsch|614-293-3600|maria.munsch@osumc.edu|
22416908|NCT00544817|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
22416909|NCT01885182|Mundipharma (China) Pharmaceutical Co. LTD|Clinical study manager|0086-10-65636800|Wei.Zhu@mundipharma.com.cn|6900
22416910|NCT00682617|Oregon Health & Science University|Dr. Nels Carlson|(503) 494-6420|carlsonn@ohsu.edu|
22416911|NCT00380692|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22416912|NCT03341546|NHS Tayside|Mark Worrall|01382632177|markworrall@nhs.net|
22416913|NCT00708708|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22416914|NCT04213209|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22416915|NCT02065713|Instituto Medicina Molecular|Elsa Vieira-Sousa|00351 217999544|elsa-sousa@hotmail.com|47221
22416916|NCT00140413|Children's Hospital Los Angeles|Dr. Mark Borchert|323-361-6219|mborchert@chla.usc.edu|
22416917|NCT02459665|University of Liverpool|Prof. Janneke van de Wijgert, Chief Investigator|+447557195108|j.vandewijgert@liverpool.ac.uk|
22416918|NCT02062801|Sharp HealthCare|Dr. David R. Gambling|858-395-5668|david.gambling@sharp.com|
22416919|NCT02560779|TRACON Pharmaceuticals Inc.|Charles Theuer|(858) 550-0780|ctheuer@traconpharma.com|
22416920|NCT00296491|GlaxoSmithKline|GSK Response Center|866-435-7343||
22416921|NCT03347838|Rocky Mountain Regional VA Medical Center / University of Colorado School of Medicine|Robert Keith, MD|720-857-5120|robert.keith@cuanschutz.edu|
22416922|NCT02136238|University of South Florida|Jason Highsmith|813-974-3806|mhighsmi@health.usf.edu|
22416923|NCT01929395|Dartmouth Hitchcock Medical Center|Dr Richard J. Barth Jr.|(603) 650-9479|Richard.J.Barth.Jr@hitchcock.org|
22416924|NCT01980342|Johns Hopkins University School of Medicine|Jenny Robinson, MD MP FACOG|4105500337|mailto:jrobin87@jhmi.edu|
22416925|NCT03604341|Oregon Health & Science University|OB/Gyn Regulatory Specialist|503-494-3666|whru@ohsu.edu|
22416926|NCT00355472|Kyowa Hakko Kirin|Project Management Department, Development Division||clinical.info@kyowa-kirin.co.jp|
22416927|NCT01265667|Can-Fite BioPharma Ltd|Zivit Harpaz|972-3-9241114|zivit@canfite.co.il|
22416928|NCT00277524|Medtronic Cardiac Rhythm Disease Management|Melinda Hoey, Clinical Research Specialist|763-526-2831|Melinda.hoey@medtronic.com|
22416929|NCT04706507|Fred Hutch Cancer Center|Dr. Michael J. Boeckh|2066676706|mboeckh@fredhutch.org|
22416930|NCT04625673|University of Pennsylvania|Regulatory Lead|215.573.7101|psom-ind-ide@pobox.upenn.edu|
22416931|NCT02310763|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22416932|NCT01118845|Symbio Pharmaceuticals|Toshihiko Nagase|81-3-5472-1127|tnagase.331@symbiopharma.com|
22416933|NCT01731886|Columbia University|Suzanne Lentzsch, MD, PhD, Professor of Medicine|646-317-4840|sl3440@cumc.columbia.edu|
22416934|NCT02280187|Medtronic Spinal and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
22416935|NCT00939627|Vanderbilt Ingram Cancer Center|Jill Gilbert, M.D.|615-343-4677|jill.gilbert@vanderbilt.edu|
22416936|NCT03396874|University of Michigan|Morand Piert|734-936-5385|mpiert@med.umich.edu|
22416937|NCT03417830|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22416938|NCT02563769|Temple University Episcopal Hospital|Yaminah Carter Research Coordinator|2678097602|yaminah.carter@tuhs.temple.edu|
22416939|NCT04072315|Pliant Therapeutics, Inc.|Éric Lefebvre, M.D., Chief Medical Officer|1-650-481-6779|ELefebvre@pliantrx.com|
22416940|NCT02598895|University of Washington/Fred Hutchinson Cancer Center|Dr. Heather Cheng|206-606-7416|hhcheng@uw.edu|
22416941|NCT01411488|Cleveland Clinic|Nancy Albert|216-444-7028|albertn@ccf.org|
22416942|NCT00303667|Masonic Cancer Center|Sarah Cooley, M.D.|612-626-4024|cool0023@umn.edu|
22416943|NCT01523587|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22416944|NCT00724373|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22416945|NCT00161382|The University of Texas Health Science Center at Houston (UTHealth) School of Public Health|Dr. Susan R. Tortolero|713-500-9634|Susan.Tortolero@uth.tmc.edu|
22416946|NCT02083926|Yale University|Dr. Michael H. Bloch|2037374539|michael.bloch@yale.edu|
22416947|NCT02919813|Oregon Health & Science University|OB/Gyn Regulatory Specialist|503-494-3666|whru@ohsu.edu|
22416948|NCT03465436|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22416949|NCT04117945|Mayo Clinic|Daniel H. Ahn, D.O.|(480) 342-4800|Ahn.Daniel@mayo.edu|
22416950|NCT01769274|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22416951|NCT00402025|Amgen, Inc.|Study Director|866-572-6436||
22416952|NCT02767934|University of Washington|Dr. Ryan Cassaday|206-606-1202|cassaday@seattlecca.org|
22416953|NCT02409329|Vanderbilt University Medical Center|Lindsay S. Mayberry, PhD, MS|615-875-5821|lindsay.mayberry@vumc.org|
22416954|NCT03391115|University of Colorado, College of Nursing|Heather Coats, PhD, APRN-BC, PI|303-724-3740|heather.coats@cuanschutz.edu|
22416955|NCT04290494|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22416956|NCT02369354|Duke University School of Medicine|Dr. L. Ebony Boulware|919-613-2099|ebony.boulware@duke.edu|
22416957|NCT03200535|Kaiser Permanente Colorado|Dr. Emily Schroeder|303-636-2478|emily.b.schroeder@kp.org|
22416958|NCT03291041|Vanda Pharmaceuticals|Vanda Pharmaceuticals|2027343400|clinicaltrials@vandapharma.com|
22416959|NCT01447225|Merrimack Pharmaceuticals, Inc.|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
22416960|NCT01451996|University of Chicago|Anup Malani, J.D., Ph.D|773-702-9602|amalani@uchicago.edu|
22416961|NCT04184999|SR Cornea Consultants|Dr. Sanjay Rao|8476685498|sanjaynraomd@gmail.com|
22416962|NCT01172821|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22416963|NCT02756637|Abramson Cancer Center of the University of Pennsylvania|John Christodouleus|215-662-2428|John.Christodouleas@uphs.upenn.edu|
22416964|NCT02985879|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22416965|NCT03940703|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22416966|NCT04079712|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
22416967|NCT01475253|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22416968|NCT06141824|Pfizer|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22416969|NCT03660241|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22416970|NCT02676284|Zambon S.A.U.|Antonio Esteras, MD|+34 93 544 64 00|antonio.esteras@zambongroup.com|
22416971|NCT00735917|University of Colorado Cancer Center|Wells A. Messersmith, M.D.||wells.messersmith@ucdenver.edu|
22416972|NCT03919448|Laboratorios Richmond|Regulatory Affairs Department|(+54 11) 5555 - 1600|info@richmondlab.com|
22416973|NCT04507126|MGH|Research Operations Director|617-724-1992|jgerber2@mgh.harvard.edu|
22416974|NCT01440010|Medical Faculty Mannheim, Heidelberg University|PD Dr. med. Elena Sperk|+496213838624|elena.sperk@medma.uni-heidelberg.de|
22416975|NCT02473783|Tri-Service General Hospital, National Defense Medical center|Dr. Chin-bin Yeh|886-2-87923311|chinbinyeh@gmail.com|17387
22416976|NCT01891305|Viamet Pharmaceuticals Inc|Neil Moore||nmoore@viamet.com|
22404762|NCT00282867|University of Virginia|Karen C. Johnston, MD, MSc|434 924-5323|kj4v@virginia.edu|
22391109|NCT02270671|University College Dublin|Dr Amanda Fitzgerald|+35317168541|amanda.fitzgerald@ucd.ie|
22391110|NCT00476242|NYS Psychiatric Institute|Adam Bisaga|646-774-6155|amb107@columbia.edu|
22391111|NCT03598699|AxeroVision, Inc.|Dr. Achim Krauss|+1 (484) 238-6255|achim.h.krauss@gmail.com|
22391112|NCT03927690|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22391113|NCT04026399|Medical University of South Carolina|Na Jin Seo|8437920084|seon@musc.edu|
22391114|NCT00126659|UT MD Anderson Cancer Center|Eric Jonasch, MD / Associate Professor||caperez@mdanderson.org|
22391115|NCT03248141|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22391116|NCT00174447|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22391117|NCT04182113|Indiana University|Clinical Research Manager|3178808495|iupdp@iupui.edu|
22391118|NCT01667406|Imperial College London|Professor Waljit Dhillo|442083833242|w.dhillo@imperial.ac.uk|
22391119|NCT00565266|Penn State Hershey College of Medicine|Vernon M. Chinchilli, PhD|717-531-4262|vchinchi@psu.edu|
22391120|NCT03539068|Department of Veterans Affairs- Office of Research and Development|Anne G. Sadler, Ph.D., R.N.|319-338-0581|anne.sadler@va.gov|7992
22391121|NCT00551135|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22391122|NCT04294667|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22391123|NCT00548847|Emory University|Martha Arellano, MD|404-778-1900|marella@emory.edu|
22391124|NCT00727415|GIMEMA|Alfonso Piciocchi|+39 06 70390513|a.piciocchi@gimema.it|
22391125|NCT03634839|Yale University|Dr. Suchitra Krishnan-Sarin|(203)974-7595|suchitra.krishnan-sarin@yale.edu|
22391126|NCT04198948|University of Sarajevo|Associate Professor Tanja Dujic, PhD|+38733586194|tanja.dujic@ffsa.unsa.ba|
22391127|NCT00302159|National Cancer Institute, national Institutes of Health|Kevin Camphausen, M.D.|301-496-5457|camphauk@mail.nih.gov|
22391128|NCT01809899|Georgetown University Medical Center|Mary Ann Dutton|2026871997|mad27@georgetown.edu|
22391129|NCT02208037|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
22391130|NCT02312206|Prothena Biosciences|Wendy Curlin|(650) 837-8550|clinicaltrials@prothena.com|
22391131|NCT03082612|Emory University|Dr. Jill Hamilton|404-727-8749|jill.b.hamilton@emory.edu|
22391132|NCT01006616|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22391133|NCT03672175|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22391134|NCT03410108|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22391135|NCT01313624|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22404763|NCT00091962|University of Pittsburgh School of Medicine|Dr. Bruce L Rollman, Principal Investigator|(412) 692-2659|rollmanbl@upmc.edu|
22404764|NCT01488409|Massachusetts General Hospital|Steven K. Grinspoon|617-724-9109|sgrinspoon@partners.org|
22404765|NCT03005041|GlaxoSmithKline|GSK Response Center|866-435-7343||
22391136|NCT02654132|Bristol Myers-Squibb|Bristol Myers-Squibb Study Director|Please email|Clinical.Trials@bms.com|
22391137|NCT01006889|University of Florida|Dr. Kenneth Cusi|352-273-8661|kcusi@ufl.edu|
22404766|NCT04311177|University of Minnesota|Christopher Tignanelli|612-626-1968|ctignane@umn.edu|
22416977|NCT01567826|Icahn School of Medicine at Mount Sinai|Dr. Pedro R. Moreno||pedro.moreno@mountsinai.org|
22416978|NCT01612884|Indiana University School of Medicine|Rolf Kreutz, MD|3179620500|rkreutz@iu.edu|
22416979|NCT00156715|Dartmouth Medical School|Christopher OKeefe, M.A|603-271-5287|chris.okeefe@hitchcock.org|
22416980|NCT00865098|Merck Serono Co., Ltd, Tokyo, Japan|Masataka Ota|+81 0 3 6853 8611||
22416981|NCT01014624|Daiichi Sankyo, Inc.|Brian Baker|973-944-2712|bbaker@dsi.com|
22416982|NCT02164734|Albany Medical Center|Joaquim Pinheiro, MD, MPH|518-262-5421|pinheij@amc.edu|
22416983|NCT03465748|Illinois College of Optometry|Dr. Yi Pang|3129497287|YPang@ico.edu|
22416984|NCT02596321|Abbott|Therapeutic Area Clinical Director|+31294477008|dmitri.kazei@abbott.com|
22416985|NCT03923699|Washington University School of Medicine|Thomas Kannampallil|(314) 273-7801|thomas.k@wustl.edu|
22416986|NCT04578886|University of Alabama at Birmingham, Department of Anesthesiology and Perioperative Medicine|Dr. Andrew B. Barker, MD|205-934-6007|abbarker@uabmc.edu|
22416987|NCT01557842|Biosense Webster, Inc.|Karen Cropper, Manager, Clinical Operations|(800) 729-9010|Kcropper@its.jnj.com|8607
22416988|NCT05611996|Massachusetts General Hospital|Dr. Jin Hui Joo|6177245317|jhjoo@mgh.harvard.edu|
22416989|NCT03053583|Anesthesiology|Jerrold Lerman MD|716-323-6570|jlerman@buffalo.edu|
22416990|NCT03851796|Virginia Commonwealth University|Dr. Melanie K Bean|804-527-4756|melanie.bean@vcuhealth.org|
22416991|NCT04479475|Johns Hopkins University|Haneefa Saleem, PhD, MPH|443-287-5130|haneefa.saleem@jhu.edu|
22416992|NCT05363683|University of Nebraska Medical Center|Elizabeth Wellsandt|402-559-4309|elizabeth.wellsandt@unmc.edu|
22416993|NCT05560763|Inari Medical|Ashleigh Willson|925-330-3446|ashleigh.willson@inarimedical.com|
22416994|NCT01835379|Smith & Nephew, Inc.|Vice President, Medical & Clinical Affairs|817-302-3914|jaime.dickerson@smith-nephew.com|
22416995|NCT00619359|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22416996|NCT06972251|Health Systems Research Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT)|Allison Lewinski, PhD, MPH, RN, FAAN|919-286-0411|allison.lewinski@va.gov|
22416997|NCT05575063|Johnson & Johnson Surgical Vision|Brian Pall, Dr.|+1 904 6292289|bpall@its.jnj.com|
22404767|NCT00507416|Millennium Pharmaceuticals Inc|Medical Director|1-800-778-2860|clinicaltrialregistry@tpna.com|
22404768|NCT03101514|the first affiliated hospital of Harbin medical university|Dr. Zhi-Ping Liu|+8613936034546|as150001@aliyun.com|
22404769|NCT01673191|Retinal Consultants of Arizona|Dr. Pravin Dugel|602-222-2221|PDugel@gmail.com|
22404770|NCT03141372|Cleveland Clinic Florida|Sara Farag, Fellow in Minimally Invasive Gynecologic Surgery|8147691904|faragsara@gmail.com|
22404771|NCT02682030|Cedars Sinai Medical Center - 8700|Dr. Ashraf Elsayegh|3105560335|ashraf.elsayegh@cshs.org|
22404772|NCT02293096|"University of Colorado Denver | Anschutz"|Andrew Monte, MD, PhD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
22404773|NCT00673894|Garvan Institute of Medical Research|Dr. Dorit Samocha-Bonet|+61292958309|d.samochabonet@garvan.org.au|
22416998|NCT00484419|Daiichi Sankyo Inc.|John Raia, Director, Professional Affairs|973-630-2683|jraia@dsus.com|
22416999|NCT01829113|Sarah Cannon Development Innovations|Senior Director, Regulatory Science|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
22417000|NCT02127073|Montefiore Medical Center|Dr. Sheldon Feldman, Chief Breast Surgery and Breast Surgery Oncology|929-246-6300|sfeldman@montefiore.org|
22417001|NCT00873119|Topotarget A/S|PRS Administrator Gunilla Emanuelson|+45 39 17 83 92|enquiries@topotarget.com|
22417002|NCT03648879|National Cancer Institute|Dr. Jeremy L. Davis|240-760-6229|jeremy.davis@nih.gov|
22417003|NCT00285584|NYU School of Medicine|Michael Marmor, Ph.D.|212-263-6667|michael.marmor@nyumc.org|
22417004|NCT01884688|University of Arkansas for Medical Sciences|Frits van Rhee|501-526-6990|vanrheefrits@uams.edu|
22417005|NCT04099641|OncXerna Therapeutics, Inc.|CDO, OncXerna Therapeutics, Inc.|(781) 907-7810|medical@oncxerna.com|
22417006|NCT00738361|Ohio State University Comprehensive Cancer Center|Thomas Olencki, D.O.|614-293-2886|Thomas.Olencki@osumc.edu|
22417007|NCT02470091|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22417008|NCT02709486|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22417009|NCT00489281|Johns Hopkins University|F Javier Bolanos Meade, MD|4106146398|fbolano2@jhmi.edu|
22417010|NCT00737737|National Institutes of Health Clinical Center|Andrew Mannes, M.D.|301-594-3427|Andrew.Mannes@nih.gov|
22417011|NCT00536484|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22417012|NCT00706355|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22417013|NCT01770431|Huazhong University of Science and Technology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong Wuhan, Hubei, China|Xiaoping Chen, Professor|+86 27 83663400|chenxp@medmail.com.cn|
22417014|NCT02549573|US WorldMeds|Regulatory Affairs Specialist||regulatoryaffairs@usworldmeds.com|
22417015|NCT02610816|Cincinnati Childrens Hospital Medical Center|Marc E. Rothenberg, MD, PhD|513-636-7177|Marc.Rothenberg@cchmc.org|
22417016|NCT02691741|Alcon, A Novartis Division|Sr. Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22417017|NCT05626803|Vaxart|Melanie Drayton|650-392-3109|ClinicalTrials@Vaxart.com|
22417018|NCT04974619|Moffitt Cancer Center|Dr. Shannon Christy|813-745-8840|Shannon.Christy@moffitt.org|
22417019|NCT01688466|National Cancer Institute|Dr. Najla El Jurdi|240-992-4033|najla.eljurdi@nih.gov|
22417020|NCT03310957|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
22417021|NCT05529511|University Hospitals of Derby and Burton NHS Foundation Trust|Hayley Carter|01332254631|hayley.carter1@nhs.net|
22417022|NCT03740113|Univeristy of Virginia|Dr. Jamie Zoellner|434-962-4488|jz9q@virginia.edu|
22417023|NCT04051684|Montefiore Medical Center|Dr. Karina Gritsenko|718-920-7246|kgritsen@montefiore.org|
22417024|NCT04146363|Eli Lilly and Company|Chief Medical officer|800-549-5929|ClinicalTrials.gov@lilly.com|
22417025|NCT00107042|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
22417026|NCT04776746|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|+1-858-261|medicalinformation@acadia-pharm.com|2897
22417027|NCT05017974|University of California, San Francisco|Dr. Jennifer Felder|415-476-7014|jennifer.felder@ucsf.edu|
22417028|NCT03265288|Laurent Pharmaceuticals Inc.|Dr Jean-Marie Houle, VP Clinical Development|514-941-2313|jmhoule@laurentpharma.com|
22417029|NCT02790034|Newron Pharmaceuticals S.p.A.|Ravi Anand MD, Chief Medical Officer|+41 793741364|regulatoryaffairs@newron.com|
22417030|NCT01057381|Baylor College of Medicine|Olutoyin A. Olutoye, M.D., M.Sc.|(832) 824-5800|oao@bcm.edu|
22417031|NCT00836017|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22417032|NCT03575871|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22417033|NCT05444556|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22417034|NCT02791893|Mount Sinai Beth Israel, New York, NY|Dr. Benjamin Natelson|212-844-6768|Benjamin.Natelson@mountsinai.org|
22417035|NCT04051463|Cornea Research Foundation of America|Marianne Price|317-814-2990|mprice@cornea.org|
22417036|NCT04943159|CLINUVEL PHARMACEUTICALS LTD|Clinical Operations Manager||mail@clinuvel.com|
22417037|NCT03738020|LG Chem|Study Leader|82-2-6987-4148|sodam@lgchem.com|
22417038|NCT04319159|Biofrontera Bioscience GmbH|Clinical Trial Department|+49 214 876 32|ameluz@biofrontera.com|66
22417039|NCT03316573|Dana-Farber Cancer Institute|Eric Jacobsen, MD|617-632-6633|edjacobsen@partners.org|
22417040|NCT04075890|UCLA|Reza Tadayon Nejad|3102066389|rtadayonnejad@mednet.ucla.edu|
22417041|NCT00894517|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22417042|NCT00971737|Johns Hopkins University|Leisha Emens, MD, PhD||emensle@jhmi.edu|
22417043|NCT02100319|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22417044|NCT04976621|Corporal Michael J. Crescenz VA Medical Center|Helene Moriarty, PhD, RN|610-519-5735|helene.moriarty@va.gov|
22417045|NCT04323098|BioMarin Pharmaceutical Inc.|Tara M Robinson, MD, PhD, Senior Medical Director, Late-Stage Clinical Development|415-455-7931|tara.robinson@bmrn.com|
22417046|NCT02589522|Johns Hopkins University|Grants Administrative Manager|4439273568|JHCCCRO@jhmi.edu|
22417047|NCT01478828|The SKCCC at Johns Hopkins|Dr. Phuoc Tran|410-614-6477|tranp@jhmi.edu|
22417048|NCT03422198|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
22417049|NCT00949988|UCSD Moores Cancer Center|Kimberly Aguilar, Clinical Trials Manager|858-534-5201|k1aguilar@ucsd.edu|
22417050|NCT01453413|Taking Control of Your Diabetes|Dr. Steven Edelman, MD|858-755-5683|svedelman@vapop.ucsd.edu|
22417051|NCT00351351|IU Health Methodist Hospital|James Lingeman, MD|317-962-0870|lrawlings@iuhealth.org|
22417052|NCT03208673|Allergan|Medical Director|714-246-4500|CTRegistration@allergan.com|
22417053|NCT00768118|Barbara Ann Karmanos Cancer Institute|Fazlul Sarkar, Ph.D.|(313) 576-8327|sarkarf@karmanos.org|
22417054|NCT03891329|BIOTRONIK SE & Co.KG|Director Clinical Project Management|+49 30 68905|mathias.freudigmann@biotronik.com|0
22417055|NCT03176784|University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|608-262-7563|sss@ctri.wisc.edu|
22417056|NCT02990806|Nichi-Iko Pharmaceutical Co., Ltd|Hiroshi Anekawa|+81-3-6262-1564|hiroshi-anekawa@nichiiko.co.jp|
22417057|NCT04625062|New York University|Dr. Tara McAllister|212-992-9445|tkm214@nyu.edu|
22417058|NCT02654587|OSE Immunotherapeutics|Chief Medical Officer Immuno-Oncology|+33 2 28 29 10 10|contact@ose-immuno.com|
22417059|NCT01825837|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com|
22417060|NCT02269631|Emory Unioversity|Hartman, Terry Professor, SPH Epidemiology|404-727-8713|terryl.johnson.hartman@emory.edu|
22417061|NCT00904748|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22417062|NCT01682148|Ipsen|Medical Director, Neurology|clinicaltrials@ipsen.com|clinicaltrials@ipsen.com|
22417063|NCT01202877|The University of Texas (UT) MD Anderson Cancer Center|Jorge Cortes, MD/Professor, Leukemia|1-877-632-6789|CR_Study_Registration@mdanderson.org|
22417064|NCT00396331|Genzyme|Medical Monitor||medinfo@genzyme.com|
22417065|NCT01099631|Masonic Cancer Center, University of Minnesota|Daniel Saltzman|612 626 4214|saltz002@umn.edu|
22417066|NCT04844021|Northwestern University|Dr. Rinad Beidas|312-503-0546|rinad.beidas@northwestern.edu|
22417067|NCT02389101|Turku Univesrity Hospital, Turku, Finland|Heikki Minn, MD|+35823130000|heikki.minn@utu.fi|30149
22417068|NCT01029392|William Beaumont Hospital|Dr. Peter Gerrits|248-551-0487|peter.gerrits@beaumont.org|
22417069|NCT01103479|Northwestern University|Kenzie A. Cameron|312-503-3910|k-cameron@northwestern.edu|
22417070|NCT00834899|University of North Carolina at Chapel Hill|Kenneth I. Ataga, MD|919-966-0178|kataga@med.unc.edu|
22417071|NCT01298778|Wake Forest School of Medicine|Dr. Jessica Booth|336-718-8278|jbooth@wakehealth.edu|
22417072|NCT02377921|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
22417073|NCT01615887|SUNY University at Buffalo|Ralph Benedict|716-323-0556|benedict@buffalo.edu|
22417074|NCT02443545|Chiesi Canada Corp.|Fernando Tricta, MD|1-800-854-3534|f.tricta@chiesi.com|7049
22417075|NCT02540447|Mansoura Faculty of Medicine|Amr Mohamed Yassen Ali Badawy|+201001497044|amryassen@hotmail.com|
22417076|NCT02139124|Purdue Pharma|Dr Lance Payne|1-800-384-5349|Lance.Payne@purdue.ca|
22417077|NCT00631852|Southern Illinois University School of Medicine|Director of Oncology Clinical Trials|217-545-8000|krobinson@siumed.edu|
22417078|NCT00560937|Durham Veterans Affairs Medical Center|Christine E. Marx, MD, MA|919 286-0411|marx0001@mc.duke.edu|7426
22417079|NCT03078478|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22417080|NCT02642237|Radboud university medical centre|Matthijs Kox|+31243653881|matthijs.kox@radboudumc.nl|
22417081|NCT03714555|HonorHealth|Gayle Jameson, MSN, ACNP-BC, AOCN|480-323-1364|clinicaltrials@honorhealth.com|
22417082|NCT04121091|Unit of Biological and Precision Psychiatry|Dr Daniel Lindqvist|+4646173885|daniel.lindqvist@med.lu.se|
22391138|NCT00623363|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22391139|NCT04706793|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22391140|NCT00823836|GlaxoSmithKline|GSK Response Center|866-435-7343||
22391141|NCT01130168|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22391142|NCT04354168|Boston University Chobanian & Avedisian School of Medicine, Family Medicine|Brian Jack, MD|617-414-6207|brian.jack@bmc.org|
22391143|NCT01781832|Cincinnati Children's Hospital Medical Center|Ethan Smith, MD|513 636-4200|Ethan.Smith@cchmc.org|
22391144|NCT02287233|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22391145|NCT03004586|UT MD Anderson Cancer Center|George Eapen,MD/ Professor, Pulmonary Medicine|(713) 563-4256|geapen@mdanderson.org|
22391146|NCT02804399|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|001800781021|ClinicalTrials.gov_Inquiries@pfizer.com|
22391147|NCT02058836|Wake Forest University Health Sciences|Dr. Ryan Terlecki|336-716-2011|rterlecki@wakehealth.edu|
22391148|NCT00835185|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22391149|NCT00573651|The MetroHealth System|Nora G Singer|216-778-2138|nsinger@metrohealth.org|
22391150|NCT01225159|Department of Anesthesiology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand|Dr.Panthila Rujirojindakul, Staff|+66 74 45 1651|rpanthi@medicine.psu.ac.th|
22391151|NCT01145547|Legacy Health System|W. Kenneth Ward|503-413-5171|kenward503@msn.com|
22391152|NCT01770314|Inflexxion|Emil Chiauzzi|617-614-0429|echiauzzi@inflexxion.com|
22391153|NCT01220856|Dompé SpA|Luisa Daffonchio, PhD|+39 583831|daffonchio@dompe.it|
22391154|NCT04814992|University of Pennsylvania|Dr. Peggy Compton|2158988283|pcompton@nursing.upenn.edu|
22391155|NCT00691678|Columbia University|Dawn L. Hershman, MD|212-305-1945|dlh23@cumc.columbia.edu|
22391156|NCT00589836|Cleveland Clinic|Zoran Popovic MD|216 444-9242|popoviz@ccf.org|
22391157|NCT02188784|Duke Clinical Research Institute|Dr. Adrian Hernandez|919-668-7515|adrian.hernandez@duke.edu|
22391158|NCT01138098|GlaxoSmithKline|GSK Response Center|866-435-7343||
22391159|NCT01568112|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22391160|NCT01329185|University of Minnesota|Dr. Priya Verghese, Director of Pediatric Kidney Transplantation|6126262922|pverghes@umn.edu|0
22391161|NCT00903760|The University of Texas (UT) MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Professor, Leukemia|713-745-3428|ggarciam@mdanderson.org|
22391162|NCT00487825|Novartis Pharmaceuticals|Study Director|862-778-8300||
22391163|NCT01256671|Endoceutics|Director of Data Analysis|418-653-0033|celine.martel@endoceutics.com|215
22391164|NCT01190644|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22391165|NCT02366143|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22391166|NCT01638390|Carl Zeiss Meditec, Inc.|Todd Otani, Senior Clinical Research Scientist|925-557-4513|todd.otani@zeiss.com|
22391167|NCT04012619|West China Hospital, Sichuan University|Prof. You Lu|13398179653|radyoulu@hotmail.com|
22391168|NCT01536587|GlaxoSmithKline|GSK Response Center|866-435-7343||
22417083|NCT03821272|University of Arkansas for Medical Sciences|Mayumi Nakagawa, M.D., Ph.D.|(501) 686-8635|MNakagawa@uams.edu|
22417084|NCT05904769|Mayo Clinic|Guru Kowlgi M.B.B.S., M.S.|507-422-0549|Kowlgi.NarayanGurukripa@mayo.edu|
22417085|NCT04266041|Dartmouth-Hitchcock Medical Center|Dr. Yinchen Song|603-650-5104|yinchen.song@hitchcock.org|
22417086|NCT02516410|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22417087|NCT01286558|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22417088|NCT01220297|Stanford Univesity|Laura Johnston, MD|650-723-0822|laura.johnston@stanford.edu|
22417089|NCT00362817|The Ohio State University Medical Center and James Cancer Hospital & Solove Research Inst.|Herbert Newton,|614-293-4448|newton.12@osu.edu|
22417090|NCT01287039|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22417091|NCT01360866|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|609 524 6788|clinicaltransparency@otsuka-us.com|
22417092|NCT05016622|Montefiore Medical Center|Dr. Balazs Halmos|718-405-8404|bahalmos@montefiore.org|
22417093|NCT02678442|Mayo Clinic|Dr. Michael B. Wallace|904-953-2222|wallace.michael@mayo.edu|
22417094|NCT03647046|University of Rochester|Study Coordinator|(585) 276-6922|keratoconusstudy@gmail.com|
22417095|NCT01784666|Massachusetts General Hospital, Center for Quantitative Health|Dr. Roy Perlis|617-643-6310|rperlis@partners.org|
22417096|NCT01231750|University of Cincinnati|Dr. Faisal Khan|513-558-4272|faisal.khan@uc.edu|
22417097|NCT01117337|Moulana Hospital|Mohamed Ismail, Chief Consultant, Moulana Hospital, Perianthalmanna|0091-9447128511|drgargpankaj@yahoo.com, mdismail13@gmail.com|
22417098|NCT01746264|Mayo Clinic|Dr. Seema Kumar|507-538-2724|Kumar.Seema@mayo.edu|
22417099|NCT00584844|USAMRIID|Mark Goldberg, MD|301-619-4562|mark.goldberg@amedd.mil|
22417100|NCT03050203|Istituto Ortopedico Rizzoli|Cristiana Forni|0039516366|cristiana.forni@ior.it|694
22417101|NCT00171301|Novartis Pharmaceuticals|Study Director|862-778-8300||
22417102|NCT04060719|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22417103|NCT03998436|Novalead Pharma Pvt. Ltd.|Supreet K. Deshpande|7066233033|supreet@novaleadpharma.com|
22417104|NCT02370914|Stanford University|Dr. Paul Auerbach|(650) 725-9445|auerbach@stanford.edu|
22417105|NCT03451006|Mayo Clinic|Mandeep Singh, M.D.|507-255-2398|Singh.Mandeep@mayo.edu|
22417106|NCT05224544|Coloplast, Clinical strategies|Malene Hornbak Landauro, Medical writer of Clinical strategies|+4549112057|dkmhla@coloplast.com|
22417107|NCT03847194|Seattle Children's Research Institute|Joyce Yi-Frazier|2068841456|joyce.yi-frazier@seattlechildrens.org|
22417108|NCT01341587|University of Maryland Baltimore|*Administrator, Division of Gerontology|4107062406|cquinn@som.umaryland.edu|
22417109|NCT04403763|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22417110|NCT00350402|University of Florida|Dr. Dawn Bowers|(352) 392-3450|dawnbowers@phhp.ufl.edu|
22417111|NCT01376310|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22417112|NCT00645944|Yale University|Cenk Tek, M.D.|203-974-7484|cenk.tek@yale.edu|
22417113|NCT00176631|Rutgers Cancer Institute of New Jersey|Dr. Robert DiPaola, MD|732-235-8675|dipaolrs@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
22417114|NCT01807117|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Raj Paspulati|1-800-641-2422|Raj.Paspulati@UHhospitals.org|
22417115|NCT01534637|Comprehensive Cancer Center of Wake Forest University|James Lovato, MS|336-713-4172|jlovato@wakehealth.edu|
22417116|NCT04070287|Saint Louis University|Dr. Juliet Iwelunmor|2405280123|juliet.iwelunmor@slu.edu|
22417117|NCT00606502|Allos Therapeutics, Inc|Medical Monitor|303-426-6262|gweems@allos.com|
22417118|NCT00604201|National Heart Lung and Blood Institute|Childs, William|+1 301 451 7128|childsr@nhlbi.nih.gov|
22417119|NCT02463799|Johns Hopkins University|Emmanuel Antonarakis, MD|410-502-8341|eantona1@jhmi.edu|
22417120|NCT00408564|Medical University of South Carolina|Kate Anderton, MPH, CCRP|843-792-2708|anderton@musc.edu|
22417121|NCT05307887|Imperial College NHS Foundation Trust|Dr Thomas Sewell|02033122152|thomas.sewell2@nhs.net|
22417122|NCT02416011|Moffitt Cancer Center|Dr. Thomas Bradon|(813) 745-1750|Thomas.Brandon@moffitt.org|
22417123|NCT02080832|VCU|F. Gerard Moeller, M.D.|804-828-4134|frederick.moeller@vcuhealth.org|
22417124|NCT01560507|Duke University Medical Center|Dr. Jed Rose|919-668-5055|jed.rose@duke.edu|
22417125|NCT03069417|Massachusetts General Hospital|Dr. Christina Psaros|617.726.7458|cpsaros@mgh.harvard.edu|
22417126|NCT00440115|Department of Preventive Medicine & Public Health|Edward F. Ellerbeck, MD, MPH, Chair|913-588-2829|eellerbe@kumc.edu|
22417127|NCT01448356|Singapore Eye Research Institute|Dr Andrea Petznick|+65 6322|andrea.petznick@seri.com.sg|4512
22417128|NCT01660022|Medicines for Malaria Venture|Fiona Macintyre|0041 22 555 0319|macintyref@mmv.org|
22417129|NCT03360539|Harvard University|Dr. Margaret McConnell|6174321232|mmcconne@hsph.harvard.edu|
22417130|NCT03545191|Idorsia Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 58 844 00 00|clinical-trials-disclosure@idorsia.com|
22417131|NCT00306163|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22417132|NCT03179163|Penn State|Lacy M. Alexander, Ph.D.|8148671781|lma191@psu.edu|
22417133|NCT01277718|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22417134|NCT00195013|Weill Cornell Medicine|Linda Vahdat, MD|646-962-9888|ltv2001@med.cornell.edu|
22417135|NCT03919162|Vivoryon Therapeutics N.V.|Study Director|0049 34555599|clinics@vivoryon.com|00
22417136|NCT04400760|The University of the West Indies, St. Augustine|Dr. Naveen Seecheran|18687537686|nseecheran@gmail.com|
22417137|NCT02746627|Vanderbilt University Medical Center|Sarah Jaser, PhD|615-343-6775|sarah.jaser@vanderbilt.edu|
22431333|NCT00573768|Novartis Consumer Health|Sandy Hamelsky|+19735037258|sandy.hamelsky@novartis.com|
22431334|NCT04023045|Orthocare Innovations, LLC|Sarah Chang|425-771-0797|schang@orthocareinnovations.com|1007
22431335|NCT03373435|Eiger BioPharmaceuticals, Inc.|Senior VP, Clinical Development|1-650-272-6138|info@eigerbio.com|
22417138|NCT02858726|Cara Therapeutics|Frédérique Menzaghi, PhD|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
22417139|NCT00754468|University of Miami|Dr. Alfonso Ribeiro|305-243-4000|Aribeiro@med.miami.edu|
22417140|NCT01688726|Alcon Research, Ltd.|Abayomi Ogundele, Global Brand Medical Affairs Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22417141|NCT00965055|UCSD|Ori Ben-Yehuda|9179697273|obenyehuda@ucsd.edu|
22417142|NCT00710749|Astra Tech AB|Head of Clinical Research Area Health Care|+46317763000||
22417143|NCT05478252|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22417144|NCT03182751|Mayo Clinic|Dr. Brandon Yuan|507-255-6112|Yuan.Brandon@mayo.edu|
22417145|NCT02287909|University of Florida|Dominick J. Angiolillo, MD, PhD|9042443378|dominick.angiolillo@jax.ufl.edu|
22417146|NCT04718194|Yale|Dr. Dani Chiaramonte|3479310195|danielle.chiaramonte@yale.edu|
22417147|NCT01215513|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22417148|NCT00821873|RTI Biologics|Robin Waite, Director, Clinical Projects|386-418-8888|rwaite@rtix.com|4172
22417149|NCT00134043|The Ohio State University Comprehensive Cancer Center|Manisha Shah, MD|614-293-8629|manisha.shah@osumc.edu|
22417150|NCT00522171|Ethicon Endo-Surgery|Sheryl Helsinger|513-337-3079|SHelsing@its.jnj.com|
22417151|NCT00289757|GlaxoSmithKline|GSK Response Center|866-435-7343||
22417152|NCT03861481|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
22417153|NCT00773734|Celgene Corporation|Anne McClain|888-243-1360|clinicaltrialdisclosure@celgene.com|
22417154|NCT01660191|University of Kansas Medical Center|Julie-Ann Dutton|913-588-4064|JDUTTON@kumc.edu|
22417155|NCT00856830|Univeristy of Alabama at Birmingham|Francisco Robert, MD, Department of Medicine, Division of Hematology and Oncology|205-934-5077|pacorobertuab@cs.com|
22417156|NCT03768726|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22417157|NCT01787279|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22417158|NCT02148913|Corewell Health|Esther Peariso|616-486-0358|esther.peariso@corewellhealth.org|
22417159|NCT01191242|Intermountain Heart Institute|John Carlquist, PhD|8014081028|john.carlquist@imail.org|74707
22417160|NCT02954159|Medical College Of Wisconsin|Andres Yarur, MD; Principal Investigator|414-955-6858|ayarur@mcw.edu|
22417161|NCT05506358|The University of British Columbia|Pranav Shrestha|6507893270|pranav.shrestha@alumni.ubc.ca|
22417162|NCT00391079|GW Pharmaceuticals|Richard Potts Clinical Operations Director|+44 1223 266800|rp@gwpharm.com|
22417163|NCT00276549|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Robert Dreicer|216-445-4623|dreicer@ccf.org|
22417164|NCT03301532|University of Texas Southwestern Medical Center|Dr. Juan Pascual|214-648-3550|juan.pascual@utsouthwestern.edu|
22417165|NCT04939519|Huntsman Cancer Institute at University of Utah|Dr. David Wetter|801-213-6178|david.wetter@hci.utah.edu|
22417166|NCT03438396|Genmab A/S|Ibrahima Soumaoro|+1 609 430 2481|clinicaltrials@genmab.com|
22417167|NCT01744093|Weill Cornell Medicine|Mei Wang, BS, CCRP|646-962-2672|mew2001@med.cornell.edu|
22417168|NCT02006628|GW Research Ltd|Medical Enquires|+44 01223 238170; 18778862810|medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
22417169|NCT00262041|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22417170|NCT00834652|Washington University School of Medicine|Patrick J. Lustman, Ph.D.|3142861320|lustmanp@psychiatry.wustl.edu|
22417171|NCT03578237|University of California San Diego|Program Manager|(858) 220-5714|baabdullah@health.ucsd.edu|
22417172|NCT01173471|AstraZeneca|Stuart McIntosh||ClinicalTrialTransparency@astrazeneca.com|
22417173|NCT01011075|University of Pittsburgh Cancer Institute|Julie E. Bauman, MD|412-648-6507|baumanje@upmc.edu|
22417174|NCT03028740|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22417175|NCT00252174|McLean Hospital at time of study|John H. Halpern, M.D.|6179065063|jhalpern@recoverycoa.com|
22417176|NCT01138826|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22417177|NCT02566993|Pharma Mar S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|0034 918466000|clinicaltrials@pharmamar.com|
22417178|NCT05206448|University of Iowa|Rachel Mejia, DO|319-356-3143|rachel-mejia@uiowa.edu|
22417179|NCT01122316|University of California Los Angeles|Tamara Horwich, MD, MS|310-825-8816|thorwich@mednet.ucla.edu|
22417180|NCT04572243|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22417181|NCT01661881|Dana-Farber Cancer Institute|Philippe Armand MD, PhD|617.632.2305|Philippe_Armand@dfci.harvard.edu|
22417182|NCT01790113|Arthrex|Clinical Affairs Manager|2392161894|melissa.hirschberg@arthrex.com|
22417183|NCT00775606|Rush University Medical Center|Allan R. Tenorio|312-942-3665|allan_s_tenorio@rush.edu|
22417184|NCT02278718|MediWound|Keren David Zarbiv|972-77-9714103|kerend@mediwound.com|
22417185|NCT04440449|University of Texas Health San Antonio|Rozmin Jiwani|210-450-8498|jiwani@uthscsa.edu|
22417186|NCT02547766|University of Utah|Associate Director of Clinical Trials|801-581-5318|heather.thiesset@hsc.utah.edu|
22417187|NCT03212794|Brigham and Women's Hospital|Joji Suzuki, MD|617-732-5752|Jsuzuki2@bwh.harvard.edu|
22417188|NCT04317313|Second Affiliated Hospital, School of Medicine, Zhejiang University|Dr. Xiaohui Zhang|+86-571-87767188|zhanghui4127@zju.edu.cn|
22417189|NCT00754494|University of California, Irvine|Dr. Timothy R. Morgan|562-826-5756|timothy.morgan@va.gov|
22417190|NCT01144403|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22417191|NCT05472116|University of Minnesota|Jonathan Strutt|(314) 578-8045|strutt@umn.edu|
22417192|NCT00253981|William Beaumont Army Medical Center|COL Richard Petri, Chief Integrative Pain Management|915-742-3245|richard.petri@amedd.army.mil|
22417193|NCT02903238|Northwestern University Medical School|Dr. Apkar Vania Apkarian|(312) 503-0404|a-apkarian@northwestern.edu|
22404774|NCT03258632|Department of Veterans Affairs|Christine Timko|650-493-5000|Christine.Timko@va.gov|23336
22404775|NCT03162458|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Head of department of clinical trials|+74952761571|PutilovskiyMA@materiamedica.ru|302
22404776|NCT00442767|Montefiore Medical Center|Dr. Rubina Heptulla|718-920-4664|rheptull@montefiore.org|
22404777|NCT04491240|MC Dinasty|Tyumina Olga|+78462039808|centr123@bk.ru|201
22404778|NCT02726113|Medical University of South Carolina|Sebastiano Gattoni-Celli, M.D.; Professor of Radiation Oncology|843-876-5103|gattonis@musc.edu|
22404779|NCT03549117|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22404780|NCT00637377|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22404781|NCT00638924|Unicamp|Juliana Gomes Zabatiero||juzabatiero@yahoo.com.br|
22404782|NCT01293084|Johns Hopkins Univeristy|Beth Laube Professor|410-502-5791|blaube@jhmi.edu|
22404783|NCT00937794|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22404784|NCT04777214|University of Pennsylvania|Samuel Cason|215-573-4336|sacason@pennmedicine.upenn.edu|
22404785|NCT04884945|Indiana University School of Medicine, Pediatrics|Stacy Keller|3172786127|stasulli@iu.edu|
22404786|NCT00107172|Boston Medical Center|Hiran C. Fernando, MD|617-638-5600|hiran.fernando@bmc.org|
22404787|NCT04268303|BioXcel Therapeutics|Vice President Head of Clinical Operations|(475) 355 5177|cgommoll@bioxceltherapeutics.com|
22404788|NCT00355134|Novartis Pharmaceuticals|Study Director|862-778-8300||
22404789|NCT04432376|Hill Dermaceuticals|Dr. Rosario G Ramirez, Medical Director|4073231887|nini.ramirez@hillderm.com|
22404790|NCT03706040|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22404791|NCT00927758|Sandoz|Study Director|609-627-8889|yaping.zhu@sandoz.com|
22404792|NCT00439725|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22404793|NCT03510910|NYU Langone Health|Thomas Youm, MD|212-348-3636|Thomas.Youm@nyulangone.org|
22404794|NCT01673490|GlaxoSmithKline|GSK Response Center|866-435-7343||
22404795|NCT00379236|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22404796|NCT00110591|CytoDyn, Inc.|Joe Meidling|360-980-8524|jmeidling@cytodyn.com|
22404797|NCT02940860|Pharmacosmos A/S|Clinical trial disclosure desk|+45 5948 5935|trial@pharmacosmos.com|
22404798|NCT04914819|University of Pennsylvania|Dr. Jennifer Lewey|215-662-7700|jennifer.lewey@pennmedicine.upenn.edu|
22404799|NCT03961295|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
22404800|NCT01807611|St. Jude Children's Research Hospital|Brandon M. Triplett, MD|866-278-5833|referralinfo@stjude.org|
22404801|NCT01625611|Yale University|Dr. Krishnan-Sarin|203.974.7595|nicholas.franco@yale.edu|
22404802|NCT02431793|Northwestern University|Dr. Danielle McCarthy|312-926-7532|d-mccarthy2@northwestern.edu|
22404803|NCT00233324|University of Alabama|Waldemar A. Carlo, M.D|(205) 934-4680|wcarlo@peds.uab.edu|
22404804|NCT01818986|University of Texas Southwestern Medical Center Dallas|Dr. Raquibul Hannan|214-645-7696|raquibul.Hannan@UTSouthwestern.edu|
22404805|NCT02286726|The University of Texas MD Anderson Cancer Center|Ghayas Issa C. MD./Assistant Professor|713-745-6798|GCIssa@mdanderson.org|
22404806|NCT00962754|Princess Amalia Children's Clinic, Isala Klinieken|Dr. J. Bekhof|0031-38-4245050|j.bekhof@isala.nl|
22404807|NCT01711541|Alliance for Clinical Trials in Oncology|Everett E. Vokes, M.D.|773-702-9306|evokes@medicine.bsd.uchicago.edu|
22404808|NCT01759160|First Affiliated Hospital of Sun Yat-sen University|Dr. Xia Feng|008613688877856|fengxiar@yahoo.cn|
22404809|NCT02707601|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22404810|NCT00223652|Northwestern University|David C. Mohr|312- 503-1403|d-mohr@northwestern.edu|
22404811|NCT00601146|DFCI|Andrea Ng|617-732-6310|ang@lroc.harvard.edu|
22404812|NCT00806078|Mutual Pharmaceutical Company, Inc.|Medical Affairs Director|215-697-1743|clinicaltrials@urlmutual.com|
22404813|NCT03004976|Duke University|Emily Poehlein, MB|919-668-8473|emily.poehlein@duke.edu|
22404814|NCT01665768|Johns Hopkins University|Douglas Gladstone, MD|4109558781|dgladst1@jhmi.edu|
22404815|NCT04406389|Weill Cornell Medicine|Dr. Maria T. DeSancho|646-962-2065|mtd2002@med.cornell.edu|
22404816|NCT01117012|Vertex|Medical Monitor|617-444-6777|medicalinfo@vrtx.com|
22404817|NCT02781454|University of Washington|Dr. Michael D. Weiss|206-598-7688|mdweiss@uw.edu|
22404818|NCT00493974|University of Minnesota|Sarah Lindberg|612-626-9011|slindberg@umn.edu|
22404819|NCT00326417|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
22404820|NCT00844285|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22404821|NCT03219892|Xuanwu Hospital|Piu Chan|010-83198677|pbchan@hotmail.com|
22404822|NCT03796182|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22404823|NCT04682353|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
22404824|NCT01586806|Hospital for Special Surgery|Dr. Mary Chisholm|2126061206|chisholmm@hss.edu|
22404825|NCT00555906|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22404826|NCT02193828|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22404827|NCT01313208|Amgen Inc.|Study Director|866-572-6436||
22431336|NCT00553254|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22404828|NCT01829217|Dana-Farber Cancer Institute|Principal Investigator: Geoffrey Oxnard, MD|617-632-6049|geoffrey_oxnard@dfci.harvard.edu|
22404829|NCT01412060|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22404830|NCT01183312|Emory University School of Medicine|Dr. Lynn Marie Trotti|404-728-4752|lbecke2@emory.edu|
22404831|NCT02661464|Janssen Vaccines & Prevention B.V.|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22404832|NCT00976248|Dana-Farber Cancer Institute|Steven P. Treon, MD, PhD|617-632-2681|steven_treon@dfci.harvard.edu|
22404833|NCT03148756|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22404834|NCT05567393|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
22404835|NCT01376362|National Institutes of Health|Hatice Nida Sen, Principal Investigator, National Eye Institute|(301) 402-3254|senh@nei.nih.gov|
22404836|NCT02540772|San Rafael University Hospital|Monica Triviño Mosquera|34958275700|monica.trivino@sjd.es|
22404837|NCT02177175|Memorial Sloan Kettering Cancer Center|Dr. Anthony Yu, MD|212-639-7932|yua3@mskcc.org|
22404838|NCT01924299|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22404839|NCT04199793|Vanderbilt University Medical Center|Sandip Zalawadiya, MBBS|6159368187|sandip.k.zalawadiya@vumc.org|
22404840|NCT03820726|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22404841|NCT00605072|University of Southern California|Dr. Ihab Hajjar|323-226-6720|ihajjar@usc.edu|
22404842|NCT00628758|AstraZeneca|Gerard Lynch|+44 1509 645895|aztrial_results_posting@astrazeneca.com|
22404843|NCT01576120|Given Imaging|"Ravit Peled | Clinical Trials Manager"|+972 (4) 909-7894|Ravit.peled@covidien.com|7894
22404844|NCT00877604|Fondazione Istituto Neurologico Carlo Besta|Alberto Albanese|+39 02 2392 4552|alberto.albanese@unicatt.it|
22404845|NCT02983799|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22404846|NCT02025829|Riley Hospital for Children|Dr. James Chmiel|317-948-7180|jfchmiel@iu.edu|
22404847|NCT01495923|The Johns Hopkins Hospital|Steven Cohen|410-955-1818|scohen40@jhmi.edu|
22404848|NCT01999348|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22404849|NCT02259127|MRC CTU at UCL|Prof Diana M Gibb (Chief Investigator)|+44 (0) 207 670 4700|diana.gibb@ucl.ac.uk|
22391169|NCT02666664|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
22391170|NCT05923112|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22391171|NCT03210519|Department of Nutrition, Chung Shan Medical University|Dr. Nae-Cherng Yang|886-0936810214|naeman@csmu.edu.tw|
22391172|NCT02367430|Columbia University|Dr. Carolyn Rodriguez|650-723-6158|cr2163@stanford.edu|
22391173|NCT00568698|Stanford University|Principal Investigator||clinicaltrials-gov@lists.stanford.edu|
22391174|NCT03865953|Lateral Pharma Pty Ltd|Mr David Kenley|+61 (0)400 151 490|dk@lateral-pharma.com|
22391175|NCT03021551|Masimo Corporation|Cristina Johnson|949-297-7000|ClinicalResearchDept@masimo.com|
22391176|NCT01777126|Pharmacy Department, University Hospitals Leuven & Department of Pharmaceutical and Pharmacological Sciences, KULeuven, Belgium|Peter Declercq|003216342340|peter.declercq@uzleuven.be|
22391177|NCT00490945|Vanda Pharmaceuticals Inc.|Marlene Dressman, Ph.D.|202-734-3462|marelene.dressman@vandapharma.com|
22391178|NCT00412880|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22391179|NCT02232399|University of Gothenburg|Prof. Albert Gyllencreutz Castellheim|+46708979820|albert.castellheim@gu.se|
22391180|NCT00567840|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|212-227-7540|Dan.Everitt@tballiance.org|
22391181|NCT03017937|Cincinnati Chidren's Hospital|Kim Foss|5136365971|kim.foss@cchmc.org|
22391182|NCT02706951|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22391183|NCT03491215|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novatis.email@novartis.com|
22391184|NCT02489734|Children's Hospital of Fudan University|Dr. Xuan Wang|021-18017591058|13818318679@139.com|
22391185|NCT01951768|Geneva University Hospitals, Balgrist University Hospital|Dr. med. Ilker Uçkay|+41 44 386 11 11|ilker.uckay@balgrist.ch|
22391186|NCT01181492|Huazhong University of Science&Technology|Zhang Xianwei|027 83662853|ourpain@163.com|
22391187|NCT00485953|University of Pittsburgh|Dr. Susan Greenspan|412-692-2476|greenspn@pitt.edu|
22391188|NCT02720211|Axon Optics|Director of Clinical Trials|8012304851|bradley.katz@hsc.utah.edu|
22391189|NCT04070768|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22391190|NCT04799418|Scion NeuroStim, Inc|Robert Black|919-260-5528|bacllc@earthlink.net|
22391191|NCT03297398|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
22391192|NCT00424554|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22391193|NCT04611347|University of Virginia|Brent DeGeorge, MD|434.982.4263|BD6U@uvahealth.org|
22391194|NCT00611715|Vanderbilt-Ingram Cancer Center|Ingrid Mayer, MD|615-936-2033|ingrid.mayer@vanderbilt.edu|
22391195|NCT00107978|Theravance, Inc|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
22391196|NCT02669407|Duke University|Marat Fudim, M.D.|919-684-8111|marat.fudim@duke.edu|
22391197|NCT00345800|Cares|UCB|+1 844 599|UCBCares@ucb.com|2273
22391198|NCT01973062|Case Comprehensive Cancer Center|Manmeet Ahluwalia, MD|216-444-6145|ahluwam@ccf.org|
22391199|NCT00350298|MassBiologics|Director of Clinical Affairs|617-474-3000|MBLClinicalDirector@umassmed.edu|
22391200|NCT00233389|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22391201|NCT01127321|MedImmune, LLC.|David Close, Director, Clinical Development|301-398-0000|closeda@medimmune.com|
22404850|NCT00719862|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2351|WWheeler@medapharma.us|
22404851|NCT01184846|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22404852|NCT01998269|University of North Carolina at Chapel Hill|Dr. Stacy Bailey|919-843-9834|scbailey@unc.edu|
22404853|NCT01736254|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22404854|NCT01987349|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
22404855|NCT02293902|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22404856|NCT00859573|University of Arkansas for Medical Sciences|Michael J. Mancino, M.D.|501-526-8442|mjmancino@uams.edu|
22404857|NCT01135394|University of Maryland School of Medicine|Soren Snitker, MD, PhD|4107061511|ssnitker@som.umaryland.edu|
22404858|NCT00462488|Sesen Bio|Rachelle Dillon, Ph.D.|204-452-7126|rachelle.dillon@sesenbio.com|308
22404859|NCT03984812|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22404860|NCT00948194|University of Colorado Denver|Nick Naughton|303-724-0833|nick.naughton@cuanschutz.edu|
22404861|NCT00438464|University of Texas (UT) MD Anderson Cancer Center|Jeri Kim, MD / Associate Professor, Genitourinary Medical Oncology|713-792-2830|CR_Study_Registration@mdanderson.org|
22404862|NCT00728936|Idera Pharmaceuticals, Inc|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
22404863|NCT03943446|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22404864|NCT02905825|Exalenz Bisocience|Avraham Hershkowitz|972-8-9737513|avrahamh@exalenz.com|
22404865|NCT05355818|LEO Pharma A/S|Clinical Disclosure|+45 4494 5888|disclosure@leo-pharma.com|
22404866|NCT01563107|Vanderbilt University Medical Center|Alfredo Gamboa MD|6158751003|alfredo.gamboa@vumc.org|
22404867|NCT01769612|Institut Pasteur of Tunis|Afif Gen Salah, MD, PhD|011-216-71-792-429|noemailavailable@no.com|
22404868|NCT00247273|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22404869|NCT01660230|ZZ Biotech, LLC|Kent Pryor, PhD, MBA, Chief Operating Officer||kpryor@zzbiotech.com|
22404870|NCT01709708|Clinvest Research|Jim Sly|4178413673|jsly@clinvest.com|
22404871|NCT00129740|The University of Texas MD Anderson Cancer Center|Cortes,Jorge E, MD./Professor|713-794-5783|jcortes@mdanderson.org|
22404872|NCT00081939|The Myeloma Institute, University of Arkansas for Medical Sciences|Director of Clinical Trials and Regulatory Affairs|501-526-6990|npetty@uams.edu|
22404873|NCT00511108|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22404874|NCT02954952|Masimo Corporation|Director of Clinical Research|949-297-7416|clinicalresearchdept@masimo.com|
22404875|NCT02911519|SAMEIN|Dr. Jenny Garcia|+57 4 219 6014|jenny.garcia@udea.edu.co|
22404876|NCT00810043|Medtronic|John Tillman|408-548-6518|tillmj1@mspexcng.medtronic.com|
22404877|NCT02001688|Kamada Ltd|Head of Clinical Operations|+972-72-2219172|sharonc@kamada.com|
22404878|NCT03744598|patientMpower Ltd|Chief Scientific Officer|353872599131|colin@patientmpower.com|
22404879|NCT02864706|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
22404880|NCT01675141|National Cancer Institute|Dr. Dickran Kazandijian|301-451-2677|kazandijiandg@nih.gov|
22404881|NCT00706394|Endologix|Sharone Trifskin|949-599-8860|strifskin@endologix.com|
22404882|NCT02307318|HealthEast Care System|Amy Fehrer|651-232-5363|afehrer@healtheast.org|
22404883|NCT01118715|Athens Orthopedic Clinic|Dr. Michael Shuler|706-549-1663|mshuler@athensorthopedicclinic.com|
22404884|NCT01902004|UCLA Semel Institute for Neuroscience and Human Behavior|Dr. Helen Lavretsky|(310)794-4619|hlavretsky@mednet.ucla.edu|
22404885|NCT02157103|Emory University|William L. Read, MD, Principal Investigator|404-778-1900|william.l.read@emory.edu|
22404886|NCT01921452|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|49-6151-72-5200|service@merckgroup.com|
22404887|NCT00047853|National Institute of Mental Health|Pao, Maryland|+1 301 435 5770|paom@mail.nih.gov|
22404888|NCT02443805|Stallergenes Greer|Martine Le Gall, Director of Clinical Development|+33 1 55 59 25 56|martine.legall@stallergenesgreer.com|
22404889|NCT00961116|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22404890|NCT00968708|Takeda|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
22404891|NCT02708966|Institute of Experimental and Clinical Therapeutics|Dra. Esperanza Martínez Abundis|+52-33-10-58-52-00|esperanzamartnezabundi@yahoo.com|34211
22404892|NCT00389441|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22404893|NCT03407170|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22404894|NCT00587834|Organogenesis Inc.|Director of Clinical Operations|781-575-0775|clinical@organo.com|
22404895|NCT00105560|Massachusetts General Hospital|Dr. Nancy Tarbell, Pediatric Radiation Oncologist|617-724-1836|NTARBELL@mgh.harvard.edu|
22404896|NCT00636441|Duke University Medical Center|P. Kelly Marcom, M.D.|919-684-3877|marco001@mc.duke.edu|
22404897|NCT00049504|Fred Hutchinson Cancer Research Center|Rachel Salit|206-667-1317|rsalit@fredhutch.gov|
22404898|NCT00305604|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22404899|NCT00334204|University of Mississippi|Tibor Fulop, M.D./Associate Professor of Medicine|601 984-5670|tfulop@umc.edu|
22404900|NCT03488914|Hunter College|Dr. Tyrel Starks|212-772-5550|tstarks@hunter.cuny.edu|
22404901|NCT02559713|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22404902|NCT00983359|The Ohio State University Comprehensive Cancer Center|Mario Ammirati, MD|614-293-1970|Mario.Ammirati@osumc.edu|
22404903|NCT01021813|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22404904|NCT00862654|Galderma|Farzi Sidou, Clinical Project Manager|+33 4 93 95 70 51|farzaneh.sidou@galderma.com|
22404905|NCT03219567|Duke University|Anthony Kuo, M.D.|919-684-3799|anthony.kuo@duke.edu|
22404906|NCT01151540|Eisai Co., Ltd.|Customer Joy Department. EJ|8133817-3700|_ML_CLNCL@hhc.eisai.co.jp|
22404907|NCT01285791|Hadassah Medical Organization|Dr Ido Mizrahi|+972-2-5844550|idomiz17@gmail.com|
22404908|NCT02261883|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
22404909|NCT00004732|Mayo Clinic|Thomas G. Brott, MD - Principal Investigator|904-953-0556|Brott.thomas@mayo.edu|
22404910|NCT01688635|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22404911|NCT02674685|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22404912|NCT01181778|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22404913|NCT01305213|NRG Oncology|Linda Gedeon for Michael Sill, PhD|716-845-1169|lgedeon@gogstats.org|
22404914|NCT00358501|Jazz Pharmaceuticals|Head of Clinical Development|650.496.3777||
22404915|NCT01269047|Children's Hospital at Montefiore|Dr. Rubina Heptulla|718-920-7004|rheptull@montefiore.org|
22404916|NCT01626989|Philips|Jeremy Powers|412-542-3669|jeremy.powers@philips.com|
22404917|NCT04021706|Tufts University|Bess Dawson-Hughes|6175563066|bess.dawson-hughes@tufts.edu|
22404918|NCT03366844|Cedars-Sinai Medical Center|Stephen Shiao, MD, PhD|310-423-2836|Stephen.Shiao@cshs.org|
22404919|NCT02480998|The catholic university of Korea, Seoul ST. Marry's Hospital|Dr.Dong-suck Lim, CI|+82-2-2258-7327||
22404920|NCT02332798|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
22404921|NCT00595868|University of Vermont|John R. Hughes, MD|802-656-3195|john.hughes@uvm.edu|
22404922|NCT02688153|Edwards Lifesciences, LLC|Mary Edwards, VP Clinical and Regulatory Affairs, HVT|949-250-2500|mary_edwards@edwards.com|1536
22404923|NCT04306900|Trishula Therapeutics, Inc.|Executive Director|1-650-509-5732|info@trishulatx.com|
22404924|NCT02687711|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22404925|NCT03140722|Akebia Therapeutics|Akebia Therapeutics|(617) 844-6128|trials@akebia.com|
22404926|NCT02061748|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22417194|NCT02777918|Bournemouth University|Prof. Katherine Appleton|+441202965985|k.appleton@bournemouth.ac.uk|
22417195|NCT00572117|Stanford University School of Medicine|Michael J. Ostacher, MD, MPH, MMSc|650-493-5000|ostacher@stanford.edu|
22417196|NCT01343095|Wake Forest Baptist Health|Matthew C. Miles|336-716-7765|mmiles@wakehealth.edu|
22417197|NCT02510014|Indivior, Inc.|Global Director, Clinical Development|804-379-1090|Robert.Bauer@Indivior.com|
22417198|NCT00654654|CBR International Corp.|Kevin Hennegan|(720)746-1190|khennegan@cbrintl.com|
22417199|NCT04179019|Brigham and Women's Hospital|Anand Vaidya|6177325666|anandvaidya@bwh.harvard.edu|
22417200|NCT01949116|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22417201|NCT03399318|University of Rochester|Professor Gretchen L. Birbeck|+ 1(517) 505-0283|gretchen_birbeck@urmc.rochester.edu|
22417202|NCT04209335|University of Salford|ISOMETRIC CORE MUSCLE ENDURANCE IN HEALTHY ACTIVE AND NON-ACTIVE WORKING AGE POPULATIONS|07488550768|H.Holmberg@edu.salford.ac.uk|
22417203|NCT04632706|MedinCell S.A.|Joel Richard - Chief Development Officer|00336984590|joel.richard@medincell.com|99
22417204|NCT01510652|Institute of Cardiology, Univ. of Bologna, Bologna, Italy|Prof. Giuseppe Boriani||giuseppe.boriani@unibo.it|
22404927|NCT01742091|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22417205|NCT04079127|Zimmer Biomet|Emilie Rohmer, Clinical Operations Manager|+41 58 85 48210|Emilie.Rohmer@zimmerbiomet.com|
22417206|NCT00307931|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22417207|NCT01251978|New England Retina Associates|Leslie Hurst- study coordinator|203-288-2020|lhurst@retinamd.com|
22417208|NCT01972035|University of Minnesota|Henry Balfour, MD|612-625-3998|balfo001@umn.edu|
22417209|NCT00233987|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623||
22417210|NCT02508259|University of California, San Diego School of Medicine|Dr. Robert K. Naviaux, MD, PhD|619-543-2904|naviaux@ucsd.edu|
22417211|NCT04553913|Atrium Health Wake Forest Baptist|Seiha Kim, DO|336-716-4498|sekim@wakehealth.edu|
22417212|NCT01481324|Shriners Hospital for Children|Dr. Todd Milbrandt|859-266-2101|tmilbrandt@shrinenet.org|
22417213|NCT01699763|Ascensia Diabetes Care|Carmine Greene|574-257-3040|carmine.greene@ascensia.com|
22417214|NCT06400745|Alcon Research, LLC|Director Clinical Trial Management, Surgical IOL|1-888-451-3937|alcon.medinfo@alcon.com|
22417215|NCT04846881|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22417216|NCT04560998|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22417217|NCT04862949|CHA Bundang Medical Center|Hong Jae Chon|82-31-780-3928|minidoctor@cha.ac.kr|
22417218|NCT02332980|Mayo Clinic|Wei Ding|5072845096|Ding.Wei@mayo.edu|
22417219|NCT05599269|Ivoclar Vivadent AG|Dr. med. dent. Ronny Watzke|+423 235 3401|Ronny.Watzke@ivoclar.com|
22417220|NCT01000610|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22417221|NCT01010126|Mayo Clinic|Henry Pitot, M.D.|(507) 284-2511|pitot.henry@mayo.edu|
22417222|NCT00635830|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22417223|NCT04495283|Nevakar, Inc.|Eric Lang, MD|(908) 367-7400|Clinicaltrials@nevakar.com|
22417224|NCT05218109|University of Florida|Sarah Bottari, M.S.|(352) 273-6455|sbottari@ufl.edu|
22417225|NCT01959490|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Paula Silverman|1-800-641-2422|CTUreferral@UHhospitals.org|
22417226|NCT04859699|University of Washington|Linda K. Ko|+1 206 707-5624|lindako@uw.edu|
22417227|NCT04718545|Goteborg University|Dr Olivier Carcuac|317863124|olivier.carcuac@gu.se|+46
22417228|NCT04843566|Weill Cornell Medicine|Jim Hu|2127463418|jch9011@med.cornell.edu|
22417229|NCT03341000|MCRA, LLC|Nicole Harris|202-552-5800|nharris@mcra.com|5823
22417230|NCT00996931|Sutter Institute for Medical Research|Carol Parise, PhD|916-733-4413|PariseC@sutterhealth.org|
22417231|NCT02698865|DePuy Synthes|FRANCHISE MEDICAL DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22417232|NCT03715998|Quantum Genomics|Dr Bruno Besse|+33 1 85 34 77 73|bruno.besse@quantum-genomics.com|
22417233|NCT02177136|Intercept Pharmaceuticals, Inc.|Medical Information|844-782-4278|medinfo@interceptpharma.com|
22417234|NCT01386684|AbbVie|Global Medical Services|800-633-9110||
22417235|NCT02130583|Alpert Brown Medical School|Shirley Yen, Ph.D., Principal Investigator|4014441915|Shirley_Yen_PhD@Brown.edu|
22417236|NCT02149290|ZOLL LifeVest|VP of Medical Affairs|412-968-3333|stevens@zoll.com|14400
22417237|NCT00836719|LSU Health Sciences Center-New Orleans|Jesus Lovera MD|5045686700|jlover@lsuhsc.edu|
22417238|NCT03111914|Duke University|Dr. Daniele Marin|919-684-7366|daniele.marin@duke.edu|
22417239|NCT02119286|GlaxoSmithKline|GSK Response Center|866-435-7343||
22431337|NCT00189137|University of Michigan Comprehensive Cancer Center|Dr. Scott Schuetze, M.D., Ph.D.|1-800-865-1125|scotschu@umich.edu|
22431338|NCT02314923|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22431339|NCT02008617|Northwestern University, Feinberg School of Medicine|Rohit Rahangdale, M.D.|312-695-4814|rrahangd@nmff.org|
22431340|NCT00976456|Krankenhaus Martha-Maria Halle-Doelau gGmbH|Prof. Dr. Wolfgang Schuette|+49 345 5591440|wolfgang.schuette@martha-maria.de|
22431341|NCT00478257|UCSD|Dr. Sonia Ancoli-Israel|858 642-7710|sancoliisrael@ucsd.edu|
22431342|NCT00806585|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDevelopment@merck.com|
22431343|NCT02507934|Dompé farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22431344|NCT03766399|AstraZeneca Clinical Study Information Center|Global Clinical Head|+1-877-240-94 79|information.center@astrazeneca.com|
22431345|NCT03331354|VA North Texas Health Care System|James LePage|214-857-0240|james.lepage@va.gov|
22431346|NCT00304161|University of Pennsylvania|Dr. Daniel Weintraub|215-349-8207|daniel.weintraub@uphs.upenn.edu|
22431347|NCT01559935|Weill Cornell Medicine|Ruben Niesvizky, MD|6469626500|run9001@med.cornell.edu|
22431348|NCT05889468|Duke University Medical Center|Brenna L. Hughes, MD, MSc|919-684-8111|brenna.hughes@duke.edu|
22431349|NCT05468918|Sonova USCS|Director of Research|630-821-5000|phonakaudiologyresearch@gmail.com|
22431350|NCT01767987|Kettering Health Network|Suzanne Coleman, PhD|937-395-8390|suzanne.coleman@khnetwork.org|
22431351|NCT01153516|University of Texas Southwestern at Dallas|Dr. Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
22431352|NCT05112640|University of Texas Medical Branch|Brett Goldman|9542632359|brettryangoldman@gmail.com|
22431353|NCT02474498|Piracicaba Dental School - University of Campinas|Prof.Dr. Enilson Antonio Sallum|+55 19 2106-5301|easallum@fop.unicamp.br|
22431354|NCT00244985|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22431355|NCT05022719|Medtronic|Melanie Crystal|774-245-8756|melanie.crystal@medtronic.com|
22431356|NCT01605097|BC Cancer|Dr Juanita Crook|250 712 3958|jcrook@bccancer.bc.ca|
22417240|NCT04109313|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22417241|NCT02694549|CaveoMed GmbH|Albertus M. Scheule, MD, PhD, MBA|+49(0)7071-53982-10|albertus.scheule@caveomed.com|
22431357|NCT05006495|Seoul National University Hospital|Researcher of Clinical Trials|+821049051485|junhiya@snu.ac.kr|
22391202|NCT00719043|GlaxoSmithKline|GSK Response Center|866-435-7343||
22417242|NCT01005706|Medical University of South Carolina|Charles F. Bratton, MD|843-792-4003|brattocf@musc.edu|
22417243|NCT01996332|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22417244|NCT02113189|University of Texas Southwestern Medical Center|Karen McCain, PT, DPT, NCS|2146481559|karen.mccain@utsouthwestern.edu|
22417245|NCT03623620|Massachusetts General Hospital, Center for Women's Mental Health|Lee Cohen, MD|617-724-8020|lcohen2@mgh.harvard.edu|
22417246|NCT00099268|Novartis Pharmaceuticals|Study Director|862 778-8300||
22417247|NCT03702049|University of California, Irvine, Sue & Bill Gross School of Nursing|Adeline M Nyamathi|(949) 824-8932|anyamath@hs.uci.edu|
22417248|NCT01763918|Amgen Inc.|Study Director|866-572-6436||
22417249|NCT00897949|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22417250|NCT01553747|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22417251|NCT00102687|Celgene Corporation|CL Beach||CLBeach@celgene.com|
22417252|NCT00767338|University of Michigan|Gregory Christman, MD|734-764-8142|growthh@umich.edu|
22417253|NCT01490931|Univeristy of Pennsylvania School of Dental Medicine|Elliot V Hersh DMD, MS, PhD Professor of Pharmacology|215-898-9686|evhersh@pobox.upenn.edu|
22417254|NCT03253744|National Cancer Institute|Dr. Deborah E. Citrin|240-760-6206|citrind@mail.nih.gov|
22391203|NCT00822770|The University of Texas (UT) MD Anderson Cancer Center|Marina Konopleva, MD, PhD / Associate Professor|713-794-1628|mkonople@mdanderson.org|
22417255|NCT06279871|Arcturus Therapeutics, Inc.|Arcturus Therapeutics, Inc.|858-900-2660|clinicaltrials@arcturusrx.com|
22417256|NCT04744155|Children's Mercy Kansas City|Melissa K. Miller MD|8162343430|mmiller@cmh.edu|
22417257|NCT05528861|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
22417258|NCT01652976|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
22417259|NCT01602172|VA Pittsburgh Healthcare System|Lauren M. Broyles, PhD, RN|412-360-2269|Lauren.Broyles@va.gov|
22417260|NCT03739138|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22417261|NCT01056640|Mayo Clinic|Dr. Paul Takahashi|507-284-2511|takahashi.paul@mayo.edu|
22417262|NCT01803269|University of Chicago|Theodore Karrison, PhD|773-702-9326|tkarrison@health.bsd.uchicago.edu|
22417263|NCT03069677|University of Pennsylvania|Veena Graff MD, MS|(215) 662-8244|veena.graff@uphs.upenn.edu|
22417264|NCT00518882|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22417265|NCT04776954|University of Minnesota|Michael Todd|6126264551|mmtodd@umn.edu|
22417266|NCT04740931|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22417267|NCT04475250|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-4200|joseph.tobias@nationwidechildrens.org|
22417268|NCT02696031|Novartis Pharma AG|Study Director|1-888-669-6682|novartis.email@novartis.com|
22417269|NCT02339740|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22417270|NCT00063882|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22417271|NCT04588688|University of Michigan|Tobias Else|734-936-1319|telse@med.umich.edu|
22417272|NCT01855048|Organization:Institute of iNtRON Biotechnology|Jun SooYoun, Ph.D. / Executive Director/ Principal researcher|+82-31-739-5332|jsy@intron.co.kr|
22417273|NCT02994355|University of Washington|Dr. R. Scott McClelland|+206-543-4278|mcclell@uw.edu|
22417274|NCT03050918|Vanderbilt University Medical Center|Maame Yaa Yiadom|615-936-0087|maya.yiadom@vumc.org|
22417275|NCT02972502|OhioHealth Research Institute|Chelsea Blessing, PhD|(513) 461-1772|chelsea.blessing@ohiohealth.com|
22417276|NCT03832738|Akros Pharma Inc.|Kazuhiro Okamiya|609-919-6123|okamiya@akrospharma.com|
22417277|NCT03852459|Aponia Labs|Kenneth Corroon|917-574-5335|kcorroon@aponialabs.com|
22417278|NCT00049842|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22417279|NCT00578071|Duke University Medical Center Radiation Oncology|Dr Brian Czito|668-7336|brian.czito@duke.edu|
22417280|NCT05486065|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22417281|NCT00854373|University of California, San Francisco|Mitchell P. Rosen, MD|415-353-7475|rosenm@obgyn.ucsf.edu|
22417282|NCT02537873|Virginia Commonwealth University|F. Gerard Moeller, M.D.|804-628-7788|lmbobb@vcu.edu|
22391204|NCT04593823|scPharmaceuticals|Dr. John Mohr, PharmD; Sr VP Clinical Development and Medical Affairs|7813017220|jmohr@scpharma.com|
22391205|NCT04974723|Radius Health, Inc.|Clinical Operations|617-551-4000|info@radiuspharm.com|
22417283|NCT02442271|AbbVie|Global Medical Services|800 633-9110||
22417284|NCT00703508|Virginia Commonwealth University|Dr. Kai Cheang|(804) 828-2257|kicheang@vcu.edu|
22417285|NCT03657108|Icahn School of Medicine at Mount Sinai|Ketan Badani|(212) 241-3919|ketan.badani@mountsinai.org|
22417286|NCT01064323|Johns Hopkins University School of Medicine|Harry Silber, M.D., Ph.D. Assistant Professor of Medicine, Division of Cardiology|410-550-5717|hsilber@jhmi.edu|
22431358|NCT01840072|Tulane University|Dr. Jiang He|5049885165|jhe@tulane.edu|
22431359|NCT01251757|Kaiser Permanente Center for Health Research|William M Vollmer, PhD|503-335-2400|william.vollmer@kpchr.org|
22417287|NCT00831623|LomaLindaU|Dr. Jason Slater|909-558-4243|jaslater@llu.edu|
22417288|NCT00486018|Genentech, Inc.|Medical Communications|800-821-8590||
22417289|NCT01138111|Piramal Imaging|Juergen Hirschfeld, Senior Director Regulatory Affairs|+49 30 461 1246 15|juergen.hirschfeld@piramal.com|
22417290|NCT01118117|Terumo Medical Corporation|Adam Thompson, Clinical Program Manager|201-398-3283|adam.thompson@terumomedical.com|
22417291|NCT02149121|Celltrion, Inc.|SungYoung Lee|+82 32 850 6532|SungYoung.Lee@celltrion.com|
22417292|NCT04464993|Arizona State University|Matthew P Buman, PhD, Director & Professor|602-496-8617|mbuman@asu.edu|
22417293|NCT07106489|Universidad Nacional de Colombia|Leidy Tatiana Reyes Vega|+573016971711|ltreyesv@unal.edu.co|
22417294|NCT00603291|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22417295|NCT03755336|University of Nebraska Omaha|Nathaniel Hunt|402-554-4195|nhunt@unomaha.edu|
22417296|NCT04583163|Hackensack Meridian Health|Tania Zielonka|5519964452|tania.zielonka@hmhn.org|
22417297|NCT03943537|McLean Hospital|Virginie-Anne Chouinard|617-855-3034|vchouinard@mclean.harvard.edu|
22417298|NCT03860207|Y-mAbs Therapeutics|Joris Wilms|+45 7026 1414|clinicaltrials@ymabs.com|
22417299|NCT00493246|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
22417300|NCT00102518|Otsuka Pharmaceutical Development & Commercialization, Inc.|Margaretta Nyilas|609-452-5673|Margaretta.nyilas@otsuka-us.com|
22417301|NCT00595335|Mayo Clinic|Dr. Rebecca S. Bahn|507-284-2462|bahn.rebecca@mayo.edu|
22417302|NCT05506930|Medical University of South Carolina|Natalie Barnett|(843) 792-5454|barnettn@musc.edu|
22417303|NCT02786277|Yale University|F. Perry Wilson|203-737-1704|francis.p.wilson@yale.edu|
22417304|NCT01013649|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
22417305|NCT00493779|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22417306|NCT01647958|EndoGastric Solutions|Adrian Lobontiu|650-474-9259|alobontiu@endogastricsolutions.com|
22417307|NCT01131299|NIH NHLBI|Dr. Marcelo Amar|301-402-0521|mamar@mail.nih.gov|
22417308|NCT01300624|Brain Rehabilitation Research Center, Malcom Randall VA, Gainesville, FL|Lisa Edmonds, PhD|352.262.4465|lisa.annamarie.edmonds@gmail.com|
22417309|NCT01398059|University of Prince Edward Island|Dr. Travis Saunders|902-566-0641|trsaunders@upei.ca|
22417310|NCT01207440|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22417311|NCT01592721|UTexas_SanAntonio|Anand B. Karnad, MD|2104501365|regulatoryaffairs@uthscsa.edu|
22417312|NCT00118378|New York State Psychiatric Institute|Dr. Judith Rabkin|212.543.5762|jgr1@columbia.edu|
22417313|NCT01408563|Massachusetts General Hospital|Dr. Zachariah DeFilipp|617-643-3944|ZDEFILIPP@mgh.harvard.edu|
22417314|NCT00997139|Northwestern University Department of Dermatology|Clinical Trials Unit Coordinator|312-695-6829|mandybrowning2015@u.northwestern.edu|
22417315|NCT00313443|Unité de Recherches Thérapeutiques. Service de Médecine Interne A. Hôpital Lariboisière. Paris, France|Dr Carmelo Lafuente-Lafuente|+33 1 49 95 63 37|c.lafuente@nodo3.net|
22417316|NCT02091141|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
22417317|NCT02246439|RedHill Biopharma Ltd.|Dr. Terry Plasse|+972-(0)3-541-3131|terry@redhillbio.com|
22417318|NCT03439852|University of Hawaii at Manoa, Office of Research Studies|Sharleen Andreshak|808 356 5762|sfa2@hawaii.edu|
22417319|NCT05713552|Johnson & Johnson Vision Care, Inc. (JJVC)|Benjamin Straker|1-800-843-2020|bstraker@its.jnj.com|
22417320|NCT04551911|OPKO Health Inc|OPKO Health Inc|305-575-4100|contact@opko.com|
22417321|NCT01383421|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
22417322|NCT00666848|Vanderbilt University School of Medicine|Nancy J. Brown, M.D.|615-343-8701|nancy.j.brown@vanderbilt.edu|
22417323|NCT01272921|Northwestern University|Mark Kendall, M.D.|312-695-2528|m-kendall@northwestern.edu|
22417324|NCT01132664|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registry@novartis.com|
22417325|NCT00882206|University of Minnesota, Pediatric Hematology Dept.|Dr. Michael Burke, MD|612.672.7422||
22417326|NCT04271735|National Heart Lung and Blood Institute (NHLBI)|Michael Sack, M.D. Principal Investigator, NIH, NHLBI|301.402.9259|sackm@nhlbi.nih.gov|
22417327|NCT04268316|Stanford University|Margot Paul|415-625-3127|mdpaul@stanford.edu|
22417328|NCT00746018|Memorial Sloan Kettering Cancer Center|Nadeem Abu-Rustum, M.D.|212-639-7051|abu-rusn@mskcc.org|
22417329|NCT02040779|Teva Branded Pharmaceutical Products R&D|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22417330|NCT02132637|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22417331|NCT01030653|University of Michigan|Manjuanth Pai|7346470006|amitpai@med.umich.edu|
22417332|NCT00922272|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22417333|NCT03197558|Tusker Medical|Laura England, PhD|(650) 223-6909|lengland@tuskermed.com|
22417334|NCT01237353|University of California San Francisco|Dr. Leslie Benet|415-476-3853|leslie.benet@ucsf.edu|
22417335|NCT02581163|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22417336|NCT03394755|Cellphire Therapeutics, Inc.|Mike Fitzpatrick, PhD|240-268-2470|mfitzpatrick@cellphire.com|
22417337|NCT03533374|Aarhus University Hospital|Professor Sandor Beniczky|+4526981536|sbz@filadelfia.dk|
22417338|NCT03633448|Reckitt Benckiser Inc.|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
22417339|NCT00946348|Geisel School of Medicine at Dartmouth|Alan I. Green, M.D.|603-650-7549|alan.i.green@dartmouth.edu|
22417340|NCT02384941|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22417341|NCT02493777|Ironshore Pharmaceuticals and Development, Inc.|Chief Scientific Officer|13457498174|bev@ironshorepharma.com|
22417342|NCT00468728|Optimer Pharmaceuticals, Inc.|Chief Scientific Officer|1-855-343-4243|medinfo@optimerpharma.com|
22417343|NCT01705236|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22417344|NCT06005597|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
22417345|NCT02224573|Greenwich Biosciences|Medical Enquiries|1-833-424-6724|medinfo@greenwichbiosciences.com|
22417346|NCT02546362|CEFALY Technology|Clinical Trials Department director|+32 4 367 67 22|info@cefaly.com|
22404928|NCT05742841|Wake Forest School of Medicine|Nick Ashburn|336-716-4646|n.ashburn@wakehealth.edu|
22404929|NCT02088541|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
22404930|NCT00612339|Duke University Medical Center|Katherine Peters, MD, PhD|9196846173|katherine.peters@duke.edu|
22404931|NCT03750240|NYU Langone Health|Guillaume Madelin, PhD|(212) 263-3343|guillaume.madelin@nyulangone.org|
22404932|NCT02848313|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
22404933|NCT03030183|Ra Pharmaceutical, Inc|Sponsor Ra Pharmaceutical, Inc|1 617 401 4060|trials@rapharma.com|
22404934|NCT03062267|University of Washington|Principal Investigator|(206) 685-9655|dbenzeev@uw.edu|
22404935|NCT02971007|Matinas Biopharma|Director Clinical Development|9082953235|jjohnson@matinasbiopharma.com|
22404936|NCT02911818|The University of Pennsylvania Center for Weight and Eating Disorders|Dr. Thomas Wadden|215-746-5046|wadden@pennmedicine.upenn.edu|
22404937|NCT01333098|Washington University School of Medicine|Eric Lenze, MD|314-362-5154|lenzee@wustl.edu|
22404938|NCT00063986|ECOG Statistical Office|Study Statistician|617-632-3012||
22404939|NCT02471586|Abbott|Kristina M Gibbens, Senior Clinical Project Manager|+1 651-756-3859|Kristina.gibbens@abbott.com|
22404940|NCT01601704|Orexigen Therapeutics, Inc.|Global Head of Development|858-875-8600|MedInfo@Orexigen.com|
22404941|NCT01783470|NIDDK / NIH|Aaron M. Cypess, MD, PhD, MMSc|301-435-9267|aaron.cypess@nih.gov|
22404942|NCT03276572|Weill Cornell Medicine|Dr. Scott Tagawa|646-962-2027|stt2007@med.cornell.edu|
22404943|NCT02580240|Subei People's Hospital|QQLv|18051063899|bonhomie2014@163.com|
22404944|NCT00607919|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22404945|NCT00646581|UMass Medical School|Matthew Goodnow|508-856-2494|matthew.goodnow@umassmed.edu|
22404946|NCT01766986|University Hospital Hamburg-Eppendorf|Dr. Matthias Reeh|+49015222816521|m.reeh@uke.de|
22404947|NCT00239356|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22404948|NCT01001572|Novartis Pharmaceuticals|Study Director|862 778-8300||
22404949|NCT01707095|University of Colorado|Thomas Robinson|303-724-2728|thomas.robinson@ucdenver.edu|
22404950|NCT01237223|Novartis Pharmaceuticals|Study Director|862-778-8300||
22404951|NCT03967847|University Hospitals Cleveland Medical Center|John Strony, MD|908-268-3663|john.strony@uhhospitals.org|
22404952|NCT00724815|NuPathe Inc.|Mark Pierce, MD, PhD|484-567-0130|mpierce@nupathe.com|
22404953|NCT01089569|International Diabetes Center|Dr. Richard M. Bergenstal|952-993-1913|richard.bergenstal@parknicollet.com|
22404954|NCT00445341|National Cancer Institute, National Institutes of Health|Kieron Dunleavy, M.D.|301-435-1007|DunleavK@mail.nih.gov|
22404955|NCT00641706|Mayo Clinic|Evanthia Galanis, M.D.|(507) 284-3902|Galanis.evanthia@mayo.edu|
22404956|NCT00813917|Mayo Clinic|Jon O. Ebbert, MD|507-266-1944|nicotineresearch@mayo.edu|
22404957|NCT05441540|UNC School of Medicine|Benjamin Succop|8284439726|benjamin_succop@med.unc.edu|
22404958|NCT01359046|Mayo Clinic|Dr. John Gebhart|507-266-7711|gebhart.john@mayo.edu|
22404959|NCT01229891|National nutrition and food technology institute|T Neyestani|0982122376471|neytr@yahoo.com|
22404960|NCT00105183|Fresenius Biotech|Regulatory Affairs|781 699 4618|anne.kuan@fresenius-biotech.com|
22404961|NCT02135900|Staten Island University Hospital|Michel Chalhoub, MD|7182269000|chalhoubmichel@gmail.com|
22404962|NCT00615914|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22404963|NCT00270998|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
22404964|NCT04075396|Janssen Research & Development, LLC|Executive Medical Director Oncology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22404965|NCT04737759|Boston College|Dr. Karen Lyons|6175526379|karen.lyons@bc.edu|
22404966|NCT00294684|NIDDK|Ed Doo||dooe@niddk.gov|
22404967|NCT01515488|Maricopa Integrated Health System|Madhumita Sinha, MD, MHSM|602-344-5404|madhumita_sinha@dmgaz.org|
22417347|NCT02025010|Dana-Farber Cancer Institute|Mary-Ellen Taplin, MD|617-582-7221|mtaplin@partners.org|
22404968|NCT01981109|Dendreon|Shabnam Vaziri|206.455.2323|svaziri@Dendreon.com|
22404969|NCT01248364|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22417348|NCT01359748|Aguiflai Iberica, SL|Angel Pons Ferré|+34 93 7540370|calidad@keito.com|
22417349|NCT02312713|University of North Carolina at Chapel HIll|Kelli Allen|919-966-0558|kdallen@email.unc.edu|
22417350|NCT02003911|Mount Sinai Kravis Children's Hospital|Dr. Lindsey Douglas|2122416500|lindsey.douglas@mssm.edu|
22417351|NCT05444543|University Hospitals Cleveland Medical Center|Dr. Thomas Sferra|(216)844-1765|Thomas.Sferra@UHhospitals.org|
22417352|NCT03808740|Vanderbilt University Medical Center|Dr Cyndya Shibao|6159364584|cyndya.shibao@vumc.org|
22417353|NCT01134627|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22417354|NCT00977431|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22417355|NCT00597116|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22417356|NCT02743728|University of Minnesota|Dr. Bernadette Gillick|612-626-5898|gillick@umn.edu|
22417357|NCT00589849|Creighton University|Dr. Aryan Mooss|402-280-4566|aryanmooss@creighton.edu|
22431360|NCT02284893|AstraZeneca|Katarina Fridman|+46(31)7762040|katarina.fridman@astrazeneca.com|62040
22431361|NCT05807945|ABC Medical Center|Angel Cruz Miranda|5516647121|cruz.angel@aol.com|
22431362|NCT03817580|Eurofins EVIC|Commercial Manager|40 213357090|luciachirita@eurofins.com|
22431363|NCT00105066|National Institute On Aging|Dr. James Strait|4105588084|straitj@mail.nih.gov|
22404970|NCT01767519|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22431364|NCT02231580|Ipsen|Vice President Early Development & Clinical Pharmacology||clinical.trials@ipsen.com|
22431365|NCT03861338|New York State Psychiatric Institute|John Mariani MD|6467748181|john.mariani@nyspi.columbia.edu|
22431366|NCT05552859|Sanofi|Trial Transparency email recommended (Toll free for US & Canada)|800-633-1610|Contact-us@sanofi.com|Option 6
22431367|NCT04261985|UCLA DGSOM|Dr. Alma Guerrero|3102672789|aguerrero@mednet.ucla.edu|
22431368|NCT05216380|UMass Chan Medical School|Jamie Faro|7744553744|Jamie.faro@umassmed.edu|
22431369|NCT01722669|Beth Israel Deaconess Medical Center, Harvard Medical School|Jeffrey Zwicker, Division of Thrombosis and Haemostasis, Division of Hematology and Oncology|617-667-9299|jzwicker@bidmc.harvard.edu|
22431370|NCT04312022|University of Nebraska at Omaha|Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
22431371|NCT02927964|Stanford University|Dr. Ronald Levy|(650) 725-6452|levy@stanford.edu|
22431372|NCT02255656|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22431373|NCT03734536|Smith+Nephew|Samantha Andrews|9789718990|samantha.andrews@smith-nephew.com|
22404971|NCT03539861|University of Michigan|Lenar Yessayan|734-763-9041|lenar@med.umich.edu|
22404972|NCT01555905|University of Florida|D. Barbara Smith|3522945315|bksmith@ufl.edu|
22404973|NCT00996593|GlaxoSmithKline|GSK Response Center|866-435-7343||
22404974|NCT01033487|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22404975|NCT02849626|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22404976|NCT02026206|Pusan Natinal University Yangsan Hospital|Professor Yong-Il Shin|82-55-360-2872|rmshin01@gmail.com|
22404977|NCT00735670|University of Michigan Spinal Cord Injury System|Dr. Denise G Tate|734 763-0971|dgtate@umich.edu|
22404978|NCT04046341|Children's Hospital of Philadelphia|Marsha Wallace|2155900119|wallacem@chop.edu|
22404979|NCT04377672|Johns Hopkins University|Sanjay K. Jain|4105028241|sjain5@jhmi.ed|
22431374|NCT03448393|National Cancer Institute|Dr. Nirali N. Shah|240-760-6970|shahnn@mail.nih.gov|
22431375|NCT00689884|Dartmouth-Hitchcock Medical Center|John M. Hill, MD - Principal Investigator|603-650-4628|john.m.hill@hitchcock.org|
22431376|NCT00937105|University Hospitals Eye Institute|Loretta Szczotka-Flynn OD, PhD|216-844-3609|loretta.szczotka@uhhospitals.org|
22431377|NCT04983979|Queen Mary University of London|Emily Kirkpatrick|02078825673|cvctu@qmul.ac.uk|
22431378|NCT04144517|Mural Oncology, Inc.|Study Director|+1 (781) 614-0100|clinicaltrials@muraloncology.com|
22431379|NCT04308512|Baylor College of Medicine|Dr. Bijan Najafi|(424) 467-7127|najafi.bijan@gmail.com|
22431380|NCT03176173|Stanford University|Clinical Associate Professor, Radiation Oncology - Radiation Therapy|(650) 723-6171|mgens@stanford.edu|
22431381|NCT05929326|Hung Vuong Hospital|Dr. Huan N Pham|+84906884435|huanpmd@gmail.com|
22431382|NCT05700422|Scheie Eye Institute|Ophthalmology Clinical Research|215-662-8038|ophth.clinicalresearch@pennmedicine.upenn.edu|
22431383|NCT02625428|Mayo Clinic|J. Scott Kriegshauser|480-342-5664|skriegshauser@mayo.edu|
22431384|NCT04093453|Imperial College London|Dr. Edward Chambers|+44 20 7594 0959|e.chambers@imperial.ac.uk|
22431385|NCT05212168|Vaxart|Maria Apkarian|+1 (650) 779-4560|mapkarian@vaxart.com|
22431386|NCT03549507|Children's Hospital of Philadelphia|Misun Hwang|267-425-7129|hwangm@chop.edu|
22431387|NCT03941093|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1337|lapis@fibrogen.com|
22431388|NCT03048682|Wake Forest Baptist Health|Dr. Catherine Matthews|336-716-4131|camatthe@wakehealth.edu|
22431389|NCT03359395|Wake Forest Health Science|T. Quinn McCutchen, MD|336.716.4498|tmccutch@wakehealth.edu|
22431390|NCT04494971|Pennington Biomedical Research Center|Dr. Hanim Ecem Diktas|(225) 763-2832|hanim.diktas@pbrc.edu|
22431391|NCT02333799|Global Alliance for TB Drug Development|Eugene Sun, MD|212-227-7540|eugene.sun@tballiance.org|
22431392|NCT05484895|Emory University|Dr. Don Operario|404-727-0503|don.operario@emory.edu|
22431393|NCT05395936|Atrium Health Wake Forest Baptist Comprehensive Cancer Center|Adam Katz|336-716-4171|akatz@wakehealth.edu|
22431394|NCT04795531|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22404980|NCT02447458|Takeda|Takeda Study Registration Call Center|+1-877-825-3327|medicalinformation@tpna.com|
22417358|NCT02854059|Hansa Biopharma AB|Elisabeth Sonesson (Director Clinical Operations)|+46 (0)708 54 86 46|elisabeth.sonesson@hansabiopharma.com|
22417359|NCT00411398|SUNY Upstate|Thomas Schwartz|3154643166|schwartt@upstate.edu|
22417360|NCT00958126|Seqirus|Clinical Trials Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com|
22417361|NCT00720226|Johns Hopkins University School of Medicine|Robert A. Wise|410 550 0545|rwise@jhmi.edu|
22417362|NCT01481740|Department of Women's & Obstetric Anesthesia, IWK Health Centre|Dr. Ronald B George|902-470-6627|rbgeorge@dal.ca|
22417363|NCT03401073|BIDMC|Christopher Gibbons MD|617-632-8454|cgibbons@bidmc.harvard.edu|
22417364|NCT00733369|DePuy Ortho Joint US|Kimberly Dwyer, PhD, CCRA||kdwyer2@its.jnj.com|
22417365|NCT01470612|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22417366|NCT01813071|PATH|Jennifer O'Reilly|202-540-4510|joreilly@path.org|
22417367|NCT01036490|Hines VA Hospiral|David J. Leehey, M.D.|(708)2022589|david.leehey@va.gov|
22417368|NCT00123955|Wake Forest Baptist Health|Dr. Dalane Kitzman|336-716-3274|dkitzman@wakehealth.edu|
22417369|NCT02218307|University of Miami|Dr. Roy Casiano|305-243-1870|rcasiano@miami.edu|
22417370|NCT04459715|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22417371|NCT02427984|Medical technology laboratory, Rizzoli Orthopaedic Institute|Susanna Stea|00390516366861|stea@tecno.ior.it|
22417372|NCT02054130|MedImmune, LLC|Fred Reid|+44 (0) 203 749 6512|information.center@astrazeneca.com|
22417373|NCT00364949|Northwestern University|Dr. Andrea Dunaif|312-503-2902|a-dunaif@northwestern.edu|
22417374|NCT00131378|Massachusetts General Hospital|Dr. Karen K. Miller|617-726-3870|kkmiller@partners.org|
22417375|NCT00003224|University of Virginia|Craig Slingluff|434-924-1730|cls8h@virginia.edu|
22417376|NCT00866658|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22417377|NCT00353652|University of Texas Southwestern Medical Center|Wanpen Vongpatanasin|2146458000|wanpen.vongpatanasin@utsouthwestern.edu|
22417378|NCT01304693|Alcon Research, Ltd.|Georges Weissgerber, Executive Director, Novartis Pharma AG|1-888-451-3937|alcon.medinfo@alcon.com|
22404981|NCT00405652|Novartis Pharmaceuticals|Study Director|862-778-8300||
22404982|NCT01637870|University of Iowa Hospitals and Clinics|Abbey Hardy-Fairbanks, MD|319-356-2291|abbey-hardy-fairbanks@uiowa.edu|
22404983|NCT00435994|Indiana University|Robert Tepper, MD, Ph.D.|317-274-9647|rtepper@iu.edu|
22404984|NCT03096444|University of Miami|Leigh Nattkemper|3055889734|Lxn202@med.miami.edu|
22404985|NCT03505749|VA Portland Health Care System|Dr. Vanessa Somohano, Postdoctoral Research Fellow|503-220-8262|vanessa.somohano@va.gov|
22404986|NCT03846219|Immunic AG|Andreas Muehler, MD|+4917678738359|andreas.muehler@imux.com|
22404987|NCT05109702|Hanall Biopharma|Project Manager|82-222041763|parksm@hanall.co.kr|
22404988|NCT00788697|Bracco Diagnostics Inc.|Maria Luigia Storto, MD Executive Director X-Ray and Ultrasound Medical Affairs|(609) 514-2200|MariaLuigia.Storto@diag.bracco.com|
22404989|NCT04350905|NIH|Jessica Manning|+85561856557|Jessica.manning@nih.gov|
22404990|NCT00629525|Duke University|Dr. Daniel George|919-668-4615|daniel.george@duke.edu|
22404991|NCT00903370|Icahn School of Medicine at Mount Sinai|Annetine C. Gelijns, PhD|212-659-9568|annetine.gelijns@mssm.edu|
22404992|NCT00367432|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22404993|NCT00014911|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22404994|NCT00744848|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
22404995|NCT05064332|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22404996|NCT00089102|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
22404997|NCT01569087|Biocad|Roman Ivanov, Director of Clinical Trials|+7 (812) 380 49 33|ivanov@biocad.ru|950
22404998|NCT04532918|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22404999|NCT03537092|University Of Pittsburgh|Leslie Meyn, PhD|412-641-4233|meynla@mwri.magee.edu|
22405000|NCT04209530|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|clinicaltrials@endo.com|
22405001|NCT01100658|Masonic Cancer Center, University of Minnesota|Alicia Kunin-Batson|612-624-6931|kunin003@umn.edu|
22405002|NCT01094808|Mayo Clinic|Dr. Michael Camilleri|507-266-2305|camilleri.michael@mayo.edu|
22405003|NCT00369278|Novartis Pharmaceuticals|Study Director|862-778-8300||
22417379|NCT00931268|Q-Med AB|Head of Clinical Development|+46 (0)18 4749000|reception.SEUPP@galderma.com|
22417380|NCT02466230|Weill Cornell Medical College|Marc Dubin, M.D.|(212) 746-5817|mrd9035@med.cornell.edu|
22417381|NCT02072148|Icahn School of Medicine at Mount Sinai|Dr. Raymond L Chai|(212) 844-8775|Raymond.Chai@mountsinai.org|
22417382|NCT00430495|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22417383|NCT04132336|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22417384|NCT02488330|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22417385|NCT01570348|FHCRC|Dr. George Georges|(206) 667-6886|ggeorges@fredhutch.org|
22417386|NCT01621191|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22417387|NCT02660528|Brigham and Women's Hospital|Dr. Jessica Harder|617-525-7919|jaharder@bwh.harvard.edu|
22417388|NCT04355663|Third Faculty of Medicine, Charles University|PhDr. Kamila Řasová, Ph.D.|+420604511416|kamila.rasova@gmail.com|
22405004|NCT02044822|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22405005|NCT02967172|University of Iowa|Michael Willey, MD|319-384-8452|michael-willey@uiowa.edu|
22417389|NCT01026181|Royal Alexandra Hospital|Xinzhe Shi|7807356735|xinzhe.shi@ahs.ca|
22417390|NCT03529461|Bristol Hospital|Makram Gedeon, MD|8605853339|mgedeon@bristolhospital.org|
22417391|NCT02787408|Edwards Lifesciences|Ted Feldman, MD|949-250-2500|Feldman_Info@edwards.com|
22417392|NCT01782482|Alcon Research, Ltd.|Sharon Thomas, O.D., Sr. Principal Clinical Scientist|1-888-451-3937|alcon.medinfo@alcon.com|
22417393|NCT02408120|Emory University|Dr. Priyathama Vellanki|404-251-8957|priyathama.vellanki@emory.edu|
22417394|NCT01010750|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22417395|NCT00466726|GIMEMA|Alfonso Piciocchi|+39 06 70390513|a.piciocchi@gimema.it|
22417396|NCT02096588|SKCCC SOM Onc Breast and Ovarian Cancer|Dr. Karen Smith ; Clinical Associate|2026606500|ksmith60@jhmi.edu|
22431395|NCT01323192|Janssen Pharm KK Japan|Medical Director|+81-3-4411-5509||
22431396|NCT00633126|Cerexa, Inc.|David Friedland, MD|510-285-9200|clinicaltrials@cerexa.com|
22431397|NCT01212900|National Heart Lung and Blood Institute|Mehta, Nehal|+1 301 827 0483|mehtann@mail.nih.gov|
22431398|NCT01276704|University of Kansas Medical Center|Bruce F. Kimler, Ph.D.|913-205-6382|bkimler@kumc.edu|
22431399|NCT01168596|University of Florida Center for Movement Disorders and Neurorestoration|Irene A. Malaty, MD|352-273-5550|Irene.Malaty@neurology.ufl.edu|
22431400|NCT00710593|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
22431401|NCT01441960|Mass General Hospital|Ala Nozari|978-318-3933|anozari@partners.org|
22431402|NCT02004158|Massachusetts General Hospital|Jeff Huffman|617-724-2910|jhuffman@partners.org|
22431403|NCT03302767|Institut Bergonié|Véronique GERAT-MULLER|0556337839|v.gerat-muller@bordeaux.unicancer.fr|
22431404|NCT01385579|Northwestern University|Dr. Muriel Jean-Jacques, Assistant professor|312-503-9642|mjean@nmff.org|
22431405|NCT01681147|Joslin Diabetes Center|Dr. Florence Brown|617-309-2675|Florence.Brown@joslin.harvard.edu|
22431406|NCT01195597|University of Catania|Prof Riccardo Polosa|0957436413|polosa@unict.it, p.caponnetto@unict.it|0039
22431407|NCT03243084|UNC Chapel Hill|Julianna Prim|919-962-5271|jhprim@email.unc.edu|
22405006|NCT02025530|University of Manchester|Professor Alexander Heazell|+441612766484|alexander.heazell@manchester.ac.uk|
22405007|NCT05364437|Imperial College London|Gary Frost|07872850308|g.frost@imperial.ac.uk|
22405008|NCT03551626|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
22405009|NCT00653328|Vanderbilt-Ingram Cancer Center|Marta Crispens, M.D.|800-811-8480|marta.crispens@vanderbilt.edu|
22405010|NCT02100410|Alcon Research, Ltd.|Joachim Nick, Dipl.-Ing. (FH), Clinical Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22405011|NCT00364819|University of California Davis|Christopher L. Bowlus, MD|916-734-8986|clbowlus@ucdavis.edu|
22405012|NCT00443846|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22417397|NCT01258101|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22417398|NCT00757848|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22417399|NCT02071953|University of Pennslyvania|Ricardo Walter|215-898-9164|walterr@dental.upenn.edu|
22417400|NCT01020799|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22417401|NCT05012865|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22417402|NCT01602016|University of Arkansas for Medical Sciences|Tracy Gatlin|501-686-6803|tlgatlin@uams.edu|
22417403|NCT02556307|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
22417404|NCT03438227|Brown University|Dr. Methodius Tuuli|401-430-1575|MTuuli@wihri.org|
22417405|NCT03977701|San Diego State University|Dr Jessica Barlow, Principal Investigator|6195943807|jbarlow@sdsu.edu|
22417406|NCT00430950|Daiichi Sankyo|Global Clinical Leader|908-992-6400|DataSharing@dsi.com|
22417407|NCT02429934|University of California at Los Angeles|Dr. Bevra Hahn|8184869745|bhahn@mednet.ucla.edu|8184869745
22417408|NCT00869024|University of Minnesota|Dr. Ganesh Raveendran|612-626-4283|ravee001@umn.edu|
22417409|NCT00293202|University of California, Davis|George Kaysen MD PhD|916-734-3774|gakaysen@ucdavis.edu|
22417410|NCT01564459|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22417411|NCT01606852|University of Minnesota|Craig Weinert MD|612-624-0999|weine006@umn.edu|
22417412|NCT03864042|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22417413|NCT01698775|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22417414|NCT01869478|Mayo Clinic|Kevin M. Barrett, MD|904-953-9740|Barrett.Kevin@mayo.edu|
22417415|NCT04527328|Alkahest, Inc.|Head of Communications|(650) 801-0474|sm-Trials-alkahest@grifols.com|
22417416|NCT01244061|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22417417|NCT03166124|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22417418|NCT00766831|Medical Affairs|Clinical Research Associate|82-2-2094-4835||
22417419|NCT01398839|Topcon Medical Systems|Bob Gibson|(201) 599-5121|RGIBSON@TOPCON.COM|
22417420|NCT00788593|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
22417421|NCT00515034|Johnson and Johnson Pharmaceutical Research and Development L.L.C.|Senior Director of Clinical Development|510 248-2310||
22417422|NCT01392326|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22417423|NCT01862419|Yale University School of Medicine|Francis Perry Wilson, MD MSCE|2037371704|francis.p.wilson@yale.edu|
22417424|NCT03487848|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22417425|NCT01558297|Yale Medical School|Dr. Rachel Barnes|2037856395|rachel.barnes@yale.edu|
22417426|NCT00094094|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22431408|NCT03641287|University of Washington Medical Center|Kathryn Pennington, MD|206-598-8300|katypenn@uw.edu|
22405013|NCT03304262|University of New Mexico|Sarah Pirio Richardson|505-272-3342|spiriorichardson@salud.unm.edu|
22417427|NCT04143243|Baylor College of Medicine|Lilian Dindo|713-440-4637|lilian.dindo@bcm.edu|
22417428|NCT02655016|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22405014|NCT03051217|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22405015|NCT00109772|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22405016|NCT01989754|Janssen Research & Development, LLC|Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22405017|NCT02516150|Massachusetts General Hospital|Courtney Balliro|617-726-1242|cballiro@partners.org|
22405018|NCT03437044|University of Florida|Dominick J. Angiolillo, MD, PhD|9042443378|dominick.angiolillo@jax.ufl.edu|
22405019|NCT01659268|College of Nursing at Ribeirão Preto, University of Sao Paulo|Cesar Eduardo Pedersoli|55(16)3602-3421|cesinhajardel@ig.com.br|
22405020|NCT00391807|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22405021|NCT01498588|Emory University|Keerthi Gogineni, MD, MSHP|404-778-1801|keerthi.gogineni@emory.edu|
22405022|NCT03168841|Western University of Health Sciences|David Shofler|9097063898|dshofler@westernu.edu|
22405023|NCT01369225|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22405024|NCT03364491|George Washington University Biostatistics Center|Principal Investigator, MFMU|301-881-9260|mfmudatasets@bsc.gwu.edu|
22405025|NCT03043807|Johns Hopkins University|Kenneth Pienta|4105023137|kpienta1@jh.edu|
22405026|NCT04539262|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22405027|NCT02351739|Acerta Pharma, LLC|Priti Patel, MD, Executive Director - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
22405028|NCT02980692|Sun Pharma Advanced Research Company Limited|Head-Clinical Development|912266455645|clinical.trials@sparcmail.com|
22405029|NCT00792701|SWOG Statistical Center|Lung Committee Statistician|206-667-6197|jmoon@fredhutch.org|
22405030|NCT01788150|Svelte Medical|Betsy Lowry|19082642181|blowry@sveltemedical.com|
22405031|NCT05507580|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22405032|NCT04702984|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22405033|NCT02665468|VA-CHOIR|Dr. Timothy P. Hogan|781-687-3181|timothy.hogan@va.gov|
22405034|NCT03862495|Skin Disease Hospital of Southern Medical University|Deputy Chief Physician Li Changchang|18585239166|lichch8@mail2.sysu.edu.cn|
22405035|NCT00064077|NRG Oncology|Angela Kuras on behalf of Michael Sill and Helen Huang|716-845-5702|kurasa@nrgoncology.org|
22405036|NCT04397796|ImmunityBio|Lennie Sender, Chief Operating Officer|855-797-9277|lennie.sender@immunitybio.com|
22405037|NCT02021071|Philips|Rami Nachabe, PhD|+1-513-926-1486|Rami.Nachabe@philips.com|
22405038|NCT03037307|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22405039|NCT00802867|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22405040|NCT01661946|Queen's University Department of Ophthalmology|Dr. Sanjay Sharma|613-544-3400|sanjay_sharma60@hotmail.com|2227
22405041|NCT03363165|Northwestern University|Mary McDermott MD|312-503-6419|mdm608@northwestern.edu|
22405042|NCT01809197|Alcon Research, Ltd.|Jessie Lemp, GMA Brand Lead - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22405043|NCT02256345|UPenn|Julio Chirinos|2158235800|julio.chirinos@uphs.upenn.edu|
22405044|NCT02052141|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22405045|NCT02156804|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22405046|NCT03000686|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22405047|NCT01484561|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22405048|NCT01112982|University of South Florida|John Carter, M.D|813-974-2473|mpatelli@health.usf.edu|
22405049|NCT03371251|Boston Pharmaceuticals, Inc.|Etienne Dumont, MD|(484) 986 8699|clinicaltrials@bostonpharmaceuticals.com|
22405050|NCT01851863|Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Institute of Digestive Disease, Shanghai, China|Sheng-Liang Chen, MD|86-21-58752345|slchenmd@hotmail.com|
22405051|NCT05425719|MediBeacon, Inc.|Richard B Dorshow, PhD|314-735-0967|rbdorshow@medibeacon.com|
22405052|NCT00889681|Medtronic- AF Solutions|Dana Wigert- Sr. Clinical Research Specialist|763-526-2802|dana.wigert@medtronic.com|
22405053|NCT01185704|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22405054|NCT00871572|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22405055|NCT04176445|Hospital Moinhos de Vento|PT Douglas Neves|(51) 9.98975514|nevesfisioup@gmail.com|
22405056|NCT00187889|University of Florida|Dr. Carl J. Pepine|352-273-9082|carl.pepine@medicine.ufl.edu|
22405057|NCT03954444|Teva Pharmaceuticals Development Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
22405058|NCT03288324|Cincinnati Childrens Hospital Medical Center|Hermine Brunner|(513) 636-6320|hermine.brunner@cchmc.org|
22405059|NCT03812588|New York State Psychiatric Institute|Dr. Bret Rutherford|646-774-8660|bret.rutherford@nyspi.columbia.edu|
22405060|NCT03094832|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22405061|NCT02679807|University of Virginia|Ronald Turner|434-981-9141|rbt2n@virginia.edu|
22405062|NCT02322411|University of Wisconsin - Madison|Dr. Nicole Pulia|6082561901|npulia@wisc.edu|11697
22405063|NCT01392378|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22405064|NCT00180271|Boston Scientific|Jill Leigh|800 227 3422|jill.leigh@bsci.com|
22405065|NCT01998880|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22405066|NCT02248857|Northwestern University|Dr. Michael Wolf|(312) 503-5592|mswolf@northwestern.edu|
22405067|NCT02671461|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22405068|NCT00345540|Novelos Therapeutics, Inc.|Vice President, Clinical Development|617-244-1616|hpalmin@novelos.com|
22405069|NCT04179786|VBI Vaccines|Dr. Francisco Diaz-Mitoma|1 613 297 3304|fdiazmitoma@vbivaccines.com|
22405070|NCT01938001|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22405071|NCT03310580|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director, Global Clinical Operations|(908) 947-3543|nramirez@aeriepharma.com|
22405072|NCT03205982|Columbia University|Rebecca Schnall, PhD, MPH|212-342-6886|rb897@columbia.edu|
22405073|NCT00607126|DAvdi Geffen School of Medicine at UCLA|Barbara Giesser,MD|310-825-7313|bgiesser@mednet.ucla.edu|
22405074|NCT01468701|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22405075|NCT02677623|Columbia University|Nisha Philip, Clinical Research Manager|212-305-4973|np2173@cumc.columbia.edu|
22405076|NCT00201760|The Ohio State University Comprehensive Cancer Center|Kari Kendra, MD|614-293-7956|Kari.Kendra@osumc.edu|
22405077|NCT02320214|Church & Dwight Co., Inc.|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
22405078|NCT01079195|Abbott|Global Medical Services|1-800-633-9110||
22405079|NCT03788616|Faculty of dentistry, Ain Shams University|Dr. Marina Fakhry assistant lecturer of pediatric dentistry|01273731722|Dr.marina.fakhry@gmail.com|+02
22405080|NCT03170258|Duke University|R. Alison Adcock, MD, PhD|919-681-7486|alison.adcock@duke.edu|
22405081|NCT00666536|Novartis Pharmaceuticals|Study Director|862-778-8300||
22405082|NCT02252068|McLean Hospital|Dr. R. Kathryn McHugh|617-855-2000|kmchugh@mclean.harvard.edu|
22405083|NCT02853123|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22405084|NCT01391468|China Medical University|II-Kuan Wang|88975681050|ikwang@seed.net.tw|
22405085|NCT03669146|The Ohio State University College of Optometry|Ann Morrison|614-570-3416|morrison.421@osu.edu|
22405086|NCT01488188|International Vaccine Institute|Dr. Jae Seung Yang|82-2-881-1198|jsyang@ivi.int|
22405087|NCT06103591|EmStop, Inc.|Phil Ebeling, CEO|763-227-9954|phil.ebeling@emstopeps.com|
22405088|NCT01510834|Pacific Health Research and Education Institute|Laurel King, PhD|808-564-5711|laurel.king@va.gov|
22405089|NCT00488059|Hoffmann-La Roche|Medical Communications|800-821-8590||
22405090|NCT04839393|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22405091|NCT00671970|Dana Farber Cancer Institute|Dr. David Reardon|(617) 632-2166|David_Reardon@DFCI.HARVARD.EDU|
22405092|NCT01510028|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22405093|NCT00633893|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22405094|NCT02741310|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22405095|NCT05091918|Stryker|Kevin Barga|+12018315073|Kevin.Barga@stryker.com|
22405096|NCT00994760|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666|clinicaltrials@nycomed.com|0
22417429|NCT02646449|University of Pittsburgh|Jack R. Cornelius, M.D., M.P.H.|412-246-5149|corneliusjr@upmc.edu|
22391206|NCT02877732|Stanford Concussion and Brain Performance Center/ Stanford Emergency Medicine|Dr. Jamshid Ghajar|(650) 725-5562|jghajar@stanford.edu|
22391207|NCT02632812|Galeno Desenvolvimento de Pesquisas Ltda.|Gilberto De Nucci, PhD, principal investigator|55.19.32516928|denucci@gilbertodenucci.com|
22391208|NCT00952848|Virginia Commonwealth University|Thomas J. Smith, MD, FACP|410-955-2091|tsmit136@jhmi.edu|
22391209|NCT03197025|National Cancer Institute|Scott Norberg, DO|301-275-9668|scott.norberg@mail.nih.gov|
22391210|NCT00217022|Mayo Clinic, Rochester MN|Dr. Darrell Pardi|507-538-1231|pardi.darrell@mayo.edu|
22391211|NCT00458393|University of California, San Francisco|David Glidden|415-514-8009|david.glidden@ucsf.edu|
22391212|NCT02725567|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22391213|NCT02625571|Penn State College of Medicine|Dr. Brian Allen|717-531-4100|ballen1@pennstatehealth.psu.edu|323492
22391214|NCT02777242|Antares Pharma, Inc.|Jonathan Jaffe, MD|609-359-3020|jjaffe@antarespharma.com|
22391215|NCT05178979|Boston College|Katelyn Sileo|617-552-3205|sileoka@bc.edu|
22391216|NCT00817336|Nathan Kline Institute|Joshua Kantrowitz|646-774-6738|jk3380@cumc.columbia.edu|
22391217|NCT03035318|Cleveland Clinic Foundation|Joseph P. Iannotti, MD, PhD|216-287-1149|IANNOTJ@ccf.org|
22391218|NCT03311269|Vascular Inisights, LLC|Ms. Lorraine Hanley, MBA|617-519-1109|lorraine.hanley@merit.com|
22391219|NCT01704547|UMGCCC|Elizabeth M. Nichols, MD|410-328-2324|enichols1@umm.edu|
22391220|NCT02413593|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22391221|NCT03845075|Saniona A/S|Janus Schreiber Larsen|7070 5225|janus.larsen@saniona.com|+45
22391222|NCT02564718|Bayer|Therapeutic Area Head|+1-888-84-22937|clinical-trials-contact@bayer.com|
22391223|NCT00104637|Columbia University|David J. Lederer, MD|212-305-7771|dl427@columbia.edu|
22391224|NCT00409409|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com|
22391225|NCT01586975|Northwestern University|Northwestern University|312.503.4394|r-bernstein@northwestern.edu|
22391226|NCT01918371|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22391227|NCT02085473|MedImmune, LLC|Meena Jain|+44 (0) 1223 895966|jainm@medimmune.com|
22391228|NCT03802617|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email olly|rinsyousiken@pharm.kissei.co.jp|
22391229|NCT00621192|Eunice Kennedy Shriver National Institute of Child Health and Human Development|David Siegel, MD|301-595-8670|siegelda@mail.nih.gov|
22391230|NCT04438382|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22391231|NCT02635386|Woman's Hospital|Dr Karen Elkind-Hirsch|2252315278|karen.elkind-hirsch@womans.org|
22391232|NCT00745498|Seoul National University Bundang Hospital Department of Ophthalmology|Dr. Se Joon Woo|+82-31-787-7377|sejoon1@hanmail.net|
22391233|NCT00358007|Thomas Jefferson University|Pramila Rani Anne, MD|215-955-6702|Pramila.Anne@jefferson.edu|
22391234|NCT00267098|Medtronic CRDM Clinical|BLOCK HF Clinical Trial Leader|763-526-2729|medtroniccrmtrials@medtronic.com|
22391235|NCT00547534|University of Rochester Medical Center|Dr. Jonathan Friedberg|585-275-4911|Jonathan_Friedberg@urmc.rochester.edu|
22391236|NCT01157377|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22391237|NCT00904722|The University of Texas (UT) MD Anderson Cancer Center|Sattva S. Neelapu, MD/Associate Professor, Lymphoma/Myeloma||CR_Study_Registration@mdanderson.org|
22405097|NCT01784211|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22405098|NCT02668952|Dept of Anesthesiology, University of New Mexico|Neal Gerstein, MD|5052722610|ngerstein@salud.unm.edu|
22405099|NCT01017549|iCAD, Inc. Xoft, Inc|Michael A. Patz MBA, RAC, Senior Director Clinical Affairs|603-882-5200|mpatz@icadmed.com|7308
22405100|NCT02057276|Cincinnati Children's Hospital Medical Center|Steve Wu, MD|513-636-4222|steve.wu@cchmc.org|
22405101|NCT01349972|University of North Carolina, Lineberger Comprehensive Cancer Center|Joshua Zeidner|(919) 962-5164|Joshua_Zeidner@med.unc.edu|
22405102|NCT01998438|Fuwai Hospital|Dr. Hongwen Ji|+86 13701229553|jihongwen@hotmail.com|
22405103|NCT03167541|Reckitt Benckiser Healthcare (UK) Ltd|Clinical Research Director, Clinical Research|+44 (0) 1482326151|clinicalrequests@rb.com|
22405104|NCT02143141|Wake Forest School of Medicine|Dr. Jessica Booth|3367188278|jbooth@wakehealth.edu|
22405105|NCT03673956|Mayo Clinic|Dr. Garret W. Choby|507-284-2533|Choby.Garret@mayo.edu|
22405106|NCT01057862|Yale University|Dr. Marc N Potenza|2037373553|marc.potenza@yale.edu|
22405107|NCT02255760|MedImmune LLC|Hasan S. Jafri, MD, Senior Director, Clinical Development|301-398-0000|jafrih@medimmune.com|
22405108|NCT00003838|National Heart Lung and Blood Institute (NHLBI)|Richard Childs, M.D. Principal Investigator, NIH, NHLBI|301.451.7128|childsr@nhlbi.nih.gov|
22405109|NCT00618813|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org|
22405110|NCT01855945|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22405111|NCT02291445|Maastricht University (Medical Center)|Z. Weerts||z.weerts@maastrichtuniversity.nl|
22405112|NCT05097157|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
22405113|NCT00770224|SWOG Statistics and Data Management Center|Lymphoma Committee Statistician|206-667-4623|lymph@crab.org|
22405114|NCT04206670|University of California, Berkeley|Robert W. Levenson|510-643-8952|boblev@berkeley.edu|
22405115|NCT02260388|University of Kansas Medical Center|Dr. Richard Barohn|9139459943|rbarohn@kumc.edu|
22405116|NCT00126672|Dana-Farber Cancer Institute|Dabora Sandra L MD|(617) 732-5500|sandy.dabora@gmail.com|
22405117|NCT00125372|Dartmouth-Hitchcock Medical Center|Konstantin Dragnev, MD|603-650-6344|Konstantin.H.Dragnev@hitchcock.org|
22405118|NCT00753623|MGH Center for Translational Pain Research|Dr. Jianren Mao|617-724-6102|mghpainresearch@partners.org|
22405119|NCT03332303|Prasco LLC|Senior Director, Quality Assurance|513-618-3333|b.inskeep@prasco.com|
22405120|NCT01296698|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Sr. Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
22405121|NCT01614912|Clinical Research, Drug Development Division|Regional Function Head of CNS Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
22405122|NCT03495817|Aclaris Therapeutics, Inc.|Aclaris Clinical Operations|1-833-225-2747|clinicaloperations@aclaristx.com|
22405123|NCT01957787|Galil Medical, a wholly owned indirect subsidiary of Boston Scientific|Sr. Clinical Trial Specialist|651-287-5000|GalilClinical@bsci.com|
22405124|NCT03380624|The Ohio State University College of Optometry|Jennifer Fogt|614-292-2020|fogt.78@osu.edu|
22405125|NCT01078558|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22405126|NCT00411086|UT MD Anderson Cancer Center|Clinical Research Operations Team, Office of VP Clinical Research|713-792-7734|CR_Study_Registration@mdanderson.org|
22405127|NCT04294095|Colorado School of Public Health|Jenn Leiferman|303-724-4386|jenn.leiferman@cuanschutz.edu|
22405128|NCT02629614|Cala Health|Sr. Director of Clinical Operations|6506515296|vivien@calahealth.com|
22405129|NCT00936299|University of Colorado Denver|Paula Riggs, MD|303.724.2235|paula.riggs@ucdenver.edu|
22405130|NCT00260429|Auxilium Pharmaceuticals, Inc.|Greg Kaufman, MD; Senior Director of Clinical Development|484 321 5900|gkaufman@auxilium.com|5920
22405131|NCT00659126|Oregon Health and Science University|Amy Huddleston|5034945626|huddlesa@ohsu.edu|
22405132|NCT02481596|Vanderbilt University Medical Center|Lindsay S. Mayberry, PhD, MS|615-875-5821|lindsay.mayberry@vumc.org|
22405133|NCT02762708|Mayo Clinic|Meera Shah, MB, ChB|507-284-0106|Shah.Meera@mayo.edu|
22405134|NCT00631540|Cook Incorporated|Scott Snyder, PhD|765-463-7537|ssnyder@medinst.com|
22405135|NCT00970268|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22405136|NCT01999946|NYU Langone Health|Joshua Lee, MD MS|646-501-3552|joshua.lee@nyulangone.org|
22405137|NCT00719953|Sourazky Tel-Aviv Medical Center|Professor N. Vaisman|972-3-6974807|vaisman@tasmc.health.gov.il|
22405138|NCT01549223|Brigham and Women's Hospital|Lawrence Tsen, MD|617-732-8216|ltsen@partners.org|
22405139|NCT02437487|Seres Therapeutics|Dr. Michele Trucksis, Chief Medical Officer|(617) 945-9626|mtrucksis@serestherapeutics.com|
22405140|NCT03801356|Cleveland Clinic|Dr. Michael Steinmetz|216-445-5754|STEINMM@ccf.org|
22405141|NCT03726333|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials_gov_Inquiries@pfizer.com|
22405142|NCT03906136|Novartis Pharmaceuticals|Study Director|(862) 778-8300|novartis.email@novartis.com|
22405143|NCT00878644|University of Utah|Marianne Gildea, BSN, MS; Director of THAPCA Trials|801-608-4907|marianne.gildea@hsc.utah.edu|
22405144|NCT01696396|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22405145|NCT01389076|University of Michigan Comprehensive Cancer Center|Dr. Mark Kaminski, M.D.|734-936-5310|mkaminsk@umich.edu|
22405146|NCT00394277|Hoffmann-La Roche|Medical Communications|800-821-8590||
22405147|NCT02371980|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22405148|NCT00547729|Abbott|Clay Cohorn - Director, Clinical Research|469-929-7116|clay.cohorn@abbott.com|
22405149|NCT01280812|UC San Francisco|Yoshimi Fukuoka, PhD, RN, FAAN|415-476-8419|yoshimi.fukuoka@ucsf.edu|
22405150|NCT01060098|Imperial College London|Sonya Abraham|+44 (0)20 3313 4114|s.abraham@imperial.ac.uk|
22391238|NCT03561597|KKWCH|Dr Chew Chu Shan Elaine|63946042|elaine.chew.c.s@singhealth.com.sg|
22391239|NCT03972397|The University of Texas Health Science Center at Houston|Anthony L Estrera, MD|713-486-5100|anthony.l.estrera@uth.tmc.edu|
22391240|NCT05347485|Janssen Scientific Affairs, LLC|Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22391241|NCT05896696|A.Stein Regulatory Affairs Consulting Ltd.|Ahava Stein|+972-9-7670002|ahava@asteinrac.com|
22391242|NCT00129935|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
22391243|NCT03445793|National Jewish Health|Jennifer Taylor-Cousar, Principal Investigator|3032702764|taylorcousarj@njhealth.org|
22391244|NCT02783573|AstraZeneca|AstraZeneca Information Center|1-877-240-9479|information.center@astrazeneca.com|
22391245|NCT00590564|Memorial Sloan Kettering Cancer Center|Dr. Gary Deng|646-888-0841|dengg@mskcc.org|
22391246|NCT00656201|Brigham and Women's Hospital|Elena Yanushpolsky, MD|617-732-4648|lgreenberg@partners.org|
22391247|NCT01434680|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22391248|NCT01012245|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22391249|NCT01367847|University of North Carolina at Chapel Hill|Deborah Jones, PhD|919-962-3995|djjones@email.unc.edu|
22405151|NCT00789724|VCU Pauley Heart Center|Antonio Abbate, MD, PhD|8048280513|aabbate@mcvh-vcu.edu|
22405152|NCT01594749|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22405153|NCT00959894|UNC School of Medicine|Michelle Floris-Moore, M.D., M.S.|919-966-2537|mfloris@med.unc.edu|
22405154|NCT00922974|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22405155|NCT01826448|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
22405156|NCT02314598|Medtronic|Ilaria Marcotullio|+39 06 32814218|ilaria.marcotullio@medtronic.com|
22405157|NCT02578992|Tri-Service General Hospital|Dr. Wei-Hung Chan|+886-2-87927128|whcken@gmail.com|
22405158|NCT03404219|Boston University|Dr. Daniel Fulford|(617) 358-6723|dfulford@bu.edu|
22405159|NCT00880100|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1- 800- 472- 263||
22405160|NCT05302804|University of Montana|Dustin Slivka|(406) 243-2389|dustin.slivka@umontana.edu|
22405161|NCT02038790|Indivior, Inc.|Global Director Clinical Development|804-379-1090||
22405162|NCT02935595|The University of Texas Health Science Center at Houston|Sudhakar Selvaraj, MD, PhD, Assistant Professor|(713) 486-2500|Sudhakar.Selvaraj@uth.tmc.edu|
22405163|NCT02431702|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22405164|NCT02058706|Karmanos Cancer Institute|Dr. Elisabeth Heath|313.576.8734|heathe@karmanos.org|
22405165|NCT02650193|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22405166|NCT03689699|Columbia University|Mark N. Stein, MD|212 305 5874|mns2146@cumc.columbia.edu|
22405167|NCT02683707|JohnsHopkinsU|Dr J William McEvoy|4109555000|jmcevoy1@jhmi.edu|
22405168|NCT01376388|GlaxoSmithKline|GSK Response Center|866-435-7343||
22405169|NCT02009930|David Grant Medical Center, Travis Air Force Base|Dr. Elijah Burton|707-423-7950|elijah.j.burton2.mil@mail.mil|
22405170|NCT02108223|Sisli etfal training anf research hospital|Fatma yazıcı yılmaz|+905079234033|fatmayazc@gmail.com|
22405171|NCT03907969|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22405172|NCT01419015|Edwards Lifesciences|Aya Saeki||Aya_Saeki@edwards.com|
22405173|NCT03943888|Seoul National University Hospital|Dr. Sang-Hwan Ji|+82-2-2072-3661|taepoongshin@gmail.com|
22405174|NCT03725293|Beaumont Hospitals|Amit Bahl, MD|(248) 898-9111|ahmit.bahl@beaumont.edu|
22405175|NCT03228394|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
22405176|NCT01525667|Pluristem Ltd.|Dr.Esther Lukasiewicz Hagai|+972-972-74-710-8600|estherl@Pluristem.com|694
22405177|NCT00291187|Vanda Pharmaceuticals Inc.|Marlene Dressman, PhD.|202-734-3462|marlene.dressman@vandapharma.com|
22405178|NCT02023268|Laboratoires Théa|Dr Pascale Pouliquen|04 73 98 14 36|p.pouliquen@laboratoires-thea.fr|
22405179|NCT01153672|University of Washington|Hannah M. Linden, MD|206-288-6989|hmlinden@u.washington.edu|
22405180|NCT00442260|West Virginia Universtiy, WVCTSI|Clinical Trials Compliance Coordinator|304-293-0216|ctgovadmin@hsc.wvu.edu|
22391250|NCT02120001|Massachusetts General Hospital|Robert Kacmarek, Director Respiratory Care|(617) 726-2000|rkacmarek@mgh.harvard.edu|
22391251|NCT04978350|UNC Lineberger Comprehensive Cancer Center|Angelo Navas|919-445-1128|angelo_navas@med.unc.edu|
22391252|NCT04991766|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22391253|NCT05781750|Kezar Life Sciences, Inc.|Regulatory Affairs|650-822-5600|clinicaltrials@kezarbio.com|
22391254|NCT05621252|Pliant Therapeutics|Pliant Therapeutics Medical Monitor|650-481-6770|clintrials@pliantrx.com|
22391255|NCT02309346|Hospital de Clínicas de Porto Alegre|Ricardo Francalacci Savaris|+55 51 33596042|rsavaris@hcpa.edu.br|
22391256|NCT01162135|Thomas Jefferson University|Jianqing Lin, MD|215-955-8874|Jianqing.Lin@jefferson.edu|
22391257|NCT01777334|GlaxoSmithKline|GSK Response Center|866-435-7343||
22391258|NCT01216072|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22391259|NCT06136897|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22391260|NCT01296555|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22391261|NCT00992992|GlaxoSmithKline|GSK Response Center|866-435-7343||
22391262|NCT01253447|The University of Texas (UT) MD Anderson Cancer Center|Marina Konopleva, MD, PHD / Professor||CR_Study_Registration@mdanderson.org|
22391263|NCT02299427|University of Alabama at Birmingham|David Schwebel|205-934-8745|schwebel@uab.edu|
22391264|NCT02108652|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22391265|NCT01182181|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22391266|NCT00511797|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22391267|NCT01278615|University of Chicago|Dr. Sonali M. Smith|773-834-2895|smsmith@medicine.bsd.uchicago.edu|
22391268|NCT02138253|Conatus Pharmaceuticals, Inc.|Steven Mento, Ph.D., CEO|858-376-2622|smento@conatuspharma.com|
22391269|NCT01390441|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22391270|NCT02446613|GlaxoSmithKline|GSK Response Center|866-435-7343||
22391271|NCT04788511|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22391272|NCT03174782|University of California, San Francisco- Fresno|Kamell Eckroth-Bernard|559-431-6226|kamell.eckroth-bernard@ucsf.edu|
22391273|NCT00778921|Novartis Pharmaceuticals|Study Director|862-778-8300||
22391274|NCT03178045|Memorial Sloan Kettering Cancer Center|Robert Allen Jr., MD|646-608-8041|allenr1@mskcc.org|
22391275|NCT01078922|Oncology Specialists, SC|Research Manager|847-410-0658|ktolzien@oncmed.net|
22391276|NCT02353468|University of Colorado|Choon-kee Lee, MD|7208489252||
22391277|NCT00153985|Dana-Farber Cancer Institute|Catherine Wu, MD|617-632-5943|cwu@partners.org|
22391278|NCT00798304|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22391279|NCT02031536|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22391280|NCT01715883|University of Pittsburgh|Matthew Morrell, MD|412-647-8477|morrellmr@upmc.edu|
22391281|NCT04211389|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
22391282|NCT01324700|University of Texas Southwestern Medical Center|E. Sherwood Brown, MD, PhD, Professor of Psychiatry|214-645-6950|sherwood.brown@utsouthwestern.edu|
22391283|NCT05479747|Faculty of Dentistry, Ain Shams University|Dr|+11112228724|AlaaMahmoud@dent.asu.edu.eg|
22391284|NCT01182207|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22391285|NCT01427738|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22391286|NCT01966978|UT Southwestern Medical Center|Dr. Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
22391287|NCT01801982|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22391288|NCT00727506|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22391289|NCT04522206|NYU LAngone Health - Long Island|Muhammad B. Tariq, M.D|602-363-1134|Muhammad.Tariq2@nyulangone.org|
22391290|NCT02650466|Alfred E. Mann Insitute at the University of Southern California|Cesar E. Blanco,PhD; Sr Director R&D|2138211619|cblanco@usc.edu|2138211619
22391291|NCT01729845|Fred Hutch Cancer Research Center|Dr. Anna Halpern|2066676233|halpern2@uw.edu|206
22405181|NCT01001234|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22405182|NCT00466661|Medical University of South Carolina|Bryan K. Tolliver, M.D., Ph.D. (Principal Investigator)|(843) 792-4869|tollive@musc.edu|
22405183|NCT01611298|Baylor College of Medicine|Dr. Robert A. Krance|832-824-4661|rakrance@txch.org|
22405184|NCT03238352|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22405185|NCT00928512|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22405186|NCT04153929|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22405187|NCT03383614|DNDi|Jean Yves Gillon|+41.22.906.92.32|jygillon@dndi.org|
22405188|NCT02801006|CooperVision|Jose Vega, O.D., MSc., FAAO|9256213761|javega@coopervision.com|
22405189|NCT01686958|Profound Medical|Mathieu Burtnyk|647-476-1350|mburtnyk@profoundmedical.com|408
22405190|NCT02486367|University Hospitals Cleveland Medical Center|Dr. David Zidar|216-791-3800|daz21@case.edu|
22405191|NCT00158223|Icahn School of Medicine at Mount Sinai|Dr. Joseph I. Friedman|631-761-3607|joseph.friedman@mssm.edu|
22405192|NCT03199638|Nemours Children's Health|Dr Dominique Darmaun, PI|904 6973674|ddarmaun@nemours.org|
22405193|NCT02807844|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22405194|NCT01669642|washington university in st louis|SRI SANKAR CHINTA PI|3144544661|schinta@wustl.edu|
22405195|NCT00108953|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22405196|NCT00992602|University of Washington|Maciej M. Mrugala, MD, PhD, MPH|206-543-4069|mmrugala@uw.edu|
22405197|NCT03595384|Emory University|Jennifer K Frediani PhD, RD|404-727-3766|jfredia@emory.edu|
22405198|NCT03803202|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22405199|NCT00293241|Medtronic Bakken|Lidwien Vainer|+31 433566752|lidwien.vainer@medtronic.com|
22405200|NCT01125293|Dana-Farber Cancer Institute|Irene Ghobrial|617-632-4101|irene_ghobrial@dfci.harvard.edu|
22405201|NCT02224638|Swedish Covenant Hospital|Nancy Chaiken|847-372-3500|nchaiken@comcast.net|
22405202|NCT01270958|GlaxoSmithKline|GSK Response Center|866-435-7343||
22405203|NCT01406652|Geneva University Hospitals|Dr.med Ilker Uçkay|+412237123311|ilker.uckay@hcuge.ch|
22405204|NCT01367860|IOT/HC University of SãoPaulo|Dr. Alexandre Cristante Fogaça|+55 11 2661-6951|aacristante@uol.com.br|
22405205|NCT02228564|Becton Dickinson|Spark Yamanoglu|480-597-8604|Spark.yamanoglu@bd.com|
22405206|NCT03383627|Northwell Health|Lubaina Presswala, DO|516-708-2540|lpresswala@northwell.edu|
22405207|NCT02633046|Mallinckrodt|Medical Information Call Center|800-844-2830|medinfo@mnk.com|
22405208|NCT02142504|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22405209|NCT02925312|Medstar Health Research Institute|Dr Michelle Magee|2028772383|michelle.f.magee@medstar.net|
22405210|NCT03644108|Reckitt Benckiser, Inc|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
22405211|NCT00971633|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
22405212|NCT03124901|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
22405213|NCT04114539|Emalex Biosciences, Inc.|Sr. Director of Clinical Operations|1847|dkim@emalexbiosciences.com|7150562
22405214|NCT01875510|Dr. Sami Ulus Children's Hospital|Dr. Serdar Beken|00903123056449|serbeken@gmail.com|
22405215|NCT02766907|TissueTech|VP Medical Affairs|8882968858|hsheha@tissuetechinc.com|
22405216|NCT02281344|Medicines for Malaria Venture|Dr Cristina Donini|+41 22 555 0312|doninic@mmv.org|
22405217|NCT01360229|University of Colorado School of Medicine|Dr. Benzi Kluger|3037242194|benzi.kluger@ucdenver.edu|
22405218|NCT00418717|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22405219|NCT01400139|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
22405220|NCT01804114|NSUHS|Michael Ujiki, MD|8475701700|rpulido@northshore.org|
22405221|NCT00677560|Queen Mary University of London|Dr Harpal Singh Kalsi|07872492181|h.kalsi@qmul.ac.uk|
22405222|NCT00795509|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22405223|NCT03984838|ViiV Healthcare|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|1
22405224|NCT03136367|Dartmouth College|Marie-Anne Durand|603-667-8601|marie-anne.durand@dartmouth.edu|
22405225|NCT00523614|Berlin Center for Epidemiology and Health Research, Germany|Juergen Dinger, MD, PhD, Principal Investigator|+49 30 94510145|dinger@zeg-berlin.de|
22391292|NCT01214421|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
22391293|NCT03545412|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
22391294|NCT02392104|William S. Middleton Memorial Veterans Hospital|Andrea Porter, PharmD|608-890-0742|andrea.porter@wisc.edu|
22391295|NCT04590404|Vanderbilt University Medical Center|Dr. Hilary Tindle|(615) 875-9726|hilary.tindle@vumc.org|
22391296|NCT03912532|NGM Biopharmaceuticals, Inc|VP, Clinical Operations|650-243-5555|ngm282@ngmbio.com|
22391297|NCT03947918|University of California, San Francisco|Suzanna Martinez|415-476-2300|suzanna.martinez@ucsf.edu|
22391298|NCT03783871|Ethicon|Erin Meyers|937-681-0322|eprifog1@its.jnj.com|
22391299|NCT05990387|Indiana University|Dr. Blair Johnson|8128558699|bj33@iu.edu|
22391300|NCT00815919|Dana-Farber Cancer Institute|John Koreth, MBBS, DPhil|617-632-2949|John_Koreth@dfci.harvard.edu|
22391301|NCT03522389|Mahidol University|Sunee Bovonsunthonchai|66855926144|sunee.bov@mahidol.ac.th|
22391302|NCT04750577|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22391303|NCT03459612|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22391304|NCT02176837|Hope Pharmaceuticals|Craig Sherman, MD|4806071970|sherman@hopepharm.com|
22391305|NCT02473042|The University of Texas MD Anderson Cancer Center|Alicia Kowalski, MD|(713) 563-5614|amkowalsk@mdanderson.org|
22391306|NCT00796627|Johns Hopkins University|Dr. John Harmon|410-550-0405|jharmon@jhmi.edu|
22391307|NCT00604188|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22391308|NCT04680637|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22391309|NCT03780010|TRACON Pharmaceuticals Inc|Medical Monitor|8585500780|clinicaltrials@traconpharma.com|
22391310|NCT01939301|Indiana University|Jeffrey A. Kline, MD|317-880-3900|jefkline@iu.edu|
22391311|NCT02242643|GlaxoSmithKline|GSK Response Center|866-435-7343||
22391312|NCT04243512|University of Maryland Baltimore|Amber Kleckner|410-706-5961|amber.kleckner@umaryland.edu|
22391313|NCT00566345|Ology Bioservices|Sr. Manager, Clinical & Regulatory Operations|386-418-8751|angie.kimbler@ologybio.com|
22391314|NCT01103232|Vakif Gureba Training and Research Hospital|ILHAN KARACAN|+ 90 212 4531700|ilhankaracan@hotmail.com|
22391315|NCT03500835|Children's Hospital Los Angeles|Alaina Vidmar|323-361-4606|avidmar@chla.usc.edu|
22391316|NCT00443599|Boston Children's Hospital|Dr. Michael Agus|617-355-5849|michael.agus@childrens.harvard.edu|
22391317|NCT03049306|Johns Hopkins University School of Medicine|Jonathan Jun|410-550-0115|jjun2@jhmi.edu|
22391318|NCT05093504|CytoSorbents|Weihong Fan|1 732-329-888|wfan@cytosorbents.com|
22391319|NCT03151551|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22391320|NCT01190449|Weill Cornell Medicine Cornell University|Cara Rosenbaum, MD|(646) 962-6500|car9156@med.cornell.edu|
22391321|NCT00212992|Ottawa Hospital Research Institute|Dr. Ian G. Stiell, Senior Scientist|613-798-5555|istiell@ohri.ca|18683
22405226|NCT02947022|UNC Chapel Hill, Department of Radiology|Clinical Research Manager|919-966-4997|rad_research@med.unc.edu|
22405227|NCT01230749|Janssen R&D US|Director, Translational Medicine|1 908 927-7881||
22405228|NCT04772469|University of California San Francisco|Dr. Carol Camlin|5109679558|Carol.Camlin@ucsf.edu|
22405229|NCT03682055|Cullinan Oncology|Phill Gallacher|+1 617 710 9127|pgallacher@cullinanoncology.com|
22405230|NCT00191386|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22405231|NCT03125018|Masimo|Tala Harake||studies@masimo.com|
22405232|NCT03077243|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat G. Canter MD MS Clinical Trial Analyst|(919) 962-0000|Melahat_Canter@med.unc.edu|
22405233|NCT01544478|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22405234|NCT00212758|Oregon Health & Science University|Dr. Amira Al-Uzri|503-494-7327|aluzria@ohsu.edu|
22405235|NCT02574481|Boston Scientific|Nicole Kilburn|970-294-4082|Nicole.Kilburn@bsci.com|
22405236|NCT01461824|The Research Institute at Nationwide Children's Hospital|Dr. Andrea Bonny|614-722-2450|andrea.bonny@nationwidechildrens.org|
22405237|NCT01105936|GlaxoSmithKline|GSK Response Center|866-435-7343||
22405238|NCT00446641|Asan Medical Center, University of Ulsan College of Medicine|Professor Sun U. Kwon|82-2-3010-3960|sukwon@amc.seoul.kr|
22405239|NCT01689324|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22391322|NCT02056626|University of Rochester|John Bisognano|585-341-7800|john_bisognano @ urmc.rochester.edu|
22391323|NCT01780454|Massachusetts General Hospital|Dr. David Sachs|617-726-4065|David.Sachs@tbrc.mgh.harvard.edu|
22391324|NCT04916002|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22391325|NCT04836559|Janssen Research & Development, LLC|Executive Medical Director Neuro|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22391326|NCT02078726|University of California, San Francisco|John Cello, MD|628-206-4767|John.Cello@ucsf.edu|
22391327|NCT02786004|GE Healthcare|Beth Heckel|262-312-7269|beth.heckel@med.ge.com|
22391328|NCT05147350|Repare Therapeutics INC|Repare Therapeutics Medical Monitor|857-340-5402|clininfo@reparerx.com|
22391329|NCT06576674|University of North Carolina at Chapel Hill|Michael Bremmer, PhD|301-827-0566|mbremmer@unc.edu|
22391330|NCT00756457|Ithaca College|Jeff Houck, PhD|585-340-9619|jhouck@ithaca.edu|
22391331|NCT02947100|Nemours/AI duPont Hospital|Dr Robin Miller|302-651-5500|rmiller@nemours.org|
22391332|NCT00926380|Massachusetts General Hospital|Natalie David||ndavid2@mgh.harvard.edu|
22405240|NCT00681291|LifeCell|Donna Jacobs|908-809-7856|djacobs@lifecell.com|
22405241|NCT00086385|University of California, San Francisco|Sharon M. Hall, PhD|415-476-7574|sharon.hall@ucsf.edu|
22405242|NCT04038385|William Paterson University, Sociology Department|Jennifer Di Noia, PhD, Principal Investigator|19737203714|dinoiaj@wpunj.edu|
22405243|NCT00302055|Northwestern University|Dr. Ronald T Ackermann|(312) 503-6400|r.ackermann@northwestern.edu|
22405244|NCT02279160|United Therapeutics|Derek Solum, PhD|919-425-8122|dsolum@unither.com|
22405245|NCT00189436|Allegheny Singer Research Institute, WPAHS|David Skoner, MD|412-359-4099|dskoner@hsc.wvu.edu|
22405246|NCT00402285|University of California, San Francisco|Peter Carroll, MD|415-353-7098|pcarroll@urology.ucsf.edu|
22405247|NCT00442611|Stanford University|Dr. Lorinda Chung|(650)493-5000|shauwai@stanford.edu|6242
22405248|NCT00784459|Washington University|Dr Jonathan Green|314-747-3591|jgreen@wustl.edu|
22405249|NCT00405275|VA Nebraska-Western Iowa Health Care System|James R. O'Dell, MD|402-559-7288|jrodell@unmc.edu|
22405250|NCT00088595|Novartis Pharmaceuticals|Study Director|862-778-8300||
22405251|NCT03180294|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22405252|NCT03870893|Samsung Medical Center|Jeong-Yi Kwon|+821045911039|jeongyi.kwon@samsung.com|
22405253|NCT01951326|RedHill Biopharma|Reza Fathi, Senior VP Research and Development|972-(0)3-541-3131|reza@redhillbio.com|
22405254|NCT03542149|Medicines for Malaria Venture (MMV)|Dr. Helen Demarest|: +41 22 555 03 24|demaresth@mmv.org|
22405255|NCT02959970|Almirall LLC|Ayman Grada|610-840-7107|ayman.grada@almirall.com|
22405256|NCT03300427|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22405257|NCT02568852|Haseki-156|Dr.Turgut Donmez|00905347400967|surgeont73@hotmail.com|
22405258|NCT01473355|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
22405259|NCT01810289|University of California at San Francisco|Dr. Elvin Geng|415-476-4082|elvin.geng@ucsf.edu|409
22417430|NCT00656968|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|886-7-3422121|pihsu@isca.vghks.gov.tw|8233
22417431|NCT00952276|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22417432|NCT04141696|National Institute of Nursing Research (NINR)|Dr. Leorey Saligan, PhD.|+1 301 451 1685|saliganl@mail.nih.gov|
22417433|NCT03959527|GARDP|Dr Alison Luckey|+41 22 559 05 39|aluckey@gardp.org|
22391333|NCT02472145|Janssen Research & Development, LLC|Senior Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22405260|NCT01597440|Children's National Health System|Dr. Mendel Tuchman||mtuchman@childrensnational.org|
22405261|NCT01502761|University of Southern California|Dr. William J Mack|323 442 7512|william.mack@med.usc.edu|
22405262|NCT02603172|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22405263|NCT00863317|Richmond Emergency Physicians Inc|Frank Petruzella|773 447-2489|fpetruzella@gmail.com|
22405264|NCT00441727|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
22405265|NCT00762528|Colgate Palmolive Company|William DeVizio, DMD|732-878-7901|william_Devizio@colpal.com|
22405266|NCT03417505|Tangible Science|Dr. Kelly Mabry|650-241-1045|kelly@tangiblescience.com|108
22405267|NCT02133001|Janssen Research & Development, LLC|Senior Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22405268|NCT04211961|University of Galway|Dr. Alberto Alvarez-Iglesias|+35391524411|alberto.alvarez-iglesias@universityofgalway.ie|
22405269|NCT05686044|Annovis Bio, Inc.|Matthew Peterson, PhD|484-875-3192|peterson@annovisbio.com|
22405270|NCT03235726|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22405271|NCT00425113|National Institute of Allergy and Infectious Diseases|Ray Chen|301-443-5816|ray.chen@nih.gov|
22405272|NCT00879437|Baylor College of Medicine|Jack Su|8328224306|jmsu@txch.org|
22405273|NCT00268463|NSABP Foundation, Inc.|Director, Division of Regulatory Affairs|412-330-4600||
22405274|NCT04685538|Sintetica SA|Anna Guaita|+41 (0)91 640 42 50|aguaita@sintetica.com|
22405275|NCT02920450|University of Florida Heath Cancer Center|Protocol Development Manager|352-273-8128|clh1230@ufl.edu|
22405276|NCT01040845|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22405277|NCT04362813|Novartis Pharmaceuticals|Study Director|(862) 778-8300|novartis.email@novartis.com|
22391334|NCT01080326|Mayo Clinic|Juliane Bingener-Casey, M.D.|507-538-9007|BingenerCasey.Juliane@mayo.edu|
22391335|NCT04919070|University of Rochester|Dr. Sally Norton|5852759814|sally_norton@urmc.rochester.edu|
22391336|NCT00632021|Vanderbilt University Medical Center|Research Coordinator|6159364819|Kathryn.m.goggins@vanderbilt.edu|
22391337|NCT01318876|Laval University|Gaston De Serres|418-666-7000|gaston.deserres@ssss.gouv.qc.ca|274
22405278|NCT04965116|University of California, San Diego|Dr. Sarah Averbach, MD, MAS|858-329-4464|familyplanningresearch@health.ucsd.edu|
22405279|NCT03882723|Rush University Medical Center|Dr. David Vines|3129424408|David_Vines@rush.edu|
22405280|NCT01732107|Hoosier Cancer Research Network|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
22391338|NCT00443209|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22391339|NCT03563313|University of Virginia|Sue Brown, MD|434-962-0602|sab2f@virginia.edu|
22391340|NCT02250534|University of Vermont|Stephen T. Higgins, PhD, Professor, Department of Psychiatry|802-735-6267|stephen.higgins@uvm.edu|
22391341|NCT02025855|Frederick Health|Thomas Smoot|2405663250|tlsmoot@frederick.health|
22391342|NCT01628692|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22391343|NCT00857233|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
22391344|NCT01560871|Texas Woman's University|Dr. Suh-Jen Lin|214-689-7718|slin@twu.edu|
22391345|NCT03042299|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22391346|NCT00572533|University of Louisville|Adam E Gaweda|502-852-0766|adam.gaweda@louisville.edu|
22391347|NCT00884897|Maryland Psychiatric Research Center|Deanna L. Kelly Pharm.D., BCPP|410-402-96860|dkelly@mprc.umaryland.edu|
22391348|NCT00003477|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22391349|NCT04069585|TEOXANE SA|Clinical Project Manager|+41(0) 22 344 96 36|clinical@teoxane.com|
22391350|NCT00980590|Cleveland Clinic|Dr. Daniel Sessler|216-445-6500|sessled@ccf.org|
22391351|NCT00672451|Wake Forest University Health Sciences|Dr. John Burkart|33671662958|jburkart@wakehealth.edu|
22391352|NCT04206085|Viveve|Vice President, Clinical & Medical Affairs|720-696-8100|clinicalaffairs@viveve.com|
22391353|NCT01473992|University of South Florida|M. Jason Highsmith|8139743806|mhighsmi@health.usf.edu|
22391354|NCT00725543|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22391355|NCT03200444|Coloplast A/S|Director of Pre-Clinical Research|49111111|dklfn@coloplast.com|+45
22391356|NCT02168478|Medimetriks|Noah L. Rosenberg, MD, Chief Medical Officer|2019194083|Noahrosie@yahoo.com|
22391357|NCT00087555|Jazz Pharmaceuticals, Inc.|Grace Wang, MD Director of Clinical Development & Medical Monitor|650-496-3777||
22391358|NCT01062971|Laboratorios Sophia|PhD. Ricardo Llamas|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
22391359|NCT01530087|Hollister Incorporated|Director, Global Clinical Affairs|847.918.3467|Stacy.Haddad@hollister.com|
22391360|NCT05523219|SERF|Sponsor|+33 4.72.05.60.10|clinical@serf.fr|
22391361|NCT02760485|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22391362|NCT03845023|Apnimed, Inc|Clinical Trials|6015008880|clinicaltrials@apnimed.com|
22391363|NCT03738397|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22391364|NCT01795859|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22391365|NCT01087814|University of Minnesota|Ann Seguin|612-625-7472|segu0017@umn.edu|
22391366|NCT00661713|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
22391367|NCT02353871|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22391368|NCT05314374|Mayo Clinic|Andres Acosta|507-266-6931|acosta.andres@mayo.edu|
22391369|NCT02658175|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
22391370|NCT01743976|Wake Forest School of Medicine|James C. Eisenach|336-716-4182|jimeisenach@gmail.com|
22391371|NCT02526186|MOMH|Amanda Crawford|7025633583|amanda.j.crawford.ctr@health.mil|
22391372|NCT02072421|Harvard Clinical Research Institute|Priscilla Driscoll-Shemp|617-307-5200|priscilla.driscoll-shempp@hcri.harvard.edu|
22391373|NCT02554383|University of Pittsburgh|Nader Shaikh|412-692-8111|nader.shaikh@chp.edu|
22391374|NCT00762645|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22391375|NCT02918292|The Emmes Company|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
22391376|NCT03783689|SPR Therapeutics, Inc|Clinical Affairs|216-378-9106|support@sprtherapeutics.com|
22391377|NCT01351337|Huashan Hospital|Dr Jinsong Wu|862152888771|wjsongc@126.com|
22391378|NCT02165826|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22405281|NCT04445688|Apnimed, Inc|Clinical Trials|617-500-8880|clinicaltrials@apnimed.com|
22405282|NCT00299416|UT-Houston Health Science Center, Department of Neurology|James C. Grotta, MD|713-500-7088|james.c.grotta@uth.tmc.edu|
22405283|NCT01363258|UAB School of Nursing|Rita Jablonski|205-975-9019|rjablonski@uabmc.edu|
22405284|NCT00918346|Santen Oy|Auli Ropo|+358405012416|auli.ropo@santen.fi|
22405285|NCT03379376|Wake Forest University Health Sciences|Meg O'Mara - Study Coordinator|336-716-5440|megreen@wakehealth.edu|
22405286|NCT02475629|TaiMed Biologics USA Corp.|Manager - Clinical Services|(949) 331-3225|bbell@taimedbio.com|
22405287|NCT04083794|Spaulding Rehabilitation Hospital Cambridge|Dr. Adina E. Draghici|617-758-5508|adraghici@mgh.harvard.edu|
22405288|NCT01170949|University Charité Berlin|Markus Magerl|+4930450618304|markus.magerl@charite.de|
22405289|NCT01511640|University of Kentucky College of Medicine|Joshua Lile, Ph.D., Professor|8593236034|jalile2@uky.edu|
22405290|NCT00224003|Watson Laboratories, Inc|Gary Hoel, RPh, PhD|801-588-6641|gary.hoel@watson.com|
22405291|NCT03549429|Tufts Medical Center|Dr. Dan Drzymalski|‪617-913-8168|ddrzymalski@tuftsmedicalcenter.org|
22405292|NCT02157168|University of Arizona|Dr. Ada Wilkinson-Lee, Co-Investigator|(520) 626-7766|adaw@email.arizona.edu|
22405293|NCT02971293|AstraZeneca|Dr Ioannis Psallidas, MD, PhD|1-877-240-9479|Information.centre@astrazeneca.com|
22405294|NCT02754661|Medtronic GIH (Given Imaging LTD)|Liron Bar Yaakov, Senior Manager Clinical Affairs|972-526060466|liron.baryaakov@medtronic.com|
22405295|NCT00661570|Netherlands Cancer Institute|Prof. Dr. F.J.M. Hilgers|+31-20-5122550|f.hilgers@nki.nl|
22405296|NCT03104985|State Scientific Center of Laser Medicine, Russia, Moscow|Sergey Moskvin|+7-905-770-1860|7652612@mail.ru|
22405297|NCT00729326|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22405298|NCT01235728|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22405299|NCT01000025|NCIC Clinical Trails Group|Dr. Keyue Ding|1-613-533-6000|kding@ctg.queensu.ca|77705
22405300|NCT04423757|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22405301|NCT01202760|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22405302|NCT01654523|University of Michigan|Joseph Himle - Professor|7343303258|himlej@umich.edu|
22405303|NCT02810951|Castle Creek Biosciences|Chief Medical Officer|(484) 713-6000|medinfo@castlecreekbio.com|
22405304|NCT01575899|Buddhist Tzu Chi General Hospital|Dr. Ming-Cheh, Chen|+886-910-521003|MingCheh_chen@tzuchi.com.tw|
22405305|NCT03097029|Children's Hospital of Philadelphia|Dr. Nina Sainath|267.426.1736|sainathn@email.chop.edu|
22405306|NCT00709124|Johns Hopkins University School of Medicine|Dr Dale Needham|(410) 955-3467|dale.needham@jhmi.edu|
22405307|NCT00373490|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22405308|NCT00753688|GlaxoSmithKline|GSK Response Center|866-435-7343||
22405309|NCT01250756|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22405310|NCT01854593|Department of Ophthalmology, Surugadai Hospital of Nihon University|Dr. Ayumu Manabe|+81-3-3293-1711|ayumu.m76@gmail.com|429
22405311|NCT02999100|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22417434|NCT06029959|University of Washington|Sandeep Khot, MD|206-744-3251|skhot@uw.edu|
22417435|NCT06357286|Cornell University|Heather Schofield|6172334775|hws44@cornell.edu|
22417436|NCT02960893|Biohaven Pharmaceuticals|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
22417437|NCT03692312|AMO Pharma Ltd.|Dr. Mike Snape, Chief Scientific Officer|+44 (0) 7775915639|mike.snape@amo-pharma.com|
22417438|NCT04963569|NHS Lothian/University of Edinburgh|Dr John (Jack) Cafferkey|0|j.cafferkey@ed.ac.uk|
22417439|NCT02631876|ImmunoGen, Inc|CMO, ImmunoGen|781-895-0600|clinicaltrials@immunogen.com|
22417440|NCT04285567|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22417441|NCT04556552|Emory University|Dr. J. Douglas Bremner|404-712-9569|doug.bremner@emory.edu|
22417442|NCT00605865|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22417443|NCT03012672|University of Washington|Anna Halpern, MD|206-606-1978|halpern2@uw.edu|
22417444|NCT03805100|Xbrane Biopharma AB|Clinical Affairs|+46 85-590 56 00|xbregistry@xbrane.com|
22417445|NCT03474432|Jesse Brown VAMC|Dr. Mladen Vidovich, study PI|312-996-6730|miv@uic.edu|
22417446|NCT02856880|GlaxoSmithKline|GSK Response Center|866-435-7343||
22417447|NCT00094458|Centocor Ortho Biotech Services, L.L.C.|Study Director|215 325-7405||
22417448|NCT03247517|Supernus|Joseph Hull, PhD, Associate Director Clinical Research|240-403-5324|jhull@supernus.com|
22417449|NCT03310411|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22417450|NCT03573505|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22417451|NCT00515541|Invitrox, Inc|Dr. Don A. Gabriel|(919) 485-4600|dgabriel@invitrox.com|
22417452|NCT01385306|electroCore LLC|Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
22417453|NCT00158756|GlaxoSmithKline|GSK Response Center|866-435-7343||
22417454|NCT01421342|VA Cooperative Studies Program Coordinating Center, West Haven, CT|Gary R. Johnson, MS|(203) 932-5711|gary.johnson4@va.gov|3774
22417455|NCT03656874|HealthPartners Institute|Dr. D. Brad Rindal|952.967.5026|D.Brad.Rindal@HealthPartners.com|
22417456|NCT01206816|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22417457|NCT00723645|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22417458|NCT02528123|London Vision Clinic|Prof Dan Z Reinstein|02072214005|dzr@londonvisionclinic.com|
22417459|NCT01939496|Janssen Scientific Affairs, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
22417460|NCT03052322|Fresenius Kabi Swiss BioSim GmbH|Eugenia Kunina, senior clinical development manager|+41791093376|clinical.development@fresenius-kabi.com|
22417461|NCT02274844|University of Wisconsin-Madison|Susan Andreae|608-265-8195|sandreae@wisc.edu|
22405312|NCT01216397|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22405313|NCT01455415|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22405314|NCT00587301|NYU Langone Health|Christine Ren Fielding, MD|2122633166|christine.ren-fielding@nyulangone.org|
22405315|NCT02867163|University of New Mexico|Dr. David Siegel|505-272-2610|dsiegel@salud.unm.edu|
22405316|NCT00983242|Mutual Pharmaceutical Company, Inc.|Medical Affairs Director|215-697-1743|clinicaltrials@urlpharma.com|
22405317|NCT01731990|Novartis Pharmaceuticals|Study Director|862-778-8300||
22405318|NCT01183104|Japan Association for Diabetes Education and Care|Prof. Yasuo Terauchi|+81-3-3514-1721|terauchi-tky@umin.ac.jp|
22405319|NCT00323310|Bracco Diagnostics Inc|Usha Halemane/Executive Director|609-514-2578|usha.halemane@diag.bracco.com|
22405320|NCT02944513|Brigham and Women's Hospital|Dr. Robert Jamison|617-732-9046|rjamison@bwh.harvard.edu|
22405321|NCT00937326|GlaxoSmithKline|GSK Response Center|866-435-7343||
22405322|NCT00790218|Can-Fite BioPharma|Sari Fishman, Director of Clincal Trials|972528998666|sari@canfite.co.il|
22405323|NCT00899600|Dartmouth-Hitchcock Medical Center|Dr. Randy Loftus|6036504642|randy.w.loftus@hitchcock.org|
22405324|NCT01149772|Michael E. DeBakey VA Medical Center|Dr. Jeffrey Cully|713-794-8526|Jeffrey.Cully@va.gov|
22405325|NCT02225925|Johns Hopkins University|Daniel Song|410-502-5875|dsong2@jhmi.edu|
22405326|NCT03424044|Oregon Health and Science University|Jessica Castle MD|503-494-7072|castleje@ohsu.edu|
22405327|NCT00505518|Massachusetts General Hospital|Albert Yeung|617-724-5138|ayeung@partners.org|
22405328|NCT04402385|Yale School of Medicine|Olga Grechukhina, MD: Assistant Professor of Obstetrics, Gynecology & Reproductive Sciences|(203) 785-3091|olga.grechukhina@yale.edu|
22405329|NCT00731666|Coloplast Corp|Clinical Trials Manager|612-302-4990|usdibe@coloplast.com|
22405330|NCT01308853|Akademikliniken, Stockholm, Sweden|Dr. Per Hedén|+46 8 614 54 00|per.heden@ak.se|
22405331|NCT00053014|SWOG statistical office|SWOG leukemia statistician|206-667-4408||
22405332|NCT03250624|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22405333|NCT00606177|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22405334|NCT00136357|The Center for Mind-Body Medicine|Dr. James Gordon|202-966-7338|jgordon@cmbm.ort|
22405335|NCT00927576|VANCHCS|Dr. David L. Woods|925-372-2571|dlwoods@ucdavis.edu|
22405336|NCT01819506|Ralph H Johnson VAMC|Michelle Woodbury|843-792-1671|Woodbuml@musc.edu|
22405337|NCT01505114|Fred Hutchinson cancer Research center|Chunyuan Wu|206-667-5567|cwu@scharp.org|
22405338|NCT00660075|Laval University|Patrick Couture|418-654-2106|patrick.couture@crchul.ulaval.ca|
22405339|NCT02074904|UPENN|Timothy Pond, MPH|215-746-1959|timpond@pennmedicine.upenn.edu|
22405340|NCT01150760|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22405341|NCT02017704|SKCCC @ Johns Hopkins Medicine|Amol Narang, MD|410-955-7390|anarang2@jhmi.edu|
22405342|NCT02076334|University University Chapel Hill|Abbie Smith-Ryan, PhD|919-962-2574|abbsmith@email.unc.edu|
22405343|NCT01963780|TransMedics, Inc.|VP, Clinical Affairs|978.552.0900|ldamme@transmedics.com|
22405344|NCT01749800|Spaulding Rehabilitation Hospital|Paolo Bonato|+1-617-952-6319|pbonato@partners.org|
22405345|NCT01975675|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22405346|NCT03639987|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22405347|NCT04354155|Johns Hopkins All Children's Hospital|Anthony Alexander Sochet|17277672912|anthony.sochet@jhmi.edu|
22405348|NCT04197986|QED Therapeutics, Inc.|Acting Chief Medical Officer|1-877-280-5655|Proof302.ct@qedtx.com|
22405349|NCT01015820|Mayo Clinic|Dr. Michael B. Wallace|904-953-6970|wallace.michael@mayo.edu|
22405350|NCT01998399|Vanderbilt University|Gordon Bernard, Professor of Medicine, Associate Vice Chancellor for Research|615-343-0077|gordon.bernard@Vanderbilt.Edu|
22405351|NCT00376246|UCSD Medical Center|Ori Ben-Yehuda, MD|619-543-2814|obenyehuda@ucsd.edu|
22405352|NCT01711658|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22405353|NCT00351819|Brigham and Women's Hospital|Dr. Shehzad Basaria|617-525-9150|sbasaria@partners.org|
22405354|NCT01877941|University of California San Francisco|Arthur Wallace, M.D., Ph.D.|415-750-2069|art.wallace@va.gov|3732
22405355|NCT00719537|William Beaumont Hospital|John Uckele|2485510610|john.uckele@beaumont.edu|
22405356|NCT02460978|AstraZeneca|Anna Maria Langkilde|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
22405357|NCT01142193|Upsher-Smith Laboratories, Inc.|Bob Anders, Sr. Director of Clinical Operations|763-315-2000|Bob.Anders@upsher-smith.com|
22405358|NCT00994162|Smith+Nephew|Rachael Winter|+44 1482 673475|rachael.winter@smith-nephew.com|
22405359|NCT00841269|University of Utah|Dr. Douglas Kondo|(801) 587-1549|doug.kondo@hsc.utah.edu|
22405360|NCT01459068|Johns Hopkins Bloomberg School of Public Health|Courtland Robinson|4104155266|crobinso@jhsph.edu|
22405361|NCT02023112|AbbVie|Global Medical Information|800-633-9110||
22405362|NCT00910728|AstraZeneca|Dr Gregory Curt, MD|+1 301 398 0109|Gregory.Curt@astrazeneca.com|
22405363|NCT01961089|Ziemer Ophthalmic Systems AG|Dr. Gregor Schmid|+41323327154|gregor.schmid@ziemergroup.com|
22405364|NCT01225172|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22405365|NCT01062009|UCSF Benioff Childrens Hospital Oakland|Natalie Cvijanovich, MD|510-428-3784|NCvijanovich@mail.cho.org|
22405366|NCT04644484|Synermore Biologics Co., Ltd.|Director of Clinical Trials|+86-512-87658266|xjli@synermore.cn|8077
22405367|NCT04366713|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|1-424-248-6500|clinicaltrials@pumabiotechnology.com|
22405368|NCT03001310|MeiraGTx|Program Manager|0044 (0)20 3866 4320|CNGB3@meiragtx.com|
22405369|NCT03404518|Loma Linda University Health System|Khanh Nguyen, MD|909-558-8558|khanguyen@llu.edu|
22405370|NCT00044655|NYSPI|Nancy H. Covell, Ph.D.|6469450227|covelln@nyspi.columbia.edu|
22405371|NCT03693404|NYU Langone Health|Philipp Leucht, MD|646-501-0291|philipp.leucht@nyulangone.org|
22405372|NCT01176240|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
22405373|NCT00771173|Loyola University Chicago|Dr. Linda Brubaker|708-216-3960|lbrubaker@lumc.edu|
22405374|NCT00807014|GlaxoSmithKline|GSK Response Center|866-435-7343||
22405375|NCT04034043|IRCSS Istituto Ortopedico Rizzoli|Federico Giardina|+390516366418|federico.giardina@ior.it|
22405376|NCT03175562|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22405377|NCT01946412|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22405378|NCT04374149|Prisma Health|Dr. Julie Martin, Director of Cancer Research|(864) 455-3667|julie.martin@prismahealth.org|
22405379|NCT05569850|DIBINE, University of Bologna|Prof. Lorenzo Breschi|+393482210664|lorenzo.breschi@unibo.it|
22405380|NCT03565991|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22405381|NCT02468804|University of Colorado Denver|Isabelle Buard, PhD|(303)472-5973|Isabelle.Buard@cuanschutz.edu|
22405382|NCT00106249|CUNY|Dr. Antonio Mantovani|212-650-5417|amantovani@med.cuny.edu|
22405383|NCT00948428|Teva Pharmaceuticals USA, Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
22417462|NCT05065983|Emergent BioSolutions|Dr. Sufia Muhammad|346-732-7331|muhammads@ebsi.com|
22417463|NCT00506129|University of Texas (UT) MD Anderson Cancer Center|Chitra M. Hosing, Professor, Stem Cell Transplantation|1-877-MDA-6789|CR_Study_Registration@mdanderson.org|
22417464|NCT01642914|Forest Research Institute|Steven Shiff, Executive Director, Clinical Development|201-427-8000|Steven.Shiff@actavis.com|8077
22417465|NCT04295135|Indiana University|Dr. Christopher A. Harle|317 278 3245|charle@iu.edu|
22417466|NCT02923674|Wake Forest School of Medicine|Barbara Nicklas, MD|336-713-8569|bnicklas@wakehealth.edu|
22417467|NCT04539886|Pulse Biosciences, Inc.|William A. Knape, VP Clinical, Regulatory and Quality Affairs|510-906-4649|bknape@pulsebiosciences.com|
22417468|NCT00140621|Sanofi|Trial Transparency Team||Contact-US@Sanofi.com|
22417469|NCT02712333|Fudan University|Dr. Haidong Kan|86-21-54237908|kanh@fudan.edu.cn|
22417470|NCT03463993|University of Zimbabwe|Dr Chipo Gwanzura|+263774718381|chipo.gwanzura@gmail.com|
22417471|NCT00251225|University of Pittsburgh Cancer Institute|Leonard J. Appleman, MD, PhD|412-648-6507|applemanlj@upmc.edu|
22417472|NCT03360916|University of Kansas Medical Center|John P. Thyfault|913-588-1790|jthyfault@kumc.edu|
22417473|NCT01825889|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22417474|NCT01231373|BTG International Inc.|David Wright MBBS|610-278-1660|david.wright@btgplc.com|
22417475|NCT01901874|W. L. Gore & Associates|Bryan Randall|928-864-4832|BRandall@WLGore.com|
22417476|NCT03078582|Ra Pharmaceuticals, Inc|Sponsor Ra Pharmaceuticals, Inc.|+1 617 401 4060|trials@rapharma.com|
22417477|NCT02039414|Western Kentucky University|Dr. Rachel Tinius, Assistant Professor|2707455026|rachel.tinius@wku.edu|
22417478|NCT02447926|Northwestern University|Dr. Josh Levitsky|312-695-4837|j-levitsky@northwestern.edu|
22417479|NCT02519621|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
22417480|NCT00106938|Abbott Vascular|Jennifer M Jones-McMeans, PhD (Associate Director Clinical Research)|408-845-1459|jennifer.jones@av.abbott.com|
22417481|NCT03676751|UCSF FI Proctor|Pr Thomas Lietman|(415) 476-1442|tom.lietman@ucsf.edu|
22417482|NCT00706992|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
22417483|NCT01401257|Hôpital La Timone, Marseille|Pr Shahram ATTARIAN|04 91 38 65|shahram.attarian@ap-hm.fr|79
22417484|NCT01491035|H. Lundbeck A/S|H. Lundbeck||LundbeckClinicalTrials@Lundbeck.com|
22417485|NCT00775684|University of Pennsylvania|Professor of Medicine, Director of Translational Research Program|215 746-0025|rickels@pennmedicine.upenn.edu|
22417486|NCT02728752|CRMG|Mikaela Raymond|866-337-1868|ctgov@clinicalresearchmgt.com|
22417487|NCT02025751|Evoke Pharma|Chief Medical Officer|8589457189|mcarlson@evokepharma.com|
22417488|NCT03345394|Federal University of Sao Paulo|Dr. André Miguel|+55 11 965884111|aqcmiguel@gmail.com|
22417489|NCT02687360|Columbia Univeristy|Diana Martinez|646-774-6160|dm437@cumc.columbia.edu|
22417490|NCT04722601|University of Chicago|Dr. Sonali Smith|855-702-8222|smsmith@bsd.uchicago.edu|
22417491|NCT00653991|Annenberg School for Communication and Journalism, University of Southern California|Professor Lynn Carol Miller|310-874-3402|lmiller@usc.edu|
22417492|NCT02181296|University of Pennsylvania|Dr. Nabil M Elkassabany|(215) 662-3793|Nabil.Elkassabany@uphs.upenn.edu|
22417493|NCT01568866|Amgen Inc.|Study Director|866-572-6436||
22417494|NCT03499119|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22417495|NCT04189445|Taiho Oncology, Inc|Taiho Oncology, Inc|609-250-7336|clinicaltrialinfo@taihooncology.com|
22417496|NCT00003138|ECOG Statistical Office|Study Statistician|617-632-3012||
22417497|NCT05142566|Essential Medical LLC (a subsidary of Teleflex, Inc.)|Darra Bigelow, Sr. Manager, Clinical Operations|610-331-7299|darra.bigelow@teleflex.com|
22417498|NCT01859130|Zimmer Biomet|Clinical Research Specialist|5745497606|tim.swanson@zimmerbiomet.com|
22431409|NCT05870345|University of CHicago|Alisa Brennan, Pediatric Emergency Medicine Fellow, Physician, Co-PI|9787585263|Brennanak@gmail.com|
22431410|NCT03594500|VA NY Harbor Healthcare System|Dr. Joshua Chodosh|212-686-7500|joshua.chodosh@va.gov|5043
22431411|NCT03130569|Memorial Sloan Kettering Cancer Center|Dr. Jennifer Hay|646-888-0039|hayj@mskcc.org|
22431412|NCT01500317|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
22405384|NCT04241120|HabitAware|Sameer Kumar|2489904720|sameer@habitaware.com|
22417499|NCT03949244|Icahn School of Medicine at Mount Sinai|Harriet Lloyd|212-979-4672|hlloyd@nyee.edu|
22431413|NCT00335829|Johns Hopkins, Interventional Radiology|Jeff Geschwind, MD|410-614-6597|jfg@jhmi.edu|
22405385|NCT02037204|UMC Utrecht|Prof. Daniel Saris|000000000000000000|d.saris@umcutrecht.nl|
22405386|NCT01495689|Ottawa Hospital Research Institute|Smita Pakhale|613-737-8899|spakhale@ohri.ca|79428
22417500|NCT02145026|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22405387|NCT03008187|Menarini Ricerche|Angela Capriati, MD|+39 055 56 80 9990|acapriati@menarini-ricerche.it|
22405388|NCT05516134|Hopeful Aging|Michael Skrajner|4404777881|mike@hopefulaging.com|
22405389|NCT01155193|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22405390|NCT03613818|Boise State Universtiy|Dr. Diana Doumas|2084261219|dianadoumas@boisestate.edu|
22405391|NCT01952288|VA Puget Sound Health Care System|Rebekah J. Rein, JD|206-764-2711|rebekah.rein@va.gov|
22405392|NCT03962634|Virginia Commonwealth University|Parthasarathy Madurantakam|804-828-4953|madurantakap@vcu.edu|
22405393|NCT01843205|University of Kentucky|Craig R. Rush, Ph.D.|(859) 257-5388|crush2@email.uky.edu|
22405394|NCT01518309|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2897|medicalinformation@acadia-pharm.com|
22405395|NCT00728728|VHA Durham|Christine E. Marx, MD|9192860411|christine.marx@va.gov|3626
22405396|NCT05935982|University of Alabama at Birmingham (UAB)|Byron Lai, PhD|205-638-9790|byronlai@uab.edu|8-9725
22405397|NCT01973972|Duke University|William S. Yancy, Jr.|919-681-2863|yancy006@mc.duke.edu|
22405398|NCT00839436|NIAID|Dr. Virginia Sheikh|3014357939|sheikhv@niaid.nih.gov|
22405399|NCT01440972|University of Iowa|Dr. Neil Segal|3193358204|segal-research@uiowa.edu|
22405400|NCT04072575|Janssen Research & Development, LLC|Director Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22405401|NCT01599806|AstraZeneca/ PPD|Gayan Makumburage|9105588682|gayan.makumburage@ppdi.com|
22405402|NCT02873208|Alkermes|Director, Corporate and R&D Communications|781-609-7000|Gretchen.Murphy@alkermes.com|
22405403|NCT00415584|Montefiore Medical Center|Dr. Maria Coco|718-920-4136|mcoco@montefiore.org|
22405404|NCT00563368|Vivus, Inc.|Wesley W. Day PhD|650-934-5200|day@vivus.com|
22405405|NCT01061567|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22405406|NCT01831804|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22405407|NCT02420990|Center on Addiction|Dr. Aaron Hogue|212-841-5278|ahogue@centeronaddiction.org|
22405408|NCT03326583|George Washington Medical Faculty Associates|Dominic Raj|(202) 741-2296|draj@mfa.gwu.edu|
22405409|NCT00228943|Indiana University|Janet S. Carpenter|317-278-6093|carpentj@iupui.edu|
22405410|NCT00176878|Masonic Cancer Center, University of Minnesota|Paul Orchard, M.D.|612-626-2313|orcha001@umn.edu|
22405411|NCT01784614|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22405412|NCT00114218|NRG Oncology|Linda Gedeon for Austin Miller, PhD.|716-845-1169|lgedeon@gogstats.org|
22405413|NCT03168555|Zealand University Hospital|Dr. Christian Borup, coordinating investigator|+4523328035|chrbo@regionsjaelland.dk|
22405414|NCT02165072|Texas Tech university Health Sciences Center, Lubbock, TX|Dr Kenneth Nugent|(806) 743-6847|Kenneth.nugent@ttuhsc.edu|
22405415|NCT02959190|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22405416|NCT01522768|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian, MD|646-888-4186|janjigiy@mskcc.org|
22405417|NCT00615459|Novartis Pharmaceuticals|Study Director|862-778-8300||
22405418|NCT01235507|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22405419|NCT01082588|Massachusetts General Hospital|Dr. David Henderson|617-912-7800|dchenderson@partners.org|
22405420|NCT02738580|IVIValencia|DR. ERNESTO BOSCH|+34 963050900|Ernesto.Bosch@ivirma.com|
22405421|NCT00583661|Berlin Heart Inc.|Robert Kroslowitz, CEO|1-281-863-9700|kroslowitz@berlinheart.com|
22405422|NCT01324687|University of Rochester|Manish N. Shah|585-276-6565|manish_shah@urmc.rochester.edu|
22405423|NCT00617591|H. Lee Moffitt Cancer Center and Research Institute|Rachid Baz, M.D.|813-745-8212|rachid.baz@moffitt.org|
22405424|NCT03380000|Penn State University|David N. Proctor|8145715234|dnp3@psu.edu|
22405425|NCT00588523|Memorial Sloan Kettering Cancer Center|Dr. Thomas Kaley, MD|212-639-7523|kaleyt@mskcc.org|
22405426|NCT00088972|SWOG|Study Statistician|206-667-4623||
22405427|NCT02910219|Georgetown University|Sandra M. Swain, MD, FACP, FASCO|202-687-4600|Sandra.Swain@georgetown.edu|
22405428|NCT01425749|University of Virginia|Craig L Slingluff Jr|434-924-1730|cls8h@virginia.edu|
22405429|NCT00214487|Dr. Thomas Aller, Optometrist Inc.|Dr. Thomas Aller|650 871-1816|cptreyes@earthlink.net|
22405430|NCT02096042|The University of Texas (UT) MD Anderson Cancer Center|Nitin Jain, MD/Assistant Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
22405431|NCT00845507|University of Cincinnati|Dr. DelBello|513-558-2989|Melissa.Delbello@uc.edu|
22405432|NCT03406715|Moffitt Cancer Center|Alberto A. Chiappori, MD|813-745-4541|Alberto.Chiappori@moffitt.org|
22405433|NCT00701441|Ohio State University|Rami Khayat|614-247-7707|rami.khayat@osumc.edu|
22405434|NCT03034057|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22405435|NCT03339401|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
22405436|NCT00718523|Translational Research In Oncology (formerly CIRG)|Matthieu Rupin|+331 58 10 08 89|matthieu.rupin@trioncology.org|
22405437|NCT01313078|National Cancer Institute, National Institutes of Health|Elise Kohn, M.D.|301-496-9336|kohne@mail.nih.gov|
22405438|NCT00537680|Santhera Pharmaceuticals|Dr Thomas Meier|+41619068964|thomas.meier@santhera.com|
22405439|NCT01068717|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22405440|NCT01822223|University of Alabama at Birmingham|Michael S. Reddy, DMD, DMSc|2059344720|mreddy@uab.edu|
22405441|NCT02758119|iLumens|David Drummond|0033144494848|david.drummond@ilumens.org|6
22405442|NCT04209400|VBI Vaccines Inc.|Dr Francisco Diaz-Mitoma|613-297-3304|fdiazmitoma@vbivaccines.com|
22405443|NCT04128527|Ambu|Signe Toräng|31267089|sito@ambu.com|
22405444|NCT04399980|Cleveland Clinic|Paul C. Cremer, MD|216-444-6765|cremerp@ccf.org|
22391379|NCT02581059|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
22391380|NCT04887506|Tavanta Therapeutics|Head, Clinical Development|+1 833776 8963|info@tavanta.com|
22391381|NCT01963169|University of Maryland, Baltimore|Eun-Shim Nahm|410-706-4913|enahm@son.umaryland.edu|
22391382|NCT02636608|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22391383|NCT00873327|Duke University Medical Center|Brian Smith, MD. MPH|919-668-8951|brian.smith@duke.edu|
22391384|NCT04913948|Ottawa Hospital Research Institute|Dr. Darine El-Chaar|(613) 737-8899|delchaar@toh.ca|78797
22391385|NCT06638840|Oticon medical|Director of Clinical Affairs|+46 31 748 61 00|studyinfor@oticonmedical.com|
22391386|NCT05238103|Johns Hopkins University|Lena Mathews, MD MHS|410-502-0469|lmathew6@jhmi.edu|
22391387|NCT05739994|Indiana University Bloomington|Dr. Hannah Block|8128555390|hjblock@iu.edu|
22391388|NCT02911805|Atlanta VA|Jeffrey H. Boatright, PhD|404-321-6111|jeffrey.boatright@va.gov|
22405445|NCT01449955|UT Southwestern/VA North Texas|Dr. Alina Suris|214-857-0334|alina.suris@va.gov|
22431414|NCT02090764|Ferrer Internacional, S.A.|Clinical Research Manager|+34 93 509 32 75|nalbareda@ferrer.com|
22431415|NCT00744861|Bioventus LLC|Manager Clinical Affairs|1-800-396-4325||
22391389|NCT04021043|MD Anderson Cancer Center|Joe Chang, MD|(713) 563-2337|jychang@mdanderson.org|
22391390|NCT00826228|Northwestern University Feinberg School of Medicine|Thomas J Schnitzer|3125032315|tjs@northwestern.edu|
22391391|NCT03526679|National Taiwan University Hospital|Dr. Tom Wei-Wu Chen|+886-2-23123456|tomwchen@ntuh.gov.tw|66002
22391392|NCT01246999|University of Rochester|John Treanor MD, Professor of Medicine|585-275-5871|John_Treanor@urmc.rochester.edu|
22391393|NCT01867047|Duke University Medical Center|Michael Bolognesi, MD||michael.bolognesi@duke.edu|
22391394|NCT00307047|Abbott Vascular|Ellen Travis|408-845-1512|ellen.travis@av.abbott.com|
22391395|NCT01641653|Rutgers-New Jersey Medical School|Vasanti Tilak, MD|973 972-7477|tilakva@njms.rutgers.edu|
22391396|NCT02825251|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22391397|NCT00349466|Can-Fite Biopharma|Pnina Fishman, PhD|011972 3 924 1114|pnina@canfite.co.il|
22391398|NCT01689363|Amphastar Pharmaceuticals, Inc.|Gisela Sharp|(909) 980-9484|GiselaS@amphastar.com|2016
22391399|NCT00321685|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
22391400|NCT00624910|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
22391401|NCT05064488|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22391402|NCT03023722|Yale University|Stacey Stein, MD|203 737-1600|stacey.stein@yale.edu|
22391403|NCT03616964|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
22391404|NCT04596995|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22391405|NCT03121820|GEROPHARM|GEROPHARM Clinical Leader|+7(812) 703-79-75|inform@geropharm.ru|
22391406|NCT02037477|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22391407|NCT01245140|GlaxoSmithKline|GSK Response Center|866-435-7343||
22391408|NCT02635360|University of Virginia|Dr. Linda R. Duska|434-944-9135|LRD5D@uvahealth.org|
22391409|NCT04082429|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22391410|NCT00334542|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|4432876489|vstearn1@jhmi.edu|
22391411|NCT03118050|University of Texas Medical Branch|Elena Volpi, MD, PhD|210-562-6139|volpi@uthscsa.edu|
22391412|NCT02833805|Johns Hopkins University|Dr. Amy DeZern|410-502-7208|adezerb1@jhmi.edu|
22391413|NCT01454739|Bioverativ Therapeutics Inc.|Bioverativ Study Medical Director|781-6631801|clinicaltrials@bioverativ.com|
22391414|NCT01952847|UT MD Anderson Cancer Center|Aung Naing, MD-Professor, Invest. Cancer Therapeutics|(713) 563-3885|anaing@mdanderson.org|
22391415|NCT05382039|Loma Linda University|Eric Johnson|9095584632|ejohnson@llu.edu|47471
22391416|NCT04464421|University of Tennessee Health Science Center|Karen Derefinko, PhD|9014482526|kderefin@uthsc.edu|
22391417|NCT02577003|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Dvelopment|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22391418|NCT01234883|Baxter Healthcare|Drew Jones, M.D.|224-270-2659|Drew_Jones@baxter.com|
22391419|NCT01013961|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
22391420|NCT01271504|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22391421|NCT02768597|Mayo Clinic|Dr. Mark E. Morrey|507-284-2511|morrey.mark@mayo.edu|
22391422|NCT00980642|Cleveland Clinic|Dr. Andrea Kurz|216 445-9924|KURZA@ccf.org|
22391423|NCT01850589|Staten Island University Hospital|Dr. Jonathan Deitch, PI, Director of Vascular Surgery|718-226-9000|jonathan_deitch@siuh.edu|1278
22391424|NCT03912662|Medtronic|Marion Blanc|+33 4 74 08 90 00|marion.blanc@medtronic.com|
22391425|NCT03845140|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22391426|NCT01592045|United Therapeutics Corporation|Allison Lim|919-425-8799|alim@unither.com|
22391427|NCT04560374|Marmara University Faculty of Health Sciences Department of Pediatric Nursing|Dr. Çağrı Çövener Özçelik|009-0216-777-57-00|ccovener@gmail.com|5773
22391428|NCT01790295|Icahn School of Medicine at Mount Sinai|Dr. John Mascarenhas|212-241-3417|john.mascarenhas@mssm.edu|
22391429|NCT03721705|Renew Research|Billy Tally, CEO|949-545-8466|bill2@stage2innovations.com|
22391430|NCT01843777|National Center for Rehabilitative Auditory Research|M. Samantha Lewis, PhD|503-220-8262|Michele.Lewis3@va.gov|51996
22391431|NCT02239744|Department of Environmental Health, School of Public Health, Fudan University|Dr. Haidong Kan|86-21-54237908|kanh@fudan.edu.cn|
22391432|NCT06533527|Cleveland Clinic Florida (Weston Hospital)|Dr. Tilak Shah|954-659-5646|shaht3@ccf.org|
22391433|NCT01821105|The Ohio State University|Edward Martin, MD|614-293-8843|Edward.Martin@osumc.edu|
22391434|NCT00420784|Vertex Pharmaceuticals Incorporated|Jeff Chodakewitz, M.D.|617-341-6777|Jeff_Chodakewitz@vrtx.com|
22431416|NCT04856527|University of Cincinnati|Sarah Schwab|5135587477|schwabsr@mail.uc.edu|
22405446|NCT00156013|Oncology Specialists|Chadi Nabhan, MD|847-268-8200|cnabhan@oncmed.net|
22405447|NCT05041062|University of Chicago|Theodore Karrison (Research Professor)|773-702-9326|tkarrison@health.bsd.uchicago.edu|
22405448|NCT04968353|Virginia Commonwealth University School of Dentistry, Orthodontics|Steven J Lindauer|8048289326|sjlindau@vcu.edu|
22405449|NCT00318370|Morphotek, Inc.|Susan Weil, MD|610-423-6182|sweil@morphotek.com|
22405450|NCT00651313|Columbia Laboratories, Inc.|George W. Creasy, MD Vice President, Clinical Research|973-486-8797|gcreasy@columbialabs.com|
22405451|NCT01760187|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|8572425142|alison.long@aegerion.com|
22405452|NCT03307629|Noxopharm|Lorena Figueroa, Director clinical Operations|+612 9144 2223|lorena.figueroa@noxopharm.com|
22405453|NCT03296787|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22405454|NCT02853032|University of Texas Health -- San Antonio|Felipe S. Salinas, Ph.D.|210-567-8214|salinasf@uthscsa.edu|
22405455|NCT02146833|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
22405456|NCT02823080|Benha university|dr khalid M Salama|01225861026|dr.khalid_sleem@yahoo.com|
22405457|NCT00676208|Louis Stokes VA Medical Center|Michelle Davidson|(216) 791-2300|michelle.davidson@va.gov|2338
22405458|NCT01379924|Boston Children's Hospital|Dr. Joanne Cox|6173557701|joanne.cox@childrens.harvard.edu|
22405459|NCT03700736|University of Connecticut|Dr. Molly Waring|860-486-1446|molly.waring@uconn.edu|
22405460|NCT00642018|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22405461|NCT01410799|University of Pennsylvania|Dr. Anne Cappola|215-573-5359|acappola@upenn.edu|
22405462|NCT00617656|Fundación GECP|Eva Pereira|+34 934302006|gecp@gecp.org|
22405463|NCT00254163|Ocala Oncology|Dr. Craig Reynolds|(352) 732-4032|Craig.Reynolds@USOncology.com|
22405464|NCT01119963|Mednax. Inc|Kimberly Maurel|714-593-9171|kimberly_maurel@mednax.com|
22405465|NCT01355497|GTx Inc.|Senior Director, Clinical Operations|1-901-261-3795|mdesordi@gtxinc.com|
22405466|NCT01838655|National Institutes of Health|Brian Brooks, MD, PhD, Principal Investigator, NEI|301-451-2238|brian.brooks@nih.gov|
22405467|NCT02579863|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22417501|NCT03261960|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
22405468|NCT04480749|LSHTM|Michael Marks|020 7636 8636|michael.marks@lshtm.ac.uk|
22405469|NCT02253394|Brigham and Women's Hospital|Dr. Bradley Maron|617-525-4857|bmaron@bwh.harvard.edu|
22405470|NCT00038142|The University of Texas (UT) MD Anderson Cancer Center|Dr. Eugenie S. Kleinerman, Professor, Pediatrics - Research|713-792-8110|ekleiner@mdanderson.org|
22405471|NCT00809614|Novartis|Study Director|862-778-8300||
22405472|NCT01224106|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22405473|NCT00446797|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22405474|NCT03210220|Department of Anesthesiology and Pain Medicine, Gil Medical Center, Gachon University|Dr Junju Choi|82-32-460-3636|jjchoi2@gilhospital.com|
22405475|NCT00420342|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22405476|NCT03053401|Akron Children's Hospital|Dr. Rami Karroum|330-543-8823|rkarroum@akronchildrens.org|
22405477|NCT03933215|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22405478|NCT04586673|University of Oxford|Dr Paola Cicconi|01865611425|paola.cicconi@ndm.ox.ac.uk|
22405479|NCT05784129|Janssen Pharmaceuticals, Inc, US Medical Affairs|Medical Director Gastroenterology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22405480|NCT00407550|Mayo Clinic|Julian R. Molina, M.D., Ph.D.|507-284-8318|molina.julian@mayo.edu|
22405481|NCT01444898|Children's Hospital Los Angeles|Dr. Mitchell Geffner|323-361-7032|mgeffner@chla.usc.edu|
22405482|NCT02238782|AstraZeneca|Gabriella Mariani|+44 7818 523 899|ClinicalTrialTransparency@astrazeneca.com|
22405483|NCT02580591|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22405484|NCT01801124|Maimonides Medical Center|Mark Kronefeld, MD|(718) 283-8816||
22405485|NCT01620658|Baptist Health South Florida|Raul Herrera, MD. Director Miami Cardiac and Vascular Institute, Research and Outcomes|786-596-3505|raulh@baptisthealth.net|
22405486|NCT01366534|GlaxoSmithKline|GSK Response Center|866-435-7343||
22405487|NCT03006926|Eisai Co., Ltd.|Eisai Inquiry Service|none|eisai-chiken_hotline@hhc.eisai.co.jp|
22405488|NCT00324272|John Radcliffe Hospital|Mr. Henk Giele, Consultant Plastic & Reconstructive Surgeon|01865 231 056|henk.giele@orh.nhs.uk|
22405489|NCT02918318|Janssen Pharmaceutical K.K., Japan|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22405490|NCT00990249|The University of Texas (UT) MD Anderson Cancer Center|Partow Kebriaei, MD/Professor, Stem Cell Transplantation|713-792-7734|CR_Study_Registration@mdanderson.org|
22405491|NCT04080752|Janssen Research & Development, LLC|BE-R and D-Research Physician - Seni|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22405492|NCT00444080|University of Virginia|Peter A. Netland, MD, PhD|434-982-1086|pan9c@virginia.edu|
22405493|NCT01641081|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
22405494|NCT01095666|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
22405495|NCT03297944|University of Kentucky|Marion Coe|859-257-6488|mcoe07@gmail.com|
22405496|NCT00744692|Duke University Medical Center|Dr. Suhag Parikh|919-668-1100|suhag.parikh@dm.duke.edu|
22405497|NCT02119468|City of Hope National Medical Center|Dr. Amrita Krishnan|626-256-4673|AKrishnan@coh.org|62405
22405498|NCT02758613|Eli Lilly and Company|Chief Medical Officer|800-545-5079||
22405499|NCT02562989|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22405500|NCT02690168|Pennington Biomedical Research Center|Dr. David McDougal|2257630278|DAVID.MCDOUGAL@PBRC.EDU|
22405501|NCT02679781|Hadassah School of Dental Medicine, P.O.Box 12272|Dr. Avia Fux-Noy|+97226776135|fuxavia@gmail.com|
22405502|NCT01496274|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22405503|NCT04018612|Nevakar, Inc.|Eric Lang, MD|(908) 367-7400|Clinicaltrials@nevakar.com|
22405504|NCT00361218|Massachusetts General Hospital|John W. Denninger, MD, PhD|617-726-2985|jdenninger@partners.org|
22405505|NCT01347632|CONRAD|Andrea Thurman|757-446-7444|thurmaar@evms.edu|
22405506|NCT03032250|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-713-1432|cnightin@wakehealth.edu|
22405507|NCT01041404|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22405508|NCT01115517|Robert Cizik Eye Clinic|Dr. Nan Wang|713-559-5200|nwang@cizikeye.org|
22405509|NCT00410904|Barbara Ann Karmanos Cancer Institute|Shirish M. Gadgeel, M.D.|313-576-8753|gadgeels@karmanos.org|
22405510|NCT01750840|Biomet|Manager of Research|973-299-9300|hallie.murray@zimmerbiomet.com|3415
22405511|NCT02650440|Coordination of Improvement of Higher Level Personnel - CAPES|Thais A. Rodrigues, MS, PT.|55 (61) 2022-6002|faleconosco@capes.gov.br|
22405512|NCT05200455|Dartmouth-Hitchcock Medical Center|Dr. Barbara Jobst|6036505000|Barbara.C.Jobst@hitchcock.org|
22405513|NCT03328624|SALSA@USC|Research Coordinator|323-442-5528|dhuyvett@usc.edu|
22405514|NCT00892957|BAXTER INNOVATIONS GmbH|Edith Hantak, Dir, Global Therapeutic Area, BioSurgery||edith_hantak@baxter.com|
22405515|NCT02091921|University of Southern California|Leonardo Clavijo, MD|3234426130|lclavijo@usc.edu|
22405516|NCT02483078|CytoDyn|Joseph Meidling Senior Director Clinical Operations|(360) 980-8524|jmeidling@cytodyn.com|
22405517|NCT04876599|Massachusetts General Hospital|Dr. Daniel Hall|‭+1 (704) 517-7273‬|dhall7@mgh.harvard.edu|
22405518|NCT01962688|Icahn School of Mediine at Mount Sinai|Dr. Jagat Narula|212-241-4122|jagat.narula@mountsinai.org|
22405519|NCT04482244|Dana-Farber Cancer Institute|Dr. Manan Nayak|617-632-5096|manan_nayak@dfci.harvard.edu|
22405520|NCT00669032|Tedec-Meiji Farma, S.A.|R&D Director|918870980|m.gimeno@tedecmeiji.com|
22405521|NCT01607073|Gillette Children's Specialty Healthcare|Beverly Wical, MD|(651) 229-3870|BWical@gillettechildrens.com|
22405522|NCT02564029|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22405523|NCT04126031|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22405524|NCT00131664|Dr. Anatoly Langer, Chair CHRC, Canadian Heart Research Centre|Dr. Robert Josse|416-977-8010|langera@chrc.net|
22405525|NCT01432756|Boston Children's Hospital|Laura Bogart|857-218-4073|laura.bogart@childrens.harvard.edu|
22405526|NCT02712008|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
22405527|NCT00364351|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22405528|NCT02748785|Seoul National University Hospital|Eun Bong Lee|+82-2-2072-4399|leb7616@snu.ac.kr|
22405529|NCT01605890|Hopital Bichat-Claude Bernard, AP-HP, Paris, France|Pr Sophie Matheron|+33140257883|sophie.matheron@aphp.fr|
22405530|NCT01780324|Seattle Children's Hospital|Neil Uspal, MD|206-987-2599|neil.uspal@seattlechildrens.org|
22405531|NCT04037462|VA Ann Arbor Healthcare System|Dr. Nithya Ramnath|(734) 845-5800|Nithya.Ramnath@va.gov|
22405532|NCT00509028|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
22405533|NCT02996110|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22405534|NCT02436915|Institute for Aging Research, Hebrew SeniorLife|Brad Manor|617-971-5332|bradmanor@hsl.harvard.edu|
22405535|NCT03805971|Centre hospitalier universitaire de Liège|Dr Olivier Bonhomme|003243667881|obonhomme@chuliege.be|
22405536|NCT01480232|Massachusetts General Hospital-Center for Addiction Medicine|A. Eden Evins, MD, MPH|617-643-4679|aeevins@mgh.harvard.edu|
22405537|NCT00364832|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22405538|NCT00810095|MindFrame, Inc .|Dr. Thomas J. McCarthy|949-204-0806|tmccarthy@mindframeinc.com|
22405539|NCT05301803|CathVision ApS|Clinical Research Manager|+4531324745|kpf@cathvision.com|
22405540|NCT02023918|UCSF|Dr. Ethan Weiss|4155140819|ethan.weiss@ucsf.edu|
22405541|NCT01838213|Vestre Viken Hospital Trust|Arne Søraas, PhD|+4790652904|arne@meg.no|
22405542|NCT04882072|Janssen Pharmaceutical K.K.|Senior Director GI Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22405543|NCT01548417|The Scripps Research Institute|Barbara J. Mason, Ph.D.|858-784-7328|mason@scripps.edu|
22405544|NCT00602771|SKCCC|Judith Karp, MD|410-502-7726|jkarp2@jhmi.edu|
22405545|NCT04583969|NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
22405546|NCT02939976|Duke University Medical Center|David Kong, M.D.|919-668-8946|David.F.Kong@duke.edu|
22405547|NCT03979872|University of Utah|Dr. Yelena Wu|801-213-5653|yelena@utah.edu|
22405548|NCT01585168|Yale University|Dr. Godfrey Pearlson|(860) 545-7757|Godfrey.Pearlson@hhchealth.org|
22405549|NCT01194414|Hoffman-LaRoche|Medical Communications|800-821-8590||
22405550|NCT01192100|Purdue University|Dr. Heather Leidy|765-496-0184|hleidy@purdue.edu|
22405551|NCT02057068|Atlanta Department of Veterans Affairs Medical Center CVNR|Patricia C. Griffiths, PhD|6783615462|pcgriff@emory.edu|
22405552|NCT00954824|UPenn|Muredach Reilly|215-573-1214|muredach@mail.med.upenn.edu|
22405553|NCT01592006|University of Chicago Medical Center|Dr. Helen S. Te|773-702-2395|hte@medicine.bsd.uchicago.edu|
22405554|NCT01098032|Clinica Mediterranea|Dr. Carlo Briguori, Principal Investigator|+390817259|carlobriguori@clinicamediterranea.it|764
22405555|NCT00643097|Duke University Medical Center|Dr. John H. Sampson|919-684-9041|john.sampson@duke.edu|
22405556|NCT02809846|Scripps TSRI|Lase Ajayi|785.218.1643|tajayi@scripps.edu|
22405557|NCT00841672|Novartis Pharmaceuticals|Study Director|862-778-8300||
22405558|NCT05563714|University of Michigan|Dr. Jacob E. Kurlander, MD, MS|734-660-4883|jkurland@umich.edu|
22405559|NCT02352103|Vattikuti Urology Institute, Henry Ford Hospital|Deepansh Dalela, MD|3139162600|ddalela1@hfhs.org|
22405560|NCT00444964|Children's Mercy Hospital|Jaylene Weigel|816-701-1359|jweigel@cmh.edu|
22405561|NCT00166517|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22405562|NCT02918656|University of Split School of Medicine|Ivan Buljan|+385989027209|ibuljan@mefst.hr|
22405563|NCT03094611|The University of Texas MD Anderson Cancer Center|Elias Jabbour, MD./ Professor, Leukemia|713-792-4764|ejabbour@mdanderson.org|
22405564|NCT04285853|Emory University|Dr. John Xerogeanes|404-778-7202|jxeroge@emory.edu|
22405565|NCT01072448|Novartis Pharmaceuticals|Study Director|862 778-8300||
22405566|NCT00721617|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
22405567|NCT00249795|sanofi-aventis|International Clinical Development, Clinical Study Director||GV-Contact-us@sanofi-aventis.com|
22405568|NCT03179410|Duke University|Andrew Armstrong, M.D.|919-668-8797|andrew.armstrong@duke.edu|
22405569|NCT05103475|Veterans Health Administration|Bella Etingen, PhD|214-857-0240|Bella.Etingen@va.gov|
22405570|NCT00196196|Codman & Shurtleff, Inc.|Jandira Ramos, MPH|508-828-3127|jramos8@its.jnj.com|
22405571|NCT02228824|University of Pittsburgh|Dr. Saul Shiffman|412-567-1761|shiffman@pinneyassociates.com|
22405572|NCT01814826|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
22405573|NCT02917629|UW Carbone Cancer Center|Dr. Howard Bailey|800-622-8922|clinicaltrials@cancer.wisc.edu|
22405574|NCT03271307|University of California Los Angeles|Dr. Kathryn Dovel|7143303416|KDovel@mednet.ucla.edu|
22405575|NCT01042938|University of Rochester Medical Center|Julie L Ryan, PhD, MPH (PI)|585-276-3862|julie_ryan@urmc.rochester.edu|
22405576|NCT03136484|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22405577|NCT00360685|Moffitt Cancer Center|Janelle Perkins, PharmD|813-745-7226|Janelle.Perkins@moffit.org|
22405578|NCT03032510|La Jolla Pharmaceutical Company|Chief Development Officer|617-715-3600|ljpcregulatory@ljpc.com|
22405579|NCT01601470|Novartis Pharmaceuticals|Study Director|862-778-8300||
22405580|NCT01203787|UNIVERSITY OF FLORIDA|Roniel Cabrera, MD|352-273-9468|RONIEL.CABRERA@MEDICINE.UFL.EDU|
22405581|NCT03061812|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22405582|NCT00431496|Amgen Inc.|Study Director|866-572-6436||
22405583|NCT02343952|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
22405584|NCT02671760|Sequential Medicine Ltd|Head of Product Development|617-818-2735|tadahl@outlook.com|
22405585|NCT01745913|Weill Cornell Medical College|Koen van Besien, MD|2127462646|kov9001@med.cornell.edu|
22405586|NCT03418064|CooperVision|Jose A. Vega, O.D., MSc., FAAO|19256213761|jvega2@coopervision.com|
22405587|NCT00136838|New York State Psychiatric Institute|Dr. Adam Bisaga|646-774-6155|bisagaa@nyspi.columbia.edu|
22405588|NCT01931150|Memorial Sloan Kettering Cancer Center|Dr. Mario Lacouture|646-888-6014|LacoutuM@mskcc.org|
22405589|NCT00845845|The University of Illinois Chicago|Scott Cotler, M.D. Professor of Medicine|708-216-3789|scotler@lumc.edu|
22405590|NCT01685203|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
22405591|NCT01570309|Jacobi Medical Center|Dr Seth I Sokol|718-918-5735|seth.sokol@nbhn.net|
22405592|NCT04095793|Theravance Biopharma|Medical Monitor|855 633 8479|medinfo@theravance.com|+1
22405593|NCT03619837|University of Southern California|Norah Terrault|323-442-5100|terrault@usc.edu|
22405594|NCT04483544|Miami Cancer Institute at Baptist Health, Inc.|Director, Research Concept & Protocol Development|(786) 527-9546|MCIResearchConceptAndProtocolDev@baptisthealth.net|
22405595|NCT01131078|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22405596|NCT02177786|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22405597|NCT01305941|UNC Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22405598|NCT04724291|George Washington University|Dr. Andrew C. Meltzer|2027412952|ameltzer@mfa.gwu.edu|
22405599|NCT00430027|University of Colorado, Denver|Dr. Tracey Schefter|720-848-0100|Tracey.Schefter@ucdenver.edu|
22405600|NCT01957215|GlaxoSmithKline|GSK Response Center|866-435-7343||
22405601|NCT04697888|Children's Mercy Hospital|Joel Lim, MD - Principal Investigator|(816)234-3000|jlim@cmh.edu|
22405602|NCT02613338|University of Tennessee|Adrija Sharma, Principal Investigator|8659747684|adrija.sharma@utk.edu|
22405603|NCT01977040|Mednax. Inc|Kimberly Maurel|714593-9171|kimberly_maurel@mednax.com|
22405604|NCT00698139|Columbia University|Dr. Paolo C. Colombo|212-305-2638|pcc2001@columbia.edu|
22405605|NCT03597503|Supernus|Gianpiera Ceresoli-Borroni/ Director Clinical Development|3018382521|gceresoliborroni@supernus.com|
22405606|NCT02027272|University of Mississippi Medical Center|James N. Martin, Jr.|601-984-5358|jnmartin@umc.edu|
22405607|NCT02667236|Aclaris Therapeutics|Judy Schnyder, Sr. Director Clinical Operations|484-329-2144|jschnyder@aclaristx.com|
22405608|NCT00634751|University of Wisconsin Carbone Cancer Center|Dr. Noelle LoConte|608-265-5883|ns3@medicine.wisc.edu|
22405609|NCT00608894|Veloxis Pharmaceuticals, Inc.|Director, Regulatory Affairs|919-591-3090|bbu@veloxis.com|
22405610|NCT03654560|United Health Products, Inc.|Gerard Abate, MD Chief Medical Officer|(386) 627-1598|G.Abate@unitedhealthproductsinc.com|
22405611|NCT01894555|Johns Hopkins School of Medicine|Rehan Qayyum|410-955-7781|rqayyum@jhmi.edu|
22405612|NCT01235338|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22405613|NCT02918721|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
22431417|NCT02610634|Newcastle University|Professor Lynn Rochester|0191 208 1291|lynn.rochester@ncl.ac.uk|
22431418|NCT04562116|Galderma|Clinical Operations|08179615000|Clinical.Studies@galderma.com|1
22405614|NCT05283499|Rutgers University School of Dental Medicine|Cecile A. Feldman|973-972-4634|feldman@rutgers.edu|
22405615|NCT02828644|Akili Interactive Labs|Kathryn Jenkins|7742666693|kjenkins@akiliinteractive.com|
22431419|NCT05078437|University of Kentucky|Daniela Moga, Associate Professor|8593239682|daniela.moga@uky.edu|
22405616|NCT02408484|Octapharma|Sigurd Knaub|55 451 21 41|sigurd.knaub@octapharma.com|+41 (0)
22405617|NCT01726504|Guang An Men Hosptial of China Academy of Chinese Medical Sciences|Liu Zhishun|86 13651016313|liuzhishun@hotmail.com|
22431420|NCT02038647|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22391435|NCT05034939|VentureMed Group, Inc.|Vice President, Clinical, Regulatory & Quality|763-296-2021|jschweiger@venturemedgroup.com|
22391436|NCT02599688|Peregrine Ophthalmic Pte Ltd|Chief Operating Officer|65 97914382|jchua@peregrineop.com|
22391437|NCT00720369|McLean Hospital|Cara McCabe, BA|617-855-2410|cfmccabe@partners.org|
22391438|NCT00996502|Columbia University|CU PRS Administrator|212-342-1643|ClinicalTrialsGov@cumc.columbia.edu|
22405618|NCT04830839|Cincinnati Children's Hospital Medical Center|Professor|+15136363370|shari.wade@cchmc.org|
22405619|NCT01117181|Johns Hopkins|Anne Casper, MA|410-955-8183|ashankli@jhsph.edu|
22405620|NCT04083404|Queen Margaret University|Dr Susan Prior|44 (0)131 474 0000|sprior@qmu.ac.uk|
22405621|NCT00179998|Nationwide Children's Hospital|Dr. Robert Castile|614-355-6670|robert.castile@nationwidechildrens.org|
22405622|NCT02933372|U of Michigan|Dr. Cathie Spino, Research Professor of Biostatistics|7346155469|spino@umich.edu|
22405623|NCT00524043|Johnson & Johnson Pharmaceutical Research & Development|Clinical Team Leader, Paliperidone|609 730-2436||
22405624|NCT03012594|Northwell health|Dr.Larry Miller|5165620334|lmiller7@northwell.edu|
22405625|NCT00517413|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22405626|NCT03938636|Navidea Biopharmaceuticals|Chief Medical Officer|614-822-2320|mrosol@navidea.com|
22405627|NCT00216086|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
22405628|NCT03531762|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22405629|NCT01080625|SNUH|Chul-Woo Jung/ Assistant professor|82-2-2072-0640|spss@snuh.org|
22405630|NCT02019758|University of North Carolina at Chapel Hill|Evan S. Dellon, MD MPH|919-966-2513|edellon@med.unc.edu|
22405631|NCT04989504|Mayo Clinic|Dr. Kimberly Corbin|855-776-0015|corbin.kimberly@mayo.edu|
22405632|NCT00735072|University of California, San Francisco|Peter W. Hunt, MD|(415) 476-4082|phunt@php.ucsf.edu|345
22405633|NCT00911144|GlaxoSmithKline|GSK Response Center|866-435-7343||
22405634|NCT01291511|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
22405635|NCT02367859|Stanford University|Dr. A. Dimitrios Colevas, Professor of Medicine (Oncology)|650-724-9707|colevas@stanford.edu|
22405636|NCT03960658|Minneapolis VA Health Care System|Dr. Paulo R. Shiroma|612-467-2264|paulo.shiroma@va.gov|
22405637|NCT01263314|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22405638|NCT02640755|AstraZeneca|Medical Science Director||clinicaltrialtransparency@astrazeneca.com|
22405639|NCT00865046|VA Pittsburgh Healthcare System|Dr. Debra K. Weiner|412-360-2920|debra.weiner@va.gov|
22405640|NCT01704976|BUAS|Slavko Rogan (Study Chair)|+41 31 848 35 56|slavko.rogan@bfh.ch|
22405641|NCT01188460|OHRI|Dr. Keith Wilson||kewilson@toh.ca|
22405642|NCT00329784|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22405643|NCT00654420|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22405644|NCT01525420|Fred Hutchinson Cancer Research Center|Jonathan B. Bricker, Ph.D.||jbricker@fhcrc.org|
22405645|NCT01421069|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22405646|NCT03378973|Hospital for Special Surgery|Ronald Emerson, MD|2127742742|emersonr@hss.edu|
22405647|NCT00588380|Mayo Clinic|Adrian Vella|507-284-3754|vella.adrian@mayo.edu|
22405648|NCT01927887|Massachusetts General Hospital|Mukesh Harisinghani|6176432009|mharisinghani@partners.org|
22405649|NCT00865202|University of Colorado|Thomas Robinson MD|303-724-2728|thomas.robinson@ucdenver.edu|
22405650|NCT02709109|Parion Sciences|Alison Church|919-313-1183|achurch@parion.com|
22405651|NCT01000818|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22405652|NCT00741260|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
22405653|NCT02565615|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22405654|NCT01787799|Boston Scientific|Peter Maurer, MPH; Director of Clinical Trials|508-683-6678|peter.maurer@bsci.com|
22405655|NCT01928082|The University of Chicago|Murray J. Favus|(773) 702-6138|mfavus@medicine.bsd.uchicago.edu|
22405656|NCT01815580|Fred Hutchinson Cancer Center|Ann Duerr|206 667 7938|aduerr@fredhutch.org|
22405657|NCT01262599|Columbia University Medical Center|Dr. Christine Rohde|(212) 342-3707|chr2111@columbia.edu|
22405658|NCT02120352|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22405659|NCT02427100|The University of Oklahoma Health Sciences Center|Dr. Darla Kendzor, Associate Professor|(405) 271-8001|Darla-Kendzor@ouhsc.edu|50478
22405660|NCT01351064|IUSM|Aaron Carroll|3172789696|aaecarro@iu.edu|
22391439|NCT02113410|Florida Atlantic University|Dr. Juyoung Park|561-297-4537|jpark14@fau.edu|
22391440|NCT02402322|Universitat Autonoma de Barcelona|Dr. Pablo Oromendia|+34 665175467|p.oromendia@gmail.com|
22391441|NCT02818998|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22391442|NCT02437071|Memorial Sloan Kettering Cancer Center|Dr. Neil Segal, MD, PhD|646-888-4187|segaln@mskcc.org|
22391443|NCT03101033|Xijing Hospital, the Fourth Military Medical University|Dr yan lu|029-84775337|yanlu001@fmmu.edu.cn|029-847753
22391444|NCT01587118|Tuscaloosa Research and Education Advancement Corp|Sandra Creel|205-554-2000|sandra.creel@va.gov|1-2840
22391445|NCT00537329|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22391446|NCT02049515|Secura Bio, Inc.|Beth Gregory, PharmD, MBA|1-702-254-0011|bgregory@securabio.com|
22391447|NCT01200498|The University of Texas MD Anderson Cancer Center|Alfonso Quintas-Cardama, MD/Assistant Professor|713-745-4009|eharriso@mdanderson.org|
22391448|NCT01640171|Retina Vitreous Associates of Florida|Steven Cohen|7274459110|scohen@health.usf.edu|
22391449|NCT01653210|Univerisity of Virginia|Sue Brown, MD||sab2f@virginia.edu|
22405661|NCT01610206|University of Virginia|Linda Duska, MD|434-982-1719|lrd5d@virginia.edu|
22405662|NCT00842361|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22405663|NCT02186561|Medtronic Neurovascular, Clinical Affairs|Senior Project Manager, Clinical Project Management|949-680-1274|darren.j.lacour@medtronic.com|
22405664|NCT02573233|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22405665|NCT00023712|Gynecologic Oncology Group(GOG) Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
22405666|NCT02999191|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22405667|NCT04454138|Prism Eye Institute|Ronaldo Santiago|905-456-3937|ronaldo.santiago@prismeye.ca|267
22405668|NCT02079519|Hoffmann-La Roche|Medical Communications|800 821-8590||
22405669|NCT01802515|Yale University|Dr. Mehmet Sofuoglu, Principal Investigator|203 937-4809|mehmet.sofuoglu@yale.edu|
22405670|NCT04821960|Northwestern University|James W. Griffith|3125035345|j-griffith@northwestern.edu|
22405671|NCT01993667|University of Utah|Dr. Scott McIntosh, MD, MPH|801-581-2730|Scott.McIntosh@hsc.utah.edu|
22405672|NCT01602549|GlaxoSmithKline|GSK Response Center|866-435-7343||
22405673|NCT05151367|Columbia University|Melissa Stockwell|2123425732|mss2112@cumc.columbia.edu|
22405674|NCT03627494|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22405675|NCT03695471|Mayo Clinic|Jason Sluzevich|904-953-6402|Sluzevich.Jason@mayo.edu|
22405676|NCT02859558|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22405677|NCT04507360|University of Washington|Tim Althoff|206-543-4243|althoff@cs.washington.edu|
22405678|NCT00400946|Dana-Farber Cancer Institute|Lewis B. Silverman, MD|617.632.6191|Lewis_Silverman@dfci.harvard.edu|
22405679|NCT01357720|Crucell Switzerland AG|Medical Affairs Director|+41(0)319086111|info@crucell.com|
22405680|NCT00439309|Integra LifeSciences|Director, Medical Affairs|609-275-0500||
22405681|NCT02892734|Northwestern University|William Gradishar, MD|312 695 4541|w-gradishar@northwestern.edu|
22405682|NCT00608244|Veloxis Pharmaceuticals A/S|Christina Sylvest|+45 20553877|csy@veloxis.com|
22405683|NCT00688623|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22405684|NCT02000219|OxThera|Chief Operating Officer|0046 86600223|elisabeth.lindner@oxthera.com|
22405685|NCT01998906|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22405686|NCT01572844|GW Medical Faculty Associates|Alison Ehrlich, MD, Chair of Department of Dermatology|202-741-2625|aehrlich@mfa.gwu.edu|
22405687|NCT05724069|Alfasigma|Sara Manzoni|3473778218|sara.manzoni@alfasigma.com|
22405688|NCT03552289|Cook Research Incorporated|Alan Saunders|765-463-7537|Alan.Saunders@CookMedical.com|
22405689|NCT00209092|Emory University|Dr. Amelia Zelnak|404-778-1900|amelia.zelnak@emory.edu|
22405690|NCT00693420|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
22405691|NCT02809118|Auris Medical|RAM|0041 61 201 13|ra@aurismedical.com|50
22405692|NCT04403802|Cedars-Sinai Medical Center|Dr. Arash Asher|310-423-1218|arash.asher@cshs.org|
22405693|NCT05241470|Stuart Therapeutics|Brian Del Buono, Executive Vice President|7034025866|brian@stuarttherapeutics.com|
22405694|NCT00257322|University of California, Irvine|Chao Family Comprehensive Cancer Center|(877) 827-8839|UCstudy@uci.edu|
22405695|NCT01156363|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22405696|NCT03135262|www.roche.com/about_roche/roche_worldwide.htm|Reference Study ID Number: BH39147|888-662-6728 (U.S. Only)|global-roche-genentech-trials@gene.com|
22405697|NCT03745989|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22405698|NCT04944758|University of British Columbia|Dr. Raymond Lam|6048227325|r.lam@ubc.ca|
22405699|NCT00047008|NRG Oncology|Wendy Seiferheld||SeiferheldW@nrgoncology.org|
22405700|NCT00429572|UT MD Anderson Cancer Center|Naoto Ueno, MD, PhD/Professor|713-792-8754|CR_Study_Registration@mdanderson.org|
22405701|NCT02773368|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22405702|NCT01665872|Yale University|Dr. Megan Smith|2037648655|megan.smith@yale.edu|
22405703|NCT01929018|University of Colorado Denver, Anschutz Medical Campus|Dr. Cory Christiansen|303.724.9101|cory.christiansen@ucdenver.edu|
22405704|NCT00748865|Alcon Research Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22405705|NCT02748525|The University of Texas Health Science Center at Houston|Isis Gayed, MD|713-704-1787|isis.w.gayed@uth.tmc.edu|
22405706|NCT03436147|bakirkoy dr sadi konuk training and research hospital|Ismail Alay|+905462375638|dr_ismailalay@hotmail.com|
22405707|NCT01047436|Xidea Solutions Limited|Dr D Bendel||daryl@xideasolutions.com|
22405708|NCT05784103|University of Pittsburgh|Dr. Surya Gnyawali, PhD|6143712027|scg92@pitt.edu|
22405709|NCT01789255|University of Michigan Comprehensive Cancer Center|Pavan Reddy, M.D.|734-647-5954|reddypr@umich.edu|
22405710|NCT02635867|University of Illinois at Chicago|Adriana Semprum-Clavier|312-966-3535|asemprum@uic.edu|
22405711|NCT02128958|Can-Fite BioPharma|Pnina Fishman, PhD, CEO|972-3-924-1114|pnina@canfite.co.il|
22405712|NCT02565576|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22405713|NCT00282568|Astellas Pharma Global Development, Inc.|Vice President, Therapeutic Area Head, Transplantation||ClinicalTrials.Disclosure@us.astellas.com|
22431421|NCT02757430|Abbott|Clinical Research Scientist|6517562885|amber.miller@abbott.com|
22405714|NCT01266070|The University of Texas (UT) MD Anderson Cancer Center|Eric Jonasch, MD/Professor, Genitourinary Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
22405715|NCT00939341|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com|28062
22405716|NCT01408732|University of Minnesota|Holly Boyer, MD|612-725-2000|boyer011@umn.edu|
22405717|NCT04904640|IRCCS Istituto Ortopedico Rizzoli|Francesco Castagnini, MD|+390516366418|francesco.castagnini@ior.it|
22405718|NCT00764322|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22405719|NCT00796003|Janssen Pharm KK Japan|Director|+81-3-4411-5801||
22405720|NCT01268943|Chinese Academic Medical Sciences|Dr. Jing Jin|010-87788503|tangyu.pumc@gmail.com|
22405721|NCT03185819|Janssen-Cilag International NV|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22405722|NCT00732641|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22405723|NCT02910089|Astrazeneca Pharmaceuticals|Susan Thomas, MD|302-886-5589|Susan.Thomas2@astrazeneca.com|
22405724|NCT01976975|McLean Hospital|David Crowley|6178554432|djcrowley@mclean.harvard.edu|
22405725|NCT03434041|Janssen Research & Development, LLC|DIRECTOR CLINICAL LEADER|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22405726|NCT03447821|Cosmo Technologies Ltd.|Richard Jones|+353 18170370|RJones@cosmopharma.com|
22405727|NCT02977507|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22405728|NCT00250497|University_of_Minnesota|Dr. Dianne Neumark-Sztainer, Professor|612-624-0880|neuma011@umn.edu|
22405729|NCT01587274|Montefiore Health|Benjamin W. Friedman, MD|7189206626|befriedm@montefiore.org|
22405730|NCT02242760|Novan, Inc.|Cathy White, Vice President, Drug Development Operations|919-485-8080|clinical@novan.com|
22405731|NCT03236506|University of Dundee|Professor John Dillon|01382 383017|j.f.dillon@dundee.ac.uk|
22405732|NCT00638274|Wake Forest University School of Medicine|Peter H. Pan, MD|336-718-82748|ppan@wakehealth.edu|
22405733|NCT01577628|Innovaderm Research|Dr Robert Bissonnette|514-521-4285|rbissonnette@innovaderm.ca|
22405734|NCT00838383|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22405735|NCT00422669|Medtronic, Inc.|Optimize RV Trial Leader|1-800-328-2518|medtroniccrmtrials@medtronic.com|
22405736|NCT03920865|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22405737|NCT04010370|Institute of Experimental andl Clinical Therapeutics|Dr. Manuel González Ortiz|+52-33-10-58-52-00|uiec@prodigy.net.mx|34212
22405738|NCT00927264|Johns Hopkins University|Cynthia Rand, Ph.D.|410-550-0487|crand@jhmi.edu|
22405739|NCT02219997|Alcon Research, Ltd.|Global Brand Med Affairs Lead, VGR|1-888-451-3937|alcon.medinfo@alcon.com|
22405740|NCT00437203|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22405741|NCT03997760|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22405742|NCT01983878|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22405743|NCT01883804|Barbara Davis Center for Diabetes, University of Colorado School of Medicine|Dr. Aaron Michels|303-724-1923|aaron.michels@ucdenver.edu|
22405744|NCT02566109|Wake Forest University Health Sciences|Gregory Hundley, MD|336-716-0607|ghundley@wakehealth.edu|
22405745|NCT01906476|Northwestern University|Mary Kwasny|312-503-2294|m-kwasny@northwestern.edu|
22405746|NCT01248585|Canadian Cancer Trials Group|Keyue Ding, Biostatistician|613-533-6430|kding@ctg.queensu.ca|
22405747|NCT00479167|Rush University Medical Center|Stephanie Gregory, MD|312-942-5982|stephanie_gregory@rush.edu|
22405748|NCT03304912|Drexel University|Alexis Roth, PhD, MPH|267.359.6123|alexisroth@drexel.edu|
22405749|NCT01576406|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22405750|NCT01627782|Janssen Research & Development, LLC|Senior Director, Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
22405751|NCT02988401|Johns Hopkins University|Dr. Ellen Mowry|4106141522|Emowry1@jhmi.edu|
22405752|NCT00142818|University of Pennsylvania|Dr. Kyle Kampman|215-222-3200|kampman@mail.med.upenn.edu|109
22405753|NCT01004159|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22405754|NCT02481440|The Third Affiliated Hospital of Sun Yat-sen University|Li-Min Rong M.D., Director of Clinical Trials|862085252900|ronglimin@21cn.com, ronglm@mail.sysu.edu.cn|
22405755|NCT03140488|University of Arizona|Meghan Hill|+64273095220|meghan.hill@auckland.ac.nz|
22405756|NCT04315298|Regeneron Pharmaceuticals, Inc.|Clinical Trials Adminstrator|844-734-6643|clinicaltrials@regeneron.com|
22405757|NCT01199198|University of Texas (UT) MD Anderson Cancer Center|Carmen Escalante,MD/Chair, General Internal Med|(713) 745-4516|cescalan@mdanderson.org|
22405758|NCT00736385|Duke University Medical Center|Christopher Kigongo|919-668-6579|christopher.kigongo@duke.edu|
22405759|NCT03267511|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22405760|NCT03050307|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22405761|NCT03950440|University Hospitals Leuven|Dr. Danny Feike Hoogma|003216344270|danny.hoogma@uzleuven.be|
22405762|NCT02043509|University of East Anglia|Dr Joanne Emery||joanne.emery@uea.ac.uk|
22405763|NCT02145754|University Medical center Ljubljana, Infectious Diseases Department|Daša Stupica|+386 1 522 21 10|dasa.stupica@kclj.si|
22405764|NCT03189563|Dong-A ST|Xiaofei Du|82-2-92-8457|duxiaofeicat@donga.co.kr|
22405765|NCT01670825|Johns Hopkins Hospital|Steven Cohen|410-955-1818|scohen40@jhmi.edu|
22405766|NCT01685060|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22405767|NCT03690674|Seattle Children's Research Institute|Dr. Pooja Tandon|206-884-1130|pooja.tandon@seattlechildrens.org|
22405768|NCT02443155|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22405769|NCT00464620|SARC|SARC|(734) 930-7600|sarc@sarctrials.org|
22405770|NCT02444936|Cleveland VA|Dr. David Canaday|216-368-8901|dxc44@case.edu|
22405771|NCT02334813|University Hospital Essen, Germany|Prof. Dr. Ulrich Dührsen|+49 201 723|ulrich.duehrsen@uk-essen.de|2417
22405772|NCT00864539|National Nutrition and Food Technology Research Institute|Dr. Tirang R. Neyestani|(+9821)22376471|neytr@yahoo.com|
22405773|NCT06048809|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
22405774|NCT02158728|Medtronic|Clinical Research Specialist L. Vainer|+31 43 3566752|lidwien.vainer@medtronic.com|
22405775|NCT01250899|University of California, Los Angeles|Dr Jordan Lake|310-557-2273|jlake@mednet.ucla.edu|
22405776|NCT01847560|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22405777|NCT01092364|Duke University Medical Center|Dr. Laura P. Svetkey|919-660-6626|laura.svetkey@dm.duke.edu|
22405778|NCT01536418|GlaxoSmithKline|GSK Response Center|866-435-7343||
22405779|NCT04210232|Johnson & Johnson Surgical Vision|Eugenia K. Thomas|+1 657 2903260|EThoma39@its.jnj.com|
22405780|NCT02658149|Beaumont Health|Dr. James Verner|1(248)551-9722|jverner1@aol.com|
22405781|NCT01525745|Beth Israel Deaconess Medical Center|Anand Mahadevan, MD|617-667-2345|amahadev@bidmc.harvard.edu|
22405782|NCT00711412|Northwestern University|Dr. Mary Mulcahy|312 695 6182|Mary.Mulcahy@nm.org|
22405783|NCT00794469|Hadassah Medical Organization|Gal Dubnov-Raz|+972+54-4570250|gal-d@bezeqint.net|
22405784|NCT02458352|University Hospital Zurich|Dr. Ronny Buechel|0041442551059|ronny.buechel@usz.ch|
22405785|NCT01680991|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22405786|NCT02498392|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22405787|NCT06073054|University of Iowa|Linnea Polgreen|(319) 384-3024|linnea-polgreen@uiowa.edu|
22405788|NCT02244619|Kettering Health Network|Skip Hickman, RPH|(937) 762-1339|skip.hickman@ketteringhealth.org|
22405789|NCT00383266|Washington University School of Medicine|Maria Baggstrom, M.D.|314-362-5740|mbaggstr@dom.wustl.edu|
22405790|NCT00068822|Mayo Clinic|David F. Kallmes, M.D.|507-266-3350|kallmes.david@mayo.edu|
22405791|NCT00617162|Abbott|Lyndahl Himes, Sr. Clinical Research Scientist|+1 214 998 1137|lyndahl.himes@abbott.com|
22405792|NCT00424099|UT MD Anderson Cancer Center|Dr. Eduardo Bruera, MD- Chair, Palliative Care Med|(713) 792-6084|ebruera@mdanderson.org|
22405793|NCT00564265|Hospital de La Serena|Dr. Marcelo A. Beltran|56 - 51 - 485923|beltran_01@yahoo.com|
22405794|NCT00435929|Roche Trial Information Hotline|F. Hoffmann-La Roche AG|+41 61 6878333|global.trial_information@roche.com|
22405795|NCT02417064|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22405796|NCT02437162|Johnson&Johnson|SENIOR DIRECTOR CLINICAL DEVELOPMENT|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22405797|NCT03321526|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22405798|NCT03097133|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22405799|NCT03605836|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22405800|NCT01933399|MUSC|David Morrisette, PhD|843-792-2940|morrisdc@musc.edu|
22405801|NCT00633360|Brigham & Women's Hospital|Dr Hadine Joffe|617-732-4906|hjoffe@partners.org|
22405802|NCT00610207|Cook Biotech, Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@CookBiotech.com|
22405803|NCT01452191|University of Nottingham|Professor Denise Kendrick||denise.kendrick@nottingham.ac.uk|
22405804|NCT02348840|Emory University|Gari D. Clifford, DPhil|404-727-0229|gari.clifford@emory.edu|
22405805|NCT01025232|Retinal Consultants of Houston|David M. Brown, MD Director of Clinical Research|713-394-7534|dmbmd@houstonretina.com|
22405806|NCT03011775|Ukrainian Medical Stomatological Academy|Prof. Igor Kaidashev|+380505858953|kaydashevip@gmail.com|
22405807|NCT03748420|HealthPartners Institute|Dr. Patrick O'Connor|952-967-5034|patrick.j.oconnor@healthpartners.com|
22405808|NCT00373880|New York State Psychiatric Institute at Columbia University Medical Center|Margaret Haney, Ph.D.|646-774-6153|meg.haney@nyspi.columbia.edu|
22405809|NCT01347073|Hyperion Therapeutics, Inc.|Craig James R.N. Associate Dir. UCD Clinical Operations|(650) 745- 7480|craig.james@hyperiontx.com|
22405810|NCT00626340|University of Pennsylvania|Dr. Cynthia Neill Epperson|215-573-8871|cepp@mail.med.upenn.edu|
22405811|NCT00621244|Novartis Pharmaceuticals|Study Director|862-778-8300||
22405812|NCT03634228|The University of Texas MD Anderson Cancer Center|Courtney DiNardo, MD/ Associate Professor|713-794-1141|CDiNardo@mdanderson.org|
22405813|NCT00312728|Hoffman-LaRoche|Medical Communications|800-821-8590||
22405814|NCT01634100|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22405815|NCT00338806|NYSPInstitute|Dr. Helen Verdeli|212 543 5262|verdelih@nyspi.columbia.edu|
22405816|NCT00744991|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22405817|NCT01662986|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22405818|NCT01501162|Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea|Dr. Ki Tae Suk|+82-33-240-5826|ktsuk@hallym.ac.kr|
22405819|NCT01594411|CardioDx, Inc.|EJ Fernandez, MD, CCRP - Sr. Manager Clinical Affairs|650-383-3350|jkuo@cardiodx.com|
22391450|NCT00224029|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com|
22391451|NCT00243022|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Glen Stevens||steveng@ccf.org|
22391452|NCT01099579|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22391453|NCT02569957|Sidney Kimmel Cancer Center at Thomas Jefferson University|Russell Schilder|215-503-3057|russell.schilder@jefferson.edu|
22391454|NCT03513068|ResMed|Maureen Crocker, Sr. Manager Market Access|+65 9815 2195|maureen.crocker@resmed.com|
22391455|NCT00521976|Stavanger University Hospital|Dennis W.T. Nilsen MD PhD FESC FAHA|+4705151|nide@sus.no|9455
22405820|NCT00924729|Johns Hopkins University|Walter J. Stark, M.D./Professor of Ophthalmology|410-955-5490|wstark@jhmi.edu|
22405821|NCT01929707|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22405822|NCT01332097|Mereo BioPharma|Dr. Jackie Parkin|+44 333 0237300|enquiries@mereobiopharma.com|
22405823|NCT00856986|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22405824|NCT01240304|University of Arkansas for Medical Sciences|Beth Scanlan|501-686-8274|bscanlan@uams.edu|
22405825|NCT02448914|LobSor Pharmaceutical AB|Roger Bolsöy, CEO|+46 (0) 72 222 44 08|roger.bolsoy@lsmgroup.se|
22405826|NCT02384993|University of Wisconsin - Madison|Ozioma C. Okonkwo|(608) 265-4479|ozioma@medicine.wisc.edu|
22405827|NCT03209362|Seikagaku Corporation|Clinical Development Dept.|(81)3-5220-8948|taku.hosaka@seikagaku.co.jp|
22405828|NCT01628042|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22405829|NCT02358863|Lombardi Comprehensive Cancer Center (LCCC)|John Marshall, MD|202-444-7064|marshalj@georgetown.edu|
22405830|NCT00098865|DFCI|Mark W. Kieran, MD, PhD|617-632-4907|mark_kieran@dfci.harvard.edu|
22405831|NCT00638651|University of Miami|Dr. Keyvan Nouri|305-243-3380|knouri@med.miami.edu|
22405832|NCT04852666|University of North Carolina at Chapel Hill|Michael Kappelman, MD, MPH|919-843-5908|michael_kappelman@med.unc.edu|
22405833|NCT01636453|Penumbra, Inc.|Michaella Corso|(510) 748-3200||
22405834|NCT05426460|University of Pittsburgh|Dr. Cynthia Conklin|4125869840|conkca@upmc.edu|
22405835|NCT00653068|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22405836|NCT02204410|Massachusetts General Hospital|Dr. Timothy Wilens|(617)643-3481|twilens@mgh.harvard.edu|
22405837|NCT04829734|Multi Radiance Medical|Douglas Johnson, ATC, EES, CLS - Chief Science Officer, Clinical and Scientific Affairs|440-542-0761|info@multiradiance.com|
22405838|NCT01405027|Chronic Liver Disease Foundation|Dr. Fred Poordad|732-381-8887|poordad@txliver.com|
22405839|NCT01193049|Merck Sharp and Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22405840|NCT05085327|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
22405841|NCT00911326|Navidea Biopharmaceuticals|Dr. Frederick O. Cope, Chief Scientific Officer|614-793-7500|fcope@navidea.com|140
22405842|NCT02734849|Allakos, Inc.|Henrik Rasmussen, MD, PhD, Chief Medical Officer|1 6505975002|hrasmussen@allakos.com|
22405843|NCT05129124|Bausch + Lomb Incorporated|Jill Schafer|0000000|Jill.Schafer@bausch.com|
22405844|NCT02234050|EORTC|Dr. Thierry Gorlia|027741652|thierry.gorlia@eortc.org|
22405845|NCT00592176|University of Alabama at Birmingham|Dr. Tyler Hall, M.D.|205-325-8310|tandrewhall@yahoo.com|
22405846|NCT04097028|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-2300|Kris.Attwood@roswellpark.org|
22405847|NCT02473289|Janssen Research & Development, LLC|ASSOCIATE DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22405848|NCT03285490|Almirall S.A.|Head of Global Clinical Development|+34932913000|rd@almirall.com|
22405849|NCT02728206|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22405850|NCT04521920|Duke University|Dr. Mehri McKellar|(919) 613-6129|mehri.mckellar@duke.edu|
22405851|NCT03689972|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22405852|NCT01131130|Bausch + Lomb|Dr. Robert Steffen|585-338-6399|robert.steffen@bausch.com|
22405853|NCT03981744|Janssen Pharmaceutical K.K.|PRODUCT DEVELOPMENT PORTFOLIO LEADER|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22405854|NCT02782104|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22405855|NCT04338321|Janssen-Cilag International NV|Europe, Middle East, Africa (EMEA) Medical Advisor Spravato|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22405856|NCT02438787|Janssen Research & Development, LLC|Scientific Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22405857|NCT03412565|Janssen Research & Development, LLC|GLOBAL MEDICAL HEAD|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22405858|NCT00371540|Indiana University School of Medicine|Kara Wools-Kaloustian|317-274-7936|kwools@iu.edu|
22405859|NCT01989572|ECOG Statistical Office|Study Statistician|617-632-3012||
22405860|NCT00262639|Medical University of South Carolina|Raymond F. Anton, M.D.|843-792-1226|antonr@musc.edu|
22405861|NCT00732238|Michael E DeBakey VA Medical Center-Baylor College of Medicine|Rabih Darouiche|713-841-3882|rdarouiche@aol.com|
22405862|NCT02280096|Instituto Mexicano del Seguro Social. Unidad de Investigación Médica en Enfermedades Neurológicas.|Dr. Israel Grijalva|(01152) 5555780240|igrijalvao@yahoo.com|
22405863|NCT06181708|Imperial College Healthcare NHS Trust|Emma Flint|02033117322|e.flint1@nhs.net|
22405864|NCT03733132|Mayo Clinic|K Sreekumaran Nair, M.D., Ph.D.|507-255-2415|Nair@mayo.edu|
22405865|NCT00246376|Baylor College of Medicine|Ashok Balasubramanyam, MD, Prinicipal Investigator|713-798-8654|ashokb@bcm.edu|
22405866|NCT02219516|Study Information Center AstraZeneca|Jesse Hall, MD|+1 877-240-9479|information.center@astrazeneca.com|
22405867|NCT01872897|Reckitt Benckiser|Clinical Data Controller||clinicaldatacontroller@reckitt.com|
22405868|NCT04254796|University of California, San Francisco|Olga Tymofiyeva|415-514-4870|olga.tymofiyeva@ucsf.edu|
22405869|NCT04159701|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22405870|NCT02463227|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s3.com|
22405871|NCT02845440|Massachusetts General Hospital, Center for Addiction Medicine|A. Eden Evins|6177333131|aeevins@mgh.harvard.edu|
22405872|NCT01782885|Universidad Autónoma de Nuevo León|M Sc Mario Simental-Mendía|+52 (81) 8329 4174|mario.simental@gmail.com|
22431422|NCT04116684|Cleveland Clinic|Venu Menon, M. D.|216-445-5390|menonv@ccf.org|
22431423|NCT03078868|University of Chicago|Shirley Rodriguez|773-834-4337|srodrigu@surgery.bsd.uchicago.edu|
22431424|NCT01983111|Mundipharma Korea Ltd.|PhD. Miyoung Song||miyoung.song@mundipharma.co.kr|
22431425|NCT03502200|OhioSUCCC|Dr. Theodore L. Wagener|614-366-4265|Theodore.Wagener@osumc.edu|
22431426|NCT00855335|Janssen Scientific Affairs, LLC|Medical Leader, Medical Department||ClinicalTrialDisclosure@its.jnj.com|
22431427|NCT00731484|TearLab, Inc.|Dr. Benjamin Sullivan|855-832-7522|bdsulliv@TearLab.com|
22431428|NCT03097289|Terumo BCT, Inc.|Ned Cosgriff, MD|+1 303-239-2316|ned.cosgriff@TerumoBCT.com|
22431429|NCT05126303|Guard Therapeutics|Sara Thuresson, Head of Clinical Operations|+46733319438|sara.thuresson@guardtherapeutics.com|
22431430|NCT02526290|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22431431|NCT02082977|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22431432|NCT00049543|NCIC Clinical Trials Group|Dr. Keyue Ding|1-613-533-6000|king@ctg.queensu.ca|77705
22431433|NCT02908178|Yale University|Shi-Yi Wang, MD, PhD|2037852886|shiyi.wang@yale.edu|
22431434|NCT05036343|Mayo Clinic|Ana L. Creo, M.D.|507-284-3300|Creo.Ana@mayo.edu|
22431435|NCT02733757|Universidade federal de Minas Gerais|Dr Renato Gomez|553134099760|renatogomez2000@yahoo.com.br|
22431436|NCT06203717|Butler Hospital|Mascha van 't Wout-Frank|401-680-4198|mascha_vant_wout@brown.edu|
22431437|NCT01275300|Upenn|Wenliang Song, MD|215-662-4652.|wenliangsong@gmail.com|
22431438|NCT01957384|Coloplast A/S|Marian Dyreborg Sinvani, Clinical Manager|+45 4911 2356|dkmards@coloplast.com|
22431439|NCT01506726|Duke University Medical Center|Harvey J. Cohen, MD|919-660-7502|harvey.cohen@dm.duke.edu|
22431440|NCT04079738|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
22431441|NCT04554836|Evangelisches Krankenhaus Hamm Werler Str. 110, 59063 Hamm|Prof. Dr. Alexander Baraniskin|+49 (0) 2381 / 589 1863|Alexander.Baraniskin@ruhr-uni-bochum.de|
22431442|NCT01380080|ACTG Network Coordinating Center, Social & Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22431443|NCT05634538|Corindus|Alison Lord|617-943-5472|alison.lord@siemens-healthineers.com|
22431444|NCT02303821|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22431445|NCT00210132|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
22431446|NCT04341012|Mayo Clinic|Tushar Patel|9049532000|patel.tushar@mayo.edu|
22431447|NCT02711202|Institute for Clinical and Experimental Medicine|Prof. Ondřej Viklický, M.D., Ph.D.|+420 2 6136 4110|ondrej.viklicky@ikem.cz|
22431448|NCT02402647|VA San Diego|Catherine Ayers|858-220-4041|catherine.ayers1@va.gov|
22431449|NCT02784587|Maine Medical Center|Research coordinator|2076622862|richaj3@mmc.org|
22431450|NCT00057577|Vanderbilt University|Dr. Steven D. Hollon|615-322-3369|steven.d.hollon@vanderbilt.edu|
22431451|NCT03826472|California Health Sciences University College of Osteopathic Medicine|Emily Johnston|9737685888|eajohnst@gmail.com|
22431452|NCT03207347|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
22431453|NCT02096107|Medical University of South Carolina|David Taber|843-792-3368|taberd@musc.edu|
22431454|NCT02371187|Colorado State University|Manager of Research Operations|9704912242|Laurie.Biela@colostate.edu|
22431455|NCT00543127|Department of Medical Oncology, Hospital Universitario Gregorio Marañón|Dr. Miguel Martin||miguel.martin@salud.madrid.org|
22431456|NCT02513641|Pennington Biomedical Research Center|Dr. Eric Ravussin|225-763-3186|eric.ravussin@pbrc.edu|
22431457|NCT00618787|Tyco Healthcare Group|Tonya Eggleston, RN, MPH, Study Director|(508) 261-8420|Tonya.Eggleston@Covidien.com|
22431458|NCT01994876|Coloplast A/S|Director of Clinical Affairs|+45 4911 25 23|dkdac@coloplast.com|
22431459|NCT06022107|Yale University|Li Yan McCurdy, PhD|2037372912|liyan.mccurdy@yale.edu|
22431460|NCT05847686|University of Washington|Anthony Back MD|2066194367|tonyback@uw.edu|
22431461|NCT03716830|Massachusetts General Hospital|Jian Kong, PI of the clinical trial|6177267893|kongj@nmr.mgh.harvard.edu|
22431462|NCT04887831|G1 Therapeutics, Inc.|Clinical Trial Info.|919-213-9835|clinicalinfo@g1therapeutics.com|
22431463|NCT03698279|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22431464|NCT02552225|Boson Medical Center|Pieter Noordzij, MD|(617) 414-1756|pieter.noordzij@bmc.org|
22405873|NCT04146038|Cancer Institute of New Jersey Rutgers|Roger K. Strair, MD, PhD|732-235-4523|strairrk@cinj.rutgers.edu|
22405874|NCT01849562|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22405875|NCT01775800|The Rogosin Institute|Dr. Nathaniel Berman|212-746-9766|nab2009@nyp.org|
22405876|NCT03136913|Tufts University|Dr. Yong Hur|6176366531|Yong.Hur@tufts.edu|
22405877|NCT03241589|VHA|Sara Peracca|415-750-2091|sara.peracca@va.gov|
22405878|NCT00693693|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-3775|sfeldman@wfubmc.edu|
22405879|NCT04599972|Orasis Pharmaceuticals, Ltd.|Head of Regulatory Affairs|+972-9-8877745|iris.meisner@orasis-pharma.com|
22405880|NCT02069704|mAbxience|Susana Millan|+34917711500|susana.millan@mabxience.com|
22405881|NCT00554853|UMichigan|PPAR-gamma agonist, rheumatoid arthritis and cardiovascular disease|734-936-7905|makaplan@umich.edu|
22405882|NCT02861118|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22405883|NCT02108522|AlloVir|Iain Fraser, MD|833-409-2281|ClinicalTrials@allovir.com|
22405884|NCT01690988|Washington University School of Medicine|Dr. Michael Avidan|314-747-4155|avidanm@wustl.edu|
22405885|NCT03696576|Emory University|Sandeep Shelly|404-686-4206|SSHELLY@emory.edu|
22405886|NCT01922986|University of Minnesota|James R. Carey|612-626-2746|carey007@umn.edu|
22391456|NCT03636373|Rutgers, The State University of New Jersey|Naomi Schlesinger, MD|732 235 6117|Naomi.Schlesinger@hsc.utah.edu|
22391457|NCT01575873|Amgen Inc.|Study Director|866-572-6436||
22391458|NCT01850030|Abbott|Erik van Leeuwen MSc, PMP|+31294479241|erik.vanleeuwen@abbott.com|
22391459|NCT01031498|UT MD Anderson Cancer Center|Jorge Cortes, MD / Professor|713-745-5783|eharrison@mdanderson.org|
22391460|NCT02688530|Hospital for Special Surgery|Meghan Kirksey, MD, PhD|212-606-1206|Kirkseym@hss.edu|
22391461|NCT01658020|Asan Midical Center|Principal Investigator|+82-2-3010-3136|ymoh55@amc.seoul.kr|
22391462|NCT04996940|University of Kansas Medical Center|Leah Lambart Graduate Research Assistant|9139457862|llambart@kumc.edu|
22391463|NCT03698019|SWOG Statistics and Data Management Center|Melanoma Committee Statistician|2066674623|jmoon@fredhutch.org|
22391464|NCT03668223|Dana Farber Cancer Institute|Dr. Abby Rosenberg|617-632-5286|abbyr_rosenberg@dfci.harvard.edu|
22391465|NCT05502783|National Heart, Lung, and Blood Institute (NHLBI) at National Institutes of Health (NIH)|Dr. Georg Aue|301.547.9490|aueg@nhlbi.nih.gov|
22391466|NCT02035696|Seqirus|Clinical Trial Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com|
22391467|NCT00379769|GlaxoSmithKline|GSK Response Center|866-435-7343||
22417502|NCT04505293|Duke University|Anthony 'Tony' T. Fuller, MD, MScGH|919-613-1813|anthony.fuller@duke.edu|
22417503|NCT01249365|GlaxoSmithKline|GSK Response Center|866-435-7343||
22417504|NCT00003875|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
22417505|NCT01551888|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
22417506|NCT01300052|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22417507|NCT03835325|Eurofarma Laboratórios S.A|Sandra Rodrigues|1150908600|sandra.rodrigues@eurofarma.com.br|8417
22417508|NCT01884064|University of Minnesota|Dr. Teresa Jacobson Kimberley|612-626-4096|tjk@umn.edu|
22417509|NCT01546649|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22417510|NCT01370213|Masonic Cancer Center, University of Minnesota|Dr. Jeffrey Miller|612-626-4024|mille011@umn.edu|
22417511|NCT01227655|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22417512|NCT01550744|Janssen Biotech, Inc|Senior Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
22417513|NCT02494817|University of Hawaii|Jason W. Mitchell, PhD, MPH|8082196729|jasonmit@hawaii.edu|
22417514|NCT00706381|NIDDK|Kong Chen, Ph.D.|301-451-1636|chenkong@niddk.nih.gov|
22417515|NCT05420012|University of Utah|Josef Stehlik|801-585-9797|josef.stehlik@hsc.utah.edu|
22417516|NCT00511992|University of Oklahoma|Ingrid Block, CTO Director|405 271-8001|ingrid-block@ouhsc.edu|
22417517|NCT00867048|University of Minnesota|Birgit Grund|612-624-8076|birgit@umn.edu|
22417518|NCT00038649|University of Texas (UT) MD Anderson Cancer Center|Jorge Cortes, MD/Professor, Leukemia Department|713-794-5783|CR_Study_Registration@mdanderson.org|
22417519|NCT03395639|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22417520|NCT01397617|Nobel Biocare Services AG|Head Clinical Trial Management|+41 43 211 42 00|isabelle.arrighi@nobelbiocare.com|
22417521|NCT02994251|Yale University|Dr. Todd Schlachter|203-785-5885|todd.schlachter@yale.edu|
22417522|NCT00567476|Novartis Pharmaceuticals|Study Director|862 778-8300||
22417523|NCT00995085|Alcobra Inc|Jonathan Rubin, MD, MBA|610-504-7814|jrubin@alcobra-pharma.com|
22417524|NCT01829919|Noven Therapeutics, LLC|Sailaja Bhaskar, Executive Director, Clinical Research|(212) 287-0798|sbhaskar@noven.com|
22417525|NCT01194973|Alexion Pharmaceuticals Inc|Alexion Pharmaceuticals Inc||clinicaltrials@alexion.com|
22417526|NCT00594620|The University of Kansas|Jeffrey Holzbeierlein, MD, FACS|913-945-8239|jholzbeierlein@kumc.edu|
22417527|NCT00767520|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22417528|NCT01338987|National Cancer Institute|Dr. Christopher Kanakry|240-760-6171|christopher.kanakry@nih.gov|
22417529|NCT02480582|University of Leeds|Dr Graham Finlayson|0113 343 7601|g.s.finlayson@leeds.ac.uk|
22417530|NCT01155778|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22417531|NCT01045031|Health and Prevention Center, Sanatorium Hera, Vienna, Austria|Dr. Robert Winker|0043(1)-31350|robert.winker@hera.co.at|45666
22417532|NCT00851643|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22417533|NCT01641133|GlaxoSmithKline|GSK Response Center|866-435-7343||
22417534|NCT03351231|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email|Clinical.Trials@bms.com|
22417535|NCT03052972|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
22417536|NCT03020719|Seattle Children's Hospital|Arthur Baines|2068841431|Arthur.Baines@seattlechildrens.org|
22417537|NCT00787020|Duke University Medical Center|DaiWai M Olson|9196683751|Olson006@mc.duke.edu|
22417538|NCT02340221|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22417539|NCT00518622|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22431465|NCT03326245|National Institute on Alcohol Abuse and Alcoholism (NIAAA)|Dr. Dardo Tomasi|+1 301 496 1589|tomasidg@mail.nih.gov|
22431466|NCT03122184|Massachusetts General Hospital|Dr. Jeff Huffman|617-724-2910|JHUFFMAN@mgh.harvard.edu|
22431467|NCT02180828|Peking University|Shangrong Fan|860755-83923333|fanshangrong@163.com|5502
22431468|NCT02276040|OrthoCarolina Research Institute|Senior Research Scientist|704-323-2260|susan.odum@orthocarolina.com|
22431469|NCT00876447|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22431470|NCT00567502|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22431471|NCT03728933|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22431472|NCT02835690|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22431473|NCT02297516|Q-Med AB|Head of Development|+ 46 (0) 18 474 90 00|reception.seupp@galderma.com|
22431474|NCT03674281|University of Virginia|Sue Brown, MD|434-982-0602|sab2f@virginia.edu|
22431475|NCT00525421|University of California San Francisco|Nita Chainani-Wu|415-476-2045|nita.wu@ucsf.edu|
22431476|NCT00582907|Shaare Zedek Medical Center/Cleveland Clinic|Philip Hashkes, MD, MSc|972-2-6555307|hashkesp@szmc.org.il|
22431477|NCT02538614|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22431478|NCT03835078|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
22431479|NCT02323048|University of Chicago|Dr. Harriet de Wit|773-702-3560|dewitlab@yoda.bsd.uchicago.edu|
22431480|NCT00189423|Advanced Circulatory Systems, Inc.|Director of Clinical Trials|651-403-5600|csetum@advancedcirculatory.com|
22417540|NCT00103402|University of Pennsylvania|J. Richard Landis, PhD|215-573-4922|hultman@upenn.edu|
22417541|NCT03168321|Bausch Health Americas, Inc|Study Director|510-259-5284|aloncaric@bauschhealth.com|
22417542|NCT02013375|University of Illinois at Chicago|Dr Damiano Rondelli|312-996-6179|drond@uic.edu|
22417543|NCT00712985|Milton S. Hershey Medical Center|Allan Lipton, MD|717-531-5960|alipton@hmc.psu.edu|
22417544|NCT01663727|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
22417545|NCT01902628|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22417546|NCT02522403|Universidad Autonoma de Nuevo Leon|Carlos Acosta-Olivo|528183467798|dr.carlosacosta@gmail.com|
22417547|NCT01553279|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22417548|NCT00619112|UCSF|Nicholas Butowski|4153532966|Butowski@neurosurg.ucsf.edu|
22417549|NCT00729248|Northwestern University|Lorenzo Gallon, MD - Study Principal Investigator|312-695-4457|l-gallon@northwestern.edu|
22417550|NCT02588950|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22417551|NCT05855616|Marques de Valdecilla University Hospital|Raquel Pelayo Alonso, Head Nurse of Nephrology, RN|+34 649443488|raquel.pelayo@scsalud.es|
22417552|NCT01936519|Penn State Milton S Hershey Medical Center|Dr Zakiyah Kadry|717 531 5921|zkadry@pennstatehealth.psu.edu|
22417553|NCT00652028|Hospira|Marcelo Garcia de Rocha MD, Global Medical Director|224-212-4424|marcelo.rocha@hospira.com|
22417554|NCT02072824|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22417555|NCT01388166|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22417556|NCT00820443|MicroPort Orthepedics|Matt C. Paul, Project Manager|(901) 867-4350|mpaul@ortho.microport.com|
22391468|NCT02852356|Ovation Fertility|Director|5126107474|tex@ovationfertility.com|
22391469|NCT03325790|Sound Pharmaceuticals, Inc.|Dr. Jonathan Kil|206-634-2559|info@soundpharma.com|
22391470|NCT00667459|Medtronic Spinal|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
22417557|NCT00127036|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-2069|jonathan.strosberg@moffitt.org|
22417558|NCT01280409|University of Texas Health Science Center at Houston|Dr Jerrie Refuerzo|713.500.7780|Jerrie.S.Refuerzo@uth.tmc.edu|
22417559|NCT01429051|Takeda|Medical Director|+1-800-778-2860|clinicaltrialregistry@tpna.com|
22417560|NCT03275766|University of Bern, University Hospital of Psychiatry, Bern|Prof. Sebastian Walther|+41 632 8979|sebastian.walther@upd.unibe.ch|
22417561|NCT01387581|MelaSciences|Mrinalini Roy|800-729-8849|mishti@melasciences.com|
22417562|NCT01797835|RAND|Dr. Elizabeth D'Amico|3103930411|damico@rand.org|6487
22417563|NCT03001219|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22417564|NCT01403064|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
22417565|NCT00973765|Washington Hospital Center|Gillian Schmitz, MD|919-724-9185|gillianmd@gmail.com|
22417566|NCT02669940|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22417567|NCT01892657|Galderma Laboratories, L.P.|Elizabeth M. Nieman, Medical Information Specialist|817-961-5130|elizabeth.nieman@galderma.com|
22417568|NCT00986180|Janssen Pharmaceuticals|Vice President, Medical Affairs, Internal Medicine|1 908 218-7250||
22417569|NCT04408599|NextCure, Inc|Chief Medical Officer|(240) 399-4900|NCClin@nextcure.com|
22417570|NCT02163486|DorkuzEU|Bahar Kuvaki|902324122836|ozbilginsule@gmail.com|
22417571|NCT03579966|Catalyst Pharmaceuticals, Inc.|Gary Ingenito, MD, Chief Medical Officer|3054203200|gingenito@catalystpharma.com|
22417572|NCT02408068|Simbec Research Ltd|Dr G Sharma|0800 691995|contact@simbec.com|
22417573|NCT03041324|Sangamo Therapeutics, Inc.|Medical Monitor|(510) 307-7266|clinicaltrials@sangamo.com|
22417574|NCT03484117|Massachusetts General Hospital|Dr. Julie Levison, PI|617-724-4698|jlevison@partners.org|
22417575|NCT03551496|Boston Scientific|Dana Hromyak|1 216-526-8534|Dana.Hromyak@bsci.com|
22417576|NCT00942331|Memorial Sloan-Kettering Cancer Center|Jonathan Rosenberg, MD|646-422-4461|rosenbj1@mskcc.org|
22417577|NCT03844789|University of Virginia Center for Diabetes Technology|Marc Breton|434-982-6484|mb6nt@virginia.edu|
22417578|NCT03856593|University of Southern California|Jason Doctor|213.821.8142|jdoctor@usc.edu|
22417579|NCT02595008|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
22417580|NCT03407118|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22417581|NCT02046525|Washington University in St. Louis|Kimberly Reske, MPH|3147474041|kreske@wustl.edu|
22417582|NCT01825122|Invion, Inc.|Mitchell Glass, M.D., EVP of R&D|+61 7 3295 0500|mitchell.glass@inviongroup.com|
22417583|NCT02689063|AFT Pharmaceuticals|Jennifer Zhang -Project Manager|+ 64 9 488 0232|jenniferz@aftpharm.com|710
22417584|NCT01797484|University Heart Centre Hamburg Eppendorf|Dr. Tjark F. Schwemer|+49 40 7410|t.schwemer@uke.de|56800
22417585|NCT01933464|UCSD Dermatology Clincal Trials|Dermatology Clinical Trial Manager|(858)657-8390|dermstudies@ucsd.edu|
22417586|NCT04017754|Aalborg University Hospital, Gynecologic and Obstetric department|Caroline Nørgaard-Pedersen|+45 41120267|carolinenp94@gmail.com|
22417587|NCT03508687|University of Michigan|Dr. Elif Oral|734-615-7271|eliforal@med.umich.edu|
22417588|NCT01347866|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22417589|NCT01635062|Brigham and Women's Hospital|Dr. Anand Vaidya (Asst Professor of Medicine)|6175258285|avaidya1@partners.org|617
22417590|NCT02999477|Dana-Farber Cancer Institute|Adrienne Waks, MD|617-632-3800|adrienne_waks@dfci.harvard.edu|
22417591|NCT01846273|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22417592|NCT02939014|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22417593|NCT00359788|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22417594|NCT01019707|University of California Los Angeles|Edythe D London|310 825 0606|elondon@mednet.ucla.edu|
22391471|NCT04986566|City of Hope Medical Center|Dr, Laleh Melstrom|626-359-8111|lmelstrom@coh.org|
22391472|NCT04546217|University of Alabama at Birmingham|Dr. Sarah dos Anjos|2059347323|smanjos@uab.edu|
22405887|NCT01975376|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22405888|NCT00356057|BIOTRONIK, Inc.|Katerina de Metz, Director Clinical Studies|5036752169|katerina.demetz@biotronik.com|
22405889|NCT01451398|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
22405890|NCT04449276|CureVac AG|Clinical Trial Information|+49 6976805870|clinicaltrials@curevac.com|
22405891|NCT01614795|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22405892|NCT00701103|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22405893|NCT00179517|Beth Israel Deaconess Medical Center|Andrew G Herzog MD,MSc|781-431-0277|aherzog@bidmc.harvard.edu|
22405894|NCT01915095|Hines VA|Audrey Wilson|3122383637|awilson03@sralab.org|
22405895|NCT02067533|Isfahan University of Medical Sciences|Amin Nemati|00989131009918|nemati@med.mui.ac.ir|
22405896|NCT04857892|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22405897|NCT00655811|University of Miami|Gil Yosipovitch, MD, Professor|305-243-5121|gyosipovitch@med.miami.edu|
22417595|NCT02143583|ANERGIS SA|G. DELLA CORTE Clinical Development Director|+41 21 651 92 30|gilles.dellacorte@anergis.ch|
22417596|NCT02220725|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
22391473|NCT02550938|Align Technology, Inc.|Allison Mossing, Sr. Clinical Research Associate|4084701046|amossing@aligntech.com|
22391474|NCT03415243|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22391475|NCT00580489|Metrohealth Medical Center|Charles Emerman|2167783577|cemerman@metrohealth.org|
22391476|NCT05765435|Cionic|Rebecca Webster|888-481-3724|rebecca@cionic.com|
22391477|NCT04328623|Centre Hospitalier Départemental Vendée|Adeline TROJET-BOSSARD|251446572|adeline.trojet-bossard@ght85.fr|+33
22391478|NCT02312557|Oregon Health & Science University|Rachel Slottke|503-494-6117|slottker@ohsu.edu|
22391479|NCT04351269|Aziyo Biologics, Inc.|Associate Director of Clinical Operations|470-514-4085|clinical@aziyo.com|
22391480|NCT00535938|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22405898|NCT00643448|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22405899|NCT00981682|Serenity Pharmaceuticals|Chief Medical Officer|8456396760|sfein@serenitypharma.com|17
22405900|NCT06436300|Washington State University|Clemma Muller|612-327-7237|clemma.muller@wsu.edu|
22405901|NCT03765736|Duke Cancer Institute|John Strickler, MD|(919) 668-6608|john.strickler@duke.edu|
22405902|NCT00365872|H. Lee Moffitt Cancer Center and Research Institute|Scott J. Antonia, M.D., Ph.D.|813-745-3883|scott.antonia@moffitt.org|
22405903|NCT00863434|University of Washington|Pamela Becker, MD, PhD|206-288-7273|pbecker@uw.edu|
22405904|NCT02632344|Massachusetts General Hospital|Dr. Sara Pai, Principal Investigator|617-726-5251|sarapaimdphd@gmail.com|
22405905|NCT00777257|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22405906|NCT01370499|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22405907|NCT04984876|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22405908|NCT02462122|Bausch Health|Study Director||anyaloncaric@bauschhealth.com|
22405909|NCT01077193|Ethicon-Endo Surgery, Inc.|Michael L. Schwiers|513-337-1172|mschwier@its.jnj.com|
22405910|NCT02784496|The University of MD Anderson Cancer Center|Prithviraj Bose, MD/Professor|713-792-7747|PBose@mdnaderson.org|
22405911|NCT04960202|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22405912|NCT02855086|Stanford University Medical Center|Gordon Li, MD, Associate Professor of Neurosurgery|650-721-1020|gordonli@stanford.edu|
22405913|NCT00054756|NIDDK|Dr Joanna Klubo-Gwiezdzinska|301-496-1211|joanna.klubo-gwiezdzinska@nih.gov|
22391481|NCT02330094|Mayo Clinic|Dr. William D. Freeman|904-953-7103|freeman.william1@mayo.edu|
22391482|NCT04486313|Romark|Sr. Director, Research Operations|8132828544|jessica.fulgencio@romark.com|
22391483|NCT03182998|Mayo Clinic|Dr. Jon C. Tilburt, MD, MPH|480-301-3401|tilburt.jon@mayo.edu|
22391484|NCT02643225|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
22391485|NCT02980523|Laboratorios Sophia|Clinical pharmacologist|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
22391486|NCT05020145|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22391487|NCT03724253|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22391488|NCT03080142|UC Davis Medical Center, Department of Anesthesiology|Jon Zhou MD|9167035028|jonzhou@ucdavis.edu|
22391489|NCT00513747|The Arthur James Comprehensive Cancer Center|John Byrd, MD|614-293-9869|john.byrd@osumc.edu|
22391490|NCT01280604|Mercer University/ Kaiser Permanente|Kendra Manigault, PharmD, BCPS, BCACP, CDE|678-547-6216|manigault_kr@mercer.edu|
22391491|NCT00855413|The University of North Carolina|Dr. Cynthia Gay|9198432726|cynthia_gay@med.unc.edu|
22417597|NCT01673698|ReShape Medical|Director of Clinical Operations|94429-6680|lfong@reshapemedical.com|
22417598|NCT02333487|H. LUndbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
22417599|NCT01297322|Daniel & Daniel Consulting, LLC|Michael A. Daniel, Consulting VP Regulatory Affairs|7753922970|madaniel@clinregconsult.com|
22417600|NCT01111019|Merck Healthcare, a business of Merck KGaA|Merck KGaA Communication Center|+49 6151 72 5200|service@merckgroup.com|
22417601|NCT01583218|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
22417602|NCT03182582|Stanford University|Geoffrey C. Gurtner, MD|650-736-2776|ggurtner@stanford.edu|
22417603|NCT01418482|Uppsala Akademiska Hospital, Dept. of Plastic Surgery|Fredrik Huss|+46 771 405 405|Fredrik.Huss@surgsci.uu.se|
22417604|NCT01232491|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22417605|NCT02932228|VA Palo Alto Health Care System|Dr Donna Zulman|650-493-5000|Donna.Zulman@va.gov|29113
22391492|NCT01236352|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22391493|NCT01536197|University of Illinois at Urbana Champaign|M. Yanina Pepino|217-300-2374|ypepino@illinois.edu|
22391494|NCT01999777|Proximagen, LLC|David Sequeira,|952-658-7437|dsequeira@proximagen.com|
22391495|NCT05903183|Icosavax Inc.|Icosavax Clinical Operations|206-737-0085|clinops@icosavax.com|
22391496|NCT03149029|Massachusetts General Hospital Cancer Center|Ryan J. Sullivan, MD|617-643-3614|RSULLIVAN7@mgh.harvard.edu|
22391497|NCT03735121|Hoffman-La-Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22391498|NCT02176863|Instituto Grifols, S.A.|Sandra Camprubi, PhD/Senior Director, Clinical Operations|+34 67 0923160|sandra.camprubi@grifols.com|
22391499|NCT02647645|Nova Southeastern University|Raymond L Ownby, MD, PhD|9542621481|ro71@nova.edu|
22391500|NCT02037256|Barbara Ann Karmanos Cancer Institute|Dr. Divaya Bhutani|501-680-9229|db3203@cumc.columbia.edu|
22391501|NCT01527162|Seattle Children's Research Institute|Kristie Bjornson, PhD, PT|206 884-2066|kristie.bjornson@seattlechildrens.org|
22391502|NCT01688310|Catholic University of Mozambique Medical School|Dr. Peter Millard|2078663503|pmillard@mac.com|
22391503|NCT04599907|Candesant Biomedical|Erin Tims, VP of Clinical Affairs|19255776863|etims@candesant.com|
22391504|NCT03007732|University of California, San Francisco|Dr. David Oh, MD, PhD|(415) 476-1000|David.Oh@ucsf.edu|
22391505|NCT03371823|University of Delaware|Dr. Megan Wenner|302-831-7343|mwenner@udel.edu|
22391506|NCT00311246|UIC|Nadera J Sweiss|312-996-5723|nsweiss@uic.edu|
22391507|NCT01466790|Janssen Research & Development, LLC|Medical Leader||ClinicalTrialDisclosure@its.jnj.com|
22391508|NCT01310699|San Francisco VA Medical Center|Dr. Tonya Kaltenbach|415-221-4810|tonya.kaltenbach@va.gov|94121
22391509|NCT02386839|Shire (Note: This product was divested to Oak Hill Bio in 2022)|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22391510|NCT00926575|Soligenix, Inc.|Dhara Patel, Clinical Coordinator|609-538-8200|dpatel@soligenix.com|
22391511|NCT00490698|The University of Texas (UT) MD Anderson Cancer Center|Shi-Ming Tu, MD / Professor||CR_Study_Registration@mdanderson.org|
22391512|NCT02634814|University of North Carolina at Chapel Hill|Brian Pietrosimone, PhD|919-962-3617|brian@unc.edu|
22391513|NCT00668785|West Coast Retina Medical Group, Inc.|J. Michael Jumper, MD|415-972-4600|jmjumper@westcoastretina.com|
22391514|NCT02101983|University of Rochester|Deborah Mulford|585-275-5823|deborah_mulford@urmc.rochester.edu|
22391515|NCT04124471|Children's Hospital of Philadelphia|Ignacio Tapia, MD|(267) 426-5842|tapia@chop.edu|
22391516|NCT04870957|University of Michigan|Afton Hassett, PsyD|734-763-5226|afton@med.umich.edu|
22391517|NCT05970640|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22391518|NCT02394925|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, OD, MS, FAAO Sr. Principal Research Optometrist|904 443-3402|TKarkkai@its.jnj.com|
22417606|NCT04385277|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22417607|NCT04905290|Medtronic|James Burrell, Senior Statistician|18006338766|burrej3@medtronic.com|
22405914|NCT04358991|University of Pittsburgh|Dr. Ryan Shields, Associate Professor of Medicine|412-864-3745|shieldsrk@upmc.edu|
22405915|NCT03687827|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22405916|NCT03630185|The University of Texas Health Science Center at Houston|Stuart A Harlin, MD|713-486-5131|Stuart.A.Harlin@uth.tmc.edu|
22405917|NCT00987727|Allergan, Inc|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22405918|NCT00981292|Northumbria university|Emma Wightman|+44 (0) 191 2437253|emma.l.wightman@unn.ac.uk|
22405919|NCT03377452|VA Greater Los Angeles Healthcare System|Jennifer Martin, PhD|818-891-7711|jennifer.martin@va.gov|36080
22405920|NCT03464136|Janssen Scientific Affairs, LLC|DIRECTOR MEDICAL AFFAIRS MD|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22405921|NCT03146403|Genocea|Jennifer LaVin|617-876-8191|jennifer.lavin@genocea.com|
22405922|NCT00481988|Division of Experimental Therapeutics, NY State Psychiatric Organization|Peter Bulow MD, Assistant Professor of Clinical Psychiatry|(212) 543 5664|pb2182@columbia.edu|
22405923|NCT02182999|Department of Orthopedic Surgery, Medical University of Innsbruck|Dr. Matthias Braito|0043 512 504|matthias.braito@gmail.com|81214
22405924|NCT01673425|VA National Center for Occupational Health & Infection Control|Lewis Radonovich|352-376-1611|Lewis.radonovich@va.gov|4988
22405925|NCT02252588|University of Minnesota|Christine Wendt, MD|612-624-0999|wendt005@umn.edu|
22405926|NCT00926185|Shire (Note: Lifitegrast was divested to Novartis in 2019)|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22405927|NCT00638690|Johnson & Johnson Pharmaceutical Research & Development|Senior Director, Clinical Research|310-914-2915||
22405928|NCT02128919|Nathan Kline institute for Psycghatric Research|Robert C Smith MD|845-398-6531|rsmiith@nki.rfmh.org|
22405929|NCT02203916|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22405930|NCT01478581|Pharmacyclics Switzerland GmbH|Dr. Bernhard Hauns, Medical Monitor|+41 52 556 0800|bhauns@pcyc.com|
22405931|NCT03531710|United Neuroscience|Medical Director|+1 (972) 809-0481|info@unitedneuroscience.com|
22405932|NCT03152110|University of Pittsburgh|Alicia Koontz|412-822-3700|akoontz@pitt.edu|
22405933|NCT02705352|Massachusetts Eye and Ear|Shyana Harper|6173915982|Shyana_harper@meei.harvard.edu|
22405934|NCT01137006|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22405935|NCT00552344|UCB Cares|UCB (Study Director)|+1 887 822 9493||
22405936|NCT00438490|Massachusetts General Hospital|Corrine Welt, MD|617-726-8437|cwelt@partners.org|
22405937|NCT04247828|Altec Inc.|Dr. Paola Contessa|508-545-8236|pcontessa@altecresearch.com|
22405938|NCT01620593|UT Health San Antonio Cancer Center|Sukeshi Arora, MD|210-450-1015|aroras@uthscsa.edu|
22405939|NCT00045630|SWOG Statistical Center|Study Statistician|206-667-4623||
22405940|NCT03536923|Renovia, Inc|Chief Medical Officer, Dr. Samantha Pulliam|866-735-8424|sjpulliam@renoviainc.com|
22405941|NCT03054740|Aultman Health Foundation|Jane Sewell|330 363 0000|Jane.Sewell@aultman.com|3334
22405942|NCT01378299|Michael E. DeBakey VA Medical Center|Reina Villareal, MD|713-794-7534|reina.villareal@va.gov|
22405943|NCT00565812|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22405944|NCT00456885|BIDMC|Jody Dushay|6177353343|jdushay@bidmc.harvard.edu|617
22405945|NCT04266158|The Ohio University|College of Medicine Office of Research Compliance Team|6145886811|comresearchcompliance@osumc.edu|
22405946|NCT03595449|Mayo Clinic|Shari A. Ochoa, M.D.|480-301-6479|Ochoa.Shari@mayo.edu|
22405947|NCT03242590|Lipocine, INC.|Nachiappan Chidambaram, Vice President, Product Development|8018819495|nc@lipocine.com|
22405948|NCT02667392|VAORD|Dr. Dorian Rose|352-376-1611|dorian.rose@va.gov; dkrose@phhp.ufl.edu|105238
22405949|NCT02896192|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
22405950|NCT03561246|Brooks Rehabilitation Clinical Research Center|Mark G. Bowden - PI|904-345-6626|mark.bowden@brooksrehab.org|
22405951|NCT00383708|Ipsen|Medical Director, Endocrinology||clinical.trials@ipsen.com|
22405952|NCT00464711|Massachusetts General Hospital|Dr. Dan Iosifescu||diosifescu@partners.org|
22405953|NCT01308294|Department of Oncology, Division of Medical Oncology University Hospital Lausanne|Prof. Olivier Michielin, MD PhD|+41 21 314 01 85|Olivier.Michielin@chuv.ch|
22405954|NCT02820038|University of North Carolina at Chapel Hill|Susan J. Blalock, PhD|919-962-0080|s_blalock@unc.edu|
22405955|NCT03934203|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22405956|NCT00899678|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22405957|NCT01311895|Montefiore Medical Center|Dr. Andrew Chang|718-920-6626|achang3@yahoo.com|
22405958|NCT01237301|International Diabetes Center|Dr. Richard Bergenstal|952-993-3796|richard.bergenstal@parknicollet.com|
22405959|NCT02512276|Brigham and Women's Hospital|Niteesh K. Choudhry, MD, PhD|617-278-0930|nkchoudhry@bwh.harvard.edu|
22405960|NCT00368472|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22405961|NCT01044056|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22405962|NCT01372813|National Cancer Institute, National Institutes of Health|Marston Linehan, M.D.|301-496-6353|linehanm@mail.nih.gov|
22405963|NCT00422240|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22405964|NCT00901394|University of Chicago|Principal Investigator|7737022544||
22405965|NCT02590640|"University of Colorado Denver | Anschutz"|Director, Research Services|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
22405966|NCT04129086|The University of Texas Health Science Center at Houston|John Andrew Harvin, MD|713-500-7292|John.Harvin@uth.tmc.edu|
22405967|NCT02650895|OncoImmune, Inc.|Dr. Pan Zheng|2027516823|pzheng@oncoimmune.com|
22405968|NCT01167153|Novartis Pharmaceuticals|Study Director|862-778-8300||
22405969|NCT04685408|Case Western Reserve University|Dr. Martha Sajatovic|216-844-2808|martha.sajatovic@uhhospitals.org|
22431481|NCT04622592|Medicago|Medical Director|+1 418-658-9393|clinicaltrialinquiries@medicago.com|
22405970|NCT05643170|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22405971|NCT00438191|Massachusetts General Hospital|Taylor Pong||tpong1@partners.org|
22405972|NCT01116661|University of California San Francisco|Mitch Berger, MD; Director of Neurosurgery|415-353-7500|Mtich.Berger@ucsf.edu|
22405973|NCT02996305|Ovid Therapeutics|Adera Matthews, MD|570 620 6290|madera@ovidrx.com|
22405974|NCT00444951|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22405975|NCT02710422|University of Miami|Sanoj Punnen MD, MAS|305-243-6596|s.punnen@med.miami.edu|
22405976|NCT00887822|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22405977|NCT02000622|AstraZeneca|Medical Science Director|1-877-240-9479|clinicaltrialtransparency@astrazeneca.com|
22405978|NCT01462045|University of New Mexico|Sang Hwan Kim, PhD/Lead Investigator|5057954545|sanghk@gmail.com|
22417608|NCT03303625|Janssen Vaccines and Prevention B.V.|Trial Physician|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22417609|NCT05140954|Departments of Global Health and Epidemiology, University of Washington|Kenneth K. Mugwanya, MBChB, MS, PhD|+1 206 520-3800|mugwanya@uw.edu|
22417610|NCT05392907|INAIL|Ing. Emanuele Gruppioni|+39 051 6936 609|e.gruppioni@inail.it|
22417611|NCT01045421|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22417612|NCT03340064|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22417613|NCT00856973|Sunovion|CNS Medical Director|866-503-6357||
22417614|NCT01108666|University of Pennsylvania|Dr. Abigail Berman|215-615-3659|Abigail.Berman@uphs.upenn.edu|
22417615|NCT01884311|Bio Products Laboratory Ltd|European Medical Affairs Lead|+44 (0)20 8957 2200|medinfo@bpl.co.uk|
22417616|NCT02858492|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22417617|NCT02944383|NeuroBo Pharmaceuticals|Vice President Clinical Operations|+1 (857) 702-9600|info@neurobopharma.com|
22417618|NCT04425538|Neely Center for Clinical Research, Tufts Medical Center|Director of Clinical Trials|617-636-5000|ncccr@tuftsmedicalcenter.org|3264
22417619|NCT01995266|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|clinical.trials@bms.com|
22417620|NCT03853148|Medical University of South Carolina|Teresa Kelechi, Associate Dean for Research and PhD Studies|843-792-4602|kelechtj@musc.edu|
22417621|NCT00090610|Duke University Medical Center|Angeles Alvarez Secord, Director of Gynecologic Oncology Clinical Trials|919-684-3765|secor002@mc.duke.edu|
22417622|NCT04029311|Tohoku University|Dr. Yasue Tanaka|+81227178396|yasue.tanaka.b3@tohoku.ac.jp|
22417623|NCT03623386|Yale School of Medicine|Sule Tinaz, MD, PhD: Associate Professor of Neurology|(877) 925-3637|sule.tinaz@yale.edu|
22417624|NCT01996943|University of California, San Francisco|Dr. Gregory Marcus|(415) 353-2554|Greg.Marcus@ucsf.edu|
22417625|NCT02802449|Charles Drew University of Medicine and Science|Dr. David Martins|323-568-3353|davidmartins@cdrewu.edu|
22417626|NCT00599521|Galderma|Michael Graeber MD/ Head of Global Clinical Project Management|609-860-8201|michael.graeber@galderma.com|
22417627|NCT00782821|University of Cincinnati|E. Steve Woodle, MD|513-558-6001|woodlees@ucmail.uc.edu|
22417628|NCT02751359|University of California Los Angeles|Dr. Ziva Cooper, Principal Investigator|310-206-9942|zcooper@mednet.ucla.edu|
22417629|NCT02667288|Aclaris Therapeutics|Judy Schnyder, Sr. Director Clinical Operations|484-329-2144|jschnyder@aclaristx.com|
22417630|NCT01196078|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22417631|NCT02400671|University of Washington|Dr. Keshet Ronen|206-685-4363|keshet@uw.edu|
22391519|NCT02272244|Thomas Jefferson Universiy|Ronald Myers(Priniciple Investigator)|215-5034085|ronald.myers@jefferson.edu|
22391520|NCT03670277|Johnson & Johnson Vision Care|Xu Cheng, MD, PhD, FAAO - Sr. Principal Clinical Scientist|1-800-843-2020|xcheng6@its.jnj.com|
22391521|NCT02660112|Mayo Clinic|Ralitza H. Gavrilova, M.D.|507-293-1283|Gavrilova.Ralitza@mayo.edu|
22391522|NCT04340843|Washington University in St. Louis School of Medicine|Dr. Mia Weiss|3147473096|m.c.weiss@wustl.edu|
22391523|NCT06862154|Marmara University School of Medicine|Dr. Emre Kudu|+902166254545|dr.emre.kudu@gmail.com|
22391524|NCT03733899|Johnson & Johnson Vision Care, Inc.|Thomas Karkkainen, OD, MS, FAAO Sr. Principal Research Optometrist|904-443-3402|TKarkkai@its.jnj.com|
22391525|NCT01882413|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22391526|NCT04650698|NYU Langone|Arthur Hertling, MD|212-598-6085|Arthur.Hertling@nyulangone.org|
22391527|NCT02358668|The Chinese University of Hong Kong|Dr Andrea Luk|852-26324276|andrealuk@cuhk.edu.hk|
22391528|NCT02104505|Center for Environmental Medicine, Asthma and Lung Biology; University of North Carolina, Chapel Hill|Allison Burbank, MD|919-843-2714|allison_burbank@med.unc.edu|
22391529|NCT02859064|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
22391530|NCT04403542|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22391531|NCT01730950|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22391532|NCT02737826|Medical University of South Carolina|Dr. Kelly Barth|843-792-0686|stephen@musc.edu|
22391533|NCT02568397|Eli Lilly and Company|Chief Medical Officer|800-545-5079||
22391534|NCT00078377|Cephalon, Inc.|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
22391535|NCT02354651|University of Florida|Dr. Barbara Smith|3522945315|bksmith@ufl.edu|
22391536|NCT01317875|Incyte Corporation|Incyte Corporation Call Center, Study Director|1-855-463-3463|medinfo@incyte.com|
22391537|NCT00581893|University of Iowa|Erik St. Louis|507-266-7456|StLouis.Erik@mayo.edu|
22391538|NCT01381575|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22391539|NCT01377389|UT MD Anderson Cancer Center|Aparicio,Ana,M.D. / Genitourinary Medical Oncology|713-792-7734|AAPARICIO@MDANDERSON.ORG|
22391540|NCT04090528|University of Wisconsin - Madison|Douglas G. McNeel, MD PhD|(608) 263-4198|dm3@medicine.wisc.edu|
22391541|NCT03020069|NYU Langone Health|Jeniece Ilkowitz RN, MA, CDE|212-263-9910|Jeniece.ilkowitz@nyulangone.org|
22391542|NCT04075903|University of Alabama at Birmingham Division of Clinical Immunology and Rheumatology|Lesley Jackson, MD, MSPH|205-934-1779|lejackson@uabmc.edu|
22391543|NCT02684123|Icahn School of Medicine at Mount Sinai|Dr. Emma Guttman-Yassky|(212) 241-9728|Emma.Guttman@mountsinai.org|
22417632|NCT03687658|Stanford University|Russell Poldrack, PhD|(650) 497-8488|poldrack@stanford.edu|
22417633|NCT04397445|U.S. Food and Drug Administration|David Strauss, MD, PhD|301-796-6323|David.Strauss@fda.hhs.gov|
22417634|NCT03921151|Virginia Commonwealth University|Liangsuo Ma, PhD|(804) 828-2871|liangsuo.ma@vcuhealth.org|
22417635|NCT01207648|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22417636|NCT00857792|The University of Chicago Medical Center|Victor Mor-Avi|773-702-7780|vmoravi@bsd.uchicago.edu|
22417637|NCT03667014|UCSF|Tina Bhutani|4153537800|tina.bhutani@ucsf.edu|
22417638|NCT01598350|University of Puget Sound|Julia Looper, PT PhD|253 879 2895|jlooper@pugetsound.edu|
22417639|NCT03760250|University of Pennsylvania|Jenny Wei|2153165151|jenny.wei@pennmedicine.upenn.edu|
22417640|NCT03733210|Stanford Medicine at Stanford University|Yu-Jin Lee, MD, MS|650-725-4711|yujinlee@stanford.edu|
22417641|NCT03728634|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
22417642|NCT00307034|GlaxoSmithKline|GSK Response Center|866-435-7343||
22417643|NCT00929331|GlaxoSmithKline|GSK Response Center|866-435-7343||
22417644|NCT04920916|University of Virginia Health System|William Petri|434-305-9633|wap3g@virginia.edu|
22417645|NCT02011113|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22417646|NCT01338649|Massachusetts General Hospital|Aleksandar Videnovic|855-644-6387|avidenovic@mgh.harvard.edu|
22417647|NCT04688931|UroGen Pharma|Head of Clinical Development|+1 855-987-6436|info@urogen.com|
22417648|NCT01507155|Genomind|Dr. Rachel Scott|267-989-3435|rscott@genomind.com|
22417649|NCT00361335|Centocor, Inc.|Senior Director Clinical Research|1-800-457-6399||
22417650|NCT03840616|Mycovia Pharmaceuticals Inc|Clinical Trial Administration|919-467-8539|adminops@mycovia.com|
22417651|NCT02034058|Stryker Neurovascular|Alice Lin, Clinical Program Manager|510 413 2673|alice.lin@stryker.com|
22417652|NCT03949803|Universidad de Murcia|Prof. Marta Garaulet Aza|+34868889478|garaulet@um.es|
22417653|NCT01765582|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22417654|NCT04493320|New York State Psychiatric Institute|Dr. Bret Rutherford|646 774 8660|bret.rutherford@nyspi.columbia.edu|
22417655|NCT03251963|University of Utah|Christopher Pannucci|801 581 2121|christopher.pannucci@hsc.utah.edu|
22417656|NCT00616941|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22417657|NCT02044796|Fred Hutchinson Cancer Research Center|Roland B. Walter|1-206-667-3599|rwalter@fredhutch.org|
22417658|NCT00714493|Centocor Ortho Biotech, Inc.|Sr. Director, Clinical Research - Medical Affairs|215-325-6811|Ddeckto2@its.jnj.com|
22417659|NCT00076804|Johns Hopkins University Center for TB Research|Richard E. Chaisson|4109551755|rchaiss@jhmi.edu|
22417660|NCT00354341|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22417661|NCT00251719|Takeda Global Research & Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
22417662|NCT00334061|Penumbra Inc|Siu Po Sit, PhD Study Coordinator|510 748 3200|siupo.sit@penumbrainc.com|221
22417663|NCT01732874|Nationwide Childrens Hospital|Dr. Christina J. Valentine MD,MS,RD|(614) 722-2000|Christina.Valentine@nationwidechildrens.org|
22417664|NCT03709823|Achieve Life Sciences|Daniel Cain, Vice President, Clinical Research|425.686.1546|dcain@achievelifesciences.com|
22417665|NCT02737332|SPARC|Head, Clinical Development|912266455645|clinical.trials@sparcmail.com|
22417666|NCT00557076|Edward Hines, Jr VA Hospital|Dr. Theresa Pape|708-202-4953|Theresa.Pape@va.gov|
22417667|NCT00688376|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22417668|NCT02303041|Stanford University|Anne Lynn S. Chang/ Associate Professor of Dermatology|650-723-6316|alschang@stanford.edu|
22417669|NCT00886288|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22417670|NCT01070771|University Hospital Southampton NHS Foundation Trust|Professor Nick Curzen|+44 023 80777222|nick.curzen@uhs.nhs.uk|
22417671|NCT00472797|EMD Serono, INc.|Fernando Dangond, MD|781 681 2348|fernando.dangond@emdserono.com|
22417672|NCT01553201|National Institute of Neurological Disorders & Stroke|Barbara Karp, MD|301-496-0150|karpb@ninds.nih.gov|
22417673|NCT00700817|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22417674|NCT00058214|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22417675|NCT03097588|Department of Pharmacy Services, Oregon health & Science University Hospital|Joseph Bubalo, PharmD (Oncology Clinical Pharmacy Specialist)|5034948007|bubaloj@ohsu.edu|
22417676|NCT01144364|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22417677|NCT00891839|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22417678|NCT02037165|Boehringer Ingelheim pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22417679|NCT02674061|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22417680|NCT03334721|Medical University of South Carolina|James J. Prisciandaro, Ph.D.|843-792-1433|priscian@musc.edu|
22417681|NCT04062448|Janssen Pharmaceutical K.K.|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22417682|NCT00573157|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22417683|NCT00609518|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22417684|NCT00903448|The Procter & Gamble Company|John Mcrorie, PhD, FACG, AGAF|513-622-1423|mcrorie.jw@pg.com|
22417685|NCT03535675|Johns Hopkins University|Channing Paller; M.D.|4109558239|cpaller1@jhmi.edu|
22417686|NCT01400919|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com|
22417687|NCT01449279|Stanford Cancer Institute|Dr. Susan J Knox|650-725-2720|sknox@stanford.edu|
22417688|NCT00846521|Yale University School of Medicine|Tania Burgurt, MD|203-785-7152|tania.burgurt@yale.edu|
22391544|NCT05224843|Yale University|Fuad Abujarad|+1 (203) 737-5088|fuad.abujarad@yale.edu|
22391545|NCT01920932|St. Jude Children's Research Hospital|Matt Ehrhardt, MD|(901) 595-5913|matt.ehrhardt@stjude.org|
22405979|NCT01145833|University of CA, San Diego Center for Healthy Eating and Activity Research|Kerri Boutelle, Principal Investigator|858-534-8037|kboutelle@ucsd.edu|
22405980|NCT01938391|NYU Langone Medical Center|Anvar Babaev, MD, PHD, FACC, FSCAI|212-263-5656|anvar.babaev@nyumc.org|
22405981|NCT04283773|Assiut Univercity|Demonstrator at pathology department|00201033986747|omar011523@med.au.edu.eg|
22405982|NCT04924114|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22405983|NCT04021628|St George's, University of London|Dr Shari Sapuan|02086729944|ssapuan@sgul.ac.uk|5382
22405984|NCT00354484|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
22405985|NCT03558828|Rush University College of Nursing|Manju Daniel|312.942.3460|manju_n_daniel@rush.edu|
22405986|NCT00378534|NIH NHLBI OCD DIR ORIC|Sara Hauffe, RN Protocol Liaison|301-827-2720|sara.hauffe@nih.gov|
22405987|NCT03537937|Pragmatic Critical Care Research Group|Chair of the Steering Committee|(615) 322-3412|matthew.w.semler@vumc.org|
22405988|NCT03671148|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22405989|NCT00425945|Stanford University School of Medicine|Dr. Randall Stafford|650-724-2400|rstafford@stanford.edu|
22405990|NCT02209259|Massachusetts General Hospital|Taylor Pong||tpong1@partners.org|
22405991|NCT03878160|Massachusetts General Hospital|Dr. Christina Luberto|617-643-9453|cluberto@mgh.harvard.edu|
22405992|NCT00673816|National Eye Institute|Catherine Meyerle, MD|301-435-7821|meyerlec@nei.nih.gov|
22405993|NCT05618808|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22405994|NCT02527564|Stanford University|Po W. Wang|650-723-2483|wangp0@stanford.edu|
22405995|NCT01804842|Elcelyx Therapeutics, Inc|Senior Director, Development|858-876-1814|info@elcelyx.com|
22405996|NCT00628134|University of Pittsburgh|Tim Corcoran, Ph.D.|412-624-8918|corcorante@upmc.edu|
22405997|NCT02365506|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22405998|NCT03774875|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22405999|NCT02352090|Helsinki University Central Hospital|Oskari Heikinheimo|+358 50 4271533|oskari.heikinheimo@helsinki.fi|
22406000|NCT04428580|Stanford University|James Lock, MD, PhD|(650) 498-9111|jimlock@stanford.edu|
22406001|NCT06048367|West China Hospital of Sichuan University|Professor. Yongsheng Wang|18980602258|wangys@wchscu.cn|
22406002|NCT02869451|Duke University Medical Center|Angela Kirby|919-286-0411|angela.kirby@duke.edu|5526
22406003|NCT00413777|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22406004|NCT01678313|Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University|Dr. Hann-Chorng Kuo|886-3-8561825|hck@tzuchi.com.tw|2113
22406005|NCT05179057|AlloVir, Inc.|Senior Vice President|+1 617-433-2605|rriese@allovir.com|
22406006|NCT03345342|Janssen Research & Development, LLC|Compound Development Team Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22406007|NCT03375203|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22406008|NCT03107793|Janssen-Cilag International N.V.|European Medicines Agency (EMEA) Advisor-Immunology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22406009|NCT03277105|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22406010|NCT02808507|Johns Hopkins Bloomberg School of Public Health|Colleen Hanrahan|410-502-9289|chanrah1@jhu.edu|
22406011|NCT05180721|Yale|Robin Whittemore|203-432-7000|robin.whittemore@yale.edu|
22406012|NCT02968277|Rehabilitation Institute of Chicago|Arun Jayaraman, PT, PhD; Director of Max Nader Lab for Rehabilitation Technologies and Outcomes|3122386875|ajayaraman@ricres.org|
22406013|NCT02040857|Dana-Farber Cancer Institute|Project Manager|617-632-5313|ctopm@dfci.harvard.edu|
22406014|NCT00976963|University of Washington|Ann Stapleton|‪(206) 880-3464‬|stapl@uw.edu|
22406015|NCT00608842|Kythera Biopharmaceuticals, Inc.|Clinical Trial Disclosure||clinical_trials@kythera.com|
22406016|NCT01791465|Vanderbilt University Medical Center|John Koethe MD|615-343-0533|john.r.koethe@vanderbilt.edu|
22406017|NCT02575300|H. Lee Moffitt Cancer and Research Center|Dr. Jonathan Strosberg, MD|813-745-7257|Jonathan.Strosberg@moffitt.org|
22406018|NCT00285649|Palmer College of Chiropractic|Ting Xia, PhD (Principal Investigator)|563-884-5161|Ting.Xia@palmer.edu|
22406019|NCT03003130|Q-Med AB|Head of Development|+ 46 (0) 18 474 90 00|reception.seupp@galderma.com|
22406020|NCT03077711|Lehigh Valley Health Network|Dr. Carolyn Botros, DO|4845917480|carolyn.botros@lvhn.org|
22406021|NCT01819194|Vistakon|Daria Wicks|904-443-1391|RA-VISUS-ClnclStds@its.jnj.com|
22406022|NCT02046382|TriHealth|Clinical Research Specialist|513-862-2341|ganga_devaiah@trihealth.com|
22406023|NCT01448707|Janssen Research & Development, LLC|EMEA Medical Affairs Program Lead||ClinicalTrialDisclosure@its.jnj.com|
22406024|NCT02033850|'L. Sacco' Department of Biomedical and Clinical Sciences University of Milan|Prof. Leonardo Pantoni, Principal Investigator|0039-02-50319865|leonardo.pantoni@unimi.it|
22406025|NCT03215667|Sunstar Americas, Inc.|Akane Takemura|8477944276|akane.takemura@us.sunstar.com|
22406026|NCT01997281|Seoul National University College of Medicine|Youn Min Cho, M.D, PhD|+82-2-2072-1965|ymchomd@snu.ac.kr|
22406027|NCT00946023|Johns Hopkins University|Rich Ambinder, MD|4109558839|rambind1@jhmi.edu|
22406028|NCT00333970|VA Connecticut Healthcare System|Dr. Joanna Fiszdon|203-932-5711|joanna.fiszdon@va.gov|2231
22406029|NCT00560794|Amgen Inc.|Study Director|866-572-6436||
22406030|NCT00614991|Garden State Infectious Disease Associates|David Condoluci|856-566-3190|dcondoluci@gsida.org|
22406031|NCT00441480|The Institute for Lipid and Atherosclerosis Research and Internal Medicine C, Sheba Medical Center, Tel Hashomer|Prof. Dror Harats|972-3-5302940|dror@vbl.co.il|
22406032|NCT01922739|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22406033|NCT00044213|Mount Sinai Medical Center|Gervasio A. Lamas, M.D.|305-674-2162|Gervasio.Lamas@msmc.com|
22406034|NCT00880607|Children's Hospital of Colorado, University of Colorado|Mindy Cohen, MD FAAP, Assistant Professor, Department of Anesthesiology||Mindy.cohen@childrenscolorado.org|
22391546|NCT01673022|Indiana University School of Medicine|Research Coordinator|317-944-2654|jmvinter@iupui.edu|
22391547|NCT05274750|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22406035|NCT05104749|Sonoran University of Health Sciences|Elizabeth Rice Principal Investigator|4809700000|e.rice@sonoran.edu|
22406036|NCT02963766|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22391548|NCT00283283|Walter Reed National Vaccine Healthcare Center Network|COL Renata J. M. Engler, MD|202-782-9461|renata.engler@na.amedd.army.mil|8819
22391549|NCT04340947|University of Oklahoma Health Sciences|Professor of Pediatrics|405-271-1903|heal-lab@ouhsc.edu|
22391550|NCT02134717|University of Pittsburgh|Kevin Gibson MD|412-624-7095|gibsonkf@upmc.edu|
22406037|NCT04964557|AstraZeneca|AstraZeneca Clinical Study Information Center|+1-877-240-9479|information.center@astrazeneca.com|
22406038|NCT02493868|Janssen Research & Development, LLC|Senior Director, Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22406039|NCT05849441|innovation Research & Training|Dr. Alison Parker|919-493-7700|aparker@irtinc.us|
22406040|NCT00093756|Roswell Park Cancer Institute|Alex A. Adjei, M.D., Ph.D.|507/284- 9265|alex.adjei@roswellpark.org|
22406041|NCT03039569|University of Nebraska-Lincoln|Weiwen Chai|402-472-7822|wchai2@unl.edu|
22406042|NCT04888507|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22406043|NCT00636155|Duke University Medical Center|Mark Lanasa, MD, PhD|919-286-6897|mark.lanasa@duke.edu|
22406044|NCT00766142|Institut Bergonié|Pr Simone Mathoulin-Pélissier|0556333333|s.mathoulin@bordeaux.unicancer.fr|
22406045|NCT02973997|University of Colorado, School of Medicine|Bryan Haugen, M.D.|507-266-0800|bryan.haugen@ucdenver.edu|
22406046|NCT01431521|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22406047|NCT00424840|University of Massachusetts Medical School|Dr. William Walsh|508-334-5539|William.Walsh@umassmemorial.org|
22406048|NCT02045979|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22406049|NCT01994109|Solstice Neurosciences|Regulatory Affairs Associate||regulatoryaffairs@usworldmeds.com|
22406050|NCT03287830|Columbia University|Dr. Melissa Stockwell|2123425732|mss2112@cumc.columbia.edu|
22406051|NCT03008889|Emory University|Dr. Lawrence Scahill|404-785-9336|lawrence.scahill@emory.edu|
22406052|NCT03598140|UTexas Southwestern|Dr. Joshua Gaston|817-637-8043|drgaston@outlook.com|
22406053|NCT05674838|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
22406054|NCT03137888|Emory University|Dr. Hui-Kuo Shu|4047781900|hgshu@emory.edu|
22406055|NCT02155712|Stryker Orthopaedics|Stryker JR Clinical Research|201-831-5000|StrykerJRClinical@stryker.com|
22406056|NCT02060903|Dr. Reddy's Laboratories Inc.|Dr. Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
22406057|NCT02418585|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22406058|NCT01024920|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22406059|NCT00077922|National Cancer Institute, National Institutes of Health|Robert J. Kreitman, M.D.|301-496-6947|kreitmar@mail.nih.gov|
22406060|NCT01328769|University of Utah|Paul Hopkins|801-585-8139|paul.hopkins@utah.edu|
22406061|NCT01688999|National Cancer Institute|Dr. Andrea Apolo|301-480-0536|apoloab@nih.gov|
22406062|NCT02768103|VA Palo Alto Health Care System|Dr Johanson|408-250-1982|lisa.johanson29@gmail.com|
22406063|NCT02951455|University of Illinois Urbana Champaign|Liliane Windsor|2173001782|lwindsor@illinois.edu|
22406064|NCT05241288|University of North Carolina at Chapel Hill|Michael B Drummond, MD|919-966-7054|brad_drummond@med.unc.edu|
22406065|NCT04246489|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22406066|NCT03039790|Takeda (Note: This product was divested to HilleVax in 2022)|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
22406067|NCT00058188|Northwestern University|Clinical Trials Office|312-695-1301||
22406068|NCT01520688|Allegheny Health Network|Deborah Gentile, MD|412-359-4099|dgentile@ahn.org|
22406069|NCT00498368|Mayo Clinic|Dr. Fernando Fervenza|507-255-3712|Fervenza.Fernando@mayo.edu|
22406070|NCT03289052|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
22406071|NCT04246541|University Hospitals Cleveland Medical Center|Dr. Michael Karns|216-844-7200|michael.karns@uhhospitals.org|
22406072|NCT02736929|Duke University School of Medicine|Angela Kirby|919-286-0411|angela.kirby@duke.edu|175526
22406073|NCT02972593|Indiana University School of Medicine Department of Orthopaedic Surgery|Dr. Brian H. Mullis|317-963-1966|bmullis@iupui.edu|
22406074|NCT01236768|Agile Therapeutics|Lisa Flood, Associate Director of Clinical Operations|609-683-1880|lflood@agiletherapeutics.com|
22406075|NCT03949621|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22406076|NCT01855425|Carestream Health, Inc.|Susan Pate, RN, MS, RAC|585-627-6557|susan.pate@carestream.com|
22406077|NCT00605358|Weill Cornell Medicine|Dr. Jo Anne Sirey|9149974333|jsirey@med.cornell.edu|
22406078|NCT01957085|Lewis Katz School of Medicine|Robert L. Bettiker, MD/MGA, Principle Investigator|215.707.1982|robert.bettiker@temple.edu|
22406079|NCT02283840|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22406080|NCT02148952|Ariadne Labs|Dr. Katherine Semrau|617-384-6555|betterbirth@ariadnelabs.org|
22406081|NCT01925014|The LOCAT Group|Kyoung Ho Lee|82317877607|kholeemail@gmail.com|
22417689|NCT01517659|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
22417690|NCT02792959|Institute Bergonie|Dr. Anne Laure Cazeau, Coordinating Investigator|0556337860|A.Cazeau@bordeaux.unicancer.fr|
22417691|NCT04392583|Smith+Nephew, Inc|Judith Horner|+44 1482 673251|judith.horner@smith-nephew.com|
22391551|NCT03023553|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
22406082|NCT01487863|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@Dendreon.com|
22406083|NCT00655057|University of Pennsylvania|Tyrone Quarterman|215-349-5537|tyroneq@upenn.edu|
22406084|NCT01437267|Novartis Vaccines Institute for Global Health|Dr. Audino Podda|+39 0577 243496|audino.podda@novartis.com|
22406085|NCT00838695|VAnderbilt University Medical Center|Dr. C. Michael Stein|615-936-3420|mike.stein@vumc.org|
22406086|NCT01810380|H. Lundbeck A/S|Email contact via||LundbeckClinicalTrials@Lundbeck.com|
22406087|NCT00033371|University of Texas (UT) MD Anderson Cancer Center|Patrick Lynch, MD/Professor, Gastroenterology/Hepatology|713-794-5073|plynch@mdanderson.org|
22406088|NCT02699125|University of California San Diego|Michael G. Ziegler, M.D.|619 543 2885|mziegler@ucsd.edu|
22406089|NCT03787095|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22406090|NCT01390038|Tornier/Wright Medical|Josh Myers|9529217119|josh.myers@wright.com|
22406091|NCT01451983|Cleveland Clinic Center for Autism|Thomas W. Frazier, PhD|216-448-6440|fraziet2@ccf.org|
22406092|NCT03799627|Akebia Therapeutics, Inc|Akebia Therapeutics, Inc|617-844-6128|trials@akebia.com|
22406093|NCT02996994|TriHealth Inc.|Dr. Rachel Pauls|513-463-4300|Rachel_Pauls@trihealth.com|
22406094|NCT02637804|CooperVision Inc.|Director, Professional Service|+81 3 5449 6619|Taku.Muraoka@jp.coopervision.com|
22406095|NCT00118404|The University of Texas Southwestern Medical Center|Dr. Robin B. Jarrett, Professor of Psychiatry|214-648-5345|Robin.Jarrett@UTSouthwestern.edu|
22417692|NCT03201250|Vanderbilt University Medical Center|Muhamed Baljevic, MD|615-936-8422|muhamed.baljevic@vumc.org|
22417693|NCT00894738|Washington University School of Medicine|Dr. Ginger Nicol|(314) 362-2461|nicolg@psychiatry.wustl.edu|
22417694|NCT02575911|Alcon, A Novartis Division|Global Brand Med Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22417695|NCT01340768|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22417696|NCT02620150|University of Pennsylvania|Chelsea Voytek|215-746-3711|chelseav@pennmedicine.upenn.edu|
22417697|NCT02878486|University of Kansas|Amber Watts, PhD|785-864-2604|amberwatts@ku.edu|
22417698|NCT03052959|Unity Health Toronto|Dr. Aisha Lofters|4163236400|aisha.lofters@utoronto.ca|3832
22417699|NCT02397408|University of California, Los Angeles|Albert J. Chang, MD, PhD|(310) 82509771|ajchang@mednet.ucla.edu|
22431482|NCT00415636|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22431483|NCT01263119|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22391552|NCT01585441|National Eye Institute|Emily Chew, MD|301-496-6583|emily.chew@nih.gov|
22391553|NCT01437423|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22391554|NCT01375751|Amgen Inc.|Study Director|866-572-6436||
22391555|NCT00633945|University of Pennsylvania|Dr. Victoria Werth|215-898-0168|werth@mail.med.upenn.edu|
22391556|NCT00882115|UCLA Department of Medicine/Center for Human Nutrition|Zhaoping Li|310-206-1987|zli@mednet.ucla.edu|
22391557|NCT02552147|Vanderbilt University Medical Center|Alan Lewis, MD, PhD|(615) 936-4997|alan.s.lewis@vumc.org|
22391558|NCT00940875|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22391559|NCT00943787|University of Virginia|Mary Oliveri|434-982-0602|mc7m@virginia.edu|
22391560|NCT01547598|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22391561|NCT01573949|University of California Los Angeles|Tamara Horwich, MD, MS|310-825-8816|thorwich@mednet.ucla.edu|
22391562|NCT00777634|McLean Hospital|Study Coordinator|617-855-2984|eryan@mclean.harvard.edu|
22391563|NCT00872001|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22391564|NCT04071301|Essity Hygiene and Health|Fredrik Agholme, Clinical Trials Manager, Clinical Affairs|+46 73 0323634|Fredrik.AGHOLME@essity.com|
22391565|NCT05186311|Becton, Dickinson and Company|Clinical Program Manager|9292850651|Pierre.Asselin@bd.com|
22391566|NCT02879383|Fractyl Laboratories, Inc.|Sarah Hackett, Director of Clinical Operations|(781) 902-8840|shackett@fractyl.com|
22391567|NCT02125279|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
22391568|NCT02018653|University of Texas (UT) MD Anderson Cancer Center|Sai-Ching J. Yeung, MD||CR_Study_Registration@mdanderson.org|
22391569|NCT02677870|UHCMC|Dr. Lori-Anne Schillaci|216-844-3936|lori-anne.schillaci@uhhospitals.org|
22391570|NCT01607879|Froedtert and the Medical college of Wisconsin|Kathryn Bylow, MD|414-805-4600|kbylow@mcw.edu|
22391571|NCT01449149|Department of Radiation Oncology, PENN MEDICINE|Michelle Alonso-Basanta, MD PhD|215 615 3782|michelleab@uphs.upenn.edu|
22391572|NCT02224469|University Medical Center Utrecht|Dr E.J. Aarnoutse|+31887555123|e.j.aarnoutse@umcutrecht.nl|
22391573|NCT03721172|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22391574|NCT02417441|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22391575|NCT05628285|Oticon Medical AB|Director of Clinical Affairs|0046-31-7486100|studyinfo@oticonmedical.com|
22391576|NCT00983853|Vertex Pharmaceuticals Incorporated|Medical Monitor|1-617-444-6777|medicalinfo@vrtx.com|
22391577|NCT02339506|Brigham and Women's Hospital|Dr. Gail Kurr Adler|(617) 732-8742|gadler@bwh.harvard.edu|
22391578|NCT00607672|Vanderbilt University School of Medicine|Dr. Mias Pretorius|16153430665|mias.pretorius@vanderbilt.edu|
22391579|NCT03016598|Portland VA|Delaney.McKechnie@va.gov|360-696-4061|Delaney.McKechnie@va.gov|32017
22391580|NCT05400837|Johns Hopkins University|Nino Isakadze|443-997-0270|nisakad1@jh.edu|
22391581|NCT01101061|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22391582|NCT00813982|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22391583|NCT00478205|Eisai Call Center|Eisai Inc.|888-422-4743||
22391584|NCT01791413|Mahidol University|Dr. Weena Krutsawad|66812070264|vna_fe2@hotmail.com|
22391585|NCT00133575|Brigham and Women's Hospital|Lindsey R. Baden, M.D.|617-732-6801|LBaden@partners.org|
22391586|NCT00825305|Novartis Vaccines and Diagnostics|Posting Director||RegContactVacUS.nvdit@Novartis.com|
22391587|NCT04016272|Florida State University|Dr. Hyochol Ahn|850-644-2647|hahn@fsu.edu|
22391588|NCT03617289|Henry Ford Health System|Dr. Jason Muir|517-861-6451|jmuir1@hfhs.org|
22406096|NCT01927068|Spectranetics LLC, now part of Philips Image Guided Therapy|Associate Director, Clinical Operations|612-297-6655|nicolas.aguirre@philips.com|
22406097|NCT01624467|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22406098|NCT03964493|TenNor Therapeutics Limited|Zhenkun Ma, PhD / CEO|+1(646) 775-1861|zhenkun.ma@tennorx.com|
22406099|NCT00398138|Memorial Sloan Kettering Cancer Center|Dr. Peter Maslak, Attending|+1212-639-5518|maslakp@mskcc.org|
22406100|NCT01947647|Ralph H. Johnson VAMC|Daniel Gros, PHD|843-789-7311|daniel.gros@va.gov|
22406101|NCT00814307|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22406102|NCT01474889|UPenn|Cornelia V. Dalton Bakes|215-746-2085|corneliv@pennmedicine.upenn.edu|
22406103|NCT02482389|Duke University Health System|Joan Cahill|(919) 668-5211|joan.cahill@duke.edu|
22406104|NCT02290340|MedImmune, LLC|M. Pamela Griffin|301-398-4095|information.center@astrazeneca.com|
22406105|NCT00045487|University of Texas Health Science Center San Antonio|Alain Mita, MD|210-450-5094|goodwine@uthscsa.edu|
22406106|NCT00251589|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22406107|NCT00323427|Portland VA Medical Center|Mitchel Turbin, Ph.D.|503-220-8262|bonnie.becker@va.gov|54525
22406108|NCT03227224|Janssen Research & Development, LLC|SENIOR DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22406109|NCT00695500|National Institute on Alcohol Abuse and Alcoholism|Ramchandani, Vijay|+1 301 402 8527|vijayr@mail.nih.gov|
22406110|NCT03782376|Janssen-Cilag Ltd.|Senior Director GI Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22406111|NCT02659098|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22406112|NCT03039192|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22406113|NCT02407236|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22406114|NCT01990703|University of Utah, Department of OBGYN|Dr. David Turok|801-581-6170|david.turok@hsc.utah.edu|
22406115|NCT03277794|Centre for Addiction and Mental Health|Dr. Sean Kidd|416-535-8501|sean.kidd@camh.ca|36295
22406116|NCT02168660|UT Southwestern Medical Center|Dr Perrin C White, Professor of Pediatrics|2146486875|perrin.white@utsouthwestern.edu|
22406117|NCT02254304|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22406118|NCT00952419|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22406119|NCT02266004|University of Miami|Corneliu Luca, MD|305-243-6732|cluca@med.miami.edu|
22406120|NCT00537771|AstraZeneca|James J. Armbrust|+44 1625 518062|ClinicalTrialTransparency@astrazeneca.com|
22406121|NCT01744041|Washington University - School of Medicine|Dr. Shannon Lenze|3143622752|slenze@wustl.edu|
22406122|NCT02465489|ApoPharma Inc.|Caroline Fradette, PhD|416-401-7543|cfradett@apopharma.com|
22406123|NCT01600105|Icahn School of Medicine at Mount Sinai|Dr. Bachir Taouli|212-824-8475|bachir.taouli@mountsinai.org|
22406124|NCT01263444|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
22406125|NCT01764022|BIOCAD|Dr. Mariia Shustova|+7812380 49 33|shustova@biocad.ru|651
22406126|NCT01987752|Allergan, Inc|Vice President GSE,|714-246-4500|clinicaltrials@allergan.com|
22406127|NCT01899768|GlaxoSmithKline|GSK Response Center|866-435-7343||
22406128|NCT04043416|The University of Ottawa|Katherine Reilly|613-562-5800|kreilly@uottawa.ca|8238
22406129|NCT00414973|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22406130|NCT01466062|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22406131|NCT00118040|University of Wisconsin|Howard H. Bailey, M.D.|608-263-8624|hhbailey@wisc.edu|
22406132|NCT02865928|Northwell Health|Louis Ballas|718-470-5827|lballas@northwell.edu|
22406133|NCT03813199|Abivax|Vice President Clinical Operations|01 53 83 08 41|paul.gineste@abivax.com|
22406134|NCT01196091|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22406135|NCT03733249|Bellicum Pharmaceuticals|Rivogenlecleucel Study Team|(832) 384-1100|clinicaltrials@bellicum.com|
22406136|NCT04476108|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22406137|NCT00850135|Stanford University School of Medicine|Yasser El-Sayed, MD|(650) 723-3198|Yasser.el-sayed@stanford.edu|
22406138|NCT02253992|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22406139|NCT00471276|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22406140|NCT03645811|University of Health Science|Dr. Demet İnangil|+905303021160|demet.inangil@sbu.edu.tr|
22406141|NCT04555811|University of Minnesota, Masonic Cancer Center|Veronika Bachanova MD, PhD|612-625-5469|bach0173@umn.edu|
22406142|NCT02324049|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|475-230-2596|clinicaltrials@alexion.com|
22417700|NCT02335983|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22417701|NCT01830205|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22417702|NCT00629265|Boston Medical Center|Dr. Susan Langmore, PhD, Director of Speech Language Pathology|617-414-1753|langmore@bu.edu|
22417703|NCT04465630|SIght Sciences, Inc|Kavita Dhamdhere, MD|877-266-1144|kdhamdhere@sightsciences.com|
22417704|NCT02356003|University of Calgary|Frank MacMaster|403-955-2784|fmacmast@ucalgary.ca|
22391589|NCT03382769|Cochlear Limited|PRS Specialist, Clinical Affairs|+612 9428 6555|cltd-prs-admin@cochlear.com|
22391590|NCT00675584|Penn State Hershey College of Medicine|Vernon M. Chinchilli, PhD|717-531-4262|vchinchi@psu.edu|
22391591|NCT02357264|Maimonides Medical Center|Eitan Dickman, MD|718-283-6057|edickman@maimonidesmed.org|
22391592|NCT03623373|Washington University School of Medicine|Brad S. Kahl, M.D.|314-273-3591|bkahl@wustl.edu|
22391593|NCT02282917|Mass General Brigham|Matthew E Stenerson, MSc, Clinical Research Project Manager|7155721100|matthew_stenerson@meei.harvard.edu|
22391594|NCT00115336|Cincinnati Children's Hospital Medical Center|Dr. Charles Quinn|5138033086|charles.quinn@cchmc.org|
22391595|NCT02482610|The Ohio State University|Richard Bruno, PhD, RD|6142925522|bruno.27@osu.edu|
22391596|NCT03272711|Washington University School of Medicine|Dr. Eric Lenze|314-362-1671|lenzee@wustl.edu|
22391597|NCT00715117|Pennsylvania State University|Jill P Smith, MD Professor Emeritus of medicine|717-531-3694|jsmith2@psu.edu|
22391598|NCT01545557|Galderma|Clinical project manager|817-961-5655|aestheticclinicaltrials@galderma.com|
22417705|NCT01912274|Helsinn HealthcareSA|Edwin de Wit - Head of Clinical development|+ 41 919852121|info-HHC@helsinn.com|
22391599|NCT03180008|University of Illinois at Chicago|Andrew DeMott, MPH|312-355-3174|ademot1@uic.edu|
22391600|NCT01018732|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22391601|NCT01536171|University of Florida|Dr. Heather K. Vincent, PhD|352-273-7410|vincehk@ortho.ufl.edu|
22391602|NCT03566979|Johnson & Johnson Worldwide|Steven Sacavage, Associate Director Clinical Research|215-273-8568|SSacavag@its.jnj.com|
22391603|NCT03725605|Lytix Biopharma AS|Director Scientific Research Baldur Sweinbjornsson|+47 413 44 682|Baldur.Sveinbjornsson@lytixbiopharma.com|
22391604|NCT01503086|Children's Oncology Group|Results Reporting Coordinator|6262411500|resultsreportingcoordinator@childrensoncologygroup.org|
22391605|NCT06017050|Center for Innovative Public Health Research|Michele Ybarra|8773026858|michele@innovativepublichealth.org|801
22391606|NCT01197612|University of Michigan|Garrett Griffin, MD||ggriffin@mw-fp.com|
22391607|NCT02419417|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22391608|NCT01240551|National Cancer Institute|Dr. Karen Kurdziel|301-443-0622|kurdziek@mail.nih.gov|
22391609|NCT01385748|Onxeo|Berangere Vasseur, MD|+33 (0)1 45 58 76 00|b.vasseur@onxeo.com|
22391610|NCT00159263|Imperial College London|Peter Barnes|+44 (0)20 7594 7959|p.j.barnes@imperial.ac.uk|
22391611|NCT01200342|UT MD Anderson Cancer Center|Sapna P. Patel, MD / Assistant Professor||CR_Study_Registration@mdanderson.org|
22391612|NCT01367444|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22391613|NCT01012947|Ajou University|Dr. Kang Soo Lee|821087812077|kpsimon@hanmail.net, antiaging@ajou.ac.kr|
22391614|NCT00246090|Eisai Call Center|Eisai Inc.|888-422-4743||
22391615|NCT03053453|NYU Langone Health|Dr. Arthur Hertling|2125986085|Arthur.Hertling@nyulangone.org|
22391616|NCT03332784|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22391617|NCT03306420|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22391618|NCT00763451|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22391619|NCT01827046|Johns Hopkins University Division of Brain Injury Outcomes|Dr. Daniel F. Hanley|4106146996|dhanley@jhmi.edu|
22391620|NCT00763490|University of Michigan Comprehensive Cancer Center|Dr. Daniel Couriel, M.D.|734-936-8785|dcouriel@umich.edu|
22391621|NCT03037203|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2159707145|ClinicalTrialDisclosure@JazzPharma.com|
22391622|NCT05594589|Eisai Korea Inc. Medical department|Serena SoYoun Kwon|+82-2-3451-5533|s-kwon@eisaikorea.com|
22391623|NCT02498236|University of California, Los Angeles|Dr. Stephen R. Marder|3104783711|SMarder@mednet.ucla.edu|83647
22391624|NCT04253119|MSD Pharmaceuticals LLC|Vladimir Achikyan, Medical Affairs Manager|79161981264|vladimir.achikyan@merck.com|
22391625|NCT01262092|University of Arkansas for Medical Sciences|Dr. Alison Oliveto|501-526-8441|olivetoalison@uams.edu|
22391626|NCT03784820|University of North Carolina at Chapel Hill|Hunna Watson, PhD|984-974-5217|hunna_watson@med.unc.edu|
22391627|NCT02336425|Novartis Pharmaceuticals|Study Director|862-778-8300||
22391628|NCT00658606|Astellas Pharma Canada, Inc.|Director, Scientific Affairs||ClinicalTrials@us.astellas.com|
22391629|NCT01191008|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22391630|NCT00978562|OHSU KCI|Edward Neuwelt, MD|503-494-5626|huddlesa@ohsu.edu|
22391631|NCT03786744|Samara Medical Center Dinasty|Volchkov Stanislav|+78469564455|quality@cordbank.ru|
22391632|NCT02394665|University of Miami|Fazilat Ishkanian MD, PhD|305-243-4200|f.ishkanian@med.miami.edu|
22391633|NCT00569127|SWOG|SWOG Statistician|206-667-4408||
22391634|NCT05147272|Repare Therapeutics|Repare Therapeutics Medical Monitor|857-340-5402|clininfo@reparerx.com|
22391635|NCT03348631|NRG Oncology|Christopher Purdy on behalf of Mike Sill, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
22391636|NCT01068210|Memorial Sloan Kettering Cancer Center|Dr. Lee Jones, PhD|646-888-8103|jonesl3@mskcc.org|
22391637|NCT03569891|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
22391638|NCT06314438|University of Washington|Principal Investigator|206-221-3595|stonew@uw.edu|
22391639|NCT03299959|Smith+Nephew, Inc|Senior Manager Clinical Compliance|07811407089|datasharing.gcs@smith-nephew.com|
22391640|NCT03170518|Janssen Research & Development, LLC|Director Clinical Leader Internal Medicine|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22391641|NCT03842436|Brigham and Women's Hospital|Peter R. Chai, MD, MMS|617-732-5640|pchai@bwh.harvard.edu|
22391642|NCT01948076|Brigham and Women's Hospital|Maria Yialamas|617-732-5500|myialamas@partners.org|
22391643|NCT00356811|GlaxoSmithKline|GSK Response Center|866-435-7343||
22391644|NCT02145169|Albert Einstein Medical Center|Kamran Mohiuddin. Director Clinical Research Emergency Department|2154562313|MOHIUDDK@EISNTEIN.EDU|
22391645|NCT03995225|Yale School of Medicine|Kathleen A Garrison|415-260-8618|kathleen.garrison@yale.edu|
22391646|NCT01907269|University of Alabama at Birmingham|Dr. Elizabeth J. Rahn|2059966552|rahneli@uab.edu|
22406143|NCT02159365|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22406144|NCT03198728|Marius Pharmaceuticals, LLC|Nita Nimmons|919-374-1913|Nita@mariuspharma.com|
22406145|NCT04051944|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22406146|NCT03083470|US Biotest, Inc.|Gere diZerega, MD; President & CEO|805-595-1300|gere.dizerega@usbiotest.com|
22406147|NCT01512693|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22406148|NCT02139280|Dartmouth-Hitchcock Medical Center|Kenneth Meehan, MD|603.650.4628|Kenneth.R.Meehan@hitchcock.org|
22406149|NCT02044367|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22406150|NCT00736450|University of Nebraska Medical Center|Julie Vose|402-559-3848|jmvose@unmc.edu|
22406151|NCT00491751|Boston University School of Medicine|Naomi M. Hamburg, MD|617-638-7462|nhamburg@bu.edu|
22406152|NCT04157751|Boehringer Ingelheim, Call Centre|Boehringer Ingelheim|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22406153|NCT04731922|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22406154|NCT02564068|Medical Faculty Associates at The George Washington University|Dr. Vivek Jain|202-741-2676|vjain@mfa.gwu.edu|
22406155|NCT01395966|Laboratorios SALVAT|Enrique Jimenez, Medical Director|+34933946470|ejimenezv@salvatbiotech.com|
22406156|NCT04401904|UT Health San Antonio|Carolina Solis-Herrera, MD|210-567-4900|solisherrera@uthscsa.edu|
22406157|NCT00981747|University of Iowa|Dr. Alicia Gerke|319-356-1616|alicia-gerke@uiowa.edu|
22406158|NCT00801138|Cleveland Clinic Foundation|Daniel I Sessler, MD|2164458396|sesslerd@ccf.org|
22431484|NCT02138825|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22406159|NCT02939651|Fox Chase Cancer Center|Namrata Vijayvergia|+1 215-214-4283|Namrata.Vijayvergia@fccc.edu|
22406160|NCT00570362|St.Mary's Hospital, College of Medicine, The Catholic University of Korea|Jung-Il Moon|82-2-3779-2114|jimoon@catholic.ac.kr|1243
22431485|NCT03014635|Revance Therapeutics, Inc.|Todd Gross, PhD, VP Data Science, Interim Head of Clinical Development|510-742-3400|tgross@revance.com|
22406161|NCT03148795|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22391647|NCT02201901|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22391648|NCT01431950|GlaxoSmithKline|GSK Response Center|866-435-7343||
22391649|NCT00738283|Baylor College of Medicine|Steven A. Abrams, MD|713-798-7164|sabrams@bcm.edu|
22391650|NCT00469859|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22391651|NCT03494985|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22391652|NCT02282059|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22391653|NCT03459846|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22391654|NCT00001481|National Institute of Mental Health (NIMH)|Dr. Peter Schmidt|+1 301 496 6120|peterschmidt@mail.nih.gov|
22391655|NCT04886518|Harmony Biosciences|Sharon Wolfe-Schwartz, Executive Director, Medical and Regulatory Writing|267-965-0270|swolfe-schwartz@harmonybiosciences.com|
22406162|NCT00441012|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22406163|NCT04489940|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center,|+49 6151725200|service@emdgroup.com|
22406164|NCT04498468|Johns Hopkins Wilmer Eye Institute|Michael Lin, BA, Research coordinator|8653851192|mlin60@jhu.edu|
22406165|NCT02092324|OHSU|Dr. Kim-Hien Dao|503-494-5074|daok@ohsu.edu|
22406166|NCT01154322|ResMed|June Mendoza|1-800-424-0737|june.mendoza@resmed.com|
22406167|NCT02224274|UMC Ljubljana|Marko Noc|+386 1 522 22 96|marko.noc@mf.uni-lj.si|
22406168|NCT00499460|Clinical Research Division, Fred Hutchinson Cancer Research Center|Danny D. Shen, Member (Retired)|206-685-2920|ds@uw.edu|
22406169|NCT00887068|UT MD Anderson Cancer Center|Dr. Richard E. Champlin, MD/ Chair, Stem Cell Transplantation|713-792-3618|rchampli@mdanderson.org|
22406170|NCT03190967|National Cancer Institute|Dr. Stanley Lipkowitz, PhD|240-760-6129|lipkowis@navmed.nci.nih.gov|
22406171|NCT00997555|Hurley Medical Center|John Alfred Carr, MD|810-262-4993|heartandbones@yahoo.com|
22406172|NCT00090766|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22406173|NCT00804986|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22406174|NCT00559013|Synovis|Lesa Hobright-Turner, Director of Clinical Affairs|651-796-7506|lesa.hobrightturner@synovissurgical.com|
22406175|NCT03418376|Hasselt University|Dr. Charly Keytsman|+32477611122|charly.keytsman@uhasselt.be|
22406176|NCT01256918|Dr. Ram Manohar Lohia Hospital|Dr. Praveen Kumar Malik|00919810405681|praveenk002@yahoo.com|
22406177|NCT02774291|Albert Einstein College of Medicine/Montefiore medical center|Braunschweig, Ira|718-798-7474|ibraunsc@montefiore.org|
22406178|NCT02253160|Terumo BCT|Raymond P. Goodrich, PhD, VP, Scientific and Clinical Affairs; Chief Science Officer - BBT|303-232-6800|Ray.Goodrich@terumobct.com|
22406179|NCT00149890|Novartis Pharmaceuticals|Study Director|862-778-8300||
22406180|NCT01387594|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22406181|NCT03054298|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
22406182|NCT03073200|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22406183|NCT04757376|CELLTRION, Inc.|Head of Clinical Planning Department|+82 32 850 4167|jeehye.suh@celltrion.com|
22406184|NCT01307046|Merch Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22406185|NCT03898323|University of California, San Francisco/San Francisco VA Health Care System|Steven L. Batki, MD|415-221-4810|steven.batki@ucsf.edu|23671
22406186|NCT01547806|National Cancer Institute|Dr. Jennifer Kanakry|301-451-3787|kanakryja@nih.gov|
22406187|NCT01611311|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22406188|NCT02569398|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22406189|NCT04511338|Fresenius Medical Care North America|Senior Director of Statistics and Data Management|1-781-249-8216|chianghong.ho@fmc-na.com|
22406190|NCT02116361|Allergan, Inc|Arlene Lum, PMP|714-246-5548|lum_arlene@allergan.com|
22417706|NCT01684436|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22406191|NCT02571972|Retina Service of Wills Eye Hospital, Mid Atlantic Retina|Dr. Jason Hsu|215-928-3092|jhsu@midatlanticretina.com|
22406192|NCT04195750|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22406193|NCT02406027|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22406194|NCT04363944|University at Buffalo|Dr. Jeanne Langan|17168292905|jlangan@buffalo.edu|
22406195|NCT03559192|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22406196|NCT03517722|Janssen Research & Development, LLC|DIRECTOR CLINICAL RESEARCH GI.|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22417707|NCT01732484|Medical University of Vienna|Prof. Dr. R. Menapace|+43 699 19660272|rupert.menapace@meduniwien.ac.at|
22417708|NCT00289874|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22417709|NCT01087489|Miami Veterans Affairs Medical Center|Dr. Ninel Gregori, MD|305-575-7000|ngregori@med.miami.edu|3081
22417710|NCT01708590|Bausch Health|Study Director|510-259-5284||
22417711|NCT05070546|Janssen Vaccines & Prevention B.V.|Director Biomarkers Viral Vaccines|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22417712|NCT02643355|Hennepin Healthcare|Dr. Marc Martel|612-873-7448|Edresearch@hcmed.org|
22417713|NCT02697240|Children's National Medical Center|Suvankar Majumdar|2024763800|smajumdar@childrensnational.org|
22417714|NCT05080426|Purdue University|Dr. Ellen Ernst Kossek|(765) 494-6852|ekossek@purdue.edu|
22417715|NCT01974440|Janssen Research & Development, LLC|Executive Medial Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22417716|NCT04988152|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
22406197|NCT00615420|BC Cancer|Dr. Philippa Hawley|(604) 877-6000|phawley@bccancer.bc.ca|67-2752
22406198|NCT01673373|Getinge|Sr. Clinical Trial Manager|603-864-5219|inka.vesela@getinge.com|
22406199|NCT00166504|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22406200|NCT03691649|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
22406201|NCT03261037|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22406202|NCT04423718|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22406203|NCT04193605|School of Nursing at the University of Alabama at Birmingham|Crystal Chapman Lambert|205-934-3481|cclamber@uab.edu|
22406204|NCT03315702|Department of Anesthesia, Xinhua hospital affiliated to Shanghai Jiaotong University School of medicine|Dr. Lai Jiang|021-25078999|jianglaimz@sina.com|
22406205|NCT00589602|Cleveland Clinic|Jarek Maciejewski, MD|216-445-5962|maciejj@ccf.org|
22406206|NCT00533780|Stanford University|Kathy Turner, RN, NP|650-724-6850|kathyt@stanford.edu|
22406207|NCT03825536|University of California, San Francisco|Sulggi A. Lee|415-735-5127|sulggi.lee@ucsf.edu|
22406208|NCT05298774|Yale University|Dr. Ira Leeds|(203)785-2616|ira.leeds@yale.edu|
22406209|NCT04992507|The Ohio State University Comprehensive Cancer Center|Dr. Aslam Ejaz|614-293-7171|aejaz@uic.edu|
22406210|NCT01058395|Wayne State University|Dr. Jay Meythaler|(313) 375-7226|jmeythal@med.wayne.edu|
22406211|NCT01266876|Regeneron Pharmaceuticals, Inc|Clinical Trial Management||clinicaltrials@regeneron.com|
22406212|NCT05016037|Vanderbilt University Medical Center|Dr. Stephen Camarata|(615) 579-5608|stephen.camarata@vumc.org|
22406213|NCT00557323|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22406214|NCT04007367|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22406215|NCT01611662|Fox Chase Cancer Center|Elizabeth Plimack, MD|215-728-3889|Elizabath.Plimack@fccc.edu|
22391656|NCT03987295|Alector|Alector Medical Information|650-826-2454|medinfo@alector.com|
22406216|NCT04098016|Duke University|Dr. Melissa Kay|7812493062|melissa.kay@duke.edu|
22406217|NCT02010567|UNC Lineberger|Robin Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
22406218|NCT02213081|Northwestern University|Dr. Serdar Bulun|312-472-3980|Serdar.Bulun@nm.org|
22406219|NCT01836029|VentiRx|Kristi Manjarrez|206 689 2256|kmanjarrez@ventirx.com|
22406220|NCT00606229|Otsuka Pharmaceutical CO., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22406221|NCT03523715|University of Southern California|Begum Ozel, MD|562-657-2961|ozel@usc.edu|
22406222|NCT01526928|Clovis Oncology|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
22406223|NCT00942422|Barbara Ann Karmanos Cancer Institute|Jeffrey Zonder, M.D.|313-576-8732|zonderj@karmanos.org|
22431486|NCT01690273|Universidade Sao Paulo|Andrea Lopes Gallinaro; Researcher|55112601|algallinaro@gmail.com|8022
22391657|NCT00310180|ECOG-ACRIN Cancer Research Group|ECOG-ACRIN statistician|617-632-3000|eatrials@jimmy.harvard.edu|
22391658|NCT04978129|University of Texas at Arlington|Melissa Lewis|817-272-9833|Melissa.Lewis@uta.edu|
22391659|NCT01443403|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
22391660|NCT02748889|Georgetown University Medical Center - Lombardi Comprehensive Cancer Center|Dr Giuseppe Giaccone|202-687-7072|gg496@georgetown.edu|
22391661|NCT00725712|GlaxoSmithKline|GSK Response Center|866-435-7343||
22391662|NCT03305887|Johnson & Johnson Medical Shanghai Ltd.|Xiaolei, Wang|+86 21 33378749|xwang183@its.jnj.com|
22391663|NCT03607422|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22391664|NCT00863512|Duke University Medical Center|David Harpole, M.D.||david.harpole@duke.edu|
22391665|NCT03941600|Washington University School of Medicine|Dr. Kerri Morgan|314-286-1659|morgank@wustl.edu|
22391666|NCT03258723|Yale School of Medicine|Marcella Nunez-Smith, MD, MHS|(203) 785-6454|marcella.nunez-smith@yale.edu|
22391667|NCT04832971|Arrowhead Pharmaceuticals, Inc.|Patrick O'Brien, Chief Operating Officer|626-304-3400|PObrien@arrowheadpharma.com|
22391668|NCT01107899|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22391669|NCT03584152|Stanford University|Sam P. Most, MD, MBA|(650) 724-8019|smost@stanford.edu|
22391670|NCT04024462|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22391671|NCT01351805|Brigham and Women's Hospital/ Harvard Medical School|Karen Costenbader|16177326088|kcostenbader@bwh.harvard.edu|
22391672|NCT00983749|Department of Emergency Medicine, University of California San Diego Health System|Kama Guluma, M.D.|619-543-6463|kguluma@ucsd.edu|
22391673|NCT04292470|University of California Davis|Dr. Michelle Dossett|916-734-5367|mdossett@ucdavis.edu|
22391674|NCT00867100|Valeant Pharmaceuticals|Director of Clinical Trials|908|binu.alexander@valeant.com|
22391675|NCT02906020|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22391676|NCT02701062|AtriCure|Nfii Ndikintum, VP Clinical Affairs and Biometrics|(513) 644-8192|nndikintum@atricure.com|
22391677|NCT01597843|Clement J Zablocki VA Medical Center|Jeff Whittle, MD, MPH|414-384-2000|jeffrey.whittle@va.gov|46444
22391678|NCT01907906|Terumo BCT Biotechnologies, LLC|Ray Goodrich, PhD|(303) 231-4832||
22391679|NCT00979953|Cubist Pharmaceuticals|VP of Clinical Research|(781) 860-8660||
22391680|NCT01124097|BIAL - Portela & Cª S.A.|Director R&D|+351-229866100|clinical.trials@bial.com|
22391681|NCT00399841|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
22391682|NCT00708851|Psoriasis Treatment Center of Central New Jersey|Jerry Bagel, MD|609-443-4501|dreamacres1@aol.com|
22391683|NCT04982588|Medtronic, Inc.|Fairy Liu|+86-02120325765|rs.evolutprochinaclinicalstudy@medtronic.com|
22391684|NCT00577135|Duke University|Jeff Sharp|919.668.7086|jeff.sharp@dm.duke.edu|
22391685|NCT00559377|UWMC Dept of Radiology|Joseph G Rajendran|206-221-4421|rajan@u.washington.edu|
22391686|NCT03792347|Ruijin Hospital, Shanghai JiaoTong University School of Medicine|Prof. Hecheng Li, Chair of Thoracic Surgery|(86)13917113402|lihecheng2000@hotmail.com|
22391687|NCT00590226|EUSOM|Guillermo Umpierrez, MD|4047781665|geumpie@emory.edu|
22391688|NCT02743897|Perelman School of Medicine|Dr. Peter Reese|215-900-3782|amussell@upenn.edu|
22391689|NCT00203047|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22391690|NCT02229227|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22391691|NCT01453023|GlaxoSmithKline|GSK Response Center|866-435-7343||
22391692|NCT00148668|Dana-Farber Cancer Institute|Dr Eric Winer|617-632-2335|eric_winer@dfci.harvard.edu|
22391693|NCT03934099|LG Chem|Younghwan Jang|02-6987-4154|younghj@lgchem.com|
22391694|NCT02869867|Centre Hospitalier Départemental Vendée|Dr Yves-Marie PLUCHON|251446248|yves-marie.pluchon@chd-vendee.fr|+33
22391695|NCT06476834|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22391696|NCT05555615|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|844-422-2342|medicalinformation@acadia-pharm.com|
22391697|NCT03218566|Penumbra, Inc.|Erin Archard, Sr. Clinical Study Manager|+1 510 995 9801|earchard@penumbrainc.com|
22391698|NCT00820664|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
22391699|NCT02872012|University of Michigan Kellogg Eye Center|Dr. Anjali Shah|734-763-8122|arshah@med.umich.edu|
22391700|NCT01728623|Eisai Inc.|Inquiry Service||eisai-chiken_hotline@hhc.eisai.co.jp|
22391701|NCT03000348|NovaBiotics Ltd|Dr Deborah O'Neil, CEO|01224 711 377|deborah@novabiotics.co.uk|
22431487|NCT01702298|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22406224|NCT00427791|UT MD Anderson Cancer Center|Dr. Partow Kebriaei, Associate Professor|713-792-2648|ytdinh@mdanderson.org|
22406225|NCT04238689|Radboudumc, Department of Medical Microbiology|Dr. Matthew B.B. McCall|+31 024 361 1111|matthew.mccall@radboudumc.nl|
22406226|NCT05559203|University of Stirling|Prof Anna C. Whittaker|0178646|a.c.whittaker@stir.ac.uk|7816
22406227|NCT00422903|GlaxoSmithKline|GSK Response Center|866-435-7343||
22406228|NCT01947894|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22406229|NCT02829775|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22406230|NCT00390429|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
22406231|NCT01562678|Beth Israel Deaconess Medical Center|Dr. Christos Mantzoros|617-667- 8630|cmantzor@bidmc.harvard.edu|
22406232|NCT02725268|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22406233|NCT01838304|University of Pennsylvania|Vice-Chair of Research|(215) 662-3766|roderic.eckenhoff@uphs.upenn.edu|
22406234|NCT03338036|University of Western Ontario|Dr Jim Dickey, Associate Professor|519-661-2111|jdickey@uwo.ca|87834
22406235|NCT00117572|UC San Diego Moores Cancer Center|Dr. Ezra E.W. Cohen||ecohen@ucsd.edu|
22406236|NCT03256136|Massachusetts General Hospital|Dr. Jessica Lin|617-724-1134|jjlin1@partners.org|
22406237|NCT01188811|Oregon Health & Science University|Rebecca Spain, MD, MSPH|503-494-5759|spainr@ohsu.edu|
22406238|NCT00654368|Amgen Inc.|Study Director|866-572-6436||
22406239|NCT00815776|Ascentia Health, Inc.|Lawrence G. Clayton, M.A., Study Director|(815) 484-9258|LGClayton@aol.com|
22406240|NCT04228445|Provepharm, Inc.|Senior Director of Clinical Operations|6106018605|todd.koch@provepharm.com|
22406241|NCT03028467|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22406242|NCT00460525|Department of Epidemiology of Parasitic Diseases, University of Bamako|Mahamadou A. Thera, MD, MPH|223-222-8109|mthera@mrtcbko.org|
22406243|NCT02550093|Northwestern University, Feinberg School of Medicine|David Walega, MD|312-695-2500|d-walega@northwestern.edu|
22406244|NCT03954704|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22406245|NCT00802880|Washington University School of Medicine|Brian Van Tine, M.D., Ph.D.|314-362-5817|bvantine@dom.wustl.edu|
22406246|NCT04035473|Athenex|Regional Project Manager|+886-277039399|lmeiying@athenex.com|
22406247|NCT00397891|Wyeth|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22406248|NCT02058251|Medical University of South Carolina|Dr. Sudie Back|843-792-5915|backs@musc.edu|
22406249|NCT00796224|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22406250|NCT01186003|University of Colorado Denver|Director, Clinical Research Administration|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
22406251|NCT00550290|Aultman Health Foundation|Jane Sewell|330-363-6793|Jane.Sewell@aultman.com|
22406252|NCT06535932|Philips|Sarah Bass|240-278-0838|sarah.bass@philips.com|
22406253|NCT02177812|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22406254|NCT00089999|GlaxoSmithKline|GSK Response Center|866-435-7343||
22406255|NCT00616772|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22406256|NCT03991468|Hamamatsu Photonics, K.K.|MCG Manager|+81-53-435-1560|fujisaka@sys.hpk.co.jp|
22406257|NCT03573804|Dartmouth-Hitchcock|Timothy B Rooney, MD, PI|603-650-5000|timothy.b.rooney@hitchcock.org|
22406258|NCT03649815|Centre for Addiction and Mental Health|Dr. Sean Kidd|416-535-8501|sean.kidd@camh.ca|36295
22406259|NCT03186261|Faculty of Dentistry, Cairo University|Ali Mostafa Shamaa|+201005276468|alishamaa@hotmail.com|
22406260|NCT04418427|Adverum Biotechnologies|Study Medical Director|650-656-9323|clinicaltrials@adverum.com|
22406261|NCT01654224|University of Pittsburgh|David Nace, MD, MPH|412 692-2366|naceda@upmc.edu|
22406262|NCT02306928|Aarhus University Hospital, Department of infectious diseases|Dr. Kristina Öbrink-Hansen|+45 7845 2845|krisoebr@rm.dk|
22406263|NCT01874353|AstraZeneca|Global Clinical Program Lead|1-877-240-9479|information.center@astrazeneca.com|
22406264|NCT03887052|Kestra Medical Technologies, Inc.|Laura Gustavson, VP Clinical Marketing|14255264759|laura.gustavson@kestramedical.com|
22406265|NCT03728881|Division of Cancer Epidemiology and Genetics, NCI|Aimée R. Kreimer, PhD|240.276.7102|kreimera@mail.nih.gov|
22406266|NCT05379686|Steno Diabetes Center Copenhagen|Dr|+45 39 68 08 00|SDC-FP-Stenoinfo@regionh.dk|
22406267|NCT04517253|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22406268|NCT04651777|Western Universtiy|Dr. Grace E Parraga|519-931-5365|gparraga@robarts.ca|
22406269|NCT05505734|Avillion Life Sciences|Chief Medical Officer|+44 (0)203 764 9530|contact@avillionls.com|
22406270|NCT00732472|GlaxoSmithKline|GSK Response Center|866-435-7343||
22406271|NCT02159768|National University Hospital|Senior Consultant|+65 67724200|eugene_liu_hc@nuhs.edu.sg|
22406272|NCT01023516|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22406273|NCT02432690|Sumitomo Pharma Oncology|Tegan Nguyen|617-674-8745|tegan.nguyen@oncology.sumitomo-pharma.com|
22406274|NCT04870099|Indiana University|Prof. Lorenzo Lorenzo-Luaces, Assistant Professor|8123456193|lolorenz@indiana.edu|
22431488|NCT00400686|Cleveland Clinic|Beth Faiman, MSN,CNP, AOCN|216-445-3738|faimanb@ccf.org|
22406275|NCT03575351|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22406276|NCT03715205|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22431489|NCT01752049|St. Michael's Hospital|Dr. Marie Faughnan|416-864-6060|marie.faughnan@unityhealth.to|5412
22406277|NCT02623699|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22406278|NCT01426009|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
22406279|NCT02283333|Ralph H. Johnson VA Medical Center|Dr. Ron Acierno, PI|843-364-1667|ron.acierno@va.gov|
22406280|NCT01856855|University of Alabama at Birmingham (UAB)|John Fiveash, MD|(205) 975-0224|jfiveash@uabmc.edu|
22406281|NCT00608491|Duke University|Jenny Ibarra|9192363291|jenny.ibarra@duke.edu|
22406282|NCT00515099|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22406283|NCT03342404|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22406284|NCT04732780|Imperial College London|Dr Vicky McKechnie|02083830689|vicky.mckechnie@nhs.net|
22406285|NCT01863901|Pacira Bioscience, Inc.|Medical Information|1-855-793-9729|MedInfo@Pacira.com|
22406286|NCT04099836|Duke University Medical Center|Dr. Thomas Stinchcombe|919-681-9509|Thomas.stinchcombe@duke.edu|
22406287|NCT03148899|Medical Faculty Associates at The George Washington University|Dr. Vivek Jain|202-741-2676|vjain@mfa.gwu.edu|
22406288|NCT00372489|Affymax|VP, Clinical Development|650-812-8700|info@affymax.com|
22406289|NCT00772889|GlaxoSmithKline|GSK Response Center|866-435-7343||
22406290|NCT03323086|The Miriam Hospital|Dr. Michael Carey|401 793 8218|michael_carey@brown.edu|
22406291|NCT02515851|University Louisville|Nancy Alsip|502-852-2610|nlalsi01@exchange.louisville.edu|
22406292|NCT01215786|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22406293|NCT00355615|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
22406294|NCT01866306|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22406295|NCT04259346|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
22406296|NCT03676465|University of Virginia|Dr. Mark DeBoer|(434) 924-5956|deboer@virginia.edu|
22406297|NCT00085644|Abbott|Global Medical Services|800-633-9110||
22406298|NCT03330106|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22406299|NCT01004874|Duke University Medical Center|Dr. Annick Desjardins, MD, FRCPC|9196846173|annick.desjardins@duke.edu|
22406300|NCT00623766|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22406301|NCT03441594|Pennington Biomedical Research Center|Candice A. Myers|12257632849|candice.myers@pbrc.edu|
22406302|NCT00486889|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22406303|NCT02750501|Alcresta Therapeutics, Inc.|"Madhumalli (Molly) Sarkar, MD, PhD, Head of Clinical Development"|617 431 8866|msarkar@alcresta.com|
22406304|NCT00893763|University of South Florida|Cindy L. Munro, APRN, PhD|813-974-7597|cmunro2@health.usf.edu|
22406305|NCT01738594|Northwestern University|Barbara Pro, MD|312-695-6832|barbara.pro@nm.org|
22406306|NCT00796549|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22406307|NCT00285246|Edith Nourse Rogers Memorial VA Hospital|Karen S. Quigley, Ph.D., Research Physiologist|781-687-2273|karen.quigley@va.gov|
22406308|NCT04107935|University of Pittsburgh|Dr. Linda Siminerio|412-559-0359|similx@upmc.edu|
22406309|NCT00376675|Mayo Clinic|Dr. Amit Sood|507-284-1623|sood.amit@mayo.edu|
22406310|NCT01425853|Bioiberica|Clinical R&D Manager|+34934904908|mherrero@bioiberica.com|
22406311|NCT03489850|University of California Los Angeles|Dr. Lara Ray|310-794-5383|lararay@psych.ucla.edu|
22406312|NCT00260195|RAND Corporation|Lisa Jaycox|703-344-8236|jaycox@rand.org|5118
22391702|NCT00723125|BrUOG|William Sikov, MD|4018633000|Roxanne_Wood@brown.edu|
22391703|NCT03329300|University of Alabama at Birmingham Department of Pediatrics|Marissa Gowey, PhD|2056386618|marissa.gowey.phd@gmail.com|
22391704|NCT01667549|Monell Chemical Senses Center|Julia A. Mennella, PhD; Study Principal Investigator|267-519-4880|mennella@monell.org|
22391705|NCT01407276|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22391706|NCT00020722|Barbara Ann Karmanos Cancer Institute|Lawrence G. Lum, M.D., D.Sc|(313) 576-8326|luml@karmanos.org|
22391707|NCT02046512|Washington University in St. Louis School of Medicine|Kimberly Reske, Research Coordinator|3147474041|kreske@wustl.edu|
22391708|NCT03482752|Savara Inc|Raymond D Pratt, Chief Medical Officer|+1 512 784 8757|ray.pratt@savarapharma.com|
22391709|NCT04947514|Montefiore Medical Center|Dr. Amy Yao|7189204800|amyao@montefiore.org|123
22391710|NCT01807182|Fred Hutchinson Cancer Center|Dr. Sylvia Lee|206-606-2274|smlee@fredhutch.org|
22391711|NCT02844777|Vidac Pharma|Max Herzberg|0544257381|maxherzberg@gmail.com|
22391712|NCT01776008|Washington University School of Medicine|Cynthia Ma, M.D., Ph.D.||cma@dom.wustl.edu|
22391713|NCT00150618|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22391714|NCT04092452|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22391715|NCT00696488|Wake Forest University Health Sciences|Steve Feldman, MD|336-716-3775|sfeldman@wakehealth.edu|
22391716|NCT02127125|San Antonio Geriatric Research, Education, and Clinical Center|Dr. Nicolas Musi|(210) 562-6140|musi@uthscsa.edu|
22391717|NCT01255761|UCB Clinical Trial Call Center|(UCB) Study Director|+1 887 822 9493||
22391718|NCT00936598|University of Pittsburgh|Professor|412-623-5965|bovbjergdh@upmc.edu|
22391719|NCT03766373|Novus Therapeutics|Clinical Director|949-679-1110|study004@novustherapeutics.com|
22391720|NCT00486252|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22391721|NCT01210651|UCSF|Sudha Prathikanti, MD|415-516-3867|sudha.prathikanti@gmail.com|
22391722|NCT02559310|Nabriva Therapeutics US, Inc.|Jennifer Schranz, MD, Chief Medical Officer|610-981-2842|jennifer.schranz@nabriva.com|
22391723|NCT04596540|Swedish Orphan Biovitrum AB (publ)|Blank Clinical Study Physician, MD|+46 8 697 20 00|medical.info@sobi.com|
22391724|NCT02950259|Earle A. Chiles Research Institute, Providence Cancer Institute|Dr. David B. Page|503-215-6588|david.page2@providence.org|
22391725|NCT01090011|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22391726|NCT00433511|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22391727|NCT01375673|WJB Dorn VAMC (VHA)|Andrea M. Boyd, PhD, Asscoaite Nurse Executive, Research/Education|803.776.4000|andrea.boyd@va.gov|5654
22391728|NCT06193967|University of Tennessee, Knoxville|Dr. Hollie Raynor|865-974-9126|hraynor@utk.edu|1
22391729|NCT04698915|Galera Therapeutics|Judy Schnyder, Sr. Vice President Clinical Operations and Data Management|484-870-9625|jschnyder@galeratx.com|
22391730|NCT02349152|University of Pittsburgh|Dr. Kathirvel Subramaniam, MD, MPH|412-647-5635|subramaniamk@upmc.edu|
22391731|NCT00880022|vanderbilt university|sheila h ridner|615-322-0831|Sheila.Ridner@Vanderbilt.edu|
22391732|NCT05687032|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22391733|NCT04829747|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22391734|NCT01535001|Aalborg University Hospital|Dr. Søren T. Skou|+4523708640|sots@rn.dk|
22391735|NCT02367352|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22391736|NCT02866669|University of Alabama at Birmingham|Dr. Andrea Cherrington|205-996-2885|acherrington@uabmc.edu|
22391737|NCT05878873|Colorado State University|Dr. Brett Fling|(970) 491-3451|brett.fling@colostate.edu|
22391738|NCT01383447|Johns Hopkins Sidney Kimmel Cancer Center|Dr. Patrick Brown|410-614-4915|pbrown2@jhmi.edu|
22391739|NCT02375347|University of Florida|Volker Mai, PhD, MPH|3522739398|vmai@epi.ufl.edu|
22391740|NCT00193479|Sarah Cannon Research Institute|John D. Hainsworth, MD|615-329-7274|jhainsworth@tnonc.com|
22391741|NCT00425607|Dana-Farber Cancer Institute|Dr. Mark Kieran|617-632-4907|mark_kieran@dfci.harvard.edu|
22391742|NCT00079339|Pediatric Brain Tumor Consortium|Pediatric Brain Tumor Consortium (James M. Boyett, Ph.D)|901-595-4986|james.boyett@stjude.org|
22391743|NCT02563548|Halozyme Therapeutics|VP, Clinical Development|858-794-8889|medinfo@halozyme.com|
22391744|NCT04312256|Mayo Clinic|J. Ross Renew, M.D.|904-956-3328|Renew.J@mayo.edu|
22391745|NCT00371176|Boston VA Healthcare System|Dr. Brett Litz|857 364 4131|brett.litz@va.gov|
22391746|NCT01580904|Universidade Estadual da Paraíba|Impacto da Atenção Farmacêutica em pacientes diabéticos (IPCD)|558387010977|patriciatrindad@yahoo.com.br|
22391747|NCT00340704|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22391748|NCT01732549|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22391749|NCT00121667|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22391750|NCT03178344|Department of Psychiatry, UNC Chapel Hill|Jhana Parikh|919-966-9929|jhana_parikh@med.unc.edu|
22391751|NCT01392703|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22391752|NCT04468230|Virginia Commonwealth University|Renato Martins, MD|804-828-1965|MasseyCPC@vcu.edu|
22391753|NCT03714659|New Jersey Regenerative Institute|Dr. Gerard Malanga|9739988301|gmalangamd@hotmail.com|
22391754|NCT01236378|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22391755|NCT03343093|University of Minnesota|Gudrun Kilian|612-626-9568|kilian@umn.edu|
22391756|NCT03994731|Horizon Therapeutics USA, Inc.|Medical Monitor|866-479-6742|clinicaltrials@horizontherapeutics.com|
22391757|NCT00325598|Washington University School of Medicine|Imran Zoberi, M.D.|314-362-8525|izoberi@radonc.wustl.edu|
22391758|NCT05288829|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22406313|NCT04925947|Weill Cornell Medicine|Barbara Ma|646-962-6444|btm9003@med.cornell.edu|
22406314|NCT04319445|Wake Forest University Health Sciences|Rebecca E Wells, MD, MPH|336-716-2357|rewells@wakehealth.edu|
22406315|NCT02150460|National Eye Centre, Kaduna. Nigeria|Dr Aminatu Ali AbdulRahman|+2348037878367|aaaminatu@yahoo.com|
22391759|NCT03377361|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22406316|NCT03150199|Massachusetts General Hospital|Dr. Jeff Huffman|617-724-2910|JHUFFMAN@mgh.harvard.edu|
22406317|NCT02104141|Zimmer Biomet Spine|Clinical Affairs|303-501-8571|tammy.stinson2@zimmerbiomet.com|
22406318|NCT03674541|Brigham and Women's Hospital|Dr. David Systrom|6175431554|dsystrom@bwh.harvard.edu|
22406319|NCT00262314|EMD Serono, Inc.|Fernando Dangond, M.D., Medical Responsible|+1 781 681 2348||
22391760|NCT00742326|NIAID|Colleen Hadigan MD MPH|301-594-5754|hadiganc@niaid.nih.gov|
22391761|NCT04937920|DermBiont, Inc|Emma Taylor, MD (Chief Medical Officer)|510-607-8155|emma@dermbiont.com|
22391762|NCT00894504|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22406320|NCT04973085|University of Vermont|Adam Sprouse Blum, MD|8028478050|Adam.Sprouse-Blum@uvmhealth.org|
22391763|NCT06733103|University of East Anglia|Sophie Livsey|07947272186|sophie.livsey1@nhs.net|
22391764|NCT03698994|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22391765|NCT04620369|Mayo Clinic|Dr. Charles L. Loprinzi|507-284-2511|cloprinzi@mayo.edu|
22391766|NCT03635086|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22391767|NCT03316807|Shanxi Medical University|Suping Wang, PhD|#86-351-4135103|spwang88@163.com|
22391768|NCT01162486|Johns Hopkins University School of Medicine|Dr. Kelly E. Dooley|410-955-3100|kdooley1@jhmi.edu|
22391769|NCT03434028|Massachusetts General Hospital|PETAL Clinical Coordinating Center PI|617-872-2882|tthompson1@mgh.harvard.edu|
22391770|NCT02037776|Osaka Medical College|Kazunari Tominaga, M.D., Ph. D.|+81-72-683-1221|in2139@osaka-med.ac.jp|8096
22391771|NCT02296892|PAION UK Ltd|Trial Information|+49 2414453101|reg_paion@paion.com|
22391772|NCT03928392|Loma Linda University|Dr. Dragana Krpalek|9095584328|dkrpalek@llu.edu|41340
22391773|NCT00794170|University of Pennsylvania|Karen Glanz|215-898-0613|kglanz@upenn.edu|
22391774|NCT01056263|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22391775|NCT04101565|Johns Hopkins Dept of Pediatrics / Division of Adolescent/Young Adult Medicine|Dr. Arik Marcell|4432878946|amarcell@jhu.edu|
22391776|NCT04461158|Medical University of South Carolina|Dr. Jim C. Oates, MD, Rheumatology Division Director|843-792-1991|oatesjc@musc.edu|
22391777|NCT03375320|Dana-Farber Cancer Institute|Jennifer A. Chan, MD, MPH|617-632-6315|jang@partners.org|
22391778|NCT03172975|George Washington University|David J. Diemert, MD|202-994-2909|ddiemert@gwu.edu|
22391779|NCT04556305|University of Illinois Chicago|Dr. Shannon Halloway|(312) 996-7800|sthallow@uic.edu|
22391780|NCT04907357|Medical University of South Carolina|Kathleen Brady, MD, PhD|843-792-5205|bradyk@musc.edu|
22391781|NCT00365547|Masonic Cancer Center, University of Minnesota|Arkadiusz Dudek, M.D.|612-624-0123|dudek002@umn.edu|
22391782|NCT00546078|GlaxoSmithKline|GSK Response Center|866-435-7343||
22391783|NCT03512197|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22391784|NCT01806389|Johns Hopkins University School of Medicine|Dr. Lauren Jansson|410-550-5438|ljansson@jhmi.edu|
22391785|NCT02121912|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 09 574 0123|CPAPtrial@fphcare.co.nz|
22391786|NCT02923193|Shockwave Medical|Birgit Greschner|650-575-6199|bgreschner@shockwavemedical.com|
22391787|NCT03358238|University of Wisconsin-Madison|Amy Cochran|608-262-0772|cochran4@wisc.edu|
22391788|NCT02633397|Dean, University of Maryland School of Medicine, Vice President for Medical Affairs, University of Maryland, Baltimore|Mark Gladwin|410-706-7410|mgladwin@som.umaryland.edu|
22391789|NCT03595878|University of North Carolina Lineberger Comprehensive Cancer Center|Colette Shen|+1 984-974-0400|cjshen@email.unc.edu|
22391790|NCT03036124|AstraZeneca|AstraZeneca Clinical Study Information Center|+1-877-240-9479|information.center@astrazeneca.com|
22391791|NCT02774668|University of Missouri|Elizabeth Parks, Professor of Nutrition and Exercise Physiology|573-882-5864|parksej@missouri.edu|
22391792|NCT05752474|Hebrew Rehabilitation Center, Hebrew SeniorLife|Dae Hyun Kim|6179715362|daehyunkim@hsl.harvard.edu|
22391793|NCT00551746|Intermountain Healthcare|Benjamin D Horne, PhD, MPH|801-507-4708|Benjamin.Horne@imail.org|
22391794|NCT05454813|Medline Industries, L:P|Julie Miller|630-418-6891|jamiller@medline.com|
22391795|NCT04949802|ViaLase Inc.|Melvin Sarayba, MD|9494662856|melvin.sarayba@vialase.com|
22391796|NCT03778294|Mayo Clinic|Dr Sujay Vora|480-342-1262|Vora.Sujay@mayo.edu|
22391797|NCT01845805|Sidney Kimmel Cancer Center at Johns Hopkins|Nilofer Azad, MD|410-614-9169|nazad2@jhmi.edu|
22391798|NCT00127842|Amgen Inc.|Study Director|866-572-6436||
22391799|NCT01515943|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
22391800|NCT03595124|Children's Oncology Group|Results Reporting Coordinator|6262411500|resultsreportingcoordinator@childrensoncologygroup.org|
22391801|NCT02113124|The Transitional Learning Center at Galveston|Dr. Brent Masel|409-762-6661|bmasel@tlcgalveston.org|411
22391802|NCT01439867|Amgen Inc.|Study Director|866-572-6436||
22391803|NCT01888874|Galapagos N.V.|Clinical Trial Information Desk|+32 (0)15 342 900|rd@glpg.com|
22391804|NCT02763215|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22406321|NCT00959699|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22406322|NCT03924427|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22406323|NCT02858713|Department of Dermatology, Odense University Hospital|M.D. Mathias Tiedemann Svendsen|+45 61265827|m_tiedemann@hotmail.dk|
22406324|NCT00609167|Mayo Clinic|Dr. A. Keith Stewart||stewart.keith@mayo.edu|
22391805|NCT00769600|MSKCCC|Charles Rudin, MD|646-888-4336|rudinc@mskcc.edu|
22391806|NCT01020877|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22417717|NCT01615263|Institut universitaire de cardiologie et de pneumologie de Québec, Laval University|Dr Jean S. Bussières, anesthesiologist, director of research|418 656-4870|jbuss@criucpq.ulaval.ca|
22391807|NCT02277054|Filatov Institite of Eye Diseases and Tissue Therapy of the NAMS of Ukraine|Dr. Oleksiy Buznyk|+380487181548|a_buznik@bk.ru|
22391808|NCT02963090|Duke Cancer Institute|Thomas Stinchcombe, MD|(919) 668-6688|thomas.stinchcombe@duke.edu|
22391809|NCT01784523|Hospital for Special Surgery|Doruk Erkan, MD|212 774-2291|erkand@hss.edu|
22391810|NCT00709228|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22391811|NCT02179177|Duke University|Nirmish Shah, MD|919-668-5178|nirmish.shah@duke.edu|
22391812|NCT00022659|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22391813|NCT00884650|Children's Hospital Colorado|Dr. Frank Chang|720-777-6900|Chang.Frank@tchden.org|
22391814|NCT04334278|University of Kentucky|Caitlin Conley|8592571939|caitlin.conley2@uky.edu|
22391815|NCT01516749|University of California, San Francisco|Kieron S. Leslie, MD|415-206-4777|lesliek@derm.ucsf.edu|
22391816|NCT00566540|The Ohio State University Comprehensive Cancer Center|Enzer Ozer, MD|614-293-8074|enver.ozer@osumc.edu|
22391817|NCT01100606|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
22391818|NCT01415934|University of Colorado|Carrie Brill|303 808 9708|CARRIE.BRILL@UCDENVER.EDU|
22391819|NCT01908751|McMaster University|Dr. Mohit Bhandari|9055274322|bhandam@mcmaster.ca|
22391820|NCT02196077|Pearl Therapeutics Inc.|Paul Dorinsky, MD, FCCP|650-305-2600|pdorinsky@pearltherapeutics.com|
22391821|NCT00732992|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22391822|NCT02977286|Tufts Medical Center|Erik Garpestad, M.D.|617-636-5388|egarpestad@tuftsmedicalcenter.org|
22391823|NCT04042077|Menarini Ricerche S.p.A.|Corporate Director of Clinical Sciences|0555680|acapriati@menarini-ricerche.it|9990
22391824|NCT00786643|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
22391825|NCT04458818|Combined Military Hospital Kharian, Punjab Pakistan|Dr Muhammad Noman Karim|+923313358884|f9noman@gmail.com|
22391826|NCT01163474|Houston VA HSR&D|Donna Smith/Project Coordinator|(713)440-4423|Donna.Smithd19d7@va.gov|
22391827|NCT02493946|Ipsen|Medical Director, Neurology||clinical.trials@ipsen.com|
22391828|NCT04530604|University of Michigan|Principal Investigator, Dr. Greg Yanik|734 232-9335|gyanik@med.umich.edu|
22391829|NCT00965497|University of South Carolina School of Medicine|Meera Narasimhan, MD|803-434-1100|shardeman@uscmed.sc.edu|
22391830|NCT00794924|Kaplan-Harzfeld Geriatric Medical Center|Hilla Zaharoni|97288595350|hilla_z@clalit.org.il|
22391831|NCT01055704|Mayo Clinic|Dr Michael Camilleri|5072662305|camilleri.michael@mayo.edu|
22391832|NCT01294436|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
22391833|NCT02389764|UT MD Anderson Cancer Center|Ueno,Naoto,M.D., PH.D. / Breast Medical Oncology|713-792-2817|nueno@mdanderson.org|
22391834|NCT01584518|Creighton University|Dr Anjan Talukdar|402-280-3586|talukdar.anjan@gmail.com|
22391835|NCT00585078|Beth Israel Deaconess Medical Center Beth Israel Deaconess|Rebecca Miksad MD MPH|617.667.2100|rmiksad@bidmc.harvard.edu|
22391836|NCT04198571|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22391837|NCT01814072|Northwestern University Feinberg School of Medicine|Bonnie Spring, PhD, ABPP|312-908-2293|bspring@northwestern.edu|
22391838|NCT00383123|GlaxoSmithKline|GSK Response Center|866-435-7343||
22391839|NCT02781311|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22391840|NCT04115189|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22391841|NCT02562898|University of California, San Francisco|Dr. Margaret Tempero|415-353-7528|Margaret.Tempero@ucsf.edu|
22417718|NCT04982874|Pharma Metric Labs, Indonesia|Pharma Metric Labs|+62 21 4265310|nabila.sutanto@pharmametriclabs.com|
22417719|NCT01610453|Stavanger UH|Professor Torbjørn Moe Eggebø|+4792699433|tme@lyse.net|
22417720|NCT00436904|Mayo Clinic|Dr. Clive Zent|507-284-5362|zent.clive@mayo.edu|
22417721|NCT00988065|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22417722|NCT00985712|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22417723|NCT03736928|QMedAB|Clinical Project Manager|(817) 961-5000|aestheticclinicaltrials@galderma.com|
22417724|NCT03096847|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22417725|NCT00279955|Medtronic CRDM Clinical Research|CRDM Core Clinical|800-328-2518|medtroniccrmtrials@medtronic.com|
22417726|NCT00359632|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22417727|NCT02931045|1st Chair and Department of Cardiology, Medical University of Warsaw|Aleksandra Gasecka, MD, PhD|+48225991951|alesandra.gasecka@wum.edu.pl|
22431490|NCT00560508|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22431491|NCT01383005|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22391842|NCT01936467|Johns Hopkins Hospital|Dr. Mouen Khashab|443-287-1960|mkhasha1@jhmi.edu|
22391843|NCT00250432|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22391844|NCT01011868|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22391845|NCT04147858|Aptinyx|Aptinyx Clinical Development|847-871-0377|clinicalstudies@aptinyx.com|1
22391846|NCT02615938|LMU/ Haunersches Kinderspital|Prof. Matthias Griese|+498944000|matthias.griese@med.uni-muenchen.de|57870
22391847|NCT06173687|Cochlear Limited|PRS Specialist|+612 9428 6555|cltd-prs-admin@cochlear.com|
22391848|NCT04905849|UC San Francisco|Dr. Joaquin A. Anguera, Associate Professor|415 502 7322|joaquin.anguera@ucsf.edu|
22391849|NCT04121897|University of North Carolina at Chapel Hill|Dana McCarty, PT, DPT|919-843-8792|dana_mccarty@med.unc.edu|
22391850|NCT05010850|SafeHeal|Heather Cronin, VP Clinical Affairs|5184289593|hcronin@safeheal.com|
22391851|NCT02810873|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Mathew Thakur|215-503-7874|mathew.thakur@jefferson.edu|
22391852|NCT00838929|Thomas Jefferson University|Wenyin Shi, MD, PhD|215-955-4111|Wenyin.Shi.@jefferson.edu|
22391853|NCT04683510|University of Tennessee Health Science Center|Principle investigator|(901)448-2383|mmart126@uthsc.edu|
22391854|NCT03771638|Bridge HIV, San Francisco Department of Public Health|Dr. Susan Buchbinder|628.217.7479|susan.buchbinder@sfdph.org|
22391855|NCT05190770|Memorial Sloan Kettering Cancer Center|Dr. Alina Markova, MD|646-608-2342|markovaa@mskcc.org|
22391856|NCT01340014|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
22391857|NCT02884492|Columbia University Medical Center (Taub Institute)|William C. Kreisl, MD|212-305-9194|wck2107@cumc.columbia.edu|
22406325|NCT00712270|Kettering Health Network|Manager, Research Operations and Regulatory Compliance|937-395-8367|innovationcenter@ketteringhealth.org|
22406326|NCT03017040|Massachusetts General Hospital|Dr. Neal Chen|617-726-4700|nchen1@mgh.harvard.edu|
22406327|NCT04412668|aTyR Pharma|Study Director|858 731 8389|clinicaltrials@atyrpharma.com|
22406328|NCT05166603|US Department of Veterans Affairs|Dawn M. Bravata, MD|3179882676|dawn.bravata2@va.gov|
22406329|NCT03637959|Mayo Clinic|Shigao Chen, Ph.D.|507-284-3703|Chen.Shigao@mayo.edu|
22406330|NCT00366444|Xanodyne Pharmaceuticals, Inc.|Steve Boesing|1-877-926-6396|clinical-trials@xanodyne.com|
22406331|NCT03979495|Massachusetts General Hospital|Dr. Jennifer Haas|617-724-1832|jhaas@mgh.harvard.edu|
22406332|NCT03763942|Emory University|Dr. Jeb Jones|404-712-2275|jeb.jones@emory.edu|
22406333|NCT02200510|CincinnatiChildrens|Lori Crosby|5136365380|lori.crosby@cchmc.org|
22406334|NCT03057106|Canadian Cancer Trials Group|Dr. Keyue Ding|1-613-533-6430|kding@ctg.queensu.ca|77705
22406335|NCT04969900|Principal Investigator|Dr. Leanne Free|303-724-8576|leanne.free@cuanschutz.edu|
22406336|NCT02881151|Stanford University School of Medicine|Dr. Jaimie Henderson|+1 (650) 723-5574|henderj@stanford.edu|
22406337|NCT00732654|Johns Hopkins University|Corinne Keet|4109555883|pediatricallergy@jhmi.edu|
22406338|NCT04284787|Yale School of Medicine|Amer Zeidan, MBBS Professor of Internal Medicine (Hematology)|(203) 200-4363|amer.zeidan@yale.edu|
22406339|NCT04574570|IRCCS Istituto Ortopedico Rizzoli|Dr Stefano Zaffagnini|+3905163665706366111|stefano.zaffagnini@unibo.it|
22406340|NCT00610714|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22406341|NCT01108263|Georgetown University|Dr. John Steinberg, Principal Investigator|202-444-0793|zr40@georgetown.edu|
22406342|NCT00576147|Baylor College of Medicine|Claudia Robertson|(713) 798-8932|claudiar@bcm.edu|
22406343|NCT02974621|Massachusetts General Hospital|Isabel Arillaga-Romany, MD PhD|877-442-3324|iarrillaga@mgh.harvard.edu|
22406344|NCT02559115|Memorial Sloan Kettering Cancer Center|Dr. Hebert A. Vargas Alvarez , MD|646-888-5410|vargasah@mskcc.org|
22406345|NCT04288089|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22406346|NCT02354690|National Center for Cancer Immune Therapy|Inge Marie Svane|0045386889339|inge.marie.svane@regionh.dk|
22406347|NCT05064007|Johns Hopkins University|Dr. Junxin Li|4105022608|junxin.li@jhu.edu|
22406348|NCT04556175|Northern Arizona University|Dr Julie Baldwin|928-523-6566|Julie.Baldwin@nau.edu|
22406349|NCT05549505|Arvinas Estrogen Receptor, Inc|Arvinas Estrogen Receptor, Inc.|475-345-3366|clinicaltrialsARV-471@arvinas.com|
22406350|NCT06408818|innovation Research and Training|Dr. Tracy Scull|9194937700|tscull@irtinc.us|
22406351|NCT00592072|Yale School of Medicine|Dr Robert Sherwin|203-785-6222|robert.sherwin@yale.edu|
22406352|NCT00403390|Children's Hospital Boston|Jeremi Carswell, MD|617-355-7476|Jeremi.Carswell@childrens.harvard.edu|
22406353|NCT01796106|DMG Dental Material Gesellschaft mbH|Manager Clinical Research|04084006|clinicalresearch@mtcompanies.com|232
22406354|NCT04430036|University of Texas Health Science Center at San Antonio|Robert Svatek, MD|210-567-5643|svatek@uthscsa.edu|
22406355|NCT01842334|Beth Israel Deaconess Medical Center|Dr. Kevin P Hill, Director of the Division of Addiction Psychiatry|617-667-1504|khill1@bidmc.harvard.edu|
22406356|NCT02268942|Medtronic Cardiac Rhythm and Heart Failure|Mary Jacoski|+15087390909|mary.v.jacoski@medtronic.com|
22406357|NCT01833026|University of Illinois at Chicago|Min Joo|3129968039||
22406358|NCT00995215|MetroHealth Medical Center|Dr. Anthony Dimarco|216-778-3906|adimarco@metrohealth.org|
22406359|NCT01332851|Family and Child Nursing, University of Washington|Dr. Monica Oxford|206-685-6107|mloxford@uw.edu|
22406360|NCT01302691|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22406361|NCT03446612|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22406362|NCT02901080|Electromedical Products International, Inc.|Science and Education Director|8174583295|josh@epii.com|
22406363|NCT01249157|Memorial Sloan Kettering|Dr. Maxine Jochelson|646-888-4507|JochelsM@mskcc.org|
22406364|NCT03796195|Northwestern University|David Walega, MD|3126952500|d-walega@northwestern.edu|
22406365|NCT04445051|Coloplast A/S|Vice President, Medical Affairs|+4549111111|clinical-studies@coloplast.com|
22406366|NCT03296280|South Texas Veterans Health Care System / UT Health San Antonio|Nilam Soni|210-949-9454|sonin@uthscsa.edu|
22406367|NCT02392468|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22406368|NCT01039428|KDL|Study Director|818058844243|toiawase@advance-cro.co.jp|
22406369|NCT01313039|University of Miami Sylvester Comprehensive Cancer Center|Judith Hurley MD|305-243-6462|JHurley@med.miami.edu|
22406370|NCT03630016|Owlet Baby Care, Inc.|Madison Kenley, CCRP, BS|801-552-8383|mkenley@owletcare.com|
22406371|NCT05083949|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22406372|NCT01678560|Yale University|Meir Kryger, MD|203-815-0914|meir.kryger@yale.edu|
22406373|NCT02201472|Cincinnati Children's Hospital|Dr. Stephanie Merhar|513-803-5180|stephanie.merhar@cchmc.org|
22406374|NCT02470429|Alcon, A Novartis Division|WW Medical Affairs Director, GMA Ophthalmics|1-888-451-3937|alcon.medinfo@alcon.com|
22406375|NCT01300767|Alcon Research|Director of Clinical Trials|1-800-241-7629||
22406376|NCT01602744|Tel Aviv University|Dvora Frankenthal|0097235326835|shai_f@zahav.net.il|
22406377|NCT00606294|Memorial Sloan Kettering Cancer Center|Dr. Nancy Lee, MD|212-639-3341|leen2@mskcc.org|
22406378|NCT01976624|Allergan, Inc|Vice President GSE,|714-246-4500|clinicaltrials@allergan.com|
22406379|NCT01885104|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22406380|NCT03887286|University of Miami|Mary Sokoloski|305 585-6683|msokoloski@med.miami.edu|
22406381|NCT00126425|GE Healthcare|Jose M Zubeldia, M.D.|011-44-1494-543137|jose.zubeldia@ge.com|
22406382|NCT01316380|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22406383|NCT01894776|Ottawa Hospital Research Institute|Dr. Bill Cameron|613-737-8899|bcameron@toh.ca|78923
22406384|NCT01895634|Johnson & Johnson K.K. Medical Company|Depertment Chief, Clinical Operation|+81-3-4411-6789|yikeda5@its.jnj.com|
22406385|NCT00471315|Medical University of South Carolina|Peter Cotton, MD|(843) 792-6999|CottonP@MUSC.edu|
22406386|NCT00108277|VA Palo Alto Health Care System / Stanford University School of Medicine|Walton T. Roth, M.D.|650-493-5000|wtroth@stanford.edu|65243
22406387|NCT02574520|Durect Corporation|Deborah Scott|408-777-1417|deborah.scott@durect.com|
22406388|NCT00886691|NRG Oncology|Linda Gedeon for Michael Sill, PhD.|716-845-1169|lgedeon@gogstats.org|
22406389|NCT01365091|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22406390|NCT03398824|Boston Children's Hospital|Akiko Shimamura|617-919-6946|akiko.shimamura@childrens.harvard.edu|
22406391|NCT05307523|University of Washington|Reham A. Abuatiq, Research coordinator and a PhD candidate|6198309638|rabuat@uw.edu|
22406392|NCT00392951|Children's Hospital of Philadelphia|David T. Teachey, MD|267-426-5802|teacheyd@email.chop.edu|
22406393|NCT05116683|Columbia University|Benjamin Izar, MD|212-304-5871|bi2175@cumc.columbia.edu|
22406394|NCT03298048|UTexas_Houston|Dr. Herbert DuPont|713-500-9366|herbert.l.dupont@uth.tmc.edu|
22406395|NCT03935594|Vanderbilt university medical center|Dr. Salam AlKassis|(615)322-2350|salam.al.kassis@vumc.org|
22406396|NCT01435122|H. Lee Moffitt Cancer Center and Research Institute|Dr. Jonathan R. Strosberg|813-745-3636|jonathan.strosberg@moffitt.org|
22406397|NCT03864627|Galapagos NV|Galapagos Medical Information|+32 15 342900|medicalinfo@glpg.com|
22406398|NCT01388491|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22406399|NCT00112840|University of Miami - Sylvester Comprehensive Cancer Center|Jaime Merchan, M.D.||jmerchan2@med.miami.edu|
22406400|NCT02875366|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22406401|NCT00683774|Virginia Commonwealth University|Dr. John Nestler|804-828-3389|jnestler@mcvh-vcu.edu|
22406402|NCT03595176|Shockwave Medical|Randee Randoll|408.577.7856|rrandoll@shockwavemedical.com|
22406403|NCT00514592|Umeå University|Dr Elias Johansson|+46907850000|elias.johansson@neuro.umu.se|
22406404|NCT02735044|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22406405|NCT02308709|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
22406406|NCT00412113|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22406407|NCT00360672|UT MD Anderson Cancer Center|Gautam Borthakur, M.D./Associate Professor|713-563-1586|eharriso@mdanderson.org|
22406408|NCT01747447|Brigham and Women's Hospital|Meryl S LeBoff, M.D.|1-800-388-3963|vitalstudy@partners.org|
22406409|NCT01592773|Forest Research Institute|Joel Trugman, MD|201-427-8681|Joel.Trugman@frx.com|
22391858|NCT02706249|Beth Israel Deaconess Medical Center, Harvard Medical School|Jeffrey Zwicker, Division of Thrombosis and Haemostasis, Division of Hematology and Oncology|617.667.9299|jzwicker@bidmc.harvard.edu|
22391859|NCT05101993|AtriCure|Randall Lee, VP Medical Affairs, Clinical Affairs|650-347-0419|RLee@atricure.com|
22391860|NCT04577573|James J. Peters VA Medical Center|Noam Y. Harel, MD, PhD|718-584-9000|noam.harel@va.gov|1742
22391861|NCT01667926|Massachusetts General Hospital|Dr. Cristina Cusin|6177263855|ccusin@mgh.harvard.edu|
22391862|NCT05302440|University of Hong Kong|Dr. Derek Yee Tak CHEUNG|3917 6652|derekcheung@hku.hk|
22391863|NCT02870972|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
22391864|NCT02878603|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22391865|NCT02689453|National Cancer Institute|Dr. Kevin Conlon|240-858-3570|conlonkc@mail.nih.gov|
22417728|NCT03978091|ARLG - Albany College of Pharmacy and Health Sciences|Thomas Lodise, PharmD, PhD|1 (518) 694-7292|Thomas.Lodise@acphs.edu|
22391866|NCT00953615|Mayo Clinic|Keith D. Lindor, M.D.|507-284-2969|lindor.keith@mayo.edu|
22391867|NCT03274895|SIFI SpA|Dr. Jelle Kleijn|+31615643708|jelle.kleijn@sifigroup.com|
22391868|NCT01969851|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22391869|NCT01754753|The University of Sheffield|Daniel Hind - Assistant Director Sheffield Clinical Trials Research Unit|441142220707|d.hind@sheffield.ac.uk|
22391870|NCT03229486|Pusan National University Yangsan Hospital|Professor|0553602756|anesktk@pusan.ac.kr|
22391871|NCT00856245|University of Kansas Cancer Center|Siddhartha Ganguly, MD|(913) 588-6030|sganguly@kumc.edu|
22391872|NCT01774045|Taipei Veterans General Hospital|Dr. Cheng-Ta Li|886-2-2871-2121|on5083@msn.com|7027
22391873|NCT02332902|The University of Texas Health Science Center at Houston|Dr. Mary Kay Koenig||Mary.K.Koenig@uth.tmc.edu|
22391874|NCT01782690|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22391875|NCT03981939|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22391876|NCT02037620|University of Louisville|Dr. Susan Harkema|502-581-8675|susan.harkema@louisville.edu|
22391877|NCT01267240|Princess Margaret Cancer Centre|Dr.Eric Chen, Principal Investigator|416-946-4501|eric.chen@uhn.ca|2263
22391878|NCT01637077|Mayo Clinic|Charles L. Loprinzi, M.D.|507/284-1623|loprinzi.charles@mayo.edu|
22391879|NCT02638103|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22391880|NCT02353312|Providence VA Medical Center|Wen-Chih Wu, MD|4012737100|wen-chih.wu@va.gov|16237
22391881|NCT04199052|University of California San Diego|Dr. Jamila K. Stockman, Professor|(858) 822-4652|jstockman@health.ucsd.edu|
22391882|NCT00699842|Thomas Jefferson University|Emmanuel Besa, MD|215-955-8874|Emmanuel.Besa@jefferson.edu|
22391883|NCT01358331|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure||ClinicalTrialsDisclosure@merck.com|
22391884|NCT04946942|Weill Medical College of Cornell University|Catherine Riffin, PhD|(203) 303-4904|acr2213@med.cornell.edu|
22391885|NCT03342196|University Hospitals, Case Comprehensive Cancer Center|Principle Investigator|216-844-0139|Leland.Metheny@uhhospitals.org|
22391886|NCT02257918|Louisiana State University Health Sciences Center|Stephanie N. Taylor, MD|(504) 658-2622|staylo2@lsuhsc.edu|
22391887|NCT02325830|Cardiac Dimensions|Vice President of Clinica Affairs|425-605-5922|aswenson@cardiacdimensions.com|
22391888|NCT03023423|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22391889|NCT01151423|Ablynx|Medical Monitor|+32 (9) 262 00 00|clinicaltrials@ablynx.com|
22391890|NCT01263054|Halyard Health, Inc.|Mark Lavigne|508-837-1427|mark.lavigne@hyh.com|
22391891|NCT00681668|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22391892|NCT01654068|University of Kentucky|Ronal McGarry|859-323-6486|rcmcga2@email.uky.edu|
22391893|NCT01227616|AMAG Pharmaceuticals|Medical Information||CTInterest@covispharma.com|
22391894|NCT04277507|Aerin Medical|Director of Clinical Operations|650-518-9624|alaborde@aerinmedical.com|
22391895|NCT00920647|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22391896|NCT00569192|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
22391897|NCT00691600|Baylor College of Medicine|Andrea T. Cruz, MD, MPH|832-824-5582|acruz@bcm.edu|
22391898|NCT00583947|Sepracor Inc|Respiratory Medical Director|866-503-6351||
22391899|NCT02314689|University of Mississippi Medical Center|Suvankar Majumdar MD|6019845220|smajumdar@umc.edu|
22391900|NCT01740154|Case Comprehensive Cancer Center|Dr. Brian Rini|216-444-9567|rinib2@ccf.org|
22391901|NCT05723263|University of North Carolina at Chapel Hill|Joseph Tucker, MD, PhD|919-966-2536|jdtucker@med.unc.edu|
22391902|NCT03358472|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
22391903|NCT03811002|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22391904|NCT05853900|Click Therapeutics|Clinical Development|347-460-8607|click_ct_contact@clicktherapeutics.com|
22391905|NCT02520310|Abbott Structural Heart|Sripad Bellary|650-353-1726|sripad.bellary@abbott.com|
22391906|NCT05032066|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22391907|NCT05564637|Mayo Clinic|Yogesh Reddy, M.B.B.S.|507-284-2904|reddy.yogesh@mayo.edu|
22391908|NCT01124838|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22406410|NCT00740116|Department of Obstetrics and Gynaecology, and Department of Clinical and Experimental Medicine, Linköpings universitet (LIU), Sweden|Professor Dr. Preben Kjölhede|+4638231188|preben.kjolhede@liu.se|
22406411|NCT00621764|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22406412|NCT02499172|Johns Hopkins Bloomberg School of Public Health|Dr. Mohammad Ali|410-502-3154|mali25@jhu.edu|
22406413|NCT01293123|University of California, San Diego|Scott Letendre, Principal Investigator|6195438080|sletendre@ucsd.edu|
22406414|NCT00121485|Thoratec Corporation|Poornima Sood, MD, MBA, Sr. Director, Clinical Affairs|781 852 8334|psood@thoratec.com|
22406415|NCT01111331|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22406416|NCT04495673|University of Minnesota|Kelvin Lim|(612) 626-6772|kolim@umn.edu|
22406417|NCT02386605|Greater Los Angeles VA Healthcare System|Dr. Felice Reddy|3104783711|felice.reddy@gmail.com|
22406418|NCT01842282|University of Michigan|Elif Oral|734-615-7271|eliforal@med.umich.edu|
22406419|NCT03738878|Yale University|Nancy J. Brown|2037854672|nancy.j.brown@yale.edu|
22406420|NCT01888965|Georgetown Lombardi Comprehensive Cancer Center|John L Marshall|202 444 7064|marshalj@georgetown.edu|
22406421|NCT04076579|University of Michigan Rogel Cancer Center|Clinical Trials Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
22406422|NCT00186121|Stanford University Medical Center|Melinda Telli, MD|650-724-9533|mtelli@stanford.edu|
22406423|NCT03650387|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|Aesthetic.Trials@merz.com|
22406424|NCT00417248|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
22406425|NCT05815758|Bausch & Lomb|Daniel Donatello|5853385306|Daniel.Donatello@bausch.com|
22406426|NCT03661983|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22406427|NCT02903966|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22406428|NCT00934791|Mayo Clinic|Dr. Patrick G. Dean|507-266-6953|dean.patrick2@mayo.edu|
22406429|NCT02353806|University of Texas Southwestern Medical Center|Jamie Morgan, MD|214-645-3838|jamie.morgan@utsouthwestern.edu|2147665011
22406430|NCT01320033|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
22406431|NCT02425891|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22406432|NCT00963469|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22406433|NCT00782756|Memorial Sloan Kettering Cancer Center|Dr. Philip Gutin|212-639-8556|gutinp@mskcc.org|
22406434|NCT00585104|University of Utah Health Sciences Center|Andrew D. Michaels, MD|(801) 585-5971|Andrew.Michaels@hsc.utah.edu|
22406435|NCT04124952|SightTrust Eye Institute|Andrew Shatz, MD|877.878.7890|ashatz@sighttrust.com|
22406436|NCT02145429|University of Pittsburgh|Charles F. Reynolds, MD|(412) 246-6414|reynoldscf@upmc.edu|
22431492|NCT00845702|Guerbet|Pierre Desche, MD, Head of Clinical and Regulatory Affairs|+33 1 45 91 50 00|pierre.desche@guerbet-group.com|
22431493|NCT00030264|Children's Hospital of Philadelphia|Ratnakar Patti|267-426-5503||
22391909|NCT02065882|Biotest AG|Dr. Christina Erb|00496103801|christina.erb@biotest.com|0
22391910|NCT06719986|Purdue Pharma|Clinical Leader|1-888-726-7535|Purduemedinfo@pharma.com|
22431494|NCT01822925|NeuroBo Pharmaceuticals, Inc.|Vice President Clinical Operations|617-313-7331|nikki.shannon@neurobopharma.com|
22431495|NCT03847519|Advaxis, Inc.|Sumitra Sheeri|609-423-2528|sheeri@advaxis.com|
22431496|NCT01650402|UConn Health|William White, MD|860-679-4556|wwhite@uchc.edu|
22431497|NCT01416025|JohnHopkinsU|Dr. Darin Ostrander|(443) 287-6217|dostrander@jhu.edu|
22406437|NCT02943577|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
22431498|NCT02300233|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
22391911|NCT04581343|PanCAN|Samantha Pedersen, Sr. Director Clinical Operations|310.706.3726|spedersen@pancan.org|
22406438|NCT01355224|Boston University School of Public Health|Dr. Catharine Wang|617-638-5187|clwang@bu.edu|
22406439|NCT03991936|Weill Cornell Medicine|Dr. Shari Lipner|6469623376|shl9032@med.cornell.edu|
22391912|NCT03213704|Children's Oncology Group|Results Reporting Coordinator|(626) 241-1500|resultsreportingcoordinator@childrensoncologygroup.org|
22431499|NCT00833690|The Parkinson Study Group|Michael A. Schwarzschild, MD, PhD|617-724-9611|mschwarzschild@partners.org|
22406440|NCT00939055|EndoGastric Solutions|Senior Director Clinical Affairs|650-823-9093|gsahyun@endogastricsolutions.com|
22406441|NCT03139435|Wake Forest Baptist Comprehensive Cancer Center|Roy Strowd|336-713-5440|rstrowd@wakehealth.edu|
22406442|NCT00584987|The University of Chicago|Dr. Robert M. Naclerio, MD|(773) 702-1865|rnacleri@surgery.bsd.uchicago.edu|
22406443|NCT03502941|University of Arkansas for Medical Sciences|David D.Church, Ph.D.|5015265709|dchurch@uams.edu|
22406444|NCT01944462|Thomas Jefferson University|Laura T. Pizzi, PharmD, MPH; Principal Investigator|215-955-1159|laura.pizzi@rutgers.edu|
22406445|NCT00808028|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22406446|NCT01866839|National Heart Lung and Blood Institute|Aue, Georg|+1 301 451 7141|aueg@nhlbi.nih.gov|
22406447|NCT01599585|National Center for Telehealth and Technology|Larry D. Pruitt, PhD|253-968-2946|larry.d.pruitt21.civ@mail.mil|
22406448|NCT00081263|NRG Oncology|Linda Gedeon for Michael Sill, PhD|716-845-1169|lgedeon@gogstats.org|
22406449|NCT01852591|H. Lee Moffitt Cancer Center and Research Institute|Frederick Locke, M.D.|813-745-3509|frederick.locke@moffitt.org|
22406450|NCT05706623|VectivBio AG|Clinical Trial Information Desk|617.621.7722|ClinicalTrialEnquiries@ironwoodpharma.com|
22406451|NCT02912572|Dana-Farber Cancer Institute|Dr. Panagiotis Konstantinopoulos|617-632-5269|Panagiotis_Konstantinopoulos@dfci.harvard.edu|
22406452|NCT01267955|Institut Bergonie|Pr Italiano Antoine, Department of Medical Oncology|0524071947|a.italiano@bordeaux.unicancer.fr|
22406453|NCT03070119|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22406454|NCT01996865|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22406455|NCT04571684|University of Kansas Medical Center|Principal Investigator|913-945-7709|skessler2@kumc.edu|
22406456|NCT05304611|National Institute of Allergy and Infectious Diseases (NIAID)|Dr. Peter Crompton|301-761-5042|pcrompton@niaid.nih.gov|
22406457|NCT00963820|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22406458|NCT00557362|University of California San Francisco Proctor Foundation|Tom M/ Lietman|4155022662|tom.lietman@ucsf.edu|
22406459|NCT04430894|Dana-Farber Cancer Institute|Elizabeth K. O'Donnell, MD|617-632-3000|Elizabeth_ODonnell@DFCI.HARVARD.EDU|
22406460|NCT02756845|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22406461|NCT05333289|ModernaTX, Inc|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
22406462|NCT02005211|AstraZeneca|Vice President, Neuroscience iMed||ClinicalTrialTransparency@astrazeneca.com|
22406463|NCT01917136|University of Pennsylvania|Dr. Yuchi Han|215-662-2855|yuchi.han@uphs.upenn.edu|
22406464|NCT00397631|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22406465|NCT02202161|GlaxoSmithKline|GSK Response Center|866-435-7343||
22406466|NCT02618512|Alexion|Alexion Medical Monitor|617-613-1071|Bert.Yao@alexion.com|
22406467|NCT03797144|Medtronic|Clinical Research Specialist|+39 3450225929|francesca.molineris@medtronic.com|
22406468|NCT02661256|NYU-Winthrop Hospital|Nazeeh Hanna, MD|6314211424|nazeehhanna@gmail.com|
22406469|NCT01878175|Durham VA Medical Center|Kelli Allen|919-286-0411|kelli.allen@va.gov|7090
22406470|NCT02092168|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22406471|NCT00195624|National Heart Lung and Blood Institute|Young, Neal|+1 301 496 5093|youngns@mail.nih.gov|
22406472|NCT01201967|Massachusetts General Hospital|Jeff C. Huffman, MD|6177242910|jhuffman@partners.org|
22406473|NCT02497287|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22406474|NCT01226472|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
22406475|NCT01425307|The University of Texas School of Public Health|Barry Robert Davis|713-500-9515|barry.r.davis@uth.tmc.edu|
22406476|NCT03128307|Zyppah|Jonathan Greenburg, DDS|(818) 414- 4817|jgreenburg@outlook.com|
22406477|NCT00758576|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22406478|NCT03109418|University of Alabama at Birmingham|Adam Sturdivant|205-934-4042|Adamsturdivant@uabmc.edu|
22406479|NCT02972658|AstraZeneca|AstraZeneca Information Center|877-240-9479|information.center@astrazeneca.com|
22406480|NCT01054339|Applied Genetic Technologies Corp.|Ellery D. Mangas|386-462-7106|emangas@agtc.com|
22406481|NCT02785588|GE Healthcare|Yvonne Celestial|+33 130709133|MarieYvonne.CELESTIAL@ge.com|
22417729|NCT02324673|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com|
22417730|NCT02477774|University of California, San Francisco|Rahul Seth, MD|415-353-9500|Rahul.Seth@ucsf.edu|
22417731|NCT02214420|Scripps Clinic|Dr. Paul Pockros|(858) 554-8879|Pockros.paul@scrippshealth.org|
22417732|NCT04700280|Galapagos NV|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
22417733|NCT01843348|Novartis Pharmaceuticals|Study Director|862-779-8300||
22417734|NCT02093221|Grifols Therapeutics LLC|Kimberly Steinmann, MD|919-308-5444|kimberly.steinmann@grifols.com|
22417735|NCT00257920|Abbott|Medical Information Specialist|1-800-633-9110||
22417736|NCT00770692|Eisai Co., Ltd.|Atsushi Kamijo, Study Director|+81-3-3817-5245|a-kamijo@hhc.eisai.co.jp|
22417737|NCT01230892|Emory University|Dr. Habib Samady|404-778-5299|hsamady@emory.edu|
22417738|NCT00725621|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22417739|NCT01189500|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22417740|NCT00062751|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22417741|NCT01000493|GlaxoSmithKline|GSK Response Center|866-435-7343||
22417742|NCT04764630|U.S. Food and Drug Administration|David Strauss, MD, PhD|301-796-6323|David.Strauss@fda.hhs.gov|
22417743|NCT03323723|Rinovum Subsidiary 2, LLC.|Clinical Development Manager|7242418932|hwhitelam@rinovum.com|
22417744|NCT00673933|Dermatology Institute|Dr Ashish Bhatia|630-942-5040|acbhatia@gmail.com|
22417745|NCT02206620|Oregon Health & Science University|Dr. Martina Mancini|5034182602|mancinim@ohsu.edu|
22417746|NCT05816200|Federal University of Rio Grande do Norte|PhD Cristianne Kalinne Santos Medeiros|+55(84)3342-2341|cristiannekalinne@gmail.com|
22417747|NCT02394730|University of New South Wales|Sean Emery, Chief Principal Investigator|+61 2 9385 0897|s.emery@unsw.edu.au|
22417748|NCT03295318|Serum Institute of India Pvt. Ltd.|Abhijeet Dharmadhikari|+91-20-26602855|abhijeet.dharmadhikari@seruminstitute.com|2855
22417749|NCT03747601|BIDMC|Daniel Press, MD Chief of Cognitive Neurology Unit|617-667-4074|dpress@bidmc.harvard.edu|
22417750|NCT04319718|University of Pittsburgh|Dr. Leslie Meyn, Research Assistant Professor|412-641-4233|meynla@mwri.magee.edu|
22417751|NCT02221037|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22417752|NCT02664363|Duke University Medical Center|Principal Investigator|9196845301|dukebrain1@duke.edu|
22417753|NCT03955471|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22417754|NCT01030341|Johns Hopkins Data Coordinating Center|Mark Van Natta|410-614-1362|mvannat1@jhu.edu|
22417755|NCT01461226|University of Antwerp/Antwerp University Hospital|dr. Luc bruyndonckx|003238213000|luc.bruyndonckx@uza.be|
22417756|NCT02307266|Galderma|Gaëlle Charier|+33 4 93 95 70 68|gaelle.charier@galderma.com|
22417757|NCT00793780|Yale University|Erin Sullivan|+1 (203) 974-7317|erin.reutenauer@yale.edu|
22417758|NCT01032018|Columbia University Medical Center|Karina W Davidson, PhD|212-342-4493|kd2124@cumc.columbia.edu|
22417759|NCT00256984|Ethicon Endo-Surgery|Susan Knippenberg, Clinical Scientist|513 337-3452|sknippen@its.jnj.com|
22417760|NCT00858143|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22417761|NCT03882528|Walter Reed Army Institute of Research|Dr. James Moon, Principal Investigator|301-319-9176|James.e.moon.mil@mail.mil|
22417762|NCT01293539|Johns Hopkins|Monica Pearl, M.D.|410-955-8525|msmit135@jhmi.edu|
22417763|NCT00418301|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
22417764|NCT04032158|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@merckgroup.com|
22417765|NCT00059787|Montefiore Medical Center - New York Cancer Consortium|NYCC Regulatory Coordinator|718-379-6862|sforde@montefiore.org|
22417766|NCT01796912|Imperiwal College London|Dudley Pennell|+44 (0)20 3811 6871|d.pennell@imperial.ac.uk|
22417767|NCT01248013|Mind-Body Digestive Center|Charles D. Gerson, M.D.|212 496 6161|cgerson@yahoo.com|
22417768|NCT00725530|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22417769|NCT04325204|Emory University|Fayron Epps, PhD, RN|404-727-6936|fepps@emory.edu|
22417770|NCT00841906|Sleep Center of Greater Pittsburgh|Sukhdev Grover MD|412-681-7771|Info@SleepCenterOfGreaterPittsburgh.com|
22417771|NCT04710979|University of Minnesota|Dr. Daheia J. Barr-Anderson|240-475-2806|barra027@umn.edu|
22417772|NCT03426137|University of Maryland School of Nursing|Research Coordinator|410-706-5975|NRSCollocaLab@umaryland.edu|
22417773|NCT00394524|Emory University|Guillermo Umpierrez, MD|404-778-1665|geumpie@emory.edu|
22417774|NCT03827564|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
22417775|NCT02070302|Arizona Arthritis & Rheumatology Research, PLLC|Amanda Santimaw|4806266653|amanda.santimaw@azarthritis.com|
22417776|NCT00891371|Ipsen|Medical Director, Gastroenterology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22417777|NCT02238626|MediciNova, Inc.|Director, Scientific Affairs|8583444535|makhay@medicinova.com|
22417778|NCT02621034|Zahedan university of medical sciences|Seyed Roholla Havaei|+989215257093|marty_zl@yahoo.com|
22417779|NCT00971841|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22406482|NCT03037489|Medivir AB|Linda Basse, Cheif Medical Officer|+46 8 546 831 00|linda.basse@medivir.com|
22406483|NCT03031327|Dompé Farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22431500|NCT02115321|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22431501|NCT04403919|NYU Langone Health|Ran Schwarzkopf, MD|646-501-7070|Ran.Schwarzkopf@nyulangone.org|
22431502|NCT03605693|Center for Behavioral Cardiovascular Health, Columbia University Irving Medical Center|Dr. Ian Kronish|212-342-1335|ik2293@columbia.edu|
22431503|NCT04752566|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22431504|NCT05134649|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22431505|NCT04618276|University Hospital Zurich|PD Dr. med. Yvonne Achermann|+41 44 396 74 18|yvonne.achermann@usz.ch|
22431506|NCT04392154|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22431507|NCT01838226|Durham VAHCS HSR&D|Dr. David Edelman|919-286-6936|david.edelman@va.gov|
22431508|NCT00023595|Duke University Health System|Dr. Eric Velazquez|919-668-8700|velaz002@mc.duke.edu|
22431509|NCT04198012|DEKA Research|Regulatory Affairs Manager|603-669-6491|psmolenski@dekaresearch.com|
22431510|NCT04486677|VA San Diego|Dr. Emily Treichler|6192288075|emily.treichler@va.gov|
22431511|NCT00509288|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
22431512|NCT02106832|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22431513|NCT03815344|Maimonides Medical Center|Pedram Bral, MD|7182836000|pbral@maimonidesmed.org|
22431514|NCT02878785|University of Maryland Greenebaum Cancer Center|Maria Baer, M.D.|410-328-8708|mbaer@umm.edu|
22431515|NCT00608062|University of Colorado Anschutz Medical Campus|Dr. Kerrie Moreau. PI|303-724-1914|kerrie.moreau@cuanschutz.edu|
22431516|NCT05205616|University of Califronia, San Francisco|Sepehr Hashemi, DMD|4133674736|sepehr.hashemi@ucsf.edu|
22431517|NCT03648892|NIH|Dr. Kevin Hall|301-402-8248|kevinh@niddk.nih.gov|
22431518|NCT01467466|MAVERIC, VA Boston|Christopher Donnelly, Chief of Data Management|857-364-2332|christopher.donnelly2@va.gov|
22431519|NCT00787150|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22391913|NCT03660826|NRG Oncology|Helen Huang on behalf of Danielle Enserro, PhD.|(716) 845-1300|huangh@nrgoncology.org|2318
22391914|NCT03931746|Northwell Health Department of Dermatology|Sr. Clinical Data Analyst|516-321-8508|astrunk1@northwell.edu|
22391915|NCT01183390|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22391916|NCT03267810|University of Miami|Elizabeth Felix|305-243-4497|efelix@med.miami.edu|
22391917|NCT04057573|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22391918|NCT04991753|Janssen Research & Development|Medical Director Rheumatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22391919|NCT05609604|UBuffalo|Paresh Dandona|17168818924|ghanim@buffalo.edu|
22391920|NCT00233480|Ahmanson-UCLA Cardiomyopathy Center|Tamara B Horwich, MD|310-825-8676|thorwich@mednet.ucla.edu|
22391921|NCT01475305|Medimmune, LLC|Hasan Jafri, Medical Director|301-398-4431|jafrih@medimmune.com|
22391922|NCT03222505|Rehabilitation Institute of Chicago|Arun Jayaraman, PT, PhD; Director of Max Nader Lab for Rehabilitation Technologies and Outcomes|3122386875|ajayaraman@ricres.org|
22391923|NCT01484431|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22391924|NCT02224404|Universitair Ziekenhuis Gent|Dr. Hilde Beele|09/332 22 87|Hilde.Beele@uzgent.be|
22406484|NCT00669240|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22406485|NCT00908050|Baylor College of Medicine/Houston Methodist|William Ondo, MD|713-363-8390|wondo@houstonmethodist.org|
22406486|NCT01712776|Cleveland Clinic|Dr. Sharon E. Mace, Director of Research, ESI|(216) 445-4598|maces@ccf.org|
22406487|NCT01997892|Amgen Inc.|Study Director|866-572-6436||
22406488|NCT00364611|Sanofi-aventis|Trial Transparency Team||Contact-us@sanofi.com|
22406489|NCT02531633|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22406490|NCT01562379|Johns Hopkins Bloomberg School of Public Health|Parul Christian|1-410-955-1188|pchrist1@jhu.edu|
22406491|NCT01030757|University of New Mexico|Ben Liem, MD|505-272-0086|bliem@salud.unm.edu|
22406492|NCT02608099|Baim Institute for Clinical Research|Director of Trial Design and Development|617-307-5200|TrialDesignandDevelopmentStaff@baiminstitute.org|
22406493|NCT03770689|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22406494|NCT00087594|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22406495|NCT01952041|University of Washington School of Medicine|Dror Ben-Zeev, PhD|(206) 685-9655|dbenzeev@uw.edu|
22406496|NCT01736176|AbbVie|Global Medical Services|800-633-9110||
22406497|NCT01569568|Children's National Medical Center|Dr. Andrea Gropman|202-476-2120|agropman@childrensnational.org|
22406498|NCT03657576|The University of Alabama at Birmingham|James Markert, MD|2059347171|jmarkert@uabmc.edu|
22406499|NCT04437511|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22406500|NCT05032755|Duke University Medical Center|Maggie Sweitzer|919-668-0094|maggie.sweitzer@duke.edu|
22406501|NCT04228276|Palo Alto VA|Dr. Jong Yoon|6504935000|jong.yoon@va.gov|
22406502|NCT02498600|NRG Oncology|Linda Gedeon for Michael Sill, PhD.|716-845-1169|linda.gedeon@roswellpark.org|
22406503|NCT06085443|YSLAB|Mélody DUTOT|33 (0)2.98.53.30.03|melody.dutot@yslab.fr|
22406504|NCT03093350|Baylor College of Medicine|Shaun Bulsara|713-798-8014|sbulsara@bcm.edu|
22431520|NCT02268656|Gil hospital|Dr. Hyun Jeong Kwak|82324603636|hyun615@gilhospital.com|
22391925|NCT01251770|Hospital General de Niños Pedro de Elizalde|Dr Facundo Jorro Barón|00541143632100|jorrobox@yahoo.com.ar|2035
22431521|NCT01262105|Nimbic Systems|Sean Self|281-565-5700|self@nimbicsystems.com|
22431522|NCT00330733|Phoenix VA Health Care System|Peter Reaven|602 277 5551|Peter.Reaven@va.gov|5817
22431523|NCT02347410|Spineology|Rose Griffith, Sr. Director, Clinical Affairs|6512568503|Rgriffith@spineology.com|
22431524|NCT00982280|Grünenthal GmbH|Dr. Ilona Steigerwald|+49 241 569 0|Clinical-Trials@grunenthal.com|
22431525|NCT01890031|University of Rochester|Robert Block, MD, MPH; Clinical Trial Director|585-275-3356|robert_block@urmc.rochester.edu|
22431526|NCT01979185|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22431527|NCT01121757|Duke University Health Center|Anne Beaven, MD, Associate Professor|9196848964|anne.beaven@duke.edu|
22391926|NCT02514239|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22391927|NCT03299049|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22431528|NCT00085839|Astellas Pharma Global Development|Medical Monitor||clinicaltrials@us.astellas.com|
22431529|NCT03229057|University of Pennsylvania|Dr Anuja Dokras|215-615-0085|adokras@pennmedicine.upenn.edu|
22431530|NCT06028464|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22406505|NCT05085275|USRC Kidney Research|Stephanie Brillhart, Senior Director Regulatory Compliance|303-881-9451|stephanie.brillhart@usrenalcare.com|
22431531|NCT03636022|Minnesota HealthSolutions|Sara Seifert|6128036998|sara@minnhealth.com|
22391928|NCT01901419|Department of Anesthesiology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan|Dr. Tso-Chou Lin|+886-2-87927128|tclin@mail.ndmctsgh.edu.tw|
22406506|NCT01319045|UCLA|Jamil Aboulhosn|310-825-5950|jaboulhosn@mednet.ucla.edu|
22406507|NCT00777036|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22406508|NCT05564039|Eli Lilly and Company|Chief Medical Officer|08004595979|ClinicalTrials.gov@lilly.com|
22406509|NCT01263470|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
22391929|NCT04486625|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22406510|NCT01327573|Yale University|Dr. Sanjay Kulkarni|203-785-6501|sanjay.kulkarni@yale.edu|
22406511|NCT00729560|Virginia Commonwealth University|Dr. John Nestler|804-828-3389|jnestler@mcvh-vcu.edu|
22406512|NCT03662789|Oslo University Hospital|Dr. Lars Gullestad|0047 97644772|lars.gullestad@medisin.uio.no|
22406513|NCT02136134|Janssen R&D US|Director, Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22406514|NCT05245071|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
22406515|NCT04916314|University of Oxford|Dr Elizabeth Morris|01865617289|RESULT@phc.ox.ac.uk|
22406516|NCT03993119|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22406517|NCT01602822|Fenway Health|Dr. Kenneth Mayer|617-927-6400|kmayer@fenwayhealth.org|
22406518|NCT03288311|Vanderbilt University Medical Center|Jonathan Casey, Assistant Professor of Medicine|6158754681|Jonathan.d.Casey@vumc.org|
22406519|NCT00854061|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22406520|NCT00853112|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22406521|NCT01553591|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22406522|NCT02477800|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
22406523|NCT01550315|Vanderbilt Universtiy|Alfredo Gamboa|6158751003|alfredo.gamboa@vumc.org|
22406524|NCT04589832|Hoosier Cancer Research Network|Fauzia Sharmin|(317) 921-2050|fsharmin@hoosiercancer.org|
22406525|NCT00952133|NYU Langone Medical Center|Jeanna Blitz, MD|212-263|jeanna.viola@nyumc.org|0667
22406526|NCT03685643|University of Hong Kong|Dr Wong Chi Wai William|(852) 2518-5650|wongwcw@hku.hk|
22406527|NCT05393570|UTSW - O'Donnell School of Public Health|Sarah E. Messiah|(972) 546-2919|Sarah.Messiah@UTSouthwestern.edu|
22406528|NCT01937624|Steadman Hawkins Clinic of the Carolinas/Greenville Health System|Dr. Kyle Cassas|864-454-7422|kcassas@ghs.org|
22406529|NCT00423592|Gilead Sciences, Inc.|Annemarie Vance|650-524-3829|Annemarie.Vance@gilead.com|
22406530|NCT00062647|Theravance, Inc|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
22406531|NCT02005510|University of Washington|Dr. Rachel Winer|2066165081|rlw@uw.edu|
22406532|NCT00002981|Memorial Sloan Kettering Cancer Center|Dr. Steven Larson, MD|212-639-7373|LarsonS@MSKCC.ORG|
22406533|NCT00255008|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22406534|NCT01300949|Wills Eye Hospital|George L. Spaeth, MD|215-928-3123|gspaeth@willseye.org|
22406535|NCT00056550|GTC Biotherapeutics|Denise Tilton, RN, MHA, Director Clinical Development|508-370-5257|denise.tilton@gtc-bio.com|
22406536|NCT00322387|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22406537|NCT00707486|HemCon Medical Technologies|Staci McAdams|(503)245-0459|staci@hemcon.com|103
22406538|NCT03296072|GlaxoSmithKline|GSK Response Center|866-435-7343 Ext:|GSKClinicalSupportHD@gsk.com|
22406539|NCT02583360|The Research Institute at Nationwide Children's Hospital|Sudarshan Jadcherla MD|614-355-6433|sudarshan.jadcherla@nationwidechildrens.org|
22431532|NCT03330847|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22431533|NCT03532256|University of Pennsylvania|Mucio Delgado, MD, Principal Investigator|215-746-8256|mucio.delgado@pennmedicine.upenn.edu|
22391930|NCT01411241|Sanofi Pasteur|Director||Contact-US@sanofi.com|
22391931|NCT02980042|University of Colorado Anschutz, Neurology Department|Dr. Timothy Vollmer|3037242187|timothy.vollmer@ucdenver.edu|
22391932|NCT00725270|Stanford University|Alan Schatzberg|650-723-8331|afschatz@stanford.edu|
22391933|NCT02521363|Memorial Sloan Kettering Cancer Center|Dr. Tiffany Traina, MD|646-888-4558|trainat@MSKCC.ORG|
22391934|NCT00953771|Mount Sinai Beth Israel|Dr. Ilan Shapira|212-844-8948|Ilan.Shapira@mountsinai.org|
22391935|NCT00974259|University of Pennsylvania|Ramon Diaz-Arrastia|215-662-9732|Ramon.Diaz-Arrastia@uphs.upenn.edu|
22391936|NCT03991741|University of California, San Diego|Gregory Daniels, MD, PhD|(858) 822-5354|CancerCTO@health.ucsd.edu|
22406540|NCT02415595|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22391937|NCT06024278|Weill Cornell Medicine|Dr. Veerawat Phongtankuel|212-746-7000|vep9012@med.cornell.edu|
22391938|NCT00592293|Massachusetts General, Hospital|Torunn Yock, MD|6177262000|tyock@mgh.harvard.edu|
22391939|NCT01933243|Nationwide Children's Hospital|Andrea Bonny|614-722-2458|andrea.bonny@nationwidechildrens.org|
22406541|NCT01251315|Charles R Drew University of Medicine and Science|Dr .Naureen Tareen|323-568-3359|aaant@aol.com|
22406542|NCT00985140|Stanford University Cancer Center|Richard T. Hoppe, MD Henry S. Kaplan Harry Lebeson Professor of Cancer Biology|(650) 723-5510|hoppe@stanford.edu|
22406543|NCT01682759|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22406544|NCT03219476|Medical College of Wisconsin|Lubna Chaudhary|414-805-4600|lchaudhary@mcw.edu|
22406545|NCT01855919|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22406546|NCT02043704|TriHealth|Clinical Research Specialist|513-862-2341|ganga_devaiah@trihealth.com|
22406547|NCT01183728|Instituto de Biología y Genética Molecular (IBGM)|Dr. Javier García-Sancho|+34 98 318 48 27|jgsancho@ibgm.uva.es|
22406548|NCT03958149|Imperial College Healthcare NHS Trust|Key investigator|02033121077|annabellelee@nhs.net|
22406549|NCT00461851|Yale University Yale Cancer Center|Dr Michael Hurwitz|2037371600|Hari.deshpande@yale.edu|
22406550|NCT00724243|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22406551|NCT03793010|Flexion Therapeutics, Inc.|David Golod, Vice President, Clinical Operations|(781) 305-7572|dgolod@flexiontherapeutics.com|
22406552|NCT02134912|SWOG|Melanoma Statistician|2066674623|jmoon@fredhutch.org|
22406553|NCT04097925|Hospital de Bellvitge|Clinical Project Manager|+34675335888|anavarroa@bellvitgehospital.cat|
22406554|NCT01935622|Virginia Commonwealth University|Antonio Abbate|8048280513|aabbate@vcu.edu|
22406555|NCT02636049|Rockwell Medical, Inc|Clinical Project Manager|248-960-9009|sgrimberg@rockwellmed.com|
22431534|NCT01346592|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22391940|NCT01270828|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22391941|NCT05330988|Department of Veterans Affairs|Dr. John H. Kindred|8437924328|john.kindred1@va.gov|
22391942|NCT00015847|OHSU Knight Cancer Institute|Dr. Brian Druker|503-494-7999|trials@ohsu.edu|
22391943|NCT01007110|University of Kansas Medical Center|Kathleen Gustafson, Ph.D.|(913) 588-0065|kgustafson@kumc.edu|
22391944|NCT04646369|University of Pittsburgh|Oliver Lindhiem|4122465909|lindhiemoj@upmc.edu|
22391945|NCT04052425|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22391946|NCT01189110|VAMC St. Louis MO|Deborah Fritz FNP PhD|314-652-4100|deborah.fritz@va.gov|53692
22391947|NCT00945672|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22391948|NCT01150461|Massachusetts General Hospital|Michael A. Fifer, MD|617 726-1832|mfifer@partners.org|
22391949|NCT01681992|GlaxoSmithKline|GSK Response Center|866-435-7343||
22391950|NCT00447590|Apollo Endosurgery|Laura Eaton, R.N., BSN, CCRN-R|949-468-9301|laura.eaton@apolloendo.com|
22391951|NCT03880019|Columbia University Medical Center|Matthew Ingham, MD|646-317-7141|mi2337@cumc.columbia.edu|
22391952|NCT04148989|Intermountain Health|Director, Office of Research|(801) 408-1991|officeofresearch@imail.org|
22391953|NCT03812029|ENYO Pharma SA|Pietro Scalfaro|+33437700219|ps@enyopharma.com|
22391954|NCT01080300|Depomed|Head of R&D|510-744-8000|msweeney@depomed.com|
22391955|NCT00405938|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22391956|NCT02526498|Cancer Institute of New Jersey|Bruce Haffty|732-235-5203|hafftybg@cinj.rutgers.edu|
22391957|NCT01093469|Wake Forest|Dr Alan Fleischer|336-716-3775|adclark@wakehalth.edu|
22391958|NCT02694445|Department of Neurology, Xuan Wu Hospital,Beijing,China|Jianping Jia|010-63150669|jiajp@vip.126.com|
22391959|NCT02269423|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22391960|NCT01281839|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com|
22391961|NCT01305239|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22391962|NCT04176731|Insulet Corporation|Dr. Trang Ly|9786007628|tly@insulet.com|
22391963|NCT04674189|CureVac SE|Clinical Trial Information|0049 6976805870|clinicaltrials@curevac.com|
22391964|NCT01261247|Mayo Clinic Cancer Center|Patrick Johnston, MD, PhD|507-284-2511|johnston.patrick@mayo.edu|
22391965|NCT05226130|VA San Diego Healthcare System, San Diego, CA|Ruth Klaming, PhD|858-552-8585|rklaming@health.ucsd.edu|
22391966|NCT03974022|Dizal Pharmaceuticals|Li Zheng|862161097899|clinicaltrials@dizalpharma.com|
22391967|NCT05304117|Western Carolina University|Dr. R Turner Goins|828.227.3515|rtgoins@wcu.edu|
22391968|NCT00217737|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22391969|NCT02259621|Johns Hopkins SKCCC Clinical Research Office Coordinating Center|Jasmine Brooks|6673068335|jbrook54@jhmi.edu|
22391970|NCT04680533|University of Rochester|Jennifer Gewandter|(585) 276-5661|jennifer_gewandter@urmc.rochester.edu|
22391971|NCT03085836|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22391972|NCT00475644|Eli Lilly and Company|Cheif Medical Officer|800-545-5979||
22391973|NCT02301377|University of Michigan|Dr. Aarti Shakkottai|734-764-4123|aartik@med.umich.edu|
22391974|NCT03466047|Imperial College London|Carel le Roux|7970719453|c.leroux@imperial.ac.uk|
22391975|NCT00790400|Novartis Pharmaceuticals|Novartis Pharmaceuticals|862-778-8300||
22391976|NCT00699153|Bausch & Lomb, Inc.|Laura Trusso, MS.|(585) 338-5561|laura.trusso@bausch.com|
22391977|NCT03054051|Emory University|Kate Winskell Enger PhD|404-727-5286|swinske@emory.edu|
22406556|NCT04806165|Washington University in St. Louis School of Medicine|Ellen E. Fitzsimmons-Craft|314-286-2074|fitzsimmonse@wustl.edu|
22406557|NCT03702439|Imperial Prostate|David Eldred-Evans|020 7594 7773|d.eldred-evans@imperial.ac.uk|
22406558|NCT02059174|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22406559|NCT03040479|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
22406560|NCT00768040|Novartis Pharmaceuticals|Study Director|862-778-8300||
22406561|NCT01196936|University of Alabama at Birmingham|Dr. Smita Bhatia|(205) 638-2120|sbhatia@peds.uab.edu|
22406562|NCT03229538|Duke University|Kevin Hill, MD|919-681-6846|kevin.hill@duke.edu|
22406563|NCT01646151|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22406564|NCT00416572|Carnegie Mellon University|Michael F. Scheier, PhD|412-268-3791|scheier@cmu.edu|
22406565|NCT00290355|GlaxoSmithKline|GSK Response Center|866-435-7343||
22406566|NCT03345849|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22406567|NCT02511106|AstraZeneca AB|Global Clinical Leader|+447920183730|ClinicalTrialTransparency@astrazeneca.com|
22406568|NCT04465240|University of Southern California|Daniel A. Hackman, Ph.D.|(213) 821-3112|dhackman@usc.edu|
22406569|NCT01222767|Pharma Mar S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|0034 91846 60 00|clinicaltrials@pharmamar.com|
22406570|NCT02773849|Ferring Pharmaceuticals|Global Clinical Compliance|+1 862-286-5200|Disclosure@ferring.com|
22406571|NCT00723489|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22406572|NCT03577028|Harpoon Therapeutics|Medical Director|1-650-452-728|HPN4241001@harpoontx.com|
22406573|NCT02274311|Hospital das Clinicas da Faculdade de Medicina da USP|Dr. Felipe Henning Gaia Duarte|+5511987550990|drfelipegaia@outlook.com|
22406574|NCT00508001|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22406575|NCT00911183|Institut Bergonié|Pr Pierre Soubeyran|33(0)556333333|p.soubeyran@bordeaux.unicancer.fr|
22406576|NCT04632589|University of Iowa|Anna Stanhewicz, PhD|3194671732|anna-stanhewicz@uiowa.edu|
22406577|NCT01685372|University of Colorado School of Medicine|Donna Curtis, MD, MPH|720-777-6981|donna.curtis@childrenscolorado.org|
22406578|NCT03233308|Aerie Pharmaceuticals, Inc|Theresa GH Heah, MD, MBA|908-947-3844|theah@aeriepharma.com|
22406579|NCT01626859|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22406580|NCT03277729|Fred Hutchinson Cancer Center|Mazyar Shadman|206-667-4216|mshadman@fredhutch.org|
22406581|NCT00638989|MedImmune, LLC|Meena Jain, MB BChir/Associate Medical Director|301-398-0000|jainm@medimmune.com|
22406582|NCT03725345|Virginia Commonwealth University|David Chester, PhD|804-828-7624|dschester@vcu.edu|
22406583|NCT05184842|Montefiore Medical Center|Mendel Goldfinger, MD|718-920-4826|mgoldfin@montefiore.org|
22406584|NCT01969565|Emory University|Jonathan Kaufman, MD|404-778-1900|jlkaufm@emory.edu|
22406585|NCT00832091|RegeneRx Biopharmaceuticals, Inc.|Nabila Turjman, PhD, Executive Director, Regulatory Affairs|301-208-9191|nturjman@regenerx.com|108
22406586|NCT04995666|Phonak Audiology Research Center|Director of Research|630-821-5000|phonakaudiologyresearch@gmail.com|
22406587|NCT01955005|Iowa City VA Health Care System|Carolyn L Turvey|319 338 0581|Carolyn.Turvey@VA.Gov|7714
22406588|NCT01828567|Durham VA Center of Innovation in Primary Care|Eugene Z Oddone, MD, MPSc|919-286-0411|eugene.oddone@va.gov|
22406589|NCT02421146|Psychiatry Research, The Zucker Hillside Hospital|Andrea Joanlanne|7184708898|ajoanlanne@northwell.edu|
22406590|NCT01099761|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22406591|NCT03325010|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22406592|NCT02614261|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22406593|NCT01637090|Boston Medical Center|Adam Lerner, MD|617-638-8265|adam.lerner@bmc.org|
22406594|NCT03512275|Janssen Research & Development, LLC|Director Clinical Research Dermatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22406595|NCT00113555|Uromedica|Timothy Plouffe|763-999-7048|tplouffe@uromedica-inc.com|
22406596|NCT04474366|University of California, San Francisco|Esther Kim|415-353-9392|Esther.kim@ucsf.edu|
22406597|NCT04063865|Indiana University|Chandrashekhar Kubal|317-312-2601|sakubal@iupui.edu|
22406598|NCT00320190|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22406599|NCT01700140|SymBio Pharmaceuticals|Nobuyuki Koseki|+81-3-5472-1127||
22406600|NCT01060124|Medical affairs, Janssen Korea, Ltd.|CRA|82220944835||
22406601|NCT03144089|University of Iowa Hospitals and Clinics|Ron Abrons, MD|(319) 353-8061|ron-abrons@uiowa.edu|
22406602|NCT00102804|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22406603|NCT02094664|UCLA Mattel Children's Hospital|Dr. Diana Chen|3108255930|dychen@mednet.ucla.edu|
22406604|NCT04330989|University of North Carolina at Chapel Hill|Benjamin Chi|9194454147|bchi@med.unc.edu|
22406605|NCT02299206|Northwestern University|Dermatology CTU|312-503-5944|NUdermatologyCTU@northwestern.edu|
22406606|NCT00691054|University of Miami Sylvester Comprehensive Cancer Center|Caio Max Rocha Lima MD|305-243-7770|crocha@med.miami.edu|
22406607|NCT00518336|GlaxoSmithKline|GSK Response Center|866-435-7343||
22406608|NCT00864123|University of South Florida|Eric Storch, Ph.D.|727-767-8230|estorch@health.usf.edu|
22406609|NCT03074318|Northwestern University|Seth Pollack, MD, Director of Sarcoma Program|312-503-5320|seth.pollack@northwestern.edu|
22406610|NCT00511706|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22406611|NCT01625897|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22406612|NCT03455530|University of Arizona|Dr. Paloma Beamer|520-626-0006|pbeamer@arizona.edu|
22406613|NCT03929029|Dana Farber Cancer Institute|Dr. Patrick A. Ott|6175829030|patrick_ott@dfci.harvard.edu|
22406614|NCT02314637|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22406615|NCT03961672|City of Hope Medical Center|Dr. Alexey Danilov, MD|626-359-8111|adanilov@coh.org|
22406616|NCT00686699|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22406617|NCT00908895|Département d'orthopédie, CHA-Pavillon Enfant-Jésus Québec|Dr Stéphane Pelet, MD, PhD|418-649-0252|stephane.pelet.ortho@gmail.com|3165
22406618|NCT00412867|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22406619|NCT03350724|The University of Texas Health Science Center at Houston|Jennifer James, DMD, MS|713-486-4383|Jennifer.D.James@uth.tmc.edu|
22406620|NCT00033514|Medical University of South Carolina|Carolyn Britten|843-792-4271|britten@musc.edu|
22406621|NCT03595982|Icahn School of Medicine at Mount Sinai|Dr. Melissa Chu Lam|520-360-8807|melissachu.md@gmail.com|
22406622|NCT04221945|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22406623|NCT03983993|Emory University|Olatunji Alese|404-778-6639|olatunji.alese@emory.edu|
22406624|NCT00974090|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22406625|NCT01626872|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22406626|NCT05626751|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22406627|NCT01625000|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22406628|NCT03912064|Dana-Farber Cancer Institute|John Koreth, MD, PhD, MBBS|617-632-3470|John_Koreth@dfci.harvard.edu|
22406629|NCT01026194|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22406630|NCT04295759|PediatricBTC|Catherine Billups|901-595-3370|catherine.billups@stjude.org|
22406631|NCT05740566|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22406632|NCT02055872|McMaster University|Simon Oczkowski|905 521 2100|oczkowsj@mcmaster.ca|42442
22406633|NCT00829010|GlaxoSmithKline|GSK Response Center|866-435-7343||
22406634|NCT06210035|University of Southern California|Dr. Mara Mather|(213) 821-1868|mara.mather@usc.edu|
22406635|NCT01029691|University of Michigan|Louise O'Brien|734 647-9064|louiseo@med.umich.edu|
22406636|NCT02591511|Taipei medical university|Dr. Chia-Yun Lin|+886919986391|windoct@hotmail.com|
22406637|NCT00369564|Nemours Children's Clinic|Scott Bradfield, MD|904-697-3793|sbradfie@nemours.org|
22406638|NCT05616221|Armata Pharmaceuticals, Inc.|Jennifer Smith|310-665-2928|jsmith@armatapharma.com|
22406639|NCT04880733|University California-Irvine|Jeffery Dusek|617-519-8082|jdusek@hs.uci.edu|
22406640|NCT00862992|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22406641|NCT05492877|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
22406642|NCT02871791|Dana-Farber Cancer Institute|Sara Tolaney, MD MPH|617-632-5743|Sara_Tolaney@dfci.harvard.edu|
22406643|NCT02782364|University Hospital of South Manchester|Karen Telford|01612916654|karen.telford@uhsm.nhs.uk|
22406644|NCT03369340|Philip Morris Products S.A.|Christelle Haziza, Director Health Science and Biostatistics|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
22406645|NCT01076270|Fred Hutchinson Cancer Research Center|Dr. William Bensinger|206-667-4730|wbensing@fredhutch.org|
22406646|NCT03737318|New York University|Tara McAllister, Associate Professor|212-992-9445|tkm214@nyu.edu|
22406647|NCT00513370|Abbott|Medical Information Specialist|1-800-633-9110||
22406648|NCT00809055|Brigham and Women's Hospital|Dr. Terrie Inder|617-525-6650|tinder@partners.org|
22406649|NCT00528840|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22406650|NCT01603628|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22406651|NCT02087241|SCRI Development Innovations|Charles H. Davis|+615-524-4341|charles.davis2@scri-innovations.com|
22406652|NCT00836953|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22406653|NCT02943668|Fred Hutch Cancer Research Center|Dr. Bart Scott|206.667.1990|bscott@fredhutch.org|
22406654|NCT01200758|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
22406655|NCT01563406|Rush University Medical Center|Mary Hayden, MD|3129428727|mhayden@rush.edu|
22406656|NCT04048876|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22406657|NCT03471143|Washington University School of Medicine|Dr. Patricia Dickson|314-273-2943|pdickson@wustl.edu|
22406658|NCT00926263|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22406659|NCT03580525|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-932-5711|mehmet.sofuoglu@yale.edu|4809
22406660|NCT04350372|Abbott Structural Heart|Karine Miquel|+32 479 600 107|karine.miquel@abbott.com|
22406661|NCT02460172|ZipLine Medical|Wendy Winters, Clinical Project Manager|408-506-1866|wwinters0@gmail.com|
22406662|NCT03858686|Foresee Pharmaceuticals|Yisheng Lee, MD, Chief Medical Officer|4088234807|yisheng.lee@foreseepharma.com|
22406663|NCT03374891|"University of Colorado Denver | Anschutz"|Daniel Matlock, MD|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
22406664|NCT00703729|CU Sports Medicine|Dr. Eric McCarty|303-441-2118|cyndi.long@ucdenver.edu|
22406665|NCT03053180|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22406666|NCT01928186|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu|
22406667|NCT04540627|mAbxience Research SL|Director of Clinical Trials|+34917711500|susana.millan@mabxience.com|
22406668|NCT01465958|Grifols Therapeutics Inc|Henry Li, PhD|800-20-2807|henry.li@grifols.com|
22406669|NCT06115681|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22406670|NCT01493024|ZS Pharma, Inc|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22406671|NCT04022343|Emory University|Mehmet Asim Bilen, MD|404-778-1900|mehmet.a.bilen@emory.edu|
22406672|NCT00211536|Sr. Clinical Research Manager|John Shin|818-576-4019|john.shin@medtronic.com|
22431535|NCT03557502|University of Oregon|Dr. Christopher Minson|541-953-2231|minson@uoregon.edu|
22406673|NCT02583399|Cumberland Pharmaceuticals Inc.|Sr. Manager, Clinical Operations|615-255-0068|bkaelin@cumberlandpharma.com|
22406674|NCT01004861|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
22406675|NCT03276494|Ohio State University|Thomas Lawson|614-366-7312|thomas.lawson@osumc.edu|
22406676|NCT04610827|Mayo Clinic|Julie M. Baughn, M.D.|507-293-1031|Baughn.Julie@mayo.edu|
22406677|NCT01823991|H. Lee Moffitt Cancer Center and Research Institute|Dr. Nagi Kumar|813-745-6885|nagi.kumar@moffitt.org|
22406678|NCT00805194|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22406679|NCT04334876|Indiana University|Courtney Rowan|317-944-7065|coujohns@iu.edu|
22406680|NCT02184520|Globus Medical|Jacqueline Myer|610-930-1800|jmyer@globusmedical.com|
22406681|NCT02185040|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|866-260-1599|ClinicalTrialDisclosure@Celgene.com|
22406682|NCT02385292|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22406683|NCT01792024|University of Chicago|Dr. Aytekin Oto|773-834-7424|aoto@radiology.bsd.uchicago.edu|
22406684|NCT00718887|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22406685|NCT02530281|Dermira, Inc.|Eugene A. Bauer, MD, Chief Medical Officer|650-421-7202|eugene.bauer@dermira.com|
22406686|NCT03557801|Vanderbilt University Medical Center|Dr. Lucy Spalluto|615 343 1187|lucy.b.spalluto@vumc.org|
22406687|NCT00535236|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22406688|NCT01671176|Oticon Medical LLC|Ravi Sockalingam|9082023524|rsoc@oticomedical.com|
22406689|NCT03558503|UroGen Pharma|Elyse Seltzer, MD|1-646-492-8518|elyse.seltzer@urogen.com|
22406690|NCT00561795|GlaxoSmithKline|GSK Response Center|866-435-7343||
22406691|NCT02094612|Kaiser Permanente Division of Research|Monique Does, Project manager|510-891-3612|monique.does@kp.org|
22406692|NCT04167514|CSL Behring|Clinical Study Disclosure Manager|1- 610-878-4697|clinicaltrials@cslbehring.com|
22406693|NCT02646891|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22406694|NCT01542632|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22406695|NCT03225833|Wave Life Sciences|Medical Director|855-215-4687|clinicaltrials@wavelifesci.com|
22406696|NCT01228084|Oregon Health & Science University, Knight Cancer Institute|Joshi Alumkal, MD|503-494-1091||
22406697|NCT06029127|BeiGene|Study Director|1 877-828-5568|clinicaltrials@beigene.com|
22406698|NCT04785144|Kaiser Permanente Washington|Lisa Jackson|206-442-5216|lisa.a.jackson@kp.org|
22406699|NCT00129376|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
22406700|NCT04240002|Astellas Pharma Global Development, Inc. (APGD)|Clinical Transparency|800-888-7704|astellas.resultsdisclosure@astellas.com|
22406701|NCT04209634|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22406702|NCT01766401|Forest Research Institute, Inc|Therapeutic Area Head|877-277-8566|IR-CTRegistration@allergan.com|
22406703|NCT00886587|Johnson & Johnson Consumer Inc|Amisha Parikh-Das, PhD/Study Director|973 385-2863 USA EST|AParikh1@its.jnj.com|
22406704|NCT01523613|University of Michigan|Dr. Mathilde Peters||mcpete@umich.edu|
22406705|NCT01108068|University of Maryland School of Medicine|Elizabeth Streeten, MD|410-328-3335|estreete@som.umaryland.edu|
22406706|NCT00398086|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22406707|NCT00696774|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22406708|NCT04084210|University of Wisconsin- Madison|Megan Piper, PhD, Director of Research Professor|608-265-5472|mep@ctri.wisc.edu|
22406709|NCT00033293|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22406710|NCT00935701|Kennedy Krieger Institute|Lana Warren|4439239312|WarrenL@kennedykrieger.org|
22406711|NCT02201251|Janssen Research & Development, LLC|Director - Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22406712|NCT01930487|Ocular Vascular Research Center, Indiana University School of Medicine|Brent Siesky, PhD, Assistant Director|317-278-0177|bsiesky@indiana.edu|
22406713|NCT02711553|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22406714|NCT05259800|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
22406715|NCT01197794|AstraZeneca|Alison Holt||ClinicalTrialTransparency@astrazeneca.com|
22406716|NCT04055844|University of Minnesota, Masonic Cancer Center|Mark Juckett , MD|612-676-4200|juck0001@umn.edu|
22406717|NCT00679380|Santarus, Inc.|Michael Huang, M.D., Senior Medical Director|858-314-5700|contact@santarus.com|
22406718|NCT03457636|Skin Sciences, PLLC|M. McAllister|5024519000|mmdermresearch@yahoo.com|
22406719|NCT00533351|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22406720|NCT01183481|Sunnybrook Health Sciences Centre|Dr. Edward Chow|416-480-4998|edward.chow@sunnybrook.ca|
22406721|NCT00678249|Bard Peripheral Vascular, Inc.|John Reviere, Director, Clinical Affairs|480-303-2644|john.reviere@crbard.com|
22406722|NCT03231228|B. Braun Medical Inc.|Diana Valencia MD|610-596-2875|diana.valencia@bbraunusa.com|
22406723|NCT04337203|Wake Forest Baptist Comprehensive Cancer Center|Carol Kittel|336-399-3832|c.kittel@wakehealth.edu|
22406724|NCT01579162|HepQuant, LLC|Elyse Handley|303-923-2109|elyse.handley@hepquant.com|
22406725|NCT04673630|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22406726|NCT05309499|Kazan State medical Universety|Niiaz Khasanov|+79050204407|dilyara_khastieva@mail.ru|
22406727|NCT03049852|Cloudbreak Therapeutics, LLC|Dr, Jinsong Ni|9496789752|Ni-Jinsong@cloudbreaktherapeutics.com|
22406728|NCT02141854|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22406729|NCT01868594|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical Research and Medical Information Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22406730|NCT03399786|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22417780|NCT00026221|The Ohio State University Comprehensive Cancer Center|William E. Carson III, MD|614-293-6306|William.Carson@osumc.edu|
22406731|NCT04564027|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|Information.center@astrazeneca.com|
22406732|NCT05827978|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
22406733|NCT04566445|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22406734|NCT04453722|Cleveland Clinic|Daniel I. Sessler, Professor & Chair|216-445-6500|DS@CCF.org|
22406735|NCT00137267|Bedford VA Medical Center|Dr. David Smelson|781-687-2845|david.smelson@va.gov|
22406736|NCT01104922|UPMC Hillman Cancer Center|Barbara Stadterman, Regulatory Supervisor; ClinicalTrials.gov Admin|412-647-5554|stadtermanbm@upmc.edu|
22406737|NCT03501979|University of Alabama at Birmingham|Dr. Erica Stringer-Reasor|205-975-2914|esreasor@uabmc.edu|
22406738|NCT02329860|clinical operation|Zexiang.huang/ project manager|13811725417|zexiang.huang@hengrui.com|
22406739|NCT02061540|Mirum|Study Physician|1 650-667-4085|medinfo@mirumpharma.com|
22406740|NCT01948518|Cleveland Clinic|Umur Hatipoğlu, MD|216-636-5344|HATIPOU@ccf.org|
22406741|NCT02599441|University at Buffalo|Research coordinator|7162043209|mk67@buffalo.edu|
22406742|NCT04005755|AFT Pharmaceuticals|Jennifer Zhang -Project Leader|+ 64 9 488 0232|jenniferz@aftpharm.com|710
22406743|NCT02289833|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22406744|NCT04509024|Carnegie Mellon University|Dr. Seth Wiener, Associate Professor|412-268-5669|sethw1@cmu.edu|
22406745|NCT02561273|University of Nebraska Medical Center|Matthew Lunning|402-559-7164|mlunning@unmc.edu|
22406746|NCT00958191|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@stryker.com|
22406747|NCT01642004|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22406748|NCT00598806|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
22406749|NCT01818765|Oxford university hospitals NHS Foundation Trust|Dr James Gamble|+441865221012|drjgamble1@jhpg.net|
22406750|NCT01562327|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22406751|NCT02079311|Universitätsklinikum Gießen und Marburg GmbH|Prof Alexander Torossian|(+49) 06421 - 286 9864|alexander.torossian@med.uni-marburg.de|
22406752|NCT01714336|Mayo Clinic|Dr. Mark Pagnano|507-284-2511|pagnano.mark@mayo.edu|
22406753|NCT03667573|Malcom Randall VA Medical Center|Dr. David Clark|352-376-1611|davidclark@ufl.edu|105244
22406754|NCT04554394|Pulse Biosciences, Inc.|William A. Knape|(919) 757-2033|bill.knape@pulsebiosciences.com|
22406755|NCT02795182|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22406756|NCT00778310|University of Texas Health Science Center at San Antonio|Steven R. Pliszka MD|210-567-5475|pliszka@uthscsa.edu|
22406757|NCT01055457|Johson & Johnson Vision Care Inc.|Kristy Canavan, O.D.- PRINCIPAL RESEARCH OPTOMETRIST, Clin Ops|904-443-3500|KCANAVA2@its.jnj.com|
22406758|NCT02724111|Korea University Guro Hospital|Dr Byung Gun Lim|82-2-2626-1437|bglim9205@korea.ac.kr|
22406759|NCT02996500|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22406760|NCT02187224|Yale University School of Medicine, Department of Psychiatry|Elizabeth Ralevski|203-932-5711|elizabeth.ralevski@yale.edu|4282
22406761|NCT00835276|Manager, Biopharmaceutics|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22406762|NCT00928304|Piramal Imaging|Dr. Juergen Hirschfeld|49 30 461 1246 15|juergen.hirschfeld@piramal.com|
22406763|NCT01010776|Jan-Cil Brazil|Medical Group Manager|55 11 3030-2770||
22406764|NCT02332876|University of San Diego, California|Dr. Sheri Hartman|8585349235|sjhartman@ucsd.edu|
22406765|NCT02402881|The Johns Hopkins University|Elliott R Haut, MD PhD|410-502-3122|ehaut1@jhmi.edu|
22406766|NCT00384449|Oregon Health & Science University|Dr. Christina J. Flaxel|(503) 418-3352|flaxelc@ohsu.edu|
22406767|NCT01369069|University of Virginia|Karen C. Johnston, MD|434 924-5323|kj4v@virginia.edu|
22406768|NCT02573012|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22406769|NCT00882362|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22406770|NCT01268514|Medtronic|Andrea DiScipio, Clinical Research Associate|781-491-5350|andrea.l.discipio@medtronic.com|
22406771|NCT01222416|Vanderbilt-Ingram Cancer Center|A Bapsi Chakravarthy, MD Program Director, Radiation Oncology|615-322-2555|babsi.chak@vanderbilt.edu|
22406772|NCT04840849|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22406773|NCT01744340|BrUOG-Brown University Oncology Research Group|Howard Safran, MD|4018633000|kristen_mitchell@brown.edu|
22406774|NCT03714256|Permobil|Vice President of Research and Innovation|+46703836763|karin.leire@permobil.com|
22406775|NCT03258762|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22406776|NCT02253173|TherapeuticsMD|Sebastian Mirkin, MD, Chief Medical Officer|561-961-1900|sebastian.mirkin@therapeuticsmd.com|1952
22406777|NCT05439876|School of Nursing, College of Medicine, National Taiwan University, Taipei, Taiwan|Shao-Yu Tsai|(02)23123456#288904|stsai@ntu.edu.tw|
22406778|NCT02545049|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22406779|NCT01586962|Novartis|Clinical Project Leader|+41223633111||
22406780|NCT04490057|Yale University|E. Jennifer Edelman, MD, MHS|203-727-7115|ejennifer.edelman@yale.edu|
22406781|NCT04191096|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22406782|NCT05954065|Erchonia|Clinical Affairs Manager|8882420571|tsammons@erchonia.com|
22406783|NCT02369211|Brigham and Women's Hospital|James Webber|(617) 732-6877|jwebber1@partners.org|
22406784|NCT02598661|Geron Corp.|Study Director|650-473-7700|mds3001-info@Geron.com|
22406785|NCT00147316|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22406786|NCT00027027|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22406787|NCT00290329|GlaxoSmithKline|GSK Response Center|866-435-7343||
22391978|NCT01997905|Methodist Hospital Houston|Basel Ramlawi, MD|713-441-5200|basel.ramlawi@gmail.com|
22391979|NCT00078338|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22391980|NCT02124811|Emory University|Robert Cotes, MD|(404) 616-4752|robert.o.cotes@emory.edu|
22391981|NCT03412916|Center for Health Outcomes and Interdisciplinary Research, Department of Psychiatry, Massachusetts General Hospital|Ana-Maria Vranceanu|(617) 724-3953|avranceanu@mgh.harvard.edu|
22391982|NCT02356705|Bassett Healthcare|Dr. David Ullman|585-750-7510|doccfi@hotmail.com|
22391983|NCT03430583|Mezzion Pharmaceuticals|Dr. Scott Oglesby|919-260-5782|Oglesby@granzer.biz|
22391984|NCT04201288|Brown University|Ethan Moitra, Associate Professor of Psychiatry and Human Behavior|401-444-1949|ethan_moitra@brown.edu|
22431536|NCT05819398|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22391985|NCT01606319|Penn State University Dept of Public Health Sciences|David Mauger, PhD|717.573.0336|dmauger@psu.edu|
22391986|NCT01634269|Medttronic|Hiroko Ookubo|81367760811|hiroko.ookubo@medtronic.com|
22406788|NCT00003389|ECOG-ACRIN Statistical Office|Study statistician|617-632-6012||
22406789|NCT01901809|Johns Hopkins University School of Medicine|Kavita Sharma, MD|410-955-7670|ksharma8@jhmi.edu|
22406790|NCT02776904|University of Arkansas for Medical Sciences|Dr. Charlotte Yates|501-450-5542|cyates@uca.edu|
22406791|NCT00935766|Denver Health Medical Center|Carlin Long, MD|303-602-3899|carlin.long@dhha.org|
22406792|NCT05158244|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22406793|NCT00775138|Insmed|Dr. Kevin Mange, Sr. Vice President, Clinical Development|908-947-2651|Kevin.Mange@Insmed.com|
22406794|NCT02009501|Mount Sinai St. Luke's|Dr. John C. Lantis II||JLantis@chpnet.org|
22406795|NCT00712712|Institute Bergonie|Dr. Jean Palussière|05 56 33 37 50|j.palussiere@bordeaux.unicancer.fr|
22406796|NCT02723019|Scripps Health|Athena Philis-Tsimikas, MD, Co-Principal Investigator|858-678-7045|philis-tsimikas.athena@scrippshealth.org|
22406797|NCT03597789|University of North Carolina at Chapel Hill|Deborah Jones, PhD|919-962-5082|djjones@email.unc.edu|
22406798|NCT00611767|Yale University School of Medicine|Dr. Ismene L. Petrakis, Professor of Psychiatry|203-932-5711|Ismene.petrakis@yale.edu|2244
22406799|NCT02718625|Smith & Nephew, Inc.|Natasha Schappell, Clinical Study Manager|817-302-3949|Natasha.Schappell@smith-nephew.com|
22406800|NCT00811395|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi-aventis.com|
22406801|NCT00779116|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22406802|NCT04050540|University of Washington, Department of Global Health|Jenell Stewart|206 520 3866|jenells@uw.edu|
22406803|NCT01947127|Faculty of Medicine, Chulalongkorn University|Khrongwong Musikatavorn, M.D.|+6622564553|kmusikatavorn@yahoo.com|
22406804|NCT00170846|Novartis Pharmaceuticals|Study director|862-778-8300||
22406805|NCT01021553|GlaxoSmithKline|GSK Response Center|866-435-7343||
22406806|NCT01950364|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22406807|NCT01469637|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22406808|NCT00887913|Syneron Medical Ltd|Hanit Brenner-Lavie|972-73-244-2200|hanitb@syneron.com|581
22406809|NCT03341728|University of North Caroilina at Chapel Hill|Jason R Franz, PhD|919-966-6119|jrfranz@email.unc.edu|
22406810|NCT03531918|Fred Hutchinson Cancer Center|Roland Walter, Member of Clinical Research Division|206-667-3599|rwalter@fredhutch.org|
22406811|NCT04716010|University of North Carolina at Chapel Hill|Lindsey Smith Taillie, PhD|(919) 445-8313|taillie@unc.edu|
22406812|NCT00572728|ACRIN|Ben Herman|401.863.9188|bherman@stat.brown.edu|
22406813|NCT01529450|Stanford University|Anne Chang, MD|(650) 721 7151|alschang@stanford.edu|
22406814|NCT01833806|Insightec|Nadir Alikacem, VP Global Regulated Clinical Affairs & CRO|(214) 630-2000|nadira@insightec.com|
22406815|NCT01229410|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22406816|NCT01736930|Jaeb Center for Health Resesarch|Roy W. Beck, MD, PhD|813-975-8690|jdrfapp2@jaeb.org|
22406817|NCT00415623|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22406818|NCT01359111|PATH|Courtney Jarrahian|206-285-3500|cjarrahian@path.org|
22406819|NCT03116841|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22406820|NCT01708915|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22431537|NCT02520154|University of Texas M D Anderson Cancer Center|Dr. Amir Jazaeri MD|(713) 745-1613|aajazaeri@mdanderson.org|
22417781|NCT03537274|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22417782|NCT04421586|Duke University|Lavanya Vasudevan, Ph.D.|919-613-1423|lavanya.vasudevan@duke.edu|
22417783|NCT02963441|IDx LLC|IDx President, Dr. Michael Abramoff|319-248-5620|info@eyediagnosis.net|
22417784|NCT00967044|University of Texas MD Anderson Cancer Center|Yasuhiro Oki, MD / Assistant Professor, Lymphoma/Myeloma|713-792-2860|CR_Study_Registration@mdanderson.org|
22391987|NCT01821937|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22417785|NCT00974974|Impax Laboratories, Inc.|Michelle Landolfi, Director, Regulatory Affairs|510-240-6402|mlandolfi@impaxlabs.com|
22417786|NCT01297465|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22417787|NCT00969540|Hologenix, LLC|Seth Casden|310-600-3673|seth.casden@celiant.com|
22417788|NCT00801099|Swiss Tropical Institute|Franziska Saxer, MD||franziskabrenneke@yahoo.com|
22417789|NCT00950963|Denver Health|Raymond Estaico, MD|303-860-9900|Ray.Estacio@cpcmed.org|
22417790|NCT04647721|Merz Aesthetics|Public Disclosure Manager|+49 69 1503 1|Aesthetic.Trials@merz.com|
22417791|NCT04380090|Cleveland Clinic Lutheran Hospital|Kathleen Gonzalez|2162174226|gonzalk2@ccf.org|
22417792|NCT00136318|Kliniken Essen-Mitte, Department of Psychiatry|Professor Dr. Martin Schaefer|+49201-17430001|m.schaefer@kliniken-essen-mitte.de|
22417793|NCT02005887|International Breast Cancer Study Group|Meredith M. Regan|+1 617-632-3012|mregan@jimmy.harvard.edu|
22417794|NCT02684201|University of Pittsburgh|Dr. Lee Fisher, PhD|412-383-1077|lef44@pitt.edu|
22417795|NCT02749292|Massachusetts General Hospital- Vasculitis and Glomerulonephritis Center|John L Niles|617-726-4132|JLNILES@mgh.harvard.edu|
22417796|NCT00251641|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22417797|NCT00876018|GlaxoSmithKline|GSK Response Center|866-435-7343||
22417798|NCT00888459|Mayo Clinic|Jon O. Ebbert|507-266-1944|ebbert.jon@mayo.edu|
22417799|NCT03629028|Principal investigator of the research|Şafak Yılmaz Baran, MD|+903224586868|safakyilmazbaran@gmail.com|
22417800|NCT03828448|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
22417801|NCT00695435|Alcon Research, LTD|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22417802|NCT02192164|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22417803|NCT03123861|University of North Carolina at Chapel Hill|Jennifer Wu, MD, MPH, Professor of OBGYN|919-966-0014|jennifer_wu@med.unc.edu|
22417804|NCT04932941|MetrioPharm Deutschland GmbH|Clinical Disclosure Officer|+49303384395|info@metriopharm.com|36
22417805|NCT00588640|Memorial Sloan Kettering Cancer Center|Dr. Natalia Moryl|646-888-2681|moryln@mskcc.org|
22417806|NCT01393730|Dana-Farber Cancer Institute|Dr. Mary-Ellen Taplin|617-582-7221|mary_taplin@dfci.harvard.edu|
22417807|NCT01524302|Michigan State University|Dr. Gary E. Stein|517-353-5126|steing@msu.edu|
22417808|NCT00986453|Medtronic Surgical Technologies|Robert Swain, PhD|+1 (603) 294-5428|robert.e.swain@medtronic.com|
22417809|NCT00448136|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22417810|NCT01856361|Weill Cornell Medical College|Peter N Schlegel, MD|2127465491|pnschleg@med.cornell.edu|
22417811|NCT03407430|University of North Carolina Medical Center|Dr. Benyam Muluneh|919-966-3213|benyam.muluneh@unchealth.unc.edu|
22417812|NCT03218163|SKCCC|Dr. Philip Imus|4109558873|pimus1@jhmi.edu|
22417813|NCT00922987|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22391988|NCT02615509|Philips AB|Daniel Stenströmer|+46 708 303 767|daniel.stenstromer@philips.com|
22391989|NCT00584077|University of Texas-Galveston|Alexander Duarte, MD|409-772-2436|aduarte@utmb.edu|
22391990|NCT02106962|California Insitute of Renal Research, Inc.|Mark M. Boiskin, M.D.|858-637-4600|mboiskin@bnmg.org|
22391991|NCT02030002|University of Minnesota|Thorsten Gruenheid|612-625-3903|tgruenhe@umn.edu|
22391992|NCT01294397|Amgen Inc.|Study Director|866-572-6436||
22391993|NCT00504075|Bio Products Laboratory Limited|Tim Aldwinckle, MD|+44 2089572565|Tim.Aldwinckle@bpl.co.uk|
22391994|NCT02406248|AstraZeneca R&D|Brilinta Global Clinical Lead|+46 31 776 10 00|kontakt@astrazeneca.com|
22391995|NCT01186705|Memorial Sloan Kettering Cancer Center|Dr. Leonard Saltz|646-888-4286|saltzl@mskcc.org|
22391996|NCT01689857|Seoul National University Bundang Hospital|Dr. Chanyeong Heo|82317877222|lionheo@snu.ac.kr|
22391997|NCT04079634|Northwestern University|Nishant Verma, MD|3129262148|nishant.verma@nm.org|
22391998|NCT00479882|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22391999|NCT03106753|Icahn School of Medicine at Mount Sinai|Dr. Natalie Porat|973-919-6166|poratnat@gmail.com|
22392000|NCT02874014|Mayo Clinic|Dr. C. Richard Choo|507-284-3261|Choo.C@mayo.edu|
22392001|NCT06381986|Sunhawk Vision Biotech|President|+886-72222660|hjuo@shvbiotech.com|
22392002|NCT01643044|Wayne State University|Steven Ondersma, PhD|313-444-9797|sondersm@med.wayne.edu|
22392003|NCT03149042|University at Buffalo|Dr. Ciprian Ionita|7164004283|cnionita@buffalo.edu|
22392004|NCT01434745|Washington State University|Dr. jean-Baptiste Roullet|5093587666|j.roullet@wsu.edu|
22392005|NCT02470780|University of Cincinnati/UC Health|Hilary Perez PhD|5135582577|perezhe@ucmail.uc.edu|
22392006|NCT01023958|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22392007|NCT01031628|SARC|Research Project Manager|(734) 930-7600|sarc@sarctrials.org|
22392008|NCT02362503|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22392009|NCT03563066|McMaster University|Gail Gauvreau|9055259140|gauvreau@mcmaster.ca|22791
22392010|NCT03017742|Masimo Corporation|Cristina Johnson|(949) 297-7000|clinicalresearchdept@masimo.com|
22392011|NCT04148651|Candela Corporation|Medical Director|+1 949.599.7657|konikap@candelamedical.com|
22392012|NCT01001390|St. Jude Children's Research Hospital|Kirsten K. Ness, PT, PhD|866-966-5934|info@stjude.org|
22392013|NCT03690427|University of California, Los Angeles|Mary Rezk-Hanna, PhD|3102068654|mrhanna@mednet.ucla.edu|
22392014|NCT03519204|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22392015|NCT04591171|The University of Texas Health Science Center at Houston|Joyce P Samuel, MD, MS|713-500-6708|joyce.samuel@uth.tmc.edu|
22392016|NCT00727740|Yale University School of Medicine|Priya Jamidar, MD|203-785-6228|priya.jamidar@yale.edu|
22392017|NCT02609672|McMaster University/University of Waterloo|Dr. Monica Maly|519-888-4567|mrmaly@uwaterloo.ca|37916
22392018|NCT03392168|Arcutis|Study Inquiry|650-847-4115|studyinquiry@arcutis.com|5
22392019|NCT00762476|University of Virginia|Dr. Ronald Turner|(434) 243-9864|RBT2N@hscmail.mcc.virginia.edu|
22392020|NCT01441635|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22392021|NCT02627118|UConn Health|Andre Kaplan, MD||kaplan@uchc.edu|
22392022|NCT02637323|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
22392023|NCT02838134|Radboud University Medical Center|Dr M.C. Warlé|+31-24362415333|Michiel.Warlé@radboudumc.nl|
22392024|NCT01912404|Conatus Pharmaceuticals Inc.|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com|
22392025|NCT01430468|Cleveland Clinic Foundation|Joseph P. Iannotti, MD, PhD|216-445-5151|iannotj@ccf.org|
22392026|NCT01443923|NIAID/NIH|Dr. Shyam Kottilil|301-435-0936|skottilil@niaid.nih.gov|
22392027|NCT01426230|Depomed|Head of R&D|510-744-8000|msweeney@depomed.com|
22392028|NCT04547023|Stanford University|Yair Blumenfeld, MD|650-498-4069|yairb@stanford.edu|
22392029|NCT01245374|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22392030|NCT04529005|University of Illinois Chicago College of Pharmacy|Scott Benken|3123554107|benken@uic.edu|
22392031|NCT02266342|W.L. Gore & Associates|Charee Robe, Biostatistician|928-864-4048|crobe@wlgore.com|
22392032|NCT00869947|Eastern Colorado Healthcare System|Dr. Alena Grabowski|303-492-5208|alena.grabowski@va.gov|
22392033|NCT04013971|Emory University|Trisha Kesar, PT, PhD|404-712-5803|tkesar@emory.edu|
22392034|NCT04297618|Centre for Ocular Research and Education|Jill Woods|(519) 888-4567|jwoods@uwaterloo.ca|36743
22392035|NCT04704219|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22392036|NCT02600897|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22392037|NCT02614183|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22392038|NCT03816761|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22417814|NCT03510182|University of Michigan|Carol Persad|734-615-8112|cpersad@umich.edu|
22392039|NCT02560753|T3DTherapeutics|John Didsbury, PhD|9199490517|didsj919@t3dtherapeutics.com|
22392040|NCT04944290|Padagis LLC|Jonathan Schwartz|929-502-7291|jonathan.schwartz@padagis.com|
22392041|NCT03388268|Washington University in St. Louis|Kimberly Reske, MPH, Research Coordinator|314-747-4041|kreske@wustl.edu|
22392042|NCT00474526|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22392043|NCT00132678|Johnson & Johnson Pharmaceutical Research and Development|Director of Clinical Research|609 730-4576||
22392044|NCT00953147|Sunovion|Respiratory Medical Director|1-866-503-6351||
22392045|NCT02296502|University of Pittsburgh|Benjamin L Handen, PhD|412-235-5445|handenbl@upmc.edu|
22392046|NCT03838731|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22392047|NCT03211234|Santen Inc|R&D Quality Manager|+1 415 268 9199|clinicaltrials@santen.com|
22392048|NCT02412735|Mesoblast, Inc.|Christopher James, VP Head of Clinical Operations|212-880-2060|Christopher.James@Mesoblast.com|7925
22392049|NCT01006980|Hoffman-LaRoche|Medical Communications|800-821-8590||
22392050|NCT04043143|"University of Colorado Denver | Anschutz"|Karsten Bartels, MD, PhD, MBA|303-724-1111|karsten.bartels@cuanschutz.edu|
22392051|NCT04307940|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22392052|NCT02734498|Wake Forest School of Medicine|James Kimball, MD|336-716-9702|jkimball@wakehealth.edu|
22392053|NCT04996004|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22392054|NCT05543174|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22392055|NCT04896008|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@MSD.com|
22392056|NCT04595682|University of Kentucky|Dr. Mark Fillmore|8592574728|fillmore@uky.edu|
22392057|NCT03322540|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22392058|NCT01594827|Johns Hopkins Unviversity School of Medicine|Dr. Mark Jennings|410-502-7044|mjenni15@jhmi.edu|
22392059|NCT03445533|Idera Pharmaceuticals, Inc.|Head of Clinical Operations|484-348-1605|lcolfer@iderapharma.com|
22392060|NCT02153905|National Cancer Institute|Dr. Steven Rosenberg|240-858-3080|sr78a@nih.gov|
22392061|NCT03334253|Jaeb Center for Health Research|Raymond Kraker, PEDIG Coordinating Center Director|8139758690|rkraker@jaeb.org|
22392062|NCT03274453|New York University School of Medicine|Kirsten Boenigk|212 598 6085|Kirsten.Boenigk@nyumc.org|
22392063|NCT00968526|GlaxoSmithKline|GSK Response Center|866-435-7343||
22392064|NCT02493062|St. Louis Fetal Care Institute|Dr. Laura Vricella|3146784488|fetalcare@ssmhealth.com|
22392065|NCT03926195|Galapagos NV|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
22392066|NCT03054337|Akebia Therapeutics|Akebia Therapeutics|(617) 844-6128|trials@akebia.com|
22392067|NCT01327612|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22392068|NCT02838979|University of Washington|Ernest Ayers|206-685-1423|ayerse@uw.edu|
22392069|NCT01762904|Universidad de Guanajuato|Alejandro E. Macías|+52 477 7 14 58 59|aaeemmhh@yahoo.com|4644
22392070|NCT01967069|Promius Pharma|Director of Clinical Operations|609-282-1476|kgulbronson@promiuspharma.com|
22392071|NCT00609947|Medtronic CardioVascular|Lynda Chaplin - Study Manager|(707) 543-5459|lynda.chaplin@medtronic.com|
22392072|NCT00346905|Boston Scientific|Director, Endoscopy Clinical Affairs|1-508-333-1015||
22392073|NCT05569421|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22392074|NCT01528319|Johnson & Johnson K.K. Medical Company|Department Chief, Clinical Development & PMS|+81-3-4411-6789|yikeda5@its.jnj.com|
22392075|NCT00874731|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22392076|NCT01736540|Novartis|Study Director|862-778-8300||
22392077|NCT00581477|Vanderbilt University Medical Center|Alfredo Gamboa MD|6158751003|alfredo.gamboa@vumc.org|
22392078|NCT03836859|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 513831|clinical.trials@dompe.com|
22392079|NCT04646291|Mosie Baby (Consultant)|Karina Loyo, Ph.D., MBA, CCDM|512-563-1393|karina@drkarina.com|
22406821|NCT03267576|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22406822|NCT00721357|Ralph H Johnson VAMC|Chris Gregory|(843)792-1078|Christopher.Gregory@va.gov|
22406823|NCT00407420|University of Bristol|Julian Hamilton-Shield|00441173420183|j.p.h.shield@bristol.ac.uk|
22406824|NCT02382276|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22406825|NCT02313506|Arthritis Research Canada|Dr. Linda Li|604-207-4020|lli@arthritisresearch.ca|
22406826|NCT02746991|EyePoint Pharmaceutical|Flavio Leonin Jr., MD|617-972-6024|fleonin@eyepointpharma.com|
22406827|NCT01987609|UCSD Medicine|Director of Clinical Trials Unit|858-657-8322|dermstudies@Ucsd.edu|
22406828|NCT01066546|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22406829|NCT03860181|Medical University of South Carolina|Josef Eichinger, MD|843-876-0111|eichinge@musc.edu|
22406830|NCT03452397|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
22406831|NCT00125268|Mayo Clinic|Dr. Matthew A. Butters|480-301-7745|butters.matthew@mayo.edu|
22406832|NCT00925522|St. Jude Medical|Nancy Ouch, Project Manager|949.769.5041|nouch@sjm.com|
22406833|NCT02561572|Sheffield Teaching Hospitals NHS Foundation Trust|Dr Matthew Wiles|00441142712381|matthew.wiles@sth.nhs.uk|
22406834|NCT02691468|Department of Anesthesiology and Pain medicine, Yeungnam University School of Medicine, Daegu, Republic of Korea|Sung Mee Jung, M.D|+82-53-620-3368|applejsm@gmail.com|
22406835|NCT00356434|Johns Hopkins Univ|Abimbola Aina|410-955-8496|aaina1@jhmi.edu|
22406836|NCT01190020|University of Iowa|Robert Summers, MD|319-356-2130|robert-summers@uiowa.edu|
22406837|NCT06853210|Adichunchanagiri Institute of Medical Sciences|Dr Naveen N|+91-9980023372|naveen_uno1@yahoo.co.in|
22406838|NCT00656799|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22406839|NCT02422186|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22406840|NCT05281094|HilleVax, Inc.|Astrid Borkowski, Chief Medical Officer|+1 (617) 213-6562|aborkowski@hillevax.com|
22406841|NCT04960397|University of Maryland|Dr. James D. Campbell|410-706-5328|jcampbel@som.umaryland.edu|
22406842|NCT03285061|Brigham & Women's Hospital|Dr. Christopher Chiodo|617-983-7363|cchiodo@bwh.harvard.edu|
22406843|NCT02683668|Imperial College London|Dr Omar Usmani|02073158051|o.usmani@imperial.ac.uk|
22406844|NCT04223778|Merck Sharp and Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22406845|NCT05325333|Purdue University|Dr. Patricia Deevy, Research Associate|765-496-1821|deevy@purdue.edu|
22406846|NCT03893630|University of Kentucky|Dr. John M. O'Brien|8592575158|john.obrien2@uky.edu|
22406847|NCT02390167|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com|
22406848|NCT02308839|W.L. Gore & Associates|Abe Letter|928-864-3113|aletter@wlgore.com|
22406849|NCT01265719|Pfizer, Inc|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22406850|NCT02442765|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22406851|NCT02049385|National Institute of Mental Health|Zarate, Carlos|+1 301 451 0861|zaratec@mail.nih.gov|
22406852|NCT01662752|St Mark's Hospital|Professor Robin Kennedy|+44(0)2082354046|robin.kennedy@nhs.net|
22406853|NCT01693562|MedImmune, LLC|Ashok Gupta|+13013981287|information.center@astrazeneca.com|
22406854|NCT05466240|Atea Pharmaceuticals, Inc.|Atea Clinical Trials|1-857-284-8891|ateaclinicaltrials@ateapharma.com|
22406855|NCT02759939|Dartmouth College|Rachel Thompson|6036530860|rachel.thompson@dartmouth.edu|
22406856|NCT04735432|argenx BV|Regulatory Manager|+32 9 310 34 00|regulatory@argenx.com|
22406857|NCT04397757|University of Pennsylvania|Regulatory Lead|512-662-4484|psom-ind-ide@pobox.upenn.edu|
22406858|NCT02306148|University of Sao Paulo - School of Medicine|Dr Isabel Sacco|0055 11 996431511|icnsacco@usp.br|
22406859|NCT04657003|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22406860|NCT00551200|Hyperion Therapeutics|Sr. Vice President and Chief Medical Officer, Bruce F. Scharschmidt|(650) 745-7851|bruce.scharschmidt@hyperiontx.com|
22406861|NCT02408016|FHCRC|Dr. Aude Chapuis|2066674369|achapuis@fredhutch.org|
22406862|NCT03818399|Virginia Commonwealth University|Roy Sabo, PhD|804-828-3047|roy.sabo@vcuhealth.org|
22417815|NCT01319773|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22417816|NCT00375492|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22417817|NCT03083821|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22417818|NCT03935464|University of California San Francisco|Dr. Monica Gandhi|415 260 6709|monica.gandhi@ucsf.edu|
22417819|NCT05011123|Sanofi Pasteur|Trial Transparency Team|800-633-1610 ext: 6#|Contact-US@sanofi.com|
22417820|NCT00461253|Center for Epidemiology and Health Research, Germany|Dr. Jürgen Dinger|0049 (0) 30 945 101 20|dinger@zeg-berlin.de|
22417821|NCT01933113|Allegheny Health Network|Donald Whiting, MD|412-359-6200|donald.whiting@ahn.org|
22417822|NCT02297438|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22417823|NCT01453894|Northwestern University Feinberg School of Medicine|David W. Baker, MD, MPH|312-503-6400|dbaker1@nmff.org|
22417824|NCT00937378|Serenity Pharmaceuticals|Chief Medical Officer|8456396760|sfein@serenitypharma.com|17
22417825|NCT03758404|MeiraGTx|Program Manager|020 3866 4320|CNGA3@meiragtx.com|
22417826|NCT02440022|Becton Dickinson (BD)|Heidi Ronhovde|480-597-8579|Heidi.Ronhovde@bd.com|
22417827|NCT00792935|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22417828|NCT03402555|Danone Asia Pacific Holdings|Digital Project Manager|82281172|jill.wong@danone.com|
22417829|NCT01404078|St John's Research Institute|Dr. Alben Sigamani|+918049467080|alben@sjri.res.in|
22417830|NCT02920918|Virginia Commonwealth University|Salvatore Carbone|804 628 3980|scarbone@vcu.edu|
22417831|NCT01969448|Washington University School of Medicine|Marissa J. Tenebaum, M.D.|314-996-8800|tenenbaumm@wustl.edu|
22417832|NCT01959035|H. Lundbeck A/S|H. Lundbeck||LundbeckClinicalTrials@Lundbeck.com|
22417833|NCT00450619|National Cancer Institute, National Institutes of Health|Dr. James Gulley, M.D.|301-435-2956|gulleyj@mail.nih.gov|
22417834|NCT03254602|Guided Therapy Systems|Rich Amodei, RDMS|480-649-8587|r.amodei@guidedtherapy.com|
22417835|NCT03309007|UNewMexico|MArk Burge|5052724658|mburge@salud.unm.edu|
22417836|NCT02963311|The Medicines Company|Frank Bosley, Vice-President, Regulatory Operaions|9732906016|frank.bosley@themedco.com|
22417837|NCT01691820|GlaxoSmithKline|GSK Response Center|866-435-7343|biliana.v.nestorova@gsk.com|
22417838|NCT03426566|Wroclaw Medical University|Dr Sutkowska Edyta|0048503077016|edytasutkowska@yahoo.com|
22417839|NCT01911897|Vascular Dynamics|Director, Clinical Operations|9492317602|lgreen@vasculardynamics.com|
22417840|NCT04442490|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22417841|NCT00333879|Atlanta VA Rehab R&D Center|David Ross|404-321-6111|rosss0128@bellsouth.net|6817
22417842|NCT01968694|Brigham & Women's Hospital|Dr. Antje M Barreveld|617-243-6298|abarreveld@partners.org|
22417843|NCT02836496|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22417844|NCT01246011|Massachusetts General Hospital|Anne Philip, Data Manager|617 726 0423|alphilip@partners.org|
22417845|NCT00063635|Columbia University Medical Center|Joel E. Lavine, MD, PhD||jl3553@columbia.edu|
22417846|NCT00415194|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22417847|NCT01646138|National Institute of Allergy and Infectious Diseases|Matthew J. Memoli|+1 301 443 5971|memolim@niaid.nih.gov|
22417848|NCT01683838|Acorda Therapeutics, Inc.|Chief Scientific Officer|914-347-4300|ablight@acorda.com|5102
22417849|NCT01524679|IZKS of the University Medical Center of the Johannes Gutenberg University Mainz|Christian Ruckes|+49 6131 17|ruckes@izks-mainz.de|9919
22417850|NCT03801265|University of Pittsburgh|Sharad Khetarpal, MD|4126235020|khetarpalsk@upmc.edu|
22417851|NCT04078126|AstraZeneca AB|AstraZeneca AB|877-240-9479|information.center@astrazeneca.com|1
22417852|NCT03056157|VA Boston Healthcare System|Dr. Brett Litz|(617)5849314|brett.litz@va.gov, litzb@bu.edu|
22417853|NCT03321630|NYU Langone Health|Paul Oberstein|2127316120|paul.oberstein@nyulangone.org|
22417854|NCT00140426|University of Colorado School of Medicine, Childrens Hospital Colorado|Jennifer Hagman MD|720-777-2539|jennifer.hagman@childrenscolorado.org|
22417855|NCT02149108|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22417856|NCT04168190|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22417857|NCT02325518|Alcon, A Novartis Division|Novartis Pharma KK|1-888-451-3937|alcon.medinfo@alcon.com|
22417858|NCT01675661|Medical University of South Carolina|Kevin Gray, MD|843-792-6330|graykm@musc.edu|
22417859|NCT04765384|Janssen Vaccines & Prevention B.V.|Vice President Medical Affairs IDV|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22417860|NCT00987389|McMaster University, Hamilton, Ontario|Dr. Michael Walsh|905-522-1155|lastwalsh1975@gmail.com|34055
22417861|NCT01342107|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
22417862|NCT02992418|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22417863|NCT00289536|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22417864|NCT03246126|NYU Langone Health|Thomas Maldonado|212-263-7311|Thomas.Maldonado@nyulangone.org|
22417865|NCT02468570|BioMarin Pharmaceutical Inc.|Karen Gu/Director, BioStatistics|650-829-4017|kgu@bmrn.com|
22417866|NCT01006135|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22417867|NCT05297578|Vaxcyte|Vice President of Clinical Development|650-585-0029|clinicaltrialsgov@vaxcyte.com|
22417868|NCT03127644|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22417869|NCT04972123|University of Wisconsin - Madison Cardiovascular Medicine|Mohamed H. Hamdan, MD, MBA|608-263-4856|mhamdan@medicine.wisc.edu|
22417870|NCT02032706|Advanced Brain Monitoring, Inc.|Daniel Levendowski|760 720 0099|dan@b-alert.com|x6040
22417871|NCT00893737|Clinvest|Rebecca Browning|(417) 841-3664|rbrowning@clinvest.com|
22406863|NCT02390323|Hospital for Special Surgery|Semih Gungor|212-606-1206|gungors@hss.edu|
22406864|NCT02987205|Prollenium Medical Technologies, Inc.|Ario Khoshbin, President|866-353-3015||
22406865|NCT01672827|GE Healthcare|Paul Sherwin, M.D.|1-609-514-6820|paulsherwin@ge.com|
22406866|NCT02807376|Ethicon|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
22406867|NCT02481986|University of Illinois Chicago|Molly A Martin, MD|312-996-2363|mollyma@uic.edu|
22406868|NCT03228836|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+8613382419112|jessica.yi@innoventbio.com|
22406869|NCT00948389|Bristol-Myers Squibb|BMS Study Director||clinical.trials@bms.com|
22406870|NCT01619176|CNR IAC|DR. Christine Nardini|+393386947833|christine.nardini.rsrc@gmail.com|
22406871|NCT00848172|NINDS|Mark Hallett|301-496-9526|hallettm@ninds.nih.gov|
22406872|NCT05306964|University of Pittsburgh|Raghavan Murugan, MD, MS, FRCP, Principal Investigator|412-647-8499|muruganr@ccm.upmc.edu|
22406873|NCT03574987|University of Bath|Professor Javier Gonzalez|0122538|j.t.gonzalez@bath.ac.uk|5518
22406874|NCT00366106|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
22406875|NCT02089191|Alcon Research, Ltd.|Global Medical Affairs Brand Lead - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22406876|NCT00750867|University of Massachusetts Medical School|Dr.Peter Novak|508-334-4973|novakp@ummhc.org|
22406877|NCT04652102|CureVac AG|Clinical Trial Information|0049 6976805870|clinicaltrials@curevac.com|
22406878|NCT00706264|Hospital Vall d'Hebron|Maria M Goya|934893085|maria.goya@vhir.org|4652
22406879|NCT01756833|University of Maryland School of Medicine|Michael L. Terrin, MDCM, MPH, Contact Principal Investigator|410-706-6139|mterrin@som.umaryland.edu|
22406880|NCT00952588|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22406881|NCT00808132|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22406882|NCT03442933|Universidad Europea de Madrid|Gerson Garrosa Martín|+34 663 294 774|g.garrosa@gmail.com|0034
22406883|NCT00890201|Hospital de La Serena|Marcelo A. Beltran, M.D. - Department of Surgery - Hospital de La Sererna|56 51 485923|beltran_01@yahoo.com|
22406884|NCT01371721|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22406885|NCT01347840|Ethicon Endo-Surgery, Inc.|Amy Mahanes|513-337-8366|amahanes@its.jnj.com|
22406886|NCT02152540|DVBIC, VA Palo Alto/Stanford School of Medicine|Dr. Maheen M. Adamson|6502136307|madamson@stanford.edu|
22406887|NCT01045551|Columbia University Medical Center|Julian Mackay-Wiggan, MD, MS|212-305-6953|jc299@cumc.columbia.edu|
22406888|NCT01846208|Icahn School of Medicine at Mount Sinai|Dr. Hugh A. Sampson|212-659-9426|hugh.sampson@mssm.edu|
22406889|NCT01432938|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22406890|NCT00369928|Procter & Gamble|Peter Thomas|513.622.4838|thomas.pr@pg.com|
22406891|NCT01875874|Vital Therapies, Inc.|Robert Ashley|858-673-6840|rashley@vitaltherapies.com|
22406892|NCT00374127|New York State Psychiatric Institute at Columbia University Medical Center|Dr. Meg Haney, Professor of Neurobiology|6467746153|meg.haney@nyspi.columbia.edu|
22406893|NCT01635244|University of Michigan|David Bach, MD|734-615-4907|dbach@med.umich.edu|
22406894|NCT00281528|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22406895|NCT02871570|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22406896|NCT02520141|M D Anderson Cancer Center|Milind Javle|(713) 792-5434|mjavle@mdanderson.org|
22406897|NCT00703781|ISTA Pharmaceuticals, Inc.|Tim McNamara, PharmD|949-788-6000|tmcnamara@istavision.com|
22406898|NCT02168816|Loyola University Medical Center|Michael Pinzur, M.D.|708-216-4993|mpinzu1@lumc.edu|
22406899|NCT01225211|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22406900|NCT00945594|University of Oklahoma Health Sciences Center|Lieschen Quiroz, MD|405-271-8787|lieschen-quiroz@ouhsc.edu|
22406901|NCT01893879|Stanford University|Leslie Roche, RN|650-723-1396|lesroche@stanford.edu|
22406902|NCT01984294|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22406903|NCT01134328|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
22406904|NCT02709889|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22406905|NCT00537810|Yale University School of Medicine|Dr. Carlos Grilo|2037852792|carlos.grilo@yale.edu|
22406906|NCT00410514|Astellas Pharma Global Development, Inc. (APGD)|Associate Medical Director, Medical Sciences||ClinicalTrials.Disclosure@us.astellas.com|
22406907|NCT00671515|University Hospitals Cleveland Medical Center|Dr. Joseph Calabrese|216-844-2865|Joseph.Calabrese@UHhospitals.org|
22406908|NCT02449915|TriHealth Inc.|Jennifer Yeung, DO|513-463-4300|Jennifer_Yeung@trihealth.com|
22406909|NCT01436357|University of New Mexico and Johns Hopkins University|Kimberly Page, Ph.D., M.P.H. and Andrea Cox, M.D., Ph.D.|505-272-2520, 410-502-2715|pagek@salud.unm.edu, acox@jhmi.edu|
22406910|NCT03300557|University of Minnesota/Masonic Cancer Center|Britt Erickson|612-626-6283|bkeric@umn.edu|
22417872|NCT01156142|Mayo Clinic|Robert C. Miller, M.D.|507/266-6247|Miller.Robert@mayo.edu|
22417873|NCT00928707|Italfarmaco SpA|Carlo Bianchini, MD|+39 02 6443 2540|c.bianchini@italfarmaco.com|
22417874|NCT00132028|SWOG Statistical Center|Study Statistician|206-667-4623||
22417875|NCT02140411|Novartis Pharmaceuticals|Study Director|862-778-1873||
22392080|NCT00790205|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22392081|NCT00759642|University of Kansas Cancer Center|Priyanka Sharma, MD|913-945-5059|PSHARMA2@kumc.edu|
22392082|NCT02676843|Columbia University|William Kreisl, MD|212-342-2380|wck2107@cumc.columbia.edu|
22392083|NCT02643628|Suneva Medical|Director of Clinical Affairs|858-324-6268|alehman@sunevamedical.com|
22392084|NCT05143138|WL Gore|Cinzia Santin, Clinical Study Mgt, Gore Medical Products|+393463645539|csantin@wlgore.com|
22392085|NCT01993849|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
22392086|NCT04245345|Medtronic|Rachel Vasseur, Sr. Clinical Research Specialist|6123550360|rachel.s.vasseur@medtronic.com|
22417876|NCT03584724|Eye Pharma|Elena Meloni|7862187339|elena.meloni@eyepharma.com|
22392087|NCT00980746|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com|
22392088|NCT02335905|Baylor College of Medicine|Sheldon L. Kaplan|832-824-4330|skaplan@bcm.edu|
22392089|NCT04805073|University of Florida Health Gainesville|Adam Wendling, MD, Division Chief Obstetric Anesthesiology|3528707461|Awendling@anest.ufl.edu|
22392090|NCT01160237|GlaxoSmithKline|GSK Response Center|866-435-7343||
22392091|NCT00422734|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22392092|NCT00848484|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22392093|NCT01059305|The University of Texas (UT) MD Anderson Cancer Center|Bonnie Glisson, MD/Professor, Thoracic/Head & Neck Med Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
22392094|NCT01081886|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com|
22392095|NCT02567708|GlaxoSmithKline|GSK Response Center|866-435-7343||
22392096|NCT00706654|Otsuka Pharmaceutical Development and Commercialization|Global Medical Affairs|800 562-3974||
22392097|NCT02097303|Carolina Research Professionals, LLC|Dr. Neal D. Shore, MD, FACS, CPI|843-449-1010|nshore@carolinaresearchprofessionals.com|243
22392098|NCT05000047|Sonova USCS|Principal Investigator, Director of Research|630-821-5000|phonakaudiologyresearch@gmail.com|
22392099|NCT03937141|Chinook Therapeutics, Inc.|Chinook Therapeutics, Inc. (formerly Aduro Biotech, Inc.)|206-485-7051|clinicaltrials@chinooktx.com|
22392100|NCT02975102|Bausch + Lomb|Associate Director, Global Clinical Operations|+49 30 330 93|natasa.orlic-pleyer@bausch.com|318
22392101|NCT00780455|Bayer Healthcare AG|Medical Affiars Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22392102|NCT05262751|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22392103|NCT00594022|R.P. Chiacchierini & Associates|R.P. Chiacchierini & Associates|(240) 683-3738|rpc@rpcaconsulting.com|
22392104|NCT02956837|GlaxoSmithKline|GSK Response Center|866-435-7343|shm60684@gsk.com|
22392105|NCT01824589|Advanced Circulatory|Sr. Clinical Research Associate|651.403.5600|nburkhart@advancedcirculatory.com|
22392106|NCT02614690|Connecticut Children's Medical Center|Dr, Mark Lee|860-837-7421|Mlee01@connecticutchildrens.org|
22392107|NCT01727505|University of Miami School of Medicine, Dept. of Pediatrics - Div. of Neonatology|Nelson Claure, MSc, PhD, Director Neonatal Pulmonary Research Lab|305 585 6408|nclaure@miami.edu|
22392108|NCT01154140|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22392109|NCT00358644|Eisai Inc.|Eisai Call Center|888-422-4743||
22392110|NCT00368875|Montefiore Medical Center - New York|NYCC Regulatory Coordinator|718-379-6862|sforde@montefiore.org|
22392111|NCT03327831|UC Irvine|Christopher Zachary|949-824-5515|czachary@uci.edu|
22392112|NCT02595372|IndianaU|Dr. Kathy Miller|(317) 948-3855|kathmill@iu.edu|
22392113|NCT02588872|Rush University Medical Center|Mukesh Ahuja|312-432-2380|cole.research@rushortho.com|
22392114|NCT00401258|McLean Hospital|Brian Brennan, M.D.|617-855-2911|bbrennan@partners.org|
22392115|NCT01661764|Vanderbilt University Medical Center|Harvey J Murff|615 936 8319|harvey.j.murff@vanderbilt.edu|
22392116|NCT01976273|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
22392117|NCT02354820|Indiana University School of Medicine|William E. Bennett, Jr. Principal Investigator|3172786928|webjr@iu.edu|
22392118|NCT03312023|Institute of Human Virology, University of Maryland Baltimore|Dr. Joel V. Chua|1-410-706-5704|jchua@ihv.umaryland.edu|
22392119|NCT02706405|Fred Hutchinson Cancer Center|Dr. Jordan Gauthier|2066672713|jgauthier@fredhutch.org|
22392120|NCT03011567|NYU Langone Health|Christina Penfield, MD, MPH|646-754-2700|christina.penfield@gmail.com|
22392121|NCT00603525|GlaxoSmithKline|GSK Response Center|866-435-7343||
22392122|NCT01483144|Cancer Prevention Pharmaceuticals|Michelle Boytim|520-908-7774|mboytim@canprevent.com|
22392123|NCT02460575|Tulane University|Dr. Richard Oberhelman|504-988-2511|oberhel@tulane.edu|
22392124|NCT04624243|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22392125|NCT03374488|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
22392126|NCT03104075|The Jackson Laboratory|Dr. Jacques Banchereau|860-837-2443|jacques.banchereau@jax.org|
22392127|NCT00944229|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu|
22392128|NCT06456385|Medical University of South Carolina|Dr. Xiaolong Peng|8437928642|pengxi@musc.edu|
22392129|NCT01810939|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com|
22392130|NCT01877148|Universidade Federal de Pernambuco|Kátia Monte-Silva|+ 55 (81) 2126-7579|monte.silvakk@gmail.com|
22392131|NCT04497389|University of Utah|Joseph Tonna, MD|801-587-6271|joseph.tonna@hsc.utah.edu|
22392132|NCT03065075|University of Massachusetts|Dr. Tania Sierra|508-334-9840|tania.sierra@umassmemorial.org|
22392133|NCT00789360|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
22417877|NCT03981419|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
22392134|NCT04400487|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22417878|NCT01330459|Oregon Health and Science University|Alison Edelman, MD, Assistant Professor|(503) 494-3666|edelmana@ohsu.edu|
22406911|NCT01394211|University of Arizona Cancer Center|Program Coordinator|5206260301|aselegue@email.arizona.edu|
22406912|NCT02469597|Northwell Health- Cohen Children's Medical Center|Dr. Kristy Williamson|718-470-7640|kwilliam12@nshs.edu|
22406913|NCT01021293|GlaxoSmithKline|GSK Response Center|866-435-7343||
22406914|NCT04335929|Lamar University|Dr. Vinaya Manchaiah, Jo Mayo Endowed Professor|(409) 812 9443|vmanchaiah@lamar.edu|
22406915|NCT01319539|Columbia University Medical Center|Kevin Kalinsky, MD|212-305-1945|kk2693@cumc.columbia.edu|
22406916|NCT00303602|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22406917|NCT02491463|GlaxoSmithKline|GSK Response Center|866-435-7343||
22431538|NCT05943990|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22406918|NCT01491802|Queen's University|Kathy Webb|613-549-6666|kw2@queensu.ca|4950
22406919|NCT03993314|University of Alabama at Birmingham|Dr. Mark Powell|205-934-6007|mfpowell@uabmc.edu|
22406920|NCT01864746|German Breast Group (GBG) Forschungs GmbH|Prof. Dr. Sibylle Loibl|+49 6102 7480|penelope@gbg.de|0
22406921|NCT01005966|GlaxoSmithKline|GSK Response Center|866-435-7343||
22406922|NCT01347931|Clinical Reseach Consulting|Richard J. Morishige, MS, RRT|510-606-0375|rjmorishige@gmail.com|
22406923|NCT02554721|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22406924|NCT04607291|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-1300|Kris.Attwood@roswellpark.org|
22406925|NCT00626327|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22406926|NCT03502265|University of Southern California|Beth Smith|323-361-4670|beth.smith@usc.edu|
22406927|NCT01273207|National Heart Lung and Blood Institute|Dr Richard Childs|+301-451-7128|childsr@nhlbi.nih.gov|
22406928|NCT03347279|AstraZeneca|Global Clinical Head|+1 302 885 1180|information.center@astrazeneca.com|
22406929|NCT04880642|Vicore Pharma|CEO Carl-Johan Dalsgaard|+46 (0) 317880560|info@vicorepharma.com|
22406930|NCT00141297|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22406931|NCT00394654|MedImmune|Don Raible, MD|301-398-0000|raibleD@medimmune.com|
22406932|NCT03442595|MedStar Health|Dr Michelle F Magee, Director MedStar Diabetes Institute|202-877-2383|michelle.f.magee@medstar.net|
22406933|NCT01228149|Dept. of Ophthalmology, University Medical Center Mainz|Dr. Dr. Katrin Lorenz|00496131174069|lorenz@augen.klinik.uni-mainz.de|
22406934|NCT01060150|Medical Affairs / Janssen-Cil Korea|Clinical Research Director|82-2-2094-4518||
22406935|NCT03018340|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2897|medicalinformation@acadia-pharm.com|
22406936|NCT01836549|University of Tennessee Health Science Center|Dr. Mehmet Kocak|9014482937|mkocak1@uthsc.edu|901
22406937|NCT02192190|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22406938|NCT00381706|Dana Farber Cancer Institute|Peter Enzinger, M.D.||peter_enzinger@dfci.harvard.edu|
22406939|NCT02364999|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22406940|NCT00550615|University of Nebraska Medical Center|Julie M Vose|402-559-348|jmvose@unmc.edu|
22406941|NCT01234337|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22406942|NCT01309646|GlaxoSmithKline|GSK Response Center|866-435-7343||
22406943|NCT02181504|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22406944|NCT02555722|CooperVision Inc.|Senior Manager, Clinical Research|925-730-6754|PChamberlain@coopervision.com|
22406945|NCT02815982|University of South Florida|Dr. Marilyn Stern|8139740966|mstern1@usf.edu|
22406946|NCT01671605|Vanderbilt University Medical Center|Valentina Kon|6153224883|valentina.kon@vanderbilt.edu|
22406947|NCT03514394|University of Washington|Morgan Johnson|17154161493|mjohn23@uw.edu|
22406948|NCT02584660|Janssen Scientific Affairs, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22406949|NCT00461552|UT Southwestern Medical Center|Dr. Abhimanyu Garg|214-648-2895|abhimanyu.garg@utsouthwestern.edu|
22406950|NCT00374452|VA Palo Alto Health Care System|Mary K. Goldstein, MD|650-493-5000|mary.goldstein@va.gov|1,1,62105
22406951|NCT02877134|Janssen Research & Development, LLC|DIRECTOR CLINICAL RESEARCH GI|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22406952|NCT00523744|Novartis Pharmaceuticals|Study Director|862-778-8300||
22406953|NCT01289028|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22406954|NCT04623255|University College London|Prof Marie Scully|+ 44 (0)20 3447 9884|m.scully@ucl.ac.uk|
22406955|NCT04922710|AdventHealth Research Institute|Kirk Erickson, Director of Translational Neuroscience|412-576-3724|kirk.erickson@adventhealth.com|
22406956|NCT02031627|Tactile Medical|Susy Peters, Clinical Trial Manager|612-540-7175|speters@tactilemedical.com|
22406957|NCT01100762|University of Maryland, Baltimore|Gad Alon, PhD, PT|410-706-7733|galon@som.umaryland.edu|
22406958|NCT01040728|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22406959|NCT01003067|Hirslanden Bern|Prof. Christoph A. Maurer|+41 31 335 33 33|christoph.maurer@hin.ch|
22406960|NCT02282930|Mayo Clinic|Dr. Fernando Fervenza|507-266-1045|fervenza.fernando@mayo.edu|
22406961|NCT06022224|ImmunityBio|Lennie Sender, Chief Operating Officer|855-797-9277|lennie.sender@immunitybio.com|
22406962|NCT01855867|The Fenway Institute|Dr. Kenneth Mayer, Medical Research Director|6179276374|kmayer@fenwayhealth.org|
22406963|NCT00542425|Radius Health, Inc.|Program Director|(617) 551-4700|info@radiuspharm.com|
22406964|NCT01424306|Fred Hutchinson Cancer Research Center|Mario Kratz|206-667-7362|mkratz@fredhutch.org|
22406965|NCT00193128|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22406966|NCT02096471|The Univ of Alabama at Birmingham|Gary Cutter, PhD|205.975-5048|cutterg@uab.edu|
22406967|NCT03344562|University of Texas Southwestern Medical Center|Dr. Amy Mathews - ASSISTANT PROFESSOR|214/645-1719|Amy.Mathews@UTSouthwestern.edu|
22406968|NCT02463331|Clinic Hospital of University of Sao Paulo|Lydia Teófilo de Moraes Falcão|55-81-996486935|lydiatmf@yahoo.com.br|81
22406969|NCT02590406|Institut universitaire Cardiologie et Pneumologie de Québec|Dr Jean S Bussières|418-656-8711|jbuss@criucpq.ulaval.ca|2944
22406970|NCT00631969|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22406971|NCT01084096|NICHDGlobal|Dr. Elizabeth McClure, Data Coordinating Center PI|919-316-3773|mcclure@rti.org|
22406972|NCT00027846|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22406973|NCT02033369|NYSPI|Franklin Schneier, MD|646-774-8041|fschneier@nyspi.columbia.edu|
22406974|NCT00387829|Intergra LifeSciences|Director of Medical Affairs|609-275-0500|clinicalaffairs-neuro@integralife.com|
22406975|NCT00663208|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22406976|NCT01451203|Astellas Pharma Inc|Vice President, Japan/Asia Clinical Development||Astellas.resultsdisclosure@astellas.com|
22406977|NCT00039377|Roswell Park Cancer Institute|Meir Wetzler, M.D.||meir.wetzler@roswellpark.org|
22406978|NCT01249404|Ipsen|Medical Director, Neurology||clinical.trials@ipsen.com|
22406979|NCT03890731|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22406980|NCT03758612|TB Alliance|Majda Benhayoun|347-601-8225|majda.benhayoun@tballiance.org|
22406981|NCT01749930|Bausch + Lomb, a division of Valeant Pharmaceuticals|H. DeCory, Director Medical Affairs|585 732-3284|heleen_H_decory@bausch.com|
22406982|NCT00945945|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22406983|NCT02500901|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317-643-5842|jsmith@hoosiercancer.org|41
22406984|NCT01191190|University of California, San Diego|Januario E Castro, MD|(858) 822-6600|jecastro@ucsd.edu|
22406985|NCT01716585|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
22406986|NCT04235959|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22406987|NCT00125138|H. Lundbeck A/S|H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
22406988|NCT00348686|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22406989|NCT02911324|Columbia University/New York State Psychiatric Institute|Reilly Kayser, MD|646-774-8118|reilly.kayser@nyspi.columbia.edu|
22406990|NCT02381795|Clinvest Research|Clinical Data Manager|417-883-7889|jsly@clinvest.com|
22406991|NCT03798366|Galapagos NV|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
22406992|NCT01117428|Symphogen A/S|Chief Scientific Officer|+45 8838 2600|info@symphogen.com|
22406993|NCT00474539|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22406994|NCT02195531|Philips Research|Senior Scientist|+31628041122|Joyca.lacroix@philips.com|
22406995|NCT04912297|Finnish Institute for Health and Welfare|Dr. Merit Melin, Research manager||merit.melin@thl.fi|
22406996|NCT02417129|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22406997|NCT00676806|Tufts Medical Center|Andreas Klein, MD|617-636-8884|aklein2@tuftsmedicalcenter.org|
22406998|NCT01657253|Laboratorios Sophia S.A. de C.V.|Leopoldo M Baiza-Duran MD, Director of Clinical Trials|52+ 33 30014200|leopoldo.baiza@sophia.com.mx|
22406999|NCT01970540|Pharma Mar S.A.|Pharma Mar S.A.|0034918466000|clinicaltrials@pharmamar.com|
22407000|NCT00242710|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22407001|NCT01057394|CardioFocus, Inc.|Burke Barrett, VP, Regulatory & Clinical Affairs|508 658-7200|bbarrett@cardiofocus.com|
22407002|NCT00579527|Duke University Medical Center|M. Louise Markert, MD, PhD Professor of Pediatrics and Immunology|919-684-6263|marke001@mc.duke.edu|
22407003|NCT03727802|Toray Industries, Inc|Clinical Trials Information Desk|+81-3-3245-8576|clinical-trials.toray.mb@mail.toray|
22407004|NCT02177942|GlaxoSmithKline|GSK Response Center|866-435-7343||
22407005|NCT04180475|University of Virginia|John Stankovic|434-982-2275|jas9f@virginia.edu|
22407006|NCT01056601|Masonic Cancer Center, University of Minnesota|Arkaduisz Dudek, M.D.|612-624-0123|dudek002@umn.edu|
22407007|NCT01694966|Cosmo Technologies Ltd|R&D Manager|111111111|rjones@cosmopharma.com|11111
22407008|NCT00702949|Mayo Clinic|Charles Loprinzi, M.D.|507/284-1623|cloprinzi@mayo.edu|
22407009|NCT00598585|Charles R. Drew University|Theodore C. Friedman MD PhD|3106685197|theodorefriedman@cdrewu.edu|
22407010|NCT00545584|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22407011|NCT01795716|Shanghai Jiaotong University School of Medicine Ruijin Hospital|Dr. Zhou Li|13816510379|lizhou999_999@yahoo.com|
22407012|NCT00135694|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22407013|NCT00660816|CCCC|Dr. Afshin Dowlati|216-844-1228|afshin.dowlati@uhhospitals.org|
22407014|NCT00998985|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22407015|NCT01601873|The University of Texas Health Science Center at Houston|Kristofer Charlton-Ouw, MD|(713) 486-5117|Kristofer.CharltonOuw@uth.tmc.edu|
22407016|NCT03196973|Laboratorios Salvat, S.A.|Medical Director|933946400|ejimenez@svt.com|
22407017|NCT01401101|RAND Corporation|Lisa S. Meredith, PhD|310.393.0411|seidel@rand.org|7365
22407018|NCT01610414|GlaxoSmithKline|GSK Response Center|866-435-7343||
22407019|NCT01555541|University of California, San Francisco|Charalambos Andreadis, MD, MSCE, Associate Professor of Clinical Medicine|877-827-3222|cancertrials@ucsf.edu|
22407020|NCT02736474|Shanghai Mental Health Center|Chief Physician Dr Du. Jiang Du|86-21-64387250|dujiangdou@163.com|
22407021|NCT03726749|MGH|Dr Sebastian Unizony|617-726-7938|sunizony@mgh.harvard.edu|
22407022|NCT00472043|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22407023|NCT04957745|Schepens Eye Research Institute of Massachusetts Eye and Ear|Dr. Jaehyun Jung|6179122525|jaehyun_jung@meei.harvard.edu|
22407024|NCT04009824|University of Maryland School of Medicine - Center for Vaccine Development|Dr. Matthew Laurens|410-706-5328|mlaurens@som.umaryland.edu|
22407025|NCT03147495|PLA Institute of Orthopaedics, Xijing Hospital, Fourth Military Medical University, No.17, Changle West Road, Xincheng District, Xi'an, Shanxi Province, China|Dr. Cheng Huang|0086-57427754027|jfj113hc@163.com, jfj906hc@163.com|
22407026|NCT01024946|Memorial Sloan Kettering Cancer Center|Dr. Lee Krug|646-888-4201|krugl@mskcc.org|
22407027|NCT02483611|University of Sao Paulo|Dra Waynice Neiva de Paula Garcia|551636021000|waynicegarcia@gmail.com|2211
22407028|NCT02608892|Children's Hospital of Eastern Ontario|Dr Denise Harrison|613-737-7600|dharrison@cheo.on.ca|4140
22407029|NCT03032523|Yale University|Laura Nally, MD, Instructor in Pediatrici Endocrinology|9728324734|laura.nally@yale.edu|
22407030|NCT05375838|ModernaTX, Inc|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
22407031|NCT00957723|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@Stryker.com|
22407032|NCT00877890|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22407033|NCT00984009|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22407034|NCT04396106|Atea Pharmaceuticals, Inc.|Atea Clinical Trials|1-857-284-8891|ateaclinicaltrials@ateapharma.com|
22407035|NCT00928499|University of California, Irvine|Karen Noblett, MD|714-456-8564|knoblett@uci.edu|
22407036|NCT02036476|Dana-Farber Cancer Institute|Dr. Robert Haddad|617.632.3090|ROBERT_HADDAD@DFCI.HARVARD.EDU|
22407037|NCT02698176|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22407038|NCT00060333|Mayo Clinic|Barbara A. Pockaj, MD|507/284-3559|pockaj.barbara@mayo.edu|
22407039|NCT02985684|W. L. Gore & Associates|Bryan Randall|928-864-4832|BRandall@WLGore.com|
22407040|NCT01497665|Angiochem Inc.|Betty Lawrence, Vice President, Development|514-788-7800|blawrence@angiochem.com|205
22407041|NCT01640353|SI-BONE, Inc.|Daniel Cher, MD, Vice President of Clinical Affairs|650-269-5763|dcher@si-bone.com|
22407042|NCT01967134|IAVI|Dr. Dereck Tait|27214424991|dtait@iavi.org|
22407043|NCT00443534|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22407044|NCT03479203|University of Pennsylvania|Felix W.Wehrli, PhD|215-662-7951|felix.wehrli@pennmedicine.upenn.edu|
22407045|NCT02679222|Université de Sherbrooke|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
22407046|NCT03419741|Medical University of SouthCarolina|Dr. Xingbao Li|843 7925729|lixi@musc.edu|
22407047|NCT03428230|Sintetica SA|Dr.Elisabetta Donati, Corporate Director Scientific Affairs|+41.91.640.42.50|edonati@sintetica.com|
22407048|NCT00836342|Clinical Unit for Research Trials in Skin, Massachusetts General Hospital|Kristen Corey|617-726-1302|kcorey1@partners.org|
22407049|NCT02719028|Golden Biotechnology Corp|Howard Cheng|+886-2-28086006|howard@goldenbiotech.com|
22407050|NCT00298766|Johnson & Johnson Pharmaceutical Research & Development|Dr. Helgi van de Velde||HVDVELDE@ITS.JNJ.COM|
22407051|NCT00303719|Masonic Cancer Center, University of Minnesota|Erica Warlick, MD|612-625-8942|ewarlick@umn.edu|
22407052|NCT04853368|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22407053|NCT03633461|Oyster Point Pharma, Inc.|Jeffery Nau|609-382-9035|jnau@oysterpointrx.com|
22407054|NCT01880320|Galderma R&D|Galderma CPM|00 33 4 93 95 70 70|clinicaltrials@galderma.com|
22407055|NCT04495166|Medical School of the University of Sao Paulo|Daniel Fatori|5511 96162-6183|daniel.fatori@gmail.com|
22407056|NCT00041119|Dana-Farber Cancer Institute|Lawrence N. Shulman, M.D.|(617)-632-2277|Lawrence_Shulman@dfci.harvard.edu|
22407057|NCT01258738|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22431539|NCT04696146|Cedars-Sinai Medical Center|Noriko Ammerman|3102488186|noriko.ammerman@cshs.org|
22407058|NCT00689611|Divisions of Cardiology and Clinical Epidemiology, Jewish General Hospital/McGill University|Dr. Mark J. Eisenberg|514.340.8222|mark.eisenberg@mcgill.ca|3564
22407059|NCT01722552|Boston University School of Public Health|Dr Lora Sabin|617-414-1272|lsabin@bu.edu|617
22407060|NCT00568399|Washington University School of Medicine|James Delmez, MD|314 362 7207|jdelmez@dom.wustl.edu|
22407061|NCT00724594|Medical University of South Carolina|Dr. Dorothea Jenkins|843-792-4341|jenkd@musc.edu|
22407062|NCT02967562|King's College London|Professor Anne Greenough|02032999000|anne.greenough@kcl.ac.uk|
22407063|NCT00405756|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22407064|NCT02404792|University of Colorado|Kristine Erlandson (PI)|303-724-4941|kristine.erlandson@ucdenver.edu|
22407065|NCT01800162|University of Pennsylvania|Dr. Kurt Barnhart|215-662-2974|KBarnhart@uphs.upenn.edu|
22407066|NCT00286156|Cleveland Clinic|Dr William Braun Consultant Staff Nephrology, Cleveland Clinic|216/444/6995|braunw@ccf.org|
22407067|NCT04586127|Wake Forest University School of Medicine|Dr. Emily Haines|(336) 716-5170|ehaines@wakehealth.edu|
22407068|NCT02870348|Instituto Grifols SA|Sandra Camprubi|+34935710049|sandra.camprubi@grifols.com|
22407069|NCT00672139|Salix Pharmaceuticals|David Sorscher|919-862-1827|david.sorscher@salix.com|
22407070|NCT01051856|Mayo Clinic|Florencia G. Que, MD|507-284-6178|que.florencia@mayo.edu|
22407071|NCT02176226|Northwestern University|David C. Mohr, PhD|312-503-1403|d-mohr@northwestern.edu|
22407072|NCT00932399|Seattle Epidemiologic Research and Information Center|Alyson Littman|206-277-4182|alyson.littman@va.gov|
22407073|NCT03894501|Rutgers Robert Wood Johnson Medical School|Nina Cooperman|732-235-8569|cooperna@rwjms.rutgers.edu|
22407074|NCT01173874|New York State Psychiatric Institute|Dr. Joshua Kantrowitz|646-774-8436|mcarlson@nyspi.columbia.edu|
22407075|NCT01488994|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22407076|NCT01072500|Wake Forest School of Medicine|Michael Miller|336-716-6837|mmiller@wakehealth.edu|
22407077|NCT02908841|Western Connecticut Health Network|Joann Petrini|203-739-6882|Joann.Petrini@wchn.org|
22407078|NCT00103207|ECOG Statistical Office|Study Statistician|617-632-3012||
22407079|NCT01611558|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22407080|NCT02465957|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22407081|NCT01520727|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22407082|NCT01245972|ucsdmed|S. Brian Jiang|8586571663|s2jiang@ucsd.edu|
22407083|NCT01412333|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22407084|NCT04005885|CooperVision. Inc|Jose A. Vega, O.D., MSc., FAAO|925 621 3761|javega@coopervision.com|
22407085|NCT01038635|The University of Texas (UT) MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
22407086|NCT01227252|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22407087|NCT04542525|Alcon Research, LLC|Director of Clinical Projects, Surgical|+1-817-909-6199|jessie.hull@alcon.com|
22407088|NCT01034709|QIAGEN|Kevin Modarress, PhD Senior Manager Regulatory Affairs Operations NA, Regulatory Affairs|301-944-7103|kevin.modarress@qiagen.com|
22407089|NCT03227692|Zimmer Biomet G.K.|Senior Manager of Clinical Affairs|+81-3-6402-6610|takahito.nakai@zimmerbiomet.com|
22407090|NCT02447952|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22407091|NCT02736149|Eiger BioPharmaceuticals, Inc.|Senior VP, Clinical Development|1-650-272-6138|info@eigerbio.com|
22407092|NCT01683058|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22407093|NCT01195636|Xenon Pharmaceuticals Inc.|Dr. Paul Goldberg, VP Clinical Development|604-484-3300|pgoldberg@xenon-pharma.com|
22407094|NCT00203294|Thomas Jefferson University|Kathleen Bradley|215-955-2025|Kathleen.Bradley@Jefferson.edu|
22407095|NCT01566981|Department of family medicine, Medical Faculty in Ljubljana|Dr. Rade Iljaž|'386 31 300- 381|radeiljaz@gmail.com|
22407096|NCT03062605|UCLA|Dr. Vladimir W. Spolsky|310-794-0700|vspolsky@dentistry.ucla.edu|
22407097|NCT02405091|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22407098|NCT01009333|Medtronic Neuromodulation|Maureen McGuire, Sr. Program Manager|763-526-8425|maureen.mcguire@medtronic.com|
22407099|NCT01948791|Novartis Pharmaceuticals|Study Director|862-778-8300||
22407100|NCT02139176|UNC Chapel Hill/UNC Project Lilongwe|Nora Rosenberg, PhD|+265 (0)99 109 0676|Nora_Rosenberg@unc.edu|
22407101|NCT02246309|Center for Human Reproduction|Dr. David Barad, Director of Clinical Research|2129944400|dbarad@theCHR.com|212
22407102|NCT01365195|Cedars Sinai Medical Center|Research project Advisor|310-423-1682|Ofelia.Elvir-Lazo@cshs.org|
22407103|NCT02076243|Icahn School of Medicine at Mount Sinai|Dr. Philip Friedlander|212-824-8584|philip.friedlander@mssm.edu|
22407104|NCT00590031|Memorial Sloan Kettering Cancer Center|Dr. David Ilson, Attending|+1646-888-4183|ilsond@mskcc.org|
22407105|NCT01809327|Janssen Research & Development, LLC|Senior Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
22407106|NCT01646346|Yale University|Dr. Suzanne Evans, MD, MPH|(203) 785-5175|suzanne.evans@yale.edu|
22407107|NCT02802735|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22407108|NCT01166386|Carolinas Healthcare System, Carolinas Medical Center|Dr. Janet Niemeier|704 355 2046|janet.niemeier@carolinashealthcare.org|
22407109|NCT01564485|University of California, Irvine|Ashwini Erande, Clinical Coordinator|714 456 7025|aerande@uci.edu|
22407110|NCT00852761|GlaxoSmithKline|GSK Response Center|866-435-7343||
22407111|NCT03922711|Prilenia|Prilenia|+972 775558|info@prilenia.com|482
22407112|NCT00420212|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
22417879|NCT02337959|Carestream Health, Inc.|Susan Pate, RN, MS, RAC|585-627-6557|susan.pate@carestream.com|
22417880|NCT03562559|Vancouver General Hospital|Marcus Tholin|604-875-4111|marcus.tholin@vch.ca|
22417881|NCT01231399|City of Hope|Paul Frankel, Ph.D.|(626) 218-5265|pfrankel@coh.org|
22417882|NCT02623348|University of California, San Francisco|Anoop Sheshadri|415-221-4810|anoop.sheshadri@ucsf.edu|22576
22417883|NCT02272634|Yungjin Pharm. Co., Ltd.|Director of Clinical Trials|82-2-2041-8318|mhlee2017@yungjin.co.kr|
22417884|NCT01437943|Brigham and Women's Hospital|Anil Chandraker, MD|617-732-7412|achandraker@partners.org|
22417885|NCT01660334|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22417886|NCT00536263|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22417887|NCT03003949|University of North Carolina at Chapel Hill|Susan Girdler, PhD|919-590-0813|rachel_kozik@med.unc.edu|
22417888|NCT02205983|University of Chicago|Dr. Harriet de Wit|773-702-3560|dewitlab@yoda.bsd.uchicago.edu|
22417889|NCT01640873|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22417890|NCT01321008|University of Texas MD Anderson Cancer Center|Bouthaina Dabaja, MD / Associate Professor, Radiation Oncology|713-563-2300|CR_Study_Registration@mdanderson.org|
22417891|NCT02458092|US Army Medical Research Unit - Kenya|Nekoye Otsyula|254-722-239-828|notsyula@wrp-ksm.org|
22417892|NCT00679913|Seoul National University Hospital|Sun-Whe Kim, M.D., Ph.D., FACS|82-2-2072-2310|sunkim@plaza.snu.ac.kr|
22417893|NCT00534794|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||clinicaltrialsdisclosure@merck.com|
22417894|NCT03431974|Syntrix Pharmaceuticals|Aaron Schuler|253-833-8009|aschuler@syntrixbio.com|21
22417895|NCT00456495|The New York Eye Cancer Center|Clinic Coordinator|212-832-8170|kchin@eyecancer.com|
22417896|NCT01301508|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22417897|NCT03329079|University of Nebraska Medical Center|Kevin Kupzyk|402-552-7262|kkupzyk@unmc.edu|
22417898|NCT02494102|Penn State Health Milton S. Hershey Medical Center|Zyad J. Carr, M.D., FASA|717-531-8521|zcarr@pennstatehealth.psu.edu|
22417899|NCT05069155|University of Pennsylvania|Clinical research coordinator|7574471579|aileen.oon@pennmedicine.upenn.edu|
22417900|NCT01346774|University of Michigan|Betsy Foxman, Hunein F. and Hilda Maassab Professor of Epidemiology|734-764-5487|bfoxman@umich.edu|
22417901|NCT01929031|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22417902|NCT01366443|University of Utah Medical Center, Dept. of OB/GYN|Dr. Michael Draper, MD University of Utah Medical Center, Dept. of OB/GYN|801-581-7647|mike.draper@hsc.utah.edu|
22417903|NCT00321594|Department of Clinical Oncology, The Chinese University of Hong Kong|Professor Winnie Yeo|852-2632|winnieyeo@cuhk.edu.hk|2118
22417904|NCT00369382|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22417905|NCT01565616|Emory University|Lakshmanan Krishnamurti, MD||lakshmanan.krishnamurti@emory.edu|
22417906|NCT01334710|Emory University|Dr. Bassel El-Rayes|404-778-1900|belraye@emory.edu|
22417907|NCT00586482|Mayo Clinic|David O. Warner, MD|507-255-4288|warner.david@mayo.edu|
22417908|NCT00321828|NSABP Foundation, Inc.|Director, Division of Regulatory Affairs|412-330-4600||
22417909|NCT00915928|Odense University Hospital, Odense, Denmark|Frantz Rom Poulsen, Professor, consultant|0045 65413600|frantz.r.poulsen@rsyd.dk|
22417910|NCT00678041|University of Pittsburgh, UPP13 WH Uro Gynecology - Cor|Gary Sutkin, MD|412--641-1440|gsutkin@mail.magee.edu|
22417911|NCT02358343|Center for Biomedical Statistics, University of Washington|Tessa Rue, Biostatistician|206-543-4246|ruet@uw.edu|
22417912|NCT00281671|Ann & Robert H. Lurie Children's Hospital of Chicago|John M. Costello, MD MPH|312 227 1551|jmcostello@luriechildrens.org|
22417913|NCT03996148|Cooper University Hospital|Ludmil Mitrev|(800) 826-6737|mitrev-ludmil@cooperhealth.edu|
22407113|NCT02390362|The Research Institute at Nationwide Children's Hospital|William E. Smoyer, MD.|6147222683|william.smoyer@nationwidechildrens.org|
22407114|NCT03999203|Queen's University Belfast|Professor Liam Heaney|02890976376|l.heaney@qub.ac.uk|
22407115|NCT00620126|University of Maryland. Baltimore|PI|410-706-3387|rcross@medicine.umaryland.edu|
22407116|NCT00784225|SWOG Statistical Center|SELECT/S0000B Statistician|2066674623|adarke@fredhutch.org|
22407117|NCT02551874|AstraZeneca|Global Clinical Lead|+46 (0)31 7761000|ClinicalTrialTransparency@astrazeneca.com|
22407118|NCT03500302|Johns Hopkins University|Allison Hays|443-287-6827|ahays2@jhmi.edu|
22407119|NCT04067310|Instituto Nacional do Câncer|Director of Clinical Trials|+552132076549|cecilia.silva@inca.gov.br|
22407120|NCT01041027|Montefiore Medical Center|Dr. Dennis Yi-Shin Kuo|718-405-8086|dykuo@montefiore.org|
22407121|NCT02493712|Holy Stone Healthcare Co., Ltd|YUCHIH, Chen|886287975966|ivychen@hshc.com.tw|272
22407122|NCT02528643|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|5473
22407123|NCT02058940|The University of North Carolina at Chapel Hill|Nicole R. Pinelli|919-962-1641|nickipinelli@unc.edu|
22407124|NCT04144140|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
22407125|NCT02146274|Duke University School of Medicine|Vice Dean of Clinical Research|919-684-4979|awindham@duke.edu|
22407126|NCT01494753|Laboratoires Théa|Dr Pascale Pouliquen - Medical Director|33 473 981 436|p.pouliquen@laboratoires-thea.fr|
22407127|NCT03384316|National Cancer Institute|Dr. Julius Y. Strauss|240-858-3999|straussjy@nci.nih.gov|
22407128|NCT00413231|Medtronic Vascular, Inc.|PJ Belmont, Clinical Research Specialist|707-480-3025|PJ.Belmont@Medtronic.com|
22407129|NCT03891199|West Virginia University|Brock A. Lindsey, MD|304-293-1317|blindsey@hsc.wvu.edu|
22407130|NCT03287960|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
22407131|NCT01641952|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22407132|NCT00656136|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22407133|NCT02990325|Abivax|Sophie Biguenet|+33 (0) 1 53 83 08 41|sophie.biguenet@abivax.com|
22407134|NCT02176031|Dana-Farber Cancer Institute|Dr. Corey Cutler|617-632-3470|CSCUTLER@PARTNERS.ORG|
22417914|NCT00577395|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22407135|NCT00107536|The Ohio State University Comprehensive Cancer Center|Tanio Bekaii-Saab, MD|614-293-9863|Tanios.Bekaii-Saab@osumc.edu|
22407136|NCT02065479|University of Florida|Dr. Dominick Angiolillo|904-244-3378|dominic.angiolillo@jax.ufl.edu|
22407137|NCT02516306|Encore Vision, Inc|Jerry M. Stein, Ph.D.|817-292-6963|summercreekc@gmail.com|
22407138|NCT00266799|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22407139|NCT00247962|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22407140|NCT00824746|Chonnam National University Hwasun Hospital|Young-Chul Kim, MD, PhD|82-61-379-7614|kyc0923@jnu.ac.kr|
22407141|NCT03525613|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
22407142|NCT02365961|Hawkins Foundation|Hawkins Foundation Research Coordinator|864 454 7458|info@hawkinsfoundation.com|
22407143|NCT02120469|City of Hope|Dr. Yuan Yuan|626-359-8111|yuyuan@coh.org|
22407144|NCT01012037|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22407145|NCT02237898|Yale School of Medicine|Dr. Megan Smith|(203) 764-8655|megan.smith@yale.edu|
22407146|NCT01402375|Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore Medical Center|Andrew Chang, MD, MS|718-920-6626|achang3@yahoo.com|
22407147|NCT02176005|Da Volterra|Dr. Annie Ducher, Chief Medical Officer|+33 1 58 39 32 20|annie.ducher@davolterra.com|
22407148|NCT01142791|InSightec|Nadir Alikacem|214-630-2000|nadira@insightec.com|
22407149|NCT02178592|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22407150|NCT03516227|National Defense Medical Center, Taiwan|Dr. Yu-Ju Chen|886-287923100|judychen37@gmail.com|18762
22407151|NCT05592145|Atrium Health Wake Forest Baptist|Renea Jennings RN,BSN,CCRP|336-716-4417|rjenning@wakehealth.edu|
22407152|NCT02975206|Menlo Therapeutics Inc.|Anna Gururajan|(650) 486-1416|agururajan@menlotx.com|
22417915|NCT04322149|Eledon Pharmaceuticals|Laura Batterman|949-874-3487|lbatterman@eledon.com|
22392135|NCT03559062|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22392136|NCT01757197|Weill Cornell Medicine|Usama Gergis, MD|(212) 746-2119|usg2001@med.cornell.edu|
22392137|NCT05646719|Opus Genetics|Sarah Callahan|984-884-6030|Scallahan@opusgtx.com|
22392138|NCT05890027|Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida|Dr. Sara T. Wester|(305)-243-2020|swester2@med.miami.edu|
22392139|NCT02154906|UT Health Science Center San Antonio|Brian L. Mealey|210-567-3567|mealey@uthscsa.edu|
22392140|NCT01677299|Elcelyx Therapeutics, Inc|Senior Director, Development|858-876-1814|info@elcelyx.com|
22392141|NCT00520845|Vanderbilt-Ingram Cancer Center|Dr. Leora Horn|615-322-4967|leora.horn@vanderbilt.edu|
22392142|NCT03057847|University of Pittsburgh|Dr. Elizabeth Krans|412-641-3532|kransee@upmc.edu|
22392143|NCT00583466|Johns Hopkins University|Johns Hopkins ClinicalTrials.gov Program|410-550-6484|registerclinicaltrials@jhmi.edu|
22392144|NCT00351377|Novartis Pharmaceuticals|Study Director|862-778-8300||
22392145|NCT00703339|Lung Rx|Rosa Negro-Vilar|240-821-1881|rnegrovilar@lungrx.com|
22392146|NCT02088957|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22392147|NCT05105087|Thomas Jefferson University|Ji-Bin Liu, MD|215-955-4862|jxl120@jefferson.edu|
22392148|NCT03470740|Chang Gung University of Science and Technology|Su-Hui Chen|886-3-2118999|sophee@mail.cgust.edu.tw|3216
22392149|NCT00755417|Depomed|Head of Research & Development|650-462-5900|msweeney@depomed.com|108
22392150|NCT02803593|Emory University|Dr. Eun Ok Im|404-712-9805|eun.ok.im@emory.edu|
22392151|NCT03443414|Verona Pharma|Brian Maurer, Senior Clinical Operations Director|(914) 767-5037|brian.maurer@veronapharma.com|
22392152|NCT03933462|Philips|Sara Garbin|724-787-8550|sara.garbin@philips.com|
22392153|NCT02522728|Stryker Orthopaedics|Eric Garling, PhD Snr. Director Medical & Scientific Affairs Europe|+31 6 467 135 18|Eric.Garling@stryker.com|
22392154|NCT01436305|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22392155|NCT01485120|GE Healthcare|Jeff Conner|414-721-2423||
22392156|NCT02344342|University of Michgan Health Systems|Todd Koelling, MD|734-936-5265|tkoellin@med.umich.edu|
22392157|NCT03355209|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22392158|NCT02251236|University of California, San Diego|Scott Letendre, Principal Investigator|6195438080|sletendre@ucsd.edu|
22392159|NCT01151215|Astrazeneca|Dr Serban Ghiorghiu||ClinicalTrialTransparency@astrazeneca.com|
22392160|NCT02597712|Trio Medicines Ltd|Dr Malcolm Boyce|+44 20 8961 4130|mboyce@triomedicines.com|
22392161|NCT00513708|SUNY Buffalo|Schieder, Jeffrey|716-645-2977|jss10@buffalo.edu|
22392162|NCT01564277|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22392163|NCT01594970|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22392164|NCT02079025|Exact Imaging|Manager, Clinical Research|905-415-0030|bwodlinger@exactimaging.com|204
22392165|NCT04276051|Emory University|Alexandra Migdal, MD|404-778-3280|alexandra.love.migdal@emory.edu|
22392166|NCT01299480|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22392167|NCT01621776|University of Florida|Janet Silverstein, MD|352-334-1390|silvejh@peds.ufl.edu|
22392168|NCT03285555|Cleveland Clinic|Viktor Krebs|216-444-2600|krebsv@ccf.org|
22392169|NCT00604708|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar-kastner@intercell.com|1175
22392170|NCT04916730|University of California, San Diego|Michael J. Wilkinson, MD|(858)246-2510|mjwilkinson@health.ucsd.edu|
22392171|NCT00617929|Masonic Cancer Center, University of Minnesota|Jakub Tolar, MD|612-624-7180|tolar003@umn.edu|
22392172|NCT02078492|Maimonides Medical Center|Dr. Sergey Motov|718-283-8693|smotov@maimonidesmed.org|
22392173|NCT00760747|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22392174|NCT01228175|University of Colorado Boulder|Dr. Kent Hutchison|303-492-8163|kent.hutchison@colorado.edu|
22407153|NCT04733664|Richard L. Roudebush VA Medical Center|Dr. Arjun D. Sinha|---|adsinha@iu.edu|
22407154|NCT01628718|Massachusetts Veterans Epidemiological Research and Information Center|Brett T. Litz, PhD|617-584-9314|litzb@bu.edu|
22407155|NCT01981096|Cincinnati Children's Hospital Medical Center|Susmita Kashikar-Zuck, PhD|513 636 6337|susmita.kashikar-zuck@cchmc.org|
22407156|NCT00807989|Yonsei University Severance Hospital|Dr. Yoon||BILEE@yuhs.ac|
22407157|NCT04129242|The Medical University of SC|Dr. Bashar Badran|843-792-6076|badran@musc.edu|
22407158|NCT03675685|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|ClinicalTrials@Endo.com|
22407159|NCT02582151|Lawson Health Research|Blayne Welk|5196466000|lawson@lawsonresearch.ca|
22407160|NCT00392210|University of Rochester|Michael K. Flynn, MD|585-273-3232||
22407161|NCT02067104|University of Arizona|Amy Selegue|520-626-0301|aselegue@email.arizona.edu|
22407162|NCT02610231|Kyowa Kirin|Development Devision - Project Management Department|609-919-1100|kkd.clintrial.82@kyowakirin.com|
22407163|NCT01431794|Johns Hopkins University School of Medicine|Dr. Ana De Jesus-Acosta|443-287-0411|adejesu1@jhmi.edu|
22407164|NCT01901679|The Rockefeller University|Dr. Peter R Holt|212-327-7706|holtp@rockefeller.edu|
22407165|NCT01279954|Oregon Health & Science University|Eric Suler, MD|503-494-5023|suhlere@ohsu.edu|
22407166|NCT02140762|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22407167|NCT01899729|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
22407168|NCT01454531|ALK-ABELLÓ|ALICIA MARIN|+34 913276127|amaes@alk.net|
22407169|NCT02067806|Sintetica SA|Dr.Elisabetta Donati, Corporate Director Scientific Affairs|+41.91.640.42.50|edonati@sintetica.com|
22407170|NCT01711359|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22407171|NCT01066637|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
22407172|NCT01385098|Houston Methodist Hosptial|Sherman Vadim|713-441-5514|vsherman@tmhs.org|
22407173|NCT00795717|Tufts University School of Medicine|Christine A. Wanke, MD|617-636-3811|christine.wanke@tufts.edu|
22407174|NCT00211692|VA San Diego Healthcare System|Samuel B. Ho, MD, Chief GI Section|858-552-8585|samuel.ho2@va.gov|2631
22407175|NCT01021423|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22407176|NCT00122317|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.||clinicaltrials@alexion.com|
22407177|NCT03756285|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22407178|NCT06334055|Masimo Corporation|Ahmed Alghazi, M.B.Ch.B|949-297-7000|studies@masimo.com|
22407179|NCT02020304|Wake Forest School of Medicine|Vernon H Ross MD|336-718-8278|vhross@wakehealth.edu|
22407180|NCT04728815|Duke University|Scott Compton, Ph.D.|919-668-0063|compt004@duke.edu|
22407181|NCT00957034|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22407182|NCT05315297|Stanford University School of Medicine|Dr. Raymond Chou, MD|650-723-5256|raymond.chou@stanford.edu|
22407183|NCT00711009|Abbott|Global Medical Services|800-633-9110||
22407184|NCT02534324|Faculty of Medicine, Chulalongkorn University|Dr. Khrongwong Musikatavorn|+66818390511|Khrongwong.m@chulahospital.org|
22407185|NCT01138995|Bioness|Keith McBride, CTO|661-362-4866|Keith.McBride@bioness.com|
22407186|NCT01459016|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22407187|NCT02889861|Immunocore, LLC|Chris Holland, Executive Director Head of Biometrics|1-267-589-9204|chris.holland2@immunocore.com|
22407188|NCT02039687|Araim Pharmaceuticals, Inc.|Chief Medical Officer|914-762-7586|info@araimpharma.com|
22407189|NCT02132169|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
22407190|NCT00053482|Emergent BioSolutions|Eddie Darton, Medical Director|240-631-3688|dartone@ebsi.com|
22407191|NCT00750360|GlaxoSmithKline|GSK Response Center|866-435-7343||
22407192|NCT01432236|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22407193|NCT05064449|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22407194|NCT00305773|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Steven Gore, MD||gorest@jhmi.edu|
22407195|NCT04354870|NYU Langone Health - Bellevue Hospital|H. Michael Belmont, MD|646-501-7400|Michael.Belmont@nyulangone.org|
22407196|NCT04450394|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
22407197|NCT01066819|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22407198|NCT02194699|AstraZeneca|Global Clinical Lead|+1 301-398-0582|ClinicalTrialTransparency@astrazeneca.com|
22407199|NCT00001151|NIH|Stephen J. Marx, M.D./National Institute of Diabetes and Digestive and Kidney Diseases|3014965051|marxs@mail.nih.gov|
22407200|NCT01539720|Planned Parenthood of the St. Louis Region and Southwest Missouri|Director of Research|314-531-7526|research@ppslr.org|384
22407201|NCT01192139|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22407202|NCT03927703|Novan|Cathy White, Vice President, Drug Development Operations|919-485-8080|clinical@novan.com|
22407203|NCT03812224|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22407204|NCT02600715|University of Kansas School of Medicine-Wichita|Jennifer Duong, MPH, Research Associate|316-962-3126|jduong@kumc.edu|
22407205|NCT01753765|Pacira Bioscience, Inc.|Medical Information|1-855-793-9729|MedInfo@Pacira.com|
22407206|NCT01667731|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22407207|NCT00612573|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22407208|NCT05386368|Atrium Health Wake Forest Baptist|Joseph Molnar MD|336-716-4171|jmolnar@wakehealth.edu|
22407209|NCT00821886|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22407210|NCT01822886|"Policlinico S.Orsola-Malpighi - Institute of Hematology L. e A. Seràgnoli, University of Bologna, Via Massarenti, 9-40138 Bologna, Italy"|Zinzani Pier Luigi/Argnani Lisa|+39 0516364042|pierluigi.zinzani@unibo.it/lisa.argnani@unibo.it|
22431540|NCT04164277|Michigan State University|Jiying Ling|5173538591|lingjiyi@msu.edu|
22431541|NCT02481414|University of Arkansas for Medical Sciences|Matthew Kovak, Director of Clinical Trials|501-686-8274|MRKovak@uams.edu|
22431542|NCT00276419|Mayo Clinic|Dr. Robin L. Smith|507-284-1210|smith.robin@mayo.edu|
22431543|NCT03493958|Clinical Center|Wallen, Gwenyth|+1 301 496 0596|gwallen@cc.nih.gov|
22431544|NCT01190527|University of Michigan Comprehensive Cancer Center|Dr. Shruti Jolly, M.D.|734-936-4300|shrutij@umich.edu|
22431545|NCT01117779|Boston Scientific|Chantal Laframboise, Clinical Research Manager|613-882-0876|chantal.laframboise@bsci.com|
22431546|NCT02448381|Soligenix, Inc.|Richard Straube, MD/Chief Medical Officer|609-538-8200|rstraube@soligenix.com|
22431547|NCT01137890|Johns Hopkins University|Dr. Annie Umbricht|410-550-1917|annieumbricht@jhu.edu|
22431548|NCT04617860|Wave Life Sciences|Medical Director|855-215-4687|clinicaltrials@wavelifesci.com|
22431549|NCT01394159|Center for Interventional Endoscopy, Florida Hospital|Dr Shyam Varadarajulu|407-303-2570|svaradarajulu@yahoo.com|
22431550|NCT02621892|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
22431551|NCT02735200|Dammam University|Dr Dalal Bubshait|+966505848281|dbubshait@ud.edu.sa|
22431552|NCT00998010|University of California at Los Angeles|Mark Glover|(310) 794-8742|mglover@mednet.ucla.edu|
22431553|NCT01734525|Federal University of Rio de Janeiro|Marcio Nucci|5521-39382463|mnucci@hucff.ufrj.br|
22431554|NCT00737360|The University of Texas M.D, Anderson Cancer Center|Dr. Anne Tsao, Principal Investigator|713-792-6363||
22431555|NCT04442893|National Yang Ming University|Chiu-Yueh Yang, Professor|886-2-28267388|cyyang3@ym.edu.tw|8862282673
22431556|NCT02421094|Galectin Therapeutics|Vice President of Regulatory Affairs|678-620-3186|horton@galectintherapeutics.com|
22431557|NCT01483560|University of Glasgow|Prof John Petrie|+44 141 330|John.Petrie@glasgow.ac.uk|3325
22431558|NCT00619866|AbbVie|Global Medical Services|800-633-9110||
22431559|NCT01656161|Debiopharm International|Eija Lundstrom, Medical Director|+41 21 321 06 03|eija.lundstrom@debiopharm.com|
22431560|NCT00963872|University of Minnesota|Dr. Claudio Brunstein|612-625-3918|bruns072@umn.edu|
22431561|NCT03949517|Stanford University|Dr. Andrei Iagaru, MD|650-725-4711|aiagaru@stanford.edu|
22431562|NCT03510273|PATH|Dr. Silvia de Sanjose|2062853500|sdesanjose@path.org|
22431563|NCT01474109|Actelion Pharmaceuticals Ltd|Angelina Marr|+41 61 565 63 69|angelina.marr@actelion.com|
22431564|NCT02589938|Wake Forest NCORP Research Base|Lead Biostatistician (Dr. Emily Dressler)|336-716-0891|NCORP@wakehealth.edu|
22431565|NCT04716894|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
22431566|NCT03338920|Currax Pharmaceuticals LLC|Dr. Michael Kyle|708.834.8254|mkyle@curraxpharma.com|
22431567|NCT01772654|Mayo Clinic|Cheolsu Shin, M.D.|507-284-4961|shin@mayo.edu|
22431568|NCT03199079|Advanced Tactile Imaging, Inc.|Egorov Vladimir, Principal Investigator|609 883-0100|egorov@tactile-imaging.com|
22431569|NCT03773484|University of Southern California|Dr. Jason Doctor|213-821-8142|jdoctor@usc.edu|
22431570|NCT04724837|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-94|information.center@astrazeneca.com|79
22431571|NCT04222673|Pittsburgh VA|Matthew Chinman|8184813909|chinman@rand.org|
22431572|NCT03112902|University of Colorado|Brice McConnell|303-724-3897|brice.mcconnell@cuanschutz.edu|
22431573|NCT03620981|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|06-6943-7722|CL_OPCJ_RDA_Team@otsuka.jp|
22431574|NCT05705375|University of Texas at Arlington|Ziyad Ben Taleb|817-272-8297|ziyad.bentaleb@uta.edu|
22431575|NCT01280942|Washington Univ Sch of Medicine|Thomas C. Bailey, MD|314-454-8293|tbailey@dom.wustl.edu|
22431576|NCT05852470|Alcon Research, LLC|Clinical Project Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22431577|NCT06071104|Alcon Research LLC|Sr. Principal Clinical Project Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22431578|NCT04118764|Columbia University|Elisa Konofagou, PhD, Robert and Margaret Hariri Professor in Biomedical Engineering and Radiology|212-342-0863|ek2191@columbia.edu|
22431579|NCT04716725|University of California, San Francisco|Dr. Ivan de Kouchkovsky, MD|(415) 221-4810|ivan.dekouchkovsky@ucsf.edu|2129
22431580|NCT04212442|University of Pennsylvania|Dr. Rebecca Brown|215-573-2021|rebecca.brown@pennmedicine.upenn.edu|
22431581|NCT02420717|The University of Texas MD Anderson Cancer Center|Dr. Nitin Jain MD./Associate Professor|713-745-6080|njain@mdanderson.org|
22431582|NCT04116489|UMass Chan Medical School; Tan Chingfen Graduate School of Nursing|Donna Perry, PhD, RN|508-856-3621|DonnaJ.Perry@umassmed.edu|
22431583|NCT03781570|Dartmouth College|Tor D Wager, PhD|(603)-646-2196|Tor.D.Wager@Dartmouth.edu|
22431584|NCT03138564|Emory University|Mi-Kyung Song, PhD, RN|404-727-3134|mi-kyung.song@emory.edu|
22431585|NCT06517394|Center for Health Outcomes and Interdisciplinary Research, Massachusetts General Hospital|Principal investigator|6177267913|apresciutti@mgh.harvard.edu|
22431586|NCT05177354|Medtronic Neuromodulation|Nancy McClelland|1-800-633-8766|nancy.l.mcclelland@medtronic.com|
22431587|NCT02936323|Tarveda Therapeutics, Inc.|Tarveda Clinical Information Center|(617) 923-4100|clinical.information@tarvedatx.com|
22431588|NCT06272383|University of Manitoba|Dr Alex Aregbesola|2047893957|Alex.Aregbesola@umanitoba.ca|
22431589|NCT05715827|Medtronic|Yewon Lee|1031132023|yewon.lee@medtronic.com|
22431590|NCT04846868|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22431591|NCT04398706|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22431592|NCT04890509|BerGenBio ASA|BerGenBio Clinical Team|+ 47 559 61 159|cmo@bergenbio.com|
22431593|NCT04116853|Advocate Aurora Research Institute|Kathryn Ross, PhD MPH|414-647-6312|Kathryn.Ross@aah.org|
22431594|NCT02953457|Roswell Park Comprehensive Cancer Center|Katy Wang|716-845-1300|Chong.Wang@Roswellpark.org|
22392175|NCT01715207|SamsungMC|Prof Duk-Kyung Kim|01099333413|dukkyung.kim@samsung.com|
22392176|NCT00402051|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22392177|NCT02281500|Instituto Grifols S.A.|Jordi Navarro Puerto|+34 935712200|jordi.navarro@grifols.com|
22392178|NCT03429166|VA HSR&D|Amanda Borsky, PhD|2024435739|amanda.borsky@va.gov|
22407211|NCT02516605|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22407212|NCT02643420|Spectrum Pharmaceuticals, Inc, Research and Development Office 157 Technology Drive Irvine, CA 92618|Shanta Chawla|(949) 788-6700|shanta.chawla@sppirx.com|
22407213|NCT02127970|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22407214|NCT01710709|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development||DT-inquiry@otsuka.jp|
22407215|NCT04446039|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22407216|NCT01398176|UFlorida|Dr. Susan S. Percival|352-392-1991|percival@ufl.edu|201
22407217|NCT01639599|Seoul St.Mary's Hospital,|Young Eun Moon|822-2258-6163|0910momo@naver.com|
22407218|NCT01871870|Legacy Health System|Dr. Ken Ward|971-570-2632|kenward503@msn.com|
22407219|NCT05102734|Perelman School of Medicine at the University of Pennsylvania|Dr. John C. Greenwood|18568167172|john.greenwood@pennmedicine.upenn.edu|
22407220|NCT03055806|Ixchelsis Limited|Chief Medical Officer|44 (0) 1227-832760|ian.osterloh@ixchelsis.com|
22407221|NCT00846027|Hoffmann-La Roche|Medical Communications|800 821-8590||
22407222|NCT01694667|University of California, San Francisco|Stephen Bent|415-221-4810|Stephen.Bent@ucsf.edu|3457
22407223|NCT04905563|Le Bonheur Children's Hospital|Lindsey Locke, MSN|(901) 287-8931|lindsey.locke@lebonheur.org|
22407224|NCT02418000|Spirita Oncology, LLC|Chief Development Officer|+1 (713) 898-8965|linda.paradiso@spiritaoncology.com|
22407225|NCT00490815|Alimera Sciences, Inc|Kathleen Billman, Senior Director of Scientific Affairs|678-527-1302|kathleen.billman@alimerasciences.com|
22407226|NCT01904760|Department of Anesthesiology, Peking University School and Hospital of Stomatology, Beijing, China|Xudong Yang|8610-82195287|kqyangxudong@163.com|
22407227|NCT00804596|Ascensia Diabetes Care|Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
22407228|NCT04249076|Laboratorios Salvat, S.A|Medical Director|+34933946400|ejimenez@svt.com|
22407229|NCT00721136|Johns Hopkins Medical Institutions|Charles Henrikson, MD|503 494 7400|chenriks@jhmi.edu|
22407230|NCT00732199|John D. Dingell VA Medical Center|Susmita Chowdhuri|313 576 1000|susmita.chowdhuri@va.gov|3685
22407231|NCT01747928|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22407232|NCT04335552|Duke University|Jason Stout, MD, MHS|919-668-0826|jason.stout@dm.duke.edu|
22407233|NCT00611351|University of Nebraska Medical Center|Lori Maness-Harris|402-559-3848|lmaness@unmc.edu|
22407234|NCT00602043|University of Pennsylvania|Dr. David Mankoff|(2015) 615-3687|david.mankoff@uphs.upenn.edu|
22407235|NCT01284127|Johns Hopkins University|Michael Levy|443-287-4612|mlevy@jhmi.edu|
22407236|NCT03243981|Stanford University|Anne Lynn Chang, MD|650-723-6316|alschang@stanford.edu|
22407237|NCT02607865|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22407238|NCT01783223|Hennepin Healthcare Department of Emergency Medicine|Director of Research|6128733000|james.miner@hmced.org|
22407239|NCT03427528|Northwestern University, CCH|Dr. Darius Tandon|+1 312 503 3398|dtandon@northwestern.edu|
22407240|NCT01351415|Hoffmann-La Roche|Medical Communications|888-6821-8590|genentech@druginfo.com|
22407241|NCT00994890|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22407242|NCT00699582|Eisai Call Center|Eisai Inc.|888-422-4743||
22407243|NCT01849289|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22407244|NCT03480360|Dartmouth-Hitchcock Medical Center|Kenneth Meehan, MD|(603) 650-4628|Kenneth.R.Meehan@hitchcock.org|
22407245|NCT00389805|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
22407246|NCT01315873|New York University School of Medicine|Michael Grossbard, MD|646 501 9305|Michael.Grossbard@nyumc.org|
22407247|NCT01756391|Boston Children's Hospital|Wanda Phipatanakul|617-355-6117|wanda.phipatanakul@childrens.harvard.edu|
22407248|NCT05223478|Ocuphire|Drey Coleman VP of Clinical Operations|8134041993|dcoleman@ocuphire.com|
22407249|NCT03117309|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22407250|NCT02583711|Imperial College London|Ms Aliza Abeles|07834987667|aliza.abeles@gmail.com|
22407251|NCT00641745|Sunovion|Josephine Cucchiaro, PhD; Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com|
22407252|NCT01326910|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, Sr. Specialist Clinical Quality Systems and Process|928-277-0715|jhauze@its.jnj.com|
22407253|NCT03701061|Emory University|Nadine Rouphael|404-712-1435|nroupha@emory.edu|
22407254|NCT02274766|Adamas Pharmaceuticals, Inc.|Head, Regulatory Affairs|+1 (510) 450-3500|drugsafety@adamaspharma.com|
22407255|NCT02130635|GlaxoSmithKline|GSK Response Center|866-435-7343||
22407256|NCT01205646|Barbara Ann Karmanos Cancer Institute|Ulka Vaishampayan, M.D.|(313) 576-8718|vaishamu@karmanos.org|
22407257|NCT00852124|UMARYLAND|Alessio Fasano|617-726-1450|afasano@partners.org|
22407258|NCT01158885|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
22407259|NCT00962780|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22407260|NCT02363322|NIAID/LIR|Dr. Richard T. Davey, Jr.|301-496-8029|rdavey@niaid.nih.gov|
22407261|NCT02055976|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22407262|NCT02504424|AirXpanders|Director of Clinical Affairs|650-390-9000|kkelley@airxpanders.com|
22407263|NCT01503229|University of Washington|Dr. Bruce Montgomery|206-598-0860|rbmontgo@uw.edu|
22407264|NCT01354964|Albert Einstein College of Medicine|Dr. Meredith Hawkins|7184302903|meredith.hawkins@einsteinmed.org|2903
22407265|NCT01062230|Huntsman Cancer Institute at the University of Utah Medical Center|Maurizio Zangari, MD Principal Investigator|801-585-3229||
22407266|NCT05604781|Center For Sight|Director of Clinical Research|8438813937|hsandoval@cepmd.com|
22407267|NCT04259749|RAND|William G. Shadel|412-683-2300|shadel@rand.org|4489
22407268|NCT02885506|Medicines for Malaria Venture|Dr Cristina Donini|0041 22 555 0312|doninic@mmv.org|
22392179|NCT01754987|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Daniel Monti|215 955-2221|daniel.monti@jefferson.edu|
22392180|NCT02194829|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22392181|NCT04427280|The Royal Marsden NHS Foundation Trust|Senior Trial Manager (for the CARDS study)|020 8642 6011|gi.trials@rmh.nhs.uk|3807
22392182|NCT00554996|Barbara Trautner, MD, PhD|Barbara Trautner, MD, PhD|713-440-4438|barbara.trautner@va.gov|
22392183|NCT02473965|Grifols Therapeutics LLC|Rhonda Griffin|919-316-6693|rhonda.griffin@grifols.com|
22392184|NCT05310201|Medical University of South Carolina|Angela Moreland, PhD|8437928209|moreland@musc.edu|
22392185|NCT01681277|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22392186|NCT04227145|Children's Mercy Kansas City|Emily Hurley|(816) 731-7093|eahurley@cmh.edu|
22392187|NCT02271984|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22392188|NCT01088984|Teva Pharmaceuticals USA|Manager|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22392189|NCT02304705|University of Kentucky|Dr. Maya Guglin|859-323-4738|maya.guglin@uky.edu|
22407269|NCT03922945|VIVUS|Sr. Director, Clinical Research|650-934-5200|clinical@vivus.com|
22407270|NCT00313716|Baylor College of Medicine|Claudia Robertson, MD|713-873-2792|claudiar@bcm.edu|
22407271|NCT02399345|AbbVie|Global Medical Information|800-633-9110||
22407272|NCT02873598|University of Colorado Cancer Center|Dr. Sana Karam|7208480141|sana.karam@cuanschutz.edu|
22407273|NCT02377674|Xeltis|Eliane Schutte, CEO|+31 40 751 7614|clinical@xeltis.com|
22407274|NCT03308799|MC2 Therapeutics|Birgitte Vestbjerg|+45 2077 2575|bve@mc2therapeutics.com|
22407275|NCT02927990|Philips Medical Systems B.V.|Pim van Lochem|+31 (0)634322891|pim.vanlochem@philips.com|
22392190|NCT00770029|Merz Pharmaceuticals GmbH|Dr. Matthias Zerm|0049-69-1503|matthias.zerm@merz.de|865
22407276|NCT00960323|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22407277|NCT03521089|Mayo Clinic|Dr. Yonas Geda|480-301-6934|geda.yonas@mayo.edu|
22407278|NCT03414372|University of North Carolina at Chapel Hill|Bryce Stamp, MPH|919-966-7430|bstamp@ad.unc.edu|
22407279|NCT01349491|University of Oklahoma Health Sciences Center|Stavros Stavrakis|405-271-9696|stavros-stavrakis@ouhsc.edu|37539
22407280|NCT04492514|University of Cincinnati|Clinical Research Director|513-584-0156|mcmahasn@ucmail.uc.edu|
22407281|NCT01524900|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22407282|NCT00959192|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22407283|NCT00772031|The EMMES Corporation|Anne S Lindblad, PhD|301 251 1161|alindblad@emmes.com|105
22407284|NCT00532441|Hoosier Cancer Research Network, Inc.|Dr. EG Chiorean, MS|317-921-2050|jsmith@hoosiercancer.org|
22407285|NCT01603615|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22407286|NCT00303329|Novartis Pharmaceuticals|Study Director|862-778-8300||
22407287|NCT00570089|Cedars-Sinai Medical Center|C. Noel Bairey Merz, MD|310-423-9680|merz@cshs.org|
22407288|NCT03474380|HSRD ADAPT|Courtney Van Houtven|919-286-6936|courtney.vanhoutven@va.gov|
22407289|NCT01101321|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
22407290|NCT00542321|University of Texas Health Science Center at Houston|Sandra K. Hanneman, PhD, RN, FAAN|713-500-2030|Sandra.K.Hanneman@uth.tmc.edu|
22407291|NCT04138758|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22407292|NCT00923481|National Cancer Institute, National Institutes of Health|Dr. Shivaani Kummar|301-435-5402|kummars@mail.nih.gov|
22407293|NCT00519090|Novartis Pharmaceuticals|Study Director|862-778-8300||
22407294|NCT00525499|AndroScience Corp|Charles CY Shih, PhD|(858) 638-7230|cyshih@androscience.com|
22407295|NCT03339999|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22407296|NCT00253747|University of CIncinnati|Dr. Theresa Winhusen|513-487-7800|winhusen@carc.uc.edu|
22407297|NCT01111058|University of Chicago|Everett Vokes, MD|(773) 702-9306|evokes@medicine.bsd.uchicago.edu|
22407298|NCT01856920|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Office|855-797-9277|Bobby.Reddy@immunitybio.com|
22407299|NCT00816062|Medtronic|Rianna Rapson|7635262170|rianna.k.rapson@medtronic.com|
22407300|NCT02790476|University of Southern California|Jason Doctor|213.821.8142|jdoctor@usc.edu|
22407301|NCT03287089|Atrium Health|Dina Bastawros, MD|336-718-1970|dina.bastawros@gmail.com|
22407302|NCT00731094|VA Pittsburgh Healthcare System|Kelly Hyman Burkitt, PhD|412-360-2202|Kelly.Burkitt@va.gov|
22407303|NCT00667381|University of California, Irvine|Arnold Seto|714-456-6699|aseto@uci.edu|
22407304|NCT02275052|GlaxoSmithKline|GSK Response Center|866-435-7343||
22407305|NCT00275834|Duke University Medical Center|Kishore Gadde|919-668-0208|kishore.gadde@duke.edu|
22407306|NCT01143116|Wellspect Health Care|Head of Medical Affairs|+46313763000|mace@wellspect.com|
22407307|NCT04601194|Indiana University|Michelle Salyers|317-274-2904|mpsalyer@iu.edu|
22407308|NCT02630459|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22407309|NCT01797302|University of Pittsburgh School of Medicine|Kumaravel Rajakumar|412-692-5822|kumaravel.rajakumar@chp.edu|
22407310|NCT00783263|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22417916|NCT02135653|University of Pennsylvania|Dr. Neha Vapiwala|(215) 662-2337|Neha.Vapiwala@pennmedicine.upenn.edu|
22417917|NCT01276301|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22417918|NCT01700049|Mayo Clinic|Dr. Scott Fosko|904-953-2303|fosko.scott@mayo.edu|
22392191|NCT00954187|Loma Linda University|Julio Narvaez, MD|9095589408|thamilton@llu.edu|
22407311|NCT00106626|Merck & Co., Inc.|Senior Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
22407312|NCT03018028|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22407313|NCT02519777|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22407314|NCT01396486|Massachusetts General Hospital|Dr. Janet Wozniak|617-724-5600|jwozniak@partners.org|
22407315|NCT00256204|Teva Branded Pharmaceutical Products R&D|Dennis Ahern, MS, Director|215-293-6339|dennis.ahern@tevausa.com|
22407316|NCT01612494|Washington University School of Medicine|Dr. Angela Lumba-Brown|314-362-4325|lumba_a@kids.wustl.edu|
22407317|NCT02541994|Ochsner Health Services|Dr. Andrew Lawton|504-842-3995|andrew.lawton@ochsner.org|
22407318|NCT03986671|Powell Mansfield Inc.|Chris Studer|6198101000|cstuder@powellmansfield.com|
22407319|NCT02074436|Emory University|Dr. Ana Antun|404-778-1900|ana.antun@emoryhealthcare.org|
22407320|NCT02169466|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|clinical.trials@bial.com|
22407321|NCT03490734|University of North Carolina at Chapel Hill|Kyle Burger, PhD, RD, MPH|9198439933|kyle_burger@unc.edu|
22407322|NCT02358876|Great Lakes NeuroTechnologies Inc|Biomedical Research Manager|2163615410|dheldman@glneurotech.com|
22407323|NCT00792922|Johns Hopkins University|Sheila K West|410 955 2606|shwest@jhmi.edu|
22407324|NCT00412425|UT MD Anderson Cancer Center|Agop Bedikian, MD Professor||asreckew@mdanderson.org|
22407325|NCT04212221|Zai Lab (Shanghai) Co.,Ltd.|Medical Director|+86 4008201022|medinfo@zailaboratory.com|
22407326|NCT03845504|Stanford University|Director, Research Development, Integrity and Strategy|(650) 736-4559|aimnoe@stanford.edu|
22407327|NCT02505269|Massachusetts General Hospital|Dr. Jeremy Abramson|617-724-4000|JABRAMSON@mgh.harvard.edu|
22407328|NCT02692560|Kaiser Permanente Washington Health Research Institute|Dori Rosenberg, PhD, MPH|206-287-2532|rosenberg.d@ghc.org|
22407329|NCT03810053|University of Arkansas for Medical Sciences|Matthew Henry|5016868274|mhenry3@uams.edu|
22407330|NCT01529827|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22407331|NCT00715949|The Children's Hospital of Philadelphia|Michael L. Nance|215-590-5932|nance@email.chop.edu|
22407332|NCT04111185|Duke University|Marat Fudim, MD, MHS|919-684-1284|marat.fudim@duke.edu|
22407333|NCT00806494|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22407334|NCT02417935|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22407335|NCT02850276|Icahn School of Medicine at Mount Sinai|Dr. Jessica Robinson-Papp|212-241-8390|jessica.robinson-papp@mssm.edu|
22407336|NCT04815291|Merit Medical Systems Inc.|Casey Holland|6178420251|casey.holland@merit.com|
22407337|NCT01914510|University Health Network - Princess Margaret Cancer Centre|Dr. Amit Oza|416-946-2818|amit.oza@uhn.ca|
22407338|NCT02994043|University of Colorado Denver|Jamie Laurin|303-724-3183|JAIME.LAURIN@CUANSCHUTZ.EDU|
22407339|NCT02646332|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|williamhsup@yahoo.com.tw|78233
22407340|NCT01775995|University of Wisconsin Madison|Aleksandra Zgierska, MD PhD|(608) 263-7882|aleksandra.zgierska@fammed.wisc.edu|
22407341|NCT02909504|University Hospitals Cleveland Medical Center|Dr. Keming Gao, MD, PhD|2168442865|keming.gao@UHhospitals.org|
22407342|NCT00751335|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 09 574 0100|CPAP.trial@fphcare.co.nz|7044
22407343|NCT04524663|Stanford University|Dr. Julie Parsonnet, MD|(650) 725-4561|parsonnt@stanford.edu|
22407344|NCT00911508|Mayo Clinic|Dr. Douglas L. Packer|507-255-6263|CABANA@mayo.edu|
22407345|NCT04308668|University of Minnesota|David Boulware, MD, MPH|6125552020|covid19@umn.edu|
22407346|NCT01266967|GlaxoSmithKline|GSK Response Center|866-435-7343||
22407347|NCT01519700|Sandoz|Dr. Roumen Nakov, Global Programme Medical Director|+49 8024 4764704|roumen.nakov@sandoz.com|
22407348|NCT05111548|University of Michigan|Dr. Cynthia Burton|734-615-9821|czburton@med.umich.edu|
22407349|NCT00103376|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
22407350|NCT02083406|Medicines for Malaria Venture (MMV)|Fiona Macintyre, PhD|+41 22 555 0319|macintyref@mmv.org|
22407351|NCT00561912|UT MD Anderson Cancer Center|Ana M. Aparicio, MD / Assistant Professor||CR_Study_Registration@mdanderson.org|
22407352|NCT03938857|Duke University|Mara L. Becker, MD, MSCE|919-613-1942|mara.becker@duke.edu|
22407353|NCT01729559|Scripps Mercy Hospital|Steven R. Shackford, MD|619-299-2600|shackford.steven@scrippshealth.org|
22407354|NCT01028131|Wayne State University|Steven J. Ondersma|313-577-6680|s.ondersma@wayne.edu|
22407355|NCT02452034|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22407356|NCT00431132|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22407357|NCT00777790|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22407358|NCT01453439|Massachusetts General Hospital|Dr. Sabine Wilhelm, Ph.D.|+1(617)724-6146|swilhelm@mgh.harvard.edu|
22407359|NCT01014442|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22407360|NCT02074059|Windtree Therapeutics, Inc.|Executive Director, Biostatistics & Data Management|215-488-9300|psimmons@windtreetx.com|9477
22407361|NCT03520842|Stanford University|Heather Wakelee|(650) 498-6000|ccto-website@stanford.edu|
22407362|NCT00014560|Dartmouth Hitchcock|Dr. Pamela Ely|603-653-9071||
22407363|NCT02195895|Northwestern University|Dr. Thomas Schnitzer|312-503-2315|tjs@northwestern.edu|
22407364|NCT01508221|University of Cincinnati|Alison Kastl|513-584-0436|Kastla@ucmail.uc.edu|
22407365|NCT04383665|Keck School of Medicine of University of Southern California|Dr Darrin Lee|(323) 442-5720|darrinjl@usc.edu|
22407366|NCT00147082|Imperial College London|Professor Louise Donnelly|+442075947895|l.donnelly@imperial.ac.uk|
22407367|NCT02242305|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22407368|NCT03547960|Imperial College London|Gary Frost|2075940959|g.frost@imperial.ac.uk|
22407369|NCT02543801|Kootenai Health|Director of Research Programs|2086254223|salbritton@kh.org|
22407370|NCT01756846|University Medical Center Utrectht|Dr. Judith Poldervaart|008875 55105|j.poldervaart@umcutrecht.nl|
22407371|NCT01521260|University Medical Center Groningen - Center for dentistry and oral hygiene|Y.C.M. de Waal|+31 50-3639051|y.c.m.de.waal@umcg.nl|
22407372|NCT00362440|BIDMC|Dr. Christos Mantzoros|617-667-8630|cmantzor@bidmc.harvard.edu|
22407373|NCT02625610|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22407374|NCT03459794|University of Georgia|Dr Adrian Wolstenholme|706 542 2404|adrianw@uga.edu|
22407375|NCT02350660|University of Virginia|Department of Medicine and Pediatrics|434.924.0000|spc7w@virginia.edu|
22407376|NCT00352027|St. Jude Children's Research Hospital|Jamie Flerlage, MD|901-595-0392|jamie.flerlage@stjude.org|
22407377|NCT04118127|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22407378|NCT04491591|Washington University School of Medicine|Mary Politi, Ph.D.|314-747-1967|mpoliti@wustl.edu|
22407379|NCT00636506|American Medical Systems|Men's Health Clinical Affairs|952-930-6328|Karen.Seybold@ammd.com|
22407380|NCT02607735|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22407381|NCT01376908|BioMarin Pharmaceutical Inc.|Medical Information Services|+1-800-983-4587|medinfo@bmrn.com|
22407382|NCT01072656|Cleveland Clinic|Dr Andre Machado|216-444-4270|machada@ccf.org|
22407383|NCT02430389|Northwester University|Laura B. Hemmer, M.D.|312-695-0061|l-hemmer@northwestern.edu|
22407384|NCT00869375|OUHSC|J. Emilio Exaire MD|405 271 4742|jose-exaire@ouhsc.edu|44744
22407385|NCT01681836|University of Pittsburgh|Dr. Kara Hughan|412-692-5170|kara.hughan@chp.edu|
22407386|NCT02394028|Hoffmann La-Roche|A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy|800 821-8590|genentech@druginfo.com|
22407387|NCT00742391|LEO Pharma|Dr. Torsten Skov|+4520736294|torsten.skov@leo-pharma.com|
22407388|NCT00205374|University of Wisconsin-Madison|J. Scott McMurray, MD|608-262-7181|mcmurray@surgery.wisc.edu|
22407389|NCT00866606|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22407390|NCT02599324|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22407391|NCT02109939|Assurex Health|Lindsey Burns|5137015068|lindsey.burns@myriad.com|
22407392|NCT01058356|Pharmbio Korea Co., Ltd.|Korea Association for the Study of Intestinal Disease (KASID)|82-2-587-2551|pharmbio@hotmail.com|
22407393|NCT04098172|First Affiliated Hospital of Xi 'an Jiaotong University|Dr. Ning Guo|13991229101|drnguo@gmail.com|+86
22407394|NCT00090844|Division of Hematology & Oncology, University of California, San Francisco|Pamela Munster, MD|415-476-1000|Pmunster@medicine.ucsf.edu|
22407395|NCT01277666|GlaxoSmithKline|GSK Response Center|866-435-7343||
22407396|NCT01869686|Amgen Inc.|Study Director|866-572-6436||
22407397|NCT01657903|GlaxoSmithKline|GSK Response Center|866-435-7343||
22407398|NCT00554840|Maryland Psychiatric Research Center|Elaine Weiner, M.D.|410-402-7694|eweiner@mprc.umaryland.edu|
22407399|NCT03474172|Guangdong Provincial Hospital of Chinese Medicine|Director of department of Clinical Epidemiology|+862081887233|darongwu@163.com|35842
22407400|NCT02312934|Vanderbilt University Medical Center|Dr. Paul A. Newhouse|(615) 327-7009|paul.newhouse@vumc.org|
22407401|NCT00807456|DENTSPLY Implants|Manager Global Clinical Affairs|+46313763500|ClinicalResearchMolndal@dentsplysirona.com|
22407402|NCT03395704|La Jolla Pharmaceutical Company|Stew Kroll, MA|650-576-9679|skroll@ljpc.com|
22407403|NCT01801189|Legacy Weight and Diabetes Institute|Dr. Valerie Halpin|503-413-7557|vhalpin@lhs.org|
22407404|NCT00498706|Northwestern University|Dr. David C. Mohr|312-503-1403|d-mohr@northwestern.edu|
22407405|NCT03359811|UT MD Anderson Cancer Center|Dr. Juan Cata, MD, Associate Professor, Anesthesiology & PeriOper Med|(713) 792-7452|jcata@mdanderson.org|
22407406|NCT00692198|Johns Hopkins Bloomberg School of Public Health|James Tonascia, PhD|410-955-8175|jtonasc1@jhu.edu|
22407407|NCT03330275|Johnson & Johnson Vision Care, Inc.|John Buch- SENIOR PRINCIPAL RESEARCH OPTOMETRIST|904 443-1707|JBUCH@its.jnj.com|
22407408|NCT02528331|Duke University|Richard Weiner, MD, PhD|919-681-8742|weine002@duke.edu|
22407409|NCT00386152|Centocor Ortho Biotech Services, LLC|Nephrology Therapeutic Area, Medical Lead|215-325-4176||
22407410|NCT02577107|Novartis Pharmaceuticals|Study Director|862-778-8300||
22407411|NCT00577382|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617.632.5053|Stephen_Hodi@dfci.harvard.edu|
22407412|NCT01345162|IRCCS Policlinico S Matteo|Dr Massimo Allegri|00390382502627|massimo.allegri@unipv.it|
22407413|NCT02049476|Wilmer Eye Institute, Johns Hopkins University School of Medicine|Jennifer E. Thorne, MD, PhD; Professor of Ophthalmology & Epidemiology,Director of Ocular Immunology|410-955-2966|jthorne@jhmi.edu|
22407414|NCT03007472|Cochlear|Cochlear Clinical Studies|(303) 790-9010|clinicalstudies@cochlear.com|
22407415|NCT02988115|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
22407416|NCT01731951|Geron Corp.|Study Director|650-473-7700|myf2001-info@geron.com|
22407417|NCT03306589|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|1
22407418|NCT00649220|Merz Pharmaceuticals GmbH|Manager Public Disclosure|+49 69 1503 865|matthias.zerm@merz.de|
22407419|NCT01977651|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22417919|NCT03084367|Philips (Volcano)|Becky Inderbitzen, Global Director, Clinical Development|+1.858.764.1336|becky.inderbitzen@philips.com|
22417920|NCT01206101|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22417921|NCT00569530|University of California, San Francisco|Roberta R. Keller, MD|415-514-3192|roberta.keller@ucsf.edu|
22417922|NCT05339334|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22417923|NCT02358135|Keck School of Medicine of University of Southern California|April W. Armstrong, MD, MPH; Associate Dean of Clinical Research|323-865-3871|april.armstrong@med.usc.edu|
22417924|NCT00368979|GlaxoSmithKline|GSK Response center|866-435-7343||
22417925|NCT00912093|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22417926|NCT00103311|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22417927|NCT00166036|Emory University|Arshed A Quyyumi, MD|404 712 2741|aquyyum@emory.edu|
22417928|NCT01462318|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22407420|NCT03028324|University of Miami|Joyce Rios Gomes-Osman|305-284-2632|j.gomes@miami.edu|
22407421|NCT03380091|University of California, San Francisco|Heather Huddleston|(415) 353-3040|Heather.Huddleston@ucsf.edu|
22407422|NCT02515890|University of Pittsburgh|Keith M. Vogt, MD., PhD.|412-999-8570|vogtkm@upmc.edu|
22407423|NCT04594213|Merz Aesthetics|Public Disclosure Manager|+1 984-301-3095|Aesthetic.Trials@merz.com|
22407424|NCT01182480|Denver Health and Hospital Authority|Andrew W. Steele, MD, MPH, MSc|303-602-9773|andy.steele@dhha.org|
22407425|NCT01980056|Weill Cornell Medicine|Clinical Trials Administrator|212-746-0284|ray2013@med.cornell.edu|
22407426|NCT00104299|DAIT/NIAID|Associate Director, Clinical Research Program|(301) 594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22407427|NCT02906644|Duke University|Clinical Research Coordinator|(919) 668-5055|al.salley@duke.edu|
22407428|NCT04646668|University of Kansas Medical Center|Leah Lambart Graduate Research Assistant|9139457862|llambart@kumc.edu|
22407429|NCT03672006|Medical College of Wisconsin|Dr. Shelia Hanson|414-266-3728|shanson@mcw.edu|
22407430|NCT03288987|Aryogen|Dr. Nasim Anjidani (Director of Medical- Clinical Trials)|009809125477964|anjidani.n@orchidpharmed.com|
22407431|NCT00608426|Center for Chronic Disease Outcomes Research|Steven Fu, Director|612-467-1979|steven.fu@va.gov|
22407432|NCT00761891|Department of Pharmacology, School of Medicine, Vanderbilt University|Olivier Boutaud, PhD|615-343-7398|olivier.boutaud@vanderbilt.edu|
22407433|NCT00368069|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22407434|NCT02512094|Faculty of Medicine Siriraj Hospital, Mahidol University|Panai Laohaprasitiporn||panailao@gmail.com|
22407435|NCT02764229|Lycera Corp.|H. Jeffrey Wilkins MD, Chief Medical Officer|484-243-6222|wilkins@lycera.com|
22407436|NCT00672490|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22407437|NCT01973205|Novartis|Clinical Project Leader|9735038000||
22417929|NCT00197392|Codman & Shurtleff, Inc|J. Thomas Megerian, MD|508.880.8274|jmegeri1@its.jnj.com|
22417930|NCT00270257|Fred Hutchinson Cancer Research Center|Senior Statistical Analyst|206-667-6167|geetha@scharp.org|
22417931|NCT01195103|Mayo Clinic|John B Leslie MD|480-301-8000|leslie.john@mayo.edu|
22417932|NCT05227300|Indiana University School of Dentistry|Dr. Kenneth Spolnik|317-274-7280|kspolnik@iu.edu|
22417933|NCT02075671|The George Washington University, Medical Faculty Associates|Dermatology Research Fellow|202-741-2632|knelson@mfa.gwu.edu|
22417934|NCT03300544|M D Anderson Cancer Center|Arvind Dasari|(713) 792-2828|adasari@mdanderson.org|
22417935|NCT01155024|The Ohio Willow Wood Company|Applied Research Engineer|740-869-3377|mariag@owwco.com|
22417936|NCT01593696|National Cancer Institute|Dr. Nirali N. Shah|240-760-6199|shahnn@nih.gov|
22417937|NCT00369655|Mayo Clinic|Dr. Timothy Hobday|507-284-1159|hobday.timothy@mayo.edu|
22417938|NCT04049617|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22417939|NCT01780987|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_inquiries@pfizer.com|
22417940|NCT03402750|University of Miami|Brian McCabe|305-248-1530|bmccabe@miami.edu|
22417941|NCT02981303|HiberCell|Chief Medical Officer|651.675.0300|CMO@hibercell.com|
22417942|NCT02534844|Mandos, LLC|Executive Vice President, Regulatory Affairs|619-905-0489|jspinella@mandoshealth.com|
22417943|NCT01971970|Erasmus University Medical Centre - Sophia Childrens Hospital|Professor J.C. Escher|+31107036076|j.escher@erasmusmc.nl|
22417944|NCT00848107|United Therapeutics Corporation|Rex Mauthe, Assoc VP, Regulatory Affairs|(919) 485-8350|RMauthe@unither.com|
22417945|NCT01831765|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22417946|NCT00859586|NIH NHLBI|Dr. Minoo Battiwalla|301-827-0939|battiwam@nhlbi.nih.gov|
22417947|NCT00080938|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
22417948|NCT04561375|Cleveland Clinic|Dr. Daniel Sessler|2168702620|ds@ccf.org|
22417949|NCT00706511|University of Chicago|Eve Van Cauter, PhD|773-702-0169|evcauter@bsd.uchicago.edu|
22417950|NCT00121472|Thoratec Corporation|Poornima Sood, MD, MBA, Sr. Director, Clinical Affairs|(781) 852-8334|psood@thoratec.com|
22417951|NCT03272464|Massachusetts General Hospital|David M. Miller, MD, PhD|617-726-2667|dmiller4@mgh.harvard.edu|
22417952|NCT02116608|University of Colorado Denver|Jeremy Prager, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
22417953|NCT03456583|Hologic|Muhammad Waqas|5088267183|Muhammad.Waqas@hologic.com|
22417954|NCT01169532|Fox Chase Cancer Center|Elizabeth Plimack|215-728-3889|Elizabeth.Plimack@fccc.edu|
22417955|NCT01775865|University of Iowa|Gary Pierce|319-335-9487|gary-pierce@uiowa.edu|
22417956|NCT00117325|GlaxoSmithKline|GSK Response Center|866-435-7343||
22417957|NCT00759187|Colgate Palmolive|William DeVizio- DMD|732-878-7901|William_Devizio@colpal.com|
22417958|NCT01468818|National Cancer Institute|Dr. Steven A. Rosenberg|301-496-4164|sar@mail.nih.gov|
22417959|NCT02266134|Kaiser Permanente Washington Health Research Institute|Dr. Cara C. Lewis|206-422-4076|Cara.C.Lewis@kp.org|
22417960|NCT00302081|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22417961|NCT02701413|Northwestern University|Dr. Christina Lewicky-Gaupp|312-472-3874|christina.lewickygaupp@nm.org|
22417962|NCT02138136|Mallinckrodt Pharmaceuticals|Clinical Team Leader|800-556-3314|clinicaltrials@mnk.com|
22407438|NCT04056325|Swiss Tropical and Public Health Institute|Prof Dr Jennifer Keiser|+41 61 284 82 18|jennifer.keiser@swisstph.ch|
22417963|NCT00535587|Oregon Health & Science University|Kim Dupree Jones|503 494 3837|joneskim@ohsu.edu|
22417964|NCT01359644|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Trials@bms.com|
22417965|NCT04795908|West Virginia University|Jessica Frey|304-598-6127|jessica.frey@hsc.wvu.edu|
22392192|NCT05620108|Mayo Clinic|J. Ross Renew, M.D.|904-956-3328|renew.j@mayo.edu|
22392193|NCT05602727|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22392194|NCT00465998|Stavanger University Hospital|Professor Torbjørn Moe Eggebø|+4792699433|tme@lyse.net|
22392195|NCT02038842|Service d'immunologie clinique - Hôpital Henri Mondor|Pr. Jean-Daniel Lelièvre|+33 1 49 81 24 55|jean-daniel.lelievre@hmn.aphp.fr|
22392196|NCT01661205|AtriCure, Inc.|Vice President, Clinical Operations|513-755-4562|SZink@AtriCure.com|
22392197|NCT00426127|University of Iowa|Daniel Berg, MD|319-353-7800|daniel-j-berg@uiowa.edu|
22392198|NCT03111095|University of Wisconsin School of Medicine and Public Health|Kara Hoppe, DO|(206) 371-4014|khoppe2@wisc.edu|
22407439|NCT03128372|Medtronic|Julia Katilius|1 303-305-2278|julia.z.katilius@medtronic.com|
22407440|NCT02030067|Processa Pharmaceuticals|Director Drug Development and Regulatory Affairs|443-631-6614|pfranks@processapharmaceuticals.com|
22407441|NCT02532998|AstraZeneca AB|AZD9977 Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
22407442|NCT00565721|GE Healthcare|Paul Gordon, PhD|011-47-2318-5822|paul.gordon@ge.com|
22407443|NCT01483378|NYU Langone Medical Center|Dr. Elisabeth J. Cohen|212-263-3262|elisabeth.cohen@nyumc.org|
22407444|NCT02813681|University of Texas Medical Branch|Denise Wilkes|409-772-1221|dwilkes@utmb.edu|
22407445|NCT00529152|ApoPharma|Dian Shaw, Manager Clinical Research|416-401-7283|dshaw@apotex.com|
22407446|NCT01878786|MedStar Georgetown Transplant Institute|Dr. Matthew Cooper|202-444-0753|Matthew.Cooper@gunet.georgetown.edu|
22407447|NCT04062240|Mayo Clinic|Dr. Matthew Ritter|507-255-5123|Ritter.Matthew@mayo.edu|
22407448|NCT03961529|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22407449|NCT03500419|Mayo Clinic|Matthew (Matt) J. Ziegelmann, M.D.|507-266-3982|Ziegelmann.Matthew@mayo.edu|
22407450|NCT01497899|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22407451|NCT02026193|Rambam health Care campus|Dr Shahar Kol , Director IVF Unit|97247773232|skol@rambam.health.gov.il|
22407452|NCT00082628|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22407453|NCT03481634|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22407454|NCT01874288|Alopexx Oncology, LLC|Chief Medical Officer||daniel.vlock@alopexx.com|
22407455|NCT03099304|Incyte|Incyte Corporation Call Center (US)|1.855.463.3463|medinfo@incyte.com|
22407456|NCT01624974|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22407457|NCT02142712|University of New Mexico - Neurology Department|Dr. Vishnumurthy Shushrutha Hedna|505-272-3342|Drshushrutha@gmail.com|
22407458|NCT00266695|Chromaderm|info@chroma-derm.com|info@chroma-derm.com||
22407459|NCT03480841|University of North Carolina at Chapel Hill|Dr. Linda Beeber|(919) 966-8148|beeber@email.unc.edu|
22407460|NCT01309581|Mount Sinai School of Medicine|James Murrough|212 241 7574|James.Murrough@mssm.edu|
22407461|NCT00606021|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22407462|NCT01362049|University of Vermont Medical Center, Burlington, VT|Dr. Sharon M. Henry|(802) 847-7633|Sharon.Henry@uvm.edu|
22407463|NCT03198884|SIHF Healthcare|John Verna|618-337-8153|jverna@sihf.org|
22407464|NCT01202643|Center for Human Reproduction|Dr. David Barad|212 994-4400|dbarad@theCHR.com|
22407465|NCT02910492|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
22407466|NCT00989664|GlaxoSmithKline|GSK Response Center|866-435-7343||
22407467|NCT00095836|Massachusetts General Hospital|John Clark, MD|617-724-4000|jrclark@partners.org|
22407468|NCT00426842|James J Peters VAMC|Dr. Jill M. Wecht|718-584-9000|jm.wecht@va.gov|3122
22407469|NCT02993783|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22407470|NCT02886338|TMU|Fat-Moon, Suk|29307930|fmsuk@tmu.edu.tw|7923
22407471|NCT01156012|Laboratoires Théa|Dr Pascale Pouliquen - Medical Director|33 473 981 436|p.pouliquen@laboratoires-thea.fr|
22407472|NCT01707667|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22407473|NCT03802331|Boehringer Ingelheim|Boehringer Ingelheim|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22407474|NCT03010358|OHSU Knight Cancer Institute|Bria Thurlow|503-494-4292|thurlow@ohsu.edu|
22407475|NCT03432819|RAND Corporation|Laura Bogart, PhD|(310) 393-0411|lbogart@rand.org|7281
22407476|NCT02135848|GlaxoSmithKline|GSK Response Center|866-435-7343||
22407477|NCT00265382|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22407478|NCT02735382|Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health|Mark Zehner, MS|6082627568|mark.zehner@ctri.wisc.edu|
22407479|NCT01474993|UMass Medical School|Andrew Zimmerman, M.D.|508-856-3279|Andrew.Zimmerman@umassmemorial.org|
22407480|NCT02996981|TriHealth Inc.|Dr. Rachel Pauls|513-463-4300|Rachel_Pauls@trihealth.com|
22407481|NCT00760994|VA Puget Sound Health Care System|Tracy Simpson, Ph.D.|206-277-3337|tracy.simpson@va.gov|
22407482|NCT03258710|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22407483|NCT03451630|UPMC Center for High-Value Health Care|Kelly Williams, PhD, MPH|412-454-1198|williamsk17@upmc.edu|
22407484|NCT03570476|University of Washington|Dr. Bruce Montgomery, PI|206-598-0860|rbmontgo@uw.edu|
22407485|NCT02041533|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22407486|NCT00545740|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22407487|NCT02117024|Clinical Development|Lori McDermott|919-794-8950|lmcdermott@heatbio.com|
22407488|NCT01957111|University of Pennsylvania|Philip Gehrman|215-746-3578|gehrman@exchange.upenn.edu|
22407489|NCT01646255|UCB|Study Director|+1877 822||9493
22407490|NCT01468844|National Institutes of Health|Catherine Cukras, MD, PhD, Principal Investigator, NEI|301-435-5061|cukrasc@nei.nih.gov|
22407491|NCT02239562|University of Miami|Christopher O'Brien|305-243-2329|CObrien@med.miami.edu|
22417966|NCT00311311|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22407492|NCT01241318|"Ariadne Labs|BWH & HSPH"|Katherine Semrau (Epidemiologist, co-PI)|6177805311|ksemrau@ariadnelabs.org|
22407493|NCT02355665|JNJWorldwide|Andrew Myers, MD, Director, Clinical Research|(215) 273-8421 USA EST|AMyers3@its.jnj.com|
22407494|NCT03194256|Brown University|Suzanne Colby|4028636621|suzanne_colby@brown.edu|
22407495|NCT02380703|Baylor College of Medicine|Mark Kunik, MD, MPH, Primary Investigator|713-794-8639|mkunik@bcm.edu|
22407496|NCT03607994|Wake Forest Baptist Health|Catherine Tegeler - Project Manager|336-716-9341|categele@wakehealth.edu|
22407497|NCT01228435|Massachusetts General Hospital|Lecia Sequist|617-726-7812|lvsequist@partners.org|
22407498|NCT02183792|University of Southern California School of Pharmacy|Tien Ng, Pharm.D.|3234421840|tienng@usc.edu|
22407499|NCT00498927|Memorial Sloan Kettering Cancer Center|Dr. Antonio Omuro|212 639 7523|omuroa@mskcc.org|
22407500|NCT01408862|Institute of Medical Research (UBA-CONICET)|Dr. Carlos Jose Pirola|541145148701|cpirola@ciudad.com.ar|167
22407501|NCT01813149|Cleveland Clinic Foundation|Michael Stanton Hicks, MD|216-445-3497|stantom@ccf.org|
22407502|NCT02853318|Roswell Park Comprehensive Cancer Institute|Katy Wang, Statistician, M.A.|7168451300|katy.wang@roswellpark.org|6269
22407503|NCT04490499|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22407504|NCT00780676|University of Texas (UT) MD Anderson Cancer Center|Stacy Moulder, MD/Associate Professor, Breast Medical Oncology|713-792-2360|CR_Study_Registration@mdanderson.org|
22407505|NCT01882439|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021||
22407506|NCT00527722|UT MD Anderson Cancer Center|Sanjay Gupta, MD|713-563-7341|srao@mdanderson.org|
22407507|NCT00245635|Montefiore Medical Center, Albert Einstein College of Medicine|Eric Hollander, MD|7189204287|eholland@montefiore.org|
22407508|NCT03125902|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22407509|NCT01997333|Celldex Therapeutics|Head of Regulatory Affairs|844-723-9363|info@celldex.com|
22407510|NCT02269709|University of Michigan|Frank W. DiPaola, MD|734-763-9650|dipaolaf@med.umich.edu|
22407511|NCT00890396|New England Research Institutes, Inc.|Susan Assmann, PhD|617-972-3048|sassmann@neriscience.com|
22407512|NCT04411472|AM-Pharma|AM-Pharma Office|+31 (0)30 22 89 222|office@am-pharma.com|
22407513|NCT00440232|Jefferson Headache Center/Thomas Jefferson University|Stephen D. Silberstein, M.D.|215-955-2243|stephen.silberstein@jefferson.edu|
22407514|NCT00362297|University of Washington|Dr. Christine Johnston|206-520-4340|cjohnsto@u.washington.edu|
22407515|NCT00819052|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22407516|NCT01558791|National Center for PTSD|Dr. Jessica Hamblen, PI|802-296-5132|Jessica.Hamblen@va.gov|5389
22407517|NCT01747655|AbbVie|Global Medical Information|1-800-633-9110||
22407518|NCT02275559|UMass Chan Medical School|Dr James Carmody|5088561205|james.carmody@umassmed.edu|
22407519|NCT00982111|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22407520|NCT03769753|Memorial Sloan Kettering Cancer Center|T. Peter Kingham, MD|212-639-5260|kinghamp@mskcc.org|
22407521|NCT01070381|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22407522|NCT00684073|Schering-Plough|Head, Clinical Trials Registry and Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com|
22407523|NCT02699632|Pennington Biomedical Research Center|Leanne Redman, Principal Investigator|2257630947|Leanne.Redman@pbrc.edu|
22407524|NCT01259388|Birmingham VA Medical Center|Dr. John Rinker|205-934-2402|John.Rinker@va.gov|
22407525|NCT00620815|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22407526|NCT01230827|Johnson & Johnson Pharmaceutical Research & Development|Senior Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
22407527|NCT00983827|University of Utah|Dr. Steven Edgley|801-581-4695|carma.hyde@hsc.utah.edu|
22407528|NCT05414422|Perception Neuroscience|Clinical Trials Group|+49 (0) 89 2153 9035|clinicaltrials@perceptionneuroscience.com|
22407529|NCT01032265|Umeå University, Umeå, Sweden|Dr. Eva Samuelsson|+46706966440|eva.samuelsson@jll.se|
22407530|NCT02728804|SWOG Statistics and Data Management Center|Cancer Care Delivery Committee Statistician|2066674623|adarke@fredhutch.org|
22407531|NCT01888367|Promius Pharma, LLC, Dr. Reddy's Laboratories|VP, Drug Development|609-375-9855|kallenby@drreddys.com|
22407532|NCT00591786|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22407533|NCT01854918|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22407534|NCT01835964|University of Virginia|Marc Breton, PhD|434-982-6484|mb6nt@virginia.edu|
22407535|NCT00673075|Forest Laboratories|John Whalen, MD Executive Director of Clinical Development - Cardiovascular and Metabolism|1-201-427-8259|John.Whalen@frx.com|
22407536|NCT01920061|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22407537|NCT00574340|University of Maryland, Baltimore|Dr. Stephen N. Davis|410-328-2488|sdavis@medicine.umaryland.edu|
22407538|NCT00198042|Hospital for Special Surgery|Scott Rodeo, MD|212-606-1000|rodeos@hss.edu|
22407539|NCT03373006|HALO Diagnostics|Chief Research Officer|760-766-2047|bernadette@halodx.com|
22407540|NCT02828982|University of Michigan|Dr. Deanna Gates|(734) 647-2698|gatesd@umich.edu|
22407541|NCT02475564|Hospital de Clínicas de Porto Alegre, RS|Dr. Ricardo Francalacci Savaris|+55 51 33598653|rsavaris@hcpa.edu.br|
22407542|NCT02705755|Theravance Biopharma|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
22407543|NCT01906489|Akebia Therapeutics|Akebia Therapeutics|617-844-6128|trials@akebia.com|
22407544|NCT03458234|University of Alabama at Birmingham (UAB)|Andrew McDonald, MD; Principal Investigator|(205) 934-5670|ammcdonald@uabmc.edu|
22407545|NCT07072962|Baylor College of Medicine|Bijan Najafi|424-467-7127|najafi.bijan@gmail.com|
22407546|NCT01078389|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22407547|NCT04823494|GN|Todd Fortune|763-772-5566|tfortune@gnresound.com|
22407548|NCT03726320|NYU Langone Health|Danil Makarov|212-263-4961|Danil.Makarov@nyulangone.org|
22407549|NCT02679560|UC Davis|Dr. Ian Brown|(916)734-1279|iebrown@ucdavis.edu|
22407550|NCT03691831|Aclaris Therapeutics, Inc.|Aclaris Clinical Operations|1-833-225-2747|clinicaloperations@aclaristx.com|
22407551|NCT02198040|Universidad de Murcia|Rubén Cuesta-Barriuso, PhD|+34 913146508|ruben.cuestab@gmail.com|
22407552|NCT00337935|Centocor Ortho-Biotech LLC.|Vice President, Medical Affairs|800.457.6399||
22407553|NCT01884675|GlaxoSmithKline|GSK Response Center|866-435-7343||
22407554|NCT02361307|Mahidol University|Piyapat Dajpratham|6624197508|piyapat.daj@mahidol.ac.th|
22407555|NCT00329433|Washington University School of Medicine|Michael S. Avidan, MBBCh|314-747-4155|avidanm@wustl.edu|
22407556|NCT01080794|Beth Israel Deaconess Medical Center|Dr. Alvaro Pascual-Leone|(617) 667-0203|apleone@bidmc.harvard.edu|
22407557|NCT01189201|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22407558|NCT01277757|University of Texas (UT) MD Anderson Cancer Center|Funda Meric-Bernstam, MD/Chair, Investigational Cancer Therapeutics|713-563-4347|fmeric@mdanderson.org|
22407559|NCT03852901|National Institute on Aging|Josephine M. Egan, MD, Clinical Director|410-558-8414|eganj@mail.nih.gov|
22407560|NCT03374982|University of Nebraska Medical Center|Zachary Houser|402-980-9633|zach.houser@unmc.edu|
22407561|NCT00240331|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22407562|NCT01409382|Hospital Federal dos Servidores do Estado|Dr. Silvia Hoirisch-Clapauch|55-21-999737500|sclapauch@gmail.com|
22407563|NCT01233076|CIBA VISION|Joe Rappon, OD, MS, FAAO / Head, Clinical Trial Management|1-678-415-3343|Joseph.Rappon@cibavision.com|
22407564|NCT04563845|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22407565|NCT04120116|Frequency Therapeutics|Director of Clinical Trials|781-315-4600|clinicaltrialsinformation@frequencytx.com|
22407566|NCT01522963|University of Minnesota|Michael Kotlyar|6126251160|kotly001@umn.edu|
22407567|NCT02210559|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|FG3019-069Study@fibrogen.com|
22407568|NCT00991458|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22407569|NCT01287403|Clinical Development Unit / Metabolic Unit|Dr Maurice Beaumont, MD, PhD|+41217858054|maurice.beaumont@rdls.nestle.com|
22407570|NCT01098266|Molmed S.p.A|Clinical Operations|003902212771|clinical.operations@molmed.com|
22407571|NCT01733758|GlaxoSmithKline|GSK Response Center|866-435-7343||
22407572|NCT02357394|University of Kansas Health System, Dept of OBGYN|Dr. Gene Lee|9135886201|glee@kumc.edu|
22407573|NCT01811004|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22407574|NCT02545270|Department of Anesthesiology, Herlev and Gentofte Hospital, University of Copenhagen, Herlev Denmark|MD. G. G. Nervil||gustavnervil@gmail.com|
22407575|NCT00727246|University of Pittsburgh|Patricia M Arenth PhD|412-648-6666|arenpm@upmc.edu|
22407576|NCT00661362|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22407577|NCT02206776|Stanford University|Dr. Carolyn Rodriguez, Assistant Professor|650-723-4095|ocdresearch@stanford.edu|
22407578|NCT00535262|Depression Evaluation Service, New York State Psychiatric Institute|Deborah A. Deliyannides, M.D. Research Psychiatrist|(212) 543-5734|deliiyan@nyspi.columbia.edu|
22407579|NCT04805892|Quality Research and Invention LLC|Zanetta Malanowska-Stega|6464001204|jstega@optonline.net|
22407580|NCT01196793|Imperial College London NHS Trust|Dr Hermione Lyall|02033126965|hermione.lyall@nhs.net|
22407581|NCT04382066|PharmaMar, S.A.|Clinical Development Virology Business Unit PharmaMar|+34 91 846 60 00|clinicaltrials@pharmamar.com|
22407582|NCT04738123|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22407583|NCT00787527|University of Texas MD Anderson Cancer Center|Yasuhiro Oki, MD/ Associate Professor|713-792-2860|yoki@mdanderson.org|
22407584|NCT03970330|MSHersheyMC|Dr. Kristin Riley|717-531-6447|kriley1@pennstatehealth.psu.edu|
22407585|NCT00083616|Amgen Inc.|Study Director|866-572-6436||
22407586|NCT01724021|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22407587|NCT03138798|Icahn School of Medicine at Mount Sinai|Dr. Eric Bergh|908-625-8148|eric.bergh@mssm.edu|
22407588|NCT02500706|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22407589|NCT01077310|Yale School of Medicine|Principle Investigator|203-737-2883|sandra.springer@yale.edu|
22407590|NCT03644173|Hackensack meridian Health|Manager, Investigator Initiated Research Program|5519961244|Elli.GournaPaleoudis@hmhn.org|
22407591|NCT03323385|Baudax Bio Inc.|Development|484-395-2440|info@baudaxbio.com|
22407592|NCT01455064|Abbott Diabetes Care|Shridhara A. Karinka, Ph.D., Director of Clinical Affairs|510-749-6393|SHRIDHARA.ALVA@ABBOTT.COM|
22407593|NCT04422951|Stanford University|Thomas N. Robinson, MD, MPH|(650) 723-5331|tom.robinson@stanford.edu|
22407594|NCT04269629|Department of Dermatology and Venerology|Assoz.-Prof. Dr. Gunter Sturm|+4331638580318|gunter.sturm@medunigraz.at|
22407595|NCT01000311|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22407596|NCT02146352|Boston Scientific Corp.|Lina Ginnetti|508-683-4512|Lina.Ginnetti@bsci.com|
22407597|NCT02918006|Vaxart, Inc.|Sean Tucker, PhD, Chief Scientific Officer|650-550-3502|stucker@vaxart.com|
22407598|NCT03969589|VISN 5 MIRECC|Amy Drapalski|443-421-6273|amy.drapalski@va.gov|
22407599|NCT04227119|Emory University|Anand Shah, MD|404-712-4063|anand.d.shah@emory.edu|
22407600|NCT02936206|Icahn School of Medicine at Mount Sinai|Dr. Amy Tiersten|212-241-3300|amy.tiersten@mssm.edu|
22407601|NCT02510885|Duke Eye Center|Dr. Priyatham Mettu|919-684-9010|priyatham.mettu@duke.edu|
22407602|NCT03091920|Cyclerion Therapeutics, Inc.|Senior Medical Director|1-857-327-8778|info@cyclerion.com|
22407603|NCT00453349|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22407604|NCT00805142|Janssen R&D, 1125 Trenton-Harbourton Road, Titusville, PA 18902, USA|Senior Director, Clinical Leader|609-730-6777||
22407605|NCT00381810|Genentech, Inc.|Medical Communications Specialist|800 821-8590|genentech@druginfo.com|
22407606|NCT00489216|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22407607|NCT00396266|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22417967|NCT01715064|University of Guelph-Humber|Dr. Daniel Santa Mina|416-798-1331|daniel.santamina@guelphhumber.ca|6065
22417968|NCT00826449|University of Texas (UT) MD Anderson Cancer Center|Faye Johnson, Associate Professor, Thoracic/Head & Neck Med Oncology||CR_Study_Registration@mdanderson.org|
22417969|NCT03670264|Children's Hospital of Philadelphia|Dr. Brian Jenssen|215-554-4390|jenssenb@chop.edu|
22417970|NCT00725751|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22407608|NCT00422942|Hoffmann-LaRoche|Medical Communications Organization|800-821-8590|genentech@druginfo.com|
22417971|NCT02327741|shiraz university of medical sciences|Professor|009836250352|kojurij@yahoo.com|
22417972|NCT02257541|Memorial Sloan Kettering Cancer Center|Dr. William Tap, MD|646-888-4163|tapw@mskcc.org|
22417973|NCT02365870|Johns Hopkins University School of Medicine|Dr. Gregory Pontone|(410) 502 - 0477|gpontone@jhmi.edu|
22417974|NCT00160641|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22417975|NCT01875471|Johnson & Johnson Vision Care|Daria Wicks|1 904 443-1391|RA-VISUS-ClnclStds@its.jnj.com|
22417976|NCT00016718|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22417977|NCT00975286|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22417978|NCT00686582|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
22417979|NCT03512262|Radius Health, Inc.|Clinical Operations|617-551-4000|info@radiuspharm.com|
22417980|NCT05882279|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22417981|NCT05742347|Medline Industries, LP|Julie J. Finley|(800) 33-5463|jjfinely@medline.com|
22417982|NCT04221789|IECS|Dr Fernando Rubinstein|01147778767|frubinstein@iecs.org.ar|
22417983|NCT01670487|Cleveland Clinic|Dr. Sharon Mace|216-445-4598|maces@ccf.org|
22417984|NCT04018664|Trevi Therapeutics|Thomas Sciascia, MD|203-304-2499|thomas.sciascia@trevitherapeutics.com|
22417985|NCT04394351|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22417986|NCT03653507|Astellas Pharma Global Development, Inc|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
22417987|NCT05205772|University of North Carolina at Chapel Hill|Miriam Sklerov, MD, MS|984-974-4401|miri@email.unc.edu|
22417988|NCT01288053|Northwestern University|Dr Richard Burt|312-695-4960|rburt@northwestern.edu|
22417989|NCT03188666|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22417990|NCT00144781|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22417991|NCT02068092|Houston Methodist Neal Cancer Center|Jenny Chang|713.790.3333|ccresearch@houstonmethodist.org|
22417992|NCT03696953|Marquette University, College of Nursing|Dr. Lisa Hanson|1-414-288-3841|lisa.hanson@marquette.edu|
22417993|NCT03502707|Janssen Vaccines & Prevention B.V.|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22417994|NCT04092894|Beth Israel Deaconess Medical Center|Balachundhar Subramaniam|7814750572|bsubrama@bidmc.harvard.edu|
22417995|NCT03299088|U of California Davis|Leslie Garcia|916-734-0156|lesgarcia@ucdavis.edu|
22417996|NCT01106014|Actelion Pharmaceuticals Ltd|Clinical trial disclosure desk||clinical-trials-disclosure@actelion.com|
22417997|NCT02935686|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22417998|NCT02579161|Northwell Health|Dr. Zeph Okeke|516-734-8500|zokeke@northwell.edu|
22417999|NCT02327117|Isfahan University of Medical Sciences|Amin Nemati|00989131009918|nemati@med.mui.ac.ir|
22418000|NCT02128217|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22418001|NCT05071313|Janssen Vaccines & Prevention B.V.|Director Biomarkers Viral Vaccines|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22418002|NCT00541970|GlaxoSmithKline|GSK Response Center|866-435-7343||
22418003|NCT03107026|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
22418004|NCT00062010|ECOG Statistical Office|Study Statistician|617-632-3012||
22418005|NCT01183221|Icahn School of Medicine at Mount Sinai|Dr. Alexander Kolevzon|(212) 659-8762|alexander.kolevzon@mssm.edu|
22418006|NCT04763564|University of North Carolina at Chapel Hill|Hans Herfarth, MD, PhD|9199666806|hherf@med.unc.edu|
22418007|NCT02470390|Depomed|Clinical Operations|510-744-8000|clinicaltrials@depomed.com|
22418008|NCT02766374|Rutgers - Robert Wood Johnson Medical School|Paul M. Lehrer, PhD|(732) 235-4413|lehrer@rutgers.edu|
22418009|NCT00852969|Tufts Medical Center|Mark Sarnak, MD|617 636-1182|msarnak@tuftsmedicalcenter.org|
22418010|NCT03596151|Antiviral Research Center, University of California, San Diego|Sheldon Morris, MD, MPH|619-543-4761|shmorris@ucsd.edu|
22418011|NCT01700036|University of Michigan Cancer Center|Dr. Pavan Reddy, MD|734-936-8785|reddypr@umich.edu|
22418012|NCT00807248|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
22407609|NCT00149227|Department of Cardiology, Kyoto Prefectural University of Medicine|Prof. Hiroaki Matsubara|+81-75-251-5511|matsubah@koto.kpu-m.ac.jp|
22407610|NCT02978339|Mayo Clinic|John E. Eaton, M.D.|507-284-3917|Eaton.John@mayo.edu|
22407611|NCT00367380|Malaria Vaccine and Drug Development|Sócrates Herrera MD, principal investigator|(572) 5216232 - 5574929|sherrera@inmuno.org|
22407612|NCT01513460|Novartis Pharmaceuticals|Study Director|862-778-8300||
22407613|NCT01665040|Boston Scientific|Roshini Jain, Director of Clinical Sciences|6619494350|rjain@bsci.com|
22418013|NCT02444793|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22407614|NCT05453006|University of Minnesota|Christina Bliss Barsness|612-625-7179|blis0015@umn.edu|
22407615|NCT00195702|Abbott|Global Medical Services|800-633-9110||
22407616|NCT03721549|WCCT Global|Erin Flynn, Associate Director of Regulatory Affairs|7207713080|erin.flynn@wcct.com|
22407617|NCT00508469|Alcon France|Severine Durier, PharmD|+33 1 47 10 48 43||
22407618|NCT04156802|Wake Forest University School of Medicine|Merideth Addicott, PhD|336-716-7792|maddicot@wakehealth.edu|
22407619|NCT02818582|National Institute of Allergy and Infectious Diseases|Higgs, Elizabeth|+1 301 768 3947|ehiggs@niaid.nih.gov|
22407620|NCT00965458|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22407621|NCT02582216|Hôpital Erasme|Dominique Mouraux|+32/2.555.38.48|dmouraux@ulb.ac.be|
22407622|NCT01545375|GlaxoSmithKline|GSK Response Center|866-435-7343||
22407623|NCT02223637|GlaxoSmithKline|GSK Response Center|866-435-7343|geetha.x.kamath@gsk.com|
22407624|NCT04177862|University of Minnesota|Dr. Jonah Pearson|218-280-8348|pears731@umn.edu|1
22407625|NCT01846039|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22407626|NCT00594958|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar-kastner@intercell.com|0
22407627|NCT05637515|Biocon Biologics Limited|Sarika S Deodhar|0802808|Sarika.Deodhar@biocon.com|5302
22407628|NCT03233009|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22407629|NCT00564876|Duke University Medical Center|Neal Ready, MD|919-668-6688|neal.ready@duke.edu|
22407630|NCT04516291|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22407631|NCT01855607|Columbia University Irving Medical Center|Dawn L. Hershman, MD, MS, FASCO|212 305-1945|dlh23@columbia.edu|
22407632|NCT02181634|ECOG-ACRIN Biostatistics Center|PrECOG Statistician|617-632-3633|pcata@jimmy.harvard.edu|
22407633|NCT04250558|Dartmouth Hitchcock Medical Center|Dr. Ida Leah Gitajn|(603) 650-5133|ida.leah.gitajn@hitchcock.org|
22407634|NCT04812678|FasciaFrance|Dr Bertrand|+33682308609|isa.bertrand.cerap@gmail.com|
22407635|NCT02843282|University of Texas at Dallas, Center for BrainHealth|Erin Venza, Research Clinician|972-883-3208|erin.venza@utdallas.edu|
22407636|NCT01091116|Menarini-Ricerche|Clinical Research Director|+39-055-56809990||
22407637|NCT03824704|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
22407638|NCT01160458|National Cancer Institute, National Institutes of Health|Dr. Raffit Hassan, M.D.|301-451-8742|hassanr@mail.nih.gov|
22407639|NCT00182793|City of Hope|Paul Frankel, Ph.D.|626-359-8111|pfrankel@coh.org|65265
22407640|NCT02155660|AstraZeneca|Ulbaldo Martin|1.301.398.0163|ulbaldo.martin@astrazeneca.com|
22407641|NCT03730987|University of Miami|Dr. Victoria Behar-Zusman|305-2849139|vbehar-zusman@miami.edu|
22407642|NCT02087085|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22407643|NCT02505945|Torax Medical|Adam Ahlstrom|651-361-8900|aahlstro@its.jnj.com|
22407644|NCT00635804|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22407645|NCT02680158|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22407646|NCT03734601|Stanford University|Robert Lowsky, Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)|650-723-0822|rlowsky@stanford.edu|
22407647|NCT01425268|AirXpanders|Director of Clinical Affairs|650-390-9000|kkelley@airxpanders.com|9003
22407648|NCT00719706|McLean Hospital|Dr. Brian Brennan|617-855-2911|bbrennan@partners.org|
22407649|NCT02681094|AstraZeneca|Global Clinical Leader|+46 766 346712|clinicaltrialtransparency@astrazeneca.com|
22407650|NCT01072175|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22407651|NCT02839330|Seqirus|Seqirus Clinical Trial Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
22407652|NCT00682539|Department of Ophthalmology, Medical University Vienna|Dr. Katharina Kriechbaum|00431 40400 79480|katharina.kriechbaum@meduniwien.ac.at|
22407653|NCT00218439|University of Minnesota College of Pharmacy|Dr. Michael Kotlyar|612-625-1160|kotly001@umn.edu|
22407654|NCT02615158|University of Maryland School of Medicine|Dr. Maureen Black|410-706-2136|mblack@som.umaryland.edu|
22407655|NCT02257970|Stanford University, School of Medicine|Dr. Stanley Rockson|650-725-7571|rockson@stanford.edu|
22407656|NCT02477215|Medical College of Wisconsin|Parameswaran Hari|414-805-4600|phari@mcw.edu|
22407657|NCT00508872|UT MD Anderson Cancer Center|Eddie Abdalla, MD/Assistant Professor|713-792-6940||
22407658|NCT00883896|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22407659|NCT02546193|Mayo Clinic|VanessaTorbenson, M.D.|507-266-9873|torbenson.vanessa@mayo.edu|
22407660|NCT00310440|Nor Consult, LLC|Lead Clinical Research Associate|2066076861|p15@nor-consult.com|
22407661|NCT00792467|Italfarmaco SpA|Maurizio Caserini, MD|+39 0264431|m.caserini@italfarmaco.com|
22407662|NCT01256424|Photocure|Vice President Research and Development|+47 22062210|ifh@photocure.no|
22407663|NCT04871451|AEON Biopharma, Inc.|Dana Testa, PharmD|949-354-6499|dt@aeonbiopharma.com|
22407664|NCT00438815|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22407665|NCT01654666|XuanWu Hospital, Capital Medical University|Xunming Ji, M.D.,Ph.D|8683198127|jixunming@vip.163.com|
22407666|NCT04168775|University of North Carolina at Chapel Hill|Michael B. Drummond, MD|919-966-7054|brad_drummond@med.unc.edu|
22407667|NCT01177943|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22407668|NCT00958282|University of Minnesota|Dr. Marc Mooney|6129916875|moon0078@umn.edu|
22407669|NCT00859495|Columbia University|Robert Taub, MD||rntaubipod@gmail.com|
22407670|NCT02467504|Peking university People's Hospital|Prof. Zhanguo Li|+86-13810001444|13810001444@163.com|
22407671|NCT04225026|Galera Therapeutics|Judy Schnyder, Sr. Vice President, Clinical Operations|484-870-9625|jschnyder@galeratx.com|
22407672|NCT04462731|University of Pennsylvania|Ya-Hsin Yu|215-898-4927|yayu@upenn.edu|
22407673|NCT00779506|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22407674|NCT00026559|National Institute of Mental Health|Pao, Maryland|+1 301 435 5770|paom@mail.nih.gov|
22407675|NCT03982069|University of Pittsburgh|Dr. Katherine Williams|412-383-1979|kvw3@pitt.edu|
22407676|NCT00914940|Fred Hutchinson Cancer Research Center|Marie Bleakley, MD|206-667-6572|mbleakle@fredhutch.org|
22407677|NCT00690612|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22407678|NCT01682876|GlaxoSmithKline|GSK Response Center|877-379-3718|GSKClinicalSupportHD@gsk.com|
22407679|NCT00578331|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22407680|NCT00957827|University of Pennsylvania|Eric Granquist|215 880-7568|eric.granquist@uphs.upenn.edu|
22407681|NCT01858701|Alcon Research, Ltd.|Jessie Lemp, GMA Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22407682|NCT01674010|Transition Therapeutics Ireland Limited|Aleksandra Pastrak,MD, PhD, VP of Clinical Development and Medical Officer|+1 416 263 1227|apastrak@transitiontherapeutics.com|
22407683|NCT01020812|Stanford University|Daniel T Chang|650-723-6171|dtchang@stanford.edu|
22407684|NCT00187655|UCSF|Richard Castro, MD|4155144363|Rich.Castro@ucsf.edu|
22407685|NCT05040295|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22407686|NCT00953849|Ralph H. Johnson VA Medical Center, Charleston, SC|M. Rita I. Young, Ph.D.|843-792-9953|rita.young@va.gov|
22407687|NCT01115166|Department of Anaestesilogy and Intensive Care|Joachim Zdolsek|+46101030000|joachim.zdolsek@lio.se|
22407688|NCT01801475|Stanford University|Dr. David R Drover|6507250364|ddrover@stanford.edu|
22407689|NCT01559649|Michael E. DeBakey VA Medical Center|Stephanie Daniels|713-743-2570|skdaniels@uh.edu|
22407690|NCT01786707|University of Miami School of Medicine|Dr. Rodolfo Alejandro|3052435324|ralejand@med.miami.edu|
22407691|NCT00421928|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537||
22407692|NCT00444028|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
22407693|NCT00346775|GlaxoSmithKline|GSK Response Center|866-435-7343||
22407694|NCT02946515|University of Minnesota - Division of Epidemiology and Community Health|Dr. Nancy E. Sherwood, Associate Professor|612-625-4567|sherw005@umn.edu|
22407695|NCT02138227|Temple University|Dr. Laura Siminoff|(215) 204-8726|lasiminoff@temple.edu|
22407696|NCT00346476|Desmond Tutu HIV Centre|Prof LG Bekker|+27216506966|Linda-Gail.Bekker@hiv-research.org.za|
22407697|NCT01881867|Cancer Immunotherapy Trials Network|CITN Director|206-667-4141|mcheever@fredhutch.org|
22407698|NCT01054209|Brighton and Sussex University Hospitals Trust|Dr Mark Harper|01273696955|mark.harper@bsuh.nhs.uk|4307
22407699|NCT03044691|Unversity of Florida|Assistant Professor|(352) 294-4997|rsalloum@ufl.edu|
22407700|NCT01096017|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22407701|NCT02158949|University of Southern California|Elizabeth Burner|3234096667|eburner@usc.edu|
22407702|NCT00638820|Masonic Cancer Center, University of Minnesota|Paul Orchard, M.D.|612-626-2313|orcha001@umn.edu|
22407703|NCT00475657|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22407704|NCT00408408|NSABP Foundation, Inc|Director, Department of Regulatory Affairs|412-339-5300|regulatory@nsabp.org|
22407705|NCT01636102|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22407706|NCT05600101|Dana-Farber Cancer Institute|Dr. Gregory Abel|(877) 442-3324|Gregory_Abel@dfci.harvard.edu|
22407707|NCT03947333|Vanderbilt University Medical Center|William Martinez, MD|(615) 936-1010|william.martinez@vumc.org|
22407708|NCT02898662|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22407709|NCT00399542|Sucampo Pharmaceuticals, Inc.|Raymond Panas, PhD|301-961-3400|info@sucampo.com|
22407710|NCT00917553|University of Michigan|Dr. Thomas W. Gardner|734 232-8404|tomwgard@med.umich.edu|
22407711|NCT01616173|Northwestern University, Feinberg School of Medicine|Rohit Rahangdale MD|312-695-3045|ryrahangdale@hotmail.com|
22407712|NCT01905241|Cleveland Clinic Foundation|Joseph P. Iannotti, MD, PhD|216-287-1149|IANNOTJ@ccf.org|
22407713|NCT02675933|Dell Children's Medical Center of Central Texas|Dr. Catherine Yee|5123240000|ceyee@ascension.org|86878
22407714|NCT04680273|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
22407715|NCT03172026|University of California Los Angeles|Dr. Bruce H. Dobkin|310-206-6500|BDobkin@mednet.ucla.edu|
22407716|NCT01430559|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22407717|NCT00504595|Novartis Pharmaceuticals|Study Director|862-778-8300||
22407718|NCT01220024|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
22407719|NCT02109731|University of Rochester|Dr. Suzanne Karan|5852751384|suzanne_karan@urmc.rochester.edu|
22407720|NCT00174460|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22418014|NCT01685411|Masonic Cancer Center, University of Minnesota|Margaret L. MacMillan, M.D.|612-626-2778|macmi002@umn.edu|
22407721|NCT00579059|Biomet, LLC|Megan Lawson, Clinical Research Specialist|1-800-348-9500|megan.lawson@biomet.com|1183
22407722|NCT00779142|Wake Forest Baptist Health Eye Center|Dr. Shree Kurup|336-716-4091|skurup@wakehealth.edu|
22418015|NCT00679926|Oklahoma State University Center for Health Sciences|Johnny Stephens|918-382-3527|johnny.stephens@okstate.edu|
22407723|NCT04652245|Meda Pharma GmbH & Co. KG (A Viatris Company)|Christine Kolb|+496172888|christine.kolb@viatris.com|2511
22407724|NCT02071823|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22407725|NCT03698370|Stanford University|Dr. Andrei Iagaru, MD|650-728-4711|aiagaru@stanford.edu|
22407726|NCT03137433|University of Minnesota|Aaron Kelly, PhD|612-626-3492|kelly105@umn.edu|
22407727|NCT01288911|Astellas Pharma Global Development, Inc. (APGD)|Executive Medical Director||Astellas.resultsdisclosure@astellas.com|
22407728|NCT02452892|Tal Medical|Dr. Atul Pande, MD, Chief Medical Officer||apande@talmedical.com|
22407729|NCT00078715|Experimental Therapeutics and Pathophysiology Branch, DIRP, NIMH|Dr. Carlos A. Zarate, Jr.|301-451-0861|zaratec@mail.nih.gov|
22407730|NCT03681808|Bausch & Lomb|Study Director|585-338-6399|Robert.Steffen@bausch.com|
22407731|NCT03742271|Johnson & Johnson Vision Care Inc.|John Buch OD F.A.A.O- Sr. Principal Research Optometrist|+1 904 443-1707|JBUCH@its.jnj.com|
22407732|NCT02694562|Boston Scientific|Angela Schutt|763-494-2166|angela.schutt@bsci.com|
22407733|NCT00807768|NRG Oncology|Linda Gedeon for Virginia Filiaci, PhD|716-845-1169|lgedeon@gogstats.org|
22407734|NCT03529162|Saint Louis University|Sarah Dawson, Research Nurse|314-977-4106|sarah.dawson@health.slu.edu|
22407735|NCT01522391|Pergamum AB|Margit Mahlapuu PhD, Assoc. Prof. in Molecular Medicine|+46 70 631 01 09|margit.mahlapuu@pergamum.com|
22407736|NCT00758420|BTG International Inc.|David Wright MBBS|610-943-3538|david.wright@btgplc.com|
22407737|NCT00554229|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22407738|NCT00784836|Biogen Idec Inc.|Biogen Idec Medical Director||clinicaltrials@biogenidec.com|
22407739|NCT00517634|GlaxoSmithKline|GSK Response Center|866-435-7343||
22407740|NCT03143855|Virginia Commonwealth University|Dr. F. Gerard Moeller|804-828-4134|fgmoeller@vcu.edu|
22407741|NCT02514889|UCLA Fielding School of Public Health, 650 Charles Young Drive, Los Angeles, CA 90095|William J. McCarthy, Ph.D., Professor|310-794-7587|wmccarth@ucla.edu|
22407742|NCT00701064|VA|Shawn Youngstedt|803-767-3208|shawn.youngstedt@asu.edu|
22407743|NCT02613910|GlaxoSmithKline|GSK Response Center|866-435-7343||
22407744|NCT02098733|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22407745|NCT03077646|Children's Hospital at Montefiore|Alyssa Silver, MD|718-741-2304|alysilve@montefiore.org|
22407746|NCT00765726|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22407747|NCT02993731|Sumitomo Dainippon Pharma Oncology|Cindy Oh|617-674-8628|coh@bostonbiomedical.com|
22407748|NCT01197495|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com|
22407749|NCT01002573|Cumberland Pharmaceuticals Inc.|Senior Manager, Clinical Operations|615-255-0068|bkaelin@cumberlandpharma.com|
22407750|NCT01519648|National Hematological Society|Professor Galina A Klyasova|+7(495)6125181|klyasova.g@blood.ru|
22407751|NCT01716221|University of Colorado|Dr. Olga Klepitskaya|303-724-8984|olga.klepitskaya@ucdenver.edu|
22407752|NCT03808298|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22407753|NCT02713490|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
22407754|NCT03039686|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22407755|NCT01793610|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
22407756|NCT03868410|Cleveland Clinic|Dr. Ela Plow|216-445-6728|plowe2@ccf.org|
22407757|NCT00224952|The Children's Mercy Hospital|J. Steven Leeder Pharm D, PhD|816-234-3059|sleeder@cmh.edu|
22407758|NCT00134563|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi-aventis.com|
22407759|NCT01827462|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
22407760|NCT03382639|Neurocrine Biosciences|Neurocrine Medical Information Call Center|877-641-3461|medinfo@neurocrine.com|
22407761|NCT00987558|Bial - Portela & Cª, S.A.|Head of Clinical Research||jose.rocha@bial.com|
22407762|NCT02624713|Tel-Hai College|Prof. Moria Golan|972547240330|moria.golan@mail.huji.ac.il|
22407763|NCT00148109|University of Michigan Comprehensive Cancer Center|Dr. Rashmi Chugh|(734) 936-5710|rashmim@umich.edu|
22407764|NCT06104423|A.MENARINI I.F.R SrL|Simone Baldini Global Clinical Operations Manager|055 56801|sbaldini@menarini.it|
22407765|NCT00538434|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000||
22407766|NCT00351611|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22407767|NCT01589185|Aridis Pharmaceuticals, Inc.|Lynne Deans, M.T.|408-385-1742|deansl@aridispharma.com|
22407768|NCT02708524|Johnson & Johnson Vision Care Inc.|Kristy Canavan, O.D. PRINCIPAL RESEARCH OPTOMETRIST|904-443-1474|KCANAVA2@its.jnj.com|
22407769|NCT00822185|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22407770|NCT03781167|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22407771|NCT00462501|Memorial Sloan Kettering Cancer Center|Dr. Leonard Saltz|646-888-4286|saltzl@mskcc.org|
22407772|NCT04435431|Integrative Research Laboratories Sweden AB|Joakim Tedroff, Chief Medical Officer|+46707601691|joakim.tedroff@irlab.se|
22407773|NCT00679354|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22407774|NCT03554798|FIDEC Corporation|Ricardo Rüttimann, PhD|+5491161188536|rruttimann@fidec-online.org|
22407775|NCT01258803|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22407776|NCT01552408|Retina Consultants of Houston|David M. Brown, MD|713-524-3434|dmbmd@houstonretina.com|
22407777|NCT00967473|Alcon Research, Ltd.|Director of Alcon Clinical|888-451-3937; 817-568-6725|medinfo@alconlabs.com|
22407778|NCT00556140|Massachusetts General Hospital|Dr. John Matthews|617-724-0847|jmatthews@partners.org|
22407779|NCT01016912|Bristol-Myers Squibb International Corporation|BristolMyers Squibb Study Director||clinical.trials@bms.com|
22407780|NCT01199952|University of California, San Francisco|Director for Research Operations|415-206-2476|abby.sokoloff@ucsf.edu|
22407781|NCT01853397|Solta Medical|Director of Clinical Programs|510-259-5284|aloncaric@solta.com|
22407782|NCT01632345|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22407783|NCT00089505|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22407784|NCT02431559|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
22418016|NCT02504671|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22418017|NCT00210249|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Pr Simone Mathoulin-Pélissier|+33 (0)5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
22418018|NCT03222583|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22418019|NCT03576183|Valneva Austria GmbH|Head Global Medical Affairs|20620|info@valneva.com|0
22418020|NCT04280705|Organization:NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
22418021|NCT01951885|Case Comprehensive Cancer Center|Betty Hamilton MD|866-223-8100|TaussigResearch@ccf.org|
22418022|NCT01687478|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22418023|NCT03188718|University of Colorado Denver|Michelle Sobremonte-King, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
22418024|NCT03716076|BC Women's Hospital|Dr. Anthony Chau|604-875-2158|anton.chau@ubc.ca|
22418025|NCT02633488|University of Virginia|Eugene J. Barrett MD PhD|434-924-1263|ejb8x@virginia.edu|
22418026|NCT00119067|CDC|Jennifer G Wright||jgwright@cdc.gov|
22418027|NCT02713386|NRG Oncology|Christopher Purdy on behalf of Michael Sill, PhD|716-845-1300|purdyc@nrgoncology.org|2296
22418028|NCT01936623|Friends Research Institute|Robert Schwartz, M.D.|410-837-3977|rschwartz@friendsresearch.org|276
22418029|NCT01383135|Stanford University|Andrei Iagaru, MD|6507362859|aiagaru@stanford.edu|
22407785|NCT02543918|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979||
22407786|NCT03503617|Flint Rehabilitation Devices|Daniel Zondervan|9493137322|dzondervan@flintrehab.com|
22407787|NCT00486720|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22407788|NCT05489146|University of Pittsburgh|Amit Sethi, Associate Professor, Department of Occupational Therapy,|4123836619|asethi@pitt.edu|
22407789|NCT03820388|University of California Davis|Dr. Hong Liu|916-734-5031|hualiu@ucdavis.edu|
22407790|NCT00469391|GI Dynamics, Inc.|Clinical Affairs Manager|781.357.3261|pkeating@gidynamics.com|
22407791|NCT05047601|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22407792|NCT00286234|Sanford School of Medicine, University of South Dakota|Dr. William Harris|16052716917|bill@omegaquant.com|2
22407793|NCT04834375|Northwell Health|Dr. Stella Hahn|516-465-5400|sthahn@northwell.edu|
22407794|NCT02347124|Kaiser Permanente Washington Health Research Institute|Dr. Jennifer McClure|206-287-2737|mcclure.j@ghc.org|
22407795|NCT02924129|Saluda Medical|Angela Leitner|651-208-4223|angela.leitner@saludamedical.com|
22407796|NCT02499380|PneumRx|Jörg Rennecke|+49 211 5422750|medical.services@btgplc.com|
22407797|NCT00596622|Indiana University School of Medicine|Amit Anand|3172747422|aanand@iupui.edu|
22407798|NCT04241627|University of Southern California Keck School of Medicine Department of Pediatrics|Caitlin Sayegh|13233617748|cssayegh@chla.usc.edu|
22407799|NCT03279731|Perelman School of Medicine at the University of Pennsylvania|Kelly C. Allison, PhD|2158982823|kca@pennmedicine.upenn.edu|
22407800|NCT00302731|University of Kansas Medical Center|Jeanne A Drisko, MD, CNS, FACN|913-588-6208|jdrisko@kumc.edu|
22407801|NCT02780869|Biom'up|Rachel Hoffman, Vice President Clinical Operations North America|404-702-9253|r.hoffman@biomup.com|
22407802|NCT01610752|Pennington Biomedical Research Center|Dr. Leanne M. Redman|2257630947|leanne.redman@pbrc.edu|
22407803|NCT00283062|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
22407804|NCT01843933|Yale University|Melissa Langhan|2037377413|melissa.langhan@yale.edu|
22407805|NCT03137173|Basilea Pharmaceutica International Ltd.|Project Physician|+41 79 701 0551|marc.engelhardt@basilea.com|
22407806|NCT01535638|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22407807|NCT05060003|Washington University School of Medicine|George Ansstas, M.D.|314-362-5677|gansstas@wustl.edu|
22407808|NCT03524664|Mt. Hope Family Center, University of Rochester|Dr. Christie Petrenko|(585) 275-2991|christie_petrenko@urmc.rochester.edu|241
22407809|NCT01482598|Abbott|Alessandra Denaro, Sr. Director Clinical Site Management||alessandra.denaro@abbott.com|
22407810|NCT01373294|H. Lee Moffitt Cancer Center and Research Institute|Dr. Mayer Fishman|813-745-8311|mayer.fishman@moffitt.org|
22407811|NCT00423267|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22407812|NCT03702166|UT Health San Antonio|John Moring, PhD|(210) 562-6716|moringj@uthscsa.edu|
22407813|NCT00827112|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22407814|NCT01333865|Massachusetts General Hospital|Gagan Joshi, MD|617-724-2344|joshi.gagan@mgh.harvard.edu|
22407815|NCT00515021|Vanderbilt University Medical Center|James Muldowney|615-936-1720|james.muldowney@vanderbilt.edu|
22407816|NCT03512028|Washington University School of Medicine|Catherine Lang|314-286-1945|langc@wustl.edu|
22418030|NCT04941521|The University of Texas Health Science at Houston|Joy M Schmitz, PhD|713-486-2867|Joy.M.Schmitz@uth.tmc.edu|
22418031|NCT02122406|University of Pavia|Vittorio Grosso MD|+393332605945|vittorio.grosso@gmail.com|
22407817|NCT01861587|Medical University of South Carolina|Jeffrey Borckardt, Ph.D|843-792-3295|borckard@musc.edu|
22407818|NCT02127931|CogCubed|Monika Roots, MD|6122509737|monika.d.heller@gmail.com|
22407819|NCT00939094|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22407820|NCT00617994|Incyte|Incyte Corporation Call Center (US)|1.855.463.3463|medinfo@incyte.com|
22407821|NCT02028182|Allerderm(dba) SmartPractice|Kathryn Shannon|6022250595|kshannon@smarthealth.com|
22407822|NCT01684930|Victoria University|Jason D. Allen, PhD|61 3 9919 4264|jason.allen@vu.edu.au|
22407823|NCT01945866|Jaeb Center for Health Research|Adam Glassman|8139758690|drcrnet@jaeb.org|
22407824|NCT01336647|Hatchtech Pty Ltd|Clinical Manager|+61 3 9092 0490|tahveninen@hatchtech.com.au|
22407825|NCT01018680|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22407826|NCT05056311|Indiana University|Elaine Cuevas|317-278-7495|elinder@iu.edu|
22407827|NCT03724305|Henry Ford Health|Chaewon Sagong|2483442409|csagong1@hfhs.org|
22407828|NCT02600559|Otonomy, Inc.|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
22407829|NCT01710007|Orient Europharma Co., Ltd.|Vivian Lu|+886-2-2755-4881|Vivian.Lu@oppharma.com|2958
22407830|NCT02965027|VA Puget Sound Health Care System|Hollie Holmes|206-277-6207|Hollie.Holmes@va.gov|
22407831|NCT00665366|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22407832|NCT02196025|University of Florida|Robyn Nelson|3522945563|r.nelson@ufl.edu|
22407833|NCT03628781|Cincinnati Children's Hospital Medical Center|Dr. Jeff Epstein|15136368296|jeff.epstein@cchmc.org|
22407834|NCT00994123|Merrimack Pharmaceuticals|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
22407835|NCT05981443|University of Kentucky|Dr. Cody Blanchard|859-323-5867|cody.blanchard@uky.edu|
22407836|NCT02718131|University of Alabama at Birmingham|Karen Cole-Plourde|205-934-5140|kplourde@uab.edu|
22407837|NCT02406586|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
22407838|NCT00285857|Stanford University|James M. Ford|(650) 498-6689|jmf@stanford.edu|
22407839|NCT03927209|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22407840|NCT03558230|Medical University of South Carolina|Dr. Na Jin Seo|843-792-0084|seon@musc.edu|
22407841|NCT02816255|Weill Cornell Medicine|Matthew R. Ebben, Ph.D.|646-962-9313|mae2001@med.cornell.edu|
22407842|NCT04051320|University of North Carolina at Chapel Hill|Crystal Schiller, PhD|919-966-5243|crystal_schiller@med.unc.edu|
22407843|NCT00733096|Johns Hopkins School of Medicine|Steven P. Cohen|410-955-1822|scohen40@jhmi.edu|
22407844|NCT01005875|University of Alabama at Birmingham|Dr. Kimberly Keene|2-5-934-5670|kkeene@uab.edu|
22407845|NCT00606931|Naviscan Inc|Judith E Kalinyak, MD, PhD, Medical Director|858-587-3641|jkalinyak@naviscan.com|108
22407846|NCT01294319|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|Dr. Lynnette Nieman|301-496-4000|niemanl@mail.nih.gov|
22407847|NCT02172820|The University of Vermont|Diann Gaalema, Ph.D., PI|802-656-9874|Diann.Gaalema@med.uvm.edu|
22407848|NCT01230021|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22407849|NCT01348828|Endologix|Sripad Bellary, Director Clinical Affairs|9257011628|sbellary@endologix.com|
22407850|NCT01135368|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22407851|NCT04246996|Dell Medical School at The University of Texas at Austin|Mary Rieger, MD, MAS|512-324-7036|mary.rieger@austin.utexas.edu|
22407852|NCT02442284|AbbVie|Global Medical Services|800-633-9110||
22407853|NCT02208466|Spaulding Rehabilitation Hospital|Dr. Felipe Fregni|6179526158|fregni.felipe@mgh.harvard.edu|
22407854|NCT04745065|Pro-Change Behavior Systems, Inc.|Kerry E. Evers|401-360-2980|kevers@prochange.com|
22407855|NCT00252499|VA Puget Sound Health Care System|Kristina Utzschneider, MD|206-277-3568|kristina.utzschneider@va.gov|
22407856|NCT01365468|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22407857|NCT03088345|Medical College of Wisconsin/Children's Hospital of Wisconsin|Dr. Amee Bigelow|5136364200|amee.bigelow@cchmc.org|
22407858|NCT01521494|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
22407859|NCT01140646|Mayo Clinic|Dr. Amit Sood|507-284-1623|sood.amit@mayo.edu|
22407860|NCT03006276|BioDelivery Sciences|Todd Kunkel, PharmD Director, Scientific Communications|913-940-1789|tkunkel@bdsi.com|
22407861|NCT04126187|Gainesville Eye Associates|Clayton Blehm, MD|17705324444|claytonblehm@gmail.com|
22407862|NCT00689728|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22407863|NCT03245372|Hospital Universitario Virgen del Rocío, Servicio Andaluz de Salud|Dr. Alejandro Domínguez-Blanco|0034660762856|aledguez@gmail.com|
22407864|NCT04047342|Geisinger Clinic|Amir Goren|5702144395|agoren@geisinger.edu|
22407865|NCT02720627|Cassiopea, SpA|Cassiopea R&D|+39 02 868 911 24|r&d@cassiopea.com|
22407866|NCT00660829|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2393|WWheeler@medapharma.us|
22407867|NCT03417999|Children's Hospital of Philadelphia|Dr. Kelly Grogan|410-279-6994|grogank@chop.edu|
22407868|NCT02185729|Emory University|Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
22407869|NCT03815006|Manchester University NHS Foundation Trust|Dr Lala Leelarathna|01612766706|lalantha.leelarathna@manchester.ac.uk|
22407870|NCT01526343|Washington University School of Medicine|Jennifer Bell, Manager of Clinical Trials|314-747-6969|jennifer.bell@wustl.edu|
22407871|NCT02539160|University of Florida College of Medicine Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3378|dominick.angiolillo@jax.ufl.edu|
22407872|NCT01681004|SI-BONE, Inc.|Daniel Cher, Vice President of Clinical Affairs|408-207-0700|dcher@si-bone.com|
22407873|NCT00372905|Northwestern University|Jane Winter, MD|312 695 4033|Jwinter@nm.org|
22407874|NCT01728454|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22407875|NCT02218424|Ann & Robert H. Lurie Children's Hospital of Chicago|Hubert Benzon, MD; Primary Investigator|312-227-5122|hbenzon@luriechildrens.org|
22407876|NCT00695318|Alimera Sciences, Inc.|Kathleen Billman, Senior Director, Scientific Affairs|678-527-1302|kathleen.billman@alimerasciences.com|
22407877|NCT02058966|Veterans Affairs Portland Healthcare System|Dr. William Hoffman|503-220-8262|hoffmanw@ohsu.edu|56491
22407878|NCT00490477|University of Turin, Italy|V. M. Ranieri, MD|00390116334001|marco.ranieri@unito.it|
22418032|NCT02455050|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22418033|NCT02605993|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1-855-752-2356|clinicaltrials@alexion.com|
22418034|NCT01383213|IRCCS Fondazione Cà Granda Policlinico Milano|Dr Roberto Cosentini|+390255033618|r.cosentini@gmail.com|3618
22418035|NCT03493386|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22418036|NCT04146116|University of Wisconsin, Madison|Dr. Marin Schweizer|6082631545|mschweizer@medicine.wisc.edu|
22418037|NCT04645264|Rush University Medical Center|Kern Singh, MD|(312) 432-2435|kern.singh@rushortho.com|
22418038|NCT03468075|University of Iowa, Holden Comprehensive Cancer Center|Clinical Assistant Professor|319-384-9497|varun-monga@uiowa.edu|
22418039|NCT00988442|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 6283313|ACTGCT.Gov@s-3.com|
22418040|NCT00271154|Medtronic CRDM|CRDM Core Clinical|800-328-2518|medtroniccrmtrials@medtronic.com|
22418041|NCT04620135|Aerie Pharmaceuticals Inc.|Michelle Senchyna, PhD. VP, Clinical Development and Medical Affairs|+1 908-947-3551|msenchyna@aeriepharma.com|
22418042|NCT04740320|Imperial College London|Clinical Project Manager|+442083831284|polly.fox@imperial.ac.uk|
22418043|NCT01442688|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22418044|NCT00762437|AbbVie|Sally Hallas, RN|209-294-5571|sally.hallas@abbvie.com|
22418045|NCT02666352|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22418046|NCT04771403|Oregon Health and Science University|Jessica Castle|503-494-7072|castleje@ohsu.edu|
22418047|NCT04480021|University of Washington|Dr. Amritha Bhat|206-543-3117|amritha@uw.edu|
22418048|NCT00857259|Novartis Pharmaceuticals|Study Director|862-778-8300||
22418049|NCT00546572|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22418050|NCT03979820|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22418051|NCT01229735|UCB Pharma|UCB Clinical Trial Call Center|+1877 822||9493
22407879|NCT01362062|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22407880|NCT01272245|UT MD Anderson Cancer Center|Kantarjian,Hagop M|713-792-7026|CR_Study_Registration@mdanderson.org|
22407881|NCT02545504|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22407882|NCT01148836|Cleveland Clinic|Jacqueline Sharp, CNP|216-636-0000|pylej@ccf.org|
22407883|NCT00434876|Philadelphia VAMC|Subhajit Chakravorty|215-823-5800|Subhajit.Chakravorty@va.gov|3405
22407884|NCT00758394|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
22407885|NCT00508820|Amgen Inc.|Study Director|866-572-6436||
22407886|NCT02926833|Kite, A Gilead Company|Medical Information|844-454-5483(1-844-454-KITE)|medinfo@kitepharma.com|
22407887|NCT02930889|University of Minnesota|Jafar Golzarian, MD|612-626-5566|jafar@umn.edu|
22407888|NCT04398030|Capillary BioMedical, Inc.|Alayne Lehman Director of Clinical Affairs|949-317-1711|alayne.lehman@capillarybio.com|
22407889|NCT01004822|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22407890|NCT01206296|MedStar Health Research Institute|Director of Clinical Trials|301-560-7300|Research@MedStar.Net|
22407891|NCT01520038|University of Pennsylvania|John Christodouleas, MD|215-662-6568|christojo@uphs.upenn.edu|
22407892|NCT03159455|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22407893|NCT02641691|Washington University School of Medicine|Hyun Kim, M.D.|314-362-8502|kim.hyun@wustl.edu|
22407894|NCT02022566|Lunds university|Physical therapist Therese Jönsson|0046703360721|therese.jonsson@med.lu.se|
22407895|NCT03503565|KYUNG HEE UNIVERSITY HOSPITAL AT GANGDONG|Dr Hyungseok Seo|+821029306885|seohyungseok@gmail.com|
22407896|NCT01714726|AstraZeneca|Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22407897|NCT00548340|Vanda Pharmaceuticals Inc.|Marlene Dressman, Ph.D.|202-734-3462|marlene.dressman@vandapharma.com|
22407898|NCT03778021|University of Washington, Department of Epidemiology|Shirley A.A. Beresford, Principal Investigator|206 543 9512|beresfrd@uw.edu|
22407899|NCT00679042|CellTrans Inc.|Jennifer Cook|312-413-7727|jenny@celltransinc.com|
22407900|NCT02687815|University of Pittsburgh|Dr. Juan Celedón|(412) 692-8429|juan.celedon@chp.edu|
22407901|NCT00379639|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22407902|NCT02558634|Vancouver Coastal Health Research Association|Amanda Chisholm, Manager, Internal Awards|6048754111|amanda.chisholm@vch.ca|21696
22407903|NCT03814824|Northwell Health|Dr. Arvind Trindade|516-387-3990|atrindade@northwell.edu|
22407904|NCT03053102|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22407905|NCT00835861|Maternal-Fetal Medicine and Obstetrics at UT Southwestern|M. Ashley Hickman Zink|469-303-3591|m.ashley.hickman@gmail.com|
22407906|NCT03735680|OncoNano Medicine, Inc.|Vice President, Clinical Operations|682-285-1411|clinicaltrials@onconanomed.com|
22407907|NCT02145949|University of Oregon|Dr. Hans Dreyer|541-346-3902|hcdreyer@uoregon.edu|
22407908|NCT04602078|Spanish Oncology GenitoUrinary Group (SOGUG)|A responsible person designated by the Sponsor|0034934344412|investigacion@mfar.net|
22407909|NCT02392078|Monteris Medical|Christa Seligman|(952) 463-7747|cseligman@monteris.com|
22431595|NCT02581930|University of North Carolina at Chapel Hill|Dr. Stergios Moschos|919-843-7713|stergios_moschos@med.unc.edu|
22431596|NCT02776735|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22418052|NCT02685202|University of North Carolina at Chapel Hill|Anne E. Sanders, PhD|919-537-3275|anne_sanders@unc.edu|
22407910|NCT01513538|Medtronic|Céline This|33 6 89 71 90 67|celine.this@medtronic.com|
22407911|NCT02079077|University of Manitoba|Keith Fowke|204-789-3296|keith.fowke@umanitoba.ca|
22407912|NCT01928758|Penn State College of Medicine|Jonathan Foulds|717-531-3504|jfoulds@psu.edu|
22407913|NCT03198559|University of Melbourne|Professor Sharon Lewin|+61 (0)3 8344 3309|sharon.lewin@unimelb.edu.au|
22407914|NCT03737812|AbbVie|Global Medical Services|800-699-9110|abbvieclinicaltrials@abbvie.com|
22407915|NCT03693846|University of Pennsylvania|Thomas Karasic, MD|215-614-1858|thomas.karasic@pennmedicine.upenn.edu|
22407916|NCT01100931|National Cancer Institute, National Institutes of Health|Dr. Giuseppe Giaccone|301-496-4916|giacconeg@mail.nih.gov|
22407917|NCT01474291|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22407918|NCT03471507|Duke University Medical Center|Lance Roy, M.D.|919-684-8111|lance.roy@duke.edu|
22407919|NCT02103608|Tennesse clinical research center|Dr. Michael Gold|615-383-2400|drgold@goldskincare.com|
22407920|NCT02557308|Celltrion Inc|JiWoong Lim|82-32-850-5702|jiwoong.lim@celltrion.com|
22407921|NCT01388946|Aretaieo Hospital University of Athens|Argyro Fassoulaki|+30 6936701333|fassoula@aretaieio.uoa.gr|
22407922|NCT04337827|Cleveland Clinic Foundation, Case Comprehensive Cancer Center|Dr. Deepa Jagadeesh|1-866-223-8100|TaussigResearch@ccf.org|
22407923|NCT02046993|Kwong Wah Hospital|Dr Lorna Ng|(852) 23322311|ngl@ha.org.hk|
22407924|NCT04491955|National Cancer Institute|Dr. Hoyoung Maeng|240-781-3253|hoyoung.maeng@nih.gov|
22418053|NCT02130882|National Institute of Allergy and Infectious Diseases, NIH|Dr. Amy Klion|301-435-8903|aklion@nih.gov|
22418054|NCT00520286|National Institutes of Health|Liza Zeinert|301-443-1138|liza.zeinert@nih.gov|
22418055|NCT01300923|Cincinnati Childrens Hospital|Craig Erickson|5136366265|craig.erickson@cchmc.org|
22418056|NCT02707861|TaiMed Biologics USA Corp.|Manager - Clinical Operations|713-478-2927|bbell@taimedbio.com|
22418057|NCT02150759|Inje University, Haeundae paik hospital|Ki Hwa Lee|82-51-797-0421|tedy3333@naver.com|
22418058|NCT00731549|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
22418059|NCT00507546|VAPAHCS|Dr. Jamie Zeitzer|6504935000|jzeitzer@stanford.edu|62410
22418060|NCT03322384|University of California, Davis|Analyst|9167348053|nlogihara@ucdavis.edu|
22418061|NCT03736213|New York University|Dr. Tara McAllister|212-992-9445|tkm214@nyu.edu|
22418062|NCT00609466|Grunenthal|René Allard|49 241 569 3223|Clinical-Trials@grunenthal.com|
22418063|NCT02287493|University Medical Center Hamburg-Eppendorf|Dr. Christina König|+49 040 7410 -0|ch.koenig@uke.de|
22418064|NCT01299805|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22418065|NCT04002063|VHAPTH|Judith A. Callan PhD, RN|412-628-1534|judith.callan@va.gov|
22418066|NCT02518919|Children's Hospital of Michigan|Dr. Nirupama Kannikeswaran, Associate Professor of Pediatrics and Emergency Medicine|313-745-5260|nkannike@dmc.org|
22418067|NCT04498403|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22418068|NCT03986138|Guerbet|Frantz Hebert, Global Head of Clinical Development|+33 (0)6 80 24 93 34|frantz.hebert@guerbet.com|
22418069|NCT00671918|Navidea Biopharmaceuticals|Dr. Frederick Cope|614-793-7500|fcope@navidea.com|140
22418070|NCT02031458|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22418071|NCT03062228|Global Innovations for Reproductive Health & Life|Dr. Allan Kember, Director of Programs|+1-902-580-8385|allan.kember@mail.utoronto.ca|
22418072|NCT02910674|Barbara Davis Center for Childhood Diabetes|Dr. Satish K. Garg|303.724.6713|satish.garg@ucdenver.edu|
22418073|NCT03182244|Astellas Pharma Inc|Clinical Transparency|+81 3-3244-6500 Japanese only|astellas.resultsdisclosure@astellas.com|
22418074|NCT02049450|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22418075|NCT02492880|Boston Scientific|Director of Clincial Sciences|855-213-9890|BSNClinicalTrials@bsci.com|
22418076|NCT02381626|Memorial Sloan Kettering Cancer Center|Dr. Jennifer Leng, MD, MPH|646-888-8057|lengj@mskcc.org|
22418077|NCT00292188|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22418078|NCT03186781|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Martin Gaudinski, MD|301-451-8715|martin.gaudinski@nih.gov|
22418079|NCT04709835|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22418080|NCT03786718|Vanderbilt University Medical Center|William Martinez, MD|(615) 936-1010|william.martinez@vumc.org|
22418081|NCT03190213|Huntsman Cancer Institute Research Compliance Office|Data Manager|8015850601|compliance@hci.utah.edu|
22418082|NCT01781481|Children's HOspital of Eastern Ontario|Dr. Janice Cohen|613-737-7600|cohen@cheo.on.ca|2497
22418083|NCT00372411|Dept. of Veterans Affairs, Cooperative Studies Program, West Haven, CT|Peter Guarino, MPH, PhD, Director, WH-CSPCC|203-932-5711|peter.guarino@va.gov|3780
22418084|NCT02326337|AOTI Ltd.|Dr. Mike Griffiths (Medical Director)|+1(760) 431 4700|mike.griffiths@aotinc.net|
22418085|NCT00667810|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22418086|NCT02369900|Beth Israel Deaconess Medical Center|Michael N. Cocchi MD|617-754-2388|mcocchi@bidmc.harvard.edu|
22418087|NCT01570686|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22418088|NCT02244918|University of Kansas Medical Center|Dr. Nicole Nollen|913-588-3784|nnollen@kumc.edu|
22418089|NCT02372071|Hadassah Hospital located in Jerusalem, Israel|PROF. BAR-OZ BENJAMIN|02-6774919|baroz@hadassah.org.il|
22418090|NCT02227147|Dompé|Flavio Mantelli, MD, PhD|02 583831|info@dompe.com|
22418091|NCT00673153|Fred Hutch Cancer Research Center|Roland B. Walter, MD, PhD, MS|(206) 667-3599||
22407925|NCT00886626|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu|
22407926|NCT05375942|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22407927|NCT00761735|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22407928|NCT03326323|Inova Heart and Vascular Institute|Eric L. Sarin MD|703-776-4138|eric.sarin@inova.org|
22407929|NCT03360695|Massachusetts General Hospital|Kelly Irwin, MD, MPH|617-643-4453|kirwin1@partners.org|
22407930|NCT00851721|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22407931|NCT04047472|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22407932|NCT01218477|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22407933|NCT02347345|Aaron Diamond AIDS Research Center|Martin Markowitz MD|212-448-5020|mmarkowitz@adarc.org|
22407934|NCT01333501|Novartis Pharmaceuticals|Study Director|862-778-8300||
22407935|NCT01303159|Weill Cornell Medical College|Michel Kahaleh|646-962-4797|mik9071@med.cornell.edu|
22407936|NCT00496782|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22407937|NCT03485976|Oregon Health & Science University, Department of Dermatology|Teri Greiling, MD, PhD|503-494-8452|PRPStudy@ohsu.edu|
22407938|NCT02132312|Omeros Corporation|Omeros Clinical Trial Information|ctinfo@omeros.com|ctinfo@omeros.com|
22407939|NCT04034225|Sensei Bio|Alice Drumheller|2404548027|adrumheller@senseibio.com|
22407940|NCT00955682|GlaxoSmithKline|GSK Response Center|866-435-7343||
22407941|NCT01680835|Medtronic|Jennifer Seamans, M.S., Clinical Research Program Manager|763-398-7455|jennifer.l.seamans@medtronic.com|
22407942|NCT03026556|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22407943|NCT01205399|C. R. Bard: Davol, Inc.|Dawn Heimer/Director, Clinical Affairs|401-825-8681|dawn.heimer@crbard.com|
22407944|NCT00877929|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22407945|NCT00842829|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22407946|NCT02155725|LFB Biomédicaments|Medical Director France|33 169827229|zitounis@lfb.fr|
22407947|NCT02612194|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
22407948|NCT00387621|Mayo Clinic|Dr Horng Chen|507-284-4343|chen.horng@mayo.edu|
22407949|NCT00689299|Greer Laboratories, Inc. for Antigen Laboratories, Inc.|Mark Hites|828-759-7548|mhites@greerlabs.com|
22407950|NCT01190839|Janssen Pharmaceuticals|Strategic Lead Gastroenterology||ClinicalTrialDisclosure@its.jnj.com|
22407951|NCT02980211|University of Iowa College of Dentistry|Dr. Gustavo Avila-Ortiz, Professor and Chair, Department of Periodontics|3193357241|gustavo-avila@uiowa.edu|
22407952|NCT01832753|The Children's Hospital of Philadelphia|Andrea Kelly, MD MSCE|215-590-3174|kellya@email.chop.edu|43174
22407953|NCT01265511|Scynexis|Katyna Borroto-Esoda|9192374431|katyna.borroto-esoda@scynexis.com|
22407954|NCT01922336|Samsung Bioepis Co., Ltd.|Director of Clinical Trials|+82 31 8061 4534|sbregistry@samsung.com|
22407955|NCT00950755|GlaxoSmithKline|GSK Response Center|866-435-7343||
22407956|NCT03539900|Yale University|Dr Carlos Grilo|203 785 7210|carlos.grilo@yale.edu|
22407957|NCT03799198|Novo Nordisk A/S|Clinical Transparency and Medical Writing Office (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22407958|NCT03427931|University of Virginia|Sue Brown, MD|4349820602|sab2f@virginia.edu|
22407959|NCT00960869|POZEN|John Fort, MD / Chief Medical Officer|919-913-1030|jfort@pozen.com|
22407960|NCT02501642|James A. Haley VA|Tracy Kretzmer, Ph.D.|813-972-2000|tracy.kretzmer@va.gov|5729
22407961|NCT05959564|University of Maryland, College Park|Xiaoli Nan|301-405-0640|nan@umd.edu|
22407962|NCT01153971|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22407963|NCT03410693|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22407964|NCT01789476|Cara Therapeutics, Inc.|Frédérique Menzaghi, PhD, Vice President Research & Development|(203) 567-1502|fmenzaghi@caratherapeutics.com|
22407965|NCT00953576|Beth Israel Deaconess Medical Center|Glenn Bubley, MD||gbubley@bidmc.harvard.edu|
22407966|NCT00501969|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22407967|NCT01798056|GlaxoSmithKline|GSK Response Center|866-435-7343||
22407968|NCT01238861|MedImmune, LLC|Rene van der Merwe, MBChB, MFPM, Medical Officer|301-398-0000|vandermerwer@medimmune.com|
22407969|NCT01269346|Eisai Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22407970|NCT00247416|University of Kentucky Markey Cancer Center|Suzane Arnold, MD|859 323 8043|smarno0@uky.edu|
22407971|NCT01008059|Washington University|Evan D. Kharasch, MD PhD|314-362-8796|kharasch@wustl.edu|
22407972|NCT02660489|Imperial College London|Professor Sebastian Johnston|+44 (0)20 7594 3764|s.johnston@imperial.ac.uk|
22407973|NCT00278473|Icahn School of Medicine at Mount Sinai|Dr. Mary V. Solanto|212-241-5420|Mary.Solanto@mssm.edu|
22407974|NCT02322866|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22407975|NCT01700907|Sapporo Medical University School of Medicine|Michiaki Yamakage|+81116112111|yamakage@sapmed.ac.jp|3568
22407976|NCT03930524|University of Michigan|Dr. Megan Patrick|734-763-5043|meganpat@umich.edu|
22407977|NCT00761761|Univeristy Of Pittsburgh Medical Center|K.N. Roy Chengappa, MD|412-246-5006|chengappakn@upmc.edu|
22407978|NCT01778296|The Second Hospital of Tangshan|Dr. Chao Chen|86-13700350471|ts_chenchao@163.com|
22407979|NCT00460421|Swedish Orphan Biovitrum|Medical Program Director|+46 8 697 20 00|clinical@sobi.com|
22407980|NCT04001790|Virginia Commonwealth University|Carol Schall|8048286979|cmschall@vcu.edu|
22418092|NCT01916590|UColorado|Colleen Dingmann R.N. Ph.D.|303-724-7494|colleen.dingmann@ucdenver.edu|
22418093|NCT01284296|University of California, San Francisco|Ronald D. Miller|415 476-9034|millerr@anesthesia.ucsf.edu|
22418094|NCT03514641|Theracos Sub, LLC|Albert Collinson|(508) 688-4221|acollinson@theracos.com|
22418095|NCT01345175|Memorial Sloan Kettering Cancer Center|Dr. Philip Paty, MD|212-639-6703|patyp@MSKCC.ORG|
22407981|NCT03472586|Thomas Jefferson University|Marlana Orloff, MD|215-955-9974|marlana.orloff@jefferson.edu|
22407982|NCT04542304|Stanford University|Tammy Lisa Sirich, MD|650-849-1907|tsirich@stanford.edu|
22418096|NCT03688282|TheraNova|Vice President of Research and Development|415-926-8616|clinicalstudy@theranova.com|
22407983|NCT04963231|Rhythm Clinical Trials|Rhythm Pharmaceuticals, Inc.|857-264-4280|clinicaltrials@rhythmtx.com|
22407984|NCT02928900|University of Washington|Pamela Kohler|206.221.5746|pkohler2@uw.edu|
22407985|NCT01059175|Medtronic|Latifa Foudali|+33 631992144|latifa.foudali@medtronic.com|
22407986|NCT02957149|Mayo Clinic|Matthew Gettman, MD|507-284-3249|Gettman.Matthew@mayo.edu|
22407987|NCT06045026|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
22407988|NCT04550234|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22407989|NCT02452320|Weill Cornell Medicine|Farrell Cooke, Senior Research Assistant|212-746-2774|fac2010@med.cornell.edu|
22407990|NCT01399619|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22407991|NCT02547064|Keimyung university|Hyun-Chang Kim|+821028862876|onidori1979@gmail.com|
22407992|NCT03911401|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22407993|NCT05602818|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22407994|NCT03417245|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22407995|NCT00598442|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
22407996|NCT04620356|kimberlyClark|Clinical Science Manager|+55 11 45034500|debora.rodrigues@kcc.com|
22407997|NCT00457951|Chimerix|Zahra Masoud|763-300-0559|zmasoud@chimerix.com|
22407998|NCT03740152|Massachusetts General Hospital|Dr. Paolo Cassano, M.D.|617-643-9622|pcassano@mgh.harvard.edu|
22407999|NCT02951143|University of Kentucky|Mikhail Koffarnus|8593236402|koffarnus@uky.edu|
22408000|NCT01590628|Gamida Cell|Kelly Myers, CRA|026595631|kelly@gamida-cell.com|
22408001|NCT02992743|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22418097|NCT01289665|AdventHealth|Dr. Ashley Hill|407-303-1444|Ashley.Hill.MD@adventhealth.com|
22418098|NCT01561430|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22418099|NCT04112173|University of Delaware|Jeremy Crenshaw, Ph.D.|302-831-4795|crenshaw@udel.edu|
22418100|NCT03347422|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22418101|NCT01736241|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22418102|NCT03161964|University of Utah|Dr. Anu Sharma|(801) 581-7761|Anu.Sharma@hsc.utah.edu|
22418103|NCT04796779|University of Virginia|Marc Breton, PhD|434-982-6484|mb6nt@virginia.edu|
22418104|NCT04234984|Department of Anaesthesiology & Pain Medicine, Maastricht University Medical Centre, Postbus 5800, 6202 AZ Maastricht, The Netherlands.|Prof. Dr. Jan Van Zundert|(+32) 475687657|jan.van.zundert@mumc.nl|
22418105|NCT01055132|Johnson & Johnson Vision Care|Ross Franklin|1-904-443-1379|RFrankl1@its.jnj.com|
22418106|NCT00158600|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22418107|NCT02570113|Ablative Solutions Inc|Kate Rumrill|+1 (650) 688-9743|krumrill@ablativesolutions.com|
22418108|NCT02038907|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22418109|NCT02746471|Medtronic|Erika Pouliot|17635261270|erika.pouliot@medtronic.com|
22418110|NCT02564211|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22418111|NCT00858962|Yale University AIDS Program|R. Douglas Bruce, MD, MA|(203) 737-6133|robert.bruce@yale.edu|
22418112|NCT00910091|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22418113|NCT02181426|Medical University of South Carolina, Department of Anesthesia and Perioperative Medicine|Research Coordinator for Anesthesia and Perioperative Medicine|843-792-2322|joneswr@musc.edu|
22418114|NCT00622466|The University of Texas Southwestern Medical Center|Dr. Barbara Haley|214-648-4180|barbara.haley@utsouthwestern.edu|
22418115|NCT01659866|Northwestern University|Dr. Anthony Schaeffer|312-908-1615|ajschaeffer@northwestern.edu|
22418116|NCT01908816|Novartis Pharmaceuticals|Study Director|862-778-8300||
22418117|NCT02252718|Medical University of Warsaw|Katarzyna Wojtyniak|(+48) 223179536|wojtyniakkasia@gmail.com|
22418118|NCT02618408|Supernus|Gianpiera Ceresoli-Borroni, PhD, Director of Clinical Research|301-838-2521|gceresoliborroni@supernus.com|
22408002|NCT03290131|RVL Pharmaceuticals, Inc.|Vice President, Regulatory Affairs and Quality|908-809-1300|Regulatory@RVLpharma.com|
22408003|NCT00398476|GlaxoSmithKline|GSK Response Center|866-435-7343||
22408004|NCT00381680|Childrens's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22408005|NCT03099096|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22418119|NCT04870138|University of North Carolina at Chapel Hill|Marcia M. Hobbs, PhD|919-843-6893|mmhobbs@med.unc.edu|
22408006|NCT00731640|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22408007|NCT00361504|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537||
22418120|NCT05183217|University of Wisconsin - Madison|Heidi Brown|619-695-4714|heidi.w.brown@kp.org|
22408008|NCT04899362|the First Hospital of Jilin University|Dr Yi Yang|0431|doctoryangyi@163.com|88782378
22408009|NCT03045926|Ipsen Pharma SAS|Medical Director|+33 (0)158335000|clinical.trials@ipsen.com|
22408010|NCT03764813|Fondazione Policlinico Gemelli IRCCS|luciana teofilili medical director of the UNICATT cord blood bank|39 06 30154180|luciana.teofili@unicatt.it|
22408011|NCT00401414|Brigham and Women's Hospital|Mark A. Creager|617-732-5267|mcreager@partners.org|
22408012|NCT03648073|University of Alabama at Birmingham|Samuel Galgano, Principal Investigator|2059341449|samuelgalgano@uabmc.edu|
22408013|NCT00683852|Massachusetts General Hospital, CTNI|Martina Flynn, Director, Clinical Trial Operations|617-643-6028|mflynn2@partners.org|
22408014|NCT00450814|Mayo Clinic|Angela Dispenzieri, M.D., Morie A. Gertz, M.D.|(507) 284-2511|Dispenzieri.Angela@mayo.edu, Gertz.Morie@mayo.edu|
22408015|NCT03724552|Massachusetts General Hospital|T. Atilla Ceranoglu, MD|617-726-1291|aceranoglu@mgh.harvard.edu|
22408016|NCT03866811|Columbia University|Dr. Lauren Chernick|2123056628|lc2243@columbia.edu|
22408017|NCT03602976|University of Pennsylvania|Dr. Ethan Weinberg|215-349-8222|ethan.weinberg@pennmedicine.upenn.edu|
22408018|NCT04837807|The University of Alabama at Birmingham|Dr. Andrew Pucker|920-579-2900|apucker@uab.edu|
22408019|NCT03260699|Department of Orthopaedic Surgery, Cleveland Clinic|Alison Klika, Research Manager|216 444-4954|klikaa@ccf.org|
22408020|NCT00334893|Memorial Sloan-Kettering Cancer Center|Dr. Martee L. Hensley|646-888-4222|hensleym@mskcc.org|
22408021|NCT00920582|Provention Bio, Inc.|Sharon Rowland|443-987-0797|SRowland@proventionbio.com|
22408022|NCT03319160|Zoll|Mike Osz|412-968-3333|mosz@zoll.com|
22408023|NCT00665002|H. Lee Moffitt Cancer Center and Research Institute|Jeffrey E. Lancet, M.D.|813-745-6841|jeffrey.lancet@moffitt.org|
22408024|NCT03604159|NYU Langone|Dr. Joshua Lee|646-501-3552|Joshua.Lee@nyulangone.org|
22408025|NCT04533204|VA Ann Arbor Healthcare System; University of Michigan|Dr. Benjamin Hampstead|734-763-9259|bhampste@med.umich.edu|
22408026|NCT01591044|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
22408027|NCT02260791|Fujifilm Kyowa Kirin Biologics Co., Ltd., EU Branch|Clinical Trial Information|+44 1896 668 173|Clinical-Trials@fk-b.com|
22408028|NCT02354599|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22408029|NCT00280059|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22408030|NCT02984228|Hospital for Special Surgery|Jennifer Cheng|6467146870|chengj@hss.edu|
22408031|NCT00495794|VA Center for Clinical Management Research; University of Michigan|Dr. Michele Heisler|734-845-3504|mheisler@umich.edu|
22408032|NCT00323479|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22408033|NCT03014700|Stanford university School of Medicine|Glyn David Williams|650-723-5728|jumbo@stanford.edu|
22408034|NCT03044730|Northwestern University, Feinberg School of Medicine|William John Gradishar, MD, FACP, FASCO|(312) 695-4541|w-gradishar@northwestern.edu|
22408035|NCT02549040|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22408036|NCT02195349|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22408037|NCT01302366|Perlmutter Cancer Center at NYU Langone|Amitabha Mazumder, MD|212-731-5757|amitabha.mazumder@nyumc.org|
22408038|NCT00847002|Tactile Systems Technology, Inc|Sunday Hoy, Director of Clinical Research|612.355.5100||
22408039|NCT00198107|Indiana University|Christopher J. McDougle, MD|781-860-1783|cmcdougle@partners.org|
22408040|NCT00934661|Anesthesiology|Dr. Pamela Nagle Assistant Professor|336-716-7180||
22408041|NCT01685320|Campus Bio-medico University|Prof. Massimiliano Carassiti|+39-06-225411952|m.carassiti@unicampus.it|
22408042|NCT01013207|ResMed Ltd|Alison Wimms|+61 8884 2583|alison.wimms@resmed.com.au|
22408043|NCT01541644|University of Maryland Baltimore Greenebaum Cancer Center|Emily Parks|410-328-7340|eparks@umm.edu|
22408044|NCT01966458|Medtronic|Thomas Vassiliades|+15085321942|thomas.a.vassiliades@medtronic.com|
22408045|NCT03342911|Thomas Jefferson University|Jennifer Johnson|215-955-8874|jxj021@jefferson.edu|
22408046|NCT05064436|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
22408047|NCT01342445|University of Rhode Island|Dr. Lisa Weyandt|(401)874-2087|lisaweyandt@uri.edu|
22408048|NCT02706327|Eastern Mediterranean University|Yasin YURT|+905338724271|fzt.yasinyurt@gmail.com|
22408049|NCT02652793|Hospital Clinic of Barcelona|Dr. José Luis Blanco|+34 932275400|jlblanco@clinic.cat|
22408050|NCT01982942|Medicinova Inc|Director, Medical Writing|8582468680|makhay@medicinova.com|
22408051|NCT04511533|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22408052|NCT01224171|Millennium Pharmaceuticals Inc.|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
22408053|NCT01097057|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
22408054|NCT01270139|Ural Institute of Cardiology|Dr. Alexander Kharlamov|0031627849118|drskharlamov@gmail.com|
22408055|NCT01512758|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22408056|NCT04384120|Henry Ford Health|Dr. Joseph Tramer|2165362904|jtramer1@hfhs.org|
22408057|NCT02702115|Sangamo Therapeutics, Inc.|Medical Monitor|(510) 307-7266|clinicaltrials@sangamo.com|
22408058|NCT06304064|Capricor Inc.|Study Director|858-727-1755|mawadalla@capricor.com|
22408059|NCT04140942|University of Michigan|Brittany Ross|(734) 764-2368|rossbrit@umich.edu|
22408060|NCT01161173|Hoffman-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
22408061|NCT01911546|Former: Cedars-Sinai Medical Center, Comprehensive Transplant Center|Dr. Joseph Kahwaji, MD, MPH|310-423-2641|joseph.m.kahwaji@kp.org|
22408062|NCT01407068|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22408063|NCT02213666|Beth Israel Deaconess Medical Center|Elad Anter, MD|617-632-9209|eanter@bidmc.harvard.edu|
22418121|NCT01663935|University of Wisconsin, Madison|Dr Michael Struck|608 263-6429|mcstruck@wisc.edu|
22418122|NCT03914950|Medical University of Graz, Department of Radiology, Division of Nuclear Medicine|Dr. Susanne Stanzel|+43-316-385-81789|susanne.stanzel@medunigraz.at|
22418123|NCT00242619|Stanford University|Dr. Natalie Rasgon|(650) 724-6689|natalie.rasgon@stanford.edu|
22418124|NCT03397771|Ixaltis|Chief Development Officer|33457260076|svanberg@ixaltis.com|
22418125|NCT02669758|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
22418126|NCT00631449|University of California, San Francisco|Steven Deeks, MD|415-476-4082|Steven.Deeks@ucsf.edu|404
22418127|NCT03393806|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22418128|NCT01259115|Purdue Pharma L.P.|Executive Medical Director, Clinical Pharmacology|800-733-1333||
22418129|NCT02849938|Billings Clinic|Patricia M Notario, MD|406-238-2143|pnotario@billingsclinic.org|
22418130|NCT00548171|GlaxoSmithKline|GSK Response Center|866-435-7343||
22418131|NCT02987959|Fox Chase Cancer Center|Protocol Developer|215-728-4097|ryan.romasko@fccc.edu|
22418132|NCT04453202|Janssen Vaccines & Prevention B.V.|CLINICAL FRANCHISE LEADER|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22418133|NCT00168311|Monash Alfred Psychiatry Research Centre|Professor Paul Fitzgerald|+61 3 9076 6564|p.fitzgerald@alfred.org.au|
22418134|NCT00001586|National Cancer Institute, National Institutes of Health|Wyndham H. Wilson, M.D.|301-435-2415|wilsonw@mail.nih.gov|
22418135|NCT01355159|Ottawa Hospital Research Institute|Dr. Mark Walker|6137378899|mwalker@ohri.ca|76655
22418136|NCT03276221|Massachusetts General Hospital|Randi M. Schuster, PhD|617-643-6673|rschuster@mgh.harvard.edu|
22418137|NCT00424775|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22418138|NCT02615171|University of Connecticut|Dr. Sherry Pagoto|8604868979|Sherry.Pagoto@uconn.edu|
22418139|NCT03554603|Memorial University|Peter Daley MD MSc|7097772089|pkd336@mun.ca|
22418140|NCT03110601|Stimgenics|VP of Clinical Affairs|309-662-4321|clinicalSG@stimgenics.com|217
22418141|NCT02384850|GSO Global Clinical Research B.V., EBC Amsterdam, Keizersgracht 62-64, 1015 CS Amsterdam|Dr. Anne L. Kranich|+49 40 44 19 54 60|kranich@gsoglobal.com|
22418142|NCT00446199|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22418143|NCT02312063|Kansai Electric Power Medical Research Institute|Dr. Daisuke Yabe|+81-6-6458-5821|ydaisuke-kyoto@umin.ac.jp|
22418144|NCT01412372|University of Utah|Dr. Ashok Tuteja|801-581-5679|Ashok.Tuteja@hsc.utah.edu|
22418145|NCT01079832|Case Comprehensive Cancer Center|Dr. Charles Kunos|330-375-4485|kunosc@summahealth.org|
22418146|NCT03544879|UC San Diego|Dr. Erik Groessl|858-642-6347|egroessl@ucsd.edu|
22418147|NCT01195272|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22418148|NCT01769339|Janssen Philippines|Medical Affairs Manager|+6328248935||
22418149|NCT04969861|Nektar Therapeutics|Study Director|415-482-5300|StudyInquiry@nektar.com|
22418150|NCT00290251|NICHD, NIH|Lynnette Nieman MD|301-496-8935|NiemanL@nih.gov|
22418151|NCT03548064|University of Maryland|Wilbur H. Chen, MD, MS|410-706-1188|wchen@som.umaryland.edu|
22418152|NCT05730556|Mayo Clinic|Amaal Starling, M.D.|715-537-1345|Starling.Amaal@mayo.edu|
22418153|NCT06218823|University of Wisconsin Center for Tobacco Research and Intervention|Associate Director of Research|6082628673|demccarthy@ctri.wisc.edu|
22418154|NCT03611543|Hologic, Inc.|Muhammad Waqas, Director of Global Clinical Affairs, BSH|(508) 263-8935|ClinicalResearch@Hologic.com|
22418155|NCT06077487|University of California, San Francisco|Dr. Brian Anderson|(415) 476-1000|Brian.Anderson@ucsf.edu|
22418156|NCT05101486|Janssen Vaccines & Prevention B.V.|Director Biomarkers Viral Vaccines|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22418157|NCT02788045|Janssen Vaccines & Prevention B.V|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22418158|NCT05538065|Brigham and Women's Hospital|Niteesh Choudhry|617-278-0930|nkchoudhry@bwh.harvard.edu|
22418159|NCT03047473|Clinique Neuro-Outaouais|Dr Francois Jacques|819-777-2500|francois.jacques@neuro-outaouais.ca|217
22418160|NCT00721630|Memorial Sloan Kettering Cancer Center|Dr. Tiffany Traina|646-888-5209|trainat@mskcc.org|
22418161|NCT01812681|Dr. Sami Ulus Children's Hospital|Dr. Serdar Beken|00903123056449|serbeken@gmail.com|
22418162|NCT04711902|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22418163|NCT03244644|Rebiotix inc, a Ferring Company|Clinical Development|651-705-8778|US8-StudyInfo@ferring.com|
22418164|NCT01398514|Massachusetts General Hospital|Dr. Naomi Simon|617-726-7913|nsimon@partners.org|
22418165|NCT04208958|Vedanta Biosciences|Jeffrey Silber|(857) 706-1427|ConsortiumIO-ctinquiries@vedantabio.com|
22418166|NCT00754650|Hoffmann-La Roche|Medical Communications|800 821-8590||
22418167|NCT03365752|Hospital for Special Surgery|Marla Sharp, MPH, MA|646-797-8419|sharpm@hss.edu|
22418168|NCT03167723|Atrium Health Wake Forest|Bradley Thomas MD|704-355-3176|bradley.thomas@atriumhealth.org|
22418169|NCT04040322|CiVi Biopharma, Inc.|Chief Executive Officer|301-968-2390|sj@civibio.com|
22418170|NCT00507130|MedImmune|Don Raible, MD|301-398-0000|raibleD@medimmune.com|
22418171|NCT02524730|Stryker|Britta von den Brincken, Sr. Clinical Study Manager|+491638999202|britta.vondenbrincken@stryker.com|
22418172|NCT01772758|Augusta University|Ryan Harris, Ph.D.|706-721-5998|ryharris@augusta.edu|
22418173|NCT01775852|Baylor College of Medicine|Lilian Dindo, PhD|713-791-1414|lilian.dindo@bcm.edu|10296
22418174|NCT01025271|University of Pittsburgh|Karin Byers, MD|412-648-6553|dlp5@pitt.edu|
22418175|NCT00699374|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22418176|NCT04536935|University of Washington|Morgan Johnson|715-416-1493|mjohn23@uw.edu|
22418177|NCT03678285|University of Wyoming|Dr. Evan Johnson|307-766-5282|ejohns54@uwyo.edu|
22431597|NCT01139515|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22418178|NCT00123474|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22392199|NCT00955708|Boston Scientific|Director of Clinical Trial Management - cRM franchise|1-800-227-3422|elaine.larson@bsci.com|
22392200|NCT02132832|The University of Texas Health Science Center at Houston|Scott D. Lane, PhD|(713) 486-2535|Scott.D.Lane@uth.tmc.edu|
22392201|NCT03165747|Emory University|Roberto Pacifici, MD|404-712-8420|roberto.pacifici@emory.edu|
22392202|NCT02160730|Cedars-Sinai Medical Center|Dr. Ning-Ai Liu|310-423-7382|ning-ai.liu@cshs.org|
22418179|NCT01059344|The Role of Centralized Reading of Endoscopy in a Randomized Controlled Trial of Mesalamine for Ulcertive Colitis|Brian G. Feagan et al|Gastroenterology 2013; 145:||149-157
22392203|NCT04028921|Children's Mercy Kansas City|Dr. Robin Shook, PhD|(816) 234-9443|rpshook@cmh.edu|
22392204|NCT01735175|Sandoz|Strategic Planning, Biopharmaceutical Clinical Development|+49 (0) 8024 476 - 0|biopharma.clinicaltrials@sandoz.com|
22392205|NCT02103114|Duke University|Dr. Edmund Jooste|919-681-4877|edmund.jooste@duke.edu|
22392206|NCT04210843|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
22392207|NCT01266161|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22392208|NCT04692467|Weill Cornell Medicine|Dr. Margaret McNairy|646-962-8140|mam9365@med.cornell.edu|
22392209|NCT01016847|Duke Asthma Allergy and Airway Center|Monica Kraft, M.D.|9194790719|denise.beaver@dm.duke.edu|
22392210|NCT01427725|Medical affairs|Medical affairs manager|+81-3-5656-0516||
22392211|NCT01374568|UAB|Dr. Amy Warriner|2059964004|awarriner@uabmc.edu|
22418180|NCT01434186|AstraZeneca AB, S-151 85 Södertälje, Sweden|Eva Johnsson, Clinical Science Lead, GLOBAL_MEDICINES_DEV|+46 31 7762484|Eva.Johnsson@astrazeneca.com|762 484
22392212|NCT02221557|Sunstar Americas, Inc.|Akane Takemura, R&D Senior Manager|847-794-4276|akane.takemura@us.sunstar.com|
22392213|NCT01277887|Yale University School of Medicine|Lisa Fucito, PhD|203 974-5759|lisa.fucito@yale.edu|
22392214|NCT00415051|US Army Medical Research Institute of infectious Diseases (USAMRIID)|COL Phillip R. Pittman, MD, MPH|301-619-4994|phillip.pitman@amedd.army.mil|
22392215|NCT04379011|University of Minnesota|Dr. Ricardo Battaglino|612-625-2661|rbattagal@umn.edu|
22392216|NCT05672771|University of Illinois|Dr. Elizabeth A L Stine-Morrow|217-244-2167|eals@illinois.edu|
22392217|NCT02080546|Duke University Medical Center|Dr Paula S Lee|919-684-3765|paula.s.lee@duke.edu|
22392218|NCT04160988|Acer Healthcare Inc.|Regulator Manager|886-6-26963131|Johnny.Lu@acer.com|5789
22392219|NCT00844597|Sarepta Therapeutics|Edward M. Kaye, MD, Interim CEO, SVP & Chief Medical Officer|617-274-4003|EKaye@Sarepta.com|
22392220|NCT01250509|University of California, San Francisco|Jennifer Daubenmier, PhD|415-514-8601|jennifer.daubenmier@ucsf.edu|
22392221|NCT01262547|Massachusetts General Hospital|Dr. Alexandra Kimball|617-726-5066|harvardskinstudies@partners.org|
22392222|NCT03321253|Necip Fazil City Hospital|Dr. Bunyamin Kutluksaman|903442282800|bkutluksaman@gmail.com|
22392223|NCT02781649|Johns Hopkins University|Christine Durand, MD|410-955-5684|cdurand2@jhmi.edu|
22392224|NCT01292304|University of Florida|Giuseppe (Joseph) Morelli, MD|352-273-9508|giuseppe.morelli@medicine.ufl.edu|
22392225|NCT00243074|SWOG Statistical Center|Lung Committee Statistician|206-667-4623|jmoon@fredhutch.org|
22392226|NCT04263987|Vanderbilt University Medical Center|Nicholas kavoussi|615-322-7401|nicholas.l.kavoussi@vumc.org|
22392227|NCT00570908|Baylor Coolege of Medicine|Dr. Mothaffar Rimawi|7137981811|rimawi@bcm.edu|
22392228|NCT01213524|Brown University|Jennifer Tidey, Ph.D.|401-863-6418|Jennifer_Tidey@brown.edu|
22392229|NCT05415748|UCSF|Dr. Scott Bauer|650-515-2879|scott.bauer@ucsf.edu|
22392230|NCT01447576|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
22392231|NCT00975676|International Breast Cancer Study Group (IBCSG)|Head Trial Activities and Deputy Director Dr. Heidi Roschitzki-Voser Organization|+41 31 511 94 00|heidi.roschitzki@ibcsg.org|
22392232|NCT02209181|McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.|Joseph Aquilina, MD, Senior Director, Clinical Research|(215) 273-8025|JAquilin@its.jnj.com|
22392233|NCT02579772|Queen's University|Dr. J. Alberto Neder|613-548-2255|nederalb@gmail.com|
22392234|NCT03128671|University of Miami|Cindy Munro|305-284-2107|cmunro@miami.edu|
22392235|NCT04072445|Mayo Clinic|Dr. Amit Mahipal|507-293-0487|Mahipal.Amit@mayo.edu|
22408064|NCT01319422|Yale University|Madhav Dhodapkar, M.D.|203-785-4144|madhav.dhodapkar@yale.edu|
22408065|NCT02918968|Astellas Pharma Inc.|Clinical Trial Disclosure|+81 3-3244-6500 Japanese only|astellas.resultsdisclosure@astellas.com|
22408066|NCT00750061|China Spinal Cord Injury Network|Dr. Wendy Cheng|+852 28660829|wendycheng@chinasci.net|
22408067|NCT03661346|University of Texas Medical Branch - Galveston|Dr. Mohamad Chaaban|281-338-0829|mrchaaba@UTMB.EDU|
22408068|NCT03814499|Fondazione Telethon|Head of Clinical Development and Operations|+3902202217224|szancan@telethon.it|
22408069|NCT00892710|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22408070|NCT01243762|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22408071|NCT00229931|Dean McGee Eye Institute|Robert E. Leonard, II, MD|405-271-6307|sonny-icks@dmei.org|
22408072|NCT01374516|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22408073|NCT04629534|Medical University of South Carolina|Carol Wagner|843-792-5179|wagnercl@musc.edu|
22408074|NCT03732534|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22408075|NCT02190604|Novartis|Study Director|862-778-8300||
22408076|NCT02797951|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22408077|NCT01901393|Cumberland Pharmaceutical Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com|
22418181|NCT00831766|H. Lee Moffitt Cancer Center and Research Institute|Dr. Jeffrey Lancet|813-745-1387|jeffrey.lancet@moffitt.org|
22408078|NCT04585906|Johns Hopkins Center for Indigenous Health|Emily E. Haroz, PhD, Co-Director of Research|410-960-9503|eharoz1@jhu.edu|
22392236|NCT04641962|Astellas Pharma Global Development, Inc|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
22392237|NCT00862836|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22392238|NCT04463680|University of Colorado Anschutz Medical Campus|Aaron Lazorwitz|3037242019|aaron.lazorwitz@cuanschutz.edu|
22392239|NCT00388804|UT MD Anderson Cancer|Andrew Lee, MD / Professor||lhamblin@mdanderson.org|
22392240|NCT05472740|Duke University|Amelia Scott, Research Program Leader|(919) 613-4584|amelia.lorenzo@duke.edu|
22392241|NCT02998476|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22392242|NCT01769430|University of Maryland, College Park|Professor & Director PHAB Lab|424-246-8358|phablab@umd.edu|
22392243|NCT00344032|GlaxoSmithKline|GSK Response Center|866-435-7343||
22392244|NCT05131477|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|contact-us@saonofi.com|6
22392245|NCT06915285|VisionQuest Biomedical Inc|Vinayak Joshi|3054845674|vjoshi@visionquest-bio.com|
22408079|NCT03125382|IMP|Drª. Milene Fernandes|00351965751328|milenefernandes@hotmail.com|
22408080|NCT04626947|University of Pittsburgh|David G. Binion|412-647-4194|binion@pitt.edu|
22408081|NCT00267202|Novartis Pharmaceuticals|Clinical Director|862-778-1768|maria.figliomeni@novartis.com|
22408082|NCT01766466|The Medicines Company|Jayne Prats, PhD - VP, Global Knowledge Management|888.779.MDCO|jayne.prats@themedco.com|1510
22408083|NCT06016556|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22408084|NCT00629343|Columbia University|Robert Taub, MD, PhD|(212) 305-4076|rnt1@columbia.edu|
22408085|NCT01428882|Hospital San Pedro de Alcantara, Caceres|Dr. Javier Molina-Infante|0034927621543|xavi_molina@hotmail.com|
22408086|NCT03907072|WAVE Life Sciences|Medical Director|855-215-4687|clinicaltrials@wavelifesci.com|
22408087|NCT00612456|GlaxoSmithKline|GSK Response Center|866-435-7343||
22408088|NCT00265109|Weill Cornell Medicine|Katharine A. Phillips MD|646-962-2820|kap9161@med.cornell.edu|
22408089|NCT02463097|Medtronic Minimed|Thomas Thoub|8185763142|thomas.troub@medtronic.com|
22408090|NCT01757821|University of Minnesota|James Carey|612-626-2746|carey007@umn.edu|
22408091|NCT03831282|Masimo|Vikram Ramakanth|949-297-7416|clinicalresearchdept@masimo.com|
22408092|NCT02078557|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22408093|NCT01830621|The Ottawa Hospital Regional Cancer Centre|Dr. Derek Jonker|613-737-7700|djonker@ottawahospital.on.ca|70170
22408094|NCT03556202|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22408095|NCT03223649|National Institutes of Health|Jack A. Yanovski, MD, PhD|3014960858|jy15i@nih.gov|
22408096|NCT00697255|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22408097|NCT05664672|Altria|Functional Director Clinical Research|8043352366|Jeffery.S.Edmiston@altria.com|
22408098|NCT01475513|Virginia Commonwealth University|Kai Cheang|8049863269|kicheang@vcu.edu|
22408099|NCT02815670|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22408100|NCT01411917|University of Wisconsin School of Medicine, Department of Anesthesiology|Kristopher Schroeder|608-232-1542|kmschro1@wisc.edu|
22408101|NCT03164629|University of Miami|Shivank Bhatia, MD|305-585-7500|SBhatia1@miami.edu|
22408102|NCT02791906|University of Pennsylvania|Associate Professor|2152007779|julio.chirinos@uphs.upenn.edu|
22408103|NCT01815099|Hartford Hospital|Gretchen Diefenbach|860-545-7685|gretchen.diefenbach@hhchealth.org|
22408104|NCT01977573|GlaxoSmithKline|GSK Response Center|866-435-7343||
22408105|NCT01441882|Oregon Health & Science University|Stephen Spurgeon|503-494-4606|spurgeos@ohsu.edu|
22408106|NCT02513732|Abbott|Hajime Kusano, Senior Adviser Clinical|+1 4088451626|hajime.kusano@abbott.com|
22408107|NCT00467051|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22408108|NCT00990782|Cleveland Clinic|Dr. John Vargo|(216) 445-5012|vargoj@ccf.org|
22408109|NCT01358266|Santen Inc.|Clinical Operations|+1-415-268-9100|clinicaltrials@santen.com|
22408110|NCT01846442|Endoceutics|Director of Data Analysis|418-653-0033|celine.martel@endoceutics.com|215
22408111|NCT03996694|BioDelivery Sciences|Todd Kunkel, PharmD Director, Scientific Communications|913-940-1789|tkunkel@bdsi.com|
22408112|NCT02477319|Seattle Children's Hospital|Umer Khan (Principal Biostatistician)|206-884-7516|umer.khan@seattlechildrens.org|
22408113|NCT02777554|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22408114|NCT02147132|UC COM Psychiatry Dept. -- Addiction Sciences Division|Jeff Theobald|5135858281|theobajy@ucmail.uc.edu|
22408115|NCT00808769|The Procter & Gamble Company|John Mcrorie, PhD, FACG, AGAF|513-622-1423|mcrorie.jw@pg.com|
22408116|NCT04070157|USWM, LLC|Medical Affairs|1-888-900-8796|medinfo@usworldmeds.com|
22408117|NCT01458535|AbbVie|Global Medical Services|800-633-9110||
22408118|NCT00151775|Daiichi Sankyo|Howard Kessler, Senior Director Regulatory Operations|732-590-5032|hmkessler@dsi.com|
22408119|NCT00474994|Memorial Sloan Kettering Cancer Center|Dr. Mary Keohan|646-888-4160|KeohanM@mskcc.org|
22408120|NCT03757585|Massachusetts General Hospital|Janet Wozniak|6176436617|jwozniak@partners.org|
22408121|NCT01711736|GlaxoSmithKline|GSK Response Center|866-435-7343||
22408122|NCT04579666|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
22408123|NCT05450198|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@msd.com|
22408124|NCT01533974|Fred Hutchinson Cancer Research Center|Jonathan B. Bricker, Ph.D.|206-667-5074|jbricker@fredhutch.org|
22408125|NCT01678586|Massachusetts General Hospital|Dr. Lucy Chen|617-724-6102|mghpainresearch@partners.org|
22418182|NCT02731326|Columbia University|Suzanne Bakken, PhD, RN|212-305-1278|sbh22@columbia.edu|
22392246|NCT06840769|Helsinn Healthcare SA|Tulla Spinelli|+41.91.985.21.21|Tulla.Spinelli@helsinn.com|
22418183|NCT01085201|BloodCenter of Wisconsin|Dr. Joshua J. Field|414-937-3848|joshua.field@bcw.edu|
22408126|NCT00591305|Boston Medical Center|Zhi Wang, MD|617-414-1590|zwang@bu.edu|
22408127|NCT00808665|Vanderbilt University Medical Center|James Blair DO|615-343-6082|james.l.blair@vanderbilt.edu|
22408128|NCT02967393|Vanderbilt University Medical Center|Kathryn M. Edwards MD|615-322-8792|kathryn.edwards@vanderbilt.edu|
22408129|NCT01694849|GENFIT|Carol Addy, MD MMSc|+01 6179536469||
22408130|NCT05227404|University of Minnesota|Eileen Denning|612-626-8049|edenning@umn.edu|
22408131|NCT01326312|Oncternal|Mary Breitmeyer|858-434-1113|mbreitmeyer@oncternal.com|
22408132|NCT02787655|Atl VA|Joe Nocera|404 321 6111|joe.nocera2@va.gov|206354
22408133|NCT00895817|Walter Reed Army Medical Center|Dr. Fouad J Moawad|(301) 295-4600|fouad.moawad@us.army.mil|
22408134|NCT00678652|Clinical Trials Center, WRAIR|Paul B. Keiser, M.D.||noinformation@available.com|
22408135|NCT05146999|Galderma Research & Development, LLC|Felipe Weinberg, MD, MPH|817-961-5000|aestheticclinicaltrials@galderma.com|
22408136|NCT00383292|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22408137|NCT03570658|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22408138|NCT01005355|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22408139|NCT03301272|University of North Carolina at Chapel Hill|Daniel Roque, MD|919-966-8178|droque@neurology.unc.edu|
22408140|NCT03457701|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22408141|NCT03329404|Terumo Blood and Cell Technologies|Robert Cortes, Jr. MD|+1.303.231.4353|Robert.Cortes@terumobct.com|
22408142|NCT02243306|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22408143|NCT02221882|Eli Lilly and Company|Chief Medical Officer|800+545-5979|ClinicalTrials.gov@lilly.com|
22408144|NCT00740129|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22408145|NCT01598831|Asahi Kasei Pharma America Corp.|Director of Clinical Operations|(781) 419-1919|pallton@akpamerica.com|
22408146|NCT02384096|Boston Scientific Neuromodulation|Director, Clinical Sciences and Scientific Communication||Roshini.Jain@bsci.com|
22408147|NCT04095039|Duke University School of Medicine|Hrishikesh Chakraborty, DrPH|919-668-1238|hrishikesh.chakraborty@duke.edu|
22408148|NCT04768881|Karyopharm Therapeutics Inc|Karyopharm Medical Information|(888) 209-9326|clinicaltrials@karyopharm.com|
22408149|NCT02903121|Oregon Health and Science University|Alison Edelman, MD, MPH|5034943666|edelmana@ohsu.edu|
22408150|NCT04236986|Yale University|Dr. Kelly Cosgrove Principal Investigator|2037376969|kelly.cosgrove@yale.edu|
22408151|NCT00545974|UCSF Memory and Aging Center|Dr. Adam L. Boxer|4154760668|aboxer@memory.ucsf.edu|
22408152|NCT01365182|Case Western Reserve University|Amy Zhang PhD|2163680968|amy.zhang@case.edu|
22408153|NCT00736840|Exalenz Bioscience|Clinical Trial Manager|972-8-9737500|avrahamh@exalenz.com|513
22408154|NCT00735839|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22408155|NCT01728194|Well Cornell Medicine|Faith M. Gunning, PhD, Vice Chair for Research, Dept of Psychiatry|212-746-5832|fgd2002@med.cornell.edu|
22408156|NCT02309372|Indiana University School of Medicine|Samir K. Gupta, MD, MS|3172747926|sgupta1@iu.edu|
22408157|NCT02054572|Amgen Inc.|Study Director|866-572-6436||
22408158|NCT00928642|Madigan Army Medical Center|COL David E. McCune, MD, MC|253-968-1155|david.e.mccune.mil@mail.mil|
22408159|NCT01475214|Jean Mayer Human Nutrition Research Center on Aging at Tufts University|Dr. Bess Dawson-Hughes|617-556-3066|bess.dawson-hughes@tufts.edu|
22408160|NCT00643851|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
22408161|NCT03289676|UNIVERSITY OF MASSACHUSETTS BOSTON|Dr. Sun Kim|6172875372|sun.kim@umb.edu|6172875372
22408162|NCT01353976|AmDerma Pharmaceuticals|Candis Edwards|631-974-7949|cedwards@amderma.com|
22408163|NCT01314261|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22408164|NCT01231620|GlaxoSmithKline|GSK Response Center|866-435-7343||
22408165|NCT01066624|South Texas Veterans Health Care System|Juan J Toro|210-617-5300|juan.toro2@va.gov|16777
22408166|NCT02576652|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22408167|NCT01756209|Pugliese Hospital of Catanzaro|Dr Francesco Peltrone, Responsible of clinical trial|+.39 0961 7123222|gallelli@unicz.it|
22408168|NCT04806334|Cedars-Sinai Medical Center|Charles J Rosser, MD|310-423-3723|Charles.rosser@cshs.org|
22408169|NCT02811640|Ottawa Hospital Research Institute|Dr. Deborah Zimmerman|613-738-8400|dzimmerman@toh.ca|81620
22408170|NCT01633398|National University Health System, Singapore|Carolyn Lam|(65)67048965|carolyn.lam@duke-nus.edu.sg|
22408171|NCT03216499|Adult Brain Tumor Consortium (ABTC)|Roy Strowd, MD|410-955-8837|jfisher@jhmi.edu|
22408172|NCT00954356|Xenon Pharmaceuticals Inc.|Vice President Clinical|6044843300|pgoldberg@xenon-pharma.com|
22408173|NCT01668017|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22408174|NCT03590613|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22442326|NCT00782834|Fox Chase Cancer Center|Margaret von Mehren, M.D., Director of Sarcoma Oncology|215-728-2814|margaret.vonMehren@fccc.edu|
22408175|NCT00951912|the First Affiliated Hospital of Sun Yat-sen University|Dr. Yan-bin Ye|8620-87755766|yanbinye72@163.com|8179
22408176|NCT01377194|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|8124
22408177|NCT01207427|Cubist Pharmaceuticals|Vice President Clinical Research|(781) 860-8660||
22442327|NCT02252939|Massachusetts General Hospital|Rachel Gottlieb, Research Coordinator|617-726-1569|rgottileb3@mgh.harvard.edu|
22442328|NCT01033448|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22442329|NCT04270370|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22442330|NCT01221311|Medical University of South Carolin|Gregory Cote|843-876-4261|cotea@musc.edu|
22442331|NCT04189224|Johnson & Johnson Vision Care, Inc.|Thomas R Karkkainen.|1-800-843-2020|tkarkkai@its.jnj.com|
22442332|NCT05283031|Imperial College Ophthalmology Research Group|Jamie Spofforth|020 3312 6666|Jamiespofforth@nhs.net|
22408178|NCT00422227|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22408179|NCT03747497|MicuRx Pharmaceuticals, Inc.|Study Director|510-782-2022|info@micrux.com|
22408180|NCT04927858|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0217|clinicaltriage.rdg@boehringer-ingelheim.com|
22408181|NCT03461705|Columbia University|Ajay Kirtane, MD, SM|212-305-7060|akirtane@columbia.edu|
22408182|NCT03377803|Verrica Pharmaceuticals|Susan Cutler, VP, Medical Affairs|484-773-0898|scutler@verrica.com|
22408183|NCT00940446|OrthoIndy|Dr David A Fisher|(317) 802-2000|dafisher@orthoindy.com|
22408184|NCT03323034|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22408185|NCT01002118|University of Iowa|Jennifer Robinson|319-384-1563|jennifer-g-robinson@uiowa.edu|
22408186|NCT02646566|Acacia Pharma|Dr Gabriel Fox|01223875919764|GabrielFox@acaciapharma.com|
22408187|NCT01905631|Center for Clinical and Cosmetic Research|Dr. Mark Nestor|3059336716|nestormd@admcorp.com|
22408188|NCT03078504|Saint Louis University|Dr.Zafar Jamkhana|314-577-8856|zafar.jamkhana@health.slu.edu|
22408189|NCT00238108|Brigham and Women's Hospital|Dr. Frank Scheer|617-732-7014|fscheer@rics.bwh.harvard.edu|
22408190|NCT01683331|University of Michigan|Akinlolu Ojo|734 936-4890|aojo@umich.edu|
22408191|NCT04341727|Washington University School of Medicine|Jane O'Halloran|314 454 0058|janeohalloran@wustl.edu|
22408192|NCT00503035|UT MD Anderson Cancer Center|Dr. Imad Shureiqi, MD|713-745-4929|ishureiqi@mdanderson.org|
22408193|NCT04645342|UCSF|Dr. Thomas Dewland|415-476-5706|thomas.dewland@ucsf.edu|
22408194|NCT05028816|UT Southwestern Department of Plastic Surgery Research|Jennifer Barillas, Research Coordinator|214-645-8907|jennifer.bqarillas@utsouthwestern.edu|
22408195|NCT04961645|Emory University|Daniel Dilks, PhD|404-727-2980|dilks@emory.edu|
22408196|NCT00070070|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22408197|NCT04576702|Seqirus|Seqirus Clinical Trial Manager|1-855-358-8966|seqirus.clinicaltrials@Seqirus.com|
22418184|NCT03893565|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22418185|NCT01708629|Bausch Health|Study Director|510-259-5284||
22418186|NCT03870477|Zimmer Biomet|Ryan Boylan, Clinical Affairs Manager|574-371-9784|ryan.boylan@zimmerbiomet.com|
22418187|NCT04558918|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22418188|NCT02256436|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22418189|NCT05961215|Cedars-Sinai Medical Center|Robert Vescio, MD|3104231825|robert.vescio@cshs.org|
22418190|NCT04480710|Hepion Pharmaceuticals Inc|Clinical Operations|732-902-4016|jgreytok@hepionpharma.com|
22418191|NCT01986010|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22418192|NCT01394952|Eli Lilly and Company|Chief Medical Officer|800-545-5979|www.ClinicalTrials.gov@lilly.com|
22418193|NCT01335997|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22418194|NCT00115297|UMass|Craig M. Lilly, MD|508-868-5106|craig.lilly@umassmed.edu|
22418195|NCT00085423|Dartmouth-Hitchcock|Dr. Marc Ernstoff|603 650 5534|marc.s.ernstoff@hitchcock.org|
22418196|NCT04740814|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22418197|NCT01103466|Coloplast A/S|Dr. Lis Hentze Poulsen|4549111111|dklhp@coloplast.com|
22418198|NCT01019928|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com|
22418199|NCT02994940|UC Davis Anesthesiology & Pain Medicine|Richard L. Applegate II MD|916-734-5028|rapplegate@ucdavis.edu|
22418200|NCT04300010|UW School of Medicine and Public Health|Eric Cotter, MD|920.362.9221|ecotter@uwhealth.org|
22418201|NCT02331368|University of Michigan Comprehensive Cancer Center|Dr. Attaphol Pawarode, M.D.|734-936-8785|pawarode@umich.edu|
22418202|NCT02302859|The University of Texas (UT) MD Anderson Cancer Center|Dr. Lorna McNeill, MPH,PHD/ Chair, Health Disparities Research|713- 563-1103|lmcneill@mdanderson.org|
22418203|NCT02654860|Sintetica SA|Dr.Elisabetta Donati, Corporate Director Scientific Affairs|+41.91.640.42.50|edonati@sintetica.com|
22418204|NCT00621049|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22418205|NCT00916136|Vanderbilt|William Obremskey MD MPH|615-936-0112|william.obremskey@vanderbilt.edu|
22418206|NCT00899470|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22418207|NCT02989168|Global Blood Therapeutics|Nick Vlahakis|16508228756|nvlahakis@gbt.com|
22418208|NCT03456960|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22418209|NCT00532935|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22418210|NCT01940497|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22418211|NCT00502801|Janssen Scientific Affairs, LLC|Vice President, Data Generation|908 927-2943||
22418212|NCT04135196|Worcester Polytechnic Institute|Dr. Karen Troy|1-(508)-831-5000|ktroy@wpi.edu|6093
22418213|NCT02523196|University of Colorado Denver|Dr. Amanda Wieland|720-848-2291|amanda.wieland@cuanschutz.edu|
22418214|NCT01733147|Mayo Clinic|Dr. Prasad Iyer|507-293-7911|iyer.Prasad@mayo.edu|
22418215|NCT02435836|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22418216|NCT01401049|NYU School of Medicine|Mitchell Lee, MD|212.263.5071|mitchell.lee@nyumc.org|
22418217|NCT01661179|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22418218|NCT01946191|University of Utah|Dr. Molly Conroy|801-581-8310|Molly.Conroy@hsc.utah.edu|
22408198|NCT01151085|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22408199|NCT00003526|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22418219|NCT04048343|AstraZeneca|Global Clinical Head|+1 302 885 1180|information.center@astrazeneca.com|
22408200|NCT02059265|NRG Oncology|Christopher Purdy on behalf of Austin Miller|(716)845-1300|purdyc@nrgoncology.org|2296
22418220|NCT02811263|University of California, San Francisco|Yvonne W. Wu, MD, MPH|(415) 353-2400|Yvonne.Wu@ucsf.edu|
22408201|NCT04548349|Beth Israel Deaconess Medical Center|Jean S. McGee, MD, PhD|(617) 667-5834|jmcgee2@bidmc.harvard.edu|
22408202|NCT02985996|Emory University|Dr. Colleen Kelley|404-712-1823|colleen.kelley@emory.edu|
22408203|NCT00401726|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22408204|NCT03948646|Botanix Pharmaceuticals|Anthony Robinson MS CRNP|+1 (445) 300-3403|trials@botanixpharma.com|
22408205|NCT00814502|Massachusetts General Hospital|Kaloyan Tanev, M.D.|617-726-7511|ktanev@partners.org|
22408206|NCT03709342|CalciMedica|Sudarshan Hebbar, MD|816-838-7105|sudarshan@calcimedica.com|
22408207|NCT03735849|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22408208|NCT05113277|Florida State University|Danielle M. Morabito|850) 645-1766|morabito@psy.fsu.edu|
22408209|NCT01050998|MedImmune, LLC|Marius Albulescu, Associate Medical Director|301-398-0000|albulescum@medimmune.com|
22408210|NCT00370994|Pain Management Center of Paducah|Dr. Laxmaiah Manchikanti|270-554-8373|drlm@thepainmd.com|101
22408211|NCT04278846|Cleveland Clinic|Raymond Isakov, MD|216 445-3765|ISAKOVR@ccf.org|
22408212|NCT01012765|Novartis Pharmaceuticals|Study Director|862-778-8300||
22408213|NCT02223520|Johns Hopkins Medical Institutions|Aaron M. Milstone, M.D., M.H.S.|410-614-3917|amilsto1@jhmi.edu|
22408214|NCT02185131|University of Pittsburgh|Jack R. Cornelius, M.D., M.P.H.|412-246-5149|corneliusjr@upmc.edu|
22408215|NCT00889928|Ethicon Endo Surgery, Inc|Sheryl Helsinger|513-337-3079|SHelsing@its.jnj.com|
22408216|NCT04717466|University of Miami|Dr. Hideki Mochizuki|305-234-4472|hxm414@med.miami.edu|
22408217|NCT04668157|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22408218|NCT02283411|Abbott Diabetes Care|Shridhara A Karinka, PhD|510-749-6393|shridhara.alva@abbott.com|
22408219|NCT05437211|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22408220|NCT02566304|Thomas Jefferson University|Usama Gergis, MD|215-955-8874|usama.gergis@jefferson.edu|
22408221|NCT03282123|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
22408222|NCT01211405|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
22408223|NCT00796367|Vivus, Inc|Wesley W Day, PhD|650.934.5200|day@vivus.com|
22408224|NCT04081727|ZSX Medical, LLC|Director of Clinical Affairs|617-631-8865|info@zsxmedical.com|
22408225|NCT02370173|University of Arizona|"Dr. William D. Scott Killgore"|(520) 621-0605|killgore@arizona.edu|
22408226|NCT01315158|Washington University School of Medicine|Faris Murad, M.D.||fmurad@northshore.org|
22408227|NCT03572153|Baylor University|Gary Elkins, PhD|254-296-0824|gary_elkins@baylor.edu|
22408228|NCT00307736|Massachusetts General Hospital|Lawrence Blaszkowsky|6177244637|lblaszkowsky@partners.org|
22408229|NCT03523390|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22408230|NCT04604015|NovaSignal|Manja Lenkin|8776387251|manja.lenkin@novasignal.com|
22408231|NCT02205177|Mayo Clinic|Stephen P Whiteside, PhD, LP|507-284-2933|Whiteside.Stephen@mayo.edu|
22408232|NCT02129192|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22408233|NCT04557189|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22408234|NCT01811693|Keck School of Medicine of USC|Nerses Sanossian, MD|323-442-7793|nsanossi@usc.edu|
22408235|NCT00976521|Atrium Medical Corporation|Leah Hollins, Director of Clinical Affairs|603-880-1433|lhollins@atriummed.com|5365
22408236|NCT03575975|Georgia Institute of Technology|Dr. Young-Hui Chang|404-894-9993|yh.chang@ap.gatech.edu|
22408237|NCT04369742|NYU Langone Health|Mark Mulligan, MD|(212) 263-5182|Mark.mulligan@nyulangone.org|
22408238|NCT01636076|Novartis Pharmaceuticals|Study Director|862-778-8300||
22408239|NCT01130831|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22408240|NCT01159665|ThromboGenics|Dr. Petra Kozma-Wiebe|+32 16751310|Petra.kozma@thrombogenics.com|
22408241|NCT02441517|Astellas Pharma Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|5473
22408242|NCT00129220|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22408243|NCT00544674|Proacta, Inc.|Director of Clinical Development|858-642-0386|clinicalops@proacta.com|
22408244|NCT01212627|Brown University Oncology Research Group (BrUOG)|Angela Taber, MD|4018633000|kayla_rosati@brown.edu|
22408245|NCT01883362|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22408246|NCT01383317|Wake Forest University Health Sciences|Dr. Scott Miller|3367167437|scmiller@wakehealth.edu|
22408247|NCT02173158|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|857-242-5142|alison.long@aegerion.com|
22408248|NCT01230489|University of Missouri-Columbia|Harold Moore|5738824433|mooreh@health.missouri.edu|
22408249|NCT00686894|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22408250|NCT00967343|Kiadis Pharma Netherlands B.V.|Andrew Sandler, MD / Chief Medical Officer|+1 206 779 9213|a.sandler@Kiadis.com|
22408251|NCT02032433|NYU School of Medicine|John Rotrosen|646-754-4763|john.rotrosen@nyumc.org|
22408252|NCT00869362|Massachusetts General Hospital Diabetes Center|Deborah J. Wexler MD|617-726-8722|dwexler@partners.org|
22408253|NCT02806700|Center for Digital Health|Director of Research|2674280125|digitalhealth@uphs.upenn.edu|
22408254|NCT01255865|3M|Terri White|651-733-0228|twhite3@mmm.com|
22408255|NCT04887922|Washington University School of Medicine|Chet Hammill, M.D., MCR|314-273-1809|hamillc@wustl.edu|
22408256|NCT00953017|Fort Belvoir Community Hospital|Dr. Michael Hjelkrem|531-231-2015|mhjelkrem@yahoo.com|
22408257|NCT01711424|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22408258|NCT00721513|Wake Forest University Health Sciences|Dr. Mercedes Porosnicu|336-716-8664|mporosni@wakehealth.edu|
22408259|NCT01548573|University of Iowa|Guido Tricot, MD, PhD|319-356-3425|guido-tricot@uiowa.edu|
22408260|NCT01366846|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22418221|NCT01822574|Mayo Clinic|Robert T. Trousdale, M.D.|507-284-6586|trousdale.robert@mayo.edu|
22418222|NCT03071094|Transgene|Associate Medical Director|+ 33 (0)3 88 27 91 00|clinical.trials@transgene.fr|
22418223|NCT02876575|Medtronic|Melody LaBeau, Director of Clinical Operations|7635262931|melody.a.labeau@medtronic.com|
22418224|NCT04732221|MSD|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22418225|NCT04791969|University of California San Francisco|Glenn-Milo Santos|(415) 476-1435|glenn-milo.santos@ucsf.edu|
22418226|NCT04305587|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22418227|NCT00824616|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22418228|NCT01200992|Prometic Biosciences Inc.|Aline Hagerimana, MD, Senior Director Clinical Affairs|(514) 781-0115|a.hagerimana@prometic.com|
22418229|NCT03398070|Massachusetts General Hospital|David Perez|6177262000|dlperez@partners.org|
22418230|NCT01997216|Alcon Research, Ltd.|Joachim Nick, Dipl.-Ing. (FH), Clinical Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22418231|NCT03614897|Transcend Medical Group|Alicia Harbison|5708874882|aliciajeanbrown@gmail.com|
22418232|NCT02067468|Universidad de Antioquia|Dr Gloria I Sanchez|+57 (4) 219 6062|sanchezg@une.net.co|
22418233|NCT01783548|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22418234|NCT04645966|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22418235|NCT04257552|University of Pittsburgh, Magee Womens Research Institute|Dr. Katherine Himes|(412) 641-1805|himekp@upmc.edu|
22418236|NCT00552578|SUNY Buffalo|R Blondell|716-898-4971|blondell@buffalo.edu|
22418237|NCT01992523|Careggi Hospital|Guido Parodi|00390557947732|parodiguido@gmail.com|
22418238|NCT04729309|Hoffmann - LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22418239|NCT01059539|Allergan|Willie R. Earley, MD Associate Vice President Clinical Development-CNS|714-246-4500|IR-CTRegistration@allergan.com|
22418240|NCT01110135|Fred Hutchinson Cancer Research Center|Ajay Gopal|206-288-2037|akgopal@fhcrc.org|
22418241|NCT01714232|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
22418242|NCT00296231|University of Iowa|Tarah Colaizy||tarah-colaizy@uiowa.edu|
22418243|NCT04091659|University of Pennsylvania|Nicholas A. Giordano, PhD RN|(215) 898-8281|ngio@upen.edu|
22418244|NCT01243112|Scott & White Healthcare|James Collins, MD|254-724-7508|jbcollins@swmail.sw.org|0612
22418245|NCT00375830|Stanford University|Andrei Iagaru, Professor of Radiology (Nuclear Medicine)|650-725-4711|aiagaru@stanford.edu|
22418246|NCT03756506|Prevent-Plus|Jeff Elbl|314-606-5046|jeff.elbl@prevent-plus.com|
22418247|NCT00616629|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22418248|NCT01447420|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22418249|NCT05472662|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
22418250|NCT03362112|Nanjing First Hospital|Ma Jianhua|8625-52887092|majianhua196503@126.com|
22418251|NCT04015908|University of Utah|Dr. Jeffrey D. Swenson|801-581-6393|jeff.swenson@hsc.utah.edu|
22418252|NCT01715571|Johns Hopkins University School of Medicine|Arthur Burnett, MD|410-614-3986|aburnet1@jhmi.edu|
22418253|NCT01687972|Johns Hopkins Univesity School of Medicine|Janice Henderson, MD Assistant Professor|443-287-2783|jhender7@jhmi.edu|
22418254|NCT04420273|Northwestern University Feinberg School of Medicine|Dr. June Robinson|3129433703|june-robinson@northwestern.edu|
22418255|NCT02944071|BSC International Medical Trading (Shanghai) Co., Ltd|Junyang Bai|+13671646036|junyang.bai@bsci.com|
22418256|NCT03569228|Department of Veterans Affairs|Candice Quinn, Principal Investigator|919-922-8046|candice.quinn@va.gov|
22418257|NCT05442866|MedStar Health Research Institute|Dr. Hunter Groninger|202-877-7445|hunter.groninger@medstar.net|
22418258|NCT01222286|Innate Pharma|Dr Renaud Buffet|33 4 30 30 30 32|renaud.buffet@innate-pharma.fr|
22418259|NCT02800213|San Antonio Uniformed Services Health Education Consortium|Dr. Michael D. April|2109160808|Michael.D.April@post.harvard.edu|210
22418260|NCT01948986|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22418261|NCT00475150|University of Wisconsin Comprehensive Cancer Center|Mark B. Juckett, MD||mbj@medicine.wisc.edu|
22418262|NCT01031953|Oregon Health & Science University|Dr. Joseph Bubalo|503-494-8007|bubaloj@ohsu.edu|
22418263|NCT01584843|GlaxoSmithKline|GSK Response Center|866-435-7343||
22418264|NCT00392236|Feinstein Institute for Medical Research|Delbert Robinson, M.D.|718 470-8195|drobinso@nshs.edu|
22418265|NCT04126213|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22418266|NCT02642575|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
22418267|NCT02853370|U.O.C. Haematology - A.O.U. Policlinico Paolo Giaccone, Palermo (Italy)|Dr. Emilio Iannitto|+39 091 6554415|emilio.iannitto@gmail.com|
22418268|NCT01520532|Medtronic AF Solutions|Jay Kelley, Director of Clinical Research|+1.760.827.0076|jay.l.kelley@medtronic.com|
22418269|NCT00643565|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22418270|NCT02317614|Western Michigan University|Dr. Anthony DeFulio|269-387-4459|anthony.defulio@wmich.edu|
22418271|NCT01011179|The Hospital for Sick Children|Dr. Jennifer Stinson|416-813-7654|jennifer.stinson@sickkids.ca|304514
22418272|NCT03285308|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22418273|NCT03283761|Hoosier Cancer Research Network|Clinical Data Analyst|3179212050|amajumdar@hoosiercancer.org|
22418274|NCT02283983|Centre Hospitalier Départemental Vendée|Dr. Frank PRIOU|0251446161|frank.priou@ght85.fr|+33
22418275|NCT03275064|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22418276|NCT03055650|Alcon Research, LLC|Senior CDMA Project Lead, CDMA Ocular Health|1-888-451-3937|alcon.medinfo@alcon.com|
22418277|NCT02829294|Eosera Inc|Joseph Griffin PhD|8447327929|info@eosera.com|
22418278|NCT00620555|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22408261|NCT00290511|UT MD Anderson Cancer Center|Dr. Felipe Samaniego, MD-Professor, Lymphoma-Myeloma|(713) 745-6824|fsamaniego@mdanderson.org|
22408262|NCT00626574|University of South Florida|Enrico M Camporesi MD|813-844-7170|ecampore@health.usf.edu|
22431598|NCT03186638|University of Rochester Medical Center, Dept of Surgery, Supportive Care in Cancer|Michelle Janelsins, PhD, MPH|585-276-4656|michelle_janelsins@urmc.rochester.edu|
22431599|NCT04099277|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22431600|NCT02367456|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22431601|NCT00284180|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
22431602|NCT02300545|Washington University School of Medicine|Brian A. Van Tine, M.D., Ph.D.|314-747-8475|bvantine@wustl.edu|
22431603|NCT02243358|Henry Ford Cancer Institute|Dr. Gazala Khan, MD|313-598-2860|gkhan1@hfhs.org|
22431604|NCT01645176|Stanford University School of Medicine|Mark C. Genovese|650-498-4528|genovese@stanford.edu|
22431605|NCT04252014|Georgetown University|Darren Mays|2026878937|dmm239@georgetown.edu|
22431606|NCT02569853|Dr. Reddy's|Director, Clinical Development|609-375-9900|ebrandschieber@drreddys.com|
22431607|NCT00402987|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22431608|NCT01668004|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22431609|NCT05528770|Center for Diabetes Technology|Manager of Clinical Research|434-982-0602|mc7m@uvahealth.org|
22431610|NCT00754572|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22431611|NCT01528592|Northwestern University|Darren Gitelman, MD|312-908-8266|d-gitelman@northwestern.edu|
22431612|NCT00427037|Emory University School of Medicine|Vin Tangpricha|404-727-7254|vin.tangpricha@emory.edu|
22408263|NCT00447265|DAIT/NIAID|Associate Director for Clinical Research|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22408264|NCT04311411|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22408265|NCT03533829|Duke Vaccine and Trials Unit|Kristen Gunnell|9196848891|kristen.gunnell@duke.edu|
22408266|NCT01976663|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com|
22408267|NCT04552769|Stanford University|Saad A. Khan, MD|650-498-6000|saad.a.khan@stanford.edu|
22408268|NCT03988049|University of Utah Dermatology|Dr. David Smart, Assistant Professor, Dermatology|8015816465|david.smart@hsc.utah.edu|
22408269|NCT04780776|Boston University School of Medicine|Dr. Michael F. Holick|(617) 358-6139|mfholick@bu.edu|
22408270|NCT05888740|Vibrato Medical|Vice President of Clinical Affairs|2139215088|bisrat@vibratomedical.com|
22408271|NCT03113760|AB2 Bio Ltd.|Eduardo Schiffrin|+41 21 694 00 40|eduardo.schiffrin@ab2bio.com|
22408272|NCT00465101|American Medical Systems|Mara M. LaRock, Senior Manager, Clinical Franchise Lead|952-930-6000|mara.larock@bsci.com|
22408273|NCT00998166|Columbia University|Mark Stoopler, MD|212-305-8230|mbs5@cumc.columbia.edu|
22408274|NCT01982539|Depomed|Clinical Operations||clinicaltrials@depomed.com|
22408275|NCT00933543|Photocure|Project director Per Fuglerud|+47 22 06 16 54|pf@photocure.no|
22408276|NCT00694070|Ascensia Diabetes Care|Clinical Research Scientist|574-257-3063||
22408277|NCT05059366|University of Miami|Alecia Sabartinelli Stein, MD|305 585 8380|asabartinelli@med.miami.edu|
22408278|NCT04988035|NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
22408279|NCT03532048|Baylor College of Medicine|Teresia O'Connor|7137986782|teresiao@bcm.edu|
22408280|NCT04366258|NYU Langone Health|Dan Iosifescu, MD|646-754-5156|Dan.Iosifescu@nyulangone.org|
22408281|NCT00308555|UCSF/San Francisco General Hospital|Dr. Donald I. Abrams|415-476-4082|dabrams@hemeonc.ucsf.edu|444
22408282|NCT02694393|University of Pittsburgh|Dr. Joseph Pilewski|(412) 692-2210‬|pilewskijm@upmc.edu|
22408283|NCT02556112|711 Human Performance Wing, U.S. Air Force|Col Nicole Armitage|937-255-3784|nicole.armitage@us.af.mil|
22408284|NCT04113746|Icahn School of Medicine at Mount Sinai|Juan P. Wisnivesky, MD, DrPH|212-824-7567|juan.wisnivesky@mountsinai.org|
22418279|NCT05308368|NC State University|Nitin Sharma|9195130787|nsharm23@ncsu.edu|
22418280|NCT00669071|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
22418281|NCT04305496|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22418282|NCT01943110|PATH|Courtney Jarrahian|206-285-3500|cjarrahian@path.org|
22418283|NCT01910389|New England Research Institutes|Brian Harty|617-972-3224|bhartY@neriscience.com|
22418284|NCT00753220|Prostate Institute of America|Dr. Duke K. Bahn|888-234-0004|DKBahn@CMHhospital.org|
22418285|NCT02912650|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22418286|NCT01898650|Washington University School of Medicine|Gary Skolnick|13144544005|gskolnic@wustl.edu|
22418287|NCT00939120|Research institute at Deaconess Clinic|Dr. Paul Siami|812-426-9548|paul.siami@deaconess.com|
22418288|NCT05896202|University of Miami|Marlon L. Wong|3052842670|mwong2@miami.edu|
22418289|NCT02357342|Raj K. Maturi, MD, PC|Raj K. Maturi, MD|317-817-1414|rmaturi@gmail.com|
22418290|NCT01674647|Bayer HealthCare AG|Bayer HealthCare AG||clinical-trials-contact@bayerhealthcare.com|
22418291|NCT02581007|Northside Hospital|Dr. Melhem Solh|404-255-1930|msolh@bmtga.com|
22418292|NCT00944749|National Heart Lung and Blood Institute|Dr Danielle Townsley|301-402-3477|townsleydm@nhlbi.nih.gov|
22418293|NCT01490866|SCRI Development Innovations|Charles H. Davis, RAC|615 524-4341|charles.davis2@scri-innovations.com|
22418294|NCT03923530|NF South Ga VAMC|Dr. Anthony Bavry|352-548-4726|anthony.bavry@va.gov|
22418295|NCT00741936|Hong Kong Baptist University|Prof. Zhao-xiang Bian|(852) 3411 2905|bzxiang@hkbu.edu.hk|
22418296|NCT01941940|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22418297|NCT03212521|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22418298|NCT00914459|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22418299|NCT03176459|Pacira Pharmaceuticals|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
22408285|NCT01717521|UWMC|Dr. Laurent Bollag|2063277328|bollag@uw.edu|
22408286|NCT04246593|State University of New York at Buffalo|Dr. Lucia Leone|(716) 829-6040|lucialeo@buffalo.edu|
22408287|NCT00429026|U.T. M.D. Anderson Cancer Center|Naoto Ueno, MD, PhD / Associate Professor|713-792-8754|CR_Study_Registration@mdanderson.org|
22408288|NCT00635362|University of Chicago|Amy Whitaker, MD|773-834-4129|awhitaker@babies.bsd.uchicago.edu|
22408289|NCT00620191|Columbia University Medical Center|Jose Luchsinger|212-3054730|jal94@cumc.columbia.edu|
22408290|NCT00499694|Barbara Ann Karmanos Cancer Institute|Ulka Vaishampayan, M.D.|(313) 576-8718|vaishamu@karmanos.org|
22408291|NCT03958045|University of Kentucky|Dr. Zhonglin Hao|859-218-6704|zhonglin.hao@uky.edu|
22408292|NCT03550989|Philip Morris Products S.A.|Christelle Haziza, Director Health Science and Biostatistics|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
22408293|NCT00674440|Children's Hospital of Philadelphia/Perelman School of Medicine, University of Pennsylvania|Lisa J. States, MD|267-425-7146|states@chop.edu|
22408294|NCT01463631|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22408295|NCT04828993|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22408296|NCT02394457|Naval Medical Center San Diego|Steven Hanling, MD|619-532-8954|steven.r.hanling@mail.mil|
22408297|NCT00617942|Brown University Oncology Research Group (BrUOG)|William Sikov, MD|4018633000|BrUOG@brown.edu|
22408298|NCT03679117|Lifespan Hospital|Margaret Bublitz|401-323-3356|mbublitz@lifespan.org|
22408299|NCT05510297|University of Southern California|Dr. Stacey Schepens Niemiec|323-442-2069|schepens@usc.edu|
22408300|NCT04409262|Hoffmann - La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22408301|NCT02249377|New York Langone Health|Eric Strauss, MD|646 501 7223|Eric.Strauss@nyumc.org|
22408302|NCT00948896|University of California, San Francisco|Dr. Grant Dorsey|415-206-4680|grant.dorsey@ucsf.edu|
22408303|NCT00945815|SWOG Statistical Center|SWOG Leukemia Statistician|206-667-4408||
22408304|NCT02023515|UKentucky|Kelly Webber, PhD, RD, LD|859-257-4351|kelly.webber@uky.edu|859
22408305|NCT04553497|Ege University Faculty of Medicine, Physical Medicine and Rehabilitation|Dr. Emine Duran|+905372103145|docemineduran@gmail.com|
22408306|NCT01990339|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22408307|NCT01038609|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22431613|NCT02468583|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
22408308|NCT01590810|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22408309|NCT01143818|Abbott|Global Medical Services|800-633-9110||
22408310|NCT01087944|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22408311|NCT00553319|Columbia University|Frances R. Levin, M.D.|646-774-6137|frl2@columbia.edu|
22408312|NCT01979003|University of Arkansas for Medical Sciences|Alexander Burnett|5016868274|aburnett@uams.edu|
22408313|NCT01731600|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22408314|NCT00465894|University of Alabama at Birmingham|Dr. Holly E. Richter|205-934-1704|hrichter@uabmc.edu|
22408315|NCT01349816|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
22408316|NCT01766024|BIOCAD|Director of Clinical Trials|7 (812) 380 49 33|biryulin@biocad.ru|925
22408317|NCT03740724|Castle Creek Biosciences|Castle Creek Biosciences Clinical Trial Director|484-713-6000|clinicalresearch@castlecreekbio.com|
22408318|NCT02696980|University of Vermont|Anne Dixon, MD|802 847 2700|anne.dixon@uvm.edu|
22408319|NCT03575806|Tsinghua University|Statistician of Clinical Trials||majunfan2@sina.com|
22408320|NCT03446846|Minerva Neurosciences, Inc.|Head of Research & Development|617.600.7375|jsaoud@minervaneurosciences.com|
22408321|NCT02842736|Channel Medsystems|Clinical and Regulatory Affairs|510-338-9301|clinreg@channelmedsystems.com|
22408322|NCT00453336|University of Miami Sylvester Comprehensive Cancer Center|Francisco Civantos MD|305-243-5276|fcivanto@med.miami.edu|
22408323|NCT04158466|Bausch Health|Study Director|(585) 338-6399|robert.steffen@bausch.com|
22408324|NCT02815540|Gillette Children's Specialty Healthcare|Director of Research|651-229-1745|Research@gillettechildrens.com|
22408325|NCT00798161|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22408326|NCT00726882|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22408327|NCT00344968|Alimera Sciences, Inc.|Kathleen Billman, Senior Director of Scientific Affairs|678-572-1302|kathleen.billman@alimerasciences.com|
22408328|NCT00594568|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22408329|NCT02526017|Five Prime Therapeutics|Helen Collins, Chief Medical Officer|650-745-9633|helen.collins@fiveprime.com|
22408330|NCT01141569|BC Cancer Agency Vancouver Cancer Centre|Dr. Christian Kollmannsberger|604-877-6000|ckollmannsberger@bccancer.bc.ca|
22408331|NCT04969653|Momentum Data Ltd|Dr Andrew McGovern|07531221970|andy.mcgovern@momentumdata.co.uk|
22408332|NCT00423137|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22408333|NCT04196023|Vanderbilt University Medical Center|Dr. Qi Dai|(615)936-0707|qi.dai@vanderbilt.edu|
22408334|NCT01499498|Imperial College London|Dr Borja Mora Peris|020 3312 6789|b.mora-peris@imperial.ac.uk|
22408335|NCT03303144|Rockwell Medical|Dr Ray Pratt|248 960-9009|rpratt@rockwellmed.com|405
22408336|NCT01797458|Preventive and Paediatric Dentistry Department of Greifswald University, Germany|Prof. Dr. Christian Splieth|+ 49 3834 867101|splieth@uni-greifswald.de|
22408337|NCT03358407|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22408338|NCT00483574|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22408339|NCT03605758|Albert Einstein College of Medicine|Dr. Christina Coyle|718-430-3525|christina.coyle@einsteinmed.edu|
22408340|NCT04804579|Boston University School of Public Health|Theresa W. Kim MD|(617) 414-6932|therkim@bu.edu|
22392247|NCT02726945|GID Bio|Director of Clinical Operations|3039524901|s.samudre@gidbio.com|105
22392248|NCT05992922|Iacta Pharmaceuticals|Chief Operating Officer|714-330-8532|sj@iactapharma.com|
22408341|NCT04753606|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
22408342|NCT00489411|University of Michigan School of Nursing|Ellen Lavoie Smith, PhD, APRN, AOCN, FAAN|734-936-1267|Ellenls@med.umich.edu|
22408343|NCT04389294|Hospital for Special Surgery|Dr. Ellen M. Soffin|(212) 606-1206|SoffinE@HSS.edu|
22408344|NCT01748162|University of Michigan|Dr. David J. Brown||davidjb@med.umich.edu|
22408345|NCT03219372|Cedars Sinai Medical Center|Shehnaz K. Hussain, PhD, ScM|310-429-9859|Shehnaz.Hussain@cshs.org|
22408346|NCT03841331|Menlo Therapeutics, Inc.|Iain Stuart|1-800-775-7936|Iain.Stuart@foamix.com|
22408347|NCT01015170|Centre for Addiction and Mental Health|Dr. Peter Selby; Dr. Laurie Zawertailo Principal Investigator|416-535-8501|laurie.zawertailo@camh.ca|77422
22408348|NCT00779857|AtriCure, Inc.|Jim Lucky|1-513-755-4101|jlucky@atricure.com|
22408349|NCT04640168|NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
22408350|NCT02866721|University Hospitals, Rainbow Babies and Children's Hospital|Erica Roesch, MD|(216) 844-3267|Erica.Roesch@UHHospitals.org|
22408351|NCT00442572|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22408352|NCT01828164|SmileSonica Inc.|John Simon, Regulatory Affairs Manager|780-975-0095|john@johnsimon.ca|
22392249|NCT03939689|Lantheus|June Li, Vice President, Biometrics and Data Sciences|978-671-8107|lij@lantheus.com|
22418300|NCT01083810|Abbott|Global Medical Services|1-800-633-9110||
22418301|NCT01602965|Istituto Ortopedico Rizzoli|Mariela Terrafino|0516366694|cristiana.forni@ior.it|0039
22392250|NCT01920477|Novartis Pharmaceuticals|Study Director|1-888-669-6682|Novartis.email@novartis.com|
22392251|NCT03554629|Clinical Research Program Manager|Kathleen H. Niebel RN BSN BSME|978-549-9325|kathleen.h.niebel@gmail.com|
22408353|NCT04259905|The University of Texas Medical Branch|Eloisa Martinez|409-266-9643|esmartin@utmb.edu|
22408354|NCT01383759|Memorial Sloan Kettering Cancer Center|Dr. Hani Hassoun|212-639-3228|hassounh@mskcc.org|
22408355|NCT01977625|University of Pennsylvania|C. Neill Epperson, M.D|215-573-8871|cepp@mail.med.upenn.edu|
22408356|NCT03455556|Mayo Clinic|Alex A Adjei, MD, PhD|(507) 284-2511|Adjei.Alex@mayo.edu|
22408357|NCT00634933|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22408358|NCT02304484|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22408359|NCT04338685|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22408360|NCT00234533|Ipsen|Medical Director, Pediatric Endocrinology||clinical.trials@ipsen.com|
22408361|NCT00976989|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22408362|NCT00570492|GlaxoSmithKline|GSK Response Center|866-435-7343||
22408363|NCT00908375|Northwestern University|K Malik|3129262280|kmalikmd@yahoo.com|
22408364|NCT00903357|Department of Pediatrics, Soonchunhyang University Hospital|Bok Yang Pyun, M.D.|+82-2-709-9339|bypyun@hanmail.net|
22408365|NCT04930562|BioNova Pharmaceutical Limited Company|Medical Director|+86(21)50901280|yu.wang@bionovapharma.com|
22408366|NCT02279888|Vanderbilt University Medical Center|Dr. Lynne Stevenson|6159368187|lynne.w.stevenson@vanderbilt.edu|
22408367|NCT00752206|SARC|SARC|(734) 930-7600|sarc@sarctrials.org|
22408368|NCT01484691|University of California, San Francisco|PI: Prescott G. Woodruff, MD, MPH|415-514-2061|prescott.woodruff@ucsf.edu|
22418302|NCT04941729|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
22418303|NCT00006721|SWOG Statistical Center|Study Statistician|206-667-4623||
22418304|NCT03845296|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
22418305|NCT05424042|Wake Forest University School of Medicine|Cynthia Stowe|336-716-0686|cynthia.stowe@advocatehealth.org|
22418306|NCT05091307|Janssen Vaccines & Prevention B.V.|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22418307|NCT05104073|Penn State College of Medicine|Ian Paul, MD|7175318006|ipaul@pennstatehealth.psu.edu|
22418308|NCT00379340|Childrens's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22418309|NCT05327816|Janssen Vaccines & Prevention B.V.|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22418310|NCT01167257|Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University|Dr. Hann-Chorng Kuo|886-3-8561825|hck@tzuchi.com.tw|2113
22418311|NCT01367665|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22418312|NCT02752906|Sanofi Pasteur Inc.|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22418313|NCT01480843|Joslin Diabetes Center|Medha Munshi, MD|617-309-4683|medha.munshi@joslin.harvard.edu|
22418314|NCT03283319|BARDA|Silvija Tresnjak-Smith|202-557-1993|Silvija.Tresnjak-Smith@hhs.gov|
22418315|NCT04663295|Medtronic MiniMed|Senior Statistician|+18185764034|dz.dai@medtronic.com|
22418316|NCT00554190|Carbylan BioSurgery Inc.|Marcee Maroney, VP Clinical Affairs|650 855 6774|mmaroney@carbylan.com|
22418317|NCT04820530|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22418318|NCT01502410|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org|
22418319|NCT05984186|Vapotherm|Katherine Gerich|5854696753|kgerich@vtherm.com|
22418320|NCT05958888|University of North Carolina at Chapel Hill|Marissa Hall, PhD|(919) 445-1310|mghall@unc.edu|
22418321|NCT01076686|Pacira Pharmaceuticals|Executive Medical Director|203-837-6500|erolo@pacira.com|
22418322|NCT00642694|UT Southwestern Medical Center|Dr.Prabha Sunderajan- Assistant Professor|214-645-6964|psunderajan@utsouthwestern.edu|
22418323|NCT02551432|Seoul National University Hospital|Bhumsuk Keam|82+10-3231-2208|bhumsuk@snu.ac.kr|
22418324|NCT01823497|Medical College of Wisconsin|Keri R. Hainsworth|414-266-6306|khainswo@mcw.edu|
22418325|NCT01007942|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22418326|NCT04492020|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22418327|NCT00325195|Savient Pharmaceuticals, Inc.|Medical Director|732-418-9300||
22418328|NCT04594707|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22418329|NCT04585789|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22418330|NCT03412396|The University of Texas MD Anderson Cancer Center|Dr. John Davis|(713) 792-3250|johndavis@mdanderson.org|
22418331|NCT05083585|Janssen Vaccines & Prevention B.V.|Director Biomarkers Viral Vaccines|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22418332|NCT01175811|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22418333|NCT00114166|NRG Oncology, Statistics and Data Management Center - Buffalo Office|Jessalyn Reboy|716-845-7738|ReboyJ@nrgoncology.org|
22418334|NCT01090921|BVARI|Nikhil C. Munshi, M.D.|857-203-6172|nikhil_munshi@dfci.harvard.edu|
22418335|NCT02109419|Pennington Biomedical Research Center|Dr. Corby K. Martin|225-763-2585|corby.martin@pbrc.edu|
22418336|NCT02628743|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22418337|NCT04715932|Montreal Heart Institute|Dr Jocelyn Dupuis (Principal Investigator)|514 376-3330|jocelyn.dupuis@icm-mhi.org|3477
22418338|NCT02740699|National Heart, Lung, and Blood Institute at the National Institutes of Health|Dr. Marcus Chen|301.496.0077|chenmy@nhlbi.nih.gov|
22418339|NCT02393248|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22418340|NCT03560986|Grünenthal GmbH|Director Clinical Trials|+49 241 569|Clinical-Trials@grunenthal.com|3223
22418341|NCT02585934|Axovant Sciences, Inc.|Ilise Lombardo, MD|646-822-8626|ilise.lombardo@axovant.com|
22408369|NCT03522506|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
22408370|NCT05705544|Vanderbilt University Medical Center|Dr. Fabian Maldonado|(615) 322-5000|fabien.maldonado@vumc.org|
22408371|NCT03480243|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22408372|NCT04365387|Galderma Research & Development, LLC|Sponsor|817 961 5000|aestheticclinicaltrials@galderma.com|
22408373|NCT05770401|University of Montana|Jane Reynolds Salois|406-243-2138|jane.salois@umontana.edu|
22408374|NCT03449342|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22408375|NCT01683565|Nationwide Children's Hospital|Dr. Sarah Keim|614-722-3177|Sarah.Keim@nationwidechildrens.org|
22408376|NCT00764465|GSIDA|David Condoluci|856-566-3190|dcondoluci@gsida.org|
22408377|NCT01195662|ClinicalTrialTransparency|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com|
22408378|NCT00863265|Washington University School of Medicine|Richard E. Ostlund MD|314-362-3516|rostlund@wustl.edu|
22408379|NCT01738672|University of Pittsburgh|Ya'aqov Abrams, MD||abramsym@upmc.edu|
22408380|NCT01326481|TRACON Pharmaceuticals Inc|Charles Theuer, Medical Monitor|8585500780|ctheuer@traconpharma.com|
22408381|NCT04794491|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@jazzpharma.com|
22408382|NCT03241485|University of Chicago Medicine|Richa Dhawan|773-702-1000|rdhawan@dacc.uchicago.edu|
22408383|NCT00242658|Penn State Milton S. Hershey Medical Center|Chris Sciamanna, MD, MPH|717-531-8161|cns10@psu.edu|
22408384|NCT01466972|University of California, San Francisco|Dr. Hope Rugo, MD|(415) 353-7070|Hope.Rugo@ucsf.edu|
22408385|NCT04524507|University of North Carolina at Chapel Hill|Luther Bartelt, MD|919-966-2537|barteltl@ad.unc.edu|
22408386|NCT01594424|Cedars-Sinai Medical Center, Comprehensive Transplant Center|Jua Choi, PharmD|310-248-8186|jua.choi@cshs.org|
22408387|NCT02939326|Bonti|Wajdie Ahmad|9493796569|wajdie@bonti.com|
22408388|NCT00508118|Duke University Medical Center|Andrew Shaw MD|919 286 6938|andrew.shaw@duke.edu|
22408389|NCT03039699|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22408390|NCT00540228|GlaxoSmithKline|GSK Response Center|866-435-7343||
22408391|NCT02569996|Roche Trial Information Hotline|F. Hoffmann-La Roche AG|+41 61 6878333|global.trial_information@roche.com|
22408392|NCT01397409|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22408393|NCT03418727|Ocugen|Vijay Tammara, VP, Strategic Regulatory Operations|484-328-4751|Vijay.tammara@ocugen.com|
22408394|NCT01941472|Peking Union Medical College Hospital|Bin Du|8610-69155036|dubin98@gmail.com|
22408395|NCT02451137|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22408396|NCT02911285|Medical University of South Carolina|Stacey Sellers, Program Manager|843-792-5807|sellersst@musc.edu|
22408397|NCT05981508|Morehouse School of Medicine|Candice L. Alick, PhD|404-752-1009|calick@msm.edu|
22408398|NCT02010359|Children's Hospital of Philadelphia|Dr. Rachana Shah|215-590-3390|shahr@email.chop.edu|
22408399|NCT01740297|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22408400|NCT02263118|Ecole Polytechnique|Dr. Jose Tomas Prieto|+50252800643|jose-tomas.prieto@polytechnique.edu|
22408401|NCT03280628|Vanderbilt University Medical Center|Dr. Holly Hanson|615-936-7317|holly.r.hanson@vumc.org|
22408402|NCT02279082|Dr. Reddy's Laboratories|Clinical Operations Director|609-282-1476|kgulbronson@promiuspharma.com|
22418342|NCT02958982|Rhizen Pharmaceuticals S.A.|Dr. Prajak Barde|+41 32 580 0113|pjb@rhizen.com|
22408403|NCT00761462|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22418343|NCT00655876|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22408404|NCT02047929|Carolinas HealthCare System|Dr. Thomas Ludden|704-608-2390|tom.ludden@carolinashealthcare.org|
22408405|NCT02848781|College of Medicine - Phoenix|Rodrick Tung, MD|602-521-3090|rodricktung@arizona.edu|
22392252|NCT01228318|Emory University|Igho Ofotokun, MD, MSc|404-616-0659|iofotok@emory.edu|
22408406|NCT02163759|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22392253|NCT03140280|Medical College of Wisconsin|Ehab Atallah, MD|414-805-4600|eatallah@mcw.edu|
22408407|NCT02883400|Atrium Health|Dr. Mark Russo,|704-355-6649|mark.russo@atriumhealth.org|
22392254|NCT05504954|Department of Medicine, Center for Dissemination and Implementation Science, University of Illinois Chicago|Dr. Geri Donenberg|312-996-8602|gerid@uic.edu|
22392255|NCT03412773|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
22408408|NCT00333437|University of California San Francisco|Jeffrey A. Golden, MD|415-353-2935|Jeff.Golden@ucsf.edu|
22408409|NCT01171794|Stanford University School of Medicine|Grant S Lipman ( PI)|4152909286|lipmangrant@gmail.com|
22392256|NCT06490302|CooperVision, Inc.|Jose A. Vega,OD,MSc, PhD|9256213761|javega@coopervision.com|
22392257|NCT02643303|Ludwig Institute for Cancer Research|Jonathan Skipper|12124501539|jskipper@lcr.org|
22392258|NCT00974818|Memorial Slaon Kettering Cancer Center|Dr. Guido Dalbagni|646-422-4394|Dalbagng@mskcc.org|
22408410|NCT03022526|University of Pittsburgh|Dr. Grace Lim|412-641-2179|limkg2@upmc.edu|
22392259|NCT05282121|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22392260|NCT02484664|Brigham and Women's Hospital|Dr. David Kwiatkowski|8573070781|dk@rics.bwh.harvard.edu|
22392261|NCT01250925|Massachusetts Eye and Ear Infirmary|Dr. Pedram Hamrah|617-573-3313|cornea_research@meei.harvard.edu|
22392262|NCT01028677|UNC_ChapelHill|Dr. Cort Pedersen|919 966-4447|cort_pedersen@med.unc.edu|
22392263|NCT00775411|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22408411|NCT03315780|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22408412|NCT02748096|University of Oxford|Professor Anrew Price|+44 1865 223421|andrew.price@ndorms.ox.ac.uk|
22392264|NCT00678301|GlaxoSmithKline|GSK Response Center|866-435-7343||
22392265|NCT04191421|Emory University|Dr. Olatunji Alese, MD|404-778-6639|olatunji.alese@emory.edu|
22408413|NCT01756586|University of Chicago|TARIQ MALIK|773-834 3643|tmalik@dacc.uchicago.edu|
22408414|NCT01479777|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.|Dr. Cristina Sadowsky|443-923-9210|sadowsky@kennedykrieger.org|
22392266|NCT02476175|CHU de Quebec-Universite Laval|Dr Stephane Bolduc||Stephane.Bolduc@fmed.ulaval.ca|
22392267|NCT02413645|Hospital Clinic-HIVACAT|Dr. Felipe Garcia|932275400|fgarcia@clinic.cat|2844
22408415|NCT00887562|Columbia University|Michio Hirano, MD|12123051048|mh29@cumc.columbia.edu|
22408416|NCT00451191|George Washington University Biostatistics Center|Kathryn Hirst, PhD, Research Professor, PI of coordinating center|301-881-9260|khirst@bsc.gwu.edu|8025
22408417|NCT01972282|St. Antonius Ziekenhuis, Nieuwegein, Netherlands|Dr. Lucas V.A. Boersma||l.boersma@antoniusziekenhuis.nl|
22408418|NCT00846573|UMass Medical School|Dr. Mitchell Albert|(617) 875-2141|albertmi@tbh.net|
22408419|NCT05732610|Medical Group Care|Tomaz Lovse|239 631 1907|tomaz.lovse@mgc.us|
22408420|NCT00656669|IndianaU|Dr. Kathy Miller|317-944-0920||
22408421|NCT04717323|Altec Inc.|Dr. Paola Contessa|5085458236|pcontessa@altecresearch.com|
22408422|NCT01553708|Faculty of Pharmaceutical Sciences, Chulalongkorn University|Associate Prof. Pornanong Aramwit, Pharm.D., Ph.D.|+66-02-218-8409|paramwit@gmail.com|
22408423|NCT00219349|New York State Psychiatric Institute|Franklin Schneier MD|2125435368|fschneier@nyspi.columbia.edu|
22408424|NCT05461742|Brown University|Dr. Tayla von Ash|401-863-6192|tayla_ash@brown.edu|
22408425|NCT01241591|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22408426|NCT01945034|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22408427|NCT00478218|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
22408428|NCT00700115|Emory University School of Medicine|Dr. Igho Ofotokun|404-616-0659|iofotok@emory.edu|
22408429|NCT02335229|St. Jude Medical|Jennifer Duggan|+32(0)27746827|jduggan@sjm.com|
22392268|NCT01016262|Forest Laboratories|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
22392269|NCT01128270|University of Florida|Peter W. Stacpoole,MD|(352) 273-9023|pws@ufl.edu|
22392270|NCT03738475|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22392271|NCT00677534|University of Kansas Medical Center|Dr. Jason Stubbs|913-588-3867|jstubbs@kumc.edu|
22392272|NCT00667394|National Cancer Institute, National Institutes of Health|Dr. Katherine Warren|301-435-4683|warrenk@box-w.nih.gov|
22408430|NCT02389621|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
22408431|NCT00661037|Ospedali del Tigullio, Lavagna, Italy|Dr Michele Brignole|0185 329567329|aritmo@asl4.liguria.it|0039
22408432|NCT02191033|Yale University|Deepa Camenga, MD|203-737-8310|deepa.camenga@yale.edu|
22408433|NCT02277665|Dartmouth-Hitchcock|Dr. Alan J. Budney|603-646-7088|alan.j.budney@dartmouth.edu|
22408434|NCT01300741|Alcon Research|Director of Clinical Trials|1-800-241-7629||
22408435|NCT04854421|Pennington Biomedical Research Center|Dr. Steven Heymsfield|(225) 763-2541|steven.heymsfield@pbrc.edu|
22408436|NCT01055184|University of Rochester|Dr. John J. Treanor|585-275-5871|john_treanor@urmc.rochester.edu|
22408437|NCT00718809|IndianaU|Dr. Patrick Loehrer|317-944-0920|ploehrer@iu.edu|
22408438|NCT00463385|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22408439|NCT00921934|Department for Complementary and Alternative Medicine|Dr. med. Martin Schencking|+0049-2602-684-614||
22392273|NCT04638660|Ocuphire Pharma, Inc.|Drey Coleman|8134041993|dcoleman@ocuphire.com|
22392274|NCT04076943|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|FG4592-092Study@fibrogen.com|
22392275|NCT05138289|HeartFlow|Saba Mirza|650-241-1221|smirza@heartflow.com|
22392276|NCT03080493|University of California, Davis|Mitchell Creinin, MD|916-734-6670|mdcreinin@ucdavis.edu|
22408440|NCT00536991|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22408441|NCT00054639|UT MD Anderson Cancer Center|Anas Younes, MD / Professor||CR_Study_Registration@mdanderson.org|
22408442|NCT01249625|University of Texas Southwestern|Dr. Trish Perl|214-648-9022|Trish.Perl@UTSouthwestern.edu|
22408443|NCT03541356|Impel NeuroPharma|Karen Craig, PhD (Medical Writer)|206-568-1466|kcraig@impelnp.com|
22408444|NCT03986216|Northwestern University|Dr. Jun Yao|3129089060|j-yao4@northwestern.edu|
22408445|NCT03413618|Pirogov Russian National Research Medical University|Dr. Kirill Lobastov|+7-985-211-63-31|lobastov_kv@hotmail.com|
22408446|NCT03246152|Cairo University|Dr. Ayman Elnahry|00201224927604|ayman_elnahri@hotmail.com|
22408447|NCT01005810|Medical University of South Carolina|Dr. Kevin M. Gray, Associate Professor|843-792-6330|graykm@musc.edu|
22408448|NCT04359758|Georgetown Lombardi Comprehensive Cancer center|Marc D. Schwartz, PhD|2026870185|schwartm@georgetown.edu|
22408449|NCT01335620|Imperial College London|Alan Winston|+442033121603|a.winston@imperial.ac.uk|21603
22408450|NCT04145531|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
22408451|NCT02067728|University of Illinois College of Medicine at Peoria|Dr. Amy L. Christison|309-655-3613|alc@uicomp.uic.edu|
22408452|NCT03557775|Medical University of South Carolina|Dr. Heather Shaw Bonilha|843-792-2527|bonilhah@musc.edu|
22408453|NCT01725217|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22408454|NCT02626910|University of Pennsylvania|Dr. Hillary R. Bogner|215-746-4181|Hillary.Bogner@uphs.upenn.edu|
22408455|NCT00585468|University of Utah|Fuad Shihab, MD|801-585-3823|fuad.shihab@hsc.utah.edu|
22408456|NCT00276458|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22408457|NCT00978120|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22408458|NCT01042288|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22408459|NCT01023815|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22408460|NCT01225029|Icahn School of Medicine at Mount Sinai|Dr. Annemarie Stroustrup|212-241-6186|annemarie.stroustrup@mssm.edu|
22408461|NCT02967055|University of Colorado Anschutz Medical Campus|Aaron Lazorwitz|3037242019|aaron.lazorwitz@cuanschutz.edu|
22408462|NCT00104858|Fred Hutchinson Cancer Research Center|Dr. Mohamed Sorror|206-667-6298|msorror@fredhutch.org|
22408463|NCT01298323|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22408464|NCT01761565|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
22408465|NCT02161380|Bascom Palmer Eye Institute.|Dr. Byron Lam.|305 326 6021|blam@med.miami.edu|
22408466|NCT00938457|Mayo Clinic|Dr. Robert C. Miller|507-284-2669|miller.robert@mayo.edu|
22408467|NCT03655951|innovation Research & Training|Dr. Tracy Scull|919-493--7700|tscull@irtinc.us|118
22408468|NCT02229513|Baylor University Medical Center|Dr. Janice Mitchell, PI|713-705-6240|janicemitchellmd@gmail.com|
22408469|NCT02486263|Nationwide Children's Hospital|Dr. Sudarshan Jadcherla|614-355-6643|sudarshan.jadcherla@nationwidechildrens.org|
22408470|NCT01078974|Dana-Farber Cancer Institute|Steven P. Treon|617-632-2681|steven_treon@dfci.harvard.edu|
22408471|NCT01393444|University of Pittsburgh|Jennifer Collinger|412-383-1274|collingr@pitt.edu|
22408472|NCT02730234|Midwest Cardiovascular Research Foundation|Nicolas W Shammas|5633242828|shammasg@mcrfmd.com|102
22408473|NCT01791543|Vanderbilt University Medical Center|William G Stevenson, MD|1-615-322-2318|william.g.stevenson@vumc.org|
22408474|NCT00963040|MedVadis Research Corporation|Egilius L.H. Spierings, M.D., Ph.D.|781-588-5430|Spierings@MedVadis.com|
22408475|NCT06212310|UT Southwestern Medical Center|Sayoni Lahiri|214-645-2563|sayoni.lahiri@utsouthwestern.edu|
22431614|NCT01493414|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
22431615|NCT01072526|University of Missouri|Lenworth Johnson, MD|573-882-8473|JohnsonLN@health.missouri.edu|
22431616|NCT04319809|Minnesota HealthSolutions|Sara Seifert, President|6128036998|sara@minnhealth.com|
22431617|NCT04773665|VBI Vaccines Inc|Francisco Diaz-Mitoma, MD, PhD|613-749-4200|fdiazmitoma@vbivaccines.com|
22431618|NCT01605669|Naval Medical Center San Deigo|LCDR William Bennett MD FACC|619-532-7400|william.bennett5@med.navy.mil|
22431619|NCT04846231|Cleveland Clinic|Luke Laffin, MD|216-372-4315|Laffinl@ccf.org|
22431620|NCT01014871|Galderma|Florence Paliargues / CPM|+33492952957|florence.paliargues@galderma.com|
22431621|NCT03057704|Wake Forest University School of Medcine|Timothy N. Harwood MD|3367164498|tharwood@wakehealth.edu|
22431622|NCT00455702|Massachusetts General Hopsital|Donald C Goff|617-912-7899|goff@psych.mgh.harvard.edu|
22431623|NCT02329587|Butler Hospital|Sarah Garnaat|401-455-6659|sgarnaat@butler.og|
22431624|NCT01143402|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|646 888 4162|chapmanp@mskcc.org|
22431625|NCT04462471|Memorial Sloan Kettering Cancer Center|Dr. Alan Ho, MD, PhD|646-608-3774|hoa@mskcc.org|
22431626|NCT02706392|Fred Hutchinson Cancer Center|Dr. David Maloney|2066675616|dmaloney@fredhutch.org|
22431627|NCT03290027|Dr. Reddys Laboratories Inc.|Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
22431628|NCT01606150|Georgetown University NICU|Judith Palafoutas, Research Director|202 444 8756|jxp11@gunet.georgetown.edu|
22431629|NCT00265122|Centocor Research & Development, Inc.|Sr. Dir. Clinical Research|1-800-457-6399||
22431630|NCT01276106|TWi Biotechnology, Inc.|Medical Director|+886-2-26573350|Carl.Brown@twipharma.com|368
22431631|NCT03078452|Emory University|Dr. Ajay Nooka|404-778-1900|anooka@emory.edu|
22431632|NCT01082939|The University of Texas MD Anderson Cancer Center|William G. Wierda, MD, PhD, BS / Associate Professor|713-745-0428|eharriso@mdanderson.org|
22431633|NCT00862940|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
22431634|NCT00485173|Medtronic Spinal|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
22431635|NCT04537650|KITE Research Institute - University Health Network|Catriona M. Steele, PhD|14165973422|catriona.steele@uhn.ca|7802
22431636|NCT00879398|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22431637|NCT00829244|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22431638|NCT05047627|Dartmouth College|Nicholas Jacobson|(603) 646-7037|Nicholas.C.Jacobson@dartmouth.edu|
22431639|NCT03374306|HK Polytechnic University|Prof. Henry Chan|+85227667937|henryhl.chan@polyu.edu.hk|
22431640|NCT04251533|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22431641|NCT06378008|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
22431642|NCT05322408|Masonic Cancer Center|Melissa Geller, MD, MS|612-626-3111|gelle005@umn.edu|
22431643|NCT04583618|Sanofi Pasteur|Trial Transparency Team|800-633-1610 ext: 6#|Contact-US@sanofi.com|
22431644|NCT03584490|Northwestern University|James W. Griffith, PhD|3125035345|j-griffith@northwestern.edu|
22418344|NCT00326963|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22418345|NCT01749995|General Hospital Groeninge, Kortrijk, Belgium|Dr. Philip Debruyne|+32 056 63 39 00|philip.debruyne@azgroeninge.be|
22418346|NCT00556400|NICHD|Dr. Pamela Stratton|301 496-9079|strattop@mail.nih.gov|
22418347|NCT00895947|Amarillo Biosciences, Inc.|Martin J. Cummins|806-376-1741|mcummins@amarbio.com|14
22418348|NCT02176408|NYU Langone Health|Kristin Szuhany|6467545161|kristin.szuhany@nyulangone.org|
22418349|NCT01739348|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22418350|NCT00328016|National Institute on Aging|Jessica McNeeley, Research Fellow|410-558-8110|mcneeleyj@mail.nih.gov|
22418351|NCT01119716|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22418352|NCT00790335|Washington University in St. Louis|Dr. Suresh Vedantham, Principal Investigator|3143622900|vedanthams@mir.wustl.edu|314
22418353|NCT00528411|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22418354|NCT02421224|University of California, San Francisco|Dr. Justin S. White|415-476-8045|justin.white@ucsf.edu|
22418355|NCT02695537|University of Alabama at Birmingham|Dr. Martina Bebin, MD|205-934-3866|ebebin@uab.edu|
22418356|NCT02792699|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22418357|NCT02737748|Transwell Biotech Co., Ltd.|Dr. Bin-Ru She|+886-3-5670399|binru.she@tw-bio.com|207
22418358|NCT00077857|Hoffman-LaRoche|Medical Communications|800-821-8590||
22418359|NCT05779943|Emory University|Dr. David Schuster|4047781900|dschust@emory.edu|
22418360|NCT05084963|Revolo Biotherapeutics|Chief Medical Officer|(888) 599-7431|clinicaltrials@revolobio.com|
22418361|NCT06354998|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
22418362|NCT03819049|Janssen Research & Development, LLC|Trial Physician|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22418363|NCT00816361|MedImmune LLC|Susan Perez MD, MSc|+1 301-398-2827|information.center@astrazeneca.com|
22418364|NCT02500641|A. Menarini Industrie Farmaceutiche Riunite SrL|Post-Registration Clinical Trial Responsible|+39 055 5680459|pfabrizzi@menarini.it|
22418365|NCT02440568|University of Illinois at Chicago|Dr. John Quigley|312-413-1300|seanq@uic.edu|
22418366|NCT01763684|Zimmer Biomet|Linda Meijer, Clinical Operations Manager|+31786292935|linda.meijer@zimmerbiomet.com|
22418367|NCT04154150|University of Pittsburgh|Dr. Rebecca Price|412-383-2150|pricerb@upmc.edu|
22418368|NCT01181271|Mass General Hospital|Yi-Bin Chen, MD|617-726-5765|ychen6@partners.org|
22418369|NCT00444457|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22418370|NCT01121666|Five Office Ltd|Dr. Melanie Ruf|+41 44 9324132|clin@five.ch|
22418371|NCT03082664|University of Chicago|Dr. Maritza G. Gonzalez|7737026118|mggonzalez@bsd.uchicago.edu|
22418372|NCT02041091|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22418373|NCT01855074|Janssen. Pharmaceutical Companies of Johnson and Johnson|Medical Manager Neurosciences|+507-3989740|dmuschet@its.jnj.com|
22418374|NCT02991430|Scion NeuroStim, LLC|Dr. Robert Black|(919) 260-5528|rblack@scionneurostim.com|
22418375|NCT03970837|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22418376|NCT02132754|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22418377|NCT02304991|University of North Carolina School of Medicine|Edwin Kim, MD, MS|919-962-4960|edwinkim@email.unc.edu|
22418378|NCT00786994|Center for Dermatooncology, Department of Dermatology, University Hospital Tübingen, Tübingen, Germany|Dr Annette Pflugfelder||annette.pflugfelder@med.uni-tuebingen.de|
22418379|NCT00578669|UT Austin School of Nursing|Dr. Richard A. Brown|512-471-8584|brown2@utmail.utexas.edu|
22418380|NCT01193127|Omeros Corporation|Chief Medical Officer|(206) 676-5000|swhitaker@omeros.com|
22418381|NCT04625426|Tan Tock Seng Hospital|George Glass, Nurse Researcher|+65 6903-5440|glass_george_frederick@ttsh.com.sg|
22418382|NCT00761865|University of Rochester|Benedict DiGiovanni|5852731611|benedict_digiovanni@urmc.rochester.edu|
22418383|NCT01573169|Stroke Unit and Division of Internal and Cardiovascular Medicine University of Perugia, Santa Maria della Misericordia Hospital|Dr. Maurizio Paciaroni|+390755786424|maurizio.paciaroni@unipg.it|
22431645|NCT02302222|Acelity|Sr Director, Global Clinical Development|2102555595|jane.hart@acelity.com|
22431646|NCT00016354|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Antonio Wolff|410-614-4192|awolff@jhmi.edu|
22431647|NCT02876172|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
22431648|NCT02769481|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
22431649|NCT02781558|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22431650|NCT04604431|Northwestern University Feinberg School of Medicine|Lucy Bilaver, Associate Professor of Pediatrics, iREACH Co-Investigator|312-503-5618|l-bilavere@northwestern.edu|
22431651|NCT00643279|Medtronic|Dana Wigert|763-526-2802|dana.wigert@medtronic.com|
22431652|NCT03274466|"KCI | 3M"|Director of Clinical Research|(210) 515-4060|actate@mmm.com|
22431653|NCT06899100|Midwest Evaluation and Research|Dr. Matthew Shepherd|8336439377|matt.shepherd@midwestevaluation.com|
22431654|NCT00131885|University of Utah|Patricia Murphy, DrPH|801-793-5729|patricia.murphy@nurs.utah.edu|
22431655|NCT01107886|AstraZeneca LP|Boaz Hirshberg MD, MBA|1 302 885 4997|ClinicalTrialTransparency@astrazeneca.com|
22431656|NCT01346176|University of Pennsylvania School of Medicine|Scott D. Halpern|215.573.9461|elcooney@exchange.upenn.edu|
22431657|NCT04630769|Masonic Cancer Center, University of Minnesota|Melissa Geller, MD|612-626-3111|gelle005@umn.edu|
22431658|NCT02445911|Kaneq Bioscience Limited|Dr. Gosse Bruinsma|1-613-800-0955|gosse.bruinsma@kaneqbioscience.ca|
22431659|NCT01334918|Astellas Scientific and Medical Affairs, Inc. / Astellas Pharma Global Development, Inc.|Senior Medical Director, Medical Affairs||ClinicalTrials.Disclosure@us.astellas.com|
22431660|NCT01270529|University of California, San Francisco|Dr. Kirsten Johansen|415-221-4810|kirsten.johansen@ucsf.edu|23598
22408476|NCT01001195|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22408477|NCT04524351|Annovis Bio|Maria Maccecchini, PhD, CEO|(610) 727-3710|maccecchini@annovisbio.com|
22408478|NCT00066573|NCIC Clinical Trials Group|Dr. Wendy Parulekar|1-613-533-6430|wparulekar@ctg.queensu.ca|
22408479|NCT02464176|Wake Forest Baptist Medical Center|Dr. James D. Turner|3367164998|jturner@wakehealth.edu|
22408480|NCT01646268|UCB Clinical Trial Call Center|Study Director|+1 844-599-2279||
22408481|NCT02222246|Duke University|Dr. Paula Tanabe|919-613-6038|paula.tanabe@duke.edu|
22408482|NCT00906776|Rotschild hospital|Prof Philippe Bouchard|+33614656947|phbouch@noos.fr|
22408483|NCT01473602|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22408484|NCT02544607|Massachusetts General Hospital|Dr. Cristina Cusin|617-726-6421|ccusin@mgh.harvard.edu|
22408485|NCT00449761|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22408486|NCT00560573|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22408487|NCT01969201|IBSA Insitut Biochimique|Project Leader|+41 58 360 10 00|rd@ibsa.ch|
22408488|NCT01198327|Wilmer Eye Institute|Peter Campocahiro|410-955-5106|pcampo@jhmi.edu|
22408489|NCT01422876|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22408490|NCT01600755|Cook MyoSite Incorporated|Ron Jankowski, PhD|412-963-7380|Ron.Jankowski@CookMyosite.com|
22408491|NCT03464110|Duke University|Dr. Kathryn Pollak|919-681-4757|kathryn.pollak@duke.edu|
22408492|NCT00938392|GlaxoSmithKline|GSK Response Center|866-435-7343||
22408493|NCT00122954|Oregon Health & Science University|Lynne Shinto, ND, MPH|503-494-5035|shintol@ohsu.edu|
22408494|NCT00558831|Northwestern University|Amy Paller, MD|312-695-6829|apaller@nmff.org|
22408495|NCT02204449|UHN Toronto|Dr. Sherry Grace|416.736.2100|sgrace@yorku.ca|22364
22408496|NCT02856282|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22408497|NCT00057330|GlaxoSmithKline|GSK Response Center|866-435-7343||
22408498|NCT02406937|Sprim (Shanghai) Consulting Co., Ltd.|Dr. Charlie Zhang|+86 (21) 51097272|charlie.zhang@sprim.cn|
22408499|NCT01491737|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22408500|NCT02354352|Ohio State University|Dr. Subha Raman|614-293-8963|raman.1@osu.edu|
22408501|NCT03772574|BC Women's Hospital|Dr. Anthony Chau|604-875-2158|anton.chau@ubc.ca|
22408502|NCT02696382|University of Colorado Denver|Dr. Jennifer Stevens-Lapsley|303.724.9170|jennifer.stevens-lapsley@cuanschutz.edu|
22408503|NCT00494234|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
22408504|NCT04446182|Huntsman Cancer Institute/University of Utah|Clinicaltrials.gov/CTRP Specialist|8012136215|IITDataManagement@hci.utah.edu|
22408505|NCT04436497|Healey Center for ALS at Massachusetts General Hospital|Healey Center for ALS Project Management|833-425-8257 (HALT ALS)|healeyalsplatform@mgh.harvard.edu|
22408506|NCT02743117|MedImmune, LLC|Raburn Mallory, MD|301-398-000|information.center@astrazeneca.com|
22408507|NCT04983589|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22408508|NCT03546270|The University of Nebraska at Omaha|Dr. Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
22408509|NCT02940392|Boston Scientific|Director, Clinical Operations|9529306000|teresa.takle-flach@bsci.com|
22408510|NCT03176953|National Center for PTSD|Sonya Norman, PhD|858-518-8266|sonya.norman@va.gov|
22408511|NCT00762073|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22431661|NCT01576783|Nationwide Children's Hospital|Dr. Sarah Keim|614-722-3177|Sarah.Keim@nationwidechildrens.org|
22408512|NCT02319642|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22408513|NCT01265875|Dartmouth-Hitchcock Medical Center|Timothy Gardner, MD|603-650-6472|timothy.b.gardner@hitchcock.org|
22408514|NCT01958593|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
22408515|NCT01049360|AstraZeneca|Esther Garcia||ClinicalTrialTransparency@astrazeneca.com|
22408516|NCT02276274|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22408517|NCT05147311|Brigham and Women's Hospital|Dr. Hermioni Amonoo, Director of Well-Being and Cancer Research Program|‭(617) 525-7472‬|hermioni_amonoo@dfci.harvard.edu|
22408518|NCT02504099|AbbVie|Global Medical Services|800-633-9110||
22408519|NCT00145795|The University of Chicago Department of Health Studies, Section of Infectious Diseases and Global Health|Dr. David Pitrak|(773) 702-2710|dpitrak@medicine.bsd.uchicago.edu|
22408520|NCT04419558|FibroGen, Inc.|Clinical Trial Information Desk|(415) 978-1427|zephyrus@fibrogen.com|
22408521|NCT05240313|Boston College|Christopher Salas-Wright|617-552-1295|christopher.salas-wright@bc.edu|
22408522|NCT01539512|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22408523|NCT02388906|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22408524|NCT02400281|Arog Pharmaceuticals|Edward McDonald|214-593-0500|emcdonald@arogpharma.com|
22408525|NCT00412360|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com|
22408526|NCT03145207|University of Maryland, Baltimore School of Pharmacy|Dr. Audra Stinchcomb|410-706-2646|astinchc@rx.umaryland.edu|
22408527|NCT01790633|Service des maladies infectieuses et tropicales - Hôpital Saint-Antoine|Dr. Julie Bottero|+33 1 49 28 04 24|julie.bottero@aphp.fr|
22408528|NCT05436067|CFD Research Corporation|Dr. Paulien Roos|256 715 6817|paulien.roos@cfd-research.com|
22408529|NCT05689554|University of Washington|Dr. Elizabeth Phelan|(206) 744-9112|phelane@uw.edu|
22408530|NCT00157157|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22408531|NCT01678794|Mayo Clinic|Horng H. Chen, M.D.|507-284-8896|chen.horng@mayo.edu|
22408532|NCT00121251|Weill Cornell Medical College|Cooperative Group Program Manager|646-962-9377|has7003@med.cornell.edu|
22408533|NCT00563706|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22408534|NCT04074109|VA Palo Alto Health Care System|Peter Bayley, PhD|650-493-5000|peter.bayley@va.gov|68653
22408535|NCT01140815|AORI|Knee Research Director|7036194423|nancylparks@gmail.com|
22408536|NCT01361308|Noven Therapeutics, LLC|Sailaja Bhaskar, Executive Director, Clinical Research|(212) 287-0798|sbhaskar@noven.com|
22408537|NCT03839693|Clinical Research Management Group|Patrick Murphy|4138210022|p.murphy@crmg-usa.com|
22408538|NCT00270205|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22408539|NCT00706901|Charleston VAMC|Elizabeth Santa Ana, Ph.D.|(843) 789-7168|elizabeth.santaana2@va.gov|
22408540|NCT00461591|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
22408541|NCT05292248|Case Western Reserve University|Kylie Meyer, Principal Investigator|216-368-1928|knm77@case.edu|
22408542|NCT01339273|Oxford University Hospitals NHS Trust|Dr Nicholas Crabtree|01865 221590|nicholas.crabtree@ouh.nhs.uk|
22408543|NCT04478994|Horizon Pharma USA, Inc.|Medical Monitor|1-866-479-6742|medicalinformation@horizontherapeutics.com|
22408544|NCT00457249|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22408545|NCT02192307|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
22408546|NCT04621227|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22408547|NCT02916056|vTv Therapeutics|Ann Gooch PhD, VP Clinical Development & Regulatory Operations|336-841-0300|agooch@vtvtherapeutics.com|80544
22408548|NCT00124709|Novartis Pharmaceuticals|Study Director|862-778-8300||
22408549|NCT01728376|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22408550|NCT02303977|Abramson Cancer Center, Penn Presbyterian Medical Center|Dr. Christine Ciunci|215-662-9801|christine.ciunci@pennmedicine.upenn.edu|
22408551|NCT02094573|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22408552|NCT02411110|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22408553|NCT04293341|Department of Veterans Affairs|Daniel Gros, PhD|843-789-7311|daniel.gros@va.gov|
22408554|NCT04199312|Zeltiq Aesthetics|Sally Hallas, RN, Director Clinical Development - Body Contouring|209-294-5571|sally.hallas@abbvie.com|
22408555|NCT00643006|Gothenburg University|Dr. K Mannerkorpi|046-31-24220|kaisa.mannerkorpi@rheuma.gu.se|
22408556|NCT01308476|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22408557|NCT00617175|MEDTRONIC Clinical Research Institute|Laura Manotta|+39022413.1|laura.manotta@medtronic.com|
22408558|NCT00812968|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22408559|NCT00556907|USC/Norris Comprehensive Cancer Center|Tali Homsey|(323) 865-0451|tali.homsey@med.usc.edu|
22408560|NCT00505765|Semel Institute at UCLA|Stephen R. Marder|310-268-3647|marder@ucla.edu|
22408561|NCT03864406|Clinical Center|Hadigan, Colleen|+1 301 594 5754|hadiganc@niaid.nih.gov|
22408562|NCT01012609|Memorial Sloan Kettering Cancer Center|Dr. Ira Dunkel, MD|212-639-2153|dunkeli@mskcc.org|
22408563|NCT01453296|GlaxoSmithKline|GSK Response Center|866-435-7343||
22408564|NCT00620776|University of Pennsylvania|Dr. Paul Crits-Christoph|(215) 662-7993|crits@mail.med.upenn.edu|
22408565|NCT00761969|Department of Vascular Diseases, University of Ljubljana Med Ctr|Ales Blinc, MD, DSc|+386 1 522 80 32|ales.blinc@kclj.si|
22408566|NCT01279265|University of Texas Health Science Center at Houston|Dr. J. Marc Rhoads, Director, Pediatric Gastroenterology|713-500-7642|j.marc.rhoads@uth.tmc.edu|
22408567|NCT03205046|Acerta Pharma B.V.|Acerta Clinical Trials|1-888-292-9613|acertamc@dlss.com|
22408568|NCT00830310|University Hospitals Case Medical Center|Christopher Bialko|216-286-4362|Christopher.Bialko@UHhospitals.org|
22408569|NCT01015118|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22408570|NCT01522755|Medtronic|Foudali Latifa|+33 631992144|latifa.foudali@medtronic.com|
22408571|NCT03414658|Dana-Farber Cancer Institute|Adrienne G. Waks, MD|617-632-3800|Adrienne_Waks@dfci.harvard.edu|
22408572|NCT05934591|University of Illinois Urbana Champaign|Dr. Liliane Windsor|2173001782|lwindsor@illinois.edu|
22408573|NCT00402298|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
22408574|NCT00480077|Medtronic Bakken Research Center|Director CRDM|31-43-3566813||
22408575|NCT00147290|Medtronic|Elisabetta Santi|003906328141|elisabetta.santi@medtronic.com|
22408576|NCT02265874|The Ohio State University Wexner Medical Center|Dr. Elliott Crouser|16142934925|elliott.crouser@osumc.edu|
22408577|NCT00938366|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22408578|NCT01215968|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22408579|NCT01250418|Northwestern University|Gildasio De Oliveira MD|312-472-3573|g-jr@northwestern.edu|
22408580|NCT06288607|The First Affiliated Hospital with Nanjing Medical University|Dr. Yang Xu|+8613851856794|yangxu@njmu.edu.cn|
22408581|NCT05966129|Duke University|Hrishikesh Chakraborty, PhD|919-668-1238|hrishikesh.chakraborty@duke.edu|
22408582|NCT05182840|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22408583|NCT04563039|Avvio Medical, Inc.|VP of RA / QA / CA|4158872037|clinicalaffairs@avviomed.com|
22408584|NCT04242498|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22408585|NCT02478281|American Regent Inc.|Hal Rathfon, RPh|631-772-3555|HRathfon@americanregent.com|
22408586|NCT02396849|Indiana University|Christina Tiller|317-044-4522|ctiller@iu.edu|
22408587|NCT03328325|University of Rochester|Angela Branche, MD, Site Principal Investigator|585-275-5871|angela_branche@urmc.rochester.edu|
22418384|NCT03190330|Johnson & Johnson Private Limited|Sr. Medical Advisor|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22408588|NCT00931515|Pioneer Surgical Technology|Director of Regulatory and Clinical Affairs|906-225-5602|emilydowns@pioneersurgical.com|
22408589|NCT00409565|University of Pittsburgh Cancer Institute|Michael Gibson, MD|412-692-2600|gibsonmk@upmc.edu|
22408590|NCT00985114|GI Dynamics, Inc.|Clinical Affairs Manager|781.357.3263|kwoessner@gidynamics.com|
22408591|NCT02950831|St. Jude Medical|Filippo Agnesi|14694184987|filippo.agnesi@abbott.com|
22408592|NCT01119118|University of Wisconsin Carbone Cancer Center|Dr. Glenn Liu|608-265-8689|gxl@medicine.wisc.edu|
22408593|NCT04487886|Emory University|Edmund Waller, MD, PhD|404-727-4995|ewaller@emory.edu|
22408594|NCT00828009|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22408595|NCT00113321|The University of Texas M. D. Anderson Cancer Center|Hagop Kantarjian, M.D., Professor|713/792-7026|eharriso@mdanderson.org|
22408596|NCT01375491|University of California, San Diego|Dr. Karen Louise Herbst|858-552-8585|kaherbst@gmail.com|7384
22408597|NCT01396434|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22408598|NCT04678557|Vertex|Medical Information|617-341-6777|medicalinfo@vrtx.com|
22408599|NCT02260804|CELLTRION, Inc.|Dr. Sung Hyun Kim|+82-32-850-5000|contact@celltrion.com|
22408600|NCT00509223|Baker IDI Heart and Diabetes Institute|Jonathan Shaw, MD, FRACP, FRCP|+61 (0) 3 8532 1821|jonathan.shaw@bakeridi.edu.au|
22408601|NCT02985541|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
22408602|NCT02383966|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22408603|NCT02503215|Nephrology Division, University of São Paulo|Dr Bruno Caldin da Silva|5511997620521|brunocaldin@hotmail.com|
22408604|NCT03965754|Geisinger Clinic|Amir Goren, PhD|5702144395|agoren@geisinger.edu|
22408605|NCT02983305|University of Michigan|Sara|734-936-7567|weisssar@umich.edu|
22408606|NCT00822237|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22408607|NCT03433482|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22408608|NCT00437294|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22408609|NCT00470301|Montefiore Medical Center|NYCC Coordinating Center|718-405-8404|jsparano@montefiore.org|
22408610|NCT02064231|Coloplast A/S|Birte Petersen Jakobsen, MD|+45 4911 1395|dkbir@coloplast.com|
22408611|NCT00518531|Amgen Inc.|Study Director|866-572-6436||
22408612|NCT00514709|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22408613|NCT04888377|RTI International|Elizabeth McClure|919-316-3773|mcclure@rti.org|
22408614|NCT00526162|Medtronic CRDM|CRDM Core Clinical Organization|800-328-2518|jamie.l.reynolds@medtronic.com|
22408615|NCT05279807|A. Menarini Industrie Farmaceutiche Riunite SrL|Clinical Operation Director|+39 055 5680459|pfabrizzi@menarini.it|
22408616|NCT01169259|Brigham and Women's Hospital; 900 Commonwealth Ave, 3rd fl.; Boston, MA 02215|VITAL Study Director|1-800-388-3963|vitalstudy@partners.org|
22408617|NCT05299359|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22408618|NCT04242446|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22408619|NCT03587116|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov.Inquiries@pfizer.com|
22408620|NCT05993299|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22408621|NCT05644756|Brown University|Dr. Ruben Martinez|4014441915|ruben_martinez@brown.edu|
22408622|NCT03110107|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22408623|NCT04058990|Boston Scientific Japan K.K.|Sachiyo Sato/Clinical Project Manager|+81-3-6853-7500|Sachiyo.Sato@bsci.com|
22408624|NCT03985982|Croma Pharma|Clinical Development - Head of Clinical Operations|+432262684680|clinical.studies@croma.at|
22408625|NCT03093480|Bioverativ, a Sanofi company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6
22408626|NCT05981365|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22408627|NCT05471921|Columbia University|Jeremy Kane|212-305-2862|jk4397@cumc.columbia.edu|
22408628|NCT03927989|Medical University of South Carolina|Dr. Alana Rojewski (PI)|843-876-1593|rojewski@musc.edu|
22408629|NCT02593175|MD Anderson Cancer Center|Clinton Yam|832-589-8343|cyam@mdanderson.org|
22408630|NCT00478933|Medtronic BRC|Margriet Kruijshoop, Clinical Research Manager|+31623910708|margriet.kruijshoop@medtronic.com|
22408631|NCT01363999|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
22408632|NCT02506101|Johns Hopkins Medicine|Dr. Ginette Okoye|410-502-7546|CTReP@jhmi.edu|
22408633|NCT02203305|University of North Carolina at Chapel Hill|Dr. Margaret Dillon|9199665251|mdillon@med.unc.edu|
22408634|NCT03586427|Gate Neurosciences, Inc|Chief Medical Officer|2032473895|ron.burch@gateneuro.com|
22408635|NCT02384200|UCSD Medical Center|Paul Zupkas, Ph.D.|6195432628|pzupkas@ucsd.edu|
22408636|NCT03193996|Mayo Clinic|Tyson Scrabeck|507-538-1016|scrabeck.tyson@mayo.edu|
22431662|NCT05489328|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22431663|NCT01083602|Novartis Pharmaceuticals|Study Director|862-778-8300||
22408637|NCT03478982|Cares|UCB|+1 844 599|UCBCares@ucb.com|2273
22408638|NCT05125224|Brigham and Women's Hospital|Rishi J Desai, PhD|617-278-0932|rdesai@bwh.harvard.edu|
22392277|NCT01304498|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22392278|NCT03325777|The University of Texas at Austin|Dr. Jasper Smits|512-475-8095|smits@utexas.edu|
22408639|NCT00593385|Getinge|Elizabeth Bulger, Director of Clinical Affairs|1-603-864-5368|elizabeth.bulger@getinge.com|
22392279|NCT01895036|NYSPI|Linda Sherman|6467747158|lsherma@nyspi.columbia.edu|
22392280|NCT03004404|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22392281|NCT01937975|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22392282|NCT02028325|Indiana University|Aaron Cohen-Gadol, MD, MSc|317-362-8760|acohen@goodmancampbell.com|
22408640|NCT01471197|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22408641|NCT02352831|Washington University School of Medicine|Andrea Wang-Gillam, M.D., Ph.D.|314-362-5740|awang-gillam@wustl.edu|
22408642|NCT00924313|National Cancer Institute, National Institutes of Health|Dr. Peter L. Choyke|301-402-8409|pchoyke@mail.nih.gov|
22418385|NCT02081209|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
22418386|NCT02370329|Mayo Clinic Arizona|Jeanne M. Palmer, MD|480/342-8000|palmer.jeanne@mayo.edu|
22418387|NCT04616430|Atossagenetics|Dr. Steven Quay|206.419.4873|steven.quay@atossainc.com|
22418388|NCT02022748|AstraZeneca Pharmaceuticals LP|Naeem Khan, MD|+1 302-885-8976|Naeem.Khan@astrazeneca.com|
22418389|NCT02700386|University of Colorado, Denver|Christine Fisher, MD, MPH|720-848-0154|christine.fisher@cuanschutz.edu|
22418390|NCT06378749|Pro-Change Behavior Systems, Inc.|Kerry E. Evers|4013602985|kevers@prochange.com|
22418391|NCT04347122|KUMC|Kyle Sweeney, MD|913886100|ksweeney2@kumc.edu|
22418392|NCT03510598|Zeltiq Aesthetics|Lori Brandt, Director Clinical Trial Management|925 621-7460|lori.brandt@abbvie.com|
22418393|NCT06262191|Northern Arizona University|PI|928-523-1787|zachary.lerner@nau.edu|
22418394|NCT01972919|Medical College of Wisconsin|Beth Erickson, MD|414-805-4462|BErickson@mcw.edu|
22418395|NCT00112866|Adult Brain Tumor Consortium (ABTC)|Mark Gilbert, MD|410-955-8837|jfisher@jhmi.edu|
22418396|NCT05367336|Corewell Health Lakeland|Rachelle Pichot; Clinical Research Specialist|240-389-7340|rachelle.pichot@corewellhealth.org|
22418397|NCT00658658|Amgen Inc.|Study Director|866-572-6436||
22418398|NCT01523457|Yale University|Jill Lacy|+1 (203) 737-1600|jill.lacy@yale.edu|
22418399|NCT02213510|UC San Diego School of Medicine|Ulrika Birgersdotter-Green, MD|858-657-5310|ubgreen@ucsd.edu|
22418400|NCT03954834|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22418401|NCT03469336|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22418402|NCT01108406|Sonitus Medical, Inc.|Lily Woodby, AuD|8668162076|lily@sonitusmedical.com|
22418403|NCT03544424|University of Manchester|Dr Joanne Taylor|0161 306 6000|joanne.taylor-2@manchester.ac.uk|
22418404|NCT02603393|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22418405|NCT01359969|Pharming Technologies BV|Anurag Relan, MD, VP Clinical Research & Medical Affairs|+31 715247400|a.relan@pharming.com|
22418406|NCT02174419|Trevi Therapeutics|Thomas Sciascia, MD|203-304-2499|thomas.sciascia@trevitherapeutics.com|
22418407|NCT00593736|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22418408|NCT01868893|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22418409|NCT01857271|Albert Einstein Cancer Center|Dr. Haiying Cheng|718-405-8404|hcheng@montefiore.org|
22408643|NCT01298362|Hellenic Society of Breast Surgeons|Christos J Markopoulos, MD, MPhil Professor of Surgery-Athens University Medical School|+30 210 6862527|cmarkop@hol.gr|
22408644|NCT01207219|The Department of Psychiatry,HKU|Dr.Lin Jingxia|+85222553064|jingxia.lin@gmail.com|
22408645|NCT00766727|Neodyne|VP, R&D/OPS|5104564128|jzepeda@neodynebio.com|128
22408646|NCT00924820|The University of Texas (UT) MD Anderson Cancer Center|John F de Groot, Professor, Neuro-Oncology|(713) 745-3072|jdegroot@mdanderson.org|
22408647|NCT01353586|Biosense Webster, Inc|Kendra McInnis, Manager, Clinical Operations|909-839-7284|kmcinnis@its.jnj.com|
22408648|NCT03992456|Duke Cancer Institute|John Strickler, MD|(507) 284-2511|john.strickler@duke.edu|
22408649|NCT01068418|Brigham and Women's Hospital, Harvard Medical School|Jonathan S. Williams|6177325666|jwilliams5@partners.org|
22408650|NCT00595946|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22408651|NCT00326625|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22408652|NCT02594384|OrphAI Therapeutics|Esther Nkrumah|267 512-1750|enkrumah@orphai-therapeutics.com|
22408653|NCT02427568|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
22408654|NCT03919669|University of WI Alzheimer's Disease Research Center|Dr. Sterling Johnson|608-262-9549|scj@medicine.wisc.edu|
22408655|NCT00625846|Mayo Clinic|Keith C. Bible, M.D., Ph.D.|507-284-2511|bible.keith@mayo.edu|
22408656|NCT00544713|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
22408657|NCT02058849|University of Kentucky|Dr. Travis Thomas, Associate Professor|859-218-0863|dth225@uky.edu|
22408658|NCT02219477|AbbVie|Global Medical Services|800-633-9110||
22408659|NCT02648646|University of North Carolina|Yvonne Golightly PT, PhD, Assistant Professor of Epidemiology|919-966-0566|golight@email.unc.edu|
22408660|NCT01891669|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22408661|NCT00761085|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
22408662|NCT04298229|Vanderbilt University Medical Center|Zachary Cox|615-966-7107|zachary.l.cox@vumc.org|
22408663|NCT00262119|Medtronic|Senior Clinical Research Manager|0039-0632814225|andrea.grammatico@medtronic.com|
22418410|NCT01853930|Jesse Brown VA Medical Center|Dr. Janet P. Szlyk, PhD|312-997-3644|janet.szlyk@va.gov|
22418411|NCT03825341|St. Jude Children's Research Hospital|Jeremie Estepp, MD|(901) 595-5703|jeremie.estepp@stjude.org|
22392283|NCT01099917|Memorial Sloan Kettering Cancer Center|Dr. Barrie Cassileth|646-888-0801|Cassileth@mskcc.org|
22392284|NCT02990468|BioMimetix JV LLC|Director of Clinical Operations|303-862-7268|contact@bmxpharma.com|
22392285|NCT03151746|Northwestern University|Paul Fitzgerald|312-695-1064|p-fitzgerald2@northwestern.edu|
22392286|NCT01193010|Massachusetts General Hospital|Rachel Gottlieb, Clinical Research Coordinator|617.724.4985|rgottlieb3@mgh.harvard.edu|
22392287|NCT01602510|GlaxoSmithKline|GSK Response Center|866-435-7343||
22392288|NCT01825577|Saint Louis University|Dr. Ahsan Khan|314-977-4826|khanay@slu.edu|
22392289|NCT02378038|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22392290|NCT03697122|Duke University|Negmeldeen Mamoun, M.D.|919-681-3551|negmeldeen.mamoun@duke.edu|
22392291|NCT04191616|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22408664|NCT00859313|AcelRx Pharmaceuticals, Inc.|Dr. Pamela Palmer|650-216-3504|ppalmer@acelrx.com|
22408665|NCT00071006|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22408666|NCT03142919|LIBR|Jonathan Savitz|9185025104|jsavitz@laureateinstitute.org|
22392292|NCT04230122|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22392293|NCT04910139|Sound Health Systems|Paramesh Gopi|408-316-3631|pgopi@soundhealth.life|
22408667|NCT05261126|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22392294|NCT01361594|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
22408668|NCT05939388|Wake Forest University Health Sciences|Michelle Olshan-Perlmutter|704-358-2800|michell.olshanperlmutter@atriumhealth.org|
22408669|NCT03901274|University of South Carolina|Dr. Mark Weist|803-777-8438|weist@mailbox.sc.edu|
22392295|NCT03697551|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22408670|NCT05570604|Ohio State University|Dr. Diane Von Ah|614-688-0722|vonah.1@osu.edu|
22392296|NCT03518567|Brown University|Elizabeth Aston, PhD|401-863-6668|elizabeth_aston@brown.edu|
22392297|NCT03874754|Johns Hopkins School of Nursing|Nada Lukkahatai|2407509867|nada.lukkahatai@jhu.edu|
22392298|NCT02670122|Ramon y Cajal University Hospital. Vascular and Interventional Radiology Service|Jose Urbano Garcia, MD, PhD, EBIR, FCIRSE|+ 34 606 31 84 30|jurbano34@gmail.com ; jurbano@salud.madrid.org|
22408671|NCT05074303|University of Florida|Dr. Wendy Dahl|3522943707|wdahl@ufl.edu|
22392299|NCT02762903|Columbia University|William N. Levine, MD|212-305-0998|wnl1@cumc.columbia.edu|
22392300|NCT00108745|NRG Oncology|Christopher Purdy on behalf of Austin Miller PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
22418412|NCT00110136|Wake Forest CCOP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
22392301|NCT00723749|RB Pharmaceuticals|Global Medical Director|+1 (804) 379 1090|Tim.Baxter@reckittbenckiser.com|
22418413|NCT00459121|Barbara Ann Karmanos Cancer Institute|Shirish Gadgeel, M.D.|313-576-8753|sgadgeel@med.umich.edu|
22392302|NCT04978090|University of Kentucky|Dr. Andrew Bernard|859-257-3253|andrew.bernard@uky.edu|
22392303|NCT03745898|Brigham and Women's Hospital|Dr. Susan Redline|(617) 732-5500|sredline@bwh.harvard.edu|
22408672|NCT03158532|ISCS|Roberto Léo da Silva|55 48 999099790|robertoleo@hotmail.com|
22418414|NCT04283500|NYU Langone Health|Ryan McCormack|2122632862|Ryan.McCormack@nyulangone.org|
22408673|NCT04527380|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22418415|NCT03599271|Intersect ENT|Andrew Campbell PhD, MPH Clinical Affairs Director|6506412100|acampbell@intersectent.com|
22418416|NCT01043653|VISN 5 MIRECC|Dr. Amy Drapalski|410-637-1855|amy.drapalski@va.gov|
22408674|NCT06241768|Wake Forest University School of Medicine|Dr. Anna Snavely|336-716-2011|asnavely@wakehealth.edu|
22418417|NCT03682224|Southern Illinois University School of Medicine|Sowmy Thuppal, Research Assistant Professor|217-545-2320|sthuppal83@siumed.edu|
22418418|NCT03875859|Stanford University|Kavita Yang Sarin|650-804-2899|ksarin@stanford.edu|
22418419|NCT00470067|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22418420|NCT01460901|Children's Mercy Hospitals and Clinics|Dr. Gary Douglas Myers|8163026817|gdmyers@cmh.edu|7-6817
22431664|NCT03198871|University of Pittsburgh School of Medicine / UPMC|Dr. Kathirvel Subramaniam MD MPH FASE|7247995852|subramaniamk@upmc.edu|
22431665|NCT01227785|Guidant, a Boston Scientific Company|Paji Vitoff, Senior Clinical Manager|651-582-5415|paji.vitoff@bsci.com|
22431666|NCT01657370|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22431667|NCT02777086|Texas Christian University|Wayne E.K. Lehman, Ph.D.|18172577226|w.lehman@tcu.edu|
22431668|NCT01133665|The University of Chicago|Dr. Everett Vokes|773-702-9306|evokes@medicine.bsd.uchicago.edu|
22431669|NCT01819272|Elcelyx Therapeutics, Inc|Senior Director, Development|858-876-1814|info@elcelyx.com|
22431670|NCT03021486|UT MD Anderson Cancer Center|David Hui, MD- Associate Professor, Palliative Care Medicine|(713) 792-6258|dhui@mdanderson.org|
22431671|NCT04043286|Loma Linda University, School of Dentistry|Dr. Sasiya Bhumpattarachai|6267565156|sbhumpattarachai@llu.edu|
22431672|NCT01732536|Intersect ENT, Inc.|James Stambaugh, Vice President of Clinical & Medical Affairs|650-641-2103|jstambaugh@intersectent.com|
22431673|NCT00805389|GlaxoSmithKline|GSK Response Center|866-435-7343||
22431674|NCT01246960|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22431675|NCT01409096|University of Texas Southwestern Medical Center|E. Sherwood Brown, MD, PhD|2146466948|sherwood.brown@utsouthwestern.edu|
22392304|NCT01791972|Director, Clinical Research|Teva Branded Pharmaceutical Products, R&D Inc.|1-215-591-3000|ustevatrials@tevapharm.com|
22392305|NCT00632502|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22418421|NCT00338455|Scios R&D, Inc.|Sr. Director Clinical Leader|650 564-5084||
22392306|NCT00277095|Uromedica|Sabitha R Shriram|763-694-9880|sshriram@uromedica-inc.com|216
22392307|NCT00630734|University of Colorado Denver|Christina Aquilante, Pharm.D.|303-724-6126|christina.aquilante@ucdenver.edu|
22392308|NCT01956097|Ewha Brain Institute, Ewha W. University|Soonhyun Ban, RN, MS|+82-2-3277-6550|soonhyun.s.ban@gmail.com|6554
22408675|NCT04957979|HealthPartners Institute|Steven P. Dehmer, PhD|952-967-5216|steven.p.dehmer@healthpartners.com|
22408676|NCT03671746|Massachusetts General Hospital|Dr. Arun Aneja, MD, PhD|617-726-6546|aaneja@mgh.harvard.edu|
22408677|NCT05445466|BIDMC|Dr. Paulo Lizano|201-776-6708|lizanopl@gmail.com|
22408678|NCT01714921|Medtronic GmbH|ProSA clinical research contact|004921598149|rs.dusclinicalcooperation@medtronic.com|0
22408679|NCT05116241|ILiAD Biotechnologies|Chief Medical Officer|800-603-3525|contact@iliadbiotech.com|
22408680|NCT04410991|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22408681|NCT03668379|University of California, San Francisco|John Sauceda, PhD, Associate Professor|415-502-1000|john.sauceda@ucsf.edu|17172
22408682|NCT01054443|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
22408683|NCT03099265|Yale School of Medicine|Kimberly L. Johung, MD, PhD Associate Professor of Therapeutic Radiology|(203) 200-2008|kimberly.johung@yale.edu|
22408684|NCT02284880|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22408685|NCT00396318|Genentech, Inc.|Medical Communications|800-821-8590||
22408686|NCT00602927|University of Pennsylvania|Dr. Caryn Lerman|215-746-7141|clerman@mail.med.upenn.edu|
22408687|NCT00296192|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22408688|NCT03504839|The Ohio State University Medical Center|Clinical Research Coordinator - Adrianne Miller|614-688-8252|adrianne.miller3@osumc.edu|
22408689|NCT03891602|Hackensack Meridian Health|Lisa Carter-Bawa, PhD, MPH, APRN, ANP-C, FAAN|2018803443|lisa.carterbawa@hmh-cdi.org|
22408690|NCT01741259|OB Anesthesia Associates|Christy Morgan, MD|314-469-6800|christylmorganmd@gmail.com|
22408691|NCT03491800|University of North Carolina at Chapel Hill|Crystal Wiley Cené, MD, MPH, FAHA|919-445-6783|crystal_cene@med.unc.edu|
22408692|NCT05604521|Sanaria Inc.|Chief Medical Officer|301-770-3222|sanaria@sanaria.com|
22408693|NCT02875340|ValiSeek Limited|Suzanne Dilly|+442030084416|suzanne.dilly@valirx.com|
22418422|NCT01517373|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22418423|NCT01963143|Bio Products Laboratory|Head of Medical Information|+44 (0)20 8957 2200|medinfo@bpl.co.uk|
22418424|NCT00851318|Astellas Pharma Inc.|Medical Director, Global Medical Sciences||ClinicalTrials.Disclosure@astellas.com|
22418425|NCT00176423|Maryland Psychiatric Research Center|Robert W. Buchanan, M.D.|410-402-7876|rbuchanan@som.umaryland.edu|
22418426|NCT01090752|University Hospital Geneva and Lausanne, Switzerland|Zanchi Anne, MD|0041213140775|azanchidel@hotmail.com|
22418427|NCT03597529|Director, Child and Adolescent Headache Program, UCSF Benioff Children's Hospitals|Dr. Amy A. Gelfand|415-502-1914|Amy.Gelfand@ucsf.edu|
22418428|NCT03769714|Maimonides Medical Center|Pedram Bral, MD|7182836000|pbral@maimonidesmed.org|
22418429|NCT00997204|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22431676|NCT02359006|Yale University|Dr. Mehmet Sofuoglu|203-932-5711|mehmet.sofuoglu@yale.edu|4809
22418430|NCT01755767|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22431677|NCT03376516|Octapharma AG|Sylvia Werner|604-1149|sylvia.werner@octapharma.com|+1 (201)
22418431|NCT00762931|electroCore LLC|Clinical Affairs electroCore LLC|+1 973 355 6683|clinical@electrocorellc.com|
22418432|NCT02196701|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22418433|NCT00673244|Department of Anesthesiology and Critical Care Medicine, George Washington University|Lakhmir S. Chawla|202-994-7903|minkchawla@gmail.com|
22418434|NCT01341782|Abbvie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22418435|NCT03796039|University of New Brunswick|Dr. Danielle Bouchard|(506) 443-3908|dboucha1@unb.ca|
22418436|NCT01140503|Stanford University Department of Dermatology|David Fiorentino|650-721-7160|fiorentino@stanford.edu|
22418437|NCT04314414|Boston Medical Center|Sabrina A Assoumou, MD MPH|(617) 414-5282|sabrina.assoumou@bmc.org|
22418438|NCT01157897|WRAIR|Donna Tosh|301-319-9332|donna.m.tosh.ctr@mail.mil|
22418439|NCT00681590|University of Miami|Dr. Silvina Levis|305-575-3388|slevis@miami.edu|
22418440|NCT01795105|KoreaOtsukaPharma|Jeong, Hyo-Won||jhw0159@otsuka.co.kr|
22418441|NCT01270724|Nationwide Children's Hospital|Megan Blue|614-722-3686|megan.blue@nationwidechildrens.org|
22418442|NCT01791153|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22418443|NCT02876926|Brown University School of Public Health|Dr. Tyler Wray|401-863-6659|tyler_wray@brown.edu|
22418444|NCT02562482|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Dr. Grace Chen, Deputy Chief, Clinical Trials Program, Vaccine Research Center|240-669-2809|grace.chen@nih.gov|
22418445|NCT04669691|Seqirus|Seqirus Clinical Trial Manager|1-855-358-8966|seqirus.clinicaltrials@Seqirus.com|
22418446|NCT04156620|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22418447|NCT03801382|Philips Research|Clinical product lead|+31646802217|daisy.van.minde@philips.com|
22418448|NCT00390221|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22418449|NCT01531738|Imperial College|Carel le Roux|07970719453|c.leroux@imperial.ac.uk|
22418450|NCT02351544|The Ohio State University|Dr. Jeffrey Janis|(614) 293-8566|jeffrey.janis@osumc.edu|
22418451|NCT02011386|Rigshospitalet, Denmark|Professor Mikkel Østergaard, MD, PhD, DMSc|+45 38633014|mo@dadlnet.dk|
22418452|NCT04555720|Duke University Medical Center|Kyle Mitchell, MD|919-668-2879|kyle.mitchell@duke.edu|
22418453|NCT00321737|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
22418454|NCT02283294|University of South Florida|David Rose, MD|813-259-8577|drose1@usf.edu|
22418455|NCT00633243|Yale University|R. Douglas Bruce|(203) 737-6133|robert.bruce@yale.edu|
22418456|NCT02799095|Mural Oncology, Inc.|Study Director|+1 (781) 614-0100|clinicaltrials@muraloncology.com|
22418457|NCT04994483|Cassava Sciences, Inc.|Study Director|737-910-1045|ClinicalTrials.gov@cassavasciences.com|
22418458|NCT00759902|Actavis Inc.|Meena Venugopal, Director, Clinical R&D|908-659-2885|MVenugopal@actavis.com|
22418459|NCT02903030|Nisonger Center|Dr. L. Eugene Arnold, MD, MED. Professor Emeritus College of Medicine|614-685-6701|l.arnold@osumc.edu|
22418460|NCT01404923|Laboratoires Mayoly Spindler|Clinical trials Manager|33 134805555|contact_essais_cliniques@mayoly-spindler.fr|
22418461|NCT04773301|Complejo Asistencial Universitario de Salamanca - Instituto de Investigación Biomédica de Salamanca (IBSAL)|Dr. Agustín Díaz Álvarez|0034 923291353|adiazal@saludcastillayleon.es|
22418462|NCT00945100|Jaeb Center for Health Research|Ray Kraker, M.S.P.H., Director of PEDIG Coordinating Center|(813) 975-8690|rkraker@jaeb.org|
22418463|NCT03700385|FARAPULSE, Inc.|Christopher (Kit) Schneider Sr. Director of Clinical & Pre-Clinical Engineering|617-686-7661|kschneider@farapulse.com|
22418464|NCT00699283|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22418465|NCT03047629|Enterin|Dr. Richard Larson, Chief Medical Officer|5054692670|l.larson@enterininc.com|
22418466|NCT02684630|Terumo BCT, Inc.|Heather Pidcoke, MD, PhD|(303) 231-4805|Heather.Pidcoke@terumobct.com|
22418467|NCT04590040|UT Health San Antonio|Bennett Amaechi BDS, MD, PhD|210 567 3185|amaechi@uthscsa.edu|
22418468|NCT01531439|Children's Mercy Hospital|Dr Ben Pieters|816-234-3464|bjpieters@cmh.edu|
22418469|NCT00000378|New York State Psychiatric Institute|Steven Roose MD|646-774-8661|spr2@columbia.edu|
22418470|NCT02813265|Kala Pharmaceuticals, Inc|VP, Clinical Development|(781) 996-5252|Results006@kalarx.com|
22418471|NCT03376061|Population Health Research Institute|Research assistant|19055212100|Austin.Browne@phri.ca|40582
22418472|NCT01284361|Hollister Incorporated|Malford Cullum PhD/Sr Clin Res Scientist|847-918-3975|malford.cullum@hollister.com|
22418473|NCT04247100|Virginia Commonwealth University|Gisela Chelimsky, MD|804-628-4859|gisela.chelimsky@vcuhealth.org|
22418474|NCT00805675|Novartis Pharmaceuticals|Study Director|862-778-8300||
22418475|NCT01806571|Mayo Clinic|Aref Al-Kali, M.D.|(507) 538-0591|alkali.aref@mayo.edu|
22418476|NCT02771795|Samsung Bioepis Co., Ltd.|Director of Clinical Trials|+82-32-728-0371|sbregistry@samsung.com|
22418477|NCT02198183|Hospital for Special Surgery, Anesthesiology|Dr Jacques Yadeau|2126061036|Yadeauj@hss.edu|
22418478|NCT01957397|Coloplast A/S|Birte Petersen Jakobsen, MD|+45 4911 1395|dkbir@coloplast.com|
22418479|NCT00505375|Benaroya Research Institute|Carla Greenbaum||cjgreen@benaroyaresearch.org|
22418480|NCT02906930|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22418481|NCT00540293|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22418482|NCT03537599|The Ohio State University Comprehensive Cancer Center|Dr. Sumithira Vasu|614-293-9869|Sumithira.Vasu@osumc.edu|
22418483|NCT04713553|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
22418484|NCT01682863|Novartis Pharmaceuticals|Study Director|862-778-8300||
22418485|NCT00977379|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22418486|NCT00918138|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22418487|NCT03972163|UMass Chan Medical School|Dr. Jennifer Tjia, Principal Investigator|774-455-3538|jennifer.tjia@umassmed.edu|
22418488|NCT01199471|Abbott|Global Medical Services|800-633-9110||
22418489|NCT04540406|Notitia Biotechnologies|Clinical Research Associate|732-230-3175|ciarra.williams@notitiabio.com|
22418490|NCT04053465|University at Buffalo|Dr. Riana Pryor|7168295456|rpryor@buffalo.edu|
22418491|NCT02085135|Alkermes|Eva Stroynowski|781-609-7000|eva.stroynowski@alkermes.com|
22418492|NCT01265433|Sellas Life Sciences|Dr. Dragan Cicic|646-200-5278|info@sellaslife.com|
22418493|NCT01212588|IndianaU|Dr. Alan Breier|317-880-8495|abreier@iupui.edu|
22418494|NCT02885181|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22408694|NCT03681769|Medical University of South Carolina|Dr. Jeff Borckardt|843-792-3295|borckard@musc.edu|
22408695|NCT03526549|Endo Pharmaceuticals|Clinical Operations|1-800-462-3636|ClinicalTrials@Endo.com|
22408696|NCT05984784|Inmagene LLC|Clinical Trials Lead|(858) 345-6927|ClinicalTrials@imagenebio.com|
22408697|NCT01510704|Acacia Pharma Ltd|Dr Gabriel Fox||gabrielfox@acaciapharma.com|
22408698|NCT02980666|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22408699|NCT03253809|Cleveland Clinic|Dr. Mark Neibauer|216-444-3160|niebaum@ccf.org|
22408700|NCT03056456|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22408701|NCT04637815|RAND|David P. Kennedy|3104673904|davidk@rand.org|6133
22408702|NCT00455923|GlaxoSmithKline|GSK Response Center|866-435-7343||
22408703|NCT02353572|University of Colorado|Choon-kee Lee, MD|7208489252||
22408704|NCT03099655|Medtronic|Erika Pouliot|+17635261270|erika.pouliot@medtronic.com|
22392309|NCT02548078|GlaxoSmithKline|GSK Response Center|866-435-7343|aal77632@gsk.com|
22408705|NCT03715335|Cincinnati Children's Hospital Medical Center|Dr. Jennifer Reed|(513) 636-7966|jennifer.reed@cchmc.org|
22408706|NCT02234427|Johns Hopkins School of Medicine|Rehan Qayyum|410-955-7781|rqayyum@jhmi.edu|
22408707|NCT02686749|Cleveland Clinic|Oussama Wazni, MD|216-444-2131|waznio@ccf.org|
22408708|NCT01244516|Johnson & Johnson Vision Care|Kathy Osborn, OD|1-904-443-1032|KOsborn@its.jnj.com|
22408709|NCT00941681|Cytokinetics, Inc.|Project Manager|650-624-2918||
22408710|NCT04762771|baptist health south florida|Raul Herrera, MD (Director Miami Cardiac & Vascular Institute)|786-596-7609|RaulH@BaptistHealth.net|
22408711|NCT00483119|NYU School of Medicine|Elise Kelman, Associate Director of Research Administration|2122639073|elise.kelman@nyumc.org|
22408712|NCT04409509|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
22408713|NCT04668066|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22408714|NCT02369874|AstraZeneca|Nassim Morsli|+44 7384 520046|nassim.morsli@astrazeneca.com|
22408715|NCT02331680|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366||
22408716|NCT00596466|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22408717|NCT04505592|Icahn School of Medicine at Mount Sinai|Dr. Hooman Poor|(212) 241-5656|hooman.poor@mountsinai.org|
22392310|NCT01040169|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
22408718|NCT04190056|University of California, San Francisco|Dr. Pamela Munster, MD|(415) 502-3598|pamela.munster@ucsf.edu|
22408719|NCT04479358|University of Chicago|Pankti Reid, MD|7737021220|pankti.reid@bsd.uchicago.edu|
22418495|NCT02971735|Linkou Chang Gung Memorial Hospital|Dr. Li-Ang Lee|886 33281200|5738@cgmh.org.tw|3972
22418496|NCT02651259|Family Health International (FHI 360|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22418497|NCT00742924|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org|
22418498|NCT01025453|Memorial Sloan Kettering Cancer Center|Dr. Eric Sherman, MD|646-888-4234|shermane@mskcc.org|
22418499|NCT03149445|Saniona A/S|Janus Schreiber Larsen|+457070 5225|janus.larsen@saniona.com|
22418500|NCT02699060|IMSechenovMMA|MD, PhD Ivashkin Vladimir Trofimovich|+79252667987|motility_2013@mail.ru|
22418501|NCT03490760|Miami Cancer Institute at Baptist Health, Inc.|Michael Chuong, M.D.|(786) 596-2000|michaelchu@baptisthealth.net|
22418502|NCT04916444|University of Florida Norman Fixel Institute for Neurological Diseases|Dr. Jun Yu|352-294-5400|jun.yu@neurology.ufl.edu|
22418503|NCT03303196|Children's Hospital of Philadelphia|Lauren Mitteer|267-426-9915|MitteerL@email.chop.edu|
22418504|NCT05005312|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22418505|NCT01283035|DFCI|Joyce Liu, MD, MPH|617-632-5269|joyce_liu@dfci.harvard.edu|
22418506|NCT06077149|University of Rochester|Ann Falsey, MD|585-922-4339|Ann_Falsey@URMC.Rochester.edu|
22418507|NCT04658095|Sight Sciences, Inc.|VP, Medical and Clinical Affairs|877-266-1144|jdickerson@sightsciences.com|
22418508|NCT01441947|Massachusetts General Hospital|Steven Isakoff, MD, PhD|617-643-5415|sisakoff@partners.org|
22418509|NCT02143973|Trevi Therapeutics|Thomas Sciascia, MD|203-304-2499|thomas.sciascia@trevitherapeutics.com|
22418510|NCT02970318|Astrazeneca Clinical Trial|Study Director|1-888-292-9613|information.center@astrazeneca.com|
22418511|NCT03384654|Janssen-Cilag International NV|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22418512|NCT01616953|University of Michigan|Dr. Darnell Kaigler|734-615-4023|dkaigler@umich.edu|
22431678|NCT01581684|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22431679|NCT02986074|Abbott|Yagna Pathak|+1-469-243-0088|yagna.pathak@abbott.com|
22431680|NCT01444911|University of Wisconsin Carbone Cancer Center|Dr. David Kushner|608-263-1210|dmkushner@facstaff.wisc.edu|
22408720|NCT03810417|University of Maryland|Stephen Gottlieb, MD|410-328-7877|sgottlie@som.umaryland.edu|
22408721|NCT00953173|Apollo Endosurgery Inc|Director of Clinical Affairs|512-279-5157|jose.naveira@apolloendo.com|
22408722|NCT01085331|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22408723|NCT05487625|Fralin Biomedical Research Institute at VTC|Roberta Freitas Lemos|540 526 2106|rflemos@vtc.vt.edu|
22408724|NCT04103645|Weill Cornell Medicine|Joseph Scandura, MD|(212) 746-2072|jms2003@med.cornell.edu|
22408725|NCT00056472|Weill Cornell Medical College|Barnett S. Meyers, MD|914-997-5721|bmeyers@med.cornell.edu|
22408726|NCT01958619|Medicines for Malaria Venture (MMV)|Dr Thomas Rueckle PhD|+41 22 799 4567|ruecklet@mmv.org|
22408727|NCT03795233|Boston Medical Center|Tamar Barlam, MD MSC|617 414 5190|tamar.barlam@bmc.org|
22408728|NCT02756182|Laborie|Clinical Research Manager|9056121170|sgallone@laborie.com|1755
22408729|NCT03225313|Theodor Bilharz Research Institute|Dr Muhammed Hussein|00201001434459|muhamed.hussein@gmail.com|
22408730|NCT01965600|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22408731|NCT03826771|Medical University of South Carolina|Chris Gregory|843-792-1078|gregoryc@musc.edu|
22408732|NCT05267652|Vanderbilt University Medical Center|Jonathan D Casey, MD, MSc|615-875-4681|Jonathan.d.Casey@vumc.org|
22431681|NCT02239926|Mayo Clinic|Dr. Yuri Saito Loftus|507-255-3680|saito.yuri@mayo.edu|
22431682|NCT01766102|Massachusetts General Hospital|Michelle Specht, MD|617-726-0340|MSPECHT@mgh.harvard.edu|
22431683|NCT00598650|Eisai Co., Ltd.|Masaki Nakagawa|+81-3-3817-5245||5245
22418513|NCT02036775|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22418514|NCT04058249|Stanford University|Protocol Director|650-800-6920|brainstimulationstudy@stanford.edu|
22418515|NCT04181723|Acadia Pharmaceuticals Inc.|Study Director|844-422-2342|medicalinformation@acadia-pharm.com|
22418516|NCT03496610|Duke University|Hector F. Martinez-Wilson, MD, PhD|919-681-6437|hector.martinez-wilson@duke.edu|
22418517|NCT00426361|GlaxoSmithKline|GSK Response Center|866-435-7343||
22418518|NCT01408628|University of Kansas Medical Center|Virginia Lewis|913-588-2097|vlewis@kumc.edu|
22418519|NCT01970865|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22418520|NCT01629966|Forest Research Institute, Inc|Therapeutic Area Head|877-277-8566|IR-CTRegistration@allergan.com|
22418521|NCT01150890|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22418522|NCT03118570|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
22418523|NCT01672970|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22418524|NCT01997229|Alexion Pharmaceuticals, Inc.|Jing-Jing Wang, MD|+1 (475) 230-2596|JingJing.Wang@alexion.com|
22418525|NCT04568031|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22418526|NCT04430855|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22418527|NCT00186043|Bipolar and Depression Research Program, Stanford University, School of Medicine, VA Palo Alto Health Care System|Trisha Suppes MD, PhD|6504962567|tsuppes@stanford.edu|
22418528|NCT04874636|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22418529|NCT01362127|Karolinska Institutet|Fredrik Klevebro|+46858580000|fredrik.klevebro@ki.se|11111
22418530|NCT01233921|Fred Hutchinson Cancer Research Cetner|Dr. Paul J. Martin|206-667-4798|pmartin@fhcrc.org|
22418531|NCT01666197|Novartis Consumer Health SA|Clinical Project Leader|41223635293||
22418532|NCT00771745|University of Cincinnati|Dr. Rita Alloway|513-558-1568|Rita.Alloway@uc.edu|
22418533|NCT00620659|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22431684|NCT01628913|Novartis Pharmaceuticals|Study Director|862-778-8300||
22431685|NCT00508521|Malcom Randall VA Medical Center, Gainesville Florida|Janis Daly, Ph.D., M.S.; Director, Brain Rehabilitation Research Center|(352) 376-1611|janis.daly@neurology.ufl.edu|6603
22418534|NCT01709838|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22431686|NCT01622296|UCSF School of Dentistry|Dr. Susan Parveen Tavana|415-476-1891|susan.tavana@ucsf.edu|
22392311|NCT02171247|Duke University Medical Center|Daniel T Boll, MD|919-684-2711|daniel.boll@duke.edu|
22408733|NCT07002632|University of Health Sciences, Gaziosmanpasa Training and Research Hospital|Ethem ilhan, MD|+90 505 591 86 50|ethem.ilhan@sbu.edu.tr|
22408734|NCT01100073|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22408735|NCT00299546|Centocor Research & Development, Inc.|Associate Director Clinical Research|1-800-457-6399||
22408736|NCT01605539|Icahn School of Medicine at Mount Sinai|Yasmin Hurd, PhD|212-824-9314|yasmin.hurd@mssm.edu|
22408737|NCT01656850|Taipei Medical University|Liu, Jen-Fang|+886-3-2118999|liujenfa@mail.cgust.edu.tw|5487
22408738|NCT00326118|GlaxoSmithKline|GSK Response Center|866-435-7343||
22408739|NCT00630994|Mayo Clinic|Dr. Ruben A. Mesa|507-284-2511|mesa.ruben@mayo.edu|
22408740|NCT01064830|University of North carolina-Chapel Hill|Aida Lugo-Somolinos MD|919-843-9447|alugosom@med.unc.edu|
22408741|NCT05553600|Kimberly-Clark Corporation|Jin Zhang|770-587-8000|jin.zhang@kcc.com|
22418535|NCT02352779|University of Rochester Medical Center|Luke J. Peppone, PhD, MPH. Assistant Professor|585-275-7827|Luke_Peppone@urmc.rochester.edu|
22418536|NCT00529282|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Clincal Team Lead|908 927-3785||
22418537|NCT00968799|Cantonal Hospital St.Gallen|Sascha Müller, MD|+41 71 494 1317|ulrich.beutner@kssg.ch|
22408742|NCT00750373|Asan Medical Center|Dr. Duk-Hyun Kang|82-2-3010-3149|dhkang@amc.seoul.kr|
22408743|NCT05027958|Division of Intramural Research, NHLBI|Kevin P. Fennelly, M.D., MPH, ATSF|301-385-0807|kevin.fennelly@nih.gov|
22408744|NCT03155269|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22392312|NCT05239598|Penn Dental Medicine|Dr. Pat Corby|215-898-1162|patcorby@upenn.edu|
22392313|NCT02592707|Ipsen Pharma|Medical Director|see email|clinical.trials@ipsen.com|
22392314|NCT02222870|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22392315|NCT04855734|Children's National Hospital|Dr. Maureen E. Lyon, Clinical Health Psychologist, Professor of Pediatrics|703-346-2873|mlyon@childrensnational.org|
22392316|NCT03832595|University of Pittsburgh|Dr. Manisha Jhamb|4126477062|jhambm@upmc.edu|
22392317|NCT03277352|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22392318|NCT03790306|Genesee Orthopedic & Hand Surgery Associates, P.C.|Andrew Wickline, MD|315-735-4496|awickline23@gmail.com|
22392319|NCT03746509|University of Minnesota|Juergen Konczak|612-624-4370|jkonczak@umn.edu|
22392320|NCT03733990|Faron Pharmaceuticals Ltd|Chief Medical Officer|+35824695151|info@faron.com|
22392321|NCT05577715|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22392322|NCT04414202|INSTITUT REGIONAL DU CANCER DE MONTPELLIER Cancer de Montpellier|Mme Aurore Moussion, Director of Direction of Clinical Research and Innovation|0467613102|drci-icm105@icm.unicancer.fr|+33
22392323|NCT03317990|University College London|Professor Greg Shaw|+44 (0)20 7679 2000|ncita.neurosafe@ucl.ac.uk|
22392324|NCT01656252|ECOG-ACRIN Biostatistics Center|PrECOG Statistician|617-632-3633|jmanola@jimmy.harvard.edu|
22392325|NCT00626197|F. Hoffmann-La Roche Ltd/Genentech Inc.|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22392326|NCT04339959|University of New Mexico|Dr. Cindy Blair|15059257907|CiBlair@salud.unm.edu|
22392327|NCT05332912|University of Alabama, Tuscaloosa|Professor Emeritus|2052002183|emerrill@ua.edu|
22392328|NCT05530577|University of Southern California|Christian Hendershot, PhD|323-442-1082|christian.hendershot@usc.edu|
22392329|NCT01174446|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22392330|NCT00929253|Virginia Tech|Dr. Warren K. Bickel|540-526-2015|wkbickel@vt.edu|
22392331|NCT00847626|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22392332|NCT03301155|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22392333|NCT02769442|University of Maryland School of Medicine, Department of Emergency Medicine|Siamak Moayedi Md|4103288025|smoayedi@em.umaryland.edu|
22392334|NCT03510455|National Institute of Dental and Craniofacial Research|Rachel I. Gafni|301-594-9924|gafnir@mail.nih.gov|
22392335|NCT00168389|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22392336|NCT00384189|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22392337|NCT04958642|Mandos, LLC|Executive Vice President, Regulatory Affairs|619-905-0489|jspinella@mandoshealth.com|
22392338|NCT02942004|Sage Therapeutics|Medical Monitor|617-299-8380|info@sagerx.com|
22392339|NCT05627258|Vaccine Research Center Clinical Trials Program, NIAID|Lesia K. Dropulic, M.D./Principal Investigator; Laura Novik, R.N., M.A./Study Coordinator|301-451-8717|lesia.dropulic@nih.gov; laura.novik@nih.gov|
22392340|NCT04517669|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov.Inquiries@pfizer.com|
22392341|NCT02138786|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
22392342|NCT01923662|VAORD|Ronald J Triolo|216-791-3800|Ronald.Triolo@va.gov|64138
22392343|NCT01199068|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22392344|NCT05048238|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22392345|NCT03289351|Phoenix Children's|Dr. Justin Lee|6029330016|jlee8@phoenixchildrens.com|
22408745|NCT02871921|MGH|Dr. Hiroko Dodge, Director of Research Analytics|724-494-3605|hdodge@mgh.harvard.edu|
22408746|NCT00910000|Dana-Farber Cancer Institute|Ursula Matulonis, MD|617-632-2334|umatulonis@partners.org|
22408747|NCT04369885|University of North Carolina at Chapel Hill|Michael B Drummond, MD|919-966-7054|brad_drummond@med.unc.edu|
22408748|NCT00337727|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22408749|NCT02511587|Medical University of Vienna|Univ.-Prof. Dr. Ursula Wiedermann|0043 1 40160 38291|ursula.wiedermann@meduniwien.ac.at|
22408750|NCT03107442|FIBAO|Dr José Antonio Vargas-Hitos|625943933|joseantoniovh@hotmail.com|+34
22408751|NCT04456998|GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.|GB002, Inc. Study Director|1-866-668-4083|ClinicalTrials@gossamerbio.com|
22408752|NCT02080273|Colgate Palmolive Company|Maria Ryan|732-878-7766|maria_ryan@colpal.com|
22408753|NCT03707145|Aberystwyth University|Dr Marco Arkesteijn|+44(0)1970628559|maa36@aber.ac.uk|
22408754|NCT04221477|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22408755|NCT04784455|Akari Therapeutics|Chief Scientific Officer|+44 208 004 0261|miles.nunn@akaritx.com|
22408756|NCT04882085|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22408757|NCT04455620|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
22408758|NCT00965562|Donaghue Medical Research Foundation|Dr. Kimberly Yonkers|1-203-764-6621|Kimberly.Yonkers@yale.edu|
22408759|NCT05681715|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22408760|NCT05455684|Janssen Research and Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22408761|NCT05204563|Evopoint Biosciences USA, Inc.|Evopoint Biosciences|646-750-2661|info@evopointbio.com|
22408762|NCT05643573|Bayer AG|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
22408763|NCT04678440|University of California Davis|Simon Cherry|(530) 754-9419|srcherry@ucdavis.edu|
22408764|NCT00457795|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22392346|NCT01370655|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22392347|NCT05214378|Cleveland Department of Veterans Affairs|Dennis Bourbeau|216-791-3800|dennis.bourbeau@va.gov|
22392348|NCT03882177|Johns Hopkins University School of Medicine|Petros C. Karakousis, MD|410-502-8233|petros@jhmi.edu|
22408765|NCT02268214|AstraZenenca|Anna Maria Langkilde|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
22408766|NCT02951130|UC Davis School of Medicine|Satyan Lakshminrusimha|916 734 5178|slakshmi@health.ucdavis.edu|
22408767|NCT04813484|University of Michigan|Kristi Gamarel|7346473178|kgamarel@umich.edu|
22408768|NCT02500732|University of Calgary|Dr. Satish R Raj|403-210-6152|satish.raj@ucalgary.ca|
22408769|NCT03378921|Department of Gastrointestinal surgery, Helsinki University Hospital|Dr. Essi Karjalainen|+358504621853|essi.karjalainen@hus.fi|
22408770|NCT03677440|Kessler Foundation|Brian Sandroff, PhD|973-965-6649|bsandroff@kesslerfoundation.org|
22408771|NCT01710839|Retina Consultants of Houston|Charles C Wykoff, PhD, MD|713-524-3434|ccwmd@houstonretina.com|
22408772|NCT02008396|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
22408773|NCT01233284|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22408774|NCT03759340|Aclaris Therapeutics, Inc.|Marco Cardillo, Clinical Trial Manager|484-540-6299|mcardillo@aclaristx.com|
22408775|NCT01652040|Hunter Holmes McGuire VA Medical Center|Ashraf S. Gorgey|8046755000|ashraf.gorgey@va.gov|3386
22408776|NCT03832907|Emory University|Dr. Umpierrez|404-778-1665|geumpie@emory.edu|
22408777|NCT01869959|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22408778|NCT05405218|Sonex Health, Inc.|Amy Stegner, Vice President Clinical Affairs|(888) 518-8780|astegner@sonexhealth.com|
22418538|NCT01540773|Pennington Biomedical Research Center|Dr. Frank Greenway, Chief of Outpatient Clinic|225-763-2578|Frank.Greenway@pbrc.edu|
22418539|NCT00719849|Fred Hutchinson Cancer Research Center|Dr. Colleen Delaney|2066671385|cdelaney@fredhutch.org|
22418540|NCT06219278|Candela|Katherine Coleman|508-358-7400|katherinec@candelamedical.com|28533
22418541|NCT03867097|CiVi Biopharma, Inc.|Chief Executive Officer|301-968-2390|sj@civibio.com|
22418542|NCT00389831|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22418543|NCT01398943|Augusta University|Ryan Harris, Ph.D.|706-721-5998|ryharris@augusta.edu|
22418544|NCT00594646|Fenway Health|Dr. Kenneth Mayer|617-927-6400|kmayer@fenwayhealth.org|
22418545|NCT03907462|University of California, San Diego|Dr. Job Godino|6195152344|jobg@fhcsd.org|2344
22418546|NCT00663026|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22418547|NCT04003896|Penn State Health|Dr. Nelson Yee|7175310003|nyee@pennstatehealth.psu.edu|280677
22418548|NCT02026687|Dept of anaesthesia, Linköping University Hospital, Sweden|Dr Lena Nilsson|0046101030000|lena.nilsson@regionostergotland.se|
22418549|NCT00806286|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22418550|NCT02006693|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22418551|NCT03151408|Helsinn Healthcare SA|Francesco Scarci|+41 (0)91 985 1946|francesco.scarci@helsinn.com|
22418552|NCT00265395|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22418553|NCT03400943|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
22418554|NCT03317834|Smith+Nephew, Inc.|Helena Kyriakou|+1 8186995700|Helena.Kyriakou@smith-nephew.com|
22418555|NCT05084716|RAND|Laura Bogart|3103930411|lbogart@rand.org|
22418556|NCT03839823|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22418557|NCT01716715|NRG Oncology|Linda Gedeon on behalf of Michael Sill, PhD.|716-845-1169|lgedeon@gogstats.org|
22418558|NCT00660400|H. Lee Moffitt Cancer Center and Research Institute|Teresa Field, M.D., Ph.D.|813-745-7202|teresa.field@moffitt.org|
22418559|NCT01161407|Purdue University|Kathleen M. Hill Gallant|765-494-0101|hillgallant@purdue.edu|
22418560|NCT01777620|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22418561|NCT04562155|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22418562|NCT02701270|Danisco Sweeteners Oy|Kirsti Tiihonen|+358 10 431 050|kirsti.tiihonen@dupont.com|
22418563|NCT00952211|UCSD|Dr. Joel Dimsdale||jdimsdale@ucsd.edu|
22418564|NCT05594264|University of Delaware|Dr. Yendelela Cuffee|(302) 831-1302|ylcuffee@udel.edu|
22418565|NCT04005352|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22418566|NCT00849186|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22418567|NCT06017479|Department of Urology, Faculty of Medicine University of Indonesia - Cipto Mangunkusumo General Hospital|Prof. dr. Harrina Erlianti Rahardjo, Sp.U(K), PhD|+62 816-825-226|harrinaerlianti@gmail.com|
22418568|NCT00936897|Amgen Inc.|Study Director|866-572-6436||
22418569|NCT04058067|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22418570|NCT00417170|Novartis Pharmaceuticals|Study Director|862-778-8300||
22418571|NCT02287818|TWi Biotechnology Inc.|JingYi Lee|886-2-26571788|jingyi.lee@twibiotech.com|201
22418572|NCT01001988|Sanofi Pasteur|Medical Director|800-633-1610|RegistryContactUS@sanofi.com|
22418573|NCT04628793|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22418574|NCT02315430|NRG Oncology|Linda Gedeon on behalf of William Brady, PhD|716-845-1169|lgedeon@gogstats.org|
22418575|NCT00613886|University of California, Irvine|Chris Nishi Clinical Trials Coordinator|949-824-3238|cnishi@uci.edu|
22392349|NCT00509249|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22408779|NCT02711306|Taipei Medical University|Dr. Sing-Chung Li|886-2-27361661|sinchung@tmu.edu.tw|6560
22408780|NCT01255449|IRCCS Azienda Ospedaliera Universitaria San Martino IST - Genova, Italy|Dr. Giovanni Barisione|+39010555|giovanni.barisione@hsanmartino.it|3367
22408781|NCT01979029|First Hospital of Jilin University|Jian Suo|0431-88785605|suojian42@hotmail.com|
22408782|NCT02996266|Becton, Dickinson and Company|Director, Global Clinical Affairs - Urology and Critical Care|9733077325|kirsten.hammitt@bd.com|
22408783|NCT00710840|University of Colorado Denver, Anschutz Medical Center|Dr. Jennifer Stevens-Lapsley|303-724-9170|Jennifer.Stevens-Lapsley@ucdenver.edu|
22408784|NCT00157820|Hospital General Universitario de Valencia, Spain|Dr.A.Quesada||aquesadad@secardiologia.es|
22408785|NCT01676818|USC/Norris Comprehensive Cancer Center|Tali Homsey|(323) 865-0451|tali.homsey@med.usc.edu|
22408786|NCT06768658|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22408787|NCT03548454|Stanford University|Dr. Vafi Salmasi|650-725-0246|vsalmasi@stanford.edu|
22408788|NCT01600677|UPittsburgh|Steven M. Handler, MD, PhD|412-864-1878|handler@pitt.edu|
22408789|NCT02899884|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22408790|NCT02207413|GlaxoSmithKline|GSK Response Center|866-435-7343||
22408791|NCT04075656|Emory University|Chia-shi Wang, MD, MS|404-727-5728|chia-shi.wang@emory.edu|
22408792|NCT01519635|Service of Nephrology, Centre Hospitalier Universitaire Vaudois, Lausanne|Prof Michel Burnier|+41 21 314 11 54|michel.burnier@chuv.ch|
22408793|NCT00347776|Johns Hopkins University|Sheila K West|410 955 2606|shwest@jhmi.edu|
22408794|NCT00968539|GlaxoSmithKline|GSK Response Center|866-435-7343||
22408795|NCT03724422|University of Louisville|Salwa Rashid|5028526964|salwa.rashid@louisville.edu|
22408796|NCT02074982|Novartis Pharmaceuticals|Study Director|862-778-8300||
22418576|NCT05502081|Mansoura University Hospital|Dr. Ahmed Hosny|+2001554658010|ahmedony26@gmail.com|+200115584
22408797|NCT03065517|Evidence-Based Practice Institute, Inc.|Angela Kelley Brimer|253-279-8659|research@jasprhealth.com|
22418577|NCT00462124|BioProtect|Galit Itzhaki|+972-9-7731929|galit@bioprotect.co.il|
22408798|NCT03305159|Northwestern University Feinberg School of Medicine|Supriya Rastogi|supriya.rastogi@northwestern.e|supriya.rastogi@northwestern.edu|
22418578|NCT01329549|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22418579|NCT00191165|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22418580|NCT03200912|Teva Pharmaceuticals Inc. USA|Senior Director, CE Studies|1-888-483-8259|USMedInfo@tevapharm.com|
22418581|NCT03196635|GE Healthcare|Sara Lam|262-548-2369|sara.j.lam@ge.com|
22418582|NCT01316315|N30 Pharmaceuticals Inc.|Janice M. Troha|720-945-7714|janice.troha@n30pharma.com|
22418583|NCT00998309|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22418584|NCT03421730|Vectura Limited|Gary Burgess, MD|+44 (0)1249 667700|clinical.enquiries@vectura.com|
22418585|NCT02865460|Miami VA Healthcare System|Nancy Klimas, MD|305-575-7000|nancy.klimas@va.gov|1-4800
22418586|NCT00555152|University of Texas (UT) MD Anderson Cancer Center|Powel H. Brown, MD/Chair, Clinical Cancer Prevention||CR_Study_Registration@mdanderson.org|
22418587|NCT00258128|Joslin Diabetes Center|Allison B. Goldfine, MD|617-309-2400|allison.goldfine@joslin.harvard.edu|
22418588|NCT00901576|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22418589|NCT01696279|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22418590|NCT00171951|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22418591|NCT01661062|University of Michigan Comprehensive Cancer Center|Avraham Eisbruch, M.D.|734-936-4302|eisbruch@umich.edu|
22418592|NCT05788289|Memorial Sloan Kettering Cancer Center|Dr. Anita Kumar, MD|646-608-3780|kumara2@mskcc.org|
22418593|NCT03490344|Memorial Sloan Kettering Cancer Center|Dr. Sham Mailankody, MBBS|646-608-3712|mailanks@mskcc.org|
22418594|NCT04154631|Department of Psychology, University of California, Berkeley|Professor of Clinical Psychology|5104736490|aharvey@berkeley.edu|
22418595|NCT02238795|Jena University Hospital, Center for Clinical Studies|Prof. Dr. Frank M. Brunkhorst|+49 3641 939|frank.brunkhorst@med.uni-jena.de|6687
22418596|NCT02174432|Trevi Therapeutics|Thomas Sciascia, MD|203-304-2499|thomas.sciascia@trevitherapeutics.com|
22418597|NCT05187013|George Washington University|Ramin Asgary|(202) 994-6803|raminasgary1@gwu.edu|
22418598|NCT04823975|Huntsman Cancer Institute|Anne Kirchhoff|801-587-4084|Anne.Kirchhoff@hci.utah.edu|
22418599|NCT01096368|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22418600|NCT05407714|BSC International Medical Trading (Shanghai) Co., Ltd|Associate Clinical Trial Manager|+13671646036|junyang.bai@bsci.com|
22418601|NCT01568320|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
22408799|NCT04476654|Virginia Commonwealth University|Dr. Vanessa Sheppard|804-828-8892|vlbsheppard@vcu.edu|
22408800|NCT02525627|Stryker EU Operations B.V. Herikerbergweg 110 1101 CM Amsterdam The Netherlands|Doug McGurty|+44 (0) 1635 500690|doug.mcgurty@stryker.com|
22408801|NCT01160770|Lundbeck LLC|Email contact via H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
22408802|NCT00242567|Novartis Pharmaceuticals|Study Director|862-778-8300||
22408803|NCT04305184|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|8008887704|astellas.resultsdisclosure@astellas.com|
22408804|NCT04928794|Anesthesiology Department, University of New Mexico|Anesthesiology Research Director|505-272-2610|HSC-Anesthesiology@salud.unm.edu|
22408805|NCT00005803|Fred Hutch|David G Maloney, MD PhD||dmaloney@fredhutch.org|
22408806|NCT00544778|City of Hope National Medical Center|Paul Frankel, Ph. D.|(626)359-8111|pfrankel@coh.org|65265
22408807|NCT00556972|Coloplast A/S|Thais Benjamin N. Christensen, Senior Clinical Project Manager|+4549112668|dkthc@coloplast.com|
22408808|NCT02116309|Johns Hopkins University|Dr. Vikesh Singh|4106146708|vakshin1@jhmi.edu|
22408809|NCT03292731|University of Pittsburgh|steve caritis|412 641 5256|scaritis@mail.magee.edu|
22408810|NCT00471237|GlaxoSmithKline|GSK Response Center|866-435-7343||
22408811|NCT00848965|GlaxoSmithKline|GSK Response Center|866-435-7343||
22408812|NCT00348348|Bausch & Lomb Incorporated|Timothy Comstock|(585) 338-6631|timothy.comstock@bausch.com|
22408813|NCT03710824|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
22408814|NCT02951182|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22408815|NCT03112720|RWJMS/Rutgers Health|william grubb md|732 235 7827|grubbwr@rwjms.rutgers.edu|
22408816|NCT02525575|Department of Veteran Affairs|Marianne Goodman, MD|718-584-9000|Marianne.Goodman@va.gov|5188
22408817|NCT01301625|Abbott Vascular|Jeffrey T. Ellis|(408) 845-8184|jeffrey.ellis@av.abbott.com|
22408818|NCT02686437|Sport and Spine Rehab Clinical Research Foundation|Jena Etnoyer-Slaski|301-251-2777|jslaski@ssrehab.com|838
22408819|NCT01993238|Solta Medical|Director of Clinical Programs|510-259-5284|aloncaric@solta.com|
22408820|NCT00615927|Duke University Medical Center|Annick Desjardins, MD, FRCPC|919-668-|annick.desjardins@dm.duke.edu|
22408821|NCT05102162|University of Florida College of Pharmacy|Nicole Maranchick|352-273-6803|n.maranchick@cop.ufl.edu|
22408822|NCT00029107|NIAID/NIH|Michael C Sneller, MD|301-496-0491|msneller@niaid.nih.gov|
22408823|NCT02181673|Janssen Research & Development, LLC|Senior Director Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
22408824|NCT00320801|Purdue Pharma L.P.|Clinical Leader, Executive Medical Director|800-733-1333||
22408825|NCT00491322|Massachusetts General Hospital|Dr. Sherri-Ann M. Burnett-Bowie|6177245594|sburnett-bowie@mgh.harvard.edu|
22408826|NCT00517868|Vaneltix Pharma, Inc.|CEO|732-354-3217|info@vaneltix.com|
22408827|NCT06067191|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22408828|NCT00323362|Rutgers Cancer Institute of New Jersey|Dr. Joseph Aisner, MD|732-235-8675|aisnerjo@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
22408829|NCT02277548|University of Pennsylvania|Dr. Erin McMenamin|251-662-2428|Erin.McMenamin@pennmedicine.upenn.edu|
22408830|NCT00890409|Children's Hospital, Fudan University|Prof. Xiaomei Shao|86-21-64931913|zhou_wenhao@yahoo.com.cn|
22408831|NCT03733418|Vanderbilt University Medical Center|Dr. Jin Han|16159360253|jin.h.han@vumc.org|
22408832|NCT03664024|Merck Sharp and Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22408833|NCT01157065|Alcon Research, Ltd.|Mehdi Hosseini, Clinical Trial Manager|1-888-451-3937|alcon.medinfo@alcon.com|
22408834|NCT00318409|San Francisco Department of Public Health|Moupali Das, MD, MPH|415-437-6204|moupali.das@sfdph.org|
22408835|NCT02060188|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22408836|NCT03426995|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22408837|NCT01886105|Johns Hopkins University|Dr. Brian H. Ladle|443-287-3534|bladle@jhmi.edu|
22408838|NCT00389168|Karolinska Institutet, Stockholm, Sweden|Thomas Kahan, MD|+46 8 123 568 61|thomas.kahan@ds.se|
22408839|NCT00510497|University of Pittsburgh|Sharon A. Riddler, MD, MPH|412-383-1675|riddler@pitt.edu|
22408840|NCT03091478|Johns Hopkins Sidney Kimmel Comprehensive Cancer Center|Rachel Levy, MS, CCRP|410-502-8738|rlevy16@jhmi.edu|
22408841|NCT03075826|Weill Cornell Medical College|Dr.Pinkal Desai|646-962-2700|pid4006@med.cornell.edu|
22408842|NCT00003726|Dartmouth-Hitchcock Medical Center|James Rigas, MD|603-650-6344|james.r.rigas@hitchcock.org|
22408843|NCT00650806|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1 800 526 7736||
22408844|NCT02242942|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22408845|NCT05014672|Calliditas Therapeutics AB|Head of Clinical Operations|+4684113005|info@calliditas.com|
22408846|NCT04228107|University of Colorado|Heather De Keyser MD MSCS|720-777-4108|heather.dekeyser@childrenscolorado.org|
22408847|NCT03792633|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
22408848|NCT00145119|Medtronic Bakken Research Center|Director CRDM|+31 43 3566||566
22408849|NCT04411641|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
22408850|NCT04342390|Arkansas Children's Research Insitute|Emir Tas|4126928688|tase2@upmc.edu|
22408851|NCT04584294|VA Puget Sound Health Care System|Lisa Callegari (Principal Investigator)|206-277-3129|Lisa.Callegari@va.gov|
22418602|NCT03233230|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22408852|NCT03447015|Mutah University|Dr Reham Khresheh|0791425992|rehamkh@mutah.edu.jo|
22408853|NCT00318357|The University of Hull; Department of Cardiology; United Kingdom|John Cleland, Professor|Telephone: 0044 1482 624084||
22408854|NCT03205605|University of Maryland, Baltimore School of Pharmacy|Dr. Audra Stinchcomb|410-706-2646|astinchc@rx.umaryland.edu|
22408855|NCT01003691|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22408856|NCT01392469|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22408857|NCT01256086|University of Florida, Department of Pharmacotherapy and Tanslational Research, 100486 Gainesville, FL 32610|Prof. Dr. Leslie Hendeles|+1 352 279|hendeles@cop.ufl.edu|6027
22408858|NCT02056431|Kaiser Permanente Division of Research|Dr. Alyce S. Adams|510-891-5921|Alyce.S.Adams@kp.org|
22408859|NCT03443973|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22408860|NCT04930536|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22408861|NCT00267020|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22408862|NCT00704717|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22408863|NCT01245595|Stanford University Medical Center|Dr. David M. Axelrod|650-723-7913|daxelrod@stanford.edu|
22408864|NCT04292171|University of Nevada Las Vegas School of Medicine|Adam V. Levy MD|702-671-2300|adam.levy@unlv.edu|
22408865|NCT04465916|ENYO Pharma SA|Pietro Scalfaro|+33437700219|ps@enyopharma.com|
22408866|NCT02989623|Thomas Jefferson University|Mathew Thakur|215-503-7874|Mathew.Thakur@Jefferson.edu|
22408867|NCT01605370|Mayo Clinic|Marek Belohlavek, M.D., Ph.D.|408-301-6694|belohlavek.marek@mayo.edu|
22408868|NCT01317199|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Channing Paller|410-955-8239|cpaller1@jhmi.edu|
22408869|NCT01353209|University of Cincinnati|Susan McMahan, Clinical Research Manager|513-558-4831|Susan.mcmahan@uc.edu|
22408870|NCT02920866|University of Colorado Denver|Dr. Jennifer Stevens-Lapsley|303.724.9170|jennifer.stevens-lapsley@cuanschutz.edu|
22408871|NCT01312948|ResMed Ltd|Alison Wimms|+6188842583|alison.wimms@resmed.com.au|
22408872|NCT03237325|Soligenix, Inc.|Richard Straube, MD/Chief Medical Officer|609-538-8200|rstraube@soligenix.com|
22408873|NCT02684370|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22408874|NCT00212446|New York Downtown Hospital (hospital bankrupt/closed)|Dr. Jeffrey Karsdon||JK_MD@yahoo.com|
22408875|NCT00627094|Coloplast|Scientific Manager|+4549113557|dkkg@coloplast.com|
22408876|NCT03862469|University of Illinois at Chicago|Ajna Hamidovic|312-355-1713|ahamidov@uic.edu|
22408877|NCT00183170|Boston University School of Public Health|Dr. Jonathan Howland, Professor||jhowl@bu.edu|
22408878|NCT01165424|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22408879|NCT00433771|Boston Scientific Corporation|Jeremy Bolt|508-683-4006|boltj@bsci.com|
22408880|NCT00138658|OncoGenex Pharmaceuticals|Dr. Patricia Stewart, Vice President Medical Affairs|425-686-1500|psstewartmd@oncogenex.com|
22408881|NCT01354015|Tulane University|Dr Vivian Fonseca|5049884026|vfonseca@tulane.edu|
22408882|NCT03952377|SpineThera|Jeff Missling, CEO|+1(612)-508-4795|jmissling@spinethera.com|
22408883|NCT00131573|Boston Scientific|Director of Clinical Operations|866-360-4747|valerie.lucero-cimmarusti@bsci.com|
22408884|NCT00380861|DePuy Orthopaedics|Tammy O'Dell|574-372-7104|TOdell2@its.jnj.com|
22408885|NCT01293682|University of Rochester|Luke J Peppone, PhD, MPH|585-275-7827|Luke_Peppone@urmc.rochester.edu|
22408886|NCT02050373|UFGoias|Daniella Salvador|556235583272|danirnsalvador@gmail.com|
22408887|NCT04342130|University of Rochester|Paul Geha|203-752-8256|paul_geha@urmc.rochester.edu|
22408888|NCT03046966|University of Arkansas for Medical Sciences|Jennifer Rumpel, MD|501-364-2980|Jarumpel@uams.edu|
22408889|NCT00807040|Icahn School of Medicine at Mount Sinai|Alan Moskowitz, MD|212-659-9568|alan.moskowitz@mountsinai.org|
22408890|NCT01067339|Mayo Clinic|Amir Lerman, MD|507-284-6429|lerman.amir@mayo.edu|
22408891|NCT01179191|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22408892|NCT01783860|Rasoule-Akram Hospital|Dr. Mohsen Bahmani-Kashkouli|00982166558811|bahmanik@eyeplasticsurgeries.com|
22408893|NCT03992261|Mayne Pharma|Lee Ann McDowell, PharmD - Director of Medical Affairs|4124776681|leeann.mcdowell@maynepharma.com|
22408894|NCT00258310|Barbara Ann Karmanos Institute|George Yoo, M.D.|(313) 576-9782|yoog@karmanos.org|
22408895|NCT00572910|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22408896|NCT00661960|UCaliforniaDavis|David Asmuth/Principal Investigator|9167348695|david.asmuth@ucdmc.ucdavis.edu|
22418603|NCT04159935|Centre for Ocular Research and Education|Jill Woods|5198884567|jwoods@uwaterloo.ca|36743
22408897|NCT00759668|Alcon Italia SpA|Marcello Fornoni|39.02.81.303.226|marcello.fornoni@alconlabs.com|
22408898|NCT01833897|New York State Psychiatric Institute|Joshua Kantrowitz|646-774-6738|jkantrowitz@nki.rfmh.org|
22392350|NCT02224703|GW Research Ltd|Medical Enquiries|+44 01223 238170; +18778862810|medinfo@gwpharm.com; medinfo@greenwichbiosciences.com|
22392351|NCT02057575|Aerie Pharmaceuticals, Inc|Theresa GH Heah, MD, MBA|908-947-3844|theah@aeriepharma.com|
22392352|NCT00332462|Novartis Pharmaceuticals|Study Director|862-778-8300||
22392353|NCT02451176|Cleveland Clinic Foundation|Dr. Michael Rosen|12164453441|rosenm@ccf.org|
22392354|NCT01476449|Retina Vitreous Associates of Florida|David Eichenbaum, MD|727-323-0077|deichenbaum@retinavitreous.com|
22392355|NCT00863681|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22392356|NCT02922023|University of Florida Colleges of Pharmacy and Medicine|Katherine Vogel Anderson, Pharm.D., BCACP, FCCP|352-273-6240|kvanderson@cop.ufl.edu|
22392357|NCT02979249|Icahn School of Medicine at Mount Sinai|Dr. Hetanshi Naik|212-659-8512|hetanshi.naik@mssm.edu|
22392358|NCT01125046|Northwestern University|Priya Kumthekar, MD||Priya.Kumthekar@nm.org|
22392359|NCT02159040|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22392360|NCT04076787|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22392361|NCT02766777|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22392362|NCT01886287|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-7257|jonathan.strosberg@moffitt.org|
22392363|NCT01445327|National Cancer Institute|Dr. Deborah E. Citrin|301-496-5457|citrind@mail.nih.gov|
22392364|NCT01371825|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22392365|NCT00895895|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22408899|NCT01870921|AstraZeneca AB|Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
22408900|NCT00806416|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
22408901|NCT01596088|Kissei Pharmaceutical Co., Ltd|Clinical Development Division||rinsyousiken@pharm.kissei.co.jp|
22408902|NCT02989922|Jiangsu HengRui Pharmaceuticals Co., Ltd|Linna Wang|+862161053363|linna.wang@hengrui.com|
22408903|NCT04035694|innovation Research & Training|Dr. Tracy Scull|(919) 493-7700|tscull@irtinc.us|
22408904|NCT01102972|ViiV Healthcare|GSK Response Center|866-435-7343||
22408905|NCT02024386|Duke University School of Medicine|Richard Moon, MD|919-684-6726|richard.moon@duke.edu|
22408906|NCT03003793|Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen|Lise Gether, MD||lise.gether.01@regionh.dk|
22408907|NCT00227591|ECOG Statistical Office|Study Statistician|617-632-3012||
22408908|NCT01360021|Astrazeneca|Goran Eckerwall, MD||aztrial_results_posting@astrazeneca.com|
22408909|NCT04881149|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
22408910|NCT05048875|Johns Hopkins School of Public Health Center for Immunization Research|Dr Anna Durbin|410-955-1622|adurbin1@jhu.edu|
22408911|NCT02255422|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22408912|NCT03222570|University of Minnesota|Meredith Gunlicks-Stoessel|612-624-9249|mgunlick@umn.edu|
22408913|NCT02339246|Veloxis Pharmaceuticals|Christina Sylvest|+4520553877|csy@veloxis.com|
22408914|NCT03628872|Columbia University College of Dental Medicine|Dr. Philip Y Kang|212-342-5244|pyk2104@cumc.columbia.edu|
22408915|NCT03179462|University of Arkansas for Medical Sciences|David D.Church, Ph.D.|5015265709|dchurch@uams.edu|
22408916|NCT01795534|Bangor University|Dr Jamie Macdonald|+441248383272|j.h.macdonald@bangor.ac.uk|
22408917|NCT03741335|Oregon Health & Science University|Dr. Kerri Winters-Stone|503-494-0813|wintersk@ohsu.edu|
22408918|NCT04049474|NYU Langone Health|Lira Gutierrez|212-263-6181|Lira.Gutierrez@nyulangone.org|
22408919|NCT02970877|University Health Network|Scientific Associate|416-340-5159|kschweng@uhnresearch.ca|
22408920|NCT04410978|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22408921|NCT05153629|Stanford University|Simon Conti, MD|650-723-3391|sconti@stanford.edu|
22408922|NCT04560088|University of Rochester Medical Center|Autumn Gallegos, PhD|5852752824|autumn_gallegos@urmc.rochester.edu|
22408923|NCT04089566|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22408924|NCT05403502|Tandem Diabetes Care|Sr. Supervisor of Clinical Operations|+18583666900|clinicalaffairs@tandemdiabetes.com|
22408925|NCT02630992|University of Pittsburgh|Nader Shaikh|412-692-8111|nader.shaikh@chp.edu|
22408926|NCT01593761|CrystalGenomics, Inc.|Seonggu Ro, Ph.D, Chief Technology Officer|82 31 628 2783|sgro@cgxinc.com|
22408927|NCT02576951|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22408928|NCT04938687|Spaulding Rehabilitation Hospital|Qing Mei Wang, MD, PhD|(617) 952-5299|wang.qingmei@mgh.harvard.edu|
22408929|NCT03505606|Anglia Ruskin University|Mrs Louisa Haine - Lecturer in Vision Sciences|01223695445|louisa.haine@aru.ac.uk|
22408930|NCT01419028|Alexion International Sarl|Alexion Pharmaceuticals||clinicaltrials@alxn.com|
22408931|NCT04020822|Medtronic Diabetes|Kusal Ahangama, Clinical Study Manager|+18185765023|kusal.c.ahangama@medtronic.com|
22408932|NCT02087865|Cleveland Clinic|Dr. Stephen M. Rao|216 312-4168|raos2@ccf.org|
22408933|NCT01319994|Queen Mary University of London|Prof M Korbonits|+442078826197|m.korbonits@qmul.ac.uk|
22408934|NCT01340794|Mayo Clinic Cancer Center|Keith Bible, M.D., Ph.D.||bible.keith@mayo.edu|
22408935|NCT00741026|American Medical Association|Vance L. Albaugh, Principle Investigator|(800) 243-1455|vance.l.albaugh@vanderbilt.edu|
22408936|NCT01568255|Cedars Sinai|Margo Minissian, PhD|310-423-5195|Margo.Minissian@cshs.org|
22408937|NCT03309072|University of Texas at Dallas|Dr. Sven Vanneste, Principal Investigator|972-883-7277|sven.vanneste@utdallas.edu|
22392366|NCT01261000|Cedars-Sinai Medical Center|Vivian Hwe|424-315-4489|hwev@cshs.org|
22408938|NCT00887965|Amgen Inc.|Study Director|866-572-6436||
22408939|NCT01432600|H. Lee Moffitt Cancer Center and Research Institute|Dr. Rachid Baz|813-745-8212|rachid.baz@moffitt.org|
22408940|NCT00398632|Stanford University Medical Center, Department of Psychiatry|Lorrin Koran, M.D., Professor of Psychiatry, Emeritus|650 498 5035|lkoran@stanford.edu|
22408941|NCT00640614|Allerderm|Kim Sullivan|602-225-0595||
22408942|NCT00367679|GlaxoSmithKline|GSK Response Center|866-435-7343||
22408943|NCT01476345|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22408944|NCT04633434|Oregon Research Behavior Intervention Strategies, Inc. dba Influents Innovations|David Smith|541-484-2123|david.smith@influetnsin.com|
22408945|NCT03354143|IEEM|Dr. Rong Zhang|214-345-4245|rongzhang@texashealth.org|
22408946|NCT01005680|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22408947|NCT02530320|MFAR|A responsibility person designate by sponsor|934344412|investigacion@mfar.net|
22408948|NCT00297882|University of Yaounde 1, Cameroon|Professor Wilfred Mbacham|+237 677579180|wfmbacham@yahoo.com|
22408949|NCT02118896|Astellas Pharma Europe Limited|Clinical Trial Disclosure||Astellas.resultsdisclosure@astellas.com|
22408950|NCT04242264|Cincinnati Children's Hospital Medical Center|Robert W Frenck, Jr, M.D.|513-636-4463|Robert.Frenck@cchmc.org|
22408951|NCT02329834|scPharmaceuticals|Sr. Vice President of Clinical Development and Medical Affairs||jmohr@scpharma.com|
22408952|NCT00659945|University of Pittsburgh|Manuel C. Vallejo, MD|412-641-4260|vallejomc@anes.upmc.edu|
22408953|NCT00578448|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22408954|NCT00302068|DukeUMC|Dr. James Blumenthal|919-684-3969|blume003@mc.duke.edu|
22408955|NCT01976104|Eisai Call Center|Eisai Inc.|888-422-4743|esi_medinfo@eisai.com|
22408956|NCT01283009|Memphis VA Medical Center|Dr. Gianfranco U. Meduri|(901) 577-7520|Gianfranco.Meduri@va.gov|
22408957|NCT04221373|Icahn School of Medicine at Mount Sinai|Dr. Chung-Ying Tsai|(212) 241-7073|chung-ying.tsai@mountsinai.org|
22408958|NCT01509638|Cleveland Clinic Florida|Marylise Boutrous, MD|954-659-5000|canedoj@ccf.org|
22408959|NCT02203604|Dana Farber Cancer Institute|Ann Silk, MD|617-632-6571|Ann_Silk@dfci.harvard.edu|
22408960|NCT00552422|Columbia University|David Lederer|212-342-4167|tjb2134@cumc.columbia.edu|
22408961|NCT00561600|DePuy Orthopaedics|Dave Whalen Clinical Portfolio Leader|574-372-7028|dwhalen@its.jnj.com|
22408962|NCT00944528|Assistant Research Practice Manager|Jennifer Mewshaw, MS RN|(919) 668-5211|Jennifer.Mewshaw@duke.edu|
22408963|NCT04139642|The Ohio State University|Dr. Ajit Chaudhari|+1-614-292-0558|chaudhari.2@osu.edu|
22408964|NCT01040624|University of Florida Health Proton Therapy Institute|Nancy P. Mendenhall, MD|904-588-1000|rtoton@floridaproton.org|
22408965|NCT02912507|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
22408966|NCT03910439|National Cancer Institute|Dr. Mark Roschewski|240-760-6183|mark.roschewski@nih.gov|
22408967|NCT00577031|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22408968|NCT00557830|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com|
22408969|NCT00538473|GlaxoSmithKline|GSK Response Center|866-435-7343||
22408970|NCT01569074|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
22408971|NCT00669110|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22408972|NCT01139801|Aultman Health Foundation|Jane Sewell|330-363-6793|Jane.Sewell@aultman.com|
22408973|NCT05168657|University of Colorado|Dr. Sean Oser|3037245828|sean.oser@cuanschutz.edu|
22408974|NCT00962013|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@stryker.com|
22408975|NCT05275673|Faeth Therapeutics, Inc|Medical Monitor|7084069282|clinicaltrials@Faeththerapeutics.com|
22408976|NCT02325739|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22408977|NCT02335411|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22408978|NCT03843775|Memorial Sloan Kettering Cancer Center|Dr. Rona Yaeger MD|646-888-5109|yaegerr@mskcc.org|
22408979|NCT02212834|Group Health Research Institute|Karen J. Wernli, PhD|206-287-2934|wernli.k@ghc.org|
22408980|NCT02222168|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22408981|NCT00530621|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22408982|NCT02596009|Novartis Pharmaceuticals|Study Director|862-778-8300||
22408983|NCT01281475|Boston Children's Hospital|Wen-Hann Tan|617-355 6394|wen-hann.tan@childrens.harvard.edu|
22408984|NCT04611152|Kodiak Sciences Inc|Pablo Velazquez-Martin|6502810850|clinops@kodiak.com|
22408985|NCT05012943|Vinmec Healthcare System|Nguyen Xuan Hung|+84-865438388|v.hungnx1@vinmec.com|
22408986|NCT00400985|Medtronic BRC, The Netherlands, Maastricht|Director CRDM|+31 43 3566||566
22408987|NCT05382637|Children's National Hospital|Andrew Dauber, MD|202-476-2121|adauber@childrensnational.org|
22408988|NCT01883141|Medtronic, plc|CRHF Clinical Research|800-328-2518|medtroniccrmtrials@medtronic.com|
22408989|NCT04755283|Anthos Therapeutics, a Novartis company|Study Director|+1-888-669-6682|Novartis.email@Novartis.com|
22408990|NCT02851069|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22408991|NCT01083121|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22408992|NCT04115488|Polpharma Biologics S.A.|Director Clinical Research and Development|+48 607 697 896|clinicaltrials@polpharmabiologics.com|
22408993|NCT00885677|Medtronic EMEA RCC|Valentina Amori|3425417863|valentina.amori@medtronic.com|
22408994|NCT00352794|The University of Texas MD Anderson Cancer Center|Dr. Srdan Verstovsek, MD., Professor|713-745-3429|sverstov@mdanderson.org|
22408995|NCT02159872|The University of Texas MD Anderson Cancer Center|Elias Jabbour MD/Professor|713-792-4764|ejabbour@mdaderson.org|
22408996|NCT00516217|University of Chicago|Sonali Smith, M.D.||smsmith@medicine.bsd.uchicago.edu|
22408997|NCT00167414|University of Rochester|Hong Zhang|585-341-6750|hong_zhang@urmc.rochester.edu|
22418604|NCT02927366|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22418605|NCT02472223|Washington University School of Medicine|Mae Gordon|3143623716|gordon.mae@wustl.edu|
22418606|NCT01676415|NORTHWESTERN UNIVERSITY|BRUCE TAN|3126958182|CPRICE2@NM.ORG|
22418607|NCT00587990|EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@emmes.com|221
22418608|NCT00206323|Baylor College of Medicine|Dr. Joseph Jankovic|713-798-6556|josephj@bcm.edu|
22418609|NCT02910063|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22418610|NCT03750292|University of Rochester|Daniel Croft|(585) 275-4861|daniel_croft@urmc.rochester.edu|
22418611|NCT03334617|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
22418612|NCT00048737|UT MD Anderson Cancer Center|Issa Khouri, MD / Professor||rvalverde@mdanderson.org|
22418613|NCT03657342|Zambon SpA|Enrica Bucchioni, MD, PhD, Global Clinical Development Senior Director|+3902665241|clinicaltrials@zambongroup.com|
22418614|NCT00827632|Columbia University|Carolyn Westhoff|212-305-4805|clw3@columbia.edu|
22418615|NCT02373189|Rush University Medical Center|John Burns|13129420379|john_burns@rush.edu|
22418616|NCT02151877|Advocate Health Care|Chawki Elzein, MD, FACS|7086843029|chawki.elzein@advocatehealth.com|
22418617|NCT02012348|UCSD Dermatology Clinical Trials|UCSD Dermatology Clinical Trials Manager|(585)-657-8390|dermstudies@ucsd.edu|
22418618|NCT03095638|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22418619|NCT00911807|EBEWE Pharma|Dr. Philipp Novak|01143-7665-8123|philipp.novak@ebewe.com|733
22418620|NCT05161806|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22418621|NCT01753336|Ipsen Biopharmaceuticals, Inc.|Medical Director||clinical.trials@ipsen.com|
22418622|NCT00855803|University of Texas Southwestern Medical Center|Dr. Robert Timmerman|214/645-7637|robert.timmerman@utsouthwestern.edu|
22418623|NCT00809159|Novartis|Study Director|862-778-8300||
22418624|NCT03201211|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22418625|NCT01576874|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
22418626|NCT01174082|UT MD Anderson Cancer Center|Qazilbash,Muzaffar,M.D. / Stem Cell Transplantation|713-792-7734|CR_Study_Registration@mdanderson.org|
22418627|NCT03918109|Otonomy, Inc.|Otonomy Medical Information Center|1-844-686-4636|medinfo@otonomy.com|
22418628|NCT01045174|University Hospitals Cleveland Medical Center|Dr. Jerri Rose|216-844-7147|jerri.rose@uhhospitals.org|
22418629|NCT03050060|University of Washington|Dr. Ramesh Rengan, Department Chair|206-598-4100|rengan@uw.edu|
22418630|NCT02304458|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22418631|NCT04188301|Washington University in St. Louis|Dr. Gary Weil|3144547787|gary.j.weil@wustl.edu|
22418632|NCT01770392|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22408998|NCT00308230|Emory University|Wendy Book|404-778-5545|wbook@emory.edu|
22408999|NCT03722459|University of North Carolina at Chapel Hill|Director, Clinical Research, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
22409000|NCT00795886|Primary Children's Medical Center|Michael Pulsipher, MD|801-662-4732|Michael.Pulsipher@hsc.utah.edu|
22409001|NCT05554471|Cordis|Jenny Jimenez|+1 646 483-6846|jenny.jimenez@cordis.com|
22409002|NCT02218619|Columbia University Irving Medical Center|Robin Goland, MD|212-851-5494|rsg2@cumc.columbia.edu|
22409003|NCT02062385|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22409004|NCT03188991|US Biotest, Inc.|Gere S. diZerega, MD|805.595.1300|gere.dizerega@usbiotest.com|
22409005|NCT00223990|Kenya Medical Research Institute|Bernhards R. Ogutu, PhD|254-57-22942|bogutu@kisian.mimcom.net|
22409006|NCT03781817|University of Alabama at Birmingham, Department of Pediatrics|James Statler, MD|(205) 638-6048|jstatler@uabmc.edu|
22409007|NCT02674568|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22409008|NCT01939834|University of Virginia|Sue Brown|434-924-1825|sab2f@virginia.edu|
22409009|NCT01808508|Children's Hospital of Philadelphia|Carole L. Marcus, MBBCh|267-426-5842|marcus@email.chop.edu|
22409010|NCT01118949|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22409011|NCT03255226|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81363617366|CL_OPCJ_RDA_Team@otsuka.jp|
22409012|NCT00648739|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22409013|NCT02712359|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22409014|NCT03387423|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22409015|NCT03572049|University of Alabama at Birmingham|Dr. Peter G. Pappas|2059347292|ppappas@uabmc.edu|
22409016|NCT03862807|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
22409017|NCT04362761|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22409018|NCT01771627|MUSC|Dr. Ben Toll|843-792-9162|toll@musc.edu|
22409019|NCT03486327|Bracco Diagnostics Inc.|Giordana Marioni, Clinical Trial Assistant|609-514-2282|giordana.marioni@diag.bracco.com|
22409020|NCT00798707|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22409021|NCT01473589|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22409022|NCT01299272|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22409023|NCT03926728|Statens Serum Institut|Per Skallerup|+4532688554|PRSK@SSI.dk|
22409024|NCT02305329|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22418633|NCT03401450|NYU Langone|Dr. Prianka Desai|212-263-5072|prianka.desai@nyulangone.org|
22409025|NCT03669640|F. Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22409026|NCT01107834|Washington University|William T. Cade|314-286-1432|tcade@wustl.edu|
22418634|NCT00228423|University Of Ottawa Heart Institute|Dr. Marc Ruel||mruel@ottawaheart.ca|
22418635|NCT02642536|VA|Dr. Gina Evans|713-440-4459|gina.evans@va.gov|
22409027|NCT03722849|The University of Melbourne|Dr Stuart Mazzone|+61383446457|stuart.mazzone@unimelb.edu.au|
22409028|NCT03993288|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22409029|NCT02729545|Beijing Hospital of Integrated Traditional Chinese and Western Medicine|Dr. Yu Cao|086|howgreenbreeze@126.com|88223667
22431687|NCT05201807|Johnson & Johnson Vision Care, Inc.|John R. Buch-Senior Principal Research Optometrist|1-800-843-2020|jbuch@its.jnj.com|
22431688|NCT05093621|Yale School of Medicine|Jeffrey Testani, MD, MTR Associate Professor of Medicine|(203) 785-7191|jeffrey.testani@yale.edu|
22431689|NCT01664624|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22431690|NCT05077969|Leidos, Inc.|Tilly Lawrence|703-578-7034|tilly.lawrence@leidos.com|
22431691|NCT01029535|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22431692|NCT01152307|Massachusetts General Hospital|Dr. Karen Sepucha|617-724-3350|ksepucha@partners.org|
22409030|NCT03533608|Center for Clinical Managment Research|Dr. Rebecca Sripada|734-222-7432|rebecca.sripada@va.gov|
22409031|NCT00915473|Mayo Clinic|Dr. David Dodick|480-301-5797|dodick.david@mayo.edu|
22418636|NCT04682730|University of Pittsburgh|Dr. Deborah Polk, PhD|14126488656|dpolk@pitt.edu|
22418637|NCT01745211|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22418638|NCT04639713|Novoxel Ltd|Ifat Klein|972-52-6009860|ifat@novoxel.com|
22418639|NCT01580813|University of Colorado Denver|Irene Schauer, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
22418640|NCT01539135|Tulane University Hospital and Clinics|Dr. Sabrina Bent|5049887137|sabrina.bent@hcahealthcare.com|
22418641|NCT00191113|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22418642|NCT00658515|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
22418643|NCT01555671|Prof.Dr.Cemil Tascioglu City Hospital|Orhan SAHIN|+90 532 240 00 12|drorhansahin@gmail.com|
22418644|NCT00631657|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22418645|NCT03929757|Janssen Vaccines & Prevention B.V.|Medical Lead|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22418646|NCT01154816|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22418647|NCT00686075|MedImmune, LLC.|Filip Dubovsky, Vice President, Clinical Development|301-398-0000|dubovskyf@medimmune.com|
22418648|NCT01119508|UT MD Anderson Cancer Center|Dr. Sapna P. Patel, Assistant Professor, Melanoma Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
22418649|NCT02563106|Synthetic Biologics|Michael Kaleko, MD|(240) 238-3862|mkaleko@syntheticbiologics.com|
22409032|NCT01389024|The Johns Hopkins University School of Medicine|Dr. James Casella|410-955-6132|jcasella@jhmi.edu|
22409033|NCT00534209|UM/Sylvester Comprehensive Cancer Center|Luis Raez MD|305-243-4909|lraez@med.miami.edu|
22409034|NCT00529802|The University of Chicago|Walter Stadler, MD|(773) 702-4150|wstadler@medicine.bsd.uchicago.edu|
22409035|NCT02209454|Menarini Ricerche S.p.A.|Corporate Director of Clinical Research|0555680|acapriati@menarini-ricerche.it|9990
22409036|NCT01900392|UPENN|Catherine Reale|2157464009|catherine.reale@uphs.upenn.edu|
22409037|NCT00315328|Jaeb Center for Health Research|Raymond Kraker|813-975-8690|pedig@jaeb.org|
22409038|NCT00826176|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22409039|NCT00740480|ENTrigue Surgical, Inc.|Gabriele Niederauer, PhD|210-298-6398|gabi.niederauer@entriguesurgical.com|6336
22409040|NCT00448630|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22409041|NCT04662086|Stanford University|Manesha Desai, PhD|(650) 725-1946|manisha.desai@stanford.edu|
22409042|NCT01687400|Washington University School of Medicine|John Welch, M.D., Ph.D.|314-362-2626|jwelch@wustl.edu|
22409043|NCT03079869|Kaiser Permanente|KPSC PRS Administrator|626-720-7463|RE-CTCAT@kp.org|
22409044|NCT01325701|Pharmacyclics, Inc.|Dr. Darrin Beaupre|855-427-8846|medinfo@pcyc.com|
22409045|NCT00665704|VA Center for Clinical Management Research Health Services Research & Development, VA Ann Arbor Healthcare System, Ann Arbor, MI.|Sonia A. Duffy, Ph.D., R.N., FAAN|734.395.0613|Sonia.Duffy@va.gov|
22409046|NCT04253756|University of Texas Southwestern Medical Center|Sonja Stutzman, Research Programs Manager|214-648-6719|sonja.stutzman@utsouthwestern.edu|
22409047|NCT01372254|University of Maryland|Laura MacPherson|6198578425|lauramac.phd@gmail.com|
22409048|NCT03731325|Washington University in St. Louis|Tina Day|314-286-0079|dayt@wustl.edu|
22409049|NCT03506646|University of Nebraska at Omaha|Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
22409050|NCT04484805|Liberating Technologies, Inc.|Dr. Todd Farrell|774-233-0873|todd.farrell@liberatingtech.com|
22409051|NCT00186875|St. Jude Children's Research Hospital|Sima Jeha, MD|866-278-5833|info@stjude.org|
22409052|NCT00539006|GlaxoSmithKline|GSK Response Center|866-435-7343||
22409053|NCT03733301|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22409054|NCT00552812|Johns Hopkins School of Medicine|Dr. Richard E. Ringel|410-614-6745|rringel@jhmi.edu|
22409055|NCT01465048|University of Oxford|Dr Susanne Sheehy||susanne.sheehy@balliol.ox.ac.uk|
22409056|NCT05444114|University of Colorado Colorado Springs|Lori James|7192554172|ljames@uccs.edu|
22409057|NCT01275170|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22431693|NCT00524121|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22409058|NCT04336189|UCSF|Grant Dorsey|415-310-0525|grant.dorsey@ucsf.edu|
22409059|NCT02316002|University of Pennsylvania (Abramson Cancer Center)|Dr. Joshua Bauml|215-662-4000|melissa.volpe@pennmedicine.upenn.edu|
22409060|NCT03917654|Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Patrick E. Duffy|301.761.5089|patrick.duffy@nih.gov|
22409061|NCT04636437|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22392367|NCT03019640|Yago Nieto, PhD / Stem Cell Transplantation Department|UT MD Anderson Cancer Center|713-792-8750|ynieto@mdanderson.org|
22409062|NCT00816166|Codman Neuro|Jonathan Megerian, MD PhD|508-880-8274|jmegeri1@its.jnj.com|
22409063|NCT01071278|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22409064|NCT02684162|The University of Texas MD Anderson Cancer Center|Betul Oran, MD / Stem Cell Transplantation|713-745-2820|BOran@mdanderson.org|
22409065|NCT05125237|Brigham and Women's Hospital|Rishi J Desai, PhD|617-278-0932|rdesai@bwh.harvard.edu|
22409066|NCT00594009|University of Texas Medical Branch|Victor Cardenas, MD|(409) 772-2436|vcardena@utmb.edu|
22409067|NCT03743571|University of Nevada Reno|Cynthia Lancaster|(775) 682-8144|cynthialancaster@unr.edu|
22409068|NCT01489865|Lombardi Comprehensive Cancer Center|Benjamin Weinberg, MD|202-444-2223|baw12@gunet.georgetown.edu|
22409069|NCT00972309|National Cancer Institute|Dr. Hoyoung Maeng|240-781-3253|hoyoung.maeng@nih.gov|
22409070|NCT03884556|Trishula Therapeutics|Trishula Info|(650) 509-5732|info@trishulatx.com|
22409071|NCT01058707|Takeda|Medical Director|+1-866-835-2233|GlobalOncologyMedinfo@takeda.com|
22409072|NCT01821391|Galderma R&D SNC|CTA Coordinator|+33 493 95 70 85|cta.coordinator@galderma.com|
22409073|NCT04479241|Istari Oncology|Head of Clinical Operations|919-245-7662|info@istarioncology.com|
22409074|NCT03417102|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22409075|NCT03285581|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
22409076|NCT00540982|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22409077|NCT01736527|Bausch & Lomb Incorporated|Raphaële Siou-Mermet, MD, MS|+33160871491|raphaele.siou-mermet@bausch.com|
22409078|NCT00795210|Massachusetts General Hospital|Steven Grinspoon, MD|617-724-9109|sgrinspoon@partners.org|
22409079|NCT02850159|Samsung Medical Center|Dr. Won Hyuk Chang|82234102818|wh.chang@samsung.com|
22409080|NCT01017731|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22409081|NCT00511329|Nationwide Children's Hospital|Julie Rice, RN|6143553142|julie.rice@nationwidechildrens.org|
22409082|NCT00685763|University of Florida Proton Therapy Institute|Charles Nichols, M.D.|904-588-1800|rnichols@floridaproton.org|
22409083|NCT02238639|Hospital Ramon y Cajal|David Jimenez|+34913368133|djimenez.hrc@gmail.com|
22409084|NCT01628159|BD|Director of Clinical Affairs|763-445-2385|anna.lovas@bd.com|
22409085|NCT00698009|UT MD Anderson Cancer Center|Eugenie S Kleinerman,MD/Professor, Pediatrics - Research|(713) 497-6226|ekleiner@mdanderson.org|
22409086|NCT02060526|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22409087|NCT00564486|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
22409088|NCT02195921|Tianjin University of Traditional Chinese Medicine|Acupuncture for Chemotherapy-Induced Nausea and Vomiting: A Randomized Clinical Trial|+86 13920921016|guoyi_168@163.com|
22409089|NCT03126682|DukeUMC|Steven T Szabo|3524540101|steven.szabo@duke.edu|3524540101
22409090|NCT01441401|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22409091|NCT00896038|National Institute on Alcohol Abuse and Alcoholism|Melanie Schwandt|3014516960|melanies@mail.nih.gov|
22409092|NCT03457727|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22409093|NCT00929201|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22409094|NCT00566969|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-932-5711|mehmet.sofuoglu@yale.edu|4809
22409095|NCT02384239|University of California, San Francisco|Dr. Hope Rugo, MD|(415) 353-7618|Hope.Rugo@ucsf.edu|
22409096|NCT00464308|Janssen-Cilag Pty Ltd|Executive Director, Medical & Scientific Affairs|+61 2 9815 3219|mhandel@its.jnj.com|
22409097|NCT01721200|Yale University|Liana Fraenkel, MD, MPH, Department of Medicine||liana.fraenkel@yale.edu|
22409098|NCT01513759|EKOS Corporation|David Hahn|4254153100|David.Hahn@btgplc.com|
22409099|NCT03606109|NYU Langone Health|Michael J. Alaia, MD|646-501-7223|Michael.Alaia@nyulangone.org|
22409100|NCT03286426|Duke Eye Center|Dr. Grace Prakalapakorn|+1 919 684 7679|grace.prakalapakorn@duke.edu|
22409101|NCT01817764|GlaxoSmithKline|GSK Response Center|866-435-7343||
22409102|NCT01956123|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
22409103|NCT00366678|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22409104|NCT01387672|Womens' College Hospital|Dr. Sophie Jamal|416-351-3732|sophie.jamal@wchospital.ca|2873
22409105|NCT01150409|The Cleveland Clinic Foundation|Jorge Guzman MD|216-445-5765|guzmanj@ccf.org|
22409106|NCT01053078|University of Minnesota|Elizabeth Seaquist|612 624 9176|seaqu001@umn.edu|
22409107|NCT00388674|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22409108|NCT00438932|University of Miami Miller School of Medicine|Tamara Isakova, MD, MMSc|305-243-4374|tisakova@med.miami.edu|
22409109|NCT01598740|Sorbent Therapeutics, Inc.|Howard Dittrich, MD|858-405-1429|hdittrich@sorbent.com|
22409110|NCT01569594|Aziyo Biolgics, Inc.|Clinical Director|510-730-7973|clinical@aziyo.com|
22409111|NCT01965431|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22409112|NCT04635631|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22409113|NCT00943826|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22409114|NCT04764669|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22409115|NCT00256217|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
22409116|NCT00877799|Cara Therapeutics Inc.|Frédérique Menzaghi, PhD, Vice President Research & Development|203-567-1502|fmenzaghi@caratherapeutics.com|
22409117|NCT04054011|UCSD Dermatology|Joyce Yuan, MD|(858) 657-8322|joyce.yuan2@ucsf.edu|
22409118|NCT00592007|UC San Diego, Moores Cancer Center|Lyudmila Bazhenova, MD|858 822 6189|lbazhenova@ucsd.edu|
22409119|NCT00595127|Memorial Sloan Kettering Cancer Center|Farid Boulad, MD, Attending|+1212-639-2429|bouladf@mskcc.org|
22409120|NCT01785472|Novartis|Study Director|862-778-8300||
22409121|NCT01341067|Rocky Mountain Diabetes and Osteoporosis Center|Mark Sulik, PharmD CCRP|208-528-9642|mark@idahomed.com|
22409122|NCT01803464|University of Delaware|Dr. Christopher Modlesky|302-831-4185|modlesky@udel.edu|
22409123|NCT02424851|Oxford University Hospitals NHS Foundation Trust|Richard Brouwer|441865226950|richard.brouwer@ouh.nhs.uk|
22409124|NCT01410565|Spectrum Pharmaceutical Inc.|Gajanan Bhat|949-743-9219|gajanan.bhat@sppirx.com|
22409125|NCT01125358|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22409126|NCT00157573|MGH DF/HCC|Richard T Penson MD MCCP|617-726-8566|rpenson@partners.org|
22409127|NCT02628418|Fondazione Salvatore Maugeri|Dr. Palmira Bernocchi|00390308253|palmira.bernocchi@fsm.it|260
22409128|NCT04007406|DAMIAN Pharma AG|Teresa Gerlock/Chief Operations Officer|+41 79 230 8591|teresa.gerlock@damianpharma.com|
22409129|NCT03159611|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22409130|NCT02587117|B.P. Koirala Institute of Health Sciences|Dr. Ramayan Prasad Kushwaha|977-9842207716|visitramayan007@yahoo.com|
22409131|NCT00605839|Indiana University School of Medicine|Aaron E. Carroll|3172780552|aaecarro@iupui.edu|
22409132|NCT00790270|Stony Brook U|Adam Singer|631 444 7856|adam.singer@stonybrook.edu|
22409133|NCT00352664|UT MD Anderson Cancer Center|Eduardo Bruera, MD / Professor|713-792-6084||
22409134|NCT02665273|Montefiore|Benjamin W. Friedman|718-920-6626|befriedm@montefiore.org|
22409135|NCT00673712|Halyard Health|Sr. Director Clinical Research|5132538033|alan.dine@hyh.com|
22409136|NCT01608321|VA Palo Alto Health Care System|Director, WRIISC|650-493-5000|wes.ashford@va.gov|
22409137|NCT01875731|Hospital General de Niños Pedro de Elizalde|Dr. Fernando Torres|+54 11 43632100|torresfernandoadrian@gmail.com|1014
22409138|NCT06212544|University of Michigan|Kristi Gamarel|7346473178|kgamarel@umich.edu|
22409139|NCT03222856|MedSIR|Scientific Director|+34 611261467|alicia.garcia@medsir.org|
22409140|NCT01035229|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22409141|NCT00359073|University of Wisconsin Madison|Gina Crisafi|608-262-5240|gmc@medicine.wisc.edu|
22409142|NCT00684645|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22409143|NCT02682069|MolecuLight Inc.|Liis Teene|416.542.5530|lteene@moleculight.com|
22409144|NCT02513095|Eagle Pharmaceuticals, Inc.|Chief Medical Officer|201 326 5300|medinfo@eagleus.com|
22409145|NCT02786810|University of Tennessee Health Science Center|Dr. David Hains|9012874876|dhains@uthsc.edu|
22409146|NCT01819467|NHRMC|Dr. Henry Easley|910. 667-9238|sandy.easley@seahec.net|
22409147|NCT03514121|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22409148|NCT00391092|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22409149|NCT00467038|James J Peters VAMC|Marianne Goodman, MD|718-584-9000|marianne.goodman@va.gov|5188
22409150|NCT00197184|GlaxoSmithKline|GSK Response Center|866-435-7343||
22409151|NCT02545868|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22409152|NCT01777191|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22409153|NCT01932801|University of Washington / Washington State University|Dr. Susan Collins|12068327885|susan.collins@wsu.edu|
22409154|NCT03286400|W. L. Gore & Associates|Eric Novak|314-440-2119|enovak@wlgore.com|
22409155|NCT00540007|Washington University School of Medicine|Todd Fehniger, M.D., Ph.D.|314-747-1385|tfehnige@wustl.edu|
22409156|NCT00568776|Transition Therapeutics Ireland Limited|Aleksandra pastrak, MD, PhD, Vice President, Clinical Development|+1 416 263 1227|apastrak@transitiontherapeutics.com|
22409157|NCT03576131|Genmab|Clinical Trial Information|+45 7020 2728|clinicaltrials@genmab.com|
22409158|NCT01456000|CardioFocus, Inc.|Burke Barrett, VP Regulatory & Clinical Affairs|508 658-7200|bbarrett@cardiofocus.com|
22409159|NCT01563029|GlaxoSmithKline|GSK Response Center|866-435-7343||
22409160|NCT03069365|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22409161|NCT02780115|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
22409162|NCT00566631|Janssen-Cilag Germany|EMEA Therapeutic Area Leader CNS|+492137955153||
22409163|NCT01327989|Medtronic|Manish Gupta, Sr. Director of Medical Affairs|949-837-3700|manish.gupta@medtronic.com|
22409164|NCT02860039|Vanderbilt-Ingram Cancer Center|Natasha Halasa, MD, MPH|800-811-8480|natasha.halasa@vumc.org|
22409165|NCT01257737|Horizon Therapeutics, LLC|Colleen Canavan, Director|1-224-383-3000|clinicaltrials@horizonpharma.com|
22409166|NCT01940276|Duke University|Daniel George, MD|919-668-4615|daniel.george@duke.edu|
22409167|NCT02723786|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22409168|NCT01143610|School of Dentistry at Bauru - USP|Adriana Campos Passanezi Sant'Ana|00 55 14 3235-8278|acpsantana@usp.br|
22409169|NCT00124579|SWOG|Robert Z. Orlowski, MD, PhD|(713) 792-2860|rorlowsk@mdanderson.org|
22409170|NCT00127192|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22409171|NCT00703261|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22409172|NCT03170271|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22409173|NCT02466776|Kaiser Permanente|Dr. Mary Zaki|503-332-2390|mary.nasry@gmail.com|
22409174|NCT02701049|Brigham and Women's Hospital|Dr. Adil H. Haider|617-525-9280|ahhaider@bwh.harvard.edu|
22409175|NCT02709759|Brown University|Christopher Kahler|401 863-6651|christopher_kahler@brown.edu|
22409176|NCT01036594|University of California, San Francisco|Dr. Terence Friedlander, MD|(415) 514-6380|Terence.Friedlander@ucsf.edu|
22409177|NCT01700335|SymBio Pharmaceuticals|Director of Clinical Trials|+81-3-5472-1127|kgoto.34@symbiopharma.com|
22409178|NCT01612780|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
22409179|NCT03466060|Johnson & Johnson Vision Care Inc.|Meredith Bishop, OD, MS, FAAO- Senior Principal Research Optometrist|904-443-1396|MBishop4@its.jnj.com|
22409180|NCT05005130|University of North Carolina at Chapel Hill|Michael Herce, MD, MPH, MSc|919-966-2537|michael_herce@med.unc.edu|
22409181|NCT03345485|Mundipharma Research Limited|Mónica Araujo - Senior Programmer, Data Management|+447922223436|monica.araujo@mundipharma-rd.eu|
22409182|NCT02985515|Washington University in St. Louis|Pawina JIramongkolchai, MD|314-393-2455|pawina@wustl.edu|
22409183|NCT01610284|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22409184|NCT03020966|Hospital for Special Surgery|Dr. Jacques Yadeau|(212) 774-2224|Yadeauj@hss.edu|
22409185|NCT01856257|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22409186|NCT02115373|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22409187|NCT04935931|Children's Mercy Kansas City|Dr. Stephani Stancil|816-234-3000|slstancil@cmh.edu|
22409188|NCT01638416|Australian and New Zealand Intensive Care Research Centre|Dr. Cooper|+61 3 9903 0071|anzicrc@monash.edu|30071
22409189|NCT00424632|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22409190|NCT01984229|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22409191|NCT02072174|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22409192|NCT05674721|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
22409193|NCT02067585|Royal Alexandra Hospital|Xinzhe Shi|7807356735|xinzhe.shi@ahs.ca|
22409194|NCT00937859|Serenity Pharmaceuticals|Chief Medical Officer|8456396760|sfein@serenitypharma.com|17
22409195|NCT04466956|Barts Health NHS Trust|Dr Anna McDougall|02078827272|anna.mcdougall@nhs.net|
22409196|NCT00091507|Tufts Medical Center|Co-Principal Investigator|617-636-8788|jbeshansky@tuftsmedicalcenter.org|
22409197|NCT00633009|Nielsen BioSciences, Inc.|Stewart Nielsen|858.571.2726|stewart@nielsenbio.com|
22409198|NCT00203931|University of Chicago|Kristen Wroblewski|773-702-7173|kwroblewski@health.bsd.uchicago.edu|
22409199|NCT03506425|Duke University|Richard Bedlack, M.D., Ph.D.|919-668-2839|richard.bedlack@duke.edu|
22409200|NCT03930615|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22409201|NCT04736316|University of Washington|Dr. Kelli O'Laughlin|206-744-2559|kolaugh@uw.edu|
22409202|NCT02864953|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22409203|NCT00981019|Max Planck Institute for Human Development, Harding Center for Risk Literacy|Dr. Odette Wegwarth|+49-30-82406|wegwarth@mpib-berlin.mpg.de|695
22409204|NCT00358670|Merck Sharpe & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22409205|NCT00865306|Massachusetts General Hospital|Dina R. Hirshfeld-Becker, PhD|617-503-1408|dhirshfeld@partners.org|
22409206|NCT05083559|Oregon Health and Science University|Jessica Castle|503-494-7072|castleje@ohsu.edu|
22409207|NCT02704130|Atrium Health|Blair Stephenson, Research Business Manager|704-446-4845|blair.stephenson@atriumhealth.org|
22409208|NCT03752866|Abbott|Vinny Podichetty, Sr. Director, Global Clinical Affairs|+1 408-845-1639|vinny.podichetty@abbott.com|
22409209|NCT05378269|Dare Bioscience, Inc.|Jessica Hatheway, VP Clinical Operations|858-926-7655|jhatheway@darebioscience.com|
22409210|NCT01838863|Denver Health Medical Center|Dr. Ernest E. Moore|303.602.1820|Ernest.Moore@dhha.org|
22409211|NCT00602979|Weill Cornell Medicine|Michele Steinkamp|212-746-2953|mls9004@med.cornell.edu|
22431694|NCT02458235|University of California, San Francisco|Dr. Christopher Dvorak, MD|(415) 476-0554|Christopher.Dvorak@ucsf.edu|
22409212|NCT01461369|Iroko Pharmaceuticals, LLC|Daniel Solorio, Executive Director of Clinical Operations|267-546-3150|dsolorio@iroko.com|
22431695|NCT00687076|Baylor College of Medicine|Gerd Brunner, PhD|713-790-5800|gbrunner@bcm.edu|
22431696|NCT02410772|Centers for Disease Control and Prevention|Dr. Ekaterina Kurbatova, MD, PhD, MPH|4046392017|ies3@cdc.gov|
22431697|NCT02369536|IRCCS Neuromed|Dr. Chiara Cerletti, operative responsible of the trial and corresponding author of the data public|0865915246|chiara.cerletti@moli-sani.org|
22431698|NCT01636284|Sillajen Biotherapeutics Inc.|Kyoung Soo Ha, Head of Clinical Development|+1-415-281-8886|ksha@kr.sillajen.com|
22431699|NCT04987372|UZ Ghent|dr. Harlinde Peperstraete|+3293325185|harlinde.peperstraete@uzgent.be|
22431700|NCT02164864|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22431701|NCT01870869|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22431702|NCT00904371|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22431703|NCT02493764|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22431704|NCT03648385|Brown University Health, Center for Advanced Lung Care|Corey Ventetuolo, MD|401-444-2733|corey_ventetuolo@brown.edu|
22431705|NCT05448950|Phraxis, Inc.|Cindy Setum, PhD|16128016730|csetum@phraxis.com|
22431706|NCT01646827|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
22431707|NCT03057548|SacEP Research|Arash Aryana, MD, PhD|916-453-2684|a_aryana@outlook.com|
22431708|NCT00934921|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22431709|NCT01242514|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
22431710|NCT02625181|Vanderbilt University Medical Center|Jonathan Wanderer|615-536-5194|jon.wanderer@vanderbilt.edu|
22431711|NCT02274571|Pennington Biomedical Research Center|Dr. Eric Ravussin|2252844345|eric.ravussin@pbrc.edu|
22431712|NCT05901636|Janssen Research & Development, LLC|Medical Lead|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22431713|NCT03193801|Edwards Lifesciences|Director of Research|949-250-2500|THV_ct.gov@edwards.com|
22431714|NCT03110562|Karyopharm Therapeutics Inc.|Karyopharm Medical Information|(888) 209-9326|clinicaltrials@karyopharm.com|
22431715|NCT01561469|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22431716|NCT02274675|Universiti Teknologi Malaysia|Project Leader||cfyeong@utm.my|
22431717|NCT02160808|Dartmouth-Hitchcock Medical Center|Timothy B. Gardner MD MS|603-650-6472|timothy.b.gardner@hitchcock.org|
22431718|NCT05239221|Amolyt Pharma|Senior VP of Clinical Development and Regulatory Affairs|+33 428 01 21 54|contact@amolyt.com|
22431719|NCT00285779|Stanford University Department of Dermatology|David Fiorentino|650-723-6316|fiorentino@stanford.edu|
22431720|NCT02114177|Janssen Infectious Diseases BVBA|Associate Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
22431721|NCT05111145|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22431722|NCT02336815|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
22431723|NCT01359956|NCI Naples|Paolo A Ascierto, M.D., Ph.D|+39 081 5903431|p.ascierto@istitutotumori.na.it|
22431724|NCT01784029|Children's Hospital at Montefiore|Hina Talib|718-920-6781|htalib@montefiore.org|
22431725|NCT03226418|University of Nebraska Medical Center|Vijaya Bhatt|402-559-5520|IITOffice@unmc.edu|
22431726|NCT02415556|Beth Israel Deaconess Medical Center (BIDMC)|Dr. Vera Novak, Principal Investigator|6176328680|vnovak@bidmc.harvard.edu|
22431727|NCT01209767|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
22431728|NCT01621178|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22431729|NCT00105534|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22431730|NCT02465931|RTI International|Dr. Don Bailey|(919) 541-6488|dbailey@rti.org|
22431731|NCT01574144|Medtronic, Inc|Amy Lautenbach|7633609163|amy.a.lautenbach@medtronic.com@medtronic.com|
22431732|NCT00730756|GlaxoSmithKline|GSK Response Center|866-435-7343||
22431733|NCT04388826|Veru|Gary Barnette PhD CSO|9194263611|gbarnette@verupharma.com|
22431734|NCT01840943|Xian Janssen Pharmaceutical LTD|Senior Director Clin Development||ClinicalTrialDisclosure@its.jnj.com|
22392368|NCT01721954|Sirtex Medical|Janet Bell, M.B.A.|+ 888-474-7839|jbell@sirtex.com|710
22392369|NCT01195623|Uppsala UH|Lena Blomgren MD PhD|+46851774173|lena.blomgren@karolinska.se|
22392370|NCT00534495|Children's Hospital at Montefiore|Dr.Norman T.Ilowite|718-696-2602|NILOWITE@montefiore.org|
22392371|NCT02278484|Entellus Medical|Ellen O'Malley|763-463-1598|eomalley@entellusmedical.com|952
22392372|NCT01346072|University of North Carolina Chapel Hill|Kirkwood F. Adams, Jr., MD|919-966-2877|kfa@med.unc.edu|
22392373|NCT02920970|CooperVision Inc.|Sr. Manager Global Medical Scientific Affairs|925-621-3761|javega@coopervision.com|
22392374|NCT01711853|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22392375|NCT01889069|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22392376|NCT01509547|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
22392377|NCT00561145|Wageningen University|Dr Lisette de Groot|+31-317482220|lisette.degroot@wur.nl|
22392378|NCT02227992|Ethicon, Inc.|Senior Franchise Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22409213|NCT01247974|CorMatrix Cardiovascular|Director, Clinical Development|240-247-1170|clinical@aziyo.com|
22409214|NCT00997672|University Federico II, Naples, Italy|Dr. Francesco Saccà|3470734774|francesco.sacca@unina.it|+39
22409215|NCT00734617|Duke Center for Nicotine & Smoking Cessation Research|Jed E. Rose, Ph.D.|919 668-5093|rose0003@mc.duke.edu|
22409216|NCT00869141|Stein Eye Institute|Dr. Simon K. Law|(310)794-1477|law@jsei.ucla.edu|
22409217|NCT03692078|Altria|Jeffery Edmiston, Functional Director Clinical Research|8043352366|Jeffery.S.Edmiston@altria.com|
22409218|NCT01339858|Indiana University Psychotic Disorders Program|Alan Breier|317-880-8495|abreier@iupui.edu|
22409219|NCT06134128|VA Portland Healthcare System|Kate Shirley, PhD|503-220-8262|kate.shirley@va.gov|52470
22409220|NCT01615822|Medicines for Malaria Venture|Fiona Macintyre, PhD|+41 22 555 0319|macintyref@mmv.org|
22409221|NCT02861534|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22409222|NCT02886494|Charsire Biotechnology Corp.|R&D associate|+886-6-702-0817|cs42@charsire.com|
22409223|NCT00194116|Univeristy Hospitals Case Medical Center|Dr. Keming Gao|216-844-2865|Keming.Gao@uhhospitals.org|
22409224|NCT00623441|Medtronic Bakken Research Center|Sofia Pateraki, MSc - Sr. Clinical Research Specialist|+31 43 3566785|sofia.pateraki@medtronic.com|
22409225|NCT00769132|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22409226|NCT01211873|Guerbet|Jing Hao, MD|+33145915000|jing.hao@guerbet.com|
22409227|NCT00537056|David Geffen School of Medicine at UCLA|Andrew Quon, M.D. Professor Division of Nuclear Medicine|310-983-1419|aquon@mednet.ucla.edu|
22409228|NCT00244881|Dana-Farber Cancer Institute|Dr Harold Burstein|617-632-3800|hburstein@partners.org|
22409229|NCT00442338|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22409230|NCT01060007|Washington University School of Medicine|Parag Parikh, M.D.|314-362-9703|pparikh@radonc.wustl.edu|
22409231|NCT00445458|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
22409232|NCT02379442|NHLBI, NIH|Sawa Ito, MD|301-326-5233|itos3@upmc.edu|
22409233|NCT01895088|AcuFocus, Inc.|Eugenia Thomas, Director Clinical Trials|9495859511|nthomas@acufocus.com|
22409234|NCT00246441|MUSC|Dr. Sarah Book|8437925200|booksw@musc.edu|
22409235|NCT01393626|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22409236|NCT02426125|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22409237|NCT01141049|NYSPI|john mariani md|646-774-6140|john.mariani@nyspi.columbia.edu|
22409238|NCT00077766|Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22409239|NCT00938015|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22409240|NCT03186794|Clinical Center|Leighton Chan|+1 301 496 4733|chanle@cc.nih.gov|
22409241|NCT00357734|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22409242|NCT02057549|The University of Texas Houston Health Science Center|Dr. Carlos J. Roldan MD|713-792 6070|croldan@mdanderson.org|
22409243|NCT00118209|Washington University School of Medicine|Nancy Bartlett, M.D.|314-362-5654|nbartlet@wustl.edu|
22409244|NCT01418365|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22409245|NCT03226366|Intermountain Healthcare|Director, Office of Research|(801) 408-1991|officeofresearch@imail.org|
22409246|NCT02575807|Aduro Biotech, Inc.|Medical Affairs|510.809.2452|MedicalAffairs@aduro.com|
22409247|NCT03319368|University of Maryland School of Medicine|Alison Lydecker, MPH|410-706-0065|alydecke@som.umaryland.edu|
22409248|NCT02181075|Oncology Clinical Trials Group|Sarah Pearson, Trial Management Director|01865 227160|sarah.pearson@oncology.ox.ac.uk|
22409249|NCT02180659|Titan Pharmaceuticals|Kate Beebe DeVarney|650-244-4990|kdevarney@titanpharm.com|
22409250|NCT04150107|Oramed, Ltd.|Miriam Kidron, PhD|+972-2-566-0001|miriam@oramed.com|
22409251|NCT01267227|University of Mississippi|Dr. Daniel Riche|601-984-2640|driche@umc.edu|
22409252|NCT00824993|UT MD Anderson Cancer Center|Lu,Huifang,M.D. PH.D. / General Internal Medicine|713-563-4462|HLU@MDANDERSON.ORG|
22409253|NCT00440193|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22409254|NCT00834366|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
22409255|NCT01955473|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22409256|NCT03409328|Rosalind Franklin University|Dr. Brian Feinstein|847-578-8736|brian.feinstein@rosalindfranklin.edu|
22409257|NCT00518011|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22392379|NCT01691950|Imperial College London|Mr Richard M Kwasnicki PhD MRCS|+44 (0) 20 759 48904|rmk107@ic.ac.uk|
22409258|NCT02998645|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
22392380|NCT01371708|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021||
22418650|NCT04689867|University of Michigan|Lindsay Bornheimer|(734) 615-2915|bornheim@umich.edu|
22409259|NCT00090259|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22409260|NCT00478673|Boston Scientific Corporation|Jim Taufen, Regulatory Affairs Manager|763-255-0683|taufenj@bsci.com|
22409261|NCT03701516|Johnson & Johnson Vision Care, Inc|Brian Pall, OD, MS, FAAO - Director|1-904-629-2289|BPALL@its.jnj.com|
22409262|NCT01153685|GlaxoSmithKline|GSK Response Center|866-435-7343||
22409263|NCT02139969|Boston Scientific Corporation|Laura Olson, Clinical Project Manager|9529306428|laura.olson2@bsci.com|
22409264|NCT03506724|Icahn School of Medicine at Mount Sinai|Dr. Dyese Taylor|973-926-5508|Dyesetaylor@gmail.com|
22409265|NCT03644927|Veterans Administration Boston Healthcare System and BU School of Medicine|Erica R Scioli, PhD|857 364 6293|ericarose.scioli@va.gov|
22409266|NCT00956813|Mayo Clinic|Debra L. Barton, RN, PhD, AOCN||barton.debra@mayo.edu|
22409267|NCT04797637|Vanderbilt University Medical Center|Lisa C. Zukerwise, MD|9144203838|lisa.zuckerwise@vumc.org|
22409268|NCT02380248|Alcon, A Novartis Division|Clinical Scientific Associate Director, GCRA-GDD|1-888-451-3937|alcon.medinfo@alcon.com|
22409269|NCT03083639|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22409270|NCT00960687|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22409271|NCT02656875|Trevena, Inc.|Kelly Arscott|6103548840|karscott@trevena.com|
22409272|NCT02184169|Boston Childrens Hospital|John Kheir|6173556000|john.kheir@childrens.harvard.edu|
22409273|NCT02357173|Medical University of South Carolina|Dr. Matthew Carpenter|843-876-2436|carpente@musc.edu|
22409274|NCT03611751|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22409275|NCT01023022|Institute of Cardiology|Prof. Hanna Szwed|48 22 343 46 00|hszwed@ikard.pl|
22409276|NCT04686500|University of Texas Southwestern Medical Center|Dr. David Parsons|214/645-8525|david.parsons@utsouthwestern.edu|
22409277|NCT03128931|Masimo Corporation|Vikram Ramakanth|949-297-7416|clinicalresearchdept@masimo.com|
22409278|NCT01371006|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22409279|NCT03256526|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22409280|NCT00891527|Boston Childrens Hospital|Kathy Jenkins MD MPH|6173557275|kathy.jenkins@cardio.chboston.org|
22409281|NCT01186744|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22409282|NCT03291847|Johns Hopkins University School of Medicine|Lauren Jansson|4105504114|ljansson@jhmi.edu|
22409283|NCT01393717|City of Hope National Medical Center|Dr. Robert Chen|626-256-4673|RChen@coh.org|82405
22409284|NCT03515837|Merck Sharp and Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22409285|NCT02325401|University of Cincinnati|Trisha Wise-Draper M.D., Ph.D., Associate Professor of Medicine, Medical Director of the UC Cancer C|(513) 558-2826|wiseth@ucmail.uc.edu|
22409286|NCT01856686|Spanish Foundation for Neurometrics Development|Dr. Moises Aguilar Domingo|+441615312645|moises@bigdata4brain.co.uk|
22409287|NCT01426828|University of Pennsylvania|CCI @ University of Pennsylvania|(215)662-4000||
22409288|NCT02406742|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22409289|NCT02367729|Medical College of Wisconsin|Dr. Katja Kovacic|4142663915|kkovacic@mcw.edu|
22409290|NCT00759174|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22409291|NCT01890109|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22409292|NCT01643928|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22409293|NCT03336645|Shire|Study Physician|1 866-842-5335|ClinicalTransparency@takeda.com|
22409294|NCT00996632|University of Trieste|Prof. Nicolò de Manzini|+390403994152|nicolo.demanzini@aots.sanita.fvg.it|
22409295|NCT01092676|LHSC Lawson HRI|Rodrick Lim|5198525496|rod.lim@lhsc.on.ca|
22409296|NCT03029104|CXL Ophthalmics, LLC|Chief Clinical Development Officer|339-234-6020|info@cxlophthalmics.com|
22409297|NCT00916617|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22409298|NCT01177735|University of Arkansas for Medical Sciences|Saad Usmani, MD|501-526-6876||
22409299|NCT00499252|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22409300|NCT02230332|Penn State University Dept of Public Health Sciences|David Mauger, PhD|717.531.3584|dmauger@psu.edu|
22409301|NCT02586909|Axovant Gene Therapies|Yi Mo, PhD|1-929-227-3828|yi.mo@axovant.com|
22409302|NCT01260194|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22409303|NCT02249065|Galderma Laboratories L.P.|Dr. Jean Philippe York|817-961-5468|jp.york@galderma.com|
22409304|NCT02086968|Luitpold Pharmaceuticals, Inc.|Angelia Butcher|610-650-4200|abutcher@lpicrd.com|811
22409305|NCT02822612|Moorfields Eye Hospital NHS Foundation Trust|Pearse Keane|02072533411|pearse.keane@moorfields.nhs.uk|
22409306|NCT00556166|Columbia University|Dennis Fowler|212-305-9914|dlf91@columbia.edu|
22409307|NCT03359473|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22409308|NCT02953418|Medtronic MITG-RGI|Director of Clinical Affairs|303-882-6759|Tumordirectedtherapiesclinical@Medtronic.com|
22409309|NCT06251154|CooperVision, Inc.|José A. Vega OD, MSc, PhD, FAAO|+19256213761|jvega2@coopervision.com|
22409310|NCT04101721|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22409311|NCT01215955|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22409312|NCT05013749|Fundación Valle del Lili|Albaro José Nieto Calvache|(+57) 6023319090|albaro.nieto@fvl.org.co|3056 - 305
22409313|NCT02858076|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|drcrnet@jaeb.org|
22409314|NCT02643394|UT Southwestern Medical Center|David McDonagh, MD|214-648-8083|david.mcdonagh@utsouthwestern.edu|
22409315|NCT00943384|DePuy Synthes Clinical Affairs|Allyson Morris, PhD, CCRP, Staff Clinical Research Scientist|610-719-5298|morris.allyson@synthes.com|
22409316|NCT00096200|University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Steven Waggoner, MD|216-844-5011|steven.waggoner@uhhospitals.org|
22409317|NCT04193033|Michael E DeBakey VAMC|Dr. Natalie Hundt|713-440-4450|Natalie.Hundt@va.gov|
22409318|NCT03265483|Vanderbilt University Medical Center|Martha J. Shrubsole|(615)936-0812|martha.shrubsole@Vanderbilt.Edu|
22409319|NCT01771172|Medtronic, Inc.|Medtronic CRDM Clinical Trial Manager|763-505-6000|medtronicCRMtrials@medtronic.com|
22409320|NCT03509766|Johns Hopkins School of Medicine|Jody Tversky|410-550-5949|jodytversky@jhmi.edu|
22409321|NCT03014570|University of Maryland School of Nursing|Barbara Resnick PhD, CRNP Professor and PI among MPIs of the trial|410 706 5178|resnick@umaryland.edu|
22409322|NCT01154673|University of Toronto|Mario Ostrowski, Principal Investigator, Professor of Medicine|416-946-5805|mario.ostrowski@gmail.com|
22409323|NCT01923961|eXcorLab GmbH|'Dr. Horst-Dieter Lemke|+49-6022-812647|horstdieter.lemke@excorlab.de|
22409324|NCT01216319|Cook Biotech Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@cookbiotech.com|
22409325|NCT03791619|Johnson & Johnson Surgical Vision|Luis Vargas, MD|714-247-8200|LVarga17@its.jnj.com|
22409326|NCT02666768|The Lundquist Institute at Harbor-UCLA Medical Center|Dr. Lynda Polgreen|310-222-1961|lpolgreen@lundquist.org|
22409327|NCT03151226|Wake Forest School of Medicine|Dr. Peter H. Pan|336-718-8278|ppan@wakehealth.edu|
22409328|NCT00903409|GlaxoSmithKline|GSK Response Center|866-435-7343||
22409329|NCT03239340|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22409330|NCT01497860|Children's National Medical Center|Associate Professor|2024765046|ehwang@childrensnational.org|
22409331|NCT03539952|Orphalan SA|Frank Verheggen - Head Clinical Operations|+31625241264|frank.verheggen@orphalan.com|
22409332|NCT02184988|Evolus, Inc|Rui L. Avelar, MD|(805)689-8668|rui@evolusinc.com|
22409333|NCT00777920|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22409334|NCT02332655|Kennedy Krieger Institute|Dr. Anne Comi|4439239172|comi@kennedykrieger.org|3-9172
22409335|NCT01977482|GlaxoSmithKline|GSK Response Center|866-435-7343||
22409336|NCT02547779|VANDERBILT UNIVERSITY MEDICAL CENTER|Matthew W. Semler, MD, MSc|(615) 322-3412|matthew.w.semler@vumc.org|
22409337|NCT01964898|The Miriam Hospital|Andrew Busch PhD|4017938189|andrew_busch@brown.edu|
22392381|NCT02514551|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22409338|NCT03569020|Beth Israel Deaconess Medical Center|Dr. Stephen Juraschek|617-754-1416|sjurasch@bidmc.harvard.edu|
22418651|NCT02240030|Acorda Therapeutics|Charles Oh|914-326-5455|coh@acorda.com|
22418652|NCT01136967|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22418653|NCT01735955|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22418654|NCT04228783|Janssen Vaccines & Prevention B.V.|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22418655|NCT03327792|Yale University|Dr. Suchitra Krishnan-Sarin|203-974-7595|suchitra.krishnan-sarin@yale.edu|
22418656|NCT00626392|Abbott|Medical Information Specialist|800-633-9110||
22418657|NCT04576923|Indiana University|Samer Gawrieh, MD|317-278-9326|sgawrieh@iu.edu|
22418658|NCT00996775|Center for Mental Healthcare and Outcomes Research, Central Arkansas Veterans Healthcare System|Michael A. Cucciare, Ph.D.|501-257-1068|michael.cucciare@va.gov|
22418659|NCT00735306|Duke University|Dr. Brian Czito|919-668-7336|brian.czito@duke.edu|
22418660|NCT03002571|Bausch Health Americas, Inc|Study Director|19083009920|susan.harris@bauschhealth.com|
22418661|NCT03151811|Oncopeptides AB|Chief Operating Officer|+46 8 615 20 40|trials@oncopeptides.com|
22418662|NCT00054665|National Cancer Institute, National Institues of Health|Wyndham Wilson, M.D.|301-435-2415|wilsonw@mail.nih.gov|
22418663|NCT01081834|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
22418664|NCT01085734|Raj K. Maturi, MD, PC|Raj K. Maturi, MD|317-817-1414|rmaturi@gmail.com|
22418665|NCT01740726|Emory University School of Medicine|Research Coordinator|404-727-4799|sean.carey@emory.edu|
22418666|NCT02045147|University of Nebraska Medical Center|Lani Zimmerman|402-472-3847|lzimmerm@unmc.edu|
22418667|NCT01475097|GE Healthcare|Debra Mansfield|609-514-6329|dabra.mansfield@ge.com|
22418668|NCT04839692|Massachusetts General Hospital|Dr. Dieter Manstein|617-726-4893|dmanstein@mgh.harvard.edu|
22418669|NCT00049530|ECOG Statistical Office|Study Statistician|617-632-3012||
22418670|NCT01045135|Akershus University Hospital|Dr.Jette Stær-Jensen, Dr. Franziska Siafarikas|+47-6796000|jett@ahus.no|
22418671|NCT03511326|Galderma R&D SNC|CTA Coordinator|+33 0493 95 70 85|cta.coordinator@galderma.com|
22418672|NCT04314648|RAND|Dr. Allison Ober|3103930411|ober@rand.org|6639
22418673|NCT01305044|Huntsman Cancer Institute|Anita Kinney, PhD, RN|801-585-1151|anita.kinney@hci.utah.edu|
22418674|NCT01392625|ISCI / University of Miami Miller School of Medicine|Joshua M. Hare, MD|305-243-5579|JHare@med.miami.edu|
22431735|NCT02862574|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22409339|NCT02428231|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22409340|NCT03151967|University of Washington|Ann Stapleton, MD|2066609981|stapl@uw.edu|
22409341|NCT02957682|Regeneron Pharmaceuticals, Inc|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
22409342|NCT02953262|Center for Healthcare Organization and Implementation Research (CHOIR) United States Department of Veterans Affairs VA Bedford Healthcare System|Stephanie Shimada, PhD|781-687-2208|Stephanie.Shimada@va.gov|
22409343|NCT03284424|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22409344|NCT00765999|Allergan, Inc.|Vice President, Clinical Development, Gastrointestinal|1-862-261-7000|IR-CTRegistration@allergan.com|
22409345|NCT00535873|The University of Texas M D Anderson Cancer Center|Alessandra Ferrajoli, MD/Associate Professor|713-792-2063|eharriso@mdanderson.org|
22409346|NCT00203892|University of Chicago|Dr. Hedy Kindler|773-702-0360|hkindler@medicine.bsd.uchicago.edu|
22409347|NCT00722007|Corin USA Limited|Lucinda Gerber|(772) 321 2478|lucinda.gerber@coringroup.com|
22409348|NCT02964910|Shandong Center for Disease Control and Prevention, Jinan, China|Shandong Provincial Key Laboratory of Infectious Disease Control and Prevention|0531-82679606|aqxuepi@163.com|
22409349|NCT03829462|Institut régional du Cancer de Montpellier|Dr Emmanuelle Samalin|467613136|emmanuelle.samalin@icm.unicancer.fr|+33
22409350|NCT02341482|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
22409351|NCT01166126|H. Lee Moffitt Cancer Center and Research Institute|Ragini Kudchadkar, M.D.|813-745-8581|ragini.kudchadkar@moffitt.org|
22409352|NCT03597620|University of Alabama at Birmingham|Dr. Boni Elewski|205-502-9960|dermresearch@uabmc.edu|
22409353|NCT03000075|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22409354|NCT00111007|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22409355|NCT01495793|UCB Pharma|UCB Clinical Trial Call Center|+1877-822||9493
22409356|NCT03332212|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22409357|NCT02362646|Icahn School of Medicine at Mount Sinai|Annetine Gelijns, PhD|212-659-9567|annetine.gelijns@mssm.edu|
22409358|NCT04141670|ARMGO Pharma, Inc|Eugene Marcantonio MD PhD|2014633634|gmarcantonio@armgo.com|
22409359|NCT03907540|Kadmon Corporation|Olivier Schueller, Senior Vice President, CMC & Clinical Pharmacology|724-778-6170|olivier.schueller@kadmon.com|
22409360|NCT00929864|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22409361|NCT03728257|University of Pittsburgh|Annette DeVito Dabbs|4126245314|ajdst42@pitt.edu|
22409362|NCT03940742|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22409363|NCT04176354|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22409364|NCT03428217|Calithera Biosciences, Inc|Study Director|650-870-1000|clinicaltrials@calithera.com|
22409365|NCT00621309|University of Washington|Dr. David L. Eaton|206-543-7468|deaton@uw.edu|
22409366|NCT00905437|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22409367|NCT05246111|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22409368|NCT01187511|National Institute on Alcohol Abuse and Alcoholism|Leggio, Lorenzo|+1 301 435 9398|lorenzo.leggio@nih.gov|
22409369|NCT01306968|Uniformed Services University of Health Sciences|Dr. R. Scott Miller, M.D.|301-816-8424|robert.s.miller@us.army.mil|
22409370|NCT02736695|Mayo Clinic|Keith Josephs, M.D.|507-266-4106|josephs.keith@mayo.edu|
22409371|NCT05794126|CooperVision Inc.|José A. Vega OD, PhD, MSc, FAAO|+19256213761|jvega2@coopervision.com|
22409372|NCT01329562|Clinvest/A Division of Banyan Group Inc.|Dr. Roger Cady|417-890-7888|jtarrasch@clinvest.com|
22409373|NCT03252015|Eli Lilly and Company|Cheif Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22409374|NCT04993339|University of Miami|Dr. Francesco Travascio|3052842371|f.travascio@miami.edu|
22409375|NCT00061568|National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH)|John Tisdale, M.D.|301.402.6497|johntis@nhlbi.nih.gov|
22409376|NCT01381068|UCSD|Neil Finer||nfiner@ucsd.edu|
22409377|NCT00797316|Novartis Pharmaceuticals|Study Director|862-778-8300||
22409378|NCT01516684|Wake Forest University Health Sciences|Thomas McLean|336-716-5440|tmclean@wakehealth.edu|
22409379|NCT00402779|UT MD Anderson Cancer Center|Dr. John V. Heymach, PHD/Chair, Thoracic-Head & Neck Med Onc|713-792-6363|jheymach@mdanderson.org|
22409380|NCT00597883|Columbia University|Eric J Heyer|212-305-9072|ejh3@cumc.columbia.edu|
22409381|NCT04933708|Hospital of the University of Pennsylvania|Fei Cai|215-313-0656|feicai90@gmail.com|
22409382|NCT01907516|John A Burns School of Medicine / University of Hawaii Dept of Obstetrics and Gynecology|Marguerite Lisa Bartholomew MD|808-983-6761|mbarthol@hawaii.edu|
22409383|NCT02262507|Cincinnati Childrens Hospital Sports Medicine|Dr. Gregory Myer|513-636-0249|greg.myer@cchmc.org|
22409384|NCT01852669|Monash University|Dr Shaun Lee|55145890|shaun.lee@monash.edu|
22409385|NCT03075215|Boston Scientific|Clinical Trial Manager|1-800-227-3422|Sara.Veraghtert@bsci.com|
22409386|NCT05376293|The Miriam Hospital|Dr. Jessica Unick|401-793-7966|junick@brownhealth.org|
22409387|NCT01121224|VA North Texas Health Care System|Dr. Subhash Banerjee|(214) 857-1608|Subhash.Banerjee@va.gov|
22409388|NCT03712462|Drexel University|Dr. Adrienne Juarascio|215-553-7154|adrienne.s.juarascio@drexel.edu|
22409389|NCT01205568|Boston Childrens Hospital|Kathy Jenkins MD MPH|6173557275|kathy.jenkins@childrens.harvard.edu|
22409390|NCT00690573|Abbott|Global Medical Services|800-633-9110||
22409391|NCT02146365|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22409392|NCT00975000|Amgen Inc.|Study Director|866-572-6436||
22409393|NCT00939367|Accutest Research Laboratories Pvt. Ltd.|Kedar Joshi|+91 22 27780718||
22409394|NCT01126359|Department of Orthopaedics|Dr. Erik Kubiak|801-587-5404|Erik.Kubiak@hsc.utah.edu|
22409395|NCT02500147|Columbia University|Aviva B Sopher, MD, MS|212-305-9362|ahs32@cumc.columbia.edu|
22431736|NCT01446874|Washington University School of Medicine|Varun Puri, M.D.|314-362-4191|varunpuri@wustl.edu|
22418675|NCT02740114|UT MD Anderson Cancer Center|Pedro Ramirez, MD /Professor, Gyn Onc & Reproductive Med|713-745-5498|peramire@mdanderson.org|
22418676|NCT00492024|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22418677|NCT03247816|Shield TX (UK) Limited|Jackie Mitchell MA DPhil|+44 (0) 191 511 8515|jmitchell@shieldtx.com|
22418678|NCT01837524|Kaiser Center for Clinical and Outcomes Research|Kristina Lewis|404-364-7150|khlewis@wakehealth.edu|
22418679|NCT01439009|Otsuka Pharmaceutical Co., Ltd|Director of Clinical Research and Development|+81-3-6361-7366||
22418680|NCT00926783|Biosense Webster EMEA|Ellen Harris, Sr. Clinical Research Associate, Clinical Operations|(800) 729-9010|eharris@its.jnj.com|
22418681|NCT00696787|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22418682|NCT01346293|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22418683|NCT01844505|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22418684|NCT02730351|GlaxoSmithKline|GSK Response Center|866-435-7343|sarah.l.west@gsk.com|
22418685|NCT00128830|Tibotec Pharmaceuticals|Trial Physician|+32-14-607-767||
22418686|NCT00311402|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22418687|NCT02640053|Mayo Clinic|Charles L. Loprinzi, M.D.|507/284-6026|cloprinzi@mayo.edu|
22418688|NCT01135186|Stanford University|Dr. Linda Anh B. Nguyen|650-736-5555|nguyenlb@stanford.edu|
22418689|NCT02754856|University of Texas M D Anderson Cancer Center|Dr. Michael Overman|(713) 792-2828|moverman@mdanderson.org|
22418690|NCT00530218|City of Hope National Medical Center|Ricardo Spielberger, MD|626-359-8111|RSpielberger@coh.org|65298
22418691|NCT01798316|Northwell|Director of Clinical Research, Department of Anesthesiology|718-470-7630|odowling@northwell.edu|
22418692|NCT03541980|Newark Beth Israel Medical Center|Dr Cena Tejani|973 926 7337|ctejani5@gmail.com|
22418693|NCT03477903|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22418694|NCT00407758|NRG Oncology|Angela Kuras on behalf of Mike Sill, PhD|716-845-5702|kurasa@nrgoncology.org|
22431737|NCT05130593|Pennington Biomedical Research Center|Jennifer C Rood, PhD|225-763-2524|jennifer.rood@pbrc.edu|
22409396|NCT05460832|Modern Biosciences|Chief Scientific Officer|+44 (0) 207 444 0066|IST-06@istesso.co.uk|
22409397|NCT00526227|Medtronic CRDM|CRDM Core Clinical Organization|800-328-2518|jamie.l.reynolds@medtronic.com|
22409398|NCT01525407|Fred Hutchinson Cancer Research Center|Dr. Marco Mielcarek|2066672827|mmielcar@fredhutch.org|
22409399|NCT05257109|Yale University|Dr. Danielle Davis|2039747607|danielle.davis@yale.edu|
22409400|NCT00858234|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22409401|NCT01678924|Allergan plc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22409402|NCT02253654|Amgen Inc.|Study Director|866-572-6436||
22409403|NCT01614925|Straumann|Michel Mallaun||michel.mallaun@straumann.com|
22409404|NCT00044005|Sunovion|Josephine Cucchiaro, PhD|201-592-2050|josepine.cucchiaro@sunovion.com|
22409405|NCT03612713|Yale University School of Medicine|Data Manager|203-737-5430|Theresa.Babuscio@yale.edu|
22409406|NCT00830388|University of Alabama at Birmingham|Wendy Cantrell|205-502-9960|wcantrell@uabmc.edu|
22409407|NCT02458365|Pro-Change Behavior Systems, Inc.|Deborah Levesque, Ph.D.|(401) 360-2975|dlevesque@prochange.com|
22409408|NCT01652573|Yale School of Medicine|Dr. Karl Insogna|203-737-2871|karl.insogna@yale.edu|
22409409|NCT01052038|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|312-926-9015|r-mccarthy@northwestern.edu|
22409410|NCT03349437|Philips|Biostatistician|412-542-3651|jeff.jasko@philips.com|
22409411|NCT00254488|Weill Cornell Medical College|Robert C. Young, MD, Professor of Psychiatry|914-997-5886|ryoung@med.cornell.edu|
22409412|NCT03638102|University of Illinois Chicago|Sirimon Reutrakul|3124135357|sreutrak@uic.edu|
22431738|NCT04563767|HealthPartners Neurology|Michael Rosenbloom, MD|651-495-6363|michael.h.rosenbloom@healthpartners.com|
22409413|NCT05723835|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22409414|NCT05226286|Medtronic|Mylene Champs|7635261627|mylene.champs@medtronic.com|
22409415|NCT00602641|ECOG Statistical Office|Study Statistician|617-632-3012||
22409416|NCT03901339|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22409417|NCT02148835|Preventive Cardiology, University of Munich|Prof. Dr. C. von Schacky|+49 89 44005 2165|clemens.vonschacky@med.uni-muenchen.de|
22409418|NCT01988337|DMG Dental Material Gesellschaft mbH|Manager Clinical Research|04084006|clinicalresearch@mtcompanies.com|232
22409419|NCT00457418|Merck Sharp & Dohme Corp.|Senior Vice President,Global CLinical Development||ClinicalTrialsDisclosure@merck.com|
22418695|NCT03347006|Queen Mary University of London|Professor Jesmond Dalli|+442078828263|j.dalli@qmul.ac.uk|
22418696|NCT01158573|University of Michigan|Michael Coffey M.D.|734-936-6267|coffeym@umich.edu|
22409420|NCT01294709|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22392382|NCT02142153|F2G|Dr Anthony Kennedy|0044 161 785 1273|TKennedy@f2g.com|
22392383|NCT00996606|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22392384|NCT03197766|BioMarin Pharmaceutical Inc.|Alice Huntsman Labed|+44 207 4203392|alice.huntsmanlabed@bmrn.com|
22392385|NCT00167206|Masonic Cancer Center, University of Minnesota|Margaret MacMillan, M.D.|612-626-2778|macmi002@umn.edu|
22409421|NCT03387735|UW Madison|CHESS Statistician|6084772614|ocody@wisc.edu|
22409422|NCT03099161|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22409423|NCT00857493|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
22409424|NCT00110084|Mayo Clinic|Dr. Vivek Roy|507-284-1159|roy.vivek@mayo.edu|
22409425|NCT02446496|GlaxoSmithKline|GSK Response Center|866-435-7343||
22409426|NCT04854707|IVFarma LLC|General Manager|+74996455342|info@ivfarma.ru|
22409427|NCT01793285|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22409428|NCT01572428|Indiana University|Rachel Lahr|317-948-0724|rlahr@iu.edu|
22409429|NCT05302414|National Yang Ming Chiao Tung University, Department of Nursing|Hui-Wen Chen Phd candidate|+886939947807|m513102001@gmail.com|
22409430|NCT00742859|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
22409431|NCT00792142|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22409432|NCT00956709|CHU de Nantes|Dr Pham Dang|33 2 53 48 24 15|charles.phamdang@chu-nantes.fr|
22409433|NCT01346501|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22409434|NCT00486642|Bristish Columbia Cancer Agency|Dr. Kim N. Chi|604-877-6000|kchi@bccancer.bc.ca|2746
22409435|NCT02564952|GW Research Ltd|Medical Enquiries|+44 01223 238170; +18778862810|medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
22409436|NCT03706209|MetrioPharm Deutschland GmbH|Clinical Disclosure Officer|+49303384395|info@metriopharm.com|
22409437|NCT03491228|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22409438|NCT01527942|ST. FRANCIS HOSPITAL AND MEDICAL CENTER|Ioannis Raftopoulos, MD||IRaftopo@stfranciscare.org|
22409439|NCT01071083|Biogen Idec Inc|Biogen Idec Medical Director|1-617-679-2000|neurologyclinicaltrials@biogenidec.com|
22409440|NCT00038467|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22409441|NCT03972709|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22409442|NCT01523301|UCB|Study Director|+1877 822 9493||
22409443|NCT01339000|National Cancer Institute|Dr. Ronald Gress|301-496-1791|gressr@mail.nih.gov|
22409444|NCT00728988|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22409445|NCT00116207|University of Michigan|Eva L. Feldman, Professor of Internal Medicine|7347637274|efeldman@med.umich.edu|
22409446|NCT02017535|University of Minnesota|Meredith Gunlicks-Stoessel|612-273-9844|mgunlick@umn.edu|
22409447|NCT05511428|Thomas Jefferson University|Adam Binder, MD|215-955-8874|Adam.binder@jefferson.edu|
22409448|NCT04088734|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
22409449|NCT03354169|University of Pennsylvania|Kelly C. Allison, PhD|215-898-2823|kca@pennmedicine.upenn.edu|
22409450|NCT02843308|Stanford University School of Medicine|Carolyn Rodriguez, MD, PhD|650-723-4095|ocdresearch@stanford.edu|
22409451|NCT00664066|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22409452|NCT04828551|Massachusetts General Hospital|Anthony Samir|6178523241|asamir@mgh.harvard.edu|
22409453|NCT00481871|Allos Therapeutics, Inc.|Michael Saunders, MD|303-426-6262|msaunders@allos.com|
22409454|NCT00345969|Washington University School of Medicine|Ellen F. Binder, MD|314-286-2707|ebinder@wustl.edu|
22409455|NCT00609115|AMES Technology, Inc.|Dr. Paul Cordo|503 970 6129|pcordo@amesdevices.com|
22409456|NCT00902486|Incyte Corporation|Study Director|855 463-3463||
22409457|NCT01843660|Janssen China, Beijing|Therapeutic Area Physician|+86-10-58218709||
22409458|NCT00209560|Eisai Inc|Eisai Medical Services|1-888-422-4743||
22409459|NCT04439110|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22409460|NCT07046403|Adichunchanagiri Institute of Medical Sciences|Dr Naveen N|+91-9980023372|naveen_uno1@yahoo.co.in|
22409461|NCT01721369|Hospital Vall hebron|Dr. Angel Moya||amoyamitjans@gmail.com|
22409462|NCT00584831|Vistakon|Kurt Moody, OD, FAAO|904-443-3088|kmoody1@its.jnj.com|
22409463|NCT01211613|University of Pittsburgh, Department of Physical Therapy'|Michael J Schneider, DC, PhD|412-383-6640|mjs5@pitt.edu|
22409464|NCT03853213|Columbia University Irving Medical Center|Dr. Jeffrey Birk|212-342-5503|jlb2287@cumc.columbia.edu|
22409465|NCT03044431|Lung Institute|Melissa Rubio, PhD, APRN|214-504-2117|pidallas@lunginstitute.com|
22409466|NCT04470622|Heron Therapeutics, Inc.|Sophie Visonneau|858-251-7232|svisonneau@herontx.com|
22392386|NCT00305344|University of Florida|Dr Michael Haller|352.273.9264|hallemj@peds.ufl.edu|
22392387|NCT01460225|Dartmouth-Hitchcock Medical Center|Dr. Brian Lacy|603-650-5215|brian.e.lacy@hitchcock.org|
22392388|NCT02755129|Medtronic|Ilaria Marcotullio|+39 06 32814218|ilaria.marcotullio@medtronic.com|
22392389|NCT00350727|GlaxoSmithKline|GSK Response Center|866-435-7343||
22392390|NCT04535544|Janssen Research & Development, LLC|Senior Director Medical Lead|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22392391|NCT02506933|City of Hope Medical Center|Dr. Ryotaro Nakamura, MD|6263598111|RNakamura@coh.org|
22409467|NCT04313023|Pulmotect, Inc.|Dr. Brenton Scott, President & COO|713-579-9226|bscott@pulmotect.com|
22409468|NCT02576054|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22409469|NCT00149669|Johns Hopkins University School of Medicine|Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
22409470|NCT00791154|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
22409471|NCT00953927|Aeras|Bernard Landry|301-547-2919|blandry@aeras.org|
22409472|NCT00934622|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22418697|NCT00750308|Vanderbilt University|Dr. Nancy J. Brown|615-343-8701|nancy.j.brown@vanderbilt.edu|
22418698|NCT01822275|University of Maryland Medical Center|Caitlin Eggleston|4103287586|caitlineggleston@umm.edu|
22418699|NCT02980874|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
22418700|NCT00513682|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
22418701|NCT02450526|Ipsen|Medical Director||clinical.trials@ipsen.com|
22418702|NCT00193427|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|ASKSARAH@scresearch.net|
22418703|NCT04271020|NeoTract, Inc.|Emily Friedland, Director, Global Clinical Affairs|1-610-331-7299|emily.friedland@teleflex.com|
22418704|NCT02582866|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22418705|NCT03567382|University of North Carolina at Chapel Hill|Peyton Thompson, MD, MSCR|919-445-0854|peyton_thompson@med.unc.edu|
22418706|NCT02175576|Zimmer Biomet|Hillary Overholser|574-933-4180|hillary.overholser@zimmerbiomet.com|
22418707|NCT03564444|MedImmune, LLC|Raburn Mallory|+1-301-398-5799|information.center@astrazeneca.com|
22418708|NCT03246646|CMC VA Medical Center|Steven L. Sayers|(215) 823-5196|steven.sayers@va.gov|
22418709|NCT02569112|Venus Concept Ltd.|Dr. Yoni Iger|8889070115|yoni@venusconcept.com|
22418710|NCT00758680|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22418711|NCT00319982|Brigham and Women's Hospital|Carolyn Ho, MD|617-732-5685|cho@partners.org|
22418712|NCT03480386|Mayo Clinic|Roberto P. Benzo, MD|507-284-0561|Benzo.Roberto@mayo.edu|
22418713|NCT02201290|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
22418714|NCT00070499|SWOG Statistical Office|SWOG Leukemia Statistician|206-667-4408||
22409473|NCT02706041|The University of Texas Health Science Center at Houston|John A. Harvin, MD, FACS, Associate Professor|(713) 500-7244|John.Harvin@uth.tmc.edu|
22409474|NCT00468312|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22409475|NCT01396161|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22409476|NCT02962739|"University of Colorado | Skaggs School of Pharmacy and Pharmaceutical Sciences"|Dr. Peter Anderson|3037246128|peter.anderson@cuanschutz.edu|
22409477|NCT03343054|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22409478|NCT01208922|Dr. Falk Pharma GmbH|Department of Clinical Research|0049 7611514|zentrale@drfalkpharma.de|0
22409479|NCT01818414|University of Minnesota|Christy Boraas, MD, MPH|612-273-7111|bora0021@umn.edu|
22409480|NCT00981409|GlaxoSmithKline|GSK Response Center|866-435-7343||
22409481|NCT00450177|Weill Cornell Medical College|Philip S. Barie, MD|646-962-2580|pbarie@med.cornell.edu|
22409482|NCT03361917|Indiana University|Rachel Lahr|3179480724|rlahr@iu.edu|
22409483|NCT00774202|Weill Cornell Medical College|James B. Bussel, M.D. Professor of Pediatrics|212-746-3474|jbussel@med.cornell.edu|
22409484|NCT03869684|Senju Pharmaceutical Co. Ltd.|Director, Clinical Development|+81 078 777 1018|senju-clinicaltrials@senju.co.jp|
22409485|NCT04056299|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
22409486|NCT03895307|SultanAbdulhamid|Adem Erbirol|+905426608788|aerbirol@hotmail.com|
22409487|NCT01227954|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22409488|NCT01316523|University of California, Davis|Leslie Garcia|916-734-0156|lesgarcia@ucdavis.edu|
22409489|NCT00720473|McLean Hospital|Dr. Brent Forester|(617) 855-3622|bforester@partners.org|
22409490|NCT00078312|Cephalon|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
22409491|NCT02846740|University of Maryland Baltimore|Nithin krishna|4103286661|nkrishna@som.umaryland.edu|
22409492|NCT01268683|Biogen|Medical Director|866-633-4636|clinicaltrials@biogen.com|
22409493|NCT05041803|Sun Pharmaceutical Industries Limited|Head, Regulatory Affairs|9122 66455645|Clinical.Trial@sunpharma.com|
22409494|NCT04256759|Mayo Clinic|Jason Sluzevich, M.D.|904-953-6192|sluzevich.jason@mayo.edu|
22409495|NCT04661540|CalciMedica|Sudarshan Hebbar, MD (Chief Medical Officer)|(816) 838-7105|sudarshan@calcimedica.com|
22409496|NCT03901352|Daiichi Sankyo|Contact of Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22409497|NCT05150340|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22409498|NCT01826201|Moleculin, LLC|Chief Medical Officer|713-953-7676|Carena@moleculin.com|232
22409499|NCT02742818|Hospital Israelita Albert Einstein|Dr. Nelson Wolosker|+55 11 2151-5423|nwolosker@yahoo.com.br|
22409500|NCT04701658|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22409501|NCT00686231|UCSF|Andrew Boyle|415-514-0827|aboyle@medicine.ucsf.edu|
22409502|NCT05349188|Northwell Health|Dr. Mark Butler, PhD|908-414-0238|markbutler@northwell.edu|
22409503|NCT02494544|restor3d|Tara Mann - Director of Clinical Affairs|(984) 888-0593|clinicalresearch@restor3d.com|
22409504|NCT02424357|University of Miami|Hilda Capo|305-326-6555|hcapo@med.miami.edu|
22409505|NCT04616768|University of Pennsylvania|Ravi Parikh|3524224285|ravi.parikh@pennmedicine.upenn.edu|
22409506|NCT03193190|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22409507|NCT03532295|Washington University School of Medicine|Dr. Milan Chheda|314-747-7222|mchheda@wustl.edu|
22409508|NCT05004181|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
22409509|NCT01526629|Medtronic|Latifa Foudali|0155381700|latifa.foudali@medtronic.com|
22409510|NCT03868059|Lipocine|Shadi Mehraban|801-994-7383|sm@lipocine.com|2191
22409511|NCT04278872|Sojournix, Inc.|Head of Regulatory Affairs|6174758469|clinicaltrials@sojournixpharma.com|
22409512|NCT02392377|University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr Jennifer Eads|(216) 844-6031|jennifer.eads@uhhospitals.org|
22409513|NCT01298661|Universidade Federal de São Carlos|Juliano Ferreira Arcuri|+55 (16) 33518343|julianoarcuri@gmail.com|
22409514|NCT01607398|GlaxoSmithKline|GSK Response Center|866-435-7343||
22409515|NCT02239692|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22409516|NCT03232749|University of Florida|MaryBeth Horodyski, Ed.D., ATC, LAT, FNATA|352-273-7074|horodmb@ortho.ufl.edu|
22409517|NCT01901146|Amgen Inc.|Study Director|866-572-6436||
22409518|NCT02675426|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22409519|NCT02277639|Children's Hospital of Philadelphia|Nancy Bunin, MD|215-590-2255|buninn@email.chop.edu|
22409520|NCT03724968|Vanderbilt University Medical Center|Teresa Melton|6159367423|teresa.melton@vumc.org|
22409521|NCT01784419|University of California, San Francisco|Dennis W. Nielson, MD, PhD||Dennis.Nielson@ucsf.edu|
22409522|NCT02237118|Clinique Mutualiste du Medoc|Dr Anne Solanilla|+33 5 56 73 11 43|annasolanilla@yahoo.fr|
22409523|NCT00080288|Cephalon|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
22409524|NCT00069160|National Cancer Institute, National Institutes of Health|Susan E. Bates, M.D.|301-402-1357|BatesS@mail.nih.gov|
22409525|NCT00821041|University of Manitoba|Study Coordinator|204-787-5098|NVincent@exchange.hsc.mb.ca|
22409526|NCT03978117|Masonic Cancer Center|Dorothy Hatsukami, PhD|(612) 626-2121|hatsu001@umn.edu|
22409527|NCT03976076|Bio-Pharm Solutions Co., Ltd.|Bio-Pharm Solutions Medical Information|NA|conference.clinical@b-psol.com|
22418715|NCT00805467|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
22409528|NCT00414011|U.S. Army Warfighter Refractive Surgery Research Center|Principal Investigator|571-231-1600|rose.sia@us.army.mil|
22418716|NCT04036799|Hospital for Sick Children|Seema Mital, Staff Cardiologist|416-813-7418|seema.mital@sickkids.ca|
22418717|NCT04240392|Yale School of Medicine|Ariadna Forray, MD|203-785-2618|ariadna.forray@yale.edu|
22392392|NCT04193826|Conformal Medical, Inc|Aly Dechert / Manager of Clinical Operations|(603) 718-8742|adechert@conformalmedical.com|
22409529|NCT02923115|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22409530|NCT01296152|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22409531|NCT01875991|Amgen Inc.|Study Director|866-572-6436||
22409532|NCT03981614|University of Texas; MD Anderson Cancer Center|Scott Kopetz, M.D.|(507) 266-0800|SKopetz@mdanderson.org|
22409533|NCT00756652|Mentor Worldwide, LLC|Sponsor|949-453-6408|mgpas@its.jnj.com|
22409534|NCT04732728|Boston Scientific|Thomas Stoltz, Clinical Trial Manager|1-800-CARDIAC|thomas.stoltz@bsci.com|
22409535|NCT04971226|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
22409536|NCT01158976|University of Chicago|Kathry Keenan|773-702-4449|kekeenan@uchicago.edu|
22409537|NCT00514501|Progenics Pharmaceuticals, Inc.|Senior Director of Clinical Communications|914 784-1825|vdipippo@progenics.com|
22409538|NCT06065176|University of Utah|Sarang Yoon, PI|801-203-0320|sarang.yoon@hsc.utah.edu|
22409539|NCT04521608|Mayo Clinic|Roberto Benzo, M.D.|480-301-8244|benzo.roberto@mayo.edu|
22409540|NCT03889197|Department of Biostatistics and Health Data Science, Indiana University School of Medicine|Kelly Mosesso, MA; Biostatistician II|317-278-5439|kmosesso@iu.edu|
22409541|NCT05256992|Midwest Evaluation and Research|Dr. Matthew Shepherd|8336439377|matt.shepherd@midwestevaluation.com|
22409542|NCT04083378|The University of Texas MD Anderson Cancer Center|Dr. Bruno Odisio|(713) 563-1066|bcodisio@mdanderson.org|
22409543|NCT05824273|Hackensack Meridian Health - Center for Discovery and Innovation|Ana Vielma|2018803100|ana.vielma@hmh-cdi.org|
22409544|NCT05711524|Weill Cornell Medicine|Dr. Melissa Cushing|212-746-3527|mec2013@med.cornell.edu|
22409545|NCT06474715|Columbia University Irving Medical Center|Lauren Houghton, PhD Msc|212-342-0246|lh2746@cumc.columbia.edu|
22409546|NCT04644237|Daiichi Sanyko, Inc|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22409547|NCT03131817|University of California, San Francisco|Dr. Simon Little|4152995650|simon.little@ucsf.edu|
22409548|NCT04824560|University of New Mexico College of Pharmacy|Alexandra Herman|505-272-7630|asible@salud.unm.edu|
22409549|NCT02061293|NYU Langone Health|Samantha Podrebarac, MSc|212-263-0912|Samantha.Podrebarac@nyulangone.org|
22409550|NCT06232408|Repare Therapeutics Inc|Repare Therapeutics Medical Monitor|1 (857) 340-5402|clininfo@reparerx.com|
22409551|NCT02949219|Mayo Clinic|Robert R. McWilliams, M.D.|507-266-9161|mcwilliams.robert@mayo.edu|
22409552|NCT03494816|University of Cambridge|Prof Grant Stewart|01223 256211|gds35@cam.ac.uk|
22409553|NCT05573113|Children's Mercy Kansas City|Sherwin Chan|816-234-3273|sschan@cmh.edu|
22409554|NCT05734014|Montana State University|Vanessa Simonds|4069947396|vanessa.simonds@montana.edu|
22409555|NCT04024254|Rush University Medical Center|Dr Lydia Usha|312-942-5904|Lydia_Usha@rush.edu|
22409556|NCT02689973|SWPS University of Social Sciences and Humanities|Dr Aleksandra Luszczynska, Principal Investigator|+4877507260|aluszczynska@swps.edu.pl|
22409557|NCT00379821|Malaria Section, Center for Vaccine Development, University of Maryland School of Medicine|Christopher Plowe, MD, MPH|410-706-2491|cplowe@medicine.umaryland.edu|
22409558|NCT00633217|GlaxoSmithKline|GSK Response Center|866-435-7343||
22409559|NCT05838755|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|
22409560|NCT01283282|Emory University|Dr. Arshed Quyyumi|404-727-3655|aquyyum@emory.edu|
22409561|NCT01682681|Janssen Korea, Location: 25F, LS , Yongsan Tower, 191, Hankangro 2-Ga, Yongsan-Gu, Seoul 140-702, Korea|Clinical Research Associate, Medical affairs|82-2-2094-4837||
22409562|NCT03515681|Columbia University|Steven J. Shea, MD|212-305-6355|ss35@cumc.columbia.edu|
22409563|NCT02044094|Indivior, Inc.|Global Director, Clinical Development|804-379-1090||
22409564|NCT00005879|University of Kansas Medical Center|Bruce F. Kimler, Ph.D.|913-588-4523|bkimler@kumc.edu|
22409565|NCT01238172|Moores Cancer Center|J. Kellogg Parsons, M.D., MHS|858-822-7874|jkparsons@ucsd.edu|
22409566|NCT05022121|University of Minnesota|Brent Leininger|6126266477|lein0122@umn.edu|
22409567|NCT01020773|Beijing Shijitan Hospital|Department of Respiratory Medicine|86-010-63926385|mayingmin@hotmail.com|
22409568|NCT03302299|University of California San Francisco|Dr. Judy Hahn|415-476-5815|judy.hahn@ucsf.edu|
22409569|NCT01458132|GlaxoSmithKline|GSK Response Center|866-435-7343||
22409570|NCT00350337|United States Army Medical Materiel Development Activity|Division of Regulated Activities and Compliance Director|301-619-0317|USAMRMCREGULATORYAFFAIRS@amedd.army.mil|
22409571|NCT01320826|University of Alberta|Dr. Michael Kolber|(780) 616-8411|mkolber@ualberta.ca|
22409572|NCT01788163|AstraZeneca|Haiyi Jiang/Asia Medical Director|+86 21 60302408|Haiyi.Jiang@astrazeneca.com|
22409573|NCT03610646|Viatris|Dr. Prasanna Ganapathi, Head of Global Clinical Strategy and Innovation|+91 80 6672800|prasanna.ganapathi@viatris.com|
22409574|NCT02803138|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22409575|NCT00424515|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617.632.5053|Stephen_Hodi@dfci.harvard.edu|
22409576|NCT04318535|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22409577|NCT01629134|Allergan, Inc.|Medical Monitor|714-246-4500|clinicaltrials@allergan.com|
22409578|NCT00021229|Pediatric Brain Tumor Consortium|Pediatric Brain Tumor Consortium (James M. Boyett, Ph.D)|901-595-4986|james.boyett@stjude.org|
22409579|NCT02007369|School of Public Health, The University of Hong Kong|Dr. Cheung, Yee Tak Derek|+852 39176652|derekcheung@hku.hk|
22409580|NCT00297492|University of Vermont|Dr. John Hughes|802-656-9610|John.Hughes@uvm.edu|
22409581|NCT02156466|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22409582|NCT00569231|University of Arkansas for Medical Sciences|Mayumi Nakagawa, MD, PhD|(501) 686-8635|mnakagawa@uams.edu|
22409583|NCT03456726|Eisai Co., Ltd|Eisai Inquiry Service|None|eisai-chiken_hotline@hhc.eisai.co.jp|
22409584|NCT00306852|University of Miami|Dr. Steven Gedde|305-326-6435|sgedde@med.miami.edu|
22409585|NCT00817778|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22409586|NCT00883740|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22409587|NCT00103259|Eastern Cooperative Oncology Group (ECOG) Statistical Office|ECOG Statistician|617-632-3012||
22409588|NCT03224234|Emory University|Dr. Umpierrez|404-251-8957|geumpie@emory.edu|
22409589|NCT02610842|Unicamp - University of Campinas|Dr. Eduardo de Paiva Magalhaes|+55 (19) 35217113|dreduardomagalhaes@gmail.com|
22409590|NCT00396981|University of California, UCSF Medical Center|S. Claiboren Johnston, MD, PhD|415-502-7487|Clay.Johnston@ucsfmedctr.org|
22409591|NCT02494583|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22409592|NCT00627458|GlaxoSmithKline|GSK Response Center|866-435-7343||
22409593|NCT03151707|McLean Hospital|Dost Ongur|6178553922|dongur@partners.org|
22409594|NCT04439149|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22409595|NCT02617446|Windtree Therapeutics, Inc.|Phillip D. Simmons, Executive Director of Biostatistics & Data Management|215-488-9300|psimmons@windtreetx.com|
22409596|NCT03030638|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22409597|NCT00530088|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22409598|NCT03974516|i Cure Biotech Co., Ltd.|David Liu|+886-955-104-105|white06041983a@gmail.com|
22409599|NCT05264506|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
22409600|NCT00644228|SWOG Statistical Center|Study Statistician|206-667-4623||
22409601|NCT06078124|Washington University in St. Louis|Dr. Lindsay Stark|314-935-4747|lindsay.stark@wustl.edu|
22409602|NCT02843529|Altoida Inc.|Ioannis Tarnanas|+18325975076|Ioannis@altoida.com|
22409603|NCT02925650|Alzheimer's Disease Cooperative Study|Howard Feldman MDCM, FRCP(C)|858-246-1347|hhfeldman@health.ucsd.edu|
22409604|NCT00417859|University Hospital of Lausanne|Prof Brigitte Jolles|0213149629|brigitte.jolles@chuv.ch|
22409605|NCT03252756|NYU Langone Health|Michael Bogenschutz, PhD|646-501-4026|Michael.Bogenschutz@nyulangone.org|
22409606|NCT04066894|M D Anderson Cancer Center|Dr. Craig Messick|(713) 745-1544|cmessick@mdanderson.org|
22409607|NCT01500434|Boston Scientific|Ruth Starzyk, PhD|508-683-6577|ruth.starzyk@bsci.com|
22409608|NCT00083226|ECOG Statistical Office|Study Statistician|617-632-3012||
22409609|NCT00909857|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22409610|NCT04800510|The University of Iowa|Jason M. Wilken, PT, PhD|319-335-6857|jason-wilken@uiowa.edu|
22409611|NCT00604175|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301)-628-3313|ACTGCT.Gov@s-3.com|
22409612|NCT03353415|Joslin Diabetes Center|Mary Elizabeth Patti, MD|6713092635|MaryElizabeth.Patti@Joslin.Harvard.edu|
22409613|NCT03205163|Bioverativ, a Sanofi company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6
22409614|NCT00131937|ECOG Statistical Office|Study Statistician|617-632-3012||
22409615|NCT06873867|Adichunchanagiri Institute of Medical Sciences|Dr Naveen N|+91-9980023372|naveen_uno1@yahoo.co.in|
22409616|NCT04647253|Boston Scientific|Patricia O'Mara|518-744-0046|patricia.omara@bsci.com|
22409617|NCT01209234|University of California, Irvine|Susan Huang, Principal Investigator & Medical Director of Epidemiology and Infection Prevention|949-824-5073|sshuang@uci.edu|
22409618|NCT04502862|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
22409619|NCT03229941|New York Veterans Affairs Healthcare System, Brooklyn|Panagiotis Kougias|718-836-6600|panagiotis.kougias@va.gov|
22409620|NCT02038959|University of Rochester|Ray Dorsey, MD|585-276-6824|ray.dorsey@chet.rochester.edu|
22409621|NCT03233737|University of Pennsylvania, School of Dental Medicine|Elliot V Hersh, DMD, Ph.D., Director Clinical Pharmacology Research|215-898-9686|evhersh@pobox.upenn.edu|
22409622|NCT00819091|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22409623|NCT00265239|Kumamoto University|Dr. Kenichi Tsujita|+81-96-373-5175|tsujita@kumamoto-u.ac.jp|
22409624|NCT04071366|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22409625|NCT01733186|MEDIPOST Co., Ltd.|Director of Product Development Department|+82-2-3465-6740|meehyunj@medi-post.co.kr|
22409626|NCT01858558|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Philip Imus, MD|410-955-8873|pimus1@jhmi.edu|
22409627|NCT01336608|GlaxoSmithKline|GSK Response Center|866-435-7343||
22409628|NCT02316678|University of Pennsylvania|James Lewis|215-573-5137|lewisjd@upenn.edu|
22409629|NCT00786019|University of Colorado|Judith Regensteiner, PhD|303-724-2247|judy.regensteiner@ucdenver.edu|
22409630|NCT00399490|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22409631|NCT02437890|Ablynx|Medical Monitor|+32 (9) 262 00 00|clinicaltrials@ablynx.com|
22409632|NCT02328547|Montefiore Medical Center|Dr. Olga C. Aroniadis, PI|718-920-4846|oaroniad@montefiore.org|
22409633|NCT00344305|MedImmune, LLC|Raburn Mallory MD/ Sr Dir Clinical Development|301-398-0000|clinicaltrialenquiries@medimmune.com|
22409634|NCT01190098|Cleveland Clinic|Nancy Foldvary-Schaefer, DO, MS|216-445-2990|foldvan@ccf.org|
22409635|NCT00176501|Rutgers Cancer Institute of New Jersey|Dr. Roger Strair, MD, PhD|732-235-8675|strairrk@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
22409636|NCT01422720|BIAL - Portela & Cª S.A.|Director R&D|+351-229866100|clinical.trials@bial.com|
22409637|NCT01614613|Ascensia Diabetes Care|Carmine Greene|574-257-3040|carmine.greene@ascensia.com|
22409638|NCT01557452|Italfarmaco SpA|Paolo Bettica, MD|+39 02 64431|p.bettica@italfarmaco.com|
22431739|NCT03639610|Oncopeptides AB|VP Chief Operating Officer|+46 8 615 20 40|trials@oncopeptides.com|
22409639|NCT00448682|University of Miami Sylvester Comprehensive Cancer Center|Bach Ardalan MD|305-243-6608|bardalan@med.miami.edu|
22409640|NCT01796860|University of Texas Southwestern Medical Center|Karen J McCain, PT, DPT, NCS, Principal Investigator|214-648-1559|karen.mccain@utsouthwestern.edu|
22409641|NCT01453101|Hackensack Meridian Health|Joshua Zenreich|15519964248|joshua.zenreich@hmhn.org|
22409642|NCT04604496|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22409643|NCT02307188|Columbia University Medical Center|Abgelo Biviano|212-305-7646|ab542@columbia.edu|
22409644|NCT01537549|Weill Cornell Medicine|Dr. Claire Henchcliffe|2127462584|clh2007@med.cornell.edu|
22409645|NCT01286207|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22409646|NCT02556931|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Amy Dezern|410-502-7208|adezern1@jhmi.edu|
22409647|NCT01307631|Dana-Farber Cancer Institute|Jennifer Curtis, MS|617-582-7183|jennifer_curtis@dfci.harvard.edu|
22409648|NCT02039817|Conatus Pharmaceuticals|Jean L. Chan, MD|858 376 2632|jchan@conatuspharma.com|
22409649|NCT00068406|NRG Oncology|Linda Gedeon for Wei Deng, PhD.|716-845-1169|lgedeon@gogstats.org|
22409650|NCT02609178|Stomatological Hospital of FMMU|Pingting Lin, PhD|+86 15249049902|biu79@hotmail.com|
22409651|NCT03583931|Denver Health and Hospital Authority|Dr Fredric Pieracci|303-602-1863|Fredric.Pieracci@dhha.org|
22409652|NCT00902265|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22409653|NCT02866695|University of California San Francisco Dept. of Dermatology|Dr. Sarah Arron, MD, PhD|415-353-9684|sarah.arron@ucsf.edu|
22409654|NCT05016765|Washington University School of Medicine|Kevin J. Black, M.D.|1-314-362-5041|kevin@wustl.edu|
22409655|NCT00068770|Johns Hopkins University|Dr. Stuart A Grossman|410-955-3657|jfisher@jhmi.edu|
22409656|NCT03891875|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
22409657|NCT02192541|National Cancer Institute|Alice P. Chen, M.D.|(240) 781-3320|chenali@mail.nih.gov|
22409658|NCT02009982|Emory University|Dr. David De Lurgio|404-251-1481|ddelurg@emory.edu|
22409659|NCT02328404|Hayat Pharmaceutical industries|DR. ALA' ABU RUQA'A|00962 6 4162607|tbd@hayatpharma.com|225
22409660|NCT03474640|TopAlliance BioSciences|Dr. Kevin Li|301-640-5166|kevin_li@topalliancebio.com|
22409661|NCT00285012|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22409662|NCT01445873|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22409663|NCT05298345|Midwest Evaluation and Research|Dr. Matthew Shepherd|8336439377|matt.shepherd@midwestevaluation.com|
22409664|NCT05631093|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@MSD.com|
22409665|NCT02873195|Duke University Medical Center|Niharika Bansal Mettu, M.D.|919-681-2954|niharika.mettu@duke.edu|
22409666|NCT03107715|University Hospitals Rainbow Babies and Children's Hospital|Lydia Furman MD, PI|216-844=8260|lydia.furman@uhhospitals.org|
22409667|NCT00094900|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Raphaela Goldbach-Mansky, MD|13014356243|goldbacr@mail.nih.gov|
22409668|NCT03739684|Lantheus Medical Imaging / Progenics Pharmaceuticals|David Myl|914-582-1120|david.myl@lantheus.com|
22409669|NCT04223193|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22409670|NCT03594175|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
22409671|NCT03732677|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22409672|NCT02181127|Massachusetts General Hospital|Dr Steven J Russell|617-726-1848|sjrussell@partners.org|
22409673|NCT00096031|SWOG Statistical Center|Study Statistician|206-667-4623||
22409674|NCT00483717|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D|601-650-4200|dbregman@lpicrd.com|828
22409675|NCT03878108|NIDDK|Kevin Hall, PhD|301-402-8248|kevin.hall@nih.gov|
22409676|NCT05073692|Kaiser Permanente Division of Research|Romain Neugebauer|510-891-3234|Romain.S.Neugebauer@kp.org|
22409677|NCT04822701|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22409678|NCT02706353|M.D. Anderson Cancer Center|Adi Diab, MD|713-792-2921|MDADiab@mdanderson.org|
22409679|NCT03560466|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22409680|NCT00545441|Cook Biotech Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@cookbiotech.com|
22409681|NCT03911960|Hennepin Healthcare|Sandra Japuntich|6128736856|sandra.japuntich@hcmed.org|
22409682|NCT01999231|Shanghai Public Health Clinical Center|Shuihua Lu|(+86)18930811818|tubercle@gmail.com|
22409683|NCT04723173|Sonova AG|Bernhard Buschle|+41 58 928 44 21|bernhard.buschle@sonova.com|
22409684|NCT02996448|NIAID, NIH|Alexandra Freeman|301-594-9045|freemaal@mail.nih.gov|
22409685|NCT00606801|Yale University|Mehmet Sofuoglu, M.D., Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu|
22409686|NCT02082262|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22409687|NCT01284244|Mount Sinai Hospital|Dr. Danny Lovatsis|416-586-4566|danny.lovatsis@sinaihealthsystem.ca|
22409688|NCT01143272|Johns Hopkins Bloomberg School of Public Health|Stephan Ehrhardt|410-502-3872|sehrhard@jhsph.edu|
22409689|NCT01726335|Janssen-Cilag Ltd.|Medical Group Manager|+55 11 30302738||
22409690|NCT01586624|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
22409691|NCT00545181|Indiana University School of Medicine|David Haas, MD MS|3176307837|dahaas@iupui.edu|
22409692|NCT02533505|AstraZeneca|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22409693|NCT01289431|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22409694|NCT00647426|Abramson Cancer Center|Tracey Evans MD|215 614 0861|Christine.Bonney@UPHS.upenn.edu|
22409695|NCT02320838|Universidad de Castilla-La Mancha|Dr. Juan Avendaño Coy|+34 925268800|juan.avendano@uclm.es|5014
22409696|NCT02748616|NYU Langone Health|Norman Javitt, MD|212-263-6588|Norman.Javitt@nyulangone.org|
22409697|NCT02018042|Columbia University Department of Dermatology Clinical Research Unit|Grace Ulerio, CCRC|212-305-6593|gu2102@cumc.columbia.edu|
22418718|NCT03589768|University of Maryland School of Medicine|Kathleen M. Neuzil, MD, MPH|410-706-5328|kneuzil@medicine.umaryland.edu|
22418719|NCT03785600|VA Portland Health Care System|Jonathan Elliott|503-220-8262|jonathan.elliott@va.gov|53874
22418720|NCT02185690|Princess Margaret Cancer Centre, University Health Network|Dr. Natasha Leighl, Sponsor-Investigator, Division of Medical Oncology|416-946-4645|natasha.leighl@uhn.ca|
22418721|NCT02155543|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22418722|NCT05307510|The University of Toledo|Laura Schmelzer|419-530-5068|laura.schmelzer@utoledo.edu|
22418723|NCT02087995|Dexcom, Inc|Andrew Balo/ EVP|8582000203|abalo@dexcom.com|
22418724|NCT04345601|Baylor College of Medicine|Dr. Laquisa Hill|713-441-1450|LaQuisa.Hill@bcm.edu|
22431740|NCT03136055|University of California, San Francisco|Dr. Emily Bergsland|(415) 353-9888|Emily.Bergsland@ucsf.edu|
22431741|NCT05067335|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22431742|NCT03610048|Alkermes|Director, Corporate and R&D Communications|781-609-7000|Gretchen.Murphy@alkermes.com|
22431743|NCT01146613|NIAAA|Megan Ryan, M.B.A.|301-443-4225|mryan1@mail.nih.gov|
22431744|NCT02136914|Adamas Pharmaceuticals, Inc.|Head, Regulatory Affairs|+1 (510) 450-3500|drugsafety@adamaspharma.com|
22431745|NCT05878067|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22409698|NCT03231709|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22409699|NCT02419469|UT MD Anderson Cancer Center|Rytting,Michael E.,M.D. / PEDIATRICS|713-792-7734|CR_Study_Registration@mdanderson.org|
22409700|NCT01785875|Amgen Inc.|Study Director|866-572-6436||
22409701|NCT03112993|University of Missouri|Dr. Boris Mraovic, MD, Professor of Clinical Anesthesiology|573-882-2568|mraovicb@health.missouri.edu|
22409702|NCT04840901|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22409703|NCT01414062|Columbia University Irving Medical Center|Dawn Hershman, MD, MS|212-342-4580|dlh23@cumc.columbia.edu|
22409704|NCT04075292|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22409705|NCT05292053|Baylor Scott & White Research Institute|Clinical Research Manager|214-820-1771|Felicia.Padilla@BSWHealth.org|
22409706|NCT01988493|Merck KGaA Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22409707|NCT00535301|SCPMG/Kaiser Permanente|John N. Nguyen, MD|562-657-2642|john.n.nguyen@kp.org|
22409708|NCT02360059|The University of Texas (UT) MD Anderson Cancer Center|Dr. David L. Ramirez, Assistant Professor, Breast Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
22409709|NCT00185731|Stanford University School of Medicine|Alice Fan, MD|650-725-6454|afan@stanford.edu|
22409710|NCT03087773|Medical University of Graz|Univ.-Prof. PD Harald Sourij, MD, MBA|+43 316 385 81310|ha.sourij@medunigraz.at|
22409711|NCT01754480|Grifols Therapeutics Inc|Henry Li, PhD|+1 919 316 6042|henry.li@grifols.com|
22409712|NCT05144477|Columbia University Irving Medical Center|Dr. Talea Cornelius|(212) 342-5503|tmc2184@cumc.columbia.edu|
22431746|NCT00949533|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22431747|NCT01493089|Norgine Ltd|Dr. Richard Ng Kwet Shing|+441895453584|RNg@Norgine.com|
22431748|NCT02234362|MGH Center for Women's Mental Health|Dr. Marlene Freeman|617-723-6403|mfreeman@partners.org|
22431749|NCT00261833|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22431750|NCT00419744|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22431751|NCT03462745|American University of Beirut Medical Center|Dr. Roland Kaddoum|01350000|rk16@aub.edu.lb|6704
22431752|NCT00583219|Mayo Clinic|Dr. Steven P. Petrou|904-953-7330|petrou.steven@mayo.edu|
22431753|NCT02131766|UVA|Sue Brown, MD|434-982-0602|sab2f@virginia.edu|
22431754|NCT01874392|Sansum Diabetes Research Institute|Director of Research and Innovation|8056827640|dkerr@sansum.org|
22431755|NCT02271880|Florida International University|Dr. William Pelham|305-348-0477|wpelham@fiu.edu|
22431756|NCT01959685|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
22431757|NCT00474903|Mayo Clinic Rochester|Paul J. Limburg, M.D., M.P.H.||limburg.paul@mayo.edu|
22431758|NCT02006927|William Beaumont Hospitals|Deborah Hasenau, RN|248 551-0804|deborah.hasenau@beaumont.org|
22431759|NCT01864434|University of Tennessee|Adrija Sharma, Ph. D.|8659742093|asharma1@utk.edu|
22431760|NCT00673920|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22431761|NCT02519842|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22431762|NCT02319486|Zhongshan Ophthalmic Center, Sun Yat-sen University|Huasheng Yang|+862087331539|yanghs64@126.com|
22431763|NCT01295710|Neovii|Anne Kuan|781 966 3832|anne.kuan@neovii.com|
22431764|NCT00859833|Univesity of Utah|Sheldon Litwin|801-581-7715|sheldon.litwin@hsc.utah.edu|
22431765|NCT01561976|GlaxoSmithKline|GSK Response Center|866-435-7343||
22431766|NCT02639390|Department of Veterans Affairs|Peter Lum|12023195181|lum@cua.edu|
22431767|NCT01463527|Yale University|Dr. Melissa Langhan|203-737-7413|melissa.langhan@yale.edu|
22392393|NCT03829501|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22418725|NCT01811316|Sunstar Americas, Inc.|Akane Takemura|+1-847-794-4276|akane.takemura@us.sunstar.com|
22418726|NCT04086407|Sleep Systems|Director of Operations|978-835-7036|e.lyons@sleepsystems-llc.com|
22431768|NCT03443635|Tulane University Goldring Center for Culinary Medicine|Principal Investigator|3373290724|dominique.monlezun@gmail.com|
22431769|NCT01977222|Boston Children's Hospital|Dr. Fred Wu|6173556508|fred.wu@cardio.chboston.org|
22431770|NCT02980107|University of Split School of Medicine|Ivan Buljan|+385989027209|ibuljan@mefst.hr|
22431771|NCT03746015|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22431772|NCT02836249|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22431773|NCT05200845|Virginia Tech|Alexandra DiFeliceantonio|540-526-2285|dife@vt.edu|
22418727|NCT04241315|On Target Laboratories, Inc.|Tommy Lee|214-289-6422|tlee@ontargetlabs.com|
22418728|NCT03047330|Brigham and Women's Hospital|Hadine Joffe, MD MSc|617-732-4906|hjoffe@bwh.harvard.edu|
22418729|NCT01908907|Sanford Health|Lora Black, Senior Director of Clinical Research|605-328-1368|lora.black@sanfordhealth.org|
22418730|NCT05773794|North Carolina A&T State University|Dr. Shengmin Sang|7042505710|ssang@ncat.edu|
22418731|NCT02487303|Medical University of South Carolina|Sylvia Wilson|8437921414|wilsosh@musc.edu|
22418732|NCT01392963|Seton Family of Hospitals|Katherine Sebastian|512-324-9999|krsebastian@seton.org|89612
22418733|NCT03783039|ETHICON, Inc|Patricia Schleckser|01 908 218 2244|PSchleck@its.jnj.com|
22418734|NCT01955837|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.||toiawase@taiho.co.jp|
22418735|NCT00837473|Medtronic Spine and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
22418736|NCT02338193|Woman's Hospital|Dr Karen Elkind-Hirsch, Director of Research|225 231-5278|karen.elkind-hirsch@womans.org|
22418737|NCT01724489|Massachusetts General Hospital|Dr. Karen K. Miller|617-726-3870|kkmiller@mgh.harvard.edu|
22418738|NCT02861014|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22418739|NCT02201212|Dana Farber Cancer Institute|Dr. David Kwiatkowski|8573070781|dk@rics.bwh.harvard.edu|
22418740|NCT02955758|Stanford University|Dr. Joel W. Neal|(650) 498-6000|jwneal@stanford.edu|
22418741|NCT00867503|University Of Arizona|Dr. Setsuko K Chambers|520/626-0950|schambers@azcc.arizona.edu|
22418742|NCT02704403|GENFIT|Carol Addy, MD MMSc|+01 6179536469|clinicaltrial@genfit.com|
22418743|NCT01839318|Alcon Research, Ltd.|Jessie Lemp, GMA Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22418744|NCT01844856|La Jolla Pharmaceutical Company|Chief Development Officer|+1.617.715.3600|ljpcregulatory@ljpc.com|
22418745|NCT03340207|VA Western NY Healthcare System|Dr. Nader D. Nader|716-862-8707|nnader@buffalo.edu|
22418746|NCT00927394|Novartis Pharmaceuticals|Study Directors|862-778-8300||
22418747|NCT01221363|Research Centre for Prevention and Health|Mette Aadahl|+45 38663359|mette.aadahl@regionh.dk|
22418748|NCT01756079|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22418749|NCT04623086|University of Washington|Arthi Thirumalai|206-221-0521|arthidoc@uw.edu|
22418750|NCT03464630|Georgia State University|Dr. Kathleen Baggett|404-413-1571|kbaggett@gsu.edu|
22418751|NCT00715624|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22418752|NCT03007238|City of Hope Medical Center|Dr. Amandeep Salhotra|626-359-8111|asalhotra@coh.org|
22418753|NCT01273896|Memorial Sloan Kettering Cancer Center|Modi, Shanu/Medicine (Assistant Attending)|+1646-888-4564|modis@mskcc.org|
22418754|NCT04524364|Biosense Webster, Inc.|Associate Director - Medical Affairs|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22418755|NCT02309138|University of Pittsburgh|Director of Center for Research on Health Care Data Center|412-692-2023|dcenter@pitt.edu|
22418756|NCT03904264|Department of Veterans Affairs|Tara Zaugg, AuD / CRH REC Consultant, VISN 20 and REC ICC Clinical Lead, VISN 20|208-422-1000|tara.zaugg@va.gov|
22418757|NCT00670202|Brigham and Women's Hospital|Anju Nohria|617-525-7052|anohria@partners.org|617
22418758|NCT00735397|Eisai Inc.|Eisai Call Center|888-422-4743||
22418759|NCT02677714|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22418760|NCT00380744|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22418761|NCT01006018|Emory University|Mary Rhee, M.D.|404-778-1666|mrhee@emory.edu|
22418762|NCT01497808|University of Pennsylvania|Dr. Amit Maity|(215) 615-6767|maity@uphs.upenn.edu|
22418763|NCT02467478|GW MFA|Sabyasachi Sen|3014616676|ssen1@gwu.edu|
22418764|NCT01955083|Chang Gung Memorial Hospital|Dr. Hsueh-Yu Li|886-3-3281200|hyli38@adm.cgmh.org.tw|3967
22418765|NCT02763826|Medical University or SC|Scott Hutchison, Manager of COBRE Research Operations|843-792-2712|hutchis@musc.edu|
22418766|NCT01559389|Loyola University Medical Center|Elizabeth Mueller, MD|708-216-2180|emuelle@lumc.edu|
22418767|NCT02871492|AiCuris Anti-infective Cures GmbH|Information Desk|+4920231763|info@aicuris.com|0
22418768|NCT04546724|Valn|Clinical Strategy Manager|+43 1 206 20|office@valneva.com|0
22418769|NCT02922738|University of Vermont|Marianne Burke|802-236-0075|marianne.burke@uvm.edu|
22418770|NCT03583086|Vanderbilt-Ingram Cancer Center|Teresa Melton|6159367423|teresa.melton@vumc.org|
22418771|NCT04113785|University of Tennessee|Richard Komistek, Principal Investigator|8659742093|rkomiste@utk.edu|
22418772|NCT00396812|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22418773|NCT00435812|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-848-5100||
22418774|NCT02914210|Duke Clinical Research Institute|Janet Bettger, ScD|919-613-0379|janet.bettger@duke.edu|
22418775|NCT02387983|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22418776|NCT00873457|Duke University Medical Center|Daphne Friedman, MD|919-684-9220|daphne.friedman@dm.duke.edu|
22418777|NCT02687217|Lady Hardinge Medical College and associated Hospitals|Dr. Swati Sattavan|9891777424|swatisattavan@gmail.com|91
22418778|NCT00724048|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22418779|NCT04874155|Noctrix Health, Inc.|Jonathan Charlesworth, PhD|804-683-4279|jcharlesworth@noctrixhealth.com|
22418780|NCT02819050|Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center|Virender Rehan|3102221965|vrehan@labiomed.org|
22418781|NCT06281171|dfusion Inc.|Lane Edwards, MPH, Project Director|8314402192|Lane.edwards@dfusioninc.com|
22418782|NCT00030992|National Cancer Institute, National Institutes of Health|Tito Fojo, M.D.|301-496-2631|FojoT@mail.nih.gov|
22418783|NCT03258853|Massachusetts General Hospital|Dr. Melissa Putman|617-726-1847|msputman@mgh.harvard.edu|
22418784|NCT04180163|Takeda|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22418785|NCT04730349|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22418786|NCT00638027|University of Rochester|Cynthia Irish, RN, MSCN|585-275-6120|cindy_irish@urmc.rochester.edu|
22418787|NCT03395405|Northwestern University Feinberg School of Medicine|Michael G Ison|3126954186|mgison@northwestern.edu|
22418788|NCT03722589|Centers for Disease Control and Prevention|Fatimah Dawood, Medical Officer|404-639-0431|hgj0@cdc.gov|
22418789|NCT04308226|Division of General Internal Medicine, Massachusetts General Hospital|Travis Baggett, MD, MPH|617-643-9314|tbaggett@mgh.harvard.edu|
22418790|NCT00660907|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
22418791|NCT04975191|Rutgers University|Dr. Danielle Dick|732-235-5607|Danielle.M.Dick@rutgers.edu|
22418792|NCT05264129|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22418793|NCT03593538|Perelman School of Medicine at the University of Pennsylvania|Dr. Rebecca Ashare|2157465789|rlashare@pennmedicine.upenn.edu|
22418794|NCT00478244|Masonic Cancer Center, University of Minnesota|John E. Wagner, M.D.|612-626-2961|wagne002@umn.edu|
22418795|NCT00998868|Seoul National University Hospital|Tai Ryoon Han, MD, PhD./Professor|+82-2-2072-3218|tairyoon@snu.ac.kr|
22418796|NCT04684238|Sedana Medical AB|Ida Sverud|+46 8 124 052 00|medinfo@sedanamedical.com|
22418797|NCT02711878|Emory university|Dr. Eun Ok IM|404-712-9805|eun.ok.im@emory.edu|
22418798|NCT02152605|GlaxoSmithKline|GSK Response Center|866-435-7343||
22418799|NCT01996449|UT Southwestern Medical Center|Wanpen Vongpatanasin|2146458000|Wanpen.Vongpatanasin@UTSouthwestern.edu|
22418800|NCT04176406|Duke University|Dr. Lawrence G. Appelbaum|919-613-7664|greg@duke.edu|
22418801|NCT00537303|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22418802|NCT01234922|Wake Forest Baptist Health|William J. Petty, MD|336-716-3313|wpetty@wakehealth.edu|
22418803|NCT01473524|Intercept Pharmaceuticals, Inc.|Medical Information|844-782-4278|medinfo@interceptpharma.com|
22418804|NCT01544179|AstraZeneca|Haiyi Jiang/Asia Medical Director|+86 21 60302408|haiyi.jiang@astrazeneca.com|
22418805|NCT02105558|The University of Texas Health Science Center at Houston|Madhumani Rupasinghe, MD|(713) 500-6200|Madhumani.Rupasinghe@uth.tmc.edu|
22418806|NCT01635283|Jonsson Comprehensieve Cancer Center|Dr. Robert Prins|310-825-7647|rprins@mednet.ucla.edu|
22418807|NCT01327508|Smith & Nephew, Inc.|Cathy Newbill|800-821-5700|cathy.newbill@smith-nephew.com|
22418808|NCT01438996|Novartis Vaccines Institute for Global Health|Dr. Audino Podda|+39 0577 243496|audino.podda@novartis.com|
22418809|NCT04516759|St George Street Capital|Mike Johnson, Managing Director|+447768335460|mike@sgscapital.org|
22418810|NCT02246114|The Milton S. Hershey Medical Center|Richard S. Legro, M.D.|717-531-6210|rsl1@psu.edu|
22418811|NCT01551030|Memorial Sloan Kettering Cancer Center|Dean Bajorin, MD|646-888-4700|bajorind@MSKCC.ORG|
22392394|NCT02964013|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22392395|NCT01123070|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8270|USMedInfo@tevapharm.com|
22418812|NCT03416829|Massachusetts General Hospital|Jarrad H Van Stan|617-643-8410|jvanstan@mghihp.edu|
22418813|NCT02351271|Ziemer Ophthalmic Systems AG|Sarah Moyle|970 308 9199|sarah.moyle@ziemergroup.com|
22418814|NCT00735618|UT MD Anderson Cancer Center|Ying Guo, MD, MS/Associate Professor||jaallo@mdanderson.org|
22418815|NCT00229723|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
22418816|NCT03769207|Stanford University|Marco Perez, Associate Professor of Medicine|(650) 723-9363|mvperez@stanford.edu|
22418817|NCT01338870|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22418818|NCT01881984|University of Pittsburgh|Dr. Gerard Vockley|412-692-7746|gerard.vockley@chp.edu|
22418819|NCT03201445|Galapagos NV|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
22418820|NCT01228019|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22418821|NCT01268501|Alcon Research, Ltd.|Director of Alcon Clinical|1-800-241-7629||
22418822|NCT03735316|Mayo Clinic|James A. Nelson, M.B.B.S.|480-342-1800|Nelson.James1@mayo.edu|
22418823|NCT00474266|GlaxoSmithKline|GSK Response Center|866-435-7343||
22418824|NCT02774642|San Diego VA Healthcare System|Dr. Peter Colvonen|858-552-8585|peter.colvonen@va.gov|2468
22418825|NCT02329847|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22418826|NCT05330468|Abbott|Director, Clinical Programs Structural Interventions & Cardiac Surgery|(651)-202-8362|ryan.palmer@abbott.com|
22418827|NCT00511095|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-848-5100||
22418828|NCT00420459|Cincinnati Childrens Hospital|Craig Erickson|5136366265|craig.erickson@cchmc.org|
22418829|NCT02828241|Dr. Reddy's Laboratories|Katherine D'Angelo|609-282-1400|kdangelo@drreddys.com|
22418830|NCT04572893|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22418831|NCT01222390|Northwestern University|John Y.S. Kim, MD|312-695-0208|jokim@nmh.org|
22418832|NCT05034276|University of Utah|Eric Garland|801-581-3826|eric.garland@socwk.utah.edu|
22418833|NCT02103270|The Sean N. Parker Center for Allergy Research at Stanford|Dr Andres Alvarez Pinzon, Director of Regulatory Affairs and Translational Medicine|9544465645|andresap@stanford.edu|
22418834|NCT03316378|University of Iowa, Department of Physical Therapy & Rehabilitation Science|Ruth Chimenti, Assistant Professor|319-335-9791|ruth-chimenti@uiowa.edu|
22418835|NCT00477295|Eisai Call Center|Eisai Inc.|888-422-4743||
22418836|NCT03039179|Istituto Ortopedico Rizzoli|Head of the Research Nursing Unit|0516366694|cristiana.forni@ior.it|0039
22418837|NCT03276780|University of Alabama at Birmingham, Department of Psychiatry and Behavioral Neurobiology|Dr. Karen Cropsey|205-975-4204|kcropsey@uabmc.edu|
22418838|NCT00510289|Duke University Medical Center|David Rizzieri, MD|919-668-1014|David.Rizzieri@duke.edu|
22418839|NCT03835221|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
22418840|NCT00861198|University of Florida|Dr. Peter V. Draganov|(352) 273-9472|Peter.Draganov@medicine.ufl.edu|
22418841|NCT02288182|gwd consult · contract research|Dr. Manfred Klasser|+49 (6108) 8256520|manfred.klasser@gwd-consult.de|
22392396|NCT04942366|Ziauddin University|Mubarra Rao|03343088915|mubarrar@gmail.com|
22392397|NCT00282672|University of north Carolina|Nicholas Shaheen|(919) 966-7047|nshaheen@med.unc.edu|
22392398|NCT02525718|Northwestern Memorial Hospital|Dr. Mohammed Alghoul||malghoul@nm.org|
22392399|NCT00747227|Abbott medical Optics, Inc.|Nicholas Taranatino, O.D., Head, Global Clinical Research & Devlopment|866-427-8477|nicholas.tarantino@amo.abbott.com|8613
22392400|NCT03284229|Spectranetics Corporation|Spectranetics Corporation|719-447-2211|Ami.Sood@philips.com|
22392401|NCT06149104|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22409713|NCT00639158|Abbott|Global Medical Services|800-633-9110||
22409714|NCT03403712|Helsinn SA|Head of Clinical Development|+41 91 985 2121|info-HHC@helsinn.com|
22409715|NCT01787188|Iroko Pharmaceuticals, LLC|Daniel Solorio, Executive Director of Clinical Operations|267-546-3150|dsolorio@iroko.com|
22409716|NCT00854607|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22409717|NCT00597727|University of North Carolina at Chapel Hill|Edwin Kim, Director UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
22418842|NCT02683265|Rhodes Pharmaceuticals L.P.|Inder Chaudhary|401-262-9272|inder.chaudhary@rhodespharma.com|
22409718|NCT01783483|Zimmer Biomet|Brian M Hatcher, PhD|904-741-4400|brian.hatcher@zimmerbiomet.com|
22409719|NCT02268045|mAbxience|Susana Millan|+34917711500|Susana.Millan@mabxience.com|9284
22409720|NCT01766310|Queen Sirikit National Institute of Child Health|Dr. Orawan Iamopas|66-2-354-8415|orawaneamopas@yahoo.com|3327
22409721|NCT00835068|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22409722|NCT01591499|CooperVision|Caroline Bonneville and Sandrine Cheneau, Study Managers|+33609202762|caroline.bonneville@coopervision-fr.com|
22409723|NCT02125734|Novartis Pharmaceuticals|Study Director|862-778-8300||
22409724|NCT01308762|Immodulon Therapeutics, The London Clinic Cancer Centre, London W1G 6JA,|Clinical Trials Co-ordinator|+44 (0)203 219 3568/3572|Ilda@immodulon.com|
22409725|NCT00646282|Emory University|Dr. Antonio Guasch|404-727-2522|aguasch@emory.edu|
22409726|NCT01556490|Boston Scientific|Clinical Research Manager|16138011844|chantal.laframboise@bsci.com|
22409727|NCT00902278|University of Massachusetts Medical School|Mary Co|5088562927|mary.co@umassmed.edu|
22409728|NCT00397904|Memorial Sloan Kettering Cancer Center|Dr. David Ilson|646-888-4183|ilsond@mskcc.org|
22409729|NCT04348292|Emory University|Jennifer Carlisle, MD|404-778-2304|jennifer.w.carlisle@emory.edu|
22409730|NCT01652872|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22409731|NCT00758706|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22409732|NCT04628221|MCRA, LLC|Nicole Harris|202-552-5800|nharris@mcra.com|5823
22409733|NCT04166851|Rutgers School of Public Health|Cui Yang|1-732-235-9754|cui.yang@rutgers.edu|
22409734|NCT03690375|Siperstein Dermatology Group|founder/physician|5613647774|info@sipderm.com|
22409735|NCT00367601|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
22409736|NCT03985293|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22409737|NCT02588651|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Study Principal Investigator|1-866-223-8100|TaussigResearch@ccf.org|
22409738|NCT05899218|University of Pennsylvania|Dr. Jennifer Tran|2158983616|jtgtran@nursing.upenn.edu|
22409739|NCT03801369|Oregon Health & Science University - Knight Cancer Institute|Gordon Mills, MD, PhD|503-346-4660|millsg@ohsu.edu|
22409740|NCT02587325|Aadi Bioscience, Inc.|Aadi Medical Information|1-888-246-2234|MedInfo@aadibio.com|
22409741|NCT00390572|VA HSRD|Christi S. Ulmer, PhD|9192860411|christi.ulmer@va.gov|4044
22409742|NCT04236635|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|clinicaltrials@endo.com|
22409743|NCT02913261|Novartis Pharmaceuticals|Study Directr|862-778-8300|novartis.email@novartis.com|
22409744|NCT01236053|GlaxoSmithKline|GSK Response Center|866-435-7343||
22409745|NCT00919932|University of Pittsburgh|Dr Han Liang|412-624-4141|liangh2@upmc.edu|
22409746|NCT02304302|Case Western Reserve University|Melissa Stasko, JD, MA|216-844-7281|Melissa.Stasko@case.edu|
22409747|NCT00391118|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22409748|NCT02251431|Baylor Scott & White Research Institute|Biostatistician|8033190755|gelareh.rahimighazikalayeh@bswhealth.org|
22409749|NCT03078192|Duke University Medical Center|Bastiaan Driehuys|919-684-7786|bastiaan.driehuys@duke.edu|
22409750|NCT01311505|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22409751|NCT03958071|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22409752|NCT01375569|National Cancer Institute|Dr. Tim Greten|301-451-4723|gretentf@mail.nih.gov|
22409753|NCT01074307|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22409754|NCT02625207|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22409755|NCT03565666|Mass. General Hospital|Dr. Steven J. Russell|617-726-8722|sjrussell@mgh.harvard.edu|
22409756|NCT02703454|Abbott|Clinical Program Director|6517566717|kristin.ruffner@abbott.com|
22409757|NCT02284373|New York University Langone Medical Center|Todd Berland, MD|212 263 5060|todd.berland@nyumc.org|
22409758|NCT02016755|AnGes USA, Inc.|Dr. Susan Pitman Lowenthal|240-780-9025|spitmanlowenthal@anges-usa.com|
22409759|NCT00822679|University of Arizona|Sairam Parthasarathy|5206266109|sparthasarathy@deptofmed.arizona.edu|
22418843|NCT01088802|Johns Hopkins Medicine|Harry Quon, MD|410-502-3877|hquon2@jhmi.edu|
22418844|NCT04619992|Hollister Incorporated|Director of Global Clinical Affairs|+1 224-206-2857|sara.wegener@hollister.com|
22418845|NCT01197755|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
22418846|NCT03365011|Washington University School of Medicine in St. Louis|Jay F. Piccirillo, MD, FACS|(314) 362-8641|piccirij@wustl.edu|
22418847|NCT00499174|Canadian Cancer Trials Group|Keyue Ding, Biostatistician|613-533-6430|kding@ctg.queensu.ca|
22418848|NCT03582826|MEBO Research|Maria De la Torre, Executive Director|786 228-6880|maria.delatorre@meboresearch.org|
22418849|NCT01413516|Stanford University|Judith Prochaska|6507243608|jodi.prochaska@stanford.edu|
22418850|NCT00804713|USUHS|James Mancuso|301-295-3734|james.mancuso@usuhs.edu|
22418851|NCT01214915|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22418852|NCT00574912|University of Maryland, Baltimore|Dr. Stephen N. Davis|4103282488|sdavis@medicine.umaryland.edu|
22418853|NCT01282723|Reproductive Research Technologies, LP|Jack McCrary|7136800200|jmc@innovalp.com|
22418854|NCT02519738|University of Michigan|Ron Hirschl|734 764-6482|rhirschl@med.umich.edu|
22418855|NCT00469911|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-0183|groplerr@mir.wustl.edu|
22418856|NCT02062294|Hoffmann-LaRoche|Clinical Operations Department|800-821-8590|switzerland.clinical-research@roche.com|
22418857|NCT01246063|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@wustl.edu|
22418858|NCT02342639|University of Kansas Medical Center|Dr. Jason Stubbs|9135886074|jstubbs@kumc.edu|
22418859|NCT03558061|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
22418860|NCT03483363|The University of Texas Health Science Center at Houston|Nagi Demian, MDDS|(713) 500-5082|Nagi.Demian@uth.tmc.edu|
22418861|NCT01200069|Rutgers/New Jersey Medical School|Vasanti Tilak, MD|974 972-5254|tilakva@njms.rutgers.edu|
22418862|NCT00761657|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441||
22418863|NCT04648696|Wake Forest University Health Sciences|John Williamson, PhD|336.713.3431|johnwill@wakehealth.edu|
22418864|NCT00618332|University of Chicago|Dr. Robert Naclerio|773-702-0080|rnacleri@surgery.bsd.uchicago.edu|
22418865|NCT03035929|Vanderbilt University Medical Center|Grace Henderson, Study Coordinator|615-936-5356|grace.henderson@vumc.org|
22418866|NCT01564537|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
22418867|NCT00573378|University of Michigan Rogel Cancer Center|Dale L. Bixby, MD|734-936-4991|dbixby@med.umich.edu|
22418868|NCT03134248|CooperVision|Jose A.Vega OD MSc., FAAO|9256213761|javega@coopervision.com|
22418869|NCT02932306|Bausch Health Americas, Inc.|Clinical Operations Director|1-510-259-5284|aloncaric@bauschhealth.com|
22418870|NCT03964649|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22418871|NCT02448706|Northwestern University|Pamela Souza|8474912433|p-souza@northwestern.edu|
22418872|NCT02065700|Galapagos NV|Galapagos Medical Information|+32 15 342900|medicalinfo@glpg.com|
22418873|NCT02315196|Cancer Institute of New Jersey|Deborah L Toppmeyer, MD|732-235-6789|toppmede@cinj.rutgers.edu|
22418874|NCT03559400|University of California, San Francisco|David Shearer, MD, MPH, Associate Professor|628-206-8812|david.shearer@ucsf.edu|
22418875|NCT02784444|Cirius Therapeutics Inc.|Jules Lee|8583336274|jlee@ciriustx.com|514
22418876|NCT04933968|AlloVir, Inc.|Senior Vice President|+1 617-433-2605|rriese@allovir.com|
22418877|NCT05119348|Desmond Tutu Health Foundation|Dr. Philip Smith|+27216501895|Philip.Smith@hiv-research.org.za|
22418878|NCT01664130|Case Comprehensive Cancer Center|Kevin Stephans MD|216-445-8285|stephak@ccf.org|
22418879|NCT04732624|University of Washington/Nepal cleft and burn center|Dr. Raslina Shrestha|+977 9849978888|raslinas@uw.edu|
22418880|NCT02679235|University of Sherbrooke|Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
22418881|NCT00923273|National Cancer Institute|Dr. Arun Rajan|301-594-5322|rajana@mail.nih.gov|
22409760|NCT02869295|Nektar Therapeutics|Study Director|415-482-5300|medicalaffairs@nektar.com|
22409761|NCT00323635|Brigham and Women's Hospital|Quentin Regestein|617-732-4497|qregestein@partners.org|
22409762|NCT03061279|Stanford University|Derek Amanatullah, MD, PhD|650-723-2257|dfa@stanford.edu|
22409763|NCT03174925|Stanford University Medical Center|Aya Kamaya, Professor of Radiology|650-725-1812|kamaya@stanford.edu|
22409764|NCT01398982|UHN|Kate Butler|416-340-4800|kbutler@uhnresearch.ca|2343
22409765|NCT04247594|Global Blood Therapeutics, Inc.|Eleanor Lisbon|+1 913 449 4319|elisbon@gbt.com|
22409766|NCT01093482|VENTILA group|Andres Esteban|34916834982|aesteban@ucigetafe.com|
22409767|NCT04440163|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22409768|NCT02577900|Queen Elizabeth Hospital|Dr. Tsang Ka-Kit|+852-35062610|kktsang3@netvigator.com|
22409769|NCT00589693|Janssen R&D US|Sr Director Clinical Development|1 510 248-2310||
22409770|NCT01128153|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com|
22409771|NCT01954082|University of Rochester|Dale Phelps|(585) 275-2972|dale_phelps@urmc.rochester.edu|
22409772|NCT01682512|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22409773|NCT01377233|H. Lundbeck A/S|Study director||LundbeckClinicalTrials@Lundbeck.com|
22409774|NCT03137082|Stony Brook University|Dr Helen C Fox|631 632 0057|helen.fox@stonybrookmedicine.edu|
22409775|NCT00417027|Northwestern University Feinberg School of Medicine|Robert J. McCarthy, PharmD|312-926-9015|r-mccarthy@northwestern.edu|
22409776|NCT04285983|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22409777|NCT02787785|Boston Scientific|Clinical Trial Manager or Director of Clinical Trials (Cardiology Rhythm Management)|1-800-227-3422|jill.leigh@bsci.com|
22409778|NCT01080209|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22409779|NCT03250507|Henry Ford Hospital|Christina Fidkowski, MD|313-916-7648|cfidkow1@hfhs.org|
22409780|NCT01440595|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22409781|NCT01850108|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
22409782|NCT03127943|UNC Department of Oral and Maxillofacial Surgery|Raymond P. White Jr DDS, PhD|919-537-3944|ray_white@unc.edu|
22409783|NCT01447628|Imperial College London|Professor Martin Wilkins|0203 313 8078|jacob.bonner@nhs.net|38078
22409784|NCT04671329|Hologic, Inc.|Muhammad Waqas, Director of Global Clinical Affairs|(508) 826-7183|ClinicalResearch@Hologic.com|
22409785|NCT01029769|Technische Universitaet Muenchen, Germany|Prof. Dr. Dr. Stefan Leucht|+498941404200|stefan.leucht@tum.de|
22409786|NCT02703779|University of Kansas Cancer Center|Dr. Sid Ganguly|913-588-6030|sganguly@kumc.edu|
22409787|NCT00965263|New York State Psychiatric Institute at Columbia University Medical Center|Margaret Haney, Ph.D.|6467746153|meg.haney@nyspi.columbia.edu|
22409788|NCT03496207|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22409789|NCT02756078|Johnson & Johnson Vision Care, Inc.|Chantal Coles-Brennan - PRINCIPAL RESEARCH OPTOMETRIST|1-904-443-3449|CColesb@its.jnj.com|
22409790|NCT00810615|San Antonio Military Medical Center, Wilford Hall Ambulatory Surgical Center|Dr. George Wolf, Associate Investigator|210-292-3483|earl.wolf.ctr@us.af.mil|
22409791|NCT02618772|MUHC|Dr. Jennifer Turnbull|514-412-4400|jennifer.turnbull@mcgill.ca|23039
22409792|NCT02058368|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22409793|NCT02181842|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22409794|NCT02441179|Teleton Institute|Dr. Angela Navarrete-Opazo|+56 0226772075|angelaandrean@gmail.com|
22409795|NCT01488071|H. Lundbeck A/S|H. Lundbeck A/S|+45 36301311|LundbeckClinicalTrials@lundbeck.com|
22409796|NCT02139306|PTC Therapeutics, Inc|Joseph McIntosh|908 912-9138|jmcintosh@ptcbio.com|
22409797|NCT04449354|HidraMed Solutions Ltd|Suzanne Moloney|+353873220509|suzanne@hidramedsolutions.com|
22409798|NCT05789420|Philip Morris Products S.A.|Xavier Jaumont, Global Head of Clinical Development and Operations|+41582421111|ClinicalTrials.PMI@pmi.com|
22409799|NCT02278952|University of California, San Francisco|Dr. John Greenland|415-476-0789|john.greenland@ucsf.edu|
22409800|NCT01220128|GlaxoSmithKline|GSK Response Center|866-435-7343||
22409801|NCT00057785|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
22409802|NCT01197456|UC San Diego|Irene Su, MD MSCE|858-822-5986|hisu@ucsd.edu|
22409803|NCT00532779|Orexigen Therapeutics, Inc.|Senior Vice President, Head of Global Development|(858) 875-8600|MedInfo@Orexigen.com|
22409804|NCT02424799|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22409805|NCT00828516|Lynda Jackson Macmillan Centre|Dr Beverley de Valois|+44(0)1923-844456|beverley.devalois@nhs.net|
22409806|NCT00689273|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22409807|NCT02953873|Medical University of South Carolina|Caitlin Schaffner|843-792-7558|schaffne@musc.edu|
22409808|NCT05406596|Seigla Medical|John Schultz|7632133026|jschultz223@gmail.com|
22409809|NCT02787746|Department of Neurology, Xuan Wu Hospital of Capital Medical University; Freindship Hospital of Capital Medical University|Jianping Jia|+86 10 83188730|jjp@ccmu.edu.cn|
22409810|NCT00834288|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
22409811|NCT00572468|Portland VA Health Care System|Wesley Stoller|503-220-8262|wesley.stoller@va.gov|54931
22409812|NCT03703297|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22409813|NCT01142466|Merck Serono GmbH, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Medical Responsible|+49 6151 72 5200|service@merckgroup.com|
22418882|NCT00843479|Laboratory of Investigation on Metabolism and Diabetes - LIMED / State University of Campinas - Brazil|Dr. Bruno Geloneze|+55 19 35218589|bgeloneze@terra.com.br|
22418883|NCT01386983|GlaxoSmithKline|GSK Response Center|866-435-7343||
22418884|NCT03146962|Weill Cornell Medicine|Dr. Manish Shah, Sponsor-Investigator|646-962-6200|mas9313@med.cornell.edu|
22418885|NCT02383810|Helsinn Healthcare SA|Director of Clinical Division|+41 91 9852121|info@helsinn.com|
22418886|NCT04505956|Vanderbilt University Medical Center - Department of Urology|Nicole Miller, M.D.|(615) 322-3807|nicole.miller@vumc.org|
22418887|NCT02549027|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22418888|NCT02278055|Memorial Sloan Kettering Cancer Center|Dr. Michael Morris, MD|646-422-4469|morrism@MSKCC.ORG|
22418889|NCT01934335|Holden Comprehensive Cancer Center|Ronald Weigel, MD, PhD|319-353-7474|ronald-weigel@uiowa.edu|
22418890|NCT02137486|cardiovascular section|taipei city hospital Ren-Ai branch|0088627093600|chenyuehchung.tw@yahoo.com.tw|3741
22392402|NCT00918879|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22392403|NCT04707664|Partner Therapeutics, Inc.|Medical Information|1-888-479-5385|PartnerTx@medcomminc.com|
22418891|NCT00451048|Princess Margaret Hospital|Dr. Karen Yee|416-946-4495|karen.yee2@uhn.on.ca|
22418892|NCT00819637|Henry Ford Health System, Detroit, Michigan|Richard M Nowak MD|313 881 0023|rnowak1@hfhs.staff|
22418893|NCT01054404|Northwestern University|Dr. John F. Bebawy, Assistant Professor of Anesthesiology & Neurological Surgery|312-695-0061|j-bebawy@northwestern.edu|
22418894|NCT02876757|ICES Western|Blayne Welk|5196466000|blayne.welk@sjhc.london.on.ca|
22418895|NCT03016975|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
22418896|NCT00811928|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22418897|NCT01085357|Transcend Medical, Inc.|Vice President of Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
22418898|NCT02910011|University of Florida|Dr. Anna DeBenedetto|352 594 1500|adebenedetto@dermatology.ufl.edu|
22418899|NCT00838435|BioMarin Pharmaceutical Inc.|Joshua Lilienstein/Medical Director, Global Medical Affairs|651.523.0310|MEDINFO@bmrn.com|
22418900|NCT02348723|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22418901|NCT00678886|GlaxoSmithKline|GSK Response Center|866-435-7343||
22418902|NCT01147107|University of Hawaii at Manoa John A Burns School of Medicine|Dr. Cecilia Shikuma|8086921328|shikuma@hawaii.edu|
22418903|NCT04435184|Johns Hopkins University - Baltimore, MD|Dr. Charles Lowenstein|4105020391|clowens1@jhmi.edu|
22418904|NCT04693416|University of Tennessee Health Science Center|Karen Derefinko, PhD|901-448-2526|kderefin@uthsc.edu|
22418905|NCT02290223|Kaiser NCAL Division of Research|Monique Does, Project Manager|510-891-3612|monique.does@kp.org|
22418906|NCT05293639|Johnson & Johnson MedTech|Reecha Sharma|949.789.3919|rshar120@its.jnj.com|
22418907|NCT02143648|Trevi Therapeutics|Thomas Sciascia, MD|203-304-2499|thomas.sciascia@trevitherapeutics.com|
22418908|NCT01404832|Dallas VAMC|Stuart Spechler|214-374-7799|sjspechler@aol.com|
22418909|NCT01695863|Aurora Gastroenterology, West Allis WI|Maqsood Khan MD FACG|414-328-8750|mkhangi@yahoo.com|
22418910|NCT01860677|McLean Imaging Center, McLean Hospital|Scott E. Lukas, Ph.D.|617-855-2767|slukas@mclean.harvard.edu|
22418911|NCT00589329|MetroHealth Medical CEnter|Larraine Presley|216-778-8927|lpresley@metrohealth.org|
22418912|NCT01687244|FKD Therapies Oy|David Sawutz, PhD|416-607-9515|david.sawutz@fkdtherapies.com|
22418913|NCT01330420|Massachusetts General Hospital|Kathleen Miller, RN|781-485-6176|kmiller16@partners.org|
22392404|NCT00357110|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22392405|NCT05817383|Hebrew Rehabilitation Center|Dr. Courtney Millar|6179715531|courtneymillar@hsl.harvard.edu|
22409814|NCT04084028|University of Vermont Department of Nutrition and Food Sciences|Mattie Alpaugh|8026569526|malpaugh@uvm.edu|
22409815|NCT00700310|Eisai Call Center|Eisai Inc.|888-422-4743||
22409816|NCT02414854|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22409817|NCT01355523|Herlev Hospital, Department of Surgery|MD Melissa Voigt Hansen|+45 20661119|melissa.voigt.hansen@regionh.dk|
22409818|NCT00303316|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22409819|NCT01543607|Mass. General Hospital|William R. Brugge|617-724-0578|wbrugge@partners.org|
22409820|NCT01528878|UNC Lineberger Comprehensive Cancer Center|Robin Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
22409821|NCT02162511|Stanford University|Erica Goodwin|253-508-3556|egood55@stanford.edu|
22409822|NCT01160198|GlaxoSmithKline|GSK Response Center|866-435-7343||
22409823|NCT01408576|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22409824|NCT00802529|Imperial College London|Professor Adolfo Bronstein (Clinical professor and Head of neuro-otology group)|(0)20 3313 5525|a.bronstein@imperial.ac.uk|+44
22409825|NCT02413879|Prescient Surgical|Director of Clinical|6504895025|lclaude@prescientsurgical.com|
22409826|NCT03067506|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22409827|NCT00552617|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22409828|NCT04651218|University of Kentucky|Dr. Kyle Flack|5182574351|kyle.flack@uky.edu|
22409829|NCT02476851|Haemonetics Corporation|Jan Hartmann, MD|(781) 348 7396|Jan.Hartmann@haemonetics.com|
22409830|NCT03940326|Mazandaran University of medical sciences|Nasim Tabrizi|+981133343015|nasimtabrizi@gmail.com|
22409831|NCT01399125|Novartis Pharmaceuticals|Study Director|8627788300||
22409832|NCT01902134|Menarini Ricerche S.p.A.|Dr. Angela Capriati, Corporate Director of Clinical Research|+3905556809933|ACapriati@menarini-ricerche.it|
22418914|NCT01671332|University of Wisconsin|Anne Traynor|608-262-5092|amt@medicine.wisc.edu|
22418915|NCT00371397|Ohio State University Institute for Behavioral Medicine Research|Janice Kiecolt-Glaser, PhD|614-292-0033|Kiecolt-Glaser.1@osu.edu|
22418916|NCT03753763|Zambon S.p.A.|Director of Clinical Trial - Charlotte Keywood, MD|+39 02 665241|charlotte.keywood@zambongroup.com|
22392406|NCT01692951|Cleveland Clinic Foundation|Daniel Sessler, MD|216-444-4900|sessled@ccf.org|
22431774|NCT00534001|Roswell Park Cancer Institute|Martin Mahoney|716-845-2300|martin.mahoney@roswellpark.org|
22431775|NCT00928668|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22431776|NCT02412670|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22431777|NCT03781479|Catalyst Pharmaceuticals, Inc.|Gary Ingenito|3054203200|gingenito@catalystpharma.com|
22431778|NCT02943473|Icahn School of Medicine at Mount Sinai|Dr. Ajai Chari|(212) 241-7873|ajai.chari@mountsinai.org|
22431779|NCT01728246|Janssen Pharmaceutica|Medical Affairs Manager|+632-8247901||
22431780|NCT05805150|CooperVision|Jose Vega|925-621-3761|jvega2@coopervision.com|
22431781|NCT03139721|Medtronic|Jessica Halverson, Clinical Research Director|763-514-9756|rs.CSHHAMMOCKPAS@medtronic.com|
22418917|NCT01104779|Allergan|Medical Director|877-277-8566|IR-CTRegistration@Allergan.com|
22418918|NCT00810576|UT MD Anderson Cancer Center|Barbara Pro, MD|713-792-2933||
22418919|NCT01372774|Mayo Clinic|Paul D. Brown, M.D.|(713) 563-2415|brown.paul@mayo.edu|
22418920|NCT00871741|GlaxoSmithKline|GSK Response Center|866-435-7343||
22418921|NCT01565850|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22418922|NCT03936101|Columbia University|Jessica L Giordano, CGC|516-521-5604|jlg2197@cumc.columbia.edu|
22418923|NCT04324073|Hopital Hotel-Dieu (AP-HP)|Dr Raphael Porcher|+33(0)1.42.34.89.87|raphael.porcher@aphp.fr|
22418924|NCT03665441|Erytech Pharma Inc|Anu Gupta, Senior Study Team Lead|7327424937|anu.gupta@erytech.com|
22418925|NCT03610516|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22418926|NCT02886624|Hôpital Saint Antoine|Prof. Karine Lacombe|+33 1 49 28 24 38|karine.lacombe2@aphp.fr|
22418927|NCT03796598|Richmond VA Medical center|Jasmohan Bajaj|8046755802|jasmohan.bajaj@va.gov|
22418928|NCT00359801|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22418929|NCT01027195|The Cleveland Clinic|Wael K Barsoum, MD|216-444-7515|barsouw@ccf.org|
22418930|NCT00661895|Creighton Cardiac Center|Tammy Burns, PharmD, Research Manager|402-280-4292|TammyBurns@creighton.edu|
22418931|NCT00826007|William Beaumont Hospital|Tamra Dukatz, CRNA, MSN|2489924741|tdukatz@beaumont.edu|
22418932|NCT02929056|Prisma Health|Dr. Thomas Oliver|864-454-8272|Tom.Oliver@prismahealth.org|
22418933|NCT00362466|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22418934|NCT02420912|The University of Texas MD Anderson Cancer Center|Nitin Jain, MD/Associate Professor|713-745-6080|njain@mdanderson.org|
22418935|NCT02245412|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22418936|NCT01056289|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22418937|NCT01917916|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22418938|NCT01650584|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
22418939|NCT00459043|DFCI|Robert Haddad|6176326725|robert_haddad@dfci.harvard.edu|
22418940|NCT01794455|Vanderbilt University|Dr. Warren Taylor|615-936-3555|warren.d.taylor@vanderbilt.edu|
22418941|NCT00270855|Penn State Hershey Medical Center|Dr. David Gater|7175314263|dgater@hmc.psu.edu|
22418942|NCT05424679|Johns Hopkins Center for Indigenous Health|Dr. Emily Haroz|(410) 449-0051|eharoz1@jhu.edu|
22418943|NCT01689779|Massachusetts General Hospital|Sadeq A. Quraishi, MD|617-726-3030|squraishi@mgh.harvard.edu|
22418944|NCT03758716|Oneness Biotech Co., Ltd.|NienYi Chen PhD|+886 2 2655 8687|nienyichen@onenessbio.com.tw|613
22418945|NCT01396512|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22418946|NCT00470392|Louis Stokes VA Medical Center and University Hospitals Case Medical Center|Kevin D. Cooper MD|216 844 3111|kevin.cooper@uhhospitals.org|
22418947|NCT02657928|Mayo Clinic|Gerardo Colon-Otero, MD|904/953-2000|gcolonotero@mayo.edu|
22418948|NCT01988129|Brigham and Women's Hospital|Steven W. Lockley PhD|16177324977|slockley@hms.harvard.edu|
22418949|NCT02500043|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
22418950|NCT00580788|University of Pittsburgh|Mara J Horwitz, MD|4126922848|horwitz@pitt.edu|
22418951|NCT01403051|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22418952|NCT00674739|Graceway Pharmaceuticals|Robert Babilon, Vice President, Product Development|267-948-0400|robert.babilon@gracewaypharma.com|20428
22418953|NCT01701011|UMCU|Henrietta Ockhuijsen 1,*, Agnes van den Hoogen, Marinus Eijkemans , Nick Macklon, Jacky Boivin|+31307553628|h.d.l.ockhuysen@umcutrecht.nl|
22418954|NCT05776862|University of Miami|Mark Nash, PhD|305-243-3628|mnash@med.miami.edu|
22418955|NCT01635218|Hospital Juárez de México|Dr. Emma del Carmen Macías-Cortés|+52 55 5747 7605|ecmc2008@hotmail.es|
22418956|NCT03262038|University of Michigan|Elizabeth Putnam|734-763-2435|eread@umich.edu|
22418957|NCT03323437|Weill Cornell Medicine|Dr. Dikoma C. Shungu|212-746-2481|dcs7001@med.cornell.edu|
22418958|NCT00282919|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22418959|NCT02656069|Xeris Pharamaceuticals, Inc.|Martin J. Cummins, VP, Clinical Development|806-282-2120|mcummins@xerispharma.com|
22418960|NCT03857750|Rigshospitalet|Dr. Matias Vested|+4524464955|matiasvested@gmail.com|
22418961|NCT00168818|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22418962|NCT01994291|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22418963|NCT01775189|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22418964|NCT02227446|METRC|Susan Collins|4105028966|scolli21@jhu.edu|
22418965|NCT00118534|VA Puget Sound (Seattle)|Dr. Miles McFall|(206) 764-2177|Miles.McFall@va.gov|
22418966|NCT00961402|University of Minnesota|Beth Lewis|612-625-0756|blewis@umn.edu|
22431782|NCT00431964|Seattle Children's Hospital|Nicole Hamblett|206-987-5725|tdncc@seattlechildrens.org|
22418967|NCT01900561|Department of Veterans Affairs|Dr. Sarah Hawley|734-936-8816|sarahawl@umich.edu|
22418968|NCT02368314|BIOCAD|Biryulin Andrey|+7812380 49 33|biryulin@biocad.ru|925
22409833|NCT00305110|Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore Medical Center|Andrew Chang, MD, MS|718-920-7476|achang@montefiore.org|
22409834|NCT00337129|SWOG Statistical Center|Head and Neck Committtee Statistician|(206)-667-4623||
22409835|NCT03141931|University of New South Wales|Dr Jacqueline Tan|+61 (02) 9385 6551|jacqueline.tan@unsw.edu.au|
22409836|NCT01230502|University of Wisconsin|Professor William Burlingham, PhD|(608) 263-0119|BURLINGHAM@SURGERY.WISC.EDU|
22409837|NCT01272193|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22409838|NCT02661282|UT MD Anderson Cancer Center|Shiao-Pei Weathers, MD, Associate Professor, Neuro-Oncology|(713) 792-3906|sweathers@mdanderson.org|
22409839|NCT03578276|Carolina Eyecare Physicians, LLC|Director of Research|8438813937|hps@cepmd.com|
22409840|NCT02626182|National Jewish Health|Jennifer Taylor-Cousar, MD, MSCS, ATSF|3032702764|Taylor-CousarJ@NJHealth.org|
22409841|NCT02267850|Biolux Research Ltd|Clinical Studies Manager|1-604-669-0674|d.skrenes@bioluxresearch.com|
22409842|NCT03005379|VA Cooperative Studies Program|Yuan Huang, Ph.D., Biostatistician|2039325711|yuanhuang1@va.gov|
22409843|NCT01084603|J&J Consumer and Personal Products Worldwide|Joyce Hauze, Sr Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
22409844|NCT02483481|Children's Mercy Kansas City|Dr. Sherwin Chan|816-234-3273|sschan@cmh.edu|
22409845|NCT02766088|GlaxoSmithKline|GSK Response Center|866-435-7343|gskclinicalhd@gsk.com|
22409846|NCT02360397|Brigham and Women's Cardiovascular Associates at Kent Hospital|Chester M. Hedgepeth, MD, PhD|(401) 737-7010|chedgepeth@kentri.org|32880
22409847|NCT01508325|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22409848|NCT02613416|Stony Brook University|Caterina Vacchi-Suzzi|631-444-8074|caterina.vacchi-suzzi@stonybrookmedicine.edu|
22409849|NCT01542684|The University of Texas MD Anderson Cancer Center|Zeev Estrov, MD/Professor|713-794-1675|eharriso@mdanderson.org|
22409850|NCT00390949|Imperial College London|Professor Simon Gregson|+4402075943279|Sajgregson@aol.com|2075943279
22409851|NCT02535247|Fox Chase Cancer Center|Protocol Development Coordinator|215-728-4097|ryan.romasko@fccc.edu|
22409852|NCT00763269|Colgate Palmolive Co.|William De Vizio|732-878-7901|William_Devizio@colpal.com|
22409853|NCT03543046|Orlando Health|Corporate Director of Compliance and Regulations|3218413687|Tara.Roberts@orlandohealth.com|
22409854|NCT02229487|Ramathibodii Hospital, Mahidol University|Sirimon Reutrakul|66922011647|sreutrakul@yahoo.com|708
22409855|NCT04936334|Indiana University, Department of Urology|Jennifer Lehman, RN, Senior Research Leader|317-948-9575|jgeck@iu.edu|
22409856|NCT02209272|Mayo Clinic|Dr. Jacob L. Sellon|507-284-2608|sellon.jacob@mayo.edu|
22409857|NCT04057118|Oscotec Inc.|Sungsil Lee/Team Leader of Clinical Development|+82316287624|sslee@oscotec.com|
22409858|NCT03402126|Medtronic Inc|Joy Aso, Clinical Research Specialist|4015454454|joy.a.aso@medtronic.com|
22409859|NCT01347879|Virginia Clinical Research, Inc.|Dr David Pariser|757-625-0151|dpariser@pariserderm.com|
22409860|NCT03747939|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22409861|NCT03273712|University of Iowa|M. Sue O'Dorisio, MD, PhD|(319) 335-7234|sue-odorisio@uiowa.edu|
22409862|NCT03111407|Zimmer Biomet|Emilie Rohmer, Clinical Operations Manager|+41 58 85 48210|Emilie.Rohmer@zimmerbiomet.com|
22409863|NCT03959137|MSD Belgium|Stephanie Coulon|0032 485 461 467|stephanie.coulon@merck.com|
22409864|NCT00837031|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22409865|NCT01542736|University of Colorado Denver|Jennifer Raybin, PhD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
22409866|NCT03674827|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22409867|NCT01289990|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdf@boehringer-ingelheim.com|
22409868|NCT00363129|Mayo Clinic|Lisa Kottschade, RN, MSN, CNP|507-284-2511|kottschade.lisa@mayo.edu|
22409869|NCT03454672|Novoxel Ltd|Ifat Klein|+972-52-6009860|ifat@novoxel.com|
22409870|NCT05166512|Johns Hopkins Bloomberg School of Public Health|Dr. Julia Wolfson|410-614-4907|jwolfso7@jhu.edu|
22409871|NCT00420849|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22409872|NCT00659581|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22409873|NCT01345058|Brigham and Women's Hospital|Jong Woo Lee, MD, PhD||JLEE38@BWH.HARVARD.EDU|
22409874|NCT02719639|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22392407|NCT03789175|NHLBI, NIH|Dr. Paul Hwang|3014353068|hwangp@mail.nih.gov|
22409875|NCT01892020|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22409876|NCT02493088|Groupe Hospitalier de la Rochelle Ré Aunis|Dr Jérôme SAINT-MARTIN, study director|+33 5 46 45 66 03|jerome.saint-martin@ch-larochelle.fr|
22409877|NCT02737072|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22409878|NCT02149199|AstraZeneca AB|Stefan Ivanov|000000000000|information.center@astrazeneca.com|
22409879|NCT02762877|Genomic Health, Inc.|Director of Clinical Trials|1.650.569.2042|kgran@genomichealth.com|
22409880|NCT01915498|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22409881|NCT01806259|UoA|Prof Patrice Forget|497 12 28 36|forgetpatrice@yahoo.fr|
22409882|NCT01083901|University of Colorado Denver|Catherine M. Jankowski|303-724-7383|catherine.jankowski@ucdenver.edu|
22409883|NCT00314262|Emory University School of Medicine|Dong Shin, MD|404-778-2980|dmshin@emory.edu|
22409884|NCT01185639|Wake Forest University Health Sciences|Dr. William Blackstock|336-713-6501|ablackst@wakehealth.edu|
22409885|NCT02662556|AcelRx Pharmaceuticals, Inc.|Pamela P. Palmer, MD, PhD, Chief Medical Officer|650-216-3504|ppalmer@acelrx.com|
22392408|NCT03425097|Stanford University|Thomas A Zikos, MD|(408) 426-5599|zikosta@stanford.edu|
22418969|NCT00369317|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordintator@childrensoncologygroup.org|
22418970|NCT00635232|Ligand Pharmaceuticals|Director of Project Management|858-550-7892|hzientek@ligand.com|
22418971|NCT02722148|University of North Carolina at Chapel Hill|Dr. Evan S. Dellon|(919) 966-2513|evan_dellon@med.unc.edu|
22418972|NCT01458106|Bioverativ|Bioverativ Study Medical Director||clinicaltrials@bioverativ.com|
22418973|NCT00073021|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22418974|NCT01425723|Bioverativ Therapeutics Inc.|Bioverativ Study Medical Director|781-6631801|clinicaltrials@bioverativ.com|
22418975|NCT03375294|Palo Alto Veterans Affairs|Dr. Carolyn Rodriguez|650-723-6158|cr2163@stanford.edu|
22418976|NCT01436799|Gachon University Gil Medical Center|Dr.HJ Kwak|82-32-460-3400|hyun615@gilhospital.com|
22418977|NCT04428333|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22418978|NCT01208220|LSUShreveport|Dr. Stanley McCallon|318-813-2996|smccal@lsushc.edu|
22418979|NCT02629354|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22418980|NCT03155945|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
22418981|NCT00704847|Nordic Bioscience A/S|Bente Juel Riis, Medical Director|+45 22901317|bjr@nordicbioscience.com|
22418982|NCT02013674|ISCI / University of Miami Miller School of Medicine|Marietsy pujol / Senior Regulatory Specialist|305-243-7273|mpujol@med.miami.edu|
22418983|NCT00416884|Center for Hematologic Malignancies|Center for Hematologic Malignancies|503-494-1551||
22418984|NCT03982199|Janssen Vaccines & Prevention B.V.|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22418985|NCT03433755|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22418986|NCT06913153|Tianjin Medical University|Zhenqiang Song, M.S., Associate Professor and Master's Supervisor|8622-18602276218|Zsong@tmu.edu.cn|
22418987|NCT05065567|SpectrumLakeland|Research Specialist|(240)389-7340|rachelle.pichot@corewellhealth.org|
22418988|NCT05323123|Columbia University|Corina Lelutiu-Weinberger, PhD|(212) 342-1502|cl4265@cumc.columbia.edu|
22418989|NCT05529472|Abbott Vascular|Ikuko Kishimoto, Principal Clinical Scientist|651.756.4878|ikuko.kishimoto@abbott.com|
22418990|NCT03408639|CinnaGen Co.|Dr. Nassim Anjidani|00989125477964|Anjidani.N@orchidpharmed.com|
22418991|NCT03383523|Drugs for Neglected Diseases Initiative|Jean Yves Gillon|+41229069232|jygillon@dndi.org|
22418992|NCT01143766|Indiana University|Gregory A. Cote|317-944-2740|gcote@iupui.edu|
22418993|NCT00213135|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22418994|NCT01328379|Acorda Therapeutics|Vice President - Clinical Development & Medical Affairs|(914) 347- 4300|hhenney@acorda.com|5138
22418995|NCT01784055|NeoChord, Inc.|Lori E Adels, PhD|1-952-698-7804|ladels@neochord.com|
22418996|NCT01924754|University of California, San Francisco|Dr. Joel Palefsky, MD|(415) 476-8885|Joel.Palefsy@ucsf.edu|
22418997|NCT03132155|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22418998|NCT04320823|Haemonetics Corporation|Jan Hartmann, MD, Vice President of Medical Affairs and Clinical Development|(781) 348 7396|Jan.Hartmann@haemonetics.com|
22418999|NCT03120325|Stanford University|Linda Nguyen|650-736-0431|nguyenlb@stanford.edu|
22419000|NCT02925403|University of Oxford|Adrian V Hill, DPhil FRCP|+44 1865 617610|vaccinetrials@ndm.ox.ac.uk|
22419001|NCT00402116|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22419002|NCT02899195|PrECOG|Dr. Zhuoxin Sun|617-632-3012|zhuoxin@jimmy.harvard.edu|
22419003|NCT03156504|Mayo Clinic|Dr. Jennifer Vande Voort|507-255-6782|VandeVoort.Jennifer@mayo.edu|
22419004|NCT00450801|University of Miami|Izidore Lossos MD|305-243-4785|ilossos@med.miami.edu|
22419005|NCT05048329|NorthShore university HealthSystem|Nirav S Shah|847-570-3542|nshah@northshore.org|
22419006|NCT00324649|Gilead Sciences|Pedro Ferrer|+34 91 771 2478|pedro.ferrer@gilead.com|
22419007|NCT02618759|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
22419008|NCT03301649|Teva Pharmaceuticals Inc. USA|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
22419009|NCT01957761|Ann & Robert H. Lurie Children's Hospital of Chicago|Larry Kociolek, MD, MSCI|312-227-4080|lkociolek@luriechildrens.org|
22419010|NCT03257865|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22419011|NCT01111825|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
22419012|NCT01377987|Brigham and Women's Hospital|Dr. Scott Sands|617 278 0911|sasands@bwh.harvard.edu|
22419013|NCT00469144|University of Texas (UT) MD Anderson Cancer Center|Richard E. Champlin, MD/Chair, Stem Cell Transplantation|713-792-3618|rchampli@mdanderson.org|
22409886|NCT00788008|Duke University Medical Center|Deborah Attix, PhD|919-668-2846|deborah.koltai@dm.duke.edu|
22409887|NCT00804349|Albert Einstein Healthcare Network|Roberta Costello; Research Compliance|215-456-7225|bcostell@einstein.edu|
22409888|NCT00563524|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22409889|NCT03608696|Thomas Jefferson University|Walter Kraft|2159559077|walter.kraft@jefferson.edu|
22409890|NCT01467570|The Medical University of Warsaw|Hanna Szajewska, Malgorzata Piescik-Lech|+48-22-45-23-309|hania@ipgate.pl|
22409891|NCT03712137|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22409892|NCT02580318|St. Luke's University Health Network|Holly Stankewicz, D.O.|610-360-2725|holly.stankewicz@gmail.com|
22409893|NCT03836729|ViiV Healthcare|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|1
22409894|NCT01207401|University of California, San Diego|Dr. Sheila Krishnan Mody|(619)543-6777|smody@ucsd.edu|
22409895|NCT01392170|University of Texas (UT) MD Anderson Cancer Center|Alfonso Quintas-Cardama, MD/Professor, Leukemia|713-745-4009|CR_Study_Registration@mdanderson.org|
22409896|NCT03870737|University of California, Los Angeles|James J. McGough, M.D.|310-794-7841|jmcgough@mednet.ucla.edu|
22409897|NCT00566618|UT MD Anderson Cancer Center|Debu Tripathy, Chair, Breast Medical Oncology|(713) 792-2817|dtripathy@mdanderson.org|
22409898|NCT02177773|Unviersity of California, San Francisco|Dr. Thomas Hope, MD|(415) 221-4810|thomas.hope@ucsf.edu|22648
22409899|NCT03964220|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22409900|NCT01305265|Dept. of Anesthesia & Perioperative Care, UCSF San Francisco|Kolodzie, Kerstin M.D, PhD, Principal Investigator|4158853647|kolodziek@anesthesia.ucsf.edu|
22409901|NCT00467818|UMDNJ|Sherie Novotny MD|(732) 235-4119|novotnsl@rutgers.edu|
22409902|NCT02135874|The University of Texas MD Anderson Cancer Center|Elias Jabbour MD/Proffessor|713-792-4764|eajabbour@mdanderson.org|
22409903|NCT01313728|Valeant Pharmaceuticals International Inc|David Lineberry, Associate Director, Clinical Operations|949-973-1153|David.Lineberry@valeant.com|
22409904|NCT02216214|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22409905|NCT00716586|University of Illinois at Chicago|Emeritus Professor of Ophthalmology|312 997-3646|gerafish@uic.edu|
22409906|NCT05354206|Washington University in St. Louis|Dr. Ismael Seáñez|3149357665|ismaelseanez@wustl.edu|
22409907|NCT04822467|Cleveland Clinic Foundation|Dr. Donald Kirby, MD|216-444-0446|kirbyd@ccf.org|
22409908|NCT00713830|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22409909|NCT01676311|Spaulding Rehabilitation Hospital|Ross Zafonte, DO|617-952-5227|rzafonte@mgh.harvard.edu|
22409910|NCT02261974|Viveve, Inc.|Debbie Wilkerson, PhD, Vice President, Clinical and Medical Affairs|610-209-9980|dwilkerson@viveve.com|
22409911|NCT02030834|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
22409912|NCT04440007|Sorrento Therapeutics, Inc.|Mike Royal, MD|858-203-4100|mroyal@sorrentotherapeutics.com|4146
22409913|NCT01466673|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-739-7200||5888
22409914|NCT02164539|GlaxoSmithKline|GSK Response Center|866-435-7343||
22409915|NCT01255722|Section Head Interventional and Cardiac Radiology - Kantonsspital Lucerne, Spitalstrasse, 6006 Lucerne, Switzerland|Prof. Dr. med. Martin HOFFMANN|+41 41 205 4660|martin.hoffmann@luks.ch|
22409916|NCT03398928|Bnai Zion Medical Center|Prof. Elad Schiff|972-506267243|elad.schiff@b-zion.org.il|
22409917|NCT05149989|Liverpool University Hospitals NHS Foundation Trust|Dr Tristan Payne|+44(0)1517064553|tristan.payne@liverpoolft.nhs.uk|
22409918|NCT04529499|Dr Reddy's Laboratories Ltd.|Dr. Srinivas Shenoy B.,|49002900|srinivassshenoyb@drreddys.com|
22409919|NCT00683904|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22409920|NCT02702271|Boston Scientific|Director of Clinical Trials|1-800-CARDIAC|peter.maurer@bsci.com|
22409921|NCT01494649|GlaxoSmithKline|GSK Response Center|866-435-7343||
22409922|NCT03091400|Icahn School of Medicine at Mount Sinai|James F Sumowski, PhD|212-241-6854|james.sumowski@mssm.edu|
22409923|NCT00975884|GlaxoSmithKline|GSK Response Center|866-435-7343||
22419014|NCT03369197|The Johns Hopkins University|Dr. Laeben Lester|410-955-7519|llester4@jhmi.edu|
22409924|NCT00294632|The University of Texas (UT) MD Anderson Cancer Center|Dr. Michael Wang, Professor, Lymphoma/Myeloma|713-792-2860|miwang@mdanderson.org|
22409925|NCT03707522|University of Nevada, Reno|Martha Zimmermann|7756368067|mzimmermann@nevada.unr.edu|
22409926|NCT00383019|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22409927|NCT01337609|Massachusetts General Hospital|Dr. Maurizio Fava|617-724-2513|mfava@partners.org|
22409928|NCT05473247|Berry College|Kameron Suire|3373968980|ksuire@berry.edu|
22409929|NCT00000135|Johns Hopkins University|Curtis Meinert, PhD|410-955-8198|cmeinert@jhsph.edu|
22409930|NCT01831596|KCI|VP, Global Clinical Development|210-255-5595|jkhart@mmm.com|
22409931|NCT03162354|Penn State College of Medicine, Penn State Health Children's Hospital|Kent P. Hymel, MD; Professor of Pediatrics; Study PI|7036748989|kphymel@gmail.com|
22409932|NCT02508649|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DK0-Disclosure@ferring.com|
22409933|NCT00446134|Valeant Pharmaceuticals International, Inc.|Senior Director Clinical Development|908-927-1782|ralph.doyle@valeant.com|
22409934|NCT02360124|University of Hong Kong|Prof. E.C.M. Lo|852-2859 0292|edward-lo@hku.hk|
22409935|NCT00567996|Novartis Pharmaceuticals|Study Director|862-778-8300||
22409936|NCT01115699|Mayo Clinic|Michelle Skime, Supervisor - Senior Clinical Research Coordinator|507-255-0501|skime.michelle@mayo.edu|
22409937|NCT02956005|MedStar Georgetown Transplant Institute|Alexander Gilbert|202-444-0621|Alexander.J.Gilbert@gunet.georgetown.edu|
22409938|NCT03125629|Stanford University|Andrei Iagaru|650-725-4711|aiagaru@stanford.edu|
22409939|NCT00743119|New York State Psychiatric Institute|Dr. Ziva Cooper|646-774-6129|zc2160@cumc.columbia.edu|
22409940|NCT02524665|GlaxoSmithKline|GSK Response Center|866-435-7343||
22409941|NCT02989610|Abbott|Tucker Tomlinson, Scientist, Clinical Research|+19725269646|Tucker.Tomlinson@Abbott.com|
22409942|NCT04179474|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22409943|NCT01407107|University of Texas Southwestern Medical Center|Dr. Jonathan Dowell|214-648-7097|jonathan.dowell@utsouthwestern.edu|
22409944|NCT02602080|Hospital for Special Surgery|George Birch|212-774-7377|birchg@hss.edu|
22409945|NCT01532349|Johns Hopkins University|Dr. Meredith Atkinson|410-955-2467|matkins3@jhmi.edu|
22409946|NCT03934437|Johns Hopkins University|Larry Chang|4109551725|lchang8@jh.edu|
22409947|NCT01066039|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22409948|NCT02574260|Amgen, Inc.|Study Director|866-572-6436||
22409949|NCT04508621|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 904-0355|Greg.Sullivan@TonixPharma.com|
22409950|NCT00752895|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
22409951|NCT03022799|Kainos Medicine, Inc|Dr. JaeMoon Lee|+1 408 202 4017|jlee@kainosmedicine.com|
22409952|NCT04881448|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22409953|NCT00683046|University of Chicago Medicine|Dr. Andrew Artz|773-834-8980|aartz@medicine.bsd.uchicago.edu|
22409954|NCT01966107|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22409955|NCT02200614|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22409956|NCT00864084|The University of Manitoba|Ms Elizabeth Harvey|204-977-5656|harveye@cc.umanitoba.ca|
22409957|NCT02175472|PhotoPharmics, Inc.|Dan Adams|801-770-6960|dan.adams@photopharmics.com|
22409958|NCT02531698|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22409959|NCT01861717|JOHN WAYNE CANCER INSTITUTE|Dr. Daniel Kelly|310-582-7450|Daniel.Kelly2@providence.org|
22409960|NCT02049931|Seoul National University|Professor Jin S. Yeom|82-31-787-7195|highcervical@gmail.com|
22409961|NCT01456494|University of Chicago|Mary Akel|773-834-4489|makel@medicine.bsd.uchicago.edu|
22409962|NCT02395536|Medtronic, PLC|Lindsay Werder, Senior Clinical Research Specialist|7635268168|lindsay.k.werder@medtronic.com|
22409963|NCT00701558|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22409964|NCT04499391|Penn State College of Medicine|Dr. Jennifer Kraschnewski|717-531-8161|jkraschnewski@pennstatehealth.psu.edu|
22409965|NCT04876482|Department of Physical Therapy, Shu-Zen Junior College of Medicine and Management, Kaohsiung, Taiwan|Yi-Ju, Lai|+886963123117|jasmine19900728@gmail.com|
22409966|NCT02598622|Indiana University|Dr. Chie Schin-Shih|317-944-8784|shih2@iu.edu|
22409967|NCT00201734|The Ohio State University Comprehensive Cancer Center|Tanios Bekaii-Saab, MD|614-293-9863|tanios.bekaii-saab@osumc.edu|
22409968|NCT01416142|Bausch & Lomb Incorporated|Dr. William Reindel|(585) 338-8129|william.reindel@bausch.com|
22409969|NCT02464059|University of North Carolina at Chapel Hill|Michael Bradley Drummond, MD|919-966-7054|brad_drummond@med.unc.edu|
22409970|NCT01318733|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
22409971|NCT00634582|Comprehensive Cancer Center of Wake Forest Univeresity|Gary Schwartz, PhD|336-716-7446|gschwart@wakehealth.edu|
22409972|NCT02499406|VACHS|Investigator|203 932 5711|suzanne.decker@va.gov|
22409973|NCT01485588|Iconic Therapeutics|Gabriela Burian, M.D.|6504371000|gburian@iconictherapeutics.com|
22409974|NCT03591107|RAND|Lisa Meredith, Senior Behavioral Scientist|310.393.0411|seidel@rand.org|7365
22392409|NCT03339245|The Rockefeller University|Dr. Peter R Holt|212-327-7706|holtp@rockefeller.edu|
22392410|NCT01182441|Boston Scientific|WATCHMAN Trial Manager|1-800-227-3422||
22392411|NCT00384774|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22392412|NCT00288639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22392413|NCT02981108|Jiangsu Hansoh Pharmaceutical Group Co., Ltd.|Alison Li|86-21-51211850|Alison.li@hspharm.com|
22392414|NCT03480932|Johns Hopkins Bloomberg School of Public Health|Dr. Shruti Mehta|4432873837|smehta@jhu.edu|
22409975|NCT00304954|NEI|Dr. Robert Nussenblatt, MD, MPH|301-496-3123|robert.nussenblatt@nih.gov|
22409976|NCT04221087|University of PIttsburgh|Dr. Allison Williams|4126925135|williamsae2@upmc.edu|
22409977|NCT00736099|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22409978|NCT01222715|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22409979|NCT03379246|TriHealth Inc.|Dr. Catrina Crisp|513-463-4300|Catrina_Crisp@trihealth.com|
22409980|NCT00948025|AxoGen, Inc|Vice President, Clinical and Translational Sciences|3864626829|edevinney@axogeninc.com|
22409981|NCT04006847|Penn State Health|Seema Naik, MD|7175318678|snaik@pennstatehealth.psu.edu|
22409982|NCT01498419|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|(212) 227-7540|Dan.Everitt@tballiance.org|
22409983|NCT03555890|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22409984|NCT03372369|University of North Carolina at Chapel Hill|Seri Link Anderson, PhD|919-619-0433|seri.link.a@gmail.com|
22409985|NCT01383954|Brigham and Women's Hospital|Ajay D. Wasan, M.D., M.Sc.||awasan@partners.org|
22409986|NCT01791127|BIOTRONIK, Inc.|Clinical Studies Engineer Manager|1-800-547-0394|crystal.miller@biotronik.com|
22409987|NCT00520494|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22409988|NCT01117090|Medtronic Restorative Therapies Group - Targeted Drug Delivery|Restorative Therapies Group Clinical Trials||medtronicneurotrials@medtronic.com|
22409989|NCT02353299|Sleep Disorders and Research Center Henry Ford Hospital|Christopher L Drake|248-344-6672|cdrake1@hfhs.org|
22409990|NCT04023994|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22409991|NCT00707174|University of Utah|Glen Bowen, MD|801-581-0255|glen.bown@hci.utah.edu|
22409992|NCT00544557|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22409993|NCT01017029|Pharmaceuticals|Novartis|+1(862)778-8300||
22409994|NCT01830920|Thrasos Therapeutics, Inc.|Jerome Rossert, MD, PhD, Chief Scientific Officer||Jerome.Rossert@thrasos.com|
22409995|NCT00422058|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22409996|NCT00572156|Ipsen|Medical Director, Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22409997|NCT00663039|MPRC|Elliot Hong|410-402-6828|ehong@mprc.umaryland.edu|
22409998|NCT03216954|University of Kentucky|William W. Stoops, PhD|859-257-5388|william.stoops@uky.edu|
22409999|NCT00323271|VA Connecticut Healthcare System|Robert Kerns, PhD|203-932-5711|robert.kerns@va.gov|3841
22410000|NCT04333199|Geisinger Clinic|Amir Goren, PhD|5702144395|agoren@geisinger.edu|
22410001|NCT03778190|Kendall Regional Medical Center|Dr. Tony Zitek|305-480-6602|zitek10@gmail.com|
22410002|NCT01333475|National Cancer Institute|Dr. Shivaani Kummar|301-435-0517|kummars@mail.nih.gov|
22410003|NCT02981602|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22410004|NCT00666718|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22410005|NCT01032330|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
22410006|NCT03304210|Ghent University|Prof|+32(0)93326251|wim.ceelen@ugent.be|
22410007|NCT02567266|University of Miami|Dr. Amanda Jensen-Doss|+1 (305)284-8332|ajensendoss@miami.edu|
22410008|NCT02983227|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22410009|NCT02020785|Geisinger|Alex Chang, MD|570-271-8026|achang@geisinger.edu|
22410010|NCT00701935|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22410011|NCT00527397|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22410012|NCT00947518|Department of Pediatrics, All India Institute of Medical Sciences, New Delhi|Mari Jeeva Sankar|+91-11-26594372|jeevasankar@gmail.com|
22410013|NCT02065791|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22410014|NCT04529096|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22410015|NCT03467971|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22410016|NCT01619085|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22410017|NCT02642991|CooperVision, Inc.|Paul Chamberlain|925 730-6754|PChamberlain@coopervision.com|
22410018|NCT00883129|David Geffen School of Medicine at UCLA|Donald P. Tashkin, M.D.|310-825-5316|dtashkin@mednet.ucla.edu|
22410019|NCT03273257|Papworth Hospital NHS Foundation Trust|David Jenkins, MD; Principal Investigator and ICA Board member|+44 1223 638000|david.jenkins1@nhs.net|
22410020|NCT01898884|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22410021|NCT00434148|Novartis Pharmaceuticals|Study Director|862-778-8300||
22410022|NCT00759759|Actavis Inc.|Meena Venugopal, Director, Clinical R&D|908-659-2885|MVenugopal@actavis.com|
22410023|NCT01556165|Email contact via H. Ludbeck A/S|Study director||LundbeckClinicalTrials@lundbeck.com|
22410024|NCT03980561|MUSC|Amanda Wagner|8437920484|wagne@musc.edu|
22410025|NCT01640964|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22410026|NCT04633187|Enanta Pharmaceuticals|Study Director|617-607-0800|enquiries@enanta.com|
22410027|NCT01998035|Columbia University Irving Medical Center|Ana Ignat|212-305-3612|ai2111@cumc.columbia.edu|
22410028|NCT00833976|Massachusetts General Hospital|Dr. Marlene Freeman, MD|617-643-6403|mfreeman@partners.org|
22410029|NCT02450760|University of Pennsylvania|Michael Mullen|215-662-3339|Michael.Mullen@Pennmedicine.Upenn.edu|
22410030|NCT04071392|Oregon Health & Science University|OB/Gyn Regulatory Specialist|503-494-3666|whru@ohsu.edu|
22410031|NCT01246973|University of Rochester|Julie Ryan|585-276-3862|julie_ryan@urmc.rochester.edu|
22410032|NCT00678379|Charlotte Eye Ear Nose and Throat|Jonathan Moss MD|704-295-3000|jmoss@ceenta.com|
22410033|NCT01835470|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22410034|NCT01011907|UCSF: EGCRC|Jennifer Mitchell, Clinical Project Director|510-985-3100|jmitchell@gallo.ucsf.edu|
22410035|NCT02685956|Global BioClinical|Jennifer Maas|206-240-8632|jen.maas@globalbioclinical.com|
22410036|NCT01222871|SEMC|Dr. Peter catalano|1-617-789-5004|peter.catalano@steward.org|
22410037|NCT00350519|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Vice President Medical Affairs COBS|215-325-4464||
22392415|NCT00663702|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
22392416|NCT03056300|Ethicon|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
22392417|NCT05262517|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22392418|NCT05241314|University of Minnesota|Sarah Hoffman|612-625-0606|hoff0742@umn.edu|
22392419|NCT02190903|University of Pennsylvania School of Medicine|Mark D Neuman|2157467468|neumanm@mail.med.upenn.edu|
22392420|NCT00387244|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
22392421|NCT01730378|GlaxoSmithKline|GSK Response Center|866-435-7343||
22392422|NCT01102764|Medical University of South Carolina|Ron Acierno, PhD|843-792-2949|acierno@musc.edu|
22392423|NCT01048697|Texas Tech UHSC|Ronald Hall|214-654-9404|ronald.hall@ttuhsc.edu|
22392424|NCT04481373|Baylor College of Medicine|Thomas Giordano|7137988918|tpg@bcm.edu|
22392425|NCT03119233|Endologix|Tammy Stiver, Manager, Clinical Affairs|5136731452|tstiver@endologix.com|
22392426|NCT01254552|Guerbet|Corinne Dubourdieu, Head of Clinical Projects and Medical Writing|+33(0)1 45 91 50 00|corinne.dubourdieu@guerbet.com|
22392427|NCT01685229|Acclarent Inc.|Clinical Manager|949-453-6408|PChen126@ITS.JNJ.com|
22392428|NCT01012362|Masonic Cancer Center, University of Minnesota|Dr. Arkadiusz Dudek|651-254-3321|Arkadiusz.Z.Dudek@HealthPartners.com|
22392429|NCT00558844|Insmed Incorporated|Kevin Mange (Senior VP, Clinical Development and Medical Affairs)|908-947-2651|kevin.mange@insmed.com|
22392430|NCT01146600|Emory University School of Medicine|Lynn Marie Trotti, MD, MSc|404-728-4752|lbecke2@emory.edu|
22392431|NCT02579135|North Carolina State University|Dr. Laura Widman|919-513-2546|lmwidman@ncsu.edu|
22392432|NCT00659880|RTI Surgical|Robin Waite, RN|386-418-8888|rwaite@rtix.com|
22392433|NCT01853475|Medicines for Malaria Ventire (MMV)|Dr Thomas Rueckle|+41 22 799 4567|ruecklet@mmv.org|
22392434|NCT02964325|Terumo Blood and Cell Technologies|Robert Cortes, Jr. MD|+1.303.231.4353|Robert.Cortes@terumobct.com|
22392435|NCT02510040|Jaeb Center for Health Research|Raymond Kraker, PEDIG Coordinating Center Director|813-975-8690|rkraker@jaeb.org|
22392436|NCT03596762|Bayer AG|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22392437|NCT03842228|The University of Texas MD Anderson Cancer Center|Dr. Timothy Yap|(713) 839-5458|tyap@mdanderson.org|
22410038|NCT00823459|University of California, San Francisco|Susan Chang, MD|(415) 353-2966|jessica.carlson@ucsf.edu|
22410039|NCT01637961|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22410040|NCT01331083|Canadian Cancer Trials Group|Lesley Seymour|6135336430|lseymour@ctg.queensu.ca|
22410041|NCT02292433|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22410042|NCT02239601|CancerCare Manitoba|Marshall Pitz|2044751431|Mpitz@cc.umanitoba.ca|
22410043|NCT04682639|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22410044|NCT04388527|University of Pennsylvania|Regulatory Lead|512-662-4484|psom-ind-ide@pobox.upenn.edu|
22410045|NCT00406107|Palmetto Retina Center|John A. Wells, III, M.D.|803-931-0077|jackwells@palmettoretina.com|
22410046|NCT03851107|McGill University|Dr. Dana Anaby|15143984400|dana.anaby@mcgill.ca|00394
22410047|NCT00331773|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22410048|NCT02773446|Johns Hopkins University|Kawsar Talaat|410-502-9627|ktalaat@jhu.edu|
22410049|NCT02513459|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22410050|NCT00923195|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
22410051|NCT00525031|UT MD Anderson Cancer Center|Wen-Jen Hwu, MD/Professor, Melanoma Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
22392438|NCT03085225|Institut Bergonié|Pr Simone Mathoulin-Pelissier|0556333333|S.Mathoulin@bordeaux.unicancer.fr|
22410052|NCT01613131|University of Colorado Denver|Chanel Mansfield|303-724-6501|chanel.mansfield@ucdenver.edu|
22410053|NCT01430182|Baylor College of Medicine|Neil Bailard|713-798-7356|bailard@bcm.edu|
22410054|NCT02454972|Pharma Mar S.A.|Clinical Development, Department of PharmaMar´s Oncology., Business Unit.|0034 91846 60 00|clinicaltrials@pharmamar.com|
22410055|NCT00787566|Aviana Consulting, LLC|Vanaja V. Ragavan, M.D.|610-795-7403|vvragavan@comcast.net|
22410056|NCT02140164|National Institutes of Health|Catherine Cukras, MD, PhD, Principal Investigator, NEI|301-435-5061|cukrasc@nei.nih.gov|
22410057|NCT00780715|University of Dundee|Professor Ewan Pearson|+44 (0) 1382 383387|e.z.pearson@dundee.ac.uk|
22410058|NCT01814761|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22410059|NCT00775983|UCSF|Abby Sokoloff|4155140440|sokoloffa@obgyn.ucsf.edu|
22410060|NCT00939705|Gateway Medical Research, Inc.|Walter A Parham|(314) 663-4550||
22410061|NCT01020305|Stanford University Medical Center|Associate Professor of Medicine (Oncology)|650-725-2078|sandysri@stanford.edu|
22410062|NCT01402115|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Dal-Sik Kim, MD|82-63-276-8284|dskim@chonbuk.ac.kr|
22410063|NCT01070966|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22410064|NCT01725113|NYU Langone Health|Candace Grant|5166632171|Candace.Grant@nyulangone.org|
22410065|NCT00446264|University of Lille|Violeta Raverdy|00 33 3 20 62 34 30|vraverdi@univ-lille2.fr|
22410066|NCT02753400|Kubota Vision Inc.|Clinical Trials Helpdesk|2068058310|clinicaltrials@kubotavision.com|
22410067|NCT03989115|Revolution Medicines|Vice-President Clinical Operations|650-779-2300|RMC-4630-02@revmed.com|
22410068|NCT01415921|New York University School of Medicine|Stuart Katz, MD|212-263-3946|stuart.katz@nyumc.org|
22410069|NCT04980521|University of North Dakota|Dr. Gary Schwartz|701-777-6598|gary.schwartz@und.edu|
22410070|NCT02660385|University of Connecticut/formerly Yale University|Meghan O'Connell, Program Manager|860-634-4152|meghan.oconnell@uconn.edu|
22410071|NCT00697112|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22410072|NCT03007537|Nanjing First Hospital, Nanjing Medical University|Dr. Xiaobin Ji|13705174622|xbji007@126.com|
22410073|NCT00720304|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Min Yao, MD|1-800-641-2422|CTUReferral@UHhospitals.org|
22410074|NCT01087801|ChiRhoClin, Inc.|Edward Purich, Ph.D.|301-476-8388|mdoerr@chirhoclin.com|
22410075|NCT04330482|Rhode Island Hospital|Geoffrey Tremont|401-444-4500|gtremont@lifespan.org|
22410076|NCT01468974|Abbott Vascular|Nadia bouhdi||nadia.bouhdi@av.abbott.com|
22410077|NCT02725671|Johns Hopkins University|Dr. Armin Zadeh|4105020549|arminzadeh@jhu.edu|
22410078|NCT00998582|Minneapolis Medical Foundation|Dr. Jason Baker|612-873-2705|baker459@umn.edu|
22410079|NCT02354976|AstraZeneca|Torbjörn Lundström|46 317064100|Torbjorn.lundstrom@astrazeneca.com|
22410080|NCT01706770|Foresight Regulatory Strategies, Inc.|William J. Gleason, O.D.|(978) 658-6888||151
22410081|NCT00068445|Mayo Clinic|Charles L. Loprinzi, M.D.|507-284-3731|cloprinzi@mayo.edu|
22410082|NCT01155284|Sanford Research|Kurt J. Griffin, PhD, MD, Director of Clinical Trials|6053126000|kurt.griffin@sanfordhealth.org|
22410083|NCT01896700|Portland VA Health Care System|Andrea Hildebrand|503-220-8262|hildeand@ohsu.edu|52016
22392439|NCT03632083|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
22410084|NCT00123487|Bristol-Myers Squibb|: Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22410085|NCT00802633|Vanderbilt University|Sam Chang|615-322-2101|sam.chang@Vanderbilt.Edu|
22410086|NCT01656967|The University of Texas Health Science Center at Houston|Dr. Carin A. Hagberg|(713) 500-6240|Carin.A.Hagberg@uth.tmc.edu|
22410087|NCT00407966|SKCCC|Judith Karp, MD|410-502-7726|jkarp2@jhmi.edu|
22410088|NCT01031134|Weill Cornell Medical College|Patrick Raue, Ph.D.|206-543-3807|praue@uw.edu|
22410089|NCT02771340|Iconic Therapeutics|Gabriela Burian, M.D.|6504371000|gburian@iconictherapeutics.com|
22410090|NCT05788237|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22410091|NCT04148508|University of Exeter|Professor Ed Watkins|01392 724692|e.r.watkins@exeter.ac.uk|
22410092|NCT03877484|Smith and Nephew|Clinical Study Manager|1482673917|rebecca.mcdonald@smith-nephew.com|+44
22410093|NCT00918229|BioProtect|Shaul Shohat|+972545423774|Shaul@bioprotect.com|
22410094|NCT00581386|UTHSC- Houston Medical School|Dr. Carin A. Hagberg|713.500.6222|maddukuri.vineela@uth.tmc.edu|
22410095|NCT00681824|Baxter Healthcare Corporation|Guenter Zuelow, Associate Medical Director||guenter_zuelow@baxter.com|
22410096|NCT03724916|Takeda|Contact|+1-877-825-3327|medinfoUS@takeda.com|
22410097|NCT04575038|Clear Creek Bio, Inc.|Barbara Powers, Vice President Clinical Operations|16177652252|clinical@clearcreekbio.com|
22410098|NCT00683332|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22410099|NCT00176852|Masonic Cancer Center, University of Minnesota|Dr. Angela Smith|612-626-2778|smith719@umn.edu|
22410100|NCT01363401|Hanyang University Seoul Hospital|Seung-Hyun Kim, M.D., Ph.D.|+82-2-2290-8114|kimsh1@hanyang.ac.kr|
22410101|NCT04335110|Oregon Health & Science University|Dr. Allison Lindauer|15034946976|lindauer@ohsu.edu|
22410102|NCT05105477|Edwards Lifesciences|Cristina Johnson|888.713.1564|CC_Clinical_Affairs@edwards.com|
22410103|NCT03101293|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22410104|NCT02833857|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22410105|NCT03182920|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22410106|NCT02542150|"University of Colorado Denver | Anschutz"|Jody Tanabe, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
22410107|NCT03333382|Vanderbilt University Medical Center|Sharee Burkeen, Research Program Manager|(615) 875-7515|sharee.k.burkeen@vumc.org|
22410108|NCT02314520|Penn State Health Milton S. Hershey Medical Center Dept of Neurosurgery|Dr. J. Christopher Zacko|717-531-1279|jzacko@pennstatehealth.psu.edu|
22410109|NCT00661674|Stanford University School of Medicine|Dr. Larry Chu|(650) 723-6632|lchu@stanford.edu|
22410110|NCT00660790|Medical University of Graz|Dr. Norbert Tripolt|+43 316 385|norbert.tripolt@medunigraz.at|78038
22410111|NCT06118359|University of Wisconsin|Angela Ingraham|513-833-5205|aingraham.md.ms@gmail.com|
22410112|NCT04214951|Peking University People's Hospital|Dr. Xiaohui Zhang, Director of Clinical Trials|86-10-88324577|zhangxh@bjmu.edu.cn|
22410113|NCT03202628|Mayo Clinic|Dr. Prashant Kapoor|507-284-2511|Kapoor.Prashant@mayo.edu|
22410114|NCT00686374|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22410115|NCT00618774|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22410116|NCT03903640|Washington University School of Medicine|Dr. George Ansstas|314-508-4426|gansstas@wustl.edu|
22410117|NCT02424565|GlaxoSmithKline|GSK Response Center|866-435-7343||
22410118|NCT02143947|Quinnipiac University|Juan C Garbalosa, PT, PhD, Director Motion Analysis Laboratory|203 582 8552|juan.garbalosa@quinnipiac.edu|
22410119|NCT01808209|Opthalmic Research Group, Aston University, Birmingham, UK|Jonathan Walker||JWalker@coopervision.co.uk|
22410120|NCT02786498|University of Maryland Baltimore, School of Medicine, Department of Orthopaedics|Dr Gerard Slobogean|410-28-6280|gslobogean@som.umaryland.edu|
22410121|NCT00374543|Massachusetts General Hospital|Naomi M. Simon, M.D., M.Sc.|(617) 726-7913|nsimon@partners.org|
22410122|NCT00685919|Vanderbilt University Medical Center|Alfredo Gamboa, MD|615-875-1003|alfredo.gamboa@vumc.org|
22410123|NCT04228302|EicOsis|Dr. William Schmidt|650-438-3018|wkschmidt@eicosis.com|
22410124|NCT02732561|Wake Forest Health Sciences|James Kimball, MD|1 (336) 716-9702|jkimball@wakehealth.edu|
22410125|NCT04736576|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22410126|NCT05180630|Sonova USCS|Director of Clinical Research|630-821-5000|phonakaudiologyresearch@gmail.com|
22410127|NCT01382901|Luitpold Pharmaceuticals, Inc.|Mark Falone, MD|601-650-4200|mfalone@luitpold.com|
22410128|NCT00709735|Massachusetts General Hospital|Roger K. Pitman, M.D.|617-726-5333|roger_pitman@hms.harvard.edu|
22410129|NCT00963599|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22410130|NCT02135094|Pain Management Associates|Dr. Ralph Ortiz|(607) 844-9979|rodoc@cnymail.com|
22410131|NCT00190684|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22410132|NCT02492295|Albert Einstein Medical Center|Kamran Mohiuddin, Director Clinical Research Emergency Department|215-456-2313|MOHIUDDK@EISNTEIN.EDU|
22419015|NCT02901548|Moffitt Cancer Center|Jingsong Zhang, MD, PhD|813-745-6926|Jingsong.Zhang@moffitt.org|
22410133|NCT01632683|Oregon Health & Science University|Michael Aziz, MD|503-494-5581|azizm@ohsu.edu|
22410134|NCT00423488|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22410135|NCT03118765|Glenmark Pharmaceuticals Ltd.|Study Director|201-684 8000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
22410136|NCT02643966|University of Pittsburgh|Dr. Wendie A. Berg|412-641-1635|bergwa@upmc.edu|
22410137|NCT01493531|Ardea Biosciences, Inc.|Nihar Bhakta, MD|1-858-652-6671|nbhakta@ardeabio.com|
22410138|NCT02245360|Abbott|Dmitri Kazei MD, PhD|+31 294477008|dmitri.kazei@abbott.com|
22410139|NCT01362959|Department of Intensive care, Deventer Hospital|Dr. Huub van den Oever|+31 570 535346|h.vandenoever@dz.nl|
22392440|NCT02195479|Janssen Research and Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22392441|NCT01834586|EvergreenHealth Multiple Sclerosis Center|Theodore Brown|425-8995350|trbrown@evergreenhealth.com|
22392442|NCT01512797|Columbia University Medical Center|Dr. Blandine Laferrere|212-851-5562|bbl14@columbia.edu|
22392443|NCT01263509|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
22392444|NCT00758342|Alcon Research, Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22392445|NCT03993210|DFCI|Clare Tempany|617-732-7858|ctempany@bwh.harvard.edu|
22392446|NCT00441259|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22392447|NCT00478192|Astellas Pharma Global Development|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com|
22392448|NCT01818531|Wake Forest University Health Sciences|Dr. Daryl Henshaw|3367166344|dhenshaw@wakehealth.edu|
22392449|NCT00214019|UW Madison|Gina Crisafi|6082654554|gmc@medicine.wisc.edu|
22392450|NCT00137969|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22410140|NCT03835975|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22410141|NCT01612702|Joint Reconstruction Center, Seoul National University Bundang Hospital|Dr. TK Kim|82-31-787-7196|osktk@snubh.org|7200
22410142|NCT03070431|Department of Radiation Oncology, University of Lübeck, Lübeck, Germany|Prof. Dr. med. Dirk Rades|0049 451 500|rades.dirk@gmx.net|45400
22410143|NCT00717873|Barnes Jewish Hospital|Darnetta Clinkscale|(314) 362-1276|MDB3455@bjc.org|
22410144|NCT00370396|GlaxoSmithKline|GSK Response Center|866-435-7343||
22410145|NCT01431755|Q-Med AB|Head of Medical Affairs|+46 (0) 18 474 90 00|reception.SEUPP@galderma.com|
22410146|NCT02282111|The Johns Hopkins Hospital|Dr. Mouen A. Khashab|410-502-0064|mkhasha1@jhmi.edu|
22410147|NCT00051636|Novartis|Study Director|862-778-8300||
22410148|NCT02340078|LG Chem|Study Leader|82-2-6987-4148|sodam@lgchem.com|
22410149|NCT00204932|U Wisconsin-Madison|Dale Schoeller Principal Investigator|608-262-1082|dschoell@nutrisci.wisc.edu|
22410150|NCT00944125|Aurora Health Care|Imran K. Niazi, MD|414-645-6070|imran.niazi@aurora.org|
22410151|NCT02176642|Duke University|Nazema Siddiqui MD||nazema.siddiqui@duke.edu|
22410152|NCT00361257|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22410153|NCT03471182|Yale University School of Medicine|Patrick Worhunsky|203-737-2668|patrick.worhunsky@yale.edu|
22410154|NCT00670267|Baylor College of Medicine|N.A. Hanania, M.D.||hanania@bcm.edu|
22410155|NCT03512067|Brigham and Women's Hospital|Dr. Gyorgy Frendl|617-732-5910|gfrendl@bwh.harvard.edu|
22410156|NCT00690924|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
22410157|NCT03451331|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22410158|NCT00289731|GlaxoSmithKline|GSK Response Center|866-435-7343||
22410159|NCT01551550|TissueTech|Medical Affairs|(888) 296-8858|info@tissuetech.com|
22410160|NCT01170364|NYPInstitute|Dr. Laurel Mayer|646-774-8067|lsm16@columbia.edu|
22410161|NCT00892697|University at Buffalo|Andrew Talal, MD|716-888-4737|ahtalal@buffalo.edu|
22410162|NCT00368537|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22410163|NCT04248855|Kanyos Bio (A wholly owned subsidiary of Anokion SA)|Medical Director|+1 857-320-6607|clinicaltrials@anokion.com|
22410164|NCT05483920|Black Hills State University|Dr. Ashley Pfeiffer|(605) 381-5370|ashley.pfeiffer@bhsu.edu|
22410165|NCT01368276|Amgen, Inc.|Study Director|866-572-6436||
22410166|NCT01427920|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22410167|NCT03341273|Duke University|Ephraim L. Tsalik, MD, MHS, PhD|919-684-3114|e.t@duke.edu|
22410168|NCT01674478|Wake Forest University Health Sciences|Dr. Qing Yang||qyang@wakehealth.edu|
22410169|NCT01717456|University of North Carolina at Chapel Hill|William E. Whitehead, PhD, Professor of Medicine|(919) 843-6961|William_Whitehead@med.unc.edu|
22410170|NCT02281409|Memorial Sloan Kettering Cancer Center|Dr. Jedd Wolchok, MD, PhD|646-888-2315|wolchokj@mskcc.org|
22410171|NCT05795062|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22410172|NCT03066440|UBMD Pediatrics|Dr. Amanda B. Hassinger, Medical Director of the UBMD Pediatrics Sleep Center|716-323-0158|albrooks@buffalo.edu|
22410173|NCT00736333|Merck Sharp & Dohme Corp.|Senior Vice President, Global Cllinical Development||ClinicalTrialsDisclosure@merck.com|
22410174|NCT03723590|Medline Industries|Julie Miller|630-418-6891|jamiller@medline.com|
22410175|NCT04991311|Zealand Pharma A/S|Head of clinical operations|+45 8877 3600|info@zealandpharma.com|
22410176|NCT01990898|Cleveland Clinic|Dr. Daniel Shoskes||dshoskes@gmail.com|
22410177|NCT00054275|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Paula Silverman, MD|216-844-3951|paula.silverman@uhhospitals.org|
22410178|NCT01106352|Bayer|Therapeutic Area Head||Clinical-Trial-Disclosure@bayer.com|
22410179|NCT03944707|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22410180|NCT01878500|Johns Hopkins University|Dr. John P Gearhart|410-955-5358|jgearha2@jhmi.edu|
22410181|NCT02444182|Kuwait University - Faculty of Dentistry|Dr. Abrar Alanzi|24636812|aalanzi@hsc.edu.kw|
22410182|NCT01959230|Bausch & Lomb Incorporated|Director, Medical Affairs||Heleen.DeCory@bausch.com|
22410183|NCT01453374|Alkermes|Bernard L. Silverman, MD|781-609-6000|Bernard.Silverman@alkermes.com|
22410184|NCT00751998|Boston Scientific Corporation|Joyce Peetermans, PhD, Director Endoscopy Clinical|508-683-4211|peetermj@bsci.com|
22410185|NCT00123110|University of Pennsylvania, School of Medicine|Anne R. Cappola, M.D., ScM|(215) 573-5359|ACappola@mail.med.upenn.edu|
22410186|NCT00996918|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22419016|NCT01266031|National Cancer Institute|Dr. Mark Gilbert|301-402-6383|gilbertmr@mail.nih.gov|
22419017|NCT04893018|Cancer Immunotherapy Trials Network|Clinical Trial Manager|206-667-2541|citn.core.reg@hvtn.org|
22410187|NCT02011516|University of Pennsylvania|Teresa R. Franklin, Ph.D., Research Associate Professor of Neuroscience in Psychiatry|215-222-3200|teresafr@mail.med.upenn.edu|119
22410188|NCT01965535|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22410189|NCT04000373|Cleveland Clinic Neurological Institute Mellen Center|Research Nurse Coordinator|216-445-5877|stoughd@ccf.org|
22410190|NCT00829439|Boston Children's Hospital|Wen-Hann Tan|617-355 6394|wen-hann.tan@childrens.harvard.edu|
22410191|NCT02525562|Stryker Orthopaedics|Stryker JR Clinical Research|201-831-5000|StrykerJRClinical@stryker.com|
22410192|NCT00886782|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22410193|NCT01946282|University of Texas Southwestern Medical Center, Moncrief Cancer Institute|Dr. Keith Argenbright, Director, Moncrief Cancer Institute|817-288-0070|keith.argenbright@utsouthwestern.edu|
22410194|NCT03031431|Boston Children's Hospital|Dr. Anne Hansen|(617)-355-6027|Anne.Hansen@childrens.harvard.edu|
22410195|NCT04130919|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22410196|NCT03216200|DeviceFarm|VP Operations|510-295-5293|timgrammer@devicefarmtech.com|
22410197|NCT02400905|Veryan Medical|Nick Yeo|+44 1403 258984|nick.yeo@veryanmed.com|
22410198|NCT02964897|Center for Healthcare Organization and Implementation Research, VA Bedford Healthcare System|Keith McInnes, Principal Investigator|617-504-1630|donald.mcinnes@va.gov|
22410199|NCT03196791|Korea university Anam Hospital|Dr. Shin Hoo Park|+82-10-6735-1824|bulsajo333@hanmail.net|
22410200|NCT02565485|University Hospitals Cleveland Medical Center|Justin R. Lappen MD|216-844-3787|Justin.Lappen@UHhospitals.org|
22410201|NCT00524394|University of Texas Health Science Center|James Murphy, PhD|713-500-5714|james.r.murphy@uth.tmc.edu|
22410202|NCT01749033|Northwerstern University|Ling Hu M.D.|312-695-3428|l-hu2@northwestern.edu|
22410203|NCT05552430|Center for Health Outcomes and Interdisciplinary Research, Massachusetts General Hospital|Dr. Ryan Mace|617-724-7030|rmace@mgh.harvard.edu|
22410204|NCT01256398|University of California San Diego Moores Cancer Center|Matthew Wieduwilt, MD, PhD|858-822-6848|mwieduwilt@ucsd.edu|
22410205|NCT00995488|University of Michigan Comprehensive Cancer Center|Dr. Maha Hussain|734-647-8903|mahahuss@umich.edu|
22410206|NCT01039584|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
22410207|NCT02740660|Pennington Biomedical Research Center|Dr. Daniel Hsia|225-763-3000|clinicaltrials@pbrc.edu|
22410208|NCT01174368|The Rogosin Institute|Angelica Nazarian|212-746-1551||
22410209|NCT01890694|NYU Langone Medical Center|Office of Clinical Trials|646-754-7431|clinicaltrials@nyumc.org|
22410210|NCT00479765|Boston Scientific Corporation|Jessie Stockwell|16126181136|jessie.stockwell@bsci.com|
22410211|NCT01166997|EKOS Corporation|Lynn Allen|4254153100|Lynn.Allen@ekoscorp.com|
22410212|NCT03550794|Montefiore Medical Center|Dr. Ari Moskowitz|7189202956|amoskowitz@montefiore.org|
22410213|NCT01864525|Syracuse University|Dr. Soren Lowell|315-443-9648|slowell@syr.edu|
22410214|NCT01890785|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22410215|NCT03296553|Instituto Nacional de Cancerología|Dr. Patricia Volkow|01 55 5628 0400|pvolkowf@gmail.com|12120
22410216|NCT00558519|University of Chicago|Wendy Stock, MD|773-834-8982|wstock@medicine.bsd.uchicago.edu|
22410217|NCT03001011|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22410218|NCT01777425|UZ Leuven|Prof. Dr. P. Hellings|+3216332340|peter.hellings@uzleuven.be|
22410219|NCT03077828|Northwestern University|Dr. Jane N. Winter, M.D.|3126954538|j-winter@northwestern.edu|
22410220|NCT02392559|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22410221|NCT02820324|Trevena, Inc.|Kelly Arscott|6103548840|karscott@trevena.com|
22410222|NCT03125915|Hunter College, CUNY|Tyrel Starks, Associate Professor|212-206-7919|tstarks@hunter.cuny.edu|934
22410223|NCT02731833|GlaxoSmithKline|GSK Response Center|866-435-7343||
22410224|NCT04816877|Beth Israel Deaconess Medical Center|Dr. Sunil Sheth|6176675576|ssheth@bidmc.harvard.edu|
22410225|NCT00727298|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@Merck.com|
22410226|NCT00295620|ABCSG|Trial Office Director|+43 1 4089230|info@abcsg.at|
22410227|NCT01309828|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22410228|NCT00217971|Columbia University|Frances R. Levin, M.D.|(212) 543-5896|frl2@columbia.edu|
22410229|NCT00808015|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22410230|NCT01397656|Ottawa Hospital Research Institute|Dr. Christian Vaillancourt|613-798-5555|cvaillancourt@ohri.ca|17012
22410231|NCT00084617|National Cancer Institute|Joanna Brell MD|240-276-7050|brelljm@mail.nih.gov|
22410232|NCT01625286|AstraZeneca|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22410233|NCT03338673|University of Michigan|Dr. Cynthia Burton|7347639259|czburton@umich.edu|
22410234|NCT01963676|UNC Chapel Hill|Dr. Flavio Frohlich|(919) 966-4584|flavio_frohlich@med.unc.edu|
22410235|NCT03627195|Sunovion Pharmaceuticals, Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
22410236|NCT03254719|Palmer Center for Chiropractic Research|Dr. Anna Walden-Cobb|563-949-0676|anna.waldencobb@palmer.edu|
22410237|NCT01883999|W.L. Gore & Associates|Abe Letter|928-864-3113|aletter@wlgore.com|
22410238|NCT00096382|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
22410239|NCT01110499|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22410240|NCT02580188|SNUBH|Dr. Bon-wook Koo|+82-10-7227-1379|tendong2@gmail.com|
22410241|NCT01977352|Icahn School of Medicine at Mount Sinai|Dr. Ali Shariat||alishariatmd@gmail.com|
22410242|NCT02412956|The George Washington University|Dr. Lorien Abroms||lorien@gwu.edu|
22410243|NCT00409188|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22410244|NCT01835132|National Institutes of Health|H. Nida Sen, MD, MHSc, Principal Investigator, NEI|301-402-3254|senh@nei.nih.gov|
22410245|NCT00856778|Coloplast Corp|Clinical Trial Manager|612-302-4990|usdibe@coloplast.com|
22392451|NCT00477490|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22392452|NCT01465763|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22392453|NCT01646177|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22392454|NCT00668265|Beth Israel Medical Center|Igor Galynker, MD|212 420 4535|igalynke@chpnet.org|
22392455|NCT02992691|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22392456|NCT00588692|Mayo Clinic|Dr. Barry A. Borlaug|507-284-4442|borlaug.barry@mayo.edu|
22392457|NCT05071586|University of Wisconsin - Madison|Bernadette Gillick|608-381-2699|bgillick@wisc.edu|
22392458|NCT00820170|Memorial Sloan Kettering Cancer Center|Dr. Monica Fornier|646-888-4563|fornierm@mskcc.org|
22392459|NCT02180243|War Related Illness and Injury Study Center|Matthew Reinhard, PsyD|202-745-8000|matthew.reinhard@va.gov|55785
22392460|NCT01137578|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22392461|NCT01495572|National Cancer Institute|Udai Kammula M.D.|301-435-8606|kammulau@mail.nih.gov|
22392462|NCT03651700|Clinical Research Coordinator|Daniela Sacchetti, MS|215-573-4336|danielas@pennmedicine.upenn.edu|
22392463|NCT02775071|Temple University|David Sarwer|215-707-8632|dsarwer@temple.edu|
22392464|NCT05479734|University of Oklahoma Health Sciences|David Bard, Director of EmBRACER Center|4052718001|David-Bard@ouhsc.edu|
22392465|NCT01461005|MCRA|Justin Eggleton, Senior Director, Spine Regulatory Affairs|2025525804|jeggleston@mcra.com|
22392466|NCT03168542|Johnson & Johnson Vision Care, Inc.|Tom Karkkainen, OD MS, FAAO - Sr. Principal Research Optometrist|904 443-3402|TKarkkai@its.jnj.com|
22392467|NCT01426347|Johns Hopkins University|Uzma Jalal Haque|410-550-0578|uhaque@jhmi.edu|
22392468|NCT00455741|Massachusetts General Hospital|Dr. Janet E. Hall|617-877-1112|hall.janet@mgh.harvard.edu|
22410246|NCT01681771|Linköping University, Department of social and welfare studies. Linköping University|Prof. RN Peter Johansson|+4613313685|peter.b.johansson@liu.se|
22410247|NCT00265083|Centocor Research and Development, Inc.|Director, Clinical Research|1-800-457-6399||
22410248|NCT02879747|Queen Silvia Children´s Hospital and University of Gothenburg|Dr Jovanna Dahlgren, PI and director of Department of Pediatrics|+46702750233|jovanna.dahlgren@gu.se|
22410249|NCT03208933|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22410250|NCT03154333|Castle Creek Pharmaceuticals, LLC|Dr. Mary Spellman|862 286 0400|mspellman@castlecreekpharma.com|
22410251|NCT00854620|Stanford University, Stanford Cancer Center|Sandy Srinivas, MD|650-725-2078|sandysri@stanford.edu|
22410252|NCT01265966|Tripler Army Medical Center|Dr. Jordan Pinsker|808-433-6338|jordan.pinsker@us.army.mil|
22410253|NCT02096029|Medical University of South Carolina|Amy Boatright, Program Coordinator|843-876-2440|boatrigh@musc.edu|
22410254|NCT04242186|Hebrew SeniorLife|Sarah Berry, MD, MPH|617-971-5355|sarahberry@hsl.harvard.edu|
22410255|NCT05319977|RTI International|Yukiko Washio|9194852794|ywashio@rti.org|
22410256|NCT00550420|GlaxoSmithKline|GSK Response Center|866-435-7343||
22410257|NCT00353938|Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corp.|Julie B. Wang, MPH, PhD/ Senior Clinical Data Scientist|(831) 429-6362|juliewang@mapsbcorp.com|
22410258|NCT00478361|UT MD Anderson Cancer Center, Community Clinical Oncology Program Research Base|Nizar M Tannir, MDChair Ad Interim, Genitourinary Medical Oncology|713-563-7265|ntannir@mdanderson.org|
22410259|NCT01872689|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22410260|NCT01456052|Lexicon Pharmaceuticals, Inc.|Manager of Regulatory Affairs|281-863-3260|plogan@lexpharma.com|
22410261|NCT03094806|New York Methodist Hospital|Jeremy A Weingarten, MD|718-780-5835|jaw9031@nyp.org|
22410262|NCT02762565|University of Pennsylvnia|Robyn Broach|215-662-7300|robyn.broach@uphs.upenn.edu|
22410263|NCT01113710|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22410264|NCT03103581|Braintree Laboratories, Inc.|Head of R&D, GI|7818432202|studydirector@sebelapharma.com|
22410265|NCT02770716|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-844-2830|clinicaltrials@mnk.com|5
22410266|NCT01042977|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
22410267|NCT02499354|Auerbach Hematology Oncology Assoc|Dr. Michael Auerbach|410-780-4050|mauerbachmd@abhemonc.com|
22410268|NCT04303845|Mayo Clinic|Rashmi B. Halker Singh, M.D.|480-301-8100|Halker.Rashmi@mayo.edu|
22410269|NCT01677910|Lexicon Pharmaceuticals, Inc.|Pablo Lapuerta, MD||plapuerta@lexpharma.com|
22410270|NCT01460927|El.En. Electronic Engineering S.p.A.|Alessandro Bizzarri|+39 055 8826807|a.bizzarri@elen.it|
22410271|NCT01703741|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22410272|NCT04132232|UAB|Christina Blanchard|205-934-7982|ctblanchard@uabmc.edu|
22410273|NCT00755937|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22410274|NCT03876873|University of Missouri-Columbia|Boris Mraovic|5738822568|mraovicb@health.missouri.edu|
22410275|NCT03547531|Prince of Songkla University|istiyanti Hapsari|+66980493996|istiyantihapsari@gmail.com|
22410276|NCT02649608|H. Lundbeck A/S|Email contact via H. Lundbeck A/S|+45 36301311|LundbeckClinicalTrials@Lundbeck.com|
22410277|NCT00183469|University of Texas Health Science Center San Antonio|Charles L. Bowden, M.D. Clinical Professor|210 567 5405|bowdenc@uthscsa.edu|
22410278|NCT02117479|Incyte Corporation|Study Director|855 463-3463||
22410279|NCT01412710|Florida International University|Fatma G. Huffman|305-348-3877|huffmanf@fiu.edu|
22410280|NCT02577042|Fundació Lluita contra la SIDA|Director of Clinical Trials|+34 93 497 84 14|enegredo@flsida.org|
22410281|NCT01223196|UT Health Science Center San Antonio|Franco Folli, MD PhD/Professor|210-567-4826|FOLLI@uthscsa.edu|
22410282|NCT02629133|Womene and Infants Hospital|Caron Zlotnick|401-474-3332|czlotnick@butler.org|
22419018|NCT00242632|Stanford University|Dr. Natalie Rasgon|(650) 724-6689|natalie.rasgon@stanford.edu|
22419019|NCT03336528|Emory University|Dr. Guillermo E. Umpierrez|(404) 778-1663|geumpie@emory.edu|
22410283|NCT02598193|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22419020|NCT00627861|The Rogosin Institute|Warren Bobb, N.P.|212-746-9114|wab9006@nyp.org|
22392469|NCT00203268|Thomas Jefferson University|Stephen D. Silberstein, MD|215-955-2243|Stephen.Silberstein@Jefferson.edu|
22392470|NCT00338988|University Texas MD Anderson Cancer Center|Melanie Thomas, MD/Assistant Professor|713-794-4869|mjlim@mdanderson.org|
22392471|NCT03564353|UT Dallas|Clinical Trial Manager|972-883-7277|Sarah.McLeod@utdallas.edu|
22392472|NCT02645123|University of Ioannina School of Medicine|Dr. Georgios Krekoukias|00306934609400|gkrekos@gmail.com|
22410284|NCT02328807|H. Lee Moffitt Cancer Center and Research Institute|Dr. Julio M. Pow-Sang|813-745-2226|julio.powsang@moffitt.org|
22410285|NCT00078819|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22410286|NCT03012815|Mayo Clinic|Ruth Bates|507-255-8716|Bates.Ruth@mayo.edu|
22410287|NCT01462695|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22410288|NCT00879970|GlaxoSmithKline|GSK Response Center|866-435-7343||
22410289|NCT02580201|FIDEC Corporation|Ricardo Rüttimann|+17863546335|rruttimann@fidec-online.org|
22410290|NCT04380701|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
22410291|NCT00065065|University of Pennsylvania|James D. Lewis, MD, MSCE|215-573-5137|lewisjd@mail.med.upenn.edu|
22410292|NCT01050673|Northwestern Medical Faculty Foundation|Dr Robert D Galiano, Assistant Professor of Surgery|312-695-6022|rgaliano@nmh.org|
22410293|NCT04363736|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22410294|NCT03797222|Children's Hospital of Philadelphia|Lauren Mitteer|215-590-3174|mitteerl@chop.edu|
22410295|NCT02122471|Synergy Pharmaceuticals Inc.|Dr. Patrick H. Griffin|212-297-0020||
22410296|NCT02720224|Estetra SPRL|Marie Mawet||mmawet@mithra.com|
22410297|NCT02556632|University of Rochester|Julie Ryan Wolf, PhD, MPH; Associate Professor of Dermatology and Radiation Oncology|585-276-3862|julie_ryan@urmc.rochester.edu|
22410298|NCT06610279|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22410299|NCT04355767|Stanford University|Kevin Schulman, MD|(650) 724-0543|kevin.schulman@stanford.edu|
22410300|NCT01999322|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22410301|NCT01005407|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-848-5100||
22410302|NCT02432456|Medical College of Wisconsin|Thomas Carver|414-955-1733|tcarver@mcw.edu|
22410303|NCT00301873|Duke Comprehensive Cancer Center|Mary Lou Affronti, RN, MSN, ANP, MHSc Senior Investigator|919-684-6239|mary.affronti@duke.edu|
22410304|NCT02936479|NYU Langone Health- Transplant Institute|Cecilia Deterville, MS, CCRC|212.263.3620|Cecilia.Deterville@nyulangone.org|
22410305|NCT03574818|Montefiore Medical Center|Balazs Halmos|7184058404|bahalmos@montefiore.org|
22410306|NCT04583592|Sagent Pharmaceuticals, Inc.|Cynthia Tinkoff, Pharm.D. Manager, Medical Affairs|847-908-6913|ctinkoff@sagentpharma.com|
22410307|NCT04523831|Dhaka Medical College|Dr. Reaz Mahmud, Principal investigator|01912270803|reazdmc22@yahoo.com|+88
22410308|NCT00995930|Novartis Pharmaceuticals|Study Director|862-778-8300||
22410309|NCT02517099|Imperial College London|Professor Sejal Saglani|02075943167|s.saglani@imperial.ac.uk|
22410310|NCT00766506|Janssen-Cilag Ltd. 50-100 Holmers Farm Way, High Wycombe , BUCKS, UK, HP12 4EG|Study Responsible Physician|+44 (0) 1494 567 444||
22410311|NCT03053622|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22410312|NCT01246986|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22410313|NCT01447329|Mike O'Callaghan Military Medical Center, Clinical Investigation Program|Amanda Crawford|(702) 653-3583|amanda.j.crawford.ctr@health.mil|
22410314|NCT01407575|University of Pittsburgh|Jordan F. Karp, MD|412-246-6048|karpjf@upmc.edu|
22410315|NCT01440647|Women & Infants Hospital of Rhode Island|Abbot R. Laptook, MD, Professor of Pediatrics The Warren Alpert Medical School of Brown University M|401-274-1122|ALaptook@WIHRI.org|7404
22410316|NCT04036227|Gesynta Pharma AB|Charlotte Edenius|+46733864246|ctg@gesynta.se|
22410317|NCT00524576|GlaxoSmithKline|GSK Response Center|866-435-7343||
22410318|NCT01406873|University of Rochester|Charles Thornton, MD|585-275-2542|Charles_Thornton@urmc.rochester.edu|
22410319|NCT03990389|The University of Chicago|Dr. David Beiser|773-702-0307|dbeiser@medicine.bsd.uchicago.edu|
22410320|NCT00207714|Centocor Research & Development, Inc.|Director Clinical Research|1-800-457-6399||
22410321|NCT02595528|Allergan, Inc|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
22410322|NCT03202511|Division of Clinical Pharmacology, School of Medicine, Indiana University|Dr. Zeruesenay Desta|317-274-2823|zdesta@iu.edu|
22410323|NCT00686790|Merck Sharp & Dohme Corp|Vice President of Late Stage Development||ClinicalTrialsDisclosure@merck.com|
22410324|NCT02460874|UAB|Dr. Hunter Boggs|205-934-5670|dboggs@uabmc.edu|
22410325|NCT03862625|Istanbul University|Dr. Merve Damla Korkmaz|+905556297264|mervedml@gmail.com|
22410326|NCT02082912|Emory University|Dr. Andrew John Butler|404-413-1415|ajbutle@emory.edu|
22410327|NCT02614703|Dostor's Hospital at Renaissance|Dr Ingrid M Chacon|(956) 362-3636|I.chacon@dhr-rgv.com|
22410328|NCT01577966|UAB|Burt Nabors, MD|205-934-2424|bnabors@uabmc.edu|
22410329|NCT00782275|Beth Israel Deaconess Medical Center|David F. McDermott MD PhD|617-632-9262|dmcdermo@bidmc.harvard.edu|
22410330|NCT04378010|Enanta Pharmaceuticals, Inc|Alaa Ahmad|1-617-607-0800|aahmad@enanta.com|
22410331|NCT01792284|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22410332|NCT02019979|Icahn School of Medicine at Mount Sinai|Dr. Anish Parikh|(212) 241-4705|anish.parikh@mountsinai.org|
22410333|NCT02732587|Yale University Dept of Psychiatry|Dr Suchitra Krishnan-Sarin|203-974-7595|suchitra.krishnan-sarin@yale.edu|
22410334|NCT00379587|Dana-Farber Cancer Institute|Corey S. Cutler, MD, MPH|617-632-5946|corey_cutler@dfci.harvard.edu|
22410335|NCT04636398|University of California San Francisco|Alison El Ayadi|415-659-8367|alison.elayadi@ucsf.edu|
22410336|NCT00534092|Medtronic Spine and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
22431783|NCT04138056|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22419021|NCT01708967|Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea|Dr. Ki Tae Suk|+82-33-240-5826|ktsuk@hallym.ac.kr|
22419022|NCT02842073|University of North Carolina at Chapel Hill|James C Garbutt, MD|984-974-2201|jc_garbutt@med.unc.edu|
22419023|NCT00195338|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22419024|NCT00385008|GlaxoSmithKline|GSK Response Center|866-435-7343||
22419025|NCT02047734|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22419026|NCT01333397|Ipsen|Medical Director|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22419027|NCT03100123|Ottawa Hospital Research Institute|Dr. Leslie Skeith|403-944-5246|laskeith@ucalgary.ca|
22419028|NCT00314951|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22419029|NCT00920790|Kyowa Hakko Kirin|Project Management Department, Development Division||clinical.info@kyowa-kirin.co.jp|
22419030|NCT04411914|Temple University|Mary Morrison, MD, MS|215=707=4037|mary.morrison@temple.edu|
22419031|NCT00599053|University of Alabama at Birmingham|Dr. David Randolph|205-934-4680|drandolph@peds.uab.edu|
22419032|NCT01504997|Shizuoka Cancer Center|Doctor Masanori Tokunaga|81-55098908777|m.tokunaga@scchr.jp|
22419033|NCT02010645|The University of Texas MD Anderson Cancer Center|Courtney DiNardo, MD/Associate Professor|713-794-1141|CDiNardo@mdanderson.org|
22419034|NCT00717041|University of Rochester|Manish N. Shah, MD MPH|585-275-1198|manish.shah@rochester.edu|
22419035|NCT02639052|Lewis Katz School of Medicine at Temple University|Susan G. Fisher, M.S., Ph.D., Associate Dean and Director, Temple Clinical Research Institute|215-707-3577|susan.fisher@tuhs.temple.edu|
22419036|NCT03065218|MedStar Health Research Institute|Dr. Douglas Van Nostrand|202-877-0300|douglasvannostrand@gmail.com|
22419037|NCT02655666|Medtronic Minimed|Willam Lv|86-21-20325454|william.lv@medtronic.com|
22419038|NCT00895414|Masonic Cancer Center, University of Minnesota|Dr. Anne Blaes|612-626-8138|blaes004@umn.edu|
22419039|NCT03203564|Isofol Medical AB|Chief Medical Officer|+46 (0)707646500|karin.ganlov@isofolmedical.com|
22419040|NCT00789737|Daiichi Sankyo Pharma Development|Director Metabolic Clinical Development|732-590-5000||
22419041|NCT02458287|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22419042|NCT01943994|Sheppard Pratt|Dr. Matthew W. Johnson|443 862 0461|mjohnson3@sheppardpratt.org|
22419043|NCT00813800|Mayo Clinic|Mark Frye, MD|507-255-9391|mfrye@mayo.edu|
22419044|NCT02365558|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22419045|NCT00642278|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
22419046|NCT03713619|Novarts Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22419047|NCT03553576|Northwestern University|Paul Fitzgerald|312-695-1064|p-fitzgerald2@northwestern.edu|
22419048|NCT02552212|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22419049|NCT00118131|Cancer Institute of New Jersey|Dr. Joseph Aisner|732-235-8675|aisnerjo@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
22419050|NCT00612430|Duke University Medical Center|David Reardon, MD|919-668-2329|David_Reardon@DFCI.harvard.edu|
22419051|NCT00418821|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22419052|NCT02823652|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22419053|NCT04853992|LEO Pharma A/S|Clinical disclosure|+45 4494 5888|disclosure@leo-pharma.com|
22419054|NCT02269163|Prometic Biotherapeutics Inc|Director, External Biologics|438-802-3497|clinical@prometic.com|
22419055|NCT02351960|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22419056|NCT01094886|Janssen Scientific Affairs, LLC|VP Medical Affairs, Internal Medicine|1 908 218-7250||
22419057|NCT03866902|University of Miami|Hudson Santos|3052845812|hsantos@miami.edu|
22419058|NCT03613727|Virginia Commonwealth University|BMT- CIT Team|804-628-6430|masseybmt@vcu.edu|
22419059|NCT02092467|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22419060|NCT01284621|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22419061|NCT02392351|Boston Scientific|Clinical Trial Manager|970-294-4082|nicole.kilburn@bsci.com|
22431784|NCT02481557|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
22431785|NCT01098422|UC San Diego|Dr. Tony Reid|8583531942|treid@ucsd.edu|
22410337|NCT01169649|Memorial Sloan Kettering Cancer Center|Dr. Diane Reidy-Lagunes|646-888-4185|reidyd@mskcc.org|
22410338|NCT01928446|Boston CSP Coordinating Center|Ryan E. Ferguson, ScD, MPH, Director|1-857-364-4201|Ryan.Ferguson@va.gov|
22410339|NCT06156969|Spaulding Rehabilitation Hospital|Paolo Bonato, PhD|617-952-6319|PBONATO@mgh.harvard.edu|
22410340|NCT01244815|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22410341|NCT01173159|Cincinnati Children's Hospital Medical Center|Crystal Slaughter, BA, CCRC|513-636-0137|crystal.slaughter@cchmc.org|
22410342|NCT02041494|University of California, San Francisco|Dr. Hobart W. Harris, Chief of General Surgery|(415) 514-3891|hobart.harris@ucsf.edu|
22410343|NCT02784925|WanFangH|Ming-Shun Wu|88629307930|mswu@tmu.edu.tw|7923
22410344|NCT05784571|Pennington Biomedical Research Center, Baton Rouge, LA|Candida Rebello|2257633159|Candida.Rebello@pbrc.edu|
22410345|NCT02348619|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
22410346|NCT00459381|Adult Brain Tumor Consortium (ABTC)|Mark Gilbert, MD|410-955-8837|jfisher@jhmi.edu|
22410347|NCT01238822|Cincinnati Children's Hospital Medical Center|Jeff Epstein||jeff.epstein@cchmc.org|
22410348|NCT02572427|University of Arkansas for Medical Sciences|Dr Richard Whit Hall|501-680-7894|HallRichardW@uams.edu|
22410349|NCT02487979|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22410350|NCT00447694|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22410351|NCT02410837|Medtronic|Jennifer Wolvers|763-258-9405|Jennifer.Wolvers@Medtronic.com|
22410352|NCT01169987|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
22410353|NCT00657917|Uniformed Services University of the Heralth Sciences|COL Naomi Aronson MC|301-295-3621|naronson@usuhs.mil|
22410354|NCT00386100|GlaxoSmithKline|GSK Response Center|866-435-7343||
22410355|NCT02523274|University of Florida|Dr. Stephen Anton|(352) 273-7514|santon@ufl.edu|
22410356|NCT01032759|Duke University Medical Center|Dr. Ashraf Habib|9196686266|habib001@dm.duke.edu|
22410357|NCT00117585|Portland VA Medical Center|Dr. David Hickam|(503) 721-7817|david.hickam@va.gov|
22410358|NCT00849524|University of California, San Diego|Januario Castro, MD|(858) 822-6600|jecastro@ucsd.edu|
22410359|NCT00919802|UAB|Timothy Ness|205-975-9643|tness@uabmc.edu|
22410360|NCT01825876|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22410361|NCT02128867|vrije universiteit brussel|filip van ginderdeuren|+3224763916|filip.vanginderdeuren@uzbrussel.be|
22410362|NCT01147016|Barbara Ann Karmanos Cancer Institute|Dr. Amy Weise|248-344-6688|aweise3@hfhs.org|
22410363|NCT01027884|University Hospital Leuven-Children Hospital|Dr Gunnar Buyse|+32 016343845|gunnar.buyse@uzleuven.be|
22410364|NCT03636542|University of Minnesota|Jason Habeck|612-625-7675|habe0073@umn.edu|
22410365|NCT03670537|Auerbach Hematology and Oncology|Michael Auerbach|4107804050|mauerbachmd@abhemonc.com|
22410366|NCT05149287|University of Kentucky|Austin Stone|(859) 323-5533|austin.stone@uky.edu|
22410367|NCT02059187|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22410368|NCT03751020|Yale University School of Public Health (Social and Behavioral Sciences)|Dr. John Pachankis|(203) 785-3710|john.pachankis@yale.edu|
22410369|NCT00528879|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22410370|NCT01159769|Alcon Research, Ltd.|Director of Medical Affairs|800-862-5266|medinfo@alconlabs.com|
22410371|NCT02555618|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22410372|NCT02217345|Massachusetts General Hospital|Dr. Karen K. Miller|617-726-3870|kkmiller@mgh.harvard.edu|
22410373|NCT00845026|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22410374|NCT01325532|Massachusetts General Hospital, Dept of Psychiatry|Dr David Mischoulon|617-724-5198|dmischoulon@partners.org|
22410375|NCT01203774|University of Colorado Denver|Director, Clinical Research Administration|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
22410376|NCT02238977|University of Arkansas for Medical Sciences|Pedro Delgado, M.D.|501-526-8100|pldelgado@uams.edu|
22410377|NCT01428024|Q-Med AB|Head of Medical Affairs|+ 46 (0) 18 4749000|reception.SEUPP@galderma.com|
22410378|NCT00061945|University of Chicago Medical Center|Wendy Stock, M.D.||wstock@medicin.bsd.uchicago.edu|
22410379|NCT03672396|University of North Carolina at Chapel Hill|Erik Hanson, PhD|19199620816|edhanson@email.unc.edu|
22410380|NCT01364298|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22410381|NCT04974645|Stanford Prevention Research Center, Department of Medicine, Stanford|Judith J. Prochaska, PhD, MPH|650-724-3608|jpro@stanford.edu|
22410382|NCT03712228|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
22410383|NCT01964105|WASHINGTON UNIVERSITY SCHOOL OF MEDICINE, SAINT LOUIS|TERENCE MICHAEL MYCKATYN, PI, PROFESSOR, PLASTIC SURGERY|314-362-4263|myckatyn@wustl.edu|
22410384|NCT04080882|QMedAB|Clinical Project Manager|(817) 961-5000|aestheticclinicaltrials@galderma.com|
22410385|NCT01254045|Stanford University School of Medicine|Scott S. Hall, PhD|650-498-4799|hallss@stanford.edu|
22410386|NCT00597207|ZOLL Medical Corporation|Sr. Director of Clinical Research|978-421-9655|uherken@zoll.com|
22410387|NCT00520351|Centre for Contact Lens Research|Craig A Woods, Research Manager|519-888-4567|cawoods@sciborg.uwaterloo.ca|36547
22410388|NCT02522949|Enzymatica AB|Enzymatica AB|+46 46 286 31 00|info@enzymatica.com|
22410389|NCT01021137|James H. Quillen VA Medical Center|Director of Vestibular Laboratory|423-926-1171|faith.akin@va.gov|7376
22410390|NCT00725725|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Develpment|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22410391|NCT03536819|Inmode Ltd|Maria Shusterman, Clinical Director|9057070975|maria.shusterman@inmodemd.com|
22410392|NCT04288115|Central Arkansas Veterans Healthcare System|Spyridoula Maraka, MD, MS|(501) 257-5848|Spyridoula.Maraka@va.gov|
22410393|NCT00729365|Northwestern University Feinberg School of Medicine|Mark E. Molitch|312 503-4130|molitch@northwestern.edu|
22410394|NCT04542330|University of Southern Denmark|Professor Christine Stabell Benn|+45 25883964|cbenn@health.sdu.dk|
22410395|NCT00928135|University of Iowa|Lakshmi Durairaj|3193537968|lakshmi-durairaj@uiowa.edu|
22410396|NCT02033382|NYU Langone Health|Principal Investigator|646-754-4843|donald.goff@nyumc.org|
22410397|NCT00393978|University of Cincinnati, Department of Psychiatry & Behavioral Neuroscience|Melissa P. DelBello, MD|513-558-2989|Melissa.DelBello@uc.edu|
22410398|NCT04556838|VivaVision Biotech, Inc.|Joanne Li, M.D.|86-02158598290|joanne.li@vivavisionbio.com|
22410399|NCT00328042|VA San Diego|Dr. Erik Groessl|858-552-8585|erik.groessl@va.gov|
22410400|NCT03877237|Astrazeneca|Łyżwa, Dawid|+48 882 345 259|dawid.lyzwa@astrazeneca.com|
22410401|NCT00382291|University of Florida|Dr. Regina Bussing|(352) 273-7550|rbussing@ufl.edu|
22410402|NCT02266706|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22410403|NCT03615079|University of Pennsylvania|Michael Mullen|215-662-3339|Michael.Mullen@Pennmedicine.Upenn.Edu|
22410404|NCT02270983|Forest Research Institute, Inc., an affiliate of Allergan|Therapeutic Area Head|862-261-7000|IR-CTRegistration@allergan.com|
22410405|NCT02609737|Memorial Sloan Kettering Cancer Center|Dr. Lisa Bodie, MD, PhD|212-639-6650|bodeil@mskcc.org|
22410406|NCT03237611|Albert Einstein College of Medicine|Dr. Richard Gralla|718-918-6235|richard.gralla@nbhn.net|
22410407|NCT00747747|Galsor s.r.l.|Dr. Sandro Soriano/Director of Clinical Trials|0039 0827 601723|sandro.soriano@galsor.it|
22410408|NCT02919475|Akros Pharma Inc.|Kazuhiro Okamiya|609-919-6123|okamiya@akrospharma.com|
22410409|NCT00275028|Dana-Farber Cancer Institute|Kimberley MacNeill|617-632-2621|kmacneill@partners.org|
22419062|NCT02377427|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22419063|NCT02293863|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22419064|NCT01621477|St. Jude Children's Research Hospital|Brandon M. Triplett, MD|901-595-2766|brandon.triplett@stjude.org|
22419065|NCT04778904|Barinthus Biotherapeutics|Chief Medical Officer|+44 (0) 1865 818 808|clinicaltrials@barinthusbio.com|
22419066|NCT03452137|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22419067|NCT04138043|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22419068|NCT03772717|Emory University|Sumit Verma, MD|404-785-9893|sumit.verma@emory.edu|
22419069|NCT02856802|Upsher-Smith Laboratories, LLC|Clinical Operations|(763) 315-2000|uslinfo@upsher-smith.com|
22419070|NCT00587860|Mayo Clinic|Yuri A. Saito Loftus, M.D., M.P.H.|507-284-5010|saito.yuri@mayo.edu|
22419071|NCT01659125|Institute of Living|Gretchen J. Diefenbach|860-545-7685|gretchen.diefenbach@hhchealth.org|
22419072|NCT00261443|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22419073|NCT02755649|Regeneron Pharmaceuticals, Inc.|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
22419074|NCT01286753|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22419075|NCT02089659|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22419076|NCT02126826|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22419077|NCT01371747|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com|
22419078|NCT03092219|Teoxane SA|Clinical Project Manager|+41(0) 22 344 96 36|m.chenet@teoxane.com|
22419079|NCT05289869|The Ohio State University|Heather Frey, MD, MSCI|614-688-6798|Heather.Frey@osumc.edu|
22419080|NCT01613768|University of Washington|Research Manager|206-606-7445|smasters@seattlecca.org|
22419081|NCT02928055|MetroHealth Medical Center|Richard Wilson, MD|216-778-4414|rwilson@metrohealth.org|
22419082|NCT05013008|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22419083|NCT02094417|Kyowa Kirin Korea Co. Ltd.,|Clinical Development Team, Clinical Development Department|82221912918|kyungmo.lee.m6@kyowakirin.com|
22419084|NCT01443728|Columbia University|Gary Brittenham, MD|212-305-7005|gmb31@cumc.columbia.edu|
22419085|NCT00411411|Gentofte University Hospital|Dr. Kasper Aaboe|+4522170200|kasper@dadlnet.dk|
22419086|NCT00887289|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22419087|NCT01368653|Rutgers, The State University of New Jersey|Danielle E. McCarthy, Ph.D.|608-265-5949|demccarthy@wisc.edu|
22419088|NCT00591773|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22419089|NCT02135614|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22419090|NCT03022084|VA RR&D National Center for Rehabilitative Auditory Research|Dr. James Henry|503-220-8262|James.Henry@va.gov|
22419091|NCT02640482|AbbVie|Global Medical Services|800-633-9110||
22419092|NCT00554606|Novartis|Study Director|+41613241111|Novartis.email@novartis.com|
22419093|NCT03634475|Panoptes Pharma|Study Director|+43 664 851 5865|ssperl@kiorapharma.com|
22419094|NCT00605540|HC/FMB-Unesp|Renata Ferrari|55 14 38116213|renataferrarifisio@gmail.com|
22419095|NCT00509366|Duke University|Neal Ready, MD, PhD|919-681-6932|neal.ready@duke.edu|
22419096|NCT01235195|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22419097|NCT02119819|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22419098|NCT01631071|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
22419099|NCT04497948|AstraZeneca|Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22419100|NCT01504958|Beth Israel Deaconess Medical Center|Alvaro Pascual-Leone, M.D., Ph.D.|617-667-0203|apleone@bidmc.harvard.edu|
22419101|NCT00127218|The Johns Hopkins Hospital, Department of Medicine, Division of Cardiology|Dr. Joao AC Lima|410-614-1284|jlima@jhmi.edu|
22392473|NCT03633799|Sebela Women's Health|Elizabeth Gray, Manager, Clinical Operations|760-593-8383|Elizabeth.gray@sebelapharma.com|
22419102|NCT02242045|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22419103|NCT01421511|Cubist Pharmaceuticals, Inc.|Philippe Prokocimer, MD|858-452-0370|philippe.prokocimer@cubist.com|241
22419104|NCT00749892|UT MD Anderson Cancer Center|Dr. Arlene O. Siefker-Radtke,Professor, Genitourinary Medical Oncology|(713) 792-2830|asiefker@mdanderson.org|
22419105|NCT00089024|University of Nebraska Medical Center|Jean L Grem|402-552-3233|jgrem@unmc.edu|
22419106|NCT00106964|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
22419107|NCT04040192|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22419108|NCT03207243|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22419109|NCT03196219|Armata Pharmaceuticals, Inc.|Clinical Operations|3106652928|info@armatapharma.com|
22419110|NCT04074616|The University of Texas Health Science Center at Houston|Argyrios Stampas, MD|713-797-5938|argyrios.stampas@uth.tmc.edu|
22419111|NCT01056315|Grünenthal|Study Director|+49 (0)-241-569-3223|clinical-trials@grunenthal.com|
22419112|NCT00603837|University of Oklahoma Health Sciences Center|Doug Dannaway, MD|405-271-5215|douglas-dannaway@ouhsc.edu|42048
22419113|NCT04611529|Montefiore Medical Center|Dr. Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
22419114|NCT02121392|University of Chicago Medical Center|Dr. Hue Luu|773-702-6937|hluu@bsd.uchicago.edu|
22419115|NCT01352416|William Beaumont Hospital|Ilana Kutinsky, DO|248-267-5050|ikutinsky@beaumont.edu|
22419116|NCT00253448|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Research Investigator|937-395-8646|douglas.einstein@khnetwork.org|
22419117|NCT02564887|University of Pittsburgh|Christine Harrison, Clinical Research Coordinator|412-647-9665|harrisonta@upmc.edu|
22419118|NCT01851330|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22419119|NCT01199016|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22419120|NCT00561418|The Ohio State University Comprehensive Cancer Center|Craig Hofmeister, MD|614-293-9869|craig.hofmeister@osumc.edu|
22419121|NCT02318303|Glenmark Pharmaceuticals Ltd|Cathy Tyrrell|91 2267720000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
22419122|NCT02960490|Eisai Co., Ltd.|Inquiry Service.||eisai-chiken_hotline@hhc.eisai.co.jp|
22419123|NCT04106661|Husson University|William Lindblad, Director of Research and Scholarship|20-7992-1958|lindbladw@husson.edu|
22419124|NCT00233402|Photocure|Yngvil Kloster Thomas|+1 2167732505|ykt@photocure.no|
22419125|NCT03280381|PATH|Dr. Patricia S. Coffey|206-302-4704|pcoffey@path.org|
22419126|NCT03503864|Sun Yat-sen Memorial Hospital|Dr Yang Li|02081332045|drliyang@126.com|
22419127|NCT00423319|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22419128|NCT00276861|Dept. of Oncology Johns Hopkins Singapore Intl Medical Center|Gilberto Lopes MD|656-880-2240|glopes@imc.jhmi.edu|
22419129|NCT02087189|BIOTRONIK SE & Co. KG|Mathias Freudigmann, Director Clinical Project Management|+49 30 68905|mathias.freudigmann@biotronik.com|1248
22419130|NCT00478426|University Health Network - Princess Margaret Cancer Centre|Dr. Amit Oza|416-946-2082|amit.oza@uhn.ca|
22419131|NCT01189487|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22419132|NCT04630158|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22419133|NCT05162014|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22419134|NCT03136965|University of Wisconsin School of Medicine and Public Health|Kenneth Lee, MD, MBA|(608) 263-9387|klee2@uwhealth.org|
22419135|NCT00390559|Virginia Commonwealth University|Thomas Eissenberg|804.827.4617|teissenb@vcu.edu|
22419136|NCT00575887|Marmara University|Ufuk Abacioglu|902123853100|ufuk@abacioglu.com|
22419137|NCT01210612|University of Toledo Health Science Campus|Phillip Gribble|(419) 530-2691|pgribbl@UTNet.UToledo.Edu|
22419138|NCT02752087|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22419139|NCT00843635|University of Miami|Donald T. Weed MD FACS|305-243-9095|dweed@miami.edu|
22419140|NCT03020589|University of North Carolina at Chapel Hill|Robert Dupuis, PharmD|919-966-6194|re_dupuis@unc.edu|
22419141|NCT02906566|Stanford University|Dr. Anne L. Chang|650-721-7195|alschang@stanford.edu|
22419142|NCT05819203|Pharmndev Experts|Dr Bernard Gout|+41798659000|bgout@pharmndev.ch|
22419143|NCT02952898|Gage Development Company|Gage Development Company|1-847-999-0600|clinicalinfo@capstonedevservices.com|
22419144|NCT04844762|OhioSUCCC|Dr. Theodore L. Wagener|614-366-4265|Theodore.Wagener@osumc.edu|
22419145|NCT00399880|Vanderbilt University Medical Center|Kathryn Goggins, Research Coordinator|6159364819|Kathryn.m.goggins@vanderbilt.edu|
22419146|NCT02802631|Melinta Therapeutics, LLC|Medical Information|1-844-633-6568|medinfo@melinta.com|
22419147|NCT00477633|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22419148|NCT02896712|The University of Texas Health Science Center at Houston|Joy Schmitz, PhD|713-486-2867|joy.m.schmitz@uth.tmc.edu|
22419149|NCT03888066|Vifor Pharma, Inc.|DIAMOND Clinical Study Team|+41 588 518 000|Diamond_Information@viforpharma.com|
22419150|NCT03278626|NYU Langone Health - Perlmutter Cancer Center|Jennifer Wu, MD|212-263-3809|Jennifer.Wu@nyulangone.org|
22419151|NCT02856555|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22419152|NCT03333941|AVITA Medical|VP Clinical Research|661-367-9710|clinicaltrial@avitamedical.com|
22419153|NCT04971187|M D Anderson Cancer Center|Dr. Xiuning Le|(713) 792-6980|xle1@mdanderson.org|
22419154|NCT00547586|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22419155|NCT04981717|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|8447346643|clinicaltrials@regeneron.com|
22419156|NCT02207634|Amgen Inc.|Study Director|866-572-6436||
22419157|NCT02077140|Medtronic Spine and Biologics|Clinical Affairs|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
22419158|NCT00974922|UCHC|Dr. William White|860-679-2104|wwhite@uchc.edu|
22419159|NCT01762800|GlaxoSmithKline|GSK Response Center|866-435-7343||
22419160|NCT00517881|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22419161|NCT01207583|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22419162|NCT01171118|University of Rochester|Dr. Suzanne Karan|585-275-5161|suzanne_karan@urmc.rochester.edu|
22419163|NCT01433549|Alcon Research, Ltd.|R. Alan Landers, O.D., M.S., F.A.A.O.|1-888-451-3937|alcon.medinfo@alcon.com|
22419164|NCT05384171|VA Boston Healthcare system|Dr. Dawne Vogt|857-364-5976|dawne.vogt@va.gov|
22410410|NCT00628394|University of Texas Southwestern Medical Center|Carol A. Tamminga, MD|214-645-2789|carol.tamminga@utsouthwestern.edu|
22410411|NCT02323295|Massachusetts General Hospital|Dr. Joseph Schwab|617-643-0547|JHSCHWAB@PARTNERS.ORG|
22410412|NCT02873481|Virginia Commonwealth University School of Nursing|Dr. Patricia Kinser, Assistant Professor|804-828-9140|kinserpa@vcu.edu|
22410413|NCT02370784|University of Pittsburgh School of Medicine|Robyn T. Domsic, MD MPH|412-383-8000|rtd4@pitt.edu|
22410414|NCT01059071|NMTRC|Giselle Sholler, MD|6162670335|giselle.sholler@helendevoschildrens.org|
22410415|NCT02962882|Molnlycke Health Care|Global Clinical Research Director|+46 31 722 30 00|info@monlycke.com|
22410416|NCT04741503|Washington University School of Medicine|Ashley J. Housten, OTD, MSCI|314-454-7958|ahousten@wustl.edu|
22410417|NCT00674219|UCLA Department of Psychiatry|Alexander Bystritsky MD PhD|(310) 206-5133|abystritsky@mednet.ucla.edu|
22410418|NCT00272337|Florida Atlantic University|Charles H. Hennekens, M.D.||chenneke@fau.edu|
22410419|NCT02184494|Florida State University|Michael J. Ormsbee|6103313126|mormsbee@fsu.edu|
22410420|NCT00881959|Zimmer Dental|Hai Bo Wen|760 929 4312|haibo.wen@zimmer.com|
22410421|NCT02791659|Gastroenterology endoscopy center|Phonthep Angsuwatcharakon, MD|6622564265|borndeb@yahoo.com|
22410422|NCT01904383|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22410423|NCT02186808|Nobel Biocare|Head of Clinical Trial Management|+41 43 211 42 00|isabelle.arrighi@nobelbiocare.com|
22410424|NCT02062606|Stryker Spine|Marissa Conrad, Senior Director of Clinical and Medical Affairs|201-749-8162|marissa.conrad@stryker.com|
22410425|NCT04313283|University of Maryland Baltimore|Sarah Dababnah|14107068076|sdababnah@ssw.umaryland.edu|
22410426|NCT04356573|UAMS|Robert Wolfe|501-526-5708|rrwolfe2@uams.edu|
22410427|NCT01577537|Starpharma|Dr Jeremy Paull||jeremy.paull@starpharma.com|
22410428|NCT00472446|Cantonal Hospital St. Gallen|Thomas Steffen, MD|0041 71 494 1111|thomas.steffen@kssg.ch|
22410429|NCT03211156|University of Alabama at Birmingham|Jane Schwebke, MD|205-975-5665|schwebke@uab.edu|
22410430|NCT01202994|University of Utah|Dr. Kevin Duff|8015859983|kevin.duff@hsc.utah.edu|801
22410431|NCT00837577|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22410432|NCT02624518|Stanford Medicine at Stanford University|David G Marcellus|650-723-4547|dmarcel2@stanford.edu|
22410433|NCT00272961|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22410434|NCT01507831|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22410435|NCT03652961|NYU Langone Health|Gregg J. Silverman, MD MACR|212 263 9440|Gregg.Silverman@nyulangone.org|
22410436|NCT01455545|SESCAM - HOSPITAL UNIVERSITARIO DE GUADALAJARA|Dr. Carlos Almonacid|+34 655 53 44 75|caralmsan@gmail.com|
22410437|NCT01280981|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22410438|NCT00833781|Mass General Hospital|Dr. Rajesh Gandhi|617-724-9690|rgandhi@partners.org|
22410439|NCT01610167|Salus Research, Inc.|Jeffery L. Milleman, DDS, MPA|(260) 755-1099||
22410440|NCT01190202|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22410441|NCT03276962|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22410442|NCT01358708|Aptalis Pharma US, Inc.|Robert Winkler MD, VP, Clinical Development and Operations|(908) 429-4479|rwinkler@aptalispharma.com|4175
22410443|NCT00827073|Robert Cizik Eye Clinic|Joseph Selem, MD|713-559-5263|laurabaker@cizikeye.org|
22410444|NCT00904189|University of Rochester Medical Center|Steven Swarts|5852755623|christine_huggins@urmc.rochester.edu|
22410445|NCT03056001|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
22410446|NCT03567239|Madonna Rehabilitation Hospital|Chase Pfeifer, Ph.D.|402-413-4504|cpfeifer@madonna.org|
22410447|NCT00614458|UNC Chapel Hill|Professor of Medicine, Director Translational Research IGHID|919 966 6388|dmargo@med.unc.edu|
22410448|NCT02769000|Virginia Commonwealth University|Timothy Harris, MD|804-828-7232|timothy.harris@vcuhealth.org|
22419165|NCT03138590|University of Texas at Dallas|Dr. Sven Vanneste, Principal Investigator|972-883-7277|sven.vanneste@utdallas.edu|
22392474|NCT00777764|Genentech, Inc.|Medical Communications|800-821-8590||
22410449|NCT00751972|HeartWare Inc|Director Clinical Project Management|508 739-0867|sbell@heartwareinc.com|
22410450|NCT02766400|University of Pittsburgh|Elizabeth R. Skidmore, PhD, OTR/L, FAOTA|(412) 383-6617|skidmore@pitt.edu|
22410451|NCT04553484|Semler Scientific|Gena Parker|669-230-2729|gparker@semlerscientific.com|
22410452|NCT03593772|James A. Haley Veteran Hospital Research Service|Dr. Jolie Haun|904-377-6796|Jolie.Haun@va.gov|
22410453|NCT03499249|Baylor College of Medicine and Texas Children's Hospital|Sanjiv Harpavat|832-824-2099|harpavat@bcm.edu|2144
22419166|NCT01342757|Emory University School of Medicine|Jeffrey J. Olson, MD|404-778-3091|jolson@emory.edu|
22410454|NCT01374906|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22410455|NCT02795780|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
22410456|NCT01364259|Stanford University Cancer Center|Dr. Scott G. Soltys, Assistant Professor|650.724.1569|sgsoltys@stanford.edu|
22410457|NCT02475980|University of New Mexico Health Sciences Center|Nancy Sokkary, MD|email|HSC-FamilyPlanningResearch@salud.unm.edu|
22410458|NCT01164137|Westview Physician Collaborative|Allan Bailey, M.D.; Study Principal Investigator|(780)-975-1131|baileymd@telusplanet.net|
22410459|NCT01203319|Jiangsu Provincial Center for Disease Control and Prevention|Fengcai Zhu|#86-25-83759418|jszfc@vip.sina.com|
22410460|NCT01880541|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Pr Simone Mathoulin-Pélissier|0556333333|s.mathoulin@bordeaux.unicancer.fr|
22410461|NCT01458119|Amicus Therapeutics|Medical Affairs|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
22410462|NCT03033069|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22410463|NCT00430638|Daiichi Sankyo|Global Clinical Leader|1-908-992-6400||
22410464|NCT01529749|Hospital Clínic|FELIPE GARCIA ALCAIDE|34619175783|FGARCIA@clinic.cat|
22410465|NCT00789828|Novartis Pharmaceuticals|Study Director|862-778-8300||
22410466|NCT02623426|Johns Hopkins Bloomberg School of Public Health|Douglas A Jabs, MD, MBA|410 -955-1254|djabs1@jhmi.edu|
22410467|NCT02094937|GlaxoSmithKline|GSK Response Center|866-435-7343||
22410468|NCT05458895|OhioSUCCC|Dr. Theodore L. Wagener|614-366-4265|Theodore.Wagener@osumc.edu|
22410469|NCT04639310|Xenon Pharmaceuticals Inc|Dr. Noam Butterfield|604 484 3300|nbutterfield@xenon-pharma.com|
22410470|NCT05166421|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|Information.center@astrazeneca.com|
22410471|NCT03770000|Rhizen Pharmaceuticals AG|Dr. Ajit Nair|+41 32 580 0113|an@rhizen.com|
22410472|NCT02464878|Massachusetts General Hospital|James Markmann|617-643-4533|jmarkmann@mgh.harvard.edu|
22410473|NCT02290028|BIOTRONIK, Inc.|Senior Manager, Scientific Affairs|1-800-547-0394|crystal.miller@biotronik.com|
22410474|NCT00833547|Massachusetts General Hospital|Dr. Dara Manoach|617-726-6148|dara@nmr.mgh.harvard.edu|
22410475|NCT00142454|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
22410476|NCT00566098|Johns Hopkins University|Ivan Borrello, MD|4109554967|iborrell@jhmi.edu|
22410477|NCT02236754|Columbia University|Dr. Paul Harris|212-305-7363|peh1@cumc.columbia.edu|
22410478|NCT01326702|Memorial Sloan Kettering Cancer Center|Dr. John Gerecitano|212-639-3748|gerecitj@mskcc.org|
22410479|NCT00830063|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22410480|NCT01847313|University College Dublin|Prof Carel le Roux|+353 1 716 6831|carel.leroux@ucd.ie|
22410481|NCT00598559|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
22410482|NCT01725984|Ludwig Maximilian Universität|Dr. Ricarda Bauer|+49 89 7095|Ricarda.Bauer@med.uni-muenchen.de|
22410483|NCT03763331|Purdue University|Dr. Bruno Roseguini|7654906284|brosegui@purdue.edu|
22410484|NCT01155063|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22410485|NCT00936884|Salix Pharmaceuticals|David Sorscher|919-862-1827|david.sorscher@salix.com|
22410486|NCT01663714|GlaxoSmithKline|GSK Response Center|866-435-7343||
22410487|NCT00597584|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
22410488|NCT02280421|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
22410489|NCT02797964|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22410490|NCT03840811|University of North Carolina at Chapel Hill|Marcia M. Hobbs, PhD|(919) 843-6893|mmhobbs@med.unc.edu|
22410491|NCT03947788|NorthShore University HealthSystem|Emily White VanGompel|224-364-7300|ewhitevangompel@northshore.org|
22410492|NCT02199652|Medical College of Georgia; Augusta University|William Vaughn McCall|7067216719|WMCCALL@augusta.edu|
22410493|NCT02951884|Loyola University Medical Center|William Lack, M.D.|708-216-1175|wlack@luc.edu|
22410494|NCT02528318|Windtree Therapeutics, Inc.|Robert Segal, MD, FACP|215-488-9300|rsegal@windtreetx.com|9450
22410495|NCT04126733|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22410496|NCT03870997|Evidation Health|Executive Director, Digital Health Outcomes|650-389-9550|results@evidation.com|
22410497|NCT03726437|GEORGIA STATE UNIVERSITY|Dr. Laura Salazar|4044131396|lsalazar1@gsu.edu|
22410498|NCT00580333|Massachusetts General Hospital|Dr. Steven Isakoff|617 726 6500|sisakoff@partners.org|
22410499|NCT01917188|Intermountain Heart Institute|Patti Spencer|8015074700|patti.spencer@imail.org|
22410500|NCT01602198|Cleveland Clinic|Stephen Rao|216-444-1025|raos2@ccf.org|
22410501|NCT03818919|Henry Ford Health System|Dr. Toufic Jildeh|(517)2308511|touficjildeh@gmail.com|
22410502|NCT01889862|BioMarin Pharmaceutical Inc|Debra Lounsbury/Sr Principle Scientist, Clinical Sciences|415-506-6348|Dlounsbury@bmrn.com|
22410503|NCT00033631|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22410504|NCT00711867|Mayo Clinic|Terrence L Trentman MD|480-301-8000|trentman.terrence@mayo.edu|
22410505|NCT00667719|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22410506|NCT01827371|Group Health Research Institute|Lisa Jackson, M.D., M.P.H.|206-442-5216|Jackson.L@ghc.org|
22410507|NCT00950599|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22410508|NCT00971204|CardioFocus, Inc.|Burke Barrett, VP Regulatory & Clinical Affairs|508 658-7200|bbarrett@cardiofocus.com|
22410509|NCT02729194|University of Michigan Rogel Cancer Center|Dr. Ajjai Alva, M.D.|734-936-0091|ajjai@umich.edu|
22410510|NCT03803085|Brandeis University|Yujun Liu|781-736-3300|lyujun@brandeis.edu|
22410511|NCT01361607|GW Pharmaceuticals Ltd.|Medical Enquiries||medinfo.USA@gwpharm.com|
22410512|NCT00125931|McLean Hospital|Beth Murphy, MD PhD|617-855-2297|BMurphy5@partners.org|
22410513|NCT03411642|University Medical Center Hamburg-Eppendorf|Prof. Dr. Götz Thomalla|+4940501377410|thomalla@uke.de|
22410514|NCT02273206|Clinical Directors Network|Andrea Cassells, MPH|212-382-0699|acass@cdnetwork.org|227
22410515|NCT03082391|Cleveland Clinic Foundation|Dr. Michael Rosen|2164453441|rosenm@ccf.org|
22410516|NCT00676585|Beth Israel Deaconess Medical Center|Dr. Michael Donnino||mdonnino@bidmc.harvard.edu|
22410517|NCT00927888|Stanford University|David Drover, MD|6507250364|ddrover@stanford.edu|
22410518|NCT02741271|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22410519|NCT00373685|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22410520|NCT02570165|GlaxoSmithKline|GSK Response Center|866-435-7343||
22410521|NCT01953783|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22410522|NCT01789281|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
22410523|NCT01252238|Brigham and Women's Hospital|Dr. Jonathan Williams|617-278-0882|jwilliams5@partners.org|
22410524|NCT03029000|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22410525|NCT00411762|Yale University|Howard Hochster||Howard.Hochster@yale.edu|
22410526|NCT04428502|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22410527|NCT01721967|Duke University Health System|Andrew Wang, MD|919-681-6197|a.wang@duke.edu|
22410528|NCT02295280|Saint Louis University|Dorothea Mostello, MD, Maternal Fetal Medicine Faculty|314-977-2090|mostello@slu.edu|
22410529|NCT02875067|NYU Langone Health|Catherine Diefenbach, MD|212-731-5670|Catherine.Diefenbach@nyulangone.org|
22410530|NCT01430104|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22410531|NCT01241565|Covidien|Noreen Fahey|203-821-4716|noreen.fahey@covidien.com|
22410532|NCT02713243|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
22410533|NCT06079853|Columbia University School of Nursing|Allison A. Norful|2123057157|aan2139@cumc.columbia.edu|
22410534|NCT00389649|Universitry of Maryland|Stephen Gottlieb, MD|4103288788|sgottlie@medicine.umaryland.edu|
22410535|NCT03404206|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22410536|NCT01133392|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22410537|NCT03751124|Myovant Sciences GmbH|Clinical Trials at Myovant|+1 650 238 0250|clinicaltrials@myovant.com|
22410538|NCT04777591|University of Virginia|John T Stranix, MD|434-924-5078|jts3v@uvahealth.org|
22410539|NCT00555399|University of Texas M D Anderson Cancer Center|Dr. Vinay K. Puduvalli|(713) 745-2343|vpuduval@mdanderson.org|
22410540|NCT00860574|Fred Hutch/University of Washington Cancer Consortium|Joachim Deeg|206.667.5985|jdeeg@fredhutch.org|
22410541|NCT02006407|University of Michigan Comprehensive Cancer Center|Dr. Carl Johannes Koschmann, M.D.|734-647-2893|ckoschma@umich.edu|
22410542|NCT02496221|GlaxoSmithKline|GSK Response Center|866-435-7343||
22410543|NCT01335399|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22410544|NCT03262233|UW-Madison|John Curtin|608-262-0387|jjcurtin@wisc.edu|
22410545|NCT01893983|San Francisco VA Healthcare System|Dr. Karen Seal|415-2214810|karen.seal@va.gov|24852
22410546|NCT01120600|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22410547|NCT00894465|Washington University School of Medicine|Dr. Paul Austin|(314) 454-6034|austinp@wustl.edu|
22410548|NCT01165242|GlaxoSmithKline|GSK Response Center|866-435-7343||
22410549|NCT03372083|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22410550|NCT01735877|Christian Medical College & Hospital|Dr Jeyaraj D Pandian|09915784750|jeyarajpandian@hotmail.com|
22410551|NCT01690520|Deverra Therapeutics|Chief Scientific Officer|206-519-5304|cdelaney@deverratx.com|
22410552|NCT01270841|Repros Therapeutics Inc.|Jennifer L. Wike|281-719-3402|jwike@reprosrx.com|
22410553|NCT01375010|Columbia University|Elizabeth Shane, MD|212-305-6289|es54@cumc.columbia.edu|
22419167|NCT00242684|Central Arkansas Veterans Healthcare System|Melinda Bopp, Project Coordinator|501-257-2045|melinda.bopp@va.gov|
22419168|NCT03150407|J3 Bioscience, Inc|R. Tyler McCabe, Ph.D.|801-550-9956|tmccabe@j3bio.com|
22419169|NCT02052011|Yale School of Medicine|Dr. Basmah Safdar|2037853453|basmah.safdar@yale.edu|
22419170|NCT00000620|Wake Forest School of Medicine|Tim Craven / Senior Biostatistician|336-716-6109|tcraven@wakehealth.edu|
22419171|NCT02648932|University of Chicago|Hongtao Liu|773-834-0589|hliu2@medicine.bsd.uchicago.edu|
22419172|NCT01590797|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22419173|NCT03106987|AstraZeneca Clinical Study Information Center|Global Clinical Head|1-877-240-94 79|information.center@astrazeneca.com|
22419174|NCT01307111|University of New Mexico|Eve Espey, MD, MPH, Principle Investigator|505-272-6372|eespey@salud.unm.edu|
22419175|NCT00682357|University of Kansas Medical Center|Dr. Herbert Lindsley|(913) 588-3402|HLINDSLE@kumc.edu|
22419176|NCT00569855|University of Arkansas, Arkansas Children's Hospital, Dept. of Pediatrics|Research Program Manager, Cardiovascular Surgery, Dept. of Pediatrics|501-364-1100|althagekarena@uams.edu|5859
22419177|NCT04482387|Cambridge University Hospitals NHS Foundation Trust|Stephen Kelleher|01223217418|research@addenbrookes.nhs.uk|
22419178|NCT01739699|Northshore University Healthsystem, Evanston Hospital|Dr. Steven Greenberg|8475702760|sbgreenb@gmail.com|
22419179|NCT02114385|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22419180|NCT00486031|Valeant Pharmaceuticals|Johnson Varughese|9089271400||
22419181|NCT03495921|Gradalis, Inc.|Clinical and Regulatory Operations|(214) 442-8100|info@gradalisinc.com|
22419182|NCT05320887|Wake Forest School of Medicine|Darcy Lockhart, Project Manager I|3367166182|alaverdi@wakehealth.edu|
22419183|NCT04520009|Dartmouth Geisel School of Medicine|Tor D. Tosteson, ScD|603 646-5724|tor.d.tosteson@dartmouth.edu|
22419184|NCT02460679|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22419185|NCT03366207|Iterum Therapeutics|Senior Director, Clinical Development|18606614035|saronin@iterumtx.com|
22419186|NCT00706485|Massachusetts General Hospital|Thomas F. DeLaney, M.D.|617-726-6876|tdelaney@mgh.harvard.edu|
22419187|NCT01651793|University of Georgia|Dr. Patrick J. O'Connor|706-542-4382|poconnor@uga.edu|
22419188|NCT02130622|Dartmouth-Hitchcock|Gastroenterology Research Team Lead|603-653-9033|Jessica.I.Chevalier@hitchcock.org|
22419189|NCT00626808|MedImmune, LLC|Chris Ambrose|301-398-0000|ambrosec@medimmune.com|
22419190|NCT03066258|Regenxbio Inc.|Sherri Van Everen, PharmD/ Vice President of Clinical Development|240.552.8181|svaneveren@regenxbio.com|
22419191|NCT02784795|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22419192|NCT01994850|University of Pennsylvania Abramson Cancer Center|Jakub Svoboda, MD|855-216-0098|PennCancerTrials@emergingmed.com|
22419193|NCT01992185|Physicians Institute|Sharon Keene, MD|(520) 290-5555|monican@appliedbiology.com|
22419194|NCT01120704|UWisconsin|Stevens Smith|608-262-7563|sss@ctri.medicine.wisc.edu|
22419195|NCT00339144|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22419196|NCT01292226|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22419197|NCT04581330|UT Southwestern Medical Center|Dr. Heather Goff|2146484229|heather.goff@utsouthwestern.edu|
22419198|NCT06154200|SCCO at MBKU|Dr. Jerry Paugh, Professor Emeritus|7144497487|jpaugh@ketchum.edu|
22419199|NCT03898908|Grupo Español Multidisciplinar en Melanoma (GEM)|GEM Technical Secretary|0034934344412|secretaria@groupgem.es|
22419200|NCT00468650|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22419201|NCT01267994|North Shore-LIJ Health System|Andrea Vambutas, MD, FACS|718-470-7748|vambutas@nshs.edu|
22419202|NCT00345943|New York State Psychiatric Institute|Dr. Rachel Marsh|6467745774|rachel.marsh@nyspi.columbia.edu|
22419203|NCT01144715|Kinetic Muscles|James Koeneman, PhD|602-677-5256|jimkoeneman509@gmail.com|
22419204|NCT01024686|U.S. Military Malaria Vaccine Program (USMMVP)|Dr. Michele Spring|301-319-9307||
22419205|NCT01881113|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
22419206|NCT00857584|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22419207|NCT00673387|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22419208|NCT02533375|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22419209|NCT00960115|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22419210|NCT01104792|Allergan|Willie R. Earley, MD Associate Vice President Clinical Development-CNS|714-246-4500|IR-CTRegistration@allergan.com,|
22419211|NCT01102374|University of Colorado School of Medicine|Adit Ginde, MD, MPH, Professor of Emergency Medicine|720-848-6777|adit.ginde@ucdenver.edu|
22419212|NCT01432379|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22419213|NCT02071849|Biostable Science and Engineering, Inc.|John Wheeler|512-386-1996|John.wheeler@biostable-s-e.com|
22419214|NCT00555360|Ann Arbor VA Healthcare System|Dr. John Piette, PhD|734-845-3626|jpiette@umich.edu|
22419215|NCT02056392|AstraZeneca|Gabriella Mariani|+44 7818 523 899|ClinicalTrialTransparency@astrazeneca.com|
22419216|NCT00103610|Genzyme Corporation|Genzyme MedInfo||medinfo@genzyme.com|
22419217|NCT00658021|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22419218|NCT02067273|Stanford University School of Medicine|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@stanford.edu|
22419219|NCT02968849|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
22419220|NCT00815360|Retina Associates of Florida, P.A.|Dr. Ivan J. Suner|813-875-6373|ivansuner@gmail.com|
22419221|NCT05292183|Dartmouth-Hitchcock Medical Center|Dr. Krzysztof Bujarski|603 650 5104|krzysztof.a.bujarski@hitchcock.org|
22419222|NCT03128060|University of Southern California|Susan Enguidanos|(213) 740-9822|enguidan@usc.edu|
22419223|NCT02017015|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
22419224|NCT03102606|BeyondSpring Pharmaceuticals|Ramon Mohanlal|6468491102|rmohanlal@beyondspringpharma.com|
22419225|NCT01277601|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22419226|NCT04021238|UNC Chapel Hill|Director, Clinical Research, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
22419227|NCT02260570|Department of Veterans Affairs|Andrew Kayser, MD PhD|925-372-2000|Andrew.Kayser@va.gov|
22419228|NCT04034927|NRG Oncology|Christopher Purdy on behalf of Danielle Enserro, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
22419229|NCT03956355|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
22419230|NCT03996447|Guerbet|Jing Hao, MD, Global Head of Medical Affairs & Clinical Development|+33 (0) 1 45 91 50 00|jing.hao@guerbet.com|
22419231|NCT05849454|Center for Behavioral Cardiovascular Health|Nadia Liyanage-Don|917-280-3776|nal2151@cumc.columbia.edu|
22419232|NCT00369486|Jaeb Center for Health Research, Diabetic Retinopathy Clinical Research Network|Adam R. Glassman, M.S., Director|(813) 975-8690|drcrnet@jaeb.org|
22419233|NCT01810302|University of Florida|Dr. Spiros Blackburn|(352) 273-9000|spiros.blackburn@neurosurgery.ufl.edu|
22419234|NCT00287586|Brigham and Women's Hospital|Shalendar Bhasin, MD||Sbhasin@partners.org|
22419235|NCT03831711|Stanford University|Dr. Andrei Iagaru, MD|650-725-4711|aiagaru@stanford.edu|
22419236|NCT00113763|Amgen Inc.|Study Director|866-572-6436||
22419237|NCT03743415|University of Arizona College of Nursing|Terry Badger, PhD|520-626-6058|tbadger@arizona.edu|
22419238|NCT00094861|Biovitrum|Hans Olivecrona, MD PhD|+46 8 697 20 00|hans.olivecrona@sobi.com|
22419239|NCT01917214|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22419240|NCT00451204|University of California Los Angeles|Dr. Rhonda Voskuhl|310-206-4636|rvoskuhl@mednet.ucla.edu|
22419241|NCT01696058|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22419242|NCT03781037|Florida International University|Dr. Jeremy Pettit|305-348-1671|jpettit@fiu.edu|
22419243|NCT02186834|H. Lee Moffitt Cancer Center and Research Institute|Dr. Rachid Baz|813-745-8212|rachid.baz@moffitt.org|
22419244|NCT04581369|Indiana University|Eric Orman|317-278-1630|esorman@iu.edu|
22419245|NCT01053000|Roger H. Stewart MD PA|Barry Galitzer MD|954-491-0510|barry@galitzer.com|
22419246|NCT04746794|University of Washington|Faith Beers|206-543-1733|fabeers@uw.edu|
22419247|NCT05204082|Mayo Clinic|Michael E. Nemergut, M.D., Ph.D.|507-255-7976|Nemergut.Michael@mayo.edu|
22419248|NCT01422187|Target Health Inc.|Glen Park|212-681-2100|gpark@targethealth.com|
22419249|NCT04867174|University of Southern California|Professor Mireille Jacobson|(213) 740-5156|mireillj@usc.edu|
22419250|NCT00856375|Nektar Therapeutics|Study Director||medicalaffairs@nektar.com|
22392475|NCT03551691|Children's Hospital of Philadelphia|Dr. Virginia Stallings|267-425-1633|stallingsv@chop.edu|
22419251|NCT02794597|Denver Health & Hospital Authority|Deborah Rinehart|303-602-2743|deborah.rinehart@dhha.org|
22419252|NCT04414345|Healey Center for ALS at Massachusetts General Hospital|Healey Center for ALS Project Management|833-425-8257 (HALT ALS)|healeyalsplatform@mgh.harvard.edu|
22419253|NCT02538965|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosur|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22419254|NCT00875797|UMCLjubljana|Lidija Kompan, principal Investigator|0038651301781|lidija.kompan@gmail.com|
22392476|NCT01876082|Department of Medical Oncology, Institut bergonié|Pr Antoine Italiano, coordinating investigator|05.47.30.60.88|a.italiano@bordeaux.unicancer.fr|
22392477|NCT04854850|University of Pittsburgh|Robyn T. Domsic|412-383-8000|rtd4@pitt.edu|
22392478|NCT04092530|University of Illinois at Chicago|Kristin Rankin|708-710-8411|krankin@uic.edu|
22392479|NCT02441985|University of Florida|Aparna Wagle Shukla|3522945400|aparna.shukla@neurology.ufl.edu|
22392480|NCT04020185|ImmuneSensor Therapeutics Inc.|Vice President of Clinical Operations and Project Management|210-380-5164|tmooneyham@immunesensor.com|
22392481|NCT04087811|Boston Scientific|Roshini Jain, Sr. Director Clinical Sciences|16619494350|roshini.jain@bsci.com|
22392482|NCT00527787|POZEN Inc|Senior Vice President, Clinical Research|919-913-1030|eorlemans@pozen.com|
22392483|NCT02783027|University of Pittsburgh|Dr. Daniel Patterson|412-864-3830|pdp3@pitt.edu|
22392484|NCT04335591|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
22392485|NCT04210427|Saint Louis University|Purnima Modi|3149772029|purnima.modi.1@slu.edu|
22392486|NCT00561431|University of Alabama at Birmingham|Ashita Tolwani, M.D.|2059752021|atolwani@uab.edu|
22392487|NCT02863289|NHS Tayside|Mr Benedict Clift|01382 660111|ben.clift@nhs.net|35160
22392488|NCT01541384|University of Pennsylvania|Dr. Peter Reese|215-898-6086|peter.reese@uphs.upenn.edu|
22392489|NCT01939353|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22392490|NCT03573947|Duke Cancer Institute|Dr. Jeffrey Clarke|9196819509|jeffrey.clarke@duke.edu|
22392491|NCT03237377|Johns Hopkins SKCCC CRO Coordinating Center|Jasmine Brooks, Senior Research Program Coordinator|667-306-8335|jbrook54@jhmi.edu|
22392492|NCT04421950|University of Arkansas for Medical Sciences and Arkansas Children's Nutrition Ce|Eva C. Diaz, Principal Investigator|5013643056|ecdiazfuentes@uams.edu|
22392493|NCT00186017|Stanford University School of Medicine|Dr. Terence A. Ketter, MD.|6507232507|tketter@stanford.edu|
22392494|NCT00335140|Johns Hopkins Cancer Center|Lode Swinnen, MD|(410) 955-8603|lswinne1@jhmi.edu|
22392495|NCT04546425|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22392496|NCT03296800|Theracos Sub, LLC|Albert Collinson|(508) 688-4221|acollinson@theracos.com|
22392497|NCT00737477|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22392498|NCT01132820|NRG Oncology /GOG|Linda Gedeon for Michael Sill, PhD|716 845-1169|lgedeon@gogstats.org|
22392499|NCT02687035|Edwards Lifesciences|Edwards THV Clinical Affairs|949-250-2500|THV_CT.gov@edwards.com|
22392500|NCT05000216|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22392501|NCT03435692|Seattle Children's Hospital|David E. Liston, MD, MPH|206-987-3996|david.liston@seattlechildrens.org|
22392502|NCT00967005|Yale University|Dr. Marc N. Potenza, M.D., Ph.D.|203-737-3553|marc.potenza@yale.edu|
22392503|NCT02593123|Virginia Commonwealth University Massey Cancer Center|Dr. Amir Toor, Principal Investigator|804 828 5116|amir.toor@vcuhealth.org|
22392504|NCT05071053|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
22392505|NCT01038427|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22392506|NCT03538938|University of Wisconsin School of Medicine and Public Health|Danielle McCarthy|6082655949|demccarthy@ctri.wisc.edu|
22419255|NCT04141930|University of Washington|Research Coordinator|2066165859|jheimo@uw.edu|
22419256|NCT00741286|Department of Neurology, Sanggye Paik Hospital, Inje University College of Medicine|Sang Won Han|82-2-950-8864|swhan@paik.ac.kr|
22419257|NCT02892149|Akebia Therapeutics, Inc.|Clinical Trial Information Desk|+1 617-844-6128|trials@akebia.com|
22419258|NCT02165735|University of Rochester|Dr. Kevin Fiscella, PI|5853244563|kevin_fiscella@urmc.rochester.edu|
22419259|NCT00101283|ECOG Statistical Office|Study Statistician|617-632-3012||
22419260|NCT00595309|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar-kastner@intercell.com|1175
22419261|NCT01654315|The Ohio State University|Dr. Stephen Page|614-292-5490|STEPHEN.PAGE@OSUMC.EDU|614
22419262|NCT05084924|University of North Carolina at Chapel Hill|Justin Riddle, PhD|850-644-9869|justin_riddle@med.unc.edu|
22419263|NCT03774407|Texas Tech|Dr Mirla Avila|8322448072|mirla.avila@ttuhsc.edu|
22419264|NCT00182325|Department of Family Medicine, McMaster University|Dr. Heather Waters|(905) 575-6782|watersh@mcmaster.ca|
22419265|NCT02054338|Institut de Recherche Pierre Fabre|Karim Keddad|+33 5 34 50 61 69|karim.keddad@pierre-fabre.com|
22419266|NCT03225001|Edwards Lifesciences|Edwards THV Clinical Affairs|(949) 250-2500|THV_CT.gov@Edwards.com|
22431786|NCT01968980|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22419267|NCT02015065|National Cancer Institute|Dr. Brigitte Widemann|240-760-6203|widemanb@nih.gov|
22419268|NCT01420965|Georgetown University|Dr. Samir Khleif|(202) 687-0100|snk48@georgetown.edu|
22419269|NCT02895100|Protagonist Therapeutics, Inc|Director Clinical Development|(+1) 888-899-1543|ptgxclintrials@ptgx-inc.com|
22419270|NCT00252239|University of Virginia Health System|Dr. E. Clarke Haley, Jr.|434-924-8041|ech@virginia.edu|
22419271|NCT02950818|University of Michigan School of Public Health|Cathleen Connell|734-647-3189|cathleen@umich.edu|
22419272|NCT02613182|Prothena|Wendy Curlin|650 837 8550|clinicaltrials@prothena.com|
22419273|NCT02785952|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
22419274|NCT03322930|Retina Foundation of the Southwest|Dr. David Birch|214-363-3911|dbirch@retinafoundation.org|105
22419275|NCT00090363|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22419276|NCT03344861|on behalf of Concordia Laboratories Inc.|Kim McDonald-Taylor|647-267-2942|kmcdonald-taylor@rogers.com|
22419277|NCT04642365|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22419278|NCT02728843|Chiesi Canada Corp.|Caroline Fradette, PhD|1-800-854-3534|c.fradette@chiesi.com|7014
22419279|NCT03185013|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
22419280|NCT02575976|Federal University of Minas Gerais|Professor Raquel Britto|+55 31 99970-4527|r3britto@gmail.com|
22419281|NCT00197496|University of Waterloo|Dr. Lora Giangregorio|5198884567|lmgiangr@uwaterloo.ca|36357
22419282|NCT03255655|Guided Therapy Systems|Rich Amodei, RDMS|480-649-8587|r.amodei@guidedtherapy.com|
22419283|NCT03040323|Indiana University Department of Radiology|Jordan Swensson ,MD|317-944-1831|jswensso@iupui.edu|
22419284|NCT01175031|Shanghai Jiao Tong University School of Medicine|Quing Yun Li, MD, PhD|86-21-64314162|liqingyun68@hotmail.com|
22419285|NCT01806506|Department of General, Transplant and Liver Surgery, Medical University of Warsaw|Piotr Kalinowski|0048 22 599 2546|kalip@o2.pl|
22419286|NCT00563576|Columiba University|Carolyn Westhoff|212-305-4805|clw3@columbia.edu|
22419287|NCT02099682|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22419288|NCT02203331|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22419289|NCT02542605|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22419290|NCT02125721|NYU Langone Health|David Goldfarb|212 263 0744|David.Goldfarb@nyulangone.org|
22419291|NCT00278889|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22419292|NCT00704730|Exelixis, Inc|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
22419293|NCT05833139|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22419294|NCT00836407|The Sidney Kimmel Comprehensive Cancer Center at Johns|Dr. Dung Le||dle@jhmi.edu|
22419295|NCT02847260|United Therapeutics Corporation|Leigh Peterson, Director, Product Development, Product Development & Global Clinical Operations|919-425-8165|lpeterson@unither.com|
22419296|NCT03104400|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22419297|NCT02968602|Maryland Psychiatric Research Center|Heidi J Wehring|410-402-6854|hwehring@som.umaryland.edu|
22419298|NCT00264550|Centocor Research & Development, Inc.|Director Clinical Research|1-800-457-6399||
22419299|NCT02129608|Mayo Clinic|Ivana Croghan|507-266-1944|domcro@mayo.edu|
22419300|NCT00129389|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
22419301|NCT05177718|Vumc|Natalizumab and chronic Blood Brain Barrier Breakdown|6159360060|francesca.r.bagnato@VUMC.ORG|
22419302|NCT02495259|Emory University|Dr. Igor Zhukov|404-268-1404|izhukov@live.com|
22419303|NCT01191944|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22419304|NCT02691143|Sport and Spine Rehab Clinical Research Foundation|Jena Slaski|240-766-0300|jslaski@ssrehab.com|838
22419305|NCT02814890|Huashan Hospital, Fudan University, Shanghai|Dr. Jun Zhang|0086-021-52887694|snapzhang@aliyun.com|
22419306|NCT02794246|Univ. of Pennsylvania|Emerging Med|855-216-0098|penncancertrials@emergingmed.com|
22419307|NCT04602546|Medtronic|Keith Holloman|6126707136|keith.holloman@medtronic.com|
22419308|NCT03578549|Univeristy of Michigan|Dr. Darya Dabiri|4198821017|daryad@umich.edu|
22419309|NCT02597127|The Medicine's Company|Global Health Science Center|1-888-997-6326|Medical.Information@themedco.com|
22419310|NCT00425373|Novartis Pharmaceuticals|Study Director|862 778-8300||
22419311|NCT04204057|Rhizen Pharmaceuticals|Prajak Barde MD|+41325800175|pjb@rhizen.com|
22419312|NCT01256944|Taipei Medical University - WanFang Hospital|Dr. Ming-I Hsu|886-2-2930-7930|hsumigni@yahoo.com.tw|2508
22419313|NCT00582010|University of Alabama at Birmingham|Rakesh Patel|205-934-3411|rakeshp@uab.edu|
22419314|NCT04797221|Veterans Health Administration|Joseph Simonetti|7207236491|joseph.simonetti@va.gov|
22419315|NCT02029196|Fontem Ventures|Dr Ana Cravo|+441173322528|AnaMaria.Cravo@fontemventures.com|
22419316|NCT01853332|Beth Israel Deaconess Medical Center|Dr. Christos Mantzoros|6176678630|cmantzor@bidmc.harvard.edu|
22419317|NCT02463357|University of Colorado Denver|Robert Roach||clinicalresearchsupportcenter@ucdenver.edu|
22419318|NCT03509857|Montefiore MC|Dr. Aravind Pothula|9178015577|apothula@montefiore.org|
22419319|NCT01371539|Alcon Research, Ltd.|Stacie Cummings, O.D.|1-800-241-7629||
22419320|NCT01399658|Dana-Farber Cancer Institute|Martin King, MD|617-732-4332|Martin_King@dfci.harvard.edu|
22419321|NCT02279108|CHU Saint-Etienne|Pr Céline CHAULEUR|04 77 82 86 11|celine.chauleur@chu-st-etienne.fr|+33
22419322|NCT02620579|University of Florida|Dr. Samuel S. Wu|3522945910|samwu@biostat.ufl.edu|
22419323|NCT01545518|Emory University|Dr. Charles M. Epstein|404-778-3633|cepstei@emory.edu|
22419324|NCT04315506|Duke University|Devon Noonan|919-684-3786|devon.noonan@duke.edu|
22419325|NCT01721317|GlaxoSmithKline|GSK Response Center|866-435-7343||
22419326|NCT02661217|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22419327|NCT01072617|BIDMC|Alvaro Pascual-Leone|617-667-0203|apleone@bidmc.harvard.edu|
22419328|NCT03168334|Bausch Health Americas, Inc|Study Director|510-259-5284|aloncaric@bauschhealth.com|
22419329|NCT01778634|University of Maryland|Rose Marie Viscardi, M.D.|410-706-1913|rviscard@som.umaryland.edu|
22419330|NCT00958893|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
22419331|NCT03907657|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat Canter|9199620000|melahat.garipagaoglu@gmail.com|
22419332|NCT00378573|sanofi-aventis|Medical Affairs study director||publicregistryUSMA@sanofi-aventis.com|
22419333|NCT00687830|Cleveland Clinic Florida|Dr. Shibu Varughese and Dr. Anand Kumar|305-310-1238|akuma003@fiu.edu|
22419334|NCT03094637|The University of Texas MD Anderson Cancer Center|Guillermo Garcia-Manero MD/Professor|713-745-3428|ggarciam@mdanderson.org|
22419335|NCT00912925|Genzyme Corporation|Genzyme Medical Information||medinfo@genzyme.com|
22419336|NCT03485365|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22419337|NCT02181790|Icahn School of Medicine at Mount Sinai|Dr Mark Lebwohl|2122413288|giselle.singer@mssm.edu|
22419338|NCT03276078|AstraZeneca PLC|Dr Sami Daoud|1-877-240-9479|Information.centre@astrazeneca.com|
22419339|NCT03332979|Marie Curie Palliative Care Research Department, Division of Psychiatry, University College London|Dr Kirsten Moore|020 7679 9488|kirsten.moore@ucl.ac.uk|
22419340|NCT03661697|University of Miami|Lisa D Grunebaum MD|3052433223|lgrunebaum@med.miami.edu|
22419341|NCT00763061|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22419342|NCT01275430|Bard Access Systems, Inc.|Sharon Molotsky|856-266-1327|sharon.molotsky@crbard.com|
22419343|NCT04988087|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22419344|NCT03968978|AstraZeneca|Global Clinical Head|+1 877-240-9479|information.center@astrazeneca.com|
22419345|NCT00863772|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22419346|NCT01758588|Weill Cornell Medicine|Assistant Director of Leukemia and BMT Clinical Trials|646-962-9305|ell2028@med.cornell.edu|
22419347|NCT03565679|Medline Industries, Inc|Kara Cassady|847-643-3809|kcassady@medline.com|
22419348|NCT00401986|Boston Scientific Corp.|G Mark Grubb, RN, CCRA|(412) 716-0717|grubbm@bsci.com|
22419349|NCT00205803|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22419350|NCT05278650|Duke University|Eleanor McConnell, Ph.D.|919-684-9229|eleanor.mcconnell@duke.edu|
22419351|NCT05038800|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22419352|NCT00121134|DFCI|Dr Harold J. Burstein|617-632-3800|hal_burstein@dfci.harvard.edu|
22419353|NCT04080544|The University of Texas at Dallas|Dr. Joseph Hennessee|408-813-4488|joseph.hennessee@utdallas.edu|
22419354|NCT04967508|Samsung Bioepis Co., Ltd|Director of Clinical Trials|+82-32-728-0371|sbregistry@samsung.com|
22419355|NCT02478320|M D Anderson Cancer Center|Dr. David Hong|(713) 563-5844|dshong@mdanderson.org|
22419356|NCT02494180|Kwong Wah Hospital|Dr SF Lai|85223322311|lsf087@ha.org.hk|
22419357|NCT04400682|Farmagen|Aydin Erenmemisoglu|+90 532 551 0082|a.erenmemisoglu@farmagenarge.com|
22419358|NCT03597464|Aurinia Pharmaceuticals|Clinical Trials Information|1 (250) 744-2487|clinicaltrials@auriniapharma.com|
22419359|NCT04328961|University of Washington|Ruanne Barnabas|206 520 3800|rbarnaba@uw.edu|
22419360|NCT01191827|Denver VA Medical Center|Research Biologist|303-724-6232|jason.tregellas@va.gov|
22419361|NCT01178528|IRCCS San Raffaele|G Rosano|0652252309|giuseppe.rosano@sanraffaele.it|
22419362|NCT03316547|Washington University|Roberta Pineda|314-286-1304|bobbi.pineda@chan.usc.edu|
22419363|NCT02156167|Cochlear|Christiane D'hondt, Clinical Research Specialist|+32 15 76 55 14|cdhondt@cochlear.com|
22419364|NCT01831258|SleepMed of South Carolina|Dr Richard Bogan|8777537633|rbogan@sleepmedinc.com|
22419365|NCT03551821|Aclaris Therapeutics|Executive Director Clinical Operations|4843247933|jschnyder@aclaristx.com|
22419366|NCT03300843|National Cancer Institute|Dr. Steven A. Rosenberg|240-858-3080|steven-rosenberg@nih.gov|
22419367|NCT05676814|Wake Forest University Health Sciences|Scott Coleman, DO|336-716-2712|srcolema@wakehealth.edu|
22419368|NCT01753297|Ipsen Pharma SAS|Medical Director|see email|clinical.trials@ipsen.com|
22419369|NCT02533180|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22419370|NCT01174043|IndianaU|Dr. Hamid Sayar|(317)278-6871|ssayar@iu.edu|
22419371|NCT03904108|Stony Brook University|Dr. Roger Keresztes|631-638-1000|roger.keresztes@stonybrookmedicine.edu|
22419372|NCT02646761|University of Pittsburgh|Dr. James J. Irrgang|(412) 383-9865|jirrgang@pitt.edu|
22419373|NCT02441660|UT Health San Antonio|Michelle Trbovich|210-617-5300|TrbovichM@uthscsa.edu|18192
22419374|NCT00794339|ACR|Donna Hartfeil|215-717-2765|dhartfeil@acr.org|
22419375|NCT04082338|Center for Asian Health, Lewis Katz School of Medicine, Temple University|Dr. Grace X. Ma|215-707-6493|grace.ma@temple.edu|
22419376|NCT02934191|Children's Hospital of Philadelphia|Dr. John Germiller|215-590-3440|germiller@email.chop.edu|
22419377|NCT01931878|Yale University School of Medicine|Bahman Jabbari M.D.|203-737-2464|bahman.jabbari@yale.edu|
22419378|NCT00492778|NRG Oncology|Linda Gedeon for Danielle Enserro, PhD.|7168451169|gedeonl@nrgoncology.org|
22419379|NCT03751007|Precigen Actobio T1D, LLC|Sven Blomme|+3292771177|sblomme@actobio.com|
22419380|NCT00841828|Department of Medical Oncology, Hospital Universitario Virgen de la Victoria|Dr. Emilio Alba||emilioalbac@gmail.com|
22419381|NCT03717012|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22419382|NCT00789035|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22419383|NCT04414618|RedHill Biopharma Ltd.|Vered Katz Ben-Yair|+13474144462|vered@redhillbio.com|
22419384|NCT00658879|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22419385|NCT02640690|Atlanta VA Health Care System|Dr. Ursula Kelly|4047272715|ukelly@emory.edu|
22419386|NCT01118975|University of Maryland|Michelle Medeiros|410-328-1160|mmedeiros@umm.edu|
22419387|NCT01645787|Columbia University|Claudia A. Chiriboga, MD, MPH|(212) 305-8549|cac3@columbia.edu|
22419388|NCT02559180|Cleveland Clinic Foundation|Rishi P Singh|772-223-5945|singhr@ccf.org|13014
22419389|NCT00900822|Institut Straumann AG|Clinial Trial Manager|+41 61 965 11 11|info@straumann.com|
22419390|NCT02806024|University of Washington|Mallory Kremer|206.616.5258|mkremer@uw.edu|
22419391|NCT01098474|GlaxoSmithKline|GSK Response Center|866-435-7343||
22419392|NCT00295061|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
22419393|NCT01598194|UT MD Anderson Cancer Center|Weston,Brian,MD / Gastroenterology Hepatology & Nutrition|713-792-7734|BWESTON@MDANDERSON.ORG|
22419394|NCT00711880|GW Pharma Ltd|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
22419395|NCT00704132|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22419396|NCT00442962|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22419397|NCT04238650|mAbxience|Susana Millan|+34917711500|susana.millan@mabxience.com|
22419398|NCT03348163|The University of Texas Health Science Center at Houston|Jordan Elizabeth Lake, MD, Associate Professor|(713) 500-6759|Jordan.E.Lake@uth.tmc.edu|
22419399|NCT02756208|Institute of Human Virology|Dr. Mohammad Sajadi|410-7061779|msajadi@ihv.umaryland.edu|
22419400|NCT02585778|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22419401|NCT03617783|Maryland Psychiatric Research Center|Dr. Robert Buchanan|410-402-7876|rwbuchanan@som.umaryland.edu|
22419402|NCT05246670|Geisinger Medical Center|Mellar P. Davis, MD, FCCP, FAAHPM|570-271-7383|mdavis2@geisinger.edu|
22419403|NCT02281422|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22419404|NCT00356525|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22419405|NCT00652340|Tragara Pharmaceuticals|Tracy Parrott|858-350-6919|tparrott@tragarapharma.com|
22419406|NCT04152291|Wihuri Research Institute|Professor Katariina Öörni|+358 40 7023711|kati.oorni@wri.fi|
22419407|NCT03597295|Incyte|Incyte Corporation Call Center (US)|1.855.463.3463|medinfo@incyte.com|
22419408|NCT00879411|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22419409|NCT05124691|Instituto de Salud Global de Barcelona - ISGLOBAL|Jose Muñoz|+34608774071|jose.munoz@isglobal.org|
22419410|NCT05211726|University of Delaware|Christopher Martens|302-831-7270|cmartens@udel.edu|
22419411|NCT01044264|Perrigo Company|Manager|718-960-0119|jonathan.schwartz@perrigo.com|
22419412|NCT04791514|Insmed Incorporated|Insmed Medical Information|1-844-446-7633|medicalinformation@insmed.com|
22419413|NCT02288156|UZ Leuven|Prof. Dr. Hellings|016336340|nkogh@uzleuven.be|
22419414|NCT05147324|University of North Carolina at Chapel Hill|Angelica Cristello Sarteau|919-445-1191|angcri@live.unc.edu|
22419415|NCT02714426|University of Florida|Michael Marsiske, Ph.D.|352.273.5097|marsiske@phhp.ufl.edu|
22419416|NCT01727726|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development||DT-inquiry@otsuka.jp|
22419417|NCT03456453|University of Kentucky|Michele Staton|859-312-8245|mstaton@uky.edu|
22419418|NCT00896480|GlaxoSmithKline|GSK Response Center|866-435-7343||
22419419|NCT01595386|University of Alabama at Birmingham, Pediatric Cardiac Critical Care|Jeffrey Alten, M.D., Director of Clinical and Translational Research Department|205-975-3123|jalten@peds.uab.edu|
22419420|NCT00373698|VA Medical Center, White River Junction, VT|Dr. Paula Schnurr and Dr. Mathew Friedman|802-296-5132|Paula.Schnurr@va.gov; Matthew.Friedman@va.gov|
22419421|NCT00725205|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22419422|NCT03014180|Microport CRM|Director of Scientific Communication|0677164209|anne.rousseauplasse@crm.microport.com|
22419423|NCT01119794|Brown University Oncology Research Group (BrUOG)|Eric Winer, MD|4018633000|kayla_rosati@brown.edu|
22419424|NCT02297698|LumaBridge|Dr. George Peoples|210 557 4291|gpeoples@lumabridge.com|
22419425|NCT02212379|Inserm, Sorbonne Universite, IPLESP|Dr Lambert Assoumou|0142164280|lambert.assoumou@iplesp.upmc.fr|
22419426|NCT04784533|Concert Pharmaceuticals, Inc.|Colleen E. Hamilton|781-860-0045|AAclinicaltrial_inquiries@concertpharma.com|
22419427|NCT02105974|GlaxoSmithKline|GSK Response Center|866-435-7343||
22419428|NCT00963560|Alcon Research, Ltd.|Director of Alcon Clinical|888-451-3937; 817-568-6725|medinfo@alconlabs.com|
22419429|NCT01462773|The Ohio State University Comprehensive Cancer Center|William Carson|614-293-6306|william.carson@osumc.edu|
22419430|NCT02454127|Tufts Medical Center|Michael Dansinger, MD|617-636-5000|mdansinger@tuftsmedicalcenter.org|
22419431|NCT02777073|State University of NY at Buffalo|Paresh Dandona|7165351850|dandona@buffalo.edu|
22419432|NCT03844386|University of North Carolina at Chapel Hill|Cynthia Gay, MD, MPH|919-843-2726|cynthia_gay@med.unc.edu|
22419433|NCT02682927|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22419434|NCT05573763|Fisher & Paykel Healthcare Ltd|Kelly Tay|+64 9-282-9734|kelly.tay@fphcare.co.nz|5634
22419435|NCT03975491|Pennington Biomedical Research Center|Dr. Justin Brown|2257632715|Justin.Brown@pbrc.edu|
22419436|NCT04582149|Emory University|Ofer Sadan, MD, PhD|470-480-6956|ofer.sadan@emory.edu|
22419437|NCT03922529|University of Pittsburgh|Daniel Forman, MD|412-360-2411|formand@pitt.edu|
22419438|NCT02465398|Zimmer Biomet|Elliott Goff|+41 79 222 23 08|elliott.goff@zimmerbiomet.com|
22419439|NCT02540850|BioChain (Beijing) Science and Technology, Inc.|Dr. Lele Song|86-10-63401580|songlele@biochainbj.com|
22419440|NCT01549405|Ministry of health Diskapi Yıldirim Beyazit Training and Research Hospital|Dr Derya Özkan|00903125962553|derya_z@yahoo.com|
22419441|NCT03760185|Denver Health and Hospital Authority|Dr Cristos Ifantides|303-436-4949|Cristos.Ifantides@dhha.org|
22419442|NCT00230178|Sanofi-aventis|International Clinical Development, Clinical Study Director||GV-Contact-us@sanofi-aventis.com|
22419443|NCT02652611|U Maryland|Haley Demyanovich|4107063935|hdemyanovich@som.umaryland.edu|
22419444|NCT01275729|University of Chicago|Dr. Jay L Koyner|773-702-4842|jkoyner@uchicago.edu|
22419445|NCT03577301|Florida State University|Sylvie Naar, PhD; Distinguished Endowed Professor|18506442334|sylvie.naar@med.fsu.edu|
22419446|NCT02252406|University of Florida, Jacksonville|Gladys Velarde, MD|904-244-2060|gladys.velarde@jax.ufl.edu|
22419447|NCT00447876|Ipsen|Medical Director||clinical.trials@ipsen.com|
22419448|NCT00005957|Juravinski Cancer Centre at Hamilton Health Sciences|Dr. Timothy J. Whelan|1(905) 387-9495|twhelan@HHSC.CA|
22419449|NCT01609023|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22419450|NCT04172597|Assertio Holdings|Howard Franklin, MD|224 419 7106|Hfranklin@assertiotx.com|
22419451|NCT01109147|Hopital Sainte Marguerite - APHM - Service du Pr. Azorin|Dr. Eric Fakra||eric.fakra@ap-hm.fr|
22419452|NCT02952586|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22419453|NCT04974749|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22419454|NCT01520870|MFAR Clinical Research|Pau Doñate||investigacion@mfar.net|
22419455|NCT01277159|HSS|Dr. Yadeau|212.606.1206|YadeauJ@hss.edu|
22419456|NCT00796107|Hoffmann-La Roche, Ltd.|Study Director|888-662-6728 (U.S.)|global-roche-genentech-trials@gene.com|
22419457|NCT04902014|Colorado State University|Dr. Kayla Nuss|9705814824|kayla.nuss@colostate.edu|
22419458|NCT02075515|GlaxoSmithKline|GSK Response Center|866-435-7343||
22419459|NCT00626561|University of Texas MD Anderson Cancer Center|Michael M. Frumovitz, MD / Professor, Gynecologic Oncology|713-792-9599|CR_Study_Registration@mdanderson.org|
22419460|NCT02797171|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22419461|NCT01372748|University of Washington, Resuscitation Outcomes Consortium|Dr. Susanne May|206-685-1302|rochelp@uwctc.org|
22419462|NCT00606632|Heidelberg Pharma AG (former Wilex AG)|Head of R&D||info@hdpharma.com|
22419463|NCT03908437|University of Pennsylvania, Dpt of Psychiatry, Perelman School of Medicine|Dr. David Metzger, Research Professor, Director of HIV Prevention Research Unit|215-746-7355|dsm@pennmedicine.upenn.edu|
22419464|NCT03633825|Harvard University|Principal Investigator|617-496-4484|jaroszewski@fas.harvard.edu|
22419465|NCT03682107|Cincinnati Children's Hospital|Dr. Grant Paulsen|513-636-4578|Grant.Paulsen@cchmc.org|
22419466|NCT02614924|UHCW NHS Trust|Dr Ratidzo Danha|02476 964000|Ratidzo.Danha@uhcw.nhs.uk|25871
22419467|NCT00214383|University of Wisconsin - Madison|Alice Pulvermacher|(608) 262-8448|alice.pulvermacher@chess.wisc.edu|
22419468|NCT01890434|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22419469|NCT00428116|University of Washington|Grace John-Stewart|206 543 4278|gjohn@uw.edu|
22419470|NCT01038297|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22419471|NCT01898221|Houston Methodist Hospital, Dept of Cardiology|Miguel Valderrabano, MD|713 441 5231|MValderrabano@houstonmethodist.org|
22419472|NCT02257385|GlaxoSmithKline|GSK Response Center|866-435-7343||
22419473|NCT01316302|The Medical Research Network, LLC|Michael R. Liebowitz, M.D.|(212) 595-5012|MLiebowitz@MedicalResearchNetwork.com|
22419474|NCT01449370|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22419475|NCT00086281|Jazz Pharmaceuticals, Inc.|Grace Wang, MD Director Clinical Development & Medical Monitor|650-496-3777||
22419476|NCT01357148|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22419477|NCT03149757|University of Minnesota|Keith Horvath|619-594-3346|khorvath@sdsu.edu|
22419478|NCT00908310|GE Healthcare|Debra Mansfield|609-514-6329|debra.mansfield@ge.com|
22419479|NCT02391987|Mayo Clinic|Charles J. Bruce|904-953-7227|bruce.charles@mayo.edu|
22419480|NCT00351533|University of Vermont|Renee Stapleton, MD PhD|802-656-7975|renee.stapleton@uvm.edu|
22419481|NCT01885195|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22419482|NCT02803229|New York State Psychiatric Institute|Frances R Levin, MD|6467746137|frl2@cumc.columbia.edu|
22419483|NCT03390426|Duke University Medical Center|William Michael Bullock, MD, PhD|919-681-6437|william.bullock@duke.edu|
22419484|NCT00259272|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22419485|NCT01325181|Seoul National University Hospital|Jang Won Heo|82220720836|hjw68@snu.ac.kr|
22419486|NCT03301623|Cedars-Sinai Medical Center|Brennan Spiegel|310-423-6467|brennan.spiegel@cshs.org|
22419487|NCT02516553|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22419488|NCT01203020|WV Cancer Institute|Abraham Kanate|3049065228|tlr0011@hsc.wvu.edu|
22419489|NCT00315731|GlaxoSmithKline|GSK Response Center|866-435-7343||
22419490|NCT00088621|Sunovion|Josephine Cucchiaro, Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com|
22419491|NCT01680497|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22419492|NCT03862755|Shanghai Pulmonary Hospital|Dr. Lei Shen|86-21-65115006|sh_leisen@126.com|2054
22419493|NCT03462459|University of Wisconsin-Madison|Nasia Safdar, Professor|608-265-1545|ns2@medicine.wisc.edu|
22419494|NCT01177059|Janssen-Cilag Pty Ltd, Australia|Executive Director Medical & Scientific|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22419495|NCT01243775|Chonnam National University Hwasun Hospital|Dr. Young-Chul Kim|82-61-379-7614|kyc0923@jnu.ac.kr|
22419496|NCT04051619|Brown University|Carolina Haass-Koffler, PharmD, PhD (PI)|4155191385|carolina_haass-koffler@brown.edu|
22419497|NCT05938621|Vanderbilt University Medical Center|Dr. Carolyn Audet|615-343-2418|carolyn.m.audet@vanderbilt.edu|
22419498|NCT02731638|University of California, San Francisco|Dr. Jennifer Rose-Nussbaumer|+1 415 502 2666|jennifer.rose-nussbaumer@ucsf.edu|
22419499|NCT04158245|Tulane University|Brian Lewis|504-988-6300|blewis@tulane.edu|
22419500|NCT02454608|Massachusetts Eye and Ear Infirmary|Benjamin Bleier|(617) 573-6966|Benjamin_Bleier@MEEI.HARVARD.EDU|
22419501|NCT04856930|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
22419502|NCT00678210|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22419503|NCT04933383|Aquilon Pharmaceuticals SA|Clinical Operations|003242292800|clinops@aquilonpharma.com|
22419504|NCT01383707|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22419505|NCT02462291|University of Verona|Massimo Venturelli - PI|+39 02503 14648|massimo.venturelli@univr.it|
22419506|NCT03624920|Theranexus|Chief Medical Officer|+33680026779|werner.rein@theranexus.fr|
22419507|NCT01125371|Johns Hopkins University|Dr. Geetanjali Chander|443-287-2030|gchande1@jhmi.edu|
22419508|NCT02473523|St. Jude Children's Research Hospital|Kirsten Ness, PT, PhD|901-595-5157|kiri.ness@stjude.org|
22419509|NCT00866879|Northwestern University|Lorenzo Gallon, MD|3126954457|l-gallon@northwestern.edu|
22419510|NCT02111603|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
22419511|NCT00976911|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22419512|NCT02954991|Mirati Therapeutics|Clinical Operations Director|858-381-5289|LatvenL@Mirati.com|
22419513|NCT00576316|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22419514|NCT01830790|Duke University|Sharon Fekrat: Associate Professor of Ophthalmology|(919) 681-0341|Sharon.Fekrat@dm.duke.edu|
22431787|NCT03189719|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22431788|NCT03012880|Mayo Clinic|Shaji Kumar|507-284-5096|Kumar.Shaji@mayo.edu|
22431789|NCT05211596|National Center for Deaf Health Research|Steven Barnett, PhD|585-506-9484|steven_barnett@urmc.rochester.edu|
22431790|NCT02293551|Chief Medical Officer|Eli Lilly and Company|800-545-5979||
22431791|NCT04532749|Janssen Research & Development, LLC|Executive Director CDTL Neuro|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22431792|NCT05395338|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
22431793|NCT00529633|University of California, Davis|George Kaysen MD PhD, Principal Investigator|916-734-3774|gakaysen@ucdavis.edu|
22431794|NCT04096417|Mayo Clinic|Tanios Bekaii-Saab M.D.|480-342-2000|Bekaii-Saab.Tanios@mayo.edu|
22431795|NCT01897493|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22431796|NCT01658059|Hadassah Medical Organization|Moti Moskovitz||motim@ekmd.huji.ac.il|
22431797|NCT03235050|AstraZeneca|AstraZenenca Information Center|1-877-240-9479|information.center@astrazeneca.com|
22431798|NCT00370292|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22431799|NCT02704208|San Diego State University|Keith J. Horvath|619-594-3346|khorvath@sdsu.edu|
22431800|NCT03545672|Renji Hospital, Shanghai Jiaotong University School of Medicine|Dr. Meng Jiang|+86 13788912766|jiangmeng0919@163.com|
22431801|NCT02935192|Institute of Virology, Vaccines and Sera, Torlak|Katarina Ilic|+381 11 3953 700|kilic@torlak.rs|214
22431802|NCT01561833|Yale University School of Medicine|Francine Foss MD|2037375312|francine.foss@yale.edu|
22431803|NCT00492557|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22431804|NCT00372957|GlaxoSmithKline|GSK Response Center|866-435-7343||
22431805|NCT03423121|Johns Hopkins University School of Medicine|Dr. Pavan Bhargava|410-614-1522|pbharga2@jhmi.edu|
22431806|NCT04790786|UPMC|Erin McCreary|4845159589|mccrearye3@upmc.edu|
22431807|NCT04102007|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22431808|NCT05173974|HALEON|Haleon Response Center|+447880182593|ww.clinical-trial-register@haleon.com|
22431809|NCT03289143|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22431810|NCT00948688|Massachusetts General Hospital|Lawrence S. Blaszkowsky, M.D.|617-219-1230|lblaszkowsky@mgh.harvard.edu|
22431811|NCT04047446|Hospital for Special Surgery|Dr. David H. Kim|212-606-1036|kimd@hss.edu|
22431812|NCT00329420|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22431813|NCT00548886|Emory University|Dr. Peter Seth Fischbach|404-256-2593|pfischb@emory.edu|
22431814|NCT02660229|Mundipharma Korea Ltd.|Mrs Suyoun Yang/CR head|82-2-527-9219|suyoun.yang@mundipharma.co.kr|
22431815|NCT01453166|Instituto de Ensino e Pesquisa do Hospital do Coração|Dr. Otavio Berwanger|+ 55 11 30536677|oberwanger@hcor.com.br|8201
22431816|NCT02727322|University of Pittsburgh|Halina Zyczynski|421-641-1440|hzyczynski@upmc.edu|
22431817|NCT01161771|Allergan, Inc.|Vice President, Global Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22431818|NCT04136145|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22431819|NCT02649920|Centre Hospitalier Départemental Vendée|Dr. Guillaume DUCARME|02 51 44 61 61|guillaume.ducarme@ght85.fr|
22392507|NCT00755105|USDA Grand Forks Human Nutrition Research Center|Janet Hunt, PhD|701-795-8353|janetrhunt@gmail.com|
22431820|NCT00329030|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com|
22431821|NCT00560417|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22410554|NCT02402933|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22419515|NCT02552303|University of Pennsylvania|Michael Perlis|(215) 746-3577|mperlis@upenn.edu|
22419516|NCT01582152|The University of Texas (UT) MD Anderson Cancer Center|Dr. Alfred Yung, Clinical Professor, Neuro-Oncology|713-792-7734|wyung@mdanderson.org|
22419517|NCT03055624|UCSD|Andrew Picel MD|619-543-3436|apicel@stanford.edu|
22419518|NCT03834142|University of Pittsburgh|Amy Monroe|412-623-6382|monroeal@upmc.edu|
22419519|NCT02437903|Baumann Cosmetic and Research Institute|Leslie Baumann, MD|(305) 531-5788|studies@derm.net|
22410555|NCT01725815|Emory University|Dr. Benjamin Druss|404-712-9602|bdruss@emory.edu|
22410556|NCT02544633|Mirati Therapeutics, Inc.|Vanessa Tassell, Vice President, Clinical Science|858-332-3438|tassellv@mirati.com|
22410557|NCT02092961|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
22410558|NCT00124176|Children's Hospital of Philadelphia|Joseph Zorc, MD|215-590-1944|zorc@email.chop.edu|
22410559|NCT01623830|Emory University|Barbara Rothbaum|404-712-8866|brothba@emory.edu|
22410560|NCT02468557|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22410561|NCT01605461|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22410562|NCT02024698|CooperVision, Inc.|Manager Global Medical/Scientific Affairs|925-621-3761|javega@coopervision.com|
22410563|NCT03322462|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
22410564|NCT04364165|Desmond Tutu Health Foundation (DTHF)|Philip Smith|+27 21 650 1895|philip.smith@hiv-research.org.za|
22410565|NCT00325403|United Therapeutics Corporation|Kevin Laliberte; Senior Director, Product Development|919-425-8176|klaliberte@unither.com|
22410566|NCT00515073|University of Texas MD Anderson Cancer Center|Anuja Jhingran, MD / Professor, Radiation Oncology Department|713-563-6900|CR_Study_Registration@mdanderson.org|
22410567|NCT02764489|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22410568|NCT01625845|Indiana University-Purdue University Indianapolis (IUPUI)|Jesse C. Stewart, Ph.D.|(317) 274-6761|jstew@iupui.edu|
22410569|NCT02853929|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22410570|NCT01294592|GlaxoSmithKline|GSK Response Center|866-435-7343||
22410571|NCT00623623|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22410572|NCT00693784|Spinal Restoration, Inc.|Jeff F. Doerzbacher|512 225-0405|jeffdoerzbacher@spinalrestoration.com|
22410573|NCT02265952|Regeneron Pharmaceuticals, Inc.|Clinical Trial Information|844-734-6643|clinicaltrials@regeneron.com|
22410574|NCT01072032|Baltimore Veterans Affairs|Dr. Ron Goodman|410-605-7000|ronald.goodman@va.gov|
22410575|NCT00326885|Fresenius Biotech|Manager, Regulatory Affairs|781-699-4652|bao.le@fresenius-biotech.com|
22410576|NCT02144259|University of Pennsylvania|Dr. Courtney Schreiber|215-615-5234|courtney.schreiber@uphs.upenn.edu|
22410577|NCT04895618|Regulatory Insight, Inc.|Elvira Cawthon|Results Point of Contact Name|elvira@reginsight.com|
22410578|NCT01759381|Duke|Carlos A. Bagley|919-943-1564|carlos.bagley@gmail.com|
22410579|NCT01464359|University of Minnesota, Pediatrics Blood and Marrow Transplant|Michael R Verneris|612-626-2961|verneris@umn.edu|
22410580|NCT00738673|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22410581|NCT02736227|Northwestern University|Josh Levitsky|312-695-4413|j-levitsky@northwestern.edu|
22410582|NCT00068237|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
22410583|NCT05288673|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|8557522356|clinicaltrials@alexion.com|
22419520|NCT02237092|Tver Regional Perinatal Center|Dr. Alexandr Ronenson|011-7-4822-776213|ronensonam@gmail.com|
22419521|NCT03545893|University of Pennsylvania|Arden McAllister, Research Program Manager|215-662-3532|arden.mcallister@pennmedicine.upenn.edu|
22419522|NCT00799825|GlaxoSmithKline|GSK Response Center|866-435-7343||
22419523|NCT00362336|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22419524|NCT02289456|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@celgene.com|
22419525|NCT01625988|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22419526|NCT02681510|Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|6082627563|sss@ctri.wisc.edu|
22419527|NCT01783912|Center for Tobacco Research and Intervention|Bruce Christiansen|608-262-4087|bc1@ctri.wisc.edu|
22419528|NCT00637494|Corcept Therapeutics|Thaddeus S. Block, MD|(650) 688-8816|tblock@corcept.com|
22419529|NCT01297985|Center on Mental Health Services Research and Policy, University of Illinois at Chicago, Department of Psychiatry|Dr. Judith A. Cook, Director|312-355-3921|jcook@uic.edu|
22419530|NCT00377832|Weill Cornell Medical College|Daniel W. Skupski, MD|718-670-1495|dwskupsk@med.cornell.edu|
22419531|NCT00134901|New York State Psychiatric Institute|Dr Adam Bisaga|(646) 774-6155|bisagaa@nyspi.columbia.edu|
22419532|NCT04841577|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22419533|NCT03287843|Ege University Hospital|Erhan Akgun,MD, Proffessor|+902323905050|z.erhan.akgun@ege.edu.tr|
22419534|NCT01004003|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22419535|NCT02064985|Pharmaceutical Product Development, LLC.|Rong Fu|86-021-80135112|rong.fu@ppdi.com|
22419536|NCT01589497|ACTG Network Coordinating Center, Social & Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22419537|NCT02593682|University of California, San Francisco|Dr. Andrew Goddard|(317) 274-3960|agoddard@fresno.ucsf.edu|
22419538|NCT02906241|Wayne State University/Karmanos Cancer Institute|Susan Eggly, PhD|313-576-8260|egglys@karmanos.org|
22419539|NCT04123561|Taiwan Liposome Company|Dr. Tien-Tzu Tai|+886 2 2655 7377|tttai@tlcbio.com|801
22419540|NCT02091466|Faculdade de Ciências Médicas da Santa Casa de São Paulo|Dr. Ricardo Caio Gracco De Bernardis|55-11-21767280|rcaiog@yahoo.com.br|
22419541|NCT00676780|LSUShreveport|Dr. Jerry W. McLarty, Ph.D.|(318)813-1446|jmclar@lsuhsc.edu|
22419542|NCT01613313|GerutZ|Dr. Zachary E.Gerut|516 295-2100|Drgerut@drgerut.com|
22419543|NCT01653912|Novartis Pharma AG|Study Director|+41 613241111||
22419544|NCT00708227|Nemours Children's Specialty Care|Kathryn Blake|9046973806|kathryn.blake@nemours.org|
22419545|NCT04007991|Emalex Biosciences, Inc.|Clinical contact|7150562|dkim@emalexbiosciences.com|1847
22419546|NCT01987479|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22419547|NCT03764618|Rigel Pharmaceuticals, Inc.|Executive Director, Global Clinical Operations|(650) 624-1100|clinicaltrials@rigel.com|
22419548|NCT03654599|Arizona State University|Dr. Sunny Kim|602-496-6789|Sunny.Kim@asu.edu|
22419549|NCT03739645|Johns Hopkins University|Fred Lenz|443.287.1609|flenz1@jhmi.edu|
22419550|NCT01290302|Luitpold Pharmaceutical, Inc|Marsha Simon|631-772-3507|msimon@lpicrd.com|61807
22419551|NCT04514679|Dartmouth Geisel School of Medicine|Tor D. Tosteson, ScD|603 646-5274|tor.d.tosteson@dartmouth.edu|
22419552|NCT03816878|Johns Hopkins University Center for Immunization Research|Kawsar Talaat|410-336-9164|ktalaat1@jhu.edu|
22419553|NCT03355469|Rutgers University|Dr. Steven Malin|848-932-705|steven.malin@rutgers.edu|
22419554|NCT02291510|Elcelyx Therapeutics, Inc|Senior Director, Development|858-876-1814|info@elcelyx.com|
22419555|NCT05612685|UCLA|Kristen Choi, Associate Professor|3107947493|krchoi@ucla.edu|
22419556|NCT03659929|Azurity Pharmaceuticals, Inc.|Vice President of Clinical Development|1-800-461-7449|david.sequeira@azurity.com|
22419557|NCT00916643|B. Braun Medical, Inc.|Kevin Minnich|610 596 2358|kevin.minnich@bbraun.com|
22419558|NCT04825912|Duke University|Katherine Ramos, Ph.D.|919-416-3434|Katherine.Ramos@duke.edu|
22419559|NCT01216735|University of Miami|Adam Wanner, MD|(305) 243-2568|awanner@med.miami.edu|
22419560|NCT01009814|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22419561|NCT01173120|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22419562|NCT00180661|Imperial College London|Professor Fan Chung|00442075947954|f.chung@imperial.ac.uk|
22419563|NCT02923232|Pacific University|Dr. Shun-nan Yang|5033522852|shunnan.yang@pacificu.edu|
22419564|NCT01977417|University of Iowa|Gary Pierce, PhD|319-335-9487|gary-pierce@uiowa.edu|
22419565|NCT02906358|The University of Texas Health Science Center at San Antonio|Barbara J Turner|210-562-5551|turner@uthscsa.edu|
22419566|NCT02699684|Alcon, A Novartis Division|Sr. Global Brand Medical Affairs Lead, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
22419567|NCT03112642|RutgersSUNJ|William R Grubb MD|7327426528|wrgrubb@aol.com|
22419568|NCT00616421|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@Novartis.com|
22419569|NCT01495702|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22419570|NCT04152863|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22419571|NCT00919126|University Hospital Schleswig-Holstein|Prof. Dr. Med Berthold BEIN|+49(0)431-5973 739|bein@anasthesie.uni-kiel.de|
22419572|NCT01644617|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22431822|NCT00320606|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsgov@niaid.nih.gov|
22392508|NCT03995316|Oregon Research Behavior Intervention Strategies, Inc. dba Influents Innovations|David Smith|541-484-2123|david.smith@influetnsin.com|
22392509|NCT02202785|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22392510|NCT02985840|OhioHealth Research Institutute|Chelsea Blessing, PhD|(513) 461-1772|chelsea.blessing@ohiohealth.com|
22392511|NCT03398902|Rory Meyers College of Nursing, New York University|Dr. Susan Malone|212-992-7047|sm7760@nyu.edu|
22392512|NCT01229878|VA Providence Healthcare System|Kel Morin|347-346-0380|kel.morin@va.gov|
22392513|NCT03945825|University of Iowa Carver College of Medicine|Patricia Winokur, MD|319-384-1735|patricia-winokur@uiowa.edu|
22392514|NCT02138097|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22392515|NCT00664534|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22392516|NCT00600613|Memorial Sloan Kettering Cancer Center|Dr. Yoshiya Yamada|212-639-2950|yamadaj@mskcc.org|
22419573|NCT02032680|VA, University of Pittsburgh|Dr. Armando Rotondi|412-360-2494|ArmandoRotondi1@gmail.com|
22419574|NCT03086486|TB Alliance|Morounfolu Olugbosi|1 212 227 7540|morounfolu.olugbosi@tballiance.org|
22419575|NCT03593395|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
22419576|NCT00741338|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22419577|NCT03713632|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22419578|NCT00719615|University of Nebraska Medical Center|Whitney S Goldner, MD|402-559-6205|wgoldner@unmc.edu|
22419579|NCT01524978|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22419580|NCT02995408|Massachusetts General Hospital|Karen Kuhlthau, PhD Researcher|6177242842|kkuhlthau@partners.org|
22419581|NCT04237272|Medical University of South Carolina|Dr. Tracy Smith|843 792 5164|smithtra@musc.edu|
22419582|NCT05445492|Analog Devices, Inc.|Emily Wycallis|9784351644|emily.wycallis@analog.com|
22419583|NCT03474874|NeXtGen Biologics Inc|Dayna Healy|352-215-9961|Dhealy@nextgenbiologics.com|
22419584|NCT04289363|NYU Langone Health|Ryan McCormack|2122632862|Ryan.McCormack@nyulangone.org|
22419585|NCT03790657|Malcom Randall VA Medical Center|David Clark|3523761611|david.clark1@va.gov|105244
22419586|NCT03126435|SynCore Biotechnology Co., Ltd.|Albert Lin, Ph.D./Special Assistant to GM|+886-2-2760-3688|JWLin@syncorebio.com|2308
22419587|NCT01375946|Agile Therapeutics|Joseph Chiodo III, Senior Medical Director|609-683-1880|jachiodo@agiletherapeutics.com|
22419588|NCT02370238|Dompé Farmaceutici SpA|Dr Pier Adelchi Ruffini, MD|+39 02 583831|info@dompe.it|
22419589|NCT01937871|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22419590|NCT02652949|Medtronic|Rianna Rapson - Clinical Study Manager|763-526-2170|rianna.k.rapson@medtronic.com|
22419591|NCT01973595|University of Florida|Dr. Bobbi Langkamp- Henken|352-392-1991|henken@ufl.edu|205
22419592|NCT01141205|Statens Serum Institut|Dr Anders Fomsgaard|+45-32683460|afo@ssi.dk|
22419593|NCT04052334|Moffitt Cancer Center|John E. Mullinax, MD, FACS|813-745-4673|John.Mullinax@moffitt.org|
22419594|NCT05831774|Houston Methodist Hospital|Haley Goble|713-441-3930|hmgoble@houstonmethodist.org|
22419595|NCT03985852|University of Utah|Dr. Kimberly Kaphingst|801-213-5724|kim.kaphingst@hci.utah.edu|
22419596|NCT03837743|DURECT Corporation|Executive Director of Regulatory Affairs|408-777-1829|jill.burns@durect.com|
22419597|NCT05199090|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22419598|NCT04868968|Novartis Pharmaceuticals|Study Director|+1 862-778-8300|novartis.email@novartis.com|
22419599|NCT00767624|STANFORD UNIVERSITY|Rachel Manber, PhD|6504981266|rmanber@stanford.edu|
22419600|NCT00384930|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22419601|NCT03431493|Johns Hopkins University|Ann Parker, MD, PhD|443-287-2616|aparke36@jhu.edu|
22419602|NCT02686138|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
22419603|NCT01547130|Wyckoff Heights Medical Center|Dr Vijaypal Arya|718-326-0400|varyamd@yahoo.com|
22419604|NCT01685840|Duke University Health System|G. Michael Felker, M.D.|919-668-8919|michael.felker@duke.edu|
22419605|NCT00710866|British Columbia Centre for Disease Control|Danuta M Skowronski, MD|604-660-6067|danuta.skowronski@bccdc.ca|
22419606|NCT03423186|Swedish Orphan Biovitrum AB|Anders Bröijersén, Medical Director|+46 8 697 20 00|anders.broijersen@sobi.com|
22419607|NCT00706589|Kiho Moon|Medical Director|+82-2-3287-9009|khmoon@otsuka.co.kr|
22419608|NCT01252277|University of Kansas Medical Center|Carol J. Fabian, M.D.|913-588-7791|cfabian@kumc.edu|
22419609|NCT04487067|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22419610|NCT04324021|Swedish Orphan Biovitrum|Henrick Andersson, Director of Statistical Science|+46760011816|henrik.andersson@sobi.com|
22419611|NCT00246324|LSU Health Sciences Center in Shreveport Department of Neurology|Alireza Minagar, MD|318-813-1481|aminag@lsuhsc.edu|
22419612|NCT00299130|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22419613|NCT02881840|Acacia Pharma Ltd|Dr Gabriel Fox|+44-(0)1223-919764|GabrielFox@acaciapharma.com|
22419614|NCT01098487|GlaxoSmithKline|GSK Response Center|866-435-7343||
22419615|NCT00345631|Cordis Corporation, a Johnson&Johnson company|Hans-Peter Stoll, M.D.|908-541-4770|hpstoll@its.jnj.com|
22419616|NCT00517556|The Milton S. Hershey Medical Center|Richard S. Legro, M.D.|717-531-6210|rsl1@psu.edu|
22419617|NCT02520297|Trevena, Inc.|Kelly Arscott|6103548840|karscott@trevena.com|
22419618|NCT01326923|LSU Health Shreveport|J.K. Miller|318 8131406|jmil12@lsuhsc.edu|
22419619|NCT03371459|Pearl Therapeutics, Inc, a Member of the AstraZeneca Group|Colin Reisner, MD FCCP, FAAAAI|9739750321|Colin.Reisner@astrazeneca.com|
22419620|NCT01906515|Cairo University School Of Medicine|Dr Wael N Awada|00201006481958|waoool@hotmail.com|
22419621|NCT01374269|Grupo Rehabilitacion en Salud|Dr. Fabio Salinas Duran|5742196475|fabios@une.net.co|
22419622|NCT04559347|The Guthrie Clinic|Poovendran Saththasivam MD|5708874882|Poovendran.Saththasivam@guthrie.org|
22419623|NCT00615199|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22419624|NCT00459355|Bedford VA Medical Center|Dr. Kathy Horvath|781-687-2006|Kathy.Horvath@va.gov|
22419625|NCT01808547|InSite Vision|Senior Manager, Clinical Sciences||manjiri.desai@sparcmail.com|
22419626|NCT00618371|University of Pittsburgh|Deborah McMahon|412-383-1675|mcmahond@pitt.edu|
22419627|NCT02969382|Sunovion Pharmaceuticals, Inc.|CNS Medical Director|1-866-503-6351|CLINICALTRIALDISCLOSURE@SUNOVION.COM|
22419628|NCT02037425|Clinvest/A Division of Banyan Group Inc.|Dr. Roger Cay, M.D.|417-883-7889|rcady@banyangroupinc.com|
22419629|NCT03870880|Laboratorios Farmacéuticos Rovi, S.A.|Director of Medical Department|91 375 62 30|departamento.medico@rovi.es|
22419630|NCT00886015|JohnHopkins U|Sheila West|410-955-2606|shwest@jhmi.edu|
22419631|NCT02013817|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22419632|NCT01145508|ECOG Statistical Office|Study Statistician|617-632-3012||
22419633|NCT01611857|Sarah Cannon Research Institute|Charles H. Davis|615-524-4341|charles.davis2@scri-innovations.com|
22419634|NCT03971474|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
22419635|NCT01103492|University Hospitals Case Medical Center|Jeffrey Marks, MD|216-983-4930|Jeffrey.Marks@uhhospitals.org|
22419636|NCT01023035|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22419637|NCT01807065|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22419638|NCT03450473|Washington University School of Medicine in St. Louis|Dr. Grant Bochicchio|314-362-9347|gbochicchio@wustl.edu|
22419639|NCT01482312|Alcon Research|Director of Alcon Clinical|1-800-241-7629||
22419640|NCT01699815|Duke University School of Nursing|Virginia C. Muckler|919-684-9307|chris.muckler@duke.edu|
22419641|NCT01295320|GlaxoSmithKline|GSK Response Center|866-435-7343||
22419642|NCT00462904|University of Texas Southwestern Medical Center|Joseph Minei|214-648-3917|joseph.minei@utsouthwestern.edu|
22419643|NCT02664181|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Nathan Pennell|1-866-223-8100|TaussigResearch@ccf.org|
22419644|NCT00699816|Seoul National University College of Medicine|Jung-Hwan Yoon, MD, PhD|+82-2-2072-2228|yoonjh@snu.ac.kr|
22419645|NCT00560391|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22419646|NCT03668808|Sansum Diabetes Research Institute|Wendy C Bevier|8056827638|wbevier@sansum.org|207
22419647|NCT00280735|UNC Lineberger Comprehensive Cancer|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22419648|NCT01895777|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|8002430127|clintriage.rdg@boehringer-ingelheim.com|
22419649|NCT00955929|Memorial Sloan Kettering Cancer Center|John Mulhall, MD|646-888-6024|mulhalj1@mskcc.org|
22419650|NCT02526667|Evic Romania|Dr. Olsavszky|40 21 335 70 90|research@evic.ro|
22419651|NCT03606343|Cincinnati Children's Hospital Medical Center|Leanne Tamm, Principal Investigator|513-803-3176|leanne.tamm@cchmc.org|
22419652|NCT02481206|Zoll|Director of Clinical Affairs|724-968-3333|mosz@zoll.com|
22419653|NCT02125877|Novartis|Study Director|862-778-8300||
22419654|NCT04223752|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22419655|NCT01822366|University of Washington|Dr. Shannon Dorsey|(206) 543-4527|dorsey2@uw.edu|
22419656|NCT03489109|Clinical Center|Hadigan, Colleen|+1 301 594 5754|hadiganc@nih.gov|
22419657|NCT02552732|Fisher and Paykel Healthcare|Dr Stanislav Tatkov|09 5740100|stanislav.tatkov@fphcare.co.nz|
22419658|NCT05061420|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
22419659|NCT01178216|Cedars-Sinai Medical Center|Noriko Ammerman, PharmD|3102488186|noriko.ammerman@cshs.org|
22419660|NCT00025259|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22419661|NCT01406444|Massachusetts General Hospital|Dr. Karen Klahr Miller|6177263870|kkmiller@mgh.harvard.org|
22419662|NCT00794508|University of California Los Angeles|Dr. Donald B. Kohn|310-794-1964|dkohn1@mednet.ucla.edu|
22419663|NCT03138655|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22419664|NCT02027428|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22419665|NCT01128543|GlaxoSmithKline|GSK Response Center|866-435-7343||
22419666|NCT01307748|Oregon Health & Science University|Irina Chamine|503.577.6211|fonareva@ohsu.edu|
22419667|NCT03340974|Galera Therapeutics|Judy Schnyder, Sr. Vice President Clinical Operations and Data Management|484-870-9625|jschnyder@galeratx.com|
22419668|NCT04642404|University of Texas Health Science Center at San Antonio|Vanessa Chrepa, DDS|210-459-3601|vanessa.chrepa@rutgers.edu|
22419669|NCT03473015|Oxford Heart Centre, Oxford University Hospitals, Oxford, United Kingdom|Professor Adrian Banning|1865 228934|adrian.banning@ouh.nhs.uk|+44
22419670|NCT01669603|University of Virginia|Ronald Turner||rbt2n@virginia.edu|
22419671|NCT00537511|Celgene|Associate Director, Clinical Trial Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22419672|NCT03010683|2nd Cardiology Department, National and Kapodistrian University of Athens, Attikon Hospital|Dr Ignatios Ikonomidis|+30 6944805732|ignoik@gmail.com|
22419673|NCT00396565|Janssen Pharmaceutical K.K.|Director of Clinical R&D Dept. 3|81-3-4411-5652||10118
22419674|NCT04877457|Yale University|Erin Longbrake, MD|203-287-6100|erin.longbrake@yale.edu|
22419675|NCT02211417|Dignity Sciences Ltd|Study Director|+353 1 2933590|dsbiopharma.regulatory@dsbiopharma.com|
22419676|NCT01198132|Merck KGaA|Title: Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22419677|NCT04697069|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
22419678|NCT05180227|James J Peters VA Medical Center|Dr. Jill Maria Wecht|(718) 584-9000|JM.Wecht@va.gov|3122
22419679|NCT02924727|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22419680|NCT02185053|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22419681|NCT01462812|OptiNose|Sr. Director of Clinical Development|(267) 364-3620|jennifer.carothers@optinose.com|
22419682|NCT02521376|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22419683|NCT00338728|UT MD Anderson Cancer Center|Dr. Arun,Banu,M.D. / Breast Medical Oncology|713-792-2817|barun@mdanderson.org|
22431823|NCT04358406|BioAegis Therapeutics Inc.|Mark J. DiNubile, MD|609-706-5866|mdinubile@bioaegistx.com|
22431824|NCT01948427|Horizon Therapeutics, LLC|Horizon Therapeutics, LLC|866-479-6742|clinicaltrials@horizontherapeutics.com|
22431825|NCT00256126|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22431826|NCT02434081|European Thoracic Oncology Platform (ETOP)|Heidi Roschitzki-Voser|+41 31 511 94 18|NICOLAS@etop-eu.org|
22431827|NCT02250417|The Ohio State University|Ulysses J. Magalang|614-292-6563|magalang.1@osu.edu|
22431828|NCT01999192|Biotest AG|Xuefei Zhou Manager Strategy & Development|+496103801|xuefei_zhou@biotest.de|1229
22431829|NCT00854360|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22431830|NCT02037529|Mayo Clinic|Minetta Liu|5072930526|Liu.Minetta@mayo.edu|
22431831|NCT00718315|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22392517|NCT02623998|McMaster University|Dr. Natalia McInnes|19055212100|natalia.mcinnes@mcmaster.ca|73794
22392518|NCT03041792|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22392519|NCT00935532|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22392520|NCT04041037|Integra LifeSciences|Allison Matthews|443-766-3869|allison.matthews@integralife.com|
22392521|NCT01399918|Memorial Sloan Kettering Cancer Center|Dr. Darren Feldman|646-888-4740|Feldmand@MSKCC.ORG|
22392522|NCT00245960|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22392523|NCT01436253|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22392524|NCT03083665|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22392525|NCT02519348|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22392526|NCT03635099|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22392527|NCT01289210|VentiRx Pharmaceuticals Inc.|Kristi Manjarrez, Vice President, Clinical Affairs|206-689-2259|kmanjarrez@ventirx.com|
22392528|NCT06285240|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22392529|NCT05380362|UBNS|Dr. Ellen Carl|716-218-1000|ecarl@ubns.com|7260
22392530|NCT04844879|Medacta International SA|Medical Affairs Department|+41 91 696 60 60|myclinicaldata@medacta.ch|
22392531|NCT05985538|University of North Carolina at Chapel Hill|Dr. Seth M. Noar|9192607269|noar@unc.edu|
22392532|NCT04363957|University of California, San Diego|Dr. Jyoti Mayadev|(858) 822-5354|CancerCTO@health.ucsd.edu|
22392533|NCT06534671|Vanderbilt University Medical Center|Prince J. Kannankeril, MD, MSCI|(615) 322-7447|prince.kannankeril@vumc.org|
22392534|NCT04103892|Clexio Biosciences Ltd|Regulatory Affairs Lead|972-733318704|myriam.belahcen@clexio.com|
22392535|NCT05576662|Stanford University|Linda N. Geng, MD, PhD|650-723-4000|geng@stanford.edu|
22392536|NCT00281320|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22392537|NCT00921947|VaxInnate|Dr. David N.Taylor|609-860-2260|david.taylor@vaxinnate.com|
22392538|NCT01647945|Stanford University|Dr. Edda Spiekerkoetter|650-724-1493|eddas@stanford.edu|
22392539|NCT03008005|Wayne State University|Dr. Christine Rabinak, Principal Investigator|(313) 577-9875|rabinak@wayne.edu|
22392540|NCT05292586|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
22392541|NCT00475228|University o Pittsburgh|Heather Hohmann, MD|412-641-1441|hhohmann@mail.magee.edu|
22392542|NCT01744704|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22392543|NCT02367040|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22392544|NCT02477618|Sage Therapeutics|Helen Colquhoun, MD - Vice President, Medical Science|(617) 229-5234|Helen@sagerx.com|
22392545|NCT05855967|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22392546|NCT02446821|Sebela Women's Health Inc.|Elizabeth Gray, Manager, Clinical Operations|760-593-8383|elizabeth.gray@sebelapharma.com|
22392547|NCT02603328|University of Chicago, Medicine and Biological Sciences Division|Agnieszka Stadnik|773-702-8996|astadnik@bsd.uchicago.edu|
22392548|NCT07025837|Citruslabs|Patrick Renner|4242450285|hello@citruslabs.com|
22392549|NCT05899413|University of California, San Francisco|Dr. Yoobin Park|6289461325|yoobin.park@ucsf.edu|
22392550|NCT01555489|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Daniel Monti|215 955-2221|daniel.monti@jefferson.edu|
22392551|NCT07149155|Dell Medical School, The University of Texas at Austin|Project Coordinator|NA|SFA@austin.utexas.edu|
22419684|NCT03859765|Duke University|Sarah A Kelleher, PhD|919-416-3405|sarah.kelleher@duke.edu|
22419685|NCT00340678|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Dr. Robert Nelson|(602) 200-5205|rnelson@phx.niddk.nih.gov|
22419686|NCT04803305|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22419687|NCT00754546|Dartmouth-Hitchcock Medical Center|Donald A. Mahler, M.D.|603 650-5533|Donald.a.mahler@hitchcock.org|
22419688|NCT01862484|The University of Texas Health Science Center at San Antonio|Steven R. Pliszka MD|210-567-0136|pliszka@uthscsa.edu|
22419689|NCT00996892|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22419690|NCT00993421|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22419691|NCT02759692|Johnson & Johnson Vision Care Inc.|Brian Pall, OD, MS, FAAO|904 443-1290|BPALL@its.jnj.com|
22419692|NCT03245827|Saint Louis University|Sandeep Dhindsa|716-977-4911|sandeep.dhindsa@health.slu.edu|
22419693|NCT00553735|Massachusetts Eye and Ear Infirmary|Reza Dana, MD, MPH, MSc|617-573-3313|Cornea_Research@MEEI.Harvard.edu|
22419694|NCT01954745|Massachusetts General Hospital Cancer Center|Dr. Lipika Goyal|617-724-4000|Lgoyal@partners.org|
22419695|NCT05314816|Medical College of Wisconsin|Dr. Kelly Graff|414-266-4123|kegraff@mcw.edu|
22419696|NCT04042376|Janssen Research & Development, LLC|Executive Medical Director Onc|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22419697|NCT02551666|Virginia Tech|Professor Michael L. Madigan, PhD|540-231-3543|mlm@vt.edu|
22419698|NCT05422625|William Beaumont University Hospital|Jennifer Giordano RN BSN/ Clinical Research Manager|248-551-3517|Jennifer.Giordano@corewellhealth.org|
22419699|NCT01433055|Maryland Psychiatric Research Center|Deanna L. Kelly, Pharm.D., BCPP|410-402-6861|dkelly@mprc.umaryland.edu|
22419700|NCT04721808|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22419701|NCT01728844|Sunstar Americas, Inc.|Akane Takemura|8477944276|akane.takemura@us.sunstar.com|
22419702|NCT00733005|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22419703|NCT01769456|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
22419704|NCT01068548|VANTHCS|Eric Mortensen, MD|214-857-1588|ericm.mortensen@va.gov|
22419705|NCT02185339|Department of Anesthesiology and Pain Medicine, The Catholic University of Korea College of Medicine, Seoul St. Mary's Hospital|Dr. Sanghyun Hong|82-2-2258-2236|shhong7272@gmail.com|
22419706|NCT01602068|Eyegate Pharmaceuticals, Inc.|Lisa Brandano|781-398-3806|lbrandano@eyegatepharma.com|
22419707|NCT05244122|BrighamHospital|Jeremy Wolfe, Principle Investigator|617-851-1166|jwolfe@bwh.harvard.edu|
22419708|NCT00599248|TissueGene, Inc|R. Ogden Copeland|(301) 921-6000|ocopeland@tissuegene.com|122
22419709|NCT02653625|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22419710|NCT03860974|University of California, San Diego|Brian Ilfeld|8582493660|bilfeld@health.ucsd.edu|
22419711|NCT03965689|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
22419712|NCT05377749|University of North Carolina Lineberger Comprehensive Cancer Center|Zev Nakamura, MD|(984) 974-3829|zev_nakamura@med.unc.edu|
22419713|NCT00478062|Johns Hopkins Sidney Kimmel Cancer Center|Yvette Kasamon|4109135018|ykasamon@jhmi.edu|
22419714|NCT02090725|Dartmouth-Hitchcock|Jeffrey A. Cohen, MD|603-650-4211|jeffrey.a.cohen@hitchcock.org|
22419715|NCT00764881|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22419716|NCT01214655|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22419717|NCT00221338|University of California San Francisco|Clinical Research Coordinator|4154769489|Christopher.Tang2@ucsf.edu|
22419718|NCT05256134|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22419719|NCT01692626|West Virginia University|Mohammed Almubarak, MD, Assistant Professor|304-293-4229|malmubarak@hsc.wvu.edu|
22419720|NCT00855894|Genentech, Inc.|Medical Communications|800 821-8590||
22419721|NCT05992623|Inova Schar Heart and Vascular|Brett D. Atwater MD|9192390127|brett.atwater@inova.org|
22392552|NCT04683627|Noven Pharmaceutical|Robert Kirshoff|5512332668|clinicaltrials@noven.com|
22419722|NCT03395288|Washington University|Jerry Lowder, MD|314-362-0063|lowderj@wustl.edu|
22419723|NCT01983566|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22419724|NCT02753920|Northwell Health|Marjorie Pilkinton|5166225114|mlpilk@gmail.com|
22419725|NCT03437031|Cedars Sinai|Melissa Wong, MD MHDS|310-423-0895|wongmsx@cshs.org|
22419726|NCT00181714|Massachusetts General Hospital|Paul Hammerness, MD|617-503-1063|phammerness@partners.org|
22419727|NCT01434810|Minnesota Medical Research Foundation and University of Minnesota|Tina M. Slusher|612-624-4586|tslusher@umn.edu|
22419728|NCT04036838|ARJ Medical, Inc.|President|813-855-1557|info@gulfcoastscientific.com|
22419729|NCT02794870|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22419730|NCT00979199|CNR Institute of Clinical Physiology, Pisa, Italy and Fondazione Toscana G. Monasterio, Pisa, Italy|Dr. Danilo Neglia|+390503152019|dneglia@ifc.cnr.it|2019
22419731|NCT02229474|Northumbria Healthcare NHS Foundation Trust|Professor Richard Walker|+441912932709|richard.walker@nhct.nhs.uk|
22419732|NCT06376682|quantum surgical|MESSNER Laetitia, Chief Clinical officer|+33 (0) 4 48 19 40 50|clinical.department@quantumsurgical.com|
22419733|NCT02439970|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
22419734|NCT01121562|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22419735|NCT05560386|Icahn School of Medicine at Mount Sinai|Nita Vangeepuram|917-478-2106|nita.vangeepuram@mssm.edu|
22419736|NCT02540083|GE Healthcare|Sara Lam|1-262-548-2369|Sara.J.Lam@ge.com|
22419737|NCT00185588|Stanford University|George Albert Fisher, Associate Professor of Medicine, Stanford University|650-725-9057|georgeaf@stanford.edu|
22419738|NCT00398866|Hospital for Special Surgery|Dr. Lisa Mandl|2127742754|MandlL@hss.edu|
22419739|NCT03001453|American Hip Institute|Dr. Benjamin Domb|630-455-7130|drdomb@americanhipinstitute.org|
22419740|NCT03277066|Noven Pharmaceuticals, Inc.|Gunnar Klauss, MD|1-551-233-2656|gklauss@noven.com|
22419741|NCT01565356|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22419742|NCT02839772|University of Hull|Jill Brooks. PhD student,|01491 839044|jb284@btinternet.com|
22419743|NCT01569295|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|ClinicalTrialDisclosures@gilead.com|
22419744|NCT02064296|University of Michigan|Richard Harris|734-998-6996|reharris@med.umich.edu|
22419745|NCT00972374|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22419746|NCT04149821|Weill Cornell Medicine|Dr. John Allan, Associate Professor of Medicine|2127463481|joa9069@med.cornell.edu|
22419747|NCT01814553|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22419748|NCT03151304|Helsinn Healthcare|Francesco Scarci, Clinical Operations Manager|+41 (0)91 985 2121|francesco.scarci@helsinn.com|
22419749|NCT00337181|Thai Ministry of Public Health|Supachai Rerks-Ngarm|6629659571|supachai@health.moph.go.th|
22419750|NCT02495623|Synthetic Biologics Inc|Michael Kaleko|(240) 238-3862|mkaleko@syntheticbiologics.com|
22419751|NCT04759768|Opiant Pharmaceuticals|Clinical Director|18043791090|PatientSafetyNA@Indivior.com|
22419752|NCT02996487|Beaumont Hospitals|Maureen Cooney|248 551-0099|maureen.cooney@corewellhealth.org|
22419753|NCT02800642|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22419754|NCT02859142|University of Chicago|Andrea King, Ph.D.|7737026181|aking@yoda.bsd.uchicago.edu|
22419755|NCT02374346|Attikon Hospital|P. Matsota|00302105831000|matsota@yahoo.gr|
22419756|NCT05299528|Vanderbilt University Medical Center|Daniel Larach, MD|(615) 322-6033|daniel.larach@vumc.org|
22419757|NCT00490841|Abbott Vascular|Ellen Travis|408-845-1512|Ellen.Travis@av.abbott.com|
22419758|NCT01277211|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22419759|NCT02252354|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22419760|NCT01107197|"Department of Clinical Nutrition and Dietetics, Azienda Ospedaliera Maggiore della Carità"|Dr. Federico D'Andrea|+39 0321.373.3275|dietologia@maggioreosp.novara.it|
22419761|NCT03516513|University of Washington|Michael Pullmann|6158304563|pullmann@uw.edu|
22419762|NCT01061476|Johns Hopkins University|Dr. Susheel Patil|410-550-0574|spatil@jhmi.edu|
22419763|NCT01301729|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22419764|NCT03071276|St. Jude Children's Research Hospital|Jeffrey E. Rubnitz, MD, PhD|901-595-2388|jeffrey.rubnitz@stjude.org|
22419765|NCT00447993|Neurotech Pharmaceuticals, LLC|CMO|401-333-3880|neurotech@neurotechusa.com|
22419766|NCT04614246|Bayer AG|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22419767|NCT00207883|Children's Healthcare of Atlanta / Emory University|Jana Stockwell, MD|404-785-1600|jana.stockwell@choa.org|
22419768|NCT03006302|SKCCC Johns Hopkins Medical Institution|Dung Le, MD|443-287-0002|Dle@jhmi.edu|
22419769|NCT03532373|Stanford University|Robin Kamal|650-721-7629|rnkamal@stanford.edu|
22419770|NCT04380961|Janssen Research & Development, LLC|Director 1 Study Responsible Physician|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22419771|NCT04140032|UCLA Fielding School of Public Health|Dr. Burt Cowgill|310-794-3569|bcowgill@ucla.edu|
22419772|NCT01059786|National Cancer Institute|Dr. Robert J. Kreitman|301-480-6187|kreitmar@mail.nih.gov|
22419773|NCT04205812|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22419774|NCT00371033|University of Pennsylvania|J. Richard Landis, PhD|215-573-4922|hultman@upenn.edu|
22419775|NCT02514447|G1 Therapeutics, Inc.|Clinical Trial Info.|919-213-9835|clinicalinfo@g1therapeutics.com|
22419776|NCT05351164|University of Michigan|Elif Oral|734-615-7271|eliforal@med.umich.edu|
22419777|NCT02905240|Zimmer Biomet|Jennifer Woodell-May, Research Associate Director|5742651885|jennifer.woodell-may@zimmerbiomet.com|
22419778|NCT05789576|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
22419779|NCT03130777|Edwards Lifesciences|Director of Research|949-250-2500|THV_CT.gov@edwards.com|
22419780|NCT03367572|University of Rochester Medical Center|Luke J. Peppone, PhD, MPH|585-275-7827|Luke_Peppone@urmc.rochester.edu|
22419781|NCT05929651|Sanofi Pasteur|Trial Transparency Team|800-633-1610 ext: 6#|Contact-US@sanofi.com|
22419782|NCT05026177|Cassava Sciences, Inc.|Study Director|737-910-1045|ClinicalTrials.gov@cassavasciences.com|
22419783|NCT06831760|Adichunchanagiri Institute of Medical Sciences|Dr Naveen N|+91-9980023372|naveen_uno1@yahoo.co.in|
22419784|NCT05109611|SaNOtize R&D Corp|Chief Science Officer|778-899-0607|chris@sanotize.com|
22419785|NCT05064384|Boston Scientific|Karen Noblett, MD, Chief Medical Officer|559-250-8082|karen.noblett@bsci.com|
22419786|NCT01887171|Republican scientific and practical center for organ and tissue transplantation|Aliaksej Shcherba|+375293330689|aleina@tut.by|
22419787|NCT03203850|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22419788|NCT02717455|St. Jude Children's Research Hospital|Dr. Arzu Onar-Thomas|901-595-5499|arzu.onar@stjude.org|
22419789|NCT01608061|Functional Neuromodulation|Todd Langevin|7636071214|todd@fxneuromod.com|
22419790|NCT02301390|Icahn School of Medicine at Mount Sinai|Betsy Ellsworth, Research Program Director|212-824-8902|betsy.ellsworth@mountsinai.org|
22419791|NCT02268877|Denver Health and Hospital Authority|Dr. John Kendall|(303)602-5187|John.Kendall@dhha.org|
22419792|NCT02481869|University of Missouri|Dr. James Cook|5738827615|cookjl@health.missouri.edu|
22419793|NCT02292940|Northern California Kaiser Permanente, Division of Research|Mary Reed, DrPH|510-891-3808|Mary.E.Reed@kp.org|
22419794|NCT01153425|University of Pennsylvania, Perelman School of Medicine|Felix W. Wehrli, Ph.D.|215-662-7951|wehrli@mail.med.upenn.edu|
22419795|NCT03154125|FHI 360|Vera Halpern, M.D., Director of Clinical Development|+1 (919) 321-3331|VHalpern@fhi360.org|3117
22419796|NCT00810511|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22419797|NCT01012336|Samsung Medical Center|Pf Duk-Soo Bae|82-2-3410-3519|huna0@naver.com|
22419798|NCT00911300|GlaxoSmithKline|GSK Response Center|866-435-7343||
22419799|NCT03022370|SAMRC|Dr Andrew Gibbs|+27(0)312034899|andrew.gibbs@mrc.ac.za|
22419800|NCT03345771|NYU Langone Health|Ran Schwarzkopf MD MSc|(646)-501-7300|ran.schwarzkopf@nyulangone.org|
22419801|NCT02142608|Bracco Diagnostics Inc.|Maria Luigia Storto, MD, Executive Director X-Ray and Ultrasound|609-514-2262|marialuigia.storto@diag.bracco.com|
22419802|NCT01965860|Ghent University|Prof. Dr. Isabelle Van Herzeele|93325108|isabelle.vanherzeele@ugent.be|+32
22419803|NCT01894087|University of Michigan|Amy Bohnert|734-845-3638|amybohne@med.umich.edu|
22419804|NCT03044028|Cleveland Clinic|Carlos Higuera|954-659-5430|higuerc@ccf.org|
22419805|NCT01275846|Detroit Medical Center, Detroit, MI|Ileana L. Piña, MD, MPH, FAHA, FACC|216-225-7385|ilppina@aol.com|
22419806|NCT03571828|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22419807|NCT00666328|The Medicines Company|Jason Campagna. MD, PhD|973-290-6199|jason.campagna@themedco.com|
22419808|NCT02288325|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22419809|NCT00717288|The Ohio State University|Kathleen Dungan, MD|614-292-3800|kathleen.dungan@osumc.edu|
22419810|NCT00769379|NRG Oncology|Director, Department of Regulatory Affairs|412-339-5300|langerj@nrgoncology.org|
22419811|NCT03607487|Incyte Corporation|Incyte Corporation Call Center|1-855-463-3463|medinfo@incyte.com|
22419812|NCT03203681|University of Miami|Dr. Ranjith Ramasamy|3052433670|ramasamy@miami.edu|
22419813|NCT04759703|Massachusetts General Hospital|John W. Winkelman, MD, PhD|6176436026|JWWINKELMAN@MGH.HARVARD.EDU|
22419814|NCT06101264|University of Connecticut School of Medicine|Prabhath Mannam|8607092371|pmannam@uchc.edu|
22419815|NCT03617458|Vanderbilt University Medical Center|Research Programs Manager|615-322-4703|ph_research@vumc.org|
22419816|NCT01350583|H. Lee Moffitt Cancer Center and Research Institute|Robert J. Gillies, Ph.D. - Principal Investigator|813-745-8355|robert.gillies@moffitt.org|
22419817|NCT04186845|Blue Earth Diagnostics|Head of R&D|+44 (0) 1865 784 186|matthew.miller@blueearthdx.com|
22419818|NCT04036110|University of North Carolina at Chapel Hill|Jia-Rong Wu, PhD, RN|859-323-4712|jiarong.wu2@uky.edu|
22419819|NCT04252092|Eksen Sağlık ve Rehabilitasyon|PT,Cansu Hayıroğlu|+905378405948|cansu5309@gmail.com|
22419820|NCT00534404|University of Michigan|Larry An, MD|734-763-6099|lcan@med.umich.edu|
22419821|NCT02676765|Virginia Commonwealth University|Dr. Brant Ward|804-828-1941|brant.ward@vcuhealth.org|
22419822|NCT02565511|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22419823|NCT01941498|Alcon Research, Ltd.|Clinical Project Lead, GCRA, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22419824|NCT01255137|National Cancer Institute, National Institutes of Health|Dr. Tito Fojo|301-496-2631|FojoT@mail.nih.gov|
22419825|NCT00104572|NIA|Josephine M. Egan,MD, clinical director NIA|410-558-8414|eganj@grc.nia.nih.gov|
22419826|NCT00098774|University of California, San Francisco|James Rubenstein, MD, PhD||jamesr@medicine.ucsf.edu|
22419827|NCT03097991|University of South Florida|Dr. James McHale|7278734848|jmchale@usf.edu|
22419828|NCT01755091|University of Illinois at Chicago|David W. Carley, PhD|312-996-3827|dwcarley@uic.edu|
22419829|NCT03452943|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22419830|NCT03307226|Washington University in St. Louis|Dr. Fred Ssewamala|3149358521|fms1@wustl.edu|
22419831|NCT01199146|University of California, San Francisco|Charles Ryan, MD|415-353-9279|charles.ryan@ucsf.edu|
22419832|NCT01330303|GlaxoSmithKline|GSK Response Center|866-435-7343||
22419833|NCT00796757|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22419834|NCT06360081|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22419835|NCT00352417|Tallikut Pharmaceuticals, Inc.|Brian Cunningham, MD|312-505-0420|brian@baycitycapital.com|
22419836|NCT02447744|MGH|Dr. Sara Lazar|617-724-7108|slazar@mgh.harvard.edu|
22419837|NCT00912912|The University of Texas (UT) MD Anderson Cancer Center|Lance Pagliaro, MD/Genitourinary Medical Oncology||CR_Study_Registration@mdanderson.org|
22419838|NCT00306995|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22419839|NCT06419907|University of Liverpool|Gemma Lewis|01744 646668|gemma.lewis@liverpool.ac.uk|
22419840|NCT03573830|BC Children's Hospital Research Institute|Dr. Mariana Brussoni|(604) 875-3712|mbrussoni@bcchr.ubc.ca|
22419841|NCT00266630|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22419842|NCT03525886|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22419843|NCT03284723|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22419844|NCT05239611|University of Kansas Medical Center|Joel Mermis|913-588-6045|jmermis@kumc.edu|
22419845|NCT00879255|Department of Veterans Affairs|Leslie A. Morland, Clinical Psychologist|(619) 497-8406|leslie.morland@va.gov|
22419846|NCT00064987|Massachusetts General Hospital|Dr. William Crowley|617-724-2470|wcrowley@partners.org|
22419847|NCT01499095|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22419848|NCT01368497|University of Pittsburgh|Dr. Steven Belle|412-624-3758|belle@edc.pitt.edu|
22419849|NCT01383720|Boston Scientific Corporation|Director of Clinical Trials, Valves|408-370-1550||
22419850|NCT05021900|Rhizen Pharmaceuticals AG|Dr. Prajak Barde|+919820503970|pjb@rhizen.com|
22419851|NCT00443729|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22419852|NCT01622257|Assistant professor of Obstetrics & Gynecology, Ain-shams faculty of medicine|Dr. Moustafa Ibrahim|00201001955996|mi_monem@yahoo.com|
22419853|NCT00782626|Dana-Farber Cancer Institute|Mark Kieran|(617) 632-4907|mark_kieran@dfci.harvard.edu|
22419854|NCT03182933|University of Wisconsin|Laura Zitur - research program manager|6082638118|lzitur@wisc.edu|
22419855|NCT00077207|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|Resultsreportingcoordinator@childrensoncologygroup.org|
22419856|NCT02099786|VA RR&D National Center for Rehabilitative Auditory Research|Dr. Dawn Konrad-Martin|503-220-8262|dawn.martin@va.gov|52962
22419857|NCT03052751|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22419858|NCT01474200|Baxter Healthcare Corporation|Drew Jones, MD, Senior Medical Director|224-270-2659|drew_jones@baxter.com|
22392553|NCT01802151|Department of Food Science and Human Nutrition, University of Florida|Dr. Wendy Dahl|352-392-1991|wdahl@ufl.edu|224
22392554|NCT00685139|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22419859|NCT03071692|Kowa Research Institute, Inc.|Director, Clinical Operations|1 (919) 433-1600|CTGResults@KowaUS.com|
22419860|NCT01427608|Weill Cornell Medicine|Dr. George S. Alexopoulos|(914) 997-5767|gsalexop@med.cornell.edu|
22419861|NCT01439581|Henry Ford Health System|Robert Behrendt|313-874-9537|Rbehren9@hfhs.org|
22419862|NCT01027702|PRA Health Sciences|Dr. Andrew Gilman|704-615-2744|gilmanandy@prahs.com|
22419863|NCT00403585|GlaxoSmithKline|GSK Response Center|866-435-7343||
22419864|NCT03514966|Department of Gastroenterology|Changhai Hospital|86-21-31161004|liaozhuan@smmu.edu.cn|86-21-6549
22419865|NCT02862730|Oregon Health and Science University|Dr. Jessica Castle|503-494-7072|castleje@ohsu.edu|
22419866|NCT02121652|University at Buffalo School of Nursing|Suzanne S. Dickerson|716-829-3254|sdickers@buffalo.edu|
22419867|NCT01090414|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22419868|NCT04342819|The University of the West Indies|Naveen Seecheran, Senior Lecturer|18687537686|Naveen.Seecheran@sta.uwi.edu|
22419869|NCT00668317|Hull and East Yorkshire Hospitals Trust|Clinical trials Manager|01482 624067|c.e.wright@hull.ac.uk|
22419870|NCT01526655|Department of Obstetrics and Gynaecology, and Department of Clinical and Experimental Medicine, Linköpings universitet (LIU), Sweden|Professor Dr. Preben Kjölhede|+4638231188|preben.kjolhede@liu.se|
22419871|NCT04753216|Northwestern University Feinberg School of Medicine|Daniela Matei, MD|312-472-4684|daniela.matei@northwestern.edu|
22419872|NCT02001987|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22419873|NCT01412086|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22419874|NCT03901092|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
22419875|NCT04347993|Hackensack Meridian Health|Joshua Zenreich|5519965900|joshua.zenreich@hmhn.org|
22419876|NCT01253902|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22419877|NCT04138823|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22419878|NCT04868500|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
22419879|NCT00548470|Nathan Kline Institute for psychaitric Research|Robert C Smith MD|845-398-6531|rsmith@nki.rfmh.org|
22419880|NCT02466685|Northwestern University|Mahdi Arshadi|3123839950|mahdi.arshadi@northwestern.edu|
22419881|NCT02593110|Northwestern University|Mary McDermott MD|312-503-6419|mdm608@northwestern.edu|
22419882|NCT01130597|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com|
22419883|NCT03022916|UAB|Director of Clinical Trials, UAB Dermatology|2055029960|Lmroop@uabmc.edu|
22419884|NCT05794503|UT Southwestern Medical Center|Tiffany Moon, MD|(214) 648-6400|tiffany.moon@utsouthwestern.edu|
22419885|NCT03052127|Aura Biosciences|Uma Chandrasekaran, Director, Clinical Development Scientist|706-294-3454|UChandrasekaran@aurabiosciences.com|
22419886|NCT03694327|MyDigitalStudy|Alankar Gupta, VP, Medical Affairs & Clinical Development|862-485-9279|agupta@clicktherapeutics.com|
22419887|NCT02936180|McGill University|Ines Colmegna, MD|514-934-1934|ines.colmegna@mcgill.ca|35639
22419888|NCT01464931|Amgen Inc.|Study Director|866-572-6436||
22419889|NCT01982812|University of Rochester|Gretchen L. Birbeck|585-273-4265|gretchen_birbeck@urmc.rochester.edu|
22419890|NCT03648853|UCalifornia San Francisco|Pekka Talke|415 306 3602|pekka.talke@ucsf.edu|
22419891|NCT00307437|Centocor Research & Development, Inc.|Senior Director, Compound Development Team Leader|1 215 793-7612||
22419892|NCT00201409|University of Michigan|Dr. Robert Hyzy|7349365201|rhyzy@umich.edu|
22419893|NCT03017612|Ms.|Tracy Shwaery, Global Clinical Research Manager|9497072740|tshwaery@revisionoptics.com|157
22419894|NCT03131544|Prostate Laser Center, PLLC|Dr. Ara Karamanian, Medical Director of the Prostate Program|(713) 904-4014|drkaramanian@halodx.com|
22419895|NCT00789997|The Ottawa Hospital Research Institute|Dr Shawn Aaron||saaron@ohri.ca|
22419896|NCT00985491|GI Dynamics, Inc.|Manager of Clinical Affairs|781.357.3261|pkeating@gidynamics.com|
22419897|NCT01893346|AstraZeneca Pharmaceuticals|Paul Newell, MBBS MRCP MFPM|+44 1625 515727|paul.newell@astrazeneca.com|
22419898|NCT02430038|Imperial College|Professor Christoph Lees|02083831000|christoph.lees@nhs.net|
22419899|NCT00464438|Allergan, Inc.|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com|
22419900|NCT02933255|National Cancer Institute|Dr. James L. Gulley|301-480-716|gulleyj@mail.nih.gov|
22419901|NCT00721227|Ethicon Endo Surgery, Inc.|Amy Mahanes, Senior Clinical Research Associate|513-337-8366|amahanes@its.jnj.com|
22419902|NCT02448368|Ardea Biosciences, Inc.|Jesse Hall, MD|(858) 652-6672|JHall@ardeabio.com|
22419903|NCT01632280|Beth Israel Deaconess Medical Center|Dr. Miguel Alonso-Alonso|617-667-0240|malonso@bidmc.harvard.edu|
22419904|NCT01734161|Weill Cornell Medicine|Klaus Kjaer, MD|(212) 746-2953|klk9001@med.cornell.edu|
22419905|NCT05680740|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
22419906|NCT05221320|Biomed Valley Discoveries|Deborah Knoerzer, Director Translational Sciences|6368876429|dknoerzer@biomed-valley.com|
22419907|NCT06473519|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov.Inquiries@pfizer.com|
22419908|NCT02586688|Neuronetics|Director of Clinical Operations|16123067393|steve.erickson@neurostar.com|
22419909|NCT04856917|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
22419910|NCT05168202|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
22419911|NCT04483583|University of Florida|Dominick J Angiolillo|904-244-2636|dominick.angiolillo@jax.ufl.edu|
22419912|NCT04011722|Abbott|Nels Engblom|3198533946|nels.engblom1@abbott.com|
22419913|NCT06389396|Coloplast A/S|Julie Schnipper, Medical Writer|004549111257|dkjuls@coloplast.com|
22419914|NCT05626231|Boston College School of Social Work|Dr. Maggi Price, PI|541-556-5016|priceml@bc.edu|
22392555|NCT01174576|Harokopio University|Dr. Mary Yannakoulia|00302109549175|myianna@hua.gr|
22419915|NCT06195930|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22419916|NCT02487966|Spaulding Rehabilitation Hospital|Dr. Felipe Fregni|6179526158|fregni.felipe@mgh.harvard.edu|
22419917|NCT00573261|Duke University Medical Center|Dr. Wei Jiang|919-668-0762|weijiang@duke.edu|
22419918|NCT00486525|Ohio State University Comprehensive Cancer Center|Janice Kiecolt-Glaser, Principal Investigator|614-293-3499|Janice.Kiecolt-Glaser@osumc.edu|
22419919|NCT00233948|City of Hope|Paul Frankel, Ph.D.|626-256-4673|pfrankel@coh.org|65265
22419920|NCT01567462|Emory University|Dr. Kenneth Ogan|404-778-3038|kogan@emory.edu|
22419921|NCT02548156|GlaxoSmithKline|GSK Response Center|866-435-7343||
22419922|NCT06184399|Swiss Tropical and Public Health Institute|Prof Jennifer Keiser|+41 61 284 82 18|jennifer.keiser@swisstph.ch|
22419923|NCT00444587|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22419924|NCT00196326|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000||
22419925|NCT00582660|University of Alabama at Birmingham|Martin J. Heslin M.D.|205-975-0450|marty.heslin@ccc.uab.edu|
22419926|NCT01473407|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22419927|NCT02422797|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22419928|NCT05223920|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@MSD.com|
22419929|NCT04071405|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22419930|NCT05044195|Seqirus|Seqirus Clinical Trial Manager|1-855-358-8966|seqirus.clinicaltrials@Seqirus.com|
22419931|NCT00369941|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22419932|NCT03685344|ADC Therapeutics SA|Clinical Trials Information|954-903-7994|clinical.trials@adctherapeutics.com|
22419933|NCT02276807|VA Center for Integrated Healthcare|Dr. Jennifer Funderburk|315-425-4400|Jennifer.Funderburk@va.gov|54703
22419934|NCT00261950|Amgen Inc.|Study Director|866-572-6436||
22419935|NCT03288714|Wave Neuroscience|Meagan Kovacs, Clinical and Regulatory Affairs Manager|9492292869|meagan@waveneuro.com|
22419936|NCT02819284|Kala Pharmaceuticals, Inc.|VP Clinical Development|(781) 996-5252|Results007@kalarx.com|
22419937|NCT02411916|Queens Hospital Center|Dr. Aleksandr Fuks|718 883-4035|fuksal@nychhc.org|
22419938|NCT02232984|Boston Scientific|Eszter Pais|6515825307|eszter.pais@bsci.com|
22419939|NCT04020887|Washington University School of Medicine|Thaddeus Budelier|314-273-8646|thaddeus.budelier@wustl.edu|
22419940|NCT01884337|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22419941|NCT02455518|Albany Medical College|Dr. Andrew Chang|2125555555|achang3@yahoo.com|
22419942|NCT02508935|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22419943|NCT02040077|Johns Hopkins University School of Medicine|Kelly Dunn|410-550-2254|kdunn9@jhmi.edu|
22419944|NCT02683421|Navidea Biopharmaceuticals|Bonnie C. Abbruzzese, MS, RD|614-822-2327|babbruzzese@navidea.com|
22419945|NCT00535405|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22419946|NCT01696760|The Ohio State University Comprehensive Cancer Center|Joel Mayerson, MD|614-293-4420|joel.mayerson@osumc.edu|
22419947|NCT01332292|GlaxoSmithKline|GSK Response Center|866-435-7343||
22419948|NCT03295630|Hull University Teaching Hospitals NHS Trust|Dr. Jayne Anderson|01482 875875|jayne.anderson@hey.nhs.uk|5099
22419949|NCT03910673|Duke Vaccine and Trials Unit|Emmanuel Walter, MD, MPH|919-620-5346|chip.walter@duke.edu|
22419950|NCT02006732|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22419951|NCT00825786|University of North Carolina, Department of Anesthesiology, University of North Carolina|Priya Kumar, MD|(919) 966-5136|pkumar@aims.unc.edu,|
22419952|NCT03168022|Tonix Pharmaceuticals|Gregory Sullivan, MD||greg.sullivan@tonixpharma.com|
22419953|NCT03091179|Stanford University|Vladimir Nekhendzy|650-498-4055|nek@stanford.edu|
22419954|NCT02171195|BIAL - Portela & Cª, S.A.|Head of Clinical Research|+351 22 9866100|francisco.rocha@bial.com|
22419955|NCT03730207|Medtronic|Jane Zhang|86+18612318110|jane.zhang7@medtronic.com|
22419956|NCT02969044|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_inquiries@pfizer.com|
22419957|NCT04650204|Mayo Clinic|William Tatum, D.O.|507 284-2511|Tatum.William@mayo.edu|
22419958|NCT03714919|Nationwide Children's Hospital|Arlyne Thung, MD|614-722-4200|Arlyne.Thung@nationwidechildrens.org|
22419959|NCT03164616|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22419960|NCT03548337|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22419961|NCT04768686|Hanmi Pharm. Co., Ltd.|Young Su (Bobby) Noh|82-2-410-9277|63forever@hanmi.co.kr|
22419962|NCT04502212|GE Research|Diane Minas|(518)698-3959|minas@ge.com|
22419963|NCT01546454|University of Arizona|Dr. Randy Bogan|520-621-1487|boganr@email.arizona.edu|
22419964|NCT01911273|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22419965|NCT02350816|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22419966|NCT02503787|Medtronic Implantable Therapies|Helen Berrier|1-800-633-8766|medtronicneurotrials@medtronic.com|
22419967|NCT04787627|Össur Iceland ehf.|Laurine Roussillon|+354 822 1812|lroussillon@ossur.com|
22419968|NCT00548093|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22419969|NCT04460560|University of Pennsylvania|K. Rajender Reddy, MD|215-662-4311|ReddyR@pennmedicine.upenn.edu|
22419970|NCT02359994|Artivion|Priya Patel|678-290-4358|priya.patel@artivion.com|
22419971|NCT01320150|Rush University Medical Center|Dr. Robert McCarthy|(312) 563-0448|Robert_J_McCarthy@rush.edu|
22419972|NCT00919854|Janssen R&D US|Senior Director R&D|1 609 730-7548||
22419973|NCT04842292|University of Kentucky|Brittany Bissell|8593239308|bdbi223@uky.edu|
22419974|NCT02374138|Children's Research Institute|Stephen Teach, MD, MPH|202 476 5134|steach@childrensnational.org|
22419975|NCT03020537|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
22419976|NCT00143247|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22419977|NCT00489827|Dept Cardiothoracic Surgery, Linköping University Hospital, SE58185 Linköping, Sweden|Rolf Svedjeholm|+46101034825|rolf.svedjeholm@regionostergotland.se|
22419978|NCT02766283|Bayer|Therapeutic Area Head|+49 30 300139003|clinical-trials-contact@bayer.com|
22419979|NCT03086551|University of Waterloo, Waterloo, Ontario, Canada|Sean K Meehan, PhD|5198884567|skmeehan@uwaterloo.ca|39278
22419980|NCT05410964|Enspectra Health|President|650 480-6022|clinical@enspectrahealth.com|
22419981|NCT03736031|Texas Tech University Health Sciences Center at El Paso|Associate Director of Ob/Gyn Research|915-215-5103|elp-obgynresearch@ttuhsc.edu|
22419982|NCT00451178|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22419983|NCT06075277|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
22419984|NCT02603146|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22419985|NCT05355532|Privolzhsky Research Medical University|Ilya Pochinka, MD|+79030561932|pochinka4@yandex.ru|
22419986|NCT03325101|Mayo Clinic|Matthew Block, MD, PhD|507-266-7446|Block.Matthew@mayo.edu|
22419987|NCT03184571|BerGenBio ASA|BerGenBio Clinical Team|+47 559 61 159|registry.postings@bergenbio.com|
22419988|NCT05579782|Medical College of Wisconsin|Tracy Wang, MD|414-955-1459|tswang@mcw.edu|
22419989|NCT03300817|Mayo Clinic|Paul J. Limburg, M.D., M.P.H.|507-284-2511|limburg.paul@mayo.edu|
22419990|NCT03122730|Aerogen Pharma|David Durand, MD|510-928-2111|ddurand@aerogenpharma.com|
22419991|NCT01581437|Virginia CU|Kenneth Ellenbogen|804-828-7565|kellenbogen@mcvh-vcu.edu|
22419992|NCT03729596|MacroGenics, Inc.|Stephen L. Eck, MD|301-251-5172|info@macrogenics.com|
22419993|NCT03713593|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22419994|NCT02229461|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22419995|NCT02574832|Northwerstern University|Paloma Toledo, M.D.|312-472-3585|p-toledo@northwestern.edu|
22419996|NCT05584189|MP Biomedicals|Dana Hummel|8008540530|Dana.Hummel@mpbio.com|7019
22419997|NCT02789137|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22419998|NCT00445432|Abbott|Global Medical Services|800-633-9110||
22419999|NCT01085760|Mayo Clinic|Dr. Jayant A. Talwalkar|507-538--4877|talwalkar.jayant@mayo.edu|
22420000|NCT04080739|University of Alabama at Birmingham|Dr. Anthony Morlandt|205-996-2799|morlandt@uab.edu|
22420001|NCT00799058|International Partnership for Microbicides|Dr John Steytler||jsteytler@ipmglobal.org|
22420002|NCT00629018|UMC Ljubljana|Prof. Dr. Bojan Vrtovec|+3861 522 2844|bvrtovec@stanford.edu|
22420003|NCT03417778|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22420004|NCT03408171|Geisinger Medical Center|David L. Diehl, MD|570-214-2411|dldiehl@geisinger.edu|
22420005|NCT02088697|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22420006|NCT01995513|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22420007|NCT01232452|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22420008|NCT01037452|Novartis|Head New Therapeutic Opportunities|973-503-8000||
22420009|NCT00247676|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22420010|NCT03594071|Smith+Nephew, Inc.|Kirsten Wall|720-338-9460|Kirsten.wall@smith-nephew.com|
22392556|NCT01255631|CUMC Plastic Surgery|Christine Rohde|212-342-3707|chr2111@cumc.columbia.edu|
22392557|NCT00515671|IUPUI|Michelle Salyers|317-274-2904|mpsalyer@iupui.edu|
22392558|NCT02420951|Brigham and Women's Hospital|Dr. Wolfgang Fitz|6177329501|wfitz@partners.org|
22392559|NCT01195948|National Institutes of Health|Robert Nussenblatt, MD, MPH|301-496-3123|robert.nussenblatt@nih.gov|
22392560|NCT02566044|Novartis Pharmaceutical|Study Director|862-778-8300|novartis.email@novartis.com|
22392561|NCT02683772|ResMed|Maureen Crocker, Manager Medical Affairs|8588366653|maureen.crocker@resmed.com|
22392562|NCT00769652|Rutgers Cancer Institute of New Jersey|Dr. Elizabeth Poplin, MD (sub-investigator)|732-235-8675|poplinea@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
22392563|NCT00225017|Northwestern University|Robert Murphy|312-503-9000|r-murphy@northwestern.edu|
22392564|NCT00818168|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22392565|NCT03512964|Johns Hopkins University School of Medicine, Division of Infectious Diseases|Joyce Jones, MD|443-287-8530|jjone154@jhmi.edu|
22392566|NCT05467293|Yuyu Pharma, Inc.|Robert Wonsang Yu|+82 2 6972 9062|wsyu@yuyu.co.kr|
22392567|NCT06264128|SleepRes|Bernie Hete|+1 615-921-2406|bhete@sleepres.com|
22392568|NCT01077128|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22392569|NCT00448201|UNC Lineberger Comprehensive Cancer Center|Dr. Thomas Shea|919-966-7746|tom_shea@med.unc.edu|
22392570|NCT01706705|UT MD Anderson Cancer Center|Dr. Ann Klopp / Associate Professor, Radiation Oncology|713-563-6930|aklopp@mdanderson.org|
22392571|NCT03417544|Dana-Farber Cancer Institute|Nancy Lin, MD|617-632-3800|Nancy_Lin@dfci.harvard.edu|
22392572|NCT02242097|Northwestern University, Feinberg School of Medicine|Dr. Reem Karmali|(312) 695-0990|reem.karmali@northwestern.edu|
22392573|NCT01562041|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22392574|NCT03079284|Maine Medical Center|Dr. Alexa Craig|207-396-7337|craiga@mmc.org|
22392575|NCT01712061|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22392576|NCT01238536|University of Washington|Janna Friedly M.D.|206-744-3664|friedlyj@uw.edu|
22392577|NCT04606901|Temple University Hospital|Dr. Ellen Hauck|2674438719|ellen.hauck@tuhs.temple.edu|
22392578|NCT00504777|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22392579|NCT03514277|Reconstructive Orthopedics|Robert Greenleaf|609-267-9400|bob.greenleaf1@gmail.com|
22392580|NCT04868539|Brigham and Women's Hospital|Dr. Charles Czeisler, Ph.D., M.D.|617-732-4013|cacadmin@partners.org|
22392581|NCT01572740|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22392582|NCT01401153|Research Institute of Child Nutrition|Prof. Dr. Mathilde Kersting|+49-231-792210-18|kersting@fke-do.de|
22392583|NCT01677767|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22392584|NCT00842244|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22392585|NCT01068665|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22392586|NCT00858689|FRAXA Research Foundation|Michael R. Tranfaglia MD|978-462-1990|info@fraxa.org|
22392587|NCT00839956|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
22392588|NCT02523690|Johns Hopkins University|Dr. Dale Needham|410-287-3343|dale.needham@jhmi.edu|
22392589|NCT00846807|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22392590|NCT00737698|Imperial College London|Dr Samantha Amanda Sathyapala|+442073518029|s.sathyapala@imperial.ac.uk|
22392591|NCT01067846|Brain Imaging Research Center|Clint Kilts, PhD|526-8163|CDKilts@uams.edu|
22392592|NCT02817906|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646-440-9333|ITCIClinicalTrials@itci-inc.com|
22392593|NCT00672737|Stanford University|Anthony Doufas, MD, PhD|(650) 498-7699|agdoufas@stanford.edu|
22392594|NCT01675453|Academician EN Meshalkin State Budget Research Institute of Circulation Pathology|Dr. Evgeny Fominskiy|+79139538754|evfominskiy@gmail.com|
22392595|NCT02193490|University of Illinois Chicago|Dr. Sandeep Jain|312-996-4476|jains@uic.edu|
22392596|NCT00201877|The Ohio State University Comprehensive Cancer Center|Kristie Blum, MD|614-293-4519|Kristie.Blum@osumc.edu|
22392597|NCT02299414|University of Alabama at Birmingham|Dr. Alan Tita|(205) 934-9616|atita@uabmc.edu|
22392598|NCT03686423|NYU Langone Health|Ryan Brown, PhD|2122633396|Ryan.Brown@nyulangone.org|
22392599|NCT04954326|Institut de Recherches Internationales Servier|Therapeutic Area in Oncology|+33155724366|clinicaltrials@servier.com|
22392600|NCT01310231|Mount Sinai Hospital|Pamela Goodwin/PI|416 586-8211|Pamela.goodwin@sinaihealth.ca|
22392601|NCT01495598|National Cancer Institute|Dr. Robert Yarchoan|240-760-6075|robert.yarchoan@nih.gov|
22392602|NCT06411613|VA Puget Sound Health Care System|Dawn Bates|206-277-3012|dawn.bates@va.gov|
22392603|NCT01110408|Janssen R&D US|Therapeutic Areas Director||ClinicalTrialDisclosure@its.jnj.com|
22392604|NCT00669877|The University of Texas (UT) MD Anderson Cancer Center|Naval Daver, Assistant Professor, Leukemia|1-877-632-6789|CR_Study_Registration@mdanderson.org|
22392605|NCT05140915|University of Massachusetts Chan Medical School|Dr. Rajani Sadasivam|(508) 856-8923|rajani.sadasivam@umassmed.edu|
22410584|NCT03056352|Montefiore Health|Benjamin W. Friedman, MD|718-920-6626|befriedm@montefiore.org|
22410585|NCT00571922|NYU Langone Medical Center|The Office of Clinical Trials|212.263.4210|clinicaltrials@nyumc.org|
22410586|NCT02971605|Johns Hopkins University School of Medicine|Frederick Barrett, Ph.D., Principal Investigator|4105509777|fbarret2@jhmi.edu|
22410587|NCT01190306|Topcon Medical Systems|Robert Gibson|(201) 599-5121|RGIBSON@TOPCON.COM|
22410588|NCT01154153|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi.com|
22410589|NCT00964223|GlaxoSmithKline|GSK Response Center|866-435-7343||
22410590|NCT03439293|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22410591|NCT00493181|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes M.D./Professor|713/794-5783|eharriso@mdanderson.org|
22410592|NCT00660049|Stanford University|Anne Chang, MD|(650) 721 7151|alschang@stanford.edu|
22420011|NCT05219448|University of Washington|Dr. Donald L. Chi|206-616-4332|dchi@uw.edu|
22420012|NCT01750190|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|060study@fibrogen.com|
22420013|NCT02287922|Ablynx NV|Medical Monitor|+32 (0)9 262 00 00|clinicaltrials@ablynx.com|
22420014|NCT05387889|State University of New York at Buffalo School of Nursing|Dr. Tania Von Visger|7168292201|Taniavon@buffalo.edu|
22420015|NCT02906670|Symphogen AS|Medical Director|004545265050|info@symphogen.com|
22420016|NCT00958828|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22420017|NCT00387335|University of Chicago|Ezra Cohen|773-702-4137|ecohen@medicine.bsd.uchicago.edu|
22392606|NCT04520659|Johns Hopkins University Bloomberg School of Public Health|Suzanne Woods, CRNP-P, CCRP, Manager, RSVPeds Team|(443) 813-0697|swoods12@jhu.edu|
22392607|NCT04430439|University of California, Irvine|Karen Lindsay|949-824-0148|kllindsa@hs.uci.edu|
22392608|NCT04485611|Durham VA Health Care System|Dr. Atilio Barbeito, Chief, Anesthesiology Service|(919) 286-6938|atilio.barbeito@va.gov|177150
22392609|NCT04879849|Takeda|Medical Director|+1-877-825-3327|Trialdisclosures@takeda.com|
22392610|NCT05371665|Montana State University|Brandon Scott|(406) 994-5218|brandon.scott2@montana.edu|
22392611|NCT03007420|Boston Children's Hospital|Pradeep Dinakar, MD|857-218-3556|Pradeep.Dinakar@childrens.harvard.edu|
22392612|NCT01655251|Connecticut Children's Medical Center|Dr. Sharon R. Smith|860-545-9000|srsmith@connecticutchildrens.org|
22392613|NCT02638883|Cochlear Limited|PRS Specialist, Clinical Affairs|+612 9428 6555|cltd-prs-admin@cochlear.com|
22392614|NCT02284009|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22392615|NCT04147195|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22392616|NCT03841526|Xeris Pharmaceuticals|Dawn Harper, VP Clinical Devlopment|1-877-XERIS-37|clinicaltrials@xerispharma.com|
22392617|NCT01435772|BioMarin Pharmaceutical Inc.|Debra Lounsbury, Principal Scientist, Clinical Sciences|415-506-6348|DLounsbury@bmrn.com|
22392618|NCT03238963|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22392619|NCT05823012|Xeris Pharmaceuticals, Inc.|Valentina Conoscenti, MD|1-877-XERIS-37|Clinicaltrials@xerispharma.com|
22392620|NCT01424813|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22392621|NCT01977677|Stanford University School of Medicine|Lawrence Recht, MD, Professor of Neurology|650-725-8630|lrecht@stanford.edu|
22392622|NCT01498887|Novartis Pharmaceuticals|Study Director|862-778-8300||
22392623|NCT01151852|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
22392624|NCT03079297|University of Texas Southwestern|Maria Monastirsky|214-648-0174|Maria.Monastirsky@utsouthwestern.edu|
22392625|NCT00667225|University of North Carolina, Chapel Hill|Dean Morrell|919-843-5539|morrell@med.unc.edu|
22392626|NCT02993406|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
22392627|NCT02248818|AstraZeneca LP|Joel Posner MD||ClinicalTrialTransparency@astrazeneca.com|
22392628|NCT04079868|Durham VA Geriatric Research Education and Clinical Center|Dr. Cathleen Colon-Emeric|9192860411|cathleen.colon-emeric@va.gov|6932
22392629|NCT04045964|The University of Texas Health Science Center at Houston|Angela Stotts, PhD|(713) 500-7590|Angela.L.Stotts@uth.tmc.edu|
22392630|NCT04325282|Stanford University|Fiona Baumer, MD, MS|(650) 723-0993|fbaumer@stanford.edu|
22392631|NCT05520775|University of North Carolina at Chapel Hill|Christian Hendershot|(213) 821-0769|christian.hendershot@usc.edu|
22392632|NCT02658877|NYU Langone Health|Joan Reibman|212 263 6479|Joan.Reibman@nyulangone.org|
22392633|NCT00608868|Medical, Astrazeneca Korea|Hui Jung Sin||huijung.sin@astrazeneca.com|
22392634|NCT03338296|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_medinfo@eisai.com|
22392635|NCT00458952|Progenics Pharmaceuticals, Inc.|Senior Director, Clinical Science Communications|914 784-1825|vdipippo@progenics.com|
22392636|NCT00702962|MSHERSHEY MC|Dr. C. Belani|717-531-1078|cbelani@psu.edu|
22392637|NCT01252355|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22392638|NCT02175641|Washington Universtiy in St. Louis|Leopoldo J. Cabassa, Associate Professor|314-935-2829|ljcabassa@wustl.edu|
22392639|NCT02931253|The Donald Guthrie Foundation for Education and Research|Pramod Deshmukh, MD|570 887 2284|Pramod.Deshmukh@guthrie.org|
22392640|NCT01876901|Institut Bergonié|Pr Simone Mathoulin-Pelissier|0556333333|S.Mathoulin@bordeaux.unicancer.fr|
22392641|NCT01734239|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22392642|NCT03031496|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22392643|NCT02339545|Cardiovascular Systems, Inc.|Clinical Trials Manager|651.259.2500|clinicaltrials_csi@csi360.com|
22392644|NCT03868787|Northwestern University Feinberg School of Medicine|Ashley Turner, MD Assistant Professor of Obstetrics and Gynecology|2316200549|ashley.turner1@nm.org|
22392645|NCT01399697|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22392646|NCT05486728|Sunhawk Vision Biotech|President|+886-7-2222660|hjuo@shvbiotech.com|
22392647|NCT02119442|UCLA|Soraya Sadeghi|3108255950|smsadeghi@mednet.ucla.edu|
22392648|NCT01701102|Hospital for Special Surgery|Jennifer Cheng|212-774-7377|chengj@hss.edu|
22392649|NCT02807272|Kura Oncology Inc.|Clinical Operations|+1 617 588-3755|KO-TIP-004@kuraoncology.com|
22392650|NCT02204657|University Malaya Medical Centre|Dr Sharmila SP|60379492299|sharmsp13@gmail.com|
22392651|NCT01162863|University of Michigan|Dr. Richard J Saad|734-936-4780|rsaad@umich.edu|
22392652|NCT00392925|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22392653|NCT03552523|MGH Diabetes Research Center|Courtney Balliro|617-726-1242|cballiro@partners.org|
22420018|NCT00918866|Lantheus Medical Imaging|Dana Washburn, M.D.|978-671-8686|dana.washburn@lantheus.com|
22420019|NCT01472692|UCSD|Department of Medicine|(858) 552-8585||
22392654|NCT04145700|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22420020|NCT03852537|Mayo Clinic|Hemang Yadav, MBBS, MS|507-266-3958|Yadav.Hemang@mayo.edu|
22420021|NCT05534061|University of Oregon|Anne Marie Mauricio, PhD|602-920-7459|amariem@uoregon.edu|
22420022|NCT01027598|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22431832|NCT02384421|Stanford University|Dr. Helen Bronte-Stewart, MD, MSE|650-723-6709|bronte-stewart-lab@stanford.edu|
22431833|NCT00399529|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Leisha Emens|412-623-3239|emensla@upmc.edu|
22431834|NCT03435380|Duke University|Kevin Oeffinger, MD|919-668-2122|kevin.oeffinger@duke.edu|
22431835|NCT01164007|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22431836|NCT02468830|CHU de Quebec-Universite Laval|Dr Stephane Bolduc||Stephane.Bolduc@fmed.ulaval.ca|
22431837|NCT03218917|Insmed Incorporated|Insmed Medical Information|1-844-446-7633|medicalinformation@Insmed.com|
22431838|NCT00680628|Indiana University School of Medicine|Jeffrey Kline|3172873004|jefkline@iupui.edu|
22431839|NCT02581891|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22392655|NCT00780559|University of Maryland School of Medicine|Clinical Research Coordinator|(410) 328-6583|inmed@som.umaryland.edu|
22420023|NCT02673775|Rutgers, the State University of New Jersey|Andrew Gow, PhD|848-445-4612|gow@pharmacy.rutgers.edu|
22420024|NCT03762239|Barcelona Institute for Global Health (ISGlobal)|Dr. Xavier Basagaña|(+34) 93 214 7306|xavier.basagana@isglobal.org|
22420025|NCT02016183|Takeda|Medical Director|1-877-825-3327|trialdisclosures@takeda.com|
22420026|NCT00770328|Vanderbilt University Medical Center|James Muldowney|615-936-1720|james.muldowney@vanderbilt.edu|
22420027|NCT01776632|San Diego State University|Elva Arredondo|(619) 594-3481|earredon@sdsu.edu|
22420028|NCT02286843|Memorial Sloan Kettering Cancer Center|Dr. Gary Ulaner, MD, PhD|212-639-7373|carrasj1@mskcc.org|
22420029|NCT02536846|McLean Hospital|Dr. Dost Öngür|617-855-3922|dongur@partners.org|
22420030|NCT04388553|Tuen Mun Hospital|Anyon Chan|24680000|Ca663@ha.org.hk|+852
22420031|NCT04604795|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22420032|NCT02864355|The Medical University of South Carolina|George Guldan, MD|843-876-5744|guldan@musc.edu|
22420033|NCT02716727|University of North Carolina at Chapel Hill|Sumitha Ahmed, DDS|919-537-3946|sumitha_ahmed@unc.edu|
22420034|NCT00174954|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22420035|NCT00839254|GlaxoSmithKline|GSK Response Center|866-435-7343||
22420036|NCT04597632|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22420037|NCT01823835|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22420038|NCT00509795|Regeneron Pharmaceuticals|Clinical Trials Administrator||clinicaltrials@regeneron.com|
22420039|NCT04895982|BioNTech clinical trials patient information|BioNTech SE|+49 6131 90840|patients@biontech.de|
22420040|NCT02213289|University of Chicago|Daniel Catenacci, MD|2-1000|dcatenac@bsd.uchicago.edu|
22420041|NCT02687529|QIAGEN Sciences|Clinical Study Coordinator|301-944-7094|andrew.schumacher@qiagen.com|
22420042|NCT00224289|Principal Investigator|Bruce Shields, MD|203-785-6288|bruce.shields@yale.edu|
22420043|NCT01579747|Univeristy of New Mexico|Nicholas Lam|505 272 2610|nlam@salud.unm.edu|
22420044|NCT00727597|Georegtown University|Dr. Princy Kumar|2024440086|kumarp@georgetown.edu|
22420045|NCT02215967|National Cancer Institute|Dr. James N. Kochenderfer|240-760-6062|kochendj@mail.nih.gov|
22420046|NCT03207867|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22420047|NCT05849259|Massachusetts General Hospital|Dr. Christine S Ritchie|415-672-1780|csritchie@mgh.harvard.edu|
22420048|NCT03560037|University of California Davis|Christopher L. Bowlus, MD|916-734-8851|clbowlus@health.ucdavis.edu|
22420049|NCT03620708|Rutgers Robert Wood Johnson Medical School|Marc L. Steinberg, Ph.D.|732-235-4341|marc.steinberg@rutgers.edu|
22420050|NCT02498613|Yale School of Medicine|Joseph Kim, MD|(203) 200-4822|joseph.w.kim@yale.edu|
22420051|NCT05126693|KU Leuven|Prof. dr. Kaat Desloovere|+32 486 40 13 73|kaat.desloovere@kuleuven.be|
22420052|NCT04761926|Oticon Medical|Nicole Amichetti, PhD|6093660424|nitc@oticonmedical.com|
22420053|NCT05061134|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22420054|NCT01013077|Southern California College of Optometry|William Ridder|714-449-7494|wridder@scco.edu|
22420055|NCT03631199|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22420056|NCT03999996|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22420057|NCT03690388|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
22420058|NCT03765788|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22420059|NCT00001521|Clinical Center|Merke, Deborah|+1 301 496 0718|dmerke@nih.gov|
22420060|NCT03176134|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22420061|NCT03915652|Brigham and Women's Hospital|Dr. Candace Feldman|6175251035|cfeldman@bwh.harvard.edu|
22420062|NCT05736861|Duke University|Susanna Naggie, MD, MHS, FIDSA|919-684-2584|susanna.naggie@duke.edu|
22420063|NCT03410056|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22420064|NCT01250210|Agile Therapeutics|Joseph Chiodo III, Senior Medical Director|609-683-1880|jachiodo@agiletherapeutics.com|
22420065|NCT01130532|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22420066|NCT02762929|Heron Therapeutics, Inc.|Clinical Operations|1-800-767-0524|cquaratino-baker@herontx.com|
22420067|NCT02656303|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
22420068|NCT02871011|SaNOtize Research & Development Corp.|Dr Chris Miller|778-899-0607|chris@sanotize.com|
22420069|NCT03041311|G1 Therapeutics, Inc.|Clinical Trial Info.|919-213-9835|clinicalinfo@g1therapeutics.com|
22420070|NCT01842438|Australian Catholic University|Prof Liz Forbat, PI|+61 475978476|elizabeth.forbat@acu.edu.au|
22420071|NCT04909853|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22431840|NCT01612676|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22392656|NCT02205034|CHU Toulouse|Pr Maithe Tauber|+33534558551|tauber.mt@chu-toulouse.fr|
22420072|NCT03397589|University of Illinois Chicago|Molly A Martin, MD|312-996-2363|mollyma@uic.edu|
22420073|NCT01198769|GlaxoSmithKline|GSK Response Center|866-435-7343||
22420074|NCT03242408|Lipocine, INC.|Nachiappan Chidambaram, Vice President, Product Development|8018819495|nc@lipocine.com|
22420075|NCT01783990|New England Research Institutes, Inc|Julie Miller|617-972-3197|JMiller@healthcore.com|
22420076|NCT01038336|VA RR&D National Center for Rehabilitative Auditory Research, Portland VA Medical Center|Gabrielle Saunders Ph.D.|503-220-2862|gabrielle.saunders@va.gov|56210
22420077|NCT02366689|Farid Ayad|Dr. Farid Ayad|416-473-1189|ayad.farid@gmail.com|
22420078|NCT03718832|MIT Sloan School of Management|Joseph doyle|6174523761|jjdoyle@mit.edu|
22420079|NCT01996241|London School of Hygiene and Tropical Medicine|Dr Tara Beattie|0044 (0)2079272613|tara.beattie@lshtm.ac.uk|
22420080|NCT02400996|Sir Ganga Ram Hospital, New Delhi, India|Md Tanveer Adil|0091-9830154566|tanveer.cmc@gmail.com|
22420081|NCT01295112|The Emmes Corporation|Traci Clemons|1-301-251-1161|tclemons@emmes.com|10212
22420082|NCT01720225|The University of Texas MD Anderson Cancer Center|Elias Joseph MD./Professor|713-792-4764|ejabbour@mdanderson.org|
22420083|NCT02604407|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22420084|NCT00661193|SWOG Statistical Center|Lung Committee Statistician|206-667-6197|jmoon@fredhutch.org|
22420085|NCT04019626|Nerudia Ltd|Paul Morris|+44 7508 708 917|paul.morris@nerudia.com|
22420086|NCT02964312|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
22420087|NCT02779166|Northwestern Univeristy Department of Orthopaedic Surgery|Dr. Michael Terry|312-926-4444||
22420088|NCT00191191|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22420089|NCT02969421|Duke University Medical Center|Tashima Lambert, MD|484-201-9332|dr.tlambert@gmail.com|
22420090|NCT00504751|Weill Cornell Medicine|Richard Furman, MD|646.962.2064|amr2017@med.cornell.edu|
22420091|NCT01231646|North Shore-LIJ Health System|Connie Lau, MS, CCRC|516-325-7022|clau@nshs.edu|
22420092|NCT00128401|National Institute of Mental Health|Cameron, Jennifer Ann|+1 301 402 9356|cameronj@mail.nih.gov|
22420093|NCT03280264|Kyowa Kirin Co., Ltd.|Research & Development Planning Department, Research & Development Division|+81-3-5205-7200|clinical.info.jp@kyowakirin.com|
22420094|NCT04882241|Merck Sharp & Dohme LLC.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicalTrialsDisclosure@msd.com|
22420095|NCT05273411|University of British Columbia|Jonathan Little, PhD|2508079876|jonathan.little@ubc.ca|
22420096|NCT00524420|University of Washington|David H. Avery, MD, Professor|206-744-4527|averydh@u.washington.edu|
22420097|NCT00577863|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22420098|NCT00897910|Barbara Ann Karmanos Cancer Institute|Zaid S. Al-Kadhimi, M.D.|313-576-8022|alkadhiz@karmanos.org|
22420099|NCT03127514|Amylyx Pharmaceuticals|Amylyx Pharmaceuticals, Head of Clinical R&D|(617) 682-0917|medinfo@amylyx.com|
22420100|NCT02738138|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22420101|NCT00295893|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22420102|NCT02543944|University of Arkansas for Medical Sciences|Dr. Alison H. Oliveto, PhD|501-526-8441|olivetoalison@uams.edu|
22392657|NCT01840410|Novartis|Study Director|862-778-8300||
22392658|NCT00594880|the Wistar Institute|Luis Montaner|215 898 3934|montaner@mail.wistar.org|
22392659|NCT02206061|University of Rochester|Jill Halterman, MD|5852755798|jill_halterman@urmc.rochester.edu|
22392660|NCT00694109|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22392661|NCT01868425|University of Wisconsin - Madison|John Shepler|608-263-8100|jashepler@wisc.edu|
22392662|NCT01077518|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22420103|NCT01648530|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22420104|NCT02665221|MS Comprehensive Care Center NYU Langone Health|Shannon Haas|646 501 7504|Shannon.Haas@nyumc.org|
22420105|NCT03639779|University of Central Florida College of Medicine|Dr. David Weinstein|(407)266-4900|david.weinstein@ucf.edu|
22420106|NCT00645970|James A. Haley Veterans' Hospital|Kristin Phillips|813-972-2000|kristin.phillips3@va.gov|6721
22420107|NCT02413229|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
22420108|NCT02932462|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
22420109|NCT02091856|West University of Timisoara|Dr. Bogdan Tudor Tulbure|+040745753061|btulbure@gmail.com|
22420110|NCT05024747|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
22420111|NCT00662649|Novartis Pharmaceuticals|Study Director|862 778-8300||
22420112|NCT01927575|Fujifilm Medical Systems, U.S.A., Inc.|Robert Uzenoff|(203) 602-3664|ruzenoff@fujifilm.com|
22420113|NCT03440840|Nova Southeastern University|Raymond L Ownby, MD, PhD|954-262-1481|ro71@nova.edu|
22420114|NCT04688671|Eliem Therapeutics|Clinical Operations|+1-888-506-2573|studyinfo@eliemtx.com|
22420115|NCT01960257|University of California, San Diego|Dr. Sara H. Browne|619 543 8080|shbrowne@health.ucsd.edu|
22420116|NCT01942993|Icahn School of Medicine at Mount Sinai|Dr. Philip A Friedlander|212-824-8584|philip.friedlander@mssm.edu|
22420117|NCT02143128|Dept of Anaesthesia and Intensive Care, Akershus University Hospital, Norway|Dr Vladimir Kuklin|98838024|vkuklin@me.com|0047
22420118|NCT01349192|University of North Carolina, Chapel Hill|Marianne S. Muhlebach, PI|(1) 919 966 1055|Marianne_Muhlebach@med.unc.edu|
22420119|NCT03749330|Children's Hospital of Philadelphia|Jennifer Walter, MD, PhD, MS Associate Professor of Pediatrics|215-590-1000|walterj1@chop.edu|
22431841|NCT03421886|University of Alabama at Birmingham|Chung How Kau, chair and professor|(205) 934-2782|ckau@uab.edu|
22431842|NCT01138475|William Beaumont Hospital|Kerstyn Zalesin|248-655-5900|Kerstyn.zalesin@beaumont.edu|
22392663|NCT04958200|Boston University|Tibor Palfai, PhD|6173539345|palfai@bu.edu|
22392664|NCT00671177|San Francisco VA Medical Center|Dr. Tonya Kaltenbach|415-221-4810|tonya.kaltenbach@va.gov|24103
22420120|NCT02144714|Samsung Bioepis|Samsung Bioepis|+82 31 8061 4534|sbregistry@samsung.com|
22392665|NCT04662060|Stanford University|Manesha Desai, PhD|(650) 725-1946|manisha.desai@stanford.edu|
22392666|NCT04157400|MUSC|Nathan Rowland|843-792-6590|rowlandn@musc.edu|
22392667|NCT03599687|Yorkshire Ambulance Service NHS Trust|Richard Pilbery|+447463734823|r.pilbery@nhs.net|
22392668|NCT03852719|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22392669|NCT04201262|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22392670|NCT05619575|Cochlear|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
22392671|NCT02819024|Barbara Ann Karmanos Cancer Institute|Anthony F. Shields, MD, PhD|3135768735|shieldsa@karmanos.org|
22392672|NCT02902770|Maimonides Medical Center|Antonios Likourezos|7182836896|alikourezos@maimonidesmed.org|
22392673|NCT05217641|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
22392674|NCT00871286|Northwestern|Rakesh Chandra|312-695-8182|rchandra@nmff.org|
22392675|NCT03682185|University of Pennsylvania|Dr. Nancy A. Hodgson|215-573-7387|hodgsonn@nursing.upenn.edu|
22392676|NCT00462605|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|B. Douglas Smith|410-614-5068|smithdo@jhmi.edu|
22392677|NCT03548220|Agios Pharmaceuticals, Inc.|Medical Affairs|833-228-8474|medinfo@agios.com|
22392678|NCT02397447|Institute of Experimental and Clinical Therapeutics|Dra. Esperanza Martínez Abundis|+52-33-10-58-52-00|esperanzamartnezabundi@yahoo.com|34211
22392679|NCT04897841|University of Wisconsin - Madison|Sharon Blohowiak|608-417-6957|sblohowiak@wisc.edu|
22392680|NCT02994069|University of Kentucky|Dr. Susanne Arnold|859-323-6522|susanne.arnold@uky.edu|
22392681|NCT06926673|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22392682|NCT06532357|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22392683|NCT03345576|Richmond VAMC|Ashraf S. Gorgey|8046755000|ashraf.gorgey@va.ogv|3386
22392684|NCT05718466|Henry Ford Health System|Marissa Gilbert|313-556-8422|mgilber6@hfhs.org|
22392685|NCT01967147|Alcon Research, Ltd.|Global Brand Med Affairs Lead, GCRA, GMA Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
22392686|NCT01882543|Department of Urology, Queens University, Ontario|J. Curtis Nickel|613-548-2497|jcn@queensu.ca|
22392687|NCT01253135|Smith & Nephew|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
22392688|NCT00833261|UT Southwestern Medical Center|Dr. Lucien Nedzi|214-645-7653|lucien.nedzi@utsouthwestern.edu|
22392689|NCT03149809|Atlanta VA Health Care System|E. Camille Vaughan, MD, MS|404 315 4100|elizabeth.vaughan2@va.gov|373100
22392690|NCT00814177|McMaster University|Sam Schulman, MD|1-905-5270271|schulms@mcmaster.ca|44479
22392691|NCT02952534|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
22392692|NCT00264303|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22392693|NCT02815579|University of California, San Francisco|Dr. Sheri Weiser|(628) 206-2427|Sheri.Weiser@ucsf.edu|
22392694|NCT02389452|Sanofi|Trial Transparency Team||Contact --US@Sanofi.com|
22392695|NCT02311673|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
22392696|NCT01006252|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22392697|NCT00414908|Abbott Products|Sven Voet - Global Communication|+41 61 487 08 56|sven.voet@abbott.com|
22392698|NCT01076153|Abbott|Global Medical Services|1-800-633-9110||
22392699|NCT04165031|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22392700|NCT04143945|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22392701|NCT03563157|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22392702|NCT02942277|Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Patrick E. Duffy|301.761.5089|patrick.duffy@nih.gov|
22392703|NCT00565773|Duke University|Allan D. Kirk, MD, PhD|919-681-1400|allan.kirk@duke.edu|
22431843|NCT02831660|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22431844|NCT00181844|Massachusetts General Hospital|Janet Wozniak, MD|617-503-1038|jwozniak@partners.org|
22431845|NCT00584857|UAB|J. Michael Straughn, MD|205-934-4986|Michael.straughn@ccc.uab.edu|
22431846|NCT03767881|Boston Scientific|Evelyne Ho, Clinical Project Manager|1-978-483-8856|Evelyne.ho@bsci.com|
22431847|NCT02303262|SARC|SARC|(734) 930-7600|sarc@sarctrials.org|
22431848|NCT02622191|Wills Eye Hospital, Glaucoma Research Center|Dr. L. Jay Katz|215-928-3123|ljkatz@willseye.org|
22431849|NCT02958345|Tulane University|Dr. Luis Balart|504-988-3047|lbalart@tulane.edu|
22431850|NCT01959932|Philip Morris Products S.A.|Christelle HAZIZA, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
22431851|NCT00758563|Colgate Palmolive|William DeVizio - DMD|732-878-7901|William_DeVizio@colpal.com|
22431852|NCT00060944|Janssen R&D US|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
22431853|NCT01138514|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
22431854|NCT00776230|Valneva Austria GmbH|Katrin Dubischar-Kastner|+43120620|info@valneva.com|0
22431855|NCT01215851|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|(212) 227-7540|dan.everitt@tballiance.org|
22392704|NCT01240915|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22392705|NCT04297631|Washington University|Venessa Riegler|3143621721|rieglerv@wustl.edu|
22392706|NCT02574845|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22392707|NCT01720277|Brown University and Providence VA Medical Center|Dr. Stefan Gravenstein|401-863-3172|Stefan_gravenstein@brown.edu|
22392708|NCT03151993|Federal Center for Brain and Neurotechnology|Dr. Eugene I. Gusev, President of the Federal Center for Brain and Neurotechnology|495-280-01-74|egusev2339@gmail.com|+7
22431856|NCT03961308|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22431857|NCT01800786|Brigham and Women's Hospital|Ina Djonlagic|617 667 5129|idjonlag@bidmc.harvard.edu|
22392709|NCT04313608|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22420121|NCT02038010|Northwestern University|William Gradishar, MD|312 695 4541|w-gradishar@northwestern.edu|
22431858|NCT00867139|FHCRC|Michael Boeckh MD|206 667 6706|mboeckh@fhcrc.org|
22431859|NCT02297412|Mayo Clinic|Charles L. Loprinzi, M.D.|507/284-6026|cloprinzi@mayo.edu|
22431860|NCT04549454|Loyola Marymount University|Dr. Bradley Trager, Research Scientist|3103385238|bradley.trager@lmu.edu|
22431861|NCT02371356|Kaiser Permanente Division of Research|De-Kun Li, MD, PhD|510.891.3749|De-Kun.Li@kp.org|
22431862|NCT05437419|Teijin America, Inc.|President|+1 (415) 887-9742|clinical-trials-contact@teijinpo.com|
22431863|NCT00545779|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22420122|NCT05027308|Takeda|Study Director|1-877-825-3327|TrialDisclosures@takeda.com|
22420123|NCT02023983|Municipal Hospital Ostrava|dr. Kamil Novobílský|+420 59 619 2660|k.novobilsky@mnof.cz|
22420124|NCT02105467|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22420125|NCT03908125|Senseonics, Inc.|Sr. Director of Clinical Operations|301-407-2946|Kathleen.Davis@senseonics.com|
22420126|NCT02262325|The Ohio State University Comprehensive Cancer Center|Dr. Eric Miller|614-293-8595|eric.miller@osumc.edu|
22420127|NCT02815995|The University of Texas MD Anderson Cancer Center|Dr. Neeta Somaiah|(713) 792-3626|nsomaiah@mdanderson.org|
22420128|NCT00397462|Binghamton University, SUNY|Professor Kenneth McLeod|(607)777-5779|kmcleod@binghamton.edu|
22420129|NCT01071915|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
22420130|NCT01288807|UCSD|Tobias Moeller-Bertram (PI)|7603211315|moellerbertram@yahoo.com|
22420131|NCT00344448|National Institute of Dental and Craniofacial Research|Gabor G Illei, Md, principal Investigator|301 496-4072|illeig@mail.nih.gov|
22420132|NCT03519087|The Ohio State University|Dr. Stephanie Di Stasi|614-685-9779|stephanie.distasi@osumc.edu|
22420133|NCT01137071|Recepta Biopharma|Director of Clinical Trials|55 11 3709-2140|recepta@receptabio.com.br|
22420134|NCT04807400|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22420135|NCT04805515|Rutgers Center for Tobacco Studies|Andrea Villanti|732 235 9585|andrea.villanti@rutgers.edu|
22420136|NCT04194645|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22420137|NCT03076775|University of North Carolina at Chapel Hill|Ashley Battarbee, MD, MSCR|205-975-2361|anbattarbee@uabmc.edu|
22420138|NCT01783886|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22420139|NCT00940316|Northwestern University|Dr. Al Benson|(312) 695-0184|albenson@nm.org|
22420140|NCT02290405|National Jewish Health|Bryan Simmons|303-398-1850|SimmonsB@NJHealth.org|
22420141|NCT00523939|Duke University Medical Center|Dr. David Rizzieri|919-668-1040|rizzi003@mc.duke.edu|
22420142|NCT02765256|University of Pennsylvania|Lindsey Albenberg, DO|267-426-0139|albenbergl@email.chop.edu|
22420143|NCT03503669|University of California, Los Angeles|Helen Lavretsky, MD|(310) 794-4619|HLavretsky@mednet.ucla.edu|
22420144|NCT04793711|Primus Pharmaceuticals, Inc.|Clinical Project Manager|4802506689|msanstead@primusrx.com|
22420145|NCT01068262|Merck Sharp and Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22420146|NCT04182490|Lumen Bioscience, Inc.|Senior Medical Director|206-899-1904|trials@lumen.bio|
22420147|NCT00743717|Los Alamitos Orthopaedic Group|Dr. Perry Secor|805-384-2748|vsarin@kinamed.com|
22420148|NCT01221207|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
22420149|NCT01811472|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22420150|NCT00074308|Abramson Cancer Center of the University of Pennsylvania|Jane Daly|215-662-2812|jane@mail.med.upenn.edu|
22431864|NCT01405196|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22392710|NCT01867333|National Cancer Institute|Ravi A. Madan|301-480-7168|rm480i@nih.gov|
22392711|NCT01145898|Indiana University|Alon Harris|317-278-00177|alharris@indiana.edu|
22392712|NCT00879775|Department of Family Medicine, Dongguk University Ilsan Hospital, Republic of Korea|Sang-Yeon Suh, M.D.,Ph.D|0082-031-961-7490|fmmodel@gmail.com|
22392713|NCT02440425|Moffitt Cancer Center|Robert M. Wenham, MD, MS, FACOG, FACS|813-745-5739|Robert.Wenham@moffitt.org|
22392714|NCT03101462|Saint Louis University|Daniel F. Hoft, MD, PhD|314-977-5500|daniel.hoft@health.slu.edu|
22392715|NCT03750786|Isofol|Karin Gedda|+46 (0) 729 9453 37|karin.gedda@isofolmedical.com|
22392716|NCT01669577|University of São Paulo|Luiz Guilherme Villares da Costa, MD|5511985584737|lgvc76@yahoo.com.br|
22392717|NCT03309813|Insightec|Nadir Alikacem, VP Global Regulated Clinical Affairs|214-630-9900|NadirA@Insightec.com|
22392718|NCT00208325|DePuy International|Kimberly Dwyer, Ph.D, CCRA||kdwyer2@its.jnj.com|
22392719|NCT01327846|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22392720|NCT01766713|UCSD|Rohit Loomba|858-534-2624|roloomba@ucsd.edu|
22392721|NCT04662931|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22392722|NCT00847522|Huntsman Cancer Institute|Mark Wade|8012135746|mark.wade@hci.utah.edu|
22392723|NCT04343976|Massachusetts General Hospital|Sponsor-Investigator|617-724-3836|chung.raymond@mgh.harvard.edu|
22392724|NCT02807883|University of Texas MD Anderson Cancer Center|Partow Kebriaei, MD / Stem Cell Transplantation Department|713-745-0663|pkebriae@mdanderson.org|
22392725|NCT01254747|Alcon Research|Director of Alcon Clinical, Atlanta|1-800-241-7629||
22392726|NCT02406677|AstraZeneca Pharmaceuticals LP|Naeem Khan, MD, VP, CVMD TA|302-886-5526|Naeem.Khan@astrazeneca.com|
22392727|NCT02654652|Universidade Federal de Minas Gerais|Dr. Maria Isabel Correia|+55 31 34098033|isabel_correia@uol.com.br|
22420151|NCT00934024|MUSC|Dr. Karen Hartwell|843-792-8174|hartwelk@musc.edu|
22420152|NCT03105518|Brigham and Women's Hospital/Harvard Medical School|Lawrence Tsen, MD|617.732.8216|ltsen@bwh.harvard.edu|
22420153|NCT04108299|NYU Langone Health|Lu Hu|646-501-3438|lu.hu@nyulangone.org|
22420154|NCT04584684|University of North Carolina at Chapel Hill|Laura Jacox, DMD, PhD, MS|847-702-0988|ljacox@live.unc.edu|
22420155|NCT02009722|Mayo Clinic|Dr. Hans Sviggum|507-581-6083|sviggum.hans@mayo.edu|
22420156|NCT02955212|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22420157|NCT02319317|University of Pennsylvania|Catherine McDonald. PhD, RN|2157468355|mcdonalc@nursing.upenn.edu|
22420158|NCT00371436|VA RR&D, NCRAR|James A. Henry, Ph.D.|5032208262|james.henry@va.gov|57466
22420159|NCT05262387|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22420160|NCT02454933|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22420161|NCT01311687|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599||
22420162|NCT02045446|University of Texas Southwestern Medical Center|Dr. Puneeth Iyengar|214/645-7603|puneeth.iyengar@utsouthwestern.edu|
22420163|NCT05274178|Phonak Audiology Research Center|Principle Investigator|630-821-5000|phonakaudiologyresearch@gmail.com|
22420164|NCT04362670|Ocular Therapeutix|Clinical Project Manager|781-357-4000|clinicalaffairs@ocutx.com|
22420165|NCT02515331|Novartis Pharmaceuticals|Study Director|862-778-8300|novartisemail@novartis.com|
22420166|NCT00124748|Novartis Pharmaceuticals|Study Director|862-778-8300||
22420167|NCT00322712|University of New Mexico|Dr. Fa Chyi Lee|505-925-0405|flee@salud.unm.edu|
22420168|NCT02071225|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22420169|NCT00567008|UPenn|Jennifer Plebani|2152223200|jplebani@mail.med.upenn.edu|152
22420170|NCT04176250|Gates MRI|Study Director|+1 857 702 2108|clinical.trials@gatesmri.org|
22420171|NCT00758524|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
22420172|NCT04090125|University of North Carolina at Chapel Hill|Kelli Allen, PhD|919-966-0558|kdallen@email.unc.edu|
22420173|NCT01342081|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
22420174|NCT00354913|Duke University Medical Center|Dr. Annick Desjardins|919-681-1691|annick.desjardins@dm.duke.edu|
22420175|NCT04720053|Mayo Clinic|Dr. Sanjeev Nanda|507-284-9919|GIMRESEARCHSTUDIES@Mayo.edu|
22420176|NCT01350271|University of Kelaniya|Dr Balachandran Kumarendran|0094112961140|drbkumaran@gmail.com|
22420177|NCT01973439|MRC Clinical Trials Unit at UCL|Trial manager|02076704825|silvia.forcat@ucl.ac.uk|
22420178|NCT03104192|Dartmouth-Hitchcock|John A. Batsis, MD|603-650-5000|john.batsis@gmail.com|
22420179|NCT02500589|Durahm VA Health Care System|Jennifer Gierisch|919-286-0411|jennifer.gierisch@va.gov; j.gierisch@duke.edu|176936
22420180|NCT02607046|Department of Veterans Affairs|Dr. Steven Prior|410-605-7000|steven.prior@va.gov|54129
22420181|NCT03164538|Massachusetts General Hospital|Dr. Jeff Huffman|617-724-2910|JHUFFMAN@mgh.harvard.edu|
22420182|NCT03656744|HighTide Therapeutics|Chief Medical Officer|314-791-0593|adibisceglie@hightidetx.com|
22420183|NCT00996489|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
22420184|NCT03142191|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22420185|NCT03112473|Department of Rehabilitation Science, The Hong Kong Polytechnic University|Prof. Shamay Ng|27664889|shamay.ng@polyu.edu.hk|
22420186|NCT01130493|Impax Laboratories, LLC|Kaihong Jiang, Senior Director, Head of Biometrics|(908) 307-2234|Kaihong.Jiang@amneal.com|
22420187|NCT03541317|University of Michigan|Amy M Kilbourne|734-845-3452|amykilbo@umich.edu|
22420188|NCT02263963|Spectrum Health|Dr. Nezar Jrebi|507-271-8284|jrebi.nezar@hotmail.com|
22392728|NCT02833077|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
22392729|NCT04608773|University of Pittsburgh|Anne Fisher|4126479665|amf91@pitt.edu|
22420189|NCT00879086|Eisai Inc.|Eisai Medical Information|888-274-2378|esi_oncmedinfo@eisai.com|+1
22420190|NCT04728802|Applied Biology, Inc.|Dr. John McCoy|+1 (949)387-4526|johnm@appliedbiology.com|
22420191|NCT03282916|Columbia University Irving Medical Center|Dr. Davangere P Devanand|646-774-8658|dpd3@cumc.columbia.edu|
22420192|NCT00719186|Yale University|Heping Zhang|203-785-5185|rmn-dcc@panlists.yale.edu|
22420193|NCT02517463|The University of Hong Kong|Dr. Raymond Li|+852 22553914|raymondli@hku.hk|
22420194|NCT00525798|Nordic Bioscience|Dr. Bente Juul Riis|+45 22901317|bjr@nordicbioscience.com|
22420195|NCT02296931|Rice 360: Institute for Global Health|Dr. Rebecca Richards-Kortum|713-348-3823|rkortum@rice.edu|
22420196|NCT01590277|VA Connecticut Healthcare System|Deepak Cyril D'Souza, MD|203-932-5711|deepak.dsouza@va.gov|2594
22420197|NCT04386616|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
22420198|NCT01377012|Novartis|Study Director|862-778-8300||
22420199|NCT00805961|Sarah Cannon Research Institute|John D. Hainsworth, MD.|877-691-7274|ASKSARAH@scresearch.net|
22420200|NCT01958073|Kaiser Permanente San Diego|Dr. Kimberly Ferrante|6199801439|klf0409@gmail.com|
22420201|NCT02972892|GE Healthcare|Research Program Integrator|262-290-6037|meghan.terry@ge.com|
22420202|NCT05022212|University of California, San Francisco|Dr Anke Hemmerling, Co-Investigator|4154765878|anke.hemmerling@ucsf.edu|
22420203|NCT02905032|Mayo Clinci|Peter A. Noseworthy, M.D.|507-255-2446|Noseworthy.Peter@mayo.edu|
22420204|NCT00739063|UT MD Anderson Cancer Center|Ana Gonzalez-Angulo, MD, MS / Associate Professor||CR_Study_Registration@mdanderson.org|
22420205|NCT02698033|Massachusetts General Hospital|Wayne Shreffler|6177266147|wshreffler@mgh.harvard.edu|
22420206|NCT04917861|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
22420207|NCT01260701|SWOG Statistical Center|Study Statistician|206-667-4623||
22420208|NCT00720382|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2393|WWheeler@medapharma.us|
22420209|NCT00289120|Emory University|Kenneth Ogan|404-778-4898|kogan@emory.edu|
22420210|NCT05192889|St. Jude Children's Research Hospital|Seth Karol, MD|(901) 595-1716|seth.karol@stjude.org|
22420211|NCT04467840|RedHill Biopharma Ltd.|Gilead Raday, COO|+972-(0)3-541-3131|info@redhillbio.com|
22420212|NCT04408183|GeneOne Life Science|Senior Clinical Operations Associate|6106576351|dkane@genels.us|
22420213|NCT06418529|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22420214|NCT06082843|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22420215|NCT02732730|HPTN Statistical & Data Management Center|HPTN Statistical Manager|206-667-4004|HPTN-Data-Access@scharp.org|
22420216|NCT00696423|GlaxoSmithKline|GSK Response Center|866-435-7343||
22420217|NCT03989102|Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Patrick E. Duffy|301.761.5089|patrick.duffy@nih.gov|
22420218|NCT04054765|play4REAL XR Lab at the Yale School of Medicine|Dr. Kimberly Hieftje|2037872402|kimberly.hieftje@yale.edu|
22420219|NCT01290068|Alcon Research, Ltd.|Brand Lead, Surgical, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
22420220|NCT01907490|Dr. Reddy's Laboratories Inc.|Dr. Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
22420221|NCT04544241|Charles R. Drew University of Medicine & Science|Sharon Cobb|323-568-3329|sharoncobb1@cdrewu.edu|
22420222|NCT02719184|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
22420223|NCT00545714|Hoffmann-La Roche|Medical Communications|800--821--8590|global-roche-genentech-trials@gene.com|
22420224|NCT01113723|Department of Anesthesiology, Cedars-Sinai Medical Center|Roya Yumul, M.D., Ph.D.|310-423-5841|(Roya.Yumul@cshs.org)|
22420225|NCT04428034|UT Health San Antonio|Kylie Meyer, PhD|210-450-5386|meyerk1@uthscsa.edu|
22420226|NCT00245518|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
22420227|NCT02556801|HAL Allergy|Andrey Larionov, MD, Head of Clinical Development|+31881959189|alarionov@hal-allergy.com|
22420228|NCT01769248|Northwestern University|Srinadh Komanduri|312-695-0484|koman1973@gmail.com|
22420229|NCT01431079|University of Cincinnati|Dr. Manoj Sharma, PI|513-556-3878|manoj.sharma@uc.edu|
22420230|NCT01626690|University of Wisconsin School of Medicine and Public Health|Dr. Kristopher Schroeder, MD|608-263-8100|kmschro1@wisc.edu|
22420231|NCT02676882|Massachusetts General Hospital Center for Women's Mental Health|Dr. Marlene Freeman|617-643-6403|mfreeman@partners.org|
22420232|NCT00114140|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22420233|NCT02414958|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22420234|NCT00815880|CHF Solutions, Inc.|Audrey Singh|952-345-4217|audrey.singh@chf-solutions.com|
22420235|NCT00811733|GlaxoSmithKline|GSK Response Center|866-435-7343||
22420236|NCT00793871|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22420237|NCT03354598|Iterum Therapeutics|Senior Director, Clinical Development|18606614035|saronin@iterumtx.com|
22420238|NCT00111241|Monash University|Prof Susan Davis|+61399030827|susan.davis@monash.edu|
22420239|NCT05934396|University of North Carolina at Chapel Hill|Marisa Marraccini, PhD|919-843-5099|mmarracc@unc.edu|
22420240|NCT02096744|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22420241|NCT04912232|Dartmouth Health|Norman A. Paradis|(603) 650-7254|Norman.A.Paradis@hitchcock.org|
22420242|NCT01994785|Cleveland Clinic|John Vargo|216 445-5012|vargoj@ccf.org|
22420243|NCT05724589|Institute of Dermatology, Thailand|Dr. Supawee Phanmamuang|6623545222|dewsupawee@gmail.com|
22420244|NCT01070953|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22420245|NCT02435524|London School of Hygiene & Tropical Medicine|Dr Veronique Filippi|+44 (0)20 7927 2874|veronique.filippi@lshtm.ac.uk|
22420246|NCT04700137|St. Luke's Health System|Dr. Anna K. Radin|208/381-8460|radina@slhs.org|
22420247|NCT01411527|Rigshospitalet|Anders Juul|+45 3545 5085|Anders.Juul@regionh.dk|
22420248|NCT00125515|New York Psychiatric Institute|Dr Adam Bisaga|212-543-6542|bisagaa@nyspi.columbia.edu|
22420249|NCT03449446|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22431865|NCT01542788|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22431866|NCT01400412|ACTG Network Coordinating Center, Social and Scientific Systems|ACTG Clinicaltrials.gov Coordinator|301-628-3313|ACTGCT.Gov@s-3.com|
22431867|NCT01649869|University of Alabama at Birmingham|David Kimberlin, MD|(205) 638-2530|DKimberlin@peds.uab.edu|
22431868|NCT00069641|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22431869|NCT04778592|Eliem Therapeutics|Clinical Operations|+1-888-506-2573|studyinfo@eliemtx.com|
22431870|NCT02673944|Laborie|Clinical Researcher|905-612-1170|sbitzos@laborie.com|1755
22431871|NCT01354223|Foresight Regulatory Strategies, Inc.|William J. Gleason, O.D.|978-658-6888||151
22431872|NCT03246087|MOMH|Amanda Crawford|7026533583|amanda.j.crawford.ctr@health.mil|
22431873|NCT01126190|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
22431874|NCT01135992|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22431875|NCT01977898|Northwestern University|Feyce Peralta, MD|312-472-3585|f-peralta@northwestern.edu|
22431876|NCT03983421|Department of Psychiatry and Behavioral Sciences, Health Sciences Center, University of New Mexico|Annette Crisanti, PhD|5052726238|acrisanti@salud.unm.edu|
22431877|NCT01049373|PASCOE pharmazeutische Präparate GmbH|Dr. Gabriele Weiss|0049/641/7960-0|klinischeforschung@pascoe.de|
22431878|NCT04573972|Carnegie Mellon University|Gretchen Chapman, PhD|4122687380|gchapman@andrew.cmu.edu|
22431879|NCT01517984|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22431880|NCT03564886|University of Missouri, Department of Orthopaedics|Lasun Oladeji, MD|573-884-7796|OladejiL@health.missouri.edu|
22431881|NCT02724839|Cincinnati Children's Hospital Medical Center|Dr.Kristen Copeland|5136361687|kristen.copeland@cchmc.org|
22431882|NCT01155050|PenningtonBRC|Ronald Horswell|225-763-2931|Ronald.Horswell@pbrc.edu|
22431883|NCT01198587|Boston Children's Hospital|Michelle Niescierenko MD MPH|617-919-4121|michelle.niescierenko@childrens.harvard.edu|
22431884|NCT01496287|Acclarent, Inc.|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com|
22420250|NCT02159079|VANDERBILT UNIVERSITY MEDICAL CENTER|Matthew W. Semler, MD, MSc|(615) 322-3412|matthew.w.semler@vumc.org|
22420251|NCT01319500|Center for Epidemiology and Health Research Berlin|Dr Juergen Dinger|+49 (0)30 945 10145|dinger@zeg-berlin.de|
22420252|NCT03048552|Columbia University/New York State Psychiatric Institute|Dr. Katherine Elkington|16467746965|ke2143@cumc.columbia.edu|
22420253|NCT03785327|The University of Texas at Dallas|Dr. Noah Sasson|972-883-2541|nsasson@utdallas.edu|
22420254|NCT03180645|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22420255|NCT04208750|Indiana University|Dr. Dawn Meyer|812-855-0559|meyerd@indiana.edu|
22420256|NCT04977479|National Institute of Allergy and Infectious Diseases|Pamela Frischmeyer-Guerrerio|301-402-9782|pamela.guerrerio@nih.gov|
22420257|NCT02201277|University of California, San Francisco, Interventional Radiology|Maureen Kohi, MD|(415) 353-1300|maureen.kohi@ucsf.edu|
22420258|NCT02730663|Taewoong Medical Co., Ltd.|JiYoung Ahn/Assistant manager|+82-70-4649-1624|sarahahn@stent.net|628
22420259|NCT00866359|Celgene Corporation|Anne McClain|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22420260|NCT01625091|Unversity of Florida|Dr. Robert Cook|352-273-5869|cookrl@ufl.edu|
22420261|NCT02163057|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
22420262|NCT03126448|Indiana University Health|Dr. Roman Natoli|713-516-8973|rnatoli@IUHealth.org|
22420263|NCT02254265|Sun Pharma Advanced Research Company Limited|SPARC|+912266455645|Clinical.Trials@Sparcmail.com|
22420264|NCT01547390|University of South Florida|Dr. Anthony Odibo|813-259-0828|aodibo@health.usf.edu|
22420265|NCT04182334|Indiana University|Babar Khan, MD, MS|(317) 274-9132|bakhan@iu.edu|
22420266|NCT03023176|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker.|650-724-4437|cdekker@stanford.edu|
22420267|NCT04536376|Mayo Clinic|Dr. Ivana T. Croghan|507-284-2511|GIMRESEARCHSTUDIES@MAYO.EDU|
22420268|NCT01191450|Eurofarma Laboratórios S.A|Eurofarma Laboratórios S.A|50 11 5090-8415|fernanda.martinez@eurofarma.com.br|
22420269|NCT05287230|University of South Carolina|Dr. Monique Brown|8037775057|brownm68@mailbox.sc.edu|
22420270|NCT02360215|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22420271|NCT00265759|Baylor College of Medicine|Matthew J. Ellis, MB, BChir, BSc., PhD, FRCP|713 798-1999|Matthew.Ellis@bcm.edu|
22420272|NCT04653454|Mayo Clinic|Adrian Dumitrascu M.D.|904-956-0081|Dumitrascu.Adrian@mayo.edu|
22420273|NCT05473182|Grand Valley State Univeristy College of Health Professions|Dr. Lisa K. Kenyon|616-331-5653|kenyonli@gvsu.edu|
22420274|NCT05525520|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22420275|NCT05878093|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
22420276|NCT04515147|CureVac AG|Clinical Trial Information|0049 6976805870|clinicaltrials@curevac.com|
22420277|NCT04123405|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22420278|NCT01050530|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22420279|NCT01339403|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22420280|NCT03983980|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
22420281|NCT01121250|Memphis VA Medical Center|Dr. Linda Nichols|901 523-8990|linda.nichols@va.gov|5082
22420282|NCT01202175|Univeristy of California, San Diego|Joachim H. Ix, MD, MAS|858-552-7528|joeix@ucsd.edu|
22420283|NCT02790437|Hansa Biopharma AB|Elisabeth Sonesson, Director Clinical Operations|+46 (0)708 54 86 46|elisabeth.sonesson@hansabiopharma.com|
22420284|NCT04747470|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22431885|NCT01959529|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22431886|NCT01440764|Beth Israel Deaconess Medical Center|Robert Banzett, PhD|(617)667-0572|rbanzett@bidmc.harvard.edu|
22431887|NCT03807089|Massachusetts General Hospital|Dr. Norman Nishioka|617-726-4422|nnishioka@partners.org|
22431888|NCT00557193|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22431889|NCT03036852|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22431890|NCT00652834|UCLA Kidney Transplant Research Program|Dr. Bunnapradist|310-794-8516|bunnapradist@mednet.ucla.edu|
22431891|NCT00991809|Johns Hopkins University, School of Medicine|Dr. D. Andrew Tompkins|410-550-5953|dtompki1@jhmi.edu|
22431892|NCT03984825|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22431893|NCT02196922|Northwell Health|Renee Pekmezaris, Ph.D., Vice President Community Health & Health Services Research|516 465-3161|rpekmeza@northwell.edu|
22431894|NCT00742625|Massachusetts General Hospital Cancer Center|Eyal Attar, MD|617-724-1124|eattar@partners.org|
22431895|NCT01365793|University of California, Davis (UC Davis Health)|Nathan Kuppermann|916-734-1535|nkuppermann@ucdavis.edu|
22431896|NCT01908140|AstraZeneca|Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22431897|NCT01307449|Emory University|Rouphael, Nadine|404-712-1435|nroupha@emory.edu|
22431898|NCT00427193|Duke University Medical Center|William E. Kraus, Director of Clinical Research, Duke Center for Living|919-681-6733|william.kraus@duke.edu|
22431899|NCT02927795|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22420285|NCT03805386|Mayo Clinic Arizona|Principal Investigator, Dr Johnny Yi|14803420612|yi.johnny@mayo.edu|
22431900|NCT01076010|AVEO Pharmaceuticals, Inc.|Cheif Medical officer|857-400-0101|Clinical@aveooncology.com|
22431901|NCT02814656|AstraZeneca|Ioannis Psallidas||ClinicalTrialTransparency@astrazeneca.com|
22431902|NCT00538850|Insys Therapeutics, Inc.|Larry Dillaha, M.D., Chief Medical Officer|602 910-2617|ldillaha@insysrx.com|
22431903|NCT02135484|UT MD Anderson Cancer Center|John C. Araujo, Associate Professor, Genitourinary Medical Oncology|(713) 792-2830|johna@mdanderson.org|
22431904|NCT00397540|Seoul National University Hospital Boramae Medical Center|Won Kim|82 2 870 2233|wonshiri@yahoo.com|
22431905|NCT01126957|University of Missouri-Columbia|Dr. David Henry|573/884-2582|henryda@missouri.edu|
22431906|NCT00956293|Novartis Pharmaceuticals|Study Director|+1 (862) 778-1873||
22431907|NCT02536664|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22431908|NCT02972996|Stratton V.A. Medical Center|Margaret M. Wilson MS, RD, LD/N, CD/N, CNSC, CDE|518 626-6889|margaret.wilson2@va.gov|
22431909|NCT03507127|Brown University|Dr. Jennifer Tidey|4018636418|jennifer_tidey@brown.edu|
22431910|NCT01497756|uNewMexico|Mark Hauswald MD|505-269-6699|markhauswald@gmail.com|
22431911|NCT02081586|University of Pittsburgh School of Nursing|Dr. Judith A. Callan PhD, RN|412-383-5321|callanja@pitt.edu|
22431912|NCT03050710|CROMA - PHARMA|Head of Clinical Operations|+43 0226268468|clinical.studies@croma.at|
22431913|NCT01355627|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22431914|NCT01230411|Thomas Jefferson University- Jefferson Headache Center|Dr. Hsiangkuo Yuan|2159552243|Hsiangkuo.Yuan@jefferson.edu|
22431915|NCT02106429|NYU Langone Health|Jeffrey Berger, MD|212-263-4004|jeffrey.berger@nyulangone.org|
22431916|NCT02666560|University College London|Joanne Lindop|07909116145|joanne.lindop.12@ucl.ac.uk|
22431917|NCT01356147|Stanford University School of Medicine/Division of Neonatology|Dr. Melissa Scala|650-724-9653|mscala@stanford.edu|
22431918|NCT00789555|Alcon Research|Terri Pasquine, Sr. Clinical Lead|817-551-4760|terri.pasquine@alconlabs.com|
22420286|NCT01525329|Cleveland Clinic|Dr. Edward Maytin|216-445-6676|maytine@ccf.org|
22420287|NCT00780338|RAND|Matthew Chinman|412 683-2300|chinman@rand.org|4287
22420288|NCT01125189|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22420289|NCT00110396|Merck Serono SA|Bettina Stubinski/Medical Responsible|+41224143396||
22420290|NCT01269918|Cleveland Clinic|Daniel Sessler, MD|216-445-6500|sesslerd@ccf.org|
22420291|NCT00245466|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
22420292|NCT00856193|Novartis Pharmaceuticals|Study Director|862-778-8300||
22431919|NCT04712669|Sumitomo Pharma America|Ravi Grewal|+1 (508) 481-6700|ravi.grewal@us.sumitomo-pharma.com|
22420293|NCT03885661|University of Pennsylvania|John Millar, PhD|215-898-0638|jsmillar@pennmedicine.upenn.edu|
22420294|NCT05064397|H. Lundbeck A/S|Email contact via H. Lundbeck A/S|+45 36301311|LundbeckClinicalTrials@Lundbeck.com|
22420295|NCT04542057|Verona Pharma plc|Chief Medical Officer|See email|info@veronapharma.com|
22420296|NCT02324582|Southern Illinois University School of Medicine|Dr. Krishna Rao|217-545-7969|krao@siumed.edu|
22420297|NCT04309617|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22420298|NCT06372210|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22420299|NCT00129545|Boston Scientific|Watchman Trial Manager|1-800-227-3422||
22420300|NCT03624192|AVITA Medical|VP, Clinical Research|661-367-9170|USClinicalTrials@avitamedical.com|
22420301|NCT04660331|Fred Hutchinson Cancer Center|Dr. Parth Shah|2066676120|pshah@fredhutch.org|
22420302|NCT02463773|University of Minnesota|Roy Cho, MD|612-626-2637|choxx548@umn.edu|
22420303|NCT01640249|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22420304|NCT00065156|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22420305|NCT00312338|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22420306|NCT00100828|SKCCC at Johns Hopkins|Arlene Forastiere|410-955-9818|af@jhmi.edu|
22420307|NCT04583735|Horizon Pharma USA, Inc.|Medical Monitor|1-866-479-6742|medicalinformation@horizontherapeutics.com|
22420308|NCT01176513|GE Healthcare|Paul Gordon, PhD|011-47-2318-5822|Paul.Gordon@ge.com|
22420309|NCT01215136|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317-643-5842|jsmith@hoosiercancer.org|41
22420310|NCT03757819|University of Iowa|Thorsten Rudroff|17205323701|thorsten-rudroff@uiowa.edu|
22420311|NCT01125917|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333||
22420312|NCT05824754|University of Michigan|Inbal Billie Nahum-Shani|7346609626|inbal@umich.edu|
22420313|NCT04421131|Duke University|Lavanya Vasudevan, Ph.D.|919-613-1423|lavanya.vasudevan@duke.edu|
22420314|NCT02308124|SNUH|Jung-Ick Byun|+8224406254|mr830611@gmail.com|
22420315|NCT00115076|Rockefeller University|James G. Krueger MD, PhD|212-327-7730|kruegej@rockefeller.edu|
22420316|NCT01957176|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22420317|NCT00952731|Northwestern University|Dr. Seema Khan|312-503-4236|s-khan2@northwestern.edu|
22420318|NCT01449812|GlaxoSmithKline|GSK Response Center|866-435-7343||
22420319|NCT05954988|Rein Therapeutics, Inc.|Shawna Evans|1 (737) 802-1989|info@reintx.com|
22420320|NCT06146361|The University of Texas Health Science Center at Houston|Maria E. Fernandez-Esquer, PhD|713-500-9657|Maria.E.Fernandez-Esquer@uth.tmc.edu|
22420321|NCT04952922|The Royal Marsden NHS Foundation Trust|Dr Grainne Brady|0000000000000|grainne.brady@rmh.nhs.uk|
22420322|NCT04075487|VA Maryland Health Care System, Geriatric Research, Education, and Clinical Center|Dr. Beth Hogans, M.D., Ph.D., Neurologist|410-605-7000|beth.hogans@va.gov|
22420323|NCT05411991|University Hospital Brussels - Vrije Universiteit Brussel|Prof. Dr. Frederik H. Verbrugge|024749657|frederik.verbrugge@uzbrussel.be|+32
22420324|NCT05655546|Scripps Research|Julia Moore Vogel|8587842275|immunocare@scripps.edu|
22420325|NCT03493685|Travere Therapeutics, Inc|Travere Therapeutics Call Center|1-877-659-5518|medinfo@travere.com|
22420326|NCT04452669|Aerogen Pharma|David Durand, MD|510-928-2111|ddurand@aerogenpharma.com|
22420327|NCT02218463|University of Missouri-Kansas City School of Medicine|Dr. Tazim Dowlut-McElroy, M.D., M.S.|816-404-5150|tdowlut@cmh.edu|
22420328|NCT03700125|Barts Health NHS Trust|Dr Simon Finney|02073777000|simon.finney2@nhs.net|
22420329|NCT04576507|New York State Psychiatric Institute|Caroline A. Arout, Ph.D.|646-774-6167|caroline.arout@nyspi.columbia.edu|
22420330|NCT02721732|The University of Texas MD Anderson Cancer Center|Dr. Aung Naing|(713) 563-3885|anaing@mdanderson.org|
22420331|NCT06227052|Queen's Medical Center|Catherine Rault|808-686-4690|crault@hawaii.edu|
22420332|NCT04479852|Sirtsei Pharmaceuticals|Greg Rigdon, PhD|+1 919-949-6862|grigdon@arrivobio.com|
22420333|NCT04589247|Johns Hopkins University|Ranh Voong, MD|4105506597|kvoong1@jhmi.edu|
22420334|NCT04100018|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22420335|NCT02848001|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22420336|NCT04358081|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22420337|NCT06379048|Çam and Sakura City Hospital|Dr. Emre Kar|+90 (0212) 909 60 00|emre.kar@sbu.edu.tr|11250
22420338|NCT00725283|GlaxoSmithKline|GSK Response Center|866-435-7343||
22420339|NCT03103087|Myovant Sciences GmbH|Clinical Trials at Myovant|+1 650 238 0250|clinicaltrials@myovant.com|
22420340|NCT00118157|Barbara Ann Karmanos Cancer Institute|Sayeh Lavasani, M.D.|(313) 576-8751|lavasans@karmanos.org|
22420341|NCT00413699|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22420342|NCT01051310|Medtronic|M. Hollander|+31620534428|maarten.hollander@medtronic.com|
22420343|NCT02115269|Abbott|Jean-Pascal Berrou, Global Medical Director CNS/Pain|+41614870457|jean-pascal.berrou@abbott.com|
22420344|NCT05989672|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22420345|NCT03283566|Cleveland Clinic Foundation, Department of Endocroine and Metabolism|EMI Research Director|216 445-3757|jenkink@ccf.org|
22420346|NCT02760004|UMass Chan Medical School / UMass Memorial Health|Nancy Byatt, Tenured Professor of Psychiatry, ObGyn, and Population & Quantitative Health Sciences|508.856.5812|Nancy.Byatt@umassmemorial.org|
22420347|NCT01495000|GlaxoSmithKline|GSK Response Center|866-435-7343||
22420348|NCT02070965|Promius Pharma, LLC|Director of Clinical Operations|609-282-1476|kgulbronson@promiuspharma.com|
22420349|NCT03889886|SilkTech Biopharmaceuticals|Brian Lawrence|6172720691|brianlawrence@silk-tech.com|
22420350|NCT04004481|University hospital Osijek|Nenad Neskovic|+385996787250|nneskov@gmail.com|
22420351|NCT01308424|Beech Tree Labs, Inc.|Dr. John McMichael|518-872-1144||
22420352|NCT00948155|University of Pennsylvania|Andrew A. Strasser, Ph.D., Associate Professor|215 746 5788|strasse3@mail.med.upenn.edu|
22420353|NCT05767905|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22420354|NCT01841593|SSAT Research, Chelsea & Westminster Hospital|Dr. Marta Boffito|+442033155601|marta.boffito@chelwest.nhs.uk|
22420355|NCT02635984|AU Medical Center / University of Georgia College of Pharmacy|Dr. Amber Clemmons, Clinical Pharmacist - BMT/Hematology & Clinical Associate Professor|706-721-6493|aclemmons@augusta.edu|
22420356|NCT03135015|Housey Healthcare ULC|Project Manager|2486637000|info@housey.com|
22420357|NCT00307086|H. Lee Moffitt Cancer Center|Mellisa Alsina, MD|813-745-6886|Melissa.Alsina@moffitt.org|
22420358|NCT01487525|University of Iowa|Dr. Neil Segal|3193358204|segal-research@uiowa.edu|
22420359|NCT03518008|Alcon Research|Senior Clinical Project Lead, GCRA - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22420360|NCT00708110|ViiV Healthcare|GSK Response Center|866-435-7343||
22420361|NCT02501928|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22420362|NCT01197911|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22420363|NCT00838526|Eisai Inc.|Eisai Medical Information, Eisai|+1 888 274 2378|esi_medinfo@eisai.com|
22420364|NCT00611624|Yale Comprehensive Cancer Center|Kira F. Pavlik, CCRP Clinical Research Coordinator Therapeutic Radiology|(203) 737-2587|kira.pavlik@yale.edu|
22420365|NCT04338022|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22420366|NCT00786409|University of Chicago|Linda Wagner-Weinter, MD|773-702-2245|lww@uchicago.edu|
22420367|NCT00610129|Memorial Sloan Kettering Cancer Center|Dr. Diane Reidy|646-888-4185|ReidyD@mskcc.org|
22420368|NCT02216097|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22420369|NCT02273388|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22420370|NCT04331808|Hopital Hotel Dieu (AP-HP)|Dr Raphael Porcher|+33 (0)1.42.34.89.87|raphael.porcher@aphp.fr|
22420371|NCT02445963|Walter Reed Army Institute of Research (WRAIR) Clinical Trials Center (CTC)|Christopher Duplessis, MD|301-319-9047|Christopher.a.duplessis.mil@mail.mil|
22420372|NCT02421055|Imperial College London|Dr Nicholas Penney|020 7589 5111|n.penney@imperial.ac.uk|
22420373|NCT03172494|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22420374|NCT04233073|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1-855-752-2356|clinicaltrials@alexion.com|
22420375|NCT00143390|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22420376|NCT04589663|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22420377|NCT00243412|Hoffman-LaRoche|Medical Communications|800-821-8590||
22420378|NCT00041132|SWOG Statistical Center|Study Statistician|206-667-4623||
22420379|NCT02764151|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22420380|NCT00736632|Washington University in St. Louis|Dr. Carlos Bernal-Mizrachi|314-362-0947|cbernal@wustl.edu|
22420381|NCT01450683|Stanford University Medical Center|Associate Professor of Medicine (Oncology)|650-725-2078|sandysri@stanford.edu|
22420382|NCT00681031|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22420383|NCT00625872|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22420384|NCT01512160|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22420385|NCT02729909|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22420386|NCT03220854|Virginia Commonwealth University Massey Cancer Center|Alfredo I Urdaneta|(804) 828-0450|MasseyRadOnc@vcu.edu|
22420387|NCT04779879|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
22420388|NCT05101343|Winthrop University|Compliance Coordinator|8033232460|smithmr@winthrop.edu|
22420389|NCT02854527|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22420390|NCT01959295|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
22420391|NCT01611779|Siesta Medical, Inc.|Michael Kolber|408-320-9424|mkolber@siestamedical.com|
22420392|NCT01004744|Columbia University|Dr. Katherine Crew|212-305-1732|kd59@cumc.columbia.edu|
22420393|NCT01682811|Medical College of Wisconsin|Harry T. Whelan MD, Bleser Professor of Neurology|414-266-7544|hwhelan@mcw.edu|
22420394|NCT01128179|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22420395|NCT03475992|MVG Industries|Luc Duchesne|0033169298156|luc.duchesne@mvg-world.com|
22420396|NCT02694328|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
22420397|NCT00134004|Johns Hopkins University|Dr. Ephraim Fuchs|410-419-6479|fuchsep@jhmi.edu|
22420398|NCT03511105|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22420399|NCT02810457|Centus Biotherapeutics Limited|Clinical Trial Information|+353 1 609 7100|Clinical-Trial@centusbio.com|
22420400|NCT01962103|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22420401|NCT02750618|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
22420402|NCT03456102|Johns Hopkins University School of Medicine|Petros C. Karakousis, MD|410-502-8233|petros@jhmi.edu|
22420403|NCT03077737|Northwestern University|Dr. Brian Hitsman, PhD|312-503-2074|b-hitsman@northwestern.edu|
22420404|NCT02094300|Cook Research Incorporated|Scott Snyder, PhD, Director of Clinical Science and Biostatistics|765-463-7537|SSnyder@medinst.com|
22420405|NCT00276484|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22420406|NCT03901313|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22420407|NCT01608100|Abbott Diagnostics Division|Karla Grasso, Clinical Research Manager|1 224-667-5602|karla.grasso@abbott.com|
22420408|NCT02423200|EIP Pharma|John Alam|617-945-0794|jalam@eippharma.com|
22420409|NCT04937881|UCLA|Dvora Joseph Davey|3107011526|dvoradavey@ucla.edu|
22420410|NCT04055740|University of Chicago|Dr. Andrew Beaser|(888) 824-0200|abeaser@bsd.uchicago.edu|
22420411|NCT01277783|Medtronic Bakken Research Center B.V.|Mireille van Ginneken, Principal Clinical Research Specialist|+31433566801|mireille.vanginneken@medronic.com|
22420412|NCT03347110|Cares|UCB|+1-844-599-2273|UCBCares@ucb.com|
22420413|NCT00116779|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
22420414|NCT01690117|University of Leipzig, Medical Faculty, Clinic and Policlinic for Psychiatry and Psychotherapy|Prof. Dr. Hermann-Josef Gertz|0049 (0)341 97 24420|Hermann-Josef.Gertz@medizin.uni-leipzig.de|
22392730|NCT00972322|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22392731|NCT01533753|University of Wisconsin Carbone Cancer Center|Dr. Justine Bruce|608-263-7107|jybruce@medicine.wisc.edu|
22392732|NCT04531098|VBI Vaccines|Dr. Francisco Diaz-Mitoma|1 613 297 3304|fdiazmitoma@vbivaccines.com|
22392733|NCT00316017|Clinical Trial Center, University of Washington, Seattle, WA|Susanne May, PhD|206-685-1302|sjmay@uw.edu|
22392734|NCT00422812|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
22392735|NCT01809834|School of Optometry, University of Waterloo|Lyndon Jones, PhD, FCO|519-888-4742|ljones@uwaterloo.ca|
22392736|NCT00623805|Hoffmann-La Roche|Medical Communications|800 821-8590||
22392737|NCT01949389|VA Connecticut Healthcare system|Eric Hermes|203 932 5711|eric.hermes@va.gov|7422
22392738|NCT02671500|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22420415|NCT01004354|University of Massachusetts Medical School|Benjamin U Nwosu, MD|5083347872|benjamin.nwosu@umassmemorial.org|
22420416|NCT01321879|UT MD Anderson Cancer Center|Dr. Issam I. Raad/ Chair, Infectious Diseases|713- 792-7943|iraad@mdanderson.org|
22420417|NCT02687451|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|clinicaltrials@endo.com|
22420418|NCT02321111|University of Texas Health San Antonio|Laurie Che Kelly|210-617-5300|che@uthscsa.edu|14731
22420419|NCT01518322|Aerocrine, Inc.|Nancy Herje|919-449-8873|Nancy.Herje@aerocrine.com|
22420420|NCT00707239|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22420421|NCT03472014|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
22420422|NCT00218387|Medical University of SC|Robert Malcolm, MD|843-792-1901|malcomr@musc.edu|
22420423|NCT01400477|University of Colorado|Dr. Robert Freedman|393 724 1000|robert.freedman@ucdenver.edu|
22420424|NCT03652051|Azura Ophthalmics|Charles Bosworth|17145598435|charles.bosworth@azuraophthalmics.com|
22420425|NCT01930162|Novartis Pharmaceuticals|Study Director|862-778-8300||
22420426|NCT01936844|Virginia Commonwealth University|Benjamin Van Tassell, PharmD|8048284583|bvantassell@vcu.edu|
22420427|NCT02394600|Kingston General Hospital|Dr. Anne Ellis|613-548-2336|ellisa@kgh.kari.net|
22420428|NCT02569801|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22420429|NCT00776035|Washington University School of Medicine|Linda R. Peterson, MD, Professor of Medicine and Radiology|314-362-4577|lpeterso@wustl.edu|
22420430|NCT03442751|Glaukos|Valerie Smith|9493679600|VSmith@glaukos.com|
22420431|NCT03934541|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22420432|NCT04408729|Massachusetts General Hospital|Jessica Haberer, MD, MS|617-724-0351|jhaberer@mgb.org|
22420433|NCT01928472|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22420434|NCT04620746|Johns Hopkins University School of Medicine|Jonathan Zenilman|410-550-9080|jzenilm1@jh.edu|
22420435|NCT04584502|Geisel School of Medicine|Sarah Lord, Ph.D.|6036467089|sarah.e.lord@dartmouth.edu|
22420436|NCT02777372|The Johns Hopkins University School of Medicine|Liisa Hantsoo, Ph.D.|410-502-2334|LHantso1@jh.edu|
22420437|NCT05807828|1. Academic Orthopaedic Department, Aristotle University Medical School, General Hospital Papageorgiou 2. Centre of Orthopaedic and Regenerative Medicine (CORE), Center for Interdisciplinary Research and Innovation (CIRI)-AUTh|Eustathios Kenanidis - Assistant Professor of Orthopaedic Surgery & Traumatology|6973693693|ekenanidis@auth.gr|
22420438|NCT03104855|University of Washington|Dr. Ian de Boer|206-616-5403|IDeBoer@Nephrology.washington.edu|
22420439|NCT03897634|Northwestern University|Kendra Marks|847-467-0897|kendra.marks@northwestern.edu|
22420440|NCT03404674|PATH|Rahsan Erdem|202-540-4546|rerdem@path.org|
22420441|NCT01924559|Lehigh Valley Hospital|Marna Rayl Greenberg, DO, MPH|484-884-7514|Marna.Greenberg@lvh.com|
22420442|NCT01903798|SCIRE|Executive Director, Southern California Institute for Research and Education|562-826-8000|Sabry.Eassa@va.gov|5747
22420443|NCT00858494|University of Washington|James A Taylor|206-616-1206|uncjat@uw.edu|
22420444|NCT03737357|Institut Straumann|Anaïs Robert, Clinical Trial Leader|+41799258750|anais.robert@straumann.com|
22420445|NCT01526057|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22420446|NCT02123446|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22420447|NCT04201197|Johns Hopkins School of Medicine|Dr. Ryan Vandrey|410-550-4036|rvandrey@jhmi.edu|
22420448|NCT02553772|Allergan, Inc|Therapeutic Area Head,|1-877-277-8566|IR-CTRegistration@allergan.com|
22420449|NCT02860546|Taiho Oncology, Inc.|Taiho|844-878-2446|medicalinformation@taihooncology.com|
22392739|NCT01807000|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22392740|NCT05235269|Attralus|Scott Stephens, Senior Director Clinical Operations|321-228-7400|sstephens@attralus.com|
22392741|NCT03361865|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
22392742|NCT03810235|School of Medicine and Public Health University of Wisconsin-Madison|Kathleen M. Antony, M.D, M.S.C.I|608-417-6099|kantony@wisc.edu|
22392743|NCT01647542|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22392744|NCT03843554|University of Pittsburgh|Associate Vice Chancelor, Clinical Trials Operations|412-383-2561|pat.corby@pitt.edu|
22392745|NCT01736943|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
22392746|NCT02218606|Memorial Sloan Kettering Cancer Center|Dr. Susan Slovin, MD, PhD|646-422-4472|slovins@MSKCC.ORG|
22392747|NCT00890695|KEMRI/Wellcome Trust Research Programme|Dr James Berkley|+254 41 522535|jberkley@kilifi.kemri-wellcome.org|
22392748|NCT04420949|University of Wisconsin - Madison|Dr. Kreg Gruben|608 262 2711|kreg.gruben@wisc.edu|
22392749|NCT04396366|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22392750|NCT01663922|St Stephens AIDS Trust|Dr Akil Jackson|0203 315 6503|akil.jackson@chelwest.nhs.uk|
22392751|NCT01534143|Barbara Ann Karmanos Cancer Institute|Zaid Al-Kahdimi, M.D.|(313) 576-8022|zalkadh@emory.edu|
22392752|NCT02988050|Menoufia University|Professor Ezzeldin Ibrahim, Professor of Anaesthesia|00201006303178|ezzeldin7@yahoo.com|
22392753|NCT01127893|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22392754|NCT01262677|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22392755|NCT00574873|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22392756|NCT04512703|ZOLL Medical Corporation|Mike Osz|4129683333|mosz@zoll.com|14104
22392757|NCT02187159|Daiichi Sankyo, Inc.|Daiichi Sankyo US Contact for Clinical Trial Results|1-908-992-6400|CTRinfo@DSI.com|
22392758|NCT01283152|Baylor University Medical Center|Robert S. Rahimi, M.D., M.S.C.R. Assistant Professor, Department of Medicine|214-820-8500|Robert.Rahimi@Baylorhealth.edu|
22392759|NCT00567567|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|Resultsreportingcoordinator@childrensoncologygroup.org|
22392760|NCT03433677|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22392761|NCT03330405|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22392762|NCT03482466|Baylor College of Medicine; Michael E. DeBakey VA Medical Center; Menninger Clinic|Ramiro Salas|7137983502|rsalas@bcm.edu|
22392763|NCT04833127|NYS Psychiatric Institute and Columbia University|Dr. Susie Hoffman|718 744 7686|sh51@cumc.columbia.edu|
22392764|NCT01736189|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22392765|NCT01499303|AstraZeneca|Bernadette Weidman|800-456-3669|ClinicalTrialTransparency@astrazeneca.com|
22392766|NCT01896557|Heart Institute of University of Sao Paulo Medical School|Remo Holanda de Mendonca Furtado|+5511 26615058|remo_holanda@hotmail.com|
22392767|NCT02383940|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22392768|NCT01517295|International Clinical Research Institute|Srinivas Nalamachu|913.317.5300|nalamachu@yahoo.com|
22392769|NCT02672852|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22392770|NCT01353859|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22392771|NCT00626626|Penn State Hershey Medical Center|Dr David Claxton|717-531-8401|dclaxton@hmc.psu.edu|
22392772|NCT03853551|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|8772409479
22392773|NCT05435482|University of California, San Francisco|Ji Won Choi|415.340.1434|jiwon.choi@ucsf.edu|
22392774|NCT01923467|University of Michigan|Larry An, MD|734-763-6099|lcan@med.umich.edu|
22392775|NCT01075958|Northumbria University|Dr Philippa Jackson|+44 191 204 8818|philippa.jackson@northumbria.ac.uk|
22392776|NCT01021618|Hartford Hospital|Gary V Heller, MD, PhD|860-545-5527|aahlber@harthosp.org|
22392777|NCT01373580|ReVision Optics|Tracy Shwaery, Global Clinical Research Manager|9497072740|tshwaery@revisionoptics.com|157
22392778|NCT02636725|University of Miami|Jonathan Trent MD|305-243-2581|JTrent@med.miami.edu|
22392779|NCT03878277|University of Colorado School of Medicine|Petter Bjornstad, M.D., Assistant Professor of Pediatrics and Medicine|7207774659|petter.bjornstad@childrenscolorado.org|
22392780|NCT00968071|The University of Texas M. D. Anderson Cancer Center|Gautam Borthakur M.D./Associate Proffesor|713-563-1586|eharriso@mdanderson.org|
22392781|NCT01696045|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
22392782|NCT01559129|Celgene Corporation|Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22392783|NCT03525392|Ipsen Pharma SAS|Medical Director|see email|clinical.trials@ipsen.com|
22392784|NCT03262662|University at Buffalo|Larry Hawk, PhD|716-829-2323|lhawk@buffalo.edu|
22392785|NCT00831129|University of Chicago|Dr. George Bakris|773-702-7936|bbrisky@medicine.bsd.uchicago.edu|
22392786|NCT01333813|GlaxoSmithKline|GSK Response Center|866-435-7343||
22392787|NCT02917603|UMissouri|Debra Parker Oliver; PI|573-356-6719|oliverdr@missouri.edu|
22392788|NCT04462289|Minneapolis VA Health Care System|Dr. Anne Melzer|6124674413|anne.melzer2@va.gov|
22392789|NCT00818779|Texas Tech University Health Sciences Center School of Medicine|Gary Meyerrose|806-743-3150|gary.meyerrose@ttuhsc.edu|
22392790|NCT00132873|Jazz Pharmaceuticals, Inc.|Mortimer Mamelak, MD|650 496 3777|roman.skowronski@jazzpharma.com|
22392791|NCT04276415|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22420450|NCT02466321|Zimmer Biomet|Elliott Goff|+41 79 222 23 08|elliott.goff@zimmerbiomet.com|
22420451|NCT01855828|Yale University|Lajos Pusztai, MD, DPhil|203-737-6858|lajos.pusztai@yale.edu|
22431920|NCT00639457|Washington Univ Med Sch|Kevin Yarasheski, PhD|3143628173|key@wustl.edu|
22392792|NCT03603002|Johns Hopkins University, Department of Radiation Oncology|Dr. K. Ranh Voong|410-550-6597|kvoong1@jhmi.edu|
22420452|NCT03649347|Stress, Trauma, and Anxiety Research Clinic (STARC) at Wayne State University|Kathleen Gorski, Research Coordinator|313-577-9202|kathleen.gorski2@med.wayne.edu|
22420453|NCT05275920|NYU Langone Health|Amrita Mukhopadhyay, MD|212-263-7751|amrita.mukhopadhyay@nyulangone.org|
22420454|NCT02614274|University of Missouri|James L. Cook, Director of Research|573-884-4689|cookjl@health.missouri.edu|
22420455|NCT00489255|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22420456|NCT03953612|Yale School of Medicine|Verica Milivojevic, PhD|203-737-5201|verica.milivojevic@yale.edu|
22420457|NCT03485352|Federal University of Uberlandia|Mrs Cibele Crispim|55 34 3218-2084|cibelecrispim@gmail.com|
22420458|NCT02028676|Medical Research Council|Professor Ann Sarah Walker|+44 20 7670 4726|rmjlasw@ucl.ac.uk|
22420459|NCT02084160|Exalenz|Avrahm Hershkowitz/ Clinical Trial Manager|972-8-9737500|avrahamh@exalenz.com|
22420460|NCT00852202|Allergan Sales LLC|Therapeutic Area Head,|877-277-8566|IR-CTRegistration@allergan.com|
22420461|NCT03691727|University of Iowa|David Hasan|319-384-8669|david-hasan@uiowa.edu|
22420462|NCT02552121|Genmab A/S|Genmab|7020 2728|clinicaltrials@genmab.com|+45
22420463|NCT03629184|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22420464|NCT01263938|University of Pennsylvania School of Medicine|Dr. Ronald Collman|215-898-0193|collmanr@pennmedicine.upenn.edu|
22420465|NCT00853099|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22420466|NCT01917682|Corindus, Inc.|John Van Vleet, VP of Clinical and Regulatory Affairs|(260)615-8892|john.van_vleet@siemens-healthineers.com|
22420467|NCT02521415|Carolinas Medical Center|Dr. Stacy Reynolds|704-355-3181|stacy.reynolds@carolinashealthcare.org|
22420468|NCT02439216|Astria Therapeutics, Inc|Andrew Nichols, PhD - Chief Scientific Officer|617-349-1971|anichols@astriatx.com|
22420469|NCT00200902|Laboratory of Brain, Behavior, and Pharmacology at the University of California Los Angeles|Andrew Leuchter, MD|310-825-0207|jpv@brain.ucla.edu|
22420470|NCT01111318|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22420471|NCT00470535|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22420472|NCT04505969|Barau Dikko Teaching Hospital, Kaduna State University|Study Principal investigator|+2348066664042|abubakarabdulkareem8@gmail.com|
22420473|NCT00725491|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22420474|NCT01094704|UNC-Chapel Hill|Scott Donaldson|919-966-9198|scott_donaldson@med.unc.edu|
22420475|NCT00942357|NRG Oncology|Linda Gedeon on behalf of Virginia Filiaci, PhD. and Helen Huang, MS.|716-845-1169|lgedeon@gogstats.org|
22420476|NCT00897715|VA Tennessee Valley Healthcare System.|Adriana Hung|615-873-7480|adriana.hung@va.gov|
22420477|NCT01641640|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22420478|NCT01545648|University of California, San Francisco|Hope Rugo, MD|877-827-3222|cancertrials@ucsf.edu|
22420479|NCT01199939|Janssen Pharmaceuticals|SENIOR MEDICAL DIRECTOR|1 609 730-2931||
22420480|NCT03238651|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22420481|NCT03875508|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22420482|NCT00711087|Baylor College of Medicine|Christopher P. Smith, MD, MBA, MSS|713-798-7498|cps@bcm.edu|
22420483|NCT02137252|Dana-Farber Cancer Institute/Brigham and Women's Hospital|Fremonta Meyer, MD||flmeyer@partners.org|
22420484|NCT04460911|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22420485|NCT00428246|Indiana University|Rajiv Agarwal|317-988-2241|ragarwal@iupui.edu|
22420486|NCT00656656|University of Lübeck|Prof. Dr. Detlef Zillikens|+49-451-500-41500|detlef.zillikens@uksh.de|
22420487|NCT00981812|University of Cincinnati Medical Center|Mary Mahoney, MD|513-584-4396|mary.mahoney@uchealth.com|
22420488|NCT02603887|UT MD Anderson Cancer Center|Dr. Elisabet Manasanch/ Assistant Professor, Lymphoma-Myeloma|713-745-8092|eemanasanch@mdanderson.org|
22420489|NCT04442464|Mayo Clinic|Cherie B. Nau, O.D.|507-284-4152|Nau.Cherie@mayo.edu|
22420490|NCT03535740|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22420491|NCT04481035|Cincinnati Children's Hospital Medical Center|Donald L. Gilbert MD|513-636-4222|donald.gilbert@cchmc.org|
22420492|NCT05198518|Icahn School of Medicine at Mount Sinai|Alfred Marc C Iloreta Jr, MD|(212) 241-9410|alfred-marc.iloreta@mountsinai.org|
22420493|NCT00890617|Barbara Ann Karmanos Cancer Institute|Dr. Frank A. Baciewicz|(313) 993-0580|FBaciewi@dmc.org; baciewic@karmanos.org|
22420494|NCT01223378|Bausch & Lomb|H DeCory, PhD|585-338-8161|heleen.decory@bausch.com|
22420495|NCT01870778|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22420496|NCT05317312|Viatris|Susanne Vogt|004906172|susanne.vogt@viatris.com|88801
22420497|NCT00124917|National Cancer Institute|Dr. Deborah Citrin|301-496-5457|Debra_Citrin@nih.gov|
22420498|NCT01805089|DFCI|Dr. Wendy Chen|617-632-3800|wychen@partners.org|
22420499|NCT00613171|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22420500|NCT04941131|King Abdulaziz University|Dr Zuhair Natto|9666943899|znatto@kau.edu.sa|
22420501|NCT00951496|NRG Oncology|Linda Gedeon for Mark Brady, PhD|716-845-1169|lgedeon@gogstats.org|
22420502|NCT01875978|China Medical University Hospital|Dr. Dalong Chen|+886-227919696|my686chen@gmail.com|1205
22420503|NCT01169350|University of Washington|Dr. Janet F. Eary|206-598-6244|jeary@uw.edu|
22420504|NCT04429945|James A Haley Veterans Hospital|Dr. Christopher Fowler|619-647-4470|christopher.fowler3@va.gov|
22420505|NCT04870710|BIDMC|Dr. Paulo Lizano|617-754-1227|plizano@bidmc.harvard.edu|
22420506|NCT01042093|Towson Orthopaedic Associates|David F. Dalury, MD|410-337-7900|ddalury@gmail.com|1221
22420507|NCT01329900|UT MD Anderson Cancer Center|Issa F Khouri, M.D. / Stem Cell Transplantation|713-745-0049|ikhouri@mdanderson.org|
22420508|NCT01866098|Connecticut Mental Health Center|Associate Professor of Psychiatry; Director, Psychosis Program, CMHC|(203) 974-7500|cenk.tek@yale.edu|
22420509|NCT04239027|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22420510|NCT03629080|Hookipa Biotech GmbH|Hookipa Front Desk|+43 1 890 63 60 0|office@hookipapharma.com|
22420511|NCT01184079|University of Pittsburgh Department of Family Medicine|Chyongchiou Jeng Lin, PhD|412/383-2360|cjlin@pitt.edu|
22420512|NCT03417687|Polarean|Laura Sutton|919-206-7900|lsutton@polarean.com|121
22420513|NCT01876446|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
22420514|NCT02108912|University of Texas Southwestern Medical Center|Karen McCain, PT, DPT, NCS|214-648-1559|karen.mccain@utsouthwestern.edu|
22420515|NCT05329259|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22420516|NCT01182376|University of Utah|Clinical Research Manager|8015873889|christina.pacchia@hsc.utah.edu|
22420517|NCT00619060|University of Arizona|Steve Stratton,PhD Chairman of Scientific Review Comittee|(520) 626-9295|SStratton@uacc.arizona.edu|
22420518|NCT01808573|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|424-248-6500|clinicaltrials@pumabiotechnology.com|
22420519|NCT02487225|Mayo Clinic|Dr. Santhi Swaroop Vege|507-284-7474|Vege.Santhi@mayo.edu|
22420520|NCT00995774|Washington DC Veterans Affairs Medical Center|Peter Lum, PhD|202-319-5181|lum@cua.edu|
22420521|NCT01523002|Medicines for Malaria Venture (MMV)|Stephan Duparc, MD, Chief Medical Officer|+41 22 555 0300|duparcs@mmv.org|
22420522|NCT01256502|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22420523|NCT01245283|UF&Shands Orthopaedics and Sports Medicine Institute|Kevin R. Vincent, M.D. Ph.D.|352-273-7458|vincekr@ortho.ufl.edu|
22420524|NCT00395161|University of Utah|Jeri Burr, MS, RN-BC, CCRC|801-587-7753|jeri.burr@hsc.utah.edu|
22420525|NCT03672227|REGENTS OF THE UNIVERSITY OF MICHIGAN|Dr. Katherine Bauer|(734)763-2546|kwbauer@umich.edu|
22420526|NCT01982955|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22420527|NCT02575833|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22420528|NCT03093259|Abivax|Sharon Skare|+33 (0) 1 53 83 08 41|sharon.skare@abivax.com|
22420529|NCT02633787|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22420530|NCT00768248|University California San Diego|Brian Ilfeld, MD, MS|858-822-0776|bilfeld@ucsd.edu|
22420531|NCT03051672|Dana-Farber Cancer Institute|Dr. Sara Tolaney|6176323800|sara_tolaney@dfci.harvard.edu|
22420532|NCT03793608|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22420533|NCT01328184|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22420534|NCT02548143|LFB USA|Kerry Biron, Director US Clinical Operations|508.370.5166|kerry.biron@lfb-usa.com|
22420535|NCT00692692|Vanderbilt University Medical Center|Jason Wendel, MD|615-936-0160|jason.wendel@vanderbilt.edu|
22420536|NCT07112885|Istanbul University, Department of Orthopedics and Traumatology|Mehmet Yağız Yenigün, MD (Principal Investigator)|+905544383142|mehmet.yenigun@istanbul.edu.tr|
22420537|NCT04004403|University of Illinois Chicago|Krista Varady|3129967897|varady@uic.edu|
22420538|NCT05120193|Medtronic, Inc.|Clinical Research Specialist|800-328-2518|medtroniccrmtrials@medtronic.com|
22420539|NCT05825404|Penn State University|Ying-Ling Jao|8148655634|yuj15@psu.edu|
22420540|NCT02243605|Institut Bergonie|Pr Italiano Antoine, Department of Medical Oncology|0524071947|a.italiano@bordeaux.unicancer.fr|
22420541|NCT03514459|University of Washington|Dr. McKenna Eastment|5742101120|mceast@uw.edu|
22420542|NCT01557504|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22420543|NCT02892955|Abbott|Joyce Chuang|9253535817|joyce.chuang@abbott.com|
22420544|NCT01365819|UCLA, Dept of Family Medicine|Dr. Steve Shoptaw|310-794-0619|sshoptaw@mednet.ucla.edu|
22420545|NCT01582490|Pacira Pharmaceuticals, Inc.|Erol Onel, MD|858-625-2424|erol.onel@pacira.com|
22420546|NCT01321749|XuanWu Hospital, Capital Medical University|Xunming Ji, M.D.,Ph.D.|8683198127|jixm70@hotmail.com , Jixm@ccmu.edu.cn|
22420547|NCT03825939|NYU Langone|Dr. Jan Koenig|516-678-2232|Jan.Koenig@nyulangone.org|
22420548|NCT04179838|Northwestern University|Thorsten Kahnt|3125032896|thorsten.kahnt@northwestern.edu|
22420549|NCT02763046|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22420550|NCT00080912|NCIC Clinical Trials Group|Dr. Bingshu Chen|613-533-6000|bechen@ctg.queensu.ca|77703
22420551|NCT03411031|Moffitt Cancer Center|Dr. Melissa Alsina|813-745-7202|Melissa.Alsina@moffitt.org|
22420552|NCT00818766|Brigham & Women's Hospital|David Oxman, MD|215-503-1198|doxman2001@yahoo.com|
22420553|NCT00086684|Janssen R&D US|SENIOR DIRECTOR CLINICAL LEADER|1 609 730-4529||
22420554|NCT02826486|BioLineRx Ltd|VP Clinical & Medical Affairs|+972-8-642-9100|clinicaltrials@biolinerx.com|
22420555|NCT01103180|University of Chicago|Dr. Emil Coccaro|773-834-4083|ecoccaro@yoda.bsd.uchicago.edu|
22420556|NCT01173523|Dana-Farber Cancer Institute|David M. Jackman, MD|617.632.3468||
22420557|NCT01067105|Sunovion|Respiratory Medical Director|1-866-503-6351||
22420558|NCT01866826|NCI|Frank Maldarelli, MD|301-846-5611|fmalli@mail.nih.gov|
22420559|NCT02493660|Stryker Company|Colleen Roden, Director, Clinical Operations|1 931 267 2041|colleen.roden@stryker.com|
22420560|NCT00709995|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22420561|NCT01276041|Memorial Sloan Kettering Cancer Center|Dr. Chau Dang, MD|914-367-7181|dangc@mskcc.org|
22420562|NCT00638508|Maimonides Medical Center|Kalpana Tyagaraj, M.D.|718-283-9162|Kalpana_tyagaraj@msn.com|
22420563|NCT03500198|Johnson & Johnson Surgical Vision|Devi Priya Janakiraman, OD, FAAO|+1 714 247- 8628|djanaki1@its.jnj.com|
22420564|NCT00654095|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22420565|NCT04650217|New York State Psychiatric Institute|Dr. Bret Rutherford|646 774 8660|brr8@cumc.columbia.edu|
22420566|NCT00595621|Texas Tech|Irene Sarosiek, MD, AGAF, FACG, CCRP|915.215.5254|Irene.sarosiek@ttuhsc.edu|
22420567|NCT02440464|The Emmes Company|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
22420568|NCT00324987|SWOG Statistical Center|SWOG Statistician|206-667-4408||
22420569|NCT00268450|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
22420570|NCT02968576|"University of Colorado | Skaggs School of Pharmacy and Pharmaceutical Sciences"|Dr. Peter Anderson|3037246128|peter.anderson@ucdenver.edu|
22420571|NCT01999920|NYSPI|Franklin Schneier, MD|6464774-8041|fschneier@nyspi.columbia.edu|
22420572|NCT02058069|MAKO Surgical Corp.|Michael Conditt|7132408675|michael.conditt@stryker.com|
22420573|NCT02222922|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22420574|NCT01998919|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22420575|NCT01268553|Los Angeles Biomedical research INst at Harbor-UCLA|Dr. Ronald Oudiz|310-222-3560|roudiz@labiomed.org|310
22420576|NCT00927589|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22420577|NCT00860795|University of Washington|James A Taylor, MD|206-616-1206|uncjat@u.washington.edu|
22420578|NCT01778530|National Cancer Institute|Dr. Joohee Sul|301-402-6298|Joohee_Sul@nih.gov|
22420579|NCT03103438|Biocad|Nadezhda Kravtsova|+7 (812) 380 49 33|kravtsovana@biocad.ru|
22420580|NCT02792517|Amgen Inc.|Study Director|866-572-6436||
22420581|NCT00882518|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22420582|NCT01958437|VA Ann Arbor Healthcare System; University of Michigan|Dr. Benjamin Hampstead|7347639259|bhampste@med.umich.edu|
22420583|NCT02200055|General Surgery, Naval Medical Center Porstmouth|Dr. Christopher Oxner|757-953-2495|christopher.r.oxner.mil@mail.mil|
22420584|NCT02015611|Wake Forest University School of Medicine|Dr. Denise Houston|336-713-8217|dhouston@wakehealth.edu|
22392793|NCT03746392|University of Washington|Program Coordinator (Elizabeth Nielsen)|206-744-9516|eniels9@uw.edu|
22431921|NCT03386773|Colorado School of Public Health|Susan L. Moore, PhD, MSPH|303-724-8858|susan.l.moore@cuanschutz.edu|
22431922|NCT00892008|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22431923|NCT00355030|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22431924|NCT00822094|Jazz Pharmaceuticals|Associate Director, Clinical Trial Disclosure & Transparency|(215) 832-3750||
22431925|NCT01693367|AO Foundation|Clinical Operations Manager of Clinical Investigation and Documentation|0041 44 200 24 67|andreas.faeh@aofoundation.org|
22431926|NCT00622726|University of Texas Health Science Center-Houston|Helen Mintz-Hittner, M.D.|713-559-5277|Helen.A.Mintz-Hittner@uth.tmc.edu|
22431927|NCT00399035|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22431928|NCT01987414|University of Minnesota|Chih-Huang Yu|6126262443|yuxxx648@umn.edu|
22431929|NCT02746809|Medtronic|Phuong-Uyen Le|763-526-0989|phuong-uyen.n.le@medtronic.com|
22431930|NCT02261961|Central Arkansas Veterans Healthcare System|Richard Dennis|501-257-5583|richard.dennis2@va.gov|
22431931|NCT03500211|Oregon Health & Science University|OB/Gyn Regulatory Specialist|503-494-3666|whru@ohsu.edu|
22431932|NCT02431325|Massachusetts General Hospital|Janet Lo, M.D., M.MSc.|617-724-3425|jlo@mgh.harvard.edu|
22431933|NCT01865487|Aeras|Dr. Dereck Tait|27214424991|dtait@aeras.org|
22431934|NCT00129285|University of Pennsylvania Treatment Research Center|Kyle Kampman|215-746-2764|kampman@mail.med.upenn.edu|
22431935|NCT01213082|University of California Davis|Susanna Park, MD|9167346074|sscpark@ucdavis.edu|
22431936|NCT01627691|Boston Scientific|Anne Cornaille|+33608863659|anne.cornaille@bsci.com|
22431937|NCT03758261|University of Pittsburgh Medical Center|Dr. Charles Luke|4127485589|lukecb@upmc.edu|
22431938|NCT01469039|Alkermes, Inc.|ARISTADA Medical Information|866-274-7823||
22431939|NCT00698828|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22431940|NCT03500289|Johns Hopkins University|Dr. Bardia Nourbakhsh|4106141522|bnourba1@jhmi.edu|
22431941|NCT02013609|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22431942|NCT03019887|Okada hospital|Dr. Ryota Ataniya|+81-4-7124-6151|ryotaataniya@pbt.nir.jp|
22431943|NCT01531998|University of Texas (UT) MD Anderson Cancer Center|Jatin J. Shah, MD/Associate Professor, Lymphoma/Myeloma|713-792-2860|CR_Study_Registration@mdanderson.org|
22431944|NCT03259295|University of Florida|Juan Carlos Roig|352-273-8985|roigjc@peds.ufl.edu|
22431945|NCT01156844|Novartis Pharmaceuticals|Study Director|862-778-8300||
22431946|NCT02976181|Medtronic|Carina Leone, Latam CVG Trial Leader|+5411 5789 8521|carina.leone@medtronic.com|
22431947|NCT02918669|Paradigm Spine|Fran Magee, DVM|212-367-7274|fran.magee@paradigmspine.com|
22431948|NCT04067011|Emergent Biosolutions|Clinical Development Representative|+1 (204) 275-4196|ctgov@ebsi.com|
22431949|NCT05209386|University of Pittsburgh|Taylor Abel|412-692-9631|abeltj@upmc.edu|
22431950|NCT04661033|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
22431951|NCT03440008|VA Puget Sound Health Care System|Dr. Joseph Iaquinto|206-277-1738|Joseph.Iaquinto@va.gov|
22431952|NCT02284191|NHS Lothian|Prof Alasdair Gray Chief Investigator|0131 242 1284|alasdair.gray@ed.ac.uk|
22431953|NCT04849897|University of Southern California|Steven Richeimer|323-442-6202|steven.richeimer@med.usc.edu|
22431954|NCT04064905|ModernaTX, Inc|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
22431955|NCT01734902|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22431956|NCT04436744|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22431957|NCT01463033|Children's National Medical Center|Dr. Pavel Klein, P.I.|301-704-4925|kleinp@epilepsydc.com|
22431958|NCT01465841|Penumbra, Inc.|Michaella Corso|415-815-8904|mcorso@penumbrainc.com|
22431959|NCT02092181|Evergreenhealth|Gowri Rajendran|425-899-5370|grajendran@evergreenhealth.com|
22431960|NCT02359903|BIOCAD|Biryulin Andrey|+7812380 49 33|biryulin@biocad.ru|925
22431961|NCT03383666|Cerenovus|Michael Liao|510-770-5376|mliao7@its.jnj.com|
22431962|NCT03381989|National Heart Lung and Blood Institute|Lederman, Robert|+1 301 402 6769|lederman@nih.gov|
22431963|NCT01240863|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22431964|NCT00746811|Biofortis Research (formerly Provident)|John Marshall, General Manager|630-748-5339|john.marshall@mxns.com|
22431965|NCT01538199|Massachusetts General Hospital|Dr. Paolo Cassano|617-643-9622|pcassano@mgh.harvard.edu|
22431966|NCT03358030|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
22431967|NCT03770286|Children's Hospital Los Angeles|Alexander Alcaraz|323-361-2130|aalcaraz@chla.usc.edu|
22431968|NCT02505425|The University of Alabama at Birmingham, School of Nursing|Marie A. Bakitas, DNSc, NP-C, FAAN|(205) 934-5277|mbakitas@uab.edu|
22431969|NCT04951193|MUSC|Dr. Jennifer Dahne|843-876-2280|dahne@musc.edu|
22431970|NCT01370551|Medinova|Doerthe Bassfeld|+41 44 306 1371|bassfeld.doerthe@medinova.ch|
22431971|NCT05175014|Epicentre|Dr Matthew E Coldiron|+33 1 40 21 55 55|matthew.coldiron@epicentre.msf.org|
22431972|NCT04756531|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22431973|NCT05643495|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22392794|NCT04522921|Department of Clinical Medicine, Aarhus University / Steno Diabetes Center Aarhus, Aarhus University Hospital|Dorthe Dalstrup Pauls|+45 28256406|dorthedalstrup@clin.au.dk|
22431974|NCT02257528|NRG Oncology|Linda Gedeon for Wei Deng|716-845-1169|linda.gedeon@roswellpark.org|
22431975|NCT01729039|James H Quillen VAMC|Dr. Courtney Hall|423-926-1171|courtney.hall@va.gov|7518
22431976|NCT03449576|Rehabilitation Research & Development|Dr. Shirley Groer (Scientific Program Manager)|202-553-9899|shirley.groer@va.gov|
22431977|NCT00404248|Adult Brain Tumor Consortium Central Office - Johns Hopkins|Director of Adult Brain Tumor Consortum|410-955-3657|jfisher@jhmi.edu|
22431978|NCT00698841|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22431979|NCT00253422|Institute of Cancer Research, Clinical Trials and Statistics Unit (ICR-CTSU)|Professor Judith Bliss (Director of ICR-CTSU)|+44 0208 722|aude.espinasse@icr.ac.uk|4349
22431980|NCT04646005|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22431981|NCT02918942|Grace Medical, Inc.|Robert Stroup|901-386-0990|robert.stroup@gracemedical.com|
22420585|NCT04277962|University of Texas Medical Branch Galveston|Dr. Antonio Saad Director of Clinical Research Division|409-772-0982|afsaad@utmb.edu|
22420586|NCT02473926|University of Colorado - Anschutz Medical Campus|Dr. Amy Huebschmann|3037242268|amy.huebschmann@cuanschutz.edu|
22420587|NCT00773474|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
22420588|NCT00202930|UPMC Children's Hospital of Pittsburgh|Jean M. Tersak, M.D.|412-692-8570|jean.tersak@chp.edu|
22420589|NCT01244503|Virginia Commonwealth University|Arun J Sanyal|804 828 6314|asanyal@mcvh-vcu.edu|
22420590|NCT04359797|Vanderbilt University Medical Center|Dr. Edward T. Qian|615-322-2386|edward.t.qian@vumc.org|
22420591|NCT01998841|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22420592|NCT00972595|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22420593|NCT01461538|Seattle Genetics, Inc.|Chief Medical Office|855-473-2436|medinfo@seagen.com|
22420594|NCT00141778|Vanderbilt University School of Medicine|Dr. Mias Pretorius|16153430665|mias.pretorius@vanderbilt.edu|
22420595|NCT02085447|University Hospitals Cleveland Medical Center|Dr. Martha Sajatovic|2168442808|martha.sajatovic@uhhospitals.org|
22420596|NCT01406574|Otsuka Pharmaceutical Co., Ltd|"Leader of Department of Small Global Clinical Development"|+81-3-6361-7366||
22420597|NCT04052620|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|
22420598|NCT01500473|Children's Hospital Los Angeles|Thomas Keens|3233612101|tkeens@chla.usc.edu|
22420599|NCT03552380|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
22420600|NCT03447743|University of Kentucky|Dr. Michele Staton|859-312-8245|mstaton@uky.edu|
22420601|NCT01112059|UAB|Amit Gaggar, MD|934-5400|agaggar@uab.edu|
22420602|NCT02153983|NICHD, National Institutes of Health|Dr. Jack Yanovski|13014960858|yanovskj@mail.nih.gov|
22420603|NCT03567980|University of Alabama at Birmingham|Dr. Boni Elewski|205-502-9960|dermresearch@uabmc.edu|
22420604|NCT01610492|GlaxoSmithKline|GSK Response Center|866-435-7343||
22420605|NCT00580502|NYULMC|Heekoung Youn|2122632174|younh01@nyumc.org|
22420606|NCT01757275|AstraZeneca|Huifang Chen|+86 21 60301335|ariel.chen@astrazeneca.com|
22420607|NCT04599075|University of Massachusetts Chan School of Medicine|Dr. Gianna Wilkie|7743642523|Gianna.Wilkie@umassmemorial.org|
22420608|NCT02139137|SDSU/UCSD Joint Doctoral Program in Clinical Psychology|Jessica Bomyea|8585528585|jbomyea@ucsd.edu|3720
22420609|NCT01821807|Adiyaman University Research Hospital, Department of Anesthesiology and Reanimation|Dr. Ruslan Abdullayev|+905063010833|ruslan_jnr@hotmail.com|
22431982|NCT05788991|Medinova|Dr. Anahí Hurtado|+41443061396|hurtado.anahi@medinova.ch|
22392795|NCT01217437|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22392796|NCT00558792|Bracco Diagnostics Inc|Usha Halemane, Executive Director of Medical Biometrics and Medical Writing|609-514-2578|usha.halemane@diag.bracco.com|
22410593|NCT05478603|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22410594|NCT00492089|The University of Texas MD Anderson Cancer Center|Monica Loghin, MD / Assistant Professor|K Hunter, RN 713-745-5769|CR_Study_Registration@mdanderson.org|
22410595|NCT03634488|Vanderbilt UniversityVanderbilt-Meharry Center of Excellence in Sickle Cell Disease|Leshana Saint Jean|6158751992|leshana.saint.jean@vumc.org|
22410596|NCT00869089|University Hospitals Case Medical Center|Neil J. Korman, MD Principal Investigator|216-844-7164|neil.korman@UHHospitals.org|
22410597|NCT00863369|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22410598|NCT00676026|University of Pennsylvania|Cynthia Neill Epperson, M.D.|215-573-8871|cepp@mail.med.upenn.edu|
22410599|NCT01169844|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|Novartis.email@novartis.com|
22410600|NCT04499235|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
22410601|NCT00281827|Masonic Cancer Center, University of Minnesota|Arkadiusz Dudek, M.D.|612-624-0123|dudek002@umn.edu|
22410602|NCT00435825|Hoffman-LaRoche|Medical Communications|800-821-8590||
22410603|NCT05003167|Purdue University|Jessica Huber, Professor and PI|765-494-3796|jhuber@purdue.edu|
22410604|NCT01010230|St. Jude Children's Research Hospital|Kirsten K. Ness, PT, PhD|866-278-5833|kiri.ness@stjude.org|
22410605|NCT00530439|Odense University Hospital|Dr. Christina Vinter|+45 21782118|c.vinter@dadlnet.dk|
22410606|NCT01189071|University of Missouri-Columbia|Dr. Mark Wakefield|573-882-0496|wakefieldmr@health.nissouri.edu|
22410607|NCT02367781|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22420610|NCT01401452|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
22420611|NCT00550459|Otsuka Pharmaceutical Development & Commercialization, Inc.|Frank Czerwiec, MD, PhD; Sr. Director, Global Clinical Development|(240) 683-3523|frank.czerwiec@otsuka.com|
22420612|NCT00584454|UAMRIID Division of Medicine|LTC Robert Rivard, MD|301-619-8244|robert.g.rivard.mil@mail.mil|
22420613|NCT02404805|University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences|Dr. Jennifer Kiser|(303) 724-6131|jennifer.kiser@ucdenver.edu|
22420614|NCT01742897|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-739-7200||5888
22420615|NCT00254592|University of California Irvine Medical Center|Rita S. MEHTA, MD|(714) 456-5153|rsmehta@uci.edu|
22420616|NCT01459783|University of California Los Angeles|Joshua Chodosh or Barbara Vickrey|310-206-7671|jchodosh@mednet.ucla.edu|
22420617|NCT04211831|Urovant Sciences|Information, Clinical Trial Results|949-226-6029|info@urovant.com|
22420618|NCT00967330|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22420619|NCT00610428|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
22420620|NCT04927845|Strive Weekly Inc|Dr. Leslie Rith-Najarian, Principal Investigator|3108002143|leslie@striveweekly.com|
22420621|NCT04563754|Baylor College of Medicine|Dr. Sharmila Anandasabapathy|713-798-8105|Sharmila.Anandasabapathy@bcm.edu|
22420622|NCT00070564|SWOG Statistical Center|Breast Committee Statistician|206-667-4623|jmiao@fredhutch.org|
22420623|NCT04796961|Johns Hopkins University School of Medicine|Gail Daumit MD, MHS|410-614-6460|gdaumit@jhmi.edu|
22420624|NCT02325973|Abbott Medical Italia|Vanoni Benedetta, Abbott Clinical Site Lead|+39340571064|benedetta.vanoni@abbott.com|
22420625|NCT03848715|UCLA|Dr. Chloe Boyle|310 794 9383|ccboyle@mednet.ucla.edu|
22420626|NCT06700512|WSAUDAS|Dr. Veronika Littmann|+4991313080|Veronika.littmann@wsa.com|
22420627|NCT01490086|Reviva Pharmaceuticals, Inc.|Marc Cantillon, M.D|408-960-2209|mcantillon@revivapharma.com|
22420628|NCT06497699|Ocumension Therapeutics (Shanghai) Co., Ltd|Director of Clinical Trials|2289 3653|clinicalop@ocumension.com|3653
22420629|NCT00679211|Genentech, Inc.|Medical Communications|800-821-8590||
22420630|NCT01922037|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22420631|NCT00931528|NRG Onoclogy|Wendy Seiferheld||seiferheldw@nrg.oncology.org|
22420632|NCT01470248|Emory University|Taofeek K. Owonikoko, MD, PhD, MSCR|404-778-1900|towonik@emory.edu|
22420633|NCT01741311|University of Connecticut|Michael Copenhaver|8602083632|michael.copenhaver@uconn.edu|
22420634|NCT05842967|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22420635|NCT04673149|GeneOne Life Science|Chief Medical Officer|6106576351|dkane@genels.us|
22420636|NCT02572570|University of North Carolina at Chapel Hill|Ricardo Walter, DDS, MS|9195373596|walterr@unc.edu|
22420637|NCT00611923|Weill Cornell Medical College and Yale School of Medicine|Margaret Altemus|646-209-6277|maltemus@med.cornell.edu|
22420638|NCT04144413|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
22420639|NCT00572936|University of Nebraska Medical Center|Carol Toris, PhD|402-559-1852|ctoris@unmc.edu|
22420640|NCT02806908|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
22420641|NCT01760304|Brigham and Women's Hospital|Dr. Miguel Divo|8573070311|mdivo@bwh.harvard.edu|
22420642|NCT02302833|The University of Texas MD Anderson Cancer Center|Dr. Camilo Jimenez|(713) 792-2841|cjimenez@mdanderson.org|
22431983|NCT04464473|Florida State University|Dr. Derek Nee|8506441963|dnee@fsu.edu|
22431984|NCT03802396|Duke University|Miles Berger, MD, PhD|919-684-8679|miles.berger@duke.edu|
22431985|NCT04066829|University of Michigan|Kao-Ping Chua|(734) 615-8169|chuak@med.umich.edu|
22392797|NCT02336451|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22392798|NCT05570630|University of Rochester|Cynthia Rand, PI|5852759316|cynthia_rand@urmc.rochester.edu|
22392799|NCT04839185|UW School of Medicine and Public Health|Dinesh Shah, MD|608-417-6099|dmshah@wisc.edu|
22392800|NCT00215137|Duke University Medical Center Dept of Psychiatry|Wei Zhang MD|919 684 5645|wei.zhang@duke.edu|
22392801|NCT03333876|Philips Respironics|Noah Papas|4122776436|Noah.Papas@philips.com|
22392802|NCT00336700|UPMC CancerCenter|Herbert Zeh, MD|412-692-2852|zehxhx@upmc.edu|
22392803|NCT00979550|University of Kentucky Healthcare|Henry C. Vasconez, MD|8593236328|betsy.fink@uky.edu|
22392804|NCT00095498|Amgen Inc.|Study Director|866-572-6436||
22392805|NCT00550589|Statistical Center of AIDS Malignancy Consortium|Jeannette Lee|(501) 526-6712|jylee@uams.edu|
22392806|NCT05020327|University Hospitals Cleveland Medical Center|Dr. Ankita Desai|216-844-3645|Ankita.Desai@UHhospitals.org|
22392807|NCT02548845|Otsuka Pharmaceutical Europe Ltd.|Medical Department|+44(0)2037475000||
22392808|NCT03002220|MedSIR|Alicia Garcia|+34 611261467|alicia.garcia@medsir.org|
22420643|NCT04429503|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22420644|NCT05516108|University of Pittsburgh|Emily K Lindsay, PhD|412-601-0585|emily.lindsay@pitt.edu|
22420645|NCT03664232|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22420646|NCT02717507|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22420647|NCT05017246|Washington University School of Medicine|Dr. Premal H Thaker|314-747-3604|thakerp@wustl.edu|
22420648|NCT00970593|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22420649|NCT02203357|Peking University Health Science Center|Dr. Hui Zhuang|86-10-82801617|zhuangbmu@126.com|
22420650|NCT01561716|University of Rochester|Dr. Isabel D Fernandez|585-275-9554|Diana_Fernandez@URMC.Rochester.edu|
22420651|NCT03073876|City University of New York - Queens College and The Graduate Center|Nancy S. Foldi, PhD; Professor|718.997.3253|nfoldi@qc.cuny.edu|
22420652|NCT02288312|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22420653|NCT02002221|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22420654|NCT01068860|Novartis Pharmaceuticals|Dr. Tom Thuren/Global Brand Medical Director|862-778-1828|tom.thuren@novartis.com|
22431986|NCT00775671|Vanderbilt University|Nancy J Brown|615-343-8701|nancy.j.brown@vanderbilt.edu|
22431987|NCT00163293|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22431988|NCT04133415|Washington University School of Medicine|Matthew Spraker, M.D., Ph.D.|314-362-8567|mspraker@wustl.edu|
22431989|NCT04237584|MANA RBM|Penelope Manasco, CEO|9195566456|pmanasco@manarbm.com|
22431990|NCT01005290|Ferrer Internacional S.A.|Natalia Oudovenko|+34 93 509 32 82|noudovenko-research@ferrergrupo.com|
22431991|NCT02051426|Herzog Hospital|Uriel Heresco-Levy, M.D.|+972-2-5316906|urielh@ekmd.huji.ac.il|
22431992|NCT03549338|Symphogen A/S|Vice President, Global Oncology|+45 8838 2600|info@symphogen.com|
22431993|NCT01492426|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22431994|NCT00269113|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22431995|NCT00652743|GlaxoSmithKline|GSK Response Center|866-435-7343||
22431996|NCT00140140|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22431997|NCT00690794|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
22431998|NCT00325143|GlaxoSmithKline|GSK Response Center|866-435-7343||
22431999|NCT02286895|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22432000|NCT02652221|Cincinnati Children's Hospital Medical Center|Andrew T. Trout, MD|513-803-3004|andrew.trout@cchmc.org|
22432001|NCT02949011|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
22432002|NCT02764996|Mike O'Callaghan Miltary Medical Center|Jill Clark, Senior Research Associate/Research Manager|(702) 653-3298|Jill.M.Clark15.ctr@mail.mil|
22432003|NCT00163189|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22432004|NCT01170663|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22432005|NCT00454116|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22432006|NCT01917318|University of Colorado|Michael H. Allen, M.D.|(303) 724-3300|Michael.Allen@ucdenver.edu|
22432007|NCT01008618|Janssen Research & Development, L.L.C. USA|Director, Clinical Research|1 609 730-3387||
22432008|NCT01093014|University of Iowa / Iowa City VA Medical Center|Richard K. Shields PhD, PT|319-335-9791|richard-shields@uiowa.edu|
22432009|NCT04460183|Thirty Respiratory Ltd|Alison Bracchi, MSc|+447763882519|alison.bracchi@30.technology|
22432010|NCT00894387|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22432011|NCT01128569|GlaxoSmithKline|GSK Response Center|866-435-7343||
22432012|NCT03338400|Cleveland Clinic Florida|Dr. David Ossin|954-659-5559|ossind@ccf.org|
22432013|NCT00487981|Boston Scientific|Lyn M. Pimentel, M.B.A.|(661) 949-4174|Lyn.Pimentel@bsci.com|
22392809|NCT01015560|SWOG Statistical Center|Study Statistician|206-667-4623||
22432014|NCT02941614|Kaiser Permanente Southern California Department of Research and Evaluation|Erin Hahn|626-564-3505|Erin.E.Hahn@kp.org|
22392810|NCT00926497|Children's Hospital of Lucerne|Martin Stocker, MD|0041412051288|martin.stocker@ksl.ch|
22432015|NCT00099021|Masonic Cancer Center, University of Minnesota|Frank G. Ondrey, M.D.|612-625-3200|ondre002@umn.edu|
22432016|NCT02609425|Henry Ford Health System|Sarah Meehan|313-916-9387|smeehan1@hfhs.org|
22432017|NCT00856609|National Institutes of Health|Dr. Jonathan Krakoff|602-200-5217|jkrakoff@mail.nih.gov|
22432018|NCT01788943|University of Pennsylvania|Jacob Dubroff,M.D., Ph.D., Assistant Professor of Radiology|215-662-3041|jacob.dubroff@uphs.upenn.edu|
22432019|NCT01816295|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22432020|NCT01119287|Alcon Research|Head, Alcon Clinical|1-888-451-3937||
22432021|NCT00783432|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2351|wwheeler@medapharma.us|
22432022|NCT00186628|Stanford University Medical Center|David Miklos, MD, PhD; Associate Professor of Medicine (Blood and Marrow Transplantation)|650-725-4626|dmiklos@stanford.edu|
22432023|NCT03892317|Imperial College Healthcare Trust|Goodall Dawn|+44 (0)20 7589 5111|dawn.goodall1@nhs.net|
22432024|NCT01331681|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22432025|NCT01130337|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22432026|NCT05525910|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22432027|NCT03886493|Johns Hopkins University School of Medicine|Kenneth Pienta, M.D.|410-502-3137|kpienta1@jhmi.edu|
22432028|NCT00107276|SWOG|Study statistician|206-667-4623||
22432029|NCT02287779|Mirum|Study Physician|1 650-667-4085|medinfo@mirumpharma.com|
22432030|NCT00476645|Stanford University Medical Center|Associate Professor of Medicine (Oncology)|650-725-2078|sandysri@stanford.edu|
22432031|NCT03498716|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22432032|NCT02257684|Jazz Pharmaceuticals|Head of Clinical Development|650-496-3777||
22432033|NCT00265850|Alliance for Clinical Trials in Oncology|Alan Venook, M.D.||Venook@cc.ucsf.edu|
22432034|NCT03139448|Vanderbilt University Medical Center|Koffi Kla, MD|615-343-9419|koffi.m.kla@vumc.org|
22432035|NCT01987557|WilfridLU|Matthew Lasswell|9056992087|lass3260@mylaurier.ca|
22432036|NCT00760552|Iowa City VA Health Care System|Dr. Gary Rosenthal|319-338-0581|gary-rosenthal@uiowa.edu|
22432037|NCT01038323|Wake Forest|dennis ang|336-716-4209|dang@wakehealth.edu|
22432038|NCT03398330|Mundipharma(China) Pharmaceutical. Co. Ltd|Rongna. A|86 10 65636885|rongna.a@mundipharma.com.cn|
22432039|NCT03261830|UMissouri|Vicki Jones|573-882-7583|jonesvicki@health.missouri.edu|
22432040|NCT01918189|VA Boston Healthcare System|Diana M. Higgins, PhD|857-364-2221|diana.higgins2@va.gov|
22432041|NCT02108288|Otsuka Pharmaceutical Co., Ltd|Director of Clinical Research and Development|+81-3-6361-7366||
22432042|NCT02160288|Massachusetts General Hospital|Dr Liliana Bordeianou|6176430541|lsavitt@mgh.harvard.edu|
22432043|NCT01832727|Amgen, Inc|Study Director|866-572-6436|medinfo@amgen.com|
22432044|NCT03323164|Wills Eye Hospital|Dr. Daniel Lee|12159283197|daniellee@willseye.org|
22432045|NCT00461708|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22432046|NCT00501644|UT MD Anderson Cancer Center|Michael E. Garcia, RN, BSN||mgarcia@mdanderson.org|
22432047|NCT02394561|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22432048|NCT02553629|Leiden University Medical Center|Prof. Dr. A. Dahan|+31 71 526 2301|a.dahan@lumc.nl|
22432049|NCT01880957|Stony Brook University|Dr. Christine DeLorenzo|(631) 638-1523|Christine.Delorenzo@stonybrookmedicine.edu|
22432050|NCT03342560|Massachusetts General Hospital|Anthony E. Samir|6176432009|asamir@mgh.harvard.edu|
22432051|NCT02604511|Dana-Farber Cancer Institute|Dr. Steven Treon|617-632-2681|steven_treon@dfci.harvard.edu|
22432052|NCT03586973|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
22432053|NCT01150357|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
22432054|NCT02661672|Icahn School of Medicine at Mount Sinai|Sydney Edwards|212-241-2524|sydney.edwards@mountsinai.org|
22432055|NCT01248793|Janssen Research & Development|Associate Director, Clinical Research|610-500-3369||
22432056|NCT00517699|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22432057|NCT01114737|BioMarin Pharmaceutical Inc.|Medical Information Services|1-800-983-4587|medinfo@bmrn.com|
22432058|NCT04606927|University Medical Center Groningen|Dr. Jozine ter Maaten|0503616161|j.m.ter.maaten@umcg.nl|
22432059|NCT02580877|Benaroya Research Institute|Carla Greenbaum, MD|1-800-425-8631|cjgreen@benaroyaresearch.org|
22432060|NCT01466491|Oregon Health & Science University|Dr. Paula Bednarek|503-494-3666|whru@ohsu.edu|
22432061|NCT01123148|University of Michigan|Jane Huggins, PhD|734-936-7177|janeh@umich.edu|
22432062|NCT01131052|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
22432063|NCT03623698|Imperial College London|Mrs. Natalia Galaz Souza|07751842851|natalia.galaz-souza16@imperial.ac.uk|
22432064|NCT03604497|University of Alabama at Birmingham|Dr David Schwebel|2059348745|schwebel@uab.edu|
22432065|NCT00811954|ACTG Network Coordinating Center, Social & Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22432066|NCT02604459|University of Missouri|Dr. Quinn Johnson|573-882-2568|johnsonql@health.missouri.edu|
22432067|NCT01204788|University of Texas (UT) MD Anderson Cancer Center|Emil Freireich, MD, Professor, Department of Medical Education|713-745-2723|CR_Study_Registration@mdanderson.org|
22432068|NCT01534481|University of Iowa|Dr. Tarah Colaizy|319-356-3508|tarah-colaizy@uiowa.edu|
22432069|NCT01247064|Cincinnati Children's Hospital Medical Center|Todd Florin|513-636-7966|todd.florin@cchmc.org|
22432070|NCT01976871|Massachusetts General Hospital|Dr. John W. Winkelman|617-643-9101|jwwinkelman@partners.org|
22432071|NCT01664247|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22432072|NCT00945659|Nemours Foundation: Dept. of Biomedical Research|Tim Wysocki, PhD|904-697-3483|twysocki@nemours.org|
22432073|NCT00658541|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22432074|NCT03179761|Vanderbilt-Ingram Cancer Center|Natasha Halasa, MD, MPH|800-811-8480|natasha.halasa@vumc.org|
22420655|NCT02568072|St George's, University of London|Dr Andrew D'Silva|020 7188 7188|adsilva@nhs.net|51554
22420656|NCT01302743|Mike O'Callaghan Federal Medical Center|Jill M. Clark, MBA/HCM|702-653-3298|jill.clark.3.ctr@us.af.mil|
22420657|NCT05263908|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22420658|NCT02714218|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22420659|NCT03743051|Helsinn Healthcare SA|Florin Muraru|+41 91985 21 21|florin.muraru@helsinn.com|
22420660|NCT01422200|Cincinnati Children's Hospital Medical Center|Dr. Brenda Wong|5136364222|brenda.wong@cchmc.org|
22420661|NCT00840749|Accuray Inc|study admin|4087164608|ccheung@accuray.com|
22420662|NCT02550561|University of California, Irvine|Phuong Linh Huynh, CRC|7144566155|plhuynh@hs.uci.edu|
22420663|NCT01285362|Columbia Universty|Dr Mercedes Martinez|212-305-3438|mm2479@cumc.columbia.edu|
22420664|NCT00489866|Durham VAMC|Christine E. Marx, MD|9192860411|marx0001@mc.duke.edu|7426
22420665|NCT03411863|James J. Peters VAMC|Dr. Noam Y. Harel|718-584-9000|noam.harel@va.gov|1742
22420666|NCT02766335|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
22420667|NCT00501995|Johns Hopkins University|Gwen Leatherman,R.N.,M.S.|410-550-8582|gleathe@jhmi.edu|
22420668|NCT02396511|TRACON Pharmaceuticals|Medical Monitor|8585500780|ctheuer@traconpharma.com|
22420669|NCT01651078|Monteris Medical|Nissa Mollema (Clinical Operations Manager)|763-253-4710|nmollema@monteris.com|
22420670|NCT00291317|Children's Specialized Hospital|Frank Castello|732 258 7065|fcastello@childrens-specialized.org|
22420671|NCT00262028|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22420672|NCT03164551|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22420673|NCT01515423|Janssen Research & Development, LLC|Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
22420674|NCT03490110|Veterans Affairs|Dr. Anthony Chen|925-372-2530|anthony.chen@va.gov|
22420675|NCT01015534|Instituto Nacional de Cancerologia de Mexico|Carlos Gamboa Vignolle/ Radiation Oncologist|0155556280400|cswgamboa@yahoo.com|441
22420676|NCT01422213|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
22420677|NCT02020278|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22420678|NCT00571324|Children's Hospital of Philadelphia|Diva De Leon, MD|267-426-5529|DELEON@email.chop.edu|
22420679|NCT01555697|UC San Diego|Neal Swerdlow, M.D., Ph.D.|619-543-6270|nswerdlow@health.ucsd.edu|
22420680|NCT00476190|Dana Farber Cancer Institute|Dr. Dan DeAngelo|6175828410|Daniel_Deangelo@dfci.harvard.edu|
22420681|NCT04782076|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22420682|NCT02577991|Northwestern University Department of Orthopaedic Surgery|Surabhi Bhatt|312-472-6024|surabhi.bhatt@nm.org|
22420683|NCT02189837|Amgen Inc.|Study Director|866-572-6436||
22420684|NCT00950365|Montefiore Medical Center|Roman Perez-Soler, MD|(718) 405-8505|RPEREZSO@montefiore.org|
22420685|NCT02513212|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
22420686|NCT02201784|Jawaharlal Nehru Medical College, AMU, Aligarh, India|Dr. Manazir Athar|+918868056469|drmanazirathar@gmail.com|
22420687|NCT00258960|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34 916 592 870|geicam@geicam.org|
22420688|NCT00473590|Hoffman-LaRoche|Medical Communications|800-821-8590||
22420689|NCT04446247|Owlet Baby Care, Inc|Madison Kenley, Clinical Research Director|801-552-8383|mkenley@owletcare.com|
22420690|NCT05493501|EQRx International|EQRx Clinical Trials|(650) 779-2300|clinicalstudies@eqrx.com|
22420691|NCT04199104|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22420692|NCT04023396|Abivax|Associate Director Clinical Operations|+33630031132|laurence.desroys@abivax.com|
22420693|NCT03150329|City of Hope Medical Center|Dr. Alex Herrera|626-359-8111|aherrera@coh.org|
22420694|NCT04748510|Perth Hip & Knee|Dr Serene Lee, Orthopaedic Research Officer|64891720|research@hipnknee.com.au|
22420695|NCT04075825|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22420696|NCT01168232|NRG Oncology Statistics and Data Management Center - Buffalo Office|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22420697|NCT03241862|DeNova Research|Steven Dayan, MD|3123352070|sdayan@drdayan.com|
22420698|NCT03220204|Massachusetts General Hospital|Dr. Christopher Celano|617-726-6485|ccelano@partners.org|
22420699|NCT04470518|Leuven Unit Health Technology Assessment Research, KU Leuven|Tine De Burghgraeve, PhD|+3216377276|tine.deburghgraeve@kuleuven.be|
22420700|NCT03879135|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22420701|NCT05201794|Janssen Research & Development, LLC|Senior Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22420702|NCT03428958|NuCana plc|Medical and Scientific Affairs Department|+44 131 357 1111|info@nucana.com|
22420703|NCT03874117|VA Palo Alto|Tammy Sirich|6504935000|tsirich@stanford.edu|
22420704|NCT04510090|Escient Pharmaceuticals|Kristin Taylor, Sr VP, Head of Clinical Development|(858) 617-8220|clinicaltrials@escientpharma.com|
22420705|NCT01127256|Eisai Korea Inc.|Jihee Mun, Pharmacist, Medical Department manager|+82-2-3451-5531|jihee_mun@eisaikorea.com|
22420706|NCT01410097|Wake Forest University|Stephen B. Kritchevsky, PhD|336-713-8548|skritche@wakehealth.edu|
22420707|NCT03657797|Nicox Ophthalmics Inc.|Doug Hubatsch / Chief Scientific Officer|832-360-3022|hubatsch@nicox.com|
22420708|NCT00711243|Northwestern University|Mary Mulcahy (MD)|312.695.6182|Mary.Mulcahy@nm.org|
22420709|NCT04074941|Marcus Institute, Hebrew SeniorLife|Shivani Sahni, PhD|6179715382|shivanisahni@hsl.harvard.edu|
22420710|NCT01402570|University of Michigan|Claire Z. Kalpakjian|734-763-0153|clairez@umich.edu|
22420711|NCT03642262|Reckitt Benckiser Inc.|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
22420712|NCT02019472|Janssen-Cilag International N.V.|Associate Director||ClinicalTrialDisclosure@its.jnj.com|
22420713|NCT03861390|University of North Carolina at Chapel Hill|Terry Noah, MD|919-966-1055|terry_noah@med.unc.edu|
22420714|NCT00513695|Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium|Jennifer Specht, MD|(206) 288-6889|jspecht@uw.edu|
22420715|NCT02157935|AstraZeneca|Tor Skärby||tor.skarby@astrazeneca.com|
22420716|NCT01417156|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22420717|NCT03192488|Indiana University|Robert Chapman|812-856-2452|rfchapma@indiana.edu|
22420718|NCT00867529|Fred Hutch|David G Maloney, MD PhD||dmaloney@fredhutch.org|
22420719|NCT04565145|University of Florida|Robyn Nelson|3522945563|r.nelson@ufl.edu|
22420720|NCT02547428|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
22420721|NCT03070236|Dana-Farber Cancer Institute (DFCI)|Ann H. Partridge, MD, MPH|617-632-3800|Ann_Partridge@dfci.harvard.edu|
22420722|NCT01634048|Imperial College|Professor Gary Frost|+44 20 7594 0959|g.frost@imperial.ac.uk|
22420723|NCT06192589|U.S. Food and Drug Administration|Jeffry Florian|301-796-4847|Jeffry.Florian@fda.hhs.gov|
22420724|NCT04552795|UT Health San Antonio|Bess Frost, PhD|210-562-5037|bfrost@uthscsa.edu|
22420725|NCT01662778|Imperial College London|Dr Omar Usmani||o.usmani@imperial.ac.uk|
22420726|NCT00742209|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
22420727|NCT02003209|NSABP Foundation|Judy Langer, Director of Regulatory Affairs|412-339-5300|langerj@nrgoncology.org|
22420728|NCT01332487|GlaxoSmithKline|GSK Response Center|866-435-7343||
22420729|NCT00485264|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22420730|NCT01514461|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22420731|NCT02548832|INSTITUTO DE TERAPÉUTICA EXPERIMENTAL Y CLÍNICA|Esperanza Martinez Abundis|3310585200|esperanzamartnezabundi@yahoo.com|34211
22420732|NCT03565900|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22420733|NCT01037218|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22420734|NCT00513240|Baylor College of Medicine|Dr. Dean B. Andropoulos|832-826-5831|dra@bcm.edu|
22420735|NCT02695446|BioPharmX, Inc.|AnnaMarie Daniels|310-701-2080|amdaniels@biopharmx.com|
22420736|NCT01656460|Brown University Oncology Research Group (BrUOG)|Thomas DiPetrillo, MD|4018633000|kayla_rosati@brown.edu|
22420737|NCT01113892|Getinge Group|Elizabeth Bulger|603 880 1433|Elizabeth.Bulger@getinge.com|5368
22420738|NCT00789854|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22420739|NCT03473925|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22420740|NCT05966506|The University of Texas Health Science Center at Houston|Nitha Mathew Joseph, PhD, RN, CNE, CGNC|713-500-2165|Nitha.Mathew@uth.tmc.edu|
22420741|NCT02756611|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22420742|NCT03125798|Wielkoposkie Centrum Pulmonologii i Torakochirurgii|Dr Piotr Gabryel|+48616654249|piotrgabryel@gmail.com|
22420743|NCT03618017|University of Michigan Rogel Cancer Center|Lauren Wallner, Ph.D.|734-232-0788|lwallner@med.umich.edu|
22420744|NCT01949662|UT MD Anderson Cancer Center|David Hui, MD/ Associate Professor, Palliative Care Medicine|713-792-6258|dhui@mdanderson.org|
22420745|NCT02291237|Gilead Sciences|Clinical Trial Disclosures & Data Transparency|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22420746|NCT07034820|Nimsai Academia|Cem Atabiner, Principal Investigator|05324593292|cem.atabiner@kecioutdoor.com.tr|
22420747|NCT00456300|Montefiore Medical College|Rubina Heptulla|832824000|rubhep@gmail.com|
22420748|NCT00978874|University of Pennsylvania|Lilie Lin, MD|215-662-6515|lin@xrt.upenn.edu|
22420749|NCT01199380|University of Maryland|Laura MacPherson|6198578425|lauramac.phd@gmail.com|
22420750|NCT02757326|Duke University Medical Center, Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy|Yubin Kang, M.D., Principal Investigator|(919) 668-2331|yubin.kang@duke.edu|
22420751|NCT03008174|Johns Hopkins University|Vinciya Pandian|4436553482|vpandia1@jhu.edu|
22420752|NCT02103855|Indiana University|Jeanne Chen|317-944-3570|jchen@iuhealth.org|
22420753|NCT03560128|Indiana University|Study Coordinator|317-948-0724|rlahr@iu.edu|
22420754|NCT03423940|Rutgers, The State University of New Jersey|Brian D. Greer, Ph.D., BCBA-D|848-800-8505|brian.greer@rutgers.edu|
22420755|NCT02586155|Resverlogix Corp.|Sr. Director of Clinical Operations|403.254.9252|clinicaltrials@resverlogix.com|
22392811|NCT03439254|Intercept Pharmaceuticals, Inc.|Medical Information|844-782-4278|medinfo@interceptpharma.com|
22420756|NCT01522456|Galderma Laboratories, L.P.|Elizabeth M. Nieman, Associate Medical Information Specialist|817-961-5130|elizabeth.nieman@galderma.com|
22420757|NCT02072980|Alcon Research, Ltd.|Cecile Maissa, Global Brand Medical Affairs Lead - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22420758|NCT00916383|Teikoku Pharma USA, Inc.|Director of Clinical Trials|(408) 501-1821||
22392812|NCT03795753|Emory University|Dr. Nancy Collop|404-712-7533|nancy.collop@emory.edu|
22420759|NCT02899962|LEO Pharma A/S|Clinical Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
22420760|NCT04778475|Medical University of South Carolina|Sinead Farrelly DPT|843-792-3069|farrelsi@musc.edu|
22420761|NCT02601014|University of Minnesota Division of Hematology, Oncology and Transplantation|Emmanuel Antonarakis, MD|612-301-2180|anton401@umn.edu|
22420762|NCT02833337|Centro de Implantologia, Cirugia Oral y Maxilofacial|Alberto Monje|+41798836264|amonjec@umich.edu|
22420763|NCT02623725|Sanofi Pasteur|Medical Director|800-633-1610|Contact-US@sanofi.com|ext 1#
22420764|NCT03918629|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22420765|NCT01243957|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22420766|NCT01891864|Sandoz|Dr Guido Wuerth - Global Program Medical Director|+4980244762925|guido.wuerth@sandoz.com|
22420767|NCT02698163|UCLA School of Dentistry|Dr. Eric Sung|(310) 206-6407|esung@dentistry.ucla.edu|
22420768|NCT01133067|Dept. of Radiation Oncology, Tata Memorial Hospital|Dr. J.P. Agarwal|+91 22 24177000|agarwaljp@tmc.gov.in|7164
22420769|NCT00349973|University of Maryland, Baltimore|Dr. Elliot Hong, Prinicipal Investigator|410-402-6828|ehong@som.umaryland.edu|
22420770|NCT04665765|City of Hope Medical Center|Dr. Alex Herrera , MD|6263598111|aherrera@coh.org|
22420771|NCT01279317|Maastricht University Medical Centre|Drs. Jan-Willem van Dijk|+31(0)433881394|janwillem.vandijk@maastrichtuniversity.nl|
22420772|NCT04021914|Emory University|Dr. Jeffrey N. Siegelman|4042518868|jsiegelman@emory.edu|
22420773|NCT02059512|First Pavlov State Medical University of St. Petersburg|Vladimir V Komok, Ph.D|8-904-632-19-00|vladimir_komok@mail.ru|
22420774|NCT00803790|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com|
22420775|NCT00728260|Sanofi Pasteur Inc|Medical Drector||RegistryContactus@sanofipasteur.com|
22420776|NCT04581824|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22420777|NCT05012098|National Cancer Institute|Dr. Charalampos Floudas|240-858-3032|charalampos.floudas@nih.gov|
22420778|NCT05573464|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22420779|NCT05734157|Abbott|Krista Stiefel, Principal Clinical Scientist|+12246689359|krista.stiefel@abbott.com|
22420780|NCT04815083|photonamic GmbH & Co. KG|Vice President Clinical Development & Regulatory Affairs|+49 (0)4101 78539 09|info@photonamic.de|
22420781|NCT06025721|Hennepin Healthcare Research Institute|Katherine Diaz Vickery|612-873-6852|katherine.vickery@hcmed.org|
22420782|NCT01749826|Stanford University School of Medicine Department of Anesthesiology|Dr. Larry F. Chu|6507236632|lchu@stanford.edu|
22420783|NCT00637312|Orthofix|Ruba Sarris|214-937-2256|rubasarris@orthofix.com|
22420784|NCT01730053|Regeneron Pharmaceuticals|Clinical Trial Management||clinicaltrials@regeneron.com|
22420785|NCT02068508|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22420786|NCT00813150|Jan-Cil Germany|Therapeutic Areas Director||ClinicalTrialDisclosure@its.jnj.com|
22420787|NCT05085834|University Hospitals Cleveland Medical Center|Grace McComsey|216-368-3731|Grace.McComsey@uhhospitals.org|
22420788|NCT04514692|Stanford University|Dr. Elizabeth Kidd|(650) 723-6171|ekidd@stanford.edu|
22420789|NCT01823328|Hennepin Healthcare|Audrey Hendrickson|612-873-9528|Audrey.Hendrickson@hcmed.org|
22420790|NCT01662635|Thoracic Oncology Unit. Instituto Nacional de Cancerología|Oscar Gerardo Arrieta-Rodríguez|+52 55 56280400|ogar@unam.mx|832
22420791|NCT01217112|GW Research Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223266800|rp@gwpharm.com|
22420792|NCT01401361|St. Jude Medical|Nancy Ouch|+19497695041|NOuch@sjm.com|
22420793|NCT00127231|Johns Hopkins University School of Medicine|Mary E McCaul|410-955-9526|mmccaul1@jhmi.edu|
22420794|NCT00595920|Opexa Therapeutics, Inc.|Kenny Frazier, VP of Clinical Development and Regulatory Affairs|281-775-0660|kfrazier@opexatherapeutics.com|
22420795|NCT00351468|Novartis|Study Director|862-778-8300||
22420796|NCT03588910|Montefiore Medical Center|Dr. Kari Plewniak|718-920-5157|kplewnia@montefiore.org|
22420797|NCT03096314|Massachusetts General Hospital|Nancy Ringwood, CCC Project Manager|617-724-9836|nringwood@mgh.harvard.edu|
22420798|NCT00471822|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22420799|NCT03318861|Kite, A Gilead Company|Medical Information|844-454-5483(1-844-454-KITE)|medinfo@kitepharma.com|
22420800|NCT01892501|Institute Bergonie|Dr. Dominique Bechade, Coordinating Investigator|0556337805|d.bechade@bordeaux.unicancer.fr|
22420801|NCT01129440|University of California, San Francisco|Dr. Stuart Gansky|415-502-8094|stuart.gansky@ucsf.edu|
22420802|NCT04335123|Kansas University Medical Center|Dr Matthias Salathe|9135886000|msalathe@kumc.edu|
22420803|NCT01254643|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22420804|NCT01299103|Chicago Center for Facial Plastic Surgery|Dr. Steven Dayan|(312) 335-2070|sdayan@drdayan.com|
22420805|NCT06160609|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22420806|NCT03359850|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22420807|NCT01280643|Fox Chase Cancer Center|Dr. Crystal Denlinger|215-214-1676|crystal.denlinger@fccc.edu|
22420808|NCT02090088|Amgen Inc.|Study Director|866-572-6436||
22420809|NCT03290378|Avenue Therapeutics|VP of Clinical Operations and Program Management|781-652-4514|mryan@avenuetx.com|
22420810|NCT01629511|UT MD Anderson Cancer Center|Dr. Chitra Hosing|713-792-8750|cmhosing@mdanderson.org|
22420811|NCT03817125|Parker Institute for Cancer Immunotherapy|Ute Dugan|203-379-6757|udugan@parkerici.org|
22420812|NCT00942084|Duke Clinical Research Institute|P. Brian Smith, MD MPH MHS|919-668-8951|brian.smith@duke.edu|
22420813|NCT01062425|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22432075|NCT00565409|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22420814|NCT01823861|London School of Hygiene and Tropical Medicine|Dr. Chris Smith|07974562199|christopher.smith@lshtm.ac.uk|
22392813|NCT00128102|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22392814|NCT02385240|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
22392815|NCT01014208|GlaxoSmithKline|GSK Response Center|866-435-7343||
22392816|NCT02124603|Casa di Cura Di Stefano|Dr.Marcello Santocono|+393356070002|santocono.m@alice.it|
22392817|NCT01008410|Bausch Health Companies|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
22392818|NCT00297427|University of Pittsburgh|Dr. Sandra Engberg|412-624-6616|sje1@pitt.edu|
22392819|NCT02324608|Cancer Institute of New Jersey Rutgers|Dr. Adam Berger|732-235-8675|ab2047@cinj.rutger|
22392820|NCT03889704|University of Pittsburgh|Dr. Edward Burton|4126924670|eab25@pitt.edu|
22392821|NCT04440839|UNIVERSITY OF CALIFORNIA DAVIS|Misty Humphries|9167342028|mdhumphries@health.ucdavis.edu|
22392822|NCT04552899|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22392823|NCT04786964|Checkpoint Therapeutics|James Oliviero|212-574-2830|jfo@checkpointtx.com|
22392824|NCT02591953|Rush|Dr. Jeremy Alland|3124322434|jeremy.alland@rushortho.com|
22392825|NCT00461981|MedImmune, LLC|Christopher Ambrose, MD|301-398-0000|ambrosec@medimmune.com|
22392826|NCT00673959|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22392827|NCT02060370|University of Texas MD Anderson Cancer Center|Dr. Eric Jonasch, MD/Professor, Genitourinary Medical Oncology|713-792-2830|ejonasch@mdanderson.org|
22392828|NCT00731133|UAMS|Dr. Alison Oliveto|501-526-8441|olivetoalison@uams.edu|
22392829|NCT00943852|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22392830|NCT03098563|Johns Hopkins University|Claudia Campbell|4105507989|ccampb41@jhmi.edu|
22392831|NCT01725126|GlaxoSmithKline|GSK Response Center|866-435-7343||
22392832|NCT01249027|Abbott Vascular|Leong Roy|8133 7475|roy.leong@abbott.com|+65
22420815|NCT01433471|NYU Langone Medical Center|Martin Wolff|(646) 329-7259|martin.wolff@nyumc.org|
22420816|NCT04784091|Tarsus Pharmaceuticals|Mark Holdbrook, Senior Vice-President of Clinical Development|408-431-6613|mark@tarsusrx.com|
22420817|NCT00395629|Novartis Pharmaceuticals|Study Director|862-778-8300||
22420818|NCT03428152|Derince Training and Research Hospital|Dr|+905336515650|handegrbz@gmail.com|
22420819|NCT01686373|University of South Carolina|Dr. Julius Fridriksson|1-803-777-5931|jfridrik@sc.edu|
22420820|NCT01564693|SAPIENZA UNIVERSITY OF ROME|PROF. ALESSANDRO LAVIANO|+390649973902|alessandro.laviano@uniroma1.it|
22420821|NCT00191477|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22420822|NCT06481709|APR Applied Pharma Research s.a.|Giorgio Reiner Chief Scientific Officer|+41.91.6957020|giorgio.reiner@apr.ch|
22420823|NCT03933904|Center for Cytokine Storm Treatment & Laboratory (CSTL), University of Pennsylvania|Dr. David Fajgenbaum|215-614-0935|davidfa@pennmedicine.upenn.edu|
22420824|NCT01108718|Beth Israel Medical Center|Diana Vu|212-844-6747|dvu@bethisraelny.org|
22420825|NCT00423878|Columbia University|Dr. Scott Stroup|212-543-5676|stroups@nyspi.columbia.edu|
22420826|NCT02857816|Medtronic Pelvic Health & Gastric Therapies|Beth Michaud / Sr. Principal Clinical Research Specialist|763.526.8102|beth.m.michaud@medtronic.com|
22420827|NCT00729937|Olive View-UCLA Medical Center|David A. Talan, MD|818-364-3107|dtalan@ucla.edu|
22420828|NCT04851873|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22420829|NCT02198963|Mercury Street Medical|Dr. John Pullman|(406) 723-1375|john.pullman@mecurystmed.com|
22420830|NCT00281957|SWOG Statistical Office|SWOG melanoma statistician|206-667-4408||
22420831|NCT03787134|University of Wisconsin - Madison|Brad Postle, PhD|608-262-4330|postle@wisc.edu|
22420832|NCT03281876|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22420833|NCT02208089|Moorfields Eye Hospital NHS Foundation Trust|Mr Bruce Allan|02075662320|bruce.allan@ucl.ac.uk|
22420834|NCT02443740|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22420835|NCT01478373|Novartis Pharmaceuticals|Study Director|862-778-8300||
22420836|NCT03098082|Indiana University School of Medicine|Jeffrey J. Easler, MD|3179440980|jjeasler@iu.edu|
22420837|NCT00683657|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22420838|NCT01074944|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22420839|NCT00194779|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu|
22420840|NCT03741400|Professor of Neurology and Neurological Sciences|Maarten G. Lansberg, MD PhD|(650) 723-4448|lansberg@stanford.edu|
22420841|NCT03200717|Novartis Pharmaceuticals|Study director|+1 862-778-8300|novartis.email@novartis.com|
22420842|NCT02771977|Yale University|F. Perry Wilson|203-737-1704|francis.p.wilson@yale.edu|
22420843|NCT05373108|University of California, Los Angeles|Rushi V. Parikh, MD|(310) 825-9011|RParikh@mednet.ucla.edu|
22420844|NCT02044380|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22420845|NCT02892331|University of Virginia|Damon Swift|(434) 924-1436|dls3s@virgina.edu|
22420846|NCT00752128|Medtronic Bakken Research Center B.V.|Marianne Wanten|+3143356|marianne.wanten@medtronic.com|6815
22420847|NCT04135937|Durham VA Health Care System|Angela Kirby|919-286-0411|angela.kirby@va.gov|175526
22420848|NCT05620082|University of Southampton|Dr Samantha J Meredith|0238120|s.j.meredith@soton.ac.uk|4656
22420849|NCT00625820|University of Michigan|Rajiv Saran, MD|734-763-6611|rsaran@umich.edu|
22420850|NCT03796988|University of Miami|Hadar Lev-Tov, Assistant Professor|305-243-4472|hltevtov@med.miami.edu|
22392833|NCT03478904|National Cancer Institute|William D. Figg, Pharm.D.|240-760-6179|figgw@mail.nih.gov|
22420851|NCT02141438|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22420852|NCT03296813|Duke University|Robert Mentz, MD|919-668-7121|robert.mentz@duke.edu|
22392834|NCT01518153|University of Texas (UT) MD Anderson Cancer Center|Richard E. Champlin, MD/Chair, Stem Cell Transplantation|713-792-8750|CR_Study_Registration@mdanderson.org|
22392835|NCT01098318|University of Pennsylvania|Dr. Jun Mao, Associate Professor|215-746-2481|jun.mao@uphs.upenn.edu|
22392836|NCT03030859|University of Pennsylvania School of Nursing|Jie Deng, PhD, PI|215-573-2393|jiedeng@nursing.upenn.edu|
22392837|NCT02145468|GlaxoSmithKline|GSK Response Center|866-435-7343||
22392838|NCT01390870|GlaxoSmithKline|GSK Response Center|866-435-7343||
22392839|NCT00635128|GlaxoSmithKline|GSK Response Center|866-435-7343||
22392840|NCT01803282|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22392841|NCT00515723|Washington University School of Medicine and Florida Atlantic University|John Newcomer, M.D.|561-297-0252|jnewcomer@fau.edu|
22392842|NCT00798434|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22392843|NCT04908631|Duke University|Howard W. Francis, MD|919-681-8069|howard.francis@duke.edu|
22392844|NCT06655558|Topmed|Edith Martin|418 683-2104|emartin@topmed.ca|1302
22392845|NCT03468478|Hospital do Rim - Fundação Oswaldo Ramos|Dr. Helio Tedesco Silva Junior|55 11 50878113|heliotedesco@medfarm.com.br|
22392846|NCT03446001|TauRx Therapeutics Management Ltd.|Sotereos Gates, PhD|+44 (0) 7771 570707|s.gates@taurx.com|
22392847|NCT05430815|Emory University|Anne Dunlop, MD, MPH|404-712-8520|amlang@emory.edu|
22392848|NCT03524092|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22392849|NCT04893460|Oregon Research Behavioral Intervention Strategies Inc.|Dr. Dana Smith|541-484-2123|danas@ori.org|
22420853|NCT02546986|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22392850|NCT03578887|University of Washington|Ellen Schur, MD, MS|206-543-8433|ellschur@uw.edu|
22392851|NCT06118957|University of Utah Obgyn|Elizabeth Turner, MPH, Senior Regulatory Coordinator|8012018929|elizabeth.e.turner@hsc.utah.edu|
22392852|NCT01099215|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22392853|NCT02896075|University of Texas at Austin|Stephanie Lapierre|512-471-8594|stephlap1116@gmail.com|
22392854|NCT00387426|UT MD Anderson Cancer Center|Srdan Verstovsek, MD / Associate Professor||eharriso@mdanderson.org|
22392855|NCT03203473|Dana Farber Cancer Institute|Toni K Choueiri, MD|(617) 632-5456|toni_choueiri@dfci.harvard.edu|
22392856|NCT01325311|University of Wisconsin|Howard H. Bailey|608-263-8624|hhbailey@wisc.edu|
22392857|NCT01732822|AstraZeneca R&D|Brilinta Global Clinical Lead|+46 31 776 10 00|kontakt@astrazeneca.com|
22392858|NCT02314780|Medical University of Vienna|Dr. Martin Andreas|+ 43 1 40400|martin.andreas@meduniwien.ac.at|69660
22392859|NCT01901432|ITALFARMACO S.p.A.|Medical Expert|+39 026443 258|p.bettica@italfarmaco.com|
22392860|NCT00129480|Portland VA Medical Center|Steven K. Dobscha MD|503-220-8262|steven.dobscha@va.gov|52207
22392861|NCT02083107|AinShams University|Dr. Mohamed S. Sweed, Dr.Mourad M.El-Said, Dr.Amgad E. Abou-Gamrah, Dr.Mohamed M. Abd-El-Hamid|01001222047|drmsweed@gmail.com|+2
22420854|NCT02513160|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com|
22392862|NCT01077271|Abbott|Global Medical Services|1-800-633-9110||
22432076|NCT04828707|Theranica Bio-Electronics Ltd|Dr Dagan Harris. VP Clinical & Regulatory Affairs|+972723909755|daganh@theranica.com|
22432077|NCT01484652|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
22432078|NCT01886235|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22432079|NCT04700423|Swiss TPH|Prof. Dr. Jennifer Keiser|+41612848218|jennifer.keiser@swisstph.ch|
22432080|NCT04211363|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844)692-6729|medinfo@arcutis.com|
22432081|NCT01991860|Acacia Pharma Ltd|Dr Gabriel Fox|44-(0)1223-919764|Gabrielfox@acaciapharma.com|
22432082|NCT03434834|Duke University|Dr. Adam Wax|919-660-5143|a.wax@duke.edu|
22432083|NCT01823289|Department of Respiratory Medicine, SHANGHAI First People's Hospital Affiliated to SHANGHAI JiaoTong University|Director of Respiratory Department|86-21-63071428|xzhou53@163.com|
22432084|NCT01306292|Bracco Diagnostics Inc.|Dr. Maria Luigia Storto|609-514-2262|marialuigia.storto@diag.bracco.com|
22432085|NCT02797821|Alexion Pharmaceuticals|Alexion Pharmaceuticals|475-230-2596|ClinicalTrials@Alexion.com|
22432086|NCT01812057|Duke University Medical Center|Dr Terrence K Allen|9196682024|terrence.allen@duke.edu|
22432087|NCT01736917|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
22432088|NCT01259011|Emory University|Dr. Mi-Kyung Song|404-727-3134|mi-kyung.song@emory.edu|
22432089|NCT02633735|HealthPartners Institute|Elyse Kharbanda|952-967-5038|elyse.o.kharbanda@healthpartners.com|
22432090|NCT00654732|UT MD Anderson Cancer Center|Dr. Hun Ju Lee, Associate Professor, Lymphoma/Myeloma|713 794-1829|hunlee@mdanderson.org|
22432091|NCT01951391|UCSD Dermatology Clinical Trials|UCSD Dermatology Clinical Trials Manager|(858)657-8390|dermstudies@ucsd.edu|
22432092|NCT01180127|Columbia University Medical Center, Division of Behavioral Medicine in Psychiatry|Richard Sloan|646-774-8940|rps7@cumc.columbia.edu|
22432093|NCT01133847|University of Texas Health Science Center Houston|Dr. Carolyn Denton|713-500-3891|carolyn.a.denton@uth.tmc.edu|
22432094|NCT01378117|EUSOM|Guillermo Umpierrez, MD|4047781665|geumpie@emory.edu|
22432095|NCT02961244|Dokuz Eylul University Medicine Faculty, General Surgery Department|Ali Kadir Degirmenci|+902324122901|alikadir@hotmail.com|
22432096|NCT01854528|AbbVie|Global Medical Information|800-633-9110||
22432097|NCT01129206|The Ohio State University Comprehensive Cancer Center|Tanios Bekaii Saab, MD|614-293-6529|Tanio.Saab@osumc.edu|
22432098|NCT01368614|Philips|Jeff Jasko|412-542-3651|jeff.jasko@philips.com|
22432099|NCT00518180|Novartis Vaccine and Diagnostics|Posting Director||RegistryContactVaccinesUS@Novartis.com|
22432100|NCT03060902|University of Oregon|Maureen Zalewski|541-346-7073|zalewski@uoregon.edu|
22432101|NCT00790673|Can-Fite Biopharma|Pnina Fishman, PhD|011972 39241114|pnina@canfite.co.il|
22432102|NCT02347085|Pearl Therapeutics Inc.|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
22432103|NCT01957865|Massachusetts General Hospital|Jessica Haberer|617 724 0351|jhaberer@partners.org|
22432104|NCT01082614|Loma Linda University|Tonya Hamilton|909-558-9408|thamilton@llu.edu|
22432105|NCT01585402|National Heart, Lung, and Blood Institute (NHLBI)|Alessandra Brofferio, M.D.|301.496.2634|alessandra.brofferio@nih.gov|
22432106|NCT03368066|University of Virginia|Dr. Brian Wentworth|9739436781|bw8xz@hscmail.mcc.virginia.edu|
22432107|NCT01419119|Umea University, Umeå, Sweden|Dr Margareta Norberg|+46702618614|margareta.norberg@umu.se|
22432108|NCT00950651|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
22432109|NCT03783780|Masimo|Tala Harake|1-949-297-7100|studies@masimo.com|
22432110|NCT03768427|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22432111|NCT01937520|Rutgers, The State University of New Jersey|Dennis Grech, MD|973 972-5007|grechde@njms.rutgers.edu|
22432112|NCT03710889|Radius Health, Inc.|Associate Director, Clinical Operations|(617) 551-4000|info@radiuspharm.com|
22432113|NCT01111162|University of Pennsylvania|Pablo Tebas|2153498092|pablo.tebas@uphs.upenn.edu|
22432114|NCT03722810|BIHAM, University of Bern|Prof. Michael Harris|+44 1761 241366|michael.harris@biham.unibe.ch|
22432115|NCT00659425|MedImmune, LLC|Mark Lanasa, MD Associate Director, Clinical Development, Oncology|301-398-0000|information.center@AstraZeneca.com|
22432116|NCT02579811|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Moshe Ornstein|1-866-223-8100|TaussigResearch@ccf.org|
22432117|NCT00833521|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22432118|NCT02121509|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22432119|NCT01061528|University of Texas at Austin|Dr. Richard A. Brown|512-471-8584|brown2@utexas.edu|
22432120|NCT00636181|Stanford Sleep Medicine Center|Clete A. Kushida, MD, PhD|(650) 721-7560|clete@stanford.edu|
22432121|NCT04336826|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22432122|NCT02993263|Cleveland Clinic|Daniel Sessler, MD|216-444-9400|sesslers@ccf.org|
22432123|NCT02561962|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22432124|NCT00896012|University at Buffalo|Oleh G. Pankewycz, MD||opankewycz@kaleidahealth.org|
22432125|NCT02735421|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22432126|NCT02006108|Stanford University, Department of Radiology|Dr. Heike E. Daldrup-Link|650-497-8601|emisquez@stanford.edu|
22432127|NCT00322049|U.S. Army Medical Component Armed Forces Research Institute of Medical Services|Wipa Chawachalasai|662-696-2700|wipac@afrims.org|4351
22432128|NCT01978145|GlaxoSmithKline|GSK Response Center|866-435-7343||
22432129|NCT01173679|Massachusetts General Hospital|Philip C. Amrein, M.D.|6177243456|pamrein@partners.org|
22432130|NCT01250054|CIBA VISION|Joe Rappon, OD, MS, FAAO / Head, Clinical Trial Management|1-678-415-3343|Joseph.Rappon@cibavision.com|
22392863|NCT00166712|Comprehensive Transplant Center, Northwestern University|Joseph Leventhal, MD, PhD, Associate Professor|(312) 695-1703|jleventh@nmh.org|
22392864|NCT04684394|Gemini Therapeutics, Inc.|Gemini Therapeutics, Inc.|617-401-4401|clinicaltrials@geminitherapeutics.com|
22392865|NCT03986944|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
22392866|NCT02225132|National Heart Lung and Blood Institute|Fitzhugh, Courtney|+1 301 402 6496|courtney.fitzhugh@nih.gov|
22392867|NCT01531673|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22392868|NCT00568178|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22392869|NCT01332630|UT MD Anderson Cancer Center|Ibrahim,Nuhad K.,M.D. / Breast Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
22392870|NCT01318018|Dept. of Anesthesiology and Intensive Care Medicine|Prof. Dr.Martin Soehle|++49-228-287-|martin.soehle@ukb.uni-bonn.de|11378
22392871|NCT04476251|National Cancer Institute|Scott M. Norberg D.O.|301-275-9668|scott.norberg@nih.gov|
22392872|NCT01008553|Janssen Research & Development, L.L.C. USA|Director, Clinical Research|1 609 730-3387||
22392873|NCT00581555|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22392874|NCT03283254|Columbia University|Elizabeth Werner, Ph.D.|646-774-8945|ew150@cumc.columbia.edu|
22392875|NCT02055781|CTI BioPharma Corp.|Beth Ziemba||bziemba@ctibiopharma.com|
22392876|NCT05816330|National Institute of Allergy and Infectious Diseases (NIAID)|Dr. Peter D Crompton|301-761-5042|pcrompton@niaid.nih.gov|
22392877|NCT00201643|Obstetrix Medical Group, Inc.|Kimberly A. Maurel, MSN, CNS|714-593-9171|kimberly_maurel@pediatrix.com|
22392878|NCT02787044|Brigham and Women's Hospital|Dr. Scott Solomon|857-307-1960|ssolomon@bwh.harvard.edu|
22392879|NCT01638429|Cedars-Sinai Medical Center|Dr Ruchi Mathur|310-423-4774|Ruchi.Mathur@cshs.org|
22392880|NCT02040584|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22392881|NCT03894618|Shattuck Labs|VP, Clinical Operations|919-864-2700|clinicaltrials@shattucklabs.com|
22410608|NCT00343642|Rush University Medical Center|Ece A Mutlu, Principal Investigator|312 942 5861|Ece_Mutlu@rush.edu|
22420855|NCT00437021|Saint Louis University Medical Center|Sharon E. Frey, M.D.|315-977-5500|sharon.frey@health.slu.edu|
22432131|NCT02026011|University of California, Los Angeles|Lara Ray|310-794-5383|lararay@psych.ucla.edu|
22432132|NCT01770743|Emergent BioSolutions|Dr. Gurdyal Kalsi|301-216-9927|kalsig@ebsi.com|
22420856|NCT04162847|Washington University in St. Louis School of Medicine|Dr. Denise Wilfley|3142862079|wilfleyd@wustl.edu|
22420857|NCT03985800|Department of Psychiatry, University of Pittsburgh|Eva Szigethy, Co-Principal Investigator, Adjunct Professor of Psychiatry, Staff Psychiatrist|412-667-0416|szigethye@upmc.edu|
22420858|NCT05258773|Sensorion|Chief Medical Officer|+33 4 67 20 77 30|contact@sensorion-pharma.com|
22420859|NCT03018288|National Cancer Institute|Dr. Kevin Camphausen|240-760-6205|camphauk@mail.nih.gov|
22420860|NCT03593473|University of North Carollina at Chapel Hill|Alison Stuebe, MD, MSc|919-966-1601|astuebe@med.unc.edu|
22420861|NCT04173507|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
22420862|NCT02832687|CHRISTUS St. Vincent Regional Medical Center|Dr. Michal Gajewski, DO|(505) 913-3361|Michal.Gajewski@stvin.org|
22420863|NCT04231825|University of California San Francisco|Dr. Theodore Zanto|415-502-7322|theodore.zanto@ucsf.edu|
22420864|NCT02844933|Radius Pharmaceuticals, Inc.|Tarek El Akkad, Head of Clinical Development|6175514000|telakkad@radiuspharm.com|
22420865|NCT01479465|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22420866|NCT00083382|UAMS Myeloma Institute|Bart Barlogie|526-6990|barlogiebart@uams.edu|2420
22420867|NCT01439802|Albert Einstein College of Medicine|Dr. Erika Levi|718-405-8260|elevi@montefiore.org|
22432133|NCT03372161|Scilex Pharmaceuticals, Inc.|Associate Director Clinical Operations|(650) 386-6709|cambrose@scilexpharma.com|
22410609|NCT02462382|Orlando Orthopaedic Center|Randy Schwartzberg, MD|407-254-2500|orlandosportsdoc@yahoo.com|
22410610|NCT01393990|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22410611|NCT02060461|Cleveland Clinic|William J Dupps, Jr, MD, PhD|216-444-8396||
22410612|NCT00740727|Massachusetts General Hospital|Stephen H. Thomas MD MPH|6177267622|stephen-thomas@ouhsc.edu|
22410613|NCT05321810|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22410614|NCT01976390|Division of Transplant Surgery OSUMC|Director of Research Operations|614-293-8021|brenda.cuson@osumc.edu|
22410615|NCT02720952|Diurnal Limited|Dr John Porter||info@diurnal.co.uk|
22410616|NCT00331630|Northwestern University|Virginia Kaklamani|312-695-1301||
22410617|NCT01014390|Hôpital Erasme|Jacques Devière, MD, PhD|(32) 0-2-555-4697.|Jacques.Deviere@erasme.ulb.ac.be|
22410618|NCT01133821|University of Pittsburgh School of Medicine|Holly A. Swartz M.D.|412-246-5588|swartzha@upmc.edu|
22410619|NCT00803959|New England Research Institutes|Heather Litman, PhD|617 972 3297|hlitman@neriscience.com|
22410620|NCT01859390|University of Colorado School of Medicine|Dr. Scott Sagel, Professor of Pediatrics|720-777-2522|scott.sagel@ucdenver.edu|
22410621|NCT02451670|HealthPartnersInstitute|Rebecca Rossom|952-883-5466|Rebecca.C.Rossom@HealthPartners.com|
22410622|NCT01151813|UPenn|Dr. Jennifer Plebani|215-222-3200|jplebani@upenn.edu|152
22410623|NCT01567371|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-4200|Joseph.Tobias@nationwidechildrens.org|
22410624|NCT00463866|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22410625|NCT01084005|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22410626|NCT02415166|LaurateInstitute|Jonathan Savitz|918 502 5104|jsavitz@laureateinstitute.org|
22410627|NCT02480010|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22432134|NCT01714323|Massachusetts General Hospital|Nancy Rigotti, MD|617-724-4709|nrigotti@partners.org|
22432135|NCT00755807|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22432136|NCT00939107|Back and Rehabilitation Center Copenhagen|Tom Petersen|+45 35304974|tom.petersen@suf.kk.dk|
22432137|NCT05010070|University of Michigan|Laura Saslow, Associate Professor|(734) 764-7836|saslowl@umich.edu|
22432138|NCT03233828|Nova Scotia Health|Principal Investigator|9024736177|carman.giacomantonio@nshealth.ca|
22432139|NCT02495285|B. Braun Melsungen|Study Manager|05661/71|studies@bbraun.com|0
22432140|NCT02094118|Mayo Clinic|Dr. Daryl Kor|507-255-6051|kor.daryl@mayo.edu|
22432141|NCT01585025|Imperial College London|Prof Julian Walters|+442033132361|julian.walters@imperial.ac.uk|
22432142|NCT00503984|University of Miami|Rakesh Singal MD|305-243-9544|rsingal@med.miami.edu|
22432143|NCT03430349|University of Antwerp|Pierre Van Damme, MD, PhD|+32 3 265 21 30|pierre.vandamme@uantwerpen.be|
22432144|NCT02122380|Vanderbilt University Medical Center|Dr. Jessica Devin|970-875-2708|jessica.devin@vumc.org|
22432145|NCT00716820|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22432146|NCT00441272|National Institute of Allergy and Infectious Diseases|Colleen Hadigan, MD, MPH|301-594-5754|hadiganc@niaid.nih.gov|
22432147|NCT00427011|Eisai Call Center|Eisai Inc.|888-422-4743||
22432148|NCT00952705|MedImmune, LLC|JA Sliman, MD, MPH, Director, Clinical Development|301-398-0000|SlimanJ@medimmune.com|
22432149|NCT04552041|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22432150|NCT03702179|SOGUG|A contact designated by the Sponsor|+34671422325|secretaria@sogug.es|
22432151|NCT02921789|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22432152|NCT01944020|Columbia University|Ari Shechter|2123424487|as4874@cumc.columbia.edu|
22432153|NCT01192126|Bausch & Lomb Incorporated|Dr. Robert Steffen OD|585-338-6399|robert.steffen@bausch.com|
22392882|NCT00795275|University of Colorado Anschutz Medical Campus|Leigh Perreault, MD|303-249-7732|leigh.perreault@ucdenver.edu|
22420868|NCT02562066|Catalyst Pharmaceuticals, Inc.|Gary Ingenito|305-420-3200|gingenito@catalystpharma.com|
22420869|NCT02392481|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22420870|NCT02502149|Bioverativ|Bioverativ Study Medical Director|781-6631801|clinicaltrials@bioverativ.com|
22420871|NCT04067050|CooperVision, Inc|Jose A. Vega|925-640-2964|javega2@coopervision.com|
22420872|NCT03207776|Atrium Health|Dr. Jason Roberge|704-898-3855|Jason.Roberge@AtriumHealth.org|
22420873|NCT03036657|Oregon Health & Science University|Alexandra Dimitrova, PI|503-494-0766|dimitroa@ohsu.edu|
22420874|NCT01087918|UZurich|Hubertus van Hedel, PhD|+41 44 762 52 91|hubertus.vanhedel@kispi.uzh.ch|
22420875|NCT02088177|NYSPI|Dr. Frances R. Levin||frl2@cumc.columbia.edu|
22420876|NCT01234350|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22420877|NCT00289848|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22420878|NCT01839708|Ohio State University|Mei-Wei Chang|(614) 292-4041|chang.1572@osu.edu|
22432154|NCT01669902|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22432155|NCT01047189|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-3775|sfeldman@wfubmc.edu|
22432156|NCT02391311|UAB|Pariya L Fazeli, PhD|205-996-0330|plfazeli@uab.edu|
22420879|NCT00754130|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22420880|NCT01836471|Novaratis Pharmaceuticals|Study Director|862-778-8300||
22392883|NCT02530970|Aziyo Biologics, Inc.|Clinical Director|470-514-4085|clinical@aziyo.com|
22392884|NCT00827099|Blood and Marrow Transplant Group of Georgia|Scott R. Solomon, MD|404-255-1930|ssolomon@bmtga.com|
22392885|NCT00743431|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22392886|NCT03291288|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22392887|NCT04978493|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22392888|NCT01896726|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22420881|NCT00774163|Tulane University School of Public Health and Tropical Medicine|Dr. Richard Oberhelman|504-988-2511|oberhel@tulane.edu|
22420882|NCT02570308|Immunocore, Ltd|Nicola McKelvie|484-534-5261|nicola.mckelvie@immunocore.com|
22420883|NCT01960413|Vanderbilt University Medical Center|Michael DeBaun, MD MPH|(615) 875-3040|m.debaun@vumc.org|
22420884|NCT02285361|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22420885|NCT01283464|Johns Hopkins Dermatology|Dr. Anna L. Chien|4105027546|ctrep@jhmi.edu|
22420886|NCT03051100|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
22420887|NCT02626026|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22420888|NCT01778855|UCLA|David S Liebeskind, MD|310-794-6379|dliebeskind@mednet.ucla.edu|
22420889|NCT02059135|LFB USA|Laura Massey, Sr. Clinical Project Manager|508-370-5157|laura.massey@lfb-usa.com|
22420890|NCT05921903|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22420891|NCT03305848|Regions Hospital|Benjamin A Willenbring, MD|651-254-3563|benjamin.a.willenbring@healthpartners.com|
22420892|NCT05365451|Washington State University|Dr. Mary Paine|509-358-7759|mary.paine@wsu.edu|
22420893|NCT05366010|Baxter Healthcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
22420894|NCT02224157|AstraZeneca AB|Stefan Ivanov|000000000|information.center@astrazeneca.com|
22420895|NCT05906628|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22420896|NCT02301169|Tools4Patient|Stephanie Alvarez|+32 71 14|stephanie.alvarez@tools4patient.com|02 00
22420897|NCT03762265|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
22420898|NCT00765102|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22420899|NCT03440229|University of Pennsylvania|Dr. James D. Lewis|215-573-5137|james.lewis@pennmedicine.upenn.edu|
22420900|NCT02289729|AbbVie|Global Medical Services|800-633-9110||
22420901|NCT00470470|Memorial Sloan-Kettering Cancer Center|Dr. Richard Carvajal|646-888-4161|carvajar@mskcc.org|
22420902|NCT02046603|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22420903|NCT02461160|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22420904|NCT00193050|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSarah@scresearch.net|
22420905|NCT02431364|Karyopharm Therapeutics Inc|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
22420906|NCT00061932|Montefiore Medical Center|Rutvi Patel|718-379-6861|rupatel@montefiore.org|
22420907|NCT03367819|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22420908|NCT02624180|Johns Hopkins Hospital|Robert G. Weiss, MD|410-955-1703|rweiss@jhmi.edu|
22420909|NCT00445146|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@Gilead.com|
22420910|NCT02456740|Amgen Inc.|Study Director|866-572-6436||
22420911|NCT01615367|Massachusetts General Hospital|Dr. Louisa Sylvia|617-643-4804|lsylvia2@partners.org|
22420912|NCT00607321|Medtronic Cardiovascular|K Bogdanovich||rs.medtroniccardiovascularclinicaltrials@medtronic.com|
22420913|NCT04720105|Icahn School of Medicine at Mount Sinai|Hassan Hamade|212-844-8811|hassan.hamade@mountsinai.org|
22420914|NCT02483676|Baltimore VA Medical Center VA Maryland Health Care System|Dr. Steven Kittner|410-706-0414|skittner@som.umaryland.edu|
22420915|NCT03717155|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22420916|NCT01941615|Boehringer Ingelheim|Boehringer Ingelheim Call Center|+1 800 243 0127|clintriage.rdg@boehringer-ingelheim.com|
22420917|NCT02654054|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22420918|NCT04871776|Brigham and Women's Hospital|Nancy Haff, MD, MPH|857-307-3826|nhaff@partners.org|
22420919|NCT01333592|Kissei Pharmaceutical Co., Ltd|Clinical Development Division||rinsyousiken@pharm.kissei.co.jp|
22420920|NCT02490631|Vanderbilt University Medical Center|Elizabeth Card|615-875-4611|elizabeth.b.card@vumc.org|
22420921|NCT00619723|Psychoneuroendocrine Research Group|Dr. Sherwood Brown|214-645-6950|sherwood.brown@utsouthwestern.edu|
22420922|NCT02844543|Stanford University|Dr. Jamshid Ghajar, MD, PhD|(650) 725-5562|acrevelt@stanford.edu|
22420923|NCT03349060|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22420924|NCT02861586|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22420925|NCT04710576|Syndax Pharmaceuticals|Chief Medical Officer|781-419-1400|clinicaltrials@syndax.com|
22420926|NCT04796909|The Hong Kong Polytechnic University|Dr. Chi-Wen Chien, Associate Professor|+85227666703|will.chien@polyu.edu.hk|
22420927|NCT05277922|Vicore Pharma AB|Cecilia Ganslandt|+46 705 797075|info@vicorepharma.com|
22420928|NCT02024607|Sumitomo Dainippon Pharma Oncology|Tegan Nguyen|617-674-8745|tnguyen@bostonbiomedical.com|
22420929|NCT05338489|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
22420930|NCT05857488|Massachusetts General Hospital|Guillermo Tearney, MD, PhD|617-724-2979|gtearney@mgb.org|
22420931|NCT03851406|University of North Carolina at Chapel Hill|Terry Noah, MD|919-966-1055|terry_noah@med.unc.edu|
22420932|NCT00075816|The EMMES Corporation|Adam Mendizabal|301-251-1161|amedizabal@EMMES.com|
22392889|NCT01128114|AstraZeneca|Gerard Lynch||clinicaltrialtransparency@astrazeneca.com|
22420933|NCT00382200|Memorial Sloan Kettering Cancer Center|Dr. Raajit Rampal, MD, PhD|646-608-3746|rampalr@mskcc.org|
22420934|NCT02445248|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
22420935|NCT01120184|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22420936|NCT03190993|Pennington Biomedical Research Center|John Apolzan|225-763-2827|john.apolzan@pbrc.edu|
22420937|NCT02596971|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22420938|NCT00824772|Inje University|Kye-Min Kim, Associate Professor, Dept of Anesthesiology & Pain Medicine|82-2-950-1168|kyemin@paik.ac.kr|
22420939|NCT00683618|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22420940|NCT04570670|Banner Life Sciences LLC|Thomas Lategan, PhD|3368990959|thomas.lategan@bannerls.com|
22420941|NCT00730483|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu|
22392890|NCT02387970|Columbia University|Panos N. Papapanou, DDS, PhD|(212) 342-3008|pp192@cumc.columbia.edu|
22392891|NCT02628028|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22392892|NCT00586612|GlaxoSmithKline|GSK Response Center|866-435-7343||
22392893|NCT01743989|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
22392894|NCT01012297|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Administration and Operations|(716) 845-5702|kurasa@nrgoncology.org|
22392895|NCT02235311|University of Missouri - Columbia|Ashley McCormick, PharmD, BCPS|573-771-7798|ausmusash@health.missouri.edu|
22392896|NCT04655027|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-94 79|information.center@astrazeneca.com|
22392897|NCT00658788|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5000|elizabeth.nieman@galderma.com|
22392898|NCT00653523|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22392899|NCT02870049|UC San Diego|Samir Gupta, MD|07/09/2018|s1gupta@health.ucsd.edu|
22392900|NCT05543707|Pardes Biosciences|Vice President, Quality|4042815163|jenna.tagliaferri@pardesbio.com|
22392901|NCT00186888|St. Jude Children's Research Hospital|Ibrahim Qaddoumi MD|1-866-278-5833|info@stjude.org|
22392902|NCT05511038|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22392903|NCT02108964|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22392904|NCT03006848|St Jude Children's Research Hospital|Dr. Michael Bishop|866-278-5833|referralinfo@stjude.org|
22392905|NCT01198067|M.D. Anderson Cancer Center|Sheeba K. Thomas, MD|713-792-2860|sthomas@mdanderson.org|
22392906|NCT03086655|University of California San Francisco|Dr. Maria Ekstrand|+1 (415) 502-1000|Maria.Ekstrand@ucsf.edu|17142
22392907|NCT00384397|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22392908|NCT04531982|Acadia Pharmaceuticals Inc.|Senior Director, Medical Information|8444222342|medicalinformation@acadia-pharm.com|
22392909|NCT00542542|University of Texas MD Anderson Cancer Center|Dr. Farzin Goravanchi, Professor, Anesthesiology & Perioperative Medicine|713-563-5613|CR_Study_Registration@mdanderson.org|
22392910|NCT04998812|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22392911|NCT04303780|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22392912|NCT03826030|Duke University|Wayne Feng, MD|919-681-1700|wayne.feng@duke.edu|
22392913|NCT00379288|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22392914|NCT00591370|Memorial Sloan-Kettering Cancer Center|Dr. Paul Chapman|212-639-7357|chapmanp@mskcc.org|
22410628|NCT00606684|GlaxoSmithKline|GSK Response Center|866-435-7343||
22420942|NCT00318474|Saint Joseph's Hospital and Medical Center|Ron Hogg, M.D.|602-406-3246|ronhogg@gmail.com|
22410629|NCT03568500|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22410630|NCT00943800|University of Chicago|Hongtao Liu|773-834-8980|hliu2@medicine.bsd.uchicago.edu|
22410631|NCT02967133|Duke University Medical Center|Neal Ready MD PhD|(919) 681-6932|neal.ready@duke.edu|
22410632|NCT01768000|Centre for Addiction and Mental Health|Sean Kidd|416-535-8501|sean.kidd@camh.ca|36295
22410633|NCT00950833|GlaxoSmithKline|GSK Response Center|866-435-7343||
22410634|NCT02655354|University of Washington School of Medicine|Douglas Zatzick|206-744-6701|dzatzick@uw.edu|
22410635|NCT01828255|The New York Eye and Ear Infirmary|Dr Gustavo De Moraes|+1 212 477 7540|demoraesmd@gmail.com|
22410636|NCT00439608|BrUOG|Howard Safran, MD|401-863-3000|Hsafran@lifespan.org|
22410637|NCT03377556|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
22410638|NCT00910858|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22410639|NCT03522584|University of Washington|Cristina Rodriguez|2066066748|rodrigcr@uw.edu|
22410640|NCT00827827|Baltimore VAMC|Frederick M. Ivey|410-375-8419|fivey@grecc.umaryland.edu|
22410641|NCT04169282|Duke University|Loretta Que, MD|919-681-8551|loretta.que@duke.edu|
22410642|NCT01275313|University of Pittsburgh|David Brienza, Professor|412-624-6383|DBRIENZA@pitt.edu|
22392915|NCT01183260|Cleveland Clinic|Alison Klika, Research Program Manager|216-444-4954|klikaa@ccf.org|
22392916|NCT03232580|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22392917|NCT01202903|Novartis Pharmaceuticals|Study Director|862-778-8300||
22392918|NCT01302080|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22392919|NCT00837694|University at Buffalo|Jennifer L. Temple|716-829-5593|jltemple@buffalo.edu|
22392920|NCT04370548|Dare Bioscience, Inc.|VP, Clinical Operations|858-926-7655|nzack@darebioscience.com|109
22392921|NCT00095056|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
22392922|NCT04019990|Hacetepe University|Ceyda Sofuoğlu M.Sc.|+905338557742|ceyda_sofuoglu@hotmail.com|
22392923|NCT02654691|Aarhus University|Nanna Finnerup|0045 78463382|finnerup@clin.au.dk|
22392924|NCT00306670|Georgetown University|Craig M Kessler, MD|202-444-8676|kesslerc@georgetown.edu|
22392925|NCT03446781|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|ClinicalTrials@Endo.com|
22392926|NCT02060539|CooperVision|Cheryl McKinnon|925-251-2034|cmckinnon@coopervision.com|
22392927|NCT02093949|Saint joseph hospital|Dr Julien Seitz|+330491807044|jseitz@hopital-saint-joseph.fr|
22392928|NCT02796300|UCLA Medical Center|Principal Investigator|310-267-8771|EdwardLee@mednet.ucla.edu|
22392929|NCT05141500|Stryker Sustainability Solutions|Monique Ketcher|602-354-0917|monique.ketcher@stryker.com|
22392930|NCT02898077|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22392931|NCT02885324|Indiana University|Dr. Scott Coven|317-944-8784|scoven@iu.edu|
22392932|NCT00996476|Janssen Pharmaceutical K.K., Japan|DIrector|81 3 44115639||
22392933|NCT01802567|Penn State Health Children's Hospital|Giselle Sholler, MD|7175310003|gsaulniersholler@pennstatehealth.psu.edu|
22392934|NCT01940939|Dr.LIU|ShanghaiMHC|862134773775|erliu110@126.com|
22392935|NCT01470001|University at Buffalo|Dr Tova Ablove|716-878-7138|tablove@buffalo.edu|
22392936|NCT01895101|Amphia Hospital|Dr. Thierry V Scohy|0031765955570|tscohy@amphia.nl|
22392937|NCT01066520|Biologische Heilmittel Heel GmbH|Dr. Istvan Zatik|+4972215013192|istvan.zatik@heel.com|
22392938|NCT02308787|Terumo BCT|Raymond P. Goodrich, PhD, VP, Scientific and Clinical Affairs; Chief Science Officer-BBT|(303) 231-4357|Ray.Goodrich@terumobct.com|
22392939|NCT02182947|Children's Mercy Hospital|Nadia Hijaz|3139204958|nmhijaz@cmh.edu|
22392940|NCT02236988|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22392941|NCT04308590|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
22392942|NCT02734576|North Shore University Hospital Northwell Health|Dr. Athos Patsalides|516-562-2244|apatsalides@northwell.edu|
22392943|NCT01156376|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
22392944|NCT01493427|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
22420943|NCT02383017|Onnit Labs|Vince Kreipke|3176954359|Vkreipke@onnit.com|
22420944|NCT02961595|University of Tampere|Hanna Viskari||hanna.viskari@uta.fi|
22420945|NCT02386319|Herlev Hospital|Dr. Anders Gram-Hanssen|004526225318|anders.gram-hanssen@regionh.dk|
22420946|NCT04341363|Yale University|Brett King|(203) 785-7421|Brett.King@yale.edu|
22420947|NCT00063934|UTMDACC|Francisco Esteva, MD, PHD / Professor|713-792-2817|Francisco.Esteva@nyumc.org|
22420948|NCT02069015|Wayne State University|Julie Gleason-Comstock|313-577-6681|jgleason@med.wayne.edu|
22420949|NCT02479451|Mass General Hospital|Sagar Nigwekar|5857298636|sagarnigs@gmail.com|
22420950|NCT00381862|OHSU Knight Cancer Institute|Joseph Bubalo, PharmD, BCPS, BCOP|503-494-1080|bubaloj@ohsu.edu|
22420951|NCT01275365|Brigham and Women's Hospital|Shalendar Bhasin, MD|617-525-9040|Sbhasin@partners.org|
22420952|NCT02215369|Angiodynamics|Ariel Bloch|7742453646|abloch@angiodynamics.com|
22420953|NCT00923013|National Cancer Institute|Dr. Robert Kreitman|301-648-7375|kreitmar@mail.nih.gov|
22420954|NCT01639157|University of Kentucky|William W. Stoops, Ph.D.|859-257-5388|william.stoops@uky.edu|
22420955|NCT01060072|Bausch & Lomb Incorporated|Tuyen Ong, MD, MRCOphth|(973) 360-6389|tuyen.ong@bausch.com|
22420956|NCT06811155|hospital universitario virgen de la victoria|eva cabrera cesar|646905201|evacabreracesar@gmail.com|
22420957|NCT02641093|University of Cincinnati|Trisha Wise-Draper, MD, PhD|513 558 2826|wiseth@ucmail.uc.edu|
22420958|NCT03123068|Stanford University|Professor of Anesthesia|650-723-6412|ang@stanford.edu|
22420959|NCT02574598|Instituto Nacional de Cancerología|Dr. Oscar Arrieta|(52) 55-5628-0400|ogar@unam.mx|71101
22420960|NCT00462917|Brigham and Women's Hospital and Harvard Medical School|Robert C. Green, MD, MPH|617-264-5838|rcgreen@genetics.med.harvard.edu|
22420961|NCT02329015|Long Island University|Marshall Hagins PhD, PT|3478048512|mhagins@liu.edu|
22420962|NCT01149863|Emory University|Dr. Harvey|404-778-4381|rdharve@emory.edu|
22420963|NCT03207386|University of Nebraska Lincoln|Dr. Katie Edwards|6034223207|katie.edwards@unl.edu|
22420964|NCT03326193|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22420965|NCT02845700|Florida State University|Dr. Wen Li|850-645-1409|wenli@neuro.fsu.edu|
22420966|NCT00822692|Wilford Hall Medical Center|Gillian Schmitz, MD|919-724-9185|gillianmd@gmail.com|
22420967|NCT03420521|Johns Hopkins University|Dr. Christine Hann|410-502-0678|chann1@jh.edu|
22420968|NCT02452476|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+39 0521 2791|clinicaltrials_info@chiesi.com|
22420969|NCT02348112|Coloplast Corp.|Liz Driessen|1-800-258-3476|usedri@coloplast.com|
22420970|NCT01408043|Case Comprehensive Cancer Center|Navneet Majhail|216-444-2199|majhain@ccf.org|
22420971|NCT03714828|University of Arizona Cancer Center|Clara Curiel-Lewandrowski, MD|(520) 626-5351|ccuriel@arizona.edu|
22420972|NCT00946920|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22420973|NCT01168427|Medtronic - CRDM|RIO Clinical Research Specialist.|1-800-328-2518|MedtronicCRMtrials@medtronic.com|63277
22420974|NCT00640315|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22420975|NCT00397514|University of British Columbia|Dr. Shubhayan Sanatani|6048752345|ssanatani@cw.bc.ca|7955
22420976|NCT01530464|Duke University Medical Center|Dr. Thies Schroeder|919 681 4721|thies.schroeder@duke.edu|
22420977|NCT01709500|Regeneron Pharmaceuticals, Inc|Clinical Trial Management||clinicaltrials@regeneron.com|
22420978|NCT02107131|California Retina Consultants|Director of Research|8059631648|gabe@californiaretina.com|
22420979|NCT02286713|UT MD Anderson Cancer Center|Clinical Research Operations Team, Office of VP Clinical Research|713-792-7734|CR_Study_Registration@mdanderson.org|
22420980|NCT04314037|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22420981|NCT04707573|Akebia Therapeutics|Akebia Therapeutics|617-844-6128|trials@akebia.com|
22420982|NCT00856492|SWOG Statistical Center|Breast Committee Statistician|206-667-4623||
22420983|NCT06389487|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22420984|NCT00955409|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22420985|NCT00485732|GlaxoSmithKline|GSK Response Center|866-435-7343||
22420986|NCT03944668|HealthPartners Neuroscience Research|Amanda Herrmann, PhD|651-495-6356|amanda.a.herrmann@healthpartners.com|
22420987|NCT05423093|Johns Hopkins University|Rheanna Platt|410-550-8753|rplatt1@jhmi.edu|
22420988|NCT03593525|The Hospital for Sick Children|Dr. Lillian Sung|416 813 5287|lillian.sung@sickkids.ca|
22420989|NCT05537233|Indiana University School of Medicine|Viral N Shah, MD|317-278-6017|shahvi@iu.edu|
22420990|NCT00210210|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials' Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
22420991|NCT02767011|Charleston Area Medical Center Research Institute|Mike Broce|304-388-9923|mike.broce@camc.org|
22420992|NCT01002989|Hypertension Center, Third University Department of Medicine, Sotiria Hospital|George S. Stergiou, MD, FRCP, Associate Professor of Medicine|+30 2107763117|gstergi@med.uoa.gr|
22420993|NCT02954601|Oramed|Chief Scientific Officer|+972-2-566-0001|miriam@oramed.com|
22420994|NCT00887575|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22420995|NCT00917852|W.L. Gore & Associates|Abe Letter|928-864-3113|aletter@wlgore.com|
22420996|NCT00471081|GlaxoSmithKline|GSK Response Center|866-435-7343||
22420997|NCT02739789|Stony Brook University|Dr. David Hsu, Assistant Professor of Psychiatry|(631) 638-1522|david.hsu@stonybrookmedicine.edu|
22420998|NCT03426124|Boston Scientific|Leslie Cass|206-641-4529|Leslie.Cass@bsci.com|
22420999|NCT02393950|Orion Corporation|Clinical Trials Information Desk|+358104261|clinicaltrials@orionpharma.com|
22432157|NCT02554799|Medicines for Malaria Venture|Dr Cristina Donini|+41 22 555 0312|doninic@mmv.org|
22432158|NCT00688467|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22432159|NCT02808897|Montreal Heart Institute|Philippe Demers|5143763330|philippe.demers@icm-mhi.org|
22421000|NCT05486091|Anxiety Disorders Center|Gretchen Diefenbach, Ph.D.|860-545-7396|gretchen.diefenbach@hhchealth.org|
22421001|NCT01607450|Indiana University|Kieren J Mather MD FRCPC|317-278-7826|kmather@iu.edu|
22421002|NCT00659711|State University of NY at Buffalo|Paresh Dandona|7165351850|dandona@buffalo.edu|
22421003|NCT02677753|University of Louisville|Dr. Sean Francis|5025617260|sean.francis@louisville.edu|
22421004|NCT01342471|National Cancer Institute|Jeremy Steeves Ph.D.|(865)-308-3506|jeremy.steeves@nih.gov|
22421005|NCT01774760|Turku University Hospital, Turku, Finland|Prof. Heikki Minn|+35823130000|heikki.minn@tyks.fi|30149
22421006|NCT03871543|Johnson & Johnson Vision Care, Inc.|Ross Franklin|1 800-843-2020|RFRANKL1@its.jnj.com|
22421007|NCT01894919|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
22432160|NCT00305448|Astrazeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
22421008|NCT00663793|University of Washington|John K Amory, MD, MPH|206-616-1727|jamory@u.washington.edu|
22421009|NCT03711188|Immodulon Therapeutics Ltd|Clinical Trial Information Desk,|0044 0203137 6346|info@immodulon.com|
22421010|NCT03534687|University of Michigan|Jacob Haus|734 647-2790|jmhaus@umich.edu|
22421011|NCT03957200|University of manitoba|Dr Helen Pymar|204-787-4184|hpymar@hsc.mb.ca|
22421012|NCT00314340|UC Davis Medical Center|Barth Wilsey MD|916-843-7165|blwilsey@ucdavis.edu|
22421013|NCT00957801|University of Texas Medical Branch|Randall J Urban, Professor and Chair, Internal Medicine|409-772-1176|rurban@utmb.edu|
22421014|NCT01120808|Stanford Department of Emergency Medicine|Dr. Grant Lipman|415-290-9286|gslipman@stanford.edu|
22421015|NCT02182492|Department of ENT of Tongji Hospital Tongji Medical College Huazhong University of Science and Technology|Dr. Zheng Liu|86 027 83663807|zhengliuent@hotmail.com|
22421016|NCT03776357|Stanford University|Derek Amanatullah, MD, PhD|650-723-2257|dfa@stanford.edu|
22421017|NCT01286467|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22421018|NCT03335475|Nationwide Children's Hospital|Jamie Jackson, Ph.D.|614-722-3585|jamie.jackson2@nationwidechildrens.org|
22421019|NCT04886596|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22421020|NCT02211209|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
22421021|NCT00749073|Vertos Medical|VP Clinical, Regulatory, Quality|9493490008|cmyers@vertosmed.com|216
22421022|NCT01719367|Florida Electrophysiology Associates|Matthew Kolek, MD|(561) 434-0353|info@heartrhythmexperts.com|
22421023|NCT04973267|Brown University - SPH|Tyler Wray, PhD|4018636659|tyler_wray@brown.edu|
22421024|NCT03751098|Eyenovia, Inc.|VP, Development|714-269-8838|gclasby@eyenoviabio.com|
22421025|NCT00266279|University of Louisville, James Graham Brown Cancer Center|University of Louisville, James Graham Brown Cancer Center Clinical Trials|502-562-3429|bcccto@louisville.edu|
22421026|NCT02964247|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22421027|NCT06018129|Genmab|CLINICAL TRIAL INFORMATION|+45 7020 2728|clinicaltrials@genmab.com|
22421028|NCT03832686|Stanford University|Heather Starmer, MD|650-529-5903|hstarmer@stanford.edu|
22421029|NCT02208362|City of Hope Medical Center|Dr. Christine Brown|626-256-4673|CBrown@coh.org|83977
22421030|NCT02290444|University at Buffalo|Curtis Wojcik, Lab Coordinator|7163230551|cmwojcik@buffalo.edu|
22421031|NCT02235454|Duke University|Sanjay Asrani|919-684-8656|sanjay.asrani@duke.edu|
22421032|NCT03323398|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
22421033|NCT03641469|Green Sun Medical|James A. Arthur|720-202-3621|jarthur@greensunmedical.com|
22421034|NCT05479435|Istanbul Medipol University|Arzu Abalay|+905075891917|arzuabalay@hotmail.com|
22421035|NCT01618344|Hunstman Cancer Institute|Dr. Yelena Wu|801-213-5653|yelena.wu@utah.edu|
22421036|NCT00955617|Guerbet|Emilie Huchet|+33 1 45 91 50 00|emilie.huchet@guerbet-group.com|7688
22421037|NCT00858273|Nemours Children's Clinic|Dominique Darmaun, MD|(904) 697 3674|ddarmaun@nemours.org|
22421038|NCT00982657|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22421039|NCT02764762|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22421040|NCT00370552|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22421041|NCT03499067|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
22421042|NCT02342678|University of California, San Francisco|Alison Huang, MD|415-514-8697|alison.huang@ucsf.edu|
22421043|NCT01833481|University of Tennessee|Dr. Richard D. Komistek|8659742093|rkomiste@utk.edu|
22421044|NCT03876743|Northwestern University|Melissa Shauver; Research Project Manager|3124726024|melissa.shauver1@nm.org|
22421045|NCT03889418|Ochsner Health|Principal Investigator|504-842-8256|eboni.pricehaywood@ochsner.org|
22421046|NCT05002790|University Hospitals Coventry &Watwickshire NHS Trust|Cyprian Mendonca|02476964000|cyprian.mendonca@uhcw.nhs.uk|25874
22421047|NCT01549587|Procter & Gamble|Clinical Trial Manager|5136225362|combs.cs@pg.com|
22421048|NCT03437863|Department of Digital Health Research (previously Center for Shared Decision Making and Collaborative Care Research)|Head of Research and Development|+47 23 03 31 67|elin.borosund@rr-research.no|
22421049|NCT00837148|Memorial Sloan Kettering Cancer Center|Dr. William Tap|646-888-4163|tapw@mskcc.org|
22421050|NCT01416636|SciPharm SàRL|Bianca Tan||b.tan@scipharm.eu|
22421051|NCT00931411|Innovaderm Research|Annie Levesque|514-521-4285|alevesque@innovaderm.ca|222
22421052|NCT01827111|UT MD Anderson Cancer Center|Adi Diab, MD-Associate Professor, Melanoma Medical Oncology|(713) 745-7336|adiab@mdanderson.org|
22421053|NCT00793455|Northwestern University|Kenzie A. Cameron, PhD, MPH|312-503-3910|k-cameron@northwestern.edu|
22421054|NCT03181633|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22421055|NCT02749617|Hematology Research Program (HRP)|Director of HRP|6048754111|alee14@bccancer.bc.ca|22958
22421056|NCT04910100|BLP Management Group LLC|Barry Butler|813-766-9539|bbutler@blpmgmt.com|
22421057|NCT04132973|The University of Sheffield|Elaine Clarke|01142226533|e.n.clarke@shef.ac.uk|
22421058|NCT04383327|NYU Langone Health|Keng-Yen Huang, PhD, MPH|646-501-2879|Keng-Yen.Huang@nyulangone.org|
22421059|NCT04837196|Astellas Pharma Inc|Clinical Transparency|08008887704|astellas.resultsdisclosure@astellas.com|
22421060|NCT00991887|Carolinas Medical Center|Rachel Seymour, PhD|704-355-6969|Rachel.Seymour@carolinashealthcare.org|
22421061|NCT01306305|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
22421062|NCT04030299|The University of Iowa|Dr. Yu-Hsaing Wu|(319) 335-9758|yu-hsiang-wu@uiowa.edu|
22421063|NCT01964976|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22421064|NCT00699998|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22421065|NCT03093701|Taiwan Liposome Company|Dr. Carl Brown|886-2-2655-7377|tlc_clinicaltrials@tlcbio.com|
22421066|NCT03482973|Beth Israel Deaconess Medical Center|Dr. Balachundhar Subramaniam|6176320706|bsubrama@bidmc.harvard.edu|0706
22421067|NCT04616612|Indiana University|Dr. Rebecca Bartlett Ellis|3172740047|rjbartle@iu.edu|
22421068|NCT04306211|Indiana University|John M. DeWitt, MD|317-944-0980|jodewitt@iu.edu|
22421069|NCT04740918|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22421070|NCT01451463|The Ohio State University|Sandra K Kostyk, MD, PhD|6142934969|sandra.kostyk@osumc.edu|
22421071|NCT00524940|Sanofi Pasteur Inc|Medical Director||RegistryContactUs@sanofipasteur.com|
22421072|NCT01256879|U of Maryland|James Polli, Professor|410-706-8292|jpolli@rx.umaryland.edu|
22421073|NCT00725920|Federal University of Sao Paulo|Marcelo F Mello|55 11 50822860|mf-mello@uol.com.br|
22421074|NCT01288079|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22421075|NCT03170544|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22421076|NCT02387840|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Deborah Runkin Gold|1-800-641-2422|CTUReferral@UHhospitals.org|
22421077|NCT01213966|Faculty of Tropical Medicine|Professor Sasithon Pukrittayakamee|(662) 354-9400-19|yon@tropmedres.ac|1435
22421078|NCT00226577|Karmanos Cancer Institute|Gerold Bepler, M.D., Ph.D. via Moffitt Cancer Center|813-745-4398|beplerg@karmanos.org|
22421079|NCT04143373|Tehran UMS|Dr. Nariman Nikparto|+989124969058|n-nikparto@razi.tums.ac.ir|
22421080|NCT05192239|Colorado State University|Christopher Bell, Associate Professor|(970) 491-7522|christopher.bell@colostate.edu|
22421081|NCT03888469|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22421082|NCT04507464|University of Illinois at Chicago|Dr. Ulf Bronas|3123555886|bronas@uic.edu|
22421083|NCT01710787|Jean Brown Research|Adam D. Marberger, DDS|801-261-2000||
22421084|NCT02696291|Emergent Product Development Gaithersburg, Inc.|Tim Babinchak, MD|(240) 631-3585|tbabinchak@ebsi.com|
22421085|NCT02409927|Université de Sherbrooke|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
22421086|NCT00420420|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22421087|NCT00273182|Medtronic, Inc.|InSync Registry Clinical Trial Leader||medtroniccrmtrials@medtronic.com|
22421088|NCT00359424|University of Cincinnati Academic Health Center|Joseph P. Broderick|513-558-5429|broderjp@ucmail.uc.edu|
22421089|NCT05081063|Loma Linda University Health|Kaushik Mukherjee|9096515948|kmukherjee@llu.edu|
22421090|NCT05425927|SyntheticMR|Erik Lange|+46(0)70-331 56 78|erik.lange@syntheticmr.com|
22421091|NCT01609790|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22421092|NCT06954493|SCYNEXIS, Inc|David Angulo, MD|(201) 884 - 5471|david.angulo@scynexis.com|
22421093|NCT03760744|Vanderbilt Medical Center|Dr. Manus J. Donahue|615.322.8350|mj.donahue@vumc.org|
22421094|NCT05207865|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22421095|NCT00739882|Merck Serono, a division of Merck KGaA, Darmstadt, Germany|Medical Responsible|+49 6151 72 5200|service@merckgroup.com|
22421096|NCT04170738|Icahn School of Medicine at Mount Sinai|Iliyan Ivanov|(212) 523-1924|iliyan.ivanov@mssm.edu|
22421097|NCT03055338|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22421098|NCT00975611|Massachusetts General Hospital Schizophrenia Research Program|Dr. David Henderson|(617) 912-7800|dchenderson@partners.org|
22421099|NCT03058705|University of Rochester|Edward Messing, MD|585-275-0998|edward_messing@urmc.rochester.edu|
22421100|NCT01880554|Institut Bergonie|Derek Dinart||d.dinart@bordeaux.unicancer.fr|
22421101|NCT01415518|AstraZeneca|Goran Eckerwall||ClinicalTrialTransparency@astrazeneca.com|
22421102|NCT01256164|Mallinckrodt|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
22421103|NCT02999269|University of New Mexico|Dr. Chris Abbott, Division Chief Neuromodulaton, Department of Psychiatry|505272223|cabbott@salud.unm.edu|
22421104|NCT01754350|JohannWGUH|Johannes Rieger|+4969630187711|j.rieger@uni-tuebingen.de|
22421105|NCT01102257|Mount Sinai School of Medicine|Dr. Penny Asbell|(212) 241-7977|penny.asbell@mssm.edu|
22421106|NCT03752970|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22421107|NCT03976362|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22421108|NCT04767282|Michigan State University|Amy Custack, Associate Professor|8106005656|saxeamym@msu.edu|
22421109|NCT02979587|Medtronic|Lindsey Gustafson, Clinical Study Manager|7635262782|lindsey.m.gustafson@medtronic.com|
22421110|NCT01467713|Takeda|Medical Director, Clinical Science|1-877-825-3327|trialdisclosures@takeda.com|
22421111|NCT04846569|Brown University|Jennifer Pellowski|4018635453|jennifer_pellowski@brown.edu|
22421112|NCT02525783|Stryker|Matt Venegoni|612-297-0939|matthew.venegoni@stryker.com|
22421113|NCT02512302|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
22392945|NCT05775991|University of Rochester|Dr. Allison Magnuson|585-602-5085|allison_magnuson@urmc.rochester.edu|
22421114|NCT03532425|University of Alberta|Dr. Stephen D. Shafran|780-407-6945|sshafran@ualberta.ca|
22421115|NCT01775813|University of Colorado School of Medicine|Dr. Megan Kelsey|720-777-0991|megan.kelsey@childrenscolorado.org|
22421116|NCT05251337|Indiana University Health|Alyson Keen|3173413060|akeen2@iuhealth.org|
22421117|NCT01735916|Medtronic|MIRACLE EF Study Manager|(763) 514-4000|medtroniccrmtrials@medtronic.com|
22421118|NCT02004366|Emory University|Priyathama Vellanki|404-778-1665|priyathama.vellanki@emory.edu|
22421119|NCT05177484|Royal Wolverhampton NHS Trust|Group Research Sponsorship Manager|01902|rwh-tr.sponsorshipofresearch@nhs.net|695065
22421120|NCT01379768|Alcon Research|Director of Alcon Clinical, Atlanta|1-800-241-7629||
22421121|NCT01067781|Valneva Austria GmbH|Head Clinical Developement|0043120620|info@valneva.com|0
22421122|NCT03334435|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22421123|NCT03922321|Immunovant, Inc|Central Study Contact|1-800-797-0414|clinicaltrials@immunovant.com|
22421124|NCT01644240|Theravance Biopharma US, Inc.|Dr. Brett Haumann, SVP, Clinical Development|650-808-6000|BHaumann@theravance.com|
22432161|NCT00002766|Memorial Sloan Kettering Cancer Center|Dr. Peter Maslak|212-639-5518|maslakp@mskcc.org|
22421125|NCT00460603|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22421126|NCT06188715|Swiss Tropical and Public Health Institute|Prof Jennifer Keiser|+41 61 284 82 18|jennifer.keiser@swisstph.ch|
22421127|NCT01651117|Corporal Michael J. Crescenz VA Medical Center|Judith A. Long, MD|215-898-4311|judith.long@va.gov|
22421128|NCT03808948|Charité - Universitätsmedizin Berlin|Prof. Dr. med. Kai Schmidt-Ott|+4930450614671|Kai.schmidt-ott@charite.de|
22421129|NCT02075203|SATVI|Dr. Mark Hatherill|+27214066145|mark.hatherill@uct.ac.za|
22421130|NCT00350207|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22421131|NCT03802825|Kaiser Permanente Center for Health Research|Dr. Stephanie L. Fitzpatrick, Senior Investigator|502-345-1476|Stephanie.L.Fitzpatrick@kpchr.org|
22421132|NCT03982511|Central Michigan University|Sarah Domoff, PhD|989-774-6461|domof1se@cmich.edu|
22421133|NCT00568451|Mayo Clinic Cancer Center|Svetomir N. Markovic M.D., Ph.D.|507-284-2511|markovic.svetomir@mayo.edu|4-2511
22421134|NCT01313897|University of Arkansas for Medical Sciences|Frits van Rhee|501-526-6990|vanrheefrits@uams.edu|
22421135|NCT02996968|TriHealth Inc.|Abigail Shatkin-Margolis, MD|513-463-4300|Abigail_Shatkin-margolis@trihealth.com|
22421136|NCT01293695|Baylor University|Dr. Gary Elkins, Director of the Mind-Body Medicine Research Laboratory|254-296-0643|gary_elkins@baylor.edu|
22421137|NCT01967862|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22421138|NCT00791778|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22421139|NCT03313180|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
22421140|NCT00553839|Stanford University|Chandra Ramamoorthy, MBBS, FRCA|650-723-5728|chandrar@stanford.edu|
22421141|NCT01058642|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
22421142|NCT01704495|AstraZeneca|Medical Science Director Bengt Larsson||ClinicalTrialTransparency@astrazeneca.com|
22421143|NCT01256450|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22421144|NCT00891020|Hoffman-LaRoche|Medical Communications|800-821-8590||
22421145|NCT02531308|Northwestern University|Dr. R Karmali|312-695-0686|reem.karmali@northwestern.edu|
22421146|NCT05188261|Ironwood Pharmaceuticals, Inc|Ironwood Study Chair|617-621-7722|info@ironwoodpharma.com|
22421147|NCT02721277|University of Florida|Josef Neu, MD|352-273-8985|neuj@peds.ufl.edu|
22421148|NCT04177095|Massachusetts General Hospital|Hannah Gilligan, MD|617-726-2000|hgilligan@mgh.harvard.edu|
22421149|NCT02275819|VA Boston Healthcare System|Dr. Jayashri Aragam|617-323-7700|Jayashri.Aragam@va.gov|
22421150|NCT01346059|Beaumont Health|Rose Callahan|248 551-5147|rose.callahan@beaumont.org|
22421151|NCT02556775|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22421152|NCT00777296|Insmed Incorporated|Dr. Kevin Mange, Sr. Vice President, Clinical Development|908-947-2651|Kevin.Mange@Insmed.com|
22421153|NCT00658723|ETHICON, Inc.|Jonathan Batiller, Director Clinical Development|908-218-2819|JBatill2@its.jnj.com|
22421154|NCT00092118|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22421155|NCT01139125|Georgia Regents University|Peter F. Buckley, MD|706-721-2231|PBuckley@gru.edu|
22421156|NCT01592786|Forest Research Institute|Joel Trugman, MD|201-427-8000|Joel.Trugman@frx.com|8681
22421157|NCT02025725|Evoke|Chief Medical Officer|858-345-1494|mcarlson@evokepharma.com|206
22421158|NCT01841047|Institut Bergonié|Pr Guy KANTOR||G.Kantor@bordeaux.unicancer.fr|
22421159|NCT00235755|GlaxoSmithKline|GSK Response Center|866-435-7343||
22421160|NCT02816736|Duke Clinical Research Institute|Kevin J. Anstrom, Ph.D., Director of Biostatistics|919-668-8902|kevin.anstrom@duke.edu|
22421161|NCT04535141|University of North Carolina Lineberger Comprehensive Cancer Center|Jonathan Ptachcinski PharmD, BCPS, BCOP|+1 919-966-9786|Jonathan.Ptachcinski@unchealth.unc.edu|
22421162|NCT01532934|University of Rochester|Marc T. Swogger, Ph.D.|585-275-7418|marc_swogger@urmc.rochester.edu|
22421163|NCT00468819|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22421164|NCT02723344|Eastern Colorado Health Care System, Rocky Mountain MIRECC|Dr. Lisa A Brenner|720-723-6488|lisa.brenner@va.gov|
22421165|NCT03473184|Castle Creek Pharmaceuticals, LLC|Dr. Mary Spellman; Chief Medical Officer|862 286 0400|mspellman@castlecreekpharma.com|
22421166|NCT03759392|Cytokinetics, Inc.|Cytokinetics MD|650-624-2929|medicalaffairs@cytokinetics.com|
22421167|NCT04762160|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22421168|NCT01370629|Correvio International|Head of Clinical Development|+41 (0) 22 907 79 70|info@correvio.com|
22421169|NCT02996227|Cleveland Clinic|Fabio Rodriguez|215 444-9950|rodrigf3@ccf.org|
22421170|NCT03576326|University of California, San Francisco|Dr. Stuart Gansky|415-502-8094|stuart.gansky@ucsf.edu|
22421171|NCT05364931|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22421172|NCT02974686|Washington University|Dr. R. Delos Santos|314-362-8351|delossantos@wustl.edu|
22421173|NCT01100086|Purdue Pharma L.P.|Stephen Harris, M.D.|203-588-7592|Stephen.Harris@Pharma.com|
22421174|NCT01174823|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
22421175|NCT01611935|University of Pennsylvania|Dr. Carrie Sims|215-588-5154|carrie.sims@uphs.upenn.edu|
22421176|NCT04168112|SightMD|Dr. Alanna Nattis|631-957-2816|anattis@sightmd.com|
22421177|NCT03158038|MedImmune, LLC|Raburn Mallory|+1-301-398-5799|information.center@astrazeneca.com|
22421178|NCT02275546|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22421179|NCT02918565|Stanford University|Brian Suffoletto|4129016892|suffbp@stanford.edu|
22432162|NCT00030147|National Institute of Mental Health|Schmidt, Peter|+1 301 496 6120|peterschmidt@mail.nih.gov|
22421180|NCT04227197|Massachusetts General Hospital|Brian G Skotko, MD, MPP, Principal Investigator|(617) 643-3196|bskotko@mgh.harvard.edu|
22421181|NCT01739231|PATH|Richard Walker|202-822-0033|rwalker@path.org|
22421182|NCT00570141|Healthpoint, Ltd.|Herbert B. Slade, M.D., FAAAI|917-900-4000|bert.slade@healthpoint.com|
22421183|NCT04547985|Weill Cornell Medicine|Dr. Holly G. Prigerson|646-962-9655|hgp2001@med.cornell.edu|
22421184|NCT02992236|Nephrology University Erlangen Germany|Prof Dr Rroland Schmieder|+49 9131 8536207|roland.schmieder@uk-erlangen.de|
22421185|NCT02549859|University of Chicago|Ms. Lani Leong, Research Coordinator|7738341688|lani@neurology.bsd.uchicago.edu|
22421186|NCT03446027|Imperial College London|Laura Burgess|0203 311 5208|l.burgess@imperial.ac.uk|
22421187|NCT03097341|Aronora, Inc.|Christina U. Lorentz, PhD, Senior Scientist and Project Manager|503-964-0250|christina.lorentz@aronorabio.com|
22421188|NCT01209949|Galderma Laboratories, L.P.|Norman Preston|817-961-5360|Norman.Preston@galderma.com|
22421189|NCT00729612|The Ohio State University|Gregory Otterson, MD|614-293-2887|Greg.Otterson@osumc.edu|
22421190|NCT00708552|GlaxoSmithKline|GSK Response Center|866-435-7343||
22421191|NCT02309411|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
22421192|NCT01904526|Yale School of Medicine|Sherry McKee, PhD|2037373529|sherry.mckee@yale.edu|
22421193|NCT00495391|Romark Laboratories, L.C.|Marc Ayers|813-282-8544|Marc.Ayers@romark.com|
22421194|NCT03214224|Penn State College of Medicine|Andrew Geronimo|717-531-0003|geronimo@psu.edu|282576
22421195|NCT03566199|University of California, San Francisco|Dr. Sabine Mueller, MD, PhD.|(415) 502-7301|Sabine.Mueller@ucsf.edu|
22421196|NCT02712320|Foresee Pharmaceuticals Co., Ltd.|Dr. John Mao|+886 2-2655-2658|john.mao@foreseepharma.com|
22421197|NCT05266053|Indiana University|Dr. Lisa Mims - Principal Investigator|7733074863|lamims@iupui.edu|
22421198|NCT05344560|Johnson & Johnson Vision Care, Inc. (JJVC)|Benjamin Straker|1-800-843-2020|bstraker@its.jnj.com|
22421199|NCT01837901|Okuvision GmbH|Dr. R. Schippert|+49 7121 15935|ruth.schippert@okuvision.de|50
22421200|NCT01468337|National Eye Institute|Emily Chew, MD|301-496-6583|emily.chew@nih.gov|
22421201|NCT01051960|University of California, Los Angeles|Rajan Saggar, MD|(310) 794-9718|rsaggar@mednet.ucla.edu|
22421202|NCT03396653|University of Connecticut|Zeely Denmat|860-455-3842|zeely.denmat@uconn.edu|
22421203|NCT00391768|Collaborative Antiviral Study Group|Penelope Jester|877-975-7280|PJester@peds.uab.edu|
22421204|NCT00607620|University of Washington|Douglas Zatzick, MD|206-744-6701|dzatzick@uw.edu|206
22421205|NCT01082328|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22421206|NCT00031590|Childrens Hospital of Philadelphia|Peter Phillips|215-590-1000|phillipsp@email.chop.edu|
22421207|NCT05506046|Georgia State University|Lyudmila Popova|404-413-9338|lpopova1@gsu.edu|
22421208|NCT03124368|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22421209|NCT00444535|Novartis Pharmaceuticals|Clinical Disclosure Office|8620778-8300||
22421210|NCT01568892|GlaxoSmithKline|GSK Response Center|866-435-7343||
22421211|NCT02962492|State University of NY at Buffalo|Dr. Paresh Dandona|7165351850|dandona@buffalo.edu|
22421212|NCT01169064|Vanderbilt University Medical Ctr., Dept OB/GYN|Dr. Kelly Bennett; Director of Maternal Fetal Medicine|6153436275|kelly.a.bennett@vanderbilt.edu|
22421213|NCT00942578|National Cancer Institute|Dr. Ravi Madan|301-480-7168|rm480i@nih.gov|
22421214|NCT01072773|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
22421215|NCT01697748|University of South Florida|Dr Sheila Connery, Associate Professor Obstetrics and Gynecology|813-259-8542|sconnery@health.usf.edu|
22421216|NCT02179892|Emory University|Dr. Colette Curtis|404-778-3900|ccurti3@emory.edu|
22421217|NCT02104219|Alexion Pharmaceuticals|Senior Medical Director, Clinical Development|203-272-2596|clinicaltrials@alxn.com|
22421218|NCT02375971|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22421219|NCT05697809|Oxular Ltd|Friedrich Asmus, MD, Chief Medical Officer|617 882 7179|friedrich.asmus@ocular-cc.com|
22421220|NCT02172664|Indiana University School of Dentistry|Dr. Jeffrey Platt|3172747229|jplatt2@iu.edu|
22421221|NCT01909934|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
22421222|NCT03810092|CHD VENDEE|Romain DECOURS|02 51 44 65 72|romain.decours@ght85.fr|+33
22421223|NCT00806403|Sahlgren's University Hospital/S, Gothenburg|Lars Grip||lars.grip@vgregion.se|
22421224|NCT03447639|Beaumont Hospital|Director of Urology Research|248.551.0804|Deborah.Hasenau@Beaumont.org|
22421225|NCT01320293|University of North Carolina|Aida Lugo-Somolinos MD|919-843-9447|alugosom@med.unc.edu|
22421226|NCT02280200|University of Minnesota|Ryan Mays PhD, MPH, MS|612-625-0430|rjmays@umn.edu|
22421227|NCT01787292|Health Science Specialist|Dr. Keith McGregor|4043216111|keith.mcgregor2@va.gov|126792
22421228|NCT01147068|Protein Sciences Corporation|Dr. Ruvim Izikson, M.D.|203-599-6064|rizikson@proteinsciences.com|163
22421229|NCT04846400|University of Michigan|David A Zopf, MD|734-936-5730|davidzop@med.umich.edu|
22421230|NCT02962648|Pharmacosmos A/S|Clinical trial disclosure desk|+45 5948 5935|trial@pharmacosmos.com|
22421231|NCT02755285|Fujifilm Medical Systems USA, Inc.|Randy Vader|(360) 356-6821|randy.vader@fujifilm.com|
22421232|NCT01597778|The Emmes Company|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
22421233|NCT03267212|Harvard Medical School|Dr J. Andrew Taylor|6177585503|jandrew_taylor@hms.harvard.edu|
22421234|NCT05691712|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22432163|NCT02217618|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22432164|NCT00003816|Roswell Park Comprehensive Cancer Center|Theresa Hahn, PhD|716-845-5819|theresa.hahn@roswellpark.org|
22432165|NCT00387088|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22432166|NCT04108273|NYU Langone Health|Francisco Castellanos, MD|6467545194|Francisco.Castellanos@nyulangone.org|
22432167|NCT02441218|Institut de Recherches Internationales Servier (I.R.I.S.)|Therapeutic Innovation Pole|+33155724366|clinicaltrials@servier.com|
22432168|NCT01541371|CDMA, Beijing|Therapeutic Area Manager|00861058218352||
22432169|NCT02154061|Emory University|Nadine Rouphael, MD|404-712-1435|nroupha@emory.edu|
22432170|NCT01936831|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22432171|NCT00383071|SAIC/National Institute of Allergy and Infectious Diseases|John Beigel, M.D.|+1 301 451 9881|jbeigel@niaid.nih.gov|
22432172|NCT02103127|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22432173|NCT01570387|Boston Medical Center|Vaishali Sanchorawala|617-638-7017|vaishali.sanchorawala@bmc.org|
22432174|NCT01876381|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366||
22432175|NCT04031729|Massachusetts General Hospital|Dr. Tracey Simon|617-724-2401|tgsimon@partners.org|
22432176|NCT00523978|Medtronic AF Solutions|Linda Nelson, RN, BSN, MBA - AF Solutions Clinical Operations Director|(763)526-2891|linda.k.nelson@medtronic.com|
22432177|NCT02170064|BIAL - Portela & Cª, SA|Head of Clinical Research|+351-22 9866100|clinical.trials@bial.com|
22432178|NCT02148588|Washington University School of Medicine|Simon Haroutounian|3142861715|simon.haroutounian@wustl.edu|314
22432179|NCT00814255|NYUmed|Howard Trachtman|646-501-2663|howard.trachtman@nyumc.org|
22432180|NCT01696643|Cubist Pharmaceuticals|Vice President, Clinical Research|1.781.860.8660||
22432181|NCT00587041|Mayo Clinic|Use of Symbiotics to Reduce Urinary Oxalate Excretion|507-266-7960|lieske.john@mayo.edu|
22432182|NCT01193101|Novartis Pharmaceuticals|Study Director|+1 (862) 778-1873||
22432183|NCT03508050|Institut universitaire de cardiologie et de pneumologie de Québec|Dr Jean S. Bussières|418-656-8711|jbuss@criucpq.ulaval.ca|
22432184|NCT04389866|Advanced Dermatology|Dr. Amy Forman Taub|8474596400|drtaub@advdermatology.com|
22432185|NCT01205503|Markey Cancer Center Biostatistics Shared Resource Facility|Emily Dressler, PhD|859 323-3076|emilydressler@uky.edu|
22432186|NCT00776789|AIIMS|Dr Anu Thukral|01126594605|dranuthukral@yahoo.com|
22432187|NCT00401843|Janssen R&D UK|Project Physician||ClinicalTrialDisclosure@its.jnj.com|
22432188|NCT03175731|Qilu Hospital of Shandong University|Prof. Gao|+86-531-82169386|gaoyanjing@sdu.edu.cn|
22432189|NCT01182298|NIAID|Shyam Kottilil||Skottilil@niaid.nih.gov|
22432190|NCT04881760|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22432191|NCT01508910|Baxalta US Inc.|Clinical Trial Registries and Results Disclosure||ClinicalTrialsDisclosure@baxalta.com|
22432192|NCT01595529|Westat|Dr. Elizabeth Rowley|(919) 941-8325|ElizabethRowley@westat.com|
22432193|NCT04016714|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22432194|NCT01822665|GlaxoSmithKline|GSK Response Center|866-435-7343||
22432195|NCT00867035|Department of Orofacial Sciences, University of California, San Francisco|Milton Robert Wirthlin, DDS, MS|415-476-1731|m.robert.wirthlin@ucsf.edu; ddsmmr@att.net|
22432196|NCT03801993|Seattle Children's Hospital|Dr. Christopher H. Goss M.D., M.Sc.|(206) 987-5725|cgoss@uw.edu|
22432197|NCT00542178|Wake Forest University School of Medicine|Dr. Walter Ambrosius, PhD|336-716-6281|wambrosi@wakehealth.edu|
22432198|NCT00829998|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22432199|NCT02499887|UBMD Emergency Medicine|Heather Lindstrom|716-898-4564|hlindstrom@ecmc.edu|
22432200|NCT02259725|USC / Norris Comprehensive Cancer Center|Victoria Soto|3238653000|soto_v@med.usc.edu|
22432201|NCT06164691|University of Pittsburgh|Dr. Matthew Neal|412-647-1158|nealm2@upmc.edu|
22432202|NCT00812955|AstraZeneca|Gerard Lynch|+44 1509 645 895|aztrial_results_posting@astrazeneca.com|
22432203|NCT03046446|Flexion Therapeutics|Scott Kelley, Chief Medical Officer|781-305-7142|skelley@flexiontherapeutics.com|
22432204|NCT03183063|Beaumont Health|Joanne Gondert|248 551-0439|joanne.gondert@beaumont.org|
22432205|NCT00399568|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
22432206|NCT00925002|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22432207|NCT02163577|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
22432208|NCT01343888|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22432209|NCT00558636|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22432210|NCT01990742|University of Rochester|Dr. Helena Temkin-Greener|585-275-8713|Helena_Temkin-Greener@urmc.rochester.edu|
22432211|NCT00800735|Hoffmann-La Roche|Medical Communications|800 821-8590||
22432212|NCT00506142|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@appirx.com|
22432213|NCT01103414|Mstabolic Solutions Company. LLC|Dr. Jerry Colca, President & CSO|269.343.6732|jcolca@msdrx.com|
22432214|NCT02133573|Children's Hospital of Philadelphia|Dr. J. William Gaynor|215-590-5806|gaynor@chop.edu|
22432215|NCT03715790|Medtronic Cardiac Rhythm Management|CRM Clinical Research|1-800-328-2518|rs.medtronicCRMtrials@medtronic.com|
22432216|NCT02213250|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|(001)8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22432217|NCT03085680|University of Florida|Dr. Robert Mankowski|+1 (352) 294-5055|r.mankowski@ufl.edu|
22432218|NCT00441766|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22432219|NCT00901303|Weill Cornell Medicine|Dr. Peter Martin||pem9019@med.cornell.edu|
22432220|NCT03848416|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22432221|NCT02808429|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22432222|NCT01436110|GlaxoSmithKline|GSK Response Center|866-435-7343||
22432223|NCT01175343|Princess Margaret Cancer Centre|Dr. Amit M. Oza|416-946-2818|amit.oza@uhn.ca|
22432224|NCT03273907|Alcon Research, LLC|CDMA Clinical Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22432225|NCT00110214|Thomas Jefferson University|William Kevin Kelly, DO||wm.kevin.kelly@jefferson.edu|
22432226|NCT01088503|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22432227|NCT01847092|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
22432228|NCT01016067|Medtronic Spinal|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
22432229|NCT01896687|Virginia Commonwealth University|Dr. Angela Starkweather|8048283986|astarkweathe@vcu.edu|
22432230|NCT01673646|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
22432231|NCT01000506|GlaxoSmithKline|GSK Response Center|866-435-7343||
22432232|NCT03064074|Baylor|dianne Nguyen|7137986694|diannen@bcm.edu|
22432233|NCT01580410|Wake Forest University Health Sciences|Dr. Edward Levine|336-716-2763|elevine@wakehealth.edu|
22432234|NCT03417466|Medtronic Minimed|Fen Peng, Biostatistician|8185763253|fen.peng@medtronic.com|
22432235|NCT00269087|GlaxoSmithKline|GSK Response Center|866-435-7343||
22432236|NCT05018689|Penn State College of Medicine|Dr. Deepa Sekhar|717-531-0003|dsekhar@pennstatehealth.psu.edu|x281334
22432237|NCT03134326|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
22432238|NCT04207320|University of Chicago|Dr. John Cunningham|773-702-6808|jcunning@bsd.uchicago.edu|
22432239|NCT01188967|Massachusetts General Hospital|Maurizio Fava M.D.|617-724-2513|mfava@partners.org|
22432240|NCT01448616|University of Washington|Rachel Bender Ignacio, MD MPH|2065204340|rbi13@uw.edu|
22432241|NCT04577781|Galapagos NV|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
22432242|NCT01464879|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22432243|NCT03763747|OrbusNeich|Stephen M. Rowland, PhD - Vice-President, Research and Development|954-730-0711|srowland@orbusneich.com|
22432244|NCT01074125|Keryx Biopharmaceuticals Inc|Medical Information|1-844-44-KERYX (1-844-445-3799|medicalinfo@keryx.com|
22432245|NCT02951780|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22432246|NCT00508482|Guang'anmen Hospital Affiliated to China Academy of Chinese Medical Sciences|Dr. Zhishun Liu|0086-010-88001124|liuzhishun@aliyun.com|
22432247|NCT00546481|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22432248|NCT00244621|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22432249|NCT01227057|VASDHS|Catherine Ayers|8585528585|catherine.ayers1@va.gov|2976
22432250|NCT02271529|Cook Research Incorporated|Scott Snyder, Director, Clinical Affairs|765-463-7537|SSnyder@medinst.com|
22432251|NCT02524561|Brigham and Women's Hospital|Dr. Rulla Tamimi|617-525-0862|rulla.tamimi@channing.harvard.edu|
22432252|NCT00811720|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
22432253|NCT03894891|Dana-Farber Cancer Institute|Robert Haddad, MD|617.632.3090|Robert_Haddad@dfci.harvard.edu|
22432254|NCT01730872|Ora|Keith Lane|9786858900|klane@oraclinical.com|
22432255|NCT01044030|Boston Children's Hospital|Louis Vernacchio, MD, MSc|617-919-4283|louis.vernacchio@childrens.harvard.edu|
22432256|NCT01186250|Stanford University|Kiran K. Khush, MD|650-721-3241|kiran@stanford.edu|
22432257|NCT01644643|AstraZeneca-PPD|Yunxia Lu|910-558-4197|Yunxia.Lu@ppdi.com|
22432258|NCT04940130|Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Dr. Patrick Duffy|301.761.5089|patrick.duffy@nih.gov|
22432259|NCT02742129|Duke Clinical Research Institute|Adrian Hernandez|919-668-7515|Adrian.Hernandez@duke.edu|
22432260|NCT00421148|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22432261|NCT03289533|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22432262|NCT00539240|Southern Arizona VA Health Care System|Christopher Wendel, MS|520 792 1450|christopher.wendel@va.gov|1824
22432263|NCT01284959|Chonbuk National University Hospital|Prof. Youngchul Chung|+82-63-250-2185|chungyc@chonbuk.ac.kr|
22432264|NCT01055613|Johnson & Johnson Vision Care Inc.|Brian Pall, O.D.- Research Principle Optometrist|904-443-1290|BPALL@its.jnj.com|
22432265|NCT00363311|GlaxoSmithKline|GSK Response Center|866-435-7343||
22432266|NCT01832610|Medtronic|Thomas Vassiliades, MD - VP MCS Clinical/Medical Affairs|+15085321956|thomas.a.vassiliades@medtronic.com|
22432267|NCT03708367|Johnson & Johnson Surgical Vision|Sanjeev Kasthurirangan, PhD|+1 408 5335282|skasthur@ITS.JNJ.com|
22432268|NCT02874092|NYU Langone|Dr. Jeffrey Berger|212-263-0855|Jeffrey.Berger@nyulangone.org|
22432269|NCT01677988|Medical University of South Carolina|Paul O'Brien, MD|843-792-4271|obrienpe@musc.edu|
22432270|NCT00928772|VAMC|Grigory Chernyak, MD|405-326-1885|grigory.chernyak@va.gov|
22432271|NCT01974284|Yale University School of Medicine|Dr. Glenda Callendar|203-737-2036|glenda.callender@yale.edu|
22432272|NCT02525679|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22432273|NCT02629861|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|1-888-483-8279|USMedInfo@Tevapharm.com|
22432274|NCT00271544|Medtronic CRDM Clinical Research|Hang Nguyen|800-328-2518|hang.t.nguyen@medtronic.com|62832
22432275|NCT01685684|Collegium Pharmaceutical|Clinical Scientist|+1.781.232.0764|clinicaltrials@collegiumpharma.com|
22392946|NCT00919191|Valeant Pharmaceuticals International, Inc|David Lineberry, Associate Director, Clinical Operations|949-973-1153|David.Lineberry@valeant.com|
22392947|NCT00821951|Yale University|Dr. Roy H Decker, MD PhD|203 737-2758|roy.decker@yale.edu|
22392948|NCT02757872|NYU Langone|Dr. Michal Melamed|212-263-0705|michal.melamed@nyulangone.org|
22392949|NCT00939822|University of Wisconsin School of Medicine and Public Health|Dr. Cynthia M. Carlsson|608-256-1901|cmc@medicine.wisc.edu|11691
22392950|NCT01072630|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22392951|NCT02683785|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22392952|NCT00416195|Eisai Call Center|Eisai Inc.|888-422-4743||
22392953|NCT01305408|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22392954|NCT01877239|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22392955|NCT04368364|The University of Texas Health Science Center at Houston|Sudipta Sen, MD, Assistant Professor|713-500-6200|Sudipta.Sen@uth.tmc.edu|
22392956|NCT01283516|Novartis Pharmaceuticals|Study Director|862-778-8300||
22392957|NCT00860847|Los Angeles Biomedical Research Inst.|Dr Matthew Budoff|310-222-4107|mbudoff@labiomed.org|
22392958|NCT00444275|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22392959|NCT04187326|UMass Chan School of Medicine|Dr. Elliot Edmiston, Associate Professor of Psychiatry & Behavioral Sciences|5088566480|kale.edmiston@umassmed.edu|
22392960|NCT00283244|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22392961|NCT05686122|Duke University School of Medicine|Sarah Kelleher, PhD|919-416-3405|sarah.kelleher@duke.edu|
22392962|NCT05543187|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22392963|NCT04777864|Seattle Children's Research Institute|Dr. Emily Kroshus|206-884-5326|Emily.Kroshus@seattlechildrens.org|
22392964|NCT06988800|Muvik|Dr. Chelsea Gordon|9063990332|chelsea@muviklabs.io|
22392965|NCT02344290|REPRIEVE Clinical Coordinating Center|REPRIEVE Project Manager|617-724-9109|mghreprievetrial@mgb.org|
22421235|NCT05303194|The University of Texas Medical Branch|Rafael Samper-Ternent|8322057994|rasamper@utmb.edu|
22421236|NCT01210560|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
22421237|NCT00226499|GlaxoSmithKline|GSK Response Center|866-435-7343||
22421238|NCT02524847|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-844-2830|clinicaltrials@mnk.com|5
22432276|NCT00606489|Cumberland Pharmaceuticals|Amy Rock, Doctor of Philosophy (Ph.D.)|6152550068|arock@cumberlandpharma.com|
22432277|NCT01563055|GlaxoSmithKline|GSK Response Center|866-435-7343||
22432278|NCT00902330|Virginia Commonwealth University|Debra Lyon, RN, PhD, FNP|804-828-7743|delyon@vcu.edu|
22432279|NCT00165789|Eisai Call Center|Eisai Inc.|888-422-4743||
22432280|NCT03571971|The Ohio State University|Stephanie Di Stasi, Principal Investigator|614-293-4220|stephanie.distasi@osumc.edu|
22421239|NCT04352101|Emory University|Andrew H. Miller, MD|404-727-8260|amill02@emory.edu|
22421240|NCT02794727|Mayo Clinic|Sanjeev Nanda, MD|507-284-2511|nanda.sanjeev@mayo.edu|
22421241|NCT01268527|Eisai Medical Research Inc.|Eisai Medical Information|1-888-274-2378|esi_medinfo@eisai.com|
22421242|NCT01008605|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22421243|NCT05795153|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
22421244|NCT03668119|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22421245|NCT03769168|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22421246|NCT05142722|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
22421247|NCT04541017|City of Hope|Paul Frankel, Ph.D.|6262185265|pfrankel@coh.org|
22421248|NCT03896503|National Cancer Institute|Dr. Anish Thomas|240-760-7343|anish.thomas@nih.gov|
22421249|NCT05400655|Centers for Disease Control and Prevention|Dr. Laura Steinhardt, PhD, MPH|1 6467641472|LSteinhardt@cdc.gov|
22421250|NCT04495946|Wake Forest University School of Medicine|Marc Kowalkowski, PhD|704-355-9902|marc.kowalkowski@advocatehealth.org|
22421251|NCT01068678|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22421252|NCT05161481|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
22392966|NCT04746846|Virginia Commonwealth University|Ingrid Pretzer-Aboff, Ph.D., RN , FGSA, FAAN|804-828-3340|iaboff@vcu.edu|
22392967|NCT06748729|Össur Iceland ehf.|Laurine Roussillon|+3548221812|lroussillon@ossur.com|
22392968|NCT00503139|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22392969|NCT01827475|Emergency Medicine, Stony Brook U|Dr. Adam Singer|631 444 7856|adam.singer@stonybrook.edu|
22392970|NCT00091169|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012||
22392971|NCT02735577|New York State Psychiatric Institute|Nasir Naqvi, MD|6467748181|nasir.naqvi@nyspi.columbia.edu|
22392972|NCT00833833|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22392973|NCT02040259|Stryker Neurovascular|Minyi Ji, Biostatistician, Clinical Evidence|+1 (510) 980-5689|minyi.ji@stryker.com|
22392974|NCT02334982|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22392975|NCT00921687|Louis Stokes Cleveland VA Medical Center|Paul Drawz, MD, MHS, MS|6126255423|draw0003@umn.edu|
22392976|NCT00316602|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
22392977|NCT01142232|IndianaU|Dr. Attaya Suvannasankha|(317) 278-9306|asuvanna@iu.edu|
22392978|NCT00626990|EORTC|Dr. Thierry Gorlia|027741652|thierry.gorlia@eortc.org|
22421253|NCT03827291|Duke University|Amanda Kumar, MD|919-681-6437|amanda.kumar@duke.edu|
22421254|NCT04795466|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
22421255|NCT04286269|University of Minnesota|Sonya Wang|612-301-1454|sgwang@umn.edu|
22421256|NCT00838903|GlaxoSmithKline|GSK Response Center|866-435-7343||
22421257|NCT00536939|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22421258|NCT04225715|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22421259|NCT01894841|Providence VAMC|Jennifer Primack|401 273-7100|jennifer.primack@va.gov|6295
22421260|NCT02955355|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22421261|NCT02612623|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22421262|NCT00981214|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
22421263|NCT02506868|Biocad|Yulia Linkova Medical Director|+7 (495) 992 66 28|linkova@biocad.ru|930
22421264|NCT04878432|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22421265|NCT03971071|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22421266|NCT00459862|Mayo Clinic|Julian Molina, M.D, Ph.D.||Molina.julian@mayo.edu|
22421267|NCT00360282|University of Pittsburgh|Joseph M. Furman, MD, PhD|(412) 647-2115|furmanjm@upmc.edu|
22432281|NCT03096886|University of Pennsylvania|Dr. Yvette Sheline|(215) 573-0082|sheline@pennmedicine.upenn.edu|
22432282|NCT03950856|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22432283|NCT01816984|University of Chicago Medicine and Biological Sciences|Dr Everett Vokes, MD|855-702-8222|evokes@medicine.bsd.uchicago.edu|
22432284|NCT03820011|Board of Trustees at University of Illinois|Dr. Mary Khetani, Associate Professor|312-996-0942|mkhetani@uic.edu|
22432285|NCT03930771|Weill Cornell Medicine|Rajiv Magge|212-746-6575|ram9116@med.cornell.edu|
22432286|NCT01222117|Grifols Therapeutics|Kimberly Steinmann, MD|919-308-5444|kimberly.steinmann@grifols.com|
22432287|NCT00810277|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22432288|NCT03531814|National Cancer Institute|Staci M Peron, Ph.D.|240-760-6025|martins@mail.nih.gov|
22432289|NCT00628498|Jazz Pharmaceuticals|Associate Director, Clinical Trial Disclosure & Transparency|(215) 832-3750||
22432290|NCT00529243|Kaiser Permanente|William Towner, MD|323-783-7855|William.J.Towner@KP.org|
22432291|NCT01856322|National Cancer Institute|Dr. Marybeth Hughes|301-594-9341|hughesm@mail.nih.gov|
22432292|NCT04592341|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22432293|NCT02896257|VA Puget Sound Health Care System|Dr. David Au|206-764-2504|David.Au@va.gov|
22432294|NCT03793621|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22432295|NCT03423602|Vivasure Medical Ltd|Dr Chris Martin|+353 91 395 442|chris.martin@vsuremed.com|
22432296|NCT00692003|Eisai Inc|Antonio Laurenza, MD, Executive Director|1 201 949-4157|antonio_laurenza@eisai.com|
22432297|NCT03257358|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22432298|NCT02332187|University of Kentucky|Gerald Supinski, MD, Professor|859-494-3480|gsupi2@email.uky.edu|
22432299|NCT01747915|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22432300|NCT00988156|BIAL - Portela & Cª, S.A.|Director R&D|351-22-9866100|clinical.trials@bial.com|
22432301|NCT02970136|University of Miami|Olveen Carrasquillo|305-243-5505|ocarrasquillo@miami.edu|
22432302|NCT03443687|University of New Mexico, Dept OBGYN|Dr. Gena Dunivan|5052729712|gdunivan@salud.unm.edu|
22432303|NCT02805790|Stealth BioTherapeutics Inc.|Rekha Sathyanarayana, Executive Director, Clinical Operations|617-762-2579|Rekha.Sathyanarayana@stealthbt.com|
22432304|NCT03420742|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22432305|NCT01773954|Mid Atlantic Retina|Michele Formoso|215-928-3092|research@midatlanticretina.com|
22432306|NCT02266147|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-665-0414|rjanssen@dynavax.com|
22432307|NCT00382174|RegeneRx Biopharmaceuticals, Inc.|Nabila Turjman, PhD, Executive Director, Regulatory Affairs|301-280-1992|nturjman@regenerx.com|108
22432308|NCT01911260|Federal University of Sao Paulo|Ana Paula Poblacion|+55 11 55391783|anapoblacion@yahoo.com.br|
22392979|NCT01507987|Abbott|Grant Kim, Program Director - Traditional Cardiac Rhythm Management|818-493-3147|grant.kim1@abbott.com|
22421268|NCT00925704|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22421269|NCT00661557|GlaxoSmithKline|GSK Response Center|866-435-7343||
22392980|NCT04138576|ServierRussia|Medical Manager-Olga Linnik|8-495-93707-00|olga.linnik@servier.com|1316
22421270|NCT04537078|Elshatby University Maternity Hospital|Dr. Aly Hussein|002-0119448000|emam_aly@me.com|
22421271|NCT03207815|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22421272|NCT03817853|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22421273|NCT01620138|Universidade Federal do Rio de Janeiro|Monica Gadelha|+552139382323|mgadelha@hucff.ufrj.br|
22421274|NCT04268771|Dr. Reddy's Laboratories Ltd.|Head-Clinical Development|91-40-4464-4000|RI-01-007@drreddys.com|
22421275|NCT05005507|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22421276|NCT02667704|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22421277|NCT03866512|University of Exeter|Dr Marlou Dirks|+44 1392 725496|m.dirks@exeter.ac.uk|
22421278|NCT00320710|Novartis|Study Director|862-778-8300||
22421279|NCT04545008|Prisma Health|Dr. Julie Martin - Director, Cancer Research|864-455-3667|julie.martin@prismahealth.org|
22432309|NCT01657305|Amryt Pharma|Head of Clinical Development|+353 1 669 4606|medinfo@amrytpharma.com|
22432310|NCT00940602|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22432311|NCT00575666|UMass Medical School|Xiaoduo Fan, MD, MPH, MS|508-856-3881|Xiaoduo.Fan@umassmed.edu|
22432312|NCT01374425|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22432313|NCT02289469|SAI Interactive|Dr. Dane Boyington|(423) 521-2309|dane@thinkingmedia.com|
22432314|NCT00956761|Novartis Vaccines and Diagnostics S.r.l|Posting Director||RegistryContactVaccinesUS@novartis.com|
22432315|NCT01904721|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22432316|NCT00532844|BioMarin Pharmaceutical Inc.|Joshua Lilienstein/Medical Director, Global Medical Affairs|651.523.0310|MEDINFO@bmrn.com|
22432317|NCT03988426|CRMG|Mikaela Raymond|866-337-1868|ctgov@clinicalresearchmgt.com|
22432318|NCT01077063|Sidney Kimmel Comprehensive Cancer Center at JHMI|Daniel Laheru, MD|410-955-8974|laherda@jhmi.edu|
22432319|NCT02750930|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22432320|NCT03734822|Nationwide Children's Hospital|Anne May, MD|614-722-4766|Anne.May@nationwidechildrens.org|
22432321|NCT00553631|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22432322|NCT02761642|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22432323|NCT02850978|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22432324|NCT00114127|Massachusetts General Hospital|Dr. Naomi Simon|617-726-7913|nsimon@partners.org|
22432325|NCT00251693|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
22432326|NCT00570713|Morphotek, Inc.|Susan Weil, MD|610-423-6182|sweil@morphotek.com|
22432327|NCT04005586|RxSight|Jeffrey Ha, Senior Director of Clinical Research|949-521-7870|jha@rxsight.com|
22432328|NCT00469833|Cincinnati VAMC|David D'Alessio, MD, Section head, Endocrinology, Cincinnati VAMC|513-475-6478|david.d'alessio@va.gov|
22432329|NCT02393339|Hadassah School of Dental Medicine, P.O.Box 12272|Dr. Avia Fux-Noy|+972507410935|fuxavia@gmail.com|
22432330|NCT04089020|Children's Mercy Kansas City|Jordan Carlson, PhD.|816-234-9240|jacarlson@cmh.edu|
22432331|NCT01816048|University of Wisconsin Carbone Cancer Center|Dr. Justine Bruce|608-262-4961|jybruce@medicine.wisc.edu|
22432332|NCT04422431|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22432333|NCT01174563|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22432334|NCT03402841|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22432335|NCT01347060|GlaxoSmithKline|GSK Response Center|866-435-7343||
22432336|NCT00444106|Novartis Pharmaceuticals|Study Director|862-778-8300||
22432337|NCT00038948|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22432338|NCT05270863|Visus Therapeutics, Inc.|Visus Therapeutics|800-281-4536|trials.info@visustx.com|
22392981|NCT00597246|Memorial Sloan Kettering Cancer Center|Ronald Blasberg, MD|646-888-2211|blasberr@mskcc.org|
22392982|NCT04142359|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22392983|NCT04410523|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22392984|NCT00490490|Stanford University Medical Center|Susan J. Knox, MD, Associate Professor of Radiation Oncology|(650) 725-2720|sknox@stanford.edu|
22392985|NCT03268603|Mayo Clinic|Nathan Staff, M.D., Ph.D.|507-293-1283|Staff.Nathan@mayo.edu|
22392986|NCT04939701|Astellas Pharma Global Development Inc|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
22392987|NCT00772330|InnFocus, Inc.|Sharon Herbert, Associate Director of Clinical Operations|(415) 268-9059|sharon.herbert@santen.com|
22392988|NCT00734591|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22392989|NCT03199118|Cairo University|Sarah Elbanna, assistant lecturer at the Oral Medicine and Periodontology department|+201000760002|srhelbanna@gmail.com|
22392990|NCT03248882|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22392991|NCT01656200|University of Liverpool|Dr Lance Turtle|+44 151 795 9626|lance.turtle@liverpool.ac.uk|
22392992|NCT01461811|Alcon Research, Ltd.|Mary Fahmy, OD, Clinical Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22392993|NCT03015129|Memorial Sloan Kettering Cancer Center|Dr. Vicky Makker, MD|646-888-4224|makkerv@mskcc.org|
22392994|NCT05032872|Brandeis University|Xin Yao Lin|6462583562|xylin@brandeis.edu|
22392995|NCT00338962|Yale University|Elizabeth Ralevski|203-932-5711|elizabeth.ralevski@yale.edu|4282
22421280|NCT03328507|Braintree Laboratories, Inc.|Head of R&D, GI|7818432202|studydirector@sebelapharma.com|
22421281|NCT00997373|UC Davis|Lloyd H. Smith MD, PhD|916-734-6945|lhsmith@ucdavis.edu|
22421282|NCT04578457|Sonova AG|Juliane Raether|+41 58 928 01 01|juliane.raether@sonova.com|
22421283|NCT00832455|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22421284|NCT05209867|University of Florida|Dr. Simone Marini|3522948951|simone.marini@ufl.edu|
22421285|NCT00717912|Biofortis|Doctor|0240205799|info@mxns.com|
22432339|NCT03984188|University of Miami|Trishul Siddharthan|305-243-6388|tsiddhar@miami.edu|
22432340|NCT03402932|Western Michigan University|Jing Shen|2693878067|jing.shen@wmich.edu|
22432341|NCT01415583|Massachusetts Eye and Ear Infirmary|Dr. Christopher Hartnick, Division Director, Pediatric Otolaryngology Director, Pediatric Airway, V|617-573-4206|christopher_hartnick@meei.harvard.edu|
22432342|NCT00552071|Cedars-Sinai Medical Center|Vivian Hwe|4224-315-4489|hwev@cshs.org|
22432343|NCT00272792|BioMarin Pharmaceutical Inc.|Medical Information Services|1-800-983-4587|medinfo@bmrn.com|
22432344|NCT01058239|Massachusetts General Hospital|Jeremy Abramson, M.D|617-724-4000|JABRAMSON@mgh.harvard.edu|
22432345|NCT03121144|Masimo Corporation|Vikram Ramakanth|(949) 297-7000|clinicalresearchdept@masimo.com|
22432346|NCT03557125|Medical University of South Carolina|Sylvia Wilson, MD|843-792-2322|wilsonsh@musc.edu|
22432347|NCT00937495|University of Wisconsin|Steven Attia, D.O.||sa2@medicine.wisc.edu|
22432348|NCT02549989|Memorial Sloan Kettering Cancer Center|Dr. Vicky Makker, MD|646-888-4224|makkerv@mskcc.org|
22432349|NCT00298389|Imperial College London|Professor Louise Donnelly|+442075947895|l.donnelly@imperial.ac.uk|
22432350|NCT02628444|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22432351|NCT00288015|Northwestern University|Mark Agulnik, MD|312-695-6182|magulnik@nm.org|
22432352|NCT00443703|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22432353|NCT01333722|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22432354|NCT02224508|Group Health Research Institute|Michael Von Korff, ScD|206-287-2874|vonkorff.m@ghc.org|
22432355|NCT00784368|Global Medical Organization; Janssen R&D|Director, Established Products|(609) 730-7674||
22432356|NCT02079909|FUJIFILM Toyama Chemical|Project Manager|+81-3-6427-6245|fftc-clinicaltrial-info1@fujifilm.com|
22432357|NCT02277249|University of California, Los Angeles|Clinical Instructor - Department of Obstetrics and Gynecology|3107942257|priyabatra@mednet.ucla.edu|
22432358|NCT01784367|University Medical Center Hamburg-Eppendorf, Germany|Prof. Dr. Stefan Kluge|+49-40-7410|skluge@uke.de|57011
22432359|NCT00720356|Northwestern University|Jeffery Raizer, MD|312-503-4724|Jeffrey.Raizer@nm.org|
22432360|NCT01869634|University of California, Davis Health, Department of Internal Medicine|Dr. David Asmuth, Professor of Medicine|916-734-8695|dasmuth@UCDAVIS.EDU|
22432361|NCT02237001|Smith+Nephew, Inc.|Kirsten Wall|720-338-9460|Kirsten.wall@smith-nephew.com|
22432362|NCT01047007|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22432363|NCT04254692|University of Wisconsin School of Medicine and Public Health|Venkat Rao, MD, MBA|(608) 263-1223|rao@surgery.wisc.edu|
22432364|NCT03759600|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22432365|NCT02098304|Clark & Watson Dental Practice|Dr Charles Ormond|+44 (0)1324 623445|charlesormond@nhs.net|
22432366|NCT00457392|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22432367|NCT00756275|Brown University|Damaris Rohsenow, PhD|401-863-6665|Damaris_Rohsenow@brown.edu|
22432368|NCT00980148|University of Arkansas for Medical Sciences|Shelly Lensing, Statistician|501-686-8203|sylensing@uams.edu|
22432369|NCT02903823|Vanderbilt University Medical Center|Peter Konrad, MD PhD - PI|6153439822|peter.konrad@vumc.org|
22432370|NCT02852967|Kadmon Corporation, LLC|Olivier Schueller, Senior Vice President, CMC & Clinical Pharmacology|724-778-6170|olivier.schueller@kadmon.com|
22432371|NCT03886948|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22432372|NCT00339040|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22432373|NCT03341637|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22432374|NCT05547412|NovaSignal|Manja Lenkin|8776387251|manja.lenkin@novasignal.com|
22432375|NCT01462929|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22432376|NCT00887159|ECOG-ACRIN Statistical Office|Study statistician|617-632-6012||
22432377|NCT01104402|Johns Hopkins University & University of Washington|Dr. Noah Lechtzin & Dr. Christopher Goss|410-502-7044|nlechtz@jhmi.edu|
22432378|NCT01109108|Boston Medical Center|Stephen I Pelton|617-414-5591|spelton@bu.edu|
22432379|NCT02071771|Alcon Research, Ltd.|Sr Global Brand Lead, GCRA, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22432380|NCT02078752|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22432381|NCT01435174|University of Michigan College of Pharmacy|Bruce A. Mueller|7346154578|muellerb@umich.edu|
22432382|NCT01482195|King Faisal Specialist Hospital and Research Center|Dr. Fowzan Al Kuraya|+966 11 442 7875|falkuraya@kfshrc.edu.sa|
22432383|NCT00753948|James J. Peters VAMC|Joshua Hobson|(718) 584-9000|joshua.hobson@va.gov|3129
22432384|NCT00592631|Indiana University|Robert Tepper, MD, Ph.D.|317-274-9647|rtepper@iu.edu|
22432385|NCT01244035|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22432386|NCT01100112|Santarus, Inc.|Michael Huang, MD, Senior Medical Director, Clinical Research|8583145700|contact@santarus.com|
22432387|NCT02776683|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22432388|NCT03975153|Oregon Health & Science University|Teri Greiling, MD, PhD, FAAD|503-494-3376|PRPStudy@ohsu.edu|
22432389|NCT00616642|University of California Los Angeles|Anthony Heaney, M.D. Ph.D|310 267 4980|aheaney@mednet.ucla.edu|
22432390|NCT00570323|Baylor College of Medicine|Tao Wang|7137985388|taow@bcm.edu|
22432391|NCT03856359|Duke University Hospital|Dr. Paul V. Suhocki|919-684-7284|suhoc001@mc.duke.edu|
22432392|NCT01023217|Asan Medical Center|Professor Young-Suk Lim|+82-2-3010-5933|limys@amc.seoul.kr|
22432393|NCT02304159|Southern California Research Center|Dr. Tarek Hassanein|619-319-3993|thassanein@livercenters.com|
22432394|NCT02347605|University of Minnesota|Michael Kotlyar|612-251-8780|kotly001@umn.edu|
22432395|NCT01567722|AMC Statistical Center|Madhu Mazumdar|(212) 659-9558|madhu.mazumdar@mountsinai.org|
22432396|NCT00332696|Novartis Pharmaceuticals|Study Director|862-778-8300||
22432397|NCT02216526|Charité Universitätsmedizin Berlin, Germany|PD Dr. Jan Kottner|+49 (0)30 450 518 218|jan.kottner@charite.de|
22432398|NCT02348203|University of Arizona|Sherry Chow|520-626-3358|schow@azcc.arizona.edu|
22392996|NCT03733314|EA Pharma Co., Ltd|Corporate Communication Dept.|+81-(0)3-6280-9600|contact_ea@eapharma.co.jp|
22392997|NCT01598662|University Louisville|Nancy Alsip|502-852-2905|nancy.alsip@louisville.edu|
22392998|NCT00910039|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|David Peereboom, MD|216-445-6068|peerebd@ccf.org|
22392999|NCT04246021|King Hussein Cancer Center|Dr. Hikmat Abdel-Razeq|0096265300460|habdelrazeq@khcc.jo|1403
22393000|NCT02147899|Symbiomix Therapeutics|VP Clinical Operations|609-722-7250|nadetoro@symbiomix.com|112
22393001|NCT04155047|Sunovion Respiratory Development Inc.|Respiratory Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunovion.com|
22393002|NCT04514510|National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH)|Arun Shet, MD, PhD|301.827.6808|arun.shet@nih.gov|
22393003|NCT00821587|University of Florida|Roberto J. Firpi-Morell, MD|352-273-9500|firpirj@medicine.ufl.edu|9466
22393004|NCT01693900|Beaumont Health|Randy Fayne, DO|248-898-1905|rfyane@beaumont.org|
22393005|NCT02781090|Montefiore Medical Center|Dr. Jonathan Shuter|718-920-7845|jshuter@montefiore.org|
22393006|NCT00643617|Accuray, Inc.|Director of Clinical Affairs|608-824-3421|sgodbold@accuray.com|
22393007|NCT02075073|Samsung Bioepis|Director, Clinical Development|+82 31 8061 4534||
22393008|NCT05731999|Kontigo Care AB|Markku Hämälainen, CSO|+46 (0)76 947 3132|markku.hamalainen@kontigocare.com|
22393009|NCT04481568|Northwell Health|Dr. Liron Sinvani, Principal Investigator|646-766-7169|ldanay@northwell.edu|
22393010|NCT01208103|UT MD Anderson Cancer Center|Dr. Michael Overman/Gastrointestinal Medical Oncology|713-745-4317|MOverman@mdanderson.org|
22393011|NCT02551653|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22393012|NCT01882764|Hutchison MediPharma Ltd|Dr. Rongjun Liu|+86 21 2067 3203|rongjunl@hmplglobal.com|
22393013|NCT00414167|Yale University School of Medicine|Dr. Marney A. White|203-785-4349|marney.white@yale.edu|
22393014|NCT02770612|Brigham and Women's Hospital|Brian T Bateman|617-278-0930|bbateman@partners.org|
22393015|NCT02233803|GlaxoSmithKline|GSK Response Center|866-435-7343||
22393016|NCT03846453|Hanall Biopharma|Project Manager|82-222041763|parksm@hanall.co.kr|
22393017|NCT01696955|University of Chicago|Theodore Karrison|773-702-9326|tkarrison@health.bsd.uchicago.edu|
22393018|NCT01404429|PGIMER, India|Varun Dhir, Assistant Professor, Internal Medicine|+91-8872229998|varundhir@gmail.com|
22393019|NCT05330676|University of Pennsylvania|John C. Greenwood, MD, MS|856-816-7172|john.greenwood@pennmedicine.upenn.edu|
22393020|NCT03653208|ImmuneMed Inc.|Byoungok Ahn|+82-2-527-8391|ahnbo@immunemed.co.kr|
22393021|NCT00436605|Yale University School of Medicine|Harriet Kluger|203-737-2572|Harriet.Kluger@yale.edu|
22393022|NCT03417570|Washington University School of Medicine|Vladimir M. Kushnir, M.D.|314-454-5960|vkushnir@wustl.edu|
22393023|NCT00573859|University of California, Irvine|Jean Gehricke, Ph.D.|949-824-1834|jgehrick@uci.edu|
22393024|NCT02416453|Janssen Research & Development, LLC|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22393025|NCT04561778|Geisinger Health System|Dr Pugazhendhi Vijayaraman|5708086020|pvijayaraman1@geisinger.edu|5444
22393026|NCT01989169|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22393027|NCT01114880|Abbott|Global Medical Services|1-800-633-9110||
22393028|NCT02539459|Fox Chase Cancer Center|Robert Uzzo, M.D.|215-728-3096|robert.uzzo@fccc.edu|
22393029|NCT04531904|CERENOVUS|Cerenovus Clinical Research Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22393030|NCT02839889|Four Seasons Compassion for Life|Janet Bull, MD|8286926178|jbull@fourseasonscfl.org|302
22393031|NCT02738853|Medtronic|Phuong-Uyen Le|763-526-0989|phuong-uyen.n.le@medtronic.com|
22393032|NCT03519997|University Texas Southwestern Medical Center|David Hsieh|214/648-4180|David.Hsieh@UTSouthwestern.edu|
22393033|NCT03361605|University of Michigan|Amy McKinney|734-647-8129|adrongo@med.umich.edu|
22393034|NCT03898167|The University of Texas MD Anderson Cancer Center|Dr. Jane Montealegre|713-792-0919|jrmontealegre@mdanderson.org|
22393035|NCT02906007|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
22393036|NCT04696653|Johns Hopkins University School of Medicine|Gail Daumit, MD, MHS|410-614-6460|gdaumit@jhmi.edu|
22393037|NCT03520712|BioMarin Pharmaceutical (UK) Ltd.|Konstantia-Maria Chavele, PhD, Director, Clinical Sciences|+44207|KonstantiaMaria.Chavele@bmrn.com|4203351
22393038|NCT04372121|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
22393039|NCT04348435|Hope Biosciences Stem Cell Research Foundation|Ridhima Vij, PhD|346-900-0340|ridhima@hopebio.org|102
22393040|NCT00660543|Oregon Health and Science University|Dr. Edward Neuwelt|503-494-5626|neuwelte@ohsu.edu|
22393041|NCT03896152|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22393042|NCT00224887|Stanford University|Dr. Donna Matheson|650-723-5895|donna.matheson@stanford.edu|
22393043|NCT01659853|Galerma Laboratories|Dr. Warren Winkelman|817-961-5494|warren.winkelman@galderma.com|
22393044|NCT03921723|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22393045|NCT05187364|Medical University of South Carolina|Dr. Amber Jarnecke|843-876-3115|jarnecka@musc.edu|
22393046|NCT03046121|Penn State University|Marie Boltz PhD|215-962-9712|mpb40@psu.edu|
22393047|NCT03214640|Wake Forest Health Science|Peter Pan, MD|336-716-1228|ppan@wakehealth.edu|
22393048|NCT01143870|University of Pennsylvania|Anjali Gopalan|575-640-3893|agopalan@upenn.edu|
22393049|NCT04091061|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22421286|NCT02841995|Sanofi ( Kadmon, a Sanofi Company )|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
22421287|NCT01051596|Georgetown University|Michael Pishvaian, MD, PhD|202-444-2223|pishvaim@georgetown.edu|
22421288|NCT02755103|Medical University of South Carolina|Therese K Killeen PhD, Principal Investigator|843-792-5232|killeent@musc.edu|
22393050|NCT00406692|Boston University|Clifford Knapp, PhD|617-414-1990|cknapp@bu.edu|
22393051|NCT04488770|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|
22393052|NCT03547739|University of Alabama at Birmingham|Janet M. Turan, PhD, MPH|2059757770|jmturan@uab.edu|
22421289|NCT00323453|Santa Barbara Cottage Hospital|Laura Isaacs (Research Quality Assurance & Integrity Analyst) on behalf of Dr. Kenneth Waxman (PI)|805-324-9255|lisaacs@sbch.org|
22421290|NCT05333601|Nemours Children's Health|Dr. Kimberly Canter|3026514501|kimberly.canter@nemours.org|
22421291|NCT01118741|Johns Hopkins University|Michael Carducci, MD|410-614-3977|carducci@jhmi.edu|
22421292|NCT02199964|Baylor College of Medicine|Stephen Pflugfelder, M.D.|713-798-6100|stevenp@bcm.edu|
22421293|NCT00739661|Genentech, Inc|Medical Communications|800-821-8590||
22421294|NCT05267236|Midwest Evaluation and Research|Midwest Evaluation and Research|620-208-6143|mer@midwestevaluation.com|
22421295|NCT03839628|The University of Utah|Micah Drummond|801-213-2737|micah.drummond@hsc.utah.edu|
22421296|NCT01289678|Brody School of Medicine|Paul R. Walker, MD|2527441888|walkerp@ecu.edu|2527441888
22421297|NCT03223350|Henry Ford Hospital|Dr. Joseph Miller, associate research director|313-916-5419|jmiller6@hfhs.org|
22421298|NCT03539302|InCarda Therapeutics|VP Clinical Operations|510-422-5522|propst.meisa@incardatherapeutics.com|111
22421299|NCT01927120|H. Lee Moffitt Cancer Center and Research Institute|Dr. Brian Betts|813-745-5410|brian.betts@moffitt.org|
22421300|NCT04564092|GE Healthcare|Yongqing Tang, MD PhD|189-1820-3986|Yongqing.Tang@ge.com|
22421301|NCT02816346|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22421302|NCT02362360|Coloplast|Head of Clinical Operations|0045 49111990|dkcfv@coloplast.com|
22421303|NCT04146012|Accidentals Inc. (Formally Artegraft Inc.)|Tony Calandra, President|973.540.1250|arc@mcguggan.com|
22421304|NCT03817190|DS Biopharma|Study Director|+35312933590|info@dsbiopharma.com|
22421305|NCT01546025|Brown University|Suzanne Colby|4018636655|Suzanne_Colby@brown.edu|
22421306|NCT00868530|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22421307|NCT01047527|University of Pennsylvania|Dr. Robert Schnoll|215-746-7143|schnoll@mail.med.upenn.edu|
22421308|NCT04955691|Yale school of Medicine|Laura Nally|203-785-5831|laura.nally@yale.edu|
22421309|NCT05336227|University of Alabama at Birmingham|Byron Lai|205.638.9790|blai@uabmc.edu|8-9725
22421310|NCT05086744|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22421311|NCT04050462|NYU Langone Health|Nina Beri, MD|212-731-5770|nina.beri@nyulangone.org|
22421312|NCT04042467|Vanderbilt University Medical Center|Filoteia Popescu|615-875-9083|filoteia.popescu@vumc.org|
22421313|NCT05151744|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22421314|NCT04053868|University of California San Francisco|Dr. Neal Benowitz|628-206-8324|neal.benowitz@ucsf.edu|
22421315|NCT05731700|Abbott|Krista Stiefel, Principal Clinical Scientist|+12246689359|krista.stiefel@abbott.com|
22421316|NCT02565628|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22421317|NCT01682226|Memorial Sloan Kettering Cancer Center|Dr. Juliet Barker, MBBS|646-608-3756|barkerj@mskcc.org|
22421318|NCT03375918|UMass Chan Medical School|Jennifer Tjia|774-455-3538|jennifer.tjia@umassmed.edu|
22421319|NCT03771898|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22421320|NCT03123120|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22421321|NCT03507608|Johns Hopkins SOM, Dept of Radiation Oncology|Dana Kaplin|443-690-7007|dkaplin1@jh.edu|
22421322|NCT03135548|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22421323|NCT02632175|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22421324|NCT02088554|Medtronic|Jessica Halverson, Director of Clinical Research|(800) 633-8766|rsperigonpivotaltrial@medtronic.com|
22421325|NCT04623216|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novatis.email@novartis.com|
22421326|NCT05022667|University of Michigan Medical Center|Dr. Paul Gauger|734-936-0231|pgauger@med.umich.edu|
22421327|NCT03521154|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22421328|NCT05468164|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22421329|NCT04632927|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|novartis.email@Novartis.com|
22421330|NCT04526639|University of Massachusetts Lowell|Jiabin Shen|978-934-3965|jiabin_shen@uml.edu|
22421331|NCT01624740|Boston Scientific|Nitzan Mekel-Bobrov, PhD|661-949-4537|Nitzan.Mekel-Bobrov@bsci.com|
22421332|NCT01220466|Abbott Medical Optics|Amelia Saliba, Sr. Manager, Clinical Research|408-273-4158|amelia.saliba@amo.abbott.com|
22421333|NCT03168711|Massachusetts General Hospital|Dr. Sabrina Paganoni|617-724-3914|spaganoni@mgh.harvard.edu|
22421334|NCT02535026|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22421335|NCT01671007|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22421336|NCT03877068|Emory University|Guillermo E. Umpierrez, MD|404-778-1665|geumpie@emory.edu|
22421337|NCT00449865|University of Rochester|Karl Kieburtz, Director of CTSI|585-275-0553|Karl.kieburtz@chet.rochester.edu|
22421338|NCT00406367|Merz Pharmaceuticals GmbH|Angelika Hanschmann|++49-69-1503|angelika.hanschmann@merz.de|538
22421339|NCT03922308|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22421340|NCT03252535|Cellavita|Cristiane Valverde Wenceslau|+55 (19) 3829.0849|cristiane.valverde@cellavitabrasil.com.br|
22421341|NCT02588612|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22421342|NCT00506415|Novartis|Study Director|862 778 8300||
22421343|NCT03809663|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22421344|NCT03376789|Director Global Clinical Operations, General Medicine|Keri L Vaughan|+1 267.980.5015|keri.vaughan@mylan.com|
22421345|NCT01703260|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22421346|NCT02042014|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
22421347|NCT01354652|AsanMC|Dr. Han Chu Lee|82230103915|hch@amc.seoul.kr|
22421348|NCT02792062|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22393053|NCT04850794|University of North Carolina at Chapel Hill|Kelsey Thompson, MS|919-966-1007|kelsey_thompson@med.unc.edu|
22393054|NCT04678505|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22393055|NCT01365481|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
22393056|NCT00757627|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22393057|NCT02946853|University of Rochester|Dr. Jonathan Steinberg|9734364155|jsteinberg@summithealth.com|
22393058|NCT00047697|University of Pittsburgh|Benjamin L. Handen, PhD|412-235-5445|handenbl@upmc.edu|
22393059|NCT00635661|New York University,. Rusk Institute|Dr. Irene Ward|212-263-6073|Irene.ward@nyumc.org|
22393060|NCT02369068|Beaumont Hospital, Royal Oak|Deborah Hasenau RN, Director, Urology Research|248-551-0804|Deborah.Hasenau@Beaumont.org|
22393061|NCT00472849|The University of Texas MD Anderson Cancer Center|William G. Wierda, MD, PhD, BS / Associate Professor|713-745-0428|eharriso@mdanderson.org|
22393062|NCT00468143|NYU School of Medicine|Dr. Lenard Adler|(212) 263-3580|lenard.adler@nyumc.org|
22393063|NCT01606670|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22393064|NCT04664075|Imperial College London|Senior Clinical Research Nurse|02083833231|flu-rsv-study@imperial.ac.uk|
22393065|NCT05254080|Medical University of South Carolina|Dr. Christopher W. Austelle|843-792-2872|austelle@musc.edu|
22393066|NCT01353118|Imperial College|Carel le Roux|07970719453|c.leroux@imperial.ac.uk|
22393067|NCT00799981|Wellspect Health Care|Head of Medical Affairs|+46313763000|mace@wellspect.com|
22393068|NCT03192475|University of Pittsburgh|Elizabeth Mary Venditti PhD, Associate Professor of Psychiatry and Epidemiology|(412) 647-1027|vendittiem@upmc.edu|
22393069|NCT01641159|University of Cincinnati College of Medicine; Department of Psychiatry|Dr. Theresa Winhusen|513-585-8227|winhust@ucmail.uc.edu|
22393070|NCT00798590|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
22393071|NCT03980808|Georgia Institute of Technology|Salimah LaForce, M.S.|404-385-4614|salimah@cacp.gatech.edu|
22393072|NCT01681121|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-970-7145|ClinicalTrialDisclosure@JazzPharma.com|
22393073|NCT02741323|University of California, San Francisco|Clinical Research Manager|415-595-1226|Rodney.Rogers@ucsf.edu|
22393074|NCT00368927|National Jewish Health|James R. Jett, M.D.|303-270-2601|JettJ@NJHealth.org|
22393075|NCT00886795|Johns Hopkins University|Clifton O. Bingham III, M.D.|410-550-0578|cbingha2@jhmi.edu|
22393076|NCT02229851|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22393077|NCT02297100|Wake Forest University Health Sciences|Dr. Robert Evans|336-713-0320|revans@wakehealth.edu|
22393078|NCT01204710|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22393079|NCT00680992|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22393080|NCT00151281|Weill Cornell Medical College|Dr. Jia Ruan|646-962-2068|jruan@med.cornell.edu|
22393081|NCT00994175|National Heart Lung and Blood Institute|Levine, Stewart|+1 301 402 1448|levines@nhlbi.nih.gov|
22393082|NCT01800890|Coloplast A/S|Marian Sinvani|+45 4911 2356|dkmards@coloplast.com|
22393083|NCT03898778|Minnesota Medical Technologies Corporation|VP of Regulatory Affairs|507-533-0366|rmanglin@mnmedicaltechnologies.com|
22393084|NCT00848588|Ottawa Hospital Research Institute|Manya Charette|613-798-5555|mancharette@ohri.ca|17758
22393085|NCT04047862|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22393086|NCT06122870|Johns Hopkins University|Dr. Kawsar Talaat|410-336-9164|ktalaat@jhu.edu|
22393087|NCT02745353|UCSD|Eric Roeland, MD|(858) 534-7079|eroeland@ucsd.edu|
22393088|NCT05014568|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
22393089|NCT04349631|Hope Biosciences Research Foundation|Ridhima Vij, PhD|346-900-0340|ridhima@hopebio.org|102
22393090|NCT04015869|Yale University School of Medicine, Department of Psychiatry|Elizabeth Ralevski|203-932-5711|Elizabeth.Ralevski@yale.edu|1-4282
22393091|NCT00905515|East Carolina University|Director of Clinical Trials|252-744-0671|bryantw@ecu.edu|
22393092|NCT00482690|University of Nebraska Medical Center|Stephen Rennard|402-559-7313|srennard@unmc.edu|
22393093|NCT00640133|Butler Hospital|Dr. Benjamin Greenberg|(401) 455-6602|be3ngreenb@gmail.com|26602
22393094|NCT00730275|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22393095|NCT04032613|University of North Carolina at Chapel Hill|Jennifer E. Flythe, MD, MPH|919-445-2656|jflythe@med.unc.edu|
22393096|NCT01652495|Istituto Ortopedico Rizzoli|Milva Battaglia, Director of Clinical Trials|0516366026|milva.battaglia@ior.it|0039
22393097|NCT01085968|VA Overton Brooks|Elizabeth Disbrow|318-6757184|edisbr@lsuhsc.edu|
22393098|NCT01141647|James A. Haley Veterans' Hospital|Lisa Ottomanelli, PhD|813-558-3917|lisa.ottomanelli-slone@va.gov|
22393099|NCT01744392|Health Services Research & Development, Durham VAMC|Hayden B. Bosworth, PhD|919-286-0411|hayden.bosworth@va.gov|7107
22393100|NCT00299494|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22393101|NCT01538966|Cedars-Sinai Medical Center|Vivian Hwe|424-315-4489|hwev@cshs.org|
22393102|NCT01417104|The Ohio State University|Sanjay Rajagopalan, MD|614-247-7760|sanjay.rajagopalan@osumc.edu|
22393103|NCT02033083|Planned Parenthood of New York City|Director of Clinical Training and Research|212-274-7340|ctri@ppnyc.org|
22393104|NCT00403767|Johnson & Johnson Pharmaceutical Research & Development L.L.C.|Head of Development, CV & UROL|1 908-927-7767||
22393105|NCT03014011|Bispebjerg Hospital|MD Malin Nilsson|50595861|mnil0028@regionh.dk|0045
22393106|NCT02755818|University of California, Davis|George Kaysen MD - Principal Investigator|916-734-3774|gakaysen@ucdavis.edu|
22393107|NCT01152814|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22393108|NCT05319912|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22393109|NCT01143181|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
22393110|NCT01280357|Monica Healthcare Ltd|Ian How|+44 (0)115912|ianhow@monicahealthcare.com|4540
22393111|NCT03284203|University of Chicago|Mary Akel|773-834-4489|makel@medicine.bsd.uchicago.edu|
22421349|NCT01216241|University of Rochester|Dr. Robert F. Betts|585-275-5871|robert_betts@urmc.rochester.edu|
22393112|NCT01140295|The Children's Hospital of Philadelphia|Petar Mamula|215-590-9146|mamula@email.chop.edu|
22393113|NCT03682302|Pacira Pharmaceuticals|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
22393114|NCT04535310|The Ohio State University College of Optometry|Jennifer Fogt|16142928858|OPT-EyeStudies@osu.edu|
22393115|NCT01489891|Hospital Universitario Infanta Cristina|Dr. Felipe de la Morena|0034659716030|felipe_de_la_morena@hotmail.com|
22393116|NCT00532493|VA Puget Sound Health Care System|Dr. Murray Rasknd|(206) 764-2702|Murray.Raskind@va.gov|
22393117|NCT00948766|Novartis Pharmaceuticals|Study Director|862 778-8300||
22393118|NCT03459443|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|1.855.752.2356|clinicaltrials@alexion.com|
22393119|NCT02153073|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22393120|NCT03189745|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22393121|NCT03702231|National Institutes of Health (NIH) / The National Heart, Lung, and Blood Institute (NHLBI)|Christopher Pleyer, M.D. Principal Investigator, NIH, NHLBI|510.709.6649|christopher.pleyer@nih.gov|
22393122|NCT01276379|GEMCAD|Joan Maurel Santasusana|+ 34 93 434 44 12|JMAUREL@clinic.cat|
22393123|NCT00421954|New York State Psychiatric Institute|Linda Sherman|(646) 774-7158|lsherma@nyspi.columbia.edu|
22393124|NCT02729831|Massachusetts General Hospital|Dr. Karen R. Sepucha|617-724-3350|KSEPUCHA@mgh.harvard.edu|
22393125|NCT00864253|Celgene Corporation|Anne McClain|888-260-1599|clinicaltrialdisclosure@celgene.com|
22393126|NCT03358251|Prudentix Ltd.|Head of QA/RA|+972-72-394-22-24|tsipi@prudentix.com|
22393127|NCT01111240|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22393128|NCT01747551|Dana-Farber Cancer Institute|Peter Enzinger|617-632-3029||
22393129|NCT01609062|BioMarin Pharmaceutical Inc.|BioMarin Medical Information Services|800-983-4587|medinfo@bmrn.com|
22421350|NCT02883062|Washington University School of Medicine|Dr. William Gillanders|314-747-0072|gillandersw@wustl.edu|
22421351|NCT04578535|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22421352|NCT00380874|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22421353|NCT03380429|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22421354|NCT00218023|The University of Texas Health Science Center at Houston|Joy M. Schmitz, PhD|(713) 486-2867|Joy.M.Schmitz@uth.tmc.edu|
22421355|NCT01707290|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22421356|NCT02314026|Exalenz Bioscience|Clinical trial manager|97289737513|avrahamh@exalenz.com|
22421357|NCT01139775|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22421358|NCT02774941|Children's Health - Children's Medical Center, Dallas|Clinical Research Coordinator - Respiratory Care Dept|214-456-1367|gerald.moody@childrens.com|
22421359|NCT01882985|University of California, Irvine|Dr. John P. Fruehauf|714-456-5153|jfruehau@uci.edu|
22421360|NCT03197389|University Hospitals Leuven|Prof. Dr. Ann Smeets|003216340903|hanne.vos@uzleuven.be|
22421361|NCT03193853|Baylor Scott and White Health|Joyce O'Shaughnessy|214-818-8472|joyce.oshaughnessy@usoncology.com|
22421362|NCT04129125|Imperative Care|Didem Aksoy, Senior Director of Clinical Affairs|650-644-8293|daksoy@imperativecare.com|
22421363|NCT06684951|AlNahrain university|Omaima Ismail Khalaf|9647831475217|khokh7871@gmail.com|
22421364|NCT02547012|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
22421365|NCT01560975|NYEE|Dr. Robert Ritch|+1 212 477 7540|ritchmd@earthlink.net|
22421366|NCT00740636|Memorial Sloan Kettering Cancer Center|Dr. Maria C. Pietanza|646-888-4203|PietanzM@mskcc.org|
22421367|NCT00204490|University of Texas Medical Branch Galveston|Dr. Lee Jane W. Lu|409-772-1730|llu@utmb.edu|
22421368|NCT03477006|University of Pittsburgh|Jason Sperry|4128028270|sperryjl@upmc.edu|
22421369|NCT02174627|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22421370|NCT02166333|Johns Hopkins University|Dr. Lawrence Appel|410-955-4156|lappel@jhmi.edu|
22421371|NCT02269098|Medstar Health Research Institute|Michelle F Magee, MD|202-877-0351|michelle.f.magee@medstar.net|
22421372|NCT00503698|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22421373|NCT01766076|Makarere University|Damalie Nakanjako|41407000|dnakanjako@gmail.com|249
22421374|NCT02245516|Kala Pharmaceuticals Inc|VP, Clinical Development||results004@kalarx.com|
22393130|NCT02245022|University of Liverpool|Catriona Waitt|0778288217|cwaitt@liverpool.ac.uk|
22421375|NCT00682786|Washington University School of Medicine|Benjamin R. Tan, M.D.|314-362-3560|btan@dom.wustl.edu|
22393131|NCT05907707|University of North Carolina at Chapel Hill|Andrea Seiler, MD|+41 316322111|andrea.seiler@insel.ch|
22393132|NCT03842358|Washington University School of Medicine|Debbie Bennett, M.D.|314-454-7696|debbie.bennett@wustl.edu|
22393133|NCT05384938|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22393134|NCT02626455|Bayer AG|Therapeutic Area Head|30 300139003|clinical-trials-contact@bayer.com|
22432399|NCT02478489|Boston University School of Public Health and School of Medicine|Richard Saitz, MD MPH|(617) 358-1343|rsaitz@bu.edu|
22393135|NCT06665919|Tbilisi State Medical University|Konstantine Liluashvili , MD., PH.D.|+995599908899|k.liluashvili@tsmu.edu|
22393136|NCT05148962|Gritstone bio, Inc.|Elizabeth Martin, Vice President, Clinical Development Infectious Disease|+1 (877) 520-2233|clinicalstudies@gritstone.com|
22393137|NCT01937026|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22393138|NCT01200290|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22393139|NCT01525238|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
22393140|NCT00607724|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22393141|NCT00452023|The University of Texas MD Anderson Cancer Center|Lucia Masarova MD/Assistant Professor|832-750-4211|LMasarova@mdanderson.org|
22432400|NCT04103450|Urovant Sciences|Information, Clinical Trial Results|949-226-6029|info@urovant.com|
22432401|NCT02455167|"University of Colorado Denver | Anschutz"|Amanda Wieland, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
22432402|NCT02259114|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22432403|NCT03937479|Verona Pharma Plc|Nancy Herje|+1 646-951-0961|nancy.herje@veronapharma.com|
22393142|NCT01946529|St. Jude Children's Research Hospital|Sara Federico, MD|901-595-2220|sara.federico@stjude.org|
22432404|NCT02578901|University of Washington|Dr. Susanne May|206-685-1302|sjmay@uw.edu|
22432405|NCT02712788|Indiana University|Heather Cero, RN - research cooordinator|317-396-1398|hcero@iupui.edu|
22432406|NCT02411461|Vanderbilt University Medical Center|Ashley Shoemaker, Principal Investigator|6153438116|ashley.h.shoemaker@vanderbilt.edu|
22432407|NCT00740181|Brown Univeristy Oncology Research Group|James Butera|401-863-3000|Kayla_Rosati@brown.edu|
22432408|NCT03789292|Celltrion Inc.|JiWoong Lim|032-850-5806|jiwoong.lim@celltrion.com|
22432409|NCT02230189|University of California, San Francisco|PI: Prescott G. Woodruff, MD, MPH|415-514-2061|prescott.woodruff@ucsf.edu|
22432410|NCT04655157|UPMC Hillman Cancer Center|Barbara M. Stadterman, MPH, MCCR|412-647-5554|stadtermanbm@upmc.edu|
22432411|NCT01313507|Octapharma USA|Michael Eppolito, Director, Clinical Operations Immunology and ICU Medicine|201 604-1155|michael.eppolito@octapharma.com|
22432412|NCT02404168|University of Maryland|James Polli|410-706-8292|jpolli@rx.umaryland.edu|
22432413|NCT00699413|USC|Michael Goran|323.442.3027|goran@usc.edu|
22432414|NCT02779777|Kura Oncology, Inc.|Clinical Operations|+1 617-588-3755|ko-tip-003@kuraoncology.com|
22432415|NCT00730886|InSightec|Nadir Alikacem|214-630-2000|nadira@insightec.com|
22432416|NCT02031302|Boston Scientific Corp.|Blessie Concepcion, Director Clinical Trials|408-385-8604|Blessie.Concepcion@bsci.com|
22432417|NCT01847443|GlaxoSmithKline|GSK Response Center|866-435-7343||
22432418|NCT04067492|R-Pharm|D.V. Bukhanova, Medical Adviser|0074959567|bukhanova@rpharm.ru|3838
22432419|NCT06158867|Taipei Medical University Hospital|Dr. Leon Tsung-Ju Lee|+886-2-27372181|TJ.LEE.SKIN@GMAIL.COM|8281
22432420|NCT00956384|University Health Network|Dr. Toni Zhong|4163404800|kbutler@uhnresearch.ca|2343
22432421|NCT05899829|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22432422|NCT01147302|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22393143|NCT02954198|Medical University of South Carolina|Dr. David Taber|843-792-4003|taberd@musc.edu|
22432423|NCT04021290|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22432424|NCT05076045|Baycrest Academy for Research & Education|Claude Alain|416-785-2500|calain@research.baycrest.org|3523
22432425|NCT03391882|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunovion.com|
22432426|NCT03092479|Geisinger Clinic|Michelle Lent, PhD|5702141004|mrlent1@geisinger.edu|
22432427|NCT04683913|University of British Columbia|Dr. Michael Hunt|604-827-4721|michael.hunt@ubc.ca|
22432428|NCT03913130|Sepul Bio|Zuhal Butuner - Chief Medical Officer|(905) 599 7887|contact@sepulbio.com|
22432429|NCT01143636|Spaulding Rehabilitation Hospital, Boston, MA.|Dr. Felipe Fregni, Director of the Laboratory of Neuromodulation|617.952.6153|info@neuromodulationlab.org|
22432430|NCT02878382|University of Sao Paulo Medical School Brazil|Dr Luis Torezan Associate Professor Dermatology|+551138491888|torezanluis@uol.com.br|
22432431|NCT01349114|University of Alabama at Birmingham|David A. Calhoun, MD|205-934-4633|dcalhoun@uab.edu|
22432432|NCT04046939|Knopp Biosciences|Vice President, Clinical and Translational Medicine|4124881776|calman@knoppbio.com|
22432433|NCT04704193|Massachusetts General Hospital|Daniel Chung, MD|617-726-8687|chung.daniel@mgh.harvard.edu|
22432434|NCT03384875|Cytosorbents|Darlene Lambert-Christie/ Director, Clinical Operations|732.822.3332|DLambert-Christie@cytosorbents.com|
22432435|NCT04790279|Prisma Health Upstate|Katelyn Pratt|2176223524|katelyn.pratt@prismahealth.org|
22432436|NCT01053507|Clinvest/A Division of Banyan Group, Inc.|Dr. Roger K. Cady|417-841-3673|jtarrasch@clinvest.com|
22432437|NCT00678288|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22432438|NCT03611881|Massachusetts General Hospital|Elyse Park, PhD, Professor of Psychiatry and Medicine, Harvard Medical School|617.724.6836|epark@mgh.harvard.edu|
22432439|NCT04472650|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22432440|NCT01861665|Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine.|Dr. Glenn Schattman, Associate Professor|646-962-3836|glschatt@med.cornell.edu|
22393144|NCT00775463|United Therapeutics Corporation|Oral Treprostinil Program Head|919-485-8350|klaliberte@unither.com|
22393145|NCT02980731|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22432441|NCT03247829|Abbott_Medical_Devices|Dr. Marie-Elena Brett, PhD; Principal Scientist Clinical Research|17815283613|marieelena.brett@abbott.com|
22432442|NCT01783444|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22432443|NCT02722408|NeuroBo Pharmaceuticals|Vice President Clinical Operations|+1 (857) 702-9600|info@neurobopharma.com|
22393146|NCT03037931|American Regent, Inc.|Elizabeth Ernst, Global Executive Director of Regulatory Affairs|631-605-5753|eernst@americanregent.com|3551
22393147|NCT02075476|Hospital Gregorio Marañón|Dr. Carlos Álvarez|0034915868000|calvargon@gmail.com|
22393148|NCT01789567|Medtronic Bakken Research Center|Kitty Schapira|+31433566802|kitty.schapira@medtronic.com|
22393149|NCT02731690|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
22393150|NCT00872989|SWOG Statisticial Center|Lung Committee Statistician|206-667-4623||
22393151|NCT02407990|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22393152|NCT01238900|University of Florida|Dr. Peter V. Draganov|(352) 273-9472|Peter.Draganov@medicine.ufl.edu|
22393153|NCT01994837|AbbVie|Global Medical Services|800-633-9110||
22393154|NCT01951352|UCSD Dermatology Clinical Trials|UCSD Dermatology Clinical Trials Manager|(858)657-8390|dermstudies@ucsd.edu|
22393155|NCT03241927|Icahn School of Medicine at Mount Sinai|Dr. Nina Bhardwaj|212-824-8427|nina.bhardwaj@mssm.edu|
22393156|NCT03573583|University of Florida|Todd Manini|(352) 273-5914|tmanini@ufl.edu|
22393157|NCT01198756|GlaxoSmithKline|GSK Response Center|866-435-7343||
22393158|NCT04004936|Atlanta VAHCS|Dr. Elizabeth Camille Vaughan/ Atlanta Site Section Chief Birmingham/Atlanta GRECC|404 315 4100|elizabeth.vaughan2@va.gov|373118
22393159|NCT02915302|Sanofi Pasteur Inc.|Medical Director|800-633-1610|RegistryContactUs@sanofipasteur.com|1#
22393160|NCT02062593|Imperial College London|Rasha Al-Lamee|+447976276923|r.al-lamee13@imperial.ac.uk|
22393161|NCT04343872|University of Alabama at Birmingham|Dr. Andrea L. Cherrington|205-996-2885|acherrington@uabmc.edu|
22393162|NCT01850446|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22393163|NCT00591721|University of Illinois at Chicago|Marcia Finlayson, PhD|312-996-4603|marciaf@uic.edu|
22393164|NCT01119105|Nabriva Therapeutics|Jennifer Schranz, M.D., Chief Medical Officer|610-981-2842|jennifer.schranz@nabriva.com|
22393165|NCT03900416|Lawrence University|Dr. Lori Hilt|920-832-7050|lori.m.hilt@lawrence.edu|
22393166|NCT00794144|Alcon Research Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22393167|NCT03207451|Inova Health System|Director of Clinical Trials|443-244-1497|kevin.bliden@inova.org|
22393168|NCT00436852|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22432444|NCT01900067|Mölnlycke Health Care AB, Surgical Division|Jenny Höglind|0046 31 722 30 00|Jenny.Hoglind@molnlycke.com|
22393169|NCT00370682|Phramongkutklao Hospital, Bangkok, Thailand|Verrachai Watanaveeradej, MD|662-644-8971|veerachaiw@yahoo.com|
22393170|NCT03167359|Emory University|Dr. Mylin Torres|404-778-3473|matorre@emory.edu|
22393171|NCT03339583|I.M. Sechenov First Moscow State Medical University|Polina Pchelina|+79036701725|polbox@mail.ru|
22393172|NCT02141620|University of Kentucky|William W. Stoops|859-257-5388|william.stoops@uky.edu|
22393173|NCT03651622|University of North Carolina at Chapel Hill|Elizabeth Mayer-Davis, PhD|919-966-7218|mayerdav@email.unc.edu|
22393174|NCT01519089|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22393175|NCT00307684|Janssen-Cilag G.m.b.H.|European Medical Affairs Director Neurology|+49 2137 955258|bschaeu2@its.jnj.com|
22393176|NCT00356408|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22393177|NCT05487586|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22393178|NCT01227382|University of Florida|Dr. Peter V. Draganov|(352) 273-9472|Peter.Draganov@medicine.ufl.edu|
22393179|NCT02638597|University of Texas Southwestern Medical Center|Principal Investigator|2146480188|madhukar.trivedi@UTSouthwestern.edu|
22393180|NCT03223662|National Cancer Institute|Caryn Steakley|240-858-3749|steaklec@nih.gov|
22393181|NCT00528931|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22393182|NCT00992225|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22393183|NCT03122223|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22393184|NCT03466073|BioAegis Therapeutics Inc.|Mark DiNubile MD|609-706-5866|mdinubile@bioaegistx.com|
22393185|NCT02285153|Medical University of Vienna|Bernd Jilma|+434040029180|bernd.jilma@meduniwien.ac.at|
22393186|NCT01390077|University of California, San Diego|William Leo Nyhan, M.D., Ph.D.|(619)543-5337|wnyhan@ucsd.edu|
22393187|NCT05833100|i-SENS, Inc.|Moon Hwan Kim|+82 (0)2 910 0521|mhkim@i-sens.com|
22393188|NCT02045875|Asthma Management Systems|Andrew G Weinstein MD|302 893 5455|agwmd@aol.com|
22393189|NCT00707759|FONDECYT|Maria Angela Delucchi|56-2-25755972|madelucchi@gmail.com|
22393190|NCT01278173|Lundbeck|H||LundbeckClinicalTrials@Lundbeck.com|
22393191|NCT02270515|University of Illinois, Chicago|Dr. Denise M. Hynes, Professor, College of Medicine|312-355-0083|dhynes@uic.edu|
22393192|NCT05745701|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22393193|NCT01118013|Blood and Marrow Transplant Group of Georgia|Asad Bashey, MD, PhD||abashey@bmtga.com|
22393194|NCT01607476|Mayo Clinic|Dr. Val Lowe|507-255-3616|vlowe@mayo.edu|
22393195|NCT04445987|Arcutis Biotherapeutics|Arcutis Medical Information|+1 844 692-6729|medinfo@arcutis.com|
22393196|NCT02091206|GW Research Ltd.|Medical Enquires||medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
22393197|NCT00749957|Applied Genetic Technologies Corporation|Chief Medical Officer|386-462-2204|jchulay@agtc.com|7205
22393198|NCT01170390|Oregon Health & Science University|Dr. Alison Edelman|503.418.2585|edelmana@ohsu.edu|
22432445|NCT01713582|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22432446|NCT04551898|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22393199|NCT03772587|Momenta Pharmaceuticals, Inc.|DIRECTOR CLINICAL RESEARCH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22410643|NCT00631670|University of Florida, Dept. of Radiation Oncology|Bridget Fitzgerald, Clinical trials coordinator|352-265-0680|fitzgb@shands.ufl.edu|87829
22410644|NCT03818737|Emory University|Kenneth Mautner, MD|404-778-7142|kmautne@emory.edu|
22410645|NCT00322309|BUPA CSU, Boston University School of Medicine|Maryam Afshar, MD|617-414-1990|maryam.afshar@bmc.org|
22410646|NCT01907737|HCFMUSP/FFM|Adriana Conforto|551126617955|adriana.conforto@gmail.com|
22410647|NCT01165684|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22410648|NCT00330421|Dana-Farber Cancer Institute|Jeffrey A. Morgan, M.D.|617-632-5204|jamorgan@partners.org|
22410649|NCT03135379|Brooke Army Medical Center|Benjamin M. Krainin|210-916-0808|Benjamin.M.Krainin.mil@mail.mil|
22410650|NCT04549259|Center for AIDS Intervention Research, Medical College of Wisconsin|Dr. Jennifer Walsh and Dr. Andrew Petroll|414-955-7710|jwalsh@mcw.edu|
22421376|NCT03644342|Baylor College of Medicine|Michelle S. Ludwig, MD, MPH, PhD|713-566-3662|Michelle.Ludwig@bcm.edu|
22421377|NCT00762710|VA Puget Sound|Dr. Tracy Simpson|(206) 277-3337|Tracy.Simpson@va.gov|
22421378|NCT02462603|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22421379|NCT01831635|Queen's University Belfast|Dr Lesley Anderson|02890632315|l.anderson@qub.ac.uk|
22421380|NCT02716714|Korea University Ansan Hospital|Ilhwan Kim|+82314125986|kumcihk@korea.ac.kr|
22421381|NCT01991743|Northwestern University|Dr. Robert J McCarthy|312-695-4976|r-mccarthy@northwestern.edu|
22421382|NCT01769573|UW Madison|Gina Crisafi|608-262-5240|gmc@medicine.wisc.edu|
22421383|NCT04704050|Tulane University|Nassir Marrouche|504-988-2025|nmarrouche@tulane.edu|
22421384|NCT05271370|CytoDyn|Vice President, Clinical Operations|3609808524|jmeidling@cytodyn.com|
22421385|NCT01135381|University of California San Francisco (UCSF); University of Alabama at Birmingham (UAB)|Dr. Christine Ritchie|415-514-0605|christine.ritchie@ucsf.edu; critchie@uab.edu|
22421386|NCT03773172|Columbia University Irving Medical Center|Henry Ginsberg, MD|212-305-9562|hng1@cumc.columbia.edu|
22421387|NCT05088460|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22421388|NCT03100864|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22421389|NCT04066244|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22421390|NCT00866281|Novartis Pharmaceuticals|Study Director|862-778-8300||
22421391|NCT02235064|Cooper University Health System|Dr. Richard L Fischer|856-342-2491|fischer-richard@cooperhealth.edu|
22421392|NCT00529087|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22421393|NCT01598064|National Cheng Kung University Hospital|Dr. Po Lin Chen|886-2353535|n939492@mail.hosp.ncku.edu.tw|4733
22421394|NCT02283268|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22421395|NCT00333983|VA Maryland Health Care System, Baltimore|Dr. Susan S. Conroy|(410) 605-7000|susan.conroy@va.gov|3213
22421396|NCT03656068|Pinnacle Clinical Research|Stephen Harrison, MD|210-982-0320|stephenharrison87@gmail.com|
22421397|NCT01436370|Department of Internal Medicine, University of Iowa|Jack Stapleton, MD|319-356-3168|jack-stapleton@uiowa.edu|
22421398|NCT02770170|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22421399|NCT03270657|Duke University|Dr. Dennis Turner|919-684-7777|dennis.turner@duke.edu|
22421400|NCT00162981|Lundbeck LLC|Email contact via H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
22421401|NCT00171210|Novartis Pharmaceuticals|Study Director|862-778-8300||
22432447|NCT03427814|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22432448|NCT03846427|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22432449|NCT01334554|Vanderbilt University Medical Center|Cyndya A. Shibao|6159364584|cyndya.shibao@vanderbilt.edu|
22432450|NCT02071901|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Sudipto Mukherjee|1-866-223-8100|TaussigResearch@ccf.org|
22432451|NCT02393859|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22432452|NCT00954447|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22432453|NCT01979614|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
22432454|NCT00488514|GlaxoSmithKline|GSK Response Center|866-435-7343||
22432455|NCT00305877|ECOG Statistical Office|Study Statistician|617-632-3012||
22432456|NCT01535287|University of Iowa|Martin Mueller|3193562633|martin-mueller@uiowa.edu|
22432457|NCT03951610|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
22432458|NCT00628446|Carolinas Healthcare System|Dr. Jesse Lieberman|704-355-0649|Jesse.Lieberman@Carolinashealthcare.org|
22432459|NCT03394781|DURECT Corporation|Executive Director, Regulatory Affairs|408-777-1829|jill.burns@durect.com|
22432460|NCT04971967|University of North Carolina at Chapel Hill Project - China|Ms. Xumeng Yan|+8615330225941|xumeng_yan@seshglobal.org|
22432461|NCT00052910|Yale Cancer Center|Charles S. Fuchs, MD, MPH|(203) 785-4095|charles.fuchs@yale.edu|
22432462|NCT00682929|UC Davis Health|Janelle Butters, NP|916-734-6276|jbutters@ucdavis.edu|
22432463|NCT00938912|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
22432464|NCT03663855|NYU Langone Health|David Goldfarb, MD|(212) 263-7300|David.Goldfarb@nyulangone.org|
22432465|NCT03181971|Stanford University|Anisha Patel, MD|(650) 497-1181|anipatel@stanford.edu|
22432466|NCT04343092|College of Medicine-University of Baghdad|Faiq I. Gorial|009647801730696|faiqig@gmail.com|
22432467|NCT00803738|Perrigo Pharmaceuticals|Jonathan Schwartz|718-960-0119|jonathan.schwartz@perrigo.com|
22432468|NCT02964273|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
22432469|NCT03012334|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22432470|NCT01823107|DSM Biomedical|Forde Hansell|484-713-2152|forde.hansell@dsm.com|
22432471|NCT01451411|Cumberland Pharmaceuticals Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com|
22432472|NCT00328172|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22432473|NCT00077974|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22432474|NCT02178800|Fred Hutch Cancer Research Center|Gordon Chau|2066672118|gchau@fredhutch.org|
22432475|NCT02897115|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22432476|NCT00420381|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22432477|NCT01424943|Institute for Families in Society, University of South Carolina|Dr. Cheri Shapiro|803-777-8760|cshapiro@mailbox.sc.edu|
22432478|NCT00439335|Baylor College of Medicine|Shital Patel, MD|713-798-3793|shitalp@bcm.tmc.edu|
22432479|NCT01144143|University of Kansas Medical Center|Dr. Herbert Lindsley|(913) 588-3402|HLINDSLE@kumc.edu|
22432480|NCT04512001|Fresenius Kabi SwissBioSim GmbH|Clinical Development|793075735|clinical.development@fresenius-kabi.com|+41
22432481|NCT03389308|Castle Creek Pharmaceuticals|Mary C. Spellman, MD|312-847-1291|mspellman@castlecreekpharma.com|
22432482|NCT03350451|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
22432483|NCT00581048|Vanderbilt University Medical Center|Ryszard Dworski|615-322-3412|ryszard.dworski@Vanderbilt.Edu|
22432484|NCT04231097|Massachusetts General Hospital|Christina Luberto, PhD|617-643-9453|cluberto@mgh.harvard.edu|
22432485|NCT03391986|Columbia University|Carolyn Westhoff, MD|212-305-4805|clw3@columbia.edu|
22432486|NCT03896477|PATH|Mark Alderson|+ 206.302.4859|malderson@path.org|
22432487|NCT01102738|Imperial College London|Dr. Kathleen Sim|(+44) (0)20 7594 3695|k.sim@imperial.ac.uk|
22432488|NCT01212471|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22432489|NCT01106157|University of Florida|Michael J Haller|3522739264|hallemj@peds.ufl.edu|
22432490|NCT01154335|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22432491|NCT02298868|University of Virginia|Dr. Zachary Henry|434-243-2718|zhenry@virginia.edu|
22432492|NCT01063348|University of Chicago|Dr. Jon Grant|773-834-1325|jongrant@uchicago.edu|
22432493|NCT00696878|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22432494|NCT01120405|Population Health Research Institute - Mc Master University, Hamilton CANADA|Yannick LE MANACH, MD, PhD|0012892606840|Yannick.Lemanach@phri.ca|
22432495|NCT03824392|aTyR Pharma|Lisa Carey|858 731 8389|clinicaltrials@atyrpharma.com|
22432496|NCT00967616|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22432497|NCT01847755|Jupiter Medical Center|Dr. Barry Miskin|561-263-5791|clinicaltrials@jupitermed.com|
22432498|NCT00746187|DENTSPLY Implants|Senior Manager Global Clinical Research|+46313763500|clinicalresearchmolndal@dentsply.com|
22432499|NCT02537730|Coopervision Japan|Director Professional Services Organization|81-3-5449-6619|taku.muraoka@jp.coopervision.com|
22432500|NCT05501639|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22432501|NCT01197547|Boston Scientific|Meaghan Wilk|5086834113|wilkm@bsci.com|
22432502|NCT01953211|University Reproductive Associates|Michael Cho|(201) 288-6330|michaelcho@nyc.com|
22432503|NCT03188263|Northwestern University|Kristen Knutson|312-503-1526|kristen.knutson@northwestern.edu|
22432504|NCT01030822|GlaxoSmithKline|GSK Response Center|866-435-7343||
22432505|NCT01628523|Washington University in St. Louis|Brian M Fuller|3147475368|fullerb@wusm.wustl.edu|
22432506|NCT00768261|Washington University|John G. Csernansky, MD|(312) 926-2323|jgc@northwestern.edu|
22393200|NCT02297139|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22393201|NCT03367429|Weill Cornell Medicine|Michael O'Dell, M.D.|19175495179|mio2005@med.cornell.edu|
22393202|NCT01821352|Regulatory Insight, Inc.|Clinical Consultant|615-712-9743|elvira@reginsight.com|
22393203|NCT05051462|University of Toronto|Barna Konkoly-Thege|+1 (705) 549 3181|konkoly.thege.barna@gmail.com|2614
22393204|NCT02425904|Dana-Farber Cancer Institute/Boston Children's Hospital|Barbara Degar, MD|617-632-5186|Barbara_Degar@dfci.harvard.edu|
22393205|NCT05260021|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22393206|NCT05597787|University of Delaware|Valerie Earnshaw|(302) 831-6500|earnshaw@udel.edu|
22393207|NCT01144377|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22393208|NCT01187381|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22432507|NCT02651545|UBMD Neurology|Michael Jaworski|716-323-0550|mgjawors@buffalo.edu|
22432508|NCT00120627|VA San Diego Healthcare System|Jill E. Bormann, PhD, RN, FAAN|858-552-8585|jill.bormann@va.gov|2378
22432509|NCT03386435|Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea|Jun-Gol Song, MD, PhD|+82-2-3010-3869|jungol.song@amc.seoul.kr|
22432510|NCT04068922|University of Florida|Dr. Emily Bartley|352-273-8934|ebartley@dental.ufl.edu|
22432511|NCT04540367|Houston Methodist Hospital|Bradley Lambert|8326872483|bslambert@houstonmethodist.org|
22432512|NCT00761345|Fox Chase Cancer Center|Dr. Steven J. Cohen|215-728-4300|steven.cohen@fccc.edu|
22432513|NCT00907621|Department of General practice, University of Oslo|Dr. Holgeir Skjeie|+4722850550|Holgeir.Skjeie@medisin.uio.no|
22432514|NCT04344184|Virginia Commonwealth University|Dr. Alpha Fowler|(804) 519-4369|alpha.fowler@vcuhealth.org|
22432515|NCT01815424|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22432516|NCT01309204|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22432517|NCT04723355|Hospital Israelita Albert Einstein|Clinical Trialist|551121515915|karla.santo@einstein.br|
22432518|NCT03374358|Helsinki University Hospital|Dr Jussi Sutinen|+358407480437|jussi.sutinen@hus.fi|
22432519|NCT02469701|Brown University Oncology Research Group|Kristen M. Mitchell, CCRP|4018633000|kristen_mitchell@brown.edu|
22432520|NCT01127633|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22432521|NCT01805687|Cornerstone Therapeutics, Inc.|W. James Alexander, MD, MPH|919-678-6925|jim.alexander@chiesi.com|
22432522|NCT01073293|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22432523|NCT01244711|Weill Cornell Medical College|james kocsis|212-746-5913|jhk2002@med.cornell.edu|
22432524|NCT02168101|Sarah Cannon Development Innovations, LLC|Sarah Cannon|844-710-6157|CANNDLClinicalScience@HCAHealthcare.com|
22432525|NCT00400517|Cleveland Clinic|Dr. Jorge Garcia|2164447774|Garciaj4@ccf.org|
22432526|NCT01194245|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|858-794-8889||
22432527|NCT05518461|University of Wisconsin - Madison|Dr. Rachel Gicquelais|(608) 890-1837|gicquelais@wisc.edu|
22432528|NCT02457247|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22432529|NCT00739310|Maimonides, Department of Pulmonary Medicine|Kathryn Fitzgerald, NP|718-283-7339|kfitzgerald@maimonidesmed.org|
22432530|NCT02954887|GW Research Ltd|Medical Enquires|+44 01223 238170; 18778862810|medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
22432531|NCT03091361|MolecuLight Inc.|Liis Teene|416.542.5530|lteene@moleculight.com|
22432532|NCT01882465|Johnson & Johnson Vision Care Inc.|Charis Lau, PharmD, OD, FAAO- Principal Research Optometrist|904-433-3500|charislau@gmail.com|
22432533|NCT03119168|Texas Tech University Health Sciences Center at El Paso|The Effect Of Adding High Dose Simethicone To A Standard Polyethylene Glycol Preparation On Adenoma|915-215-4678|antonio.mendoza-ladd@ttuhsc.edu|
22432534|NCT01824290|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22432535|NCT00800982|University of California San Francisco|Dr Ethan Levin|4154764019|levine@derm.ucsf.edu|
22432536|NCT01490918|The Catholic University of Korea, Seoul St Mary's Hospital|Yoon Hee Choi|82-2-2258-8288|choiyh@catholic.ac.kr|
22432537|NCT02099084|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
22432538|NCT01545765|Galderma|Farzaneh Sidou Clinical Project Manager)|00.33.4.93.95.70.70|farzaneh.sidou@galderma.com|
22432539|NCT02379195|Center for Cancer Immune Therapy, Herlev Hospital|Dr. Inge Marie Svane|38683868|inge.marie.svane@regionh.dk|
22432540|NCT02706925|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22432541|NCT00003631|Memorial Sloan Kettering Cancer Center|Dr. Joachim Yahalom|1212-639-5999|yahalomj@mskcc.org|
22432542|NCT00959907|CBED|Débora Zechmeister do Prado|55 51 30262633|cbed@cbed.org.br|
22432543|NCT02665260|Montefiore Medical center|Dr. Steven Cohen|718-920-8470|dermpharmeinstein@gmail.com|
22432544|NCT01261975|Bausch & Lomb|Omid Khodai|(949) 521-7894|Omid.Khodai@bausch.com|
22432545|NCT01722929|Northwestern University|Murad Alam, MD|312-695-4761|m-alam@northwestern.edu|
22432546|NCT00716274|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22432547|NCT01932788|Professor of Pediatrics|Carol,Wagner, MD|843-792-8829|wagnercl@musc.edu|
22432548|NCT04290624|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
22432549|NCT01171677|NYUMED|John Rotrosen|212 951 3294|john.rotrosen@nyumc.org|
22432550|NCT02421757|University of Maryland School of Medicine|Dr. Peter Rock|410-328-6933|prock@som.umaryland.edu|
22432551|NCT00656370|Halozyme Therapeutics|Dimitrios Chondros, M.D., Chief Medical Officer|858-794-8889|dchondros@halozyme.com|
22432552|NCT01342094|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
22393209|NCT01241604|Philips Respironics|Jeremy Powers|412-542-3669|jeremy.powers@philips.com|
22393210|NCT01214642|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22432553|NCT01600287|Postgraduate Institute of Medical Education and Research|Dr G D Puri|00919914209509|gdpuri007@hotmail.com|
22432554|NCT03111030|Unviersity of British Columbia|Dr. Kathleen Martin Ginis|250-807-9768|Kathleen_martin.ginis@ubc.ca|
22432555|NCT02806414|UCSD Dermatology|Director of Clinical Trials Unit|8586571697|dermstudies@ucsd.edu|
22432556|NCT02382588|Northwestern Universtiy|Dr. Robert Feder|3126958150|r-feder@northwestern.edu|
22432557|NCT03198156|The Ohio State University Wexner Medical Center|Dr. Ulysses Magalang|614-292- 4307|Ulysses.Magalang@osumc.edu|
22432558|NCT01646814|PLxPharma|Regulatory Affairs Director|17138421249|regaffairs@plxpharma.com|
22432559|NCT01846702|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22432560|NCT01911351|NYCHHC Jacobi Medical Center|Dr. Sandra Cunningham|718 918 5250|sandra.cunningham@nbhn.net|
22432561|NCT05653700|Wake Forest University Health Sciences|Kevin Lobdell, MD|704.355.1585|kevin.lobdell@atriumhealth.org|
22432562|NCT00713193|Ohio State University|Spero R Cataland|6142939441|spero.cataland@osumc.edu|
22432563|NCT01333436|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22432564|NCT00543985|University of Missouri|Kevin C. Dellsperger, MD, PhD, Professor, Internal Medicine|573-884-2013|dellspergerk@health.missouri.edu|
22432565|NCT01634152|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22432566|NCT03848455|Zhujiang Hospital of Southern Medical University|Xiaoya Gao|18680282869|4356975@qq.com|
22432567|NCT02481258|Mayo Clinic|Jordan D. Miller, Ph.D.|507-293-0813|Miller.Jordan@mayo.edu|
22432568|NCT03210701|School of Pharmacy, Memorial University|Dr. Debbie Kelly|709 864 7805|dvkelly@mun.ca|
22432569|NCT01900665|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22432570|NCT02199041|St. Jude Children's Research Hospital|Brandon Triplett, MD|901-595-2766|brandon.triplett@stjude.org|
22432571|NCT02317627|Kadmon Corporation, LLC|Associate VP, Clinical Operations|833-900-5366|karin.herrera@kadmon.com|
22432572|NCT04749914|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22432573|NCT00279214|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22432574|NCT00403130|Stanford University Medical Center|George Albert Fisher, MD, PhD|650-725-9057|georgeaf@stanford.edu|
22432575|NCT01280968|Duke University Medical Center|Alexey G Mukhin, M.D., Ph.D.|Telephone: 919-668-5055|amukhin@duke.edu|
22432576|NCT00806260|Vivus, Inc.|Wesley W Day, PhD|650-934-5200|day@vivus.com|
22432577|NCT01903005|TRY Research|Kent Hoffman, DO|(407) 691-3960|Suboxdoc1@yahoo.com|
22432578|NCT03682965|Pharma Initiatives|Mark Shapiro|9193063675|mshapiro@pharmainitiatives.com|
22432579|NCT00953706|Vertex|Medical Monitor|617-444-6777|medicalinfo@vrtx.com|
22432580|NCT02670473|CooperVision Inc.|Senior Manager Global Medical Scientific Affairs|925 621-3761|javega@coopervision.com|
22432581|NCT01404234|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22432582|NCT01214837|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22432583|NCT05414175|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22432584|NCT00834197|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22432585|NCT00027560|Memorial Sloan-Kettering Cancer Center|Dr. Hugo Castro-Malaspina|212-639-8197|castro-h@mskcc.org|
22432586|NCT04028648|seca gmbh & co. kg|Kristin Klückmann|040200000232|kristin.klueckmann@seca.com|
22432587|NCT04050384|Nationwide Children's Hospital|Dr. Lance M. Relland|614-722-5971|lance.relland@nationwidechildrens.org|
22432588|NCT03559270|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22432589|NCT00577278|City of Hope Medical Center|Dr. Matthew Mei|626-359-8111|mamei@coh.org|
22432590|NCT04743011|São Paulo State University (UNESP)|Professor Matheus Bertanha, Ph.D.|+551438801444|matheusbertanha@gmail.com|
22432591|NCT04011592|The University of Texas Health Science Center at Houston|Sudhakar Selvaraj, MD, PhD, Assistant Professor|713-486-2837|Sudhakar.Selvaraj@uth.tmc.edu|
22432592|NCT01364480|University of Pittsburgh|Debbie Harrington, CCRP, senior research coordinator|4123831355|debbie.harrington@pitt.edu|
22432593|NCT04776161|Brigham and Women's Hospital|Candace Feldman, MD, MPH, ScD|617-525-1035|CFELDMAN@BWH.HARVARD.EDU|
22432594|NCT00342628|PDMI, NICHD, NIH|Feng-Ying (Kimi) Lin, MD, MPH|301-496-0295|link@mail.nih.gov|
22432595|NCT01187095|Aarhus University|Yoon Frederiksen|+4587565871|yoonf@psy.au.dk|
22432596|NCT04103112|Imperial College London|Professor Alun Davies|02033117320|a.h.davies@imperial.ac.uk|
22432597|NCT00456755|Department of Otorhinolaryngology, Head & Neck Surgery, West China Hospital, Sichuan University, China|Zhao Yu||yutzhao@gmail.com|
22432598|NCT04005391|University of Colorado|Margo Harrison|19176555178|margo.harrison@cuanschutz.edu|
22432599|NCT01475721|GlaxoSmithKline|GSK Response Center|866-435-7343||
22432600|NCT01048242|University of Pennsylvania|Nalaka Gooneratne|215 349 5938|ngoonera@mail.med.upenn.edu|
22432601|NCT03358355|Northwestern University|Mary McDermott MD|312-503-6419|mdm608@northwestern.edu|
22432602|NCT02291133|Institute of Oncology Ljubljana|Dr Gregor Serša|+38615874343|gsersa@onko-i.si|
22432603|NCT01772550|Becton, Dickinson and Company|Randall Jones, MD|801 565-2843|randall_jones@bd.com|
22393211|NCT01639495|Biosense Webster, Inc.|Robert Stagg, PhD, Manager, Clinical Franchise|(949) 450-7779|rstagg@its.jnj.com|
22393212|NCT05263388|Ferring Pharmaceuticals|Global Clinical Compliance|+1 862-286-5200|Disclosure@ferring.com|
22393213|NCT02551718|University Of Washington|Dr. Percival|206-606-1320|mperciva@seattlecca.org|
22393214|NCT02366468|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22393215|NCT00359216|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22432604|NCT00559104|City of Hope National Medical Center|Dr. Auayporn Nademanee|626-256-4673|anademanee@coh.org|62691
22432605|NCT04567524|Lyndra Therapeutics|Nayana Nagaraj, Senior Medical Director|3023040091|Nnagaraj@lyndra.com|
22432606|NCT01147393|Weill Cornell Medicine|Peter Martin, MD|646.962.2064|amr2017@med.cornell.edu|
22393216|NCT05540717|Allergy Therapeutics (UK) Ltd.|Pieter-Jan De Kam, Clinical Director|+44 (0) 1903 844 700|pieter-jan.dekam@allergytherapeutics.com|
22393217|NCT01144052|Ospedale Civico|Claudio Globbi, Dr. med.|+41 91 811 6921|claudio.gobbi@eoc.ch|
22393218|NCT00105001|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org|
22393219|NCT03836716|Zevra Denmark A/S|Medical Affairs|+1-888-289-5607|medicalaffairs@zevra.com|
22393220|NCT01879722|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22393221|NCT01983254|Duke University|Christopher Cox, PI|9196817232|christopher.cox@duke.edu|
22393222|NCT00697697|MAP Pharmaceuticals, Inc. a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
22393223|NCT00037830|Thomas Jefferson University|Dr. Jay Schneider|215-503-0370|jay.schneider@jefferson.edu|
22410651|NCT01886300|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22410652|NCT00901628|Joint Reconstruction Center, Seoul National University Bundang Hospital|Tae Kyun Kim|82-31-787-7196|osktk@snubh.org|
22432607|NCT01291108|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22432608|NCT00512278|Cleveland Clinic|Nizar Zein|216-444-6126|zeinn@ccf.org|
22410653|NCT00608205|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. David Adelstein|216-444-9310|adelstd@ccf.org|
22410654|NCT02008721|Department of Neurology, Ludwig-Maximilians-University Munich, Munich, Germany|Prof. Dr. Johannes Levin||johannes.levin@med.uni-munechen.de|
22410655|NCT01630200|Ludwig Boltzmann Institute for COPD and Respiratory Epidemiology|Dr. Matthias Urban|+43(0)6508125980|matthias.urban1@gmx.net|
22410656|NCT00295854|Medicinova Inc|Richard E. Gammans PhD Chief Developing Officer|848-373-1500|gammans@medicinova.com|
22410657|NCT01095757|Winship Cancer Institute Emory University|Dr. Edmund Waller|404-727-4995|ewaller@emory.edu|
22410658|NCT00208949|Emory University|Dr. Sagar Lonial|404-778-1900|SLONI01@emory.edu|
22410659|NCT01967888|Dompé|Mauro P. Ferrari, Pharm D|+3902583831|info@dompe.com|
22410660|NCT00004143|Duke University Medical Center|Mitchell Horwitz, MD|919-668-1045|Mitchell.Horwitz@duke.edu|
22410661|NCT04535609|Reneo Pharmaceuticals, Inc.|Alex Dorenbaum, MD, Chief Medical Officer|(415) 328-9115|adorenbaum@reneopharma.com|
22410662|NCT03175120|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22410663|NCT04120194|Novavax Inc|Novavax Customer Service Center|1-844-Novavax (668-2829)|Clinicaltrials@novavax.com|
22410664|NCT02622074|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22410665|NCT02114931|Amgen Inc.|Study Director|866-572-6436||
22410666|NCT01859325|National Institute of Allergy and Infectious Diseases|Sneller, Michael|+1 301 496 0491|MSNELLER@niaid.nih.gov|
22410667|NCT03565211|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DK0-Disclosure@ferring.com|
22410668|NCT00986154|Daiichi Sankyo, Inc.|Lee Schwocho, Sr. Director|732-590-5000|lschwocho@dsi.com|
22410669|NCT00267007|Centocor Ortho Biotech Services, LLC (COBS)|Vice President|215 325 4464||
22410670|NCT02400073|ResMed|Senior Manager, Medical Affairs|+61 8884 1123|alison.wimms@resmed.com|
22410671|NCT01205529|Vanderbilt University Medical Center|Dan Roden|6153220067|dan.roden@Vanderbilt.Edu|
22410672|NCT03840135|NPO Petrovax Pharm, LLC|Nikolay Dodonov, Head of medical department|+7(495) 730-75-45|DodonovNS@petrovax.ru|125
22410673|NCT04133519|metaMe Health|Dr. David Recker, Chief Medical Officer|1-888-463-8262|info@metamehealth.com|
22410674|NCT00323609|Medtronic|John Tillman|408-548-6518|tillmj1@mspexcng.medtronic.com|
22410675|NCT00267293|Penn State Children's Hospital|Ian M Paul, MD, MSc|717-531-5656|ipaul@hmc.psu.edu|
22410676|NCT02372682|Saint Louis University|Anna Hardy, Research Nurse Coordinator|314-268-5785|anna.hardy@health.slu.edu|
22410677|NCT01684722|University of Washington|Ian de Boer, MD, MS|2066165403|deboer@u.washington.edu|
22410678|NCT01664494|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22410679|NCT00219557|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22410680|NCT03063632|Cancer Immunotherapy Trials Network|Anna Wright|206-667-2541|akwright@fredhutch.org|
22410681|NCT01612156|University of Southern California|Begum Ozel, MD|323-441-9589|ozel@usc.edu|
22410682|NCT00410410|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22410683|NCT01783496|Solta Medical|Director of Clinical Programs|510-259-5284|aloncaric@solta.com|
22410684|NCT01023269|Medtronic International Trading Sarl|Alexandra Delacour, Clinical Research Manager|0041218027622|alexandra.delacour@medtronic.com|
22410685|NCT00106028|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22410686|NCT00947011|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
22410687|NCT01172353|Hospital Sao Lucas|Vitor Osório Gomes, MD, PhD|55 51 33203494|pesquisa@cardiarte.com.br|
22410688|NCT05266456|Vaxcyte|Vice President of Clinical Development|(650) 585-0029|clinicaltrialsgov@vaxcyte.com|
22410689|NCT05267574|Reneo Pharmaceuticals, Inc.|Alex Dorenbaum, MD, Chief Medical Officer|(415) 328-9115|adorenbaum@reneopharma.com|
22410690|NCT02995694|Alvogen Pine Brook|Meena Venugopal|973-532-7824|meena.venugopal@alvogen.com|
22410691|NCT00973856|Cleveland Clinic Akron General|Eliot Mostow, MD||emostow@akronderm.com|
22410692|NCT02746705|NYU Langone Health|Leigh Charvet|929 455 5125|leigh.charvet@nyulangone.org|
22410693|NCT00479401|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22410694|NCT00677924|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com|
22410695|NCT00928252|The Queen's Medical Center|Sandi Kwee, MD, PhD|8086915466|skwee@queens.org|
22410696|NCT02257632|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22410697|NCT04967313|Northwell Health|Joan Duer-Hefele, RN, MA|646-766-7153|jduerhefele@northwell.edu|
22432609|NCT03432494|National Heart, Lung, and Blood Institute (NHLBI)|Dr. Robert Lederman, Principal Investigator|301.402.6769|ledermar@nhlbi.nih.gov|
22432610|NCT00775268|National Cancer Institute|Dr. Esther Mena|240-760-6111|esther.menagonzalez@nih.gov|
22432611|NCT00825994|Massachusetts General Hospital|Marlene Freeman, MD|617-643-6403|mfreeman@partners.org|
22432612|NCT02921295|University of Pittsburgh|Dr. Goeran Fiedler|4126246475|gfiedler@pitt.edu|
22432613|NCT01162551|CHOP|Susan Rheingold, MD|215-590-2801|cancertrials@email.chop.edu|
22432614|NCT01833494|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
22432615|NCT03068897|Montefiore|Dr. Benjamin W. Friedman|718-920-6626|befriedm@montefiore.org|
22432616|NCT03745768|Washington University School of Medicine St. Louis|Pilar Cristancho M.D.|314 362 2413|cristanchopimiento.l@wustl.edu|
22432617|NCT00443118|FUNDASAMIN-Fundacion para la Salud Materno Infantil|Edgardo Szyld MD, MSc|5491144093095|eszyld@gmail.com|
22432618|NCT03723980|Dow University of Health Sciences|Dr. Juzer Shabbir Saifee|92-333-2352134|dr.juzer.shabbir@gmail.com|
22432619|NCT01029912|MetroHealth Medical Center|Dr. Jayme Knutson|2167787342|jsk12@case.edu|216
22432620|NCT00506779|University of Texas (UT) MD Anderson Cancer Center|David Gershenson, MD|713-745-2565|DGershen@mdanderson.org|
22432621|NCT04263766|Georgia Institute of Technology|Dr. Dobromir Rahnev|6466378219|rahnev@psych.gatech.edu|
22432622|NCT04232943|PATH|Rahsan Erdem, MD, Senior Medical Officer|+1 202 540 4546|rerdem@path.org|
22432623|NCT02639247|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22432624|NCT01891396|Anika Therapeutics, Inc.|Carol Pekar, VP Clinical Affairs|781.457.9218|cpekar@anikatherapeutics.com|
22432625|NCT00573391|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990|pettynathanm@uams.edu|2461
22432626|NCT02607124|Cincinnati Childrens Hosptial Medical Center|Renee Doughman|513-636-1699|renee.doughman@cchmc.org|
22432627|NCT01821326|Shanghai Jiaotong University|Dr.Zhizheng GE|86-68383015|tanwei_1987@163.com|
22432628|NCT04011735|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22432629|NCT02831855|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22432630|NCT03368196|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22432631|NCT01118780|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22432632|NCT03962855|University of Massachusetts Medical School|Jeffrey J Rade MD|774-441-6310|jeffrey.rade@umassmed.edu|
22432633|NCT03326063|Brigham and Women's Hospital|Tanya Laidlaw, MD|617-525-1034|tlaidlaw@bwh.harvard.edu|
22432634|NCT02750514|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22432635|NCT02020590|Bone Therapeutics|Chief Medical Officer|+32 71 12 10 00|regulatory@bonetherapeutics.com|
22432636|NCT02756403|MedStar Washington Hospital Center|Principal Investigator|202-877-7479|peggy.ye@medstar.net|
22432637|NCT00527618|University of Washington, Virology Research Clinic|Tara Perti, MD|(206) 520-4340|tarap@u.washington.edu|
22432638|NCT03046836|Medical University of South Carolina - Institute of Psychiatry|Stacey Sellers|8437925807|sellersst@musc.edu|
22432639|NCT03141255|The University of Chicago|Jonathan D. Paul, MD|(773) 702-9461|jpaul@bsd.uchicago.edu|
22432640|NCT02240121|Bausch Health Americas, Inc.|Director of Clinical Operations|908-927-0873|lindsey.mathew@bauschhealth.com|
22432641|NCT02967679|MedDay Pharmaceuticals|Dr Frédéric SEDEL, Chief Scientific Officer and Co-founder|+33 1 80 40 14 40|frederic.sedel@medday-pharma.com|
22432642|NCT00243191|SARC|SARC, Chief Operating Officer|734-930-7600|sarc@sarctrials.org|
22432643|NCT01684839|The Second Hospital of Tangshan|Dr. Chao Chen|86-13700350471|ts_chenchao@163.com|
22432644|NCT04615624|University of Hawaii and Hawaii Pacific Health|Melanie Maykin|8089836000|mmaykin@hawaii.edu|
22432645|NCT04571060|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
22432646|NCT01253369|Dana-Farber Cancer Institute|David Jackman, MD|617-632-6049|DJACKMAN@PARTNERS.ORG|
22432647|NCT04410159|UNIVERSITI SAINS ISLAM MALAYSIA|NURUL AZMAWATI MOHAMED|+603 42892400|drnurul@usim.edu.my|2417
22432648|NCT01220401|University of Tulsa|Dr. Noelle Balliett|918-631-3976|noelle-balliett@utulsa.edu|
22432649|NCT01853462|Aristotle University of Thessaloniki|Lazaros Lazarou||lazarosphysiotherapist@gmail.com|
22432650|NCT03139032|Arena Pharmaceuticals, Inc.|Head of Document Operations|858-453-7200|ct.gov@arenapharm.com|
22432651|NCT02030821|Duke University|Michael Bolognesi, M.D.|919-668-4732|michael.bolognesi@duke.edu|
22432652|NCT03132467|UT MD Anderson Cancer Center|Dr. Jennifer Litton, MD- VP, Clinical Research, Clinical Research|(713) 792-2817|jlitton@mdanderson.org|
22432653|NCT01088906|Fundación GECP|Eva Pereira|+34 934302006|epereira@gecp.org|
22432654|NCT03670160|University of Tennessee Medical Center|Janet Parkey, Director - Research Compliance|865-305-6194|jparkey@utmck.edu|
22432655|NCT00457626|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22432656|NCT03965403|Spaulding Rehabilitation Hospital|Paolo Bonato, PhD|6179526319|pbonato@partners.org|
22432657|NCT03366454|INA-RESPOND|Publication Division|+62214208693|inapublikasi@ina-respond.net|
22432658|NCT02836470|Palisade Bio|Mitchell Jones, CMO|858-704-4900|mitchell.jones@palisadebio.com|
22432659|NCT00535769|MGH Curtis|Dr. Alexa B. Kimball|617-726-5066|harvardskinstudies@partners.org|
22432660|NCT02364037|Washington University School of Medicine|Rachel Paul|3147478176|paulr@wustl.edu|
22432661|NCT01453036|The Catholic University of Korea|Dr. Jin Il Kim|+82-2-3779-2382|jikim@catholic.ac.kr|
22432662|NCT04072835|Milestone Pharmaceuticals Inc.|Cameron Szakacs _PhD_VP Drug Development|1 704-594-4102|cszakacs@milestonepharma.com|
22432663|NCT01336712|Blood and Marrow Transplant Group of Georgia|Scott R. Solomon, MD (Principal Investigator)|404-255-1930|ssolomon@bmtga.com|
22432664|NCT00841776|GlaxoSmithKline|GSK Response Center|866-435-7343||
22421402|NCT00253435|Chidlren's Hospital Los Angeles|Araz Marachelian, MD, NANT Medical Director|323-3691-5687|amarachelian@chla.usc.edu|
22421403|NCT03187301|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
22421404|NCT01808963|UC Davis Medical Center|Dr. Neal Fleming|916-734-5394|nwfleming@ucdavis.edu|
22421405|NCT00304096|University of Virginia|Kimberly Bullock, PhD and David Brenin, MD|434-924-0180|kb9d@virginia.edu|
22421406|NCT02158585|DENT Neurosciences Research Center|Dr. Jennifer Cox|716-250-7002|jcox@dentinstitute.com|
22421407|NCT01966120|Biofrontera Bioscience GmbH|Clinical Trial Department,|+49 2148763226|ameluz@biofrontera.com|
22421408|NCT00461630|Clinical Trial Service Unit, University of Oxford|Professor Jane Armitage|+44 (0)1865 743743|thrive@ctsu.ox.ac.uk|
22421409|NCT02546375|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22432665|NCT02848092|Cincinnati Children's Hospital Medical Center|Jeff Epstein, Ph.D.|513-636-8296|jeff.epstein@cchmc.org|
22432666|NCT02189889|UT Southwestern Medical Center|Philip Greilich -PROFESSOR|214/645-8018|PHILIP.GREILICH@UTSouthwestern.edu|
22410698|NCT03167099|West Virginia University|Dr. David Hubbard|304-293-3900|dhubbard@hsc.wvu.edu|
22432667|NCT00290810|Mayo Clinic|Tait Shanafelt, M.D.||shanafelt.tait@mayo.edu|
22432668|NCT02126319|Fox Chase Cancer Center|Dr. Suzanne M. Miller|215 728-4069|Suzanne.Miller@fccc.edu|
22432669|NCT01428219|University of Michigan Comprehensive Cancer Center|Dr. David C. Smith, M.D.|734-764-3066|dcsmith@umich.edu|
22432670|NCT01516632|Center for Innovative Public Health Reserch|Dr. Michele Ybarra|(877) 302-6858|michele@innovativepublichealth.org|1-801#
22432671|NCT00355368|Medical Intensive care unit, University Hospital Basel|Stephan Marsch|+ 41 61 265 2525|smarsch@uhbs.ch|
22432672|NCT00437398|Mayo Clinic|Dr. Yogish Kudva|507-284-3964|kudva.yogish@mayo.edu|
22432673|NCT01694433|UCLA|Dr. Jenny Kim|310-825-5420|jekim@mednet.ucla.edu|
22432674|NCT03071861|University of Utah|Tara DuPont|8015814178|tara.dupont@hsc.utah.edu|
22432675|NCT00374595|University of Nebraska Medical Center|Jennifer Larsen|(402) 559-4837|jlarsen@unmc.edu|
22432676|NCT00410189|University of Texas (UT) MD Anderson Cancer Center|Anne S. Tsao, MD / Associate Professor, Thoracic/Head & Neck Med Oncology|713-792-6363|CR_Study_Registration@mdanderson.org|
22432677|NCT00641108|University of Pennsylvania|Tyrone Quarterman|215-349-5537|tyroneq@upenn.edu|
22432678|NCT01665911|Indiana University School of Dentistry|Frank Lippert|317-274-8822|flippert@iu.edu|
22410699|NCT00720798|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22410700|NCT04126057|SightGlass Vision, Inc.|Joe Rappon, OD, MS, FAAC|678-642-9117|joe@sightglassvision.com|
22410701|NCT02806232|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22410702|NCT00434161|Swedish Orphan Biovitrum AB|Medical Director|+4686972000|clinical@sobi.com|
22410703|NCT03342898|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22410704|NCT03997448|Hoosier Cancer Research Network|Clinical Data Analyst|3179212050|amajumdar@hoosiercancer.org|
22410705|NCT01312779|Edwards Lifesciences, LLC|Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Andrey_Nersesov@edwards.com|0225
22410706|NCT01621490|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22410707|NCT00506753|University of Rhode Island|Dr. Lynda Stein, Ph.D.|401-874-5562|lynda_stein@uri.edu|
22410708|NCT00461500|GlaxoSmithKline|GSK Response Center|866-435-7343||
22410709|NCT00521456|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
22410710|NCT02057952|Regenstried Institute|Daniel O. Clark, PhD|317-274-9292|daniclar@iu.edu|
22410711|NCT01267266|University of Chicago|Walter M. Stadler|773-702-4150|wstadler@medicine.bsd.uchicago.edu|
22410712|NCT02149303|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
22410713|NCT01335477|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22410714|NCT02275923|Medtronic|Jennifer Seamans, Principal Clinical Research Specialist|7635262835|jennifer.l.seamans@medtronic.com|
22410715|NCT03549130|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22410716|NCT01078623|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
22432679|NCT01881009|Stanford University|Bruce Buckingham, M.D.|408-356-0911|buckingham@stanford.edu|
22432680|NCT01151020|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
22432681|NCT00648037|Memorial Sloan Kettering Cancer Center|Papadopoulos, Esperanza, MD (Attending)|+1212-639-8276|papadope@mskcc.org|
22432682|NCT01635998|Icahn School of Medicine at Mount Sinai|Sam Cammack|(212) 824-8931|sam.cammack@mountsinai.org|
22432683|NCT00846846|Medtronic Cardiovascular|Lisa Bousquette, Director Clinical Research Coronary and Renal Denervation||lisa.r.bousquette@medtronic.com|
22432684|NCT04419467|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
22432685|NCT03511001|California State University San Marcos|Dr. Kim Pulvers|760 750 4127|kpulvers@csusm.edu|
22432686|NCT02471313|National Institutes of Health Clinical Center|Dr. Elliot Levy, Staff Clinician, Radiology & Imaging Sciences|301-402-5368|levyeb@cc.nih.gov|
22432687|NCT00600067|Vivus, Inc|Wesley W. Day, PhD|650-934-5200|day@vivus.com|
22432688|NCT03502915|University of North Carolina at Chapel Hill|Kathleen A. Smith, MD|9199665136|ksmith@aims.unc.edu|
22432689|NCT00881894|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22432690|NCT01361217|University of Washington|Nina Isoherranen|206-5432517|ni2@uw.edu|
22432691|NCT03943290|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22432692|NCT02765399|Helsinki University and Helsinki University Hospital|Prof. Marja-Riitta Taskinen|+358-9-47171990|marja-riitta.taskinen@helsinki.fi|
22432693|NCT02103062|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22432694|NCT03958331|Cincinnati Children's Hospital Medical Center|Dr. Avani Modi|513-636-4864|avani.modi@cchmc.org|
22432695|NCT01991483|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22432696|NCT03192137|InSite Vision|Senior Manager, Clinical Sciences|+91 9987096080|manjiri.desai@sparcmail.com|
22432697|NCT01070979|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22432698|NCT00437268|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22432699|NCT01569815|Novartis Pharmaceuticals|Study Director|862-778-8300||
22432700|NCT04417257|Laurent Pharmaceuticals Inc.|Vice president Clinical Development|514-941-2313|jmhoule@laurentpharma.com|
22432701|NCT01939145|MGUH Center for Wound Healing and Hyperbaric Medicine|Paul J. Kim, DPM, Director of Research|202-444-3059|Paul.J.Kim@gunet.georgetown.edu|
22432702|NCT00601367|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com|
22432703|NCT03484429|Central Virginia Veterans Affairs Health Care System|Dr. Denise Lester|804-675-5000|denise.lester@va.gov|
22432704|NCT04466384|Medtronic|Ami Stuart PhD|8017934800|ami.stuart@medtronic.com|
22432705|NCT01328743|Brown University|Christopher Kahler|4018636651|christopher_kahler@brown.edu|
22432706|NCT02751814|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|225.763.2500|amanda.staiano@pbrc.edu|
22432707|NCT01152437|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22432708|NCT02015039|National Institutes of Health|Dr. Mark Hallett|301-496-9526|hallettm@ninds.nih.gov|
22432709|NCT01897532|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22421410|NCT01965756|Massachusetts General Hospital|Dr. Steven E. Arnold MD|617-643-5607|SEARNOLD@mgh.harvard.edu|
22421411|NCT03309943|Duke University School of Medicine|Jason A. Oliver, Ph.D.|(919) 668-0093|Jason.A.Oliver@duke.edu|
22421412|NCT03123393|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22393224|NCT04343287|BRIM Biotechnology, Inc.|Erin Chang, Vice President of Portfolio Management Department|0226598779|erin.chang@brimbiotech.com|119
22393225|NCT03582943|Washington University School of Medicine|Dr. Catherine Lang|314-286-1945|langc@wustl.edu|
22393226|NCT02440659|Arbor Research Collaborative for Health|Francesca Tentori|734-665-4108|christina.pustulka@arborresearch.org|
22393227|NCT01631227|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com|
22393228|NCT01153321|AstraZeneca|Anna Malmgren||ClinicalTrialTransparency@astrazeneca.com|
22393229|NCT03385343|Mayo Clinic|Kevin Buller Clinical Research Coordinator|507-255-4803|Buller.Kevin@mayo.edu|
22393230|NCT01177800|Beijing, China R&D|Senior Therapeutic Area Physician|+86 010 58218358||
22393231|NCT03527550|McLean Hospital|Dr. Andrew Peckham|617-855-2946|adpeckham@mclean.harvard.edu|
22393232|NCT01841931|Maimonides Medical Center|Director of Research, Department of Psychiatry|718-283-7162|tjacob@maimonidesmed.org|
22393233|NCT03398213|Bnai Zion Medical Center|Prof. Elad Schiff|972-506267243|elad.schiff@b-zion.org.il|
22393234|NCT03053518|NYU Langone Health|Mary Sevick, MD|646-501-2621|Mary.Sevick@nyulangone.org|
22393235|NCT02683876|MEBO Research|Maria De la Torre|7862286880|maria.delatorre@meboresearch.org|
22393236|NCT01232738|UKansasMCRI|Yunxia Wang|913-588-6970|ywang@kumc.edu|
22393237|NCT02503852|Kerastem|Eric Daniels, M.D., Chief Medical Officer|858.348.8050|edaniels@puregraft.com|
22393238|NCT03231800|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
22393239|NCT00488475|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22393240|NCT00942305|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
22393241|NCT00400725|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22393242|NCT00252577|VA San Diego Healthcare System|John Kelsoe|858-552-8585|john.kelsoe@va.gov|5704
22393243|NCT00560066|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22393244|NCT01163292|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22393245|NCT02535091|SK Life Science, Inc.|Medical Director|402-835-5977|smisra@sklsi.com|
22393246|NCT00359983|GlaxoSmithKline|GSK Response Center|866-435-7343||
22393247|NCT02643472|Children's National Health System|Dr. Karen Fratantoni|202-476-4793|kfratant@childrensnational.org|
22432710|NCT01352286|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22432711|NCT00000134|Johns Hopkins University|Curtis Meinert, PhD|410-955-8198|cmeinert@jhsph.edu|
22432712|NCT01074931|Abbott|Global Medical Services|1-800-633-9110||
22393248|NCT02818244|Cleveland Clinic|Marc Gillinov MD|216 445-8841|GILLINOM@ccf.org|
22393249|NCT01259089|Northwestern University|Clinical Trials Office|312-695-1301||
22393250|NCT01215188|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22393251|NCT00688870|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22393252|NCT03835351|Cleveland Clinic Foundation|Dr. Michael Rosen|12164453441|rosenm@ccf.org|
22393253|NCT01151410|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
22393254|NCT01253018|VA Maryland Health Care System|Dr. Christopher T. Bever, Jr. MD, MBA|(410) 605-7000|christopher.bever@va.gov|7130
22393255|NCT01593787|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300||
22393256|NCT01717742|Hospital for Sick Children|Dr. Eyal cohen|416-813-7654|eyal.cohen@sickkids.ca|
22393257|NCT01133418|Cincinnati Children's Hospital Medical Center|Dr. Jeff Epstein|5136368296|jeff.epstein@cchmc.org|
22393258|NCT04150068|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22393259|NCT05316701|Orca Biosystems, Inc.|Chief Medical Officer|530-414-9743|info@orcabio.com|
22393260|NCT04679935|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22393261|NCT05820295|Weill Cornell Medicine|Lisa Kern, MD, MPH|646-962-5889|lmk2003@med.cornell.edu|
22393262|NCT02199743|UT Southwestern Medical Center|Debra Bushong, MS, LPC|214-648-4653|debra.bushong@utsouthwestern.edu|
22393263|NCT02158052|Massachusetts General Hospital|Thomas Spitzer, MD|6177241124|tspitzer@mgh.harvard.edu|
22393264|NCT00969709|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|8124
22393265|NCT03695237|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22393266|NCT02516332|Duke University|Patrick Smith, Ph.D.|919-681-3006|patrick.j.smith@duke.edu|
22393267|NCT00055601|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22393268|NCT02217332|Knopp Biosciences|Head of Regulatory|4124881776|greg@knoppbio.com|
22393269|NCT02081443|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3933|dominick.angiolillo@jax.ufl.edu|
22393270|NCT00834626|Kirloskar Hospital|Dr. Neeraj Gupta|+91-40-23296241|drugale@kirloskarhospital.com|
22393271|NCT02295553|The Hospital for Sick Children, Toronto, Ontario, Canada|Dr. Jason Hayes|416-813-7654|jason.hayes@sickkids.ca|208963
22393272|NCT02134977|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22432713|NCT05393245|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22432714|NCT03508674|Levita Magnetics|Vivian Soto|+56958360507|VSoto@Levita.com|
22393273|NCT03828747|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22393274|NCT01658150|Icahn School of Medicine at Mount Sinia|Dr. Katherine Burdick|212-659-8841|katherine.burdick@mssm.edu|
22393275|NCT04187989|University of Michigan|Dr. Erin Bonar|7347647936|erinbona@med.umich.edu|
22432715|NCT03137771|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
22432716|NCT00972023|Barbara Ann Karmanos Cancer Institute|Elaina Gartner|800-527-6266|egartner@seagen.com|
22393276|NCT03646656|Department of Veterans Administration|Dr. Karen Goldstein|919.826.0411|karen.goldstein@va.gov|1707764
22393277|NCT00127205|SWOG Statistics & Data Management Center|SWOG statistician|2066674263|jmiao@fredhutch.org|
22393278|NCT01327495|University of Washington|Stephanie Page, MD, PhD|206-616-0483|page@uw.edu|
22393279|NCT03377699|Novo Nordisk A/S|Clinical Transparency Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22393280|NCT03784001|University of California, Los Angeles|Tanera van Diggelen|4086231219|tvandiggelen@gmail.com|
22393281|NCT02580305|Suven Life Sciences|Ramakrishna Nirogi, PhD|+9140 2319 3956|nvsrk@suven.com|
22393282|NCT00700427|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22393283|NCT05560243|University of Alabama at Birmingham|Isabel Scarinci, Principal Investigator|2059757177|scarinci@uab.edu|
22393284|NCT04587752|Yale University|Dr. Janet Lydecker|2037374299|janet.lydecker@yale.edu|
22393285|NCT05870228|University of Strathclyde|Stephanie McCrory|07538376660|stephanie.mccrory@strath.ac.uk|
22393286|NCT01244529|Johnson & Johnson Vision Care|Kathy Osborn, OD|1-904-443-1032|kosborn@its.jnj.com|
22393287|NCT04560010|NYU Langone|Arthur Hertling, MD|212-263-5072|Arthur.hertling@nyulangone.org|
22393288|NCT01871805|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22393289|NCT00859222|Dana-Farber Cancer Institute|Patrick Y. Wen, MD|617-632-2166|Patrick_Wen@dfci.harvard.edu|
22393290|NCT02006251|Cleveland Clinic|Wael Barsoum|2164444954|barsouw@ccf.org|
22393291|NCT01911390|Department of Environmental and Radiological Health Sciences|Dr Elizabeth Ryan|970-491-1536|E.P.Ryan@colostate.du|
22393292|NCT00941070|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Charles Kunos|330-375-4485|kunosc@summahealth.org|
22393293|NCT03500159|Aquinox Pharmaceuticals (Canada) Inc.|Clinical|604-629-9223|clinical@aqxpharma.com|
22393294|NCT03535597|Memorial Healthcare Systerm|Dr. Jianli Niu|954-265-6653|jniu@mhs.net|
22393295|NCT02111187|Associate professor of oncology and urology|Emmanuel Antonarakis|443-287-0553|eantona1@jhmi.edu|
22393296|NCT04075994|University of Pittsburgh|Dr. Jared Magnani|(412)383-0611|magnanij@pitt.edu|
22393297|NCT01247285|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22393298|NCT01263665|W.L. Gore & Associates|Keli Sapp|9288643964|kesapp@wlgore.com|
22393299|NCT00267085|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes M.D./Professor|713/794-5783|eharriso@mdanderson.org|
22393300|NCT04073446|Boston Scientific|Roshini Jain, Sr. Director Clinical Sciences|16619494350|roshini.jain@bsci.com|
22393301|NCT01480219|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22421413|NCT05245526|Stryker Sustainability Solutions|Monique Ketcher|602-354-0917|monique.ketcher@stryker.com|
22421414|NCT01609296|Medtronic|Kristel Wittebols Clinical Research Director|+31433566580|kristel.wittebols@medtronic.com|
22421415|NCT01155180|Beth Israel Deaconess Medical Center|Dr. Christos Manztoros|617-667-8630|cmantzor@bidmc.harvard.edu|
22421416|NCT02230904|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22421417|NCT03197038|University of Illinois at Chicago|Dr. Ulf Bronas|312-355-5886|bronas@uic.edu|
22421418|NCT02069041|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22421419|NCT01464333|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22421420|NCT00343044|Benaroya Research Institute at Virginia Mason|Thomas Malpass, M.D., Principal Investigator|206-223-6193|thomas.malpass@vmmc.org|
22421421|NCT01511978|Jacobus Pharmaceutical Company, Inc.|Dr. Kathy Aleš, Medical Director|6099217447|kathy.ales@jacobus-pharmaceutical.com|231
22421422|NCT05047211|UTMB Galveston|Dr Antonio Saad Director of PRD|4097721795|antalar@me.com|
22421423|NCT00561392|Novartis Pharmaceuticals|Study Director|862 778-8300||
22421424|NCT03321968|Medicago|Medical Director|+1 418-658-9393|clinicaltrialinquiries@medicago.com|
22421425|NCT03822468|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
22432717|NCT03052608|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22432718|NCT02433496|University of Wisconsin - Madison|Andrew Quanbeck|6082627385|arquanbe@wisc.edu|
22393302|NCT02797080|Horizon Pharma Ireland, Ltd, Dublin, Ireland|Julie Ball, MS, Executive Director, Clinical Development & Operations|(224) 383-3000|clinicaltrials@horizonpharma.com|
22410717|NCT00950183|OrthoCarolina|Dr. Robert B. Anderonson|704-323-2000|robert.anderson@orthocarolina.com|
22410718|NCT02883673|Alydia Health|Kathryn Wine, VP Clinical Operations|415-990-4104|kathryn@alydiahealth.com|
22410719|NCT01809054|Sinai Center for Thrombosis Research|Kevin Bliden|4106014795|kbliden@lifebridgehealth.org|
22410720|NCT03263195|Department of Pediatrics Ribeirão Preto Medical School|Dr. Marisa Mussi-Pinhata|55-16-3602-2807|mmmpinha@fmrp.usp.br|
22410721|NCT00698022|Corcept_Therapeutics|Robert Roe, MD|650-688-8812|rroe@corcept.com|
22410722|NCT00621686|Mayo Clinic|Evanthia Galanis, M.D.|507/284-3559|Galanis.evanthia@mayo.edu|
22410723|NCT00447603|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22410724|NCT01156571|The Medicines Company|Meredith Todd - Sr. Director Program Management|+1.973.290.6088|meredith.todd@themedco.com|
22410725|NCT01797120|PrECOG, LLC|Carolyn Andrews|267-207-4070|candrews@precogllc.org|
22410726|NCT04634110|University of Colorado Hospital|Dr. Chad Rusthoven|720-516-0150|chad.rusthoven@cuanschutz.edu|
22410727|NCT00992264|Group Health Research Institute|Jennifer McClure|206-287-2737|mcclure.j@ghc.org|
22410728|NCT05751629|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22410729|NCT01136226|Chesapeake Urology Research Associates|Heather Thomas, Administrator|443.471.5742|hthomas@cua.md|
22410730|NCT01909466|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22410731|NCT02491788|Stanford University|Dr. Jamie Zeitzer|16504935000|jzeitzer@stanford.edu|
22410732|NCT00772577|Novartis Pharmaceuticals|Study Director|862-778-8300||
22410733|NCT00672620|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22393303|NCT00951015|ViiV Healthcare|GSK Response Center|866-435-7343||
22393304|NCT01416389|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22393305|NCT03992131|pharmaand GmbH|Medical Information Department|+43/1/3560006|medinfo@pharmaand.com|
22393306|NCT00929110|Novartis Pharmaceuticals|Study Director|862 778-8300||
22393307|NCT03794700|University of Colorado Anschutz Medical Campus|Channing Tate, PHD Assistant Professor|3037248985|channing.tate@cuanschutz.edu|
22393308|NCT01258595|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22393309|NCT02310100|Abbott|Lori Rusch, Ph.D.|1-651-756-2668|lori.rusch@abbott.com|
22393310|NCT00673400|Cantonal Hospital St. Gallen, Department of Surgery|Ulrich Beutner PhD|+41 71 494 1111|ulrich.beutner@kssg.ch|
22393311|NCT01680640|University of Southampton|Christopher D Byrne|44 (0)23 8120 8818|cdtb@soton.ac.uk|
22393312|NCT00477659|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22393313|NCT00744757|Medical Affairs, Janssen Taiwan|Medical Director|+886-2-23761255||
22393314|NCT01820585|Bial - Portela & Cª, S.A.|Head of Clinical Research Section|+ 351 22 986 61 00|clinical.trials@bial.com|
22393315|NCT01712659|National Cancer Institute|Kevin C. Conlon|240-858-3570|conlonkc@mail.nih.gov|
22393316|NCT00548262|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22393317|NCT00924118|Johns Hopkins Hospital|Steven P. Schulman, MD|4109557378|sschulma@jhmi.edu|410
22393318|NCT00841555|The Ohio State University Comprehensive Cancer Center|Mario Ammirati, MD|614-293-1970|Mario.Ammirati@osumc.edu|
22393319|NCT01769326|University of California Irvine|Steven Cramer, M.D.|(949) 824-8748|scramer@uci.edu|
22393320|NCT01036438|Molnlycke Health Care AB|Ann Larkö|+46 722 3338|ann.larko@molnlycke.com|
22432719|NCT03460652|KemPharm|Gerald Orehostky|321-250-3699|gorehostky@kempharm.com|
22432720|NCT00548197|Iran university of medical Sciences|Mehdi Modarres|009888602217|mmodarres51@yahoo.com|
22432721|NCT05554146|Montefiore Medical Center|Dr. Deepika Slawek|718-920-3786|dslawek@montefiore.org|
22432722|NCT01139411|Weight Control and Diabetes Research Center|Dr. Elissa Jelalian|(401) 793-9716|elissa_jelalian@brown.edu|
22393321|NCT00888927|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
22393322|NCT03592745|Feinstein Institutes for Medical Research at Northwell Health|Senior Research Coordinator|5165623646|jchang14@northwell.edu|
22421426|NCT02198664|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
22421427|NCT02632409|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22421428|NCT04426006|Institut Bergonié|Pr Simone Mathoulin-Pelissier|0556333333|S.Mathoulin@bordeaux.unicancer.fr|
22421429|NCT06180122|Imperial College Healthcare NHS Trust|Sophie Connolly|02033117322|sophie.connolly1@nhs.net|
22421430|NCT01262872|GlaxoSmithKline|GSK Response Center|866-435-7343||
22421431|NCT04709562|Vapotherm Inc|Kathy Gerich|(585) 469-6753|kgerich@vtherm.com|
22421432|NCT01000155|Brigham&Women's Hospital|Maureen Okam, MD, MPH|617-732-5048|mokam@partners.org|
22421433|NCT03193684|UTHSCSA|Dr. Muhammad Abdul-Ghani|210 567 6691|abdulghani@uthscsa.edu|
22421434|NCT00720213|Sleepcare Diagnostics|Shahrokh Javaheri, MD|513-459-7750|javaheri@snorenomore.com|
22421435|NCT01198470|Globus Medical|Jacqueline Myer|610-930-1800|jmyer@globusmedical.com|1669
22421436|NCT00097448|Massachusetts Eye and Ear Infirmary|Dr. Steven Rauch|617-573-1166|steven_rauch@meei.harvard.edu|
22421437|NCT00620945|Cleveland Clinic|Muhammad A. Mumtaz, MD|216 444 9125|mumtazm@ccf.org|
22421438|NCT01924689|BioMed Valley Discoveries, Inc.|Brent Kreider|816-960-4644|bkreider@biomed-valley.com|
22421439|NCT05271175|Cyprus rTMS|Georgios Mikellides|0035799430330|george.mikellides@gmail.com|
22421440|NCT02492867|University of Michigan Rogel Cancer Center|ClinicalTrials.gov CC Admin|734-936-9499|clinicaltrialsgov_ccadmin@med.umich.edu|
22421441|NCT03296527|Ferring Pharmaceuticals|Global Clinical Compliance|-|DK0-Disclosure@ferring.com|
22421442|NCT01597973|University of Michigan|Jolene Daniel|732 235-7713|jd1557@rwjms.rutgers.edu|
22421443|NCT01326845|Novartis Pharmaceuticals|Study Director|862-778-8300||
22421444|NCT02692859|jiangsuPCDCP|Kai Chu|18915999781|chukai19812007@163.com|
22421445|NCT00867659|Virginia Center for Reproductive Medicine|Dr Fady Sharara|7034377722|fsharara@vcrmed.com|
22421446|NCT03807544|Theranova|Director of Clinical Trials|14159268616|clindquist@theranova.com|
22421447|NCT01662492|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22421448|NCT01591096|SeattleChildrens|Catherine Amlie-Lefond MD|206-987-2078|calefond@seattlechildrens.org|
22421449|NCT03655405|a. Community Pharmacy, Center for Primary Care and Public Health (Unisanté), University of Lausanne, Switzerland|Dr Anne Niquille|+41213144845|anne.niquille@unisante.ch|
22421450|NCT02859337|Oregon Health & Science University|Dr. A Edelman|503-418-2585|edelmana@ohsu.edu|
22421451|NCT00833105|Oregon Health & Science University|Dr. Paul Cordo|503 418 2520|cordop@ohsu.edu|
22421452|NCT02898597|University of Massachusetts Boston|Dr. Sun Kim|617-287-6831|sun.kim@umb.edu|
22421453|NCT01135329|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Yvette Kasamon|410-955-8839|ykasamo1@jhmi.edu|
22421454|NCT05340764|Washington University School of Medicine GI Division|Dr. Chien-Huan Chen|3143623201|chen330@wustl.edu|
22421455|NCT01011816|formerly Spinal Restoration, Inc|Jeff Doerzbacher||jdoerzbacher@renascentmed.com|
22421456|NCT01081769|Janssen-Cilag Germany|EMEA Medical Affairs Director Psychiatry||ClinicalTrialDisclosure@its.jnj.com|
22421457|NCT01681212|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22421458|NCT01464424|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
22421459|NCT01069510|Oregon Health and Science Univ.|Dr. Craig Broberg|503-494-7400|brobergc@ohsu.edu|
22421460|NCT02282813|OPKO Health, Inc.|Douglass Laidlaw, PhD, Vice President, Medical Affairs|305-575-4172|dlaidlaw@opko.com|
22421461|NCT00529308|Yale University|Dr. Angeli Landeros-Weisenberger||angeli.landeros-weisenberger@yale.edu|
22421462|NCT06509438|EspadPharmed|Hamidreza Kafi|+989129232594|Kafi.h@orchidpharmed.com|
22421463|NCT03331796|Veterans Affairs Palo Alto Health Care System|Joy L Taylor, PhD|650-776-3385|joyt@stanford.edu|
22421464|NCT02092298|UT MD Anderson Cancer Center|Brian Badgwell,Professor, Surgical Oncology|713-745-3715|csentonn@mdanderson.org|
22421465|NCT00920439|GlaxoSmithKline|GSK Response Center|866-435-7343||
22421466|NCT01808066|CogCubed|Chief Medical Officer|612-250-9737|monika@cogcubed.com|
22421467|NCT00660517|Meda Pharmaceuticals|David Ginsberg, D.O.|7325642364|david.ginsberg@meda.us|
22421468|NCT02949973|Aurinia Pharmaceuticals|Rashieda Gluck|1 (250) 744-2487|clinicaltrials@auriniapharma.com|
22421469|NCT01420068|Noden Pharma DAC|Ciara Walsh|+ 353 1 9121573|cwalsh@nodenpharma.com|
22421470|NCT01252095|Progen Pharmaceuticals Ltd|Director of Clinical Development|+61 7 32739133||
22421471|NCT00365794|University of Southern California|Fred Sattler, MD|323-409-4635|fsattler@usc.edu|
22421472|NCT00586703|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu|
22421473|NCT04760626|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22421474|NCT02452944|Department of Anesthesiology, Gachon University Gil Hospital|Mi Geum Lee|82-32-460-3637|mikeum2@gilhospital.com|
22421475|NCT00745901|North America Pharmaceutical (Ortho-McNeil Janssen Scientific Affairs, LLC)|Chief Scientific Officer|1-888-526-5060||2915
22421476|NCT03337087|Accru|Dr. Tanios Bekaii-Saab|507/266-0800|Bekaii-Saab.Tanios@mayo.edu|
22421477|NCT02554682|Children's Hospital of Philadelphia|Dr. Carol Ford|267-426-3938|fordc@email.chop.edu|63938
22421478|NCT00758290|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
22421479|NCT00884117|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22421480|NCT01753310|Ipsen Biopharmaceuticals, Inc.|Medical Director||clinical.trials@ipsen.com|
22421481|NCT02946463|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22421482|NCT02022202|Mayo Clinic|Matthew P. Goetz MD and Judy C. Boughey MD|507-284-2511|Goetz.Matthew@mayo.edu|
22421483|NCT03957473|Penumbra, Inc.|Study Manager|+1 415-601-9561|apascua@penumbrainc.com|
22421484|NCT05581641|BioNTech SE|BioNTech clinical trials patient information|61319084|patients@biontech.de|+49
22421485|NCT04390763|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22421486|NCT01786993|St. Jude Medical|Director of Clinical Studies|972-309-8000|ccohorn@sjm.com|8087
22421487|NCT00450437|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@Novartis.com|
22421488|NCT01890122|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22421489|NCT04025879|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22421490|NCT02174510|Shanghai Xuhui Central Hospital, Drug Clinical Trial Institution|Prof.Hu Chaoying|13816319160|cyhu@shxh-centerlab.com|
22421491|NCT01565889|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22421492|NCT00122382|Bristol-Myers Squibb|Study Director||Clinical.Trials@bms.com|
22421493|NCT02040805|University of California, San Francisco|Dr. Kevin L. Delucchi|415-476-4180|kevin.delucchi@ucsf.edu|
22421494|NCT00908544|MUC Research GmbH|Dr. phil. Eva Wolf|+49 (0)89-558703-0|Eva.Wolf@MUCResearch.de|
22421495|NCT01225250|DeNova Research|Steven Dayan, MD|3123352070|sdayan@drdayan.com|
22421496|NCT00071110|University of Pittsburgh|Benoit H. Mulsant, MD|(416) 535-8501|benoit_mulsant@camh.net|3655
22421497|NCT01759602|Johns Hopkins University|Michael Levy, MD, PhD|443-287-4412|mlevy@jhmi.edu|
22421498|NCT03523520|University of Missouri Health Care|Dr. Kara B. Goddard|5738841605|goddardk@health.missouri.edu|
22421499|NCT01845441|University Hospitals Cleveland Medical Center|Dr. Kristine Blackham|216-403-2705|kristine.blackham@gmail.com|
22421500|NCT02188147|ZOLL|Vice President Medical Affairs|412-968-3333|stevens@zoll.com|4400
22421501|NCT03859427|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22421502|NCT03175536|Harvard Medical School and Harvard Pilgrim Health Care Institute|Dr. Alison Galbraith|6178674893|alison_galbraith@harvardpilgrim.org|
22421503|NCT02045264|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22421504|NCT00722137|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22421505|NCT00848718|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22421506|NCT02389829|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|718-920-6266|befriedm@montefiore.org|
22421507|NCT04031846|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22421508|NCT00571727|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22421509|NCT01622673|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22421510|NCT03757312|Nationwide Children's Hospital|Marco Corridore, MD|614-722-4200|Marco.Corridore@nationwidechildrens.org|
22421511|NCT01295671|Boston Children's Hospital|Dr. David Ludwig|617-355-4878|david.ludwig@childrens.harvard.edu|
22421512|NCT01944878|Hallym University College of Medicine, Chuncheon Sacred Heart Hospital|Dr. Chang Seok Bang|+82-33-240-5000|cloudslove@naver.com|
22421513|NCT02395848|McMaster University|Christine Lee|2505191898|clee@mcmaster.ca|
22421514|NCT02276560|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22421515|NCT00616343|Loma Linda University|Dr. David Swope|909-558-4908|Thamilton@llu.edu|
22421516|NCT02366637|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22421517|NCT01317095|Thomas Jefferson University|Hitoshi Hirose, Professor of Surgery|2159556925|Hitoshi.Hirose@jefferson.edu|
22421518|NCT01609010|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22421519|NCT01202578|Acclarent, Inc.|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com|
22421520|NCT01134107|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22421521|NCT02314260|kasr EL alini|Dr Ahmed Kamel|0201120022332|dr.ahmed.m.kamel@gmail.com|
22421522|NCT01644292|University of Manitoba|Ed Giesbrecht|204-977-5630|Ed.Giesbrecht@med.umanitoba.ca|
22421523|NCT03204786|Stanford University|Antonio Hardan, MD|(650)736-1235|autismdd@stanford.edu|
22421524|NCT00695292|Sarah Cannon Research Institute|Dr. David Spigel|615-329-7274|askSARAH@scresearch.net|
22421525|NCT01543178|Salix|David Sorscher|919-862-1827|david.sorscher@salix.com|
22421526|NCT04541589|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
22421527|NCT04376346|Centers for American Indian and Alaska Native Health, University of Colorado Anschutz Medical Campus|Carol Kaufman|303-880-7795|carol.kaufman@cuanschutz.edu|
22421528|NCT03581123|University of Washington|Eric Meier, Study Biostatistician|206-450-0020|emeier11@uw.edu|
22421529|NCT04195685|VA Pacific Islands Healthcare System|Dr. Judy Carlson|808-433-6677|judy.carlson@va.gov|
22421530|NCT01323517|Memorial Sloan Kettering Cancer Center|Dr. Charlotte Ariyan, MD|212-639-6280|ariyanc@mskcc.org|
22421531|NCT00300235|Rho Federal Systems Division|Karen Kesler, PhD|919-408-8000|karen_kesler@rhoworld.com|244
22421532|NCT00455403|Wash. Univ. School of Medicine|Janet McGill, MD|314-362-8681|jmcgill@wustl.edu|
22421533|NCT04509076|San Diego State University|D. Keith Horvath, Professor of Psychology|619-594-3346|khorvath@sdsu.edu|
22421534|NCT04557215|Cedars-Sinai Medical Center|Mohamad Rashid|310.423.7302|mastprogram@cshs.org|
22421535|NCT00558701|USAISR|Leopoldo C. Cancio, COL, MC|210-916-3301|leopoldo.c.cancio.mil@mail.mil|
22421536|NCT00427648|NorthShore Health|Frank F. Tu|8475702521|ftu@northshore.org|
22421537|NCT01532518|Menarini Ricerche|Dr. Angela Capriati|+39 05556809990|acapriati@menarini-ricerche.it|
22421538|NCT04577807|Istari Oncology|Head of Operations|919-245-7662|info@istarioncology.com|
22432723|NCT03073525|Gradalis, Inc|Clinical and Regulatory Operations|214-442-8100|info@gradalisinc.com|
22432724|NCT01976299|Osprey Medical, Inc|Michele Shepard, Vice President of Clinical Affairs|9529558236|mshepard@ospreymed.com|
22432725|NCT00672594|Duke University|Dr. Daniel George|919-668-4615|daniel.george@duke.edu|
22432726|NCT00856323|Friends Research Institute, Inc.|Dr. Cathy Reback|323-463-1601|reback@friendsresearch.org|
22432727|NCT01639469|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov|
22432728|NCT01119443|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22432729|NCT00913510|Wellspect HealthCare|Dikran Shamoun|+46313764000||
22432730|NCT02329743|Auven Therapeutics|S Weiss|201 486-0396|sid.weiss@auventx.com|
22432731|NCT05160363|Medicines for Malaria|Senior Director, Program Leadership and Strategy|+41 22 555 03 26|borghinii@mmv.org|
22432732|NCT02462187|Novan, Inc.|Cathy White, Vice President, Drug Development Operations|919-485-8080|clinical@novan.com|
22432733|NCT00347932|Bausch & Lomb Incorporated|Timothy Comstock|(585) 338-6631|timothy.comstock@bausch.com|
22432734|NCT01484496|GlaxoSmithKline|GSK Response Center|866-435-7343||
22432735|NCT01645735|Cerexa, Inc|Medical Monitor|(510) 285-9200||
22432736|NCT00344175|Kowa Research Institute|Bill Arana|919 433-1600|barana@kowaus.com|
22432737|NCT01553292|University of Manitoba|Dr Yahya Al Ethawi|0012049634721|yalethawi@hsc.mb.ca|
22432738|NCT01718522|Kinder- und Jugendkrankenhaus Auf der Bult|Prof. Dr. Thomas Danne|0511-8115-3331|danne@hka.de|
22432739|NCT04860869|University of Texas Medical Branch|Randall Urban|409-772-5476|rurban@utmb.edu|
22432740|NCT01775553|Icahn School of Medicine at Mount Sinai|Dr. Ajai Chari|212-241-7873|ajai.chari@mountsinai.org|
22432741|NCT00705874|Progen Pharmaceuticals Pty Ltd|Director of Clinical Trials|+61 7 32739133|darrynb@progen-pharma.com|
22432742|NCT01859013|University of Minnesota|Claudia Fox|612-626-6616|lusc0001@umn.edu|
22432743|NCT01492088|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22432744|NCT00590967|Washington University School of Medicine|Perry Grigsby, M.D.|314-362-8502|grigsby@radonc.wustl.edu|
22432745|NCT01881789|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22432746|NCT00920556|GlaxoSmithKline|GSK Response Center|866-435-7343||
22432747|NCT01299389|Janssen Pharmaceutical K.K|Medical director|+81-3-4411-5509||
22432748|NCT02834819|Children's Hospital Colorado/University of Colorado|Cortney Braund, MD|4406696880|Cortney.Braund@childrenscolorado.org|
22432749|NCT03637491|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22432750|NCT00889707|Sophiris Bio Corp (formerly Protox Therapeutics)|Chief Medical Officer|858-255-4711|richard@sophiris.com|
22432751|NCT02185534|AstraZeneca|Brilinta Global Clinical Leader|+46 31 776 1000|ClinicalTrialTransparency@astrazeneca.com|
22432752|NCT02694601|Université de Sherbrooke|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
22432753|NCT00149799|Rhode Island Hospital|Katharine A. Phillips, MD|401-444-1646|katharine_phillips@brown.edu|
22432754|NCT02246010|American University of Beirut|Dr. Mona Nabulsi|9611350000|mn04@aub.edu.lb|5523
22432755|NCT01176877|Northwestern University, Feinberg School of Medicine, Department of Dermatology|Dr. Steven Nwe, Clinical Research Fellow|312-695-4625|steven.nwe@northwestern.edu|
22432756|NCT02153489|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
22432757|NCT02737501|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22432758|NCT02012218|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22432759|NCT04819113|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22432760|NCT00786422|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22432761|NCT00553410|International Breast Cancer Study Group (IBCSG)|Meredith M. Regan|+1 617 632 3012|mregan@jimmy.harvard.edu|
22432762|NCT01085214|Massey Cancer Center, Virginia Commonwealth University|Steven Grant, M.D.|804-828-5211|stgrant@vcu.edu|
22432763|NCT01482715|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
22432764|NCT01985022|Emory University|Nathan Call, PhD|404-785-9400|nathan.call@choa.org|
22432765|NCT05599100|University of Washington School of Public Health, Department of Health Systems and Population Health|Magaly Ramirez, PhD, MS, MS|206-543-9773|maggiera@uw.edu|
22432766|NCT02043145|Allergan, Inc|Vice President GSE,|714-246-4500|clinicaltrials@allergan.com|
22432767|NCT03761056|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
22432768|NCT00996658|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22432769|NCT02161536|Motus GI Medical Technologies Ltd.|Ravit Peled -Director of Clinical Trial|+972 526145354|ravit@motusgi.com|
22432770|NCT04566731|Clinical Research Coordinator|Daniela Sacchetti, MS|215-573-4336|danielas@pennmedicine.upenn.edu|
22432771|NCT04267926|Department of Veterans Affairs MS Center of Excellence-West and Portland, Oregon Health & Science University|Vijayshree Yadav MBBS, MCR|503-494-3813|yadavv@ohsu.edu|
22432772|NCT00532129|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22432773|NCT01396187|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22432774|NCT00551031|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22432775|NCT01273038|Coloplast A/S|Director of Medical Affairs|4549111111|dkbir@coloplast.com|
22432776|NCT00413660|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22393323|NCT00293059|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22393324|NCT03568643|UCSF FI Proctor Foundation|Dr Catherine Oldenburg|(415) 502-8843|catherine.oldenburg@ucsf.edu|
22432777|NCT01791517|Johnson & Johnson Vision Care, Inc.|Chantal Coles-Brennan, PRINCIPAL RESEARCH OPTOMETRIST, Global Med Affairs|904-443-3500|CColesb@ITS.JNJ.com|3449
22393325|NCT03621787|co-PI|Kathleen Sienko|734647249|sienko@umich.edu|
22432778|NCT00589797|Aesculap Inc.|Associate Director of Medical and Scientific Affairs|800-258-1946|mikhail.chkolnik@aesculap.com|5173
22432779|NCT00353301|University of Colorado, Denver|Dr. Thomas Flaig|(720) 848-0655|Thomas.Flaig@ucdenver.edu|
22432780|NCT02141672|Aurinia Pharmaceuticals|Rashieda Gluck|1 (250) 744-2487|clinicaltrials@auriniapharma.com|
22432781|NCT02688192|Rutgers Cancer Inst. of NJ|Dr. Katie Devine|7322357549|katie.devine@rutgers.edu|
22432782|NCT03012191|University of Southern California Department of Dermatology|Dr. David Woodley|(323)442-0084|dwoodley@med.usc.edu|
22432783|NCT02817594|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22432784|NCT02010593|International Partnership for Microbicides|Dr John Steytler||jsteytler@ipmglobal.org|
22432785|NCT01773967|Cincinnati Children's Hospital Medical Center|Dr. David Schnadower|5138035526|david.schnadower@cchmc.org|
22432786|NCT01135459|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22432787|NCT01803880|Smith & Nephew, Inc|Stephan Mangin, Director, Global Clinical Strategy|M +1 (512) 913-8192|stephan.mangin@smith-nephew.com|
22393326|NCT04362189|Hope Biosciences Stem Cell Research Foundation|Ridhima Vij, PhD|346-900-0340|ridhima@hopebio.org|102
22393327|NCT02111681|Memorial Sloan Kettering Cancer Center|Dr. Daphna Gelblum, MD|914-367-7273|gelblumd@mskcc.org|
22393328|NCT03981861|ChildrensMHC|Tania Burgert|203 676 4545|tsburgert@cmh.edu|
22393329|NCT05116540|Hope Biosciences Research Foundation|Maureen Gerwin|(346) 900-0340|maureen@hopebio.org|
22393330|NCT00452426|Ethicon Endo-Surgery|James Martin, PhD|513 337-7000||
22393331|NCT04058366|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22393332|NCT03918499|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22393333|NCT00682851|Magee-Womens Research Institute|Lorna Rabe|412-641-6042|lrabe@mwri.magee.edu|
22393334|NCT02914275|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
22393335|NCT00923260|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran|Dr. Miguel F Herrera|(+52) 55 54870208|miguelfherrera@gmail.com|
22393336|NCT00661479|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22393337|NCT01546636|NorthShore University HealthSystem|Glenn Murphy, MD, Director of Clinical Research|847-570-2760|gmurphy@northshore.org|
22393338|NCT02738203|Stanford University, Department of OB/GYN|Research Manager|6507211562|familyplanningresearch@stanford.edu|
22393339|NCT05087979|Virginia Commonwealth University|Vishal Yajnik, MD, MS|804-663-3519|vishal.yajnik@vcuhealth.org|
22393340|NCT01135537|Sickkids|Dr Tal Schechter-Finkelstein|4168136906|tal.schechter-finkelstein@sickkids.ca|
22393341|NCT03507777|Abbott Vascular|Jana Buccola, Director Clinical Programs|+1-408-845-1049|jana.buccola@abbott.com|
22393342|NCT00446043|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22393343|NCT02483000|Fred Hutchinson Cancer Research Center|Dr. Ajay Gopal|206-606-2037|agopal@uw.edu|
22393344|NCT02796625|University of Maryland Baltimore|Dr. David Seminowicz|14107063476|dseminowicz@umaryland.edu|
22393345|NCT00355199|Ospedale Papa Giovanni XXIII, Bergamo|Alessandro Rambaldi|0352673684|arambaldi@asst-pg23.it|+39
22393346|NCT02071290|St. Michael's Hospital|Dr. Ori Rotstein|416-864-6060|rotsteino@smh.ca|5304
22393347|NCT03535506|Georgetown University|Nicole Swanson|2026879194|ns1209@georgetown.edu|
22393348|NCT05126563|Hope Biosciences Research Foundation|Ridhima Vij, PhD|346-900-0340|ridhima@hopebio.org|102
22393349|NCT06612255|Melinta Therapeutics, LLC|Medical Information|1-844-633-6568|medinfo@melinta.com|
22393350|NCT04245228|Mayo Clinic|Dr. Cassie Kennedy, PI|1-507-284-2511|kennedy.cassie@mayo.edu|
22393351|NCT00964886|VA San Diego Healthcare System|Joseph H. Atkinson MD|858 552 8585|joseph.atkinson@va.gov|2568
22393352|NCT02758847|University of Pittsburgh|Dr Rabih Chaer|4128023333|chaerra@upmc.edu|
22393353|NCT03484273|University of Calgary|Dr. Satish R. Raj|403-210-6152|satish.raj@ucalgary.ca|
22393354|NCT00468104|Midwest Pulmonary and critical care|George Thommi|402 206 7372|tommi4@cox.et|
22393355|NCT00294515|Hoffmann-La Roche|Medical Communications|800-821-8590||
22432788|NCT03703232|University of Washington|Murray Maitland PT, PhD, Associate Professor|425-286-5278|mmaitlan@uw.edu|
22432789|NCT01816776|Respicardia, Inc.|Linda Nelson, VP Clinical Affairs|952-540-4479|lnelson@respicardia.com|
22432790|NCT03885154|University of Kentucky|Kimberly Jones, MD|859-218-5011|kimberly.jones@uky.edu|
22432791|NCT03889028|Clinical University Hospital of Valencia|David Navarro|+34961973500|david.navarro@uv.es|
22432792|NCT00579553|University of Oklahoma Health Science Center|Andrew Elimian, MD|19146465194|aelimian@aol.com|
22432793|NCT04345900|BeyondSpring Pharmaceuticals|Ramon Mohanlal|6468491102|rmohanlal@beyondspringpharma.com|
22432794|NCT02651116|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22432795|NCT02803203|Memorial Sloan Kettering Cancer Center|Dr. Helena Yu, MD|646-608-3912|YuH@mskcc.org|
22432796|NCT01887717|BTG International Inc.|Manager of Clinical Development|613-801-1844|TheraSphereClinical@btgplc.com|
22432797|NCT02592421|University of Texas Health San Antonio|Ralph DeFronzo|210-567-6691|defronzo@uthscsa.edu|
22432798|NCT00598819|University of California, Irvine Medical Center|Dr. Jeffrey C. Milliken|714-456-3634|jcmillik@uci.edu|
22432799|NCT02251496|University of Iceland|Dr. Áróra Rós Ingadóttir|8461601|aroraros@landspitali.is|
22432800|NCT02041299|Chiesi Canada Corp.|Fernando Tricta, MD|1-416-558-6342|ftricta@chiesi.com|
22432801|NCT02389465|University of Pennsylvania|Dr. Yvette Sheline, McLure Professor of Radiology, Neurology and Psychiatry|(215) 573-0082|sheline@pennmedicine.upenn.edu|
22432802|NCT01925768|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22432803|NCT01224236|University of Texas Health Science Center - Houston|Kathleen Kennedy|+1 (713) 500-5651|Kathleen.A.Kennedy@uth.tmc.edu|
22432804|NCT00943631|Center for Vaccine Development, University of Maryland|Karen Kotloff, MD|401-706-5328|kkotloff@medicine.umaryland.edu|
22432805|NCT00530634|City of Hope|Jeff Longmate, Ph.D.|626-256-4673|jlongmat@coh.org|62478
22393356|NCT00324675|"University Hospital Carl Gustav Carus, Dresden"|Dr. Frank Pistrosch|0049 351 4400580|frank.pistrosch@uniklinikum-dresden.de|
22393357|NCT04928287|Hope Biosciences Research Foundation|Ridhima Vij, PhD|346-900-0340|ridhima@hopebio.org|102
22393358|NCT01941719|TUSPM|Dr. Jinsup Song|2157775872|jsong@temple.edu|
22393359|NCT00381615|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22393360|NCT01670760|3M|Terri White|651-733-0228|twhite3@mmm.com|
22393361|NCT01167452|Texas Tech University Health Sciences Center|Ronald Hall, PharmD, MSCS|214-358-9009|ronald.hall@ttuhsc.edu|
22393362|NCT03819634|Stanford|Bruce Buckingham|6508040476|buckingham@stanford.edu|
22393363|NCT00958841|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22393364|NCT02402153|UNEEG medical A/S|Clinical Manager|+45 41414244|lybl@UNEEG.com|
22393365|NCT01125514|Novartis Pharmaceuticals|Study Director|862-778-8300||
22393366|NCT00858364|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22393367|NCT00632489|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22393368|NCT01655693|ONXEO|Olivier De Beaumont; Chief Medical Officer|+33 (0) 1 45 58 95 33|o.debeaumont@onxeo.com|
22393369|NCT00357331|Weill Medical College|Assistant Professor of Medicine|212-746-1670|sinhana@med.cornell.edu|
22393370|NCT02120287|UPMC Hillman Cancer Center|Barbara Stadterman|412-647-5554|stadtermanbm@upmc.edu|
22393371|NCT01012414|Thomas Jefferson University|David Whellan MD|215 955 5050|david.whellan@jefferson.edu|
22393372|NCT02601300|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22393373|NCT02571153|Pontificia UCSP|Eduardo Toshiyuki Moro||eduardo_moro@terra.com.br|
22421539|NCT03591874|Ocugen|Vijay Tammara, VP, Strategic Regulatory Operations|484-328-4751|Vijay.tammara@ocugen.com|
22421540|NCT02259010|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22421541|NCT03194542|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22421542|NCT02976129|VHsquared|Chief Medical Officer|+44 (0)1223 837650|info@vhsquared.com|
22421543|NCT02640664|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22421544|NCT05514873|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22421545|NCT01267019|VA Greater Los Angeles, VISN 22 MIRECC|Michael F. Green, PhD|(310) 268-3376|mgreen@ucla.edu|
22421546|NCT02729025|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22421547|NCT01276860|Arkansas Children's Hospital|Clinical Research Coordinator|501-364-2018|boswelljl@archildrens.org|
22421548|NCT05009602|Imperial College London|Laura Burgess|0203 311 5208|l.burgess@imperial.ac.uk|
22421549|NCT03525678|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22421550|NCT05096403|Swedish Orphan Biovitrum AB|Luis López Lazaro|46733319155|luis.lopezlazaro@sobi.com|
22421551|NCT03208166|Medical University of South Carolina|Marc Chimowitz, MD|843-792-3020|mchimow@musc.edu|
22421552|NCT05343000|Mayo Clinic|Roberto Benzo, M.D.|480-301-8244|benzo.roberto@mayo.edu|
22421553|NCT04432831|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22421554|NCT03782792|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22421555|NCT00617890|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22421556|NCT02527746|Evivebiotech|Catrina Wang / Senior Medical Director|021-61760866|catrina.wang@evivebiotech.com|
22421557|NCT00154284|Novartis Pharmaceuticals|Study Director|862-778-8300||
22432806|NCT00087698|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22410734|NCT02965820|Alcon, A Novartis Division|Head, CDMA Vision Care Franchise|1-888-451-3937|alcon.medinfo@alcon.com|
22410735|NCT00815490|Duke University Medical Center|Dr David MacLeod|919-812-3201|david.macleod@duke.edu|
22432807|NCT00362882|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22410736|NCT03051256|Relmada Therapeutics|Chief Medical Officer|646-876-3459|info@relmada.com|
22432808|NCT02073162|The Cleveland Clinic Foundation|Dr. Daniel Sessler|216-444-4900|ds@or.org|
22410737|NCT04272775|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22410738|NCT01578707|Pharmacyclics, LLC|Anita Szoke|(669) 215-7235|aszoke@pcyc.com|
22410739|NCT03534986|International Biophysics Corporation|VP of Engineering and Quality|512-814-0046|quailty@biophysicscorp.com|
22410740|NCT02063698|Mayo Clinic|Aminah Jatoi, MD|(507) 284-7202|Jatoi.Aminah@mayo.edu|
22432809|NCT04179305|Weill Cornell Medicine|Sophia Kakarala|(646) 962-5650|sok4004@med.cornell.edu|
22432810|NCT00361972|university of utah|kathryn peterson|8015817804|kathryn.peterson@hsc.utah.edu|
22432811|NCT01737762|Smith and Nephew|Dr Innes Cargill|817-302-3913|innes.cargill@smith-nephew.com|
22410741|NCT01092702|Mayo Clinic|J Taylor Hays. MD|507-266-1944|nicotineresearch@mayo.edu|
22410742|NCT00449930|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22410743|NCT01068873|Lewis Katz School of Medicine at Temple University|Lisa Landsberg|12157077303|lisa.landsberg@temple.edu|
22432812|NCT00326599|Roswell Park Cancer Institute|Alex A. Adjei, M.D., Ph.D.|716-845-4101|alex.adjei@roswellpark.org|
22410744|NCT00575328|Depression Clinical and Research Program, Massachusetts General Hospital|Dr. David Mischoulon, Director|617-724-5198|dmischoulon@partners.org|
22410745|NCT02124746|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22432813|NCT03542266|Weill Cornell Medical College|Jia Ruan, MD, PhD|646-962-2064|jruan@med.cornell.edu|
22432814|NCT00625586|MacroGenics, Inc.|Chief Medical Officer|301-251-5172|info@macrogenics.com|
22410746|NCT01722266|University at Buffalo|Nitesh D Kuhadiya,MD,MPH ;Co-Investigator;Assistant Professor of Medicine, Section of Endocrinology|716-626-7998|niteshku@buffalo.edu|
22410747|NCT04322968|VA Ann Arbor Healthcare System|Dr. Alisher Dadabayev, Pain POC|734-222-7639|Alisher.Dadabayev@VA.GOV|
22410748|NCT00124449|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22410749|NCT03811249|Refocus Group, Inc.|Linda Stewart, Director of Regulatory and Quality|214-368-0200|lstewart@refocus-group.com|431
22432815|NCT02272946|University of California, San Francisco|Priscilla Hsue, MD|628-206-5801|Priscilla.hsue@ucsf.edu|
22432816|NCT01591408|NavalMCSD|Julie Onton|619-553-6228|julie.a.onton.ctr@mail.mil|
22410750|NCT01712230|University of Colorado Anschutz Medical Campus|Wendy Kohrt, PhD|303-724-1913|Wendy.Kohrt@CUAnschutz.edu|
22432817|NCT00873821|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22432818|NCT04721158|Johns Hopkins Medicine|Dr. Risa Wolf|410-955-6463|rwolf@jhu.edu|
22432819|NCT00405288|The Hospital for Sick Children|Dr. Gideon Koren||gkoren@sickkids.ca|
22432820|NCT00142792|MetroHealth Medical Center|Richard WIlson, MD|216-957-3559|rwilson@metrohealth.org|
22410751|NCT01504867|Mayo Clinic|Dr. Daryl J. Kor|507-284-7678|Kor.Daryl@mayo.edu|
22410752|NCT01785186|Tropical Institute of the Ludwig-Maximilians University in Munich, Germany|Dr. Norbert Heinrich|0049 89 2180 17605|heinrich@lrz.uni-muenchen.de|
22410753|NCT03124381|Johnson & Johnson Consumer Inc.|Ali Fassih, Ph.D.|908-904-3259|Afassih@its.jnj.com|
22410754|NCT02163811|VA Puget Sound Health Care System|Dr. Aaron Turner|(206) 277-6134|Aaron.Turner@va.gov|
22410755|NCT02473510|MedImmune, LLC|Ashwin Swami, MD|+1 301 398 5000|information.center@astrazeneca.com|
22410756|NCT00990093|Coloplast|Kristine Gjødsbøl, PhD|+4549113557|dkkg@coloplast.com|
22432821|NCT05110781|University of California, Davis|Principal Investigator|916-734-2790|abewley@UCDAVIS.EDU|
22432822|NCT00833027|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22432823|NCT00444925|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22393374|NCT02935660|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
22393375|NCT00291642|UCB S.A.|UCB|+1844 599|UCBCares@ucb.com|2273
22393376|NCT00684723|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22393377|NCT00939159|UT MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Associate Professor|713-792-7305|eharriso@mdanderson.org|
22393378|NCT02544451|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22393379|NCT02338973|National Institutes of Health|Wadih Zein, MD, Principal Investigator, NEI|301-496-8118|zeinw@nei.nih.gov|
22393380|NCT01472549|Washington University|Methodius Tuuli|6785582874|methodiustuuli@yahoo.com|
22393381|NCT03001076|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
22393382|NCT02327351|National Research Center for Pediatric Hematology , Moscow, Russian Federation|Balashov Dmitriy, head of HSCT department|84956647078|Dmitriy.Balashov@fccho-moscow.ru|6534
22393383|NCT04602221|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
22393384|NCT02576587|Cleveland Clinic|Dr. Reena Mehra|216-444-4946|mehrar@ccf.org|
22393385|NCT00844532|Abbott Vascular|David R Rutledge|408-845-3820|david.rutledge@av.abbott.com|
22393386|NCT01080716|Vaccine Trial Treatment Center, Mahidol University|Punnee Pitisutithum, MBBS, DTM&H, FRCPT|66-2-643-5599|tmppt@mahidol.ac.th|
22393387|NCT01056718|Mercy Hospital East Communities|Denise Janosik, MD|314-251-3920|Denise.Janosik@mercy.net|
22393388|NCT03590366|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
22393389|NCT00738894|W. L. Gore & Associates|Bryan Randall|928-864-4832|BRandall@WLGore.com|
22393390|NCT05017103|M D Anderson Cancer Center|Neeta Somaiah, MD|713-792-3626|nsomaiah@mdanderson.org|
22393391|NCT02656329|GE Healthcare|Francois Tranquart, M.D., Ph.D.|0-44-1494-543037|francois.tranquart@ge.com|
22393392|NCT03699826|University of Iowa|Aaron Boes|319-353-8587|aaron-boes@uiowa.edu|
22410757|NCT04929522|AinShams University|Director of Clinical Trials in Endodontics|+2022639083|endohashem@gmail.com|
22410758|NCT00378482|AstraZeneca Clinical Study Information Center|Global Clinical Lead|8772409479|information.center@astrazeneca.com|
22410759|NCT03185949|Endobar Solutions LLC|Director, Clinical Affairs|8456800424|nodar@endobarsolutions.com|
22410760|NCT02926053|National Center of Cancer Immune Therapy, Department of Oncology|Troels Holz Borch, MD, PhD, principal investigator|004524460492|troels.holz.borch@regionh.dk|
22410761|NCT00500656|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22410762|NCT02322242|Sunnybrook Health Sciences Centre|Dr. Stephen Choi|4164804864|stephen.choi@sunnybrook.ca|
22410763|NCT02482805|University of Texas at Austin|Michelle Davis|214-470-1371|michelledavis@utexas.edu|
22410764|NCT01806597|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22410765|NCT01144663|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22410766|NCT05569148|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22410767|NCT03081767|Stanford University|Andrei Iagaru|6507254711|aiagaru@stanford.edu|
22410768|NCT04160078|Emory University|Dayna Johnson, PhD, MPH, MSW, MS|404-727-8708|dayna.johnson@emory.edu|
22410769|NCT01473758|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22410770|NCT02763579|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22410771|NCT00936377|University of Colorado|Robert MacLaren|303 724-2622|rob.maclaren@ucdenver.edu|
22410772|NCT01003886|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22410773|NCT00909727|Vertex|Medical Monitor|617-444-6777|medicalinfo@vrtx.com|
22410774|NCT00287287|University of Kentucky|Kenneth Ain|8593236652|kenneth.ain@uky.edu|
22410775|NCT00671671|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22410776|NCT01567306|Roxall Medicina España S.A.|Dr. M Cruz Gómez project manager of Roxall Medicina España S.A.|+34 944438000|maricruz.gomez@roxall.es|
22410777|NCT01684566|Camurus AB|Håkan Olsson DDS, PhD|+46 46 2863852|Hakan.Olsson@camurus.com|
22410778|NCT00829413|Bracco Diagnostics Inc.|Maria Luigia Storto, MD Executive Director X-Ray and Ultrasound Medical Affairs|(609) 514-2200|MariaLuigia.Storto@diag.bracco.com|
22410779|NCT00294723|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22410780|NCT02145403|University of Michigan Rogel Cancer Center|Attaphol Pawarode, M.D.|734-936-8785|pawarode@med.umich.edu|
22410781|NCT00891774|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Sr. Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
22410782|NCT02578732|Brown University Oncology Research Group|Howard Safran, MD|401-863-300|BrUOG@BROWN.EDU|
22410783|NCT02619799|Rangaraya medical college|Dr.Paleti Sophia|9948599758 ,08842343023|dr.sophia29@gmail.com|
22410784|NCT02662608|The University of Texas (UT) MD Anderson Cancer Center|Dr. Renata Ferrarotto, Asst Professor/Thoracic/Head & Neck Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
22410785|NCT03255031|National Institute on Alcohol Abuse and Alcoholism (NIAAA)|Dr. Gene-Jack Wang|301-496-5012|gene-jack.wang@nih.gov|
22410786|NCT01809314|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22410787|NCT01042496|Mayo Clinic|Dr. Mark A. Frye|507-284-6213|MFrye@mayo.edu|
22410788|NCT00863057|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22410789|NCT02539563|Wake Forest School of Medicine|Lynnette Harris, BSN|336-716-6049|lcharris@wakehealth.edu|
22410790|NCT02296606|The University of Texas Southwestern Medical Center|DaiWai Olson|214-648-8946|Daiwai.Olson@UTSouthwestern.edu|
22410791|NCT02087046|Abbott|Clinical Research Scientist|972-309-8000|mike.frassica@abbott.com|
22410792|NCT02444533|Mayo Clinic|Dr. Daniel Price|507-293-4395|Price.Daniel@mayo.edu|
22410793|NCT00198081|Indiana University|Christian M. Schmidt, MD|317-278-8349|maxschmi@iupui.edu|
22410794|NCT02974114|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22393393|NCT01081665|Abbott|Global Medical Services|1-800-633-9110||
22393394|NCT01630694|University of Rochester|Jacek Wojtczak|585-273-2972|jacek_wojtczak@urmc.rochester.edu|
22393395|NCT03796962|Xenon Pharmaceuticals Inc.|Medical Affairs|+1-604-484-3300|medicalaffairs@xenon-pharma.com|
22393396|NCT00719329|Johns Hopkins Bloomberg School of Public Health|Dr. Luke Mullany|410-502-2626|lmullany@jhsph.edu|
22421558|NCT03417557|CooperVision|Myhanh Nguyen, Sr. Optometrist|19257306716|MNguyen@coopervision.com|
22421559|NCT04506463|Sun Pharmaceutical Industries Limited|Head-Clinical Development|2266455645|Clinical.Trial@sunpharma.com|5689
22421560|NCT02058537|Temple University Hospital|Ron Schey|215-540-0120|Ron.schey@tuhs.temple.edu|
22421561|NCT04229095|The Scripps Research Institute|Dr. Barbara J. Mason, Ph.D. Professor|(858 784-7324|mason@scripps.edu|
22421562|NCT01780038|University of Nebraska Medical Center|Julia F Houfek|402-660-4046|jhoufek@unmc.edu|
22421563|NCT01085630|HealthPartners Cancer Care Center|Arkadiusz Z. Dudek M.D., Ph.D.|651 254-3321|Arkadiusz.Z.Dudek@HealthPartners.Com|
22421564|NCT01237041|NICHD, National Institutes of Health|Dr. Jack Yanovski|13014960858|yanovskj@mail.nih.gov|
22421565|NCT02609607|University of Pittsburgh Medical Center|Dr. David Levinthal|14123030525|levinthald@upmc.edu|
22421566|NCT01033032|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22421567|NCT03691207|Ayala Pharmaceuticals|Chief Medical Officer|+1-857-444-0553|info@ayalapharma.com|
22421568|NCT00651261|Dana Farber Cancer Institute|Richard Stone, MD||rstone@partners.org|
22421569|NCT02027545|VA Ann Arbor Healthcare System|Sameer D. Saini, MD, MS|734-845-5865|sameer.saini@va.gov; sdsaini@med.umich.edu|
22421570|NCT03351608|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22421571|NCT02877004|Mayo Clinic|Dr. Ivana Croghan|507-266-1944|nicotineresearch@mayo.edu|
22421572|NCT02727478|Karolinska Instituet|Dr Breiffni Leavy|+46852488814|breiffni.leavy@ki.se|
22421573|NCT02633293|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
22421574|NCT01343043|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22421575|NCT02017210|Garvan Institute of Medical Research|Dr. Dorit Samocha-Bonet|+61292958309|d.samochabonet@garvan.org.au|
22421576|NCT00216125|Hoosier Cancer Research Network|Georgia Gould|3176385842|ggould@hoosiercancer.org|10
22421577|NCT04029584|University of California, San Francisco|Leslie Benet, PhD|(415) 476-3853|leslie.benet@ucsf.edu|
22421578|NCT00502242|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22421579|NCT00778817|The University of Chicago|Walter M. Stadler, MD|(773) 702-6149|wstadler@medicine.bsd.uchicago.edu|
22421580|NCT02509507|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22421581|NCT02356588|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
22421582|NCT01418378|DePuy Synthes|Dave Whalen|574-372-7028|dwhalen@its.jnj.com|
22421583|NCT01987089|Crescenz VA Medical Center|Subhajit Chakravorty|(215)-823-5800|Subhajit.Chakravorty@va.gov|
22421584|NCT04742400|National Institutes of Health|Daniel Reich, MD|301-496-1801|reichds@ninds.nih.gov|
22421585|NCT01812109|University of Texas Southwestern Medical Center|Dr. Linda Baker|214/456-2480|Linda.baker@childrens.com|
22421586|NCT00442897|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22421587|NCT03448419|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22421588|NCT02348918|Allegro Ophthalmics, LLC|Director of Clinical Research|949-940-8130|info@allegroeye.com|
22421589|NCT00245128|OHSU Knight Cancer Institute|Dr. Michael Mauro|503-494-1080|maurom@ohsu.edu|
22421590|NCT04548193|Roswell Park Comprehensive Cancer Center|Katy Wang|716-845-2300|Chong.Wang@roswellpark.org|
22421591|NCT00630825|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22421592|NCT04610346|Jefferson Moss Rehabilitation Research Institute|Sharon Antonucci, Ph.D CCC-SLP, C-AAIS|215-663-6561|sharon.antonucci@jefferson.edu|
22421593|NCT00931255|UMaryland|Abdolreza Haririan, MD|410-328-5720|ahariria@medicine.umaryland.edu|
22421594|NCT05028790|University of Houston|David A Berntsen, OD PhD|713-743-5836|dberntsen@uh.edu|
22421595|NCT02019264|Eisai Ltd|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22421596|NCT02187198|Yale University School of Medicine, Department of Psychiatry|Elizabeth Ralevski, PhD|203-932-5711|elizabeth.ralevski@yale.edu|4282
22421597|NCT00546377|Memorial Sloan Kettering Cancer Center|Dr. Renier Brentjens, Associate Attending|+1212-639-7053|brentjer@mskcc.org|
22421598|NCT01575834|Amgen Inc.|Study Director|866-572-6436||
22421599|NCT03821259|University of Edinburgh/NHS Tayside|Klaudia Suchorab|+44 1738 621151|klaudia.suchorab@nhs.net|
22421600|NCT00488644|UT MD Anderson Cancer Center|Victor Levin, MD, BS / Professor||kuhunter@mdanderson.org|
22421601|NCT03831932|The Ohio State University Comprehensive Cancer Center|Dr. Dwight Owen|614-685-2039|Dwight.Owen@osumc.edu|
22421602|NCT02170220|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22421603|NCT01956773|Duke University Medical Center|Dr. Lori A. Orlando, Director Program in Precision Medicine|919-660-6606|orlan002@duke.edu|
22421604|NCT01383174|University of California San Francisco|Dr. Anna Maria Napoles|415-476-6290|anapoles@ucsf.edu|
22421605|NCT00126750|VA Bedford CHOIR|Dr. Thomas Houston II|781-687-2884|thomas.houston2@va.gov|
22421606|NCT01153815|GlaxoSmithKline|GSK Response Center|866-435-7343||
22421607|NCT02169271|UT MD Anderson Cancer Center|Dr. Therese Bevers / Clinical Cancer Prevention Department|713-745-8048|tbevers@mdanderson.org|
22421608|NCT04926831|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22421609|NCT00564850|Ipsen|Medical Director, Endocrinology||clinical.trials@ipsen.com|
22421610|NCT03126968|University of Maryland|Robert M. Reed|4103288141|rreed@som.umaryland.edu|
22421611|NCT00030901|SWOG Statistical Center|Study Statistician|206-667-4623||
22421612|NCT02757053|Heartland Regional Medical Center dba Mosaic Life Care|Clinical Research Development Manager|816 271 7937|Linda.Schumacher@mymlc.com|
22421613|NCT01806051|Children's Hospital Los Angeles|Linda Randolph, M.D.|323-361-2178|lrandolph@chla.usc.edu|
22432824|NCT03870048|University of Iowa|Thorsten Rudroff|17205323701|thorsten-rudroff@uiowa.edu|
22432825|NCT02881775|University of North Carolina at Chapel Hill|Deborah Givens, PhD|919-843-8660|deborah_givens@med.unc.edu|
22432826|NCT03069716|Vanderbilt University Medical Center|Dr. Evan L. Brittain|(615) 322-4382|Evan.brittain@vumc.org|
22432827|NCT00714948|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin|646-422-4333|bajorind@mskcc.org|
22432828|NCT01673126|Coma Science Group, University of Liège|Aurore Thibaut and Pr Steven Laureys|003243662362|athibaut@ulg.ac.be|
22432829|NCT04421404|UCSF|Dr. Annie Luetkemeyer|415-476-4082|annie.luetkemeyer@ucsf.edu|130
22432830|NCT00237042|University of Washington|Dr. Judith Turner|206-543-3997|jturner@u.washington.edu|
22432831|NCT03111316|University of Oklahoma Health Sciences Center|Director of Women's Health Research|4052718001|christy-zornes@ouhsc.edu|48137
22432832|NCT02965989|Hospital Universitario 12 de Octubre de Madrid|Ph.D. Ignacio Zaragoza-García|913908000|izaragoz@ucm.es|4646
22421614|NCT02576847|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
22421615|NCT01205776|Abbott Vascular|Rhonda Hensley, Clinical Project Manager|+1 828-559-0080|rhonda.hensley@abbott.com|
22421616|NCT02418182|University of Alabama at Birmingham|Deidre Gunn, Assistant Professor|205-934-1030|ddowns@uabmc.edu|
22421617|NCT02431676|Johns Hopkins University|Dr. Jessica Yeh|410-614-4316|hyeh1@jhmi.edu|
22421618|NCT02573597|Stanford University School of Medicine|Dr. Brendan Carvalho|(650) 861-8607|bcarvalho@stanford.edu|
22421619|NCT00298272|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
22421620|NCT05253573|University of Oklahoma Stephenson Cancer Center|Thanh Cong Bui, MD, DrPH|1-405-271-8001|thanh-c-bui@ouhsc.edu|50559
22421621|NCT01344824|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22421622|NCT00566020|GlaxoSmithKline|GSK Response Center|866-435-7343||
22421623|NCT01754129|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22421624|NCT02126579|University of Virginia|Craig Slingluff, MD; Professor, Department of Surgery; Program Director, UVA Cancer Center|4349249311|cls8h@virginia.edu|
22421625|NCT04630002|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22421626|NCT04381728|WOMED|Pauline Chirouze|0785225561|pauline@womedtech.com|+33
22421627|NCT04498182|Alcon Research, LLC|Scientific Advisor, Clinical Research and Development|1-888-451-3937|alcon.medinfo@alcon.com|
22421628|NCT02182843|Zimmer Biomet Spine|Clinical Affairs|303-501-8571|spinemedinfo@zimmerbiomet.com|
22421629|NCT01788631|Dana-Farber Cancer Institute|Dr. David G. Nathan|61746322155|David_Nathan@dfci.harvard.edu|
22421630|NCT00375973|University of Cincinnati College of Medicine|Lesley M. Arnold, M.D.|513-558-7700|lesley.arnold@uc.edu|
22421631|NCT03137160|The Ohio State University- Dermatology|Dr. Benjamin Kaffenberger, MD|6143463399|Benjamin.Kaffenberger@osumc.edu|
22421632|NCT03291080|Nova Laboratories|Dr Hussain Mulla|+44 (0) 116 223 0100|hussain.mulla@novalabs.co.uk|
22421633|NCT01339260|Helsinn Healthcare SA|Head of Clinical Development|+41 91 9852121|marco.palmas@helsinn.com|
22421634|NCT03097757|Montefiore Medical Center|Roger Hicks|718-862-1751|roger.hicks@einsteinmed.org|
22421635|NCT00288626|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22421636|NCT01372618|NYU Langone|David Kleinberg|646 501 7504|david.kleinberg@nyumc.org|
22421637|NCT00558467|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22421638|NCT03038867|Weill Cornell Medical College|Research coordinator|212-746-5385|mac4015@med.cornell.edu|
22421639|NCT01684423|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22421640|NCT01741688|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22421641|NCT01548040|Theragen Inc.|Richard Pearce|901 634 0544|richard.pearce@theragen.com|
22421642|NCT02744430|Baylor College of Medicine|Perla Ramirez|713-798-8514|Perla.Ramirez@bcm.edu|
22421643|NCT03850496|Imperial College London|Dr Tristan Lane, Clinical Lecturer|02033117317|tristan.lane@imperial.ac.uk|
22421644|NCT01417741|OHSU department of APOM|Dr. Christine Martin, assistant professor|503 494 7641|martich@ohsu.edu|
22421645|NCT00869999|Massachusetts General Hospital Cancer Center|Jeffrey Barnes, MD|617-724-4000|jabarnes@partners.org|
22421646|NCT01514292|Dexcom, Inc|Andy Balo, SVP, Regulatory, Clinical and Biometrics|8582000200|abalo@dexcom.com|
22421647|NCT03858998|Weill Cornell Medicine|Dr. Robert Peck|(646) 962-8140|rnp2002@med.cornell.edu|
22421648|NCT03674112|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22421649|NCT04157348|AstraZeneca|Global Clinical Head|1-877-240-9479|information.center@astrazeneca.com|
22421650|NCT00426166|University of Toledo|Dr. Martin Skie|419-383-3515|martin.skie@utoledo.edu|
22421651|NCT02220764|Zahnärztliche Prothetik|Dr. Konstantinidis Ioannis|+49 351 458 4231|ioannis.konstantinidis@uniklinikum-dresden.de|
22421652|NCT03020992|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22421653|NCT05000164|Johnson & Johnson Vision Care (JJVC)|Ross Franklin, BAppSc-Optom|1-800-843-2020|RFRANKL1@its.jnj.com|
22421654|NCT01006122|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22421655|NCT03493854|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22421656|NCT02422446|Brigham and Women's Hospital|Dr. Luc Djousse|617-525-7591|Ldjousse@rics.bwh.harvard.edu|
22421657|NCT00410813|SWOG Statistical Center|SWOG Breast Committee Statistician|206-667-4623||
22421658|NCT04205643|CELLTRION, Inc.|Head of Clinical Planning|+82-32-850-4160|YunJu.Bae@celltrion.com|
22421659|NCT04526288|Fred Hutchinson Cancer Center|Dr. Filippo Milano, Director of FHCC Cord Blood Transplant Program|206.667.5925|fmilano@fredhutch.org|
22421660|NCT02097745|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22421661|NCT02748356|MedStar Health Research Institute|Inger Ljungberg|202-877-1694|inger.h.ljungberg@medstar.net|
22421662|NCT00425750|Vanderbilt-Ingram Cancer Center|Barbara Murphy, M.D.|615-343-4677||
22393397|NCT02186600|University of Nebraska Medical Center|Laura Bilek|402-559-6923|lbilek@unmc.edu|
22432833|NCT01913327|University of California San Francisco|Michael Minzenberg|5104122199|MMinzenberg@mednet.ucla.edu|
22432834|NCT02151786|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22393398|NCT03026075|Motus GI Medical Technologies Ltd.|Ravit Peled -Director of Clinical Trial|0733243823|ravit@motusgi.com|203
22393399|NCT03381339|Marquette Univeristy|Associate Dean|4142885944|andrew.dentino@marquette.edu|
22393400|NCT03117998|REMD Biotherapeutics, Inc|"Dung Zung Thai, MD, PhD"|415-225-9338|zungthai@remdbio.com|
22393401|NCT04927247|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22393402|NCT03970538|LimFlow|Director, Clinical Affairs|559-970-1012|kmccaffrey@limflow.com|
22393403|NCT02001064|UCSD HIV Neurobehavioral Research Program (HNRP)|Dr. David J Moore, Professor of Psychiatry|619-543-5093|djmoore@ucsd.edu|
22393404|NCT03776539|Eloxx Pharmaceuticals|Executive Director Clinical Trials|1-781-577-5300|CTI@eloxxpharma.com|
22393405|NCT00432666|Merz Pharmaceuticals GmbH|Angelika Hanschmann|++49-69-1503|angelika.hanschmann@merz.de|538
22393406|NCT00978627|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22393407|NCT01506453|St. Jude Children's Research Hospital|Doralina Anghelescu, MD|(901) 595-4034|doralina.anghelescu@stjude.org|
22393408|NCT03541174|Idorsia Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 58844 1977|idorsiaclinicaltrials@idorsia.com|
22393409|NCT00605215|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22393410|NCT04461483|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22393411|NCT00275262|Abbott|Global Medical Services|800-633-9110||
22393412|NCT02002650|Xijing hospital of digestive diseases|Hui Luo|862984771536|fmmulh@163.com|
22393413|NCT01304238|GlaxoSmithKline|GSK Response Cente|866-435-7343||
22393414|NCT00603304|University of Alabama at Birmingham|Dr. Alan Cantor|(205) 934-6887|acantor@uab.edu|
22393415|NCT01076192|AbbVie|Global Medical Information|800-633-9110||
22393416|NCT01290315|Luitpold Pharmaceuticals, Inc.|Angelia Butcher|610-650-4200|abutcher@luitpold.com|811
22393417|NCT03725085|Reckitt Benckiser Inc.|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
22393418|NCT00705679|University of Washington|Jeanne Marrazzo, MD, MPH, FACP, FIDSA|206-744-3679|jmm2@uw.edu|
22393419|NCT03527173|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22393420|NCT01248780|Janssen Research & Development|Associate Director, Clinical Research|610-500-3369||
22393421|NCT02699086|BioLite, Inc.|Hsien-Ming Wu|+886-6579631|sonnywu@bioliteinc.com|
22393422|NCT01227577|Novartis|Study Director|862-778-8300||
22393423|NCT03809429|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DK0-Disclosure@ferring.com|
22393424|NCT00194987|Weill MC|Dr James Bussel|917-291-5091|jbussel@med.cornell.edu|
22393425|NCT01664598|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22393426|NCT02778932|University Hospital Schleswig-Holstein, Campus Kiel|Priv.-Doz. Dr. med. Axel Fudickar|0049500|axel.fudickar@uksh.de|20801
22393427|NCT03182725|University of California - San Diego Health|Dr. Pam Taub|858-246-2342|ptaub@health.ucsd.edu|
22393428|NCT02245737|AstraZeneca|AstraZeneca Information Center|1-877-240-9479|information.center@astrazeneca.com|
22421663|NCT00996125|GlaxoSmithKline|GSK Response Center|866-435-7343||
22421664|NCT02798380|Hallux, Inc.|Thomas M Tremblay, RN BSN, Vice President of Clinical Affairs|(415) 305-3491|ttremblay@halluxinc.com|
22421665|NCT00952068|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
22421666|NCT04331067|Washington University School of Medicine|Andrew Davis, M.D.|314-273-3581|aadavis@wustl.edu|
22421667|NCT05236764|Baylor College of Medicine|Dr. Erin Morales|832-826-0860|erin.moralesubico@bcm.edu|
22421668|NCT03527589|Merit Medical|Casey Holland|6178420251|casey.holland@merit.com|
22421669|NCT02147834|North Florida South Georigai Veteran Health System|Anthony A Bavry, M.D.|352-548-6000|anthony.bavry@va.gov|104726
22421670|NCT04873869|Neurocrine Biosciences|Neurocrine Medical Information|+1 877-641-3461|medinfo@neurocrine.com|
22421671|NCT02062450|TORNIER SAS|Nathalie TRETOUT|+33 4 76 71 35 00|nathalie.tretout@tornier.com|
22421672|NCT02555228|MOHH Holdings|Dr Song Mingjun|86337635|mingjun.song0950c@gmail.com|
22421673|NCT01873846|Bausch Health Americas, Inc|Robert Steffen||Robert.Steffen@bausch.com|
22421674|NCT01796392|Pulmonx Corporation|Narinder Shargill|650-216-0108|nshargill@pulmonx.com|
22421675|NCT03482635|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22421676|NCT00979654|MedImmune, LLC|Jerry Green|1-888-483-7729|rtpsafety@ppdi.com|
22421677|NCT01804946|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Head of department of clinical trials|+74952761575|PutilovskiyMA@materiamedica.ru|302
22421678|NCT05286450|Sohag University|dr magdy mohamed amin|(093)- 4602963|portal@med.sohag.edu.eg|
22421679|NCT01129557|Columbia University Medical Center, Division of Nephrology|Andrew Bomback, MD|212-305-5020|asb68@columbia.edu|
22421680|NCT01486446|Xenon Pharmaceuticals Inc.|Dr. Y Paul Goldberg|604 484 3300|pgoldberg@xenon-pharma.com|
22421681|NCT01445730|Helsinki University and Helsinki University Hospital|Prof. Marja-Riitta Taskinen|+358-9-4717 1990|marja-riitta.taskinen@helsinki.fi|
22421682|NCT03134144|Institute of Occupational and Social Medicine and Health Services Research, University of Tübingen|Tessy Luger|004970712984364|Tessy.Luger@med.uni-tuebingen.de|
22432835|NCT02112656|Imunon, Inc.|Chief Medical Officer|(609) 896-9100|clinical@imunon.com|
22421683|NCT01938092|University of Missouri-Columibia, Dept. Ob/Gyn|Erma Z. Drobnis, Associate Director, Research Success Center|573-817-3124|drobnise@health.missouri.edu|
22393429|NCT03866798|Clinical Research Management Group|Patrick Murphy|4138210022|p.murphy@crmg-usa.com|
22393430|NCT03786042|Dartmouth college|Research Scientist|603-646-5408|john.brand@dartmouth.edu|
22421684|NCT01367886|Washington University School of Medicine|H. Henry Lai, MD|314-362-8295|laih@wudosis.wustl.edu|
22393431|NCT00836745|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22421685|NCT00574704|Cytos Biotechnology AG|Head of Clinical Develpment|+41 44 733 4|info@cytos.com|7 47
22421686|NCT01167140|Myoscience|Francis Rogers Palmer III, MD|650-474-2600|thenry@myoscience.com|
22421687|NCT00985504|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22421688|NCT03805412|University of Washington Diabetes Institute|Dr. Nicole Ehrhardt|202-741-3422|nehrhard@uw.edu|
22421689|NCT02817763|Institute of Science and Technology of São José dos Campos (Unesp)|Dr. Mauro P. Santamaria|+55 (16) 981937777|mauro.santamaria@ict.unesp.br|
22421690|NCT03711786|University of North Carolina at Chapel Hill|Brian Pence, PhD|919-966-7430|bpence@unc.edu|
22421691|NCT01465412|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22421692|NCT00669669|Fred Hutch Cancer Research Center|Hans-Peter Kiem, M.D., Ph.D.|206.667.4425|hkiem@fredhutch.org|
22421693|NCT04390113|AlloVir, Inc.|Senior Vice President|+1 617-433-2605|rriese@allovir.com|
22421694|NCT01611883|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22421695|NCT02689154|Children's Hospital of Los Angeles|Dr. Alaina Vidmar|323-361-3385|avidmar@chla.usc.edu|
22421696|NCT03379727|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22421697|NCT00715273|University of Washington|Xue-Qiao Zhao|206-744-8305|xueqiao@uw.edu|
22421698|NCT02021929|University of Pennsylvania|Dr. Steven Kawut|215-573-0258|kawut@upenn.edu|
22421699|NCT00734994|Duke University, Division of Urology|Brant A. Inman, MD, MS|919 684-1322|brant.inman@duke.edu|
22421700|NCT07091916|Medtronic Japan Co., Ltd.|Takuto Yamamoto|+818046716498|takuto.yamamoto@medtronic.com|
22421701|NCT05682729|University of Dayton|Mary Wagner|9372292775|mwagner8@udayton.edu|
22421702|NCT03100903|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22421703|NCT04659993|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|3367135440|Katie.Duckworth@advocatehealth.org|
22421704|NCT04850989|National University of Singapore|Nur Hani Zainal|+65 6516 3749|hanizainal@nus.edu.sg|
22421705|NCT01540487|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22421706|NCT03503370|Baltimore VA Medical Center|Dr. Mary-Claire Roghmann|(410) 706-0062|Mary-Claire.Roghmann@va.gov|
22421707|NCT03483961|Emergent BioSolutions|Sharmila Rajendran|650-486-0244|rajendras@ebsi.com|
22421708|NCT00457002|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22421709|NCT01623310|OptiNose|Vice President Global Clinical Operations & Outsourcing|267-364-3508|jennifer.carothers@optinose.com|
22421710|NCT00326716|Bristol-Myers Squibb|BMS Study Director||clinical.trials@bms.com|
22421711|NCT00684411|Dana-Farber Cancer Institute|Eric Jacobsen, MD|617.632.6633|EDJACOBSEN@PARTNERS.ORG|
22421712|NCT00734162|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22421713|NCT04134767|Rollins School of Public Health at Emory University|Dr. Hannah LF Cooper|404-727-0261|hcoope3@emory.edu|
22421714|NCT00603902|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22421715|NCT05483686|ISA Associates, Inc.|Dr. Samantha Leaf|703-739-0880|sleaf@isagroup.com|4
22421716|NCT05780983|Wake Forest University Health Sciences|Jaime M Hughes, PhD, MPH, MSW|336-716 -0835|jane.hughes@wfusm.edu|
22421717|NCT03126630|Mayo Clinic|Dr. Aaron Mansfield|(507) 284-2511|mansfield.aaron@mayo.edu|
22421718|NCT06028438|Janssen Research & Development|Medical Director Rheumatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22421719|NCT01593670|Masonic Cancer Center, University of Minnesota|Dr. Erica Warlick|612-625-5467|ewarlick@umn.edu|
22421720|NCT01017874|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22421721|NCT00808210|F. Hoffmann-La Roche Ltd|Medical Communications|+41 616878333|global.trial_information@roche.com|
22421722|NCT02044302|Yale Center for Clinical Investigations|Katisha Brown CPC|(203) 737-7495|katisha.brown@yale.edu|
22421723|NCT01953302|Varazdin General Hospital|Alen Pajtak|+38542393053|alen.pajtak@obv.hr|
22421724|NCT03150719|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22421725|NCT01790984|University of Surrey|Professor Bruce A.Griffin|+44 0483 689724|b.griffin@surrey.ac.uk|
22421726|NCT00383760|Princess Margaret Cancer Centre|Dr. Malcolm Moore|416-945-2263|malcolm.moore@uhn.ca|
22421727|NCT01346696|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
22421728|NCT05541003|Robert Wood Johnson|Dr. Keerthana Kesavarapu|6784690425|kk1132@rwjms.rutgers.edu|
22421729|NCT01051791|University of Pittsburgh Cancer Institute|Barbara Stadterman, Regulatory Supervisor|412-647-5554|stadtermanbm@upmc.edu|
22421730|NCT01691560|GlaxoSmithKline|GSK Response Center|866-435-7343||
22421731|NCT01932060|Stanford University School of Medicine|Dr. Alexander Butwick|(650) 736-8513|ajbut@stanford.edu|
22421732|NCT01954056|University of New Mexico|Dr. Kristi Watterberg|505-272-8609|KWatterberg@salud.unm.edu|
22421733|NCT04005404|Helios Center for Research and Innovation|Director Prof. Dr. Petra Thürmann|0049 (0)202 896-1851|petra.thuermann@helios-gesundheit.de|
22421734|NCT02344238|Medical University of South Carolina|Dr. Aimee McRae-Clark||mcraeal@musc.edu|
22421735|NCT00746889|UCSD|Jeannie Chao|858-657-7040|j5chao@ucsd.edu|
22421736|NCT02403479|St. Joseph's Healthcare London|Dr. Leigh Sowerby|519-646-6143|leigh.sowerby@sjhc.london.on.ca|
22421737|NCT02461966|Tanta university|Sherief Abd-Elsalam|00201095159522|sherif_tropical@yahoo.com|
22421738|NCT04244084|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22421739|NCT04332081|NYU Langone|David Lee|212-263-3293|David.lee@nyulanogne.org|
22421740|NCT02249728|Prana Biotechnology|Dr Dianne Angus|+61 393494906|info@pranabio.com|
22421741|NCT02155283|Radiancy Ltd|Dr. Daniele Perl-Treves, Clinical Director|972-97757556|daniele@radiancy.com|
22421742|NCT00470717|UHClevelandMC|Dr. Lydia Furman|216-844-8260|Lydia.Furman@uhhospitals.org|
22421743|NCT00232739|Cordis|Sidney Cohen, MD PhD, Vice President|650 614-2726|scohen7@its.jnj.com|
22421744|NCT03090958|UNC-Chapel Hill|Lisa Hightow Weidman, MD|919 966 2536|lisa_hightow@med.unc.edu|
22421745|NCT00676364|Lehigh Valley Health Network|Jenny Boucher|610-402-8844|jenny.boucher@LVH.com|
22421746|NCT05209464|Spaulding Rehabilitation Hospital|Paolo Bonato, PhD|617-952-6319|pbonato@mgh.harvard.edu|
22421747|NCT00999609|Spark Therapeutics|Clinical Director||clinicaltrials@sparktx.com|
22421748|NCT02818946|Duke University|Sujata Ghate, MD|919-684-2711|sujata.ghate@duke.edu|
22421749|NCT04123496|Medical University of South Carolina|Donna Robers, MD|843-792-9343|Robertdr@musc.edu|
22421750|NCT02268916|VA Ann Arbor|Pearl Lee, MD|734-845-3182|Pearl.Lee2@va.gov|
22421751|NCT01391858|UTexas Southwestern Medical Center|Babatunde Ogunnaike|(214) 590|Babatunde.Ogunnaike@UTSouthwestern.edu|8536
22421752|NCT01699373|Changi General Hospital|Dr Lim Yean Chin|+65 68503831|yean_chin_lim@cgh.com.sg|
22421753|NCT00594165|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22421754|NCT04830969|University at Buffalo|Lu Li|7168296284|lli59@buffalo.edu|
22421755|NCT02359955|Shanghai No. 9 People's Hospital|Dr. Haixin Qian|13501961651|drqian8167@126.com|
22421756|NCT04639219|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22421757|NCT03111940|Oxford Heart Centre, John Radcliffe Hospital|Prof Adrian Banning|01865 228934|Adrian.Banning@ouh.nhs.uk|
22421758|NCT02712554|Charleston Laboratories, Inc.|Chief Commercial Officer|561-748-2007|cliregulatory@charlestonlabs.com|
22421759|NCT02503540|Cole Eye Institute Cleveland Clinic Foundation|Dr.Justis P. Ehlers|2166360183|ehlersj@ccf.org|
22421760|NCT00413582|Children's Mercy Hospital|Shawn D. St. Peter, MD|816-983-6479|sspeter@cmh.edu|
22421761|NCT01205269|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22421762|NCT03218995|Sarepta Therapeutics, Inc.|Medical Director|800-690-2003|clinicaltrials@sarepta.com|
22421763|NCT03830333|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22421764|NCT00987337|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22421765|NCT02571673|Memorial Sloan Kettering Cancer Center|Dr. Talya Salz, PhD|646-227-3646|salzt@mskcc.org|
22421766|NCT03334344|Ceevra|Russ Yoshinaka|415-926-9434|ryoshinaka@ceevra.com|
22421767|NCT02747108|VA Center for Clinical Management Research|Jeffrey Kullgren, MD, MS, MPH - Principal Investigator|(734) 845-3502|jkullgre@med.umich.edu|
22421768|NCT03103152|Queen Mary University, London.|Professor Jack Cuzick, Director of The Wolfson Institute|+44 (0)207 882 3504|j.cuzick@qmul.ac.uk|
22421769|NCT05966584|Memorial Sloan Kettering Cancer Center|Dr. Alina Markova, MD|646-608-2380|markovaa@mskcc.org|
22421770|NCT03548779|University of North Carolina at Chapel Hill|Jonathan Berg, MD, PhD|919-966-7043|jonathan_berg@med.unc.edu|
22421771|NCT06360588|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22421772|NCT04010240|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Pr Antoine Italiano|0556333333|a.italiano@bordeaux.unicancer.fr|
22421773|NCT01481766|Hospital for Sick Children, Toronto, Canada|Dr. Patricia Parkin|416-81307654|patricia.parkin@sickkids.ca|
22421774|NCT00347958|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22421775|NCT00754234|United States Department of Agriculture (USDA) Grand Forks Human Nutrition Research Center|Brenda Ling|701-795-8300|brenda.ling@ars.usda.gov|
22421776|NCT00570687|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
22421777|NCT03263936|Therapeutic Advanced in Childhood Leukemia and Lymphoma|Ellynore Florendo|323-361-3022|eflorendo@chla.usc.edu|
22421778|NCT06045325|Berkeley Eye Center|Tetiana Huff|713-620-7640|tetiana.huff@berkeleyeye.com|
22421779|NCT04545489|Durham VA Health Care System|Dr. Hayden Bosworth, PhD|919-286-0411|Hayden.Bosworth@va.gov|177101
22421780|NCT00652626|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22421781|NCT04003636|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22421782|NCT00454246|Hoffman-LaRoche|Medical Communications|800-821-8590||
22421783|NCT00356603|GlaxoSmithKline|GSK Response Center|866-435-7343||
22421784|NCT05326529|University Hospital of Derby and Burton|Charlotte Smith|01283 593150|charlotte.smith79@nhs.net|3150
22421785|NCT01234870|Northwestern University|Dr. James Carr|(312)695-4218|jcarr@northwestern.edu|
22421786|NCT01262287|University of Connecticut School of Medicine|Dr. Jonathan Covault|860-679-7560|jocovault@uchc.edu|
22421787|NCT00932373|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
22421788|NCT02273063|Neuromodulation Research Clinic|Director|401-455-6200|Linda_Carpenter_MD@Brown.edu|
22421789|NCT05125848|Zynex Monitoring Solutions|ZMS Clinical|(800) 495-6670|clinical@zynexmonitoring.com|
22421790|NCT02492984|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22421791|NCT01841762|Actelion Pharmaceuticals US, Inc.|Scott Tsurutani / Associate Director, Clinical Operations|6508086586|scott.tsurutani@actelion.com|
22421792|NCT00693498|University of Rochester|Jill M. Cholette MD, Principle Investigator|585-275-8138|Jill_Cholette@urmc.rochester.edu|
22421793|NCT03611777|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22421794|NCT06152224|UW School of Medicine and Public Health|Ushma Patel, MD|(608) 287-5898|upatel@uwhealth.org|
22421795|NCT05625802|University of Michigan|Christopher Fung|734-763-4091|chfung@med.umich.edu|
22421796|NCT01164579|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22421797|NCT00725153|Alcon Research, Ltd.|Jessie Lemp, MS|817-615-2739|Jessie.Lemp@alconlabs.com|
22421798|NCT03892642|OU Health Stephenson Cancer Center|Associate Professor|405-271-6900|kelly-stratton@ouhsc.edu|
22421799|NCT01163851|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22421800|NCT00789373|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22421801|NCT04938180|AmMax Bio., Inc.|Dorothy Nguyen, MD|(650)285-6560|clinical@ammaxbio.com|
22421802|NCT01964222|Washington University's School of Medicine|Mary C. Politi, PhD|314-747-1968|politim@wudosis.wustl.edu|
22432836|NCT04749745|Butler Hospital|Dr. Shiwen Yuan|2025783000|shiwen_yuan@brown.edu|
22432837|NCT01365455|Novartis Pharmaceuticals|Study Director|862-778-8300||
22432838|NCT04522167|Formycon AG|Public Register Contact|+49 89 864667 100|clinicaltrials@formycon.com|
22432839|NCT01234480|Becton Dickinson|Karen Yanson|410-316-4793|karen_a_yanson@bd.com|
22432840|NCT03370419|Wayen State University|Heather Fritz|313-577-9499|heather.fritz@wayne.edu|
22432841|NCT03844672|Medical University of South Carolina|Dr. Tracy Smith|8437925164|smithtra@musc.edu|
22432842|NCT02220426|University of North Carolina at Chapel Hill|Rosa Tamara Branca, PhD|9199622229|rtbranca@unc.edu|
22432843|NCT02595879|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP|4126475554|stadtermanbm@upmc.edu|
22432844|NCT03145064|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22432845|NCT00661830|Interdisciplinary Center for Clinical Trials (IZKS Mainz)|A. Kaiser|++49(0)6131-179921|kaiser@izks-mainz.de|
22432846|NCT01898286|CBR International|Dr. Jeanne Novak|7207461190|jnovak@cbrintl.com|
22432847|NCT01650831|Exalenz.Bioscience Ltd.|Avraham Hershkowitz, Clinical Trials Manager|+972-8-9737513|avrahamh@exalenz.com|
22432848|NCT00288886|Salem Veterans Affairs Medical Center|Steven Lash, Ph.D.|(540)982-2463|Steven.Lash@va.gov|2593
22432849|NCT01897727|University of Alabama at Birmingham|Dr. Eric Judd|205 934-9281|ejudd@uab.edu|
22432850|NCT04245449|Medical University of South Carolina|Michelle Woodbury, PhD|843-792-0651|woodbuml@musc.edu|
22432851|NCT02477527|Midtown Medical Center|Edward W Braun, MD|8139353221|Dr.Braun@DrEdwardBraun.com|
22432852|NCT03692403|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DK0-Disclosure@ferring.com|
22432853|NCT02479880|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22432854|NCT02840253|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-4200|Joseph.Tobias@nationwidechildrens.org|
22432855|NCT00856635|Teva Pharmaceuticals, Medical Affairs|Scott Kolodny, M.D.|440-327-1811|scott.kolodny@tevapharm.com|
22432856|NCT01349673|Bausch Health Companies|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
22432857|NCT03688919|University of Michigan School of Public Health|Professor Alison Miller|7346157459|alimill@umich.edu|
22432858|NCT00118274|University of Virginia|Dr. Craig Slingluff|4349249311|cls8h@virginia.edu|
22393432|NCT01587027|Medical Center of the Rockies|Gary Luckasen, M.D.|(970)624-1686|gary.luckasen@uchealth.org|
22393433|NCT01239043|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22393434|NCT01008319|University of Oklahoma|LaTasha Craig, MD|405-271-8787|latasha-craig@ouhsc.edu|
22393435|NCT02929329|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22393436|NCT02121301|Ciurem Pharma Inc|Gosse B. Bruinsma|613-866-9609|gbb@CIUREM.COM|
22393437|NCT01033422|Can-Fite BioPharma Ltd|Zivit Harpaz|972-3-9241114|zivit@canfite.co.il|
22393438|NCT01954966|University of Pennsylvania|Claudia Iannelli|6104424426|Claudia.iannelli@pennmedicine.upenn.edu|
22393439|NCT00434213|Noven Pharmaceuticals, Inc.|Amaury Sanchez, Sr. Manager, Regulatory Affairs||asanchez@noven.com|
22393440|NCT01699503|Indiana University|Dr. Nicole Fowler|317-274-9021|fowlern@iupui.edu|
22393441|NCT00831753|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22393442|NCT01639560|Mayo Clinic|Jon O. Ebbert, MD|507-266-1944|nicotineresearch@mayo.edu|
22393443|NCT00774930|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22393444|NCT01467882|Debiopharm International, S.A.|Eija Lundström|:+41 21 3210111|eija.lundstrom@debiopharm.com|
22393445|NCT01181323|Cincinnati Children's Hospital Medical Center|Mark Steinhoff, MD|513-636-2791|Mark.steinhoff@cchmc.org|
22421803|NCT01050582|Johnson & Johnson Pharmaceutical Research and Development, L.L.C.|Clinical Leader|609-730-6581||
22421804|NCT01831076|University of Colorado|Anthony Elias|720-848-0347|anthony.elias@ucdenver.edu|
22421805|NCT01019694|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22421806|NCT04994691|Cincinnati Children's|Dr. William B. Brinkman|513-636-2576|bill.brinkman@cchmc.org|
22421807|NCT00795002|The Sidney Kimmel Comprehensive Cancer Center|Judith Karp, MD|410-502-7726|jkarp2@jhmi.edu|
22421808|NCT00441129|Medtronic Minimed|Suiying Huang, Statistician|8184763319|suiying.huang@medtronic.com|
22421809|NCT00463047|Cephalon, Inc.|Medical Monitor|1-800-896-5855||
22421810|NCT03283787|Integra LifeSciences|Allison Matthews|443-766-3869|allison.matthews@integralife.com|
22421811|NCT02266797|NYU Langone Medical Center|Michael Gerling|(718) 630-8600|Michael.Gerling@nyumc.org|
22421812|NCT02905981|Rockwell Medical|Ray Pratt, MD|248 960-9009|rpratt@rockwellmed.com|405
22421813|NCT03365635|Penn Presbyterian Medical Center|Michael R. Rudnick, MD|215-662-8738|rudnickm@uphs.upenn.edu|
22393446|NCT00766363|EnVivo Pharmaceuticals, Inc.|Maria Gawryl, Ph.D., Vice President, Regulatory Affairs & Drug Development|617-225-4264|mgawryl@envivopharma.com|
22421814|NCT04278417|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22421815|NCT03146806|Emory University|Vinita Singh, MD|404-686-2410|vinita.singh@emory.edu|
22421816|NCT01732458|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22421817|NCT05870371|Musculoskeletal Research Laboratory (MRL) of Physiotherapy Department University of West Attica, Athens, Greece|Dr. George Georgoudis|+30-210-5387487|physiolab@uniwa.gr|
22421818|NCT02203721|Abbott Medical Optics|Kendra Hileman, Ph.D., Director of Clinical Research and Development|714-247-8613|kendra.hileman@abbott.com|
22421819|NCT00703157|Medtronic Bakken Research Center, Coronary and Structural Heart Disease Management|Ber Kleijnen|+31 (0) 43 356 6566|ber.kleijnen@medtronic.com|
22421820|NCT00347009|GlaxoSmithKline|GSK Response Center|866-435-7343||
22421821|NCT04495751|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-713-5440|hklepin@advocatehealth.org|
22421822|NCT00708461|University of Minnesota|Jennifer A. Linde, Ph.D.|612-624-0065|linde074@umn.edu|
22421823|NCT02907177|Actelion Pharmaceuticals Ltd (a Janssen Pharmaceutical Company of Johnson & Johnson)|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22421824|NCT02968173|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22421825|NCT04681066|CalciMedica|Sudarshan Hebbar (Chief Medical Officer)|(816) 838-7105|sudarshan@calcimedica.com|
22421826|NCT01099618|Emory University SOM|Dawn Smiley|4047781665|dsmiley@emory.edu|
22421827|NCT04495829|Woolfson Eye Institute|R. Doyle Stulting, MD, PhD|(770) 255-3330|dstulting@icloud.com|
22421828|NCT02003404|Loyola University of Chicago|Dr James Swan, MD|708-485-1271|jswan@lumc.edu|
22421829|NCT02438423|Georgia Tech|Mark Prausnitz, PhD|404-894-5135|prausnitz@gatech.edu|
22421830|NCT00673439|James Graham Brown Cancer Center|Goetz H Kloecker, MD, MSPH|502/562-4358|ghkloe01@exchange.edu|
22421831|NCT00314327|NSLIJ|Delbert Robinson, M.D.|718-470-8195|Drobinson@nshs.edu|
22421832|NCT01207687|Johns Hopkins Comprehensive Neurofibromatosis Center|Dr. Jaishri Blakeley|410-614-3853|jblakel3@jhmi.edu|
22421833|NCT03474965|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22421834|NCT04722315|Kennedy Krieger Institute|Dr. Jacqueline Harris|6672054295|harrisjac@kennedykrieger.org|
22421835|NCT03868930|VA Boston Healthcare System|Dr. Catherine B. Fortier|857-364-4361|Catherine.Fortier@va.gov|
22421836|NCT06047366|Indiana University School of Dentistry|Dr. Ken Spolnik|317-274-7280|kspolnik@iu.edu|
22421837|NCT04033237|University of Vermont|Sarah H. Heil, PhD|802-656-8712|Sarah.Heil@uvm.edu|
22393447|NCT03020576|Columbia University Medical Center/ Dept. of Rehabilitation & Regenerative Medicine|Lauri Bishop, PT, DPT Research Physical Therapist|212-305-6095|LB2413@cumc.columbia.edu|
22421838|NCT02151851|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22421839|NCT02159053|Novartis Pharmaceuticals|Study Director|8627788300||
22432859|NCT00564733|University of Washington|Keith D. Eaton, MD, PhD|2062886249|kdeaton@uw.edu|
22432860|NCT01285024|Cleveland Clinic|President and CEO Cleveland Clinic Florida|216-444-7515|barsouw@ccf.org|
22432861|NCT02621476|Kaiser Permanente Northern California|Julie Schmittdiel, PhD, MA|5108913872|Julie.A.Schmittdiel@kp.org|
22432862|NCT03198767|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22432863|NCT03462758|University of California, San Diego|Dr. Sarah Averbach, MD, MAS|858-329-4464|familyplanningresearch@health.ucsd.edu|
22432864|NCT02820844|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22432865|NCT04423939|Duke University Medical Center|Dr. Anthony Sung|919-668-1000|anthony.sung@duke.edu|
22432866|NCT04701411|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22432867|NCT01692743|University of Maryland School of Medicine|Raymond K. Cross, MD, MS, AGAF|410-706-3387|rcross@som.umaryland.edu|
22432868|NCT01722994|University of Mississippi Medical Center|Dr. Robert Brodell|601-815-8000|rbrodell@umc.edu|
22432869|NCT01206140|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22432870|NCT02655887|Becton Dickinson (BPV)|Megan Hill|480-350-6468|Megan.Hill@bd.com|
22432871|NCT00833443|UCLA|Keith Heinzerling MD|323-461-3106|kheinzerling@mednet.ucla.edu|
22432872|NCT04245709|Duke University|Dwight Koeberl, MD,PhD|919-681-9919|dwight.koeberl@duke.edu|
22432873|NCT04339413|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22432874|NCT00442416|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22432875|NCT03301779|Hemanext|William Iselin|7813017446|william.iselin@hemanext.com|
22432876|NCT00633087|Rutgers Cancer Institute of New Jersey|Dr. Robert DiPaola, MD|732-235-8675|dipaolrs@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
22432877|NCT01964378|Grünenthal GmbH|Study Director|+49 241 569 3223|Clinical-Trials@grunenthal.com|
22432878|NCT02358993|University of Pennsylvania|Dr Uduak Andy|215-662-7709|uduak.andy@pennmedicine.upenn.edu|
22432879|NCT01841021|H. Lee Moffitt Cancer Center and Research Institute|Dr. Lubomir Sokol|813-745-8212|lubomir.sokol@moffitt.org|
22432880|NCT01072136|University of Arkansas for Medical Sciences|Shelly Lensing|501-686-8203|sylensing@uams.edu|
22432881|NCT03503396|University of Missouri|Dr. Denis McCarthy|573-882-0426|mccarthydm@missouri.edu|
22432882|NCT00657267|Dana-Farber Cancer Institute / Brigham & Women's Hospital|Patrick Y. Wen, MD|617-632-2166|pwen@partners.org|
22432883|NCT04872569|University of Michigan|Dr. Claire Kalpakjian|734-763-0153|clairez@umich.edu|
22432884|NCT00742170|McLean Hospital|Scott E. Lukas, Ph.D.|617-855-2767|slukas@mclean.harvard.edu|
22432885|NCT00480740|Children's National Medical Center|Dr. Julia Finkel|202-476-4867|jfinkel@childrensnational.org|
22432886|NCT02382991|OTTOBOCK FRANCE|Aurélie LACROIX|0033 (0)7 86 29 52 03|market.access@ottobock.fr|
22432887|NCT04951622|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22432888|NCT03129464|Cleveland Clinic Florida|Pamela Frazzini Padilla|9546595559f|frazzip@ccf.org|
22432889|NCT02568722|Unity Health Toronto|Dr. Ron Wald|(416) 867-3703|ron.wald@unityhealth.to|
22432890|NCT02891226|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22432891|NCT02317692|Marquette University|Dr. Alyson Gerdes|414-288-6145|alyson.gerdes@mu.edu|
22432892|NCT01445847|King Saud University Medical City - College of Medicine|Dr. Khalid Al-Faleh, Chairman, Institutional Review Board|966556031222|kfaleh@ksu.edu.sa|
22432893|NCT04570384|Asklepion Pharmaceuticals, LLC|Gurdyal Kalsi, MD, MFPM (Hon)|+1 410.736.3750|gurdyal.kalsi@asklepionpharm.com|
22432894|NCT03654274|Myovant Sciences GmbH|Clinical Trials at Myovant|+1 650 238 0250|clinicaltrials@myovant.com|
22432895|NCT02454530|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22421840|NCT02640950|Sheppard Pratt Health System|Director of Clinical Research|4109383125|saaronson@sheppardpratt.org|
22421841|NCT03048747|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22421842|NCT05336630|Dartmouth-Hitchcock Medical Center|Dr. Timothy B. Gardner|603-653-9033|timothy.b.gardner@hitchcock.org|
22421843|NCT00915018|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
22421844|NCT02582242|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22421845|NCT00300885|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22421846|NCT01637922|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22421847|NCT00638404|Wake Forest School of Medicine-Anesthesiology|Peter H. Pan MD, MSEE|336-718-8278|ppan@wakehealth.edu|
22421848|NCT02101736|The University of Alabama at Birmingham|Karen Cole-Plourde, Program Director -NFCTC|(205) 514-1317|kplourde@uab.edu|
22421849|NCT02282631|Institute of Health and Society, Newcastle University|Dr Samuel Ginja|+44191208|samuel.ginja@newcastle.ac.uk|4565
22421850|NCT00459290|Gynecologic Oncology Group Statistical and Data Center|Jessalyn Reboy|716-845-7738|ReboyJ@nrgoncology.org|
22421851|NCT00687271|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22421852|NCT02453334|American Regent, Inc|Mark A. Falone, MD MPH|631-772-3544|mfalone@americanregent.com|61844
22421853|NCT02362672|Nektar Therapeutics|Medical Affairs||StudyInquiry@nektar.com|
22421854|NCT02669901|Univesity of New Mexico School of Medicine|Dr. Joanna Katzman, Principal Investigator|(505) 272-2321|JKatzman@salud.unm.edu|
22421855|NCT02693106|Université de Sherbrooke|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
22432896|NCT00326001|Biotronik GmbH&Co. KG, Berlin, Germany|Dejan Danilovic|+49 9131 8924 7832|dejan.danilovic@biotronik.com|
22432897|NCT03265145|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22432898|NCT03640325|Dana-Farber Cancer Institute|Dr Abby Rosenberg|617.632.5286|abbyr_rosenberg@dfci.harvard.edu|
22421856|NCT03981900|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22421857|NCT00184717|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22421858|NCT01369030|Pamlab, Inc.|Lori W Barrentine, MS, PA-C, Director of Clinical Affairs|985-867-5788|lbarrentine@pamlab.com|
22421859|NCT02829320|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22421860|NCT02110758|National Committee for Quality Assurance|Sarah Hudson Scholle|202-955-1726|scholle@ncqa.org|
22421861|NCT04090060|Medical college of Wisconsin|Alan Nyitray, PhD|414-955-7701|anyitray@mcw.edu|
22421862|NCT02074358|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22421863|NCT03337113|Kent State University|William Lechner|814-450-1093|wlechner@kent.edu|
22421864|NCT03070600|University of Washington|Grace John-Stewart|206-543-4278|gjohn@uw.edu|
22421865|NCT02215200|Benaroya Research Institute|Carla Greenbaum, MD|1-800-425-8361|cjgreen@benaroyaresearch.org|
22421866|NCT00507455|Astellas Pharma Global Development, Inc.|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com|
22421867|NCT02176655|Clinvest/A Division of Banyan Group Inc.|Heather Manley|417-841-3664|hmanley@clinvest.com|
22421868|NCT01372995|Emory University|Jenny Han, MD|404-616-0821|jehan2@emory.edu|
22421869|NCT01483963|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22421870|NCT06110494|University of Pennsylvania|Dr. Bekir Karabucak Chair of the Department of Endodontics|215-898-4927|bekirk@upenn.edu|
22421871|NCT00105079|Hoffman-LaRoche|Medical Communications|800-821-8590||
22421872|NCT01464593|Celsion Corporation|Chief Medical Officer|609-896-9100|nborys@celsion.com|
22421873|NCT02182115|University of Minnesota|Dr. Susan Kline|612-626-3662|kline003@umn.edu|
22421874|NCT00435708|Queen's University Belfast|Professor Michelle McKinley|02890978936|m.mckinley@qub.ac.uk|
22421875|NCT01605552|Indiana University-Purdue University Indianapolis (IUPUI)|Jesse C. Stewart, Ph.D.|(317) 274-6761|jstew@iupui.edu|
22421876|NCT01921322|Medtronic Diabetes|John Shin, PhD|818-576-4019|john.shin@medtronic.com|
22421877|NCT04042623|Aravive|Dr. Reshma Rangwala, Chief Medical Officer|936-355-1910|rrangwala@aravive.com|
22393448|NCT03292432|University of North Carolina at Chapel Hill|Rachel Goolsby - Research Manager|9198430685|rwgoolsby@unc.edu|
22421878|NCT01737710|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22421879|NCT03935425|Flint Rehab|Daniel Zondervan|9493137322|dzondervan@flintrehab.com|
22421880|NCT00885664|University of Cincinnati|Dr. Carl J. Fichtenbaum|513-584-6361|carl.fichtenbaum@uc.edu|
22421881|NCT01342770|Mayo Clinic|Dennis Wigle, M.D., Ph.D.|507-284-2511|wigle.dennis@mayo.edu|
22421882|NCT00921557|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22421883|NCT02527434|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22421884|NCT01413750|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22421885|NCT03187730|NYU Langone|Elizabeth Vargas|310-486-9775|elizabeth.varagas@nyulangone.org|
22421886|NCT00504712|Barnsley Hospital NHS Foundation Trust|Professor TH Jones|01226 431684||
22421887|NCT00086138|JHU|Paul Rosenberg|410-550-9883|prosenb9@jhmi.edu|
22421888|NCT03546491|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
22421889|NCT05630287|Eli Lilly and Company|Chief Medical Officer|8005955979|ClinicalTrials.gov@lilly.com|
22421890|NCT02589639|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22421891|NCT01014169|Boston University School of Medicine/Boston Medical Center|Dr Caroline Kistin|617-414-3642|caroline.kistin@bmc.org|
22421892|NCT01276756|Cairo University|Dr. Hany Shehab|00201111111071|h.shehab@drshehab.com|
22421893|NCT05868577|Atrium Health Wake Forest Baptist|Michael Jones, DPM|704-355-2000|michael.jones4@advocatehealth.org|
22421894|NCT03308097|Rhode Island Hospital|Larry K. Brown, MD|(401) 793 - 8808|lkbrown@lifespan.org|
22421895|NCT02522884|Intact Vascular, Inc.|Joseph C. Griffin, III|4842531048|JGriffin@intactvascular.com|1043
22421896|NCT03289754|restor3d, Inc.|Director of Clinical Affairs|(984) 888-0593|clinicalresearch@restor3d.com|
22421897|NCT04873934|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22421898|NCT01934582|United Therapeutics Corp.|Global Medical Information|919-425-8350|clinicaltrials@unither.com|
22421899|NCT03584854|University of Chicago|Dr. Naida Cole|773-702-6700|nmcole@bsd.uchicago.edu|
22421900|NCT02630251|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|1
22421901|NCT02134015|Daiichi Sankyo, Inc.|Global Clinical Leader|9089926400|DataSharing@dsi.com|
22421902|NCT01022307|VANCHCS|David L. Woods, Chief Clinical Neurophysiology|925-372-2571|David.Woods@va.gob|
22421903|NCT01777282|GlaxoSmithKline|GSK Response Center|866-435-7343||
22421904|NCT04015518|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22421905|NCT04818034|University of California, San Francisco|Marshall Stoller|415-514-0918|victoria.hogue@ucsf.edu|
22421906|NCT02186873|Johnson&Johnson|Senior Director Clinical Development, Immunology General||ClinicalTrialDisclosure@its.jnj.com|
22421907|NCT03694002|SWOG Statistics and Data Management Center|Study Statistician|2066672894|mhsieh@fredhutch.org|
22421908|NCT01760655|Tevogen Bio|Dolores Grosso|848-256-5751|dolores.grosso@tevogen.com|
22421909|NCT03187418|Centre Hospitalier de l'Universite de Montreal (CHUM)|Dr. Michael Marchand, MD|514-890-8000|michael.marchand-gareau@umontreal.ca|
22421910|NCT01568034|BIAL - Portela & Cª S.A.|Head of Clinical Research|+351-229866100|clinical.trials@bial.com|
22421911|NCT01068730|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22421912|NCT02919423|University of Arkansas for Medical Sciences|Merideth Addicott, Assistant Professor|501-526-8436|maddicott@uams.edu|
22421913|NCT04134429|insel Gruppe AG|Dr. med. Christa König|+41 31 632 21 11|christa.koenig@insel.ch|
22421914|NCT01515865|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22432899|NCT03046927|University of Mass Medical|Benjamin U. Nwosu, MD|5083406936|bnwosu1@northwell.edu|
22432900|NCT01566149|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22432901|NCT01848977|Seoul National University Hospital|Jin-Tae Kim|82-10-6260-8490|jintae73@gmail.com|
22432902|NCT03687957|Washington University School of Medicine|Dr. Milan Chheda|314-747-2712|mchheda@wustl.edu|
22432903|NCT03718325|University of Michigan|Dr. Scott Lempka|734-647-9052|NeuromodulationLab@med.umich.edu|
22432904|NCT02197572|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22432905|NCT02956746|Synermore Biologics Co., Ltd.|Director of Clinical Trials|+886 2 2659 0988|achuang@synermore.com|
22432906|NCT02383862|Regenstrief Institute|Research Coordintor|317-274-9288|tltalib@regenstrief.org|
22432907|NCT03346083|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22432908|NCT02630693|Canadian Cancer Trials Group|Dr. Wendy Parulekar|613-533-6430|wparulekar@ctg.queenus.ca|
22432909|NCT03801928|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22432910|NCT02763059|King Abdulaziz University|Prof. Maha A Bahammam|00966126400000|mbahammam@kau.edu.sa|
22432911|NCT01724216|Spectrum Health|Mark Charles DeLano, M.D., Principal Investigator|616-363-7339|delanom@msu.edu|
22432912|NCT00175916|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22432913|NCT04105868|University of Pittsburgh|Mary Woody, PhD Assistant Professor of Psychiatry|4123832143|mlw114@pitt.edu|
22432914|NCT01456130|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22432915|NCT00382265|George Washington University|Andrew Meltzer, MD, MS|202-741-2952|ameltzer@mfa.gwu.edu|
22432916|NCT02661997|VA Boston Healthcare System|Barbara L. Niles, Ph.D.|857-364-4128|barbara.niles@va.gov|
22432917|NCT03369665|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22432918|NCT03230318|Basilea Pharmaceutica International Ltd, Allschwil|Dr Manuel Häckl, MD|+41 76 302 53 10|manuel.haeckl@basilea.com|
22432919|NCT02933879|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
22432920|NCT00075764|SWOG|Breast Committee Statistician|206-667-4623||
22432921|NCT01531582|University of South Florida, Morsani College of Medicine|Edwin J. Weeber, Ph.D.|(813) 396-9995|eweeber@health.usf.edu|
22432922|NCT01057693|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22432923|NCT02959463|The University of Texas MD Anderson Cancer Center|Matthew Stephen Ning, MD, MPH|(832) 710-8779|msning@mdanderson.org|
22432924|NCT02413996|IRCCS Istituto Ortopedico Galeazzi, Milano|Davide Tornese|0266214046|davidzai@tin.it|
22432925|NCT00709319|Jaeb Center for Health Research|Adam R. Glassman, Director DRCR.net Coordinating Center|813-975-8690|drcrstat3@jaeb.org|
22432926|NCT00090779|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22432927|NCT02032758|Mayo Clinic in Arizona|Dr. Charles H. Adler|480-301-8100|cadler@mayo.edu|
22432928|NCT01672879|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22432929|NCT02179424|University of Hong Kong|Professor Lam Tai-Hing|39179287|hrmrlth@hku.hk|
22432930|NCT04930198|Vanderbilt University Medical Center|Dr. Martin Were|(617) 319-6462|martin.c.were@vumc.org|
22432931|NCT05069649|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22432932|NCT03951766|Massachusetts General Hospital, Psychiatry Department|Dr. Bettina Hoeppner|6176431988|bhoeppner@mgh.harvard.edu|
22432933|NCT00041470|University of Washington|Julie Gralow, MD|206-288-2053|pink@u.washington.edu|
22432934|NCT00515528|Department of Medicine|Thomas F. Gajewski|773-702-4601|tgajewsk@medicine.bsd.uchicago.edu|
22432935|NCT02623972|Dana-Farber Cancer Institute|Filipa Lynce, MD|617-632-4056|Filipa_Lynce@DFCI.HARVARD.EDU|
22432936|NCT04158375|Mayo Clinic|Dr. Sreekumaran Nair - Principal Investigator|507-284-2511|nair.sree@mayo.edu|
22432937|NCT04847843|University of Utah|Tanya Halliday, PhD, RD|801-213-1364|tanya.halliday@utah.edu|
22432938|NCT02734004|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22432939|NCT05615220|Emalex Biosciences Inc.|Drug Development and Medical Affairs|773 343 0671|mmiller@emalexbiosciences.com|
22421915|NCT04181606|The Pennsylvania State University|Dr. David Proctor|(814)863-0724|dnp3@psu.edu|
22421916|NCT02510664|Baylor College of Medicine|Marisa Hilliard PhD, Principal Investigator|832-824-7209|marisa.hilliard@bcm.edu|
22421917|NCT02053766|The University of Texas Health Science Center at Houston|Maria Matuszczak|713 -500-5075|maria.matuszczak@uth.tmc.edu|
22421918|NCT02414243|Laboratorios Ordesa|Roser De Castellar|+34 902105243|Roser.DeCastellar@ordesa.es|
22421919|NCT01297517|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22421920|NCT02914613|OcuTerra Therapeutics, Inc.|Chief Medical Officer|(617) 701-7382|info@ocuterratx.com|
22421921|NCT00423332|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22421922|NCT02035202|UCSD|Colin Depp|858 822 4251|cdepp@ucsd.edu|
22421923|NCT01998932|Imperial College London|Miss Sarah Onida|: +44 (0) 20 3311 7335|s.onida@imperial.ac.uk|
22421924|NCT00402688|Ortho-McNeil Janssen Scientific Affairs, LLC|Therapeutic Area Lead, Anti-Infective Franchise|908-927-5220||
22421925|NCT00758485|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22421926|NCT01136356|Johns Hopkins University, School of Medicine|Eric C. Strain, MD|410-550-1191|estrain1@jhmi.edu|
22421927|NCT00656292|Mayo Clinic|Michael J. Brown, M.D.|507-284-6317|Brown.Michael3@mayo.edu|
22421928|NCT03259425|Huntsman Cancer Institute|Data Manager, Research Compliance Office|8015850601|compliance@hci.utah.edu|
22421929|NCT04157296|University of Michigan|Yanni Liu|734-936-9275|yanniliu@med.umich.edu|
22421930|NCT02892110|MUSC|Amanda Wagner, Program Manager|843-792-0484|wagne@musc.edu|
22421931|NCT02088905|University of Pittsburgh|Benjamin L. Handen, PhD|412-235-5445|handenbl@upmc.edu|
22432940|NCT02388880|Advanced Circulatory Systems|Clinical Research Associate|651.403.5600|nburkhart@advancedcirculatory.com|
22432941|NCT01459666|University Hospitals Cleveland Medical Center|Dr. Kevin Cooper|216-844-3100|Kevin.Cooper@UHhospitals.org|
22432942|NCT01061385|ReShape Medical|Director of Clinical Operations|949-429-6680|lfong@reshapemedical.com|
22432943|NCT01404650|Sarah Cannon Research Institute|Johanna Bendell, MD|877-691-7274|asksarah@sarahcannon.com|
22432944|NCT00533429|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22432945|NCT03800030|University of North Carolina at Chapel Hill|Justin Riddle, PhD|6617131602|justin_riddle@med.unc.edu|
22432946|NCT04570371|Mayo Clinic|Dr. Andrea Cheville|(507) 284-2747|cheville.andrea@mayo.edu|
22432947|NCT02379052|Regeneron Pharmaceuticals, Inc|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
22432948|NCT04828135|Duke University|Loretta Que|919-681-8551|loretta.que@duke.edu|
22432949|NCT00127855|GlaxoSmithKline|GSK Response Center|866-435-7343||
22432950|NCT02343302|Johns Hopkins University|Director of Clinical Trials|410-955-7518|sleung7@jhu.edu|
22432951|NCT05089292|Icahn School of Medicine at Mount Sinai|Lina Jandorf|(212) 659-5506|lina.jandorf@mssm.edu|
22432952|NCT04229888|Indiana University School of Optometry|Anna Tichenor|812-855-0520|annatich@iu.edu|
22432953|NCT01282866|Laser & Skin Surgery Medical Group Inc.|Suzanne Kilmer, MD|916-456-0400|Study@skinlasers.com|
22432954|NCT04834726|University of Pennsylvania|Dr. Shivan Mehta|215-898-6027|shivan.mehta@pennmedicine.upenn.edu|
22432955|NCT00318929|Virginia Commonwealth University|Alan R. Towne, MD|804-282-9869|atowne@mcvh-vcu.edu|
22432956|NCT01339936|Optometric Technology Group|Dr Michel Guillon|+44 2072224224|mguillon@otg.co.uk|
22432957|NCT03542019|University of Jordan|Dr. Ahmad El-Ma'aita|+9626535 5000|a.maaita@ju.edu.jo|
22432958|NCT02948582|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
22432959|NCT03606486|University of Washington|Dr. Barbara Norquist|206-543-3669|bnorquis@uw.edu|
22432960|NCT00869167|California Pacific Medical Center|Brandon Lu, M.D., M.S.|415-923-3421|lubs@sutterhealth.org|
22432961|NCT00730353|Hoosier Oncology Group|Nasser Hanna, M.D.|317-274-3515|nhanna@iupui.edu|
22432962|NCT00415870|UCSD|Project Coordinator|858-534-9329|ldillon@ucsd.edu|
22432963|NCT04500457|Florida State University|Jesse Cougle|8506458729|cougle@psy.fsu.edu|
22432964|NCT01265992|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22432965|NCT02137070|University of Florida|Dr. Ronald Cohen|352-273-6124|roncohen@ufl.edu|
22432966|NCT03941483|Astellas Pharma Inc.|Clinical Trial Disclosure|+81 3-3244-6500 Japanese only|astellas.resultsdisclosure@astellas.com|
22393449|NCT00911937|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22432967|NCT04541667|University of Nebraska Medical Center|Chinenye Dike|402-955-5700|chinenye.dike@unmc.edu|
22432968|NCT02292537|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
22432969|NCT03154476|Mayo Clinic|Dr. Alexander Egbe|507-284-3725|Egbe.Alexander@mayo.edu|
22432970|NCT01444430|AstraZeneca Research and Development|Carin Jorup, Global Clinical Lead (GCL) SYMBICORT|+46 31 7761000|Carin.Jorup@astrazeneca.com|
22432971|NCT03368781|Acutus Medical, Inc.|Steve McQuillan|4422326080|steven.mcquillan@acutus.com|
22432972|NCT03300206|Hologic|Hologic Clinical Research Team|508.263.2900|ClinicalResearch@Hologic.com|
22432973|NCT01142388|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
22432974|NCT00802997|Baylis Medical|Meghal Khakhar, Director of Regulatory and Scientific Affairs|9056024875|mkhakhar@baylismedical.com|
22432975|NCT04357730|Denver Health Medical Center|Dr. Ernest Moore, Director of Surgical Research|3036021820|ernest.moore@dhha.org|
22432976|NCT05265728|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22432977|NCT03493451|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22432978|NCT01032954|Brazilian Center for Studies in Dermatology|Dr Doris Hexsel|555130262633|cientifico@cbed.org.br|
22432979|NCT03132532|Mayo Clinic|Dr. Steven E. Schild|480-342-4800|sschild@mayo.edu|
22432980|NCT02415244|University of Iowa Hosptials and Clinics|Kenichi Ueda|3193562633|kenichi-ueda@uiowa.edu|
22432981|NCT04150913|Massachusetts General Hospital|Director, Cellular Immunotherapy Program|857-367-1486|mghcancercenter@partners.org|
22432982|NCT01693250|University of California San Francisco|Dr. Jyu-Lin Chen|415-502-6015|jyu-lin.chen@ucsf.edu|
22432983|NCT01147965|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22432984|NCT02257242|Brown University Oncology Research Group|BrUOG|4018633000|BrUOG@BROWN.EDU|
22432985|NCT00600106|Cedars-Sinai Medical Center|C. Noel Bairey Merz|310-423-9680|Noel.BaireyMerz@cshs.org|
22432986|NCT00620373|Mayo Clinic|Dr. Deborah J. Rhodes|507-538-1703|rhodes.deborah@mayo.edu|
22432987|NCT04312932|Nationwide Children's Hospital|Sarah Keim|614-722-2000|sarah.keim@nationwidechildrens.org|
22432988|NCT01683630|Unversity of Manotiba|Salah Mahmud|204-272-3139|salah.mahmud@umanitoba.ca|
22393450|NCT01498679|GlaxoSmithKline|GSK Response Center|866-435-7343||
22410795|NCT03654898|Baylor College of Medicine Childrens Foundation Malawi|Maria Kim|+26599869090|mkim@tingathe.org|
22432989|NCT02213926|AstraZeneca Clinical -Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22432990|NCT01465386|FHCRC|Elihu Estey, MD|206-288-7176|eestey@seattlecca.org|
22432991|NCT02656836|Queen's University Belfast|Augusto Azuara-Blanco|2890976350|a.azuara-blanco@qub.ac.uk|
22432992|NCT02746406|Laborie|Clinical Researcher|9056121170|sbitzos@laborie.com|1755
22432993|NCT01279044|San Francisco Department of Public Health|Dr. Phillip Coffin, Director of Substance Abuse Research Unit|(415) 437 6282|phillip.coffin@sfdph.org|
22432994|NCT02975804|The Hong Kong Polytechnic University|Dr tamis W Pin|85227666751|tamis.pin@polyu.edu.hk|
22432995|NCT01408277|Smith & Nephew Biotherapeutics|Jaime E Dickerson, Jr, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
22393451|NCT01767701|Queen Mary University of London|Professor Gavin Giovannoni||g.giovannoni@qmul.ac.uk|
22432996|NCT03783962|University of Vermont Department of Nutrition and Food Sciences|Mattie Alpaugh|8026569526|malpaugh@uvm.edu|
22432997|NCT02370368|The University of the West Indies, Mona|Dr. Sharmella Roopchand-Martin|876-927-2235|sharmella.roopchandmartin@uwimona.edu.jm|
22432998|NCT01169337|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22410796|NCT00545233|Hoffman-LaRoche|Medical Communications|800-821-8590||
22410797|NCT06371079|Basrah Medical College|Loay Abdulmutalib Almusawi|009647705559205|loay.almusawi@uobasrah.edu.iq|
22410798|NCT01238211|The Ohio State University|Guido Marcucci, M.D.||Guido.Marcucci@osumc.edu|
22410799|NCT02868281|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22410800|NCT01335464|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22410801|NCT04525157|CLINUVEL PHARMACEUTICALS LTD|Clinical Operations Manager||mail@clinuvel.com|
22410802|NCT01741480|WashingtonU|Dr. Marin Kollef|314-454-8764|mkollef@dom.wustl.edu|
22410803|NCT02533999|Nemours Children's Specialty Care|Kathryn Blake, PharmD|904-697-3806|kathryn.blake@nemours.org|
22410804|NCT03210259|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22410805|NCT01392859|Children's Mercy Hospital|Dr. Bridgette Jones|816-302-3811|bljones@cmh.edu|
22410806|NCT03940586|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22410807|NCT04304950|Rush University Medical Center|Dr. Garth R. Swanson|312-563-3871|Garth_Swanson@rush.edu|33871
22410808|NCT02006147|Taiwan Liposome Company|Dr. Carl Brown|886-2-2655-7377|tlc_clinicaltrials@tlcbio.com|
22410809|NCT00990561|UCSF|John Koo, Principle Investigator|415-476-4701|john.koo@ucsfmedctr.org|
22410810|NCT03182686|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|7204376500|clinicaltrials@ampiopharma.com|
22410811|NCT01154127|Novartis Pharmaceuticals|Study Director|862-778-8300||
22410812|NCT01697449|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22410813|NCT01337050|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22410814|NCT00003102|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22410815|NCT05037409|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22410816|NCT04643782|Northwestern University|Phyllis Zee, MD|312-503-5944|SleepSensors@northwestern.edu|
22410817|NCT01989195|Stanford University|Phillip C. Yang, MD|650-498-8008|phillip@stanford.edu|
22410818|NCT01559818|Immodulon Therapeutics Ltd|Chief Medical Officer|+44 (0)20 3137 6346|info@immodulon.com|
22410819|NCT01565382|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22410820|NCT01512979|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22410821|NCT00529568|GlaxoSmithKline|GSK Response Center|866-435-7343||
22410822|NCT04049552|UT Health San Antonio|Dean L Kellogg Jr.|210-617-5311|kelloggd@uthscsa.edu|
22421932|NCT02653144|Montefiore Medical Center|Dr. Amaresh Vydyanathan|7189204316|avydyana@montefiore.org|
22421933|NCT04724538|P. Hertsen Moscow Oncology Research Institute|Mariia Sedova, MD|+79253093463|mariya.sedova58@gmail.com|
22421934|NCT02649439|National Cancer Institute|Dr. Ravi Madan|301-480-7168|rm480i@nih.gov|
22421935|NCT00911612|Mayo Clinic|Dr. Michael Camilleri|507-266-2306|camilleri.michael@mayo.edu|
22421936|NCT02097238|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22421937|NCT05393869|The Ohio State University College of Public Health|Dr. Joanne G. Patterson|614-247-1780|patterson.1191@osu.edu|
22421938|NCT01282372|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
22421939|NCT00214786|Baylor University Medical Center|Dr. Marlon Levy|214-820-2050|Marlon.Levy@baylorhealth.edu|
22421940|NCT02993250|Janssen Pharmaceutical K.K., Japan|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22421941|NCT00776295|H. Lee Moffitt Cancer Center|Mohamed Kharfan Dabaja, MD|961-1350000|MK143@aub.edu.lb|5350
22421942|NCT02861807|University of New Mexico|Katie Witkiewitz|505-277-4121|katiew@unm.edu|
22421943|NCT02560922|University of North Carolina at Chapel Hill|Kelli D. Allen, PhD|919-966-0558|kdallen@email.unc.edu|
22421944|NCT02094352|HSS|Dr. Richman|212.517.4481|RichmanD@HSS.EDU|
22421945|NCT00568061|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22421946|NCT05027451|InterveXion Therapeutics, LLC|Chief Operating Officer|501-554-2377|misty.stevens@intervexion.com|
22421947|NCT00356148|Marmara University School of Medicine|Prof. Bahadir M Gulluoglu|902164256565|bmgulluoglu@marmara.edu.tr|4012
22421948|NCT04316104|University of Kansas Alzheimer's Disease Research Center|Jaime Perales Puchalt|913-588-3716|jperales@kumc.edu|
22421949|NCT02693002|University of Kentucky|Dr. Gretchen Wells, PI||gretchen.wells@uky.edu|
22421950|NCT00812981|GlaxoSmithKline|GSK Response Center|866-435-7343||
22421951|NCT00694473|Massachusetts General Hospital|Steven J Russell, M.D. PhD|617-726-8722|sjrussell@mgh.harvard.edu|
22421952|NCT04666259|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22432999|NCT01692496|GEIS|Clinical Trial Coordinating Investigator|912866807|secretaria@grupogeis.org|
22433000|NCT01643408|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
22433001|NCT03726658|Gate Neurosciences, Inc|Chief Medical Officer|203-247-3895|ron.burch@gateneuro.com|
22433002|NCT05710640|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22433003|NCT04188509|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22433004|NCT04581785|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22433005|NCT01757301|Richard L. Roudebush VA Medical Center|Erica Evans|317-988-3476|erica.evans2@va.gov|
22433006|NCT02213068|Northwestern University|Lorenzo Gallon, MD|312-695-4457|l-gallon@northwestern.edu|
22433007|NCT03810014|Duke University|Wendy P O'Meara, PhD|919-681-7711|wpo@duke.edu|
22433008|NCT00958477|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22433009|NCT00049322|University of California Los Angeles|Carolyn Britten, M.D.|310 829 4971|cbritten@mednet.ucla.edu|
22433010|NCT00703963|Mayo Clinic|Dr. Hartzell V. Schaff|507-255-7068|schaff@mayo.edu|
22433011|NCT01081262|NRG Oncology|Linda Gedeon on behalf of William Brady, PhD|716-845-1169|lgedeon@gogstats.org|
22433012|NCT04684576|University of Washington Department of Rehabilitation Medicine|Dr. Heather Feldner, Study PI|2065433721|hfeldner@uw.edu|
22433013|NCT03994211|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22433014|NCT01107964|Milton S. Hershey Medical Center|Dr. David Liang|717-497-9469|dliang12@yahoo.com|
22433015|NCT01791491|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22433016|NCT00955474|Massachusetts General Hospital|John D. Matthews, MD|6177249144|jdmatthews@partners.org|
22433017|NCT04342091|Yale University|Brett King|(203) 785-7421|Brett.King@yale.edu|
22433018|NCT02148263|The University of Alabama at Birmingham|Dr. Andrew Pucker|920-579-2900|apucker@uab.edu|
22433019|NCT03900728|Columbia University Irving Medical Center|Carolyn Westhoff, MD|2123057070|clw3@cumc.columbia.edu|
22433020|NCT00517010|University of California Davis|Susanna Park MD PhD|916-734-6074|sscpark@ucdavis.edu|
22433021|NCT00585637|Dana-Farber Cancer Institute|Kimmie Ng, MD, MPH|617-632-4150|Kimmie_Ng@dfci.harvard.edu|
22433022|NCT00906178|Center for Innovative Public Health Reserch|Dr. Michele Ybarra|877-302-6858|michele@innovativepublichealth.org|1-801#
22433023|NCT01183429|Memorial Sloan Kettering Cancer Center|Brian Kushner, MD|212-639-6793|kushnerb@mskcc.org|
22433024|NCT01272037|SWOG Statistics and Data Management Center|Breast Committee Statistician|206-667-4623|dlew@fredhutch.org|
22433025|NCT01393899|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22433026|NCT02503085|Reckitt Benckiser Healthcare (UK) Ltd.|Clinical Research Director|+441482 326151||
22433027|NCT01027559|University of Pennsylvania|Dr. Yvette Sheline|215-573-0082|sheline@pennmedicine.upenn.edu|
22433028|NCT01162473|The Children's Hospital of Philadelphia|Rushani W. Saltzman MD|215-590-2549|allergyandimmunology@email.chop.edu|
22433029|NCT01144416|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22433030|NCT03662282|University of South Florida|Thao Ho|813-844-3437|tho1@usf.edu|
22433031|NCT02534883|St. Louis University|Donald Gregory Ward, MD|314-781-1505|dgreg.ward@health.slu.edu|1
22433032|NCT03328832|Kaohsiung Chang Gung Memorial Hospital|Dr. Wang JW|+886-7-7317123|wangjw@adm.cgmh.org.tw|8003
22433033|NCT00886769|Novartis Pharmaceuticals|Study Director|862-778-8300||
22433034|NCT00049257|Translational Oncology Research International|Dr. Fairooz Kabbinavar, Chief Medical Officer|310 824 1934|FKabbina@mednet.ucla.edu|
22433035|NCT00132301|VA Puget Sound Health Care System|Dr. Bruce Montgomery|206-277-6878|Robert.Montgomery@va.gov|
22433036|NCT03163134|University of Pittsburgh|Benita Valappil|412.864.1744|valappilb2@upmc.edu|
22433037|NCT01890265|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|067study@fibrogen.com|
22433038|NCT03674970|Penn State College of Medicine|Patricia Sue Grigson|717-531-5772|pgrigsonkennedy@pennstatehealth.psu.edu|
22433039|NCT05102383|The Ohio State University College of Optometry|Jennifer Fogt, OD MS|16142928858|OPTEyeStudies@osu.edu|
22433040|NCT05119582|Bispebjerg University Hospital|Prof. Joergen Serup|+1 21424888|joergen.vedelskov.serup@regionh.dk|
22433041|NCT03670355|San Francisco Department of Public Health|Dr. Albert Liu|4154377408|albert.liu@sfdph.org|
22433042|NCT03517436|Edwards Lifesciences|Director of Research|949-250-2500|THV_CT.gov@Edwards.com|
22433043|NCT04271540|Brigham and Women's Hospital|Brittany Weber, MD, PhD|6177326291|bweber@bwh.harvard.edu|
22433044|NCT02101788|NRG Oncology|Linda Gedeon for Austin Miller, PhD|716-845-1169|linda.gedeon@roswellpark.org|
22433045|NCT04587869|RAND|Laura Bogart|3103930411|lbogart@rand.org|7281
22433046|NCT02752490|The University of Texas Health Science Center at Houston|Nana-Ama E Ankumah, MD|713-500-6421|Nana.Ama.E.Ankumah@uth.tmc.edu|
22433047|NCT01102491|Joint Reconstruction Center, Seoul National University Bundang Hospital|TK Kim|82-31-787-7196|osktk@snubh.org|
22433048|NCT05823974|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22433049|NCT00316706|GlaxoSmithKline|GSK Response Center|866-435-7343||
22433050|NCT04956731|University of California, San Diego|Office of Clinical Trials Administration|858-822-2940|octa@ucsd.edu|
22433051|NCT04473950|University of California, San Francisco|David Andrew Tompkins, MD, MHS|628-206-3645|david.tompkins@ucsf.edu|
22433052|NCT01134614|ECOG Statistical Office|Study Statistician|617-632-3012||
22433053|NCT03279237|Massachusetts General Hospital|Dr. Theodore Hong|(617) 726-2000|TSHONG1@mgh.harvard.edu|
22433054|NCT01485796|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22433055|NCT02440139|Virginia Tech|Dr. ShihChung Benedict Lo|301-9215754|benlo@vt.edu|
22433056|NCT01766037|Aspire Bariatrics, Inc.|VP Regulatory & Quality|484-200-1031|monica.ferrante@aspirebariatrics.com|
22393452|NCT00424385|Oncology Specialists, SC|Sigrun Hallmeyer, MD Director of Research; Chadi Nabhan, MD FACP (PI)|847-268-8200|shallmeyer@oncmed.net|
22393453|NCT02057523|Loyola University Medical Center|Sanjeev Akkina|7082166389|sanjeev.akkina@lumc.edu|
22393454|NCT03307005|Johns Hopkins University|Rashmi Nisha Aurora, MD, MHS|443-513-6535|rnaurora@jhmi.edu|
22393455|NCT03174431|The Ohio State University|Silpa Nekkanti|614-293-4643|silpa.nekkanti@osumc.edu|
22421953|NCT02737930|University of Rochester|Bogachan Sahin|(585) 275-2530|bogachan_sahin@urmc.rochester.edu|
22421954|NCT04178122|VA Boston Healthcare System|Morgan Danowski|617-595-5385|morgan.danowski@va.gov|
22421955|NCT03124407|Vizuri Health Sciences|Vice President Clinical Operations|919-397-4782|twarneke@vizuriusa.com|
22421956|NCT05343364|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-7428|medicalinformation@phathompharma.com|
22421957|NCT01791894|Stanford University School of Medicine, Department of Dermatology|Jean Y Tang MD PhD|650-721-7149|baileyhi@stanford.edu|
22421958|NCT02705365|Massachusetts General Hospital|Sanja Percac-Lima, MD, PhD|617-643-6980|spercaclima@partners.org|
22421959|NCT00984542|Vanderbilt-Ingram Cancer Center|Leora Horn, MD|615-936-2033|leora.horn@vanderbilt.edu|
22421960|NCT01422889|Boston Scientific|Peter Maurer, MPH; Director, Clinical Trials|508-683-6678|Peter.Maurer@bsci.com|
22421961|NCT01757184|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22421962|NCT01959464|Carolinas Healthcare System|Bradley Hurst, M.D., Director of Assisted Reproduction|704-355-3149|bhurst@carolinas.org|
22421963|NCT04468347|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
22421964|NCT00994461|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22421965|NCT04339062|Dana-Farber Cancer Institute|Dr. Glenn Hanna|617-632-3090|glenn_hanna@dfci.harvard.edu|
22421966|NCT04586244|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22421967|NCT02505217|University of Vermont|David J Schneider, MD|802-656-8955|david.schneider@uvm.edu|
22421968|NCT00953654|The University of Georgia|Matthew P. Herring, PhD|706-542-4381|mph8@uga.edu|
22421969|NCT01334229|Laval University|Dr. Patrick Couture MD, PhD, FRCP|418-654-2106|patrick.couture@crchul.ulaval.ca|
22421970|NCT00153179|Brigham and Women's Hospital|Mark A. Creager|603-650-8283|Mark.A.Creager@hitchcock.org|
22421971|NCT03517540|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22421972|NCT04573322|Diffusion Pharmaceuticals|Chris Galloway, MD (Chief Medical Officer)|(434) 220-0718|cgalloway@diffusionpharma.com|
22421973|NCT00615550|Columbia Laboratories|George W Creasy MD|973-486-8797|Gcreasy@columbialabs.com|
22421974|NCT01408303|AstraZeneca Pharmaceuticals|Torbjörn Lundström||ClinicalTrialTransparency@astrazeneca.com|
22421975|NCT01801865|Cincinnati Children's Hospital Medical Center|Dr. Beth Kline-Fath|(513) 636-1856|beth.kline-fath@cchmc.org|
22421976|NCT02644668|Cytokinetics, Inc.|MD Cytokinetics|650-624-2929|medicalaffairs@cytokinetics.com|
22421977|NCT02915705|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
22421978|NCT01500382|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22421979|NCT05763875|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22421980|NCT01941745|"Tufts Medical Center | Division of Newborn Medicine"|Jonathan M. Davis, MD|(617) 636-5322|jdavis@tuftsmedicalcenter.org|
22421981|NCT00068393|ECOG Statistical Office|Study Statistician|617-632-3012||
22421982|NCT01399047|University of Rochester Medical Center|Erika Augustine, MD, MS|585-275-2808|erika_augustine@urmc.rochester.edu|
22421983|NCT00836888|Ono Pharmaceutical Co. Ltd|Ohyama Yukiya||y.ohyama@ono.co.jp|
22421984|NCT00893997|UT MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Associate Professor|713-792-7305|eharriso@mdanderson.org|
22421985|NCT03300505|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
22421986|NCT04532619|University of Oregon|Camille C. Cioffi|541-525-4886|ccioffi@uoregon.edu|
22421987|NCT01108341|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22421988|NCT01976650|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22421989|NCT04973176|University Hospitals Coventry and Warwickshire NHS Trust|Dr Cyprian Mendonnca|02476964000|cyprian.mendonca@uhcw.nhs.uk|25784
22421990|NCT00769067|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22421991|NCT05127330|Butler Hospital|Brandon Gaudiano, Ph.D.|401-455-6457|bgaudiano@butler.org|
22421992|NCT04981470|neuroloop|Clinical Affairs|+497611543390|study@neuroloop.de|
22421993|NCT04402138|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|SCRI.InnovationsMedical@scri.com|
22421994|NCT03960008|Lahey Hospital & Medical Center|Julia Roache, Manger, Research Programs|7817443055|julia.roache@lahey.org|
22421995|NCT03056638|Memorial Sloan Kettering Cancer Center|Dr. Michael Zelefsky, MD|212-639-6802|zelefskm@mskcc.org|
22421996|NCT00784238|Clinical Research Team, Medical Affairs Korea|Senior Clinical research Associate|82-2-2094-4804||
22421997|NCT02530125|Northwestern University|Winter, Jane MD|312 695 4033|Jwinter@nm.org|
22421998|NCT04325568|New York University|Dr. Lawrence Yang|(212) 992-6334|lawrence.yang@nyu.edu|
22421999|NCT00468481|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22422000|NCT00078767|Allegheny Singer Research Institute|Judith Cohen, MD||judith.cohen@ahn.org|
22422001|NCT00728468|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22422002|NCT00596687|Emory Univ SOM|Guillermo Umpierrez|4047781665|geumpie@emory.edu|
22422003|NCT06098339|CooperVision Inc.|José A. Vega, O.D., MSc., PhD, FAAO|925-621-3761|JVega2@coopervision.com|
22422004|NCT03831113|University of Pittsburgh|Dr Steve Caritis|412 641 4874|scaritis@mail.magee.edu|
22422005|NCT03508726|University of Iowa, Holden Comprehensive Cancer Center|Varun Monga, MD|319-384-9497|varun-monga@uiowa.edu|
22393456|NCT03097484|University of Kentucky|John Bauer, MD|859-218-2927|john.bauer@uky.edu|
22422006|NCT02498444|Stanford University|Jeffrey Feinstein, MD|6507252297|jeff.feinstein@stanford.edu|
22422007|NCT04286581|University of Minnesota|Dr. Jacob Hutchins, MD|612-624-9990|hutc0079@umn.edu|
22422008|NCT05656534|The Ohio State University|Dr. Stephanie Gorka|614-366-1027|stephanie.gorka@osumc.edu|
22422009|NCT00302848|Berlin Center for Epidemiology and Health Research, Germany|Juergen Dinger, MD, PhD, Principal Investigator|+49 30 94510145|dinger@zeg-berlin.de|
22422010|NCT01450306|Hartford Hospital|Dr David Tolin|860-545-7685|david.tolin@hhchealth.org|
22422011|NCT04687137|Shire|Study Director|: +1 866 842 5335|ClinicalTransparency@shire.com|
22422012|NCT00302328|Glostrup Hospital|Ulrik Christensen|+4538634825|bisan@regionh.dk|
22422013|NCT02464163|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
22422014|NCT00386360|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22422015|NCT00775229|University of Chicago|Dr. Jon Grant|773-834-1325|jongrant@uchicago.edu|
22422016|NCT02490371|QEHHongKong|Dr. Helen LUK|852-9208 5366|clkyz02@ha.org.hk|
22422017|NCT01718535|Mount Sinai Services Inc.|Azar Azad|416-856-8545|aazad@mtsinai.on.ca|
22422018|NCT03782012|William Jewell College|Dr. Amy Elizabeth Barth|816-415-7622|bartha@william.jewell.edu|
22422019|NCT02476578|CLALIT HEALTH SERVICES|Dr. Nir Tsabar|+97246049512|NIR.TSABAR@CLALIT.ORG.IL|
22422020|NCT01073605|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22422021|NCT03018080|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
22422022|NCT03491462|Zevra Denmark A/S|Medical Affairs|+1-888-289-5607|medicalaffairs@zevra.com|
22422023|NCT00740792|Meda Pharmaceuticals|David Ginsberg,D.O.|7325642364|david.ginsberg@meda.us|
22422024|NCT03612596|The University of Texas Medical Branch|Eloisa Martinez|409-266-9643|esmartin@utmb.edu|
22422025|NCT00026494|Memorial Sloan Kettering Cancer Center|Dr. Lisa Deangelis|212-639-7997|deangell@mskcc.org|
22422026|NCT01455597|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22422027|NCT04632069|Medical University of South Carolina|Dr Dorothea Jenkins|843-792-2112|jenkd@musc.edu|
22422028|NCT02573181|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22422029|NCT03412734|TriHealth Inc.|Catrina Crisp, MD MSc|513-463-4300|Catrina_Crisp@trihealth.com|
22393457|NCT01426867|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22422030|NCT03777436|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22422031|NCT00685399|Novartis Pharmaceuticals|Study Director|862-778-8300||
22422032|NCT03363776|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email:|Clinical.Trials@bms.com|
22422033|NCT01562782|The Rogosin Institute|Lisa Hudgins, M.D.|646-317-0805|lih2013@nyp.org|
22422034|NCT03451591|University of Edinburgh|Prof Joanna Wardlaw|0131 465 9599|joanna.wardlaw@ed.ac.uk|
22422035|NCT01421225|Boston Children's Hospital|Garry Steil (Assistant Prof. of Pediatrics)|617-355-7504|garry.steil@childrens.harvard.edu|
22422036|NCT00835224|James J Peters VAMC|Dr. Jill M. Wecht|718 584-9000|jm.wecht@va.gov|3122
22422037|NCT00945035|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22422038|NCT03761030|New York State Psychiatric Institute|Dr. Bret Rutherford|646 774 8660|bret.rutherford@nyspi.columbia.edu|
22422039|NCT03004638|MedImmune LLC|Richard George|+1-301-398-5681|information.center@astrazenea.com|
22422040|NCT05653479|Upstream Bio|Sumathi Sivapalasingam, Vice President of Clinical Development|1 917-499-0789|sumathi.sivapalasingam@upstreambio.com|
22422041|NCT02343939|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22422042|NCT02064816|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22422043|NCT05107492|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22422044|NCT03896022|Columbia University|Carolyn Westhoff, MD|212-305-4805|clw3@cumc.columbia.edu|
22422045|NCT02741076|Janssen Pharmaceuticals, Inc.|John Han, Associate Director, Statistics|484-354-3547|jhan9@its.jnj.com|
22422046|NCT01779440|Dartmouth-Hitchcock|Mary F. Brunette, MD|603-229-5419|Mary.F.Brunette@hitchcock.org|
22422047|NCT04138498|Cingulate Therapeutics|VP of Clinical Operations and Regulatory Affairs|913-942-2304|hmitzel@cingulatetherapeutics.com|
22422048|NCT00550745|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22422049|NCT00764660|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22422050|NCT01131455|ColumbiaOG|Vicki L Jones, Research Coordinator|573-443-2402|v.jones@columbiaorthogroup.com|4391
22422051|NCT02046005|Brigham and Women's Hospital|Dr. Elizabeth Karlson|617-732-5078|ekarlson@bwh.harvard.edu|
22422052|NCT04556084|Medical College of Wisconsin|Michael Burke|4149554198|mmburke@mcw.edu|
22422053|NCT04797611|Scion NeuroStim, Inc|Robert Black|919-260-5528|bacllc@earthlink.net|
22422054|NCT03867409|Mayo Clinic of Jacksonville|Dr. Janice Krieger|904-953-6160|krieger.janice@mayo.edu|
22422055|NCT05864612|Wake Forest University Health Sciences|Heidi Munger-Clary, MD, MPH, FACNS, FAES|336-716-7110|heidi.mungerclary@advocatehealth.org|
22422056|NCT05119595|B.Braun Aesculap|Diana Kupferschmid, Study Manager of B. Braun|0049746195|studies@aesculap.de|0
22422057|NCT01806961|Sipirig AG|Dr. Francine Santoro|+41 62 387 87 87|francine.santoro@galderma.com|87 20
22422058|NCT03100968|University of Alabama at Birmingham|Adam Sturdivant|205-934-4042|Adamsturdivant@uabmc.edu|
22422059|NCT00839800|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22393458|NCT00461513|Veterans Health Administration|Dr. Meg Plomondon|303-370-75770|Meg.Plomondon@va.gov|
22433057|NCT03697161|Ovid Therapeutics|Todd F. Baumgartner, M.D., MPH|8027525168|tbaumgartner@ovidrx.com|
22433058|NCT00292045|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
22433059|NCT02236572|Yale Cancer Center|Lajos Pusztai, MD, DPhil|(203) 200-2328|lajos.pusztai@yale.edu|
22433060|NCT00606411|Massachusetts General Hospital|Dr. John W. Winkelman|617-643-9101|jwwinkelman@partners.org|
22433061|NCT00412958|ThromboGenics|Petra Kozma-Wiebe, MD|+32 16751310|petra.kozma@thrombogenics.com|
22433062|NCT01318135|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
22433063|NCT01017042|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22433064|NCT00598507|H. Lee Moffitt Cancer Center and Research Institute|Ronald DeConti, M.D., Principal Investigator|813-745-8466|ronald.deconti@moffitt.org|
22433065|NCT04767061|Weill Cornell Medicine|Princess Osma|646-962-5910|pro4001@med.cornell.edu|
22433066|NCT03465722|Blueprint Medicines|Medical Information Call Center|1-888-258-7768|medinfo@blueprintmedicines.com|
22433067|NCT01541865|Boston Scientific|Angela Schutt, Clinical Trial Manager|763-494-2166|angela.schutt@bsci.com|
22433068|NCT00604552|Medtronic Vascular|Angela Parsons|707-591-2293|angela.r.parsons@medtronic.com|
22433069|NCT01140867|Eisai Korea Inc.|Jihee Mun, Pharmacist, Medical Department manager|+82-2-3451-5531|jihee_mun@eisaikorea.com|
22433070|NCT03205358|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22433071|NCT03579693|University of Washington|Bryan Kestenbaum, MD|206-685-7343|brk@uw.edu|
22433072|NCT04970069|Cleveland Clinic|Dr. Alparslan Turan|2162172312|turana@ccf.org|
22433073|NCT00503425|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22433074|NCT00881530|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22433075|NCT02100930|Memorial Sloan Kettering Cancer Center|Dr. Brian Kushner, MD|212-639-6793|kushnerb@mskcc.org|
22433076|NCT00003869|Mayo Clinic|Dr. Edith A. Perez||perez.edith@mayo.edu|
22433077|NCT00763256|Colgate Palmolive Co.|William DeVizio, DMD|732-878-7901|william_devizio@colpal.com|
22433078|NCT03364231|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
22433079|NCT02622295|University of Iowa Department of Physical Therapy and Rehabilitation Science|Dr. Richard K. Shields|319-335-9791|richard-shields@uiowa.edu|
22433080|NCT00124072|CTSU, University of Oxford|CTSU Reception|01865 743743|secretary@ctsu.ox.ac.uk|
22433081|NCT04373421|Tekirdag Namik Kemal University|Dr. Volkan Kaplan|+90282250000|dr.volkankaplan61@gmail.com|6307
22433082|NCT02157909|Alcon Research, Ltd.|Head Clinical Development, Vision Care, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
22433083|NCT00943761|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22433084|NCT02268383|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22433085|NCT04581811|UAB Hospital|David Page - PI|205-975-7387|dpage1@uabmc.edu|
22433086|NCT02708680|Syndax Pharmaceuticals, Inc.|Kate Madigan, MD, Chief Medical Officer|858-888-3798|kmadigan@syndax.com|
22433087|NCT01342926|GlaxoSmithKline|GSK Response Center|866-435-7343||
22433088|NCT04162470|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22433089|NCT03382912|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22433090|NCT04687917|The Ohio State University|Dr. Bryan R. Garner|6142573462|bryan.garner@osumc.edu|
22433091|NCT05441527|University of Iowa|Dr. Robert Bowers|(319) 467-3199|robert-bowers@uiowa.edu|
22433092|NCT01402869|Loma Linda University|Dr. Lauren Gutenberg|909-558-4690|lgutenberg@llu.edu|
22433093|NCT01544348|MedImmune|Claire Birrell, Senior Clinical Scientist|301-398-0000|birrellc@medimmune.com|
22433094|NCT00642707|CytoDyn, Inc.|Kush Dhody|301-956-2536|kushd@amarexcro.com|
22433095|NCT05069012|Beth Israel Deaconess Medical Center|Philip Hess|617-667-3112|phess@bidmc.harvard.edu|
22433096|NCT00125788|Emmaus Medical, Inc.|Yutaka Niihara, MD, MPH|310-214-0065|yniihara@emmausmedical.com|
22433097|NCT02573948|UMR 1058 (Inserm/University of Montpellier/EFS)|NAGOT NICOLAS|+33 4 34 35 91 09|n-nagot@chu-montpellier.fr|
22433098|NCT00707993|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22433099|NCT01876212|UPMC Hillman Cancer Center|Barbara Stadterman, MPH MCCR|412-647-5554|stadtermanbm@upmc.edu|
22433100|NCT00436436|National Cancer Institute|Dr. Mark Gilbert|301-402-6383|gilbertmr@mail.nih.gov|
22433101|NCT00947219|Lexington International, LLC|David Michaels|561-417-0200|dm@hairmax.com|
22433102|NCT01837680|Roosevelt Hospital, Mount Sinai Health System|Dr. Kimberly M. Herrera||kimmerher@gmail.com|
22433103|NCT03008070|Inventiva S.A.|Dr Michael Cooreman, Chief Medical Officer|+33380447616|native.public@inventivapharma.com|
22433104|NCT05005273|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@BMS.com|
22433105|NCT04409834|Brigham and Women's Hospital|COVID-PACT Project Manager|(617) 278-0145|covid-pact@bwh.harvard.edu|
22433106|NCT03081689|Fundación GECP|Eva Pereira|+34934302006|gecp@gecp.org|
22433107|NCT03960684|Levita Magnetics|Vivian Soto|+56958360507|VSoto@Levita.com|
22393459|NCT02706899|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
22433108|NCT05223673|Institut de Recherches Internationales Servier (I.R.I.S.)|Clinical Studies Department|+33 1 55 72 60 00|scientificinformation@servier.com|
22433109|NCT04266912|M.D. Anderson Cancer Center|Timothy A. Yap|713-563-1930|tyap@mdanderson.org|
22422060|NCT03915587|University of Colorado|Sarkis Chris Derderian|720-777-6163|sarkis.derderian@childrenscolorado.org|
22422061|NCT02417142|UMass Medical School|Xiaoduo Fan, MD, MPH|(508) 856 -3881|xiaoduo.fan@umassmed.edu|
22422062|NCT04511520|National medical research center for therapy and preventive medicine|Dr. Maria Makhinova|+79104803524|longtimeaftertomorrow@gmail.com|
22422063|NCT03421210|Duke University|Anthony DeVito, MD|919-684-1377|anthony.devito@duke.edu|
22422064|NCT00912743|Astra Zeneca LLP|Angela Sawyer, Clinical Delivery Director|+44 1625 512397|angele.sawyer@astrazeneca.com|
22422065|NCT02973503|CHU Clermont-Ferrand|Armand Abergel|+33473750523|aabergel@chu-clermontferrand.fr|
22422066|NCT03431831|University of Nebraska Medical Center|Trina Aguirre|308-632-0410|taguirre@unmc.edu|0412
22422067|NCT00179660|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22422068|NCT04478695|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22422069|NCT00644917|Smith & Nephew Biotherapeutics|Jaime E Dickerson, Jr, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
22422070|NCT00178685|University of Rochester|Dr. Geoffrey Williams|585-530-2050|geoffrey_williams@urmc.rochester.edu|
22422071|NCT00927862|Intermountain Healthcare|Dr. Jeffrey L. Anderson, Director of CV Research and Professor of Medicine|801-507-4704|jeffrey.anderson@imail.org|
22422072|NCT00820248|Canadian Cancer Trials Group|Wendy Parulekar|613-533-6430|wparulekar@ctg.queensu.ca|
22422073|NCT01566539|Emory University|Dr. James Rilling|404-727-3062|jrillin@emory.edu|
22422074|NCT02049905|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22422075|NCT03980145|Indiana University|Peter Altenburger|3172780703|paltenbu@iu.edu|
22422076|NCT01057810|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22422077|NCT00267969|Centocor Research & Development, Inc.|Dir. Clinical Research|1-800-457-6399||
22422078|NCT00862823|University of Alabama at Birmingham|Jennifer King|205-934-2696|jenking@uab.edu|
22422079|NCT00887315|Department of Health Studies, University of Chicago|Dr. Sang Mee Lee|773-834-6765|slee@health.bsd.uchicago.edu|
22422080|NCT01309360|Helios-Kliniken Schwerin|Dr.med.Ronald Seidel|0049 (0)385 520-4251|ronald.seidel@helios-kliniken.de|
22422081|NCT00291876|GlaxoSmithKline|GSK Response Center|866-435-7343||
22422082|NCT00619892|UCSF Fresno|Andrew Goddard, M.D.|559-499-6580|agoddard@fresno.ucsf.edu|
22422083|NCT02901067|Denver Health Medical Center|Study Coordinator, James Chandler|303-602-3798|james.chandler@dhha.org|
22422084|NCT00942890|University of Tennessee Health Science Center|Dr. Laura Talbot|901-448-3630|ltalbot@uthsc.edu|
22422085|NCT00821964|University of Washington|Principal Investigator||TrialTVG@medicine.washington.edu|
22422086|NCT00857896|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22422087|NCT02308540|PATH|Dr. Steve Lamola|1-206-285-3500|slamola@path.org|
22422088|NCT01091662|Sunovion Phamaceuticals Inc.|Eslicarbazepine acetate Medical Director|866-503-7813|clinicaltrialsdisclosure@sunovion.com|
22422089|NCT04109391|Tanvex|Study Director|19494838507|jennifer.lai@tanvex.com|
22422090|NCT02285166|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22422091|NCT00443079|UCSDMED|Dr. Heather Patton|619-543-2470|hpatton@ucsd.edu|
22422092|NCT01106911|University of Pittsburgh|Dr. Jules H. Sumkin|412-641-1976|jsumkin@upmc.edu|
22422093|NCT04922255|University of Pittsburgh|Megan Bradley, MD|2487701681|megsbrad2010@gmail.com|
22422094|NCT02073448|Galderma K.K|Clinical Project Manager|+81 3 5937 3850|GaldermaKK.ClinDev@galderma.com|
22422095|NCT00648115|VA North Texas Health Care System|James LePage|210-857-0240|james.lepage@va.gov|
22422096|NCT05708976|University of California San Francisco|Ashley E. Mason, PhD|4155146820|ashley.mason@ucsf.edu|
22422097|NCT02684097|Icahn School of Medicine at Mount Sinai|Dr. Emma Guttman|212-241-9728|emma.guttman@mountsinai.org|
22422098|NCT03218826|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
22422099|NCT02683928|Ichnos Sciences SA|Study Director|2013314000|clinicaltrialsdisclosuredesk@ichnossciences.com|
22422100|NCT02858583|University of Alberta|Georg Schmölzer|780-735-4647|schmolze@ualberta.ca|
22422101|NCT01786161|Massachusetts General Hospital|Hsin Lin|6177241314|hlin13@mgh.harvard.edu|
22422102|NCT00580151|University of Texas-Galveston|Walter Meyer, M.D.|409-770-6718|wmeyer@utmb.edu|
22422103|NCT01453088|Hackensack Meridian Health|Joshua Zenreich|15519964248|joshua.zenreich@hmhn.org|
22422104|NCT03564119|Sol-Gel Technologies, Ltd.|Sol-Gel|972-8-9313433|info@sol-gel.com|
22422105|NCT00634036|University of Pittsburgh|Dr. Fernando Holguin|412-692-2817|holguinf@upmc.edu|
22422106|NCT00961350|POZEN|John Fort, MD / Chief Medical Officer|919-913-1030|jfort@pozen.com|
22422107|NCT03867201|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22422108|NCT01190410|Cares|UCB|+1844599|UCBCares@ucb.com|2273
22422109|NCT02260869|Lumbrera LLC|David Cedeno|3098266974|dclumbrera@gmail.com|
22422110|NCT02986282|Warsaw Medical University|Dr Jacek Lewandowski|5992828|jlewandowski@wum.edu.pl|+48 22
22422111|NCT01283334|Emory University|Nabil F. Saba, MD|404-778-1900|nfsaba@emory.edu|
22422112|NCT03467217|Johns Hopkins Bloomberg School of Public Health|Laura Wilson|410-955-0719|lwilson9@jhu.edu|
22422113|NCT04390503|Columbia University|Jessica Justman, MD|212-342-0537|jj2158@cumc.columbia.edu|
22422114|NCT01113385|Children's National|Asha Moudgil MD, Professor of Pediatrics|202-476-5058|amoudgil@childrensnational.org|
22422115|NCT04392375|The Ohio State University|Kara Rood, MD|440-321-0264|Kara.Rood@osumc.edu|
22433110|NCT02685826|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22433111|NCT02052661|GlaxoSmithKline|GSK Response Center|866-435-7343||
22433112|NCT01133756|Eisai Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22433113|NCT02234713|Hospital for Sick Children|Dr. Ann Yeh|416-813-7353|ann.yeh@sickkids.ca|207353
22433114|NCT03941873|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
22393460|NCT03211117|Mayo Clinic|Ashish V. Chintakuntlawar, MBBS, Ph.D.|(855) 776-0015|Chintakuntlawar.Ashish@mayo.edu|
22393461|NCT00633880|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
22393462|NCT03916458|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22393463|NCT01413503|University of California, San Francisco|Paul A. Fitzgerald, MD|415-665-1136|Paul.Fitzgerald2@ucsf.edu|
22393464|NCT02546921|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
22393465|NCT01373151|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
22393466|NCT01546675|Department of Veterans Affairs|Linda Resnik, PT, PhD|401-273-7100|linda.resnik@va.gov|2368
22393467|NCT01253070|Washington University School of Medicine|Geoffrey Uy, MD||guy@dom.wustl.edu|
22393468|NCT00878826|Stanford University|Dr. Deirdre Lyell|650-736-1191|dlyell@stanford.edu|
22393469|NCT01468181|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22393470|NCT00545753|ParaPRO LLC|Director of Quality and Regulatory|317-810-6205|kerrym@parapro.com|
22393471|NCT00513305|Cephalon, Inc.|Sponsor's Medical Expert, Clinical Research|1-800-896-5855||
22393472|NCT00636805|Duke University Medical Center|Mary Lou Affronti|919-6846239|mary.affronti@dm.duke.edu|
22393473|NCT01262027|The University of Texas (UT) MD Anderson Cancer Center|Vicente Valero, MD/Professor, Breast Medical Oncology|713-792-7734|vvalero@mdanderson.org|
22393474|NCT03491891|First Hospital of Jilin University|Xiang Wang|+86-13504321434|jdwxiang123@126.com|
22393475|NCT00710905|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22393476|NCT01011153|MELA Sciences, Inc.|Joanna Adrian, Director of Clinical Operatons and Medical Affairs|914-591-3783|adrian@melasciences.com|732
22393477|NCT03014479|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22393478|NCT00610740|Masonic Cancer Center, University of Minnesota|Levi Downs, Jr., M.D.|612-626-6628|downs008@umn.edu|
22393479|NCT00531453|Johnson & Johnson Pharmaceutical Research & Development|Dr. Helgi van de Velde||HVDVELDE@ITS.JNJ.COM|
22393480|NCT03419832|Wake Forest School of Medicine|Joseph E. Andrews, Jr., PhD, CIP, CCRP|336-716-7658|jandrews@wakehealth.edu|
22393481|NCT01081132|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22393482|NCT03973931|University of Colorado|Dr. Michael Ho|303-590-5969|michael.ho@cuanschutz.edu; p.michael.x-ho@kp.org|
22393483|NCT04214600|Cairo University|Dr. Nadine Mansour|(+2)01001482455- 01001465719|lotfynadine@gmail.com|
22393484|NCT00896051|Tibotec|Senior Director|+32 (0) 14 641 265||
22393485|NCT02935452|University of Southampton|Ms Lindsay Welch|07881205106|lw13e14@soton.ac.uk|
22393486|NCT00210470|University of Michigan Hospital|Gregory T. Wolf||gregwolf@umich.edu|
22393487|NCT01813929|University of Colorado Denver|Irene Schauer, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
22393488|NCT00007345|National Cancer Institute|Dr. Kieron Dunleavy|301-435-1007|DunleavK@mail.nih.gov|
22393489|NCT04433585|Nektar Therapeutics|Study Director|8554828676|StudyInquiry@nektar.com|
22393490|NCT00936741|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
22393491|NCT03356626|Seoul National University Hospital, Seoul National University College of Medicine|Seong-Ho Kong|+82-2-2072-4199|seongho.kong@snu.ac.kr|
22393492|NCT01164644|University of Wisconsin School of Medicine and Public Health|Dr. Scott R. Chaiet|(608) 263-1092|scottchaiet@yahoo.com|
22393493|NCT04513652|American Genomics, LLC|Martin Uram, MD|848-444-0665|martin@amgenomics.net|
22393494|NCT00692276|Vertiflex|Steve Reitzler|442-325-5934|sreitzler@vertiflex.com|
22393495|NCT04988867|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|+1-858-261|medicalinformation@acadia-pharm.com|2897
22393496|NCT02015455|University of Washington|Dr. Sandra K Johnston, PhD, RN Executive Administrative Director- CLEAR Center|206-221-7444|stonesk@uw.edu|
22393497|NCT01097707|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22393498|NCT03212989|University of North Carolina at Chapel Hill|Cynthia Gay, MD, MPH|919-966-6712|cynthia_gay@med.unc.edu|
22393499|NCT03775434|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
22433115|NCT03276728|Amgen (EUROPE) GmbH|IHQ Medical Info-Clinical Trials|866-572-6436|MedInfoInternational@amgen.com|
22422116|NCT03656692|Mallinckrodt|Medical Information Call Center|800-844-2830|medinfo@mnk.com|
22422117|NCT02497040|uludag university|Dr.Banu Otlar Can|+905323827044|botlar@hotmail.com|
22422118|NCT03233529|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22422119|NCT03260244|Abbott|Associate Director, Clinical Research, Electrophysiology|651-756-3813|anne.sarver@abbott.com|
22422120|NCT01177293|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22422121|NCT00594100|W. L. Gore & Associates|Andrew Garcia|(800) 437-8181|AGarcia@WLGore.com|
22422122|NCT02448537|Massachusetts General Hospital|Gregory Cote, M.D., Ph.D|617-724-4000|gcote@partners.org|
22422123|NCT03528369|Vizuri Health Sciences|Vice President Clinical Operations|919-397-4782|twarneke@vizuriusa.com|
22422124|NCT04725812|Cedars-Sinai Medical Center|Professor of Medicine, Cedars-Sinai Medical Center|310-423-7608|sananth.karumanchi@csmc.edu|
22422125|NCT05778851|PAVmed Inc., Lucid Diagnostics Inc.|Victoria T. Lee, MD CMO, SVM Clinical Affairs|425.218.6535|VTL@PAVmed.com|
22422126|NCT00742963|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilson@thresholdpharm.com|
22422127|NCT00735969|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|High Dose Ribavirin in Combination With Peginterferon for Patients With Chronic Hepatitis C Genotype|(301) 402-5115|mg228m@nih.gov|
22422128|NCT02801617|Laboratorios Sophia|Dr. Oscar Olvera|(33) 3001 4200|oscar.olvera@sophia.com.mx|1074
22422129|NCT04747886|Cedars-Sinai Medical Center|Dr. Sarah-Jeanne Salvy|310-423-6423|sarah.salvy@cshs.org|
22422130|NCT02237196|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22422131|NCT03728348|Exact Sciences|Alexandra Massoud, Sr. Director of Clinical Affairs|608.284.5700|clinicaltrials@exactsciences.com|
22422132|NCT01814696|Partners Healthcare Connected Health Innovation|Kamal Jethwani, MD, MPH|617-724-3410|kjethwani@partners.org|
22422133|NCT02730403|NYU Grossman School of Medicine|John Rotrosen|646-754-4763|john.rotrosen@nyulangone.org|
22422134|NCT05310071|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22422135|NCT02105987|GlaxoSmithKline|GSK Response Center|866-435-7343||
22433116|NCT01541735|Instituto Mexicano del Seguro Social|PhD. Manuel González Ortiz|33 36176000|uiec@prodigy.net.mx|31494
22433117|NCT00617084|Medtronic Bakken Research Center B.V.|Miraida Weldam|+ 31 43 356|miraida.weldam@medtronic.com|6652
22422136|NCT02418949|Shirley Ryan AbilityLab|Alexander Barry|3122381435|abarry@sralab.org|
22422137|NCT00396656|Novartis Pharmaceuticals|Study Director|862 778-8300||
22422138|NCT02755467|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
22422139|NCT01303172|Immodulon Therapeutics Ltd|Chief Medical Officer|+44 (0) 20 3137 6346|info@immodulon.com|
22422140|NCT00462709|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22422141|NCT03635515|University of Minnesota|Ronald Ordinola Zapata DDS, MS, PhD|(612) 624-9900|rordinol@umn.edu|
22422142|NCT03278223|Visioncare Research Ltd.|Mr Thomas Boyes, Clinical Project Manager|+441252 718719|t.boyes@visioncare.co.uk|223
22422143|NCT02099110|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22422144|NCT01435304|Maine Medical Center|Dr. Robert S Kramer|207-662-1486|Kramer@mmc.com|
22422145|NCT02293512|VA Portland Healthcare System|Erin Martz, PhD|503.220.8262|erin.martz@va.gov|56006
22422146|NCT03515811|Medtronic|Andrea DiScipio, Senior Clinical Research Specialist|781-491-5350|andrea.l.discipio@medtronic.com|
22422147|NCT00237458|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22422148|NCT04657198|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22422149|NCT02977572|INTENSIVE CARE UNIT. HOSPITAL GENERAL UNIVERSITARI CASTELLO|Dr. Alberto Belenguer Muncharaz|0034-964-725000|belengueralberto8@gmail.com|
22422150|NCT04571645|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
22422151|NCT01166438|RTI International|Dr. Marie Gantz|919-597-5110|mgantz@rti.org|
22422152|NCT01075256|GlaxoSmithKline|GSK Response Center|866-435-7343||
22422153|NCT03502070|Director Global Clinical Operations, General Medicine|Keri L Vaughan|+1 267.980.5015|keri.vaughan@mylan.com|
22422154|NCT04321356|University of Tennessee|Michael LaCour|865-974-9376|mlacour@utk.edu|
22422155|NCT01197534|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
22422156|NCT02115581|Children's Medical Center|Giv Heidari-Bateni MD/MPH|3142991984|givhb@yahoo.com|
22422157|NCT03723850|University of Chicago|Dr. David Gallo|773-702-8829|dgallo@uchicago.edu|
22422158|NCT03147690|Boston Children's Hospital|Dr. David Mooney, MD MPH|617-355-7800|david.mooney@childrens.harvard.edu|
22422159|NCT02593097|Mayo Clinic|Amaal J. Starling, M.D.|480-301-6574|Starling.Amaal@mayo.edu|
22422160|NCT03759587|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22422161|NCT02060838|Nationwide Children's Hospital|Aymen Naguib, MD|(614) 722-0596|Aymen.Naguib@nationwidechildrens.org|
22422162|NCT00591565|SUNY Upstate|Thomas Schwartz|3154643166|schwartt@upstate.edu|
22422163|NCT00454363|UT MD Anderson Cancer Center|Dr. James Yao, MD/Professor, GI Medical Oncology, Study Principal Investigator|713-792-2828|jyao@mdanderson.org|
22422164|NCT02811965|Lincoln Memorial University|Jennifer Savage, DNP, APN, FNP-BC||jennifer.savage@lmunet.edu|
22422165|NCT01554527|University of Michigan|Dr. Ronald Chervin|734-647-9064|chervin@med.umich.edu|
22422166|NCT01094574|Stanford School of Medicine|Martin Angst, MD, Professor, Dept. of Anesthesia, Stanford SOM|650-498-5109|ang@stanford.edu|
22422167|NCT01863667|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22422168|NCT01992172|Physicians Institute|Sharon Keene, MD|(520) 290-5555|monican@appliedbiology.com|
22422169|NCT01537042|UCB Clinical Trial Call Center|Study Director|+1 887 822 9493||
22422170|NCT01115244|Vanderbilt University Medical Center|Mary Beth Cole|(615) 322-6485||
22422171|NCT00315458|Purdue Pharma L.P.|Clinical Leader, Executive Medical Director|800-733-1333||
22422172|NCT01294241|Amryt Pharma|Head of Clinical Development|+353 1 669 4606|medinfo@amrytpharma.com|
22422173|NCT01669863|Hannover Medical School|Dr Marius Hoeper|00495115323530|hoeper.marius@mh-hannover.de|
22422174|NCT00086619|Massachusetts General Hospital|Robert Neer, MD|617-726-6723|rneer@partners.org|
22422175|NCT00489918|Zosano Pharma Inc.|Don Kellerman, VP of Clinical Development and Medical Affairs|(510) 745-4004|dkellerman@zosanopharma.com|
22422176|NCT02748213|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22433118|NCT03573206|Cardiva Medical|Terry Alverson, Director of Regulatory and Clinical|650-207-0563|Terry_Alverson@cardivamedical.com|
22433119|NCT00416494|Duke University Medical Center|Brant Hamel|919-68-1861|brant.hamel@duke.edu|
22433120|NCT02574078|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22433121|NCT02222688|University of California, San Diego|Thomas Kipps, MD, PhD|858-534-5400|tkipps@ucsd.edu|
22433122|NCT06219967|SUNY Upstate Department of Emergency Medicine|Michael Keenan, MD|315-416-4457|keenanm@upstate.edu|
22433123|NCT05875727|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22433124|NCT01530178|Children's Hospital at Montefiore|Dr. Rubina Heptulla|718-920-7004|rheptull@montefiore.org|
22433125|NCT05935878|University of Oxford, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences|Professor David W Murray|+44 01865 27457|david.murray@ndorms.ox.ac.uk|
22433126|NCT03980743|Washington University School of Medicine|Dr. Ginger E. Nicol|314-747-1862|nicolg@wustl.edu|
22433127|NCT02709512|Polaris Pharmaceuitcals Inc|Dr. Mirla Langlois|858-452-6688|mlanglois@polarispharma.com|161
22433128|NCT02155101|University of Liverpool|Professor Anna Maria Geretti|+44(0)151 795 9625|Geretti@liverpool.ac.uk|
22433129|NCT01834287|Brown University|Bess Marcus|4018636850|bess_marcus@brown.edu|
22433130|NCT05327660|Consumer Wellness Solutions/RVO Health|Dr. Kristina Mullis|765-265-9169|kmullis@rvohealth.com|
22433131|NCT00276406|Mayo Clinic|Adil E. Bharucha, MD|507-284-6439|bharucha.adil@mayo.edu|
22433132|NCT04248712|Mayo Clinic|Dawn Francis, M.D.|904-953-2254|Francis.Dawn@mayo.edu|
22433133|NCT02297815|Children's Hospital of Philadelphia|Dr. Jeffrey Gerber|(267) 426-8775|gerberj@email.chop.edu|
22433134|NCT00662831|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22433135|NCT01966354|Complejo Hospitalario de Navarra|Dr. Mikel Batllori|0034 848422174|mikel.batllori.gaston@cfnavarra.es|
22433136|NCT00252512|Minneapolis VA Health Care System|Hildi Hagedorn|612-467-3875|hildi.hagedorn@va.gov|
22433137|NCT02346903|Bassett Healthcare Network Research Institute|Melissa B Scribani|6075477635|melissa.scribani@bassett.org|
22433138|NCT03440463|Old Dominion University|Dr. Abby Braitman|757-683-3708|abraitma@odu.edu|
22433139|NCT02397915|GlaxoSmithKline|GSK Response Center|866-435-7343||
22433140|NCT03292874|Cedars Sinai Medical Center|Dr. Hyung L Kim|310-423-4700|kimhl@cshs.org|
22433141|NCT00368745|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22433142|NCT02476032|University of Minnesota|Patricia Lenton Director of Oral Health Research Clinic||lento001@umn.edu|
22433143|NCT00293813|Amgen Inc.|Study Director|866-572-6436||
22433144|NCT01188551|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-4200|Joseph.Tobias@nationwidechildrens.org|
22433145|NCT01537315|University of Arkansas for Medical Sciences|Dumitru Rotaru, MD, PI|501/526-6919|drotaru@uams.edu|
22433146|NCT03323853|University of Arkansas for Medical Sciences|Dr. Michael Wilson|501-686-5515|MPWilson@uams.edu|
22433147|NCT01306643|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22433148|NCT01179984|Bard Peripheral Vascular|Associate Director of Clinical Affairs|480-379-2838|josh.smale@crbard.com|
22433149|NCT01947335|Heart Institute (Incor)|Dr. Pedro A. Lemos|+55 11 2661 5000|pedro.lemos@incor.usp.br|
22433150|NCT00901225|Duke University Medical Center|Mitchell E Horwitz, MD, Principal Investigator|919-668-1045|mitchell.horwitz@duke.edu|
22433151|NCT03458325|scPharmaceuticals|Sr. Vice President, Clinical Development and Medical Affairs|(855) 727 4276|jmohr@scpharma.com|
22433152|NCT00414076|UT MD Anderson Cancer Center|Coleman,Robert,M.D. / Gyn Onc & Reproductive Medicine|7137923203|RColeman@mdanderson.org|
22433153|NCT02720523|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22433154|NCT03146663|NuCana Plc|Medical and Scientific Affairs Department|01313571116|info@nucana.com|
22433155|NCT01166347|Medtronic|Thomas Vassiliades|+15085321942|thomas.a.vassiliades@medtronic.com|
22433156|NCT03541499|Vanderbilt Vaccine Research Program|Dr. C Buddy Creech|615-3430332|buddy.creech@vanderbilt.edu|
22433157|NCT05588440|Oncternal Therapeutics|Mary Breitmeyer|760-703-2802|mbreitmeyer@oncternal.com|
22422177|NCT03232931|Emory University|Dr. Nathalie Maitre|404-712-8920|nathalie.linda.maitre@emory.edu|
22422178|NCT02989246|Children's Hospital Los Angeles|Dr Robinder Khemani, Associate Director of Research ACCM|323-361-2376|rkhemani@chla.usc.edu|
22422179|NCT02207803|Virginia Commonwealth University|Dr. Paul Perrin|8048273894|pperrin@vcu.edu|
22422180|NCT01270464|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22422181|NCT01620190|University of Washington|Research Manager|206-606-7445|smasters@seattlecca.org|
22422182|NCT01750697|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22422183|NCT00744965|UT Southwestern Medical Center|Kenneth J. Leveno, MD|214-648-2316|kenneth.leveno@utsouthwestern.edu|
22422184|NCT00288366|Northwestern University|Herbert Y Meltzer|1 312 503 0309|h-meltzer@northwestern.edu|
22433158|NCT05526521|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
22433159|NCT03929913|National Heart, Lung, and Blood Institute (NHLBI)|Dr. Robert Lederman, Principal Investigator|301.402.6769|ledermar@nhlbi.nih.gov|
22433160|NCT04792190|University of Rochester|Mehmet Aktas, MD|585-275-4775|mehmet_aktas@urmc.rochester.edu|
22433161|NCT03919929|University of Colorado Anschutz Medical Campus|Melanie Cree, MD, PhD|720-777-5743|melanie.cree@childrenscolorado.org|
22433162|NCT03533660|University of Pittsburgh|Andrea DiMartini|14122164550|dimartiniaf@upmc.edu|
22433163|NCT01671956|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22433164|NCT04685213|Baylor College of Medicine|Prof. Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
22433165|NCT00971282|Galderma|Florence Paliargues|0033 4 92 95 29 57|Florence.Paliargues@Galderma.com|
22433166|NCT04446312|Braintree Laboratories, Inc.|Head of R&D, GI|781-843-2202|studydirector@sebelapharma.com|
22433167|NCT02610972|Gynuity Health Projects|Hillary Bracken|2124481230|hbracken@gynuity.org|
22433168|NCT03816176|Astellas Pharma Global Development, Inc|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
22433169|NCT03581292|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22433170|NCT05200572|University of Rochester|Lee Kehoe, Ph.D.|(585) 276-7686|leekehoephd@gmail.com|
22433171|NCT01144624|AstraZeneca|Justin Lindemann||ClinicalTrialTransparency@astrazeneca.com|
22433172|NCT02524145|University of Texas Southwestern Medical Center|Dr. Satyam Sarma|214-345-7111|SatyamSarma2@texashealth.org|
22433173|NCT01682356|Washington University School of Medicine|Linda R. Peterson, MD|314-362-4577|lpeterso@wustl.edu|
22433174|NCT07214935|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22433175|NCT03574610|Houston Methodist Hospital|Rose Khavari, MD|7134419118|rkhavari@houstonmethodist.org|
22433176|NCT01945216|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22433177|NCT01664117|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22433178|NCT02982772|Florida International University|Maria Jose Miguez|561-839-0223|mjmiguez@fiu.edu|
22433179|NCT00626782|Wills Eye Hospital|Prinicipal Investigator|484-434-2700|mpro2020@yahoo.com|
22433180|NCT01747343|University of Kansas|Brian D. Greer, Ph.D.|386-852-7171|brian.greer@unmc.edu|
22433181|NCT03107052|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22433182|NCT03015363|CardioVascular Research New Brunswick (CVR-NB)|Sohrab Lutchmedial, MD, FRCP(C)|506-648-6101|sohrab.lutchmedial@horizonnb.ca|
22433183|NCT00958360|Hines VA Blind Center|Joan Stelmack, O.D., M.P.H.|708-202-2124|joan.stelmack@va.gov|
22433184|NCT01061723|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22433185|NCT00500357|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22433186|NCT02263326|Northwestern University|Babafemi Taiwo|312-695-5085|b-taiwo@northwestern.edu|
22433187|NCT01734785|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22433188|NCT02482298|AstraZeneca|Brilinta Global Clinical Leader|+46 31 776 10 00||
22433189|NCT00960401|Winthrop-University Hospital, Division of Hematology and Oncology|Dr. Alexander Hindenburg|516-663-9500|AHindenburg@winthrop.org|
22433190|NCT01685242|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
22433191|NCT01582009|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22433192|NCT03592771|Emory University|Ilana Graetz, PhD|404-727-1483|ilana.graetz@emory.edu|
22433193|NCT01642901|MetroHealth Rehabilitation Institute|Christina V Oleson, MD|216-778-4414|coleson@metrohealth.org|
22433194|NCT00348946|Thomas Jefferson University|Judith L. Ross, M.D.|215-955-1648|judith.ross@jefferson.edu|
22433195|NCT05069597|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22433196|NCT03650413|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22433197|NCT03093207|São Paulo State University - Unesp|Dr Mauro Pedrine Santamaria|+5516981937777|mauro.santamaria@unesp.br|
22433198|NCT00310375|GlaxoSmithKline|GSK Response Center|866-435-7343||
22433199|NCT03332173|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22433200|NCT04024436|Taiho Oncology, Inc|Taiho Oncology, Inc|+1 844-878-2446|medicalinformation@taihooncology.com|
22433201|NCT00540592|GlaxoSmithKline|GSK Response Center|866-435-7343||
22433202|NCT00131352|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22433203|NCT02553928|H. Lundbeck A/S|H. Lundbeck||LundbeckClinicalTrials@Lundbeck.com|
22433204|NCT05507567|Pneumagen Ltd|CEO|+44 7748357352|douglas.thomson@pneumagen.com|
22433205|NCT00383331|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22433206|NCT04830215|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22433207|NCT03569878|Department of Psychiatry, University of Washington School of Medicine|Douglas Zatzick|206 744-6701|dzatzick@uw.edu|
22433208|NCT02509936|"Wuqu' Kawoq | Maya Health Alliance"|Dr Peter Rohloff|6174473034|peter@wuqukawoq.org|
22433209|NCT00770562|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22433210|NCT05338710|OHSU|Allison Lindauer, PhD, APRN|5034944347|lindauer@ohsu.edu|
22433211|NCT01194219|Celgene Corporation|Anne McClain|1-888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22422185|NCT02907918|Washington University School of Medicine|Foluso O. Ademuyiwa, M.D., MPH|314-454-8313|bisiademuyiwa@wustl.edu|
22422186|NCT02156908|Nathan Kline Institute|Joshua Kantrowitz|646-774-6738|josh.kantrowitz@nki.rfmh.org|
22422187|NCT01371110|Baylor College of Medicine (previously Icahn School of Medicine at Mount Sinai)|Wayne Goodman|713-798-4945|wayne.goodman@bcm.edu|
22422188|NCT03219840|The University of Texas Health Science Center at Houston|Flavia S. Lakschevitz, DDS, PhD, MSc|604-822-3863|flavia.lakschevitz@dentistry.ubc.ca|
22422189|NCT00832572|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22393500|NCT03047395|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22422190|NCT00384839|Texas Oncology, P.A|Dr. Guru Sonpavde|(281) 332-7505|Guru.Sonpavde@USOncology.com|
22422191|NCT00863343|Meso Scale Diagnostics, LLC.|Dennis Mertz, Director Regulatory and Clinical Affairs|240 631-2522|dmertz@mesoscale.com|2809
22422192|NCT02049814|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22422193|NCT04081610|Laboratorios Sophia|Dr. Alejandra Sanchez-Rios|+52 (33) 3001 4200|alejandra.sanchez@sophia.com.mx|1190
22422194|NCT02714595|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
22433212|NCT01081951|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22433213|NCT03377816|University of Haifa|Johanna Czamanski-Cohen|+97246146234|jczamansk@univ.haifa.ac.il|
22433214|NCT05226598|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22433215|NCT04503551|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22433216|NCT01794312|Laboratoires Théa|Clinical Development Director|+33(0)473981414|Corentin.LECAMUS@theapharma.com|
22433217|NCT01871545|Icahn School of Medicine at Mount Sinai|Dr. Bachir Taouli|212-824-8475|bachir.taouli@mountsinai.org|
22433218|NCT02569476|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22393501|NCT01145209|National Heart Lung and Blood Institute|Wiestner, Adrian MD, PhD|+1.301.594.6855|wiestnea@nhlbi.nih.gov|
22393502|NCT02335710|University of Tennessee|Richard D. Komistek, Ph. D.|8659742093|rkomiste@utk.edu|
22393503|NCT04771611|Mayo Clinic|James L. Kirkland, M.D., Ph.D.|507-538-3817|Kirkland.James@mayo.edu|
22393504|NCT04811131|Arcutis|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
22393505|NCT04718779|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22393506|NCT00741390|Becton Dickinson|Kenneth Kassler-Taub, VP Medical Affairs|201-847-7009|kenneth_kassler_taub@bd.com|
22393507|NCT00003453|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22393508|NCT00620282|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22393509|NCT02217475|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22393510|NCT01127763|Mt Sinai School of Medicine|Amy Tiersten, MD|212-249-3300|amy.tiersten@mssm.edu|
22393511|NCT02615002|Neurim Pharmaceuticals|Tali Nir, DVM, VP Clinical and Regulatory Affairs|+972-3-7684902|talin@neurim.com|
22393512|NCT04738292|Froedtert / Medical College of Wisconsin|Sailaja Kamaraju, MD, MS|414-805-4600|skamaraju@mcw.edu|
22422195|NCT00713258|Nycomed|Clinical Trial Operations|+45 4677 1111|clinicaltrials@nycomed.com|
22422196|NCT01322490|Bavarian Nordic A/S|Program Lead, Clinical Operations|+ 45 3326|info@bavarian-nordic.com|8383
22422197|NCT00497289|B.Braun Melsungen AG|Study manager|+49 5661 71|studies@bbraun.com|0
22422198|NCT02257489|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22422199|NCT04606394|PRISM|Gary T Ferguson, M.D.|248-514-6063|garytferguson@msn.com|
22422200|NCT01431716|Actelion Pharmaceuticals Ltd|Thomas Pfister, PhD, Senior Clinical Scientist|+41 61 565 5932|thomas.pfister@actelion.com|
22422201|NCT02307279|Gelesis|Harry Leider, MD, MBA|(443)934-4906|hleider@gelesis.com|
22422202|NCT02484456|National Institute of Mental Health|Zarate, Carlos|+1 301 451 0861|zaratec@mail.nih.gov|
22422203|NCT00708214|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22422204|NCT02199795|MetroHealth Medical Center|Dr. Jayme Knutson|2169573557|jsk12@case.edu|
22422205|NCT01214083|VA Connecticut Healthcare System|Gihyun Yoon, MD|203-932-5711|gihyun.yoon@va.gov|7421
22422206|NCT01908829|Astellas Pharma Europe Ltd|Clinical Trial Disclosure|+44 (0)20 3379 8000|Astellas.resultsdisclosure@astellas.com|
22422207|NCT01339923|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22422208|NCT04972110|Repare Therapeutics Inc|Repare Therapeutics Medical Monitor|1 (857) 340-5402|clininfo@reparerx.com|
22422209|NCT00828568|Taro Pharmaceuticals USA|Medical Director|(914) 345-9001|medical.affairs@taro.com|6427
22422210|NCT00608777|DermResearch, PLLC|Leon Kircik, M.D.|502-5451-9000|wedoderm@yahoo.com|
22422211|NCT02091089|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22422212|NCT00460811|Ironwood Pharmaceuticals|Doug Levine, MD|617.374.3906|dlevine@ironwoodpharma.com|
22422213|NCT02821754|Principal Investigator|Dr. Tim F. Greten|240-760-6114|tim.greten@nih.gov|
22422214|NCT03480542|Hackensack Meriden Health|Cole McCoy|551-204-5529|cole.mccoy@hmhn.org|
22422215|NCT00514215|Barbara Ann Karmanos Cancer Institute|Peter Littrup, M.D.|313-576-8758|littrupp@karmanos.org|
22422216|NCT00364923|Allos Therapeutics, Inc|Michael Saunders, M.D.|303-426-6262|msaunders@allos.com|
22422217|NCT02324504|Boston Children's Hospital|Dr. Michael Agus|617 355-5849|michael.agus@childrens.harvard.edu|
22422218|NCT00799474|The University of North Carolina at Chapel Hill, Gillings School of Global Public Health|Dr. Noel Brewer, PhD|919-966-3282|ntb1@unc.edu|
22422219|NCT04002115|Penn State Health|Dr. Seema Naik|7175310003|snaik@pennstatehealth.psu.edu|289626
22422220|NCT00766636|University of Texas MD Anderson Cancer Center|Jason B. Fleming, MD / Surgical Oncology|713-563-2300|CR_Study_Registration@mdanderson.org|
22422221|NCT01355575|Imperial College London|Dr Jeremy Cobbold|+44 1865228756|jeremy.cobbold@ndm.ox.ac.uk|
22422222|NCT00461773|The Christ Hospital|Gina G. Chung, MD|(513) 564-7771|gina.chung@thechristhospital.com|
22422223|NCT02477332|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
22422224|NCT01877642|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7777|ClinicalTrialsInfo@alexza.com|
22422225|NCT00853645|Boston Scientific|Gena Kantor, MPH|1-800-227-3422|gena.kantor@bsci.com|
22422226|NCT03627546|Weill Cornell Medicine|Kristen Marks|212-746-4177|markskr@med.cornell.edu|
22422227|NCT01731119|UNC-Chapel Hill|Dr. Linmarie Sikich||linmarie_sikich@med.unc.edu|
22422228|NCT02837731|Baxter Healthcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
22422229|NCT02965573|argenx BVBA|Regulatory Manager|+32 93103400|regulatory@argenx.com|
22422230|NCT01329380|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22422231|NCT00523848|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22422232|NCT00913263|Dept. of Surgery, Tampere University Hospital, Tampere, Finland|Teuvo Tammela, Professor|+358-3-31164621|teuvo.tammela@uta.fi|
22422233|NCT02461433|Johns Hopkins University|Mahmoud Malas|410-550-4546|bmalas1@jhmi.edu|
22422234|NCT01209520|University of Miami|Ikechukwu Akunyili MD|305-243-6626|IAkunyili@med.miami.edu|
22422235|NCT02508077|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22422236|NCT03291431|Stanford University School of Medicine, Department of Psychiatry and Behavioral Sciences|Dr. Timothy C. Durazzo/Project PI|650-493-5000|tdurazzo@stanford.edu|62982
22422237|NCT06868654|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22422238|NCT05908526|University of Maryland, Baltimore|Emerson Wickwire, PhD|410-706-4771|ewickwire@som.umaryland.edu|
22422239|NCT04925557|State University of New York at Buffalo|Dr. Robert Zivadinov|716-248-2140|rzivadinov@bnac.net|
22422240|NCT01736397|Keryx Biopharmaceuticals|Keryx Medical Information|1-844-44-KERYX (844-445-3799)|medicalinfo@keryx.com|
22422241|NCT00076752|National Cancer Institute, National Institutes of Health|Dr. Steven Pavletic|301-402-4899|pavletis@mail.nih.gov|
22422242|NCT01288937|Columbia University|Thomas H. Brannagan, MD|(212) 305-0405|tb2325@cumc.columbia.edu|
22422243|NCT01517763|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 09 574 0100|CPAPtrial@fphcare.co.nz|
22422244|NCT02875613|UC San Diego - Moores Cancer Center|Dr. Assuntina Sacco|858-822-5210|agsacco@ucsd.edu|
22422245|NCT00892151|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
22422246|NCT04075682|University of South Carolina|Dr. James F. Thrasher|803.777.4862|thrasher@sc.edu|
22422247|NCT01222520|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22422248|NCT01896128|Burke Rehabilitation Hospital|Pasquale Fonzetti MD|(914) 597-2502|pfonzett@burke.org|
22422249|NCT00954941|The University of Texas MD Anderson Cancer Center|Jorge Cortes, MD / Professor|713-794-5783|eharriso@mdanderson.org|
22422250|NCT01996254|SPR Therapeutics, Inc.|Clinical Affairs|216-378-9108|support@SPRTherapeutics.com|
22422251|NCT03423173|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22422252|NCT02920008|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
22422253|NCT05478135|Prova Health|Dr Jack Halligan|07742161980|jack.halligan@provahealth.com|
22422254|NCT02411396|Johns Hopkins University School of Medicine|Sophie Lanzkron, MD, MHS, Associate Professor of Medicine and Oncology|410-502-8642|slanzkr@jhmi.edu|
22422255|NCT00555464|Medical College of Wisconsin|Beth Drolet, MD|414-955-2817|sjoachim@mcw.edu|
22422256|NCT00436475|Tufts Medical Center|Dr. Anastassios G. Pittas|617-636-5689|apittas@tuftsmedicalcenter.org|
22422257|NCT02016105|Sandoz|Global Program Medical Director|+49 8024 476|biopharma.clinicaltrials@sandoz.com|0
22422258|NCT00090493|University of Arkansas for Medical Sciences - MIRT|Frits van Rhee, MD, PhD|(501) 686-8230|vanrheefrits@uams.edu|
22422259|NCT02071706|GE Healthcare|Yvonne Celestial|+33625023857|MarieYvonne.CELESTIAL@ge.com|
22422260|NCT00179777|University of Helsinki|Professor Mikael Knip|+3582941 25222|mikael.knip@helsinki.fi|
22422261|NCT02865499|Univ TX Health Science Center San Antonio|Dean L. Kellogg, Jr, MD, PhD|2106175197|kelloggd@uthscsa.edu|
22422262|NCT02247440|Institut de Recherche pour le Developpement|Gonzague Jourdain|+66818830065|Gonzague.Jourdain@ird.fr|
22422263|NCT02792192|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22422264|NCT02320058|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22422265|NCT00729157|Memorial Sloan Kettering Cancer Center|Dr. David Pfister|646-888-4237|pfisterd@mskcc.org|
22422266|NCT00661609|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22422267|NCT01663285|University of Michigan Comprehensive Cancer Center|Dr. Ajjai Alva|734-647-8921|ajjai@umich.edu|
22422268|NCT03521115|PIRE|Dr. Brenda A. Miller|5105205889|BMiller@prev.org|
22422269|NCT02261948|Centro Cardiologoco Monzino|Piergiuseppe Agostoni|02 5800|piergiuseppe.agostoni@ccfm.it|2772
22422270|NCT01430403|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22422271|NCT03522714|Northwestern University|Peter Ullrich, Clinical Research Coordinator|3129267037|peter.ullrich@nm.org|
22422272|NCT02677922|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22422273|NCT01080118|Northwestern University Feinberg School of Medicine|Dr. Gildasio DeOliveira|312-472-3573|g-jr@northwestern.edu|
22422274|NCT00637000|Reckitt Benckiser Pharmaceuticals, Inc.|Rolley E. Johnson, PharmD, Vice President, Clinical, Scientific and Regulatory Affairs|804-379-1090|ed.johnson@reckittbenckiser.com|7089
22422275|NCT02196688|Hutchison Medipharma Ltd|Dr. Songhua Fan|+86 21 2067 3058|songhuaf@hmplglobal.com|5058
22422276|NCT00562302|Angiotech|Thomas Doyle|352.338.0440|tdoyle@angio.com|
22422277|NCT03615144|Memorial Sloan Kettering Cancer Center|Maria Cancio, MD|212-639-7196|canciom@mskcc.org|
22422278|NCT04791319|Janssen Research & Development, LLC|Director Clinical Research Dermatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22422279|NCT03660189|The MetroHealth System|Dr. Chloe Castro|2167784527|ccastro@metrohealth.org|
22422280|NCT01860040|Western Regional Medical Center|Director of Clinical Research|6232073000|jessica.coats@ctca-hope.com|
22422281|NCT01931995|Massachusetts General Hospital|Dr. Mark Eldaief|6177261728|MELDAIEF@PARTNERS.ORG|
22422282|NCT00791661|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22422283|NCT04513080|Talkspace|Aarthi Padmanabhan|240-273-6191|aarthi.padmanabhan@talkspace.com|
22422284|NCT00679289|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22422285|NCT00937040|Ortho-McNeil Janssen Scientific Affairs, LLC|VP Medical Affairs, CNS|609-730-2136||
22422286|NCT05753904|University of Missouri|Vicki Jones|573-882-7583|jonesvicki@health.missouri.edu|
22422287|NCT00183885|USC/Norris Comprehensive Cancer Center|Victoria Soto|(323) 865-0451|victoria.soto@med.usc.edu|
22422288|NCT03620643|The Royal Marsden NHS Foundation Trust|Clinical Trial Manager|02078082887|rolo.trial@rmh.nhs.uk|
22422289|NCT00014495|Memorial Sloan Kettering Cancer Center|Dr. Martin Tallman|212-639-3842|tallmanm@mskcc.org|
22422290|NCT00403481|Daiichi Sankyo|John J. Raia, R.Ph, Pharm. D.|1-877-437-7763|druginfo@dsus.com|
22422291|NCT00556946|University of California, Irvine|Kristen M. Kelly, M.D.|949-824-7103|kmkelly@uci.edu|
22422292|NCT02929589|MOMMC|Amanda Crawford|702-653-3583|amanda.j.crawford.ctr@health.mil|
22422293|NCT01537926|UTHealth Science Center at Houston|Dr. Ali J. Marian|713-500-2310|Ali.J.marian@uth.tmc.edu|
22422294|NCT04668248|Brigham and Women's Hospital|Julie Lauffenburger, PharmD, PhD|617-525-8865|jlauffenburger@bwh.harvard.edu|
22422295|NCT02743936|Brooke Army Medical Center|Dr. Michael D. April|210-916-0808|Michael.D.April@post.harvard.edu|
22422296|NCT00520533|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22422297|NCT00305084|Clinical Operations|MolMed S.p.A.|0039 02212771|clinical.operations@molmed.com|
22393513|NCT02601976|Getz Pharma|Mr. Jaffer Bin Baqar|111111511|jaffer.baqar@getzpharma.com|2710
22393514|NCT03181789|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22393515|NCT01131182|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22393516|NCT00735475|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
22393517|NCT02442336|Fox Chase Cancer Center|Carolyn Fang|215-728-4062|carolyn.fang@fccc.edu|
22393518|NCT05086276|Frequency Therapeutics|Director of Clinical Trials|781-315-4600|clinicaltrialsinformation@frequencytx.com|
22393519|NCT00777088|Medtronic|Darren LaCour|949-680-1274|darren.j.lacour@medtronic.com|
22393520|NCT00350103|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22393521|NCT01879553|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22393522|NCT00320528|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22393523|NCT04828837|NTUNHS|Wang Szu-Yi|886-97140315|jachiex@gmail.com|
22393524|NCT01397422|Adamas Pharmaceuticals, Inc.|Head, Regulatory Affairs|+1 (510) 450-3500|drugsafety@adamaspharma.com|
22393525|NCT01030406|Acura Pharma|Dr. Ron Spivey|847-705-7709|rspivey@acurapharm.com|
22393526|NCT00760474|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22393527|NCT04540887|Wake Forest Institute for Regenerative Medicine|Dr. Stephen Walker|33-713-7272|swalker@wakehealth.edu|
22393528|NCT04664400|Dartmouth College|Tor D Wager, PhD|(603)-646-2196|Tor.D.Wager@Dartmouth.edu|
22393529|NCT02688218|Oregon Health and Science University|Joseph El Youssef|503-418-5128|elyoussj@ohsu.edu|
22393530|NCT02101385|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
22393531|NCT00835900|Roswell Park Cancer Institute|Dr. Martin Mahoney|7168452300|martin.mahoney@roswellpark.org|
22393532|NCT02489968|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22393533|NCT02299089|Camurus AB|Clinical Trial Manager|+46 46 2876 530|Info@Camurus.com|
22393534|NCT01982448|Dana-Farber Cancer Institute|Clinical Trials Office|617-632-5313|ctopm@dfci.harvard.edu|
22393535|NCT02594163|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
22393536|NCT01342341|Ernest Gallo Clinic and Research Center|Dr. Jennifer Mitchell, Clinical Project Director|510-985-3921|jmitchell@gallo.ucsf.edu|
22393537|NCT04497142|Brigham and Women's Hospital|Steven Tobochnik, MD|617-732-7432|stobochnik@bwh.harvard.edu|
22393538|NCT01022268|Imperial College London|Dr Jethro Herberg|+44 - 0207 594 3990|j.herberg@imperial.ac.uk|
22422298|NCT00006178|National Institutes of Health|Dr. Allan D. Kirk||allank@intra.niddk.nih.gov|
22422299|NCT02171234|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|francisco.rocha@bial.com|
22422300|NCT00697463|Columbia University|Elizabeth Shane, MD|212-305-7225|es54@cumc.columbia.edu|
22422301|NCT02568189|Icahn School of Medicine at Mount Sinai|James W Tsung MD, MPH|212 241 6272|james.tsung@mountsinai.org|
22422302|NCT00966992|Washington University School of Medicine|Perry Grigsby, M.D.|314-362-8502|pgrigsby@radonc.wustl.edu|
22422303|NCT00603473|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22422304|NCT00691444|Oregon Health and Science University|OHSU Integrity Department|1-877-733-8313|irb@ohsu.edu|
22422305|NCT03850483|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22422306|NCT03225105|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22422307|NCT05488470|Division of Cardiology at the Rhode Island and Miriam Hospital, Warren Alpert School of Medicine, Brown University|Antony Chu, M.D., FACC, FAHA, FHRS, FACP, Director of Complex Ablation - Arrhythmia Services Section|401-444-8689|antony_chu@brown.edu|
22422308|NCT04019613|Mayo Clinic|Dr. Brandon M. Wiley|507-255-1051|Wiley.Brandon@mayo.edu|
22422309|NCT01106677|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1 800 526 7736||
22422310|NCT00972816|Novartis Vaccines and Diagnostics|Posting Director||RegContactVacUS.nvdit@Novartis.com|
22422311|NCT03806933|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|Aesthetic.Trials@merz.com|
22422312|NCT05088603|Atrium Health Wake Forest Baptist Health Department of Neurosurgery|Dr. Kyle Fargen|336-716-6702|kfargen@wakehealth.edu|
22422313|NCT01868438|Medicines for Malaria Venture|Stephan Duparc|+41 22 799 4070|duparcs@mmv.org|351
22422314|NCT01694069|West Virginia Universtiy, WVCTSI|Clinical Trials Compliance Coordinator|304-293-0216|ctgovadmin@hsc.wvu.edu|
22422315|NCT00955955|Massachusetts General Hospital- Depression Clinical and Research Program|Dr. George Papakostas- Director of Treatment Resistant Depression Studies|617-726-6697|gpapakostas@partners.org|
22422316|NCT00863356|HemCon Medical Technologies|V.P., Clinical Affairs|971.223.4904|jody.oyama@hemcon.com|
22422317|NCT02023411|PGIMER|Dr Ashu Rastogi|9781001046|ashuendo@gmail.com|
22422318|NCT01053663|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22422319|NCT04594070|University of Texas Medical Branch Galveston|Dr. Melody Safarzadeh|9082854962|mesafarz@utmb.edu|
22422320|NCT03533114|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
22422321|NCT01862250|University of Toronto|Estelle B. Gauda|416-813-4908|estelle.gauda@sickkids.ca|
22422322|NCT03852264|University of Arizona|Dr. Evan MacLean|520-621-0386|evanmaclean@arizona.edu|
22422323|NCT00693238|University of Florida|Randal Henderson, MD, MBA|904-588-1800|rhenderson@floridaproton.org|
22422324|NCT01631149|Leiden University Medical center|Dr. Albert Dahan|3171 526 2301|a.dahan@lumc.nl|
22422325|NCT02244463|Dana-Farber Cancer Institute|Kartik Sehgal, MD|(617) 632-3090|Kartik_Sehgal@dfci.harvard.edu|
22422326|NCT05481125|Alcon Research, LLC|Director, Clinical Projects, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22422327|NCT03879525|Wake Forest School of Medicine|Heidi Munger Clary, MD, MPH|336-716-7110|hmungerc@wakehealth.edu|
22422328|NCT03834766|Tris Pharma, Inc.|Antonio Pardo|19175149058|apardo@trispharma.com|
22422329|NCT01769508|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22422330|NCT03457116|NYU Langone Health|Judy Lee, MD|(646) 501-7906|Judy.Lee@nyulangone.org|
22422331|NCT00839527|GlaxoSmithKline|GSK Response Center|866-435-7343||
22422332|NCT02295020|LSUHSC-NO -Orthopaedic Department|Dr. Vinod Dasa|(504) 412-1700|vdasa@lsuhsc.edu|
22422333|NCT02751450|GlaxoSmithKline|GSK Response Center|866-435-7343||
22422334|NCT01290679|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com|
22422335|NCT01855243|Cairo University|Eman Said Sayed|01001186079|gaviota_3011@hotmail.com|002
22422336|NCT00943150|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com|
22422337|NCT02587598|Call Center|Incyte Corporation|1-855-463-3463|medinfo@incyte.com|
22422338|NCT04709692|University of Kentucky|R. Kiplin Guy|859-257-5290|kip.guy@uky.edu|
22422339|NCT04431908|Yale School of Medicine|Dr. R. Peter Manes|(203) 785-5430|rpeter.manes@yale.edu|
22422340|NCT02726906|UC San Diego|Judy Pa, PhD|858-246-1333|jpa@ucsd.edu|
22422341|NCT01704651|Mayo Clinic|Dr. Jamie N. Bakkum-Gamez|507-266-8661|Bakkum.Jamie@mayo.edu|
22422342|NCT02793674|Presbyterian Hospital|Thomas Weiler, MD|505-724-7044|tweiler@gmail.com|
22393539|NCT00734097|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22422343|NCT02477826|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22422344|NCT01045187|Xoft, Inc.|Kelly W Elliott RN, MS|408-419-2428|Kelliott@xoftinc.com|
22433219|NCT01071954|Amgen (EUROPE) GmbH|IHQ Medical Info-Clinical Trials||MedInfoInternational@amgen.com|
22433220|NCT01152788|NCIC Clinical Trials Group|Dr. Janet Dancey|1-613-533-6430|jdancey@ctg.queensu.ca|
22433221|NCT01653587|Santa Casa de Marília|Dr. Pedro Beraldo de Andrade|+551434025561|pedroberaldo@gmail.com|
22433222|NCT00778336|Boston Scientific Corporation|DeeAnn Tinjum|763-450-8707|deeann.tinjum@bsci.com|
22433223|NCT04585269|Rutgers Cancer Institute|Dr. Katie Devine (PI)|7322357549|katie.devine@rutgers.edu|
22433224|NCT06006078|Cleveland Clinic Foundation|Dr. John Vargo|2164455012|vargoj@ccf.org|
22433225|NCT03307785|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22433226|NCT03666988|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22433227|NCT02517398|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49 6151-72-5200|service@emdgroup.com|
22433228|NCT05111613|Inari Medical|Ashleigh Willson|925-330-3446|ashleigh.willson@stryker.com|
22433229|NCT04209387|VA Bedford Healthcare System|Mo Modarres, PhD|2164966169|mmodarres@verizon.net|
22433230|NCT01154452|Memorial Sloan Kettering Cancer Center|Dr. Mrinal Gounder|646-888-4167|gounderm@mskcc.org|
22433231|NCT01392573|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22433232|NCT04704713|CLINUVEL PHARMACEUTICALS LIMITED|Clinical Operations Manager||mail@clinuvel.com|
22433233|NCT01941927|University of California, San Francisco|Adil Daud, MD|(415) 353-7392|Adil.Daud@ucsf.edu|
22433234|NCT00648648|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22433235|NCT00841412|Tennessee Valley Healthcare System, GRECC and Vanderbilt University, School of Medicine, Division of Geriatrics, Center for Quality Aging|Sandra F. Simmons, PhD, Associate Professor of Medicine|615-343-6729|Sandra.Simmons@Vanderbilt.edu|
22433236|NCT00325130|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22433237|NCT03896750|Alliance for Multispecialty Research|William Smith, MD|(865) 305-9100|william.smith@amrllc.com|
22433238|NCT00932035|City of Hope|Carolyn Behrendt, Ph.D.|(626)359-8111|Cbehrendt@coh.org|61148
22433239|NCT03744910|CSL Behring|Study Director|16108784000|clinicaltrials@cslbehring.com|
22433240|NCT02744612|City of Hope Medical Center|Dr. Alex Herrera, MD|6263598111|aherrera@coh.org|
22433241|NCT00283803|University of Washington|Dr. Celestia Higano, MD|206-606-1187|mjcampbe@seattlecca.org|
22433242|NCT01127607|Florida International University|Dr. James Waxmonsky|717 531 8646|jwaxmons@fiu.edu|
22433243|NCT02220855|IndianaU|Dr. Patrick Loehrer|317-944-0920|ploehrer@iu.edu|
22433244|NCT03419897|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
22433245|NCT05112679|University of Pittsburgh|Sashwati Roy, PI|412 6240422|sar453@pitt.edu|
22433246|NCT05730725|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22433247|NCT04105738|University of Massachusetts|Arlene Williams|508-856-5584|arlene.williams@umassmed.edu|
22433248|NCT03866538|Mayo Clinic|Joseph A. Murray, M.D.|507-284-2631|Murray.Joseph@mayo.edu|
22433249|NCT00106119|National Institute of Diabetes and Digestive and Kidney Diseases|Dr. Kong Chen|3014511636|chenkong@niddk.nih.gov|
22433250|NCT03053440|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22433251|NCT01675297|Hanlim Pharma|Clinical Trial Unit|82-2-3489-6297|yrsong@hanlim.com|
22433252|NCT01432145|University of Oxford Clinical Trials & Research Governance|Ms Heather House|01865 572245|heather.house@admin.ox.ac.uk|
22433253|NCT02998684|Medical University of South Carolina|Dr. Jane Joseph|843-792-7683|josep@musc.edu|
22433254|NCT00391053|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22433255|NCT02248766|Optometry Research Group (GIO) University of Valencia|Robert Montes-Mico, O.D., PhD|34-9635-44764|robert.montes@uv.es|
22433256|NCT00473889|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22433257|NCT02140970|University of Colorado|Dr. Kyle Rove|720 777 5893|kyle.rove@childrenscolorado.org|
22433258|NCT02440204|Severance|Dr. Jae Chul Koh|82-010-8702-3931|jaykoh82@gmail.com|
22422345|NCT01342523|University of Wisconsin|Stevens Smith, PhD|608-262-7563|sss@ctri.wisc.edu|
22422346|NCT01218087|Boston Children's Hospital|Michele DeGrazia|617-919-1222|michele.degrazia@childrens.harvard.edu|
22422347|NCT03170362|Department of Veteran Affairs|David Oslin|215-823-5894|dave.oslin@va.gov|
22422348|NCT00552396|Innate Pharma|Dr Renaud Buffet Senior Director, Clinical Development and Translational Research|+33430303032|renaud.buffet@innate-pharma.fr|
22422349|NCT00842023|Western University of Health Sciences|Dr. Sheryl L. Chow|9094695379|schow@westernu.edu|
22422350|NCT03340454|NYU Langone Health|Yi-Ling Tan|646-501-3489|yi-ling.tan@nyulangone.org|
22422351|NCT02948751|Columbia University|Kevin Kalinsky, MD|212-305-0170|kk2693@columbia.edu|
22422352|NCT01464164|Feinstein Institutes for Medical Research|Adrianna Vlachos, MD|516-562-1506|avlachos@northwell.edu|
22422353|NCT01972438|National Institutes of Health|Manuel B. Datiles, III, MD, Principal Investigator, NEI|301-594-7052|DatilesM@nei.nih.gov|
22422354|NCT03307252|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22433259|NCT00460655|GlaxoSmithKline|GSK Response Center|866-435-7343||
22433260|NCT00590122|Baylor College of Medicine|Christine Hunter|713-798-6556|chunter@bcm.edu|
22393540|NCT05130047|Mayo Clinic|Michael Camilleri, M.D., D.Sc.|507-284-2687|camilleri.michael@mayo.edu|
22433261|NCT03050450|Johns Hopkins All Children's Hospital (St. Petersburg, FL)|Dr Stacie Stapleton|17274701017|stacie.stapleton@jhmi.edu|
22433262|NCT04077424|Vanderbilt University Medical Center|Spyros Kalams, MD|6153222035|Joan.e.eason@vumc.org|
22433263|NCT00735553|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
22433264|NCT02705105|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
22433265|NCT04908683|Janssen Vaccines & Prevention B.V.|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22433266|NCT00910910|Celgene Corporation|Anne McClain, Senior Manager of Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22433267|NCT01973231|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22433268|NCT03754556|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22433269|NCT03809078|Stanford University|Dr. Andrei Iagaru, MD|650-725-4711|aiagaru@stanford.edu|
22433270|NCT00040742|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu|
22433271|NCT00624468|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22433272|NCT05384834|Emory University|Dr. Holly Gooding|404-778-1429|holly.gooding@emory.edu|
22433273|NCT01523743|Hopital Raymond poincare|Pref. Emmanuel Chartier-kastler|+33 1 42 17 71 29|emmanuel.chartier-kastler@psl.aphp.fr|
22433274|NCT01434654|St Vincent's Hospital, Sydney|Prof. Bruce Brew|+61 2 8382 1111|b.brew@unsw.edu.au|4100
22433275|NCT00363142|GlaxoSmithKline|GSK Response Center|866-435-7343||
22433276|NCT02137447|Massachusetts General Hospital|Dr. Daniel Dante Yeh, Assistant Professor of Surgery|6177248604|dyeh2@partners.org|
22433277|NCT01313910|UCaliforniaDavis|David Asmuth, MD|9167348695|david.asmuth@ucdmc.ucdavis.edu|
22433278|NCT01340664|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1 908 927-5775||
22433279|NCT03232827|UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR|Dr. Theodore Wagener|405-271-4407|theodore-wagener@ouhsc.edu|50486
22433280|NCT01926444|PCC INC.|Patrick Colin|514-586 9297|PCOLIN@VIDEOTRON.CA|
22433281|NCT03786224|Massachusetts General Hospital|Randi Schuster, PhD|617-643-6673|rschuster@mgh.harvard.edu|
22433282|NCT00894699|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
22433283|NCT02626156|Medical University of South Carolina|Teresa J. Kelechi|843-792-4602|kelechtj@musc.edu|
22433284|NCT02243371|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dung Le, MD|443-287-0002|dle@jhmi.edu|
22433285|NCT02441101|University of Iowa|Barry London|319-356-2750|barry-london@uiowa.edu|
22433286|NCT02691416|The Third Central Clinical College of Tianjin Medical University, Tianjin the Third Central Hospital|Dr.Haiyun Wang|13752211206|why819@126.com|
22433287|NCT02528942|Thomas Jefferson University|Yevgeniy Vinogradskiy PhD|2159553605|yevgeniy.vinogradskiy@Jefferson.edu|
22433288|NCT00271856|UCSF Osher Center for Integrative Medicine|Patricia Moran, PhD|415.353.9745|moranp@ocim.ucsf.edu|
22433289|NCT04599803|Verily Life Sciences LLC|Gabriel Kowalsky|9709011616|gabekowalsky@verily.com|
22433290|NCT02544750|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
22433291|NCT03751371|The Ohio State University|Anne Kloos|614-688-5942|kloos.4@osu.edu|
22433292|NCT03035864|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22433293|NCT02371785|Corindus Vascular Robotics|Vice President, Clinical and Regulatory Affairs|260-615-8892|john.vanvleet@corindus.com|
22433294|NCT02340169|Taro Pharmaceuticals|Senior Director, Clinical Research|+1 914-345-9001|natalie.yantovskiy@taro.com|
22433295|NCT00100802|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreporingcoordinator@childrensoncologygroup.org|
22433296|NCT02847169|CooperVision Inc.|Senior Manager Global Medical Scientific Affairs|925 621-3761|javega@coopervision.com|
22433297|NCT03063606|Yale University|Dr. Carlos Grilo|203-785-7210|carlos.grilo@yale.edu|
22433298|NCT03079531|Stanford University|Anne Lynn Chang, MD|650-723-6316|alschang@stanford.edu|
22433299|NCT06590441|CooperVision Inc.|José A. Vega|+1 (925) 621-3761|JVega2@coopervision.com|
22433300|NCT02683980|Boston Scientific|Clinical Program Manager|612-322-1189|teri.bird@bsci.com|
22393541|NCT02233543|Novartis Pharmaceuticals|Study Director|862-778-8300||
22433301|NCT02712983|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22433302|NCT03280303|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22433303|NCT00064259|Montefiore Medical Center - New York|NYCC Regulatory Coordinator|718-405-8404|jsparano@montefiore.org|
22433304|NCT02953093|Albert Einstein College of Medicine|Dr. Nir Barzilai|718-430-3144|nir.barzilai@einsteinmed.edu|
22433305|NCT01132651|Northwestern University|Mandy Browning|312-695-6829|mandybrowning2015@u.northwestern.edu|
22433306|NCT00948857|Center for Human Reproduction|Dr. Norbert Gleicher|212-994-4400|ngleicher@thechr.com|
22433307|NCT01321216|American University of Beirut|Dr Ghassan Dbaibo|961-1-350000|gdbaibo@aub.edu.lb|4819
22433308|NCT03430843|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
22433309|NCT03608371|Neumora Therapeutics|Study Contact|8577600900|clinicaltrials@neumoratx.com|
22433310|NCT03452033|D. Western Therapeutics Institute|Shigenobu Nakazora|+81-52-218-8785|shinakazora@dwti.co.jp|
22433311|NCT05360966|Alcon Research, LLC|Scientific Advisor, Clinical Research and Development|1-888-451-3937|alcon.medinfo@alcon.com|
22433312|NCT05396014|UNC Chapel Hill|Matthew Mauck, MD, PhD|(919) 966-5136|Matt_Mauck@med.unc.edu|
22433313|NCT03501992|Mayo Clinic|Robert M Jacobson, MD|507-250-4576|jacobson.robert@mayo.edu|
22433314|NCT01477710|University of Cincinnati|Richard Branson|513-558-6785|bransonrd@uc.edu|
22433315|NCT05258890|Brigham and Women's Hospital|Amar Dhand, MD, PhD|617-732-7432|adhand@bwh.harvard.edu|
22433316|NCT02974140|Alcon, A Novartis Division|Sr. Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22433317|NCT01905943|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22433318|NCT01238991|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22433319|NCT02351063|Alere, Inc.|William Arnold, PhD|8588053177|william.arnold@alere.com|
22433320|NCT03372434|Johnson & Johnson Surgical Vision|Eugenia Thomas, OD|+1 657 2903260|EThoma39@its.jnj.com|
22433321|NCT05516797|HealthPartners Institute|Holly Willis|952-993-3219|holly.willis@parknicollet.com|
22433322|NCT05959447|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22433323|NCT02522429|UCLA|Principal Investigator|3108258546|monti@ucla.edu|
22433324|NCT00294671|Amyloidosis Center, Boston Medical Center|Dr. John L. Berk|617-638-4494|jberk@bu.edu|
22433325|NCT00332579|University of Minnesota|Jon E. Grant|612-273-9800|grant045@umn.edu|
22433326|NCT02200757|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22433327|NCT01893411|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
22433328|NCT00566982|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|Shionogiclintrials-admin@shionogi.co.jp|
22433329|NCT01308814|University of North Carolina at Chapel Hill|Susan S. Girdler, Ph.D.|919-966-2179|susan_girdler@med.unc.edu|
22433330|NCT01961297|Icahn School of Medicine at Mount Sinai|Dr. Kristina Simonyan|212-241-0656|kristina.simonyan@mssm.edu|
22433331|NCT01947283|Disparities Research Unit, Department of Medicine, Massachusetts General Hospital|Margarita Alegria|617-724-4987|malegria@mgh.harvard.edu|
22433332|NCT01498692|Boston Scientific|Ruth M. Starzyk, PhD|508-683-6577|ruth.starzyk@bsci.com|
22433333|NCT04729972|Neurotech Pharmaceuticals, LLC|CMO|401-333-3880|neurotech@neurotechusa.com|
22433334|NCT05002985|University of Kentucky|Dawn Brewer|859-257-1661|dawn.brewer@uky.edu|
22433335|NCT03782259|University of Washington|Francis Kim, MD|206-744-8305|fkim@uw.edu|
22433336|NCT00603941|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22433337|NCT00422448|Medical University of Graz - Austria|Prof. Dr. Iris Zalaudek|+436763328269|iris.zalaudek@gmail.com|
22433338|NCT02707965|University of Maryland, School of Pharmacy|Dr. James Polli|410-706-8292|jpolli@rx.umaryland.edu|
22433339|NCT00249808|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center,|496151725200|service@merckgroup.com|
22433340|NCT00711594|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22433341|NCT03286829|Saniona A/S|Dr.Kim Krogsgaard, MD, DMSc, CMO|+45 20 14 83 84|kim.krogsgaard@saniona.com|
22433342|NCT00485758|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22433343|NCT03024112|University of Colorado, Denver|Dr. Jason Brainard|720-848-3257|Jason.Brainard@ucdenver.edu|
22433344|NCT00211172|Kaiser Permanente Center for Heatlh Research|David H. Smith|503-335-6302|david.h.smith@kpchr.org|
22433345|NCT01399229|Reproductive Research Technologies, LP|Jack McCrary|7136800200|jmc@innovalp.com|
22433346|NCT02253433|Environmental Health, Baylor College of Medicine|Dr. Winifred J. Hamilton|713-798-1052|hamilton@bcm.edu|
22433347|NCT00253513|OHSU Knight Cancer Institute|Eneida Nemecek, MD|(503) 494-0829|nemeceke@ohsu.edu|
22433348|NCT04283656|Thomas Jefferson University|Dr. Walter K. Kraft|(215) 955-9077|Walter.Kraft@jefferson.edu|
22433349|NCT00803361|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22433350|NCT04445519|Nicox Ophthalmics, Inc.|Doug Hubatsch/Chief Scientific Officer|984-710-5354|hubatsch@nicox.com|
22433351|NCT03782064|Beth Israel Deaconess Medical Center|Emma Logan, Director of Research Nursing|6176675984|eklogan@bidmc.harvard.edu|
22433352|NCT00394329|Penn State College of Medicine|Vernon M. Chinchilli, PhD|717-531-4262|vchinchi@psu.edu|
22433353|NCT02446769|Philips|Chuck Cain|412-542-3605|chuck.cain@philips.com|
22433354|NCT04482439|Newsom Eye and Laser Center|T. Hunter Newsom, MD|813-908-2020|hunter@newsomeye.net|
22433355|NCT01103440|Icahn School of Medicine at Mount Sinai|Dr. Annapoorna S Kini|(212) 241-4181|Annapoorna.Kini@mountsinai.org|
22393542|NCT01302067|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22433356|NCT03072043|Moffitt Cancer Center|David Sallman, MD|813-745-6841|David.Sallman@moffitt.org|
22433357|NCT00645840|UT Southwestern Medical Center|Perrin White|214 648 6875|perrin.white@utsouthwestern.edu|
22433358|NCT01823198|University of Texas MD Anderson Cancer Center|Richard Champlin, MD / Stem Cell Transplantation Department|713-792-3618|rchampli@mdanderson.org|
22422355|NCT01052480|Leidos Biomedical Research, Inc. is support to the National Institute of Allergy and Infectious Diseases (NIAID)|John Beigel, M.D.|301-451-9881|jbeigel@niaid.nih.gov|
22422356|NCT00529373|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development,|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22422357|NCT01074268|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22422358|NCT01578239|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22422359|NCT03000010|University of Michigan|G. Ying Li|734-936-5715|yingyuli@med.umich.edu|
22422360|NCT01017536|Aeras|Bernard Landry|301-547-2900|blandry@aeras.org|
22422361|NCT02347813|University of Rochester|Alice Pentland, MD|585-275-1998|alice_pentland@urmc.rochester.edu|
22422362|NCT01385137|SWOG Statistical Center|Study Statistician|206-667-4623||
22422363|NCT01119859|Hoffmann-La Roche|Medical Communications|800 821-8590||
22422364|NCT01134939|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22422365|NCT03456804|Karmanos Cancer Institute|Elisabeth Heath, M.D.|313-576-8717|heathe@karmanos.org|
22422366|NCT00389532|Sanofi pasteur Inc|Medical Director||RegistryContactUS@sanofipasteur.com|
22422367|NCT02981082|University of Pittsburgh|Dr. Robert Lafyatis|412-648-7040|lafyatis@pitt.edu|
22422368|NCT04892706|Bausch Health Americas, Inc|Study Director|908-541-8664|alison.magnotti-nagel@bauschhealth.com|
22422369|NCT02835625|Cancer Registry of Norway|Prof. Solveig Hofvind|+47 22928828|solveig.hofvind@kreftregisteret.no|
22422370|NCT03634033|Grand Valley State University|Dr. Sandra Spoelstra|616-331-5905|spoelsts@gvsu.edu|
22422371|NCT03396315|Columbia University|Mariana Bucovsky|12123057225|mb3523@cumc.columbia.edu|
22422372|NCT01828983|Memphis VA Medical Center|Dr. Linda Nichols|901 523-8990|linda.nichols@va.gov|5082
22422373|NCT00956592|Oregon Health & Science University|Michael Aziz|503-494-5581|azizm@ohsu.edu|
22422374|NCT02162719|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22422375|NCT03555565|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22422376|NCT00723255|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22422377|NCT00614523|Amgen Inc.|Study Director|866-572-6436||
22422378|NCT01450826|Duke University Medical Center|Mary Lou Affronti, DNP, RN, MHSc, ANP|9196845301|mary.affronti@duke.edu|
22422379|NCT03966924|Recros Medica|Head of Clinical Development|925-223-8581|clinical@recrosmedica.com|
22422380|NCT01070095|St. Michael's Hospital|Dr. Samir Gupta|(416) 864-6060|guptas@smh.ca|2252
22422381|NCT00655707|ImperialC|Professor Nagy Habib|+442033138574|nagy.habib@imperial.ac.uk|
22422382|NCT03138252|University Hospitals Cleveland Medical Center|Dr. Alison Bauer|216-844-3787|alison.bauer@uhhospitals.org|
22422383|NCT03854370|Wright State University|Dr. Geoffrey Towers|937-208-2850|geoffrey.towers@wright.edu|
22422384|NCT00452673|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22422385|NCT02656290|Edwards Lifesciences, LLC|Aya Westbrook, PhD, Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Aya_Westbrook@edwards.com|
22422386|NCT04638881|Stanford University School of Medicine|Dr. Richard K. Kim|3475869661|rkwkim@stanford.edu|
22422387|NCT00394836|GlaxoSmithKline|GSK Response Center|866-435-7343||
22422388|NCT03692325|Dana-Farber Cancer Institute|Glenn Hanna, MD|617-632-3090|gjhanna@partners.org|
22422389|NCT02817516|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22422390|NCT00748189|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22422391|NCT02062710|Montefiore Medcial Center|Peter Dicpinigaitis, MD|718-904-2676|pdicpini@montefiore.org|
22422392|NCT04481191|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22422393|NCT02593526|UNewMexico|Mark Unruh|5052728800|MLUnruh@salud.unm.edu|
22422394|NCT00546117|Washington University|Judith Lieu, MD|314-454-6162|lieuj@wustl.edu|
22422395|NCT00527644|University of Missouri Health Care|Bruce Ramshaw, M.D.|5738841925|kadysj@health.missouri.edu|
22422396|NCT00382590|UT MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Associate Professor|713-745-3428|eharriso@mdanderson.org|
22422397|NCT00610155|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22422398|NCT01560234|AstraZeneca R&D|Ajay Aggarwal||ClinicalTrialTransparency@astrazeneca.com|
22422399|NCT02028767|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22422400|NCT01284348|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22393543|NCT01034176|Brigham and Women's Hospital|Dr. Anil Chandraker|617-525-8203|achandraker@partners.org|
22433359|NCT04677543|Insmed Incorporated|Insmed Medical Information|1-844-446-7633|medicalinformation@insmed.com|
22433360|NCT01740258|Duke University|Annick Desjardins, MD, FRCPC|919-681-1691|annick.desjardins@duke.edu|
22433361|NCT02342288|West Virginia University|Dr. Sanford Emery|304-293-1170|semery@hsc.wvu.edu|
22433362|NCT02727816|CooperVision Inc.|Senior Manager Global Medical Scientific Affairs|925 621-3761|javega@coopervision.com|
22433363|NCT04188834|Georgia Institute of Technology Atlanta|Dr. Annabelle Singer|404.385.4936|annabelle.singer@bme.gatech.edu|
22433364|NCT00553436|Ethicon Endo-Surgery, Inc|Amy Mahanes, Clinical Research Associate II|513-337-8366|amahanes@its.jnj.com|
22433365|NCT02455336|James J. Peters VA Medical Center|Michael F. La Fountaine, EdD, ATC, FACSM|718-584-9000|michael.lafountaine@va.gov|3121
22433366|NCT00391430|NYU Langone|Marylene Cloitre|2122632471|marylene.cloitre@nyulangone.org|
22433367|NCT01158820|Department of Anesthesiology & Critical Care|Jeff E Mandel MD MS|2156150553|mandelj@uphs.upenn.edu|
22433368|NCT00577707|Memorial Sloan Kettering Cancer Center|Dr. Mark Kris|646-888-4205|krism@mskcc.org|
22433369|NCT03299244|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22433370|NCT02561481|Univ of Massachusetts Medical School|Andrew Zimmerman, MD|4109350488|andrew.zimmerman@umassmemorial.org|
22433371|NCT01574287|Emory University|Schuster, David|404-712-4859|dschust@emory.edu|
22433372|NCT01667250|electroCore LLC|Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
22433373|NCT00962871|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22433374|NCT03706430|Masimo|Dr. William C. Wilson, CMO, SVP|949-297-7000|william.wilson@masimo.com|
22393544|NCT00715962|Birmingham VAMC|Cynthia J. Brown, MD, MSPH|205-933-8101|cynthia.brownd44b2@va.gov|7300
22393545|NCT00266227|Genentech, Inc.|Medical Communications Specialist|800-821-8590||
22393546|NCT00670631|University of Iowa|Guido Tricot, MD, PhD||guido-tricot@uiowa.edu|
22393547|NCT02924428|Venus Concept Ltd.|Director, Clinical Affairs|416-222-6144|mgronski@venusconcept.com|517
22393548|NCT02680002|BARDA|Silvija Tresnjak-Smith|202-557-1993|Silvija.Tresnjak-Smith@hhs.gov|
22393549|NCT02704754|Howard University|Thomas A Mellman|12022575961|TMellman@Howard.edu|
22422401|NCT03325816|Georgetown University|Chul Kim, MD|202-444-2223|Chul.Kim@gunet.georgetown.edu|
22422402|NCT00638716|ConjuChem Biotechnologies Inc.|Associate Director of Regulatory Affairs|310-405-7549|Aleece.Nolasco@nantbio.com|
22422403|NCT00083759|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22422404|NCT02347774|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
22422405|NCT04306965|Tufts Medical Center|Study Coordinator|617-636-1579|courtney.donovan@tuftsmedicine.org|
22422406|NCT04112043|University of Florida|Dr. Robert Mankowski|352-294-5055|r.mankowski@ufl.edu|
22422407|NCT00181285|University of Illinois at Chicago|Jerry A. Krishnan|312-413-0637|jakris@uic.edu|
22422408|NCT03567005|Alcon Research|CDMA Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22422409|NCT02799667|Tufts Medical Center|Ashley T. Peterson, MD, Study Coordinator|617-636-5000|apeterson@tuftsmedicalcenter.org|2382
22422410|NCT05338502|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22422411|NCT04903496|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22422412|NCT00756236|Department of Anesthesia. OUHSC|Dr. Mehmet Ozcan, MD|405-271-4351|mehmet-ozcan@ouhsc.edu|
22422413|NCT01062113|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22422414|NCT03499899|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
22422415|NCT03655470|Brown University|Anthony Spirito, PI|4014441929|anthony_spirito@brown.edu|
22422416|NCT03063086|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22422417|NCT01316211|Paradigm Spine|Fran Magee, DVM|212-367-7274|fran.magee@paradigmspine.com|
22393550|NCT02856828|Duke University Health Systems|Dr. Rachel Reilly|919-668-0291|rachel.reilly@duke.edu|
22422418|NCT03702010|Hospital Universitario de Salamanca|Dr. Francisco José Sánchez Montero|923291100|fjsmontero@saludcastillayleon.es|
22422419|NCT01131169|Memorial Sloan Kettering Cancer Center|Sergio Giralt, MD|646-608-3731|GiraltS@mskcc.org|
22422420|NCT02449798|Bard Access Systems, Inc.|Gina Gilbert, BSN, RN|407-489-0935|Gina.Gilbert@crbard.com|
22422421|NCT02209519|University of Alabama at Birmingham|Jane Schwebke, MD|205-975-5665|jschwebk@uabmc.edu|
22422422|NCT01721096|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com|
22422423|NCT02401048|Pharmacyclics|Emily Liu|(669) 224-1899|aliu@pcyc.com|
22422424|NCT01826513|University of Western Australia|Prof. David Hillman & Prof. Peter Eastwood|+61 8 9346 1706|peter.eastwood@health.wa.gov.au|
22422425|NCT02549287|Georgia State University|Dr. Daniel Whitaker|404-413-1282|dwhitaker@gsu.edu|
22422426|NCT03793842|Michigan Medicine|Robert Hyzy, MD|734-936-5201|rhyzy@med.umich.edu|
22422427|NCT00638222|The University of Toledo, HSC|Christopher Cooper, MD|419.383.6030|christopher.cooper@utoledo.edu|
22422428|NCT00427921|Abbott Laboratories|Medical Information Specialist|Phone: (800) 633-9110||
22422429|NCT02685358|VA Palo Alto Health Care System|Eric Kuhn, PhD|650-493-5000|eric.kuhn@va.gov|23160
22422430|NCT00765336|Medicis Global Services Corporation|Director of Clinical Trials||ClinicalTrials@Medicis.com|
22422431|NCT00733421|Foot & Ankle Surgical Centre|Jan Jakobsson PI, MD, PhD, Professor|46702500960|jan.jakobsson@ki.se|
22422432|NCT01523782|ERYTECH Pharma|Denise Tilton, Global Head Clinical Operations & Program Management|+1 857-706-1587|dtilton@erytech.com|
22422433|NCT04185220|National Cancer Institute|Dr. Kevin Conlon|240-858-3570|conlonkc@mail.nih.gov|
22422434|NCT01029782|Interior Health|Dawn Dalen|250-862-4449|dawn.dalen@interiorhealth.ca|
22422435|NCT01030289|Medical University of South Carolina|Jeffrey Borckardt, Ph.D|843-792-3295|borckard@musc.edu|
22422436|NCT00687544|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22422437|NCT02195869|Pharmacyclics LLC, An AbbVie Company|Manuela Juretic, Associate Director, Clinical Operations|(408) 215.3628|mjuretic@pcyc.com|
22422438|NCT03063437|Microbiome Health Research Institute|Majdi Osman, MD, MPH|6175752201|majdi@openbiome.org|
22422439|NCT01314872|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22422440|NCT06366087|BARDA|Michael D. Schwartz, MD MPH/Division of CBRN Countermeasures|(202)-260-0849|Michael.Schwartz@hhs.gov|
22422441|NCT01351480|AARDS Research, Inc.|Norman B Gaylis, MD|305-652-6676|drnbg@rheum-care.com|
22422442|NCT00199797|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22422443|NCT03717051|University of Hong Kong|Dr. Derek Cheung|39176652|derekcheung@hku.hk|
22422444|NCT03652636|Indiana University|Jordan Swensson, MD|317-944-1837|jswensso@iu.edu|
22422445|NCT02195622|IU Health Physicians Urology|James Lingeman, MD|317-962-3700||
22422446|NCT03190668|University of Florida|Christoph Seubert, MD|352-273-8960|cseubert@anest.ufl.edu|
22422447|NCT00251303|National Institute of Mental Health, Pediatrics and Developmental Neuroscience Branch|Dr. Susan E. Swedo|301-496-5323|swedos@mail.nih.gov|
22422448|NCT00679029|University of Nebraska|Elizabeth Reed|(402) 559-5388|ereed@unmc.edu|
22433375|NCT01928433|Universityhospital Gießen and Marburg, Germany|Prof. Dr. med. Florian Wagenlehner|+49-641-98544516|Florian.Wagenlehner@chiru.med.uni-giessen.de|
22422449|NCT00504725|Duke University Medical Center|Andrew Shaw MD|9192866938|andrew.shaw@duke.edu|
22393551|NCT00423943|University of California, Los Angeles|Michael Minzenberg|310-825-7642|MMinzenberg@mednet.ucla.edu|
22422450|NCT03937908|Oregon Health & Science University|Dr. Amala Soumyanath|503-494-6878|soumyana@ohsu.edu|
22393552|NCT03730480|Ascensia Diabetes Care|Pragathi Shelat|1 (862) 229-6679|pragathi.shelat@ascensia.com|
22393553|NCT00504660|UT MD Anderson Cancer Center|Charles A. Conrad, MD / Professor|713-745-1896|skang@mdanderson.org|
22393554|NCT04097301|AGC Biologics|Anna Stornaiuolo|0221277440|astornaiuolo@agcbio.com|
22393555|NCT04464954|Mike O'Callaghan Military Medical Center|Amanda Crawford|7026532067|amanda.j.crawford.ctr@health.mil|
22393556|NCT00538915|DallasAllergyImmunology|Richard L. Wasserman, M.D., Ph.D.|(972) 566-7788|drrichwasserman@gmail.com|
22393557|NCT02716818|Diurnal Limited|Information Line|+44 (0) 2920 682069|info@diurnal.co.uk|
22393558|NCT02480153|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22393559|NCT01403610|UT Health San Antonio|Andrew Brenner|210-450-1000|regulatoryaffairs@uthscsa.edu|
22422451|NCT03875092|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22422452|NCT03205761|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
22422453|NCT00636194|Bausch & Lomb|Robert Steffen OD|(585) 338-6399|robert.steffen@bausch.com|
22422454|NCT03470012|cyberDERM|Danielle Fendrick|610-325-0881|dfendrick@cyberderm-inc.com|
22422455|NCT04114357|Indiana University|Heba M Ismail|317-278-8326|heismail@iu.edu|
22422456|NCT02163226|UT MD Anderson Cancer Center|Dr. Quynh-Nhu Nguyen, MD,Associate Professor, Radiation Oncology Department|(713) 563-2450|qnnguyen@mdanderson.org|
22422457|NCT01770366|Baystate Medical Center|Sofija Zagarins|413-794-2876|sofija.zagarins@baystatehealth.org|
22422458|NCT01585324|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22422459|NCT03448575|Kaiser Permanente Washington Health Research Institute|Robert Penfold, PhD|206-316-7544|robert.b.penfold@kp.org|
22422460|NCT05318092|AngioDynamics, Inc.|Elizabeth Manning|339-237-2765|liz.manning@angiodynamics.com|
22422461|NCT00287872|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Ivan Borrello|(410) 955-4967|iborrell@jhmi.edu|
22422462|NCT00160706|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22422463|NCT03214380|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22422464|NCT02230696|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
22422465|NCT01934517|U of Montreal|Vincent Peloquin|514-343-6056|vincent-claude.peloquin@umontreal.ca|
22422466|NCT02153671|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22422467|NCT02796352|University of Pittsburgh Cancer Institute|Barbara Stadterman, Regulatory Supervisor|(412) 647-5554|stadtermanbm@upmc.edu|
22422468|NCT02579343|Counseling and Psychological Services|Adam McCabe|239-590-7950|amccabe@fgcu.edu|
22422469|NCT04984278|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
22422470|NCT04292912|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22422471|NCT00280397|Eisai Co., Ltd.|Akihiko Tsuruoka|+81-3-3817-5252||5252
22422472|NCT06175026|Stanford University|Dr. Anna H. Grummon, PhD|(650) 644-7366|agrummon@stanford.edu|
22422473|NCT03348930|University of Chicago|Dr. Jon Grant|7738341325|jgrant4@bsd.uchicago.edu|
22422474|NCT01598090|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
22422475|NCT03628339|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22422476|NCT00355147|VA Stroke QUERI Center, Roudebush VAMC|Teresa Damush, Ph.D.|317-988-4277|Teresa.Damush@va.gov|
22422477|NCT01146379|Washington University School of Medicine|Dr. Catherine Lang|314-286-1945|langc@wustl.edu|
22422478|NCT01985932|University of Pennsylvania|Curtiland Deville, MD|215-662-2428|deville@uphs.upenn.edu|
22422479|NCT03474731|University of Kentucky|Dr. Nancy Schoenberg|(859) 323-8175|nesch@uky.edu|
22422480|NCT00554515|Beth Israel Deaconess Medical Center|David F. McDermott, MD||dmcdermo@bidmc.harvard.edu|
22422481|NCT03139578|Johnson & Johnson Vision|Anna Sulley BSc MCOptom FAAO|+44 1344864043|asulley1@its.jnj.com|
22422482|NCT04087720|Horizon Therapeutics USA, Inc.|Supra Verma, MD|866-479-6742|clinicaltrials@horizontherapeutics.com|
22422483|NCT02880475|Mundipharma (China) Pharmaceutical Co. , Ltd|Junjiao Ma|01065636711|Junjiao.Ma@mundipharma.com.cn|
22422484|NCT00900159|Brigham and Women's Hospital; Harvard Medical School|Dr. Orfeu M. Buxton|617-507-9177|Orfeu_Buxton@HMS.Harvard.edu|
22422485|NCT01707108|Rambam Health Care Campus|Director of Trial|+97247772983|j_horwitz@rambam.health.gov.il|
22422486|NCT01377922|Catalyst Pharmaceuticals, Inc.|Gary Ingenito|305-420-3200|gingenito@catalystpharma.com|
22422487|NCT04615403|Glaukos|Study Manager|949-481-8076|ldoan@glaukos.com|
22422488|NCT00665431|Pozen|Sr VP Clinical Research|919 913 1030|eorlemans@pozen.com|
22422489|NCT02145260|Brigham and Women's Hospital|Finnian Mc Causland|6177326432|fmccausland@bwh.harvard.edu|
22422490|NCT01726270|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22422491|NCT02157376|AstraZeneca|Barry Traxler||barry.traxler@astrazeneca.com|
22422492|NCT02547220|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22422493|NCT03817229|Cincinnati Children's Hospital Medical Center|Avani Modi, Ph.D.|5136364864|avani.modi@cchmc.org|
22422494|NCT03771560|UCSF|Dr. Robert Hendren|415-502-3500|STAR@ucsf.edu|
22422495|NCT02887183|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22422496|NCT04471194|Pennsylvania State University College of Medicine|Jennifer L. Moss, PhD|717-531-0003|jmoss1@pennstatehealth.psu.edu|323429
22422497|NCT03649932|University of Texas Medical Branch|Dr. Sunil Jain|4097722815|amnahqasim@gmail.com|
22422498|NCT02702388|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22393560|NCT00901186|Novartis Pharmaceuticals|Study Director|1-862-778-8300||
22393561|NCT02080312|UCSD|Julie Bykowski|619-543-6766|jbykowski@ucsd.edu|
22422499|NCT02729051|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22422500|NCT04138953|Emory University|Michael Borich, DPT, PhD|404-712-0612|michael.borich@emory.edu|
22422501|NCT00869622|VA Boston Healthcare System|Antonio A. Lazzari, M.D., Ph.D|(857) 364-6381|Antonio.Lazzari@va.gov|
22422502|NCT00602836|Mayo Clinic|Dr. Tait Shanafelt||shanafelt.tait@mayo.edu|
22422503|NCT01397786|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22422504|NCT04432090|AdventHealth, Orlando|Richard Pratley|407-303-2519|richard.pratley.md@adventhealth.com|
22422505|NCT04250350|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
22433376|NCT00145626|St. Jude Children's Research Hospital|Brandon Triplett, MD|866-278-5833|referralinfo@stjude.org|
22433377|NCT00766116|University of California, San Diego|Edward D. Ball, MD|858-822-6600|tball@ucsd.edu|
22433378|NCT03381287|HighTide Therapeutics|Dr. Adrian Di Bisceglie, CMO|314-791-0593|adibisceglie@hightidetx.com|
22433379|NCT02709720|Fundación GECP|Eva Pereira|+34934302006|gecp@gecp.org|
22433380|NCT02132572|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22433381|NCT01198574|South East Asia Ministers of Education Organization, Regional Center for Food and Nutrition|Dr. Min Kyaw Htet, Township Health Officer, Ministry of Health, Myanmar|+62-857-27262672|kyawhtet@gmail.com|
22433382|NCT04439539|Janssen Research & Development, LLC|Senior Director Medical Lead|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22433383|NCT02013778|University of Pennsylvania|Gregory Nadolski, MD, Principal Investigator|215-662-7892|gregory.nadolski@pennmedicine.upenn.edu|
22433384|NCT02719691|University of Colorado|Jennifer Diamond, MD|303-724-5499|jennifer.diamond@cuanschutz.edu|
22433385|NCT03308968|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22433386|NCT04397939|Mount Sinai Hospital|Annapoorna S Kini, M.D.|(212) 241-4181|annapoorna.kini@mountsinai.org|
22433387|NCT00776594|Dana Farber Cancer Institute|Mary-Ellen Taplin, MD|617-632-6328|Mary_taplin@dfci.harvard.edu|
22433388|NCT01521923|UCB Cares|UCB (Study Director)|+1 887 822 9493||
22433389|NCT03037476|University of Washington|Jason Kilmer, Ph.D.|206-685-4512|jkilmer@uw.edu|
22433390|NCT02403817|University of California, San Diego|Jeanne Townsend, PhD, Professor of Neurosciences|858-246-1931|jtownsend@ucsd.edu|
22433391|NCT02414607|University of Missouri|Dr. David Beversdorf|(573) 882-6081|beversdorfd@health.missouri.edu|
22433392|NCT00501592|Intercept Pharmaceuticals, Inc.|Cathi Sciacca, Sr. Director, Clinical Operations|858-652-6800|csciacca@interceptpharma.com|
22422506|NCT00860249|Northwestern University, Department of General Internal Medicine|Kenzie A. Cameron, PhD, MPH|312-503-3910|K-Cameron@northwestern.edu|
22422507|NCT00743288|Oncotherapeutics|Director, Clinical Operations|323-623-1200|lthulin@oncotherapeutics.com|
22422508|NCT00743730|Medical College of Wisconsin|Keri R. Hainsworth, PhD, Research Director|414-266-6306|khainswo@mcw.edu|
22422509|NCT02836236|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22422510|NCT00378508|Yale University|Kevan Herold, MD|203-785-6507|kevan.herold@yale.edu|
22422511|NCT01435018|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22422512|NCT00593684|Baylor Health Care System|Furgan Moin, MD|214-820-7604|Furgan.Moin@baylorhealth.edu|
22422513|NCT03625466|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22422514|NCT04082572|M.D. Anderson Cancer Center|Michael J. Overman, MD|(713) 792-2828|moverman@mdanderson.org|
22422515|NCT00809471|Vivus, Inc|Wesley W Day PhD|650-934-5200||
22422516|NCT01058993|University of Washington|David D. Dale, MD|206-543-7215|dcdale@u.washington.edu|
22422517|NCT00831311|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22422518|NCT00730730|Medtronic Aortic and Peripheral Vascular|Arslan Malik - Senior Clinical Research Manager|(707) 541-3256|arslan.malik@medtronic.com|
22422519|NCT01608087|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22422520|NCT00908791|Norris Cotton Cancer Center|Burton Eisenberg, MD, Deputy Director, Norris Cotton Cancer Center|603-653-3613|Burton.L.Eisenberg@Dartmouth.edu|
22422521|NCT00981669|Instituto Butantan|Alexander Roberto Precioso|+5511-2627-9372|alexrp@butantan.gov.br|9372
22422522|NCT01323153|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
22422523|NCT00722566|Johnson & Johnson Pharmaceutical Research & Development|Helgi Van de Velde, M.D., Ph.D.||HVDVELDE@ITS.JNJ.COM|
22422524|NCT00977704|Medicis R&D Clinical Research Department|Head of Clinical Trials||ClinicalTrialsQuery@Medicis.com|
22422525|NCT04696055|Bayer AG|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22422526|NCT03969901|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22422527|NCT00348595|Johns Hopkins University School of Medicine|Mario Eisenberger|(410) 614-3511|eisenma@jhmi.edu|
22422528|NCT01920958|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22393562|NCT00107120|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|Daniel Ventura, PhD|201-427-8252|daniel.ventura@frx.com|
22433393|NCT01208324|University of Pennsylvania|C. Neill Epperson, M.D|215-573-8871|cepp@mail.med.upenn.edu|
22433394|NCT02978157|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
22433395|NCT04556591|University of Michigan|Dr. Noelle E. Carlozzi|734-764-0644|PMR-CODAlab@med.umich.edu|
22433396|NCT00984165|National Cancer Institute|Dr. Ronald E. Gress|301-496-1791|gressr@dc10a.nci.nih.gov|
22433397|NCT00654836|Loyola University|Shelly S. Lo, M.D.|708-327-3154|shlo@lumc.edu|
22433398|NCT00135330|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22433399|NCT01771991|Sanford Health|Dr Chad Spanos MD|605-328-8200||
22433400|NCT04381052|Columbia University|David J. Cohen, MD|212-305-3273|djc5@cumc.columbia.edu|
22433401|NCT00807586|Minneapolis Heart Institute Foundation|Dr. Daniel Melby|612-863-3900|daniel.melby@allina.com|
22433402|NCT02229825|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22433403|NCT01309997|FHCRC|Stephanie J. Lee MD MPH|206-667-6190|sjlee@fhcrc.org|
22433404|NCT04474197|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22433405|NCT01532921|Medtronic, Bakken Research Center Coronary and Structural Heart Disease Management (CSH), Endepolsdomein 5, 6229 GW Maastricht, The Netherlands|Ber Kleijnen|+3143356 6566|ber.kleijnen@medtronic.com|
22433406|NCT02526212|Montefiore Medical Center-Albert Einstein College of Medicine|Aaron Fox, Principal Investigator|718-920-7173|adfox@montefiore.org|
22433407|NCT01260688|Princess Margaret Cancer Centre|Dr. Lillian Siu|416-946-2911|lillian.siu@uhn.ca|
22433408|NCT00237666|The Medical Research Network, LLC|Dr. Michael Liebowitz|(212) 595-5012|MLiebowitz@MedicalResearchNetwork.com|
22433409|NCT00588237|Memorial Sloan Kettering Cancer Center|Dr. Jason Konner|646-888-4219|konnerj@mskcc.org|
22433410|NCT01390298|Wake Forest School of Medicine|James C. Eisenach, M.D.|336-716-4498|jimeisenach@gmail.com|
22433411|NCT00436046|Baylor College of Medicine|Robert Couch, MD|713-798-4474|rcouch@bcm.tmc.edu|
22433412|NCT02443337|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22433413|NCT03645096|UT Southwestern Medical Center|Dr. Sherwood Brown|214-645-6950|Sherwood.Brown@utsouthwestern.edu|
22433414|NCT02096952|Massachusetts General Hospital|Dr. Gahan Joshi|617-726-8392|joshi.gagan@mgh.harvard.edu|
22433415|NCT03520920|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22433416|NCT04169529|Medtronic|Andy St. Martin|(952) 220-4009|andy.stmartin@medtronic.com|
22433417|NCT02346643|St. Jude Medical|Roni Diaz|+1 972 309 8601|RDiaz@sjm.com|
22433418|NCT00372619|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|ResultsReportingCoordinator@childrensoncologygroup.org|
22433419|NCT00066222|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
22433420|NCT00635349|Janssen Korea / 25F, LS Yongsan Tower, 191 Hankangro 2-Ga, Yongsan-Gu, Seoul 140-702 Korea|Clinical Research Director|82-2-2094-4518||
22433421|NCT05141708|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22433422|NCT04904744|Cincinnati Children's|Dr. William B. Brinkman|513-636-2576|bill.brinkman@cchmc.org|
22433423|NCT04998318|Duke University Medical Center|Megan Huchko, MD, MPH|(919) 684-8111|megan.huchko@duke.edu|
22393563|NCT04390022|Barcelona Institute for Global Health|Carlos Chaccour|0034666293112|carlos.chaccour@isglobal.org|
22393564|NCT03241225|Weill Cornell Medicine|Dr. Jo Anne Sirey|914-997-4333|jsirey@med.cornell.edu|
22393565|NCT00852540|GlaxoSmithKline|GSK Response Center|866-435-7343||
22422529|NCT05406479|Insitute of Tropical Medicine|Carolien Hoof|+32470102562|choof@itg.be|
22422530|NCT00140244|BIDMC|Dr. Christos Mantzoros|617-667-8630|cmantzor@bidmc.harvard.edu|
22422531|NCT03192306|Benu BioPharma, Inc.|Dr. Eric Morrel, VP Clinical Research|5082085634|emorrel@benubio.com|
22422532|NCT04932655|Cassava Sciences, Inc.|Nadav Friedmann, PhD, MD|512-501-2444|eschoen@cassavasciences.com|
22422533|NCT02589626|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22422534|NCT00379080|Adult Brain Tumor Consortium|Stuart A Grossman, MD Director of ABTC|410-955-8837|grossman@jhmi.edu|
22422535|NCT02780713|AstraZeneca AB|AZD9496 Global clinical leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
22422536|NCT01931475|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22422537|NCT03461952|Canadian Cancer Trials Group|Janet Dancey|613-533-6430|jdancey@ctg.queensu.ca|
22422538|NCT01089608|Laboratoires Thea|Dr Pascale POULIQUEN|0473981436|p.pouliquen@laboratoires-thea.fr|
22422539|NCT04347564|Augenheilkunde Lindenthal|Daniela Claessens|017229227962|daniela.claessens@gmx.de|
22422540|NCT02225860|Tufts Medical Center|Ronald D. Perrone|6176362372|rperrone@tuftsmedicalcenter.org|
22422541|NCT01028014|University of Alabama at Birmingham|Dr. William Jerod Greer|205-934-7874|wjgreer@uab.edu|
22422542|NCT01250873|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22422543|NCT01127451|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22422544|NCT00425061|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22422545|NCT02111577|SOTIO a.s.|Prof. Radek Spisek, M.D., Ph.D.|+420 2241 75101|spisek@sotio.com|
22422546|NCT03055897|Alcon Research, LLC|Senior CDMA Project Lead, CDMA Ocular Health|1-888-451-3937|alcon.medinfo@alcon.com|
22422547|NCT02429778|VA Palo Alto Health Care System|Christine Gould, PhD|650-493-5000|Christine.Gould@va.gov|68899
22422548|NCT04501640|Astellas Pharma China, Inc.|Clinical Trial Disclosure|+86-(0)10-85216666|astellas.resultsdisclosure@astellas.com|
22422549|NCT03341143|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP|4126475554|stadtermanbm@upmc.edu|
22422550|NCT03557931|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22422551|NCT02394340|Bausch Health Americas, Inc.|Director of Clinical Operations||aloncaric@bauschhealth.com|
22433424|NCT02888691|Steno Diabetes Center Copenhagen|Dr Signe Schmidt|+4551174785|signe.schmidt@regionh.dk|
22422552|NCT00634803|Yale University|Richard S. Schottenfeld, M.D.|203-974-7349|richard.schottenfeld@yale.edu|
22433425|NCT01524224|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22433426|NCT05398159|InMode|Maria Shusterman|9057076787|Maria.Shusterman@inmodemd.com|
22433427|NCT05371054|National Cancer Institute|Dr. Christopher J. Melani|240-760-6057|christopher.melani@nih.gov|
22433428|NCT00456625|GlaxoSmithKline|GSK Response Center|866-435-7343||
22433429|NCT05420961|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22433430|NCT02625220|Johnson & Johnson Vision Care Inc.|Benjamin Straker, BAppSc(Optom)(HonS) Principal Research Optometrist|904-443-3500|Bstraker@ITS.JNJ.com|1380
22433431|NCT01119066|Memorial Sloan Kettering Cancer Center|Richard O'Reilly, MD|646-888-2157|oreillyr@MSKCC.ORG|
22433432|NCT00783835|Janssen-Cilag Farmaceutica Ltda|Medical Manager|+55 11 30302738||
22433433|NCT00295646|ABCSG (Austrian Breast & Colorectal Cancer Study Group)|Trial Office Director|+43 1 4089230|info@abcsg.at|
22433434|NCT00995436|ChestyerfieldNDRH|Jonathan Sandler|01246512106|JonSandler57@gmail.com|
22433435|NCT00418093|Dana-Farber Cancer Institute|Neil Horowitz, MD|617-732-8843|nhorowitz@partners.org|
22433436|NCT01232127|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22433437|NCT02880228|Mayo Clinic|Shaji K Kumar MD|5072842511|kumar.shaji@mayo.edu|
22433438|NCT03506412|Mayo Clinic|Naveen L. Pereira, M.D.|507-284-8612|Pereira.Naveen@mayo.edu|
22433439|NCT03162796|Janssen Research & Development, LLC|Head Rheumatology Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22433440|NCT02623205|Department of Psychiatry, Renaissance School of Medicine at Stony Brook University|Kathryn Hill|904-252-3449|kathryn.hill@stonybrookmedicine.edu|
22433441|NCT01176617|Hospital of the University of Pennsylvania|Dr. Sanjay Dixit|215-615-4337|sanjay.dixit@uphs.upenn.edu|
22433442|NCT02375373|University of Florida|Volker Mai, PhD, MPH|352-273-9398|vmai@epi.ufl.edu|
22433443|NCT02725476|Xencor, Inc.|Vice President, Biometrics|858-480-3414|bburington@xencor.com|114
22433444|NCT02749201|maimonides medical center|Danny Sherwinter|7182837952|dsherwinter@maimonidesmed.org|
22433445|NCT00289289|Medtronic CRDM Clinical|Jen Lahr||jen.lahr@medtronic.com|
22433446|NCT01445613|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com|
22433447|NCT00407602|Second Sight Medical Products, Inc.|Jessy Dorn, PhD, Director of Clinical and Scientific Affiars|8188335089|jdorn@secondsight.com|
22433448|NCT01169701|Novartis Pharmaceuticals|Study Director|862-778-8300||
22433449|NCT02619591|UMASS Memorial Department of Emergency Medicine|Executive Vice Chairman|508-421-1400|Romolo.Gaspari@umassmemorial.org|
22433450|NCT06875284|RTI International|Marni Kan, PhD|919-248-1836|mkan@rti.org|
22433451|NCT06631274|Florida State University|Dr. Lyndsay Jenkins|(850) 644-4592|lnjenkins@fsu.edu|
22433452|NCT03054805|Chang Gung Memorial Hospital|Dr. Hsun-Chin Chao|88633281200|chaohero@yahoo.com|8969
22433453|NCT02141633|University of Miami|Dr Adam Wanner Professor of Medicine Division of Pulmonary and Critical Care Medicine|(305) 243-3045|awanner@med.miami.edu|
22433454|NCT00833469|Massachusetts General Hospital|Dr. Marlene Freeman, MD|617-643-6403|mfreeman@partners.org|
22433455|NCT02943070|Boston Scientific Corporation|Director, Clinical Operations|952-930-6000|teresa.takle-flach@bsci.com|
22433456|NCT01701362|Pfizer, Inc|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22433457|NCT00570778|Novartis Pharmaceuticals|Study Director|862-778-8300||
22433458|NCT01861704|InSound Medical, Newark, California|Tanya Arbogast, Study Principal Investigator|510-792-4000|Srikant.Mantha@phonak.com|
22433459|NCT00443872|University of Kansas Medical Center|Dr. Kelly Lyons|9135887159|klyons@kumc.edu|
22433460|NCT01014767|Tufts Medical Center|Research Administration|617-636-1142|mcoughlin@tuftsmedicalcenter.org|
22433461|NCT00700622|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
22433462|NCT00282087|SARC|Research Project Manager|(734) 930-7600|sarc@sarctrials.org|
22433463|NCT00405392|GlaxoSmithKline|GSK Response Center|866-435-7343||
22433464|NCT04301934|Mayo Clinic|Johnny Yi, M.D.|480-342-0612|Yi.Johnny@mayo.edu|
22393566|NCT01597141|Maine Medical Center Research Institute|William R. McFarlane, M.D.|207-662-4348|mcfarw@mmc.org|
22422553|NCT02805179|University of Michigan|Michelle Kim, MD|734-936-4300|michekim@med.umich.edu|
22422554|NCT00886743|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22422555|NCT00478777|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22422556|NCT03388645|National Institute of Allergy and Infectious Diseases|Lesia Dropulic|+1 301 496 7675|dropulicl@niaid.nih.gov|
22422557|NCT01323387|Synthes Spine|Clinical Research Associate|610-719-5942|knappk@synthes.com|
22422558|NCT00511914|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22422559|NCT04200651|New York Eye Surgery Center; University of Colorado|Dr. Nicholas Tan|3476175971|tannicholas97@gmail.com|
22422560|NCT02434146|University of Wisconsin Carbone Cancer Center|Margo L Hoover-Regan|608-263-6200|mhooverregan@pediatrics.wisc.edu|
22422561|NCT01031680|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
22422562|NCT02703467|Imperial College London|Professor Fan Chung|00442075947954|f.chung@imperial.ac.uk|
22422563|NCT00757042|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22422564|NCT03319732|RVL Pharmaceuticals, Inc.|Vice President Regulatory Affairs and Quality|908-809-1300|regulatory@rvlpharma.com|
22422565|NCT02934698|MUSC|Patrick Flume|843-792-3167|flumepa@musc.edu|
22433465|NCT01703091|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22433466|NCT02550288|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22433467|NCT00988052|Teva Pharmaceutical Industries, Ltd|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22433468|NCT00842153|GlaxoSmithKline|GSK Response Center|866-435-7343||
22433469|NCT03352141|Zeltiq Aesthetics|Lori Brandt, Director Cinical Trial Management|(925) 621-7460|lori.brandt@abbvie.com|
22393567|NCT01635920|Alcon Research, Ltd.|Sharon Holden Thomas, O.D., Sr. Principal Clinical Scientist|1-888-451-3937|alcon.medinfo@alcon.com|
22393568|NCT00704379|Baylor College of Medicine|Dr. Ricardo Jorge|713-794-7010|Ricardo.Jorge@bcm.edu|
22422566|NCT02654977|University of Michigan|Dr. Elif Oral|734-615-7271|eliforal@umich.edu|
22422567|NCT01266291|University of Pennsylvania|John Pollard, MD|215-873-5909|john.pollard@uphs.upenn.edu|
22422568|NCT00481351|Universidade de São Paulo|Otavio Celeste Mangili, MD|+554499928818|otaviomangili@yahoo.com.br|
22422569|NCT00596817|H. Lundbeck A/S|H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
22422570|NCT05129293|Trinity Health Of New England|Mandell Center Research Team|860-714-3005|MSResearch@TrinityHealthOfNE.org|
22422571|NCT00519428|NYSPInstitute|Jonathan W. Stewart, M.D.|212-543-5745|jws6@columbia.edu|
22422572|NCT01729338|Duke University Medical Center|Gwynn Long|919-668-0838|gwynn.long@duke.edu|
22422573|NCT00688701|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22422574|NCT00029536|Beth Israel Deaconess Medical Center|Dr. Andrew G. Herzog|781-431-0277|aherzog@bidmc.harvard.edu|
22422575|NCT03962790|Johnson & Johnson Vision Care|Brian Pall, Director Clinical Science, Vision Care|1-800-843-2020|bpall@its.jnj.com|
22422576|NCT02877095|Duke Clinical Research Institute|Rachel Olson, Project Leader|919-309-5544|rachel.e.olson@duke.edu|
22422577|NCT02223650|Jaeb Center for Health Research|Ray Kraker, M.S.P.H., Director of PEDIG Coordinating Center|(813) 975-8690|rkraker@jaeb.org|
22422578|NCT05167370|Cincinnati Children's Hospital Medical Center|Dr. Sonata Jodele|(513) 636-5917|Sonata.Jodele@cchmc.org|
22422579|NCT01767506|Johns Hopkins University|Sheila K West|410 955 2606|shwest@jhmi.edu|
22422580|NCT01322594|MedImmune, Limited|Ed Piper|+44 (0) 1223 471 471|pipered@medimmune.com|
22422581|NCT01470651|New York State Psychiatric Institute-Research Foundation for Mental Hygene|Judith Rabkin|646-774-8075|jgr1@cumc.columbia.edu|
22422582|NCT00664859|Veloxis Pharmaceuticals, Inc.|Director, Regulatory Affairs|919-591-3090|bbu@veloxis.com|
22422583|NCT01943851|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22422584|NCT02806544|Vanderbilt University|Laila Agrawal|615-322-4967|laila.saied@vanderbilt.edu|
22422585|NCT00401544|Amgen Inc.|Study Director|866-572-6436||
22422586|NCT03645395|Molecular Templates, Inc.|Study Director|862-204-7184|trials@mtem.com|
22422587|NCT02317276|UCSF Dermatology|Sarah Arron, MD, PhD|415-353-9684|Sarah.Arron@ucsf.edu|
22422588|NCT01289639|VA Puget Sound Health Care System|Kristina Utzschneider|206-277-3568|kutzschn@u.washington.edu|6-3568
22422589|NCT02821338|US Food and Drug Administration|Office of Generic Drugs, Center for Drug Evaluation and Research|240-402-7920|genericdrugs@fda.hhs.gov|
22422590|NCT02278939|University of California San Francisco, School of Nursing|Dr. Melinda Sarmiento Bender and Dr. Yoshimi Fukuoka|(415) 514-3151|melinda.bender@ucsf.edu; yoshimi.fukuoka@ucsf.edu|
22422591|NCT02669836|Washington University|David D. Limbrick MD|314-454-3212|T.Meehan@wustl.edu|
22422592|NCT01665950|Massachusetts General Hospital, Center for Quantitative Health|Dr. Roy Perlis|617-643-6310|rperlis@partners.org|
22422593|NCT02423343|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22422594|NCT04826965|Duke University|Suhail Mithani, MD|919-681-8390|suhail.mithani@duke.edu|
22422595|NCT00860535|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22422596|NCT01949844|Cedars-Sinai Medical Center|Dr. Behzad Sharif, Assistant Professor|310-423-7758||
22422597|NCT04429555|Medicinova Inc|Malath Makhay|8582468680|makhay@medicinova.com|
22422598|NCT00930774|National Center for Rehabilitative Auditory Research, Portland VA Medical Center|Dr. Gabrielle H Saunders|503-220-8262|gabrielle.saunders@va.gov|56210
22422599|NCT00712881|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22422600|NCT03200704|Novadaq Technologies ULC, now a part of Stryker|Colleen Roden, Director of Clinical Sciences and Operations|931-267-2041|colleen.roden@stryker.com|
22422601|NCT01680861|Miami Transplant Institute|Jeffrey Gaynor, Ph.D. biostatistician||jgaynor@med.miami.edu|
22422602|NCT02274870|Northwell Health|Director of Research, Anesthesiology|718-470-7630|odowling@northwell.edu|
22422603|NCT01975571|University of Iowa|Dr. Camille Dunn|3193538776|camille-dunn@uiowa.edu|
22422604|NCT00887783|Dept. Oncology, Odense University Hospital|Dr. Olfred Hansen, Professor, Ph.D.|+4524241588|olfred.hansen@rsyd.dk|
22422605|NCT04590586|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22422606|NCT01609543|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22422607|NCT01893281|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22422608|NCT01254318|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22422609|NCT03933618|Albany Medical Center|Dr. Charles Welliver|518-262-3341|wellivr@amc.edu|
22422610|NCT00910208|Albert Einstein College of Medicine|Polly Bijur, PhD|718-430-4217|polly.bijur@einstein.yu.edu|
22422611|NCT01137110|Washington University|Dr Theresa Human|314-747-8799|theresa.human@bjc.org|
22433470|NCT05312697|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
22433471|NCT02858440|GlaxoSmithKline|GSK Response Center|866-435-7343|lrs54533@gsk.com|
22433472|NCT00402324|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22433473|NCT01277822|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22433474|NCT00997984|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22433475|NCT01569737|HRA Pharma|Christine Adelbrecht, Clinical Trial Coordinator|+33 1 40 33 32 74|c.adelbrecht@hra-pharma.com|
22433476|NCT01945996|University of Southern California|Elizabeth Burner|3232266667|eburner@usc.edu|
22433477|NCT04396795|University of Miami, Miller School of Medicine - Desai Sethi Urology Institute|Dr Ranjith Ramasamy|305-243-4562|ramasamy@miami.edu|
22433478|NCT02136004|Weill Cornell Medical College|S. Chiu Wong, MD|212-746-4644|scwong@med.cornell.edu|
22433479|NCT01107392|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22433480|NCT01539070|Instituto Mexicano del Seguro Social|MPH. Gloria Oliva Martínez Andrade|5556059862|gloria_olivam@hotmail.com|21075
22433481|NCT02689206|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22433482|NCT02520388|Ironshore Pharmaceuticals and Development, Inc.|Chief Scientific Officer|13457498174|bev@ironshorepharma.com|
22433483|NCT05007899|Nationwide Children's Hospital|Chelsea Kebodeaux|(614) 722-2250|Chelsea.Kebodeaux@nationwidechildrens.org|
22433484|NCT00431444|Novartis Pharmaceuticals|Study Director|862-778-8300||
22433485|NCT01955369|Klinikum der Stadt Ludwigshafen|Dr. Joachim Wolf|0049-621|joachim.wolf@diakonissen.de|4200
22433486|NCT01618240|Massachusetts General Hospital|Hooman Mirzakhani|617-291-9779|hmirzakhani@partners.org|
22433487|NCT04201639|Centre for Ocular Research and Education|Jill Woods|5198884567|jwoods@uwaterloo.ca|36743
22433488|NCT01352221|Shield Therapeutics|Jackie Mitchell MA DPhil|+44 (0) 191 511 8515|jmitchell@shieldtx.com|
22433489|NCT00200967|Penn State College of Medicine|Vernon M. Chinchilli|717-531-4262|vchinchi@psu.edu|
22433490|NCT00980460|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22433491|NCT02842086|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22433492|NCT00928187|UMI 233 IRD Montpellier|Dr Laura Ciaffi|00237 694926786|lauraciaffi2002@yahoo.fr|
22433493|NCT05696444|Medtronic|Michele Masters, Sr. Clinical Research Program Manager|4848948925|michele.masters@medtronic.com|
22433494|NCT03759639|IntraBio Ltd|Taylor Fields, Chief Product Development Officer|+44 8081 641283|tfields@intrabio.com|
22433495|NCT01461499|Shiga University of Medical Science|Steering Committee: Takashi Uzu|81-77-548-2222|takuzu@belle.shiga-med.ac.jp|
22433496|NCT01282242|Massachusetts General Hospital|Lee H. Schwamm, MD|617-724-1597|lschwamm@mgh.harvard.edu|
22433497|NCT00078806|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22433498|NCT00161616|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22433499|NCT00336284|Biotronik, Inc.|Justin Michalski, M.S. / Clinical Studies Engineer|503-675-2155|justin.michalski@biotronik.com|
22433500|NCT01658709|University of Kentucky|Phillip Gribble|8592180885|phillip.gribble@uky.edu|
22433501|NCT00861757|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22433502|NCT04908384|University of Washington|Jennifer Sonney|206-685-2161|jsonney@uw.edu|
22433503|NCT04123093|OhioHealth|Dr. Mitch Silver|614-566-1250|mitch.silver@ohiohealth.com|
22433504|NCT01756573|University of Chicago|TARIQ MALIK|773-8342643|tmalik@dacc.uchicago.edu|
22433505|NCT03462641|University of Michigan|Stiven Roytman|734 998-8400|stivenr@med.umich.edu|
22433506|NCT03938103|University of North Carolina at Chapel Hill|Derek Hales, PhD|919-966-6089|derekh@email.unc.edu|
22433507|NCT00392834|University of Arkansas for Medical Sciences|Jeannette Lee, Ph.D.|501-526-6712|jylee@uams.edu|
22433508|NCT02923531|X4 Pharmacueticals|Chief Medical Officer|(857) 529-8300|patientinfo@x4pharma.com|
22433509|NCT02201329|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22433510|NCT02997865|Washington University School of Medicine in St. Louis|Kenneth E. Freedland, PhD|314-286-1311|freedlak@wustl.edu|
22433511|NCT01736267|Massachusetts Eye & Ear Infirmary|Dr. Daniel Lee|6175736391|Daniel_Lee@meei.harvard.edu|
22433512|NCT04660552|JelikaLite Corp|Katya Sverdlov, Chief Executive Officer|9175668151|katya@jelikalite.com|
22433513|NCT03012828|Medicines Development Limited|Sally Kinrade, Vice President (Clinical Development)|+613 9629 6111|sally.kinrade@medicinesdevelopment.com|
22433514|NCT01509846|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22433515|NCT03115411|Stanford University School of Medicine|Dr. Subhas Banerjee, MD|650-723-2623|sbanerje@stanford.edu|
22433516|NCT01637584|UPittsburgh|Dr. Anne Germain|4123832150|germax@upmc.edu|
22433517|NCT02366923|Coopervision|Jose A. Vega, OD, Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|jvega@coopervision.com|
22433518|NCT02484443|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22433519|NCT01970241|HCMC|Lisa Fish MD|612-873-2705|lisa.fish@hcmed.org|
22433520|NCT00992056|University of Miami|Richard A Preston MD MSPH MBA|305 243 5930|rpreston@med.miami.edu|
22433521|NCT02595866|HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute|Kathryn Lurain, M.D.|240-858-3257|kathryn.lurain@nih.gov|
22433522|NCT00295334|Ben-Gurion University of the Negev|Iris Shai|+972086477443|irish@bgu.ac.il|
22433523|NCT01001767|University Hospitals Case Medical Center|Grace McComsey, MC|216-844-3607|mccomsey.grace@clevelandactu.org|
22433524|NCT00177294|University of Pittsburgh|Charles F. Reynolds III, MD|412-246-6414|reynoldscf@upmc.edu|
22433525|NCT02131311|Procter & Gamble Company Global Clinical Sciences|Mylissa Trowbridge||trowbridge.mm@pg.com|
22393569|NCT00353522|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
22393570|NCT04955444|The Methodist Hospital Research Institute|Elsie Rizk|7134412557|erizk@houstonmethodist.org|
22393571|NCT02235831|Alcon Research, Ltd.|Sr. Global Brand Lead, GCRA, Vision Care|1-888-451-3937||
22393572|NCT03568331|Vanda Pharmaceuticals Inc.|Vanda Pharmaceuticals Inc.|202-734-3400|clinicaltrials@vandapharma.com|
22393573|NCT03699085|University of Washington|Lauren Whiteside, Primary Investigator|206-744-8464|laurenkw@uw.edu|
22393574|NCT00158860|GlaxoSmithKline|GSK Response Center|866-435-7343||
22393575|NCT04638920|University Hospital Zurich|Prof. Malcolm Kohler, Sponsor-Investigator|+41442551111|malcolm.kohler@usz.ch|
22393576|NCT01801735|Iroko Pharmaceuticals, LLC|Alexis Gomez, Director of Clinical Operations|267-546-1426|agomez@iroko.com|
22393577|NCT01435616|Eli Lilly and Company|Chief Medical Officer|800 545 5979||
22393578|NCT04080908|NYU Langone Health|Stuart Katz|2122633946|Stuart.Katz@nyulangone.org|
22393579|NCT00371683|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22393580|NCT01237587|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22393581|NCT00060424|Fred Hutch|David G Maloney, MD PhD||dmaloney@fredhutch.org|
22393582|NCT01011387|Mölnlycke Health Care AB|Jenny Thorell|0046 31 7223000|jenny.thorell@molnlycke.com|
22393583|NCT01139580|GlaxoSmithKline|GSK Response Center|866-435-7343||
22393584|NCT01285609|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22393585|NCT01142115|Clinical Regulatory Development, Global R&D|Trine Møller Kruse|+4549112174|dktrm@coloplast.com|
22393586|NCT03208036|Minneapolis VA Health Care System|Tasha Nienow|612-467-1004|tasha.nienow@va.gov|
22393587|NCT00700778|Fox Chase Cancer Center|Dr. Jose Russo|215-728-4782|Jose.Russo@fccc.edu|
22393588|NCT01504477|Georgetown University|Michael Pishvaian|202-444-2223|pishvaim@georgetown.edu|
22393589|NCT00453193|The University of Texas M D Anderson Cancer Center|Farhad Ravandi-Kashani MD/Associate Professor|713-745-0394|eharriso@mdanderson.org|
22393590|NCT02387268|M.C.Carmel|Dr.Kobie Dickstein|048250055|kobiedi@clalit.org.il|
22393591|NCT03230877|Fisher & Paykel Healthcare Ltd.|Sarah Gunson|+64 9 574 0123|sarah.gunson@fphcare.co.nz|7675
22393592|NCT02559895|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
22393593|NCT03122691|Johns Hopkins University School of Medicine|Dr. Ryan Vandrey|410-550-4036|rvandrey@jhmi.edu|
22393594|NCT03762200|ETHICON, Inc|Patricia Schleckser|01 908 218 2244|PSchleck@its.jnj.com|
22393595|NCT03738423|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22393596|NCT01846494|Duke Clinical Research Institute|Allison DeLong|919-668-6855|allison.delong@duke.edu|
22393597|NCT00588900|UNC Lineberger Comprehensive Cancer Center|Bert O'Neil, M.D.||bert_oneil@med.unc.edu|
22393598|NCT04949243|Duke University|Saira Siddiqui, MPH|919-688-8464|saira.siddiqui@duke.edu|
22393599|NCT01728337|CBED|Dr Doris Hexsel|30262633|cbed@cbed.com.br|
22393600|NCT01865747|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
22393601|NCT02592876|Seattle Genetics, Inc.|Chief Medical Officer|(855)473-2436|medinfo@seagen.com|
22393602|NCT00867308|Johns Hopkins University|Amy DeZern, MD|4105027208|adezern1@jhmi.edu|
22393603|NCT01464775|MercyMC|Dr. Fermin Barrueto|410-321-8452|fbarrueto@mdmercy.com|
22433526|NCT01479764|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com|
22433527|NCT03082677|Memorial Sloan Kettering Cancer Center|Dr. Doris Ponce, MD|646-608-3739|ponced@mskcc.org|
22433528|NCT03020004|Ascletis Pharmaceuticals Co., Ltd|Clinical Trial Disclosures|+86057185389732|yicheng.zhao@ascletis.com|
22433529|NCT00255723|Memorial Sloan Kettering Cancer Center|Dr. Craig Moskowitz|212-639-7992|moskowic@mskcc.org|
22393604|NCT00611975|Yale School of Medicine|Margaret Altemus|646-209-6277|margaret.altemus@yale.edu|
22393605|NCT03960047|University Of Guelph|Professor Barbara A. Morrongiello|5195461637|bmorrong@uoguelph.ca|
22393606|NCT05618912|Indiana University School of Medicine|Dr. Syril Keena T. Que|317-944-7744|ques@iu.edu|
22433530|NCT03711370|California Polytechnic State University|Dr. Alison Ventura|(805) 756-5693|akventur@calpoly.edu|
22433531|NCT01030952|Novartis Pharmaceuticals|Study Director|+1-800-244-7668||
22433532|NCT02008149|Department of Veterans Affairs|Dr. Gary S. Beaupre|(650) 493-5000|Gary.Beaupre@va.gov|64272
22433533|NCT02781571|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22433534|NCT03554018|Montefiore|Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
22433535|NCT00130039|Asan Medical Center, University of Ulsan|Sun U. Kwon, MD, PhD, Prof|82-2-3010-3960|sukwon@amc.seoul.kr|
22433536|NCT01740687|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
22433537|NCT01562886|Imperial College London|Dr Borja Mora Peris|020 3312 6789|b.mora-peris@imperial.ac.uk|
22433538|NCT02953561|The University of Texas MD Anderson Cancer Center|Naval Daver MD./Associate Professor|713-794-4392|ndaver@mdanderson.org|
22433539|NCT01433042|Given Imaging Ltd.|Director of Clinical affairs|+972-4-9097774|Hila.Debby@givenimaging.com|
22433540|NCT00848237|University of north Carolina|Nicholas Shaheen|(919) 966-7047|nshaheen@med.unc.edu|
22433541|NCT00556439|Cleveland Clinic|Carol A Langford, MD MHS|216-445-6056|langfoc@ccf.org|
22433542|NCT02100423|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Paolo Caimi|1-800-641-2422|paolo.caimi@uhhospitals.org|
22433543|NCT00703846|GlaxoSmithKline|GSK Response Center|866-435-7343||
22433544|NCT04601532|University of Pittsburgh|Eleanor Shirley, MA CCRC|412-383-7712|shirleye@upmc.edu|
22433545|NCT02195700|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22433546|NCT00670930|Novartis Pharmaceuticals|Study Director|862-778-8300||
22433547|NCT00936663|University of Nebraska Medical Center|Vijay Shivaswamy|402-559-6208|vshivaswamy@unmc.edu|
22433548|NCT03062280|Diurnal Limited|Clinical Trials Information|+44 (0) 292 068 2069|info@diurnal.co.uk|
22433549|NCT01340625|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22433550|NCT00854724|BPRL, McLean Hospital|David M. Penetar|617-855-2913|dpenetar@mclean.harvard.edu|
22433551|NCT00879034|Dana-Farber Cancer Institute|Dr. Mark Kieran|617-632-4907|mark_kieran@dfci.harvard.edu|
22433552|NCT02159898|Merit Medical, Inc|Casey Holland|7816817983|casey.holland@merit.com|
22433553|NCT01498744|Ann and Robert H. Lurie Children's Hospital of Chicago|Katherine A Barsness|3122274210|kbarsness@luriechildrens.org|
22433554|NCT02058511|UCSF|Matthias Behrends|415 476 3761|matthias.behrends@ucsf.edu|
22433555|NCT01519791|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22433556|NCT00459875|Memorial Sloan Kettering Cancer Center|Dr. Robert Motzer|646-422-4312|motzerr@mskcc.org|
22433557|NCT01525862|Stryker ENT|Principal Clinical Research & Publications Manager|764-463-1598|ellen.omalley@stryker.com|
22433558|NCT00576628|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22433559|NCT01289275|UC San Diego, California Smokers' Helpline|Sharon Cummins, Ph.D.|8583001046|scummins@ucsd.edu|
22433560|NCT04136548|University of Texas Southwestern Medical Center|Dr. Craig Crandall|2143454623|craigcrandall@texashealth.org|
22433561|NCT02377752|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22433562|NCT02789345|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22433563|NCT01709110|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22433564|NCT03286543|SPR Therapeutics|Clinical Affairs|216-378-9106|support@sprtherapeutics.com|
22433565|NCT01204905|University of Maryland, Baltimore, IHV|Gregory Brogden|410-706-1660|gbrogden@ihv.umaryland.edu|
22433566|NCT02836717|Department of Surgery, Cantonal Hospital St. Gallen|Dr Lukas Marti|+41 71 494 11 11|lukas.marti@kssg.ch|
22433567|NCT00104416|GlaxoSmithKline|GSK Response Center|866-435-7343||
22433568|NCT00438360|Novartis Pharmaceuticals|Study Director|862-778-8300||
22433569|NCT00070109|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org|
22422612|NCT00422695|Rutgers School of Dental Medicine|Eli Eliav|973 972 7210|eliavel@sdm.rutgers.edu|
22422613|NCT00737204|New York State Psychiatric Institute|Judith G. Rabkin, Ph.D., M.P.H.|(646) 774-8075|jgr1@columbia.edu|
22422614|NCT02828124|Bristol Myers-Squibb|Phase 1/2 Study of BMS-986183 in Subjects with Advanced Hepatocellular Carcinoma|Please email|Clinical.Trials@bms.com|
22422615|NCT03990571|The University of Texas M D Anderson Cancer Center|Dr. Renata Ferrarotto|(713) 745-6774|rferrarotto@mdanderson.org|
22422616|NCT03605862|Romark Laboratories, L.C.|Jessica Fulgencio|813-282-8544|jessica.fulgencio@romark.com|
22422617|NCT05229952|University of Alabama at Birmingham|Dr Sonia Fargue|2059756932|sfargue@uab.edu|
22422618|NCT00778869|Merck, Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22422619|NCT00675428|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
22422620|NCT04105218|University of Colorado Anschutz Medical Campus|Clinical Research Support Center|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
22422621|NCT00482677|Canadian Cancer Trials Group|Keyue Ding|613-5336430|kding@ctg.queensu.ca|
22422622|NCT02553499|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22422623|NCT01582178|Vitkovice Hospital|Premysl Falt, MD|+420595633|faltprem@centrum.cz|205
22422624|NCT00570063|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22422625|NCT02819973|Duke Clinical Research Institute|Kevin Thomas, MD|919-668-8700|kevin.thomas@duke.edu|
22422626|NCT00550043|Incyte Corporation|Study Director|1-855-463-3463||
22422627|NCT04201574|Allysta Pharmaceuticals, Inc.|Clinical Trial Admin|(510) 560-6592|clinicaltrial.admin@allysta.com|
22422628|NCT01186692|Medtronic|Susan Patterson|763.526.1544|susan.patterson@medtronic.com|
22422629|NCT00789698|Sunovion Pharmaceuticals|Medical Director, CNS|1-866-503-6351||
22422630|NCT01921101|University of Illinois at Chicago|Dr. Carol Braunschweig, Professor|3129962575|braunsch@uic.edu|
22422631|NCT00150488|Queen Unviersity|J. Curtis Nickel|613 548 2497|jcn@queensu.ca|
22422632|NCT02428309|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22422633|NCT01953874|ResMed|Adam Benjafield|(858)836-6782|adam.benjafield@resmed.com|
22422634|NCT00811317|Massachusetts General Hospital|Steven Russell|6177261848|sjrussell@mgh.harvard.edu|
22422635|NCT01275755|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
22422636|NCT01168908|Kennedy Krieger Institute|Kathryn Wagner, MD, PhD|443-923-9525|wagnerk@kennedykrieger.org|
22422637|NCT03653351|Washington University in Saint Louis|Eric Lenze MD|314-362-5154|lenzee@wustl.edu|
22422638|NCT04420585|Montefiore Medical Center|Dr. Kerry Morrone|718-741-2342|kmorrone@montefiore.org|
22422639|NCT00653133|I-Flow Corporation|Alan Dine Director of Clinical Research|513-253-8033|alan.dine@kcc.com|
22422640|NCT03693612|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22422641|NCT04364802|University of Kentucky|Alexandra Kejner|859-323-6741|aeke234@uky.edu|
22422642|NCT01669174|Novartis Pharmaceuticals|Study Director|862-778-8300||
22422643|NCT03788434|Vedanta Biosciences|Jeffrey Silber|(857) 706-1427|ConsortiumIO-ctinquiries@vedantabio.com|
22422644|NCT01953601|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22422645|NCT01246349|The Hospital for Sick Children|Beverly Walpole|416. 813 7654|bwalpole@uoguelph.ca|328363
22422646|NCT02991729|UNC School of Medicine Maternal Fetal Medicine|Laura Carlson, MD|8643503140|lauramosbycarlson@gmail.com|
22422647|NCT05537441|Yale University|Daniella Meeker|(213)926-2658|daniella.meeker@yale.edu|
22422648|NCT01905553|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22422649|NCT04310397|The University of Texas MD Anderson Cancer Center|Rodabe Amaria, MD|(713) 792-2921|rnamaria@mdanderson.org|
22422650|NCT05225298|Stanford University|Shuchi Anand, MD, MS|650-725-2207|sanand2@stanford.edu|
22422651|NCT01916681|University of Pennsylvania|Dr. Lisa Levine|2156626913|lisa.levine@uphs.upenn.edu|
22422652|NCT02703272|Janssen Research & Development, LLC|Clinical Scientist|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22422653|NCT00623935|University of Michigan Comprehensive Cancer Center|Dr. Gregory Yanik, M.D.|734-936-8785|gyanik@umich.edu|
22422654|NCT03315286|Weill Cornell Medicine|Dr. George Varghese, Principal Investigator|646-962-3376|giv9006@med.cornell.edu|
22422655|NCT00747474|Taiwan Liposome Company, Ltd.|Shu Chi Hsu|650-872-8816|shuchi@tlcbio.com|102
22422656|NCT01590121|Imperial College London|Dr. Claire Shovlin, Principal Investigator|+44 208 383 1178|c.shovlin@imperial.ac.uk|
22422657|NCT02829723|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22422658|NCT02989649|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22422659|NCT00330343|JHU|Myron Yaster|9552393|myaster1@jhmi.edu|
22422660|NCT00256854|GlaxoSmithKline|GSK Response Center|866-435-7343||
22393607|NCT03296033|Wake Forest School of Medicine|Daryl Henshaw, MD|336-716-6344|dhenshaw@wakehealth.edu|
22422661|NCT00281632|GlaxoSmithKline|GSK Response Center|866-435-7343||
22393608|NCT02383056|University of Miami|Dr. Keyvan Nouri|305-243-3380|Knouri@med.miami.edu|
22422662|NCT03613909|Cochlear Ltd|Marian Jones, Principal Investigator|+61498008181|mjones@cochlear.com|
22422663|NCT06586788|Indiana School of Medicine|Dr. Rebecca McNally Keehn|(317) 274-2121|mcnallyr@iu.edu|
22433570|NCT02579421|University of Minnesota|Dr. Sharon Allen|612-624-0446|allen001@umn.edu|
22410823|NCT03360656|CoolTech|Director of Clinical Operations|2036856352|channan@cooltechcorp.com|
22422664|NCT03514485|Children's Hospital of Philadelphia|Tyra Bryant-Stephens, MD|215-590-5261|stephenst@chop.edu|
22410824|NCT00738920|University at Buffalo, SUNY|Dr. Jeffrey Lackner|716-898-5671|lackner@buffalo.edu|
22410825|NCT03821324|Venus Concept|Director of Clinical Affairs|888-907-0115|mgronski@venusconcept.com|
22410826|NCT05113901|Rush University Medical Center|Methylprednisolone Taper to Treat Delayed Post-Operative Recovery After Total Knee Arthroplasty: a D|3124322468|anne.debenedetti@rushortho.com|
22410827|NCT04147611|University of Miami|Dr. Hillary Snapp|305-243-4611|hsnapp@med.miami.edu|
22410828|NCT01799213|Veterans Health Administration, West Haven, CT|Lisa G. Suter, MD|2039325711|lisa.suter@va.gov; lisa.suter@yale.edu|
22410829|NCT00951899|Mayo Clinic|Dr. Adrian Vella|507-284-3289|vella.adrian@mayo.edu|
22410830|NCT01123980|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22410831|NCT04385199|Henry Ford Health System|Dr Geneva Tatem|313-916-2431|gtatem1@hfhs.org|
22410832|NCT02557672|Mayo Clinic|Gregory A. Nuttall, M.D.|(507) 255-3298|gnuttall@mayo.edu|
22410833|NCT03705169|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22410834|NCT00458302|Jan-Cilag Germany|EMEA Medical Affairs Director Virology|+49 7624 907580||
22410835|NCT02661126|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22410836|NCT01513551|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22410837|NCT02917447|VA Puget Sound Health Care System|Keren Lehavot, PhD|206-277-1511|keren.lehavot@va.gov|
22410838|NCT01706198|GlaxoSmithKline|GSK Response Center|866-435-7343||
22410839|NCT00549198|GlaxoSmithKline|GSK Response Center|866-435-7343||
22410840|NCT04229303|Zambon SpA|Arnd Mueller, MD|+39 02 665241|clinicaltrials@zambongroup.com|
22410841|NCT01764854|Ardelyx, Inc.|Chief Development Officer|617 513-4929|drosenbaum@ardelyx.com|
22410842|NCT03273387|Department of Cardiology and Vascular Medicine, Universitas Indonesia|dr. Bambang WIdyantoro, FIHA, PhD|+628128164299|bambang_ui@yahoo.com|
22410843|NCT02668783|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22410844|NCT04480463|SamChunDang Pharm. Co. Ltd.|Byung Jhip Ha, Director of Bio Research Center|+82-31-869-7327|scd411clinical@scd.co.kr|
22410845|NCT01399723|KEMRI-Wellcome Trust Research Prorgamme|Dr. Ambrose Agweyu|254202715160|aagweyu@kemri-wellcome.org|
22410846|NCT00673361|Duke University Medical Center|Michael A Morse, M.D.|919-681-3480|morse004@mc.duke.edu|
22410847|NCT02203565|Stanford University School of Medicine|Dr. Kathleen Horst|6507256009|kateh@stanford.edu|
22410848|NCT00981253|Duke Health|Dr. James A. Blumenthal|919-684-3828|james.blumenthal@duke.edu|
22410849|NCT00730522|Catalyst Pharmaceuticals|Chief Scientific Officer|305-420-3200|gingenito@catalystpharma.com|
22410850|NCT01769378|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22410851|NCT01958281|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22410852|NCT03038113|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22410853|NCT02784106|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22410854|NCT02927847|Duke University|Maggie M Sweitzer, PhD|919-668-0094|maggie.sweitzer@duke.edu|
22410855|NCT00553540|Cleveland Clinic Florida|Dr. David Westerdahl|954-659-5422|westerd@ccf.org|5422
22410856|NCT02004704|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22410857|NCT01755858|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
22410858|NCT03882047|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22410859|NCT00417274|Clevland BioLabs|Michael Kurman, MD|716-849-6810|mkurman@cbiolabs.com|
22410860|NCT00175019|Takeda Global Research & Development Center, Inc.|Senior Vice President, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22410861|NCT01142297|University of Texas Health Science Center at San Antonio|Thomas W. Oates|210-567-3590|oates@uthscsa.edu|
22410862|NCT03124797|Masimo|Tala Harake||studies@masimo.com|
22410863|NCT03596918|AMC Statistical and Data Analysis Center|Dr. Jeannette Y. Lee|(501) 526-6712|jylee@uams.edu|
22422665|NCT03075891|Galderma|Rajeev Chavda|0033492382928|rajeev.chavda@galderma.com|
22422666|NCT01813214|Lombardi Comprehensive Cancer Center|Dr Michael Atkins|202-687-2795|mba41@georgetown.edu|
22422667|NCT01878084|Alexandria University|Prof. Mona K. Marei|002-03-4858353|mona.marei@gmail.com|
22422668|NCT02410798|Synapse Biomedical|Anthony Ignagni|440-774-2488|aignagni@synapsebiomedical.com|110
22422669|NCT01878812|GlaxoSmithKline|GSK Response Center|866-435-7343||
22422670|NCT05093530|Pneumagen Ltd|CEO|+44 7748357352|douglas.thomson@pneumagen.com|
22422671|NCT02521051|Massachusetts General Hospital|Justin Gainor, MD|617-724-4000|jgainor@partners.org|
22422672|NCT05819086|University of Wisconsin School of Medicine and Public Health Center for Tobacco Research and Intervention|Regulatory Manager|608-262-7568|mark.zehner@ctri.wisc.edu|
22422673|NCT00926848|University of Nebraska Medical Center|Bernice Yates|402-861-1713|bcyates@unmc.edu|
22422674|NCT01551264|Washington University School of Medicine|Matthew Dobbs MD|561-844-5255|mdobbs@paleyinstitute.org|
22422675|NCT01303406|National Hospital for Neurology and Neurosurgery|Dr Paola Giunti|020 3448 3141|violet.le-fevre@uclh.nhs.uk|
22422676|NCT03831360|Butler Hospital|Dr. Lisa Uebelacker|401-455-6381|LUebelacker@butler.org|
22422677|NCT00582608|Memorial Sloan Kettering Cancer Center|Dr. Shakeel Modak|212-639-7623|modaks@mskcc.org|
22422678|NCT03482453|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
22422679|NCT03478644|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22422680|NCT01870973|The Ohio State University|Dr. Melissa Drum|6142923596|drum.13@osu.edu|
22422681|NCT03763929|Diffusion Pharmaceuticals Inc|Clinical Operations|434-220-0718|clinicaltrials@diffusionpharma.com|
22422682|NCT02504827|University of Southern California|Paul Beringer|323-442-1402|beringer@usc.edu|
22422683|NCT00686829|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22422684|NCT00712543|Cumberland Pharmaceuticals Inc.|Bryan Voss, Ph.D.|615-255-0068|bvoss@cumberlandpharma.com|
22422685|NCT04740827|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22422686|NCT00940823|Prism Eye Institute|Dr. Iqbal Ike K. Ahmed|905-456-3937|ike.ahmed@utoronto.ca|
22422687|NCT00784550|GlaxoSmithKline|GSK Response Center|866-435-7343||
22422688|NCT02715700|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22422689|NCT00477750|Mayo Clinic|Dr. Vivek Roy||roy.vivek@mayo.edu|
22422690|NCT03558152|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22422691|NCT04166591|New York University|Dr. Sudha Arunachalam|212-998-4139|sudha@nyu.edu|
22422692|NCT03960021|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Pr Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
22422693|NCT00601172|GlaxoSmithKline|GSK Response Center|866-435-7343||
22422694|NCT04434469|Genetech|Medical Communications|800-821-8590|genentech@druginfo.com|
22422695|NCT01579045|Vistakon/Johnson & Johnson Vision Care|Katherine Osborn Lorenz, OD MS|904-443-3123|kosborn@its.jnj.com|
22422696|NCT01300338|Mayo Clinic|Dr. Frederick North|507-284-5164|North.Frederick@mayo.edu|
22422697|NCT02461524|Medtronic|Kristel Wittebols Sr. Clinical Research Director|31 (0)43-3566566|kristel.wittebols@medtronic.com|
22422698|NCT00880581|Stanford University|Ronald Levy|6507256452|levy@stanford.edu|
22422699|NCT00101036|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22422700|NCT00381238|GlaxoSmithKline|GSK Response Center|866-435-7343||
22422701|NCT00061373|NIH/NINDS and University of Texas Southwestern, Clinical Research Institute of Austin|Steven Warach, MD, PhD; Principal Investigator|512-324-8383|swarach@seton.org|
22422702|NCT00843037|University Health Network|Dr. Jennifer Knox, PI|(416) 946-2000|jennifer.knox@uhn.ca|5131
22422703|NCT03535194|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
22422704|NCT04411810|NYU Langone Health|David Polsky, MD, PhD|212-263-9087|David.Polsky@nyulangone.org|
22422705|NCT02564900|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|1-908-992-6400|CTRinfo@dsi.com|
22422706|NCT01665157|National Taiwan University Hospital|Han-Mo Chiu, M.D., Ph.D.||hanmochiu@ntu.edu.tw|
22422707|NCT03991299|Vanderbilt University Medical Center|Dr Cyndya Shibao|6159364584|cyndya.shibao@vumc.org|
22422708|NCT04304235|The University of British Columbia|J Mark Ansermino|1 604 875 2711|anserminos@yahoo.ca|
22422709|NCT04470544|Mayo Clinic|Alan Haruo Bryce, M.D.|(480)301-8335|Bryce.Alan@mayo.edu|
22422710|NCT02005692|Leaf Healthcare, Inc.|Barrett Larson, MD, Chief Medical Officer|650-701-3652|barrett.larson@leafhealthcare.com|
22422711|NCT04967885|Dartmouth College|Elizabeth Saunders|6036467006|elizabeth.c.saunders@dartmouth.edu|
22422712|NCT01011465|Harvard School of Public Health|Dr. Laura Kubzansky|617-432-3589|lkubzans@hsph.harvard.edu|
22422713|NCT03921840|Johns Hopkins University|Junxin Li|4105022608|jli248@jhu.edu|
22422714|NCT02042950|UT MD Anderson Cancer Center|Dr. Hun Ju Lee/ Assistant Professor, Lymphoma/Myeloma|(713) 794-1829|hunlee@mdanderson.org|
22422715|NCT00723008|U.S. Army Institute of Surgical Research|LTC. Elizabeth Mann-Salinas, PhD, RN,CCRN,CCNS|210-916-3527|Elizabeth.Mann@us.army.mil|
22433571|NCT02767869|Institute of Experimental andl Clinical Therapeutics|Dr. Manuel González Ortiz|+52-33-10-58-52-00|uiec@prodigy.net.mx|34212
22433572|NCT03125031|Masimo|Tala Harake||studies@masimo.com|
22433573|NCT03660865|RxSight|Jeffrey Ha, Senior Director of Clinical Research|949-521-7870|jha@rxsight.com|
22433574|NCT01164891|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
22433575|NCT00441142|Dana-Farber Cancer Institute|Dr. Eudocia Quant Lee|617-632-2166|eqlee@partners.org|
22433576|NCT00338286|Janssen Research and Development|Director, Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
22433577|NCT00022763|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22433578|NCT03248531|Cares|UCB|+1-844-599-2273|UCBCares@ucb.com|
22433579|NCT04908865|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22433580|NCT05286658|University of Wisconsin - Madison|Carrie Niziolek, PhD|(608) 262-7583|cniziolek@wisc.edu|
22433581|NCT00470262|Denver VA Medical Center|Dr. Neda Rasouli|303-399-8020|neda.rasouli@ucdenver.edu|4314
22433582|NCT02110485|Nationwide Children's Hospital|Beth Fischer|614-355-0338|beth.fischer@nationwidechildrens.org|
22433583|NCT00851552|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22433584|NCT00652314|Vascular Solutions, Inc.|Lisa Gallatin, RAC|763-656-4399|lgallatin@vasc.com|
22433585|NCT01558596|Minneapolis VA Medical Center|Santiago Garcia, MD|6124673670|santiago.garcia@va.gov|
22433586|NCT01437111|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22433587|NCT00595881|Children's Hospital of Pittsburgh|Jennifer Marin|412-692-7692|jennifer.marin@chp.edu|
22433588|NCT02473471|Jordanian University of science and Technology|Dr.Amal Alkebsi|00966552358684|amalkibsi@gmail.com,aalkebsi13@den.just.edu.jo|
22433589|NCT01667133|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22433590|NCT01181804|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com|
22433591|NCT01916824|Emory University|Boadie Dunlop, MD|404-727-8969|bdunlop@emory.edu|
22433592|NCT00626886|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
22433593|NCT02057640|Cleveland Clinic Taussig Cancer Center|Jason Valent, MD|216-445-7238|valentj3@ccf.org|
22433594|NCT03835481|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22433595|NCT00191945|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22433596|NCT02846792|University of Washington|Research Manager|206-606-7445|smasters@seattlecca.org|
22433597|NCT01116466|Otto Bock Healthcare Products GmbH|Medical Affairs Manager|004315233786733|Milana.Mileusnic@ottobock.com|
22433598|NCT00581399|University of California, Irvine Medical Center|Dr. Jeffrey C. Milliken|714-456-3634|jcmillik@uci.edu|
22433599|NCT02063984|Geisel School of Medicine at Dartmouth Center for Technology and Behavioral Health|Alan J. Budney, Ph.D|603-646-7088|alan.budney@dartmouth.edu|
22433600|NCT04175340|Bausch + Lomb Incorporated|Senior Manager, Clinical Trials|(585) 623-9588|Margaret.Swartzenberg@bausch.com|
22433601|NCT04222699|VA Maryland Healthcare System|Dr. Mary-Claire Roghmann|410 706 0062|mroghmann@som.umaryland.edu|
22433602|NCT01958580|Albert Einstein College of Medicine - Montefiore Medical center|Dr. Jessica Atrio - Professor, Department of Obstetrics & Gynecology and Women's Health|917-721-6155|jatrio@montefiore.org|
22433603|NCT02901249|Universidade Federal do Rio Grande do Sul|D.r. Ana Flávia Barros da Silva Lima|51999185180|afbslima@gmail.com.br|
22433604|NCT01536561|GlaxoSmithKline|GSK Response Center|866-435-7343||
22433605|NCT01145001|Yale University|Dana Cavallo, Assistant Professor|2039747607|dana.cavallo@yale.edu|
22433606|NCT02368093|Taichung Veterans General Hospital|Der-Yuan Chen|884-4-23592525|dychen@vghtc.gov.tw|3354
22433607|NCT01763333|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22393609|NCT02550470|Rutgers - New Jersey Medical School|Dr. Eloy, PI|973 972 5007|eloyje@njms.rutgers.edu|
22433608|NCT03583359|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|Aesthetic.Trials@merz.com|
22433609|NCT00508105|Ottawa Hospital Research Institute|Peter Lapner|613-737-8899|plapner@toh.ca|74700
22433610|NCT01625416|University of Washington|Dr. Douglas Zatzick|2067446701|dzatzick@uw.edu|
22433611|NCT01831466|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22433612|NCT02299141|Washington University School of Medicine|Ramaswamy Govindan|314-362-5654|rgovindan@wustl.edu|
22433613|NCT03497039|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22433614|NCT02567799|Humanetics Corporation|Michael D. Kaytor|952-400-0406|mkaytor@humaneticscorp.com|
22433615|NCT02131662|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22433616|NCT01925040|Kulzer GmbH|Global Scientific Affairs Management|+4915116891006|andrea.leyer@kulzer-dental.com|
22433617|NCT03148379|Medacta USA|Rena Mandino, Director of Clinical Research|352-359-3581|rmandino@medacta.us.com|
22422716|NCT05896527|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22422717|NCT01279070|Parc Sanitari Sant Joan de Déu|Dr. Aida Farreny|+34 936406350|afarreny@pssjd.org|2373
22422718|NCT02935179|Taipei Medical University|Dr. Sing-Chung Li|886-2-27361661|sinchung@tmu.edu.tw|6560
22422719|NCT00882778|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22422720|NCT00832871|University of New Mexico Comprehensive Cancer Center|Dr. Fa-chyi Lee|505-925-0405|FLee@salud.unm.edu|
22422721|NCT03766165|Johns Hopkins University; Indiana University|Dr. Larissa Jennings Mayo-Wilson|1-812-856-0902|ljmayowi@iu.edu|
22422722|NCT02217410|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22422723|NCT00187681|UCSF|Kathy Giacomini, Ph.D|4154761936|Kathy.Giacomini@ucsf.edu|
22422724|NCT00626821|Coloplast|Helle Aaes Senior Scientific Manager|+45 49112949|dkheaa@coloplast.com|
22422725|NCT01940887|Ophthotech Corp.|Keith Westby|212-845-8200|Keith.Westby@ophthotech.com|
22422726|NCT02655510|Mayo Clinic|Vijay Shah, M.D.|507-284-3917|Shah.Vijay@mayo.edu|
22422727|NCT01471340|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22422728|NCT02475265|Massachusetts General Hospital|Dr. Pouneh Fazeli|617-726-3870|pkfazeli@partners.org|
22422729|NCT05875025|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
22422730|NCT01098500|GlaxoSmithKline|GSK Response Center|866-435-7343||
22422731|NCT02218736|Duke Clnical Research Institute|Kathy Hijek, Associate Director of Clinical Operations|919-668-8700|kathy.hijek@duke.edu|
22422732|NCT03452488|Biophytis S.A.|Cendrine Tourette|+331 44 27 33 00|cendrine.tourette@biophytis.com|
22422733|NCT00565643|Lehigh Valley Health Network|Daniel Kiefer|484-664-7521|daniel_g.kiefer@lvhn.org|
22422734|NCT01876784|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22422735|NCT03047720|Indiana University|Dr Benjamin Whittam|317.944.8896|bwhittam@iupui.edu|
22422736|NCT01475851|GlaxoSmithKline|GSK Response Center|866-435-7343||
22422737|NCT04603482|Case Western Reserve University|Jaclene Zauszniewski, PhD|216.368.3612|jaz@case.edu|
22422738|NCT00732758|Children's Hospital of Pittsburgh|Kumaravel Rajakumar|412-692-5822|rajakumark@upmc.edu|
22422739|NCT00373958|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22422740|NCT01552915|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22422741|NCT01777568|Cleveland Clinic|Kurz, M.D., Andrea|(216) 445-9924|KURZA@ccf.org|
22422742|NCT00179673|Celgene Corporation|Senior Manager, Clinical Trials Disclosure|888-260-1599|clinicaltrialdisclosure@celgene.com|
22422743|NCT00492648|GlaxoSmithKline|GSK Response Center|866-435-7343||
22422744|NCT02387957|Ophthotech Corp.|Denise Teuber|646-753-8461|denise.teuber@ophthotech.com|
22422745|NCT02887248|Sarah Cannon Development Innovations, LLC|Sarah Cannon|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
22422746|NCT02294396|Astellas Pharma Inc.|Medical Director|+81-3-3244-0512|astellas.resultsdisclosure@astellas.com|
22422747|NCT02120833|Johnson & Johnson Consumer and Personal Products Worldwide|Chirstopher Nunez, PhD/Study Director|973-385-7984 USA EST|cnunez1@its.jnj.com|
22422748|NCT02438826|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22422749|NCT02397122|Kirikkale University|Dr. H. Gencay Keceli|+905326714377|monsieur_gencay@yahoo.com|
22422750|NCT03613649|DynPort Vaccine Company LLC, a GDIT Company|George A. Saviolakis, MD, PhD, Medical Director|1-240-651-8116|George.Saviolakis@gdit.com|
22422751|NCT03429244|Indianan University School of Medicine|Jennifer Lehman|3179489575|jgeck@iu.edu|
22422752|NCT03421145|3M Health Care Business Group|Manager of Biostatistics|6518152737|swalters@mmm.com|
22422753|NCT00474201|National Institutes of Health|Scott Penzak|301-496-2997|sp286u@nih.gov|
22422754|NCT01500187|University of Health Science Center|Franklin Garcia-Godoy DDDS, MS PhD||fgarciagodoy@gmail.com|
22422755|NCT02380261|Alcon, a Novartis company|Dir Clinical Operations - LACAR, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
22422756|NCT00750139|Merz Pharmaceuticals, LLC|Associate Medical Director- Dermatology|800-334-0514||
22410864|NCT00475852|Johnson & Johnson Pharmaceutical Research & Development, LLC|Vice President, Franchise Development|610-651-6628||
22422757|NCT02784613|San Diego Sexual Medicine|Irwin Goldstein|619-265-8865|dr.irwingoldstein@gmail.com|
22422758|NCT04192071|University of Florida|Melissa Vilaro, Assistant Professor|352-2733525|mgraveley@ufl.edu|
22422759|NCT00586820|Mayo Clinic|Dr. Amir Lerman|507-255-6670|lerman.amir@mayo.edu|
22422760|NCT02073929|Center of Endocrinology and Metabolism, Dept. of Internal Medicine, Herlev Gentofte Hospital, Denmark|Professor Jens Faber|+4538689016|jens.faber@regionh.dk|
22422761|NCT00430573|BostonUCRC|Michael W. Otto, Ph.D.|(617)353-9610|mwotto@bu.edu|
22422762|NCT01483027|Boston Scientific|Chantal Laframboise|+1 613 882 0876|chantal.laframboise@bsci.com|
22422763|NCT00684320|San Diego State University/University of California Joint Doctoral Program in Clinical Psychology|Dr. Nader Amir|(619) 229-3740|namir@mail.sdsu.edu|
22422764|NCT02219581|Emory University|Thomas L. Bradbury, MD|404-759-3912|tombradburymd@gmail.com|
22422765|NCT00840307|UT Southwestern Medical Center|Dr. Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
22422766|NCT04184362|SFVA|Joannalyn Delacruz, Ph.D.|415-375-5748|Joannalyn.Delacruz@va.gov|
22422767|NCT01936181|Samsung Bioepis|Director, Clinical Development|+82 31 8061 4534||
22422768|NCT01346189|University of Pennsylvania and Department of Veteran Affairs|Dr. Kevin G. Volpp||volpp70@wharton.upenn.edu|
22422769|NCT00900757|Duke University Medical Center|Mary Lou Affronti|919-684-6239|mary.affronti@dm.duke.edu|
22422770|NCT00697541|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
22422771|NCT00384748|University of Georgia|Neale Chumbler, PhD|706-369-5975|chumbler@uga.edu|
22422772|NCT01014988|GlaxoSmithKline|GSK Response Center|866-435-7343||
22422773|NCT05835011|Taiho Oncology, Inc.|Taiho Central|844-878-2446|medicalinformation@taihooncology.com|
22422774|NCT01683266|Sanofi|Trial Transparency Team||Contact--US@sanofi.com|
22422775|NCT02222545|Omeros Corporation|Clinical Trial Manager|(206) 676-5000|ctinfo@omeros.com|
22422776|NCT00090220|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22422777|NCT00941863|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22422778|NCT02651155|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22422779|NCT00823043|Vistakon|Arthur Shedden MD|904-443-1557||
22422780|NCT00489086|Children's Hospital of Oakland Research Institute, Oakland|Ervin H Epstein Jr., MD|510-450-5688|eepstein@chori.org|
22422781|NCT04016779|Supernus|Joseph Hull, Ph.D., Director Clinical research|240-403-5324|jhull@supernus.com|
22422782|NCT00979875|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|(858) 794-8889||
22422783|NCT01945970|Unilever R&D Research Vlaardingen|Dr Theo Mulder|+31 10 460 8315|theo.mulder@gmail.com|
22422784|NCT02738879|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22422785|NCT00890084|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22422786|NCT02798289|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22422787|NCT00205868|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
22422788|NCT01323595|Weill Cornell Medical College|Chairman, Department of Urology|212 746-5491|pnschleg@med.cornell.edu|
22422789|NCT04143594|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22422790|NCT00405522|The Hospital for Sick Children, Toronto, Ontario, Canada|Dr. Jason Hayes|416-813-7654|jason.hayes@sickkids.ca|208963
22422791|NCT01023256|MorphoSys|Roman Korolkiewicz|+498989927|Roman.Korolkiewicz@morphosys.com|208
22422792|NCT03089697|Institute of iNtRON Biotechnology|Jun SooYoun, Ph.D. / Executive Director/ Principal researcher|+82-31-739-5332|jsy@intron.co.kr|
22422793|NCT00638443|University of Rochester|John Markman, MD|585-340-8926|maria_frazer@urmc.rochester.edu|
22422794|NCT01044290|HSRD, Durham VAMC|Karen Steinhauser, PhD|919 668-2148|karen.steinhauser@duke.edu|
22422795|NCT00438100|The University of Tokyo|Tempei Miyaji|+81-3-5800-9086|tmiyaji@m.u-tokyo.ac.jp|
22422796|NCT01967706|Philip Morris Products S.A.|Christelle HAZIZA|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
22422797|NCT01154088|GlaxoSmithKline|GSK Response Center|866-435-7343||
22422798|NCT01023841|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22422799|NCT03861871|NYU Langone Health|Latoya King|646 558 083|latoya.king@nyulangone.org|
22422800|NCT00282113|University of California Davis|Mark A. Underwood MD|916-734-5061|mark.underwood@ucdmc.ucdavis.edu|
22422801|NCT03382834|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|3016283313|ACTGCT.Gov@s-3.com|
22410865|NCT00297479|UT MD Anderson Cancer Center|Dr. Sharon Giordano, MD/Chair, Health Svcs Research-Clinical|713-563-0020|sgiordan@mdanderson.org|
22410866|NCT03263819|Vanderbilt University Medical Center|Dr.Cyndya A. Shibao|6159364584|cyndya.shibao@vumc.org|
22410867|NCT03563027|Crescenz Veterans Affairs Medical Center|Dr. Mitesh S. Patel|215-898-3367|mpatel@pennmedicine.upenn.edu|
22410868|NCT00386724|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
22410869|NCT00686920|Bausch Health Companies|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
22410870|NCT01215123|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22410871|NCT02752256|University of Iowa Hospitals and Clinics|Brett Faine|319-384-6800|brett-faine@uiowa.edu|
22410872|NCT00814658|Jan-Cil Brazil|Medical Group Manager|55 11 3030-2770||
22410873|NCT01141283|Purdue Pharma LP|Clinical Leader, Medical Director|800-733-1333||
22410874|NCT04726514|Berendo Scientific, LLC|Eric Kezirian|4152358706|eric.kezirian@gmail.com|
22410875|NCT01208402|Duke University Medical Center - Department of Anesthesiology|William White / Statistician|919-684-4081|white013@mc.duke.edu|
22410876|NCT02077192|Rigel Pharmaceuticals, Inc.|Director of Clinical Operations|(650) 624-1100|clinicaltrials@rigel.com|
22410877|NCT01571635|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22410878|NCT02005354|Plymouth Hospitals NHS Trust|Dr David Tucker|01752 432595|david.tucker1@nhs.net|
22422802|NCT02949843|Wake Forest Baptist Comprehensive Cancer Center|William Petty|3367163313|wpetty@wakehealth.edu|
22422803|NCT01088672|Stryker NV|Amelia Saliba, AIS Clinical Program Manager|510-413-2500|aisstudies@stryker.com|
22422804|NCT05831644|Vicore Pharma AB|Director Clincial Operations|+46 (0) 31 788 05 60|info@vicorepharma.com|
22422805|NCT02783729|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22422806|NCT02388815|Abbott Diabetes Care|Jolyon Bugler, Snr Director Clinical Development & Regulatory Affairs|01993863164|joe.bugler@abbott.com|
22422807|NCT02693171|United Therapeutics Corp.|Odette Jordan, MD, PMP|919-425-5606|ojordan@unither.com|
22422808|NCT00319592|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22422809|NCT01512446|Ruhr-Universität Bochum|Johannes Pfeilschifter, MD||Johannes.Pfeilschifter@rub.de|
22422810|NCT00658775|Eisai Call Center|Eisai Inc.|888-422-4743||
22422811|NCT03085238|MTrap|Vice President, RA/QA/CA|3013258537|cmitchell@m-trap.com|
22422812|NCT02258373|Jaeb Center for Health Research|Katrina Ruedy|8139758690|kruedy@jaeb.org|
22422813|NCT01992653|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22422814|NCT01435460|Bausch & Lomb, Incorporated|Tuyen Ong|(973) 360-6389|tuyen.ong@bausch.com|
22422815|NCT01706939|Icahn School of Medicine at Mount Sinai|Dr. Marshall R Posner|(212) 659-5461|marshall.posner@mssm.edu|
22422816|NCT01046903|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22422817|NCT00977314|Sonitus Medical, Inc.|Clinical Trials Manager|8668162076|lily@sonitusmedical.com|
22422818|NCT00153543|CDC/Arctic Investigations Program|Karen Miernyk|9077293453|kmiernyk@cdc.gov|
22422819|NCT04678232|Case Western Reserve University|Norah Feeny, PhD|(216) 368-2695|ncf2@case.edu|
22422820|NCT00688662|Medical University of South Carolina|Dr Peter Cotton|8438767217|cottonp@musc.edu|
22422821|NCT03010800|Oklahoma University Health Science Center|Dr. Robert Hurst|405-271-3930|Robert-Hurst@ouhsc.edu|
22422822|NCT04463251|R-Pharm|Sergey Grishin, Director, Dep. of Clinical Development and Medical Expertise in Autoimmune Diseases|0074959567937|sa.grishin@rpharm.ru|1506
22422823|NCT05020665|Kronos Bio, Inc.|VP, Corporate Affairs|+16507815200|media@kronosbio.com|
22422824|NCT03318497|UT Southwestern Medical Center|Kelli Key, PhD|214-648-8152|Kelli.Key@UTSouthwestern.edu|
22422825|NCT03297645|Virginia Commonwealth University|Robin S. Everhart, PhD|(804) 828-7249|reverhart@vcu.edu|
22422826|NCT01743560|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22422827|NCT02965729|Pennington Biomedical Research Center|Dr. Amanda Staiano|225-763-2729|amanda.staiano@pbrc.edu|
22422828|NCT02842580|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
22422829|NCT01732640|Johns Hopkins University|Hao Wang|410-614-3426|hwang76@jhmi.edu|
22422830|NCT04574908|Wake Forest University Health Sciences|Portable Hemodynamic Monitoring on Hosp Units|336.716.4498|akhanna@wakehealth.edu|
22422831|NCT00877487|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22422832|NCT03070002|Northwestern University|MASSIMO CRISTOFANILLI, MD|312-503-1114|massimo.cristofanilli@nm.org|
22422833|NCT03687684|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22422834|NCT02118727|University of Missouri Health Care|Richard Barohn, MD|573-882-3693|rbarohn@health.missouri.edu|
22422835|NCT03425396|Paratek Pharmaceuticals, Inc.|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
22422836|NCT02863445|Oregon Health and Science University|Dr. Alison Edelman|503-494-3666|edelmana@ohsu.edu|
22422837|NCT01082211|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22422838|NCT04999163|Procyrion, Inc.|Sr. Director, Clinical Affairs|650-208-1118|tami@procyrion.com|
22422839|NCT06229132|Columbia University|Corina Lelutiu-Weinberger, PhD|(212) 342-1502|cl4265@cumc.columbia.edu|
22422840|NCT03527264|Brown Oncology Research Group|Don S. Dizon, MD|4018633000|BrUOG@Brown.edu|
22422841|NCT05903924|Vanda Pharmaceuticals|Vanda Pharmaceuticals|2027343400|clinicaltrials@vandapharma.com|
22422842|NCT04338269|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22422843|NCT00174967|Takeda Global Research & Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22422844|NCT03030989|University of Chicago|Randee Estes, Study Coordinator|773-702-1209|restes@medicine.bsd.uchicago.edu|
22422845|NCT02730377|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22422846|NCT03917472|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22422847|NCT02706886|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
22422848|NCT01154296|Department of Sociomedical Sciences/Mailman School of Public Health/Columbia University|Lisa Metsch, PhD, Stephen Smith Professor and Chair of Sociomedical Sciences|212-305-3577|lm2892@columbia.edu|
22422849|NCT02203851|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22422850|NCT02086448|University of Pittsburgh|Dr. Francesca Facco|412-641-1220|Faccof@upmc.edu|
22422851|NCT01968356|3M Health Care|Joan E. Paulson|651-736-6583|jepaulson@mmm.com|
22422852|NCT02161484|University of Pittsburgh|Dr. Rita Merman, P.I.|41256322137|MermanRB@upmc.edu|
22422853|NCT02031640|Teva Branded Pharmaceutical Products, R&D, Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22422854|NCT00654875|Novartis Pharmaceuticals|Study Director|862-778-8300||
22422855|NCT02879617|UPMC Hillman Cancer Center|Barbara Stadterman, Regulatory Specialist Supervisor|412-647-5554|stadtermanbm@upmc.edu|
22422856|NCT01867710|Janssen Pharmaceutica N.V|Medical Affairs Director||ClinicalTrialDisclosure@its.jnj.com|
22422857|NCT05113979|OnPointVision|Lynne Archer|949-749-4170|larcher@onpoint-vision.com|
22422858|NCT02048826|University of California at Irvine|Prof. David Reinkensmeyer|949-824-5218|dreinken@uci.edu|
22422859|NCT00976820|GlaxoSmithKline|GSK Response Center|866-435-7343||
22422860|NCT00526669|GlaxoSmithKline|GSK Response Center|866-435-7343||
22422861|NCT00968981|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22422862|NCT04259424|Medical University of South Caroina|Ryan Ross|843-792-3477|rossre@musc.edu|
22422863|NCT02233296|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22422864|NCT00784303|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22422865|NCT01913535|Massachusetts General Hospital|Maurizio Fava, MD|617-724-2513|mfava@mgh.harvard.edu|
22422866|NCT01981954|Astellas Pharma Europe B.V.|Medical Director|+31 (0) 715455050|astellas.resultsdisclosure@astellas.com|
22422867|NCT01489254|Synthon BV|VP Clinical Development|+3124727700|clinicaltrials@synthon.com|
22422868|NCT01730534|AstraZeneca|Global Study Leader|+49 4103 708 3792|Sandra.ranft@astrazeneca.com|
22422869|NCT02980341|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22422870|NCT01647516|Celgene Corporation|Anne McClain, Senior Manager|908-673-9100|ClinicalTrialDisclosure@Celgene.com|
22422871|NCT01676896|UTexasAustin|Sharon Horner|512-471-7951|shorner@mail.nur.utexas.edu|
22422872|NCT03614078|PRCL Research Inc|Caroline Fortier|1-514-708-4417|caroline.fortier@prclresearch.com|
22422873|NCT03886519|University of North Carolina at Chapel Hill|Emily Gower, PhD|919-966-1420|egower@unc.edu|
22422874|NCT04964544|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22422875|NCT03875274|BPKIHS|Dr. Pankaj Baral|9856037077|pankajbaral7@gmail.com|
22422876|NCT01613222|GEHealthcare|Jeffrey Conner|414-477-8374|Jeffrey.Conner@ge.com|
22422877|NCT04748458|IRCCS Istituto Ortopedico Rizzoli|Dr Francesco Castagnini|+390516366418|francescocastagnini@hotmail.it|
22422878|NCT02691936|Cleveland Clinic Foundation|Dr. Marie Fidela Paraiso|216-444-3428|PARAISM@ccf.org|
22422879|NCT03829618|Penn State Hershey Medical Center|Zoulfira Nisnevitch-Savarese, M.D.|717-531-6597|znisnevitchsavarese@pennstatehealth.psu.edu|
22422880|NCT00749684|Merck Sharp and Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
22422881|NCT01194531|Natera (formerly Gene Security Network)|Nina Wemmer, MS,CGC, Study Coordinator|650-249-9090|nwemmer@natera.com|
22422882|NCT04798989|Tisento Therapeutics|Clinical Research|1-857-259-5371|hello@tisentotx.com|
22422883|NCT01343277|Janssen Research & Development, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
22422884|NCT02344251|MUSC|Dr. Aimee McRae-Clark||mcraeal@musc.edu|
22422885|NCT01894100|University of North Carolina at Chapel Hill|Yvonne M. Golightly, PT, PhD|919-966-0566|golight@email.unc.edu|
22422886|NCT00288600|Fundação Oswaldo Cruz|Maria Elisabeth Moreira|552125541911|bebeth@iff.fiocruz.br|
22422887|NCT00135512|GlaxoSmithKline|GSK Response Center|866-435-7343||
22422888|NCT01094301|SPRTherapeutics|Clinical Affairs|216-378-9108|support@SPRTherapeutics.com|
22422889|NCT03600194|Philips|Jeff Jasko|412-542-3836|jeff.jasko@philips.com|
22422890|NCT00251238|Radboud University Nijmegen, The Netherlands|Dr. SJH Bredie, MD, PhD|0031 24 3618819|bas.bredie@radboudumc.nl|
22422891|NCT00604591|Columbia University|Edward D. Huey, MD|212-305-1134|edh2126@cumc.columbia.edu|
22422892|NCT01965366|Emory University|Dr. Barbara Rothbaum|404-712-8866|brothba@emory.edu|
22422893|NCT04152837|Centessa Pharmaceuticals|Milena Kanova|+44 7780 430583|milena.kanova@centessa.com|
22422894|NCT02439814|Medical University of South Carolina|Dr. McRae-Clark|843-792-5216|mcraeal@musc.edu|
22422895|NCT02119455|University of Connecticut- Division of Orthodontics|Dr. Flavio Uribe|8606792550|furibe@uchc.edu|
22422896|NCT02754427|University of British Columbia|Dr. Kristin Campbell|604-827-4704|kristin.campbell@ubc.ca|
22422897|NCT04553471|Washington University School of Medicine|Pamela Samson, M.D.|314-747-1786|psamson@wustl.edu|
22422898|NCT02147158|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22422899|NCT01441765|Beth Israel Deaconess Medical Center|Dr. David Avigan, Principal Investigator|617-667-9920|davigan@bidmc.harvard.edu|
22422900|NCT04520997|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22422901|NCT03689374|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22422902|NCT05367973|Dare Bioscience, Inc.|Jessica Hatheway, VP Clinical Operations|858-926-7655|jhatheway@darebioscience.com|
22422903|NCT00986921|Boston University Department of Obstetrics and Gynecology|Director of Clinical Research|617-414-5175|rstudy@bmc.org|
22422904|NCT00813813|DePuy Synthes Spine|Mark Lotito|508-880-8045|mlotito@its.jnj.com|
22422905|NCT01758731|University of Colorado, Denver|Dr. David Raben|303-724-3027|david.raben@ucdenver.edu|
22422906|NCT04445714|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22422907|NCT02396420|South Florida Medical Imaging|Cynthia Toot ARNP|954-267-6626|cynthia.toot@holy-cross.com|
22422908|NCT06137131|Ghent University|Dr. Iris Meerschman|+32499294636|iris.meerschman@ugent.be|
22422909|NCT00569673|NRG Oncology, Statistics and Data Management Center, Buffalo Office|Jessalyn Reboy|716-845-7738|ReboyJ@nrgoncology.org|
22422910|NCT01273623|Boston Scientific|Susanna Kennedy|763.494.2601|susanna.kennedy@bsci.com|
22422911|NCT01640379|Johns Hopkins University|Dr. Maria Trent|4109552910|mtrent2@jhmi.edu|
22422912|NCT04223635|Daiichi Sanyko, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22422913|NCT04934189|Hunter College of the City University of New York|Danielle S. Berke, Ph.D.|212-772-5550|db2800@hunter.cuny.edu|
22422914|NCT01470781|McLean Hospital/Harvard Medical School|Dr. Kathryn Lewandowski|617-855-2886|klewandowski@mclean.harvard.edu|
22422915|NCT03320850|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
22422916|NCT05210101|Brigham and Women's Hospital|Sophia Koo, MD|6175258418|skoo@bwh.harvard.edu|
22422917|NCT06207149|Vanderbilt University|Meghan Burke|6153431014|meghan.burke@vanderbilt.edu|
22422918|NCT02002533|University of Rochester|Gary Morrow|585-275-9961|gary_morrow@urmc.rochester.edu|
22422919|NCT04630249|The Medical University of South Carolina|Constance Guille|843-792-6489|guille@musc.edu|
22422920|NCT02147522|USC Suzanne Dworak-Peck School of Social Work|Kathleen Ell, DSW, Principle Investigator|760-399-0263|ell@usc.edu|
22422921|NCT03796442|Seoul National University Hospital|Prof. Ho Young Hwang|00-82-2-2072-3020|scalpel@snu.ac.kr|
22422922|NCT02893553|James J Peters VAMC|Dr. Jill Wecht|718-584-9000|jm.wecht@va.gov|3122
22422923|NCT01429064|Orion Pharma, Development, R&D|Head of Oncology|+358 10 4261|mika.mustonen@orionpharma.com|
22422924|NCT03408444|Johnson & Johnson Vision Care, Inc.|Xu Cheng - Sr. Principal Clinical Scientist|1-800-843-2020|xcheng6@its.jnj.com|
22422925|NCT00231114|Asthmatx, Inc.|Narinder S Shargill, PhD|408-419-0100||
22422926|NCT00823069|Medicis|Mary Sanstead|480-291-5926|msanstead@medicis.com|
22422927|NCT02173522|University of Miami|Shivank Bhatia|305-243-7500|sbhatia1@med.miami.edu|
22422928|NCT01194999|Barrie Urology Associates - The Male/Female Health and Research Centre|Joseph A Zadra, MD CM FRCSC|705-727-0551|joezadra@rogers.com|
22422929|NCT01895270|University of Arkansas for Medical Sciences|Alison Oliveto, PhD|501-526-8441|olivetoalison@uams.edu|
22422930|NCT00635453|Universidade Federal de Ciências da Saúde de Porto Alegre|Dr. Marcia Vitolo|+555133038798|marciavitolo@hotmail.com|
22422931|NCT02091375|GW Research Ltd.|Medical Enquires||medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
22422932|NCT00068367|SWOG Statistical Center|Study Statistician|206-667-4623|sarcoma@crab.org|
22422933|NCT02682823|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22422934|NCT03834974|University of Connecticut|Dr. Sherry Pagoto|860-486-8979|sherry.pagoto@uconn.edu|
22422935|NCT03781583|University of Michigan Medical School|James Weiland|734-764-9793|weiland@umich.edu|
22422936|NCT04807205|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
22422937|NCT01938430|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22422938|NCT00949403|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
22422939|NCT00537316|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22422940|NCT01883817|University of Cincinnati|Director Clinical Research Management|513-558-8621|gayathri.kavikondala@uc.edu|
22422941|NCT00782184|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22422942|NCT01438294|Universidade Nove de Julho|Evelim Leal de Freitas Dantas Gomes, PhD PT|5511976333349|evelimfreitas@hotmail.com|
22422943|NCT02233101|Rush University Medical Center|Craig J. Della Valle, MD|312-432-2350|craigdellavalle@rushortho.com|
22422944|NCT01302444|Rhode Island Hospital|James R Klinger, MD||jklinger@lifespan.org|
22422945|NCT03330262|Barron Associates|Principal Research Scientist|434-973-1215|barron@barronassociates.com|125
22422946|NCT02050919|OHSU Knight Cancer Institute|Christopher Ryan, MD|503-494-8487|ryanc@ohsu.edu|
22422947|NCT03696108|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22422948|NCT03505593|ENvizion Medical|Clinical Director|+972-72-2288240|anath@envizionmed.com|
22422949|NCT02319174|Rice 360: Institute for Global Health|Dr. Rebecca Richards-Kortum|713-348-3823|rkortum@rice.edu|
22422950|NCT02822573|Wake Forest NCORP Research Base|Lead Biostatistician (Emily Dressler, PhD)|336-716-0891|NCORP@wakehealth.edu|
22422951|NCT03891862|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22422952|NCT01053962|Synergy Pharmaceuticals Inc|Dr. Laura Barrow/Senior Vice President Clinical Development|212-297-0020|lbarrow@synergypharma.com|
22422953|NCT02833844|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22422954|NCT00308087|Genzyme Corporation|Genzyme MedInfo||medinfo@genzyme.com|
22422955|NCT02809859|Fisher & Paykel Healthcare|Clinical Research Scientist|+64 9 574 0123|CPAP.TRIAL@fphcare.co.nz|7044
22422956|NCT01646021|Janssen-Cilag International NV|Director, Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
22422957|NCT02347891|Northwell Health|Principal Investigator|5167082550|gmarder@northwell.edu|
22422958|NCT05129137|Unither Pharmaceuticals|Non-Clinical and Clinical Project Manager|+33 (0)1 44 63 51 78|clinicaltrials@unither-pharma.com|
22422959|NCT02737631|Church & Dwight Co., Inc|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
22422960|NCT00727844|Tuberculosis Research Section, LCID, NIAID, NIH|Dr. Clifton Barry|301-451-9554|cbarry@niaid.nih.gov|
22422961|NCT04439214|ECOG-ACRIN Cancer Research Group|Study Statistician|16176323012|eatrials@jimmy.harvard.edu|
22422962|NCT05476250|Masimo Coporation|Ahmed Alghazi|949-297-7000|studies@masimo.com|
22422963|NCT00671528|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22422964|NCT04013672|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|David Peereboom, MD|1-866-223-8100|TaussigResearch@ccf.org|
22422965|NCT04257032|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22422966|NCT02847494|Montefiore Health|Benjamin W. Friedman, MD|17189206626|befriedm@montefiore.org|
22422967|NCT00556933|Wright State University, Dayton, Ohio|R. Brian Stevens, MD, PhD|937-545-4817|rbstevens1@icloud.com|
22422968|NCT00767455|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
22422969|NCT00746564|St. Jude Medical|Director, Clinical Studies|1-800-733-3455|tshipman@sjm.com|
22393610|NCT01775475|AIDS Malignancy Consortium Statistical and Data Analysis Center|Study Statistician|(212) 659-9558|amcpm@emmes.com|
22393611|NCT03076333|Joint UNC/NC State Department of Biomedical Engineering|David S Lalush|919-513-7671|dslalush@ncsu.edu|
22393612|NCT00435591|Astellas Pharma Global Development|Senior Medial Director, Medical Affairs||clinicaltrials@us.astellas.com|
22393613|NCT02618915|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|Medinfo@ultragenyx.com|
22433618|NCT02870985|Fuwai Hospital|Prof. Yuejin Yang|008613701151408|yangyjfw@126.com|
22433619|NCT00343564|Cytokinetics,Inc.|Project Manager|650-624-2918||
22433620|NCT03913013|UCLA Semel Institute for Neuroscience and Behavior|David J. Miklowitz, Ph.D., Principal Investigator|(310) 267-2659|dmiklowitz@mednet.ucla.edu|
22433621|NCT03693144|University of Michigan|Dr. Susan Woolford|734 615-8214|swoolfor@med.umich.edu|
22433622|NCT01016132|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22433623|NCT04068948|University of Washington|Travis Nelson|206-543-0980|tmnelson@uw.edu|
22433624|NCT00790582|Forbes Norris MDA/ALS Center|Giovanna Kushner|415-600-3983|kushneg@cpmcri.org|
22433625|NCT00803595|Daiichi Sankyo Pharma Development|Howard Kessler|732-590-5032|hmkessler@dsi.com|
22433626|NCT02566785|University of Nebraska Medical Center College of Nursing|Dr. Rita McGuire|402-472-4712|rita.mcguire@unmc.edu|
22433627|NCT01597908|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
22433628|NCT02384044|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
22433629|NCT02949024|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
22433630|NCT01027650|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22433631|NCT05160415|Edgewise Therapeutics, Inc.|Joanne Donovan MD PhD, Chief Medical Officer|720-262-7002|studies@edgewisetx.com|
22433632|NCT00933608|NYU School of Medicine|Lidia Glodzik|212.263.5698|Lidia.Glodzik@nyumc.org|
22433633|NCT02331589|Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea|Dr. Ki Tae Suk|+82-33-240-5826|ktsuk@hallym.ac.kr|
22433634|NCT00623233|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22433635|NCT00559845|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22433636|NCT03206970|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22433637|NCT03654040|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22433638|NCT01951586|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22433639|NCT02802293|University of Texas Health -- San Antonio|Felipe S. Salinas, Ph.D.|210-567-8214|salinasf@uthscsa.edu|
22433640|NCT01222091|Stanford University School of Medicine|Dr. Larry Chu|(650) 723-6632|lchu@stanford.edu|
22433641|NCT02120781|Castle Creek Biosciences|Head, Research and Development|13128471291|medinfo@castlecreekbio.com|
22433642|NCT02685566|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
22410879|NCT01365845|University of Florida Proton Therapy Institute|Dr. Julie Bradley|904-588-1800|jbradley@floridaproton.org|
22433643|NCT00694577|Massachusetts General Hospital|Alphonse Taghian|6177261160|ataghian@mgh.harvard.edu|
22410880|NCT05017493|Hiwa Hospital - KRG|Dr. Dara Omer|+9647701586707|mailto:danaomar1979@gmail.com|
22410881|NCT01488019|Mylan UK|Dik Ng, PhD, Director Clinical Science|+44 1304626895|dik.ng@mylan.co.uk|
22410882|NCT00345683|GlaxoSmithKline|GSK Response Center|866-435-7343||
22410883|NCT00096486|Memorial Sloan Kettering Cancer Center|Dr. Mark Kris|646-888-4205|krism@mskcc.org|
22410884|NCT04071626|University Hospitals Cleveland Medical Center|Dr. Trevor Jenkins|(216)844-1229|Trevor.Jenkins@UHhospitals.org|
22410885|NCT00125359|Dartmouth-Hitchcock Medical Center|Konstantin Dragnev, MD|603-650-6344|Konstantin.H.Dragnev@Hitchcock.org|
22410886|NCT01201356|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22410887|NCT00585039|Phoenix Children's Hospital|Dr Blake Bulloch|602-546-1950|bbulloch@phoenixchildrens.com|
22410888|NCT02173301|Dr Reddy's Laboratories Ltd.|Dr. Srinivas Shenoy B.,|49002900|srinivassshenoyb@drreddys.com|
22410889|NCT01585831|University of Colorado Denver|Nicole Tartaglia, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
22410890|NCT01225991|University of California, Los Angeles|Dr. Helen Lavretsky,|310-794-4619|hlavretsky@mednet.ucla.edu|
22410891|NCT04079842|Masimo Corporation|Ahmed Alghazi|949-297-7000|aalghazi@masimo.com|
22410892|NCT02904200|Mölnlycke Health Care|Global Clinical Research Director|+46 31 722 30 00|info@monlycke.com|
22410893|NCT02133352|Boston University|Kimberly Finch|617-638-4475|kimtobin@bu.edu|
22410894|NCT04444752|Head of Clinical Operations US|Malinda Longphre|+15105203361|Mlongphre@connectpharm.com|
22410895|NCT00579254|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22410896|NCT02038634|Medical College of Wisconsin|Karen Gonzalez|414-955-3221|kgonzalez@mcw.edu|
22410897|NCT03220230|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22410898|NCT03572933|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
22410899|NCT01381900|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
22410900|NCT01772368|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000||
22410901|NCT02449291|Acacia Pharma Ltd|Gabriel Fox|01-223919764|gabrielfox@acaciapharma.com|
22410902|NCT00112489|NRG Oncology - Buffalo Office|Melissa Leventhal|716-341-3408|mleventhal@gogstats.org|
22410903|NCT02462421|University of Maryland School of Medicine|Dr. Simeon Taylor (Professor of Medicine)|410-706-6439|staylor2@som.umaryland.edu|
22410904|NCT02891200|Johns Hopkins University|Principle Investigator|410-637-7152|habouma1@jhmi.edu|
22410905|NCT02231710|Bellicum Pharmaceuticals|Rivogenlecleucel Study Team|(832) 384-1100|clinicaltrials@bellicum.com|
22410906|NCT01339910|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
22410907|NCT02322879|BIDMC|Michael Ganetsky, MD|617-754-2323|mganetsk@bidmc.harvard.edu|
22422970|NCT00022698|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22422971|NCT01827267|Puma Biotechnology|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
22422972|NCT00725361|StanfordU|Lorinda Chung|650-736-0727|shauwei@stanford.edu|
22422973|NCT03699280|Imperial College London|Ms Nandita Deo|07939360357|nandita.deo@gmail.com|
22422974|NCT01684943|Massachusetts General Hospital|Courtney A Balliro|617-726-1242|cballiro@partners.org|
22422975|NCT03395184|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22422976|NCT02060058|Kaohsiung Medical University Hospital|Hepatitis Center and Hepatobiliary Division, Department of Internal Medicine|+886-7-3121101|hsmonyan@gmail.com|6770
22422977|NCT00170625|Charite Campus Vichow Klinikum|Prof. Dr. Jalid Sehouli|+49 30-450564052|jalid.sehouli@charite.de|
22422978|NCT04965311|OHSU Knight Cancer Institute|Dr. Brett Sheppard|503-494-9169|sheppard@ohsu.edu|
22422979|NCT02551770|GWD Consult|Dr. Manfred Klasser|+49 6108 825 65 20|manfred.klasser@gwd-consult.de|
22422980|NCT02122887|Bar Ilan University|Moran Influs|972-35317943|moran.influs@gmail.com|
22422981|NCT05033262|The University of Pennsylvania School of Nursing|Emily Summerhayes|6099233786|esummer@nursing.upenn.edu|
22422982|NCT00765895|Johns Hopkins Data Coordinating Centers|Mark Van Natta|410-614-1362|mvannat1@jhu.edu|
22422983|NCT01482065|Johns Hopkins University|Dr. Seva Polotsky, M.D., PhD|410-550-6386|vpolots1@jhmi.edu|
22422984|NCT04720911|UMass Chan Medical School|Dr. Celine Larkin|5084211436|celine.larkin@umassmed.edu|
22422985|NCT04533412|Icahn School of Medicine at Mount Sinai|Alex D. Federman, MD, MPH|(212) 824-7565|alex.federman@mountsinai.org|
22422986|NCT03261674|VA Palo Alto|Dr Ansgar Furst; Rayma Williams|(650) 339-4015|ansgar.furst@va.gov; rayma.williams@va.gov|
22422987|NCT02004886|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22422988|NCT01369108|3M Oral Care Solutions Division|Rolf Halvorson|651-733-3384|rhhalvorson@mmm.com|
22422989|NCT01895608|James H Quillen VAMC|Dr. Courtney Hall|423-926-1171|courtney.hall@va.gov|7518
22422990|NCT02643849|SRS Medical|Director of Clinical Trials|800-345-5642|info@srsmedical.com|
22422991|NCT02892422|H. Lundbeck A/S|Email contact via|+45 36301311|LundbeckClinicalTrials@Lundbeck.com|
22422992|NCT04323306|MMV|Benoit Bestgen|+41 79 765 18 68|bestgenb@mmv.org|
22422993|NCT00759785|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22422994|NCT00089778|National Cancer Institute (NCI), National Institutes of Health (NIH)|James Yang, M.D.|301-496-1574|jamesyang@mail.nih.gov|
22422995|NCT04712019|3M|Biostatistics Manager|651-382-2876|swalters@mmm.com|
22422996|NCT04525079|Celltrion Inc|JiWoong Lim|82-32-850-5806|jiwoong.lim@celltrion.com|
22422997|NCT02581475|Shandong University Qilu Hospital|Dr. Yanqing Li|+86-531-82169236|liyanqing@sdu.edu.cn|
22422998|NCT00725608|RB Pharmaceuticals|Global Medical Director|+1 (804) 379 1090|Tim.Baxter@reckittbenckiser.com|
22422999|NCT01021761|Bucci Laser Vision|Frank A. Bucci, Jr., MD|570-825-5949|Buccivision@aol.com|
22423000|NCT00614120|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22423001|NCT01968707|3M|Joan Paulson|651-736-6583|jepaulson@mmm.com|
22423002|NCT01084668|Abbott|Global Medical Services|800-633-9110||
22423003|NCT01118624|Spectrum Pharmaceuticals|Pankaj Sharma, MD|949-743-9264|pankaj.sharma@sppirx.com|
22423004|NCT04789291|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22423005|NCT03729570|Emory University|Aaron Siegler, PhD|404-712-9733|asiegle@emory.edu|
22423006|NCT02474589|SIGA Technologies|Dennis E Hruby, PhD, Chief Scientific Officer|541-753-2000|dhruby@siga.com|
22423007|NCT00459706|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22423008|NCT02447497|3M|Nancy Klinger|651 491 9433|nmklinger@mmm.com|
22423009|NCT02017912|Brainstorm Cell Therapeutics|Chief Medical Officer|+1-201-488-0460|ClinicalTrial@brainstorm-cell.com|
22423010|NCT04569968|Bolu Abant İzzet Baysal University|Tamer ÇANKAYA|5335519171|tamercankaya@hotmail.com|+90
22423011|NCT06191393|Aptitude Medical Systems, Inc|Brad Killingsworth|2814674855|brad.killingsworth@aptitudemedical.com|
22423012|NCT03912818|Stanford University|Sandy Srinivas|650-725-2078|sandysri@stanford.edu|
22423013|NCT00985959|Janssen Pharm KK Japan|Director|+81-3-4411-5801||
22423014|NCT00979420|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22423015|NCT02107859|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22423016|NCT02235077|Duke Clinical Research Institute|Adrian Hernandez, MD|919 668 7515|adrian.hernandez@duke.edu|
22423017|NCT02964208|Abbott|Ryan Gage|+1 612 805 6398|ryan.gage@abbott.com|
22423018|NCT03767153|Venus Concept|Clinical Research Manager|888-907-0115|rmays@venusconcept.com|
22423019|NCT00792688|Glycotex, Inc.|Dr. Reinhard Koenig, CEO|301-670-2825|Reinhard.Koenig@glycotexinc.com|
22423020|NCT03887442|TTCC Grupo Español de Tratamiento de Tumores de Cabeza y Cuello|Carmen Montalbán, Manager|+34676154172|ttccmanager@yahoo.com|
22423021|NCT06343467|TRIA Orthopedic Center|Megan Reams; Director of Orthopaedic Research|(952) 806-5329|megan.reams@tria.com|
22423022|NCT00101166|H. Lee Moffitt Cancer Center and Research Institute|Dr. Sophie Dessureault|813-745-1965|sophie.dessureault@moffitt.org|
22423023|NCT01868022|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22393614|NCT02074553|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22393615|NCT02342743|CEFALY Technology|Clinical Trials Department director|+3243676722|info@cefaly.com|
22393616|NCT00686725|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22393617|NCT04875676|Vaxart|Vice President Regulatory|(650) 747-6028|mdrayton@vaxart.com|
22393618|NCT03064035|Methodist Hospital|Zachary Stoecker, PharmD|952-977-5520|Zachary.Stoecker@parknicollet.com|
22393619|NCT03602066|University of Arizona Cancer Center|Jared Robbins, MD|520-626-6724|jrobbins@arizona.edu|
22393620|NCT00092495|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22423024|NCT01628198|Icahn School of Medicine at Mount Sinai|Dr. Vivek Y Reddy|212-241-7114|vivek.reddy@mountsinai.org|
22423025|NCT03386994|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22423026|NCT00322231|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22423027|NCT03226769|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22423028|NCT01516008|Janssen Research & Development, L.L.C.|Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
22423029|NCT04679311|Washington University School of Medicine|Steven Weintraub MD|314-652-4100|weintraub@wustl.edu|55298
22423030|NCT01217476|Olympus France S.A.S|Mr. Akira Kondo, Manager, Clinical R&D|+33-1-4560-6849|akira.kondo@olympus.fr|
22423031|NCT03033602|VA Boston Healthcare System & Boston University School of Medicine|Dr. Denise Sloan, Professor of Psychiatry|857-364-6333|dsloan@bu.edu|
22423032|NCT03129945|University of California, Irvine|Judith Chung|714-456-8695|judithc@hs.uci.edu|
22423033|NCT02036840|Nationwide Children's Hospital|Ralph Beltran, MD|614-722-4200|Ralph.Beltran@nationwidechildrens.org|
22423034|NCT01923298|The University of Arizona Cancer Center|Dr. Pavani Chalasani|520-626-0191|pchalasani@uacc.arizona.edu|
22423035|NCT01493284|St Jude Medical|Sr Clinical Scientist|4159179696|alicia.kimber@abbott.com|
22423036|NCT00325156|GlaxoSmithKline|GSK Response Center|866-435-7343||
22423037|NCT04064411|Radius Health, Inc.|Clinical Operations|617-551-4000|info@radiuspharm.com|
22423038|NCT01188876|Massachusetts General Hospital|Marcela del Carmen, MD, MPH|617-724-4800|MDELCARMEN@mgh.harvard.edu|
22423039|NCT03512210|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|301-628-3348|ACTGCT.gov@fstrf.org|
22423040|NCT01672710|Institute for Health and the Environment, University at Albany|David O. Carpenter MD|518-525-2660|dcarpenter@albany.edu|
22423041|NCT03725761|Wisconsin Institutes for Medical Research|Joshua M Lang, MD, MS|(608) 265-8131|jmlang@medicine.wisc.edu|
22423042|NCT03197467|AIO-Studien-gGmbH|AIO-Studien-gGmbH Help Desk|0049-30-8145344|info@aio-studien-ggmbh.de|31
22423043|NCT03666533|Department of Veterans Affairs Northeast Ohio Healthcare system|Dr. Svetlana Pundik|216-791-3800|svetlana.pundik@va.gov|63732
22423044|NCT02017717|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22423045|NCT01515462|Fondazione Telethon ETS|Sean Russell|+39 02 2022 17210|srussell@telethon.it|
22423046|NCT04488419|Athira Pharma|Dr. Javier San Martin, CMO|1-866-725-0930|clinicaltrials@athira.com|
22423047|NCT03309657|University of Queensland Center for Clinical Research|Prof. Jason Roberts|+61 7 334 65032|j.roberts2@uq.edu.au|
22423048|NCT00970632|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22423049|NCT03192995|University of California at San Francisco|Dr. Glenn-Milo Santos, Associate Professor|415-867-1151|glenn-milo.santos@ucsf.edu|
22423050|NCT03506568|Devers Eye Institute|Dr. Robert Kinast|503-413-8202|robertkinast@gmail.com|
22423051|NCT01286168|Mayo Clinic|Dr. Amy C. Degnim|507-284-6357|Degnim.Amy@mayo.edu|
22423052|NCT02487771|University of Kansas Medical Center|Susan Carlson, PhD|(913) 588-5359|SCARLSON@kumc.edu|
22423053|NCT01871402|Therapeutics, Inc.|Clinical Research, Therapeutics, Inc.|858-571-1800|clinicalresearch@therapeuticsinc.com|
22423054|NCT04594941|GE HealthCare|Francois Tranquart, M.D., Ph.D|447775543206|francois.tranquart@ge.com|
22423055|NCT04984681|University of Alabama at Birmingham|Crystal Chapman Lambert|205-934-3481|cclamber@uab.edu|
22423056|NCT04327661|Vanda Pharmaceuticals Inc.|Vanda Pharmaceuticals Inc.|2027343400|clinicaltrials@vandapharma.com|
22423057|NCT02091960|Astellas Global Development, Inc. (APGD)|Clinical Transparency|800-888-7704|astellas.resultsdisclosure@astellas.com|
22423058|NCT01579084|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22423059|NCT01942486|University of Utah|Bradley Katz|8015871079|bradley.katz@hsc.utah.edu|
22423060|NCT03728426|Brigham and Women's Hospital/Dana-Farber Cancer Institute|Dr. Amy Sherman|6175253575|acsherman@bwh.harvard.edu|
22423061|NCT02064270|University of Missouri, Department of Orthopaedic Surgery|Stacee Clawson, Research Manager|5738849017|clawsons@health.missouri.edu|
22423062|NCT02424630|Chuncheon Sacred Heart Hospital|Dr Jung-Taek Hwang|82 33 240 5197|drakehjt@hanmail.net|
22423063|NCT02637895|University of Miami Miller School of Medicine|Dr. Philip Harvey|305 243 4094|pharvey@med.miami.edu|
22423064|NCT03794661|Abbott Medical Devices Neuromodulation|Binith Cheeran|+15122864262|binith.cheeran@abbott.com|
22423065|NCT04810247|The Miriam Hospital|Dr. KayLoni Olson|401-793-8971|kayloni.olson@lifespan.org|
22423066|NCT01741792|Amgen, Inc.|Study Director|866-572-6436||
22423067|NCT01995175|GlaxoSmithKline|GSK Response Center|866-435-7343|lr24921@gsk.com|
22423068|NCT00984061|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22423069|NCT05139303|University of Kentucky College of Dentistry Division of Orofacial Pain|Dr. Isabel Moreno Hay|8593233440|imo226@uky.edu|
22423070|NCT02045862|Astellas Pharma Europe B.V.|Clinical Trial Disclosure|+44 (0) 20 3379 8000|astellas.resultsdisclosure@astellas.com|
22423071|NCT03961061|Wake Forest Health Sciences|Justin B. Moore, PhD|336-716-3702|jusmoore@wakehealth.edu|
22393621|NCT02454179|Acerta Pharma, LLC|Priti Patel, MD, Executive Director - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
22423072|NCT02697890|TuftsUSDM|Y. Natalie Jeong|6176366531|natalie.jeong@tufts.edu|
22393622|NCT03103763|Penobscot Bay Medical Center|Caroline Knight, RN, Clinical Research Manager|207-301-8959|cknight@pbmc.org|
22423073|NCT02353442|São Carlos Fedetal University|Dayana Rosa|+55 16 33066695|dad_rosa@hotmail.com|
22423074|NCT02360631|University of Kansas Medical Center|Lisa Sanderson Cox|913-588-2643|lcox@kumc.edu|
22423075|NCT01075646|Department of Anesthesia, Reanimation Bellvitge University Hospital|Noelia Fustran|932607323|nfustran@bellvitgehospital.cat|
22433644|NCT01977729|Yale University|Dr. Wendy Silverman|(203) 737-7053|wendy.silverman@yale.edu|
22423076|NCT01520558|Coronado Biosciences|Vice President, Clinical Operations|7816524516|nsilver@coronadobio.com|
22423077|NCT05239494|University of Alabama at Birmingham|Andrew Pucker, OD, PhD|920-579-2900|andrewpucker@hotmail.com|
22423078|NCT02855359|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
22423079|NCT03155178|3M|Joan E. Paulson|651-736-6583|jepaulson@mmm.com|
22423080|NCT04874233|Prism Clinical Research|Amy Eastenson, MD|1-651-641-2900|aeastenson@prismresearchinc.com|
22423081|NCT02523924|Johns Hopkins University|Steven Rowe, MD|4105028052|srowe8@jhmi.edu|
22423082|NCT02677038|M D Anderson Cancer Center|Dr. Milind Javle|713-792-5434|mjavle@mdanderson.org|
22423083|NCT01460654|Massachusetts General Hospital|Dr. Benjamin Leder|6177266723|bzleder@partners.org|
22423084|NCT02777970|Menarini Ricerche|Dr. Angela Capriati (Clinical Sciences Director)|+39 055 5680|acapriati@menarini-ricerche.it|9933
22423085|NCT02319967|University of Illinois at Chicago|Jerry A. Krishnan, MD, PhD|312-413-3291|chicagotrial@uic.edu|
22423086|NCT00742872|American University of Beirut Medical Center|Dr. Ala Sharara|+961-3-350000|as08@aub.edu.lb|
22423087|NCT02195310|KCI Europe Holding B.V.|Daniela Weichert, PhD|+353 (0) 860436155|daniela.weichert@acelity.com|
22423088|NCT02541669|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22423089|NCT00834639|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22423090|NCT01917812|Johns Hopkins University School of Medicine|Dr. Seth S Martin|410-955-7376|smart100@jhmi.edu|
22423091|NCT04739722|Geneoscopy Inc.|Chief Medical and Science Officer|314-887-7777|contact@geneoscopy.com|
22423092|NCT05010512|Alcon Research, LLC|Associate Director, Clinical Projects - CDMA Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22423093|NCT00805870|Western Michigan University|Dr. Christopher C. Cheatham|269-387-2542|chris.cheatham@wmich.edu|
22423094|NCT01576276|Massachusetts General Hospital|Dr. Jian Kong|617-726-7893|jkong2@mgh.harvard.edu|
22423095|NCT02083185|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22423096|NCT01322035|University of South Alabama, Department of Surgery|Dr. William O. Richards|251-471-7993|brichards@health.southalabama.edu|
22423097|NCT00535847|Vertex Pharmaceuticals Incorporated|Jeff Chodakewitz, M.D.|617-341-6777|Jeff_Chodakewitz@vrtx.com|
22423098|NCT01546168|Icahn School of Medicine at Mount Sinai|Dr. Vivek Y Reddy|212-241-7114|vivek.reddy@mountsinai.org|
22423099|NCT02850016|The Rockefeller University|Marina Caskey|212-327-7396|mcaskey@rockefeller.edu|
22423100|NCT01902758|University of Montana|Director of the Montana Center for Work Physiology and Exercise Metabolism|406-243-2117|brent.ruby@mso.umt.edu|
22423101|NCT00715728|Vienna General Hospital/University of Vienna|Olga Plattner, Medical Doctor|43-1-40-400-4103|olga.plattner@meduniwien.ac.at|
22423102|NCT00570349|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
22423103|NCT01054196|Weill Cornell Medicine|Roger Pearse, M.D. PhD|646-962-6500|rnp2001@med.cornell.edu|
22423104|NCT03845491|Stryker Neurovascular|Sr. Clinical Project Manger|510-413-2500|lisa.park@stryker.com|
22423105|NCT02223546|Medical University of Graz|Gerald Seidel, MD|+43 316 385 12394|gerald.seidel@medunigraz.at|
22423106|NCT04060199|NS Pharma, Inc.|Medical Affairs|+1(201) 986-3860|trialinfo@nspharma.com|
22423107|NCT00478699|Fundación GECP|Eva Pereira|+34 934302006|epereira@gecp.org|
22423108|NCT01508130|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22423109|NCT02200536|Damascus University|Assistant Professor Easter Joury|00963955650456|easterjoury@icloud.com|
22433645|NCT05332392|Masimo|Ahmed Alghazi|949-297-7437|aalghazi@masimo.com|
22423110|NCT01629290|University of Michigan School of Dentistry|Danika Downey, DDS|330-877-8783|danika.downey@gmail.com|
22433646|NCT01268046|Massachusetts General Hospital|Janet Hall, MD|617-877-1112|janet.hall@nih.gov|
22423111|NCT04676451|Penn State Hershey Medical Center|Amy Longenecker|717-531-1513|alongenecker@pennstatehealth.psu.edu|
22433647|NCT03850093|faculty of medicine- Zagazig university|assistant professor Abeer M. Elnakera|00201005720754|nakera35@hotmail.com|
22433648|NCT02008942|PLx Pharma|Ronald Zimmerman, President & CEO|713-842-1249|ron.zimmerman@plxpharma.com|205
22433649|NCT03636893|RUIJIN HOSPITAL|Dr BIRENDRA KUMAR SAH|0086-64370045|rjsurgeon@hotmail.com|671302
22433650|NCT02314156|Northwestern University|Seema A. Khan, MD|312-503-4236|s-khan2@northwestern.edu|
22433651|NCT00224120|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com|
22433652|NCT03415581|New York State Psychiatric Institute|Jermaine Jones PhD|6467746113|jermaine.jones@nyspi.columbia.edu|
22433653|NCT04918381|Pulse Biosciences, Inc.|William Knape / VP, Clinical, Regulatory and Quality Affairs|919-757-2033|bknape@pulsebiosciences.com|
22433654|NCT02455804|Medinol|Dina Kofler, VP Clinical Affairs|+97237679032|dinak@medinol.com|
22433655|NCT00758069|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22433656|NCT04560816|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22433657|NCT03226249|Northwestern University, Feinberg School of Medicine|Jane N. Winter, M.D.|(312) 695-4538|j-winter@northwestern.edu|
22433658|NCT02277691|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22433659|NCT01312805|Indiana University School of Medicine|Aaron E. Carroll, MD, MS|3172789616|aaecarro@iu.edu|
22433660|NCT02846389|Hackensack Meridian Health|Joshua Zenreich|15519964248|joshua.zenreich@hmhn.org|
22433661|NCT04343534|Massachusetts General Hospital|Dr. Karen R. Sepucha|617-724-3350|KSEPUCHA@mgh.havard.edu|
22433662|NCT01804049|VAORD - Portland VA Health Care System|Dr Robert Klein|503-220-8268|kleinro@ohsu.edu|57496
22433663|NCT02544035|National Institute of Child Health and Human Development|Dr. Diane Putnick|301-496-6291|putnickd@mail.nih.gov|
22433664|NCT03985943|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22433665|NCT01265563|VA- STVHCS|Dr. Shweta Bansal|2105674700|bansals3@uthscsa.edu|
22433666|NCT02029755|Taipei medical university hospital|Dr. Hsiao-Chien Tsai|+886-2-27372181|hctsai.anes@gmail.com|8310
22433667|NCT01858545|Integra LifeSciences|Manager, Clinical Research|443-766-3869|allison.matthews@integralife.com|
22433668|NCT04075513|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22433669|NCT05730335|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22423112|NCT01880086|Weill Cornell Medical College|Dr. Peter N. Schlegel|2127465491|pnschleg@med.cornell.edu|
22423113|NCT05600270|Lahey Hospital and Medical Center|Neev Mehta|781-744-1933|neev.n.mehta@lahey.org|
22423114|NCT00901017|Institut Straumann AG|Marc Quirynen, Professor|+4161965|michael.hotze@straumann.com|1235
22423115|NCT02288091|Massachusetts General Hospital|Sabrina Paganoni, MD, PhD|617-724-3914|spaganoni@mgh.harvard.edu|
22423116|NCT02458768|LG Life Sciences|Jonghee Jin|82-2-6924-3122|jonghee@lgls.com|
22423117|NCT02773212|University of Illinois at Chicago|Dr. Margaret Wardle|(312)413-5564|mwardle@uic.edu|
22423118|NCT03843632|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22423119|NCT01820572|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22423120|NCT00595517|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22423121|NCT05356533|University of Washington|Jennifer Cadigan|206-543-5689|cadiganj@uw.edu|
22423122|NCT03852628|RTI International|PASA Core Leadership|919-541-6002|shirsch@rti.org|
22423123|NCT01931956|Abbott Vascular|Jeffrey T Ellis||jeffrey.ellis@av.abbott.com|
22423124|NCT00602459|Ohio State University|John Byrd, M.D.||john.byrd@osumc.edu|
22423125|NCT01746420|Wright Medical|Justin Moss|615-236-4984|justin.moss@wright.com|
22423126|NCT02600845|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22423127|NCT00197002|GlaxoSmithKline|GSK Response Center|866-435-7343||
22423128|NCT02345265|Dana-Farber Cancer Institute|Dr. Joyce Liu|617-632-5269|Joyce_Liu@dfci.harvard.edu|
22423129|NCT05072106|Pharma Mar S.A.|Clinical Developtment, Department of PharmaMar's Oncology, Business Unit,|0034918466000|AEincoming@pharmamar.com|
22423130|NCT03839459|University of Rochester Medical Center|Brea Lipe, MD|(585) 275-4099|Brea_Lipe@URMC.Rochester.edu|
22423131|NCT05376241|University of Colorado|Laura Scherer|303-724-5749|laura.scherer@cuanschutz.edu|
22423132|NCT01632150|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22433670|NCT01959178|Bausch Health|Study Director||robert.steffen@bausch.com|
22433671|NCT01534351|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22423133|NCT05027048|Stanford|Dr. Jessica Ansari|650-723-5349|jansari@stanford.edu|
22423134|NCT02879994|Jonsson Comprehensieve Cancer Center|Dr. Edward Garon|(310)586-2098|egaron@mednet.ucla.edu|
22433672|NCT01122446|LundU|Helena Elding Larsson, PI|+4640337676|helena.elding_larsson@med.lu.se|
22433673|NCT01369199|University of Pittsburgh|Dr. Steven Belle|412-624-5419|belle@edc.pitt.edu|
22423135|NCT02143791|Abbott|Devyani Nanduri|+1 510 561 4328|devyani.nanduri@abbott.com|
22423136|NCT04112160|UT Southwestern Dept of Urology|Dr. Brett Johnson|214-645-3526|brett.johnson@utsouthwestern.edu|
22423137|NCT03051516|Fred Hutchinson Cancer Center|Margaret M. Madeleine, PhD|206-667-4630|mmadelei@fredhutch.org|
22423138|NCT00535782|Hoffman-LaRoche|Medical Communications|800-821-8590||
22423139|NCT00507819|The Children's Hospital of Philadelphia|David J. Goldberg, MD|267-426-8143|goldbergda@email.chop.edu|
22423140|NCT01187771|University of Pittsburgh|Sanjay Patel|412-692-2035|patelsr2@upmc.edu|
22423141|NCT02691013|University of California San Diego|Dr. Robert Owens|858-657-5258|rowens@ucsd.edu|
22423142|NCT02357706|Charite Department of Sleepmedizin|Prof Dr med Ingo Fietze|+49 30 450 513 122|ingo.fietze@charite.de|
22423143|NCT02275780|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22423144|NCT03960866|Ocuphire Pharma, Inc.|Mina Sooch|248-681-9815|msooch@ocuphire.com|
22423145|NCT00631410|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22423146|NCT03998163|Cara Therapeutics|Frédérique Menzaghi, PhD|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
22423147|NCT03419598|University of Bath|Professor Richie Gill|01225 383627|r.gill@bath.ac.uk|
22423148|NCT01223469|St. Jude Medical/Endosense|Hendrik Lambert PhD, VP of Clinical and Regulatory Affairs||Hendrik.Lambert@endosense.com|
22423149|NCT00380081|Purdue Pharma LP|Clinical Leader|800-733-1333||
22423150|NCT02231879|LMI/NIAID/NIH|Dr. David H. McDermott|301-761-6647|dmcdermott@niaid.nih.gov|
22423151|NCT00189306|Graceway Pharmaceuticals|Medical Director|267-984-0400|jim.lee@gracewaypharma.com|
22423152|NCT03640481|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
22423153|NCT04889157|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22423154|NCT00070018|SWOG Statistical Center|Study Statistician|206-667-4623||
22423155|NCT02939716|University of Nottingham|Robin Spiller|01158231090|robin.spiller@nottingham.ac.uk|
22423156|NCT02747849|UPittsburgh|Rajeev Chaudhry, MD|412-692-7932|rajeev.chaudhry@chp.edu|
22423157|NCT00574249|Abbott|Medical Information Specialist|1-800-633-9110||
22423158|NCT03197870|EyePoint Pharmaceuticals, Inc|David Bauer|8573410747|dbauer@eyepointpharma.com|
22423159|NCT01570634|Salient Pharmaceuticals Incorporated|Richard scruggs|7135899859|rscruggs@salientpharmaceuticals.com|
22423160|NCT01618019|Hanyang University|Dr. Yongsoon Park|82-2-2220-1205|yongsoon@hanyang.ac.kr|
22423161|NCT01542034|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
22423162|NCT02612610|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22423163|NCT01260272|L-MARC Research center|Kathy Schmitz, Site Manager|502 214 3990|kschmitz@lmarc.com|
22423164|NCT01546571|Polynoma|Clinical Program Director|5418405451|karihatten@polynoma.com|
22423165|NCT02105246|San Francisco VA Healthcare System|Dr. Mary Whooley|415-221-4810|mary.whooley@va.gov|
22423166|NCT00387010|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22423167|NCT00430352|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22423168|NCT03099694|Children's Hospital of Chongqing Medical University, Ministry of Education Key Laboratory of Child Development and Disorders, Key Laboratory of Pediatrics in Chongqing|Prof. Shi Yuan|13508300283|15084335697@163.com|
22423169|NCT04326439|Emory University|Dr. Himalee Sabnis|404-727-3285|hsabnis@emory.edu|
22423170|NCT01892709|Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore Medical Center|Andrew Chang, MD, MS|718-920-7476|achang@montefiore.org|
22423171|NCT01167881|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22423172|NCT00789256|Dartmouth-Hitchcock Medical Center|Marc Gautier, MD - Principal Investigator|603-650-5529|marc.gautier@hitchcock.org|
22423173|NCT00471718|Vanderbilt-Ingram Cancer Center|Jeff Sosman, MD|615-936-3048|jeff.sosman@vanderbilt.edu|
22423174|NCT01446237|GlaxoSmithKline|GSK Response Center|866-435-7343||
22423175|NCT03492398|Seoul National University Hospital|Inseung Jeon|82-2-2072-1920|isjeon0127@snu.ac.kr|
22423176|NCT03951064|University of North Carolina at Chapel Hill|Jackson Pettee|984-215-6872|jackson_pettee@med.unc.edu|
22423177|NCT02294175|James A. Haley Veterans Hospital and Clinics|Dr. Linda Cowan|813-558-3932|linda.cowan@va.gov|
22423178|NCT01901653|AbbVie Stemcentrx|Senior Director, Clinical Operations|(650) 827-4879|isobel.lakatos@abbvie.com|
22423179|NCT02548351|Intercept Pharmaceuticals, Inc.|Medical Information|844-782-4278|medinfo@interceptpharma.com|
22423180|NCT01668173|Memorial Sloan Kettering Cancer Center|Dr. Raajit Rampal|212-639-2194|RampalR@mskcc.org|
22423181|NCT01295827|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22423182|NCT02640677|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22433674|NCT00617097|University of California, Davis|Dr. Catherine Cansino|9167346930|Catherine.Cansino@ucdmc.ucdavis.edu|
22433675|NCT00745290|Pacira Pharmaceuticals Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
22433676|NCT03248167|NYU Langone Health|Charles Marmar, MD|646-754-4855|Charles.marmar@nyumc.org|
22433677|NCT02122146|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22433678|NCT03472495|Virginia Commonwealth University|Tammy Nguyen, PharmD|8046630969|Tammy.Nguyen@vcuhealth.org|
22393623|NCT00938470|Mayo Clinic|Steven R Alberts MD MPH|507-284-4918|alberts.steven@mayo.edu|
22393624|NCT02336178|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22393625|NCT03245151|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22393626|NCT01970345|Icahn School of Medicine at Mount Sinai|Dr. Alexander Kolevzon|(212) 659-8762|alexander.kolevzon@mssm.edu|
22393627|NCT01346475|University of Washington|Dr. Christine Johnston|206-520-4340|cjohnsto@u.washington.edu|
22393628|NCT01552603|Legacy Health System|Kenneth Ward|971-570-2632|kenward503@msn.com|
22393629|NCT00618618|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
22393630|NCT01488877|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22393631|NCT00621777|Massachusetts General Hospital|A. Eden Evins, MD, MPH|6176434679|a_eden_evins@hms.harvard.edu|
22393632|NCT01236365|Nemours Children's Clinic|Nelly Mauras, MD|904-697-3674|nmauras@nemours.org|
22393633|NCT00955253|Imperial College London|Dr Paresh Malhotra|0208 846 1234|p.malhotra@imperial.ac.uk|
22393634|NCT00558259|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22393635|NCT00703937|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
22393636|NCT03840915|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22393637|NCT00700258|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22393638|NCT00473265|Columbia University Medical Center|John P. Bilezikian MD|212-305-2663|jpb2@columbia.edu|
22393639|NCT03250234|USARIEM|Dr. Lee Margolis|508-206-2335|lee.m.margolis.civ@mail.mil|
22393640|NCT02663518|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22393641|NCT02470910|DFCI/BWH|Anthony D'Amico|8572151489|adamico@bwh.harvard.edu|
22393642|NCT00560560|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22393643|NCT00006011|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22393644|NCT01004848|Icahn School of Medicine at Mount Sinai|Carol R. Horowitz, MD, MPH|212-659-9567|carol.horowitz@mountsinai.org|
22393645|NCT03178643|DCRI|Dr. Steve Taylor|9198245232|steve.taylor@duke.edu|
22393646|NCT00795366|University of Miami|Kenneth Proctor, PhD, Professor of Surgery|305-585-1178|kproctor@med.miami.edu|
22393647|NCT01236534|University of Rochester|Andrew Goodman, MD|585-275-7854|andrew_goodman@urmc.rochester.edu|
22393648|NCT01844687|Columbia University Medical Center|Margaret Haney, PhD., Professor|(646) 774-6153|mh235@columbia.edu|
22393649|NCT02029872|Johns Hopkins University School of Nursing|Dr. Jason Farley|4105027563|jfarley1@jhu.edu|
22393650|NCT01963923|Complejo Hospitalario Universitario A Coruña|Esther Gimenez Moolhuyzen|679336288|raquel.sebio@udc.es|
22393651|NCT03215810|Moffitt Cancer Center|Ben Creelan, MD|813-745-4541|ben.creelan@moffitt.org|
22393652|NCT02318992|University of Texas School of Public Health|Dr. Herbert DuPont|713 500 9366|herbert.l.dupont@uth.tmc.edu|
22393653|NCT04887064|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22423183|NCT00537576|University of California, San Francisco|Anke Hemmerling, Project Director|415-597-4963|ahemmerling@globalhealth.ucsf.edu|
22423184|NCT02805660|Mirati Therapeutics|Tavette Neskorik, Senior Director, Clinical Science|858-332-3552|neskorikt@mirati.com|
22423185|NCT02572076|Motus GI Medical Technologies Ltd.|Ravit Peled -Director of Clinical Trial|0733243823|ravit@motusgi.com|203
22423186|NCT02778074|Linkoping University|Dr Peter Johansson|0460700896548|peter.b.johansson@liu.se|
22423187|NCT02255305|NorthShore UH|Jennifer Grant|847-570-2420|jgrant@northshore.org|
22423188|NCT03489707|Medical College of Wisconsin|Alan Nyitray, PhD|414-955-7701|anyitray@mcw.edu|
22423189|NCT05685264|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22423190|NCT01290978|cyberDERM Clinical Studies|Dr. Gary Grove|610-325-0112||
22423191|NCT02342197|Kasr El-Aini Hospital|Nawara Mohamed|0223654060|nawaram@kasrelaini.edu.eg|002
22423192|NCT01817582|Bausch & Lomb Incorporated|Director of Clinical Operations||Jon.Williams@bauschhealth.com|
22423193|NCT03053063|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22423194|NCT02341495|Loyola University Medical Center|Dr. Elizabeth Henry|708-327-3153|ehenry@lumc.edu|
22423195|NCT03963232|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
22423196|NCT00356135|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22423197|NCT03617770|University of Illinois at Chicago|Dr. Pamela Martyn-Nemeth|3129967903|pmartyn@uic.edu|
22423198|NCT00321698|Portland VAMC|Dr. Mark Garzotto|541-728-0665|garzotto@ohsu.edu|
22423199|NCT05270395|University of Kentucky|Dr. McLouth|859-562-2526|laurie.mclouth@uky.edu|
22423200|NCT03055494|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22423201|NCT00538512|University of Michigan School of Public Health|Arnold S. Monto, MD|734-764-5453|asmonto@umich.edu|
22423202|NCT03569293|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22423203|NCT04843761|University of Minnesota|Shweta Sharma Mistry|612-626-9021|shwetas@ccbr.umn.edu|
22393654|NCT01781078|Boston Scientific|Kelly Aspinwall|651-582-4560|Kelly.Aspinwall@bsci.com|
22393655|NCT02217501|UT Southwestern Medical Center|Subhash Banerjee, MD|214-857-1608|Subhash.Banerjee@utsouthwestern.edu|
22423204|NCT03036098|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22423205|NCT05773781|University of Liverpool|Mr Jason Fleming|0151 529 5259|Jason.Fleming@liverpool.ac.uk|
22393656|NCT02019667|National Institutes of Health|Dr. William Theodore|301-496-1505|theodorw@ninds.nih.gov|
22393657|NCT02577822|Northwestern University|David Manning, MD|312-695-6800|david.manning@nm.org|
22393658|NCT03748992|Medical University of South Carolina|Patrick Flume, MD|843-792-3167|flumepa@musc.edu|
22393659|NCT02432196|Edwards Lifesciences, LLC|Sabrina Hundt, Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Sabrina_Hundt@edwards.com|
22393660|NCT03924765|Georgia Institute of Technology|Dr. Aaron Young|404-385-5306|aaron.young@me.gatech.edu|
22393661|NCT03417895|Jiangsu Hengrui Pharmaceuticals Co., Ltd.|Yuanchao Wang; SPM|86-18036618707|yuanchao.wang@hengrui.com|
22393662|NCT01942785|Email contact via H. Lundbeck A/S|Study director||LundbeckClinicalTrials@lundbeck.com|
22393663|NCT05452278|Imperial Brands PLC|Libby Clarke|+44 (0117) 3320221|libby.clarke@impbrands.com|
22393664|NCT03663257|Philips Medical Systems Nederland B.V.|Joris de Groot|+31621949619|joris.ah.de.groot@philips.com|
22393665|NCT05453201|James J. Peters Veterans Affairs Medical Center|Dr. Marianne Goodman|6462457071|mggoodman2001@yahoo.com|
22393666|NCT01934790|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22393667|NCT05061472|University of Colorado Anschutz Medical Campus|Adnin Zaman, MD|5852761001|adnin.zaman@cuanschutz.edu|
22393668|NCT04688320|"LLC SuperGene"|Dr. Sergey Markin|(495) 287-98-07|info@supergene.ru|+7
22393669|NCT00552929|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22423206|NCT04240886|Basilea Pharmaceutica International Ltd, Allschwil|Study Director|+41 79 701 0551|marc.engelhardt@basilea.com|
22423207|NCT02276053|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22423208|NCT01296542|Bucci Laser Vision|Frank A. Bucci Jr., MD|570-825-5949|buccivision@aol.com|
22423209|NCT04743804|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22423210|NCT02059434|AstraZeneca|AstraZeneca Clinical Study Information Center||ClinicalTrialTransparency@astrazeneca.com|
22423211|NCT02956447|Massachusetts General Hospital|Dr. Stephanie Seminara|617-724-5390|MGHKisspeptinResearch@partners.org|
22423212|NCT00771264|Uroplasty, Inc.|Susan Holman, Cheif Operating Officer|952-426-6143|susan.holman@uroplasty.com|
22423213|NCT02928770|Stanford University|Clete A. Kushida, M.D., Ph.D.|6507217560|clete@stanford.edu|
22423214|NCT03201874|Seattle Children's Hospital|Tonya Palermo, Professor, Anesthesiology and Pain Medicine, Seattle Children's Hospital|206-884-4208|tonya.palermo@seattlechildrens.org|
22393670|NCT03670004|Jesse Brown VA Medical Center|Dr. Matthew Major|312-503-5731|matthew.major2@va.gov|
22410908|NCT00810732|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22410909|NCT00124020|Theravance, Inc|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
22410910|NCT01799590|Janssen Pharmaceutical KK Japan|Group Manager|+81-3-4411-5072||
22410911|NCT00752791|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22410912|NCT01127581|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22410913|NCT01977092|Public Health Institute|Elizabeth Mahoney|(818)310-2684|lmahoney@bhrsca.org|
22410914|NCT05117099|University of Oregon Prevention Science Institute|Dr. Allison Caruthers|503-412-3770|ascaru@uoregon.edu|
22410915|NCT00514137|Mayo Clinic Cancer Center|Shaji Kumar, M.D.||kumar.shaji@mayo.edu|
22410916|NCT01155583|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Jason Valent|+1 216-445-7238|VALENTJ3@ccf.org|
22410917|NCT05085613|Johns Hopkins Bloomberg School of Public Health|Caitlin Weiger|301-712-8357|cweiger2@jhmi.edu|
22410918|NCT01413399|Mecklenburg EMS Agency|Jonathan R Studnek PhD|7049436046|jonst@medic911.com|
22410919|NCT00886483|The Ohio State University|L. Eugene Arnold, M.D. M.Ed.|614-685-6708|L.Arnold@osumc.edu|
22410920|NCT01001169|GlaxoSmithKline|GSK Response Center|866-435-7343||
22410921|NCT00602030|Syndax Pharmaceuticals, Inc.|Michael Meyers, MD, PhD, Chief Medical Officer|+1-646-690-7620|mmeyers@syndax.com|
22410922|NCT01138150|The Johns Hopkins University School of Medicine|Dr. Lee Peterlin|410-550-5452|lpeterlin@jhmi.edu|
22410923|NCT01580020|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22410924|NCT01724359|Jan-Cil Mexico|GERENTE MEDICO REGIONAL|52 55 5237 3410||
22410925|NCT01534975|Los Angeles Biomedical Research Institute|Matthew Budoff|3102224107|mbudoff@labiomed.org|310
22410926|NCT00397839|Hoffmann-La Roche|Medical Communications|800-821-8590||
22410927|NCT02151461|NuSirt Biopharma|Barbara Cannon|6156567898|BCannon@nusirt.com|
22410928|NCT02168270|University of Nebraska Medical Center|Dr. Nicole Shonka|402-559-5166|nshonka@unmc.edu|
22410929|NCT00252187|Mayo Clinic|Dr. Horng H. Chen|507-778-2354|chen.horng@mayo.edu|
22410930|NCT00593333|Department of Surgery/Division of Orthopaedics|Taylor Vlack, Research Nurse Coordinator|205-996-6781|tmwebb@uabmc.edu|
22410931|NCT01738581|University of Minnesota|Dr. Teresa Kimberley|612-626-4096|tjk@umn.edu|
22410932|NCT01665053|Boston Scientific|Patricia O'Mara, Clinical Trial Manager|518-792-5673|patricia.o'mara@bsci.com|
22410933|NCT01033383|Yale University|Dr. Manisha Juthani-Mehta|(203)785-7571|manisha.juthani@yale.edu|
22410934|NCT02191579|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22410935|NCT02862535|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22410936|NCT02280356|Memorial Sloan Kettering Cancer Center|Dr. Marisa Kollmeier, MD|212-639-3952|KollmeiM@mskcc.org|
22410937|NCT02611206|University of Minnesota|Kathryn Cullen|612-625-3403|rega0026@umn.edu|
22410938|NCT01086215|Boston Scientific Corporation|DeeAnn Tinjum|763-450-8707|deeann.tinjum@bsci.com|
22410939|NCT01965652|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|1454
22410940|NCT01033864|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22410941|NCT02524106|University of California San Francisco|Priscilla Hsue, PI|415-206-8257|priscilla.hsue@ucsf.edu|
22410942|NCT01121900|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
22433679|NCT03578926|CooperVision Inc.|Jose A. Vega, O.D., MSc., FAAO|9256213761|javega@coopervision.com|
22433680|NCT02584452|Vanderbilt University Medical Center|Christopher Sobey, MD|615-322-4311|christopher.m.sobey@vumc.org|
22433681|NCT02998671|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22433682|NCT02038946|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22423215|NCT02210247|Pacira Pharmaceuticals Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
22423216|NCT02515994|Johnson & Johnson Vision Care Inc.|Kristy Canavan, O.D., F.A.A.O. Principle Research Optometrist|904-443-1474|KCANAVA2@its.jnj.com|
22423217|NCT01424514|GlaxoSmithKline|GSK Response Center|866-435-7343||
22423218|NCT04598451|Argenx|Regulatory Manager|Please email:|regulatory@argenx.com|
22423219|NCT02653170|Michigan State University|Dr. Mathew Reeves|517-353-8623|reevesm@msu.edu|
22423220|NCT02963558|Wake Forest University School of Medicine|D Clark Files, MD|336-716-8898|dfiles@wakehealth.edu|
22423221|NCT01272141|Emory University School of Medicine|William Read, MD|1-888-946-7447|william.l.read@emory.edu|
22423222|NCT01131884|University of Rochester|K.Rao Poduri, M.D., Chair of Physical Medicine & Rehab|585-275-6978|kr_poduri@urmc.rochester.edu|
22423223|NCT04063657|University of California, Davis|Dr. Christopher Kreulen|(916) 734-6805|ckreulen@ucdavis.edu|
22423224|NCT01214252|Covidien|Annie Choi|781-839-1756|annie.choi@covidien.com|
22423225|NCT02817698|Yale University|Marc Grasso|2037377074|marc.grasso@yale.edu|
22423226|NCT01371877|University of Nebraska Medical Center|Dr. Jill Poole|402-559-4087|japoole@unmc.edu|
22423227|NCT05932225|Alcon Research, LLC|Clinical Trial Lead, CDMA Trial Management Operations|1-888-451-3937|alcon.medinfo@alcon.com|
22423228|NCT01473394|Forest Research Institute, Inc.|Carl Gommoll|201 427-8000||
22423229|NCT01877551|Washington University School of Medicine|Dr. Dominic Reeds|3143628430|dreeds@wustl.edu|
22423230|NCT00761280|Isarna Therapeutics GmbH, formerly Antisense Pharma GmbH|Medical Officer|+49-89-890831|info@isarna-therapeutics.com|0
22423231|NCT03875482|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22423232|NCT04507256|AstraZeneca|Global Clinical Head|1-877-240-9479|information.center@astrazeneca.com|
22423233|NCT02111785|Department of Neurosurgery, University of Virginia Health System|Dr. Daniel Raper|4349823244|raper@virginia.edu|
22423234|NCT02327403|Massachusetts General Hospital|Dr. Leonardo V Riella, MD, PhD|6176436266|LRIELLA@MGH.HARVARD.EDU|
22423235|NCT02256982|Massachusetts General Hospital|Ted Hong, MD|617-726-6050|tshong1@partners.org|
22423236|NCT03369067|University of Virginia Center for Diabetes Technology|Marc Breton, PhD|434-982-6484|mb6nt@virginia.edu|
22423237|NCT00981045|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
22423238|NCT01054300|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22423239|NCT05129475|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22423240|NCT01899742|GlaxoSmithKline|GSK Response Center|866-435-7343||
22423241|NCT00135798|University Colorado, Denver|Gregory T. Everson, M.D., Director of Hepatology|720-848-2245|greg.everson@UCDenver.edu|
22423242|NCT00738881|Roswell Park Cancer Institute|Alex A. Adjei, M.D., Ph.D|507/538-1760|alex.adjei@roswellpark.org|
22423243|NCT02662764|AcelRx Pharmaceuticals, Inc|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
22423244|NCT00387751|University of Texas Health Science Center at San Antonio|Dr. John Sarantopoulos|210-450-1000|sarantopoulo@uthscsa.edu|
22423245|NCT05028075|Center for Digital Health|Director of Research|2674280125|digitalhealth@uphs.upenn.edu|
22423246|NCT02035748|Alcon, a Novartis company|EMEA Medical Affairs Lead, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
22423247|NCT01740128|James J. Peters VAMC|Noam Y. Harel, MD, PhD|718-584-9000|noam.harel@va.gov|1742
22423248|NCT01041976|Edith Nourse Rogers Memorial VA|Lisa Mueller|781-687-3192|Lisa.Mueller@va.gov|
22423249|NCT02658734|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22423250|NCT01890226|Emory University|Dr. Benjamin Druss|404-712-9602|bdruss@emory.edu|
22423251|NCT04240457|ChicagoArbor Eye Care|David Lubeck, MD|708-798-6633|david.lubeck@chicagoarboreye.com|
22423252|NCT00976209|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22423253|NCT04756128|Methodist Hospital|Daniel Delaney, PharmD|952-993-5442|daniel.delaney@parknicollet.com|
22423254|NCT00844480|Northwestern University|Thomas Schnitzer|312-503-2315|tjs@northwestern.edu|
22423255|NCT02858180|Duke University|Andrew Muir, MD|919-684-2052|muir0002@duke.edu|
22423256|NCT00669552|Columbia University|Jose' Dizon, MD|212-305-8559|jmd11@columbia.edu|
22423257|NCT03488849|InnoVital Systems|Chief Medical Officer|2022862328|amit@innovitalsystems.com|
22423258|NCT01252563|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22423259|NCT01421186|MorphoSys AG|Dr Winrich Rauschning, Clinical Project Lead (external)|+4989 89927|winrich.rauschning@external.morphosys.com|0
22423260|NCT01866657|University Hospitals Cleveland Medical Center|Dr. Edwin Avery|440-391-0690|Edwin.avery@uhhospitals.org|
22423261|NCT00271011|University of Michigan Comprehensive Cancer Center|Dr. Mark Zalupski|734-615-3969|zalupski@umich.edu|
22423262|NCT03403751|Atox Bio, Ltd.|Wayne M Dankner, MD, Chief Medical Officer|1-919-219-6377|wayned@atoxbio.com|
22423263|NCT01623037|Zeltiq Aesthetics|Kerrie Jiang, Executive Director Regulaory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
22423264|NCT02071810|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22423265|NCT00520481|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22433683|NCT04560686|UT MD Anderson Cancer Center|Dr. Tina Cascone,MD- Assistant Professor, Thoracic-Head & Neck Med Onc|(713) 792-6363|tcascone@mdanderson.org|
22393671|NCT01147536|Agenus Inc.|Agenus, Inc. Clinical Trial Information|781-674-4265|clinicaltrialinfo@Agenusbio.com|
22433684|NCT02548910|Ottawa Hospital Research Institute|Dr. Guillaume Martel|6137378899|gumartel@toh.ca|71053
22433685|NCT00771927|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22433686|NCT01267864|Albert Einstein College of Medicine, Montefiore Medical Center|Benjamin Friedman, MD|718-920-6626|befriedm@montefiore.org|
22433687|NCT02467192|Hopitaux Universitaires de Geneve|Dr Jerome Stirnemann|+41223729101|jerome.stirnemann@hcuge.ch|
22433688|NCT03213938|Guang'anmen Hospital, China Academy Chinese Medical Sciences|Zhishun Liu|+86 010 88002331|liuzhishun@aliyun.com|
22433689|NCT01814046|National Cancer Institute|Dr. Steven Rosenberg|301-496-4164|steven-rosenberg@nih.gov|
22433690|NCT00429182|University of Texas MD Anderson Cancer Center|Naoto Ueno, MD / Professor||CR_Study_Registration@mdanderson.org|
22433691|NCT00434993|Acute Respiratory Distress Syndrome (ARDS) Network|David Schoenfeld, ARDSNet CCC PI|617-726-6111|dschoenfeld@partners.org|
22433692|NCT03335150|VASDHS|Dr. Dawn Schiehser|858-552-8585|Dawn.Schiehser@va.gov|2664
22433693|NCT02991898|Masonic Cancer Center, University of Minnesota|Claudio Brunstein|612-625-3918|bruns072@umn.edu|
22433694|NCT00778167|University of Colorado Denver|Dr. David R. Camidge|720-848-0449|ross.camidge@ucdenver.edu|
22433695|NCT02218697|GlaxoSmithKline|GSK Response Center|866-435-7343||
22433696|NCT02122666|Washington University School of Medicine|Samantha Adamson, MD, PhD|314-362-3500|sadamson@wustl.edu|
22433697|NCT02142803|Dana Farber Cancer Institute|Christine Sceppa McCluskey|617-632-5394|christine_sceppa@dfci.harvard.edu|
22433698|NCT02591472|University of Florida|MaryBeth Horodyski, EdD|352-273-7074|horodmb@ortho.ufl.edu|
22393672|NCT00383110|Ralph H. Johnson VAMC|Leonard Egede, MD, MS|843-789-6670|leonard.egede@va.gov|
22433699|NCT05111002|University of Washington|Lisa E Manhart|206-744-3646|lmanhart@uw.edu|
22433700|NCT04380753|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22433701|NCT04776720|University of California, San Francisco|Alison Huang, MD, MAS, MPhil|415-353-7900|alison.huang@ucsf.edu|
22433702|NCT02311881|GlaxoSmithKline|GSK Response Center|866-435-7343||
22433703|NCT03306433|University of Colorado, SoDM|Clifton Carey|3037241046|clifton.carey@cuanschutz.edu|
22433704|NCT00451958|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22433705|NCT02521974|FIDEC Corporationa|Ricardo Rüttimann|+17863546335|rruttimann@fidec-online.org|
22433706|NCT01042158|Johns Hopkins University|Paul Hassoun, MD|410-614-5158|phassoun@jhmi.edu|
22433707|NCT01575808|Toyko Jikei University Hospital|Dr. Takao Ohki|81-090-2478-8304|takohki@msn.com|
22433708|NCT02025634|AdventHealth|Brad Homan|407-303-4270|Brad.Homan.MD@AdventHealth.com|
22433709|NCT01527045|Fred Hutchinson Cancer Research Center|Dr. Marco Mielcarek|(206) 667-2827|mmielcar@fredhutch.org|
22433710|NCT03224403|JNJWorldwide|Andrew Myers, MD|(215) 273-8421 USA EST|AMyers3@its.jnj.com|
22433711|NCT00875485|GlaxoSmithKline|GSK Response Center|866-435-7343||
22433712|NCT01271010|Hoffmann-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22433713|NCT01631747|Northwestern University|Mary J. Kwasny|312-503-2294|m-kwasny@northwestern.edu|
22433714|NCT02908685|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22433715|NCT02954406|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22433716|NCT00782171|Institut Straumann AG - Clinical Research|Institut Straumann AG|+41 61 965 11 11|research@straumann.com|
22433717|NCT01691014|Pfizer ClinicalTrials.gov Call Center, Pfizer, Inc.|Pfizer Inc.|001 800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22433718|NCT05244603|Utah State University|Dr. Sarah Yoho Leopold|6145708258|sarah.leopold@usu.edu|
22433719|NCT05897242|Fred Hutchinson Cancer Center|Jaimee Heffner, Associate Professor|2066677314|jheffner@fredhutch.org|
22433720|NCT03522246|pharmaand GmbH|Medical Information Department|1-800-506-8501|medinfo@pharmaand.com|
22433721|NCT00814580|Ortho-McNeil Janssen Scientific Affair, LLC|Senior Director of Clinical Development, Pain|(908)927-5469|GVorsang@its.jnj.com|
22433722|NCT02482428|Novartis Pharmaceuticals|Study Director|862-778-8300||
22433723|NCT04309370|Indiana University|Clinical Research Manager|3178808495|iupdp@iupui.edu|
22433724|NCT00809835|Yale University School of Medicine|Kathleen M. Carroll, Ph.D., Albert E Kent Professor of Psychiatry|203.937.3486|kathleen.carroll@yale.edu|7403
22433725|NCT02547038|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
22433726|NCT00516893|Biogen Idec Inc.|Biogen Idec Medical Director||clinicaltrials@biogenidec.com|
22433727|NCT00284557|Emory University|Anne L. Dunlop, MD, MPH|404-712-8520|amlang@emory.edu|
22433728|NCT04812028|University of Minnesota|Gwenyth Fischer|612-625-9950|fisch662@umn.edu|
22433729|NCT05924165|Icahn School of Medicine at Mount Sinai|Dr. Mantu Gupta|(212) 241-1272|Mantu.Gupta@mountsinai.org|
22433730|NCT01681186|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22433731|NCT04308239|Virginia Tech|Michael Madigan|(540) 231-3543|mlm@vt.edu|
22433732|NCT03713398|University of North Carolina at Chapel Hill|Amy Wilson, PhD|919-962-3598|amyblank@email.unc.edu|
22433733|NCT05791565|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22433734|NCT00880269|Novartis Pharmaceuticals|Study Director|862-778-8300||
22433735|NCT00241176|NYU School of Medicine, NYU Child Study Center|Barbara J Coffey, M.D, M.S.|(212)263-3926|barbara.coffey@mssm.edu|
22433736|NCT02516982|Imperial College London|Dr Josip Car|+44(0)2075940799|josip.car@imperial.ac.uk|
22433737|NCT01129765|Advanced Pediatrics|Mary Margaret Thorne|703-938-5555|mthorne@pop.powweb.com|
22433738|NCT01475643|Valeant Pharmaceuticals NA|Denise Raimondo|9089721885|denise.raimondo@valeant.com|
22393673|NCT03136445|NHS Blood and Transplant|A/Prof Lise Estcourt|44 1865 387789|Lise.Estcourt@nhsbt.nhs.uk|
22433739|NCT03487588|Aclaris Therapeutics|Executive Director Clinical Operations|4843247933|jschnyder@aclaristx.com|
22433740|NCT03645421|AstraZeneca|Global Clinical Lead|+13028851180|ClinicalTrialTransparency@astrazeneca.com|
22433741|NCT03379259|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22433742|NCT03195660|ResMed|Adam Benjafield|+61 466 634 609|adam.benjafield@resmed.com|
22433743|NCT00375427|Novartis Pharmaceuticals|Study Director|862-778-8300||
22423266|NCT04586634|Coloplast|Director of Clinical Strategy|+4549111111|clinical-studies@coloplast.com|
22423267|NCT04442269|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22423268|NCT03802565|Neurana Pharmaceuticals, Inc.|Randall Kaye, MD - Chief Medical Officer|858-732-0708|rkaye@neuranapharma.com|
22423269|NCT03559868|Yale University, Yale School of Medicine|Mehal Wajahat MD, DPhil|877.925.3637|wajahat.mehal@yale.edu|
22423270|NCT01089933|OHRI|Dr Michelle Chiu|613-798-5555|mchiu@toh.ca|14169
22423271|NCT01004406|VA North Texas Health Care System, Dallas, TX and University of Texas Southwestern Medical Center|Dr. Subhash Banerjee|214-857-1608|Subhash.Banerjee@va.gov, Subhash.Banerjee@UTSouthwestern.edu|
22423272|NCT00929474|St. Jude Medical|Manager of Clinical Studies|818-493-2522|klee3@sjm.com|
22423273|NCT02907593|Oregon Health & Science University|Dr. Cindy McEvoy|5034945598|mcevoyc@ohsu.edu|
22423274|NCT01944670|Skeletal Dynamics, LLC|Ana Escagedo|305-596-7585|AEscagedo@SkeletalDynamics.com|
22423275|NCT05128773|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22423276|NCT04250714|Boston Scientific|Nele Cielen - Clinical Trial Manager|0032470991143|nele.cielen@bsci.com|
22423277|NCT04769466|LifeBio|Lisbeth Sanders|937-303-4574|beth@lifebio.com|
22423278|NCT02759055|HealthPartners Institute|Patrick J O'Connor|952-967-5034|Patrick.J.OConnor@HealthPartners.Com|
22423279|NCT00623597|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22423280|NCT01849068|Laval University|Dr. Patrick Couture MD, PhD, FRCP|418-654-2106|patrick.couture@crchul.ulaval.ca|
22423281|NCT02210286|Stanford University|Alison Myoraku|6507244559|myoraku@stanford.edu|
22423282|NCT04045132|The Children's Hospital of Philadelphia|Dr. James Guevara|2155901130|guevara@chop.edu|
22423283|NCT00552032|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22423284|NCT03391232|Treos Bio|Chef Scientific Officer|+3615500826|eniko.toke@treosbio.com|
22423285|NCT00345878|GlaxoSmithKline|GSK Response Center|866-435-7343||
22423286|NCT02045732|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22423287|NCT04178824|Icahn School of Medicine at Mount Sinai|Allan Geliebter PhD|212-523-4574|Allan.Geliebter@mountsinai.org|
22423288|NCT04777201|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22423289|NCT02355821|RGNKC|Ekaterina Dudinskaya, head of age-related metabolic and endocrine disorders laboratory|+79031914690|katharina.gin@gmail.com|
22423290|NCT06017752|Boise State University|Dr. Aida Midgett|2084261219|aidamidgett@boisestate.edu|
22423291|NCT00880230|Medtronic Aortic and Peripheral Vascular|Arslan Malik - Senior Clinical Research Manager|(707) 541-3256|arslan.malik@medtronic.com|
22423292|NCT00177307|University of Pittsburgh|Nathan Bahary, MD|412-864-7764|baharyn@upmc.edu|
22423293|NCT02416193|Loyola University Chicago|Mary Byrn, R.N., Ph.D.|(773) 508-8973|mbyrn@luc.edu|
22423294|NCT01282164|Cleveland Clinic|Dr. Amir H. Hamrahian|216-445-8555|hamraha@ccf.org|
22423295|NCT04521621|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22423296|NCT03671564|Daiichi Sankyo, Inc.|Clinical Director|908-992-6400|CTRinfo@dsi.com|
22423297|NCT01663779|Yale School of Medicine|Kevin M. Schuster|203-785-2572|kevin.schuster@yale.edu|
22423298|NCT02609100|Washington University School of Medicine in St. Louis|Dr. Vladimir M. Kushnir|314-362-3685|vkushnir@wustl.edu|
22423299|NCT05845567|Italfarmaco SpA|Maurizio Caserini, MD|+ 39 02 64431|m.caserini@italfarmacogroup.com|
22423300|NCT02946073|Braeburn|Susan Franks, SVP, Head of Regulatory Affaires|6104678719|sfranks@braeburnrx.com|
22423301|NCT01104246|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|801-588-6641|gary.hoel@watson.com|
22423302|NCT05803096|Beth Israel Medical Center|Dr. Heidi Rayala|16176673739|hrayala@bidmc.harvard.edu|
22423303|NCT05178641|Procter & Gamble Co.|Dr. Susanna Brink, Clinical Scientist|+49 6196 89 4474|brink.s@pg.com|
22423304|NCT01869699|University of California, San Francisco|Dr. Hildy Schell-Chaple|415-353-1039|hildegarde.schell-chaple@ucsf.edu|
22423305|NCT01783639|Gardia Medical|Dr. Vardit Segal|+972-4-6277166|Vardit@Gardiamedical.com|106
22423306|NCT01083186|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22423307|NCT00343785|Fred Hutchinson Cancer Research Center|Dr. Rainer Storb, Director Transplantation Biology|2066676839|rstrob@fredhutch.org|
22423308|NCT03783130|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Martin Gaudinski, MD|301-451-8715|martin.gaudinski@nih.gov|
22423309|NCT01867294|Mayo Clinic|Aminah Jatoi, M.D.|507.284.1623|jatoi.aminah@mayo.edu|
22423310|NCT00978250|National Cancer Institute|Dr. James Doroshow|240-781-3320|jim_doroshow@nih.gov|
22423311|NCT05174949|University of Oklahoma Health Sciences Center|Dr. Yuan Yang (Principal Investigator) C/o Dr. Shirley James (Project Biostatistician)|4052712131|shirley-james@ouhsc.edu|46812
22423312|NCT02029989|UMN, College of Pharmacy|Dr. Mark E. Schneiderhan|8452540458|meschnei@d.umn.edu|
22423313|NCT04351373|Mayo Clinic|Dr. Matthew Carlson|507-284-8532|Carlson.Matthew@mayo.edu|
22423314|NCT04537910|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22423315|NCT00896181|Stanford University|Dr. A. Dimitrios Colevas, Professor of Medicine (Oncology)|650-724-9707|colevas@stanford.edu|
22423316|NCT01123941|Novartis Vaccines Institute for Global Health|Dr. Audino Podda, MD|+39 0577 243496|audino.podda@novartis.com|
22433744|NCT00924612|Clarus Therapeutics, Inc.|Robert E. Dudley, PhD, CEO and President|847-562-4300|rdudley@clarustherapeutics.com|
22433745|NCT00924001|National Cancer Institute, National Institutes of Health|Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
22433746|NCT03249909|Mölnlycke Health Care|Andrea Marie Picchietti|260 2583879|andrea.picchietti@molnlycke.com|
22433747|NCT03517371|Center for Neurorehabilitation, College of Health & Rehabilitation, Sargent College, Boston University|Terry Ellis|617-353-2724|tellis@bu.edu|
22433748|NCT05411822|Icahn School of Medicine at Mount Sinai|Mariana Figueiro, PhD|(518) 366-9306|Mariana.Figueiro@mountsinai.org|
22433749|NCT01345929|Cubist Pharmaceuticals, Inc.|Dr. Obi Umeh, Vice President Global Medical Sciences|781-860-8415|obiamiwe.umeh@cubist.com|
22433750|NCT02819297|Braintree Laboratories, Inc.|VP, Clinical Affairs|781-843-2202|john.mcgowan@sebelapharma.com|
22433751|NCT01670279|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22433752|NCT02318368|AVEO Pharmaceuticals, Inc.|Chief Medical Officer|(857) 400-0101|Clinical@aveooncology.com|
22433753|NCT01901614|Oregon Health & Science University|David Huang, MD, PhD|503-494-3000|huangd@ohsu.edu|
22433754|NCT03629223|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22433755|NCT02702609|Sunstar Americas, Inc.|Akane Takemura|8477944276|akane.takemura@us.sunstar.com|
22433756|NCT02674464|Johns Hopkins University School of Medicine|Dr. Lisa Cooper, Principal Investigator|4106143659|lisa.cooper@jhmi.edu|
22433757|NCT04153981|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22433758|NCT01555073|Northwestern University, Feinberg School of Medicine|Antoun Nader, MD|312-695-3045|a-nader2@northwestern.edu|
22433759|NCT01262638|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
22433760|NCT01071252|Novartis Pharmaceuticals|Study Director|862-778-8300||
22433761|NCT01066104|MGH|Dr. Ellen Dutta|6177248256|edutta@mgh.harvard.edu|
22433762|NCT01781806|UCLA CARE Center|Dr. Raphael J. Landovitz|(310) 825-6689|rlandovitz@mednet.ucla.edu|
22433763|NCT03902392|University of Bari|Thea TM Magrone, BD|+39 080 5478584|thea.magrone@uniba.it|
22433764|NCT00260832|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_medinfo@eisai.com|
22433765|NCT01104545|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22433766|NCT01576939|Stanford University|Quynh Le|650-725-0203|qle@stanford.edu|
22433767|NCT00564902|James A. Lovell Federal Health Care Center|Dr. Stuart P. Richer|224-610-5440|Stuart.Richer1@va.gov|
22433768|NCT00958347|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|ellen.axelson@stryker.com|
22433769|NCT02723916|The Ohio State University, College of Nursing|Dr. Susie Breitenstein|6146884614|breitenstein.5@osu.edu|
22433770|NCT04552288|Memorial Sloan Kettering Cancer Center|Dr. Alina Markova, MD|646-608-2342|markovaa@mskcc.org|
22433771|NCT04532294|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22433772|NCT03089047|Duke University|Ian Welsby, M.D.|919-681-6752|ian.welsby@duke.edu|
22433773|NCT00375505|Novartis|Study Director|862-778-8300||
22433774|NCT02146131|Medical University of South Carolina|Kate Taylor|843-792-2297|Talykat@musc.edu|
22433775|NCT02097719|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22433776|NCT02285023|Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University|Prof. Kanokvalai Kulthanan|(662)419-4333|kanokvalai.kul@mahidol.ac.th|
22433777|NCT00809926|Novartis Pharmaceuticals|Study Director|862-778-8300||
22433778|NCT00295009|DePuy Synthes|Erin Prifogle|508-977-6451|eprifog1@its.jnj.com|
22433779|NCT01108731|Beth_IsraelMC|Dr Benjamin Natelson|212-844-6747|bnatelson@chpnet.org|
22433780|NCT03321071|University of South Carolina|R. Glenn Weaver|803-777-5606|weaverrg@email.edu|
22433781|NCT02227810|Chang Gung memorial hospital|Dr Huang Chung-Chi|88632118800|yhchen@mail.cgu.edu.tw|5233
22433782|NCT01451749|Dongzhimen Hospital,Beijing University of Chinese Medicine|Dr.Jinzhou Tian|86-10-84013380|jztian@hotmail.com|
22433783|NCT01063062|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22433784|NCT02175277|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22442161|NCT03110770|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
22442162|NCT00260962|Ottawa Hospital Research Institute|Dr. Hany Bissada|613-798-5555|hbissada@ottawahospital.on.ca|78042
22442163|NCT01086358|Cleveland Clinic Foundation|Jennifer Kriegler, MD|216-444-8265|krieglj@ccf.org|
22442164|NCT01179113|Cedars Sinai Medical Center|Dr. Roya Yumu', Anesthesiology Program Director|310-423-1682|Roya.Yumul@cshs.org|
22442165|NCT01996839|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22442166|NCT03206788|Kansas University Medical Center|Dr. Matthias Salathe|913 588 6045|msalathe@kumc.edu|
22442167|NCT02082340|American University of Armenia|Dr. Harutyunyan||aharutyunyan@aua.am|
22442168|NCT00833417|Genentech, Inc.|Medical Communications|800-821-8590||
22442169|NCT01625260|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22442170|NCT05573386|Andrews Research & Education Foundation|Director of Research|8509168570|jessica.truett@andrewsref.org|
22442171|NCT03899805|Dana Farber Cancer Institute|Suzanne George MD, PI|6176326826|suzanne_george@dfci.harvard.edu|
22442172|NCT05246514|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22442173|NCT04195893|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
22442174|NCT01802073|Stanford University|Dr. Kenneth Cox|(650) 723-5070|KCox@stanfordchildrens.org|
22442175|NCT05037578|University of Kansas Alzheimer's Disease Research Center|Jaime Perales Puchalt|913-588-3716|jperales@kumc.edu|
22442176|NCT01805791|Hutchison MediPharma Ltd|Dr. Rongjun Liu|+86 21 2067 3203|rongjunl@hmplglobal.com|
22442177|NCT01327482|Massachusetts General Hospital|Dr. Caroline Mitchell|617-724-2182|caroline.mitchell@mgh.harvard.edu|
22442178|NCT01018810|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22442179|NCT03672097|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22442180|NCT00080899|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|: 60094
22442181|NCT02872935|University of Iowa|Dr. Kokila Thenuwara|319-384-5876|kokila-thenuwara@uiowa.edu|
22442182|NCT03530124|Duke University|Dr. Rachel Greenberg|919 668 4725|rachel.greenberg@duke.edu|
22442183|NCT05343624|University Hospitals Cleveland Medical Center|Dr. Tanureet Arora|(440)892-6424|Tanureet.Arora@UHhospitals.org|
22442184|NCT00530816|Onyx Pharmaceuticals, Inc.|Onyx Medical Information|1-877-ONYX-121|medinfo@onyx.com|
22442185|NCT02445794|Retrotope, Inc|Frederic Heerinckx/VP Clinical Operations|650-437-0700|frederic@retrotope.com|109
22442186|NCT01388985|Institute of Tropical Medicine Antwerp|Dr. Patrick Soentjens|+32 3 247 66 41|psoentjens@itg.be|
22442187|NCT01057589|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22442188|NCT03761368|Medical University of Łódź|Karolina Stokfisz|+48422014260|stokfisz.karolina@gmail.com|
22442189|NCT01519167|Hospira|Marcelo Garcia de Rocha MD, Global Medical Director|224-212-4424|marcelo.rocha@hospira.com|
22442190|NCT00556504|TCM Biotech International|Dr. Ya-Chun Wang, EVP/CSO|886-2-26581677|yachunwang@tcmbio.com|733
22442191|NCT00580671|Geisel School of Medicine at Dartmouth|Alan J. Budney, PhD|855-290-2822|alan.j.budney@dartmouth.edu|
22442192|NCT00870584|Novartis Pharmaceuticals|Study Director|862-778-8300||
22442193|NCT02560025|Massachusetts General Hospital|Amir Fathi, MD|617-724-1124|AFATHI@mgh.harvard.edu|
22433785|NCT00335283|Vanderbilt University Medical Center|Manager, Clinical Trials|615-322-4643|tina.higginbotham@vanderbilt.edu|
22393674|NCT03647488|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22393675|NCT00153062|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22433786|NCT03818607|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22433787|NCT03560102|Kantonsspital Winterthur|Christoph A Binkert (Sponsor-Investigator)|+41 52 266 2602|christoph.binkert@ksw.ch|
22433788|NCT01231334|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22433789|NCT01147250|Sanofi|Trail Transparency Team||Contact-US@sanofi.com|
22433790|NCT03588806|University of Pittsburgh|Dr. Ajay D. Wasan|4126658030|wasanad@upmc.edu|
22433791|NCT02249091|GSO mbH|Dr Anne L. Kranich|+494044195460|kranich@gsoglobal.com|
22433792|NCT02342691|Forsyth|Hatice Hasturk|617-892-8499|hhasturk@forsyth.org|
22433793|NCT00716482|SuperSonic Imagine|Research Coordinator|+33 442 99 24 24|sharon.bruce@supersonicimagine.fr|
22433794|NCT00765037|DJO Surgical|Jane M. Jacob - Manager of Clinical Affairs|512-834-6323|jane.jacob@djosurgical.com|
22433795|NCT03177512|Bridge HIV, San Francisco Department of Public Health|Albert Liu|628-217-7408|albert.liu@sfdph.org|
22433796|NCT02125838|DorkuzEU|Sule Ozbilgin|902324122836|ozbilginsule@gmail.com|
22433797|NCT04855240|Acadia Pharmaceuticals Inc.|Study Director|844-422-2342|medicalinformation@acadia-pharm.com|
22433798|NCT02812238|NHLBI|Dr. Michael N. Sack|301-402-9259|sackm@nih.gov|
22433799|NCT01994746|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22433800|NCT00244725|GlaxoSmithKline|GSK Response Center|866-435-7343||
22433801|NCT02688270|Covis Pharma|Clinical Trial Interest|18773744177|CTInterest@covispharma.com|
22433802|NCT04004221|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22433803|NCT03423238|Wake Forest School of Medicine|Tina Brinkley|336-713-8534|tbrinkle@wakehealth.edu|
22433804|NCT02688829|Microport Medical, Shanghai, China|Dr Zhang Haotian|8621-38954600|zhanght@microport.com|8552
22433805|NCT00506454|Sepsicure L.L.C.|Vice President|212-606-4352|bianuale@metromediacompany.com|
22433806|NCT03745638|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22433807|NCT00976716|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22433808|NCT01356498|Savient Pharmaceuticals, Inc.|Chief Medical Officer|732-418-9300||
22433809|NCT00602225|University of Washington|Pamela Becker, MD, PhD|206-288-7273|pbecker@uw.edu|
22433810|NCT02993822|NeRRe Therapeutics Limited|Dr. Stephen Pawsey|+44 (0)1438906960|steve.pawsey@nerretherapeutics.com|
22433811|NCT01271907|National Cancer Institute, National Institutes of Health|James Yang, M.D.|301-496-1574|jamesyang@mail.nih.gov|
22423317|NCT05036668|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22423318|NCT01537068|NYSPI|David Hellerstein MD|646-774-8000|desdesk@nyspi.columbia.edu|
22423319|NCT06011161|VISN 2 Center of Excellence for Suicide Prevention|Dev Crasta|585-364-8119|Dev.Crasta@va.gov|
22423320|NCT02291601|Bioscience Labs|C Beausoleil|460-782-5498|cbeausoleil@biosciencelabs.com|
22423321|NCT05870956|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22423322|NCT03724877|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22423323|NCT04017832|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22423324|NCT01565369|Avid Radiopharmaceuticals|Chief Medical Officer|215-798-0700|clinicaloperations@avidrp.com|
22423325|NCT02468154|Istituto Ortopedico Rizzoli|Luisa Veronesi|0516366694|cristiana.forni@ior.it|0039
22423326|NCT01744184|University Hospitals Dorset NHS Foundation Trust|Dr Simon McLaughlin|01202303626|Simon.McLaughlin@uhd.nhs.uk|
22423327|NCT00072280|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22423328|NCT02091986|AstraZeneca|Global Clinical Lead Göran Eckerwall||ClinicalTrialTransparency@astrazeneca.com|
22423329|NCT02841280|Indiana University|Dr. Rajiv Agarwal|3179882241|ragarwal@iu.edu|
22423330|NCT00125242|VA Salt Lake City Health Care System|Dr. Julie Wambaugh|801-582-1565|julie.wambaugh@health.utah.edu|1363
22423331|NCT01664949|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22423332|NCT04654754|Rush University|Dr. Jie Li|3125634643|jie_li@rush.edu|
22423333|NCT04616573|Sight Sciences, Inc.|Kavita Dhamdhere, MD, PhD|877-266-1144|kdhamdhere@sightsciences.com|
22423334|NCT03641326|National Cancer Institute|Dr. Mark Gilbert|240-760-6023|mark.gilbert@nih.gov|
22423335|NCT02727777|UT MD Anderson Cancer Center|Dr. Jason R. Westin/Lymphoma/Myeloma|713-792-3750|jwestin@mdanderson.org|
22423336|NCT03003494|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22423337|NCT00957268|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22423338|NCT05152966|FARAPULSE|Christopher (Kit) Schneider|6176867661|christopher.schneider@bsci.com|
22423339|NCT01738503|Indivior, Inc.|Global Director, Clinical Development|804-379-1090||
22423340|NCT03005327|X4 Pharmaceuticals|Chief Medical Officer|(857) 529-8300|patientinfo@x4pharma.com|
22423341|NCT01340027|Astellas Pharma Europe, B.V.|Medical Director||Astellas.resultsdisclosure@astellas.com|
22423342|NCT00833482|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22423343|NCT00915876|University of Michigan|Amy Pai|7346470005|amypai@med.umich.edu|
22423344|NCT01490073|University of Washington|Elizabeth Micks|206-616-4939|emicks@uw.edu|
22423345|NCT02782065|Boston Children's Hospital|Leah Abecassis|6173552299|leah.abecassis@childrens.harvard.edu|
22423346|NCT01662791|Mayo Clinic|Dr. John K. DiBaise|480-301-6990|DiBaise.John@mayo.edu|
22433812|NCT01221753|Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA02215|Robert Haddad, MD|617-632-3090|robert_haddad@dfci.harvard.edu|
22433813|NCT00617058|The University of North Carolina at Chapel Hill|Linmarie Sikich, M.D.|(919) 972-7499|lsikich@med.unc.edu|
22423347|NCT02496091|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
22423348|NCT02272842|Innlandet Hospital Trust|Tor Strand|+4790971086|tors@me.com|
22423349|NCT03518619|Butler Hospital|Ana M. Abrantes, Ph.D.|401-455-6440|Ana_Abrantes@Brown.edu|
22423350|NCT01794793|RECORDATIGROUP|Mario Maldonado, MD / Head of Clinical Development Global Endocrinology|+41798030344|maldonado.m@recordati.com|
22423351|NCT02234596|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian,|646-888-4186|janjigiy@mskcc.org|
22423352|NCT04852679|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22423353|NCT01632904|Incyte Corporation|Study Director|855 463-3463||
22423354|NCT03050541|University of Chicago|Office of Clinical Research|(773) 834-1238|tkyeo@bsd.uchicago.edu|
22423355|NCT01752634|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22423356|NCT06474078|Chang Gung Memorial Hospital|Dr. Chun Bing Chen|03-3281200|chunbing.chen@gmail.com|8494
22423357|NCT00962949|Vanderbilt University Medical Center|Hossam Mustafa|615-343-6499|adcresearch@vanderbilt.edu|
22423358|NCT05409131|Insulet Corporation|Dr. Trang Ly|9786007628|tly@insulet.com|
22423359|NCT04644185|Sinocelltech Ltd.|Dr.|13522038372|yuanxin_chen@sinocelltech.com|
22423360|NCT04697056|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
22423361|NCT04542499|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22423362|NCT02142361|Optometry Research Group (GIO)|Robert Montés-Mico O.D., MPhil, PhD Optometry|34-9635-44764|robert.montes@uv.es|
22423363|NCT05906836|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22423364|NCT04281784|University of Washington|Janaki Torrence, Research Coordinator|206-402-7357|jtorrenc@uw.edu|
22423365|NCT04035434|CRISPR Therapeutics AG|Annie Weaver, PhD: Study Director|+1 617-315-4600|info@crisprtx.com|
22423366|NCT04488497|Weill Cornell Medicine|Dr. Iris Navarro Millan|646-962-7875|vam4007@med.cornell.edu|
22423367|NCT04322539|HUTCHMED International|William Schelman, MD, PhD|+1-973-306-4490|williams@hutch-med.com|
22423368|NCT02111746|The University of Texas Health Science Center at Houston|Dr. Kristofer M Charlton-Ouw|(713) 486-5100|Kristofer.CharltonOuw@uth.tmc.edu|
22423369|NCT04161079|Medtentia International Ltd Oy|Olli Keränen / Chief Executive Officer|+358 50 3567090|ok@medtentia.com|
22423370|NCT01702532|GlaxoSmithKline|GSK Response Center|866-435-7343||
22423371|NCT03617861|Mayo Clinic|Michael Camilleri, MD|507-266-2305|camilleri.michael@mayo.edu|
22423372|NCT01451164|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials||CL_OPCJ_RDA_Team@otsuka.jp|
22423373|NCT00326781|University of Pennsylvania|Caryn Lerman, Ph.D.|215-746-7141|clerman@mail.med.upenn.edu|
22423374|NCT00308750|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22423375|NCT01358578|Novartis|Study Director|862-778-8300||
22423376|NCT01643798|Medical University of South Carolina|Joseph Taylor|8437295729|taylorjj@musc.edu|
22423377|NCT03605849|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22423378|NCT02659514|Spectrum Pharmaceuticals, Inc, Research and Development Office 157 Technology Drive Irvine, CA 92618|Shanta Chawla|9497886700|shanta.chawla@sppirx.com|
22423379|NCT03409107|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22423380|NCT01588457|UT Health San Antonio|Charles Bowden, MD|2105675393|bowdenc@uthscsa.edu|
22423381|NCT01013844|Northwestern University Department of Dermatology|June Robinson, MD|312-695-6624|june-robinson@northwestern.edu|
22423382|NCT02062944|Northwestern University|Josh Levitsky|312 695 4413|josh.levitsky@nm.org|
22423383|NCT01482962|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22423384|NCT00278148|Case Comprehensive Cancer Center|Dr. Nathan Pennell|21684459281|penneln@ccf.org|
22423385|NCT02407457|Endologix, Inc.|Sharone Trifskin|949-599-8860|strifskin@endologix.com|
22423386|NCT00258349|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
22423387|NCT01088243|National Jewish Health|Dr. Lisa A. Maier|303-398-1983|MaierL@NJHealth.org|
22423388|NCT01152359|VA Medical Center|William S. Yancy, Jr.|919-286-0411|william.yancy2@va.gov|7770
22423389|NCT02174913|Mahidol University|Department of Anesthesiology, Siriraj Hospital|66-2-41979889|manee95@hotmail.com|501
22423390|NCT02262000|West Virginia Universtiy, WVCTSI|Clinical Trials Compliance Coordinator|304-293-0216|ctgovadmin@hsc.wvu.edu|
22423391|NCT01007136|University of Texas Southwestern|Timea Hodics, M.D.||Timea.Hodics@UTSouthwestern.edu|
22423392|NCT01230424|Tufts Medical Center|Dr. Timothy McAlindon|6176365610|tmcalindon@tuftsmedicalcenter.org|
22423393|NCT01128218|SIU Medicine|Barbara Lokaitis, BA, CCRP / Senior Clinical Research Coordinator|217.545.9737|blokaitis@siumed.edu|
22423394|NCT05007041|Duke University|Dr. Kenneth Schmader|919-660-7572|kenneth.schmader@duke.edu|
22423395|NCT04495816|Icahn School of Medicine at Mount Sinai|Dr. David Lerner|212-241-9410|david.lerner2@mountsinai.org|
22423396|NCT02901275|Johns Hopkins University School of Medicine|Dr. Kelly Dunn|410-550-2254|kdunn9@jhmi.edu|
22423397|NCT01459718|Novartis Pharmaceuticals|Study Director|862-778-1873||
22423398|NCT01258075|Daiichi Sankyo|Contact of Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22423399|NCT04360174|Ocular Therapeutix|Chief Medical Officer|7813574000|clinicalaffairs@ocutx.com|
22423400|NCT03826628|AFT Pharmaceuticals Ltd.|Ioana Stanescu|+64 9 488 0232|ioana.stanescu@aftpharm.com|712
22423401|NCT01330394|Federal University of Espírito Santo|Dr. Ester Miyuki Nakamura-Palacios|+55 27 7775-7337|emnpalacios@gmail.com|
22423402|NCT02951533|Janssen-Cilag GmbH|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22423403|NCT01597375|Brigham and Women's Hospital|Tanya Laidlaw|617-525-1034|tlaidlaw@bwh.harvard.edu|
22423404|NCT02375555|Dana Farber Cancer Institute|Ajantha Nithi|857-215-2829|ajantha_nithi@dfci.harvard.edu|
22423405|NCT02046395|Tulane University|Vechi Batuman|(504)988-5346|vbatuma@tulane.edu|
22433814|NCT01939977|Hospital Universitari de Bellvitge|Dr. Josep M. Cruzado|0034932607602|jmcruzado@bellvitgehospital.cat|
22433815|NCT02959853|Baylor College of Medicine|Rui Chen|812-239-1855|rui.chen2@bcm.edu|
22433816|NCT03641716|University of Pittsburgh|Dr. Angela Caldwell|412-383-7231|arl78@pitt.edu|
22433817|NCT01603043|Alcon Research, Ltd.|Yamini Patel, PhD, Clinical Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22433818|NCT01917929|Stryker Orthopaedics|Kevin Barga, Senior Manager, Clinical Affairs|201-831-5000|kevin.barga@stryker.com|
22433819|NCT01696981|Early Detection Research Group, NCI, NIH|Paul F. Pinsky, Ph.D.|301-496-8544|pinskyp@mail.nih.gov|
22433820|NCT03599518|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22433821|NCT01962428|General Hospital of Chinese People's Armed Police Forces|huiliang Liu|+8601057976707|lhl518@vip.sina.com|
22433822|NCT02798315|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22433823|NCT00005947|Dendreon Corporation|Kathleen Picha|206-274-6762|kpicha@dendreon.com|
22433824|NCT00465972|Duke University School of Medicine|Andrew Krystal, MD, MS, Professor of Psychiatry and Behavioral Sciences|919-681-8742|andrew.krystal@duke.edu|
22433825|NCT02530476|The University of Texas MD Anderson Cancer Center|Naval Daver, MD/Associate Professor|713-794-4392|NDaver@mdanderson.org|
22433826|NCT05356910|University of California, San Diego|Heather Pines|619-594-2481|hpines@health.ucsd.edu|
22433827|NCT02712996|Vanderbilt University Medical Center|Michael Tramontana,PhD|615-327-7144|michael.tramontana@vumc.org|
22433828|NCT00972517|GlaxoSmithKline|GSK Response Center|866-435-7343||
22433829|NCT00819156|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22433830|NCT00984594|RTI Biologics|Director, Clinical Projects|386-418-8888|rwaite@rtix.com|4172
22433831|NCT00851890|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22433832|NCT03135431|Mayo Clinic|Vanessa Torbenson, M.D.|507-266-9873|Torbenson.Vanessa@mayo.edu|
22433833|NCT00943098|IBSA Institut Biochimique|Barbara Gugliotta, Clincial Research Manager|+41 58 360 10 00|barbara.gugliotta@ibsa.ch|
22433834|NCT00281099|Medtronic, Inc.|MVP Clinical Trial Leader||medtroniccrmtrials@medtronic.com|
22433835|NCT00104728|H. Lee Moffitt Cancer Center and Research Institute|Dr. Eric Haura|813-745-6826|eric.haura@moffitt.org|
22433836|NCT03206918|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22433837|NCT02701764|University of Miami|Dr. Anat Galor|305-450-6050|agalor@med.miami.edu|
22433838|NCT00475085|University of Rochester|Dr. Charles Heckler|585 273-1141|checkler@urmc.rochester.edu|
22433839|NCT01059357|Wake Forest University Health Sciences|Dr. Joshua Waltonen|3367169068|jwaltone@wakehealth.edu|
22433840|NCT06899737|KDH Research & Communication|Kristen D. Holtz, PhD|4043958711|kholtz@kdhrc.com|
22433841|NCT01082081|GlaxoSmithKline|GSK Response Center|866-435-7343||
22433842|NCT01170273|Miami VA Medical Center|Silvina Levis MD|305-575-3388|silvina.levis-dusseau@va.gov|
22433843|NCT03159468|Arizona State University|Kelly Cue Davis|602-496-3217|Kelly.Cue.Davis@asu.edu|
22433844|NCT00375674|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1800718|ClinicalTrials.gov_Inquiries@pfizer.com|1021
22433845|NCT00912782|Emory University|Monnie Wasse MD/MPH / Associate Professor of Medicine|404-727-1598|hwasse@emory.edu|
22433846|NCT05280158|University of California, Los Angeles|Yusaku Michael Shino, MD|(310) 866-6327|MShino@mednet.ucla.edu|
22433847|NCT01375127|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22433848|NCT00301262|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22423406|NCT00606554|Boston University School of Medicine|Allan Walkey, MD, MSc|617-638-4860|alwalkey@bu.edu|
22423407|NCT02663102|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22433849|NCT03530995|Kadmon Corporation|Olivier Schueller, Senior Vice President, CMC & Clinical Pharmacology|833-900-5366|olivier.schueller@kadmon.com|
22433850|NCT01668628|The Catholic University of Korea|Dr. Hye Eun Yoon|82-32-280-5886|berrynana@catholic.ac.kr|
22433851|NCT01716039|Alimentiv (Formerly Robarts Clinical Trails)|Dr.Jenny Jeyarajah (Sr. Biostatistician)||jenny.jeyarajah@alimentiv.com|
22423408|NCT01984892|Icahn School of Medicine at Mount Sinai|Dr. Nina Bhardwaj|212-824-8427|nina.bhardwaj@mssm.edu|
22433852|NCT01842035|University of Alabama at Birmingham|Fadi Hage|2059757123|fadihage@uab.edu|
22433853|NCT01443364|UCB|UCB Clinical Trial Call Center|+1877 822||9493
22433854|NCT02650804|BPGbio Inc|Head of Clinical Operations|6175880083|clinicaltrials.connect@berghealth.com|
22433855|NCT02643615|The Ohio State University Wexner Medical Center|Dr. Sergio Bergese|6142933559|sergio.bergese@osumc.edu|
22433856|NCT00801723|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22433857|NCT01986231|Legacy Health System|Kenneth Ward|971-570-2632|kenward503@msn.com|
22433858|NCT02150057|Andrews Institute for Orthopaedics & Sports Medicine|Dr. Roger Ostrander|850-916-3700|rostrander@flboneandjoint.com|3725
22433859|NCT02388165|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22433860|NCT03230890|Atrium Health Wake Forest Baptist|Charles H. Tegeler, MD|336-716-9447|BBRP@wakehealth.edu|
22433861|NCT02926027|Lundquist Institute|Matthew Budoff|3102224107|mbudoff@lundquist.org|
22433862|NCT04551963|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22433863|NCT02974855|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22433864|NCT01474772|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22433865|NCT00633074|GlaxoSmithKline|GSK Response Center|866-435-7343||
22433866|NCT00365105|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
22433867|NCT00748618|University of Nebraska Medical Center|Fang Yu|(402) 559-9436|fangyu@unmc.edu|
22433868|NCT06004895|Aston University|Professor James S Wolffsohn|07833049245|j.s.w.wolffsohn@aston.ac.uk|
22433869|NCT00466947|GlaxoSmithKline|GSK Response Center|866-435-7343||
22433870|NCT00878254|University of Miami|Izidore Lossos MD|+1 (305) 2434785|ilossos@med.miami.edu|
22433871|NCT01995526|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22433872|NCT01132846|Duke University|Kevin Anstrom|919-668-8902|kevin.anstrom@dm.duke.edu|
22433873|NCT05445921|Washington University School of Medicine, Dept. of Otolaryngology - Head and Neck Surgery|Dr. Andrew Peterson, Resident Physician|314-362-5626|pandrew@wustl.edu|
22433874|NCT03367403|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22433875|NCT04928885|The University of Illinois at Chicago|Dr. Julie Bobitt, PhD|312.355.0247|jbobitt@uic.edu|
22433876|NCT02363972|Avenu Medical|Gene Reu EVP and General Manager|9492762483|greu@avenumedical.com|
22433877|NCT01295840|Hospital Universitario Virgen de la Victoria|Dr Javier Alzueta|+34 952 64 15 50|jalzueta@telefonica.net|
22433878|NCT02321319|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
22433879|NCT01334216|Indiana University School of Medicine|Stephen M. Downs, MD, MS|3172780552|stmdowns@iu.edu|317
22433880|NCT03497975|Trevi Therapeutics, Inc.|Chief Development Officer|203-304-2499|info@trevitherapeutics.com|
22433881|NCT02141399|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
22433882|NCT03806556|University of Pittsburgh Medical Center|Meghan McCormick, MD MS|412-692-6938|meghan.mccormick3@chp.edu|
22433883|NCT00606034|Mountain Diabetes and Endocrine Center|Dr. Wendy Lane, Director of Clinical Research|828-258-2404|mountaindiabetes@msn.com|314
22433884|NCT01734395|Jan-Cil Korea|Clinical Research Director|82 2 2094||4518
22433885|NCT01250184|university of Antioquia, Research Group Rehabilitation in Health|Dr. Luz Helena Lugo, Head of Research Group Rehabilitation in Health|+57 4 2196475|luzh.lugo@gmail.com|
22433886|NCT01407952|Mayo Clinic|Bernard Bendok, MD|3129269441|bendok.bernard@mayo.edu|
22433887|NCT00935493|Yale University|Christopher van Dyck|203-764-8100|christopher.vandyck@yale.edu|
22433888|NCT03115827|Vanderbilt University Medical Center|Dr. Katherine McDonell|615-875-7987|katherine.mcdonell@vumc.org|
22433889|NCT01355679|NMTRC at Spectrum Health|Giselle Sholler, MD|616-267-0334|giselle.sholler@helendevoschildrens.org|
22433890|NCT02027311|Digestive Disease Center and Department of Internal Medicine, Cheju Halla General Hospital|Dr. Byung Hyo Cha, Director of ETOMI-1 study|+82-64-740-8050|drhyo@hotmail.com|
22433891|NCT00142168|DFCI|Steven P. Treon MD PhD|617 632 2681|steven_treon@dfci.harvard.edu|
22433892|NCT00964002|Department of Medical Oncology, Institut bergonié|Pr Nadine Houede, oncologist||nadine.HOUEDE@chu-nimes.fr|
22433893|NCT02593903|Medical College of Wisconsin|Clinical Research Coordinator|414-337-3441|ebedjeti@mcw.edu|
22433894|NCT03768089|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22433895|NCT01825512|Consorzio per Valutazioni Biologiche e Farmacologiche|Donato Bonifazi|+393936698076|ceo@cvbf.net|
22433896|NCT02091362|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22433897|NCT02565147|The Medicines Company|Global Health Science Center|1.888.977.6326|medical.information@themedco.com|
22433898|NCT00787839|Atlanta VA Medical Center|Lawrence S Phillips, MD|404-728-7608|lawrence.phillips@va.gov|
22433899|NCT03087604|Wake Forest University Health Sciences|Dr. Sean Dobson|3367168834|sdobson@wakehealth.edu|
22433900|NCT03799952|University of New Brunswick|Dr. Danielle Bouchard|1 (506) 443-3908|danielle.bouchard@unb.ca|
22433901|NCT00902850|Bausch & Lomb Incorporated|Robert Steffen, OD, MS|585-338-6399|Robert.Steffen@bausch.com|
22433902|NCT01006655|Rambam medical Center|Prof Lea Bentur|xx 972 4 854 3263|l_bentur@rambam.health.gov.il|0502062400
22433903|NCT03292640|Dr. Reddy's Laboratoris, Inc|Srinivas Sidgiddi, Senior Director, Clinical Development|9084585362|srinivassidgiddi@drreddys.com|
22433904|NCT02015481|Bioblast Pharma|Warren Wasiewski|717-368-0780|Warren.wasiewski@bioblastpharma.com|
22433905|NCT05253755|Dermbiont Inc|Joanna Jay|415.819.4816|joanna.j@dermbiont.com|
22433906|NCT03122145|Holy Cross Hospital|Lauren Tabor Gray|954 542 3429|lauren.tabor@holy-cross.com|
22433907|NCT00079391|NIH National Heart, Lung and Blood Institute|Minocher Battiwalla|301-402-4170|battiwalla@nhlbi.nih.gov|
22433908|NCT00837161|Philips Healthcare|Sarah Baxter|425-487-7665|sarah.baxter@philips.com|
22433909|NCT01456195|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22433910|NCT02109432|Pennington Biomedical Research Center|Corby Martin, Associate Professor|225-763-2585|corby.martin@pbrc.edu|
22433911|NCT03304054|Catalyst Pharmaceuticals, Inc.|Gary Ingenito|305-420-3200|gingenito@catalystpharma.com|
22433912|NCT03372551|Coopervision|Myhanh Nguyen, Sr. Optometrist|925-730-6716|mnguyen@coopervision.com|
22433913|NCT04523454|Imperial College London|Dr Rochan Agha-Jaffar|0203 311 3000|Rochan.Agha-Jaffar@nhs.net|21253
22433914|NCT04500171|American Samoa Community Cancer Coalition|Va'atausili Tofaeono|648-699-0110|vtofaeono@cancercoalition.as|
22433915|NCT03179982|American University|Caroline Kuo|2028853054|ckuo@american.edu|
22433916|NCT04148482|Massachusetts General Hospital|Sara Cromer|6177247303|scromer@mgh.harvard.edu|
22433917|NCT04683029|Janssen Pharmaceutical K.K.|Senior Director Clinical Research MD|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22433918|NCT03804021|Adverum Biotechnology, Inc.|Chief Development Officer|650-649-1413|sseyedkazemi@adverum.com|
22433919|NCT04299308|University of Kansas Medical Center|Dr. Jill Morris|9139457675|jmorris2@kumc.edu|
22433920|NCT02551094|Montreal Heart Institute|Dr. Jean-Claude Tardif (Principle Investigator)|514-376-3330|jean-claude.tardif@icm-mhi.org|3612
22433921|NCT02920528|Lundquist Institute|David Tanen|310-222-3624|dtanen@emedharbor.edu|
22433922|NCT05422365|Biopharma Plasma LLC|Igor Rudenko, Clinical Research Physician|+380503300865|i.rudenko@biopharma.ua|
22433923|NCT03596047|Boston Medical Group|Carolina Sandoval - Director Research|+57 3133920816|csandoval@bostonmedical.com.co|
22433924|NCT00066703|ETOP IBCSG Partners Foundation|Dr. Heidi Roschitzki-Voser, PhD Head Trial Activities / Deputy Director|41 31 511 94 00|Heidi.Roschitzki@etop.ibcsg.org|
22433925|NCT01696968|Early Detection Research Group, NCI, NIH|Paul F. Pinsky, Ph.D.|301-496-8544|pinskyp@mail.nih.gov|
22433926|NCT00734604|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22433927|NCT02199314|Cincinnati Children's Hospital Medical Center|John J McAuliffe, MD|1513-636-4408|john.mcauliffe@cchmc.org|
22433928|NCT04848220|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22433929|NCT02222909|Johns Hopkins School of Public Health|Christine Weston|443-287-8039|cweston1@jhu.edu|
22433930|NCT00814697|The NY Memory and Healthy Aging Services|Dr. Gayatri Devi|212-517-6881|gd@nymemory.org|
22433931|NCT00117715|Children's Mercy Hospital|J. Steven Leeder|816-234-3059|sleeder@cmh.edu|
22433932|NCT02557100|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22433933|NCT03289910|Johns Hopkins University|Grants Administrative Manager|4439273568|JHCCCRO@jhmi.edu|
22433934|NCT01460875|The Ohio State University Comprehensive Cancer Center|William Carson, MD|614-293-6306|William.Carson@osumc.edu|
22433935|NCT02513485|Emory University|Dr. Jennifer Felger|404-727-3987|jfelger@emory.edu|
22433936|NCT03811847|Massachusetts General Hospital|Steven Arnold, MD|617-643-5607|searnold@mgh.harvard.edu|
22433937|NCT00611442|Carl R Darnall Army Medical Center|Dr. Joel Stengel|2545531804|joel.stengel@us.army.mil|
22433938|NCT02034175|Somnarus Inc|Maria Merchant|4087610884|somnarus@gmail.com|
22433939|NCT01511614|NIH/NIDA|Dr. Amy Janes|667.312.5164|amy.janes@nih.gov|
22433940|NCT01436656|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22433941|NCT01406938|Novartis Pharmaceutical|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22433942|NCT03462927|MC2 Therapeutics|Birgitte Vestbjerg|+45 2077 2575|bve@mc2therapeutics.com|
22433943|NCT01576146|Amgen, Inc|Study Director|866-572-6436||
22433944|NCT03454399|Henry Ford Hospital|Yoshihisa Morita|3059784358|YOSHIHISA.MORITA@JEFFERSON.EDU|
22433945|NCT03654404|Dana-Farber Cancer Institute|Hermioni L. Amonoo, Director of Well-Being and Cancer Research Program|617-525-7472|Hermioni_Amonoo@dfci.harvard.edu|
22433946|NCT00654745|Daiichi Sankyo|James McCarthy|732-590-3430|jmccarthy@dsi.com|
22423409|NCT04464720|University of California San Francisco|Dr. Stephanie M Holm|415-514-0878|stephanie.holm@ucsf.edu|
22423410|NCT02156895|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22423411|NCT05723328|Hackensack Meridian Carrier Clinic|Zachary D. Fischer PhD, MT-BC|908-281-1324|Zachary.Fischer@hmhn.org|
22423412|NCT03476174|Hoosier Cancer Research Network|Jeff Smith|317-634-5842|jsmith@hoosiercancer.org|41
22423413|NCT04089904|University of Chicago|Theodore Karrison (Research Professor)|7737029326|tkarrison@health.bsd.uchicago.edu|
22423414|NCT02000882|US Oncology Research|Taqi Mohammad|7138702175|taqi.mohammad@mckesson.com|
22423415|NCT02417961|AstraZeneca|Mitchell Goldman, Global Clinical Lead Benralizumab|+1 301 398 0323|Mitchell.Goldman@astrazeneca.com|
22423416|NCT01390428|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22423417|NCT05897827|University of Pittsburgh|Robert W. S. Coulter|412-624-0647|robert.ws.coulter@pitt.edu|
22423418|NCT03339726|JNJWorldwide|Steven Sacavage, PharmD, Associate Director, Global Pain & Allergy Clinical Research|215 273-8568|ssacavag@its.jnj.com|8568
22423419|NCT03681990|3M|Joan E. Paulson|651-736-6583|jepaulson@mmm.com|
22433947|NCT03086408|Stanford University|Vladimir Nekhendzy, M.D., FASA|650-498-4055|nek@stanford.edu|
22433948|NCT00194077|Johns Hopkins University School of Medicine|Robert Findling, MD,MBA Director, Child and Adolescent Psychiatry|410-614-3225|rfindli1@jhmi.edu|
22433949|NCT03470194|U Mass Memorial|Dr Danielle Taylor|508-334-9840|danielle.taylor@umassmemorial.org|
22433950|NCT01822899|GlaxoSmithKline|GSK Response Center|866-435-7343||
22433951|NCT02628405|Accru|Dr Grzegorz S. Nowakowski|507-422-6553|Nowakowski.Grzegorz@mayo.edu|
22433952|NCT00759876|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22433953|NCT01450696|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22433954|NCT02570152|GlaxoSmithKline|GSK Response Center|877-379-3718|GSKClinicalSupport@gsk.com|
22423420|NCT04599933|Orasis Pharmaceuticals, Ltd.|Head of Regulatory Affairs|+972-9-8877745|iris.meisner@orasis-pharma.com|
22423421|NCT05098067|Women and Infants Hospital|Dr. Lauren Murphy|2107222589|lmmurphy@wihri.org|
22423422|NCT02872857|The University of Texas Health Science Center at Houston|HuiMahn Alex Choi, Associate Professor|713-500-5638|Huimahn.A.Choi@uth.tmc.edu|
22423423|NCT01279564|Rambam Health Care Campus|Dr. Michal Barak|972 4 8542487|m_barak@rambam.health.gov.il|
22423424|NCT00546455|UCSD|MARIO CHOJKIER|858-552-8585|mchojkier@gmail.com|7283
22423425|NCT01813734|Massachusetts General Hospital|Dr. Alice Shaw|617-724-4000|ASHAW1@mgh.harvard.edu|
22433955|NCT02684617|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22433956|NCT00853242|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22433957|NCT01380197|Morehouse School of Medicine|Iris Buchanan|404-398-9578|ibuchanan@msm.edu|
22433958|NCT03915574|UAMS|Nadir Sharawi|5016866119|nelsharawi@uams.edu|
22423426|NCT01911780|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22433959|NCT04027803|BIOCAD|Morozova Maria|+7 (495) 992 66 28|morozovama@biocad.ru|8436
22433960|NCT02078180|University of Michigan|Dr. Duxin Sun|734-763-9783|pharmacy.research@umich.edu|
22433961|NCT02516098|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22433962|NCT01092780|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22433963|NCT01257230|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22433964|NCT02652208|Massachusetts General Hospital|Dr. Karen Sepucha|617-724-3350|ksepucha@partners.org|
22423427|NCT03870529|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-716-4760|jkettler@wakehealth.edu|
22423428|NCT04516343|Biomotum|Chief Science Officer|(800) 566-2531|zach@biomotum.com|
22423429|NCT03833804|UW School of Medicine and Public Health|Majid Afshar, MD|608-263-1792|mafshar@medicine.wisc.edu|
22423430|NCT06303167|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22423431|NCT02677896|Astellas Pharma Inc.|Clinical Trial Disclosure|+81 3-3244-0512|astellas.resultsdisclosure@astellas.com|
22423432|NCT03902522|CytoDyn|Joseph Meidling|13609808524|jmeidling@cytodyn.com|
22423433|NCT02729038|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22423434|NCT00348790|Northwestern University|Jeffrey Raizer, MD|312-503-4724|jraizer@nmff.org|
22423435|NCT03719287|3M|Helen Han|651-737-9234|mhan3@mmm.com|
22423436|NCT01185509|Dana-Farber Cancer Institute|Ian Krop, MD, PhD|617.632.6973|Ian_Krop@dfci.harvard.edu|
22423437|NCT03687372|Aclaris Therapeutics, Inc.|Aclaris Clinical Operations|1-833-225-2747|clinicaloperations@aclaristx.com|
22423438|NCT02614222|The Cooper Health System|Dr. Ronak Desai|856-342-2000|desai-ronak@cooperhealth.edu|
22423439|NCT00655733|Hutchison MediPharma|Hua Mu,Senior Vice President of Clinical Research and Development|861 3564487805|huam@hmplglobal.com|
22423440|NCT01608815|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22423441|NCT02370667|McMaster University|Dr. Monica Maly|905-525-9140|mmaly@mcmaster.ca|27823
22423442|NCT03536949|RVL Pharmaceuticals, Inc.|Senior Director of Clinical Operations|908-809-1423|mvelasco@osmotica.com|
22423443|NCT00705718|Medtronic|Karla Betz, Principal Clinical Research Specialist|763-526-2737|karla.h.betz@medtronic.com|
22423444|NCT02954653|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22423445|NCT00711828|Mayo Clinic|Craig B. Reeder, M.D.||Reeder.Craig@mayo.edu|
22423446|NCT02160847|Georgia State University|Dr. Jenelle Shanley Chatham|404-413-1340|jshanley@gsu.edu|
22423447|NCT04329091|UNIVERSITY OF CHICAGO|Al McAuley, Clinical Research Manager|7738343274|amcauley1@bsd.uchicago.edu|
22423448|NCT00423189|Retina Consultants of Houston|David M. Brown|713-524-3434|dmbmd@houstonretina.com|
22423449|NCT04106089|Rutgers University Camden|Dr. Lauren Daniel|856-225-6535|lauren.daniel@rutgers.edu|
22423450|NCT03787303|Aultman Hospital|Shruti Trehan MD|3303634162|trehanshruti4@gmail.com|
22423451|NCT01844206|Columbia University|Dr. Allison Lee|305-582-6077|al3196@cumc.columbia.edu|
22423452|NCT05028413|University of Pennsylvania|Associate Professor Mucio C. Delgado, MD, MS|215-74-826|mucio.delgado@pennmedicine.upenn.edu|
22423453|NCT00108342|Department of Veterans Affairs - VAGLA|Nina G. Schneider, Ph.D., Principle Investigator|310-268-3059|ngs@ucla.edu|
22423454|NCT01210495|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22423455|NCT03141983|University of Pennsylvania|Natalie Kuzla|2672524208|nkuzla@pennmedicine.upenn.edu|
22423456|NCT01695330|Oncotherapeutics|Dr. James Berenson|310-420-9649|jberenson@berensonocology.com|
22423457|NCT01826370|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22423458|NCT04416737|Stanford University|Dr. Rayhan Lal|650-725-2908|inforay@stanford.edu|
22423459|NCT03332628|University of Iowa|Nicole Brogden, Associate Professor|(319) 335-8752|nicole-brogden@uiowa.ed|
22423460|NCT00640653|University of Pennsylvania|Dr. John B. Jemmott III|215-573-9366|jjemmott@asc.upenn.edu|
22423461|NCT02938949|Virginia Commonwealth University|Cory Trankle, MD|804-213-2679|cory.trankle@vcuhealth.org|
22423462|NCT02543892|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22433965|NCT01205061|Galderma|Clinical Scientist|+46184749000|reception.seupp@galderma.com|
22423463|NCT01801280|Charité University Hospital - Department of Nephrology|Olesja Rissling|+49 30 450 514 153|olesja.rissling@charite.de|
22433966|NCT04026009|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22433967|NCT01988662|Novartis Pharmaceuticals|Study Director|862-778-8300||
22433968|NCT00615719|VCU|John D. Grizzard|804-828-8569|jdgrizzard@vcu.edu|
22423464|NCT00392496|Sunnybrook Health Sciences Centre|Dr. Rena Buckstein|416-480-5847|rena.buckstein@sunnybrook.ca|
22423465|NCT04150705|Washington University School of Medicine|Tyler Fraum, M.D.|314-362-2928|tylerjfraum@wustl.edu|
22423466|NCT04021121|University of California, San Francisco|Dr. Felicia Chow|(628) 206-4449|felicia.chow@ucsf.edu|
22423467|NCT00214149|UW Hospital and Clinics|Diana Trask, research coordinator for study|608-263-9528|trask@humonc.wisc.edu|
22423468|NCT01323010|University of Sao Paulo|Dr Fabio Pereira Muchão|+5511 983835563|fabiomuchao@gmail.com|
22423469|NCT00351741|USAISR|Principal Investigator|210-916-3054|kevin.chung@us.army.mil|
22423470|NCT04050124|NYU Langone Health|Scott Gorenstein, MD|5166638498|Scott.Gorenstein@nyulangone.org|
22423471|NCT05168878|University of Colorado|Dr. Maya Haasz|7204789231|maya.haasz@childrenscolorado.org|
22423472|NCT05083923|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22423473|NCT01203826|Alexion Pharmaceuticals, Inc.|Director of Clinical Trials|475-230-2596|ClinicalTrials@alexion.com|
22423474|NCT03336268|Chestnut Health Systems|Dr. Dennis Watson|312-274-5316|dpwatson@chestnut.org|
22423475|NCT02751879|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22423476|NCT02560324|University of Pennsylvania|Principal Investigator|215-746-5789|rlashare@pennmedicine.upenn.edu|
22423477|NCT05805085|CooperVision Inc.|José A. Vega OD, MSc, PhD, FAAO|+19256213761|jvega2@coopervision.com|
22423478|NCT01785849|Amgen Inc.|Study Director|866-572-6436||
22423479|NCT00381043|University of North Carolina at Chapel Hill|Dr. J.C. Garbutt|919-966-4652|jc_garbutt@med.unc.edu|
22423480|NCT04065451|Indiana University|Clinical Research Specialist|317-948-0724|rlahr@iu.edu|
22423481|NCT02880865|PATH|Jorge Flores, MD|(202) 822-0033|jeflores@path.org|
22423482|NCT03379753|TriHealth Inc.|Rachel Pauls, MD|513-463-4300|Rachel_Pauls@trihealth.com|
22423483|NCT04383938|Aprea Therapeutics|Senior Medical Advisor|215-948-4119|info@aprea.com|
22423484|NCT03728985|W.L. Gore and Associates|Rizwan Afzal|1-623-234-5408|rafzal@wlgore.com|
22423485|NCT05079750|University of Oxford|Dr. Paola Cicconi|01865 611425|paola.cicconi@ndm.ox.ac.uk|
22423486|NCT00642603|Genentech, Inc.|Medical Communications|800-821-8590||
22423487|NCT05091346|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_medinfo@eisai.com|
22423488|NCT05573672|Canadian College of Naturopathic Medicine|Monique Aucoin|416 498 1255|maucoin@ccnm.edu|223
22423489|NCT03384784|University of Pennsylvania|Rebecca Ashare|215.746.7143|rlashare@pennmedicine.upenn.edu|
22393676|NCT01773291|Kaohsiung Chang Gung Memorial Hospital|Wen-Long Hu, Deputy Director, Department of Chinese Medicine|+886-7-7317123|oolonghu@gmail.com|2334
22393677|NCT00203476|TuscaloosaREAC|Raela Williford, PharmD|(205) 554-2000|Raela.Williford@va.gov|2433
22393678|NCT03310268|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22393679|NCT04797650|Concert Pharmaceuticals, Inc.|Colleen E. Hamilton|781-860-0045|AAclinicaltrial_inquiries@concertpharma.com|
22393680|NCT03480217|Center for Behavioral Cardiovascular Health, Columbia University Irving Medical Center|Ian Kronish|212-342-1335|ik2293@columbia.edu|
22393681|NCT04772898|Creighton University|Anastasia Kyvelidou|4022805749|aky61380@creighton.edu|
22393682|NCT00832637|University of New Mexico|Yehuda Patt, MD|5059250405|yzpatt@salud.unm.edu|
22393683|NCT00309959|NRG Oncology|Angela Kuras on behalf of James Kauderer|716-845-5702|kurasa@nrgoncology.org|
22393684|NCT02937454|Vifor (International) AG.|FER-CARS-06 Clinical Study Team|+41 588 518 000|FER-CARS-06.study@viforpharma.com|
22393685|NCT01253304|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22393686|NCT04601870|University of Wisconsin-Madison School of Medicine and Public Health Center for Tobacco Research and Intervention|Mark Zehner|16082627568|mark.zehner@ctri.wisc.edu|
22393687|NCT01854138|ProMedica|Karl J. Beer, MD|419-578-4260|karl.beer@promedica.org|
22393688|NCT01879059|University of Kansas Medical Center|John P. Thyfault, PhD|913-588-1790|jthyfault@kumc.edu|
22393689|NCT01534689|Regulatory Insight, Inc.|Clinical Consultant|6157129743|elvira@reginsight.com|
22393690|NCT01888900|National Institute of Diabetes and Digestive and Kidney Diseases|Dr. Marc Ghany|301-402-5515|marcg@mail.nih.gov|
22393691|NCT01160289|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22393692|NCT03909529|CMP Pharma|Paul Sudhakar|816-507-8249|pauls@ptspharma.com|
22393693|NCT01090479|Northwestern University|Michael Murray, MD|312-926-4444|m.murray8278@gmail.com|
22393694|NCT01156792|GlaxoSmithKline|GSK Response Center|866-435-7343||
22393695|NCT00768079|MedImmune, LLC|Joseph M. Parker, Director, Clinical Development|+1 301-398-4095|information.center@astrazeneca.com|
22393696|NCT03271021|Foamix Pharmaceuticals|Senior Director, Clinical Operations|9089630117|kendra.gulbronson@foamix.com|
22393697|NCT01474434|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22393698|NCT02876159|Emory University|Dr. Mark J. Mulligan, M.D., F.I.D.S.A|404-712-1370|mmulli2@emory.edu|
22393699|NCT02207569|Medtronic|Kristin Smith|763-526-3095|kristin.m.smith@medtronic.com|
22393700|NCT02585232|Tuscaloosa VA Medical Center|Dr. Michelle Hilgeman|205-554-2000|Michelle.Hilgeman@va.gov|3278
22393701|NCT04595318|Montefiore Health System|Dr. Shadi Nahvi|718 920 5379|snahvi@montefiore.org|
22393702|NCT01039792|UCSF|Dr. Robert Hendren|415-502-3500|STAR@ucsf.edu|
22393703|NCT00580645|Yale School of Medicine|Sherry McKee PhD|203-737-3529|sherry.mckee@yale.edu|
22393704|NCT01157676|University of Miami|Dipen Parekh, MD|305 243 6591|parekhd@miami.med.edu|
22393705|NCT00682890|Virginia Commonwealth University|Dr. John Nestler|804-828-3389|jnestler@mcvh-vcu.edu|
22393706|NCT01721460|University od Wisconsin - Madison|Dr. Aeyal Raz|608-263-8100|raz@wisc.edu|
22393707|NCT03028220|Imperial College London|Prof Nick Oliver|02075942460|nick.oliver@imperial.ac.uk|
22410943|NCT03493698|Spring Bank Pharmaceuticals, Inc.|Don Mitchell, Vice President, Operations & Corporate Development|(508) 689-9737|dmitchell@springbankpharm.com|
22410944|NCT00408876|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22410945|NCT00291330|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22410946|NCT00566709|"University Hospital Virgen del Rocío"|Santiago R Leal-Noval, MD, PhD|0034954012528|srlealnoval@gmail.com|
22410947|NCT03443869|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22410948|NCT02390219|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22410949|NCT00299728|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22410950|NCT03654209|Indiana University|Clinical Research Coordinator|317-948-0724|rlahr@iu.edu|
22423490|NCT01779167|Weill Cornell Medicine|Peter Martin, MD|646.962.2064|amr2017@med.cornell.edu|
22393708|NCT00141219|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22393709|NCT01577745|MedImmune, LLC|Mohammed Dar|301-398-1008|information.center@astrazeneca.com|
22393710|NCT02325557|Advaxis, Inc.|Sumitra Sheeri|609-423-2528|sheeri@advaxis.com|
22410951|NCT00931385|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22410952|NCT02033876|Mayo Clinic|Dr. Michael Camilleri|507-284-2687|camilleri.michael@mayo.edu|
22410953|NCT02230085|Fisher & Paykel Healthcare|Clinical Research Scientist|+6495740123|cpaptrial@fphcare.co.nz|
22410954|NCT00580983|University of Michigan Comprehensive Cancer Center|Dr. Avraham Eisbruch, M.D.|734-936-4302|eisbruch@umich.edu|
22410955|NCT01360632|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22410956|NCT00811070|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22410957|NCT04582409|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22410958|NCT00665626|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
22410959|NCT02046369|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
22410960|NCT03120520|Bausch Health Americas, Inc|Clinical Operations Director|908-927-0873|lindsey.mathew@bauschhealth.com|
22410961|NCT03927781|University of Missouri|Dr Katie Murray|573-884-8768|murraykat@health.missouri.edu|
22433969|NCT02300558|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22433970|NCT01471028|Vital Therapies, Inc.|Robert Ashley|858-673-6840|rashley@vitaltherapies.com|
22433971|NCT02957747|VISN 17 Center of Excellence for Research on Returning War Veterans|Dr. Suzannah Creech, Ph.D.|254-297-3025|Suzannah.Creech@va.gov|
22433972|NCT00940290|ITESM|Carlos A. Cuello-García|+52 (81)88882154|carlos.cuello@gmail.com, carlos.cuello@itesm.mx|
22433973|NCT00625391|Texas Tech University Health Sciences Center|Dr. Chwan-Li Shen|(806) 743-2815|Leslie.Shen@ttuhsc.edu|
22393711|NCT01975974|University of Iowa Hospitals and Clinics|Dr. Kenichi Ueda|319-356-2633|kenichi-ueda@uiowa.edu|
22393712|NCT00396019|AstraZeneca|Dr. Regina Jakacki||regina.jakacki@astrazeneca.com|
22393713|NCT00468559|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
22393714|NCT02703259|Christiana Care Health Systems|Dr. Terri Huynh|302-623-4410|terri.huynh@christianacare.org|
22393715|NCT01856868|UC Davis Health|Dr. Craig McDonald, Professor and Chair|(916) 734-4293|cmmcdonald@ucdavis.edu|
22393716|NCT02971761|Department of Medical Oncology, City of Hope|Yuan Yuan, MD, PhD.|626-256-4673|yuyuan@coh.org|89200
22393717|NCT02624791|UVa Center for Behavioral Medicine Research|Project Coordinator|434-924-8656|tab2v@hscmail.mcc.virginia.edu|
22393718|NCT00662818|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22393719|NCT01302860|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
22393720|NCT01146782|ApniCure, Inc.|Andrea Brown, Director, Clinical Affairs|650-361-9000|abrown@apnicure.com|122
22410962|NCT04345471|Mochida Pharmaceutical Company, Ltd.|Director of Clinical Research Department|+81332256331|clinical.trials.contact@mochida.co.jp|
22423491|NCT01573767|GlaxoSmithKline|GSK Response Center|866-435-7343||
22423492|NCT02339155|GlaxoSmithKline|GSK Response Center|866-435-7343||
22423493|NCT00842075|UColorado|Dr. H. Peter Chase|303-724-2323|peter.chase@ucdenver.edu|
22423494|NCT00850096|CPEX Pharmaceuticals, Inc.|Chief Medical Officer|603-658-6100||503
22423495|NCT03226678|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
22423496|NCT02176083|University of California, San Diego|Irene Su, MD MSCE|8588225986|hisu@ucsd.edu|
22423497|NCT04946552|Yale School of Medicine|Renata Belfort De Aguiar, MD, PhD|(203) 785-5331|renata.aguiar@yale.edu|
22433974|NCT02016716|Amgen Inc.|Study Director|866-572-6436||
22410963|NCT01025193|Hospital of the University of Pennsylvania|Jennifer Trofe-Clark|215-614-4274|jennifer.trofe-clark@uphs.upenn.edu|
22410964|NCT01901211|Holland Bloorview Kids Rehabilitation Hospital|Darcy Fehlings, MD, MSc, FRCP(C)|416-425-6220|dfehlings@hollandbloorview.ca|3586
22410965|NCT01710306|Department of Veteran's Affairs- Office of Research and Development|Anne G. Sadler, Ph.D., R.N.|319-338-0581|anne.sadler@va.gov|7992
22410966|NCT02378506|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22410967|NCT00433381|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
22410968|NCT01387282|Helsinn Therapeutics (US), Inc.|Richard K. Bourne, Ph.D.|732-603-2852|richard.bourne@helsinn.com|
22410969|NCT04582266|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
22410970|NCT03015142|Philips|Rami Nachabe|+1-513-926-1486|rami.nachabe@philips.com|
22410971|NCT03974152|Eastern Virginia Medical School|Dr. Paul Harrell|757-446-6047|harrelpt@evms.edu|
22410972|NCT01034137|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22410973|NCT01466686|Sidney Kimmel Comprehensive Cancer Center @ Johns Hopkins Medicine|Kristin Redmond, MD|4109556980|kjanson3@jhmi.edu|
22410974|NCT02049359|Campbell University|Jennifer Smith|2522439800|jsmith@cfhcnc.org|224
22410975|NCT00658320|Novartis Pharmaceuticals|Study Director|862-778-8300||
22410976|NCT01405950|Acorda Therapeutics, Inc.|Herbert Henney, PharmD|914-347-4300|hhenney@acorda.com|5138
22410977|NCT01975090|Novate Medical|Gordon Crowley|+353 91 750 030|gordon.crowley@novate.ie|
22410978|NCT02410252|Partners Connected Health Innovations|Amanda Centi|6177242158|acenti@partners.org|
22410979|NCT00820235|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
22410980|NCT01007916|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22410981|NCT03877055|Memorial Sloan Kettering Cancer Center|Dr. Gilles Salles, MD, PhD|646-608-4153|SallesG@mskcc.org|
22423498|NCT02102100|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-932-5711|mehemt.sofuoglu@yale.edu|4809
22423499|NCT05014815|BeiGene|Study Director|1 877-828-5568|clinicaltrials@beigene.com|
22393721|NCT01605916|Biometrics Department, Science Affairs Division, R&D, Astrazeneca Japan|Masahiro Nii||Masahiro.Nii@astrazeneca.com|
22393722|NCT00470366|Memorial Sloan Kettering Cancer Center|Dr. Darren Feldman, MD|646-422-4491|feldmand@mskcc.org|
22393723|NCT02478710|Premier Health|Director of Clinical Research|19374747850|jllader@premierhealth.com|
22393724|NCT01021215|University of Texas (UT) MD Anderson Cancer|Dr. Powel H. Brown, MD Anderson Phase I/II Prevention Consortium|(713) 745-3672|CR_Study_Registration@mdanderson.org|
22393725|NCT01103362|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com|
22393726|NCT02842151|Alcon, A Novartis Division|Senior Global Brand Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22393727|NCT00438672|Massachusetts General Hospital|Dr. David Ring|617-724-3953|dring@partners.org|
22393728|NCT01099475|Maastricht University Medical Centre|Dr. MAJ van den Broek, MD|31 43 3884502|m.vandenbroek@maastrichtuniversity.nl|
22393729|NCT03965351|Cincinnati Children's Hospital Medical Center|Mary Banks|513-636-2147|mary.banks@cchmc.org|
22393730|NCT01394978|Davol, Inc.|Dawn Heimer, PhD|+1-401-825-8681|Dawn.Heimer@CRBard.com|
22393731|NCT03691909|Hope Biosciences Stem Cell Research Foundation|Linette Rehkopf RPh|346-900-0340|linette@hopebio.org|102
22393732|NCT05121246|mAbxience Research S.L.U.|Dr. Susana Millán|+34 682821346|susana.millan@mabxience.com|
22393733|NCT05038163|NBER|Sarah Holmes Berk|617-588-1445|sholmes@nber.org|
22393734|NCT04512430|Fundación GECP|Eva Pereira|+34934302006|gecp@gecp.org|
22393735|NCT01905150|Hirschfeld Oncology|Dr. Azriel Hirschfeld|718-732-4050|ah@honcology.com|
22393736|NCT03562975|University Of South Florida|Clinical Research Manager|18139749423|amjackson@usf.edu|
22393737|NCT01758900|Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine|Zhizheng Ge, MD. Ph.D. Director of the Clinical Trials|86-21-68383015|zhizhengge@yahoo.com.cn|
22393738|NCT02631577|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22393739|NCT04577001|Mayo Clinic|Dr. Hilary DuBrock|(507) 284-2957|DuBrock.Hilary@mayo.edu|
22393740|NCT00604825|GlaxoSmithKline|GSK Response Center|866-435-7343||
22393741|NCT03465904|CEFALY Technology|Clinical Trials Department director|+32 4 367 67 22|ClinicalTrial@cefaly.com|
22393742|NCT05593445|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22393743|NCT00812331|Janssen Research & Development United States|Global Clinical DVLP Manager||ClinicalTrialDisclosure@its.jnj.com|
22393744|NCT03694275|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22393745|NCT01783847|Iran university of Medical Sciences|Mohsen Bahmani Kashkouli|00989121777003|mkashkouli2@gmail.com|
22393746|NCT01007643|University of Manitoba|Dr Erika Persson|780-492-4752|epersson@ualberta.ca|
22393747|NCT01710332|Mid Atlantic Retina|Allen C. Ho, MD|215-459-0477|mformoso@midatlanticretina.com|
22393748|NCT02359877|BIOCAD|Biryulin Andrey|+7812380 49 33|biryulin@biocad.ru|925
22393749|NCT02110147|Wellstat Therapeutics Corporation|Wellstat Medical Information|800.914.0071|medinfo@wellstat.com|
22393750|NCT02340767|National Dental PBRN|Dr. Sonia Makhija|2059965298|smakhija@uab.edu|
22393751|NCT01621737|UCSD|David Feifel|(858) 412-4130|dfeifel@kadimanp.com|
22393752|NCT03029351|State University of NY at Buffalo|Paresh Dandona|7165351852|dandona@buffalo.edu|
22393753|NCT00910689|Ohio University|Kenneth Holroyd|(740) 593-1085|holroyd@ohio.edu|
22393754|NCT01290029|Amgen Inc.|Study Director|866-572-6436||
22393755|NCT00189488|Biovitrum|Hans Olivecrona, MD PhD|+46 8 697 20 00|hans.olivecrona@sobi.com|
22393756|NCT01764685|University of Pennsylvania Perelman School of Medicine|Henry R. Kranzler, M.D.|215-386-6662|kranzler@mail.med.upenn.edu|
22393757|NCT02349425|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22393758|NCT00616902|Abbott|Global Medical Services|800-633-9110||
22393759|NCT01877837|Hackensack Meridian Health|Elana Smilow|5519965673|Elana.Smilow@hmhn.org|
22393760|NCT00645801|retired|Director of Gastrointestinal Research||anngimd@icloud.com|
22423500|NCT04247880|University of Washington|Dr. Marissa Baker|206 616 4709|bakermg@uw.edu|
22423501|NCT05185622|Santhera|Dr Shabir Hasham|+41 61 906 89 50|Shabir.Hasham@santhera.com|
22423502|NCT05283135|Oregon Medical Research Center, PC|Benjamin Ehst, MD, PhD|5032451525|behst@oregonmedicalresearch.com|
22423503|NCT00916344|BIOTRONIK SE & Co.KG|Dr. Evelyn Diessel|+49 (0) 30 68905|evelyn.diessel@biotronik.com|1231
22423504|NCT00984139|GlaxoSmithKline|GSK Response Center|866-435-7343||
22423505|NCT03991013|University of Cape Town|Prof Graeme Meintjes|+27 (0) 21 4066075|Graeme.Meintjes@uct.ac.za|
22423506|NCT00108485|Diabetes Research Institute|Dr. Ronald Goldberg|305-243-6574|RGoldber@med.miami.edu|
22423507|NCT00828074|City of Hope|Paul Frankel, Ph.D.|626-359-8111|pfrankel@coh.org|65265
22423508|NCT02725580|Amicus Therapeutics|Amicus Therapeutics Patient Advocacy|+1 609-662-2000|clinicaltrials@amicusrx.com|
22423509|NCT00878969|Vanderbilt University|T. Alp Ikizler, MD|615-343-6104|alp.ikizler@vanderbilt.edu|
22423510|NCT02634268|VA Puget Sound Health Care System|Margaret Collins|206.764.2085|margaret.collins@va.gov|
22423511|NCT01701193|University of Saskatchewan|Roger Pierson, PhD|306-884-1059|roger.pierson@usask.ca|
22423512|NCT03054064|Parker Hannifin Corporation|Ryan J. Farris, Ph.D., P.E.|2168963335|ryan.farris@parker.com|
22423513|NCT01384019|Seoul national university Bundang hospital|Dr. Chang-Hwan Yoon|+82-31-787-7052|changhwanyoon@snubh.org|
22423514|NCT01575275|Cleveland Clinic|Dr. Michael Vogelbaum|2164448564|vogelbm@ccf.org|
22393761|NCT00759915|Actavis Inc.|Meena Venugopal, Director, Clinical R&D|908-659-2885|MVenugopal@actavis.com|
22393762|NCT04259645|UPMC Department of Anesthesiology and Perioperative Medicine|Anna Uskova, MD|412-623-2167|uskoaa@upmc.edu|
22423515|NCT02619396|John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust|Dr Milena Leo|0186522055|milena.leo@ouh.nhs.uk|
22393763|NCT00932113|Tufts Medical Center|Nicole Dumont|617 636 7462|ndonovan1@tuftsmedicalcenter.org|
22423516|NCT04489381|Romark, L.C.|Jessica Fulgencio|8132828544|jessica.fulgencio@romark.com|
22393764|NCT01190514|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22423517|NCT02865590|Department MESVA - University of L'Aquila|Enrico Marchetti DDS, PhD|+39862433304|enrico.marchetti@univaq.it|
22423518|NCT03199612|Montefiore Einstein|Omar Saeed|718-920-2626|osaeed@montefiore.org|
22423519|NCT01199822|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22423520|NCT01500213|Tesaro|Martin Huber, M.D., Senior Vice President and Chief Medical Officer|862.228.2483|mhuber@tesarobio.com|
22423521|NCT04027075|Oregon Research Behavioral Intervention Strategies, Inc.|Dana Smith|541-484-2123|dana.smith@influentsin.com|
22423522|NCT02335749|Zeltiq Aesthetics|Kerrie Jiang, Director Clinical Affairs|925-621-7462|kerrie.jiang@allergan.com|
22423523|NCT01043705|Medtronic plc|Lynn Landborg, Clinical Research Manager|763 526 2877|lynn.landborg@medtronic.com|
22423524|NCT00669019|University of Chicago|Dr. Thomas F. Gajewski|773-702-4601|tgajewsk@medicine.bsd.uchicago.edu|
22423525|NCT02635542|University of Chicago|Rebecca M Gerlach, MD|773-702-6700|rgerlach@dacc.uchicago.edu|
22423526|NCT02003963|Pennington Biomedical Research Center|Dr. Amanda Staiano|2257632729|amanda.staiano@pbrc.edu|
22423527|NCT01195844|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22423528|NCT00176644|Cancer Institute of New Jersey|Dr. Mark Stein|732-235-8675|steinmn@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
22423529|NCT00581542|University of Rochester, Strong Mem orial Hospital|Franci Gigilotti|585 275-0588|francis_gigilotti@urmc.rochester.edu|
22423530|NCT05020366|University of Pittsburgh|Dr. Angela Caldwell|412-383-7231|arl78@pitt.edu|
22423531|NCT03526055|Ohio Pain Clinic|Dr. Amol Soin|937-434-2226|drsoin@ohiopainclinic.com|
22423532|NCT00195494|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22423533|NCT02787057|Peking University First Hospital|Dr. Jie Dong|+86 010 66551708|jie.dong@bjmu.edu.cn|
22423534|NCT00756561|University of Washington, Dept. of Medicine|Mara Roth, MD|(206) 221-0519|mylang@u.washington.edu|
22423535|NCT03045276|Children's Hospital of Philadelphia|Dr. Sandra Amaral|2678443097|amarals@chop.edu|
22423536|NCT02224820|Dept of Transplant Surgery, Uppsala University Hospital|Dr. Tomas Lorant|+46 70 677 29 01|tomas.lorant@surgsci.uu.se|
22423537|NCT00347919|GlaxoSmithKline|GSK Response Center|866-435-7343||
22423538|NCT00624195|UCSD|Dr. Ron Ellis|619-543-5079|roellis@ucsd.edu|
22423539|NCT01508052|Gachon University|Dr.Kwak|82324603400|hyun615@gilhospital.com|
22423540|NCT01190267|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22423541|NCT01852201|Medical University of SC|Jonathan Lena, MD|843-792-9226|lena@musc.edu|
22423542|NCT02057419|The Miriam Hospital|Dr Kate Guthrie, Principal Investigator, Project WISH Lead Investigator|401-793-8180|kate.guthrie@brownhealth.org|
22423543|NCT05513703|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22423544|NCT01177709|Nathan Kline insistute for Psychiatric Research|Robert C smith MD|845-298-6531|rsmith@nki.rfmh.org|
22423545|NCT00796705|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22423546|NCT03376256|University of Miami|Dr. Ralf Gebhard|3055858365|rgebhard@med.miami.edu|
22423547|NCT02251106|University of Alberta|Dr. Greg Kawchuk|780-492-6891|greg.kawchuk@ualberta.ca|
22423548|NCT02267772|The University of Texas Health Science Center at Houston|Jerrie S. Refuerzo, MD, Associate Professor|713-500-6416|jerrie.s.refuerzo@uth.tmc.edu|
22423549|NCT04450407|Eli Lilly and Company|Chief Medical Officer|800- 545-5979|ClinicalTrials.gov@lilly.com|
22423550|NCT04542421|u of colorado|Dr Anna Maw|720-848-4289|anna.maw@cuanschutz.edu|
22423551|NCT04696354|Philips|Danielle Op den Kamp, Sr Manager Clinical Operations|+31 (0)627218737|Danielle.op.den.kamp@philips.com|
22423552|NCT03040804|Montefiore Medical Center|Steven R. Cohen, MD, MPH|7189208352|srcohen@montefiore.org|
22423553|NCT00533702|Eli Lilly and company|Chief Medical Officer|800-545-5979||
22423554|NCT01187498|Birmingham VA Medical Center|Kathryn L. Burgio, PhD|205-558-7064|kburgio@uabmc.edu|
22423555|NCT01970475|Amgen Inc.|Study Director|866-572-6436||
22423556|NCT00342563|Yale University School of Medicine|Dr. Elizabeth Ralevski|+1 203-932-5711|elizabeth.ralevski@yale.edu|x4282
22423557|NCT04413552|Indivior, Inc.|Global Director, Clinical Development|804-594-4488|TrialDisclosure@Indivior.com|
22423558|NCT01317797|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22423559|NCT03026530|Region Ostergotland|Dr. Kihlstedt Pasquier|0046101041000|ebba.kihlstedt.pasquier@regionostergotland.se|
22423560|NCT03955081|OLYMPUS EUROPA SE & CO. KG|Peter Teichmann, PhD|+49 40 23773|peter.teichmann@olympus.com|7835
22423561|NCT03721835|Smith+Nephew, Inc.|Karlie Morgan|+1.512.496.7507|Karlie.Morgan@smith-nephew.com|
22423562|NCT03495154|Medtronic|Alyssa Sutch, Senior Clinical Research Specialist|612-214-9756|alyssa.m.sutch@medtronic.com|
22423563|NCT05013788|The University of Texas Health Science Center at Houston|Monica Kodakandla, MD|713-500-5666|RMonica.Kodakandla@uth.tmc.edu|
22423564|NCT00688935|Oregon Health and Science University|OHSU Integrity Department|1-877-733-8313|irb@ohsu.edu|
22423565|NCT01294696|Merck Sharp & Dohme Corp|Vice President, Late Stage Group Development Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22442194|NCT01497366|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22442195|NCT03800420|Clinical Trials_inquiries|Clinical Trials_inquiries|+82-31-8092-3280|clinicaltrials.gov_inquiries@bridgebiorx.com|
22442196|NCT00746512|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22442197|NCT00419445|CoMentis (formerly Athenagen)|Carl Grove|650-869-7600|cgrove@comentis.com|
22442198|NCT02745080|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22442199|NCT01303224|Menarini Ricerche S.p.A.|Angela Capriati MD PhD, Corporate Director of Clinical Research|+39 055 5680|acapriati@menarini-ricerche.it|9933
22393765|NCT00512317|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
22393766|NCT01143038|Amgen Inc.|Study Director|866-572-6436||
22393767|NCT03346161|Washington University School of Medicine|Mary C. Politi, Ph.D.|314-747-1967|mpoliti@wustl.edu|
22393768|NCT00706433|Dusa Pharmaceuticals, Inc.|Anna Houlihan||houlihana@dusapharma.com|
22393769|NCT01035073|University of Pennsylvania|Tyrone Quarterman|215-349-5537|tyroneq@upenn.edu|
22393770|NCT04101318|Coloplast|Vice President, Medical Affairs|+45 4911 1111|clinical-studies@coloplast.com|
22393771|NCT00717067|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22393772|NCT02090959|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22393773|NCT00522873|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22393774|NCT00657020|GlaxoSmithKline|GSK Response Center|866-435-7343||
22393775|NCT01183234|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22393776|NCT02190045|CAVHS/ UAMS|Kalpana Padala, MD|501-257-1000|kppadala@uams.edu|
22393777|NCT02029846|Johns Hopkins University|Dr. Hsin-Chieh Yeh|410-614-4316|hyeh1@jhmi.edu|
22393778|NCT02561754|University of Kansas Medical Center|Dr. Joseph Donnelly|785-864-3880|jdonnelly@ku.edu|
22423566|NCT05633992|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22393779|NCT02966301|MEDSENIC|RIEGER François - CEO - Scientific Director|+33671733159|fr@medsenic.org|
22393780|NCT00822172|CPC Clinical Research|William Hiatt, MD, President|3038609900|william.hiatt@cpcmed.org|
22393781|NCT02349646|St. Jude Medical|Jennifer Duggan|+32(0)27746827|jduggan@sjm.com|
22393782|NCT00370331|GlaxoSmithKline|GSK Response Center|866-435-7343||
22393783|NCT02367820|Nektar Therapeutics|Medical Affairs|855-482-8676|StudyInquiry@nektar.com|
22393784|NCT00993668|UCB, Inc|UCB Clinical Trial Call Center|+1 877 822 9493||
22393785|NCT01847469|Yale University School of Medicine, VA Connecticut Healthcare System|Dr. Ismene Petrakis|(203) 932-5711|ismene.petrakis@yale.edu|
22393786|NCT02313233|Kaohsiung Municipal TA- TUNG Hospital|Dr. Ching- Chia Li|886-7-291-1101||
22393787|NCT02095951|Wayne State University School of Medicine - Children's Hosp. of Michigan|Eric McGrath, MD|313-745-5862|emcgrath@med.wayne.edu|
22393788|NCT03618823|UPMC Children's Hospital of Pittsbugh|Senior Research Associate|1412-692-9879|nelsonjl2@upmc.edu|
22393789|NCT05383508|Philip Morris Products S.A.|Christelle Haziza, Global Head Clinical Research and Execution|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
22393790|NCT03139669|University of Virginia|Dr. Emma Mitchell Associate Professor|4342433962|emm6z@virginia.edu|
22393791|NCT01621568|National Cancer Institute|Dr. Arun Rajan|240-760-6236|rajana@mail.nih.gov|
22393792|NCT02930226|University of Cincinnati|Jose A. Cancelas, M.D., Ph.D.|513-558-1324|Jose.Cancelas@cchmc.org|
22393793|NCT00920075|Medical University of South Carolina|Deborah A Bowlby, Asst.Professor, Pediatric Endocrinology|843-792-6807|bowlbyd@musc.edu|
22393794|NCT03814031|Henry Ford Hospital|Yoshihisa Morita|3059784358|YOSHIHISA.MORITA@JEFFERSON.EDU|
22393795|NCT02224690|GW Research Ltd.|Medical Enquires||medinfo.USA@gwpharm.com, medinfo@greenwichbiosciences.com|
22393796|NCT00297596|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSarah@scresearch.net|
22393797|NCT01506609|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22393798|NCT01710891|MinneapolisMRF|Brian Driver|6128739528|Brian.Driver@hcmed.org|
22393799|NCT01580423|Dartmouth-Hitchcock Medical Center|Donald A. Mahler|603 650-5533|Donald.a.mahler@hitchcock.org|
22393800|NCT02261597|Beth Israel Deaconess Medical Center, Harvard Medical School|Dr. Monika Haack|617-667-5234|mhaack@bidmc.harvard.edu|
22423567|NCT00715104|Dendreon Corporation|Lynn Ngo|206-274-6763|lngo@dendreon.com|
22423568|NCT04216784|Rush University Medical Center|Lance Lineberger|312-942-5126|Lance_Lineberger@rush.edu|
22393801|NCT01990560|Ichan School of Medicine at Mount Sinai|Dr. Alice C. Levine|212-241-1500|alice.levine@mountsinai.org|
22393802|NCT01153958|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22393803|NCT00895154|Washington University|Dr. Allison King|314-454-4291|king_a@wustl.edu|
22393804|NCT03954392|Vanderbilt University|Judy Garber, Ph.D., Professor of Psychology and Human Development|16153305605|judy.garber@vanderbilt.edu; jgarber.vanderbilt@gmail.com|
22393805|NCT00669682|Columbia University|Jose' Dizon, MD|212-305-8559|jmd11@columbia.edu|
22393806|NCT00312923|Rush University Medical Center|Barbara Swanson|312-942-8977|barbara_a_swanson@rush.edu|
22393807|NCT01688830|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22393808|NCT00935818|Mayo Clinic|Dr. Jon Ebbert|507-284-4736|ebbert.jon@mayo.edu|
22393809|NCT01305200|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreporingcoordinator@childrensoncologygroup.org|
22393810|NCT05559476|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22393811|NCT00925353|St. Luke's Mountain States Tumor and Medical Research Institute|Colleen K. Lambertz, MBA, MSN, FNP|208 463 6018|lambertc@slhs.org|
22393812|NCT02502799|Florida International University|Dr. William E. Pelham Jr.|305-348-3002|wpelham@fiu.edu|
22393813|NCT03706313|Duke University|Jeff Gadsden|919-681-6437|jeff.gadsden@duke.edu|
22393814|NCT00690040|Hemek Medical center|Dr. Raed Salim|97246494031|salim_ra@clalit.org.il|
22393815|NCT01589237|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22423569|NCT05741346|BioCryst Pharmaceuticals Inc.|Study Director|+001 919859 1302|clinicaltrials@biocryst.com|
22423570|NCT04439357|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22423571|NCT03790618|University of Chicago|Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
22393816|NCT00117845|National Cancer Institute, National Institutes of Health|Thomas Waldmann, M.D.|301-496-6656|tawald@mail.nih.gov|
22393817|NCT03207009|bluebird bio, Inc|Study Medical Director|+1-833-999-6378|clinicaltrials@bluebirdbio.com|
22393818|NCT01491672|Novartis|Study Director|862-778-8300||
22423572|NCT01668966|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22423573|NCT02663752|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22423574|NCT03602391|University of Texas at Arlington|JEREMY A FORSBERG|8172722105|ogcs@uta.edu|
22423575|NCT01527487|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22423576|NCT01892085|University of Florida|Leslie Parker|352 215 9360|Parkela@ufl.edu|
22423577|NCT01472757|Vectura Limited|Gary Burgess, MD|+44(0)1249 667700|clinical.enquiries@vectura.com|
22423578|NCT00597506|Duke University Medical Center|Herbert Hurwitz, MD|919-668-1861|herbert.hurwitz@duke.edu|
22423579|NCT02961062|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22423580|NCT00371644|VA North Texas Health Care System|Dr. Alina Suris|2148572312|alina.suris@va.gov|
22393819|NCT01197833|BTG International Inc|David Wright MB FRCS|610-278-1660|david.wright@btgplc.com|
22393820|NCT01336803|Stanford University|Heike Daldrup-Link|650-723-8996|heiked@stanford.edu|
22423581|NCT00081731|University of Toledo|Christopher Cooper, MD|419-383-6297|christopher.cooper@utoledo.edu|
22423582|NCT01135069|Spear Pharma|K.L. Spear M.D.|239-433-3442|spear@spearpharma.com|
22423583|NCT03258008|UT MD Anderson Cancer Center|Dr. John Heymach, PHD-Chair, Thoracic-Head & Neck Med Onc|(713) 792-6363|jheymach@mdanderson.org|
22423584|NCT01629823|ALA-ACRC|Janet T Holbrook, PhD, MPH|443-287-3170|jholbro1@jhu.edu|
22423585|NCT00785213|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22423586|NCT02386345|Abbott|Clinical Program Director|6517566717|kristin.ruffner@abbott.com|
22423587|NCT03207074|Imperial College London|Dr Diana Marcus|07525133957|d.marcus16@imperial.ac.uk|
22423588|NCT00526331|UT MD Anderson Cancer Center|Gabriel Mena, MD / Professor||CR_Study_Registration@mdanderson.org|
22423589|NCT00455520|Johnson & Johnson Pharmaceutical Research & Development|Senior Director, Clinical Leader|609-730-4537||
22423590|NCT00109876|Rhode Island Hospital/Alpert Medical School|Damian E. Dupuy, MD|401 - 444 - 5184|ddupuy@lifespan.org|
22423591|NCT01099774|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22423592|NCT00033657|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
22423593|NCT01683422|Loma Linda University Health|Gary Yang|909 558 4000|gyang@llu.edu|88056
22393821|NCT00642772|Center for Health Services Research in Primary Care, Durham VA Medical Center|Dr. Kelli Allen|919-286-0411|kelli.allen@va.gov|7090
22393822|NCT02947087|MUSouthCarolina|Hongjun Wang, PhD|8437921800|wangho@musc.edu|
22393823|NCT00888628|Massachusetts General Hospital|James F. Markmann, M.D. Ph.D - Chief, Division of Transplant Surgery|617-643-4087|kcrisalli@mgh.harvard.edu|
22393824|NCT00545051|Hoffmannb-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22393825|NCT01375114|UT MD Anderson Cancer Center|Dr. Sriram Yennu, MD-Professor, Palliative Care Med|(713) 792-3938|syennu@mdanderson.org|
22393826|NCT04193436|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22393827|NCT01749904|Bausch + Lomb, a division of Valeant Pharmaceuticals|H. DeCory, Director Medical Affairs|585 732-3284|heleen_H_decory@bausch.com|
22393828|NCT04256629|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22393829|NCT01859988|Regeneron Pharmaceuticals, Inc|Clinical Trial Management||clinicaltrials@regeneron.com|
22393830|NCT00652327|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22393831|NCT00564889|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
22393832|NCT00635427|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22393833|NCT05753670|Endeavor Health|Dr. Ghazaleh Rostami Nia|847-570-4729|GRostamiNia@northshore.org|
22393834|NCT01096823|Pediatric Pain and Palliative Care Program; University of California, Los Angeles|Dr. Lonnie K. Zeltzer, MD|(310) 825-0731|LZeltzer@mednet.ucla.edu|
22393835|NCT00577473|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22393836|NCT02595073|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
22393837|NCT00732225|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22393838|NCT01324440|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22393839|NCT02884908|University of Maryland School of Medicine|Dr. Melanie Bennett|4107060892|mbennett@som.umaryland.edu|
22393840|NCT02450799|Alcon, A Novartis Division|Phase IV, Clinical and Regulatory Affairs, Alcon Japan|1-888-451-3937|alcon.medinfo@alcon.com|
22393841|NCT01293487|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22393842|NCT04860297|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
22393843|NCT00862719|IndianaU|Dr. Sherif Farag|317-944-0920|ssfarag@iu.edu|
22393844|NCT01642251|ECOG-ACRIN Cancer Research Group|Study Statistician||eatrials@jimmy.harvard.edu|
22393845|NCT00998790|American Medical Systems|Laura Olson, Clinical Project Manager|952-930-6428|laura.olson2@bsci.com|
22393846|NCT01993927|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22393847|NCT03988920|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
22393848|NCT00287690|Imperial College London|Dr Carolyn Webb|+44 3301288121|c.webb@imperial.ac.uk|
22393849|NCT02414932|Trinity College Dublin|Dr Martha Finnegan|0035312493385|mfinneg@tcd.ie|
22393850|NCT00540046|Basic Health International|Miriam Cremer MD MPH|(646) 593-8694|miriam.cremer@gmail.com|
22393851|NCT01588431|UT Health San Antonio|Anand Karnad, MD|210-450-1267|karnad@uthscsa.edu|
22393852|NCT02632526|AstraZeneca AB|A study to assess the safety, tolerability, pharmacokinetics & dynamics of AZD5718 in healthy male||ClinicalTrialTransparency@astrazeneca.com|
22393853|NCT00185965|School of Medicine, Stanford University|Ronald Levy, MD / Robert K and Helen K Summy Professor of Medicine|650-725-6452|levy@stanford.edu|
22393854|NCT02533531|LifeWatch Services, Inc.|Paul Hanneman|1 847 720 2231|Phanneman@gobio.com|
22393855|NCT03814187|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22393856|NCT02047903|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22393857|NCT00513604|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
22393858|NCT01014533|University of Michigan|Kirk Brower||kbrower@med.umich.edu|
22393859|NCT03901482|Satsuma Pharmaceuticals, Inc.|Vice President of Regulatory Affairs and Quality|650-837-0799|clin.inquiries@satsumarx.com|
22423594|NCT03448939|Sol-Gel Technologies, Ltd.|Sol-Gel|972-8-9313433|info@sol-gel.com|
22423595|NCT01259375|Huntsman Cancer Institute|Dr. Sunil Sharma|801-587-5559|sunil.sharma@hci.utah.edu|
22393860|NCT00412061|Novartis Pharmaceuticals|Study Director|862-778-8300||
22423596|NCT00986986|University of Hawaii at Manoa|Dominic Chow|(808)737-2751|dominicc@hawaii.edu|
22423597|NCT00628095|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22423598|NCT03124121|Guy's & St Thomas' Hospital|Dr Mark Samaan|07740637713|mark.samaan@gstt.nhs.uk|
22423599|NCT03235115|CooperVision|Jose Vega, O.D., MSc., FAAO|9256213761|javega@coopervision.com|
22423600|NCT01005888|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22423601|NCT01797159|The SKCCC at Johns Hopkins|The SKCCC at Johns Hopkins|4109556980|kjansen3@jhmi.edu|
22423602|NCT00503997|Vanderbilt-Ingram Cancer Center|Jill Gilbert, M.D.|615-343-4677|jill.gilbert@vanderbilt.edu|
22393861|NCT02689518|University of California San Diego|Professor Michael Goldbaum|858 534 3516|mgoldbaum@ucsd.edu|
22393862|NCT01853774|Arizona State University|Professor, College of Nursing and Health Innovation|6024960740|linda.larkey@asu.edu|
22393863|NCT01942590|Duke University Health System|Dwight Koeberl, M.D., Ph.D.|919-684-2036|dwight.koeberl@duke.edu|
22393864|NCT02433340|AbbVie|Global Medical Services|800-633-9110||
22393865|NCT01226095|Abbott|Global Medical Services|800-633-9110||
22393866|NCT03032393|Youngstown State University|Associate Professor|330941-2702|wge@ysu.edu|
22393867|NCT00857272|Braintree Laboratories, Inc.|John McGowan, Associate Director, Clinical Research|781-843-2202|jmcgowan@braintreelabs.com|
22393868|NCT04822597|University of Wisconsin School of Medicine and Public Health|Heather B Neuman, MD, MS, FACS|(608) 263-7064|neuman@surgery.wisc.edu|
22393869|NCT03283072|University of Florida|Mark Bishop|3522736112|bish@ufl.edu|
22393870|NCT03797677|Baxter Healthcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
22393871|NCT02552368|Washington University School of Medicine - Department of Neurology|Dr. Thy Huskey|314-362-4503|huskeyt@wustl.edu|
22393872|NCT00911768|Kyung Hee East-West Neo Medical Center|Jae-Woo Park, KMD, PhD|+082-02-440-6219|pjw2907@khu.ac.kr|
22393873|NCT03661762|Norfolk and Norwich University Hospitals NHS Foundation Trust|Mr John Phillips|: +44 1603 593054|john.phillips@mac.com|
22393874|NCT02859324|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22393875|NCT02819557|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22393876|NCT02665338|Medical University of South Carolina|Dr. Xingbao Li|843 7925729|lixi@musc.edu|
22393877|NCT00998335|University of Florida|Dr. Kenneth Cusi|352-273-7236|KCusi@ufl.edu|
22410982|NCT00387712|Baltimore VAMC|Charlene Hafer-Macko|410-605-7000|charlene.hafer-macko@va.gov|5451
22410983|NCT00006170|University of Pittsburgh|Dr. Michele Levine|412-647-0703|levinem@upmc.edu|
22410984|NCT02030574|Brown Oncology Research Groupl|Kristen M. Mitchell|4018633000|kristen_mitchell@brown.edu|
22410985|NCT01411267|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
22410986|NCT02117193|Federal University of Rio Grande do Sul|Dr Marco Aurélio Vaz|555133085860|marcovaz@esef.ufrgs.br|
22410987|NCT04467697|Marius Pharmaceuticals, LLC|Nita Nimmons|919-374-1913|Nita@mariuspharma.com|
22410988|NCT00268346|Cleveland Clinic Taussig Cancer Institute|David Adelstein MD|216-444-9310|adelstd@ccf.org|
22410989|NCT01924871|Chung-Ang University Hospital|Dr. Chong Wha Baek|82-2-6299-2579|nbjhwa@naver.com|
22410990|NCT02043366|Tianjin Medical University General Hospital|Dr. Guolin Wang|+8615822855556|wangguolinghad@hotmail.com|
22410991|NCT01489956|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22410992|NCT00422656|Dana-Farber Cancer Institute|Irene M. Ghobrial, MD|617-632-4198|irene_ghobrial@dfci.harvard.edu|
22410993|NCT00723554|Actelion Pharmaceuticals, US, Inc.|Wade Benton, PharmD/ Director, Medical Affairs Veletri and Ventavis|(650) 624-6900|wade.benton@actelion.com|
22410994|NCT01405820|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22410995|NCT01665170|PASCOE pharmazeutische Präparate GmbH|Dr. Gabriele Weiß|0641-7960|klinischeforschung@pascoe.de|
22410996|NCT03222141|Edwards Lifesciences|Edwards THV Clinical Affairs|(949) 250-2500|THV_CT.gov@Edwards.com|
22410997|NCT01614509|Yeungnam University College of Medicine|Dr. Min Sagong|82-53-620-4191|msagong@ynu.ac.kr|
22410998|NCT00827359|Beth Israel Deaconess Medical Center|Rupal Bhatt|6177352060|rbhatt@bidmc.harvard.edu|
22410999|NCT02436135|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22411000|NCT02345486|Vanderbilt University Medical Center|Dr. Matthew Semler|615-322-3412|matthew.w.semler@vumc.org|
22411001|NCT00415532|Amgen Inc.|Study Director|866-572-6436||
22411002|NCT01698320|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com|
22411003|NCT01107535|Abbott|Global Medical Services|1-800-633-9110||
22411004|NCT03567057|Adamas Pharmaceuticals, Inc.|Head, Regulatory Affairs|+1 (510) 450-3500|drugsafety@adamaspharma.com|
22411005|NCT01271933|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22411006|NCT01620983|Virginia Commonwealth University|Dr. Daniel L. Riddle|804-828-0234|dlriddle@vcu.edu|
22411007|NCT02777931|Aevi Genomic Medicine|Garry A Neil, MD|610-254-4208|garry.neil@aevigenomics.com|
22411008|NCT03156270|Dept. of Otolaryngology-Head and Neck Surgery, The Ohio State University|Kai Zhao, PhD.|614-293-3857|zhao.1949@osu.edu|
22411009|NCT00591253|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22411010|NCT00362401|Aarhus University Hospital, Skejby|Dr. Thais A. Pedersen, primary investigator|+45 8949 5484|thais.a.pedersen@ki.au.dk|
22411011|NCT01783730|AbbVie|Global Medical Services|800-633-9110||
22411012|NCT01841359|Joslin Diabetes Center|Mary Elizabeth Patti, MD|6173092635|MaryElizabeth.Patti@joslin.harvard.edu|
22411013|NCT00871169|University of New Mexico Comprehensive Cancer Center|Fa-chyi Lee, MD|505-925-0405|flee@salud.unm.edu|
22411014|NCT03764059|Peking University Hospital of Stomatology|Xiaoyan Wang|010-82195525|wangxiaoyanpx@163.com|
22393878|NCT05110690|Washington University School of Medicine|Michael Avidan, MBBCh, FCASA|314-273-4136|avidanm@wustl.edu|
22393879|NCT01586910|Medtronic, Inc.|Peggy Yunker|763-514-4000|surtavi@medtronic.com|
22393880|NCT00953407|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22423603|NCT01065714|DermResearch, PLLC|Leon Kircik, M.D.|502-451-9000|wedoderm@yahoo.com|
22393881|NCT02186223|Bio2 Medical, Inc.|Chief Medical Officer|720-833-5675|langel@bio2medical.com|
22393882|NCT00252733|AstraZeneca|Niklas Berglind, GPS Atacand|+46 31 7766310|ClinicalTrialTransparency@astrazeneca.com|
22393883|NCT01111474|Federal University of São Paulo|Dr. Olga Dumont Flecha - PHD student|38 35326082|olgaflecha@gmail.com|
22393884|NCT00618982|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22393885|NCT04289051|Sunstar Americas, Inc.|Akane Takemura|18477944276|akane.takemura@us.sunstar.com|
22393886|NCT00156819|Johns Hopkins Center for Clinical Trials|Razan Yasin|443-287-5796|ryasin1@jhu.edu|
22393887|NCT01689337|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22393888|NCT05877508|University of California San Francisco|Michael Peluso|(415) 502-2449|michael.peluso@ucsf.edu|
22393889|NCT04800432|University of South Florida|Tatyana Harris|(813) 974-7454|trharris1@usf.edu|
22393890|NCT05398237|University of Arizona Cancer Center|Clara Curiel-Lewandrowski, MD|(520) 626-5351|ccuriel@arizona.edu|
22393891|NCT02370810|Anglia Ruskin Univeristy|Eldre Beukes|1223698847|eldre.beukes@anglia.ac.uk|2847
22393892|NCT01312857|Memorial Sloan Kettering Cancer Center|Dr. Nancy Kemeny, MD|646-888-4180|kemenyn@MSKCC.ORG|
22393893|NCT01248065|Penn State University Dept. of Public Health Sciences|Tonya S. King, PhD|717-531-7178|tking@psu.edu|
22393894|NCT02234687|New York University School of Medicine|Charles Marmar, MD|646 754 4855|Charles.Marmar@nyumc.org|
22393895|NCT01762501|Sogo Rinsho Medefi Co., Ltd|Naoyuki Takano|+81-3-6901-6079|takano.naoyuki@sogo-medefi.jp|
22393896|NCT02781844|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22393897|NCT00321373|GlaxoSmithKline|GSK Response Center|866-435-7343||
22393898|NCT01383499|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22393899|NCT01774487|Baylor College of Medicine and Texas Children's Hospital|Sanjiv Harpavat|832-824-2099|harpavat@bcm.edu|2144
22393900|NCT02192879|Duke University Medical Center|Elizabeth Malinzak, MD|919-681-9660|elizabeth.malinzak@duke.edu|
22393901|NCT01833845|BioLineRx LTD|Dr. Arnon Aharon|972-2-548-9100|arnona@biolinerx.com|104
22423604|NCT03973918|ABTC Consortium|Director of ABTC Consortium|410-955-8837|jfisher@jhmi.edu|
22423605|NCT04281901|Department of Otorhinolaryngology and Cervicofacial Surgery, University Medical Centre Ljubljana, Ljubljana, Slovenia. Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.|Domen Vozel, M.D., Saba Battelino, M.D., PhD.|+386 (0)1 522 83 07|domen.vozel@kclj.si|
22423606|NCT03584464|Medtronic, plc|Alissa Anderson, Clinical Study Manager|7075912434|alissa.anderson@medtronic.com|
22423607|NCT03338803|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22423608|NCT02978859|Columbia University|Benjamin Izar|212 304 5871|bi2175@cumc.columbia.edu|
22423609|NCT02719938|University of North Carolina at Chapel Hill|Laura C. Hanson, MD, MPH|919-843-4096|lhanson@med.unc.edu|
22423610|NCT00955968|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22423611|NCT01455181|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22423612|NCT00565669|Carolina Eye|Helga Sandoval||hps@cepmd.com|
22423613|NCT02513498|H. Lee Moffitt Cancer Center|Dr. Joseph Pidala|813-745-2556|joseph.pidala@moffitt.org|
22393902|NCT00477334|Novartis Pharmaceuticals|Study Director|862-778-8300||
22423614|NCT02767492|Hawkins Foundation|Kyle Adams|864 454-7458|kyle.adams@hawkinsfoundation.com|
22423615|NCT03596723|Kala Pharmaceuticals, Inc|VP Clinical Development|781-996-5252|Results010@kalarx.com|
22423616|NCT02484651|Universidade Aberta, Mathematics Section|Prof. Catarina S Nunes|+351 300 001 705|cnunes@bio-mathematics.org|
22423617|NCT04972968|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22423618|NCT00150800|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22423619|NCT01698879|CETLAM|Dr. Jordi Sierra|+34 93 434 44 12|jsierra@santpau.cat|
22423620|NCT03649178|Vanderbilt University Medical Center|C. Michael Stein MD|615-936-3420|michael.stein@vumc.org|
22423621|NCT04120584|Inmode|Maria Shusterman|9057076787|Maria.Shusterman@inmodemd.com|
22423622|NCT03619902|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
22423623|NCT03660475|Penn State Hershey Medical Center|Joseph Sassani, MD, MHA|717 531 8783|jsassani@pennstatehealth.psu.edu|
22423624|NCT02251548|Dana-Farber Cancer Institute|Matthew Davids, MD|617-632-6331|matthew_davids@dfci.harvard.edu|
22423625|NCT00794040|Mood, Brain and Development Unit, Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health|Dr Argyris Stringaris|(301) 443-8019|argyris.stringaris@nih.gov|
22423626|NCT04687072|Argenx|Regulatory manager|Please email|regulatory@argenx.com|
22423627|NCT01263782|UT MD Anderson Cancer Center|Dr. George Simon, Thoracic/Head & Neck Med Onc|713-794-4740|GSIMON@MDANDERSON.ORG|
22423628|NCT02336360|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
22423629|NCT04545567|University of Virginia|Mark DeBoer|1 434 924 0123|mdd5z@virginia.edu|
22423630|NCT03979807|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22423631|NCT02754674|Samsung Medical Center|Wang, JoonHo|82-2-3410-3507|mdwang88@gmail.com|
22423632|NCT04009668|University of Michigan|Dr. Zubin Modi|(734) 232-6798|modiz@med.umich.edu|
22442200|NCT01888432|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22393903|NCT02572882|University of Pennsylvania|Natalie Kuzla|215-573-2935|nkuzla@pennmedicine.upenn.edu|
22393904|NCT00952120|University of Chicago|Lawrence Gottlieb|(773) 702-6302|lgottlie@surgery.bsd.uchicago.edu|
22393905|NCT04745026|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
22423633|NCT03626363|Michigan Technological University|Kelly Kallio, Assistant Vice President of Sponsored Programs|9064872226|kmkallio@mtu.edu|
22423634|NCT00965341|The University of Texas (UT) MD Anderson Cancer Center|Rony Dev, DO / Assistant Professor|713-745-4192|HMoreno@mdanderson.org|
22423635|NCT01077739|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22423636|NCT00960986|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22423637|NCT00877071|University of Pittsburgh Medical Center|Dr. David Geller|412-692-2001|gellerda@upmc.edu|
22423638|NCT01842906|Stanford Department of Emergency Medicine|Dr. Grant Lipman|415-290-9286|gslipman@stanford.edu|
22423639|NCT01556997|Symplmed Pharmaceuticals LLC|Jeff Feldstein, Sr. Vice President and CMO|888-552-9769|feldstein@symplmed.com|
22423640|NCT05459558|HALEON|Haleon Response Center|+447880182593|ww.clinical-trial-register@haleon.com|
22423641|NCT03278847|Imperial College London|Dr Chris Gale, Reader in Neonatal Medicine|+44 203 3153519|christopher.gale@imperial.ac.uk|
22423642|NCT05175131|Abbott|Suntje Sander-Struckmeier, PhD|+49 (0) 511 6750 3254|suntje.sander@abbott.com|
22423643|NCT05711381|Hanmi Pharmaceutical Co., Ltd.|Moon Hee Lee, MD|+82 2 410 9062|mhlee7@hanmi.co.kr|
22423644|NCT00182728|University of North Carolina Lineberger Comprehensive Cancer Center|Robin V Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22423645|NCT00250458|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22423646|NCT00741091|Boston Scientific Corporation|Todd Kornmann, Specialist, Prin Reg Affairs|763-494-1348|Todd.Kornmann@bsci.com|
22423647|NCT03502018|Maimonides Medical Center|Dr. Kevin Kang|718-283-8805|kkang@maimonidesmed.org|
22423648|NCT00201240|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
22423649|NCT00525902|Oregon Health & Science University|Eric B. Suhler|503-494-5023|suhlere@ohsu.edu|
22423650|NCT00480493|University of Massachusetts, Worcester|Susan Sullivan-Bolyai|508-856-4185|susan.sullivan-bolyai@umassmed.edu|
22423651|NCT03747302|Norris Cotton Cancer Center|Dr. Ardis Olson|603-643-2385|Ardis.Olson@dartmouth.edu|
22423652|NCT00583375|Wright Medical|Stephen Roach|615-656-7466|Stephen.Roach@wright.com|
22423653|NCT03769675|Mayo Clinic|Narayan R. Kissoon, M.D.|507-284-4961|Kissoon.Narayan@mayo.edu|
22423654|NCT02844907|Durham VAMC|David D'Alessio, MD|919-684-5778|david.dalessio2@va.gov|
22423655|NCT00738062|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
22423656|NCT02945254|Brigham and women's Hospital|Andrew Wellman|6174078483|awellman@rics.bwh.harvard.edu|
22423657|NCT00783224|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22423658|NCT01711619|Medtronic|Global Clinical Study Manager||medtronicneurotrials@medtronic.com|
22423659|NCT03422159|Community Medical Center Department of Critical Care, Department of Nephrology|Jose Iglesias, DO|732-557-8070|jiglesias23@gmail.com|
22423660|NCT04631107|Apnimed, Inc.|Clinical Trials|617-500-8880|clinicaltrials@apnimed.com|
22423661|NCT04601103|3M Health Care Business Group|Brenda Coalwell, Clinical Affairs Manager|16517362456|bccoalwell1@mmm.com|
22423662|NCT01068626|University of Gothenburg|Kristjan Karason|+46 31 342 7554|kristjan.karason@gu.se|
22423663|NCT04424966|Ivy Brain Tumor Center|Dr. Nader Sanai|602-406-8605|research@ivybraintumorcenter.org|
22423664|NCT03932331|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22433975|NCT02931838|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22433976|NCT01963767|University of South Florida|Dr. Brent Small|813-974-9746|bsmall@usf.edu|
22433977|NCT01659996|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22393906|NCT02926898|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22393907|NCT02292927|Imperial Colege London|Colin Bicknell|02033126072|alison.deslandes@imperial.nhs.uk|
22393908|NCT01656733|University of Connecticut School of Medicine|Cheryl Oncken, MD, MPH|860-679-3425|oncken@uchc.edu|
22393909|NCT00116337|MetroHealth Medical Center|Dr. Anthony Dimarco|216-778-3906|adimarco@metrohealth.org|
22393910|NCT01415531|Forest Research Institute|Tatjana Lukic, MD, MSc|(201) 427-8649|tanya.lukic@frx.com|
22393911|NCT00122460|Merck Serono|Inmaculada Ollero/Clinical Trial Manager|+34935655433|iollero@merck.es|
22393912|NCT02962960|AstraZeneca AB|Global Clinical Lead|301-398-5799|ClinicalTrialTransparency@astrazeneca.com|
22393913|NCT01236339|W.L. Gore and Associates, Inc.|Arthur Scott / Clinical Study Manager|623.234.5263|artscott@wlgore.com|
22393914|NCT02054741|University of Rochester, Medical Center|Dr. Supriya Mohile, Professor of Medicine|585-275-0394|URCC_GAP70@urmc.rochester.edu|
22393915|NCT00394082|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22393916|NCT03430531|Penn State Hershey Medical Center|Dr. Verghese Cherian|7175318521|vcherian@pennstatehealth.psu.edu|
22393917|NCT02344004|Insmed Inc|Kevin Mange (Senior Vice President, Clinical Development & Medical Affairs, ALIS)|908-947-2651|kevin.mange@insmed.com|
22423665|NCT01032239|Medtronic Clinical Neuromodulation|Alessandra Calabrese, PhD||alessandra.calabrese@medtronic.com|
22423666|NCT01940900|Ophthotech Corp.|Denise Teuber||denise.teuber@ophthotech.com|
22393918|NCT01768117|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22393919|NCT01945060|University of Virginia|Marc D Breton|14349826484|mb6nt@virginia.edu|
22423667|NCT04535531|Novan|Cathy White, Vice President, Drug Development Operations|919-485-8080|clinical@novan.com|
22423668|NCT00204477|University of Texas Medical Branch Galveston|Leejane W. Lu|(409)772-1011|llu@utmb.edu|
22423669|NCT04713592|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22423670|NCT03098498|Department of Periodontology, University Hospital Wuerzburg|Dr. Yvonne Jockel-Schneider|49-931-201-72620|jockel_y@ukw.de|
22423671|NCT02225366|UT MD Anderson Cancer Center|Dr. Rodabe Amaria,MD, Associate Professor, Melanoma Medical Oncology|(713) 792-2921|rnamaria@mdanderson.org|
22423672|NCT00654992|Seoul National University Bundang Hospital|Effect of erythropoietin in kidney after cardiac surgery|82-31-787-7014|kyna@snubh.org|
22423673|NCT01056198|Healthpoint Biotherapeutics|Jaime E. Dickerson, PhD; Sr. Director Clinical Affairs|817-302-3914|jaime.dickerson@healthpoint.com|
22423674|NCT03782298|Smtih + Nephew, Inc|Judith Horner|+44 1482 673251|Judith.horner@smith-nephew.com|
22423675|NCT00742508|GlaxoSmithKline|GSK Response Center|866-435-7343||
22423676|NCT02431806|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22423677|NCT01382225|Alcon Research, Ltd.|Michela Montecchi-Palmer, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22423678|NCT02426749|University of Manitoba|Dr Zahra Moussavi|204 474 7023|Zahra.Moussavi@umanitoba.ca|
22423679|NCT01797081|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22423680|NCT01793688|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22423681|NCT01419080|Saint Luke's Hospital of Kansas City|John Spertus|816-932-8270|jspertus@saint-lukes.org|
22423682|NCT05238025|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
22423683|NCT01638312|Kaohsiung Medical University Chung-Ho Memorial Hospital|JihJin Tsai, MD|886-7-3121101|jijits@cc.kmu.edu.tw|6358
22423684|NCT03814720|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Alicia T Widge, M.D.|301-451-8715|alicia.widge@nih.gov|
22423685|NCT02135107|Eisai Co., Ltd. and EA Pharma Co., Ltd.|Public Relations Group (EA Pharma Co., Ltd.)|+81-(0)3-6280-9600|contact_ea@eapharma.co.jp|
22423686|NCT03083561|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22423687|NCT00474045|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22423688|NCT01095978|Abbott|Global Medical Services|1-800-633-9110||
22423689|NCT02009397|University of Louisville, James Graham Brown Cancer Center|Dr. Jason Chesney|502-562-3429|jason.chesney@louisville.edu|
22423690|NCT05523011|Paracrine Therapeutics Private Limited|Lai Ruenn Chai|+6593375977|ruennchai.lai@paracrinetherapeutics.com|
22423691|NCT00581347|University of Rochester Medical Center|Peter Szilagyi|585-275-5798|peter_szilagyi@urmc.rochester.edu|
22423692|NCT02987374|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
22423693|NCT02278120|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
22423694|NCT00287989|MSKCC|Charles M. Rudin, MD, PhD.|646-888-4527|rudinc@mskcc.org|
22423695|NCT00808639|Dana-Farber Cancer Institute|Toni Choueiri, MD|617-632-5456|toni_choueiri@dfci.harvard.edu|
22423696|NCT01966068|Children's Hospital of Philadelphia|Alexander Fiks, MD, MSCE|267-426-2304|fiks@email.chop.edu|
22423697|NCT02266472|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
22423698|NCT03197324|Theracos Sub, LLC|Albert Collinson, Ph.D.|508-688-4221|acollinson@theracos.com|
22423699|NCT00129727|Massachusetts General Hospital|Richard T Penson MD MRCP|617-726-5867|rpenson@partners.org|
22423700|NCT03589976|NYU Langone Health|Jose-Alberto Palma, MD, PhD|212-263-7225|JoseAlberto.PalmaCarazo@nyulangone.org|
22423701|NCT02776644|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22423702|NCT02089334|Rexahn Pharmaceuticals Inc.|Doug Swirsky/ Chief Executive Officer|240-268-5300|swirskyd@rexahn.com|
22423703|NCT04778059|US Biotest, Inc.|Dr. Gere diZerega|8055951300|gere.dizerega@usbiotest.com|
22423704|NCT02832375|GlaxoSmithKline|GSK Response Center|866-435-7343||
22423705|NCT01378377|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22423706|NCT05537792|Georgia Institute of Technology|Dr. Aaron Young|404.385.5306|aaron.young@me.gatech.edu|
22423707|NCT02100670|GlaxoSmithKline|GSK Response Center|866-435-7343||
22423708|NCT00549601|Novartis Pharmaceuticals|Study Director|862-778-8300||
22423709|NCT02824562|UAB|Jessica Merlin|2059967894|jmerlin@uabmc.edu|
22423710|NCT02389374|Menzies School of Health Research|Benedikt Ley|889468643|benedikt.ley@menzies.edu.au|
22411015|NCT01752920|Basilea Pharmaceutica International Ltd.|Study Director|+41 79 701 0551|marc.engelhardt@basilea.com|
22411016|NCT00769015|Thomas Jefferson University|Robin Casten|215-503-1250|Robin.Casten@jefferson.edu|
22411017|NCT00771901|Washington University School of Medicine in Saint Louis, Missouri|Samuel Klein, M.D.|314-362-8708|sklein@wustl.edu|
22411018|NCT00947765|Dr. Chetan Muralidhara Rao Dojode. Resident in Orthopaedics and Traumatology.|Dr. Chetan Muralidhara Rao Dojode, MBBS,MS(Ortho)|91 9844592532|docchetanmd@yahoo.co.in|
22411019|NCT01328054|GlaxoSmithKline|GSK Response Center|866-435-7343||
22411020|NCT01855126|Rensselaer Polytechnic Institute|Mariana Figueiro|(518)687-7142|figuem@rpi.edu|
22411021|NCT01491490|GW Research Ltd.|Mr Colin Stott|+44 (0)1980 557000|cgs@gwpharm.com|
22411022|NCT01298596|University of Washington|Dr. Michael H. Chung|‭(206) 302-8361‬|mhchung@uw.edu|
22411023|NCT01629693|Alcon Research, Ltd.|Jessie Lemp, GMA Affairs Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22411024|NCT03740100|MD Anderson Cancer Center|Dr. Faye Johnson|7137922121|fmjohns@mdanderson.org|
22411025|NCT02340156|SynerGene Therapeutics, Inc.|Senior Consultant|301-706-1509|clinicaltrial@synergeneus.com|
22411026|NCT01191255|Keryx Biopharmaceuticals Inc|Medical Information|1-844-44-KERYX (1-844-445-3799|medicalinfo@keryx.com|
22411027|NCT00185211|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22411028|NCT00254397|University of Texas MD Anderson Cancer Center|Patrick Hwu, MD / Professor, Melanoma Medical Oncology|713-792-2921|phwu@mdanderson.org|
22411029|NCT01759537|NYU College of Dentistry|Ismael Khouly|212-998-9800|iek3@nyu.edu|
22411030|NCT01386879|University of Missouri Columbia|Boris Mraovic|573-882-2568|mraovicb@health.missouri.edu|
22411031|NCT01715415|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
22411032|NCT01015612|Medtronic|Dr Deama Amr (PhD)|+61 2 9857 9157|deama.amr@medtronic.com|
22411033|NCT00420290|Vanderbilt University|Adriana Hung, MD||adriana.hung@vanderbilt.edu|
22411034|NCT05028751|Kronos Bio, Inc.|VP, Corporate Affairs|+16507815200|media@kronosbio.com|
22411035|NCT04578548|Galapagos NV|Galapagos Medical Information|+3215342900|medicalinfo@glpg.com|
22393920|NCT00138671|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22393921|NCT02534038|Avanir Pharmaceuticals, Inc.|Sanjay Dubé, M.D.|949-389-6700|sdube@avanir.com|
22423711|NCT00908596|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22423712|NCT00224406|Dompé farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22423713|NCT01010009|Northumbria university|Emma Wightman|+44 (0) 191 2437253|emma.l.wightman@unn.ac.uk|
22423714|NCT02020837|University of Arkansas for Medical Sciences|Beth Scanlan|5016868274|BScanlan@uams.edu|
22423715|NCT01250171|Novartis Pharmaceuticals|Study Director|862 778-8300||
22423716|NCT05103176|University of Michigan|Dr. Michael Vesia, Assistant Professor|734 763-3905|mvesia@umich.edu|
22423717|NCT03711058|Sidney Kimmel Cancer Center at Johns Hopkins|Nilofer Azad, MD|610-614-9169|nazad2@jhmi.edu|
22423718|NCT02672332|Novan, Inc.|Cathy White, Vice President, Drug Development Operations|919-485-8080|clinical@novan.com|
22423719|NCT03427268|Pharmamar, S.A.|Clinical Developtment, Department of PharmaMar´s Oncology, Business Unit.|0034 91846 60 00|clinicaltrials@pharmamar.com|
22423720|NCT02638129|Orexigen Therapeutics, Inc.|Global Head of Development|858-875-8600|MedInfo@Orexigen.com|
22423721|NCT03117881|University of Alabama at Birmingham|Dr. Tapan Mehta|205) 975-9171|tapan@uab.edu|
22423722|NCT05070468|Alborz University of Medical Sciences|Dr. Masoumeh Farahani|09123783823|drfarahani73@yahoo.com|
22423723|NCT02309723|Tufts Medical Center|Dr.Yue Zhong, Project Director of Center for the Evaluation of Value and Risk in Health|6176361424|yzhong@tuftsmedicalcenter.org|
22423724|NCT02560623|Mayo Clinic|Dr. Prasad G. Iyer|507-293-7911|iyer.Prasad@mayo.edu|
22423725|NCT01349322|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22423726|NCT04527003|MSHersheyMC|Dr. Kristin Riley|7175316647|kriley1@pennstatehealth.psu.edu|
22423727|NCT01565668|Contact for Clinical Trial Information|Daiichi Sankyo|1-908-992-6400|CTRinfo@dsi.com|
22423728|NCT01097421|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22423729|NCT02063178|University of Tennessee Health Science Center|Rebecca Krukowski|9014482426|rkrukows@uthsc.edu|
22423730|NCT06137703|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22423731|NCT01801358|Array BioPharma, Inc.|Study Director|303-381-6604|clinicaltrials@arraybiopharma.com|
22423732|NCT02570139|3M Critical and Chronic Care Solutions Division|Anne Swearingen, Manager, Clinical Operations|651 736 7826|aswearingen@mmm.com|
22423733|NCT04093492|Medical College of Wisconsin|Dr. Mir A Basir|414-266-6820|mbasir@mcw.edu|
22423734|NCT02303990|University of Pennsylvania|Dr. Amit Maity|215) 662-3759|maity@uphs.upenn.edu|
22423735|NCT01576003|Cincinnati Children's Hospital Medical Center|Conrad R. Cole, MD|513-636-6155|conrad.cole@cchmc.org|
22423736|NCT01928797|Brigham and Women's Hospital|Dr. Bhavani Kodali|617-732-8220|BKODALI@BWH.HARVARD.EDU|
22423737|NCT03436199|Adamas Pharmaceuticals, Inc.|Head, Regulatory Affairs|+1 (510) 450-3500|drugsafety@adamaspharma.com|
22423738|NCT02525536|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22423739|NCT00087126|NRG Oncology|Angela Kuras on behalf of James Kauderer|716-845-5702|kurasa@nrgoncology.org|
22423740|NCT01432275|Abbott Diabetes Care|Snr Director, Clinical Development & Regulatory Affairs|01993863164|joe.bugler@abbott.com|
22423741|NCT01839799|University of Pennsylvania|Jennifer Louie, Program Manager|215-220-9668|Jennifer.Louie2@pennmedicine.upenn.edu|
22423742|NCT01836809|Virginia Commonwealth University|Keyur Shah, MD|804-828-4571|kshah@mcvh-vcu.edu|
22423743|NCT01935128|University of Toledo Medical Center|Michael A. Rees, MD, PhD|419 383-3961|michael.rees2@utoledo.edu|
22423744|NCT00096993|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
22423745|NCT00475878|Butler Hospital|Dr. Michael Stein|401-455-6646|michael_stein@brown.edu|
22423746|NCT01225289|Tehran University of Medical Sciences|The Study of the Effects of Vitamin A Supplementation on Immune System and Th1/Th2 Balance in Patien|+98 912 2182815|sjafarirad@gmail.com|
22423747|NCT02203162|Montefiore Medical Center|Peter Dicpinigaitis, MD|718-904-2676|pdicpini@montefiore.org|
22423748|NCT01438814|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22423749|NCT01739764|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22423750|NCT00404924|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22423751|NCT03887429|Promentis Pharmaceuticals|Chad Beyer|(414) 238 2992|cbeyer@promentispharma.com|
22423752|NCT00513357|University of Texas MD Anderson Cancer Center|Dr. Egidio Del Fabbro|713-563-4157|ammarin@mdanderson.org|
22423753|NCT01162122|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22423754|NCT02020512|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22423755|NCT01001806|Bucci Laser Vision|Frank A. Bucci, Jr., MD|570-825-5949|Buccivision@aol.com|
22423756|NCT05127304|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22393922|NCT02084056|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22393923|NCT01488487|Div. of Hematology and Oncology, Univ. of North Carolina at Chapel Hill|Dr. Hanna Sanoff|919-966-4431|hanna_sanoff@med.unc.edu|
22393924|NCT00395460|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22393925|NCT02943226|The University of Texas Health Science Center at Houston|Joseph P. Hasapes, M.D.|(713) 566-5440|Joseph.P.Hasapes@uth.tmc.edu|
22393926|NCT00250926|Dana Farber Cancer Institute|Steven P. Treon MD PhD|617 632 2681|steven_treon@dfci.harvard.edu|
22393927|NCT00298090|UTHSCSA|Jane Youngers|210-567-2340|youngers@uthscsa.edu|
22393928|NCT02354443|Fate Therapeutics, Inc.|Chris Storgard, Chief Medical Officer|866-875-1833|chris.storgard@fatetherapeutics.com|
22393929|NCT01708213|TauTona Group|Ann Thomas|650-331-2461|athomas@tautonagroup.com|
22423757|NCT00656851|Washington Univ Med Sch|Kevin Yarasheski, PhD|3143628173|key@wustl.edu|
22423758|NCT00835679|Vanderbilt-Ingram Cancer Center|Emily Chan, MD|615-343-4677|emily.chan@vanderbilt.edu|
22393930|NCT02489123|University of Washington|Ajay K. Gopal, MD|206-606-2037|agopal@uw.edu|
22393931|NCT00938860|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22393932|NCT01605019|Houston Methodist Research Institute|Raquel R Bunge|713-441-3912|rrbunge2@houstonmethodist.org|
22393933|NCT01464840|University of Alabama at Birmingham|Amelia Sutton, M.D., Ph.D.|205-934-5612|alsutton@uab.edu|
22393934|NCT04223830|Boston Scientific|Victoria Lazzari|508-382-9132|victoria.lazzari@bsci.com|
22393935|NCT00324116|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22393936|NCT01806623|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22393937|NCT01737827|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22393938|NCT01451827|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22393939|NCT01964924|The Ohio State University Comprehensive Cancer Center|Bhuvaneswari Ramaswamy|614-293-8858|Bhuvaneswari.Ramaswamy@osumc.edu|
22393940|NCT01528345|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22393941|NCT01034163|Novartis|Study Director|862-778-8300||
22393942|NCT00528645|Mayo Clinic|Julian R. Molina, M.D., Ph.D.|507-284-8318|molina.julian@mayo.edu|
22393943|NCT00296400|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22393944|NCT05332145|HealthPartners Institute|Stephanie Hooker, PhD, MPH|952-967-5056|stephanie.a.hooker@healthpartners.com|
22393945|NCT02734953|Allegheny Health Network|Dr Raymond Benza|412-359-3131|raymond.benza@ahn.org|
22393946|NCT03406078|AstraZeneca|Global Clinical Head|+1 302 885 1180|information.center@astrazeneca.com|
22393947|NCT00467350|Children's Mercy Hospitals and Clinics|Melissa Miller MD|8162343000|mmiller@cmh.edu|
22393948|NCT03538301|Nitto Denko Corporation|Nitto Denko Corporation Study Director|858-255-3010|clinicaltrialinfo005@nitto.com|
22393949|NCT03616977|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22393950|NCT00591851|Memorial Sloan-Kettering Cancer Center|Dr. Chau Dang|914-367-7181|dangc@mskcc.org|
22393951|NCT00515853|University of Southampton|Sophie A. Pilkington|+44 (0)23 8059 5058|rgioinfo@soton.ac.uk|
22393952|NCT04041453|Universidad Nacional de Salta|Alejandro J Krolewiecki|+54 911 3183-8673|alekrol@hotmail.com|
22393953|NCT03798691|UW School of Medicine and Public Health|Freddy Caldera, DO|608-628-8201|fcaldera@medicine.wisc.edu|
22393954|NCT04548544|University of California, San Francisco|Olga Tymofiyeva|415-514-4870|Olga.Tymofiyeva@ucsf.edu|
22393955|NCT02368457|Oral and Maxillofacial Surgeon|Dr. Miriam Martos|+34932746179|miryam.martos@gmail.com|
22393956|NCT04807582|Imperial College London|Professor Eric Aboagye|0203 313 3720|eric.aboagye@imperial.ac.uk|
22411036|NCT02248285|BioFire Diagnostics|Director of Clinical Affairs|8017366354|kevin.bourzac@biofiredx.com|
22411037|NCT00972153|Nimbic Systems|Sean Self|281-565-5715|self@nimbicsystems.com|
22411038|NCT04192799|The Dartmouth Institute for Health Policy & Clinical Practice|Stephanie Acquilano, Research Project Director|603-646-5937|stephanie.acquilano@dartmouth.edu|
22411039|NCT01077713|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
22411040|NCT04136626|Massachusetts General Hospital|Dr. Sabine Wilhelm, Chief of Psychology|617-724-6146|swilhelm@mgh.harvard.edu|
22393957|NCT00715754|University of Utah|Laurie Moyer-Mileur|801/587-7488|Laurie.Moyer-Mileur@hsc.utah.edu|
22393958|NCT04609306|University of Orthopaedics|Jonathan Wright, MD|(352) 273-7001|wrightjo@ortho.ufl.edu|
22393959|NCT02808143|Northwestern University Feinberg School of Medicine|Joshua Meeks, MD, PhD|312-363-8959|Joshua.meeks@northwestern.edu|
22393960|NCT01874431|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22393961|NCT03834051|Vancouver Island Health Authority|Dr. Christine Lee|250 519 1898|christine.lee@viha.ca|
22393962|NCT03718533|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
22393963|NCT01147601|Oregon Health & Science University|Dr. Alfons Krol|503-494-9993|krola@ohsu.edu|
22393964|NCT02469389|VISN 5 MIRECC|Dr. Melanie Bennett|(410) 637-1850|Melanie.Bennett@va.gov|
22393965|NCT04275089|Reia, LLC|Kaitlin Maier|2032742886|kaitlin@reiahealth.com|
22393966|NCT01079663|Dexcel Pharma|Clinical Trial Department Manager|972-4-6364000|sigalit.melcer@dexcel.com|467
22393967|NCT02418676|State University of Maringá - Paraná - Brazil|Dra. Graciette Matioli|55 44 3011-3868|gmatioli@uem.br|
22393968|NCT03606668|NYU Langone Health|Leigh Charvet, PhD|(929) 455-5141|Leigh.Charvet@nyulangone.org|
22393969|NCT01014143|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
22393970|NCT01028937|NTK Enterprises, Inc.|Nancy Lockerman|831-869-1384|nlockerman@opti-k.com|
22393971|NCT02354508|Novartis Pharmaceuticals|Study Director|826-778-8300|novartis.email@novartis.com|
22393972|NCT00760006|Chilsren's Hospital of Pittsburgh of UPMC|Dr. Joseph E. Losee|412-692-6203|joseph.losee@chp.edu|
22393973|NCT04447846|Kenndey Krieger Institute|Dr. Anne Comi|443-923-9127|comi@kennedykrieger.org|
22393974|NCT00461032|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22393975|NCT00297232|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22393976|NCT00180323|Rigshospitalet, Copenhagen Unviversity Hospital, Denmark|Dr. Jesper Hastrup Svendsen||jesper.hastrup.svendsen@rh.regionh.dk|
22393977|NCT02350777|Memorial Sloan Kettering Cancer Center|Dr. Roni Tamari, MD|212-639-5987|tamarir@mskcc.org|
22393978|NCT03536143|Krystal Biotech|Dr. Hubert Chen, MD, Senior Vice President of Clinical Development|(412) 586-5830|inquiries@krystalbio.com|
22393979|NCT01878214|Washington University School of Medicine in St. Louis|Jaime Strickland, MA|314-454-7337|jstrickl@dom.wustl.edu|
22393980|NCT03038438|Medtronic|Stephanie Cihlar|763.258.9524|stephanie.a.cihlar@medtronic.com|
22423759|NCT05020899|Boston Medical Center|Lisa Quintiliani, PhD|617-638-2777|lisa.quintiliani@bmc.org|
22423760|NCT02738255|Brigham and Women's Hospital|Andrew Wellman|6174078483|awellman@rics.bwh.harvard.edu|
22423761|NCT00359736|Miami VAHS|Dr. Robert M Jackson, ACOS/R|305-575-3548|robert.jackson4@va.gov|
22423762|NCT00191282|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22423763|NCT00102531|Insmed|Margaret Galluzzi|(908) 977-9900|Margaret.Galluzzi@Insmed.com|
22423764|NCT00288067|University of Washington|Dr. Ajay Gopal|206-288-2035|agopal@uw.edu|
22423765|NCT02807506|Penn Medicine Center for Physical Medicine and Rehabilitation|Dr. Michelle J. Johnson|4148130128|johnmic@pennmedicine.upenn.edu|
22393981|NCT01174160|Cardiome Pharma|Jonathan Mather, Director, Head of Regulatory Affairs|+44 (0)7581148916|jmather@cardiome.com|
22393982|NCT00992433|Baylor College of Medicine|Hana El Sahly, MD|713-798-2058|hanae@bcm.edu|
22393983|NCT01590017|AMC Statistical Center|Jeannette Lee, PhD.|501-526-6712|jylee@uams.edu|
22423766|NCT04756154|3M|Linda Olson|651-736-3586|lkolson2@mmm.com|
22423767|NCT01790828|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22423768|NCT00710684|GlaxoSmithKline|GSK Response Center|866-435-7343||
22423769|NCT00514904|GlaxoSmithKline|GSK Response Center|866-435-7343||
22423770|NCT00084318|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22423771|NCT05250102|Medline Industries, LP|Julie J. Finley|(800) 633-5463|jjfinley@medline.com|
22423772|NCT02921750|Mölnlycke Health Care|Maria Åberg Håkansson|+46 31722 3000|maria.aberghakansson@molnlycke.com|
22423773|NCT01361113|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22423774|NCT04676412|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22423775|NCT04550832|LigaChem Bioscience, Inc.|Seonghye Cheon|+82)02-6952-0689|scheon@ligachembio.com|
22423776|NCT04823130|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22423777|NCT03312595|Acera Surgical, Inc.|Chief Science Officer|844-879-2237|information@acera-surgical.com|
22423778|NCT03315455|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22423779|NCT04765722|McMaster University|Dr. Imran Satia|905 5212100|satiai@mcmaster.ca|76228
22423780|NCT03596671|BlueWind Medical|Medical Affairs|612-203-5739|peter.rodine@bluewindmedical.com|
22423781|NCT02407132|University of Arkansas for Medical Sciences|Dr. Pearl McElfish|479-713-8680|pamcelfish@uams.edu|
22393984|NCT02038543|Mayo Clinic|Dr. John C. Lieske|507-284-2064|Lieske.John@mayo.edu|
22423782|NCT01458951|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22423783|NCT00585013|Baylor College of Medicine|Paul Checchia MD|832-826-5011|checchia@bcm.edu|
22423784|NCT01846221|Columbia University|Allison Lee, MD - Assistant Professor of Anesthesiology|212-342-2028|al3196@cumc.columbia.edu|
22423785|NCT04392167|Duke University|Dr. Adam Wax|919-660-5143|a.wax@duke.edu|
22423786|NCT03309696|University of Arkansas for Medical Sciences|Dr Mark Mennemeier|205 410 2413|msmennemeier@uams.edu|
22423787|NCT03327948|Axonics, Inc.|Gita Ghadimi|9497516412|gita.ghadimi@axonics.com|
22423788|NCT02304380|University of North Carolina at Chapel Hill|Renée Ferrari, PhD|(919) 843-1341|rferrari@unc.edu|
22423789|NCT01027897|Grady Health System|Prasad Abraham|404-616-3246|pabraham@gmh.edu|
22423790|NCT00328094|Beth Israel Deaconess Medical Center, Boston, MA|Dr. Balachundhar Subramaniam, MD MPH|6177542675|bsubrama@bidmc.harvard.edu|
22423791|NCT00577005|University of Massachusetts Medical School|Gerardo Gonzalez, MD|508 856 6480|gerardo.gonzalez@umassmed.edu|
22423792|NCT02667626|University of California, San Diego|Irene Su, MD MSCE|8588225986|hisu@ucsd.edu|
22393985|NCT00093808|Mayo Clinic|Winston Tan, MD|904-953-7290|Tan.Winston@mayo.edu|
22393986|NCT00871780|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
22393987|NCT02647866|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
22393988|NCT03406260|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22393989|NCT03098420|University of Alabama at Birmingham|Dr. Joel Feinstein|205-934-4696|jfeinstein@uabmc.edu|
22393990|NCT01029652|Novartis Pharmaceuticals|Study Director|862 778-8300||
22393991|NCT05767021|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22393992|NCT03575754|London Health Sciences Centre|Dr. Derek Cool|519-685-8500|derek.cool@lhsc.on.ca|54965
22393993|NCT00944073|Center for Vaccine Development, University of Maryland|Karen Kotloff, MD|401-706-5328|kkotloff@medicine.umaryland.edu|
22393994|NCT00523640|University of Chicago|Theodore Karrison, PhD|773-702-9326|tkarrison@health.bsd.uchicago.edu|
22393995|NCT06377488|Johnson & Johnson Vision Care|Johnson & Johnson Vision Care Study Contact|1-800-843-2020|RFrankl1@its.jnj.com|
22393996|NCT03476707|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
22393997|NCT02399254|Saint Francis Hospital and Medical Center|Richard ZuWallack, MD|860-714-4055|RZuWalla@TrinityHealthOfNE.org|
22393998|NCT02334423|Evolus, Inc|Rui L. Avelar, MD|(805)689-8668|rui@evolusinc.com|
22393999|NCT02065687|NRG Oncology|Christopher Purdy on behalf of Michael Sill, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
22394000|NCT01076647|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22394001|NCT02765802|Eiger BioPharmaceuticals, Inc|SVP, Clinical Development|1-650-618-1621|info@eigerbio.com|
22394002|NCT03545503|New Hanover Regional Medical Center|William F. Powers, IV, MD, FACS|910-667-9232|william.powers@nhrmc.org|
22394003|NCT04494256|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22394004|NCT00262951|University of Minnesota, Masonic Cancer Center|Edward Greeno, M.D.|612-626-6418|green049@umn.edu|
22394005|NCT02483585|Amgen Inc.|Study Director|866-572-6436||
22394006|NCT01485055|Nationwide Childrens Hospital|Rajinder Bajwa|6147222000|rajinder.bajwa@nationwidechildrens.org|
22394007|NCT01935180|VA Medical Center|Dr. Heiko Pohl|8022959362|heiko.pohl@dartmouth.edu|5595
22394008|NCT00825916|Capstone Therapeutics|Denise Lamon, Director of Regulatory Affairs|800-937-5520|dlamon@capstonethx.com|5206
22394009|NCT01778023|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22394010|NCT01098097|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22394011|NCT01000636|Galderma|Farzaneh SIDOU Clinical Project Manager|00 33 4 93 95 70 70|farzaneh.sidou@galderma.com|
22394012|NCT00509587|Princess Margaret Cancer Centre|Dr. Natasha Leighl|416-946-2399|natasha.leighl@uhn.ca|
22394013|NCT00577577|Insmed|Insmed Medical Information|1-844-446-7633|medicalinformation@insmed.com|
22394014|NCT01090427|Janssen Research & Development, LLC|VICE PRESIDENT IMMUNOLOGY||ClinicalTrialDisclosure@its.jnj.com|
22394015|NCT01154010|Massachusetts Eye and Ear Infirmary|Director of the Ocular Immunology and Uveitis Service|617-573-5549|George_Papaliodis@meei.harvard.edu|
22394016|NCT03294148|Weill Cornell Medicine|Dr. Yoni Ashar|(646) 962-2820|joa9188@med.cornell.edu|
22394017|NCT02073747|University Medical Center of Southern Nevada|Emergency Department Research Coordinator|702-224-7124|wesley.forred@umcsn.com|
22394018|NCT01465347|Diffusion Pharmaceuticals Inc|Chief Executive Officer|(434) 220-0718|DKalergis@diffusionpharma.com|
22394019|NCT02413333|Alcon Research, Ltd.|Global Medical Affairs Franchise Head, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22394020|NCT00906945|Washington University School of Medicine|Geoffrey Uy, M.D.|314-454-8304|guy@wustl.edu|
22394021|NCT02996474|National Heart Lung and Blood Institute|Christopher Hourigan|+1 301 451 0257|christopher.hourigan@nih.gov|
22394022|NCT02434497|AstraZeneca Plc|Robin Mukherjee|+46317761000|robin.mukherjee@astrazeneca.com|
22423793|NCT00473824|ADMA Biologics, Inc.|Rebecca Avila|561-989-5853|reavila@admabio.com|
22423794|NCT05216991|Mayo Clinic|J. Ross Renew, M.D.|904-956-3328|renew.j@mayo.edu|
22423795|NCT02539134|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22423796|NCT01143064|Besins Healthcare Ireland Ltd|Global Chief Medical Officer|+353 87 1039215|clinicaldevelopment@besins-healthcare.com|
22423797|NCT02453282|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22423798|NCT00985426|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-665-0414|rjanssen@dynavax.com|
22423799|NCT00323037|CTI Clinical Trial and Consulting Services|Sandy Stagge, RN, BSN|513-619-1837|sstagge@ctifacts.com|
22423800|NCT02327013|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
22423801|NCT02380859|Dartmouth-Hitchcock Medical Center|Stephen L. Lee, MD PhD|603-650-5104|stephen.l.lee@hitchcock.org|
22423802|NCT03506945|University of California San Diego|Brent Mausbach|8588227529|bmausbach@ucsd.edu|
22423803|NCT04076059|Astellas Pharma China, Inc|Clinical Transparency|+86-(0)10-85216666|astellas.resultsdisclosure@astellas.com|China only
22423804|NCT04186806|3M Health Care|Elaine Egging/Project Manger|651-737-0263|eegging@mmm.com|
22423805|NCT05363072|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22423806|NCT01661933|The Prince Charles Hospital|Dr John Croese. The Chief Investigator|+61733716164|jcroese@bigpond.com|
22423807|NCT03385304|University of Maryland, Baltimore|Research Administrator|410-706-6823|ahowe@som.umaryland.edu|
22423808|NCT01120249|SWOG|Melissa Plets|206.667.2707|mplets@fredhutch.org|
22423809|NCT04258254|University of Delaware|Anjana Bhat, Study PI|4435238680|abhat@udel.edu|
22423810|NCT02720744|Flamel Ireland Limited|Jennifer Gudeman|+1 (314) 750-2751|jgudeman@avadel.com|
22423811|NCT02255552|Sarepta Therapeutics, Inc.|Medical Director|+1-800-690-2003|clinicaltrials@sarepta.com|
22423812|NCT02122770|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22423813|NCT00558896|Mayo Clinic|Dr. Martha Lacy||lacy.martha@mayo.edu|
22433978|NCT02709577|GI Dynamics, Inc.|Manager of Clinical Affairs|781.357.3263|kwoessner@gidynamics.com|
22433979|NCT03823287|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22433980|NCT00978419|Vanderbilt University Medical Center|Burn Unit Director|(615) 322-4590||
22433981|NCT01059864|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22433982|NCT03108521|Department of Pharmacy, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital|Dr. Xingwei Wu and Professor Enwu Long|+8615928017367|wuxw1988@126.com|
22433983|NCT05629312|UZLeuven|Prof. Maria Cadenas|+3216332017|maria.cadenas@uzleuven.be|
22433984|NCT01308840|University of Rochester|Aram F Hezel|585-275-5823|aram_hezel@urmc.rochester.edu|
22433985|NCT03281629|Maryland Psychiatric Research Center, University of Maryland School of Medicine|Dr. Xiaoming Du|410 402 6036|xdu@som.umaryland.edu|
22433986|NCT03974932|Heron Therapeutics, Inc.|Clinical Operations|1-800-767-0524|cquaratino-baker@herontx.com|
22433987|NCT00921115|University of Kansas Cancer Center|Qamar Khan, MD|(913) 588-6029|QKHAN@kumc.edu|
22433988|NCT01380535|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
22433989|NCT00489424|Novartis Pharmaceuticals|Study Director|862-778-8300||
22433990|NCT00394251|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22433991|NCT00962741|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22433992|NCT01545934|Cal Poly|Suzanne Phelan|805-756-2087|sphelan@calpoly.edu|
22423814|NCT00230022|Wayne State University|Steven J. Ondersma|313-577-6680|s.ondersma@wayne.edu|
22423815|NCT00723190|Shionogi USA|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
22423816|NCT03181503|Galderma|Clinical Operations|(0) 4 93 95 70 70|Clinical.Studies@galderma.com|+33
22423817|NCT00001656|National Institute of Mental Health|Judith L. Rapoport, M.D.|301-496-6080|rapoporj@mail.nih.gov|
22423818|NCT01573325|Northwestern Memorial Hospital|Rebecca Duke DNP, MSN, NP-BC Transplant Surgery Nurse Practitioner|3126951686|rduke@nmh.org|
22423819|NCT00767039|Boston Medical Center|Alan Fujii MD (PI)|617-4414-3735|Alan.Fujii@bmc.org|
22423820|NCT02505334|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22423821|NCT02833935|McGill University|Shane Sweet|514-398-4184|shane.sweet@mcgill.ca|09903
22423822|NCT02523235|University California San Diego|Brian Ilfeld, MD, MS|858-822-0776|bilfeld@ucsd.edu|
22423823|NCT01549041|DukeUMC|Joseph P McEvoy, MD|9198199295|JPMCEVOY@DUKE.EDU|
22423824|NCT01313494|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22423825|NCT00667186|University of Cincinnati College of Medicine|Michael S. Lyons|513-558-0890|lyonsme@ucmail.uc.edu|
22423826|NCT04472026|University Of Florida|Naykky Singh Ospina|352) 273-8656|naykky.singhospina@medicine.ufl.edu|
22423827|NCT01404208|MGH|Dr. Daniel Geller|617 724 5141|dan.geller@mgh.harvard.edu|
22423828|NCT02382796|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22423829|NCT03077659|NanOlogy, LLC|Gere S. diZerega, MD|805-595-1300|gere.dizerega@usbiotest.com|
22423830|NCT02570321|UCSF, Proctor Foundation|Sarah Abedelrahman, Research Data Analyst|2135093817|sarah.abdelrahman@ucsf.edu|
22423831|NCT02258542|AstraZeneca|Ubaldo Martin, Global Clinical Lead Benralizumab|+1 301 398 0163|Ubaldo.Martin@astrazeneca.com|
22423832|NCT04068688|Duke University|Lauren Franz MBChB, MPH|919-681-0023|lauren.franz@duke.edu|
22423833|NCT04679051|Texas Tech University|Joaquin U Gonzales|806 834 5944|joaquin.gonzales@ttu.edu|
22423834|NCT02772276|MediBeacon|Richard B Dorshow, PhD|314-735-0967|rbdorshow@medibeacon.com|
22423835|NCT00550862|Intercept Pharmaceuticals|Dr. David Shapiro|858-652-6800|dshapiro@interceptpharma.com|
22423836|NCT02248974|Baylor College of Medicine|Dr. Jennifer Blumenthal-Barby|(713) 798-3785|jennifer.blumenthal-barby@bcm.edu|
22423837|NCT03488225|The University of Texas MD Anderson Cancer Center|Elias Joseph Jabbour, MD./ Professor|713-792-4764|ejabbour@mdanderson.org|
22423838|NCT04742309|University of California San Diego|Brian Ilfeld, MD, MS|(858) 822-0776|bilfeld@health.ucsd.edu|
22423839|NCT00085098|Children's Oncology Group|Results Coordinator|(626) 447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22423840|NCT01935700|Kaohsiung Medical University Hospital|Dr. Zu-Yau Lin|88677317123|linzuyau@yahoo.com.tw|
22423841|NCT00231283|Cordis|Sidney Cohen, MD PhD, Vice President|650 614-2726|scohen7@its.jnj.com|
22423842|NCT03280225|Central Arkansas Veterans Healthcare System|Dr. Sara J. Landes|501-257-3385|sara.landes@va.gov|
22423843|NCT01273155|National Cancer Institute|Naoko Takebe, M.D., Ph.D.|240-781-3398|Takeben@mail.nih.gov|
22423844|NCT02419612|AstraZeneca|Global Clinical Lead|+1 877-240-9479|information.center@astrazeneca.com|
22423845|NCT00078949|NCIC|Seninor Biostatistician for LY12|613-533-6000|bechen@ctg.queensu.ca|77703
22423846|NCT00396877|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi-aventis.com|
22423847|NCT02584959|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22423848|NCT00422422|UCB Clinical Trial Call Center|Study Director|+1 887 822 9493||
22423849|NCT03442699|Hartford Hospital/Institute of Living|David Tolin, Ph.D.|860-545-7685|david.tolin@hhchealth.org|
22423850|NCT00926536|Stanford University|Dr Nishita Kothary|6504986020|kothary@stanford.edu|
22423851|NCT00435487|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22423852|NCT00492817|The University of Texas MD Anderson Cancer Center|Amol J. Ghia, MD|(832) 628-7357|ajghia@mdanderson.org|
22423853|NCT03301844|NTC srl|Alessandro Colombo|+39 02 4385 0490|alessandro.colombo@ntcpharma.com|
22423854|NCT05087966|San Diego State University|Dr. Aaron Blashill|619-594-2245|ajblashill@sdsu.edu|
22423855|NCT01914159|Dept of Ophthalmology, University of Bonn, Bonn, Germany|Tim U. Krohne, MD, FEBO|+49 228 287|krohne@uni-bonn.de|15505
22423856|NCT01267201|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22423857|NCT00501059|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22423858|NCT00483704|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22423859|NCT04250298|Medical University Graz|Dr. Camilla Drexler-Helmberg|0043316385|camilla.drexler@uniklinikum.kages.at|83066
22423860|NCT02968433|Stanford University|Dr. Helen Bronte-Stewart|650-723-6709|hbsmovlab@gmail.com|
22423861|NCT00875433|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22423862|NCT04272606|University of Iowa|Catherine Olinger|319-384-5892|catherine-olinger@uiowa.edu|
22423863|NCT00725101|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22423864|NCT01131065|Instituto Grifols, S.A.|Michael Woodward, BSc, M.Sc|+34 935712200|michael.woodward@grifols.com|
22423865|NCT01996410|OhioHealth|John Elliott|614-566-3643|John.Elliott@ohiohealth.com|
22423866|NCT03912428|National Institute of Mental Health|Dr. Robert Innis|+1 301 594 1368|robert.innis@nih.gov|
22423867|NCT02537431|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|Medinfo@ultragenyx.com|
22423868|NCT01717482|Mayo Clinic|Dennis Wigle, M.D., Ph.D.|507-284-8462|Wigle.Dennis@mayo.edu|
22423869|NCT02345460|Case Comprehensive Cancer Center|Dr. Davendra Sohal|216-444-8258|sohald@ccf.org|
22423870|NCT00655473|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
22423871|NCT01312233|Spine Institute for Quality|Christine M Goertz, DC, PhD (Study Principal Investigator)|301-335-0071|cgoertz@spineiq.org|
22433993|NCT02710981|OB-GYN department, Assiut University, Egypt|Essam R. Othman|+201006607801|essamrash@yahoo.com|
22433994|NCT00760435|University of California, San Diego|Dr. Adriana H. Tremoulet|858-246-0012|atremoulet@ucsd.edu|
22433995|NCT01843673|Virginia Commonwealth University|Joshua Evans, Ph.D.|804-628-0661|jevans2@mcvh-vcu.edu|
22433996|NCT01320553|SPARC|Shravanti Bhowmik, MD||shravanti.bhowmik@sparcmail.com|
22433997|NCT00695955|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22433998|NCT00888329|Mayo Clinic|Javier Magrina MD|480-301-8000|magrina.javier@mayo.edu|
22433999|NCT04826094|Henry M Jackson Foundation for the Advancement of Military Medicine|David Fetterer, MS (Programmer Analyst)|301.500.3818|dfetterer@global-id.org|
22434000|NCT03549572|Spaulding Rehabilitation Hospital|Yelena Bodien|(617) 643-3956|ybodien@mgh.harvard.edu|
22434001|NCT00542490|University of Oklahoma|Lisa Landrum, MD|405 271-8001|lisa-landrum@ouhsc.edu|
22434002|NCT04405999|Almazov National Medical Research Centre|Evgeny Mikhaylov|+7(812)7023764|e.mikhaylov@almazovcentre.ru|
22434003|NCT00586716|Loma Linda University Medical Center|Dr. Pedro Baron|909-558-6792|PBaron@llu.edu|
22434004|NCT03928418|University of California San Francisco|Dr. Judy Hahn|415-476-5815|judy.hahn@ucsf.edu|
22434005|NCT05319600|University of Vermont|Amy Hughes Lansing, PhD|(802) 656-3801|amy.hughes.lansing@uvm.edu|
22434006|NCT00904670|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22434007|NCT02771574|Stanford University School of Medicine|Cindy Lamendola|650-723-3141|clamendola@stanford.edu|
22434008|NCT01780337|Columbia University|William Whang|212-305-8620|ww42@cumc.columbia.edu|
22434009|NCT00690430|Novartis Pharmaceuticals|Study Director|862-778-8300||
22434010|NCT02120300|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22434011|NCT03231917|White River Junction VAMC|Dr Joseph Anderson|8022959363|joseph.anderson@dartmouth.edu|
22434012|NCT01721486|Beaumont Hsopital|Kaveh Aslani, MD|248-898-1907|kaveh.aslani@beaumont.org|
22434013|NCT03587428|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22434014|NCT00286091|Amgen Inc.|Study Director|866-572-6436||
22434015|NCT02936869|World Bank|Dr. Adanna Chukwuma|9173712931|adc785@mail.harvard.edu|
22434016|NCT00335738|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org|
22434017|NCT05066750|University of Colorado Colorado Springs|Lori James|7192554172|ljames@uccs.edu|
22434018|NCT05141175|Duke University|Dr. Anthony Viera|919 681 3178|anthony.viera@duke.edu|
22434019|NCT02036580|AstraZeneca|Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22434020|NCT02445014|Mass General Hospital|Gary Tearney, MD|617-724-2979|gtearney@partners.org|
22434021|NCT03800537|University of North Carolina at Chapel Hill|Desma Jones|919-843-9463|desma_jones@med.unc.edu|
22434022|NCT01928290|Washington University School of Medicine|Haeseong Park, M.D.|314-747-6268|haeseongpark@wustl.edu|
22434023|NCT01032603|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
22434024|NCT03098433|Virginia Commonwealth University|Francesco S. Celi, MD, MHSc.|804-828-9696|francesco.celi@vcuhealth.org|
22434025|NCT04470050|Bioxcel Therapeutics|Vice President Head of Clinical Operations|(475) 355 5177|cgommoll@bioxceltherapeutics.com|
22434026|NCT01813058|Boston Children's Hospital|susan Goobie, MD, FRCPC|6173667737|susan.goobie@childrens.harvard.edu|
22434027|NCT03585764|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
22434028|NCT02777203|The Advanced Gyn Surgery Institute|Mary Johnston|6303641112|mjohnston@drcharlesmiller.com|
22434029|NCT01581021|University of Mississippi Medical Center|Dr. Lawrence Haber|601-984-6525|lhaber@umc.edu|
22434030|NCT03604172|University of Pennsylvania|Dr. Ariana Chao|215-746-7183|arichao@upenn.edu|
22434031|NCT00054327|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Kenneth Cooke MD|216-844-3345|kenneth.cooke@uhhospitals.org|
22434032|NCT01642056|National Human Genome Research Institute|Gahl, William|+1 301 402 2739|gahlw@mail.nih.gov|
22434033|NCT03028129|Federal University of Mato Grosso do Sul|Julio Croda|+5567981229959|julio.croda@ufms.br|
22434034|NCT00923351|National Cancer Institute, National Institutes of Health|Dr. John Glod|301-451-0391|john.glod@nih.gov|
22434035|NCT00182078|Massachusetts General Hospital|Dr. Frederick J. Stoddard Jr., M.D.|6173714762|fstoddard@partners.org|
22434036|NCT01076205|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22434037|NCT00361231|Massachusetts General Hospital|Dr. Andrew X. Zhu|617-724-4000|azhu@mgh.harvard.edu|
22434038|NCT03657134|NYU Langone Health|Lior Jankelson, MD, PhD|212-263-7149|Lior.Jankelson@nyulangone.org|
22434039|NCT01732510|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22434040|NCT00313144|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22434041|NCT03403361|Washington University School of Medicine|Dr. Clifford Robinson|314-362-8567|clifford.robinson@wustl.edu|
22434042|NCT01253148|H. Lee Moffitt Cancer Center and Research Institute|Sarah Hoffe, M.D.|813-745-3814|sarah.hoffe@moffitt.org|
22434043|NCT02487654|Imperial College London|Professor Prapa Kanagaratnam|+44 20 3313 1000|p.kanagaratnam@imperial.ac.uk|
22434044|NCT02443116|NGM Biopharmaceuticals, Inc|VP, Clinical Operations|650-243-5555|ngm282@ngmbio.com|
22434045|NCT01932372|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22434046|NCT05352412|Washington University School of Medicine|Dr. Michael J. Durkin, Principal Investigator|314-454-8225|mdurkin@wustl.edu|
22434047|NCT03594747|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
22434048|NCT04382586|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22434049|NCT02425956|GE Healthcare|Research Manager|262-521-6819|Sandhya.Parameswaran@med.ge.com|
22434050|NCT05818956|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22434051|NCT02265536|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22434052|NCT03869385|University Hospital of Jena|Prof. Dr. Yasser Sakr|01742191538|yasser.sakr@med.uni-jena.de|0049
22434053|NCT00349349|GlaxoSmithKline|GSK Response Center|866-435-7343||
22434054|NCT02907216|GlaxoSmithKline|GSK Response Center|866-435-7343|kap69137@gsk.com|
22434055|NCT03009162|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22434056|NCT00136695|Massachusetts General Hospital|Dr. Benjamin Leder|617-726-6723|bzleder@partners.org|
22434057|NCT02485639|Emory University|Rafi Ahmed, PhD|404-727-3571|rahmed@emory.edu|
22434058|NCT02597452|Penn Medicine|Dr. Ari D Brooks|215-829-8461|ari.brooks@pennmedicine.upenn.edu|
22434059|NCT03236909|MED-EL Corporation|Clinical Research Manager|888-633-3524|research.us@medel.com|
22434060|NCT01673854|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22434061|NCT00334737|University of New Mexico|Dr. Robin K Ohls|505-272-6753|rohls@salud.unm.edu|
22434062|NCT00258908|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22434063|NCT02374060|Johns Hopkins University|Elizabeth Sugar, PhD|(410) 614-7837|esugar2@jhu.edu|
22434064|NCT02640625|Oslo University Hospital|Dr. Dag Henrik Reikvam|+4722119881|dagrei@ous-hf.no|
22434065|NCT01579565|Omeros Corporation|Chief Medical Officer|(206) 676-5000|swhitaker@omeros.com|
22434066|NCT02013206|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22434067|NCT03045406|FadoiFoundation|Giorgio Vescovo|00390685355188|irenezaratti@fadoi.org|
22434068|NCT05425732|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22434069|NCT02582814|AstraZeneca|A clinical pharmacology and long-term safety study|+819039706431|Yu.Shimizuishi@astrazeneca.com|4669
22434070|NCT03990415|University of Missouri|Dr. Dana Duren|(573) 884-7023|durendl@health.missouri.edu|
22434071|NCT01558115|Columbia University|John P. Bilezikian, MD|212-305-6257|jpb2@cumc.columbia.edu|
22434072|NCT01696994|Early Detection Research Group, NCI, NIH|Paul F. Pinsky, Ph.D.|301-496-8544|pinskyp@mail.nih.gov|
22434073|NCT04644276|Philips|Chuck Cain|412-657-1814|chuck.cain@philips.com|
22434074|NCT00705250|Memorial Sloan Kettering Cancer Center|Craig Moskowitz, MD|(212) 639-7992|moskowic@mskcc.org|
22434075|NCT01558492|Weill Cornell Medicine|Himisha Beltran, MD|646-962-2072|hip9004@med.cornell.edu|
22434076|NCT01667224|Clinical Trial Center for Functional Food in Chonbuk National University Hospital|Dr. Soo-Wan Chae|82-63-250-2348|soowan@jbnu.ac.kr|
22434077|NCT03350035|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
22434078|NCT00316225|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22434079|NCT01811485|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22434080|NCT00425698|Saarland University Medical Centre|Prof. Dr. Danilo Fliser|(49) 6841|indfli@uks.eu|1623526
22434081|NCT02209545|Northwestern Medicine|Dr. Magdy Milad|3126946447|mmilad@nm.org|
22434082|NCT01113008|H Virgen de la Victoria|Dr Manuel Jiménez Navarro|951 032 354|jimeneznavarro@secardiologia.es|0034
22434083|NCT03503591|Preceptis Medical|Steve Anderson, CEO|612-327-4795|steve@preceptismedical.com|
22434084|NCT03831191|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22434085|NCT01177553|University of South Florida|Research Coordinator|813-259-8680|obgynclinicalresearch@health.usf.edu|
22434086|NCT01812213|Navidea Biopharmaceuticals|Chief Medical Officer|6149737555|mblue@navidea.com|
22434087|NCT01421303|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22434088|NCT03640507|Beth Israel Deaconess Medical Center|Cassandra R. Duffy, MD, MPH|617-667-2636|cduffy3@bidmc.harvard.edu|
22434089|NCT03525600|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
22434090|NCT02676895|GlaxoSmithKline|GSK Response Center|866-435-7343|antonella.s.scire@gsk.com|
22434091|NCT02168062|University of California, San Francisco|Li Zhang, PhD|(415) 476-5339|Li.Zhang@ucsf.edu|
22434092|NCT01270880|Barbara Ann Karmanos Cancer Institute|Elisabeth I. Heath, M.D.|313-576-8715|heathe@karmanos.org|
22434093|NCT00613327|Medical Affairs, Janssen Korea|Clinical Research Associate|+82-2-2094-4935||
22434094|NCT00344318|GlaxoSmithKline|GSK Response Center|866-435-7343||
22434095|NCT00118248|Washington University School of Medicine|Jeffrey F. Moley, M.D.||moleyj@wustl.edu|
22434096|NCT00683930|Hoffmann-La Roche|Medical Communications|800-821-8590||
22434097|NCT00395486|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22434098|NCT01454505|Alcon Research, Ltd.|Terri Pasquine, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22434099|NCT00869791|Impax Laboratories, Inc.|Michelle Landolfi, PhD. Sr. Director, Regulatory Affairs|(510) 240-6496|Michelle.Landolfi@impaxlabs.com|
22434100|NCT00290771|Novartis Pharmaceuticals|Study Director|862 778-8300||
22434101|NCT00893152|VA HSR&D Center for Mental Healthcare & Outcomes Research|Ellen P. Fischer, PhD|501-257-1711|Ellen.Fischer@va.gov|
22434102|NCT04154293|Timber Pharmaceuticals|Alan Mendelsohn, MD|2673004249|amendelsohn@timberpharma.com|
22434103|NCT04731298|Sobi|Emmanuel Monnet|+41225519156|Emmanuel.Monnet@sobi.com|
22434104|NCT01208961|AstraZeneca Pharmaceuticals|Torbjörn Lundström, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22434105|NCT01262560|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22434106|NCT06423456|afyonkarahisar health sciences university hospital|Dr. Betül Ahat|05467240341|drbetula@gmail.com|
22434107|NCT00744380|University of Colorado|Robert MacLaren|303 724-2622|rob.maclaren@ucdenver.edu|
22434108|NCT00350870|Yale University School Of Medicine Department of Psychiatry|Dr. Kathleen M. Carroll|203-937-3486|kathleen.carroll@yale.edu|7403
22434109|NCT00810771|VA Ann Arbor Healthcare System, Center for Clinical Management Research|Sarah Hawley, Ph.D.|734-936-8816|sarahawl@umich.edu|
22434110|NCT05079347|Vanderbilt University Medical Center|Carolyn Audet|615-343-2418|carolyn.m.audet@vumc.org|
22423872|NCT06350461|Seattle Children's|Margaret Kloster|206-884-7862|margaret.kloster@seattlechildrens.org|
22423873|NCT03430895|Memorial Sloan Kettering Cancer Center|Dr. Samuel Funt, MD|646-888-4770|funts@mskcc.org|
22423874|NCT00754208|University of Nebrasa Medical Center|Joan Daughton|402-552-6006|jdaughton@childrensomaha.org|
22423875|NCT03597009|University of North Carolina Lineberger Comprehensive Cancer Center|Robin Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
22423876|NCT01239212|Cincinnati Children's Hospital Medical Center|Dr. Stephanie Merhar|513-636-4200|stephanie.merhar@cchmc.org|
22423877|NCT01037127|GlaxoSmithKline|GSK Response Center|866-435-7343||
22423878|NCT02584998|CMC VAMC|Emily Carter Paulson, MD MSCA|215-823-5880|emily.paulson@va.gov|
22423879|NCT00954512|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22423880|NCT04814368|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22423881|NCT00456508|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22423882|NCT01173055|University of Michigan|Daniel Clauw, MD|734-998-6901|dclauw@med.umich.edu|
22423883|NCT04325698|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22423884|NCT04253782|Yale School of Medicine|Daniel Joseph, MD|(203) 785-4404|daniel.joseph@yale.edu|
22423885|NCT04530591|Hospital of the University of Pennsylvania|Jacob Brenner, Assistant Professor of Medicine|215-662-2222|Jacob.Brenner@pennmedicine.upenn.edu|
22423886|NCT04216589|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22423887|NCT01690910|St. Joseph Mercy Hospital|Amy Burghardt|734-712-2027|amy.burghardt@stjoeshealth.org|
22423888|NCT01254851|Loyola University Medical Center|Linda Brubaker|708-216-4033|lbrubaker@lumc.edu|
22423889|NCT02326298|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22423890|NCT04198584|University of North Carolina at Chapel Hill|Donna Evon, PhD|919-966-6732|donna_evon@med.unc.edu|
22423891|NCT02889835|UAB School of Dentistry|Nathaniel Lawson DMD PhD|205-975-8302|nlawson@uab.edu|
22423892|NCT01834716|Mayo Clinic|Neill Graff-Radford|9049537103|graffradford.neill@mayo.edu|
22423893|NCT02342548|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22423894|NCT02987972|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22423895|NCT01726036|TriHealth|Rachel G. Sinkey MD - PI|513-862-6918|pam_plummer@trihealth.com|
22423896|NCT01047332|Brigham and Women's Hospital|Dr. David L. Carr-Locke, MD, FRCP||dcarrlocke@chpnet.org|
22423897|NCT03521817|Pennington Biomedical Research Center|John W Apolzan|225-763-2827|john.apolzan@pbrc.edu|
22423898|NCT00787917|Novartis Pharmaceuticals|Study Director|862 778-8300||
22423899|NCT05530980|University of South Carolina College of Nursing|Dr. Demetrius Abshire|803-576-6262|abshired@mailbox.sc.edu|
22423900|NCT05685732|Corium, LLC|Ronald Tashjian|6172337474|rtashjian@corium.com|
22423901|NCT02640404|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22423902|NCT00778102|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22423903|NCT05397171|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22423904|NCT01328548|McMaster University|Dr. Mark Loeb|905 515 9140|loebm@mcmaster.ca|26679
22423905|NCT03200847|University of Colorado Hospital|Dr. Martin McCarter|13037242725|martin.mccarter@cuanschutz.edu|
22423906|NCT01066793|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22423907|NCT01520519|The University of Texas MD Anderson Cancer Center|Jan Burger MD./Professor|713-563-1487|jaburger@mdanderson.org|
22423908|NCT04643964|The Ohio State University|Dr. Daniel Strunk|6146884891|strunk.20@osu.edu|
22423909|NCT01048905|Emory University School of Medicine|Claudia R. Morris MD, FAAP|404-727-5500|claudia.r.morris@emory.edu|
22423910|NCT02607280|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22423911|NCT02368210|Therapeutics, Inc.|Clinical Research Director|858-571-1800|projectmanager@therapeuticsinc.com|
22423912|NCT00590538|The Children's Hospital of Philadelphia|Ronald Rubenstein, MD, PhD|1-215-590-1281|rubensteinr@email.chop.edu|
22423913|NCT01125813|Octapharma AG|Dr Sigurd Knaub|41 55 451 21 41|sigurd.knaub@octapharma.ch|
22423914|NCT04395391|Exact Sciences|Alexandra Massoud, Vice President of Clinical Affairs|608-284-5700|clinicaltrials@exactsciences.com|
22423915|NCT00766467|Dana-Farber Cancer Insitute|Eudocia Quant Lee, MD|617-632-2166|eqlee@partners.org|
22423916|NCT02718248|Ottawa Hospital Research Institute|Sarah MacLean|6137378899|samaclean@ohri.ca|73011
22423917|NCT04339179|INA-RESPOND|Publication Division|+62214208693|inapublikasi@ina-respond.net|
22423918|NCT04812795|University of Pennsylvania|Dr. Andy Tan|2157466546|andy.tan@asc.upenn.edu|
22423919|NCT00980018|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22423920|NCT01985958|University of Pennsylvania|Edgar Ben-Josef, M.D.|215-662-3932|Edgar.Ben-Josef@uphs.upenn.edu|
22423921|NCT00551161|North Shore-LIJ Health System|Marc L. Gordon,MD|516-562-3492|MLGordon@nshs.edu|
22423922|NCT00934856|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
22423923|NCT00772005|Cephalon, Inc.|Vice President, Clinical Research, CNS/Pain|1-800-896-5855||
22423924|NCT01828216|Chinese University of Hong Kong|David SC Hui|852 2632 2211|dschui@cuhk.edu.hk|
22423925|NCT01256385|University of Chicago|Dr. Tanguy Seiwert|(773) 702-2452|tseiwert@medicine.bsd.uchicago.edu|
22423926|NCT01440569|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22423927|NCT01044758|Johns Hopkins University School of Medicine|Gregory Krauss, M.D.|(410) 955-2822|gkrauss@jhmi.edu|
22423928|NCT01666210|Ocular Therapeutix, Inc.|Eric Ankerud|781-357-4013|eankerud@ocutx.com|
22423929|NCT02273908|Medical Affairs, Pfizer Japan Inc.|Study Director : Koichi Fujii, MD|81-3-5309-9370|koichi.fujii@pfizer.com|
22423930|NCT03887117|Philip Morris Products S.A.|Christelle Haziza, Global Head Clinical Research and Execution|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
22423931|NCT04908475|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22423932|NCT00878605|VA Greater Los Angeles Healthcare System|Dr. Zhaoping Li, Section Chief|310-268-3528|zhaoping.li@va.gov|
22423933|NCT02124759|UTHSC San Antonio|Dr. Nicolas Musi|630-5001|musi@uthscsa.edu|210
22423934|NCT01294371|Abbvie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22423935|NCT03325894|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22423936|NCT05727306|University of Sheffield|Andrew G. Messenger|+44 114 222 2000|a.g.messenger@sheffield.ac.uk|
22423937|NCT03482167|University of Delaware|Christopher R. Martens, Ph.D.|302-831-7270|cmartens@udel.edu|
22423938|NCT01319851|Emory University|Dr. John Horan|404-785-1272|jthoran@emory.edu|
22423939|NCT00622336|Celgene Corporation|Senior Manager, Clinical Trial Disclosure|1-888-260-1599|ClinicalTrialDisclosure@celgene.com|
22423940|NCT00819780|Amgen Inc.|Study Director|866-572-6436||
22423941|NCT04612777|New York State Psychiatric Institute|Dr. Michael Compton|4043759231|mtc2176@cumc.columbia.edu|
22423942|NCT00810446|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22423943|NCT05497960|IMPACTIV (Vivo)|Eric Levitan|770-331-3208|eric@teamvivo.com|
22423944|NCT04148287|Basilea Pharmaceutica International Ltd, Allschwil|Study Director|+41 79 701 0551|marc.engelhardt@basilea.com|
22423945|NCT00106639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22423946|NCT01553240|New York State Psychiatric Institute|Linda Sherman|(646) 774-7158|lsherma@nyspi.columbia.edu|
22423947|NCT01550705|University of Utah|John D. Phillips, Ph.D.|801-581-6650|john.phillips@hsc.utah.edu|
22423948|NCT00754520|Zimmer Biomet|Clinical Project Lead|+31 62 395 6378|lisette.smid@zimmerbiomet.com|
22423949|NCT01645891|EO2 Concepts|Dr. Mark Q Niederauer|2103387703|m.niederauer@eo2.com|
22423950|NCT00138073|Massachusetts General Hospital|Jaime Chang|617-726-9069|jchang4@partners.org|
22423951|NCT02847182|Duke University|Jesse D. Troy, PhD, MPH|919-668-1102|cordbloodtherapyinfo@dm.duke.edu|
22423952|NCT00962091|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22423953|NCT00003910|ECOG Statistical Office|Study Statistician|617-632-3012||
22423954|NCT01306045|National Cancer Institute|Dr. Arun Rajan|240-760-6236|rajana@nih.gov|
22423955|NCT05072964|FARAPULSE|Allison Anderson|651-582-5077|Allison.Anderson@bsci.com|
22423956|NCT04231396|BioSpeech|K. Lindaas, Principal Investigator|(503) 522-6276|kirstylindaas@biospeech.com|
22423957|NCT03153982|University of California, San Francisco|WIlliam Ryan, MD|(415) 502-1877|William.Ryan@ucsf.edu|
22423958|NCT02172040|Kitov Pharmaceuticals, Ltd.|J. Paul Waymack, M.D., Chief Medical Officer|(202) 965-2215|paul@kitovpharma.com|
22423959|NCT01463267|Kent State University|Joel Hughes|3306727721|jhughes1@kent.edu|
22423960|NCT02539654|Alcon, A Novartis Division|Clinical Scientific Director, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
22423961|NCT04908202|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22423962|NCT04149574|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
22423963|NCT04506905|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22423964|NCT01709864|Novartis Pharmaceuticals|Study Director|862-778-8300||
22423965|NCT03774394|University of Florida|Francesco Franchi, MD|+1-904-244-2060|francesco.franchi@jax.ufl.edu|
22423966|NCT02697916|Duke University; Duke Clinical Research Institute|W. Schuyler Jones, MD|919-668-8917|schuyler.jones@duke.edu|
22423967|NCT01313221|Amgen Inc.|Study Director|866-572-6436||
22423968|NCT03246061|Relievant Medsystems|Chris Hilker, Sr. Director Clinical Affairs|(650) 368-1000|chilker@relievant.com|
22423969|NCT02864316|Sidney Kimmel Comprehensive Cancer Center|Patrick Forde, MBBCh|410-955-3974|pforde1@jhmi.edu|
22423970|NCT00290693|University of Miami Sylvester Comprehensive Cancer Center|Caio Max Rocha Lima MD|305-243-7770|crocha@med.miami.edu|
22423971|NCT05625477|Zhuhai Trinomab Pharmaceutical Co., Ltd.|Wenxi Xiang|18083065921|xiangwenxi@trinomab.com|
22423972|NCT01692002|Imperial College London|Prof Gary Frost Head of Section for Nutrition Research|07872850308|g.frost9296@gmail.com|
22423973|NCT01092637|National Perinatal Epidemiology Unit, University of Oxford|Clinical Trials Unit|+44 1865 289700|ctu@npeu.ox.ac.uk|
22423974|NCT04703270|St George's, University of London|Dr Sarah Sturrock|020 8672 9944|ssturroc@sgul.ac.uk|
22423975|NCT01716520|GlaxoSmithKline|GSK Response Center|866-435-7343||
22423976|NCT03749499|University of Chicago Illinois|Heather M. Prendergast MD, MS, MPH, Professor, Department of Emergency Medicine|3124131214|hprender@uic.edu|
22423977|NCT05916131|University of Michigan|Yu Kuei Lin, MD|734-232-1573|yuklin@med.umich.edu|
22434111|NCT02095873|University of Warwick|Paul J Thornalley|+442476968594|P.J.Thornalley@warwick.ac.uk|
22423978|NCT03030118|Penn State Hershey College of Medicine|Nancy J Olsen MD, Professor of Medicine|717-531-4921|nolsen@pennstatehealth.psu.edu|
22423979|NCT01447446|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22423980|NCT02052596|GlaxoSmithKline|GSK Response Center|866-435-7343||
22423981|NCT02657577|Pennington Biomedical Research Center|Leanne Redman, Principal Investigator|2257630947|Leanne.Redman@pbrc.edu|
22423982|NCT04829331|Acera Surgical|Matthew MacEwan|440-477-1890|macewan@acera-surgical.com|
22423983|NCT05323994|Sevier|Denis Morozov|8-495-93707-00|denis.morozov@servier.com|
22423984|NCT01967641|New York State Psychiatric Institute|Dr. Maria A. Sullivan, M.D., Ph.D|646-774-6152|mas23@columbia.edu|
22423985|NCT00454818|Celladon Corporation|Jeffrey J. Rudy, Vice President|1 858-366-4288|jrudy@celladon.net|
22423986|NCT03180515|Stanford School of Medicine|Bronte-Stewart Lab|6507236709|hbsmovlab@gmail.com|
22423987|NCT00676572|Imperial College London|Professor Kian Fan Chung|00442075947954|f.chung@imperial.ac.uk|
22423988|NCT00565916|Washington University School of Medicine|Dr. Robert Gropler MD|314-747-3878|groplerr@mir.wustl.edu|
22423989|NCT00943670|Hoffman-LaRoche|Medical Communications|800-821-8590||
22423990|NCT02604550|Emory University|John Xerogeanes, MD|404-778-7202|jxeroge@emory.edu|
22423991|NCT00908076|Baylor College of Medicine|Christine Hunter|713-798-6556|chunter@bcm.edu|
22423992|NCT04526574|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22423993|NCT01032070|Astellas Pharma Global Development, Inc|Senior Medical Director, Medical Oncology||ClinicalTrials.Disclosure@us.astellas.com|
22423994|NCT02554318|Medical Faculty Wijaya Kusuma Surabaya|Dr. Budhi Setiawan|+6287751644522|nehesa@gmail.com|
22423995|NCT01541839|University of Alberta|Dr. Erin Wright|780-407-7656|erin.wright@me.com|
22423996|NCT02332239|Department of Emergency Medicine, Alpert Medical School, Brown University|Megan L. Ranney, MD, MPH, FACEP|401-444-2557|megan_ranney@brown.edu|
22423997|NCT00894790|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22423998|NCT01472965|St. Jude Children's Research Hospital|Joshua Wolf, MBBS, BA|901-595-1475|joshua.wolf@stjude.org|
22423999|NCT00006305|University of Pittsburgh|Dr. Maria Brooks|4126241618|brooks@edc.pitt.edu|
22424000|NCT00662558|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22424001|NCT00329641|SWOG Statistical Office|SWOG Melanoma Statistician|206-667-4408||
22424002|NCT01075399|Certus International, Inc.|Edward M. Aten, MD, President|603.627.1212|eaten@certusintl.com|
22424003|NCT01393132|Wayne State Univeristy, Detroit, MI|Gabriel Sosne, MD|248-594-6702|gsosne@med.wayne.edu|
22424004|NCT00115037|UPENN|David Oslin, MD|215-823-5894|oslin@upenn.edu|
22424005|NCT01398410|Eisai Co., Ltd.|Nobuyuki Sugisaki|+81-3-3817-3908||3908
22424006|NCT00334802|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22424007|NCT02348359|Brace Pharma Capital|Vice President, Clinical and Regulatory|240-403-7153|info@Tyrogenex.com|
22424008|NCT01881087|Fundación Valle del Lili|Dr. Fredy Ariza, MD., MSc., PhD(a).|+57 3319090|fredyariza@hotmail.com|4122
22424009|NCT02669914|Washington University School of Medicine|Ramaswamy Govindan, M.D.|314-362-5737|rgovindan@wustl.edu|
22424010|NCT03515629|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22424011|NCT03329248|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22424012|NCT01886781|University of Stellenbosch, South Africa|Cheryl Stevenson|0827514411|cheryl@retaildc.co.za|
22424013|NCT00987402|University Hospital, Geneva|Stephan Harbarth MD|+41-22-372.3357|stephan.harbarth@hcuge.ch|
22424014|NCT01996657|Wuhan Asia Heart Hospital|Dr.Litao Zhang|+862765796888|zhengleetau@qq.com|8204
22424015|NCT03000530|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22424016|NCT01523704|Fujita Health University School of Medicine|Eiichi Watanabe, MD, PhD|+81-562-93-2312|enwatan@fujita-hu.ac.jp|
22424017|NCT03597022|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22424018|NCT01430624|Medical University of South Carolina|Heidi Resnick, Ph.D.|843-792-2945|resnickh@musc.edu|
22424019|NCT01118988|Pediatric Pain and Palliative Care Program; University of California, Los Angeles|Dr. Lonnie K. Zeltzer, MD|310-825-0731|LZeltzer@mednet.ucla.edu|
22424020|NCT00416793|UT MD Anderson Cancer Center|Gauri Varadhachary, MD Associate Professor|713-792-2828|mjlim@mdanderson.org|
22424021|NCT01672294|VA HSRD Durham VA Medical Center|Karen Steinhauser, PhD|9196682148|karen.steinhauser@va.gov|
22424022|NCT03379792|AdventHealth Translational Research Institute|Richard E. Pratley|407-303-2519|richard.pratley.md@adventhealth.com|
22424023|NCT00306787|Novartis Pharmaceuticals|Study Director|862-778-8300||
22424024|NCT00336323|Jaeb Center for Health Research, Diabetic Retinopathy Clinical Research Network|Name/Official Title: Adam Glassman, M.S., Director|(813) 975-8690|drcrnet@jaeb.org|
22424025|NCT00369161|Novartis Pharmaceuticals|Study Director|862-778-8300||
22424026|NCT01440387|GlaxoSmithKline|GSK Response Center|866-435-7343||
22424027|NCT01870297|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979||
22424028|NCT00719914|Brigham and Women's Hospital|C. Michael Gibson, MS, MD|617-632-7753|mgibson@perfuse.org|
22424029|NCT04249622|Mayo Clinic|Saranya Chumsri, MD|904-953-2000|Chumsri.Saranya@mayo.edu|
22424030|NCT03604705|Basilea Pharmaceutica International Ltd, Allschwil|Study Director|+41 79 701 0551|marc.engelhardt@basilea.com|
22424031|NCT03689543|National Institute of Mental Health|Dr. Peter Schmidt|+1 301 496 6120|peterschmidt@mail.nih.gov|
22424032|NCT00586508|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22424033|NCT05619536|Cidara Therapeutics, Inc.|Chief Medical Officer|858-888-7868|clinicaltrialinfo@cidara.com|
22424034|NCT03301740|University of North Carolina at Chapel Hill|Jennifer E. Flythe, MD, MPH|(919) 445-2656|jflythe@med.unc.edu|
22424035|NCT00334633|University of Alabama at Birmingham|jane R Schwebke, MD|205-975-5665|schwebke@uab.edu|
22424036|NCT02345889|Indiana University|Rachel Lahr|3179480724|rlahr@iu.edu|
22424037|NCT01768845|West Virginia Universtiy|Michael Craig, MD|304-293-4980|craigm@wvumedicine.org|
22434112|NCT02091531|Memorial Sloan Kettering Cancer Center|Dr. Dana Rathkopf, MD|646-422-4379|rathkopd@mskcc.org|
22434113|NCT00945529|Nemours Cardiac Center at A. I. duPont Hospital for Children|Ellen Spurrier, MD|302-651-6600|ellen.spurrier@nemours.org|
22434114|NCT00792740|Italfarmaco SpA|Tiziano Oldoni, MD|+39 0264432540|t.oldoni@italfarmaco.com|
22434115|NCT02791516|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22434116|NCT02524275|University of Nebraska Medical Center|Dr. Apar Ganti|402-559-8121|aganti@unmc.edu|
22434117|NCT01439971|Catalyst Biosciences|Chief Medical Officer|1-650-266-8671|hlevy@catbio.com|
22434118|NCT02628600|Insmed Inc|Kevin Mange (Senior Vice President, Clinical Development & Medical Affairs, ALIS)|908-947-2651|kevin.mange@insmed.com|
22434119|NCT03763656|Nova Laboratories Ltd|Dr Hussain Mulla, Head of Clinical Development|0116 223 0101|hussain.mulla@novalabs.co.uk|
22434120|NCT03479541|Oregon Health and Science University|Dr. Laurie King|5034182602|kingla@ohsu.edu|
22434121|NCT04912089|UC San Diego|Jessica Bomyea|858-822-1470|jbomyea@health.ucsd.edu|
22434122|NCT03110029|UAB|Leslie Roop|2059754917|lmroop@uabmc.edu|
22434123|NCT01088295|University of California, Los Angeles|Jordan E. Lake, M.D., M.Sc.|(310)557-1891|jlake@mednet.ucla.edu|
22434124|NCT02453750|SickKids|Dr Theo Moraes|416 813 2196|theo.moraes@sickkids.ca|
22434125|NCT02316353|CSL Behring|Michelle Hellstern|6102907515|michelle.hellstern@cslbehring.com|
22434126|NCT01101958|ThoraxKlinik, University of Heidelberg|Prof. Dr. F.J.F. Herth|650-216-0176|Felix.Herth@thoraxklinik-heidelberg.de|
22434127|NCT05455580|Hunter-Bellevue School of Nursing, Hunter College, The City University of New York|Tara Heagele, PhD, RN|212-396-7206|th1591@hunter.cuny.edu|
22434128|NCT03407053|NIDDK|Kevin Hall, PhD|301-402-8248|kevin.hall@nih.gov|
22434129|NCT03724981|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22434130|NCT03284333|Cutera|Margot Doucette|415-357-5518|mdoucette@cutera.com|
22434131|NCT00511433|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22434132|NCT00197145|ViiV Healthcare|GSK Response Center|866-435-7343||
22434133|NCT01740089|Biocad|Yulia Linkova Medical Director|+7 (495) 992 66 28|linkova@biocad.ru|930
22434134|NCT03703310|Sol-Gel Technologies, Ltd.|VP Clinical & Regulatory Affairs|+972-73-3729453|Ofra.Levy-Hacham@sol-gel.com|
22434135|NCT00790868|BostonUCRC|Michael W. Otto, Ph.D.|(617)353-9610|mwotto@bu.edu|
22434136|NCT03040011|Magee-Womens Hospital of UPMC|Dr. Lauren Giugale, PI|412-641-1498|giugalele@upmc.edu|
22434137|NCT02867813|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22434138|NCT02791191|Eli Lilly and Company|Chief Medical Officer|800-545-5079|Clinicaltrials.gov@lilly.com|
22434139|NCT02370537|AstraZeneca AB|Stefan Carlsson||Stefan.C.Carlsson@astrazeneca.com|
22434140|NCT01952665|CooperVision|Donald Siegel, OD Principal Investigator|(949) 597-4700|dsiegel@coopervision.com|
22434141|NCT02578680|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22434142|NCT02964559|Emory University|Dr. Michael Lowe|404-778-7215|mlowe3@emory.edu|
22434143|NCT01559259|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22434144|NCT03727646|University of Washington|Dr. Kevin Douglas O'Brien|2065984300|cardiac@uw.edu|
22434145|NCT06523010|Bitlis Eren University|Asst. Prof. Ömer Dursun|5426088687|fztomrdrsn@gmail.com|+90
22434146|NCT02150551|Children's National Hospital|Catherine Bollard, MD|202-476-4776|cbollard@childrensnational.org|
22434147|NCT00306293|GlaxoSmithKline|GSK Response Center|866-435-7343||
22434148|NCT05081167|Relmada Therapeutics|Marco Pappagallo, MD|786-638-7384|info@relmada.com|
22434149|NCT01089413|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22434150|NCT01971463|University of Pennsylvania|Michael Mullen|215-662-3339|mmullen@pennmedicine.upenn.edu|
22434151|NCT01814878|Janssen Korea/25F, LS Yongsan Tower, 191 Hankangro 2-Ga, Yongsan-Gu, Seoul 140-702, Korea|Clinical Research Director|82-2-2094-4518||
22434152|NCT05096247|Cynosure|Jamie Trimper|(978) 256-4200|jamie.trimper@cynosure.com|
22434153|NCT01280058|The Ohio State University Comprehensive Cancer Center|Anne Noonan, MD|614-685-6912|Anne.Noonan@osumc.edu|
22434154|NCT04115748|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22434155|NCT01200407|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22434156|NCT00152477|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22434157|NCT00123162|MS Hershey Medical Center|Richard S Legro MD|717-531-8478|rsl1@psu.edu|
22434158|NCT00730041|Medtronic Xomed, Inc.|David Hodge|904-281-2774|david.l.hodge@medtronic.com|
22434159|NCT02292082|Hospital for Special Surgery|George Birch|2127747377|birchg@hss.edu|
22434160|NCT00433966|Cardiovascular Research Foundation|Ori Ben-Yehuda, MD, Executive Director, Clinical Trials Center|646-434-4123|obenyehuda@crf.org|
22434161|NCT01296711|UCB BIOSCIENCES GmbH|Clin Trial Reg & Results Disclosure|001-844-599-2273|clinicaltrials@ucb.com|
22434162|NCT01707654|The Second Hospital of Tangshan|Dr. Chao Chen|86-13700350471|ts_chenchao@163.com|
22434163|NCT01328535|Mayo Clinic|Roxana S. Dronca, M.D.|507/284-2511|Dronca.Roxana@mayo.edu|
22434164|NCT01035463|University of Nebraska Medical Center|Julie M Vose|402-559-3848|jmvose@unmc.edu|
22434165|NCT04528017|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22434166|NCT01126268|The University of Texas Health Science Center at Houston|Dr. Adelaide A Hebert|(713) 500-8339|Adelaide.A.Hebert@uth.tmc.edu|
22434167|NCT03425006|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
22434168|NCT02972606|King's College London|Dr Whitney Scott|02071885421|whitney.scott@kcl.ac.uk|
22434169|NCT00614445|Duchesnay, Inc.|Michael Gallo|450-433-7734|mgallo@duchesnay.com|
22434170|NCT02126553|The University of Texas MD Anderson Cancer Center|Tapan Kadia MD./Professor|713-563-3534|tkadia@mdanderson.org|
22434171|NCT01467037|McGill University Health Centre|Dr Caroline Quach, Pediatric Infectious Diseases Consultant & Medical Microbiologist|514-934-1934|caroline.quach@mcgill.ca|24485
22434172|NCT03748706|Cassava Sciences|Lindsay Burns, SVP of Neuroscience|512-501-2484|lburns@cassavasciences.com|
22434173|NCT01194089|Mayo Clinic|Dr. Toby N. Weingarten|507-255-1612|weingarten.toby@mayo.edu|
22434174|NCT03070171|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22434175|NCT03374683|University of British Columbia|Dr. Mariana Brussoni|604-875-3712|mbrussoni@bcchr.ubc.ca|
22434176|NCT01059682|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
22434177|NCT00610857|University of Pittsburgh Cancer Institute|Ahmad Tarhini, MD|4126486507|tarhiniaa@upmc.edu|
22434178|NCT00158249|McLean Hospital|Scott E. Lukas, Ph.D.|617-855-2767|slukas@mclean.harvard.edu|
22434179|NCT03655054|Valencia Technologies|Jacqueline Dister|7604294787|jdister@valenciatechnologies.com|
22434180|NCT01626118|Iroko Pharmaceuticals, LLC|Daniel Solorio|267-546-3150|dsolorio@iroko.com|
22434181|NCT00002540|Early Detection Research Group, NCI, NIH|Paul F. Pinsky, Ph.D.|301-496-8544|pinskyp@mail.nih.gov|
22434182|NCT03931382|Senior Director|John Jacob|604-875-2393|john.jacob@cw.bc.ca|
22434183|NCT02151903|Alopexx Oncology, LLC|Chief Medical Officer||daniel.vlock@alopexx.com|
22434184|NCT01864148|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22434185|NCT03316118|Northwestern University|Paul Fitzgerald|312 695 1064|p-fitzgerald2@northwestern.edu|
22434186|NCT01500252|UAlberta|Dr. Lauren Beaupre|780-407-3945|lauren.beaupre@albertahealthservices.ca|
22434187|NCT00778375|University of Texas (UT) MD Anderson Cancer Center|Farhad Ravandi-Kashani, Professor, Leukemia Department||CR_Study_Registration@mdanderson.org|
22434188|NCT03490292|UW Carbone Cancer Center|Nataliya Uboha, MD, PhD|(608) 265-9966|nvuboha@medicine.wisc.edu|
22434189|NCT06003777|Pfizer Inc.|Name or Official Title: Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22434190|NCT04181593|OmegaD LLC|Dr. Gregory Smith, MD|3023833948|SGSmith@omegad.com|
22434191|NCT00435227|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22434192|NCT00712725|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22434193|NCT05319899|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22434194|NCT00582712|University of Wisconsin Carbone Cancer Center|Director of Clinical Research|608-265-0540|clinicalresearch@surgery.wisc.edu|
22394023|NCT01210664|University of California San Francisco Diabetes Center|Jeffrey Bluestone, PhD|415-502-5677|jeff.bluestone@ucsf.edu|
22424038|NCT03191864|Ellodi Pharmaceuticals (Formerly Adare Pharmaceuticals)|Senior Director Clinical Operations and Medical Affairs|(609) 450-1312|karol.knoop@ellodipharma.com|
22424039|NCT02086682|Mayo Clinic|Dr. Marie Hogan|507-266 -1963|Hogan.Marie@mayo.edu|
22424040|NCT02044874|Arena Pharmaceuticals, Inc|Head of Document Operations|858-453-7200|ct.gov@arenapharm.com|
22424041|NCT00415597|King Pharmaceuticals Research and Development, Inc.|Vice President, Clinical Development|919-653-7001||
22424042|NCT03976323|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22424043|NCT02913105|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22424044|NCT02168777|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22424045|NCT05243563|USA Health|Catera Duhon|251-415-1598|cduhon@health.southalabama.edu|
22424046|NCT00441363|VeroScience|Donna Cowan|401 816-0525|donna_cowan@veroscience.com|
22424047|NCT01043094|Kowa Research Institute, Inc.|Roger Morgan, MD, FACS|919-433-1600|RMorgan@KowaUS.com|
22424048|NCT02437188|Baylor College of Medicine|Dr. Lilian Dindo, Assistant Professor|713-440-4637|lilian.dindo@bcm.edu|
22394024|NCT01853644|Northwestern University|Daniela Matei|312.472.4684|daniela.matei@northwestern.edu|
22394025|NCT02891837|Asklepion Pharmaceuticals, LLC|Gurdyal Kalsi, MD, MFPM (Hon)|+1 410.736.3750|gurdyal.kalsi@asklepionpharm.com|
22424049|NCT01663857|Eli Lilly and Company|Chief Medical Officer|800-575-5979|Clinicaltrials.gov@lilly.com|
22424050|NCT02517021|Helsinn Healthcare SA|Dr. Ruben Giorgino|+41 91 985 2121|ruben.giorgino@helsinn.com|
22424051|NCT03529799|University of Miami|Michael Hoffer|305 243-1484|michael.hoffer@miami.edu|
22424052|NCT00499343|U.T. M.D. Anderson Cancer Center|Chitra M. Hosing, MD / Associate Professor|713-792-8750||
22424053|NCT03315962|UCSF|Gabe Chamie|(415) 476-4082|gabriel.chamie@ucsf.edu|
22424054|NCT02578940|Blue Earth Diagnostics, Ltd.|Peter Gardiner MB ChB, MRCP, FFPM|1-781-552-3403|P.Gardiner@blueearthDx.com|
22424055|NCT01911793|Cedars Sinai Medical Center|Phillip Fleshner, MD|310-289-9224|pfleshner@aol.com|
22424056|NCT03334422|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22424057|NCT00994214|Ipsen|Medical Director, Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22424058|NCT02217800|Strongbridge Biopharma|Fredric Cohen, MD|610-254-9200|f.cohen@strongbridgebio.com|
22424059|NCT00401401|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com|
22424060|NCT04710368|Mount Sinai Hospital|Annapoorna S Kini, M.D.|(212) 241-4181|annapoorna.kini@mountsinai.org|
22424061|NCT03282591|Menlo Therapeutics Inc.|Anna Gururajan|(650) 486-1416|agururajan@menlotx.com|
22424062|NCT01777139|GlaxoSmithKline|GSK Response Center|866-435-7343||
22424063|NCT03959488|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22424064|NCT04987931|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22424065|NCT01887288|CTCA|Jessica L. Coats|6232073899|jessica.coats@ctca-hope.com|
22424066|NCT02635009|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
22424067|NCT02278367|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
22424068|NCT02949908|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22424069|NCT04105010|Dizal Pharmaceuticals|Rika Chen|862161095875|clinicaltrials@dizalpharma.com|
22424070|NCT01211483|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22424071|NCT01675154|UT Southwestern Medical Center|Dr. Abhimanyu Garg|214-648-8295|abhimanyu.garg@utsouthwestern.edu|
22424072|NCT03724084|The Ohio State University Comprehensive Cancer Center|Dr. James Blachly|614-293-7484|James.Blachly@osumc.edu|
22424073|NCT02971800|CHU de Québec|Dr Philippe Laberge|+1(418)525-4444|philippe.laberge@fmed.ulaval.ca|
22424074|NCT00595114|Brigham and Women's Hospital|Dr. Bruce D. Levy|617-525-5407|blevy@partners.org|
22424075|NCT00616603|Loma Linda University Department of Anesthesiology|Patricia Moore, CCRP|909-558-8493|pamoore@llu.edu|
22424076|NCT05765253|Argon Medical Devices|Danyel Carr|469-731-1421|Danyel.Carr@argonmedical.com|
22424077|NCT01285492|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22424078|NCT01121536|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22424079|NCT03646149|VA Greater Los Angeles|Sonya Gabrielian, MD, Investigator|310-478-3711|sonya.gabrielian@va.gov|49853
22424080|NCT02649426|ReCor Medical Inc.|Chief Clinical Officer|+1-650-420-8048|hreeve-stoffer@recormedical.com|
22424081|NCT03303391|University of Texas Southwestern Medical Center|Peter Van Buren|214-645-8293|peter.vanburen@utsouthwestern.edu|
22424082|NCT01593254|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22424083|NCT02079636|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22424084|NCT00561470|sanofi-aventis|International Clinical Development Study Director||contact-us@sanofi.com|
22424085|NCT00637806|Endo Pharmaceuticals Inc.|M. Todd Kirby, PhD|(484) 216-6491|kirby.todd@endo.com|
22424086|NCT02315872|Providence Health & Services|Lynette Currie|503-216-1034|lynette.currie@providence.org|
22424087|NCT01592292|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22424088|NCT00885742|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22424089|NCT02923245|Brown University|Almaz Dessie, MD||almaz@brown.edu|
22424090|NCT02680834|TactileMedical|Clinical Research Director|612-540-5267|astone@tactilemedical.com|
22424091|NCT00656487|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu|
22424092|NCT01712334|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22424093|NCT00232596|GlaxoSmithKline|GSK Response Center|866-435-7343||
22394026|NCT05924945|Masimo Corporation|Chelsea Frank|9492977000|clinicalresearchdept@masimo.com|
22394027|NCT00928018|Dana Farber Cancer Institute|Philippe Armand, MD, PhD|617-632-2305|parmand@partners.org|
22394028|NCT00943111|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22394029|NCT00847808|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22394030|NCT05652647|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22394031|NCT05326815|The Cleveland Clinic Foundation|Kim Jenkins|216-445-4791|jenkink@ccf.org|
22394032|NCT00728910|University of Pennsylvania|Richard Dunbar MD|215-662-9024|richard.dunbar@uphs.upenn.edu|
22394033|NCT04155203|Padagis|Jonathan Schwartz|929-502-7291|jonathan.schwartz@padagis.com|
22394034|NCT00669279|University of Florida|Dr. Benjamin J Epstein|3523590945|epstein@cop.ufl.edu|
22394035|NCT00979134|AstraZeneca|Donal Landers|+44 1625 231890|Donal.Landers@astrazeneca.com|
22394036|NCT03387137|Johns Hopkins University Bloomberg School of Public Health|Suzanne Woods, CRNP-P, CCRP, Manager, RSVPeds Team|(410) 614-1880|swoods12@jhu.edu|
22394037|NCT00133809|Emory University|Nicole Turgeon MD|404-727-3257|nturgeo@emory.edu|
22394038|NCT00729378|University of Arizona|Dr. Scott Going, Ph.D.|520-626-3432|going@u.arizona.edu|
22394039|NCT01966380|Sahlgrenska university hospital|Prof. Jan Faergemann|031-3421000|jan.faergemann@derm.gu.se|
22394040|NCT01980654|Pharmacyclics|Dr. Jutta Neuenburg|408-215-3735|jneuenburg@pcyc.com|
22394041|NCT00850603|Sanofi Pasteur Inc|Medical Director||RegistryContactUs@sanofipasteur.com|
22394042|NCT00484289|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22394043|NCT00690443|Aegerion Pharmaceuticals|Chief Medical Officer|617-500-7867||
22394044|NCT02502097|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22394045|NCT02204176|Wayne State University and Michigan State University|Dr. Phuong Vo|616-634-0566|votrucph@msu.edu|
22394046|NCT02564354|ProQR Therapeutics|Medical Monitor|+31 6 20 183 437|clinical@proqr.com|
22394047|NCT01776541|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22394048|NCT02874924|Univ TX Health Science Center San Antonio|Dean L. Kellogg, Jr, MD, PhD|2106175197|kelloggd@uthscsa.edu|
22394049|NCT00624923|Joslin Diabetes Center|Dr. Allison Goldfine|617-309-2400|allison.goldfine@joslin.harvard.edu|
22394050|NCT00903006|University of Texas MD Anderson Cancer Center|Ana Gonzalez-Angulo, MD / Associate Professor, Breast Medical Oncology|713-792-2817|CR_Study_Registration@mdanderson.org|
22394051|NCT03405792|University of Florida|Ashley Ghiaseddin, MD|352-273-9000|ashley.ghiaseddin@neurosurgery.ufl.edu|
22394052|NCT02257567|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22394053|NCT00946101|MedImmune, LLC an affiliate of AstraZeneca AB|Elissa Malkin, D.O.|301-398-0000|malkine@medimmune.com|
22394054|NCT00495586|CAMFIC|Carl Llor|+34 3011777|carles.llor@urv.cat|
22394055|NCT01347762|Beth Israel Deaconess Medical Center|Kevin P. Hill, M.D., M.H.S., Principal Investigator|617 667 1597|khill1@bidmc.harvard.edu|
22394056|NCT02527343|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
22394057|NCT04426851|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22394058|NCT00568802|Stanford University|Principal Investigator||clinicaltrials-gov@lists.stanford.edu|
22394059|NCT03256851|Wayne State University|Dr. Nora Fritz|(313) 577-1096|nora.fritz@wayne.edu|
22394060|NCT03625895|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22394061|NCT01065844|The University of Iowa|John M. Buatti, M.D., Chair, Department of Radiation Oncology|319-356-2699|john-buatti@uiowa.edu|
22394062|NCT02081417|Department of Psychiatry and Behavioral Sciences, University of New Mexico|Annette Crisanti, PhD|505-850-7430|acrisanti@salud.unm.edu|
22394063|NCT01288521|University of Iowa|Sony Tuteja, Pharmd|215-573-7834|sony.tuteja@gmail.com|
22394064|NCT00801931|Columbia University|Prakash Satwani, MD|212-305-0223|ps2087@cumc.columbia.edu|
22394065|NCT04196101|Enanta Pharmaceuticals, Inc|Guy De La Rosa, MD Senior Director, Infectious Diseases|(617) 607-0800|gdelarosa@enanta.com|
22394066|NCT03086213|Shenzhen Third People,s Hospital|Thoracic surgical department|13823135410|daoren_000113@126.com|
22394067|NCT01502631|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22394068|NCT02939170|Alcon, A Novartis Division|Clinical Project Lead, Clinical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
22394069|NCT01808326|GlaxoSmithKline|GSK Response Center|866-435-7343||
22394070|NCT02424734|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22394071|NCT01445301|GlaxoSmithKline|GSK Response Center|866-435-7343||
22394072|NCT00752557|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22394073|NCT02150343|Circassia Ltd|VP Clinical Operations|+44 1865 405560|kirsten.evans@circassia.com|
22394074|NCT00190749|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22394075|NCT00439231|NHLBI/NIH|Georg Aue|301.451.7141|AueG@nhlbi.nih.gov|
22394076|NCT04493502|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22394077|NCT02891408|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22394078|NCT00709852|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22394079|NCT01048671|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22394080|NCT05249829|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
22394081|NCT00578461|Baylor College of Medicine|Robert Krance, MD|832-824-4661|rakrance@txch.org|
22394082|NCT00196976|GlaxoSmithKline|GSK Response Center|866-435-7343||
22394083|NCT01535560|Alcon Research, Ltd.|Sally Schieb, Sr. Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22394084|NCT02009761|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22424094|NCT02637713|Montefiore Medical Center|Dr. Erin Moran-Atkin|718-920-4800|emoran2@montefiore.org|
22424095|NCT02681757|Children's Hospital Colorado|Choi Young Mee MD|7207770859|youngmeeyoungmee@gmail.com|
22424096|NCT04102865|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
22424097|NCT00291161|Houston HSRD Center of Excellence|Mark Kunik, MD, MPH|713-794-8639|kunik.marke@va.gov|
22424098|NCT01764997|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22424099|NCT01650545|University of Maryland|Aldo Tullio Iacono|410 328 4351|aiacono@umm.edu|
22424100|NCT02093390|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22424101|NCT00073983|SARC|SARC Chief Operating Officer|734-930-7600|sarc@sarctrials.org|
22424102|NCT04010747|Boston Medical Center & BU Chobanian & Avedisian School of Medicine|Emily R Kline, PhD|401-206-0586|emily.kline@bmc.org|
22424103|NCT02294461|Astellas Pharma Inc|Clinical Trial Disclosure|8008887704|astellas.resultsdisclosure@astellas.com|
22424104|NCT03800836|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22424105|NCT05670314|University of Nottingham|Dr Afroditi Kouraki|0115 8231676|afroditi.kouraki1@nottingham.ac.uk|+44
22394085|NCT02740374|The Ohio State University Wexner Medical Center - Department of Anesthesiology|Alberto Uribe|6142933559|alberto.uribe@osumc.edu|
22394086|NCT00825825|Steward St. Elizabeth's Medical Center|Tara Lauriat, Ph.D.|617-789-2404|tara.lauriat@steward.org|
22394087|NCT00882687|Shire (Note: Lifitegrast was divested to Novartis in 2019)|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22394088|NCT04555031|Bausch & Lomb|Study Director|5853386399|robert.steffen@bausch.com|
22394089|NCT02649946|BD/Bard|Heather Lam, Associate Project Manager, Clinical Affairs|(763) 390-8616|heather.lam@bd.com|
22394090|NCT01178385|University of South Florida|Dr. Eric Storch|727-767-8230|estorch@health.usf.edu|
22394091|NCT00985946|University of Wisconsin Carbone Cancer Center|Noelle LoConte|608-265-5883|ns3@medicine.wisc.edu|
22394092|NCT03002753|Christoph-Dornier-Stiftung Münster|Christian Rupp, M. Sc.|00492514183440|rupp@cds-muenster.de|
22394093|NCT04619251|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22394094|NCT03103490|Professor of Radiology (Nuclear Medicine)|Andrei Iagaru|(650) 725-4711|aiagaru@stanford.edu|
22394095|NCT02008877|SARC|SARC|(734) 930-7600|sarc@sarctrials.org|
22394096|NCT01116102|Baxter Healthcare Corporation|George Harb, MD, MPH||george_harb@baxter.com|
22424106|NCT03341936|Dana Farber Cancer Institute|Glenn J. Hanna, MD|6176326799|GJHANNA@partners.org|
22394098|NCT05000931|Cochlear|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
22394099|NCT05172050|Dompé Farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22394100|NCT02909764|Monell Chemical Senses Center|Julie A. Mennella|2675194880|mennella@monell.org|
22394101|NCT06298669|Rutgers|Maya Guglin|9085968459|maya.guglin@rutgers.edu|
22394102|NCT04617275|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22394103|NCT04227704|Washington University School of Medicine|Dr. David Monks|314-323-1845|dmonks@wustl.edu|
22394104|NCT00192647|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22394105|NCT01592500|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
22394106|NCT01765192|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22394107|NCT00292162|NHS|Michael MacDonald|01412112000|michael.macdonald@nhs.net|
22424107|NCT04849416|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22424108|NCT04529850|Galera Therapeutics|Judy Schnyder|484-870-9625|jschnyder@galeratx.com|
22424109|NCT00593606|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22424110|NCT02397291|"University of Colorado Denver | Anschutz"|Henry Galan|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
22424111|NCT00869557|Gilead Sciences, Inc|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22424112|NCT01472939|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22424113|NCT00114738|National Cancer Institute|Dr. Wyndham Wilson|301-435-2415|wyndham_wilson@nih.gov|
22424114|NCT05940077|Tufts University|Dr. Evan Papa|617-636-4056|evan.papa@tufts.edu|
22424115|NCT01492101|Nektar|Alison Hannah, MD||AHannah@nektar.com|
22424116|NCT01004432|Janssen Scientific Affairs, LLC|Study Director|215-325-4209|rdehorat@its.jnj.com|
22424117|NCT01253668|Merck|Dr. Stephen Keefe|215-220-9693|stephen.keefe@merck.com|
22424118|NCT01149421|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22424119|NCT04108988|Yale School of Medicine|Dr. Kimberly Hieftje|(203) 737-3301|kimberly.hieftje@yale.edu|
22424120|NCT03738800|Mayne Pharma|Mayne Pharma|1 252 752 3800|us.medicalinformation@maynepharma.com|
22424121|NCT02719353|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
22424122|NCT02651415|BC Cancer|Dr. Barbara Melosky|604-877-6000|bmelosky@bccancer.bc.ca|
22424123|NCT02777944|Bournemouth University|Prof. Katherine Appleton|+441202965985|k.appleton@bournemouth.ac.uk|
22424124|NCT02223819|Columbia University|Shaheer A. Khan, DO|212-342-5162|sk4488@cumc.columbia.edu|
22424125|NCT00259285|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22424126|NCT01917344|Boston Children's Hospital|Susan Waisbren, P.h.D|617-355-7346|susan.waisbren@childrens.harvard.edu|
22424127|NCT03435224|Masimo|Chelsea Frank|(949) 297-7000|studies@masimo.com|
22424128|NCT00367484|Merck Serono, a division of Merck KGaA, Darmstadt, Germany|Bettina Stubinski/Senior Medical Director|+49 6151 72 5200|service@merckgroup.com|
22424129|NCT00412217|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22424130|NCT01777295|GlaxoSmithKline|GSK Response Center|866-435-7343||
22424131|NCT02609724|UZ Leuven|Prof. Nele Devoogdt|0032 16 34 25 15|nele.devoogdt@uzleuven.be|
22424132|NCT00624559|University of Delaware|Dr. William Farquhar|302-831-6178|wbf@udel.edu|
22424133|NCT04007107|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22424134|NCT01678885|Pennington Biomedical Research Center|Corby Martin, Ph.D.|225-763-2585|corby.martin@pbrc.edu|
22424135|NCT00426660|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22424136|NCT00980174|Amgen Inc.|Study Director|866-572-6436||
22424137|NCT03114657|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22424138|NCT01546038|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22424139|NCT04245202|Ege University Medical Faculty Hospital|Dr. Aykut Eşki|05303009760|aykuteski1984@gmail.com|
22424140|NCT02470403|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22394108|NCT01016977|GlaxoSmithKline|GSK Response Center|866-435-7343||
22394109|NCT02394951|Washington University in Saint Louis|Dr. Simon Haroutounian|3143622628|sharout@wustl.edu|
22424141|NCT02631070|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22424142|NCT01153620|B. Braun Medical, Centre of Excellence|Medical Affairs Manager|+41 58 258 55 47||
22424143|NCT01522235|Beth Israel Deaconess Medical Center|Dr. Roy Freeman|6176328454|rfreeman@bidmc.harvard.edu|
22424144|NCT00312572|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
22394110|NCT04005053|University of Minnesota|Kathryn Cullen|612-273-9732|rega0026@umn.edu|
22394111|NCT03184870|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
22394112|NCT05081388|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|8447346643|clinicaltrials@regeneron.com|
22394113|NCT01529203|Galderma|Clinical Project Manager|(33) 4 92 38 67 33|may.ma@galderma.com|
22434195|NCT01901289|Cook Research Incorporated|Manager, Biostatistics|7654637537|Alan.Saunders@CookMedical.com|321204
22434196|NCT00787241|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|312-926-9015|r-mccarthy@northwestern.edu|
22434197|NCT01014936|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22434198|NCT00700882|ECOG-ACRIN Statistical Office|Study Statistician|6176323012|eatrials@jimmy.harvard.edu|
22394114|NCT00893984|Minneapolis Heart Institute Foundation|Chief Medical Officer|612-863-3900|scott.sharkey@allina.com|
22394115|NCT02725801|University of Kentucky Division of Plastic Surgery|Lesley Wong|859-323-7505|lesley.wong@uky.edu|
22424145|NCT05385224|EnteraSense Ltd.|David Collins, Director of Technical Operations|091 750 246|david@enterasense.com|
22394116|NCT00346632|Kyowa Kirin Pharmaceutical Development, Inc.|Project Leader|6099191100|clinical.info@kyowakirin.com|
22394117|NCT00918580|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22394118|NCT04882995|UMass Chan Medical School|Dr. Deepali Maheshwari|4137948764|deepali.mahesh@gmail.com|
22394119|NCT03587974|UCaliforniaDavis|Dr. Ladson Hinton|9167343485|lwhinton@ucdavis.edu|
22424146|NCT01688141|University of Leicester|Professor Nigel Brunskill|+44 116 258 8043|njb18@le.ac.uk|
22424147|NCT04521114|CytoDyn Inc.|Joseph Meidling, Senior Director - Clinical Operations|(360) 980-8524|jmeidling@cytodyn.com|
22424148|NCT01362517|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
22424149|NCT03878875|Imperial|Hemna Santilale|020|hemna.santilale@nhs.net|
22424150|NCT01133288|Kennedy Krieger Institute|Eric Levey, M.D.|443-923-9148|levey@kennedykrieger.org|
22424151|NCT02614131|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22424152|NCT01832818|RTI Surgical|Robin Waite|386-418-8888|rwaite@rtix.com|
22424153|NCT03209518|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22424154|NCT00798018|Department of Anesthesiology, West China Second Hospital|Han Huang|80-028-8550-3753|huanghan1981@hotmail.com|
22434199|NCT01606176|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
22434200|NCT01591954|Department of Biomedical Engineering, Johns Hopkins University|Jeffrey H. Siewerdsen, PhD / Professor of Biomedical Engineering|443-287-6269|jeff.siewerdsen@jhu.edu|
22434201|NCT01818258|Organization: Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
22434202|NCT02839720|UAB Heersink School of Medicine|Bruce R. Korf, MD, PhD|205-996-9487|bkorf@uabmc.edu|
22434203|NCT03927482|The Miriam Hospital|Beth Bock, PhD|4017938020|Beth_Bock@Brown.edu|
22434204|NCT00107900|Daiichi Sankyo, Inc.|Victor Fernandez|732-590-5000|vfernandez@dsi.com|
22434205|NCT03088930|University of Colorado Cancer Center|Dr. Tejas Patil|7208489264|tajas.patil@cuanschutz.edu|
22434206|NCT00569309|The Ohio State University Comprehensive Cancer Center|Craig Hofmeister, MD|614-293-9869|Craig.Hofmeister@osumc.edu|
22434207|NCT03614416|Bioserenity|Eléonore CAILLET|01 57 27 40 00.|eleonore.caillet@bioserenity.com|
22434208|NCT01760473|New York State Psychiatric Institute|Dr. Sandra Comer|646 774-6146|sdc10@columbia.edu|
22434209|NCT00678535|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merck.de|
22434210|NCT01022359|Imperial College London|Neill Duncan|+44 (0 )207 594 7243|n.duncan@imperial.ac.uk|
22434211|NCT04178993|University of Kentucky|Dr. Craig Rush, Ph.D.|8592575388|crush2@uky.edu|
22434212|NCT03100539|Richard L Roudebush VA Medical Center|Dr. Matthew Bair, Director of Center for Health Information and Communication|317-988-2058|Matthew.Bair@va.gov|
22434213|NCT03817463|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22434214|NCT04140695|Vanda Pharmaceuticals Inc.|Vanda Pharmaceuticals Inc.|202-734-3400|clinicaltrials@vandapharma.com|
22434215|NCT01215643|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
22434216|NCT02596958|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22434217|NCT00983515|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clincialtrials@urlmutual.com|
22434218|NCT01995669|University of Texas M D Anderson Cancer Center|Dr. Loretta Nastoupil|(713) 792-2860|lnastoupil@mdanderson.org|
22434219|NCT04753658|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22424155|NCT00568334|GlaxoSmithKline|GSK Response Center|866-435-7343||
22424156|NCT01897571|Epizyme, Inc.|Medical Lead or Designee|(855) 500-1011|clinicaltrials@epizyme.com|
22424157|NCT00401960|Weill Medical College|K Rhee|6469626224|kyr9001@med.cornell.edu|
22424158|NCT01606202|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
22424159|NCT00625404|FHI 360|Jennifer Deese, Principal Investigator|919-544-7040|jdeese@fhi360.org|11292
22424160|NCT03217968|CEFALY Technology|Clinical Trial Department director|+3243676722|info@cefaly.com|
22424161|NCT00337779|Teva Pharmaceutical Industries, Ltd.|Chen Duksin, MD|972-9-863-4642|chen.duksin@teva.co.il|
22424162|NCT03008278|Yale School of Medicine|Michael Cecchini, MD|(203) 200-4422|michael.cecchini@yale.edu|
22424163|NCT01074255|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22424164|NCT01389258|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
22424165|NCT03313310|UNC Chapel Hill, ATN Coordinating Center|Betty Rupp|919-962-6603|brupp@email.unc.edu|
22424166|NCT03019003|Massachusetts General Hospital Cancer Center|Dr. Sara Pai, MD, PhD|6178779118|sara.pai@mgh.harvard.edu|
22424167|NCT00032630|VA Medical Center, Denver, Colorado|Frederick Grover, MD|303-393-2863|Frederick.Grover@ucdenver.edu|
22424168|NCT01897792|UAB Department of Anesthesiology|Jean-Francois Pittet, MD|205-996-4755|jpittet@uabmc.edu|
22424169|NCT02292186|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
22424170|NCT03653091|Fractyl Health, Inc.|Sarah Hackett, Sr. Director of Clinical Operations|(781) 902-8840|shackett@fractyl.com|
22424171|NCT00932451|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22424172|NCT03627416|Jagiellonian University Medical College|Dr. Jakub Antczak|+48 795 421 153|jantczak@uj.edu.pl|
22424173|NCT02167815|Nemocnice Podlesí|MuDr Jan Stryja|+420 558 304 111|Jan.stryja@atlas.cz|
22424174|NCT01096589|Centre for Reasearch and Implementation of Clinical Practice (CRICP)|Prof. Christine Moffatt, Principal Investigator|+44 20 73 51 14 11|christine.moffatt@cricp.org.uk|
22424175|NCT02520427|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22424176|NCT00793624|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22424177|NCT00157248|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22424178|NCT03467763|Memorial Sloan Kettering Cancer Center|Dr. James Flory|6468883790|floryj@mskcc.org|
22424179|NCT02073565|OrbusNeich|Debbie Morrell, Clinical Research Manager|954-730-0711|DMorrell@OrbusNeich.com|
22424180|NCT03850691|Masonic Cancer Center, University of Minnesota|Evidio Domingo-Musibay, MD|612-625-9604|musib024@umn.edu|
22424181|NCT02227368|AstraZeneca Pharmaceuticals LP|Naeem Khan, MD|+1 302-885-8976|Naeem.Khan@astrazeneca.com|
22424182|NCT03765229|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat G. Canter MD MS, Clinical Trial Analyst|(919) 962-0000|Melahat_Canter@med.unc.edu|
22424183|NCT03046056|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22424184|NCT03089853|University of Alabama at Birmingham|Surya P Bhatt|205-934-5555|sbhatt@uabmc.edu|
22424185|NCT01172808|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22394120|NCT03486457|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22394121|NCT00372229|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22394122|NCT03235284|Federal University of Bahia - FUBA|Dr.Pietro Araújo|71992520519|pietro.araujo@ufba.br|
22394123|NCT01382706|USC/Norris Comprehensive Cancer Center|Tali Homsey|(323) 865-0451|tali.homsey@med.usc.edu|
22394124|NCT04055090|Helixmith Co., Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
22394125|NCT01984671|Duke University School of Medicine|Tamara Somers, PhD|919-416-3408|tamara.somers@duke.edu|
22394126|NCT05478499|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22394127|NCT01944371|University of California, San Francisco|Steven G. Deeks|4156064082|Steven.Deeks@ucsf.edu|404
22394128|NCT00249002|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22394129|NCT02319525|UAB|Dr. Jasvinder Singh, Principal Investigator|2059343235|jasvinder.md@gmail.com|
22394130|NCT04299438|University of Pennsylvania|Dr. Jennifer McCoy|215 662 4000|jennifer.mccoy@pennmedicine.upenn.edu|
22394131|NCT02141451|Masonic Cancer Center, University of Minnesota|Dr. Veronika Bachanova|612-625-5469|bach0173@umn.edu|
22394132|NCT02729753|C2 Therapeutics|Marcia Wachna, Director of Clinical Research||marcia@c2therapeutics.com|
22394133|NCT02842827|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22394134|NCT01815138|UConn Helth|Lawrence Engmann|8605258283|lengmann@uchc.edu|
22394135|NCT00577356|Virginia Mason Medical Center|Jacqueline Vuky, MD|(206) 223-6193|Jacqueline.Vuky@vmmc.org|32246
22394136|NCT00950950|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22394137|NCT01047293|Huntsman Cancer Institute|Sunil Sharma|801-587-5559|sunil.sharma@hci.utah.edu|
22434220|NCT05659719|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22434221|NCT02290691|PharmaJet, Inc|Tara Miller, MS, Clinical Affairs Manager|888-900-4321|tara.miller@pharmajet.com|4163
22434222|NCT04324541|University of North Texas Health Science Center|Leigh Johnson, PhD|817-735-2938|Thanhtruc.Truong@unthsc.edu|
22434223|NCT00185380|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22434224|NCT00218634|Mass General Hospital|Steven Safren|617 724 0817|ssafren@partners.org|
22434225|NCT02589665|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22434226|NCT00978380|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22434227|NCT01120236|Department of Medicine, Division of Oncology, University of Washington|Evan Y. Yu, MD||evenyu@u.washington.edu|
22434228|NCT00176488|Cancer Institute of New Jersey|Deborah Toppmeyer, MD|732-235-8675|toppmede@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
22434229|NCT00327015|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22434230|NCT01892436|Novartis Pharmaceuticals|Clinical Disclosure Office|+1 (862) 778-8300|novartis.email@novartis.com|
22434231|NCT02918396|Johns Hopkins University|Dr. Tarek Zghaib|410-955-5000|tzghaib1@jhmi.edu|
22434232|NCT02923830|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
22434233|NCT00837265|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22434234|NCT00583414|Massachusetts General Hospital|Matthew Eagleton, MD|617-726-8279|meagleton@mgh.harvard.edu|
22434235|NCT01751906|Abbott Vascular|Latania Chura / Project Manager|503.935.3002|latania.chura@abbott.com|
22434236|NCT00733291|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22434237|NCT01018134|Taro Pharmaceuticals U.S.A., Inc.|Director, Clinical Research|914-345-9001|natalie.yantovskiy@taro.com|
22434238|NCT02242435|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|7204376500|clinicaltrials@ampiopharma.com|
22434239|NCT04925076|University of Minnesota|Jeff Boissoneault, PhD|612-624-7357|jboisson@umn.edu|
22434240|NCT00510718|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22434241|NCT03258281|Sinai Center for Thrombosis Research|Director of Clinical Trials|443-244-1497|kpbliden@gmail.com|
22434242|NCT04051710|Aurobindo Pharma|Dr. Joseph Marialouis|9196150585|jmarialouis@aurobindousa.com|4013
22434243|NCT00420004|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22434244|NCT00591149|University of Kansas Medical Center|Chao Huang, MD|913-588-6029|chuang2@kumc.edu|
22434245|NCT01606787|Memorial Sloan Kettering Cancer Center|Dr. Jonathan Coleman, MD|646-422-4432|colemanj@mskcc.org|
22434246|NCT03015649|Envision Healthcare Scientific Intelligence, Inc.|Women's Imaging Director|9549397729|clinicaltrials@shcr.com|
22434247|NCT01610557|National Eye Institute (NEI) at National Institutes of Health (NIH)|Henry E Wiley, MD, Principal Investigator|(301) 451-4260|wileyhe@mail.nih.gov|
22434248|NCT01942668|TherapeuticsMD|Sebastian Mirkin, MD, Chief Medical Officer|561-961-1900|smirkin@therapeuticsmd.com|1952
22434249|NCT02003638|University of Pennsylvania|Dr. Emil deGoma|2156156521|emil.degoma@uphs.upenn.edu|
22434250|NCT00713349|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
22434251|NCT03299881|Elira Therapeutics, Inc.|Stephanie Amlung, PhD, RN, Vice President, Clinical Affairs|513-236-6799|samlung@elira.com|
22434252|NCT01289353|NYU Langone Health - PCC CTO|Carmen Perez, MD, PhD|212-731-5003|carmen.perez@nyulangone.org|
22434253|NCT01505673|University of Texas Southwestern Medical Center at Dallas|Dr. Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
22434254|NCT00129701|Imperial College London|Prof Martyn R Patridge|+44 (0)20 7594 7959|m.patridge@imperial.ac.uk|
22434255|NCT00006164|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|James E. Everhart, MD, MPH, Project Officer|301-594-8878|EverhartJ@extra.niddk.nih.gov|
22434256|NCT02750345|Cycle Pharmaceuticals Ltd|James Price|+44 1223 803638|james.price@cyclepharma.com|
22434257|NCT00223808|CTVHCS|Charles Burgar, MD|254/743-0085|charles.burgar1@va.gov|
22434258|NCT00635739|Tufts University|Dr. Roger Fielding|6175563083|Roger.Fielding@tufts.edu|
22434259|NCT00191724|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22434260|NCT00366028|Department of Veterans Affairs|Dr. Carol VanDeusen Lukas|857-364-5685|carol.vandeusenlukas@va.gov|
22434261|NCT01231321|Abbott|Global Medical Services|800-633-9110||
22434262|NCT00489736|sanofi-aventis|International Clinical Development, Clinical Study Director||GV-Contact-us@sanofi-aventis.com|
22434263|NCT04021524|University of Washington|Dr. Jason E. Hsu|(206) 543-3690|jehsu@uw.edu|
22434264|NCT06422364|Indiana University|Dr. Harish Rao, Assistant Professor of Clinical Pediatrics|317-948-7208|harirao@iu.edu|
22434265|NCT03713294|Mayo Clinic|Sikander Ailawadhi|904/953-6468|ailawadhi.sikander@mayo.edu|
22434266|NCT05260073|Almirall S.A.|Head of Global Clinical Development|+34932913000|rd@almirall.com|
22434267|NCT03458910|University of Southern California|Dr. Mara Mather|(213) 821-1868|mara.mather@usc.edu|
22434268|NCT02752633|Landspitali - The National University Hospital of Iceland|Vidar Orn Edvardsson|+3545431000|vidare@landspitali.is|3452
22434269|NCT04478071|The University of Texas Health Science Center at Houston|Bentley J. Bobrow, MD|713-500-7863|Bentley.J.Bobrow@uth.tmc.edu|
22434270|NCT06053541|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22434271|NCT05742646|Medical University of South Carolina|Dr. Michelle Nichols|8437928515|nicholmg@musc.edu|
22434272|NCT05059301|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22434273|NCT01106651|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise||ClinicalTrialDisclosure@its.jnj.com|
22434274|NCT00323960|IRCCS Istituto Giannina Gaslini|Dr. Nicolino Ruperto|+39-010-382854|nicolaruperto@gaslini.org|
22434275|NCT02466425|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22434276|NCT00889603|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22434277|NCT01153711|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22424186|NCT01084148|Orfagen|Clinical Project Manager|0033 5 34 50 64 62|caroline.miklaszewski@orfagen.com|
22434278|NCT01832493|Medtronic CRHF|Medtronic SOCR Clinical Trial Leader|1-800-328-2518|medtronicCRMtrials@medtronic.com|
22434279|NCT03158740|Connecting Health Innovations|Senior Scientist|8649154636|admin@chi-llc.net|
22434280|NCT01814397|University of Michigan Comprehensive Cancer Center|Dr. Norah Lynn Henry|734-936-4991|norahh@med.umich.edu|
22434281|NCT02661737|LG Chem|Study Leader|82-2-6987-4148|sodam@lgchem.com|
22434282|NCT01179217|Emmaus Medical, Inc|Yutaka Niihara, MD, MPH|310-214-0065|yniihara@emmausmedical.com|
22424187|NCT00525876|UT MD Anderson Cancer Center|Issa F. Khouri, MD/ Professor||celsaenz@mdanderson.org|
22424188|NCT00693485|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22424189|NCT03539484|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22424190|NCT00858468|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22424191|NCT04525131|University of Kansas Medical Center|Dr. John A Taylor|9135888170|jtaylor27@kumc.edu|
22424192|NCT02131636|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22424193|NCT02173379|Abbott Vascular|Kelly A. Stockelman, PhD|720-951-8649|Kelly.Stockelman@abbott.com|
22424194|NCT06226649|National Cheng Kung University|Mr. Chun-Yi Ho|886-6-2353535|eggman0011@gmail.com|5852
22424195|NCT02598778|MMC - Dentistry|Kakanantadilok, Nuntiya|(888) 700-6623|nkakanan@montefiore.org|
22424196|NCT02370056|Cleveland Clinic|Dr. Emre Gorgun|216 444-1244|GORGUNE@ccf.org|
22424197|NCT00791037|University of Washington|Dr. Mary L. Disis|206-543-8557|ndisis@u.washington.edu|
22424198|NCT00998205|University of Missouri-Columbia|Anand Chockalingam|573-882-2296|chockalingama@missouri.edu|
22424199|NCT02553798|Dermira, Inc.|Eugene A. Bauer, MD, Chief Medical Officer|650-421-7202|eugene.bauer@dermira.com|
22424200|NCT05869864|American University|Caroline Kuo, DPhil, MPhil|2028857385|ckuo@american.edu|
22424201|NCT00981058|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22424202|NCT02667587|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22424203|NCT02542293|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22424204|NCT00310466|ALK-Abelló A/S|Kim Simonsen, Senior Director|+4545747576||
22424205|NCT00810017|MedStar Health Research Institute|Scientific Center Administrator, Oncology Research|(301) 560-7300|Research@MedStar.net|
22424206|NCT02305446|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22424207|NCT01636947|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22424208|NCT02289105|Fostering Improvement in End-of-Life Decision Science Program|Dr. Scott Halpern|215-5739461|shalpern@exchange.upenn.edu|
22424209|NCT03933020|The University of Texas Health Science Center at Houston|Rohini D. Samudralwar, MD|(832) 325-7077|Rohini.D.Samudralwar@uth.tmc.edu|
22424210|NCT01463358|Casa di Cura san Pio XI|Massimo Santini MD FESC FACC|+390666494491|m.santini@rmnet.it|
22424211|NCT02696434|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
22424212|NCT01586871|University of Minnesota|Aaron Kelly PhD|612-626-3492|kelly105@umn.edu|
22424213|NCT00445744|FHCRC|H. Joachim Deeg MD|206 667 4409|jdeeg@fhcrc.org|
22424214|NCT00316914|Mayo Clinic|Dr. Axel Grothey|507-184-2779|grothey.axel@mayo.edu|
22424215|NCT04566133|National Cancer Institute|Dr. Tim F. Greten|2407606114|gretentf@mail.nih.gov|
22424216|NCT00355706|Pain Management Center of Paducah|Laxmaiah Manchikanti, MD|2705548373|drm@asipp.org|100
22424217|NCT05873335|Gabi SmartCare|Edouard Carton|472537844|edouard.carton@gabismartcare.com|
22424218|NCT00717275|University of Florida|Dr. Erin M. Dunbar|352-273-9000|edunbar@neurosurgery.ufl.edu|
22424219|NCT00231309|Emory University|Kuang-Yueh Chiang, MD|404-785-1441|kuang-yueh.chiang@choa.org|
22424220|NCT00424021|Gilead Sciences, Inc.|Karen L Miller, PhD|650-524-3892|KarenL.Miller@gilead.com|
22424221|NCT03769194|Valneva Austria GmbH|Director Clinical Strategy|+43120620|office@valneva.com|0
22424222|NCT02600767|CDC|Alexandre Macedo de Oliveira|404 718 4751|acq7@cdc.gov|
22424223|NCT01069315|McMaster University|Paula McKay, Manager|9055274322|mckayp@mcmaster.ca|44131
22424224|NCT01797094|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22424225|NCT00456261|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22424226|NCT04482036|Eskenazi Health|Jessica Broughton|317-903-6276|jessica.broughton@eskenazihealth.edu|
22424227|NCT01443494|Intensive Care Unit, Zhongda Hospital, Southeast University|Jingyuan Xu|86-025-83262550|xujingyuanmail@163.com|
22424228|NCT03083769|Southern Medical University|Dr. Liang Li|86 20 61648510|liliang@smu.edu.cn|
22424229|NCT03677934|Hoffmann-La Roche|Medical Communications|800 821-8590|global-roche-genentech-trials@gene.com|
22424230|NCT04769739|Evergreen General Hospital|Chi-Liang Cheng|0919768058|chiliang.cheng@gmail.com|
22424231|NCT05972941|The Ohio State University College of Public Health|Dr. Joanne G. Patterson|614-247-1780|patterson.1191@osu.edu|
22424232|NCT01451632|Merrimack Pharmaceuticals, Inc.|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
22424233|NCT00585715|University of California, Irvine|Kristen M. Kelly, M.D.|949-824-7103|kmkelly@uci.edu|
22424234|NCT04891406|Imperial Tobacco Ltd|Simon McDermott|+44 (0)117 332 0225|simon.mcdermott@uk.imptob.co|
22424235|NCT04395274|Ohio State University Comprehensive Cancer Center|Dr. Alayna Tackett|614-558-2679|alayna.tackett@osumc.edu|
22424236|NCT02028169|AbbVie|Global Medical Services|800-633-9110||
22424237|NCT00737893|Johns Hopkins Brady Urological Institute|Dr. Hiten Patel|410-502-7710|hiten.patel@lumc.edu|
22424238|NCT01876979|OMFS & HD|Department Chair|302-320-6458|dmeara@christianacare.org|
22424239|NCT02240069|University of Montana|Curtis Noonan|406-243-4957|curtis.noonan@umontana.edu|
22424240|NCT00948506|University of Pennsylvania|Joy Wan|2157466364|joy.wan@uphs.upenn.edu|
22424241|NCT01294007|ATEC Spine|Saba Pasha, Director Clinical Research & Data Science|760-356-6639|spasha@atecspine.com|
22424242|NCT03233204|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22424243|NCT02202044|University of Colorado|Tracey MacDermott|303-724-2757|Tracey.MacDermott@ucdenver.edu|
22424244|NCT02814227|University of Michigan|J. Todd Arnedt, PhD|734-615-8666|tarnedt@med.umich.edu|
22424245|NCT02407054|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22424246|NCT00932698|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22424247|NCT01863498|Children's Mercy Kansas City|Dr. Shawn St. Peter|816-234-3575|sspeter@cmh.edu|
22424248|NCT00642954|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22424249|NCT01317004|Novartis Pharmaceuticals|Study Director|862-778-8300||
22424250|NCT04542278|University of Wisconsin - Madison School of Medicine and Public Health|Dawn Elfenbein, MD, MPH, FACS|(608) 263-1387|elfenbein@surgery.wisc.edu|
22424251|NCT01890759|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22424252|NCT01344759|Cincinnati Children's Hosptial Medical Center|Dr. Mohamed Mahmoud|513-636-4408|Mohamed.Mahmoud@cchmc.org|
22424253|NCT01080976|BIDMC|Charles Safran|617-278-8170|csafran@bidmc.harvard.edu|
22424254|NCT04114656|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22424255|NCT00703326|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22424256|NCT03364036|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22424257|NCT02661061|Trinity College Dublin|Dr Martha Finnegan|0863638264|mfinneg@tcd.ie|
22424258|NCT01393106|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22424259|NCT02732015|UT MD Anderson Cancer Center|Saroj Vadhan,MD-Clinical Professor, Cytokine & Supportive Oncology|713-792-7966|svadhanr@mdanderson.org|
22424260|NCT03052920|Washington University in St. Luis|Jill B Firszt, PI|314-362-4760|FirsztJ@wustl.edu|
22424261|NCT01980628|Pharmacyclics, LLC|Isaiah Dimery, MD, Senior Medical Director|408-215-3579|idimery@pcyc.com|
22424262|NCT05437640|University of Alabama at Birmingham|Dr. Christine Ferguson|205-934-7773|cfergus2@uab.edu|
22424263|NCT02474355|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22424264|NCT02287688|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22424265|NCT03015194|National Heart Lung and Blood Institute (NHLBI)|Robert Lederman, M.D. Principal Investigator, NIH, NHLBI|301.402.6769|ledermar@nhlbi.nih.gov|
22424266|NCT05251064|University of Virginia|Dr. Mark Miller|(434) 243-7778|mdm3p@uvahealth.org|
22424267|NCT01937715|Pfizer Inc.|Pfizer ClincialTrials.gov Call Center|+18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22424268|NCT00632632|Weill Cornell Medical College|JoAn Difede, PhD|212 746 3079|jdifede@med.cornell.edu|
22424269|NCT01698268|Beaumont Health|Kaveh Aslani, MD|248-898-81905|kaslani@beaumont.org|
22424270|NCT00433017|Novartis Pharmaceuticals|Study Director|862 778-8300||
22424271|NCT00153816|Geisel School of Medicine at Dartmouth|Leila A. Mott, Statistical Analyst|603-650-3447|Leila.A.Mott@Dartmouth.EDU|
22424272|NCT02263729|University of Pittsburgh|James J. Irrgang|412-383-9865|jirrgang@pitt.edu|
22424273|NCT04591015|Scripps Health|Athena Philis-Tsimikas, MD, Co-Principal Investigator|858-678-7045|philis-tsimikas.athena@scrippshealth.org|
22424274|NCT02509078|Mass General Hospital (PETAL Clinical Coordinating Center)|Katie Oldmixon|617-726-4777|coldmixon@mgh.harvard.edu|
22424275|NCT02030886|Yale School of Medicine|Dr James Liu|+1 203 785 2020|liu.ji@yale.edu|
22424276|NCT00888290|Albert Einstein College of Medicine|Michal Melamed|718-430-2496|michal.melamed@einsteinmed.org|
22424277|NCT03594955|Sanofi-Aventis Research & Development|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22424278|NCT01829997|RTI Surgical|Kristina Shine|386-418-8888|kshine@rtix.com|4404
22424279|NCT06046209|CooperVision, Inc.|Lee Hall|+19252516684|lhall@coopervision.com|
22424280|NCT00674479|The University of Texas MD Anderson Cancer Center|Farhad Ravandi-Kashani, MD/Professor|713-745-0394|fravandi@mdanderson.org|
22424281|NCT04997265|Vanderbilt University Medical Center|Whitney Gannon|6109095789|whitney.gannon@vumc.org|
22424282|NCT01450072|UBNS|Dr. Ellen Carl|716-218-1000|ecarl@ubns.com|7260
22424283|NCT00631163|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22424284|NCT01056913|St John of God Hospital Vienna|Bernhard Dauser (MD)|+43121121|bernhard.dauser@gmail.com|5098
22424285|NCT02290925|Faculty of Medicine & Allied Sciences, Rajarata University of Sri Lanka|Professor Sisira Siribaddana|+94777326940|sisira.siribaddana@gmail.com|
22424286|NCT01973335|Ziekenhuis Oost-Limburg|Dr. Frederik Verbrugge, researcher|0473924199|frederik.verbrugge@zol.be|+32
22424287|NCT00506714|Arthritis Foundation|Meika A. Fang, MD|310-478-3711|meika.fang@va.gov|84503
22424288|NCT00894244|Northwestern University|Dr. Murad Alam|(312) 695-6785|m-alam@northwestern.edu|
22424289|NCT00388297|The George Washington University Biostatistics Center|Elizabeth Thom, Ph.D.|301-881-9260|e_thom@bsc.gwu.edu|
22394138|NCT00757783|Johnson & Johnson Pharmaceutical Research & Development|Vice President, Tibotec Therapeutics Clinical Affairs|877-732-2488||
22394139|NCT02372136|Gerber Foundation, UT Southwestern Med Ctr, Children's Medical Center|National Grant Gerber Foundation) (LPB); George L. MacGregor Professorship (CRR); National Children'|214-648-3903|luc.brion@utsouthwestern.edu|
22394140|NCT02679508|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22394141|NCT01588496|Amgen Inc.|Study Director|866-572-6436||
22394142|NCT03143166|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22394143|NCT01986075|New York State Psychiatric Institute|Kenneth Carpenter, PhD|646-774-8181|kenneth.carpenter@nyspi.columbia.edu|
22394144|NCT02003573|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22394145|NCT00803751|UT Medical School, Houston|Maria Matuszczak|713-498-2768|maria.matuszczak@uth.tmc.edu|
22394146|NCT03102645|Department of Clinical Pharmacology, University Hospital Bispebjerg and Frederiksberg|Jonatan Kornholt|+4538635604|jonatan.kornholt@regionh.dk|
22394147|NCT01413087|Anchiano Therapeutics Israel Ltd.|Dr. David Kerstein|857-259-4626|david.kerstein@anchiano.com|
22394148|NCT03683823|The University of Texas at Austin|Dr. Michael Telch|512-560-4100|telch@austin.utexas.edu|
22394149|NCT03456427|GE Healthcare|Beth Heckel|1-262-312-7269|beth.heckel@med.ge.com|
22394150|NCT05026710|University of Michigan|Khurshid Ghani, MD|734-763-2797|kghani@med.umich.edu|
22394151|NCT01323972|GlaxoSmithKline|GSK Response Center|866-435-7343||
22394152|NCT00994682|University of Florida|Dr. Kenneth Cusi|352-273-8662|kcusi@ufl.edu|
22394153|NCT03218397|Duke University|Vance Fowler, MD, MHS|919-613-5678|vance.fowler@duke.edu|
22394154|NCT02677428|VA Connecticut Healthcare System|Marc Rosen|203-932-5711|marc.rosen@va.go|2112
22394155|NCT01796548|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-792-7200||5888
22394156|NCT03539887|The University of Texas Health Science Center at Houston|Rodrigo Machado-Vieira, MD, PhD, MSc|(713) 741-5000|Rodrigo.MachadoVieira@uth.tmc.edu|
22394157|NCT01049217|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22394158|NCT00126503|Vanderbilt-Ingram Cancer Center|Jeffrey Sosman, MD|615-936-3048|jeff.sosman@vanderbilt.edu|
22394159|NCT00589121|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22394160|NCT02495792|Brooke Army Medical Center|MAJ Jamie Morris|210-221-3700|jamie.b.morris.mil@mail.mil|
22394161|NCT03519971|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22394162|NCT00925132|University of Iowa|Mohammed Milhem|319-356-2324||
22394163|NCT02545933|University of Florida|Dr. Dominick Angiolillo|9042443378|dominick.angiolillo@jax.ufl.edu|
22394164|NCT03149549|CytomX Therapeutics|Monika Vainorius|(650) 515-3185|clinicaltrials@cytomx.com|
22394165|NCT03141905|University of Maryland, Baltimore|Jeffrey C. Fink MD, MS (Principal Investigator)|410-328-4822|jfink@som.umaryland.edu|
22394166|NCT05180500|University of Pittsburgh|Dr. Sharon Hillier, PhD|412-641-6435|hillsl@mwri.magee.edu|
22394167|NCT02760277|ReveraGen Biopharma Inc.|Dr. Eric P. Hoffman|240-672-0295|ericphoffman@gmail.com|
22394168|NCT04927884|CSSIFM|Chaitali Nangia, MD Oncologist|855-797-9277|Chaitali.nangia@cssifm.org|
22394169|NCT01775124|Novartis|Study Director|862-778-8300||
22394170|NCT05917470|Oncternal Therapeutics|Mary Breitmeyer|760-703-2802|mbreitmeyer@oncternal.com|
22394171|NCT02317432|Disparities Research Unit, MGH|Margarita Alegria, PI|617-724-1237|malegria@mgh.harvard.edu|
22394172|NCT01533597|Soonchunhyang Bucheon Hospital|Dr. Kwang-Woo Lee|+82 32 621 5465|urolkw@schmc.ac.kr|
22434283|NCT01849692|Alcon Research, Ltd.|Clinical Project Group Leader, GCRA, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
22434284|NCT04238481|Astellas Pharma Inc|Clinical Trial Disclosure|+81 3-3244-6500 Japanese only|astellas.resultsdisclosure@astellas.com|
22434285|NCT02247011|Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital,Chinese Academy of Medical Science|Dr. Weibo Xia|86-10-6915-5076|xiaweibo@medmail.com.cn|
22434286|NCT02152371|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22434287|NCT01818739|The Ohio State University Comprehensive Cancer Center|Floor Backes, MD|614-730-6968|Floor.Backes@osumc.edu|
22434288|NCT00656058|National Cancer Institute|Dr. Ronald E. Gress|301-496-1791|gressr@dc10a.nci.nih.gov|
22434289|NCT02609841|ZS Pharma, Inc.|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22434290|NCT00349921|Wake Forest University Health Sciences|Regina Curry, RN, CCRC|(336) 716-4294|recurry@wfubmc.edu|
22394173|NCT03224351|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22394174|NCT01328717|Ascensia Diabetes Care|Dr. Daniel Brown|574-256-7754|daniel.brown@ascensia.com|
22394175|NCT00346268|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22394176|NCT01036763|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22394177|NCT04487834|Calisia University, Kalisz, Poland|Jacek Piatek|+48883389788|drpiatek@interia.eu|
22394178|NCT01177722|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22394179|NCT02831387|Parion Sciences|Jose Boyer|919-313-1182|jboyer@parion.com|
22394180|NCT01828073|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22394181|NCT04234425|Montana State University|Dr. Lauren Davis|8287736328|lauren.davis6@montana.edu|
22394182|NCT02079610|University of Pittsburgh School of Medicine|Kymberly Young, PhD|412-648-6179|youngk@pitt.edu|
22394183|NCT05220254|Stanford University|Judith Prochaska|(650) 724-3608|jpro@stanford.edu|
22394184|NCT00118755|Hoffmann-La Roche|Medical Communications|800-821-8590||
22394185|NCT01557283|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22394186|NCT02080221|Brown University Oncology Research Group|Howard Safran, MD|4018633000|BrUOG@BROWN.EDU|
22394187|NCT03786783|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22394188|NCT01285843|Medacta International|Ing. Elisa Bonacina, Clinical Data Manager|+41 91 696 60 60|bonacina@medacta.ch|
22394189|NCT04279392|University of Nebraska Medical Center|Laura Bilek|402-690-3524|lbilek@unmc.edu|
22394190|NCT01981473|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22394191|NCT00738582|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22394192|NCT01052103|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22394193|NCT00549783|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22394194|NCT00666679|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22394195|NCT02518490|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
22394196|NCT00211185|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22394197|NCT00552240|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22394198|NCT02679573|Melinta Therapeutics, Inc.|Sue Cammarata|312-724-9401|scammarata@melinta.com|
22394199|NCT02476279|Division of Gastroenterology & Hepatology, Medical University of South Carolina|Dr. B. Joseph Elmunzer|8437926982|elmunzer@musc.edu|
22394200|NCT02128542|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22394201|NCT00912301|Mayo Clinic|Michael L. Camilleri, MD|507-266-2306|camilleri.michael@mayo.edu|
22394202|NCT01411215|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22424290|NCT01004718|University of Pennsylvania|Ellen Napier, CRNP|215.279.1972|ellen.napier@pennmedicine.upenn.edu|
22424291|NCT01522131|The University of Texas Health Science Center at Houston|Rosemary Thomas, DMD, MS|713-486-4074|rosemary.thomas@uth.tmc.edu|
22424292|NCT01810705|Erytech Pharma|Anne-Sophie Clermont|+33 4 78 78 15 70|anne-sophie.clermont@erytech.com|
22424293|NCT00427999|Novartis Pharmaceuticals|Study Director|862-778-8300||
22424294|NCT02284568|Teva Pharmaceutical Industries Ltd|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22424295|NCT00460265|Amgen Inc.|Study Director|866-572-6436||
22424296|NCT00176436|Maryland Psychiatric Research Center|M. Patricia Ball, R.N., C.,M.S.|410-402-7663|pball@mprc.umaryland.edu|
22424297|NCT03570554|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22434291|NCT03194568|Children's Hospital of Philadelphia|Dr. Patrick Cahill|2155901000|cahillp1@chop.edu|
22394203|NCT02684851|CarolinasHS|Rachel Seymour, PhD|704-355-6969|Rachel.Seymour@carolinashealthcare.org|
22394204|NCT01616056|FHCRC|Stephanie J. Lee MD MPH|206-667-6190|sjlee@fhcrc.org|
22394205|NCT03339570|Hospital Gregorio Maranon|Dr. Mikel Aburto|34915868000|mikelaburto@hotmail.com|7007
22394206|NCT03451162|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22394207|NCT03305731|University of Illinois at Chicago|Dr. Emily Kringle|312-996-9665|kringle@uic.edu|
22424298|NCT02454075|Trio Medicines|Dr Malcolm Boyce|020 8961 4130|mboyce@hmrlondon.com|
22424299|NCT01642485|Richmond Pharmacology Ltd|Dr Jorg Taubel|+44(0)2086645200|j.taubel@richmondpharmacology.com|
22424300|NCT01966419|Mallinckrodt|Medical Information Call Center|800-844-2830|MedInfo@mnk.com|
22424301|NCT02956057|Tomas Bata Hospital|Kojecky Vladimir|+420577552512|kojecky@bnzlin.cz|
22424302|NCT00985517|Sangamo Therapeutics|Medical Monitor|510-970-6000|clinicaltrials@sangamo.com|
22424303|NCT01420679|Spectrum Pharmaceuticals, Inc|Gajanan Bhat|949-743-9219|gajanan.Bhat@sppirx.com|
22424304|NCT03956615|Vrije Universiteit Brussel|Dr. Matthias D'Huyvetter|+3224776013|afspraak_nucleaire@uzbrussel.be|
22424305|NCT01069419|UCB Clinical Trial Call Center|UCB (Study Director)|+1887 822 9493||
22424306|NCT00956631|Vertos Medical|VP of Clinical, Regulatory and Quality|9493490008|cmyers@vertosmed.com|216
22424307|NCT00365209|University of California, Irvine|Dr. Frank L. Meyskens, Jr.|714-456-6310|flmeyske@uci.edu|
22424308|NCT00236899|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22424309|NCT02565706|William Paterson University|Jennifer Di Noia|973.720.3714|dinoiaj@wpunj.edu|
22424310|NCT02447575|Baylor College of Medicine|Dr. Nicola Hanania|(713) 873-3454|hanania@bcm.edu|
22424311|NCT02477709|Afferent Pharmaceuticals, Inc.|Chief Medical Officer|650-286-1276|info@afferentpharma.com|
22424312|NCT01281956|National Institutes of Health|Dr. William Theodore|301-496-1505|theodorw@ninds.nih.gov|
22424313|NCT01904903|MedStar|Allison Moses|301-256-2728|Allison.E.Moses@medstar.net|
22424314|NCT05708703|University of Minnesota, Masonic Cancer Center|Dr. Rachel Vogel|612-624-6928|isak0023@umn.edu|
22424315|NCT01634659|Alcon Research, Ltd.|Jami Kern, MBA, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
22424316|NCT00335959|SWOG Statistical Center|Study Statistician|206-667-4623||
22424317|NCT01343667|W. L. Gore & Associates|Bryan Randall, Clinical Biostatistician|928-864-4832|BRandall@WLGore.com|
22424318|NCT01447927|University Hospitals of Cleveland, Case Medical Center|Dr. Amitabh Chak|216-844-5385|Amitabh.chak@case.edu|
22424319|NCT00082017|National Cancer Institute, National Institues of Health|Wyndham Wilson, M.D.|301-435-2415|wilsonw@mail.nih.gov|
22424320|NCT02190721|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|USMedInfo@tevapharm.com|
22424321|NCT01760447|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22424322|NCT01214668|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22424323|NCT02907619|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22424324|NCT03326518|Lument AB|Dr Thomas Fork|+46 705336996|thomas.fork@lumentab.com|
22424325|NCT06439095|Van Yuzuncu Yil University Faculty of Dentistry|Dr. Burçin Avcı, Assistant Professor|+90 5359558140|burcinavci@yyu.edu.tr|
22424326|NCT02485418|University of Texas Southwestern|Deryk Walsh, MD|2144566393|deryk.walsh@utsouthwestern.edu|
22424327|NCT03484403|Dallas VA Medical Center|Dr Thiru Annaswamy|214-857-0273|thiru.annaswamy@va.gov|
22424328|NCT01937884|University of Arizona|Dr. Katri Typpo|5206265485|ktyppo@email.arizona.edu|
22424329|NCT03706469|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22424330|NCT01179737|Novartis Pharnaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22424331|NCT01254721|SM&M Korea|Hui Jung Sin / Clinical Project Leader|82-2-2188-2165|ClinicalTrialTransparency@astrazeneca.com|
22424332|NCT01955109|DBV Technologies|Chief Medical Officer|33-1-55-42-78-78|clinicaltrials@dbv-technologies.com|
22424333|NCT00904839|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22424334|NCT04344535|Stony Brook University|Elliott Bennett-Guerrero|6314446026|elliott.bennett-guerrero@stonybrookmedicine.edu|
22424335|NCT01853696|Cornea Research Foundation of America|Marianne Price, PhD|317-814-2990|mprice@cornea.org|
22424336|NCT01167634|University of Pennsylvania School of Medicine|Laurie Norton|2155738799|lanorton@mail.med.upenn.edu|215
22424337|NCT00553358|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@Novartis.com|
22424338|NCT01656187|UT Southwestern Medical Center|E. Sherwood Brown, MD, PhD|214-645-6950|sherwood.brown@utsouthwestern.edu|
22424339|NCT02798120|Novan|Cathy White, Vice President, Drug Development Operations|9194858080|clinical@novan.com|
22424340|NCT02854605|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22424341|NCT03003000|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22424342|NCT04933617|National Cancer Institute|Dr. Mark Roschewski|240-760-6183|mark.roschewski@nih.gov|
22424343|NCT05268016|Meiji Pharma USA Inc.|Meiji Pharma USA Inc. Study Lead|+1 201-777-7133|mpu.contact@meiji.com|
22424344|NCT02191046|Thammasat university|Dr.Araya Satdhabudha|0813414900|araya221@gmail.com|662
22424345|NCT01964716|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22424346|NCT02147067|Emory University|Habib Samady, MD|(404) 778-1237|hsamady@emory.edu|
22424347|NCT00791492|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22424348|NCT00090987|AMC|Jeannette Y. Lee, Director of Statistical Center|(501) 526-6712|jylee@uams.edu|
22424349|NCT00713661|Nycomed|Clinical Trial Operations|+45 4677 1111|clinicaltrials@nycomed.com|
22424350|NCT00990665|St. Jude Medical|Clay Cohorn: Director, Clinical Study Management|972 309 8087|ccohorn@sjm.com|
22424351|NCT00270231|University of Pennsylvania|Caryn Lerman, Ph.D.|215-746-7141|clerman@mail.med.upenn.edu|
22424352|NCT02603562|aTyr Pharma|Study Director|858 731 8389|clinicaltrials@atyrpharma.com|
22424353|NCT01432561|University of California San Diego|Dr. Ranjan Dohil, P.I.|619-471-9554|rdohil@ucsd.edu|
22394208|NCT04634825|MacroGenics, Inc.|Chief Medical Officer|301-251-5172|info@macrogenics.com|
22394209|NCT01952054|UT MD Anderson Cancer Center|Ueno,Naoto,M.D., PH.D. / Breast Medical Oncology|713-792-2817|nueno@mdanderson.org|
22394210|NCT01127139|Abbott|Global Medical Services|1-800-633-9110||
22394211|NCT01100034|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22394212|NCT00402597|Johnson & Johnson Pharmaceutical Research and Development, L.L.C.|VP FRANCHISE MED LDR|1 908 927 7767||
22394213|NCT01831856|Institut de Recherche Pierre Fabre|Karim KEDDAD, MD, PhD Head of Medical Unit|+33 5 34 50 61 69|Karim.keddad@pierre-fabre.com|
22424354|NCT00574795|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22424355|NCT00314132|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22424356|NCT00957905|Memorial Sloan Kettering Cancer Center|Dr. Darren Feldman|646-422-4491|feldmand@mskcc.org|
22424357|NCT01260584|Daiichi Sankyo|Brian Baker|973-944-2712|bbaker@dsi.com|
22424358|NCT03434249|SOFAR S.p.A|LAURA PATRUCCO|+390202 909 362291|laura.patrucco@sofarfarm.it|
22424359|NCT02918552|University of Pittsburgh|Tara Sheila Stakich|412-864-2082|tss54@pitt.edu|
22424360|NCT01001598|Boston Children's Hospital|Colin A. Sieff|617 919-4241|colin.sieff@childrens.harvard.edu|
22424361|NCT02722837|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22424362|NCT04877535|Washington University School of Medicine|Christopher King|(314) 362-8649|christopherking@wustl.edu|
22424363|NCT01969084|Beth Israel deaconess Medical Center|Aristidis Veves|617 632 7075||
22424364|NCT02920177|University of Michigan|Jordyn Sessel|734-615-0934|jsessel@med.umich.edu|
22424365|NCT03164265|University of Pittsburgh|Dr. Angus Thomson|(412) 624-6392|thomsonaw@upmc.edu|
22424366|NCT04907227|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22424367|NCT00824382|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22424368|NCT03673345|University of Rochester|Jennifer Nayak, MD, PI|5852750526|Jennifer_nayak@urmc.rochester.edu|
22424369|NCT01362244|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22424370|NCT01253174|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22424371|NCT02267135|Novartis Pharmaceuticals|Study Director|+1 (800) 778-8300|trialandresults.registries@novartis.com|
22424372|NCT03806231|Intermountain Healthcare|Molly Adams, Clinical Research Project Coordinator|(801)507-7030|molly.adams@imail.org|
22424373|NCT02919267|Institut universitaire de cardiologie de de pneumologie de Québec|Dr Jean Bussières|418-656-8711|jbuss@criucpq.ulaval.ca|2944
22424374|NCT04608344|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22424375|NCT00467961|NIH NHLBI|Minocher Battiwalla, MD|301-827-0939|minoo.battiwalla@mail.nih.gov|
22424376|NCT00326170|UT MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Associate Professor|713-792-7305|eharriso@mdanderson.org|
22424377|NCT02908074|Mereo BioPharma Group|Jackie Parkin|+44 (0) 333 023 7300|enquiries@mereobiopharma.com|
22424378|NCT01043562|Vanderbilt University (current institution)|Dr. Andrew E. Radbill|615-322-7447|andrew.radbill@vanderbilt.edu|
22424379|NCT02429310|Imperial College London|Professor Alun Davies|02033117320|a.h.davies@imperial.ac.uk|
22424380|NCT00394433|Dana-Farber Cancer Institute|Peter C. Enzinger, MD|617-632-6855|Peter_Enzinger@dfci.harvard.edu|
22424381|NCT03646305|York University|Keisha C. Gobin, MA|416-736-2100|kgobin@yorku.ca|33153
22424382|NCT01554176|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22424383|NCT02678000|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22424384|NCT03816644|Albert Einstein College of Medicine|Dr. Joe Verghese|7184303808|joe.verghese@einsteinmed.edu|
22424385|NCT00756600|Boston Children's Hospital Anesthesia Foundation|Dr Mary Ellen McCann|6173557737|mary.mccann@childrens.harvard.edu|
22424386|NCT00684749|University of Minnesota|Umar Choudry/Bruce Cunningham|6126250697|choud008@umn.edu|
22424387|NCT00004088|City of Hope|Brenda Williams, Senior Director, Clinical Trials Office|626-218-2702|bwilliams@coh.org|
22424388|NCT03004924|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22424389|NCT02867202|the 1st affiliated hospital of Wenzhou Medical University.|the 1st affiliated hospital of Wenzhou Medical University.|0886-0577-88069525|zfy983023@hotmail.com|
22424390|NCT03924505|RTI International|Dr. Barrot H Lambdin|628-200-6707|blambdin@rti.org|
22424391|NCT00939471|Acclarent, Inc.|Laura England, Manager-Clinical|650-687-4466|lenglan1@its.jnj.com|
22424392|NCT00089635|Amgen Inc.|Study Director|866-572-6436||
22424393|NCT02943785|Daiichi Sankyo|Contact for Clinical Trial Information|+ 1 908-992-6400|CTRinfo@dsi.com|
22424394|NCT02603107|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22424395|NCT00821015|Icahn School of Medicine at Mount Sinai|Dr. Vivek Y Reddy|212-241-7114|vivek.reddy@mountsinai.org|
22424396|NCT04103515|University of Tennessee|Dr. Michael LaCour|8659742093|mlacour@utk.edu|
22424397|NCT03170609|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22424398|NCT01361867|Spaulding Rehabilitation Hospital|Paolo Bonato|617-952-6319|pbonato@partners.org|
22424399|NCT05656885|CooperVision Inc.|Dr. Jose A Vega OD, MSc, FAAO|+19256213761|javega@coopervision.com|
22424400|NCT02366403|War Related Illness and Injury Study Center, VA Palo Alto Healthcare System|Peter Bayley, PhD|650 493-5000|peter.bayley@va.gov|68653
22424401|NCT01887678|Biologische Heilmittel Heel GmbH|Christine Frank, PhD, Global Clinical Project Manager|+49 7221 501 3188|christine.frank@heel.com|
22424402|NCT02572856|University of Washington Medical Center|David Flum, MD|206 616-5440|daveflum@uw.edu|
22424403|NCT03013985|Emory University|Dr. Guillermo Umpierrez|404-778-1665|GEUMPIE@emory.edu|
22424404|NCT01044589|Cleveland Clinic|Dr. Massarat Zutshi|(216) 444-3540|zutshim@ccf.org|
22394214|NCT04756960|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
22434292|NCT05285644|Alcon Research, LLC|Scientific Advisor, Clinical Research and Development|1-888-451-3937|alcon.medinfo@alcon.com|
22434293|NCT03306979|Sunnybrook Health Sciences Centre|Dr. Krista Lanctôt, Senior Scientist|416-480-6100|krista.lanctot@sunnybrook.ca|62241
22434294|NCT00920387|Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corp.|Berra Yazar-Klosinski, PhD / Chief Scientific Officer|(831) 429-6362|trialdata@mapsbcorp.com|
22434295|NCT04114071|University of Alabama at Birmingham|Dr. Pamela G. Bowen|12059342778|pbowen@uab.edu|
22434296|NCT01448824|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22434297|NCT00932620|University of Ioannina|Prof Moses Elisaf|+302651007509|egepi@cc.uoi.gr|
22434298|NCT01537081|Reckitt Benckiser LLC|Gail Solomon,MS; Director Clinical Development|973-404-2752|gail.solomon@rb.com|
22434299|NCT01981863|Stanford University Medical Center|Peter van der Starre|6507236412|pieterva@stanford.edu|
22434300|NCT02450383|University of Iowa|Gustavo Avila-Ortiz|3193357241|gustavo-avila@uiowa.edu|
22434301|NCT01110330|Jan-Cil Switzerland|Director Infectious Diseases|41 41 7673477||
22434302|NCT02759107|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22434303|NCT02390414|Dana-Farber Cancer Institute|Dr. Gregory A. Abel|6176322304|gaabel@partners.org|
22434304|NCT02383420|Carestream Health, Inc.|Susan Pate, Senior Clinical Affairs Manager|585-627-6557|susan.pate@carestream.com|
22434305|NCT02526524|Elcelyx Therapeutics, Inc|Chief Scientific Officer|858-876-1814|info@elcelyx.com|
22434306|NCT03002818|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22434307|NCT00780481|Vanderbilt University Medical Center|James Muldowney|615-936-1720|james.muldowney@vanderbilt.edu|
22434308|NCT03764631|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22434309|NCT01549886|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
22434310|NCT00473668|GlaxoSmithKline|GSK Response Center|866-435-7343||
22434311|NCT02039219|Indiana University School of Medicine|Naga Chalasani, MD|(317) 278-0414|nchalasa@iu.edu|
22434312|NCT01084278|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22434313|NCT02226562|GlaxoSmithKline|GSK Response Center|866-435-7343||
22434314|NCT04569136|National Cheng Kung University|Dr. Kuan-Yin Lin|+886-6-2353535|10802003@gs.ncku.edu.tw|6737
22434315|NCT00611468|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com|
22434316|NCT03257202|Keck Medical Center of USC|Dr. George Hatch|323-442-5860|ghatch.md@gmail.com|
22434317|NCT01466660|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22434318|NCT03576066|Assembly Biosciences|Linda Bahr, Sr. Director, Clinical Operations|415-521-3808|clinicaltrials@assemblybio.com|
22434319|NCT00608023|Theratechnologies|Marilyn de Chantal, Global Senior Medical Director|1 438-315-6624|Mdechantal@theratech.com|
22434320|NCT03333317|Janssen Research & Development, LLC|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22434321|NCT05275010|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22434322|NCT02975999|LUrie Children's Hospital|Dr. Jamie Penk, co-investigator|7735773782|jpenk@luriechildrens.org|
22434323|NCT04484649|Columbia University Irving Medical Center|Samantha Garbers-Adams, PhD|212-305-0123|svg2108@cumc.columbia.edu|
22434324|NCT01681069|Analyze & Realize GmBH|Dr Christof Jänicke|+49 30 40 00 83 23|cj@a-r.com|
22434325|NCT01463696|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22434326|NCT04726137|Fondazione Penta ETS|Giorgia Dalla Valle|393783022748|giorgia.dallavalle@pentafoundation.org|
22434327|NCT03883165|University of Michigan Medical School|James T Eckner, MD, MS|734-647-5568|jeckner@med.umich.edu|
22434328|NCT00967694|University of Utah Department of Anesthesiology|Dr. Eric Fox|775-340-0219|ericbfox@yahoo.com|
22434329|NCT00245050|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Vivian von Gruenigen, MD|216-844-5011|vev1@case.edu|
22434330|NCT03544476|University of Washington|Sarah Iribarren|2065435211|sjiribar@uw.edu|
22434331|NCT03275246|Zimmer Biomet|Oliver Schaetti|0041588548901|oliver.schaetti@zimmerbiomet.com|
22434332|NCT02301546|University of Utah|Kevin Duff|8015859983|kevin.duff@hsc.utah.edu|
22434333|NCT01491789|Kennedy Krieger Institute|Dr. Alberrt Recio|443-923-9227|recio@kennedykrieger.org|
22434334|NCT00729677|Beth Israel Cancer Center|Victoria Rosenwald, RN MPH|212 844-8285|vrosenwa@chpnet.org|
22394215|NCT05208866|Centessa Pharmaceuticals|Milena Kanova|+44 7780 430583|milena.kanova@centessa.com|
22424405|NCT01370616|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22434335|NCT05526781|Eye Consultants of Atlanta|Dr Joseph Christenbury|14043512220|jchristenbury@eyeconsultants.net|
22434336|NCT03905265|Medicines Development for Global Health Limited|Clinical Project Manager|+61 399122400|MDGH-MOX-2001@medicinesdevelopment.com|
22434337|NCT01636063|Baystate Medical Center|David R Kattan|413-794-5256|davidrkattan@gmail.com|
22434338|NCT04952597|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22434339|NCT03632993|Endo Pharmaceuticals|Clinical Operations|800-462-3636|clinicaltrials@endo.com|
22434340|NCT01005316|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22434341|NCT00632827|University of California, San Francisco|Lawrence Kaplan, MD|(415) 353-2661|LKaplan@ucsf.edu|
22434342|NCT02925078|University of Michigan|Clinical Research Coordinator|7347633346|aliceou@umich.edu|
22424406|NCT00462449|Department of Physical Medicine and Rehabilitation University of Pittsburgh|Dr. Michael C. Munin|412-648-6848|muninm@upmc.edu|
22424407|NCT02322333|Clinvest Research|Jim Sly MS|4178413673|jsly@clinvest.com|
22424408|NCT00076999|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22424409|NCT00803205|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22424410|NCT05821296|Dermosciences France|Sara Bayo Rodriguez|638966321|clinicaltrials@dermaceutic.com|0033
22424411|NCT01217385|American College of Radiology|Donna Hartfeil, Director Protocol Management|215-717-2765|dhartfeil@acr.org|
22424412|NCT05604794|University of Toronto|Dr Chris Lo|65 6709 3003|chris.lo@utoronto.ca|203
22424413|NCT01534208|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
22424414|NCT05749068|Silicon Valley Gastroenterolgy|Dr. George Triadafilopoulos|(650) 988-7530|info@siliconvalleygi.com|
22424415|NCT04208321|ICON Early Phase Services, LLC|Dr. Cassandra Key, Senior Medical Director|210-283-4120|Cassandra.key@iconplc.com|
22424416|NCT02046772|Hospital Universitario Príncipe de Asturias|Antonio Rodríguez Miguel|+34 91 887 81 00|antonio.hupa@gmail.com|2610
22424417|NCT02117713|Mirum Pharmaceuticals|Mirum Clinical Trials|650-667-4085|medinfo@mirumpharma.com|
22424418|NCT00672841|University of Utah|Kimberly E. Hanson, MD, MHS|801.585.2867|kim.hanson@hsc.utah.edu|
22424419|NCT02638259|Sandoz|Sandoz Biopharma Clinical Development - Strategic Planning|0049(0)80244760|biopharma.clinicaltrials@sandoz.com|
22424420|NCT04299048|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22424421|NCT02569086|Aarhus University Hospital, Department of infectious diseases|Dr. Kristina Öbrink-Hansen|+45|krisoebr@rm.dk|78452845
22424422|NCT03578146|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
22424423|NCT01094782|Massachusetts General Hospital|Dr. Lucy Chen|6177246102|mghpainresearch@partners.org|
22424424|NCT00634049|Astellas Pharma Global Development, Inc.|Vice President, Medical Head ID/IM/TX|(224) 205-8800|Astellas.resultsdisclosure@astellas.com|
22424425|NCT01717391|The University of Iowa|John M. Buatti, MD|319-356-2699|john-buatti@uiowa.edu|
22424426|NCT02503254|Philip Morris Products S.A.|Cam Tuan Tran|+41 (58) 242 2620|CamTuan.Tran@pmi.com|
22424427|NCT02952872|Wayne State University|Dr. Emily Grekin|313-577-2820|grekine@wayne.edu|
22424428|NCT04292639|Vital USA Inc.|Mark H Khachaturian, PhD|+1(561)282-6074|mark.khachaturian@vvvital.com|
22424429|NCT00045734|Adult Brain Tumor Consortium (ABTC)|Patrick Wen, MD|410-955-8837|jfisher@jhmi.edu|
22424430|NCT02069093|Novartis Pharmaceuticals|Study Director|862-778-8300||
22424431|NCT02624388|UVA Health|William Petersen|434-924-8499|wcp3g@uvahealth.org|
22424432|NCT00474786|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22434343|NCT00368836|Carolinas Medical Center|Dr. Jeffrey Kline|704-355-3181|jkline@carolinas.org|
22434344|NCT02084706|Brigham and Women's Hospital|Dr. Philip Blazar|617-732-5384|pblazar@partners.org|
22434345|NCT03272828|University of Washington|Dr. Mats Kronstrom|425-877-7345|mk33@uw.edu|
22434346|NCT02808052|Melinta Therapeutics|Global Health Science Center|1-844-633-6568|medinfo@melinta.com|
22434347|NCT03888235|University of British Columbia Department of Family Practice|Dr. Helene Bertrand|7782277776|dr.hbertrand@gmail.com|
22434348|NCT01054560|Covidien|Director of Clinical Affairs|9498373700||
22434349|NCT01232504|Department of Hematology, Shanghai Jiao Tong University Affiliated First People's Hospital, China|Chun Wang||wangchun2@medmail.com.cn|
22434350|NCT02591537|Northwestern University|Dr. Robert Galiano, Associate Professor of Surgery|312.695.3908||
22434351|NCT01923363|Loma Linda University Medical Center|Dr. Steven Forland|909-558-4000|sforland@llu.edu|43980
22434352|NCT01178944|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22434353|NCT00005901|National Institute of Child Health and Human Development|Joan Marini|+1 301 594 3418|marinij@cc1.nichd.nih.gov|
22424433|NCT02892513|Medical College of Wisconsin|Carrie Y. Peterson, MD, MS|414-955-5783|cypeterson@mcw.edu|
22424434|NCT00900731|Novartis Pharmaceuticals|Study Director|862 778-8300||
22424435|NCT00131365|InSightec|Nadir Alikacem|214.630.2000|nadira@insightec.com|
22424436|NCT05249127|Clarity Pharmaceuticals|Dr Othon Gervasio, Chief Medical Officer|+61 2 9209 4037|info@claritypharmaceuticals.com|
22424437|NCT02436031|Brigham and Women's Hospital|Andrew Wellman, MD, PhD||awellman@rics.bwh.harvard.edu|
22424438|NCT03053427|Astellas Pharma Inc.|Clinical Trial Disclosure|+81 3-3244-0512|astellas.resultsdisclosure@astellas.com|
22424439|NCT01801241|Cleveland Clinic Foundation|Joseph P. Iannotti, MD, PhD|216-287-1149|IANNOTJ@ccf.org|
22424440|NCT03240406|Albert Einstein College of Medicine|Dr. Yasmin Mossavar-Rahmani|718-430-2136|yasmin.mossavar-rahmani@einsteinmed.edu|
22424441|NCT02607306|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22424442|NCT01324570|Purdue Pharma L.P.|Clinical Leader|800-733-1333|stacy.baldridge@pharma.com|
22424443|NCT02360475|GlaxoSmithKline|GSK Response Center|866-435-7343||
22424444|NCT00316862|Memorial Sloan-Kettering Cancer Center|David H. Ilson, M.D., Ph.D.||ilsond@mskcc.org|
22424445|NCT01160380|Oncotherapeutics|Director of Clinical Operations|310-623-1200|lthulin@oncotherapeutics.com|
22424446|NCT02510820|CooperVision|Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com|
22424447|NCT01859949|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22424448|NCT01153009|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22424449|NCT00810498|Philips|Jeff Jasko|412-542-3651|jeff.jasko@philips.com|
22424450|NCT04316260|Medical University of South Carolina|Noelle Natale|843-876-2426|natalen@musc.edu|
22424451|NCT03307837|Concentric Analgesics|Dr. John Donovan, President and Founder|415-676-8940|JOHN@CONCENTRICANALGESICS.COM|
22424452|NCT01744483|Oregon Health Science & Science University|Dr Miriam Treggiari|(503) 494-8311|treggiar@ohsu.edu|
22424453|NCT03041467|Medtronic|Phally Roffe, Clinical Study Manager|763.526.0350|phally.s.roffe@medtronic.com|
22424454|NCT01238341|University of Florida|Dr. Peter V. Draganov|(352) 273-9472|Peter.Draganov@medicine.ufl.edu|
22424455|NCT02330172|Seoul national university Bundang Hospital|Eunsu Choi|821032990658|potterydoll@hanmail.net|
22434354|NCT00244933|Barbara Ann Karmanos Cancer Institute|Amy Weise, M.D.|313-576-8599|weisea@karmanos.org|
22434355|NCT00866047|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
22434356|NCT02928029|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22434357|NCT03703817|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22434358|NCT04674111|Boston Scientific Corporation|Amy Maurer, Director of Clinical Trials|800-876-9960|amy.maurer@bsci.com|
22434359|NCT00616018|Denver Health|Jody Green|303-389-1246|jody.green@rmpdc.org|
22434360|NCT03315793|Shionogi|Shionogi Clinical Trial Administrator|+81-6-6209-7885|shionogiclinicaltrials-admin@shionogi.co.jp|
22434361|NCT01521871|Oslo University Hospital, Rikshospitalet|Dr. Ole Øyen|+4723070000|ooyen@ous-hf.no|
22434362|NCT01301521|MOMH|Amanda Crawford|702-653-3583|amanda.j.crawford.ctr@health.mil|
22434363|NCT01463111|Emory University|Dr. Boadie Dunlop|404-727-8969|bdunlop@emory.edu|
22434364|NCT00882583|FDA|Shanthi Marur|2404026373|shanthi.marur@fda.hhs.gov|
22434365|NCT04086693|Beaumont Health|Amit Bahl, MD|248-551-1792|Amit.Bahl@beaumont.edu|
22434366|NCT03018418|University of Cincinnati Cancer Center|Jordan Kharofa, MD|513-584 4775|kharofjr@ucmail.uc.edu|
22434367|NCT00966849|Imperial College London|Professor Simon Gregson|+4402075943279|Sajgregson@aol.com|2075943279
22434368|NCT00100230|Retina Foundation of the Southwest|Dennis Hoffman, Ph.D., Sr. Research Scientist|214-363-3911|dhoffman@retinafoundation.org|125
22434369|NCT03389555|Beth Israel Deaconness Medical Center Emergency Department|Michae Donnino|(617) 754-2882|mdonnino@bidmc.harvard.edu|
22434370|NCT01885208|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)||clinicaltrials@novonordisk.com|
22434371|NCT00883168|Meda Pharmaceuticals, Inc.|David Ginsberg,D.O.|732 564-2364|david.ginsberg@meda.us|
22434372|NCT00920218|GlaxoSmithKline|GSK Response Center|866-435-7343||
22434373|NCT00923975|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
22434374|NCT01709422|Prince of Songkhla University|Dr. Nisa Netinatsunton|6674451965|nisasan@yahoo.com|9
22434375|NCT02130687|Yale University|Nancy J. Brown, M.D.|16153644022|nancy.j.brown@yale.edu|
22434376|NCT04417218|Vanderbilt University Medical Center|Dr. Jane Ferguson|6158759896|jane.f.ferguson@vumc.org|
22434377|NCT00873041|Novartis Pharmaceuticals|Study Director|862-778-8300||
22434378|NCT01074463|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22434379|NCT02449889|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
22434380|NCT00758264|GlaxoSmithKline|GSK Response Center|866-435-7343||
22434381|NCT02141867|South African Surgical Outcomes Study|Prof Bruce Biccard|+27312604328|biccardb@ukzn.ac.za|
22434382|NCT01082874|Population Health Research Institute|P.J. Devereaux, MD, PhD, FRCPC|905-527-4322|philipj@mcmaster.ca|40654
22434383|NCT02899650|University of Texas at Austin|Koichiro Hayashi|512-471-8594|k-hayashi@kokugakuin.ac.jp|
22434384|NCT02163967|Weill Cornell Medical College|Margaret Altemus|646-209-6277|maltemus@med.cornell.edu|
22434385|NCT03176472|Regenacy Pharmaceuticals Inc.|Dr. David Michelson, CMO|2676639826|dmichelson@regenacy.com|
22434386|NCT01846663|Bausch Health Americas, Inc|Study Director|7072851528|Varsha.Bhatt@bauschhealth.com|
22434387|NCT00986401|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22434388|NCT03570918|MacroGenics, Inc.|Chief Medical Officer|301-251-5172|info@Macrogenics.com|
22434389|NCT04392141|Kermanshah University of Medical Sciences|Prof. Ali Mostafaie|+989188302044|amostafaie@kums.ac.ir|
22434390|NCT04295681|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22434391|NCT02357472|Ji Ai Genetics & IVF Institute|Dr.Jing Fu|86-021-63459977|fujing_givf@163.com|
22434392|NCT05623475|College of Nursing, Taipei Medical University, Taiwan|Kee-Hsin Chen, R.N., Ph.D.|+886-2-27361661|keehsin@tmu.edu.tw|3613
22434393|NCT00803400|Psychiatry Academic Unit at J.A.Fernandez Hospital, University of Buenos Aires Medicine School Department of Mental Health|Dr. Marcelo Rudelir|54 11 48254740|mrudelir@hotmail.com|
22434394|NCT02210689|Teva Pharmaceuticals USA. Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
22434395|NCT00675441|UT MD Anderson Cancer Center|Amin Alousi, MD / Assisstant Professor||CR_Study_Registration@mdanderson.org|
22434396|NCT02959827|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22434397|NCT05427539|Johnson & Johnson Vision Care, Inc. (JJVC)|Ben Straker|1-800-843-2020|bstraker@its.jnj.com|
22434398|NCT00410826|University of Washington|Renato G. Martins, MD, MPH|2062882048|rgmart@uw.edu|
22434399|NCT05129449|OLYMPUS EUROPA SE & CO. KG|Dr. Peter Teichmann|+49 40 23773|peter.teichmann@olympus.com|7835
22434400|NCT01777217|Century Cancer Centers|Dr. Sanjay Mehta|713-631-8181||
22434401|NCT03814382|Massachusetts General Hospital|Jessica Gerber, DAc.|617-724-1992|jgerber2@mgh.harvard.edu|
22434402|NCT02901054|Washington University School of Medicine|Simon Haroutounian, PhD|3142861715|simon.haroutounian@wustl.edu|
22434403|NCT00642434|University of New Mexico Health Sciences Center|Dr. Kathleen Colleran|505-272-4658|KColleran@salud.unm.edu|
22394216|NCT04578574|University of Miami|Eva Widerstrom-Noga, PhD; Roberta Vastano, PhD|305243-7125; 305243-8847|ewiderstrom-noga@med.miami.edu; Rxv331@med.miami.edu|
22394217|NCT02388646|OrthoIndy|Dr. Frank Kolisek|3178845160|fkolisek@orthoindy.com|
22394218|NCT02996565|HealthPartners Institute|Karen Margolis, MD MPH|952-967-7301|Karen.L.Margolis@HealthPartners.com|
22394219|NCT00836095|Penn State Milton S. Hershey Medical Center|Sonia Vaida MD, Professor of Anesthesiology|7175318433|svaida@hmc.psu.edu|
22394220|NCT01602562|GlaxoSmithKline|GSK Response Center|866-435-7343||
22394221|NCT03609853|Johns Hopkins School of Medicine|Dr. Ryan Vandrey|410-550-4036|rvandrey@jhmi.edu|
22394222|NCT04964414|UPMC Children's Hospital of Pittsburgh|Dr. Amber Shaffer|412-692-6874|shafferad@upmc.edu|
22394223|NCT01366495|Friends Research Institute|Dr. Michael S. Gordon, Senior Research Scientist|410-837-3977|mgordon@friendsresearch.org|251
22394224|NCT01765465|DongGuk University Ilsan Hospital|Dr. In Woong Han||cardioman76@gmail.com|
22394225|NCT03572387|Icahn School of Medicine at Mount Sinai|Vaibhav Patel, MD|212-659-5511|vaibhav.patel@mountsinai.org|
22394226|NCT00232544|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov|
22394227|NCT02581631|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22394228|NCT00116753|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
22394229|NCT01200589|Novartis Pharmaceuticals|Study Director|862-778-8300||
22394230|NCT00986973|The Children's Hospital of Philadelphia|Dr. Can Ficicioglu|2155905876|ficicioglu@email.chop.edu|
22394231|NCT00598273|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
22394232|NCT01590082|The University of Texas (UT) MD Anderson Cancer Center|Sapna P. Patel, Associate Professor, Melanoma Medical Oncology|(713) 792-2921|sppatel@mdanderson.org|
22394233|NCT02549196|Allergan, Inc|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
22394234|NCT01442779|Texas Tech University Health Sciences Center|Lorenz Lutherer, MD, PhD|806-743-2532|Lorenz.Lutherer@ttuhsc.edu|
22394235|NCT02666846|Futura Medical Developments Limited|Director of Clinical Development|01483685683|tim.holland@futuramedical.com|
22394236|NCT03386110|Hunter College|Tyrel J. Starks|212-206-7919|tstarks@hunter.cuny.edu|
22394237|NCT02684253|Memorial Sloan Kettering Cancer Center|Dr. Sean McBride, MD, MPH|646-608-2450|mcbrides@mskcc.org|
22394238|NCT05195489|NYU Langone Health|Kimberly Hoagwood, PhD|240-401-4289|Kimberly.Hoagwood@nyulangone.org|
22394239|NCT05406752|Unither-Pharmaceuticals|Non-Clinical & Clinical Project Manager|+33 (0)1 44 63 51 78|clinicaltrials@unither-pharma.com|
22394240|NCT00409773|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22434404|NCT03718884|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22434405|NCT02708849|Yale School of Medicine|Chadi Abdallah|347-987-0717|chadi.abdallah@yale.edu|
22394241|NCT01201343|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22394242|NCT01919814|Pennington Biomedical Research Center|Frank Greenway, MD|2257632578|frank.greenway@pbrc.edu|
22434406|NCT02099344|Kaiser Permanente NW|Earl Schuman, MD|503-331-6017|kathleen.ann.arnold@kpchr.org|
22394243|NCT02164383|University of Wisconsin Center for Tobacco Research and Intervention|Tanya Schlam, PhD|608-262-4149|trschlam@ctri.wisc.edu|
22394244|NCT01672723|University of California, Los Angeles|Dr. Naomi Eisenberger|310-267-5196|neisenbe@ucla.edu|
22394245|NCT00743275|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22394246|NCT00619762|LifeCell|Director of Clinical Operations|908.809.7856|djacobs@lifecell.com|
22394247|NCT00575029|University of Arkansas|Dr. Donald Bodenner|501-526-5710|bodennerdonald@uams.edu|
22394248|NCT03572478|University of Chicago|Walter STadler|773-702-4150|wstadler@medicine.bsd.uchicago.edu|
22394249|NCT03057977|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22394250|NCT01201317|AstraZeneca|Heather Bryson||clinicaltrialtransparency@astrazeneca.com|
22394251|NCT01350336|Boston Scientific Corp.|G Mark Grubb|(412) 716-0717|grubbm@bsci.com|
22394252|NCT02795429|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22394253|NCT04964388|UNIVERSITY OF MISSISSIPPI MEDICAL CENTER|Amy Wigglesworth|6018153164|ajwigglesworth@umc.edu|
22394254|NCT00250679|Sepracor Inc.|Respiratory Medical Director|1-866-503-6351||
22394255|NCT00448279|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22394256|NCT03907410|Children's Hospital of Philadelphia|Chen Kenyon|2674266339|kenyonc@chop.edu|
22394257|NCT04776148|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22394258|NCT01155375|AMAG Pharmaceuticals, Inc.|Medical Information|+1-877-411-2510|amag@druginfo.com|
22394259|NCT00757588|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22394260|NCT02440451|University of Coimbra|Prof. Dr. Miguel Castelo-Branco|+351239790000|mcbranco@fmed.uc.pt|
22394261|NCT00881608|Repros Therapeutics|Jennifer Wike|2817193402|jwike@reprosrx.com|
22394262|NCT00701220|The Ohio State University|Philip F. Binkley, MD, MPH|(614) 293-3956|binkley.2@osu.edu|
22394263|NCT02700945|Medtronic|Carola Alfaro Vives|763-526-1539|carola.alfaro.vives@medtronic.com|
22394264|NCT04018092|University of Florida - Norman Fixel Brain Institute|Dr. Dawn Bowers|3522220100|dawnbowers@phhp.ufl.edu|
22394265|NCT06469242|Alcon Research, LLC|Sr. Principal, Clinical Project Management, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22394266|NCT01205152|Alexion Pharmaceuticals, Inc.|Director of Clinical Trials|475-230-2596|ClinicalTrials@alexion.com|
22394267|NCT00069108|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22394268|NCT02783768|CUIMC|Elizabeth C. Oelsner, MD, MPH|212-305-9056|eco7@cumc.columbia.edu|
22394269|NCT02208999|CEMKA|Stéphane Bouée, Medical director|331.41.87.95.25|stephane.bouee@cemka.fr|
22394270|NCT00319839|University of California, Irvine|Chao Family Comprehensive Cancer Center|(877) 827-8839|UCstudy@uci.edu|
22394271|NCT00986674|ECOG Statistical Office|Study Statistician|617-632-3012||
22394272|NCT01853137|Osama AlAli|Dr.|00963992262582|osama-alali@hotmail.com|
22394273|NCT03658668|NYU Langone Health|Mathew Lustberg, MA|929 445 5090|Matthew.Lustberg@nyulangone.org|
22394274|NCT02777385|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP|4126475554|stadtermanbm@upmc.edu|
22394275|NCT01136772|Columbia University|T. Scott Stroup|646-774-8435|stroups@nyspi.columbia.edu|
22394276|NCT03881553|University of Pittsburgh School of Medicnie|Elisabeth Salisbury, PhD|412-246-5378|salisburye2@upmc.edu|
22394277|NCT01718353|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22394278|NCT01959516|Novartis Pharmaceuticals|Study Director|862-778-8300||
22394279|NCT02316366|Nationwide Children's Hospital|Dr. Renee Quarrie, fellow|2037136871|reneepetagae@gmail.com|
22394280|NCT01759368|VTT Technical Research Centre of Finland|Anna-Leena Orsama|+358408485966|anna-leena.orsama@vtt.fi|
22394281|NCT01191268|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22434407|NCT00404755|New York State Psychiatric Institute|Jonathan W. Stewart, M.D.|646-774-8000|jws6@columbia.edu|
22394282|NCT00336895|UPittsburgh|Dr. Roberto Lopez-Solis|412-647-5173|lopezrc@upmc.edu|
22394283|NCT01959334|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22394284|NCT01313689|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
22394285|NCT01768637|University of Arkansas for Medical Sciences|Nishank Jain, MD|5016865295|njain2@uams.edu|
22394286|NCT01054170|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22434408|NCT05145322|University of Minnesota School of Dentistry|Hooi Pin Chew|6126256975|chew0014@umn.edu|
22434409|NCT06359028|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
22434410|NCT04700540|University of Minnesota|Dr. Jude Mikal|385-212-4185|jpmikal@umn.edu|
22434411|NCT05248997|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22434412|NCT03515551|Immunocore, Ltd|Study Director|1-844-IMMUNO-1|clinicaltrials@immunocore.com|
22434413|NCT00673231|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
22434414|NCT02952313|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
22434415|NCT02063867|University of California, Irvine|Susan Huang, Principal Investigator & Medical Director of Epidemiology and Infection Prevention|949-824-5073|sshuang@uci.edu|
22434416|NCT01335724|Novartis Consumer Health|Clinical project Leader|+41223635528||
22394287|NCT02951767|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22394288|NCT01337115|Centro Hospitalar do Porto|Dr Raul Carvalho|+351226176114|raul@meo.pt|
22394289|NCT02697292|Mayo Clinic|Sean J. Pittock, M.D.|507-2084-4741|Pittock.Sean@mayo.edu|
22394290|NCT03426267|Sun Pharma Advanced Research Company Limited|Head-Clinical Development|912266455645|clinical.trials@sparcmail.com|
22394291|NCT01981772|The Ohio State University College of Dentistry|Sara Fowler|6142923596|fowler.276@osu.edu|
22394292|NCT00609765|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-2069|jonathan.strosberg@moffitt.org|
22394293|NCT02094755|University of Southern California|Dr. Leonardo Clavijo|3234426130|lclavijo@usc.edu|
22424456|NCT04757805|Nationwide Children's Hospital|Giorgio Veneziano, MD|614-722-4200|Giorgio.Veneziano@nationwidechildrens.org|
22424457|NCT02469168|Walter Reed National Military Medical Center|Jody Richardson, MSN, RN|301-295-7798|jody.richardson.ctr@usuhs.edu|
22424458|NCT00298363|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22424459|NCT00135356|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22424460|NCT01533688|UOklahoma|Dr. Mohammad Madhoun|405-456-326-|mohammad-madhoun@ouhsc.edu|
22424461|NCT04046263|"University of Colorado Denver | Anschutz"|Jessica Kendrick, MD|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
22424462|NCT01306214|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22424463|NCT02686814|Medtronic|Jessica Halverson, Clinical Research Director|(800) 633-8766|rs.perigonjapantrial@medtronic.com|
22424464|NCT02065518|University of Tennessee Health Science Center|Dr. Laura Talbot|901-448-3630|ltalbot@uthsc.edu|
22424465|NCT01110967|Medtronic Spinal & Biologics|Cristina Faria|+41 (0)21 802 70 00|cristina.faria@medtronic.com|
22424466|NCT01090050|Clinvest/A Division of Banyan Group Inc.|Jeanne Tarrasch|417-841-3673|jtarrasch@clinvest.com|
22424467|NCT00983541|Huntsman Cancer Institute|Christopher Anker, MD|801-213-4241|candace.larson@hci.utah.edu|
22424468|NCT03624569|The Ohio State University|Richard Bruno, Principal Investigator|6142925522|bruno.27@osu.edu|
22424469|NCT02826577|University of Chicago|Compliance Specialist|773-702-6505|czwieg@bsd.uchicago.edu|
22424470|NCT00935064|University of Delaware/Christiana Care Health System|Dr. Raelene E. Maser|302-831-8400|rmaser@udel.edu|
22424471|NCT04103034|Band Therapeutics|Tia DeFeo-Fraulini|7819186561|tia.defeo-fraulini@bandtherapeutics.com|
22424472|NCT03943823|The University of Texas Health Science Center at Houston|Sunbola Ashimi, PhD|713-500-6410|Sunbola.S.Ashimi@uth.tmc.edu|
22424473|NCT01294748|Micell Technologies|Jeffrey Mifek, VP Clinical Affairs|919-313-2102|jmifek@micell.com|
22424474|NCT00310076|Comprehensive Cancer Center of Wake Forest University|Greg Russell, MS|336-716-5449|grussell@wakehealth.edu|
22424475|NCT02555930|Imperial College London|Dr Harriet Kemp|+44 20 3315 8816|h.kemp@imperial.ac.uk|
22424476|NCT01010399|Franco Felizarta, MD|Franco Felizarta, MD|661-324-3128|felizarta@pol.net|
22424477|NCT03743402|University of Washington|Dr. Mark Sullivan|2066853184|sullimar@uw.edu|
22424478|NCT03611101|Exalenz Bioscience|Clinical Trial Manager|+972-8-9737513|avrahamh@exalenz.com|
22424479|NCT00466206|UCSF-Benioff Children's Hospital|Michael Harrison, MD|415 476-2538|pedsurg@ucsfmedctr.org|
22424480|NCT01464619|The Children's Hospital of Philadelphia|James Guevara, MD, MPH|215-590-1130|guevara@email.chop.edu|
22394294|NCT00491829|Sprout Pharmaceuticals|Scientific Program Director|9198820850|clinicaltrials@sproutpharma.com|
22394295|NCT01001559|Red Oak Psychiatry Associates|Dr. Lawrence Ginsberg|281-893-4111|larrydg@earthlink.net|151
22394296|NCT02054520|NewLink Genetics Corporation|Manager, Clinical Operations|515-598-5020|csmith@linkp.com|2624
22394297|NCT02027623|Washington University|Linda van Dillen, PT, PhD, FAPTA; Research Division Director|314-286-1427|vandillenl@wustl.edu|
22394298|NCT01043393|Taro Pharmaceuticals U.S.A., Inc.|Director, Clinical Research|914-345-9001|natalie.yantovskiy@taro.com|
22394299|NCT01272804|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22394300|NCT03801915|National Cancer Institute|Dr. Jonathan Hernandez|240-760-6072|jonathan.hernandez@nih.gov|
22394301|NCT02308020|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979|ClinicalTrials.gov@lilly.com|
22424481|NCT03411902|Wake Forest School of Medicine|Kristen Beavers|336-758-5855|beaverkm@wfu.edu|
22424482|NCT02410213|Luitpold Pharmaceuticals, Inc.|Angelia Butcher|610-650-4200|abutcher@lpicrd.com|811
22424483|NCT01693185|Konkuk University Medical Center|Dr. Tae-Yop Kim, Professor of Anesthesiology|82-2-2030-5445|taeyop@gmail.com|
22424484|NCT00419159|Novartis Pharmaceuticals|Study Director|862-778-8300||
22424485|NCT01017601|Mayo Clinic|Julian Molina, M.D, Ph.D.|507-284-1328|Molina.julian@mayo.edu|
22424486|NCT04964986|VectivBio AG|Clinical Trial Information Desk|617.621.7722|ClinicalTrialEnquiries@ironwoodpharma.com|
22424487|NCT01857102|Johnson and Johnson Vision Care Inc.|Kathrine E. Osborn, OD, MS, FAAO- DIRECTOR GLOBAL STRATEGIC CLAIMS|904-443-1032|KOSBORN@its.jnj.com|
22424488|NCT02648477|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22424489|NCT01115556|Vitreous Retina Macula Consultants of New York|K. Bailey Freund, MD (or Galyna Ganieva, Research Manager)|212-861-9797|gganieva@vrmny.com|6929
22424490|NCT02735096|Innervo Technology|Dr. Hui Tang|5732896776|htang@innervotech.com|
22424491|NCT00497770|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22424492|NCT00438802|Mayo Clinic|Thomas E. Witzig, M.D.||witzig.thomas@mayo.edu|
22424493|NCT00796744|US Biotest|Dr. Shelagh Verco|805-595-1300|shelagh.verco@usbiotest.com|
22424494|NCT01080391|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22424495|NCT04493151|Center for Anti-Infective Research and Development, Hartford Hospital|Dr. Joseph L. Kuti, PharmD, FIDP, FCCP|(860) 972-3612|Joseph.Kuti@hhchealth.org|
22424496|NCT04779606|Sintetica SA|Dr.Elisabetta Donati, Corporate Director Scientific Affairs|+41.91.640.42.50|edonati@sintetica.com|
22424497|NCT01712308|The University of Texas MD Anderson Cancer|Prithviraj Bose MD/Associate Professor|713-792-7747|PBose@mdanderson.org|
22424498|NCT03725033|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22424499|NCT02083653|Symphogen A/S|Chief Scientific Officer|+45 8838 2600|info@symphogen.com|
22424500|NCT02073656|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22424501|NCT02638051|Clifford Hospital|Prof. Clifford LK Pang, President of Clifford Hospital|(8620) 34710038|cpang@cliffordgroup.com|
22424502|NCT00428922|The Ohio State University Comprehensive Cancer Center|Bhuvaneswari Ramaswamy, MD|614-293-0066|Bhuvaneswari.Ramaswamy@osumc.edu|
22424503|NCT02536781|Khon Kaen University|Faculty of Pharmaceutical Science|+66-43-362092|lsucharat@gmail.com|
22424504|NCT03423147|Icahn School of Medicine at Mount Sinai|Nicola Tavella|212-241-3888|nicola.tavella@mssm.edu|
22424505|NCT01048099|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22424506|NCT03290547|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
22424507|NCT01731470|Beaumont Hospital, Royal Oak|Kenneth Peters MD|248-551-0387|Kenneth.Peters@Beaumont.edu|
22424508|NCT01889355|AgaMatrix, Inc|Senior Clinical Research Technician|603-328-6035|krocha@agamatrix.com|
22424509|NCT04164004|Stanford University|Alexander Sandhu|9097671214|ats114@stanford.edu|
22424510|NCT02450552|Massachusetts General Hospital - Neurological Clinical Research Institute|Protocol Investigator|617-726-2000|Brian.Wainger@MGH.HARVARD.EDU|
22424511|NCT01524783|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22394302|NCT03265938|Icahn School of Medicine at Mount Sinai|Dr. Samuel DeMaria|(212) 241-1518|samuel.demaria@mountsinai.org|
22394303|NCT01211288|University of Alabama at Birmingham|Dr. Toni Tien Neumeier|205-934-5459|neumeier@uab.edu|
22394304|NCT01551212|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22394305|NCT00705523|UPenn|Dr. Jennifer Plebani|215-222-3200|jplebani@mail.med.upenn.edu|152
22394306|NCT02471833|Emory University|Whitney Wharton, PhD|404-712-7359|w.wharton@emory.edu|
22394307|NCT02673515|Medical University of Graz|Assoc.-Prof.Dr. Harald Sourij|+43 316 385|norbert.tripolt@medunigraz.at|78038
22424512|NCT01625689|PATH|Senior Clinical Research Scientist|206-285-3500|klewis@path.org|
22424513|NCT00889187|Brigham and Women's Hospital / Dana Farber Cancer Institute|Harvey Mamon, MD, PhD|617-732-8564|HMAMON@LROC.HARVARD.EDU|
22424514|NCT03723070|Boston Scientific|Clinical Trial Manager|+32 470 991143|nele.cielen@bsci.com|
22424515|NCT02208050|St. Vincent's University Hospital|Professor Christopher McGuigan|+35312214209|C.McGuigan@svhg.ie|
22424516|NCT02770768|University of Chicago|Compliance Specialist|773-702-6505|czwieg@bsd.uchicago.edu|
22424517|NCT00824434|Boston Scientific|Ruth Starzyk, PhD|508-683-6577|ruth.starzyk@bsci.com|
22424518|NCT00721279|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22424519|NCT05153148|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22424520|NCT01732471|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22424521|NCT04494425|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22424522|NCT01291264|University of California, San Francisco|Dr. Julius Schachter, Professor of Laboratory Medicine|415 824 5115|julius.schachter@ucsf.edu|
22424523|NCT01270321|Emory University|Dr. Taofeek Owonikoko|404-778-5575|TOWONIK@emory.edu|
22424524|NCT03151083|VA Connecticut Healthcare System|Dr. Eric Hermes|203 932 5711|eric.hermes@va.gov|7422
22424525|NCT04003623|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22424526|NCT02918097|Universidade Federal do Rio Grande do Sul|D.r. Ana Flávia Barros da Silva Lima|5551999185180|afbslima@gmail.com.br|
22424527|NCT04640038|Children's Hospital of Philadelphia|Misun Hwang|267-425-7129|hwangm@chop.edu|
22424528|NCT02242019|Regulatory Insight, Inc.|Clinical Consultant|615-712-9743|elvira@reginsight.com|
22424529|NCT01190189|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22424530|NCT03525808|Boston Scientific|Ornela Gjata|(508)-683-4155|Ornela.Gjata@bsci.com|
22424531|NCT05206734|Royal Hospital for Children and Young People, Edinburgh|Richard K Russell|0131 312 0431|richard.russell@nhs.scot|
22424532|NCT00762034|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22424533|NCT00734656|University of Connecticut Health Center|Jonathan Covault|860-679-7560|jocovault@uchc.edu|
22424534|NCT01225926|Alcon Research, Ltd.|Manoj Venkiteshwar, Brand Lead, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
22424535|NCT03214679|University School of Medicine, New York|Ben Eckhardt|212-562-1000|benjamin.eckhardt@nyumc.org|
22424536|NCT01601067|VA San Diego|Sonya Norman, PhD|858-552-8585|sonya.norman@va.gov|
22424537|NCT04513899|University of California, Irvine, Sue & Bill Gross School of Nursing|Dr Adeline Nyamathi|(949) 824-8932|anyamath@hs.uci.edu|
22424538|NCT02707172|Kaohsiung Medical University|Dr. Ming-Tsang Wu|+886-7-3121101|e_encourage@yahoo.com|2315
22424539|NCT03083353|The University of Texas at Austin|Sara Reedy|512-232-4319|Sarah.Fella@austin.utexas.edu|
22424540|NCT01754766|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22424541|NCT03972501|Azura Ophthalmics|Charles Bosworth|17145598435|charles.bosworth@azuraophthalmics.com|
22424542|NCT01709409|OHRI|Dr. Brigitte Lemyre|613-737-8899|blemyre@toh.on.ca|71882
22424543|NCT02412878|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22424544|NCT04571385|Acesion Pharma|Birgitte Vestbjerg|+45 20772575|bve@acesionpharma.com|
22424545|NCT04676152|Masimo Corporation|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
22424546|NCT01888653|Columbia University Medical Center/New York State Psychiatric Institute|Yuval Neria|6467748092|yuval.neria@nyspi.columbia.edu|
22424547|NCT01928199|Washington University in St. Louis|Rowena Delos Santos|314-362-8351|delossantos@wustl.edu|
22424548|NCT00755261|SKCCC, Johns Hopkins University|Christian Meyer, M.D., Ph.D.|4105025940|cmeyer13@jhmi.edu|
22424549|NCT00571103|University of Iowa Carver College of Medicine|Dr. Donald W Black|319-3534431|donald-black@uiowa.edu|
22424550|NCT02368886|Mayo Clinic Arizona|Tanios Bekaii-Saab, M.D.|507/266-0800|Bekaii-Saab.Tanios@mayo.edu|
22424551|NCT02339974|Henry Ford Health|Dr. Brian O'Neill|313-970-6483|boneil3@hfhs.org|
22424552|NCT04278924|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22424553|NCT04767529|Akero Therapeutics, Inc.|Kitty Yale|(650) 487-6488|harmonystudies@akerotx.com|
22424554|NCT04847232|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22424555|NCT02476916|Agios Pharmaceuticals, Inc.|Medical Affairs|833-228-8474|medinfo@agios.com|
22424556|NCT06010732|Indiana University School of Dentistry|Domenick T. Zero|3179877507|dzero@iu.edu|
22424557|NCT03491397|University of California Los Angeles|Siddharth A. Padia, MD|310-825-2992|SPadia@mednet.ucla.edu|
22424558|NCT00253370|ECOG Statistical Office|Study Statistician|617-632-3012||
22424559|NCT03699540|University of Kentucky|Shanna Babalonis, Ph.D.|859-257-1881|babalonis@uky.edu|
22424560|NCT02697591|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
22424561|NCT02636699|DBV Technologies|Chief Medical Officer|33-1-55-42-78-78|clinicaltrials@dbv-technologies.com|
22424562|NCT00624832|Novartis Pharmaceuticals|Study Director|862-778-8300||
22424563|NCT01939223|Bayer|Therapeutic Area Head|+49 30 300139003|clinical-trials-contact@bayer.com|
22424564|NCT04379700|NYU Langone Health|Bedros Taslakian, MD|212-263-5898|bedros.taslakian@nyulangone.org|
22424565|NCT04595279|Johns Hopkins University|Matthew Johnson|410-550-0056|mwj@jhu.edu|
22424566|NCT02258334|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22434417|NCT04470908|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22434418|NCT04376684|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22434419|NCT01666119|BDSI|Enoch Bortey|919 582 9050|ebortey@bdsi.com|
22434420|NCT02835313|University of Delaware|Dr. Darcy Reisman, PT, PhD, FAPTA|302-831-0508|dreisman@udel.edu|
22434421|NCT04084366|OBI Pharma, Inc.|Dr. Wayne Saville, Chief Medical Officer|619-537-7821|waynesaville@obipharmausa.com|
22434422|NCT02713997|University of Minnesota|Melena Bellin|612-625-4686|bell0130@umn.edu|
22434423|NCT05487040|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22434424|NCT02470585|AbbVie|Global Medical Services|1-800-633-9110|abbvieclinicaltrials@abbvie.com|
22434425|NCT02602275|Biologische Heilmittel Heel GmbH|Head of Clinical Research|+49 7221 501|info@heel.com|0
22434426|NCT02244840|Seoul National University Hospital|Professor|82-2-2072-2901|kjparkmd@plaza.snu.ac.kr|
22434427|NCT03028415|Ferring Pharmaceuticals|Global Clinical Compliance|-+1 833-548-1402|DK0-Disclosure@ferring.com|
22394308|NCT00974376|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu|
22394309|NCT02523599|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
22394310|NCT01892540|University Hospitals|Philipp Frank Graner|+1 216-844-8275|philipp.graner@uhhospitals.org|
22394311|NCT01370590|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22394312|NCT03110224|Zimmer Biomet|Annette Tieu|971-482-9622|annette.tieu@zimmerbiomet.com|
22394313|NCT00727311|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclsoure@merck.com|
22394314|NCT03992846|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
22394315|NCT00031551|NINR/NIH|Suzanne Wingate|301-827-0982|suzanne.wingate@nih.gov|
22394316|NCT00235547|University of Washington|Dr. Sarah Prager|415-206-8715|pragers@uw.edu|
22394317|NCT01440374|Novartis Pharmaceuticals|Study Director|862-778-8300||
22394318|NCT04812548|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
22394319|NCT01845220|Johns Hopkins University|Jed W. Fahey, Sc.D.|4106142607|jfahey@jhmi.edu|
22394320|NCT02141984|AbbVie|Global Medical Services|800-633-9110||
22394321|NCT02049151|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Centre|496151725200|service@merckgroup.com|
22424567|NCT00925652|Dana-Farber Cancer Institute|Erica Mayer MD MPH|617-632-2335|emayer@partners.org|
22394323|NCT00876928|Charles R. Drew University|Mayer B. Davidson, MD|323 357-3439|mayerdavidson@cdrewu.edu|
22394324|NCT01716117|Stryker Neurovascular|Scott Courts, Clinical Program Manager|5104132170|scott.courts@stryker.com|
22394325|NCT00861263|University of FLorida|Dr. Peter Draganov MD|352-273-9472|peter.draganov@medicine.ufl.edu|
22394326|NCT03645057|University of Rochester|Julie Ryan|(585) 276-3862|Julie_Ryan@URMC.Rochester.edu|
22394327|NCT04187053|University of Texas Health Science Center at Houston|Srinivas Ayilavarapu, BDS, DSc, MDS|713-486-4390|srinivas.ayilavarapu@uth.tmc.edu|
22394328|NCT02978144|Columbia University|Gebhard Wagener, MD|(212) 305-6494|gw72@cumc.columbia.edu|
22394329|NCT01171807|Quince Therapeutics (former Erydel SpA)|Irene Maccabruni, M.Sc.|+39 02 36504470|imaccabruni@quincetx.com|
22394330|NCT01901341|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
22394331|NCT01093521|University of Washington|Christopher H. Goss, MD MSc|206-543-3166|goss@u.washington.edu|
22394332|NCT02563522|Helixmith Co., Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
22394333|NCT01749605|University of Iowa|Brett Faine, PI|319-310-8067|brett-faine@uiowa.edu|
22394334|NCT04874415|University of Pittsburgh|Dr. Mary Ellen Vajravelu|412-692-6533|MaryEllen.Vajravelu@pitt.edu|
22394335|NCT05559099|National Institute of Allergy and Infectious Diseases|Lori Dodd|2406695247|doddl@niaid.nih.gov|
22394336|NCT01037244|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22394337|NCT00690820|Solvay Pharmaceuticals|Sven Voet - Global Communication|+32(0)2 509 69 77|sven.voet@solvay.com|
22394338|NCT00848926|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
22394339|NCT00903630|University of Minnesota, Dept. of OBGYN|Dr. Levi Downs, Jr|612-626-3111|downs008@umn.edu|
22394340|NCT04025580|National Institutes of Health|Rachel Sparks|240-292-4642|rachel.sparks@nih.gov|
22394341|NCT02216357|Cumberland Pharmaceuticals Inc.|Senior Manger, Clinical Operations|615-255-0068|bkaelin@cumberlandpharma.com|250
22394342|NCT04147650|Aurinia Pharmaceuticals|Clinical Trial Support|(250) 744-2487|clinicaltrials@auriniapharma.com|
22394343|NCT00235326|McMaster University|John Marshall|9055212100|marshllj@mcmaster.ca|76782
22394344|NCT04409886|Maimonides Medical Center|Gene Sobol|718-283-6000|gsobol@maimonidesmed.org|
22394345|NCT01849822|California Institute of Technology|Dr. Richard Andersen|16263958336|andersen@vis.caltech.edu|
22394346|NCT01790126|Janssen Research & Development, LLC|EXECUTIVE MEDICAL DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22394347|NCT01477333|United Therapeutics Corp.|Kevin LaLiberte, PharmD|919-425-8176|KLaliberte@unither.com|
22394348|NCT00455325|Washington University School of Medicine|Janet McGill, MD|(314) 362-8688|jmcgill@wustl.edu|
22394349|NCT01178671|Research Foundation for Mental Hygiene|Franklin Schneier MD|6467748041|fschneier@nyspi.columbia.edu|
22394350|NCT02435966|Physios & Universidad Europea de Madrid|Gracia M. Gallego, M.Sc.|+34 609036607|gracia.maria.gallego@gmail.com|
22394351|NCT04620811|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
22394352|NCT02501538|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
22394353|NCT01078675|AstraZeneca, R&D, B&I|Niklas Berglind, GPS|+46317766310|niklas.berglind@astrazeneca.com|
22394354|NCT00928746|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22424568|NCT05822648|Stanford University|Dr. Eric Stice|650-723-7885|estice@stanford.edu|
22424569|NCT03564795|KeraNetics|Luke Burnett|336.725.0621|lburnett@keranetics.com|
22424570|NCT05079230|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22424571|NCT00770133|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
22424572|NCT00564395|Children's Hospital at Montefiore|Dr. Rubina Heptulla|718-920-7004|rheptull@montefiore.org|
22424573|NCT00100841|Montefiore Medical Center|Lisa Escobar-Peralta|718-379-6866|lescobar@montefiore.org|
22424574|NCT02054910|University of Alabama at Birmingham|Jaypal Ramesh|205-975-9564|jramesh@uab.edu|
22424575|NCT01782352|Brigham and Women's Hospital; 900 Commonwealth Ave, 3rd fl.; Boston, MA 02215|VITAL Study Director|1-800-388-3963|vitalstudy@partners.org|
22424576|NCT00477607|VA RR&D National Center for Rehbilitative Auditory Research|Dawn Konrad-Martin|503-220-8262|dawn.martin@va.gov|52962
22424577|NCT00432276|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22394355|NCT01804062|Medtronic|Michael Luna-Victoria|303 305 2463|michael.luna-victoria@medtronic.com|
22394356|NCT03311334|Sumitomo Pharma America|Mimi M. Lee, MSW, CCRP|617-674-6800|mimi.lee@oncology.sumitomo-pharma.com|
22394357|NCT02745392|Zosano Pharma Corporation|Dr. Donald Kellerman|(510) 745-4004|dkellerman@zosanopharma.com|
22394358|NCT04129216|Johns Hopkins University|Dr. Mehran Habibi|4105505522|mhabibi2@jhmi.edu|
22394359|NCT00968227|Washington University|Michael Diringer PI|314-362-2999|diringerm@wustl.edu|
22394360|NCT02004353|Cochlear|Jasmin Kaur|+41612058238|jakaur@cochlear.com|
22394361|NCT04023110|University of Pennsylvania|Bonnie Ky, MD, MSCE|215-573-6606|bonnie.ky@pennmedicine.upenn.edu|
22394362|NCT01651442|National Jewish Health|Bryan Simmons|303-398-1850|simmonsb@njhealth.org|
22394363|NCT01007448|Bausch Health Americas, Inc.|Director of Clinical Operations||aloncaric@bauschhealth.com|
22394364|NCT02481947|Braintree Laboratories, Inc.|Vice President, Clinical Affairs|781-843-2202|john.mcgowan@sebelapharma.com|
22394365|NCT02751320|GlaxoSmithKline|GSK Response Center|866-435-7343||
22394366|NCT03426605|OrphAI Therapeutics|Esther Nkrumah|2675121750|enkrumah@orphai-therapeutics.com|
22394367|NCT01886378|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
22424578|NCT00594386|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22424579|NCT01210144|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22424580|NCT00083720|ImClone, LLC|Chief Medical Officer||ClinicalTrials@imclone.com|
22424581|NCT03260426|Cedars Sinai Medical Center|Phillip Fleshner, MD|310-289-9224|pfleshner@aol.com|
22424582|NCT02664922|University of California, Los Angeles|Jennifer Scovotti|310.206.4484|jscovotti@mednet.ucla.edu|
22424583|NCT00207727|Centocor Research & Development, Inc.|Sr. Dir. Clinical Research|1-800-457-6399||
22424584|NCT03759366|Alexion Pharmaceuticals Inc.|Alexion Europe SAS European Clinical Trial Information|7 87148158|clinicaltrials.eu@alexion.com|
22424585|NCT00539032|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22424586|NCT03557684|UCLA|Joshua H. Cho, MD, PhD|3104286218|hjcho@mednet.ucla.edu|
22424587|NCT00714753|Mayo Clinic|Thomas M. Pisansky, M.D.||Pisansky.Thomas@mayo.edu|
22424588|NCT00505661|UT MD Anderson Cancer Center|John Kavanagh, MD / Professor|713-792-2933||
22424589|NCT01093651|Washington Univ Med Sch|Kevin Yarasheski, PhD|3143628173|key@wustl.edu|
22424590|NCT03611582|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22424591|NCT01573754|University of Texas Medical Branch Galveston|Dr. Karl Anderson|409-772-4661|kanderso@utmb.edu|
22424592|NCT02061683|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22424593|NCT00463840|New York University Cancer Institute|Theresa Ryan, MD|212-731-5430|theresa.ryan@nyumc.org|
22424594|NCT04438499|Laborie Medical Technologies|Adele Campbell|16032558251|ACampbell@laborie.com|
22424595|NCT04284930|Cleveland Clinic|Risal Djohan|216 312-6146|djohanr@ccf.org|
22424596|NCT00602290|University of California, Los Angeles|Dr. Helen Lavretsky|310-794-4619|hlavretsky@mednet.ucla.edu|
22424597|NCT01533948|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22424598|NCT04228965|Medical University of South Carolina|Erin A. McClure, Principal Investigator|843-792-7192|mccluree@musc.edu|
22424599|NCT02081014|Xeris Pharmaceuticals, Inc.|Martin J. Cummins, VP Drug Development|512-498-2675|mjcummins@xerispharma.com|
22424600|NCT01026818|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22424601|NCT01641471|Cleveland Clinic - Section of Adult Reconstrution|Research Program Manager|216-444-4954|klikaa@ccf.org|
22424602|NCT04575584|Merck Sharp & Dohme, LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22424603|NCT02634801|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22424604|NCT03678675|Tufts Medical Center|Jean Hostage|617-636-4549|jeanhostage@gmail.com|
22424605|NCT00199849|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22424606|NCT01548768|Columbia University Irving Medical Center|Dr. Joan Bathon, MD|212-305-6327|jmb2311@cumc.columbia.edu|
22424607|NCT03300050|PATH|Jorge Flores, MD|(202) 822-0033|jeflores@path.org|
22424608|NCT02499263|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22424609|NCT01375374|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22424610|NCT01908582|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22424611|NCT00424593|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22424612|NCT01108237|DePuy Orthopaedics, Inc.|Sam Himden|574-372-7231|SHimden@its.jnj.com|
22424613|NCT01681095|William Beaumont Hospital|Marc P. Sakwa, M.D.|248/898-0123|marc.sakwa@beaumont.org|
22424614|NCT02178358|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
22424615|NCT01066663|Dana-Farber Cancer Institute|Jennifer R Brown MD PhD|l 617-632-4894|Jennifer_Brown@dfci.harvard.edu|
22394368|NCT01736865|Tufts Medical Center|Dr. Anastassios Pittas|617-636-5694|apittas@tuftsmedicalcenter.org|
22394369|NCT03513588|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22394370|NCT01270971|Anacor Pharmaceuticals, Inc.|Sheryl Baldwin, RN/Associate Director|650-223-8597|clinicaltrials@anacor.com|
22394371|NCT02292654|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22394372|NCT02411357|University of Vermont|Sarah H. Heil, PhD|802-656-8712|sarah.heil@uvm.edu|
22424616|NCT02232061|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
22424617|NCT03735407|CheckCap|Clinical Director|972-4-8303401|daniella.bleistein@check-cap.com|
22424618|NCT03297021|Icahn School of Medicine at Mount Sinai|Dr. Daniel Katz|212-241-7475|Daniel.Katz@mountsinai.org|
22424619|NCT03108066|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22394373|NCT00001984|NIDDK, NIH|Dr. Alan Kirk||allank@intra.niddk.nih.gov|
22394374|NCT03333837|Wake Forest University School of Medicine|Christina Hugenschmidt, PhD|336-713-8116|chugensc@wakehealth.edu|
22394375|NCT02858349|University of Cincinnati|Pierce Boyne|5135587499|Pierce.Boyne@uc.edu|
22394376|NCT04217590|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astazeneca.com|
22394377|NCT01013285|UCLA Neuro-Oncology Program|Albert Lai|310-825-5321|albertlai@mednet.ucla.edu|
22394378|NCT03324451|College of Nursing,Kaohsiung Medical University|Ruey-Hsia Wang|886-3-3121101|wrhsia@kmu.edu.tw|2641
22394379|NCT02232243|University of Kentucky|Peng Wang|(859) 257-4488|p.wang@uky.edu|
22394380|NCT00704405|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22394381|NCT01395888|GlaxoSmithKline|GSK Response Center|866-435-7343||
22394382|NCT01946438|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22394383|NCT02457559|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22394384|NCT02412371|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22394385|NCT02374671|Refocus Group, Inc.|Director of Regulatory & Quality|214-368-0200|lstewart@refocus-group.com|431
22394386|NCT00979810|Memorial Sloan Kettering Cancer Center|Michelle Bradbury, MD, PhD|646-888-3373|bradburm@mskcc.org|
22394387|NCT03169101|University of Pennsylvania|Rebecca Ashare, PhD|7168296273|rlashare@pennmedicine.upenn.edu|
22394388|NCT02641496|Veterans Affairs Palo Alto Health Care System|Lisa Kinoshita, Ph.D. (Principal Investigator)|650-493-5000|Lisa.Kinoshita@va.gov|65633
22394389|NCT02250092|University of Minnesota|Bernadette Gillick|612-626-6415|gillick@umn.edu|
22394390|NCT05590884|Guerbet|Frantz Hebert, Global Head of Clinical Development|+33 680249334|frantz.hebert@guerbet.com|
22394391|NCT02112838|Rigel Pharmaceuticals|Sandra Tong|1-650-624-1207|stong@rigel.com|
22394392|NCT04308395|Sol-Gel Technologies, Ltd.|VP Clinical & Regulatory Affairs|+972-73-3729453|Ofra.Levy-Hacham@sol-gel.com|
22394393|NCT01134952|LondonHSC|Dr Vivian McAlister|5196632920|vmcalist@uwo.ca|
22394394|NCT02437253|Los Angeles Biomedical Research Institute at Harbor-UCLA|Dr. Lynda Polgreen (PI)|310-222-1961|lpolgreen@labiomed.org|
22394395|NCT04134845|Vanderbilt University Medical Center|Dr. William Stevenson|615-322-2318|William.g.stevenson@vumc.org|
22394396|NCT03440320|Colorado State University|Dr Arlene Schmid|970-491-7562|arlene.schmid@colostate.edu|
22394397|NCT01912456|CSL Behring GmbH|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
22394398|NCT01340196|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22394399|NCT00185679|Stanford Cancer Institute|Ginna G Laport, MD|650-723-8222|ginna.laport@stanford.edu|13911
22394400|NCT01422226|University of Colorado Denver|Christina Gavito|303-724-5559|christina.gavito@ucdenver.edu|
22394401|NCT00709696|University of Minnesota|Dr. Marc Mooney|612-991-6875|moon0078@umn.edu|
22394402|NCT00171704|Novartis Pharmaceuticals|Novartis Pharmaceuticals|862-778-8300||
22394403|NCT02673151|Stanford University|Andrei Iagaru, Professor of Radiology (Nuclear Medicine)|(650) 725-4711|aiagaru@stanford.edu|
22394404|NCT04262947|Lahey Hospital and Medical Center|Thomas Schnelldorfer|781-744-5100|thomas.schnelldorfer@lahey.org|
22394405|NCT00816400|MedImmune|A Dose-escalation Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-575|1-877-240-9479|information.center@astrazeneca.com|
22394406|NCT00320541|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22394407|NCT01097785|University of Missouri|Paul Fadel|1-573-884-5220|fadelp@health.missouri.edu|
22394408|NCT00029172|Roudebush VAMC Center of Excellence|Dr. Linda Williams|317-988-3337|linda.williams6@va.gov|
22394409|NCT02482870|Recep Tayyip Erdogan University School of Medicine|Dr. Başar Erdivanlı|+904642130491|berdivanli@gmail.com|2128
22394410|NCT01620255|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22394411|NCT03077360|"University of Colorado Denver | Anschutz"|Bryan Bergman|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
22394412|NCT03794908|University of Michigan|Helen Burgess|734-615-8303|bhelen@umich.edu|
22394413|NCT02730988|Wake Forest University|Kristen Beavers|3367585855|beaverkm@wfu.edu|
22394414|NCT01322048|Vanderbilt University Medical Center|Mayur B. Patel|6153225000|mayur.b.patel@vanderbilt.edu|
22394415|NCT01873495|Emory University|Martha Arellano, MD|404-778-1900|marella@emory.edu|
22394416|NCT04344600|Johns Hopkins School of Medicine|Mark Sulkowski|410-955-7538|msulkowski@jhmi.edu|
22394417|NCT04335812|Lamar University|Dr. Vinaya Manchaiah, Jo Mayo Endowed Professor|(409) 812 9443|vmanchaiah@lamar.edu|
22394418|NCT03890419|Duke University|Padma Gulur|919-681-4660|padma.gulur@duke.edu|
22394419|NCT03864146|Minneapolis VAHCS|Eric Dieperink, MD|612-467-4010|eric.dieperink@va.gov|
22394420|NCT00605644|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22394421|NCT00799513|San Raffaele Hospital IRCCS|Principal Investigator|0226437649|ferreri.andres@hsr.it|
22394422|NCT00691327|Allergan, Inc.|Medical Monitor|714-246-4500|clinicaltrials@allergan.com|
22394423|NCT05062759|AstraZeneca Clinical Study Information Center|Global Clinical Head|+187724094 79|information.center@astrazeneca.com|
22394424|NCT04981366|University of São Paulo|Prof. Hamilton Roschel|+55 11 30618789|hars@usp.br|
22394425|NCT04371198|Duke University Health System|Joan Cahill BNS OCN CCRP|(919) 668-5211|Joan.Cahill@duke.edu|
22394426|NCT01112306|Actelion Pharmaceuticals Ltd|Scientific Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22394427|NCT03214094|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22394428|NCT00427336|UT MD Anderson Cancer Center|Paolo Anderlini, MD / Professor||mvpacheco@mdanderson.org|
22394429|NCT02579174|Northwestern University|Melissa Shauver, MPH|312-472-6024|melissa.shauver1@nm.org|
22394430|NCT00655486|UCB, Inc|UCB Clinical Trial Call Center|+1 877 822 9493||
22394431|NCT00310037|University of California, San Francisco|Lawrence D. Kaplan, MD||lkaplan@medicine.ucsf.edu|
22394432|NCT02136420|Massachusetts Eye and Ear Infirmary|Faisal Karmali|617-573-5593|faisal_karmali@meei.harvard.edu|
22394433|NCT00440999|Medicines for Malaria Venture|Stephan Duparc, MD|+41 22 555 0300|duparcs@mmv.org|
22394434|NCT04218084|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22394435|NCT05041101|The University of Texas MD Anderson Cancer Center|Sadia Saleem, MD|(281) 566-1900|ssaleem@mdanderson.org|
22394436|NCT03401229|AstraZeneca|Maria Jison, MD Global Clinical Head, FASENRA, Late-stage R&I|+13013980340|Maria.Jison@astrazeneca.com|
22394437|NCT00842985|Yale University|Mehmet Sofuoglu, M.D., Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu|
22394438|NCT05333224|Istanbul Medeniyet University|Ayca Evkaya Acar|+905544263263|ayca.evkaya@gmail.com|
22394439|NCT00585377|Huntsman Cancer Institute|Mark Wade|801-213-5746|mark.wade@hci.utah.edu|
22394440|NCT01122862|GlaxoSmithKline|GSK Response Center|866-435-7343||
22394441|NCT02832154|Wake Forest University Health Sciences|Study coordinator|336-713-5061|drlittle@wakehealth.edu|
22394442|NCT04316182|APICES|Juan Luis Sanz (MW)|+34 918166804|juanluis.sanz@apices.es|103
22394443|NCT00966277|University of Texas (UT) MD Anderson Cancer Center|Saroj Vadhan-Raj, MD/Professor, Sarcoma Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
22394444|NCT01249274|Yale University|Kimberly A. Yonkers, M.D.|203-764-6621|kimberly.yonkers@yale.edu|
22394445|NCT01498653|GlaxoSmithKline|GSK Response Center|866-435-7343||
22394446|NCT04040400|University of Louisville Brown Cancer Center|Shiao Woo, MD Principal Investigator|502-562-4360|shiao.woo@louisville.edu|
22394447|NCT02959450|INCMNSZ|Dr. Aurora Serralde|+52-55-54870900|aurora.serraldez@incmnsz.mx|2193
22394448|NCT02070588|GE Healthcare|Chief Medical Officer - Head Health Initiative|262-544-3633|Victor.Miranda@ge.com|
22394449|NCT03421431|Enanta Pharmaceuticals|Kristin Sanderson|617-607-0775|ksanderson@enanta.com|
22394450|NCT00141726|University of Michgan Comprehensive Cancer Center|Gregory Yanik, M.D.|734-936-8785|gyanik@umich.edu|
22394451|NCT00972205|National Cancer Institute (NCI), National Institutes of Health (NIH)|Susan S. Bates, M.D.|301-402-0984|Batess@mail.nih.gov|
22394452|NCT00828841|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com|
22394453|NCT02513303|Vascular Therapies, Inc.|Rakesh Raghubanshi|9176204369|rakesh@vasculartx.com|
22394454|NCT01691768|CAPRISA|Nonhlanhla Yende-Zuma|+27 31 260 4392|nonhlanhla.yende@caprisa.org|
22394455|NCT03362879|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22394456|NCT01809002|Axogen|Stacy Arnold, VP of Clinical Research|770-833-2570|sarnold@axogeninc.com|
22394457|NCT01920854|Rockwell Medical|Senior Director, Clinical Research & Operations|248-960-9009|rd@rockwellmed.com|
22394458|NCT00679627|Johnson & Johnson Pharmaceutical Research & Development|Director, Clinical Research|1 609-730-7674||
22394459|NCT00419666|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
22394460|NCT00462332|GIMEMA Foundation Data Center|Alfonso Piciocchi|+39 06 70390513|a.piciocchi@gimema.it|
22394461|NCT02549014|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22394462|NCT02382016|Actelion Pharmaceuticals Ltd.|Clinical Trial Disclosure Desk|+41 61 565 6565|clinical-trials-disclosure@its.jnj.com|
22394463|NCT01729156|Department of Nuclear Medicine & PET Centre, Aarhus University Hospital|Lars C. Gormsen, Consultant|004578456260|lars.christian.gormsen@clin.au.dk|
22394464|NCT03607539|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+8613382419112|jessica.yi@innoventbio.com|
22394465|NCT04363801|Leap Therapeutics, Inc.|Douglas Onsi / President and CEO|617-218-1116|donsi@leaptx.com|
22394466|NCT01146054|Stanford University Comprehensive Cancer Center|Albert C. Koong, M.D., Ph.D., Sue and Bob McCollum Professor, Associate Chair of Radiation Onocology|650-498-7703|akoong@stanford.edu|
22394467|NCT00959166|Imperial College London|Prof Alan Winston|+44 (0)20 3312 1603|a.winston@imperial.ac.uk|
22394468|NCT01776424|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22394469|NCT02955147|Mass General Hospital|Dr. Sebastian Unizony|(617) 726-7938|sunizony@mgh.harvard.edu|
22394470|NCT00819390|ACTG Network Coordinating Center, Social and Scientific Systems|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22394471|NCT02294227|Novartis Pharmaceuticals|Clinical Disclosure Office|+1 (862) 778-8300|Novartis.email@novartis.com|
22394472|NCT00887432|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-1300|Kris.Attwood@roswellpark.org|
22394473|NCT00899548|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Antonio C. Wolff, M.D.|410-614-4192|awolff@jhmi.edu|
22394474|NCT00551460|SWOG Statistics and Data Management Center|Leukemia Committee Statistician|2066674623|amoseley@fredhutch.org|
22394475|NCT00448123|William Beaumont Hospital|Robert Swor, DO|248-89-81970|raswor@beaumont.edu|
22394476|NCT00818649|Masonic Cancer Center, University of Minnesota|Erica Warlick, M.D.|612-625-5467|ewarlick@umn.edu|
22394477|NCT01275131|Halozyme Therapeutics, Inc|Vice President, Endocrinology Clinical Development|(858)794-8889||
22394478|NCT02791945|University of California, San Francisco/San Francisco VA Healthcare System|Dr. Steven L. Batki, MD|415-221-4810|steven.batki@ucsf.edu|23671
22394479|NCT02464033|Linkoeping University|Johnny Ludvigsson, MD, PhD, Prof Linkoeping University|+46 13 28 68 54|Johnny.Ludvigsson@liu.se|
22394480|NCT06172881|The Ohio State University College of Optometry|Dr. Jennifer Fogt, OD, MS|614-292-0882|fogt.78@osu.edu|
22434428|NCT02241733|Edward Hines Jr., VA Hospital|Eileen Collins RN, PhD, Research Nurse Scientist|312-413-5621|ecollins@uic.edu|
22434429|NCT04570605|University of Utah School of Medicine|Glen Lau, MD|801-213-2700|Glen.Lau@hsc.utah.edu|
22434430|NCT03269968|MedStar Health Reseach Institute|Rachael Overcash|202-877-6093|rachael.overcash@medstar.net|
22434431|NCT01866111|SK Life Science|Chief Medical Officer|201-421-3830|mkamin@sklsi.com|
22434432|NCT05549232|Hemanext Inc.|Sr. Director, Clinical Affairs|781-301-7474|jill.bagdasarian@hemanext.com|
22434433|NCT03829969|Shanghai Junshi Bioscience Co., Ltd.|Huimei Xie|86-021-50796193|huimei_xie@junshipharma.com|
22434434|NCT04113018|Atrium Health Levine Cancer|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
22434435|NCT03802630|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22434436|NCT00157196|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22434437|NCT05005013|NYU Langone Health|Matthew Lustberg|929-455-5090|matthew.lustberg@nyulangone.org|
22434438|NCT06099223|Hartford Hospital|Aseel Walker|860-972-1778|aseel.walker@hhchealth.org|
22434439|NCT04818216|University of Texas Health San Antonio|Dr. Subrata Debnath, Assistant Professor|210-450-8333|nath@uthscsa.edu|
22434440|NCT04283994|University of Washington|Dr. Erin Kross|206-744-4649|ekross@uw.edu|
22434441|NCT00583752|University of Iowa, Holden Comprehensive Cancer Center|David Lubaroff, MD|3193561527|david-lubaroff@uiowa.edu|
22434442|NCT00526656|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Jorge Garcia, MD|216-444-7774|garciaj4@ccf.org|
22434443|NCT04091581|Centre for Ocular Research and Education|Jill Woods|5198884567|jwoods@uwaterloo.ca|36743
22434444|NCT01795495|Nationwide Children's Hospital|David Martin, MD|6147224200|David.Martin@nationwidechildrens.org|
22434445|NCT01331837|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22434446|NCT03345160|Johns Hopkins School of Medicine|Dr. Robert Wood|410-919-7617|RWood@JHMI.edu|
22434447|NCT01263015|GlaxoSmithKline|GSK Response Center|866-435-7343||
22434448|NCT05599451|Philip Morris Products S.A.|Christelle Haziza, Global Head Clinical Research and Operations|+41582421111|ClinicalTrials.PMI@pmi.com|
22434449|NCT02723006|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22434450|NCT01461928|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22434451|NCT00731653|Massachusetts General Hospital|Maurizio Fava, MD|617-724-2513|mfava@partners.org|
22434452|NCT03711929|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
22434453|NCT03086707|Philip Morris Products S.A.|Julia Hoeng, PhD|+41 (58) 242 11 11|ClinicalTrials.PMI@pmi.com|
22434454|NCT00309140|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22434455|NCT00539513|Yale University School of Medicine|Christopher Pittenger, MD Ph.D|203-974-7675|christopher.pittenger@yale.edu|
22394481|NCT01911065|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
22394482|NCT02112708|Institut Català de la Salut|Principal Investigator: Carme Rovira Aler|+34686838979|crovira.bcn.ics@gencat.cat|
22394483|NCT00953745|Washington University School of Medicine|Dr. Charles R. Conway, MD|314-362-7566|conwayc@psychiatry.wustl.edu|
22394484|NCT00490724|Clinical Science Initiative Dept. Janssen Pharmaceutical K.K./ Tokyo Japan|Manager|+81.3.4411.5653||
22394485|NCT03063125|University of Kansas Medical Center|Katie Glavin|913-588-8721|kglavin@kumc.edu|
22394486|NCT01427595|University of Virginia Center for Research in Reproduction|Dr. Christine Burt Solorzano|4342436911|pcos@virginia.edu|
22394487|NCT00903682|Janssen-Cilag EMEA|EMEA Medical Affairs Director Virology|+31 6 542 454 37||
22394488|NCT03866473|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|drcrnet@jaeb.org|
22394489|NCT03110185|Washington University School of Medicine Department of Anesthesiology|Dr. Ben Palanca|314-273-9076|palancab@wustl.edu|
22394490|NCT00600886|Novartis Pharmaceuticals|Study Director|862-778-8300||
22394491|NCT03075410|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22394492|NCT02053792|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
22394493|NCT01427751|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com|
22394494|NCT01028027|Bausch & Lomb Incorporated|Tuyen Ong, MD|(973) 360-6389|tuyen.ong@bausch.com|
22394495|NCT03801473|Sultan Abdulhamid Han Training and Research Hospital|Tugba Ozsoy|+902165422020|tugbaozsoyy@gmail.com|3876
22394496|NCT01321151|UT Southwestern Medical Center|Megan Marks, Ph.D.|214-648-0882|megan.marks@utsouthwestern.edu|
22394497|NCT02775695|Froedtert and the Medical College of Wisconsin|Susan Tsai, MD|414-805-9720|stsai@mcw.edu|
22394498|NCT04546789|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22424620|NCT02784288|University of Michigan|Paul Swiecicki|734-647-1017|pswiecic@med.umich.edu|
22424621|NCT02734862|Cidara Therapeutics, Inc.|Taylor Sandison, M.D., MPH|858-888-7868|clinicaltrialinfo@cidara.com|
22424622|NCT02757625|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22424623|NCT00564278|Columbia Univ Med Center and New York State Psychiatric Institute|Roberto Lewis-Fernandez, MD, Professor of Psychiatry CUMC - NYSPI|646-774-8102|rlewis@nyspi.columbia.edu|
22424624|NCT00645671|Bausch & Lomb|Dr. Tuyen Ong|(973) 360-6389|Tuyen.Ong@bausch.com|
22424625|NCT00560703|Organization: Galderma R&D, Inc|Michael Graeber|609-409-7701|clinicaltrials@galderma.com|
22424626|NCT02095197|Northwestern University, Feinberg School of Medicine|David Walega, MD|312-695-2500|d-walega@northwestern.edu|
22424627|NCT00493311|Mallinckrodt Pharmaceuticals|Lawrence Hill|(908) 238-6370|lawrence.hill@mallinckrodt.com|
22424628|NCT02779075|Mayo Clinic|Adrian Vella|507-202-8490|vella.adrian@mayo.edu|
22424629|NCT00790556|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22424630|NCT03077607|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22424631|NCT04400656|Imperial College London|Ms Puja Jadav|0203 311 5473|p.jadav@imperial.ac.uk|
22424632|NCT05600036|Alumis Inc.|SVP, Development Operations|(650) 231-6625|clinicaltrials@alumis.com|
22424633|NCT04401202|King Abdulaziz University|Dr. Abdulrahman Koshak|0543292333|aekoshak@kau.edu.sa|
22424634|NCT02714036|MEDICINOVA, INC|Director, Research and Development|858-373-1500|clinicaltrialinfo@medicinova.com|
22424635|NCT03141034|Washington University School of Medicine|Kian-Huat Lim, M.D., Ph.D.|314-362-6157|kian-huat.lim@wustl.edu|
22424636|NCT03688802|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
22424637|NCT05697627|University of Michigan|Hannah Becker|(734) 764-2580|hcbecker@umich.edu|
22424638|NCT04122625|Debiopharm International S.A.|Head Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
22424639|NCT04348500|Cedars Sinai Medical Center|Dr. Stanley C. Jordan, MD|310-423-2641|sjordan@cshs.org|
22424640|NCT02722746|University of Florida, College of Medicine|Dr. Terrie Vasilopoulos|3522738910|tvasilopoulos@anest.ufl.edu|
22424641|NCT00895934|Fred Hutchinson Cancer Research Center|Roland B. Walter, MD, PhD|206-667-3599|rwalter@fhcrc.org|
22424642|NCT02053259|Arizona State University|Dr. Marc Adams|602-827-2470|marc.adams@asu.edu|
22424643|NCT02343380|University of Turin|Dr Simona Bo|0039116335543|simona.bo@unito.it|5541
22424644|NCT00591019|University of Arkansas for Medical Sciences (UAMS)|Dr John Dornhoffer|501 686-5140|dornhofferjohnl@uams.edu|
22424645|NCT04165135|Hoffmann-La Roche|Medical Communications|800 821 8590|genentech@druginfo.com|
22424646|NCT00530790|GlaxoSmithKline|GSK Response Center|866-435-7343||
22424647|NCT03714776|Ionis Pharmaceuticals, Inc|Ionis Pharmaceuticals, Inc|800-679-4747|patients@ionisph.com|
22424648|NCT00423358|University of Wisconsin|Karen E Hansen, MD, MS|608-263-3457|keh@medicine.wisc.edu|
22424649|NCT01618916|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22424650|NCT00438256|Massachusetts General Hospital|Theodore Hong, MD|617-724-1159|TSHONG1@mgh.harvard.edu|
22424651|NCT04000360|The Cleveland Clinic Foundation|Dr. Jay L. Alberts|440-708-3735|albertj@ccf.org|
22424652|NCT03292471|VA Pittsburgh/California State University, East Bay|Dr. Michelle Gravier|510 885-3215|michelle.gravier@csueastbay.edu|
22424653|NCT02865811|Dana-Farber Cancer Institute|Dr. Ursula Matulonis|617-632-2334|ursula_matulonis@dfci.harvard.edu|
22424654|NCT00911586|Clarus Therapeutics, Inc.|Robert E. Dudley, PhD, CEO and President|847-562-4300|rdudley@clarustherapeutics.com|
22424655|NCT03014622|Revance Therapeutics, Inc.|Todd Gross, PhD, VP Data Science, Interim Head of Clinical Development|510-742-3400|tgross@revance.com|
22424656|NCT00849290|Dendreon Corporation|Director, Clinical Operations|206-455-2476|clinical@dendreon.com|
22424657|NCT00938587|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22394499|NCT03430206|Stanford University|Thomas Caruso, MD, MEd|(626) 275-0341|tjcaruso@stanford.edu|
22394500|NCT00368992|SWOG|Lung Committee Statistician|206-667-4623||
22394501|NCT04877730|University of Virginia|Sue Brown|434-982-0602|sab2f@virginia.edu|
22394502|NCT00790751|Vivus, Inc|Wesley W Day PhD|650-934-5200||
22394503|NCT00286078|Boston Scientific|Clinical Research Information|855-213-9890|BSNClinicalTrials@bsci.com|
22394504|NCT02427464|Helixmith Co., Ltd.|Jinsub Lee, PhD|+82-10-8256-0439|jinsub.lee@helixmith.com|
22424658|NCT02540161|Duke University Medical Center|Principal Investigator|9196845301|dukebrain1@duke.edu|
22424659|NCT02819440|Vanderbilt University Medical Center|Evan Brittain|6153224382|evan.brittain@vumc.org|
22424660|NCT03763058|Centre d'Evaluation et Traitement de la Douleur|Dr Guilhem Parlongue|00262262912037|guilhem_parlongue@hotmail.com|
22424661|NCT02759835|National Cancer Institute|Azam Ghafoor|240-858-3289|azam.ghafoor@nih.gov|
22424662|NCT00602446|Masonic Cancer Center, University of Minnesota|Linda J. Burns, MD|612-624-8144|burns019@umn.edu|
22424663|NCT01267422|Department of Ophthalmology, Tongji Hospital Tongji Medical College, Huazhong University of Science and Technology|Bin Li|+86-13638673626|libin-12@163.com|
22424664|NCT02334384|Eastern Virginia Medical School|Kenji Cunnion|7574465125|cunniokm@evms.edu|
22424665|NCT00055497|Abbott|Global Medical Services|800-633-9110||
22424666|NCT00048165|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22424667|NCT00731731|Mayo Clinic|Evanthia Galanis, M.D.||galanis.evanthia@mayo.edu|
22424668|NCT01084538|Abbott|Global Medical Services|1-800-633-9110||
22424669|NCT03742258|Northwestern University|Dr. Reem Karmali, MD|(312) 695-0711|reem.karmali@northwestern.edu|
22424670|NCT00678470|University of California at San Francisco|John Koo MD|4154764701|john.koo@ucsfmedctr.org|
22424671|NCT01938989|Alcon Research, Ltd.|Melvin Sarayba, Franchise Head Cataract, GMA|1-888-451-3937|alcon.medinfo@alcon.com|
22424672|NCT01687283|GlaxoSmithKline|GSK Response Center|866-435-7343||
22424673|NCT02442206|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22424674|NCT00497146|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22424675|NCT01471444|University of Texas MD Anderson Cancer Center|Richard Champlin, MD / Stem Cell Transplantation|713-792-3618|rchampli@mdanderson.org|
22424676|NCT03915626|University of Maryland, Baltimore School of Pharmacy|Dr. Audra L. Stinchcomb|410-706-2646|astinchc@rx.umaryland.edu|
22424677|NCT01741350|University of Connecticut|Dr. Michael M. Copenhaver, Ph.D.|860 208-3632|michael.copenhaver@uconn.edu|
22424678|NCT02107313|Prana Biotechnology|Dr Caroline Herd|+61393494906|info@pranabio.com|
22424679|NCT02830074|John D. Dingell VA Medical Center|Dr. M.Safwan Badr, MD, Ph.D.|3135763548|m.badr@va.gov|
22424680|NCT01031004|Vistakon|John Buch/Principal Research Optometrist|904-443-1707||
22424681|NCT02788188|National Institute of Allergy and Infectious Diseases|Davey, Richard|+1 301 496 8029|rdavey@niaid.nih.gov|
22424682|NCT00582426|Novartis|Study Director|1-800-778-8300||
22424683|NCT00940576|University of Jena, Institute of Nutrition, Department of Nutritional Physiology Jena, Thuringia, Germany|Gerhard Jahreis, Prof. Dr.|+(49)3641/949610|gerhard.jahreis@uni-jena.de|
22424684|NCT00662311|Departments of Radiation Oncology and Global Health University of Washington Medical Center|Shilpen Patel|206-598-4100|shilpenp@uw.edu|
22424685|NCT02164318|Duke University Medical Center|Dr. Jeffrey Lawson|919-681-2533|lawso006@mc.duke.edu|
22424686|NCT04727528|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22424687|NCT04656301|NY State Psychiatric Institute|Dr. Franklin Schneier|6467748041|franklin.schneier@nyspi.columbia.edu|
22424688|NCT02508103|University of North Carolina at Chapel Hill|Dr. Susan Girdler|919-966-2179|susan_girdler@med.unc.edu|
22424689|NCT02335346|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22424690|NCT01964989|Seqirus|Clinical Study Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com|
22424691|NCT02769312|Providence VA Medical Center, Center for Neurorestoration and Neurotechnology|Dr. Noah S. Philip|401-273-7100|noah.philip@va.gov|6235
22424692|NCT01579669|Portland State University|Christina Nicolaidis, MD, MPH|5037259603|nicol22@pdx.edu|
22424693|NCT01148459|GlaxoSmithKline|GSK Response Center|866-435-7343||
22424694|NCT02496039|Avanir Pharmaceuticals|Nadine Knowles; Executive Director, Research & Development Operations|1-949-268-8972|nknowles@avanir.com|
22424695|NCT01038752|Optimum Therapeutics|Dr. M. Guillaume Wientjes||gwientjes@optimumtx.com|
22424696|NCT02700698|University of Arkansas for Medical Sciences; Arkansas Children's Research Institute|Elisabet Borsheim, PhD|501-364-3053|EBorsheim@uams.edu|
22424697|NCT00703118|Tibotec|Medical Leader|1 609 730-3174||
22424698|NCT00915603|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22424699|NCT05053035|Alector|Alector Medical Information|650-826-2454|medinfo@alector.com|
22424700|NCT01918072|VA Greater Los Angeles Healthcare System, West Los Angeles, CA|Donna L. Washington, MD, MPH|310-478-3711|donna.washington@va.gov|49479
22424701|NCT02005627|Imperial College London|Stephen R Durham|+44207-351-8024|s.durham@imperial.ac.uk|
22424702|NCT03760458|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
22424703|NCT00750919|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22424704|NCT04006509|University of Florida|Leslie A. Parker|352 273 6384|parkela@ufl.edu|
22424705|NCT01243294|Coloplast A/S|Pia Nordmand, Clinical Trial Manager|+4549113250|dkpialn@coloplast.com|
22424706|NCT00048997|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||seiferheldw@nrgoncology.org|
22424707|NCT01701505|Big Grins Pediatric Dentistry|Dr. Gregory D. Evans, DDS|970-407-1020|greg@biggrinswithdrgreg.com|
22424708|NCT00002525|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012||
22424709|NCT03304184|University of Michigan|Elizabeth Van Tubergen|2487045640|evantub@umich.edu|
22424710|NCT01505179|UCSD MED CLINICAL TRIALS|Denise Barnard, MD|858 246-2996|dbarnard@ucsd.edu|
22424711|NCT00284154|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22394505|NCT04016558|University of California, San Francisco|Danielle Hessler|415-476-6196|danielle.hessler@ucsf.edu|
22434456|NCT00711113|DENTSPLY Implants|Manager Global Clinical Operations|+46313763500||
22434457|NCT02456636|University of Kansas Medical Center|Christie Befort, PhD|913 588-3338|cbefort@kumc.edu|
22434458|NCT02913430|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MSCR|412-647-5554|stadtermanbm@upmc.edu|
22434459|NCT05312632|Eisai Korea Inc. Medical department|Serena SoYoun Kwon|+82-10-7409-5623|s-kwon@eisaikorea.com|
22434460|NCT02379221|Travis AFB OMFS Clinic|Dr. Jason May|707-423-7085|jason.may.11@us.af.mil|
22434461|NCT00519376|GlaxoSmithKline|GSK Response Center|866-435-7343||
22434462|NCT01792817|electroCore, LLC|Clinical Affairs|+1 973-355-6683|clinical@electrocorellc.com|
22434463|NCT03812185|Henry Ford Health System|Yoshihisa Morita|3059784358|moritayoshihisa2016@gmail.com|
22434464|NCT01591837|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
22434465|NCT03130439|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|617-632-5743|Sara_Tolaney@dfci.harvard.edu|
22434466|NCT02731820|Istituto Ortopedico Rizzoli|Director of Clinical Trials|+39 051.6366392|ctc@ior.it|
22434467|NCT02704702|Celerion|Dr.Laura Sterling|1-402-476-2811|laura.sterling@celerion.com|
22434468|NCT04838054|Stony Brook University|Srinivas Rao Myneni Venkatasatya, DDS, PhD|631-632-8739|srinivas.MyneniVenkatasatya@stonybrookmedicine.edu|
22434469|NCT01801436|Janssen Pharmaceutical Taiwan|Medical Affairs Director|+886-2-23762155||
22434470|NCT01294306|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22434471|NCT04085458|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22434472|NCT02447250|OHSU|Cindy McEvoy, MD|5034940223|mcevoyc@ohsu.edu|
22434473|NCT02743949|Takeda|Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
22434474|NCT01921218|Emory University|Idelberto R. Badell, MD|404-712-6562|ibadell@emory.edu|
22434475|NCT00960011|The University of Hong Kong|Dr. Joe Fan King Man|852-22553111|drfanj@gmail.com|
22434476|NCT01498575|The Children's Hospital of Philadelphia|Dennis Durbin, MD, MSCE|215-590-7331|DURBIND@EMAIL.CHOP.EDU|
22434477|NCT01345513|Ontario Institute for Cancer Research|Janet E. Dancey|1-613-533-6430|janet.dancey@oicr.on.ca|
22434478|NCT02613117|Procter and Gamble|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
22434479|NCT00090142|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22434480|NCT01126437|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22434481|NCT01418703|University of Virginia|Marc D Breton, Ph.D.|434-982-6484|mb6nt@virginia.edu|
22434482|NCT01220973|Rutgers Cancer Institute of New Jersey|Susan Goodin PharmD, FCCP, BCOP|732-235-6783|goodin@cinj.rutgers.edu|
22434483|NCT00006046|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22434484|NCT00596154|Memorial Sloan Kettering Cancer Center|Dr. Christian Grommes, MD|212-610-0344|grommesc@mskcc.org|
22434485|NCT01215110|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|212-227-7540|Dan.Everitt@tballiance.org|
22434486|NCT00642369|Guang Dong Provinical Mental Health Institute|Zhang Bin|86-20-81888553|zhang73bin@hotmail.com|
22434487|NCT03582553|Pennington Biomedical Research Center|Dr. Candida Rebello|225-763-3159|Candida.Rebello@pbrc.edu|
22434488|NCT00996281|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22434489|NCT01382303|Ajou University|Kwan Woo Lee|82-31-219-4526|LKW65@ajou.ac.kr|
22434490|NCT02493257|The University of Texas Health Science Center at Houston|Dr. Amber U. Luong, Associate Professor and Director of Research|(713) 500-5410|Amber.U.Luong@uth.tmc.edu|
22434491|NCT05593913|Acer Medical Inc.|Regulator Manager|886-2-26960366|AcerMedicalofficial@gmail.com|
22434492|NCT01258790|Cincinnati Children's Hospital Medical Center|Steve Wu, MD|513-636-4222|steve.wu@cchmc.org|
22434493|NCT04934800|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|6151-72-5200|service@emdgroup.com|+49
22434494|NCT00516906|3M|J M Heilman|651-733-9897|jmheilman@mmm.com|
22434495|NCT01974206|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22434496|NCT05413512|Baylor University|Debroah Holland|(254) 710-1438|Deborah_L_Holland@baylor.edu|
22434497|NCT02059499|AMC Statistical Center|Dr Himanshu Joshi, MBBS, MPH, PhD (Assistant Professor)|212-259-9635|himanshu.joshi@mountsinai.org|
22434498|NCT00053677|University of Chicago|Dr. Jon E. Grant|773-834-1325|jongrant@uchicago.edu|
22434499|NCT03645941|Mayo Clinic|Christi A. Patten, MD|507-266-2554|patten.Christi@mayo.edu|
22434500|NCT03989349|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22434501|NCT02684058|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
22434502|NCT01802580|Wake Forest University Health Sciences|Dr. Steve Feldman, Professor of Dermatology, Public Health Scienes, and Pathology|336-716-7740|sfeldman@wakehealth.edu|
22434503|NCT03255967|NYU Langone Health|Abraham Brody|2129927341|Abraham.Brody@nyulangone.org|
22434504|NCT01252186|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22434505|NCT02620878|Università di Padova-Italy|Dr. Daniela Bruttomesso|00390498212183|daniela.bruttomesso@unipd.it|
22434506|NCT02664311|Beth Israel Deaconess Medical Center|Eleanor Greene|617-667-1836|ergreene@bidmc.harvard.edu|
22434507|NCT01327053|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22434508|NCT00778258|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22394506|NCT04443153|UVA Center for Diabetes Technology|Marc Breton, PhD|434-982-6484|marc.breton@virginia.edu|
22394507|NCT02572843|Swiss Cancer Institute|Regulatory Affairs|+41 31 389 91 91|regulatory@swisscancerinstitute.ch|
22394508|NCT04118374|Vanderbilt University Medical Center|Justin M Gregory, MD, MSCI|(615) 322- 7427|metabolism@vumc.org|
22394509|NCT00557947|Ethicon Inc|John Lombard|908-218-2877|Jlombar8@its.jnj.com|
22394510|NCT01078454|ECOG Statistical Office|Study Statistician|617-632-3012||
22394511|NCT04737187|Taiho Oncology, Inc.|Taiho|+1-844-878-2446|medicalinformation@taihooncology.com|
22394512|NCT05227703|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22394513|NCT05849103|Vanderbilt University Medical Center|Sarah Osmundson, MD, MS|6158752231|sarah.osmundson@vumc.org|
22394514|NCT03373201|Vanda Pharmaceuticals|Medical Director|202-734-3400|clinicaltrials@vandapharma.com|
22394515|NCT03464097|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22424712|NCT04527978|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22394516|NCT03035201|Wake Forest University School of Medicine|Mark Espeland, PhD; Multiple Principal Investigator|336-716-2826|mespelan@wakehealth.edu|
22394517|NCT02390050|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
22394518|NCT01522469|Arog Pharmaceuticals|Edward McDonald|214-593-0500|emcdonald@arogpharma.com|
22394519|NCT03432260|DURECT Corporation|Director of Regulatory Affairs|408-777-1418|jill.burns@durect.com|
22394520|NCT04763421|Ethicon Endo-Surgery|Senior Director of Clinical Affairs|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22394521|NCT02186847|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22394522|NCT00345293|Rockefeller University|Mayu Frank, MS, ANP, Clinical Research Nurse Practitioner|212-327-7443|frankm@rockefeller.edu|
22394523|NCT01307579|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22394524|NCT05370521|Spruce Biosciences|Chief Medical Officer|415-655-4169|clinicaltrials@sprucebio.com|
22394525|NCT03727438|Department of Veteran Affairs ADAPT|Jennifer Zervakis|919 286-0411|jennifer.zervakis@va.gov|17 6174
22394526|NCT06729606|University of Minnesota|Shweta Sharma Mistry|612-626-9021|shwetas@ccbr.umn.edu|
22394527|NCT04849507|Medical University of South Carolina|Dr Dorothea Jenkins|843-792-2112|jenkd@musc.edu|
22394528|NCT03170349|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
22394529|NCT02491632|UT MD Anderson Cancer Center|Sriram Yennu,MD- Professor, Palliative Care Med|(713) 792-3938|syennu@mdanderson.org|
22394530|NCT00001962|NIH National Heart, Lung and Blood Institute|Neal Young MD|301-496-5093|youngns@nhlbi.nih.gov|
22394531|NCT03660553|The Lundquist Research Institute|Rajesh Garg|310-222-1968|rajesh.garg@lundquist.org|
22394532|NCT00231153|Cadence Pharmaceuticals, Inc.|Catherine Hardalo, MD Vice President Anti-Infectives, Clinical Development|858-436-1439|chardalo@cadencepharm.com|
22394533|NCT04109196|Rush University Medical Center|Dr. Philip Held|312-942-1423|philip_held@rush.edu|
22394534|NCT00604279|Xian-Janssen Pharmaceutical Ltd|Local Trial Manager|86-10-5821 8213||
22394535|NCT03938545|Immunovant, Inc|Central Study Contact|1-800-797-0414|clinicaltrials@immunovant.com|
22394536|NCT00355056|St. Jude Medical|Director, Global Clinical Affairs|818-493-3648|aoza@sjm.com|
22394537|NCT01060540|Durham VA Medical Center|Corrine Voils, PhD|919-286-0411|corrine.voils@va.gov|5196
22394538|NCT02884427|Universidad Andrés Bello|Professor Hernán Andrés de la Barra O., DC,PT,Mg|56226618402|quiropraxiayequilibrio@gmail.com|
22394539|NCT02647320|Daiichi Sankyo|Daiichi Sankyo Contact for Clinical Trial Information|+81-3-6225-1111(M-F 9-5 JST)|dsclinicaltrial@daiichisankyo.co.jp|
22394540|NCT00596427|Kinemed, Inc|Carine Beysen, PhD|5106556525|cbeysen@kinemed.com|123
22394541|NCT02401867|Fenway Community Health|Sari Reisner, ScD|617-927-6017|sari.reisner@childrens.harvard.edu|
22394542|NCT01650246|Ardea Biosciences, Inc.|Maple Fung, MD|1-858-652-6721|mfung@ardeabio.com|
22424713|NCT02104167|Zimmer Biomet|Clinical Affairs|303-501-8571|tammy.stinson2@zimmerbiomet.com|
22424714|NCT02112877|Boston Scientific|Nancy O'Connell, Sr. Clinical Research Manager|763-494-2706|nancy.oconnell@bsci.com|
22424715|NCT02051335|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22424716|NCT03780972|ONL Therapeutics|Director of Clinical Operations|(734) 412-8787|info@onltherapeutics.com|
22424717|NCT03973697|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
22424718|NCT01490697|Massachusetts General Hospital|Roger K. Pitman, MD|617-726-5333|roger_pitman@hms.harvard.edu|
22424719|NCT00090584|New England Research Institutes|Anne Stoddard, ScD|617-972-3331|astoddard@neriscience.com|
22424720|NCT00379808|University of Florida|Dr Julie Johnson, PI|352-273-6007|johnson@cop.ufl.edu|
22424721|NCT01578499|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22424722|NCT00508157|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22424723|NCT01987232|Amgen Inc.|Study Director|866-572-6436||
22424724|NCT01605032|Albert Einstein College of Medicine/Montefiore Medical Center|Ira Braunschweig, MD|718-920-4057|IBRAUNSC@montefiore.org|
22424725|NCT01952080|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22424726|NCT00687882|Johns Hopkins All Children's Hospital|Dr. Neil A Goldenberg, Associate Dean of Research|727-767-3674|neil@jhmi.edu|
22424727|NCT01236326|Weill Cornell Medical College|Meredith J. Aull, Pharm.D.|(212) 746-0727|mea9008@med.cornell.edu|
22424728|NCT03092934|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22424729|NCT01333956|Hospital for Special Surgery|Dr. Jacques YaDeau|212-606-1206|yadeauj@hss.edu|
22424730|NCT02134353|Pharmaxis|Dr Brett Charlton|+61 2 9454 7200|Brett.Charlton@pharmaxis.com.au|210
22424731|NCT01953432|Michael E. DeBakey VA Medical Center|Daryl Shorter, MD|713-798-4870|shorter@bcm.edu|
22424732|NCT00655681|University of New Mexico Carrie Tingley Hospital|Elizabeth A. Szalay MD|505 272-5214|eszalay@salud.unm.edu|
22424733|NCT05362695|Ironwood Pharmaceuticals, Inc|Ironwood Study Chair|617-621-7722|info@ironwoodpharma.com|
22434509|NCT00661726|NERI|Nancy Gee, TCRN Network Manager|617-972-3295|ngee@neriscience.com|
22434510|NCT02147197|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22424734|NCT01783821|Mayo Clinic|Dr. Emir Festic|904-953-9758|Festic.Emir@mayo.edu|
22424735|NCT00986947|Johns Hopkins University School of Medicine|Andrew Singer, MD|410-550-6484|registerclinicaltrials@jhmi.edu|
22394543|NCT00081770|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22394544|NCT02268474|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
22394545|NCT03435497|RAND Corporation|Laura Bogart, PhD|3103930411|lbogart@rand.org|7281
22394546|NCT01072877|BTG International Inc|David Wright MB FRCS|610-278-1660|david.wright@btgplc.com|
22394547|NCT00601419|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22394548|NCT02315352|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22394549|NCT03719170|VA Ann Arbor Healthcare System|Dr. Sameer Saini|734-845-3504|sameer.saini@va.gov|
22394550|NCT04281004|University of Utah|Mark Mifflin, MD|801-583-4152|mark.mifflin@hsc.utah.edu|
22394551|NCT00701779|Deaconess Clinic, Inc.|Paul F. Siami, MD CPI|812-426-9576|research.paul.siami@deaconess.com|
22394552|NCT02245672|Mylan Pharma UK Ltd|Dik Ng, PhD|+44-7467-941703|dik.ng@mylan.co.uk|
22394553|NCT00362453|Tufts Medical Center|Chenchen Wang, MD, MSc, Associate Professor|617-636-3251|cwang2@tuftsmedicalcenter.org|
22394554|NCT00971932|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22394555|NCT01217957|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22394556|NCT01640054|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
22434511|NCT02644096|University of Copenhagen|Chief researcher Britta Hørdam|+ 45 22214383|britta@hordam.dk|
22394557|NCT04878731|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22394558|NCT01206777|The Ohio State University Comprehensive Cancer Center|Jeffrey Jones, MD|614-688-7942|Jeffrey.Jones@osumc.edu|
22394559|NCT01535014|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical Research and Medical Information Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22394560|NCT00730171|Ironwood Pharmaceuticals, Inc.|Michael Hall, MD|(617) 621-7722||
22394561|NCT01256658|Novartis|Study Director|41 61 324 1111||
22394562|NCT00719563|University of Michigan School of Nursing|Debra L. Barton, RN, PhD, AOCN, FAAN|734-763-3868|debbartn@umich.edu|
22394563|NCT02047643|Stanford University|Bruce Buckingham, M.D.|408-356-0911|buckingham@stanford.edu|
22394564|NCT04256603|MetroHealth|c. kim|216 778 7800|ckim3@metrohealth.com|
22394565|NCT02120625|Nimbus Concepts, LLC|J. Scott Bainbridge, MD (PI)|303-522-5219|jscottbainbridge@gmail.com|
22394566|NCT02113241|INSTITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
22394567|NCT02901041|Boston University|Dr. Todd Farchione|(617) 353-9610|tfarchio@bu.edu|
22394568|NCT00762970|Vistakon USA|XU CHENG, PRINCIPAL CLINICAL SCIENTIST|1 904 443-1245|xcheng6@its.jnj.com|
22434512|NCT00322452|AstraZeneca|Gerard Lynch||AZTrial_results_posting@AstraZeneca.com|
22434513|NCT02438384|Department of Emergency Medicine, UNC School of Medicine|Tim Platts-Mills, MD|559-240-6073|tim_platts-mills@med.unc.edu|
22434514|NCT02650128|Shockwave Medical, Inc.|Beaux Alexander, Vice President Clinical Affairs|510-279-4262|balexander@shockwavemedical.com|145
22434515|NCT00303446|National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH)|Kenneth Fischbeck, M.D.|301-435-9318|kf@ninds.nih.gov|
22434516|NCT00450294|Department of Anesthesia|Dr. Amit Chopra|204-880-5370|amitchopra1@live.com|
22434517|NCT03116828|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunovion.com|
22434518|NCT00230802|Brigham & Women's Hospital|Erik Alexander, MD|6177325666|ekalexander@partners.org|
22434519|NCT05243745|HALEON|Haleon Response Center|+441932 95 95 00|ww.clinical-trial-register@haleon.com|
22434520|NCT05160168|Theseus Pharmaceuticals (a subsidiary of Concentra Biosciences)|Stew Kroll|(650) 576-9679|skroll@concentrabiosciences.com|
22434521|NCT01746511|University of Rochester|Carl D'Angio|585-273-4911|carol_dangio@urmc.rochester.edu|
22434522|NCT04187144|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22434523|NCT03842969|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22434524|NCT01044745|University of Nebraska Medical Center|R. Gregory Bociek, MD|402-559-5388|rgbociek@unmc.edu|
22434525|NCT02890303|Mynosys Cellular Devices, Inc.|Daniel Marinsik|(510) 857-6296|dmarinsik@mynosys.com|
22434526|NCT04388319|Rose Research Center|Dr. Jed E. Rose|9193282345|jed.rose@roseresearchcenter.com|
22394569|NCT01480674|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22434527|NCT01159171|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22434528|NCT02264665|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22434529|NCT01962987|Teva Pharmaceuticals USA, Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
22434530|NCT00789581|Sarah Cannon Development Innovations|Charles H. Davis, RAC|615 524-4341|charles.davis2@scri-innovations.com|
22434531|NCT01468207|AbbVie|Global Medical Information|1-800-633-9110||
22434532|NCT00470093|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Carol Ann Huff|410-955-8842|huffca@jhmi.edu|
22434533|NCT00664560|POZEN Inc|Sr VP Clinical Research|919-913-1030|eorlemans@pozen.com|
22434534|NCT01328041|ViiV Healthcare|GSK Response Center|866-435-7343||
22434535|NCT03440723|Elm Tree Medical Inc.|CEO|2158050862|evamartin@elmtreemedical.com|
22394570|NCT00975507|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22394571|NCT03249714|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22394572|NCT03818204|VA Central Western Massachusetts|Kevin Houston|781-588-7674|kevin.houston2@va.gov|
22394573|NCT01996813|Loyola University Medical Center|Douglas Evans, M.D.|708-216-2523|devans@lumc.edu|
22394574|NCT00887250|Merck & Co., Inc.|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
22394575|NCT05754333|Astellas Pharma Global Development, Inc|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
22394576|NCT00879762|Saint Louis University Medical Center|Sharon E. Frey, M.D.|315-977-5500|sharon.frey@health.slu.edu|
22394577|NCT03008707|University of Pusa|Dario Tartaglia|+393334491229|dario261184@gmail.com|
22394578|NCT04754477|Cochlear|PRS Specialist, Clinical Affairs|+61 2 9428 6555|cltd-prs-admin@cochlear.com|
22394579|NCT00645047|University of California San Diego|Zia Agha|858-552-8585|zagha@ucsd.edu|
22394580|NCT01105754|University of Rochester|Dr. Jill Halterman|585-275-5798|jill_halterman@urmc.rochester.edu|
22394581|NCT02709096|BioPharmX, Inc.|AnnaMarie Daniels|310-701-2080|amdaniels@biopharmx.com|
22394582|NCT00505284|Eisai Call Center|Eisai Inc.|888-422-4743||
22394583|NCT00940108|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
22394584|NCT03581825|Johnson & Johnson Vision Care|Thomas R. Karkkainen, OD, MS, FAAO- Sr. Principal Research Optometrist|904-443-3402|TKarkkai@its.jnj.com|
22394585|NCT00770341|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@Merck.com|
22394586|NCT02739360|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22394587|NCT02533570|Seattle Genetics, Inc|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
22394588|NCT00529958|University of Calgary Sport Medicine Centre|ACL RCT Research Coordinator|403-220-8944|aclstudy@ucalgary.ca|
22394589|NCT03756129|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22394590|NCT01340651|Incyte Corporation|Study Director|855 463-3463||
22394591|NCT01315353|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22394592|NCT04469270|Helixmith Co., Ltd.|Jinsub Lee, PhD.|+82-10-8256-0439|jinsub.lee@helixmith.com|
22394593|NCT05572021|Atrium Health|Greg Scarola, MS, MBA|704-355-5766|Gregory.Scarola@advocatehealth.org|
22394594|NCT05328167|Thomas Jefferson University|Dr. John Eisenbrey, Associate Professor|215-503-5188|john.eisenbrey@jefferson.edu|
22394595|NCT03319849|Neurotech Pharmaceuticals, LLC|CMO|401-333-3880|neurotech@neurotechusa.com|
22394596|NCT03143816|Barbara Davis Center for Diabetes, University of Colorado|Satish Garg MD|3037246713|satish.garg@ucdenver.edu|
22394597|NCT03045068|The University of Texas Health Science Center at Houston|Nischal K Gautam, MD|713-500-6200|Nischal.K.Gautam@uth.tmc.edu|
22394598|NCT00112047|Gilead Sciences|Dara Wambach MA, Associate Director, Regulatory Affairs|650-522-5163|dara.wambach@gilead.com|
22394599|NCT02871258|Baxter Healthcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
22394600|NCT01122160|USDA|Beverly Clevidence|301-504-8367|beverly.clevidence@ars.usda.gov|
22394601|NCT04873232|Helixmith, Co., LTD|Jinsub Lee, PhD|+82-10-8256-0439|jinsub.lee@helixmith.com|
22394602|NCT05929339|Wake Forest University School of Medicine|James C. Eisenach, MD|336716-4182|jimeisenach@gmail.com|
22394603|NCT02101034|Washington University School of Medicine|Douglas R. Adkins, M.D.|314-362-4471|dadkins@wustl.edu|
22394604|NCT00995020|Affiliation: Oswaldo Cruz Foundation|Investigator: MJCamargo [Camargo Maria José] Official Title: PHD|00552199777009|mariaj.camargo@hotmail.com|
22394605|NCT01614197|Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL)|Roy Leong|323-361-5132|rleong@chla.usc.edu|
22394606|NCT05779397|Masimo Corporation|Ahmed Alghazi|949-297-7000|aalghazi@masimo.com|
22394607|NCT00876694|Novartis Pharmaceuticals|Study Director|862-778-8300||
22394608|NCT00288509|Ipsen|Senior Director, Medical Development, Neurology||clinical.trials@ipsen.com|
22394609|NCT00084266|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22394610|NCT01215422|UNIVERSITY OF ALBERTA|DR. JOAN ROBINSON|780-248-5540|jr3@ualberta.ca|
22434536|NCT03392883|Center for Technology and Behavioral Health, Geisel School of Medicine, Dartmouth College|Lisa A. Marsch, PhD|603-646-7092|Lisa.a.marsch@dartmouth.edu|
22434537|NCT01245738|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22434538|NCT02688088|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22434539|NCT01247363|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22434540|NCT01246479|Valneva Austria GmbH|Senior Scientist Clinical Research|+43120620|info@valneva.com|0
22434541|NCT04022226|The University of New Mexico|Dr. Jeremy Miller|5052724490|jermiller@salud.unm.edu|
22394611|NCT00420017|Purdue University|James E Tisdale PharmD|317-613-2315|hwroblew@iupui.edu|306
22394612|NCT01386788|EKoch|Ernst Koch|++49 6257 1788|Ernst.MW.Koch@t-online.de|
22394613|NCT00462865|BrUOG|Bachir Sakr, MD|4018633000|kayla_rosati@brown.edu|
22394614|NCT03290196|Andrews Research and Education Foundation|Jessica Truett|8509168570|jessica.truett@andrewsref.org|
22434542|NCT03691844|Amzell B.V.|Clinical Trial Manager|+41614864000|amzell-disclosure@amzell.com|
22394615|NCT06336603|Regulatory Affairs|Head|9122 66455645|Clinical.Trial@sunpharma.com|
22394616|NCT00388453|Vanderbilt University|Michael Vaezi, MD, PhD|615.322.3739|michael.vaezi@vanderbilt.edu|
22394617|NCT01295034|Icahn School of Medicine at Mount Sinai|Andrea D. Branch PhD|212 659 8371|andrea.branch@mssm.edu|
22394618|NCT00819260|Dartmouth-Hitchcock|Carolyn L. Kerrigan MD|603-650-5148|carolyn.kerrigan@hitchcock.org|
22434543|NCT02970006|The Ohio State University- Neurological Institute|Vibhor Krishna, MD|6142939274|Vibhor.Krishna@osumc.edu|
22434544|NCT02241655|Washington University|Dr. Michael Avidan, MBBCh|314-332-7265|avidanm@wustl.edu|
22394619|NCT00824161|The University of Texas M.D. Anderson Cancer Center|Scott Kopetz, MD|713-792-2828||
22394620|NCT01115660|Wake Forest School of Medicine|Dr. Cheryl Bushnell|(336) 716-2357|cbushnel@wakehealth.edu|
22434545|NCT00799227|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22424736|NCT02978885|Columbia University|Gebhard Wagener, MD|212-305-6494|gw72@cumc.columbia.edu|
22424737|NCT01669785|Salus Research, Inc.|Jeffery L. Milleman, DDS, MPA|260-755-1099||
22424738|NCT01653327|Dartmouth-Hitchcock Medical Center|Dr. Thomas Davis|1-603-650-8626|Thomas.H.Davis@hitchcock.org|
22424739|NCT00422292|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22424740|NCT02440854|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22424741|NCT02243046|Global Research Consultants|Dr. Franklin Garcia-Godoy|954-888-9102|fgarciagodoy@gmail.com|
22424742|NCT02669082|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22424743|NCT04918355|University of Colorado|Heather Tolle|303-724-9924|heather.tolle@cuanschutz.edu|
22424744|NCT02301039|Sarcoma Alliance for Research Through Collaboration|Research Manager|734-930-7600|sarc@sarctrials.org|
22424745|NCT04683939|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
22424746|NCT04852276|National Institute of Allergy and Infectious Diseases (NIAID)|Emily Ricotta, PhD|240-550-3474|emily.ricotta@nih.gov|
22424747|NCT02092649|University of Guelph|Sebastian Jannas-Vela MSc|(519)-824-4129|sjannas@uoguelph.ca|53907
22424748|NCT00385827|Janssen Research & Development|Director||ClinicalTrialDisclosure@its.jnj.com|
22424749|NCT00410072|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22424750|NCT01421147|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22424751|NCT02232477|Lundquist Institute|Dr. Agnes Chen|424-306-7635|ahchen@lundquist.org|
22424752|NCT01268189|USAISR|Leopoldo C. Cancio, COL, MC|210-916-3301|leopoldo.c.cancio.mil@mail.mil|
22424753|NCT00904917|Children's Hospital of Philadelphia|Rhonda C. Boyd, Ph.D.|215-590-3945|boydr@email.chop.edu|
22424754|NCT05025332|Neuren Pharmaceuticals|Chief Medical Officer|+61 (3) 9092 0480|MedicalInformation@neurenpharma.com|
22424755|NCT01299896|Vanderbilt University|Dr. Hilary A. Tindle|615-875-9726|hilary.tindle@vanderbilt.edu|
22424756|NCT01467271|Guerbet|Corinne Dubourdieu, Head of Clinical Projects and Medical Writing|+33(0)1 45 91 50 00|corinne.dubourdieu@guerbet.com|
22424757|NCT01515566|University of Texas MD Anderson Cancer Center|David Hui, MD, MSc, FRCPC / Asst. Professor, Palliative Care and Rehabilitation Medicine|713-792-6085|CR_Study_Registration@mdanderson.org|
22424758|NCT02085070|Yale Cancer Center|Director, Clinical Trials Office|12037372572|Joyce.Tull@yale.edu|
22424759|NCT01411319|University of Miami|Alan Pollack, MD, PhD|305-243-4916|apollack@med.miami.edu|
22424760|NCT02815267|Foamix Pharmaceuticals, Inc.|Iain Stuart, PhD.|1 800-775-7936|Iain.Stuart@foamix.com|
22424761|NCT04948827|Camino Pharma|Gonul Velicelebi|858-201-2901|gonul@caminopharma.com|
22424762|NCT04126317|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22424763|NCT00527124|Barbara Ann Karmanos Cancer Institute|Elisabeth I. Heath|313-576-8715|heathe@karmanos.org|
22424764|NCT00660595|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22424765|NCT01602679|University of Virginia Center for Research in Reproduction|Dr. Christopher R. McCartney|4342430329|cm2hq@virginia.edu|
22424766|NCT00948922|H. Lee Moffitt Cancer Center and Research Institute|Dr. Melissa Alsina|813-745-7202|melissa.alsina@moffitt.org|
22424767|NCT04854057|Spaulding Rehabilitation|Dr. Randy Trumbower|6179526822|randy.trumbower@mgh.harvard.edu|
22434546|NCT00515294|Boston University|Jonathan Howland, Professor|617 638 5158|jhowl@bu.edu|
22394621|NCT01990209|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
22394622|NCT01774110|University of Texas Southwestern Medical Center|Karen McCain, PT, DPT, NCS, Principal Investigator|214-648-1559|karen.mccain@utsouthwestern.edu|
22394623|NCT00063154|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
22394624|NCT01222273|Children's Hospital of Pittsburgh of UPMC|Joseph M. Pilewski, MD|(412) 692-2164|pilewskijm@upmc.edu|
22394625|NCT02699983|Rutgers Robert Wood Johnson Medical School|Jeanne Ferrante|848-932-5252|jeanne.ferrante@rutgers.edu|
22394626|NCT03575143|University of California San Diego|Robert L. Owens, MD|8586575258|rowens@health.ucsd.edu|
22394627|NCT02566265|Yale University School of Medicine|Andrew Branagan, MD|617-459-5234|andrew.branagan@yale.edu|
22394628|NCT01259726|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22394629|NCT00490009|Stanford University Medical Center|Susan J Knox, MD, Associate Professor of Radiation Oncology|650-725-2720|sknox@stanford.edu|
22394630|NCT01211197|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22394631|NCT00261846|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22394632|NCT02145247|UCSDMED|R. Jeffrey Chang|858-534-8930|rjchang@ucsd.edu|
22394633|NCT04781387|Crestone, Inc.|Vice President, Clinical Development|(609) 900-5733|lboccumini@crestonepharma.com|
22394634|NCT01636960|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22394635|NCT01209780|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22394636|NCT01745848|University of Pittsburgh|Dr. Jessica Bon Field|412-648-6494|bonjm@upmc.edu|
22394637|NCT03463161|University of Chicago|Theodore Karrison, PhD|(773) 702-9326|tkarrison@health.bsd.uchicago.edu|
22394638|NCT05007808|Buzzz Pharmaceuticals Limited|Deirdre O'Keefe, PhD, Head of IP and Portfolio Management|+447733104786|deirdre@hotmail.co.uk|
22394639|NCT02318797|University of Pittsburgh Department of Psychiatry|Charles Reynolds, MD|412-246-6414|reynoldscf@upmc.edu|
22394640|NCT01740323|Emory University|Andrew Miller, MD|404-727-8260|amill02@emory.edu|
22394641|NCT06338462|Yale School of Public Health|Dr. J. Lucian Davis|203-785-3665|lucian.davis@yale.edu|
22394642|NCT00928447|Halozyme Therapeutics|Chief Medical Officer|855-495-3639|halozyme@EVERSANA.com|
22394643|NCT00390182|University of Maryland Baltimore|Nancy Kennedy|410-328-2513|nkennedy@umm.edu|
22394644|NCT01001832|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22394645|NCT00926211|Restoration Robotics|Miguel Canales, M.D.|650-965-3612|miguel@restorationrobotics.com|206
22394646|NCT01242800|ECOG-ACRIN Cancer Research Group|Study Statistician|16176323012|eatrials@jimmy.harvard.edu|
22394647|NCT03527238|University of Florida|Ali Zarrinpar|352-265-0606|ali.zarrinpar@surgery.ufl.edu|
22394648|NCT03598088|Dare Bioscience, Inc.|Jessica Hatheway VP, Clinical Operations|858-926-7655|jhatheway@darebioscience.com|
22394649|NCT00511901|University of Medicine and Dentistry of New Jersey|Jeffrey L Carson, MD|732-235-7122|carson@umdnj.edu|
22394650|NCT02447172|Innocoll|Charlene A. Tucker MS, Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
22394651|NCT06020118|Duke University|Dr. Emmanuel Walter|919 620 5346|chip.walter@duke.edu|
22394652|NCT00983931|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22394653|NCT03525431|University of California, San Francisco|Mary Norton|(415) 476 4080|mary.norton@ucsf.edu|
22394654|NCT02953860|University of Colorado|Professor Anthony Elias|720-848-0347|anthony.elias@cuanschutz.edu|
22434547|NCT01453205|MedImmune, LLC|Mohammed Dar|301-398-4095|information.center@astrazeneca.com|
22434548|NCT05596734|BioNTech SE|BioNTech clinical trials patient information|+49 6131 90840|patients@biontech.de|
22434549|NCT02187887|RAND|Eric Pedersen|3103930411|ericp@rand.org|6078
22434550|NCT02333396|ChildrensMemorialH|Karen Rychlik, MS|(773) 755-6310|krychlik@luriechildrens.org|
22434551|NCT02118766|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22434552|NCT04210245|NGM Biopharmaceuticals|VP, Clinical Operations|(650) 243-5555|ngm282@ngmbio.com|
22434553|NCT02248649|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov|
22434554|NCT03172884|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22434555|NCT05470842|UNiversity of East Anglia|Dr Katharina Mattishent|01603286286|k.mattishent@uea.ac.uk|
22434556|NCT04621240|Center for BrainHealth at the University of Texas at Dallas|Erin Venza|972-883-3208|erin.venza@utdallas.edu|
22434557|NCT01221623|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22394655|NCT00585195|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22424768|NCT02131233|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22424769|NCT02693717|UT MD Anderson Cancer Center|Jianjun Gao, MD PHD, Associate Professor, Genitourinary Medical Oncology|(713) 563-4195|jgao1@mdanderson.org|
22424770|NCT05114564|CooperVision|José A. Vega, O.D., MSc., FAAO|925-621-3761|JVega2@coopervision.com|
22424771|NCT00255840|CIPRA-SA|Dr Ian Sanne|+27 11 276 8800|isanne@witshealth.co.za|
22424772|NCT00177866|University of Pittseburgh|George Arnold, MD|412 621-2334|Arnoldgl@upmc.edu|
22424773|NCT03247322|Medical University of South Carolina|David Taber, PharmD, MS|843-792-3368|taberd@musc.edu|
22424774|NCT01005901|Novartis Pharmaceuticals|Study Director|862-778-8300||
22424775|NCT03798327|Icahn School of Medicine at Mount Sinai|Dr. Nathan Goldstein|212-844-1712|Nathan.goldstein@mssm.edu|
22424776|NCT00715520|Emory University|Dr. Cathrin Buetefisch|4047121894|cathrin.buetefisch@emory.edu|
22424777|NCT01006590|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22434558|NCT00780143|Pharma Mar, S.A.|Clinical Development Department of PharmaMar´s Oncology,Business Unit.,|+34 918466000|clinicaltrials@pharmamar.com|
22434559|NCT01098253|University of Pennsylvania, Perelman School of Medicine|Dr. Hillary R Bogner|215-746-4181|hillary.bogner@uphs.upenn.edu|
22424778|NCT03332095|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22424779|NCT00178646|UTHealth|Gerard E. Francisco|7137975246|Gerard.E.Francisco@uth.tmc.edu|
22424780|NCT04942210|Sanofi Pasteur|Trial Transparency Team|800-633-1610 ext: 6#|Contact-US@sanofi.com|
22424781|NCT03420222|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22424782|NCT02651688|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22424783|NCT03292614|Dietrich-Bonhoeffer-Klinikum|Ulrike Holland|+49 395 775 3427|aug-st2@dbknb.de|
22424784|NCT00212264|University of Alabama at Birmingham|Patricia S Goode, MD|2055587064|pgoode@uabmc.edu|
22424785|NCT00187278|St Jude Medical|Pascale Ducloux, Clinical Manager|+3227746709|pducloux@sjm.com|
22424786|NCT00595101|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
22424787|NCT01380691|Eli Lilly Company|Chief Medical Officer|800-545-5979||
22424788|NCT04100590|New York State Psychiatric Institute|Caroline A Arout, PhD|646-774-6167|caroline.arout@nyspi.columbia.edu|
22424789|NCT00006110|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22424790|NCT02949141|Patan Academy of Health Science|Darlene R House, MD|+977 9810339799|dhouse@iupui.edu|
22424791|NCT00460746|Tibotec Therapeutics Clinical Affairs, Division of Centocor Ortho Biotech Services, LLC|Vice President, Tibotec Therapeutics Clinical Affairs|877-732-2488|rfalcon@its.jnj.com|
22424792|NCT03260790|Mayo Clinic|Avni Y. Joshi, M.D., M.S.|507-284-3165|Joshi.Avni@mayo.edu|
22424793|NCT02791438|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22424794|NCT01603394|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22424795|NCT00862459|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22424796|NCT03426436|North Shore University Hospital|Director of Clinical Research for Emergency Medicine|(516) 562-1513|TLi2@northwell.edu|
22424797|NCT03168919|St. Jude Children's Reaserch Hospital|Asim K. Bag, MD Bag|9015953347|asim.bag@stjude.org|
22424798|NCT01085136|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22434560|NCT01585779|Medtronic Coronary and Structural Heart|Shari Benoit|(763) 514-4000|shari.g.benoit@medtronic.com|9749
22434561|NCT00830375|University of Minnesota|Jon E. Grant|612-273-9800|grant045@umn.edu|
22434562|NCT01700959|St. Jude Children's Research Hospital|Tara M. Brinkman, PhD|(901) 595-5683|tara.brinkman@stjude.org|
22434563|NCT01457014|Sleep and Alertness Research Inc.|Sharon A. Chung|416-603-5275|sachung@uhnres.utoronto.ca|
22434564|NCT02461290|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22434565|NCT03319953|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22434566|NCT02889289|Washington DC VA Medical Center|Dr. Shane Chanpimol|202-745-8000|shane.chanpimol@va.gov|55854
22434567|NCT00845039|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22434568|NCT04027049|Johns Hopkins University|Department of Neurology|410-955-2228|ezink1@jhmi.edu|
22434569|NCT03895632|Medical Physics & Clinical Engineering, Royal Liverpool Hospital|Dr. Tristan Payne|0151 7064225|tristan.payne@nhs.net|
22434570|NCT00871923|UT MD Anderson Cancer Center|James Welsh,MD- Associate Professor, Radiation Oncology Department|(713) 563-2447|jwelsh@mdanderson.org|
22434571|NCT02263911|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22434572|NCT03020017|Northwestern University|Priya Kumthekar|312 908 5073|p-kumthekar@northwestern.edu|
22434573|NCT00496483|Veloxis A/S|Christina Sylvest, Sr VP, Global Clinical Development and Operations|+45 20553877|csy@veloxis.com|
22434574|NCT03571672|Lantheus Medical Imaging, Inc|Istvan Molnar|978-671-8686|istvan.molnar@lantheus.com|
22434575|NCT04258995|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22434576|NCT04580277|Cedars Sinai Inflammatory Bowel Disease Center|Dr. Gil Y. Melmed|310-423-4100|gil.melmed@cshs.org|
22434577|NCT03285958|University of Michigan|Dr. Mary Janevic|734 647 3194|mjanevic@umich.edu|
22434578|NCT02998203|Cyprus University of Technology|Dr. Konstantinos C. Makris|00357-25-002398|konstantinos.makris@cut.ac.cy|
22434579|NCT01065051|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22434580|NCT01145352|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22434581|NCT04385238|Harvard T.H. Chan School of Public Health|Sonia Hernandez-Diaz|6174323942|shernan@hsph.harvard.edu|
22434582|NCT00316693|GlaxoSmithKline|GSK Response Center|866-435-7343||
22434583|NCT01967823|National Cancer Institute|Dr. Steven A. Rosenberg|240-858-3080|sar@mail.nih.gov|
22434584|NCT01559922|Suneva Medical, Inc.|Suneva Medical,Inc.||Acne.ScarInfo@sunevamedical.com|
22434585|NCT01332188|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
22434586|NCT00413894|Hoffmannb-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22434587|NCT04225676|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22434588|NCT00866034|UMC Utrecht|Ouijdane Hamdine, MD|+31-88-7557524|O.Hamdine@umcutrecht.nl|
22434589|NCT05289271|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22434590|NCT02019108|University of British Columbia|Dr. Michael Hunt|604-827-4721|michael.hunt@ubc.ca|
22434591|NCT00484393|Fraser Health|Brandi Newby|604-585-5666|brandi.newby@fraserhealth.ca|774374
22434592|NCT00908115|GlaxoSmithKline|GSK Response Center|866-435-7343||
22434593|NCT04924530|University of Bath|Professor Javier Gonzalez|01225 38|j.t.gonzalez@bath.ac.uk|5518
22434594|NCT00313313|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22434595|NCT01973387|Janssen Research & Development, LLC|Vice President (VP)||ClinicalTrialDisclosure@its.jnj.com|
22434596|NCT01345591|University of Pittsburgh|J. Peter Rubin|412-624-9703|rubipj@upmc.edu|
22434597|NCT02851797|Italfarmaco SpA|Dr Paolo Bettica, MD and PhD|+3902 66041503|p.bettica@italfarmacogroup.com|
22434598|NCT00832598|Memorial Sloan Kettering Cancer Center|Dr. Ronald Blasburg, MD|646-888-2211|blasberr@mskcc.org|
22434599|NCT03622112|AstraZeneca AB|Global Clinical Lead|301-398-5799|ClinicalTrialTransparency@astrazeneca.com|
22434600|NCT01671293|Universidad del Desarrollo|J. Carola Pérez Ewert|5623279875|janetperez@udd.cl|
22434601|NCT01165320|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22434602|NCT03305419|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22434603|NCT01155466|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22394656|NCT03995667|Oregon Health & Science University|Dr. Timur Mitin, MD, PhD|503-494-8756|mitin@ohsu.edu|
22394657|NCT01163916|Abbott|Global Medical Services|800-633-9110||
22434604|NCT02075047|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22434605|NCT00075946|ECOG Statistical Office|Study Statistician|617-632-3012||
22434606|NCT03552536|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22434607|NCT03639623|Zydus Therapeutics Inc.|Dr Deven Parmar|7324050886|dparmar@zydustherapeutics.com|
22434608|NCT04154605|Stryker|Robyn Schacherer, Manager Clinical Affairs|763-463-7054|robyn.schacherer@stryker.com|
22434609|NCT03709277|Vanderbilt University Medical Center|Amanda Kibbons|615-875-4745|amanda.m.kibbons@vumc.org|
22434610|NCT01229254|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
22434611|NCT02231892|National Institute on Drug Abuse|Dr. Elliott Stein|443-740-2650|estein@mail.nih.gov|
22434612|NCT01191736|Maricopa Integrated Health System|David Drachman|602-344-5161|david.drachman@mihs.org|
22434613|NCT03119181|Tusker Medical|Laura England, PhD|(650) 223-6909|lengland@tuskermed.com|
22434614|NCT00223977|Watson Laboratories, Inc|Gary Hoel, RPh, PhD|801-588-6641|gary.hoel@watson.com|
22434615|NCT03539211|ChristianaCare|Brian Catania|302-838-4700|bcatania@christianacare.org|
22434616|NCT01534260|IndianaU|Dr. Hamid Sayar|(317) 948-7576|ssayar@iu.edu|
22434617|NCT02359045|AstraZeneca AB|Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
22434618|NCT03655301|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22434619|NCT00405509|Allegheny General Hospital|Deborah Gentile, MD|412-359-6654|dgentile@wpahs.org|
22434620|NCT00835198|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22434621|NCT00793572|Fred Hutchinson Cancer Research Center|Dr. Marco Mielcarek|(206) 667-2827|mmielcar@fhcrc.org|
22434622|NCT03858335|Samsung Medical Center|Jeong-Yi Kwon|+821045911039|jeongyi.kwon@samsung.com|
22434623|NCT01342965|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22434624|NCT00856206|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
22434625|NCT01175434|University of Rochester|Dr. Jill Halterman|5852755798|jill_halterman@urmc.rochester.edu|
22434626|NCT00499655|City of Hope|Karen L. Reckamp, M.D.|(626) 256-4673|kreckamp@coh.org|
22434627|NCT02780856|Calcivis Ltd|Director of Clinical Research|+ 44 131 658 5152|mwillins@calcivis.com|
22434628|NCT03354546|The Ottawa Hospital|Dr. Daniel McIsaac|613-761-4940|dmcisaac@toh.ca|
22434629|NCT05747209|Allegheny General Hospital|Colin Champ, MD|412-734-7605|colin.champ@ahn.org|
22434630|NCT02488135|University of Alberta|Scott Murray|587-891-6240|sipmurray@gmail.com|
22434631|NCT02802241|BIDMC|Judy Nee|6176672193|jnee@bidmc.harvard.edu|
22434632|NCT02226198|AstraZeneca Plc|Robin Mukherjee|+46 31 776 1000|robin.mukherjee@astrazeneca.com|
22434633|NCT04545047|VA Cooperative Studies Program|Project Manager|2062774780|Sarah.Keithly@va.gov|
22434634|NCT01440517|GE Healthcare|Arnold Jacobson, M.D.|1-609-514-6325|Arnold.Jacobson@ge.com|
22434635|NCT00859339|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
22434636|NCT01288612|Mayo Clinic|Prasad G. Iyer|507-284-6469|iyer.prasad@mayo.edu|
22434637|NCT00642174|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22434638|NCT00896363|GlaxoSmithKline|GSK Response Center|866-435-7343||
22434639|NCT01730339|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22434640|NCT02200328|Cleveland Clinic Florida|Dr.Alison Schneider|9546595646|schneia2@ccf.org|
22434641|NCT01739933|Vanderbilt University Medical Center|Dr. Pratik Pandharipande, Vice Chair Faculty Affairs, PI|6153436268|pratik.pandharipande@vumc.org|
22434642|NCT02642393|Massachusetts General Hospital|Dr. Michael Schwarzschild|617-724-9611|michaels@helix.mgh.harvard.edu|
22434643|NCT03356977|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22434644|NCT01846195|Zynex Monitoring Solutions|Donald Gregg|1-800-495-6670|dgregg@zynex.com|
22434645|NCT00201448|Virginia Commonwealth University|Stuart Adler|8048281807|sadler@vcu.edu|
22434646|NCT00396006|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22434647|NCT02442310|ApoPharma Inc.|Caroline Fradette, PhD|416-401-7543|cfradett@apopharma.com|
22434648|NCT01562314|GW Research Ltd|Medical Enquiries||medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
22434649|NCT00585546|University of Michigan|Francis Pagani|734 647-2894|fpagani@med.umich.edu|
22434650|NCT01180036|Mayo Clinic|Dr. Fernando Fervenza|507-266-1045|fervenza.fernando@mayo.edu|
22434651|NCT04243577|Purdue University|Georgia Malandraki|7654960206|malandraki@purdue.edu|
22434652|NCT03077438|Sanofi Pasteur Inc.|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22434653|NCT00813865|Patient Advocacy|Amicus Therapeutics|+1-609-662-2000|Clinicaltrials@amicusrx.com|
22434654|NCT02512874|Mayo Clinic|Dr. Cassie C. Kennedy|507-266-3958|kennedy.cassie@mayo.edu|
22434655|NCT00543803|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22434656|NCT01190475|Mereo BioPharma|Jacqueline Parkin|+44 333 0237300|enquiries@mereobiopharma.com|
22434657|NCT00624585|H. Lee Moffitt Cancer Center and Research Institute|Alan F. List, Executive Vice President & President, Moffitt Medical Group|813-745-6086|alan.list@moffitt.org|
22434658|NCT02330653|Boston Children's Hospital|Dr. Stacy A. Kahn|617-355-6058|stacy.kahn@childrens.harvard.edu|
22434659|NCT02563860|Montefiore MC|Aleksandra Djukic|7189204378|adjukic@montefiore.org|
22394658|NCT02337751|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22434660|NCT03777709|Mayo Clinic|Dr. LaPrincess Brewer|5072661376|brewer.laprincess@mayo.edu|
22434661|NCT04154345|University of Antwerp|Prof. Filip Struyf|32652783|filip.struyf@uantwerpen.be|0032
22434662|NCT03505788|Ziekenhuis Oost-Limburg|Prof. dr. Wilfried Mullens|+32(0)89327140|wilfried.mullens@zol.be|
22434663|NCT03368053|GlaxoSmithKline|GSK Response Center|877-379-3718|GSKClinicalSupportHD@gsk.com|
22434664|NCT01535599|Alcon Research, Ltd.|Sally Scheib, Sr. Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22394659|NCT01009580|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22394660|NCT01607112|GlaxoSmithKline|GSK Response Center|866-435-7343||
22394661|NCT05677893|Oneness Biotech Co., Ltd.|Director of Clinical Research|+886-2-2703-1098|Jessica.Ho@onenessbio.com.tw|
22394662|NCT03217266|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22394663|NCT01390181|Grand Traverse Heart Associates|Anna Booher|231 935-5800|annabooher3@gmail.com|
22394664|NCT03081052|Duke University|Kamrouz Ghadimi, M.D., M.H.Sc.|919-681-6532|kamrouz.ghadimi@duke.edu|
22394665|NCT01709747|CTI Clinical Trial and Consulting Services|Heather Kapushoc, Sr. Biostatistician|571-315-2574|hkapushoc@ctifacts.com|
22394666|NCT01101477|Chang Gung Memorial Hospital|Dr. Ting-Yu Lin|886 3 3281200|yuebaoyuebao@yahoo.com.tw|5108
22394667|NCT00720941|Novartis Pharmaceuticals|Study Director|862 778 8300|Novartis.email@Novartis.com|
22394668|NCT01222507|Washington University|Dr. Jay Piccirillo|314-362-7508|piccirilloj@ent.wustl.edu|
22394669|NCT03511053|Dallas VA Medical Center|Dr. Thiru M. Annaswamy, Staff Physician, PM&R Service|2148570273|thiru.annaswamy@va.gov|
22394670|NCT01605292|Long Beach VA Medical Center|Arnold Seto, MD, MPA|(562) 826-8000|arnold.seto@va.gov|5486
22394671|NCT03836989|Oregon Health and Science University|Dr. Myriam Loyo|503-494-8510|loyo@ohsu.edu|
22394672|NCT01786174|Massachusetts General Hospital|James D. Berry, MD, MPH|617-726-5097|jdberry@mgh.harvard.edu|
22394673|NCT01824160|Johns Hopkins University|RICHARD RINGEL|410-714-6745|rringel@jhmi.edu|
22394674|NCT03628898|Masimo Corporation|Chelsea Frank|949-297-7000|studies@masimo.com|
22394675|NCT03442985|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22394676|NCT00985166|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22394677|NCT00300781|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
22394678|NCT03330457|Portola Pharmaceuticals|Head of Clinical Development|650-246-7000|ClinicalTrials@Portola.com|
22394679|NCT01708122|Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center - Urology|Richard Reznichek|3102222724|RReznichek@dhs.lacounty.gov|
22394680|NCT00567268|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22394681|NCT00294554|Johns Hopkins University School of Medicine|Laura Marsh, MD|713-794-8907|laura.marsh2@va.gov|
22394682|NCT02598557|UT MD Anderson Cancer Center|Parijatham S. Thomas, MD., Associate Professor, Clinical Cancer Prevention|(713) 745-1075|psthomas@mdanderson.org|
22394683|NCT02864381|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22394684|NCT02986334|Northwestern University|Apkar Vania Apkarian|312-503-0404|a-apkarian@northwestern.edu|
22394685|NCT04142450|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22394686|NCT00120406|Cook|Scott Snyder, PhD, Director of Clinical Science and Biostatistics|765-463-7537|ssnyder@medinst.com|
22394687|NCT05398016|University of Nevada Las Vegas|Dr. Brenna Renn, PI|7028950569|brenna.renn@unlv.edu|
22394688|NCT00667355|Abbott|Global Medical Services|1-800-633-9110||
22394689|NCT01313637|GlaxoSmithKline|GSK Response Center|866-435-7343||
22394690|NCT01274585|Massachusetts General Hospital|Does Percutaneous Tibial Nerve Stimulation (PTNS) Improve Outcomes in Patients|617-643-0541|lsavitt@partners.org|
22394691|NCT00795951|Rady Children's Hospital, San Diego, CA|SE Jacob, MD and L Eichenfield, MD|858-576-1700|leichenfield@rchsd.org|4825
22424799|NCT02655419|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22424800|NCT02604173|Stanford University|Dr. Grant Lipman|415-290-9286|gslipman@stanford.edu|
22424801|NCT04226495|University of Nebraska Medical Center|Jeffrey Songster|308-520-2847|jeffrey.songster@unmc.edu|
22424802|NCT02993354|Montefiore Medical Center|Dr. Peter Bernstein|718-904-2767|pbernste@montefiore.org|
22424803|NCT02333383|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22424804|NCT04459598|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22424805|NCT00866333|Syndax Pharmaceuticals, Inc.|Michael L. Meyers, MD, PhD, Chief Medical Officer|+1-646-690-7620|mmeyers@syndax.com|
22424806|NCT01854879|Cochlear Americas|Lori O'Neill Director of Research|(303) 790-9010|loneill@cochlear.com|
22424807|NCT00136214|BIDMC|Nezam Afdhal|617632118|nafdhal@bidmc.harvard.edu|
22424808|NCT04985942|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646 440-9333|ITCIClinicalTrials@itci-inc.com|
22424809|NCT00171158|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22424810|NCT02757352|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22424811|NCT04750278|Foresee Pharma|Chief Medical Officer|408-823-4807|yisheng.lee@foreseepharma.com|
22424812|NCT01212159|Temple University School of Medicine|Alfred A. Bove|215-707-9259|alfred.bove@tuhs.temple.edu|
22424813|NCT00576524|Children's Hospital of Philadelphia|Marsha Wallace|(215) 590-0119|wallacem@email.chop.edu|
22424814|NCT04392219|Ridgeback Biotherapeutics|Dr. Wendy Painter|786-687-2495|EIDD2801@ridgebackbio.com|
22424815|NCT03738163|Mölnlycke Health Care|Sabrina Chowdhury|+44 (0)7769 907654|sabrina.chowdhury@molnlycke.com|
22424816|NCT02020135|Progenics Pharmaceuticals, Inc.|Dr. Vincent A. DiPippo|(646) 975-2502|vdipippo@progenics.com|
22424817|NCT03610334|Inflectis Bioscience|Dr Anne Visbecq (Chief Medical Officer)|0630632020|annevisbecq@inflectisbioscience.com|33
22424818|NCT02776670|Alcon, A Novartis Division|Head, CDMA Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22424819|NCT02066727|Tianjin Medical University General Hospital|Dr Yuechun LU|15902233666|luyuechun@sina.com|
22424820|NCT05460078|Atrium Health|Dr. Jason Roberge|7043550268|jason.roberge@atriumhealth.org|
22424821|NCT00957424|Roswell Park Cancer Institute|Richard O'Connor|716-845-4517|richard.oconnor@roswellpark.org|
22424822|NCT05835063|University of Michigan|Melissa Cousino|(734) 936-4220|melcousi@med.umich.edu|
22424823|NCT01280682|Department of Endocrinology, First Affiliated Hospital of Nanjing Medical University|Yang Tao|+86-13851498409|dryangtao@sina.com|
22434665|NCT00676520|Abbott Vascular|Ellen Travis|408-845-3000|Ellen.Travis@av.abbott.com|
22434666|NCT03848208|Achieve Life Sciences|Daniel Cain, Vice President, Clinical Research|425.686.1546|dcain@achievelifesciences.com|
22434667|NCT03466099|KalVista Pharmaceuticals|Director Clinical|857-999-0075|clinicalinfo@kalvista.com|
22434668|NCT01558362|University of Ottawa Heart Institute|Dr. Terrence Ruddy, Principal Investigator|613-696-7267|truddy@ottawaheart.ca|
22434669|NCT03826173|Brown University School of Public Health|David M Williams|4018636248|david_m_williams@brown.edu|
22434670|NCT00590824|University of Madison Carbone Cancer Center|Paul Sondel, MD, PhD|(608) 263-9069|pmsondel@humonc.wisc.edu|
22434671|NCT00932438|University of Louisville|Robert Martin, Md, PhD|602-629-3355|robert.martin@louisville.edu|
22434672|NCT00744978|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22434673|NCT03773133|Ipsen|Ipsen Medical Director|See email|clinical.trials@ipsen.com|
22434674|NCT03770728|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22434675|NCT02778555|Stanford University|Dr. Beth Darnall, Clinical Associate Professor, Division of Pain Medicine|(650) 721-2104|bdarnall@stanford.edu|
22434676|NCT02379988|Peace Health St. Joseph's cancer center|Victor Gonzalez|360-788-8222|vgonzalez1@peachehealth.org|
22434677|NCT00178919|Vanderbilt University|Italo Biaggioni|615-343-6499|italo.biaggioni@vanderbilt.edu|
22434678|NCT02089464|Nexstim Plc|Vice President, Medical Affairs||jarmo.laine@nexstim.com|
22434679|NCT01895543|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22434680|NCT00503581|NRG Oncology|Linda Gedeon for James Kauderer|716-845-1169|linda.gedeon@roswellpark.org|
22434681|NCT04262882|University of Texas at San Antonio|Dr. Katelyn Sileo|210-458-7900|katelyn.sileo@utsa.edu|
22434682|NCT01301066|Kowa Research Institute, Inc.|Roger Morgan, MD, FACS|919-433-1600|RMorgan@kowaus.com|
22434683|NCT00868140|Virginia Commonwealth University|Dr. John Nestler|(804) 828-3389|john.nestler@vcuhealth.org|
22434684|NCT04003207|Icahn School of Medicine at Mount Sinai|Alexander Kolevzon, MD|(212) 659-9134|alexander.kolevzon@mssm.edu|
22434685|NCT01790178|Duke University|Lisa Hobson-Webb|919-668-2277|lisa.hobsonwebb@dm.duke.edu|
22434686|NCT02950155|Karolinska Institutet|Prof. Fredrik Piehl|+46 736718101|fredrik.piehl@ki.se|
22434687|NCT00468676|Dept Psychiatry, University of Washington Medical School|Dr Wayne Katon, Professor and Vice Chair|206-543-7177|wkaton@uw.edu|
22434688|NCT03569748|University of Catania|Maria Signorelli|095.378.2636/794|maria.signorelli@unict.it|
22434689|NCT00722722|Mayo Clinic|Mark Stegall, MD|507-266-2812|Stegall.Mark@mayo.edu|
22434690|NCT00721578|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22434691|NCT01926041|National Taiwan University Hospital & College of Medicine|Dr. Chien-Hsieh Chiang|+88623123456|jiansie@gmail.com|66699
22434692|NCT04319380|London School of Hygiene and Tropical Medicine|Professor Daniel Chandramohan|+447570410351|daniel.chandramohan@lshtm.ac.uk|
22434693|NCT00147017|Imperial College London|Professor Louise Donnelly|+442075947895|l.donnelly@imperial.ac.uk|
22434694|NCT04432064|Indiana University|Prof. Joshua Brown|812 855-9282|jwmbrown@iu.edu|
22434695|NCT02256384|Cincinnati Children's Hospital Medical Center|Mario Patino|513-636-4200|mario.patino@cchmc.org|
22434696|NCT04448392|UAB|Dr. Nicole Samies|570-271-6440|nsamies2@geisinger.edu|
22434697|NCT04420598|Medica Scientia Innovation Research (Medsir)|Alicia García Sanz PhD|611261467|contact.trials@medsir.org|+34
22434698|NCT05032690|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22434699|NCT00487942|Cephalon, Inc.|Medical Monitor|1-800-896-5855||
22434700|NCT00211757|Montefiore Medical Center|Dr. Eric Hollander|718-920-4287|eholland@montefiore.org|
22434701|NCT05151445|Ohio State University College of Nursing|Tara O'Brien|614-292-8045|obrien.782@osu.edu|
22434702|NCT02298179|GlaxoSmithKline|GSK Response Center|866-435-7343|kt144805@gsk.com|
22434703|NCT04098367|Alcon Research, LLC|Sr. CDMA Project Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22434704|NCT01728077|Cares|UCB|+1844599||2273
22434705|NCT01366612|Hackensack Meridian Health|Joshua Zenreich|15519964248|joshua.zenreich@hmhn.org|
22434706|NCT00378599|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22434707|NCT01106859|Purdue Pharma LP|Clinical Leader|800-733-1333||
22434708|NCT04857437|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22434709|NCT03224507|University of Alabama at Birmingham|Luciano J Costa- Principal Investigator|2059349695|ljcosta@uabmc.edu|
22434710|NCT01032291|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22394692|NCT00816348|NSLIJ Health System|Cindy Haller MD|516-472-3650|challer@lij.edu|
22394693|NCT00655863|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22394694|NCT01138007|GlaxoSmithKline|GSK Response Center|866-435-7343||
22394695|NCT03548987|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22394696|NCT04572841|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22394697|NCT04661878|Duke University School of Nursing|Dr. Marta Mulawa|(919) 684-9555|marta.mulawa@duke.edu|
22394698|NCT05093699|Mayo Clinic|Dr Robert Anderson|507-284-4341|anderson.robert2@mayo.edu|
22394699|NCT05103228|Dunamenti REK IVF Center (former Kaali Institute)|Dr Peter Kovacs|+3612022802|peterkovacs1970@hotmail.com|
22394700|NCT00712673|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22394701|NCT01323647|GlaxoSmithKline|GSK Response Center|866-435-7343||
22424824|NCT04677387|University of North Carollina at Chapel Hill|Delesha Carpenter, PhD, MSPH|828-250-3916|dmcarpenter@unc.edu|
22424825|NCT00431067|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22424826|NCT01912352|Seoul National University|Dr. Jae-Won Kim|822-2072-3648|adore412@paran.com|
22424827|NCT01178814|Columbia University Irving Medical Center|Mark Heaney, MD|646-317-5199|mlh2192@cumc.columbia.edu|
22424828|NCT01687387|Innate Pharma|Director Clinical Operations|+33043030|info@innate-pharma.fr|30
22424829|NCT03838510|San Francisco Department of Public Health, University fo California San Francisco|Phillip Coffin, MD, MIA|628-217-6282|phillip.coffin@sfdph.org|
22424830|NCT02612688|Brown University|Jessica A. Ogarek, Senior Biostatistician|401-863-9356|jessica_ogarek@brown.edu|
22424831|NCT01660802|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22424832|NCT03913104|University of California, San Francisco|Natalie Morris|(415) 353-4724|natalie.morris@ucsf.edu|
22424833|NCT01119846|GlaxoSmithKline|GSK Response Center|866-435-7343||
22424834|NCT01404949|Memorial Sloan Kettering Cancer Center|Dr. Jae Park, MD|646-608-3743|parkj6@mskcc.org|
22424835|NCT02007278|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22424836|NCT01429441|ThromboGenics N.V.|Dr. Petra Kozma-Wiebe|+32 16 751 497|petra.kozma@thrombogenics.com|
22424837|NCT02279745|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
22424838|NCT03409120|University of Alabama at Birmingham|Christopher Gonzalez|2059753732|clg17@uab.edu|
22424839|NCT01606748|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22424840|NCT02603926|UC Davis MIND Institute|Dr. Randi Hagerman|916-703-0247|rjhagerman@ucdavis.edu|
22424841|NCT01706575|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22424842|NCT02230540|Rigshospitalet, Department of Urology|Per Bagi, MD|+45 3545 8310|Per.bagi@regionh.dk|
22424843|NCT03469999|Columbia University Irving Medical Center|Dr. Heakyung Kim|212-305-9416|hk2641@cumc.columbia.edu|
22424844|NCT03084315|University of Minnesota|Anne Joseph, MD, MPH|612-625-3789|lagre010@umn.edu|
22424845|NCT03439462|Aadi Bioscience, Inc.|Aadi Medical Information|1-888-246-2234|MedInfo@aadibio.com|
22424846|NCT02155322|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22424847|NCT04424914|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22424848|NCT02820181|The First Hospital of Shanxi Medical University|Dr.Jun Tian|+8618612270351|zguotian@126.com|
22424849|NCT02787681|Loma Linda University|H. Bryant Nguyen, MD|909-558-4000|hbnguyen@llu.edu|
22424850|NCT00789685|Faron Pharmaceuticals Limited|Dr Ilse Piippo, MD|+358 2469 5151|ilse.piippo@faronpharmaceuticals.com|
22394702|NCT03603028|UAB|David A. Brown|205-975-2788|dbrownpt@uab.edu|
22394703|NCT01468831|National Institutes of Health|Catherine Cukras, MD, PhD, Principal Investigator, NEI|301-435-5061|cukrasc@nei.nih.gov|
22394704|NCT02768870|Edwards Lifesciences, LLC|Sabrina Hundt, Director, Clinical Affairs, Surgical Structural Heart|949-250-2500|Sabrina_Hundt@edwards.com|
22394705|NCT02963610|Fox Chase Cancer Center|Hossein Borghaei, DO, MS|215-214-4297|Hossein.Borghaei@fccc.edu|
22394706|NCT02203695|Johns Hopkins University, School of Medicine|Dr. Daniel Song|410-502-5875|dsong2@jh.edu|
22394707|NCT00640016|MedImmune, LLC|Meena Jain, MB BChir/Associate Medical Director|301-398-0000|jainm@medimmune.com|
22394708|NCT00846391|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22394709|NCT01287065|GlaxoSmithKline|GSK Response Center|866-435-7343||
22394710|NCT00700973|VA Palo Alto Health Care System|Christine Timko|650-617-2746|Christine.Timko@va.gov|
22394711|NCT01580969|Huntsman Cancer Institute|Josiah Hawks|801-585-0601|Josiah.Hawks@hci.utah.edu|
22394712|NCT02656160|Brigham and women's Hospital|Andrew Wellman, MD, PhD||awellman@rics.bwh.harvard.edu|
22394713|NCT02019927|Will Eye Hopsital|Ann Murchison MD|267-733-9617|Visionresearch@willseye.org|
22394714|NCT02169453|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22394715|NCT03181451|Shield Therapeutics|Jackie Mitchell MA DPhil|+44 (0) 191 511 8515|jmitchell@shieldtx.com|
22394716|NCT00604812|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22394717|NCT01259284|UT MD Anderson Cancer Center|Ara Vaporciyan, MD, BS / Professor||CR_Study_Registration@mdanderson.org|
22394718|NCT00069238|National Cancer Institute|Dr. Wyndham WIlson|301-435-2415|wilsonw@mail.nih.gov|
22394719|NCT02271425|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22394720|NCT02453360|University of Wisconsin School of Medicine|Kristopher Schroeder|608-263-8100|kmschro1@wisc.edu|
22394721|NCT01326533|University of Pittsburgh|Frederico Toledo|412-692-2848|.toledofs@upmc.edu|
22394722|NCT03353350|Hanmi Pharmaceutical Co., Ltd.|Sujin Jung|+82-2-410-0473|sujin.jung@hanmi.co.kr|
22394723|NCT02594826|Fox Chase Cancer Center|Dr. Carolyn Fang|1-888-369-2427|carolyn.fang@fccc.edu|
22394724|NCT01134016|Golden Biotechnology Corp.|Dr. Howard Cheng, Director of clinical trials|886-2808-6006|howard@goldenbiotech.com.tw|
22394725|NCT01012713|University of California San Francisco|Dr. John Koo|4154764701|john.koo@ucsfmedctr.org|
22394726|NCT01564628|Acarix A/S|Claus Christensen|+45 29724411|dkcbc@acarix.com|
22394727|NCT02409368|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22394728|NCT01296347|ImperialNHSTrust|Dr Gillian Chumbley|+44 203 311 1000|gillian.chumbley@imperial.nhs.uk|Bleep 5865
22394729|NCT03343301|Amgen|Study Director|866-572-6436|medinfo@amgen.com|
22394730|NCT04633551|University of South Carolina|Abbi Lane-Cordova|8037777568|lanecord@mailbox.sc.edu|
22394731|NCT02668185|Imperial College London|Professor Wajit Dhillo|+44 (0)20 7594 2489|w.dhillo@imperial.ac.uk|
22394732|NCT01013597|University of Wisconsin Carbone Cancer Center|Abigail Mapes, Thoracic Oncology Research Program Manager|608-262-8158|acmapes@medicine.wisc.edu|
22394733|NCT02678247|Northwestern University|Dr. Stefania Fatone, Principle Investigator|3125035717|s-fatone@northwestern.edu|
22394734|NCT01837069|NYU Langone Health|Jeffrey Berger|212 263 4004|Jeffrey.Berger@nyulangone.org|
22394735|NCT04968197|Mayo Clinic|Gaurav N. Pradhan, Ph.D.|(480) 301-5351|Pradhan.Gaurav@mayo.edu|
22394736|NCT02425644|Actelion Pharmaceuticals Ltd (a Janssen Pharmaceutical Company of Johnson & Johnson)|Senior Director Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22394737|NCT02720536|Novartis Pharmaceuticals|Study Director|888-778-8300|Novartis.email@novartis.com|
22394738|NCT02525861|Baxalta|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22394739|NCT01810692|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22394740|NCT01942720|Medtronic|Clinical Trials Manager|+972-4-9097952|michal.kedar-datel@medtronic.com|
22394741|NCT01607554|University of New Mexico Comprehensive Cancer Center|Valerie Parks, RN|505-925-0390|vparks@salud.unm.edu|
22394742|NCT05580588|Shanghai Pharma Biotherapeutics USA Inc.|CSO|8587755354|kenneth@sphbio.com|
22394743|NCT05195814|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22424851|NCT02910726|Memorial Sloan Kettering Cancer Center|Neeta Pandit-Taskar, MD|1-833-MSK-KIDS|pandit-n@mskcc.org|
22424852|NCT01215435|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22424853|NCT00394771|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22424854|NCT03383692|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22424855|NCT01218971|Alkermes, Inc.|Bernard L. Silverman, MD|781-609-6000|bernard.silverman@alkermes.com|
22424856|NCT03884985|University of Rochester|Martina Poletti|(585) 275-4801|martina_poletti@urmc.rochester.edu|
22424857|NCT02906033|Helsinki University Hospital|MNSc Maria Pulkkinen|+358 50 427 2678|maria.pulkkinen@hus.fi|
22424858|NCT00358956|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22424859|NCT00093847|Massachusetts General Hospital|Dr George Papakostas, M.D.|6177266697|gpapakstas@partners.org|
22424860|NCT03417024|GE Healthcare|Sr. Clinical Affairs Project Manager|2624095722|kevin.r.siewert@ge.com|
22424861|NCT02195427|Teoxane|Clinical Project Manager|+41 (0) 22 344 96 36|m.chenet@teoxane.com|
22424862|NCT00386425|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22424863|NCT00624650|OHSU|Samantha Ruimy|5034940724|ruimy@ohsu.edu|
22424864|NCT03782974|USANA Health Sciences|Dr. Jeremy Tian|01-801-954-7658|jeremy.tian@usanainc.com|
22424865|NCT03704948|University of Iowa|Lisa S. Segre|13193357079|lisa-segre@uiowa.edu|
22394744|NCT00756470|University of Texas (UT) MD Anderson Cancer Center|Ricardo Alvarez, MD/Breast Medical Oncology|713-792-2817|CR_Study_Registration@mdanderson.org|
22424866|NCT01726621|Medtronic MiniMed, Inc|Clinical Research Manager|8185765171|julie.sekella@medtronic.com|
22394745|NCT00325039|New England Research Institutes, Inc.|Heather Litman, PhD|617 972 3297|hlitman@neriscience.com|
22394746|NCT02287376|Depomed|Clinical Operations|510-744-8000|clinicaltrials@depomed.com|
22394747|NCT01009203|University of Pittsburgh Medical Center|Julie E. Bauman, MD|4126486507|baumanje@upmc.edu|
22394748|NCT02796001|University of Virginia School of Medicine|Ronald Turner, MD|4349819964|rbt2n@virginia.edu|
22394749|NCT02974088|Medical Entomology Centre|Ian Burgess|+44 1223 810070|ian@insectresearch.com|
22394750|NCT00892723|Capstone Therapeutics|Denise Lamon|800-937-5520|dlamon@capstonethx.com|5206
22394751|NCT01032382|US Army Medical Materiel Development Activity (USAMMDA)|Director, Division of Regulated Activites and Compliance|301-619-0197|usarmy.detrick.medcom-usammda.mbx.usamrmc-regulatory-affairs@mail.mil|
22394752|NCT00985153|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22394753|NCT00982995|University of Michgan Comprehensive Cancer Center|Susan Urba|734-615-4762|surba@umich.edu|
22394754|NCT01679405|University Medical Center Mainz|Prof. Dr. Markus Moehler|0049613117|Markus.Moehler@unimedizin-mainz.de|7275
22394755|NCT04508023|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22394756|NCT04819776|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
22394757|NCT02341859|Coopervision Japan|Taku Muraoka, OD, Director Professional Services Organization|81-3-5449-6619|taku.muraoka@jp.coopervision.com|
22394758|NCT04845633|Damascus University|Dr. Line Droubi|00963966896989|droubiline@gmail.com|
22394759|NCT01668667|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
22394760|NCT02988622|Univeristy of Iowa, Hospitals and Clinics|Dr. Marta VanBeek|(319) 384-6012|marta-vanbeek@uiowa.edu|
22394761|NCT03562247|Vanderbilt University Medical Center|Lisa Lancaster, MD|615-322-2386|lisa.lancaster@vumc.org|
22394762|NCT04009850|Yale School of Medicine|Dr. Krysten Bold|203-974-7603|krysten.bold@yale.edu|
22394763|NCT01281969|NIMH|Dr. David I. Driver|301.496.1683|david.driver@nih.gov|
22394764|NCT04640077|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22394765|NCT02240693|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22394766|NCT02041520|Instituto Mexicano del Seguro Social, UMAE HE No. 1 Bajio|Dr. Norma Amador|+524777174800|norma.amador@imss.gob.mx|31315
22394767|NCT00413972|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22394768|NCT03087019|Dana-Farber Cancer Institute|Jonathan Schoenfeld, MD, MPH|617-632-3591|jonathan_schoenfeld@dfci.harvard.edu|
22394769|NCT00427895|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22394770|NCT01907360|Ironshore Pharmaceuticals and Development, Inc.|Chief Scientific Officer|13457498174|bev@ironshorepharma.com|
22394771|NCT00603720|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
22394772|NCT02796560|University of Sherbrooke|Dr Marjorie Carbonneau|819-346-1110|Marjorie.Carbonneau@USherbrooke.ca|22180
22394773|NCT03804502|Sight Sciences, Inc.|VP, Medical and Clinical Affairs|1-877-266-1144|jdickerson@sightsciences.com|
22394774|NCT03816332|Johns Hopkins University/SKCCC|Grants Administrative Manager|4439273568|jmurra33@jhmi.edu|
22394775|NCT05330312|Vicore Pharma|Director Clinical Operations|+46317880560|info@vicorepharma.com|
22394776|NCT03534284|University of Washington|Dr. Raj Mehrotra|206-221-7138|rmehrotr@uw.edu|
22394777|NCT03316300|Neurotech Pharmaceuticals, LLC|CMO|401-333-3880|neurotech@neurotechusa.com|
22394778|NCT05462886|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
22394779|NCT03164564|HPTN Statistical & Data Management Center|HPTN Statistical Manager|206-667-4004|HPTN-Data-Access@scharp.org|
22394780|NCT00423930|Memorial Sloan Kettering Cancer Center|David Pfister, MD|646-888-4232|pfisterd@mskcc.org|
22394781|NCT04002401|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
22394782|NCT02618642|Rzeszow University|Jolanta Zwolińska PhD|48 505095199|jolantazwolinska@op.pl|
22394783|NCT01910181|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22394784|NCT00822523|Loma Linda University|Gordon Perterson, MD|909-558-4000|gpeterson@llu.edu|
22394785|NCT03567434|Baylor University|Dr. Jason Carter|254-710-4499|jason_carter1@baylor.edu|
22394786|NCT01000285|Washington University School of Medicine|Lee Ratner, M.D., Ph.D.|314-362-8836|lratner@dom.wustl.edu|
22394787|NCT02181387|Wake Forest School of Medicine|Peter H. Pan, MD, MSEE|336-718-8278|ppan@wakehealth.edu|
22394788|NCT02880540|Children's National Hospital|Janelle Vaughns MD|202-476-2025|jvaughns@childrensnational.org|4165
22394789|NCT02881957|University of Utah|Dr. Michael Karsy|801-581-6908|michael.karsy@hsc.utah.edu|
22394790|NCT04485858|CorNeat Vision|Clinical Research Associate|0586753739|talia@corneat.com|
22394791|NCT03413735|The Ohio State University|Dr. Richard Bruno|614-292-5522|bruno.27@osu.edu|
22394792|NCT05269355|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22394793|NCT01050790|Virginia Commonwealth University/Massey Cancer Center|Amir A. Toor, MD, Associate Professor of Medicine|804-828-4360|atoor@mcvh-vcu.edu|
22394794|NCT03705832|Columbia University|Emily DiMango, MD|212-305-0631|ead3@columbia.edu|
22424867|NCT04504175|Washington University in St. Louis|Dr. Eric Lenze|314-362-5154|lenzee@wustl.edu|
22424868|NCT04607980|Amgen Inc.|Study Director|8665726436|medinfo@amgen.com|
22424869|NCT00448812|Boston Scientific Corp.|G Mark Grubb, RN, CCRA|+1 (412) 716-0717|grubbm@bsci.com|
22424870|NCT02012959|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
22424871|NCT03372382|McGovern Medical School, University of Texas, Health Science Center at Houston|Dr Jenifer Dinis, MD|713 500 6421|jenifer.dinis@uth.tmc.edu|
22424872|NCT01128400|Washington University School of Medicine|M. Yanina Pepino|3143628113|ypepino@dom.wustl.edu|
22434711|NCT00347438|University of Chicago Medical Center|Dr. Funmi Olopade|773-702-1632|folopade@medicine.bsd.uchicago.edu|
22424873|NCT04474054|FARAPULSE|Christopher (Kit) Schneider|617-686-7661|christopher.schneider@bsci.com|
22394795|NCT01880528|Mayo Clinic|Terence T Sio, MD, MS|480/301-7050|Sio.Terence@mayo.edu|
22394796|NCT00081497|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22434712|NCT03010137|UC Davis Medical Center|Dr. Yunfeng Xue|408-603-0507|yunxue@ucdavis.edu|
22394797|NCT01439360|GlaxoSmithKline|GSK Response Center|866-435-7343||
22394798|NCT05203068|"Federal State Budgetary Institution National Medical Research Center of Phthisiopulmonology and Infectious Diseases of the Ministry of Health of the Russian Federation"|Dr. Kazakov Aleksey Vladimirovich, principal investigator|+79254666638|alexeykazakov1982@yandex.ru|
22394799|NCT02390245|Wills Eye Hospital|Dr. L. Jay Katz|215-825-4713|jmolineaux@willseye.org|
22394800|NCT03769181|Sanofi Aventis Recherche & Développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22394801|NCT00826111|Steward St. Elizabeth's Medical Center of Boston, Inc.|Tara Lauriat, Ph.D.|617-789-2404|tara.lauriat@steward.org|
22394802|NCT01195545|University of Washington|Brant Oelschlager, MD|206-543-3518|brant@uw.edu|
22394803|NCT01929980|Cincinnati Children's Hospital Medical Center|Pooja Khandelwal, MD|513-803-9063|Pooja.Khandelwal@cchmc.org|
22394804|NCT00426153|Mayo Clinic|Marie Hogan, MD, PhD, Assistant Prof of Medicine, College of Medicine|507-266-9364|hogan.marie@mayo.edu|
22394805|NCT00150969|University Health Network|Dr. Angela M Cheung|416-340-4841|jscher@uhnresearch.ca|
22394806|NCT00615836|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22394807|NCT01630434|TransMedics, Inc.|VP, Clinical Affairs|978.552.0900|ldamme@transmedics.com|
22394808|NCT00687973|Novartis Pharmaceuticals|Study Director|862 778-8300||
22394809|NCT02269332|Mike O'Callaghan Military Medical Center|Senior Research Associate/Research Manager|7026533583|amanda.j.crawford.ctr@health.mil|
22394810|NCT00610467|University of California Irvine|Professor|949-824-6001|msu@uci.edu|
22434713|NCT01529515|Janssen Research & Development, LLC|Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
22434714|NCT01706497|University Hospitals Leuven (UZ Leuven) and KU Leuven|Prof Dr Geert Meyfroidt, Associate Professor|0032 16 344021|geert.meyfroidt@uzleuven.be|
22434715|NCT00322023|Nathan Kline Institute|Dr. Daniel Javitt|845-398-6534|javitt@nki.rfmh.org|
22434716|NCT03327220|Pacira CryoTech, Inc.|Kent Jones/ Sr. Director, Quality and Medical Affairs|510-933-1513|kent.jones@pacira.com|
22434717|NCT03920293|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22434718|NCT00523705|University of Pennsylvania|Ellen Freeman, Principal Investigator|215 662-3329|freemane@mail.med.upenn.edu|
22434719|NCT00693017|Eisai Inc|Antonio Laurenza, MD, Executive Director|1 201 949-4157|antonio_laurenza@eisai.com|
22434720|NCT00504504|University of Texas (UT) MD Anderson Cancer|Anas Younes, MD / Professor||CR_Study_Registration@mdanderson.org|
22434721|NCT01952444|Elusys Therapeutics Inc.|Senior Director of Regulatory|973-808-0222|cdillon@elusys.com|
22434722|NCT01691885|GlaxoSmithKline|GSK Response Center|866-435-7343||
22434723|NCT03555981|London School of Hygiene & Tropical Medicine|Dr Helen Brotherton|07481474150|helen.brotherton@lshtm.ac.uk|
22434724|NCT00615589|University of Michigan Comprehensive Cancer Center|Dr. Attaphol Pawarode, M.D.|734-936-8785|pawarode@umich.edu|
22434725|NCT00688324|Maryland Psychiatric Research Center|Robert W. Buchanan, M.D.|410-402-7876|rwbuchanan@som.umaryland.edu|
22434726|NCT03989427|Melaka-Manipal Medical College|Dr. Rajesh Hosadurga|+6062896662|rajesh.hosadurga@manipal.edu.my|3823
22434727|NCT01972308|University of Pennsylvania|Andrea J Apter, MD|215 349-5120|andrea.apter@uphs.upenn.edu|
22434728|NCT00746239|Penn State Hershey Medical Center|Ravi Singareddy|717-531-0040|rsingare@gmail.com|
22434729|NCT00847665|University Hospital Virgen de las Nieves|Dr. Francisco Manzano|34958020125|fmanzano@mailpersonal.com|
22434730|NCT04035564|"Hospital del Niño de Saltillo Dr. Federico Gomez Santos"|Carlos Sanchez|+528441757244|sanchez.carlos8516@gmail.com|
22434731|NCT03617536|Cara Therapeutics|Director of Clinical Trials|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
22434732|NCT03333252|Weill Medical College of Cornell University|Sara J. Czaja|646-962-7141|sjc7004@med.cornell.edu|
22434733|NCT00939029|Mayo Clinic|Dr. Jon Ebbert|507-284-4736|ebbert.jon@mayo.edu|
22434734|NCT04686084|UCLA Oral & Maxillofacial Radiology|Sanjay M Mallya|3108251689|smallya@dentistry.ucla.edu|
22434735|NCT02576041|Allergology Unit, Azienda Ospedaliero-Universitaria Policlinico di Modena|Patrizia Pepe, MD|+39. 059 4225449||
22434736|NCT01779856|Medtronic, plc|RCS Sr. Director of Medical Affairs|763-505-4566|amy.denise.roettger@medtronic.com|
22434737|NCT02494518|Cleveland Clinic|Dr. Susan Linder|(216) 445-9815|linders@ccf.org|
22434738|NCT01425359|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22434739|NCT03960580|OptiNose|John Messina, PharmD, SVP of Clinical Research & Medical Affairs|265-521-0565|john.messina@optinose.com|
22434740|NCT01528891|Children's Hospital of Pittsburgh of UPMC|Peter J. Davis, MD|4126925260|davispj@anes.upmc.edu|
22434741|NCT04452435|Vicore Pharma|Carl-Johan Dalsgaard|+46 70 975 98 63|carl-johan.dalsgaard@vicorepharma.com|
22434742|NCT02135029|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22434743|NCT00668382|UMass Medical Scool|Dr. Sheila Noone|508 856 5015|Sheil.Noone@umasmed.edu|
22394811|NCT00527592|Alcon Research, Ltd.|Director of Medical Affairs|1-800-862-5266|medinfo@alconlabs.com|
22394812|NCT04465760|OREGON HEALTH & SCIENCE UNIVERSITY|Joseph Shatzel MD MCR|5034948311|shatzel@ohsu.edu|
22394813|NCT00815685|H. Lee Moffitt Cancer Center and Research Institute|Nagi Kumar, Ph.D., via Moffitt Cancer Center|813-745-6885|nagi.kumar@moffitt.org|
22394814|NCT00511472|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22394815|NCT01079741|Icahn School of Medicine at Mount Sinai|Dr. Nina Bhardwaj|212-824-8427|nina.bhardwaj@mssm.edu|
22394816|NCT00406653|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22394817|NCT00446992|University of Nevada School of Medicine|Dr. Brian Kirkpatrick|775-682-8459|bkirkpatrick@medicine.nevada.edu|
22394818|NCT02075541|GlaxoSmithKline|GSK Response Center|866-435-7343|lp542096@gsk.com|
22394819|NCT00731120|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22394820|NCT02349360|University of Florida|Wendy Dahl Associate Professor|3522943707|wdahl@ufl.edu|
22394821|NCT02618031|Cleveland Clinic Akron General|John Elias|330-344-6176|eliasj@ccf.org|
22394822|NCT01054846|Parkview Health|Thein Zhu|260-266-1279|thein.zhu@parkview.com|
22394823|NCT02434939|Makerere University ,College of Health Sciences, Department of Anesthesia and Critical care|Dr.Lubega Felix Anthony|+256777756571|falubega@chs.mak.ac.ug|
22394824|NCT00394953|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22394825|NCT03586687|Penn State Hershey Medical Center|Cayce Onks, DO|7175317127|conks@pennstatehealth.psu.edu|
22394826|NCT04250987|Coloplast|Vice President, Medical Affairs|+45 4911 1111|clinical-studies@coloplast.com|
22424874|NCT01523834|Azienda Sanitaria Universitaria Integrata di Udine (A.S.U.I. Udine) - SOC Clinica Ematologica|Dr. Francesco Zaja, Co-Investigator of the Study|+39 0432559604|francesco.zaja@asuiud.sanita.fvg.it|
22424875|NCT05725824|University of Arizona|Dr. Bryan Wong|5206268549|bryanwong@arizona.edu|
22424876|NCT03782571|Johnson & Johnson Vision Care, Inc.|Thomas R. Karkkainen, OD, MS, FAAO|904 443-3402|TKarkkai@its.jnj.com|2126
22424877|NCT03504189|Nuvo Group|VP Clinical|+972-3-6242266|adar.shani@nuvocares.com|1630
22424878|NCT00950729|Centre hospitalier universitaire de Sherbrooke (CHUS)|François Cabana|1-819-346-1110|francois.cabana@usherbrooke.ca|14233
22424879|NCT01088711|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22424880|NCT01240902|Medtronic, Inc.|Hatice Bilgic Lim||rs.medtroniccardiovascularclinicaltrials@medtronic.com|
22424881|NCT02665741|University of California, Davis|Dr. Sooraj Tejaswi|916-734-7215|stejaswi@ucdavis.edu|
22424882|NCT03543176|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22424883|NCT01267929|Postgraduate Studied Program, faculty of medicine, Thammasat University|Miss Namfon Mahasup|+66 867733596|namfon_pt@yahoo.com|
22424884|NCT02626000|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22424885|NCT01796301|Amgen Inc.|Study Director|866-572-6436||
22424886|NCT01679028|Tasly Pharmaceuticals, Inc.|Dr. Henry SUN|240-744-6225|henrysunusa@gmail.com|
22424887|NCT02589847|Rebiotix, Inc.|Clinical Development|651-705-8778|US8-StudyInfo@ferring.com|
22424888|NCT02570750|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22424889|NCT01884545|NYU Rory Meyers College of Nursing|Allison A. Vorderstrasse, DNSc, APRN, FAAN|212-998-5786|allisonvorderstrasse@nyu.edu|
22424890|NCT01410240|Baxter BioScience|Maurice Bagot D'Arc, MD, Sr Medical Director Medical Affairs , BioSurgery||maurice_bagot_d'arc@baxter.com|
22424891|NCT00496587|The University of Texas MD Anderson Cancer Center|Dr. Nazir Tannir/|713-792-7734|CR_Study_Registration@mdanderson.org|
22424892|NCT02488018|Addis Ababa University [Office telephone +251011-655-1927]|Abera Belay (PhD Candidate)|Mobile +251911840655|ab.berabelay@gmail.com|
22424893|NCT03571607|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22394827|NCT01426763|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22424894|NCT05537428|Yale University|Philip Corlett|2039747866|philip.corlett@yale.edu|
22424895|NCT00592592|Massachusetts General, Hospital|Torunn Yock, MD|6177262000|tyock@mgh.harvard.edu|
22424896|NCT01134263|Sanofi Pasteur|Trial Transparency Team||Contact-US@sanofi.com|
22424897|NCT01557517|National Cancer Institute|Dr. Najla El Jurdi|240-992-4033|najla.eljurdi@nih.gov|
22424898|NCT00162097|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22424899|NCT01204918|Yale University|Gerard Sanacora, PhD, MD: Professor of Psychiatry; Director, Yale Depression Research Program|(203) 974-7535|gerard.sanacora@yale.edu|
22424900|NCT00770913|Eisai Co.,Ltd. Eisai Product Creation Systems|Tomoki Kubota, Study Director|+81-3-3817-3908|t2-kubota@hhc.eisai.co.jp|
22424901|NCT02893423|Maimonides Medical Center|Kalpana Tyagaraj|718-283-1753|KTyagaraj@maimonidesmed.org|
22424902|NCT00269477|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22424903|NCT00548249|Rockwell Medical|Richard C. Yocum, MD|858-229-8585|ryocum@rockwellmed.com|
22424904|NCT02347072|Pearl Therapeutics Inc.|Colin Reisner, MD, FCCP, FAAAAI|650-350-2600|creisner@pearltherapeutics.com|
22424905|NCT02259699|University of California, Irvine|Dr. Lari Wenzel|949-824-3926|lwenzel@uci.edu|
22424906|NCT01134393|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22424907|NCT00080483|University of Pennsylvania|Peter J. Snyder M.D.|215-898-0208|pjs@mail.med.upenn.edu|
22424908|NCT02445859|The Universit yof Leeds|Andrew Kirby|0044 113 3923989|a.kirby@leeds.ac.uk|
22424909|NCT01557868|American Orthopaedic Society for Sports Medicine|Dr. Barton Mann|847-292-4900|bart@aossm.org|
22424910|NCT04475718|Orange Square Designs|Lisa Marceau|4014284197|lisa@orangesquare.com|
22424911|NCT02886884|University of Miami|Dr. Joshua M. Hare, MD|305-243-5579|jhare@med.miami.edu|
22424912|NCT00625183|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22424913|NCT02670382|Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University|Dr. Stefania Lamon-Fava, Scientist I|617-556-3105|stefania.lamon-fava@tufts.edu|
22424914|NCT03244618|Unilever|Dr Jane Matheson|+44 (0)1516413633|jane.matheson@unilever.com|
22424915|NCT01897766|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22424916|NCT01810783|H. Lundbeck A/S|Email contact via||LundbeckClinicalTrials@Lundbeck.com|
22424917|NCT05011890|University of North Carolina Lineberger Comprehensive Cancer Center|Gita Mody|+1 919-966-3382|gita_mody@med.unc.edu|
22424918|NCT04776018|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22424919|NCT00793546|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22424920|NCT00732680|Mayo Clinic|Rizwan Siwani, MBBS|507-284-9155|siwani.rizwan@mayo.edu|
22424921|NCT00435019|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22424922|NCT04503668|University of Michigan Rogel Cancer Center|University of Michigan Rogel Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
22424923|NCT02306694|Oregon Health & Science University|Dr. Jayson Taylor|503-494-8716|taylojas@ohsu.edu|
22424924|NCT01665677|Medical College of Wisconsin|Dr. Medhi Hamadani|414-805-6800|mhamadani@mcw.edu|
22424925|NCT01907217|St Patrick's University Hospital|Prof Declan McLoughlin|+353 1 2493343|d.mcloughlin@tcd.ie|
22424926|NCT00742027|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22424927|NCT01180049|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22424928|NCT01764659|UMMC MSGCC|Howard Zhang, PhD|(410)706-6510|hzhang@umm.edu|
22424929|NCT01210352|Endo Pharmaceuticals|Saji Vijayan|(800) 462-3636|ClinicalTrials@Endo.com|
22424930|NCT03396822|University of Maryland School of Medicine|Daniel Harrison|410-328-5605|dharrison@som.umaryland.edu|
22424931|NCT01305772|Duke University Medical Center|Neal Ready,MD|919-681-6932|neal.ready@dm.duke.edu|
22424932|NCT03630705|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
22424933|NCT03488563|AOBiome Therapeutics|Hyun Kim, Vice President Clinical Operations|617-639-9980|hkim@aobiome.com|
22424934|NCT03441685|Vanderbilt University Medical Center|Dr. C. Melanie Schuele|615-936-5256|melanie.schuele@vanderbilt.edu|
22424935|NCT00339833|National Institutes of Health|Jonathan Krakoff, M.D./National Institute of Diabetes and Digestive and Kidney Diseases|6022005217|jkrakoff@mail.nih.gov|
22424936|NCT00217581|Barbara Ann Karmanos Institute|Philip A. Philip, M.D., Ph.D., F.R.C.P|(313) 576-8746|philipp@karmanos.org|
22424937|NCT02829047|Vibrant Gastro|Clinical trials manager|046663322|service@vibrantgastro.com|
22424938|NCT00329745|GlaxoSmithKline|GSK Response Center|866-435-7343||
22394828|NCT01614743|DeNova Research|Steven H Dayan, MD|312-335-2070|sdayan@drdayan.com|
22424939|NCT01597492|GlaxoSmithKline|GSK Response Center|866-435-7343||
22424940|NCT03146741|University of Pennsylvania|Dr. Peter Reese|215-900-3782|peter.reese@uphs.upenn.edu|
22424941|NCT03224624|VA San Diego Healthcare System|Dena Rifkin|8585528585|dena.rifkin@va.gov|2784
22424942|NCT01424241|Columbia University Medical Center|Pamela Freda, MD|212-305-2254|puf1@columbia.edu|
22424943|NCT05050448|Medical Pain Consultants|Dr. Ralph Ortiz|607-844-9979|rodoc@cnymail.com|
22424944|NCT00482170|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22394829|NCT02446886|Weill Cornell Medicine|Research Coordinator|6469625736|liz4005@med.cornell.edu|
22394830|NCT01610011|McLean Hospital|Marc J. Kaufman, Ph.D., Principal Investigator|617-855-3469|kaufman@mclean.harvard.edu|
22424945|NCT00777062|University of Pennsylvania|Dr. Kyle Kampman|215-222-3200|kampman@mail.med.upenn.edu|109
22424946|NCT00098670|The Ohio State University|Dr. Thomas Lin||thomas.lin@osumc.edu|
22424947|NCT02548949|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22424948|NCT03230838|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22424949|NCT00497055|San Francisco Department of Public Health|Phillip O. Coffin, Director of Substance Use Research|415-437-6282|phillip.coffin@sfdph.org|
22424950|NCT00575510|Mayo Clinic|Dr. Carmen Radecki Breitkopf|507-266-0969|radeckibreitkopf.carmen@mayo.edu|
22424951|NCT00459368|Henry Ford Health System|L. Keoki Williams, MD, MPH|313-874-5454||
22424952|NCT02697734|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22424953|NCT02324699|Icahn School of Medicine at Mount Sinai|Dr. Bruce Sands|212-241-8100|bruce.sands@mssm.edu|
22424954|NCT03970200|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
22424955|NCT01607346|GlaxoSmithKline|GSK Response Center|866-435-7343||
22424956|NCT01098162|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22424957|NCT01605825|Acorda Therapeutics, Inc.|Study Director|914-347-4300||
22424958|NCT02740335|Clinical Research Management Group|Patrick Murphy|413-821-0022|p.murphy@crmg-usa.com|
22424959|NCT00380718|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22424960|NCT01349933|Mayo Clinic|Brigette Buig-Yue Ma, MBBS, FRACP||brigette@clo.cuhk.edu.hk|
22424961|NCT02033200|Vivus Inc|VP of Development|650-934-5200||
22424962|NCT04333225|Baylor Scott & White Research Institute|Peter A. McCullough, MD, MPH|2148412000|peteramccullough@gmail.com|
22424963|NCT04318132|Nidek.co., ltd.|Tadakazu Ichimura|+81-533-67-8904|tadakazu_ichimura@nidek.co.jp|
22424964|NCT01863732|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
22424965|NCT01124370|Respicardia|Linda Nelson, VP Clinical Affairs|952-540-4479|lnelson@respicardia.com|
22424966|NCT00822328|Cheng Hsin Rehabilitation Medical Center|Dr.Yi-Hsien Lin|+886-2-28264400|d49311001@ym.edu.tw|5750
22424967|NCT00840034|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22424968|NCT05811026|Department of Dermatology, National Taiwan University Hospital, Taipei, Taiwan|Dr. Chang-Ming Huang|+886-2-23123456|daniel510791@gmail.com|262141
22424969|NCT02870205|Glenmark Pharmaceuticals Ltd|Study Director|(201) 684-8000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
22424970|NCT02839876|Duke University Medical Center|Dr. Jeff Gadsden|919-681-6437|jeff.gadsden@duke.edu|
22424971|NCT01313351|Rapid Pathogen Screening, Inc|Robert Sambursky, MD|9415581853|rob.sambursky@lumosdiagnostics.com|
22424972|NCT01156051|Children's Specialized Hospital|Thomas A Rugino MD|732-797-3826|trugino@childrens-specialized.org|
22424973|NCT03816007|VA San Diego Healthcare System|Dr. Erik Groessl|858-642-6347|erik.groessl@va.gov|
22424974|NCT03628716|Bavarian Nordic A/S|Bavarian Nordic Call Center|1-844-422-8274|medical.information_us@bavarian-nordic.com|
22424975|NCT00856843|Braintree Laboratories, Inc.|John McGowan|781-843-2202|jmcgowan@braintreelabs.com|
22424976|NCT02179749|The Scripps Research Institute|Barbara J. Mason, Ph.D.|858-784-7328|mason@scripps.edu|
22424977|NCT00094536|Cooper Surgical|Chief Medical Officer|203-601-5200|Robert.Auerbach@coopersurgical.com|
22424978|NCT02620384|Aultman Hospital|Director of Research Programs|330-363-7274|mary.amos@aultman.com|
22424979|NCT01327313|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22424980|NCT00628927|University of Cincinnati|Dr. Theresa Winhusen|513-487-7800|winhusen@carc.uc.edu|
22424981|NCT02798354|Children's Hospital at Montefiore and Albert Einstein College of Medicine|Dr. Michael Rinke|718-741-2597|mrinke@montefiore.org|
22424982|NCT01298141|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22424983|NCT03338569|University of Minnesota|Ronald Reilkoff, MD|612-624-0999|rreilkof@umn.edu|
22424984|NCT00350779|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclsoure@merck.com|
22424985|NCT00528372|AstraZeneca Pharmaceuticals|Boaz Hirshberg||ClinicalTrialTransparency@astrazeneca.com|
22424986|NCT02006056|Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto|Dr. Edward Chow|416-480-4974|edward.chow@sunnybrook.ca|
22424987|NCT01289574|AndroScience Corp|Charles CY Shih, PhD|(858) 638-7230|cyshih@androscience.com|
22424988|NCT00262002|Novartis Vaccine and Diagnostics S.r.l|Posting Director||RegistryContactVaccineUS@novartis.com|
22424989|NCT02526160|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
22424990|NCT04227405|University of Maryland|Dr. Mariana Falconier, Associate Professor|301-405-4004|marianak@umd.edu|
22424991|NCT03536663|Fresenius Medical Care North America|Senior Director of Statistics and Data Management|781-699-4203|ChiangHong.Ho@fmc-na.com|
22424992|NCT01775787|UConn Health|Dr. Cheryl Oncken|860-679-3425|oncken@uchc.edu|
22424993|NCT01502956|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
22424994|NCT01616758|Oncternal Therapeutics|Mary Bretimeyer|8582092082|mbreitmeyer@oncternal.com|208
22424995|NCT03231397|Washington University School of Medicine|Dr. Sean J. English|(314) 362-5707|sjenglish@wustl.edu|
22424996|NCT04076319|USC Suzanne Dworak-Peck School of Social Work|Dr. Benjamin Henwood|+1 (213) 821-0496|bhenwood@usc.edu|
22424997|NCT01054222|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22424998|NCT02135016|First Hospital of CMU|Dr. Jun Wang|8602483283100|wjun2000@hotmail.com|
22424999|NCT03252145|University of California, San Francisco|Betty Smoot, DPTSc, PT|(707) 494-8262|Betty.Smoot@ucsf.edu|
22425000|NCT01466075|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
22394831|NCT02335125|University of Washington Harborview Medical Center|Douglas Zatzick, MD|(206) 744-6701|dzatzick@uw.edu|
22425001|NCT01662856|Grifols Therapeutics Inc|Henry Li, PhD|+1 919 316 6042|henry.li@grifols.com|
22425002|NCT01763827|Amgen Inc.|Study Director|866-572-6436||
22425003|NCT00168428|Allergan, Inc.|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com|
22425004|NCT00667563|AMC|Jeannette Y. Lee|5015266712|jylee@uams.edu|
22425005|NCT01041274|NYU Langone Medical Center|Principal Investigator|646-754-4843|donald.goff@nyumc.org|
22425006|NCT03130959|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22425007|NCT02028780|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22425008|NCT00777335|University of California Los Angeles (UCLA) / Cancer International Research Group (CIRG) (Translational Research in Oncology TRIO) Inc.|Dr. Richard Finn|+ 1 310 586 2091|RFinn@mednet.ucla.edu|
22425009|NCT02384538|AbbVie|Global Medical Services|800-633-9110||
22425010|NCT02872909|University of Dundee|Professor Sally Ibbotson|01382 383499|s.h.ibbotson@dundee.ac.uk|
22425011|NCT04446429|Applied Biology|Director of Clinical Trials|+1-949-387-4526|monican@appliedbiology.com|
22425012|NCT05205005|Harry S. Truman Memorial Veterans' Hospital|Harry S. Truman Memorial Veterans' Hospital Research Service|573- 814-6000|Camila.Manrique-Acevedo@va.gov|56550
22425013|NCT02187029|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22425014|NCT03042910|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22425015|NCT02985021|VA Puget Sound HCS|Dr. Bruce Montgomery, PI|2062776878|rbmontgo@uw.edu|
22425016|NCT02187861|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22425017|NCT03083808|Hoosier Cancer Research Network|Fauzia Sharmin|(317) 634-5842|fsharmin@hoosiercancer.org|75
22425018|NCT01491841|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu|
22425019|NCT01301079|Federal University of Sao Paulo|Plínio da Cunha Leal|55-98-8852-2021|pliniocunhaleal@hotmail.com|
22425020|NCT04105842|Centre for Ocular Research and Education|Jill Woods|5198884567|jwoods@uwaterloo.ca|36743
22425021|NCT00313586|ECOG Statistical Office|Study Statistician|617-632-3012||
22425022|NCT00264290|University of California, San Francisco|Peter W. Hunt, M.D.|415-476-4082|phunt@php.ucsf.edu|345
22425023|NCT04472494|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22425024|NCT00707980|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22425025|NCT01537835|Denver Health and Hospital Authority|Marisha Burden, MD|303-602-5011|Marisha.Burden@dhha.org|
22425026|NCT01909973|Northwestern University|David C. Mohr, PhD|312-503-1403|d-mohr@northwestern.edu|
22425027|NCT01152996|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22425028|NCT02163681|University of Missouri|Talissa Altes, MD|573-882-1026|altest@health.missouri.edu|
22425029|NCT02455453|Washington University School of Medicine|Farrokh Dehdashti, M.D.|314-747-1604|dehdashtif@wustl.edu|
22425030|NCT02094326|Hospital Virgen de la Macarena|Dr. Federico Navarro Sarabia|+34 955 00 80 00|federico.navarro.sarabia@gmail.com|
22425031|NCT01535443|Laboratorios Sophia, SA de CV|Baiza-Duran Leopoldo, Medial Director|+52 (33)30014200|lbaiza@sophia.com.mx|
22425032|NCT00893074|Johns Hopkins University|Ryan Vandrey, PhD|410-550-4036|rvandrey@jhmi.edu|
22425033|NCT00760487|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22425034|NCT02260817|Decatur Memorial Hospital, Decatur, IL|Thomas H. Tarter, M.D., Ph.D - Director, Urologic Oncology, Cancer Care Specialists of Illinois|(217) 876-6600|ttarter@ccsci.net|
22425035|NCT03299101|Pittsburgh VA Healthcare System, CHERP|Dr. Daniel E Hall|4123602016|daniel.hall2@va.gov|
22425036|NCT06363292|Laboratorios Sophia|Alejandra Sanchez Rios|+ 52 33 3001 4200|alejandra.sanchez@sophia.com.mx|1190
22425037|NCT05391555|University of California San Francisco|Rachel Eshima McKay|415-476-9035|rachel.eshima@ucsf.edu|
22425038|NCT03585712|HRA Pharma|Agnes Hemon|0140337092|a.hemon@hra-pharma.com|
22425039|NCT03319810|Sutter Institute for Medical Research|Carol Parise, PhD, Research Scientist|(916) 887-4744|PariseC@sutterhealth.org|
22425040|NCT00621517|East Tennessee State University|Max Bayard MD|802-524-8805|mmbayard3@gmail.com|
22425041|NCT02071082|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22425042|NCT02101359|Laboratoires Thea|Medical director|33-4-73-98-14-36|p.pouliquen@laboratoires-thea.fr|
22425043|NCT00494221|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22425044|NCT01900431|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22425045|NCT03040427|Cleveland Clinic Foundation|Dr. Wael A. Jaber|216.444.8305|jaberw@ccf.org|
22425046|NCT01841567|Klinik und Poliklinik für Orthopädie und Unfallchirurgie der Uniklinik Köln|Dr Kourosh Zarghooni|+49 2247887294|kourosh.zarghooni@uk-koeln.de|
22425047|NCT03172364|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22425048|NCT00630747|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22425049|NCT02732327|Allergan|David Melnick, MD|201-427-8554|Melnick_David@Allergan.com|
22425050|NCT03858894|Santen Inc|R&D Quality Manager|415 268 9199|evelyn.chikere@santen.com|
22425051|NCT00603382|GlaxoSmithKline|GSK Response Center|866-435-7343||
22425052|NCT00583102|University of Iowa|Raymond Hohl, MD|319-356-8110|rhohl@pennstatehealth.psu.edu|
22425053|NCT01078298|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22425054|NCT02379273|Cochlear Americas|Aaron J Parkinson, PhD, Principal Clinical Project Manager|3035242563|aparkinson@cochlear.com|
22425055|NCT02432144|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
22425056|NCT01051440|Steward St. Elizabeth's Medical Center|Tara Lauriat|617-789-2404|tara.lauriat@steward.org|
22425057|NCT00958412|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22425058|NCT02552888|Tulane School of Medicine|Dr. Jing Chen|5049886110|jchen@tulane.edu|
22425059|NCT01833936|Orthopedic Foot and Ankle Center|Dr. Christopher Hyer|6148958747|ofacresearch@orthofootankle.com|
22425060|NCT02371668|National Institute of Allergy and Infectious Diseases|Memoli, Matthew|+1 301 443 5971|mm982v@nih.gov|
22425061|NCT00398216|Daiichi Sankyo, Inc.|William Maxwell, Assoc. Director|732-590-5000|wmaxwell@dsi.com|
22394832|NCT00710996|Alcon Research, Ltd.|Rick Potvin|817-551-4815|Rick.Potvin@alconlabs.com|
22394833|NCT03021954|Dr Cipto Mangunkusumo Hospital|dr. Fernandi Moegni|+62-82298111778|fernandi71@ui.ac.id|
22394834|NCT02917278|Purdue University|Kathleen Hill Gallant|765-494-0101|hillgallant@purdue.edu|
22394835|NCT02196714|Pearl Therapeutics Inc.|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
22394836|NCT00690833|Wake Forest University Health Sciences|Dr Steve feldman|336-716-3775|sfeldman@wakehealth.edu|
22394837|NCT02120716|University of Michigan|Golfo Tzilos, PhD|7349987120|gtzilos@med.umich.edu|
22394838|NCT04079803|Cassava Sciences, Inc.|Nadav Friedmann, PhD, MD, Chief Medical Officer|512-501-1900|nfriedmann@cassavasciences.com|
22394839|NCT00759330|Teikoku Pharma USA, Inc.|Director of Clinical Trials|408-501-1821||
22394840|NCT00807235|Discovery Laboratories, Inc.|Robert Segal, MD|215-488-9300|rsegal@discoverylabs.com|
22394841|NCT01210079|School of Nursing, University of California, Los Angeles|Margaret (Peggy) Compton, RN PhD|(310) 206-2825|pcompton@sonnet.ucla.edu|
22394842|NCT04677179|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
22394843|NCT01536015|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22394844|NCT03261700|National Center for PTSD, located at the VA Boston Healthcare System|Dr. Katherine Iverson, PI|857-364-2066|katherine.iverson@va.gov|
22394845|NCT01204398|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22394846|NCT01723254|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22394847|NCT01257425|Ipsen|Director, Uro-oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22394848|NCT01822301|University of Pittsburgh|J. Peter Rubin|412-624-9703|rubipj@upmc.edu|
22394849|NCT04262817|Yale School of Medicine|Asti Jackson, Ph.D.|475-241-4904|asti.jackson@yale.edu|
22394850|NCT04947527|Advantage Silver Dental Arrest, LLC|Dr. Peter Milgrom|2062516831|drmilgrom@silverarrest.com|
22394851|NCT02656823|DENTSPLY IH AB,|Ulrika Bonander|31 376 30 68|ulrika.bonander@dentsplysirona.com|+46
22394852|NCT06609135|UMASS Chan Medical School|Dr. Lawrence Rhein, Chair of Pediatrics at UMASS Chan Medical School|5083346581|lawrence.rhein@umassmemorial.org|
22394853|NCT06729593|University of Minnesota|Shweta Sharma Mistry|612-626-9021|shwetas@ccbr.umn.edu|
22394854|NCT05199571|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22394855|NCT02892344|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22394856|NCT03938454|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
22394857|NCT05888103|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22394858|NCT00955487|University of Colorado School of Medicine/Children's Hospital Colorado|Dr. John Kinsella|(303) 724-2853|john.kinsella@ucdenver.edu|
22394859|NCT01028222|Study Director|Novartis|862-778-8300||
22394860|NCT00146328|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22425062|NCT01048944|Southern Illinois University Carbondale|David G. Gilbert, Ph.D.|618-45303558|dgilbert@siu.edu|
22425063|NCT01962948|Fox Chase Cancer Center|Protocol Development Coordinator|215-728-4097|ryan.romasko@fccc.edu|
22425064|NCT00376532|Thomas Jefferson University|David J. Whellan MD|215 955 2636|david.whellan@jefferson.edu|
22425065|NCT01133704|Dendreon Corporation|Kathleen Picha|206-265-4545|kpicha@dendreon.com|
22425066|NCT02207400|GlaxoSmithKline|GSK Response Center|866-435-7343||
22425067|NCT02849704|Children's Hospital of Philadelphia|Virginia Stallings, MD|267.425.1633|stallingsv@email.chop.edu|
22425068|NCT02957357|The University of North Carolina at Chapel Hill|Dr. Ronald Chen|984-974-0400|ronald_chen@med.unc.edu|
22425069|NCT04096001|Stanford Prevention Research Center, School of Medicine, Stanford University|Judith J Prochaska, PhD|650-724-3608|jpro@stanford.edu|
22425070|NCT03519919|CooperVision.Inc|Jose A. Vega, O.D., MSc., FAAO|9256213761|javega@coopervision.com|
22425071|NCT03076996|FHI 360|Dr. Lisa Dulli|919-544-7040|ldulli@fhi360.org|11396
22425072|NCT01027468|Medical University of Vienna|Assoc.Prof.PD.Dr.Stefan Sacu|+43404001|stefan.sacu@meduniwien.ac.at|7937
22425073|NCT00988000|Imperial College|Professor Martyn Partridge|+44 (0)20 7594 7959|m.partridge@imperial.ac.uk|
22425074|NCT00587795|Mayo Clinic|Dr. David Dennison|507-284-7405|Dennison.David@mayo.edu|
22425075|NCT02144077|Biofrontera Bioscience GmbH|Clinical Trial Department|+49 214 876 32 66|ameluz@biofrontera.com|
22425076|NCT01869777|Wake Forest University Health Sciences|Principal investigator|336-716-5440|tpardee@wakehealth.edu|
22425077|NCT01951573|Alcon Research, Ltd.|Mary Fahmy, Head, Clinical Development, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22425078|NCT04399889|Duke University|Emily Poehlein, MB|919-668-8473|emily.poehlein@duke.edu|
22425079|NCT00943592|University of Chicago|Dr. Andrew Artz|773-834-8980|aartz@medicine.bsd.uchicago.edu|
22425080|NCT00460239|Johns Hopkins University School of Medicine|Eric C. Strain, M.D.|410-550-1191|ecsgss@aol.com|
22425081|NCT00368459|Stanford University|Victor Henderson|650-723-5456|vhenderson@stanford.edu|
22434744|NCT05898672|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22434745|NCT03832322|Evergreen General Hospital, Taiwan|Dr. Chi-Liang Cheng|0919768058|chiliang.cheng@gmail.com|
22434746|NCT04463693|University of Colorado Anschutz Medical Campus|Aaron Lazorwitz|3037242019|aaron.lazorwitz@cuanschutz.edu|
22434747|NCT01778049|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22434748|NCT02186652|Duke Clinical Research Institute|Chad Livingston|919-668-1935|chad.livingston@duke.edu|
22434749|NCT01218958|Alkermes, Inc.|Bernard L. Silverman, VP, Clinical Development|781-609-6000|bernard.silverman@alkermes.com|
22434750|NCT00503776|Vanderbilt-Ingram Cancer Center|Barbara Murphy, MD|615-343-9444|barbara.murphy@vanderbilt.edu|
22434751|NCT00107315|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22434752|NCT01849575|Umea University, Sweden|Dr Margareta Norberg|+46907865544|margareta.norberg@umu.se|
22394861|NCT01717989|Amgen Inc.|Study Director|866-572-6436||
22394862|NCT03224325|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|+1
22394863|NCT01213589|Medtronic|Richard Jonkers, PhD|800-217-1617|richard.jonkers@medtronic.com|3727
22394864|NCT02072434|Daiichi Sankyo, Inc.|Daiichi Sankyo US Contact for Clinical Trial Results|1-908-992-6400|CTRinfo@dsi.com|
22394865|NCT03599557|University of California, Los Angeles|Principal Investigator|(310) 206-6328|pszilagyi@mednet.ucla.edu|
22394866|NCT01117454|Vanderbilt University Medical Center|Dr. Prince J. Kannankeril, MD, MSCI|615 322-7447|prince.kannankeril@vanderbilt.edu|
22394867|NCT00389857|Sanofi Pasteur Inc|Medical Director||RegistryContactUs@sanofipasteur.com|
22394868|NCT00888433|Baker IDI Heart and Diabetes Institute|Murray Esler, Principal Investigator||murray.esler@bakeridi.edu.au|
22394869|NCT04452877|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
22394870|NCT02276872|United Therapeutics|Derek Solum, PhD|919-425-8122|dsolum@unither.com|
22394871|NCT04175808|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22394872|NCT03312348|Sheffield Children's NHS Trust|Dr Shammi Ramlakhan - Chief Investigator|+44 1142262331|shammi.ramlakhan@sch.nhs.uk|
22394873|NCT02544217|Khondrion B.V.|Edwin Spaans, PharmD.|+31654997700|spaans@khondrion.com|
22394874|NCT03278106|Mayo Clinic|Amit Mahipal MBBS|+1 (507) 293-0487|Mahipal.amit@mayo.edu|
22394875|NCT05057923|DreamTec Research Limited|Keith Kwong|+85237052355|keithkwong@dreamtec.hk|
22394876|NCT00676065|Center for Epidemiology and Health Research Germany|Juergen Dinger, MD, PhD|+49 30 945 101 20|dinger@zeg-berlin.de|
22394877|NCT03952806|Biohaven Pharmaceuticals, Inc|Chief Medical Officer|+1 203-404-0410|clinicaltrials@biohavenpharma.com|
22394878|NCT00068588|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22394879|NCT03867175|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|3367130031|mfarris@wakehealth.edu|
22394880|NCT04823221|Boao Yiling Life Care Center|Dr. Ming Liu|139 1103 6970|liuming9876@yeah.net|+86
22394881|NCT02027701|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22394882|NCT02875977|Loyola University Medical Center|Cynthia Brincat, M.D., Ph.D.|708-216-2180|cbrincat@lumc.edu|
22394883|NCT00820027|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22425082|NCT02620683|University of North Carolina Chapel Hill|Dr Raymond P. White Jr|919-537-3944|ray_white@unc.edu|
22425083|NCT04957212|Cinnagen Co.|Dr.Nasim Anjidani|0989125477964|anjidani.n@orchidpharmed.com|
22425084|NCT02813473|ECRI|Ron van Amsterdam|+31102062802|RvAmsterdam@cardialysis.nl|
22425085|NCT02438280|University of Washington|Dr. Greg Huang, Professor and Chair of Orthodontics|(206) 616-6996|ghuang@uw.edu|
22425086|NCT04217317|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-713-5878|dfunes@wakehealth.edu|
22425087|NCT02087943|CelgeneCorp|Anne McClain, Senior Manager, Clinical Trial Disclosure|1-888-260-1599|amcclain@celgene.com|
22425088|NCT01690299|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|clinicaltrialdisclosure@celgene.com|
22425089|NCT01263717|Massachusetts General Hospital|Steven K. Grinspoon, MD|617-724-9109|sgrinspoon@partners.org|
22425090|NCT05753735|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Nikola Anusic, Protocol Study Coordinator|216-421-5986|a.nikolau@icloud.com|
22425091|NCT01882803|Secura Bio, Inc.|Beth Gregory, PharmD, MBA|1-702-254-0011|bgregory@securabio.com|
22425092|NCT02869893|Cincinnati Children's Hospital Medical Center|Dr. Andrew Trout|513-803-3004|andrew.trout@cchmc.org|
22425093|NCT01563913|VA Portland Health Care System|Kathryn Chung, MD|5037211091|Kathryn.Chung@va.gov|
22425094|NCT03066778|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22425095|NCT00551525|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22425096|NCT00519584|Cleveland Clinic|K. C. Cummings III, MD|216-444-1016|cummink2@ccf.org|
22425097|NCT01648920|Aerocrine, Inc.|Nancy Herje, BSN, RN, MBA. Director, Clinical Development and Medical Affairs|919-449-8873|nancy.herje@aerocrine.com|
22425098|NCT05259917|KalVista Pharmaceuticals Ltd.|Vice President Clinical|1 (857) 999-0075|clinical@kalvista.com|
22425099|NCT00303472|Amgen Inc.|Study Director|866-572-6436||
22425100|NCT00596102|Valneva Austria GmbH|Katrin Dubischar-Kastner|+43 1 20620|info@valneva.com|0
22425101|NCT00004500|Discovery Laboratories, Inc.|Dr. Robert Segal|215-488-9300|rsegal@discoverylabs.com|
22425102|NCT01963091|MUSC|Dr. Moran-Santa Maria|843-792-8187|moranm@musc.edu|
22425103|NCT03517449|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22425104|NCT01090141|Unknown|Tawanda Gumbo||Unknown@utsouthwestern.edu|
22425105|NCT01808222|Emory University|David Schuster MD|404-712-4859|dschust@emory.edu|
22425106|NCT00795769|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
22425107|NCT02912455|Cleveland Clinic|Dr. Sangeeta Kashyap|(216) 445-2679|kashyas@ccf.org|
22425108|NCT00073008|GlaxoSmithKline|GSK Response Center|866-435-7343||
22425109|NCT02036541|Allergan plc|Rupali Nangia|714-246-6020|rupali.nangia@allergan.com|
22425110|NCT01836185|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22425111|NCT02356107|University of Utah|Brent Kious, MD, PhD|(801) 581-4888|Brent.Kious@hsc.utah.edu|
22425112|NCT00523809|UT MD Anderson Cancer Center|Naoto Ueno, MD / Professor||CR_Study_Registration@mdanderson.org|
22425113|NCT00808470|University of Texas at Dallas|Dr. Colleen Le Prell|214-905-3018|colleen.leprell@utdallas.edu|
22425114|NCT01778751|Durham Veterans Affairs Medical Center|Dr Matthew J Crowley|919-286-6936|matthew.crowley@va.gov|
22425115|NCT03337048|Coloplast A/S|Vice President, Medical Affairs|+45 49111111|clinical-studies@coloplast.com|
22425116|NCT02669667|MedImmune|Rene van der Merwe|+44 (0)1223 898263|information.center@astrazeneca.com|
22425117|NCT01819844|Massachusetts General Hospital|Steven J. Russell|617-726-8722|sjrussell@partners.org|
22425118|NCT03557476|The University of Nebraska at Omaha|Dr. Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
22425119|NCT01945294|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22425120|NCT00636961|Novartis Pharmaceuticals|Study Director|862-778-8300||
22425121|NCT02721017|University of California San Francisco Department of Surgery|Dr. Benjamin Padilla|415-476-3642|Benjamin.Padilla@ucsf.edu|
22425122|NCT00868751|Tufts Medical Center|Research Administration||mcoughlin@tuftsmedicalcenter.org|
22425123|NCT01428115|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22425124|NCT02774005|Santhera Pharmaceuticals (Switzerland) Ltd|Head of Regulatory Affairs EU|+41 6190689|julien.gaudias@santhera.com|50
22425125|NCT01790516|Inova Health Care System|Dr John Deeken, PI|703 776 8161|john.deeken@inova.org|
22425126|NCT01402986|MedImmune, LLC|Meena Jain, MB BChir, Director, Clinical Development,|301-398-0000|JainM@medimmune.com|
22425127|NCT01085084|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22425128|NCT02749799|Dr. Reddys Laboratories Inc|Dr. Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
22425129|NCT03749109|Ferring Pharmaceuticals|Global Clinical Compliance|-|DK0-Disclosure@ferring.com|
22425130|NCT02070978|Merck KGaA Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22425131|NCT03178851|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22425132|NCT03951753|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22425133|NCT04633291|Coloplast A/S|Vice President, Medical Affairs|+4549111111|clinical-studies@coloplast.com|
22425134|NCT01905592|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22425135|NCT02669043|Massachusetts General Hospital|Dr.Cristina Cusin|617-726-6421|ccusin@partners.org|
22425136|NCT03884270|Loyola University Chicago|Dr. Sarah Kinsinger|708-216-0464|sarah.kinsinger@lumc.edu|
22425137|NCT01483599|Janssen Research & Development, LLC|Senior Director, Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
22425138|NCT02109445|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22425139|NCT00727090|Northwestern University|Andrew M Naidech|312-503-3592|a-naidech@northwestern.edu|
22425140|NCT01037816|Hisamitsu Pharmaceutical Co., Inc.|Yoshinobu Higashi, Section Manager, International Regulatory Affairs|+81-3-5293-1712|Yoshinobu_Higashi@hisamitsu.co.jp|
22425141|NCT00966355|Korea University College of Medicine|Prof. Soon Ho Um|+82-2-920-5019|umsh@korea.ac.kr|
22425142|NCT00401193|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22425143|NCT01844817|Sarah Cannon Development Innovations|Charles Davis, RAC||Charles.Davis2@scri-innovations.com|
22425144|NCT04508647|University of Colorado Hospital|Manali Kamdar, MD|720-848-6400|manali.kamdar@cuanschutz.edu|
22425145|NCT02447328|AstraZeneca Korea|Karin Otter, MD, PhD|+82 2 2188 0968|Karin.Otter@astrazeneca.com|
22425146|NCT00707967|GlaxoSmithKline|GSK Response Center|866-435-7343||
22425147|NCT00596453|Johns Hopkins Medical Institutions|Misop Han, M.D.|410-502-7454|mhan1@jhmi.edu|
22425148|NCT02771860|University Gent|Prof. dr. Ruth Wittoek|+3293322522|anuschka.vandenbogaert@uzgent.be|
22425149|NCT00314808|Duke University|Deborah H. Allen, MSN, RN, CNS, FNP-BC, AOCNP|(919) 681-4719|allen079@mc.duke.edu|
22425150|NCT04304508|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22425151|NCT00699400|EMD Serono, Inc.|Mary C. Mahony, PhD, HCLD (AAB)|781.681.2438|mary.mahony@emdserono.com|
22425152|NCT02113007|Sarah Cannon Development Innovations|Charles H. Davis, RAC|615-524-4341|charles.davis2@scri-innovations.com|
22425153|NCT00885378|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22425154|NCT02579382|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22425155|NCT03091738|Virginia Commonwealth University|Jasmohan Bajaj, MD|804-828-4060|jasmohan.bajaj@vcuhealth.org|
22425156|NCT01826981|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22425157|NCT01393522|Mercy Health Research|Timothy R. Smith, MD|314-251-8895|Timothy.Smith@mercy.net|
22425158|NCT02213380|The second affiliated hospital and Yuying children's hospital of Wenzhou medical university|Ting Li|008613587876896|liting1021@aliyun.com|
22425159|NCT03746405|Duke University|Dr Lysianne Beynel|919-681-1157|lysianne.beynel@duke.edu|
22425160|NCT03479008|Unversity of Michigan|Dr. Benjamin Bassin|734 763-2134|bsbassin@med.umich.edu|
22425161|NCT00412932|Daiichi Sankyo|John Raia|973-630-2683|jraia@dsus.com|
22425162|NCT02753816|Spectrum Health|Dr. Betsy Steensma|(616) 391-5701|elizabeth.steensma@spectrumhealth.org|
22425163|NCT01473940|Northwestern University|Mary Mulcahy, MD|312-695-0990|Mary.Mulcahy@nm.org|
22425164|NCT03132415|University of Pennsylvania|Jose Bauermeiser|215-898-9993|bjose@upenn.edu|
22425165|NCT02630563|Roche Trial Information Hotline|F. Hoffmann-La Roche AG|+41 61 6878333|global.trial_information@roche.com|
22425166|NCT00929994|Toronto Rehab|Dr.|4169781739|dina.brooks@utoronto.ca|
22425167|NCT03258645|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22425168|NCT02061813|Dr. Reddy's Laboratories Inc.|Dr Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
22425169|NCT01705080|Abbott|Steven Madej|651-756-2230|smadej@sjm.com|
22425170|NCT00581061|University of California, Irvine|Doug Skarecky|714-456-6744|dwskarec@uci.edu|
22425171|NCT01704755|AbbVie (prior sponsor, Abbott)|Global Medical Information|800 633-9110||
22425172|NCT01400906|GlaxoSmithKline|GSK Response Center|866-435-7343||
22425173|NCT02256917|Octapharma|Sylvia Werner|415 260-9577|sylvia.werner@octapharma.com|
22425174|NCT02933528|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
22425175|NCT02982863|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22425176|NCT01753115|Emergent BioSolutions|Robert Hopkins, MD, MPH & TM, FACP, FIDSA, Medical Monitor|301-944-0136|HopkinsR@ebsi.com|
22425177|NCT03642067|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dung Le, MD|443-287-0002|dle@jhmi.edu|
22394884|NCT02604433|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22394885|NCT03285178|Cyclerion Therapeutics, Inc.|Senior Medical Director|1-857-327-8778|info@cyclerion.com|
22394886|NCT01128894|GlaxoSmithKline|GSK Response Center|866-435-7343||
22394887|NCT01128738|GlaxoSmithKline|GSK Response Center|866-435-7343||
22394888|NCT00973362|Hologic, Inc.|Vice President Clinical Affairs|858-410-8000|rainer.ziermann@hologic.com|
22394889|NCT01917513|Helios Dr. Horst Schmidt Kliniken, Wiesbaden, Germany|Prof. Ralf Kiesslich||ralf.kiesslich@hsk-wiesbaden.de|
22394890|NCT00887679|Duke University Medical Center|Dr. Ashwin A Patkar Associate Professor|919-668-3626|ashwin.patkar@duke.edu|
22394891|NCT02683941|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22394892|NCT00146757|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22394893|NCT03554954|National University of Singapore|Dr. Kim Jung Eun|65161136|fstkje@nus.edu.sg|+65
22394894|NCT00256451|University of Pennsylvania|David Oslin, MD|2158235894|oslin@upenn.edu|
22394895|NCT01971203|Icahn School of Medicine at Mount Sinai|Cindy J. Aaronson, MSW, PhD|212-241-3169|cindy.aaronson@mssm.edu|
22394896|NCT03037619|University of South Carolina|Christine Pellegrini|803-777-0911|cpellegrini@sc.edu|
22394897|NCT00307125|DAIT/NIAID|Director, Clinical Research Operations Program (CROP)|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22394898|NCT02571049|Dr. Reddy's|Director of Clinical Development|609-375-9900|cfritz@drreddys.com|
22394899|NCT03552822|University of Alabama at Birmingham|Dr. Mark Powell|2059346007|mfpowell@uabmc.edu|
22394900|NCT01055262|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com|
22394901|NCT00865969|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
22394902|NCT00561951|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22394903|NCT01596621|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22394904|NCT00421707|GlaxoSmithKline|GSK Response Center|866-435-7343||
22394905|NCT01201265|Hoffmann-La Roche|Medical Communications|800-821-8590||
22394906|NCT01992393|Case Western Reserve University|Joy Yala, Data & Regulatory Coordinator II|216-368-0783|jxy790@case.edu|
22394907|NCT01898923|Oneness Biotech Co., Ltd.|Henry Chang, Associate Director of Clinical Research|+886 2 2703 1098|henry.chang@onenessbio.com.tw|366
22394908|NCT00723021|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22394909|NCT00282282|Dana-Farber Cancer Institute|Vincent T. Ho, MD Associate Professor of Medicine, Harvard Medical School|(617) 632-5938|vincent_ho@dfci.harvard.edu|
22394910|NCT02737917|Lincoln Medical Center|Dr. Nicholas Caputo|718-579-6010|ncaputo.md@gmail.com|
22394911|NCT02739412|Beth Israel Deaconess Medical Center|Michael Curry MD|617-632-9852|mcurry@bidmc.harvard.edu|
22394912|NCT02975700|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22425178|NCT04313400|Amarex Clinical Research, LLC|Dr. Ahmad Bayat, Sr Director II, Regulatory Affairs|301-956-2523|ahmadb@amarexcro.com|
22394913|NCT02441686|Dana-Farber Cancer Institute|Emily Benjamin|6176324167|emily_benjamin@dfci.harvard.edu|
22394914|NCT05497284|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22394915|NCT02264613|Consultant|Allen Annis|617-921-9467|aannis@aileronrx.com|
22394916|NCT02254278|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@gmail.com|
22394917|NCT02903368|Dana-Farber Cancer Institute|Mary-Ellen Taplin, MD|617-582-7221|mtaplin@partners.org|
22394918|NCT05437510|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22394919|NCT02788903|Penn State College of Medicine|Jennifer Kraschnewski|717-531-8161|jkraschnewski@pennstatehealth.psu.edu|
22394920|NCT00147823|SUNY Upstate Medical University|Timothy A. Damron, MD|315-464-8604|damront@upstate.edu|
22394921|NCT04441905|Pharmaceutical Product Development (PPD), part of Thermo Fisher Scientific|Kristie Miller, MD|512-747-1504|kristie.miller@ppd.com|
22394922|NCT03922802|Shirley Ryan AbilityLab|Kelly Mckenzie, Research Physical Therapist|31223872111|kmckenzie@sralab.org|
22394923|NCT04486716|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22394924|NCT04987307|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22425179|NCT02091414|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22425180|NCT00657657|GlaxoSmithKline|GSK Response Center|866-435-7343||
22394925|NCT03650400|Novartis Pharmaceuticals|Study Director|882 778 8300|Novartis.email@Novartis.com|
22425181|NCT01515696|Medical University of Vienna|Nadja Haiden M.D.|+431404003232|nadja.haiden@meduniwien.ac.at|
22425182|NCT02521792|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22425183|NCT01188668|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22425184|NCT00902746|Nobelpharma|Department director of clinical development department 1|+81-3-5651-1177|murakami@nobelpharma.co.jp|
22425185|NCT02081001|Xeris Pharmaceuticals, Inc.|Martin J. Cummins, VP for Drug Development|512-498-2675|mcummins@xerispharma.com|
22425186|NCT00123682|VA New York Harbor Healthcare System|Dr. Scott Sherman, PI|212-686-7500|scott.sherman@va.gov|7386
22425187|NCT02937636|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22425188|NCT00359294|PharmaMar USA Inc|Responsible medical officer|1 212 201 6770|ccoronado@pharmamar.com|
22425189|NCT04208412|KalVista Pharmaceuticals Ltd.|Vice President Clinical|1 (857) 999-0075|clinical@kalvista.com|
22425190|NCT02946021|Tactile Medical|Jill Christensen|(612) 355-5123|jchristensen@tactilemedical.com|
22425191|NCT02588092|ADC Therapeutics|ADC Therapeutics|954-903-7994|clinical.trials@adctherapeutics.com|
22425192|NCT01348100|Novartis Pharmaceuticals|Study Director|862 778-8300||
22425193|NCT03882957|Geisel School of Medicine (Dartmouth College)|Diane Gilbert-Diamond|603-646-5403|diane.gilbert-diamond@dartmouth.edu|
22394926|NCT06390085|University of Virginia, Systems and Information Engineering|Gregory Gerling|4349240533|gg7h@virginia.edu|
22394927|NCT00792805|Novartis Pharmaceuticals|Study Director|862 778-8300||
22394928|NCT05541861|BioNTech SE|BioNTech clinical trials patient information|061319084|patients@biontech.de|+49
22394929|NCT05678959|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22394930|NCT02065336|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
22425194|NCT03658642|Yale School of Medicine|Ted Melnick, MD, MHS Associate Professor of Emergency Medicine and of Biostatistics (Health Informat|(203) 785-5174|edward.melnick@yale.edu|
22425195|NCT03290391|Boston Medical Center and BU Chobanian & Avedisian School of Medicine|Jeffrey Samet, MD MA MPH|(617) 414-7288|jsamet@bu.edu|
22425196|NCT03762681|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22425197|NCT03148067|University of Sao Paulo|Physician|551126616900|priscila.rosalba@hc.fm.usp.br|
22425198|NCT01396551|Varian Medical Systems|Julie Allen|206-330-2605|julie.allen@varian.com|
22425199|NCT00435188|Durham VA Research and Development|Miriam C. Morey, Ph.D.|919-286-0411|miriam.morey@va.gov|6776
22425200|NCT01915771|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|617-500-5142|alison.long@aegerion.com|
22394931|NCT03226392|Novartis pharmaceutical|Study Director|862-778-8300|Novartis.email@novartis.com|
22425201|NCT03852498|bluebird bio, Inc|Study Medical Director|+1-833-999-6378|clinicaltrials@bluebirdbio.com|
22425202|NCT00334295|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22425203|NCT01420016|HealthPartners Institute|Dr. Patrick O'Connor|952-967-5034|patrick.j.oconnor@healthpartners.com|
22425204|NCT01454414|University of North Carolina at Chapel Hill|Dr. Meagan Vaughn|9196986208|meagan.vaughn@unc.edu|
22425205|NCT03755518|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
22425206|NCT01714609|Yale University|Dr. Garcia-Tsao|(203) 737-6063|guadalupe.garcia-tsao@yale.edu|
22425207|NCT03403621|Mayo Clinic|Dr. Alexander Meves|507-284-3668|Meves.Alexander@mayo.edu|
22425208|NCT02183909|University of California, San Francisco|Janet Myers, PhD, MPH, MA|415-502-1000|janet.myers@ucsf.edu|14626
22434753|NCT00945061|University Hospitals Cleveland Medical Center , Case Comprehensive Cancer Center|Dr. Janice A. Lyons, MD|+1 216-844-2536|Janice.Lyons@uhhospitals.org|
22434754|NCT02509039|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22425209|NCT00395642|BIOTRONIK, Inc.|Katerina de Metz (Director, Clinical Studies)|800-547-0394|katerina.demetz@biotronik.com|
22425210|NCT03489941|Bausch & Lomb|Heleen DeCory|(585) 338-8161|heleen.decory@bausch.com|
22425211|NCT00659776|Oregon Health and Science University|Amy Huddleston|503-494-2910|huddlesa@ohsu.edu|
22425212|NCT00182000|Massachusetts General Hospital|Sabine Wilhelm, PhD|6177246146|swilhelm@partners.org|
22425213|NCT01738191|Medical University of South Carolina|Dr. Vanessa Hinson|843-792-9115|hinsonvk@musc.edu|
22425214|NCT02483572|University of Nebraska Medical Center|Wayne Fisher|4025598863|wfisher@unmc.edu|
22425215|NCT04811664|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|hvtn.covpn.sdmc@hvtn.org|
22425216|NCT02717442|Otonomy, Inc.|Otonomy Medical Information Center|1-844-686-4636|medinfo@otonomy.com|
22425217|NCT00535392|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22425218|NCT00723697|Merck Sharp & Dohme Corp|Vice President of Late Stage Development||ClinicalTrialsDisclosure@merck.com|
22425219|NCT03275389|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22425220|NCT02770846|Folktandvården Skåne AB|Björn Gjelvold|+46709467870|bjorn.gjelvold@gmail.com|
22425221|NCT03402230|University of Arizona|Sherry Chow, PhD|5206263358|schow@azcc.arizona.edu|
22425222|NCT00978341|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22425223|NCT03035916|China-Japan Unit Hospital of Jilin University|Dr. Guoqing Zhao|0435-84995117|zhaogq65@126.com|
22425224|NCT03885999|The Chinese University of Hong Kong, Department of Surgery, Prince of Wales Hospital|Dr. Kaori Futaba|0085264630121|kfutaba@surgery.cuhk.edu.hk|
22425225|NCT01451554|Mayo Clinic|Jon O. Ebbert, MD|507-255-3965|ebbert.jon@mayo.edu|
22425226|NCT02452554|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22425227|NCT00076258|UT Southwestern Medical Center|Madhukar H Trivedi|214-648-0188|madhukar.trivedi@utsouthwestern.edu|
22425228|NCT00570960|University of Virginia|Patrick G. Northup, M.D.|434-924-0000|northup@virginia.edu|
22425229|NCT01142947|Center for Individualized and Genomic Medicine Research, Henry Ford Health System|L. Keoki Williams, MD, MPH|313-874-5454|kwillia5@hfhs.org|
22425230|NCT04378569|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
22425231|NCT01290952|Azienda Ospedaliera Luigi Sacco|Dr. Massimo Lemma|0039 0239042876|lemma.massimo@hsacco.it|
22425232|NCT05346237|University hospital Osijek|Željka Laksar Klarić|+38598666494|zeljka.l.klaric@gmail.com|
22425233|NCT03638466|Supernus Pharmaceuticals|Gianpiera Ceresoli-Borroni Director Clinical Research|3018382521|gceresoliborroni@supernus.com|
22425234|NCT02576977|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22425235|NCT04530838|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22425236|NCT02672176|University of California, Davis|Heather M. Young, Principal Investigator|916-734-4745|hmyoung@ucdavis.edu|
22425237|NCT03117634|Singapore National Eye Center|Gemmy Cheung, Principal Investigator|+65 6322 8335|gemmy.cheung.c.m@singhealth.com.sg|
22425238|NCT02362425|National Institute of Nursing|Katherine Meileur Chief, Neuromuscular Symptoms Unit|301-435-1503|meilleurk@mail.nih.gov|
22425239|NCT03565874|Department of Child and Adolescent Psychiatry, University Hospital of Lausanne|Dr. Sébastien Urben|+41 21 314 7492|sebastien.urben@chuv.ch|
22425240|NCT02155309|Henry Jackson Military Foundation for Naval Medical Research Unit - Dayton|Daniel Geyer, MPH|(937) 938-3922|daniel.geyer.1.ctr@us.af.mil|
22425241|NCT03417752|VA Center of Excellence for Suicide Prevention|Elizabeth Karras, PhD|585-393-7285|elizabeth.karras-pilato@va.gov|
22394932|NCT03056755|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
22394933|NCT00402363|GlaxoSmithKline|GSK Response Center|866-435-7343||
22394934|NCT02090374|Imperial College London|Professor Trevor Hansel|+44 (0)20 3312 5733|t.hansel@imperial.ac.uk|
22394935|NCT00596648|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
22394936|NCT04667949|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22394937|NCT04504630|UT Southwestern Medical Center|Christian LoBue, PhD|2146484658|Christian.LoBue@utsw.edu|
22394938|NCT00568321|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22394939|NCT01859078|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22394940|NCT00937833|Cook Biotech Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@CookBiotech.com|
22394941|NCT04266301|Novartis Pharmaceuticals|Study Director|862-778-3000|novartis.email@novartis.com|
22394942|NCT03215758|Novartis Pharmaceutical|Study Director|862-778-8300|Novartis.email@novartis.com|
22394943|NCT01707225|Virginia Commonwealth University|Rajiv Malhotra, DO|804-828-9071|rajiv.malhotra@vcuhealth.org|
22394944|NCT04091048|Medtronic Cardiovascular|Katie Flor, Clinical Research Manager|262 693 6127|katie.j.flor@medtronic.com|
22394945|NCT02175004|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
22394946|NCT00162032|Lantheus Medical Imaging|Cesare Orlandi, MD, Chief Medical Officer|978-671-8686|Cesare.Orlandi@lantheus.com|
22394947|NCT01137955|Celiac Disease Center at Columbia University|Dr. Peter Green|(212) 305-5590|mtm2111@columbia.edu|
22394948|NCT03210662|M.D. Anderson Cancer Center|Chelsea C. Pinnix, MD|713-563-2300|ccpinnix@mdanderson.org|
22394949|NCT02977988|University of Southern California|David Black|8184260733|davidbla@usc.edu|
22394950|NCT05341115|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22394951|NCT03827109|Abigail Wexner Research Institute at Nationwide Children's Hospital|Kelly Boone|614-722-3749|kelly.boone@nationwidechildrens.org|
22394952|NCT04263909|BWH Anesthesia|Linda S. Aglio, MD MS|6177328480|laglio@bwh.harvard.edu|33328
22394953|NCT05630001|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22394954|NCT05386680|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22394955|NCT03946670|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22394956|NCT03840486|Emory University|Steven Lindsey, MD|913-706-0232|steven.m.lindsey@emory.edu|
22394957|NCT03780725|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22394958|NCT03437278|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22394959|NCT05116046|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22394960|NCT03136328|Montefiore Medical Center|Charito Love, MD|718-406-8462|clove@montefiore.org|
22394961|NCT04328727|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22394962|NCT02019888|NCRAR|M. Patrick Feeney|503-273-5306|Patrick.Feeney@va.gov|
22394963|NCT02311998|The University of Texas MD Anderson Cancer Center|Nitin Jain MD/Associate Professor|713-745-6080|njain@mdanderson.org|
22394964|NCT02604199|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
22394965|NCT02604212|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
22394966|NCT04659863|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22434755|NCT03359785|Neurocrine Biosciences|Neurocrine Medical Information Call Center|877-641-3461|medinfo@neurocrine.com|
22434756|NCT01907321|University of Florida|Dr. Karen Hegland, PI|352 294-8366|kwheeler@ufl.edu|
22434757|NCT01024972|University of Massachusetts Medical School|Dr. Susanne Muehlschlegel|508-421-5500|susanne.muehlschlegel@umassmemorial.org|
22434758|NCT03276026|Jefferson|Dr. Adam Thaler|215-901-0749|thaler.adam@gmail.com|
22434759|NCT03650803|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Holly Marshall|216-844-5330|Holly.Marshall@uhhospitals.org|
22425242|NCT02688764|Vifor Fresenius Medical Care Renal Pharma France|Milica Enoiu / Clinical Research Manager|+41588518264|milica.enoiu@viforpharma.com|
22425243|NCT03026283|Northwell Health|Pamela Noack|212 434 4926|pnoack@northwell.edu|
22425244|NCT02501161|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22425245|NCT00824655|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22425246|NCT04336475|Cukurova University|Dr Nihan Cuzdan, MD, principal investigator|05052706846|nihancuzdan@hotmail.com|
22425247|NCT03304106|Cochlear Limited|Laura Chenier, Clinical Project Manager|422-325-4171|lchenier@cochlear.com|
22425248|NCT01441245|Department of Internal Medicine, University of Siena, Le Scotte hospital, Siena, Italy|Alberto Palazzuoli MD, Cardiology Unit|+39577585363|palazzuoli2@unisi.it|
22425249|NCT03188523|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22425250|NCT04560868|Kaiser Permanente Washington Health Research Institute|Director, Investigative Science|206-287-2737|jennifer.b.mcclure@kp.org|
22425251|NCT01649362|Centre Hospitalier de Luxembourg|Dr Manon Bache|+352 4411 3157|manon.bache@hotmail.com|
22425252|NCT01944644|Weill Cornell Medical College|Marc Dubin, M.D.|(212) 746-5817|mrd9035@med.cornell.edu|
22425253|NCT02906579|Cyclerion Therapeutics, Inc.|Senior Medical Director|1-857-327-8778|info@cyclerion.com|
22425254|NCT02030119|Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh S. Patel|215-898-3367|mpatel@upenn.edu|
22425255|NCT00759655|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22425256|NCT03457818|Columbia University|Dr. Mishaela Rubin|2019528237|mrr6@cumc.columbia.edu|
22394967|NCT01110876|University of Texas (UT) MD Anderson Cancer Center|John de Groot, MD/Associate Professor, NEURO-ONCOLOGY|(713) 745-3072|jdegroot@mdanderson.org|
22394968|NCT01768520|Hanlim Pharm|Clinical Trial Unit|82234896297|yrsong@hanlim.com|2234896297
22394969|NCT00343252|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22394970|NCT01026454|University of Washington|Connie Celum, MD, MPH|206-520-3800|ccelum@uw.edu|
22425257|NCT02179047|taipei city hospital|chen yueh-chung|88627093600|chenyuehchung.tw@yahoo.com.tw|3741
22425258|NCT02096276|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22425259|NCT02090777|Duke Eye Center|Jullia Rosdahl MD PhD|919-684-8850|jullia.rosdahl@duke.edu|
22425260|NCT03063619|M D Anderson Cancer Center|Dr. Banu Arun|(713) 792-2817|barun@mdanderson.org|
22425261|NCT03331263|Medline Industries, Inc.|Senior Regulatory Affairs Specialist|8476433515|aminarcik@medline.com|
22425262|NCT01703169|Huntsman Cancer Institute|Kimberlee Taylor|8012135673|Kimberlee.Taylor@hci.utah.edu|
22425263|NCT00905567|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22425264|NCT04026750|High Point Clinical Trials Center|Melanie Fein, MD|1-336-841-0700|mfein@highpointctc.com|2530
22425265|NCT00112918|Hoffman-LaRoche|Medical Communications|800-821-8590||
22425266|NCT04812184|Indiana University School of Medicine|Nicholas Pettit|18653688599|nrpettit@iu.edu|
22425267|NCT00621257|children's Hospital Boston|Helen Pappa, MD, MPH, Principal Investigator|617-355-6058|helen.pappa@childrens.harvard.edu|
22425268|NCT00184002|USC Norris Comprehensive Cancer Center|Victoria Soto - Project Specialist|(323) 865-0454|Victoria.Soto@med.usc.edu|
22425269|NCT01999985|H. Lee Moffitt Cancer Center and Research Institute|Thoracic CRO, attn: Dr. Ben Creelan|813-745-3050|ben.creelan@moffitt.org; thoraciccro@moffitt.org|
22425270|NCT00828061|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22425271|NCT02075008|Novartis Pharmaceuticals|Study Director|862-778-8300||
22425272|NCT02821416|AstraZeneca|Maria Jison|001-202-577-6213|Maria.Jison@astrazeneca.com|
22425273|NCT05886907|Alcon Research, LLC|Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22425274|NCT01763203|Icahn School of Medicine at Mount Sinai|Dr. Barbara Vickrey; Chair of Neurology|2122415698|barbara.vickrey@mssm.edu|
22425275|NCT02756819|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22425276|NCT02700425|The University of Chicago|Dr. Gaurav A. Upadhyay, MD|773-702-5988|gupadhyay@medicine.bsd.uchicago.edu|
22425277|NCT01639703|Guerbet|Corinne Dubourdieu, PharmD, Head of Clinical Projects and Medical Writing|+33 (0) 1 45 91 50 00|corinne.dubourdieu@guerbet-group.com|
22425278|NCT00479115|Cincinnati Children's Hospital Medical Center|Stella Davies, MBBS, PhD, MRCP|513-636-1371|Stella.Davies@cchmc.org|
22425279|NCT00878800|Topotarget A/S|PRS Administrator Gunilla Emanuelson|+45 39 17 83 92|enquiries@topotarget.com|
22425280|NCT00649792|Acorda Therapeutics, Inc.|Andrew Blight, PhD Chief Scientific Officer|914-347-4300|ablight@acorda.com|4102
22425281|NCT03476642|Penn State MS Hershey College of Medicine-PennState Health|Dr. Sanjib Adhikary|717-531-6140|sadhikary@pennstatehealth.psu.edu|
22425282|NCT02826161|Sumitomo Dainippon Pharma Oncology|Matthew Hitron, MD|617-674-6800|mhitron@bostonbiomedical.com|
22425283|NCT02457195|The Pennsylvania State University College of Medicine|Dr. Piotr Janicki|7175315680|pjanicki@pennstatehealth.psu.edu|
22425284|NCT05347966|UBC|Dr. Haakon Nygaard|604-827-0600|haakon.nygaard@ubc.ca|
22425285|NCT05980013|Zynex Monitoring Solutions|ZMS Clinical|888-386-4185|clinical@zynex.com|
22425286|NCT03739710|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22425287|NCT03124160|FHI 360|David Hubacher|+1-919-321-3459|dhubacher@fhi360.org|
22425288|NCT04892446|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22425289|NCT01461473|Stanford University|Clete A. Kushida, M.D., Ph.D.|650-721-7560|clete@stanford.edu|
22425290|NCT02328937|Johnson & Johnson Vision Care Inc.|Tawnya Wilson - PRINCIPAL RESEARCH OPTOMETRIST|+1 904 443-1834|TWilson@ITS.JNJ.com|
22425291|NCT01784926|Oslo University Hospital|Dr. Olav Kristianslund|+4723015168|olav.kristianslund@medisin.uio.no|
22425292|NCT00551174|Hoffmann-La Roche|Medical Communications|800-821-8590||
22425293|NCT01534416|Icahn School of Medicine at Mount Sinai|Dr. Rachel L. Barr Grzesh|212-241-2995|rachel.barr@mssm.edu|
22425294|NCT00435461|GlaxoSmithKline|GSK Response Center|866-435-7343||
22425295|NCT02681458|Islamic Azad University of Mashhad|Dr. Hassan Yazdanfar|00985136631004|hasanyazdanfar@yahoo.com|
22425296|NCT04676724|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22425297|NCT00287729|InterMune, Inc.|Bill Bradford, MD, PhD|(415) 466-2200|bbradford@intermune.com|
22425298|NCT02782377|University Hospital of South Manchester|Nick Heywood|+447739002473|nheywood@doctors.org.uk|
22425299|NCT00237692|Center for Primary Care, HSRD COIN|Hayden B. Bosworth, PhD|919-286-0411|hayden.bosworth@va.gov|7107
22425300|NCT00685360|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22425301|NCT00803712|Amgen Inc.|Study Director|866-572-6436||
22425302|NCT02823470|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22425303|NCT01563198|Hypnalgesics, LLC d/b/a Comfort Talk|Elvira V. Lang, MD (PI of SBIR grant)|617 734 9087|drevlang@gmail.com|
22425304|NCT01310127|Discover Vision Centers|Melissa Toyos, MD|816-478-1230|mtoyos@discovervision.com|
22425305|NCT01490840|Novartis|Study Director|862-778-8300||
22425306|NCT03639857|University of Central Florida College of Medicine|Dr. David Weinstein|407-266-4900|david.weinstein@ucf.edu|
22425307|NCT01025284|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22425308|NCT01465230|Yale University|Dr. Terri Parker|203-737-5312|terri.parker@yale.edu|
22425309|NCT00389467|Georgetown University|Chelsea S. Kidwell, MD|202-687-7302|ck256@georgetown.edu|
22425310|NCT02362191|University of North Carolina at Chapel Hill|David Rubinow, MD|919-445-0220|drubinow@med.unc.edu|
22425311|NCT01738919|Aarhus University Hospital|Janni Kjaergaard Thillemann|+45 28137303|teamjanni@gmail.com|
22394971|NCT02893930|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22425312|NCT00547248|GlaxoSmithKline|GSK Response Center|866-435-7343||
22425313|NCT00534248|Merck Sharp & Dohme Corp|Vice President of Late Stage Development||ClinicalTrialsDisclosure@merck.com|
22425314|NCT02849171|Memorial Sloan Kettering Cancer Center|Ronald Blasberg, MD|646-888-2211|blasberr@mskcc.org|
22394972|NCT02919657|Medfit Rx|David Michael|9196109893|dmichael@medfitrx.net|
22394973|NCT01592864|GlaxoSmithKline|GSK Response Center|866-435-7343||
22394974|NCT01762722|Duke University Medical Center|Dr David MacLeod|919-812-3201|david.macleod@duke.edu|
22394975|NCT04318951|Medical School Berlin|Prof. Dr. Benjamin Stahl|+49 30 7668 375 708|benjamin.stahl@medicalschool-berlin.de|
22394976|NCT01519466|Abbott Diabetes Care|Snr Director, Clinical Development & Regulatory Affairs|01993 863164|joe.bugler@abbott.com|
22394977|NCT05569759|Kezar Life Sciences, Inc.|Regulatory Affairs|650-822-5600|clinicaltrials@kezarbio.com|
22394978|NCT04150029|Novartis Pharmaceuticals|Study Director|862-778-3000|novartis.email@novartis.com|
22425315|NCT02532257|The University of Texas MD Anderson Cancer Center|Loretta Nastoupil, MD|(713) 792-2860|lnastoupil@mdanderson.org|
22425316|NCT02259400|"AOU G. Martino Universitary Hospital of Messina"|Dr. Vincenzo Salvo|+39 0902212132|salvovincenzo@virgilio.it|
22394979|NCT02577029|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
22394980|NCT04379518|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|igor.puzanov@roswellpark.org|
22394981|NCT05135000|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22394982|NCT04652726|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22425317|NCT00315614|University of Miami|Dr. Rodolfo Alejandro|3052435324|ralejand@med.miami.edu|
22425318|NCT02224612|Medline Industries, Inc.|Ed Drower|847-643-3874|edrower@medline.com|
22425319|NCT03498313|University of Illinois at Chicago|Dr. Tory Eisenlohr-Moul, Assistant Professor of Psychiatry|859-317-0503|temo@uic.edu|
22425320|NCT02372383|UColorado|Dr. Stacey Martiniano|7207776181|stacey.martiniano@childrenscolorado.org|
22425321|NCT03084302|University of Pittsburgh|Bethany Barone Gibbs, Associate Professor, University of Pittsburgh|412-383-4002|bbarone@pitt.edu|
22425322|NCT01255904|Baylor College of Medicine|Jason Reynolds|(210) 704-2680|jmreynol@bcm.edu|
22425323|NCT00305227|University of Washington|Ann Stapleton, MD|206-616-4121|stapl@uw.edu|
22425324|NCT00856791|Onconova Therapeutics, Inc.|Francois E. Wilhelm, MD, PhD|609 281-7086|fwilhelm@onconova.us|
22425325|NCT00694356|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22425326|NCT01247675|Ascendis Pharma A/S|Michael Beckert, MD|(+49) 172-155-2596|mb@ascendispharma.com|
22425327|NCT00741598|Mood and Anxiety Disorders Program, Icahn School of Medicine at Mount Sinai|Dr. Dan V. Iosifescu|212-241-4480|dan.iosifescu@mssm.edu|
22425328|NCT01042392|Novartis Pharmaceuticals|Study Director|862-778-8300||
22425329|NCT03117361|Pharma Mar, S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|+34 918466000|clinicaltrials@pharmamar.com|
22425330|NCT03318003|University of Michigan|Louise O'Brien|734 647-9064|louiseo@med.umich.edu|
22425331|NCT02072941|University of California San Francisco|Dr. Rebecca Sudore|(415) 221-4810|rebecca.sudore@ucsf.edu|23475
22425332|NCT01462305|Philips|Sr. Clinical Development Scientisit|+41 79 460 0622|fatima.sertkuniyoshi@philips.com|
22425333|NCT01247350|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22425334|NCT00169104|Dartmouth-Hitchcock Medical Center / Norris Cotton Cancer Center|Gary N. Schwartz MD|(603) 653-6181|gary.n.schwartz@hitchcock.org|
22425335|NCT01457417|Healthcare Pharmaceuticals, Inc|Cynthia Sirard, MD|617-714-0357|CSirard@hcven.com|
22425336|NCT00715299|VAHSRD and Medical University of South Carolina|Steve Kautz, PhD, Principal Investigator|843-792-3867|kautz@musc.edu|
22425337|NCT02020889|GlaxoSmithKline|GSK Response Center|866-435-7343||
22425338|NCT01540981|UNMC|Joyce Black|(402) 559-6573|jblack@unmc.edu|
22425339|NCT00809094|Stanford University|Dr. Carol Conrad|650-723-8325|cconrad@stanford.edu|
22425340|NCT00232557|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov|
22425341|NCT00235573|University of Florida|Gail Kauwell|352-392-1991|gkauwell@ufl.edu|227
22425342|NCT01753713|Case Comprehensive Cancer Center|Manmeet Ahluwalia, MD|216-844-5060|ahluwam@ccf.org|
22425343|NCT03549598|Mayo Clinic|John P. Bois, M.D.|507-284-3545|Bois.John@mayo.edu|
22425344|NCT02768792|University of North Carolina Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
22425345|NCT04819438|Zambon S.p.A.|Dr. Mathias Knecht, Chief Medical Officer|+41.91.960.4187|mathias.knecht@zambongroup.com|
22425346|NCT02716506|Kanta-Häme Central Hospital|Dr Nina Mattsson|+358407338307|nina.mattsson@fimnet.fi|
22425347|NCT04607135|Duke University|Kathy Nightingale, Ph.D.|919-660-5175|kathy.nightingale@duke.edu|
22434760|NCT00118352|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org|
22434761|NCT00252694|AstraZeneca|Niklas Berglind, GPS Atacand|+46 31 7766310|ClinicalTrialTransparency@astrazeneca.com|
22394983|NCT02738008|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
22394984|NCT05192382|Crinetics Pharmaceuticals, Inc.|Clinical Research Director|(833) 276-4636|medinfo@crinetics.com|
22394985|NCT02673203|Yale University School of Medicine|Renata Belfort De Aguiar, MD, PhD; Assistant Professor of Medicine (Endocrinology)|(877) 925-3637|renata.aguiar@yale.edu|
22434762|NCT03651856|Medical University of SC|Dr. Gonzalo Revuelta|843-792-7262|revuelta@musc.edu|
22434763|NCT00367744|Case Western Reserve University|Dr. Grace McComsey|216 844 3607|mccomsey.grace@clevelandactu.org|
22434764|NCT03664674|Otonomy, Inc.|Otonomy Medical Information Center|1-844-686-4636|medinfo@otonomy.com|
22434765|NCT01101971|Queen's University|Dr. Robert Reid|6135332898|reidr@queensu.ca|32898
22434766|NCT05082428|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22434767|NCT00895752|Cincinnati Childrens Hospital|Craig Erickson MD|5136366265|craig.erickson@cchmc.org|
22434768|NCT02638207|CRMG|Mikaela Raymond|866-337-1868|ctgov@clinicalresearchmgt.com|
22434769|NCT04584346|National Institutes of Health|Dr. Debra Ehrlich|301-443-7888|debra.ehrlich@nih.gov|
22434770|NCT00607269|Friends Research Institute, Inc.|Jesse B. Fletcher, Ph.D., Statistician|323-463-1601|jfletcher@friendsresearch.org|
22434771|NCT00534118|Roswell Park Cancer Institute|Theresa Hahn|716-845-2300|theresa.hahn@roswellpark.org|
22434772|NCT04270682|Mirum Pharmaceuticals|Mirum Clinical Trials|650-667-4085|medinfo@mirumpharma.com|
22434773|NCT00589056|University of Pennsylvania|Ramesh Rengan, M.D., Ph.D.|(215) 662-2428|Rengan@xrt.upenn.edu|
22434774|NCT03894969|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22434775|NCT02979093|University of Iowa|Lane Strathearn|3193849464|lane-strathearn@uiowa.edu|
22434776|NCT02308163|Astellas Pharma Inc.|Clinical Trial Disclosure|+81 3-3244-0512|astellas.resultsdisclosure@astellas.com|
22434777|NCT03478254|Ciudad Real University Hospital. Castilla La Mancha Health Service.|Angela M. Seco Segura RN, Endocrinology and Nutrition Department.|926278000|amsese@live.com|79510
22434778|NCT00443053|GlaxoSmithKline|GSK Response Center|866-435-7343||
22434779|NCT00541866|Sunesis Pharmaceuticals, Inc.|Mike Johnston, Senior Director Regulatory Affairs|(650) 266-3727|mjohnston@sunesis.com|
22394986|NCT04702776|Laboratorios Sophia|Alejandra Sanchez Ríos|+ 52 33 3001 4200|alejandra.sanchez@sophia.com.mx|1190
22394987|NCT02076178|GlaxoSmithKline|GSK Response Center|866-435-7343||
22425348|NCT03465709|Apellis Pharmaceuticals. Inc.|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
22425349|NCT05359952|Fox Chase Cancer Center|Dr. Jennifer Reese, Associate Professor|215-214-3223|Jennifer.Reese@fccc.edu|
22425350|NCT03836209|PrECOG|Li Chen, MS; Statistician|857-284-3670|Li Chen <lic@ds.dfci.harvard.edu>|
22425351|NCT04167189|PhenoSolve|Lynn Feldman|617-879-1670|lynn@phenosolve.com|
22425352|NCT01768559|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22425353|NCT00398047|Wake Forest University Health Sciences|Ralph D'Agostino Jr., Ph.D.|113-716-3483|rdagosti@wfubmc.edu|
22425354|NCT01737879|Amgen Inc.|Study Director|866-572-6436||
22425355|NCT00351936|Massachusetts General Hospital Schizophrenia Research Program|Dr. David Henderson|(617) 912-7800|dchenderson@partners.org|
22425356|NCT04274075|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
22425357|NCT00583011|University of Oklahoma Health Science Center|Andrew Elimian, MD|9142317323|aelimian@aol.com|
22425358|NCT03360214|Columbia University|Sherene Ishtihar|212-342-3681|si2271@cumc.columbia.edu|
22425359|NCT01386944|UCB|UCB Clinical Trial Call Center|++1 877 822 9493||
22425360|NCT01129804|UConn Health|Mark D. Litt, PhD; Principal Investigator|860-679-4680|litt@uchc.edu|
22425361|NCT01608672|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22425362|NCT00531947|Mylan Specialty L.P.|Kim Portland, Ph.D.|908.542.2636|kimberly.portland@mylan.com|
22425363|NCT02383355|Radboudumc|Wouter van der Heijden|0031 24 3616980|wouter.vanderheijden@radboudumc.nl|
22425364|NCT00524680|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22425365|NCT00521885|Lehigh Valley Health Network|Leslie Baga, Director of Research|610 402 1285|Leslie.Baga@lvhn.org|
22425366|NCT01146561|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22425367|NCT01096680|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22425368|NCT02801370|Otonomy|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
22425369|NCT03092791|Takeda|Senior Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
22425370|NCT04485637|University of Southern California|Wandi Bruine de Bruin|4126385875|wandibdb@usc.edu|
22425371|NCT02182830|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22425372|NCT04399538|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22425373|NCT01446250|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
22425374|NCT00586898|Memorial Sloan Kettering Cancer Center|Dr. Howard Scher|646-422-4323|Scherh@mskcc.org|
22434780|NCT00522418|Cyberonics, Inc|Mark Bunker, Senior Director, Global Medical Affairs|281-228-7223|Mark.Bunker@cyberonics.com|
22434781|NCT02438683|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22434782|NCT01404559|University of South Florida|William S. Quillen|8139749863|wquillen@health.usf.edu|
22434783|NCT00082368|National Cancer Institute|Dr. Peter Choyke|301-402-8409|peter_choyke@nih.gov|
22434784|NCT02320812|jCyte, Inc|Terry O'Neal, Chief Operating Officer|949-243-0688|terry.oneal@jcyte.com|
22434785|NCT02825420|Pharma Mar S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|0034 91846 60 00|clinicaltrials@pharmamar.com|
22434786|NCT04910074|Albert Einstein College of Medicine|Timothy P. Levine, DMD|718-918-5635|timothy.levine@nychhc.org|
22434787|NCT03638908|UTSouthwestern medical center|Kelly Chin, MD|2146456493|kelly.chin@utsouthwestern.edu|
22434788|NCT02074345|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22434789|NCT02994953|Merck KGaA, Darmstadt, Germany|Communication Center|6151 72 5200|service@merckgroup.com|
22434790|NCT02043197|Abbott|Tatiana V. Vladimirova|+74952584280|tatiana.vladimirova@abbott.com|
22434791|NCT00445939|Abbott|Global Medical Services|800-633-9110||
22434792|NCT00416715|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu|
22434793|NCT03879044|The Ohio State University Wexner Medical Center|Dr. Ulysses Magalang|614-292- 4307|Ulysses.Magalang@osumc.edu|
22434794|NCT01007435|Hoffmann-La Roche|Medical Communications|800 821-8590||
22434795|NCT02576535|NYU Langone Medical Center|Paul Huang|212-263-6414|Paul.Huang@nyumc.org|
22434796|NCT02545517|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22434797|NCT03334851|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22434798|NCT00210353|International Extranodal Lymphoma Study Group (IELSG)|Prof. Emanuele Zucca MD, Scientific and Medical Director|+41 91 811 9040|ielsg@eoc.ch|
22434799|NCT00396136|Biotronik, Inc.|Clinical Studies|503-451-8050|katerina.demetz@biotronik.com|
22434800|NCT03397394|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
22394988|NCT03975595|University of Virginia|Dr. Patrick Finan|(720) 244-1702|tpx4xe@virginia.edu|
22434801|NCT03172325|CinnaGen Co.|Dr. Nassim Anjidani|00989125477964|anjidani.n@orchidpharmed.com|
22434802|NCT03520348|Laboratorios Sophia|Ricardo Alonso Llamas Velázquez (clinical safety pharmacologist)|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
22434803|NCT02292758|Dana-Farber Cancer Institute|Kimmie Ng, M.D., M.P.H.|(617) 632-4150|Kimmie_Ng@dfci.harvard.edu|
22394989|NCT00051363|Stanford University|Deborah A. Nichols|208-908-7364|dnichols@cableone.net|
22394990|NCT03370471|Atlanta VA Health Care System|Amy D Rodriguez, PhD|404-321-6111|amy.rodridguez@va.gov|204201
22434804|NCT01437098|Medtronic|Hiroko Ookubo|81367760811|hiroko.ookubo@medtronic.com|
22434805|NCT00385944|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22434806|NCT00823212|Boston Scientific Corporation|Ruth Starzyk, PhD|508-683-6577|ruth.starzyk@bsci.com|
22434807|NCT01694121|Center on Gender Equity and Health at UCSD|Dr. Anita Raj|8588220229|anitaraj@ucsd.edu|
22434808|NCT00521599|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22434809|NCT01114971|Cedars Sinai Medical Center|Proffesor Paul F. White|2147703775|paul.white@cshs.org|
22434810|NCT00496197|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22434811|NCT00149994|Novartis Pharmaceuticals|Study Director|862-778-8300||
22434812|NCT01610713|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
22434813|NCT01025076|Royal Alexandra Hospital/CAMIS|Xinzhe Shi|7807356735|xinzhe.shi@ahs.ca|
22434814|NCT01364558|University of Minnesota|Dr. James Cloyd, Director for Center for Orphan drug research|612-624-4609|cloyd001@umn.edu|
22434815|NCT03943550|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22434816|NCT00543296|Duke University Medical Center|Glenn J. Jaffe, MD|919-684-4458|jaffe001@mc.duke.edu|
22434817|NCT00934947|UNC Department of Anesthesiology|Samuel McLean|919-966-7315|smclean@aims.unc.edu|
22434818|NCT04077996|Instituto Mexicano del Seguro Social|Dr. Jesus Venegas-Ramírez|3143058373|nefrojesusvr@gmail.com, jesus.venegas@imss.gob.mx|
22434819|NCT00096226|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
22434820|NCT06107803|Minerva Neurosciences|Joseph Reilly|617-600-7373|JReilly@minervaneurosciences.com|
22434821|NCT05129072|Bausch + Lomb Incorporated|Steffen Robert, Senior Director Clinical Affairs|15853386399|robert.steffen@bauschcloud.com|
22434822|NCT03099174|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
22434823|NCT02388490|Seoul National University Hospital|Tae Min Kim|82+2-2072-3559|gabriel9@snu.ac.kr|
22434824|NCT02378298|Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg|Helena Filipsson Nyström|0046-705833398|helena.filipsson@medic.gu.se|
22434825|NCT04173260|University of Pennsylvania|Dr. Andres Deik|2158297049|adeik@upenn.edu|
22394991|NCT04176848|Canadian Cancer Trials Group|Dr. Lesley Seymour|6135336430|lseymour@ctg.queensu.ca|
22434826|NCT04730635|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22434827|NCT04762043|Altec, Inc.|Dr. Joshua Kline|5085458212|jkline@altecresearch.com|
22434828|NCT03070223|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22434829|NCT05235971|University of Michigan|Lara N. Coughlin, Ph.D.|734-936-3101|laraco@med.umich.edu|
22434830|NCT03609385|Charité-Universitätsmedizin Berlin|Dr. Christian Nolte|+4930450560676|christian.nolte@charite.de|
22394992|NCT01765179|Clarus Therapeutics|Sr. VP Clinical and Medical Affairs|847-562-4300|tdanoff@clarustherapeutics.com|
22394993|NCT05358717|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22394994|NCT02640157|AbbVie|Global Medical Services|800-633-9110||
22425375|NCT01588405|United Therapeutics|Nicole Leedom|919-425-5870|nleedom@unither.com|
22425376|NCT00893971|Pearl Therapeutics Inc.|Colin Reisner, MD, FCCP, FAAAAI|605-305-2600|creisner@pearltherapeutics.com|
22425377|NCT03268005|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22425378|NCT01926197|Stanford Medicine at Stanford University|Samantha Wong|650-498-8495|swong8@stanford.edu|
22425379|NCT00492232|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22425380|NCT00980655|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22425381|NCT03939533|CRMG|Patrick Murphy|413-821-0022|p.murphy@crmg-usa.com|
22425382|NCT04162795|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22425383|NCT01416155|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22425384|NCT03078127|University of North Carolina at Chapel Hill|Scott Donaldson, MD|984-974-9198|scott_donaldson@med.unc.edu|
22425385|NCT00829829|Regeneron Pharmaceuticals, Inc. Phone:|Clinical Trial Management||clinicaltrials@regeneron.com|
22425386|NCT00382109|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22425387|NCT03634813|Yale School of Medicine|Robert B. Schonberger, Director of Clinical Scientist Track Program|203-785-3941|robert.schonberger@yale.edu|
22425388|NCT03251482|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22425389|NCT01196377|Vanderbilt University School of Medicine|Dr. Donald H Arnold|6155790516|don.arnold@vanderbilt.edu|
22425390|NCT03859648|MED-EL Corporation|MED-EL Corporation|919-314-1437|research.us@medel.com|
22425391|NCT03159299|Yale School of Nursing|Robin Whittemore, PhD|203-737-2351|robin.whittemore@yale.edu|
22425392|NCT02511132|Gradalis, Inc.|Clinical and Regulatory Operations|214-442-8100|info@gradalisinc.com|
22425393|NCT01990573|Washington University School of Medicine|Dr. Anshuman Sharma|314-457-3147|sharma.a@wustl.edu|
22425394|NCT03834025|University of North Carolina at Chapel Hill|Marisa Domino, PhD|919-966-3891|domino@unc.edu|
22425395|NCT01983826|University of Iowa|Dr. Darren P. Casey||darren-casey@uiowa.edu|
22425396|NCT04541329|University of California, San Francisco|Raymond Cho, MD, PhD|415 353 7800|rashes@ucsf.edu|
22425397|NCT03335813|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. John Greskovich|1-866-223-8100|taussigresearch@ccf.org|
22425398|NCT02014519|GlaxoSmithKline|GSK Response Center|866-435-7343||
22425399|NCT00947310|University of Rochester, Heart Research Follow-up Program|Dr. Arthur J. Moss|585-275-5391|arthur.moss@heart.rochester.edu|
22425400|NCT02020369|LFB USA Inc.|Jeffry Lawrence, MD, Vice President, Clinical Development|+1.508.370.5113|jeffry.lawrence@lfb-usa.com|
22425401|NCT04727736|UPMC Hillman Cancer Center|Barbara M Stadterman, Clinical Research Manager - Regulatory|412-647-5554|stadtermanbm@upmc.edu|
22425402|NCT00697593|Merck Serono S.A., a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22425403|NCT00320242|Beth Israel Deaconess Medical Center and Harvard Medical School|Dr. David K. Simon, Associate Professor of Neurology|617-735-3251|dsimon1@bidmc.harvard.edu|
22425404|NCT00558012|University of Pittsburgh|Dr. Susan Greenspan|412-692-2477|greenspn@pitt.edu|
22425405|NCT05133323|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
22425406|NCT02697214|The Cleveland Clinic|Marc Gillinov, MD|216 445-8841|GILLINOM@ccf.org|
22425407|NCT00909220|Northwestern University|Jackie Gollan, Ph.D. Associate Professor of Psychiatry and Behavioral Sciences|312-695-6121|j-gollan@northwestern.edu|
22434831|NCT03006458|CooperVision|Myhanh Nguyen|9257306716|MNguyen@coopervision.com|
22434832|NCT03219034|Texas A&M University College of Dentistry|Dr. Emet Schneiderman|2148288377|eschneiderman@tamu.edu|
22434833|NCT00118846|Director, Atherosclerosis Research Unit, University of Southern California|Howard N. Hodis, M.D.|323-442-1478|athero@usc.edu|
22434834|NCT00726037|Northwestern Medicine Regional Medical Group|Margret Shoup|630-352-5450|MSHOUP@lumc.edu|
22434835|NCT01468233|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
22434836|NCT02480166|Stanford University Medical Center|Mindie H. Nguyen, MD, MAS|650-4985691|mindiehn@stanford.edu|
22434837|NCT01574157|VA Salt Lake City Healthcare System|Dr. Kalani Raphael, Principal Investigator|801-582-1565|kalani.raphael@va.gov|1794
22434838|NCT00578877|CONRAD|Jill Schwartz, M.D.|703-276-3913|jschwartz@conrad.org|
22434839|NCT02406573|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
22434840|NCT01202188|Novartis Pharmaceuticals|Study Director|862-778-8300||
22434841|NCT01632241|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22434842|NCT00772915|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
22434843|NCT03111550|Johnson & Johnson Surgical Vision|Devi Priya Janakiraman,OD, FAAO|+1 714-247-8628|djanaki1@its.jnj.com|
22434844|NCT00457977|University of Minnesota|Sarah Harnden|612-626-9011|sharnden@ccbr.umn.edu|
22434845|NCT04696276|Saint Savvas Hospital of Athens|Maria Bourazani|+302106409000|mbourazani@yahoo.com|
22434846|NCT01846299|Novartis|Study Director|862-778-8300||
22434847|NCT03559517|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22434848|NCT01330628|Spectranetics|Amanda Johnson, VP of Regulatory & Medical Affairs|(719) 447-2000|amanda.johnson@spnc.com|
22434849|NCT03761394|UMass Chan Medical School|Edith Mensah Otabil|774-455-6574|edith.mensahotabil@umassmed.edu|
22434850|NCT01657344|Lurie Children's Hospital|Elizabeth Alpern|312-227-6080|ealpern@luriechildrens.org|
22434851|NCT01686750|Johns Hopkins University|Dr. Gregory M.Lucas|410-614-0560|glucas@jhmi.edu|
22434852|NCT01080768|Novartis Pharmaceuticals|Study Director|862-778-8300||
22434853|NCT02956044|Translational Medicine Group|Program Director|617-726-4236|yhalvorsen@ccib.mgh.harvard.edu|
22434854|NCT03832114|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22434855|NCT00559468|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22434856|NCT04274153|Johns Hopkins SOM Department of GYN/OB|Dr. Jenell Coleman|(410)614-9178|colemanj@jhmi.edu|
22434857|NCT00580034|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu|
22434858|NCT01939002|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22434859|NCT00750191|The Center for Clinical Research|Dr. Leonard Kapural|1-336-765-6181|LKapural@ccrpain.com|
22434860|NCT01165112|Fred Hutchinson Cancer Research Center|Ajay Gopal|206-288-2037|akgopal@fhcrc.org|
22434861|NCT00098748|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22434862|NCT03095027|Alcon, A Novartis Division|Senior Clinical Project Lead, GCRA - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22434863|NCT02982018|Johnson & Johnson Vision|John Buch- SENIOR PRINCIPAL RESEARCH OPTOMETRIST|904 443-1707|JBUCH@its.jnj.com|
22434864|NCT03245736|Genmab A/S|Clinical Trial Information|70202728|clinicaltrials@genmab.com|
22434865|NCT01942161|Otsuka Pharmaceutical Co., Ltd|Director of Clinical Trials|+81-3-6361-7366||
22434866|NCT01783574|Massachusetts General Hospital|Dr. Karen K. Miller|617-726-3870|KKMILLER@MGH.HARVARD.EDU|
22434867|NCT01257568|Stryker Orthopaedics|Shaherah Yancy, Director, Clinical Operations|901-650-6601|shaherah.yancy@stryker.com|
22434868|NCT01116024|Medtronic, Inc.|Ryan Palmer, Principal Clinical Research Specialist|763-514-9732|ryan.j.palmer@medtronic.com|49732
22434869|NCT00132691|Center for Presventive Ophthalmology and Biostatistics, Department of Ophthalmology, University of Pennsylvania|John H. Kempen, MD, PhD, MUST Trial Vice-Chairman|215-615-1500|john.kempen@uphs.upenn.edu|
22434870|NCT02251717|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22434871|NCT01545232|University of Texas Health Science Center - Houston|John Holcomb, M.D.|713-500-5493|John.Holcomb@uth.tmc.edu|
22434872|NCT00798317|ThromboGenics|Petra Kozma-Wiebe|+32 16751310|petra.kozma@thrombogenics.com|
22434873|NCT00919867|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22434874|NCT04028765|Thomas Jefferson University Health System|Dr. Whitney Bender|4342948416|whitney.bender@jefferson.edu|
22434875|NCT01477463|Stanford University School of Medicine|Jean Y Tang MD PhD, assistant professor|650-721-7149|baileyhi@stanford.edu|
22434876|NCT02002936|SymBio Pharmaceuticals|Katsuhisa Goto|+81-3-5472-1127||
22434877|NCT00369226|Dana-Farber Cancer Institute|John Koreth, MBBS, D.Phil|(617) 632-2949|jkoreth@partners.org|
22434878|NCT03093636|University of Virginia Center for Diabetes Technology|Marc Breton, PhD|(434) 982-6484|MB6NT@uvahealth.org|
22434879|NCT03361189|UCLA|Dr. Jeremy P. Moore|310-267-7667|RGoldstein@mednet.ucla.edu|
22434880|NCT03575065|BeiGene|Study Director|+1 - 877-828-5568|clinicaltrials@beigene.com|
22434881|NCT03344549|University of Colima|Ari Cisneros Hernández|3335762299|aricisneroshernandez@gmail.com|
22434882|NCT02323126|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22434883|NCT01679600|Bern University of Applied Sciences|Dr. Oliver Stoller|+41344264195|oliver.stoller@bfh.ch|
22434884|NCT00108303|VA|Dr. Robert Freedman|3037244940|Robert.Freedman@ucdenver.edu|
22434885|NCT01685801|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22434886|NCT00113399|Radiation Therapy Oncology Group|Wendy Seiferheld||wseiferheld@acr.org|
22434887|NCT03350256|Abbott|Filippo Agnesi|+19725264860|filippo.agnesi@abbott.com|
22434888|NCT00666588|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22434889|NCT04043234|Infinite Biomedical Technologies, LLC|Chief Executive Officer|(443) 451-7177|rahul@i-biomed.com|
22425408|NCT01449864|University of Pennsylvania|John Plastaras, MD, PhD|267-972-3539|plastaras@uphs.upenn.edu|
22425409|NCT02082769|Department of Endocrinology, Xijing Hospital, Fourth Military Medical University|Qiuhe Ji|+86-29-84775213|qiuheji@hotmail.com|
22425410|NCT04152083|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
22425411|NCT02087670|Universidad de Antioquia|Jesus Alberto Plata Contreras|5742196478|rehabilitacionsalud@siu.udea.edu.co|
22425412|NCT00411450|Amgen Inc.|Study Director|866-572-6436||
22425413|NCT03904420|Cochlear Limited|Laura Chenier|+14423254171|lchenier@cochlear.com|
22425414|NCT00614874|Creighton University School of Medicine|Dr. Tammy Wichman|402-449-4486|wichman@creighton.edu|
22425415|NCT04435808|The University of New Mexico School of Medicine|Walter Dehority|5052725535|wdehority@salud.unm.edu|
22425416|NCT00807612|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
22425417|NCT00705341|Johns Hopkins University|Anne Capser|410-955-8183|ashankli@jhsph.edu|
22425418|NCT00205660|Washington University|Michael Yingling|5735791412|yinglinm@wustl.edu|
22425419|NCT04736069|Ufuk University|Nihan Cüzdan|5052706846|nihancuzdan@hotmail.com|
22425420|NCT01504672|Umeå University|Dr. Maria Gustafsson|0046703978717|maria.gustafsson@umu.se|
22425421|NCT04978337|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22425422|NCT00074815|Duke University School of Medicine|Jeffrey Sapyta, PhD|919-668-0069|jeffrey.sapyta@duke.edu|
22425423|NCT01436227|M.D. Anderson Cancer Center|Eric Jonasch, MD|713-792-2830|ejonasch@mdanderson.org|
22425424|NCT00972283|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22425425|NCT03124537|Brandeis University|Alycia Bisson|781 736 3284|lifespanlab@brandeis.edu|
22425426|NCT02308371|University of North Carolina|Dr. Melissa Hines|901-652-6138|mhinesthomas@gmail.com|
22425427|NCT00830518|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22425428|NCT01181947|St. Antonius Ziekenhuis|Dr. Robin Heijmen|0031306092047|r.heijmen@antoniusziekenhuis.nl|
22425429|NCT00410059|UT MD Anderson Cancer Center|Vice President Clinical Research/Clinical Research Operations|713-792-7734|CR_Study_Registration@mdanderson.org|
22425430|NCT02756364|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22425431|NCT02223364|Mayo Clinic|Dr. Sandra L. Kopp|507-284-6637|Kopp.Sandra@mayo.edu|
22425432|NCT02984267|Arizona Anesthesia Consultants|Dr. Thomas Vernon|480-570-7082|tvernon@azanesthesia.net|
22425433|NCT02685072|Yale School of Public Health|Kimberly Yonkers, MD|(203) 764-6621|kimberly.yonkers@yale.edu|
22425434|NCT01994902|Coloplast A/S|Medical Director|+45 49111395|dkbir@coloplast.com|
22425435|NCT03597139|Aurinia Pharmaceuticals|Mary Palmen|1 (250) 744-2487|clinicaltrials@auriniapharma.com|
22425436|NCT01342172|Icahn School of Medicine at Mount Sinai|Dr. Matthew Galsky|212-241-8816|matthew.galsky@mssme.edu|
22425437|NCT05052697|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22425438|NCT03796676|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22425439|NCT02724410|Atrium Health|Dr. B. Todd Heniford|704-355-3168|Todd.Heniford@atriumhealth.org|
22434890|NCT03106844|Brigham and Women's Hospital|Jessica Allegretti MD MPH|617-525-7322|jallegretti@bwh.harvard.edu|
22434891|NCT01187446|Stanford University Medical Center|Youn H Kim, MD|650-521-3545|younkim@stanford.edu|
22434892|NCT00380029|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22434893|NCT00834990|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22434894|NCT01235923|University of Utah|Robin Ohls|801-581-7052|robin.ohls@hsc.utah.edu|
22434895|NCT00791479|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22434896|NCT01794741|Meda Pharmaceuticals|Dr Nancy Ruiz, MD|732 564 2390|nancy.ruiz@meda.us|
22434897|NCT03405935|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22394995|NCT00710021|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22394996|NCT00026208|Stanford Univeristy Medical Center|Jessica C Lam, BS|650-723-0437|jclam11@stanford.edu|
22394997|NCT05741372|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22394998|NCT04837040|Crinetics Pharmaceuticals, Inc.|Clinical Research Director|(833) 276-4636|medinfo@crinetics.com|
22394999|NCT02961218|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22395000|NCT00602667|St. Jude Children's Research Hospital|Amar Gajjar, MD|866-278-5833|amar.gajjar@stjude.org|
22425440|NCT01900899|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22425441|NCT02772809|University of Pennsylvania|Michelle J Johnson|215 893-2665|johnmic@pennmedicine.upenn.edu|
22425442|NCT02860507|Merck Pharmaceuticals|Chadwick Neal / Medical Affairs Director|2056010605|chadwick.neal@merck.com|
22425443|NCT02828137|Inha University Hospital|Dr. Sung Woo Kwon|821031133363|kwonswdr@gmail.com|
22425444|NCT00534105|Baystate Medical Center|Glenn Markenson MD|413-794-8073|glenn.markenson@bhs.org|
22425445|NCT02427802|Innocoll|Lesley Russell, MBChB, MRCP, Chief Medical Officer|484-406-5206|lrussell@innocoll.com|
22425446|NCT02226120|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22425447|NCT02946489|New York State Psychiatric Institute|Elias Dakwar, MD|6467748728|elias.dakwar@nyspi.columbia.edu|
22425448|NCT03034135|Cantex Pharmaceuticals|Stephen Marcus MD|9543153660|smarcus@cantex.com|
22425449|NCT00661453|University of Utah|Dr. Kathryn Swoboda|801-585-9717|swoboda@genetics.utah.edu|
22425450|NCT02919007|Home Skinovations|Dr Liora Levi|+97249097470|LioraL@silkn.com|
22395001|NCT04765059|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22425451|NCT00467558|University of Minnesota|Jon E. Grant, MD|612-273-9736|grant045@umn.edu|
22425452|NCT04679948|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22434898|NCT04979897|Universidad del Desarrollo|Ana Castro-Avila|+56223279648|anacastro@udd.cl|
22434899|NCT01774097|UT-Houston School of Public Health|Lemuel Moye, MD, PhD|713-500-9518|lemmoye@msn.com|
22434900|NCT03828422|University Medical Centre Ljubljana|dr. Aleš Blinc, MD, PhD|+38615227124|ales.blinc@kclj.si|
22434901|NCT01180894|Denver Health Hospital|Dr. Fredric Pieracci|303-436-4029|fredric.pieracci@dhha.org|
22434902|NCT00585494|University of Wisconsin Madison|Ann Marie Sheehy, M.D., M.S.|608-335-6734|asr@medicine.wisc.edu|
22434903|NCT04659174|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22434904|NCT02781792|Washington University School of Medicine|Dr. Milan Chheda|314-747-2712|mchheda@wustl.edu|
22434905|NCT03061721|Zydus Therapeutics Inc.|Dr Deven Parmar|7324050886|dparmar@zydustherapeutics.com|
22434906|NCT03447314|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22434907|NCT01083979|William Beaumont Hospital|Kenneth M. Peters, MD|248-551-0387|kmpeters@beaumont.edu|
22434908|NCT01920568|GlaxoSmithKline|GSK Response Center|866-435-7343||
22434909|NCT04011826|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 09 574 0123|CPAP.trial@fphcare.co.nz|7044
22434910|NCT00350363|Stanford|Professor|650-723-6995|cta@stanford.edu|
22434911|NCT04599959|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22434912|NCT04049266|Kodiak Sciences Inc.|Pablo Velazquez-Martin, MD|1 (650) 281-0850|ClinOps@kodiak.com|
22434913|NCT01703208|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
22434914|NCT02309645|Ethicon Inc.|Senior Franchise Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22395002|NCT04300309|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22395003|NCT04647526|Eli Lilly and Company|Chief Medical Officer|08004595979|ClinicalTrials.gov@lilly.com|
22395004|NCT03282240|Sanofi Pasteur Inc.|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22395005|NCT01675479|Abbott Medical Optics|Head of Clinical Science|714-247-8613|khileman@its.jnj.com|
22395006|NCT02910739|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22395007|NCT03816891|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
22395008|NCT05666505|University of Arkansas for Medical Sciences|Samantha Kleindienst Robler, AuD, PhD|9074340433|skrobler@uams.edu|
22395009|NCT04417127|Brown University School of Public Health|Omar Galarraga, PhD (Study Contact PI)|+1 (401) 863-2331|omar_galarraga@brown.edu|
22434915|NCT01933230|Cleveland Clinic|Dr. Jose Javier Provencio, Faculty, Neuroinflammation Research Center|216-445-242|provenj@ccf.org|
22434916|NCT04600076|University of Michigan|Katherine Jo Gold|734 998-2499|ktgold@med.umich.edu|
22434917|NCT01639339|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22434918|NCT02891681|Washington University School of Medicine|Quing Zhu, Ph.D.|314-935-7519|zhu.q@wustl.edu|
22434919|NCT01170598|University Health Network|Sara O'Neill|416-597-3422|o'neill.sara@torontorehab.on.ca|7860
22434920|NCT01271712|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22434921|NCT01431014|Chang Gung Memorial Hospital|Lun-Jou Lo, MD,Hye-Young Kim, MD||lunjoulo@cgmh.org.tw|
22434922|NCT02685748|CPD Dr Laza Lazarevic, Belgrade, Serbia|Pavicevic Dragana|0652207970|gagapavicevic@yahoo.com|+381
22434923|NCT01394692|Johann Wolfgang Goethe University|Dr. Christian Senft|+49 69 63015939|c.senft@med.uni-frankfurt.de|
22434924|NCT01944098|TeamHealth Anesthesia|Enrico Camporesi MD|813-844-7170|ecampore@health.usf.edu|
22434925|NCT02136680|University of Maryland Baltimore, School of Medicine|Dr. Carla Alexander|410-328-7129|calexand@medicine.umaryland.edu|
22434926|NCT03397134|Minerva Neurosciences|Senior Vice President and Head of R&D|617-600-7378|rkuchibhatla@minervaneurosciences.com|
22434927|NCT00868218|University of Bergen|Professor Rebecca Jane Cox|+4755974668|rebecca.cox@uib.no|
22434928|NCT03287674|National Center for Cancer Immune Therapy, Herlev Hospital|Anders Kverneland, MD|38686467|anders.kverneland@regionh.dk|
22434929|NCT03136497|Hackensack Meridian Health|Joshua Zenreich|551-996-4248|joshua.zenreich@hmhn.org|
22434930|NCT00735826|Dartmouth-Hitchcock Medical Center|Konstnatin Dragnev, MD Professor of Medicine|603-650-6344|Konstantin.H.Dragnev@Hitchcock.org|
22434931|NCT00557310|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22434932|NCT02351349|MUHC|Sameena Iqbal|5146302225|sameena.iqbal@mcgill.ca|1841
22434933|NCT02649218|Novartis Pharmaceuticals|Study Lead|+1 (862) 778-8300|novartis.email@novartis.com|
22434934|NCT01224821|GlaxoSmithKline|GSK Response Center|866-435-7343||
22434935|NCT02174523|Phase I Clinical Research Unit , Shanghai Xuihui Central Hospital|Dr.Hu Chaoying|021-54036058|cyhu@shxh-centerlab.com|
22434936|NCT00794365|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22434937|NCT01509677|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22434938|NCT01451931|University of California, San Francisco|Dr. Rebecca Smith-Bindman|415-353-4946|rebecca.smith-bindman@ucsf.edu|
22434939|NCT04422561|Zagazig University|Dr. Waheed Shouman|+201114812048|shouman66@gmail.com|
22434940|NCT05494736|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22434941|NCT01638052|Ann & Robert H. Lurie Children's Hospital of Chicago|Santhanam Suresh, MD|312-227-5147|SSuresh@luriechildrens.org|
22434942|NCT00230282|Stanford University|Steven E. Coutre, Associate Professor of Medicine|650-723-6661|coutre@stanford.edu|
22425453|NCT02636439|Wake Forest School of Medicine|Dalane W. Kitzman, MD|336-716-3274|dkitzman@wakehealth.edu|
22434943|NCT01352442|AcuFocus, Inc.|Eugenia Thomas, OD|949-585-9511|ethomas@acufocus.com|
22434944|NCT05131971|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22434945|NCT04669262|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22434946|NCT01638013|Astellas Pharma Inc.|Clinical Trial Disclosure|+81 3-3244-6500 Japanese only|astellas.resultsdisclosure@astellas.com|
22434947|NCT02701777|Hines VA|Reagan Morehouse|312-238-2993|rmorehouse@sralab.org|
22434948|NCT02637427|Rutgers, The State University of New Jersey|Jeffrey L Carson, MD|732-235-7122|Jeffrey.Carson@Rutgers.edu|
22434949|NCT00445211|William Beaumont Hospital|Dr. Justin Trivax|(248)587-2300|Justin.Trivax@beaumont.edu|
22434950|NCT01960998|Birmingham VA Medcial Center|Kathryn L. Burgio, PhD|205-999-9537|kburgio@uabmc.edu|
22434951|NCT03088748|University of Tennessee|Dr. Michael LaCour|8659742093|mlacour@utk.edu|
22434952|NCT01904149|Menarini Ricerche S.p.A.|Dr. Angela Capriati, Corporate Director of Clinical Research|+3905556809933|ACapriati@menarini-ricerche.it|
22434953|NCT01357161|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22434954|NCT01824823|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
22434955|NCT03349645|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|7204376500|clinicaltrials@ampiopharma.com|
22434956|NCT02910401|University of Virginia|Larry Borish, MD|4342436570|lb4@virginia.edu|
22434957|NCT01182805|University of Michigan|Theodore J. Kolias, MD|(734) 615-4907|tkolias@umich.edu|
22434958|NCT01660672|University of Rochester Medical Center|Gretchen Birbeck|585-273-4265|Gretchen_Birbeck@URMC.Rochester.edu|
22434959|NCT00433160|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22425454|NCT02494401|University of New Mexico|Janet Poole|(505) 272-1753|JPoole@salud.unm.edu|
22425455|NCT05188729|Verrica Pharmaceuticals|Susan Cutler, VP Medical Affairs|484-773-089|scutler@verrica.com|
22425456|NCT01732445|Mayo Clinic|Ruben A. Mesa, M.D.|480/301-8335|mesa.ruben@mayo.edu|
22425457|NCT00520767|Barbara Ann Karmanos Cancer Institute|Jeffrey Zonder, M.D.|313-576-8732|zonderj@karmanos.org|
22425458|NCT00463801|Novartis Pharmaceuticals|Study Director|862-778-8300||
22425459|NCT01073163|Teva Pharmaceuticals USA|Manager|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22425460|NCT00802672|Perrigo Company|Jonathan Schwartz|718-960-0119|jonathan.schwartz@perrigo.com|
22425461|NCT00703677|Westat|René Gonin, PhD (Math. Stats.)|301-251-1500|renegonin@westat.com|
22425462|NCT01220726|Weill Cornell Medical College|Dr. Alexis Te|646-962-4811|aet2005@med.cornell.edu|
22425463|NCT04441788|Ionis Pharmaceuticals, Inc|Ionis Pharmaceuticals, Inc|800-679-4747|patients@ionisph.com|
22425464|NCT00753298|Astra Tech AB|Head of Therapeutic Area Health Care|+46317763000||
22425465|NCT01952418|Massachusetts General Hospital|Norman Nishioka, MD|6177264422|NNISHIOKA@PARTNERS.ORG|
22425466|NCT02484092|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22425467|NCT02793947|University of Iowa Hospitals and Clinics|Dr. Michael Willey|319-384-8452|michael-willey@uiowa.edu|
22425468|NCT02959918|Selecta Biosciences, Inc.|Dr. Peter Traber|713-540-9776|ptraber@selectabiosciences.com|
22425469|NCT01549340|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22395010|NCT06060717|Fisher & Paykel Healthcare Ltd|Kelly Tay|+64 9-282-9734|kelly.tay@fphcare.co.nz|5634
22395011|NCT06018844|Children's Mercy Research Institute|Priscilla Connell|8166014543|Endocrine-RisingT1deAlliance@cmh.edu|
22395012|NCT04596384|City of Hope|Virginia Sun, Professor|+16269888652|VSun@coh.org|
22395013|NCT04751656|University of Florida|Megan McVay|352-294-1638|megan.mcvay@ufl.edu|
22395014|NCT03253926|New York State Psychiatric Institute|Margaret Haney|646-774-6153|mh235@cumc.columbia.edu|
22395015|NCT05591274|University of Miami, Miller School of Medicine|Russell Saltzman|3052431152|R.Saltzman@med.miami.edu|
22395016|NCT01485354|Spaulding Rehabilitation Hospital|Paolo Bonato|617-952-6319|pbonato@partners.org|
22395017|NCT03566810|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22395018|NCT05640466|Sohag University|Hussien Sedik Mohamed, Orthopedic Surgery Resident, Sohag University|+20-1065840049|hussien_sediek_post@med.sohag.edu.eg|
22395019|NCT00509665|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
22395020|NCT01444651|Massachusetts General Hospital|Dr. Jennifer Ho|617-726-6411|jho1@partners.org|
22395021|NCT03338192|Washington University Pain Center in St. Louis|Burel Goodin|3142736403|burel@wustl.edu|
22395022|NCT03874325|Moffit Cancer Center|Hung Khong, MD|813-745-3828|hung.khong@moffitt.org|
22395023|NCT00733993|Virginia Commonwealth University|F. Gerard Moeller|804-828-4134|fgmoeller@vcu.edu|
22395024|NCT03236246|Keryx|Keryx Medical Information|1-844-44-KERYX (844-445-3799)|medicalinfo@keryx.com|
22395025|NCT02952001|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
22395026|NCT00148954|Boston Scientific|Greg Voss, Clinical Director|651-581-3068|gregory.voss@bsci.com|
22395027|NCT01681628|Thought field Therapy Foundation UK Ltd.|Dr R H Robson|+44 (0)1952550688|r.robson2@btinternet.com|
22395028|NCT01794520|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22395029|NCT04796896|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
22395030|NCT02021292|Actelion Pharmaceuticals Ltd.|Clinical Trial Disclosure Desk||clinical-trials-disclosure@actelion.com|
22395031|NCT04356183|Duke University|Kim Huffman, MD, PhD|919-613-7797|kim.huffman@duke.edu|
22395032|NCT01637623|University of Wisconsin School of Pharmacy|John M. Dopp|608-265-9352|john.dopp@wisc.edu|
22395033|NCT00969878|Baylor|Thomas Kosten|7137947032|kosten@bcm.edu|
22395034|NCT02824263|Johns Hopkins University School of Medicine|Jonathan Jun|410-550-0115|jjun2@jhmi.edu|
22395035|NCT01676909|Department of Veterans Affairs, VAMHCS MIRECC|Mary Brighid Walsh|410-637-1860|marybrighid.walsh@va.gov|
22395036|NCT04615247|Principal Investigator|Alison Huang, MD|415-353-7900|alison.huang@ucsf.edu|
22395037|NCT00247377|UCI|Ninh Nguyen|714-456-8598|ninhn@uci.edu|
22395038|NCT00823901|MGH CURTIS|Alexandra B. Kimball, MD|617-726-5066|harvardskinstudies@partners.org|
22395039|NCT01369511|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22395040|NCT01376349|Alliance for Clinical Trials in Oncology|Debra Barton, R.N., Ph.D.||debbartn@med.umich.edu|
22395041|NCT00718640|Janssen Inc., Canada|Director, Medical Affairs Oncology|416-382-5078||
22395042|NCT02147353|Icahn School of Medicine at Mount Sinai|Dr. Shelbi C. Jim On|212-241-6500|shelbi.jimon@mountsinai.org|
22395043|NCT00592761|UAMS Medical Center|Gary McCullough|501-852-7886|mcculloughgaryh@uams.edu|
22395044|NCT00550368|Stanford University|Dr. Julie Parsonnet|(650) 725-4561|parsonnt@stanford.edu|
22395045|NCT02121834|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22395046|NCT02578862|Ochsner Medical Center|Edward D McCoul, MD, MPH|504-842-4080|edward.mccoul@ochsner.org|
22395047|NCT00759291|UT Southwestern|Dr. Joshua Beckman|214-648-3100|joshua.beckman@utsouthwestern.edu|
22395048|NCT00696761|the Department of Urology, Asan Medical Center, University of Ulsan College|Kanghyon Song, Myung-Soo Choo, Kyu-Sung Lee, Ji-Yeon Han, Young-Suk Lee,|82-2-3010-3735|mschoo@amc.seoul.kr|
22395049|NCT04388774|Icahn School of Medicine at Mount Sinai|Dr. Alexander Kolevzon|(212) 659-8762|alexander.kolevzon@mssm.edu|
22395050|NCT01230788|Emory University|Dr. Todd Cooper|404-785-3000|tmcoope@emory.edu|
22395051|NCT01142596|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22395052|NCT03478163|Cedars Sinai|Melissa Wong, MD MHDS|310-423-0895|wongmsx@cshs.org|
22395053|NCT01294683|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22395054|NCT01794923|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22395055|NCT01881750|Stanford University School of Medicine|Antonio Hardan, MD|650-736-1235|hardanay@stanford.edu|
22395056|NCT03318809|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22395057|NCT04668586|Haukeland University Hospital|Øyvind Ulvik|+47 97 50 00|doc.ulvik@online.no|
22395058|NCT00637923|Romark Laboratories, L.C.|Marc Ayers|813-282-8544|Marc.Ayers@romark.com|
22395059|NCT02513719|Abbott Vascular|Kusano Hajime|408-645-1626|hajime.kusano@av.abbott.com|
22395060|NCT02577601|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|503-494-0757|mccrimmo@ohsu.edu|
22395061|NCT01572922|St. Jude Children's Research Hospital|Jane Hankins, MD|866-278-5833|Jane.Hankins@stjude.org|
22395062|NCT05312151|Compass Pathways|Chief Medical Officer|07443136539|info@compasspathways.com|
22395063|NCT03620890|The University of Texas Health Science Center at Houston|Michal Fishel Bartal, MD, Assistant Professor|713-500-6421|Michal.F.Bartal@uth.tmc.edu|
22434960|NCT01774253|NMTRC|Giselle Sholler, MD|6162670335|genevieve.bergendahl@helendevoschildrens.org|
22395064|NCT02087748|Lotus Clinical Research, LLC|Anne Arriaga, VP of Clinical Operations|626-397-3412|anne@lotuscr.com|
22395065|NCT01103245|Vanderbilt University Medical Center|James M. Luther|(615) 936-3420|james.luther@vanderbilt.edu|
22434961|NCT00772369|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22395066|NCT03219320|Aptinyx|Aptinyx Clinical Development|847-871-0377|clinicalstudies@aptinyx.com|1
22395067|NCT03078907|Actelion Pharmaceuticals Ltd|Clinical Registry group|844-434-4210|clinical-trials-disclosure@its.jnj.com|
22434962|NCT03802344|MC2 Therapeutics|Irene Sandholdt|+45 2015 7033|isa@mc2therapeutics.com|
22434963|NCT02240368|University of Foggia|Alberto Sciusco||alberto.sciusco@gmail.com|
22434964|NCT03510468|Clinical Center|Dr. Joseph Kovacs|+1 301 496 9907|jkovacs@mail.nih.gov|
22434965|NCT01010568|Georgetown University Hospital|Bruce D. Cheson|202-444-1212|bdc4@georgetown.edu|
22434966|NCT03372460|Center for Neurorestoration and Neurotechnology, VA Providence Healthcare System|Dr. Noah S Philip, MD|4012737100|noah_philip@brown.edu|16200
22434967|NCT02793817|Kala Pharmaceuticals, Inc.|Head, Clinical Operations|781-996-5252|Results005@kalarx.com|
22434968|NCT01097642|The Methodist Hospital Research Institute|Dr. Jenny Chang|713 441-0680|jcchang@houstonmethodist.org|
22434969|NCT02023801|Minerva Surgical, Inc.|Dr. Eugene Skalnyi, VP Medical Affairs|(1) 650-284-3500|eugenes@minervasurgical.com|
22434970|NCT03995680|Swiss Tropical and Public Health Institute|Dr. Jennifer Keiser|+41612848218|jennifer.keiser@swisstph.ch|
22434971|NCT00916058|Weill Cornell Medical College|Tsiporah Shore|646-962-7950|tbs2001@med.cornell.edu|
22434972|NCT00871117|GlaxoSmithKline|GSK Response Center|866-435-7343||
22434973|NCT03222973|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22434974|NCT02080481|Cleveland Clinic|Aplarslan Turan, MD|216-445-9857|turana@ccf.org|
22434975|NCT02345772|CTCA|Jessica L. Coats, RN|6232073899|jessica.coats@ctca-hope.com|
22434976|NCT02439450|NightHawk Biosciences Inc.|Vice President, Clinical Development|9197948950|info@nighthawkbio.com|
22434977|NCT03998670|PEDIG Coordinating Center, Jaeb Center for Health Research|Raymond Kraker, PEDIG Coordinating Center Director|813 975 8690|rkraker@jaeb.org|
22434978|NCT04644796|Missouri Orthopaedic Institute|Angela Atkinson|573-884-1128|avadd9@umsystem.edu|
22434979|NCT03730961|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22434980|NCT00101816|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22434981|NCT04508751|University of California Los Angeles|Dr. Kara Calkins|3108259330|kcalkins@mednet.ucla.edu|
22395068|NCT01955122|UMC Utrecht|Prof. Peter Siersema|+31 88 7559338|P.D.Siersema@umcutrecht.nl|
22395069|NCT01672788|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22395070|NCT02445196|Stanford University|Dr. C. Barr Taylor|415-987-1810|btaylor@stanford.edu|
22395071|NCT04612036|University of Tennessee|Michael LaCour|865-974-9376|mlacour@utk.edu|
22395072|NCT01088464|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22395073|NCT03018587|Cutera, Inc.|Margot Doucette|(415) 657-5518|mdoucette@cutera.com|
22395074|NCT01128361|University of Kansas Medical Center|Dr. Jeffrey Burns|913-588-0555|jburns2@kumc.edu|
22395075|NCT02464228|Kura Oncology, Inc.|Clinical Operations|+1 617-588-3755|KO-TIP-002@kuraoncology.com|
22395076|NCT00257686|Kowa Research Institute|Bill Arana|9194331600|barana@kowaus.com|
22395077|NCT00846651|Penn State Milton S. Hershey Medical Center|Sonia Vaida|7175318433|svaida@hmc.psu.edu|
22395078|NCT06078579|Cairo university|Dr. Bahaa Mahmoud Fawzy|+201033559646|bahaamust66@gmail.com|
22395079|NCT05972733|HilleVax, Inc.|Astrid Borkowski, Chief Medical Officer|+1 (617) 213-6562|aborkowski@hillevax.com|
22395080|NCT01177787|Gachon University of Medicine and Science|Dr. Kyu Rae LeeMD.PhD.|8232-770-1215|baria07@daum.net|
22395081|NCT01570036|Cancer Insight|Program Director, Karen Arrington, RN, BSN|210-243-5711|karrington@cancerinsight.com|
22395082|NCT00818389|Massachusetts General Hospital|Elizabeth Simpson|617-726-3430|esimpson1@partners.org|
22395083|NCT00819286|Biomet Microfixation|Brian Hatcher|904-741-4400|brian.hatcher@biomet.com|
22395084|NCT05193500|New York University|Dr. Sudha Arunachalam|212-998-4139|sudha@nyu.edu|
22395085|NCT03871829|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22395086|NCT02993523|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22395087|NCT03694418|Montana State University|Dr. Elizabeth Rink|4066000297|elizabeth.rink@montana.edu|
22395088|NCT01806129|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22395089|NCT04288778|Janssen Research & Development, LLC|Medical Advisor|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22395090|NCT04442737|Janssen Scientific Affairs, LLC|Vice President Medical Affairs Infectious Disease and Vaccines (IDV)|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22395091|NCT01139021|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22395092|NCT04092101|University of Vermont|Stacey C. Sigmon, PhD|802-656-9987|stacey.sigmon@uvm.edu|
22395093|NCT05458479|Massachusetts General Hospital Lurie Center for Autism|Dr. Robyn Thom|7818601700|rthom@mgh.harvard.edu|
22395094|NCT00784693|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22395095|NCT01978262|Johns Hopkins University|Kawsar Talaat|410-502-9627|ktalaat@jhu.edu|
22395096|NCT02982187|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22395097|NCT02202551|Adamas Pharmaceuticals, Inc.|Reed Johnson|510-450-3500|rjohnson@adamaspharma.com|
22395098|NCT02888665|Northwestern University|Seth Pollack, MD, Director of Sarcoma Program|312-503-5320|seth.pollack@northwestern.edu|
22395099|NCT02349451|AbbVie|Global Medical Services|800-633-9110||
22434982|NCT00391469|University of Washington|Francis Kim, MD Associate Professor of Medicine|206-744-8712|fkim@u.washington.edu|
22395100|NCT02168842|University of Rochester Medical Center, Department of Biostatistics and Computational Biology|David Oakes, PhD|5852752405|david_oakes@urmc.rochester.edu|
22395101|NCT02064855|Stryker Spine|Marissa Conrad, Senior Director of Clinical and Medical Affairs|201-749-8162|marissa.conrad@stryker.com|
22395102|NCT00186069|Stanford University|Anna Girsen, Manager of Research Operations|(650) 725-5720|agirsen@stanford.edu|
22395103|NCT03128008|Duke University Health System|Linda Kaltenbach, PhD|(919) 681-6804|Linda.Kaltenbach@duke.edu|
22395104|NCT01423253|Sunovion|1-866-503-6351|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
22395105|NCT00392327|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22395106|NCT00894686|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22395107|NCT03267940|Halozyme Therapeutics|VP, Medical, Regulatory and Drug Safety|858-794-8889|medinfo@halozyme.com|
22395108|NCT01869075|Sunnybrook HSC|Artemis Diamantouros|416-480-6100|artemis.diamantouros@sunnybrook.ca|3654
22395109|NCT02197767|Mayo Clinic|Dr. Stephen B. Erickson|507-284-4083|Erickson.Stephen@mayo.edu|
22395110|NCT01280110|Departamento de Oftalmologia - Universidade Estadual de Campinas - Campinas - Brazil|Vital Paulino Costa|55-19-35217396|vp.costa@uol.com.br|
22395111|NCT01759407|Nationwide Children's Hospital|Nicole Elsey, MD|614-722-4200|Nicole.Elsey@nationwidechildrens.org|
22395112|NCT01477320|University of Louisville|Dr. Mohamed Saad|5028525841|mohamed.saad@louisville.edu|
22395113|NCT04526197|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22395114|NCT01209143|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
22395115|NCT01136811|University of Chicago|Shirley Rodriguez|773-834-4337|srodrigu@surgery.bsd.uchicago.edu|
22395116|NCT02441062|University of Iowa, Holden Comprehensive Cancer Center|M.Sue O'Dorisio|(319) 335-7234|sue-odorisio@uiowa.edu|
22395117|NCT02279394|Dana-Farber Cancer Institute|Dr. Irene Ghobrial|617-632-4198|Irene_Ghobrial@dfci.harvard.edu|
22395118|NCT02740972|NS Pharma, Inc.|Medical Affairs|(201) 986-3860|trialinfo@nspharma.com|
22395119|NCT01116882|Harvard Clinical Research Institute|Priscilla Driscoll-Shemp|617-307-5200|priscilla.driscoll-shempp@hcri.harvard.edu|
22434983|NCT00901511|Fondazione IRCCS Policlinico San Matteo Pavia|Francesca Mariani|+39 0382 503590|fr.mariani@smatteo.pv.it|
22434984|NCT02880514|Intersect ENT, Inc.|James Stambaugh, Vice President of Clinical & Medical Affairs|650-641-2103|jstambaugh@intersectent.com|
22395120|NCT00547365|University of Tennessee Graduate School of Medicine|Alan Solomon, MD|865-305-9167|asolomon@utmck.edu|
22395121|NCT03933774|St. Vincent's Hospital|Dr. Jung Min Bae|82-31-881-8982|jminbae@gmail.com|
22395122|NCT01139658|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22434985|NCT02436668|Pharmacyclics, An AbbVie Company|George Cole|(408) 990-7340|gcole@pcyc.com|
22434986|NCT00937118|Oregon Health & Science University|John Mayberry, MD|503-494-5300|mayberrj@ohsu.edu|
22434987|NCT01660737|PASCOE Pharamzeutische Präparate GmbH|Jennifer Lebert|0049+(0)641-7960-955|Jennifer.lebert@pascoe.de|
22434988|NCT01444027|University of Washington, School of Nursing|Dr. George Demiris|206-221-3866|gdemiris@uw.edu|
22434989|NCT01485380|Massachusetts General Hospital|Dr. Oluwaseun Johnson-Akeju|6177247200|oluwaseun.akeju@mgh.harvard.edu|
22434990|NCT03551665|Arizona State University|Daniel Peterson|602-543-9373|daniel.peterson1@asu.edu|
22434991|NCT05538312|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22434992|NCT03966885|Columbia University|Jeremy Kane, PhD, MPH|7179914098|jk4397@cumc.columbia.edu|
22434993|NCT00840060|Lamar University|Monica Harn|409-880-8174|monica.harn@lamar.edu|
22434994|NCT01514240|Biometrics Department, Science Affairs Division, R&D, AstraZeneca Japan|Masahiro Nii||Masahiro.Nii@astrazeneca.com|
22434995|NCT00509093|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Anjali Advani|+1 216-445-9354|advania@ccf.org|
22434996|NCT05013424|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22434997|NCT01103063|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22434998|NCT05858450|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22434999|NCT02068846|University of North Carolina at Chapel Hill|Jennifer Webster-Cyriaque, DDS, PhD|(919) 537-3492|jwebster@email.unc.edu|
22435000|NCT03899064|MC2 Therapeutics|Birgitte Vestbjerg|+44 2077 2575|bve@mc2therapeutics.com|
22435001|NCT03283098|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22435002|NCT03115853|Vanderbilt University Medical Center|James Muldowney, MD|615-936-1720|james.muldowney@vanderbilt.edu|
22435003|NCT03515226|University of Washington, Department of Psychiatry & Behavioral Sciences|Dr. Patricia Arean, Director, UW ALACRITY Center|206-221-8692|parean@uw.edu|
22435004|NCT01069861|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22435005|NCT00354107|Children's Oncology Group|Results Reporting Coordinator|3522730558|resultsreportingcoordinator@childrensoncologygroup.org|
22435006|NCT02868034|University of Utah|Julie Fritz|18015872237|julie.fritz@utah.edu|
22435007|NCT03538444|Medical University of South Carolina|Gregory Sahlem MD|843-792-5716|sahlem@musc.edu|
22435008|NCT01035346|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22435009|NCT01459653|Sandoz GmBH|Andriy Krendyukov, Global Medical Director|+49 8024 4764855|andriy.krendyukov@sandoz.com|
22435010|NCT04420572|SultanAbdulhamid|Adem Erbirol|+905426608788|aerbirol@hotmail.com|
22435011|NCT00457821|Vertex|Medical Monitor|617-444-6777|medicalinfo@vrtx.com|
22435012|NCT00842946|Department of Veterans Affairs (formerly Drexel University)|Dr. Erica England|207-239-6323|elengland02@yahoo.com|
22435013|NCT02139878|University of Prince Edward Island|Kim S. Stote PhD, MPH, RD|518-587-2100|Kim.Stote@esc.edu|2873
22435014|NCT00790647|Boston Medical Center|Vaishali Sanchorawala|617-638-8265|vaishali.sanchorawala@bmc.org|
22435015|NCT02305017|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22435016|NCT02302092|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22435017|NCT02437409|phenox GmbH|Clinical Affairs|+49 (0)234 36 919|ARTESp@phenox.info|0
22435018|NCT00027378|University of Pittsburgh|Jack R. Cornelius, M.D., M.P.H.|412-246-5149|corneliusjr@upmc.edu|
22435019|NCT03296137|National Center for Cancer Immune Therapy, Herlev Hospital|Anders Kverneland, MD, PhD|+4538686467|anders.kverneland@regionh.dk|
22435020|NCT01369680|Medical University of South Carolina|Dr. Amy-Lee Bredlau|843-792-2957|bredlau@musc.edu|62872
22435021|NCT03549871|Sanofi ( Genzyme, a Sanofi Company )|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
22435022|NCT01687088|Thomas Jefferson University|Michael J. Marmura, MD|215-955-2243|michael.marmura@jefferson.edu|
22395123|NCT00352911|VGX Pharmaceuticals, LLC|Mary Giffear, Sr. Clinical Scientist|267 440 4220|mgiffear@inovio.com|
22395124|NCT03717129|Johns Hopkins University|Dr. Craig Hendrix|4109559707|chendrix@jhmi.edu|
22395125|NCT01783041|Children's Hospital at Montefiore, Albert Einstein College of Medicine|Mamta Fuloria|718-904-4105|mfuloria@montefiore.org|
22395126|NCT03796260|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22435023|NCT00737568|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22435024|NCT01133626|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22435025|NCT00951080|KCI|VP, Global Clinical Development|12102555595|jkhart@mmm.com|
22435026|NCT01713283|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22435027|NCT00835640|Manager, Biopharmaceutics|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22435028|NCT00350272|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22435029|NCT00760461|Yale University|Anish A Sheth M.D|203-785-4576|anish.sheth@yale.edu|
22435030|NCT00235391|Novartis Pharmaceuticals|Study Director|862-778-8300||
22435031|NCT01044212|University of Rochester|Gunhilde Buchsbaum, Division Director Urogynecology|585-273-3233|gunhilde_buchsbaum@urmc.rochester.edu|
22435032|NCT02927925|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22435033|NCT03955250|Butler Hospital|Brandon Gaudiano, Ph.D.|401-455-6457|BGaudiano@Butler.org|
22435034|NCT00075725|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22435035|NCT03352557|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22435036|NCT01560637|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
22435037|NCT02538419|Brigham and Women's Hospital|Dr. Jessie Bakker|617-732-5987|jpbakker@bwh.harvard.edu|
22435038|NCT01070693|Helsinki University Central Hospital|Dr. Georgios Pierides|+358 9 4711|georgios.pierides@hus.fi|
22435039|NCT02071420|University of Iowa|Lucas Carr, PhD|319-353-5432|lucas-carr@uiowa.edu|
22435040|NCT05894538|Duke University|Susanna Naggie, MD, MHS, FIDSA|919-684-2584|susanna.naggie@duke.edu|
22435041|NCT04962230|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22435042|NCT02387801|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22435043|NCT02275117|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
22435044|NCT01327274|UCSF Benioff Children's Hospital|Jill Imamura-Ching, RN|415-476-3446|Jill.Imamura-Ching@ucsf.edu|
22435045|NCT00386477|Indiana University School of Medicine|David M. Haas, MD, MS|317-630-7837|dahaas@iupui.edu|
22435046|NCT01081301|University of Alberta|Dr. Wendy Duggleby|780-492-8660|wendy.duggleby@ualberta.ca|
22435047|NCT02266277|University of Massachusetts Medical School|Dr. Sarah Cutrona|508-856-3086|sarah.cutrona@umassmed.edu|
22435048|NCT01646645|Memorial Sloan Kettering Cancer Center|Dr. Susan Prockop|212-639-6715|prockops@mskcc.org|
22435049|NCT00717522|Celgene Corporation|Associate Director, Clinical Trial Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22435050|NCT01799239|Coloplast A/S|Camilla Felsvang Vibjerg, Senior Clinical manager|+45 4911 1990|dkcfv@coloplast.com|
22435051|NCT04209114|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
22435052|NCT02403895|AstraZeneca|Medical Science Director||clinicaltrialtransparency@astrazeneca.com|
22435053|NCT00167180|Masonic Cancer Center, University of Minnesota|Dr. Jeffrey Miller|612-625-7409|mille011@umn.edu|
22435054|NCT03785587|Botanix Pharmaceuticals|Anthony Robinson MS CRNP|+1 (445) 300-3403|trials@botanixpharma.com|
22435055|NCT04143217|Supernus Pharmaceuticals Inc.|Jonathan Rubin, MD, MBA, Senior Vice President/Chief Medical Officer|240-403-5710|jrubin@supernus.com|
22435056|NCT00395291|University of Virginia|W. Kline Bolton, MD|434-924-9692|wkb5s@Virginia.edu|
22435057|NCT02210832|University of Vermont|Stephen T. Higgins|802-735-6267|stephen.higgins@uvm.edu|
22435058|NCT02968381|University of Arizona|Judith Gordon|520-626-4970|judithg@email.arizona.edu|
22435059|NCT00471887|UCLA|Antoni Ribas, MD|310-206-3928|aribas@mednet.ucla.edu|
22435060|NCT04790812|The University of Texas Health Science Center at Houston|Harry Gilbert, DDS|713-486-4315|Harry.D.Gilbert@uth.tmc.edu|
22395127|NCT00753272|GlaxoSmithKline|GSK Response Center|866-435-7343||
22395128|NCT02265367|University of Minnesota|Michael Kotlyar|612-625-1160|kotly001@umn.edu|
22395129|NCT02092220|Massachusetts General Hospital|Dr Steven J Russell|617-726-1848|sjrussell@partners.org|
22395130|NCT00960531|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22395131|NCT00593957|Kennedy Krieger Institute|Dr Sakkubai Naidu Professor of Neurology and Pediatrics|443-923-2778|naidu@kennedykrieger.org|
22435061|NCT03824405|Botanix Pharmaceuticals|Head of Development|+1 (445) 300-3403|trials@botanixpharma.com|
22395132|NCT03481023|Riverside Medical Center|Dr. Brad Suprenant|(815) 939-9400|blsuprenant@comcast.net|
22395133|NCT00494481|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22395134|NCT01030198|Cynosure, Inc.|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22395135|NCT02791737|The Ohio State University Comprehensive Cancer Center|Dr. Ashley Rosko|614-293-3196|Ashley.Rosko@osumc.edu|
22435062|NCT02154048|Duke University|Steve Melton, MD|919.668.2047|steve.melton@duke.edu|
22435063|NCT01278407|Eisai Co., Ltd.|Masaki Nakagawa|+81-3-3817-5245||5245
22435064|NCT03710876|Ferring Ventures Ltd|Lindsay Caygill Clinical Trial Manager|+44 (0) 74 213 02230|linsdsay.caygill@trizell.com|
22395136|NCT01411839|University of California, San Francisco|Dr. John A. Sauceda|415-460-6045|john.sauceda@ucsf.edu|
22395137|NCT05089656|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22395138|NCT02535416|Arrowhead Pharmaceuticals, Inc.|James Hamilton, MD|626-696-3400|jhamilton@arrowheadpharma.com|
22395139|NCT03706417|MaineHealth|Principal Investigator|207-396-6920|alexa.craig@mainehealth.org|
22395140|NCT05938998|University of Kansas Medical Center|Dr. Amy Bodde|913-588-7983|abodde@kumc.edu|
22395141|NCT01611948|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu|
22395142|NCT04641299|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22395143|NCT03662139|Department of PM&R, Marmara University School of Medicine|Naime Evrim Karadag-Saygi, Prof. Dr.|00902166570606|evrimkaradag4@hotmail.com|1628
22395144|NCT01890148|AstraZeneca|Larsson, Bengt|+46 (0) 317064277|ClinicalTrialTransparency@astrazeneca.com|
22395145|NCT00619190|UNC Chapel Hill|Linmarie Sikich, MD|919-972-7499|lsikich@med.unc.edu|
22395146|NCT00530868|UAB|Lisle Nabell|205 934-3061|Lnabell@uabmc.edu|
22395147|NCT01774851|Merrimack Pharmaceuticals|MM-111 Medical Director|617-441-1000||
22395148|NCT01566682|ProLung|Michael Garff, Chief Operating Officer|8012049625|mag@prolunginc.com|
22395149|NCT00281021|James Graham Brown Cancer Center, University of Louisville|Dr. Goetz Kloecker|502-562-4358|ghkloe01@exchange.louisville.edu|
22395150|NCT04229472|Oxford University Hospitals NHS Foundation Trust|Timothy R Betts|+44 (0)1865 220256|timothy.betts@cardiov.ox.ac.uk|
22425470|NCT03173456|Department of Emergency Medicine Albert Einstein Coll of Med|Dr. Polly Bijur|914-661-4707|polly.bijur@einsteinmed.org|
22395151|NCT05736211|Wake Forest University School of Medicine|Dr. Parissa Ballard|704-355-2000|parissa.ballard@advocatehealth.org|
22425471|NCT01733121|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22425472|NCT03061188|Northwestern University, Feinberg School of Medicine|Young Kwang Chae, MD, MPH, MBA|312-926-4248|YCHAE@nm.org|
22425473|NCT01309451|Raj K. Maturi, MD, PC|Raj K. Maturi, MD|317-817-1414|rmaturi@gmail.com|
22425474|NCT04865419|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22425475|NCT05446142|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22425476|NCT00889915|Duke Clinical Research Institute - Duke University School of Medicine|John S. March, MD, MPH|919-668-7818|john.march@duke.edu|
22425477|NCT00547157|Amgen Inc.|Study Director|866-572-6436||
22425478|NCT00090870|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
22425479|NCT01151345|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22425480|NCT00290654|Masonic Cancer Center, University of Minnesota|Todd Tuttle, M.D.|612-625-2991|tuttl005@umn.edu|
22425481|NCT03883477|Cedars-Sinai Medical Center, Department of Orthopedic Surgery|Clinical Trial RN|3104235900|rodriquezsv@csmns.org|
22425482|NCT03853291|Weill Cornell Medicine|Dr. Catherine Riffin, Assistant Professor of Psychology in Medicine|646.962.7160|acr2213@med.cornell.edu|
22425483|NCT02974803|Canadian Cancer Trials Group|Lesely Seymour|6135336430|lseymour@ctg.queensu.ca|
22425484|NCT04186221|TransMedics, Inc.|Laura Damme, VP Clinical Affairs|978-552-0900|ldamme@transmedics.com|
22425485|NCT01658904|National Cancer Institute|Dr. Ronald Gress|301-496-1791|gressr@dc10a.nci.nih.gov|
22425486|NCT02432209|Yale School of Public Health|Fangbai Sun|2037855185|fangbai.sun@yale.edu|
22425487|NCT02611765|Baylor College of Medicine|Jose Serpa-Alvarez|713 798-7910|jaserpaa@bcm.edu|
22425488|NCT02998996|Eurocine Vaccines AB|Anna-Karin Maltais|+46 76 233 81 62|annakarin.maltais@eurocine-vaccines.com|
22425489|NCT01087203|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22425490|NCT01961167|W. L. Gore & Associates|Melissa Zambeck|928-856-4900|mzambeck@wlgore.com|
22425491|NCT00305565|Cyberonics Inc.|Mark Bunker Sr. Director, Global Medical Affairs|281-228-7223|Mark.Bunker@cyberonics.com|
22425492|NCT02446847|The Rockefeller University|Dr. Marina Caskey, Associate Professor of Clinical Investigation|212-327-7396|mcaskey@rockefeller.edu|
22425493|NCT01616160|Massachusetts General Hospital|Daniel L. Hamilos, M.D.|617-726-5090|dhamilos@partners.org|
22425494|NCT04074330|Takeda|Medical Director|1-877-825-3327|TrialDisclosures@takeda.com|
22425495|NCT03790865|Millendo Therapeutics|Clinical Trial Information|+1 734-845-9000|millendo@millendo.com|
22425496|NCT00502853|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22425497|NCT01429298|Department of Emergency Medicine, Montefiore Medical Center|Andrew Chang, MD, MS|718-920-7464|achang@montefiore.org|
22425498|NCT02903420|Edwards Lifesciences|Director of Research|949-250-2500|THV_CT.gov@edwards.com|
22425499|NCT03866278|Massachusetts General Hospital|Principal investigator|6176709739|patrick.purdon@MGH.HARVARD.EDU|
22425500|NCT00227019|Stanford University|Heather Wakelee, MD|650-736-7221|hwakelee@stanford.edu|
22425501|NCT00181883|Massachusetts General Hospital|Janet Wozniak, MD|617-503-1038|jwozniak@partners.org|
22425502|NCT05305989|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|#6
22425503|NCT03162328|Philips|Gary Garcia|6085129475|gary.garcia@philips.com|
22425504|NCT00913770|Yale University|Gail D'Onofrio, MD, MS|203-785-4404|gail.donofrio@yale.edu|
22425505|NCT01990768|University of Washington, Resuscitation Outcomes Consortium|Dr. Susanne May|206-685-1302|rochelp@uwctc.org|
22425506|NCT02348008|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317-921-2050|jsmith@hoosiercancer.org|
22425507|NCT03479944|Alcon Japan Ltd.|Group Manager, Surgical, Alcon Japan|03-6899-5061|alcon.medinfo@alcon.com|
22425508|NCT02029274|Novartis Pharmaceuticals|Study Director|862-778-8300||
22425509|NCT02320227|Church & Dwight Co., Inc.|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
22425510|NCT01249833|Trial Management Group Inc.|Joanne Morris, Clinical Research Quality Manager|4169297717|joanne@tmginvestigators.com|
22425511|NCT00669318|Mayo Clinic Cancer Center|Timothy G. Call MD||call.timothy@mayo.edu|
22425512|NCT02315664|Arthritis Research Canada|Dr. Linda Li, Professor, University of British Columbia|604-207-4020|lli@arthritisresearch.ca|
22435065|NCT02534935|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22435066|NCT01460719|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22435067|NCT02630017|University of Arkansas for Medical Sciences|Merideth Addicott|501-526-8436|maddicott@uams.edu|
22435068|NCT01151761|Stanford University Cancer Center|Dr. Daniel Chang|650-724-3547|dtchang@stanford.edu|
22435069|NCT03602885|DFCI|Andrea Enzinger, MD|617-582-7335|andrea_enzinger@dfci.harvard.edu|
22435070|NCT01430325|Intermountain Healthcare|Lindell K. Weaver, MD|801-408-3623|lindell.weaver@imail.org|
22435071|NCT02838901|Wake Forest School of Medicine|Dr. Cheryl Bushnell|336-716-4101|cbushnel@wakehealth.edu|
22435072|NCT01007123|Albireo|Dr Mats Ekelund|+46 31 741 14 80|info@albireopharma.com|
22435073|NCT04431713|UCL|Professor Foltynie|020 3448 8726|t.foltynie@ucl.ac.uk|
22435074|NCT04114604|KITE Research Institute - Toronto Rehabilitation Institute, University Health Network|Director, Swallowing Rehabilitation Research Laboratory|416 597 3422|tri-swallowinglab@uhn.ca|7802
22435075|NCT02285114|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22435076|NCT00320255|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22435077|NCT00773786|Saint Francis Hospital and Medical Center|Richard ZuWallack, MD||rzuwalla@stfranciscare.org|
22435078|NCT00683917|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
22435079|NCT02725879|2nd Department of Paediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, AHEPA University Hospital, 54636 Thessaloniki,|Professor Assimina Galli-Tsinopoulou|+302310994802|agalli@auth.gr|
22435080|NCT04699032|VectivBio AG|Reda Sheik|+41615513030|clinicaltrials@vectivbio.com|
22435081|NCT03022097|AstraZeneca|Global Clinical Head|1-877-240-9479|information.center@astrazeneca.com|
22435082|NCT00358332|University of Maryland School of Medicine|Christopher V. Plowe|410-706-3082|cplowe@medicine.umaryland.edu|
22435083|NCT03660228|Dana-Farber Cancer Institute|Gregory A. Abel, MD|617-632-2304|GAABEL@PARTNERS.ORG|
22435084|NCT03640052|Brigham and Women's Hospital|Luigi Taranto Montemurro, MD|6177326541|ltarantomontemurro@bwh.harvard.edu|
22435085|NCT00623545|University of Wisconsin-Madison|Dale A Schoeller|608-262-1082|dschoell@nutrisci.wisc.edu|
22435086|NCT04283942|Zhongshan Hospital, Fudan University|Dr. Hua Bian|+86 64041990|zhongshan_bh@126.com|
22435087|NCT05479097|University of Wisconsin School of Medicine and Public Health|Dr. Sean Duffy|608-263-3111|sean.duffy@fammed.wisc.edu|
22435088|NCT04126564|Sadhguru Center for a Conscious Planet, BIDMC|Dr. Balachundar Subramaniam|(617)632-8071|bsubrama@bidmc.harvard.edu|
22435089|NCT04854031|Boys Town National Research Hospital|Adam Bosen|531-355-5030|adam.bosen@boystown.org|
22435090|NCT02540330|Atossa Therapeutics, Inc.|Heather Fraser, VP Clinical, Regulatory & CMC|206-707-3088|heather.fraser@atossainc.com|
22435091|NCT03941964|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22435092|NCT00445848|Swog Statistical Center|Lung Committee Statistican|2066674623|jmoon@fredhutch.org|
22435093|NCT05605691|Apyx Medical|Kari Larson, Sr. Director of Clinical Affairs|8012440058|kari.larson@apyxmedical.com|
22435094|NCT01644695|Institute For Advanced Reconstruction|Dr. Andrew Elkwood, MD|732-741-0970|aelkwood@hotmail.com|
22435095|NCT00855933|The Procter & Gamble Co.|Jon Witt|513-622-2963|witt.jj.2@pg.com|
22435096|NCT05463744|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22435097|NCT02851407|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-870-9177|ClinicalTrialDisclosure@JazzPharma.com|
22435098|NCT01311115|University of California, San Francisco|Justin White|415-476-8045|Justin.White@ucsf.edu|
22435099|NCT02124018|First Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens|Professor Konstantinos A. Gatzoulis|6944580369|kgatzoul@med.uoa.gr|0030
22395152|NCT02158520|Mayo Clinic|Svetomir N. Markovic MD, PhD|507/266-0800|markovic.svetomir@mayo.edu|
22425513|NCT01677182|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22425514|NCT00995722|University Of Miami|Dr. Benatar|305-243-6480|MBenatar@med.miami.edu|
22425515|NCT00667992|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22425516|NCT01431313|University of Pittsburgh|Marc A. Simon, MD|4128023131|SIMONMA@UPMC.EDU|
22425517|NCT02748057|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22425518|NCT02588586|The Rockefeller University|Dr. Marina Caskey, Professor of Clinical Investigation|2123277396|mcaskey@rockefeller.edu|
22425519|NCT03512353|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22425520|NCT02090283|Amicus Therapeutics, Inc.|Patient Advocacy|+1-609-662-2000|clinicaltrials@amicusrx.com|
22425521|NCT00459810|Oregon Health & Science University Knight Cancer Institute|Study Coordinator|(503) 494-2897|eilersk@ohsu.edu|
22425522|NCT01867515|VA Portland HCS, RR&D National Center for Auditory Rehabilitative Research|Michelle R. Molis, PhD|503-220-8262|michelle.molis@va.gov|55574
22425523|NCT02171429|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22425524|NCT00281697|Genentech, Inc.|Medical Communications|800 821-8590||
22395153|NCT05104476|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
22425525|NCT00632125|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|0049 80244760|biopharma.clinicaltrials@sandoz.com|
22425526|NCT02459197|Tools4Patient|Chief Scientific Officer|+32 71 91|alvaro.pereira@tools4patient.com|94 00
22425527|NCT00577772|Mayo Clinic|Dr. John K. DiBaise|480-301-6990|dibaise.john@mayo.edu|
22425528|NCT01761643|UC San Diego|Mike Duszynski|6195438080|mduszynski@health.ucsd.edu|
22425529|NCT01354197|Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand|Kaweesak Chittawatanarat|053-935533|kchittaw@gmail.com|
22425530|NCT00540644|IndianaU|Dr. Attaya Suvannasankha|317-944-0920|asuvanna@iu.edu|
22425531|NCT00105989|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22425532|NCT01716663|Biosense Webster|Ellen Harris, Project Manager, Clinical Operations|909-839-7376|eharris8@its.jnj.com|
22425533|NCT01059773|Janssen-Cilag France|EMEA THERAPEUTIC AREA LEADER|+33 6 15167408||
22425534|NCT02258217|OhioHealth Research Institute|Anand Gupta|614-788-3868|anand.gupta@ohiohealth.com|
22425535|NCT01101750|MedStar Health Research Institute|Veronica Gomez-Lobo, MD|202-877-4099|veronica.gomez-lobo@medstar.net|
22425536|NCT01806168|Vancouver Coastal Health / Vancouver General Hospital|Kawai Leong, MD, MSc, FRCPC|604-875-8289|kawai.leong@vch.ca|
22425537|NCT02693262|University of California, San Diego|Jonathan Hsu, MD, MAS|858-246-2972|jonathan.hsu@ucsd.edu|
22425538|NCT02620787|Center for Anti Infective Research and Development|Dr. David P. Nicolau|(860) 972-3941|david.nicolau@hhchealth.org|
22425539|NCT01100723|University of Colorado|Dr. David M. Spiegel|303-724-7797|david.spiegel@ucdenver.edu|
22425540|NCT02104427|TaiGen Biotechnology Co., Ltd.|Li-Wen Chang|+886-2-8177-7072|lwchang@taigenbiotech.com|1227
22425541|NCT01462630|Fox Chase Cancer Center|Protocol Development Coordinator|215-728-4097|ryan.romasko@fccc.edu|
22435100|NCT02585830|University of Colorado Anschutz Medical Campus|Stacey L. Simon|720-777-5681|stacey.simon@childrenscolorado.org|
22435101|NCT00812006|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com|
22435102|NCT00068250|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22435103|NCT03242772|Duke Center for Autism and Brain Development|Dr. Geraldine Dawson, PhD, PI of Duke Autism Center of Excellence|919-668-0070|geraldine.dawson@duke.edu|
22435104|NCT04677660|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22435105|NCT02499900|Teva Pharmaceutical Industries Ltd.|Director, Clinical Research|+01 215-591-3000|USMedInfo@tevapharm.com|
22435106|NCT03416920|Massachusetts General Hospital|Dr. Pradeep Natarajan|617-724-3526|PNATARAJAN@PARTNERS.ORG|
22435107|NCT01648296|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
22435108|NCT03385265|Nemours Children's Health|Dr. Susana Patton|904-697-2000|susana.patton@nemours.org|
22435109|NCT01089023|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22435110|NCT02434354|Abramson Cancer Center|Dr. Tara Mitchell|215-662-7908|tara.mitchell@pennmedicine.upenn.edu|
22435111|NCT03410797|University of Pittsburgh|Jacqueline Gartner-Schmidt|412-232-8970|jgs@pitt.edu|
22435112|NCT01185964|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22435113|NCT04465877|Akros Pharma Inc.|Kazuhiro Okamiya|609-919-6123|okamiya@akrospharma.com|
22435114|NCT02794844|Nemours Children's Hospital|James P. Franciosi, MD|407-567-3832|jfrancio@nemours.org|
22435115|NCT02257177|Galecto|Professor Bertil Lindmark|+4570705210|info@galecto.com|
22395154|NCT03865940|Vanderbilt University Medical Center|Shelby Meier, PhD - Senior Scientific Project Manager|6159369228|shelby.meier@vumc.org|
22435116|NCT03440918|Vanderbilt University Medical Center|Dr. Sophie Katz|615-343-6190|sophie.e.katz@vumc.org|
22435117|NCT03576755|University of California San Francisco|Principal Investigator: Dr. Monika Sarkar|415-502-2656|monika.sarkar@ucsf.edu|
22435118|NCT04346108|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22435119|NCT01598753|University of Washington|Dennis C. Turk, Ph.D.|(206)616-2626|turkdc@uw.edu|
22395155|NCT00980681|Guerbet|Pierre Desche, MD, Head of Clinical and Regulatory Affairs|+33 1 45 91 50 00|pierre.desche@guerbet-group.com|
22435120|NCT02014480|GlaxoSmithKline|GSK Response Center|866-435-7343||
22435121|NCT00724854|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22435122|NCT01338610|Alcon Research, Ltd.|Christian Leisner|1-888-451-3937|alcon.medinfo@alcon.com|
22435123|NCT01865812|Intercept Pharmaceuticals, Inc.|Medical Information|+1 844-782-4278|medinfo@interceptpharma.com|
22435124|NCT04092907|Harbour Biomed|Nina Shen|18251811067|nina.shen@harbourbiomed.com|
22435125|NCT02032407|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22435126|NCT03383757|GE Healthcare|Clinical Affairs Project Manager|262-443-7008|stephanie.karwedsky@ge.com|
22435127|NCT02324205|GE Healthcare|Sara Lam|1-262-548-2369|Sara.J.Lam@ge.com|
22435128|NCT04685707|University of Southern Mississippi|Dr. Nuno Oliveira|6012665804|nuno.oliveira@usm.edu|
22435129|NCT00090233|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22435130|NCT04863248|G1 Therapeutics, Inc|Clinical Trial Info|919-213-9835|clinicalinfo@g1therapeutics.com|
22435131|NCT02536300|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22435132|NCT03760016|University of Cincinnati|Pierce Boyne|5135587499|Pierce.Boyne@uc.edu|
22435133|NCT01482169|Ochsner Clinic Foundation|Dr. Robert Bober|504-842-4135|rbober@ochsner.org|
22435134|NCT01777542|Boston Children's Hospital|Dr. Mustafa Sahin, Director of Translational Neuroscience Center|617-919-6258|ResearchTNC@childrens.harvard.edu|
22435135|NCT02270255|McGill University Health Centre|Louis-Martin boucher|5149341934|lmboucher@yahoo.com|44454
22435136|NCT01030874|VAORD|Mark Helfand, MD|5032203406|mark.helfand@va.gov|
22435137|NCT03630198|Vanderbilt Univeristy Medical center|Dr. Brian Drolet|615-322-2918|brian.c.drolet@vumc.org|
22435138|NCT02279719|Sumitomo Dainippon Pharma Oncology|Matthew Hitron, MD|617-674-6800|mhitron@bostonbiomedical.com|
22435139|NCT05257148|A. Menarini Industrie Farmaceutiche Riunite SrL|Clinical Operation Director|+39 055 5680459|pfabrizzi@menarini.it|
22435140|NCT03541187|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22435141|NCT02299570|Rebiotix|Assoc. Director of Clinical Research|651-705-8778|Sarah.Mische@Ferring.com|
22435142|NCT00869050|Columbia University|Dr. Paul Oberstein|212-305-0592|po2178@cumc.columbia.edu|
22435143|NCT00899717|University of Santiago de Compostela|Urbano Santana Penín|0034647344093|urbano.santana@usc.es|
22435144|NCT00383643|Stanford University School of Medicine, Dept of Psychiatry|Dr. Jed Black|650 736 4559|jedblack@stanford.edu|
22435145|NCT02251561|Alcon Japan, Ltd.|Director, Clinical & Regulatory Affairs, Division of Medical Affairs||alcon.medinfo@alcon.com|
22435146|NCT03199053|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22435147|NCT02769338|Department of Veterans Affairs|Dr. Dawn M. Bravata|317-988-2676|Dawn.Bravata2@va.gov|
22435148|NCT00561002|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22435149|NCT03298984|Sumitomo Dainippon Pharma Oncology, Inc.|Susan Smith|2104147702|Susan.smith@sdponcology.com|
22435150|NCT01571284|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22435151|NCT03964246|Veterans Affairs San Diego Healthcare System|Barton W. Palmer|8582460765|bpalmer@ucsd.edu|
22435152|NCT03403231|VA Center for Clinical Management Research|Bradley Youles, Project Manager|734-845-5055|Bradley.Youles@va.gov|
22435153|NCT03883113|Vaccitech Ltd.|Tom Evans, MD|+44 01865 591 445|enquiries@vaccitech.co.uk|
22435154|NCT02323204|University of Iowa/ University of Minnesota|Dr. Marizen R Ramirez|612-624-3143|mramirez@umn.edu|
22435155|NCT00395135|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22435156|NCT02046226|Halyard Health, Inc.|David T Curd|470-448-5178|david.curd@hyh.com|
22435157|NCT01095653|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
22435158|NCT00171925|Novartis Pharmaceuticals|Study Director|862-778-8300||
22435159|NCT02692040|Imperial College London|Dr Tricia Tan|020 838 38038|t.tan@imperial.ac.uk|
22435160|NCT03089879|GlaxoSmithKline|GSK Response Center|866-435-7343|ass77028@gsk.com|
22435161|NCT02470754|University of California, San Francisco|Natalie Nardone, PhD|415-514-1450|natalie.nardone@ucsf.edu|
22435162|NCT01819129|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)||clinicaltrials@novonordisk.com|
22435163|NCT02825966|ZOLL|Director, Clinical Operations|4129683333|mosz@zoll.com|
22435164|NCT02752958|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22435165|NCT01863134|First Department of Cardiac Surgery, Medical University of Silesia, Katowice, Poland|Miroslaw Wilczynski|+48 32 20 24 025|miroslaw.wilczynski@cardiosurg.pl|
22435166|NCT00054691|University of Texas (UT) MD Anderson Cancer Center|Bonnie Glisson, MD / Professor, Thoracic/Head & Neck Med Oncology|713-792-6363|CR_Study_Registration@mdanderson.org|
22435167|NCT02836873|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
22435168|NCT03190265|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dung Le, MD|443-287-0002|dle@jhmi.edu|
22435169|NCT00853125|Rutgers Cancer Institute of New Jersey|Roger Strair, MD, PhD|732-235-7298|strairrk@cinj.rutgers.edu|
22435170|NCT02914548|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22435171|NCT00711490|National Eye Institute|Catherine Meyerle, MD|301-435-7821|meyelec@nei.nih.gov|
22435172|NCT02599649|The University of Texas MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/Professor|713-745-3428|ggarciam@mdanderson.org|
22435173|NCT03746600|University of Kentucky College of Medicine|Carolyn Lauckner, PhD|989-928-2359|carolyn.lauckner@uky.edu|
22435174|NCT03023826|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22435175|NCT00182767|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
22435176|NCT00977938|Harvard Clinical Research Institute|Priscilla Driscoll Shempp, Sr. Director Trial Design, Development and Strategy|617.307.5200|pdriscoll@hcri.harvard.edu|
22435177|NCT01310179|University of Alabama at Birmingham|Eben Rosenthal, MD|205-934-9713|erosenthal@uabmc.edu|
22425542|NCT03665077|George Washington Cancer Center|Dr. Pavani Chalasani|(202)-741-2277|pavani.chalasani@email.gwu.edu|
22425543|NCT02364388|Seno Medical Instruments, Inc|Shaan Schaeffer, VP Clinical Operations|2106156501|sschaeffer@senomedical.com|
22425544|NCT00837967|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22425545|NCT00613379|Cytodyn, Inc.|Dr. Nader Pourhassan|360-980-8524|npourhassan@cytodyn.com|
22425546|NCT02504320|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22425547|NCT02404610|Hennepin Healthcare|Audrey Hendrickson|6128739528|audrey.hendrickson@hcmed.org|
22425548|NCT02306850|Saint Louis University|John Richart, MD|314-577-8854|john.richart@health.slu.edu|
22425549|NCT02420262|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22425550|NCT02497404|Weill Cornell Medical College|Sebastian Mayer, MD|646-962-7950|sam2033@med.cornell.edu|
22425551|NCT01408901|Northwestern University|Mary McDermott MD|312-503-6419|mdm608@northwestern.edu|
22425552|NCT05593770|Research Organization (KC) Ltd|Clinical Project Manager|+44 (0) 7494 795 982|nectar@rokcservices.com|
22425553|NCT02098395|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22435178|NCT00832130|TearScience, Inc. (formerly Kolis Scientific)|Christy Stevens, OD|919-459-4815|cstevens@tearscience.com|
22435179|NCT02142283|Stryker Neurovascular|Cheryl Fontana, Sr. Manager, Clinical Services|510-413-2948|cheryl.fontana1@stryker.com|
22435180|NCT02460783|National Institute on Aging|Dimitrios Kapogiannis|+1-202-290-0433|kapogiannisd@nih.mail.gov|
22435181|NCT01484834|UNESC|Dr. Antonio Jose Grande|04834312500|grandeto@unesc.net|2571
22435182|NCT00747344|Janssen Research & Development, LLC|Director, Clinical Research|215-793-7646||
22435183|NCT01371643|NYU Langone Medical Center|David Kleinberg|212 263 6772|David.Kleinberg@nyumc.org|
22435184|NCT00712530|Szent Laszlo Hospital, Budapest, Hungary|Dr. Denes Banhegyi|+3614558152|immunol@mail.datanet.hu|
22435185|NCT02374814|SUNY Upstate Medical University|Dr. Timothy Endy|315-464-7692|endyt@upstate.edu|
22435186|NCT00884039|Cornea Research Foundation of America|Marianne Price, PhD|317-814-2990|mprice@cornea.org|
22435187|NCT02170363|St. Jude Medical|Poornima Sood|+17818528334|PSood@sjm.com|
22435188|NCT01861925|Haag Streit AG|Dr. Lucio Robledo, Clinical Trials Biometry|+41 31 978 01 11|lucio.robledo@haag-streit.com|209
22435189|NCT02648022|Va San Diego Healthcare System|Dr. Samuel B. Ho|858-552-8585|Samuel.Ho2@va.gov|3280
22435190|NCT02182440|AM-Pharma B.V.|JAcques Arend MD, DiMD, Chief Medical Officer|+31302598836|j.arend@am-pharma.com|
22435191|NCT03754582|Eisai Co., Ltd.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22435192|NCT00167102|University of Minnesota|Dr. Maria Hordinsky|612-624-5721|hordi001@umn.edu|
22435193|NCT00072293|IBCSG|Rudolf Maibach, Executive Officer for International Trial Activities|+41 31 389 91 96|rudolf.maibach@ibcsg.org|
22435194|NCT01561755|Icahn School of Medicine at Mount Sinai|Dr. David Simpson|212-241-8748|david.simpson@mssm.edu|
22435195|NCT01166958|University of Wisconsin Osteoporosis Clinical Research Program|Neil Binkley, MD|608-265-6410|uwosteoporosis@gmail.com|
22435196|NCT01605227|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
22435197|NCT02847858|University of California San Francisco|Dr. Kathleen Tebb|415-514-0941|Kathleen.Tebb@ucsf.edu|
22435198|NCT00624819|GlaxoSmithKline|GSK Response Center|866-435-7343||
22435199|NCT04151628|Shockwave Medical Inc|Randee Randoll, Director Clinical Affairs|1-408-577-7856|rrandoll@shockwavemedical.com|
22435200|NCT02826421|Alcon, A Novartis Division|Sr Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22435201|NCT04899440|Procter & Gamble|Clinical Trial Manager|5136225362|combs.cs@pg.com|
22435202|NCT02210221|UZA|Prof. Em. Dr Andrew Maas|0032 3 821 45 37|andrew.maas@uza.be|
22435203|NCT01550341|Yale University|Dr. Frederick Altice, Principal Investigator|203-737-2883|frederick.altice@yale.edu|
22435204|NCT00405964|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22425554|NCT01310582|Clinical Research Group|Kirtanaa Voralu, Associate Director Research Management|215-255-7878|kirtanaa.voralu@drexelmed.edu|7878
22435205|NCT05291936|Johnson & Johnson Vision Care, Inc.|Benjamin Straker|1-800-843-2020|bstraker@its.jnj.com|
22425555|NCT04060797|Zhongda Hospital Affiliated to Southeast University|Dr. Gaojun Teng|13805175100|gjteng@vip.sina.com|
22425556|NCT01861002|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Roy Leong, BA, CCRP|323-361-5132|rleong@chla.usc.edu|
22425557|NCT00110357|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22425558|NCT05285787|Epizon Pharma|John Rudy|2127551000|jrudey@epizonpharma.com|
22425559|NCT04004260|Lamar University|Vinaya Manchaiah, Jo Mayo Endowed Professor|(409) 821 9443|vmanchaiah@lamar.edu|
22425560|NCT01509612|Medical University of Vienna|Michael Frass, MD|+436645453040|office@ordination-frass.at|
22425561|NCT02360280|Minneapolis VA Medical Center|Paulo R. Shiroma|612-467-2264|paulo.shiroma@va.gov|
22425562|NCT03021317|University of Chicago|Sr. Compliance Specialist|773-702-6505|czwieg@bsd.uchicago.edu|
22425563|NCT04633226|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22425564|NCT02536105|Massachusetts General Hospital|Dr. Thomas Spencer|617-724-5600|spencer@helix.mgh.harvard.edu|
22425565|NCT01765569|Organization: Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22425566|NCT06329687|Oyster Point Pharma Inc|Marian Macsai, MD|3122592477|marian.macsai@viatris.com|
22425567|NCT02733341|The Royal Wolverhampton NHS Trust|Professor James Cotton|01902307999|jamescotton@nhs.net|
22425568|NCT05415462|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
22425569|NCT01030718|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22425570|NCT00423813|Jazz Pharmaceuticals, Inc.|Grace Wang, MD, Medical Monitor & Director of Clinical Development|650-496-3777||
22425571|NCT00544908|City of Hope|Paul Frankel, Ph.D.|626-256-4673|pfrankel@coh.org|65265
22425572|NCT01904032|Loyola University Chicago|Sue Penckofer, Ph.D., F.A.A.N.|773-508-8949|spencko@luc.edu|
22425573|NCT01654263|Group Health Research Institute|Lisa A. Jackson, MD, MPH|206-442-5216|Jackson.L@ghc.org|
22425574|NCT00882661|Globus Medical|Jacqueline Myer|610-930-1800|jmyer@globusmedical.com|
22425575|NCT04270695|China Medical University|Ms Weng|0975127007|chuyu0608@gmail.com|
22425576|NCT02373137|Kaiser Permanente / University of California, San Francisco|Dr. Jennifer Rose-Nussbaumer|650-299-2111|Jennifer.Rose-Nussbaumer@kp.org|
22425577|NCT00003896|SWOG Statistical Center|Gynecologic Committee Statistician|206-667-4623||
22425578|NCT01398358|University of Michigan|Julie Lumeng, MD|jlumeng@umich.edu|jlumeng@umich.edu|
22425579|NCT00537290|Hospital for Special Surgery|Doruk Erkan, MD|212 774-2291|erkand@hss.edu|
22411228|NCT01956279|Durham VA Medical Center|Christine Marx, MD MA|919-286-0411|marx0001@mc.duke.edu|3626
22411229|NCT02265848|Center for Clinical Research / Carolinas Pain Institute|Dr. James North MD|3367656181|jhong@ccrpain.com|
22411230|NCT02224456|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22411231|NCT01241461|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22411232|NCT01379781|Columbia University Medical Center|Catherine Monk, Ph.D., Assoc Professor|(646) 774-8941|cem31@columbia.edu|
22411233|NCT02247479|Hoffmann-La Roche|Medical Communications|800 821 - 8590|genentech@druginfo.com|
22411234|NCT03740698|Imperial College London|Prof Nick Oliver|+44 (0)20 7594 1796|nick.oliver@imperial.ac.uk|
22411235|NCT02625766|University of Maryland Medical Center|Research Administrator|4103289579|NO'Hara@som.umaryland.edu|
22411236|NCT01467063|Nemours Children's Health System|Dominique Darmaun|904-697-3674|Ddarmaun@nemours.org|
22411237|NCT02802514|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22411238|NCT01045499|Columbia University|Jeffrey Zitsman, MD|212-305-8862|jlz2@cumc.columbia.edu|
22411239|NCT05216978|Brigham and Women's Hospital|Dr. Hermioni Amonoo, Director of Well-Being and Cancer Research Program|‭617-525-7472‬|hermioni_amonoo@dfci.harvard.edu|
22411240|NCT02429869|University of California, San Francisco|Rodney Rogers|415-514-6454|Rodney.Rogers@ucsf.edu|
22411241|NCT03467412|Follicum AB|CEO Jan Alenfall|+46 (0)70 931 51 15|jan.alenfall@follicum.com|
22411242|NCT01717014|Covidien|Julie Doyle|781-839-1729|Julie.Doyle@Covidien.com|
22411243|NCT00746668|Jesse Brown VAMC|Dr. Janet P. Szlyk, PhD|312-997-3644|Janet.Szlyk@va.gov|
22411244|NCT00557882|MedStar Washington Hospital Center|Andrew Sokol, MD|2028776526|andrew.i.sokol@medstar.net|
22411245|NCT03433001|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
22411246|NCT03043274|University of Kentucky|Dr. Khaled M. Ziada|8593236036|khaled.ziada@uky.edu|
22411247|NCT01299038|Beth Israel Deaconess Medical Center|Jeffrey Zwicker, MD|617-667-9299|jzwicker@bidmc.harvard.edu|
22411248|NCT01162499|Children's Hospital of Philadelphia|Diva De Leon, MD|267-426-5529|DELEON@email.chop.edu|
22411249|NCT00322556|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22435206|NCT00391391|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22435207|NCT01300819|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22435208|NCT02649855|National Cancer Institute|Dr. Ravi A. Madan|301-480-7168|madanr@mail.nih.gov|
22435209|NCT05434013|BU School of Public Health|Jennifer Ross, PhD|617 358 1905|jjross@bu.edu|
22435210|NCT03058666|Ony Biotech|James Cummings, MD|7166369096|jcummings@onybiotech.com|
22435211|NCT03561701|Mycovia Pharmaceuticals Inc|Clinical Trial Administration|919-467-8539|adminops@mycovia.com|
22435212|NCT00438854|Massachusetts General Hospital|Philip C. Amrein, M.D.|617-726-8748|pamrein@partners.org|
22435213|NCT04948307|Orexo US, Inc.|David Capano|9085079909|david.capano@orexo.com|
22435214|NCT00428220|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22435215|NCT00434356|Genentech, Inc.|Medical Communications Specialist|800-821-8590||
22435216|NCT03131596|Fuxing Hospital, Capital Medical University, Beijing, China|Dr. Shi Xiaoyu|+86 18618496384|petershi1990@163.com|
22435217|NCT00734071|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22435218|NCT03654885|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22435219|NCT05275582|VA Center for Integrated Healthcare|Dr. Julie Gass|716-834-9200|julie.gass@va.gov|25429
22435220|NCT02384434|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP|4126475554|stadtermanbm@upmc.edu|
22435221|NCT00549900|GlaxoSmithKline|GSK Response Center|866-435-7343||
22435222|NCT05693922|University of North Carolina at Chapel Hill|Erin Bondy, PhD|919-843-7694|erin_bondy@med.unc.edu|
22435223|NCT00607113|UT MD Anderson Cancer Center|Dr. James Yao|713-792-2828|mjlim@mdanderson.org|
22435224|NCT01722292|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22435225|NCT01176565|University of Minnesota|Adnan I. Qureshi, MD|612-624-2431|qureshai@gmail.com|
22435226|NCT02754141|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22435227|NCT02680041|Blue Earth Diagnostics, Ltd.|Peter Gardiner MB ChB, MRCP, FFPM|1-781-552-3403|P.Gardiner@blueearthDx.com|
22435228|NCT04239222|Ottobock SE & Co. KGaA|Clinical Project Manager|+4955278483054|pawel.maciejasz@ottobock.com|
22435229|NCT00937404|GlaxoSmithKline|GSK Response Center|866-435-7343||
22435230|NCT01779869|Washington University School of Medicine|Pamela K. Woodard, M.D.|314-362-7130|woodardp@wustl.edu|
22435231|NCT04754230|Stanford University|Zara M. Patel, MD|650-723-5651|zmpatel@stanford.edu|
22435232|NCT01318278|Baylor College of Medicine|Dr. Danielle R. Rios|832-826-1380|drrios@texaschildrens.org|
22435233|NCT01691105|Yale School of Medicine|Dr. Steven Bernstein|203-737-3574|steven.bernstein@yale.edu|
22435234|NCT00957944|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22435235|NCT03232645|Boston Scientific|Clinical Trial Manager|00393421994999|alberto.belligoli@bsci.com|
22435236|NCT00803517|Samsung Medical Center|Jiwon Lim|82-10-9933-5596|samnyasa@naver.com|
22435237|NCT01323270|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22435238|NCT01924442|VA Medical Center, Denver, Colorado|Frederick Grover, MD|303-724-2798|Frederic.Grover@ucdenver.edu|
22435239|NCT02229214|VIVUS Inc.|Craig Peterson, Sr. Director, Clinical Research|650-934-5200|ClinicalTrials@vivus.com|
22435240|NCT01057225|Mayo Clinic|Joseph Riad Mikhael, M.D.||Mikhael.Joseph@mayo.edu|
22435241|NCT00246025|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22435242|NCT02115750|Coherus BioSciences, Inc|Barbara K. Finck, MD Chief Medical Officer|650-649-3529|Bfinck@coherus.com|
22435243|NCT03305081|TulaneU|Resident of OB/GYN|858-499-2702|sjunya@tulane.edu|
22435244|NCT01218100|Forest Research Institute|Manfred Stapff, MD, PhD|201-427-8000|Manfred.stapff@frx.com|
22435245|NCT02437305|Northwestern Univeristy|Dr. Roopal Kundu|312-926-4926|rkundu@nm.org|
22435246|NCT01118520|Imperial College London|Professor Neil Poulter|+44(0) 20 7594 3446|n.poulter@imperial.ac.uk|
22435247|NCT01170065|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22435248|NCT03220581|UConn Health|Kristyn Zajac, PhD|860-679-8572|zajac@uchc.edu|
22435249|NCT01071200|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22435250|NCT01527513|BIAL - Portela & Cª SA|Director R&D|+351-229866100|clinical.trials@bial.com|
22435251|NCT01920893|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22435252|NCT01396265|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22435253|NCT01767493|Invicro|Stephanie Pizarro|203-990-1613|spizarro@invicro.com|
22435254|NCT02446418|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22435255|NCT01286987|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22435256|NCT02230761|Topokine Therapeutics, Inc.|Chief Scientific Officer|617 203 2034|CSO@topokine.com|
22435257|NCT00885638|Lund University|Professor Bo Ahrén|+46462220758|Bo.Ahren@med.lu.se|
22435258|NCT03093974|Zambon S.p.A.|Michela Meroni - Clinical Trial Manager|+39 02 665241|clincaltrials@zambongroup.com|
22435259|NCT05418153|Center For Sight|Director of Clinical Research|8438813937|hsandoval@cepmd.com|
22435260|NCT03109262|Stanford University|Andrei Iagaru, PROFESSOR OF RADIOLOGY (NUCLEAR MEDICINE)|1650-725=4711|aiagaru@stanford.edu|
22435261|NCT02330523|The McGuire Institute|E. Todd Scheyer DDS, MS|713-783-544|etsperio@swbell.net|
22435262|NCT01009346|Johns Hopkins|Ranee Mehra, MD||rmehra1@jhmi.edu|
22435263|NCT00033540|Southwest Oncology Group (SWOG) Statistical Center|Study Statistician|206-667-4623||
22435264|NCT01001546|Durham VA Medical Center - HSRD|Dr. Patrick S. Calhoun|919-286-0411|patrick.calhoun2@va.gov|7970
22435265|NCT01253265|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22435266|NCT02863523|East Carolina University|Dr. Doyle Cummings|252-744-2607|FLOYDS14@ecu.edu|
22435267|NCT00066469|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org|
22435268|NCT03271047|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22435269|NCT00711802|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
22435270|NCT01275092|Columbia University Medical Center, New York, NY, 10032|Giora Weisz, MD; Director of Clinical Resarch Center for Interven tional Vascular Therapy|212-305-7060|gweisz@crf.org|
22435271|NCT00882908|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com|
22435272|NCT03283150|University of Wisconsin-Madison|Jeremy Sullivan|6082639976|jasullivan@wisc.edu|
22435273|NCT00581828|University of Wisconsin|Dr Karen Hansen|608-263-3457|keh@medicine.wisc.edu|
22435274|NCT02981407|Rutgers Robert Wood Johnson Medical School|Dr. Jeffrey Carson|732-235-7122|jeffrey.carson@rutgers.edu|
22435275|NCT02466074|The University of Texas Health Science Center at Houston|John A. Lincoln, MD, PhD|713-500-7016|John.A.Lincoln@uth.tmc.edu|
22435276|NCT02410824|CooperVision Inc.|Sr. Manager Clinical Research|925-730-6754|pchamberlain@coopervision.com|
22435277|NCT02436408|University of Michigan Rogel Cancer Center|Cagri Besirli, MD, PhD|734-232-8404|cbesirli@med.umich.edu|
22435278|NCT00392808|Centro Superior de Investigacion en Salud Publica|Javier Diez-Domingo|+34961925937|diez_jav@gva.es|
22435279|NCT02084238|Peking University People's Hospital|Dr. Jing He|86|hejing1105@126.com|1861170734
22435280|NCT02818036|University of Pittsburgh|Dr. Tristen Inagaki|412-624-4211|inagaki@pitt.edu|
22435281|NCT01038713|Dartmouth-Hitchcock Medical Center|Timothy Gardner|603-650-6472|timothy.b.gardner@hitchcock.org|
22435282|NCT03777917|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|Aesthetic.Trials@merz.com|
22435283|NCT01154283|UMichigan|Kirsten Gruis|7346041172|klgruis@gmail.com|
22435284|NCT04063787|University of Chicago|Dr. Mary Hammes|773-702-6134|mhammes@bsd.uchicago.edu|
22435285|NCT00320372|Cyberonics, Inc|Mark Bunker, PharmD, Sr. Director, Global Medical Affairs|281-228-7223|mark.bunker@cyberonics.com|
22435286|NCT01416441|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22435287|NCT04627675|Providence Portland Medical Center|Dr. Rom Leidner|503-215-5696|rom.leidner@providence.org|
22435288|NCT01243567|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22435289|NCT01256281|Icahn School of Medicine at Mount Sinai|Dr. Jeffrey Glassberg|(212) 824-8056|jeffrey.glassberg@mountsinai.org|
22435290|NCT03959982|University of Iowa|Dr. Spyridon Fortis|319-356-4419|spyridon-fortis@uiowa.edu|
22435291|NCT04030247|Stanford University|Rajesh Dash, MD|650-725-7087|rdash@stanford.edu|
22435292|NCT02191605|Wayne State University, Merrill Palmer Skillman Institute|Dr. Jessica Beatty|3136642518|jbeatty@wayne.edu|
22435293|NCT03809910|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22435294|NCT01309269|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22435295|NCT04787055|Sonova US Corporate Services, LLC|Director of Research|630-821-5000|phonakaudiologyresearch@gmail.com|
22435296|NCT03880838|Geisinger Clinic|Amir Goren|5702144395|agoren@geisinger.edu|
22435297|NCT03647267|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|drcrnet@jaeb.org|
22435298|NCT05079477|University of Pennsylvania|Dr. Laura Gibson|215-898-7093|gibla@pennmedicine.upenn.edu|
22435299|NCT01798641|Johns Hopkins University|Dr. Daniele Rigamonti, MD FACS|410-955-2259|hydrocephalus@jhmi.edu|
22435300|NCT05320393|Evolus, Inc.|Rui Avelar|1-949-284-4689|rui.avelar@evolus.com|
22435301|NCT05264116|Stryker Sustainability Solutions|Monique Ketcher|602-354-0917|monique.ketcher@stryker.com|
22435302|NCT04411420|Duke University|Leo Brothers|919-668-8322|joseph.l.brothers@duke.edu|
22435303|NCT03187834|F.I. Proctor Foundation, University of Califonia, San Francisco|Dr. Thomas Lietman|415-502-2662|tom.lietman@ucsf.edu|
22435304|NCT00240110|Univeristy of Miami|Dr. Ihsan Salloum|305-243-7931|isalloum@med.miami.edu|
22435305|NCT01330966|George Clinical|Lindsey Munn|901-350-8801|lmunn@georgeclinical.com|
22435306|NCT01344538|University of Michigan|Suzanna M Zick|734-998-9553|szick@umich.edu|
22435307|NCT01655381|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22435308|NCT04195438|University of Maryland School of Medicine|Dr. Cherif Boutros (Surgical Oncologist)|410-328-7320|cboutros@som.umaryland.edu|
22435309|NCT00613925|Oregon health & Science University|Alison Edelman, Associate Professor|503-418-2585|edelmana@ohsu.edu|
22435310|NCT00929773|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com|
22435311|NCT01156389|Shin Poong Pharmaceutical Co., Ltd.|Jangsik Shin|+82-2-2189-3468|jsshin@shinpoong.co.kr|
22395156|NCT01176968|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22395157|NCT04658186|Cares|UCB|+1-844-599-2273|UCBCares@ucb.com|
22435312|NCT01703117|Icahn School of Medicine at Mount Sinai|Dr. Ana Pereira|212-241-6984|ana.pereira@mssm.edu|
22395158|NCT04231539|Roswell Park Comprehensive Cancer Center|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
22435313|NCT00350623|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22395159|NCT05057247|Dana-Farber Cancer Institute|Glenn J. Hanna, M.D.|617-632-309|glenn_hanna@dfci.harvard.edu|
22395160|NCT00528866|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22395161|NCT00993915|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22395162|NCT02465463|Emory|Dr. Tanvi Dhere|404-686-1000|tdhere@emory.edu|
22395163|NCT01368809|Department of Anesthesiology at Cedars-Sinai Medical Center in Los Angeles|Paul F White|214-7703775|paul.white@cshs.org|
22435314|NCT00328653|Santen Inc|R&D Quality Manager|415 268 9199|evelyn.chikere@santen.com|
22435315|NCT01893372|The Universtiy of Texas MD Anderson Cancer Center|Courtney DiNardo, MD/Associate Professor|713-794-1141|CDiNardo@mdanderson.org|
22435316|NCT04081961|Kazakhstan Academy of Preventive Medicine|Baurzhan Zhussupov|87774822171|baurzhan.zhussupov@gmail.com|
22435317|NCT01752400|Massachusetts General Hospital|Alice Shaw, MD, PhD|617-724-4000|ashaw1@mgh.harvard.edu|
22435318|NCT05740332|Medline Industries LP|Director Clinical Operations|630-418-6891|jamiller@medline.com|
22435319|NCT03837665|University of Kansas Medical Center|Hinrich Staecker, MD, PhD|913-588-6701|hstaecker@kumc.edu|
22435320|NCT03315104|Emergent BioSolutions|Dr. Christine Hall|204-275-4200|chall@ebsi.com|4248
22435321|NCT01309906|Bausch Health|Study Director||robert.steffen@bausch.com|
22435322|NCT00330928|InfraReDx, Inc|Director Clinical and Regulatory|781-221-0053|pshah@infraredx.com|
22435323|NCT03028480|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22435324|NCT05074888|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22435325|NCT04706273|W. L. Gore & Associates|Eric Novak|314-440-2110|enovak@wlgore.com|
22435326|NCT06239441|Hôpital du Sacre Coeur de Montreal|Catherine Lemiere|514 338 2492|catherine.lemiere@umontreal.ca|
22435327|NCT00759356|Actavis Inc.|Meena Venugopal, Director, Clinical R&D|908-659-2885|MVenugopal@actavis.com|
22435328|NCT02089113|Ocular Therapeutix|Jamie L. Metzinger, Medical Affairs|781-357-4000|jmetzinger@ocutx.com|
22435329|NCT00970814|NIAAA|Megan Ryan - Clinical Trials Project Manager|301-443-4225|mryan1@mail.nih.gov|
22435330|NCT02403635|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
22435331|NCT00359944|Sunovion|Medical Director, CNS|1-866-503-6351||
22435332|NCT00585221|Huntsman Cancer Institute|Director of Clinical Trials|801-213-4241|candace.larson@hci.utah.edu|
22435333|NCT02509052|Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA 91010|Michael Rosenzweig, MD|626-218-2405|mrosenzweig@coh.org|
22435334|NCT04942665|University of Florida|Dr. Ali Zarrinpar|(352) 265-0606|ali.zarrinpar@surgery.ufl.edu|
22435335|NCT00620425|Zogenix, Inc|Edward Smith III, PhD, VP Regulatory Affairs & Product Quality/Safety|510 550 8325|esmith@zogenix.com|
22435336|NCT03554772|Dr Reddy's Laboratories, Inc.|Srinivas Shenoy B.|6099550249|srinivasshenoyb@drreddys.com|
22435337|NCT03263923|Case Western Reserve University|Dr. Carol M. Musil|216-368-2545|cmm4@case.edu|
22435338|NCT04600505|AstraZeneca Clinical Study Information Center|Global Clinical Head|1-877-240-9479|information.center@astrazeneca.com|
22435339|NCT00241631|Imperial College London|Ian M Adcock|+44 (0)20 7594 7840|ian.adcock@imperial.ac.uk|
22435340|NCT03114124|UF Health- Jacksonville|Andrea Goosen|904-244-5617|andrea.ggosen@jax.ufl.edu|
22435341|NCT00435162|Novartis Pharmaceuticals|Study Director|862-778-8300||
22435342|NCT00694096|Huntsman Cancer Institute|Mark Wade, Ph.D. - Compliance Officer|801-213-5746|mark.wade@hci.utah.edu|
22435343|NCT02129478|The Hospital for Sick Children|Dr. Laura Lee Dupuis|416-813-7654|lee.dupuis@sickkids.ca|309355
22435344|NCT03468816|Åby vårdcentral, County council of Östergötland|Dr. Fredrik Iredahl|010-103 00 00|fredrik.iredahl@liu.se|
22435345|NCT02042534|Asan Medical Center, University of Ulsan|Sun U. Kwon, MD, PhD, Prof|82-2-3010-3960|sukwon@amc.seoul.kr|
22435346|NCT02078102|IndianaU|Dr. Sherif Farag|(317) 278-0460|ssfarag@iu.edu|
22435347|NCT02185014|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22435348|NCT02141490|National Cancer Institute|Dr. Ismail B. Turkbey|240-760-6112|turkbeyi@nih.gov|
22435349|NCT01813721|Amgen Inc.|Study Director|866-572-6436||
22435350|NCT02133664|Oregon Health & Science University|Lynne Shinto, ND, MPH|503-494-5035|shintol@ohsu.edu|
22435351|NCT03906656|Ottobock|Russ Lundstrom|6127182025|russ.lundstrom@ottobock.com|
22435352|NCT01688843|Boston Scientific|Gena Kantor, MPH|1-800-227-3422|gena.kantor@bsci.com|
22435353|NCT00343915|GlaxoSmithKline|GSK Response Center|866-435-7343||
22425580|NCT02559570|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22425581|NCT02934555|Beth Israel Deaconess Medical Center|Dr. Michael Donnino|6177542882|mdonnino@bidmc.harvard.edu|
22425582|NCT01183416|Memorial Sloan Kettering Cancer Center|Dr. Brian Kushner, MD|212-639-6793|kushnerb@mskcc.org|
22425583|NCT02364076|Georgetown University Medical Center -Lomabardi Comprehensive Cancer Center|Dr Giuseppe Giaccone|202-687-7072|gg496@georgetown.edu|
22425584|NCT01066871|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22425585|NCT00729300|Baylor College of Medicine|Christopher Verrico|713-791-1313|verrico@bcm.edu|26020
22425586|NCT00357890|Nemours Children's Health|Larry A Fox, MD|9046973600|larry.fox@nemours.org|
22425587|NCT00845676|San Francisco General Hospital/UCSF|Brad Hare, MD|415-476-4082|chare@php.ucsf.edu|556
22425588|NCT01680653|Stanford University|Dr. Bruce Buckingham|650-725-6549|bbendo@stanford.edu|
22425589|NCT00681265|Eyeon Therapeutics, Inc.|David M. Kleinman||dave@eyeontherapeutics.com|
22425590|NCT00477204|University of Colorado Denver|David Maahs, MD, PhD|303-724-2323|david.maahs@ucdenver.edu|
22425591|NCT00248833|WRAIR|Paul B. Keiser|866-856-3259|clinical1@na.amedd.army.mil|
22395164|NCT01087931|Vanderbilt University|Kevin O'Neill|615-936-5677||
22395165|NCT01067326|Mayo Clinic|Dr. Amir Lerman|507-255-4152|lerman.amir@mayo.edu|
22425592|NCT01554163|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22435354|NCT00915655|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Medical Leader|+1 609 730-7548||
22395166|NCT00323297|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22395167|NCT01176773|Allergan Medical|Medical Monitor|(805) 961-5000|devicetrials@allergan.com|
22395168|NCT00927160|Icahn School of Medicine at Mount Sinai|Dr. William Hung|718-584-9000|william.hung@mssm.edu|
22395169|NCT04384848|Northwestern University|David Cella|312-503-1725|d-cella@northwestern.edu|
22395170|NCT01285050|Johns Hopkins University|David Thomas|410-502-6043|dthomas@jhmi.edu|
22395171|NCT01498289|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|mduong@fredhutch.org|
22395172|NCT01862133|Regenstrief Institute|William M. Tierney, MD|(317) 274-9094|wtierney@regenstrief.org|
22395173|NCT00078754|The University of Chicago|Dr. Emil F. Coccaro, MD|773-834-4083|ecoccaro@yoda.bsd.uchicago.edu|
22395174|NCT00809523|Yale University|Paul Desan, MD, PhD|203 785 2618|paul.desan@yale.edu|
22425593|NCT01941537|Rockefeller University|James Krueger|2123277730|kruegej@rockefeller.edu|
22425594|NCT00857961|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22425595|NCT02634983|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22425596|NCT03646487|University of Illinois Chicago|Mary Dawn Koenig, PhD, RN, FACNM|312-996-7982|marydh@uic.edu|
22425597|NCT02014051|SymBio Pharmaceuticals|Director of Clinical Trials|+81-3-5472-1127|kgoto.34@symbiopharma.com|
22425598|NCT03031340|Montefiore Medical Center|Dr.Singh Nair|7189205932|sinair@montefiore.org|
22425599|NCT06785090|College of Medicine, University of Baghdad|Enas Sabeeh|09647704294077|inas.abd2206m@comed.uobaghdad.edu.iq|
22425600|NCT01449734|CSCC Germany, Jena University Hospital|Christiane Hartog, MD|+49 3641 9323171|christiane.hartog@med.uni-jena.de|
22425601|NCT02675764|Medical University of South Carolina|Dr. Na Jin Seo|8437920084|seon@musc.edu|
22425602|NCT04780815|ImperialBrands PLC|Simon McDermott|+44 (0)117 332 0225|simon.mcdermott@uk.imptob.com|
22425603|NCT02245815|Instituto Mexicano del Seguro Social|Dra. Guadalupe Gómez Rodríguez|477 75 23 166|lupitaneonato@gmail.com|
22425604|NCT01543568|Retina Consultants of Houston|David Brown, MD|713-524-3434|dmbmd@houstonretina.com|
22425605|NCT00006244|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
22425606|NCT00762762|Colgate Palmolive Co.|William DeVizio, DMD|732-878-7901|william_devizio@colpal.com|
22425607|NCT02489448|Yale School of Medicine|Lajos Pusztai, MD, DPhil Professor of Medicine (Medical Oncology)|(203) 737-8309|lajos.pusztai@yale.edu|
22425608|NCT05554640|Johnson & Johnson Vision Care (JJVC)|John R. Buch, O.D., M.S.|1-800-843-2020|jbuch@its.jnj.com|
22425609|NCT00215644|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center,|496151725200|service@merckgroup.com|
22425610|NCT02861664|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22425611|NCT02542397|Atrium Health/Levine Cancer Institute, Department of Cancer Biostatistics|Danielle M Boselli|12017903385|Danielle.Boselli@AtriumHealth.org|
22425612|NCT00652145|University of Pennsylvania|James D. Lewis, MD, MSCE|215-573-5137|lewisjd@mail.med.upenn.edu|
22425613|NCT00493012|Heart and Diabetes Center North Rhine-Westfalia|Dr. Armin Zittermann|+49 5731 97|azittermann@hdz-nrw.de|1912
22425614|NCT01965002|Stanford Univeristy Medical Center|Pejman Ghanouni, MD, PhD|650-498-4485|ghanouni@stanford.edu|
22425615|NCT04147247|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22425616|NCT01724177|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|1-888-260-1599|ClinicalTrialDisclosure@Celgene.com|
22425617|NCT03397121|The Medicines Company|Vice President - Regulatory Operations|973-985-0597|frank.bosley@novartis.com|
22425618|NCT00472732|Children's Research Institute|Andrea Gropman, M.D.|202-476-2120|agropman@childrensnational.org|
22425619|NCT00327340|OncoGenex Pharmaceuticals|Monica S. Krieger, PhD|425-686-1558|mkrieger@oncogenex.com|
22425620|NCT04846270|Essity Hygiene and Health AB|Fredrik Agholme|+4670323634|fredrik.agholme@essity.com|
22425621|NCT00700375|Osaka General Medical Center|Prevention on Conrast-Induced Nephropathy With Bolus Injection of Sodium Bicarbonate|81-6-6692-1201|u_hiromichi@yahoo.co.jp|
22425622|NCT00206427|Baylor Breast Cancer|Dr. Mothaffar Rimawi|713-798-1311|rimawi@bcm.tmc.edu|
22425623|NCT04085601|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
22425624|NCT03492437|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22425625|NCT02418234|Hangzhou first people's hospital|Prof. Shenglin Ma|086057156007664|mashenglin@medmail.com.cn|
22425626|NCT02915159|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22425627|NCT04534517|Johnson & Johnson Vision Care Inc.|Thomas Karkkainen, OD, MS, FAAO- Sr. Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
22425628|NCT02121795|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230|ClinicalTrialDisclosures@gilead.com|
22425629|NCT01914393|Sunovion Pharmaceuticals Inc.|CNS Medical Director|866-503-6351|ClinicalTrialDisclosure@sunovion.com|
22425630|NCT00572455|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22425631|NCT02609386|Eterna Therapeutics|VP of Quality|212-582-1199|info@eternatx.com|
22425632|NCT00610168|GlaxoSmithKline|GSK Response Center|866-435-7343||
22425633|NCT01369745|Zalicus|Margaret Lee,PhD|617-301-7142|mlee@zalicus.com|
22425634|NCT00613821|Oregon Health & Science University|Dr. Alison Edelman|503-494-3666|whru@ohsu.edu|
22425635|NCT00141518|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22425636|NCT02896569|Venus Concept Ltd|Yoni Iger|888-907-0115|yoni@venusconcept.com|
22395175|NCT01290601|WRAIR|Shirley Lee-Lecher|301-251-5000|usarmy.detrick.medcom-wrair.mbx.ocid@mail.mil|
22395176|NCT00775450|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22395177|NCT04071795|NYU Langone Health|Erin Rogers|6465012544|Erin.Rogers@nyulangone.org|
22395178|NCT03057808|University of Virginia|Dr. Rebecca Krukowski|4349245303|wae4mq@virginia.edu|
22395179|NCT01749540|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22395180|NCT01581541|Stanford University School of Medicine|Dr. Shivaani Kummar|650-724-9084|skummar@stanford.edu|
22395181|NCT00752622|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22395182|NCT03681886|Alcon, LLC|Sr. Clinical Trial Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22395183|NCT00576836|Duke University Medical Center|M. Louise Markert, MD, PhD Professor of Pediatrics and Immunology|919-684-6263|marke001@mc.duke.edu|
22395184|NCT04329832|Intermountain Healthcare|Naresh Kumar|8013827483|naresh.kumar@imail.org|
22395185|NCT03272763|Fisher & Paykel Healthcare Ltd.|Rebecca Thomson|+64 9 574 0123|Rebecca.Thomson@fphcare.co.nz|7675
22395186|NCT00132496|Eisai Medical Research Inc.|Yufang Lu, MD, PhD, Study Director|201-403-2500||
22395187|NCT00287339|UNC_ChapelHill|Dr Nicholas Shaheen|919 9667047|nshaheen@med.unc.edu|
22395188|NCT00986440|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22395189|NCT00388154|University of Texas (UT) MD Anderson Cancer Center|Jubilee Brown, MD/Associate Professor, Gynecology Oncology & Reproductive Medicine|713-745-8837|CR_Study_Registration@mdanderson.org|
22395190|NCT00178126|University of PIttsburgh|David Brienza|(412) 624-6383|DBrienza@pitt.edu|
22395191|NCT01074216|Memorial Sloan Kettering Cancer Center|Dr. Barrie Cassileth|646-888-0801|Cassileth@mskcc.org|
22395192|NCT01401907|MGH|Jennifer Temel MD|617-724-4000|jtemel@partners.org|
22395193|NCT01323634|GlaxoSmithKline|GSK Response Center|866-435-7343||
22395194|NCT05056987|Alcon Research, LLC|Senior Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22395195|NCT01575028|Nationwide Children's Hospital|Tarun Bhalla|(614) 722-4200|Tarun.Bhalla@NationwideChildrens.org|
22395196|NCT01182194|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22395197|NCT01948908|Columbia University College of Physicians and Surgeons|Daniel S. Tsze|212-305-9825|dst2141@columbia.edu|
22395198|NCT01585987|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22395199|NCT03291587|Wake Forest NCORP Research Base|Lead Biostatistician|3367160891|NCORP@wakehealth.edu|
22395200|NCT00796120|PharmaMar SA Av de los Reyes 1, Poligono Industrial La Mina 28770 Colmenar Viejo, Madrid, Spain|Medical Specialist, Clinical Oncology|+34 91 646-6087||
22395201|NCT02520284|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22395202|NCT03737474|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22395203|NCT00803270|New England Resesarch Institutes|Anne M. Stoddard|617-972-3331|astoddard@neriscience.com|
22395204|NCT01966471|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22395205|NCT04223856|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
22395206|NCT03454828|Yale University School of Medicine: Pediatrics Endocrinology|Nicola Santoro|2037376356|nicola.santoro@yale.edu|
22395207|NCT03722407|Moffitt Cancer Center|Eric Padron, MD|813-745-2864|eric.padron@moffitt.org|
22395208|NCT00992511|GlaxoSmithKline|GSK Response Center|866-435-7343||
22395209|NCT01180998|Johnson & Johnson Vision Care|Kathy Osborn, OD|1-904-443-1032|KOsborn@its.jnj.com|
22395210|NCT04098068|Sidney Kimmel Comprehensive Center at Johns Hopkins University|Dung Le, MD|443-287-0002|dle@jhmi.edu|
22395211|NCT00744523|Medtronic Aortic and Peripheral Vascular|Arslan Malik, Senior Clinical Research Manager|(707) 541-3256|arslan.malik@medtronic.com|
22411250|NCT01506323|VA San Diego Healthcare System|Dr. Jill E. Bormann|858-552-8585|jill.bormann@va.gov|x2378
22411251|NCT03907280|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22411252|NCT03843957|Wake Forest University School of Medicine|Dr. David P. Miller, Jr|336-713-5218|dmiller@wakehealth.edu|
22411253|NCT04690413|NOWDiagnostics|Beth Cobb|479-966-4531|beth.cobb@nowdx.com|
22411254|NCT02637076|CAMH|Dr. Stephen Kish|416-535-8501|stephen.kish@utoronto.ca|36256
22411255|NCT00130520|Arizona Cancer Center, University of Arizona|Setsuko K. Chambers, M.D.|520-626-0950|schambers@azcc.arizona.edu|
22411256|NCT03487796|Rhode Island Hospital|Larry K. Brown, MD|(401) 793-8808|lkbrown@lifespan.org|
22411257|NCT03581474|Ambu A/S|Anna Charlotte Lundgaard|+4529643748|aclu@ambu.com|
22411258|NCT01626820|GlaxoSmithKline|GSK Response Center|866-435-7343||
22411259|NCT00613574|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22411260|NCT00176904|Masonic Cancer Center, University of Minnesota|Paul Orchard, M.D.|612-626-2313|orcha001@umn.edu|
22411261|NCT02588573|CooperVision Inc.|Senior Manager Global Medical Scientific Affairs|925 621-3761|javega@coopervision.com|
22411262|NCT04604184|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22411263|NCT01751412|Massachusetts General Hospital|Thomas F. DeLaney, MD|617-726-6876|TDELANEY@mgh.harvard.edu|
22411264|NCT00582036|University of Oklahoma Health Sciences Center|George Selby, MD|405-271-4022|george-selby@ouhsc.edu|
22411265|NCT03734237|USUHS|Timothy Burgess, MD, MPH|(301) 295-9792|timothy.burgess@usuhs.edu|
22411266|NCT02711956|Zenith Epigenetics Ltd|Zenith Study Team|(415) 470-5600|ZEN003694-002@zenithepigenetics.com|
22411267|NCT01844583|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22411268|NCT01625377|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22411269|NCT03513497|University of North Carolina at Chapel Hill|Julie Marchesan, DDS, PhD|919-537-3853|julie_marchesan@unc.edu|
22411270|NCT01412541|Becton Dickinson|Anna Lovas|7634452382|anna.lovas@bd.com|
22411271|NCT03294538|Teva Pharmaceuticals USA, Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
22395212|NCT01720173|NRG Oncology|Angela Kuras on behalf of Wei Deng, PhD|716-845-5702|kurasa@nrgoncology.org|
22395213|NCT03673865|Emory University|Dina Amin|404-251-8895|dina.amin@emory.edu|
22395214|NCT03588728|University of Pittsburgh|Cynthia Conklin, Ph.D.|4125869840|conkca@upmc.edu|
22395215|NCT01388790|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22395216|NCT01386658|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22395217|NCT02513745|Carolina Eyecare Physicians, LLC|Helga P. Sandoval, MD, MSCR. Director of Research|8438813937|helga.sandoval@carolinaeyecare.com|
22395218|NCT00381303|Tibotec Therapeutics Clinical Affairs (TTCA), Division of Centocor Ortho Biotech Services, LLC|Vice President, Tibotec Therapeutics Clinical Affairs|877-732-2488||
22411272|NCT03295643|Pivot Health Technologies Inc.|Senior Director of Clinical Affairs and Data Science|650-906-4255|craig@pivot.co|
22435355|NCT00536874|Memorial Sloan-Kettering Cancer Center|Dr. Eileen O'Reilly|646-888-4182|oreillye@mskcc.org|
22435356|NCT01853072|Alcon Research, Ltd.|Therapeutic Unit Head, Cornea and Inflammation|1-888-451-3937|alcon.medinfo@alcon.com|
22435357|NCT00930969|Medtronic Cardiac Rhythm Disease Management|ST Detect Study Team|1-800-328-2518|medtronicCRMtrials@medtronic.com|
22435358|NCT01287221|Mayo Clinic|Dr. Phillip A. Low|507-284-3375|low@mayo.edu|
22435359|NCT04883528|Duke University|Stephen J. Greene, MD|919-684-3854|stephen.greene@duke.edu|
22435360|NCT03515941|Baylor College of Medicine|Eunji Jo|713-798-4923|ejo@bcm.edu|
22435361|NCT03559699|Agios Pharmaceuticals, Inc|Medical Affairs|833-228-8474|medinfo@agios.com|
22435362|NCT00031460|Collaborative Antiviral Study Group|Penelope M. Jester|(205) 934-2424|pjester@peds.uab.edu|
22435363|NCT01401699|Massachusetts General Hospital|Gary Tearney, PI|617-724-2979|gtearney@partners.org|
22435364|NCT02080260|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
22435365|NCT05438602|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc.|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22435366|NCT01930890|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22435367|NCT02091284|Federal University of Espírito Santo|Dr. Ester Miyuki Nakamura-Palacios|+55 27 3335-7337|emnpalacios@gmail.com|
22435368|NCT02853435|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22435369|NCT03747120|University of Texas Southwestern Medical Center|Dr. Heather McArthur, Professor IM-Hem Onc|214-645-9380|heather.mcarthur@utsouthwestern.edu|
22435370|NCT02418312|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
22435371|NCT00803413|Hospital das Clínicas - São Paulo University School of Medicine|Mario Fereira Junior|55 11 3069-7691|mariofj@uol.com.br|
22435372|NCT02209948|MFAR Clinical Research|Pau Doñate|0034934344412|investigacion@mfar.net|
22435373|NCT03911752|University of A Coruña|Thais Pousada García|+34 981 167 000|thais.pousada.garcia@udc.es|5870
22435374|NCT00297102|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22435375|NCT00043108|Fox Chase Cancer Center|Dr. Mark Hallman|215-728-2581|Mark.Hallman@fccc.edu|
22435376|NCT01690546|Duke University Medical Center|Paolo Mannelli, M.D|919-681-0613|paolo.mannelli@dm.duke.edu|
22435377|NCT03362931|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22435378|NCT01998893|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22435379|NCT03276052|AstraZeneca|Global Clinical Head|+187724094 79|information.center@astrazeneca.com|
22435380|NCT02061397|University of Pennsylvania|Dr. Vera Krymskaya|215-573-9861|krymskay@pennmedicine.upenn.edu|
22435381|NCT03404804|Medical College of Wisconsin|Dr. David Vyles, DO|414-266-2625|dvyles@mcw.edu|
22435382|NCT00711347|Alcon Research, Ltd.|Erin Rogut|813-426-4036|Erin.Rogut@alconlabs.com|
22435383|NCT05136898|UroGen Pharma|Head of Clinical Development|+1 855-987-6436|info@urogen.com|
22435384|NCT01994863|Coloplast A/S|Director Clinical Affairs||dkdac@coloplast.com|
22435385|NCT05357664|DePuy Synthes|Dave Whalen|574-404-9399|dwhalen@its.jnj.com|
22435386|NCT01655043|Northwestern University|Dr. James Carr|(312)926-2270|jcarr@northwestern.edu|
22435387|NCT03784846|Pacific University|Michael Christopher, Ph.D.|503-352-2498|mchristopher@pacificu.edu|
22435388|NCT00931723|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22435389|NCT03054350|Akebia Therapeutics|Akebia Therapeutics|(617) 844-6128|trials@akebia.com|
22435390|NCT01643850|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22435391|NCT01133405|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22395219|NCT01211522|Vanderbilt University Medical Center|E Wesley Ely|‭(615) 936-3395‬|wes.ely@vumc.org|
22395220|NCT01777269|GlaxoSmithKline|GSK Response Center|866-435-7343||
22395221|NCT00504881|UCB Clinical Trial Call Center|UCB (Study Director)|+1 877 822 9493||
22395222|NCT00742053|C.R. Bard|Christopher DiMatteo/Clinical Scineces Manager|801-522-5487|chris.dimatteo@crbard.com|
22395223|NCT03349892|University of California, Los Angeles|Robert K. Chin, MD, PhD , Assistant Clinical Professor|(310) 825-9771|rkchin@mednet.ucla.edu|
22395224|NCT02411578|Jaeb Center for Health Research|Stephanie DuBose|813-975-8690|t1dstats2@jaeb.org|
22395225|NCT02973048|Centre Hospitalier Universitaire Saint Pierre|Panayota Kapessidou|+32.2.535|pkapessi@ulb.ac.be|3750
22395226|NCT00332189|BioMarin Pharmaceutical, Inc.|Medical Information Services|1-800-983-4587|medinfo@bmrn.com|
22395227|NCT02370043|Kaneq Bioscience Limited|Dr. Gosse Bruinsma|1-613-800-0955|gosse.bruinsma@kaneqbioscience.ca|
22395228|NCT01231516|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22395229|NCT04427501|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22395230|NCT03170154|Alcon Research, LLC|Sr. Clinical Trial Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22395231|NCT01906346|University of Kentucky|Joshua A. Lile, Ph.D.|859-420-0503|jalile2@uky.edu|
22395232|NCT04974515|University of Miami, Miller School of Medicine|Naresh M. Punjabi, MD, PhD|305-243-6388|npunjabi@miami.edu|
22395233|NCT04936841|University of Wisconsin School of Medicine and Public Health|Zachary Morris, MD, PhD|(608) 263-2603|zmorris@humonc.wisc.edu|
22395234|NCT02279862|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22395235|NCT01444209|University of Texas Southwestern Medical Center|Dr. Robert Timmerman|214/645-7637|robert.timmerman@utsouthwestern.edu|
22395236|NCT02460666|University of California, Los Angeles|Helen Lavretsky, MD|(310) 794-4619|HLavretsky@mednet.ucla.edu|
22395237|NCT05266586|NewAmsterdam Pharma|Study Director|+1(305) 627-3081|study.director@newamsterdampharma.com|
22395238|NCT02225353|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|clinical-trials@grunenthal.com|
22395239|NCT03707925|UT MD Anderson Cancer Center|Roberto Casal, MD/ Associate Professor, Pulmonary Medicine|713-745-2645|rfcasal@mdanderson.org|
22425637|NCT03929263|Oklahoma State University|Kara Kerr|9186971478|kara.kerr@okstate.edu|
22395240|NCT01193920|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22425638|NCT02134795|Scion NeuroStim|Dr. Robert Black|(919) 260-5528|rblack@scionneurostim.com|
22425639|NCT00844090|Omaha VA Medical Center|Cyrus Desouza MD|402-995-5506|cyrus.desouza@va.gov|
22425640|NCT03060291|University of Oregon Prevention Science Institute|Dr. Allison Caruthers|503-412-3770|ascaru@uoregon.edu|
22425641|NCT00718094|University Louisville|Gerald Dryden, MD|502-852-0156|gwdryd01@louisville.edu|
22425642|NCT01509664|New York Obesity Nutrition Research Center|Dr Allan Geliebter|212-523-4184|ag58@columbia.edu|
22425643|NCT02237989|Eskisehir Osmangazi University|Dr. Fulya Bakılan|+905057737335|fulyabakilan@gmail.com|
22425644|NCT01210222|NRG Oncology|Linda Gedeon for Michael Sill, PhD.|716-845-1169|lgedeon@gogstats.org|
22425645|NCT00941304|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22425646|NCT03774888|University of Alabama at Birmingham|Hussein Basma, DDS, MS|2059344506|basma86@uab.edu|
22425647|NCT00320788|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator||clinicaltrials@regeneron.com|
22425648|NCT04585243|Pennsylvania State University College of Medicine|Jennifer L. Moss, PhD|717-531-0003|jmoss1@pennstatehealth.psu.edu|323429
22395241|NCT03431857|Zimmer Biomet|Emilie Rohmer, Clinical Ops manager|+41588548210|emilie.rohmer@zimmerbiomet.com|
22395242|NCT01323621|GlaxoSmithKline|GSK Response Center|866-435-7343||
22395243|NCT01117857|Massachusetts General Hospital|Dr. Marlene Freeman, MD|617-643-6403|mfreeman@partners.org|
22425649|NCT04156906|The Children's Hospital of Philadelphia|Stella Chou, MD|215-590-0947|chous@chop.edu|
22435392|NCT02737553|Ege University|Ali Akdemir|+905056748904|md.aliakdemir@gmail.com|
22435393|NCT00867087|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22435394|NCT03300024|Johns Hopkins University|Thomas Reifsnyder|410-955-7518|treifsn1@jhmi.edu|
22435395|NCT01238835|Edwards Lifesciences|Edwards THV Clinical Affairs|949-250-2500|THV_CT.gov@edwards.com|
22435396|NCT02088073|ZS Pharma, Inc.|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22435397|NCT04612842|Oregon Health & Science University|Dr. Hiroko Kiyoshi-Teo (Assistant Professor)|5034943858|kiyoshi@ohsu.edu|
22435398|NCT02419131|Massachusetts General Hospital, Harvard Medical School|Dr. Tim Houle|617-724-2111|thoule1@mgh.harvard.edu|
22435399|NCT03060512|AstraZeneca Pharmaceutical LP|Catherine J. Datto, MD, MS, Movantik Medical Head, USMA|+1 302 885 1180|Information.Center@astrazeneca.com|
22435400|NCT00904618|Centre Hospitalier Universitaire de Sherbrooke|Louis-Olivier Gagnon|1-819-437-4965|louis.olivier.gagnon@gmail.com|
22435401|NCT01672658|Rehabilitation Instititute of Chicago|Arun Jayaraman, PT, PhD|312-238-2091|a-jayaraman@northwestern.edu|
22435402|NCT03444766|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22435403|NCT00902018|Weill Cornell Medical College|Dr James Bussel|22-746-3474|jbussel@med.cornell.edu|
22435404|NCT02969590|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|5034940757|mccrimmo@ohsu.edu|
22435405|NCT03421743|Savara Inc|Paymond D Pratt, Chief Medical Officer|+1 512 784 8757|ray.pratt@savarapharma.com|
22435406|NCT03900923|NYU Langone Health|Francisco X Castellanos, MD|646-754-5194|Francisco.Castellanos@nyulangone.org|
22435407|NCT03373890|SeattleChildrens|Kristie Bjornson, PT, PhD|206-884-2066|kristie.bjornson@seattlechildrens.org|
22435408|NCT02881112|Regenesis Biomedical|Clinical Operations Manager|602-428-7041|heather.vanderploeg@regenesisbio.com|
22435409|NCT02680574|Akebia Therapeutics, Inc.|Clinical Trial Information Desk|+1 617-844-6128|trials@akebia.com|
22435410|NCT00402714|Yale University School of Medicine|Francine Foss MD|2037375312|francine.foss@yale.edu|
22435411|NCT02387164|Skåne University Hospital|Helena Elding Larsson|+4640337676|helena.larsson@med.lu.se|
22435412|NCT02370641|UCLA Department of Medicine/Center for Human Nutrition|Zhaoping Li, Professor|310-206-1987|zli@mednet.ucla.edu|
22435413|NCT03398265|University of Washington|Dr. Caleb Banta-Green|206-543-0937|calebbg@uw.edu|
22435414|NCT01036529|Boston Scientific|Valerie Lucero-Cimmarusti|661-949-4745|Valerie.Lucero-Cimmarusti@bsci.com|
22435415|NCT01719003|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
22435416|NCT02370095|University of North Carolina at Chapel Hill|Wayne H Anderson, PhD|919-445-0351|wayne_anderson@med.unc.edu|
22435417|NCT00700102|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22435418|NCT01667562|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22435419|NCT02525939|DalCor Pharmaceuticals|Dr. Don Black, Chief Medical Officer|‭+1 (609) 613-6637‬|dblack@dalcorpharma.com|
22435420|NCT01028716|Fred Hutchinson Cancer Center|Rachel Salit|2066671317|rsalit@fredhutch.org|
22435421|NCT02130986|University of Pittsburgh|David T Huang, MD, MPH, Associate Professor|412-647-6818|huangdt@upmc.edu|
22435422|NCT01129882|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22435423|NCT03236168|London School of Hygiene and Tropical Medicine|Dr Michael Marks|02079272566|michael.marks@lshtm.ac.uk|
22435424|NCT03849690|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22435425|NCT01319721|State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University|Dr. Shiyou Zhou|+86-020-87331540|zhoushiy@mail.sysu.edu.cn|
22435426|NCT02653495|Rockefeller University|Dr. Ursula Andreo|212-327-7894|uandreo@gmail.com|
22435427|NCT03840525|Florida International University|Dr. Gladys Ibanez|305-348-4920|gibanez@fiu.edu|
22435428|NCT02761694|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22435429|NCT01628614|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22435430|NCT02652416|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22435431|NCT02395055|BIOCAD|Biryulin Andrey|+7812380 49 33|biryulin@biocad.ru|925
22435432|NCT01896271|UT Southwestern Medical Center|Dr. Raquibul Hannan|214-645-8525|Raquibul.Hannan@UTSouthwestern.edu|
22435433|NCT01357135|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22435434|NCT03002623|National Cancer Institute|Dr. Naris Nilubol|301- 451-2355|niluboln@nih.gov|
22435435|NCT01540409|Sarepta Therapeutics, Inc.|Medical Director|+1-888-727-3782|clinicaltrials@sarepta.com|
22435436|NCT00526110|The University of Texas (UT) MD Anderson Cancer Center|Jaffer Ajani, MD/Professor, GI Medical Oncology|1-877-632-6789|CR_Study_Registration@mdanderson.org|
22435437|NCT00953680|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
22435438|NCT04895293|Midwest Eye Institute|Raj K. Maturi, M.D.|317-817-1423|maturi.md@midwesteye.com|
22435439|NCT03762616|Exact Imaging|Dr. Brian Wodlinger|6475279032|bwodlinger@exactimaging.com|
22435440|NCT00758589|AstraZeneca|Alison Holt||ClinicalTrialTransparency@astrazeneca.com|
22435441|NCT06034652|Integra LifeSciences Corporation|Andrew Tummon, Director, Global Clinical Operations|609-936-5490|andrew.tummon@integralife.com|
22435442|NCT00583791|Abbott|Maren Wagner|6517565585|maren.wagner@abbott.com|
22435443|NCT00203021|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22435444|NCT04699812|Apple Inc.|Clinical Health Product Clinician|866-905-5303|htclinicalquestions@apple.com|
22435445|NCT03204890|Boston Medical Group|Dr. José Pablo Saffon|+573208899777|jsaffon@bostonmedical.com.co|
22435446|NCT04973696|Center for Health Outcomes and Interdisciplinary Research, Massachusetts General Hospital|Dr. Ana-Maria Vranceanu|617-724-4977|avranceanu@mgh.harvard.edu|
22435447|NCT00628589|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
22435448|NCT04562597|Medical University of South Carolina|Dr. Sylvia Wilson|843-792-2322|wilsosh@musc.edu|
22435449|NCT01838785|Chang Gung Memorial Hospital|Dr. kun-Ju Lin|033281200|lin4857@adm.cgmh.org.tw|2632
22435450|NCT04524455|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22435451|NCT01688739|Amgen Inc.|Study Director|866-572-6436||
22435452|NCT02406443|Renal Physiology Laboratory|University Health Network|416-340-4800|vesta.lai@uhn.ca|8508
22435453|NCT00490776|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22435454|NCT03383783|Oral Health Research Institute|Domenick T Zero, DDS, MS|317-274-8822|dzero@iu.edu|
22435455|NCT00308165|Columbia University|Jeffrey N. Bruce, MD|212-305-7346|jnb2@columbia.edu|
22435456|NCT06276881|Dandelion Science|Chief Executive Officer (CEO)|628-777-3477|info@dandelion.science|
22435457|NCT02583230|Northwestern University|David C. Mohr, PhD|312-503-1403|d-mohr@northwestern.edu|
22435458|NCT01340937|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22435459|NCT00046930|ECOG Statistical Office|Study Statistician|617-632-3012||
22435460|NCT00440310|Light Sciences Oncology, Inc.|Vice President of Regulatory Affairs and Clinical Operations|425-957-8986|lisak@lsoncology.com|
22435461|NCT01694108|Rigshospitalet|Lone Graff Stensballe, Research leader, Pediatrician, PhD|+0045 35459727|lone.graff.stensballe@regionh.dk|
22435462|NCT01657760|Harbor-UCLA Department of Psychiatry|Todd Zorick|310-781-3400|tzorick@mednet.ucla.edu|
22435463|NCT02469415|The University of Texas MD Anderson Cancer Center|Courtney DiNardo, MD/Assistant Professor|713-794-1141|CR_Study_Registration@mdanderson.org|
22435464|NCT02119156|GlaxoSmithKline|GlaxoSmithKline|866-435-7343|GSKClinicalSupportHD@gsk.com|1
22435465|NCT02506660|Hospital of Special Surgery|Dr. Richard Kahn|212-774-7274|KahnR@HSS.EDU|
22435466|NCT02124512|University of Kentucky|Philip Kern|859-323-2232|pake222@uky.edu|
22435467|NCT01410812|University of Pennsylvania|Katherine L. Milkman, Ph.D.|215-573-9646|kmilkman@wharton.upenn.edu|
22435468|NCT00940485|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22435469|NCT01113580|Seqirus|Clinical Study Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com|
22435470|NCT02961946|Massachusetts General Hospital|Dr. Brian Ghoshhajra|617-726-5954|BGHOSHHAJRA@mgh.harvard.edu|
22435471|NCT05039671|Yale University|Dr. Elizabeth Connors|12038150685|elizabeth.connors@yale.edu|
22435472|NCT01987219|NYU School of Medicine|Dr. Horacio Kaufmann|212 263 7225|horacio.kaufmann@nyumc.org|
22435473|NCT04599166|Penn State College of Medicine|Dr. Benjamin Levi|717-531-8778|BHLevi@psu.edu|
22435474|NCT01974752|AstraZeneca|Karin Bowen|+001 301 398 3254|karin.bowen@astrazeneca.com|
22435475|NCT02317809|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22395244|NCT01119001|University of Michigan|Jane Huggins|734-936-7177|janeh@umich.edu|
22395245|NCT00954421|University of Florida|Dr. Kelly Foote|352-273-5550|foote@neurosurgery.ufl.edu|
22395246|NCT00403754|Novartis Pharmaceuticals|Study Director|862 778-8300||
22425650|NCT02984644|University of Texas Health Science Center at San Antonio|Dr. Eugenio Cersosimo|210-358-7200|cersosimo@uthscsa.edu|
22425651|NCT03620383|Oregon Health & Science University|Ramsey Al-Hakim, MD|503-494-7660|alhakim@ohsu.edu|
22425652|NCT00184093|USC Norris Comprehensive Cancer Center|Victoria Soto - Project Specialist|(323) 865-0454|Victoria.Soto@med.usc.edu|
22425653|NCT01540513|University of Wisconsin Carbone Cancer Center|Dr. Lance Hall|608-263-5585|lhall@uwhealth.org|
22425654|NCT02273362|Mayo Clinic|Kenneth K. Tanabe, M.D.|507-284-2511|ktanabe@partners.org|
22425655|NCT00805129|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin, MD|646-888-4700|bajorind@mskcc.org|
22425656|NCT00571662|University of Nebraska Medical Center|R Gregory Bociek|402-559-5388|rgbociek@unmc.edu|
22425657|NCT03167255|NS Pharma, Inc.|Medical Affairs|+1(201) 986-3860|trialinfo@nspharma.com|
22425658|NCT03681184|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
22425659|NCT03338244|UC San Francisco - Proctor Foundation|Thomas Lietman|(415) 476-1442|tom.lietman@ucsf.edu|
22425660|NCT04229771|William Beaumont Hospital|Dr. Dianne Schlachter, Staff Physician|248-551-2020|dianne.schlachter@beaumont.org|
22425661|NCT02710084|Icahn School of Medicine at Mount Sinai|Alexander Kolevzon, MD|212-659-9134|alexander.kolevzon@mssm.edu|
22425662|NCT01909141|Cairo University|Dr. Ghada Abdel Fattah|00201006513305|ghadaabdelfatah2007@yahoo.com|
22425663|NCT04672044|Birmingham VA Medical Center|Research Integrity Officer|2059338101|latanya.higginbottom@va.gov|337436
22425664|NCT00792116|Baylor|Craig Johnston|713-798-2068|caj@bcm.edu|
22425665|NCT02453256|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22425666|NCT01440634|UT Southwestern Medical Center|Dr. Carlos H Timaran|2146450533|timaran1@msn.com|
22425667|NCT03373461|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22425668|NCT01366638|Janssen Pharmaceutical K.K., Japan|Director|81 3 44115639||
22425669|NCT01243177|UCB Cares|UCB (Study Director)|+1 887 822 9493||
22425670|NCT03020550|University of California, Davis|Michelle Dossett, MD, PhD|916-734-5367|mdossett@ucdavis.edu|
22425671|NCT05259163|Evolution Optiks|Raul Mihali|2039815480|raul.mihali@evolutionoptiks.com|
22425672|NCT05251233|Washington University School of Medicine|Natasha Leigh-Matijakovich, M.D.|314-362-7147|leigh@wustl.edu|
22425673|NCT00913081|University of Pennsylvania|Richard L. Dunbar, MD, PI|609 413-1067|richard.dunbar@uphs.upenn.edu|
22425674|NCT02726789|Replicor Inc.|Chief Scientific Officer|514 733 1998|availlant@replicor.com|
22425675|NCT01639144|Center for Research & Grants, Baptist Health South Florida|Gary M. Kiebzak, Ph.D., Co-investigator and Clinical Research Administrator|786-268-6224|garyk@baptisthealth.net|
22425676|NCT01000974|GlaxoSmithKline|GSK Response Center|866-435-7343||
22425677|NCT03365934|JNJWorldwide|Amisha Parikh-Das|973-255-8701|aparikh1@its.jnj.com|
22425678|NCT01307891|University of Alabama at Birmingham|Andres Forero, M.D.|205-934-7167|aforero@uab.edu|
22425679|NCT02937740|Acerus Pharmaceuticals Corporation|Dr. Nathan Bryson, Chief Scientific Officer|1-416-679-0776|nbryson@aceruspharma.com|
22425680|NCT04194489|Mt. Hope Family Center, University of Rochester|Dr. Christie Petrenko|(585) 275-2991|christie.petrenko@rochester.edu|241
22425681|NCT00983645|Loma Linda University Medical Center Transplantation Institute|Dr. Pedro Baron|909-558-3636|pbaron@llu.edu|36792
22425682|NCT02964338|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22425683|NCT02239640|Medtronic|Oscar Bolanos|949-527-0822|Oscar.bolanos@medtronic.com|
22425684|NCT04611542|Oregon Research Behavioral Intervention Strategies, Inc. dba Behavioral Influents Innovations|Dr. Jeremy Jones|541-484-2123|jeremy.jones@influentsin.com|
22425685|NCT02291029|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22425686|NCT03872843|Wake Forest|Dr. Jorge Gutierrez|336-716-2011|jgutierrez@wakehealth.edu|
22425687|NCT00823264|Emory University|Dr. Brent Morgan|404-616-4403|bmorg02@emory.edu|
22425688|NCT00856999|Oregon Health & Sciences University|Roger Dailey, MD, FACS|503-494-3020|daileyr@ohsu.edu|
22425689|NCT02465437|Corbus Pharmaceuticals, Inc.|John Skutnik, MS|781-562-9853|jskutnik@corbuspharma.com|
22425690|NCT00003483|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22425691|NCT01308463|Zimmer Biomet|Kelly Francher|574-371-9783|kelly.francher@zimmerbiomet.com|
22425692|NCT01065571|University of Illinois at Chicago|Joanne Tobacman, MD|312-569-7826|jkt@uic.edu|
22425693|NCT00103662|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22425694|NCT03280056|Brainstorm Cell Therapeutics|Chief Medical Officer|+1-201-488-0460|ClinicalTrial@brainstorm-cell.com|
22425695|NCT01135524|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333||
22425696|NCT02051790|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22425697|NCT02907463|Edwards Lifesciences, LLC|Mary Edwards, VP Clinical and Regulatory Affairs, Surgical Structural Heart|949-250-2500|mary_edwards@edwards.com|1536
22425698|NCT01266824|Children's Hospital of Philadelphia|Dr. Amy Cohen|215-590-1000|cohenam@email.chop.edu|
22425699|NCT02302846|The University of Texas MD Anderson Cancer Center|Courtney DiNardo, MD/Assistant Professor|713-794-1141|CR_Study_Registration@mdanderson.org|
22425700|NCT00397189|Neurim Pharmaceuticals|VP clinical and regulatory affairs|+972-3-6499340|Talin@neurim.com|
22425701|NCT01936363|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22425702|NCT01447407|NovaDigm Therapeutics, Inc.|John P. Hennessey, Jr.|12676405189|john_hennessey@novadigm.net|
22425703|NCT00580957|Vanderbilt University|Italo Biaggioni, M.D. Professor of Medicine|(615) 936-3420|italo.biaggioni@vanderbilt.edu|
22425704|NCT00872521|Jan-Cil Australia|Regional Medical Affairs Director Asia Pacific|61 427564369||
22435476|NCT02435680|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22435477|NCT02233738|Ralph H. Johnson VA Medical Cneter|Dr. Elizabeth Santa Ana|843-789-7168|Elizabeth.Santaana2@va.gov|
22435478|NCT00096174|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
22435479|NCT00953524|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22435480|NCT00294645|Medtronic CRDM|CRDM Clinical|800-328-2518|medtroniccrmtrials@medtronic.com|
22435481|NCT01975519|TRACON Pharmaceuticals Inc|Charles Theuer, Medical Monitor|8585500780|ctheuer@traconpharma.com|
22435482|NCT00554619|GlaxoSmithKline|GSK Response Center|866-435-7343||
22435483|NCT02250807|Janssen R&D BE|Trial Physician||ClinicalTrialDisclosure@its.jnj.com|
22435484|NCT00907803|SIGA Technologies, Inc.|Annie Frimm, Vice President, Regulatory Affairs|951-303-8797|afrimm@siga.com|
22435485|NCT00909545|Feinberg School of Medicine, Northwestern University|Tanya Simuni, MD|312-503-2970|TSimuni@nmff.org|
22435486|NCT05426031|University of Miami|Michael Fabbro II, DO|305-689-1106|mxf790@miami.edu|
22435487|NCT00089986|GlaxoSmithKline|GSK Response Center|866-435-7343||
22435488|NCT01310400|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
22435489|NCT04065074|Flexion Therapeutics, Inc.|David Golod, Vice President, Clinical Operations|(781) 305-7572|dgolod@flexiontherapeutics.com|
22435490|NCT02334683|Icahn School of Medicine at Mount Sinai|David Simpson, M.D.|(212) 241-8748|david.simpson@mssm.edu|
22435491|NCT01062841|University of Michigan|Lona Mody, MD, MSc|734-764-8942|lonamody@umich.edu|
22435492|NCT03958656|National Cancer Institute|Dr. James N. Kochendefer|240-760-6062|kochendj@mail.nih.gov|
22435493|NCT03831880|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22435494|NCT02081638|National Institute of Allergy and Infectious Diseases|Dr. Irini Sereti|301-496-5533|isereti@niaid.nih.gov|
22435495|NCT03158012|UCSD Dermatology|Teruaki Nakatsuji|8588227814|tnakatsuji@ucsd.edu|
22435496|NCT02788201|National Cancer Institute|Dr. Andrea Apolo|301-480-0536|apoloab@nih.gov|
22435497|NCT01874275|Independent Principal Investigator|Charlotte Stelly-Seitz, MD|713-523-3463|drstellyseitzmd@gmail.com|
22435498|NCT04662073|Stanford University|Manesha Desai, PhD|(650) 725-1946|manisha.desai@stanford.edu|
22435499|NCT00681564|Universidad del Valle|Jorge Hernán Ramírez and Adolfo Contreras (adolfo@yahoo.com).|5723753778|jorge.h.ramirez00@gmail.com|
22435500|NCT02342379|University of Texas Health San Antonio|Andrew Brenner, MD, PhD|210-450-5936|brennera@uthscsa.edu|
22435501|NCT00762996|Vistakon|Kurt Moody, OD, FAAO|904-443-3088||
22435502|NCT00657150|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22435503|NCT02649192|St. Jude Children's Research Hospital|Nehali Patel, MD|866-278-5833|info@stjude.org|
22435504|NCT00468845|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22435505|NCT00787930|Duke University Medical Center|John Beyer, MD|919-668-0209|john.beyer@dm.duke.edu|
22435506|NCT01400243|Southern Illinois University Carbondale|David G. Gilbert|618-453-3527|dgilbert@siu.edu|
22435507|NCT04316741|University of Michigan|Dr. Erin Bonar|7347647936|erinbona@med.umich.edu|
22435508|NCT01442064|Genentech|Genentech||ctg-post-d@gene.com|
22435509|NCT01360398|GlaxoSmithKline|GSK Response Center|866-435-7343||
22435510|NCT02153346|GlaxoSmithKline|GSK Response Center|866-435-7343||
22435511|NCT01710527|GlaxoSmithKline|GSK Response Center|866-435-7343||
22435512|NCT04765644|Imperial College London|Dr Ricky Vaja|020 7589 5111|r.vaja@imperial.ac.uk|
22395247|NCT02979925|VA San Diego Healthcare System|Albert Leung, MD|858-552-8585|albert.leung@va.gov|3866
22435513|NCT03597178|Johnson & Johnson|Brian Pall OD, MS, FAAO- Director of Clinical Sciences|9044431290|BPALL@its.jnj.com|
22435514|NCT00908648|Gastroenterology Unit, Valduce Hospital - Como - Italy|Dr Vittorio Terruzzi, Director of Gastroenterology Unit|+39031324009|vterruzzi@valduce.it|
22435515|NCT03946124|University of Pennsylvania|Dr. Lily Arya|215-662-3230|larya@pennmedicine.upenn.edu|
22395248|NCT04343248|Romark, L.C.|Sr. Director, Research Operations|8132828544|jessica.fulgencio@romark.com|
22435516|NCT00529126|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
22435517|NCT02370004|Brigham and Women's Hospital|Dr. Elliot Israel|6177328201|eisrael@partners.org|
22435518|NCT01187004|UTurin|Dr Daniela Pasero|00390116335511|daniela.pasero@unito.it|
22435519|NCT01909180|GE Healthcare|RIchard Petrisko|262-548-4637|richard.petrisko@ge.com|
22435520|NCT02118597|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22435521|NCT01891344|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
22435522|NCT01852825|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22435523|NCT01414205|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22435524|NCT01166373|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
22435525|NCT02498067|University of Chicago|Soo Young Lee|6513430045|sooyoungl@uchicago.edu|
22435526|NCT02030080|Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh S. Patel|215-898-3367|mpatel@upenn.edu|
22435527|NCT02214225|Seqirus|Seqirus Clinical Trial Disclosure Lead||Seqirus.ClinicalTrials@Seqirus.com|
22435528|NCT03987932|University of South Carolina|Christine Pellegrini|803-777-0911|pellegca@mailbox.sc.edu|
22435529|NCT01394614|Center for Advanced Research in Sleep Medicine|Dr. Jacques Montplaisir|514-388-2693|jy.montplaisir@umontreal.ca|
22435530|NCT01669421|University of Miami|Michael Campos|305-243-3045|mcampos1@med.miami.edu|
22435531|NCT00320749|The Ohio State University Comprehensive Cancer Center|Tanios Bekaii-Saab, M.D.|614-293-9863|Tanios.Bekaii-Saab@osumc.edu|
22435532|NCT02740543|NYU Langone Health - Bellevue Hospital|Angeliki Kazeros, MD|212-263-6479|Angeliki.Kazeros@nyulangone.org|
22435533|NCT02813668|Emory University|Dr. Mary Beth Weber|404-712-1902|mbweber@emory.edu|
22435534|NCT02961790|Mayo Clinic|Charles L. Loprinzi, M.D|507/284-4565|loprinzi.charles@mayo.edu|
22435535|NCT01007071|Stanford University|Dr. Laurence Katznelson|650-736-9551|katznels@stanford.edu|
22435536|NCT01053013|The Rogosin Institute|Betty-Jane Sloan, Clinical Research Manager|646-317-0701|bjsloan@nyp.org|
22435537|NCT02594098|Icahn School of Medicine at Mount Sinai|Dr. Emma Guttman|212-241-9728|emma.guttman@mountsinai.org|
22435538|NCT00706329|Children's Hospital Boston and South Shore Hospital|Dr. Neil Feins|6173556915||
22435539|NCT01866423|USC Norris Comprehensive Cancer Center|Victoria Soto, Project Specialist|323-865-0454|Victoria.Soto@med.usc.edu|
22435540|NCT03366103|Johns Hopkins University/SKCCC|Judy Murray|443-927-3568|jmurra33@jhmi.edu|
22435541|NCT00300482|Abbott|Medical Information Specialist|800-633-9110||
22435542|NCT00541099|Barbara Ann Karmanos Cancer Institute|Shirish Gadgeel, M.D.|(313) 576-8753|sgadgeel@med.umich.edu|
22435543|NCT00921310|Washington University School of Medicine|Maria Baggstrom, M.D.|314-362-5737|mbaggstr@dom.wustl.edu|
22435544|NCT00048815|Cedars Sinai Medical Center|Mark Hyman Rapaport, M.D.|310-423-2600|mark.rapaport@cshs.org|
22435545|NCT05590000|Abbott|Devyani Nanduri, Senior Director, Clinical & Regulatory Affairs|+16698329450|devyani.nanduri@abbott.com|
22435546|NCT01174004|ACADIA Pharmaceuticals Inc.|Roger Mills, MD|858-202-7563|rmills@acadia-pharm.com|
22435547|NCT00837824|Genzyme Corporation|Genzyme MedInfo|800-745-4447|medinfo@genzyme.com|
22435548|NCT01241344|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
22435549|NCT00434759|Central Institute of Mental Health, Mannheim, Germany|Prof. Martin Bohus|+49 621 1703 4002|martin.bohus@zi-mannheim.de|
22435550|NCT00539617|University of California, San Francisco|W. Michael Korn, MD|415-502-2844|michael.korn@ucsf.edu|
22435551|NCT01143896|Michael E. DeBakey VA Medical Center|Fasiha Kanwal, MD, MSHS|(713) 440-4495|Fasiha.Kanwal@va.gov|
22435552|NCT01318070|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
22435553|NCT00042432|Amgen Inc.|Study Director|866-572-6436||
22435554|NCT02165462|Universidad Católica San Antonio de Murcia|Rubén Cuesta-Barriuso, PhD|+34 913146508|ruben.cuestab@gmail.com|
22435555|NCT02966795|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22435556|NCT00432744|University of Florida|Dr. Peter W Stacpoole|352-273-9023|pws@ufl.edu|
22435557|NCT01735708|Butler Hospital|Lisa Uebelacker|401-455-6381|luebelacker@butler.org|
22435558|NCT00461305|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22435559|NCT02513823|Texas Woman's University|Carolyn Moore|713-794-2377|cmoore8@twu.edu|
22435560|NCT02743780|Alcon, A Novartis Division|Translational Medicine Expert II, TM-Ophthalmic|1-888-451-3937|alcon.medinfo@alcon.com|
22435561|NCT01294462|AstraZeneca|Judith Hsia||ClinicalTrialTransparency@astrazeneca.com|
22435562|NCT00085254|Adult Brain Tumor Consortium (ABTC)|Louis Burt Nabors, MD|205-934-1432|bnabors@uab.edu|
22435563|NCT04342689|Yale School of Medicine|Sherry Mansour, MD, MS Assistant Professor|(203) 785-4184|sherry.mansour@yale.edu|
22435564|NCT01460407|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22435565|NCT02818114|Minneapolis VA Health Care System|J. Irene Harris|612-467-1654|jeanette.harris2@va.gov|
22395249|NCT05629962|Atea Pharmaceuticals, Inc.|Atea Clinical Trials|1-857-284-8891|ateaclinicaltrials@ateapharma.com|
22435566|NCT00844805|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22435567|NCT00259298|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22435568|NCT01287377|UCSD|Dr. Shu-Hong Zhu|8583001056|szhu@ucsd.edu|
22435569|NCT01011933|Gynecologic Oncology Group Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
22435570|NCT01216943|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22435571|NCT00475865|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi.com|
22435572|NCT02726880|UConn Health|Kristyn Zajac, PhD|860-679-8572|zajac@uchc.edu|
22435573|NCT00787202|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22435574|NCT01510145|Alcon Research, Ltd|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
22435575|NCT01822535|James J. Peters VA Medical Center|Dr. John P. Handrakis|718-584-9000|john.handrakis@va.gov|5439
22435576|NCT01071356|Public Health Institute: Alcohol Research Group|Dr. Douglas Polcin|510-597-3440|dpolcin@arg.org|277
22435577|NCT02278614|Laboratoires Théa|Director of Medical Operations|04 73 98 50 89|J.AUGER@laboratoires-thea.fr|
22435578|NCT02279498|Anthera Pharmaceuticals|Monica Gangal|510-856-5600|info@anthera.com|
22435579|NCT00737711|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22435580|NCT02739321|The Cleveland Clinic|Dr. Thomas Frazier||fraziet2@ccf.org|
22435581|NCT02558400|Aerie Pharmaceuticals, Inc|Theresa GH Heah, MD, MBA|908-947-3844|theah@aeriepharma.com|
22435582|NCT01258153|Menarini Ricerche|Dr. Angela Capriati|+39 05556809990|acapriati@menarini-ricerche.it|
22435583|NCT02230683|Conatus Pharmaceuticals Inc.|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com|
22435584|NCT00624780|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22435585|NCT03052530|OrbusNeich|Debbie Morrell, Clinical Research Manager|954-730-0711|DMorrell@OrbusNeich.com|
22435586|NCT04068519|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22435587|NCT00969761|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22435588|NCT03081858|LIPAC Oncology|Karl Bean|714-900-4412|karl@lipaconcology.com|
22435589|NCT00340379|Duke University|Frederick Cassidy|919-575-7801|cassi002@mc.duke.edu|
22435590|NCT02936284|Children's Mercy Hospital, Kansas University|Kai Ling Kong, PhD|816-731-7239|kkong@cmh.edu|
22435591|NCT01610596|Therapeutics, Inc.|Clinical Research, Therapeutics Inc.|858-571-1800|clinicalresearch@therapeuticsinc.com|
22435592|NCT03037541|Wake Forest University Health Sciences|Joseph Jorizzo, MD|336-716-3775|jjorizzo@wakehealth.edu|
22435593|NCT00799591|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22435594|NCT02098369|University of Illinois at Chicago|Jerry A. Krishnan, MD, PhD|312-413-0637|jakris@uic.edu|
22435595|NCT00570037|Duke University Medical Center|Emmanuel Walter MD, Principal Investigator|919-620-5374|walte002@mc.duke.edu|
22435596|NCT00145418|Oncology Specialists, S.C.|Chadi Nabhan, MD|847-268-8200|cnabhan@oncmed.net|
22435597|NCT00413920|Novartis Pharmaceuticals|Study Director|862-778-8300||
22435598|NCT01765426|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22435599|NCT01665430|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22435600|NCT02310230|University of Vermont Medical Center|Alexander Friend, Clinical Research Coordinator|802-847-4259|alexander.friend@uvmhealth.org|4259
22435601|NCT00545532|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22435602|NCT03593681|Boston Scientific|Clinical Trial Project Manager|612-209-9532|blake.hedstrom@bsci.com|
22435603|NCT01149486|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22435604|NCT00598078|Jazz Pharmaceuticals|Grace Wang, MD Director Clinical Development and Medical Monitor|650-496-3777||
22435605|NCT04066686|Imperial College Healthcare NHS Trust|Dr Annabelle Lee|02033121077|annabellelee@nhs.net|
22435606|NCT01479595|Novartis|Study Director|862-778-8300||
22435607|NCT02120365|Virginia Commonwealth University|Albert Arias|8046286777|albert.arias@vcuhealth.org|
22435608|NCT01726673|Feinstein Institute for Medical Research at Northwell Health|Johanna Chang, Senior Research Coordinator|(516) 562-3646|jchang14@northwell.edu|
22435609|NCT01344629|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22435610|NCT00900146|Novartis Pharmaceuticals|Study Director|862-778-8300||
22435611|NCT02305849|Astellas Pharma Inc.|Clinical Trial Disclosure|+81-3-3244-6500 Japanese only|Astellas.resultsdisclosure@astellas.com|
22435612|NCT00355342|GlaxoSmithKline|GSK Response Center|866-435-7343||
22435613|NCT02689076|James J. Peters VA Medical Center|Kimberly M. Judon|718-584-9000|Kimberly.Judon@va.gov|1174
22435614|NCT00933244|University of Wisconsin - School of Medicine & Public Health|Dr. Karen E Hansen|608-265-8162|keh@medicine.wisc.edu|
22435615|NCT02944565|The Ohio State University Comprehensive Cancer Center|Hallie Barr, PharmD BCOP|614-685-5803|Hallie.Barr@osumc.edu|
22435616|NCT00997425|James A. Haley VA Hospital, Tampa, FL|Dorothy H. Moore, PhD|813 558-3931|Dorothy.Moore4@va.gov|
22435617|NCT00495521|Jacobus Pharmaceutical Company, Inc.|Dr. Kathy Aleš, Medical Director|609-921-7448|kathy.ales@jacobus-pharmaceutical.com|238
22435618|NCT02312765|University of Pennsylvania|Dr Nalaka Gooneratne|215 573 2048|ngoonera@upenn.edu|
22435619|NCT00693472|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22435620|NCT02782325|University of North Carolina at Chapel Hill|Hans Herfarth, MD|919-966-6806|hherf@med.unc.edu|
22435621|NCT02481713|VA Connecticut Healthcare System|Joanna Fiszdon, PhD|2039325711|joanna.fiszdon@va.gov|2231
22435622|NCT01527383|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22435623|NCT00849875|GlaxoSmithKline|GSK Response Center|866-435-7343||
22435624|NCT02989844|University of Minnesota, Masonic Cancer Center|Jeffrey Miller|612-625-7409|mille011@umn.edu|
22435625|NCT02575118|NORCE|Dr. Trine Lise Lundekvam Berge|+47 56 10 72 12|trbe@norceresearch.no|
22435626|NCT01689350|School of Pharmaceutical Sciences, Sun Yat-sen University|Lingyan CHEN, Master candidate|+8615018706960|chlingy@mail2.sysu.edu.cn|
22435627|NCT00554099|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22435628|NCT04240093|Brown University|Jaclyn White Hughto, PhD, MPH|401-863-6580|jaclyn_hughto@brown.edu|
22435629|NCT02839902|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22435630|NCT04957758|Oyster Point Pharma Inc|Marian Macsai, MD|312-259-2477|mmacsai@oysterpointrx.com|
22435631|NCT03353922|Neurana Pharmaceuticals|Judy Caron, Chief Operating Officer|(617) 640-5043|jcaron@neuranapharma.com|
22435632|NCT03688555|Idorsia Pharmaceuticals Ltd|Clinical Trials Disclosure Desk|+41 588 441977|clinical-trials-disclosure@idorsia.com|
22435633|NCT00886119|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22435634|NCT05044104|Mayo Clinic|Dr. Vinay Chandrasekhara|207-284-2687|Chandrasekhara.Vinay@mayo.edu|
22435635|NCT03553498|Albert Einstein College of Medicine|Polly Bijur|718-430-4217|polly.bijur@einsteinmed.org|
22435636|NCT01498185|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
22435637|NCT02032641|Bascom Palmer Eye Institute|Dr. Sara T. Wester|3053266132|SWester2@med.miami.edu|
22435638|NCT01453946|Perrigo|Beatriz North|718-960-0163|beatriz.north@perrigo.com|
22435639|NCT00846040|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Kevin Hall, PhD|3014028248|kevinh@niddk.nih.gov|
22435640|NCT00957333|WanFangH|Ruei-Ming Chen|02-27361661|rmchen@tmu.edu.tw|3222
22435641|NCT02827500|Duke Clinical Research Institute|Dr. Robert Mentz|919-668-7121|robert.mentz@duke.edu|
22435642|NCT03343080|Mayo Clinic|Dr. Troy Seelhammer|507-255-6051|seelhammer.troy@mayo.edu|
22435643|NCT03697993|Vaccine Treatment Evaluation Unit (VTEU)|Nadine Rouphael, MD, MSc|(404) 822-1411|nroupha@emory.edu|
22435644|NCT04384107|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22435645|NCT02423122|EIP Pharma|John Alam||jalam@eippharma.com|
22435646|NCT01591863|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22435647|NCT00160654|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22435648|NCT00831701|Department of Urology, University Hospital Zürich, Switzerland|Räto T. Strebel|0041-44-2551111|raeto.strebel@ksgr.ch|
22435649|NCT02366767|Stanford School of Medicine|Bruce Buckingham|650-725-9549|buckingham@stanford.edu|
22435650|NCT02242981|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22435651|NCT00579995|University of Nebraska Medical Center|Scott Shurmur, M.D.|402-559-6463|sshurmur@unmc.edu|
22435652|NCT03474081|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22435653|NCT00737594|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
22435654|NCT00459537|Novartis Pharmaceuticals|Study Director|862 778-8300||
22435655|NCT00546260|Portola Pharmaceuticals Inc.|Kevin Romanko, Senior Director Clinical Operations|650-246-7305|kromanko@portola.com|
22435656|NCT04559022|UT Southwestern|Research Coordinator|2146458907|jennifer.barillas@utsouthwestern.edu|
22435657|NCT00131456|Columbia University|Dr. Frances R. Levin|212-543-5896|frl2@columbia.edu|
22435658|NCT00664326|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22435659|NCT01307462|FHCRC|Guang-Shing Cheng MD|206-667-7074|gcheng2@fhcrc.org|
22435660|NCT01161537|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22435661|NCT00996801|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clincaltrialsdisclosure@merck.com|
22435662|NCT00289198|GlaxoSmithKline|GSK Response Center|866-435-7343||
22435663|NCT04332614|Geisinger Clinic|Amir Goren, PhD|5702144395|agoren@geisinger.edu|
22435664|NCT02559414|New York University School of Medicine|Jeffrey Berger, MD|212 263 4004|Jeffrey.Berger@nyumc.org|
22435665|NCT03369431|University College London|Susan Simmons|+44 7952961881|susan.simmons.16@ucl.ac.uk|
22435666|NCT00004445|Louis Stokes Cleveland VAMC|Lisa Lombardo, MPT|216-791-3800|lisa.lombardo2@va.gov|4909
22435667|NCT00076336|Novartis Pharmaceuticals|Study Director|862-778-8300||
22435668|NCT03435562|Virginia Commonwealth University|Alison Breland|804 628 2300|abbrelan@vcu.edu|
22435669|NCT04214639|Bausch Health Americas, Inc|Study Director|7072851528|Varsha.Bhatt@bauschhealth.com|
22435670|NCT02937766|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
22435671|NCT02753127|Sumitomo Dainippon Pharma Oncology|Keiichi Saito|+1 (617)674-6800|keiichi.saito@SDPOncology.com|
22435672|NCT01670565|Hospital For Special Surgery|Annel Fernandez|212 774 2123|fernandeza@hss.edu|
22435673|NCT02151331|University of Michigan|Amy Kilbourne, PhD|734-845-3452|amykilbo@umich.edu|
22435674|NCT01519674|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22435675|NCT02867618|Columbia University|Ana Ignat|212-305-3612|ai2111@cumc.columbia.edu|
22435676|NCT06687824|Manipal University College Malaysia|Heng Sy Xuan|+601110752589|hengsyxuan@hotmail.com|
22435677|NCT02046174|The Rogosin Institute|Betty-Jane Sloan, Clinical Research Manager|646-317-0701|bjsloan@nyp.org|
22435678|NCT00733135|Covidien|Director of Medical Communications|763-591-3047|jean.ahlstrom@covidien.com|
22435679|NCT00186537|Stanford University|Dr. Gerald Reaven|650-724-3416|greaven@stanford.edu|
22435680|NCT01854632|PATH|Senior Clinical Research Scientist|206-285-3500|klewis@path.org|
22435681|NCT03180398|Henry Ford Health|Dr. Stephen Brown|3135858415|sbrown1@hfhs.org|
22395250|NCT03951220|University of Oxford|Gaurav Agarwal|07826636655|gaurav.agarwal@medsci.ox.ac.uk|
22395251|NCT05245097|ActiveProtective|Dr Rebecca J Tarbert|267-242-6125|Rebecca@activeprotective.com|
22395252|NCT04770493|Brown University|Dr. Robert Miranda Jr.|401-863-6658|Robert_Miranda_Jr@brown.edu|
22395253|NCT04683731|Trustees of Indiana University|Dr. Peter H. Schwartz, MD, PhD|317-278-4037|phschwar@iu.edu|
22395254|NCT00883051|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22395255|NCT00692978|Imperial College London|Dr Omar Usmani|02073158051|o.usmani@imperial.ac.uk|
22395256|NCT03604523|UMass Medical School|Dr. David Cave|508-856-8399|david.cave@umassmemorial.org|
22395257|NCT00458341|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22395258|NCT05461794|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
22395259|NCT02083705|University of Alberta|Georg Schmölzer|7807354647|georg.schmoelzer@me.com|
22395260|NCT02730598|University of Kansas Medical Center|Neil Segal|(913) 945-8985|segal-research@kumc.edu|
22395261|NCT00810394|University of California Davis|Analyst|916 734 0294|pkaujla@ucdavis.edu|
22395262|NCT02271477|Ente Ospedaliero Cantonale|Dr. med. Andrea Saporito, Vice-Director of Anaesthesiology|091/811.89.78|andrea.saporito@eoc.ch|
22395263|NCT00467285|Samuel Stratton VAMC|Dr. Subhashini Yaturu|518-626-5642|Subhashini.Yaturu@va.gov|
22435682|NCT01146288|Rabin Medical Center|Dr Boris Zingerman||borisz@clalit.org.il|
22395264|NCT03891524|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22395265|NCT01210118|Hellenic Anticancer Society|Professor Panagiotis Behrakis|00302106470056|pbehraki@hsph.harvard.edu|
22395266|NCT01079130|Novartis Pharmaceuticals|Study Director|862-778-8300||
22395267|NCT03019796|University of Castilla-La Mancha|Proffessor|925268800|ricardo.mora@uclm.es|
22395268|NCT00763867|Duke University|Jenny Ibarra|919.236.3291|jenny.ibarra@duke.edu|
22395269|NCT01389765|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22395270|NCT01696942|Milton S. Hershey Medical Center|Dr. David Stewart|717-531-0003|dstewart@pennstatehealth.psu.edu|
22395271|NCT01598311|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22395272|NCT03144804|Massachusetts General Hospital|Aparna Parikh, MD|617-339-8452|aparna.parikh@mgh.harvard.edu|
22395273|NCT00959647|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
22395274|NCT06515483|Loops, LLC|Steven Kayser, President|360-366-3009|stevenkayser@flossloops.com|
22395275|NCT00523718|Yale University|Christopher Pittenger|(203) 974-7675|christopher.pittenger@yale.edu|
22395276|NCT01306890|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@Dendreon.com|
22395277|NCT02217436|Rady Children's Hospital San Diego|Dr. Amy Williams Bryl|8589668036|abryl@rchsd.org|
22395278|NCT02656420|JHSPH|Dr. Thomas W. Kensler|410-955-1292|tkensle1@jhu.edu|
22395279|NCT00234494|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
22395280|NCT04533451|Mayo Clinic|Dr. Aminah Jatoi|507-266-9160|Jatoi.Aminah@mayo.edu|
22395281|NCT05344092|Department of Veterans Affairs|Dr. Erin Reilly|781-687-2000|Erin.Reilly@va.gov|4191
22395282|NCT02634346|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
22395283|NCT02170389|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
22395284|NCT02743377|National Institute of Mental Health|Dr Robert Innis|+1 301 693 2979|innisr@mail.nih.gov|
22395285|NCT03260595|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22395286|NCT03801902|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22395287|NCT05664763|Yale University|Stephen R Baldassarri, M.D.|203-785-3627|stephen.baldassarri@yale.edu|
22395288|NCT04485104|Jazz Pharmaceuticals, Inc.|Director Clinical Trial Disclosure & Transparency|+1 215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
22395289|NCT00908232|Janssen-Cilag Germany|EMEA Medical Affairs Director Oncology|+49 2137 955-492||
22395290|NCT03153137|Actelion Pharmaceuticals Ltd|Senior Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22395291|NCT01821378|Sunovion|1-866-503-6351|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
22395292|NCT00195507|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22395293|NCT02260882|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22395294|NCT02267356|Mycovia Pharmaceuticals|Sr Vice President, Clinical Development|(919) 467-8539|info@viamet.com|
22395295|NCT00559585|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22395296|NCT04209621|National Institutes of Health (NIH) / The National Heart, Lung, and Blood Institute (NHLBI)|Sun, Clare, M.D. Principal Investigator, NIH, NHLBI|301.402.1806|clare.sun@nih.gov|
22395297|NCT04044183|Center for Health Outcomes and Interdisciplinary Research, Department of Psychiatry, Massachusetts General Hospital|Ana-Maria Vranceanu|(617) 724-3953|avranceanu@mgh.harvard.edu|
22395298|NCT00769860|University of Kansas Medical Center|Dr. Richard Barohn|(913) 588-6094|RBAROHN@kumc.edu|
22395299|NCT05467774|MetroHealth Hospital/Case Western Reserve University|Dr. James Sulzer|5125419036|jss280@case.edu|
22395300|NCT01633814|University of Missouri|Principal Investigator|573-884-5220|fadelp@health.missouri.edu|
22395301|NCT01106404|Neuromodulation Emerging Therapy Clinical Research, Medtronic, Inc|Mark Sun, Senior Clinical Research Manager|763-526-8098|mark.sun@medtronic.com|
22435683|NCT03630302|Abbott neuromodulation|Erika Ross|972-526-8207|erika.ross@abbott.com|
22435684|NCT01135914|Novartis Pharmaceuticals|Study Director|862-778-8300||
22411273|NCT01090765|National Cancer Institute|Dr. William Dahut|301-496-4251|dahutw@mail.nih.gov|
22435685|NCT00353431|Intern Medicine Solothurn, Switzerland|Robert Thomann, MD|+41326274501|endodiab.bss@bluewin.ch|
22435686|NCT00931801|Community Research Initiative of New England|Calvin J. Cohen MD, MSc, Director of Research|617-502-1700|ccohen@crine.org|
22435687|NCT00746733|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22435688|NCT00610441|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22435689|NCT00334282|GlaxoSmithKline|GSK Response Center|866-435-7343||
22435690|NCT04432493|Rutgers University|Travis Baker, PhD|18622503351|travis.e.baker@rutgers.edu|
22435691|NCT00837876|Vanderbilt-Ingram Cancer Center|Jordan Berlin, MD|615-343-4128|jordan.berlin@vanderbilt.edu|
22435692|NCT00506597|The University of Texas (UT) MD Anderson Cancer Center|Robert J. Wells, MD / Professor||CR_Study_Registration@mdanderson.org|
22435693|NCT00276094|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
22435694|NCT00787137|PanGenetics UK Limited|John Powell|+441763257869|info@pangenetics.com|
22435695|NCT00985907|University of California, San Francisco|Dr. Thomas Martin, MD|(415) 353-9365|Tom.Martin@ucsf.edu|
22435696|NCT00130923|Psychopharmacology Research Group|Dr. Mary Brunette|603-271-5747|mary.f.brunette@hitchcock.org|
22435697|NCT02075632|GlaxoSmithKline|GSK Response Center|866-435-7343||
22435698|NCT03464422|Yale University|Dr. John Pachankis|6463444060|john.pachankis@yale.edu|
22435699|NCT01370837|Maastricht University Medical Center|Kristy Pickwell|+31433877019|k.pickwell@mumc.nl|
22435700|NCT01628367|University of Michigan|Dr. Hom-Lay Wang|734-647-6175|homlay@umich.edu|
22435701|NCT00740714|Weill Medical College of Cornell University|M. Flint Beal, MD|212-746-6575|fbeal@med.cornell.edu|
22435702|NCT00660985|Galderma|Michael Graeber, MD, Head of Global Clinical Project Management and US Development|609-860-8201|michael.graeber@galderma.com|
22435703|NCT01955434|Mayo Clinic|P. Leif Bergsagel, MD|480/301-8335|Bergsagel.leif@mayo.edu|
22435704|NCT00394901|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22435705|NCT02076399|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
22435706|NCT05260333|Baylor College of Medicine|Dr. Leah Antoniewicz, MD-PI|832-8267458|leah.antoniewicz@bcm.edu|
22435707|NCT00686842|AMC|Susan Krown, MD, Protocol Chair|301-251-1161|amcpm@emmes.com|
22435708|NCT03503292|Mayo Clinic|Yvette N. Martin McGrew, M.D., Ph.D.|507-255-7481|martin.yvette@mayo.edu|
22435709|NCT01049802|The Rehabilitation Institute of Chicago|Richard L. Harvey, MD|312-238-1000|rharvey@ric.org|
22435710|NCT01335750|Erdy/Searcy Group|Dr. Gary Andrasko, MS|(614) 459-3363|gandrask@columbus.rr.com|
22411274|NCT01787825|CapsoVision, Inc.|Director of Clinical Affairs|408-624-1488|andra.thomas@capsovision.com|117
22435711|NCT00462735|Florida Radiation Oncology Group|Dr. Johnny Kao|813-661-6442|johnnykaomd@gmail.com|
22435712|NCT01886690|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22435713|NCT01439074|Changhai Hospital of Shanghai|Prof Xia, Zhaofan|+86 2181873471||
22435714|NCT02463032|Oncternal|Mary Breitmeyer|858-434-1113|MBreitmeyer@oncternal.com|
22435715|NCT00612508|Women's Health Research Unit|Oregon Health & Science University|503-494-3666|whru@ohsu.edu|
22435716|NCT02008357|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22435717|NCT02312219|Mass General Hospital|Ahmed Tawakol, MD|617-726-0791|atawakol@mgh.harvard.edu|
22435718|NCT04941807|Weill Cornell Medicine|Dr. Shari Lipner|6469623376|shl9032@med.cornell.edu|
22435719|NCT01100567|Boston Children's Hospital|Dr. Amy DiVasta, PI|6173553792|amy.divasta@childrens.harvard.edu|
22435720|NCT02741570|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22435721|NCT02953665|Cedars-Sinai|Vicki Manoukian, Neurology Clinical Research Program Manager|310-423-5067|Vicki.Manoukian@cshs.org|
22435722|NCT00946322|Trauma Recovery Center, Cincinnati VA Medical Center|Jeremiah A. Schumm, PhD, Associate Director|859-572-6717|Jeremiah.Schumm@va.gov|
22435723|NCT01075971|Schering-Plough|Head, Clinical Trials Registry & Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com|
22435724|NCT02367391|Penn State College of Medicine|Project Coordinator|7175310003|jyingst@phs.psu.edu|289511
22435725|NCT03352453|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
22435726|NCT00858897|Nemours Children's Clinic|Dr. Dominique Darmaun|904-697-3863|ddarmaun@nemours.org|
22435727|NCT03158272|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22435728|NCT00514020|Vanderbilt-Ingram Cancer Center|Laura Goff, MD|615-936-0059|laura.goff@vanderbilt.edu|
22435729|NCT01688921|PharmaJet, Inc.|Tara Miller, Clinical Affairs Manager|888-900-4321|tara.miller@pharmajet.com|4163
22435730|NCT04064346|Centessa Pharmaceuticals|Milena Kanova|+44 7780 430583|milena.kanova@centessa.com|
22435731|NCT01667146|ANZIC - RC, Monash University|Prof Carol Hodgson|+61 (3) 99030598|carol.hodgson@monash.edu|
22435732|NCT03190694|University Medical Center Groningen|Prof.dr.H.J. Lambers-Heerspink|+31 50 361 7859|h.j.lambers.heerspink@umcg.nl|
22435733|NCT01048866|Reckitt Benckiser Inc.|Gail Solomon, Director, Clinical Development|973-404-2752|gail.solomon@rb.com|
22442201|NCT03159260|Sport and Spine Rehab Clinical Research Foundation|Jena Slaski|301-251-2777|jslaski@ssrehab.com|838
22442202|NCT01856218|Ultragenyx Pharmaceutical Inc|Kim Mooney, Associate Director, Patient Advocacy Medical Services|408-981-3526|kmooney@ultragenyx.com|
22442203|NCT02490670|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22442204|NCT01754402|Duke University Medical Center|Cristina Gasparetto, MD|919-668-1017|cristina.gasparetto@duke.edu|
22442205|NCT00955305|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
22442206|NCT01221285|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22442207|NCT02123251|University of Hawaii, Center on Disability Studies|Dr. Chuan Chinn|8089565379|chuanc@hawaii.edu|
22442208|NCT00594945|Jazz Pharmaceuticals, Inc.|Executive Director, Clinical Development|650 496 3777||
22442209|NCT00407381|University of Nebraska|Quan Dong Nguyen, MD, MSc|4025591855|quan.nguyen@unmc.edu|
22395302|NCT01774084|Karolinska Institutet, Department of Clinical Science and Education, Södersjukhuset, Stockholm, Sweden;|Thomas Nyström MD, PhD|+4686163211|thomas.nystrom@ki.se|
22395303|NCT01629784|Northwestern University|Hae Bae, CRCC|312-695-6829|j-bae@northwestern.edu|
22395304|NCT03712189|Children's Hospital Los Angeles|Dr Todd P Chang|13233612109|tochang@chla.usc.edu|
22395305|NCT03026127|Weill Cornell Medicine|Dr. Dimitris Kiosses|914-997-4381|dkiosses@med.cornell.edu|
22395306|NCT01182766|University of Virginia School of Medicine|Dr. Nassima Ait-Daoud Tiouririne|(434) 243-0570|NAT7B@uvahealth.org|
22395307|NCT03027557|Aalborg University Hospital|Professor Peter Vestergaard|+45 97 66 36 00|p.vestergaard@rn.dk|
22395308|NCT03270332|University of Miami|Dr. Adam Wanner|3053010563|awanner@miami.edu|
22395309|NCT02430051|University of Southern California|Dr. Leah Stein Duker|(323)442-0371|lstein@chan.usc.edu|
22395310|NCT02198430|Real Fundación Victoria Eugenia|Dr. Rubén Cuesta-Barriuso|+34913146508|ruben.cuestab@gmail.com|
22395311|NCT01050907|Fast-Track Drugs and Biologics, LLC|Jonathan D. Berman|301-922-2097|jberman@fasttrackresearch.com|
22395312|NCT02030405|Stanford University Medical Center|Bruno Carneiro de Medeiros, MD|650-498-6000|bruno.medeiros@stanford.edu|
22395313|NCT00564018|UT Southwestern Medical Center|Soumya Adhikari, MD|214 456 5959|soumya.adhikari@utsouthwestern.edu|
22395314|NCT03482583|University of Florida|Dr. Ramzi Salloum, Assistant Professor|352-294-4997|rsalloum@ufl.edu|3522944994
22395315|NCT00717054|Drexel University College of Medicine|Michael Green, DO|215-762-7798|michael.green@drexelmed.edu|
22395316|NCT00267631|Maimonides Medical Center|Dr. Estevan Garcia, MD; Principal Investigator|718-283-6352|EsGarcia@maimonidesmed.org|
22395317|NCT01145755|AstraZeneca|Gerard Lynch|645895|aztrial_results_posting@astrazeneca.com|+44 1509
22395318|NCT00372385|Vertex Pharmaceuticals Incorporated|Jeff Chodakewitz, M.D.|617-341-6777|Jeff_Chodakewitz@vrtx.com|
22395319|NCT01222260|Columbia University Medical Center|Suzanne Lentzsch, M.D., PhD.|212-304-5485|sl3440@cumc.columbia.edu|
22395320|NCT05062083|National Institute of Mental Health (NIMH)|Dr. Robert Innis|301-594-1368|robert.innis@nih.gov|
22395321|NCT01009554|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
22395322|NCT01605253|Rush University Medical Center|Mark Pollack, MD|3129425372|mark_pollack@rush.edu|
22395323|NCT02554903|Actelion Pharmaceuticals US, Inc|Medical Affairs Associate Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22395324|NCT01405937|Merck Sharp & Dohme Corp|Vice President, Late Stage Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22395325|NCT00822588|Astra Tech AB|Head of Clinical Research Area Health Care|+46317763000||
22395326|NCT02097641|University of California San Francisco|Michael A. Matthay, MD|415-502-7434|michael.matthay@ucsf.edu|
22395327|NCT02340091|LG Chem|Study Leader|82-2-6987-4148|sodam@lgchem.com|
22395328|NCT01244451|GIMEMA|Alfonso Piciocchi|+39 06 70390528|a.piciocchi@gimema.it|
22395329|NCT03099005|UCSD|Brook Henry|(619) 543-4737|blhenry@ucsd.edu|
22395330|NCT04195958|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22435734|NCT03582813|Center on Mental Health Services Research and Policy, University of Illinois at Chicago, Department of Psychiatry|Dr. Judith A. Cook, Director|312-355-3921|jcook@uic.edu|
22395331|NCT01721603|University of California, San Francisco|Alain Algazi, MD|(415) 353-7552|Alain.Algazi@ucsf.edu|
22395332|NCT04226833|Genentech, Inc|Medical Communications|800 821-8590|genentech@druginfo.com|
22395333|NCT02088788|Geisinger|Melissa Troup|570-214-5433|matroup@geisinger.edu|
22395334|NCT02876835|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22395335|NCT00475033|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22395336|NCT03645954|Lithuanian Univrsity of Health Sciences|Principal Investigator Inna Jaremko|+37064857386|inna.jaremko@kaunoklinikos.lt|
22395337|NCT01335009|Eisai Inc.|Eisai Medical Information|18882742378|esi_medinfo@eisai.com|
22395338|NCT04824521|University of Montana|Dr. Sarah Reese|7313940288|Sarah.reese@mso.umt.edu|
22395339|NCT01078220|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22395340|NCT04650282|University of Michigan|Michael Popovich|(734) 936-1808|mipopovi@med.umich.edu|
22395341|NCT01920594|GlaxoSmithKline|GSK Response Center|866-435-7343||
22395342|NCT04906616|University of California, San Francisco|Dr. Amy Conroy|415-476-6021|Amy.Conroy@ucsf.edu|
22395343|NCT01521897|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22395344|NCT02194062|Yale School of Medicine|Paul Neubauer|2037855430|paul.neubauer@yale.edu|
22395345|NCT04147234|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|001
22395346|NCT01426516|Genomind|Dr. Rachel Scott|267-989-3435|rscott@genomind.com|
22395347|NCT00538304|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22395348|NCT04498169|Aerie Pharmaceuticals Inc.|Michelle Senchyna, PhD. VP, Clinical Development and Medical Affairs.|+1 908-947-3551|msenchyna@aeriepharma.com|
22425705|NCT02762071|Johns Hopkins University|Uma Srikumaran|443-546-1550|us@jhmi.edu|
22425706|NCT00433550|Mayo Clinic|Robert R. McWilliams, M.D.||mcwilliams.robert@mayo.edu|
22425707|NCT01029262|Celgene Corporation|Anne McClain, Senior Study Manager|888-260-1588|clinicaltrialdisclosure@celgene.com|
22425708|NCT01001910|Montefiore Medical Center|Clinical Supervisor|718-405-8395|bkhaksari@montefiore.org|
22425709|NCT01468454|Children's Hospital of Philadelphia - Department of Radiology|Lisa J. States, MD|267-245-7146|states@chop.edu|
22425710|NCT03200548|University of Michigan|Suzanna Zick|734-998-9553|szick@med.umich.edu|
22435735|NCT00316524|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
22395349|NCT01754857|University of Wisconsin Carbone Cancer Center|Julie Chang, MD|800-622-9822|clinicaltrials@cancer.wisc.edu|
22395350|NCT04964960|University of Kentucky|Dr. John Villano|859-323-0405|jlvillano@uky.edu|
22395351|NCT02076113|Lahey Hospital & Medical Center|Zoher Ghogawala, MD|781-744-8984|zoher.ghogawala@lahey.org|
22435736|NCT02525094|MedImmune, LLC|Rene van der Merwe|301-398-2532|information.center@astrazeneca.com|
22435737|NCT02789410|Mayo Clinic|Dr. Hans P. Sviggum|507-284-9697|sviggum.hans@mayo.edu|
22435738|NCT01751776|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22435739|NCT03172130|University of Utah|Krishna Sundar|801-581-7806|krishna.sundar@hsc.utah.edu|
22435740|NCT03295396|Chimerix, Inc.|Chief Medical Officer|919-806-1074|clinicaltrials@chimerix.com|101
22435741|NCT00474617|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22395352|NCT04682977|University of Illinois Chicago|Dr. Mansha Mirza|312-355-5427|mmirza2@uic.edu|
22395353|NCT02960854|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email|Clinical.Trials@bms.com|
22395354|NCT00221195|Tulane University|Cindy Leissinger|504-988-5433|cleissi@tulane.edu|
22395355|NCT01247571|NRG Oncology|Linda Gedeon for William Brady, PhD.|716-845-1169|lgedeon@gogstats.org|
22395356|NCT02431650|Medicines for Malaria Venture|Dr. Jörg J. Möhrle|+41 22 555 0369|moehrlej@mmv.org|
22395357|NCT03942406|ILiAD Biotechnologies|Chief Medical Officer|800-603-3525|contact@iliadbiotech.com|
22395358|NCT05073679|Penn State College of Medicine|Dr. Rosemary Claire Roden|717-531-1383|rroden@pennstatehealth.psu.edu|
22395359|NCT05640648|Yale School of Public Health|Dr. J. Lucian Davis|203-785-3665|lucian.davis@yale.edu|
22395360|NCT01162317|Atlanta VAMC|Wei Huang (PI)|404-321-6111|wei.huang@va.gov|6517
22395361|NCT05090995|Yale University School of Medicine|Lisa Fucito, PhD|203-200-1470|Lisa.fucito@yale.edu|
22395362|NCT01005459|Wake Forest School of Medicine-Anesthesiology|Peter H. Pan MD, MSEE|336-718-8278|ppan@wakehealth.edu|
22395363|NCT03049735|Myovant Sciences GmbH|Clinical Trials at Myovant|+1 650 238 0250|clinicaltrials@myovant.com|
22395364|NCT03254485|Akebia Therapeutics|Akebia Therapeutics|6178446128|trials@akebia.com|
22395365|NCT02146326|Indiana University|Michelle Salyers, PhD / Professor, Department of Psychology|317-274-2904|mpsalyer@iupui.edu|
22395366|NCT03153111|Actelion|Clinical Scientific Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22395367|NCT01104116|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu|
22395368|NCT02958267|OhioHealth|Joseph J Ruane, DO|614-566-3810|joseph.ruane@ohiohealth.com|
22395369|NCT04225221|University of North Carolina at Chapel Hill|Jessica Baker, PhD|984-235-0858|jhbaker@med.unc.edu|
22395370|NCT00777946|Novartis Pharmaceuticals|Study Director|862-778-8300||
22395371|NCT02684357|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22435742|NCT02218593|Nemours Children's Health|Director of Clinical Trials|4076507652|kristen.gibbs@nemours.org|
22435743|NCT01800318|University of Arkansas for Medical Sciences|Richard W. Hall, professor of pediatrics, co-director of neonatal intensive care unit|501-680-7894|HallRichardw@uams.edu|
22435744|NCT00262847|Gynecologic Oncology Group (GOG) Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
22435745|NCT00387647|H. Lee Moffitt Cancer Center and Research Institute|Jeffrey Lancet, M.D.|813-745-6841|jeffrey.lancet@moffitt.org|
22435746|NCT01825941|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|718-920-6266|befriedm@montefiore.org|
22435747|NCT00528996|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22435748|NCT03495102|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22435749|NCT03938324|Duke University|Sharron Docherty, PhD|919-668-3836|sharron.docherty@duke.edu|
22435750|NCT05160766|University Hospital Cologne|Prof. Dr. med. Oliver A. Cornely|0049 221 478 85523|oliver.cornely@uk-koeln.de|
22435751|NCT01282294|Synthes GmbH|Clinical Research Scientist|0041 32 720 44 65|clinicalaffairs.emea@synthes.com|
22435752|NCT02408523|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22435753|NCT02943915|Moss Rehabilitation Research Institute, Elkins Park, PA, USA|Dylan Edwards|215-663-6554|dylan.edwards@jefferson.edu|
22435754|NCT03769311|University of Wisconsin Carbone Cancer Center|Justine Bruce, MD|608-262-4961|jybruce@medicine.wisc.edu|
22435755|NCT00877370|University of Michigan|Bruce A. Mueller|(734) 615-4578|muellerb@umich.edu|
22435756|NCT04172467|Hematology Oncology Kaiserslautern|Prof. Hartmut Link|0631|praxis-link@kabelmail.de|3503709
22435757|NCT01062061|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22435758|NCT00524589|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22435759|NCT01266317|University of Pittsburgh|Dr. Michael Donahoe|412-383-2049|donahoem@upmc.edu|
22435760|NCT00098722|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22435761|NCT00890682|Pacira Pharmaceuticals, Inc|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
22435762|NCT01352637|Weill Cornell Medical College|Dr. JoAnn Difede|212 746 3079|jdifede@med.cornell.edu|
22435763|NCT02046070|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22435764|NCT00419315|Philadelphia VA Medical Center|David Oslin|215 823 5894|dave.oslin@va.gov|
22435765|NCT00306475|Vanderbilt Psychiatric Hospital|Herbert Meltzer, M.D.|615-327-7049|herbert.meltzer@vanderbilt.edu|
22435766|NCT05991934|Johns Hopkins Bloomberg School of Public Health|Johannes Thrul, PhD|(443) 318-6633‬|jthrul@jhu.edu|
22435767|NCT05601102|University of Stirling|Professor Anna C. Whittaker|0178646|a.c.whittaker@stir.ac.uk|7816
22395372|NCT01853982|Cubist Pharmaceuticals, Inc.|Vice President, Clinical Research|1.781.860.8660||
22395373|NCT00390910|GlaxoSmithKline|GSK Response Center|866-435-7343||
22395374|NCT03221192|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22411275|NCT04394754|Yale University|Francis Perry Wilson|203-737-1704|francis.p.wilson@yale.edu|
22395375|NCT05066724|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22395376|NCT01491893|Istari Oncology|Garrett Nichols, MD|(919) 245.7662|gnichols@istarioncology.com|
22395377|NCT02069353|University of Pittsburgh|Jonathan Elmer|412-647-9489|elmerjp@upmc.edu|
22395378|NCT01422850|CytoVac A/S|Christer Lundell-Ek, Project Manager - Clinical Development||cle@cytovac.dk|
22395379|NCT04484831|University of Florida|Dr. Michelle Cardel, Adjunct Professor|352-273-8811|mcardel@ufl.edu|
22395380|NCT00508352|Ottawa Hospital Research Institute|Dr. Jean-Michel Caudrelier|613-737-8899|jcaudrelier@toh.ca|70216
22395381|NCT02244996|Hong Kong Polytechnic University|Dr. Henry Chan|85227667937|henryhl.chan@polyu.edu.hk|
22395382|NCT00174265|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22395383|NCT01473160|Alcon Research, Ltd.|Joachim Nick, Dipl. Ing.|+49 6022 240 520|joachim.nick@cibavision.com|
22395384|NCT03231943|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22395385|NCT03471871|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22395386|NCT00047320|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|Resultsreportingcoordinator@childrensoncologygroup.org|
22395387|NCT03040622|Inova Heart and Vascular Institute|Kevin Bliden|443-244-1497|kevin.bliden@inova.org|
22395388|NCT02818920|Duke University|Neal Ready, MD, PhD|919-681-6932|neal.ready@duke.edu|
22395389|NCT00445068|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22395390|NCT02673619|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22395391|NCT03444324|Biotest AG|Dr. Christina Erb|00496103801|christina.erb@biotest.com|0
22395392|NCT03834038|Vancouver Island Health Authority|Dr. Christine Lee|250-519-1898|christine.lee@islandhealth.ca|
22395393|NCT00658684|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22395394|NCT00688103|School of Medicine, Toho University|Dr. Hideto Kameda|+81-3-3468-1251|hideto.kameda@med.toho-u.ac.jp|2326
22395395|NCT06071754|Masimo Corporation|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
22395396|NCT03226275|Merck KGaA Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22395397|NCT03824639|VA Boston Healthcare System|Dr. David Sparrow|857-364-6400|david.sparrow@va.gov|
22395398|NCT05959629|University of Pennsylvania School of Dental Medicine|Dr. Bekir Karabucak|215-898-4927|bekirk@upenn.edu|
22395399|NCT03022318|Robert W Snyder, MD, PhD, PC|Dr. Robert W. Snyder|5206616516|rsnyder781@gmail.com|
22395400|NCT01436071|GlaxoSmithKline|GSK Response Center|866-435-7343||
22435768|NCT05621239|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22435769|NCT06504524|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22435770|NCT04284813|McLean Hospital/Harvard Medical School|Julie M. McCarthy, PhD|6178553521|jmccarthy@mclean.harvard.edu|
22435771|NCT03846531|Pulse Biosciences, Inc.|William A. Knape|(510) 906-4649|bill.knape@pulsebiosciences.com|
22435772|NCT03859739|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22435773|NCT01145053|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22435774|NCT00293709|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22435775|NCT02785458|Northwestern University|Dr. Michael S. Wolf, PhD MPH|312-503-5592|mswolf@northwestern.edu|
22435776|NCT01146652|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22435777|NCT03476876|Baylor College of Medicine|Prof. Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
22435778|NCT02499692|The General Hospital of ShenYang Military|Dr Hanyaling|02428851876|hanyl@medmail.com.cn|
22435779|NCT00273754|University of Texas Medical School/ Houston|Samia Khalil, M.D./ Professor|713-500-6242|Samia.N.Khalil@uth.tmc.edu|
22435780|NCT03523273|Mayo Clinic|Dr. Michael Camilleri|507-266-2305|camilleri.michael@mayo.edu|
22435781|NCT02590562|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22435782|NCT01457950|GlaxoSmithKline|GSK Response Center|866-435-7343||
22435783|NCT02963987|Laboratory for the Study of Human Ingestive Behavior, The Pennsylvania State University|Dr. Barbara J. Rolls|814-863-8481|bjr4@psu.edu|
22435784|NCT03351114|Duke University|Dr. Adela R. Cardones|9196843110|adela.cardones@duke.edu|
22435785|NCT02337530|Canadian Cancer Trials Group|Lesely Seymour|6135336430|lseymour@ctg.queensu.ca|
22435786|NCT03249935|University of Arkansas for Medical Sciences|Jeannette Lee|501-526-6712|jylee@uams.edu|
22435787|NCT00989235|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22435788|NCT01229943|Dana-Farber Cancer Institute|Matthew Kulke, MD, MMSc||matthew_kulke@dfci.harvard.edu|
22435789|NCT00852527|Southern AZ VA Health Care System|Dr. Judith Babcock-Parziale, PI|520-7921450|judith.babcock@va.gov|5698
22435790|NCT04610489|Carilion Clinic|John Epling, MD, MSEd|540-581-0123|jwepling@carilionclinic.org|
22435791|NCT01352741|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223||
22435792|NCT00376805|Masonic Cancer Center, University of Minnesota|Sarah Cooley, MD|612-625-8474|cool0023@umn.edu|
22435793|NCT04070326|Takeda|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22435794|NCT00645528|Hunter Holmes McGuire VA Medical Center|Sonja K Fredrickson, MD|804-675-5151|sonja.fredrickson@va.gov|
22435795|NCT01367704|Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center|Dr. Elizabeth Miller|412-692-8504|elizabeth.miller@chp.edu|
22435796|NCT05182580|Orbis International|Dr. Nathan Congdon, Director of Research|646-674-5514|ncongdon1@gmail.com|
22435797|NCT03077698|Xenetic Biosciences Inc|Dr. Curtis Lockshin|781-778-7720|info@xeneticbio.com|
22395401|NCT01194453|Sun Yat-sen University Cancer Center|Dr. Li Zhang|87342288|zhangli6@mail.sysu.edu.cn|
22411276|NCT00718159|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22395402|NCT03808688|Aerie Pharmaceuticals|VP, Medical Affairs|949-246-8731|jmwilliams@aeriepharma.com|
22395403|NCT01974089|Centre for Clinical Research, North Denmark Regional Hospital, Hjoerring, Denmark|Dorte Melgaard|+4526281086|dmk@rn.dk|
22395404|NCT00749879|Repros Therapeutics Inc, an Allergan Affiliate|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
22395405|NCT03335163|University of Colorado Anschutz Medical Campus|Dr. Aaron Lazorwitz|3037242019|aaron.lazorwitz@cuanschutz.edu|
22395406|NCT02137512|Jaeb Center for Health Research|John Lum, Artificial Pancreas Project Director|8139758690|jlum@jaeb.org|
22395407|NCT01215175|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22395408|NCT01016964|Lexington International, LLC|David Michaels|5614170200|las@hairmax.com|
22395409|NCT03872453|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
22395410|NCT00352885|Emory University|Bobbi Woolwine|404-712-9620|bwoolwi@emory.edu|
22395411|NCT01678209|Icahn School of Medicine at Mount Sinai|Beth Krone, PhD|212-241-8014|beth.krone@mssm.edu|
22395412|NCT02960113|Rutgers Robert Wood Johnson Medical School|Shaul Cohen, MD|732-235-8717|chohensh@rwjms.rutgers.edu|
22395413|NCT00863109|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22395414|NCT03756350|Venus Concept|Dr. Matthew Gronski|(888) 907-0115|mgronski@venusconcept.com|
22395415|NCT04283981|The University of Texas Health Science Center at Houston|Simon Young|(713) 486-2568|simon.young@uth.tmc.edu|
22395416|NCT00440700|University of Minnesota|Dr. Linda Chlan|612-624-6658|chlan001@umn.edu|
22395417|NCT01096342|Mayo Clinic Cancer Center|Shaji Kumar, M.D.||kumar.shaji@mayo.edu|
22395418|NCT00385203|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22395419|NCT03422172|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22395420|NCT02496897|Altimmune|Stephanie Holland, Clinical Project Manager|240-654-1450|SHolland@Altimmune.com|40
22395421|NCT00140231|BIDMC|Christos Mantzoros|6176678633|cmantzor@bidmc.harvard.edu|
22395422|NCT00293722|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22395423|NCT01008696|Medical Affairs, Seoul, Korea|Clinical Research Associate|82-2-2094-4835||
22395424|NCT01383161|University of California, Los Angeles|Gary Small, MD|310-825-0291|gsmall@mednet.ucla.edu|
22395425|NCT00833911|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
22395426|NCT01736085|UCSD|Principal Investigator|8583001056|szhu@ucsd.edu|
22395427|NCT01423812|The Ruth M. Rothstein CORE Center|Gregory Huhn, MD|312-572-4575|ghuhn@cookcountyhhs.org|
22395428|NCT02616614|Teva Pharmaceuticals USA, Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
22395429|NCT02748018|Medtronic Diabetes|Colleen Haberman, Sr. Clinical Research Manager|6127503275|colleen.p.haberman@medtronic.com|
22395430|NCT06069778|BioNTech SE|BioNTech clinical trials patient information|+49 61319084|patients@biontech.de|0
22395431|NCT03952585|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22395432|NCT04704336|NYU Langone Health|Olugbenga Ogedegbe, MD|646-501-3435|Olugbenga.Ogedegbe@nyulangone.org|
22395433|NCT02119325|GlaxoSmithKline|GSK Response Center|866-435-7343||
22395434|NCT02249767|Spear Pharmaceuticals|Dr. Spear|239-560-2411|spear@spearpharm.com|
22395435|NCT01372410|GlaxoSmithKline|GSK Response Center|866-435-7343||
22395436|NCT04585646|CooperVision, Inc|Lee Hall, PhD|(925) 251 6684|lhall@coopervision.com|
22395437|NCT04614662|The Hospital for Sick Children|Lillian Sung|4168135287|lillian.sung@sickkids.ca|
22395438|NCT01236105|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22395439|NCT04086433|Regulatory Mark|Alison Sathe|5133047971|alison@regulatorymark.com|
22395440|NCT00852592|UPittsburgh|Assistant Professor of Psychiatry|412-246-5248|sitdk@upmc.edu|
22395441|NCT01452854|UCSF|Dr. Mitchell Rosen|415-353-7394|thomas.remble@ucsfmedctr.org|
22395442|NCT01862640|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|DT-inquiry@otsuka.jp|
22395443|NCT02178553|Mayo Clinic Rochester|Dr. James D. Hannon|507-284-7289|hannon.james@mayo.edu|
22435798|NCT05445206|Analog Devices, Inc.|Emily Wycallis|9784351644|emily.wycallis@analog.com|
22395444|NCT05085665|Washington University in St. Louis|Dr. Philip Budge|314-747-5532|pbudge@wustl.edu|
22395445|NCT03030235|Saint Luke's Hospital of Kansas City|PRESERVED-HF Study Manager|816-932-9858|PRESERVED-HF@saint-lukes.org|
22395446|NCT03294109|university of Californiia|Siamak Rahman, MD|310 2678839|sirahman@mednet.ucla.edu|
22395447|NCT01717768|TesoRx Pharma LLC|Michael Oefelein, MD, Chief Medical Officer|909-595-0500|karl@tesorx.com|104
22395448|NCT00448435|GlaxoSmithKline|GSK Response Center|866-435-7343||
22395449|NCT02804178|Millendo Therapeutics|Clinical Trial Information|+1 734-845-9000|millendo@millendo.com|
22395450|NCT00934141|University of Wisconsin - Madison|Dr. David H Gustafson|608-890-1436|dhgustaf@wisc.edu|
22395451|NCT00412971|Fredriksberg hospital|Gregers G. Hermann|(+45) 38163536|gregershermann@hotmail.com|
22395452|NCT01387230|GlaxoSmithKline|GSK Response Center|866-435-7343||
22395453|NCT01163721|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22395454|NCT00408603|Sunesis Pharmaceuticals, Inc.|Dr. Linda Neuman, Vice President, Clinical Development|(650) 266-3760|lneuman@sunesis.com|
22395455|NCT01786239|Northwell Health|Delbert Robinson MD|7184708195|drobinso@northwell.edu|
22395456|NCT00364156|University of Pennsylvania|Dr. Caryn Lerman|215-746-7141|clerman@mail.med.upenn.edu|
22435799|NCT03461406|Instituto Grifols, S.A.|Sandra Camprubi Gimenez|+34670923160|sandra.camprubi@grifols.com|
22435800|NCT01140568|UCSD - Moores Cancer Center|Lara Rose|858-822-6575|ljrose@ucsd.edu|
22395457|NCT01050205|University of Pittsburgh|Dr. Andrea Kriska|412-383-1286|aky@pitt.edu|
22395458|NCT01472380|Mutual Pharmaceutical Company, Inc.|VP, Clinical Development and Medical Affairs|215-697-1743|clinicaltrials@urlmutual.com|
22395459|NCT01295281|Wellspect HealthCare|Dikran Shamoun|+46313764275|dikran.shamoun@wellspect.com|
22411277|NCT01462565|GlaxoSmithKline|GSK Response Center|866-435-7343||
22395460|NCT00292461|Eisai Co., Ltd.|Takao Ishii, Asia regulatory affaires|81-3-3817-3914||
22395461|NCT00633061|Univesity of Oklahoma College of Medicine|Janna Journeycake, MD||janna-journeycake@ouhsc.edu|
22395462|NCT02708095|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22395463|NCT04931836|University of Minnesota|Mark Pereira, PhD|612-624-4173|map@umn.edu|
22395464|NCT06389838|Kranus Health GmbH|Director of Clinical Trials|+491756939818|medical@kranushealth.com|
22395465|NCT06268288|Mayo Clinic|Lytitia Shea, M.D.|507-422-9847|shea.lytitia@mayo.edu|
22395466|NCT04821869|Pulmonary Research Institute of Southeast MIchigan|Gary T Ferguson, MD, Director|248-478-6908|garytferguson@msn.com|
22395467|NCT06605391|Emory University|Fayron Epps, PhD, RN|678-723-8188|fepps@emory.edu|
22395468|NCT00724308|VA NY Harbor Healthcare System|Dr. Scott Sherman|212-686-7500|scott.sherman@va.gov|7386
22395469|NCT01313117|Northwestern University|Jeffrey Allen M.D.|312-695-8636|jallen1@nmff.org|
22395470|NCT03602261|OPKO Health|Akhtar Ashfaq|305-575-423|AAshfaq@opko.com|
22395471|NCT02310672|Actelion Pharmaceuticals Ltd|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22395472|NCT03258554|NRG Oncology|Wendy Seiferheld|2155743208|seiferheldw@nrgoncology.org|
22395473|NCT01214187|Brigham and Women's Hospital|Ivan Rosas, MD|617-278-0434|irosas@rics.bwh.harvard.edu|
22395474|NCT01662115|Cleveland Clinic Florida|Chief Academic Office|9546595278|weisse@ccf.org|
22395475|NCT00998426|Johns Hopkins Medicine|Kirti Shetty, MD|202 660 5555|kshetty1@jhmi.edu|
22395476|NCT02691260|University of Wisconsin-Madison|Corrine Voils|608-262-9636|voils@surgery.wisc.edu|
22395477|NCT02308007|Curatek Pharmaceuticals|Vice President|847-806-7680|info@curatek.com|
22395478|NCT03118674|Wake Forest School of Medicine|Herbert L. Bonkovsky, MD|3367137341|hbonkovs@wakehealth.edu|
22395479|NCT01233869|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22395480|NCT01324323|Celgene Corporation|Senior Manager, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22395481|NCT00537485|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6131-7366||
22395482|NCT02967354|Uppsala University Hospital|Dr Per-Ola Carlsson|+46184714425|per-ola.carlsson@mcb.uu.se|
22395483|NCT01158651|UAB|Karen Cole-Plourde|205-934-5140|kplourde@uab.edu|
22395484|NCT01191541|Department of pediatrics, Institute of Hematology and Blood Diseases Hospital.|xiaofan Zhu|+86 22 23909001|xfzhu@ihcams.ac.cn|
22395485|NCT01601847|Case Western Reserve University|Dr. Anna Maria Hibbs|216-844-3387|annamaria.hibbs@cwru.edu|
22395486|NCT00631189|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22395487|NCT04464265|University of Michigan Medical School|Zirui Huang, PhD|734-615-2875|huangzu@med.umich.edu|
22395488|NCT01063829|AiCuris Anti-infective Cures GmbH|Chief Medical Officer|004920231763|info@aicuris.com|0
22395489|NCT00533468|Children's Hospital of Philadelphia|Dr James Reingold|6027516093|reingoldj@email.chop.edu|
22395490|NCT00954174|NRG Oncology|Linda Gedeon on behalf of Virginia Filiaci, PhD.|716-845-1169|Linda.Gedeon@roswellpark.org|
22395491|NCT02234323|Bioverativ, a Sanofi company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6
22395492|NCT02644941|Humacyte Global Inc|Shamik Parikh, Chief Medical Officer|919-313-9633|sparikh@humacyte.com|130
22395493|NCT00867113|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22395494|NCT01145495|Weill Cornell Medical College|Peter Martin, M.D.||pem9019@med.cornell.edu|
22395495|NCT00706550|Michael E. DeBakey Veterans Affairs Medical Center|Dr. Maria C. Rodriguez-Barradas|713-794-7384|Maria.Rodriguez-Barradas2@va.gov|
22395496|NCT01886313|Winston Pharmaceuticals|Dr. Scott B. Phillips|8473628200|scott@winstonlabs.com|
22395497|NCT01603082|AstraZeneca|Tomas LG Andersson, MD, PhD|1-800-236-9393|ClinicalTrialTransparency@astrazeneca.com|
22395498|NCT00846885|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22395499|NCT04884763|Indiana University School of Dentistry|Dr. Domenick Zero|3179877507|dzero@iu.edu|
22395500|NCT00695253|Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center|Rodney A. White, M. D.|310 963-5230|rawhite@ucla.edu|
22395501|NCT01641809|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22395502|NCT04195581|CooperVision, Inc|Jose Vega, OD, MSc, FAAO|925-621-3761|JVega2@coopervision.com|
22395503|NCT00821431|ConvaTec|Kim Peters, Director of Clinical Affairs|07889841338|kim.peters@convatec.com|
22425711|NCT03428100|Eli Lilly and Company|Chief Medical Officer|800-459-5979|ClinicalTrials.gov@lilly.com|
22395504|NCT04561765|Yale University|Ondrej Blaha|203.737.4468|ondrej.blaha@yale.edu|
22395505|NCT01464229|MGH|Esther Howe|617-726-8895|ehowe3@partners.org|
22425712|NCT03407417|University of Florida|Dr. Benjamin Lok|352-214-9829|lok@ufl.edu|
22425713|NCT01048541|Coloplast|Kristine Gjødsbøl, PhD|+4549113557|dkkg@coloplast.com|
22425714|NCT00922116|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22425715|NCT05612217|Servier|olga linnik|8-495-93707-00|olga.linnik@servier.com|
22425716|NCT02258659|University of Chicago|Dr. Everett Vokes|773-702-9306|evokes@medicine.bsd.uchicago.edu|
22425717|NCT03990051|Glia, LLC|Wei-wei Chang, PhD; President|(617) 794-8922|chang@gliacell.com|
22425718|NCT01411852|Resuscitation Outcomes Consortium|Susanne May, PhD, Principal Investigator|206-685-1302|sjmay@uw.edu|
22395506|NCT04233164|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Franco, Luis|+1 240 220 4366|luis.franco@nih.gov|
22395507|NCT01699789|RAND Corporation|Kenneth B. Wells|310-794-3728|kwells@mednet.ucla.edu|
22395508|NCT00639223|U. of Pennsylvania Health System|Steven Halbert MD, MSCE|215 510 2221|shalbert@mail.med.upenn.edu|
22395509|NCT04201821|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
22395510|NCT00651157|Mayo Clinic Cancer Center|Evanthia Galanis, M.D.||galanis.evanthia@mayo.edu|
22395511|NCT03510988|Weill Cornell Medicine|Katerina Dodelzon, MD|646 962 9650|kad9090@med.cornell.edu|
22395512|NCT02511678|Galil Medical, a wholly owned indirect subsidiary of Boston Scientific|Sr. Clinical Trial Specialist|651-287-5000|GalilClinical@bsci.com|
22395513|NCT00324701|Ralph H. Johnson VAMC|Leonard E. Egede, MD, MS|843-789-6670|Leonard.Egede@va.gov|
22395514|NCT00680823|Children's Hospital of Pittsburgh|Dr. Robert Hickey|412 692 7692|robert.hickey@chp.edu|
22395515|NCT02075411|Children's Hospital of Philadelphia|Harshad Gurnaney, MBBS, MPH|215-590-1858|gurnaney@email.chop.edu|
22395516|NCT02000427|Amgen Inc.|Study Director|866-572-6436||
22395517|NCT02208297|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22395518|NCT05125679|Janssen-Cilag Limited|Senior EMEA Medical Advisor Immunology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22395519|NCT03829319|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22435801|NCT03618628|Washington University School of Medicine|Dr. Mary Hastings|3142861433|hastingsmk@wustl.edu|
22395520|NCT04484259|University of Florida College of Medicine Jacksonville|Francesco Franchi, MD|904-244-5515|francesco.franchi@jax.ufl.edu|
22395521|NCT04498832|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22395522|NCT05101707|Medical University of South Carolina|Dr Dorothea Jenkins|(843)792-2112|jenkd@musc.edu|
22395523|NCT01313650|GlaxoSmithKline|GSK Response Center|866-435-7343||
22395524|NCT04029480|Merck Sharp & Dohme LLC|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22395525|NCT04893577|University of Utah MidValley Dermatology|Christopher Hull, MD|801-213-0375|adrianne.evans@hsc.utah.edu|
22395526|NCT02593786|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22395527|NCT01839487|Halozyme Therapeutics|VP, Clinical Development|858-794-8889|medinfo@halozyme.com|
22395528|NCT03714425|Brigham and Women's Hospital|Robert Jamison|617-732-9046|rjamison@bwh.harvard.edu|
22395529|NCT03877432|Taipei Medical University|Dr. Chih-Wei Peng|886-2-27361661|cwpeng@tmu.edu.tw|3070
22395530|NCT01377753|National Cancer Institute|Dr. Peter Pinto|240-760-6249|pintop@mail.nih.gov|
22395531|NCT01019980|Novartis Pharmaceuticals|Study Director|862-778-8300||
22395532|NCT01351753|University of Iowa|Gary Pierce, PhD|13193359487|gary-pierce@uiowa.edu|
22395533|NCT01474863|Vanderbilt University Medical Center|Todd Rice, MD|6153223412|todd.rice@vanderbilt.edu|
22395534|NCT02038920|Takeda|Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
22395535|NCT00866697|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
22395536|NCT01829399|Anesthesiology Department, University of NC at Chapel Hill|Randall F. Coombs, M.D.|919-966-5136|rcoombs@aims.unc.edu|
22395537|NCT02906787|Perelman School of Medicine, University of Pennsylvania|Janet Audrain-McGovern, Ph.D. Director, Addictions, Department of Psychiatry|(215) 746-7145|audrain@pennmedicine.upenn.edu|
22395538|NCT01703663|University of Michigan|Devin L. Brown, MD, MS|734-936-9075|devinb@umich.edu|
22395539|NCT03823768|Medical University of South Carolina|Professor|8437922724|taberd@musc.edu|
22395540|NCT03901053|The University of Iowa|Jason M. Wilken, PT, PhD|319-335-6857|jason-wilken@uiowa.edu|
22395541|NCT01786187|Michigan State University|Amy Hoffman, RN, PhD|517 355 8348|amy.hoffman@ht.msu.edu|
22395542|NCT01350453|University of Southampton|Jane Burridge|+44(0)2380 598 885|jhb1@soton.ac.uk|
22395543|NCT03442114|Cincinnati Children's Medical Center|Dr. Lori Crosby|5136365380|Lori.Crosby@cchmc.org|
22395544|NCT05772156|NewYork-Presbyterian Hospital, Columbia University Irving Medical Center|Intramuscular Methylergonovine to Decrease Blood Loss During Cesarean Delivery for Twins: A Triple-B|877-843-2229|hbg2115@cumc.columbia.edu|
22395545|NCT04890054|Oregon Rural Practice Research Network|Robert Durr, M.P.H.|503-418-3592|durrr@ohsu.edu|
22395546|NCT04313153|Akebia Therapeutics, Inc.|Akebia Therapeutics, Inc.|6178446128|trials@akebia.com|
22395547|NCT05586269|Boston Children's Hospital|Dr. Allison Wu|6173556058|allison.wu@childrens.harvard.edu|
22395548|NCT03047551|Columbia University|Carolyn Westhoff, MD|212-305-4805|clw3@cumc.columbia.edu|
22395549|NCT00726622|Mayo Clinic|Tonia M. Young-Fadok, M.D.||youngfadok.tonia@mayo.edu|
22395550|NCT01999569|Carolinas Healthcare System|Bradley Hurst, M.D., Director of Assisted Reproduction|704-355-3149|bhurst@carolinas.org|
22395551|NCT02462928|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
22395552|NCT00395863|Bracco Diagnostics Inc.|Gianpaolo Pirovano, MD, Executive Director, Head Corporate Medical Development|609-514-2226|gianpaolo.pirovano@diag.bracco.com|
22395553|NCT03998176|University of Nebraska Medical Center|Josh Havens|402-559-2674|jhavens@unmc.edu|
22435802|NCT01969500|University of Washington|Dror Ben-Zeev|(206) 685-9655|dbenzeev@uw.edu|
22435803|NCT02193087|Takeda|Medical Director Clinical Science, Study Official|+1-877-825-3327|trialdisclosures@takeda.com|
22435804|NCT04096820|Queen's University/Kingston General Health Research Institute|Heather McFarlane, Administrative Assistant|613-549-6666|heather.mcfarlane@kingstonhsc.ca|8171
22435805|NCT01241760|Janssen Infectious Diseases BVBA|Compound Development Team Leader|32 14 64 13 70||
22435806|NCT00884910|Netherlands Cancer Institute|Prof Dr FJM Hilgers|+31 20 512 2550|f.hilgers@nki.nl|
22435807|NCT01636713|GlaxoSmithKline|GSK Response Center|866-435-7343||
22435808|NCT01213823|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22435809|NCT00276614|David Geffen School of Medicine at UCLA|Matthew Rettig, M.D.|310-794-3565|mrettig@mednet.ucla.edu|
22395554|NCT02348775|Baylor College of Medicine|R. V. Sekhar M.D.|713-798-3908|rsekhar@bcm.edu|
22435810|NCT02248740|Virginia Commonwealth Univeristy|Dr. Malcolm Sydnor|(804) 828-0534|malcolm.sydnor@vcuhealth.org|
22435811|NCT02117349|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22435812|NCT02033213|KBC Zagreb|Maja Karaman Ilić, MD PhD|00385 1 2385 122|majakilic1@gmail.com|
22435813|NCT01977690|Johann Wolfgang Goethe University|Stephan Duetzmann|001491781470479|stephan.duetzmann@gmail.com|
22435814|NCT01176955|Wake Forest Baptist Medical Center|Brad Yentzer|336-716-4735|byentzer@wakehealth.edu|
22435815|NCT01711866|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22435816|NCT00456599|University of Michigan|Mark Zalupski, MD|734-615-3969|zalupski@med.umich.edu|
22435817|NCT00260065|Eisai Inc.|Eisai Call Center|888-422-4743||
22435818|NCT02246608|Kettering Health Network|Manager, Research Operation and Regulatory Compliance|937-395-8367|innovationcenter@ketteringhealth.org|
22435819|NCT02410577|Memorial Sloan Kettering Cancer Center|Dr. Joseph Osborne, MD, PhD|212-639-7788|osbornej@mskcc.org|
22435820|NCT02382848|Penn State University College of Medicine|Dr. Fauzia Mahr|717 531-8133|fmahr@pennstatehealth.psu.edu|
22435821|NCT03780959|Amgen Inc.|Study Director|866-572-6436||
22435822|NCT02831933|Houston Methodist Neal Cancer Center|Eric Bernicker|713.790.3333|ccresearch@houstonmethodist.org|
22435823|NCT04802187|Massachusetts General Hospital|Madeline Davies|617-726-6653|medavies@mgh.harvard.edu|
22435824|NCT01969435|Washington University School of Medicine|Amanda F. Cashen, M.D.|314-454-8304|acashen@wustl.edu|
22435825|NCT03875664|Atrium Health|Dr. Sarah Evans|704-304-1660|sarah.evans@atriumhealth.org|
22435826|NCT00520910|University of Miami|Dr. Robert Kirsner|305-243-4472|RKirsner@med.miami.edu|
22435827|NCT00358436|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22435828|NCT04129411|Mayo Clinic|Dr. Marius Stan|507-284-2463|stan.marius@mayo.edu|
22435829|NCT05065190|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22435830|NCT00168454|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
22435831|NCT00668811|MedStar Washington Hospital Center|Dr Kenneth D. Burman|202-877-8109|kenneth.d.burman@medstar.net|
22435832|NCT02769962|National Cancer Institute|Dr. Anish Thomas|240-760-7343|anish.thomas@nih.gov|
22435833|NCT05565937|Bausch & Lomb|Daniel Donatello|5853385306|Daniel.Donatello@bausch.com|
22435834|NCT04544683|University of Utah Orthopaedic Center/ Physical Medicine & Rehabilitation|Aaron Conger, MD|801-587-1493|u6007025@umail.utah.edu|
22435835|NCT00151372|Weill Cornell Medical College|George S. Alexopoulos, M.D.|914-997-5767|gsalexop@med.cornell.edu|
22435836|NCT04253587|UCSF Dept of Neurology|Peter Wais, Principal Investigator|415-502-1212|peter.wais@ucsf.edu|
22435837|NCT04732949|Synairgen|Brooke Clarke, SVP, Head of Communications|02380 512 800|info@synairgen.com|
22435838|NCT01023672|Mayo Clinic|Dr. Bradley F. Boeve|507-266-4106|bboeve@mayo.edu|
22435839|NCT01286077|Janssen-Cilag Greece|EMEA Medical Affairs Director|+30 210 8090738||
22435840|NCT02654236|IU School of Medicine|Dr. Suthat Liangpunsakul|(317) 988-3232|sliangpu@iu.edu|
22435841|NCT01549873|Nationwide Children's Hospital|David Martin, MD|614-722-4200|David.Martin@nationwidechildrens.org|
22435842|NCT02905006|Cares|UCB|+1877 822|UCBCares@ucb.com|9493
22435843|NCT00418977|Icahn School of Medicine at Mount Sinai|Katharine Loeb, PhD|212-659-8724|katharine.loeb@mssm.edu|
22435844|NCT03627065|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22435845|NCT02797184|Washington University in St. Louis|Dr. Lauren Park|3143633915|l.park@wustl.edu|
22435846|NCT06250738|Rollins School of Public Health|Dr. Andrea Lopez-Cepero|404-727-3956|andrea.a.lopez-cepero@emory.edu|
22435847|NCT02677844|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22435848|NCT01635764|AbbVie|Global Medical Services|800-633-9110||
22435849|NCT02227836|Mayo Clinic|Karthik Ravi, MD|507-284-4824|Ravi.Karthik@mayo.edu|
22435850|NCT01556061|University of Texas at Houston Medical School/ Dept. of Anesthesiology|Dr. Davide Cattano MD PhD|713-500-6235|davide.cattano@uth.tmc.edu|
22435851|NCT01816906|Staffordshire University|Professor Nachiappan Chockalingam|+44 1782 295853|n.chockalingam@staffs.ac.uk|
22435852|NCT04375397|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22435853|NCT00086502|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22435854|NCT01304329|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22435855|NCT02568449|Karmanos Cancer Instiute|Dr. Dipesh Uprety|313-576-8722|upretyd@karmanos.org|
22435856|NCT01312389|University of Pennsylvania|Director of Clinical Trial Operations|215-662-3324|tracey.thomas@pennmedicine.upenn.edu|
22435857|NCT05545644|University of New Mexico|Dr. Barbara McCrady|505-925-2388|bmccrady@unm.edu|
22435858|NCT00525629|Beth Israel Deaconess Medical Center|Christos Mantzoros|617-667-8630|cmantzor@bidmc.harvard.edu|
22435859|NCT01643876|Université de Montréal|Dr. Elham Emami|5143436111|elham.emami@umontreal.ca|6053
22435860|NCT01945775|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22435861|NCT02876328|National Institute of Allergy and Infectious Diseases (NIAID)|John Tierney, Director of Office of the Clinical Research Policy and Regulatory Operations (OCRPRO)|301.451.5136|JTierney@niaid.nih.gov|
22435862|NCT01995552|India Medtronic Pvt. Ltd.|Vinay Rajan Ph.D|+91 22.3307.4700|vinay.rajan@medtronic.com|
22435863|NCT00885768|Kidney Reasearch Center, Tehran University of Medical Sciences|Mohammad Reza Khatami MD|00982161192659|khatami@hbi.ir|
22435864|NCT02068118|CDM e-Health|Clinical Development Physician|33 (0) 1 39 07 62 86|fralsi-ctpublication@airliquide.com|
22435865|NCT01152515|Department of Anaesthesiology and Pain Medicine and Anaesthesia and Pain Research Institute, Yonsei University College of Medicine|Dr. Shin Ok Koh|82-2-2228-2420|sokoh@yuhs.ac|
22435866|NCT00353873|GlaxoSmithKline|GSK Response Center|866-435-7343||
22435867|NCT01420627|Leadiant Biosciences, Inc.|Scott Rodgers, MS, CCRA, ACRP-PM / Sr Director Clinical Operations|301-670-1565|scott.rodgers@leadiant.com|
22435868|NCT00453973|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
22395555|NCT01940354|Hospital of the University of Pennsylvania|Scott Trerotola, MD|215-662-6983|scott.trerotola@uphs.upenn.edu|
22395556|NCT02020863|University of California, Irvine Health|Maxime Cannesson, PhD|714- 456-5059|mcanness@uci.edu|
22395557|NCT03157232|Masimo|Tala Harake||studies@masimo.com|
22395558|NCT00702845|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22395559|NCT00682565|Cytokinetics, Inc.|Medical Director|650-624-3053||
22395560|NCT00928564|UC Irvine|Dr. Felicia Lane|17144566155|kbacca@uci.edu|
22395561|NCT04697264|University of Surrey|Miss Irene Ray|07490749704|i.ray@surrey.ac.uk|
22395562|NCT02393677|Govt. Medical College, Haldwani.|Dr. Bikramjit Das|(05946)-228393|bikramjit_81@rediff.com|
22395563|NCT00813319|Emory University Rollins School of Public Health|Dr. Ralph DiClemente, Principal Investigator|404-727-0237|rdiclem@emory.edu|
22395564|NCT03434353|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22395565|NCT03739762|Kaiser Permanente|Dori Rosenberg, Principal Investigator|206-287-2532|dori.e.rosenberg@kp.org|
22425719|NCT00272844|Boston Children's Hospital|Dr. Mira Irons|617-355-2449|mira.irons@childrens.harvard.edu|
22425720|NCT03193047|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
22425721|NCT02855567|Icahn School of Medicine at Mount Sinai|Dr. Charles Ascher-Walsh|212-241-2827|Charles.ascher-walsh@mssm.edu|
22425722|NCT00791700|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22425723|NCT01472822|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Jeong-Hwan Seo, MD|82-63-276-8284|vivaseo@jbnu.ac.kr|
22425724|NCT00996034|Yale University|Irina Esterlis, Ph.D.|203-932-5711|irina.esterlis@yale.edu|3109
22425725|NCT01720524|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22425726|NCT02493452|Synergy Pharmaceuticals Inc.|VP Regulatory Affairs & Clinical QA|646-675-7283|ejaeger@synergypharma.com|
22425727|NCT00527826|GlaxoSmithKline|GSK Response Center|866-435-7343||
22425728|NCT00158262|Massachusetts General Hospital|Roger K. Pitman, M.D.|617-726-5333|roger_pitman@hms.harvard.edu|
22425729|NCT03628378|Columbia University Irving Medical Center|Jeffrey A. Geller, MD|212-305-1120|jg2520@cumc.columbia.edu|
22425730|NCT00883415|University of Maryland Baltimore|Jeffrey C. Fink MD, MS; Principal Investigator|410-328-4822|jfink@som.umaryland.edu|
22425731|NCT02264210|Sun Yat-sen University Cancer Center|Dr. Si-Yu Wang|86-20-87343439|wangsy@sysucc.org.cn|
22425732|NCT01150903|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22425733|NCT03293394|Spedali Civili di Brescia|Prof. Barbara Borroni|+39 0303995631|bborroni@inwind.it|
22425734|NCT02716584|VA Greater Los Angeles Healthcare System|Dr. Robert Kern|310-478-3711|Robert.Kern2@va.gov|49229
22425735|NCT00420628|Bausch & Lomb|Timothy Comstock OD|(585) 338-6631|tcomstock@bausch.com|
22425736|NCT01903993|Hoffmann-La Roche|Medical Communications|800 821|genentech@druginfo.com|8590
22425737|NCT03283930|National Institute of Mental Health (NIMH)|Dr. Daniel Pine|+1 301 594 1318|daniel.pine@nih.gov|
22425738|NCT02588664|Wake Forest University Health Sciences|Dr. Pamela W. Duncan|(336) 716-5068|pduncan@wakehealth.edu|
22425739|NCT02500719|University of Arkansas for Medical Sciences|Dr. Keith A. Bush|501.526.8347|kabush@uams.edu|
22425740|NCT02787083|Philadelphia Urosurgical Associates, PC|Kristene E Whitmore MD|215-704-1457|bladder1@aol.com|
22425741|NCT00154375|Novartis Pharmaceuticals|Study Director|862-778-8300||
22425742|NCT03538691|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22425743|NCT03715452|Osprey Medical, Inc.|Vice President of Clinical Affairs|952.955.8236|kknish@ospreymed.com|
22425744|NCT00481767|GlaxoSmithKline|GSK Response Center|866-435-7343||
22425745|NCT00636636|Depomed|Head of R&D|650-462-5900|msweeney@depomed.com|108
22425746|NCT00524173|NIDDK|Marc Ghany, MD|301-402-5115|marcg@intra.niddk.nih.gov|
22425747|NCT03300180|Indiana University School of Medicine; Indiana University Center for Aging Research; Regenstrief Institute, Inc.|Nicole R. Fowler, PhD, MHSA; Associate Professor of Medicine|317-274-9021|fowlern@iu.edu|
22425748|NCT04233671|The University of Alabama|Dr. Mercy Mumba|205-348-6317|mnmumba@ua.edu|
22425749|NCT04776928|University of Michigan|Jennifer Waljee|(734) 936-8925|filip@med.umich.edu|
22425750|NCT00103285|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22425751|NCT00452439|University of Texas (UT) MD Anderson Cancer Center|Maria Cabanillas, Associate Professor, Endocrine Neoplasia and HD|(713) 563-0764|mcabani@mdanderson.org|
22425752|NCT00395993|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
22425753|NCT01381926|UAB|Dr. Amy Warriner|205-996-4004|awarriner@uabmc.edu|
22425754|NCT02271217|Acorda Therapeutics|Holly Roberts, Executive Medical Director|914-326-5000|hroberts@acorda.com|
22425755|NCT03974802|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
22425756|NCT02624947|Novavax Inc|Novavax Customer Service Center|1-844-Novavax (668-2829)|Clinicaltrials@novavax.com|
22425757|NCT01550510|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Daniel Monti|215 955-2221|daniel.monti@jefferson.edu|
22425758|NCT03107182|University of Chicago|Ari Rosenberg|773-702-8222|arirosenberg@bsd.uchicago.edu|
22425759|NCT05787860|Icahn School of Medicine at Mount Sinai|Giselle Singer|212-241-3288|giselle.singer@mssm.edu|
22425760|NCT01065558|Psyadon Pharmaceuticals|Dr. Richard Chipkin|301-919-2020|rchipkin@psyadonrx.com|
22425761|NCT03654729|Egetis Therapeutics AB|Kristina Sjoblom Nygren|+46732344698|kristina.sjoblom@egetis.com|
22425762|NCT00588146|Mayo Clinic|Karen L. Swanson, D.O.|507-255-3214|swanson.karen@mayo.edu|
22425763|NCT02100839|Linear Clinical Research Ltd|Dr. Janakan Krihnarajah, MBBS (Hons), FRACP|800 393 8820|JKrishnarajah@linear.org.au|
22425764|NCT03440619|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
22435869|NCT03743064|Helsinn Healthcare SA|Florin Muraru|+41 91985 21 21|florin.muraru@helsinn.com|
22395566|NCT00929656|Malcom Randall VAMC|Dr. Dorian Rose, Research Health Scientist|352-376-1611|Dorian.Rose@va.gov|5238
22435870|NCT05242354|Biruni University|Dr Mustafa YILMAZ|+90 533 7129952|myilmaz@biruni.edu.tr|
22435871|NCT02759315|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22435872|NCT00870194|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22435873|NCT01219933|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22435874|NCT00582738|Pharmaceuticals|Novartis|41613241111||
22435875|NCT00693654|Wake Forest University Health Sciences|Alan Fleischer, Jr., MD|336-716-7753|afleisch@wfubmc.edu|
22435876|NCT01557881|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Philipp Frank Graner|+1 216-844-8275|philipp.graner@uhhospitals.org|
22435877|NCT02210091|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22435878|NCT01831817|GlaxoSmithKline|GSK Response Center|866-435-7343||
22435879|NCT00958217|VA San Diego Healthcare System/UCSD|Susan R. Tate, Ph.D., Clinical Psychologist|619-426-9402|srtate@ucsd.edu|
22435880|NCT01685021|MorphoSys AG|Dr. Sumeet Ambarkhane, Director, Clinical Program Leader|004989899270|sumeet.ambarkhane@morphosys.com|
22435881|NCT02198235|Hospital for Special Surgery|Dr. Jacques YaDeau|212-606-1206|yadeauj@hss.edu|
22435882|NCT02440789|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22435883|NCT01999218|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22435884|NCT01073930|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22435885|NCT04979910|Icahn School of Medicine at Mount Sinai|Esther Lee|212-585-6133|esther.lee@mssm.edu|
22435886|NCT04030962|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22435887|NCT04424225|University of Minnesota|Jessica Nielson|714-904-7939|jnielson@umn.edu|
22435888|NCT05288166|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22435889|NCT01114360|Emory University|Frederic Rahbari-Oskoui, Associate Professor of Medicine|404-727-2590|frahbar@emory.edu|
22435890|NCT03007745|Corporal Michael J. Crescenz VA Medical Center|Samuel T. Kuna, MD|215-823-4400|Samuel.Kuna@va.gov|
22435891|NCT03298841|Toyos Clinic|Melissa Toyos|6153274015|mtoyos@toyosclinic.com|
22435892|NCT04912895|Emory University|Larry Anderson, MD|404-727-1746|larry.anderson@emory.edu|
22435893|NCT02981524|Sidney Kimmel Cancer Center at Johns Hopkins|Nilofer Azad, MD|410-614-9169|nazad2@jhmi.edu|
22435894|NCT00520013|Dana-Farber Cancer Institute|Susana M. Campos, MD, MPH|617-632-5269|susana_campos@dfci.harvard.edu|
22435895|NCT00159913|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22435896|NCT03294135|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22435897|NCT02763254|Cell Medica|Dr. Kurt Gunter (Chief Medical Officer)|832-581-4480|Kurt.Gunter@cellmedica.com|
22435898|NCT02811913|VA Northeast Ohio Healthcare System|Dr. Svetlana Pundik|(216)791-3800|svetlana.pundik@va.gov|
22435899|NCT03684304|University Hospitals|University Hospitals|216-844-1000|info@uhhospitals.org|
22435900|NCT00824005|UT-Houston School of Public Health|Lemuel Moye, MD, PhD|713-500-9518|Lemmoye@msn.com|
22435901|NCT01510184|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|gajanan.Bhat@sppirx.com|
22435902|NCT01143051|Amphastar Pharmaceuticals, Inc.|Stephen A. Campbell, Esq.|(909) 980-9484|stephenc@amphastar.com|2016
22435903|NCT03458702|Texas Tech University|Dr. Jacalyn McComb|806-834-6306|jacalyn.mccomb@ttu.edu|
22435904|NCT01390779|UCSD|Mona Moshtaghi|858 534-6290|momoshta@ucsd.edu|
22435905|NCT00765882|Forest Research Institute|Paul F.C. Eng, PhD. Director, Clinical Development|201-427-8071|Paul.Eng@frx.com|
22435906|NCT04709484|SultanAbdulhamid|Adem Erbirol|+905426608788|aerbirol@hotmail.com|
22435907|NCT02231762|Ipsen|Medical Director||clinical.trials@ipsen.com|
22435908|NCT03455829|G1 Therapeutics, Inc.|Clinical Trial Info.|919-213-9835|clinicalinfo@g1therapeutics.com|
22435909|NCT01697462|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22435910|NCT00168103|CSL Behring|Clinical Program Director|Use email contact|clinicaltrials@cslbehring.com|
22435911|NCT03446053|Institute of iNtRON Biotechnology|Jun SooYoun, Ph.D. / Executive Director/ Principal researcher|+82-31-739-5332|jsy@intron.co.kr|
22435912|NCT01789138|Department of Public Health, University of Tartu, ESTONIA|Prof. Anneli Uusküla|+372 7374195|anneli.uuskula@ut.ee|
22435913|NCT03532932|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22435914|NCT05268744|UCSF|Dr. Robert Hendren|(415) 476-7500|robert.hendren@ucsf.edu|
22435915|NCT02255565|Dept. of Psychiatry, University of Washington|Dr. Mark Stein|206-987-1161|mstein42@uw.edu|
22435916|NCT02699450|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22435917|NCT00810901|University of Hawaii, School of Nursing|Cheryl Albright|8089569716|cherylal@hawaii.edu|
22435918|NCT01305655|NOPHO|Dr Jesper Heldrup|+46705172389|jesper.heldrup@skane.se|
22435919|NCT03689712|Galera Therapeutics|Megan Holm|484-615-2036|mholm@galeratx.com|
22435920|NCT01224444|White River Junction VA|Heiko Pohl|802-295-9363|heiko.pohl@dartmouth.edu|5595
22435921|NCT01221194|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
22435922|NCT01342549|Michael E. DeBakey VAMC|Dr. Ricardo Jorge|713-794-7010|ricardo.jorge@va.gov|
22435923|NCT03119389|University of Maryland|Kerri Thom|410-706-6124|kthom@som.umaryland.edu|
22435924|NCT02674425|PolyPhotonix|Dr|00441740625|duncan@polyphotonix.com|557
22435925|NCT01133275|H. Lee Moffitt Cancer Center and Research Institute|Dr. Rami Komrokji|813-745-4692|rami.komrokji@moffitt.org|
22435926|NCT01811303|RSSL|Rungano Munyuki (Clinical Project Manager)|0118 9184034||
22435927|NCT02266875|OhioHealth|Dr. Kruti Patel, DO|614-857-7735|kruti.patel@ohiohealth.com|
22435928|NCT00413010|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22395567|NCT00607880|Mayo Clinic|Albert G. Hakaim, M.D.||Hakaim.Albert@mayo.edu|
22395568|NCT01170039|Emory University|Jennifer Christie|404-778-4594|jchris6@emory.edu|
22395569|NCT01990534|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22395570|NCT01831544|Medtronic|Methee Schreuder|+31611597388|methee.schreuder@medtronic.com|
22395571|NCT00390611|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22395572|NCT01131351|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22395573|NCT01205438|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22395574|NCT05787782|Masimo|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
22395575|NCT02645760|Khonkaen University|Rungthip Chalermsan|+66 835603675|chalermsanrungthip@gmail.com|
22395576|NCT02267603|Cancer Immunotherapy Trials Network|Administrative Director|206-667-6609|citn.core.reg@hvtn.org|
22395577|NCT04606771|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22395578|NCT01346488|AbbVie|Global Medical Information|800-633-9110||
22395579|NCT00786825|University of Minnesota|Elizabeth Seaquist, MD|612-624-9176|seaqu001@umn.edu|
22395580|NCT01207596|International Clinical Research Institute|Srinivas Nalamachu|913-317-5300|nalamachu@yahoo.com|
22395581|NCT03083847|National Institute of Allergy and Infectious Diseases|Patrick Duffy|(301) 761-5089|Patrick.Duffy@nih.gov|
22395582|NCT00216203|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
22395583|NCT01621230|UTexasSouthwestern|Margaret Craig, MD|2142638919|maggieanes@gmail.com|
22435929|NCT02956850|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22395584|NCT00733304|GlaxoSmithKline|GSK Response Center|866-435-7343||
22395585|NCT02596620|Chang Gung Memorial Hospital, Taiwan|Dr. Wei-Chen Tai|886-975056026|luketai1019@gmail.com|
22395586|NCT01627002|ProtAffin Biotechnologie AG|ProtAffin Biotechnologie AG||office@protaffin.com|
22395587|NCT03155373|Imperial College Healthcare NHS Trust|Jonathan Afoke|02033132026|j.afoke@nhs.net|
22395588|NCT01054144|Moffitt Cancer Center|Rachid Baz, MD|813-745-3163|Rachid.Baz@moffitt.org|
22395589|NCT02856893|EORTC|Yassin Pretzenbacher|+32 2 774 1365|yassin.pretzenbacher@eortc.org|
22395590|NCT00528567|Hoffman-LaRoche|Medical Communications|800-821-8590||
22395591|NCT00467389|Substance Abuse Research Laboratory, Kansas City VA Medical Center|Kenneth Grasing|(816) 922-2756|kenneth.grasing@va.gov|
22395592|NCT01284062|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22395593|NCT03189862|University of Michigan|Leah E. Robinson|(734) 647-7645|lerobin@umich.edu|
22395594|NCT05341700|Virginia Tech|Dr. Enette Larson-Meyer|5402311025|enette@vt.edu|
22395595|NCT03326895|Ethicon Endo-Surgery|Jason Waggoner, PhD|+1 513.337.8310|jwaggon1@its.jnj.com|
22395596|NCT00931944|Knopp Biosciences|Head of Regulatory|4124881776|greg@knoppbio.com|
22395597|NCT05361668|Crinetics Pharmaceuticals, Inc.|Study Director|(858) 450-6464|medinfo@crinetics.com|
22395598|NCT00642382|Cartiva, Inc|Director Clinical Operations|770-754-3805|rtownsend@cartiva.net|
22435930|NCT00708734|Tampa VA Hospital|Tatjana Bulat|8135583932|tatjana.bulat@va.gov|
22435931|NCT03412604|Massachusetts General Hospital|Emiliano Santarnecchi|617-667-0326|esantarnecchi@mgh.harvard.edu|
22435932|NCT02634606|UCLA Department of Medicine/Center for Human Nutrition|Zhaoping Li, Professor|310-206-1987|zli@mednet.ucla.edu|x61987
22435933|NCT05810714|The Ohio State University Comprehensive Cancer Center|Dr. Mira Katz|614-293-6603|Mira.katz@osumc.edu|
22435934|NCT00283816|University of Rochester Medical Center|Kathleen M. Hoeger, MD, MPH|585-275-7891|Kathy_Hoeger@urmc.rochester.edu|
22435935|NCT01797380|Duke University Health Systems|Harold Goforth, M.D.|216-636-3999|goforth@ccf.org|
22435936|NCT00993499|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22435937|NCT02469714|Illinois Institute of Technology|Patrick Corrigan|(312)567-6751|corrigan@iit.edu|
22435938|NCT05432167|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22435939|NCT01287195|Brigham and Women's Hospital|Scott B. Snapper, M.D., Ph.D.|617-919-4973|ssnapper@partners.org|
22435940|NCT03562793|Richard L. Roudebush VA Medical Center|Dr. Marianne Matthias|317-988-4514|Marianne.Matthias@va.gov|
22435941|NCT00892606|University Louisville|Nancy Alsip|502-852-2905|nlalsi01@exchange.louisville.edu|
22435942|NCT00140842|Massachusetts General Hospital|Madhu Misra, MD|617-724-5602|mmisra@partners.org|
22435943|NCT00283868|University of California, San Diego|Brett C. Meyer, MD|619-543-7760|bcmeyer@ucsd.edu|
22435944|NCT01515475|Jaeb Center for Health Research|Ray Kraker M.S.P.H.|813-975-8690|rkraker@jaeb.org|
22435945|NCT01968057|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22435946|NCT03558074|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
22435947|NCT01511809|Ospedale San Raffaele|Dr. Antonella Castagna|00390226437934|castagna.antonella1@hsr.it|
22435948|NCT01996592|Wake Forest School of Medicine|Jessica L. Booth, MD|336-718-8278|jbooth@wakehealth.edu|
22435949|NCT01406015|Brigham and Women's Hospital|Dr. Rajesh K. Garg||RGARG@bwh.harvard.edu|
22435950|NCT01483209|Duke University Medical Center|Dr. Cynthia Shortell|919-681-2223|cynthia.shortell@duke.edu|
22395599|NCT01207726|SKCCC|Charlie Rudin, MD|646.888.4527|rudinc@mskcc.org|
22395600|NCT04325308|University of Alabama at Birmingham|Ariel Salas|2059344680|asalas@uab.edu|
22395601|NCT00634010|The University of Texas (UT) MD Anderson Cancer Center|Eduardo Bruera, MD, Chair, Palliative Care Medicine||CR_Study_Registration@mdanderson.org|
22411278|NCT01238848|Hospital General de Niños Pedro de Elizalde|Maria I. Espelt, MD|541146136968|cespelt@fibertel.com.ar|
22435951|NCT00707746|Genzyme Corporation|Genzyme Medical Information|617-252-7832||
22395602|NCT02545322|Department of Therapeutic Radiology and Oncology, Medical University of Graz|Peter Winkler, PhD (Head of Medical Physics)|+43 316 385|peter.winkler@medunigraz.at|83193
22395603|NCT00882310|Columbia University|Paul Oberstein, MD|212-305-0592|po2178@cumc.columbia.edu|
22395604|NCT01395316|University of Chicago|Dr. Adil Javed||ajaved@neurology.bsd.uchicago.edu|
22395605|NCT05103280|University of Nebraska at Omaha|Sara A. Myers, PhD - Professor|(402) 554-3246|samyers@nebraska.edu; ffallahtafti@unomaha.edu|
22395606|NCT04786119|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
22395607|NCT03610165|Cleveland Clinic Foundation|Dr. Kamal Maheshwari|216-4454311|maheshk@ccf.org|
22395608|NCT03196232|Stanford University|George A Fisher, Colleen Haas Chair in the School of Medicine|650) 725-9057|georgeaf@stanford.edu|
22395609|NCT04752475|Associate Professor of Prenatal Pediatrics at CUIMC|Russell Miller, MD|212-305-3151|rsm20@cumc.columbia.edu|
22395610|NCT04532372|City of Hope Medical Center|Dr. Sanjeet Dadwal|626-359-8111|sdadjeet@coh.org|
22395611|NCT03435003|Stony Brook University|Dr. Konstantinos Spaniolas|631-444-8330|konstantinos.spaniolas@stonybrookmedicine.edu|
22395612|NCT01310803|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22395613|NCT03746951|Nationwide Children's Hospital|Dr. Senthil Krishna|614-722-4200|Senthil.Krishna@nationwidechildrens.org|
22395614|NCT02113579|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
22395615|NCT00789867|Imperial College|Samia Soussi|0207 594 7980|s.soussi@imperial.ac.uk|
22395616|NCT00594516|Johnson & Johnson Pharmaceutical Research & Development|Mila Etropolski, MD Clinical Leader|609-730-4537|metropol@its.jnj.com|
22395617|NCT03873493|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22395618|NCT04085341|Graybug Vision|Director, Global Clinical Development Operations|5622098872|bpatel@graybug.vision|
22395619|NCT01448213|Cornea Research Foundation of America|Marianne O. Price, PhD|317-814-2990|mprice@cornea.org|
22395620|NCT00454532|Bionovo|Mary Tagliaferri, MD|5106012000|clinicaltrials@bionovo.com|
22395621|NCT03503513|University of Michigan|Dr. Denise Tate|(734) 647-5195|dgtate@umich.edu|
22395622|NCT03308942|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22395623|NCT01281007|EMS|Manager of Clinical Trials|+5501938874176|pesquisa.clinica@ems.com.br|
22395624|NCT04621734|University of Texas Health Science Center at San Antonio|Dr. Veronica Armijo-Garcia|210-274-8969|mirelesv@uthscsa.edu|
22395625|NCT01524133|Atlanta VAMC|Sheila Rauch|404-321-6111|sheila.rauch@va.gov|3122
22395626|NCT01087957|Innovative Neurotronics|Helen Rogers PT, PhD|512-721-1922|hrogers@ininc.us|
22395627|NCT03632109|University of Washington|Dr. Lindley Barbee, Principal Investigator|206.744.2595|lbarbee@u.washington.edu|
22395628|NCT01122576|Bausch & Lomb Incorporated|Quintus Ngumah, OD, PhD|(973) 360-6450|Quintus.Ngumah@bausch.com|
22395629|NCT05696236|University of Michigan|Charles Schuler|734-232-2154|schulerc@med.umich.edu|
22395630|NCT01829360|University of Kansas|Holly Storkel|7858640099|hstorkel@ku.edu|
22395631|NCT01026142|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22395632|NCT00041067|SWOG|Study statistician|206-667-4623||
22395633|NCT00778622|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22395634|NCT01463384|Huntington Medical Research Institutes|Principal Investigator|6263975840|mrs@hmri.org|
22395635|NCT01251120|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22395636|NCT01968070|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22395637|NCT03078595|Johann Wolfgang Goethe-University Frankfurt|Prof. Dr. med. dent. Peter Eickholz|+4915112433230|eickholz@med.uni-frankfurt.de|
22395638|NCT04722250|Medtronic Cardiovascular|Myra Fan Director|763 514 4000|rs.smarttrial@medtronic.com|
22395639|NCT04556396|Loyola University Medical Center|Kristin Baldea|708-216-9000|kbaldea@lumc.edu|
22395640|NCT01843218|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
22395641|NCT04145544|Nurami Medical Ltd|Dr. Amir Bahar (COO & Clinical Director)|+972-747408888|Amir@nurami-medical.com|
22395642|NCT00688181|Boston Scientific Corporation|Director, Clinical Operations|(952) 930-6300|Teresa.Takle-Flach@bsci.com|
22395643|NCT01891721|VA Greater Los Angeles Healthcare System|Dr. Carol Jahchan|310-478-3711|carol.jahchan@va.gov|42953
22395644|NCT02846532|Janssen Research & Development, LLC|SR DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22395645|NCT04908189|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22395646|NCT05118204|Albert Einstein College of Medicine|Aaron Fox|718-920-7173|adfox@montefiore.org|
22395647|NCT00607022|University of Iowa|Clark Stanford|319-335-7381|CStanford@uiowa.edu|
22395648|NCT05393037|MSD|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22395649|NCT04409353|Cedars-Sinai Medical Center|Samuel Eberlein|310-423-6721|samuel.eberlein@cshs.org|
22395650|NCT01012739|Novartis Pharmaceuticals|Study Director|862 778-8300||
22395651|NCT04540133|UCSF|Dr. Alessandro Villa|415-476-2045|Alessandro.Villa@ucsf.edu|
22395652|NCT04014361|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22395653|NCT06308666|Centre for Ocular Research and Education|Jill Woods|(519) 888-4567|jwoods@uwaterloo.ca|36743
22435952|NCT00183963|USC Norris Comprehensive Cancer Center|Victoria Soto, Project Specialist, Clinical Investigations Support Office|323-226-6384|Victoria.Soto@med.usc.edu|
22435953|NCT02573246|Duke University Health System|Dr. Andrada D. Neacsiu|919-684-6714|andrada.neacsiu@duke.edu|
22435954|NCT01902888|W.L. Gore and Associates, Inc.|Arthur Scott / Clinical Study Manager|623.208.3365|artscott@wlgore.com|
22435955|NCT02256267|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22395654|NCT05225103|Duke University|David Goldston|919-681-1100|david.goldston@duke.edu|
22395655|NCT06132763|Virginia Commonwealth University|Sarah Farthing|804-527-4756|sarah.malone@vcuhealth.org|
22395656|NCT01130051|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22395657|NCT03622619|Eye Research Group, SOVS, UNSW Sydney|Dr Jacqueline Tan|02 9385 6551|jacqueline.tan@unsw.edu.au|
22395658|NCT04585776|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22395659|NCT01544023|University of Rostock, Klinikum Südstadt der Hansestadt Rostock, Frauenklinik|Dr. Max Dieterich|+4938144016145|max.dieterich@uni-rostock.de|
22395660|NCT00835120|University Hospitals Case Medical Center|Carla Conroy|216-844-2871|carla.conroy@Uhhospitals.org|
22395661|NCT01658826|AiCuris Anti-infective Cures GmbH|Information Desk|+4920231763|info@aicuris.com|0
22395662|NCT00617188|Masonic Cancer Center, University of Minnesota|Peter Argenta, M.D.|612-626-6037|argenta@umn.edu|
22395663|NCT02383589|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22395664|NCT04600336|Mayo Clinic|Bradley J. Stish, MD|507-538-6120|stish.bradley@mayo.edu|
22395665|NCT04223791|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22395666|NCT01493557|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22395667|NCT01244243|University of California, Irvine|Steve Cramer|7144566876|scramer@uci.edu|
22395668|NCT02973425|UMass Chan Medical School|Rajani Sadasivam|15088568923|Rajani.Sadasivam@umassmed.edu|
22395669|NCT00909792|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22395670|NCT03823404|Quince Therapeutics, Inc.|Dr. Karen Smith|650 722 9813|ksmith@quincetx.com|
22395671|NCT00966823|Rhode Island Hospital|Francois I. Luks, MD, PhD|401-228-0556|Francois_Luks@brown.edu|
22395672|NCT00059839|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22395673|NCT00698451|Janssen Services, LLC|Senior Director|1 215 325-5329|tmcgowan@its.jnj.com|
22395674|NCT01292447|Women and Infants Hospital|Rebecca Allen|4012741122|rhallen@wihri.org|
22435956|NCT03149003|Sumitomo Pharma Oncology|Sheila Dhaskali|617-674-6800|Sheila.dhaskali@oncology.sumitomo-pharma.com|
22435957|NCT01685983|Janssen R&D BE|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22435958|NCT01443130|University of Maryland School of Medicine|Miriam K. Laufer, MD, MPH|410-706-5333|mlaufer@medicine.umaryland.edu|
22435959|NCT02758301|Medtronic, PLC|Lindsay Werder, Senior Clinical Research Specialist|6123003066|lindsay.k.werder@medtronic.com|
22435960|NCT00364533|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-6780||
22435961|NCT01842594|Shin Kong Wu Ho-Su Memorial Hospital|Kwan-Hwa Chi|+886-28332211|M006565@ms.skh.org.tw|2612
22435962|NCT01490294|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22435963|NCT01902459|Ethicon, Inc|Richard Kocharian, MD, PhD|+1 908-218-2013|rkochar1@its.jnj.com|
22435964|NCT01266590|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22435965|NCT00511134|Yale University|Andrea H. Weinberger, Ph.D.|203-974-7598|andrea.weinberger@yale.edu|
22435966|NCT01949090|GlaxoSmithKline|GSK Response Center|866-435-7343||
22435967|NCT00541346|University of Oklahoma Health Sciences Center|Thomas M. Lock, M.D.|405-271-5700|Thomas-Lock@ouhsc.edu|45167
22435968|NCT02008773|Indiana University Psychotic Disorders Program|Alan Breier, MD|317-880-8495|abreier@iupui.edu|
22435969|NCT04638127|University of Cincinnati|Principal Investigator: Ashley Weber, PhD, RN, RNC-NIC|513-5580132|ashley.weber@uc.edu|
22435970|NCT01733771|Bnai Zion Medical Center|Dr. Samuel Attias|+972524707304|samuel.attias@b-zion.org.il|
22435971|NCT02804750|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
22435972|NCT00167388|University of Pittsburgh|Dr. Toby Yanowitz|412-641-4111|yanotd@mail.magee.edu|
22435973|NCT04144959|Penumbra, Inc.|Erin Archard, Senior Director of Clinical Research, Vascular|+1 802 377 9715|earchard@penumbrainc.com|
22435974|NCT04435600|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22435975|NCT01973608|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22435976|NCT05501795|Bismarck Lasik|Dr Stephen Wexler|701-222-2020|drwexler@bismarcklasik.com|
22435977|NCT03133221|University of Maryland Greenebaum Comprehensive Cancer Center|Jean Yared, MD|410-328-1230|jyared@umm.edu|
22435978|NCT05970120|Biosense Webster, Inc.|Director Medical Affairs|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22435979|NCT05149313|Almirall S.A|Head of Global Clinical Development|+34932913000|gco@almirall.com|
22435980|NCT04243330|VA Rocky Mountain MIRECC|Nazanin Bahraini, PhD|720-723-6490|Nazanin.Bahraini@va.gov|
22435981|NCT04927663|University of California, San Francisco|Dr. Rahul Aggarwal, MD|(415) 353-7171|rahul.aggarwal@ucsf.edu|
22435982|NCT03826342|University of Michigan|Golfo Tzilos Wernette|734-988-3424|gtzilos@med.umich.edu|
22435983|NCT05251753|Wake Forest School of Medicine|Caleb Suggs|3367164171|csuggs@wakehealth.edu|
22435984|NCT02212678|University of Minnesota|Lisa Coles, MS, PhD|4109264788|durh0016@umn.edu|
22435985|NCT02337634|University of Chicago|Dr. Jon Grant|7738341325|jgrant4@bsd.uchicago.edu|
22435986|NCT03493607|Icahn School of Medicine at Mount Sinai|Christina Layton|212-241-6231|christina.layton@mssm.edu|
22435987|NCT02428205|University of Missouri|Dr David Beversdorf|5738826081|beversdorfd@health.missouri.edu|
22435988|NCT02888743|Department of Data Science, Dana-Farber Cancer Institute|Anita Giobbie-Hurder, MS (Study biostatistician)|617-632-2193|agiohur@ds.dfci.harvard.edu|
22435989|NCT00527319|Oxford Pharmaceutical Resources, Inc.|Dr. Richard Guarino|973-256-0600|Guarino@oxfordpharm.com|
22435990|NCT05138549|Prisma Health|Harley T. Davis|8032969533|pamela.davis2@prismahealth.org|
22435991|NCT01804582|University of Maryland, Baltimore|Gloria M. Reeves, M.D.|410-328-3522|greeves@psych.umaryland.edu|
22435992|NCT04495868|Emory University|Brian Bobzien, MD|404-616-4226|brian.patrick.bobzien@emory.edu|
22435993|NCT00431951|SIGA Technologies, Inc.|Annie Frimm, Vice President, Regulatory Affairs|951-303-8797|afrimm@siga.com|
22435994|NCT00385723|Institute for Behavioral Medicine Research, Ohio State University College of Medicine, OH, USA|Dr. Janice K. Kiecolt-Glaser|+1 614 293 3499|Janice.Kiecolt-Glaser@osumc.edu|
22435995|NCT01757561|FirstSunYetSen|Juan-ying Guo|8602087755766(8273)|gjunying@aliyun.com|
22435996|NCT00689793|Departement of ambulatory care and community medicine, University of Lausanne, Switzerland|Dr Bernard Favrat MD|+41795566183314|Bernard.favrat@chuv.ch|
22435997|NCT01920152|University of Colorado, Denver|Omer Mei-Dan, MD|3033159900|omer.meidan@cuanschutz.edu|
22435998|NCT01777945|Hoffmann-La Roche|Medical Communications|1-800-821-8590||
22435999|NCT03035773|Johns Hopkins School of Public Health/SKCCC|Dr. Katherine C. Smith|443.927.3350|ksmit103@jhu.edu|
22436000|NCT02228343|University of New Mexico Health Sciences|Hadya Khawaja|505-272-7028|hkhawaja@salud.unm.edu|
22436001|NCT01167907|Wake Forest School of Medicine|Robert S. Weller, MD|336-716-7150|rweller@wakehealth.edu|
22436002|NCT02916407|Inje University, Haeundae Paik hospital|Dr Ki Hwa Lee|82-51-797-0421|tedy3333@naver.com|
22436003|NCT03094286|Fundación GECP|Eva Pereira|+34 934302006|gecp@gecp.org|
22436004|NCT01893359|Avedro, Inc.|Vineeta Belanger, VP of Clinical Affairs|781-768-3459|vbelanger@avedro.com|
22436005|NCT01814670|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22436006|NCT00973102|University of Washington|Scott Emerson, PhD|206-616-6678|semerson@uw.edu|
22436007|NCT01066780|Advanced Bionics, LLC|Kenneth Ripley, Director of Clinical Research|1.661.362.1400|clinical.research@advancedbionics.com|
22436008|NCT02360293|VA ORD|Laura Damschroder|734-845-3603|laura.damschroder@va.gov|
22436009|NCT02226549|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22436010|NCT03099148|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22436011|NCT01269385|Mayo Clinic|Stephen M. Ansell MD||Ansell.Stephen@mayo.edu|
22436012|NCT02945553|University of Vermont College of Medicine|Michael Toth|802-656-7989|michael.toth@med.uvm.edu|
22436013|NCT01005212|Houston Methodist Research Institute - Heart Center Research|Bevin Lopez, Clinical Trials Manager|7134413912|balopez@houstonmethodist.org|
22436014|NCT00624416|Pennington Biomedical Research Center|Leanne Redman|225-763-0947|Leanne.Redman@pbrc.edu|
22436015|NCT00687609|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22436016|NCT02713529|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22436017|NCT02700165|Zeltiq Aesthetics|Kerrie Jiang, Exective Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|Kerrie.Jiang@allergan.com|
22436018|NCT00915148|Stavanger UH|Torbjørn Moe Eggebø, phd|004792699433|tme@lyse.net|
22436019|NCT00167661|University of Wisconsin - Madison|Dr. Sharon Bartosh|(608) 265-6020|smbartosh@wisc.edu|
22436020|NCT03667690|Cidara Therapeutics, Inc.|Taylor Sandison, M.D., MPH|858-888-7868|clinicaltrialinfo@cidara.com|
22436021|NCT01706588|The School of Dentistry, University of Birmingham|Prof. Thomas Dietrich|+44-121-46 65494|t.dietrich@bham.ac.uk|
22436022|NCT02349685|SeoulNUBH|Nayoung Kim|+ 82-31-787-7008|nayoungkim49@empas.com|
22436023|NCT01192568|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22436024|NCT02593825|Duquesne University|Regina Harbourne, Primary Investigator|4026570538|harbourner@duq.edu|
22436025|NCT06359080|JelikaLite Corp|Katya Sverdlov, Chief Operating Officer|9175668151|katya@jelikalite.com|
22436026|NCT04558359|University of Kentucky|Alexander Flannery, PharmD, PhD|859-562-2766|alexander.flannery@gmail.com|
22395675|NCT02224599|Kiromic|CMO and Head of Clinical Operations|(832) 968-4888|sdahlbeck@kiromic.com|
22395676|NCT05178134|Scandinavian Biopharma Holding AB|Head of Clinical Development|+4684705600|info@scandinavianbiopharma.se|
22395677|NCT02315898|University of Michigan|Dr. Kathleen Stringer|734-647-4775|stringek@med.umich.edu|
22395678|NCT01330914|San Francisco Veterans Affairs Medical Center|Dr. Anne Schafer|(415) 221-4810|anne.schafer@va.gov|24895
22395679|NCT04344860|University Of Pittsburgh|Nicoletta Machin|(412) 209-7280|machinnc2@upmc.edu|
22395680|NCT02445755|Stanford University School of Medicine|Vinod K. Bhutani, MD|(650) 723-5711|bhutani@stanford.edu|
22395681|NCT03239483|"Fundacio Lluita Contra la Sida, Hospital Universitari Germans Trias | Pujol"|Dr. Ross D. Cranston|34-934-657-897|rdcranston@outlook.com|
22395682|NCT04504357|Boston University School of Public Health, Departments of Global Health and Epidemiology|Jacob Bor, ScD SM|(617) 358-2176|jbor@bu.edu|
22395683|NCT05352048|University of Kentucky|Dr. Francis Farhadi|859-323-5661|francis.farhadi@uky.edu|
22395684|NCT03352011|VA Center for Integrated Heathcare|Dr. Kyle Possemato|315-425-4400|kyle.possemato@va.gov|53551
22395685|NCT03085758|Adrenomed AG|Jens Zimmermann|+49 (0) 3302 20 77 810|jzimmermann@adrenomed.com|
22395686|NCT00056862|National Institute of Diabetes and Digestive and Kidney Diseases|Jay H. Hoofnagle, M.D.|3014961333|hoofnaglej@extra.niddk.nih.gov|
22395687|NCT03974334|University of Massachusetts Medical School|Dr. Paula Gardiner|7744416716|paula.gardiner@umassmed.edu|
22395688|NCT01109173|Alcon Research|Dana Sager, Clinical Manager Group Leader|1-817-551-8603|dana.sager@alconlabs.com|
22395689|NCT03610399|Acre Health State Secretariat|Suiane Negreiros|55 68 9983 1266|omsvalle@hotmail.com|
22395690|NCT01132612|Novartis Pharmaceuticals|Study Director|862-778-8300||
22395691|NCT00729781|Medtronic Xomed, Inc.|David Hodge, Project Manager|(+1-904) 281-2774|david.l.hodge@medtronic.com|
22395692|NCT00072358|Memorial Sloan Kettering Cancer Center|Dr. Brian Kushner, MD|1-833-MSK KIDS|kushnerb@MSKCC.ORG|
22395693|NCT02459769|University of Rochester|Charles Kamen, PhD|585-275-9958|charles_Kamen@urmc.rochester.edu|
22395694|NCT01049243|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-1877|sfeldman@wfubmc.edu|
22395695|NCT01936909|Virginia Commonwealth University|Benjamin Van Tassell|8048284583|bvantassell@vcu.edu|
22395696|NCT00312221|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333||
22395697|NCT02060721|Actelion Pharmaceuticals Ltd.|Clinical Scientific Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22436027|NCT02706197|Program for Clinical Oximetry and Imaging Geisel School of Medicine & Dartmouth Health; Dartmouth College|Periannan (Kupps) Kuppusamy MS, PhD|603-646-5490|Periannan.Kuppusamy@dartmouth.edu|
22436028|NCT02783170|Duke University|Dr. Geeta Swamy|919-681-5220|geeta.swamy@duke.edu|
22436029|NCT03350906|Mayo Clinic|Ian R. Lanza, Ph.D.|507-255-8147|Lanza.Ian@mayo.edu|
22436030|NCT03323736|Smith+Nephew|Laura England, PhD|(650) 223-6909|laura.england@smith-nephew.com|
22436031|NCT01806064|TRACON Pharmaceuticals Inc.|Charles Theuer|(858) 550-0780|ctheuer@traconpharma.com|233
22436032|NCT01885910|DermResearch, PLLC|Dr. Leon Kircik|502-451-9000|wedoderm@yahoo.com|
22436033|NCT01778426|Medtronic|Neuromodulation, Clinical Study Management||medtronicneurotrials@medtronic.com|
22436034|NCT03046225|Hospital de Clínicas de Porto Alegre|Graciele Sbruzzi|55 51 9423-9420|graciele.sbruzzi@ufrgs.br|
22436035|NCT00701805|Abbott|Global Medical Services|800-633-9110||
22436036|NCT05063539|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22436037|NCT04256512|Mayo Clinic|Pooja P. Advani, MBBS|904-953-7291|Advani.Pooja@mayo.edu|
22436038|NCT03199469|Astellas Pharma Global Development, Inc. (APGD)|Clinical Transparency|8008887704|astellas.resultsdisclosure@astellas.com|
22436039|NCT02262078|Mayo Clinic|Barry A. Borlaug, MD||Borlaug.Barry@mayo.edu|
22436040|NCT04692077|HPTN Statistical & Data Management Center|HPTN Statistical Manager|+1 (206) 667-4004|HPTN-Data-Access@scharp.org|
22436041|NCT01751139|GlaxoSmithKline|GSK Response Center|435-7343|GSKClinicalSupportHD@gsk.com|866
22436042|NCT03344172|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR; CRS Regulatory Supervisor|412-647-5554|stadtermanbm@upmc.edu|
22436043|NCT03106415|Mayo Clinic|Saranya Chumsri MD|904-953-2000|Chumsri.Saranya@mayo.edu|
22436044|NCT00300677|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22436045|NCT01300351|AstraZeneca China|Guofei Dai|+86 21 60301242|guofei.dai@astrazeneca.com|
22436046|NCT03040414|HealthPartners Institute|Amy Becker LaFrance, Sr. Manager, Research Project Management Office|952.967.5079|Amy.B.LaFrance@healthpartners.com|
22436047|NCT05824936|Nemours Children's Hospital|Dr. Abigail Strang|3026516400|astrang@nemours.org|
22436048|NCT00096018|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22436049|NCT00673881|Radiant Research|Michael H. Davidson, MD FACC|312-494-2220|michaeldavidson@radiantresearch.com|2220
22436050|NCT00483041|MedImmune|Joseph Parker, MD|301-398-0000|parkerj@medimmune.com|
22436051|NCT02258529|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22436052|NCT02459275|University of Miami|Dr. D. Dante Yeh|305-585-1822|dxy154@med.miami.edu|
22436053|NCT00875056|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22436054|NCT01189292|Department of General, Abdominal and Transplant Surgery, University of Heidelberg|Dr. Ignazio Tarantino||ignazio.tarantino@med.uni-heidelberg.de|
22436055|NCT01173029|Universidade Gama Filho|Paulo Robeto Benchimol Barbosa|+55-21-95320182|ecgar@yahoo.com|
22436056|NCT01012921|Institut Straumann AG|Julia Dorn|0041619651111|julia.dorn@straumann.com|
22436057|NCT03028987|Stanford University School of Medicine, Dept. of Pediatrics|Cornelia Dekker, MD|6507244437|cdekker@stanford.edu|
22395698|NCT01019317|University of Texas (UT) MD Anderson Cancer Center|Elias Joseph Jabbour MD/Assistant Professor|713-792-4764|eharriso@mdanderson.org|
22411279|NCT03421652|Karmanos Cancer Institute|Nitin Vaishampayan, MD|313-576-9624|nvaisham@med.wayne.edu|
22411280|NCT01894984|XIAN-JANSSEN PHARMACEUTICAL|Medical affairs director|86-10-58218307||
22436058|NCT01842581|Bausch Health Americas, Inc.|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
22436059|NCT03973905|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22436060|NCT02648217|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22436061|NCT02553538|Massachusetts General Hospital|Dr. Sanja Percac-Lima|617-643-6980|spercaclima@partners.org|
22436062|NCT01656629|Johns Hopkins University|Dr. Suzanne Jan De Beur|410-550-0100|sjandebe@jhmi.edu|
22436063|NCT01403376|Sanofi|Trial Transparency Team||Contact_US@sanofi.com|
22436064|NCT03412097|Parker University|Dr. Katherine A Pohlman|972 438 6932|kpohlman@parker.edu|7148
22436065|NCT00815191|Cleveland Clinic Foundation|Daniel Sessler|216-444-4900|DS@OR.org|
22436066|NCT02900170|Albert Einstein Medical Center|Basma Abdulhadi|215456500|abdulhab@einstein.edu|
22436067|NCT01873729|Pediatric Psychopharmacology at Massachusetts General Hospital|Dr. Thomas Spencer|6177243883|tspencer@partners.org|
22436068|NCT01741532|ApoPharma Inc.|Caroline Fradette|416-401-7543|cfradett@apopharma.com|
22436069|NCT00613080|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.com|
22436070|NCT04983797|Biosense Webster, Inc.|Associate Director Medical Affairs|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22436071|NCT02012686|Department of Anesthesiology and Pain Medicine, Gangnam Severance Hospital, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul 135-720, Republic of Korea|Dr Dong Woo Han|82-2-2019-3549|HANESTH@yuhs.ac|
22436072|NCT01703065|University of Washington|Dr. Celestia Higano, MD|206-606-1152|thigano@u.washington.edu|
22436073|NCT02124772|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22436074|NCT01827332|MUSC|Aimee McRae-Clark|843-792-5216|mcraeal@musc.edu|
22436075|NCT01739803|University of Tennessee College of Pharmacy|Marie Chisholm-Burns|901-448-7141|mchisho3@uthsc.edu|
22436076|NCT01244633|Psyadon Pharmaceuticals|Dr. Richard Chipkin|3019192020|rchipkin@psyadonrx.com|
22436077|NCT01428336|Cleveland Clinic Foundation|Seenia Peechakara|216 4105901|peechas@ccf.org|
22436078|NCT03759041|Seres Therapeutics|Lisa von Moltke, MD, Chief Medical Officer|617-945-9626|clinicalstudies@serestherapeutics.com|
22436079|NCT02449018|Novartis Pharmaceuticals|Study Director|8627781873||
22436080|NCT02378207|Desmond Tutu HIV Foundation, Cape Town, South Africa|Dr. Linda-Gail Bekker|+27214066959|linda-gail.bekker@hiv-research.org.za|
22436081|NCT01985763|Icahn School of Medicine at Mount Sinai|Dr. Sofya Pintova|212-824-8461|Sofya.Pintova@mountsinai.org|
22436082|NCT00525824|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
22436083|NCT00552448|TexasTech|Dr. Adaobi Kanu|806 743 7336|adaobi.kanu@ttuhsc.edu|
22436084|NCT02645617|Advantage Silver Dental Arrest, LLC|Peter Milgrom|2062516831|drmilgrom@silverarrest.com|
22436085|NCT01522404|Emory University|Allan I. Levey, MD, PhD|404-727-7220|alevey@emory.edu|
22436086|NCT02698371|University Fernando Pessoa|Prof. Patricia Manarte-Monteiro; Associate Professor|+351 225 071 300|patmon@ufp.edu.pt|
22436087|NCT03306641|CooperVision, Inc|Lee Hall, BSc, PhD, MCOptom, FBCLA|925 251 6684|lhall@coopervision.com|
22436088|NCT01440881|University of Florida|Dr. Thomas Beaver|352-273-5501|thomas.beaver@surgery.ufl.edu|
22436089|NCT01274611|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
22436090|NCT02644356|Collinge and Associates, Inc.|William Collinge, PhD, MPH|541-632-3502|william@collinge.org|
22436091|NCT02290938|RAND|Elizabeth D'Amico|310-393-0411|damico@rand.org|6487
22436092|NCT00897390|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22436093|NCT04500769|University of Kentucky|Douglas Long|859-323-5438|delong2@uky.edu|
22436094|NCT05011513|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22436095|NCT01511562|Massachusetts General Hospital|Tracy Batchelor, MD, MPH|617-643-1938|tbatchelor@partners.org|
22436096|NCT04736199|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22436097|NCT04744831|Daiichi Sanyko, Inc|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22395699|NCT00728481|Mayo Clinic|Dr. Amy Foxx-Orenstein, D.O., Associate Prof. of Medicine, College of Medicine|480-301-8806|foxx-orenstein.amy@mayo.edu|
22395700|NCT03690141|Effector Therapeutics|Mark Densel, Vice President Development Operations|8589258215|mdensel@effector.com|
22395701|NCT01505010|University of Leuven|Dr. Jan A. Staessen|+32 16 34 7104|jan.staessen@med.kuleuven.be|
22395702|NCT04744285|Roswell Park Comprehensive Cancer Center|Kris Attwood|877-275-7724|askroswell@roswellpark.org|
22395703|NCT00626210|VAPAHCS|Dr. Jamie Zeitzer|6504935000|jzeitzer@stanford.edu|62410
22395704|NCT04553068|Evofem|Catherine Maher|8585501900|cmaher@evofem.com|
22395705|NCT01822522|AMC Operations and Data Management Cener|Kim Mosby-Griffin|301-251-1161|kmosby@emmes.com|10158
22395706|NCT00890929|Stanford University Medical Center|Bruno C Medeiros, MD|650-498-6000|bruno.medeiros@stanford.edu|
22395707|NCT00108069|National Cancer Institute|Kathy Warren, M.D.|301-435-4683|warrenk@box-w.nih.gov|
22395708|NCT02558231|Actelion Pharmaceuticals Ltd.|Principal Clinical Scientist|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22395709|NCT02257957|Universidad Nacional de Colombia|Dr Marcel Y Avila|+5713165000|myavilac@unal.edu.co|15119
22395710|NCT02066051|Mayo Clinic|Dr. Joanne F. Shen|480-301-8377|shen.joanne@mayo.edu|
22436098|NCT05111847|UNEEG medical|Clinical Operations, Medical Affairs|+45 41414244|LYBL@uneeg.com|
22436099|NCT06024096|Emory University|Daniel S. Graciaa, MD, MPH, MSc|404-712-1370|dsgraci@emory.edu|
22436100|NCT05818137|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22436101|NCT04938037|ErciyesU|Dr. Isa Cuce|+905056263723|dr.icüce@hotmail.com|
22436102|NCT05925374|Wayne State University|Dr. Erin Madden|2156053230|efmadden@wayne.edu|
22436103|NCT06071884|University of Pittsburgh, UPMC|Steven Orebaugh, MD|412-650-2965|orebaughsl@upmc.edu|
22436104|NCT03320330|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22436105|NCT05206370|Achieve Life Sciences|Roxann Becco, Sr. Director, Clinical Operations|425-686-1500|rbecco@achievelifesciences.com|
22436106|NCT04998851|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22436107|NCT05845398|Dicerna Pharmaceuticals, Inc., a Novo Nordisk company|Clinical Reporting Office (2834)|866-867-7178|clinicaltrials@novonordisk.com|(+1)
22436108|NCT03028948|Rutgers Cancer Institute of New Jersey|Dr. Sharon Manne|7322356759|mannesl@cinj.rutgers.edu|
22436109|NCT06038123|Medtronic|Peter Tang, Principal Clinical Research Specialist|862138986622|peter.tang@medtronic.com|
22436110|NCT05218499|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
22436111|NCT05048433|The University of Texas Health Science Center at Houston|Timothy J Walker, PhD|713-500-9664|Timothy.J.Walker@uth.tmc.edu|
22436112|NCT04831424|Columbia University|Martin Picard|6467748967|mp3484@columbia.edu|
22436113|NCT05010018|Johns Hopkins University|Joel Gittelsohn|1-410-274-5310|jgittel1@jh.edu|
22436114|NCT05431387|Achieve Life Sciences|Julie Ball, Vice President, Clinical Operations|425-686-1540|jball@achievelifesciences.com|
22436115|NCT03199391|Zimmer Biomet|Madison Murphy|5745262059|madison.murphy@zimmerbiomet.com|
22436116|NCT01867086|Gradalis, Inc.|Director of Clinical Trials|2144428124|info@gradalisinc.com|
22436117|NCT04257929|Harmony Biosciences|Sharon Wolfe-Schwartz, Executive Director, Medical and RegulatoryWriting|267-965-0270|swolfe-schwartz@harmonybiosciences.com|
22436118|NCT06036914|Mayo Clinic|Yogesh Reddy, M.B.B.S.|507-284-2904|Reddy.Yogesh@mayo.edu|
22436119|NCT04697381|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22436120|NCT01727011|Centre Antoine Lacassagne|Professeur JM Hannoun-Levi|04.92.03.12.60|jean-michel.hannoun-levi@nice.unicancer.fr|
22436121|NCT02733653|Boston Scientific Japan K.K.|Yoko Takizawa/Clinical Project Manager|+81-3-6853-7500|Yoko.Takizawa@bsci.com|
22436122|NCT00759525|Brigham and Women's Hospital|Mark A. Creager, MD|617-732-5267|mcreager@partners.org|
22436123|NCT02486718|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22436124|NCT04271475|Actelion Pharmaceuticals Ltd|Clinical Science Director CP|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22436125|NCT04555837|The University of Texas MD Anderson Cancer Center|Faye Johnson, MD|(713) 792-6363|fmjohns@mdanderson.org|
22436126|NCT05910775|Yale University|Sina Nikayin, MD|203-688-9719|sina.nikayin@yale.edu|
22436127|NCT04088331|Boston Scientific|Winnie Chen|952-930-6000|Winnie.Chen@bsci.com|
22436128|NCT01818284|UT MD Anderson Cancer Center|Chitra Hosing, MD/Professor, Stem Cell Transplantation|713-792-7734|cmhosing@mdanderson.org|
22436129|NCT03298451|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1 8772409479|information.center@astrazeneca.com|
22436130|NCT04908280|University of Rochester|Christopher T Richardson MD, PhD|585 - 275 - 7546|crichardson@urmc.rochester.edu|
22436131|NCT00343863|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu|
22436132|NCT01299571|GlaxoSmithKline|GSK Response Center|866-435-7343||
22436133|NCT03826199|UCLA|Dvora Joseph Davey|3107011526|dvoradavey@ucla.edu|
22436134|NCT00286221|Johns Hopkins School of Medicine|Dr. Bradford Winters|4109559080|bwinter1@jh.edu|
22436135|NCT00357656|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22436136|NCT04904809|Abbott Vascular|Sandeep Pingle|858-222-9673|sandeep.pingle1@abbott.com|
22436137|NCT02805725|Institut Bergonie|Pr Antoine Italiano|+ 33 5 47 30 60 88|a.italiano@bordeaux.unicancer.fr|
22436138|NCT05926544|University of North Carolina at Chapel Hill|Abby Gamble, MA|828-513-0636|abigail_gamble@email.unc.edu|
22436139|NCT05702918|Second Faculty of Medicine, Charles University|Mgr. Jakub Katolický|+420702088258|jakubkatolicky@gmail.com|
22436140|NCT03982420|Boston Scientific|Megan White|(763) 494-1700|Megan.White2@bsci.com|
22436141|NCT03267134|Alcon Research, LLC|Clinical Project Lead, CRD Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22436142|NCT06144918|Skye Bioscience|Chief Medical Officer|858-410-0266|info@skyebioscience.com|
22436143|NCT03500172|Johns Hopkins Bloomberg School of Public Health|Dr. Stefan Baral|4105028975|sbaral@jhu.edu|
22436144|NCT02683993|Boston Scientific|Teri Bird|6123221189|teri.bird@bsci.com|
22436145|NCT03171545|University of Michigan|Dr. Tiffany Veinot|734-615-8281|tveinot@umich.edu|
22436146|NCT06274723|University of Hawaii Cancer Center|Donghee Nicole Lee, Assistant Professor|8084418184|nlee@cc.hawaii.edu|
22436147|NCT05851937|Texas Christian University|Alison Prahl|8172575962|a.prahl@tcu.edu|
22436148|NCT03824158|University of Pittsburgh|Yael Schenker, MD, MAS, FAAHPM|415-254-9958|yas28@pitt.edu|
22436149|NCT04409457|Icahn School of Medicine at Mount Sinai|Laura Berner|332-243-7259|laura.berner@mssm.edu|
22436150|NCT04865770|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22436151|NCT02322840|Medtronic|Yetunde Ishola (Clinical Study Manager)|734-221-8182|yetunde.a.ishola@medtronic.com|
22436152|NCT06987201|East Coast Institute for Research at Universal Axon Clinical Research|Rebecca Goldfaden, PharmD, CCRP|904-854-1354|rg@roviaclinical.com|
22436153|NCT04763824|The University of Kansas Medical Center|Jennifer Klemp, PhD, Principal Investigator|9135887750|jklemp@kumc.edu|3662
22436154|NCT04539808|Oregon Health & Science University|Dr. Charles Lopez, Professor|503-494-1080|GIResearch@ohsu.edu|
22436155|NCT04522973|Virginia Commonwealth University|Michelle Peace, PhD|804-828-8240|mrpeace@vcu.edu|
22436156|NCT04007796|San Francisco VA Health Care System|Dr. Liz Goldstein|415-694-3443|lizabeth.goldstein2@va.gov|
22436157|NCT03573401|Biofrontera Discovery GmbH|Clinical Trial Management|Not available|ctm@bfinc.com|
22436158|NCT05579249|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22436159|NCT05028517|Mt. Hope Family Center, University of Rochester|Christie L. M. Petrenko, Ph.D.|5852752991|christie_petrenko@urmc.rochester.edu|241
22436160|NCT00267150|Novartis Pharmaceuticals|Study Director|862-778-8300||
22436161|NCT00475215|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22436162|NCT00699218|UC Davis|Guohua Xia|916-734-3574|gxia@ucdavis.edu|
22436163|NCT00969436|GlaxoSmithKline|GSK Response Center|866-435-7343||
22436164|NCT00351273|University of South Florida|John D. Carter, M.D.|(813) 974-2681|jocarter@health.usf.edu|
22436165|NCT01672866|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22436166|NCT01018095|Tulane University|Patricia Kissinger, PhD|5049887320|kissing@tulane.edu|
22436167|NCT02544373|University of Michigan|Tiffany J. Braley, MD, MS, Associate Professor of Neurology|734-936-6267|tbraley@med.umich.edu|
22436168|NCT04514341|Penn State College of Medicine|Karen Kim|7175318326|kkim5@pennstatehealth.psu.edu|
22436169|NCT01280695|Metabolic Solutions Development Company|Jerry Colca, PhD|269.343.6732|jcolca@msdrx.com|
22436170|NCT01216683|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22436171|NCT01350115|Novartis Pharmaceuticals|Study Director|862-778-8300||
22436172|NCT04327024|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22436173|NCT05101798|Icahn School of Medicine at Mount Sinai|Orli Weiss|9086700847|orli.weiss@icahn.ismms.edu|
22436174|NCT03968159|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261|medicalinformation@acadia-pharm.com|2897
22436175|NCT00864851|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22436176|NCT00443781|Medtronic Spine and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
22436177|NCT00430937|Novartis Pharmaceuticals|Study Director|862-778-8300||
22436178|NCT01533922|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22436179|NCT02942654|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22436180|NCT00895661|Massachusetts General Hospital Cancer Center|Jeremy Abramson, MD|617-724-4000|jabramson@mgh.harvard.edu|
22436181|NCT02006069|Abbott|Kwangdeok Lee PhD|+19725269673|kwangdeok.lee@abbott.com|
22436182|NCT00958932|National Jewish Health|Dr. Bruce Bender|303-398-1697|benderb@njhealth.org|
22436183|NCT02989805|Emory University|Benjamin Druss, MD, MPH|404-712-9602|bdruss@emory.edu|
22436184|NCT02776033|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22436185|NCT00685373|Novartis Pharmaceuticals|Study Director|862-778-8300||
22436186|NCT01302054|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22436187|NCT02639338|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22436188|NCT00201123|NYU School of Medicine|William Rom MD|212 263-6479|William.Rom@nyumc.org|
22436189|NCT00853840|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22436190|NCT00966719|Children's Hospital of Eastern Ontario|Dr Catherine Pound|613-737-7600|cpound@cheo.on.ca|
22436191|NCT02641522|Benaroya Research Institute|Sarah Robinson/ Administrative Assistant|(206) 342-6931|diabetes@benaroyaresearch.org|
22436192|NCT03242018|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
22436193|NCT01852383|New York State Psychiatric Institute|Dr. D.P. Devanand|(646) 774-8658|dpd3@columbia.edu|
22436194|NCT02365285|Vanderbilt University Medical Center|Cyndya Shibao, MD|615-322-2318|cyndya.shibao@vumc.org|
22436195|NCT00160199|Solvay Pharmaceuticals|Sven Voet - Global Communication|+32(0)2 509 69 77|sven.voet@solvay.com|
22436196|NCT03262116|Massachusetts General Hospital|Dr Steven J. Russell, MD, PhD|617.726.1848|sjrussell@mgh.harvard.edu|
22436197|NCT02968914|AstraZeneca Clinical Study Information Center|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22436198|NCT02635347|Rutgers-NJ Medical School|Baburao Koneru, MD, MPH|973-972-9599|koneruba@njms.rutgers.edu|
22436199|NCT03923582|University of Minnesota|Gudrun Kilian|612-624-0358|kilian@umn.edu|
22436200|NCT01727791|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22436201|NCT02144155|UCSD|David Feifel||dfeifel@kadimanp.com|
22436202|NCT00635089|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22436203|NCT01304407|Baylor College of Medicine|Dr. Steven Abrams|512-495-4700|sabrams@bcm.edu|
22436204|NCT01283542|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22442210|NCT00375609|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
22442211|NCT02338882|University of Plymouth|Dr Phillip Buckhurst|01752 588884|phillip.buckhurst@plymouth.ac.uk|
22442212|NCT02184455|DeCell Technolpogies Inc.|Dr. Paul F. Gratzer, CSO|902-223-2179|pfgratzer@decelltechnologies.com|
22442213|NCT01049945|Mayo Clinic|Shaji K. Kumar, M.D.||kumar.shaji@mayo.edu|
22442214|NCT02248675|VA Center of Excellence for Suicide Prevention|Wilfred R. Pigeon, PhD|(585) 393-7945|wilfred.pigeon2@va.gov|
22442215|NCT00617669|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22442216|NCT02506985|University of Kentucky|Susan Smyth|859-323-2274|susansmyth@uky.edu|
22442217|NCT03619811|UCSD|Clinical Research Coordinator|858-246-5236|mgreytak@ucsd.edu|
22442218|NCT00926029|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
22442219|NCT02250703|University of Mississippi Medical Center|Madhankumar Sathyamoorthy. PI|6018157066|msathyamoorthy@umc.edu|
22442220|NCT00577798|University of Nebraska Medical Center|Thomas Porter, MD|+1 (402) 559-8150|trporter@unmc.edu|
22442221|NCT02291016|University of Tennessee Graduate School of Medicine|Clinical Trials Coordinator|865-305-7975|jferris@utmck.edu|
22442222|NCT01137604|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22436205|NCT02725593|Study Information Center|Global Clinical Lead|+1-887-240-9479|information.center@astrazeneca.com|
22436206|NCT03689244|Actelion Pharmaceuticals Ltd|Senior Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22436207|NCT03283436|Brigham and Women's Hospital|Dr. Jon Einarsson|617-525-8582|jeinarsson@partners.org|
22436208|NCT01355796|University of Iowa|Janice Launspach|319-356-2047|janice-launspach@uiowa.edu|
22436209|NCT00444067|Integra LifeSciences|Director, Medical Affairs|609-275-0500||
22395711|NCT04721821|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22395712|NCT03836807|Dompé farmaceutici S.p.A.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22395713|NCT00685685|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22395714|NCT04029116|SCYNEXIS|Dr. David Angulo|(201) 884-5471|david.angulo@scynexis.com|
22395715|NCT01272947|Novartis Consumer Health S.A.|Clinical Project Leader|+41 22 3635528||
22395716|NCT03531788|University of Pittsburgh|Roxanna M. Bendixen, Principal Investigator|4123836603|bendixen@pitt.edu|
22395717|NCT02019420|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22395718|NCT02469896|Barrow Neurological Institute|Shafeeq Ladha, MD|602-406-8989|Shafeeq.Ladha@Barrowneuro.org|
22395719|NCT02510560|Elgan Pharma Ltd.|Miki Olshansky, Chief Executive Officer|972-4-6098626|Miki@elganpharma.com|
22395720|NCT01294150|NeoTract|Emily Hergenreter Director of Clinical Affairs|650-739-5570|ehergenreter@neotract.com|
22395721|NCT02401412|Hollister Incorporated|Stacy Haddad, Global Clinical Affairs Director|847-680-2837|stacy.haddad@hollister.com|
22395722|NCT02374398|Eastern Maine Medical Center|Dr. Alexandru Seviciu|207-973-5918|aseviciu@emhs.org|
22395723|NCT02756351|CytaCoat AB|Dr Jacob Odeberg|+46 (0) 70 2087571|jacob.odeberg@scilifelab.se|
22395724|NCT03684642|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22395725|NCT01431534|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22395726|NCT01643525|Johns Hopkins University|Dr. Paul Nyquist||pnyquis1@jhmi.edu|
22395727|NCT06154213|University of Connecticut|Sherry Pagoto, PhD|(860) 486-5917|sherry.pagoto@uconn.edu|
22395728|NCT06263582|UNC Lineberger Comprehensive Cancer Center|Sorgi Kate|919-966-5280|kasorgi@email.unc.edu|
22395729|NCT04252287|Janssen Scientific Affairs, LLC|Director CVM Health Equity|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22395730|NCT03857321|Atrium Health Wake Forest|Suzanne Craft, PhD|336-713-8846|suzcraft@wakehealth.edu|
22395731|NCT01080677|Stanford University School of Medicine|Professor of Neurology|650-723-5184|chos@stanford.edu|
22395732|NCT02564926|Astrazeneca, Korea|EunYoung Kim / Local Study Specialist|82 2 2188 0946|EunYoung.Kim@astrazeneca.com|0946
22395733|NCT00671554|Greenville Hospital System|Joe Stephenson, MD|864-455-3600|joe.stephenson@usoncology.com|
22395734|NCT01554488|William S. Middleton Memorial VA Hospital|Mihaela Teodorescu, MD-Principle Investigator|(608)2561901|mt3@medicine.wisc.edu|11080
22395735|NCT00012298|Mayo Clinic|Thomas E. Witzig, M.D.||witzig.thomas@mayo.edu|
22395736|NCT00447382|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22395737|NCT00977574|NRG Oncology|Linda Gedeon for Virginia Filiaci, PhD|716-845-1169|lgedeon@gogstats.org|
22395738|NCT01681810|University of Pittsburgh|Dr. Kara Hughan|4126925173|kara.hughan@chp.edu|
22395739|NCT01826851|URochester|Peter A. Knight, MD|(585) 275-6340|Peter_Knight@URMC.Rochester.edu|
22436210|NCT03897036|Senhwa Biosciences|Jason Huang, MD / Chief Medical Officer and Acting Chief Executive Officer|(858) 552-6808|jasonhuang@senhwabio.com|112
22395740|NCT03627767|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22395741|NCT00283049|sanofi-aventis|Medical Affairs study director||publicregistryUSMA@sanofi-aventis.com|
22395742|NCT02953639|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22395743|NCT01667081|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22395744|NCT03034460|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
22395745|NCT02294682|GlaxoSmithKline|GSK Response Center|866-435-7343||
22395746|NCT01516970|Janssen-Cilag GmbH|Medical Leader, Medical Department||ClinicalTrialDisclosure@its.jnj.com|
22395747|NCT00434421|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22395748|NCT02366728|Duke University|Mustafa Khasraw, M.D.|919-668-6688|mustafa.khasraw@duke.edu|
22395749|NCT01002456|Dept. of Veterans Affairs|Dr. Madeline McCarren|708 786 7987|madeline.mccarren@va.gov|
22395750|NCT01399190|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22395751|NCT01636414|OrthoCarolina Research Institute|Senior Research Scientist|704-323-2265|susan.odum@orthocarolina.com|
22395752|NCT03829241|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
22436211|NCT02718040|Galderma Laboratories|Jay Mashburn||jay.mashburn@galderma.com|
22436212|NCT05714943|innovation Research & Training|Dr. Alison Parker|919-493-7700|aparker@irtinc.us|
22436213|NCT01122108|Louisville Metabolic and Atherosclerosis Research Center (L-MARC)|Harold E. Bays, MD|502-515-5672|kschmitz@lmarc.com|
22436214|NCT00054028|The Ohio State University Comprehensive Cancer Center|Maryam Lustberg, MD|614-293-0066|Maryam.Lustberg@osumc.edu|
22436215|NCT04208087|Seikagaku Corporation|Clinical Development Dept.|(81)3-5220-8593|722_clinical_project_team@seikagaku.co.jp|
22436216|NCT01198509|New York University School of Medicine|Steven B. Abramson, MD|212-263-8003|StevenB.Abramson@nyumc.org|
22436217|NCT00408590|Mayo Clinic|Evanthia Galanis, M.D.|(507) 284-2511|galanis.evanthia@mayo.edu|
22436218|NCT02675114|Edwards Lifesciences|Research Director|949-250-2500|THV_CT.gov@Edwards.com|
22436219|NCT00582998|University of Alabama at Birmingham|Asya Love, RN|205-996-6781|asyalove@uab.edu|
22436220|NCT00837759|NIDDK, National Institutes of Health|Dr. Rana Malek|3015945288|malekr@mail.nih.gov|
22436221|NCT01597635|GlaxoSmithKline|GSK Response Center|866-435-7343||
22436222|NCT01755455|Dartmouth-Hitchcock Medical Center|Alex H. Gifford, M.D.|603-650-5533|alex.h.gifford@hitchcock.org|
22436223|NCT01267175|Medtronic Diabetes|Harold Torunsky|(818) 576 5445|harold.torunsky@medtronic.com|
22436224|NCT02688868|Shanghai Microport Medicine|HT Zhang|+862138954600|zhanght@microport.com|8552
22436225|NCT02690649|Parkview Health|Julie Hughbanks|260-266-1444|julie.hughbanks@parkview.com|
22436226|NCT02066129|Penn State University Dept of Public Health Sciences|David Mauger, PhD|717.531.3584|dmauger@psu.edu|
22436227|NCT00316888|ECOG-ACRIN Statistical Office|ECOG-ACRIN statistician|617-632-3012||
22436228|NCT00110461|Otsuka Pharmaceutical Development & Commercialization, Inc.|Andy Forbes||andy.forbes@otsuka-us.com|
22436229|NCT00857948|Sanofi Topaz|Medical Director||RegistryContactUs@sanofipasteur.com|
22436230|NCT00180297|Boston Scientific|Elisabeth Mouton - Clinical Trial Manager|+33 1 39 30 11 90|elisabeth.mouton@bsci.com|
22436231|NCT00493636|ACORN Research, LLC|Study Chair|901-435-5570|lschwartzberg@acornresearch.net|
22436232|NCT01565941|Boston Children's Hospital|Dr. Michael Agus|617-355-5849|michael.agus@childrens.harvard.edu|
22436233|NCT03230292|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22436234|NCT02855944|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
22436235|NCT03757130|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22436236|NCT01639755|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22436237|NCT01439126|Concordia Pharmaceuticals Inc.|John AR McCleery, CPA, CA, Managing Director and CFO|1-246-256-1861|jmccleery@concordiarx.com|
22436238|NCT02282904|NIAID|Elizabeth Kang|3014027567|ekang@niaid.nih.gov|
22436239|NCT01617447|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366||
22436240|NCT05059977|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22436241|NCT00576472|St. Jude Children's Research Hospital|Heather Conklin PhD|1-866-278-5833|info@stjude.org|
22436242|NCT03443427|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22395753|NCT01660607|Stanford University|Dr. Everett Meyer|650-725-5816|evmeyer@stanford.edu|
22436243|NCT04285489|Integra LifeSciences (Shanghai) Co., Ltd.|Dr. Hua Tang|0086 21 63179772|hua.tang@integralife.com|8029
22436244|NCT04405245|EyePoint Pharmaceuticals, Inc|David Bauer|8573410747|dbauer@eyepointpharma.com|
22436245|NCT02478580|University Of Texas Southwestern Medical Center|Dr. Enas Kandil|214-590-8509|Enas.Kandil@UTSouthwestern.edu|
22436246|NCT02576860|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
22436247|NCT00780273|University if Rochester Medical Center|Dr. George Romanos|585-276-4149|GeorgiosRomanos@urmc.rochester.edu|
22436248|NCT02391961|Louis Stokes VAMC|Alessandro Serra|2167913800|Alessandro.Serra@va.gov|
22436249|NCT00477269|Novartis Pharmaceuticals|Study Director|862-778-8300||
22436250|NCT04498377|Evive Biotech|Jianmin Chen|6095124566|jianmin.chen@evivebiotech.com|
22436251|NCT01541917|Children's Mercy Hospital|Mark Connelly, PhD (Principal Investigator)|816-234-3000|mconnelly1@cmh.edu|3193
22436252|NCT03544307|The University of Nebraska at Omaha|Dr. Song-Young Park|402-554-3774|song-youngpark@unomaha.edu|
22436253|NCT00121641|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22436254|NCT01792518|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22436255|NCT04807387|Baylor College of Medicine|Dr Julie Hakim|832-826-7464|julie.hakim@bcm.edu|
22436256|NCT02011490|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22436257|NCT01014455|Mayo Clinic|David O. Warner MD|5072846277|warner.david@mayo.edu|
22436258|NCT01565564|Tianjin Medical University|Dr. Xilin Yang|+86 22 83336727|yangxilin@tijmu.edu.cn|
22436259|NCT00249613|UCLA Integrated Substance Abuse Programs|Michael Prendergast|310-267-5503|mlp@ucla.edu|
22436260|NCT01184417|Alameda County Medical Center|Jonathan Rosenson MD|510-407-6743|jonrosenson@yahoo.com|
22436261|NCT03335254|TesoRx Pharma, LLC|Michael Oefelein, MD, Chief Medical Officer|909-595-0500|karl@tesorx.com|104
22436262|NCT00806442|Brigham and Women's Hospital|Elliot Israel, MD|617-732-2801|eisrael@partners.org|
22395754|NCT03678103|Masimo Corporation|Chelsea Frank|949-297-7000|studies@masimo.com|
22395755|NCT04214301|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
22395756|NCT01674712|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com|
22436263|NCT04728594|Geisinger Clinic|Amir Goren, PhD|5702144395|agoren@geisinger.edu|
22395757|NCT02024165|Winnie Palmer Hospital for Women and Babies|John Busowski, MD|407-435-1485|john.busowski@orlandohealth.com|
22436264|NCT00654004|Oregon Health & Science Univeristy|Dr. Melanie Gillingham|503-494-1682|gillingm@ohsu.edu|
22436265|NCT01965899|Medtronic, plc|CRHF Clinical Research|800-328-2518|MedtronicCRMtrials@medtronic.com|
22436266|NCT01497613|University of Miami Miller School of Medicine|Dr. Sara J. Czaja|305-355-9068|sczaja@med.miami.edu|
22436267|NCT00535821|Loma Linda University|H. Bryant Nguyen|909-558-4000|hbnguyen@llu.edu|44023
22436268|NCT00128713|New England Research Institutes|Susan Assmann, PhD|617-923-7747|sassmann@neriscience.com|548
22395758|NCT03574441|Augusta University|Efrain Riveros Perez|7067217361|eriverosperez@augusta.edu|
22436269|NCT02528357|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22436270|NCT04039867|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
22436271|NCT01455220|University of South Florida|Dr.Tuan Vu/ Dr. Derrick Robertson|813-974-6378|droberts@health.usf.edu|
22436272|NCT02621073|University of Missouri, Department of Orthopaedics|Brett Crist, MD|573-882-6562|cristb@health.missouri.edu|
22436273|NCT01595581|University of Southern California|Edward Schroeder|323-442-2498|eschroed@usc.edu|
22436274|NCT03028636|Pelvalon|Clinical Management|650-276-0130|steve@pelvalon.com|
22436275|NCT01969721|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22436276|NCT00495755|Dana-Farber Cancer Institute|Corey S. Cutler, MD, MPH, FRCP(C)|617-632-5946|cscutler@partners.org|
22436277|NCT02920957|CooperVision Inc|Sr.Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com|
22436278|NCT01058941|Oregon Health & Science University|Dr. Lynne Shinto, ND, MPH|503-494-5035|shintol@ohsu.edu|
22436279|NCT01789606|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22395759|NCT00201838|The Ohio State Unversity Comprehensive Cancer Center|Miguel Villalona-Calero, MD|614-293-5484|Miguel.Villalona@osumc.edu|
22436280|NCT00428207|Joslin Diabetes Center|Howard Wolpert, MD|6173092665|howard.wolpert@joslin.harvard.edu|
22436281|NCT03180307|On Target Laboratories|Tommy Lee, MSHS, Vice President, Clinical Operations|765-588-4547|Tlee@ontargetlabs.com|
22436282|NCT03159104|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22395760|NCT00381563|New England Baptist Hospital|Director of Clinical Trials|(617)754-6602|pmccree@caregroup.harvard.edu|
22395761|NCT00024167|University of Texas (UT) MD Anderson Cancer Center|Shi-Ming Tu, MD/Professor, Genitourinary Medical Oncology|713-792-2830|CR_Study_Registration@mdanderson.org|
22395762|NCT02252536|NIAAA|Megan Ryan|3014434225|mryan1@mail.nih.gov|
22395763|NCT01438151|Mount Sinai|Dr. Shradha Agarwal|212-659-9261|shradha.agarwal@mssm.edu|
22395764|NCT02340728|Memorial Sloan Kettering Cancer Center|Mark Schattner, MD|212-639-3148|schattnm@mskcc.org|
22395765|NCT00859950|Weill Cornell Medical College|Dr. Ana Krieger|646-962-7378|ack2003@med.cornell.edu|
22395766|NCT01836042|Glaukos|Jeff Wells, PharmD, MBA, RAC|949-367-9600|jwells@glaukos.com|227
22395767|NCT02822950|Michigan State University|Gary Stein|517-353-5126|steing@msu.edu|
22395768|NCT00006392|SWOG Statistical Center|Study Statistician|2066674623||
22436283|NCT01294163|Radboudumc, Department of Anaesthesiology|Dr. Jan HOFLAND|+31243611111|Jan.Hofland@radboudumc.nl|3658
22436284|NCT01563172|GlaxoSmithKline|GSK Response Center|866-435-7343||
22436285|NCT04350307|Yale University|Dr. Robin Raju|203-688-8800|robin.raju@yale.edu|
22436286|NCT01120990|Hypertension Center, Third University Department of Medicine, University of Athens|George S Stergiou, MD|+30 210 7763117|gstergi@med.uoa.gr|
22436287|NCT01742065|Kaiser Permanente Center for Health Research|Gloria D. Coronado|503 335 2427|Gloria.D.Coronado@kpchr.org|
22436288|NCT01858753|Castle Creek Biosciences|Head, Research and Development|13128471291|medinfo@castlecreekbio.com|
22436289|NCT00720343|Stanford University|Pamela Flood, M.D.|201-370-3933|pflood@stanford.edu|
22436290|NCT01840527|Massachusetts General Hospital Cancer Center|Ryan Sullivan|6177244000|rsullivan7@mgh.harvard.edu|
22436291|NCT03459365|Cleveland Clinic|Carlos Higuera|954 659-5430|higuerc@ccf.org|
22436292|NCT01356628|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Avnish Bhatia|215-955-8874|avnish.Bhatia@jefferson.edu|
22436293|NCT00344500|Psychiatry Department at VA Greater Los Angeles Healthcare System|Dr. Donna Ames, Principal Investigator|310-478-3037|donna.ames@va.gov|
22436294|NCT00599755|Merck Sharp and Dohme Corp|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22395769|NCT01186796|Mayo Clinic|Johannes. D. Veldhuis, M.D.|507-255-0902|Veldhuis.Johannes@mayo.edu|
22395770|NCT03838198|University of Michigan|Ewa Czyz|734-764-9466|ewac@umich.edu|
22436295|NCT04037254|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22436296|NCT02198794|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22436297|NCT01306656|Columbia University|Shonni Silverberg, MD|212-305-6291|sjs7@cumc.columbia.edu|
22436298|NCT01364740|Stanford University|Clete A. Kushida, MD, PhD|650-721-7560|clete@stanford.edu|
22436299|NCT01329848|Western University of Health Sciences|Dr. Chris Chase|909 706-3882|cchase@westernu.edu|
22436300|NCT01085435|Boston Scientific|Jens Goetzke|1-800-227-3422|jens.goetzke@bsci.com|
22436301|NCT01918332|Yonsei University Healthcare System Severance Hospital|Prof. YangSoo Jang|82-2-6924-3109|yejung@lgls.com|
22436302|NCT00789672|Jaeb Center for Health Research|Raymond Kraker, MSPH|813-875-8690|pedig@jaeb.org|
22436303|NCT02252965|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22436304|NCT00680797|VA Greater Los Angeles|Dr. Cathy Lee|310-478-3711|cathy.lee2@va.gov|42627
22436305|NCT04736628|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22436306|NCT04279613|Yale University|Dr. Kevan Herold|203-785-6507|kevan.herold@yale.edu|
22436307|NCT02478164|Dana-Farber Cancer Institute|Eudocia Q. Lee, MD, MPH|617-632-2166|eqlee@partners.org|
22436308|NCT04051827|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22436309|NCT05779007|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|018002430127|clintriage.rdg@boehringer-ingelheim.com|
22436310|NCT01424566|GW Pharmaceuticals Ltd.|Medical Enquiries||medinfo.USA@gwpharm.com|
22436311|NCT02484950|Rush University Medical Center|Brian Cole|(312) 432-2818|Brian.cole@rushortho.com|
22436312|NCT00680368|Loma Linda VA Healthcare System|T. Michael Kashner, PhD, PI|909 825-7084|michael.kashner@va.gov|2853
22436313|NCT03779503|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
22436314|NCT00889200|Butler Hospital|Linda Carpenter, MD|401 455 6349|Linda_Carpenter_MD@Brown.edu|
22436315|NCT00875342|Weil Cornell Medical College|Program director|212 821 0783|jdifede@med.cornell.edu|
22436316|NCT02771626|Calithera Biosciences, Inc|Study Director|650-870-1000|clinicaltrials@calithera.com|
22436317|NCT02392403|Cochlear|Chris James|+33 534 638 584|cjames@cochlear.com|
22436318|NCT01264614|UNION COLLEGE|Cay Anderson-Hanley, PhD|518-388-6355|andersoc@union.edu|
22436319|NCT02616393|Kadmon Corporation|Miranda Ross|724-778-6170|Miranda.Ross@kadmon.com|
22436320|NCT00657371|UT MD Anderson Cancer Center|Robert S. Bresalier, MD / Professor||CR_Study_Registration@mdanderson.org|
22395771|NCT02378220|Harding University College of Pharmacy / Unity Health - White County Medical Center, Searcy, Arkansas, USA|Lindsay Elliott|5012794800|lselliott@harding.edu|
22395772|NCT00578786|Gilead Sciences, Inc.|Hunter Gillies, MD, DSEM|650-522-1214|hunter.gillies@gilead.com|
22395773|NCT00000125|Washington University School of Medicine|Michael Kass MD|314-362-5713|kass@vision.wustl.edu|
22395774|NCT03568045|Yale School of Medicine|Dr. Melissa Knauert|203-785-4162|melissa.knauert@yale.edu|
22395775|NCT01761279|Portsmouth Hospitals NHS Trust|Dr Pete Basford, Endoscopy Research Fellow|+447890990445|petebasford@hotmail.com|
22395776|NCT00117507|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22395777|NCT00866723|Dana-Farber Cancer Institute|Panagiotis Konstantinopoulos|(617) 632-5269|panagiotisa_konstantinopoulos@dfci.harvard.edu|
22436321|NCT02642965|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22436322|NCT00652899|University of Minnesota, Dept. Ob/Gyn|Melissa Geller, M.D.|612-626-3111|gelle005@umn.edu|
22436323|NCT04557787|Coloplast A/S|Vice President, Medical Affairs|+454911 1111|clinical-studies@coloplast.com|
22436324|NCT02713867|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22436325|NCT00701636|LA BioMed at Harbor-UCLA Medical Center|Loren Miller MD|310-222-3813|Lgmiller@ucla.edu|
22436326|NCT02657564|Evergreen General Hospital|Dr. Chiliang Cheng|+886-3-4631230|chiliang.cheng@gmail.com|1510
22436327|NCT04135859|Nationwide Children's Hospital|Jamie Jackson, Ph.D.|614-722-3585|jamie.jackson2@nationwidechildrens.org|
22436328|NCT01291836|Alere San Diego|William Arnold|858-505-2000|william.arnold@alere.com|
22436329|NCT01600053|University of California, San Diego|Thomas Kipps, MD|(858) 534-5400|tkipps@ucsd.edu|
22436330|NCT00084149|University of California, San Diego|Dr. Florin Vaida|619 543-8045|fvaida@ucsd.edu|
22436331|NCT02715726|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22436332|NCT02445573|Guang'anmen hospital of China Academy of Chinese Medical Sciences|Dr. Huanfang Xu|+86 10 8800 1124|huanfang_xu@126.com|
22436333|NCT03123614|University of Utah Moran Eye Center|Mark Mifflin, MD|801-213-4152|Mark.Mifflin@hsc.utah.edu|
22436334|NCT04047420|University of Pittsburgh|Sharon Riddler, MD, MPH|4123831741|riddler@pitt.edu|
22436335|NCT00996346|University of New Mexico Cancer Center|Monte Shaheen, MD / Study Principal Investigator|505-925-0404|MoShaheen@salud.unm.edu|
22436336|NCT01581008|VA Eastern Colorado Health Care System|David Bekelman, MD, MPH|720-857-5088|david.bekelman@va.gov|
22436337|NCT03619135|University of Iowa College of Dentistry|Dr. Kyle Stein|319-384-5105|kyle-stein@uiowa.edu|
22436338|NCT03629912|Western Kentucky University|Dr. Matthew Shake|270-745-3918|matthew.shake@wku.edu|
22436339|NCT02608450|Cassiopea SPA|Cassiopea R&D|+39 02 868 911 24|r&d@cassiopea.com|
22436340|NCT02565810|Samsung Bioepis Co., Ltd.|Director of Clinical Trials||sbregistry@samsung.com|
22436341|NCT01848847|namik kemal university|cem celik|905324205365|cemcel@yahoo.com|
22436342|NCT02636946|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22436343|NCT03089944|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22436344|NCT02308488|NYU Langone Health - Perlmutter Cancer Center|Carmen A. Perez, M.D., Ph.D.|212-731-5003|Carmen.Perez@nyulangone.org|
22436345|NCT01365624|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D|610-650-4200|dbregman@lpicrd.com|828
22436346|NCT03263780|Cedars-Sinai Medical Center|Timothy Daskivich, M.D.|310-423-4700|timothy.daskivich@cshs.org|
22436347|NCT04075409|Cares|UCB|+1844599|UCBCares@ucb.com|2273
22436348|NCT01839656|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22436349|NCT01994993|Duke University Medical Center|Michael Cohen-Wolkowiez, M.D|9196688812|michael.cohenwolkowiez@duke.edu|
22436350|NCT00499746|Johns Hopkins University School of Medicine|Eric C. Strain, M.D.|410-550-1191|ecsgss@aol.com|
22436351|NCT01605942|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22436352|NCT01012323|Octapharma USA|Michael Eppolito, Director, Clinical Operations Immunology and ICU Medicine|201 604-1155|michael.eppolito@octapharma.com|
22436353|NCT00790478|University of Tennessee|Paul Terry|(865) 305-9341|pterry@utmck.edu|
22436354|NCT00558272|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22436355|NCT03449433|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
22436356|NCT00737633|Vivus, Inc|Wesley W Day, PhD|650-934-5200|day@vivus.com|
22436357|NCT02145351|Mayo Clinic|Barry A. Borlaug, M.D.|507-255-4152|Borlaug.Barry@mayo.edu|
22395778|NCT05105789|UW School of Medicine and Public Health|Ellen Wald, MD|(608) 263-8558|erwald@pediatrics.wisc.edu|
22436358|NCT00795288|Washington University|Michael Diringer|314-362-2999|diringerm@wustl.edu|
22395779|NCT00038727|George Washington University|Marinella Temprosa, PI of Coordinating Center|3018819260|ella@bsc.gwu.edu|
22395780|NCT01003990|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22395781|NCT01271803|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22395782|NCT05211739|Alcon Research, LLC|Clinical Project Lead, CRD Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22395783|NCT04178967|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
22395784|NCT02616523|University Clinical Center Ljubljana|dr. Lea Andjelković|0038615223810|lea.andjelkovic@gmail.com|
22395785|NCT01975428|Scripps Translational Science Institute|Eric J. Topol, M.D.|858-554-5708|etopol@scripps.edu|
22395786|NCT02187809|H. Lundbeck A/S|H. Lundbeck||LundbeckClinicalTrials@Lundbeck.com|
22395787|NCT00628251|AstraZeneca|Paula del Rosario|+44 7884 735492|ClinicalTrialTransparency@astrazeneca.com|
22395788|NCT02354781|Nationwide Children's Hospital|Dr. Jerry Mendell|1-614-722-4877|Jerry.Mendell@nationwidechildrens.org|
22395789|NCT02080455|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|617-242-5142|alison.long@aegerion.com|
22436359|NCT01105377|Johns Hopkins Oncology Center|Nilofer S. Azad, M.D.||nazad2@jhmi.edu|
22436360|NCT02495454|Fondazione Italiana Linfomi ONLUS|Dr. Luigi Marcheselli - FIL statistician|059 4223873|lmarcheselli@filinf.it|
22436361|NCT02409342|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22436362|NCT00279812|Institute of Food Research|Dr Charlotte Armah|01603 255 000|charlotte.armah@ifr.ac.uk|5360
22436363|NCT01399008|Metabolex|Mary Jean Stempien, M.D., Acting Chief Medical Officer|510-293-8800|mjstempien@metabolex.com|
22436364|NCT00370838|Johns Hopkins University|Dr. Harvey Singer|410-955-7212|hsinger@jhmi.edu|
22436365|NCT03834220|Debiopharm International S.A.|Head Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
22436366|NCT00527332|Deptartment of Obstetrics and Gynecology, University Hospital, Linköping, Sweden|Dr Preben Kjolhede|+46101030000|Preben.Kjolhede@lio.se|3187
22436367|NCT05498467|Department of Dermatology and Allergy - Herlev-Gentofte Hospital|Kelvin Yeung|38673243|kelvin.yeung@sund.ku.dk|0045
22436368|NCT03684694|ADC Therapeutics SA|Clinical Trials Information|954-903-7994|clinical.trials@adctherapeutics.com|954
22436369|NCT02100475|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22436370|NCT03268941|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22436371|NCT02069119|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366||
22436372|NCT02720692|Baudax Bio Inc.|Development|484-395-2440|info@baudaxbio.com|
22436373|NCT03878758|Becton Dickinson|Michael Gibney|201-847-6170|michael.gibney@bd.com|
22436374|NCT01769196|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22436375|NCT00765063|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22436376|NCT03614325|Beth Israel Deaconess Medical Center|Dr. Brian P. O'Gara|6177543189|bpogara@bidmc.harvard.edu|
22436377|NCT00321464|Amgen Inc.|Study Director|866-572-6436||
22436378|NCT00119366|Fred Hutchinson Cancer Research Center|Johnnie Orozco, MD, PhD|(206) 667-4102|jorozco@fredhutch.org|
22436379|NCT01673620|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22395790|NCT01807923|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22395791|NCT02403622|Microbiome Health Research Institute|Majdi Osman, MD, MPH|6175752201|mosman@openbiome.org|
22436380|NCT00652951|GlaxoSmithKline|GSK Response Center|866-435-7343||
22436381|NCT01022424|Otsuka Pharmaceutical Co.,Ltd.|Director of Clinical Trials|+81-3-6361-7366||
22436382|NCT01206582|Mayo Clinic|Dr. Adil E. Bharucha|507-284-6439|bharucha.adil@mayo.edu|
22436383|NCT02100969|University of Kansas Medical Center|Dr. Mazen Dimachkie|913-588-6970|mdimachkie@kumc.edu|
22436384|NCT00528801|Children's Hospital of Oakland and Research Institute|Elliott Vichinsky, MD|510-428-3651|evichinsky@mail.cho.org|
22436385|NCT02207491|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
22436386|NCT00477152|Baxter Halthcare Corporation|George Harb, MD, MPH||george_harb@baxter.com|
22436387|NCT00372697|Novartis Pharmaceuticals|Study Director|862 778-8300||
22436388|NCT02692755|Georgetown University|Nicole Swanson|2026879194|ns1209@georgetown.edu|
22436389|NCT00527982|UT MD Anderson Cancer Center|Waun K. Hong, MD/Professor||CR_Study_Registration@mdanderson.org|
22436390|NCT04473664|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22436391|NCT01939366|Grünenthal GmbH|Study Director|+49 241 569 3223|Clinical-Trials@grunenthal.com|
22436392|NCT02708485|USherbrooke|Stephen Cunnane|1-819-780-2220|Stephen.Cunnane@USherbrooke.ca|45670
22436393|NCT00231413|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22436394|NCT02066415|Amgen Inc.|Study Director|866-572-6436||
22436395|NCT03842683|Steno Diabetes Center North Denmark|Dr. Morten Hasselstrøm Jensen|+4522226964|mhj@hst.aau.dk|
22436396|NCT01423916|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22436397|NCT02276547|Neovasc|Lisa Read, Clinical Study Manager|8558025180|lread@neovasc.com|323
22436398|NCT00106691|GTx, Inc.|Senior Director, Clinical Operations|901-523-9700|mdesordi@gtxinc.com|
22436399|NCT00530920|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22436400|NCT03208530|Brigham and Women's Hospital|Kei Ouchi, MD, MPH|(617) 732-5640|kei_ouchi@dfci.harvard.edu|
22436401|NCT00678834|The Ohio State University Wexner Medical Center|Dr. Chandan K. Sen, PhD. Professor and Associate Dean|614-247-7658|chandan.sen@osumc.edu|
22436402|NCT01177969|University of South Florida|Dr. Eric Storch|727-767-8230|estorch@health.usf.edu|
22436403|NCT03833713|Stanford University|Brian Suffoletto|4129016892|suffbp@stanford.edu|
22436404|NCT02768753|General Hospital of Jinan Military Area|Dr.Qing Qing He，Dr.Gao Feng Ni|15653853675|m15653853675@163.com|
22436405|NCT03984487|Cincinnati Children's Hospital|Dr. Amie Duncan|513-803-2416|Amie.Duncan@cchmc.org|
22436406|NCT01353911|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22436407|NCT01504204|Wake Forest University Health Sciences|Irma M Richardsom, MHA|336-716-2903|irichard@wakehealth.edu|
22436408|NCT00047619|University of Calgary|Dr. Chester Ho|(403) 944 4620|chester.ho@albertahealthservices.ca|
22436409|NCT04468074|University of Colorado, Boulder|Marta Ceko|443-835-6587|Marta.Ceko@colorado.edu|
22436410|NCT02049138|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22436411|NCT03995355|Johnson & Johnson Vision|Meredith Bishop, OD, MS, FAAO - Sr. Principal Research Optometrist|1-800-843-2020|MBishop4@its.jnj.com|
22436412|NCT00094107|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22436413|NCT00587847|North Shore-Long Island Jewish Health System|Kanti Rai, MD|(718) 470-4050|krai@nshs.edu|
22436414|NCT00860015|Columbia University|Rober Taub, MD - Vivian and Seymour Milstein Family Prof. of Clinical Medicine||rntaubipod@gmail.com|
22436415|NCT00343382|Mayo Clinic|Dr. Charles L. Loprinzi|507-284-1623|cloprinzi@mayo.edu|
22436416|NCT03945019|CELLTRION, Inc.|Head of Clinical Planning|+82-32-850-4160|YunJu.Bae@celltrion.com|
22436417|NCT00721539|Stanford|Edward Damrose, MD, associate professor|650-725-6500|edamrose@stanford.edu|
22395792|NCT00995007|National Cancer Institute|Dr. Katherine E. Warren|301-435-4683|warrenk@box-w.nih.gov|
22395793|NCT03933397|Duke Clinical Research Institute - Duke University Medical Center|Huiman Barnhardt, PhD|919-668-7313|huiman.barnhart@duke.edu|
22395794|NCT03367715|NYU Langone Health - Perlmutter Cancer Center|Sylvia Kurz, MD, PhD|212-731-6267|Sylvia.Kurz@nyulangone.org|
22395795|NCT01237340|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22395796|NCT01610687|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
22395797|NCT02218190|Washington University School of Medicine|Michael P. Kelly, MD, MSc|314-747-2511|kellymi@wustl.edu|
22395798|NCT03675776|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
22395799|NCT01093625|Vistakon|Katherine E. Osborn||clinicalstudies@its.jnj.com|
22395800|NCT00698932|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22395801|NCT02014740|University of Miami|Prof Gianluca Iacobellis|3052433636|giacobellis@med.miami.edu|
22395802|NCT02608879|NYU Langone Medical Center|Patricia Corby, Principal Investigator|646-501-2615|patricia.corby@nyumc.org|
22395803|NCT01621542|Sunovion Pharmaceuticals Inc.|WT2725 Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
22395804|NCT02742766|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22395805|NCT03739437|The University of Oklahoma Health Sciences Center|Dr. Darla Kendzor|(405) 271-8001|Darla-Kendzor@ouhsc.edu|50478
22395806|NCT01351623|Memorial Sloan Kettering|Nikoletta Lendvai, MD|(212) 639-3368|lendvain@mskcc.org|
22395807|NCT01959048|Hadassah-Hebrew University|Jacob Strahilevitz|972508946353|jstrahilevitz@hadassah.org.il|
22395808|NCT01130974|Bausch & Lomb Inc.|Robert Steffen|(585) 338-6399|robert.steffens@bausch.com|
22395809|NCT01868139|University of Maryland School of Medicine|Dr. Bruce Greenwald|4103288731|bgreenwa@medicine.umaryland.edu|
22395810|NCT03359590|Profil Institut für Stoffwechselforschung GmbH|Dr. Christoph Kapitza|+49 2131 4018|christoph.kapitza@profil.com|157
22395811|NCT02536755|Genzyme, a Sanofi Company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22395812|NCT02540538|MaastrichtUMC|Astrid ML Oude Lashof, MD, PHD|0031433876644|a.oudelashof@mumc.nl|
22395813|NCT05649657|New Taipei Municipal Tucheng Hospital, Chang Gung Memorial Hospital|Dr. Shu-Chun Huang|0952818169|h0711@ms13.hinet.net|
22395814|NCT04598477|Argenx|Regulatory Manager|Please email:|regulatory@argenx.com|
22395815|NCT05183360|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22436418|NCT00499408|Comprehensive Cancer Center of Wake Forest University|K.C. Balaji, MD|336-716-5690|kbalaji@wakehealth.edu|
22436419|NCT00424268|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22436420|NCT03002454|Winnipeg Regional Health Authority|Dr. Sandor Demeter|1 (204) 787-3375|sdemeter@hsc.mb.ca|
22411281|NCT01427803|Bayer HealthCare LLC, Consumer Care|Head Medical Affairs||clinical-trials-contact@bayerhealthcare.com|
22436421|NCT02966015|Clinical operations,Medical Affairs|Head of clinical operations|+45 49113267|dkphl@coloplast.com|
22436422|NCT02241187|Memorial Sloan Kettering Cancer Center|Dr. Kenneth Yu, MD|646-888-4188|YuK1@mskcc.org|
22436423|NCT02356887|Toronto western Hospital/UHN|Emad Al Azazi|416-603-5800|emad.alazazi@uhnresearch.ca|6237
22436424|NCT00199888|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22436425|NCT01020903|Staten Island University Hospital|Michael Silverberg/Principal Investigator|718-226-6629|msilverberg@siuh.edu|
22436426|NCT02030288|VA Boston Healthcare System|Nicholas Livingston|857-364-6360|nicholas.livingston@va.gov|
22395816|NCT03140423|Division of Infectious Diseases, University of California Irvine School of Medicine|Dr. Susan S. Huang, MD, MPH|(714) 456-5047|sshuang@hs.uci.edu|
22395817|NCT02876302|Dana-Farber Cancer Institute|Dr. Filipa Lynce, MD, Principal Investigator|617-632-3800|Filipa_Lynce@dfci.harvard.edu|
22395818|NCT05579990|University of Alabama at Birmingham|Dr. Camille Worthington|205-975-7274|cschneid@uab.edu|
22395819|NCT00332839|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300||
22395820|NCT01876251|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22395821|NCT00521924|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22395822|NCT00982865|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22395823|NCT01355484|GTx Inc.|Senior Director, Clinical Operations|1-901-261-3795|mdesordi@gtxinc.com|
22395824|NCT03876171|University of Miami|Louis Herns Marcelin, Ph.D.|3052848493|lmarcel2@miami.edu|
22395825|NCT02012296|University of Chicago|Theodore Karrison|773-702-9326|tkarrison@health.bsd.uchicago.edu|
22395826|NCT04321980|Orpheris, Inc.|Jeffrey L Cleland, PhD, Executive Chair|650-505-5048|cleland@orpheris.com|
22395827|NCT00727649|Birmingham VA Medical Center|Dr. Alayne Markland, PI of this clinical trial|205-933-8101|alayne.markland@va.gov|6365
22395828|NCT01650285|BrUOG|Dr. Anthony Mega|4018633000|kayla_rosati@brown.edu|
22395829|NCT04163900|NuCana plc|Medical and Scientific Affairs Department|+44 131 357 1111|info@nucana.com|
22436427|NCT05219669|Opiant Pharmaceuticals|Clinical Director|18043791090|PatientSafetyNA@Indivior.com|
22436428|NCT05216627|University of Pennsylvania|Daniel Blumenthal|215-746-7155|daniel.blumenthal@pennmedicine.upenn.edu|
22436429|NCT02177838|Rutgers Cancer Institute of New Jersey|Sung Kim, MD|732-235-3986|sk1375@cinj.rutgers.edu|
22436430|NCT03274804|Universitätsklinikum Heidelberg, NCT|Dr. Georg Martin Haag|+49 (0) 6221 56|GeorgMartin.Haag@med.uni-heidelberg.de|4801
22436431|NCT02404649|Harvard School of Dental Medicine|Dr. Kevin Guze|6177210707|kevin_guze@hsdm.harvard.edu|
22436432|NCT02299076|VAL HEALTH, LLC|Daniel Astrachan|2033769388|dastrachan@valhealth.com|
22436433|NCT00162266|Bristol-Myers Squibb|BMS Study Director||clinical.trials@bms.com|
22436434|NCT00330668|Ipsen|Ipsen Medical Director|See email|clinical.trials@ipsen.com|
22436435|NCT02273960|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22436436|NCT01102894|University of Minnesota|Dr. Joanne Slavin|612-624-7234|jslavin@umn.edu|
22436437|NCT00712582|Memorial Sloan Kettering Cancer Center|Dr. Andrew Zelenetz, MD, PhD|646-608-3728|zeleneta@mskcc.org|
22436438|NCT03442296|Johns Hopkins University School of Medicine|Dr. Carrie Nieman|410-502-6965|cnieman1@jhmi.edu|
22436439|NCT00447122|BrUOG|Howard Safran, MD|4018633000|BrUOG@brown.edu|
22436440|NCT03907033|Mayo Clinic|Dr. Johnny Yi|480-342-0612|Yi.Johnny@mayo.edu|
22436441|NCT04046250|Tosk, Inc.|Emile Youssef, MD, PhD|312.244.0068|eyoussef@tosk.com|
22436442|NCT00709878|Northwestern University|Mario Lacouture, MD|212-610-0079|LacoutuM@mskcc.org|
22436443|NCT02020408|UCSD Department of Psychiatry|Walter H. Kaye, MD|858-534|wkaye@ucsd.edu|8019
22436444|NCT02806960|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22436445|NCT01882868|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22436446|NCT01629953|VA North Texas Health Care System|James LePage, Ph.D. Chief Research and Development|214-857-0240|james.lepage@va.gov|
22436447|NCT05532891|Imperial College London|Dr Emma Rose McGlone|07949565678|e.mcglone@ic.ac.uk|
22436448|NCT03221842|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
22436449|NCT02504580|Heron Therapeutics, Inc.|Clinical Operations|1-800-767-0524|cquaratino-baker@herontx.com|
22436450|NCT01387464|InSite Vision|Senior Manager, Clinical Sciences||manjiri.desai@sparcmail.com|
22436451|NCT00007020|Retrophin, Inc.|Retrophin Medical Information|+1 8776595|medinfo@retrophin.com|518
22436452|NCT04909229|Yale University|Joseph Ross, MD, MHS|203-785-2987|joseph.ross@yale.edu|
22436453|NCT00450073|Emory University|Vin Tangpricha|4047277254|vin.tangpricha@emory.edu|
22436454|NCT01100528|Cleveland Clinic, Case Comprehensive Cancer Center|Yogen Saunthararajah, MD|866-223-8100|CancerCenterResearch@ccf.org|
22436455|NCT03242252|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
22436456|NCT01659255|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22436457|NCT01116427|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22436458|NCT03675516|Momentum Data|Dr Andrew McGovern|+447531221970|andy.mcgovern@momentumdata.co.uk|
22436459|NCT03316950|UT Southwestern|Research Coordinator|214-645-8907|jennifer.barillas@utsouthwestern.edu|
22436460|NCT04094584|University of California, San Francisco|Ralph Wang|(415) 353-4890|ralph.wang@ucsf.edu|
22436461|NCT01754194|Medtronic MITG|Maria Young - Clinical Research Manager|+353 (0)1 4381611|maria.young@medtronic.com|
22436462|NCT00907296|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22436463|NCT00791557|University Hospitals of Cleveland|Dr. Amanda Suggs, MD|216-844-7546|Amanda.suggs@uhhospitals.org|
22436464|NCT01079936|University of Texas (UT) MD Anderson Cancer Center|Muzaffar H. Qazilbash, Professor, Stem Cell Transplantation||CR_Study_Registration@mdanderson.org|
22436465|NCT02322190|National Cancer Institute|Dr. Ronald Gress|240-760-6167|rg26g@nih.gov|
22436466|NCT03344640|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22436467|NCT00537407|Debiopharm International S.A.|Jean-Maurice Dumont, Vice President Medical Affairs|4121 321 01 11|jean-maurice.dumont@debiopharm.com|
22436468|NCT02809053|Archigen Biotech Ltd|Medical Director|+44 (0)20 3749 5000|info@archigenbio.com|
22395830|NCT01830855|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22395831|NCT00699803|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22395832|NCT01847430|GlaxoSmithKline|GSK Response Center|866-435-7343||
22436469|NCT01147900|GlaxoSmithKline|GSK Response Center|866-435-7343||
22436470|NCT00025155|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22436471|NCT05086510|AinShamsU|Dr. Mohammad Gamal|2001114115331|mdgamal92@gmail.com|
22436472|NCT03022981|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22436473|NCT01462877|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com|
22436474|NCT00884832|Mayo Clinic|Dr. Adil E. Bharucha|507-266-9156|bharucha.adil@mayo.edu|
22436475|NCT02337725|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22436476|NCT00141115|New York State Psychiatric Institute|John J. Mariani|2125435987|jm2330@columbia.edu|
22436477|NCT01264770|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
22436478|NCT00129961|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22436479|NCT00084487|Case Comprehensive Cancer Center|Afshin Dowlati MD|216-844-1228|afshin.dowlati@uhhospitals.org|
22436480|NCT03294629|Sleep Center, Taoyuan Chang Gung Memorial Hospital|Ning-Hung, Chen|+886-3-3281200|ninghung@yahoo.com.tw|2281
22436481|NCT04881747|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22436482|NCT02138240|Johns Hopkins University School of Medicine|Kimberly Gudzune|443-287-7238|gudzune@jhu.edu|
22436483|NCT01175395|University of Illinois at Chicago|Jennifer I Lim MD|312-413-0704|jennylim@uic.edu|
22436484|NCT04054999|Mayo Clinic|Sher-Lu Pai, M.D.|904-956-3327|Pai.SherLu@mayo.edu|
22436485|NCT00225784|Dartmouth-Hitchcock|J. Marc Pipas, MD|603-650-9474|J.Marc.Pipas@hitchcock.org|
22436486|NCT02598128|Alcresta Therapeutics, Inc.|Russell G. Clayton, D.O., Chief Medical Officer|215.813.5100|rclayton@alcresta.com|
22436487|NCT01378429|Sunovion|Respiratory Medical Director|866-503-6351||
22436488|NCT01064687|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22436489|NCT00619489|Millennium Pharmaceuticals Inc|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
22436490|NCT03134183|Virginia Commonwealth University|Frances Casey, MD|804-828-5076|frances.casey@vcuhealth.org|
22436491|NCT02504931|UT Health San Antonio|Dr. John Roache|210-562-5406|roache@uthscsa.edu|
22436492|NCT02265796|Malcom Randall VA Medical Center|Dr. Anthony Bavry|352-376-1611|anthony.bavry@va.gov|6325
22436493|NCT02477553|Indiana University|Peter H. Schwartz, M.D., Ph.D.|317-278-4037|phschwar@iu.edu|
22436494|NCT04311463|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22436495|NCT04023682|University of Iowa Hospitals and Clinics|Sundara Reddy, MBBS|(319) 356-2108|sundarareddy-durgempuditripura@uiowa.edu|
22436496|NCT00454649|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22436497|NCT01599741|Philips|Thijs Grunhagen|+31 6 11645166|thijs.grunhagen@philips.com|
22436498|NCT02745535|Institute of Human Virology, University of Maryland|Dr. Eleanor Wilson|1(410)706-1710|eleanor.wilson@ihv.umaryland.edu|
22436499|NCT00440830|Columbia University|Pamela Flood, MD|212-305-2008|pdf3@columbia.edu|
22436500|NCT01291277|Yale School of Medicine|Dr. Loren Laine|203-937-3462|loren.laine@yale.edu|
22436501|NCT00377364|UT Southwetern Medical Center at Dallas|E.Sherwood Brown, M.D., Ph.D.|214-645-6950|Sherwood.Brown@utsouthwestern.edu|
22436502|NCT00716742|Allergan, Inc.|Vice President, Global Health Outcomes Strategy and Research|714-246-4500|clinicaltrials@allergan.com|
22436503|NCT03480009|University of Pittsburgh|Principal Investigator, MD MPH|412-641-5496|fpr@upmc.edu|
22436504|NCT01638559|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22436505|NCT02014584|GlaxoSmithKline|GSK Response Center|866-435-7343||
22436506|NCT00483002|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22436507|NCT01181674|McMaster University|Dr. Natalia McInnes (nee Yakubovich)|905-521-2100|natalia.mcinnes@mcmaster.ca|
22395833|NCT01950247|American Regent, Inc.|Mark Falone, MD.|631.772.3544|mfalone@americanregent.com|
22395834|NCT01831921|Wake Forest School of Medicine|Mara Z. Vitolins, DrPH, MPH, RDN|(336) 716-2886|mvitolin@wakehealth.edu|
22395835|NCT01798992|University of Colorado, Denver|Dr. Michael Bristow, MD PhD|303-724-5453|Michael.Bristow@ucdenver.edu|
22395836|NCT03842163|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22395837|NCT04216251|Massachusetts General Hspital|Andrew T. Chan, MD, MPH|617-726-3212|achan@partners.org|
22395838|NCT01187550|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22395839|NCT00129623|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22395840|NCT00596934|University of Michigan|Dr. Elif A. Oral|734-615-7271|eliforal@med.umich.edu|
22395841|NCT01296035|Women & Infants Hospital|Director of Clinical Trials|401-274-1122|jmari@wihri.org|
22395842|NCT00744211|University of South Carolina SOM|Francis G. Spinale|803-777-3964|cvctrc@uscmed.sc.edu|
22395843|NCT02797067|Changhai Hospital|Yangyang Qian|13818040017|919835863@qq.com|
22395844|NCT01078207|Covidien|Fran Haury, RRT Research Coordinator, Clinical Affairs|303 305-2314|fran.haury@covidien.com|
22395845|NCT01245387|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22395846|NCT00601705|Cleveland Clinic|Dr. David Adelstein|216 444-9310|ADELSTD@ccf.org|
22395847|NCT04513665|Memorial Sloan Kettering Cancer Center|Dr. Vicky Makker, MD|646-888-4224|makkerv@mskcc.org|
22395848|NCT01653964|Mayo Clinic|Dr. Carrie Hruska|5072663991|hruska.carrie@mayo.edu|
22395849|NCT02232282|Loyola University Chicago|Larissa Bresler, MD|7086433827|lbresler@lumc.edu|
22395850|NCT02146599|Abbott Medical Optics|Anne Buteyn; Manager, Clinical Research|949-505-2029|anne.buteyn@abbott.com|
22395851|NCT02101021|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22395852|NCT01368042|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22395853|NCT02632721|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22395854|NCT00544648|Vanderbilt-Ingram Cancer Center|Vicki Keedy, MD|615-936-3524|vicki.keedy@vanderbilt.edu|
22436508|NCT02651220|Teva Pharmaceuticals USA, Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
22436509|NCT01447121|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3062|carmine.greene@ascensia.com|
22395855|NCT01416987|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22436510|NCT01274429|University of North Carolina at Chapel Hill|Dr. Edwin Kim, Director of the UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
22436511|NCT01439373|GlaxoSmithKline|GSK Response Center|866-435-7343||
22436512|NCT00007644|Minneapolis VA Medical Center|Timothy Wilt, MD|612-467-2158|timothy.wilt@va.gov|
22436513|NCT04576897|Indiana University|Samer Gawrieh|317-278-9326|sgawrieh@iu.edu|
22395856|NCT02322229|Alcon, A Novartis Division|Worldwide Medical Affairs Director, GMA Retina Lucentis|1-888-451-3937|alcon.medinfo@alcon.com|
22411282|NCT03412019|Tufts Medical Center|Dan Drzymalski, MD|617 636 4526|ddrzymalski@tuftsmedicalcenter.org|
22395857|NCT03065023|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22436514|NCT00574548|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22395858|NCT00705432|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22395859|NCT00521053|Provectus Biopharmaceuticals, Inc.|Eric Wachter, Chief Technology Officer|1-865-769-4011|wachter@pvct.com|23
22395860|NCT01667107|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22395861|NCT01557348|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22395862|NCT03427125|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
22395863|NCT02281357|AstraZeneca|Global Clinical Lead|+1 301-398-0582|ClinicalTrialTransparency@astrazeneca.com|
22395864|NCT01162239|University of California, San Francisco|Dr. Gary Humfleet, PhD|(415) 476-7674|Gary.Humfleet@ucsf.edu|
22395865|NCT06132425|University of California, Los Angeles|Nora Barnes-Horowitz|(310) 825-2961|nbarneshorowitz@ucla.edu|
22395866|NCT03454308|Medical University of South Carolina|Dr. Jessica Chandler|843-792-1928|chandlje@musc.edu|
22395867|NCT04448756|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22395868|NCT02733185|Mount Sinai Medical Center of Florida|Dr. Gervasio Lamas|305-674-2162|Gervasio.Lamas@msmc.com|
22395869|NCT05315947|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22395870|NCT02767128|Rockwell Medical, Inc|Clinical Project Manager|248-960-9009|sgrimberg@rockwellmed.com|
22395871|NCT02499770|G1 Therapeutics|Chandra Lovejoy|001 9192991250|clovejoy@g1therapeutics.com|
22395872|NCT00823303|Washington University School of Medicine|Dr. Daniel W. Coyne|3143627211|dcoyne@dom.wustl.edu|
22395873|NCT02129205|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22436515|NCT02593318|University of Kansas Medical Center|Russell H. Swerdlow, MD|9135885000|rswerdlow@kumc.edu|
22436516|NCT03109184|NORTHEASTERN UNIVERSITY|DR. CHRISTIE RIZZO|(617) 373-2486|C.RIZZO@NORTHEASTERN.EDU|
22436517|NCT02315560|University of Pittsburgh|Dr. Heidi Stephany|412-692-7932|heidi.stephany@chp.edu|
22436518|NCT04599465|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22436519|NCT04566601|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22436520|NCT02522325|University of Kentucky|William W. Stoops|859-257-5388|william.stoops@uky.edu|
22436521|NCT01209078|GlaxoSmithKline|GSK Response Center|866-435-7343||
22436522|NCT04996251|Northwell Health (previously) now at Advocate Aurora Health|Dr. Vini Chopra Konowitz|859-905-8782|vinichopra924@gmail.com|
22436523|NCT02146001|University of Pittsburgh|Dr. Bethany Barone Gibbs|412-383-4002|bbarone@pitt.edu|
22436524|NCT02702180|Savara Inc|Raymond D. Pratt, MD, PACP - Chief Medical Officer|+1 512 784 8757|ray.pratt@savarapharma.com|
22436525|NCT00785980|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22436526|NCT03603106|Guerbet|Jing Hao, MD|+33 (0) 1 45 91 50 00|jing.hao@guerbet.com|
22436527|NCT00793169|Northwestern University|Murad Alam, MD|312-695-6785|m-alam@northwestern.edu|
22436528|NCT00448747|Aeterna Zentaris|Nicola Ammer|+496942602|nammer@aezsinc.com|3472
22436529|NCT00387725|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22436530|NCT00568126|Depression Clinical and Research Program, Massachusetts General Hospital|Dr. David Mischoulon, Director|617-724-5198|dmischoulon@partners.org|
22436531|NCT02241343|Imperial College London|Miss Kate Williams||k.williams@imperial.ac.uk|
22436532|NCT04680975|Sanofi (Kadmon, a Sanofi Company)|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22436533|NCT04724967|University of Miami|Robert Kirsner|305-689-2646|rkirsner@med.miami.edu|
22436534|NCT02429791|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22436535|NCT02615691|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22436536|NCT04201093|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22436537|NCT00881504|Georgetown University Medical Center|Dr. John L Marshall|202-444-7064|marshalj@georgetown.edu|
22436538|NCT01276223|Alcon Research|Director of Alcon Clinical|1-888-451-3937||
22436539|NCT02017522|University of Michigan|Venkatesh Murthy, MD||vlmurthy@umich.edu|
22436540|NCT02596230|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22436541|NCT00771615|GlaxoSmithKline|GSK Response Center|866-435-7343||
22436542|NCT01854268|University of Florida|Alexandra E. Brandimore, M.A. CCC/SLP|352-273-3711|aessman@ufl.edu|
22436543|NCT02704689|Stryker|Jennifer Warnke|(201) 749-8000|jennifer.warnke@stryker.com|
22436544|NCT00802893|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
22436545|NCT00320424|GlaxoSmithKline|GSK Response Center|866-435-7343||
22436546|NCT03123328|Masimo Corporation|Director, Clinical Research|949-297-7416|clinicalresearchdept@masimo.com|
22436547|NCT02540668|Eli Lilly and Company|Chief Medical Officer|800-545-5079||
22436548|NCT03270891|University of Michigan|Laurie Buis|734-998-5694|buisl@med.umich.edu|
22436549|NCT00849108|Lantheus Medical Imaging|Cesare Orlandi, MD, Chief Medical Officer|978-671-8686|cesare.orlandi@lantheus.com|
22395874|NCT02877927|Paratek Pharmaceuticals, Inc.|Dr. Paul McGovern; Vice President, Clinical Affairs|484-751-4935|Paul.Mcgovern@paratekpharma.com|
22436550|NCT02211313|Washington University School of Medicine|Alana Desai, M.D.|(314) 362-7581|desaia@wustl.edu|
22436551|NCT01943552|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22436552|NCT01475162|Medical College of Wisconsin|William R. Drobyski|414-456-4941|wdrobysk@mcw.edu|
22436553|NCT00545103|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22436554|NCT05026853|University of Michigan|Dr. Dinesh Khanna|734-763-7182|khannad@med.umich.edu|
22395875|NCT00708175|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22395876|NCT02204566|Massachusetts General Hospital|Dr. Gary Tearney, PI|617-724-2979|GTEARNEY@PARTNERS.ORG|
22395877|NCT01093326|Actelion Pharmaceuticals Ltd|Director Clinical Leader Neuroscience|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22395878|NCT04435782|Actelion Pharmaceuticals Ltd|Study Responsible Scientist|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22395879|NCT03672461|University of California, San Francisco|Alison Huang, MD|415-353-7900|Alison.Huang@ucsf.edu|
22395880|NCT04225806|InterVene, Inc|Clinical Affairs|6509957137|ClinSupport@intervene-med.com|
22395881|NCT00315939|University of Virginia|Boris Kovatchev, PhD|434-924-5592|bpk2u@virginia.edu|
22395882|NCT07052682|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22395883|NCT04667247|Krupp Center for Integrative Research, University of California San Diego|Gordon Saxe, M.D./Ph.D.|6195435765|gsaxe@health.ucsd.edu|
22395884|NCT05460273|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22395885|NCT04124614|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22395886|NCT05749952|University of Pittsburgh|Sashwati Roy|412 624 0422|sasr453@pitt.edu|
22436555|NCT02358044|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22436556|NCT01732913|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22436557|NCT00903331|Actelion Pharmaceuticals Ltd|Parisa Danaietash||parisa.danaietash@actelion.com|
22436558|NCT02723175|Medical University of South Carolina|Jeffrey Borckardt|843-792-3295|borckard@musc.edu|
22436559|NCT03233438|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
22436560|NCT04596085|Natural Supplements LLC|Dr. Mahir Abduldaim|+966557880299|maherdaim@yahoo.com|
22436561|NCT02219503|AbbVie|Global Medical Services|800-633-9110||
22436562|NCT03249103|Aptinyx|Aptinyx Clinical Development|847-871-0377|clinicalstudies@aptinyx.com|1
22436563|NCT00257660|Ipsen|Senior Director, Medical Development, Neurology||clinical.trials@ipsen.com|
22436564|NCT04109976|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
22436565|NCT00491608|ZymoGenetics, a Bristol-Myers Squibb company|John Pribble, Vice President, Medical Affairs; Scot Maxon, Scientific Information|(206) 428-2756; (206) 434-3365|John.Pribble@bms.com; Scot.Maxon@bms.com|
22436566|NCT04897607|Christiana Care Health System|Dr. Scott Siegel|302-623-4500|ssiegel@christianacare.org|
22436567|NCT03781791|Enterin|Richard Larson, MD Chief Medical Officer|505-469-2670|r.larson@enterininc.com|
22436568|NCT02025439|Edward Hines VA Hospital|Theresa Bender-Pape|708-202-4953|Theresa.BenderPape@va.gov|
22436569|NCT00413374|Brigham and Women's Hospital|Research Coordinator|617-732-6984|arao2@partners.org|
22436570|NCT00552760|Lehigh Valley Hospital|Edward R. Norris, MD|(610) 402-5766|Edward.Norris@lvh.com|
22436571|NCT01944345|Wenzel Spine, Inc.|Director, Quality & Regulatory Affairs|5123148271|bnowatzke@wenzelspine.com|
22436572|NCT03615066|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22436573|NCT04079881|Wash Univ School of Medicine|Janet McGill, MD|(314) 362-8681|jmcgill@wustl.edu|
22436574|NCT00924404|University of Iowa|Lakshmi Durairaj|319-353-7968|lakshmi-durairaj@uiowa.edu|
22436575|NCT03831945|National Institute of Allergy and Infectious Diseases|Sneller, Michael|+1 301 496 0491|MSNELLER@niaid.nih.gov|
22436576|NCT03426631|Brigham and Women's Hospital|Luigi Taranto Montemurro, MD|6177326541|ltarantomontemurro@bwh.harvard.edu|
22436577|NCT04032080|Baylor Scott & White Health|Joyce O'Shaughnessy, MD|214-818-8472|joyce.oshaughnessy@usoncology.com|
22436578|NCT00500760|Amgen Inc.|Study Director|866-572-6436||
22436579|NCT01325714|Houston Center for Innovations in Quality, Effectiveness, and Safety|Mark Kunik, MD, MPH|713-794-8639|kunik.marke@va.gov|
22436580|NCT00721175|Khon Kaen University|Assist. Prof. Apichat Sangchan|66850004651|apichaz@yahoo.com|
22436581|NCT03691779|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22436582|NCT00521222|Columbia University Irving Medical Center|Marjorie Slankard, MD|212-326-8410|ms53@columbia.edu|
22436583|NCT03869333|PATH|Rahsan Erdem|+1 202 540 4546|rerdem@path.org|
22436584|NCT01927055|H. Lundbeck A/S|Study director||LundbeckClinicalTrials@Lundbeck.com|
22436585|NCT00649428|CBR International Corp.|Kevin Hennegan|720-746-1190|khennegan@cbrintl.com|
22436586|NCT01237613|Orthopedic Foot and Ankle Center|Terrence M. Philbin, DO|614-895-8747|ofacresearch@orthofootankle.com|111
22436587|NCT02503501|HealthPartners Neuroscience Research|Clinical Research Manager|651-495-6363|aleta.l.svitak@healthpartners.com|
22436588|NCT01740401|Icahn School of Medicine at Mount Sinai|Dr. Nina Bhardwaj|212-824-8427|nina.bhardwaj@mssm.edu|
22436589|NCT02008227|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22436590|NCT00757822|Central Arkansas Veterans Healthcare System|Dr. Muhammad Jaffar|501-688-9310|Muhammad.Jaffar@va.gov|
22436591|NCT03858530|Children's Mercy Kansas City|Dr. Sherwin Chan|816-234-3273|sschan@cmh.edu|
22436592|NCT01463072|City of Hope|Dr. Mina Sedrak|626-359-8111|msedrak@coh.org|
22436593|NCT05856227|Basilea Pharmaceutica International Ltd, Allschwil|Marc Engelhardt, MD, Study Director|+41 79 701 0551|marc.engelhardt@basilea.com|
22436594|NCT01571232|Retina Macula Institute|Ron P. Gallemore M.D., Ph.D.|310-944-9393|rongallemoremd@gmail.com|
22436595|NCT06225466|University of Texas Southwestern Medical Center|Dr. Proshad Efune|2144566393|proshad.efune@utsouthwestern.edu|
22436596|NCT04394715|Yale University|Nihar Desai|203-767-6399|nihar.desai@yale.edu|
22395887|NCT00311376|Allergan, Inc.|Therapeutic area Head|714-246-4500|clinicaltrials@allergan.com|
22395888|NCT00257166|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22436597|NCT02294734|GlaxoSmithKline|GSK Response Center|866-435-7343||
22436598|NCT00548717|Dana Farber Cancer Institute|Dr. Corey Cutler|617-632-3470|Corey_Cutler@dfci.harvard.edu|
22436599|NCT03157583|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22436600|NCT01722435|Centre for Interdisciplinary Addiction research of Hamburg University ZIS|Prof. Dr. Jens reimer|+4940741057900|reimer@uke.de|
22436601|NCT00908037|GlaxoSmithKline|GSK Response Center|866-435-7343||
22436602|NCT01953913|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22436603|NCT02925741|Cleveland Clinic|Mary Montague|216-444-1878|montagm@ccf.org|
22436604|NCT00494507|University of Rochester|Robert Griggs, MD|585-275-3707|robert_griggs@urmc.rochester.edu|
22436605|NCT04882787|Sonova|Jinyu Qian, Director Innovation Centre Toronto|905-677-1167|jinyu.qian@sonova.com|5873
22436606|NCT02437084|Stanford University School of Medicine|Dr Joshua W. Knowles, MD, PhD; Assistant Professor, Cardiovascular Medicine|650-723-1431|knowlej@stanford.edu|
22436607|NCT00454181|Amarillo Biosciences, Inc.|Martin J. Cummins|806-376-1741|mcummins@amarbio.com|14
22436608|NCT02613169|University of Washington|Dr. Sylvia M. LaCourse|206-616-5978|sylvial2@uw.edu|
22436609|NCT03729245|Nektar Therapeutics|Study Director|4154825300|StudyInquiry@nektar.com|
22436610|NCT02096263|GlaxoSmithKline|GSK Response Center|866-435-7343||
22436611|NCT01407523|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22436612|NCT01571453|Study Director|Email contact via H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
22436613|NCT04971941|Harvard School of Dental Medicine|Dr. Jeffry R Shaefer|(781) 718-6793|jeffry_shaefer@hms.harvard.edu|
22436614|NCT02976103|Dana-Farber Cancer Institute|Donna Berry, PhD, RN|617-632-1909|donna_berry@dfci.harvard.edu|
22436615|NCT01985360|NYU Langone Health|Sripal Bangalore|(212) 263 3540|Sripal.Bangalore@nyulangone.org|
22436616|NCT00694304|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
22395889|NCT02592551|Baylor College of Medicine|Bryan Burt, MD|713-798-6376|burt@bcm.edu|
22395890|NCT00761306|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
22436617|NCT00509171|London Health Sciences Centre|Emil H. Schemitsch, MD, FRCS|5196633349|emil.schemistch@lhsc.on.ca|
22436618|NCT04040621|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22436619|NCT00845065|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22436620|NCT00181610|Massachusetts General Hospital|Corrine Welt, MD|617-726-8437|cwelt@partners.org|
22436621|NCT02228096|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22436622|NCT02383433|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Davendra Sohal|+1 216-444-8258|sohald@ccf.org|
22436623|NCT02208349|St Vincent Hospital|Jestin Carlson|8144525000|jcarlson@svhs.org|
22436624|NCT00952614|Duke University Medical Center|Glenn J. Jaffe, MD|919-684-4458|jaffe001@mc.duke.edu|
22436625|NCT00569868|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|5015266990|pettynathanm@uams.edu|2461
22395891|NCT05162027|University of Maryland, School of Dentistry|Dr. Marcela Romero Reyes|4107067168|mromero@umaryland.edu|
22395892|NCT00483561|University of Nebraska Medical Center|Ralph Hauke, MD|402-354-8124|rhauke@nebraskacancer.com|
22395893|NCT00993954|University of Alberta|Dr Andrew Dixon|780-492-3553|andrew.dixon@albertahealthservices.ca|
22395894|NCT04415658|Washington University in St. Louis School of Medicine|Dr. Rajat Dhar|3143622999|dharr@wustl.edu|
22395895|NCT01025492|University of Utah|Scott Low|801-585-1380|scott.low@hsc.utah.edu|
22395896|NCT00916539|Massachusetts General Hospital|Taylor Pong, Research Coordinator|617-726-1569|tpong1@partners.org|
22395897|NCT00907257|Valeant Pharmaceuticals International, Inc|David Lineberry|949-973-1153|David.Lineberry@valeant.com|
22395898|NCT04296877|The Ohio State University College of Optometry|Jennifer Fogt|16142928858|OPT-EyeStudies@osu.edu|
22395899|NCT01873417|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
22395900|NCT00785044|GE Healthcare|Jose M Zubeldia, M.D.|011-44-1494-543137|jose.zubeldia@ge.com|
22395901|NCT01628107|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22395902|NCT01069120|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
22395903|NCT00763971|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22395904|NCT02713542|Arthrex|Clinical Affairs Manager|2395984302|INC_ClinicalResearch@arthrex.com|
22395905|NCT03631667|Oregon State University|David E. Williams, PhD|541-737-3277|david.williams@oregonstate.edu|
22395906|NCT01540825|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22395907|NCT00884325|DermResearch, PLLC|Leon H. Kircik, M.D.|502-451-9000|wedoderm@yahoo.com|
22395908|NCT01446016|Houston Methodist|Dr. Jenny Chang|713-441-0681|jcchang@houstonmethodist.org|
22395909|NCT02525055|hVIVO Services Limeted|Dr Nicolas Noulin|+442077561365|n.noulin@hvivo.com|
22436626|NCT02963701|Boehringer Ingelheim|Boehringer Ingelheim Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22436627|NCT01345682|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22436628|NCT00896649|Boston Medical Center|Gustavo Mercier, House Radiologist|617-638-6610|gustavo.mercier@bmc.org|
22436629|NCT01181258|Masonic Cancer Center, University of Minnesota|Dr. Veronika Bachanova|612-625-5469|bach0173@umn.edu|
22436630|NCT01075984|Merck Sharp & Dohme Corp.|Senior Vice President, Global Cllinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22436631|NCT03652675|Columbia University / New York State Psychiatric Institute|Jennifer C Elliott, PhD|646 774 7953|jce2130@cumc.columbia.edu|
22436632|NCT03101085|University of Kansas Medical Center|Dr. Russell Swerdlow|913-588-0970|rswerdlow@kumc.edu|
22436633|NCT01154751|Abbott Vascular|Margo Zaugg|408-845-0576|margo.zaugg@av.abbott.com|
22436634|NCT02986854|GlaxoSmithKline|GSK Response Center|866-435-7343|mb116236@gsk.com|
22436635|NCT00375167|Queens University|Dr. Terry Krupa|613-533-6236|terry.krupa@queensu.ca|
22436636|NCT01895309|Samsung Bioepis|Director, Clinical Development|+82 31 8061 4534||
22436637|NCT02454153|Johns Hopkins University|Naresh M. Punjabi|410-550-6487|npunjabi@jhmi.edu|
22436638|NCT01555125|Novartis Pharmaceutical|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
22436639|NCT04836247|University of Delaware|Valerie Earnshaw|302-831-4772|earnshaw@udel.edu|
22436640|NCT02039856|VA Greater Los Angeles Healthcare System|Elizabeth M. Yano, PhD, MSPH|(818) 891-7711|elizabeth.yano@va.gov|36031
22436641|NCT01441466|Princess Amlia Children's Clinic, Isala|Jolita Bekhof|+31384245050|j.bekhof@isala.nl|
22436642|NCT02048371|SARC|SARC|734-930-7600|sarc@sarctrials.org|
22436643|NCT01174173|Northwestern University|Sanjiv J. Shah, MD|3129262926|sanjiv.shah@northwestern.edu|
22436644|NCT00602420|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu|
22436645|NCT01735981|The Ohio State University|Anne Kloos|614-688-5942|kloos.4@osu.edu|
22436646|NCT00592124|Johns Hopkins University|Craig W. Hendrix, MD|1 410 955-9707|chendrix@jhmi.edu|
22436647|NCT02885246|GlaxoSmithKline|GSK Response Center|866-435-7343|gskclinicalhd@gsk.com|
22436648|NCT00575965|Dana Farber Cancer Institute|Steven P. Treon MD, PhD|617 632 5880|steven_treon@dfci.harvard.edu|
22436649|NCT03335774|Nivagen Pharmaceuticals|Dr Vishal S Narang|+919820020278|vnarang@nivagen.com|
22436650|NCT03828331|VA Eastern Colorado Healthcare System|Dr. Alena Grabowski|303-492-5208|alena.grabowski@va.gov|
22395910|NCT00436618|Mayo Clinic|Thomas E. Witzig M.D.|(507) 284-0527|witzig.thomas@mayo.edu|
22436651|NCT00746863|UNC Hospitals|Gena Dunivan, MD|919-966-4717|gdunivan@med.unc.edu|
22436652|NCT05126836|University of Minnesota|Dr. Markus Meyer|612.625-9538|meye3249@umn.edu|
22436653|NCT03775512|Biosense Webster, Inc.|Franchise Medical Manager|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22436654|NCT00082407|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22436655|NCT03464019|Milestone Pharmaceuticals Inc.|Cameron Szakacs_PhD_VP Drug Development|1 704-594-4102|cszakacs@milestonepharma.com|
22436656|NCT00767806|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22436657|NCT02489942|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0217|clintriage.rdg@boehringer-ingelheim.com|
22436658|NCT00858208|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22436659|NCT01272635|Penn State University|David Mauger|717-531-7178|dtm5@psu.edu|
22436660|NCT01543776|University of Chicago|Theodore Karrison|773-702-9326|tkarrison@health.bsd.uchicago.edu|
22436661|NCT00306527|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22436662|NCT00567359|Massachusetts General Hospital|Lecia Van Dam Sequist, M.D.|617-724-4000|LVSEQUIST@PARTNERS.ORG|
22436663|NCT00539305|University of Washington|Monique Cherrier PhD.|206-277-3594|cherrier@u.washington.edu|
22436664|NCT02870101|UCLA David Geffen School of Medicine and Fielding School of Public Health|Jeffrey D. Klausner, MD, MPH|310-557-2273|JDKlausner@mednet.ucla.edu|
22436665|NCT00126776|Minneapolis VAMC|Kathryn Rice MD|612 725 2000|kathryn.rice@va.gov|4400
22436666|NCT02893917|Yale School of Medicine: Medical Oncology|Joseph Kim, MD|(203) 200-4822|joseph.w.kim@yale.edu|
22436667|NCT01815840|Hoffmann-La Roche|Medical Communications|800 821-8590||
22436668|NCT01055314|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22436669|NCT04395690|Aula Dental Avanzada|G. Esteve-Pardo|965215755|guillem@clinicaesteve.com|
22436670|NCT00434642|Hoffman-LaRoche|Medical Communications|800-821-8590||
22436671|NCT04120363|Pennington Biomedical Research Center|Jennifer C Rood, PhD|225-763-2524|jennifer.rood@pbrc.edu|
22436672|NCT00753454|UCB Clinical Trial Call Center|UCB (Study Director)|1-887-822-9493||
22436673|NCT03909152|Memorial Sloan Kettering Cancer Center|Dr. Rachel Grisham, MD|646-888-4653|grishamr@mskcc.org|
22436674|NCT05011058|Viracta Therapeutics|Dr. Darrel Cohen|858-400-8470|ClinicalTrials@Viracta.com|
22436675|NCT01272869|Coloplast A/S|Director Medical Affairs|4549111111|dkbir@coloplast.com|
22436676|NCT02271945|MedImmune, LLC|Mohammed Dar|301-398-4095|information.center@astrazeneca.com|
22436677|NCT02455076|Emory University|Guillermo Umpierrez|(404)778-1665|geumpie@emory.edu|
22436678|NCT00687102|Wake Forest University Health Sciences|Sally A. Shumaker, PhD|336-71696934|sshumake@wakehealth.edu|
22436679|NCT00663403|University of Michigan College of Pharmacy|Bruce A. Mueller|7347636629|muellerb@umich.edu|
22436680|NCT00719680|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22436681|NCT03445559|VA New York Harbor Healthcare System|Dr. Danil V. Makarov|212-686-7500|Danil.Makarov@Va.gov|
22436682|NCT02466009|University of Rochester|Aram Hezel|585-275-5823|Aram_Hezel@urmc.rochester.edu|
22436683|NCT04676867|DalCor Pharmaceuticals|David Kallend|+1 514-508-5099|dkallend@dalcorpharma.com|
22436684|NCT01395277|University of Texas at Austin|Dr. R. Matthew Brothers|512-232-6016|r.m.brothers@austin.utexas.edu|
22436685|NCT05375214|Johns Hopkins University|Kevin Li|443-475-0671|kevinli@jhmi.edu|
22436686|NCT01141478|Loma Linda University Medical Center|Diane Scavone, research coordinator|909 558-3636|dscavone@llu.edu|33670
22436687|NCT03096873|The University of Nebraska at Omaha|Dr. Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
22436688|NCT02411929|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22436689|NCT00628147|SF VA Medical Center|Dr. Tonya Kaltenbach|415-221-4810|tonya.kaltenbach@va.gov|24103
22436690|NCT00551291|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22436691|NCT02636712|Zhongshan Hospital|Dr Yangang Su|+86 13788905096|suyangang111@163.com|
22436692|NCT01581619|Massachusetts General Hospital|Alphonse Taghian, MD, PhD|617-726-7559|ATAGHIAN@mgh.harvard.edu|
22436693|NCT04268173|University of Wisconsin-Madison|Dr. Ryan Westergaard|(608) 265-7927|rpw@medicine.wisc.edu|
22436694|NCT01375608|NIH, NHLBI, MCHB|Dr Matthew Hsieh|301-402-7687|matthewhs@nhlbi.nih.gov|
22436695|NCT01463202|Center for Family Planning Research|Principal Investigator|412-641-5496|fpr@upmc.edu|
22436696|NCT02825212|Icahn School of Medicine at Mount Sinai|Dr. Peter D. Gorevic|212-241-0968|peter.gorevic@mountsinai.org|
22436697|NCT03836677|AstraZeneca AB|AstraZeneca AB|1-877-240-9479|information.center@astrazeneca.com|
22436698|NCT00906958|ResMed Ltd|Alison Wimms|+44 7901332675|alison.wimms@resmed.com|
22436699|NCT03098745|CooperVision Inc.|Dr.Jose A.Vega O.D., MSc., FAAO|9256213761|javega@coopervision.com|
22436700|NCT00710385|Substance Abuse|Sandra D. Comer|646-774-6146|sdc10@columbia.edu|
22436701|NCT00079677|Cephalon|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
22436702|NCT04598269|Aclaris Therapeutics, Inc.|Clinical Operations|1-833-225-2747|clinicaloperations@aclaristx.com|
22436703|NCT00424190|Cerexa|Vice President, Clinical Sciences|(510) 285-9200|clinicaltrials@cerexa.com|
22436704|NCT03040986|National Cancer Institute|Dr. Udo Rudloff|240-760-6238|udo.rudloff@nih.gov|
22436705|NCT02925728|Centre Hospitalier Départemental Vendée|Sylvie VERBRUGGHE|0251446161|sylvie.verbrugghe@ght85.fr|
22436706|NCT04042727|Stony Brook University|Andreas KAlogeropoulos|4045124463|Andreas.Kalogeropoulos@stonybrookmedicine.edu|
22436707|NCT02102399|Federal University of Bahia|Lilian Paternostro|+55 (71) 8191-9730|lilian_fono@hotmail.com|
22436708|NCT00491374|Schering-Plough|Head, Clinical Trials Registry & Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com|
22395911|NCT00698204|University of Connecticut Health Center|Dr. Rajesh V. Lalla|860-679-8007|lalla@uchc.edu|
22436709|NCT02539511|New York State Psychiatric Institute|Elias Dakwar, MD|6467748728|elias.dakwar@nyspi.columbia.edu|
22436710|NCT03385330|Children's Hospital of Philadelphia|Dr. Sara DeMauro|445-225-6400|demauro@chop.edu|
22436711|NCT00086411|University of Pennsylvania|Peter Gariti, Ph.D.|215-222-3200|gar1iti@mail.med.upenn.edu|0
22436712|NCT02530996|Salt Lake VAMC and University of Utah|Dr. Tracy Frech|801 213 2312|tracy.frech@hsc.utah.edu|
22436713|NCT00695864|Stanford University|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@pain.stanford.edu|
22436714|NCT04484207|New York State Psychiatric Institute|Yuval Y. Neria|646-774-8092|ny126@cumc.columbia.edu|
22436715|NCT01624090|National Cancer Institute|Dr. David S. Schrump|240-858-7000|schrumpd@nih.gov|
22436716|NCT00752726|GlaxoSmithKline|GSK Response Center|866-435-7343||
22436717|NCT01403116|Clarus Therapeutics|Theodore Danoff, MD, PhD|847-562-4300|tdanoff@clarustherapeutics.com|
22436718|NCT00042666|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22436719|NCT04232215|Mayo Clinic|Yvonne S. Butler Tobah, M.D.|507-284-0210|ButlerTobah.Yvonne@mayo.edu|
22436720|NCT04268745|New York University|Dr. Anat Lubetzky|2129989195|anat@nyu.edu|
22436721|NCT01086852|Bio Products Laboratory|Miranda Norton|020 8 957 2661|miranda.norton@bpl.co.uk|
22436722|NCT05327361|University of Miami|Enzo Berardesca|3052434472|exb743@med.miami.edu|
22436723|NCT00626405|Mayo Clinic|Svetomir Markovic, M.D., Ph.D.|5072840527|markovic.svetomir@mayo.edu|
22436724|NCT02147769|Stanford University|Valerie Chock, MD|650-723-5711|vchock@stanford.edu|
22436725|NCT01962870|Stanford University|Antonio Hardan, MD|(650) 736-1235|hardanay@stanford.edu|
22436726|NCT02227667|Memorial Sloan Kettering Cancer Center|Dr. Neil Segal, MD, PhD|646-888-4187|segaln@mskcc.org|
22436727|NCT01593592|Tropical Medicine Departement, Faculty of Medicine, Zagazig University, Egypt|Dr Mohamed Emara|+2 0100 272 4482|emara_20007@yahoo.com|
22436728|NCT03047031|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22436729|NCT01041287|Emory University|Dr. Arshed Quyyumi|404-727-3655|aquyyum@emory.edu|
22436730|NCT01721226|George Washington University|Dr. Irene Kuo|202-994-0367|ikuo@gwu.edu|
22436731|NCT01971008|Innsbruck Medical University|Prof. Dr. Klaus Seppi|004351250481498|klaus.seppi@tirol-kliniken.at|
22436732|NCT03416127|INSTITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
22436733|NCT02629822|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22436734|NCT01610336|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22436735|NCT00856726|University of Alabama at Birmingham|Orlando Gutierrez|205-996-2736|ogutierrez@uabmc.edu|
22436736|NCT02397057|American Regent, Inc|Mark A. Falone, MD MPH|6317723544|mfalone@americanregent.com|61844
22436737|NCT02352753|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22436738|NCT03267888|Emory University|Mohammad K Khan|404-778-3473|m.k.khan@emory.edu|
22436739|NCT00679172|Emergent Product Development Gaithersburg|Dr. Tim Babinchak|(240) 631-3585||
22436740|NCT00417963|C.R. Bard Inc.|Director of Clinical Affairs|480-303-2644|john.reviere@crbard.com|2644
22436741|NCT00901199|Children's Hospital & Research Center at Oakland|Ashutosh Lal, MD|510-428-3172|ashutosh.lal@ucsf.edu|
22436742|NCT00704288|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
22436743|NCT00414518|University of Colorado Denver|Michelle A. Barron|303-724-4939|michelle.barron@ucdenver.edu|
22436744|NCT03927144|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22436745|NCT05346653|University of Chicago|Sr. Compliance Specialist|773-702-6505|czwieg@bsd.uchicago.edu|
22436746|NCT00615030|Novartis Pharmaceuticals|Study Director|862-778-8300||
22436747|NCT03433417|Cutera, Inc.|Margot Doucette|(415) 657-5518|mdoucette@cutera.com|
22436748|NCT04532931|Shin Poong Pharm. Co., Ltd.|Shin Poong Pharm. Co., Ltd.|82-2-2189-3478|bwon@shinpoong.co.kr|
22436749|NCT02917733|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22436750|NCT03781505|Aga Khan University|Dr. Muhammad Saad Yousuf|+92213486|saad.yousuf@aku.edu|4253
22436751|NCT00581867|University of Kansas Medical Center|Dr. Jeffrey Burns|(913) 588-0555|jburns2@kumc.edu|
22436752|NCT00308074|University of Massachusetts Medical School|Dr. Jean A. Frazier|508-856-5896|ChildResearch@umassmed.edu|
22436753|NCT03002311|WASHINGTON UNIVERSITY MEDICAL SCHOOL|Brian F. Gage, MD|3144548697|bgage@wustl.edu|
22436754|NCT02092311|OMID FERTILITY CENTER|Dr.Navid Pooyan|00989124474032|navidpooyan@yahoo.com|
22436755|NCT03908476|Abbott|Marie Fahey|+15122864398|Marie.fahey@abbott.com|
22436756|NCT05194267|UCSD|Jean-Phillipe Miron|514-890-8000|jmiron@health.ucsd.edu|26489
22436757|NCT00652080|Berg LLC|Nathaniel DiTommaso|617-588-1002|nate.ditommaso@berghealth.com|
22436758|NCT01329939|North Shore - Long Island Jewish Health System; Hofstra North Shore-LIJ School of Medicine|Dr. Sherry Farzan, Attending Physician, Assistant Professor of Medicine and Pediatrics|5166225070|sfarzan@nshs.edu|
22436759|NCT03722524|AO Servier|Natalya LOGUNOVA|+7 495 9370700|Natalya.LOGUNOVA@servier.com|
22436760|NCT02868229|Novo Nordisk A/S|Clinical Transparency and Medical Writing Office|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22436761|NCT00687674|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
22436762|NCT06151288|Vaxcyte, Inc.|Study Director: Clinical Development|650-585-0029|clinicaltrialsgov@vaxcyte.com|
22436763|NCT04369950|The University of Texas Health Science Center at Houston|Linden Lee, MD, Assistant Professor|(713) 500-6200|Linden.O.Lee@uth.tmc.edu|
22436764|NCT00989963|Lung Biotechnology PBC|Lung Biotechnology PBC Study Director||info@lungbiotechnology.com|
22436765|NCT02408263|HSS|Dr. Gungor|212.606.1206|GungorS@hss.edu|
22395912|NCT01949155|Otonomy, Inc.|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
22395913|NCT00314249|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|Robert Palmer, MD|1-201-427-8218|robert.palmer@frx.com|
22395914|NCT02448225|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
22395915|NCT00789750|Daiichi Sankyo, Inc.|Global Clinical Leader|9089926400||
22395916|NCT01287364|Sunovion|Respiratory Medical Director|1-866-503-6351||
22395917|NCT04234672|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22395918|NCT00713479|University of California, Los Angeles|Dr Edythe London|(310) 825-0606|elondon@mednet.ucla.edu|
22395919|NCT00113230|UT MD Anderson Cancer Center|Christopher H. Crane, MD / Associate Professor|713-792-2933||
22395920|NCT05372653|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81363617366|CL_OPCJ_RDA_Team@otsuka.jp|
22395921|NCT00711529|Stanford Hospital|Shannon MacLaughlan, MD|650-724-0456|smaclaug@stanford.edu|
22395922|NCT03740997|GE HealthCare|David Thompson, MD, PhD|+44 7775 543206|david.thompson1@gehealthcare.com|
22395923|NCT00928174|The Queen's Medical Center|Sandi Kwee, Principal Investigator|808-691-5466|skwee@queens.org|
22395924|NCT04246801|Laboratorios Salvat, S.A|Medical Director|+34933946400|ejimenez@svt.com|
22395925|NCT02743351|Fate Therapeutics|Executive Director, Clinical Operations|858.875.1800|info@fatetherapeutics.com|
22395926|NCT03694613|Fundacion Santa Fe, Bogotá, Colombia|Dr. Sergio Lerma|+57 3017752726|serlerma@gmail.com|
22395927|NCT04207801|Aurigene Discovery Technologies Limited|Divyesh Mandavia|9427181182|divyesh_m@aurigene.com|
22395928|NCT02663271|University of Florida|David Tran, MD, PhD|352-273-9000|david.tran@neurosurgery.ufl.edu|
22395929|NCT01572675|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22395930|NCT00223678|Vanderbilt Medical Center|Dr. Anthony Langone|615-936-1179|anthony.langone@vanderbilt.edu|
22395931|NCT00460551|Genmab A/S|Eva Järlid Westerberg PhD|+45 7020 2728|E.Westerberg@genmab.com|
22395932|NCT00690235|University of Texas Southwestern Medical Center|Carol A. Tamminga, MD|214-645-2789|carol.tamminga@utsouthwestern.edu|
22395933|NCT02966223|Indiana University|Mark Tann, MD|317- 948-8782|matann@iupui.edu|
22395934|NCT01326728|National Cancer Institute|Dr. Ronald Gress|301-496-1791|gressr@mail.nih.gov|
22395935|NCT01184053|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22436766|NCT00612560|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22395936|NCT02939989|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22395937|NCT04399122|Joint Warfighter Refractive Surgery Center, Wilford Hall Ambulatory Surgical Center|Dr. Jose E. Capo-Aponte|(210) 292-2554|Jose.E.CapoAponte.ctr@mail.mil|
22395938|NCT03620019|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat Canter|(919) 962-0000|Melahat_Canter@med.unc.edu|
22395939|NCT01083628|University of California, Berkeley|Dr. Adrian Aguilera|510-642-8564|aguila@berkeley.edu|
22395940|NCT01174238|University of California, San Francisco|Adil Daud, MD|415-353-7392|adaud@medicine.ucsf.edu|
22395941|NCT01102803|Southern Methodist University|Dr. Jasper Smits|214-768-4125|jsmits@smu.edu|
22395942|NCT05390580|Washington University School of Medicine - Neurology Department|Dr. Osvaldo J. Laurido-Soto, PI|314-362-7382|ojlaurido-soto@wustl.edu|
22395943|NCT03747419|Dana-Farber Cancer Institute|Kent Mouw|6176325734|kent_mouw@dfci.harvard.edu|
22395944|NCT04376060|Saint Joseph University|Dr Sarah Khalil|0096170322739|sarahfkhalil2@gmail.com|
22395945|NCT04275297|Osher Center for Integrative Health|A. Gracie Kelly, MS, Research Assistant|6153431554|gracie.kelly@vumc.org|
22395946|NCT01791803|North Shore Medical Center|Dr. Faysal M. Hasan|978-741-1200|fhasan@partners.org|4901
22436767|NCT00759408|Brigham and Women's Hospital|Anju Nohria, MD|617-525-6852|ANOHRIA@PARTNERS.ORG|
22436768|NCT01240200|Emory University School of Medicine|Christopher Newton, MD|404-355-4393|cnewton@atlantadiabetes.com|
22436769|NCT00765570|Summa Health System|Tracy Mondello, MS|330-375-6131|mondellot@summahealth.org|
22436770|NCT02251938|Santen Inc|R&D Quality Manager|+1 415 268 9199|evelyn.chikere@santen.com|
22436771|NCT04071158|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22436772|NCT01178099|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22436773|NCT02473367|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22436774|NCT06328660|CooperVision Inc.|José A. Vega|+1 (925) 621-3761|JVega2@coopervision.com|
22436775|NCT03194438|State University of New York at Buffalo School of Nursing|Tania Von Visger, APRN, PhD, PCCN|7168292201|Taniavon@buffalo.edu|
22436776|NCT01286740|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22436777|NCT01646203|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22436778|NCT01557959|Wake Forest Baptist Health|Dr. William J. Petty|336-716-3313|wpetty@wakehealth.edu|
22436779|NCT00997620|Westernsky|Lyndon E Mansfield, MD|915-544-2557|immunman@westernskymed.com|
22436780|NCT02903394|Duke University|Kengyeh Chu|919-681-2093|ken.chu@duke.edu|
22436781|NCT02717130|Thriving Mind South Florida|John W. Newcomer, M.D., President & CEO|305-860-0653|jnewcomer@thrivingmind.org|
22436782|NCT00549770|Novartis Pharmaceuticals|Study Director|862-778-8300||
22436783|NCT02435706|Columbia University College of Dental Medicine|Elena Sanz Miralles, DDS, PhD|212-342-3008|ecs2181@cumc.columbia.edu|
22436784|NCT00524017|SKCCC|Dr. Zubair Khan|4109553157|zkhan@jhmi.edu|
22436785|NCT02335424|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22436786|NCT02712424|Geisel School of Medicine|Dr C Fordham von Reyn|6036505000|fvr@dartmouth.edu|
22395947|NCT04572854|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
22436787|NCT05236712|Univcersity of Washington|Oleg Zaslavsky|2068493301|ozasl@uw.edu|
22395948|NCT04115878|University of Arizona|Daniel Combs, MD|520-626-7780|combs89@arizona.edu|
22436788|NCT02421601|Seikagaku Corporation|Clinical Development Department|(81)3-5220-8948|kyoichi.osano@seikagaku.co.jp|
22436789|NCT00290498|U.T. MD Anderson Cancer Center|Dr. Luis E. Fayad / Lymphoma/Myeloma|7137922860|lefayad@mdanderson.org|
22436790|NCT03222414|Vanderbilt University Medical Center|Laura Sorabella||laura.sorabella@vumc.org|
22436791|NCT00599638|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22436792|NCT03006887|Eisai, Inc.|Inquiry Service||eisai-chiken_hotline@hhc.eisai.co.jp|
22436793|NCT02895945|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22436794|NCT00462748|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22436795|NCT03429543|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
22436796|NCT01600092|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22436797|NCT01561963|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22436798|NCT04018313|Celltrion. Inc|Keumyoung Ahn/Head of Clinical Planning 2 Department|+82 32 850 4190|Keumyoung.ahn@celltrion.com|
22436799|NCT01548742|Minneapolis VA Medical Center|Kelvin O. Lim, MD (Principal Investigator)|612-467-3323|kolim@umn.edu|
22436800|NCT00637572|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22436801|NCT01887353|Intermountain Healthcare|T. Jared Bunch|8015074701|jared.bunch@imail.org|
22436802|NCT00896441|Stanford University|Mike Greicius|650-723-8331|greicius@stanford.edu|
22436803|NCT02423980|Xeris Pharmaceuticals, Inc.|Martin Cummins, VP Drug Development|512-498-2675|mcummins@xerispharma.com|
22436804|NCT04667104|Janssen Research & Development, LLC|Clinical Registry Group|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22436805|NCT02107157|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22436806|NCT01078168|Clinic of Psychiatry and Psychotherapy, University Medical Center JGU Mainz|Prof. Dr. Andreas Fellgiebel|+49-6131-17-7363|Andreas.Fellgiebel@unimedizin-mainz.de|
22436807|NCT05066165|Intellia Therapeutics|Trial Manager|833-888-0387|clinicalscience@intelliatx.com|
22436808|NCT03210961|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22436809|NCT02467582|SAKK|Regulatory affairs|+41 31 389 91 91|regulatory@sakk.ch|
22436810|NCT01370265|Mayo Clinic|Dr. Panithaya Chareonthaitawee|507-284-1648|chareonthaitawee.panithaya@mayo.edu|
22436811|NCT03343626|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22436812|NCT01178268|Abbott Vascular|Dana Haudek|928-925-4054|dana.haudek@av.abbott.com|
22436813|NCT05388617|Cynosure|Jamie Trimper|9782564200|jamie.trimper@cynosure.com|
22436814|NCT00301418|Feinstein Institute for Medical Research|John Boockvar, MD|212-434-3900|jboockvar@northwell.edu|
22436815|NCT03592368|University of Colorado, Anschutz Medical Campus|Joel Stoddard|(720) 777-5702|joel.stoddard@cuanschutz.edu|
22436816|NCT01107665|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
22436817|NCT00742417|Instituto Grifols S.A.|Mireia Torres|+34935710500|mireia.torres@grifols.com|12273
22436818|NCT00627367|Department of Emergency Medicine, Albert Einstein College of Medicine|Andrew Chang, MD, MS|718-920-7464|achang@montefiore.org|
22436819|NCT00258817|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22436820|NCT00965575|Cincinnti Childrens|Sejal Jain|513-636-4222|sejal.jain@cchmc.org|
22436821|NCT02814175|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22436822|NCT03121365|The Children's Hospital of Phiadelphia|Dr. James Guevara|215-590-1130|Guevara@email.chop.edu|
22436823|NCT04207749|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22436824|NCT00655629|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22436825|NCT00741013|Washington University School of Medicine|Delphine L. Chen|314-362-7029|chend@mir.wustl.edu|
22436826|NCT01754493|New York State Psychiatric Institute|Roberto Lewis-Fernandez|646-774-8102|rlewis@nyspi.columbia.edu|
22436827|NCT01425632|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22436828|NCT03461146|Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608 Japanese only|cti-inq-ml.JP@ml.tanabe-pharma.com|
22436829|NCT02140047|Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608|cti-inq-ml.JP@ml.tanabe-pharma.com|
22436830|NCT02702414|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22436831|NCT04541628|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22436832|NCT02781480|MeiraGTx|Chief Medical Officer|+1 973 609-2156|robert.zeldin@meiragtx.com|
22436833|NCT01452919|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22436834|NCT00859937|University of Chicago Comprehensive Cancer Center|Dr. Stuart Wong|773-702-9311|swong@mcw.edu|
22436835|NCT00151476|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22436836|NCT03446456|University of Maryland School of Nursing|Rachel Massalee|4107068244|rmassalee@umaryland.edu|
22436837|NCT00383942|Loyola University|Scott Graziano, M.D.|708-216-6288|sgrazia@lumc.edu|
22436838|NCT00065806|Duke University Medical Center|Laura Schanberg, MD|919-684-6575|laura.schanberg@duke.edu|
22436839|NCT00658814|SWOG|Study Statistician|206-667-4623||
22436840|NCT02703480|Tufts University School of Dental Medicine|Associate Professor|6176366659|yumi.ogata@tufts.edu|
22436841|NCT04816721|Enanta Pharmaceuticals, Inc.|Medical Monitor|+1 6176070800|enquiries@enanta.com|
22436842|NCT00455143|Icahn School of Medicine at Mount Sinai|Department of Anesthesiology|212-241-7473||
22436843|NCT02387294|Fluart Innovative Vaccines Ltd|Zsolt Németh|+3620|info@fluart.hu|4197020
22436844|NCT04856904|Galderma R&D, Inc.|Clinical Scientist|+46184749000|reception.seupp@galderma.com|
22436845|NCT00847015|Memorial Sloan Kettering Cancer Center|Dr. M. Catherine Pietanza|646-888-4203|pietanzm@mskcc.org|
22436846|NCT01641822|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22436847|NCT02760810|Johnson & Johnson Vision Care Inc.|Andrea Le, OD, MBA - Manager, Global Medical Affairs|904 4431866|ale3@ITS.JNJ.com|
22436848|NCT04122170|SFJ Pharmaceuticals, Inc.|Michele LaRussa SVP, Chief Regulatory Officer|925-223-6233|Bentracimab.General@SFJ-Pharma.com|
22436849|NCT03847909|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22436850|NCT00869401|Mayo Clinic|Nadia Laack M.D.|5072844561|laack.nadia@mayo.edu|
22436851|NCT00581360|Clinical Research Services, UPCI|Rita Johnson, Associate Director of Clinical Research Services|412-647-8571|johnsonr1@upmc.edu|
22436852|NCT00082381|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22436853|NCT03286283|Apyx Medical (formerly Bovie Medical Corporation)|Shawn Roman/Vice President of Research and Development|1-727-384-2323|shawn.roman@apyxmedical.com|
22436854|NCT02345330|OncoSec Medical Incorporated|Sharron E Gargosky, Chief Clinical Regulatory Officer|+1 858-255-4729|ClinicalTrialsInfo@OncoSec.com|
22436855|NCT01786252|Michigan State University|Dr. Asgerally Fazleabas|(517) 884-6031|asgi@hc.msu.edu|
22436856|NCT00109577|University of Calgary|Dr. Bonnie Kaplan|403-955-7363|kaplan@ucalgary.ca|
22436857|NCT03322423|Johnson & Johnson Vision Care Inc.|Thomas Karkkainen, OD, MS, FAAO- Sr. Principal Research Optometrist|1-904-443-3402|TKarkkai@its.jnj.com|
22436858|NCT04891107|Boston University Department of Physical Therapy & Athletic Training|Terry Ellis PT, PhD, FAPTA|617-353-7571|tellis@bu.edu|
22436859|NCT02453555|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22436860|NCT03045341|Yale University|Dr Carlos Grilo|203 785 7210|carlos.grilo@yale.edu|
22436861|NCT03689855|Washington University School of Medicine|Daniel Morgensztern, M.D.|314-747-7948|danielmorgensztern@wustl.edu|
22436862|NCT03178669|InDex Pharmaceuticals|Karin Arnesson, Clinical Trial Manager|+46 8 122 038 57|karin.arnesson@indexpharma.com|
22436863|NCT02914561|Galapagos NV|Galapagos Medical Information|+32 15 342900|medicalinfo@glpg.com|
22436864|NCT01300455|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22436865|NCT03074682|Yale University|Dr. Marc Auerbach|203-688-3333|marc.auerbach@yale.edu|
22436866|NCT01218399|Astra Zeneca|Elena Pizzi|+1 302 885 2677|Elena.Pizzi@astrazeneca.com|
22436867|NCT00651625|University of New Mexico|Wilmer L. Sibbitt, MD, Principal Investigator|505 272-4761|wsibbitt@salud.unm.edu|
22436868|NCT01008969|University of California, San Francisco|Youngho Seo, PhD|415-353-9464|youngho.seo@ucsf.edu|
22436869|NCT01848366|William Beaumont Hospital|Dr. Kenneth Peters|248-551-0387|Kenneth.Peters@Beaumont.org|
22436870|NCT00576576|Emory|Dr. Habib Samady|4047781237|hsamady@emory.edu|
22436871|NCT03445390|Stanford University|Dr. Mark Burbridge|(650) 353-8484|markburb@stanford.edu|
22436872|NCT00803062|NRG Oncology Statistics and Data Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22436873|NCT00718770|University of Colorado School of Medicine|Joshua Klopper, MD|303-724-3921|joshua.klopper@ucdenver.edu|
22436874|NCT00772109|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22436875|NCT00410605|Univerisity of Wisconsin Carbone Cancer Center|Dr. Natalie Callander|608-265-8690|nsc@medicine.wisc.edu|
22436876|NCT04583956|NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
22436877|NCT00703924|Institute Pasteur Tunisia|Afif Ben Salah, MD, PhD|216-71-792-429|afif.bensalah@pasteur.rns.tn|
22436878|NCT00680459|Baystate Medical Center|Dr. Christine McKiernan|413-794-5370|Christine.McKiernan@bhs.org|
22436879|NCT02625844|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22436880|NCT02376179|Nationwide Children's Hospital|Kris Jatana, MD|614-722-6032|Kris.Jatana@nationwidechildrens.org|
22436881|NCT01248741|British Columbia Cancer Agency|Dr Juanita Crook|2507123958|jcrook@bccancer.bc.ca|
22436882|NCT01115673|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Sr Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
22436883|NCT00389493|New York State Psychiatric Institute|Dr. Helen Blair Simpson|646-774-7000|kimeldo@nyspi.columbia.edu|
22436884|NCT01900054|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22436885|NCT00791089|University of Michigan|Hakan Oral|734 936-6868|oralh@med.umich.edu|
22395949|NCT00972777|Bausch & Lomb Incorporated|Tuyen Ong, MD, MRCOphth|(973) 360-6389|tuyen.ong@bausch.com|
22395950|NCT00805038|Case Western Reserve University|Ash Sehgal|216-778-7728|axs81@cwru.edu|
22395951|NCT02246582|Medtronic Diabtes|Smita Barua, Clinical Trial Manager|818.576.5534|smita.barua@medtronic.com|
22436886|NCT01959841|Maruho Co.,Ltd. Kyoto R&D Center|linical Development Dept.|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
22436887|NCT00860171|Fred Hutchinson Cancer Research Center|Ajay K. Gopal, MD|206-288-2037|agopal@u.washington.edu|
22436888|NCT02170870|Mayo Clinic|Dr. Adil E. Bharucha, Principal Investigator|507-284-2687|bharucha.adil@mayo.edu|
22436889|NCT01128192|Veterans Medical Research Foundation|Principal Investigator|858-552-8585|rrhenry@ucsd.edu|
22436890|NCT00125957|McLean Hospital|Dr. Beth Murphy|617-855-2000|bmurphy5@partners.org|2297
22436891|NCT00482625|Weill Cornell College of Medicine|Dr. Steven Lipkin|212-774-7160|stl2012@med.cornell.edu|
22436892|NCT01078363|Stanford University|William F. Fearon, M.D.|650 725-2621|wfearon@stanford.edu|
22436893|NCT00924508|UCSF|John Koo, MD|415-476-6281|john.koo@ucsfmedctr.org|
22436894|NCT02277925|University of North Carolina at Chapel Hill|Jennifer Wu, MD, MPH|919-966-0014|jennifer_wu@med.unc.edu|
22436895|NCT01835223|Roswell Park Cancer Institute|Katy Wang, Statistician, M.A.|716-845-1300|katy.wang@roswellpark.org|6269
22436896|NCT00244101|Vermont Oxford Network|Roger F. Soll, MD|802 865 4814|roger.soll@uvmhealth.org|212
22436897|NCT00495625|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-7257|jonathan.strosberg@moffitt.org|
22436898|NCT03679624|Weill Cornell Medicine|Dr. John Allan, Associate Professor of Medicine|2127463481|joa9069@med.cornell.edu|
22436899|NCT01912339|Boston Scientific Corporation|Kevin Hagelin, Clinical Program Manager|(800) 328-3881|kevin.hagelin@bsci.com|
22436900|NCT04097379|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22436901|NCT06222892|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22436902|NCT00200356|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22436903|NCT04508530|Clinical Research Management Group|Patrick Murphy|4138210022|p.murphy@crmg-usa.com|
22436904|NCT04148352|Sean N Parker Center for Allergy & Asthma Research at Stanford University|Sayantani B. Sindher, MD|650-521-7237|snpcenterallergy_inquiry@stanford.edu|
22436905|NCT03950492|WVU Rockefeller Neuroscience Institute|James Mahoney, PhD|304-293-5323|james.mahoney@hsc.wvu.edu|
22436906|NCT05216224|Aclaris Therapeutics, Inc.|Clinical Operations|1-833-225-2747|clinicaloperations@aclaristx.com|
22436907|NCT03245008|Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml.JP@ml.tanabe-pharma.com|
22436908|NCT01580670|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22436909|NCT02176161|NYU Langone Health|Aaron Katz, MD|516-535-1900|Aaron.Katz@nyulangone.org|
22436910|NCT03266172|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22436911|NCT00454584|Centocor Research & Development, Inc.|Senior Director, Compound Development Team Leader|1 215-793-7612||
22436912|NCT02250664|University of Vermont|Stephen T. Higgins, PhD, Professor|802-735-6267|stephen.higgins@uvm.edu|
22436913|NCT03957876|Cleveland Clinic Foundation, Case Comprehensive Cancer Center|Sudipto Mukherjee, MD, PhD, MPH|216-444-0506|mukhers2@ccf.org|
22436914|NCT01753401|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22436915|NCT01946126|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22436916|NCT00295932|Memorial Sloan Kettering Cancer Center|Dr. Carol Portlock|212-639-8109|portlocc@mskcc.org|
22436917|NCT01141491|MabVax Therapeutics, Inc.|Dave Hansen|858.259.9405|dhansen@mabvax.com|301
22436918|NCT01054625|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com|
22436919|NCT02409719|Universidad Autonoma de Nuevo Leon|FELIX VILCHEZ CAVAZOS|8183476698|vilchez.doctor@gmail.com|
22436920|NCT00614484|Professor of Radiation Medicine, Loma Linda University Medical Center|David Bush MD|909-558-4280|dbush@llu.edu|
22436921|NCT00565136|Boston Urogynecology Associates|Peter Rosenblatt, MD; Director of Urogynecology|(617) 354-5452|prosenbl@mah.harvard.edu|
22436922|NCT00412074|Medical University of South Carolina|Carol Wagner|18437922112|wagnercl@musc.edu|
22436923|NCT01399268|HSS|Dr. Jules|212.606.1206|JulesK@hss.edu|
22436924|NCT01026220|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22436925|NCT00778895|GlaxoSmithKline|GSK Response Center|866-435-7343||
22436926|NCT03332160|Tactile Medical|Heather Smith|612.800.5539|HSmith@tactilemedical.com|
22436927|NCT01008462|Fred Hutchinson Cancer Research Center|Dr. Mohamed L. Sorror|(206) 667-6298|msorror@fredhutch.org|
22436928|NCT01459913|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22436929|NCT01915823|Meda Pharmaceuticals|Dr.Nancy Ruiz,MD|7325642390|nancy.ruiz@meda.us|
22436930|NCT05096312|East Avenue Medical Center|Dr. Monqiue Lianne Lim-Ang|0287100957|moniquelianne.lim@gmail.com|
22436931|NCT03135210|University of Minnesota|Amanda Sharp|(612) 626-4691|sharp@umn.edu|
22436932|NCT03517566|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22436933|NCT00671437|Washington University School of Medicine|Dr. Douglas R. Adkins|314-362-5654|dadkins@dom.wustl.edu|
22436934|NCT04349033|Wayne State University|Dr. Mark A. Lumley, Professor|3135772247|mlumley@wayne.edu|
22436935|NCT02837042|UAB|Gurudatta Naik, Scientist 3|205-996-5530|alkanand@uab.edu|
22436936|NCT00971295|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22436937|NCT01704456|UBC|Dr Lori Brotto|604-875-4111|lori.brotto@vch.ca|68898
22436938|NCT00988364|Baylor College of Medicine|Dr. Chu-Huang Chen|832-355-9026|chu-huang.chen@bcm.edu|
22436939|NCT00609739|Masonic Cancer Center, University of Minnesota|Margaret MacMillan, M.D.|612-626-2778|macmi002@umn.edu|
22436940|NCT00915551|LEO Pharma|Dr. Torsten Skov|+4520736294|torsten.skov@leo-pharma.com|
22436941|NCT04390841|Biotronik (Beijing) Medical Device Limited|Senior Clinical Study Project Manager|+86 10 6522 3851-863|lan.chen@biotronik.com|
22436942|NCT02540291|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22436943|NCT01031979|Ralph H. Johnson VAMC|Dr. Peter Tuerk|(843) 789-6188|peter.tuerk@va.gov|
22436944|NCT03831100|Medical University of South Carolina|Evan Graboyes|843-792-0719|graboyes@musc.edu|
22436945|NCT02566590|University of Utah|Micah Drummond|8015877764|micah.drummond@hsc.utah.edu|
22436946|NCT02454478|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22436947|NCT01732770|Amgen Inc.|Study Director|866-572-6436||
22436948|NCT01450098|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22436949|NCT05443256|University of New Mexico|Dr. James F. Cavanagh|5052773890|jcavanagh@unm.edu|
22436950|NCT03229109|Maale Carmel Mental Health Center|Anatoly Kreinin|(+972) -4-8559315|kranata@gmail.com|
22436951|NCT03653988|University of Iowa Hospitals and Clinics|Melinda Seering, M.D.|(319) 384-8466|melinda-seering@uiowa.edu|
22436952|NCT03329196|Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608 Japanese only|cti-inq-ml.JP@ml.tanabe-pharma.com|
22436953|NCT06476548|Moffitt Cancer Center|Dr. Christine Vinci|813-745-5421|Christine.Vinci@moffitt.org|
22436954|NCT04493281|Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml.JP@ml.tanabe-pharma.com|
22436955|NCT04481750|Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please e-mail|cti-inq-ml.JP@ml.tanabe-pharma.com|
22436956|NCT03176771|Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please e-mail|cti-inq-ml.JP@ml.tanabe-pharma.com|
22436957|NCT03439137|Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608 Japanese only|cti-inq-ml.JP@ml.tanabe-pharma.com|
22436958|NCT00691028|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22436959|NCT03387020|St. Jude Children's Research Hospital|Dr. Arzu Onar-Thomas|901-595-5499|arzu.onar@stjude.org|
22436960|NCT04776135|Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml.JP@ml.tanabe-pharma.com|
22436961|NCT03372252|CHU de Poitiers|Dr RAULT Christophe|0549445348|christophe.rault@chu-poitiers.fr|
22436962|NCT04512976|University of Texas Southwestern Medical Center|Craig Crandall|214-345-4623|craigcrandall@texashealth.org|
22436963|NCT03392649|Univerisity of Chicago Medicine|Dr. Gaurav Upadhyay|773-702-9461|gupadhyay@medicine.bsd.uchicago.edu|
22436964|NCT04897763|Institut de cancérologie de l'Ouest|Dr Caroline ROUSSEAU|+33 2 40 67 99 31|caroline.rousseau@ico.unicancer.fr|
22436965|NCT04617496|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov|
22436966|NCT01596335|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22436967|NCT01192412|St. George's, University of London|Dr. Laura A. Magee|+442086729944|LMagee@sgul.ac.uk|52621
22436968|NCT02421588|Pharma Mar S.A.|Pharma Mar S.A.|0034918466000|clinicaltrials@pharmamar.com|
22436969|NCT04103593|Salem VAMC|Dr. Krisann Oursler|5409822463|krisann.oursler@va.gov|4981
22436970|NCT01004952|Memorial Sloan Kettering Cancer Center|Dr. Jennifer Hay, PhD|646-888-0039|hayj@MSKCC.ORG|
22436971|NCT01359943|Novartis Pharmaceuticals|Study Director|862-778-8300||
22436972|NCT01529034|Proximagen, LLC|David Sequeira|952-658-7438|dsequeira@proximagen.com|
22395952|NCT02899078|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
22395953|NCT02060383|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22436973|NCT01166412|Premier Research|Clint Dart|948-238-1243|clint.dart@premier-research.com|
22436974|NCT03436693|Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml.JP@ml.tanabe-pharma.com|
22436975|NCT04481789|Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please e-mail|cti-inq-ml.JP@ml.tanabe-pharma.com|
22436976|NCT01976572|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22436977|NCT06649019|Johnson & Johnson Vision Care|Johnson & Johnson Vision Care Study Contact|1-800-843-2020|RFrankl1@its.jnj.com|
22436978|NCT04655144|Florida Interventional Institute|Prasoon Mohan, MD|305-204-7276|contact@flinterventionalinstitute.com|
22436979|NCT04317742|St. Jude Children's Research Hospital|Tara Brinkman, PhD|901-595-5683|Tara.Brinkman@STJUDE.ORG|
22436980|NCT02678923|The Medicines Company|Global Health Science Center|1-888-977-6326|medical.information@themedco.com|
22436981|NCT02159118|The University of Texas Health Science Center|Chatchawin Assanasen, MD|210-567-7456|assanasen@uthscsa.edu|
22436982|NCT01554514|Washington University|Dr. Elaine Majerus|314-362-8866|emajerus@wustl.edu|
22436983|NCT01274520|Columbia University College of Physicians and Surgeons - Center for Liver Disease and Transplantation|James V. Guarrera, MD, FACS|(212)305.3839|jjg46@cumc.columbia.edu|
22436984|NCT01966445|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22436985|NCT01374178|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22436986|NCT01422824|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
22436987|NCT00490022|University of Washington|Dr. Stephanie Page, PhD, MD|206.616.0483|page@u.washington.edu|
22436988|NCT02981966|UTexas_SanAntonio|Ralph DeFronzo, MD|210-567-6691|defronzo@uthscsa.edu|
22436989|NCT02522442|Sleep Therapy & Research Center|Eric Powell, Ph.D.|(210) 614-6000|powell.eric@sleeptrc.com|
22436990|NCT00975143|Cipher Pharmaceuticals Inc.|Julia Chan, RAC|905-602-5840|jchan@cipherpharma.com|326
22436991|NCT00470418|James J Peters VA Medical Center|Dr. Hillel Grossman|718-584-9000|hillel.grossman2@va.gov|5752
22436992|NCT03129360|NYU Langone Health|Donald Goff, MD|646.485.4843|Donald.Goff@nyulangone.org|
22436993|NCT01818492|Sobi AB|Carl Johan Treutiger|46 76 00 11 815|CarlJohan.Treutiger@sobi.com|
22436994|NCT01729208|CooperVision Inc.|Paul Chamberlain|925 730-6754|PChamberlain@coopervision.com|
22436995|NCT02428413|Teleflex|Thomas Philbeck, PhD, MBA, Senior Director of Global Research and Scientific Services|210-581-7778|thomas.philbeck@teleflex.com|
22436996|NCT00885482|Catholic University of S. Heart|Andrea De Luca|+390630155366|deluca.andrea@fastwebnet.it|
22436997|NCT02772978|University of California at San Francisco|Andrew Kayser, MD PhD|415-502-7332|Andrew.Kayser@ucsf.edu|
22436998|NCT02438813|Allergan, Inc|Medical Director/ Epidemiologist|714-246-4500|clinicaltrials@allergan.com|
22436999|NCT04684992|Cairn Diagnostics|Chief Scientist and Compliance Officer|615-376-5464|cwilliams@cairndx.com|
22437000|NCT00409344|Massachusetts General Hospital|Ulrich Schmidt, MD PhD|617-724-6490|uschmidt@partners.org|
22437001|NCT00552409|University of Washington|Dr. Ian de Boer|206-616-5403|deboer@u.washington.edu|
22437002|NCT02879578|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
22437003|NCT01919216|New York State Psychiatric Institute|Bret Rutherford|6467748660|brr8@cumc.columbia.edu|
22437004|NCT00534833|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22437005|NCT01879072|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
22437006|NCT02108691|Hanyang University|Dr. Yongsoon Park|82-2-2220-1205|yongsoon@hanyang.ac.kr|
22437007|NCT00671606|UT MD Anderson Cancer Center|Dr. Michael Frumovitz, ND/Assistant Professor||tjohnsto@mdanderson.org|
22437008|NCT02933502|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
22437009|NCT00123604|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu|
22437010|NCT02666105|University of Minnesota|Manish Patel, DO|612-625-2654|patel069@umn.edu|
22437011|NCT00411632|UT MD Anderson Cancer Center|Dr. John V Heymach, PHD/ Chair, Thoracic-Head & Neck Med Onc|713-792-6363|jheymach@mdanderson.org|
22437012|NCT01264419|Silk Road Medical, Inc.|Richard Ruedy, Exec VP Clinical Affairs|408-828-7281|ric@silkroadmed.com|
22437013|NCT00659230|Tuscaloosa VA Medical Center|Lori L. Davis, MD|205-554-2000|lori.davis@va.gov|3819
22437014|NCT05249569|UT Southwestern Medical Center|Dr. David Hsieh|214/648-4180|david.hsieh@utsouthwestern.edu|
22437015|NCT03703856|UCSD|Neal R. Swerdlow, M.D., Ph.D.|619-471-9455|nswerdlow@health.ucsd.edu|
22437016|NCT03402386|Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608 Japanese only|cti-inq-ml.JP@ml.tanabe-pharma.com|
22437017|NCT05138419|University of Arkansas for Medical Sciences|Andrea Easom, APRN|5018379556|easomandreak@uams.edu|
22437018|NCT01048853|The University of Texas MD Anderson Cancer Center|Kathleen Schmeler, MD|(713) 854-9150|kschmele@mdanderson.org|
22437019|NCT05342597|Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml.JP@ml.tanabe-pharma.com|
22437020|NCT05095935|Medtronic|Jennifer Bell|303-241-2107|jennifer.bell@medtronic.com|
22437021|NCT01532570|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22437022|NCT01585155|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22437023|NCT00597493|Duke University Health System|David Reardon, MD|617-632-2166|David_Reardon@DFCI.harvard.edu|
22437024|NCT00805766|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22437025|NCT04254913|Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml.JP@ml.tanabe-pharma.com|
22395954|NCT03426787|Washington University in St. Louis School of Medicine|Dr. Mary C Politi|3147471967|mpoliti@wustl.edu|
22395955|NCT01944293|Columbia University Medical Center - NY State Psychiatric Institute|Michael Grunebaum, MD|646-774-7573|michael.grunebaum@nyspi.columbia.edu|
22395956|NCT02039726|Contact for Clinical Trial Information|Daiichi Sankyo|1-908-992-6400|CTRinfo@dsi.com|
22395957|NCT02460497|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22395958|NCT00908583|University of Cincinnati|E. Steve Woodle|513-558-6001|woodlees@ucmail.uc.edu|
22395959|NCT00713817|GW Pharma Ltd|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
22395960|NCT00860951|University of Michigan|Jane Huggins|734-936-7177|janeh@umich.edu|
22395961|NCT02982239|Sleep and Health Research Program - University of Arizona|Dr. Michael Grandner|5206260105|grandner@psychiatry.arizona.edu|
22437026|NCT02354222|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22437027|NCT04300218|IMSechenovMMA|Polina Pchelina|+79036701725|polbox@mail.ru|
22437028|NCT02911142|National Cancer Institute|Dr. Ramya Ramaswami|240-506-1088|ramya.ramaswami@nih.gov|
22437029|NCT05451940|University of Pittsburgh|Julia Z. Xu, MD|412-648-6466|xujz2@upmc.edu|
22437030|NCT03645863|Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608 Japanese only|cti-inq-ml.JP@ml.tanabe-pharma.com|
22437031|NCT02220907|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22437032|NCT00542815|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22437033|NCT06726343|GE HealthCare|Product Manager|+44 (7384) 249324|212612107@gehealthcare.com|
22437034|NCT01716104|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Director of Clinical Research and Medical Information|+74952761571|PutilovskiyMA@materiamedica.ru|302
22437035|NCT00117793|Dept. of Veterans Affairs, Rehabilitation Research & Development Service|Glenn K. Klute, PhD|206-277-6724|Glenn.Klute@va.gov|
22437036|NCT05387564|Nemours Children's Health|Corinna Schultz|302-651-5500|corinna.schultz@nemours.org|
22437037|NCT01069705|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22437038|NCT03624127|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22437039|NCT01304589|University of Tennessee Health Science Center|Dr. Candace Brown|901-412-4341|csbrown@uthsc.edu|
22437040|NCT02891382|Universidad Peruana Cayetano Heredia|Dr. J Jaime Miranda|+511 241 69 78|Jaime.Miranda@upch.pe|
22437041|NCT02516228|Philips|Sr. Clinical Operations Manager|3034753417|pat.olsen@philips.com|
22437042|NCT03916484|University of North Carolina at Chapel Hill|Kate Muessig, PhD|850-644-3299|kmuessig@fsu.edu|
22437043|NCT01776723|H Lee Moffitt Cancer Center & Research Institute|Eric Padron, MD|813-745-3907|Eric.Padron@Moffitt.org|
22437044|NCT01727414|Cincinnati Children's Hospital|Tanya Froehlich|5136361154|tanya.froehlich@cchmc.org|
22437045|NCT03281304|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22437046|NCT00858637|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22437047|NCT01431391|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@dendreon.com|
22437048|NCT02292706|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22437049|NCT00006400|New England Research Institutes, Inc|Julie Miller|617-972-3197|JMiller@healthcore.com|
22437050|NCT01705106|University of Chicago|Manish R. Sharma, MD|773-834-0312|msharma@bsd.uchicago.edu|
22437051|NCT02188849|Institute of Nutrition and Food Technology University of Chile|Sandra Hirsch MD|+56 229781485|shirsch@inta.uchile.cl|
22437052|NCT03968848|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22437053|NCT05777798|SIFI SpA|Clinical Development|00390957922111|giulia.faraci@sifigroup.com|
22437054|NCT03929224|Michigan Ear Institute|Seilish Babu, MD|(248) 865-4444|sbabu04@gmail.com|
22437055|NCT05740618|University of North Carolina at Chapel Hill|Subhashini Sellers, MD, MSCR|919-966-2531|sasellers@med.unc.edu|
22437056|NCT04588389|UMass Chan Medical School|Dr Alexander Chan for Eman Nada, MD|7743030338|alexander.chan@umassmemorial.org|
22437057|NCT02354235|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22437058|NCT00510744|University of Pittsburgh|Stephen O'Keefe|412 648 7217|sjokeefe@pitt.edu|
22437059|NCT06045507|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22437060|NCT04176224|Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml.JP@ml.tanabe-pharma.com|
22437061|NCT03321552|LimFlow SA|Kristi McCaffrey|+1 559 970-1012|kristi.mccaffrey@stryker.com|
22437062|NCT02004977|University of Minnesota|Dr. Susie Nanney|612-626-6794|msnanney@umn.edu|
22437063|NCT00902174|Novartis Pharmaceuticals|Study Director|862-778-8300||
22437064|NCT03688100|Cedars-Sinai Medical Center|Dr. Waguih IsHak|310-423-3515|Waguih.IsHak@cshs.org|
22437065|NCT04783077|University of Minnesota|Susan Telke|6125902697|telke001@umn.edu|
22437066|NCT02479139|Allergan, Inc|Therapeutic Area Head,|1-877-277-8566|IR-CTRegistration@allergan.com|
22437067|NCT00849862|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22437068|NCT00084656|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22437069|NCT00989781|UCSD|R. Jeffrey Chang, M.D.|858-534-8930|rjchang@ucsd.edu|
22437070|NCT01532869|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22437071|NCT01331291|Massachusetts General Hospital|Tracy T. Batchelor, MD|617-643-1938|tbatchelor@mgh.harvard.edu|
22437072|NCT03776461|Venus Concept|Director of Clinical Affairs|888-907-0115|mgronski@venusconcept.com|
22437073|NCT02163421|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22437074|NCT01389323|BristolMyers Squibb|BristolMyers Squibb Study Director||Clinical.Trials@bms.com|
22437075|NCT02647346|Podimetrics Inc|Brian Petersen|860-558-9204|brian@podimetrics.com|
22437076|NCT01805037|Northwestern University, Feinberg School of Medicine|Barbara Pro, MD|312-695-6180|barbara.pro@northwestern.edu|
22437077|NCT04566692|Grifols Therapeutics LLC|Rhonda Griffin|+1 919 757 1744|rhonda.griffin@grifols.com|
22437078|NCT01183468|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22437079|NCT00590577|Johnson & Johnson Pharmaceutical Research & Development|Compound Development Team Leader, Paliperidone|609-730-4530||
22437080|NCT00303511|Emory University|Dr. Wendy Book|404-778-5545|wbook@emory.edu|
22437081|NCT00439374|Northwestern University Medical School|William Grobman, MD|312-472-4661|w-grobman@northwestern.edu|
22437082|NCT02128074|Keryx Biopharmaceuticals, Inc|Keryx Medical Information|1-844-44-KERYX (844-445-3799)|medicalinfo@keryx.com|
22437083|NCT04033068|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22437084|NCT01817959|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22437085|NCT03235089|CooperVision, Inc|Lee Hall, BSc, PhD, MCOptom, FBCLA|925 251 6684|lhall@coopervision.com|
22437086|NCT01204216|Research Service, Cincinnati VA Medical Center|Robert M Cohen, MD, Physician,|5136748676|robert.cohen@uc.edu|
22437087|NCT03665688|UTMB Galveston|Antonio Saad Director of Clinical Research Division|409 772 0982|afsaad@utmb.edu|
22437088|NCT03238924|Medical University of South Carolina|Dr. Julianne Flanagan|843-792-5569|Hellmuth@musc.edu|
22437089|NCT03576716|University of Washington|Dr. Ian de Boer|206-616-5403|IDeBoer@Nephrology.washington.edu|
22437090|NCT00559988|Biotronik, Inc|Crystal Miller|503-451-8051|crystal.miller@biotronik.com|
22437091|NCT04943432|University of North Carolina at Chapel Hill|Catherine Paquette, MA, MPS|919-962-5082|cpaq@live.unc.edu|
22437092|NCT01123707|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22437093|NCT01229722|Dimagi Inc.|Dr. Vikram Kumar|6176492214|information@dimagi.com|
22437094|NCT00241904|Johns Hopkins University|Dr. Jerilyn Allen|410-614-4882|jallen1@jhu.edu|
22437095|NCT01990612|Northwestern University|Dr. William Grobman|312-472-4661|w-grobman@northwestern.edu|
22437096|NCT02725866|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22437097|NCT01549977|Takeda|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22437098|NCT04365452|Indiana Univiersity|Theresa Joyce, Quality Improvement Consultant, Research Complaince|3172921882|tajoyce@iu.edu|
22437099|NCT02980133|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22437100|NCT01854281|University Hospital Motol|Jakub Honek, MD|+42022443|jakub.honek@gmail.com|4901
22437101|NCT03208088|Johnson & Johnson Vision Care, Inc.|Thomas Karkkainen SR Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
22395962|NCT02230254|Second Affiliated Hospital of Zhejiang University|Dr. Wang Jian'an|010-85216440|Yuwei.Zhang@bsci.com|
22395963|NCT00295633|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22395964|NCT02251379|Johns Hopkins University|Corinne Keet|410-955-5883|ckeet1@jhmi.edu|
22395965|NCT02334787|Otsuka Pharmaceutical Co., LTD.|Study Director, Department of Clinical Management|+81-3-6361-7366||
22395966|NCT01641237|GlaxoSmithKline|GSK Response Center|866-435-7343||
22395967|NCT04439071|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22395968|NCT00832117|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22395969|NCT01301456|Pfizer, Inc.|Pfizer ClinicalTrials.gov|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22437102|NCT01000324|GlaxoSmithKline|GSK Response Center|866-435-7343||
22437103|NCT00360724|NY State Psychiatric Institute|David Hellerstein MD|6467748000|hellers@nyspi.columbia.edu|
22437104|NCT02508324|Weill Cornell Medicine|Alexandra Gomez Arteaga, MD|646-962-7950|alg9117@med.cornell.edu|
22437105|NCT00605345|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22437106|NCT02577016|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22437107|NCT05399290|Michigan State University|Erika Malana|5173038716|malanaer@msu.edu|
22437108|NCT03304119|Hôpital Privé Antony|V Chassaing|+33 1 46 74 37 00|vchassaing92@gmail.com|
22437109|NCT00666224|Teva Pharmaceutical Industries, Ltd.|Yossi Gilgun, PhD, Global Clinical Leader|972-9-863-1491|yossi.gilgun@teva.co.il|
22437110|NCT03521141|Vanderbilt University Medical Center|Stephen King|615-875-9394|stephen.king@vumc.org|
22437111|NCT01350232|Thomas Jefferson University|Joanne Filicko-O'Hara, MD|215-955-8874|jef001@jefferson.edu|
22437112|NCT03828617|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22437113|NCT03354273|GE HealthCare|Francois Tranquart, M.D., Ph.D|447775543206|francois.tranquart@ge.com|
22437114|NCT00303485|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22437115|NCT03738891|Zeltiq Aesthetics|Lori Brandt, Director, Clinical Trial Management|(925) 621-7460|lori.brandt@abbvie.com|
22437116|NCT00971243|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22437117|NCT00200343|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22437118|NCT04099511|University of Missouri|Dr. Gregory Petroski|(573) 884-2119|petroskig@health.missouri.edu|
22437119|NCT06581094|Taipei medical university|YiWen Chien, PhD|02-2736-1661|ychien@tmu.edu.tw|6556
22437120|NCT02942485|University of Helsinki|Dr. Svetlana Vakkilainen|+358407693375|svetlanakostjukovitch@gmail.com|
22437121|NCT01991522|St. Michael's|Dr. Samir C. Grover|416-864-5628|samir.grover@utoronto.ca|
22437122|NCT02227394|Zambon S.p.A.|Luca Raiteri, MD|+39 02 6652461|luca.raiteri@zambongroup.com|
22437123|NCT04251819|UAB|Karen Cropsey|2059754204|kcropsey@uabmc.edu|
22437124|NCT04302545|King Edward Medical University, Lahore, Pakistan|Shazia Saaqib|+92-3214708583|shaziasaaqib@gmail.com|
22437125|NCT02516592|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22437126|NCT04921332|University of Pittsburgh|Erica Osborn DNP, CRNP|814-282-9793|elo25@pitt.edu|
22437127|NCT03077204|Ascension Texas Spine and Scoliosis|Devender Singh, Research Scientist|512 324 3580|dpsingh@ascension.org|15916
22437128|NCT00764673|DJO Surgical|Manager of Clinical Affairs|512-832-9500|jane.jacob@djosurgical.com|6323
22437129|NCT01438177|Perlmutter Cancer Center|Amitabha Mazumder, MD|212-731-5757|amitabha.mazumder@nyumc.org|
22437130|NCT00619099|Eisai Inc.|Erhan Berrack, M.D.|888-422-4743||
22437131|NCT01270256|University of Chicago|Dr. Robert M Naclerio|773-702-0080|rnackeri@surgery.bsd.uchicago.edu|
22437132|NCT04547582|University of Pittsburgh|Dr. Lee Fisher, PhD|412-383-1326|lef44@pitt.edu|
22437133|NCT03040115|University of Cincinnati|Elizabeth Kopras, Senior Research Associate|513-558-7205|koprasej@uc.edu|
22437134|NCT02964585|George Washington University Medical Faculty Associates|Dr. Sabyasachi Sen|202-741-2233|ssen1@email.gwu.edu|
22437135|NCT03927404|University of Pittsburgh|Dr. Sashwati Roy|412-648-8297|sar453@pitt.edu|
22437136|NCT02641067|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22437137|NCT01229449|Reckitt Benckiser Healthcare International|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
22437138|NCT02851823|Izmir Katip Celebi University, Dentistry Faculty|Assoc.Prof.Dr. Mehmet Sağlam|+90 530 324 99 48|dtmehmetsaglam@gmail.com|
22437139|NCT03203291|Columbia University Irving Medical Center|Sunil Agrawal, PhD|(212) 854-2841|sunil.agrawal@columbia.edu|
22437140|NCT01300260|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22437141|NCT02533726|Stanford University School of Medicine|Dr David Pickham|650 701 6830|dpickham@stanford.edu|
22437142|NCT05098509|Radius Pharmaceuticals, Inc.|Ellie Ratigan|617-444-1800|scout015@radiuspharm.com|
22437143|NCT01147848|GlaxoSmithKline|GSK Response Center|866-435-7343||
22437144|NCT02540265|Recro Pharma, Inc.|Randall Mack|484-395-2470|rmack@recropharma.com|2406
22437145|NCT00908466|University of Nebraska|Quan Dong Nguyen, MD, MSc|4025591855|quan.nguyen@unmc.edu|
22437146|NCT03157037|Linköping University|Professor Mårten Segelmark|+46 70 287 19 44|marten.segelmark@liu.se|
22437147|NCT00324233|Coloplast A/S|Kristine Gjødsbøl, PhD|+4549113557|dkkg@coloplast.com|
22437148|NCT01972789|Novartis Pharmaceutical|Study Director|862-778-8300|novartis.email@novartis.com|
22437149|NCT00418574|Menarini Ricerche SpA|Clinical Research Director||abagovomab@menarini-ricerche.it|
22395970|NCT00892177|Mayo Clinic|Evanthia Galanis, M.D.|(507) 284-7733|galanis.evanthia@mayo.edu|
22437150|NCT00498355|University of California San Francisco|Dr. Nisha Acharya|415-476-8131|nisha.acharya@ucsf.edu|
22395971|NCT03583450|University of California, San Francisco|Dr. Jina Sinskey|857-998-0137|jina.sinskey@ucsf.edu|
22437151|NCT00881647|University of California, San Francisco|Thomas C. Neylan, MD|415-750-6961|thomas.neylan@ucsf.edu|
22437152|NCT02474407|SK Bio-pharmaceuticals Co, Ltd|Lee Min Jae, Associate Manager||minj.lee@sk.com|
22437153|NCT03262441|Fred Hutchinson Cancer Research Center|Dr. Joshua Schiffer|(206)667-7359|jschiffe@fredhutch.org|
22437154|NCT01860950|Medical University of South Carolina|Dr. Jeffrey J. Borckardt|8437923295|borckard@musc.edu|
22437155|NCT04775264|AtriAN Medical Ltd|Barry O'Brien|+353872934292|barry.obrien@atrianmedical.com|
22437156|NCT01455194|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22437157|NCT05090852|UPenn|Natasha Mirza, MD|215 662 2979|natasha.mirza@pennmedicine.upenn.edu|
22437158|NCT01196416|Memorial Sloan Kettering Cancer Center|Dr. Mark Dickson|646-888-4164|DicksonM@mskcc.org|
22437159|NCT00504894|Weill Cornell Medicine|Kane Pryor|(212) 746-2953|kap9009@med.cornell.edu|
22437160|NCT00148941|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22437161|NCT03050320|McMaster University/University of Waterloo|Dr. Monica Maly|519-888-4567|mrmaly@uwaterloo.ca|37916
22437162|NCT02673684|Defense and Veterans Center for Integrative Pain Management|Mary McDuffie|301-400-4242|mmcduffie@dvcipm.org|
22437163|NCT01092663|KineMed, Inc.|Carine Beysen, PhD|510-655-6525|cbeysen@kinemed.com|123
22437164|NCT01008904|Virginia Commonwealth University|Thomas J. Smith, MD|410-955-2091|tsmit136@jhmi.edu|
22437165|NCT00788710|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22437166|NCT04407234|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22437167|NCT03908970|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22437168|NCT02280317|Valirx plc|Dr Suzanne Dilly|+44 2476796496|suzanne.dilly@valirx.com|
22437169|NCT00727558|Vistakon|Kurt Moody OD, FAAO/ Director|904-443-3088|kmoody1@its.jnj.com|
22437170|NCT00365274|The University of Texas (UT) MD Anderson Cancer Center|Michelle Fanale, MD / Associate Professor||CR_Study_Registration@mdanderson.org|
22437171|NCT04534881|Saint Louis University|Sandeep Dhindsa|13149774911|sandeep.dhindsa@health.slu.edu|
22437172|NCT01729494|University of Cincinnati|Rita R. Alloway, Pharm.D., Director of Clinical Trials|513-558-1568|rita.alloway@uc.edu|
22437173|NCT01717326|Merck Sharp & Dohme Corp.|Results Point of Contact* Name or Official Title Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22437174|NCT00771056|Northwell Health (formerly North Shore LIJ Health System)|Kanti R Rai, MD|(718)470-4050|krai@nshs.edu|
22437175|NCT02262754|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22437176|NCT00223704|Vanderbilt University|Mias Pretorius, Associate Professor of Anesthesiology and Clinical Pharmacology|615-8757402|mias.pretorius@vanderbilt.edu|
22437177|NCT01299116|FHI 360|Dr. David Hubacher|919 544 7040|dhubacher@fhi360.org|11223
22437178|NCT02986802|Kaiser Permanente Division of Research|De-Kun Li, MD, PhD|510.891.3755|De-Kun.Li@kp.org|
22437179|NCT04079114|Zimmer Biomet|Emilie Rohmer, Clinical Operations Manager|+41 58 85 48210|Emilie.Rohmer@zimmerbiomet.com|
22437180|NCT00629798|Memorial Sloan Kettering Cancer Center|Dr. Roni Tamari, MD|646-608-3738|tamarir@mskcc.org|
22437181|NCT01108523|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
22437182|NCT00687531|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22437183|NCT03253328|Washington University School of Medicine|Mohamed A Zayed|314-362-5648|zayedm@wustl.edu|
22437184|NCT00547521|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22437185|NCT03077919|RTI International|Kristine L. Rae Olmsted, MSPH|919-541-8035|krolmsted@rti.org|
22437186|NCT00826618|University of Miami|Thomas A. Albini, MD|3054825006|talbini@med.miami.edu|
22437187|NCT02175979|Catharina Hospital|dr Misha Luyer|+31402399111|misha.luyer@catharinaziekenhuis.nl|
22437188|NCT01487265|Sarah Cannon Research Institute|Charles H. Davis|615-524-4341|charles.davis2@scri-innovations.com|
22437189|NCT03043391|Istari Oncology|W. Garret Nichols, MD MS|919-245-7662|info@istarioncology.com|
22395972|NCT00404066|Stanford University Medical Center|George Albert Fisher, MD, PhD|650-725-9057|georgeaf@stanford.edu|
22395973|NCT01186939|Celgene Corporation|CL Beach||CLBeach@celgene.com|
22395974|NCT03938038|The University of Texas Health Science Center at Houston|Gabrielle Hatton, MD|713-500-7211|gabrielle.e.hatton@uth.tmc.edu|
22437190|NCT00610311|National Cancer Institute, National Institues of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
22437191|NCT00385138|The Medicines Company|Meredith Todd|973.290.6088|meredith.todd@themedco.com|
22437192|NCT02133781|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
22437193|NCT00635167|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Edouard Trabulsi|215-955-1000|edouard.trabulsi@jefferson.edu|
22437194|NCT00193180|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
22437195|NCT03274414|Memorial Sloan Kettering Cancer Center|Dr. Marc Cohen, MD|212-639-3769|cohenm2@mskcc.org|
22437196|NCT02381015|Wake Forest University Health Sciences|Dr. Aubrey R. Turner|336-918-3585|aubreyturner@gmail.com|
22437197|NCT00904488|UNC Eshelman School of Pharmacy|Dr. Jo Ellen Rodgers|(919) 962-2249|jerodgers@unc.edu|
22437198|NCT02688985|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
22437199|NCT01726582|Froedtert and the Medical College of Wisconsin|Susan Tsai, MD|414-955-1412|stsai@mcw.edu|
22437200|NCT02630472|UPenn|Nithin D. Adappa, Principal Investigator|215-662-2360|Nithin.Adappa@uphs.upenn.edu|
22437201|NCT02967510|ITF Research Pharma SLU|Javier Suárez Almarza|+34 916572323|jsuarez@itfsp.com|
22437202|NCT01832155|University of Minnesota|Corjena Cheung, Assistant Professor|612-624-5198|corjena@umn.edu|
22437203|NCT00787189|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com|
22437204|NCT01279616|Nationwide Children's Hospital|Kristy Ott|614-722-6313|kristy.ott@nationwidechildrens.org|
22437205|NCT00413036|Celgene|Associate Director, Clinical Trial Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22437206|NCT01369641|Thomas Jefferson University|David Cognetti, MD|215-955-6670|David.Cognetti@jefferson.edu|
22437207|NCT01458418|Children's Mercy Hospital|Corey Schurman|8162343000|crschurman@cmh.edu|
22437208|NCT01483183|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22437209|NCT00239928|Pfizer, Inc.|Pfizer Clinical Trails.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22437210|NCT02524158|VA San Diego|Dr. Erik J. Groessl|858-552-8585|erik.groessl@va.gov|6347
22437211|NCT02638168|Penn State Health Milton S Hershey Medical Center|Raman Baweja, MD, MS|7175318134|rbaweja@pennstatehealth.psu.edu|
22437212|NCT04047979|Emory University|Dr. Nadine Rouphael|404-712-1435|nroupha@emory.edu|
22437213|NCT04427072|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22437214|NCT00300365|University of Pennsylvania|Dr. Richard L. Dunbar|(215) 315-3378|richard.dunbar@uphs.upenn.edu|
22437215|NCT00077649|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22437216|NCT04003987|Indiana University School of Medicine|Yar Yeap|(317) 274-0275|yyeap@iupui.edu|
22437217|NCT01727336|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22437218|NCT03550404|Pacific Institute for Research and Evaluation|Cathleen Willging|505-765-2328|cwillging@pire.org|
22437219|NCT02953886|University of Michigan|Emily Yanca|734-763-3988|emthorpe@umich.edu|
22437220|NCT00820222|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22437221|NCT02690714|Prometic Biotherapeutics Inc.|Senior Director, Clinical Development|301-549-9761|clinical@prometic.com|
22437222|NCT00666965|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22437223|NCT01707381|Bausch + Lomb|Heleen DeCory, Ph.D.|(585) 338-8161|Heleen.DeCory@bausch.com|
22437224|NCT00955513|Novartis Consumer Health|Clinical Project Leader Pain category|+41223635528||
22437225|NCT03596450|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22437226|NCT03001778|Klein Buendel|Valerie Myers, PhD|3035654343|vmyers@kleinbuendel.com|
22437227|NCT02013245|Centre Hospitalier Universitaire Vaudois (CHUV)|Dr. François Spertini, Associate Professor, Division Immunology & Allergy|+41 21 31 40 799|Francois.Spertini@chuv.ch|
22437228|NCT04058886|University of North Carolina at Chapel Hill|Kim Faurot, PhD|919-966-8586|faurot@med.unc.edu|
22437229|NCT04016077|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22437230|NCT00699335|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com|
22437231|NCT04118595|University of North Carolina at Chapel Hill|Michelle Meyer, PhD|919-966-6539|mlmeyer@unc.edu|
22437232|NCT03036189|Montana State University|Suzanne Held|4069946321|suzanne@montana.edu|
22437233|NCT02607228|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22437234|NCT01227005|University of Texas Health Science Center-Houston|Bryan A. Cotton, MD, MPH|713-500-7354|bryan.a.cotton@uth.tmc.edu|
22437235|NCT02684188|University of Montana|Tom Seekins, Ph.D.|2432654|TOm.Seekins@UMontana.edu|406
22437236|NCT00488826|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22437237|NCT03595527|Centre hospitalier de l'Université de Montréal|Valréie Martel-Laferrière, MD|5148908000|valerie.martel-laferriere.med@ssss.gouv.qc.ca|
22437238|NCT02413047|Indiana University|Dr. Matthew Bohm, DO (Principal Investigator)|3179485136|mbohm@iu.edu|
22437239|NCT02974842|nVision Medical|Surbhi Sarna|408 655 3577|surbhi@nvisionmedical.com|
22437240|NCT01959243|Bausch & Lomb Incorporated|Director, Medical Affairs||Heleen.DeCory@bausch.com|
22437241|NCT02126839|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22437242|NCT01369732|Yonsei University College of Medicine|Dr. Yon Hee Shim|82220193547|tren125@yuhs.ac|
22437243|NCT00812565|Octapharma USA|Michael Eppolito, Director, Clinical Operations Immunology and ICU Medicine|201-604-1155|michael.eppolito@octapharma.com|
22437244|NCT02596945|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22395975|NCT00791258|Daiichi Sankyo, Inc|John Raia|(973) 944-2683|jraia@dsi.com|
22395976|NCT02066311|The Feinstein Institute for Medical Research|Dr. Meggan Mackay|516-562-3838|mmackay@northwell.edu|
22395977|NCT01372150|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22395978|NCT02316340|UT Health San Antonio|Dr. Sukeshi Arora|2104502872|ARORAS@UTHSCSA.EDU|
22395979|NCT01835015|Alcon Research, Ltd.|Director, Translational Medicine Expert, Ophthalmology|1-888-451-3937|alcon.medinfo@alcon.com|
22395980|NCT01178333|New England Research Institutes|Dr. Susan Assmann, Principal Research Scientist|617-972-3048|sassmann@neriscience.com|
22395981|NCT00975715|Novartis|Study Director|41 61 324 1111||
22395982|NCT00418951|The University of Texas MD Anderson Cancer Center|Jorge Cortes, MD / Professor|713-745-5783|eharrison@mdanderson.org|
22395983|NCT01241552|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22395984|NCT04004429|SynAct Pharma|Thomas Jonassen, Chief Scientific Officer|+45 4015 6669|tj@SynActpharma.com|
22395985|NCT02606461|Karyopharm Therapeutics Inc|Karyopharm Medical Information|(888) 209-9326|clinicaltrials@karyopharm.com|
22395986|NCT05395104|Shionogi|Shionogi Clinical Trials Administrator Clinical Support Help Line|1-800-849-9707|Shionogiclintrials-admin@shionogi.co.jp|
22395987|NCT01534013|Imperial College London|Prof Nick Oliver|02075942433|nick.oliver@imperial.ac.uk|
22395988|NCT04422990|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22395989|NCT01849497|Amgen Inc.|Study Director|866-572-6436||
22437245|NCT00422383|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22395990|NCT01514136|Coloplast A/S|Birte Petersen Jakobsen, MD|+45 4911 1990|dkbir@coloplast.com|
22395991|NCT02729740|Penumbra, Inc.|Director of Clinical Affairs|+1 510 995 2183|blawson@penumbrainc.com|
22395992|NCT03044249|Mediti Pharma Inc.|Chief Executive Officer|1-514-993-7207|ivan.shaw@meditipharma.com|
22395993|NCT00955279|Johnson & Johnson Pharmaceutical Research & Development|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
22395994|NCT02221349|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
22395995|NCT00999713|Penn State College of Medicine|Neal J. Thomas, M.D.|717-531-5337|nthomas@psu.edu|
22395996|NCT03346057|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22395997|NCT02921269|Johns Hopkins University|ETCTN Grants Administrative Manager|443-927-3568|jmurra33@jhmi.edu|
22395998|NCT01995578|Memorial Sloan Kettering Cancer Center|Dr. Roni Tamari MD|646-608-3738|tamarir@mskcc.org|
22395999|NCT00703053|Saint Louis University|Robert Belshe, MD|314-977-9030|belsherb@slu.edu|
22396000|NCT00387764|GlaxoSmithKline|GSK Response Center|866-435-7343||
22396001|NCT02301936|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22396002|NCT00822354|Northwestern University|Clinical Trials Coordinator|312-695-6829|j-bae@northwestern.edu|
22396003|NCT04411953|Cycle Pharmaceuticals|Head of Global Regulatory Affairs and Clinical Development|+441223803635|claudia.percivalle@cyclepharma.com|
22396004|NCT05975840|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22396005|NCT05180279|Medical University of South Carolina|Dr Garth Swanson|843-876-2152|swansong@musc.edu|
22396006|NCT00232141|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22396007|NCT00782288|Johns Hopkins University|Pamela L. Zeitlin, M.D., Ph.D., Professor and Director of SOM Pediatric Pulmonary|443-287-8981|pzeitlin@jhmi.edu|
22396008|NCT00601250|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22396009|NCT01810016|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|(212) 450-1539|jskipper@lcr.org|
22396010|NCT05564299|Massachusetts General Hospital|Ingrid V Bassett|617-724-3341|ibassett@mgh.harvard.edu|
22396011|NCT04263896|University of Chicago|Dr. Sandra Laveaux|773-702-6118|slaveaux@bsd.uchicago.edu|
22396012|NCT06950879|Ghent University|Ruth Van der Looven|003293324237|ruth.Vanderlooven@uzgent.be|
22437246|NCT00566254|Eisai Call Center|Eisai Inc.|888-422-4743||
22437247|NCT00238238|Meyer Cancer Center, Weill Cornell Medical College|John P Leonard, M.D.||jpleonar@med.cornell.edu|
22437248|NCT04978818|Johns Hopkins School of Public Health|Dr. Laura Hammit|4436510000|lhammitt@jhu.edu|
22437249|NCT04517643|Johns Hopkins Medicine|Robert Hobbs|410-502-1229|rhobbs3@jhmi.edu|
22437250|NCT01007838|UWalesBangor|Danielle Kirkman|00 44 1248 388254|pepa03@bangor.ac.uk|
22437251|NCT02277119|Topcon|Charles Reisman|201-599-5283|CREISMAN@topcon.com|
22437252|NCT04699461|ADC Therapeutics|Contact ADC Therapeutics|954-903-7994|clinical.trials@adctherapeutics.com|
22437253|NCT00761527|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22437254|NCT00554372|SillaJen Biotherapeutics, Inc.|Manager, IP, Contracts, Translational Research|415 281 8886|tchiaverotti@sillajen.com|
22437255|NCT02301624|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22437256|NCT00895310|University of California Davis|Analyst|9167340294|pkaujla@ucdavis.edu|
22437257|NCT03738618|Ferring Pharmaceuticals|Global Clinical Compliance|-|DK0-Disclosure@ferring.com|
22437258|NCT01332253|Senior Manager, Clinical Operations|Byron Kaelin|615-255-0068|bkaelin@cumberlandpharma.com|250
22437259|NCT00491491|Chaim Sheba Medical Center|Dr Avichai Shimoni|972 3 530 5303|ashimoni@sheba.health.gov.il|
22437260|NCT01937260|Valeant Pharmaceuticals|Director of Clinical Trials|908|binu.alexander@valeant.com|
22437261|NCT00801229|Massachusetts General Hospital|Joseph Biderman, MD|617-726-1746||
22437262|NCT03032263|Wake Forest University Health Sciences|Dr. Thomas Templeton|336-716-4285|ttemplet@wakehealth.edu|
22437263|NCT02950480|University of California, San Francisco|Dr. Pamela Munster|(415) 885-7810|pamela.munster@ucsf.edu|
22437264|NCT01363661|ECSOR|Jacques Bruhwyler, Project Manager|3267444093|Jacques.Bruhwyler@ecsor.com|
22437265|NCT00705367|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22437266|NCT01959139|SWOG Statistical Center|SWOG Statistician|2066674623|mduong@fredhutch.org|
22437267|NCT01193114|The Ohio State University|Dr. Natasha Slesnick|614 247-8469|slesnick.5@osu.edu|
22437268|NCT02255461|St. Jude Children's Research Hospital|Jie Huang|9015955750|jie.huang@stjude.org|
22437269|NCT01378325|AUBMC|Sahar Siddik-Sayyid|9611350000|ss01@aub.edu.lb|6380
22437270|NCT01559675|Cedars Sinai Medical Center|Dr. Phillip Fleshner|310-289-9224|pfleshner@aol.com|
22437271|NCT01496469|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22437272|NCT01963845|University of California, San Diego|Rohit Loomba, MD professor of Medicine|858-543-2230|roloomba@ucsd.edu|
22437273|NCT01357551|Durham VA Medical Center|Dr. Corrine Voils|9192860411|corrine.voils@va.gov|5196
22437274|NCT02219334|Baylor College of Medicine|Shabana Yusuf/Associate Professor of Pediatrics|832-824-5388|syusuf@bcm.edu|
22437275|NCT04784143|Lykos Therapeutics|Study Director|877-627-7722|trialdata@lykospbc.com|
22437276|NCT06292130|Pro-Change Behavior Systems, Inc.|Sara Johnson, PhD|401.360.2980|sjohnson@prochange.com|
22437277|NCT00891228|NICHD|H. Trent MacKay, MD, MPH|301-435-6988|mackayt@mail.nih.gov|
22437278|NCT00118742|Hoffmann-La Roche|Medical Communications|800-821-8590||
22437279|NCT02445326|Ocular Therapeutix|Jamie L. Metzinger, Medical Affairs|781-357-4000|jmetzinger@ocutx.com|
22437280|NCT00930553|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22437281|NCT01964963|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22437282|NCT01235234|Can-Fite Biopharma|Pnina Fishman, PhD|011972 39241114|pnina@canfite.co.il|
22437283|NCT01015781|VA RR&D, NCRAR|James A. Henry, Ph.D., Principal Investigator|5032208262|james.henry@va.gov|57466
22437284|NCT00607867|Minneapolis VA Health Care System, Metabolic Research Labortory|Mary C. Gannon, Ph.D.|6124672895|ganno004@umn.edu|
22437285|NCT01177189|Salt Lake City VAMC|Van Reese|801 582 1565|van.reese@hsc.utah.edu|
22437286|NCT03606187|SGX Medical|VP of Clinical Affairs|6613108409|wpark@sgxmedical.com|
22437287|NCT03704688|Memorial Sloan Kettering Cancer Center|Dr. Kathryn Arbour|646-608-3792|arbourk@mskcc.org|
22437288|NCT01566500|Columbia University|Marie Chesaniuk|212-854-0127|mc3333@columbia.edu|
22437289|NCT00847886|Lexicon Pharmaceuticals, Inc.|Joel P. Freiman, MD, MPH - Medical Director, Drug Safety|281-863-3000||
22437290|NCT00183625|Semel Institute at UCLA|Stephen R. Marder, M.D.|310-268-3647|marder@ucla.edu|
22437291|NCT03400163|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22437292|NCT00842543|Nemours Children's Clinic|J. Atilio Canas MD|9046973600|jcanas@nemours.org|3674
22437293|NCT03276546|Queen's University, Belfast|Professor Margaret Cupples|07714233204|m.cupples@qub.ac.uk|
22437294|NCT01835158|Harvard|Toni K. Choueiri, MD|(617) 632-5456|toni_choueiri@dfci.harvard.edu|
22437295|NCT00596830|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22437296|NCT00887926|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22437297|NCT00939562|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22437298|NCT04865237|Imperial College London|Professor Christopher Chiu|02083832301|c.chiu@imperial.ac.uk|
22437299|NCT00293020|BioDelivery Sciences International|Andrew Finn, Pharm.D.|919-582-9050|AFinn@bdsi.com|
22437300|NCT01336023|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22437301|NCT01417455|Instituto de Medicina Molecular|João Eurico Fonseca|+351217999544|jecfonseca@gmail.com|47221
22437302|NCT04373746|Nationwide Children's Hospital|Dr. Joseph D. Tobias|614-722-4200|joseph.tobias@nationwidechildrens.org|
22437303|NCT03037983|Palo Alto VA|Jong Yoon|510-220-7086|jhyoon1@stanford.edu|
22437304|NCT01894022|GlaxoSmithKline|GSK Response Center|866-435-7343||
22437305|NCT02697188|Clarus Therapeutics|Theodore Danoff, MD, PhD|847-562-4300|tdanoff@clarustherapeutics.com|212
22437306|NCT02202538|Parker Hannifin Corporation|Ryan Farris|(216) 896-3335|ryan.farris@parker.com|
22437307|NCT04496453|Emory University|Lavanya Vasudevan, Ph.D., M.P.H., C.P.H.|404-727-3956|lavanya.vasudevan@emory.edu|
22437308|NCT01846741|Cyberonics, Inc.|Bita Najimipour, Clinical Study Manager|(281) 228-7370|bita.najimipour@cyberonics.com|
22437309|NCT01853878|GlaxoSmithKline|GSK Response Center|866-435-7343||
22396013|NCT06291831|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22396014|NCT01330134|University of Chicago|John P. Kress, MD|773-702-1000|jkress@medicine.bsd.uchicago.edu|
22396015|NCT00525044|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22396016|NCT02553265|NYU Langone Health|Horacio C Kaufmann, MD|212-263-7225|Horacio.Kaufmann@nyulangone.org|
22396017|NCT01653288|Children's Hospital of Philadelphia|Dr. Nancy Kassam-Adams|2155903118|adamsn@email.chop.edu|
22396018|NCT01817907|Brigham and women's Hospital|D. Andrew Wellman|617-732-8483|awellman@rics.bwh.harvard.edu|
22396019|NCT00659529|National Jewish Health|Jennifer L. Taylor-Cousar, MD|(303) 270-2764|Taylor-CousarJ@NJHealth.org|
22437310|NCT01361178|University of Pittsburgh|Andrej Petrov, MD|412-648-6215|petrovaa@upmc.edu|
22437311|NCT01399866|Massachusetts General Hospital - Harvard Medical School|A. Eden Evins, MD, MPH. Director of the MGH-Harvard Center for Addiction Medicine|6176434679|a_eden_evins@hms.harvard.edu|
22437312|NCT00767819|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22437313|NCT04294147|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22437314|NCT00604045|San Diego State University/University of California Joint Doctoral Program in Clinical Psychology|Dr. Nader Amir|6192293740|namir@mail.sdsu.edu|
22437315|NCT03029091|Cincinnati Children's Hospital Medical Center|Marc E. Rothenberg, MD, PhD|513 636-7177|marc.rothenberg@cchmc.org|
22437316|NCT03916081|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
22437317|NCT03929640|Milton S. Hershey Medical Center|Serdar Ural|717-531-6209|sural@pennstatehealth.psu.edu|
22437318|NCT04146935|Yale School of Medicine|Dr. Karl Insogna|203-785-3272|karl.insogna@yale.edu|
22437319|NCT01371305|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
22437320|NCT04038567|Duke University|Christopher Cox|919-681-7232|christopher.cox@duke.edu|
22437321|NCT02726022|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22437322|NCT00235716|Dept. of Veterans Affairs Cooperative Stduies Program|Peter Guarino, PhD, Director WH-CSPCC|203-932-5711|peter.guarino@va.gov|3780
22437323|NCT02999633|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22396020|NCT01086410|GlaxoSmithKline|GSK Response Center|866-435-7343||
22377010|NCT02548455|Abbott|Clay Cohorn, Clinical Program Director|972-309-8087|clay.cohorn@abbott.com|
22377011|NCT05095272|Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Dr. Patrick E. Duffy; Lab Chief|240.381.1317|patrick.duffy@nih.gov|
22377012|NCT01782443|DFCI|Dr. Jennifer Chan|617-632-6315|jang@partners.org|
22396021|NCT01022996|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registry@novartis.com|
22396022|NCT02767323|Duke University|Dr. Lysianne Beynel|9193386273|lysianne.beynel@gmail.com|
22396023|NCT00930722|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22396024|NCT03523728|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22396025|NCT00621751|Atrium Health; Currently at Indiana University School of Medicine|Flora Hammond, MD|317-292-6781|flora.hammond@rhin.com|
22396026|NCT02023242|Ivantis, Inc.|Richard Hope|949-333-1310|rhope@ivantisinc.com|
22377013|NCT00386880|Doylestown Hospital|Abraham A. Ashkenazi, MD-Principal Investigator|215-625-2894|aashkenazi2001@yahoo.com|
22377014|NCT03901326|People's Liberation Army General Hospital|Dr Junjie Yang|13581662680|fearlessyang@126.com|86
22377015|NCT02525874|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22377016|NCT02794285|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22377017|NCT00423176|Merck, Sharp & Dohme Corp.|Senior Vice Presdient, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22377018|NCT04535947|SilkTech Biopharmaceuticals|Brian Lawrence|6172720691|brianlawrence@silk-tech.com|
22377019|NCT02396745|Allegheny Singer Research Institute|Mara Yerk, Administrative Director|412-389-3059|mara.yerk@ahn.org|
22377020|NCT04111757|Bausch & Lomb|Johnson Varughese|9089271162|johnson.varughese@bausch.com|
22377021|NCT00420992|King Pharmaceuticals Research and Development, Inc.|Vice President, Clinical Development|919-653-7001||
22377022|NCT02003352|Brain Synergy Institute|Frederick R Carrick|321-868-6464|drfrcarrick@post.harvard.edu|
22377023|NCT04867369|NYU Langone Health|Arthur Hertling, MD|212-598-6085|arthur.hertling@nyulangone.org|
22377024|NCT04224155|Bausch & Lomb|Johnson Varughese|9089271162|johnson.varughese@bausch.com|
22377025|NCT03712891|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
22377026|NCT01904448|University of North Carolina at Chapel Hill|Craig A. Buchman, MD, FACS|314-362-7395|buchmanc@wustl.edu|
22377027|NCT03896035|VANTHCS|Una Makris, MD (PI)|2148570240|una.makris2@va.gov|
22377028|NCT01518868|Bausch Health|Study Director||robert.steffen@bausch.com|
22377029|NCT02635880|Cutera|Ginger Pocock|4156575702|gpocock@cutera.com|
22377030|NCT00930293|University of Pittsburgh|Jill M. Cyranowski, PhD|412-246-5588|cyranowskijm@upmc.edu|
22377031|NCT01798550|Emory University|Christine Kempton MD, MSc|404-778-1900|ckempto@emory.edu|
22377032|NCT01570829|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22377033|NCT00675766|West Los Angeles Veterans Association|Dr. Charles Hinkin|310-478-3711|chinkin@ucla.edu|44214
22377034|NCT01749982|Columbia University|Megan N Hall|212-305-3161|mh2825@columbia.edu|
22377035|NCT02677116|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22377036|NCT02958969|BWH|Gregory Piazza|6177326984|gpiazza@bwh.harvard.edu|
22396027|NCT00760019|Brigham and Women's Hospital|Dr. Joshua Beckman|617-732-6186|jbeckman@partners.org|
22396028|NCT04311697|Applied Pharma Rersearch|Paola Prina|4847169881|paola.prina@apr.ch|
22377037|NCT00694603|Massachusetts General Hospital|Dr. Lecia Sequist|617-724-4000|lvsequist@partners.org|
22377038|NCT01684748|Virginia Polytechnic Institute & State University|Elaina Marinik, Ph.D.|5402318299|emarinik@vt.edu|
22411283|NCT03979677|Vanderbilt University Medical Center|Richard A. Roberts, Ph.D.|6153227384|richard.a.roberts@vanderbilt.edu|
22377039|NCT01207102|Duke University Medical Center|Dr Kimberly Blackwell|919-6681748|black034@mc.duke.edu|
22437324|NCT01545050|CSL behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
22437325|NCT01124955|Federal University of São Paulo|Tatiana Molinas Hasegawa|55 115576 4239|tatianamolinas@hotmail.com|
22437326|NCT02249182|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22437327|NCT03274518|University of São Paulo|Dr. Bruno Caldin da Silva|+5511997620521|bruno.caldin@hc.fm.usp.br|
22437328|NCT00692419|VA Pittsburgh Healthcare System, Center for Health Equity Research and Promotion|Steven D. Weisbord MD|412-360-3911|steven.weisbord@va.gov|
22437329|NCT04450329|Samsung Bioepis Co., Ltd|Director of Clinical Trials|+82-32-728-0371|sbregistry@samsung.com|
22437330|NCT03244826|Dana-Farber Cancer Institute|Dr. Gregory Abel (Principal Investigator)|617-632-1906|gregory_abel@dfci.harvard.edu|
22437331|NCT04356040|Abbott|Anne Sarver|6517563813|anne.sarver@abbott.com|
22437332|NCT00416455|NRG Oncology Statistics and Data Management Center|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22437333|NCT01008449|UAB|Principal Investigator|205-934-3411|dana_figueroa_marzilli@hotmail.com|
22437334|NCT01114438|GI Dynamics|Clinical Affairs Manager|781.357.3263|kwoessner@gidynamics.com|
22437335|NCT00428844|Cubist Pharmaceuticals, Inc.|Ed Campanaro, VP Clinical Operations|781-860-8318|ed.campanaro@cubist.com|
22437336|NCT00753363|Baltimore VAMC|Dr. Alice Ryan|410-605-7851|aryan@grecc.umaryland.edu|
22437337|NCT00492336|Maryland Psychiatric Research Center|Dr. Robert Buchanan, M.D.|410-402-7876|rbuchanan@som.umaryland.edu|
22437338|NCT03043651|United Therapeutics|Louis Holdstock|919-425-8866|lholdstock@unither.com|
22437339|NCT01345669|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22437340|NCT01793883|Aviragen Therapeutics, Inc.|Anna Novotney-Barry|678-221-3356|abarry@aviragentherapeutics.com|
22437341|NCT01549925|Huntsman Cancer Institute|Mark Wade|801-213-5746|mark.wade@hci.utah.edu|
22437342|NCT02353728|Weill Cornell Medical College|Dr.Ellen K.Ritchie|646-962-2700|ritchie@med.cornell.edu|
22437343|NCT04254666|University of Massachusetts Chan Medical School|Carol Curtin|774-455-6527|carol.curtin@umassmed.edu|
22437344|NCT02566317|Arizona State University|Matthew Buman, PhD|602-827-2289|mbuman@asu.edu|
22437345|NCT02611817|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22437346|NCT02798978|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22437347|NCT02475278|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22437348|NCT03712787|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22437349|NCT01865448|Unidad de Apoyo a la Investigacion. Hospital Rio Hortega|Dr. Daniel de Luis|983420400|dadluis@yahoo.es|83523
22437350|NCT03499314|NYU Langone Health|Leigh Charvet, PhD|(929) 455-5141|Leigh.Charvet@nyulangone.org|
22437351|NCT01618695|Eisai Co., Ltd.|Inquiry Service.||eisai-chiken_hotline@hhc.eisai.co.jp|
22437352|NCT00952081|UMDNJ|Alex Bekker, MD, PhD|973-972-5007|bekkeray@umdnj.edu|
22437353|NCT00439296|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
22437354|NCT01016600|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
22437355|NCT04794270|Johnson & Johnson VIsion Care, Inc.|Benjamin Straker - Principal Research Optometrist|1-904-312-0604|bstraker@its.jnj.com|
22437356|NCT00954993|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22437357|NCT01271725|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22437358|NCT00704938|National Cancer Institute, National Institues of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
22437359|NCT00265317|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com|
22437360|NCT00725049|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
22437361|NCT00732875|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22437362|NCT03826186|University of Iowa Hospitals and Clinics|Vice Chair for Research|319-335-9595|donna-hammond@uiowa.edu|
22437363|NCT02300259|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22437364|NCT02737475|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22437365|NCT02510001|University of Oxford Clinical Trials and Research Governance (CTRG)|Heather House|01865 572245|heather.house@admin.ox.ac.uk|
22437366|NCT06831513|UT Southwestern Medical Center - School of Health Professions|Dara Spivey, CPO, LPO|(214) 645-8250|dara.spivey@utsouthwestern.edu|
22437367|NCT05148806|NHS Blood and Transplant|Gillian Powter Trial Manager|44 7590 353091|gillian.powter@nhsbt.nhs.uk|
22437368|NCT04042324|Rockwell Medical, Inc|Raymond Pratt, MD|248 960 9009|rpratt@rockwellmed.com|405
22437369|NCT03251937|Boston Scientific|Director of Clinical Sciences|661 949 4350|roshini.jain@bsci.com|
22437370|NCT00724984|Pharmacyclics|Dr. Thorsten Graef|855-427-8846|pharmacyclics@medcomsol.com|
22437371|NCT01468350|Acorda Therapeutics, Inc.|Vice President - Clinical Development & Medical Affairs|914-347-4300|hhenney@acorda.com|
22437372|NCT04648683|Vanderbilt University Medical Center|Carrie Brintz|615-875-9885|carrie.brintz@vumc.org|
22437373|NCT01362894|Alcon Research, Ltd.|Stacie Cummings, O.D.|1-800-241-7629||
22437374|NCT00711971|University of Michigan|Ellen Mozurkewich, Adjunct Assistant Professor|(734) 546-2772|emozurkewich@salud.unm.edu|
22437375|NCT01336413|VHA Durham|Christine E. Marx, MD MA|9192860411|christine.marx@va.gov|3626
22437376|NCT00887549|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22437377|NCT03041896|MCRA|Glenn Stiegman|2025525800|gstiegman@mcra.com|
22437378|NCT01317901|Aptevo Therapeutics|Scott C. Stromatt|206-859-6675|sstromatt@apvo.com|
22437379|NCT02097030|CooperVision|Jose A. Vega, OD, Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|jvega@coopervision.com|
22437380|NCT01919801|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22437381|NCT01059994|University of Texas Medical Branch|Melinda Sheffield-Moore|4097728126|melmoore@utmb.edu|
22437382|NCT01677858|Amgen Inc.|Study Director|866-572-6436||
22377040|NCT01018394|Mayo Clinic|Dr. Jon Ebbert|507-266-1944|nicotineresearch@mayo.edu|
22377041|NCT03792126|University Hospitals Dorset NHS Foundation Trust|Louise Johnson|0300 019 4473|Louise.Johnson@uhd.nhs.uk|
22377042|NCT04302350|The First Affiliated Hospital of Nanjing Medical University|Dr.cunming Liu|13951890866|cunmingliu@njmu.edu.cn|
22377043|NCT00490646|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22377044|NCT04184791|Feinstein Institute for Medical Research at Northwell|Dr. Ritesh Ramdhani|516-325-7000|rramdhani@northwell.edu|
22377045|NCT00983073|Grünenthal GmbH|Clinical Trial Helpdesk|+49 241 569|clinical-trials@grunenthal.com|3223
22377046|NCT01417026|Children's Hospital of Philadelphia|Robert Schultz, PhD|267-426-7540|schultzrt@email.chop.edu|
22377047|NCT02962908|PepTcell Ltd (trading as SEEK)|Dr Olga Pleguezuelos, Chief Scientific Officer|+44 020 7153 6601|olga.pleguezuelos@seekacure.com|
22377048|NCT03543254|St. Olavs Hospital HF|Knut Hagen|+4795401579|knut.hagen@ntnu.no|
22377049|NCT02077166|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22377050|NCT02899728|Dana- Farber Cancer Institute|Jacob Sands, MD|617-632-6049|Jacob_Sands@DFCI.HARVARD.EDU|
22377051|NCT01962493|GlaxoSmithKline|GSK Response Center|866-435-7343||
22377052|NCT01951625|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22377053|NCT01839734|The Ruth M. Rothstein CORE Center|Dr. Gregory Huhn|312-572-4575|ghuhn@cookcountyhhs.org|
22377054|NCT03754803|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22377055|NCT05338333|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22377056|NCT04951336|Krupp Center for Integrative Research, University of California San Diego|Gordon Saxe, M.D./Ph.D.|6195435765|gsaxe@health.ucsd.edu|
22377057|NCT04348604|Case Western Reserve University|Joy Yala, Data Manager|216-368-0783|jxy790@case.edu|
22377058|NCT05745142|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22377059|NCT01100255|Stanford University|Dr. Carolyn Rodriguez, Assistant Professor|6507236158|carolynrodriguez@stanford.edu|
22377060|NCT03073148|Tangible Science|Director of Research and Development|650-241-1045|kelly@tangiblescience.com|108
22377061|NCT02822222|RMJ Holdings LLC d/b/a RMJH Rx|Russell Jaffe, M.D., Chief Executive Officer|(703) 840-4440|rjaffe@rmjholdings.com|
22377062|NCT00833560|Jan-Cil Germany|Therapeutic Areas Director|+49 2137 955-492||
22377063|NCT00414817|Kaiser Permanente, Center for Health Research|Dr. William Vollmer, Senior Investigator|503-335-6755||
22377064|NCT03382782|Illinois Institute of Technology|Dr. Lindsay Sheehan, Co-Investigator|312-567-7983|lsheehan@iit.edu|
22377065|NCT01143688|National Jewish Health|Michael E. Wechsler M.D.|617-285-4987|wechslerm@NJHealth.org|
22377066|NCT01791725|Transition Therapeutics Ireland Limited|Aleksandra Pastrak,MD, PhD, VP of Clinical Development and Medical Officer|+1 416 263 1227|apastrak@transitiontherapeutics.com|
22377067|NCT00385580|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22377068|NCT02690974|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22377069|NCT01666951|Veloxis Pharmaceuticals|Christina Sylvest|+4520553877|csy@veloxis.com|
22377070|NCT03148470|University of Fribourg|Prof. Dr. Jean-Marie Annoni|++4126 306 3802|jean-marie.annoni@unifr.ch|
22377071|NCT03338894|Atlantic Children's Health/Atlantic Health Outpatient|Dr. Alycia Leiby|973--971-5676|alycia.leiby@atlantichealth.org|
22377072|NCT01826227|Memorial Sloan Kettering Cancer Center|Dennis Chi, MD|212-639-5016|chid@mskcc.org|
22377073|NCT03294330|Penn State College of Medicine|Colette Pameijer|717-531-5272|cpameijer@pennstatehealth.psu.edu|
22377074|NCT04452292|University of Kentucky|Dr. Charles Kunos|859-323-2354|charles.kunos@uky.edu|
22377075|NCT04139564|AppliedVR|Vice President of Research|13108901584|tmaddox@appliedvr.io|
22377076|NCT02249819|Northwell Health|Johanna Chang, Senior Research Coordinator|(516)562-3646|jchang14@northwell.edu|
22377077|NCT00254982|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22377078|NCT02261493|Allergan, Inc|Tanya Brandstetter|714-246-2567|brandstetter_tanya@Allergan.com|
22377079|NCT00558428|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22377080|NCT02570126|GlaxoSmithKline|GSK Response Center|866-435-7343||
22377081|NCT00626028|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22377082|NCT05224050|Rutgers, The State University of New Jersey|Dr. Teresa Leyro|848-445-2090|tml124@psych.rutgers.edu|
22377083|NCT01335204|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
22377084|NCT01292876|University of Pittsburgh|Maria Alexander, Office Manager|412-624-5308|alexanderm3@upmc.edu|
22377085|NCT00917579|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22377086|NCT01627327|GlaxoSmithKline|GSK Response Center|866-435-7343||
22377087|NCT04208516|UPMC|Jeremy Kearns, MD|412-623-5296|kearnsjt@upmc.edu|
22377088|NCT01175850|Medtronic - CardioVascular|Clinical Research Director|+31433566580|kristel.wittebols@medtronic.com|
22377089|NCT04294966|University of Chicago|Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
22377090|NCT05763628|CooperVision Inc.|José A. Vega OD, PhD, MSc, FAAO|+19256213761|jvega2@coopervision.com|
22377091|NCT01137474|Clinical Trial Transparency|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com|
22377092|NCT02161133|Veterans Affairs New Jersey Healthcare System|Lisa McAndrew|862-400-3317|lisa.mcandrew@va.gov|
22377093|NCT01515410|Depomed|Head of R&D|510-744-8000|msweeney@depomed.com|
22377094|NCT00363675|Shrines Hospitals for Children - Boston|Mary Jo Baryza, Diredtor of Therapeutic Services|617-371-4749|mbaryza@shrinenet.org|
22377095|NCT00868439|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com|
22377096|NCT01132326|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
22377097|NCT04109703|Soovu Labs|Charles Chabal, MD|206-579-4910|Chuck@Soovu.com|
22377098|NCT00338884|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22377099|NCT00911534|Eisai Call Center|Eisai Inc.|888-422-4743||
22437383|NCT00988091|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22437384|NCT01806675|Stanford University|Sanjiv Sam Gambhir, Professor for Clinical Investigation in Cancer Research and Professor|650-725-6175|sgambhir@stanford.edu|
22437385|NCT03078855|University of Rochester|Michael Brady, PhD|585-275-5830|michael_brady@urmc.rochester.edu|
22437386|NCT00391027|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22437387|NCT03194646|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
22437388|NCT04869358|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22437389|NCT05232864|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
22437390|NCT04493203|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MSCCR, CCRP, Clinical Research Manager|4126475554|stadtermanbm@upmc.edu|
22437391|NCT00773773|Memorial Sloan Kettering Cancer Center|Dr. Paul Tempst, PhD|212-639-8923|liljah@mskcc.org|
22437392|NCT03068754|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
22437393|NCT01110382|Janssen R&D US|Therapeutic Areas Director||ClinicalTrialDisclosure@its.jnj.com|
22437394|NCT00098306|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22437395|NCT00129467|Portland Veterans Affairs Medical Center|Dr. Linda Ganzini|(503) 220-8262|linda.ganzini@va.gov|56492
22437396|NCT01009086|Janssen Research & Development, LLC|Director, Clinical Research|1-800-526-7736||
22437397|NCT01192828|University of Colorado Denver|Dr. Johan Van Hove, Primary Investigator|303-724-2338|johan.vanhove@childrenscolorado.org|
22437398|NCT02456857|MD Anderson Cancer Center|Dr. Clinton Yam|(832) 589-8343|cyam@mdanderson.org|
22437399|NCT00781859|ThromboGenics|Petra Kozma-Wiebe|+32 16751310|petra.kozma@thrombogenics.com|
22437400|NCT01138501|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22437401|NCT00360568|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22437402|NCT03696589|Teachers College, Columbia University|Lori Quinn|212-678-3424|lq2165@tc.columbia.edu|
22437403|NCT01220180|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22437404|NCT01990859|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22437405|NCT00348309|GlaxoSmithKline|GSK Response Center|866-435-7343||
22437406|NCT01338857|New York University Langone Medical Center|Matthias A. Karajannis, MD|212-263-9630|matthias.karajannis@nyumc.org|
22437407|NCT04016844|University of Iowa|Dr.Thorsten Rudroff|17205323701|thorsten-rudroff@uiowa.edu|
22437408|NCT01364389|Novartis Pharmaceuticals|Study Director|862-778-8300||
22437409|NCT01534195|Ora|Keith Lane|9786896500|klane@oraclinical.com|
22437410|NCT02554981|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22437411|NCT00516165|Massachusetts General Hospital|Dr.Andrew X. Zhu|617-724-4000|azhu@mgh.harvard.edu|
22437412|NCT00767767|Weill Cornell Medicine|Kane Pryor|(212) 746-2969|kap9009@med.cornell.edu|
22437413|NCT03068767|Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation|Chief of internal medicine department|+886-2-6628-9779|uld888@yahoo.com.tw|2317
22437414|NCT00061633|Theravance, Inc|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
22437415|NCT01431963|GlaxoSmithKline|GSK Response Center|866-435-7343||
22437416|NCT01946152|UT MD Anderson Cancer Center|Michael Wang,MD/ Professor, Lymphoma-Myeloma|(713) 792-2860|miwang@mdanderson.org|
22437417|NCT02291419|Cleveland Clinic|Dr. Venu Menon|216-445-5390|menonv@ccf.org|
22437418|NCT00931606|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22437419|NCT00871338|GlaxoSmithKline|GSK Response Center|866-435-7343||
22437420|NCT02391363|Baylor College of Medicine|Melinda A. Stanley, PhD|713-794-8841|mstanley@bcm.edu|
22437421|NCT00799266|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22437422|NCT00872599|Vanderbilt University|Nancy J. Brown, M.D.|615-343-8701|nancy.j.brown@vanderbilt.edu|
22437423|NCT01336140|Rush University Medical center|Rami Doukky|312-942-4655|rami_doukky@rush.edu|
22437424|NCT01504841|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22437425|NCT04756804|Zurex Pharma, Inc.|VP, Reg Affairs|608.203.9090|customercare@zurexpharma.com|
22437426|NCT03149055|Memorial Sloan Kettering Cancer Center|Genovefa Papanicolaou MD|212-639-8361|papanicg@mskcc.org|
22437427|NCT04440813|Vanderbilt University Medical Center|Dr. Carolyn Audet|615-343-2418|carolyn.m.audet@vumc.org|
22437428|NCT00660179|Actelion Pharmaceuticals Ltd|Parisa Danaietash||parisa.danaietash@actelion.com|
22437429|NCT04120402|Eupraxia Pharmaceuticals Ltd.|Chief Scientific Officer|250-590-3968|amalone@eupraxiapharma.com|
22437430|NCT00581581|University of Rochester|Ronnie Guillet, MD, PhD|585-275-6209|ronnie_guille@urmc.rochester.edu|
22377100|NCT02133534|Duke University Medical Center|Research Practice Manager|919 681 6819|bixby001@duke.edu|
22377101|NCT05072080|Bavarian Nordic|Medical Information|1-844-422-8274|medical.information_na@bavarian-nordic.com|
22377102|NCT03492281|Urovant Sciences|Information, Clinical Trial Results|949-226-6029|info@urovant.com|
22377103|NCT03342638|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
22377104|NCT00554970|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
22377105|NCT03028974|Stanford University|Cornelia Dekker, MD|650-724-4437|cdekker@stanford.edu|
22377106|NCT02654808|Columbia University|Dr. Timothy Ryntz|212-305-4973|ter2111@cumc.columbia.edu|
22377107|NCT00113568|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22437431|NCT00291018|DePuy Synthes Spine|Erin Prifogle|508-977-6451|eprifog1@its.jnj.com|
22437432|NCT01504412|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|+81 362251111 (M-F 9-5 JST)|dsclinicaltrial@daiichisankyo.co.jp|
22377108|NCT01625221|Torax Medical, Inc.|VP of Clinical Affairs|651-361-8900|aderosier@toraxmedical.com|
22377109|NCT02191267|Brigham and Women's Hospital|Dr. Martha Shenton|617-699-6152|shenton@bwh.harvard.edu|
22377110|NCT02186210|Seoul National University Hospital Dept of Anesthesiology|Dr Yunseok Jeon|82-2-2072-2465|jeonyunseok@gmail.com|
22377111|NCT03213158|University of Wisconsin - Madison|Fahid Aziz, MD|(608) 262-5420|faziz@wisc.edu|
22377112|NCT00587964|Memorial Sloan Kettering Cancer Center|Dr. Kathryn Beal|212-639-5159|bealk@mskcc.org|
22377113|NCT01921296|University of Michigan Hospital|Dr. Norah Lynn Henry, Associate Professor of Internal Medicine|734-936-4991|norahh@umich.edu|
22377114|NCT01569438|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22377115|NCT03649230|Purdue Pharma (Canada)|Graeme Donnelly|905.837-6498|graeme.donnelly@purdue.ca|
22437433|NCT00630344|Dana-Farber Cancer Institute|Mary-Ellen Taplin, MD|617-582-8313|mary_taplin@dfci.harvard.edu|
22377116|NCT00452387|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com|
22377117|NCT00579280|University of South Florida College of Medicine|David V. Sheehan, MD, MBA|813-974-4544|dsheehan@health.usf.edu|
22377118|NCT01693068|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22377119|NCT04126408|northwell health|northwell health|5165620100|trebeiz@northwell.edu|
22377120|NCT03591068|Optinose|Jennifer Carothers|908-432-3061|jennifer.carothers@optinose.com|
22377121|NCT00617344|Sanofi Pasteur Inc.|Medical Director||Contact-US@sanofi.com|
22377122|NCT02747238|Icahn School of Medicine at Mount Sinai|Dr. Barbara Orlando|917-496-7490|barbara.orlando@mountsinai.org|
22377123|NCT02258477|University of Colorado, Anschutz Health and Wellness Center|Dr. James Hill|303-724-9974|james.hill@ucdenver.edu|
22377124|NCT05245864|UAMS|Arny A. Ferrando|501-526-5711|AFerrando@uams.edu|
22377125|NCT01475136|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22377126|NCT01323530|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
22377127|NCT01077830|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22377128|NCT01194570|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22377129|NCT04171102|University of Cagliari|Prof. Dr. Giuseppe Amato|337963197|amatomed@gmail.com|
22377130|NCT01751126|Santen Inc|R&D Quality Manager|4152689199|evelyn.chikere@santen.com|
22377131|NCT01377480|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22377132|NCT00915031|University of California, Irvine|Linda Huynh|7144567354|lindamh@uci.edu|
22377133|NCT00876915|University of Rochester|Charles Francis, MD|(585) 275-5823|charles_francis@urmc.rochester.edu|
22377134|NCT02673398|City of Hope|Dr. Yuan Yuan|626-359-8111|Yuyuan@coh.org|
22377135|NCT01735201|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22377136|NCT02063230|AstraZeneca|Gabriella Mariani|+44 7818 523 899|ClinicalTrialTransparency@astrazeneca.com|
22377137|NCT02238925|Jazz Pharmaceuticals|Associate Director, Clinical Trial Disclosure & Transparency||tom.chmielewski@jazzpharma.com|
22377138|NCT01203930|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22377139|NCT02178059|AstraZeneca R&D|Göran Eckerwall, Medical Science Director|1-800-236-9933|Goran.Eckerwall@astrazeneca.com|
22377140|NCT01835262|Maimonides Medical Center|Antonios Likourezos|718-283-6896|alikourezos@maimonidesmed.org|
22377141|NCT01266850|Vanderbilt University Medical Center|Kathryn M. Edwards, MD|615-322-3078|kathryn.edwards@vanderbilt.edu|
22377142|NCT05616962|Primus Pharmaceuticals, Inc.|Director of Clinical Trials|480-483-1410|info@primusrx.com|
22377143|NCT04924283|Medical University of South Carolina|Christine Hahn|843-518-2875|hahnc@musc.edu|
22377144|NCT00857207|Malcom Randall VAMC|Julia Kay Waid-Ebbs, Health Science Specialist|352-871-0282|Julia.Waid-Ebbs@va.gov|
22377145|NCT02030015|University of Minnesota|Jeanine Jarnes, PharmD|612-626-5131|utzx0002@umn.edu|
22377146|NCT04098406|Clene Nanomedicine|Jeremy Evan, PA-C|5419086335|jeremy@clene.com|
22377147|NCT03014674|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22377148|NCT01332227|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22377149|NCT03764449|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22377150|NCT00477230|CardioFocus, Inc.|Burke T. Barrett, Study Director|508 658-7200|bbarrett@cardiofocus.com|
22377151|NCT01316510|UC Davis|Mark Underwood|916-734-8672|munderwood@ucdavis.edu|
22377152|NCT01785680|Washington University School of Medicine in St. Louis|Mark Manary|3144542178|manary@kids.wustl.edu|
22377153|NCT00428090|GlaxoSmithKline|GSK Response Center|866-435-7343||
22377154|NCT03409666|Zimmer Biomet|Lisette Smid|+31 62 395 6378|lisette.smid@zimmerbiomet.com|
22377155|NCT00361140|Moffitt Cancer Center|Dr. Teresa Field|(813) 745-7202|Teresa.Field@moffitt.org|
22377156|NCT02366910|Coopervision|Jose A. Vega, OD, Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|jvega@coopervision.com|
22377157|NCT02623322|Hoffmann-La Roche|Medical Communications|(+41) 616878333|global.trial_information@roche.com|
22377158|NCT03104699|Agenus, Inc.|Clinical Trial Information|1-781-674-4265|clinicaltrialinfo@Agenusbio.com|
22377159|NCT02462876|W. L. Gore & Associates|Eric Novak|314-440-2119|enovak@wlgore.com|
22377160|NCT01786512|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22377161|NCT02450331|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22377162|NCT02080871|W.L. Gore & Associates|Hector R Novoa|928-864-3867|hnovoa@wlgore.com|
22377163|NCT00234052|Northwestern University|Clinical Trials Office|312-695-1301||
22377164|NCT01410474|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22377165|NCT02428296|Children's National Medical Center|Dr. Kim Keppler-Noreuil|2024766287|kkepplerno@childrensnational.org|
22377166|NCT03384173|University of Wisconsin, Madison|Matthew Harer|608-417-6236|mwharer@wisc.edu|
22377167|NCT04493931|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22377168|NCT01291498|Oxford University Hospitals NHS Trust|Mr Radu Mihai||radu.mihai@ouh.nhs.uk|
22377169|NCT00420199|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22437434|NCT01626092|Masonic Cancer Center, University of Minnesota|Weston P Miller, MD|612-626-2778|mill4991@umn.edu|
22437435|NCT05690555|Cleveland Clinic|Cecile Ferrando, M.D.|216-444-0642|ferranc2@ccf.org|
22437436|NCT05362058|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22437437|NCT02380443|Mirror Biologics, Inc|Dr. Michael Har-Noy|7602167494|harnoy@mirrorbio.com|
22437438|NCT00921843|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
22437439|NCT03626545|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
22437440|NCT05651867|Quantum Surgical|Marion Chassouant|0033781425198|m.chassouant@quantumsurgical.com|
22437441|NCT02462720|BTG International Inc.|Lynn Allen|425-410-3152|lynn.allen@btgplc.com|
22437442|NCT00972530|Department of Research and Development County Council of Gavleborg/Uppsala University|Dr Tomas Weitoft|+46 26 154388|tomas.weitoft@lg.se|
22437443|NCT03397342|Montefiore Medical Center|Dr. Madhur Garg|718-920-4140|mgarg@montefiore.org|
22437444|NCT04240574|Rosalind Franklin University|Jacque Ortiz|847-578-8423|jacquelyn.ortiz@rosalindfranklin.edu|
22437445|NCT05173012|Sage Therapeutics|Carrie Vaudreuil|(857) 259-4766|carrie.vaudreuil@sagerx.com|
22437446|NCT03668613|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22437447|NCT01858740|Fred Hutchinson Cancer Center|Marie Bleakley, MD|206-667-6572|mbleakle@fredhutch.org|
22437448|NCT00972725|GlaxoSmithKline|GSK Response Center|866-435-7343||
22437449|NCT00517361|The University of Chicago|Dr. Rita Nanda|773-834-2756|rnanda@medicine.bsd.uchicago.edu|
22437450|NCT01077401|University of Nebraska|Quan Dong Nguyen, MD, MSc|4025591855|quan.nguyen@unmc.edu|
22437451|NCT01340053|Ardelyx|Chief Development Officer|510 745 1752|drosenbaum@ardelyx.com|
22437452|NCT00734968|University of Missouri|Daniel Jackson MD|573 499 6041|jacksondl@health.missouri.edu|
22437453|NCT00286494|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22437454|NCT04776317|Saint Louis University|Daniel F. Hoft, MD, PhD|314-977-5500|daniel.hoft@health.slu.edu|
22437455|NCT00896025|University of Texas Southwestern Medical Center|William M. Lee, MD|214-645-6111|william.lee@utsouthwestern.edu|
22437456|NCT03100058|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22437457|NCT00465088|Abbott|Global Medical Services|800-633-9110||
22437458|NCT03671304|UT Southwestern Medical Center|Dr. Muhammad Beg|214-648-4180|muhammad.beg@utsouthwestern.edu|
22437459|NCT01067144|Stanford University|Dr. Ian Carroll|(650) 723-6411|ic38@stanford.edu|
22437460|NCT01871441|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Neal Flomenberg|215 955-0182|dolores.gross@jefferson.edu|
22437461|NCT02718716|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22437462|NCT01578577|Northwestern University|Dr. Stephen Persell|312-503-6464|spersell@nm.org|
22437463|NCT00646399|Biosynexus|Irwin Scher, MD|301-330-5800|irwinscher@biosynexus.com|
22437464|NCT04067609|Yale School of Medicine|Dr Audrey Merriam|203-785-7813|audrey.merriam@yale.edu|
22437465|NCT04765202|Mallinckrodt|Medical Information Call Center|800-844-2830|medinfo@mnk.com|
22437466|NCT04929249|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22437467|NCT05758402|Novartis Pharmaceuticals|Study Director|1 862 778 8300|Novartis.email@Novartis.com|
22437468|NCT02332291|Vanderbilt University Medical Center|Warren D. Taylor, MD, MHSc|615-322-1073|warren.d.taylor@vumc.org|
22437469|NCT01987583|Ministry of Health|Dr. Nouran Aleyeidi|00966504304577|dr.nouran@live.com|
22437470|NCT01424228|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22437471|NCT00844558|University of Iowa|Neil Segal|3193560737|segal-research@uiowa.edu|
22437472|NCT02951429|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22437473|NCT01436266|Boston Medical Center|Sarita Sonalkar, MD|617 414 7304|sarita.sonalka@bmc.org|
22437474|NCT01628965|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22437475|NCT02841241|Intermountain Medical Center|Office of Research|8015077000|officeofresearch@imail.org|
22437476|NCT02387008|University of North Carolina at Chapel Hill|Gidgetta Kang|919-537-3968|gidget_jenkins@unc.edu|
22437477|NCT04356352|Wake Forest University Health Sciences|Michael Norton, MD|336-716-8791|mnorton@wakehealth.edu|
22437478|NCT05546229|Cari Health Inc.|Chief Medical Officer|619 2343725|drcarr@carihealth.com|
22437479|NCT01983774|Columbia University|Emily DiMango, MD|212-305-0631|ead3@cumc.columbia.edu|
22437480|NCT01339897|N30 Pharmaceuticals Inc.|Janice M Troha|720-945-7714|janice.troha@n30pharma.com|
22437481|NCT00847197|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22437482|NCT00622388|GlaxoSmithKline|GSK Response Center|866-435-7343||
22437483|NCT01068158|Sanofi Topaz|Medical Director||RegistryContactUs@sanofipasteur.com|
22437484|NCT02478255|Duke University|Bastiaan Driehuys, PhD (Professor of Radiology)|919 684-7786|bastiaan.driehuys@duke.edu|
22437485|NCT02813889|Penn Medicine Center for Physical Medicine and Rehabilitation|Dr. Michelle J. Johnson|4148130128|johnmic@pennmedicine.upenn.edu|
22437486|NCT05128578|University of Pittsburgh|Shari Rogal|412-360-6177|rogalss@upmc.edu|
22437487|NCT05589610|Equillium, Inc.|Clinical Trial Manager|8582401200|clinicaltrials@equilliumbio.com|
22377170|NCT00754338|Centre for Contact Lens Research|Craig A Woods, Research Manager|1 519 888 4567|cawoods@sciborg.uwaterloo.ca|36547
22437488|NCT05224453|Prince Sattam bin Abdulaziz University|Dr. Gopal Nambi|0501878382|physio_gopal@rediffmail.com|
22437489|NCT01128244|University of Florida|Dr. Jesse F. Gregory|(352) 392-1991|jfgy@ufl.edu|225
22437490|NCT02974257|BIDMC|Dr. Katherine Berg|617-754-2281|kberg@bidmc.harvard.edu|
22377171|NCT00831779|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
22437491|NCT00398567|Puma Biotechnology, Inc|Senior Director, Clinical Operations|+1 424 248 6500|clinicaltrials@pumabiotechnology.com|
22437492|NCT02837029|Northwestern University, Feinberg School of Medicine|Aparna Kalyan, MBBS, FRACP|312 926 4291|Aparna.kalyan@northwestern.edu|
22396029|NCT00931242|Tufts Medical Center|Alice B Gottlieb, MD, PhD|617 636 4802|agottlieb@tuftsmedicalcenter.org|
22396030|NCT03498131|Providence Health & Services|Director of PBSI /WC Clinical Research Program|(503) 216-1012|Chiayi.Chen@providence.org|
22396031|NCT03383289|Columbia University in the City of New York|Jeanne Teresi, EdD, PhD|212-305-9379|jat61@cumc.columbia.edu|
22437493|NCT01363908|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22437494|NCT05258149|Johnson & Johnson Vision Care, Inc.|Thomas R. Karkkainen, OD, MS, FAAO|1-800-843-2020|TKarkkai@its.jnj.com|
22437495|NCT03370042|Kamineni Institute of dental sciences|Dr. Raga Bindu|09849441800|ragha.j16@gmail.com|
22437496|NCT03437577|University of Minnesota|Susan Marino|612-624-2964|marin007@umn.edu|
22377172|NCT04020341|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22437497|NCT01013194|ISMETT-UPMC|Dr Giada Pietrosi|+390912192111|gpietrosi@ismett.edu|
22437498|NCT00526591|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|Dr. Jorge Garcia|216-444-7774|garciaj4@case.edu|
22437499|NCT02461927|VA CT Healthcare System, Yale University|Dr. Gihyun Yoon|(203) 932-5711|gihyun.yoon@yale.edu|7421
22437500|NCT04273893|University of Virginia|UVA Radiation Oncology Clinical Research Coordinator|434-243-0008|UVARADONCClinicalTrials@uvahealth.org|
22437501|NCT04774926|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22437502|NCT01393639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22437503|NCT05613257|Cedars Sinai Medical Center|Joel Arnold|310-423-9839|joel.arnold@cshs.org|
22437504|NCT04274556|Demiroglu Bilim University|Nurten OZEN|+90 212 213 64 86|ozenurten@yahoo.com.tr|
22437505|NCT00793325|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22437506|NCT01440816|OncoSec Medical Incorporated|Sharron E Gargosky, Chief Clinical Regulatory Officer|+1 858-255-4729|ClinicalTrialsInfo@OncoSec.com|
22437507|NCT00694018|VA Ann Arbor Center for Clinical Management Research|Sarah L. Krein, PhD, RN|734-845-3621|sarah.krein@va.gov|
22437508|NCT00345865|Masonic Cancer Center, University of Minnesota|Dr.Veronika Bachanova|612-625-5469|bach0173@umn.edu|
22437509|NCT02159976|Department of Internal Medicine, Seoul National University Bundang Hospital|Nayoung Kim, M.D., Ph.D.|+ 82-31-787-7008|nayoungkim49@empas.com|
22437510|NCT03250182|Pearl Therapeutics, Inc.|Pearl Therapeutics, Inc.|1-877-240-9479|information.center@astrazeneca.com|
22437511|NCT05979922|Photozig, Inc.|Bruno Kajiyama|6506947595|info@photozig.com|
22437512|NCT00100789|SWOG Statistical Center|Study Statistician|206-667-4623||
22437513|NCT02936843|The University of Michigan|Rodica Pop-Busui, MD, PhD|Phone 734-647-9809|rpbusui@med.umich.edu|
22437514|NCT03472950|University of Kansas Medical Center|Jeffrey Statland, MD|913-945-9933|Jstatland@kumc.edu|
22437515|NCT01393821|Mayo Clinic|Aminah Jatoi, M.D.|(507) 284-7202|Jatoi.Aminah@mayo.edu|
22437516|NCT05419232|Nationwide Children's Hospital|Jason Newland|6147223416|jason.newland@nationwidechildrens.org|
22437517|NCT02106494|Heron Therapeutics|Robert Geller, M.D.|650-366-2626|rgeller@herontx.com|
22437518|NCT02608463|University of Arkansas for Medical Sciences|Dr. Shona Ray-Griffith|501-526-8428|slray@uams.edu|
22437519|NCT03386487|Yale University|Dr. Deepak Cyril D'Souza, M.D.|203-932-5711|deepak.dsouza@yale.edu|2594
22437520|NCT01318408|Drexel University College of Medicine|Carol Lippa, MD|215-762-7090|clippa@drexelmed.edu|
22437521|NCT01068769|Dana-Farber Cancer Institute|Dr. Suzanne George|617-632-5204|sgeorge2@partners.org|
22437522|NCT01948063|BIDMC|Michael W Donnino|617-754-2341|mdonnino@bidmc.harvard.edu|
22437523|NCT01858766|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22437524|NCT05234957|Benha University|Dr. Mohamed Farid|00201003354636|mohamed.farid@fmed.bu.edu.eg|
22437525|NCT00887510|University of Florida|Rhonda M Cooper-DeHoff|352 273-6184|dehoff@cop.ufl.edu|
22437526|NCT00894361|PI/study coordinator retired due to personal family health matters and study sponsor then withdrew funding. Study terminated and no data was collected or analyzed from any participant.|Terence J. Gioe, M.D.||tjgioe@gmail.com|
22437527|NCT02920749|Department of Anaesthesiology and Intensive Therapy, University of Pecs|Dr. Timea Bocskai|36 72 507374|bocskai.timea@pte.hu|
22437528|NCT04207060|Mayo Clinic|Dr. Santhi Swaroop Vege|(507) 266-6931|vege.santhi@mayo.edu|
22437529|NCT05438576|Mayo Clinic|Demilade Adedinsewo, M.B, Ch.B.|904-953-0859|adedinsewo.demilade@mayo.edu|
22437530|NCT00156390|University of Pittsburgh|Dr. Samir Saba|412-802-3372|sabas@upmc.edu|
22437531|NCT02881762|University of Maryland, Baltimore|Dr Lydia Tang|14107066567|lydiatang@ihv.umaryland.edu|
22437532|NCT00245037|Oregon Health and Science University|Richard T. Maziarz, MD|503-494-6345|maziarzr@ohsu.edu|
22437533|NCT04054375|Northwestern University School of Medicine|Dr. Senda Ajroud-Driss|(312) 944-0063|s-ajroud@northwestern.edu|
22437534|NCT00296140|Roudebush VA Medical Center|Dr. Linda Williams|317-988-2715|Linda.Williams6@va.gov|
22437535|NCT00774800|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|(858) 794-8889||
22437536|NCT01843062|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22437537|NCT00994422|Sanofi Topaz|Medical Director||RegistryContactUs@sanofipasteur.com|
22437538|NCT02669212|National Institutes of Health|Dr. Brian Walitt|202-549-7669|brian.walitt@nih.gov|
22437539|NCT02465372|Wake Forest University Health Sciences|Dr. Justin Moore|336-716-3702|jusmoore@wakehealth.edu|
22437540|NCT03549104|University of Illinois at Chicago|Pamela Martyn-Nemeth|312-996-7903|pmartyn@uic.edu|
22437541|NCT04124705|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22437542|NCT00532298|GlaxoSmithKline|GSK Response Center|866-435-7343||
22437543|NCT00479856|GlaxoSmithKline|GSK Response Center|866-435-7343||
22437544|NCT04406649|Satsuma Pharmaceuticals, Inc.|Vice President of Regulatory Affairs and Quality|650-837-0799|clin.inquiries@satsumarx.com|
22437545|NCT04164732|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22377173|NCT04528069|Alcon Research, LLC|Director of Clinical Projects, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22377174|NCT02872701|On Target Laboratories|Tim Biro|216-533-3082|tbiro@ontargetlabs.com|
22437546|NCT02141360|GE Healthcare|Chief Medical Officer - Head Health Initiative|262-544-3633|Victor.Miranda@ge.com|
22437547|NCT00661622|Thomas Jefferson University|Takami Sato, MD|215-955-8874|Takami.Sato@jefferson.edu|
22437548|NCT04016259|The University of Texas Health Science Center at Houston|"Hyochol Brian Ahn, PhD, RN, MSN, Associate Professor"|713-500-2179|Hyochol.Ahn@uth.tmc.edu|
22437549|NCT01716455|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22437550|NCT00932165|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22437551|NCT01868334|University of Pittsburgh|Richard K. Zimmerman, MD, MPH, MA|412-383-2354|zimmer@pitt.edu|
22437552|NCT03997825|Relievant Medsystems|Diane Sahr, VP of Clinical Research|(650) 368-1000|dsahr@relievant.com|
22437553|NCT02518191|Shanghai 6th People's Hospital Affiliated to Shanghai Jiao Tong University|Dr. ZONG|86 (21) 24058549|tigerzong@msn.com|
22437554|NCT00761202|Allergan, Inc.|Vice President Medical Affairs - Europe|(714)246-4500|clinicaltrials@allergan.com|
22437555|NCT02355210|University of Nebraska-Lincoln|Heather Rasmussen, Assistant Professor|402-472-1373|hrasmussen2@unl.edu|
22437556|NCT03824587|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
22437557|NCT01300572|Fred Hutchinson Cancer Research Center|Brenda Sandmaier, MD|(206) 667-4961|bsandmai@fredhtuch.org|
22437558|NCT01368081|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22437559|NCT01424033|University of Michigan|Jan Stevens|7349365566|janstev@med.umich.edu|
22437560|NCT02461745|Southern California Permanente Medical Group|Division of Clinical Trials Research|(626) 564-5667|clinical.trials@kp.org|
22437561|NCT02921087|SUNY College of Optometry Clinical Vision Research Center|Danielle Iacono, OD|212-938-5936|diacono@sunyopt.edu|
22437562|NCT00571974|Roswell Park Cancer Institute|Gal Shafirstein, D.Sc.|716-845-4025|Gal.Shafirstein@RoswellPark.org|
22437563|NCT02828436|University of Minnesota|Manda Keller-Ross|612-625-3175|kell0529@umn.edu|
22437564|NCT02644343|Cochlear|Cochlear Clinical Studies|(303) 790-9010|clinicalstudies@cochlear.com|
22437565|NCT00536471|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22437566|NCT01439594|Massachusetts General Hospital|Dr. Gary Tearney, PI|617-724-2979|GTEARNEY@PARTNERS.ORG|
22437567|NCT02932748|University of Kansas Medical Center|Anna M. Gorczyca, PhD|913-588-9077|agorczyca@kumc.edu|
22437568|NCT00475904|EpiCept Corporation|Chief Medical Officer|914-606-3500|sallard@epicept.com|
22437569|NCT00880191|Mayo Clinic|Debra L. Barton RN, PhD, AOCN|507/284-1623|barton.debra@mayo.edu|
22437570|NCT01635881|Boston Scientific|Andrey Nersesov, Clinical Trial Manager|1-508-683-4988|Andrey.Nersesov@bsci.com|
22437571|NCT00066963|Professor, S/D- PREV/REST|Stuart Gansky|415-502-8094|stuart.gansky@ucsf.edu|
22437572|NCT00773747|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22437573|NCT00836186|Johns Hopkins University|Jean Wright, MD PI|410-614-3950|jwrigh71@jhmi.edu|
22437574|NCT04079816|Masimo Corporation|Ahmed Alghazi|949-297-7000|aalghazi@masimo.com|
22437575|NCT03422536|University of Arizona Cancer Center|Rachel Jarrett|5206260375|rjarrett@email.arizona.edu|
22437576|NCT01973998|Lewis Katz School of Medicine Temple University|Michael R. Jacobs - Director of Research Development|2157072242|michael.jacobs@tuhs.temple.edu|
22437577|NCT01763606|Memorial Sloan Kettering Cancer Center|Dr. Lisa DeAngelis, MD|212-639-8000|deangell@mskcc.org|
22437578|NCT01636986|Alcon Research, Ltd.|Jami Kern, PhD|1-888-452-3937|alcon.medinfo@alcon.com|
22437579|NCT03937960|University of Alabama at Birmingham|Dr. Bhuvana Sunil|2056389107|dr.bhuvana.s@gmail.com|
22437580|NCT02160145|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Devlopment|609 524 6788|clinicaltransparency@otsuka-us.com|
22437581|NCT04867733|University of Iowa|Nicole Brogden|319-335-8752|nicole-brogden@uiowa.edu|
22437582|NCT00395850|University of Arkansas for Medical Sciences|Dr. Alison Oliveto|501-526-8441|olivetoalison@uams.edu|
22437583|NCT00820872|Mayo Clinic|Alvaro Moreno-Aspitia, M.D.|(904) 953-7291|morenoaspitia.alvaro@mayo.edu|
22437584|NCT03197922|Emory University|Nathan Call, PhD|404-785-9428|ncall@emory.edu|
22437585|NCT02540993|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22437586|NCT00881465|University of South Florida|Eric Storch, Ph.D.|7277678230|estorch@health.usf.edu|
22437587|NCT00588094|Memorial Sloan Kettering Cancer Center|Dr. Craig Moskowitz|212-639-7992|moskowic@mskcc.org|
22437588|NCT00705146|VIHA|Helia Sillem MScOT|2507557611|helia.sillem@viha.ca|
22437589|NCT03777319|The Abigal Wexner Research Institute at Nationwide Children's Hospital|Dr. Kevin Flanigan|614-722-5615|kevin.flanigan@nationwidechildrens.org|
22437590|NCT01620528|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
22437591|NCT04569357|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22437592|NCT01122849|GlaxoSmithKline|GSK Response Center|866-435-7343||
22437593|NCT03256253|New York State Psychiatric Institute|John Mariani MD|6467748181|john.mariani@nyspi.columbia.edu|
22437594|NCT01457846|Astrazeneca|Donal Landers|+44 1625 231890|Donal.Landers@astrazeneca.com|
22437595|NCT00383162|GlaxoSmithKline|GSK Response Center|866-435-7343||
22437596|NCT01153698|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22437597|NCT01323140|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|801-588-6641|gary.hoel@watson.com|
22437598|NCT01623739|UTHSCSA Periodontics|Guy Huynh-Ba|2105673569|huynhba@uthscsa.edu|
22437599|NCT05392803|University of California San Diego|Brian Ilfeld, MD, MS|(858) 220-5714|baabdullah@health.ucsd.edu|
22437600|NCT00465647|Purdue Pharma L.P.|Executive Medical Director|800-733-1333||
22437601|NCT01240135|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
22437602|NCT02220712|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22437603|NCT03533244|Allgenesis Biotherapeutics|Tan Nguyen|+886-2-8787-1232|tan.nguyen@allgenesis.com|
22437604|NCT00760838|Ghent University Hospital|dr. Brusselle Guy|003293322604|guy.brusselle@uzgent.be|
22437605|NCT00923845|National Cancer Institute|Dr. Daniel Fowler|301-435-8641|fowlerda@mail.nih.gov|
22437606|NCT02561221|Pennington Biomedical Research Center|Dr. Peter T. Katzmarzyk, Associate Executive Director of Population and Public Health Sciences|225-763-2536|doctors@pbrc.edu|
22437607|NCT03368235|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22437608|NCT01743040|UCLA Biomed|Joseph Thomas, MD|310-222-2544|jthomas@labiomed.org|
22437609|NCT00830180|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22437610|NCT01832532|Cincinnati Children's Hospital Medical Center|Raouf Amin, MD|(513) 636-7945|Raouf.Amin@cchmc.org|
22437611|NCT01366885|OHSU|Dr. Gene Stubbs|503-939-7351|stubbsgene@comcast.net|
22437612|NCT00392990|Northwestern University|Leo Gordon, MD||l-gordon@northwestern.edu|
22437613|NCT04331002|University of Kentucky|Dr. Austin Stone|859-218-3131|austin.stone@uky.edu|
22437614|NCT01630889|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|059study@fibrogen.com|
22437615|NCT03845738|Dentsply IH AB d.b.a Dentsply Sirona Implants|Director Center of Clinical Research, AnnaKarin Lundgren|+46 31 376 30 00|annakarin.lundgren@dentsplysirona.com|
22437616|NCT00991406|Cleveland VAMC|Elizabeth Hardin|216-791-3800|Elizabeth.HardinvandenBogert@va.gov|4698
22437617|NCT03755661|Boston University|LaNeia Thomas|617-358-6346|laneia@bu.edu|
22437618|NCT02038075|University of Utah|Dr. Craig Bryan|8015877978|craig.bryan@utah.edu|
22437619|NCT04000581|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-1300|Kris.Attwood@roswellpark.org|
22437620|NCT02110264|UCLA|David Farabee|3109630009|dfarabee@mednet.ucla.edu|
22437621|NCT02519595|Children's Hospital of Michigan|Nirupama Kannikeswaran|313-745-5260|nkannike@dmc.org|
22437622|NCT00387036|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
22437623|NCT03188510|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
22437624|NCT05261009|Wake Forest School of Medicine|Daryl Henshaw, MD|336-716-4498|dhenshaw@wakehealth.edu|
22437625|NCT01736618|Boston Scientific - Rhythm Management|Clinical Trial Manager or Director of Clinical Trials (Cardiology Rhythm Management)|1-800-227-3422|jill.leigh@bsci.com|
22437626|NCT02634827|Mayo Clinic|Aref Al-Kali, MD|507-538-0871|AlKali.Aref@mayo.edu|
22437627|NCT04167137|Synlogic|Aoife Brennan, MB, BCh, BAO, MMSc|(857) 999-0767|aoife@synlogictx.com|
22437628|NCT02762331|Virginia Commonwealth University|Donald Brophy, PharmD|(804) 827-1455|dbrophy@vcu.edu|
22437629|NCT01748825|National Cancer Institute|Dr. Naoko Takebe|240-781-3320|takeben@nih.gov|
22437630|NCT01849419|University of Chicago|Dr. Harriet de Wit|(773) 702-3560|hdew@uchicago.edu|
22437631|NCT02714283|Oregon Health & Science University|Emily Henkle, PhD, MPH|503-494-6226|henkle@ohsu.edu|
22437632|NCT01730586|The University of Texas (UT) MD Anderson Cancer Center|Dr. Michael Overman, Associate Professor, GI Medical Oncology|713-792-7734|MOverman@mdanderson.org|
22437633|NCT00211887|Icahn School of Medicine at Mount Sinai|Dr. Fred D. Lublin|212-241-6854|fred.lublin@mssm.edu|
22437634|NCT02964767|SinghRK|Dr. Ranjan K Singh|91+9431263911|dr_ranjankumarsingh@yahoo.com|
22442223|NCT00591318|New York State Psychiatric Institute|Brian Fallon|646-774-8052|brian.fallon@nyspi.columbia.edu|
22442224|NCT01776307|Sumitomo Dainippon Pharma Oncology|Tegan Nguyen|617-674-8745|tnguyen@bostonbiomedical.com|
22442225|NCT00567255|Orexigen Therapeutics, Inc.|Senior Vice President, Head of Global Development|(858) 875-8600|MedInfo@Orexigen.com|
22442226|NCT03194737|Teleflex/NeoTract|Emily Friedland, Director, Global Clinical Operations|925.387.6014|emily.friedland@teleflex.com|
22442227|NCT02657408|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22442228|NCT01403948|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22442229|NCT02184572|GlaxoSmithKline|GSK Response Center|866-435-7343||
22442230|NCT03764293|Jiangsu Hengrui Pharmaceuticals Co., Ltd.|Yongli Xie|18581831003|yongli.xie@hengrui.com|
22442231|NCT00763698|St. Jude Medical|Director, Clinical Affairs|(408) 522-6410|tshipman@sjm.com|
22442232|NCT02495038|Yonsei University Wonju college of medicine|Dr. Wooyoung Park|563664250|wongulung28@gmail.com|971
22442233|NCT05051631|Vanderbilt University Medical Center|Dr. Lucy Spalluto|615-875-5649|lucy.b.spalluto@vumc.org|
22442234|NCT01459497|University of Texas Southwestern Medical Center|Dr. Puneeth Iyengar|214-645-7603|puneeth.iyengar@utsouthwestern.edu|
22442235|NCT01120717|Novartis Pharmaceuticals|Study Director|862 778-8300||
22442236|NCT03117140|Univesity of Iowa Hospitals and Clinics|Melinda Seering|3193561616|melinda-seering@uiowa.edu|
22442237|NCT02640508|UT Health San Antonio|Virginia Kaklamani, MD|210-450-3838|kaklamani@uthscsa.edu|
22442238|NCT00862082|Proacta, Inc.|Director of Clinical Development|858-642-0386|clinicalops@proacta.com|
22442239|NCT01966718|Arthritis Treatment Center|Dr. Nathan Wei|301-694-5800|nwei@arthritistreatmentcenter.com|
22442240|NCT01454258|University Hospital Frankfurt|Prof Dr Dr Kai Zacharowski, FRCA|004969630186668|kai.zacharowski@kgu.de|
22442241|NCT02751385|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22442242|NCT02791763|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|7343
22442243|NCT05334212|University Hospitals Cleveland Medical Center|Dr. Gabriel Smith|(440)827-5088|Gabriel.Smith@UHhospitals.org|
22442244|NCT04534686|University of Illinois at Chicago|Tanvi Bhatt|3123554443|tbhatt6@uic.edu|
22442245|NCT03179605|Prosoft Clinical|Robert Babilon President|4843202068|b.babilon@prosoftclinical.com|
22442246|NCT00910299|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22442247|NCT01456897|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials||CL_OPCJ_RDA_Team@otsuka.jp|
22442248|NCT01400880|University of Florida|Dr. Tony Gregg|352-265-0111|greggar@ufl.edu|
22442249|NCT01396070|Stanford University Medical Center|Youn H Kim, MD|650-521-3545|younkim@stanford.edu|
22442250|NCT04535453|Janssen Vaccines & Prevention B.V.|SENIOR ADVISOR CLINICAL DEVELOPMENT|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22442251|NCT04530136|Pharming Technologies BV|Anurag Relan, MD|0031 (0)71 5247400|a.relan@pharming.com|
22396032|NCT05097716|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22396033|NCT01011439|CLIOSS S.r.l.|Dr. Cristina Davite|+39 0031 58|regulatory@clioss.com|1482
22396034|NCT00058552|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22396035|NCT00006151|University of Pennsylvania|Peter Gariti||gar1iti@mail.med.upenn.edu|
22396036|NCT03781323|University of Rochester|Richard Dunne|585-275-5823|Richard_Dunne@urmc.rochester.edu|
22396037|NCT01364623|Acerus Pharmaceuticals Corporation|Dr. Nathan Bryson, Vice President, Scientific Affairs|1-416-679-0776|nbryson@aceruspharma.com|
22396038|NCT00588536|Memorial Sloan Kettering Cancer Center|Dr. Tanya Trippett|212-639-8267|trippet1@mskcc.org|
22396039|NCT00239226|Medtronic BRC - Medtronic Italia SpA|Giorgio Corbucci - Sr Principal Scientist|+39 02 241371|giovanna.zucchi@medtronic.com|
22396040|NCT02764164|Cincinnati Childrens Hospital Medical Center|Dr. Ernest Pedapati|5137361901|ernest.pedapati@cchmc.org|
22396041|NCT04060563|MOMH|Amanda Crawford|7026533583|amanda.j.crawford.ctr@health.mil|
22396042|NCT00851682|Washington University|Robert Grubb, III|314 454-7185|grubbr@wudosis.wustl.edu|
22396043|NCT01892306|Massachusetts General Hospital|Kristen Ellard, PhD|617-726-6422|kellard@partners.org|
22396044|NCT00806676|Johns Hopkins University School of Medicine|Dr. Jeffrey Fadrowski|410-955-2467|jfadrow1@jhmi.edu|
22396045|NCT01379573|NYU Langone Health|Jill Buyon|+1 212 263 0746|Jill.Buyon@nyulangone.org|
22396046|NCT02224313|Eastern Virginia Medical School|Dr.David Archer|7574467444|archerdf@evms.edu|
22437635|NCT03621657|University of Wisconsin-Madison|Dr. Nasia Safdar|608-263-1545|ns2@medicine.wisc.edu|
22437636|NCT03058692|Baylor College of Medicine|Robert L. Atmar, M.D.|713-798-6849|ratmar@bcm.edu|
22437637|NCT04255862|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22437638|NCT05111249|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22377175|NCT01814371|Washington University School of Medicine|Stephanie Fritz, MD, MSCI|3144544115|fritz.s@wustl.edu|
22377176|NCT04683926|Syntrix Pharmaceuticals|Aaron Schuler|253-833-8009|aschuler@syntrixbio.com|21
22377177|NCT00941993|Acclarent|Clinical Director|650-687-5888|lenglan1@its.jnj.com|
22377178|NCT01692782|Sunovion|1-866-503-6351|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
22377179|NCT04158050|Helsinki University Hospital|Dr Paula Kauppi|+358504286802|paula.kauppi@hus.fi|
22377180|NCT04341116|I-Mab Biopharma US Ltd|Claire Xu|3177558242|Claire.Xu@i-mabbiopharma.com|
22377181|NCT00952367|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22377182|NCT00885092|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
22377183|NCT04321239|University of Michigan|Mary Janevic|734 647 3194|mjanevic@umich.edu|
22377184|NCT00382824|Lahey Hospital & Medical Center|Jordan Jara|7817442958|jordan.jara@lahey.org|2958
22377185|NCT03205371|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22377186|NCT02835339|Oregon Health and Science University|Kathleen Brookfield, MD, PhD, MPH|503-494-2101|brookfie@ohsu.edu|
22377187|NCT04273139|Dana-Farber Cancer Institute|Jorge J. Castillo, Md|617-632-2681|jorgej_castillo@dfci.harvard.edu|
22377188|NCT01826812|The Wilmer Eye Institute, Johns Hopkins|Dr. Esen K. Akpek|410-955-5214|esakpek@jhmi.edu|
22377189|NCT01955954|Palo Alto Health Sciences, Inc|Debra Reisenthel|9255948404|debra@pahealthsciences.com|
22377190|NCT00969501|Georgia Institute for Clinical Research, LLC|Arnold Weil, MD|770-421-2030|research@lowbackpain.com|
22377191|NCT00736645|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
22377192|NCT00668902|Indiana University School of Medicine|Zeruesenay Desta|+1 (317) 274-2823|zdesta@iu.edu|
22377193|NCT02300220|Imperial College London|Professor Jadwiga Wedzicha|02075947947|j.wedzicha@imperial.ac.uk|
22377194|NCT04322682|Montreal Heart Institute|Dr. Jean-Claude Tardif (Principle Investigator)|514 376-3330|jean-claude.tardif@icm-mhi.org|3612
22377195|NCT02238379|Yale University|Dr. Helena Rutherford|203-737-3408|helena.rutherford@yale.edu|
22377196|NCT04123067|Penn State Hershey Medical Center|Dr. Kerstin Bettermann|717-531-1803|kbettermann@pennstatehealth.psu.edu|
22377197|NCT03085485|University of Alabama at Birmingham|Bo Liu|(205) 975-7868|boliu@uabmc.edu|
22377198|NCT00605280|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22377199|NCT03088826|Maimonides Medical Center|Sergey Motov|718283600|smotov@maimonidesmed.org|
22377200|NCT04365660|Stanford University|Dr. Kristen Ganjoo, MD|650-498-6000|kganjoo@stanford.edu|
22377201|NCT01311674|Emergent Biosolutions|Christine Hall, Sr. Director Clinical Research||chall@ebsi.com|
22377202|NCT02137369|Emory University|Dr. Dunlop|404-727-8969|bdunlop@emory.edu|
22377203|NCT02959996|Massachussetts General Hospital|Malavika Prabhu|6177249028|mprabhu@mgh.harvard.edu|
22377204|NCT03036163|Nearmedic Plus|Viсtoria Shcherbakova|+7 (495) 741 49 89|Viktoriya.Shcherbakova@nearmedic.ru|3869
22377205|NCT02680054|Oxford University Hospitals NHS Trust|Dr Rachel Besser|01865 741741|rachel.besser@ouh.nhs.uk|
22377206|NCT04907942|Click Therapeutics|Shaheen Lakhan, MDPhD, FAAN Study Chair|Not applicable|Science@clicktherapeutics.com|
22377207|NCT01329029|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22377208|NCT03962894|University of Florida|Jennifer Fishe|904-244-4046|Jennifer.Fishe@jax.ufl.edu|
22377209|NCT04133831|Carnegie Mellon University|Gretchen Chapman|412-268-3665|gchapman@andrew.cmu.edu|
22377210|NCT00680407|Meda Pharmaceuticals, Inc.|Associate Director, Clinical Research and Operations||michael.purzycki@meda.us|
22377211|NCT01321554|Eisai, Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22377212|NCT01865708|Children's Healthcare of Atlanta|Dr. Jana Stockwell|404-785-1868|jana.stockwell@choa.org|
22377213|NCT01139190|PLx Pharma LLC|Ronald Zimmerman, CEO & President|713-842-1249|ron.zimmerman@plxpharma.com|205
22377214|NCT04128293|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22411284|NCT01952574|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22377215|NCT04177680|Matinas BioPharma|Dr. James J Ferguson, MD|(908) 505-0964|jferguson@matinasbiopharma.com|
22377216|NCT00514943|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22377217|NCT00499031|NRG Oncology Statisics and Data Management Center, Buffalo Office|Melissa Leventhal|716-845-4030|mleventhal@gmail.com|
22377218|NCT02298361|OCHIN, Inc.|Jennifer E. DeVoe, MD, DPhil|503-943-2618|devoej@ohsu.edu|
22377219|NCT05072457|Hearts for Hearing|Lead Investigator|405-548-4335|phonakaudiologyresearch@gmail.com|
22377220|NCT02001194|Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh Patel||mpatel@upenn.edu|
22377221|NCT01355588|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com|828
22377222|NCT01699022|SPARC|Dr. Shravanti Bhowmik|02266455645|shravanti.bhowmik@sparcmail.com|5626
22377223|NCT03284788|University of Florida|Dr. Michelle Cardel, Adjunct Professor|352-273-8811|mcardel@ufl.edu|
22377224|NCT04539821|VA Connecticut Healthcare System|Dr. Brent Moore|203-435-2243|brent.moore@va.gov|
22377225|NCT00605293|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22377226|NCT03581981|Atlanta VAHCS|Sheila Rauch|404-321-6111|sheila.rauch@va.gov|203122
22377227|NCT00781391|Daiichi Sankyo, Inc.|James Hanyok, Sr. Director|732-590-5000|jhanyok@dsi.com|
22377228|NCT01984684|Melinta Therapeutics, Inc.|Sue Cammarata (Chief Medical Officer)|1-844-MELINTA (1-844-635-4682)|clinicaltrials@melinta.com|
22377229|NCT04322604|Allakos|Medical Information|650-597-5002|medinfo@allakos.com|
22377230|NCT00850889|Allergan, Inc.|Steven P. James, MD, VP, Global Medical Affairs|714-246-4500|james_steven@allergan.com|
22377231|NCT04886479|CooperVision Inc.|Director Global Clinical Affairs|+19256213761|jvega2@coopervision.com|
22377232|NCT00053989|Roswell Park Comprehensive Cancer Center|Theresa Hahn, PhD|716084505819|theresa.hahn@roswellpark.org|
22377233|NCT01077544|Novartis Pharmaceuticals|Study Director|82-778-8300|trialandresults.registries@novartis.com|
22377234|NCT00689221|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22377235|NCT03182868|University of Miami|Michael Hoffer|305 243-1484|michael.hoffer@miami.edu|
22377236|NCT00262821|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22377237|NCT01777854|UH|Carissa Wentland DO|320-392-4737|carissa.wentland@gmail.com|
22377238|NCT00295022|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22377239|NCT01551199|Michael E. DeBakey VA Medical Center|Dr. Ellen Teng|(713) 791-1414|ellen.teng@va.gov|25513
22377240|NCT00734630|Forest Laboratories, Inc.|Noah Rosenberg , MD, Exec. Dir, Clin Dev, Cardiovascular and Metabolism|2014278000|noah.rosenberg@frx.com|2133
22377241|NCT01239030|Rhodes Pharmaceuticals|Akwete Adjei, PhD|401-202-9408|Akwete.Adjei@pharma.com|
22377242|NCT04403698|Study Principal Investigator Ghent Universitary Hospital|Prof. dr. Ruth Wittoek|+329 332 25 20|Ruth.Wittoek@Ugent.be|
22377243|NCT00977665|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22377244|NCT01330433|Loma Linda University, Dept of Cardiovascular and Thoracic Surgery|Research Coordinator|909-558-4355|vayermiller@llu.edu|
22377245|NCT03084666|University of Alabama at Birmingham|Brant Wagener, MD, PhD|12059346007|bwagener@uabmc.edu|
22377246|NCT00441090|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
22377247|NCT01441102|National Institutes of Health|Catherine Cukras, MD, PhD, Principal Investigator, NEI|301-435-5061|cukrasc@nei.nih.gov|
22377248|NCT01662882|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22377249|NCT00518115|GlaxoSmithKline|GSK Response Center|866-435-7343||
22377250|NCT04891419|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22377251|NCT02235493|Alexion Pharmaceuticals|Senior Medical Director, Clinical Development|203-272-2596|clinicaltrials@alxn.com|
22377252|NCT01055769|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22377253|NCT00827918|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22377254|NCT00802074|Garden State Infectious Disease Associates|David Condoluci|856-566-3190|dcondoluci@gsida.org|
22377255|NCT02979262|Yale University Child Study Center|Dr. Carla Stover|2037853486|carla.stover@yale.edu|
22377256|NCT00843167|Oregon Health & Science University|Dr. Jackilen Shannon|541-706-6861|shannoja@ohsu.edu|
22377257|NCT02291614|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22377258|NCT00127101|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
22437639|NCT00555880|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22437640|NCT02346461|National Human Genome Research Institute|Carrillo, Nuria|+1 301 402 2324|nuria.carrillo@nih.gov|
22437641|NCT03004911|School of Medicine at the University of Sao Paulo|Amélia Pasqual Marques|+55 11 3091 7451|pasqual@usp.br|
22437642|NCT00941915|Assistant Research Practice Manager|Joan Cahill, BSN RN OCN CCRP|(919) 668-5211|joan.cahill@duke.edu|
22437643|NCT01702025|Department of Health and Exercise Science|Christopher Bell, Ph.D.|(970) 491-7522|christopher.bell@colostate.edu|
22437644|NCT02679755|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22437645|NCT01061359|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22437646|NCT02477124|Duke University|Jennifer Gallagher|9199701551|jennifer.gallagher@duke.edu|
22437647|NCT03038126|University of Maryland Baltimore|Jeffrey C. Fink, MD MS; Principal Investigator|410-328-4822|jfink@som.umaryland.edu|
22437648|NCT02610777|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22437649|NCT01724866|Spectrum Pharmaceuticals, Inc, Research and Development Office 157 Technology Drive Irvine, CA 92618|Shanta Chawla|(949) 788-6700|shanta.chawla@sppirx.com|
22437650|NCT02324283|Juntendo University|Dr. Izumi Kawagoe|+81338133111|ikawago@juntendo.ac.jp|
22437651|NCT01340586|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22396047|NCT00770770|Alimera Sciences, Inc.|Kathleen Billman, Senior Director, Scientific Affairs|678-527-1302|kathleen.billman@alimerasciences.com|
22396048|NCT02486653|University of Wisconsin - Madison|Dr. Evie Carchman, MD|608-263-2521|carchman@surgery.wisc.edu|
22396049|NCT00800436|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22411285|NCT01189240|Adult Brain Tumor Consortium (ABTC)|Dr. Edward Pan||Edward.Pan@UTSouthwestern.edu|
22437652|NCT00411671|University of Texas (UT) MD Anderson Cancer Center|George Blumenschein, MD / Professor, Thoracic/Head & Neck Med Oncology||CR_Study_Registration@mdanderson.org|
22437653|NCT01173601|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22437654|NCT04737278|BDL Biochemistry, consultant for Mitosynergy|Dr Barbara Leinweber, PhD|(520)334-5444|barb@bdlbiochem.com|
22437655|NCT03671213|Moximed, Inc.|Rose Weinstein, Director of Clinical Affairs|415-312-0255|rsweinstein@moximed.com|
22437656|NCT00889512|University Reproductive Associates|Dr. Peter G. McGovern|201-288-6330|mcgovepg@uranj.com|
22437657|NCT00546000|Fougera Pharmaceuticals Inc.|Angela C. Kaplan|631-659-2256|angela.kaplan@sandoz.com|
22437658|NCT03223337|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22437659|NCT03688074|AstraZeneca|Globall Clinical Head|+1 877-240-9479|information.center@astrazeneca.com|
22437660|NCT01362608|Novartis|Clinical Disclosure Office|862-778-8300||
22437661|NCT00726414|Mutual Phrmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22437662|NCT00721188|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
22437663|NCT03928717|Providence College|Dr. Nick Tarantino|4018651612|ntaranti@providence.edu|
22437664|NCT01048658|Oregon Health & Science University|Dr. Rosenne Botha|503-494-3666|whru@ohsu.edu|
22437665|NCT04171219|M.D. Anderson Cancer Center|Aung Naing, MD|713-563-3885|anaing@mdanderson.org|
22437666|NCT04809285|Medtronic|Binh Ngo (Clinical Research Director)|9492027218|binh.ngo@medtronic.com|
22437667|NCT03350815|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22437668|NCT03526146|San Francisco Veterans Affairs Health Care System, San Francisco, CA|Linda L. Chao|415-221-4810|linda.chao@ucsf.edu|24386
22437669|NCT03571555|Royal Holloway University of London|Dr. Michael Evangeli|00447801543681|michael.evangeli@rhul.ac.uk|
22437670|NCT01442714|Stanford University|Dr. Bruno Medeiros|650-723-5007|brunom@stanford.edu|
22437671|NCT01703507|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Wenyin Shi|215-955-6702|Wenyin.Shi@jefferson.edu|
22437672|NCT06068426|Cincinnati Children's|Dr. David Vitale|(513) 517-7040|David.Vitale@cchmc.org|
22437673|NCT05380505|NYU Langone Health|Marie Bragg, PhD|646-501-2717|Marie.Bragg@nyulangone.org|
22437674|NCT00783614|Minneapolis Medical Foundation|Dr. Jason Baker|612-873-2705|baker459@umn.edu|
22437675|NCT01979952|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22437676|NCT01511068|Cincinnati Children's Hospital Medical Center|Dr. Bruce Trapnell|513636-6361|Bruce.Trapnell@cchmc.org|
22437677|NCT00203424|Translational Oncology Research International|Dr. Fairooz F. Kabbinavar, Chief Medical Officer|310-824-1934|FKabbina@mednet.ucla.edu|
22437678|NCT01053988|GlaxoSmithKline|GSK Response Center|866-435-7343||
22437679|NCT00626444|Thomas Jefferson University|Daniel Monti, MD|215-955-4410|Daniel.Monti@jefferson.edu|
22437680|NCT01922271|Novartis Pharmaceuticals|Study Director|862-778-8300||
22437681|NCT00719355|University of Illinois at Chicago|Eileen G. Collins PhD, RN|312-413-5621|ecollins@uic.edu|
22437682|NCT01856582|Cincinnati Children's Hospital Medical Center|Rebecca Marsh, MD/Associate Professor of Pediatrics|513-803-9063|Rebecca.Marsh@cchmc.org|
22437683|NCT01824355|Ascensia Healthcare|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
22437684|NCT01331109|Forest Research Institute|Robert Palmer, MD|1-201-427-8200|robert.palmer@frx.com|8218
22437685|NCT04260347|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22437686|NCT01151371|Vistakon|Kathy Lorenz-Osborn, OD|+1 904 443-1032|kosborn@its.jnj.com|
22437687|NCT03688620|GlaxoSmithKline|Enhanced safety surveillance of GSK's quadrivalent seasonal influenza vaccines|877-379-3718|GSKClinicalSupportHD@gsk.com|
22437688|NCT02828020|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22437689|NCT01515046|The University of Iowa|Joseph J. Cullen, MD, FACS|319-353-8297|joseph-cullen@uiowa.edu|
22437690|NCT01183065|Memorial Sloan Kettering Cancer Center|Ho, Alan, MD, PhD (Assistant Attending)|+1646-888-4235|HoA@mskcc.org|
22437691|NCT02578186|Procter & Gamble|Andrew L. Carr, PhD|513-622-0928|carr.an@pg.com|
22437692|NCT03657095|Lung Biotechnology PBC Study Director|Lung Biotechnology PBC|301-608-9292|info@lungbiotechnology.com|
22437693|NCT01894243|AstraZeneca|Anitra Fielding - Senior Research Physician||ClinicalTrialTransparency@astrazeneca.com|
22437694|NCT02713659|The Children's Hospital of Philadelphia|Dr. James Guevara|215-590-1130|guevara@email.chop.edu|
22437695|NCT00828750|GlaxoSmithKline|GSK Response Center|866-435-7343||
22437696|NCT04006392|Erchonia Corporation|Clinical Affiairs|888.242.0571|tsammons@erchonia.com|501
22437697|NCT01067469|UT MD Anderson Cancer Center|Dr. John F de Groot/Chair Ad Interim, Neuro-Oncology|713- 745-3072|jdegroot@mdanderson.org|
22437698|NCT01620944|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22437699|NCT04378114|Medtronic Diabetes|Robin Mottackel|8185764886|robin.e.mottackel@medtronic.com|
22437700|NCT00825812|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22437701|NCT01078844|Johns Hopkins University School of Medicine|Eric Samstad, MD|410-550-0171|esamsta1@jhmi.edu|
22437702|NCT00986362|ThromboGenics NV|Dr. Petra Kozma-Wiebe|+32 16751310|petra.kozma@thrombogenics.com|
22437703|NCT03597061|University of Cincinnati|Cathleen Stough, Ph.D.|513-556-5589|odarcc@ucmail.uc.edu|
22437704|NCT01853605|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com|
22437705|NCT00895453|Vienna Medical School|Armin Witt MD|+43140400|armin.witt@meduniwien.ac.at|2821
22437706|NCT00850538|New England Baptist Hospital|Carl Talmo|617-724-5474|ctalmo@nebh.org|
22437707|NCT01088399|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22377259|NCT03743038|Foamix Pharmaceuticals, Inc.|Iain Stuart, PhD.|1 800-775-7936|Iain.Stuart@foamix.com|
22377260|NCT01159054|Brigham and Women's Hospital|Kambiz Zandi-Nejad|617-732-6660|kzandinejad@partners.org|34769 page
22377261|NCT01830127|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22377262|NCT00683826|Columbia University Medical Center|Henry N. Ginsberg MD, Gissette Reyes Soffer MD|2123059298|gr2104@columbia.edu|
22377263|NCT01302847|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|MPAACT.ctgov@fstrf.org|
22377264|NCT01565707|Astellas Pharma Europe B.V.|Medical Director, Medical Science - Urology||Astellas.resultsdisclosure@astellas.com|
22377265|NCT01371851|University of Arkansas for Medical Sciences|Alison Oliveto, PhD|501-526-8441|olivetoalison@uams.edu|
22377266|NCT00450411|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22377267|NCT02430194|Eiger BioPharmaceuticals, Inc.|Senior VP, Clinical Development|1-650-618-1621|info@eigerbio.com|
22377268|NCT03969719|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22377269|NCT05608629|Icahn School of Medicine at Mount Sinai|Dr. Benjamin H Natelson|(212) 844-6665|Benjamin.Natelson@mountsinai.org|
22377270|NCT02130193|GlaxoSmithKline|GSK Response Center|866-435-7343||
22377271|NCT01212770|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22377272|NCT01297959|Excited States/Exoxemis, Inc|Jackson T Stephens, Jr|(402) 884-2316|sstephens@exoxemis.com|
22377273|NCT02243943|LUMC|Prof Dr A. Dahan|+31 71 526 2301|a.dahan@lumc.nl|
22377274|NCT03519854|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22377275|NCT00707031|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22377276|NCT00951275|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22377277|NCT02460692|University of California, San Diego|Thomas D. Marcotte, PhD|619-543-5044|tmarcotte@health.ucsd.edu|
22377278|NCT02925676|UNEEG medical|Clinical Research Associate|+45 25657550|clinical@uneeg.com|
22377279|NCT02048072|Cantonal Hospital of St. Gallen|Jochen Vehoff|0041714941111|jochen.vehoff@kssg.ch|
22377280|NCT04304833|University of Arkansas for Medical Sciences|Judith Weber|5012961982|weberjudithl@uams.edu|
22377281|NCT03776136|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22377282|NCT02858895|Medicenna Therapeutics Inc|Rosemina Merchant - Chief Development Officer|604-340-3081|nmerchant@medicenna.com|
22377283|NCT03163758|Peking Union Medical College Hospital|Dr. Weihong Zhang|01069159581|ZhangWeiHong@pumch.cn|
22377284|NCT04427202|University of Chicago Medicine|Mai T. Pho, MD MPH|773-834-3689|mpho@bsd.uchicago.edu|
22377285|NCT00251745|Takeda Global Research & Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
22377286|NCT02543658|First affilitated hospital of Nanchang university|Wenhua He|+8613879182642|hewenhua@ncu.edu.cn|
22377287|NCT00789815|Chung Gung Memorial Hospital|Ting-Yu Lin|886 3 3281200|yuebaoyuebao@yahoo.com.tw|5108
22377288|NCT02018445|SeaSpine|Sara Tish Mikoczi|760-216-5652|tish.mikoczi@seaspine.com|
22377289|NCT01478009|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Chang-Seop Lee|82-63-276-8284|lcsmd@jbnu.ac.kr|
22377290|NCT03255824|Montefiore Medical Center|Dr. Patrick Nolan|718-405-8195|pnolan@montefiore.org|
22377291|NCT03247790|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22377292|NCT01866943|Hospital for Special Surgery|Research Fellow|917-843-6655|berlinerz@hss.edu|
22377293|NCT01091155|novoGI|Eran Choman, VP Clinical Affairs & Statistics|+972 9 8603000|eran.choman@novogi.com|
22377294|NCT03432364|Sangamo Therapeutics, Inc.|Medical Monitor|(510) 307-7266|clinicaltrials@sangamo.com|
22377295|NCT00522301|Memorial Sloan Kettering Cancer Center|Dr. William Tew|646-888-4220|teww@mskcc.org|
22377296|NCT03040713|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
22396050|NCT04808622|Diffusion Pharmaceuticals|Chris Galloway, MD (Chief Medical Officer)|(434) 220-0718|cgalloway@diffusionpharma.com|
22377297|NCT01490502|The Johns Hopkins University School of Medicine|Sandra D. Cassard, ScD|443-287-4353|scassar1@jhmi.edu|
22377298|NCT00772590|Kirby Institute, University of New South Wales|Sean Emery|+612 938509900|semery@kirby.unsw.edu.au|
22377299|NCT04635579|University of Washington|Dr Scott Telfer|2062292022|telfers@uw.edu|
22377300|NCT03813238|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
22377301|NCT02066402|Bayer|Therapeutic Area Head|+49 30 300139003|clinical-trials-contact@bayer.com|
22377302|NCT00152464|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22377303|NCT02565914|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22377304|NCT00828984|Northwestern University|Dr. Seema Khan|312-503-4236|s-khan2@northwestern.edu|
22377305|NCT00863655|Novartis Pharmaceuticals|Study Director|862-778-8300||
22377306|NCT00187226|St. Jude Children's Research Hospital|Thomas E. Merchant, DO, PhD|901-595-3604|thomas.merchant@stjude.org|
22377307|NCT00319748|Masonic Cancer Center, University of Minnesota|Melissa Geller, M.D.|612-626-3111|gelle005@umn.edu|
22377308|NCT01016938|Universtity of Maryland School of Medicine|Warren D'Souza, PhD, MBA|410-328-7159|wdsouza@umm.edu|
22377309|NCT00617981|Celsion Corporation|Nicholas Borys, M.D. Senior Vice President and Chief Medical Officer|609-896-9100|nborys@celsion.com|
22377310|NCT00716092|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22377311|NCT02436330|University of Illinois College of Medicine at Peoria|Dr. Amy L. Christison|309-624-9188|alc@uic.edu|
22377312|NCT02054806|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22396051|NCT05417607|Duke University|Lauren Franz MBChB, MPH|919-681-0023|lauren.franz@duke.edu|
22396052|NCT01673568|Hvidovre Hospital University of Copenhagen|Mette W. Christoffersen|38625826|mette.willaume@gmail.com|
22377313|NCT00677235|Bard Peripheral Vascular|John Van Vleet|1-800-321-4254|John.VanVleet@CRBard.com|
22377314|NCT01040260|University of California, San Francisco|Dr. Timothy Carmody|(415) 221-4810|Timothy.Carmody@ucsf.edu|26344
22377315|NCT05120115|MetroHealth Hospital|James Sulzer|5125419036|jss280@case.edu|
22377316|NCT03871595|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22377317|NCT03616184|University of Nebraska Medical Center|Vijaya Bhatt|402-559-8008|vijaya.bhatt@unmc.edu|
22377318|NCT00708916|New York University School of Medicine|Andrew Franks, MD, Principal Investigator|212-263-5244|andrew.franks@nyumc.org|
22377319|NCT04270292|Demiroglu Bilim University|Nurten OZEN|+90 (212) 275 75 82|ozenurten@yahoo.com.tr|
22377320|NCT02681614|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Bryan Traughber|+1 216-884-2516|bryan.traughber@uhhospitals.org|
22377321|NCT03923959|LancasterGH|Halle Becker|7175441401|halle.becker@pennmedicine.upenn.edu|
22377322|NCT04212091|Fred Hutchinson Cancer Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22377323|NCT04575051|University of Pittsburgh|Dr. Catherine Palmer|412-383-6565|cvp@pitt.edu|
22377324|NCT00951483|Loyola University Chicago|Angelos Halaris, MD, PhD|708-216-3275|ahalaris@lumc.edu|
22377325|NCT03565887|RVL Pharmaceuticals, Inc.|Senior Director of Clinical Operations|908-809-1423|mvelasco@osmotica.com|
22377326|NCT01292239|Janssen Pharmaceutical K.K., Japan|Director|81 3 44115639||
22377327|NCT00765388|Coloplast A/S|Seema Suchdev Wrisberg|+4549113519|dkssw@coloplast.com|
22377328|NCT03923933|Head of Nephrology Hospital General de México|Rafael Vadez-Ortiz M.D. PhD|+52 2789-2000|rafavaldez@gmail.com|1253
22377329|NCT01995461|Marshfield Clinic Research Foundation|Dr. Rachel Stankowski|715-389-3442|stankowski.rachel@mcrf.mfldclin.edu|
22377330|NCT02671032|Cochlear|Bernadette Pickering|+61296115909|bpickering@cochlear.com|
22377331|NCT01939548|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22377332|NCT03311373|Pearl Therapeutics, Inc.|Pearl Therapeutics, Inc.|1-877-240-9479|information.center@astrazeneca.com|
22377333|NCT02115633|RxFunction, Inc.|Lars Oddsson, PhD|8572340382|loddsson@rxfunction.com|
22377334|NCT01022762|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22377335|NCT01302119|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@Pfizer.com|
22377336|NCT01775904|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22377337|NCT03030222|Saint Luke's Hospital of Kansas City|Study Manager|816-932-9858|EMBRACE-HF@saint-lukes.org|
22377338|NCT01662310|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
22377339|NCT03156660|University of Virginia|Dr. Rebecca Krukowski|4349245303|wae4mq@virginia.edu|
22377340|NCT02432105|Alcon, A Novartis Division|Clinical Scientific Director, GCRA - Global Clinical Development|1-888-451-3937|alcon.medinfo@alcon.com|
22377341|NCT00205348|University of Wisconsin-Madison|Dr. Herbert Chen|608-263-1387|chen@surgery.wisc.edu|
22377342|NCT05725317|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22377343|NCT00829387|VA Connecticut Healthcare System|Rebecca Czlapinski|203-932-5711|rebecca.czlapinski@va.gov|3357
22377344|NCT02085252|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22377345|NCT01460940|The Ohio State University Comprehensive Cancer Center|Dr. Kristie Blum|614-293-4590|Kristie.Blum@osumc.edu|
22377346|NCT03260868|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22377347|NCT02813070|GE Healthcare|Paul Sherwin, M.D., PhD|+1-774-843-3888|PaulSherwin@ge.com|
22377348|NCT03645759|Michael E. Debakey VA Medical Center|Dr. Gina Evans|832-269-3048|gina.evans@va.gov|
22377349|NCT03195010|FHCRC|Dr Bethany Samuelson Bannow|5034949925|samuelsb@ohsu.edu|
22377350|NCT02693743|University of Arkansas for Medical Sciences|Favrin Smith|1 (501) 526-8488|SmithFavrinM@uams.edu|
22377351|NCT02626780|The GID Group|Director of Clinical Affairs|3039524901|GIDAA-01@thegidgroup.com|
22377352|NCT05540522|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22377353|NCT02459574|Imperial College London|Prof. Prapa Kanagaratnam|02033123783|p.kanagaratnam@imperial.ac.uk|
22377354|NCT00636649|Duke University Medical Center|Kishore Gadde|919-668-0208|kishore.gadde@duke.edu|
22377355|NCT04508699|San Diego State University|AVP for Research Support Services|619-594-5938|rss@sdsu.edu|
22377356|NCT05520138|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22377357|NCT03854461|Queen's University Belfast|Prof. Jayne Woodside|+44 (0)28 9097 8942|j.woodside@qub.ac.uk|8942
22377358|NCT02586025|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22377359|NCT03822117|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22377360|NCT04280653|Mati Therapeutics Inc.|Deepank Utkhede|778-991-3301|dutkhede@matitherapeutics.com|
22377361|NCT00415610|University of Minnesota|Adnan I Qureshi, MD|612-624-2431|qureshai@gmail.com|
22377362|NCT00455975|Sarah Cannon Research Institute|John Hainsworth MD|1-877-691-7274|asksarah@scresearch.net|
22377363|NCT01610427|GlaxoSmithKline|GSK Response Center|866-435-7343||
22377364|NCT01357616|Alcon Research, Ltd.|Mandy Ye, Head, Clinical Trial Management, Asia|1-888-451-3739|alcon.medinfo@alcon.com|
22377365|NCT05443659|Theranica|Dr Dagan Harris, VP Clinical and Regulatory Affairs|+972542220121|daganh@theranica.com|
22377366|NCT04186780|Universidade de Sorocaba|Dr. Luciane Cruz Lopes|+ 55 15 2101-7104|luciane.lopes@prof.uniso.br|
22377367|NCT03509974|Cochlear|George Cire|+13038855440|gcire@cochlear.com|
22377368|NCT02258139|Bausch Health|Study Director|585-338-6399|robert.steffen@bausch.com|
22377369|NCT04465357|Clinvest Research|Jim Sly|4178413673|jsly@clinvest.com|
22377370|NCT01040858|Portland VA Healthcare System|Dr. Daniel Storzbach|503-220-8262|Daniel.Storzbach@va.gov|56497
22396053|NCT01750931|GlaxoSmithKline|GSK Response Center|866-435-7343||
22396054|NCT01343485|Planned Parenthood Federation of America|Zoe Unger, Research Program Coordinator|212-261-4702|zoe.unger@ppfa.org|
22377371|NCT02606903|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22377372|NCT00378352|National Institute on Aging, NIH|Edward Lakatta, M.D.|410-558-8218|lakattae@grc.nia.nih.gov|
22377373|NCT00430248|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
22377374|NCT01624948|UCSF|Allison Webber MD|415 353 8382|allison.webber2@ucsf.edu|
22377375|NCT00002558|Memorial Sloan Kettering Cancer Center|Dr. Robert Motzer|646-422-4312|motzerr@mskcc.org|
22377376|NCT03039595|Oxford Univeristy Hospitals NHS Foundation Trust|Dr Helen Jones|01865 235657|helen.jones3@ouh.nhs.uk|
22377377|NCT03046212|Hospital de Clínicas de Porto Alegre|Graciele Sbruzzi|55 51 9423-9420|graciele.sbruzzi@ufrgs.br|
22377378|NCT01260350|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22377379|NCT04385368|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22377380|NCT01982240|Synergy Pharmaceuticals Inc.|Dr. Patrick H. Griffin|212-297-0020||
22377381|NCT02123108|University of California Los Angeles|Dr. Fady M. Kaldas|310-825-8138|FKaldas@mednet.ucla.edu|
22377382|NCT02219048|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22377383|NCT04721925|University of Michigan|Erin Bonar|7347647936|erinbona@med.umich.edu|
22377384|NCT00995501|Cleveland clinic|Daniel Sessler, MD|216-445-4900|sesseld@ccf.org|
22377385|NCT03802123|ImaginAb|Director, Regulatory Affairs|: +1.310.730.5869|ethomas@imaginab.com|
22377386|NCT01274182|Sandoz|Global Program Medical Director|+49 8024 476|biopharma.clinicaltrials@sandoz.com|0
22377387|NCT01970982|Philip Morris Products S.A.|Christelle HAZIZA, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
22377388|NCT01146496|University of Edinburgh|Michael Eddleston|01312426776|m.eddleston@ed.ac.uk|
22377389|NCT01701414|Dept of Emergency Medicine, Rhode Island Hospital|Francesca Beaudoin MD, MS|401-444-2577|fbeaudoin@lifespan.org|
22377390|NCT01133158|GELTAMO|Francisco Javier Peñalver|91 621 98 24|fjpenalver@fhalcorcon.es|
22377391|NCT04555096|Galera Therapeutics|Judy Schnyder, SVP Clinical Operations and Data Management|2155937119|jschnyder@galeratx.com|
22377392|NCT01851174|CTCA|Jessica L. Coats|6232073899|jessica.coats@ctca-hope.com|
22377393|NCT04040751|Emory University|Sarah Blanton, PT, DPT|404-712-2222|sblanto@emory.edu|
22377394|NCT02862457|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22377395|NCT03364751|Philip Morris Products S.A.|Christelle Haziza, Director Clinical Science & Biostatistics|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
22377396|NCT02413580|Grifols Therapeutics LLC|Rhonda Griffin|9193166693|Rhonda.Griffin@grifols.com|
22377397|NCT02342886|TB Alliance|Leandra Lombard, Director, Clinical Operations|+27 87 700 3900|Leandra.Lombard@tballiance.org|
22377398|NCT00862134|Proacta, Inc.|Director of Clinical Development|858-642-0386|clinicalops@proacta.com|
22377399|NCT00765674|Novartis Pharmaceuticals|Study Director|862 778-8300||
22377400|NCT03015402|University of Pittsburgh|Dr. Michael Risbano, Director of Advanced Cardiopulmonary Exercise Testing Program|412-692-2210|risbanomg@upmc.edu|
22377401|NCT03138096|Radboud University Medical Center|Dr. M.B.B. McCall|+31642166480|Matthew.McCall@radboudumc.nl|
22377402|NCT01813474|AstraZeneca|Medical Director||ClinicalTrialTransparency@astrazeneca.com|
22377403|NCT00316082|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
22377404|NCT00528775|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22377405|NCT01011829|University of California, Los Angeles|Steve Shoptaw PhD|310 794 0619|sshoptaw@mednet.ucla.edu|225
22396055|NCT01829425|University of New Mexico|Dr. Yuko Komesu|5052490726|ykomesu@salud.unm.edu|
22396056|NCT03681951|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22396057|NCT01020448|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22396058|NCT01230554|Bausch Health Americas, Inc|Robert Steffen||Robert.Steffen@bausch.com|
22396059|NCT03837379|Medical University of South Carolina|Dr. Jennifer Dahne|843-876-2280|dahne@musc.edu|
22396060|NCT03530917|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22396061|NCT01006265|Actelion Pharmaceuticals Ltd.|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22396062|NCT01390272|Durham VA Medical Center, Durham, NC|Dr. George Lee Jackson, PhD MHA|919-286-0411|George.Jackson3@va.gov|7091
22396063|NCT01177384|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22396064|NCT00590044|Emory University SOM|Guillermo Umpierrez|4047781663|geumpie@emory.edu|
22396065|NCT00888381|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
22396066|NCT00307333|University of Virginia|Joseph R. Moorman, MD|434-982-3367|rm3h@virginia.edu|
22396067|NCT00531882|University Hospitals Case Medical Center|Michael W Konstan, MD|2168445267|michael.konstan@uhhospitals.org|
22396068|NCT00757003|Stanford University|Dr. Daniel Sze, Principal Investigator|650-723-0728|dansze@stanford.edu|
22396069|NCT04267770|Imperial College London|Nick Oliver|+44 20 7594 1796|nick.oliver@imperial.ac.uk|
22396070|NCT04166383|National Cancer Institute|Dr. Tim F. Greten|240-760-6114|gretentf@mail.nih.gov|
22396071|NCT03044886|Department of Stomatology, Beijing Chao-yang Hospital, Capital Medical University|Dr. Wang Zuomin|+86-010-85231492|wzuomin@sina.cn|
22396072|NCT05426759|AtriAN Medical Ltd|Barry O'Brien PhD|+353872934292|barry.obrien@atrianmedical.com|
22396073|NCT02499081|University of Arkansas for Medical Sciences|Maurizio Zangari, MD|501-686-8274|MZangari@uams.edu|
22396074|NCT00375219|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22396075|NCT00824824|Massachusetts Eye and Ear Infirmary|Louis R. Pasquale, MD|617-573-4270|Louis_Pasquale@meei.harvard.edu|
22396076|NCT02684279|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
22396077|NCT00228566|Cephalon, Inc.|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
22396078|NCT01479829|Loyola University Medical Center|Dr. Angelos Halaris|708-216-3272|ahalaris@luc.edu|
22396079|NCT01578967|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22396080|NCT00591825|Laureate Institute for Brain Research (LIBR)|Robin Aupperle, PhD|(913) 588-9078|raupperle@laureateinstitute.org|
22396081|NCT01444456|Amgen Inc.|Study Director|866-572-6436||
22396082|NCT05868811|Children's Mercy Hospital|Dr. Kai Ling Kong|5157712880|kkong@cmh.edu|
22396083|NCT00683163|UNIVERSITY OF CALIFORNIA, SAN FRANCISCO|Dr. Dennis Black|415-514-8159|dblack@psg.ucsf.edu|
22437708|NCT03193736|iSTAR Medical|Zubair Hussain, VP Clinical and Regulatory Affairs|+3210771658|zubair@istarmed.com|
22437709|NCT00852241|Loyola Medicine|Rebecca Tung, MD|(708) 216-4962|rtung@loyolamedicine.org|
22437710|NCT02697435|VAPHS|Debra Kaye Weiner, M.D.|412-360-2920|Debra.Weiner@va.gov|
22437711|NCT03777059|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22437712|NCT00889824|WashingtonU|Joel Goebel, MD|(314) 362-7344|goebelj@ent.wustl.edu|
22437713|NCT02363621|Sierra Eye Associates|Dr. Arshad Khanani|775-329-0286|Arshad.Khanani@gmail.com|
22437714|NCT03056339|The University of Texas MD Anderson Cancer Center|Dr. Loretta Nastoupil, M.D. / Stem Cell Transplantation and Cellular Therapy Department|713-792-2860|lnastoupil@mdanderson.org|
22437715|NCT00939536|Accutest Research Laboratories Pvt. Ltd.|Kedar Joshi|+91 22 27780718||
22437716|NCT03974945|Rocky Mountain Regional Department of Veterans Affairs|Dr. Alena Grabowski|303-492-5208|alena.grabowski@va.gov|
22437717|NCT04506502|Zeltiq Aesthetics|Sally Hallas, RN, Director Clinical Development - Body Contouring|209-294-5571|sally.hallas@abbvie.com|
22437718|NCT01449006|St Vincent's Hospital, Sydney, Australia|Prof. Bruce Brew|61 2 8382 1111|bruce.brew@svha.org.au|4100
22437719|NCT02214290|Texas Tech University|Dr. Arturo Figueroa|8068345587|arturo.figueroa@ttu.edu|
22437720|NCT02517541|Scientific and Regulatory affairs|Zenia M Størling|+45 49111869|dkzenst@coloplast.com|
22437721|NCT04220554|University of Southern Denmark|Consultant, MD, PhD Mathias Tiedemann Svendsen|0045 61265827|mtsvendsen@health.sdu.dk|
22437722|NCT02034877|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22437723|NCT03782701|Bascom Palmer Eye Institute|Dr. Wendy Lee|(305) 243-2020|wlee@med.miami.edu|
22437724|NCT01898429|Dartmouth Hitchcock Medical Center|Paul E. Holtzheimer, MD|603-650-4914|Paul.E.Holtzheimer@hitchcock.org|
22437725|NCT01159015|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
22437726|NCT01036321|H. Lee Moffitt Cancer Center and Research Institute|Nagi Kumar, Ph.D.|813-745-6885|nagi.kumar@moffitt.org|
22437727|NCT00381693|Mayo Clinic|Dr. Ruben A. Mesa|507-284-3533|mesa.ruben@mayo.edu|4-3533
22437728|NCT01687101|Thomas Jefferson University, Jefferson Headache Center|Stephen D Silberstein, MD|215-955-2243|bruce.smith@jefferson.edu|
22437729|NCT02598297|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22437730|NCT02553395|CooperVision Inc.|Paul Chamberlain|925 730-6754|PChamberlain@coopervision.com|
22437731|NCT03369249|New York State Psychiatric Institute|Katherine Elkington|16467746965|ke2143@cumc.columbia.edu|
22437732|NCT02546492|University of MAryland sSchool of Medicine|A Haririan|410-328-5720|ahariria@som.umaryland.edu|
22437733|NCT02003534|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22437734|NCT03040674|Lung Health Institute|Melissa Rubio, PhD, APRN|2145042117|pidallas@thelunghealthinstitute.com|
22437735|NCT01073449|Dept. of Arrhythmology - Cliniche Humanitas Gavazzeni|Dr. Giosue Mascioli|+39 035 4204159|giosuemascioli@mac.com|
22437736|NCT02206035|Froedtert and the Medical college of Wisconsin|William Drobyski, MD|414-456-4941|wdrobysk@mcw.edu|
22437737|NCT01934010|Auris Medical Inc.|Thomas Meyer, CEO|+1 312 396 4150|hear@aurismedical.com|
22437738|NCT04112303|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22437739|NCT01685697|Univeristy of Alberta|Georg Schmolzer|7807354660|georg.schmoelzer@me.com|
22437740|NCT02703324|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22437741|NCT01854034|Massachusetts General Hospital|Lecia Van Dam Sequist, M.D.|617-724-4000|lvsequist@partners.org|
22437742|NCT02096549|Department of Anesthesiology and Pain medicine, Yeungnam University School of Medicine, Daegu, Republic of Korea|Sung Mee Jung, M.D|+82-53-620-3368|applejsm@gmail.com|
22437743|NCT04303572|University of Pittsburgh|Dr. Margaret Ragni, Principal Investigator|412-209-7288|ragni@pitt.edu|
22437744|NCT04428619|UCLA|Lin Chang|310-206-0192|linchang@mednet.ucla.edu|
22437745|NCT03517228|Memorial Sloan Kettering Cancer Center|Dr. Mario Leitao, MD|212-639-3987|leitaom@mskcc.org|
22437746|NCT01543074|Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston TX|Rod Dashwood|7136777806|rdashwood@ibt.tamhsc.edu|
22437747|NCT00945256|University of Texas Medical Branch|Dr Melinda Sheffield-Moore, Professor of Medicine|409-772-8707|melmoore@utmb.edu|
22437748|NCT03781414|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22437749|NCT06041919|Thirty Respiratory Ltd|Inva Hoti|+44 (0) 1235 431200|Inva.Hoti@30.technology|
22437750|NCT02576795|BioMarin (UK) Ltd|Konstantia-Maria Chavele, PhD, Director, Clinical Sciences|+44 207-4203351|KonstantiaMaria.Chavele@bmrn.com|
22437751|NCT03605914|The University of Texas Health Science Center at Houston|Martin J. Citardi, MD, Professor and Chair, Department of Otorhinolaryngology|(713) 500-5410|Martin.J.Citardi@uth.tmc.edu|
22437752|NCT01620762|Circassia Ltd|VP Clinical Operations|+44 1865 405560||
22437753|NCT03664765|JOHN D DINGELL VA MEDICAL CENTER|Dr. Abdulghani Sankari Principal Investigator|13135761000|abdulghani.sankari@va.gov|63105
22437754|NCT03202134|AZSintJanAV|Jan Mulier|003250452490|jan.mulier@azsintjan.be|
22437755|NCT00177255|University of Pittsburgh|Nathan Bahary, MD|412-864-7764|baharyn@upmc.edu|
22437756|NCT00966550|Illinois Institute of Technology|Dr. Britt Burton-Freeman|312-567-5307|bburton@iit.edu|
22437757|NCT01128946|GlaxoSmithKline|GSK Response Center|866-435-7343||
22437758|NCT00527904|POZEN|Senior Vice President, Clinical Research|919-913-1030|eorlemans@pozen.com|
22437759|NCT02467842|SK bioscience|Hayoung Lee|+82-2-2008-2552|haylee@sk.com|
22396084|NCT02229539|Mayo Clinic|Robert C. Miller, MD, MS|904-953-1003|miller.robert@mayo.edu|
22377406|NCT02216773|Imperial College London|Professor Long Jiao|+44 2033133937|l.jiao@imperial.ac.uk|
22377407|NCT01163097|Swedish Orphan Biovitrum|Medical Program Director|+46 8 697 20 00|clinical@sobi.com|
22377408|NCT04540874|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22377409|NCT00796302|Ohio State University|Michael Aman|614-688-4196|Aman.1@osu.edu|
22377410|NCT02510144|University of Maryland Baltimore|Dr. Mohit Gilotra|(301) 502-4102|mgilotra@som.umaryland.edu|
22377411|NCT01188109|Emory University|Shishir K. Maithel, MD|404-778-1900|smaithe@emory.edu|
22377412|NCT01522417|Medicure|Kyle Brown|204-594-3411|kbrown@medicure.com|
22377413|NCT00182754|Mayo Clinic|Aminah Jatoi, M.D|507-284-4918|jatoi.aminah@mayo.edu|
22377414|NCT00506064|UT MD Anderson Cancer Center|Una Srejic, MD / Professor|713-792-6914|CR_Study_Registration@mdanderson.org|
22377415|NCT00941330|Emory University|Jane Meisel, MD|404-778-1900|jane.l.meisel@emory.edu|
22377416|NCT00541450|Merck Sharp & Dohme Corp|Vice President of Late Stage Development||clinicaltrialsdisclosure@spcorp.com|
22377417|NCT00981084|University of Missouri - Kansas City|Dr. Jared Bruce|401-499-4043|brucejm@umkc.edu|
22377418|NCT01112579|Medtronic Cardiac Rhythm and Heart Failure|DEFEAT-HF Clinical Team|1-800-328-2518|MedtronicCRMtrials@medtronic.com|
22377419|NCT01648270|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
22377420|NCT04969263|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|extension
22377421|NCT01389973|Janssen, R&D, LLC, Spring House, PA|Senior Director, Clinical Development, Immunology||ClinicalTrialDisclosure@its.jnj.com|
22377422|NCT00725296|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22377423|NCT03360942|Dartmouth-Hitchcock Medical Center|Cristina Ferrazzano Yaussy, MPH, CCRP, Research Regulatory Affairs Specialist|603-650-5333|Cristina.Ferrazzano.Yaussy@hitchcock.org|
22377424|NCT03456700|Mayo Clinic|Aminah Jatoi MD|507/284-2511|Jatoi.Aminah@mayo.edu|
22437760|NCT02873338|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
22437761|NCT00952393|University of Colorado|Dr. Robert Freedman|3037244940|Robert.Freedman@ucdenver.edu|
22437762|NCT00766051|University of Utah at the time of the study|Lynne La Corte, PhD, OTR/L, OTD|970 4330981|lflacorte@independence.net|
22437763|NCT01320202|Rockwell Medical|Senior Director, Clinical Research & Operations|248-960-9009|rd@rockwellmed.com|
22437764|NCT00635882|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22437765|NCT02006979|University of Alberta|Dr. Amy Kirkham, Postdoctoral Research Fellow|7804926874|amy.kirkham@ualberta.ca|
22437766|NCT06037408|Emphycorp, Inc.|Dr. Alain Martin|(908) 237-1561|al.martin.hq@emphycorp.com|
22437767|NCT01211340|University of Missouri|Debra Parker Oliver|573-884-5301|oliverdr@missouri.health.edu|
22437768|NCT03477838|Virginia Commonwealth University|Evan Sisson, PharmD|804-828-8076|emsisson@vcu.edu|
22437769|NCT01931163|The Methodist Hospital Research Institute|Dr. Jenny Chang|713 441-0680|jcchang@houstonmethodist.org|
22437770|NCT03139344|University of Iowa Department of Physical Therapy and Rehabilitation Science|Dr. Richard K. Shields|319-335-9791|richard-shields@uiowa.edu|
22437771|NCT04230213|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22437772|NCT00524472|Cleveland Clinic|Andra Duncan, MD|216 445-2372|DUNCANA@ccf.org|
22437773|NCT02748070|Stanford University|Michael Chang|(650) 725-6500|michael.t.chang@stanford.edu|
22437774|NCT04338971|Neurolutions|Director of Clinical Affairs|831-316-5466|lsouders@neurolutions.com|
22437775|NCT00240500|GlaxoSmithKline|GSK Response Center|866-435-7343||
22437776|NCT00619307|Merck Serono, a division of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22437777|NCT00928694|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22437778|NCT00861471|New York University Cancer Institute|Anna Ferrari, MD|212-731-5389|anna.ferrari@nyumc.org|
22437779|NCT00669383|OHSU|Cindy McEvoy, MD|503-494-0223|mcevoyc@ohsu.edu|
22437780|NCT02069392|University of Maryland School of Medicine|Britta Hahn, Ph.D.|4104026112|bhahn@som.umaryland.edu|
22396085|NCT03441334|Texas Woman's University|Hui-Ting Goh, Assistant Professor|2146897723|HGoh1@twu.edu|
22437781|NCT00269633|Thomas Jefferson University|Roseann Talarico|215 503 4743|roseann.talarico@jefferson.edu|
22377425|NCT00613951|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22377426|NCT03053050|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22377427|NCT00655980|University of Chicago Medicine|Principal Investigator|7737022544||
22377428|NCT01367262|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22377429|NCT00254202|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
22377430|NCT05501860|American Genomics, LLC|Michelle Widmann|919-600-1819|mwidmann@calclinicalsolutions.com|
22377431|NCT04866017|BeiGene|Study Director|1-877-828-5568|clinicaltrials@beigene.com|
22377432|NCT01266642|UT MD Anderson Cancer Center|Dr. Benjamin Smith, Professor, Radiation Oncology Department|(713) 563-2380|bsmith3@mdanderson.org|
22377433|NCT00806234|Johns Hopkins University|Dr. Mark Riddle|410-302-6120|mriddle1@jhmi.edu|
22377434|NCT01337674|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22437782|NCT01574651|Novartis Pharnaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22437783|NCT04412707|Oncopeptides AB|VP Chief Operating Officer|+46 8 615 20 40|trials@oncopeptides.com|
22437784|NCT00855959|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22437785|NCT01424501|GlaxoSmithKline|GSK Response Center|866-435-7343||
22437786|NCT00699608|GlaxoSmithKline|GSK Response Center|866-435-7343||
22437787|NCT00566462|Eisai Call Center|Eisai Inc.|888-422-4743||
22437788|NCT02551822|University of New Mexico Health Sciences Center, Department of Obstetrics & Gynecology, Division of Urogynecology|Dr. Yuko Komesu, MD|505-272-6382|YKomesu@salud.unm.edu|
22437789|NCT04306510|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionis.com|
22437790|NCT04720417|Thomas Jefferson University|Rino Seedor, MD|215-955-8874|Rino.Seedor@Jefferson.edu|
22437791|NCT03329092|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22437792|NCT04878211|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22437793|NCT03574779|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22437794|NCT00856544|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22437795|NCT03755882|Johnson & Johnson Vision Care Inc.|Brian Pall, OD, MS, FAAO- Director of clinical Sciences|904 443-1290|BPALL@its.jnj.com|
22437796|NCT04808141|Sword Health Inc|Fernando Dias Correia|+1 (646) 379-6751|fcorreia@swordhealth.com|
22437797|NCT01401517|TheraVasc Inc.|Tony Giordano|318-349-3851|tgiordano@theravasc.com|
22437798|NCT04846322|Yale University|Ula Hwang, MD|+1 (203) 7371774|ula.hwang@yale.edu|
22437799|NCT00377858|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22437800|NCT02506192|Minneapolis VA Health Care System|Ronald R Bach, PhD, Principal Investigator|(612)467-6315|ronald.bach@va.gov|
22437801|NCT04042909|Brown University|Kate B. Carey|4018636558|kate_carey@brown.edu|
22437802|NCT06312592|Washington University in St. Louis|Dr. Lindsay Stark|314-935-4747|lindsaystark@wustl.edu|
22437803|NCT03785405|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22437804|NCT03705559|University of Kentucky|Shanna Babalonis, Ph. D.|859-257-1881|babalonis@uky.edu|
22437805|NCT01147055|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22437806|NCT03724890|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22437807|NCT04210622|Medtronic, Inc|Clinical Research Specialist|800-328-2518|medtroniccastrials@medtronic.com|
22437808|NCT02362464|National Cancer Institute|Dr. Hoyoung Maeng|240-781-3253|maengh@mail.nih.gov|
22437809|NCT02123823|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22437810|NCT02093962|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilson@thresholdpharm.com|
22437811|NCT03254940|Duke University|Dr. Gary G. Bennett (PI/Dean of Trinity College of Arts & Sciences)|(919) 808-7821|gary.bennett@duke.edu|
22437812|NCT01635855|Merz Pharmaceuticals North America|Merz Pharmaceuticals North America|800-334-0514|clinicaltrials@merzusa.com|
22437813|NCT03190460|University of Washington School of Nursing|Dr. Hilaire Thompson|2066165641|hilairet@uw.edu|
22437814|NCT02104947|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22437815|NCT01844778|Novartis|Study Director|862-778-8300||
22437816|NCT03521479|Squarex LLC|Hugh McTavish|6512078270|hmctavish@squarex-pharma.com|
22437817|NCT00095173|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22437818|NCT01623869|Memorial Sloan-Kettering Cancer Center|Sandra Pierina D'Angelo, M.D.||dangelos@mskcc.org|
22437819|NCT03514433|Boston Medical Center|Tracy A Battaglia, MD, MPH|617 638 7428|Tracy.Battaglia@bmc.org|
22437820|NCT02161757|AstraZeneca|Global Clinical Lead|+1 301-398-0582|ClinicalTrialTransparency@astrazeneca.com|
22437821|NCT00391625|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22437822|NCT00328861|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
22437823|NCT02275156|Amgen Inc.|Study Director|866-572-6436||
22437824|NCT01130896|Johns Hopkins University|Henry Halperin, MD|410-955-2412|nsaju1@jhmi.edu|
22437825|NCT02106403|GlaxoSmithKline|GSK Response Center|866-435-7343||
22437826|NCT02343406|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22437827|NCT00874848|Biothera|Jamie Lowe, Vice President, Clinical Development|651-256-4653|jlowe@biothera.com|
22437828|NCT01496846|University of Michigan|Dr Tatiana Botero, Director of Postgraduate Program in Endodontics|734-936-2526|tbotero@umich.edu|
22437829|NCT03089541|Yale School of Medicine|Dr. Deepa Camenga, Principal Investigator|12037378310|deepa.camenga@yale.edu|
22437830|NCT02024724|Northwestern University, Feinberg School of Medicine|Antoun Nader, M.D.|312-695-4814|a-nader2@northwestern.edu|
22437831|NCT01772576|Boston Scientific|Ursula Appl|003224167213|ursula.appl@bsci.com|
22437832|NCT05169424|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
22437833|NCT02326233|Samsung Bioepis Co., Ltd.|Director of Clinical Trials||sbregistry@samsung.com|
22437834|NCT02019875|University of Washington|Kenneth Thummel|206-543-0819|thummel@u.washington|
22437835|NCT00639626|Nationwide Children's Hospital|Julie Rice, RN|6143553142|julie.rice@nationwidechildrens.org|
22437836|NCT03301350|University of Wisconsin Carbone Cancer Center|Kari Wisinski, MD|608-262-2876|kbwisinski@medicine.wisc.edu|
22437837|NCT00379912|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
22437838|NCT04698993|Draegerwerk AG & Co. KGaA|Dr Rainer Polzius|+498824514429|rainer.polzius@draeger.com|
22437839|NCT01371734|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22437840|NCT00958165|CardioFocus, Inc|Burke T. Barrett|508 658-7200|bbarrett@cardiofocus.com|
22437841|NCT00145574|Daiichi Sankyo|Howard Kessler|732-590-5032|hmkessler@dsi.com|
22437842|NCT00621140|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22437843|NCT03323801|University of Washington School of Medicine|Dr. John Amory|2066161727|jamory@uw.edu|
22437844|NCT01298765|BIODELIVERY|Vice President, Operations|919-582-0294|twarneke@bdsi.com|
22437845|NCT03565237|Takeda|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22437846|NCT02021955|VA Puget Sound Health Care Sysem|Margaret Collins|206.764.2085|margaret.collins@va.gov|
22396086|NCT00088907|ECOG Statistical Office|Study Statistician|617-632-3012||
22396087|NCT04946825|University of Vermont|Elias Klemperer, PhD|802-656-1641|elias.klemperer@med.uvm.edu|
22377435|NCT02355067|Children's Hospital of Philadelphia|Dr. James Guevara|215-590-1130|guevara@email.chop.edu|
22377436|NCT01553318|Wake Forest Baptist|dennis ang|336-716-4209|dang@wakehealth.edu|
22377437|NCT00695786|UT MD Anderson Cancer Center|Felipe Samaniego,MD/Professor, Lymphoma-Myeloma|(713) 745-6824|fsamaniego@mdanderson.org|
22377438|NCT02542839|University of Florida|Aparna Wagle Shukla|3522945400|aparna.shukla@neurology.ufl.edu|
22377439|NCT00791843|University of Pennsylvania|Tyrone Quarterman|215-349-5537|tyroneq@upenn.edu|
22377440|NCT04244396|Abbott_Medical_Devices|Emily Jesser Clinical Research Scientist II|6514482520|emily.jesser@abbott.com|
22377441|NCT01787097|Imperial College|Dr Omar S Usmani|+44 (0)20 7351 8051|o.usmani@imperial.ac.uk|
22377442|NCT00245102|Memorial Sloan-Kettering Cancer Center|Dr. William Tap|646-888-4163|tapw@mskcc.org|
22377443|NCT00289887|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22377444|NCT01857882|University Health Network|Dr. Toni Zhong|416-340-3858|toni.zhong@uhn.ca|
22377445|NCT02293395|Janssen Research & Development, LLC|Associate Director||ClinicalTrialDisclosure@its.jnj.com|
22377446|NCT01464021|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22377447|NCT04639193|University of California San Diego|Dr Chris Schmickl|8582462154|cschmickl@health.ucsd.edu|
22377448|NCT01023568|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org|
22377449|NCT00224770|Johns Hopkins University|Dr. Daniel F. Hanley|(410) 614-6996|dhanley@jhmi.edu|
22377450|NCT01106430|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22377451|NCT00437645|Novartis Pharmaceuticals|Study Director|862 778-8300||
22377452|NCT00297115|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22377453|NCT02124889|WakeForest|Dr. Adolfo Fernandez|336-716-6099|afernand@wakehealth.edu|336
22377454|NCT00175825|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22377455|NCT03704584|Emory University|Dr. Charles Daly|404-919-6168|charles.a.daly@emory.edu|
22377456|NCT03412812|University of Alabama at Birmingham|Dr. John Fiveash|205-975-0224|jfiveash@uabmc.edu|
22377457|NCT02127372|Duke University Medical Center|Gordana Vlahovic, MD|919-681-4047|Gordana.vlahovic@dm.duke.edu|
22377458|NCT04141774|UW School of Medicine and Public Health|Dr. Vivek Prabhakaran, MD, PhD|(608) 265-5269|vprabhakaran@uwhealth.org|
22377459|NCT03548207|Janssen Research & Development, LLC|Vice President Research and Development, Cellular Therapy|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22377460|NCT01756352|Brigham and Women's Hospital|Marcelo DiCarli, MD|(617) 732-6290|mdicarli@bwh.harvard.edu|
22377461|NCT02281448|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22377462|NCT02641392|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|amcclain@celgene.com|
22377463|NCT03466086|Johnson & Johnson Vision|Meredith Bishop, OD, MS, FAAO|904-443-1396|MBishop4@its.jnj.com|
22377464|NCT01113502|Abramson Cancer Center of the University of Pennsylvania|Dr. Noelle Frey||noelle.frey@pennmedicine.upenn.edu|
22377465|NCT01144026|Thymon LLC|Dr. Gideon Goldstein|(973) 467-9558|gidgold@gmail.com|
22377466|NCT04475549|Cyclerion Therapeutics, Inc.|Cyclerion Clinical Development|1-857-327-8778|info@cyclerion.com|
22377467|NCT04852055|Brown University|Project Director|(401) 863-7345|ellen_mccreedy@brown.edu|
22377468|NCT03575325|Moffitt Cancer Center|Bijal D. Shah, MD, MS|813-745-4294|Bijal.Shah@moffitt.org|
22377469|NCT03440372|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22377470|NCT05711641|Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo|Dr. Tatiane Vacaro Campos|+551126617585|tati_vacaro@hotmail.com|
22377471|NCT03574597|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22377472|NCT03804710|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22377473|NCT04542018|University of Michigan|Prashant Singh, MBBS|734-647-1191|singhpr@med.umich.edu|
22377474|NCT03583554|Baylor College of Medicine and Michael E. DeBakey VA Medical Center|Dr. Marijn Lijffijt, Assistant Professorq|713-798-5642|marijn.lijffijt@bcm.edu|
22377475|NCT03178266|ZipLine Medical|Wendy Winters, Clinical Project Manager|4085061866|wwinters0@gmail.com|
22377476|NCT01215292|University of Washington|Mara Roth, MD|206-221-0519|mylang@uw.edu|
22377477|NCT00526123|Tufts Medical Center|Dr. Klemens B. Meyer|617-636-9421|kmeyer@tuftsmedicalcenter.org|
22377478|NCT01029054|University of Michigan Hospital|Dr. Mark Kaminski, M.D.|734-936-5310|mkaminsk@umich.edu|
22377479|NCT00036569|National Cancer Institute|Kathy Warren, M.D.|301-435-4683|warrenk@mail.nih.gov|
22377480|NCT01596582|Boston Medical Center|Paul C. Schroy III, MD, MPH|671-638-8335|paul.schroy@bmc.org|
22377481|NCT01846182|Central Texas Veterans Health Care System|Charles J. Foulks, M.D., ACOS/R|254 743 2643|Charles.Foulks@va.gov|
22377482|NCT01786967|University of North Carolina at Chapel Hill|Jennifer Wu, MD, MPH|919-966-0014|jennifer_wu@med.unc.edu|
22377483|NCT02012491|University of Pennsylvania|Dr. Courtney Schreiber|215-615-5234|Courtney.Schreiber@uphs.upenn.edu|
22377484|NCT01667432|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22377485|NCT02339831|Brigham and Women's Hospital|Wolfgang Fitz MD|617-732-9500|wfitz@partners.org|
22377486|NCT00553696|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22377487|NCT01054768|Children's Hospital & Research Center at Oakland|Ashutosh Lal, MD|5104283172|ashutosh.lal@ucsf.edu|
22377488|NCT02471651|California Retina Consultants|Dr. Gabriel Gordon|8059631648|gabe@californiaretina.com|3034
22377489|NCT00686881|Merck Sharp & Dohme Corp..|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22377490|NCT00671931|Cincinnati Children's Hospital|Mohamed Mahmoud, MD Principal Investigator|513 636-7426|mohamed.mahmoud@cchmc.org|
22377491|NCT01298999|Columbia University Medical Center|Julian A Abrams, MD|2123059541|ja660@cumc.columbia.edu|
22396088|NCT00682448|Rush University Medical Center|Stephanie Cavanaugh, MD||Stephanie_Cavanaugh@rush.edu|
22396089|NCT00829049|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22377492|NCT02816138|Vanderbilt University Medical Center|Warren D. Taylor, MD|6153221073|warren.d.taylor@vanderbilt.edu|
22377493|NCT00818753|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22377494|NCT00902694|Johns Hopkins University School of Medicine|Gail Daumit, MD, MHS|410-614-6460|gdaumit@jhmi.edu|
22377495|NCT04154787|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22377496|NCT01116934|JWGUniversity|Prof. Dr. Peter Eickholz|+49-69-6301|eickholz@med.uni-frankfurt.de|5642
22377497|NCT01437449|Stanford University|Dr. A. Dimitrios Colevas, Professor of Medicine (Oncology)|650-724-9707|colevas@stanford.edu|
22377498|NCT02532179|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22377499|NCT00989092|Amgen Inc.|Study Director|866-572-6436||
22377500|NCT02713711|UC de Maule|Professor Gabriel Nasri Marzuca Nassr|56 71 203463|gmarzuca@gmail.com|
22377501|NCT03837509|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22377502|NCT01207570|The Hong Kong Polytechnic University|Dr. Marco Pang|85227667156|Marco.Pang@inet.polyu.edu.hk|
22377503|NCT01267292|The University of Texas Health Science Center at Houston|Scott Lane, PhD|713-486-2535|Scott.D.Lane@uth.tmc.edu|
22377504|NCT01798394|University of Minnesota|Nicole Tosun|612-624-5439|tosun004@umn.edu|
22377505|NCT03320018|Stony Brook Medicine|Christine Pol|6314449083|christiana.pol@stonybrookmedicine.edu|
22377506|NCT00549757|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22377507|NCT00715650|Yale University|Dr. Marc Rosen|203-932-5711|marc.rosen@yale.edu|2575
22377508|NCT03026790|University of Minnesota|Erin Krebs|612-629-7558|Erin.Krebs@va.gov|
22377509|NCT01291784|Icahn School of Medicine at Mount Sinai|Dr. John O. Mascarenhas|212-241-6756|john.mascarenhas@mssm.edu|
22377510|NCT02360319|Vanguard Research Group|Patrica Marcy|3474398035|pmarcy@northwell.edu|
22377511|NCT01256411|Novartis Pharmaceuticals|Study Director|862-778-8300||
22377512|NCT02274857|Abbott|Clinical Program Director|651-756-6717|kristin.ruffner@abbott.com|
22377513|NCT02403180|Alcon Research, Ltd.|Global Medical Affairs Franchise Head, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22377514|NCT00117676|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22377515|NCT00952822|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22377516|NCT00691938|Washington University School of Medicine|Geoffrey Uy, M.D.|314-454-8304|guy@wustl.edu|
22377517|NCT01965782|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22377518|NCT00594854|Pozen Inc.|Senior Vice President, Clinical Research|919-913-1030|eorlemans@pozen.com|
22377519|NCT01250990|University of Pennsylvania|Richard L Dunbar|215-662-9024|richard.dunbar@uphs.upenn.edu|
22377520|NCT03786952|Ohio Northern University|Phillip Zoladz|419-772-2142|p-zoladz@onu.edu|
22377521|NCT04918147|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22377522|NCT03292146|Massachusetts General Hospital|Karen K. Miller, MD|617-724-7388|KKMILLER@mgh.harvard.edu|
22377523|NCT06134180|Case Western Reserve Unviersity|Kylie Meyer|2163681928|knm77@case.edu|
22377524|NCT01362439|Janssen-Cilag SpA, Cologno Monzese, Milan - Italy|Therapeutic Area Medical Manager|+39 0225101||
22377525|NCT03905330|Mirum Pharmaceuticals|Mirum Clinical Trials|650-667-4085|medinfo@mirumpharma.com|
22377526|NCT02712905|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22377527|NCT03624504|Medtronic (Shanghai) Management Co., Ltd.|Weifan Sun, Clinical Study Manager|021-20325267|weifan.sun@medtronic.com|86
22377528|NCT02975973|Baylor College of Medicine|Raymond Cho|713-798-7781|Raymond.Cho@bcm.edu|
22377529|NCT01812655|Arkansas Children's Hospital|Debra Jeffs, PhD, RN, Principal Investigator|501-364-3239|jeffsda@archildrens.org|
22377530|NCT01428076|BTG International Inc.|David Wright MB FRCS|610-278-1660|david.wright@btgplc.com|
22377531|NCT04435665|NFlection|Director of Clinical Operations|7078532199|comara@nflectionrx.com|
22377532|NCT02454101|AinShamsU|ahmed kotb|0100868199|ahmedmkotp@hotmail.com|+2
22377533|NCT00419263|BioCryst Pharmaceuticals, Inc.|William P. Sheridan, MBBS|(919) 859-1302||
22377534|NCT00387673|Miami VA Healthcare System|Kristina Beekhuizen|305-575-7000|Kristina.Beekhuizen@va.gov|
22377535|NCT00540124|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22377536|NCT02124265|Johns Hopkins University School of Medicine|Carisa Cooney|443-287-4629|ccooney3@jhmi.edu|
22377537|NCT00058123|North American Brain Tumor Consortium|Susan Chang, MD|410-955-8837|jfisher@jhmi.edu|
22377538|NCT02732366|University of Pittsburgh, Department of Physical Therapy|Christine M. McDonough, Assistant Professor of Physical Therapy|4123834603|cmm295@pitt.edu|
22377539|NCT00344461|University of Maryland, Institute Of Human Virology|Charles E. Davis, Jr., MD|410-706-4608|cdavis@ihv.umaryland.edu|
22377540|NCT01723722|Eastern Maine Medical Center|Dr Mark S Brown|207-973-8670|mbrown@emh.org|
22377541|NCT04839965|Ampio Pharmaceuticals|Dr. Howard Levy / Chief Medical Officer|17204376500|clinicaltrials@ampiopharma.com|
22377542|NCT02291679|Ironwood Pharmaceuticals, Inc.|Michael Hall, MD|(617) 621-7722||
22377543|NCT02355028|Alcon, A Novartis Division|Clinical Scientist, NIBR|1-888-451-3937|alcon.medinfo@alcon.com|
22377544|NCT02276222|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
22377545|NCT02170025|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22377546|NCT01525602|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
22377547|NCT01031810|New York State Psychiatric Institute|Dr. Patrick J. McGrath|(646) 774-8076|mcgrath@nyspi.columbia.edu|
22377548|NCT02669784|Milton S. Hershey Medical Center|Rekha Cherian, M.D.|717-531-6735|rcherian@pennstatehealth.psu.edu|
22411286|NCT02040766|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22377549|NCT01880723|University of Arizona|Courtney Wheatley|507-266-2696|wheatley.courtney@mayo.edu|
22377550|NCT03703466|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22377551|NCT02412137|Texas Scottish Rite Hospital for Children|Dr. Brandon Ramo|2145597755|brandon.ramo@tsrh.org|
22377552|NCT00506493|Medtronic, Inc.|Kristin Lawman|763-514-9809|kristin.j.lawman@medtronic.com|
22377553|NCT02240108|Bausch Health Americas, Inc.|Director of Clinical Operations|908-927-0873|lindsey.mathew@bauschhealth.com|
22377554|NCT00119405|Case Western Reserve University|Grace McComsey|216-844-3607|mccomsey.grace@clevelandactu.org|
22377555|NCT00800839|The University of Texas (UT) MD Anderson Cancer Center|Amin M. Alousi, MD/Stem Cell Transplantation||CR_Study_Registration@mdanderson.org|
22377556|NCT00939484|St. Jude Children's Research Hospital|Tong Lin (Biostatistician)|9015952048|Tong.Lin@stjude.org|
22377557|NCT04233372|Hospital Clínic of Barcelona|Dr. Alexy Inciarte|+34932275400|ajinciar@clinic.cat|
22377558|NCT04958785|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230|GileadClinicalTrials@gilead.com|GILEAD-0
22377559|NCT01090310|Novartis|Study Director|862-778-8300||
22377560|NCT01224925|UiT The Arctic University of Norway (Tromsø university)|Associate professor Rita Kundzina|+4777649118|rita.kundzina@uit.no|
22377561|NCT01341977|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22377562|NCT04149925|Lexington Medical Inc.|Annette Dunn|480-313-8505|annette@lexington-med.com|
22377563|NCT02472652|Thomas D Gazda MD PC|Thomas D Gazda MD|480 518 6299|goodgazda@yahoo.com|
22377564|NCT04586569|Boston Children's Hospital|Dr. Linda Bulich|617-355-7737|linda.bulich@childrens.harvard.edu|
22377565|NCT03185832|Boston Scientific|Caroline Beaudoint|+32479904163|Caroline.Beaudoint@bsci.com|
22377566|NCT03675451|Weill Cornell Medicine|Junaid Niaz|212.746.5793|mjn3001@med.cornell.edu|
22377567|NCT01083641|University of Wisconsin Carbone Cancer Center|Dr. Kari Wisinski|608-262-2876|kbwisinski@medicine.wisc.edu|
22377568|NCT03439189|Exalenz Bioscience|Clinical trial manager|00 972 546605412|avrahamh@exalenz.com|
22377569|NCT01777321|GlaxoSmithKline|GSK Response Center|866-435-7343||
22377570|NCT02173548|Virginia Commonwealth University|Antonio Abbate, MD, PhD|(804) 828-0513|antonio.abbate@vcuhealth.org|
22377571|NCT03597568|University of I|Dr. Diana Jalal|319-338-0581|diana-jalal@uiowa.edu|
22377572|NCT03722927|Wake Forest Baptist Health|Dr. Christopher Runyan|336-716-4171|crunyan@wakehealth.edu|
22377573|NCT00999466|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22377574|NCT05131165|RAND Corporation|Sebastian Linnemayr|310-393-0411|slinnema@rand.org|6734
22377575|NCT00526630|University of Cincinnati|Alberto Espay, MD|513-403-4600|alberto.espay@uc.edu|
22377576|NCT01904864|Baylor College of Medicine|Jacquelyn M. Powers, MD||jacquelyn.powers@bcm.edu|
22377577|NCT00337272|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com|
22377578|NCT00832767|Covidien|Jessica Carlson|203-821-4734|jessica.carlson@covidien.com|
22377579|NCT03043079|University of Pennsylvania|Dr. John P Fischer|2156627300|john.fischer2@uphs.upenn.edu|
22377580|NCT05674890|University of Iowa Hospitals and Clinics Department of Ophthalmology and Visual Sciences|Dr. Andrew Pouw|3193562928|andrew-pouw@uiowa.edu|
22377581|NCT04647032|University of California San Francisco|Dr. Theodore Zanto|415-502-7322|theodore.zanto@ucsf.edu|
22377582|NCT03856515|M.D. Anderson Cancer Center|Jason Robinson|713-792-2265|nicotinestudy@mdanderson.org|
22377583|NCT02650219|St Joseph Hospital Marseille|Dr Christine Serratrice|0041798731474|cserratrice@hotmail.fr|
22377584|NCT02094443|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
22377585|NCT05906368|UPMC, University of Pittsburgh|Dr. Katherine Grace Lim|412-641-1778|limkg2@upmc.edu|
22377586|NCT01127646|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22377587|NCT03387579|Indiana University School of Medicine|Dr. Katie Huff|3179449395|huffka@iupui.edu|
22377588|NCT00595504|Massachusetts General Hospital|David C. Henderson, M.D.|617-912-7800|dchenderson@partners.org|
22377589|NCT00293267|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22377590|NCT01804816|Cleveland Clinic Foundation|Dr. W.H. Wilson Tang, MD|(216) 444-2121||
22377591|NCT01754467|Northwestern University|Christine Pellegrini, PhD|312-503-1395|c-pellegrini@northwestern.edu|
22377592|NCT01235546|University of Alabama at Birmingham, Maternal & Fetal Medicine|Alan Tita, MD|205-934-9616|atita@uab.edu|
22377593|NCT01123382|MetroHealth Medical Center|Richard WIlson, MD|216-957-3559|rwilson@metrohealth.org|
22377594|NCT00330174|Medical University of South Carolina|Susan Sonne, PharmD, BCPP|843.792.5221|sonnesc@musc.edu|
22377595|NCT01032733|University of Florida|Stephen Anton|352-273-7514|santon@ufl.edu|
22377596|NCT00834106|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22377597|NCT02230956|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22396090|NCT04050670|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22377598|NCT01445652|Alcon Research, Ltd.|Jami Kern, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
22377599|NCT03002610|University of Split School of Medicine|Ivan Buljan|+385989027209|ibuljan@mefst.hr|
22377600|NCT00929162|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22377601|NCT01822587|MUSC|Michael Saladin|843-792-5306|saladinm@musc.edu|
22396091|NCT00268437|Mayo Clinic|Aminah Jatoi, M.D.|507/284-4918|jatoi.aminah@mayo.edu|
22396092|NCT02053909|Boca Raton Regional Hospital|Dr. Alexander Kulik|561-955-6300|alex_kulik@yahoo.com|
22396093|NCT01651104|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22396094|NCT02528370|Hospital Galdakao-Usansolo|Dr Cristobal Esteban|0034 94 400 7000|cristobal.estebangonzalez@osakidetza.eus|7002
22377602|NCT04225533|Serpin Pharma, LLC|Dr. Cohava Gelber|7033433258|cgelber@serpinpharma.com|
22377603|NCT00658567|ACADIA Pharmaceuticals Inc.|Roger Mills, MD|858-202-7563|rmills@acadia-pharm.com|
22377604|NCT01755702|GlaxoSmithKline|GSK Response Center|866-435-7343||
22396095|NCT00388505|Novartis Pharmaceuticals|Study Director|862-778-8300||
22396096|NCT02650999|University of Pennsylvania, Clinical Research Unit|Ellen Napier, Nurse Pracitioner|215.279.1972|ellen.napier@pennmedicine.upenn.edu|
22377605|NCT01319799|Sahlgrenska University Hospital,Cardiothoracic Anesthesia, 41345 Gothenburg ,SWEDEN|Dr Bjorn Reinsfelt|0046702954263|bjorn.reinsfelt@gu.se|
22377606|NCT04860518|Faron|Dr Juho Jalkanen|+358407071046|juho.jalkanen@faron.com|
22377607|NCT03882879|Rush University Medical Center|Dr. Jori Fleisher|13125632900|jori_fleisher@rush.edu|
22377608|NCT02355743|BloodCenter of Wisconsin, Medical College of Wisconsin|Lynn Malec|414-257-2424|lynn.malec@bcw.edu|
22377609|NCT04496219|University of Washington|Dr. Sarah Psutka, MD, MS|206-598-4294|spsutka@uw.edu|
22377610|NCT02652481|Boston Scientific|Clinical Trial Manager|+32479983495|anneleen.viville@bsci.com|
22377611|NCT02279043|University of California, San Francisco|Edith Fox|4152062544|edith.fox@ucsf.edu|
22377612|NCT00490282|The University of Texas (UT) MD Anderson Cancer Center|Adam Garden, MD/Radiation Oncology Department|(713) 563-2300|agarden@mdanderson.org|
22377613|NCT00374322|GlaxoSmithKline|GSK Response Center|866-435-7343||
22377614|NCT02306759|The Brooklyn Hospital Center|Director, Emergency Medicine Clinical Research Program|718-250-6250|bsin@tbh.org|
22377615|NCT00636610|Genentech, Inc.|Medical Communications|800-821-8590||
22377616|NCT02495025|University of California Los Angeles|Principal Research Manager, Health Services Research Program|310-825-8624|lindseythompson@mednet.ucla.edu|
22377617|NCT00313820|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22377618|NCT02721082|U. Kansas Medical Center|Dr. Kimber Richter|9134490157|krichter@kumc.edu|
22377619|NCT00416182|Vermont Children's Hospital at Fletcher Allen Health Care|Dr. Thomas Lahiri, Principal Investigator|802-847-8600|thomas.lahiri@vtmednet.org|
22377620|NCT02151266|Emory University|Dr. Gary|404-727-8360|ragary@emory.edu|
22377621|NCT01169675|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22377622|NCT02354664|University of Florida|Barbara Smith, Assistant Professor|352-294-5315|bksmith@phhp.ufl.edu|
22377623|NCT04102579|Neurocrine Biosciences|Neurocrine Medical Information Call Center|877-641-3461|medinfo@neurocrine.com|
22377624|NCT05899686|UCaliforniaSF|Pekka Talke|4153063602|pekka.talke@ucsf.edu|
22377625|NCT00572195|NeuroPace, Inc.|Dr. Martha Morrell, Chief Medical Officer|650-237-2776|mmorrell@neuropace.com|
22377626|NCT01602536|University of California, Irvine|Cornelia Pechmann|310-892-0619|cpechman@uci.edu|
22377627|NCT03076970|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22377628|NCT00949884|Daiichi Sankyo, Inc.|Robert Dubiel, PharmD|973-944-2963|bdubiel@dsi.com|
22377629|NCT02565901|University of Washington|Dr. Bruce Montgomery|206-598-0860|rbmontgo@uw.edu|
22377630|NCT02512679|Children's Hospital Los Angeles|Neena Kapoor, M.D.|343-361-2434|nkapoor@chla.usc.edu|
22377631|NCT03701295|Johns Hopkins University|ETCTN Grants Administrative Manager|410-955-4044|jmurra33@jhmi.edu|
22377632|NCT02287350|Depomed|Clinical Operations|510-744-8000|clinicaltrials@depomed.com|
22377633|NCT03391765|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22377634|NCT03896009|Axsome Therapeutics, Inc.|Caroline Streicher, Executive Director, Clinical Operations|212-332-5061|cstreicher@axsome.com|
22377635|NCT00662857|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
22377636|NCT03966053|Feinstein Institutes for Medical Research|Adrianna Vlachos, MD|5165623757|avlachos@northwell.edu|
22377637|NCT03586583|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
22377638|NCT02832622|Abbott|Kwangdeok Lee, PhD|1-972-526-9673|kwangdeok.lee@abbott.com|
22377639|NCT00998400|University of Bologna|Professor Chiara Rafanelli|0039 051 2091847|chiara.rafanelli@unibo.it|
22377640|NCT03202472|Jonsson Comprehensive Cancer Center|Mark Glover|310 794-8742|mglover@mednet.ucla.edu|
22377641|NCT00800202|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22377642|NCT02691182|Supernus Pharmaceuticals|Gianpiera Ceresoli-Borroni/ Director Clinical Development|3018382521|gceresoliborroni@supernus.com|
22377643|NCT00105235|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22377644|NCT02052310|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1200|063study@fibrogen.com|
22377645|NCT01964326|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22377646|NCT03708588|Aurora Health Care|Suhail Allaqaband, MD|414-469-3491|suhail.allaqaban@aah.org|
22377647|NCT02563002|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22377648|NCT03518125|BARDA|Susan Hollingsworth/Regulatory Operations Specialist|202-691-2040|Susan.Hollingsworth@hhs.gov|
22377649|NCT02416492|SanBio, Inc.|Bijan Nejadnik M.D.; Chief Medical Officer|650-625-2205|Bijan.Nejadnik@sanbio.com|
22377650|NCT02093663|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22377651|NCT00508404|Amgen Inc.|Study Director|866-572-6436||
22377652|NCT05453110|Baylor University Keller Army Community Hospital Division 1 Sports Physical Therapy Fellowship|Dr. Kelly M. Scott|509-595-7263|kmsid119@gmail.com|
22377653|NCT01505387|Analyze & Realize|Felix Alt|+49 30 40008100|Falt@a-r.com|
22377654|NCT01197508|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22396097|NCT01655329|Georgetown University Medical Center|Matthew T. Freedman|4105429680|MTFreedman@verizon.net|
22396098|NCT00710879|Bausch & Lomb Incorporated|Joseph Barr, OD, MS|(585) 338-6439|joseph.t.barr@bausch.com|
22396099|NCT01809132|UTexas Southwestern Medical Center|Dr. Mack C. Mitchell|2146485036|mack.mitchell@utsouthwestern.edu|
22396100|NCT04854434|Karyopharm Therapeutics Inc|Karyopharm Medical Information|(888) 209-9326|clinicaltrials@karyopharm.com|
22377655|NCT00266825|University of Kansas Medical Center|Dr. Susan Carlson|913-588-5359|SCARLSON@kumc.edu|
22377656|NCT02629991|Albert Einstein College of Medicine|Bonnie Taylor|7188397530|botaylor@montefiore.org|
22377657|NCT02799784|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22377658|NCT01662063|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22377659|NCT01949870|AstraZeneca|Dr Gabriella Mariani|+44 7818 523 899|ClinicalTrialTransparency@astrazeneca.com|
22437847|NCT01140061|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22437848|NCT00428389|Novartis Pharmaceuticals|Study Director|862-778-8300||
22437849|NCT03302247|Fox Chase Cancer Center|Martin Edelman|215-728-5682|Martin.Edelman@fccc.edu|
22437850|NCT02669121|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22437851|NCT02708355|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22437852|NCT04384523|Wuhan Healthgen Biotechnology Corp.|Daichang Yang|18602708398|dyang@oryzogen.com|
22437853|NCT03216746|UFParaná|Dr Luciana Reichert Assunção Zanon|554133604025|lurassuncao@yahoo.com.br|
22437854|NCT02687581|State University of New York College of Optometry|Dr. Jingyun Wang|212-938-5759|jwang@sunyopt.edu|
22437855|NCT00835341|Peking University School of Oncology|Department of Etiology|+8610-88196752|dengdajun@bjmu.edu.cn|
22437856|NCT01340573|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22437857|NCT00195663|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22437858|NCT03214406|Church & Dwight Co., Inc|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
22437859|NCT01098305|University of Pennsylvania|Dr. Robert Schnoll|215-746-7143|schnoll@mail.med.upenn.edu|
22437860|NCT01957410|Janssen Research & Development, LLC|Director||ClinicalTrialDisclosure@its.jnj.com|
22437861|NCT04551950|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22437862|NCT01100775|University of Maryland Baltimore|Ms. Dawn Detamore|410 402 6820|DDetamore@som.umaryland.edu|
22437863|NCT04310566|Johnson & Johnson Vision Care|Thomas Karkkainen - Sr.Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
22437864|NCT02748928|Syneron Medical|Director of Clinical Affairs|+972-73-2442347|shlomitm@syneron-candela.com|
22437865|NCT04677504|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22437866|NCT03301298|Promentis Pharmaceuticals|Dean Brostowin|617-300-6172|dbrostowin@promentispharma.com|
22437867|NCT03182907|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22437868|NCT01711645|Vanderbilt Medical Center|Kathryn M. Edwards, MD|615-322-3078|Kathryn.edwards@vanderbilt.edu|
22437869|NCT01041521|Tufts University|Christine Wanke, Principal Investigator||christine.wanke@tufts.edu|
22437870|NCT03170193|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22437871|NCT03637517|Medicines for Malaria Venture|Stephan Chalon, MD|+41 22 555 0369|chalons@mmv.org|
22437872|NCT03848949|Rush University Medical Center|Dr. Daniel D. Bohl|414.640.7245|danielbohl@gmail.com|
22437873|NCT00118430|Indiana University|Kurt Kroenke|3172749046|kkroenke@regenstrief.org|
22437874|NCT00534976|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22437875|NCT02147288|Yale University|Dr. Marc Walker||marc.walker@yale.edu|
22437876|NCT00965419|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22437877|NCT00997594|Mie University|Dr. Koichiro Yamakado|+81-59-231-5029|yama@clin.medic.mie-u.ac.jp|5630
22437878|NCT02222610|Retina Consultants of Texas|Dr. Amy C. Schefler|(713) 524-3434|acsmd@retinaconsultantstexas.com|
22437879|NCT00615017|AstraZeneca|Justin Lindemann||ClinicalTrialTransparency@astrazeneca.com|
22437880|NCT00806988|Icahn School of Medicine at Mount Sinai|Alan Moskowitz, MD|212-659-9568|alan.moskowitz@mountsinai.org|
22437881|NCT02232022|Northwell Health|Jeffrey M. Katz|516-562-3062|jkatz2@northwell.edu|
22437882|NCT04775953|Duke University|Thomas L. Holland, MD|919-613-4268|thomas.holland@duke.edu|
22437883|NCT01698814|Alcon Research, Ltd.|Terri Pasquine, Sr. Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22437884|NCT00368641|Vantive|Global CORP Clinical Trials Disclosure|+1 2249484283|Global.CORP.ClinicalTrialsDisclosure@vantive.com|
22437885|NCT04014062|Lambda Therapeutic Research Ltd.|Dr. Anshul Attrey, M.D. Principal Investigator|+91-79-40202020|anshulattrey@lambda-cro.com|
22437886|NCT01980095|RedHill Biopharma|Dr. Ira Kalfus|1-917-817-7517|ira@redhillbio.com|
22437887|NCT00328614|Thomas Jefferson University|Edouard Trabulsi, MD|215-955-1000|Edouard.Trabulsi@jefferson.edu|
22437888|NCT02783599|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22437889|NCT01564732|Duke University Medical Center|Dana Portenier, M.D.|919-470-7031|dana.portenier@duke.edu|
22437890|NCT04343755|Hackensack Meridian Health|Joshua Zenreich|15519964248|joshua.zenreich@hmhn.org|
22437891|NCT00394706|University of Washington|Siobhan Brown, PhD-Biostatistician|206-685-1302|spes@uw.edu|
22437892|NCT03920254|Theravance Biopharma|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
22437893|NCT05274269|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22437894|NCT00108862|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22437895|NCT00900666|Mary Free Bed Rehabilitation Hospital|Krisanne B. Chapin, PhD|616-493-9831|krisanne.chapin@maryfreebed.com|
22437896|NCT01137032|Fougera Pharmaceuticals Inc.|Angela C. Kaplan, Associate Director Clinical Development|631-659-2256|angela.kaplan@sandoz.com|
22437897|NCT01746368|Tuscaloosa VA Medical Center (Retired)|Ann Mahaney-Price, DNP|205-409-8301|amparnp@yahoo.com|
22437898|NCT05636852|GE HealthCare|Paul Sherwin, MD, PhD|+1 (609) 510-3686|PaulSherwin@gehealthcare.com|
22437899|NCT03534141|University of California, San Francisco|Dr. Michael P. Bokoch, Principal Investigator|415-476-8389|Michael.Bokoch@ucsf.edu|
22437900|NCT00709618|GlaxoSmithKline|GSK Response Center|866-435-7343||
22437901|NCT00687804|Novartis Pharmaceuticals|Study Director|862 778-8300||
22437902|NCT03829449|Akari Therapeutics Plc|Dr Wynne Weston-Davies|0208 004 6106|wynne.weston-davies@akaritx.com|
22437903|NCT04390880|VA Greater Los Angeles Healthcare System|Gholam Berenji, M.D.|310-268-3547|Gholam.Berenji@va.gov|
22437904|NCT02557542|Imperial College London|Mr Roshan Bootun|+442033117335|r.bootun@imperial.ac.uk|
22437905|NCT00195091|Memorial Sloan Kettering Cancer Center|Dr. Tiffany Traina MD|646-888-4558|trainat@MSKCC.ORG|
22437906|NCT01028846|Albert Einstein College of Medicine|Dr. Meredith Hawkins|718-839-7975|meredith.hawkins@einsteinmed.edu|
22437907|NCT00795236|Oregon Health & Science University|Alfred Lewy|(503) 494-7746|lewy@ohsu.edu|
22437908|NCT01821859|Oregon Health and Science University|Tanja Pejovic|503-494-5125|pejovict@ohsu.edu|
22437909|NCT00475709|St Jude Medical|Kelly Erickson|16517566580|kaerickson@sjm.com|
22437910|NCT00684775|"Johns Hopkins School of Medicine: Department of Psychiatry"|Dr. Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
22437911|NCT00555672|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22437912|NCT04526145|Ohio State University|Dr. Kathy Wright|614-292-0309|wright.2104@osu.edu|
22437913|NCT04759157|University of Utah|Dr. Kelly Baron|801-585-7588|kelly.baron@utah.edu|
22437914|NCT04491539|Florida State University|Henna Budhwani|(850) 644-3296|hbudhwani@fsu.edu|
22437915|NCT04211441|Medtronic, Inc|Director of Clinical Research|800-328-2518|medttroniccastrials@medtronic.com|
22437916|NCT01415401|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader|1-888-451-3937|alcon.medinfo@alcon.com|
22437917|NCT02652468|University of Madison Carbone Cancer Center|Vaishalee Kenkre|(608) 263-1699|vpkenkre@medicine.wisc.edu|
22437918|NCT00548145|Osaka University Hospital|Hiroaki Kazui,Ph.D.|81-6-6879-3051|kazui@psy.med.osaka-u.ac.jp|
22437919|NCT00961714|Alphatec Spine, Inc.|Glen Seidner, Clinical Affairs|760-494-6789|gseidner@alphatecspine.com|
22437920|NCT02484222|the Children's Hospital of Fudan University|Dr.Wang Xuan|18017591058|18017591058@163.com|
22437921|NCT00206440|Baylor College of Medicine|Mothaffar Rimawi|713 798 1999|rimawi@bcm.tmc.edu|
22437922|NCT01746225|International Breast Cancer Study Group (IBCSG)|Heidi Roschitzki-Voser|+41 31 511 94 18|heidi.roschitzki@ibcsg.org|
22437923|NCT00595478|Dartmouth College|Catherine Stanger, Ph.D.|603-646-7023|catherine.stanger@dartmouth.edu|
22437924|NCT02713828|ECOG Stats Center|Dr Zhuoxin Sun|617-632-3012|zhuoxin@jimmy.harvard.edu|
22437925|NCT04090242|Becton Dickinson|Edward Mahoney|978-901-7248|Edward.Mahoney@bd.com|
22437926|NCT02513472|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22437927|NCT01019369|Baylor College of Medicine|Anitra Beasley, MD, MPH|832-826-7318|anitra.beasley@bcm.edu|
22437928|NCT04405076|ModernaTX, Inc.|Moderna Clinical Trials Support Center|1-877-777-7187|clinicaltrials@modernatx.com|
22437929|NCT01380834|Children's Hospital of UPMC|Dr. Mihaela Visoiu|412-692-5260|visoium@upmc.edu|
22437930|NCT00604695|Brigham & Women's Hospital|C. Michael Gibson, MS, MD|617-632-7753|mgibson@perfuse.org|
22437931|NCT01898013|Durham VA Medical Center|Jennifer C. Naylor, PhD|9192860411|jennifer.naylor2@va.gov|
22437932|NCT03747640|Florida State University|Hyochol Ahn, PhD, MSN, MS-ECE, MS-CTS, APRN, ANP-BC, FAAN|850-644-2647|hahn@fsu.edu|
22437933|NCT03691662|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
22437934|NCT03771274|Carolina Eyecare Physicians, LLC|Director of Research|8438813937|helga.sandoval@carolinaeyecare.com|
22437935|NCT00172042|Novartis Pharmaceuticals|Study Director|862-778-8300||
22437936|NCT00384332|University of Alabama at Birmingham|Candace Cromer|2059753442|clreed@uab.edu|
22437937|NCT00375518|Memorial Sloan Kettering Cancer Center|Dr. David Amar|212-639-6798|amard@mskcc.org|
22437938|NCT01771250|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22437939|NCT02058563|GlaxoSmithKline|GSK Response Center|866-435-7343||
22437940|NCT00166439|Mayo Clinic|Patrick B. Johnston, M.D., Ph.D.|507/284-5362|johnston.patrick@mayo.edu|
22437941|NCT01180296|Fetal Medicine Foundation?USA|David McKenna|937-208-4005|dsmckenna@mvh.org|
22437942|NCT02560012|The University of Texas Health Science Center, Houston|Research Manager|713-500-6919|Marka.Lyons@uth.tmc.edu|
22437943|NCT00483938|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22437944|NCT03052816|UH Hospitals Cleveland Medical Center/MetroHealth Medical Center at time of study protocol|Andrey Petrikovets MD|323 243 9091|andrepetrikovets@yahoo.com|
22437945|NCT03850535|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22437946|NCT00801398|Endo Pharmaceuticals|Saji Vijayan|(800) 462-3636|ClinicalTrials@Endo.com|
22437947|NCT00264537|Centocor Research & Development, Inc.|Director Clinical Research|1-800-457-6399||
22437948|NCT00447226|GlaxoSmithKline|GSK Response Center|866-435-7343||
22437949|NCT03449758|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22437950|NCT01606709|UConnHealth|Lawrence Engmann|8605258283|lengmann@uchc.edu|
22437951|NCT00584012|Holden Comprehensive Cancer Center|Cena Jones-Bitterman|319-353-4596|cena-jones@uiowa.edu|
22437952|NCT02607618|Motif BioSciences|Stephanie Noviello|908-432-7802|stephanie.noviello@motifbio.com|
22437953|NCT03937713|VA ORD|Associate Chief of Staff for Research|716-862-6528|ali.el-solh@va.gov|
22437954|NCT02871635|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22437955|NCT02420379|Sarepta Therapeutics, Inc.|Medical Director|+1-888-727-3782|clinicaltrials@sarepta.com|
22437956|NCT01402817|Indiana University School of Medicine - Pediatrics|Chie-Schin Shih, MD|317-948-8568|shih2@iu.edu|
22437957|NCT00502671|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22437958|NCT03795116|SUNY Downstate Health Sciences University|Jared Jagdeo MD, MS|347-466-9263|jared.jagdeo@downstate.edu|
22437959|NCT00681629|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22437960|NCT00977171|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
22437961|NCT01410890|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22437962|NCT00412893|Astellas Pharma Global Development, Inc.|Medical Head Immunology, Transplant and Infectious Disease Therapeutic Area||resultsdisclosure@astellas.com|
22437963|NCT03401671|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22437964|NCT02305238|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22437965|NCT01746173|Dana-Farber Cancer Institute|Philippe Armand MD, PhD|617.632.2305|Philippe_Armand@dfci.harvard.edu|
22437966|NCT02815644|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22377660|NCT01477853|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22377661|NCT01050816|Eulji General Hospital|Lee Gyeong Tae|+82-11-214-3323|lkt2408@hanmail.net|
22377662|NCT03086330|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22377663|NCT01970462|Ohio State University|Kathleen Dungan|614-685-3333|kathleen.dungan@osumc.edu|
22377664|NCT02740049|Imperial College London|Dr Coen Wiegman|+44(0)2075947846|c.wiegman@imperial.ac.uk|
22377665|NCT00948298|Charles Drew University of Medicine and Science|Dr. David Martins|323-568-3353|davidmartins@cdrewu.edu|
22377666|NCT00330915|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22377667|NCT04570436|Viatris|Dik WH Ng|+44 (0)1304 626895|dik.ng@viatris.com|
22377668|NCT00645164|DFB Pharmaceuticals|Herbert B. Slade MD, FAAAAI|817.302.3919|bert.slade@dfbpharmaceuticals.com|
22377669|NCT03172702|AstraZeneca|Global Clinical Lead|+18772409479|information.center@astrazeneca.com|
22377670|NCT03673306|IRCCS Ospedale Policlinico San Martino, Genoa, Italy|Matteo Lambertini|+39 010 555 4254|matteo.lambertini@unige.it|
22377671|NCT04280562|David Putrino|Icahn School of Medicine at Mount Sinai|212-824-8369|david.putrino@mountsinai.org|
22377672|NCT02061202|Icahn School of Medicine at Mount Sinai|Dr. Jeffrey Glassberg|212-241-3650|jeffrey.glassberg@mountsinai.org|
22377673|NCT00162370|Lantheus Medical Imaging|Director, Clinical Operations|978-671-8118|Sandra.Monte@lantheus.com|
22377674|NCT04559568|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22377675|NCT03628287|City University of New York, School of Public Health|Denis Nash, PhD|347-331-6554|denis.nash@sph.cuny.edu|
22377676|NCT03678545|Cincinnati Children's Hospital Medical Center|Regina Yearout|513-517-2108|regina.yearout@cchmc.org|
22377677|NCT03721965|Incyte Corporation|Incyte Corporation Call Center|(0)330 100 3677|globalmedinfo@incyte.com|
22377678|NCT03088267|Tris Pharma, Inc.|Antonio Pardo MD|16107502210|apardo@trispharma.com|
22377679|NCT00774579|Imperial College Healthcare London|Prof. Desmond Johnston|020 3312 1253|desmond.johnston@imperial.ac.uk|
22377680|NCT04209075|NIDDK|Dr. Stephanie Chung|301-402-2122|Stephanie.Chung@NIH.gov|
22377681|NCT04639128|The Permanente Medical Group|Dr. Adrian Hinman|510-454-7292|adrian.d.hinman@kp.org|
22377682|NCT01218126|GlaxoSmithKline|GSK Response Center|866-435-7343||
22377683|NCT02411565|H. Lee Moffitt Cancer Center and Research Institute|Dr. Hye Sook Chon|813-745-7205|hyesook.chon@moffitt.org|
22377684|NCT02574910|UT Southwestern Medical Center|Dr Perrin White|2146489246|perrin.white@utsouthwestern.edu|
22377685|NCT02963974|University of North Carolina at Chapel Hill|Lisa Park, AuD, CCC-A|984-215-2871|lisa_park@med.unc.edu|
22377686|NCT05380947|Boehringer Ingelheim|Boehringer Ingelheim Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
22377687|NCT01563536|AbbVie|Global Medical Services|800-633-9110||
22377688|NCT01860703|ApoPharma Inc.|Fernando Tricta, MD|416-401-7332|ftricta@apopharma.com|
22377689|NCT01270126|Otto-von-Guericke University of Magdeburg, Medical Faculty, Institute of Medical Psychology, Magdeburg, Germany|Prof. Bernhard A. Sabel|0049 3916721800|bernhard.sabel@med.ovgu.de|
22437967|NCT00714311|Medical University of Vienna|Stephan Doering|+43140400|stephan.doering@meduniwien.ac.at|25190
22437968|NCT02218008|Alkermes, Inc.|Eva Stroynowski|781-609-7000|eva.stroynowski@alkermes.com|
22437969|NCT01718444|UIC|Albert Asante, MD MPH|3123552634|akdasante@yahoo.com|
22437970|NCT01511081|UT MD Anderson Cancer Center|Joe Chang, MD/Professor, Radiation Oncology Department|713-792-7734|CR_Study_Registration@mdanderson.org|
22437971|NCT00408434|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22437972|NCT04039217|Emory University|Dr. Colleen Kelley|404-712-1823|colleen.kelley@emory.edu|
22437973|NCT00106353|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22437974|NCT01278797|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22437975|NCT00588354|Mayo Clinic|Dr. Marc A. Huntoon|(507) 284-2511|huntoon.marc@mayo.edu|
22437976|NCT01371552|Alcon Research, Ltd.|Joachim Nick, Dipl. Ing.|+49 6022 240 520|joachim.nick@cibavision.com|
22437977|NCT03364309|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22437978|NCT00167310|UPittsburgh|Dr. Jeffrey K. Yao, Research Professor|412-360-6781|jkyao@pitt.edu|
22437979|NCT00615992|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22437980|NCT04182672|The University of Texas Health Science Center at Houston|Pritish Bawa, MD|713-500-7702|Pritish.Bawa@uth.tmc.edu|
22437981|NCT04522141|Lucerne University of Applied Sciences and Arts|Dr. Mirjam Stieger|0041798852810|mirjam.stieger@hslu.ch|
22437982|NCT03052049|Northwestern Medical Group|Jennifer Karp RN|312-926-5289|jkarp@nm.org|
22437983|NCT03508609|Caladrius Biosciences, Inc.|William Sietsema|9495352391|bsietsema@caladrius.com|
22437984|NCT02328027|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22437985|NCT03304873|NYU Grossman School of Medicine|Jennifer Lighter, MD|212-263-5454|Jennifer.Lighter@nyulangone.org|
22437986|NCT03319212|Johnson & Johnson Vision Care, Inc.|Elizabeth Dow, OD, FAAO - Principal Research Optometrist|904-443-1061|edow1@its.jnj.com|
22437987|NCT00400569|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D.|813-745-2158|alberto.chiappori@moffitt.org|
22437988|NCT01895959|University of California, San Francisco|Xiaojuan Li, PhD|415-353-4909|Xiaojuan.li@ucsf.edu|
22437989|NCT01868477|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22377690|NCT02532556|Imperial College London|Miss Kate Williams||k.williams@imperial.ac.uk|
22377691|NCT06213701|Center for Healthy Minds|Simon Goldberg|(608) 265-8986|sbgoldberg@wisc.edu|
22377692|NCT00538590|Hospital of Universität Köln|Thomas Dietlein, Ph. D., MD|+49 221 4785862|thomas.dietlein@uk-koeln.de|4300
22377693|NCT01256567|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22377694|NCT00567190|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
22437990|NCT00349778|Stanford University|Dr. Sally Arai|650-723-0822|sarai1@stanford.edu|
22377695|NCT04898231|UCSD|Dr. Adriana Tremoulet|858-246-0012|atremoulet@health.ucsd.edu|
22377696|NCT06030414|Lumen Bioscience|Senior Medical Director|206-899-1904|trials@lumen.bio|
22377697|NCT03184792|University of Washington|Dr. Fatma Inanici|2067872692|finanici@uw.edu|
22377698|NCT01352598|Mercy|Jaymeson Stroud, MD|314-251-6844|Jaymeson.Stroud@mercy.net|
22377699|NCT02453685|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22377700|NCT02778100|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22377701|NCT05238233|Prisma Health|Aimee Hanvey|864-760-7350|aimee.hanvey@prismahealth.org|
22377702|NCT00825266|Stanford University|Roham Zamanian|650-725-5495|roham.zamanian@stanford.edu|
22377703|NCT04120233|University of Kentucky|Dr. Linda J. Van Eldik|1-859-257-5566|linda.vaneldik@uky.edu|
22377704|NCT05809596|Boston Scientific|Nicole Kelly, Clinical Trial Manager|1-800-CARDIAC|Nicole.Kelly2@bsci.com|
22377705|NCT03770494|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22377706|NCT01984697|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22377707|NCT01345630|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22377708|NCT04676425|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22377709|NCT01410058|University of Zimbabwe College of Health Sciences|Tsitsi G Monera-Penduka|307148|moneratg@yahoo.co.uk|
22377710|NCT03027414|University of Pennsylvania|Nicholas Balderston|2157463058|nicholas.balderston@pennmedicine.upenn.edu|
22377711|NCT01364922|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22377712|NCT05178121|University of Washington|Doyanne Darnell|206-744-9108|darnelld@uw.edu|
22377713|NCT01953003|Institut de Recherche Pierre Fabre, Toulouse France|Karim Keddad, Head of Medical Unit|+33.5.34.50.61.69|Karim.keddad@pierre-fabre.com|
22377714|NCT03717402|Dana-Farber Cancer Institute|Andrea C. Enzinger, MD|617-582-7335|Andrea_Enzinger@DFCI.HARVARD.EDU|
22377715|NCT00553501|University of Vermont, Vermont Cancer Center|Barbara Grant, MD||barbara.grant@vtmednet.org|
22377716|NCT02597907|Kyungpook National University|Dr Younghoon Jeon|82534205871|jeon68@gmail.com|
22377717|NCT00949715|Medtronic CRDM|Rachael Rose|763-526-2332|rachael.k.rose@medtronic.com|
22377718|NCT04672096|Neuronoff, Inc.|Jasmine Wilson|408-858-2612|jasmine@neuronoff.com|
22377719|NCT01582789|CooperVision, US|Don Siegel, OD|623-544-3877|dsiegel@coopervision.com|
22377720|NCT03496974|XBiotech|Ashley Otero, Corporate and Clinical Relations Manager|512-386-2930|aotero@xbiotech.com|
22377721|NCT02364180|The University of Toledo|Shashi Bhatt, MD|419-383-3556|Shashi.Bhatt@utoledo.edu|
22377722|NCT01783418|Ste-Justine's Hospital|Catherine Malboeuf-Hurtubise, Post-doctoral fellow|514-343-6111|catherine.malboeuf-hurtubise@umontreal.ca|4594
22377723|NCT00508261|GlaxoSmithKline|GSK Response Center|866-435-7343||
22377724|NCT00180479|Abbott Vascular|Ellen Travis, Clinical Science|408-845-1512|Ellen.Travis@av.abbott.com|
22377725|NCT01422135|Agile Therapeutics|Joseph Chiodo III, Senior Medical Director|609-683-1880|jachiodo@agiletherapeutics.com|
22377726|NCT01446666|Asan Medical Center, University of Ulsan College of Medicine|Professor Young-Suk Lim|+82-02-3010-5933|limys@amc.seoul.kr|
22377727|NCT04044456|Malcom Randall VAMC|Health Science Specialist|352-376-1611|julia.waid-ebbs@va.gov|105224
22396101|NCT03349775|Beth Israel Deaconness Medical Center|Dr. Jennifer Ho|617-735-4102|jho@bidmc.harvard.edu|
22396102|NCT02667275|Aclaris Therapeutics|Judy Schnyder, Sr. Director Clinical Operations|484-329-2144|jschnyder@aclaristx.com|
22396103|NCT01274715|Michael DeBakey VAMC|Aanand Naik, MD|713-794-8541|anaik@bcm.edu|
22396104|NCT04479436|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|9089926400|CTRinfo@dsi.com|
22396105|NCT02022085|Radboud University Medical Centre, Nijmegen, The Netherlands|Professor Emmanuel Mylanus|+31 24 361 1111|Emmanuel.Mylanus@radboudumc.nl|
22396106|NCT04774250|Washington University in St. Louis|Dr. Craig Buchman, Lindburg Professor & Chair, Department of Otolaryngology-Head & Neck Surgery|314-362-2914|buchmanc@wustl.edu|
22396107|NCT00986544|"Department of Surgery, Hospital P. Colombo, Via Orti Ginnetti 7, 00049 Velletri (Rome), Italy"|Marcello Picchio|+39696102228|marcellopicchio@libero.it|
22377728|NCT00939874|St Vincents Hospital|Professor Andrew Carr|+61 2 8382 3359|andrew.carr@svha.org.au|
22377729|NCT02231177|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22377730|NCT02316769|Vanderbilt University|Bret Alvis|6159365836|bret.d.alvis@vanderbilt.edu|
22377731|NCT04504331|Stanford Medicine at Stanford University|Jennifer Lee Caswell-Jin, MD|1-310-332-6541|caswell@stanford.edu|
22377732|NCT04209725|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
22377733|NCT02643862|Stanford|Dr. Kari Nadeau|650-867-4592|knadeau@stanford.edu|
22377734|NCT01281644|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
22377735|NCT02954354|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|Shionogiclintrials-admin@shionogi.co.jp|
22377736|NCT03468933|Tulane University|Dr. Fayez Kheir|504-988-3541|fkheir@tulane.edu|
22377737|NCT03039023|Cleveland Clinic Foundation|Jennifer Wilcox|216-636-6153|kirsopj@ccf.org|
22377738|NCT04026529|Omaha VA Medical Center|Dr. Debra Romberger|4025597539|debra.romberger@va.gov|
22377739|NCT03338829|University of Minnesota|Sarah A. Wernimont MD, PhD|612-301-3408|swernimo@umn.edu|
22377740|NCT05163418|Topmed|Edith Martin|418 683-2104|emartin@topmed.ca|1302
22377741|NCT00448448|University of Iowa Dept of Orthopaedics and Rehabilitation|Dr. Lori A. Dolan|319-356-1075|lori-dolan@uiowa.edu|
22377742|NCT02340026|The Children's Hospital of Philadelphia|Laura A. Prosser, PT, PhD|215-590-2495|ProsserL@chop.edu|
22377743|NCT02684006|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22377744|NCT04642898|University of Kentucky|Dr. Sauer-Zavala|859-562-1571|ssz@uky.edu|
22377745|NCT04495179|AstraZeneca Clinical Study Information Center|Global Clinical Head|1-877-240-94 79|information.center@astrazeneca.com|
22377746|NCT03434678|Memorial Sloan Kettering Cancer Center|Dr. Florence Grant, MD|212-639-8829|moses-gf@mskcc.org|
22377747|NCT02968420|Vaccine Evaluation Center|Dr. Manish Sadarangani|604-875-2422|msadarangani@bcchr.ubc.ca|
22377748|NCT01895972|Bausch + Lomb, a division of Valeant Pharmaceuticals|H. DeCory, Director Medical Affairs|585 732-3284|heleen_H_decory@bausch.com|
22377749|NCT04085328|Alcon Research, LLC|Expert CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22377750|NCT05608499|Icahn School of Medicine at Mount Sinai|Giselle Singer|212-241-3288|giselle.singer@mssm.edu|
22377751|NCT02865720|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22377752|NCT01422408|Knight Cancer Institute, Oregon Health & Science University|Emile Latour|503-418-9601|latour@ohsu.edu|
22377753|NCT02954523|Georgetown University|Chul Kim|12024442223|Chul.Kim@gunet.georgetown.edu|
22377754|NCT02038894|Cincinnati Children's Hospital Medical Center|Dr. Mario Patino|5132538190|mario.patino@cchcm.org|
22377755|NCT00724152|VA Connecticut Healthcare System|Dr. Caroline Schmidt, Co-investigator|203-932-5711|Caroline.Schmidt@va.gov|3391
22377756|NCT03124979|Masimo|Tala Harake||studies@masimo.com|
22377757|NCT01328080|Johns Hopkins Dermatology|Ginette Okoye, MD, Director of Ethnic Skin Program|410-502-7546|ctrep@jhmi.edu|
22377758|NCT00045305|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
22377759|NCT03266770|University Hospitals Cleveland Medical Center|Dr. Kyle Scarberry|(216)844-3009|Kyle.Scarberry@UHhospitals.org|
22377760|NCT04274894|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22377761|NCT01936857|Oregon Health & Science University|Dr. Todd Korthuis|503-494-8044|korthuis@ohsu.edu|
22377762|NCT03848403|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22377763|NCT00168038|CSL Behring|Clinical Trial Disclosure Manager||clinicaltrials@cslbehring.com|
22377764|NCT00101933|Medtronic Neuromodulation|Jim Vollhaber, Clinical Study Manager|763-526-8093|medtronicneurotrials@medtronic.com|
22377765|NCT02080468|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|617-500-5142|alison.long@aegerion.com|
22377766|NCT02386995|Toronto Western Hospital/UHN|Emad Al Azazi|416-603-8500|emad.alazazi@uhnresearch.ca|6237
22377767|NCT00976352|University of Florida|Dr. Barry Byrne, Professor and Associate Chair|352-273-6563|bbyrne@ufl.edu|
22377768|NCT01494584|GlaxoSmithKline|GSK Response Center|866-435-7343||
22377769|NCT02563496|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22377770|NCT00251862|Boston Medical Center|Dr. Paul C. Schroy III|617-638-8335|paul.schroy@bmc.org|
22377771|NCT00860379|Shriners Hospitlas for Children|Maggie Dylewski Begis|617-872-8567|mdylewski@shrinenet.org|
22377772|NCT01515748|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22377773|NCT03221387|Lewis Katz School of Medicine at Temple University|Adam Nester, JD, MS|215-707-1986|coisom@temple.edu|
22377774|NCT00522626|Johns Hopkins University School of Medicine|Dr. Lauren Jansson|410-550-5438|ljansson@jhmi.edu|
22377775|NCT02365519|Alcon, A Novartis Division|Ophthalmology & Medical Lead, Translational Medicine, NIBR|1-888-451-3937|alcon.medinfo@alcon.com|
22377776|NCT01971723|Florida State University|Dr. Michael J. Ormsbee|(850) 644-4793|mormsbee@fsu.edu|
22377777|NCT02073461|Galderma K.K.|Clinical Project Manager|+81 3 5937 3850|GaldermaKK.ClinDev@galderma.com|
22377778|NCT03017079|THE SECOND AFFILIATED HOSPITAL ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE|Dr|18817821529|hm198699@126.com|
22377779|NCT04450108|Bosch Healthcare Solutions|Dr. Klaus Müller, Study director|+49 160 90816081|klaush.mueller@de.bosch.com|
22377780|NCT04648150|Hopital fondation Rothschild|Dr Amélie YAVCHITZ|+33148036454|ayavchitz@for.paris|
22377781|NCT02821403|The Hong Kong Polytechnic University|Dr. Tsz Wing Leung|27664268|jeffrey.TW.leung@polyu.edu.hk|
22377782|NCT06223373|Wake Forest University Health Sciences|Kristen Faith Nicholson, PhD|704-355-2000|Kristen.Nicholson@advocatehealth.org|
22377783|NCT05050578|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22377784|NCT02243280|AbbVie|Global Medical Services|800-633-9110||
22377785|NCT00990964|Medtronic, Inc.|Attain Success Clinical Trial Leader|800-328-2518|medtronicCRMtrials@medtronic.com|62864
22377786|NCT05377359|Sonova|Bilal Sheikh, Research Audiologist|2268083260|bilal.sheikh@sonova.com|
22377787|NCT04682119|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22377788|NCT03386032|The Procter & Gamble Company|Laurie Moulton, M.S., Statistical Group Scientist|+1-513-544-3636|moulton.lt@pg.com|
22377789|NCT03364348|Stanford Medicine at Stanford University|Sinyoung Park|650-721-4485|sinyoung@stanford.edu|
22377790|NCT03276637|Baylor College of Medicine|Jill Robinson|7137985848|jill.robinson@bcm.edu|
22377791|NCT04082442|Johns Hopkins University|Thorsten Leucker, MD|410-502-0469|tleucke1@jhmi.edu|
22377792|NCT04525547|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22377793|NCT03122119|Star Spine and Sports|Dr. Douglas Hemler, Prinical Investigator|3035701834|dhemler@starcolorado.com|
22377794|NCT01768832|Washington University in St. Louis|Dr. Gammon M. Earhart|314-286-1407|earhartg@wustl.edu|
22377795|NCT04372628|Vanderbilt University Medical Center|Clinical Trials Operations Manager|(615) 875-3080|kelly.walsh@vumc.org|
22377796|NCT01580072|Landeskrankenanstalten-Betriebsgesellschaft|Dr. Hannes Steinberger|+4346355212 50303|hannes.steinberger@kabeg.at|
22377797|NCT01493687|Galderma R&D, LLC|Clinical Science Director|609-409-7701||
22377798|NCT00521144|Memorial Sloan-Kettering Cancer Center|Dr. Lee Krug|646 888 4201|krugl@mskcc.org|
22396108|NCT04872348|Sight Sciences, Inc.|VP, Medical and Clinical Affairs|1-877-266-1144|jdickerson@sightsciences.com|
22396109|NCT00467779|Hoffmann-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22396110|NCT01195090|Department of Internal Medicine, Mackay Memorial Hospital|Dr. Sung-Chen Liu|886-2-2543-3535|pine3.tw@yahoo.com.tw|2174
22377799|NCT01705496|Biomed valley discoveries|Dr. Michelle Zhang, Executive Director|7815339412|mzhang@biomed-valley.com|
22377800|NCT00089141|Fred Hutchinson Cancer Research Center (FHCRC)|Paul J. Martin, M.D.|206-667-4798|pmartin@fhcrc.org|
22437991|NCT02465203|Novartis|Study Director|+41613241111||
22437992|NCT00620113|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22437993|NCT02973516|Guerbet|Jing Hao, MD, Head of Global Medical Affairs and Clinical Development|+33 (0) 1 45 91 50 00|jing.hao@guerbet.com|
22437994|NCT00042991|Operations and Biostatistics Center for Pediatric Brain Tumor Consortium (PBTC)|Mehmet Kocak|9015952947|mehmet.kocak@stjude.org|
22437995|NCT02387554|Bundang Seoul National University Hospital|Principal Investigator||mekka@snu.ac.kr|
22437996|NCT04072887|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22437997|NCT00856297|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22437998|NCT02248636|Puget Sound VA|William Banks, Associate Chief of Staff for Research|206 764-2701|william.banks4@va.gov|
22437999|NCT02022436|University of Pittsburgh Medical Center|Rabih Chaer|4128023025|chaerra@upmc.edu|
22438000|NCT03369236|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|1 855-752-2356|clinicaltrials@alexion.com|
22438001|NCT00423449|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22438002|NCT02524418|University of Florida|Dr. Peter V. Draganov MD|352-273-9472|peter.draganov@medicine.ufl.edu|
22438003|NCT03334812|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22438004|NCT01153724|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22438005|NCT02508428|Anderson Orthopaedic Research Institute|C. Anderson Engh, Jr., MD|703-619-4411|research@aori.org|
22438006|NCT01979133|University of Texas Southwestern Medical Center|E. Sherwood Brown, MD, PhD|2146466948|sherwood.brown@utsouthwestern.edu|
22438007|NCT00486824|Stanford University|Dr. Deirdre Lyell|6507255720|dlyell@stanford.edu|
22438008|NCT02859441|National Institutes of Health|Henry E Wiley, M.D., Principal Investigator, NEI|301-496-6583|wileyhe@nei.nih.gov|
22438009|NCT04371666|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|FG3019-093DMDStudy@fibrogen.com|
22438010|NCT00445770|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22438011|NCT00947115|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22438012|NCT02092025|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22438013|NCT02927938|Levine Cancer Institute|Dr. James Symanowski; Chair, Department of Cancer Biostatistics|9804422371|james.symanowski@atriumhealth.org|
22438014|NCT03274856|GLWL Research Inc|Caroline Fortier|1.514.708.4417|caroline.fortier@glwlresearch.com|
22438015|NCT00934128|The University of Texas (UT) MD Anderson Cancer Center|David Hui, MD, MSc, FRCPC||HMoreno@mdanderson.org|
22438016|NCT03228212|Johnson & Johnson Vision Care Inc.|John Buch -SENIOR PRINCIPAL RESEARCH OPTOMETRIST|904 443-1707|JBUCH@its.jnj.com|
22438017|NCT02834247|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22438018|NCT02476006|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22438019|NCT01704404|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
22438020|NCT01807299|Universidade Federal de São Paulo|PhD José Carlos F. Galduróz||galduroz@unifesp.br|
22438021|NCT00811174|Octapharma|Michael Eppolito|201-604-1155|michael.eppolito@octapharma.com|
22438022|NCT01938040|Rutgers/State University of New Jersey (NJMS)|Alex Bekker, MD, PhD|973 972-5007|bekkeray@njms.rutgers.edu|
22438023|NCT02309944|Masonic Cancer Center, University of Minnesota|Deanna GK Teoh|612-626-3111|dkteoh@umn.edu|
22438024|NCT03049917|University of Washington|Dr.|206-422-5564|jsyker@uw.edu|
22438025|NCT01860287|University of Chicago|Dr. Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
22438026|NCT02848222|University of Alabama at Birmingham|Dr Jason Nichols|205-975-3497|jjn@uab.edu|
22438027|NCT02451943|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22438028|NCT03951077|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22438029|NCT00681889|Massachusetts Eye and Ear Infirmary|Dr. Reza Dana|617-573-3313|Cornea_Research@meei.harvard.edu|
22438030|NCT00086047|Cincinnati Children's Hospital Medical Center|Susmita Kashikar-Zuck, PhD|513 636 6337|Susmita.Kashikar-Zuck@cchmc.org|
22438031|NCT01395901|Helsinn Healthcare SA|Salvatore Chessari|+41 91 985 21 21|salvatore.chessari@helsinn.com|
22438032|NCT03923790|The University of Texas Health Science Center at Houston|Anjail Sharrief, MD, MPH, Associate Professor|713-500-6538|anjail.z.sharrief@uth.tmc.edu|
22438033|NCT01165983|Beth Israel Deaconess Medical Center|Aristidis Veves, Research Director|617-632-7075|aveves@bidmc.harvard.edu|
22438034|NCT03579940|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22438035|NCT01217944|Novartis Pharmaceuticals|Study Director|862-778-8300||
22438036|NCT00853151|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22438037|NCT01751984|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
22438038|NCT00587158|Mayo Clinic|Hatem Amer, MD, FASN; Assistant Professor of Medicine; Division of Nephrology and Hypertension|507-256-1963|amer.hatem@mayo.edu|
22438039|NCT01136408|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22438040|NCT02274792|Amgen Inc.|Study Director|866-572-6436||
22438041|NCT01510158|Ardea Biosciences, MD|Nihar Bhakta, MD|1-858-652-6671|nbhakta@ardeabio.com|
22438042|NCT03078556|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22377801|NCT01559948|Texas Woman's University|Dr. Kelli Brizzolara|214-689-7722|kbrizzolara@twu.edu|
22377802|NCT03315143|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
22377803|NCT01746095|Savara Inc.|Head of Clinical Development|+45 7930 1414|info@savarapharma.com|
22377804|NCT01242748|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22377805|NCT00840801|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22377806|NCT00335452|sanofi-aventis|Trial Information Transparency Team||GV-Contact-us@sanofi-aventis.com|
22377807|NCT02736825|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
22377808|NCT00790452|UT MD Anderson Cancer Center|Victor A Levin, MD, BS / Professor||CR_Study_Registration@mdanderson.org|
22377809|NCT02901626|Christiana Care Health System, Department of Obstetrics & Gynecology|Matthew Hoffman, MD, MPH|(302) 301-3350|mhoffman@christianacare.org|
22377810|NCT04082884|Yale School of Medicine|Laura Marie Nally, MD|(877) 925-3637|laura.nally@yale.edu|
22377811|NCT03724487|Case Western Reserve University|Dr. Carolyn Still, Assistant Professr|216-368-6338|cwh11@case.edu|
22377812|NCT03687190|Changhua Christian Hospital|Chung-Min Chiu|*886-982-506-067|shongdiah@gmail.com|
22377813|NCT00659490|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22377814|NCT01649232|Spanish Neurometrics Foundation|Dr. Moises Aguilar-Domingo, Chairman of Spanish Neurometrics Foundation|+34 634548720|moises.aguilar@gmail.com|
22377815|NCT02421666|Center for Asian Health, Lewis Katz School of Medicine, Temple University|Dr. Grace X. Ma|2157078823|grace.ma@temple.edu|
22377816|NCT03662074|Wake Forest Baptist Comprehensive Cancer Center|Study Nurse|336-716-0230|saverill@wakehealth.edu|
22377817|NCT01078155|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
22377818|NCT01621880|Sun Yat-sen Memorial Hospital, Sun Yat-sen University|Yamei Tang|08613556001992|yameitang@hotmail.com|
22377819|NCT00580814|UCaliforniaIrvine|Tim Wigal, Ph.D., director UCI CHild Development Center|949-824-1812|tlwigal@uci.edu|
22377820|NCT01804101|Fred Hutchinson Cancer Center|Dr. Roland B. Walter|206-667-3599|rwalter@fredhutch.org|
22377821|NCT02202746|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
22377822|NCT03701399|Biohaven Pharmaceuticals|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
22377823|NCT04179032|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22377824|NCT03945292|Arrowhead Pharmaceuticals, Inc.|Patrick O'Brien, Chief Operating Officer|626-304-3400|PObrien@arrowheadpharma.com|
22377825|NCT03033225|Mayo Clinic|Kenneth K. Wang, MD|507-284-2511|wang.kenneth@mayo.edu|
22377826|NCT00946296|UMass Medical School|Dr. Giles Whalen|508-334-5202|Giles.Whalen@umassmemorial.org|
22377827|NCT04283448|Montana State University|Mary P Miles|406 994-6678|mmiles@montana.edu|
22377828|NCT01368965|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
22377829|NCT02618967|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22377830|NCT06060457|ModernaTX, Inc.|Moderna WeCare Team|+1-866-663-3762|WeCareClinicalTrials@modernatx.com|
22377831|NCT00673309|University of Texas Medical Branch|Tina Mack-Moshay- ClinicalTrials.gov Administrator|409-266-6917|tlmackmo@utmb.edu|
22377832|NCT02676375|Department of Psychiatry, University of California San Diego|Dr. Arthur Brody|8585528585|abrody@ucsd.edu|3775
22377833|NCT00569582|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
22377834|NCT05656040|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22377835|NCT05103384|Cleveland Clinic|Jay Alberts, PhD|216-445-3222|albertj@ccf.org|
22377836|NCT02612311|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
22377837|NCT05288660|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22377838|NCT00514735|Medtronic|Linda Nelson, Director of Clinical Research|763-526-2891|linda.k.nelson@medtronic.com|
22377839|NCT02782169|University of Hawaii|Family Planning Department|808-983-6000|hawaiimedab@gmail.com|
22377840|NCT00765232|Mayo Clinic|Mitchell R. Humphreys MD|480-301-8000|humphreys.mitchell@mayo.edu|
22377841|NCT00226239|UPMC Cancer Centers|Rita Johnson, Associate Director of Clinical Research Services|412-647-8571|johnsonr1@upmc.edu|
22377842|NCT04751942|Univeristy Hosptials Cleveland Medical Center|Rachael Kilkenny|216-545-4850|Rachael.Kilkenny@UHhosptials.org|
22377843|NCT02953938|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22377844|NCT03365154|Libra Medical|Phil Zhang, MD|6692039308|pzhang@libramed.com|
22377845|NCT02440633|Otsuka Pharmaceutical Co., Ltd.|Study Director, Yoshitaka Kotobuki, Mr|+81-3-6361-7366||
22377846|NCT01160848|Photocure ASA|Project Director|+47 22062210|pf@photocure.no|
22377847|NCT04510675|Princeton Consumer Research Corp.|Principal Investigator|727-576-7300|bd@princetonconsumer.com|
22377848|NCT04198805|Indiana University School of Medicine|Naga Chalasani, MD|(317) 278-0414|nchalasa@iu.edu|
22377849|NCT03078816|UCSF Movement Disorders|Aaron Viser|415 353 9453|aaron.viser@ucsf.edu|
22377850|NCT02114151|Janssen Infectious Diseases - Diagnostics BVBA|Associate Director||ClinicalTrialDisclosure@its.jnj.com|
22377851|NCT01499082|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22377852|NCT04557930|Dartmouth-Hitchcock|Dr. Amber E. Barnato|603-646-5609|Amber.Barnato@dartmouth.edu|
22377853|NCT04653766|Bioxodes|Medical Writer|+32 (0)71 239 602|stephanie.demoulin@bioxodes.com|
22377854|NCT00500903|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22377855|NCT03063294|Veterans Affairs Greater Los Angeles Healthcare System|David Avram Ganz, MD, PhD|310-478-3711|David.Ganz@va.gov|
22377856|NCT03818672|Bausch Health Americas, Inc|Study Director|7072851528|Varsha.Bhatt@bauschhealth.com|
22377857|NCT00803452|University of Louisville|Professor Douglas Borchman|502 852 7435|borchman@louisville.edu|
22377858|NCT03987841|University of Alabama at Birmingham|Caroline Presley|205-934-7609|capresley@uabmc.edu|
22377859|NCT04506970|Mayo Clinic|Mauro Schenone|5072840210|schenone.mauro@mayo.edu|
22377860|NCT01255592|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22377861|NCT02882282|MD Anderson Cancer Center|Renata Ferrarotto, MD|713-792-6363|rferrarotto@mdanderson.org|
22377862|NCT03928028|Children's Hospital of Philadlephia|C. Alix Timko|2674265467|timkoc@chop.edu|
22377863|NCT01042509|Hospital Universitario|Dr. David Gomez-Almaguer|5281-83488510|hematohu@yahoo.com|
22377864|NCT02802501|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22377865|NCT02012192|Medical University of Innsbruck|Prof. Dr. Nicole Concin|+43 512 504|nicole.concin@i-med.ac.at|81433
22377866|NCT02710292|Alcon Japan Ltd.|Clinical Manager|1-888-451-3937|alcon.medinfo@alcon.com|
22438043|NCT00832416|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
22438044|NCT01999400|University of Michigan|Dr. Duxin Sun|734-763-9783|pharmacy.research@umich.edu|
22438045|NCT04421482|NYU Langone Health|Nazeeh Hanna, MD|516-663-3853|Nazeeh.hanna@nyulangone.org|
22438046|NCT01466127|Massachusetts General Hospital|Elizabeth Hoge, M.D.|617-724-0859|ehoge@mgh.harvard.edu|
22438047|NCT05786508|University of Minnesota|Brent Leininger|6126266477|lein0122@umn.edu|
22438048|NCT04426318|Center for Healthy Minds|Matthew Hirshberg|608-262-0035|hirshberg@wisc.edu|
22438049|NCT02751580|Sidney Kimmel Cancer Center at Thomas Jefferson University|Nicole Simone, MD|215-955-6702|nicole.simone@jefferson.edu|
22438050|NCT04587050|Imperial College london|Dr Tamara Elliott|02075946230|te04@ic.ac.uk|
22438051|NCT02588261|Astellas Pharma Global Development, Inc.|Senior Medical Director|1800 888-7704|astellas.resultsdisclosure@astellas.com|
22438052|NCT03781778|Fred Hutchinson Cancer Research Center|Marian L. Neuhouser, PhD|2066674797|mneuhous@fredhutch.org|
22438053|NCT02287467|NIAID|Dr. Richard Davey|301-496-8029|rdavey@niaid.nih.gov|
22438054|NCT03106636|University of Oregon|Dr. Philip Fisher|541-346-4968|philf@uoregon.edu|
22438055|NCT01915173|Massachusetts General Hospital|Michelle L. Dossett, MD, PhD, MPH|617-643-6034|mdossett@mgh.harvard.edu|
22438056|NCT01456169|Takeda GlobalResearch and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22438057|NCT02292446|Novaratis Pharmaceuticals|Study Director|888-669-6682|novartis.email@novartis.com|
22438058|NCT00412243|The University of Texas M. D. Anderson Cancer Center|Stefan Fader, M.D./Associate Professor|713/745-4613|eharriso@mdanderson.org|
22438059|NCT00935311|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22438060|NCT02652156|Midwestern Regional Medical Center|Director of Clinical Trials|847-731-1648|Bruce.Steinert@CTCA-Hope.com|
22438061|NCT02223338|Loma Linda University|Dr. David Sierpina|9095582154|dsierpina@llu.edu|
22438062|NCT00496080|Ethicon|Piet Hinoul MD|908-218-2585|phinoul@its.jnj.com|
22438063|NCT03329846|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22438064|NCT00479336|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22438065|NCT02741596|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22438066|NCT02021643|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22438067|NCT02947646|Actuated Medical|Director Quality Assurance & Regulatory Affairs|814-355-0003|medical.affairs@actuatedmedical.com|
22438068|NCT02631551|Glenmark Pharmaceuticals Ltd.|Study Director|(201) 684-8000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
22438069|NCT01664182|Gene Upshaw Memorial Tahoe Forest Cancer Center, Truckee, CA 96161|Thomas J Semrad, MD, MAS|+1 530 582 6450|tsemrad@tfhd.com|
22438070|NCT01076036|Corindus, Inc|Michail M. Pankratov, MD, PhD, Vice President of Clinical & Regulatory Affairs|508-653-3335|Michail.Pankratov@Corindus.com|206
22438071|NCT02221674|Grünenthal GmbH|Director of Clinical Trials|+49 241 569|Clinical-Trials@grunenthal.com|3223
22438072|NCT05292131|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22438073|NCT01345188|Midwest Cardiovascular Research Foundation|Dr Nicolas W Shammas|5633242828|shammas@mchsi.com|
22438074|NCT04752358|Adaptimmune|Clinical Trials Management|+1 (215) 825-9260|clinicaltrials@adaptimmune.com|
22438075|NCT04607837|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov.Inquiries@pfizer.com|
22438076|NCT01870505|Memorial Sloan Kettering Cancer Center|Dr. Sarat Chandarlapaty, MD, PhD|646-888-4311|ChandarS@MSKCC.ORG|
22438077|NCT00465452|The University of Toledo|Julia Spears|419-383-6728|julia.spears@utoledo.edu|
22438078|NCT02687139|Johns Hopkins University|Mohamad Allaf, MD|410-502-7710|mallaf@jhmi.edu|
22438079|NCT04030520|University of California San Francisco|Dr Rachel King|+256785304516|rachel.king@ucsf.edu|
22438080|NCT05236257|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22438081|NCT05870865|TrialSpark|TrialSpark|Please Email|soothe.info@trialspark.com|
22438082|NCT03427749|University of Ottawa Heart Institute|Dr. Terrence Ruddy|613-696-7267|truddy@ottawaheart.ca|
22438083|NCT01350245|Thomas Jefferson University|Dolores Grosso, CRNP, DNP|215-955-8874|Dolores.Grosso@jefferson.edu|
22438084|NCT03828019|JHSPH Center for Clinical Trials|Elizabeth E. Sugar|410-614-7837|esugar2@jhu.edu|
22438085|NCT05715242|Stanford University School of Medicine|Michele L. Patel, PhD|650-549-7047|michele.patel@stanford.edu|
22438086|NCT02211456|Oxford University Hospitals NHS FT|Dr James Gamble|00441865221012|james.gamble@ouh.nhs.uk|
22438087|NCT01090063|Tufts Medical Center|Dr. Alice Gottlieb|617-636-7462|Agottlieb@tuftsmedicalcenter.org|
22438088|NCT02324816|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
22438089|NCT04560075|University of Pittsburgh|Dr. Tina Goldstein|(412) 246-5604|goldtr@upmc.edu|
22438090|NCT02109809|Wake Forest University Health Sciences|Dr. Gordon Phillips|336-716-0659|gophilli@wakehealth.edu|
22438091|NCT02936635|Cytokinetics, Inc.|MD Cytokinetics|650-624-2929|medicalaffairs@cytokinetics.com|
22438092|NCT02407223|Janssen Research & Development, LLC|Scientific Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22438093|NCT01478971|Takeda|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
22438094|NCT00988013|University of Illinois at Chicago|Dr. Damiano Rondelli|312-996-6179|drond@uic.edu|
22438095|NCT00763386|Zimmer|Kacy Arnold, Associate Director, Clinical Affairs|574-371-8336|kacy.arnold@zimmer.com|
22438096|NCT00922623|Merz Aesthetics, Inc.|Merz Aesthetics, Inc.|650-286-4000|clinicaltrials@merzaesthetics.com|
22438097|NCT02451917|Endocrinology Division, University of São Paulo Medical School,|Marcia Silva Queiroz, MD, PhD|+ 5511 26616293|marcia.queiroz@hc.fm.usp.br|
22438098|NCT03796637|PTC Therapeutics, Inc.|Medical Information|1-866-562-4620|medinfo@ptcbio.com|
22438099|NCT03726489|University of Pennsylvania|Brooke Bishop|215-615-0523|brooke.bishop@pennmedicine.upenn.edu|
22438100|NCT00950846|Baylor College of Medicine/Texas Children's Hospital|Dr. Caridad A. Martinez|832-824-4692|camartin@texaschildrens.org|4670
22438101|NCT02114606|University of North Carolina at Chapel Hill|Evan Dellon, MD|919-966-2511|evan_dellon@med.unc.edu|
22438102|NCT03361293|University of Minnesota|Jeffrey Wozniak, PhD, LP|612-273-9741|jwozniak@umn.edu|
22438103|NCT00571038|Clement J. Zablocki VA Medical Center|Jeff Whittle, MD, MPH|414-384-2000|jeffrey.whittle@va.gov|46444
22438104|NCT04829916|Guard Therapeutics|Head of Clinical Operations|+46733319438|trials@guardtherapeutics.com|
22438105|NCT01761019|Department of Dermatology, University of Pittsburgh School of Medicine|Laura K. Ferris, MD, PhD|412-647-2013|ferrlk@upmc.edu|
22438106|NCT00225498|Feinstein Institute for Medical Research, Zucker Hillside Hospital|Anil K. Malhotra, MD|718-470-8012|malhotra@lij.edu|
22438107|NCT02660853|Imperial College London|Professor Fan Chung|00442075947954|f.chung@imperial.ac.uk|
22438108|NCT03594773|University of Pittsburgh School of Medicine|Holly Swartz, MD|4122465588|SwartzHA@upmc.edu|
22438109|NCT04854551|University of Colorado Anschutz Medical Campus|Joshua Gowin|3037243769|joshua.gowin@cuanschutz.edu|
22438110|NCT01284517|Sunovion|Medical Director, CNS|1-866-503-6351||
22438111|NCT03393494|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
22438112|NCT04390243|Cedar Sinai Medical Center|Andrew Hendifar, M.D.|310-423-2217|Andrew.Hendifar@cshs.org|
22438113|NCT01314001|University of Pennsylvania|Paul M. Sanborn, M.S.|215-746-7150|sanborn@mail.med.upenn.edu|
22438114|NCT01521507|TearScience, Inc.|Study Director|919-467-4007|cstevens@tearscience.com|
22438115|NCT04034004|UC San Diego|Dr. Fadel Zeidan|858-246-8342|zeidanlaboratory@ucsd.edu|
22438116|NCT04317040|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22438117|NCT03672292|Scynexis|David Angulo|201-884-5471|David.Angulo@scynexis.com|
22438118|NCT00799903|GlaxoSmithKline|GSK Response Center|866-435-7343||
22438119|NCT02518971|Michigan Medicine|Andrew Urquhart|734-936-6636|andrewu@med.umich.edu|
22438120|NCT03088917|Radboudumc|Prof. dr. J.P.H. Drenth|0031243613999|joost.drenth@radboudumc.nl|
22438121|NCT04477759|Medical College of Wisconsin|Musaddiq Awan, MD|414-805-4497|mawan@mcw.edu|
22438122|NCT01514201|St. Jude Children's Research Hospital|Catherine Billups|901-595-3709|catherine.billups@stjude.org|
22438123|NCT02352844|Washington University School of Medicine|Saiama Waqar, M.D.|314-362-5737|saiamawaqar@wustl.edu|
22438124|NCT00590863|Univeristy of Texas Southwestern Medical Center, Dallas|Madhukar H. Trivedi, M.D.|214-648-0188|Madhukar.Trivedi@UTSouthwestern.edu|
22438125|NCT03124836|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
22438126|NCT02735343|MOMH|Amanda Crawford|7026533583|amanda.j.crawford.ctr@health.mil|
22438127|NCT01070173|Tripler Army Medical Center|Dr. Jordan Pinsker|808-433-6338|jordan.pinsker@us.army.mil|
22438128|NCT03318016|University of Colorado Hospital|Daniel Pollyea, MD Associate Professor|720-848-8084|daniel.pollyea@cuanschutz.edu|
22438129|NCT01804881|North York Family Health Team|Principal Investigator|4164943003|dsouthgate@nyfht.com|130
22438130|NCT00566852|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22438131|NCT03165916|GI Clinical Research Enterprise|Tina Higginbotham|615-322-4643|tina.higginbotham@vumc.org|
22438132|NCT02186665|Galderma|Michael Graeber|(817)961-5000|michael.graeber@galderma.com|
22438133|NCT04531241|Johnson & Johnson Vision Care, Inc.|Meredith Bishop, OD, MS, FAAO|1-800-843-2020|mbishop4@its.jnj.com|
22438134|NCT03830359|Laboratoires Thea|ESTRADE|0635156453|marielle.estrade@theapharma.com|
22438135|NCT02715609|Washington University School of Medicine|Dr. Jiayi Huang|314-362-8516|jiayi.huang@wustl.edu|
22438136|NCT03983304|Zeltiq Aesthetics|Lori Brandt, Director, Clinical Trial Management|925 621-7460|lori.brandt@abbvie.com|
22438137|NCT01702246|UCSF Benioff Children's Hospital Oakland|Dr. Carolyn Hoppe|(510)428-3193|choppe@mail.cho.org|
22438138|NCT00432341|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22438139|NCT01518374|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22438140|NCT03035331|Mayo Clinic|Yi Lin|507-293-5189|Lin.Yi@mayo.edu|
22438141|NCT02023996|Memorial Sloan Kettering Cancer Center|Dr. Neeta Pandit-Taskar, MD|212-639-3046|pandit-n@MSKCC.ORG|
22438142|NCT04209205|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22438143|NCT03400176|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22438144|NCT01561053|Grifols|AMBAR clinical manager|+34 935712200|AMBARclinical@grifols.com|
22438145|NCT02910102|Axovant Sciences, Inc.|Director, Clinical Development|1-833-296-8268|clinicaltrials@axovant.com|
22438146|NCT00048347|NIAID|Peter Mannon, MD|205-934-4726|pmannon@uab.edu|
22438147|NCT02863328|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22438148|NCT04565951|Center to Improve Veteran Involvement in Care (CIVIC), HSR&D Center of Innovation, VA Portland Health Care System|Dr. Alan Teo|503-220-8262|alan.teo@va.gov|52461
22438149|NCT00429169|Columbia University/NYSPI|Michael F. Grunebaum, MD|212-543-5842|mfg14@columbia.edu|
22438150|NCT04649177|BostonSight|Daniel Brocks, MD|(781)726-7337|ecrowley@bostonsight.org|
22438151|NCT00999544|University of Kentucky|Dr. Sharon Walsh|859-257-6485|sharon.walsh@uky.edu|
22438152|NCT01392547|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22377867|NCT01920282|Virginia Tech|Dr. Kevin Davy|(540) 231-3487|kdavy@vt.edu|
22377868|NCT02803125|VA Boston Healthcare System|Anica Pless Kaiser, PhD|857-364-5309|Anica.PlessKaiser@va.gov|
22377869|NCT05067439|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22438153|NCT04683835|Neurosteer|Nathan Intrator, Prof.|+1 (401) 837-0351|nathan@neurosteer.com|
22438154|NCT00597402|Duke University Medical Center|Annick Desjardins, MD, FRCPC|9196846173|annick.desjardins@duke.edu|
22438155|NCT04864639|Duke University|Leonor Corsino, MD, MHS|919-684-4005|leonor.corsinonunez@duke.edu|
22377870|NCT03135535|Baylor College of Medicine|Prof.|17137987536|bijan.najafi@bcm.edu|
22377871|NCT02323646|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22438156|NCT04050618|CooperVision, Inc.|Jose A. Vega, O.D., MSc, FAAO|925-621-3761|javega@coopervision.com|
22438157|NCT04404556|Cincinnati Children's Hospital Medical Center|Avani Modi, Ph.D.|513-636-4864|avani.modi@cchmc.org|
22438158|NCT05561582|University of Central Florida|Abigail Wilson|407-823-1026|Abigail.Wilson@ucf.edu|
22438159|NCT00948753|University of Pennsylvania Abramson Cancer Center|David Porter|215-662-2862|david.porter@pennmedicine.upenn.edu|
22438160|NCT00655538|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
22438161|NCT03652181|University of Chicago, Medicine and Biological Sciences Division|Agnieszka Stadnik|(773) 702-8996|astadnik@bsd.uchicago.edu|
22377872|NCT02459262|MinervaX ApS|Per Fisher DPhil|+45 20 25 20 38|pbf@minervax.com|
22377873|NCT05168579|University of Pittsburgh|Dr. Deepika Mohan|404-375-9325|dem73@pitt.edu|
22377874|NCT00387894|University of California San Francisco|Michael Prados, MD|415-353-7500|PradosM@neurosurg.ucsf.edu|
22377875|NCT00827541|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22396111|NCT05111041|Duke University|Devon Noonan, Ph.D.|919-684-3786|devon.noonan@duke.edu|
22396112|NCT04912245|Wake Forest University Health Sciences|Tele Voice|336.716.8028|jgabbard@wakehealth.edu|
22396113|NCT01205230|GlaxoSmithKline|GSK Response Center|866-435-7343||
22438162|NCT01101035|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22438163|NCT01798966|Hamilton Glaucoma center|Anjali Parekh|+1858 822-1553|anjalism@gmail.com|
22438164|NCT03110471|swansea university|sue jordan|+44 (0) 1792 518541|s.e.jordan@swansea.ac.uk|
22396114|NCT00041080|Gynecologic Oncology Group (GOG) Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
22438165|NCT00713544|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22438166|NCT00269919|Janssen Korea Ltd., Korea|Medical CRA|+82-2-2094-4804||
22438167|NCT01641601|UCSF|Kirsten Salmeen|628-213-5314|kesalmeen@gmail.com|
22438168|NCT01908530|Imperial College London|Prof Nick Oliver|07957163617|nick.oliver@imperial.ac.uk|
22438169|NCT01799226|UMichigan|Janet Kinney|734-615-5452|kinneyj@umich.edu|
22438170|NCT02178995|Stanford University|Jesse Adams, MD|2069144771|jadamsuw@stanford.edu|
22438171|NCT00287222|University of Arkansas for Medical Sciences|Sandy Annis|5016868274|amannis@uams.edu|
22438172|NCT00476827|Duke University|Kimberly Blackwell, MD|919-668-1748|kimberly.blackwell@duke.edu|
22438173|NCT01388907|Sofradim Production COVIDIEN|Patrice BECKER, Global Director, Clinical Affairs|+33 4 74 08 92 38|patrice.becker@covidien.com|
22438174|NCT00981461|Lexington International, LLC|David Michaels|5614170200|dm@hairmax.com|
22438175|NCT01910402|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22438176|NCT00483405|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
22438177|NCT03010319|Integra LifeSciences|Andrew Tummon Director, Global Clinical Affairs|609-936-5490|andrew.tummon@integralife.com|
22438178|NCT02128724|University of Oxford|Stasya Ng|+441865 617083|octo-BKM120@oncology.ox.ac.uk|
22438179|NCT01023711|University of Rochester|John Treanor, M.D.|585-275-5871|john_treanor@urmc.rochester.edu|
22438180|NCT01957202|GlaxoSmithKline|GSK Response Center|866-435-7343||
22396115|NCT02428855|Massachusetts General Hospital|Dr. Bruce Giantonio|617-724-4000|BGIANTONIO@mgh.harvard.edu|
22396116|NCT00210184|Institut Bergonie|Pr Marianne Fonck|+33556333333||
22396117|NCT03198520|Solvay® Dental 360|Tim Shary Compliance and Product Specialist|770-772-8665|Tim.shary@solvay.com|
22396118|NCT00823823|Children's Hospital Boston|Dr. Donald Bae|617-355-6808|donald.bae@childrens.harvard.edu|
22438181|NCT01822457|Imperial Vascular Unit|Mr Pasha Normahani|+44 (0) 20 759 48904|pnormahani@gmail.com|
22438182|NCT02640547|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22438183|NCT04098809|Benaroya Research Institute at Virginia Mason|Dr. Andrew Stamm|206-223-6772|Andrew.Stamm@virginiamason.org|
22438184|NCT00193206|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
22438185|NCT03101254|Dana-Farber Cancer Institute|Dr. Elizabeth Buchbinder|6176325055|elizabeth_buchbinder@dfci.harvard.edu|
22438186|NCT01200368|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22438187|NCT03618420|University of Colorado School of Medicine|Petter Bjornstad, M.D., Assistant Professor of Pediatrics and Medicine|7207774659|petter.bjornstad@childrenscolorado.org|
22377876|NCT01750879|Massachusetts General Hospital|Dr. Wayne Shreffler|617-726-6147|WSHREFFLER@mgh.harvard.edu|
22377877|NCT02347657|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22377878|NCT00338598|Yale University|Elizabeth Ralevski Assistant Professor of Psychiatry|+1 203-932-5711|elizabeth.ralevski@yale.edu|4282
22377879|NCT00677352|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22377880|NCT01532128|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22377881|NCT02573402|The University of Texas Health Science Center at Houston|Argyrios Stampas, MD|(713) 797-5007|Argyrios.Stampas@uth.tmc.edu|
22377882|NCT02182973|University of Louisville|Paula Radmacher|5028525532|paula.radmacher@louisville.edu|
22377883|NCT00238433|Oregon Health & Science University|Richard Maziarz, MD|503-494-6365|maziarzr@ohsu.edu|
22377884|NCT01814748|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22377885|NCT03641313|Vanderbilt-Ingram Cancer Center|Jordan Berlin|6153434128|jordan.berlin@vumc.org|
22377886|NCT05735587|Hebrew Rehabilitation Center|Dr. Courtney Millar|6179715531|courtneymillar@hsl.harvard.edu|
22377887|NCT00762450|Colgate Palmolive Co.|William De Vizio|732-878-7901|William_Devizio@colpal.com|
22377888|NCT05614089|University of Pittsburgh|Dr. Jing Luo, MD, MPH, Associate Professor of Medicine|412-383-3559|luoj@pitt.edu|
22377889|NCT05163522|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22377890|NCT01712477|Michigan State University|Chet A Morrison, M.D.|9897901001|chet.morrison@cmich.edu|
22438188|NCT01290757|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22396119|NCT01338415|Actelion Pharmaceuticals Ltd|Principal Clinical Scientist||ClinicalTrialDisclosure@its.jnj.com|
22396120|NCT01118325|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22438189|NCT00570310|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22438190|NCT00352001|CCCC|Dr. Mikkael Sekeres|216-445-9353|sekerem@ccf.org|
22438191|NCT00759161|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22438192|NCT03066193|Yale University|Dr. Michael H. Bloch|2037374539|michael.bloch@yale.edu|
22438193|NCT00535002|Medical University of South Carolina|Dr. McRae-Clark|843-792-5216|mcraeal@musc.edu|
22438194|NCT03071887|Massachusetts General Hospital|Dr. Christina Psaros|617.726.7458|cpsaros@mgh.harvard.edu|
22438195|NCT00181766|Massachusetts General Hospital|Joseph Biederman, MD|617-726-1743|jbiederman@partners.org|
22438196|NCT01337336|GlaxoSmithKline|GSK Response Center|866-435-7343||
22438197|NCT04498143|University of Denver|Dr. Kathryn Fox|3015202715|Kathryn.Fox@du.edu|
22438198|NCT00757237|Gilead Sciences, Inc.|Mark Bresnik, MD, Director, Clinical Research|(650) 522-5934|mark.bresnik@gilead.com|
22438199|NCT01843023|Friends Research Institute|Dr. Shannon Gwin Mitchell|410-837-3977|smitchell@friendsresearch.org|238
22438200|NCT01022138|Karmanos Cancer Institute|Dr. Abhinav Deol|313-576-8093|deola@karmanos.org|
22438201|NCT01397461|Ferrer Internacional, S.A.|Clinical Research Manager|+34 93 509 32 75|nalbareda@ferrer.com|
22438202|NCT05139927|NYU|Marya Gwadz, PhD|917-863-2125|mg2890@nyu.edu|
22438203|NCT04980612|University of California San Francisco|Wolf Mehling, MD|415|wolf.mehling@ucsf.edu|9021331
22438204|NCT05730387|Institute for Global Health at BC Children's Hospital and BC Women's Hospital + Health Centre|Matthew O. Wiens|6048292562|matthew.wiens@bcchr.ca|
22438205|NCT01588444|UT Health Sci Ctr San Antonio|Dr. Brian Mealey|210-567-3567|mealey@uthscsa.edu|
22438206|NCT03364738|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22438207|NCT03245398|Swiss Tropical and Public Health Institute|Dr Jennifer Keiser|+41 61 284 8218|jennifer.keiser@swisstph.ch|
22438208|NCT00637416|University of Kansas Medical Center|Director, ENT Clinical Research|(913) 588-7154|ksykes@kumc.edu|
22438209|NCT04137731|Joint Replacement Center of Montefiore Medical Center|Clinical Research Director|9292466352|sereffer@montefiore.org|
22438210|NCT02403999|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22438211|NCT00310817|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22438212|NCT00799435|Baylor|David Aguilar, MD|713-798-0280|daguilar@bcm.edu|
22438213|NCT01587040|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22438214|NCT02314221|VA RR&D National Center for the Medical Consequences of Spinal Cord Injury|Ann M. Spungen, EdD|718-584-9000|ann.spungen@va.gov|5814
22377891|NCT03937219|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
22377892|NCT05417620|Johns Hopkins Bloomberg School of Public Health|Dr. Sheree Schwartz|443-983-2564|sschwartz@jhu.edu|
22377893|NCT04393441|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22377894|NCT04003610|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22377895|NCT00771810|Tarix Pharmaceuticals|Elizabeth Wagner|6178760223|elizabeth.wagner@tarixpharma.com|
22377896|NCT05198466|Baylor College of Medicine|Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
22377897|NCT02660827|Medtronic Minimed|Vivian Chen, Statistician|8185763309|vivian.chen@medtronic.com|
22377898|NCT03371082|Gan & Lee Pharmaceuticals USA Corp.|Jia Lu, MD, PhD Executive Director of US Clinical Sciences|+1 888-288-5395|Jia.Lu@ganlee.us|
22377899|NCT02657031|University Medical Center Emergency Department|Dr. Tony Zitek|7022247124|zitek10@gmail.com|
22377900|NCT03599349|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 865|clinicaltrials@merz.com|
22377901|NCT06821412|Liberating Technologies, Inc.|Jen Johansson|774-233-0874|jen.johansson@liberatingtech.com|
22377902|NCT00810264|BIOTRONIK|Clinical Studies Engineer Group Manager|800-547-0394|celestial@biotronik.com|
22377903|NCT00072761|Vanderbilt University School of Medicine|Michael R. DeBaun, MD, MPH|615-875-3040|m.debaun@vanderbilt.edu|5-3040
22377904|NCT01648348|Mayo Clinic|Evanthia Galanis, M.D.|(507) 284-1370|galanis.evanthia@mayo.edu|
22377905|NCT00696410|University of Michigan|Jennifer Cowger, MD, Assistant Professor|734 936-5265|jennmatt@med.umich.edu|
22377906|NCT02134587|School of Pharmaceutical Scientes of Universidade Estadual Paulista Júlio de Mesquita Filho, Araraquara, SP (Brazil)|Fabiana Rossi Varallo|5516997629496|varallo.f.r@gmail.com|
22377907|NCT00265889|Case Comprehensive Cancer Center|Brian Bowell, MD|216-444-6922|bolwelb@ccf.org|
22377908|NCT00453986|GlaxoSmithKline|GSK Response Center|866-435-7343||
22377909|NCT00303862|University of Chicago|Theodore Karrison, PhD|773-702-9326|tkarrison@health.bsd.uchicago.edu|
22377910|NCT02925611|PGIMER|Dr. Steve Joys|7087617352|stevejoys@gmail.com|91
22377911|NCT01001052|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22377912|NCT01811212|The Ohio State University Compreshive Cancer Center|Manisha Shah, MD|614-366-6994|manisha.shah@osumc.edu|
22377913|NCT03419364|University of North Carolina at Chapel Hill|Kim Boggess, MD|919-966-1601|kboggess@med.unc.edu|
22377914|NCT04913363|University of Virginia|Jennifer Roe|434-982-4567|jjr4b@virginia.edu|
22377915|NCT01165775|Stanford School of Medicine|Yasser El-Sayed, MD|(650) 723-3198|Yasser.el-sayed@stanford.edu|
22377916|NCT03355326|Indiana University, School of Medicine|Dr. Alan Ladd, Principle Investigator|317-274-4606|aladd@iupui.edu|
22377917|NCT04574882|University of Pennsylvania|Director of Research|2674280125|digitalhealth@pennmedicine.upenn.edu|
22377918|NCT00791323|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22377919|NCT04620681|Moffitt Cancer Center|Dr. Joseph Pidala|813-745-2556|joseph.pidala@moffitt.org|
22377920|NCT00608582|VA Boston Healthcare System and Boston University School of Medicine|Margaret Naeser, PhD|857-364-4030|mnaeser@bu.edu|
22396121|NCT00536809|GlaxoSmithKline|GSK Response Center|866-435-7343||
22396122|NCT03334409|Mayo Clinic, Rochester|Lance Pagliaro, M.D.|(507)293-0566|Pagliaro.lance@mayo.edu|
22438215|NCT05725746|Washington University in St. Louis|Cindy Schwarz|314-935-3063|cschwarz@wustl.edu|
22438216|NCT00367835|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22377921|NCT04922554|Paratek Pharmaceuticals Inc|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
22377922|NCT03308825|Sanofi Pasteur Inc.|Medical Director|800-633-1610|RegistryContactUs@sanofipasteur.com|1#
22377923|NCT00278538|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
22377924|NCT03559218|KeraNetics|Ryan Clohessy, PhD|4102513940|rclohessy@keranetics.com|
22377925|NCT04277455|Mercy Research|Dr. Johnson Thomas|417-888-5660|johnson.thomas@mercy.net|
22377926|NCT01936896|Virginia Commonwealth University|Antonio Abbate|8048280513|antonio.abbate@vcuhealth.org|
22377927|NCT02760056|OHSU|Anna Orban|503-494-3549|orban@ohsu.edu|
22377928|NCT03810534|University of North Carolina at Chapel Hill|Mark Toles, MPH|919-966-5684|mtoles@email.unc.edu|
22377929|NCT04737109|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
22377930|NCT03092375|UF Hepatology Research at CTRB|Lauren Morelli|3522739508|LAUREN.MORELLI@MEDICINE.UFL.EDU|
22377931|NCT01679301|Philips Respironics|Chuck Cain|+1 724 7335835|chuck.cain@philips.com|
22377932|NCT01909570|University Hospital Virgen de las Nieves|Dr. Ana Clavero|0034958020482|anaclaverogilabert@gmail.com|
22377933|NCT02790073|Sanifit|Rekha Garg MD MS|18582815978|rekha.garg@sanifit.com|
22377934|NCT03328143|Aurora Neuroscience Innovation Institute|Richard A Rovin, MD|4143851922|richard.rovin@aurora.org|
22377935|NCT00861614|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22377936|NCT00944658|Imperial College London|Peter Taylor|+44 (0) 2075941872|jrco@imperial.ac.uk|
22377937|NCT02259517|Duke University|Jonathan Posner, MD|1 919 684 2403|jonathan.posner@duke.edu|
22438217|NCT03453489|Barbara Ann Karmanos Cancer Institute|Anthony F. Shields, MD, PhD|313-576-8735|shieldsa@karmanos.org|
22438218|NCT04346654|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
22438219|NCT05747027|Endeavor Health|Urogynecology Research Coordinator|847-570-4729|JLee5@northshore.org|
22377938|NCT01272960|University of Alabama School of Medicine|Dr. Lorie Harper|205-975-0515|lmharper@uabmc.edu|
22438220|NCT00999518|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22438221|NCT03868254|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22438222|NCT02029911|Minerva Surgical, Inc.|Dr. Eugene Skalnyi, VP Medical Affairs|(1) 650-284-3500|eugenes@minervasurgical.com|
22377939|NCT00963911|Institut Bergonié|Pr Pierre Soubeyran|33(0)556333333|p.soubeyran@bordeaux.unicancer.fr|
22438223|NCT03633344|Omnifarma Kyiv LLC|Oleg Kurchenko|+380503319653|Kurchenko@omnifarma.kiev.ua|
22377940|NCT01289418|Laval University|Gaston De Serres|418-666-7000|gaston.deserres@ssss.gouv.qc.ca|274
22438224|NCT00859547|ZymoGenetics|John Pribble, Vice President, Medical Affairs; Scot Maxon, Scientific Information|(206) 428-2756; (206) 434-3365|John.Pribble@bms.com; Scot.Maxon@bms.com|
22377941|NCT00551070|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
22438225|NCT01764711|Vanderbilt Universtiy|Alfredo Gamboa|6158751003|alfredo.gamboa@vumc.org|
22438226|NCT02279667|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22438227|NCT00797277|National Taiwan University Hospital|Dr. Tzung-Jeng Hwang|+886-2-23123456|tjhwang@ntu.edu.tw|66792
22377942|NCT01352585|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22438228|NCT00786799|University of California, San Francisco|Robert L. Hendren, D.O.|415-476-7198|robert.hendren@ucsf.edu|
22438229|NCT02544503|Emory University|Cathrin Buetefisch, MD, PhD|404-712-5507|cathrin.buetefisch@emory.edu|
22438230|NCT04640311|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22438231|NCT03906071|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
22438232|NCT02152761|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22377943|NCT00605202|Oulu University Hospital, Department of Internal Medicine|Janne Hukkanen|+358-8-315 6212|janne.hukkanen@oulu.fi|
22438233|NCT01797263|VA Center for Health Information and Communication|Dr. Matthew J. Bair|317-988-2058|mbair@iupui.edu; matthew.bair@va.gov|
22438234|NCT01485094|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|Clinical-Trials@grunenthal.com|
22377944|NCT00838682|The Catholic University of Korea, Uijeongbu St. Mary's Hospital|Hiun-Suk Chae|82-31-820-3019|chs@catholic.ac.kr|
22438235|NCT02148523|University of Pennsylvania|Dr. Peter P. Reese|215-898-6086|peter.reese@uphs.upenn.edu|
22377945|NCT02305381|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22438236|NCT01165541|Geisel School of Medicine At Dartmouth|Mary Brunette, MD|603-271-7642|mary.brunette@dartmouth.edu|
22438237|NCT00080301|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22377946|NCT02276066|University of Florida Board of Trustees Contracts & Grants|Mark S. Segal|352-273-5357|segalms@medicine.ufl.edu|
22377947|NCT01807156|Emory University|Bassel El-Rayes, MD|404-778-1900|bassel.el-rayes@emoryhealthcare.org|
22438238|NCT00991939|New England Research Institutes, Inc.|Susan F. Assmann, PhD|617-923-7747|sassmann@neriscience.com|548
22377948|NCT01370525|AstraZeneca|Gerard Lynch|1625 518062|aztrial_results_posting@astrazeneca.com|+44
22438239|NCT01965704|Stanford University|David Drover|650-725-0364|ddrover@stanford.edu|
22377949|NCT02943941|Medtronic Inc|Verla Laager|(800) 328.2518|verla.l.laager@medtronic.com|
22377950|NCT03642938|Duquesne University (now at University of Texas at Dallas)|Benedict Kolber|972-883-7225|Benedict.kolber@utdallas.edu|
22377951|NCT01424930|Janssen R&D US|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
22377952|NCT01566331|University of Padua|Dr. Erich Cosmi|+393398146745|ecosmi@hotmail.com|
22377953|NCT03685396|Azienda Ospedaliera San Paolo - Università degli Studi di Milano|Dr.Fulvio Gatti|3396441920|fudy@libero.it|
22377954|NCT03286751|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22377955|NCT01119768|AstraZeneca|Gerard Lynch||az_trials_posting@astrazeneca.com|
22377956|NCT01301391|CLIOSS S.r.l.|Dr. Davite Cristina|+39 0031 58|regulatory@clioss.com|1482
22438240|NCT00061893|Children's Oncology Group|Results Reporting Coordinator||resultsreportingcoordinator@childrensoncologygroup.org|
22377957|NCT01059643|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22438241|NCT02524171|Center for Innovation to Implementation, VA Palo Alto|Daniel M. Blonigen, PhD|650-493-5000|daniel.blonigen@va.gov|27828
22377958|NCT00106184|University of Pittsburgh|Chester V. Oddis, MD|412-383-8861|cvo5@pitt.edu|
22438242|NCT00947271|The Miriam Hospital|Dr. Michael Carey|401-793-8218|michael_carey@brown.edu|
22438243|NCT02868554|University of North Carolina at Chapel Hill|Ching-Chang Ko, DDS, PhD|919-537-3763|ching-chang_ko@unc.edu|
22377959|NCT01583686|National Cancer Institute|Dr. Steven A. Rosenberg|240-858-3080|sar@nci.nih.gov|
22438244|NCT05150990|University of California Santa Barbara|Dr. Nancy Collins|805-568-0042|ncollins@ucsb.edu|
22438245|NCT05282927|Durham VA Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT)|Dr. Kelli Allen|919-286-0411|Kelli.Allen@va.gov|177090
22438246|NCT05447663|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-3000|novartis.email@novartis.com|
22438247|NCT01100320|Purdue Pharma L.P.|Stephen Harris, MD|203-588-7592|Stephen.Harris@Pharma.com|
22438248|NCT04181762|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
22438249|NCT04669301|University of Rochester|Dr. Allison Magnuson|585-602-5085|allison_magnuson@urmc.rochester.edu|
22438250|NCT02586727|Murray Ocular Oncology & Retina|Dr. Timothy Murray|3054877470|tmurray@murraymd.com|
22377960|NCT05292534|Sonova|Dr. Ieda Ishida|6472847562|ieda.ishida@sonova.com|
22438251|NCT05888181|UZ Leuven|Patrick Verschueren|003216342541|patrick.verschueren@uzleuven.be|
22438252|NCT03054649|Alcon Research, LLC|Sr. Clinical Trial Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22438253|NCT02534909|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22377961|NCT00053495|Emergent BioSolutions|Eddie Darton, Medical Director|240-631-3688|dartone@ebsi.com|
22438254|NCT05431478|Alcon Research, LLC|Sr. Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22438255|NCT00132808|Novartis Pharmaceuticals|Study Director|862-778-8300||
22438256|NCT05049850|Hansa Biopharma AB|Study Director|+46 46 16 56 70|clinicalstudyinfo@hansabiopharma.com|
22438257|NCT01938833|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Maysa Abu-Khalaf|215 503-4685|maysa.abu-khalaf@jefferson.edu|
22438258|NCT00676013|University of Texas Medical Branch|David Herndon, MD|409-770-6731|dherndon@utmb.edu|
22438259|NCT00577824|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22438260|NCT00362648|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22377962|NCT00409682|Abbott|Global Medical Services|800-633-9110||
22438261|NCT02204072|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|18002430127|clintriage.rdg@boehringer-ingelheim.com|
22438262|NCT03319134|UT Dallas|Clinical Trial Manager|9723337277|Sarah.McLeod@utdallas.edu|
22377963|NCT03581084|UCSF Airway Clinical Research Center|Ariana Lowman|14155141539|ariana.baum@ucsf.edu|
22438263|NCT03375489|Massachusetts General Hospital|Jennifer Temel, MD|617-724-4000|jtemel@mgh.harvard.edu|
22438264|NCT03838978|Moximed, Inc.|Alexandra Kraenzlin, Director of Clinical Affairs|+41 44 515 62 06|akraenzlin@moximed.com|
22438265|NCT02451514|GlaxoSmithKline|GSK Response Center|866-435-7343||
22438266|NCT01092910|Envoy Medical Corp.|Elizabeth Anderson, PhD|651-361-8080|landerson@envoymedical.com|
22438267|NCT01773187|CTI BioPharma Corp.|Beth Ziemba|206-272-4347|bziemba@ctibiopharma.com|
22438268|NCT02978833|Hospital for Special Surgery|Jennifer Cheng|6467146870|chengj@hss.edu|
22438269|NCT00186901|St. Jude Children's Research Hospital|Sue Kaste, DO|866-278-5833|referralinfo@stjude.org|
22438270|NCT01811186|Asan Medical Center|Hoseong Lee|82-2-3010-3521|hosng@amc.seoul.kr|
22438271|NCT02268994|Keryx Biopharmaceuticals, Inc.|Keryx Medical Information|1-844-44-KERYX (844-445-3799)|medicalinfo@keryx.com|
22438272|NCT03294850|AdventHealth Translational Research Institute|Dr. Karen Corbin|(407) 303-7100|Karen.Corbin@AdventHealth.com|
22438273|NCT00870545|Memphis VAMC|Dr. Linda Nichols|901 523-8990|linda.nichols@va.gov|5082
22438274|NCT02178696|University of Michigan|Jon-Kar Zubieta||JONKAR.ZUBIETA@hsc.utah.edu|
22438275|NCT02696759|University of Arkansas for Medical Sciences|Beth Scanlan|5016868274|bscanlan@uams.edu|
22438276|NCT00003199|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
22438277|NCT01445080|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22438278|NCT03887221|Zambon S.p.A.|Valentina Zanin|+39 02 665241|valentina.zanin@zambongroup.com|
22438279|NCT02487030|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22438280|NCT03857542|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22438281|NCT02123576|The Pennsylvania State University Division of Gastroenterology and Hepatology Milton S. Herhsey Medical Center|Dr. Jonathan G. Stine|717-531-0003|jstine@pennstatehealth.psu.edu|28-9478
22438282|NCT00900029|Smith & Nephew, Inc.|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
22438283|NCT02395614|Vanderbilt university medical center|Dr. Kent K. Higdon|615-936-0160|kent.hidgon@vumc.org|
22438284|NCT02709330|Duke University|Richard Bedlack, MD, PhD|919-668-2839|richard.bedlack@duke.edu|
22438285|NCT01985425|Population Health Research Institute|Dr. Philip Devereaux|905-527-4322|philipj@mcmaster.ca|40654
22438286|NCT03152591|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22377964|NCT03319537|Memorial Sloan Kettering Cancer Center|Dr. Marjorie Zauderer, MD|646-608-3790|zauderem@mskcc.org|
22377965|NCT04710927|University Malaya Kuala Lumpur, Malaysia|Dr Tengku Nurfarhana Nadirah Tengku Hamzah|0379674802|tengkunurfarhana@um.edu.my|4865
22377966|NCT03595332|Northern Arizona University|Dr. Hendrik de Heer|9285231499|dirk.deheer@nau.edu|
22377967|NCT02227875|Mylan, Inc.|Keri L. Vaughan, Director Global Clinical Operations, General Medicine||keri.vaughan@mylan.com|
22377968|NCT01201811|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22438287|NCT02587819|Biosceptre UK|Dr Shaun McNulty|01223496092|shaun.mcnulty@biosceptre.com|
22438288|NCT02968368|Shield Therapeutics|Jackie Mitchell MA DPhil|+44 (0) 191 511 8515|jmitchell@shieldtx.com|
22438289|NCT05280717|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
22438290|NCT03315572|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22438291|NCT00337207|Northwestern University|Clinical Research Office Administrator|312-695-1301|cancertrials@northwestern.edu|
22438292|NCT02562716|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|smcdonou@fredhutch.org|
22438293|NCT02753946|Nabriva Therapeutics plc|Chief Medical Officer|(610) 816-6640|officeUS@nabriva.com|
22438294|NCT00684996|SWOG Statistical Center|Study Statistician|206-667-4623||
22438295|NCT02519439|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
22438296|NCT01775371|Albert Einstein College of Medicine|Dr. Polly Bijur|718-430-4217|polly.bijur@einsteinmed.edu|
22438297|NCT00895284|Mayo Clinic|Dr. Rosanne Kho|408-301-5811|kho.rosanne@mayo.edu|
22438298|NCT03030417|National Cancer Institute|Dr. Alice P. Chen|240-781-3320|chenali@mail.nih.gov|
22438299|NCT02175017|Ono Pharmaceutical Co., Ltd.|Medical Information Center||clinical_trial@ono-pharma.com|
22438300|NCT04915729|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22438301|NCT04961541|Novavax Inc.|Novavax Customer Service Center|1-844-Novavax (668-2829)|Clinicaltrials@novavax.com|
22438302|NCT00466921|Northwestern University|Clinical Trials Office|312-695-1301||
22438303|NCT03305770|Alcon, A Novartis Division|Sr Director Project Leadership|1-888-451-3937|alcon.medinfo@alcon.com|
22438304|NCT03539601|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22438305|NCT00587678|University of Virginia|Dr Christopher Kramer|434-243-0736||
22438306|NCT03710642|Alzheimer's Disease Cooperative Study (ADCS)|Clinical Operations|858-246-1333|alzinfo@ucsd.edu|
22438307|NCT01970306|Memorial Sloan Kettering Cancer Center|Dr. Vivian Strong, MD|212-639-5056|strongv@mskcc.org|
22396123|NCT02563093|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22438308|NCT00226811|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22438309|NCT02727907|BIOCAD|Linkova Yuliya|+7(495)9926628|linkova@biocad.ru|930
22438310|NCT01427933|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22438311|NCT01633541|University of Michigan Rogel Cancer Center|Dr. Paul Swiecicki|734-647-1017|pswiecic@med.umich.edu|
22438312|NCT01643382|University of California, San Francisco|Justin Parekh, MD, MAS|415-595-3707|justin.parekh@ucsfmedctr.org|
22438313|NCT03472326|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22438314|NCT01010971|Sunovion|Respiratory Medical Director|1-866-503-6351||
22438315|NCT03676972|Peking University Third Hospital|Dr. Lulin Ma|13701010872|malulin@medmail.com.cn|+86
22438316|NCT00773513|Hoffmann-La Roche|Medical Communications|(+41) 616878333|global.trial_information@roche.com|
22438317|NCT01128426|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22438318|NCT02330055|Beth Israel Deaconess Medical Center|Dr. Matthias Eikermann|6176673364|meikerma@bidmc.harvard.edu|
22438319|NCT01592071|University of Miami|Dr. John Lewis|(305) 243-6227|jelewis@miami.edu|
22438320|NCT05729568|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22438321|NCT00550953|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22438322|NCT01502228|IndianaU|Dr. Theodore Logan|(317) 948-7449|tlogan@iu.edu|
22438323|NCT00632619|Florida International University|James G Waxmonsky|305 348 3258|jwaxmons@fiu.edu|
22438324|NCT01221350|Centro Universitario de Ciencias de la Salud, Mexico|Fernando R Siller Lopez, Ph.D.|523310585200|fsiller@cucs.udg.mx|33723
22438325|NCT01717001|University of Tennessee|Rebecca Robertson|865-974-2093|rrober28@utk.edu|
22438326|NCT02326597|Emory University|Lakshmanan Krishnamurti, MD|4047270710|lkrishn@emory.edu|
22438327|NCT04739436|Duke University Medical Center|Sherri L. Smith, PhD, AuD, CCC-A|(919) 684-2426|sherri.smith@duke.edu|
22438328|NCT00428948|Otsuka Pharmaceutical Development and Commercialization|Global Medical Affairs|800 562-3974||
22438329|NCT05919888|SSMHealth SLUCare Physician Group|Dr. Randall Otto|314-614-2970|randall.otto@slucare.ssmhealth.com|
22438330|NCT03071393|University of Florida|Emily Fox, Principal Investigator|904-742-2500|ejfox@phhp.ufl.edu|
22438331|NCT04752332|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22438332|NCT00924443|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22438333|NCT03657849|Regions Hospital|Meghan O'Brien / Study Coordinator|612-437-1141|meghan.e.obrien@healthpartners.com|
22438334|NCT03402035|University of Pittsburgh|Jason Sperry|4128028270|sperryjl@upmc.edu|
22438335|NCT03559933|Stimdia Medical, Inc.|Tim Miller|612.940.3454|tmiller@stimdia.com|
22438336|NCT02119663|Incyte Corporation|Study Director|855 463-3463||
22438337|NCT01248949|MedImmune, LLC|Mohammed Dar, MD|301-398-0000|information.center@astrazeneca.com|
22438338|NCT00286429|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22438339|NCT00942825|CanBas Co., Ltd.|Takumi Kawabe, MD, PhD|81559543666|takumi@canbas.co.jp|
22438340|NCT03197376|PATH|Dr. Steve Lamola|+ 1 206.302.6067|slamola@path.org|
22438341|NCT00112125|Impulse Dynamics (USA) Inc|Angela Stagg, Sr. Director, Clinical and Data Operations|8453592389|angelas@impulse-dynamics.com|
22396124|NCT01495858|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22396125|NCT00233363|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22438342|NCT01123395|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22438343|NCT00122369|Beth Israel Deaconess Medical Center (at time of study); now Hypnalgesics, LLC|Elvira V. Lang, MD|978 404 9724|elang@bidmc.harvard.edu|
22438344|NCT00667849|Bioventus LLC|Peter Heeckt, MD (CMO)|1-800-396-4325|peter.heeckt@bioventusglobal.com|
22438345|NCT02921490|Mayo Clinic|Vance Lehman|1-507-284-2511|lehman.vance@mayo.edu|
22377969|NCT02857426|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22438346|NCT00782483|University of Arkansas for Medical Sciences/Arkansas Children's Hospital|Dr. Gal Shafirstein|501-364-7546|jboswell@uams.edu|
22377970|NCT01960725|Duke University School of Medicine|Dr. Dennis Clements|919-684-7790|dennis.clements@duke.edu|
22438347|NCT01052077|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22377971|NCT02831257|Massachusetts General Hospital|Scott Plotkin|617-724-5369|splotkin@mgh.harvard.edu|
22438348|NCT01802710|Hospital Galdakao-Usansolo|Dra Miren Orive|0034 944007105|miren.orivecalzada@osakidetza.net|
22377972|NCT01844284|Abbott Vascular|Hajime Kusano|408-845-1626|hajime.kusano@av.abbott.com|+1
22438349|NCT02528786|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22377973|NCT00611858|Dana-Farber Cancer Institute|Jeffrey Meyerhardt, MD, MPH|617-632-6855|Jeffrey_Meyerhardt@dfci.harvard.edu|
22438350|NCT01099397|University of Florida|Mariellen Moore|352-273-6381|marielm@ufl.edu|
22438351|NCT00950248|National Institute of Allergy and Infectious Diseases, National Institutes of Health|Dr. Bibiana Bielekova|(240) 669-2724|bibi.bielekova@nih.gov|
22438352|NCT02919072|Sintetica SA|Anna Guaita|+41 (0)91640 42 50|aguaita@sintetica.com|
22377974|NCT01069354|Merz North America, Inc.|Ashlee Duncan|984-222-6040|ashlee.duncan@merz.com|
22438353|NCT02424175|Brigham and Women's Hospital|Dr. Jessica Allegretti|6177325500|jallegretti@bwh.harvard.edu|
22438354|NCT00650845|Guerbet|Pierre Desché, MD - VP Development, Medical and Regulatory Affairs.|+33 1 45 91 50 00|pierre.desche@guerbet-group.com|
22438355|NCT01594931|Medicines for Malaria Venture (MMV)|Stephan Duparc, MD, Chief Medical Officer|+41 22 555 0300|duparcs@mmv.org|351
22377975|NCT03138733|Basilea Pharmaceutica|Dr Marc Engelhardt, MD|+41 79 701 0551|marc.engelhardt@basilea.com|
22438356|NCT02744092|Dana-Farber Cancer Institute|Dr. Jean Connors|(617) 632-3000|jconnors@bwh.harvard.edu|
22377976|NCT04723823|University of Pittsburgh|Debbie Harrington, CCRP|412-383-1355|debbie.harrington@pitt.edu|
22438357|NCT01929226|Elusys Therapeutics, Inc.|Senior Director of Regulatory|973-808-0222|cdillon@elusys.com|
22438358|NCT01525615|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22377977|NCT04421092|Medical University of South Carolina - Department of Otolaryngology|Shaun A. Nguyen, MD - Director of Clinical Research|8437921356|nguyensh@musc.edu|
22438359|NCT01473732|Montefiore Medical Center|Dr. Enver Akalin, Medical Director Kidney Transplant|718-920-4815|eakalin@montefiore.org|
22438360|NCT03271424|University of North Carolina Chapel Hill|Dr. Audrey Pettifor|919-966-7439|apettif@email.unc.edu|
22438361|NCT06083987|University of Pittsburgh|Dr. Ana Radovic|4126927227|anr94@pitt.edu|
22438362|NCT04473963|Ablacon, Inc|Eliza Lawrence|+16507049907|elawrence@cortexep.com|
22438363|NCT04685798|Washington University School of Medicine|Gloria J. Guzman Pérez-Carrillo, M.D.|314-362-5950|guzman.gloria@wustl.edu|
22438364|NCT01717872|Women and Children's Hospital of buffalo|Dr. Jerrold Lerman|716 878 7701|jerrold.lerman@gmail.com|
22438365|NCT00592904|Eisai Call Center|Eisai Inc.|888-422-4743||
22438366|NCT03187119|West Virginia University|Dr. Christina Duncan|304-293-1289|Christina.Duncan@mail.wvu.edu|
22438367|NCT03018691|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22438368|NCT03369418|UCLA|Kirsten Tillisch|1 310 208-5400|ktillisch@mednet.ucla.edu|
22438369|NCT02859246|Massachusetts Eye and Ear Infirmary|Dr. Reza Dana|617-573-4331|Reza_Dana@meei.harvard.edu|
22377978|NCT02597036|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22438370|NCT00740584|Starpharma Pty Ltd|Clinical Development Manger|+61 3 9532 2700|clare.price@starpharma.com|
22438371|NCT01461707|University of California, San Francisco|JiWon Choi|415-514-2534|jiwon.choi@ucsf.edu|
22438372|NCT00855816|VA Palo Alto Health Care System / Stanford University School of Medicine|Walton T. Roth, M.D.|650-493-5000|wtroth@stanford.edu|65243
22438373|NCT01526213|UNC-Chapel Hill|Mary F. Paine, RPh, PhD|919-966-9984|mpaine@unc.edu|
22438374|NCT03573323|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22438375|NCT03188432|Wake Forest Baptist Comprehensive Cancer Center|Principal investigator|3367135440|Michael.G.Kelly@advocatehealth.org|
22438376|NCT03869008|UTMC|Bashar Kahaleh, MD|4193834271|bashar.kahaleh@utoledo.edu|
22438377|NCT06260670|Ablacon, Inc|Eliza Lawrence|+16507049907|elawrence@cortexep.com|
22438378|NCT04502290|University of Pittsburgh|Amit Sethi|4123836619|asethi@pitt.edu|
22438379|NCT00206336|Baylor College of Medicine|Dr. Joseph Jankovic|713-798-6556|josephj@bcm.edu|
22438380|NCT01196026|GlaxoSmithKline|GSK Response Center|866-435-7343||
22438381|NCT04912583|The University of Texas Health Science Center at Houston|Radha Korupolu, MD|713-797-5233|Radha.korupolu@uth.tmc.edu|
22438382|NCT01290614|University of Minnesota|Paul Drawz, MD|6126255423|draw0003@umn.edu|
22438383|NCT00452868|Wake Forest Baptist Health|Dr. Janet Tooze|336-716-0286|jtooze@wakehealth.edu|
22438384|NCT02486016|University of Maryland, Baltimore School of Pharmacy|Dr. Audra Stinchomb (PI)|410-706-2646|astinchc@rx.umaryland.edu|
22438385|NCT02109640|University of Edinburgh|Hugh M Paterson|44 131 537 1000|hugh.paterson@ed.ac.uk|
22438386|NCT01155336|University of Rochester|Dr. Robert Block|585 275-3356|robert_block@urmc.rochester.edu|
22377979|NCT02521285|UT MD Anderson Cancer Center|Robert S. Bresalier, MD- Professor, Gastroenterology Hepat & Nutr|(713) 745-4340|rbresali@mdanderson.org|
22377980|NCT02499679|HeartFlow|Sarah Mullen|650-241-1221|smullen@heartflow.com|
22377981|NCT05701995|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22377982|NCT00715429|University of Wisconsin School of Pharmacy|Dr. Mary Elliott|608-695-7501|meelliott@pharmacy.wisc.edu|
22377983|NCT00406133|Jaeb Center for Health Research|Roy W. Beck, M.D., Ph.D., Director|813-975-8690|rbeck@jaeb.org|
22377984|NCT04899245|University of Wisconsin School of Medicine and Public Health|Dr. Ryan Coller|608-263-9408|rcoller@pediatrics.wisc.edu|
22438387|NCT02336230|Mesoblast, Inc.|Christopher James, VP Head of Clinical Operations|212-880-2060|Christopher.James@Mesoblast.com|7925
22438388|NCT02526277|The Ohio State University|Ariane Park, MD|614.293.4969|Ariane.Park@osumc.edu|
22438389|NCT01379183|Mayo Clinic|Dr. Jeff L. Fidler|507-284-5010|fidler.jeff@mayo.edu|
22438390|NCT01620086|University of Arkansas for Medical Sciences|Erik Messias, MD|501-526-8142|emessias@uams.edu|
22438391|NCT01695135|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22438392|NCT02507388|Alcon, A Novartis Division|Global Program Clinical Head, Ophthalmology|1-888-451-3937|alcon.medinfo@alcon.com|
22438393|NCT05065905|Saint-Petersburg State Medical Academy n.a. I.I.Mechnikov of Ministry of Health, Saint-Petersburg, Russia, 195067|Dr. med. Sc., Prof. Tamara Sologub|+78125439609|mechnik@mail.ru|
22438394|NCT00580723|University of California, Irvine|Brian Swasdibutra, Clinical Research Coordinator|9498247103|bswasdib@uci.edu|
22438395|NCT00490269|Uniformed Services University for the Health Sciences|Dr. Lou Cantelina|301-295-3240|louis.cantelina@usuhs.edu|
22438396|NCT04400058|CRMG|Patrick Murphy|4138210022|p.murphy@crmg-usa.com|
22438397|NCT01078441|ECOG Statistical Office|Study Statistician|617-632-3012||
22438398|NCT00216671|Janssen Cilag Spain|EMEA Medical Affairs Director Psychiatry|+34 91 7228043||
22438399|NCT02714569|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22377985|NCT04880395|Fundación Huésped - Buenos Aires|Dr. María Inés Figueroa|+54 11 2120-9999|maria.figueroa@huesped.org.ar|
22438400|NCT01684202|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22438401|NCT00191308|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22438402|NCT00779025|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Sr. Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
22438403|NCT02741635|Fisher & Paykel Healthcare Ltd.|Christine Lambert|+64 9 574 0123|christine.lambert@fphcare.co.nz|7172
22438404|NCT03797586|Guang'anmen Hospital, China Academy Chinese Medical Sciences|Dr.Zhishun Liu|+86 010 88002331|liuzhishun@aliyun.com|
22438405|NCT02864901|Office of Regulated Activities|Emily Badraslioglu, Senior Regulatory Advisor & FDA Sponsor Representative|(301) 619-6828|emily.d.badraslioglu.civ@health.mil|
22438406|NCT00666406|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22438407|NCT01951651|Baylor|Mandeep Bajaj|713-798-1712|bajaj@bcm.edu|
22438408|NCT01219985|Centre Hospital-Universitaire d'Amiens|Pr. Marc-Etienne Meyer|+33 3 22 45 59 64|meyer.marc-etienne@chu-amiens.fr|
22438409|NCT01369784|Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea (GELTAMO)|Dr. Carlos Panizo|+ 34 948 25 54 00|cpanizo@unav.es|
22438410|NCT03359174|Yale Univeristy|Clinical Research Coordinator|203 737 6839|laura.cusack@yale.edu|
22438411|NCT02680665|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22438412|NCT02905266|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22438413|NCT04871425|University of Washington|Complex Family Planning Division|206.221.9074|uwfp@uw.edu|
22438414|NCT00596752|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22438415|NCT03715803|Universidad de Buenos Aires|Dr. Agustín Sampietro|+5491158336327|asampietro@live.com.ar|
22438416|NCT02538042|Duke University|Dr. F. Joseph McClernon|9196682963|joseph.mcclernon@duke.edu|
22377986|NCT04686422|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
22438417|NCT04445662|Massachusetts General Hospital|Travis P Baggett MD MPH|617-643-9314|tbaggett@mgh.harvard.edu|
22438418|NCT01870726|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22438419|NCT01973413|Univeristy of VIrginia|Marc Breton, PhD|434-982-6484|mb6nt@virginia.edu|
22438420|NCT03245775|University of Virginia|Dr. Jamie Zoellner, Professor of Public Health Sciences|4349624488|jz9q@virginia.edu|
22438421|NCT02937558|Xeris Pharmaceuticals, Inc.|Khaled Junaidi|312-517-1461|xerisclintrials@xerispharma.com|
22438422|NCT03691571|The Hospital of the University of Pennsylvania|Dr. Cory M. Tschabrunn|215-614-0482|coryt@pennmedicine.upenn.edu|
22438423|NCT02363959|Duke University|Scott Shofer MD, PhD|919-668-2402|scott.shofer@duke.edu|
22438424|NCT03421106|University of Connecticut|Caitlin Caspi|(860) 486-2834|caitlin.caspi@uconn.edu|
22438425|NCT02578199|YALE|Dr. Rachel Barnes|203-785-6395|rachel.barnes@yale.edu|
22377987|NCT03531320|InnoPharmax Inc.|Staff of Medical Affairs|886-2-8797-7607|yuan.lin@innopharmax.com|
22377988|NCT00386022|Massachusetts General Hospital|Dr. Janet E. Hall|617-877-1112|hall.janet@mgh.harvard.edu|
22377989|NCT04475432|Tarsus Pharmaceuticals, Inc.|Mark Holdbrook, Senior Vice-President of Clinical Development|408-431-6613|mark@tarsusrx.com|
22377990|NCT00504426|Headwuarters of New Product Evaluation and Development, Otsuka Pharmaceutical Co., Ltd.|IMAOKA, Kyoji, Operatin Officer, Gemeral Manager|+81-3-6361-7366||
22377991|NCT04029129|UConnHealth|Dr. Douglas Brugge|860-679-8814|brugge@uchc.edu|
22377992|NCT01714804|SeaSpine|Vice President, Orthobiologics Research & Development|760.216.5138|frank.vizesi@seaspine.com|
22377993|NCT00490256|Emory University|Paul Kirshbom, MD|404-785-6330|pkirshb@emory.edu|
22377994|NCT04188067|Massachusetts General Hospital|Dr. Alexandra Touroutoglou PhD|6176436348|ATOUROUTOGLOU@mgh.harvard.edu|
22377995|NCT03988166|Teleflex|Ricardo De Medeiros, Director Scientific Clinical Affairs|612.812.5008|ricardo.demedeiros@teleflex.com|
22377996|NCT02286089|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22377997|NCT05460325|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22377998|NCT06916468|University Hospitals Cleveland Medical Center|Dr. Bryan Carroll|(216)844-8200|Bryan.Carroll@UHhospitals.org|
22377999|NCT04295005|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22378000|NCT00045708|Johns Hopkins - Adult Brain Tumor Consortium (ABTC)|Director Adult Brain Tumor Consortium|410-955-8837|jfisher@jhmi.edu|
22378001|NCT00685945|Vanderbilt University|Dr. Mias Pretorius|615-343-0665|mias.pretorius@vanderbilt.edu|
22378002|NCT01266447|NRG Oncology|Linda Gedeon, Clinical Data Coordinator|716-845-1169|lgedeon@gogstats.org|
22438426|NCT00940498|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22438427|NCT01364584|University of Colorado School of Medicine|Judith G Regensteiner, PhD|303-724-2247|judy.regensteiner@ucdenver.edu|
22438428|NCT03310723|BC Women's Hospital, Department of Anesthesia|Research Assistant|604-875-2424|james.taylor1@phsa.ca|6076
22438429|NCT02098746|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22438430|NCT00217425|ECOG Statistical Office|Study Statistician|617-632-3012||
22438431|NCT01227980|National Institute on Alcohol Abuse and Alcoholism|Melanie Schwandt|301-451-6960|melanies@mail.nih.gov|
22438432|NCT00671034|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22438433|NCT00330759|Amgen Inc.|Study Director|866-572-6436||
22438434|NCT00972335|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22438435|NCT02380287|BIOCAD|Biryulin Andrey|+7812380 49 33|biryulin@biocad.ru|925
22438436|NCT01508312|Memorial Sloan Kettering Cancer Center|Dr. Alison Moskowitz|212-639-4839|moskowia@mskcc.org|
22438437|NCT02123849|University of Arizona|Dr. Sherry Chow|5206263358|schow@azcc.arizona.edu|
22438438|NCT02322281|Clovis Oncology|Vi Nguyen|+1 415 915 9982|vnguyen@clovisoncology.com|
22438439|NCT00936702|Mayo Clinic|Matthew P. Goetz, M.D.|507 284-2511|goetz.matthew@mayo.edu|
22438440|NCT00824473|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2393|WWheeler@medapharma.us|
22438441|NCT01359904|MUHC|Sameena Iqbal|5149341934|sameena.iqbal@mcgill.ca|44034
22438442|NCT00466440|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22438443|NCT02707146|Division of Research, Kaiser Permanente Northern California|Dr. Richard Grant|510-891-5993|Richard.W.Grant@kp.org|
22438444|NCT03191630|The Ohio State University|Dr. Tara O'Brien|6142928045|obrien.782@osu.edu|
22438445|NCT01550757|US Department of Veterans Affairs|Thomas O'Toole, MD|(401) 273-7100|thomas.otoole@va.gov|6359
22438446|NCT02342223|VA Northern California Health Care System|Jared Jagdeo, MD, MS|917-837-9796|jrjagdeo@gmail.com|
22438447|NCT01426958|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22438448|NCT00040443|RespireRx Pharmaceuticals|Richard Purcell|732-492-1797|rpurcell@respirerx.com|
22438449|NCT01172535|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22438450|NCT01631994|NYU Winthrop Hospital, Dep't of Gastroenterology|David Friedel, MD|(516) 663-2528|DFriedel@nyuwinthrop.org|
22438451|NCT00413218|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|5473
22438452|NCT00837213|GlaxoSmithKline|GSK Response Center|866-435-7343||
22438453|NCT01479868|Janssen Research & Development|Director & Study Responsible Scientist||ClinicalTrialDisclosure@its.jnj.com|
22438454|NCT01618669|Astellas Pharma Global Development, Inc. (APGD)|Senior Medical Director, Medical Affairs||Astellas.resultsdisclosure@astellas.com|
22438455|NCT01508169|Hospital de Clinicas da Universidade Estadual de Campinas (Unicamp)|Cecilia de Morais Barbosa|+55-19-35217113|cecimbarbosa@gmail.com|
22438456|NCT01698502|University of Copenhagen|Michael Lund|+45 3532 7519|michaeltl@sund.ku.dk|
22438457|NCT00004092|City of Hope National Medical Center|Paul Frankel, Ph.D.|(626) 256-4673|pfrankel@coh.org|65265
22438458|NCT01961271|Mundipharma Pte Ltd|Valerie Anne Leck|+65 6511 1165|info.rma@mundipharma.com.sg|
22438459|NCT03600740|Mayo Clinic|Erik H. Middlebrooks, M.D.|904-953-6696|Middlebrooks.Erik@mayo.edu|
22438460|NCT02396212|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22438461|NCT04950465|HALEON|Haleon Response Center|+44 7880 182593|ww.clinical-trial-register@haleon.com|
22438462|NCT03740659|NTC srl|Alessandro Colombo|+390243850490|alessandro.colombo@ntcpharma.com|
22438463|NCT06309953|Bausch & Lomb|Jason Vittitow, PhD|908-541-3060|jason.vittitow@bausch.com|
22438464|NCT00940901|Johns Hopkins University, School of Medicine|Dr. Arthur L. Burnett, Director of Sexual Medicine Fellowship Program|410-614-3986|aburnett@jhmi.edu|
22438465|NCT01788566|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22438466|NCT00740207|Bracco Diagnostics Inc.|Usha Halemane|609-514-2578|usha.halemane@diag.bracco.com|
22438467|NCT00556998|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22438468|NCT02721875|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22438469|NCT02888106|Hepatera LLC|Yana Deloveri|+7 495 762 52 53|deloveri@hepatera.ru|42-14
22438470|NCT00857285|Daiichi Sankyo, Inc.|Senior Director, Regulatory Operations|732-590-5000|hmkessler@dsus.com|
22438471|NCT00837200|Milton S Hershey Medical Center|Joseph J Drabick, MD|717-531-5911|jdrabick@hmc.psu.edu|
22438472|NCT04142034|University of Arkansas for Medical Sciences|Jeannette Lee|5015266712|jylee@uams.edu|
22438473|NCT01425801|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
22438474|NCT03386721|Hoffmann-La Roche|Medical Communications|08008218590|genentech@druginfo.com|
22438475|NCT03066596|Montefiore Medical Center|Marina Reznik, MD, MS|718-741-2494|mreznik@montefiore.org|
22438476|NCT00700713|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22438477|NCT02959437|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22378003|NCT00847405|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22378004|NCT01728792|Takeda|Takeda Study Registration Call Center, Central Contact|+1-877-825-3327|medicalinformation@tpna.com|
22378005|NCT00705133|UC Los Angeles|Rajan Saggar|310-206-6766|rsaggar@mednet.ucla.edu|
22378006|NCT00514683|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22378007|NCT01564368|American College of Radiology|Senior Director Clinical Research Administration|215-574-3150|info@acr.org|
22378008|NCT01802437|University of Minnesota|Meredith Gunlicks-Stoessel|612-273-9844|mgunlick@umn.edu|
22438478|NCT02728089|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22438479|NCT04544358|University of Illinois at Chicago|Dr. David X Marquez|312.996.1209|marquezd@uic.edu|
22438480|NCT04089761|Theranica Bio-Electronics Ltd|Dr Dagan Harris. VP Clinical and Regulatory Affairs|+972723909755|daganh@theranica.com|
22378009|NCT04810221|Life Meter Srl|Dr. Fernando De Benedetto/President|+39 391 4334 090|fernando.debenedetto@lifemetersrl.com|
22438481|NCT02506634|FirstSunYetSen|Dr. Niandi Tan|+86 15989117039|tanniandi@126.com|
22438482|NCT03868943|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-716-7548|rstrowd@wakehealth.edu|
22438483|NCT04896593|Anxiety Disorders Center|David Tolin, Ph.D.|860-545-7685|david.tolin@hhchealth.org|
22438484|NCT02915978|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com|
22438485|NCT02451124|Case Comprehensive Cancer Center|Amitabh Chak|2168443217|axc22@cwru.edu|
22438486|NCT00892775|GlaxoSmithKline|GSK Response Center|866-435-7343||
22438487|NCT00103740|Novartis Pharmaceuticals|Study Director|862-778-8300||
22438488|NCT01463306|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22438489|NCT01971385|Massachusetts General Hospital|Dr. Maria Alora-Palli|6177265066|mpalli@mgh.harvard.edu|
22438490|NCT00250276|GlaxoSmithKline|GSK Response Center|866-435-7343||
22438491|NCT01135095|Department of Medicine, Cardiology Division, Columbia University Medical Center and New York Presbyterian Hospital, New York|Dr. Andrew J. Einstein|+1 212 305-4275|Andrew.einstein@columbia.edu|
22438492|NCT02781610|Seattle Children's|Michelle Skalland (Biostatistician)|206-884-7519|michelle.skalland@seattlechildrens.org|
22438493|NCT00983385|Grünenthal GmbH|Director of Clinical Trials|+49 241 569|Clinical-Trials@grunenthal.com|3223
22438494|NCT00163020|Obstetrix Medical Group, Inc|Kimberly Maurel|714-593-9171|kimberly_maurel@pediatrix.com|
22438495|NCT03074409|University of Electronic Science and Technology of China|Dr. Shuxia Yao|+8618111297596|yaoshuxia@uestc.edu.cn|
22438496|NCT00985673|GlaxoSmithKline|GSK Response Center|866-435-7343||
22438497|NCT02252146|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
22438498|NCT00531284|Amgen, Inc.|Study Director|866-572-6436||
22438499|NCT03057496|Schepens Eye Research Institute of Massachusetts Eye and Ear|Alex Bowers|617 912 2512|alex_bowers@meei.harvard.edu|
22438500|NCT00280917|Can-Fite Biopharma|Pnina Fishman, PhD|011972 39241114|pnina@canfite.co.il|
22438501|NCT01560286|BioMarin Pharmaceutical Inc|Sr. Medical Director, Clinical Science|415-475-5854|Ari.Gershman@bmrn.com|
22438502|NCT02372877|Fresenius Kabi|Jason Friedmann|847-550-2365|jason.friedmann@fresenius-kabi.com|
22438503|NCT02362321|CHU de Québec|Principal Investigator|418-649-0252|michel.prudhomme.chuq@gmail.com|
22438504|NCT01982123|University of Washington Medical Center|Dr. Jing Zeng|2065984110|jzeng13@uw.edu|
22438505|NCT00997035|University of California, San Francisco|Kathryn Ray|415-514-3227|kathryn.ray@ucsf.edu|
22438506|NCT02471014|University of Florida|Mathew Sebastian, PhD|8644901978|mathewsebastian@ufl.edu|
22438507|NCT05098028|Bausch Health Americas, Inc|Varsha Bhatt|7072301712|varsha.bhatt@bauschhealth.com|
22438508|NCT00984308|Department of Veterans Affairs|Dawn M. Bravata, MD|317-988-2676|dawn.bravata2@va.gov|
22438509|NCT02222558|TesoRx Pharma, LLC|Michael Oefelein, MD, Chief Medical Officer|909-595-0500|karl@tesorx.com|104
22438510|NCT02532465|Nationwide Children's Hospital|Senthil Krishna, MD|614-722-4200|Senthil.Krishna@nationwidechildrens.org|
22438511|NCT00790192|Sunovion|Josephine Cucchiaro, PhD, Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com|
22438512|NCT00354679|Memorial Sloan Kettering Cancer Center|Dr. David Ilson|646-888-4183|ilsond@mskcc.org|
22438513|NCT03456076|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22438514|NCT02493036|Synthetic Biologics Inc|Michael Kaleko|(240) 238-3862|mkaleko@syntheticbiologics.com|
22438515|NCT01844388|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22438516|NCT03187132|CedarsSinaiMC|R. Brennan Spiegel|310-423-6784|Brennan.Spiegel@cshs.org|
22438517|NCT02045095|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22438518|NCT02525588|Stryker|Britta von den Brincken, Clinical Study Manager|+491638999202|britta.vondenbrincken@stryker.com|
22438519|NCT02459119|Dana Farber Cancer Institute|Dr. Guru Sonpavde, MD|617-632-2429|gsonpavde@gmail.com|
22438520|NCT01837277|Federal University of Bahia|Professor Carlos Brites|+5555992329552|crbrites@hotmail.com|
22438521|NCT01433016|Exalenz Bioscience|Clinical Trials Manager|+972-8-9737513|avrahamh@exalenz.com|
22438522|NCT05413668|Quotient Sciences|Jeffrey Levy|+44 (0)115 974 9000|jeffrey.levy@quotientsciences.com|
22438523|NCT00714415|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22438524|NCT01588561|McLean Hospital|Scott Lukas, Ph.D.|617-855-2767|slukas@mclean.harvard.edu|
22438525|NCT01450761|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22438526|NCT01818596|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22438527|NCT01582139|University of Virginia|Marc D Breton, Ph.D.|434-982-6484|mb6nt@virginia.edu|
22438528|NCT03767257|Memorial Sloan Kettering Cancer Center|Dr. Malin Hultcrantz, MD, PhD|646-608-3714|hultcram@mskcc.org|
22438529|NCT04435366|Astellas Pharma Global Development, Inc|Clinical Transparency|800-888-7704|astellas.resultsdisclosure@astellas.com|
22438530|NCT01556451|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22438531|NCT04497116|Repare Therapeutics Inc|Repare Therapeutics Medical Monitor|1 (857) 340-5402|clininfo@reparerx.com|
22438532|NCT04152772|Butler Hospital|Mascha van 't Wout-Frank|401-680-4198|Mascha_vant_Wout@brown.edu|
22438533|NCT05963022|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22411287|NCT01523964|DART Therapeutics|Chief Operating Officer|415-341-5783|egoldstein@dartrx.com|
22438534|NCT02501590|Head of The Pediatric Neurology and Developmental Unit|Aviva Mimouni-Bloch|97297709048|abloch@clalit.org.il|
22438535|NCT02698826|Cooper University Health Care|Brian Roberts, MD/ REOX Study Director|856-342-2352|roberts-brian-w@cooperhealth.edu|
22438536|NCT02545608|Q-Med AB|Head of Development|+ 46 (0) 18 474 90 00|reception.seupp@galderma.com|
22378010|NCT01181726|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22438537|NCT00945282|ViiV Healthcare|GSK Response Center|866-435-7343||
22438538|NCT02915263|Beth Israel Deaconess Medical Center|Christopher Gibbons MD|617-632-8454|cgibbons@bidmc.harvard.edu|
22438539|NCT02478463|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22438540|NCT01358825|GlaxoSmithKline|GSK Response Center|866-435-7343||
22438541|NCT01825187|New Hanover Regional medical Center|Dr. William Hope|(910)667-9233|william.hope@nhrmc.org|667
22438542|NCT01177007|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu|
22378011|NCT01264380|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22378012|NCT01860586|Mid-Atlantic Retina|Dr. Jason Hsu, Principal Investigator|215-928-3092|jshu@midatlanticretina.com|
22378013|NCT04998604|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22378014|NCT02659787|University of Chicago|Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
22378015|NCT03953898|Yale School of Medicine|Rory Shallis, MD|(203) 200-4363|rory.shallis@yale.edu|
22378016|NCT01537302|Austin Heart|Matthew Selmon, MD|512-788-2692|matthew.selmon@hcahealthcare.com|
22378017|NCT04711356|London School of Hygiene & Tropical Medicine|Dr Daniela Manno, clinical trial coordinator and responsible physician|+44 20 7927|daniela.manno@lshtm.ac.uk|2092
22378018|NCT00643123|Cedars Sinai Medical Center|Felicia Mayes|310-423-0825|mayesf@cshs.org|
22378019|NCT04219618|The University of Texas Health Science Center at Houston|Igor D. Gregoric, MD|713-486-6714|Igor.D.Gregoric@uth.tmc.edu|
22378020|NCT05711537|Wake Forest School of Medicine|Heather Columbano, MD|336-716-4498|hcolumba@wakehealth.edu|
22378021|NCT01896869|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Dung Le|443-287-0002|dle2@jhmi.edu|
22378022|NCT01691833|Carolinas Healthcare System|Dr. Rachel Seymour|704-355-2000|Rachel.Seymour@carolinas.org|
22378023|NCT03059901|Klein Buendel|Valerie Myers, PhD|3035654343|vmyers@kleinbuendel.com|
22378024|NCT00530062|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22378025|NCT00454571|The University of Chicago|Walter M. Stadler, MD|(773) 702-6149|wstadler@medicine.bsd.uchicago.edu|
22378026|NCT01376323|GlaxoSmithKline|GSK Response Center|866-435-7343||
22378027|NCT04681729|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22378028|NCT02436811|Universidade Federal do Paraná|Dr Luciana Reichert Assunção Zanon|554133604025|lurassuncao@yahoo.com.br|
22378029|NCT00792103|NuPathe Inc.|Mark Pierce, MD PhD|484-567-0130|mpierce@nupathe.com|
22378030|NCT02856113|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22378031|NCT03494166|University of Arizona College of Nursing|Terry Badger, PhD (MPI) and Alla Sikorskii, PhD (MPI)|520-626-6058|tbadger@arizona.edu|
22378032|NCT01155154|SUNY Downstate Medical Center|Shahriar Zehtabchi|718-245-2973|shahriar.zehtabchi@downstate.edu|
22378033|NCT02470494|Earlens Corporation|Dr. Suzanne Levy, Director of Clinical Research|650-739-4447|Suzanne.Levy@Earlens.com|
22438543|NCT01702558|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22378034|NCT02110901|Proteon Therapeutics, Inc|Steven Burke, MD|781-890-0102|Clinical@ProteonTx.com|
22378035|NCT01238640|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Sr. Specialist, Clinical Research Operations|928-277-0715|jhaue@its.jnj.com|
22378036|NCT00855595|Intendis GmbH|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22378037|NCT00723099|Fred Hutchinson Cancer Research Center|Rachel Salit|206-667-1317|rsalit@fredhutch.org|
22378038|NCT01058304|Health Services Research & Development, Durham VAMC|Kelli D. Allen|919-286-0411|kelli.allen@va.gov|7090
22378039|NCT01820559|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com|
22378040|NCT02496767|Cytokinetics, Inc.|MD Cytokinetics|650-624-2929|medicalaffairs@cytokinetics.com|
22378041|NCT00166296|Hospital Universitari Germans Trias i Pujol, Autonomous University of Barcelona|Crisanto Diez-Quevedo|+34934978814|cdiezquevedo.germanstrias@gencat.cat|
22378042|NCT03477279|University of North Carolina at Chapel Hill|Nora Rosenberg, PhD, MSPH|919-843-6580|nora_rosenberg@unc.edu|
22378043|NCT04035200|Imbrium Therapeutics|Medical Information|1-888-726-7535|Purduemedinfo@pharma.com|
22378044|NCT02277990|Medtronic|Daniel Lexcen, Sr. Clinical Program Manager|+17635269702|daniel.lexcen@medtronic.com|
22438544|NCT03782233|The First Affiliated Hospital of Nanjing Medical University|Dr. He Huang|13852476684|hh19871117@126.com|
22378045|NCT04581200|Duke University|Christopher Cox|9196817232|christopher.cox@duke.edu|
22378046|NCT04711603|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email olly|rinsyousiken@pharm.kissei.co.jp|
22378047|NCT03351738|MedImmune, LLC|Richard George|+1-301-398-5681|information.center@astrazeneca.com|
22378048|NCT03997513|VA Pittsburgh Healthcare System|Dr. Jessica Bon Field|412-360-6823|jessica.field@va.gov|
22378049|NCT03821337|VA Medical Center|Program Manager|843-792-0476|lisa.nunn@va.gov|
22378050|NCT01089374|Dartmouth-Hitchcock Medical Center|Dr. Richard Barth|603-650-9479|Richard.J.Barth.Jr@hitchcock.org|
22378051|NCT02098538|Memorial Sloan Kettering Cancer Center|Dr. Alan Ho, MD, PhD|646-608-3774|hoa@mskcc.org|
22378052|NCT05887947|University of Kansas Medical Center|Eleanor Leavens|913-945-7875|eleavens@kumc.edu|
22378053|NCT05107960|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22378054|NCT03459287|Cerus Corp|Richard Benjamin, M.D., Ph.D.|925 288 6000|rbenjamin@cerus.com|
22438545|NCT00195039|Weill Cornell Medicine|Scott Tagawa, MD||guonc@med.cornell.edu|
22438546|NCT01680666|Stanford University|Matias Bruzoni, MD|650-723-6439|mbruzoni@stanford.edu|
22438547|NCT03259087|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22438548|NCT04524858|Aclaris Therapeutics, Inc.|Ajay Aggarwal|484-540-6296|Clintrials@aclaristx.com|
22378055|NCT01533493|Massachusetts General Hospital|Joseph Biederman|617-724-1743|jbiederman@partners.org|
22378056|NCT01456299|Ajou University|Dr.Kim|82-32-460-3400|kjyeop@ajou.ac.kr|
22396126|NCT03000088|Ajou University School of Medicine|Dr. Jiyoung Lee|82-31-219-5689|leejiyoung0616@gmail.com|667
22396127|NCT01526551|University of Kentucky College of Public Health|Dr. Robin Vanderpool|859-218-2102|robin@kcr.uky.edu|
22438549|NCT03571204|National Institute of Allergy and Infectious Diseases|Sneller, Michael|+1 301 496 0491|msneller@niaid.nih.gov|
22438550|NCT01623115|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22438551|NCT04797780|Syros Pharmaceuticals|Tiffany Crowell|617-674-9069|info@syros.com|
22438552|NCT02940496|MD Anderson Cancer Center|Ahmed Kaseb, MD|(713) 792-2828|akaseb@mdanderson.org|
22438553|NCT05973006|Novavax Inc.|Novavax Customer Service Center|1-844-Novavax (668-2829)|Clinicaltrials@novavax.com|
22438554|NCT05167825|Janssen Pharmaceutical K.K.|Executive Medical Director CP|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22438555|NCT01807598|Stanford University|Jason R. Gotlib|650-736-1253|jason.gotlib@stanford.edu|
22438556|NCT02440685|Libertas BioSciences|Niranjan Rao|908-872-1133|niranjan@libertasbiosciences.com|
22438557|NCT02286921|SKCCC at JHU|Dr. Samual Denmeade|410-955-8875|denmesa@jhmi.edu|
22438558|NCT03622814|Medical University of South Carolina|Teresa Kelechi|843-810-3157|kelechtj@musc.edu|
22438559|NCT04417361|UCSF|Jeffrey D. Sharon|4153532757|jeffrey.sharon@ucsf.edu|
22438560|NCT00165672|Eisai Co.,Ltd. Eisai Product Creation Systems|Nobuyuki Sugisaki, Study Director|+81-3-3817-3908|n-sugisaki@hhc.eisai.co.jp|
22438561|NCT01895946|AstraZeneca UK Limited|Dr Justin P. O. Lindemann, MBChB MBA, Medical Science Director, AZD5363|(0)7920 250301|Justin.Lindemann@astrazeneca.com|+44
22438562|NCT04186871|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22438563|NCT00746694|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22438564|NCT00555217|VA Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh, PA|Linda Fried, MD, MPH|412-360-3930|Linda.Fried@va.gov|
22438565|NCT01546688|Eisai Call Center|Eisai Inc.|888-422-4743||
22438566|NCT02771197|The Blood and Marrow Transplant Group of Georgia/Northside Hospital|Dr. Scott Solomon|404-255-1930|ssolomon@bmtga.com|
22438567|NCT03543137|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22438568|NCT02155920|University of Texas Southwestern Medical School|Daniel C. Bowers, MD|214-648-3896|Daniel.Bowers@utsouthwestern.edu|
22378057|NCT00525525|University of California San Francisco|Michael D. Prados, MD, FACP|415-353-2383|pradosm@neurosurg.ucsf.edu|
22378058|NCT00057551|Weill Cornell Medical College|James H. Kocsis, M.D.|212-746-5913|jhk2002@med.cornell.edu|
22378059|NCT04672941|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22378060|NCT03685591|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22378061|NCT00689026|Georgia Regent University|Dr. Sherman M. Chamberlain, Professor of Medicine|706-721-2238|schamberlain@gru.edu|
22378062|NCT03034018|Brigham and Women's Hospital|Hadine Joffe, MD MSc|617-732-4906|hjoffe@bwh.harvard.edu|
22378063|NCT00944047|University of Kansas Cancer Center|Dr. Qamar Khan|(913) 588-6029|ctnursenav@kumc.edu|
22378064|NCT04859660|University of Arizona|Martina Gabra|520-626-6636|mgabra2@gmail.com|
22378065|NCT03996291|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22378066|NCT03933826|University of Washington|Dr. John Gore|206-543-9926|cistopm@uw.edu|
22378067|NCT02638948|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb Study Director|Please email|clinical.trials@bms.com|
22378068|NCT04992546|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22378069|NCT04506775|UMass Chan Medical School|J. Aaron Scott, DO|774-303-4156|jamesaaron.scott@umassmemorial.org|
22378070|NCT05007392|Eisai Co., Ltd.|Eisai Inquiry Service|none|eisai-chiken_hotline@hhc.eisai.co.jp|
22378071|NCT02703922|Groupe Hospitalier de la Rochelle Ré Aunis|Caroline Allix-Béguec, clinical research manager|+33516494246|caroline.allix-beguec@ght-atlantique17.fr|
22378072|NCT00818116|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22378073|NCT05070416|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
22378074|NCT04058353|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22378075|NCT05340855|Mayo Clinic|Christi A Patten, Ph.D.|507-266-2554|patten.Christi@mayo.edu|
22378076|NCT00985010|Materno-Perinatal Hospital of the State of Mexico|Hugo Mendieta Zerón|+52-722-2176605|mezh_74@yahoo.com|
22378077|NCT00316173|GlaxoSmithKline|GSK Response Center|866-435-7343||
22378078|NCT02390531|Jaeb Center for Health Research|Raymond Kraker, PEDIG Coordinating Center Director|8139758690|rkraker@jaeb.org|
22378079|NCT03407794|University of North Florida|Andrea Arikawa|9044798995|andrea.arikawa@unf.edu|
22378080|NCT03764072|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22378081|NCT03657277|University of Iowa|Nicole Brogden|3193358752|nicole-brogden@uiowa.edu|
22378082|NCT00566579|Department of OBGYN, Faculty of Medicine, Khon Kaen University, 40002, THAILAND|Bandit Chumworathayi|66818733327|bunchu@kku.ac.th|
22378083|NCT01024608|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22378084|NCT04791761|UPMC Children's Hospital of Pittsburgh|Dr. Amber Shaffer|4126926874|shafferad@upmc.edu|
22378085|NCT04669600|Sanofi aventis recherche & développement|Trial Transparency Team|8006331610|Contact-US@sanofi.com|6#
22378086|NCT01163643|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22378087|NCT00676130|Brigham and Women's Hospital|Daniel J. Pallin, MD, MPH|617-525-6614|dpallin@partners.org|
22378088|NCT01861574|Medical University of South Carolina|JEFFREY J BORCKARDT|(843)792-3295|borckard@musc.edu|
22378089|NCT04857034|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email|Clinical.Trials@bms.com|
22378090|NCT01342458|University of Sao Paulo|Dr. Francis Trombini-Souza|55 11 3091 8426|trombinisouza@usp.br|
22378091|NCT00530803|Montefiore Medical Center|Associate Professor, Dept of Pediatrics|718-741-2460|cskae@montefiore.org|
22438569|NCT01045694|University of Missouri-Columbia|Stephen Colbert|573-882-2275|colberts@health.missouri.edu|
22378092|NCT00261495|Janssen Pharmaceutica NV|EMEA Medical Affairs Director Analgesia|+49 4107 312356|kpappert@its.jnj.com|
22378093|NCT02032212|Imperial Tobacco Group|Tanvir Walele|0044 177 933 7589|tanvir.walele@uk.imptob.com|
22378094|NCT01520402|Mount Sinai School of Medicine|Dr. Daniella Kadian-Dodov|(212) 241-9454|daniella.kadian-dodov@mssm.edu|
22378095|NCT02287584|Sumitomo Dainippon Pharmaceutical|Clinical Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
22378096|NCT02269371|Mike O'Callaghan Federal Medical Center|Jill M. Clark, MBA/HCM|7026533298|jill.clark.3.ctr@us.af.mil|
22378097|NCT02162680|Duke University Medical Center|Julia Aucoin, DNS|1 919 613 6406|julia.aucoin@dm.duke.edu|
22378098|NCT01722162|Washington University School of Medicine|Manik A. Amin, M.D.|314-362-9115|manikamin@wustl.edu|
22378099|NCT03086018|Bernafon AG|Julie Tantau|+41 31 998 1646|juta@bernafon.com|
22378100|NCT01538472|University of Texas (UT) MD Anderson Cancer Center|Issa Khouri, MD / Professor, Stem Cell Transplant|713-745-2803|CR_Study_Registration@mdanderson.org|
22378101|NCT01892345|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22378102|NCT00659984|NANT Consortium|NANT Operations Center|323-361-5687|nantops@chla.usc.edu|
22378103|NCT02133872|University of Florida|Dr. Carl J. Pepine|(352) 339-0696|carl.pepine@medicine.ufl.edu|
22378104|NCT02923739|M D Anderson Cancer Center|Dr. Anil Sood|713-745-5266|asood@mdanderson.org|
22378105|NCT00248781|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov|
22378106|NCT02623855|UCSF Benioff Children's Hospital Oaland|Dr. Nooshin Razani, Principal Investigator|415-428-3129|nrazani@mail.cho.org|
22378107|NCT00948974|Drexel University|Evan Forman|215.553.7113|evan.forman@drexel.edu|
22378108|NCT02487810|Fostering Improvement in End-of-Life Decision Science (FIELDS) Program|Beth Cooney, Assistant Director of FIELDS Program|215-573-9461|elcooney@exchange.upenn.edu|
22378109|NCT01972529|Eisai Inc|Eisai Medical Services|1-888-274-2378|esi_medinfo@eisai.com|
22378110|NCT01889186|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22378111|NCT00252538|VA Long Beach Healthcare System|Peter Hauser|562 826 8000|peter.hauser2@va.gov|2629
22378112|NCT00801801|UAB|Dr. Francisco Robert|205-934-5077|pacorobertuab@cs.com|
22378113|NCT00118716|GlaxoSmithKline|GSK Response Center|866-435-7343||
22378114|NCT00621543|University of Rochester|Sarah Betstadt, MD, MPH|585-276-5368|sarah_betstadt@urmc.rochester.edu|
22378115|NCT00855062|Harvard School of Public Health|Sachiko Miyahara|617-432-2837|miyahara@sdac.harvard.edu|
22378116|NCT03745222|Celgene Corporation|Anne McClain|908-673-9100|ClinicalTrialDisclosure@Celgene.com|
22378117|NCT02657317|University of Texas Health Science Center at San Antonio|Donald McGeary, PhD|210-567-5454|mcgeary@uthscsa.edu|
22378118|NCT02755597|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22378119|NCT03643224|Medtronic CAS|Josman Suri|7635050262|josman.suri@medtronic.com|
22378120|NCT04252742|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22378121|NCT06289192|Johns Hopkins University|Alejandra Ellison-Barnes|n/a|aelliso6@jhmi.edu|
22378122|NCT01220869|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22378123|NCT03759834|Mayo Clinic|Matthew Carlson, M.D., M.B.A.|507-284-8532|Carlson.Matthew@mayo.edu|
22378124|NCT01091948|Cleveland Clinic Foundation|Dr. Basem Abdelmalak|216-444-3746|abdelmb@ccf.org|
22378125|NCT00031486|University of Alabama at Birmingham|Penny Jester|(877) 975-7280|pjester@peds.uab.edu|
22378126|NCT01685138|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22378127|NCT01542957|Universitat de Barcelona|Prof. Guillem Feixas|0034 933125100|gfeixas@ub.edu|
22378128|NCT03934736|Dynavax Technologies Corporation|Robert Janssen, MD, Senior Vice President & Chief Medical Officer|5106650414|rjanssen@dynavax.com|1414
22378129|NCT05805657|University of California, Berkeley|Dr. Allison Harvey, Professor of Clinical Psychology|5104736490|aharvey@berkeley.edu|
22378130|NCT01951638|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22378131|NCT00552084|Vanderbilt University Medical Center|Dr. C Michael Stein|615-936-3420|mike.stein@vanderbilt.edu|
22378132|NCT01338025|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22378133|NCT03188055|University of Wisconsin, Madison|Margaret Lee Schwarze, MD, MPP, FACS|(608) 265-2358|schwarze@surgery.wisc.edu|
22378134|NCT04349280|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22378135|NCT04549363|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22378136|NCT01774149|Norwegian Center for Integrated Care and Telemedicine|Dr. Stein Olav Skrøvseth|+4795805841|stein.olav.skrovseth@telemed.no|
22378137|NCT00657618|WRAIR|Roseanne A. Resnner, MD|301-295-6400|rose.resnner@us.armyh.mil|
22378138|NCT01659151|Moffitt Cancer Center|Amod Sarnaik, M.D.|813-745-8581|Amod.Sarnaik@moffitt.org|
22378139|NCT05774197|Harvard Medical School|Desiree Azizoddin, PsyD|4052718001|desiree_azizoddin@dfci.harvard.edu|50516
22378140|NCT05073133|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22378141|NCT04981678|MaineHealth, Department of Anethesiology|Lead Research Coordinator|207-662-2862|janelle.richard@mainehealth.org|
22378142|NCT02235545|Abbott|Nicole Harbert, Program Director|1 972-526-4841|nicole.harbert@abbott.com|
22378143|NCT05650164|Merck Healthcare KGaA, DarmstadtGermany, an affiliate of Merck KGaA,Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22378144|NCT02044848|Novartis Pharmaceuticals|Study Director|862-778-8300||
22378145|NCT00249249|Kowa Research Europe, Ltd.|Dr Neil Hounslow|+44 118 922 9004|nhounslow@kowa.co.uk|
22378146|NCT00284141|Sanofi|Trial Transparency Team||Contact-Us@Sanofi.com|
22378147|NCT05418777|William Beaumont Hospitals|Maureen Cooney, RN Clinical Research Manager|2485510099|maureen.cooney@corewellhealth.org|
22378148|NCT00201864|The Ohio State University|Ewa Mrozek|614-293-7956|Ewa.Mrozek@osumc.edu|
22378149|NCT02882711|The University of Texas Health Science Center at Houston|Salih Selek, M.D.|713-741-3936|salih.selek@uth.tmc.edu|
22378150|NCT02597790|David Geffen School of Medicine at UCLA|Kara Chew, MD, MS|310-825-0796|kchew@mednet.ucla.edu|
22378151|NCT00299000|BioMarin Pharmaceutical Inc.|Medical Information Services|800-983-4587|medinfo@bmrn.com|
22378152|NCT01782742|Cleveland Clinic Lou Ruvo Center for Brain Health|Jeffrey Cummings, MD, ScD|702.483.6029|cumminj@ccf.org|
22378153|NCT04170686|University of Pennsylvania|Dr. Melissa G. Hunt|610-529-8055|mhunt@psych.upenn.edu|
22378154|NCT04389333|National Clinical Research Center for Digestive Diseases Department of Gastroenterology|Dr. Zhuan Liao|21-31161004|liaozhuan@smmu.edu.cn|+86
22378155|NCT04425902|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22378156|NCT01191840|Duke University Health System|Vance Fowler|919-668-8044|fowle003@mc.duke.edu|
22378157|NCT01544998|Mayo Clinic|Horng Chen, MD, Professor of Medicine|507-284-8846|chen.horng@mayo.edu|
22378158|NCT00691808|Lexicon Pharmaceuticals, Inc.|Joel P. Freiman, MD, MPH - Medical Director, Drug safety|281-863-3000||
22378159|NCT00331344|Oakland Medical Center|Andrea Harzstark, M.D.|510-752-6789|andrea.l.harzstark@kp.org|
22378160|NCT01007656|PingTung Christian Hospital Ruiguang Branch|Dr. Choo-Aun Neoh|886-8-736-8686|neohca@gmail.com|5310
22378161|NCT02940574|KU Leuven|Prof. Dr. Kaat Alaerts|16 37 64 46|kaat.alaerts@kuleuven.be|+32
22378162|NCT04538144|Institute for Exercise and Environmental Medicine|Dr. Craig Crandall|214-345-4623|craigcrandall@texashealth.org|
22378163|NCT00520975|ECOG-ACRIN Statistical Office|ECOG-ACRIN statistician|617-632-3012||
22378164|NCT01682213|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman, MD|646-888-4162|chapmanp@mskcc.org|
22378165|NCT04382924|Algernon Pharmaceuticals|Dr. Christopher Bryan|2045572308|cbryan@algernonpharmaceuticals.com|
22378166|NCT00642902|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22378167|NCT00429663|Boston Medical Center|Paul Tornetta III, MD|617-414-6295|paul.tornetta@bmc.org|
22378168|NCT04207840|Amphastar Pharmaceuticals, Inc.|Amphastar Pharmaceuticals, Inc.|(909) 980-9484|info@amphastar.com|
22378169|NCT05383417|University of California San Diego Health|Dr. Andrew Vahabzadeh-Hagh|858-249-4070|avahabz@health.ucsd.edu|
22378170|NCT03243422|University of North Carolina, Chapel Hill|Lisa Gravens-Mueller, Biostatistician/Supervisor|919 962-3098|lgravens@email.unc.edu|
22378171|NCT01083654|University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|608-262-7563|sss@ctri.wisc.edu|
22378172|NCT03420781|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22378173|NCT00229957|McMaster University|Dr. Julie Richardson|905-525-9140|jrichard@mcmaster.ca|27811
22378174|NCT03525548|Vertex Pharmaceuticals Incorporated|Medical Monitor|617 341 6777|medicalinfo@vrtx.com|
22378175|NCT01226511|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22378176|NCT02696564|School of Medicine, Johns Hopkins University|Robert A. Wise, M.D.|410-550-0545|rwise@jhmi.edu|
22378177|NCT05267600|argenx BV|Regulatory Manager|+32 93103400|regulatory@argenx.com|
22378178|NCT04067401|University of Rochester Medical Center, Psychiatry Dept|Dr. Peter Wyman|5852733372|peter_wyman@urmc.rochester.edu|
22378179|NCT02579876|The Children's Hospital of Philadelphia|Jonathan Spergel|215 590 1000|spergel@email.chop.edu|
22378180|NCT03633929|Biomedical Development Corporation|Gregg Siegel|2108638053|gsiegel@biodevcorp.com|
22378181|NCT00141739|Blood and Marrow Transplant Program, University of Michigan|Dr. John E. Levine|734-936-8456|jelevine@med.umich.edu|
22378182|NCT03430063|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22378183|NCT03124199|Hospital Universitario de la Princesa|Mercedes Ramas|913093911|mercedesramas@gmail.com|
22378184|NCT02798211|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22378185|NCT01784068|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22378186|NCT06351371|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22378187|NCT04359784|Fred Hutchinson Cancer Center|Jordan Gauthier|206-667-2713|jgauthier@fredhutch.org|
22378188|NCT02063828|Wake Forest NCORP Research Base|Emily Dressler, PhD|336 716-0891|ncorp@wakehealth.edu|
22378189|NCT02753595|Eisai, Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22378190|NCT02453581|Qeensland Institute of Medical Research|Dr James McCarthy|+61 7 3845 3796|James.McCarthy@qimr.edu.au|
22378191|NCT02515279|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22378192|NCT01800968|Duke Clinical Research Institute|Adrian Hernandez, MD|919-668-7515|adrian.hernandez@duke.edu|
22378193|NCT02257099|UBMD Orthopaedics and Sports Medicine|John Marzo, MD|7168292982|jmmarzo@buffalo.edu|
22378194|NCT04987762|Purdue Pharma L.P.|Clinical Leader|1-800-745-7445|nelson.sessler@imbriumthera.com|
22378195|NCT02068495|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22438570|NCT04408040|Northside Hospital|H. Kent Holland, MD|404-255-1930|kholland@bmtga.com|
22438571|NCT01657292|Birken AG|Head of pharmaceutical development|+49 7233 97490|t.zahn@birken.eu|
22438572|NCT01900652|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22438573|NCT03761810|Sol-Gel Technologies, Ltd.|Sol-Gel|972-8-9313433|info@sol-gel.com|
22438574|NCT04178720|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22438575|NCT00869518|University of California, San Francisco|Brian S. Schwartz, MD|415-476-5767|brian.schwartz@ucsf.edu|
22438576|NCT03566082|Smith + Nephew|Fleur Derdeyn, Principal Clinical Study Manager|0032 497 60 20 32|fleur.derdeyn@smith-nephew.com|
22438577|NCT02663622|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22438578|NCT00857857|GlaxoSmithKline|GSK Response Center|866-435-7343||
22438579|NCT00930930|Vanderbilt-Ingram Cancer Center|Dr. Ingrid Mayer|615-936-2033|ingrid.mayer@vanderbilt.edu|
22438580|NCT03678311|Cleveland Clinic|Dr. Reena Mehra|216-444-2165|mehrar@ccf.org|
22378196|NCT00755040|Vanderbilt Ingram Cancer Center|Madan Jagasia, M.D.|(615) 936-8422|madan.jagasia@vanderbilt.edu|
22378197|NCT01666808|Emory University|Dr. Ashesh Jani|404-778-3827|abjani@emory.edu|
22378198|NCT02220894|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22378199|NCT03217747|M D Anderson Cancer Center|Aung Naing|713-563-1930|anaing@mdanderson.org|
22378200|NCT03248375|Icahn School of Medicine at Mount Sinai|Dr. Edward Kim|(212) 241-7409|Edward.Kim@mountsinai.org|
22378201|NCT00394355|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22378202|NCT00079001|Massachusetts General Hospital|Matthew Smith, MD, PhD||smith.matthew@mgh.harvard.edu|
22378203|NCT02618616|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22378204|NCT00459342|The University of Texas (UT) MD Anderson Cancer Center|Faye Johnson, MD / Associate Professor|713-792-7734|fmjohns@mdanderson.org|
22378205|NCT00558064|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22378206|NCT02027402|Seoul St Mary's hospital|Teaho Hong|821052065266|gshth@catholic.ac.kr|
22378207|NCT04251884|Ospedale Regionale di Lugano|Dr. Francesco Mongelli|+41764706297|francesco.mongelli@mail.com|
22378208|NCT04108000|Emory University|Professor Mi-Kyung Song, PhD, RN|404-727-3134|mi-kyung.song@emory.edu|
22378209|NCT03904043|Washington University School of Medicine|Dr. Michael Waters|314-747-7236|m.r.waters@wustl.edu|
22378210|NCT01387139|Ucolorado|Keith Weisz|303-724-2592|keith.weisz@childrenscolorado.org|
22378211|NCT04839354|Emory University|Claudia Morris, MD|404-785-7141|claudia.r.morris@emory.edu|
22378212|NCT05878197|Ghent University|drs. Anke Adriaansen|0471028622|anke.adriaansen@ugent.be|
22378213|NCT05002218|Columbia University Irving Medical Center|Scott Barbuto, MD|518-275-9588|sb3779@cumc.columbia.edu|
22378214|NCT03779906|Bracco Diagnostics Inc.|Maria Luigia Storto, MD, Executive Director Medical Planning and Management X-ray products|609-514-2262|MariaLuigia.Storto@diag.bracco.com|
22378215|NCT03421808|Medical University of South Carolina|Mark S. George, MD|18438765142|georgem@musc.edu|
22378216|NCT03764774|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22378217|NCT07069764|National Institute of Laser Enhanced Sciences (NILES), Cairo University|DR.hala shaaban attiyah|01012894478|std.halashaaban@niles.edu.eg|
22378218|NCT06027619|Cleveland Clinic, Dermatology and Plastic Surgery Institute, Case Comprehensive Cancer Center|Edward V Maytin|(216) 445-6676|maytine@ccf.org|
22378219|NCT00766675|Janssen Pharmaceutics Taiwan|Medical Affairs Director|+886-2-23762155||
22378220|NCT03183388|Yale School of Medicine|Dr. Hilary Blumberg|203-785-6180|hilary.blumberg@yale.edu|
22378221|NCT04716413|Montefiore Medical Center|Dr. Naum Shaparin|718-920-4316|nshapari@montefiore.org|
22378222|NCT01493960|Index Pharmaceuticals|Dr Thomas Knittel|0046 8 508 847 31|thomas.knittel@indexpharma.com|
22378223|NCT01679236|University of Wisconsin|James M. Davis MD, Assistant Professor, Duke University|608-217-9405|jjamesdavis@hotmail.com|
22378224|NCT03935217|Lupin Pharmaceuticals|Director of Clinical Operations|443-301-3146|jackieshaw@lupin.com|
22378225|NCT00071721|Alzheimer's Disease Cooperative Study|Paul Aisen|858-622-2028|paisen@ucsd.edu|
22378226|NCT02412501|Medtronic Coronary/Structural Heart|Beth Moe, Clinical Study Manager|763-526-1184|beth.moe@medtronic.com|
22378227|NCT01160484|Oncotherapeutics|Director, Clinical Operations|323-623-1200|lthulin@oncotherapeutics.com|
22378228|NCT00803101|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22378229|NCT02623816|MetroHealth Medical Center|Nisheet Waghray|2167785736|nwaghray@metrohealth.org|
22378230|NCT02026232|Washington University School of Medicine|Dr. Janet McGill|314-273-3929|jmcgill@wustl.edu|
22378231|NCT01529008|Bone Therapeutics|Chief Medical Officer|+32 493 09 73 66|Regulatory@bonetherapeutics.com|
22378232|NCT01382602|Cook MyoSite Incorporated|Ron Jankowski, PhD|412-963-7380|Ron.Jankowski@CookMyosite.com|
22378233|NCT01486615|B. P. Koirala Institute of Health Sciences|Dr Krishna Pokharel|0977-9841986321|drkrishnapokharel@gmail.com|
22378234|NCT01686165|University of Arizona Cancer Center|Daniel Persky, M.D.|520-626-8908|dpersky@uacc.arizona.edu|
22378235|NCT00939731|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22378236|NCT01392300|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
22378237|NCT02487498|Novartis Pharmaceuticals|Study Director|862-778-1873||
22378238|NCT00755222|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22378239|NCT03168295|University of Texas Health San Antonio|Carolina Solis-Herrera|(210) 567-6691|solisherrera@uthscsa.edu|
22378240|NCT01887470|Cumberland Pharmaceuticals, Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com|
22378241|NCT02228967|San Diego State University Research Foundation|Mark B. Reed/Professor and Interim Associate Dean|619-594-6664|mreed@sdsu.edu|
22378242|NCT01610154|Fuwai Hospital|Dr. Hui Wang|86-010-88396587|wh_endo@163.com|
22378243|NCT06369779|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
22378244|NCT01995539|Medtronic Minimed|Suiying Huang, Statistician|8184763319|suiying.huang@medtronic.com|
22378245|NCT02466646|Marmara University Faculty of Dentistry, Department of Periodontology|Prof. Dr. Basak Dogan|00905332621170|basak.sdogan@gmail.com|
22378246|NCT03261271|University of Kansas Medical Center|Dr. Jill Hamilton-Reeves|913-588-7650|jhamilton-reeves@kumc.edu|
22378247|NCT02173054|Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University|Papapit Tuchinda|+662-419-4333|papapitt@gmail.com|
22378248|NCT01932697|Mayo Clinic|Daniel J. Ma, M.D.|507/284-3261|Ma.Daniel@mayo.edu|
22378249|NCT02401464|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22378250|NCT01330316|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22378251|NCT00215540|Discovery Laboratories, Inc.|Dr. Robert Segal|215-488-9300|rsegal@discoverylabs.com|
22378252|NCT00817999|Creighton University|Tammy Burns, PharmD|402-280-4292|TammyBurns@creighton.edu|
22378253|NCT00246337|Merck Sharp & Dohme Corp|Vice President of Late Stage Development|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com|
22378254|NCT01222195|The University of Texas M. D. Anderson Cancer Center|Gautam Borthakur, MBBS / Assistant Professor|713-792-7305|eharriso@mdanderson.org|
22378255|NCT00674570|San Francisco VA Health Care System|Sabra Inslicht, Ph.D.|415-221-4810|sabra.inslicht@ucsf.edu|23341
22378256|NCT01337986|Washington Univerisity St. Louis|Robert Naismith, MD|314-747-5576|naismithr@wustl.edu|
22378257|NCT02313909|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22378258|NCT02167217|Washington University School of Medicine|Anne M. Connolly, MD FAAN|314-362-6981|connollya@wustl.edu|
22378259|NCT01782872|Hospital for Special Surgery|Dr. Jacques YaDeau|212774224|yadeauj@hss.edu|
22378260|NCT02309112|University of Oxford|Marcy McCall, Lead Researcher|+441865 289300|marcy.mccall@kellogg.ox.ac.uk|
22378261|NCT02080195|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Javier Bolaños Meade, MD|410-614-6398|fbolano2@jhmi.edu|
22378262|NCT03505476|University of Iowa|Dr. Jennifer Hrabe Clinical Associate Professor|319-384-7359|jennifer-hrabe@uiowa.edu|
22378263|NCT04026165|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22378264|NCT03607825|Minnetronix Neuro|Director of Clinical Trials|651-917-4060|info@cerevention.com|
22378265|NCT01287611|DrLutfi|Dr. Cem Turan|00905323513423|cemturan@gmail.com|
22378266|NCT02255357|new york psychiatric institute|wilfrid raby, m.d.|2129233031|wilfrid.raby@nyspi.columbia.edu|
22378267|NCT01856712|University of Wisconsin|Randall Brown|6082636558|rtbrown@wisc.edu|
22378268|NCT03357614|Iterum Therapeutics|Senior Director, Clinical Development|18606614035|saronin@iterumtx.com|
22378269|NCT02192970|University of Wisconsin - Madison|Michael M Altaweel, MD|(608) 263-7290|mmaltaweel@wisc.edu|
22378270|NCT01321541|Institut de Recherches Internationales Servier|Anton Egorov, Associate Project Director Clinical Development|+33 1 55 72 31 94|anton.egorov@servier.com|
22378271|NCT04074590|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22378272|NCT01355458|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
22378273|NCT00509236|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22378274|NCT06097676|Azurity Pharmaceuticals, Inc.|David Sequeira|(913) 389-7961|david.sequeira@azurity.com|
22378275|NCT00828308|BrUOG|Anthony Mega, MD|4018633000|BrUOG@brown.edu|
22378276|NCT02709005|University of Iowa Hospitals and Clinics|Patricia Winokur, MD|319-384-4590|patricia-winokur@uiowa.edu|
22378277|NCT01572389|Department of Veteran Affairs|Aanand, Naik, MD|713-794-8541|anaik@bcm.edu|
22378278|NCT02634788|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com|
22378279|NCT00758459|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22378280|NCT01112228|Imperial College|Carel le Roux|07970719453|c.leroux@imperial.ac.uk|
22378281|NCT02489110|Photozig, Inc.|Bruno Kajiyama|6506947595|info@photozig.com|
22378282|NCT01780935|Novartis Pharmaceuticals|Study Director|862-778-8300||
22378283|NCT01281202|National Institute on Drug Abuse|David McCann, Ph.D.|301-443-2999|dmccann@nida.nih.gov|
22378284|NCT01215357|Psyadon Pharmaceuticals|Dr. Richard Chipkin|301-919-2020|rchipkin@psyadonrx.com|
22378285|NCT05479604|Mayo Clinic|Amar Miglani, M.D.|4803422929|miglani.amar@mayo.edu|
22378286|NCT01591382|Brigham and Women's Hospital|Dr. Srdjan S. Nedeljkovic||snedeljkovic@partners.org|
22378287|NCT02620917|University of Padova|Daniela Bruttomesso|0039 049/8212183|daniela.bruttomesso@unipd.it|
22378288|NCT02044991|Loyola University|Colleen Fitzgerald, M.D., M.S.|708-216-2180|cfitzgerald@lumc.edu|
22378289|NCT00701038|The Ohio State Universtiy|Rami Khayat|614-247-7707|rami.khayat@osumc.edu|
22378290|NCT01398280|UCSD Dermatology Clinical Trials|UCSD Dermatology Clinical Trials Manager|(858)657-8390|dermstudies@ucsd.edu|
22378291|NCT02362048|Acerta Pharma, LLC|Priti Patel, MD, Executive Director - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
22378292|NCT05099926|Columbia University Irving Medical Center|Dr. Andrea T. Duran|212-342-4491|atd2127@cumc.columbia.edu|
22378293|NCT00227617|UCSF Helen Diller Family Comprehensive Cancer Center|Dr. Emily Bergsland|415-885-7810|Emily.Bergsland@ucsf.edu|
22378294|NCT03479697|Atrium Wake Forest Baptist Health School of Medicine|Charles Tegeler, MD|336-716-9447|BBRP@wakehealth.edu|
22378295|NCT03520322|University of Rochester Medical Center|Otolaryngology Research Program Manager|5852751186|paul_allen@urmc.rochester.edu|
22378296|NCT01257880|Swedish Medical Center|Jill T. Jesurum, Ph.D.|206-683-1505|jill.jesurum@swedish.org|
22378297|NCT01059630|Genentech|Medical Communications|800-821-8590|genentech@druginfo.com|
22378298|NCT02569437|Icahn School of Medicine at Mount Sinai|Dr. Benjamin Malkin||Benjamin.D.Malkin@kp.org|
22378299|NCT00441701|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22378300|NCT05028426|Groupe Hospitalier de la Rochelle Ré Aunis|Dr. Vivien Fontaine|+33546455050|recherche.clinique@ght-atlantique17.fr|
22378301|NCT00985985|GlaxoSmithKline|GSK Response Center|866-435-7343||
22378302|NCT03155932|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
22378303|NCT02206217|School of Optometry, The Hong Kong Polytechnic University|Prof. Carly Sin Yin Lam|2766 6091|carly.lam@polyu.edu.hk|
22378304|NCT03532308|Yale University School of Medicine|Michael S. Leapman, MD|(203) 785-2815|michael.leapman@yale.edu|
22378305|NCT03720938|Abant Izzet Baysal University|Dr. Halil Ibrahim Atasoy|90 532 599 89 53|halilibrahimatasoy@gmail.com|
22378306|NCT02535364|Juno Therapeutics|Dr. Nikolaus Trede|206-566-5886|Nick.Trede@junotherapeutics.com|
22378307|NCT00499863|Noven Pharmaceuticals, Inc.|Amaury Sanchez, Sr. Manager, Regulatory Affairs||asanchez@noven.com|
22378308|NCT00571701|Northwell Health (previously known as NorthShore-LIJ Health System)|Dr. Bettie Steinberg|516-562-1159|bsteinbe@northwell.edu|
22378309|NCT00691132|University of Minnesota|Dr. Dorothy Hatsukami|612-626-2121|hatsu001@umn.edu|
22378310|NCT03467932|Oramed Pharmaceuticals|Miriam Kidron, Ph.D.|+972-2-566-0100|miriam@oramed.com|
22378311|NCT01959347|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
22396128|NCT00874770|Bristol-Myers Squibb International Corporation|BristolMyers Squibb Study Director||clinical.trials@bms.com|
22378312|NCT01282801|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22378313|NCT02252432|Cedars Sinai Medical Center|Ofelia Loani Elvir Lazo, MD|310-423-1682|Loani.Elvir-Lazo@cshs.org|
22378314|NCT02889133|Columbia University Medical Center|Dr. Eldad Hod|212-305-4109|eh2217@cumc.columbia.edu|
22378315|NCT01673893|Cardiovascular Institute of the South Clinical Research Corporation|Deanna K. Benoit, LPN, CCRC|985-876-0300|deanna.benoit@cardio.com|5613
22378316|NCT01781390|Mesoblast, Inc.|Kenneth Borow, MD (Lead, Global Cardiovascular Development)|(212) 880-2060|Ken.Borow@Mesoblast.com|7951
22378317|NCT01862796|National Institute of Diabetes Digestive and Kidney Diseases/NIH|Dr. Marci E. Gluck|602-200-5317|gmarci@mail.nih.gov|
22378318|NCT03485911|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
22378319|NCT04037436|University of Waterloo|The MoveStrong program for promoting balance and functional strength training and adequate protein i|519-888-4567|lmgiangr@uwaterloo.ca|46357
22378320|NCT01375205|Oregon Health & Science University|Eric Simpson, MD, MCR|503-494-3968|simpsone@ohsu.edu|
22378321|NCT01859793|Medical College of Wisconsin|Michael E. Widlansky|414-955-6806|mwidlans@mcw.edu|
22378322|NCT01856530|Boston University|Dr. Stefan G. Hofmann|617-353-9233|shofmann@bu.edu|
22378323|NCT04708223|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
22378324|NCT04954586|McMaster University|Dr. Lisa Carlesso|9055259140|carlesl@mcmaster.ca|23811
22378325|NCT01849263|Washington University School of Medicine|Nancy L. Bartlett, M.D.||nbartlet@dom.wustl.edu|
22378326|NCT04130802|Oculis SA|Chief Development Officer|0041 21 711 39 70|info@oculis.com|
22378327|NCT03899753|Montefiore Medical Center|Konrad Gruson, MD|3475774412|kgruson@montefiore.org|
22378328|NCT03185481|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22438581|NCT01633788|Allergan plc|Ronald Bradford|1-714-846-5486|Bradford_Ron@allergan.com|
22378329|NCT02303184|Clearside Biomedical, Inc.|Thomas Ciulla, MD|(678) 392-2318|thomas.ciulla@clearsidebio.com|
22378330|NCT03371940|Indiana University School of Medicine|Dr. Mary de Groot|317-278-1965|mdegroot@iu.edu|
22378331|NCT01064297|GlaxoSmithKline|GSK Response Center|866-435-7343||
22378332|NCT02003508|Melbourne Sexual Health Centre|A/Prof Marcus Chen|+613 93416260|mchen@mshc.org.au|
22378333|NCT00462280|University of California, Irvine|Dr. Kenneth G. Linden|714-456-3719|kglinden@uci.edu|
22378334|NCT03210155|Texas A&M University Corpus Christi|Dr. Christina Murphey|316.825.3747|christina.murphey@tamucc.edu|
22378335|NCT00947661|Sun Pharma Advanced Research Company|Dr Shravanti Bhowmik||shravanti.bhowmik@sparcmail.com|
22378336|NCT00586170|Biomet|Manager of Research|973-299-9300|hallie.murray@zimmerbiomet.com|3415
22378337|NCT04278625|Nationwide Children's Hospital|Dr. Peter Winch|614-722-5936|peter.winch@nationwidechildrens.org|
22378338|NCT03538015|University of Utah|Dr. Owen Chan|801-581-7755|ochan@u2m2.utah.edu|
22378339|NCT00511875|University of Michigan|Dr. Thomas W. Gardner|734 232-8404|tomwgard@med.umich.edu|
22378340|NCT01349920|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22378341|NCT02686034|electroCore INC|Clinical Affairs|+1 973 355 6683|clinical@electrocore.com|
22378342|NCT00542880|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
22378343|NCT01678131|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22378344|NCT04552743|Stanford Medicine at Stanford University|Khanh Nguyen|650-721-2372|khanhpn@stanford.edu|
22378345|NCT03152084|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22378346|NCT00982930|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22378347|NCT00941798|Novartis Pharmaceuticals|Study Director|862-778-8300||
22378348|NCT05597722|University of Pittsburgh|Dr. Eva Szigethy|412-667-0416|szigethye@upmc.edu|
22378349|NCT00404495|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22378350|NCT05361655|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22378351|NCT04411849|Ohio State University|Dr. Paul Reiter|614-292-4803|reiter.36@osu.edu|
22378352|NCT03750006|VA Kansas City Healthcare System|Bruce Troen|913-574-4896|bruce.troen@va.gov|
22378353|NCT03538951|Vidac Pharma|Max Herzberg|0544257381|maxherzberg@gmail.com|
22378354|NCT01816763|VA Palo Alto|Karl Lorenz MD MSHS, Principal Investigator|6504935000|kalorenz@stanford.edu|
22378355|NCT02128646|University of Kansas Medical Center|Michael Moncure, MD|913-588-1240|mmoncure@kumc.edu|
22378356|NCT02243202|Janssen Research & Development, LLC|Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
22378357|NCT01147822|Novartis Pharmaceuticals|Study Director|1-862-778-8300|Novartis.email@Novartis.com|
22378358|NCT01916655|VA San Diego Healthcare System|Carl J. Stepnowsky, PhD|858-642-1240|Carl.Stepnowsky@va.gov|
22378359|NCT03010462|Nexstim Plc|Vice President, Medical Affairs|+358927271710|jarmo.laine@nexstim.com|
22378360|NCT01966003|Amgen Inc.|Study Director|866-572-6436||
22378361|NCT00571961|Yale University AIDS Program|R. Douglas Bruce, MD, MA, MSc|(203) 737-6133|robert.bruce@yale.edu|
22378362|NCT01817374|UAB Radiology Research|Marianne Vetrano|205-934-4080|mvetrano@uabmc.edu|
22378363|NCT03154281|Avera Cancer Institute|Dr. Casey Williams|6053223588|Casey.Williams@avera.org|
22378364|NCT00871403|GlaxoSmithKline|GSK Response Center|866-435-7343||
22378365|NCT02748694|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22378366|NCT01005303|Belfast Health and Social Care Trust|Dr Nick McKeag|02895048487|nick.mckeag@belfasttrust.hscni.net|
22378367|NCT00077064|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
22378368|NCT02007434|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
22378369|NCT00763958|University of Alabama at Birmingham|Dr. Karen Cropsey|205-917-3786|kcropsey@uab.edu|205
22378370|NCT00927355|Emory|Dr. George Beck|404-686-1000|gbeck@emory.edu|
22378371|NCT03299686|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22378372|NCT02348684|Medical College of Wisconsin|Dr. Carmen Bergom|414-805-4365|cbergom@mcw.edu|
22378373|NCT01060553|Veteran Affairs New Jersey Health Care System|Thomas W. Findley, MD, PhD|973-676-1000|thomas.findley@va.gov|2713
22378374|NCT01446796|Duke University Medical Center|Michel Khouri, MD|919 684 8111|michel.khouri@duke.edu|
22438582|NCT02986711|Penn State University College of Medicine|Jessica Yingst|7175310003|jmy5048@psu.edu|289511
22438583|NCT02302365|Terumo BCT|Isobelle Galeon, MD, MPH, MSCS, Medical Monitor Clinical Safety|+1 303 542-5166|Isobelle.Galeon@Terumobct.com|
22438584|NCT01467505|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22438585|NCT00227721|Barbara Ann Karmanos Cancer Institute|Robert Morris, M.D.|313-576-9436|rmorris@med.wayne.edu|
22438586|NCT01875159|Uniformed Services University|Carl E. Hunt, M.D.|240-694-2676|carl.hunt@usuhs.edu|
22438587|NCT01848158|Seattle Children's Hospital|Jane Di Gennaro, MD MS|206-987-6988|jane.digennaro@seattlechildrens.org|
22438588|NCT01389882|Seoul National University Hospital|Dr. Juyoung Lee|lamb4122@snu.ac.kr|lamb4122@snu.ac.kr|
22438589|NCT03790111|TerSera Therapeutics Inc.|Janine North, Executive Director-Clinical Development|888 600 8116|jnorth@tersera.com|
22438590|NCT00942903|The Netherlands Cancer Institute|Prof. Dr. F.J.M. Hilgers|+31-20-5122550|f.hilgers@nki.nl|
22438591|NCT03811340|TriHealth Inc.|Rachel Pauls, MD|513-463-4300|Rachel_Pauls@trihealth.com|
22438592|NCT01045967|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22438593|NCT00383786|Baylor College of Medicine|Sanjay Mathew, MD/PI|7137985439|sjmathew@bcm.edu|
22438594|NCT05736874|Duke University|Susanna Naggie, MD, MHS, FIDSA|919-684-2584|susanna.naggie@duke.edu|
22438595|NCT00291135|University of Kansas Medical Center Research Institute|Carol J. Fabian, M.D.|913-588-7791|cfabian@kumc.edu|
22438596|NCT02219464|Vanderbilt University Medical Center|Cindy Pastern, RN BSN CCRP|615-343-0259|cindy.pastern@vanderbilt.edu|
22438597|NCT00984256|US Army Medical Materiel Development Activity (USAMMDA)|Michelle Mathers|301-619-8061|Michelle.mathers@us.army.mil|
22438598|NCT02040623|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
22438599|NCT02981368|Lantheus Medical Imaging / Progenics Pharmaceuticals|David Myl|914-582-1120|david.myl@lantheus.com|
22438600|NCT02544321|University of Colorado Denver|Irene Schauer, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
22438601|NCT03529110|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22438602|NCT03493945|National Cancer Institute|Dr. James L. Gulley|301-480-7164|gulleyj@mail.nih.gov|
22438603|NCT05104450|Veterans Health Administration|Dr. Lucas Donovan|206-277-6783|Lucas.Donovan@va.gov|
22438604|NCT01584232|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22438605|NCT01307319|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22438606|NCT03689582|University of Michigan Rogel Cancer Center|Morand Piert, MD|734-936-5388|mpiert@med.umich.edu|
22438607|NCT02735239|Ludwig Institute for Cancer Research|Jonathan Skipper|212-450-1539|jskipper@lcr.org|
22438608|NCT01026012|University of Maryland Cardiology|Dr. Scott Jerome|410-876-0086|sjerome@medicine.umaryland.edu|
22438609|NCT00769886|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
22438610|NCT02152631|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22438611|NCT05904470|Atea Pharmaceuticals, Inc.|Atea Clinical Trials|1-857-284-8891|ateaclinicaltrials@ateapharma.com|
22438612|NCT03776747|University of Iowa|Dr. Eric Hoffman|(319) 356-1381|eric-hoffman@uiowa.edu|
22438613|NCT04662359|University of Pennsylvania|Dr. Michael George|215-662-2454|michael.george@pennmedicine.upenn.edu|
22438614|NCT00404651|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22438615|NCT02785185|Bausch Health|Study Director||anya.loncaric@bauschhealth.com|
22438616|NCT00666666|Rutgers Cancer Institute of New Jersey|Robert DiPaola, MD|732-235-8675|zelinsta@cinj.rutgers.edu, dipaolrs@cinj.rutgers.edu, rizzoji@cinj.rutgers.edu|
22438617|NCT02960516|Vanderbilt university medical center|Dr. Wesley Thayer|+1 (615)936-3759|wesley.thayer@vumc.org|
22438618|NCT01072188|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
22438619|NCT00896298|UT Southwestern Medical Center|Dr. Abhimanyu Garg|214-648-2895|abhimanyu.garg@utsouthwestern.edu|
22438620|NCT03315039|Moleculin Biotech Inc|Chief Scientific Officer|862-273-1432|DPicker@moleculin.com|
22438621|NCT01327677|Johns Hopkins University School of Medicine|Athir Morad, M.D.|4109552611|morada@jhmi.edu|
22438622|NCT01220739|University of California, San Diego|Dr. Thomas Hemmen|858-657-7190|themmen@ucsd.edu|
22438623|NCT00123123|University at Buffalo|Frank A. Scannapieco|716-829-3373|fas1@buffalo.edu|
22438624|NCT02794766|Universidade de Passo Fundo|Prof. Fernando Fornari|+555433168395|fernandofornari@gmail.com|
22438625|NCT02073682|Daiichi Sankyo, Inc.|Daiichi Sankyo US Contact for Clinical Trial Results|1-908-992-6400|CTRinfo@DSI.com|
22438626|NCT03801174|University of Wisconsin - Madison|Corrine Voils, PhD|608-262-9636|voils@surgery.wisc.edu|
22438627|NCT01740414|New York State Psychiatric Institute|Dr. Sandra Comer|646-774-6146|comersd@nyspi.columbia.edu|
22438628|NCT03081156|Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center|William Stringer, MD|424-571-7626|stringer@ucla.edu|
22438629|NCT04112810|Medical College of Wisconsin|William R Drobyski, MD, FACP, FASTCT|414-456-4941|wdrobysk@mcw.edu|
22438630|NCT02293798|Mark Mofid, M.D.|Dr. Mark Mofid|8589099000|drmofid@drmofid.com|
22438631|NCT01687296|GlaxoSmithKline|GSK Response Center|866-435-7343||
22438632|NCT01539759|University of North Carolina|Erika Levi, MD and Gretchen Stuart, MD|(919) 843-5633|Erika.Levi@gmail.com|
22438633|NCT03967054|Colorado State University|Brian D. Foy, PhD.|970-491-3470|Brian.Foy@colostate.edu|
22438634|NCT03890588|HealthPartners Institute|JoAnn Sperl-Hillen, MD, Senior Clinical Investigator|952-967-5009|joann.m.sperlhillen@healthpartners.com|
22438635|NCT02052752|GlaxoSmithKline|GSK Response Center|866-435-7343||
22438636|NCT03201419|Ferring Pharmaceuticals|Global Clinical Compliance|-|DK0-Disclosure@ferring.com|
22438637|NCT03635424|Medtronic Coronary and Structural Heart Clinical|Hatice Bilgic Lim, PhD; Principal Clinical Research Specialist|763-526-1018|hatice.bilgic.lim@medtronic.com|
22378375|NCT01991821|Acacia Pharma|Dr Gabriel Fox|01223875130|GabrielFox@acaciapharma.com|149
22378376|NCT00632281|University of Florida|Bridget Fitzgerald, Clinical Research Coordinator|352-265-0680|fitzgb@shands.ufl.edu|87829
22378377|NCT00954733|Northwestern University|Gildaasio De Oliveira, M.D.|312-472-3573|gjr@northwestern.edu|
22378378|NCT03131960|MicroTransponder Inc.|Study Director|8556289375|studies@microtransponder.com|
22378379|NCT04707196|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22378380|NCT01625923|University of Michigan|Allen Lee|734-936-9454|allenlee@umich.edu|
22378381|NCT02918500|University of Ottawa Heart Institute|Dr. Andrew Pipe|613-696-7000|apipe@ottawaheart.ca|
22378382|NCT01462162|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22378383|NCT03333928|HighTide Therapeutics|Dr. Adrian Di Bisceglie, CMO|314-791-0593|adibisceglie@hightidetx.com|
22378384|NCT02583763|Region Östergötland / University of Linköping|Olov Änghagen PhD student|+461047246|olov.anghagen@regionostergotland.se|
22378385|NCT00728962|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
22378386|NCT00438880|Mayo Clinic Cancer Center|Thomas E. Witzig, M.D.||witzig.thomas@mayo.edu|
22378387|NCT00584402|University of Califonia, Davis|John McGahan, M.D.|(916)734-0519|john.mcgahan@ucdmc.ucdavis.edu|
22378388|NCT01987817|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
22378389|NCT05390970|University of Iowa Healthcare|Dr. Annah J. Vollstedt|712-253-1627|annah-vollstedt@uiowa.edu|
22378390|NCT01802086|SormlandCC|Beatrice Olsson Duse|0704948359|bod257@hotmail.com|
22378391|NCT05918978|argenx BVBA|Regulatory Manager|+32 93103400|regulatory@argenx.com|
22378392|NCT00622180|UT Southwestern Medical Center at Dallas|Amit Pandya, M.D.|214-645-8300|amit.pandya@utsouthwestern.edu|
22378393|NCT02280239|Providence Health Care|Vininder Kour Bains|604-682-2344|VBains@providencehealth.bc.ca|62207
22378394|NCT00698646|Novartis Pharmaceuticals|Study Director|862-778-8300||
22378395|NCT00995072|ECIR|Benjamin Epstein, PharmD|904-854-1354|benjamin.epstein@eastcoastresearch.net|
22378396|NCT00279201|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22378397|NCT00916032|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22378398|NCT01345721|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22378399|NCT01995487|Medinol|Dina Kofler, VP Clinical Affairs|+97237679032|dinak@medinol.com|
22378400|NCT02080780|Ventrus Biosciences|Ventrus|646-706-5208|VEN307@ventrusbio.com|
22378401|NCT02498834|University of North Carolina at Chapel Hill|Betsy Sleath, PhD|(919) 962-0079|betsy_sleath@unc.edu|
22378402|NCT04204200|Centre Hospitalier de Ham|Dr. Jean-Francois Cazeneuve, Surgeon|06 62 29 24 51|jfc.laon@gmail.com|0033
22378403|NCT03513757|Medical College of Wisconsin|Susan Taylor MD|414-266-3560|sutaylor@mcw.edu|
22378404|NCT04179721|Northwell Health|Dr. Liron Sinvani, Principal Investigator|646-766-7169|ldanay@northwell.edu|
22378405|NCT01489189|Jaeb Center for Health Research|Adam Glassman|813-975-8690|drcrnet@jaeb.org|
22378406|NCT00112580|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22378407|NCT05559866|Mayo Clinic|Dr. Omar Ghanem|507-284-2095|ghanem.omar@mayo.edu|
22378408|NCT06615544|Ivoclar Vivadent AG|Head of Department Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
22378409|NCT06412146|Children's Mercy Research Institute|Sophie MacColl|8166011485|risingT1DE@cmh.edu|
22378410|NCT03444376|Clinical Development|• Project Lead|+82-2-6098-2756|yoonjeong.choi@genexine.com|
22378411|NCT02584725|Columbia University Irving Medical Center|Robert Maniker, MD|212-305-9876|rm3046@cumc.columbia.edu|
22378412|NCT03881696|DAIT/NIAID|Director, Clinical Research Operations Program|202-604-9855|DAITClinicalTrialsGov@niaid.nih.gov|
22378413|NCT05690776|Zimmer Biomet|Julie Nicoux|+33672613502|julie.nicoux@zimmerbiomet.com|
22378414|NCT04081220|UT HEALTH MAYS CANCER CENTER|Dr Zohra Nooruddin|2013362409|nooruddinz@uthscsa.edu|
22378415|NCT00856167|University of Arizona|Dr. Cheryl Ritenbaugh, Principal Investigator|520-822-6710|ritenbau@email.arizona.edu|
22378416|NCT03284112|Columbia University|Dr. James M. Noble|212-342-4126|jn2054@columbia.edu|
22378417|NCT01061333|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22378418|NCT02764775|Fort Worth Independent School district|Dr. Julie Brown|214-725-8232|jbrown18@twu.edu|
22378419|NCT00975221|Amgen Inc.|Study Director|866-572-6436||
22378420|NCT04022889|Cerus Corporation|Carol Moore|9258766819|cmoore@cerus.com|
22378421|NCT02783820|Medicines for Malaria Venture|Dr Cristina Donini|+41 22 555 0312|doninic@mmv.org|
22378422|NCT01186328|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
22378423|NCT02202434|Boston Scientific|Amy Maurer|508-683-6647|amy.maurer@bsci.com|
22378424|NCT03237858|Boston Scientific|Joe Hobbs, Clinical Trial Manager|612-206-4703|JOE.HOBBS@BSCI.COM|
22378425|NCT02337517|HCI Research Compliance Office|Data Manager|8015850601|compliance@hci.utah.edu|
22378426|NCT00582946|EarLens Corporation|Sunil Puria|650-366-9000|spuria@earlenscorp.com|
22378427|NCT00864708|NF/SG VA Medical Center, Gainesville Florida|Janis Daly, Ph.D., M.S.; Director, Brain Rehabilitation Research Center of Excellence|(352) 376-1611|janis.daly@neurology.ufl.edu|5223
22378428|NCT02207725|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
22378429|NCT01391325|Ardea Biosciences, Inc.|Vice President, Clinical Research and Development|858.652.6587|sbaumgartner@ardeabio.com|
22378430|NCT03395808|Avenue Therapeutics|Micheal Ryan, VP Clinical|781-652-4514|mryan@avenuetx.com|
22378431|NCT01105702|Perlmutter Cancer Center at NYU Langone|Michael Gruber, MD|212-731-5577|michael.gruber@nyumc.org|
22378432|NCT00185640|Stanford University|Robert Lowsky|650-723-0822|rlowsky@stanford.edu|
22378433|NCT00058422|Memorial Sloan Kettering Cancer Center|Paul A. Hamlin, M.D.|646-608-1667|hamlinp@mskcc.org|
22378434|NCT03170375|VA Ann Arbor Health System|Scott Hummel|734-845-5283|scott.hummel@va.gov|
22378435|NCT01691521|GlaxoSmithKline|GSK Response Center|866-435-7343||
22378436|NCT02343003|Halyard Health|David Curd|470-448-5178|david.curd@hyh.com|
22378437|NCT01923805|Cleveland Clinic|Alison Klika; Research Program Manager, Adult Reconstruction|216-444-4954|klikaa@ccf.org|
22378438|NCT00560612|Durham VA Medical Center|Christine Marx, MD|919 286-0411|marx0001@mc.duke.edu|7426
22378439|NCT00622713|Novartis Pharmaceuticals|Study Director|862-778-8300||
22378440|NCT04404478|Ohio State University|Dr. Holly Jones|760-415-6147|jones.7935@osu.edu|
22378441|NCT00861601|GlaxoSmithKline|GSK Response Center|866-435-7343||
22378442|NCT02299258|The First People's Hospital of Yuhang District|Dr.Ding Shi|+8657189369162|shidingyuhang@163.com|
22378443|NCT00699140|Instituto Grifols, S.A|Marta Carretero, PhD, Clinical Project Leader|+ 34 93 571 22 00|marta.carretero@grifols.com|
22378444|NCT04750655|University of California, San Francisco|Ying Han|(415) 353-2020|ying.han@ucsf.edu|
22378445|NCT00879996|SUNY Buffalo|Dr. Richard Blondell|716-898-4971|blondell@buffalo.edu|
22378446|NCT02786264|Yale School of Medicine|Dr. Robert Schonberger|2037852802|robert.schonberger@yale.edu|
22378447|NCT05414318|W.L. Gore & Associates|Charee Robe|928-864-4048|crobe@wlgore.com|
22378448|NCT01148862|Medtronic|Thomas P Troub|818-576-3142|thomas.troub@medtronic.com|
22378449|NCT03056534|Smith+Nephew, Inc|Senior Manager Clinical Compliance|+44 7811 407089|datasharing.gcs@smith-nephew.com|
22378450|NCT04543188|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22378451|NCT03815019|University of Kansas Medical Center|Ann Davis, PhD, MPH, ABPP, Director, Center for Children's Healthy Lifestyles & Nutrition|(913) 588-1227|adavis6@kumc.edu|
22378452|NCT05398796|Vaccine Research Center Clinical Trials Program, NIAID|Lesia K. Dropulic, M.D./Principal Investigator; Laura Novik, R.N., M.A./Study Coordinator|301-451-8717|lesia.dropulic@nih.gov; laura.novik@nih.gov|
22378453|NCT06199934|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22378454|NCT04270747|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22378455|NCT05004688|Mass General|Kayla McEachern|617 643 5265|kmceachern2@mgh.harvard.edu|
22378456|NCT05960097|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22396129|NCT00718549|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22396130|NCT01303965|IndianaU|Dr. Sherif Farag|(317) 278-0460|ssfarag@iu.edu|
22396131|NCT03633526|Vertex Pharmaceuticals Incorporated|Medical Monitor|+1 617 341 6777|medicalinfo@vrtx.com|
22396132|NCT04534491|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
22396133|NCT03331861|Columbia University Irving Medical Center|Barry Fine, MD|212-305-5755|bmf2002@cumc.columbia.edu|
22396134|NCT02871778|Parion Sciences|Karl Donn|919 313 1185|kdonn@parion.com|
22396135|NCT02945150|Massachusetts General Hospital|Dr. Raymond Chung|617-724-7562|Chung.Raymond@mgh.harvard.edu|
22396136|NCT02653300|Oramed Pharmaceuticals|Miriam Kidron, Ph.D.|+972-2-566-0100|miriam@oramed.com|
22396137|NCT00369785|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
22396138|NCT00800683|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22396139|NCT02247960|University of Rochester|Jean Joseph|585-341-7795|jean_joseph@urmc.rochester.edu|
22396140|NCT01848353|University of Oklahoma Health Sciences Center|Kevin Short, PhD, Associate Professor|(405) 271-8001|kevin-short@ouhsc.edu|43094
22396141|NCT01170546|Department of Physical Medicine and Rehabilitation, Chang Gung Memorial Hospital|Shih-Wei Chou, MD, PhD|88633281200|h0711@ms13.hinet.net|3846
22396142|NCT03606980|Children's Hospital of the King's Daughters|Dana Reesman, PT, DPT|757-668-4894|dana.reesman@chkd.org|
22396143|NCT01196533|Morristowm Memorial Hospital|Dr. Frank Smart|973-214-2601|frank.smart@atlantichealth.org|
22396144|NCT04458103|Massachusetts General Hospital|David D'Alessandro|617-726-8841|DADALESSANDRO@mgh.harvard.edu|
22396145|NCT01983839|Aarhus University Hospital, Department of infectious diseases|Dr Kristina Öbrink-Hansen|+4578452845|krisoebr@rm.dk|
22396146|NCT00911625|Rush University Medical Center|David Baldwin, MD|312-942-2813|david_baldwin@rush.edu|
22396147|NCT01560923|Masonic Cancer Center, University of Minnesota|Dr.Gautam Jha|612-624-5373|jhaxx014@umn.edu|
22396148|NCT03785678|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22396149|NCT01159912|GlaxoSmithKline|GSK Response Center|866-435-7343||
22396150|NCT01932242|Elusys Therapeutics, Inc.|Senior Director of Regulatory|973-808-0222|cdillon@elusys.com|
22396151|NCT02142738|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22396152|NCT03713034|Yale University|Tyra Pendergrass Boomer|(203) 737-6101|tyra.pendergrass@yale.edu|
22396153|NCT02615470|Auburn University|Salisa Westrick|3348448314|westrsc@auburn.edu|
22396154|NCT03042780|H Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, MD|813-745-7257|Jonathan.Strosberg@moffitt.org|
22396155|NCT02000596|University of Maryland Greenebaum Comprehensive Cancer Center|Kate Tkaczuk|410-328-7394|ktkaczuk@umm.edu|
22396156|NCT00880555|Department of Veterans Affairs|Dr. David Glenn Clark|843-792-7446|clarkda@musc.edu|
22378457|NCT02134925|University of Pittsburgh|Robert E. Schoen, M.D., M.P.H|412-864-7078|rschoen@pitt.edu|
22378458|NCT02158884|Major Extremity Trauma and Rehabilitation Consortium|Susan Collins (Study Manager)|410 502 8966|scolli21@jhu.edu|
22378459|NCT05158296|Sepul Bio|Zuhal Butuner - Chief Medical Officer|(905) 599-7887|contact@sepulbio.com|
22378460|NCT02402296|Al-Azhar University- Faculty of dental medicine (Girls branch)|Professor Hala Helmi Hazzaa|00201014129297|hala.hazzaa@yahoo.com|
22378461|NCT01521884|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22378462|NCT04098250|Mayo Clinic|Todd Schwedt, M.D.|480-301-9721|Schwedt.Todd@mayo.edu|
22378463|NCT01089231|Leibniz Universität Hannover|M. Sc. Simone Schmidt|+49 (511) 762 5931|Schmidt@nutrition.uni-hannover.de|
22378464|NCT00633464|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22378465|NCT04241094|Center for Care Delivery & Outcomes Research|Laura Meis, PhD|651-467-4516|laura.meis@va.gov|
22378466|NCT05096156|The Ohio State University College of Optometry|Dr. Jennifer Fogt, OD MS, Principal Investigator|16142928858|OPT-EyeStudies@osu.edu|
22396157|NCT02982590|HOSPITAL UNIVERSITI SAINS MALAYSIA|DR W YUS HANIFF W ISA|09-767 3000|wyhaniff@usm.my|
22396158|NCT04196803|Vanderbilt University Medical Center|Dr. Qi Dai|615)936-0707|qi.dai@vanderbilt.edu|
22396159|NCT01168973|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22396160|NCT00419120|Tengion, Inc.|Sunita Sheth, MD - Chief Medical Officer|267-960-4805|sunita.sheth@tengion.com|
22396161|NCT01756040|University of Maryland Baltimore|Rose Marie Viscardi, M.D.|410-328-6003|rviscard@som.umaryland.edu|
22396162|NCT01848288|Alcon Research, Ltd.|Doug Fanney, Director, Global Medical Affairs, Cataract Instrumentation|1-888-451-3937|alcon.medinfo@alcon.com|
22396163|NCT01007032|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22396164|NCT01871220|University of Iowa College of Dentistry|Dr. Christopher Barwacz|3193843002|chris-barwacz@uiowa.edu|
22396165|NCT01825057|Yale School of Medicine|Steve Martino|203-932-5711|steve.martino@yale.edu|7418
22396166|NCT01688596|Penn State Milton S. Hershey Medical Center|Dr. Matthew F. Davies, M.D.|7175310003|mdavies@hmc.psu.edu|283519
22396167|NCT02716675|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22396168|NCT02015442|Imperial College London|Prof Gary Frost|020 7594 0959|g.frost@imperial.ac.uk|
22396169|NCT00290290|Baylor College of Medicine|Rabih Darouiche, M.D.|713-794-8858|rabihd@bcm.edu|
22396170|NCT01172197|NHS Tayside|Dr G McLeod|+44 1382 7974440848|g.a.mcleod@dundee.ac.uk|
22396171|NCT00003895|Providence Cancer Center, Earle A. Chiles Research Institute, Robert W. Franz Cancer Center|Walter J. Urba, MD, PhD; Physician Director of Research|503-215-5696|Walter.Urba@providence.org|
22396172|NCT01380730|Amgen Inc.|Study Director|866-572-6436||
22396173|NCT01817855|AstraZeneca|Naimish Patel|+1 781 839 4061|Naimish.Patel@astrazeneca.com|
22396174|NCT05686928|Galderma|Thu Q. Nguyen, PhD|8179615495|thu.nguyen@galderma.com|
22396175|NCT01509079|HealthPartnersInstitute|Dr. Alice Shapiro|952-993-1704|shapia@parknicollet.com|
22396176|NCT03945591|NYU Langone Health|Ahmad Al-Homsi|6465017621|Samer.Al-Homsi@nyulangone.org|
22396177|NCT00359021|Tibotec|SENIOR DIRECTOR R&D|1 609 730-7548||
22396178|NCT03861936|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22378467|NCT02612064|GlaxoSmithKline|GSK Response Center|866-435-7343||
22396179|NCT00702364|Craig Hospital|Cynthia Harrison-Felix, PhD|303-789-8565|charrison-felix@craighospital.org|
22396180|NCT01312038|Middle Ear Physiology Laboratory|Ellen Mandel, MD|412-692-6214|mandele@pitt.edu|
22396181|NCT01670539|West Virginia University|Georgia L Narsavage|304-293-6729|gnarsavage@hsc.wvu.edu|
22396182|NCT04353596|Medizinische Universität Innsbruck/ Medical University Innsbruck|Prof. Dr. Axel Bauer|0043 512 504 25621|Axel.Bauer@i-med.ac.at|
22396183|NCT01236573|National Cancer Institute|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
22396184|NCT02783443|University Hospital Hradec Kralove|Dr. David Astapenko|+420608177374|astapenko.d@seznam.cz|
22396185|NCT05418673|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22438638|NCT02701283|Medtronic Structural Heart & Aortic Clinical Research & Medical Science|Kristin Smith, Clinical Research Manager|763-526-3095|kristin.m.smith@medtronic.com|
22438639|NCT04544956|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22438640|NCT04266795|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22438641|NCT05017701|Masimo Corporation|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
22438642|NCT00699660|Veterans Affairs at TVHS|Theodore Speroff PhD|615-636-9476|ted.speroff@va.gov|
22438643|NCT03915470|Destiny Pharma|Clinical Project Manager|+44 (0)1273-704440|info@destinypharma.com|
22378468|NCT06387472|Mayo Clinic|Matthew Hall, M.D.|904-953-6412|Hall.Matthew@mayo.edu|
22378469|NCT04182880|Cali Biosciences|Chief Medical Officer|12038376500|e.onel@calibiosciences.com|
22378470|NCT02036645|AstraZeneca Pharmaceuticals|Michael Pomfret, Project Director, IMED Neuroscience||Clinicaltrialstransparency@astrazeneca.net|
22378471|NCT03522077|Aurora Health Care|Dr. Muhammad Fuad Jan|414-649-3491|fuad.jan@aah.org|
22378472|NCT00717860|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22378473|NCT00696384|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22378474|NCT03995784|Catalyst Biosciences|Howard Levy, Chief Medical Officer|+1.650.266.6871|hlevy@catbio.com|
22378475|NCT02624739|ResMed|Paul Phillips|01 906 8861|paul.phillips@resmed.com|
22378476|NCT03015116|Landstuhl Regional Medical Center|Dr. Ann Kobiela Ketz|8022656263|annketz@gmail.com|
22378477|NCT01862991|Stanford University|Principal Investigator|650-497-5175|gynresearch@stanford.edu|
22378478|NCT04858802|Medtronic plc|Xiaomin Deng|707-566-1311|Xiaomin.deng@medtronic.com|
22378479|NCT00332332|Amgen Inc.|Study Director|866-572-6436||
22378480|NCT01108458|Stanford University Medical Center|George Albert Fisher, MD|650-725-9057|georgeaf@stanford.edu|
22378481|NCT03075501|University of Illinois at Chicago|Emma Childs|312-355-2726|echilds@uic.edu|
22378482|NCT00857805|Loma Linda University Health|David Bush, MD, Professor Radiation Medicine|909 558 1000|DBush@llu.edu|88056
22378483|NCT03921346|University Hospitals of Geneva|Dr Johan N. Siebert|+41795534072|Johan.Siebert@hcuge.ch|
22378484|NCT01746043|UT MD Anderson Cancer Center|Lin,Steven H,M.D. Ph.D. / Radiation Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
22425765|NCT03272347|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22425766|NCT01971567|Wake Forest School of Medicine|Dr. Charles H. Tegeler|+1 (336) 716-7651|ctegeler@wakehealth.edu|
22425767|NCT00391872|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22425768|NCT04826484|Johns Hopkins University School of Medicine|Andrew T. Gabrielson, MD|410-955-5000|atg@jhmi.edu|
22425769|NCT02581488|Smith and Nephew|SR. Clinical Study Manager, US Global Clinical Operations|+1 817-302-3959|Darrell.Lange@smith-nephew.com|
22425770|NCT01520207|Brigham and Women's Hosptial|Dr. Finnian Mc Causland|6177326432|fmccausland@partners.org|
22438644|NCT03160898|Cytokinetics, Inc.|MD Cytokinetics|650-624-2929|medicalaffairs@cytokinetics.com|
22378485|NCT00710606|Columbia University|Carolyn Westhoff|212-305-4805|clw3@columbia.edu|
22378486|NCT02670538|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22378487|NCT03863522|Johns Hopkins University|Dr. Sara Sukumar|4106142479|saras@jhmi.edu|
22378488|NCT01247428|Micell Technologies|Dennis Donohoe, MD, Chief Medical Advisor|919-313-2102|ddonohoeconsult@gmail.com|
22378489|NCT00708435|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22378490|NCT02660801|UQTR|Pr Martin Descarreaux|819-376-5011|martin.descarreaux@uqtr.ca|3791
22378491|NCT04766086|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22378492|NCT02281760|National Human Genome Research Institute|Gahl, William|+1 301 402 2739|gahlw@mail.nih.gov|
22378493|NCT02635724|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
22378494|NCT00100932|Eisai|Dr. Peter Tarassoff|888-422-4743||
22378495|NCT01453348|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22378496|NCT02756832|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22378497|NCT03160287|University of Washington|Oleg Zaslavsky|2066163242|ozasl@uw.edu|
22378498|NCT03579290|Yale University|Theresa Babuscio Data Manager|203-737-5430|theresa.babuscio@yale.edu|
22378499|NCT02881008|MYR GmbH|Dr. med. Alexander Alexandrov|+491777168259|alexandrov@myr-pharma.com|
22378500|NCT01674621|Radius Health Inc.|Program Director|(617) 551-4700|info@radiuspharm.com|
22378501|NCT01725386|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22378502|NCT00094211|Stanford University|Dr. Abby C. King|650-725-5394|king@stanford.edu|
22378503|NCT01216163|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22378504|NCT02914314|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22378505|NCT00532155|Sanofi-aventis|Trial Transparency Team||Contact-Us@sanofi.com|
22378506|NCT03483038|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
22378507|NCT03635489|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22378508|NCT01368900|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
22378509|NCT02492854|Boston Medical Center|Jeffrey Siracuse, MD|617-638-8488|Jeffrey.Siracuse@bmc.org|
22378510|NCT00361439|University of Chicago|Jayant Pinto, MD|773-702-6727|jpinto@surgery.bsd.uchicago.edu|
22378511|NCT04027348|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-2300|Kris.Attwood@roswellpark.org|
22378512|NCT02487472|GlaxoSmithKline|GSK Response Center|866-435-7343|lzr30020@gsk.com|
22378513|NCT01313286|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22378514|NCT00654901|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22378515|NCT00724464|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@Merck.com|
22378516|NCT04843930|Weill Cornell Medicine|Lindsay Victoria, PhD|646-962-3973|liv3002@med.cornell.edu|
22378517|NCT02552238|Bracco Diagnostics Inc.|Melda S. Dolan, MD, FACC, FASE, Head, Medical Affairs and Cardiac Ultrasound|1-609-514-2506|Melda.Dolan@diag.bracco.com|
22378518|NCT02010632|Khon Kaen University|Miss Nontaya Nakkam|66862642540|nonna_na@hotmail.com|
22378519|NCT02404389|Novartis Pharmaceuticals|Study Director|862-778-8300||
22378520|NCT01576718|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22378521|NCT04631705|Institute of Virology|Prof. Florian Klein|49221478|florian.klein@uk-koeln.de|85800
22378522|NCT05741385|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22378523|NCT02070484|OhioHealth|Josepha Shehadi, MD|614-220-5648|joseph@drshehadi.com|
22378524|NCT01742364|PATH|Courtney Jarrahian|206-285-3500|cjarrahian@path.org|
22378525|NCT02821819|Instituto Bernabeu|Dr. Juan Carlos Castillo|+34650562634|jcastillo@institutobernabeu.com|
22378526|NCT02332590|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22378527|NCT01949779|Stryker Neurovascular|Cheryl Fontana, Sr. Manager, Clinical Services|510-413-2948|cheryl.fontana1@stryker.com|
22378528|NCT04225988|Cedars Sinai Medical Center|Dr. Edmund Huang, MD|310-423-2641|edmund.huang@cshs.org|
22378529|NCT03466918|Edwards Lifesciences|Director of Research|949-250-2500|THV_CT.gov@edwards.com|
22378530|NCT05619003|Coloplast|Senior Scientific Manager|+45 49112880|dkcpov@coloplast.com|
22378531|NCT06238999|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
22378532|NCT00811382|BIOTRONIK|Mathias Freudigmann|+49(0)30 68905 - 1248|mathias.freudigmann@biotronik.com|
22378533|NCT02272725|Stanford University School of Medicine|Dr. Grant Lipman|415-290-9286|gslipman@stanford.edu|
22378534|NCT07018999|Department of Anaesthesiology & Perioperative Medicine, Hong Kong Children's Hospital|Dr. Vansie Kwok, Consultant|+852-96737367|kv314@ha.org.hk|
22378535|NCT04226365|Penn Medicine / Lancaster General Hospital|Halle Becker, MPH, Research Project Manager|7175441777|Halle.Becker@pennmedicine.upenn.edu|
22378536|NCT04739761|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22378537|NCT00429494|The University of Texas (UT) MD Anderson Cancer Center|Dr. Naoto T. Ueno, MD, PhD / Professor||CR_Study_Registration@mdanderson.org|
22378538|NCT04684641|Yale University|Dr. Jonathan Koff|475-224-8167|jon.koff@yale.edu|
22378539|NCT00976703|Metrohealth Medical Center|Kelly S Gibson, MD|216-778-5498|kgibson@metrohealth.org|
22378540|NCT02075021|NYU Clinical Cancer Center|Amitabha Mazumder, MD|(212) 731-5757|Amitabha.Mazumder@nyumc.org|
22378541|NCT03091673|Xeris Pharmaceuticals, Inc.|Martin J. Cummins, VP, Clinical Development|806-282-2120|mcummins@xerispharma.com|
22378542|NCT01289041|Novartis Pharmaceuticals|Study Director|862-778-8300||
22378543|NCT01886963|Carolinas HealthCare System|Dr. Todd Heniford|7043551813|todd.heniford@carolinashealthcare.org|
22378544|NCT03610737|Vertos Medical|Angie Lee|949-349-0008|alee@vertosmed.com|
22378545|NCT02357290|Massachusetts General Hospital|Dr. Janet Wozniak|617-724-5600|jwozniak@partners.org|
22378546|NCT01129531|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22378547|NCT02714868|Department of Occupational Therapy, Boston University|Dr. Jessica Kramer, Assistant Professor, PI|617-353-2702|kramerj@bu.edu|
22378548|NCT02938169|Department of Rehabilitation Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine|Dr. Juseok Ryu|+82-10-4382-2328|jseok337@snu.ac.kr|
22378549|NCT05056870|Johnson & Johnson Vision Care, Inc.|Benjamin Straker-Principal Research Optometrist|1-800-843-2020|bstraker@its.jnj.com|
22378550|NCT03171480|The Ohio State University|Kara Rood, MD|440-321-0264|kara.rood@osumc.edu|
22378551|NCT05044325|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22378552|NCT03941015|Department of Anesthesiology, Beijing Anzhen Hospital, Capital Medical University|Dr. Jun Ma|13370103671|18710168703@163.com|
22378553|NCT01373931|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22378554|NCT00674323|Novartis Pharmaceuticals|Study Director|862-778-8300||
22378555|NCT00742079|Massachusetts General Hospital|Jennifer Gottlieb, PhD|617-912-7800|jgottlieb2@partners.org|
22378556|NCT01678443|Fred Hutchinson Cancer Research Center|Ajay K. Gopal, MD|206-288-2037|agopal@u.washington.edu|
22378557|NCT01751230|Pennington Biomedical Research Center|Dr. Leanne Redman|2257630947|leanne.redman@pbrc.edu|
22378558|NCT01175148|Mary Babb Randolph Cancer Center|Pam Bunner, Clinical Research Specialist|304-598-4511|bunnerp@wvuhealthcare.com|
22378559|NCT02013388|Nivalis Therapeutics, Inc.|Nivalis Therapeutics, Inc. (Formerly N30 Pharma)|720-945-7700|steven.shoemaker@nivalis.com|
22378560|NCT01676532|St.Michael's Hospital|Sloane Freeman|416-864-6060|freemansl@smh.ca|77042
22378561|NCT01010477|Rutgers-Robert Wood Johnson Medical School|Jill Williams, MD, Principal Investigator|7322354341|Jill.williams@rutgers.edu|
22378562|NCT01559454|University at Buffalo|Dr. Ricahrd Blondell|716-816-7237|blondell@buffalo.edu|
22378563|NCT01114204|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
22378564|NCT05582304|Johnson & Johnson Vision Care, Inc. (JJVC)|John R Buch|1-800-843-2020|jbuch@its.jnj.com|
22378565|NCT00991341|New England Research Institutes|Susan Assmann, PhD|617-972-3048|sassmann@neriscience.com|
22438645|NCT02601833|University of Michigan School of Dentistry|Emily Yanca Project and Data Manager|734-763-3988|emthorpe@umich.edu|
22438646|NCT03405818|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22438647|NCT00434109|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-7257|jonathan.strosberg@moffitt.org|
22438648|NCT02315534|Sumitomo Dainippon Pharma Oncology|Connor Marshall|843-364-8039|cmarshall@bostonbiomedical.com|
22438649|NCT00549445|University of Alabama at Birmingham|J. Edwin Blalock, PhD|205-934-6439|blalock@uab.edu|
22438650|NCT03932760|University of Utah|Gwen Latendresse|801-587-9636|Gwen.Latendresse@nurs.utah.edu|
22438651|NCT03922620|Geisinger Medical Center|Dr. Gerard Cush|5702716700|MSKIresearch@geisinger.edu|
22438652|NCT04725500|Philips|Chuck Cain|412-657-1814|chuck.cain@philips.com|
22438653|NCT00662545|UCSF SFGH|Anne Luetkemeyer|415 476 4082|aluetkemeyer@php.ucsf.edu|130
22438654|NCT00511238|Onyx Pharmaceuticals|Onyx Medical Information|1-877-ONYX-121|medinfo@onyx.com|
22378566|NCT03036384|Centre Hospitalier Universitaire Saint Pierre|Panayota Kapessidou|+32.2.535|pkapessi@ulb.ac.be|3750
22378567|NCT03145766|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22378568|NCT00431184|McLean Hospital|Beth Murphy MD|617-855-2297|BMurphy5@partners.org|
22378569|NCT02799472|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22378570|NCT02801669|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22378571|NCT03645967|Medline Industries, LP|Keri Jorgenson|2243014670|kajorgenson@medline.com|
22378572|NCT00462670|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7314||
22378573|NCT04461795|Clinvest Research|Jim Sly|417-841-3673|jsly@clinvest.com|
22378574|NCT00615264|CBR International|Dr. Jeanne Novak|7207461190|jnovak@cbrintl.com|
22378575|NCT00548132|Washington University School of Medicine|Bernard C. Camins, MD|3144548351|bcamins@dom.wustl.edu|
22378576|NCT01187914|Arrhythmia Research Center, University of Utah|Dr. Kavitha Damal, Clinical research Manager|8012133775|kavitha.damal@carma.utah.edu|
22378577|NCT01134601|National Cancer Institute|Dr. Deborah E. Citrin|301-496-5457|citind@mail.nih.gov|
22378578|NCT00633932|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22378579|NCT00482274|Oregon Health & Science University Knight Cancer Institute|Study Coordinator|503 494-2897|eilersk@ohsu.edu|
22378580|NCT04836858|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22378581|NCT02884414|Stanford University|Jennifer Hledik|650-493-5000|jerhart@stanford.edu|62388
22378582|NCT02396537|University of Alabama at Birmingham|Dr. Christopher Pruitt|2056389587|cpruitt@peds.uab.edu|
22378583|NCT01982435|Cleveland Clinic Foundation|Dr. Justis Ehlers|216-636-0183|Ehlersj@ccf.org|
22378584|NCT00304512|Medical Affairs|Amicus Therapeutics|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
22378585|NCT00787319|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22378586|NCT03954743|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22378587|NCT03315936|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22378588|NCT01153269|Abbott|Global Medical Services|1-800-633-9110||
22378589|NCT03541044|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22378590|NCT00860067|MedImmune LLC, an affiliate of AstraZeneca AB|Judith Falloon, MD/ Sr. Dir. Clinical Development|301-398-0000|falloonj@medimmune.com|
22378591|NCT04048863|B. Braun Medical Inc.|Dr. Diana Valencia|610-596-2875|diana.valencia@bbraunusa.com|
22378592|NCT01159743|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22378593|NCT02387996|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22378594|NCT00770432|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22378595|NCT00312702|Walter Reed Army Institute of Research|James F. Cummings, MD|301-319-9312|james.cummings@us.army.mil|
22396186|NCT02665052|Baltimore VA Medical Center VA Maryland Health Care System|Dr. Susan S. Conroy|(410) 637-3213|susan.conroy@va.gov|
22396187|NCT02234284|University of California San Francisco|Dr. David Thom|415-206-2278|David.Thom@UCSF.edu|
22396188|NCT03923556|University of Colorado School of Medicine|Dr. Ana Fernandez-Bustamante|720-848-6744|ana.fernandez-bustamante@cuanschutz.edu|
22396189|NCT01986920|Aclaris Therapeutics|Christopher Powala, Chief Operating Officer|484-324-7933|cpowala@aclaristx.com|
22396190|NCT01690897|University of British Columbia|Dr. Lori Brotto|604 875 4111|Lori.Brotto@vch.ca|68901
22396191|NCT03023059|Robert W Snyder, MD, PhD, PC|Dr. Robert W. Snyder|5206616516|rsnyder781@gmail.com|
22396192|NCT05215262|Mount Sinai Adolescent Health Center|Sarah Wood, MD, MSHP|(332) 227-4355|Sarah.Wood@mountsinai.org|
22396193|NCT00866749|The University of Texas MD Anderson Cancer Center|Michael Andreeff MD./Professor|713-792-7261|mandreeff@mdanderson.org|
22396194|NCT04880447|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22396195|NCT01353508|Novartis|Study Director|862-778-1873||
22396196|NCT03496324|Reckitt Benckiser Healthcare (UK) Ltd|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
22396197|NCT02092350|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
22396198|NCT01614821|Dana-Farber Cancer Institute|Dr. Steven Treon|617-632-2681|steven_treon@dfci.harvard.edu|
22396199|NCT00646906|University of Pennsylvania|Tilo Grosser, MD|215-573-7600|tilo@pennmedicine.upenn.edu|
22396200|NCT00956657|NHS Greater Glasgow & Clyde|Gavin H. Taylor, Clinical Psychologist|0141 211 2134|gavin.taylor@ggc.scot.nhs.uk|
22396201|NCT00729482|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
22396202|NCT02137122|University of Florida|Adam Woods|352-294-5842|ajwoods@phhp.ufl.edu|
22396203|NCT00433914|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22396204|NCT02844920|Gynesonics|Taraneh G. Farazi, Ph.D. (Vice President, Clinical Affairs)|650-216-3878|tfarazi@gynesonics.com|
22396205|NCT00240981|Brigham & Women's Hospital|Dr. Shalender Bhasin|617-525-9150|sbhasin@partners.org|
22396206|NCT02518997|Stanford University|Melissa Scala|650-723-5711|mscala@stanford.edu|
22396207|NCT01365585|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22396208|NCT02678416|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
22396209|NCT00953719|DePuy Orthopaedics, Inc.|Sam Himden|574-372-7231|shimden@its.jnj.com|
22438655|NCT04437485|Indiana University-Purdue University Indianapolis (IUPUI)|Jesse C. Stewart, PhD., Principal Investigator|317-274-6761|jstew@iupui.edu|
22438656|NCT03553758|Massachusetts General Hospital DACCPM|Dr. Oluwaseun Johnson-Akeju|617-724-7200|oluwaseun.akeju@mgh.harvard.edu|
22438657|NCT02614729|Purdue University|Dr. Heather Leidy|765-496-0184|hleidy@purdue.edu|
22438658|NCT04456634|Medicines for Malaria Venture (MMV)|Jacques Herve|+41 79 370 40 63|hervej@mmv.org|
22438659|NCT04367831|Columbia University|Sahil A. Parikh, MD|212-305-3617|sap2196@cumc.columbia.edu|
22438660|NCT00381004|The University of Texas (UT) MD Anderson Cancer Center|Alessandra Ferrajoli, MD/Professor, Leukemia||CR_Study_Registration@mdanderson.org|
22438661|NCT00527735|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22438662|NCT01302483|Department of Periodontics & Endodontics, School of Dental Medicine, University of Buffalo, SUNY|Dr. Sebastian Ciancio|(716) 829-3848|ciancio@buffalo.edu|
22438663|NCT00181363|Maastro Radiation Oncology|J. Buijsen,|+31 (0)88-44-55-666|jeroen.buijsen@maastro.nl|
22438664|NCT01121146|AORI|C. Anderson Engh, Jr., MD|703-619-4411|research@aori.org|
22438665|NCT01276639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22438666|NCT04363879|AtriumHealth|Dr. Brad Hurst, Director of Assisted Reproduction Program|7043553153|Brad.Hurst@atriumhealth.org|
22438667|NCT01822197|Nationwide Childrens Hospital|Dr Ben Kopp|6147224766|benjamin.kopp@nationwidechildrens.org|
22438668|NCT03999515|Fred Hutchinson Cancer Center|Dr. Michael Schweizer|2066066252|mtschwei@fredhutch.org|
22438669|NCT01132807|Alliance for Clinical Trials in Oncology|David J. Straus, MD|212-639-8365|strausd@mskcc.org|
22438670|NCT01380769|Cerulean Pharma Inc.|Adrian Senderowicz|617 551 9600|asenderowicz@ceruleanrx.com|
22425771|NCT01851655|University of Florida|Dr. Terese Chmielewski|352-273-6104|tchm@ufl.edu|
22425772|NCT05076604|Washington University School of Medicine|Matthew Schill|3147470707|schillm@wustl.edu|
22425773|NCT00552695|Stony Brook U|Adam Singer|631-444-7857|adam.singer@stonybrook.edu|
22425774|NCT03557918|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22425775|NCT04575090|UTSouthwestern Medical Center|Zahid Ahmand, MD|214-648-2377|zahid.ahmad@utsouthwestern.edu|
22425776|NCT04391179|University of Michigan|Jason Knight, MD, PhD|734-763-3031|jsknight@med.umich.edu|
22425777|NCT03373760|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
22425778|NCT04218279|University of Pittsburgh|P. Daniel Patterson|412-864-3830|pdp3@pitt.edu|
22425779|NCT00003537|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22425780|NCT01001520|University of Pennsylvania|Caryn Lerman, PhD|215-746-7141|clerman@mail.med.upenn.edu|
22425781|NCT02958787|University of Michigan Comprehensive Cancer Center|Dr. Daniel Spratt, MD|734-232-5244|sprattda@umich.edu|
22425782|NCT01588158|Massachusetts General Hospital|Neal Chen, MD||nchen1@partners.org|
22425783|NCT04254081|University of California, San Diego|UCSD Family Planning Research|(858) 329-4464|familyplanningresearch@health.ucsd.edu|
22425784|NCT02820870|VA Center for Clinical Management Research|Jeremy Sussman, MD, MS - Principal Investigator|(734) 845-5200|jeremysu@med.umich.edu|
22425785|NCT02754518|University of Chicago|Sara Kalantari, MD|773-834-6853|skalantari@medicine.bsd.uchicago.edu|
22425786|NCT01896193|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22425787|NCT01300247|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22438671|NCT00178477|University of Rochester Medical Center|Walter O'Dell, Ph.D.|585-275-9996|walter_odell@urmc.rochester.edu|
22438672|NCT03654690|Brown University|Dr. Tyler Wray|4018636659|tyler_wray@brown.edu|
22438673|NCT00203229|Thomas Jefferson University|M. Alan Stiles|215-955-6215|Alan.Stiles@Jefferson.edu|
22378596|NCT01498822|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22378597|NCT03592277|Saint Francis Hospital and Medical Center|David Shapiro, MD, MHCM, FACS, FCCM CMO of Saint Francis Hospital and Medical Center|860-833-5673|dshapiro@trinityhealthofne.org|
22378598|NCT01566630|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22378599|NCT02917265|Oklahoma Medical Research Foundation|Aikaterini Thanou, MD|405-271-7805|aikaterini-thanou@omrf.org|
22378600|NCT02481375|University of British Columbia|Crystal Karakochuk|604 822 0421|crystal.karakochuk@ubc.ca|
22378601|NCT03982043|University of Pittsburgh|Tina R. Goldstein, Ph.D.|4122465604|goldtr@upmc.edu|
22378602|NCT05436912|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22378603|NCT01616576|Advanced Bionics, LLC|Cedric Navarro, Vice President of Regulatory/Clinical Affairs and Quality|(661) 362-1963|Clinical.Research@advancedbionics.com|
22378604|NCT00979602|GlaxoSmithKline|GSK Response Center|866-435-7343||
22378605|NCT02413463|Faculty of Medicine, Cairo University|Ahmed Awadein, MD|201223911743|ahmedawadein@yahoo.com|
22378606|NCT02002182|Baylor College of Medicine|Dr. Andrew Sikora|7137983909|Andrew.Sikora@bcm.edu|
22378607|NCT04203537|Concentric Analgesics|Nancy Wu|(415) 484-7921|nancy@concentricanalgesics.com|
22378608|NCT01320943|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22378609|NCT02227316|UCLA Department of Radiological Sciences|Director of Clinical Research|310-794-8995|schaabane@mednet.ucla.edu|
22378610|NCT01081041|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22378611|NCT01669798|Duke University Medical Center|Angeles Alvarez Secord|919-684-3765|secor002@mc.duke.edu|
22378612|NCT03125005|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
22378613|NCT02439749|Medtronic|Pamela McKenna, Sr. Principal Clinical Research Specialist|(773) 597-5241|pamela.m.mckenna@medtronic.com|
22378614|NCT01806584|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22378615|NCT00140205|BIDMC|Dr. Christos mantzoros|6176671656|cmantzor@bidmc.harvard.edu|
22378616|NCT00311155|Daiichi Sankyo Pharma Development|Sr. Director, Regulatory Operations|732-590-5032|hmkessler@dsi.com|
22378617|NCT02241720|Huntsman Cancer Institute|Kimberlee Taylor|801-213-5673|Kimberlee.Taylor@hci.utah.edu|
22378618|NCT00552786|National Taiwan University|Dr. Yue-Liang Guo|+886-2-33228216|leonguo@ntu.edu.tw|
22378619|NCT03549234|University of California San Diego|Matthew Swisher, MD|415-314-4099|matthew.swisher@gmail.com|
22378620|NCT03289481|Clinical Research|Caroline Knight|2079218959|CKnight@pbmc.org|
22378621|NCT01265030|Maine Medical Center|Dr. Aaron Weiss, Principal Investigator|2073967565|Aaron.Weiss@mainehealth.org|
22378622|NCT02243631|Zablocki VA Medical Center|Dr. Ann Rosenthal , MD ACOS/Research|414-384-2000|ann.rosenthal@va.gov|41430
22378623|NCT03117517|Khyber Medical University|Dr. Mohsin Shah (Associate Professor)|3429620074|mohsin.ibms@kmu.edu.pk|+92
22378624|NCT01959945|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
22378625|NCT01992549|Octapharma|Sylvia Werner|415 260-9577|sylvia.werner@octapharma.com|
22378626|NCT01590771|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22378627|NCT01785628|China Medical University Hospital|The chief, Department of Neurology|8864-22052121|d8079@mail.cmuh.org.tw|5035
22378628|NCT00369681|Johns Hopkins University|Dr. Yvette Kasamon|410-955-8839|ykasamon@jhmi.edu|
22378629|NCT00584701|UCSF|Robert Hendren, DO|415-476-7198|robert.hendren@ucsf.edu|
22378630|NCT01671839|Merz Pharmaceuticals|Public Disclosure Manager|+49 69 1503 0|clinicaltrials@merz.com|
22378631|NCT00612222|National Cancer Institute (NCI), National Institutes of Health (NIH)|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
22378632|NCT02169895|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22378633|NCT01250119|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22378634|NCT01932294|University of Alabama at Birmingham|RongBing Xie|205-975-3624|rongbingxie@uabmc.edu|
22378635|NCT02150837|Medifast|Chris Coleman|410-504-8161|ccoleman@choosemedifast.com|
22378636|NCT00409786|University of Pittsburgh|Kathleen McTigue|412-692-2940|mctiguekm@upmc.edu|
22378637|NCT02211534|Regenesis Biomedical|Heather Vander Ploeg|602-4287041|Heather.VanderPloeg@regenesisbio.com|
22378638|NCT02596022|NYSPI|Linda Sherman|6467747158|lsherma@nyspi.columbia.edu|
22378639|NCT02608905|Baylor College of Medicine|Mandeep Bajaj|713-798-1712|bajaj@bcm.edu|
22378640|NCT03075904|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22378641|NCT00597714|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu|
22378642|NCT02228395|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
22378643|NCT02924324|Memorial Sloan Kettering Cancer Center|Dr. Ellen Basu, MD, PhD|212-639-5204|BasuE@mskcc.org|
22378644|NCT00829686|Wilford Hall Medical Center|Gillian Schmitz, MD|919-724-9185|gillianmd@gmail.com|
22378645|NCT02424591|NYU School of Medicine|John Ard, MD|212.263.5072|john.ard@nyumc.org|
22378646|NCT00818363|Durect Corporation|Deborah Scott|408-777-1417|deborah.scott@durect.com|
22378647|NCT00988221|Hoffman-La Roche|Medical Communications|800 821-8590||
22378648|NCT00633919|ALK-Abelló S.A.|Santiago Martín - Trial Manager|+34 913276127|santiago.martin@alk-abello.com|
22378649|NCT04559282|Cochlear|Therese Agat|+46766498562|tagat@cochlear.com|
22378650|NCT01108757|Cleveland Clinic|Lynn Borzi|2164453158|borzil@ccf.org|
22438674|NCT03477396|City of Hope|Dr. MIna Sedrak|626-359-8111|msedrak@coh.org|
22378651|NCT02904902|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22378652|NCT03885011|Orasis|Head of Regulatory Affairs|+972-9-8877745|iris.meisner@orasis-pharma.com|
22378653|NCT02712398|Becton Dickinson|Dawn Heimer / Sr. Director Medical Affairs|401-479-1253|dawn.heimer@bd.com|
22378654|NCT01719237|University of New Mexico|Dr. Nicholas Lam|505-272-2610|nlam@salud.unm.edu|
22378655|NCT03597035|University Hospitals Cleveland Medical Center|Sanjay Rajagopalan|216-844-5125|Sanjay.Rajagopalan@UHhospitals.org|
22378656|NCT03564782|Istari Oncology|W. Garrett Nichols, MD MS|919-245-7662|info@istarioncology.com|
22378657|NCT00993824|International Diabetes Center|Roger Mazze PhD|952-993-3796|rmazze@aol.com|
22378658|NCT03434457|Douglas Mental Health University Institute|Dr Patricia Pelufo Silveira|1514-761-6131|patricia.silveira@mcgill.ca|3928
22378659|NCT02192775|University of Arkansas for Medical Sciences|Brittany Lehman|501-686-8274|blehman@uams.edu|
22378660|NCT01973036|Geisinger|Dr. A. Dhanya Mackeen|570-714-1099|admackeen@geisinger.edu|
22378661|NCT02255032|Clearside Biomedical, Inc.|Thomas Ciulla, MD|(678) 392-2318|thomas.ciulla@clearsidebio.com|
22378662|NCT04772053|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22378663|NCT06131294|Ivoclar Vivadent AG|Team Leader Study Management|+4232353780|patrizia.elkuch-hoch@ivoclar.com|
22378664|NCT00125593|Clinical Trial Service Unit & Epidemiological Studies Unit, University of Oxford|Professor Colin Baigent|+44 1865 743743|colin.baigent@ctsu.ox.ac.uk|
22378665|NCT04146896|Aptinyx|Aptinyx Clinical Development|847-871-0377|clinicalstudies@aptinyx.com|1
22378666|NCT03107377|Evofem|Chief Medical Officer|858-550-1900|kculwell@evofem.com|
22378667|NCT01597505|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22378668|NCT02914379|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22378669|NCT02675465|Amicus Therapeutics, Inc.|MedInfo|001 609-662-2000|MedInfoUSA@amicusrx.com|
22378670|NCT00453102|University of Miami|Izidore S. Lossos|305-243-4785|ilossos@med.miami.edu|
22378671|NCT05031078|Emory University|Dr. Erin Scherer|404-712-6904|erin.margaret.scherer@emory.edu|
22378672|NCT03728972|Memorial Sloan Kettering Cancer Center|Dr. Malin Hultcrantz MD, PhD|646-608-3714|hultcram@mskcc.org|
22378673|NCT03154944|Coloplast|Head of Medical Writing and Biostatistics|49113143|dkpen@coloplast.com|+45
22378674|NCT04249219|University of Massachusetts Chan Medical School|Elise Stevens|(774) 455-6684|elise.stevens@umassmed.edu|56684
22378675|NCT03787680|University of Michigan Rogel Cancer Center|Cancer Center ClinicalTrials.gov Admin|734-936-9499|ClinicalTrialsgov_CCAdmin@umich.edu|
22378676|NCT05652036|Houston Methodist Hospital Department of Urology|Dr. Rose Khavari|713-441-6455|rkhavari@houstonmethodist.or|
22378677|NCT05454410|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|novartis.email@novartis.com|
22378678|NCT00895622|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22438675|NCT00068341|Jonsson Comprehensive Cancer Center|Helena Chang, M.D., Ph.D., Revlon/UCLA Breast Center|310-794-5640|hchang@mednet.ucla.edu|
22378679|NCT01490125|Novartis|Study director|41 61 324 1111||
22378680|NCT01224158|Johnson & Johnson Consumer and Personal Products Worldwide|Director Oral Health, Medical Affair & Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22378681|NCT01622010|St. Boniface Hospital|Kelly Codispodi BMR PT|204-237-2138|kcodispodi@sbgh.mb.ca|
22378682|NCT00335257|Center for Epidemiology and Health Research, Germany|Juergen Dinger, MD, PhD|0049(0)30 945 10120|dinger@zeg-berlin.de|
22378683|NCT01412801|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22378684|NCT01919970|Baylor College of Medicine|Dr. Eric Storch|727-767-8230|eric.storch@bcm.edu|
22378685|NCT00990340|Teva Neuroscience|Thomas Smith, MD, VP, Medical Affairs|816-508-5000|tom.smith@tevapharm.com|
22378686|NCT04615182|TransMedics Inc.|Laura Damme, VP Clinical Affairs|9785520900|ldamme@transmedics.com|
22378687|NCT01126060|Samsung medical center|Dr. Man Ki Chung|82-2-3410-1845|manki.chung@samsung.com|
22378688|NCT01874145|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22378689|NCT00402337|Ironwood Pharmaceuticals|Doug Levine, MD|617.374.3906|dlevine@ironwoodpharma.com|
22378690|NCT03565068|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22378691|NCT00658138|University of Bologna, Italy|Professor Giovanni Dondi dall'Orologio|+39 051-2088132|gdondi@alma.unibo.it|
22378692|NCT03879603|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Julie E. Ledgerwood, DO (Study Chair)|301-594-8502|ledgerwood@mail.nih.gov|
22378693|NCT02239380|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|001-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22438676|NCT01080807|Cephalon, Inc.|Vice President, Medical Affairs|610-727-6353||
22378694|NCT03857230|IVFarma LLC|General Manager|+7(499)6455342|info@ivfarma.ru|1
22378695|NCT02914132|ExThera Medical Corporation|Sr. Director of Regulatory and Clinical Affairs|9258392079|erdie@extheramedical.com|
22378696|NCT02707692|UC San Diego|David (Davey) Smith|619-300-9638|d13smith@health.ucsd.edu|
22378697|NCT01495221|Vitreous Retina Macula Consulatants of New York|Jason S. Slakter, MD|212-861-9797|mail@vrmny.com|
22438677|NCT02271698|Duke University Health System|Dr. Stuart Alan Grant|919-681-6437|stuart.grant@duke.edu|
22438678|NCT02430090|Ankara Numune Training and Research Hospital|Dr. Müge Çakırca|+905054433177|mugeturkoglu81@hotmail.com|
22438679|NCT03922581|Emory University|Abigail Lott, PhD|404-712-0159|abigail.lott@emoryhealthcare.org|
22438680|NCT04472611|Yale University School of Medicine|Dr. Alexandra Lansky|203 737 2142|alexandra.lansky@yale.edu|
22438681|NCT00764699|Nationwide Children's Hospital|Julie Rice, RN|6143553142|julie.rice@nationwidechildrens.org|
22438682|NCT02223715|Otsuka Pharmaceutical Co., LTD.|Study Director, Yoshitaka Kotobuki, Mr|+81-3-6361-7366||
22438683|NCT01745367|Aveo Pharmaceuticals, Inc.|Chief Medical Officer|857-400-0101|Clinical@aveooncology.com|
22438684|NCT00494585|The University of Texas M. D. Anderson Cancer Center|Srdan Verstovsek M.D./Associate Professor|713-792-7305|eharriso@mdanderson.org|
22378698|NCT02019563|The Hospital for Sick Children|Trang Nguyen|6473300825|trang.nguyen@easternhealth.ca|
22378699|NCT00767104|Wake Forest University Health Sciences|Alan Fleischer, Jr. MD|336-716-3775|Afleisch@wfubmc.edu|
22438685|NCT01507688|VA HSRD PRIS-M QUERI and CHIC HSRD Centers|Teresa Damush Ph.D.|317-988-4277|Teresa.Damush@va.gov|
22438686|NCT02366312|NYU College of Dentistry|Dr. Brian Schmidt|212-998-8900|brianl.schmidt@nyu.edu|
22438687|NCT00965081|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22438688|NCT00964496|Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine|Zhizheng Ge, MD. Ph.D. Director of the Clinical Trials|86-21-68383015|zhizhengge@yahoo.com.cn|
22438689|NCT02541812|University of Manitoba|Dr. Mandana Modirrousta|2042372303|mmodirrousta@sbgh.mb.ca|
22438690|NCT04308941|BostonSight|Dr. Daniel Brocks|(781) 726-7506|ecrowley@bostonsight.org|
22438691|NCT02230566|Ultragenyx Pharmaceutical Inc|Kim Mooney, Associate Director, Patient Advocacy Medical Services|408-981-3526|kmooney@ultragenyx.com|
22438692|NCT03435185|University of Health Sciences Dr. Lütfi Kırdar Kartal Training and Research Hospital|Dr. Cem Bölük|+902164413900|cem.boluk@sbu.edu.tr|
22438693|NCT01076959|Abbott|Global Medical Services|800-633-9110||
22438694|NCT02491983|MedSIR|Alicia Garcia|+34 611261467|alicia.garcia@medsir.org|
22438695|NCT02021565|Atlanta VA Medical Center|Patricia C. Griffiths|404-321-6111|Patricia.Griffiths@va.gov|7138
22438696|NCT00851279|Stereotaxis Inc.|Dr Qun Sha, MD, Director of Clinical Trials|314 678 6143|qun.sha@stereotaxis.com|
22438697|NCT01887132|National Institute of Mental Health (NIMH)|Ashura W Buckley|(301) 496-5190|shu.buckley@nih.gov|
22438698|NCT03575403|University of Kentucky|Dr. Craig R. Rush, Ph.D.|8592575388|crush2@uky.edu|
22438699|NCT02292719|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22438700|NCT01332994|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22438701|NCT01451385|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
22438702|NCT00731679|Salix|David Sorscher|919-862-1827|david.sorscher@salix.com|
22438703|NCT02481297|The University of Texas MD Anderson Cancer Center|Dr. Nitin Jain/Associate Professor|713-745-6080|njain@mdanderson.org|
22438704|NCT02412098|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22438705|NCT03089580|University of Michigan / Kellogg Eye Center|Sarah Wood|734-615-2479|skwood@med.umich.edu|
22438706|NCT03087513|Toronto Western Hospital/University Health Network|Study Coordinator|416-603-5800|emad.alazazi@uhnresearch.ca|6237
22438707|NCT04170543|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22438708|NCT00770601|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|Novartis.email@novartis.com|
22438709|NCT04628780|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22438710|NCT05315479|Baudax Bio|Development|484-395-2440|info@baudaxbio.com|
22438711|NCT03269994|Memorial Sloan Kettering Cancer Center|Dr. Michael D'Angelica, MD|212-639-3226|dangelim@mskcc.org|
22438712|NCT03884790|GreenBone Ortho SpA|Senior Clinical Affairs Manager|+393479747691|sonia.granados@greenbone.it|
22438713|NCT00592488|Vanderbilt University|Todd Rice, MD|615 322-3412|todd.rice@vanderbilt.edu|
22438714|NCT01987102|Isofol Medical AB|Chief Medical Officer|+46 (0)702433750|karin.ganlov@isofolmedical.com|
22438715|NCT01288989|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22438716|NCT04378270|University of Pittsburgh|Jeffrey Gusenoff, MD|(412) 641-3960|gusenoffja@upmc.edu|
22438717|NCT01327599|Alcon Research, Ltd.|Doug Hubatsch, Therapeutic Unit Head, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
22438718|NCT01132313|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22438719|NCT01236521|VA Center for Health Information and Communication|Dr. Matthew J. Bair|317-988-2058|mbair@iupui.edu; Matthew.Bair@va.gov|
22438720|NCT01168726|University of Missouri|Dr. Matthew P. Martens, Professor; Division Executive Director|573-882-3382|martensmp@missouri.edu|
22438721|NCT04854694|FaceView Mask, LLC|Jeanne Hahne, MSN, RN|4155188574|jeannehahne@gmail.com|
22438722|NCT02784171|Canadian Cancer Trials Group|Dr. Lesley Seymour|613533600|lseymour@ctg.queensu.ca|75544
22438723|NCT04661150|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22438724|NCT04965688|Inova Health System|Adam Cohen, MD|7035767279|adam.cohen@inova.org|
22438725|NCT05864586|OhioSUCCC|Dr. Theodore L. Wagener|614-366-4265|Theodore.Wagener@osumc.edu|
22438726|NCT00369577|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
22438727|NCT04618744|Oramed, Ltd.|Chief Scientific Officer|+97225660001|miriam@oramed.com|
22438728|NCT01454791|MS Center at Evergreenhealth Care|Theodore R, Brown, MD Principle Investigator|425-899-5350|trbrown@evergreenhealth.com|
22438729|NCT02719171|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22438730|NCT02807623|Defense Health Agency Immunization Healthcare Division South Atlantic Region Vaccine Safety hub|Laurie Housel|910-432-4015|laurie.a.housel.civ@mail.mil|
22438731|NCT01083849|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22438732|NCT05298202|University of Montana|Dustin Slivka|(406) 243-2389|dustin.slivka@umontana.edu|
22438733|NCT04002960|Masimo|Chelsea Frank|949-297-7000|studies@masimo.com|
22438734|NCT02107703|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22438735|NCT03170661|LUMC|Drs. Maarten Honing|0715264038|g.h.m.honing@lumc.nl|
22438736|NCT00631358|Alcon Labs|Alcon Clinical|1-888-451-3937; 1-817-568-6725|medinfo@alconlabs.com|
22438737|NCT04140396|Stanford University|Chi-Ho Ban Tsui|(650) 200-9107|bantsui@stanford.edu|
22438738|NCT02513121|University of California, San Diego|Dr. Jeffrey Schwimmer|858-966-8907|jschwimmer@ucsd.edu|
22438739|NCT01020786|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22378700|NCT00840996|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org|
22378701|NCT03047174|Department of Radiation Oncology, University of Lübeck, Germany|Prof. Dr. med. Dirk Rades|0049 451 500|dirk.rades@uksh.de|45401
22438740|NCT01303939|Wills Eye Hospital, Glaucoma Research Center|George L. Spaeth, MD|215-928-3123|gspaeth@willseye.org|
22438741|NCT01176058|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22438742|NCT02254473|TRIA Orthopaedic Center|Megan Reams|952-806-5329|megan.reams@tria.com|
22438743|NCT00256724|Advanced Circulatory|Nathan Burkhart|651.403.5600|nburkhart@advancedcirculatory.com|
22438744|NCT01217463|Olympus France S.A.S|Mr. Akira Kondo, Manager, Clinical R&D|+33-1-4560-6849|akira.kondo@olympus.fr|
22438745|NCT01879683|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22438746|NCT03507036|UT Southwestern|Jennifer Barillas|214-645-8907|jennifer.barillas@utsouthwestern.edu|
22438747|NCT01338818|Novartis Pharmaceuticals|Study Director|8627788300||
22438748|NCT05202418|Emory University|Dr. Bonney Reed|404-727-8312|ebreed@emory.edu|
22438749|NCT03901144|Perrigo/ACO Hud Nordic|Dr Tina Holm|+46732744113|tina.holm@perrigo.com|
22438750|NCT00239733|Weill Cornell|Kristen Marks|212-746-4177|markskr@med.cornell.edu|
22438751|NCT00279916|Mayo Clinic|Dr. Laura Orvidas|507-284-3410|orvidas.laura@mayo.edu|
22438752|NCT04532034|Temple University|Elizabeth THomas|215-204-1699|tug66715@temple.edu|
22438753|NCT00700440|Cancer Center, Sun Yat-sen University|Dr. Lu Tai-xiang|86-20-87343372|lutx@mail.sysu.edu.cn|
22438754|NCT01598922|McLean Hospital|Dr.Isabelle Rosso|6178552607|irosso@partners.org|
22438755|NCT02488005|Icahn School of Medicine at Mount Sinai|Becky Phan|212-824-7785|becky.phan@mssm.edu|
22438756|NCT04289311|Medical University of South Carolina|Shannon Phillips, PhD, RN, Associate Professor|843-792-9379|phillipss@musc.edu|
22438757|NCT00650767|Array BioPharma, Inc.|Study Director|303-381-6604|clinicaltrials@arraybiopharma.com|
22438758|NCT03384940|Daiichi Sanyko, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22438759|NCT04184297|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22438760|NCT03649074|Akili Interactive|Clinical Operations and Research Manager|8572543399|dfarlow@akiliinteractive.com|
22438761|NCT04303559|University of Pittsburgh|Dr. Margaret Ragni, Principal Investigator|412-209-7288|ragni@pitt.edu|
22438762|NCT01862536|VA Boston Healthcare System|Dr. Ronald Goldstein|857-203-6578|Ronald.Goldstein@va.gov|
22438763|NCT01156714|VAORD|Fred Ivey|410-605-7000|Frederick.Ivey@va.gov|6582
22438764|NCT03946748|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22438765|NCT03775486|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22438766|NCT00801216|IRCCS Ospedale San Raffaele|Dr. Andrés José Maria Ferreri|022643 7649|ferreri.clinicaltrials@hsr.it|
22438767|NCT05907395|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22438768|NCT05214768|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22438769|NCT05481359|Cortex, Inc|Eliza Lawrence|+16507049907|elawrence@cortexep.com|
22438770|NCT03066063|Barron Associates, Inc.|Richard Adams|434-973-1215|adams@bainet.com|
22438771|NCT03043872|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22438772|NCT03741088|HistoSonics, Inc.|Clinical Affairs Manager|651.398.7586|christine.sullivan@histosonics.com|
22438773|NCT02777827|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
22438774|NCT04551066|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22438775|NCT04491136|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22438776|NCT04441255|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22438777|NCT00319254|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22438778|NCT00848783|NYU Cancer Institute|Franco Muggia, MD|212-263-6485|franco.muggia@nyumc.org|
22438779|NCT01712204|TWi Biotechnology, Inc.|Medical Director|+886-2-26573350|Carl.Brown@twipharma.com|368
22438780|NCT02452424|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
22438781|NCT01059318|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22438782|NCT03790917|National Medical Research Center for Preventive Medicine|professor Sergey Yu. Martsevich|89161643690|sergeymartsevich@mail.ru|
22438783|NCT00121186|SWOG Statistical Center|Study Statistician|206-667-4623||
22438784|NCT00291486|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22438785|NCT01840345|Virginia Commonwealth University|Dr. Dace Svikis|(804) 827-1184|dssvikis@vcu.edu|
22438786|NCT01150097|Novartis Pharmaceuticals|Study Director|862-778-8300||
22438787|NCT02679170|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22438788|NCT01408459|University of Illinois at Chicago|Dr. Phyllis E. Bowen|708-524-0586|pbowen@uic.edu|
22438789|NCT01025830|University of California Berkeley|Jayne Byakika Tusiime|1 510 219 7567|tusiimej@berkeley.edu|
22438790|NCT00543387|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22438791|NCT02267538|Peking University First Hospital|Dr. Dong-Xin Wang,PHD,the director of department of Anesthesiology and Critical Care Medicine|+8613910731903|wangdongxin@hotmail.com|
22438792|NCT02774148|Spectrum Health|Andrea Mantel|616-486-2051|andrea.mantel@spectrumhealth.org|
22438793|NCT02373774|Columbia University Medical Center|Raquel Schrager|(212) 305-4687|rs3823@cumc.columbia.edu|
22438794|NCT02137096|University of Florida|John Fort, MD|352-273-9120|john.fort@ufl.edu|
22438795|NCT00513435|Memorial Sloan-Kettering Cancer Center|Matthew Fury, MD|646-888-4233|furym@mskcc.org|
22438796|NCT03145259|University of Maryland, Baltimore School of Pharmacy|Dr. Audra Stinchcomb|410-706-2646|astinchc@rx.umaryland.edu|
22438797|NCT01223183|University of Pittsburgh|Tim Corcoran|412-624-8918|corcorante@upmc.edu|
22438798|NCT01279681|Mayo Clinic|Joleen M. Hubbard, M.D.|507 284-3121|hubbard.joleen@mayo.edu|
22378702|NCT01108835|The Chinese University of Hong Kong|Fanny Ko|85226323133|fannyko@cuhk.edu.hk|
22438799|NCT01943591|Centre hospitalier de l'Université de Montréal Research Centre|Dr. Jean Raymond|514-890-8000|jraymond.nri@gmail.com|27235
22438800|NCT03772665|Acucela, dba Kubota Vision|Dr. Jeff Gregory|2068058310|clinicaltrials@acucela.com|
22438801|NCT01232868|Emory University|Nadine Rouphael, MD|404-712-1435|nroupha@emory.edu|
22438802|NCT01412164|Shanghai Microport Medical (Group) Co.,Ltd.|Kefei Li|+86-21-38954600×6700|kfli@microport.com|
22438803|NCT04481243|Mayo Clinic|Ana L. Creo, M.D.|507-284-3300|Creo.Ana@mayo.edu|
22438804|NCT02539797|University of California, Los Angeles|Dr. Yuri Rassovsky|3104783711|yurir@ucla.edu|
22438805|NCT01432405|Baylor College of Medicine|Mandeep Bajaj|713-798-1712|bajaj@bcm.edu|
22438806|NCT02467179|University of California San Diego|Dr. Gregory Feld|(858) 246-2972|gfeld@ucsd.edu|
22438807|NCT02796677|AstraZeneca AB|Global Clinical Leader|+46 766 346712|clinicaltrialtransparency@astrazeneca.com|
22438808|NCT02752880|Chang Gung Memorial Hospital|Dr. YH Huang|+886975360240|igighuang@gmail.com|
22438809|NCT00961181|University Medical Center, Freiburg i.Br., Germany|Prof. Dr. Christoph Hehrlein|+49 761 270|christoph.hehrlein@uniklinik-freiburg.de|6095
22438810|NCT01777308|GlaxoSmithKline|GSK Response Center|866-435-7343||
22438811|NCT03410628|electroCore Inc.|Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
22438812|NCT03212326|Weill Cornell Medical College|Dr. Christopher Liu|212-746-2655|chl7001@med.cornell.edu|
22438813|NCT03430791|Miami Cancer Institute at Baptist Health, Inc.|Yazmin Odia|786-596-2000|YazminO@baptisthealth.net|
22438814|NCT02918617|University of Texas Health San Antonio|Bennett Amaechi, DDS|210-567-3185|amaechi@uthscsa.edu|
22438815|NCT03270943|University of North Carolina at Chapel Hill|Christine Lathren, MD, MPH|919-966-8586|lathren@email.unc.edu|
22438816|NCT01131507|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
22438817|NCT01517750|HELIOS-Klinik Ambrock|Dr Georg Nilius|+492331-9742005|klinik-ambrock.pneumo@t-online.de|
22438818|NCT01116401|Brigham & Women's Hospital|Hadine Joffe|617-732-4906|hjoffe@partners.org|
22438819|NCT01855412|Cardiovascular Systems, Inc.|Clinical Trials Manager|651.259.2500|clinicaltrials_csi@csi360.com|
22438820|NCT00754377|Louis Stokes VA Medical Center|Dr. David Aron|(216) 791-2300|david.aron@va.gov|5836
22438821|NCT00763412|Washington University in St Louis|Ana Maria Arbelaez|314-286-1138|arbelaez_a@kids.wustl.edu|
22438822|NCT03714178|Farapulse|Kit Schneider|617-686-7661|kschnieder@farapulse.com|
22438823|NCT05030350|Vistagen Therapeutics, Inc.|Ester Salman, MPH|650-577-3693|clinicalstudies@vistagen.com|
22438824|NCT00742183|Mölnlycke Health Care|Viktoria Ahlenius Körner|+46-31-722 32 46|viktoria.ahleniuskorner@molnlycke.com|
22438825|NCT04057807|Yale School of Medicine|Adam Mecca|203.764.8100|adam.mecca@yale.edu|
22438826|NCT02843165|University of California, San Diego|Andrew Sharabi|(858) 822-5354|CancerCTO@health.ucsd.edu|
22438827|NCT03985761|Rutgers The State University of NJ|Dr. Gerard G Fluet DPT, PhD|(973) 972-8529|fluetge@shp.rutgers.edu|
22438828|NCT01367834|UNC Chapel Hill|Rebecca Knickmeyer Santelli|9199662216|rebecca_knickmeyer@med.unc.edu|
22438829|NCT02609308|Universidad Autónoma de Nuevo León|Carlos Acosta-Olivo, PhD|+52 81 8347-3056|dr.carlosacosta@gmail.com|
22438830|NCT01569841|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22438831|NCT01858363|Spectranetics|Nicolas Aguirre|+1-312-297-6655|nicolas.aguirre@philips.com|
22438832|NCT03148613|Carrot Inc.|Director Clinical Affairs|650-906-4255|craig@carrot.co|
22438833|NCT02878317|University of Nottingham|Professor Maarten Taal|01332 224618|m.taal@nottingham.ac.uk|
22438834|NCT00057863|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
22438835|NCT00764361|Nanotherapeutics, Inc.|John Abernethy, MD - Medical Director|386-462-9663|jabernethy@nanotherapeutics.com|326
22438836|NCT03174366|Western University of Health Sciences|David Shofler|9097063898|dshofler@westernu.edu|
22438837|NCT02090426|Massachusetts Institute of Technology|Amy Finkelstein, PhD|6173246995|jgubb@mit.edu|
22438838|NCT02462148|Wake Forest Baptist Health|Dr. Jimmy Turner|3368064498|jturner@wakehealth.edu|
22438839|NCT01141712|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
22438840|NCT03480152|National Cancer Institute|Dr. Steven Rosenberg|240-858.3080|steven-rosenberg@nih.gov|
22438841|NCT05350163|Miami Cancer Institute at Baptist Health, Inc.|Director, Research Concept & Protocol Development|(786) 527-9546|MCIResearchConceptAndProtocolDev@baptisthealth.net|
22438842|NCT01308736|Rutgers Robert Wood Johnson Medical School|Dr. Marc Steinberg|7322354341|marc.steinberg@rutgers.edu|
22438843|NCT03634085|Venn Life Sciences|Simone van Broekhoven / Clinical Trial Manager|+310765480625|simone.vanbroekhoven@vennlife.com|
22438844|NCT04276233|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22438845|NCT00876200|Hospices Civils de Lyon|Dr Behrouz KASSAI-KOUPAI|472116911|behrouz.kassai-koupai@chu-lyon.fr|+33
22438846|NCT03609177|Dana Farber Cancer Institute|James Tulsky, MD, Chair of Suppportive Oncology Department|617-582-9201|JamesA_Tulsky@dfci.harvard.edu|
22438847|NCT03246789|Weill Cornell Institute of Geriatric Psychiatry|Dr. Patricia Marino|(914) 997-8691|pam2029@med.cornell.edu|
22438848|NCT01946139|Emmes Company, LLC|Kimberly Mosby-Griffin|301 251-1161|kmosby@emmes.com|10158
22438849|NCT01191723|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
22438850|NCT00101686|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22438851|NCT00296816|Sanofi|Trial Trans[parency Team||Contact_us@sanofi.com|
22438852|NCT01292187|Tarsa Therapeutics, Inc.|Dr. David Krause, Chief Medical Officer|1-267-273-7940|dkrause@tarsatherapeutics.com|
22438853|NCT03880058|Scarless Labs Inc.|Dr. Elisabeth Leeflang|213-788-2128|Clin_Info@scarlesslabs.com|
22438854|NCT01814527|East Carolina University|Joseph Armen DO|252-744-3212|armenj@ecu.edu|
22438855|NCT00687401|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22438856|NCT02520726|University of Utah|Brent Kious, MD|801-585-1418|brent.kious@hsc.utah.edu|
22438857|NCT00721396|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22438858|NCT00488488|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22438859|NCT01126723|Institute for Aging Research, Hebrew SeniorLife|Dr. Lewis Lipsitz|617-971-5318|lipsitz@hsl.harvard.edu|
22396210|NCT02017379|Texas Tech University Health Sciences Center at El Paso|Research Compliance Officer|915-215-4814|jackie.roberts@ttuhsc.edu|
22396211|NCT01910116|Seoul National University Hospital|Prof. Eun Bong Lee|822-2072-3944|leb7616@snu.ac.kr|
22396212|NCT01727765|University of Portsmouth|Dr Mitch Lomax|02392845297|mitch.lomax@port.ac.uk|
22396213|NCT02289352|Teva Pharmaceuticals USA, Inc.|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
22396214|NCT03123250|PROCEPT BioRobotics Corporation|Angela Lee|650-232-7215|a.lee@procept-biorobotics.com|
22396215|NCT02361944|Vanderbilt University|Frederic T. BIllings IV|6159368487|frederic.t.billings@vumc.org|
22396216|NCT03945357|Prisma Health|Aimee Hanvey|864-760-7350|aimee.hanvey@prismahealth.org|
22396217|NCT01561495|AbramsonCC Radiation Oncolocy|Susan Prendergast, RN|215-662-4267|susan.prendergast@pennmedicine.upenn.edu|
22438860|NCT00430716|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22438861|NCT00782717|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937 and 817.568.6725|medinfo@alconlabs.com|
22438862|NCT02446717|AbbVie|Global Medical Services|800-633-9110||
22438863|NCT03149172|Tufts University|Dr. Yong Hur|6176366531|Yong.Hur@tufts.edu|
22438864|NCT04936061|CoolTech|Clinical Trial Manager|570-228-8140|jholland@cooltechcorp.com|
22438865|NCT00154297|Novartis Pharmaceuticals|Study Director|862-778-8300||
22438866|NCT03095248|Cincinnati Children's Hospital Medical Center|Senior Regulatory Specialist|15135350640|andrea.bidwell@cchmc.org|
22438867|NCT03116685|OxThera|Chief Operating Officer|0046 86600223|elisabeth.lindner@oxthera.com|
22438868|NCT00398320|Stanford University School of Medicine|Pamela L Kunz, MD|650-725-8738|pkunz@stanford.edu|
22438869|NCT00064792|NICHD, NIH|Dr. Forbes Porter, Clinical Director, NICHD|301-435-4432|fdporter@mail.nih.gov|
22438870|NCT03137225|Virginia Commonwealth University|Henry J. Rozycki, MD|8048289602|henry.rozycki@vcuhealth.org|
22438871|NCT02110095|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
22438872|NCT00992459|Hyperion Therapeutics|Bruce Scharschmidt, MD, SVP, Chief MedicaL & Development Officer|650-745-7851|bruce.scharschmidt@hyperiontx.com|
22438873|NCT01023724|Bucci Laser Visiosn|Frank A. Bucci, Jr., MD|570-825-5949|Buccivision@aol.com|
22438874|NCT04177212|Merz Aesthetics|Public Disclosure Manager|+1 984-301-3095|Aesthetic.Trials@merz.com|
22438875|NCT01792115|NIDDK|Dr. Yaron Rotman|301-451-6553|rotmanyaron@mail.nih.gov|
22438876|NCT02831764|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22438877|NCT01139814|Catheter Robotics, Inc.|Vice President, Clinical and Regulatory Affairs|973-426-0300|research@catheterrobotics.com|
22438878|NCT01609348|Johns Hopkins University|Paul Rosenberg, MD|410-550-9883|prosenb9@jhmi.edu|
22438879|NCT01790594|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22438880|NCT03347123|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22438881|NCT03273673|Virginia Tech|Dr. Robin Queen|(540) 231-3134|rmqueen@vt.edu|
22438882|NCT00346216|Pfizer, Inc|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22438883|NCT03431441|Johnson & Johnson Vision Care|Meredith Bishop OD, MS, FAAO|904-443-1396|mbishop4@its.jnj.com|
22438884|NCT03788057|The Regional Public Hospital in Lesko, Poland|Dr. Janusz Ciółkowski|+48 134698071|ciolkowski.janusz@gmail.com|
22438885|NCT02163824|Kala Pharmaceuticals, Inc|VP, Clinical Development||Results001@kalarx.com|
22438886|NCT04115384|HealthPartners Institute|Manager Research Operations|651-495-6363|ClinicalTrials@HealthPartners.com|
22438887|NCT01794000|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22438888|NCT00255190|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22438889|NCT01156480|NorthShore University HealthSystem|Dr. Brandy Frost|847-570-2033|bfrost@northshore.org|
22438890|NCT04537793|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22438891|NCT01255423|Novartis Consumer Health|Clinical Project Leader|0041223635528||
22438892|NCT05470387|Palisade Bio|Mitchell Jones, CMO|858-704-4900|mitchell.jones@palisadebio.com|
22438893|NCT00988598|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22438894|NCT03367858|University of Rhode Island|Dr. Sarah Feldstein Ewing|401-874-4251|feldsteinewing@uri.edu|
22438895|NCT03831477|Venus Concept|Director of Clinical Affairs|888-907-0115|mgronski@venusconcept.com|
22438896|NCT02197702|StJustineH|Dr Francine Ducharme|5143454931|Francine.m.ducharme@umontreal.ca|4398
22438897|NCT01619839|Nektar Therapeutics|Study Director|415-482-5300|medicalaffairs@nektar.com|
22438898|NCT03822897|Canadian Cancer Trials Group|Dr. Wendy Ranjana Parulekar|613 533 6430|wparulekar@ctg.queensu.ca|
22438899|NCT01859923|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22438900|NCT00429949|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
22438901|NCT02485561|Washington University in St. Louis|Amy McQueen|3142862016|amcqueen@wustl.edu|
22438902|NCT02079038|Vertiflex|Steve Reitzler|442-325-5934|Stephen.reitzler2@bsci.com|
22438903|NCT00985465|GlaxoSmithKline|GSK Response Center|866-435-7343||
22438904|NCT03101566|University of Michigan Rogel Cancer Center|Vaibhav Sahai, MBBS, MS|734-936-4991|vsahai@med.umich.edu|
22438905|NCT01054456|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22438906|NCT04701333|Stanford University|Principal Investigator|650-497-5175|gynresearch@stanford.edu|
22438907|NCT01012258|Merck Serono (Beijing) Pharmaceutical R&D Co., Ltd.|Medical Responsible|+49-6151-72-5200|service@merckgroup.com|
22396218|NCT04666350|PATH|Chris F Ockenhouse, MD, PhD|+1 (202) 716-5849|cockenhouse@path.org|
22438908|NCT03742973|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22396219|NCT02431897|University of Texas Southwestern Medical Center Dallas|Dr. David D. Rahn|12146486430|david.rahn@utsouthwestern.edu|
22438909|NCT02366195|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22438910|NCT00113841|UT MD Anderson Cancer Center|Saroj Vadhan-Raj, MD/Professor|713-792-9660|xzhou@mdanderson.org|
22438911|NCT00148759|Emory University|Ighovwerha Ofotokun, MD, MSc|404-616-0659|iofotok@emory.edu|
22438912|NCT00434226|Genentech, Inc.|Medical Communications Specialist|800-821-8590||
22438913|NCT03324802|Mayo Clinic|Carlos E. Vargas, M.D.|4803421262|Vargas.Carlos@mayo.edu|
22438914|NCT02451995|Imperial College Healthcare|Dr Vishal Luther|07828913612|v.luther14@imperial.ac.uk|
22438915|NCT03948334|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22438916|NCT05114473|University of Valencia|Dr. Borja Perez-Dominguez|697464680|f.borja.perez@uv.es|34
22438917|NCT02021942|Klinik und Poliklinik für Neurologie der Universitaet Regensburg|Prof. Dr. Berthold Schalke|+49 941 941|berthold.schalke@medbo.de|3010
22438918|NCT02946034|Massachusetts General Hospital|Dr. Raymond Chung|617-726-5925|Chung.Raymond@mgh.harvard.edu|
22438919|NCT02927392|University of Colorado Anschutz Medical Campus|Edward L. Melanson, PhD|303-724-0935|ed.melanson@cuanschutz.edu|
22438920|NCT01708317|Washington University School of Medicine|Dr. Fahd A Ahmad|314-286-0298|ahmad_f@kids.wustl.edu|
22438921|NCT01685567|Silk Road Medical, Inc.|Linda Ruedy. Sr. Director, Clinical and Regulatory Affairs|(408) 585-2113|lruedy@silkroadmed.com|
22438922|NCT02800863|Abbott Vascular|Nicole Harbert|(972) 526-4841|Nicole.harbert@abbott.com|
22438923|NCT01550809|Departamento de Endocrinología y Nutrición, Hospital Clínico Universitario de Valencia, Universitat de València, Valencia, Spain|Francisco Javier Ampudia Blasco|+34 96 3862665|Francisco.J.Ampudia@uv.es|
22438924|NCT06098937|Bausch & Lomb|Jeffery Schafer, OD, MS Director, Clinical Research|585-338-5664|jeffery.schafer@bausch.com|
22438925|NCT04332107|University of California, San Francisco FI Proctor Foundation|Dr. Thomas Lietman, Director of the UCSF FI Proctor Foundation|415-476-1442|tom.lietman@ucsf.edu|
22438926|NCT00271102|Geisinger|Office of Research Compliance|570-214-9628|orc@geisinger.edu|
22438927|NCT01670721|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22438928|NCT03061201|Pfizer Inc.|Pfizer Clinical Trials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22438929|NCT01572480|National Cancer Institute|Dr. Elizabeth Hill|240-760-6183|Elizabeth.Hill@nih.gov|
22438930|NCT05081219|Atrium Health Wake Forest Baptist|Suzanne Craft, PhD|336.713.8846|Suzanne.Craft@advocatehealth.org|
22438931|NCT03446313|University of California, San Francisco|Linda Park, Principle Investigator|415-502-6616|linda.park@ucsf.edu|
22438932|NCT06019728|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
22438933|NCT06235905|Navitorpharma|Senior Director Clinical Development|3018382521|gceresoliborroni@supernus.com|
22438934|NCT04894669|Masimo|Chelsea Frank|949-297-7000|clinicalresearchdept@masimo.com|
22438935|NCT00866814|C.R. Bard: Davol, Inc.|Dawn Heimer/Director, Clinical Affairs|401-825-8681|dawn.heimer@crbard.com|
22438936|NCT02756572|University of Washington/Seattle Cancer Care Alliance|Mary-Elizabeth Percival, MD, MS|206-606-1320|mperciva@seattlecca.org|
22378703|NCT01015807|Univerisity of Washington|Dr. Laurent Bollag|+12063277328|bollag@uw.edu|
22378704|NCT02200939|Smith+Nephew, Inc.|Laura England, Sr. Director Global Clinical Strategy|+1 650 223 6941|Laura.England@smith-nephew.com|
22378705|NCT04567693|Montefiore Medical Center|Dr. Jonathan Ross|718-920-7064|joross@montefiore.org|
22378706|NCT02134210|Coherus BioSciences, Inc|Barbara K. Finck, MD Chief Medical Officer|650-649-3529|Bfinck@coherus.com|
22378707|NCT02970032|University of Utah Health|Corinne Bertolaccini, PharmD|801-581-2167|Corinne.Bertolaccini@hsc.utah.edu|
22378708|NCT01596283|Memorial Sloan Kettering Cancer Center|Dr. Mary Fischer MD|212-639-6745|fischerm@mskcc.org|
22378709|NCT03722264|Virginia Commonwealth University|Eser Tufekci, DDS, PhD|804-828-9326|etufekci@vcu.edu|
22378710|NCT00957931|University of California, San Francisco|Dr. Sandhya Kharbanda, MD||Sandhya.Kharbanda@ucsf.edu|
22378711|NCT01486758|Washington University in St. Louis|Dr. Avraham Beigelman (PI)|314-454-2694|beigelman_a@kids.wustl.edu|
22378712|NCT01403441|Stanford University|Dr. Hugh Brent Solvason|650 776 4793|solvason@stanford.edu|
22378713|NCT03926065|Laboratory for the Study of Human Ingestive Behavior, The Pennsylvania State University|Dr. Barbara J. Rolls|814-863-8481|bjr4@psu.edu|
22378714|NCT02392611|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22378715|NCT03463915|University of Louisville|Sean Francis|502-561-7260|Sean.francis@louisville.edu|
22378716|NCT01334944|Cumberland Pharmaceutical Inc.|Dr. Amy Rock|615-255-0068|arock@cumberlandpharma.com|
22378717|NCT02687412|SichuanCHRI|Dr Cui Ling|+8618181422637|cuiling1985@qq.com|
22378718|NCT00553202|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22378719|NCT03239873|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22438937|NCT05551611|Kocaeli University|Dr. Suzi ÖZDEMİR|05548488674|suzi.ozdemir@gmail.com|
22378720|NCT00970216|Chang Gung Memorial Hospital|Chau-Ting Yeh|88633281200|chautingy@gmail.com|8121
22378721|NCT00805493|Emotion and Development Branch, NIMH-IRP|Kenneth Towbin, M.D., Chief Clinical Child and Adolescent Psychiatry|301-402-4403|Kenneth.Towbin@nih.gov|
22378722|NCT01703702|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22378723|NCT02045433|UT Southwestern/Simmons Cancer Center-Dallas|Dr.Kevin Albuquerque|2146458499|Kevin.Albuquerque@UTSouthwestern.edu|
22378724|NCT03585296|Aclaris Therapeutics|Executive Director Clinical Operations|4843242144|jschnyder@aclaristx.com|
22378725|NCT00041756|Procter & Gamble|Peter Thomas|513.622.4838|thomas.pr@pg.com|
22378726|NCT03270514|University of Pittsburgh Medical Center Department of Anesthesiology and Perioperative Medicine|Kathirvel Subramaniam, MD, MPH, FASE|724-799-5852|subramaniamk@upmc.edu|
22378727|NCT02002884|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
22378728|NCT02110732|Helsinki University Hospital|Anne Pitkäranta|+358406430511|anne.pitkaranta@hus.fi|
22378729|NCT02948959|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22438938|NCT03858049|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22438939|NCT02079740|Massachusetts General Hospital|Ryan Corcoran, MD PhD|617-724-4000|rbcorcoran@mgb.org|
22378730|NCT01778946|Vanderbilt University Medical Center|Dr. Paul Newhouse|6159360928|paul.newhouse@vanderbilt.edu|
22438940|NCT02777021|Children's Hospital of Philadelphia|Dr. Richard Aplenc|267-426-7252|aplenc@email.chop.edu|
22378731|NCT03802864|Weill Cornell Medicine|Russell Hayden|2127465566|rph9002@med.cornell.edu|
22378732|NCT01800201|University of Pennsylvania|Noora Marcus|215-746-4429|noora.marcus@uphs.upenn.edu|
22378733|NCT01480596|GlaxoSmithKline|GSK Response Center|866-435-7343||
22378734|NCT03338621|TB Alliance|Morounfolu Olugbosi|1 212 227 7540|morounfolu.olugbosi@tballiance.org|
22378735|NCT03812536|Ohio State University|Dr. Syed Husain|6142938772|syed.husain@osumc.edu|
22378736|NCT00152009|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22378737|NCT01306201|Covidien|Ulf Borg, Director of Clinical Affairs|303-305-2400|ulf.borg@covidien.com|
22378738|NCT00989586|The Ohio State University Comprehensive Cancer Center|Beth Christian|614-293-8858|beth.christian@osumc.edu|
22378739|NCT00980005|GlaxoSmithKline|GSK Response Center|866-435-7343||
22378740|NCT00572624|Washington University School of Medicine|Dr. Linda Peterson, M.D.|314-362-4577|lpeterso@dom.wustl.edu|
22378741|NCT01821417|University of Alabama at Birmingham|Nicolaas C. Geurs, DDS MS|2059344506|ngeurs@uab.edu|
22378742|NCT02037438|Stanford University|Dr. Clete Kushida|650-721-7560|clete@stanford.edu|
22378743|NCT05400746|University of Oxford|Dr. Angela M Minassian|01865611424|angela.minassian@bioch.ox.ac.uk|
22438941|NCT00599872|Greer Laboratories|Bob Esch, VP Research & Development|828.759.7845|esch@greerlabs.com|
22378744|NCT05375955|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22438942|NCT01474317|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
22438943|NCT00387881|GlaxoSmithKline|GSK Response Center|866-435-7343||
22438944|NCT01914003|QOL Medical, LLC|Heather Smith, Director of One Patient Services|919-832-4949|hsmith@onepatientservices.com|
22438945|NCT00453154|Duke University Medical Center|Dr. Neal Ready||ready001@mc.duke.edu|
22378745|NCT05261191|MacroGenics, Inc.|Chief Medical Officer|301-251-5172|info@macrogenics.com|
22378746|NCT03879408|Johnson & Johnson Consumer, Inc.|ASSOCIATE DIRECTOR CLINICAL RESEARCH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22378747|NCT04522180|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionisph.com|
22438946|NCT02719535|The Hong Kong Polytechnic University|Dr. Andrew Lam|85227666109|andrew.kc.lam@polyu.edu.hk|
22438947|NCT03629886|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22378748|NCT06334042|Hacettepe University Department of Anesthesiology and Intensive Care|Oguzhan Kahveci, MD|+903123051207|kahveci.oguz@hotmail.com|
22438948|NCT03052101|University of Cincinnati|Elizabeth Kopras|513-558-4831|koprasej@uc.edu|
22378749|NCT04571099|Philips Clinical & Medical Affairs Global|Marijke van Vlimmeren|+31 6 31042408|marijke.van.vlimmeren@philips.com|
22378750|NCT03267680|University of Southern California|Tali Homsey|3238650430|tali.homsey@med.usc.edu|
22378751|NCT02055157|BioMarin Pharmaceutical Inc.|Alice Hunstman-Labed|+44 207 4203392|alice.huntsmanlabed@bmrn.com|
22378752|NCT03976466|ISSEMyM Instituto de Seguridad Social del Estado de Mexico y Municipios|Julio Carlos Vélez de Lachica, Head of the orthopedics department at Regional Hospital Tlalnepantla|5526269200|activeknee@gmail.com|2100
22438949|NCT05473026|University of Florida|Lakeshia Cousin, PhD, APRN, AGPCNP-BC|352-273-6318|lakeshiacousin@ufl.edu|
22438950|NCT02038153|Montefiore|Dr. Ira Braunschweig|718 920-4826|ibraunsc@montefiore.org|
22378753|NCT02034708|Guerbet|Corinne Dubourdieu, PharmD, Head of Clinical Projects and Medical|+33 (0) 1 45 91 51 84|corinne.dubourdieu@guerbet-group.com|
22378754|NCT02247336|William S Middleton Memorial Veterans Hospital|Corrine Voils, PhD|608-256-1901|corrine.voils@va.gov|12208
22438951|NCT03683173|Washington University School of Medicine|Diana Parra Perez, Ph.D.|314-286-1426|parrad@wustl.edu|
22378755|NCT00733499|DePuy Ortho Joint US|Tamiko Magee-Rodgers, PhD||TMageeRo@its.jnj.com|
22438952|NCT02647281|GlaxoSmithKline|GSK Response Center|866-435-7343||
22438953|NCT01050634|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22438954|NCT00496015|GlaxoSmithKline|GSK Response Center|866-435-7343||
22438955|NCT01590979|Staten Island University Hospital, Northwell Health|Soad Bekheit, MD|718-226-6629|msills@northwell.edu|
22378756|NCT00733980|GlaxoSmithKline|GSK Response Center|866-435-7343||
22438956|NCT02730728|University of Pennsylvania|Dr Nabil Elkassabany|2156628000|nabil.elkassabany@uphs.upenn.edu|
22378757|NCT01931735|VA Palo Alto Research|Jessica Asay|650-493-5000|asay@stanford.edu|65971
22438957|NCT01293825|University Hospitals of Cleveland|Martha Sajatovic, Professor of Psychiatry|(216) 844-2808|martha.sajatovic@uhhospitals.org|
22438958|NCT00669214|Genentech, Inc.|Medical Communications|800-821-8590||
22438959|NCT02711137|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22378758|NCT01986101|Sumitomo Dainippon Pharmaceutical|Clinical Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
22378759|NCT02719990|Aravive, Inc.|Chief Operating Officer|(936) 355-1910|clinicaltrials@aravive.com|
22378760|NCT03020225|BGU|Prof. Iris Shai|+972 52-579-3040|irish@bgu.ac.il|
22438960|NCT03956550|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22378761|NCT00652938|GlaxoSmithKline|GSK Response Center|866-435-7343||
22378762|NCT03324880|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22378763|NCT01769170|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
22396220|NCT02054325|UPECLIN|Dr. Matheus Bertanha|+55 14 38116305|matheus.fameca@ig.com.br|
22396221|NCT02374021|Brigham and Women's Hospital|Dr. Daniel Solomon|617-732-5356|dsolomon@bwh.harvard.edu|
22378764|NCT01547299|Medivation, Inc.|William Novotny, MD, Sr. Director, Clinical Development|415- 983-3066|william.novotny@medivation.com|
22396222|NCT00732251|Cedars Sinai Medical Center|Felicia Mayes|310-423-0825|mayesf@cshs.org|
22438961|NCT03400852|Mallinckrodt|Medical Information Call Center|1-800-844-2830|MedInfo@mnk.com|
22438962|NCT00248495|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22438963|NCT01285401|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22378765|NCT05076149|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22438964|NCT02341235|The University of Texas Medical Branch|Eloisa Martinez|409-266-9643|esmartin@utmb.edu|
22378766|NCT02087501|Endospan|Jessica Kleine||j.Kleine@endospan.com|
22438965|NCT05200143|Providence Portland Medical Center|Dr. Matthew Taylor|503-215-1979|canrsrchstudies@providence.org|
22438966|NCT03719131|Emory University|Kavita Dhodapkar, MD|404-785-1112|kavita.dhodapkar@emory.edu|
22438967|NCT04244253|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22438968|NCT01544920|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22438969|NCT00411749|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22438970|NCT01495286|University of Arkansas|Anita Mitchell PhD, coinvestigator|501-686-7021|AMitchell@uams.edu|
22378767|NCT01481545|National Cancer Institute of Naples|Dr. Antonio Avallone|+39 081 5903629|a.avallone@istitutotumori.na.it|
22378768|NCT03682705|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22438971|NCT03001557|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_medinfo@eisai.com|
22438972|NCT01272232|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22438973|NCT02159066|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-102|ClinicalTrials.gov_Inquiries@pfizer.com|
22438974|NCT00796666|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22438975|NCT02531217|aTyr Pharma|Study Director|858 731 8389|clinicaltrials@atyrpharma.com|
22438976|NCT00628030|Virginia Commonwealth University|Suzanne E Mazzeo, Professor of Psychology|804-827-9211|semazzeo@vcu.edu|
22438977|NCT03392935|University of Utah Dermatology|Dr. Karen Stolman, Assistant Professor, Dermatology|8015816465|ks@checkmateproductions.com|
22378769|NCT00094328|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
22438978|NCT02119871|Department of Cardiothoracic Surgery, Lund University|Maya Landenhed Smith|+4646173639|maya.landenhed_smith@med.lu.se|
22438979|NCT00675909|Seattle Children's Hospital|Eileen Klein, MD, MPH|206-987-2599|eileen.klein@seattlechildrens.org|
22438980|NCT01894607|University of Texas (UT) MD Anderson Cancer Center|Ott Le, MD/Associate Professor, Diagnostic Radiation Body Imaging||CR_Study_Registration@mdanderson.org|
22438981|NCT02673918|University of British Columbia|Bolette Rafn|604-827-1914|bolette.rafn@ubc.ca|
22378770|NCT00117156|Dana-Farber Cancer Institute|Jennifer R. Brown, MD, PhD|(617) 632-3316|Jennifer_Brown@dfci.harvard.edu|
22378771|NCT02213328|Desmond Tutu HIV Foundation|Dr Katherine Gill|+2721 785 3121|katherine.gill@hiv-research.org.za|
22438982|NCT01787461|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22378772|NCT04043962|Seattle Children's Hospital|Tonya Palermo, Professor, Anesthesiology and Pain Medicine, Seattle Children's Hospital|206-884-4208|tonya.palermo@seattlechildrens.org|
22438983|NCT03259555|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22438984|NCT03957551|University of Iowa|John Rieth, MD|(319) 356-1616|john-rieth@uiowa.edu|
22438985|NCT02021669|Washington University School of Medicine|Robert M. Carney, Ph.D|314-286-1305|carneyr@wustl.edu|
22438986|NCT02717494|Westat|Lauren Laimon, Senior Study Director|240-453-2987|LaurenLaimon@westat.com|
22378773|NCT01654601|The Catholic university of Korea|Won-myung Bahk. M.D. PhD.|82-2-3779-1051|wmbahk@catholic.ac.kr|
22378774|NCT02636270|Cincinnati Childrens Hospital Medical Center|Philippe Backeljauw|513-636-8444|philippe.backeljauw@cchmc.org|
22378775|NCT04236258|Brigham and Women's Hospital|Dr. Elizabeth Yoselevsky|314-413-1254|eyoselevsky@bwh.harvard.edu|
22378776|NCT02053077|MUG|Thomas Pieber|004331638512383|thomas.pieber@medunigraz.at|
22378777|NCT04834817|University of California, Irvine|Dr. Kristen Kelly, Professor and Chair, Dept. of Dermatology|949-824-5515|kmkelly@hs.uci.edu|
22438987|NCT04037865|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22378778|NCT02209636|Rocky Mountain VA Medical Center|Anna Jovanovich, MD|303-724-8677|anna.jovanovich@va.gov|
22378779|NCT00856934|CHUV - CPR|Dr. Wassim Raffoul|+41 21 314 25 05|Wassim.Raffoul@chuv.ch|
22378780|NCT03285295|Abbott Laboratories|George Chen (Associate Director Clinical Affairs)|224-668-9185|george.chen@abbott.com|
22378781|NCT02762981|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
22438988|NCT01125800|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
22378782|NCT00976482|ospedale S Orsola- Malpighi, Bologna, Italy|dr Mauro Biffi|+393337661449|mauro.biffi@aosp.bo.it|
22378783|NCT02796274|Santhera Pharmaceuticals|Vanessa Dos Reis Ferreira|+41 61 906 89 50|office@santhera.com|
22378784|NCT04867785|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22438989|NCT00066677|Fox Chase Cancer Center|Steven J. Cohen|215-728-2450|s_cohen@fccc.edu|
22438990|NCT01808196|Cincinnati Children's Hospital Medical Center|Pablo Abonia, MD|513-636-|pablo.abonia@cchmc.org|
22378785|NCT02959671|University of Minnesota|Thorsten Gruenheid, DDS, PhD|612-625-3903|tgruenhe@umn.edu|
22396223|NCT00314353|NSABP Foundation, Inc.|Diana Gosik|412-330-4692|diana.gosik@nsabp.org|
22438991|NCT00479713|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22396224|NCT00846547|Seaside Therapeutics|Dr. Paul Wang, Vice President of Clinical and Medical Affairs|617-374-9009|pwang@seasidetherapeutics.com|1015
22396225|NCT00121836|Hoffmann-LaRoche|Medical Communications|800-821-8590||
22396226|NCT00316355|Hartford Hospital|David Tolin|860-545-7685|david.tolin@hhchealth.org|
22438992|NCT00214539|Boston Scientific Corporation|G Mark Grubb, RN, CCRA|412-716-0717|Mark.Grubb@bsci.com|
22438993|NCT04106609|Maple Tree Cancer Alliance|Dr. Karen Wonders|937-477-8213|karen.wonders@mapletreecanceralliance.org|
22396227|NCT00382720|sanofi-aventis|International Clinical Development Clinical Study Director||contact-us@sanofi-aventis.com|
22438994|NCT00141102|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22438995|NCT05477485|Virginia Commonwealth University|Dr. April D. Kimmel|(804) 628-6273|adkimmel@vcu.edu|
22438996|NCT05274958|Carilion Clinic|Director Psychiatry Clinical Research|540-527-4900|askablinger@carilionclinic.org|
22438997|NCT01505374|Hospital for Special Surgery|Stavros G. Memtsoudis, MD, PhD|212-606-1206|memtsoudiss@hss.edu|
22438998|NCT04266925|University of Alabama at Birmingham|Dr David Schwebel,|205-934-4068|schwebel@uab.edu|
22438999|NCT00386243|Center on Implementing Evidence Based Practice|Matthew J. Bair, MD MS|317-988-2058|mbair@iupui.edu|
22439000|NCT02682992|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, Regulatory Specialist Supervisor|412-647-5554|stadtermanbm@upmc.edu|
22439001|NCT00176462|Rutgers Cancer Institute of New Jersey|Richard Drachtman, MD|732-235-8675|drachtri@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu|
22439002|NCT03274063|University of Edinburgh|Dr Philip Riches|07944625313|priches@staffmail.ed.ac.uk|
22439003|NCT02679287|University of Virginia|Sue Brown, MD|434-982-0602|sab2f@virginia.edu|
22439004|NCT01511016|Baylor College of Medicine|Leanne Scott, PhD, Director of Sponsored Programs|713-798-6978|lbscott@bcm.edu|
22439005|NCT00320515|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22439006|NCT01114828|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
22439007|NCT00794950|University of Michigan|Alon Z. Weizer, MD, MS|734-615-6662|aweizer@umich.edu|
22439008|NCT02485704|ParaPRO, LLC|Kerry W. Mettert, MBA, MT(ASCP)|317-810-6205|kerrym@parapro.com|
22439009|NCT03628976|Georgia Institute of Technology|Dr. Minoru Shinohara|404-894-1030|shinohara@gatech.edu|
22439010|NCT00851786|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22439011|NCT01253642|OHSU Knight Cancer Institute|Kristi Eilers|503-494-2897|eilersk@ohsu.edu|
22439012|NCT04290039|BARDA|Brenda Wolling, Regulatory SME|(202) 692-4763|Brenda.Wolling@hhs.gov|
22439013|NCT01572207|Case Western Reserve University|Matthew Plow|216-368-8969|map208@case.edu|
22439014|NCT04617782|Corium, Inc.|Ronald Tashjian, Sr. Director of Clinical Operations|6172337474|rtashjian@coriumintl.com|
22439015|NCT04104256|University of California Los Angeles, Division of General Internal Medicine and Health Services Research|Project Manager|310-825-8253|cvillaflores@mednet.ucla.edu|
22439016|NCT01650298|ABBOTT|Grant Kim|818-493-3147|gkim@sjm.com|
22439017|NCT02849418|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22439018|NCT01405768|Washington University School of Medicine|L. Stewart Massad, M.D.|314-362-3181|massadl@wudosis.wustl.edu|
22439019|NCT01147042|NIH CC|Dr. John Gallin|301-827-5428|jgallin@cc.nih.gov|
22439020|NCT04388111|Houston Methodist Hospital|Research Coordinator|346 238 1603|tsullivan@houstonmethodist.org|
22439021|NCT00934635|Janssen Cilag|Medical Development Manager; Medical and Scientific Affairs|0049-2137-955-1240||
22439022|NCT00914186|Taisho Pharmaceutical R&D Inc.|Fred Henry MS, MPH,|973-898-6200|F-Henry@taihso-rd.com|
22439023|NCT05552027|Children's Hospital of Philadelphia|Morgan O'Donald|267-499-4114|ODONALDM@chop.edu|
22439024|NCT03360682|Hospital Clínic/IDIBAPS, University of Barcelona|Jose M. Miro Meda (PI), MD, PhD, Consultant, Infectious Diseases Service|93 227 54 30|JMMIRO@clinic.cat|
22439025|NCT02420093|University of Michigan Health System|Patricia Connors, PT, DScPT, OMPT|734-763-6464|pattyconnors219@gmail.com|
22439026|NCT02525653|Memorial Sloan Kettering Cancer Center|Dr. Paul Paik, MD|646-608-3759|paikp@mskcc.org|
22439027|NCT03244917|Hebrew SeniorLife|Susan Mitchell MD, MPH|6172813669|smitchell@hsl.harvard.edu|
22439028|NCT01147666|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441||
22439029|NCT02748863|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22439030|NCT01135134|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22439031|NCT02576639|Novartis Pharmaceuticals|Study Director|862-778-8300||
22439032|NCT04177706|Medical University of South Carolina|Prinicipal Investigator|8438761199|JONJEN@musc.edu|
22439033|NCT02111447|GLA|Research Coordinator|7163236570|tgensler@greatlakesanes.com|
22439034|NCT00271375|Atlanta VAMC|Patricia Griffiths|404-321-6111|Patricia.Griffiths@va.gov|7138
22439035|NCT02052544|DSM Nutritional Products Ltd Branch Pentapharm|Anne Brisset|41 61 706 4837|Anne.Brisset@pentapharm.com|
22439036|NCT03865446|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22439037|NCT01329978|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22439038|NCT02952365|Stanford University School of Medicine|Edward E. Manche|6507255765|edward.manche@stanford.edu|
22439039|NCT01188772|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22439040|NCT00287716|InterMune, Inc.|Bill Bradford, MD, PhD|(415) 466-2200|bbradford@intermune.com|
22439041|NCT03081884|Emory University|David M. Schuster, MD|404-712-4859|dschust@emory.edu|
22439042|NCT02294058|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|AMcClain@celgene.com|
22439043|NCT05006261|Spaulding Rehabilitation Hospital|Paolo Bonato, PhD|617-952-6319|pbonato@mgh.harvard.edu|
22439044|NCT02303093|Octapharma Pharmazeutika Produktionsgesm.b.H.,|Dr. Bernhard Rohrbacher|+431610324182|bernhard.rohrbacher@octapharma.com|
22439045|NCT00431626|Northwestern U|Borko D. Jovanovic, MS, PhD|312 503 2008|borko@northwestern.edu|
22439046|NCT00510835|UPittsburgh|Derek C. Angus, MD, MPH, FRCP|(412) 647-6965|angusdc@ccm.upmc.edu|
22439047|NCT05470985|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22439048|NCT01917747|UK Dept. of Otolaryngology Head and Neck Surgery|Dr. Matthew L. Bush|859-218-2168|matthew.bush@uky.edu|
22439049|NCT04388254|Cassava Sciences|Sr. Associate Director|5125013180|bmurray@cassavasciences.com|
22396228|NCT02414399|University of Washington|Dr. Patricia Pavlinac|206 616-8326|ppav@uw.edu|
22439050|NCT06451965|University of East Anglia|Ercan Hassan (Trainee Clinical Psychologist)|07496337806|nue22cyu@uea.ac.uk|
22439051|NCT02870283|Universidade Federal do Rio Grande do Sul|Dra. Ana Flávia Silva Lima|+5551999185180|afbslima@gmail.com|
22396229|NCT02737852|Church & Dwight Co., Inc|Annahita Ghassemi|6098061200|annhita.ghassemi@churchdwight.com|
22396230|NCT01704287|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22396231|NCT01717287|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22396232|NCT00886704|Ludwig Maximilians-University Munich|Clemens von Schacky, Head, Preventive Cardiology, University of Munich|+498951600|clemens.vonschacky@med.uni-muenchen.de|2165
22396233|NCT04968041|Florida State University|Julia Sheffler|850-644-4199|julia.sheffler@med.fsu.edu|
22396234|NCT04490395|Duke University|Jennifer Plumb Vilardaga, PhD|919-668-6123|jennifer.plumb.vilardaga@duke.edu|
22396235|NCT01667536|Progenics Pharmaceuticals, Inc.|Senior Director, Clinical Science Communications|914 784-1825|vdipippo@progenics.com|
22396236|NCT01861028|Conformis|Director of Clinical and Technical Research|781-345-9103|sumesh.zingde@conformis.com|
22396237|NCT01408992|Khon Kaen University|Dr. Kwanchanok Yimtae|66-43348396|kwayim@kku.ac.th|
22396238|NCT01021956|STEBA Biotech|Bertrand Gaillac International Project Leader|+33 9 74 19 79 05|b.gaillac@stebabiotech.com|
22396239|NCT02285920|University of Pennsylvania|Laura M. Dember, MD|215-573-5264|ldember@pennmedicine.upenn.edu|
22396240|NCT02247765|Medtronic|Michael Luna-Victoria|3034068955|michael.luna-victoria@medtronic.com|
22396241|NCT02357134|UT MD Anderson Cancer Center|David Hui, MD/ Associate Professor, Palliative Care Medicine|(713) 792-6258|dhui@mdanderson.org|
22396242|NCT00623974|UT MD Anderson Cancer Center|Mimi Hu, MD / Professor||CR_Study_Registration@mdanderson.org|
22396243|NCT01701999|California Department of Public Health|Dr. Jessica Khouri|510-231-7600|Jessica.Khouri@cdph.ca.gov|
22396244|NCT01179672|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22396245|NCT01994382|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
22396246|NCT04667377|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22396247|NCT02319668|GlaxoSmithKline|GSK Response Center|866-435-7343||
22396248|NCT01161043|Medtronic Diabetes|Suiying Huang|8185763319|suiying.huang@medtronic.com|
22396249|NCT02164929|Duke University Medical Center|Timothy Miller, MD||timothy.miller2@duke.edu|
22396250|NCT03496220|Angulus|Dr. Perry Dubin|‪(917) 426-5911‬|perry@angulus.us|
22396251|NCT00365456|Nycomed|Clinical Trial Operations|+45 4677 1111|clinicaltrials@nycomed.com|
22396252|NCT00550654|National Cancer Institute, National Institutes of Health|Deborah Citrin, M.D.|301-496-5457|citrind@mail.nih.gov|
22396253|NCT04754802|Vistagen Therapeutics, Inc.|Ester Salman, MPH|650-577-3693|clinicalstudies@vistagen.com|
22396254|NCT02150499|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351|clinicaltrialsdisclousre@sunovion.com|
22396255|NCT00701090|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22396256|NCT00873366|Mayo Clinic|Dr. Matthew P. Goetz|507-284-2511|goetz.matthew@mayo.edu|
22396257|NCT01576172|University of Chicago|Theodore Karrison, PhD|(773) 702-9326|tkarrison@health.bsd.uchicago.edu|
22396258|NCT01033552|University of Minnesota, Masonic Cancer Center|Dr. Jakub Tolar|(612) 626-5654|tolar003@umn.edu|
22396259|NCT00303979|Medtronic Cardiac Rhythm Disease Management|IMPROVE HF, Clinical Research Specialist||medtronicCRMtrials@medtronic.com|
22396260|NCT01958788|Concordia University|Elizabeth Hebert|1-514-848-2424|el_heber@live.concordia.ca|2199
22396261|NCT00962390|Ausio Pharmaceuticals, LLC|Rick Schwen, PhD, DABT, RAC / Vice President of Regulatory Affairs|513-731-0222|rick@ausiopharma.com|
22396262|NCT02613884|Kate Farms|Vanessa Millovich|3522634409|vannanole@gmail.com|
22396263|NCT04366050|UCSD|Rohit Loomba, MD, MHSc|858-246-2201|roloomba@ucsd.edu|
22396264|NCT00619970|CHLA|Brynie Slome Collins MD|323 361 2181|bcollins@chla.usc.edu|
22396265|NCT01299376|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22396266|NCT00766090|GlaxoSmithKline|GSK Response Center|866-435-7343||
22396267|NCT00528580|University of Chicago|Millie Maleckar|773-702-1472|mmalecka@bsd.uchicago.edu|
22396268|NCT03024970|CooperVision, Inc.|Myhanh Nguyen, OD, FAAO|925-730-6716|mnguyen@coopervision.com|
22396269|NCT00131469|OHSU|Eric Orwoll|15034940225|orwoll@ohsu.edu|
22396270|NCT00574288|Janssen Research & Development, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
22396271|NCT01106027|Mayo Clinic|Dr. Mark Stegall|507-284-6275|Stegall.Mark@mayo.edu|
22396272|NCT00356889|University of Wisconsin Cancer Center|William Schelman, M.D.||wrs@medicine.wisc.edu|
22396273|NCT00736034|Sourazky Tel-Aviv Medical Center|Dr. V. Vakhapova|972-3-6973698|vedanicek@gmail.com|
22396274|NCT01772004|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22396275|NCT03591354|University of Virginia|Sue Brown, MD|434-982-0602|sab2f@virginia.edu|
22396276|NCT01688856|The MetroHealth System|Dr. Jayme Knutson|216-957-3557|jsk12@case.edu|
22396277|NCT00773136|University of Miami|Dr. Sara Wester|305-326-6132|swester2@med.miami.edu|
22396278|NCT01210170|University of Miami|Adam Wanner, MD|(305) 243-2568|awanner@med.miami.edu|
22396279|NCT02032550|University of Pennsylvania|Ravishankar Jayadevappa|215-898-3798|jravi@pennmedicine.upenn.edu|
22439052|NCT00512876|U.S. Army Warfighter Refractive Surgery Research Center|Principal Investigator|571-231-1600|rose.sia@us.army.mil|
22439053|NCT02741245|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22439054|NCT02401347|Stanford Medicine at Stanford University|Melinda L Telli, MD|(650) 724-9533|mtelli@stanford.edu|
22396280|NCT02463071|AstraZeneca|Torbjorn Lundstrom, MD, PhD|+46 31 706 4100|torbjorn.lundstrom@astrazeneca.com|
22396281|NCT05144113|Spaulding Rehabilitation Hospital|Dr. J.Andrew Taylor|616-758-5503|jandrew_taylor@hms.harvard.edu|
22396282|NCT03422679|Cellestia Biotech AG|Maria Bobadilla, Chief Development Officer|+41616332957|maria.bobadilla@cellestia.com|
22396283|NCT00175877|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
22396284|NCT02705807|GlaxoSmithKline|GSK Response Center|866-435-7343||
22439055|NCT02354534|Johns Hopkins University|Cornelia L. Trimble, MD|410-502-0512|CervixDoctor@jhmi.edu|
22439056|NCT02997501|Astrazeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22378786|NCT01062763|Dept. of Endocrinology, Odense University Hospital|Dr. Ib A. Jacobsen|+45 27203135|ib.abildgaard@rsyd.dk|
22378787|NCT02494921|University of California, San Francisco|Dr. Rahul Aggarwal, MD|(415) 353-9278|Rahul.Aggarwal@ucsf.edu|
22439057|NCT00152503|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22378788|NCT03260127|VA San Diego Healthcare System|Laura Crocker|8586426484|laura.crocker@va.gov|
22378789|NCT00981474|Northwestern University|Paul C. Fitzgerald RN, BSN, MS|312-695-1064|p-fitzgerald2@northwestern.edu|
22439058|NCT00607087|sanofi-aventis|Medical Affairs Study Director||publicregistryGMA@sanofi-aventis.com|
22439059|NCT01887184|The University of Hong Kong|Professor Chi Wai Cheung|22553303|cheucw@hku.hk|
22439060|NCT01774799|Hebrew SeniorLife|Dr. Susan Mitchell|617-971-5326|smitchell@hsl.harvard.edu|
22439061|NCT04487106|The University of Texas MD Anderson Cancer Center|Nichols Short MD/Associate Professor|713-563-4485|NShort@mdanderson.org|
22439062|NCT04393493|hospital civil de guadalajara|Dr Jonathan Chavez Iñiguez|3313299609|jonarchi_10@hotmail.com|
22378790|NCT00605319|Weill Cornell Medical College|Dr. Alexis Te|646-962-4811|aet2005@med.cornell.edu|
22439063|NCT02910466|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22439064|NCT00965250|National Cancer Institute, National Institutes of Health|Dr. Arun Rajan|301-594-5322|rajana@mail.nih.gov|
22378791|NCT02991482|European Thoracic Oncology Platform (ETOP)|Heidi Roschitzki|+41 31 511 94 00|Heidi.Roschitzki@etop-eu.org|
22439065|NCT02537717|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
22439066|NCT05051579|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22439067|NCT00717249|Johnson & Johnson Vision Care Inc.|Brian Pall, O.D., M.S. Principal Research Optometrist|904-443-3500|BPALL@its.jnj.com|1290
22378792|NCT01567943|Washington State University|Michael McDonell|509 368-6967|mmcdonell@wsu.edu|
22439068|NCT02093793|Boston Scientific|Director of Clinical Sciences|6619494350|roshini.jain@bsci.com|
22439069|NCT03370718|M.D. Anderson Cancer Center|Mouhammed A. Habra, MD|713-792-2841|mahabra@mdanderson.org|
22439070|NCT06172348|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22439071|NCT01116648|Dana-Farber Cancer Institute|Dr. Joyce Liu|617-632-5269|joyce_liu@dfci.harvard.edu|
22439072|NCT04539938|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22439073|NCT04037891|Akari|Wynne H Weston-Davies|+44(0)7801 281283|wynne.weston-davies@akaritx.com|
22378793|NCT01213043|Grifols Therapeutics Inc.|Benjamin King, PhD||ben.king@grifols.com|
22439074|NCT00990106|VA Puget Sound Health Care System|Murray Raskind, MD|206-277-3797|Murray.Raskind@va.gov|
22439075|NCT04194944|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22378794|NCT01155830|University of Utah|Dr. Christian Yost|801/581-7052|christian.yost@hmbg.utah.edu|
22378795|NCT02887989|Cedars-Sinai Health System|Garth Fuller|3236003890|garth.fuller@cshs.org|
22378796|NCT05648357|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22439076|NCT03400475|University of Iowa|Dr. Ahmed Mahrous|3193336517|ahmedmohamed-mahrous@uiowa.edu|
22378797|NCT00768430|Baylor College of Medicine|Dr. Sanjay Mathew|7137911414|sjmathew@bcm.edu|5439
22439077|NCT03737123|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
22439078|NCT01519323|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22378798|NCT02949921|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
22378799|NCT03215901|Boston University|Jacob Bor, Assistant Professor|617-358-2176|jbor@bu.edu|
22378800|NCT04887948|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22378801|NCT02312856|CERENOVUS|Christopher Hendricks|415-656-6565|chendric@its.jnj.com|
22378802|NCT04415151|Yale School of Medicine|Hyung Chun, MD, FAHA|(203) 785-6012|hyung.chun@yale.edu|
22396285|NCT02003014|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22396286|NCT00617604|Astellas Pharma Europe B.V|Senior Director Medical Science||Astellas.resultsdisclosure@astellas.com|
22396287|NCT04029961|Medical College of Wisconsin|John LaDisa|414-288-6739|jladisa@mcw.edu|
22396288|NCT03086265|Stanford University|Vladimir Nekhendzy, M.D., FASA|650-498-4055|nek@stanford.edu|
22396289|NCT00688155|Wake Forest School of Medicine|Mark Espeland, PhD|336-761-2826|mespelan@wakehealth.edu|336
22396290|NCT04310085|Medicines for Malaria Venture|Dr Stephan Chalon|+41 22 555 0379|chalons@mmv.org|
22396291|NCT00445224|University of Kentucky|Dr. Tim L. Uhl Principal Investigator|859-323-1100|tluhl2@uky.edu|80858
22396292|NCT03184077|Virginia Commonwealth University|Lindsay Morrell, MD|410-823-1120|lmorrellmcv@gmail.com|
22396293|NCT04136184|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|760-603-2346|globalregulatoryaffairs@ionis.com|
22396294|NCT03318978|Oregon State University|David E. Williams, PhD|541-737-3277|david.williams@oregonstate.edu|
22439079|NCT00445549|National Cancer Institute, National Institutes of Health|Elise C. Kohn, M.D.|301-496-4916|kohne@mail.nih.gov|
22439080|NCT03439280|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22378803|NCT00638235|Eastern Virginia Medical School|Dr. James C Lukban, Professor & Director Division of urogynecology|7574467900|lukbanjc@evms.edu|
22378804|NCT01488708|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22378805|NCT01588990|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22378806|NCT02367716|Cardiac Rhythm Management, Abbott Medical Devices|Clay Cohorn, Clinical Program Director|+19723098087|clay.cohorn@abbott.com|
22378807|NCT01473381|Forest Research Institute|Suresh Durgam, MD Clinical Asset Lead for Vilazodone - Senior Director - Clinical Development|201 427-8000|suresh.durgam@frx.com|8172
22396295|NCT01499953|University Hospital Dresden, Centre for Vascular Medicine|PD Dr. med. Jan Beyer-Westendorf|+49-351-4582899|Jan.Beyer@uniklinikum-dresden.de|
22439081|NCT03096834|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22439082|NCT00246519|University of Florida|Julie A. Johnson|352-273-6007|johnson@cop.ufl.edu|
22439083|NCT01600326|University of Michigan|Jon Jacobson|734 936-4365|jjacobsn@umich.edu|
22439084|NCT00915954|Cedars-Sinai Medical Center|Dr. Odelia Cooper|310-423-2830|coopero@cshs.org|
22439085|NCT01521026|UCSD|Elizabeth Twamley, PhD|6195436684|etwamley@ucsd.edu|
22439086|NCT01169103|Massachusetts General Hospital|Madhusmita Misra|617-724-5602|mmisra@partners.org|
22439087|NCT06039579|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22439088|NCT02792231|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22439089|NCT03309878|Johns Hopkins University|Grants Administrative Manager|443-927-3568|JHCCCRO@jhmi.edu|
22439090|NCT00558246|Ethicon|Phyllis Britnell|1 908 218-3060|pbritnel@its.jnj.com|
22439091|NCT00303823|The University of Arizona|H-H. Sherry Chow, Ph.D.|520-626-3358|schow@azcc.arizona.edu|
22439092|NCT03518294|The Penn State College of Medicine|Dr. Jonathan Stine|7175311017|jstine@pennstatehealth.psu.edu|
22439093|NCT00657046|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
22439094|NCT03004365|Armata Pharmaceuticals, Inc.|Clinical Operations|3106652928|info@armatapharma.com|
22439095|NCT00706446|Brigham and Women's Hospital|Dr. Elliot Israel|6177328201|eisrael@partners.org|
22439096|NCT03827655|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22439097|NCT02519023|University of Minnesota|Dr. Jacob Hutchins|6122505535|hutc0079@umn.edu|
22439098|NCT03935126|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22439099|NCT01092728|The University of Texas (UT) MD Anderson Cancer Center|Kevin Kim, MD/Melanoma Medical Oncology|1-877-MDA-6789|CR_Study_Registration@mdanderson.org|
22439100|NCT02336607|Astrazeneca|BP of Astrazeneca|+86 21 60302288|aztrial_results_posting@astrazeneca.com|
22439101|NCT00961311|Medtronic Cardiovascular|K. Bogdanovich||rs.medtroniccardiovascularclinicaltrials@medtronic.com|
22439102|NCT00646646|University of Alabama at Birmingham|Dr. Michael Froelich|205-934-4711|froelich@uab.edu|
22439103|NCT01454596|National Cancer Institute|Dr. Steven A. Rosenberg|240-858-3080|sar@nci.nih.gov|
22439104|NCT00230126|The Ohio State University|Miguel Villalona|614-366-5068|miguel.villalona@osumc.edu|
22439105|NCT02314936|KGK Synergize Inc.|Dr. Tetyana Pelipyagina|5194389374|drtetyana@kgksynergize.com|
22439106|NCT04875806|NextCure, Inc|Senior VP, Clinical and Translational Development|240-399-4900|NCClin@nextcure.com|
22439107|NCT03318549|University of Miami|Vice Chair of Research|305-326-6373|fmedeiros@med.miami.edu|
22439108|NCT00104650|Amgen Inc.|Study Director|866-572-6436||
22439109|NCT03515824|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22439110|NCT01623479|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22439111|NCT03084796|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
22439112|NCT02586623|H. Lundbeck A/S|Email contact via|+45 36301311|LundbeckClinicalTrials@lundbeck.com|
22439113|NCT03799341|VA Pittsburgh Healthcare System|Sarah Forster, PhD|412-209-9208|sarah.forster2@va.gov|
22439114|NCT03064490|Duke University Health System (DUHS)|Linda Kaltenbach/Regulatory Coordinator|(919) 668-3726|linda.kaltenbach@duke.edu|
22439115|NCT02647723|University of Chicago|Dr. Kate Keenan|773-702-4449|kekeenan@uchicago.edu|
22439116|NCT05524220|The University of Texas Health Science Center at Houston|Erikka Washington, MD|713-500-6202|Erikka.L.Washington@uth.tmc.edu|
22439117|NCT05579977|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22439118|NCT00348673|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22439119|NCT00543777|UT MD Anderson Cancer Center|Haesun Choi, MD/Professor, Abdominal Imaging Department|(713) 745-4693|hchoi@mdanderson.org|
22439120|NCT01928927|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22439121|NCT01137370|Department of Medicine and Lung Institute, Seoul National University College of Medicine|Jae-Joon Yim|+82-2-2072-2059|yimjj@snu.ac.kr|
22439122|NCT00350844|Ann and Robert H. Lurie Children's Hospital of Chicago|Dr. Robert I. Liem|312-227-4842|Rliem@luriechildrens.org|
22439123|NCT01420926|Weill Medical College of Cornell University|Gail Roboz, M.D||gar2001@med.cornell.edu|
22439124|NCT00932321|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22439125|NCT04564846|Oramed, Ltd.|Chief Scientific Officer|+97225660001|miriam@oramed.com|
22439126|NCT03798717|University of Portsmouth|Dr. Ant Shepherd|02392845289|ant.shepherd@port.ac.uk|
22439127|NCT00179621|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22439128|NCT00865345|Medtronic|Scott Lee M.D.|818-576-4204|scott.w.lee@medtronic.com|
22439129|NCT01459588|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22439130|NCT00966654|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
22439131|NCT03692208|The University of Chicago|Dr. Elbert Huang|(773) 834-9143|ehuang@medicine.bsd.uchicago.edu|
22378808|NCT00539643|Memorial Sloan Kettering Cancer Center|Dr. Anne Covey, MD|212-639-6746|coveya@MSKCC.ORG|
22378809|NCT02508532|Blueprint Medicines|Medical Information|1-888-258-7768|medinfo@blueprintmedicines.com|
22378810|NCT01641926|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22378811|NCT01111838|Memorial Sloan Kettering Cancer Center|Dr. Andrea Cercek|646-888-4189|CercekA@mskcc.org|
22378812|NCT04399356|Tufts Medical Center|Dorothy Dulko, PhD - Research Project Director|(617) 636-5009|ddulko@Tuftsmedicalcenter.org|
22378813|NCT01916941|University of New Mexico|Dr. Claire Wilcox|505-272-2333|cewilcox@salud.unm.edu|
22396296|NCT03007979|Washington University School of Medicine|Cynthia X. Ma, M.D., Ph.D.|314-362-9383|cynthiaxma@wustl.edu|
22378814|NCT00098254|National Cancer Institute|Giuseppe Giaccone, M.D., PH.D.|301-496-4916|giacconeg@mail.nih.gov|
22378815|NCT02118337|MedImmune, LLC|Farzana Walcott|+1 301-398-3063|information.center@astrazeneca.com|
22378816|NCT02835846|Loyola University Chicago|Alan J Wolfe|7082165814|awolfe@luc.edu|
22378817|NCT00130793|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22378818|NCT00211237|Medtronic Spine and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
22378819|NCT01121172|4th Department of Pediatrics, School of Medicine, Aristotle University of Thessaloniki|Assimina Galli-Tsinopoulou, As.Professor of Pediatric Endocrinology|00302310991537|agalli@auth.gr|
22378820|NCT01003639|University of Iowa Hospitals and Clinics|Dr. Michael Wall|319-353-3942|michael-wall@uiowa.edu|
22378821|NCT02237508|Zambon SpA|Isabella Salerio, PhD|+39 02665241|clinicaltrials@zambongroup.com|
22378822|NCT01650519|Cumberland Pharmaceutical Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com|
22378823|NCT05458024|University of North Carolina at Chapel Hill|Sam McLean, MD, MPH|+1 (919) 843-5931|samuel_mclean@med.unc.edu|
22378824|NCT04986085|Grupo Español de Tumores Neuroendocrinos y Endocrinos|A responsible Person Designated by the Sponsor|0034934344412|investigacion@mfar.net|
22378825|NCT04000594|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22378826|NCT05807919|University of Mihcigan|Prashant Singh|734-647-9252|singhpr@med.umich.edu|
22378827|NCT00747123|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22378828|NCT03489057|University of North Carolina Lineberger Comprehensive Cancer Center|Xianming Tan, PhD|+1 919-966-8450|xianming@email.unc.edu|
22378829|NCT01786902|Asan Medical Center|Dr. Hanwook Yoo|82-2-3010-3374|hwyoo@amc.seoul.kr|
22378830|NCT00674466|ConjuChem Biotechnologies Inc.|Associate Director of Regulatory Affairs|310-405-7549|Aleece.Nolasco@nantbio.com|
22378831|NCT02277743|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
22378832|NCT01557322|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22378833|NCT00943306|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|857-242-5142|alison.long@aegerion.com|
22378834|NCT02739347|Baylor College of Medicine|Raymond Cho|7137987781|Raymond.Cho@bcm.edu|
22378835|NCT01552954|Department of Internal Medicine, Seoul National University Bundang Hospital|Ho Jun Chin|+82-10-7360-7025|mednep@snubh.org|
22378836|NCT00779779|GlaxoSmithKline|GSK Response Center|866-435-7343||
22378837|NCT01395823|Dialysis Clinic Inc|Karen Majchrzak|615-342-0483|karen.majchrzak@dciinc.org|
22378838|NCT00070135|The Ohio State University|Steven Devine, MD||steven.devine@osumc.edu|
22378839|NCT03300570|Fox Chase Cancer Center|David Weinberg, M.D., M.Sc.|215-214-1424|david.weinberg@fccc.edu|
22378840|NCT00116272|Amgen Inc.|Study Director|866-572-6436||
22378841|NCT03188120|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22378842|NCT00920023|Massachusetts General Hospital|Ralph Weissleder|6177268226|RWEISSLEDER@MGH.HARVARD.EDU|
22378843|NCT01235403|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22378844|NCT02296190|Milestone Pharmaceuticals|Francis Plat _MD_Chief Medical Officer|514-336-0444|fplat@milestonepharma.com|225
22378845|NCT01472874|Yale|Dr. Schilsky|203-785-2565|michael.schilsky@yale.edu|
22378846|NCT00717314|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22378847|NCT05096208|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22378848|NCT00782496|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
22378849|NCT00584935|UAB Department of Dermatology|Wendy Cantrell, CRNP|205-502-9960|wcantrell@uabmc.edu|
22378850|NCT01483937|BalanceSense LLC|Karen L. Atkins PhD PT|407 625 9680|atkins.balancesense@gmail.com|
22378851|NCT00399763|Denver Health|Christian Thurstone, M.D.|303-436-6006|christian.thurstone@dhha.org|
22378852|NCT03536546|Department of Veterans Affairs|Paul N Pfeiffer, MD MS|(734) 769-1000|Paul.Pfeiffer@va.gov|
22378853|NCT01833143|Memorial Sloan Kettering Cancer Center|Gregory Riely, MD, PhD|646-608-3913|rielyg@mskcc.org|
22378854|NCT00116844|GlaxoSmithKline|GSK Response Center|866-435-7343||
22378855|NCT00926003|Michigan State University|Dr. Michael J. Boivin|5174324204|Michael.Boivin@hc.msu.edu|
22378856|NCT00051168|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22378857|NCT02417532|The Chris Moody Centre|Nick Birch|+44 1604 215440|nickbirch@doctors.org.uk|
22378858|NCT00386308|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22378859|NCT01167179|Radboud University Nijmegen Medical Center|Jacqueline de Leeuw MSc|+31243614925|j.deleeuw@kno.umcn.nl|
22378860|NCT02769065|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22378861|NCT03017235|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DKO-Disclosure@ferring.com|
22378862|NCT03518658|CRHF Clinical|Keith Holloman|763-526-1545|keith.holloman@medtronic.com|
22378863|NCT00649389|Daiichi Sankyo|Howard Kessler|732-590-5032|hmkessler@dsi.com|
22378864|NCT04662671|EmitBio, Inc.|Chief Scientific Officer|(919) 321-1734|nstasko@emitbio.com|
22378865|NCT02746575|Washington University|Principal Investigator|7737022544||
22378866|NCT02608489|Soonchunhyang University Hospital|Dr. JinKwon Chung|82-2-709-9354|schcornea@schmc.ac.kr|
22378867|NCT03800979|Institute of Dermatology|Dr. Chinmanat Lekhavat (My old last name is Tangjaturonrusamee.)|+660847607474|chinmanat@hotmail.com|
22378868|NCT02419547|Brigham and Women's Hospital|Douglas Shook, MD, Chief, Divison of Cardiac Anesthesia|617-732-8219|dshook@bwh.harvard.edu|
22378869|NCT03728153|Massachusetts General Hospital|Farrah Mateen|16177248653|fmateen@mgh.harvard.edu|
22378870|NCT00432835|University of Mississippi Medical Center|Thomas L. Abell, MD, Professor of Medicine|6019844540|tabell@umc.edu|
22378871|NCT04042285|Hull University Teaching Hospitals NHS Trust|Louise Hitchman|01482 311925|l.hitchman@nhs.net|
22378872|NCT01662531|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
22378873|NCT00750282|Piramal Imaging|Dr. Juergen Hirschfeld|49 30 461 1246 15|juergen.hirschfeld@piramal.com|
22378874|NCT02341456|AstraZeneca|Lone Ottesen|1-877-240-9479|ClinicalTrialTransparency@astrazeneca.com|
22378875|NCT01077362|Janssen Research & Development, LLC|Senior Director, Clinical Research|1-800-526-7736||
22378876|NCT04343586|Northwestern University|Dermatology CTU|312-503-5944|NUderm-research@northwestern.edu|
22378877|NCT00500240|UT MD Anderson Cancer Center|Khanh D Vu, MD/ Associated Professor|713-745-4516|eharriso@mdanderson.org|
22378878|NCT00509002|The University of Texas (UT) MD Anderson Cancer Center|George R Blumenschein Jr, MD, Professor, Thoracic/Head & Neck Med. Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
22378879|NCT00301080|Northwestern University|Clinical Research Office|312-695-1301|cancertrials@northwestern.edu|
22378880|NCT01287520|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22378881|NCT03587142|Temple University|Dr. Henry Parkman|(215) 707-7579|henry.parkman@temple.edu|
22378882|NCT03673462|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@Sanofi.com|6#
22378883|NCT01581840|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
22378884|NCT01299090|Moy, Fincher, Chipps Medical Group|Lisa Chipps, MD|(310) 274-5372|lchipps@ucla.com|
22378885|NCT01616771|Seoul National University Hospital|Jin-Tae Kim|82-10-6260-8490|jintae73@gmail.com|
22378886|NCT00595270|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar.kastner@intercell.com|0
22378887|NCT01767935|Wake Forest University Health Sciences|Dr. David Childs|336-716-2471|dchilds@wakehealth.edu|
22378888|NCT04359771|faculty of medicine, Cairo University|Dr. Ahmed Abdelbaki|00201066642728|a.abdelbaki@kasralainy.edu.eg|
22378889|NCT01422369|Kowa Research Institute, Inc|Roger Morgan, MD FACS|919-433-1600|RMorgan@kowaus.com|
22378890|NCT04041440|Customized Learning Exercises for Aural Rehabilitation|Chief Operating Officer|314 399-9943|chris@amptify.com|
22378891|NCT02306265|GE Healthcare|Sara Lam|1-262-548-2369|Sara.J.Lam@ge.com|
22378892|NCT00517075|New York State Psychiatric Institute|Linda Sherman|(646) 774-7158|lsherma@nyspi.columbia.edu|
22378893|NCT02247804|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22378894|NCT01187329|Cleveland Clinic|Andra E. Duncan, M.D|216-445-2372|DUNCANA@ccf.org|
22378895|NCT01346514|VA Puget Sound|Carol Malte|206.277.3780|carol.malte@va.gov|
22378896|NCT00909480|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22378897|NCT01962025|Ottawa HRI|Dr. Deborah Zimmerman|613-722-7000|dzimmerman@toh.ca|
22378898|NCT05737433|Hepion Pharmaceuticals Inc|Jill Greytok|732-902-4000|jgreytok@hepionpharma.com|
22378899|NCT03002038|Isfahan University of Medical Sciences|Dr. Vahid Shaygannejad|+98 913 313 3550|shaygannejad@med.mui.ac.ir|
22378900|NCT01054573|Janssen Research & Development, LLC|Medical Leader|1 609 730-3174||
22378901|NCT00393523|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22378902|NCT02207439|University of Pennsylvania|Alexander Lin, MD|215-662-3198|alexander.lin2@pennmedicine.upenn.edu|
22378903|NCT03148236|Virginia Commonwealth University|Cory Trankle, MD|804-213-2679|cory.trankle@vcuhealth.org|
22378904|NCT01735396|Tisch Cancer Center, Icahn School of Medicine at Mount Sinai|Dr. Matthew David Galsky|212-689-5412|matthew.galsky@mssm.edu|
22378905|NCT03452176|Massachusetts General Hospital|Dr. Michael Levy|617-726-0412|mlevy11@mgh.harvard.edu|
22378906|NCT03724396|University of California San Diego|Dr. Dawn Eichen|858-249-1123|deichen@ucsd.edu|
22378907|NCT04616014|Oramed, Ltd.|Chief Scientific Officer|972-2-566-0001|miriam@oramed.com|
22378908|NCT00280826|National Eye Institute|Robert Nussenblatt, MD, MPH|301-496-3123|drbob@intra.nei.nih.gov|
22378909|NCT00682643|GlaxoSmithKline|GSK Response Center|866-435-7343||
22378910|NCT01875185|Johns Hopkins University School of Medicine|RhondaLyn McLean|(215) 662-4949|rhondalyn.mclean@uphs.upenn.edu|
22378911|NCT03238300|Medical University of South Carolina|Lindsay M. Squeglia, PhD|843-792-5451|squegli@musc.edu|
22378912|NCT00818961|Blood and Marrow Transplant Group of Georgia|Scott R. Solomon, MD|404-255-1930|ssolomon@bmtga.com|
22378913|NCT01286441|Santalis Pharmaceuticals|Dr. Paul Castella Ph.D.|210-399-2316|paulc@santalispharma.com|101
22378914|NCT00524225|University of Pittsburgh|Dr. Margaret Ragni, Professor of Medicine|412-209-7288|ragni@dom.pitt.edu|
22378915|NCT01226914|Medical University of South Carolina - Department of Otolaryngology - Head and Neck Surgery|Shaun A. Nguyen, MD, FAPCR|8437921356|nguyensh@musc.edu|
22378916|NCT04064242|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22378917|NCT03389477|Washington University School of Medicine|Douglas Adkins, M.D.|(314) 362-4471|dadkins@wustl.edu|
22378918|NCT04512066|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22378919|NCT03403426|Reflow Medical|Isa Rizk|9494810399|info@reflowmedical.com|
22378920|NCT01044576|Imperial College London|Professor Paolo Muraro|02075946670|p.muraro@imperial.ac.uk|
22378921|NCT00626366|University of Nebraska Medical Center|Erin K O'Brien|402-559-6463|irbora@unmc.edu|
22396297|NCT03734016|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22439132|NCT00882440|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
22439133|NCT02682381|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22439134|NCT05482308|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22439135|NCT00905450|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22439136|NCT01693029|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|004980244760|biopharma.clinicaltrials@sandoz.com|
22439137|NCT01329263|University of Pennsylvania|Dr. Andrew Strasser|2157465788|strasse3@mail.med.upenn.edu|
22378922|NCT00971750|Gundersen Lutheran Health System|Dr. Shanu Kothari|608-775-2331|snkothar@gundluth.org|
22378923|NCT01657266|Laboratorios Sophia S.A. de C.V.|Leopoldo M Baiza-Duran MD, Clinical trials Director|52+ (33) 30 01 42 00|leopoldo.baiza@sophia.com.mx|
22396298|NCT02715466|B. Braun Melsungen AG|Study Manager|00495661/71|studies@bbraun.com|0
22378924|NCT03520400|VA Palo Alto Health Care System|Dr. Jonathan Myers|6504503440|Drj993@aol.com|
22378925|NCT00445679|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22378926|NCT01316770|NIDCR/NIH|Ilias Alevizos|3014966207|alevizosi@mail.nih.gov|
22378927|NCT04366726|Radius Health, Inc.|Associate Director, Clinical Operations|(617) 551-4000|info@radiuspharm.com|
22378928|NCT00909428|Loyola University Chicago|Mary P FitzGerald|708-216-2170|mfitzg8@lumc.edu|
22378929|NCT01015976|University of North Dakota - Neuropsychiatric Research Institute|James L. Roerig PharmD, BCPP|701 365 4919|jroerig@nrifargo.com|
22378930|NCT01933880|Xi'an Janssen Pharmaceutical Ltd.|Director - CNS & Pain, CDMA, China R&D and SA|+86 10 5821-8307||
22378931|NCT01125722|Ethicon Endo-Surgery|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
22378932|NCT03474549|Rapid-Medical|Dr. Walid Haddad- Chief Clinical Officer|+972 72 2503331|walid@rapid-medical.com|
22378933|NCT00069784|sanofi|Trial Transparency Team||Contact_US@sanofi.com|
22396299|NCT01624259|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22396300|NCT01298518|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22396301|NCT02273726|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|064study@fibrogen.com|
22396302|NCT01979835|principal investigator|Ellen Wiebe|6047095611|ellenwiebe@gmail.com|
22396303|NCT01744353|Brown Oncology Research Group|Helena Lau|4018633000|helena_lau@brown.edu|
22425788|NCT05171270|University of Oxford|Professor Laura Coates|07870257823|laura.coates@ndorms.ox.ac.uk|
22378934|NCT01755143|Medtronic Cardiac Rhythm and Heart Failure|5076MRI Clinical Team|1-800-328-2518|MedtronicCRMtrials@medtronic.com|
22425789|NCT03743025|Emory University|Dr. Francisco J. Pasquel|404-778-1695|fpasque@emory.edu|
22425790|NCT04501952|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22425791|NCT00573872|University of Alabama at Birmingham|John Fiveash, MD|205-975-0224|jfiveash@uabmc.edu|
22425792|NCT00086450|Icahn School of Medicine at Mount Sinai|Dr. Valentin Fuster, M.D., Ph.D.|212-860-1056|valentin.fuster@mssm.edu|
22425793|NCT03509181|McLean Hospital|Courtney Beard|617-855-3557|cbeard@mclean.harvard.edu|
22425794|NCT04550364|Universoty of Oslo|Psychologist and PhD Bente Sommerfeldt|004793221280|bsommerfeldt@gmail.com|
22425795|NCT03382418|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22425796|NCT03138577|Weill Cornell Medical College|Dr. Tiffany Tedore|212-746-2725|tft9001@med.cornell.edu|
22425797|NCT02022735|University of Miami|Corneliu Luca, MD, PhD|305-243-6732|cluca@med.miami.edu|
22425798|NCT04283253|UNIVERSITY OF PITTSBURGH|George Wittenberg|4126484178|GEOWITT@PITT.EDU|
22425799|NCT01189461|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22425800|NCT02497937|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22378935|NCT04466215|The Scripps Research Institute|Dr. Barbara J.. Mason, Ph.D.|(858) 784-7324|mason@scripps.edu|
22396304|NCT03697720|NorthShore University HealthSystem|Kevin Hellman, Research Associate Professor|847-570-2622|khellman@northshore.org|
22425801|NCT00360009|University of Florida Department of Neurology|Michael Okun, M.D.|352-273-5550|okun@neurology.ufl.edu|
22425802|NCT05095311|Indiana University|Curtis Goss, Student Investigator|8178080085|csgoss13@gmail.com|
22425803|NCT03471832|CooperVision|Jose A.Vega, O.D., MSc., FAAO|9256213761|javega@coopervision.com|
22425804|NCT02385110|The University of Texas MD Anderson Cancer Center|Naval Daver, MD./Professor|713-794-4392|NDaver@mdanderson.org|
22425805|NCT00534638|GlaxoSmithKline|GSK Response Center|866-435-7343||
22425806|NCT00990509|University of Arizona|Chelsea Kidwell, MD|(520) 626-7159|ckidwell@neurology.arizona.edu|
22425807|NCT00282152|Vanderbilt University Medical Center|David Charles, MD||david.charles@Vanderbilt.Edu|
22425808|NCT00585325|University of Wisconsin-Madison|Cindy Schmitz, RN, MS, NP|608-262-2664|CSchmitz@uwhealth.org|
22425809|NCT03301831|Case Western Reserve University|Valerie Boebel Toly, PhD, RN, CPNP|(216) 368-3082|vab@case.edu|
22425810|NCT01919164|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22425811|NCT01239394|Massachusetts General Hospital Cancer Center|Jeremy Abramson, MD|617-724-4000|jabramson@mgh.harvard.edu|
22425812|NCT01476267|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
22425813|NCT00905632|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22425814|NCT03569098|Ipsen Pharma|Medical Director|see email|clinical.trials@ipsen.com|
22425815|NCT03939923|West Virginia University|Director of Research in Department of Anesthesiology|304-598-4122|david.scalzo@hsc.wvu.edu|
22425816|NCT01666912|UNC_ChapelHill|Amy G. Bryant, Assistant Professor|919-843-5633|amy_bryant@med.unc.edu|
22425817|NCT02485483|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22425818|NCT00377637|Hoffman-LaRoche|Medical Communications|800-821-8590||
22425819|NCT00193414|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22425820|NCT02922153|AtriCure|Nfii Ndikitum|513-644-8192|nndikintum@atricure.com|
22425821|NCT01116921|Unviersity of Minnesota|Kari D. Roberts, MD|612-625--9577|rober694@umn.edu|
22425822|NCT00522548|University of Pennsylvania|Roy Bloom, MD|215-662-4643|roy.bloom@uphs.upenn.edu|
22425823|NCT00956839|Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow|Professor Eesh Bhatia|00915222494382|ebhatia@sgpgi.ac.in|
22425824|NCT03506438|Duke|Christopher Cox|9196817232|christopher.cox@duke.edu|
22425825|NCT01128296|UPMC CancerCenter|Herbert Zeh, MD|412-692-2852|zehxhx@upmc.edu|
22425826|NCT04155463|Boise State University|Dr. Cynthia Curl|208-426-3924|cynthiacurl@boisestate.edu|
22378936|NCT00709059|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22425827|NCT00113295|Massachusetts General Hospital|Naomi M. Simon, M.D., M.Sc.|(617) 726-7913|nsimon@partners.org|
22425828|NCT01714544|Promius Pharma|Director Clinical Operations|609-282-1404|jfraser@drreddys.com|
22378937|NCT01786330|University of Kansas School of Medicine - Wichita|Zachary Kuhlmann, DO|316-685-7234|zkuhlmann@kumc.edu|
22378938|NCT00720902|Columbia University|Pamela Freda, MD|212-305-3725|puf1@columbia.edu|
22378939|NCT00708526|University of Utah|Dwayne Westenskow, PhD|801-581-2478|Dwayne.Westenskow@hsc.utah.edu|
22378940|NCT01478113|Massachusetts General Hospital|Maren Nyer|617-643-4897|mnyer@partners.org|
22378941|NCT00289770|GlaxoSmithKline|GSK Response Center|866-435-7343||
22378942|NCT02430818|Washington University School of Medicine|Evan Schwarz|3147473690|schwarze@wustl.edu|
22378943|NCT00674115|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22378944|NCT02966002|University of Michigan|Adam Lubert|734-764-5177|luberta@med.umich.edu|
22378945|NCT00067990|University_of_Minnesota|Hassan N. Ibrahim, MD|(612) 624-9444|ibrah007@umn.edu|
22378946|NCT02291432|Cook MyoSite Incorporated|Ron Jankowski, PhD|412-963-7380|Ron.Jankowski@CookMyosite.com|
22378947|NCT02145078|Barbara Ann Karmanos Cancer Institute|Gerold Bepler|(313)576-8670|beplerg@karmanos.org|
22378948|NCT01350141|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22378949|NCT00810082|Dartmouth College|Dr. Jon D. Lurie, MD, MS|603-653-3575|Jonathan D. Lurie <Jonathan.D.Lurie@hitchcock.org>|
22378950|NCT03327402|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22378951|NCT02134119|University of Georgia|Jamie Cooper|7065424903|jamie.cooper@uga.edu|
22378952|NCT01454830|The Pennsylvania State University|Amy M. Sawyer, PhD|814-863-1020|ams24@psu.edu|
22378953|NCT03810313|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22378954|NCT00584805|USAMRIID Medical Division|Anthony Cardile, D.O.|301-619-8833|anthony.cardile.mil@mail.mil|
22378955|NCT00872430|Hospital de Clínicas de Porto Alegre|Dr. Paulo Dornelles Picon|55 xx 51 21018752|paulopicon@gmail.com|
22378956|NCT04048759|University of Kansas Medical Center|Dr. Lauren Ptomey|913-588-7983|lptomey@kumc.edu|
22378957|NCT02648971|Wake Forest University|Dr. John Hubbard|336-998-1297|jhubbard@wakehealth.edu|
22378958|NCT00247624|August Health University|Vaughn McCall|706-721-3141|wmccall@augusta.edu|
22378959|NCT02768662|Otonomy, Inc.|Otonomy Medical information Center|1-844-686-4636|medinfo@otonomy.com|
22378960|NCT02294630|Wayne State University|Beena G. Sood, MD, MS|313-745-5638|bsood@med.wayne.edu|
22378961|NCT02352363|Acorda Therapeutics|Charles Oh|914-326-5455|coh@acorda.com|
22378962|NCT02567825|UPMC Children's Hospital of Pittsburgh|Alejandro Hoberman, MD|412-999-3277|hobermana@upmc.edu|
22378963|NCT01737684|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22396305|NCT05907213|University of Pittsburgh, UPMC Department of Anesthesiology & Perioperative Medicine|Dr. Katherine Grace Lim, Chief of the Division of OB & Women's Anesthesiology|412-641-1778|limkg2@upmc.edu|
22396306|NCT03688880|Grünenthal GmbH|Grünenthal Clinical-Trials Helpdesk|+49 241 569|clinical-trials@grunenthal.com|3223
22396307|NCT01183143|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22396308|NCT05745675|UCSF Hypoxia Research Laboratory|Dr. Philip Bickler|1-415-476-1411|philip.bickler@ucsf.edu|
22396309|NCT04042740|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22396310|NCT04024228|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22396311|NCT00938717|Ironwood Pharmaceuticals|Doug Levine, MD|617.374.3906|dlevine@ironwoodpharma.com|
22396312|NCT00998049|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
22439138|NCT01366872|Orthopaedic Associates of Michigan, PC|Dr. John G. Anderson|616-459-7101|John.Anderson@oamichigan.com|797
22439139|NCT01631435|Given Imaging- Covidien|Ravit Peled , Clinical trials manager|+972 (4) 909-7894|Ravit.peled@covidien.com|7894
22439140|NCT01421017|NYU Langone Health|Sylvia Adams|212-731-5795|sylvia.adams@nyumc.org|
22439141|NCT02313766|CaenUH|Pr Jean-Luc Hanouz|33 2 31 06 47 36|hanouz-jl@chu-caen.fr|
22439142|NCT04233008|Brigham and Women's Hospital|Sarah Little|617-732-5452|selittle@bwh.harvard.edu|
22439143|NCT01005251|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22439144|NCT01702844|University of North Carolina Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22439145|NCT02123134|Allergan, Inc|Beta Bowen|714-246-4446|Bowen_Beta@allergan.com|
22439146|NCT02995980|University of Alabama at Birmingahm|Rachael Lancaster, MD|205-934-4080|mvetrano@uabmc.edu|
22439147|NCT01173016|Masonic Cancer Center, University of Minnesota|Dr. Paul Orchard|612-626-2313|orcha001@umn.edu|
22439148|NCT00141453|Daiichi Sankyo, Inc|Howard Kessler|732-590-5032|hmkessler@dsi.com|
22439149|NCT01458639|Cyclomedica Australia Pty Ltd|Gary Somerville, Quality and Regulatory Manager|+61 (0)2 9541 0411|gsomerville@cyclomedica.com.au|
22439150|NCT02656017|University of Pittsburgh|Dr. Kyongtae Bae|412-647-3500|baek@upmc.edu|
22439151|NCT04245111|Dartmouth Health Orthopaedics|Dr. Ida Leah Gitajn|(603) 650-5133|Ida.Leah.Gitajn@hitchcock.org|
22439152|NCT01884077|Washington University School of Medicine - Dept of Orthopaedic Surgery|Dr. Aaron Chamberlain|314-362-9283|chamberlaina@wudosis.wustl.edu|
22439153|NCT00981149|ECU SODM|Sharon Gordon, DDS|2527377125|gordons@ecu.edu|
22439154|NCT01220167|Par Pharmaceutical|Medical Affairs|800-828-9393|DrugInfo@strativapharma.com|
22439155|NCT01008943|Cook Medical|Scott Snyder, PhD, Director of Clinical Science and Biostatistics|765-463-7537|ssnyder@medinst.com|
22439156|NCT00861705|Warren Alpert Medical School of Brown University, Department of Medicine|William M. Sikov, M.D.|401-793-7151|wsikov@lifespan.org|
22439157|NCT02634333|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|mhuggins@jaeb.org|
22378964|NCT03195465|Loma Linda University School of Allied Health Professions|Amy Sadek, PhD Rehabilitation Science|951-212-2104|asadek@llu.edu|
22378965|NCT03097861|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22378966|NCT05061537|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22378967|NCT00553098|Fred Hutch Cancer Research|Dr. Lauri Burroughs|206-667-2396|lburroug@fredhutch.org|
22378968|NCT03502616|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22378969|NCT04503096|Medical University of South Carolina|Andreana Benitez PhD|(843) 876-8479|benitez@musc.edu|
22378970|NCT01785563|University of Iowa|Tarah T. Colaizy|3193255640|tarah-colaizy@uiowa.edu|
22378971|NCT01872910|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22378972|NCT00628901|Boston Scientific|Ana Becker / Sr. Clinical Program Manager|651-581-4605|Ana.Becker@bsci.com|
22378973|NCT00744328|Northwestern University|Research Study Coordinator|312-695-8441|emily.pinheiro@northwestern.edu|
22378974|NCT01576367|Novartis Pharmaceuticals|Study Director|862-778-8300||
22378975|NCT00815035|University of North Carolina at Chapel Hill|Edwin Kim, Director UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
22378976|NCT02387216|Elevation oncology|VP, Clinical Operations|+1-716 371 1125|clinical@elevationoncology.com|
22378977|NCT02091739|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
22378978|NCT03469349|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22378979|NCT03528174|Oregon Health and Science University|Jessica Castle MD|503-494-7072|castleje@ohsu.edu|
22378980|NCT00868699|Sunovion|Medical Director, CNS|1-866-503-6351||
22378981|NCT04251065|SC Ematologia - Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) - Trieste|Prof. Francesco Zaja|+ 39 040 3992015|francesco.zaja@asugi.sanita.fvg.it|
22378982|NCT00817804|Respironics California|Adam Seiver|760-703-6993|adam.seiver@philips.com|
22378983|NCT01458990|Hunter Holmes McGuire VA Medical Center|Jasmohan Bajaj|804 675 5802|jasmohan.bajaj@va.gov|
22378984|NCT05288023|University of California San Francisco|Kieran O'Brien|(415) 476-1442|kieran.obrien@ucsf.edu|
22378985|NCT02235701|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22378986|NCT00525265|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7314||
22378987|NCT01778556|NIDDK|Dr. Rebecca Brown|301-594-0609|brownrebecca@mail.nih.gov|
22378988|NCT00576732|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Clinical Leader|609 730 2317||
22378989|NCT00265330|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22378990|NCT03571737|Brody School of Medicine @ East Carolina University|Dr. Jennifer Stahl|2527442570|stahlj@ecu.edu|
22378991|NCT02139358|H. Lee Moffitt Cancer Center and Research Institute|Dr. Hatem Soliman|813-745-4933|hatem.soliman@moffitt.org|
22378992|NCT04485130|University of California, San Francisco|Dr. Sulggi Lee|415-735-5127|sulggi.lee@ucsf.edu|
22378993|NCT02178566|Inova Health Systems|Christopher King, MD|7037763067|christopher.king@inova.org|
22378994|NCT02658630|VA Pittsburgh Healthcare System|George F. Wittenberg|412-648-4178|GeoWitt@Pitt.edu|
22378995|NCT00085202|St. Jude Children's Research Hospital|Amar Gajjar, MD|866-278-5833|info@stjude.org|
22378996|NCT02081950|Chemi SpA (Part of Italfarmaco Group)|Paolo Bettica, MD|+39 02 64431|p.bettica@italfarmaco.com|
22378997|NCT01436201|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22378998|NCT00110890|Amgen Inc.|Study Director|866-572-6436||
22378999|NCT01686581|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22379000|NCT01975220|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22379001|NCT01870388|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22379002|NCT00263328|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22379003|NCT03619590|GlaxoSmithKline|GSK Response Center|866-435-7343|sk994601@gsk.com|
22379004|NCT03245255|Thomas Jefferson University|Jaydev Dave|2158684795|dave.jaydev@mayo.edu|
22379005|NCT01087996|The EMMES Corporation|Adam Mendizabal|301 251 1161|amendizabal@emmes.com|221
22379006|NCT01008475|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22379007|NCT01301274|Intensive Care Unit - Hospital Pedro de Elizalde|Dr Facundo Jorro Barón|00541143632100|jorrobox@yahoo.com.ar|2035
22379008|NCT00661661|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22379009|NCT02917941|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22379010|NCT01893827|NYU Langone Health|Mia Malone|646-501-3577|mia.malone@nyulangone.org|
22379011|NCT00859651|Columbia University|Katherine Crew, MD|212-305-1732|kd59@cumc.columbia.edu|
22379012|NCT03021668|Johns Hopkins Hospital|Dr. Matthew J. Weiss|4106143368|mweiss5@jhmi.edu|
22379013|NCT00583622|The University of Texas MD Anderson Cancer|Yago Nieto, MD, PhD / Professor||celsaenz@mdanderson.org|
22379014|NCT02444988|Vanderbilt University Medical Center|Matthew W. Semler, MD, MSc|(615) 322-3412|matthew.w.semler@vumc.org|
22379015|NCT01382940|Hoffmann-La Roche|Medical Communications|800 821-8590||
22379016|NCT02105636|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22379017|NCT00291655|UCB Pharma|UCB Clinical trial call center|+1 877 822 9493||
22379018|NCT03366220|The University of Texas Health Science Center at Houston|Dr. Lillian S Kao|(713) 500-6280|Lillian.S.Kao@uth.tmc.edu|
22379019|NCT02341287|Weill Cornell Medicine|Matthew R. Ebben, Ph.D.|646-962-9313|mae2001@med.cornell.edu|
22379020|NCT02254408|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22379021|NCT01993017|Center for Behavioral Cardiovascular Health|Ian Kronish, MD, MPH, Principal Investigator|212-342-1335|ik2293@columbia.edu|
22379022|NCT00003511|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22439158|NCT02855203|Peter MacCallum Cancer Centre|Office of Cancer Research|+61 3 85597364|OCR@petermac.org|
22379023|NCT00917267|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22379024|NCT03638635|Inova Health System|Erica Emery|703-776-7615|erica.emery@inova.org|
22379025|NCT00423293|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
22379026|NCT03355755|Ekso Bionics|Leslie Van Hiel|4042268017|leslie.vanhiel@gmail.com|
22379027|NCT02406885|The Johns Hopkins University School of Medicine|Dr. Brent Petty|410-955-8181|bpg@jhmi.edu|
22379028|NCT01200030|The Hong Kong Polytechnic University|Dr. Shamay Ng|(852) 2766-4889|Shamay.Ng@polyu.edu.hk|
22379029|NCT00519896|University of Washington|Renato G Martins|206-288-2048|rgmart@uw.edu|
22379030|NCT01129336|Novartis Pharmaceuticals|Study Director|862-778-8300||
22379031|NCT00136812|Stanord University|Judith Prochaska, PhD, MPH; Associate Professor|650-724-3608|JPro@stanford.edu|
22439159|NCT03776864|University of Washington|Dr. Ryan Lynch|206-606-1739|rclynch@uw.edu|
22439160|NCT04864249|University of Pittsburgh Medical Center, Magee-Womens Hospital|Dr. Alisse Hauspurg|412-641-1381|janickia@upmc.edu|
22439161|NCT00300755|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22439162|NCT02694744|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com|
22439163|NCT00883779|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22439164|NCT04575155|Northwestern University|Dr. Michael Wolf|(312) 503-5592|mswolf@northwestern.edu|
22439165|NCT06237049|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov.Inquiries@pfizer.com|
22439166|NCT03748823|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22439167|NCT04678115|VA Central Western Massachusetts|Kevin Houston|781-588-7674|kevin.houston2@va.gov|
22439168|NCT01363700|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
22439169|NCT03649217|Moterum Technologies, Inc.|Brianne Darcy|(864) 659-3180|brie@moterumtechnologies.com|
22439170|NCT02643459|Herlev Hospital, Department of Cardiology|Dr. Martin Schultz|004538683868|martin.schultz@regionh.dk|
22439171|NCT02552966|Northwestern University|Dr. John Pandolfino, Principal Investigator|3126950182|j-pandolfino@northwestern.edu|
22439172|NCT00226590|Karmanos Cancer Institute (formerly at Moffitt Cancer Center)|Gerald Bepler, M.D., Ph.D., c/o Moffitt Cancer Center|813-745-4398|beplerg@karmanos.org|
22439173|NCT01091675|Unidad de Reumatología, Hospital Parc Tauli de Sabadell. Institut Universitari UAB|Dr. Jordi Gratacós Masmitjá|937.23.10.10|jgratacosmas@gmail.com|
22439174|NCT02794207|Children's Hospital of Philadelphia|Dr. Richard Aplenc|267-426-7252|aplenc@email.chop.edu|
22439175|NCT01775774|University of California San Francisco|Michael A. Matthay, MD|415-353-1206|michael.matthay@ucsf.edu|
22439176|NCT03483896|University of Southern California|Prof. Kyle Konis, Ph.D|(213) 740-2723|kkonis@usc.edu|
22439177|NCT02365649|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22439178|NCT01506271|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22439179|NCT00973752|Massachusetts General Hospital|Dr. Amir Fathi|617-724-1124|afathi@partners.org|
22439180|NCT01433172|H. Lee Moffitt Cancer Center and Research Institute|Dr. Jhanelle Gray|813-745-3050|jhanelle.gray@moffitt.org|
22439181|NCT01391663|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22439182|NCT00920855|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22439183|NCT00539994|GlaxoSmithKline|GSK Response Center|866-435-7343||
22439184|NCT01406990|Creighton University|Dr. Katie Packard, PharmD|402-280-4566|kathleenpackard@creighton.edu|
22439185|NCT01857297|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
22439186|NCT01611194|Intermountain Healthcare|Lindell Weaver, MD, FACP, UHM|801-408-3623|lindell.weaver@imail.org|
22439187|NCT03492125|MingSight Pharmaceuticals|Kai Zhang|8582055958|kzhang@mingsight.com|
22439188|NCT02464410|Veterans Health Administration|Amy Bohnert|734-845-3638|amybohne@med.umich.edu|
22439189|NCT01871519|Medtronic Spinal|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
22439190|NCT01777776|Array BioPharma, Inc.|Study Director|303-381-6604|info@arraybiopharma.com|
22439191|NCT02775916|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
22439192|NCT02722564|St. Luke's University Health Network|Holly Stankewicz, D.O.|484-526-4000|holly.stankewicz@gmail.com|
22439193|NCT02426580|The Nephrology Department, the Chengdu Second Affiliated Hospital of Chongqing Medical University, the Third Peoples's Hospital of Chengdu|Dr. Gong Rong, Dr. Han Tianzhao, Dr. Leonard Stern|+86 028-61318708|gongr2006@sina.com|
22439194|NCT00762359|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22439195|NCT00467077|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22439196|NCT01535807|Inova Heart and Vascular Institute|Lisa Fornaresio, PhD|703-776-7071|lisa.fornaresio@inova.org|
22439197|NCT01378988|Hospira|Marcelo Garcia de Rocha MD, Global Medical Director|224-212-4424|marcelo.rocha@hospira.com|
22439198|NCT00833040|AcelRx Pharmaceuticals, Inc.|Dr. Pamela Palmer|650-216-3504|ppalmer@acelrx.com|
22439199|NCT00416624|Mayo Clinic|Charles L. Loprinzi, M.D.|507-266-6247|loprinzi.charles@mayo.edu|
22439200|NCT02193776|TB Alliance|Almari Conradie, Director, Clinical Operations|+27 12 991 6328|almari.conradie@tballiance.org|
22439201|NCT02754570|University of Colorado|Rachel Gerle|720-848-5096|rachel.gerle@ucdenver.edu|
22439202|NCT00904813|Karolinska Institutet|Anna Martling|+46851770000|anna.martling@ki.se|
22439203|NCT00657540|Rocky Mountain Poison and Drug Center|Victoria Anderson - Research Projects Manager|303-389-1236|victoria.anderson@rmpdc.org|
22439204|NCT02043938|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
22439205|NCT03480048|Michigan State University|Jean Kerver, PhD, MSc, RD, Assistant Professor|231-392-8227|jkerver@epi.msu.edu|
22439206|NCT04375150|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22379032|NCT00791921|Professor, Department of Allergy and Rheumatology, Division of Internal Medicine, Graduate School of Medicine, University of Tokyo|Dr. Kazuhiko Yamamoto, Medical Advisor of the Clinical Trial|+81 3 5800 8825|yamamoto-tky@umin.ac.jp|
22379033|NCT02444663|University of Oxford|Thomas Hamilton, Clinical Research Fellow|01865227696|thomas.hamilton@ndorms.ox.ac.uk|
22379034|NCT03921190|University of Jordan|Dr. Ahmad El-Ma'aita|+9625355000|a.maaita@ju.edu.jo|
22396313|NCT00415506|Oregon Health & Science University|Dr. Eric B. Suhler|503-494-5023|suhlere@ohsu.edu|
22396314|NCT00618436|University of Pittsburgh|Dr. Lori Shutter|1-412-647-8410|shutterla@upmc.edu|
22396315|NCT01942148|Otsuka Pharmaceutical Co., Ltd|Director of Clinical Trials|+81-3-6361-7366||
22396316|NCT02248259|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22439207|NCT04755816|University of Michigan College of Pharmacy|Dr. MICHAEL DORSCH|734/647-1452|mdorsch@umich.edu|
22439208|NCT00659802|Hutchison Medipharma|Dr. Rongjun Liu|+86 21 2067 3203|rongjunl@hmplglobal.com|
22439209|NCT02611479|Surgical Outcomes Research Center - SORCE|Dr. Amy Cizik - Research Assistant Professor, Ph.D., M.P.H.,|206-744-4631|amorgan2@uw.edu|
22439210|NCT01441843|Erasmus University Medical Centre|Dr. M. Klimek|+31107033713|m.klimek@erasmusmc.nl|
22439211|NCT03936608|The University of Kansas|Amit Noheria|9135889757|amit.noheria@gmail.com|
22439212|NCT02422498|Memorial Sloan Kettering Cancer Center|Dr. Simon Powell, MD|212-639-3639|powells@mskcc.org|
22439213|NCT02653326|Universidad de Valparaiso|Carla Taramasco|2508306|carla.taramasco@uv.cl|+56 32
22439214|NCT01620060|Sunovion|Medical Director, CNS|1-866-503-6351||
22439215|NCT01960140|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22439216|NCT03452540|Afimmune|Study Director|+353 1 2946380|regulatory.afimmune@afimmune.com|
22439217|NCT05075746|Bausch & Lomb|Johnson Varughese|9089271162|johnson.varughese@bausch.com|
22439218|NCT04664153|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22439219|NCT03388346|UIHC|Dr. Michael Graham|319-356-4302|michael-graham@uiowa.edu|
22439220|NCT00231777|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22439221|NCT00524485|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22439222|NCT01600885|Yale University|John Krystal, MD|203-785-6396|john.krystal@yale.edu|
22439223|NCT00474123|Heart Institute (InCor) Hospital of the Faculty of Medicine, University of São Paulo (HCFMUSP)|Comparison of Antiplatelet and Anti-inflammatory Effects of High Dose Statin Monotherapy Versus Mode|55-11-30695058|eduardopesaro@hotmail.com|
22439224|NCT00702468|GW Pharma Ltd|Richard Potts Clinical Operations Director|+44 1353 616600|rp@gwpharm.com|
22439225|NCT01889667|Oramed|Chief Scientific Officer|+972-2-566-0001|aviva@oramed.com|
22439226|NCT00716963|McMaster University|Dr. Gail Gauvreau|905-525-9140|gauvreau@mcmaster.ca|22791
22439227|NCT00642356|Novartis Pharmaceuticals|Study Director|862 778-8300||
22439228|NCT02767271|Bausch Health Americas, Inc|Director of Clinical Operations||aloncaric@bauschhealth.com|
22439229|NCT01009060|GlaxoSmithKline|GSK Response Center|866-435-7343||
22439230|NCT00005906|TMB/NHLBI|Joel Moss|301-496-1597|mossj@nhlbi.nih.gov|
22439231|NCT04551989|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22439232|NCT04201431|University of Oxford|Dr. Angela Minassian|01865611425|angela.minassian@ndm.ox.ac.uk|
22439233|NCT02726620|Vanderbilt University Medical Center|Jonathan Wanderer|615-536-5194|jon.wanderer@vanderbilt.edu|
22379035|NCT01540565|NRG Oncology|Christopher Purdy on behalf of Mike Sill|(716)845-1300|purdyc@nrgoncology.org|2296
22379036|NCT01827254|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22379037|NCT04145037|AVROBIO, Inc|AVROBIO MedInfo|617-914-8419|medinfo@avrobio.com|
22379038|NCT01756560|University of Chicago|TARIQ MALIK|773-8342643|tmalik@dacc.uchicago.edu|
22379039|NCT02307513|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22379040|NCT01560260|Sarcoma Alliance for Research through Collaboration (SARC)|Kristen Nuyen, Research Project Manager|734-930-7600|sarc@sarctrials.org|
22379041|NCT01107743|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22379042|NCT02224482|Fox Chase Cancer Center|Dr. Suzanne Miller|215-728-4069|Suzanne.Miller@fccc.edu|
22379043|NCT00744263|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22379044|NCT01913639|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian, MD|646-888-4186|janjigiy@mskcc.org|
22379045|NCT00910520|Allergan, Inc|Therapeutic Area Head,|714-246-4500 ext:|clinicaltrials@allergan.com|
22379046|NCT01290822|Columbia University|Henry M. Spotnitz, MD|(212) 305-6191|hms2@columbia.edu|
22379047|NCT04078035|University of Pittsburgh|Dr. Anna Marsland|14123705622|marsland@pitt.edu|
22379048|NCT03758118|IRCCS Fondazione Bietti|Dr, Vincenzo Parisi|+390686356727|vmparisi@gmail.com|
22379049|NCT04296890|ImmunoGen, Inc|CMO, ImmunoGen|781-895-0600|clinicaltrials@immunogen.com|
22379050|NCT02100722|Stanford University|William Fearon, MD|650-725-2621|wfearon@stanford.edu|
22379051|NCT01782963|Massachusetts General Hospital|Noopur Raje, MD|617-724-4000|NRAJE@mgh.harvard.edu|
22379052|NCT04986982|BIAL - Portela & Ca, SA|Responsible of Clinical Operations|+351229866100|clinical.trials@bial.com|
22379053|NCT03500640|University of Pittsburgh School of Medicine|Elizabeth M. Venditti PhD, Associate Professor of Psychiatry and Epidemiology|4123025228|vendittiem@upmc.edu|
22379054|NCT02613221|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22379055|NCT01353222|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@dendreon.com|
22379056|NCT01119898|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22379057|NCT01807650|Amryt Pharma|Head of Clinical Development|+353 1 518 0200|medinfo@amrytpharma.com|
22379058|NCT02260401|University of Washington|Dr. Janna Friedly|206-744-3000|friedlyj@uw.edu|
22379059|NCT01122381|Vetarans Administration Pittsburgh Healthcare System|Kathy Gardner MD|(412) 360-6185|kathy.gardner@va.gov|
22379060|NCT02217280|Missouri Orthopaedic Institute|Dr. Christina Goldstein|573-884-9022|goldsteincl@health.missouri.edu|
22379061|NCT00736489|AstraZeneca|Carin Jorup, MSD||ClinicalTrialTransparency@astrazeneca.com|
22396317|NCT00625989|McMaster University|Dr. Gail Gauvreau|905-525-9140|gauvreau@mcmaster.ca|22791
22439234|NCT04055675|Kendall Regional Medical Center|Dr. Tony Zitek|305-480-6602|zitek10@gmail.com|
22439235|NCT00088530|CTIBioPharma Corp.|Simran Bedi Singh|(206) 272-4000|ssingh@ctibiopharma.com|
22439236|NCT04571944|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22439237|NCT03192826|Patras Medical School|OPHTHALMOLOGY PATRAS|6975801961|cgeorg@upatras.gr|
22439238|NCT00686777|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22439239|NCT00499681|Vanderbilt-Ingram Cancer Center|Ingrid Mayer, MD, Principal Investigator|615-936-2033|ingrid.mayer@vanderbilt.edu|
22439240|NCT00890825|AstraZeneca|Tracy Cunningham|1-877-400-4656|clinicaltrialtransparency@astrazeneca.com|
22439241|NCT02920892|Rush University Medical Center|Elizabeth Berry-Kravis, MD PhD|312-942-4036|Elizabeth_Berry-Kravis@rush.edu|
22439242|NCT01721161|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22439243|NCT01216202|Karolinska Institutet|Anna Martling|+46851770000|anna.martling@ki.se|
22439244|NCT02851303|Brown Family Medicine|Dr. Mary Beth Sutter|401-921-7981|marybeth_sutter@brown.edu|
22439245|NCT00614380|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22439246|NCT03476135|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22439247|NCT00689390|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22439248|NCT02570503|Virginia Commonwealth University|Teresa Potter|804-828-6749|teresa.potter@vcuhealth.org|
22439249|NCT04908397|Vanderbilt University Medical Center|Anna R. Hemnes|615-343-8227|anna.r.hemnes@vumc.org|
22439250|NCT00462306|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|312-926-9015|r-mccarthy@northwestern.edu|
22439251|NCT02221869|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-970-7145|ClinicalTrialDisclosure@JazzPharma.com|
22439252|NCT01673828|Department of Neurology, School of Medicine, University of California, Davis|Dr. Michael Rogawski|916-734-6285|rogawski@ucdavis.edu|
22439253|NCT00191334|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22439254|NCT00452790|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22439255|NCT02918357|University of California, San Francisco|Dr. Thomas Hope|(415) 221-4810|thomas.hope@ucsf.edu|2264
22439256|NCT03213834|University of Florida|Erin Silverman, Research Coordinator|352-273-5870|erin.silverman@medicine.ufl.edu|
22439257|NCT01663012|Stanford University School of Medicine650-|Lawrence Recht, MD, Professor of Neurology|650-725-8630|lrecht@stanford.edu|
22439258|NCT02926638|SWOG|Lung Committee Statistician|2066677733|kmini@fredhutch.org|
22439259|NCT02360228|University of North Carolina at Chapel Hill|Dr. Flavio Frohlich|(919) 966-4584|flavio_frohlich@med.unc.edu|
22439260|NCT01604291|Hoffmann-La Roche|Medical Communications|800-821-8590|Genentech@druginfo.com|
22439261|NCT01063153|Massachusetts General Hospital|Chief, Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD|(617)-724-0006|jbiederman@partners.org|
22439262|NCT01908426|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
22439263|NCT01273766|Comprehensive Cancer Center of Wake Forest University|Dr. Mary Ann Knovich|336-716-7973|mknovich@wakehealth.edu|
22439264|NCT01782898|Northwestern University|Gildasio De Oliveira, M.D.|312-695-4858|gjr@northwestern.edu|
22439265|NCT02973100|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22439266|NCT00383552|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22439267|NCT00960622|St Luke's Roosevelt Hospital New York|Dr. Donald Phillip Kotler|212 523 3670|dkotler@chpnet.org|
22439268|NCT04046328|Pharmascience Inc.|Clinical Study Manager|514-340-9800|researchsupport@pharmascience.com|
22439269|NCT01195701|TriHealth Hatton Research Institute|Academic Clinical Research Supervisor|513-862-2330|Angie_Fellner@trihealth.com|
22439270|NCT01419236|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22439271|NCT04456504|University of Wisconsin School of Pharmacy|Mary Hayney, PharmD, MPH, FCCP, BCPS|608-265-4666|mary.hayney@wisc.edu|
22439272|NCT00414635|Community Research Initiative of New England (CRINE)|Calvin Cohen, MD|617 502 1700|ccohen@crine.org|
22439273|NCT01342913|GlaxoSmithKline|GSK Response Center|866-435-7343||
22439274|NCT03112681|Zydus Therapeutics Inc.|Dr Deven Parmar|7324050886|dparmar@zydustherapeutics.com|
22439275|NCT05295849|University of Connecticut|Sherry Pagoto, PhD|860-486-5917|sherry.pagoto@uconn.edu|
22439276|NCT03287791|Teva Pharmaceuticals Inc. USA|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
22439277|NCT01381016|University of Colorado Denver|Associate Professor|(303) 724-2037|alex.polotsky@ucdenver.edu|
22439278|NCT01048879|University of Michigan|Bruce A. Mueller|7346154578|muellerb@umich.edu|
22396318|NCT02807480|Laureate Institute for Brain Research|Robin Aupperle|918-502-5744|raupperle@laureateinstitute.org|
22439279|NCT02764385|Oregon Health & Science University|Sue Flocke|5034946697|flocke@ohsu.edu|
22439280|NCT03598036|Aurinia Pharmaceuticals Inc.|Clinical Trial Support|1 (250) 744-2487|clinicaltrials@auriniapharma.com|
22439281|NCT02891174|University of Michigan|Dr. Elizabeth Langen|734-764-3406|elangen@med.umich.edu|
22439282|NCT04319198|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22439283|NCT03893396|Groupe Hospitalier de la Rochelle Ré Aunis|Caroline Allix-Béguec, clinical research manager|+33516494246|caroline.allix-beguec@ght-atlantique17.fr|
22439284|NCT02250326|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22439285|NCT05801991|Southern California College of Optometry|Erin Rueff, OD, PhD (Principal Investigator)|714-463-7586|erueff@ketchum.edu|
22439286|NCT01838694|Invion, Inc.|Mitchell Glass, M.D., EVP of R&D|+61 7 3295 0500|mitchell.glass@inviongroup.com|
22439287|NCT04235140|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22439288|NCT03016312|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22439289|NCT00945958|SPARC|Dr Shravanti Bhowmik||shravanti.bhowmik@sparcmail.com|
22439290|NCT02039115|Center for Interventional Endoscopy|Robin (Barron-Nelson) Kangas|407.303.5503|Robin.Barron@flhosp.org|
22396319|NCT01180478|CROES|J. de la Rosette, chairman CROES|+31 20 5666030|info@croesoffice.org|
22439291|NCT01755234|Northwestern University|Gildasio De Oliveira|312-695-4858|g-jr@northwestern.edu|
22439292|NCT02836652|Abbott|Poornima Sood|7818528334|poornima.sood@abbott.com|
22439293|NCT03812380|UT Southwestern Medical Center|Khashayar Sakhaee, MD|214-648-0324|Khashayar.Sakhaee@UTSouthwestern.edu|
22439294|NCT03679975|Aquestive Therapeutics|Gary Slatko, Chief Medical Officer|908-941-7050|clinicaltrials@aquestive.com|
22439295|NCT02349633|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22439296|NCT00667628|Taiho Oncology, Inc.|Taiho Central|+1 844-878-2446|medicalinformation@taihooncology.com|
22439297|NCT05789745|Nucleus Network|Trisha Shamp, Ph.D|651-641-2925|t.shamp@nucleusnetwork.com|
22439298|NCT04663321|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
22439299|NCT05108246|SUNY at Buffalo|Nikhil Satchidanand|7168162884|ns1@buffalo.edu|
22439300|NCT00622505|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22439301|NCT00619515|Case Comprehensive Cancer Center|Dr. Lee Ponsky|216-844-4831|lee.ponsky@uhhospitals.org|
22439302|NCT01839058|Western University|Keith McIntosh|519-646-6100|keith.mcintosh@sjhc.london.on.ca|61312
22439303|NCT03294590|Boston University Henry M. Goldman School of Dental Medicine|Belinda Borrelli, PhD|617-358-3358|belindab@bu.edu|
22439304|NCT03232346|NYS Psychiatric Institute|Dr. Adam Bisaga|646-774-6155|adam.bisaga@nyspi.columbia.edu|
22439305|NCT01962441|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22439306|NCT04862065|Abbott Laboratories|Tuan Bui (Manager Clinical Research)|224-668-4702|tuan.l.bui@abbott.com|
22439307|NCT02055898|Imperial College London|Keith Boland||k.boland@imperial.ac.uk|
22439308|NCT01453140|Hackensack University Medical Center|Dr. Michele Donato, MD|551-996-2000|MDonato@hackensackumc.org|3524
22439309|NCT01500772|Debiopharm International S.A.|Vice President, Clinical Research and Development|4121 321 01 11|info-international@debiopharm.com|
22439310|NCT00743249|Alcon Research, Ltd.|Theresa A. Landry, Ph.D.|1-888-451-3937|alcon.medinfo@alcon.com|
22439311|NCT00718510|Department of Psychiatry, University of Alberta|Dr. Serdar Dursun|(780) 492-7319|dursun@ualberta.ca|
22439312|NCT02201524|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22439313|NCT01332123|university of pittsburgh|Goeran Fiedler|4126246475|gfiedler@pitt.edu|
22439314|NCT00423657|Cerexa, Inc.|Vice President, Clinical Sciences|(510) 285-9200|clinicaltrials@cerexa.com|
22439315|NCT02314052|Dicerna Pharmaceuticals|Ralf Rosskamp|617-621-8097|rrosskamp@dicerna.com|
22439316|NCT00474955|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22439317|NCT01752426|The University of Texas MD Anderson Cancer Center|Jan Burger MD./Professor|713-563-1487|jaburger@mdanderson.org|
22439318|NCT02269124|Massachusetts Eye and Ear|Dr. Michael S. Cohen, MD|6175733190|Michael_Cohen@MEEI.HARVARD.EDU|
22439319|NCT00966186|Seoul National University Bundang Hospital|Jung-Won Hwang|82-31-787-7499|jungwon@snubh.org|
22439320|NCT00667888|UT MD Anderson Cancer Center|Karen Huffman, MD/ Associate Professor, Radiation Oncology Department|(713) 563-2339|khoffman1@mdanderson.org|
22439321|NCT01945021|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22439322|NCT00739401|Endologix|Elisa Hebb, VP Clinical Affairs|949-598-4628|ehebb@endologix.com|
22439323|NCT03808090|University of Alabama at Birmingham|Dr Kyle Wood|205-996-2295|kylewood@uabmc.edu|
22439324|NCT01239381|Massachusetts General Hospital|Theodore S Hong, MD, physician radiation oncology|617-726-6050|TSHONG1@mgh.harvard.edu|
22439325|NCT00791908|Northwestern University|Murad Alam, MD|312-695-6785|m-alam@northwestern.edu|
22439326|NCT05550779|University of Colorado Colorado Springs|Dr. Lori James|7192554172|ljames@uccs.edu|
22439327|NCT03349723|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22439328|NCT00399308|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22439329|NCT03409796|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22439330|NCT00770653|Takeda Pharma GmbH, Aachen (Germany)|Medical Director|+49 800 8253325|clinicaltrialregistry@tpna.com|
22439331|NCT00837252|National Eye Institute|Catherine M. Meyerle, MD|301-435-7821|meyerlec@nei.nih.gov|
22439332|NCT00683878|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
22439333|NCT02869633|Vanderbilt-Ingram Cancer Center|Teresa Melton|615-936-7423|teresa.melton@vumc.org|
22439334|NCT03441477|NIDEK Co., LTD.|Tadakazu Ichimura|+81-533-67-8904|tadakazu_ichimura@nidek.co.jp|
22439335|NCT02714400|UCSD|Dillon Gilbertson|8582452155|dcgilbertson@health.ucsd.edu|62155
22439336|NCT01314313|Edwards Lifesciences|Tenley Koepnick||Tenley_Koepnick@edwards.com|
22439337|NCT04494841|MMJ Labs|Dr. Amy Baxter|1 877 805 2899|abaxter@mmjlabs.com|
22439338|NCT04346745|Columbia University|Associate Professor|2128512246|jl4658@columbia.edu|
22439339|NCT04607668|G1 Therapeutics, Inc|Clinical Trial Info|+1 9192139835|clinicalinfo@g1therapeutics.com|
22439340|NCT01451723|Louisiana Health Sciences Center-New Orleans|Jesus Lovera MD|50-903 9302|jlover@lsuhsc.edu|
22439341|NCT02210000|GlaxoSmithKline|GSK Response Center|866-435-7343||
22439342|NCT00308139|AstraZeneca|ClinicalTrialTransparency@astrazeneca.com||ClinicalTrialTransparency@astrazeneca.com|
22439343|NCT02152826|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
22439344|NCT02780401|University of Washington Medical Center|Jennifer S. Childs|2066162305|childj@u.washington.edu|
22439345|NCT01893801|Cancer Research and Biostatistics|Adam Rosenthal|(206) 839-1797|adamr@crab.org|
22439346|NCT00322777|Canadian Institute of Natural and Integrative Medicine|Dr. Badri Rickhi|403-220-0022|b.ricki@cinim.org|0
22439347|NCT00962208|The Hong Kong Polytechnic University|Prof Pauline Cho|(852) 2766-6100|sopaulin@polyu.edu.hk|
22439348|NCT00791388|Procter & Gamble|Peter Thomas|513.622.4838|thomas.pr@pg.com|
22439349|NCT02690181|GlaxoSmithKline|GSK Response Center|866-435-7343||
22379062|NCT02395133|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
22439350|NCT01731912|University of Washington|Dr. Bruce Montgomery|206-598-0860|rbmontgo@uw.edu|
22439351|NCT03285724|Edwards Lifesciences, LLC|Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Andrey_Nersesov@edwards.com|0225
22439352|NCT03010527|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22439353|NCT00443040|Tioga Pharmaceuticals|Dr. Allen Mangel, Chief Medical Officer|919-485-5668|mangel@tiogapharma.com|
22439354|NCT04750824|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22439355|NCT02469623|Acutus Medical, Inc.|Steve McQuillan, Sr. Vice President Regulatory, Clinical, & Quality Assurance|442232608-|steven.mcquillan@acutus.com|
22439356|NCT04073186|Johnson & Johnson Vision Care|Thomas Karkkainen- Sr. Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
22439357|NCT01096316|Dept Psychiatry & Behavioral Sciences University of Washington|Jurgen Unutzer MD MPH MA, Professor and Chair|206-543-3752|unutzer@uw.edu|
22439358|NCT02763644|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
22439359|NCT00473434|Jan-Cil Australia|Regional Medical Affairs Therapeutic Lead Immunol|61 2 88753219||
22439360|NCT05757648|University Hospitals Cleveland Medical Center|Dr. Ying An|(216)368-3277|Ying.An@UHhospitals.org|
22439361|NCT02356159|National Cancer Institute|Dr. Najla El Jurdi|240-992-4033|najla.eljurdi@nih.gov|
22439362|NCT06418152|Cleveland Clinic|Jay Alberts, PhD|216-445-3222|albertj@ccf.org|
22439363|NCT05796557|Yale|Oliver Karam|203-785-4651|oliver.karam@yale.edu|
22439364|NCT05256901|Emory University|Viola Vaccarino, MD, PhD, Principal Investigator|404-727-8710|lvaccar@emory.edu|
22439365|NCT02529852|M D Anderson Cancer Center|Jason Westin|(713) 792-3750|jwestin@mdanderson.org|
22439366|NCT00117637|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22439367|NCT03255902|William Beaumont Hospitals|Donna Marvicsin, Nurse Practitioner, Pediatric Endocrinology|248-568-6932|donna.marvicsin@beaumont.org|
22439368|NCT02646826|Wellesley Pharmaceuticals, LLC|David Dill|2154930168|ddill@wellesleypharma.com|
22439369|NCT03206216|Stanford University Medical Center|Seema Nagpal, MD|650-725-8630|snagpal@stanford.edu|
22439370|NCT03650088|University of North Carolina at Chapel Hill|Deborah F. Tate, PhD|919-966-5851|dtate@unc.edu|
22439371|NCT01814774|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22439372|NCT01582061|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22439373|NCT00097500|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22439374|NCT03043534|WakeForest|Dr Amy McMichael|336-716-3775|amcmicha@wakehealth.edu|
22439375|NCT00119847|Stony Brook University|Dr. Eric J. Rashba|631-444-3575|eric.rashba@stonybrookmedicine.edu|
22439376|NCT03581279|MDC Associates, Inc.|Manager, Regulatory and Clinical Affairs|9787055012|t2@mdcassoc.com|
22439377|NCT03119259|Indiana University|Dr. Richard Holden|812-586-1965|rjholden@iu.edu|
22439378|NCT00099372|RTI International|Dr. Marie Gantz|919-597-5110|mgantz@rti.org|
22439379|NCT00003468|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22439380|NCT02527681|Basilea Pharmaceutica International Ltd.|Project Physician|+41 79 701 0551|marc.engelhardt@basilea.com|
22439381|NCT02972931|AIDS Research Institute IrsiCaixa|Dr. Judith Dalmau|934656374|jdalmau@irsicaixa.es|161
22439382|NCT00756106|Massachusetts General Hospital|Dr. Elizabeth Gerstner||EGERSTNER@mgh.harvard.edu|
22439383|NCT00647296|Knopp Biosciences|Head of Regulatory|4124881776|greg@knoppbio.com|
22439384|NCT01300234|GlaxoSmithKline|GSK Response Center|866-435-7343||
22439385|NCT03253679|M D Anderson Cancer Center|Dr. Siqing Fu|713-792-4318|siqingfu@mdanderson.org|
22439386|NCT04816214|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
22439387|NCT04879628|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610 ext 6#|Contact-US@sanofi.com|
22439388|NCT00055692|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
22439389|NCT02348593|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-970-7145|ClinicalTrialDisclosure@JazzPharma.com|
22439390|NCT00360412|Eisai Call Center|Eisai Inc.|888-422-4743||
22439391|NCT00871871|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22439392|NCT04612725|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22439393|NCT03863509|University of Wisconsin-Madison|Dr James H. Stein|608-262-2075|jhs@medicine.wisc.edu|
22439394|NCT03861273|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22439395|NCT02511379|Alcon, A Novartis Division|Study Director Med Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
22439396|NCT01855360|Brigham and WQomen's Hospital|Rodney H Falk|6175257053|rfalk@bwh.harvard.edu|
22439397|NCT00948064|University of Texas (UT) MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/Professor, Leukemia Department|713-745-3428|CR_Study_Registration@mdanderson.org|
22439398|NCT00740220|Wake Forest University|Arjun Chatterjee, MD, MS, FCCP|336.716.4649|achatter@wfubmc.edu|
22439399|NCT00633477|Takeda|Takeda Study Registration Call Center|800-778-2860|medicalinformation@tpna.com|
22439400|NCT02539823|Icahn School of Medicine at Mount Sinai|Yasmin Hurd, PhD|212 824 9314|yasmin.hurd@mssm.edu|
22439401|NCT00289653|Centre for Addiction and Mental Health|Dr. Peter Selby|416-535-8501|peter.selby@camh.ca|36859
22439402|NCT01962792|Pharmacyclics LLC|Thorsten Graef, Head of Clinical Development|+1 (408) 215-3127|tgraef@pcyc.com|
22439403|NCT04906499|University of North Carolina at Chapel Hill|Caroline Lisee, PhD|919-962-2025|liseecar@email.unc.edu|
22379063|NCT01583101|Indiana University School of Medicine|Aaron E. Carroll, MD, MS|3172789616|aaecarro@iu.edu|
22379064|NCT02907814|Rutgers New Jersey Medical School|Dr. Elliot Crane|973-972-2020|cranees@njms.rutgers.edu|
22379065|NCT00834808|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
22379066|NCT03573908|Ironwood Pharmaceuticals, Inc.|Vanessa Chong|(617) 374-3923|vchong@ironwoodpharma.com|
22379067|NCT04006925|Stanford University|Emmanuel During|212-844-8888|Emmanuel.During@mountsinai.org|
22439404|NCT05622734|University of Washington School of Nursing|Oleg Zaslavsky|2068493301|ozasl@uw.edu|
22439405|NCT03346434|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22439406|NCT03240601|Shepherd Center|Dr. Edelle Field-Fote|4046034274|edelle.field-fote@shepherd.org|
22439407|NCT02081677|Johnson & Johnson Vision Care Inc.|Tawnya Wilson, Principal Research Optometrist|904-443-1834|TWilson@ITS.JNJ.com|
22439408|NCT01414634|Neuroimmunology and MS Research, Department of Neurology, University Hospital Zürich, 8091 Zürich, Switzerland|Roland Martin|044 255 11 25|roland.martin@usz.ch|
22439409|NCT03270436|University of Arkansas for Medical Sciences|Dr. Pearl A. McElfish|479-713-8680|pamcelfish@uams.edu|
22439410|NCT00575185|University of Minnesota|Hank Balfour MD|(612) 626-5670|balfo001@umn.edu|
22439411|NCT04416204|University of Alabama at Birmingham|Dr. Rita Basu|2059341200|rbasu@uabmc.edu|
22439412|NCT01959503|C.R. Bard|Dawn Heimer|401-825-8681|Dawn.Heimer@crbard.com|
22439413|NCT01364896|University of Pittsburgh|Ross Cranston|412-383-1675|rdc27@pitt.edu|
22439414|NCT01393158|Oregon Health & Science University|Dr. Eric Simpson,|503-494-2121|simpsone@ohsu.edu|
22439415|NCT02413918|University of Texas HEalth Science Center San Antonio|Charles Bowden, MD|210-567-5405|BowdenC@uthscsa.edu|
22439416|NCT04233801|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22439417|NCT02173769|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22439418|NCT01419795|Fred Hutchinson Cancer Research Center|Dr. Mohamed Sorror|206-667-6298|msorror@fredhutch.org|
22439419|NCT01391364|Bausch Health|Study Director||robert.steffen@bausch.com|
22439420|NCT02985827|Ora|Senior Director of Research and Development|9786858900|klane@oraclinical.com|
22439421|NCT01977547|Washington University School of Medicine|Dr. Philip C. Spinella|3142860858|pspinella@wustl.edu|
22439422|NCT01841281|UC Davis|Dr. Nicholas Kenyon|916-734-3564|njkenyon@ucdavis.edu|
22439423|NCT04024891|Ocuphire Pharma, Inc.|Drey Coleman|8134041993|dcoleman@ocuphire.com|
22439424|NCT02041325|BVARI|Dr. Nikhil C. Munshi|857-203-6172|nikhil_munshi@va.gov|
22439425|NCT03397264|Opthea|Director of Clinical Research|+61 3 9826 0399|info@opthea.com|
22439426|NCT03095651|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22439427|NCT00851357|UCSD|Principal Investigator|858-300-1056|szhu@ucsd.edu|
22439428|NCT04124939|Urology Department, Wake Forest University|Sachin N. Vyas, Research Manager|336-713-4098|svyas@wakehealth.edu|
22439429|NCT01751061|Duke University|Dr. Christopher Cox|9196817232|Christopher.cox@duke.edu|
22439430|NCT02412306|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22439431|NCT00435409|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22439432|NCT05196828|Noctrix Health, Inc.|Jonathan Charlesworth, PhD|804-683-4279|jcharlesworth@noctrixhealth.com|
22439433|NCT03192176|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22439434|NCT03631940|Sharp Healthcare|Dr. Anup Katheria|8589394170|Anup.Katheria@sharp.com|
22439435|NCT00836589|BIOTRONIK, INC|Kelly Mohr|800-547-0394|kelly.mohr@biotronik.com|
22439436|NCT03324607|Duke University Medical Center|Yuh-Chin T. Huang, MD, MHS|9196843069|huang002@mc.duke.edu|
22439437|NCT02914639|OcuTerra Therapeutics, Inc.|Chief Medical Officer|(617) 701-7382|info@ocuterratx.com|
22439438|NCT01890343|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22439439|NCT01045460|Johns Hopkins University|Ivan Borrello, MD|4109554967|iborrell@jhmi.edu|
22439440|NCT00436332|SWOG Statistical Center|Lung Committee Statistician|206-667-6197|jmoon@fhcrc.org|
22439441|NCT00472108|Galderma R&D SNC|CTA Coordinator|+33 493 95 70 85|cta.coordinator@galderma.com|
22396320|NCT02163187|Memorial Sloan Kettering Cancer Center|Dr. Martin Weister, MD|212-639-6698|weiser1@mskcc.org|
22425829|NCT01053741|Johns Hopkins School of Medicine|Associate Director, Drug Development Unit|(410)614-8762|ejfuchs@jhmi.edu|
22425830|NCT00666211|Vanderbilt-Ingram Cancer Center|Nancy Wells, Director of Nursing Research Patient Care Svcs|615-322-6184|nancy.wells@vanderbilt.edu|
22425831|NCT02881658|The University of Hong Kong|Dr Cheung Ching Lung|(852)28315085|lung1212@hku.hk|
22425832|NCT02824224|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|5034940757|mccrimmo@ohsu.edu|
22425833|NCT04668209|University of Arizona|Jessica Winters|520-780-1882|jwinters1@arizona.edu|
22425834|NCT05225558|LigaChem Biosciences, Inc.|Seonghye Cheon|+82)2-6952-0689|scheon@ligachembio.com|
22425835|NCT00572260|Duke University Health System|Yong Choi, Clinical Research Coordinator|919-684-7584|yong.choi@duke.edu|
22425836|NCT00875563|Cook Research Incorporated|Scott Snyder, PhD, Director of Clinical Science & Biostatistics|765-463-7537|SSnyder@medinst.com|
22425837|NCT00313846|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333||
22425838|NCT01464190|Vifor Pharma|Medical Information|41 58 851 8222|medinfo@viforpharma.com|
22425839|NCT02592447|H Lee Moffitt Cancer Center and Research Institute|Heather Jim, PhD|813-745-6369|Heather.Jim@moffitt.org|
22425840|NCT02028507|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
22425841|NCT00618826|University of Cincinnati|Alison Kastl|513-584-0436|kastla@ucmail.uc.edu|
22425842|NCT01556932|Virginia Commonwealth University/ Hospice & Pallative Medicine|Devon S. Flecher, MD|804-828-9723|dsfletcher@mcvh-vcu.edu|
22425843|NCT01960465|Jesse Brown VAMC|Dr. Bharati Prasad|312-569-6343|bharati.prasad@va.gov|
22425844|NCT02038179|University of Alabama at Birmingham|Dr. Elizabeth Rahn|205-996-6552|elizabethrahn@uabmc.edu|
22425845|NCT03672344|BioStream Technologies, LLC|Michael Farber|856-222-1122|farberm@biostreamtech.com|
22425846|NCT02105285|Otsuka Pharmaceutical Co., Ltd.|Deputy General Manager, Headquarters of Clinical Development|+81-3-6361-7366||
22425847|NCT01421641|Oregon Health & Science University|Paula Bednarek|(503) 418-4500|bednarek@ohsu.edu|
22425848|NCT02420119|HaEmek Medical Center|Dr.Frieda Wolf|97246495476|friedawolf@hotmail.com|
22439442|NCT00062439|SWOG Statistical Center|Lung Committee Statistician|206-667-4623||
22396321|NCT02369848|Shockwave Medical, Inc.|Gheda Sahyun, Director of Clinical Affairs|510-624-9073|gsahyun@shockwavemedical.com|
22396322|NCT00257725|New York State Psychiatric Institute|Laurence Greenhill, MD|212-543-5340|GREENHIL@nyspi.columbia.edu|
22396323|NCT02573870|GlaxoSmithKline|GSK Response Center|866-435-7343||
22396324|NCT01858532|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22396325|NCT00514514|Novartis|Study Director|862-778-8300||
22396326|NCT02829307|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22396327|NCT02081534|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
22396328|NCT00338039|UT MD Anderson Cancer Center|Christopher H. Crane, MD / Professor||CR_Study_Registration@mdanderson.org|
22396329|NCT03947983|The University of Texas Austin|Kavita Radhakrishnan|5124717936|kradhakrishnan@mail.nur.utexas.edu|
22396330|NCT05506956|Johns Hopkins University|Kristen Murray, Program Manager|410-614-6707|kmeckel2@jhmi.edu|
22396331|NCT02091778|Podiatry and Foot health, Stott Lane Salford ,UK|Paul Chadwick|0161 206 4710|paul.chadwick@salford.nhs.uk|
22396332|NCT01841749|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
22396333|NCT00677820|MedImmune LLC, an affiliate of AstraZeneca|Raburn Mallory, MD/ Sr Dir Clinical Development|301-398-0000|malloryr@medimmune.com|
22396334|NCT01480284|GlaxoSmithKline|GSK Response Center|866-435-7343||
22396335|NCT04746833|VA Connecticut Healthcare System|Dr. Brent A. Moore|2034352243|brent.moore@yale.edu|
22396336|NCT00066742|SWOG Statistical Center|Lung Committee Statistician|206-652-2267||
22396337|NCT03374995|Wake Forest University Health Sciences|Principal investigator|336-716-5440|kwinkfie@wakehealth.edu|
22396338|NCT00393796|University of Michigan Comprehensive Cancer Center|Dr. Maha Hussain, M.D.|1-800-865-1125|mahahuss@umich.edu|
22396339|NCT01383096|Nucleus Network|Peter Hodsman|+ 613 9076 8900|businessdevelopment@nucleusnetwork.com.au|
22396340|NCT01211535|Alcon Global Medical Affairs|Jami Kern, Ph.D.|1-888-451-3937||
22396341|NCT04013789|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22439443|NCT01924845|BioMarin Pharmaceuticals|Debra Lounsbury, Principal Scientist, Clinical Sciences|415-506-6348|DLounsbury@bmrn.com|
22439444|NCT03780452|UAB Department of Orthopaedic Surgery|Dr. Ashish Shah|(205) 930-8339|ashishshah@uabmc.edu|
22439445|NCT02388269|electroCore LLC|Clinical Affairs Department electroCore LLC|+1 973 355 6683|clinical@electrocorellc.com|
22439446|NCT01995708|Memorial Sloan Kettering Cancer Center|Dr. David Chung, MD, PhD|646-608-3770|ChungD1@MSKCC.ORG|
22439447|NCT00265564|Office of Mental Health Operation, Veterans Health Administration|Jodie Trafton, Director Program Evaluation and Resource Center|650-493-5000|Jodie.Trafton@va.gov|22474
22439448|NCT01553084|Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|6082627563|sss@ctri.wisc.edu|
22439449|NCT04698343|Noctrix Health, Inc.|Jonathan Charlesworth, PhD|804-683-4279|jcharlesworth@noctrixhealth.com|
22439450|NCT05139680|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22439451|NCT03882021|Abbott|Laura Zitella Verbick|+1-612-961-7336|laura.zitellaverbick@abbott.com|
22439452|NCT03582215|U.S. Food and Drug Administration|David Strauss, MD, PhD|301-796-6323|David.strauss@fda.hhs.gov|
22439453|NCT02174731|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
22439454|NCT00983346|Huntsman Cancer Institute|Mark Wade|801-213-5746|mark.wade@hci.utah.edu|
22439455|NCT04657679|Georgetown University|Sandra Swain, MD,|(202) 687-8487|sandra.swain@georgetown.edu|
22439456|NCT00325897|Denver Health Medical Center|Dr. Richard Albert|303-436-6900|ralbert@dhha.org|
22439457|NCT05748275|Multack Eye Care|Dr Sam Multack|815-889-3333|smultack@mecvision.com|
22439458|NCT03915717|Sonavex|Katy Feeny|443-862-2024|kfeeny@sonavex.com|
22439459|NCT06047210|Swedish Orphan Biovitrum|Medical Director|+4686972000|clinical@sobi.com|
22439460|NCT02903160|Icahn School of Medicine at Mount Sinai|Dr. Bobby Liaw|212-604-6010|bobby.liaw@mountsinai.org|
22439461|NCT01838317|University of Texas Southwestern Medical Center|Dr. Muhammad Shaalan Beg|214-648-4180|muhammad.beg@utsouthwestern.edu|
22439462|NCT01664910|The University of Texas MD Anderson Cancer Center|Dr. Issa Khouri, MD/Stem Cell Transplantation and Cellular Therapy Department|713-745-0049|ikhouri@mdanderson.org|
22439463|NCT02525471|Massachusetts General Hospital|Sabrina Paganoni, MD, PhD|617-724-3914|spaganoni@mgh.harvard.edu|
22439464|NCT02240485|Université du Québec à Trois-Rivières|Dr. Joël Tremblay|4186592170|joel.tremblay@uqtr.ca|2820
22439465|NCT02374164|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
22439466|NCT00844376|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22425849|NCT03231306|UAB|Coretta Thomas, Scientist & Data Manager for NF Consortium|2059758629|coretta@uab.edu|
22425850|NCT01502033|Mayo Clinic|Dr. Paul Croarkin|(507) 293-2557|croarkin.paul@mayo.edu|
22425851|NCT02983045|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
22425852|NCT01808261|GlaxoSmithKline|GSK Response Center|866-435-7343||
22425853|NCT02585713|Mayo Clinic|Robert D. McBane, M.D.|507/284-4565|Mcbane.robert@mayo.edu|
22425854|NCT03956030|Penn State Health, Milton S. Hershey Medical Center|Dr. Christina DeAngelis|717-531-5994|cdeangelis2@pennstatehealth.psu.edu|3763
22425855|NCT02080364|vTv Therapeutics LLC|Ann Gooch PhD,RAC,CCRP; Vice President Clinical Development & Regulatory Operations|336-841-0300|agooch@vtvtherapeutics.com|80544
22425856|NCT02609984|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22425857|NCT00991289|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22425858|NCT01456143|Mt Sinai|Brett Miles||Brett.Miles@mountsinai.org|
22425859|NCT02256839|QIAGEN Sciences|Clinical Study Coordinator|301-944-7094|andrew.schumacher@qiagen.com|
22425860|NCT01843803|Department of Veterans Affairs|Frances M Weaver|708-202-5866|frances.weaver@va.gov|
22439467|NCT00837902|Vanderbilt University Medical Center|Dr. C. Michael Stein|615-936-3420|mike.stein@vumc.org|
22439468|NCT00539981|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22439469|NCT01759420|Carl R Darnall Army Medical Center|Peter Moffett MD|254-288-8302|peter.m.moffett.mil@mail.mil|
22439470|NCT01129622|Mount Sinai Hospital|Robert F Casper|416-972-0777|casper@lunenfeld.ca|
22439471|NCT00732212|CURE Digestive Diseases Research Center|Dennis M. Jensen, M.D.|310-268-3569|djensen@mednet.ucla.edu|
22439472|NCT01991808|University of Pennsylvania|Lilie Lin, MD|215-622-6515|lin@uphs.upenn.edu|
22439473|NCT03069352|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22439474|NCT02621424|VA Palo Alto|Jauhtai Cheng, MD, Staff Neurologist|650-493-5000|jauhtai.cheng2@va.gov|63617
22439475|NCT01697397|G-Tech Medical|Steve Axelrod, PhD, CEO|650-269-1479|steve.axelrod@gtechhealth.com|
22439476|NCT01690052|Indiana University School of Dentistry|Juan F. Yepes DDS, MD, MPH, MS, DrPH, Associate Professor|317-944-9601|jfyepes@iupui.edu|
22439477|NCT05635461|Cerevance|Michelle Charles, Executive Director Regulatory Affairs|(408) 220-5722|michelle.charles@cerevance.com|
22439478|NCT04709068|Current Health|Clinical Research Lead|617-208-4239|study.team@currenthealth.com|
22439479|NCT03859024|University of Alabama at Birmingham|Dr. Adam Baumgarten|205-996-6769|abaumgarten@uabmc.edu|
22439480|NCT02648204|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22439481|NCT04349891|Mayo Clinic Arizona|Dr. Jay Pasricha|(480)301-4279|pasricha.jay@mayo.edu|
22439482|NCT00614575|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22439483|NCT00189098|Wilhelmina Children's Hospital, University Medical Center Utrecht|Prof. A. Schilder|0031 302504580|A.Schilder@umcutrecht.nl|
22439484|NCT00189540|AnGes|Director of Clinical Operations|240-780-9031|information@anges-mg.com|
22439485|NCT00286442|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22439486|NCT04309110|Firstkind Ltd|Dr Kieron Day|+44 (0) 1494 572040|kieron.day@firstkindmedical.com|
22439487|NCT02163902|Allergan, Inc|Beta Bowen|714-246-4446|Bowen_Beta@allergan.com|
22439488|NCT00079040|ECOG Statistical Office|Study Statistician|617-632-3012||
22439489|NCT04079296|Astellas Pharma Global Development Inc|Clinical Trial Disclosure|8008887704|astellas.resultsdisclosure@astellas.com|
22439490|NCT06133816|University of Pennslyvania|Katharine Rendle, PI|215-349-5442|katharine.rendle@pennmedicine.upenn.edu|
22439491|NCT00467740|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22439492|NCT00867165|Merck Sharp & Dohme.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22439493|NCT03275740|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22439494|NCT02639494|Mayo Clinic|Dr. Rajiv Gulati|507-538-6325|Gulati.Rajiv@mayo.edu|
22439495|NCT00988884|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22439496|NCT04368260|University of Virginia|Dr. Amy Mathers|434-924-9678|ajm5b@virginia.edu|
22439497|NCT04621448|University of California, San Francisco|Dr. Deborah Barnes|415-502-2943|deborah.barnes@ucsf.edu|
22439498|NCT00549640|Mayo Clinic|Dr. Richard D. Hurt|507-266-1944|nicotineresearch@mayo.edu|
22439499|NCT03550378|MedImmune, LLC|Lars Hansen|+1 301 398 4563|information.center@astrazeneca.com|
22439500|NCT04486235|Corporal Michael J. Crescenz VA Medical Center|Jocelyn Remmert, PhD|215-823-5800|jocelyn.remmert@va.gov|
22439501|NCT00626275|Cubist Pharmaceuticals|Vice President, Clinical Research|1.781.860.8660||
22439502|NCT04999839|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22439503|NCT01362348|GlaxoSmithKline|GSK Response Center|866-435-7343||
22439504|NCT00399516|Boston Scientific|Brad Hershey, MS|(661) 949-4828|Brad.Hershey@bsci.com|
22439505|NCT01046565|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
22439506|NCT00377520|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22439507|NCT00292942|Uniformed Services University of the Health Sciences|Louis Cantilena, Jr., MD, PhD|301-295-0016|lcantilina@usuhs.mil|
22439508|NCT00644358|Allergan, Inc.|Therapeutic Area Head|1-877-277-8566|IR-CTRegistration@allergan.com|
22439509|NCT03180385|Children's Hospitals and Clinics of Minnesota|Mark Lo Galbo, MPH, CCRP|(612)-813-7828|mark.logalbo@childrensmn.org|
22439510|NCT02732600|VISN 5 Mental Illness Research, Education, and Clinical Center|Richard Goldberg|410-637-1851|Richard.Goldberg@va.gov|
22439511|NCT00651924|VA Connecticut Healthcare System|Robert Kerns, Ph.D.|203-932-5711|robert.kerns@va.gov|3841
22439512|NCT00758771|UCSF|John V. Fahy, MD, MSc|4154769940|john.fahy@ucsf.edu|
22439513|NCT00960063|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22439514|NCT00625131|VA Medical Center, Durham, NC|Angela Kirby, MS; Regulatory Coordinator|9192860411|angela.kirby@va.gov|5526
22439515|NCT01636765|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22439516|NCT03111875|Cleveland Clinic|Daniel I. Sessler, MD|216-444-4900|sessled@ccf.org|
22439517|NCT03273426|Seoul National University Hospital|Dr. Wonshik Han|+82-2-2072-1958|hanw@snu.ac.kr|
22411288|NCT03944486|Imperial College London|Research Integrity Officer|+44 (0)20 7594 1872|e.magnusson@imperial.ac.uk|
22439518|NCT05083351|Masimo|Director, Clinical Lab Operations|(949) 297-7000|studies@masimo.com|
22439519|NCT05288816|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22439520|NCT03360903|University of Chicago|Aaron Fox|(773) 702-0021|aaronfox@uchicago.edu|
22439521|NCT01422161|New York University School of Medicine|Preeti Raghavan, MD|212 598 6206|raghap01@nyumc.org|
22439522|NCT02051764|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
22439523|NCT00591006|The University of Texas Southwestern Medical Center|E. Sherwood Brown|214 645 6950|sherwood.brown@utsouthwestern.edu|
22439524|NCT02898454|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22425861|NCT01850394|Faculty of Medicine, Ramathibodi Hospital, Mahidol University|Dr. Paphon Sa-ngasoongsong|66-2-2011589|chan3s@hotmail.com|
22425862|NCT00436826|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22425863|NCT00784719|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22425864|NCT00271219|Departments of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology, Johns Hopkins University School of Medicine|Dr. Hendree Jones|919-485-2664|hjones18@jhmi.edu|
22425865|NCT02651337|Alcyone LifeSciences|Director of Clinical Operations|9787091946|jmcguire@alcyonels.com|
22425866|NCT02401035|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22425867|NCT00869128|Shoham Geriatric Medical Center, Pardes Hana, Israel|D. Garfinkel , MD|Tel: 972-4-6375667|dorong@shoham.health.gov.il|
22425868|NCT05137002|CinCor Pharma|Yuan-Di Halvorsen|617-675-8126|yhalvorsen@cincor.com|
22425869|NCT00985686|Canadian Institute of Natural and Integrative Medicine|Dr. John Toews|4032200022|j.toews@cinim.org|111
22425870|NCT03046953|CRCTU Birmingham|C Morland Cinical Trial Coordinator|+44 121 371 7862|avail-t@trials.bham.ac.uk|
22425871|NCT03828214|College of St. Scholastica|Dr. Alexandra Borstad|614-395-1708|aborstad@css.edu|
22425872|NCT04039204|Wake Forest University School of Medicine|Bruce Lessey, Ph.D., M.D.|336-713-0380|blessey@wakehealth.edu|
22425873|NCT04388176|Vicore Pharma AB|Carl-Johan Dalsgaard|+46 70 975 98 63|carl-johan.dalsgaard@vicorepharma.com|
22425874|NCT01689441|Brigham and Women's Hospital|David Leaf, MD, MMSc|617-732-5500|deleaf@partners.org|
22425875|NCT02600611|Motif BioSciences|David Huang|936-577-5770|david.huang@motifbio.com|
22425876|NCT00396383|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22425877|NCT01124292|Georgia Institute of Technology|Dr. Maysam Ghovanloo|404-385-7048|mgh@gatech.edu|
22425878|NCT01237327|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22425879|NCT02557516|Innate Pharma|Dr. Agnes BOYER-CHAMMARD, Medical Director|+33430303030|Agnes.BOYER-CHAMMARD@innate-pharma.fr|
22425880|NCT01972464|Yale School of Medicine|Ariadna Forray|2037648620|ariadna.forray@yale.edu|
22425881|NCT02358031|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22425882|NCT00335517|University of Rochester|Glenn Rectine, MD|585-275-8780|glenn_rectine@urmc.rochester.edu|
22425883|NCT00052078|Johns Hopkins University|John Walkup|212-746-1891|jtw9001@med.cornell.edu|
22425884|NCT01398852|Topcon Medical Systems|Bob Gibson|(201) 599-5121|RGIBSON@TOPCON.COM|
22425885|NCT03442725|Ipsen|Medical Director|See email|clinical.trials@ipsen.com|
22425886|NCT04980014|Takeda|Study Director|+1 877-825-3327|TrialDisclosures@takeda.com|
22425887|NCT00940888|Saint Jude Medical|Grant Kim, Director Clinical Studies|818-493-3147|gkim@sjm.com|
22425888|NCT00578279|Indiana University Medical Center|Julia K. LeBlanc, MD|(317) 948-8125|juleblan@iupui.edu|
22425889|NCT00678015|University of California, San Francisco|Dr. Terence Friedlander|415-353-7171|terence.friedlander@ucsf.edu|
22425890|NCT01409915|"University of Colorado Denver | Anschutz Medical Campus"|John O'Shaughnessy, MS, Clinical Research Services Principal Professional|3037247924|john.oshaughnessy@cuanschutz.edu|
22425891|NCT00511173|Creighton University|Christopher Destache|402-280-4744|destache@creighton.edu|
22425892|NCT05122624|Johns Hopkins Bloomberg School of Public Health|Dr. Yeonsoo Baik|410-955-2378|ybaik3@jh.edu|
22425893|NCT02250300|Froedtert and the Medical college of Wisconsin|Mehdi Hamadani, MD|414-805-4600|mhamadani@mcw.edu|
22425894|NCT02603211|Temple University|Chang-hee Won|2152046158|cwon@temple.edu|
22425895|NCT00715559|Mount Sinai School of Medicine|Dr. James Murrough|212-241-7574|james.murrough@mssm.edu|
22425896|NCT00758498|Cephalon, Inc.|Medical Monitor|1-800-896-5855||
22425897|NCT01845597|Rebound Research and Education Foundation.|Pamela Fairchild|3604498728|pfairchild@reboundmd.com|
22425898|NCT03782987|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22425899|NCT00308516|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22425900|NCT01516736|Sandoz|Strategic Planning, Biopharmaceutical Clinical Development|+49 (0) 8024 476 - 0|biopharma.clinicaltrials@sandoz.com|
22425901|NCT04403113|Marmara University|Assoc. Prof Gonul Acar|5323778878|gonulacar34@gmail.com|+90
22425902|NCT00524771|Center for Epidemiology and Health Research, Germany|Dr. Juergen Dinger|0049 (0)30 945 101 20|dinger@zeg-berlin.de|
22425903|NCT02781818|UNC Dermatology|Dr. Christopher Sayed|984-974-3900|christopher_sayed@email.unc.edu|
22425904|NCT01877668|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021||
22425905|NCT02317991|Sarah Cannon Development Innovations, LLC|Sarah Cannon Development Innovations, LLC|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
22425906|NCT01223404|University of Maryland School of Medicine|Dr. Britta Hahn|4104026112|bhahn@mprc.umaryland.edu|
22425907|NCT02492165|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22425908|NCT00707057|SCOLR Pharma Inc|Stephen Turner, VP and Chief Technical Officer|425-368-1050|sturner@scolr.com|1001
22425909|NCT01697800|Johns Hopkins Medicine|Zubair Khan|410-955-3157|zkhan@jhmi.edu|
22425910|NCT00954122|AstraZeneca|Gerard Lynch|4415 09645895|clinicaltrialtransparency@astrazeneca.com|
22425911|NCT03782181|University of Balearic Islands|José Mingorance|+34677602465|josea.mingorance@uib.es|
22425912|NCT01587105|Seattle Children's Hospital|Rita Mangione-Smith, MD, MPH|2068848242|Rita.Mangione-Smith@seattlechildrens.org|
22425913|NCT01957579|MedImmune, LLC|Medical Director||ClinicalTrialTransparency@astrazeneca.com|
22425914|NCT02019550|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22425915|NCT01781208|Cincinnati Children's Hospital Medical Center, Department of Radiology|Jonathan Dillman, MD|513 803-7114|jonathan.dillman@cchmc.org|
22425916|NCT02750332|Cycle Pharmaceuticals Ltd|James Price|+44 1223 803638|james.price@cyclepharma.com|
22425917|NCT01000987|Yale University|Sherry McKee PhD|203-737-3529|sherry.mckee@yale.edu|
22379068|NCT02669095|Johnson & Johnson Vision Care Inc.|Kristy Canavan, O.D., FAAO Principal Research Optometrist|904 443-1474|KCANAVA2@its.jnj.com|
22379069|NCT00045435|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|206-667-4961|bsandmai@fhcrc.org|
22379070|NCT00738101|Baylor College of Medicine|Dr. Muralidhar H Premkumar|8328267980|premkuma@bcm.edu|
22379071|NCT03621202|Saranas, Inc.|Zaffer Syed|833-375-9273|zaffer@saranas.com|
22379072|NCT01396317|Hospital for Special Surgery|Dr. Robert Spiera|212-774-2048|spierar@hss.edu|
22379073|NCT02906683|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.|+81-3-3293-2455|toiawase@taiho.co.jp|
22379074|NCT01158378|HyperBranch Medical Technology, Inc|Michael Carnahan, PhD|919-433-3329|michaelc@hyperbranch.com|
22379075|NCT02326844|National Cancer Institute|Dr. Jung-Min Lee|301-443-7735|leej6@mail.nih.gov|
22379076|NCT04602494|Massachusetts General Hospital|A. Eden Evins, MD, MPH|6176434679|aeevins@mgh.harvard.edu|
22379077|NCT02531295|University of California, San Francisco|Sulggi Lee, MD PhD|415-735-5127|sulggi.lee@ucsf.edu|
22379078|NCT00453310|Memorial Sloan Kettering Cancer Center|Dr. Robert Motzer|646-422-4312|motzerr@mskcc.org|
22379079|NCT01806740|Guerbet|Corinne Dubourdieu, Head of Clinical Projects|+33145915000|corinne.dubourdieu@guerbet.com|
22379080|NCT04666922|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22379081|NCT04651114|University of Michigan|Dr. Claire Kalpakjian|734-763-0153|clairez@umich.edu|
22379082|NCT03661996|Centrexion Therapeutics Corporation|Clinical Operations|617-837-6911|info@centrexion.com|
22379083|NCT01161472|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22379084|NCT03472287|Castle Creek Pharmaceuticals, LLC|Dr. Mary Spellman/Chief Medical Officer|862 286 0400|mspellman@castlecreekpharma.com|
22379085|NCT03980184|Yale University|Rajita Sinha, PhD, Study PI|203-737-5805|rajita.sinha@yale.edu|
22379086|NCT02176421|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com|
22379087|NCT01749501|William Beaumont Hospital|Dr. Martin Espinosa|248-898-0633|Martin.espinosa@beaumont.edu|
22379088|NCT02265224|Zambon S.p.A.|Isabella Salerio, PhD|+3902665241|clinicaltrials@zambongroup.com|
22379089|NCT01965158|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|1454
22425918|NCT00675987|Brigham and Women's Hospital|Mark A. Creager, MD|617-732-5267|mcreager@partners.org|
22425919|NCT00823134|ResMed Germany Inc|Oliver Munt|0899901|oliver.munt@resmed.de|00
22425920|NCT00078403|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22425921|NCT02880254|Baystate Medical Center|Rushika Conroy MD|413 794 5437|rushika.conroy@bhs.org|
22425922|NCT04421040|Mayo Clinic|Dr. Grace Lin|507-255-1267|lin.grace@mayo.edu|
22425923|NCT03979066|Columbia University|Gulam Manji, MD, PhD|212-305-0592|gam2140@columbia.edu|
22425924|NCT03799614|Virginia Commonwealth University|Dr. Ingrid Pretzer-Aboff|804-828-3340|iaboff@vcu.edu|
22425925|NCT03316586|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|617-632-2335|Sara_Tolaney@dfci.harvard.edu|
22425926|NCT00994110|Memorial Sloan Kettering Cancer Center|Dr. Peter Allen|212-639-5132|allenp@mskcc.org|
22425927|NCT00619827|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com|
22425928|NCT02806713|University of Massachusetts UMass Memorial|Michael K Flynn|(508) 856-5152|michael.flynn@umassmemorial.org|
22425929|NCT02163395|Clinical Research|Intsitut Straumann AG|0041619651111|research@straumann.com|
22425930|NCT04878055|Dompé Farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22425931|NCT01968811|Sahlgrenska university Hospital|Dr Marcus Langenskiöld|+46 709 433160|marcus.langenskiold@vgregion.se|
22425932|NCT03868839|University of Massachusetts Medical School|Xiaoduo Fan|5088563881|xiaoduo.fan@umassmed.edu|
22425933|NCT01178125|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22425934|NCT01004978|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22425935|NCT00369915|NIMH/NIH|Maura Furey, PhD|301-594-7773|mfurey@mail.nih.gov|
22425936|NCT00814138|University of Kansas Medical Center|Richard J. Barohn, MD/ Chairman of Neurology|913-588-6094|rbarohn@kumc.edu|
22425937|NCT02372344|AstraZeneca Pharmaceuticals|Stefan C Carlsson, MD, PhD, Global Clinical Lead|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
22425938|NCT00268983|GlaxoSmithKline|GSK Response Center|866-435-7343||
22425939|NCT00848757|Yale University School of Medicine|Michelle Van Name|203-785-5831|michelle.vanname@yale.edu|
22425940|NCT02532374|Philip Morris Products S.A.|Loyse Felber Medlin|+41 (58) 242 2686|Loyse.FelberMedlin@pmi.com|
22425941|NCT01089127|Novartis Pharmaceuticals|Study Director|862 778-8300||
22425942|NCT00059228|National Institute of Mental Health|Schmidt, Peter|+1 301 496 6120|peterschmidt@mail.nih.gov|
22425943|NCT00511810|University of Cincinnati|Robert McNamara, PhD|513-558-5601|robert.mcnamara@uc.edu|
22425944|NCT02659943|National Cancer Institute|Dr. James N. Kochenderfer|240-760-6062|kochendj@nih.gov|
22425945|NCT03861780|Bioscience Laboratories|Principal Investigator II/Training Coordinator|(406) 587-5735|cduley@biosciencelabs.com|110
22425946|NCT01096160|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22425947|NCT01460732|Hypertension Center, Third University Department of Medicine|George S. Stergiou|0030 210 7763117|gstergi@med.uoa.gr|
22425948|NCT02697071|Lewis Gale Medical Center|Corey Heitz, MD|5406322364|coreyheitzmd@gmail.com|
22425949|NCT04767373|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22425950|NCT00121719|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
22425951|NCT02472886|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22425952|NCT04346199|AstraZeneca|Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22425953|NCT04533438|Aerin Medical|Sr. Manager of Clinical Operations|312-888-0441|tdang@aerinmedical.com|
22379090|NCT00467142|Institut Bergonié|Pr Yves Becouran||y.becouarn@bordeaux.unicancer.fr|
22439525|NCT03040141|Visterra Inc.|Head of Regulatory Affairs|+1 617-498-1070|info@visterrainc.com|
22425954|NCT05568797|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22425955|NCT00099632|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22425956|NCT03131687|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22439526|NCT04731636|LifeTechScientific|Clinical manager|15695219339|Xuwei@lifetechmed.com|
22439527|NCT01384734|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22439528|NCT01290523|University of California San Francisco Department of Radiology|Dr Nicholas Fidelman|(415) 353-1300|Nicholas.Fidelman@ucsf.edu|
22439529|NCT03071263|Vifor Pharma Inc.|Clinical Support & Regulatory Intelligence, Regulatory Affairs Director|+1 250 708 4296|Clive.Burge@viforpharma.com|
22439530|NCT00662207|Hines VA Hospital, Research Service|James S. Walter, Ph.D.|708-202-5805|James.Walter@va.gov|
22439531|NCT02922725|University of Utah|Brent M. Kious|801-585-1418|brent.kious@hsc.utah.edu|
22439532|NCT05626673|Pray.com|Breanne Laird|9095574002|breanne.laird@pray.com|
22439533|NCT02856412|San Francisco Veterans Health Care System|Thomas Neylan, MD|415-750-6961|Thomas.Neylan@va.gov|
22439534|NCT05148234|National Cancer Institute|Dr. Najla El Jurdi|240-992-4033|najla.eljurdi@nih.gov|
22439535|NCT02099864|Oregon Health & Science University|Dr. Alexandra Sokolova, M.D.|(503) 494-4396|sokolova@ohsu.edu|
22439536|NCT01400698|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merck.de|
22439537|NCT04750642|Cochlear|Aaron Parkinson|13039414951|aparkinson@cochlear.com|
22439538|NCT01650194|Astellas Pharma Global Development, Inc. (APGD)|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22439539|NCT06319898|Atrium Health Wake Forest Baptist|Dr. Erin Franks|7043041160|erin.franks@atriumhealth.org|
22439540|NCT01602224|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22439541|NCT01352117|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22425957|NCT02137226|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22425958|NCT00768287|Medexus Pharma, Inc.|Clinical Trial Manager|1-312-548-3125|julissa.leon@medexus.com|
22425959|NCT03472521|Stanford University|Dr. Pamela Flood, MD, MA|201-370-3933|pflood@stanford.edu|
22425960|NCT01603407|University of Rochester|Robert Griggs|585-275-6072|robert_griggs@urmc.rochester.edu|
22439542|NCT00644423|Durham VA Medical Center|Christine Marx, MD MA|919-286-0411|marx0001@mc.duke.edu|3626
22425961|NCT04789382|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22425962|NCT02100280|SNUBH|Dr. Bon-wook Koo|+82-10-7227-1379|tendong2@gmail.com|
22425963|NCT01325350|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22425964|NCT02692586|Inari Medical|Ashleigh Willson|877-923-4747|ashleigh.willson@inarimedical.com|
22425965|NCT01095497|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22425966|NCT03407313|Recros Medica|Head of Clinical Development|925-223-8581|clinical@recrosmedica.com|
22379091|NCT00154310|Novartis Pharmaceuticals|Study Director|862-778-8300||
22425967|NCT01396083|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22425968|NCT01063855|Janssen Research & Development, LLC|CDTL, Cardiovascular and Metabolism|1 908 704-4648||
22425969|NCT01165307|Mayo Clinic|Dr. Abimbola O. Famuyide|507-284-7035|Famuyide.Abimbola@mayo.edu|
22379092|NCT03771157|University of Rochester|Michael Brady|585-276-3203|michael_brady@urmc.rochester.edu|
22425970|NCT02492802|University Medical Center Groningen|Jan-Willem Alffenaar, PhD|+31503614035|j.w.c.alffenaar@umcg.nl|
22425971|NCT01126099|VA Puget Sound|Lucy Wang|206-277-5089|wanglucy@u.washington.edu|
22425972|NCT03234036|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22425973|NCT02472730|Baylor College of Medicine|Dr. Kalpesh K. Patel|7137980947|kalpeshp@bcm.edu|
22379093|NCT03447730|Synlogic|Andrew Marsh, Head Clinical Operations|617-401-9975|andrew.marsh@synlogictx.com|9135
22425974|NCT02999789|University of California, San Francisco|Eddie Cruz-Romero, MD, MPH|(628) 206-2837|Edward.Cruz@ucsf.edu|
22379094|NCT02086162|Dartmouth-Hitchcock|Dr. Mary F. Brunette|603-229-5419|mary.f.brunette@hitchcock.org|
22425975|NCT01195779|GlaxoSmithKline|GSK Response Center|866-435-7343||
22425976|NCT01111565|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22425977|NCT02537951|Erasmus MC|Joost L.M. Jongen|+31107041415|j.jongen@erasmusmc.nl|
22425978|NCT01401595|Perelman School of Medicine at the University of Pennsylvania|Kelly C. Allison, Ph.D.|215-898-2823|kca@mail.med.upenn.edu|
22425979|NCT02683239|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22425980|NCT03846544|Brussels IVF|Dr Liese Boudry|024779857|liese.boudry@uzbrussel.be|
22425981|NCT00521365|AstraZeneca|Gerard Lynch|09645895|ClinicalTrialTransparency@astrazeneca.com|4415
22425982|NCT00368108|Eisai Call Center|Eisai Inc.|888-422-4743||
22425983|NCT03150082|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22425984|NCT01718483|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22425985|NCT03049501|University of Miami|David Loewenstein|305-355-7016|dloewenstein@miami.edu|
22425986|NCT03180957|University of Oxford|Professor Jagdeep Nanchahal|+44(001865 612633|jagdeep.nanchahal@kennedy.ox.ac.uk|
22425987|NCT04131712|University of Kentucky|Douglas Long|859-323-5438|delong2@uky.edu|
22425988|NCT02363387|Johns Hopkins University School of Medicine|Kenneth Silverman|443-617-6051|ksilverm@jhmi.edu|
22425989|NCT02299388|Tulane University|Dr. Tina Thethi|504-988-5044|tthethi@tulane.edu|
22439543|NCT03525444|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22425990|NCT03334188|"University of Colorado | School of Medicine | ACCORDS"|Dr. Larry Allen, Professor of Medicine|303-724-4713|larry.allen@cuanschutz.edu|
22379095|NCT03349268|University of Michigan|Keith Kaye|732 235-9312|kk1116@rwjms.rutgers.edu|
22379096|NCT01248962|Memorial Sloan Kettering Cancer Center|Dr. Roisin O'Cearbhaill, MD|646-888-4227|ocearbhr@mskcc.org|
22379097|NCT00985543|St Stephens Centre, Chelsea and Westminster Hospital|Dr Marta Boffito|+44 2088 466 507|marta.boffito@chelwest.nhs.uk|
22379098|NCT04848662|Avillion LLP|Chief Medical Officer|+44 (0)203 764 9530|avillion@avillionllp.com|
22379099|NCT01350505|VA Palo Alto Health Care System|Dr. Jamie Zeitzer|650-493-5000|jamie.zeitzer@va.gov|62410
22379100|NCT01834222|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|001-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22379101|NCT04702568|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
22379102|NCT00779558|Stanford University|Alan Schroeder|408 885-5260|alan.schroeder@hhs.sccgov.org|
22379103|NCT00423852|Memorial Sloan Kettering Cancer Center|Dr. Darren Feldman, Assistant Attending|+1646-422-4491|Feldmand@mskcc.org|
22379104|NCT04205929|Oregon Health & Science University|Dr. Alison Edelman|503-494-3666|edelmana@ohsu.edu|
22379105|NCT00308737|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
22379106|NCT01805882|National Institute of Allergy and Infectious Diseases|Shyam Kottilil MD|+1 410 706 4872|Skottilil@ihv.umaryland.edu|
22379107|NCT01225822|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22379108|NCT00089895|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22379109|NCT05644353|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22379110|NCT01535274|University of Michigan|Dr. Paul Picton|734-936-4280|ppicton@umich.edu|
22379111|NCT01737281|VA NY Harbor Healthcare System|Dr. Scott Sherman|212-686-7500|scott.sherman@va.gov|7386
22379112|NCT02954458|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
22379113|NCT05777174|MediBeacon, Inc.|Richard B Dorshow, PhD|314-735-0967|rbdorshow@medibeacon.com|
22379114|NCT02690077|Advocate Aurora Health|Jessica J F Kram, MPH|414-219-5594|jessica.kram@aah.org|
22379115|NCT01845974|Advocate Medical Group Cardiology|Scott M. Miller MD|847-698-5500|scott.miller@advocatehealth.com|
22379116|NCT02667886|X4 Pharmaceuticals|Chief Medical Officer|(857) 529-8300|patientinfo@x4pharma.com|
22379117|NCT01905046|City of Hope|Victoria Seewaldt, M.D.|6262564674|vseewaldt@coh.org|67321
22379118|NCT05672680|Icahn School of Medicine at Mount Sinai|Celia Divino|(212) 241-3348|celia.divino@mountsinai.org|
22379119|NCT03929562|University of Michigan|Anne C. Fernandez|734-232-0521|acfernan@med.umich.edu|
22379120|NCT02201056|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22379121|NCT01970787|Laser Surgery Care|Stephen E Goldstone|212-242-6500|segmd@prodigy.net|
22379122|NCT02778399|Clinical Operations|Medical Responsible|+41 (0)22 552 1560|clinicaltrials@obseva.ch|
22379123|NCT03501043|MossRehab|Stella Lee|215-663-6665|leest@einstein.edu|6665
22379124|NCT02978443|Georgetown University|Suthee Rapisuwon|202-877-6583|Suthee.Rapisuwon@medstar.net|
22379125|NCT00405639|Mayo Clinic|Dr. Horng H. Chen|507-538-2354|chen.horng@mayo.edu|
22379126|NCT02081456|Cayuga Medical Center|Dr. Michael Costello, PT, DSc, OCS, MTC|607-252-3500|mcostellopt@gmail.com|
22379127|NCT01905254|Universitiy Clinic Hamburg eppendorf|PD Dr. Ulrike Denzer|040741055380|u.denzer@uke.de|
22379128|NCT00612534|AcelRx|Pamela Palmer, MD PhD|650-216-3500|ppalmer@acelrx.com|
22379129|NCT02101918|UT MD Anderson Cancer Center|Dr. Daniel M. Halperin/ GI Medical Oncology|713-792-2828|DMHalperin@mdanderson.org|
22379130|NCT01508013|East Tennessee State University|Dr. Joel Hillhouse|423-439-4332|hillhous@etsu.edu|
22379131|NCT04557826|EmitBio|Director of Clinical Trials|919-321-1734|info@emitbio.com|
22379132|NCT01474213|Department of Anaesthetics, Shanghai Ninth People's Hospital affiliated to Shanghai Jiao Tong University, School of Medicine|Dr. Jiang Hong|86-21-13512122883|hr310@vip.sina.com.cn|
22379133|NCT02130284|Medtronic Minimed|Suiying Huang, Statistician|818-576-3319|suiying.huang@medtronic.com|
22379134|NCT03482505|Masimo|Cristina Johnson|949-297-7000|clinicalresearchdept@masimo.com|
22379135|NCT01852058|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22379136|NCT01279343|Washington University School of Medicine|Jeanine Carbone MD|314-362-8523|jfcarbone@hotmail.com|
22379137|NCT03287414|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
22379138|NCT01199926|Purdue University|Dr. Dorothy Teegarden|765-494-8791|teegarden@purdue.edu|
22379139|NCT05093049|Apyx Medical|Senior Director of Clinical Affairs|801-244-0058|kari.larson@apyxmedical.com|
22379140|NCT02569710|Alios BioPharma, Inc|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22379141|NCT02946918|UT Southwestern Medical Center|Dr. Alex Tessnow-ASSOC PROFESSOR|214/648-3685|Alex.Tessnow@UTSouthwestern.edu|
22379142|NCT02654990|pharmaand GmbH|Medical Information Department|+43/1/3560006|medinfo@pharmaand.com|
22379143|NCT00674622|University of Pittsburgh School of Medicine Department of Psychiatry|Ronald Glick, MD|412-623-3023|glickrm@upmc.edu|
22379144|NCT03203694|University of Missouri|Jaume Padilla|(573) 882-7056|padillaja@missouri.edu|
22379145|NCT04686279|Johns Hopkins University|Dr. Craig Hendrix|410-955-9707|chendrix@jhmi.edu|
22379146|NCT00855010|UT Southwestern Medical Center|Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
22379147|NCT04255342|University of Iowa|Chris Barwacz|(319) 384-3002|chris-barwacz@uiowa.edu|
22379148|NCT04934137|University of Texas Medical Branch|Dr. Melissa Morrow|409-266-0344|memorrow@utmb.edu|
22379149|NCT00663117|Pennsylvania State University, College of Medicine Hershey, PA 17033|Jill P Smith, MD Professor of Medicine, Gastroenterology Division|717-531-3694|jsmith2@psu.edu|
22379150|NCT02781506|UT Southwestern Medical Center|Dr. Raquibul Hannan|214-645-8525|Raquibul.Hannan@UTSouthwestern.edu|
22379151|NCT02593539|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22379152|NCT01542541|BIDMC|Dr Alan Moss|6176673197|amoss@bidmc.harvard.edu|
22379153|NCT00437125|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22379154|NCT02248961|R-Pharm|Boris Berezhanskiy, Medical Advisor|0074959567937|berezhanskiy@rpharm.ru|2468
22425991|NCT00716807|UCSF|Jon Levine MD, PhD|415-476-5108|jon.levine@ucsf.edu|
22425992|NCT01093586|Case Comprehensive Cancer Center|Brenda Cooper MD|216-844-3213|brenda.cooper@uhhospitals.org|
22425993|NCT00357877|Kaiser Permanente Data Coordinating Center|Dr. William Vollmer|503-335-6755|william.vollmer@kpchr.org|
22425994|NCT03570047|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22425995|NCT01351090|Luitpold Pharmaceuticals, Inc.|David Bregamn, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com|828
22425996|NCT00028262|National Institute of Child Health and Human Development|Dr. Anil Mukherjee|+1 301 496 7213|mukherja@exchange.nih.gov|
22425997|NCT00613366|Oregon Health & Science University|Dr. Alison Edelman|503.494.5949|edelmana@ohsu.edu|
22425998|NCT00943397|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22425999|NCT02948829|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
22426000|NCT02381678|Guangdong General Hospital|Dr. Huiming Guo (Chief in Cardiac Surgical Department)|86-13609089789|guohuiming@vip.tom.com|
22426001|NCT01050946|Medical College of Wisconsin|Jeanne Palmer,MD|414-805-6800|jpalmer@mcw.edu|
22426002|NCT00583908|Vistakon|Kurt Moody, OD FAAO|904-443-3088|kmoody1@its.jnj.com|
22426003|NCT01749410|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22426004|NCT01719380|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22426005|NCT00249873|sanofi-aventis|International Clinical Development, Clinical Study Director||GV-Contact-us@sanofi-aventis.com|
22426006|NCT00412841|NYULMC|Dr. H. Michael Belmont|212-598-6518|michael.belmont@nyumc.org|
22426007|NCT02762084|PellePharm, Inc.|Chief Medical Officer|(510) 502-6144|Info@Pellepharm.com|
22439544|NCT01941485|Alcon Research, Ltd.|Global Brand Med Affairs Lead, Refractive, VGR|1-888-451-3937|alcon.medinfo@alcon.com|
22426008|NCT00928434|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22426009|NCT00716456|Memorial Sloan Kettering Cancer Center|Dr. Gregory J. Riely|646-888-4199|rielyg@mskcc.org|
22426010|NCT00447772|Ipsen|Medical Director, Neurology||clinical.trials@ipsen.com|
22426011|NCT01765296|CrystalGenomics, Inc.|Chief Medical Officer|+82-31-628-2871|sang-yoon.lee@cgxinc.com|
22439545|NCT00262860|University of Rochester|Jonathan W. Friedberg|585-273-4150|jonathan_friedberg@urmc.rochester.edu|
22426012|NCT00848016|Mayo Clinic Cancer Center|Michael E. Menefee, M.D.||menefee.michael@mayo.edu|
22439546|NCT02741128|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22426013|NCT03478371|Procter & Gamble Co|Jan Streicher-Scott, PhD, RPh|513-634-5584|streicherscott.jl@pg.com|
22426014|NCT00627497|Medtrionic spinal and biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
22426015|NCT00838097|Amgen Inc.|Study Director|866-572-6436||
22426016|NCT01715948|Capital Health|Dr. Manohar Bance|902-473-5975|m.bance@dal.ca|
22426017|NCT00438204|Barbara Ann Karmanos Cancer Institute|Antionette J. Wozniak, M.D., F.A.C.P.|(313)576-8752|wozniakt@karmanos.org|
22426018|NCT01715233|Baylor University Medical Center Dallas Texas|Ronan J. Kelly MD MBA|214-820-2828|Ronan.Kelly@bswhealth.org|
22426019|NCT03576924|University of British Columbia|Dr. Mary Jung|1-250-807-9670|mary.jung@ubc.ca|
22426020|NCT03134911|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22426021|NCT01118663|Cumberland Pharmaceuticals Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com|
22426022|NCT00656175|UCLA CARE Center|Dr. Jordan Lake|310-557-9679|jlake@mednet.ucla.edu|
22426023|NCT04878120|University of Virginia|Dr. Chiara Fabris|4344220240|cf9qe@virginia.edu|
22426024|NCT01877161|Seoul National University Bundang Hospital|Nam-Jong Paik|031-787-7731|njpaik@snu.ac.kr|7731
22426025|NCT00672633|Boston Children's Hospital|Dr. Stavroula Osganian, Principal Investigator|8572184728|stavroula.osganian@childrens.harvard.edu|
22426026|NCT02824627|University of Nebraska Medical Center|Soonjo Hwang|402-552-6351|soonjo.hwang@unmc.edu|
22426027|NCT01868165|Imperial College London|Dr Ruth Peters|07950289662|r.peters@imperial.ac.uk|
22439547|NCT01419769|Boston Scientific Corp.|Lina Ginnetti|508-683-4512|Lina.Ginnetti@bsci.com|
22439548|NCT00878501|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22439549|NCT03406377|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
22439550|NCT01183689|Wake Forest University School of Medicine|Mark Espeland|336-716-2826|mespelan@wakehealth.edu|
22439551|NCT00281463|Human Engineering Research Laboratories|Rory Cooper, PhD|412-822-3700|rcooper@pitt.edu|
22439552|NCT02542046|UCaliforniaSF|Dr. Benjamin Yeh|4155149318|ben.yeh@ucsf.edu|
22439553|NCT01194830|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22379155|NCT00670462|University of Minnesota|Robert W. Jeffery PhD|612-626-8580|jeffe001@umn.edu|
22439554|NCT04682197|Atrium Wake Forest Baptist Health|Dr. Charles H. Tegeler|336-716-9447|BBRP@wakehealth.edu|
22439555|NCT00866177|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|646-888-4162|chapmanp@mskcc.org|
22439556|NCT05626738|ENDOSTART SRL|Alessandro Tozzi|0571843033|a.tozzi@endostart.com|0039
22439557|NCT04951115|Weill Cornell Medicine|Ashish Saxena|646-962-2066|ahs9018@med.cornell.edu|
22439558|NCT02681809|ThromboGenics|Global Clinical Development|+3216751310|info@oxurion.com|
22439559|NCT05120713|University of Southern California|Dr. Andy Kim|213-740-5156|andyk@usc.edu|
22379156|NCT01060020|Washington University School of Medicine|Brian R. Lindman, MD, Assistant Professor of Medicine|314-747-3617|brlindman@wustl.edu|
22379157|NCT02835443|Enspire DBS Therapy, Inc.|Director of Clinical Trials|123-456-7890|info@enspiredbs.com|
22379158|NCT04551196|Washington University School of Medicine|David Leonard, MD, Principal Investigator|314-454-2136|dsleonard@wustl.edu|
22396342|NCT03319407|Mayo Clinic|Robert L. McClain, M.D.|904-956-1728|Mcclain.Robert@mayo.edu|
22439560|NCT03316196|VA San Diego Healthcare System|Dr. Jessica Bomyea|8585528585|jessica.bomyea@va.gov|1416
22439561|NCT02498925|McLean Hospital|Christian Webb, PhD|6178554429|cwebb@mclean.harvard.edu|
22442252|NCT02878798|Virginia Commonwealth University|Dr. A. Gordon Smith|801-828-9869|gordon.smith@vcuhealth.org|
22379159|NCT00244374|University of California, San Francisco|Dr. Paula J. Lum|415-476-4082|plum@php.ucsf.edu|411
22379160|NCT01517243|Dartmouth College|Lionel Lewis|1-603-650-8685|lionel.d.lewis@dartmouth.edu|
22379161|NCT03462706|Indiana University|Clinical Research Specialist|317-948-0724|rlahr@iu.edu|
22379162|NCT00871819|Boston Scientific|Nitzan Mekel-Bobrov, Ph.D.|(661) 949-4537|Nitzan.Mekel-Bobrov@bsci.com|
22379163|NCT01411501|Guang'an Men Hospital Affiliated to China Academy of Chinese Medical Sciences|Liu Zhishun|8610-010-88001124|liuzhishun@aliyun.com|
22379164|NCT00708721|Huntsman Cancer Institute|Dr. Paul Shami|801-585-0100|paul.shami@hci.utah.edu|
22379165|NCT05197257|University of Colorado|Dr. Bennett Chin|720-848-0000|Bennett.Chin@cuanschutz.edu|
22379166|NCT04105972|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22379167|NCT02802319|UT Health Science Center at San Antonio|Dr. Brian Mealey|210-567-3567|mealey@uthscsa.edu|
22379168|NCT01966796|Far Eastern Memorial hospital|Dr. Ping-huai Wang|886-2-89667000|pinghuaiwang@gmail.com|2816
22379169|NCT01923896|Emory University|William G. Sharp Ph.D.|404-419-5162|wgsharp@emory.edu|
22379170|NCT01097395|University of Colorado|Jennifer Kiser|3037246131|jennifer.kiser@cuanschutz.edu|
22379171|NCT03545113|Wake Forest University Health Sciences|Mariana Murea, MD|336-716-5777|mmurea@wakehealth.edu|
22379172|NCT00235443|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22379173|NCT02010697|UCSD|Principal Investigator|8583001056|szhu@ucsd.edu|
22379174|NCT00474929|Mayo Clinic|Thomas E. Witzig, M.D.||witzig.thomas@mayo.edu|
22379175|NCT00819403|Univ Maryland|Dr Michael Miller|410 328-6299|mmiller@medicine.umaryland.edu|
22379176|NCT03321513|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|mhuggins@jaeb.org|
22379177|NCT03029247|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|1
22379178|NCT02593305|University of Iowa|Dr. Darren P. Casey|3193841009|darren-casey@uiowa.edu|
22379179|NCT02757521|Washington University|Ben J Palanca, MD PhD MSC|314-286-0132|palancab@wustl.edu|
22379180|NCT00462722|University of Colorado Anschutz Medical Campus|Catherine Jankowski|303-724-7383|catherine.jankowski@ucdenver.edu|
22379181|NCT00798174|Washington University in St. Louis|Dr. Timothy W. Smith|314-286-1501|tsmith@wustl.edu|
22379182|NCT01395043|Aalborg Hospital|Dr Nils Bjerregaard|004522860649|niheb@rn.dk|
22379183|NCT02342314|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22379184|NCT01683994|National Cancer Institute|Dr. William Dahut|240-760-6070|william_dahut@nih.gov|
22379185|NCT00999661|Ethicon Endo-Surgery, Inc.|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
22379186|NCT00335725|IBSA instutut Biochimique SA|IBSA Clinical Research Manager|+41 58 360 1000|sd@ibsa.ch|
22379187|NCT02250521|The University of Texas Health Science Center at Houston|Carin A. Hagberg, MD|713-500-6200|Carin.A.Hagberg@uth.tmc.edu|
22379188|NCT00312858|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22379189|NCT01603420|The Proton Collaborative Group|Corey Woods|630-836-8668|cwoods@pcgresearch.org|
22379190|NCT02318719|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22379191|NCT00252590|VA San Diego Healthcare/University of California, San Diego|Dr. Susan Tate|619-426-9402|srtate@ucsd.edu|
22379192|NCT00854295|Zimmer Biomet|Erin Osborn|574-371-9884|erin.osborn@zimmerbiomet.com|
22379193|NCT02440594|University of Pennsylvania|Shahrzad Mavandadi|215-823-5211|shahrzad.mavandadi@va.gov|
22379194|NCT00152763|University Health Network, Toronto General Hospital|Dr. Jane Irvine|(416) 736-5115|jirvine@yorku.ca|22444
22379195|NCT02912468|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1
22379196|NCT01515189|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22379197|NCT00284089|Novartis Pharmaceuticals|Study Director|862 778-8300||
22379198|NCT02541383|Intergroupe Francophone du Myélome|Chief Executive Officier|+33 1 40 21 24 02|ifmclinicaltrials@myelome.fr|
22379199|NCT05796518|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-713-0031|mnjenkin@wakehealth.edu|
22379200|NCT00594217|University of Virginia Center for Research in Reproduction|Dr. Christopher R. McCartney|4342436911|cm2hq@virginia.edu|
22379201|NCT02117934|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-848-5100||
22379202|NCT05778526|The Hong Kong Polytechnic University.|Dr. Ka Po Wong|64860214|portia.wong@polyu.edu.hk|
22379203|NCT01985828|Advocate Health|Geraldine Lara|8477238239|geraldine.lara@aah.org|
22379204|NCT03108157|ProcreaTec|Dr. Alexandra Izquierdo, Medical and Scientific Director at ProcreaTec|0034651879266|endoscratchtrial@gmail.com|
22379205|NCT01435655|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22379206|NCT03557086|Massachusetts General Hospital|Dr. Nneka Ufere|617-643-3408|nneka.ufere@mgh.harvard.edu|
22379207|NCT02839343|Mayo Clinic|Frank Sinicrope|5072664338|Sinicrope.Frank@mayo.edu|
22379208|NCT02223754|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, O.D., M.S., F.A.A.O., Sr. Principal Research Optemtrist|904-443-3500|TKarkkai@its.jnj.com|3402
22379209|NCT01960530|Diurnal Limited|Dr John Porter|02920 682069|info@diurnal.com|
22379210|NCT04395183|University of Utah|Brent Kious, MD, PhD|801-585-1418|brent.kious@hsc.utah.edu|
22379211|NCT02668016|Imperial College London|Professor Darrel Francis|0207 594 9647|d.francis@imperial.ac.uk|
22379212|NCT04472377|Hygeia Touch Inc.|Lance Yang|+886-3-6675616|cyyang@hygeiatouch.com|
22379213|NCT01022073|San Francisco VA Medical Center|William J. Marks, Jr., M.D.|415-750-2100|William.Marks@va.gov|
22379214|NCT04999644|Johns Hopkins University School of Medicine|Justin Strickland|4105501975|jstric14@jhmi.edu|
22379215|NCT01536184|Child Development Clinic SSCY Centre|Dr. Ana Hanlon-Dearman|204-258-6628|ahdearman@hsc.mb.ca|
22379216|NCT01974700|Indiana University|Dr. Aaron Cohen-Gadol|317-396-1300|ACohen@goodmancampbell.com|
22379217|NCT02234063|Icahn School of Medicine at Mount Sinai|Dr. Carol R. Horowitz|212-659-9564|carol.horowitz@mssm.edu|
22379218|NCT00510458|Stryker Orthopaedics|Director, Clinical Operations|201-831-5401|ellen.axelson@stryker.com|
22379219|NCT01620567|Tufts University|Elizabeth J. Johnson, PhD|617.556.3204|elizabeth.johnson@tufts.edu|
22379220|NCT03535337|Florida State University|Sylvie Naar, PhD; Distinguished Endowed Professor|18506442334|sylvie.naar@med.fsu.edu|
22379221|NCT05879198|Henry Ford Health|Dr. Julia Felton|313-598-0841|jfelton4@hfhs.org|
22426028|NCT03621956|Neonatal Research Institute, Sharp Mary Birch Hospital for Women & Newborns|Anup Katheria, M.D.|858-939-4170|anup.katheria@sharp.com|
22426029|NCT05664581|AbbVie|Global Medical Services|001 8006339110|abbvieclinicaltrials@abbvie.com|
22426030|NCT03101150|King Fahd Medical City|Consultant Obstetritian and Gynecologist|00966539417217|amali@kfmc.med.sa|
22426031|NCT05541939|Vogenx|Chief Scientific Officer|919-659-5677|info@vogenx.com|
22426032|NCT02772666|Mashhad University of Medical Sciences|Dr. Amirhossein Vejdani|+9151105411|amirhosein_vejdani@yahoo.com|
22426033|NCT01317641|Orion Pharma, Development, R&D|Head of Oncology|+358 10 4261|mika.mustonen@orionpharma.com|
22439562|NCT03661723|Dana-Farber Cancer Institute|David A. Reardon, MD (Clinical Director, Center for Neuro-Oncology)|617-632-2166|david_reardon@dfci.harvard.edu|
22426034|NCT00329108|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22426035|NCT01302418|QIAGEN|Tony Lam|301-944-7090|tony.lam@qiagen.com|
22439563|NCT03760029|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22426036|NCT02749227|Columbia University|Pamela U. Freda, MD|212-305-2254|puf1@cumc.columbia.edu|
22426037|NCT01289548|Department of Anaesthesiology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology|Hua zheng|00862783663173|huaz1980@hotmail.com|
22426038|NCT03143257|Medtronic Xomed|Sr Manager, Clinical Affairs|904-296-9600|rs.entgm@medtronic.com|
22426039|NCT03477162|Dartmouth Hitchcock Medical Center|Joseph Phillips, MD|603-650-5000|Joseph.D.Phillips@hitchcock.org|
22426040|NCT02498678|Instituto da Criança do Hospital das Clínicas da Universidade de São Paulo|Dr. Ricardo Vieira Carlos|55-11-99911-6677|ricardovieirac@gmail.com|
22439564|NCT00910104|Boston Children's Hospital|Mark Puder MD PhD|617-355-1838|mark.puder@childrens.harvard.edu|
22426041|NCT03257436|BostonScientific|Sharda Mehta|6785967330|sharda.mehta@bsci.com|
22426042|NCT01619852|Northwestern University|Gildasio De Oliveira, M.D.|312-695-4858|gjr@northwestern.edu|
22426043|NCT00970489|Harvard School of Public Health|Namasha Schelling|617-432-1734|nschelling@hsph.harvard.edu|
22426044|NCT05417412|San Diego State University|Dr. V. Robin Weersing|619-594-8892|robin.weersing@sdsu.edu|
22426045|NCT01576575|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
22426046|NCT00891813|Abbott|Global Medical Services|1-800-633-9110||
22426047|NCT05438277|Campbell Foundation|Research Manager|9017595413|mknack@campbell-foundation.org|
22426048|NCT01305811|New England School of Acupuncture|Lisa Conboy|6175581788|lconboy@nesa.edu|145
22426049|NCT01723072|Novartis Pharmaceuticals|Study Director|1-888-669-6682||
22426050|NCT04474483|University at Buffalo, SUNY|Sanjay Sethi MD|7168884864|ssethi@buffalo.edu|
22426051|NCT00954681|NYSPI/Columbia University|John J. Mariani|6467746140|john.mariani@nyspi.columbia.edu|646
22426052|NCT01610037|Novartis Pharmaceuticals|Study Director|862-778-8300||
22426053|NCT02256696|Vanderbilt University|Dr. Kelly Dooley|(615) 322-8972|kelly.e.dooley@vumc.org|
22426054|NCT03877744|University of Alabama at Birmingham|Dr. David Schwebel|205-934-8745|schwebel@uab.edu|
22426055|NCT02778152|The Research Institute at Nationwide Children's Hospital|Dr. Peter Minneci|614-722-3066|peter.minneci@nationwidechildrens.org|
22439565|NCT03137654|UFlorida|Ben Lewis, Assistant Professor, UF Department of Psychiatry|3522948724|benlewis@ufl.edu|
22426056|NCT03489343|Symphogen AS|Medical Director|0045 45265050|info@symphogen.com|
22426057|NCT00327717|Eisai Co., Ltd.|Takao Ishii, Asia regulatory affairs|81-3-3817-3914||
22426058|NCT01912950|Cutera|Margot Doucette|415-657-5518|mdoucette@cutera.com|
22426059|NCT03242941|Medtronic|Lilian Kornet|+31433566710|lilian.kornet@medtronic.com|
22426060|NCT01630135|GlaxoSmithKline|GSK Response Center|866-435-7343||
22426061|NCT02658669|VA San Diego Healthcare System|Dr. Henry Orff|(858) 642-6492|Henry.Orff@va.gov|
22426062|NCT01387178|GlaxoSmithKline|GSK Response Center|866-435-7343||
22426063|NCT02550743|Brown University Oncology Research Group (BrUOG)|Howard Safran, MD, Principal Investigator|14018633000|kayla_rosati@brown.edu|
22426064|NCT01246895|Piramal Healthcare (Canada) Limited - Bio-Orthopaedics Division|David Castelo, Clinical Research Manager|450-686-2437|david.castelo@piramal.com|313
22426065|NCT03311841|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22426066|NCT01129245|Oregon Health and Science University|Alison Edelman|503-494-5949|edelmana@ohsu.edu|
22426067|NCT00977613|Beth Israel Cancer Center|Victoria Rosenwald|212 844-8285|vrosenwa@chpnet.org|
22426068|NCT05464420|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22426069|NCT01472445|Stanford University|Melinda Telli, Associate Professor of Medicine (Oncology)|650-724-9533|mtelli@stanford.edu|
22426070|NCT01383018|Boston Scientific|Amanda Vail, Clinical Project Manager|612-749-5366|amanda.vail@bsci.com|
22426071|NCT01051817|Novartis Pharmaceuticals|Study Director|862-778-8300||
22426072|NCT00382785|University of Delaware|Paula Klemm, PhD, RN, OCN|(302) 831-8501|klemmpa@udel.edu|
22426073|NCT01598610|Ascensia Diabetes Care|Carmine Greene|574-257-3040|carmine.greene@ascensia.com|
22426074|NCT00627926|Vertex Pharmaceuticals Incorporated|Jeff Chodakewitz, M.D.|617-341-6777|Jeff_Chodakewitz@vrtx.com|
22439566|NCT03583099|Weill Cornell Medicine|Fernando J. Martinez, MD, MS|646-962-2370|fjm2003@med.cornell.edu|
22379222|NCT01598298|SWOG Statistics and Data Management Center|Leukemia Committee Statistician|2066674623|amoseley@fredhutch.org|
22379223|NCT04668989|Coopervision|Jose A. Vega, O.D., MSc, FAAO|9256213761|jvega2@coopervision.com|
22426075|NCT01951118|New York State Psychiatric Institute|Dr. Davangere Devanand|646-774-8658|dpd3@cumc.columbia.edu|
22426076|NCT02989402|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|novartis.email@novartis.com|
22426077|NCT03066830|Lexicon Pharmaceuticals, Inc.|Medical Affairs|510-338-6064|medical-information@lexpharma.com|
22426078|NCT03414229|Memorial Sloan Kettering Cancer Center|Dr. Sanda D'Angelo, MD|646-888-4159|dangelos@mskcc.org|
22426079|NCT03505372|Beth Israel Deaconess Medical Center|Dr Jordana Phillips|617 667 1630|jphilli2@bidmc.harvard.edu|
22379224|NCT01355419|CHU St Pierre|Dr Marie Bruyneel|00325354219|Marie_BRUYNEEL@stpierre-bru.be|
22379225|NCT02951351|Mayo Clinic|Margaret M. Reynolds, MD|507-284-2733|margaretmmreynolds@gmail.com|
22426080|NCT03065647|University of Michigan|Robert Neumar|734-936-0253|neumar@umich.edu|
22426081|NCT01408719|Agriculture and Agri-food Canada|Dr. Nancy Ames|204-474-7187|nancy.ames@agr.gc.ca|
22426082|NCT02797678|Philips Respironics|Senior Data Manager|7243877949|Jeff.Jasko@philips.com|
22426083|NCT04693078|Shaare Zedek Medical Center|Dr. Dan Meir Livovsky|+34603833576|danlivo@yahoo.com|
22426084|NCT01830933|University of California, San Francisco|Celia P. Kaplan, Professor|415-502-5601|celia.kaplan@ucsf.edu|
22426085|NCT01064362|GlaxoSmithKline|GSK Response Center|866-435-7343||
22426086|NCT00333710|VA Boston Healthcare System|Amy Silberbogen, Ph.D.|857-364-4707|amy.silberbogen@va.gov|
22426087|NCT02149264|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22426088|NCT02487797|Northwestern University, Yale University|Dr. Moeun Son|475-414-5328|moeun.son@yale.edu|
22426089|NCT01938846|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22426090|NCT00929344|The Scripps Research Institute|Barbara J. Mason, Ph.D.|858-784-7328|mason@scripps.edu|
22426091|NCT02499120|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22426092|NCT02282163|Bracco Diagnostics Inc.|Melda S. Dolan, MD, FACC, FASE, Head, Medical Affairs and Cardiac Ultrasound Programs|1-609-514-2506|Melda.Dolan@diag.bracco.com|
22426093|NCT01839916|University of Chicago|Dr. Hongtao Liu|773-834-1736|hliu2@medicine.bsd.uchicago.edu|
22426094|NCT01888952|CTRC@UTHSCSA|Anand Karnad, MD|210-450-1000|karnad@uthscsa.edu|
22379226|NCT01622348|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
22426095|NCT01216332|Vanderbilt|Dr. Natasha Halasa|6153223346|natasha.halasa@vanderbilt.edu|
22379227|NCT03765762|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
22379228|NCT00474175|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22426096|NCT03677869|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|drcrnet@jaeb.org|
22379229|NCT01619787|SUNYBuffalo|Leonard H. Epstein|716-829-3400|ckk@buffalo.edu|
22426097|NCT05219968|Lyra Therapeutics|Senior Vice President, Clinical Affairs|617-393-4600|lyraclinical@lyratx.com|
22426098|NCT03877224|Astrazeneca|Łyżwa, Dawid|+48 882 345 259|dawid.lyzwa@astrazeneca.com|
22426099|NCT00461097|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsgov@niaid.nih.gov|
22426100|NCT04587336|Health Systems Research Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT)|Allison Lewinski, PhD, MPH, RN, FAAN|919-286-0411|Allison.Lewinski@va.gov|174048
22426101|NCT01466361|GlaxoSmithKline|GSK Response Center|866-435-7343||
22426102|NCT01212094|NINDS, NIH|Dr. Bibiana Bielekova, Prinicipal Investigator|301-402-4488|bibiana.bielekova@nih.gov|
22426103|NCT01490892|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Flemming Forsberg|215-955-4870|flemming.forsberg@jefferson.edu|
22426104|NCT02787304|Mirum|Study Physician|1 650-667-4085|medinfo@mirumpharma.com|
22426105|NCT01450319|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22426106|NCT04754646|TEOXANE SA|Clinical Project Manager|+41(0) 22 344 96 36|clinical@teoxane.com|
22426107|NCT04771013|GIMUNICAH|Héctor M. Ramos-Zaldívar|+56934988958|hramos@unicah.edu|
22426108|NCT01051921|Conatus Pharmaceuticals Inc.|Vice President, Clinical Development|(858) 457- 7227|MHuyghe@conatuspharma.com|
22426109|NCT00379834|West Virginia University|Dr. Tony Realini|3045986926|realinia@wvuhealthcare.com|
22426110|NCT01519817|National Cancer Institute|Dr. James Gulley|301-480-8870|gulleyj@mail.nih.gov|
22426111|NCT01460303|UMass Medical School|Dr. Michael K. Flynn||Michael.Flynn@umassmemorial.org|
22426112|NCT01716806|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
22426113|NCT02189668|Nationwide Children's Hospital|Peter Minneci|6147223066|peter.minneci@nationwidechildrens.org|
22426114|NCT00735709|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22426115|NCT01145482|The University of Texas at Austin|Dr. Andreana Haley|512-232-0863|haley@psy.utexas.edu|
22426116|NCT04547140|Grifols Therapeutics LLC|Rhonda Griffin, Clinical Program Leader/Director|+1 919 757 1744|Rhonda.griffin@grifols.com|
22426117|NCT02119299|Scientific Intake|Richard P. Schneider|917-676-6251|rschneider@scientificintake.com|
22426118|NCT00873730|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22426119|NCT04613739|Harvard Pilgrim Health Care Institute|Dr. Alison Galbraith|617-867-4893|alison_galbraith@harvardpilgrim.org|
22426120|NCT03442088|University Hospitals Cleveland Medical Center|Dr. Neil Korman, Director Clinical Trials Unit|216-844-8200|Neil.Korman@UHhospitals.org|
22426121|NCT02541422|St. Luke's University Health Network|Holly Stankewicz, D.O.|610-360-2725|holly.stankewicz@gmail.com|
22426122|NCT01051557|Memorial Sloan Kettering Cancer Center|Dr. Thomas Kaley|212-639-5122|kaleyt@mskcc.org|
22426123|NCT00130689|Dana-Farber Cancer Institute|Jennifer Ang Chan, MD, MPH|617-632-6315|jennifer_chan@dfci.harvard.edu|
22426124|NCT00766597|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22426125|NCT00048035|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22426126|NCT01099358|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22426127|NCT05137717|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22426128|NCT02619617|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22379230|NCT04537897|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22396343|NCT01488279|Frist Clinic Endocrinology|Dr. Annis Marney|615-403-8398|annis.marney@hcahealthcare.com|
22396344|NCT03593850|Universidad del Rosario|Dr. Juan Sebastian Martin Saavedra|2672200532|juans.martin@urosario.edu.co|
22396345|NCT02490475|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22396346|NCT04130633|Johns Hopkins University School of Medicine|C. Austin Zamarripa, PhD|410-550-6969|czamarr2@jh.edu|
22396347|NCT00616434|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
22396348|NCT00119041|Louis Stokes VA Medical Center|David C. Aron, MD, MS|(216) 791-2300|david.aron@va.gov|5702
22396349|NCT00914927|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
22396350|NCT04784897|Innovation Pharmaceuticals Inc.|Senior Vice President, Clinical Sciences|978-921-4125|info@ipharminc.com|
22396351|NCT00324753|Center for Health Equity Research and Promotion (VAPHS)|Maria K. Mor|(412) 360-2240|maria.mor@va.gov|
22396352|NCT00112671|Princess Margaret Phase II Consortium|Dr. Srikala Sridhar|416-946-4501|srikala.sridhar@uhn.ca|2662
22396353|NCT02170779|VA Research and Development|Cinda Hugos, Physical Therapist|503-220-8262|hugosc@ohsu.edu|52338
22396354|NCT02367066|AstraZeneca|Dr. Stanko Skrtic, MD, PhD||ClinicalTrialTransparency@astrazeneca.com|
22396355|NCT00995475|University of Dundee|Professor Brian J Lipworth|+44 1382 383188|b.j.lipworth@dundee.ac.uk|
22396356|NCT00199836|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22396357|NCT01692691|Western Regional Medical Center|Jessica L. Coats|623-207-3899|jessica.coats@ctca-hope.com|
22396358|NCT01883986|VA Puget Sound Health Care System|Lynn F. Reinke, PhD, ARNP|206-277-4186|lynn.reinke1@va.gov|
22396359|NCT00982007|Luitpold Pharmaceuticals, Inc.|Mark A. Falone|610-650-4200|mfalone@luitpold.com|
22396360|NCT00805025|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22396361|NCT00615472|Columbia University|Eric J Heyer|212-305-9072|ejh3@cumc.columbia.edu|
22396362|NCT01353079|GREER Laboratories, Inc.|Terrance Coyne, M.D., Executive Vice President of Research & Development; Chief Medical Officer|(828) 759-7495|tcoynemd@greerlabs.com|
22439567|NCT04890652|Department of Psychiatry, Yale University School of Medicine|Dongju Seo, Associate Professor|475-441-3457|dongju.seo@yale.edu|
22396363|NCT02336763|UCLA|Mitchell Kamrava, MD|310-825-9775|mkamrava@mednet.ucla.edu|
22439568|NCT04364386|InPress Technologies Inc|Jan Segnitz, MD|(408) 238-9279|jsegnitz@gmail.com|
22439569|NCT05753449|Allegheny Health Network|Megan Hendricks, regulatory Specialist|412-330-6206|megan.hendricks@ahn.org|
22439570|NCT04019379|University of Minnesota|Kathleen M. Hill Gallant, PhD|612-625-5285|hillkm@umn.edu|
22439571|NCT00807911|Asan Medical Center|Dr. Tae Won Kim|+82-2-3010-3910|twkimmd@amc.seoul.kr|
22439572|NCT04175730|University of Illinois at Chicago|Dr. Michael Abern|312-996-9330|mabern1@uic.edu|
22439573|NCT04851691|University of California Los Angeles, Division of General Internal Medicine and Health Services Research|Project Manager|310-825-8253|cvillaflores@mednet.ucla.edu|
22439574|NCT03789669|Johnson & Johnson Surgical Vision|Brian Pall, Dr.|+1 904 6292289|bpall@its.jnj.com|
22439575|NCT04386291|NYS Psychiatric Institute|Dr. Brian A Fallon|646-774-8052|baf1@cumc.columbia.edu|
22439576|NCT02595983|Alnylam Pharmaceuticals Inc|Chief Medical Office|866.330.0326|Clinicaltrials@alnylam.com|
22439577|NCT03550118|University of Washington|Daniel Ballesteros|206-221-5873|danieb25@uw.edu|
22439578|NCT01187017|NIHNHLBI|Bhavisha Patel, MD|301.402.3477|bhavisha.patel@nih.gov|
22439579|NCT02399215|Roswell Park Comprehensive Cancer Center|Katy Wang|716-845-1300|Chong.Wang@Roswellpark.org|
22439580|NCT00772538|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22439581|NCT00524511|UMass Memorial Medical Center|Dawn Tasillo, MD|5083346255|tasillod@ummhc.org|
22439582|NCT03130738|Hill Dermaceuticals, Inc.|Rosario G Ramirez, MD|407-323-1887|nini.ramirez@hillderm.com|
22439583|NCT02689427|The University of Texas MD Anderson Cancer Center|Clinton Yam, MD|(832) 589-8343|cyam@mdanderson.org|
22439584|NCT04602390|Anokion US|Medical Director|+1 857.320.6607|clinicaltrials@anokion.com|
22439585|NCT01210716|Fenwal, Inc|Sr. Mgr. Clinical Affairs|847-550-5620|carrie.pineda@fenwalinc.com|
22439586|NCT01791244|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22439587|NCT00703014|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22439588|NCT04949191|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22439589|NCT03022396|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
22439590|NCT04590014|Vapotherm Inc|Katherine Gerich|5854696753|kgerich@vtherm.com|
22439591|NCT00468299|University of Rochester|Dr. Sarah Betstadt|585-276-5368|sarah_betstadt@urmc.rochester.edu|
22439592|NCT03546621|Hepatera LLC|Dr.Alexander Alexandrov|+7 (495) 726-52-53|alexandrov@myr-pharma.com|42-03
22439593|NCT00660192|Yale School of Medicine|Baman,Jabbari M.D. Porfessor of Neurology|203-737-2464|bahman.jabbari@yale.edu|
22439594|NCT00982735|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22439595|NCT03740048|Wake Health|Dr Zhidong Lin|3367138720|zlin@wakehealth.edu|
22439596|NCT03261336|Inova Schar Cancer Institute|Stephanie Van Bebber, Sr. Director Clinical Trials|5714720213|Stephanie.VanBebber@inova.org|
22439597|NCT01069484|Norwegian School of Sport Sciences, Department of Sports Medicine, Oslo, Norway|Dr. Gunvor Hilde|+47 41366045|gunvor.hilde@gmail.com|
22439598|NCT04097431|Mount St Mary's University|Dr. Griffin Rooker|(301) 447-5143|g.w.rooker@msmary.edu|
22439599|NCT04326920|UZ Gent|Cedric Bosteels|+3293325909|cedric.bosteels@ugent.be|
22439600|NCT02343263|Indiana University|Bruce H. Matt, MD, MSc|3172781215|bmatt@iupui.edu|
22439601|NCT02228681|GOG Foundation|Linda Gedeon for Virginia Filiaci, PhD|716-845-1169|lgedeon@gogstats.org|
22396364|NCT00932425|University of California San Francisco|Wade Smith, MD, PhD|415-353-8897|smithw@neurology.ucsf.edu|
22396365|NCT01252810|GE Healthcare|Ruben Sheng, M.D.|609-514-6899|Rubin.Sheng@ge.com|
22379231|NCT01034579|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22379232|NCT01532817|electroCore LLC|Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
22379233|NCT00197028|GlaxoSmithKline|GSK Response Center|866-435-7343||
22379234|NCT03893825|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22379235|NCT02979626|University of Colorado Denver|Dr. Suchitra Rao|7207771234|suchitra.rao@childrenscolorado.org|
22379236|NCT04488003|Biomed Valley Discoveries|Caroline Emery, PhD|816-960-4615|cemery@biomed-valley.com|
22379237|NCT01336959|Mereo BioPharma|Dr. Ian Hodgson|+44 333 0237300|enquiries@mereobiopharma.com|
22379238|NCT00058019|University of Chicago Medical Center|Dr. Sonali M. Smith|773-834-2895|smsmith@medicine.bsd.uchicago.edu|
22379239|NCT01468922|National Cancer Institute|Dr. Alice Chen|240-781-3274|chenali@mail.nih.gov|
22379240|NCT02551744|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
22379241|NCT00007475|National Institute of Diabetes & Digestive & Kidney Diseases|Jeffrey B. Kopp, MD|+1 (301) 594-3403|jbkopp@nih.gov|
22379242|NCT01719224|Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital|Matthias Eikermann, MD, PhD|617-643-7735|meikermann@partners.org|
22379243|NCT00258440|Oregon Health and Science Univeristy|Joseph Bubalo|503-494-8007|bubaloj@ohsu.edu|
22379244|NCT00737061|Hologic, Inc.|Edward Evantash, MD, Medical Director, Vice President Medical Affairs|508-263-8475|edward.evantash@hologic.com|
22379245|NCT03000673|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22379246|NCT00692406|DukeUMC|Dr. F. Joseph McClernon|919-668-3987|mccle011@mc.duke.edu|
22379247|NCT03501693|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
22379248|NCT02300285|Boston Children's Hospital|Michael SD Agus, MD|617 355-5849|michael.agus@childrens.harvard..edu|
22379249|NCT04186403|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22379250|NCT01447849|TexasTech|Dr. Jerzy Sarosiek, Director, Mol. Medicine Research|915-215-5255|jerzy.sarosiek@ttuhsc.edu|
22379251|NCT01407354|University Maryland Rehabilitation and Orthopaedic Institute|Paula Richley Geigle PT PhD|410 448 6773|pgeigle@umm.edu|
22379252|NCT01036022|GlaxoSmithKline|GSK Response Center|866-435-7343||
22379253|NCT00578721|UC Irvine Health - Chao Family Comprehensive Cancer Center|Jason Zell, DO, MPH, MS|714-456-5153|jzell@hs.uci.edu|
22379254|NCT02487095|National Cancer Institute|Dr. Anish Thomas|240-760-7343|thomasa6@nih.gov|
22379255|NCT01065350|Mayo Clinic|Nathan J. Smischney, MD|507-255-6032|smischney.nathan@mayo.edu|
22379256|NCT02205801|The University of Chicago Medicine & Biological Sciences|Dr. Raymond H. Grogan|773-702-7125|rgrogan@surgery.bsd.uchicago.edu|
22379257|NCT00962247|SUNY Buffalo|Leonard H. Epstein|716-829-3400|lhenet@buffalo.edu|
22379258|NCT00402194|Indiana University|Dr. Kieren Mather|317-278-7826|kmather@iu.edu|
22379259|NCT01292070|Tunitas Therapeutics|Nolan Sigal, MD, PhD, CEO, Tunitas Therapeutics|(650) 887-4747|nsigal@tunitastherapeutics.com|
22379260|NCT01555164|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22379261|NCT00697190|Vistakon|John Buch OD|904-443-1707||
22379262|NCT00886639|Schön Klinik BGL|Dr. Klaus Kenn|0865293|iheinzelmann@schoen-kliniken.de|1540
22379263|NCT01871558|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22379264|NCT01709305|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22379265|NCT02281526|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22379266|NCT02875834|AstraZeneca|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22379267|NCT01302938|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22379268|NCT00267696|The Ohio State University Comprehensive Cancer Center|Larry Copeland, MD|614-293-8697|Larry.Copeland@osumc.edu|
22379269|NCT03443713|Oregon Health and Science University|Jessica Castle MD|503-494-7072|castleje@ohsu.edu|
22379270|NCT01672853|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22379271|NCT02969525|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22379272|NCT03445065|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22379273|NCT02172625|Georgia State University|Dr. Gerald S. Zavorsky|404-413-1271|zavorsky@gsu.edu|
22379274|NCT03315130|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
22379275|NCT00524030|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22379276|NCT02944656|Emory University|Tiffany Hailstorks, MD, MPH|404-778-1385|tiffany.p.hailstorks@emory.edu|
22379277|NCT04398537|University of Alabama at Birmingham|Stefanie Woodard|205-996-4132|swoodard@uabmc.edu|
22379278|NCT00118898|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22379279|NCT04235582|Aurora Health Care|Mindy Waite, Behavioral Health Research Scientist|414-773-4323|mindy.waite@aah.org|
22379280|NCT05473000|The University of British Columbia|Dr. Michael Koehle|604-822-3838|michael.koehle@ubc.ca|
22379281|NCT02714205|University of California, San Francisco|Mike Schembri, Data Systems Analyst|415-353-7161|michael.schembri@ucsf.edu|
22379282|NCT02073097|Cleveland Clinic Foundation, Case Comprehensive Cancer Center|Dr. Brian T. Hill|1-866-223 8100|TaussigResearch@ccf.org|
22379283|NCT00186498|Stanford University|Dr. Hugh Brent Solvason|650 776 4793|solvason@stanford.edu|
22379284|NCT03813147|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
22379285|NCT01693692|Theravance Biopharma|Medical Monitor|1-855-633-8479|medinfo@theravance.com|
22379286|NCT02805595|Beth Israel Deaconess Medical Center|Martina Porter - Associate Directory of Dermatology Research|6176675834|mporter3@bidmc.harvard.edu|
22379287|NCT01811563|Duke University Medical Center|Samuel Wellman, MD|919-681-4055|samuel.wellman@duke.edu|
22426129|NCT00509899|Incyte Corporation|Study Director|1-855-463-3463||
22439602|NCT00849940|Duke University Medical Center|David MacLeod, M.B.|919-681-3551|david.macleod@dm.duke.edu|
22439603|NCT01784991|Albert Einstein Medical Center|Kamran Mohiuddin, Director Clinical Research Emergency Department|2154562313|MOHIUDDK@EINSTEIN.EDU|
22439604|NCT02588599|Arizona Institute of Footcare Physicians|Kerry Zang DPM|480-834-8804|kerryzang@aol.com|
22439605|NCT03353675|Transgene|Director of Medical Affairs|+ 33 (0)3 88 27 91 00|clinical.trials@transgene.fr|
22439606|NCT00402168|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22439607|NCT00582361|UAB|Research Nurse Coordinator|205-996-6781|Talyor.vlack@ortho.uab.edu|
22439608|NCT00550407|GlaxoSmithKline|GSK Response Center|866-435-7343||
22439609|NCT00584415|University of Oklahoma Health Sciences Center|Sunny Po, MD., Study Principal Investigator|405-271-9696|sunny-po@ouhsc.edu|
22439610|NCT02370420|Universidad Autonoma de Nuevo Leon|Felix Vilchez Cavazos|811 049 80 70|vilchez.doctor@hotmail.com|
22439611|NCT00556894|Can-Fite Biopharma|Pnina Fishman, PhD|011972 39241114|pnina@canfite.co.il|
22439612|NCT03883581|NOVA Southeastern University|Lauren Tabor Gray|954-914-5447|Lauren.taborgray@nova.edu|
22439613|NCT02649556|Philip Morris Products S.A.|Christelle Haziza|+41 58 242 11 11|christelle.haziza@pmi.com|
22439614|NCT03224130|Cincinnati Children's Hospital Medical Center|Dr. Heidi Sucharew (Biostatistician)|513-803-1920|heidi.sucharew@cchmc.org|
22439615|NCT01453049|GlaxoSmithKline|GSK Response Center|866-435-7343||
22439616|NCT02660788|BC Cancer|Dr. Alan Nichol|604-877-6046|anichol@bccancer.bc.ca|
22439617|NCT04861597|Montefiore Medical Center|Ruby Greywoode M.D. M.S., Assistant Professor of Medicine|347-671-8205|rgreywoode@montefiore.org|
22439618|NCT01317472|Indiana University|Terese Stevens, Dept administrator|317-278-3187|tstevens@iupui.edu|
22439619|NCT01815918|Hospital for Special Surgery|Kethy Jules-Elysee, MD|212-606-1206|JulesElyseeK@HSS.EDU|
22439620|NCT04673214|MEXICAN SOCIAL SECURITY INSTITUTE|Dr. GILBERTO CRUZ ARTEAGA|55 87 44 22|gilberto.cruz@imss.gob.mx|15320
22439621|NCT03804840|University of Chicago|Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
22439622|NCT03793751|Tata Main Hospital, Tata Steel|Dr.Deb Sanjay Nag|+91-9431166582|debsanjay@gmail.com|
22439623|NCT03532542|Sarepta Therapeutics, Inc.|Medical Director|1-888-727-3782|SareptAlly@sarepta.com|
22439624|NCT01018030|GlaxoSmithKline|GSK Response Center|866-435-7343||
22439625|NCT01089504|University of Rochester|Ronnie Guillet|585-275-6209|ronnie_guillet@urmc.rochester.edu|
22439626|NCT00001832|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
22439627|NCT00713609|GlaxoSmithKline|GSK Response Center|866-435-7343||
22439628|NCT04529083|VA North Texas Health Care System|Dr. James Le Page|214-857-1437|james.lepage@va.gov|
22439629|NCT00060528|National Cancer Instititute (NCI), National Institutes of Health (NIH)|James L. Gulley, M.D.|301-435-2956|gulleyj@mail.nih.gov|
22439630|NCT04196686|Lucile Packard Children's Hospital Stanford|Samuel Rodriguez, MD|(650)723-6412|sr1@stanford.edu|
22439631|NCT01048593|Eyepoint Pharmaceuticals, Inc.|Regulatory Affairs Specialist|6179726318|dbauer@eyepointpharma.com|
22439632|NCT04701814|Pharos university in Alexandria|P.T Moataz Abdelaal|1060081213|moataz.abd.student@pua.edu.eg|+20
22439633|NCT00914849|Washington University School of Medicine|John DiPersio, M.D., Ph.D.|314-454-8304|jdipersi@dom.wustl.edu|
22439634|NCT01001221|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi.com|
22439635|NCT05106959|University of New Mexico South West Clinical Trials Network|Cade Arnink|505-918-0341|clarnink@salud.unm.edu|
22439636|NCT03448406|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22439637|NCT00087152|SWOG|Lead Statistician - Breast Cancer Committee|(206) 839-1761|williamb@crab.org|
22439638|NCT01292486|Terumo BCT|Jerome R Bill, M.D.|303-231-4729|jerry.bill@terumobct.com|
22439639|NCT04369404|Massachusetts General Hospital|Karen Sepucha, PhD|617-724-3350|ksepucha@mgh.harvard.edu|
22439640|NCT02542865|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22439641|NCT05005260|Mayo Clinic|Johar Paul|5072556804|Paul.Johar@mayo.edu|
22439642|NCT01277744|UT MD Anderson Cancer Center|Andrea Hayes-Jordan M.D. / Surgical Oncology|713-794-4616|AHJORDAN@MDANDERSON.ORG|
22439643|NCT01490151|Stanford University|Dr. Bruce Buckingham, MD|408-356-0911|buckingham@stanford.edu|
22439644|NCT02358473|Kyowa Kirin Pharmaceutical Development, Inc.|Regional_Program Lead|1-609-919-1000|clinical.info@kyowa-kirin-pharma.com|
22439645|NCT01856270|University of Washington|Dr. Jeanne Hoffman|206-221-6511|jeanneh@uw.edu|
22439646|NCT00730158|UPMC Hillman Cancer Center|Edward Chu, MD|(412) 648-6589|chue2@upmc.edu|
22439647|NCT02970981|NYU Langone Health - Perlmutter Cancer Center|Jeffrey S. Weber, MD, PhD|212 731 6262|Jeffrey.Weber@nyulangone.org|
22439648|NCT03535974|Fundatia Bio-Forum|Dr. Felician Stancioiu|+40727500402|felicians11@gmail.com|
22439649|NCT04059549|UW Madison|Olivia Vjorn|6084772614|ocody@wisc.edu|
22439650|NCT02678351|Stanford Medicine at Stanford University|Andrea Otte|650-736-4183|anotte@stanford.edu|
22439651|NCT03259230|Swedish Orphan Biovitrum|Medical Director|+4686972000|clinical@sobi.com|
22439652|NCT02913482|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22439653|NCT01919229|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22439654|NCT01011673|Montefiore Medical Center, Albert Einstein College of Medicine|Benjamin Friedman, MD|718-920-6626|BEFRIEDM@montefiore.org|
22439655|NCT05468814|Hospital Universitario Reina Sofía|Ms. Irene Calzado Álvarez de Lara|+34618093419|ircaalla@gmail.com|
22379288|NCT04424290|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22379289|NCT02936037|MedDay Pharmaceuticals|Dr Frédéric SEDEL, Chief Scientific Officer and Co-founder|+33180401440|frederic.sedel@medday-pharma.com|
22379290|NCT01267825|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|718-920-6266|befriedm@montefiore.org|
22439656|NCT00803283|Janssen Taiwan|Medical Advisor|886-2-23762158||
22439657|NCT01983228|Minneapolis Veterans Affairs Health Care System|Dr. Diana Burgess, Principal Investigator|612-467-1591|diana.burgess@va.gov|
22379291|NCT04249336|Dow University of Health Sciences|Syed Jaffar Abbas Zaidi|00923412481371|jaffar.zaidi@duhs.edu.pk|
22379292|NCT00983489|Deen Dayal Upadhaya Hospital, New Delhi|Dr Kanchan Sharma|919417938224|psaiims@yahoo.co.in|
22379293|NCT01189890|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22379294|NCT00077636|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22379295|NCT01045122|University of Rochester Medical Center|Dr. Suzanne Karan|585-275-5161|Suzanne_Karan@urmc.rochester.edu|
22379296|NCT00068380|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22379297|NCT01976364|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22439658|NCT04716426|ELJ Consultancy|Ernesto Cesar Pinto Leal Junior|+55 11 975222856|ceo@eljconsultancy.com|
22439659|NCT04797585|Cleveland Clinic Foundation|Cecile Ferrando, M.D.|216-444-0642|ferranc2@ccf.org|
22379298|NCT01190215|GlaxoSmithKline|GSK Response Center|866-435-7343||
22379299|NCT01449240|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22379300|NCT02914184|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22379301|NCT00802659|Washington University School of Medicine|Jeffrey Bradley, M.D.|314-362-8525|jbradley@radonc.wustl.edu|
22379302|NCT00806624|Daiichi Sankyo.,LTD|Atsushi Nonogaki, Manager|81-80-3029-7553|nonogaki.atsushi.zz@daiichisankyo.co.jp|
22379303|NCT03093428|Dana Farber Cancer Institute|Atish Choudhury|617-632-6328|achoudhury@partners.org|
22379304|NCT00525135|University of California San Francisco|UCSF PRS Administrator|415-502-3212|Elaine.Cooperstein@ucsf.edu|
22379305|NCT00936481|Vanderbilt Universit|Kanika Bagai, MD, Assistant Professor|6153220283|kanika.bagai@vanderbilt.edu|
22379306|NCT01336634|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22379307|NCT01973491|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22379308|NCT01432535|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22379309|NCT01863043|University of Florida|Dr. Leslie Parker|352 215 9360|parkela@ufl.edu|
22379310|NCT00313911|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22379311|NCT01987596|Barbara Ann Karmanos Cancer Institute|Dr. Maxim Yankelevich|313-745-5515|myankele@med.wayne.edu|
22379312|NCT01971580|UT Southwestern|Ari Cedars|3149224788|acedars97@gmail.com|
22379313|NCT02632786|Prothena|Wendy Curlin|650 837 8550|clinicaltrials@prothena.com|
22396366|NCT02347488|UCLA Department of Anesthesiology|Nir Nahum Hoftman, MD|310-267-8679|nhoftman@mednet.ucla.edu|
22396367|NCT02811549|Advanced Bionics|Ankur Kaushal, VP of Global Regulatory Affairs|661 362 1400|clinicalresearch@advancedbionics.com|
22396368|NCT05293743|The Hospital for Sick Children|Dr. Maryse Bouchard|4168137654|maryse.bouchard@sickkids.ca|224522
22396369|NCT05314712|Center for American Indian and Rural Health Equity|Vernon Grant|406-531-9310|vernon.grant@montana.edu|
22396370|NCT01200238|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617.632.5053|Stephen_Hodi@dfci.harvard.edu|
22396371|NCT05834348|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22411289|NCT00798889|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22411290|NCT00617461|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
22411291|NCT05085964|Sepul Bio|Zuhal Butuner - Chief Medical Officer|(905) 599-7887|contact@sepulbio.com|
22411292|NCT01821625|UT Southwestern Medical Center at Dallas|William M Lee, MD|214 645 6111|william.lee@utsouthwestern.edu|
22411293|NCT03559010|HRA Pharma|Christine VENARD|33 1 84 13 92 44|c.venard@hra-pharma.com|
22411294|NCT01620489|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22411295|NCT00947856|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
22411296|NCT00982410|Ann Arbor Veteran Affairs|Dr. Mark Ilgen|(734) 845-3646|Mark.Ilgen@va.gov|
22411297|NCT01016652|Johnson & Johnson Vision Care|Thomas R. Karkkainen OD, MS, FAAO Senior Principal Research Optometrist|(904)443-3402|TKarkkai@its.jnj.com|
22411298|NCT02034799|Ethicon, Inc|Senior Director of Ethicon Clinical R&D|(908) 218-2492|jbatill2@its.jnj.com|
22411299|NCT03827213|Montefiore Medical Center|Elilary Medilla Medrano|(718) 920-4316|emontill@montefiore.org|
22411300|NCT03381248|Avanos Medical|David Curd|470-448-5178|david.curd@avanos.com|
22411301|NCT01717898|University of California, San Francisco|Charles Ryan, MD|877-827-3222|clinicaltrials@ucsf.edu|
22411302|NCT01341639|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22411303|NCT01590433|Beth Israel Deaconess Medical Center|Jody Dushay|617-667-9344|jdushay@bidmc.harvard.edu|
22411304|NCT00555009|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22411305|NCT02040428|Ethicon, Inc.|Richard Kocharian, MD, PhD|1 (908) 218-2013|rkochar1@ITS.JNJ.com|
22411306|NCT02058628|GlaxoSmithKline|GSK Response Center|866-435-7343||
22411307|NCT00832078|Coloplast|Scientific Manager|+4549113557|dkkg@coloplast.com|
22411308|NCT02961920|Department of Anesthesiology and Pain Medicine, Gil Medical Center, Gachon University|Dr Junju Choi|82324603624|jjchoi2@gilhospital.com|
22411309|NCT02243020|MicroTransponder Inc.|VP Clinical Affairs|5123714160|brent@microtransponder.com|
22411310|NCT01452529|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
22411311|NCT03551730|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
22411312|NCT01038557|Oregon Health & Science University|Dr. Martin A. Schreiber|503-494-8324|schreibm@ohsu.edu|
22411313|NCT02363010|Drexel University|Dr. Meghan Butryn|215-553-7108|mlb34@drexel.edu|
22411314|NCT03347695|Fujian Medical University Union Hospital|Dr. Liangwan Chen|861335825333|chenliangwan@tom.com|
22411315|NCT00996866|Winthrop-University Hospital|John Aloia, MD|516-663-2442|jaloia@winthrop.org|
22411316|NCT00671879|Meda Pharma US|David Ginsberg, DO Sr Dir Medical Scientific Affairs|732 564 2347|david.ginsberg@meda.us|
22411317|NCT04633837|American Health Network|Brian Badman|317-208-3866|bbadman@gmail.com|
22439660|NCT01650558|University of Maryland School of Medicine|Miriam K. Laufer, M.D., M.P.H.|410-706-5333|mlaufer@som.umaryland.edu|
22439661|NCT02960217|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
22439662|NCT02734693|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
22439663|NCT03174353|University of Washington|Dr. Venu Pillarisetty|206-616-4924|vgp@uw.edu|
22439664|NCT00079326|Dana-Farber Cancer Institute|Craig Bunnell|617-632-3800|cbunnell@partners.org|
22439665|NCT02675907|Recro Pharma, Inc.|Randall Mack|484-395-2470|rmack@recropharma.com|2406
22439666|NCT01611792|University of Vermont Medical Center, Burlington, VT|Dr. Sharon M. Henry|802 847-6733|Sharon.Henry@uvm.edu|
22439667|NCT03416868|Massachusetts General Hospital; Harvard Medical School|Jarrad Van Stan, PhD, CCC-SLP|617-643-8410|jvanstan@mgh.harvard.edu|
22439668|NCT02970799|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22439669|NCT00960375|V Maryland Healthcare System|Dr. Melanie Bennett, Research Health Scientist|410-637-1859|Melanie.Bennett@va.gov|
22439670|NCT03624881|Biosense Webster, Inc.|Senior Safety Officer CSS|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22439671|NCT00995761|Gyeongsang National University Hospital|Gyeong-Won Lee M.D.Ph.D.|82-55-750-8066|brightree@lycos.co.kr|
22439672|NCT03473236|GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.|R. Aranda M.D. / Senior Vice President of Clinical Development|(858) 684-1300|raranda@gossamerbio.com|
22439673|NCT04264442|Fulcrum Therapeutics|Call Center|617-651-8853|clinicaltrials@fulcrumtx.com|
22439674|NCT03309020|National Institutes of Health|Teresa Magone, MD, Principal Investigator, NEI|301-435-4562|teresa.magonedequadroscosta@nih.gov|
22439675|NCT03371836|KennedyKrieger|Project Director|443-923-7600|Salpekar@kennedykrieger.org|
22439676|NCT04897711|Utah State University|Stephanie Borrie|435-797-1388|stephanie.borrie@usu.edu|
22439677|NCT02362724|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
22439678|NCT01854359|National Institutes of Allergy and Infectious Diseases|Dr. Peter Kosa (Staff Scientist)|(301) 731-6444|peter.kosa@nih.gov|
22439679|NCT05190120|University of California San Francisco|Dr. Pedram Aleshi|(415) 271-1627|pedram.aleshi@ucsf.edu|
22439680|NCT03062358|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22439681|NCT05893862|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22439682|NCT04158583|Hoffman-La-Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22439683|NCT03043885|UCSF|Daniel Clark|415.476.1101|daniel.clark@ucsf.edu|
22379314|NCT00709592|Virginia Commonwealth University|Amir A Toor, MD|804-828-4360|atoor@mcvh-vcu.edu|
22379315|NCT03223272|UAB|Physician|4346545260|dacalhou@sentara.com|
22379316|NCT01231841|Cleveland Clinic Foundation|Jaroslaw Maciejewski, MD PhD, Principal Investigator|216-445-5962|maciejj@ccf.org|
22379317|NCT00451217|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22426130|NCT01254656|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22426131|NCT02946892|UTSW|Ryan Butts|2144565822|ryan.butts@utsouthwestern.edu|
22426132|NCT02326272|Cares|UCB|+1844599|UCBCares@ucb.com|2273
22426133|NCT02196857|The University of Texas MD Anderson Cancer Center|Ravandi-Kashani,Farhad MD./Professor|713-745-0394|fravandi@mdanderson.org|
22426134|NCT00270296|Harvard TH Chan School of Public Health|Dr. Roger Shapiro|617-432-2334|rshapiro@hsph.harvard.edu|
22426135|NCT01265394|GE Healthcare|Dr. Paul Sherwin|1-609-514-6820|paulsherwin@ge.com|
22426136|NCT01116037|Medtronic|Ryan Palmer|+17635149732|ryan.j.palmer@medtronic.com|
22426137|NCT04033146|Georgia Insitute of Technology|Dr. Gregory S. Sawicki; Professor Mechanical Engineering|919 448 5099|gregory.sawicki@me.gatech.edu|
22426138|NCT01348139|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22426139|NCT01015326|Northwestern University|Mandy Browning|312-695-6829|mandybrowning2015@u.northwestern.edu|
22426140|NCT02254772|Stanford Univeristy Medical Center|Ronald Levy, MD, Professor of Medicine|650-725-6452|levy@stanford.edu|
22426141|NCT00483652|Acorda Therapeutics, Inc.|Andrew Blight, Chief Scientific Officer|(914) 347-4300|ablight@acorda.com|102
22426142|NCT03006562|Johns Hopkins Brady Urological Institute|Dr. Mohamad Allaf|410-955-6100|mallaf@jhmi.edu|
22426143|NCT02644278|Merck KGaA Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22426144|NCT02862080|The University of Texas Health Science Center at Houston|Marcie Kern, PT, MSPT|713-799-6995|neurorecoveryresearch@memorialhermann.org|
22426145|NCT02427841|OHSUKCI|Dr. Gina Vaccaro|503-216-6300|vaccarog@ohsu.edu|
22426146|NCT01841970|Medtronic Surgical Innovations|Study Director, Clinical Research|508-452-4028||
22426147|NCT05926648|Masimo Corporation|Ahmed Alghazi|949-297-7000|studies@masimo.com|
22426148|NCT01805895|Augusta University|Dr Jeffrey Switzer|7067211691|jswitzer@augusta.edu|
22426149|NCT03064113|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
22426150|NCT00496340|H. Lee Moffitt Cancer Center and Research Institute|Marcie Riches, MD|813-745-6284|marcie.riches@moffitt.org|
22426151|NCT02050334|Chemigen|Consultant|317 293-0852|farlowds@yahoo.com|
22426152|NCT03075267|Pearl Therapeutics, Inc.|Pearl Therapeutics, Inc.|1-877-240-9479|information.center@astrazeneca.com|
22426153|NCT03874013|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
22426154|NCT00274742|Amgen Inc.|Study Director|866-572-6436||
22426155|NCT03421379|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22426156|NCT03742986|NYU Langone Health - Perlmutter Cancer Center|Maryann Kwa, MD|(212) 731-6364|maryann.kwa@nyulangone.org|
22426157|NCT02925858|Jewish General Hospital|Dr Matthew Cameron|514-340-8222|matthew.cameron@mcgill.ca|25701
22426158|NCT03771963|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22426159|NCT00102596|NINDS/NIH|Mark Hallett, M.D.|301-496-9526|hallettm@ninds.nih.gov|
22426160|NCT02017093|University of Haifa|Prof. Eli Carmeli|972-4-8288-397|ecarmeli@univ.haifa.ac.il|
22379318|NCT02674490|Johns Hopkins University School of Medicine|Dr. Argye Hillis, MD|4109552228|argye@jhmi.edu|
22379319|NCT03154359|Children's Mercy Hospital|James Steven Leeder, PharmD, PhD|816-731-7116|sleeder@cmh.edu|
22379320|NCT04250337|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22379321|NCT03664739|Bausch Health Americas, Inc|Study Director|19083009920|susan.harris@bauschhealth.com|
22379322|NCT00569803|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22379323|NCT01993823|Laboratorios SALVAT|Enrique Jimenez, Medical Director|+39933946470|ejimenezv@salvatbiotech.com|
22379324|NCT02006420|University of Michigan|Dinesh Khanna|734-763-7182|khannad@umich.edu|
22379325|NCT02392767|Dr. Loges + Co. GmbH|Dr. Birgit Goyvaerts|0049-4171-707182|goyvaerts@loges.de|
22379326|NCT00389974|Princess Margaret Hospital, Toronto, Canada|Dr. Helen Mackay|(416) 946-2253|helen.mackay@uhn.ca|
22379327|NCT01592695|University of Iowa|Mark Vander Weg, PhD|319-338-0581|mark-vanderweg@uiowa.edu|7717
22379328|NCT00422799|Dana-Farber Cancer Institute|Irene M. Ghobrial|(617) 632-4218|Irene_Ghobrial@DFCI.HARVARD.EDU|
22379329|NCT00453479|GlaxoSmithKline|GSK Response Center|866-435-7343||
22379330|NCT03029780|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22379331|NCT00178256|University of Rochester|Yuhchyau Chen MD, PhD|585-275-5575|yuhchyau_chen@urmc.rochester.edu|
22379332|NCT03066622|Regions Hospital|Meghan O'Brien|651-254-5303|meghan.e.obrien@healthpartners.com|
22379333|NCT01763788|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22379334|NCT03321006|NYP Institute|Dr. Katharine Brewster|646 774 6380|Katharine.Brewster@nyspi.columbia.edu|
22379335|NCT00749125|University of Pennsylvania|Yvette Sheline|215-573-0082|sheline@pennmedicine.upenn.edu|
22379336|NCT02006121|Britannia Pharmaceuticals|Medical Director|+44 1189209500|reception@britannia-pharm.com|
22379337|NCT02354859|University of Washington|Christopher H. Goss, Professor of Medicine and Pediatrics|206-543-3166|goss@uw.edu|
22379338|NCT02357043|Remington-Davis Inc.|Dr. Ian Baird|6144872560|hbaird@remdavis.com|
22379339|NCT04498247|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22379340|NCT01737996|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22379341|NCT01003184|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22379342|NCT00557622|GlaxoSmithKline|GSK Response Center|866-435-7343||
22379343|NCT02765490|Janssen Research & Development, LLC|Trial Physician, Medical Department|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22379344|NCT01923389|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22439684|NCT01766050|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22439685|NCT01097668|Apitope Technology (Bristol) Ltd|Chief Executive Officer|+44(0)117 3707720|keith.martin@apitope.com|
22439686|NCT00812708|University of California Los Angeles|Kevin M. Miller, MD|(310) 206-9951|millerpatients@jsei.ucla.edu|
22439687|NCT02421172|Novartis Pharmaceuticals|Study Director|8627788300||
22439688|NCT00928486|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|1-888-260-1599|ClinicalTrialDisclosure@celgene.com|
22379345|NCT03237013|San Diego State University|Dr. Aaron Blashill|619-594-2245|ajblashill@sdsu.edu|
22439689|NCT01021020|Mutual Pharmaceutical Company, Inc.|Medical Affairs Director|215-697-1743|clinicaltrials@urlmutual.com|
22439690|NCT00755183|Andover Eye|Dr. Mark Abelson|9784750705||
22439691|NCT02670811|Centro de Investigación en Alimentación y Desarrollo, A.C.|Dr. Belinda Vallejo Galland|526622892400|vallejo@ciad.mx|365
22439692|NCT02587520|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22439693|NCT00672555|Department of surgery, Cantonal hospital of St. Gallen|Lukas Marti; principal investigator|0041794120153|lukas.marti@kssg.ch|
22439694|NCT00350025|Fox Chase Cancer Center|Dr. Yu-Ning Wong|215-728-3889|yu-ning.wong@fccc.edu|
22439695|NCT04516746|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22439696|NCT03489863|University of Florida College of Medicine Jacksonville|Dominick J. Angiolillo|9042443378|dominick.angiolillo@jax.ufl.edu|
22439697|NCT00503750|Emory University|Dr. Ruth O'Regan|404-778-8808|roregan@emory.edu|
22439698|NCT00768989|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22439699|NCT02153086|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22439700|NCT00446849|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22439701|NCT03115359|Pennsylvania State University|Aleksandra E. Zgierska, MD, PhD|717-531-8187|azgierska@pennstatehealth.psu.edu|
22439702|NCT04992312|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22439703|NCT05546476|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22439704|NCT03585660|Department of Radiology, University of Chicago|Dr. Aytekin Oto, MD, MBA|1-773-702-8553|aoto@bsd.uchicago.edu|
22379346|NCT05266963|Vanderbilt University Medical Center|Dan Moore, M.D., Ph.D.|615-322-7247|daniel.moore@vumc.org|
22379347|NCT00152971|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22379348|NCT04091360|Verona Pharma|Medical Science Director|6464130307|margot.macdonald-berko@veronapharma.com|
22379349|NCT02597933|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22379350|NCT01617005|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22379351|NCT01097915|University of Cagliari|Iole Tomassini Barbarossa, Associate Professor|+390706754144|tomassin@unica.it|
22379352|NCT03961009|Kedrion S.p.A|Dr. Mirella Calcinai, MD, Clinical Research Director|+393486559761|m.calcinai@kedrion.com|
22439705|NCT05719311|Entero Therapeutics|VP, Regulatory, QA & Compliance|9194491484|AChandler@Enterothera.com|
22379353|NCT01336621|GlaxoSmithKline|GSK Response Center|866-435-7343||
22379354|NCT04534114|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22379355|NCT02759185|Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corporation|Berra Yazar-Klosinski, PhD / Chief Scientific Officer|(831) 429-6362|trialdata@mapsbcorp.com|
22379356|NCT04765735|Medtronic|Janelle Blum|262-289-8419|janelle.blum@medtronic.com|
22379357|NCT00525603|The University of MD Anderson Cancer Center|William G. Wierda, MD/Associate Professor|713-745-0428|eharriso@mdanderson.org|
22379358|NCT00513786|The Ohio State University Comprehensive Cancer Center|Dr. David O'Malley|614-293-3873|David.O'Malley@osumc.edu|
22379359|NCT00539279|VA San Diego Healthcare System|Steven R. Thorp, Ph.D., ABPP|(858) 552-8585|Steven.Thorp@va.gov|2468
22379360|NCT03221660|Ivoclar Vivadent AG|Dr. med. dent. Lukas Enggist, Dentist internal clinic (Principal Investigator)|+423 235 34 46|lukas.enggist@ivoclarvivadent.com|
22379361|NCT03104647|Shaare Zedek Medical Center|Dr. Yair Barzilay, PI|+972-2-6555166|barzilay@szmc.org.il|
22379362|NCT02791490|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22379363|NCT02960763|Washington University in St. Louis|Dr. Eric Lenze|314-362-5154|lenzee@wustl.edu|
22379364|NCT01017120|GlaxoSmithKline|GSK Response Center|866-435-7343||
22379365|NCT05340751|Hospital for Special Surgery|Dr. Friedrich Boettner|2127742127|BoettnerF@hss.edu|
22379366|NCT04502056|JPAL North America|Tristan Loisel|6307476739|tloisel@povertyactionlab.org|
22379367|NCT01014975|Grifols Therapeutics, Inc.|Henry Li, PhD|800-520-2807|henry.li@grifols.com|
22379368|NCT01642602|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22379369|NCT01112514|Massachusetts General Hospital|Andrew T. Chan|617 726 3212|achan@partners.org|
22379370|NCT01024959|Gen-Probe, Incorporated|Jennifer Reid, Director of Clinical Affairs|858-731-5985|jennifer.reid@hologic.com|
22379371|NCT02961881|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22379372|NCT00543400|Momenta Pharmaceuticals|Jim Roach, MD Chief Medical Officer|617-491-9700|jroach@momentpharma.com|
22379373|NCT00636792|Millennium Pharmaceutical Inc|Carol Satler|(617) 551-3729||
22379374|NCT01928225|University of Colorado|Cynthia Frinhaber|720-848-0000|cynthia.firnhaber@cuanschutz.edu|
22379375|NCT01582880|Massachusetts Eye and Ear Infirmary|Dr. Joseph Ciolino, MD|617-573-4437|joseph_ciolino@meei.harvard.edu|
22379376|NCT00574990|Salt Lake City VA HSRD IDEAS 2.0 Center of Innovation|Dr. Charlene Weir|801-582-1565|charlene.weir@utah.edu|5114
22379377|NCT01235975|GlaxoSmithKline|GSK Response Center|866-435-7343||
22379378|NCT00641719|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22379379|NCT03303469|The University of Alabama at Birmingham|Janis O'Malley|205-934-6504|jomalley@uabmc.edu|
22379380|NCT00885352|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22379381|NCT03560258|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22379382|NCT01460160|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22379383|NCT03101241|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-870-9177|ClinicalTrialDisclosure@JazzPharma.com|
22379384|NCT00669903|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22379385|NCT00251927|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22379386|NCT01678820|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22379387|NCT01381874|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22379388|NCT03283696|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22379389|NCT00245856|University of Oklahoma Health Sciences Center|Suman Rathbun MD|4052714742|suman-rathbun@ouhsc.edu|44773
22379390|NCT01472562|Weill Cornell Medicine|Jia Ruan M.D, Ph.D|646.962.2064|amr2017@med.cornell.edu|
22379391|NCT01512745|Fudan University Shanghai Cancer Center, Shanghai; PLA Cancer Centre, The 81 Hospital of PLA, Nangjing|Co-Director of Clinical Trials|021-64433755|fudanlijin@163.com,qinsk@csco.org.cn|
22379392|NCT00439179|BrUOG|Howard Safran, MD|4018633000|Hsafran@lifespan.org|
22379393|NCT02761629|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22379394|NCT02357810|Northwestern University|Mary Mulcahy, MD|312-695-0990|Mary.Mulcahy@nm.org|
22379395|NCT00562978|City of Hope National Medical Center|Dr. Auayporn Nademanee|626-256-4673|ANademanee@coh.org|82405
22379396|NCT00258180|Johns Hopkins School of Medicine|Maria Oliva-Hemker MD|410-955-8769|moliva@jhmi.edu|
22439706|NCT05316597|University of Washington|Dr. Gregory Bratman|2065437591|bratman@uw.edu|
22439707|NCT01706458|UWCCC|Mary Jane Staab - Program Manager|608-262-4304|mjs@medicine.wisc.edu|
22439708|NCT03547518|William Beaumont Hosptial|Jennifer Giordano, RN BSN Clinical Research Manager|248-551-3517|jennifer.giordano@corewellhealth.org|
22439709|NCT00907426|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22439710|NCT04854135|Washington University in St. Louis|Paulina Cruz Bravo, MD|314-922-8620|pcruz@wustl.edu|
22439711|NCT02766023|University of California San Francisco|Craig Cohen, MD, MPH|(415) 476-5874|Craig.Cohen@ucsf.edu|
22439712|NCT00286468|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22439713|NCT03103542|Swedish Orphan Biovitrum AB|Medical Information|+468 6972000|medical.info@sobi.com|
22439714|NCT02953652|Huya Japan G.K.|Huya Japan Clinical Development||japanclinical@huyabio.com|
22439715|NCT05875532|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22439716|NCT00072462|Queen Mary University of London|Professor Jack Cuzick|+442078823504|j.cuzick@qmul.ac.uk|
22439717|NCT02384551|VA ORD|Heidi J Silver|615-875-9355|heidi.j.silver@vumc.org|
22439718|NCT03679247|Brigham and Women's Hospital|Lipika Samal|6177327063|lsamal@bwh.harvard.edu|
22439719|NCT05164120|MedStar Health Georgetown Transplant Institute|Alexander Kroemer, MD; Khalid Kahn, MD|202-444-3700|Alexander.Kroemer@gunet.georgetown.edu; Khalid.M.Khan@gunet.georgetown.edu|
22439720|NCT02887820|University of Pittsburgh|Amy Monroe|412-623-6382|monroeal@upmc.edu|
22439721|NCT03035032|Astellas Pharma Sinagpore Pte Ltd|Clinical Trial Disclosure|+65 6500 9330|astellas.resultsdisclosure@astellas.com|
22439722|NCT03406780|Capricor, Inc.|Mark Awadalla|858-727-1755|clinicaltrialsgov@capricor.com|
22439723|NCT02795117|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
22439724|NCT00442169|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22439725|NCT01809938|GuysThomasNHSTrust / Rockingham General Hospital|Dr. Sam Hillyard|+61424055820|sghillyard@yahoo.co.uk|
22439726|NCT01903356|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22439727|NCT03305666|Denver Health and Hospital Authority|Dr. Fredric Pieracci|(303) 436-4029|Fredric.Pieracci@dhha.org|
22439728|NCT02051452|Harvard Medical School|Dr. Ken Solt, MD, Associate Professor of Anaesthesia|6177264359|ksolt@mgh.harvard.edu|
22439729|NCT02546609|Nusirt Biopharma Inc.|Barbara Cannon|615-656-7898|BCannon@nusirt.com|
22439730|NCT02212015|Universität Heidelberg/Universitätsmedizin Mannheim|Prof. Dr. med. Peter Hohenberger|+49 0621 383 2609|peter.hohenberger@umm.de|
22439731|NCT02756338|BIOTRONIK, Inc.|Crystal Miller|800-547-0394|crystal.miller@biotronik.com|
22439732|NCT03098641|Groupe Hospitalier de la Rochelle Ré Aunis|Dr Philippe Ferry|+33 5 46 45 50 50|philippe.ferry@ch-larochelle.fr|
22439733|NCT01546857|Rutgers-New Jersey Medical School|Jean Daniel Eloy|9739721470|eloyje@njms.rutgers.edu|973
22439734|NCT01339689|Marinus Pharmaceuticals, Inc.|Marinus Clinical Trials Submission Manager|484-801-4670|clinicaltrials@marinuspharma.com|
22439735|NCT01176032|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22439736|NCT01469221|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
22439737|NCT00375999|Gangnam Severance Hospital, Yonsei University College of Medicine|Dr. Jae Yong Cho|82-2-2019-4363|chojy@yuhs.ac|
22439738|NCT00659061|Aga Khan University|Professor Zulfiqar Ahmed Bhutta|4930051|zulfiqar.bhutta@aku.edu|4782
22439739|NCT03164668|University of Minnesota|Michael Kotlyar|612-625-1160|kotly001@umn.edu|
22439740|NCT00790803|Wake Forest Baptist Health Eye Center|Dr. Shree Kurup|336-716-4091|skk@retinacenterspc.com|
22439741|NCT04205240|The Ohio State University Comprehensive Cancer Center|Dr. Srinivas Devarakonda|614-293-3196|Srinivas.Devarakonda@osumc.edu|
22439742|NCT05121766|Hackensack Meridian Health|Arunima Sarkar, MD|5519961140|arunima.sarkar@hmhn.org|
22439743|NCT01632020|University of Arkansas for Medical Sciences|Daisy Wade|5016868274|dewade@uams.edu|
22439744|NCT02955589|Huya Japan G.K.|Huya Japan clinical development||japanclinical@huyabio.com|
22439745|NCT02987231|Institute of Science and Technology of São José dos Campos (Unesp)|Dr. Mauro P. Santamaria|+55 (16) 981937777|mauro.santamaria@unesp.br|
22439746|NCT00528957|Gilead Sciences|Clinical Trial Disclosures & Transparency||GileadClinicalTrials@gilead.com|
22439747|NCT02654782|Mayo Clinic|Dr. William C. Oliver, Jr.|507-255-4240|oliver.william@mayo.edu|
22379397|NCT00675506|Massachusetts General Hospital|Steven K. Grinspoon MD|617-726-3890|sgrinspoon@partners.org|
22426161|NCT02288819|Ziekenhuis Oost-Limburg|Dr. Frederik Verbrugge|0473924199|frederik.verbrugge@zol.be|+32
22426162|NCT00765856|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|clinicaltrials@endo.com|
22426163|NCT02039778|Mount Sinai Beth Israel|Dr. Rahul Parikh|732-253-3939|parikhrr@cinj.rutgers.edu|
22426164|NCT01678664|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
22426165|NCT01670045|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22426166|NCT01462110|Johnson & Johnson Consumer Inc.|Michael Lynch|908-433-6423|mlynch23@ITS.JNJ.com|
22426167|NCT05279131|Almirall S.A.|Head of Global Clinical Development|+34932913000|rd@almirall.com|
22426168|NCT00964028|GlaxoSmithKline|GSK Response Center|866-435-7343||
22426169|NCT03705286|Duke University|Miriam Treggiari|919-681-9933|miriam.treggiari@duke.edu|
22426170|NCT01401543|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22426171|NCT00069823|Johns Hopkins University|Ellen Brown|443-287-3170|ala-acrc@jhsph.edu|
22426172|NCT00593450|CATT Research Group|Dr. Maureen Maguire|215-615-1501|maguirem@mail.med.upenn.edu|
22426173|NCT02359110|Penn State Milton S. Hershey Medical Center|Timothy Deimling, M.D.|717-531-3503|tdeimling@pennstatehealth.psu.edu|
22426174|NCT00419757|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22426175|NCT03045653|Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative innovation center for Cancer Medicine|Zhongyu Yuan|+8613798027658|yuanzhy@sysucc.org.cn|
22426176|NCT02962427|University of Colorado|Cristina Wood, MD|7208483323|cristina.wood@ucdenver.edu|
22426177|NCT01491022|University of Miami|Dr Corneliu Luca|3052432235|cluca@med.miami.edu|
22426178|NCT03934216|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22426179|NCT04735705|Perfect Care Distribution|Mihnea Mihalache, Chief Executive Officer|+40 786 749 087|contact@perfectcare.ro|
22426180|NCT01711983|W. L. Gore & Associates|Bryan Randall|928-864-4832|BRandall@WLGore.com|
22426181|NCT00735943|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22426182|NCT01064414|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
22426183|NCT01164202|FFCD|Mrs Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
22426184|NCT00165503|Brigham and Women's Hospital|Dr. David Sugarbaker|617-732-5004|dsugarbaker@partners.org|
22426185|NCT00643201|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22426186|NCT02976519|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22426187|NCT02346708|University of Colorado Denver - Anschutz Medical Campus|Isabelle Buard, PhD|(303)724-5973|Isabelle.Buard@cuanschutz.edu|
22426188|NCT03416270|University Health Network|Dr. David Cherney|416.340.4151|david.cherney@uhn.ca|
22426189|NCT01781962|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22426190|NCT01687114|Tufts University|Oliver Chen|617-5563128|oliver.chen@tufts.edu|
22439748|NCT03485924|Johns Hopkins Medical Institute|Dr. Eun Ji Shin|4106140950|eshin3@jhmi.edu|
22439749|NCT00083889|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22439750|NCT00168844|Boehringer Ingelheim|Boehringer Ingelheim|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22439751|NCT03138369|Neurovalens Ltd|Paul McGeoch, MD|858-232-3312|paul.mcgeoch@neurovalens.com|+1
22439752|NCT02994108|Florida State University College of Medicine|Mary Gerend|8506451541|mary.gerend@med.fsu.edu|
22439753|NCT00089297|ECOG Statistical Office|Study Statistician|617-632-3012||
22439754|NCT00904969|American Medical System|Laura Olson, Clinical Project Manager|952-930-6000|laura.olson2@bsci.com|
22439755|NCT04396756|Pliant Therapeutics, Inc.|Gregory P. Cosgrove, MD, Vice President, Clinical Development|1-650-481-6770|GCosgrove@pliantrx.com|
22439756|NCT00574197|Cedars-Sinai Medical Center|Ernst Schwarz, MD, PhD|(310) 840-7089|Ernst.Schwarz@cshs.org|
22439757|NCT03965130|Yale|Dr. Kitt Falk Petersen|203 737 1942|kitt.petersen@yale.edu|
22439758|NCT00558142|University of Edinburgh|Prof M Eddleston|01312426776|m.eddleston@ed.ac.uk|
22439759|NCT04515771|Richard L. Roudebush VA Medical Center|Dr. Johanne Eliacin|317-988-5000|Johanne.Eliacin@va.gov|
22439760|NCT00278343|Juarvinski Cancer Centre|Dr. Hal Hirte|905-387-9495|hirteh@hhsc.ca|
22439761|NCT02535481|UCL|EPIGRAAFT Trial team|020 7679 2000|epigraaft@gmail.com|
22439762|NCT02464540|Federal University of Pelotas|Dr Noéli Boscato|5553999530000|noeliboscato@gmail.com|
22439763|NCT02047032|Gunang'anmen Hospital|Zhishun Liu|86 88002331|liuzhishun@aliyun.com|
22439764|NCT02927301|Genentech|Medical Communications|800-821-8590|genentech@druginfo.com|
22439765|NCT04742556|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22439766|NCT02903771|Kazia Therapeutics Ltd|Jeremy Simpson|+61 400410974|Jeremy.simpson@kaziatherapeutics.com|
22439767|NCT04247347|Case Western Reserve University|Jaclene Zauszniewski, PhD|216.368.3612|jaz@case.edu|
22439768|NCT03562195|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22439769|NCT02218372|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22439770|NCT02923726|Boston Scientific|Jacqueline Beaulieu, Sr. Clinical Trial Manager|1-800-227-3422|jacqueline.beaulieu@bsci.com|
22439771|NCT02753283|University of Pittsburgh|Dr. Susan Greenspan|+14126922477|greenspn@pitt.edu|
22439772|NCT03988400|Ralph H. Johnson VA|Jesse Dean|8437929566|deaje@musc.edu|
22439773|NCT04913610|Drugs for Neglected Diseases initiative|Clinical Trial Data|41 22 906 9230|ctdata@dndi.org|
22439774|NCT03186209|AstraZeneca|Global Clinical Head|1-877-240-9479|information.center@astrazeneca.com|
22439775|NCT03853473|Medical College of Wisconsin|Matthew J. Durand, Ph.D., Principal Investigator|414-955-5619|mdurand@mcw.edu|
22439776|NCT00590187|Cyclacel Pharmaceuticals|Julius, Huang, PhD.|760-877-2708|jhuang@cyclacel.com|
22439777|NCT05444855|Children's Mercy Hospitals and Clinics|Melissa Miller MD|816234300|mmiller@cmh.edu|
22439778|NCT00953667|UPenn|Muredach Reilly|215-573-1214|muredach@mail.med.upenn.edu|
22439779|NCT04038359|Secura Bio, Inc.|Ohad Bentur, MD, MHA, MSc|1-702-254-0011|obentur@securabio.com|
22439780|NCT00475670|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22439781|NCT01500733|National Heart Lung and Blood Institute|Ahn, Inhye|+1 301 827 1203|inhye.ahn@nih.gov|
22439782|NCT02004236|BrainMech Foundation|Moises Domingo president of Brainmech Foundation|+441615312645|moises@bigdata4brain.co.uk|
22439783|NCT01184898|Thomas Jefferson University|Margaret Kasner, MD|215-955-8874|Margaret.Kasner@jefferson.edu|
22439784|NCT00551759|ECOG Statistical Office|Study Statistician|617-632-3012||
22439785|NCT00918385|Duke University|Dr. Daniel George|(919) 668 4615|daniel.george@duke.edu|
22439786|NCT04076696|University of North Carolina at Chapel Hill|Director, Clinical Research, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
22439787|NCT03207126|Imperial College London|Diana Marcus|07525133957|diana.marcus@nhs.net|
22439788|NCT00322881|Dana-Farber Cancer Institute|Ursula A. Matulonis, MD|617-632-2334|umatulonis@partners.org|
22439789|NCT01476722|alcon Blobal Medical Affairs|Jami Kern, Ph.D.|1-888-451-3937||
22439790|NCT00526292|Memorial Sloan Kettering Cancer Center|Dr. Katherine Hsu|646-888-2667|hsuk@mskcc.org|
22439791|NCT03496844|University of Arizona|Phillip Kuo, MD PhD|5206268318|pkuo@arizona.edu|
22439792|NCT02296164|Helsinn Therapeutics (U.S.), Inc.|Bill Bailey|+1 732 603 2848|bill.bailey@helsinn.com|
22379398|NCT06173570|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22379399|NCT03820323|University of Washington|Rena C. Patel|206-520-3800|rcpatel@uw.edu|
22379400|NCT03151395|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22379401|NCT00366301|Brigham and Women's Hospital|Aruna Pradhan|617-732-8777|apradhan@partners.org|
22379402|NCT02153359|Johns Hopkins University|Dr. Sonali Bose|410-550-2708|kladson1@jhmi.edu|
22379403|NCT01348776|Syneron Beauty|Doran Rozen, Director of Clinical Affairs|+972-54-7800260|Doran.Rozen@syneron.com|
22379404|NCT01372605|University of North Carolina-Chapel Hill|Dr. Brian Pence|9199667446|bpence@unc.edu|
22379405|NCT02641249|University of California|Dr. Kalpashri Kesavan|3108256304|KKesavan@mednet.ucla.edu|
22379406|NCT00706784|MGH|Alexandra B. Kimball, MD|617-726-5066|akimball@partners.org|
22379407|NCT01830881|Oregon Health and Science University|Lisa Bayer, MD|503-494-3666|whru@gmail.com|
22379408|NCT00734214|McMaster University|Dr. Karen Choong|905-5212100|choongk@mcmaster.ca|75617
22379409|NCT01320735|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22439793|NCT02005016|VA Pittsburgh Healthcare System|Dr. Michael Dickey|412-360-6467|michael.dickey@va.gov|
22439794|NCT03324776|MODEL Clinical Research LLC|Philip Levin, MD|4102413438|pal3420@yahoo.com|
22379410|NCT04599101|William Beaumont Hospitals|Christine Batchelder, Research Nurse Manager|2488981075|christine.batchelder@corewellhealth.org|
22439795|NCT01003301|Johns Hopkins University|Sarbjit S. Saini|410-550-2129|ssaini@jhmi.edu|
22439796|NCT00918281|GE Healthcare|Matthew Miller|011-44-1494-543981|matthew.miller@ge.com|
22379411|NCT05952297|University of Utah|Dr. Kelly Baron|8015857588|kelly.baron@utah.edu|
22379412|NCT03856996|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22379413|NCT03959592|Duke University|Alessandro Jammal, M.D., Ph.D.|919-684-0202|alessandro.jammal@duke.edu|
22379414|NCT04362137|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22379415|NCT00771875|University of Cincinnati|E. Steve Woodle, MD|513-558-6001|woodlees@ucmail.uc.edu|
22379416|NCT02934620|Ohio State University, College of Public Health|Maria Gallo|16146882145|gallo.86@osu.edu|
22379417|NCT03556358|Tanvex|Study Director|19494838507|jennifer.lai@tanvex.com|
22379418|NCT01298921|Geisinger Health System|Office of Research Compliance|570-214-9628|orc@geisinger.edu|
22379419|NCT05067933|Vaxart|Melanie Drayton|650-392-3109|ClinicalTrials@Vaxart.com|
22379420|NCT01373450|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22379421|NCT02716038|Columbia University Irving Medical Center|Catherine A. Shu, MD|212-305-3997|cas2145@cumc.columbia.edu|
22379422|NCT00550550|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22379423|NCT02459093|Stony Brook Medicine|Dr David Garry|631-444-7650|david.garry@stonybrookmedicine.edu|
22379424|NCT00118092|Karmanos Cancer Institute at Wayne State University|Elisabeth Iljas Heath, M.D.||heathe@karmanos.org|
22379425|NCT00591864|Mayo Clinic|Amy Lynn Conners MD|(507) 284-2511|MBI@mayo.edu|
22379426|NCT03519243|BIOCAD|Linkova Iuliia|+7 (495) 992 66 28|linkova@biocad.ru|930
22379427|NCT03331185|University of Manitoba|Dr. Jonathan Bouwer|204 898 1132|jfbouwer@gmail.com|
22379428|NCT01103960|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22379429|NCT04921969|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22379430|NCT04287868|National Cancer Institute|Dr. Charalampos Floudas|240-858-3032|charalampos.floudas@nih.gov|
22379431|NCT01242176|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22379432|NCT00358215|Amgen Inc.|Study Director|866-572-6436||
22379433|NCT00871351|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22379434|NCT00744237|Forest Laboratories, Inc|Noah Rosenberg , MD, Exec. Dir, Clin Dev, Cardiovascular and Metabolism|2014278000|noah.rosenberg@frx.com|2133
22379435|NCT01118455|Cyberonics, Inc.|Mark Bunker, PharmD, Sr. Director, Global Medical Affairs|281-228-7223|Mark.Bunker@cyberonics.com|
22379436|NCT05033743|Indiana University School of Medicine|Chemen M. Neal, Associate Professor|3172789639|chmtate@iupui.edu|
22379437|NCT01798186|Johns Hopkins University|Ryan Vandrey|410-550-4036|rvandrey@jhmi.edu|
22379438|NCT03354325|University of Utah|Eric Coon|801-662-3645|Eric.Coon@hsc.utah.edu|
22379439|NCT00101660|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22379440|NCT01421589|Massachusetts General Hospital|Hideo Makimura, MD, PhD|617-726-8277|hmakimura@partners.org|
22379441|NCT00658697|DFCI|Rana R. McKay, MD|6176323237|rana_yehia@dfci.harvard.edu|
22379442|NCT01170884|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22379443|NCT00452413|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22379444|NCT00773955|Washington University|Maria Q. Baggstrom, M.D.||Mbaggstr@im.wustl.edu|
22379445|NCT03119610|UT Health San Antonio|Sara Espinoza, MD|210-617-5197|espinozas2@uthscsa.edu|
22379446|NCT00114634|NICHD, NIH|Forbes D Porter|301-435-4432|fdporter@mail.nih.gov|
22379447|NCT02223065|AstraZeneca AB, S-151 85 Södertälje, Sweden|Eva Johnsson, Clinical Science Lead, GLOBAL_MEDICINES_DEV|+46 31 7762484|Eva.Johnsson@astrazeneca.com|762 484
22379448|NCT00684762|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22379449|NCT02104830|Biocad|Roman Ivanov, Director of Clinical Trials|+7 (812) 380 49 33|ivanov@biocad.ru|950
22379450|NCT05150587|Alfasigma|Nicola Gargano - Senior Clinical Scientist|0039 (0)6 91395072|nicola.gargano@alfasigma.com|
22379451|NCT00332605|University of Chicago|Jon E. Grant|773-834-1325|jongrant@uchicago.edu|
22379452|NCT01614847|Northeastern State University Oklahoma College of Optometry|Thomas O. Salmon, OD, PhD, Professor|918-444-4011|salmonto@nsuok.edu|
22379453|NCT02991144|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
22379454|NCT03662997|Molnlycke Health Care|David Pham|678-231-9655|david.pham@molnlycke.com|
22379455|NCT01466764|Stanford University|Gary Peltz|650-721-2487|gpeltz@stanford.edu|
22379456|NCT02378402|Department of Radiology, Chang Gung Memorial Hospital|Gigin Lin, MD, PhD|886-3-3281200|giginlin@cgmh.org.tw|2575
22379457|NCT01035333|Albany College of Pharmacy and Health Sciences|Dr Margaret Malone|518 694 7275|margaret.malone@acphs.edu|
22379458|NCT00936221|AstraZeneca|Gabriella Mariani|+44 7818 523 899|ClinicalTrialTransparency@astrazeneca.com|
22379459|NCT01232465|North Shore|Dennis Marchesi|516-562-1761|dmarches@nshs.edu|
22379460|NCT01844115|Forest Research Institute, Inc|Therapeutic Area Head|877-277-8566|IR-CTRegistration@allergan.com|
22379461|NCT00545363|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22379462|NCT00210119|Institut Bergonie|Dr Gabriel Etienne||g.etienne@bordeaux.unicancer.fr|
22379463|NCT00951509|Human Engineering Research Labs|Rory Cooper, PhD|412-822-3700|rcooper@pitt.edu|
22379464|NCT01361620|George Washington University|Dr. Timothy McCaffrey|(202) 994-8919|mcc@email.gwu.edu|
22379465|NCT03125941|rigshospitalet|kristin steinthorsdottir, md|31666112|kjs@dadlnet.dk|
22379466|NCT00350701|University at Buffalo|Dr. Paresh Dandona|7165351850|dandona@buffalo.edu|
22379467|NCT02459080|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
22426191|NCT06331507|University of Michigan|Prachi Agarwal|734-232-5132|prachia@med.umich.edu|
22426192|NCT01278342|Novartis Pharmaceuticals|Study Director|862-778-8300||
22379468|NCT00406419|F. Hoffmann-La Roche Ltd|Medical Communications|+41 616878333|global.trial_information@roche.com|
22411318|NCT00955032|Center for Neurological Restoration Cleveland Clinic|Dr. Hubert Fernandez|(216) 445-1108|fernandez@neurology.ufl.edu|
22439797|NCT02978417|Duke University|Michele Easter, Ph.D.|919-385-0862|michele.easter@duke.edu|
22439798|NCT01323582|University of Florida|Baharak Moshiree MD|305-243-2515|bmoshiree@med.miami.edu|
22439799|NCT00564681|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22411319|NCT04527471|Verona Pharma|Margot MacDonald-berko|833-417-0262|margot.macdonald-berko@veronapharma.com|
22411320|NCT05432271|University of Pennsylvania|Dr. Laura Gibson|215-898-7093|gibla@pennmedicine.upenn.edu|
22411321|NCT02203747|Abbott Medical Optics|Carrie Garufis|714-566-3728|carrie.garufis@abbott.com|
22426193|NCT03760224|University of Hong Kong|Dr. Derek Cheung|39176652|derekcheung@hku.hk|
22426194|NCT01139996|Memorial University Medical Center|Imran Siddiqui, MD|912-350-8707|research2@memorialhealth.com|
22426195|NCT02276963|Johns Hopkins University|Michael Levy|443-287-4412|mlevy@jhmi.edu|
22426196|NCT02154139|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22426197|NCT02130999|Vince and Associates Clinical Research|Melodie Armstrong, MD, MPH|913-696-1601||
22426198|NCT00473655|AstraZeneca|Gerard Lynch|09645895|aztrial_results_posting@astrazeneca.com|44 15
22426199|NCT02076100|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22426200|NCT03335800|Associate Professor of Medicine, Stanford University|Minang (Mintu) Turakhia, Associate Professor of Medicine, Stanford University|(650) 493-5000|mintu@stanford.edu|
22426201|NCT02389959|Stanford University|Peter H. Hwang, MD|(650) 723-5281|hwangph@stanford.edu|
22426202|NCT01668836|Heart Institute (InCor), University of São Paulo Medical School|Antonio de Padua Mansur - Associate Professor|55-11-26615387|apmansur@usp.br; apmansur@yahoo.com|
22426203|NCT00807885|Baxter Healthcare Corporation|George Harb, MD, MPH||george_harb@baxter.com|
22426204|NCT02899065|UC Davis Medical Center|Larissa May, MD, MSHS, MSPH, Director of Emergency Medicine Innovation and External Partnerships|916-734-1593|lsmay@ucdavis.edu|
22426205|NCT00367003|Emory University|Dr. Patricio Riva Posse||privapo@emory.edu|
22426206|NCT00186485|Stanford University|Dr. Hugh Brent Solvason|650 776 4793|solvason@stanford.edu|
22426207|NCT01166750|University of Kansas Medical Center|Michael A. Rapoff, PhD., Principal Investigator|913-588-6323|mrapoff@kumc.edu|
22426208|NCT05225389|Cogntion Therapeutics Inc|Chief Medical Officer, Head of R&D|914-221-6730|acaggiano@cogrx.com|
22426209|NCT02417753|National Cancer Institute|Dr. Tim Greten|301-451-4723|gretentf@nih.gov|
22426210|NCT04805671|INVIVYD, Inc.|Study Inquiry|+1 781-819-0080|ClinicalTrials@invivyd.com|
22426211|NCT03804268|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22426212|NCT02849587|University of California, San Diego; Center for Medicinal Cannabis Research|Thomas D. Marcotte, Phd|619-543-5044|tmarcotte@ucsd.edu|
22426213|NCT03380377|Cedars Sinai Medical Center|Stan Jordan, MD|3104232641|stan.jordan@cshs.org|
22426214|NCT00385918|University of Maryland Rehabiitation and Orthopaedic Institute|Peter H. Gorman, MD Chief Division of Rehabilitation Medicine|410-448-6261|pgorman@umm.edu|
22426215|NCT00128661|GlaxoSmithKline|GSK Response Center|866-435-7343||
22426216|NCT01261390|Brigham and Women's Hospital|Dr. Susan Redline|617-732-5859|sredline1@rics.bwh.harvard.edu|
22426217|NCT00614172|Loma Linda University Health|David Bush, MD, Vice Chair Clinical Affairs Radiation Medicine|909 558 1000|DBush@llu.edu|
22426218|NCT01951417|Galderma Labratories, L.P.|Elizabeth M Nieman|817-961-5130|elizabeth.nieman@galderma.com|
22426219|NCT04010461|University of Michigan|Stephan Taylor|(734) 936-4955|sftaylor@med.umich.edu|
22426220|NCT01026948|University of Liverpool|Professor Zarko Alfirevic|00 44(1)51 702|zarko@liverpool.ac.uk|4100
22426221|NCT00826150|BioCancell Ltd.|VP Clinical|+97225486553|monique.ben-am@biocancell.com|
22426222|NCT03360019|University of Florida|Glenn Smith|352-273-6556|glennsmith@ufl.edu|
22426223|NCT03801642|University of Kansas Medical Center|Dr. Jeffrey Burns|913-588-0555|jburns2@kumc.edu|
22426224|NCT00753675|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22426225|NCT01211756|UCSD|David Feifel||dfeifel@kadimanp.com|
22426226|NCT02477358|University of Nebraska Medical Center|Elisabeth Easley|530-524-6020|eleasley@gmail.com|
22426227|NCT01074177|Massachusetts General Hospital|Lecia Van Damn Sequist|617-724-4000|lvsequist@partners.org|
22426228|NCT02106351|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22426229|NCT01801111|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22426230|NCT01210482|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22426231|NCT01223937|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22426232|NCT05176717|Sepul Bio|Zuhal Butuner - Chief Medical Officer|(905) 599-7887|contact@sepulbio.com|
22426233|NCT03284853|Aerie Pharmaceuticals Inc.|Michelle Senchyna, PhD. Vice President, Clinical Development & Medical Affairs.|+1 908 947 3551|msenchyna@aeriepharma.com|
22426234|NCT00534417|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
22426235|NCT00765817|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22426236|NCT00765947|Novartis Pharmaceuticals|Study Director|862-778-8300||
22426237|NCT02058589|GlaxoSmithKline|GSK Response Center|866-435-7343||
22426238|NCT02143024|UC Davis Department of Psychiatry and Behavioral Sciences|Ladson Hinton, MD|(916) 734-3485|lwhinton@ucdavis.edu|
22426239|NCT02308228|University of Kentucky|Douglas Long|859-323-5438|DELONG2@UKY.EDU|
22426240|NCT06597084|BIAL - Portela & Ca, SA|Responsible of Clinical Operations|+351229866100|clinical.trials@bial.com|
22426241|NCT01043133|USUHS|Ronald W. Gimbel|301-295-3077|rgimbel@usuhs.mil|
22426242|NCT01575756|Octapharma USA|Director of Clinical Operations|201 604-1149|sylvia.werner@octapharma.com|
22426243|NCT00490971|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Clinical Leader|609-730-2436||
22379469|NCT01461993|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22379470|NCT04394845|Hoffmann-La Roche|Medical Communications|800 821-8590|global-roche-genentech-trials@gene.com|
22379471|NCT01821898|Baylor College of Medicine/Texas Children's Hospital|Carla M. Davis, MD|832-824-1319|carlad@bcm.edu|
22379472|NCT01121484|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22379473|NCT04112940|University Health Network|Director, Swallowing Rehabilitation Research Laboratory|4165973422|tri-swallowinglab@uhn.ca|7802
22379474|NCT05415124|NYU Langone Health|Melissa Debordeaux, MD|(212) 263-7300|Melissa.Debordeaux@nyulangone.org|
22379475|NCT06390826|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22379476|NCT03679767|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22379477|NCT03915951|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22379478|NCT05408468|University Hospitals Cleveland Medical Center|Dr. Grant Pignatiello|216-368-4480|gap54@case.edu|
22379479|NCT02130453|The University of Texas MD Anderson Cancer Center|Nicolas Palaskas, MD|(713) 745-1942|nlpalaskas@mdanderson.org|
22379480|NCT01960075|Medical University of South Carolina|Jordan Elm, PhD Biostatistician|843-876-1605|elmj@musc.edu|
22379481|NCT02204579|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22379482|NCT01396395|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22379483|NCT02120664|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22379484|NCT02460263|Outset Medical, Inc|Clinical Operations|(669) 231-8200|clinical@outsetmedical.com|
22379485|NCT03916744|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
22379486|NCT00884754|London Health Sciences Centre|Philip Jones|519-685-8500|philip.jones@lhsc.on.ca|36306
22379487|NCT03176238|Novartis Pharmaceuticals|Study Director|888-669-6682|Novartis.email@novartis.com|
22379488|NCT00315588|University of Miami Miller School of Medicine Miami Fl|Dr. Rodolfo Alejandro|305 243 5324|ralejand@med.miami.edu|
22379489|NCT01642082|NRG Oncology|Linda Gedeon, BA, CCRP Clinical Research Coordinator|716-845-1169|lgedeon@gogstats.org|
22379490|NCT01351025|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|301-628-3313|ACTGCT.Gov@s-3.com|
22379491|NCT00515437|Solstice Neurosciences, Inc|Regulatory Affairs Specialist||regulatoryaffairs@usworldmeds.com|
22379492|NCT02066896|Federal University of Sao Paulo|Tania Sales de Alencar Fidelix|11991346992|fidelixtania@gmail.com|11
22379493|NCT00479089|The University of Texas (UT) MD Anderson Cancer Center|Arlene Siefker-Radtke, MD/Associate Professor, Genitourinary Medical Oncology|713-792-2830|CR_Study_Registration@mdanderson.org|
22379494|NCT01986361|Reckitt Benckiser Inc.|Gail Solomon, Director, Clinical Development|973-404-2752|gail.solomon@rb.com|
22379495|NCT03697980|Medtronic Cardiac Rhythm and Heart Failure|CRM/MCS Clinical Team|800-328-2518|MedtronicCRMtrials@medtronic.com|
22379496|NCT02089230|The University of Texas MD Anderson Cancer Center|Farhad Ravandi-Kashani MD/Professor|713-745-0394|fravandi@mdanderson.org|
22379497|NCT04591977|Pennsylvania State University College of Medicine|Jennifer L. Moss, PhD|7175310003|jmoss1@pennstatehealth.psu.edu|323429
22379498|NCT00405353|UCLA|Dr. Rhonda Voskuhl|(310) 206-4636|rvoskuhl@mednet.ucla.edu|
22379499|NCT03469284|UT MD Anderson Cancer Center|Dr. Carlos Roldan, Associate Professor, Pain Medicine|(713) 563-7402|croldan@mdanderson.org|
22379500|NCT02410967|Florida International University|Dr. Jeremy Pettit|305-348-1671|jpettit@fiu.edu|
22379501|NCT02032173|Novartis Pharmaceuticals|Study Director|862-778-1873||
22379502|NCT05082142|Northwestern University|Nicholas Dean (current fellow)|7806906285|nicholas.dean@northwestern.edu|
22379503|NCT00398398|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
22379504|NCT02291289|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22379505|NCT01622543|The Ottawa Hospital - Cancer Centre|Dr. Derek Jonker|613-737-7700|djonker@ottawahospital.on.ca|70170
22379506|NCT02310126|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, O.D., M.S., F.A.A.O., Sr. Principal Research Optometrist|904-443-3500|TKarkkai@its.jnj.com|3402
22379507|NCT00249496|Johns Hopkins School of Medicine: Department of Psychiatry|Dr. Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
22379508|NCT01539863|Karolinska Institutet|Ass professor Iben Axén|+46704400618|iben.axen@ki.se|
22379509|NCT02524054|Beth Israel Deaconess Medical Center|Robert Banzett, PhD|6176670572|rbanzett@bidmc.harvard.edu|
22379510|NCT02693834|Baylor Institute for Rehabilitation|Priya Karakkattil, PT PhD|469-888-5172|Pjke7991@gmail.com|
22379511|NCT00000143|Johns Hopkins School of Public Health|Curtis Meinert, PhD|410-955-8198|cmeinert@jhsph.edu|
22379512|NCT02111213|Stanford University|Principal Investigator|6507232880|desparza@stanford.edu|
22379513|NCT00759772|Massachusetts General Hospital|Pouneh K. Fazeli, MD|617-726-3870|pkfazeli@partners.org|
22379514|NCT01568827|The Ohio State University|Dr. Joseph Kitzmiller|6142928438|joseph.kitzmiller@osumc.edu|
22379515|NCT02226172|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22379516|NCT01989598|Princess Margaret Cancer Centre|Dr. Suzanna Trudel|4169464501|Suzanne.Trudel@uhn.ca|4566
22379517|NCT04548531|Massachusetts General Hospital|Karen Sepucha|6177243350|ksepucha@mgh.harvard.edu|
22379518|NCT04957732|University of Florida Shands Emergency Department|Richard Petrik, MD, Clinical Assistant Professor|352-265-5911||
22379519|NCT03767634|Imperial College London|Dr Chris Gale|+44 (0)20 3315 3519|christopher.gale@imperial.ac.uk|
22379520|NCT00758160|Janssen Pharmaceutical, Taiwan|Medical Affairs Director|+886-2-23762155||
22379521|NCT04785326|Dong-A ST|Clinical Research Manager|02-920-1111|imspring@donga.co.kr|
22379522|NCT01108510|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22379523|NCT00582491|Yale University School of Medicine|Peter Morgan, MD, PhD|203-974-7515|Peter.Morgan@yale.edu|
22379524|NCT02136498|Group Health Research Institute|Principle Investigator|206-287-2737|mcclure.j@ghc.org|
22411322|NCT03158298|Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany|Dr. Benjamin Schleenvoigt|+49 3641 9 32 46|benjamin.schleenvoigt@med.uni-jena.de|70
22411323|NCT02884206|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22411324|NCT01628120|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22411325|NCT01492582|University of Alabama at Birmingham|Dr. Wendy Landier, Deputy Director, Institute for Cancer Outcomes and Survivorship|(205) 638-2120|wlandier@peds.uab.edu|
22411326|NCT01259427|VISN 5 MIRECC|Amy Drapalski|410-637-1855|amy.drapalski@va.gov|
22411327|NCT01165996|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Yogen Saunthararajah, MD|216-444-8170|saunthy@ccf.org|
22411328|NCT00096265|Radiation Therapy Oncology Group|Wendy Seiferheld||wseiferheld@acr.org|
22411329|NCT01172600|Cleveland Clinic|Alparslan Turan, MD|216-445-9857|turana@ccf.org|
22411330|NCT02232074|Boston Medical Center|Tracy Battaglia|617.638.8036|tracy.battaglia@bmc.org|
22411331|NCT01927757|Amgen Inc.|Study Director|866-572-6436||
22411332|NCT00017563|OHSU Knight Cancer Institute|Tomasz Beer, M.D.|503-494-1080|beert@ohsu.edu|
22411333|NCT00444795|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@Pfizer.com|
22411334|NCT00988169|Memorial Sloan Kettering Cancer Center|Dr. Mark Kris|646-888-4205|krism@mskcc.org|
22411335|NCT00704418|ISTA Pharmaceuticals, Inc.|Tim McNamara, Vice President, Clinical Research & Medical Affairs|949-788-6000|tmcnamara@istavision.com|
22411336|NCT01464827|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22411337|NCT01075763|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22411338|NCT00586521|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22411339|NCT00580853|Yale University|Sherry McKee PhD|203-737-3529|sherry.mckee@yale.edu|
22411340|NCT03083483|Duke University|Hannah Palmer|919-613-7665|hlp14@duke.edu|
22439800|NCT03557970|Oregon Health and Science University|Elie Traer, MD PhD|5034943553|traere@ohsu.edu|
22439801|NCT00112736|Adult Brain Tumor Consortium (ABTC)|Dr. Patrick Y Wen||pwen@partners.org|
22439802|NCT00988832|Merck Sharp and Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22439803|NCT00409539|Sunovion|Medical Director, Urology|1-866-503-6351||
22439804|NCT01239511|Sinphar Pharmaceutical Co., Ltd.|Melanie Huang|886-2-27603688|wthuang@sinphar.com.tw|2190
22439805|NCT00525512|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22439806|NCT01601535|New Approaches to Neuroblastoma Therapy|NANT Medical Director|323-361-5687|nantops@chla.usc.edu|
22439807|NCT00534365|Cleveland Clinic|Lynn Borzi (Research Administrator)|216-445-3158|BORZIL@ccf.org|
22439808|NCT03600909|Memorial Sloan Kettering Cancer Center|Dr. Farid Boulad, MD|1-833-MSK-KIDS|bouladf@MSKCC.ORG|
22439809|NCT04576988|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22439810|NCT03218384|NYU Langone Health|Stuart Katz, MD|2122633946|Stuart.Katz@nyulangone.org|
22439811|NCT01128049|University of Rochester Medical Center, Flaum Eye Institute|James Aquavella, MD|585-275-8944|James_Aquavella@URMC.Rochester.Edu|
22439812|NCT03332459|Janssen Research & Development, LLC|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22439813|NCT05790460|Abramson Cancer Center at the University of Pennsylvania|Charu Aggarwal, MD, MPH|215-662-6318|charu.aggarwal@pennmedicine.upenn.edu|
22439814|NCT02919761|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22439815|NCT03724942|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81363617366|CL_OPCJ_RDA_Team@otsuka.jp|
22439816|NCT00410956|Memorial Sloan Kettering Cancer Center|Dr. William Jarnagin, MD|212-639-7601|jarnagiw@mskcc.org|
22439817|NCT00880698|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22439818|NCT03863795|National Cancer Institute|Annette Kaufman|301-467-8521|kaufmana@mail.nih.gov|
22439819|NCT01295814|IC Study, LLC|Philip C. Bosch, MD|760-743-3135|pboschmd@gmail.com|
22439820|NCT03414983|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
22439821|NCT00948246|Allergan Medical|Medical Monitor|(805) 961-5000|devicetrials@allergan.com|
22439822|NCT00148317|Weill Cornell Medical College|Jennifer Hess|6469629440|jmh2004@med.cornell.edu|
22439823|NCT02326155|Celltrion Inc|JiWoong Lim|82-32-850-5702|jiwoong.lim@celltrion.com|
22439824|NCT04199351|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22439825|NCT03623243|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
22439826|NCT03365102|Brown University|Richard Jones|401-444-1943|rich_jones@brown.edu|
22439827|NCT00979901|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22439828|NCT03924622|University of Washington|Becky Ostrem CIP Compliance Administrator, Regulatory Affairs|2066858138|bostrem@uw.edu|
22439829|NCT03649646|Boryung Pharm. CO., LTD|Myung Sook Hong|82-2-708-8238|mshong@boryung.co.kr|
22439830|NCT03085095|Myovant Sciences GmbH|Clinical Trials at Myovant|650-278-8743|ClinicalTrials@Myovant.com|
22439831|NCT05941702|University of Manchester|Krishna Panchmatia|07857543272|krishna.panchmatia@postgrad.manchester.ac.uk|
22439832|NCT02814916|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22439833|NCT04392739|SIGA Technologies|Emily Blum, Assoc. Director of Clinical Research|541-224-1305|eblum@siga.com|
22439834|NCT05543265|Massachusetts General Hospital|Mark Clapp, MD|617-724-2000|mark.clapp@mgh.harvard.edu|
22439835|NCT02182895|Brigham and Women's Hospital|Dr. Rajesh Garg, MD|617-732-5584|rgarg@partners.org|
22439836|NCT03359629|Maale Carmel Mental Health Center|Anatoly Kreinin|(+972) -4-8559315|kranata@gmail.com|
22411341|NCT02710071|University of California San Diego|Michael G. Ziegler, M.D.|619 543 2885|mziegler@ucsd.edu|
22411342|NCT01633827|Brigham and Women's Hospital|David Andrew Wellman|617-732-8483|awellman@rics.bwh.harvard.edu|
22439837|NCT03557294|Arizona State University|Scott Leischow, PhD|602-496-3300|scott.leischow@asu.edu|
22379525|NCT00779584|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22379526|NCT03487718|University of Kentucky|Ridge Preservation with Leukocyte Platelet Rich Fibrin: A Clinical, Radiographic, and Histomorphomet|8593236193|firasayafi@uky.edu|
22379527|NCT01115491|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22379528|NCT04071470|Vanderbilt University Medical Center|Carolyn Audet|615-343-2418|carolyn.m.audet@vanderbilt.edu|
22379529|NCT01868074|University of Iowa|Neil Segal, M.D., M.S.|3193560737|segal-research@uiowa.edu|
22379530|NCT03306043|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22379531|NCT01544491|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22379532|NCT02494206|Memorial Sloan Kettering Cancer Center|Dr. Babak Mehrara MD|212-639-3099|mehrarab@mskcc.org|
22379533|NCT01013792|HCA Retreat Hospital, Institute of Plastic and Reconstructive Surgery|Joseph V. Boykin, Jr., MD|804-353-8100|joseph.boykin@HCAhealthcare.com|
22379534|NCT01234649|Woman's Hospital|Dr Karen Elkind-Hirsch|225 231-5275|karen.elkind-hirsch@womans.org|2
22379535|NCT00566943|Synovis Surgical Innovations|Lesa Hobright-Turner, Director Clinical Affairs|651-796-7506|lesa.hobrightturner@synovissurgical.com|
22379536|NCT00580229|University of South Florida|John D. Carter, M.D.|813-974-2681|jocarter@health.usf.edu|
22379537|NCT00680056|UNIFESP|Danilo Berton|55-11-55718384|dcberton@gmail.com|
22379538|NCT03688711|Zealand Pharma A/S|Dr Kim Mark Knudsen|+4550603780|KMKnudsen@zealandpharma.com|
22379539|NCT05229653|NYU Langone Health|Kathy Huang, MD|(212) 545-5400|Kathy.Huang@nyulangone.org|
22379540|NCT01370005|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22379541|NCT03691948|Medical University of South Carolina|Jenna L. McCauley, PhD, Assistant Professor of Psychiatry|8437923922|mccaule@musc.edu|
22379542|NCT02009696|Biotronik, Inc.|Clinical Studies Engineer|503-927-7230|justin.michalski@biotronik.com|
22379543|NCT03428126|MD Anderson Cancer Center|Dr. Michael Overman|(713) 792-2828|moverman@mdanderson.org|
22379544|NCT01018563|Eisai Medical Information|Eisai Medical Information|888 422 4743|esi_medinfo@eisai.com|
22379545|NCT02344537|New York State Psychiatric Institute|Brian Fallon, MD|6467748052|brian.fallon@nyspi.columbia.edu|
22379546|NCT00798486|Ascensia Diabetes Care|Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
22411343|NCT05487456|Philip Morris Products S.A.|Christelle Haziza, Global Head Clinical Research and Execution|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
22411344|NCT01236170|VA Pittsburgh Healthcare System|Dr. Larissa Myaskovsky|4123602241|Larissa.Myaskovsky@va.gov|
22411345|NCT00958256|University of Texas (UT) MD Anderson Cancer Center|Jorge Romaguera, MD/Professor, Lymphoma/Myeloma|713-792-2860|CR_Study_Registration@mdanderson.org|
22411346|NCT05431153|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22411347|NCT00678392|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22411348|NCT03341507|Iuliu Hatieganu University of Medicine and Pharmacy- Cluj Napoca Romania|Dr Ioan Florin Marchis|+40757065205|marchis.ioan@umfcluj.ro|0757065205
22411349|NCT03352427|University of Michigan|Carl Koschmann, MD|734-615-2736|ckoschma@umich.edu|
22411350|NCT00989261|Contact for Clinical Trial Information|Daiichi Sankyo|1-908-992-6400|CTRinfo@dsi.com|
22411351|NCT00782509|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22411352|NCT00928083|Medicines for Malaria Venture|Dr. Joerg Moehrle|+41 22 555 0330|moehrlej@mmv.org|
22411353|NCT01224210|Tufts Medical Center|Ioana Preston MD|617-636-7609|ipreston@tuftsmedicalcenter.org|
22411354|NCT01401478|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22411355|NCT03151499|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22411356|NCT01814137|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22411357|NCT01945138|University of Minnesota|Dr. Melena Bellin|612-624-5409|bell0130@umn.edu|
22411358|NCT02746263|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22411359|NCT02536378|Silk Road Medical, Inc.|Ric Ruedy, Executive VP, Clinical, Regulatory and Quality Affairs|408-585-2112|ric@silkroadmed.com|
22411360|NCT02418910|Biomedical Development Corporation|Gregg Siegel|2108638053|gsiegel@biodevcorp.com|
22411361|NCT02472977|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Clinical.Trials@bms.com|Clinical.Trials@bms.com|
22411362|NCT01829295|F.I. Proctor Foundation, UCSF|Dr. Nisha Acharya|4154768131|Nisha.Acharya@ucsf.edu|
22411363|NCT00757666|Boston Scientific|Director of Clinical Affairs|651-582-2277|cshd@bsci.com|
22411364|NCT02629965|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22411365|NCT03331965|Duke University Medical Center|Dr. James Ronald|919.684.7299|james.ronald@duke.edu|
22411366|NCT02457728|St John of God Hospital Vienna|Bernhard Dauser, MD, PhD|+4321121|b.dauser@hotmail.com|5098
22411367|NCT03387059|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22411368|NCT01606137|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
22411369|NCT00528437|NYU Langone|Dr. Sharon Gardner|212-263-9913|Sharon.Gardner@nyulangone.org|
22411370|NCT00634283|Laboratory of Brain, Behavior, and Pharmacology at UCLA|Director of the Laboratory of Brain|310-825-0207|info@brain.ucla.edu|
22411371|NCT03501550|Cocrystal Pharma Inc|Luz Pascual|9083611678|lpascual@cocrystalpharma.com|
22379547|NCT00589550|The Ohio State University Comprehensive Cancer Center|Thomas Olencki, DO|614-293-2886|Thomas.Olencki@osumc.edu|
22411372|NCT01743677|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22411373|NCT03092089|University of Alberta Hospital|Dr Kevin Bainey|780-407-2176|Kevin.Bainey@albertahealthservices.ca|
22411374|NCT03586830|Janssen Research & Development, LLC|Senior Director Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22411375|NCT00395083|VA Boston Healthcare System - MAVERIC|Dr. Sarah Leatherman|857-364-4220|sarah.leatherman@va.gov|
22439838|NCT04090203|Cleveland Clinic|Dr. Jaclyn Bjelac|216 445-1449|bjelacj2@ccf.org|
22439839|NCT03299556|Purdue Pharma L.P.|Thomas Alfieri, PhD - Director, Medical Affairs Strategic Research|(475) 299-6085|thomas.alfieri@pharma.com|
22439840|NCT01488045|St. Joseph Mercy Hospital|Robert K. Cleary, MD|734.712.8150|Robert.Cleary@trinity-health.org|
22439841|NCT05043363|Imperial College London|Mr James Kinross|02033121947|j.kinross@imperial.ac.uk|
22439842|NCT00671658|The University of Texas (UT) MD Anderson Cancer Center|Hagop Kantarjian, MD./ Chair|713-792-7026|eharriso@mdanderson.org|
22411376|NCT00628745|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22379548|NCT05490329|Florida State University|Lisa Hightow-Weidman, MD, MPH|8506443296|lhightowweidman@fsu.edu|
22379549|NCT04524598|Limbix Health|Janel Shelton-DeMagnus, Research Operations Manager|8885462495|janel@limbix.com|709
22379550|NCT03936777|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22379551|NCT04195880|Providence VAMC|Vincent Mor, Principal Investigator|4012737100|vincent_mor@brown.edu|6259
22379552|NCT02306122|Brown University|Joanne Michaud|401-863-9317|joanne_michaud@brown.edu|
22379553|NCT01811940|NYSPI|Frances R. Levin, M.D.|646-774-6137|Frances.levin@nyspi.columbia.edu|
22379554|NCT03734991|SCYNEXIS|Dr. David Angulo|(201) 884-5471|david.angulo@scynexis.com|
22379555|NCT02638623|West Virginia University Department of Orthopaedics|Matthew J. Dietz, MD|304-285-7445|mdietz@hsc.wvu.edu|
22379556|NCT00180713|Imperial College London|Professor Martin R Wilkins|+44 (0)20 8383 2049|m.wilkins@imperial.ac.uk|
22379557|NCT05295732|LEO Pharma A/S|Clinical Disclosure|+4544945888|disclosure@leo-pharma.com|
22379558|NCT02322814|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22379559|NCT04152343|Dartmouth-Hitchcock Medical Center|Dr. Eric Hoffer, Director of Interventional Radiology|603 650 7417|hoffer@hitchcock.org|
22379560|NCT01965938|Vanderbilt University School of Medicine|Dr. Bret Alvis, MD|615-343-6268|bret.d.alvis@vanderbilt.edu|
22379561|NCT01164228|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22379562|NCT01741454|University of Wisconsin School of Medicine & Public Health|Shuang Li (Linda)|608.263.8336|lis@urology.wisc.edu|
22379563|NCT01744860|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22379564|NCT03311230|University of Pennsylvania|Joseph Harrison|2157461249|joseph.harrison@uphs.upenn.edu|
22379565|NCT02998021|University of Pittsburgh|Alicia Koontz, PhD|4128223700|akoontz@pitt.edu|
22379566|NCT01586312|Instituto de Biología y Genética Molecular (IBGM)|Professor Javier Garcia-Sancho|34 983 423 084|jgsancho@ibgm.uva.es|
22379567|NCT00309608|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22379568|NCT05200936|Mind Medicine Inc|Medical Affairs|1-332-245-4732|MedAffairs@mindmed.co|
22379569|NCT00127413|VA Boston Healthcare System|John D. Otis|8573645740|john.otis@va.gov|
22379570|NCT02415998|University of Iowa|Kenichi Ueda|319-356-2633|kenichi-ueda@uiowa.edu|
22379571|NCT03713021|Washington University School of Medicine|Ryan Jackson, M.D.|314-362-0365|jackson.ryan@wustl.edu|
22379572|NCT01076283|Brown University|Lorenzo Leggio, MD|401-863-1000|lorenzoleggio@gmail.com|
22379573|NCT01338012|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@dendreon.com|
22379574|NCT01288781|UWalesBangor|Mr Justin Stevan Lawley|00441248382810|pepa16@bangor.ac.uk|
22379575|NCT01946243|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22379576|NCT02550132|Université du Québec à Trois-Rivières|Dr Martin Descarreaux DC, PhD|18193765011|martin.descarreaux@uqtr.ca|3791
22379577|NCT00154063|Eisai Call Center|Eisai Inc.|888-422-4743||
22379578|NCT03483077|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22379579|NCT00603265|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
22379580|NCT04399551|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22379581|NCT00010439|Medical University of South Carolina|Deborah A Bowlby, M.D., Assistant Professor, Pediatric Endocrinology|843-792-6807|bowlbyd@musc.edu|
22379582|NCT02122341|USC Intitute of Urology|Dr. Matthew Dunn|323-865-3700|mdunn@med.usc.edu|
22379583|NCT02721641|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
22379584|NCT03384953|Osher Center for Integrative Medicine|Dr. Lindsey C. McKernan|615-320-7770|lindsey.mckernan@vumc.org|
22379585|NCT01912781|Alcon Research, Ltd.|Clinical Project Lead, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
22379586|NCT01414413|Liverpool School of Tropical Medicine|Dr Peter MacPherson|0044151 705 3100|p.macpherson@liv.ac.uk|
22379587|NCT03377790|Verrica Pharmaceuticals|Susan Cutler, VP, Medical Affairs|484-773-0898|scutler@verrica.com|
22379588|NCT01533714|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
22379589|NCT02564055|GlaxoSmithKline|GSK Response Center|866-435-7343||
22379590|NCT04542226|NPO Petrovax Pharm, LLC|Nikolay Dodonov, Head of medical department|Phone: +7(495) 730-75-45 ext.|DodonovNS@petrovax.ru|125
22379591|NCT01047475|Microbio / Sophie Chang|Director of Clinical Trials|886-2-2570-5596|sophie_chang@fountainmab.com|556
22379592|NCT00919893|Clinic for urology and pediatric urology, JL-University, Giessen, Germany|Dr. F.M.E. Wagenlehner|0049 641 9944518|wagenlehner@AOL.com|
22379593|NCT01375959|Albert Einstein College of Medicine|Dr. Jill Crandall|718-430-3765|jill.crandall@einstein.yu.edu|
22379594|NCT01580098|Landeskrankenanstalten-Betriebsgesellschaft|Dr. Hannes Steinberger|+4346355212 50303|hannes.steinberger@kabeg.at|
22379595|NCT03308058|University of Nebraska Medical Center|Jane Meza|402-559-6825|jmeza@unmc.edu|
22379596|NCT00345384|Baylor Research Institute|President Baylor Research Institute|214-820-3296|researchclinicaltrials@baylorhealth.edu|
22379597|NCT00365378|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22439843|NCT02918370|UT Southwestern|E. Sherwood Brown MD PhD MBA|214-645-6950|sherwood.brown@utsouthwestern.edu|
22379598|NCT04741802|Duke University|Nia S. Mitchell, MD, MPH|919-668-7202|nia.s.mitchell@duke.edu|
22379599|NCT03278886|Boston Medical Center|Dr. Jeffrey Samet|617-414-7444|jsamet@bu.edu|
22379600|NCT01316341|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage@boehringer-ingelheim.com|
22379601|NCT04161807|Theranica Bio-Electronics Ltd|Dr Dagan Harris. VP Clinical @Regulatory Affairs|0542220121|daganh@theranica.com|
22379602|NCT04229030|Raziel Therapeutics|Racheli Gueta, Director of Clinical trials|97289126941|racheli@raziel-therapy.com|
22379603|NCT00708305|GlaxoSmithKline|GSK Response Center|866-435-7343||
22379604|NCT04711460|University of MN|Joan D. Lund|612-273-9115|Lund1687@umn.edu|
22379605|NCT00192023|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22379606|NCT01576055|W.L. Gore & Associates|Thomas Sabin|928-864-3153|tsabin@wlgore.com|
22379607|NCT01930435|UCSF|Dr. Sue Yom|415-353-7175|yoms@radonc.ucsf.edu|
22379608|NCT00535743|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22379609|NCT02572817|National Institute of Allergy and Infectious Diseases (NIAID)|John Beigel, M.D.|301-451-9881|jbeigel@niaid.nih.gov|
22379610|NCT01165840|Texas Tech University HSC|Ronald Hall|214-358-9009|ronald.hall@ttuhsc.edu|
22379611|NCT00299195|Memorial Sloan Kettering Cancer Center|Dr. Jay Boyle, MD|212-639-2906|boylej@mskcc.org|
22379612|NCT01290536|University of California San Francisco|Nicholas Fidelman, MD|1-415-353-1300|Nicholas.Fidelman@ucsf.edu|
22379613|NCT01258660|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22379614|NCT04192630|Bausch + Lomb Incorporated|Anya Loncaric, Executive Director, Global Clinical Operations|(310) 770-7750|Anya.Loncaric@bauschcloud.com|
22379615|NCT01193582|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22379616|NCT01448421|keystoneheart|Karen Jaffe, VP RA./QA/CA|97246158005|karen.jaffe@keystoneheart.com|8005
22379617|NCT02289989|Rutgers Robert Wood Johnson Medical School|Amy Pappert, MD|732-235-7765|papperas@rwjms.rutgers.edu|
22379618|NCT02590068|The Rockefeller University|Dr. Aileen O'Connell, Laboratory Manager|212-327-7047|aoconnell@rockefeller.edu|
22379619|NCT01775930|UT MD Anderson Cancer Center|Dr. Eric Jonasch, MD / Professor, Genitourinary Medical Oncology|713- 563-7232|ejonasch@mdanderson.org|
22379620|NCT01208415|Cook Research Incorporated|Scott Snyder, PhD, Director of Clinical Affairs|765-463-7537|Scott.Snyder@CookMedical.com|
22379621|NCT02340520|UConn Health|Nausherwan Burki, MD||nburki@uchc.edu|
22379622|NCT01840319|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22379623|NCT01586338|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22379624|NCT02201446|Department of Burn Surgery, Changhai Hospital, The Second Military Medical University, Shanghai, People's Republic of China|Guo-sheng Wu|+86 18019359841|drwuguosheng@sina.cn|
22379625|NCT04475848|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22379626|NCT00896454|Amgen Inc.|Study Director|866-572-6436||
22379627|NCT02228525|Memorial Sloan Kettering Cancer Center|Dr. Eytan Stein, MD|646-608-3749|steine@mskcc.org|
22379628|NCT05064735|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22379629|NCT00930943|MedVadis Research Corporation|Egilius L.H. Spierings, M.D., Ph.D.|781-588-5430|Spierings@MedVadis.com|
22379630|NCT00856661|H. Lundbeck A/S|study director||LundbeckClinicalTrials@Lundbeck.com|
22379631|NCT02301156|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
22379632|NCT00735449|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22379633|NCT06536465|Recursion Pharmaceuticals, Inc.|Recursion Pharmaceuticals|385-374-1724|clinicaltrials@recursionpharma.com|
22379634|NCT03797326|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22379635|NCT03012061|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22379636|NCT02736968|University of California, San Diego|Sharon Reed, MD|858-822-2808|slreed@ucsd.edu|
22379637|NCT03342053|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22379638|NCT02294474|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22379639|NCT02961374|Cancer Prevention Network (CPN) - Mayo Clinic College of Medicine|Paul J. Limburg, M.D., M.P.H.|507-284-2511|limburg.paul@mayo.edu|
22379640|NCT00171873|KKS Marburg|Carmen Schade-Brittinger|0049-6421-2866458|carmen.brittinger@kks.uni-marburg.de|
22379641|NCT02041923|University of Illinois at Chicago|Rosemary White-Traut|312-996-7935|rwt@uic.edu|
22379642|NCT02780622|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22379643|NCT01928680|Chinese Academy of Medical Science|Dr. Qiao Li|86-18500027849|liqiaopumc@qq.com|
22379644|NCT02023879|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22379645|NCT00874432|University of Wisconsin - Madison|Dr. Arjang Djamali|(608) 262-9306|axd@medicine.wisc.edu|
22411377|NCT02322528|University of Rochester|Dr. James V. Aquavella|585-276-7439|rick_barrett@urmc.rochester.edu|
22379646|NCT05256381|SOTIO Biotech a.s.|Richard Kapsa|(+420) 2241 74448|kapsa@sotio.com|
22379647|NCT04635059|Medical College of Wisconsin|Deepak Kilari, MD|414-805-4600|dkilari@mcw.edu|
22379648|NCT00802737|GlaxoSmithKline|GSK Response Center|866-435-7343||
22379649|NCT03864926|University of Wisconsin Hospital and Clinics|Sandesh Parajuli, MD, MBBS|(608) 265-0152|sparajuli@medicine.wisc.edu|
22379650|NCT00445601|SWOG Statistics and Data Management Center|Catherine Tangen, Genitourinary Committee Statistician|206-667-2933|ctangen@fredhutch.org|
22379651|NCT01340482|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
22379652|NCT00619476|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
22379653|NCT01091428|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22379654|NCT00214903|Center for Epidemiology and Health Research, Germany|Juergen Dinger, MD, PhD|+49 (0) 30 945 101 20|dinger@zeg-berlin.de|
22379655|NCT01282476|Massachusetts General Hospital Cancer Center|Jeremy Abramson, MD|617-724-4000|jabramson@mgh.harvard.edu|
22411378|NCT05188521|Mayo Clinic|Dr. Aaron R. Mangold, Principal Investigator|480-301-9196|mangold.aaron@mayo.edu|
22411379|NCT01132118|Brigham and Women's Hospital|Dr. Daniel H. Solomon|617-525-8127|dsolomon@partners.org|
22411380|NCT01644890|Nippon Kayaku Co., Ltd.|Pharmaceuticals Group|+81-3-6731-5200||
22411381|NCT04942379|UMass Chan Medical School|Dr. Michelle Trivedi|7744418086|Michelle.Trivedi3@umassmed.edu|
22411382|NCT01413204|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22411383|NCT03287050|University of Michigan|Zachery Reichert|764-3066|zreiche@med.umich.edu|
22411384|NCT00313703|Montefiore Medical Center|Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
22411385|NCT02497391|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22411386|NCT02452060|NYU Langone Medical Center|Jing Wang|212-460-0176|jing.wang@nyulangone.org|
22411387|NCT03031899|The Oxford Dental college|Dr. Anisha Yaji|9480718531|dr.anishayaji@gmail.com|
22411388|NCT01664052|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22411389|NCT01060670|Integra LifeSciences, Inc.|Katie Bush, PhD- Manager, Global Medical Affairs- Tissue Technology|617-268-1616|katie.bush@integralife.com|267
22411390|NCT04682444|Farmak|Clinical Enquiry Manager|+ 38 (067) 464-28-27|Farmak-Clinical-Affairs@regenold.com|
22411391|NCT03705351|Providence Health & Services|Chiayi Chen / Director of PBSI and WC Clinical Research Program|(503) 216-1012|Chiayi.Chen@providence.org|
22411392|NCT00401882|Beaumont|David Haines, MD|248-898-4198|david.haines@beaumont.edu|
22411393|NCT00633152|Cerexa, Inc.|Vice President, Clinical Sciences|510-285-9200|clinicaltrials@cerexa.com|
22411394|NCT02180061|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22411395|NCT02557945|New York State Psychiatric Institute|Scott Small, MD|212-305-1269|sas68@cumc.columbia.edu|
22411396|NCT00056160|Celgene Corporation|Robert Knight, M.D.|908-673-9749|rknight@celgene.com|
22411397|NCT01469364|Duke University|Dr. Scott Palmer|919-684-0245|palme002@mc.duke.edu|
22411398|NCT01579474|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22411399|NCT02295774|Humanitas Research Hospital & Humanitas University|Alessandro Repici MD|00390282247493|alessandro.repici@hunimed.eu|
22411400|NCT03256968|Universtiy of Alabama at Birmingham|Steven Rowe|205-975-9776|srowe@uabmc.edi|
22439844|NCT03617172|Vanderbilt University Medical Center|Sr. Clinical Trials Operations Manager|6159360815|stephanie.anne.smith@vumc.org|
22439845|NCT01680341|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22439846|NCT01166139|Hospital For Special Surgery|Annel Fernandez|212 774 2123|fernandeza@hss.edu|
22439847|NCT02587221|Seqirus|Seqirus Clinical Trial Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
22439848|NCT01499940|West Virginia Universtiy|Gerald Higa, PharmD|(304) 293-1461|ghiga@hsc.wvu.edu|
22439849|NCT04739982|Stanford University|Kaiti Dunlap, Clinical Research Coordinator|650-497-9214|kdunlap2@stanford.edu|
22439850|NCT01349543|Imperial College London|Prof Peter JM Openshaw|07973820801|p.openshaw@imperial.ac.uk|
22439851|NCT04914364|Duke University|Ashley Poole|919-538-6272|ashley.poole@duke.edu|
22439852|NCT01168349|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22439853|NCT01033240|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22439854|NCT03521570|Emory University|Nabil F. Saba MD, FACP|404-778-0278|nfsaba@emory.edu|
22439855|NCT01026844|Massachusetts General Hospital|Lecia Sequist, MD|617-724-4000|lvsequist@partners.org|
22439856|NCT01260649|MGH|Dr. Cristina Cusin|617 726 64221|ccusin@mgh.harvard.edu|
22439857|NCT02138890|Zimmer Biomet|Mr. Cahit Akbas|+31622981737|Cahit.Akbas@zimmerbiomet.com|
22439858|NCT05435339|Genmab|CLINICAL TRIAL INFORMATION|+45 7020 2728|clinicaltrials@genmab.com|
22439859|NCT01446159|MedImmune, LLC|Shahram Rahimian|+1-800-236-9933|information.center@astrazeneca.com|
22439860|NCT03174184|Vanderbilt University Medical Center|Kelly Dooley, MD, PhD|6153228972|kelly.e.dooley@vumc.org|
22439861|NCT00593346|Washington University School of Medicine|Imran Zoberi, M.D.|314-362-8525|izoberi@radonc.wustl.edu|
22439862|NCT01336933|University of Nebraska Medical Center|Julie M Vose|402-559-3848|jmvose@unmc.edu|
22439863|NCT05135871|Shanghai LianBio Development Co., Ltd|Brianna Sun|+862123081188|brianna.sun@lianbio.com|
22439864|NCT04258423|Indiana University|Dr. Chandrashekhar Kubal|317-312-2601|sakubal@iupui.edu|
22439865|NCT03542812|University of Utah|Candice Fike|801-587-7804|candice.fike@hsc.utah.edu|
22439866|NCT03980730|vTv Therapeutics LLC|VP Clinical Operations|3368410300|jfreeman@vtvtherapeutics.com|
22439867|NCT01247324|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22439868|NCT04076540|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22439869|NCT00880620|Impax Laboratories, LLC|Kaihong Jiang, Senior Director, Head of Biometrics|908-307-2234|kaihong.jiang@amneal.com|
22439870|NCT03125226|University of Washington School of Medicine|Dr. Jing Zeng|2065985998|jzeng13@uw.edu|
22439871|NCT02787564|University of Hohenheim|Prof. Dr. Nanette Ströbele-Benschop|+49711 459 24260|N.Stroebele@uni-hohenheim.de|24260
22439872|NCT03474588|Yale University Department of Psychiatry|Dr. Brian Kiluk, Ph.D.|203-737-1544|brian.kiluk@yale.edu|
22439873|NCT03902418|University of CApe Town|Landon Myer|0829430578|landon.myer@uct.ac.za|
22439874|NCT01607957|Taiho Oncology, Inc.|Taiho|+1 844-878-2446|medicalinformation@taihooncology.com|
22439875|NCT04570930|University of Michigan|Dr. Noelle E Carlozzi|734-764-0644|PMR-CODAlab@med.umich.edu|
22439876|NCT01691794|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22439877|NCT04972786|University of New Mexico|Dr. Jeremy Hogeveen|773-941-2182|jhogeveen@unm.edu|
22439878|NCT02016781|The Emmes Company|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
22439879|NCT04886154|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22439880|NCT03919773|UT Southwestern Medical Center|Dr. Steven Vernino|214-648-8816|steven.vernino@utsouthwestern.edu|
22439881|NCT02702492|Karyopharm Therapeutics Inc|Karyopharm Medical Information|(888) 209-9326|clinicaltrials@karyopharm.com|
22411401|NCT01617577|University of South Florida|Professor Juan Sanchez-Ramos|813-974-5841|jsramos@health.usf.edu|
22379656|NCT02543723|East Carolina University|Essie Torres|252-328-1818|torrese@ecu.edu|
22379657|NCT01625910|University of Minnesota, Department of Family Medicine and Community Health|Steven D. Stovitz, MD, MS|612-310-2344|sstovitz@umphysicians.umn.edu|
22379658|NCT02873286|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
22379659|NCT03918239|Shire|Study Director|+1 866-842-5335|ClinicalTransparency@takeda.com|
22379660|NCT00963989|Penumbra, Inc.|Director of Clinical Affairs|+1 510 995 2183|blawson@penumbrainc.com|
22379661|NCT01439087|Massachusetts General Hospital|Gary Tearney, MD, PhD|617-724-2979|GTEARNEY@PARTNERS.ORG|
22379662|NCT02240589|Indiana University School of Medicine|Flora Hammond, MD|317-329-2106|flora.hammond@rhin.com|
22379663|NCT01984424|Amgen Inc.|Study Director|866-572-6436||
22379664|NCT00592319|Trustee of Boston Univ. Medical Campus|Dr. Zhi Wang|617-414-1590|zwang@bu.edu|
22379665|NCT02354924|Mackay Memorial Hospital_Taipei|Dr. Huey-Chuan Cheng|886-2-25433535|hccheng@ms2.mmh.org.tw|
22379666|NCT01807221|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22379667|NCT02949674|Instituto Mexicano del Seguro Social|Dr. Juan Lopez|+5257473500|juanlopez110@hotmail.com|25538
22379668|NCT04995497|University of Iowa Healthcare|Archit Sharma, M.D.|(319) 384-7911|archit-sharma@uiowa.edu|
22379669|NCT01912222|Takeda|Medical Director|+1-866-835-2233|GlobalOncologyMedinfo@takeda.com|
22379670|NCT01804673|Clinic for Anaesthesiology, Intensive Care Unit and Pain Therapy at the Westfälische Wilhelms-Universität Münster, Albert-Schweitzer-Str. 33, 48149 Munster.|Head|+49 251 / 83 - 4 72 52||
22379671|NCT01857934|St. Jude Children's Research Hospital|Sara M. Federico, MD|866-278-5833|referralinfo@stjude.org|
22379672|NCT00282815|University of Michigan|Devin Brown, MD|734-936-9075|devinb@umich.edu|
22379673|NCT01560377|Novadaq Technologies, Inc.|Alicia Wilton|1.905.629.3822|awilton@novadaq.com|209
22379674|NCT04012814|Venus Concept|Director of Clinical Affairs|1-888-907-0115|mgronski@venusconcept.com|
22379675|NCT04789577|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22379676|NCT02441946|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22379677|NCT00600743|St. Luke's/Roosevelt Hospital|Harry R. Kissileff|212-523-4200|hrk2@columbia.edu|
22379678|NCT00579982|GlaxoSmithKline|GSK Response Center|866-435-7343||
22379679|NCT00988351|Malcom Randall VA|Dr. Richard B. Berry|3522621575|Richard.Berry@medicine.ufl.edu|
22379680|NCT02038764|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22379681|NCT00240526|GlaxoSmithKline|GSK Response Center|866-435-7343||
22379682|NCT01812005|The Ohio State University James Comprehensive Cancer Center|Kristie Blum, MD|614-293-7807|Kristie.Blum@osumc.edu|
22379683|NCT01450787|Coa Research Foundation|Kenneth A Beckman, MD|614-506-4720|kenbeckman22@aol.com|
22379684|NCT01464255|Clinical Research Center, University of California, Berkeley, School of Optometry|Thao N Yeh, O.D.|(510) 642-9649|thaoyeh@berkeley.edu|
22379685|NCT01644396|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22379686|NCT01304082|Massachusetts General Hospital|Brian Wainger|617-726-8810|bwainger@partners.org|
22379687|NCT03912220|Johns Hopkins University|Dr. Ahmet Hoke|410-955-2227|ahoke1@jh.edu|
22379688|NCT04719013|InMode|Maria Shusterman|9057076787|Maria.Shusterman@inmodemd.com|
22379689|NCT04175912|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22379690|NCT04654468|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22379691|NCT01155661|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22379692|NCT01356667|UCLA, Integrated Substance Abuse Programs|Dr. Daniel Dickerson|562-277-0310|daniel.dickerson@ucla.edu|
22379693|NCT04694482|ASST Monza|Dr. Alice Caldiroli|+3495009941|a.caldiroli@asst-monza.it|
22379694|NCT04844970|Lahey Hospital & Medical Center|Julia Roache, Manger, Research Programs|7817443055|julia.roache@lahey.org|
22379695|NCT00447954|Neurotech Pharmaceuticals, LLC|CMO|401-333-3880|neurotech@neurotechusa.com|
22379696|NCT03757234|Paratek Pharmaceuticals, Inc.|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
22379697|NCT03599986|DataClin|Medical Writer|(+2) 01001566602|mariam.abdalla@dataclin.com|
22379698|NCT04908449|Medical College of Wisconsin|Dr. Anne L. Castro|(414) 805-8700|anncastro@mcw.edu|
22379699|NCT01152294|Massachusetts General Hospital|Karen Sepucha, Ph.D.|617-724-3350|ksepucha@partners.org|
22379700|NCT00610701|University of Missouri|Brett D. Crist, MD|5738826562|cristb@health.missouri.edu|
22379701|NCT02401308|St. Joseph's Hospital and Medical Center|Lisa Arnold - Operations Manager Neurosurgery Clinical Research|602-406-9593|lisa.arnold@dignityhealth.org|
22379702|NCT01518946|Shire|Study Director|+1 866-842-5335|ClinicalTransparency@shire.com|
22379703|NCT00381641|University of Chicago|Dr. Tanguy Seiwert|(773) 702-2452|tseiwert@medicine.bsd.uchicago.edu|
22379704|NCT01086605|Mayo Clinic|Alvaro Moreno-Asptia, M.D.|507/284-1159|morenoaspitia.alvaro@mayo.edu|
22379705|NCT01681368|National Cancer Institute|Dr. Christina Annunziata|301-402-7189|annunzic@mail.nih.gov|
22379706|NCT03884231|Abbott|Tucker Tomlinson|+1/ 972 526 9646|tucker.tomlinson@abbott.com|
22379707|NCT00900627|Astrazeneca|Dr Serban Ghiorghiu||ClinicalTrialTransparency@astrazeneca.com|
22379708|NCT00373295|New York State Psychiatric Institute|Dr. Margaret Haney|646-774-6129|reslabsurc@gmail.com|
22379709|NCT00830947|OrthoAccel Technologies, Inc.|Zaffer Syed, Director of Clinical & Regulatory Affairs|(832) 803-0339|zsyed@orthoaccel.com|
22379710|NCT04176133|Mayo Clinic|Robert J. Pignolo, MD, PhD|507-255-8716|Pignolo.Robert@mayo.edu|
22379711|NCT00548041|Temple University Hospital|Dr. Ellen Tedaldi|215-707-2000|ellen.tedaldi@tuhs.temple.edu|
22379712|NCT01087723|The Medicines Company|Global Health Science Center|800-388-1183||
22379713|NCT01868035|GlaxoSmithKline|GSK Response Center|866-435-7343||
22379714|NCT01649596|Genesys Regional Medical Center|Surgeon|810-606-6500|twasfie@gmail.com|
22379715|NCT01617083|University of South Florida Rothman Center|Study Coordinator|7277678393|ebrenna1@health.usf.edu|
22379716|NCT01757665|Edwards Lifesciences, LLC|Aya Westbrook, PhD, Director of Clinical Program Management|949-250-2500|aya_westbrook@edwards.com|4035
22379717|NCT01394250|The Chidren's Hospital of Philadelphia|Deb Potts|215-590-7098|pottsd@email.chop.edu|
22411402|NCT03532009|Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22411403|NCT00368966|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22411404|NCT02866175|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22411405|NCT01602614|University of Alabama at Birmingham|David Kimberlin, MD|205 934-2424|Dkimberlin@peds.uab.edu|
22411406|NCT01584609|Penumbra, Inc.|Michaella Corso|(510) 748-3200|mcorso@penumbrainc.com|
22411407|NCT01694485|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22411408|NCT02907203|W. L. Gore and Associates|Rizwan Afzal|6236404888|rafzal@wlgore.com|
22411409|NCT01798485|Synta Pharmaceuticals|President, Chief Executive Officer|781-541-7261||
22411410|NCT03687125|Mundipharma Research Limited|Terry Nichols|(0044)1223424444|terry.nichols@mundipharma-rd.eu|
22411411|NCT00770991|Cleveland Clinic|Dr. Carol Burke|216 444-6864|burkec1@ccf.org|
22379718|NCT00601718|Fred Hutchinson Cancer Research Center|Ajay Gopal|206-288-2037|akgopal@fhcrc.org|
22411412|NCT02159859|Beaumont Health|Lama Hsaiky, Pharm.D. (Primary investigator)|313-593-7264|lama.hsaiky@beaumont.org|
22379719|NCT01865617|Fred Hutchinson Cancer Research Center|Dr. Jordan Gauthier|206-667-2713|jgauthier@fredhutch.org|
22379720|NCT02500979|AstraZeneca|Dr. Peter Ohman|+1 (301) 398-0120|Peter.Ohman@astrazeneca.com|
22379721|NCT00267111|Mount Sinai Hospital|Dr. Vibhuti Shah|416-586-4816|vshah@mtsinai.on.ca|
22379722|NCT01613027|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22379723|NCT04267614|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22379724|NCT02707523|UAB|Dr. Michele Kong, PI|205-6389387|mkong@peds.uab.edu|
22379725|NCT00183456|Johns Hopkins Bloomberg School of Public Health|Carl Latkin, PhD||clatkin@jhsph.edu|
22379726|NCT03632434|University of East London|Professor Cynthia Fu|07563 240193|c.fu@uel.ac.uk|
22379727|NCT04297241|Cincinnati Children's Hospital|Mary Banks|513-636-2147|mary.banks@cchmc.org|
22379728|NCT04038346|University of Pittsburgh Children's Hospital of Pittsburgh|Desiree Neville|412-692-7692|desiree.neville@chp.edu|
22379729|NCT00981825|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
22379730|NCT02836613|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
22379731|NCT03881059|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22379732|NCT02697006|Fresenius MCD|Dr. Anja Derlet-Savoia|+49 6172 608 2801|Anja.Derlet@fmc-ag.com|
22379733|NCT01844193|OrthoIndy|Dr. Frank Kolisek|3178845160|fkolisek@orthoindy.com|
22379734|NCT00786474|Duke University Medical Center|Thomas Ortel, MD, PhD, Principal Investigator|919-684-5350|thomas.ortel@duke.edu|3
22379735|NCT04276090|University of Kentucky|Dr. Michael Cavnar|859-323-8920|michael.cavnar@uky.edu|
22379736|NCT01799720|Universidad Miguel Hernández|Dr. Elena García García|965222025|egarcia@umh.es|2025
22379737|NCT04131959|CytoSorbents|CytoSorbents|732-329-8885|info@cytosorbents.com|
22379738|NCT02874066|National Taiwan University Hospital|Chen-Hua Liu|+886-972651880|jacque_liu@mail2000.com.tw|
22379739|NCT03141528|Inselspital|Dr. Tina Pedersen|+4522125797|tinaheidipedersen@yahoo.dk|
22379740|NCT02667444|Novan, Inc.|Cathy White, Vice President, Drug Development Operations|919-485-8080|clinical@novan.com|
22379741|NCT01597388|AstraZeneca|Julie Charlton|+ 01625-582828|ClinicalTrialTransparancy@astrazeneca.com|
22379742|NCT05407311|Clarity Pharmaceuticals|Dr. Othon Gervasio, Chief Medical Officer|+61 (0)2 9209 4037|info@claritypharmaceuticals.com|
22379743|NCT01265823|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22379744|NCT01263106|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22379745|NCT05525286|SOTIO Biotech a.s.|Richard Kapsa|(+420) 2241 74448|kapsa@sotio.com|
22379746|NCT05027074|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22379747|NCT03169881|University of Utah|Robin K Ohls, MD|801-581-7052|robin.ohls@hsc.utah.edu|
22379748|NCT00220961|University of Texas Health Science Center at San Antonio|Ralph DeFronzo, MD|210-567-6691|defronzo@uthscsa.edu|
22379749|NCT00461292|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22379750|NCT02180438|University of Washington|Dr. Geoffrey S Gottlieb. MD PhD (PI)|1-206-616-2631|gottlieb@uw.edu|
22379751|NCT00785707|MED-EL Corporation|Sr. Clinical Research Associate||clinicaltrials@medelus.com|
22379752|NCT02090634|UCSD HIV Neurobehavioral Research Program (HNRP)|Dr. David J Moore, Professor of Psychiatry|619-543-5093|djmoore@ucsd.edu|
22379753|NCT00977769|Oslo University Hospital|Professor Leiv Arne Rosseland|+4723070000|lrossela@ous-hf.no|
22379754|NCT02578914|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
22379755|NCT00147225|University of Texas MD Anderson Cancer Center|Dr. Saroj Vadhan-Raj|713-792-7966|svadhanr@mdanderson.org|
22379756|NCT03396432|Children Hospital of Philadelphia|Dr. John Fiadjoe, PI|267-426-2961|fiadjoej@email.chop.edu|
22379757|NCT01032044|Mayo Clinic, Jacksonville, Florida, USA|Dr Michael B. Wallace|904 953-7630|wallace.michael@mayo.edu|
22411413|NCT00490061|Stanford University|Quynh Le|650-498-5032|qle@stanford.edu|6506370734
22411414|NCT00952484|Alexion Pharma GmbH|Alexion Pharma GmbH|(617) 494-1393|ClinicalTrials@alxn.com|
22411415|NCT02750306|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22439882|NCT03577275|NorthSea Therapeutics BV|Dr Patrick Round|+44(0)7979502770|patrick.round@northseatherapeutics.com|
22379758|NCT01719900|University of Calgary|Dr. Raylene Reimer|14032208218|reimer@ucalgary.ca|
22379759|NCT01861457|Medical University of South Carolina|Shaun A. Nguyen, MD, Associate Professor- Director of Clinical Research|8437921356|nguyensh@musc.edu|
22379760|NCT04536571|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
22379761|NCT01567865|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22411416|NCT02422290|New York State Psychiatric Institute|Pablo H. Goldberg, MD|646-774-6318|Pablo.Goldberg@nyspi.columbia.edu|
22379762|NCT02061696|Borgess Heart Institute|Frank Saltiel, MD|269-381-3963||
22379763|NCT04613882|Coopervision|Jose A. Vega, OD, MSc, FAAO|9256213761|javega@coopervision.com|
22379764|NCT01283321|University of Maryland|Dr. Kenichi Tanaka|412-328-0205|ktanaka@anes.umm.edu|
22379765|NCT02274649|Shepherd Center|Michael Jones, PhD, Director Research|4043507595|mike_jones@shepherd.org|
22379766|NCT01051063|GlaxoSmithKline|GSK Response Center|866-435-7343||
22379767|NCT05569954|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22379768|NCT02708433|University of North Carolina at Chapel Hill|Raymond P. White, Jr. DDS, PhD|919-537-3944|ray_white@unc.edu|
22379769|NCT04885530|Duke University|Susanna Naggie, MD, MHS, FIDSA|919-684-2584|susanna.naggie@duke.edu|
22379770|NCT03857841|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
22379771|NCT00384059|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22379772|NCT01774071|Memorial Sloan Kettering Cancer Center|Dr. Steven Larson, MD|646-888-2212|LarsonS@MSKCC.ORG|
22379773|NCT04386746|Johns Hopkins Sidney Kimmel Comprehensive Cancer Center|Max Kates, MD|4105028130|mkates@jhmi.edu|
22411417|NCT01982383|Medical Faculty Associates|Nicole Swanson|202-741-2437|nswanson@mfa.gwu.edu|
22411418|NCT00585351|University of Iowa|Enrique Leira, MD, MS|319-356-8755|enrique-leira@uiowa.edu|
22411419|NCT00192296|MedImmune|Joseph Parker, MD|301-398-0000|parkerj@medimmune.com|
22411420|NCT04071951|Cedars-Sinai Medical Center|Joshua Pevnick|310.423.4683|pevnickj@cshs.org|
22411421|NCT01608295|UCLA|Helen Lavretsky, M.D.|310-794-4619|hlavretsky@mednet.ucla.edu|
22411422|NCT02227849|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22411423|NCT02950753|UMCSouthernNevada|Dr. Tony Zitek|702-383-7885|zitek10@gmail.com|3
22411424|NCT00457665|UTSouthwestern Medical Center|Dr. Abhimanyu Garg|214-648-2895|abhimanyu.garg@utsouthwestern.edu|
22411425|NCT02535000|Serviço de Anestesiologia de Joinville|Antonio Bedin|+554734331666|abjoimailbox-ct@yahoo.com|
22411426|NCT00565370|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
22411427|NCT04317781|The University of Texas MD Anderson Cancer Center|Qaiser Bashir, M.D. / Stem Cell Transplantation and Cellular Therapy Department|713-794-4422|qbashir@mdanderson.org|
22411428|NCT01847196|BiO2 Medical|Margaret Tumas, VP of Clinical Affairs|720-635-3232|mtumas@bio2medical.com|
22411429|NCT00707915|Minami-hanno Hospital|Director of clinical trials|81.42.972.7111|haloperidol1mg@hotmail.com|
22411430|NCT00706706|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22411431|NCT01943461|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22411432|NCT02175966|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
22411433|NCT00210626|Centocor Ortho Biotech Services, LLC (COBS)|Vice President Medical Affairs|215-325-4464||
22411434|NCT03361956|Janssen Sciences Ireland UC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22411435|NCT01505465|HSS|Dr. Memtsoudis|(212) 606-1000|MemtsoudisS@hss.edu|
22411436|NCT02330081|Terumo BCT|Beth Crump|+1 303 231-4606|beth.crump@terumobct.com|
22411437|NCT02277769|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
22411438|NCT02707432|University of North Carolina at Chapel Hill|Stephanie Hoover, PhD|919-966-1649|stephanie_hoover@med.unc.edu|
22411439|NCT01957657|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22411440|NCT03775681|UT MD Anderson Cancer Center|Katherine Hagan, Associate Professor, Anesthesiology & PeriOper Med|(713) 794-5945|khagan@mdanderson.org|
22411441|NCT00961051|Abbott Medical Optics|Eugenia Thomas, O.D.|714-247-8723|eugenia.thomas@amo.abbott.com|
22411442|NCT02123459|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22411443|NCT02196506|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
22411444|NCT01098240|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22411445|NCT01070394|NYU School of Medicine|Dr. Lenard Adler|(212) 263-3580|lenard.adler@nyumc.org|
22411446|NCT00066807|IBCSG|Rudolf Maibach, Executive Officer for International Trial Activities|+41 31 389 91 96|rudolf.maibach@ibcsg.org|
22411447|NCT03507439|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22411448|NCT00874757|University of Nebraska Medical Center|Timothy R McGuire|402-651-2496|trmcguir@unmc.edu|
22411449|NCT00974142|University of Pittsburgh Medical Center|Michael Donahoe MD|412-648-9636|donahoem@upmc.edu|
22411450|NCT01486407|Teleflex|Tatiana Puga||tatiana.puga@teleflex.com|
22411451|NCT03698669|Boston University|Michael Stein, MD|617 358 1956|mdstein@bu.edu|
22411452|NCT03346538|Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please email|cti-inq-ml.JP@ml.tanabe-pharma.com|
22411453|NCT03369756|B. Braun Medical Inc.|Dr. Diana Valencia|610-596-2875|diana.valencia@bbraunusa.com|
22411454|NCT04014959|University of Pennsylvania|Dr. Desmond Oathes, Principal Investigator|215-573-9390|oathes@pennmedicine.upenn.edu|
22411455|NCT05286528|Pfizer ClinicalTrials.gov Call Center|Pfizer Inc.|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22411456|NCT02004847|Philips GmbH Innovative Technologies Aachen|Prof. Dr. Matthias Born|+491735321764|matthias.born@philips.com|
22411457|NCT02220920|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22411458|NCT00202449|VA PSHCS|Murray Raskind, MD|206-764-2702|Murray.Raskind@va.gov|
22411459|NCT01535326|Dalin Tzu Chi Hospital|Dr. Yu-Hsi Hsieh|88652648000|hsieh.yuhsi@msa.hinet.net|5241
22411460|NCT00494975|Dermatology|Ko Mei-Ju|886-223123456|kmjmay@gmail.com|2141
22411461|NCT00929500|Beth Israel Deaconess Medical Center|Dr. Vera Novak|617-632-8680|vnovak@bidmc.harvard.edu|
22411462|NCT00789802|Washington University|Dr. Tessa Madden|3147471331|maddent@wustl.edu|
22411463|NCT02811861|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
22426244|NCT06450457|The University of Texas Health Science Center at Houston|Kaitlin Benjamin, PT, DPT|610-639-0431|Kaitlin.Benjamin@memorialhermann.org|
22411464|NCT00958581|NYU hospital for Joint Diseases|Dr. Thomas Errico (Chief of Spine), Dr. Kushagra Verma (Co-investigator)|212-598-6076|thomas.errico@nyumc.org; vermak01@gmail.com|
22411465|NCT04081337|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22411466|NCT06624072|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22411467|NCT05076422|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22411468|NCT01387737|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22411469|NCT02642627|Suneva Medical|Director of Clinical Affairs|858-324-6268|alehman@sunevamedical.com|
22411470|NCT00707954|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22411471|NCT04326257|UPMC|Barbara Stadterman, MPH, CCRP|7245532539|stadtermanbm@upmc.edu|
22411472|NCT06509100|University of North Carolina at Chapel Hill|David Rauscher|828-405-0588|david_rauscher@med.unc.edu|
22411473|NCT05002569|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22411474|NCT06076681|TenNor Therapeutics (Suzhou) Limited.|TenNor Medical Information|0512-86861979|info@tennorx.com|
22411475|NCT00118053|Cancer Institute of New Jersey|Deborah Toppmeyer, MD|732-235-8675|toppmede@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
22411476|NCT00220701|NY State Psychiatric Institute|David Hellerstein MD|6467748000|hellers@nyspi.columbia.edu|
22411477|NCT02971956|Dana-Farber Cancer Institute|Peter C. Enzinger MD|(877) 442-3324|Peter_Enzinger@dfci.harvard.edu|
22411478|NCT04041570|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
22411479|NCT05211336|National Cancer Institute|Dr. Rahul Lakhotia|240-858.7242|rahul.lakhotia@nih.gov|
22411480|NCT02337829|Acerta Pharma B.V.|Acerta Clinical Trials|1-888-292-9613|acertamc@dlss.com|
22411481|NCT01418352|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22411482|NCT00619619|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22411483|NCT05332626|Poznan University of Life Sciences|Iskandar Harahap|+48618486330|iskandar.harahap@up.poznan.pl|
22411484|NCT01992107|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22411485|NCT02022007|Woman''s Hospital|Dr Karen Elkind-Hirsch|225-231-5275|karen.elkind-hirsch@womans.org|
22411486|NCT01214603|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22411487|NCT01507896|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22411488|NCT00621179|Colorado Center for Reproductive Medicine|Eric Surrey|303-788-8300|esurrey@colocrm.com|
22411489|NCT01110681|Q-Med AB|Head of Medical Affairs|+ 46 (0)18 4749000|reception.SEUPP@galderma.com|
22411490|NCT03503474|University of Leeds|Professor Mark Wilcox|+441133926818|mark.wilcox@nhs.net|
22411491|NCT00446654|Progen Pharmacauticals Ltd|Director of Clinical Trials|+61 7 32739133||
22411492|NCT00168337|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22411493|NCT01102777|VA Ann Arbor Center for Clinical Management Research|Fatima Makki|+1 (734) 845-3623|Fatima.Makki@va.gov|
22411494|NCT01875445|University of Chicago|Dr. Jon Grant|773-834-3778|jongrant@uchicago.edu|
22426245|NCT03999749|NYU Langone Health|Janice Mehnert, M.D.|212-731-5431|janice.mehnert@nyulangone.org|
22426246|NCT00255164|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
22426247|NCT02735473|University of Minnesota|Jeffrey R Wozniak|612-273-9741|jwozniak@umn.edu|
22379774|NCT04435795|Research Institute of the McGill University Health Center|Dr Nicole EZER|514-934-1934|nicole.ezer@mcgill.ca|76192
22379775|NCT01222832|SEMC|Peter catalano|617-789-5004|peter.catalano@steward.org|
22379776|NCT02959138|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22379777|NCT02391038|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22379778|NCT04213989|Laser Lipo and Vein Center|Thomas Wright, MD|636-397-4012|info@laserlipoandveins.com|
22379779|NCT01327547|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22379780|NCT00440180|University of Utah|Marie Gibson|801-213-2845|marie.gibson@hsc.utah.edu|
22379781|NCT03390036|Anika|Carol Pekar, VP Clinical Affairs|781-457-9218|cpekar@anikatherapeutics.com|
22379782|NCT01026909|Seattle Children's Hospital|Dr Klane White|206-987-5678|klane.white@seattlechildrens.org|
22379783|NCT03076359|Vanderbilt University|Carolyn Audet|615-343-2418|carolyn.m.audet@vanderbilt.edu|
22379784|NCT02040792|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
22379785|NCT01474512|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22379786|NCT03888885|The Chinese University of Hong Kong|Dr. Sum Kim Wai Raymond|+852 39436091|kwsum@cuhk.edu.hk|
22379787|NCT01118962|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22379788|NCT01938664|Baylor College of Medicine|Thomas Kosten, MD|713-794-7032|kosten@bcm.edu|
22379789|NCT01089556|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22379790|NCT00594906|University of Rochester|Dr. J. Edward Puzas|(585) 275-3664|edward_puzas@urmc.rochester.edu|
22379791|NCT02165904|Hospital Universitario Puerta de Hierro Majadahonda, Madrid|Dr. Vaquero Crespo|91 191 7760|jesus.vaquero@salud.madrid.org|
22379792|NCT00956540|Hospital Virgen de la Salud|Dr. Gonzalo Hernández|0034629625428|ghernandezm@telefonica.net|
22379793|NCT01027364|Bioverativ|Bioverativ Study Medical Director||clinicaltrials@bioverativ.com|
22379794|NCT02222896|Microbac|Dr. Bashir|703-925-9366|muhammad.bashir@microbac.com|
22379795|NCT03772314|Emory University|Dr. Lynn Marie Trotti|404-712-7240|lbecke2@emory.edu|
22379796|NCT02354963|IIS La Fe|Dr Cesar Diaz-Garcia|961 24 67 00|cesar.diaz@ivirma.com|
22379797|NCT00119262|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
22411495|NCT04029090|Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608|cti-inq-ml.JP@ml.tanabe-pharma.com|
22411496|NCT00501046|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22411497|NCT05056727|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22411498|NCT02622113|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22411499|NCT03404180|Malcom Randall VAMC/University of Florida|Jose R. Soberon, Jr., MD|352-376-1611|jose.soberon@va.gov|10-3581
22411500|NCT03289208|Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please Email|cti-inq-ml.JP@ml.tanabe-pharma.com|
22411501|NCT05245682|Emory University|Nicole Schmitt|404-778-0278|nicole.cherie.schmitt@emory.edu|
22411502|NCT01840605|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22411503|NCT05308472|Disc Medicine|CMO|(617) 674-9274|clinicaltrials@discmedicine.com|
22411504|NCT03469271|Mayo Clinic|Aminah Jatoi, M.D.|507-266-0984|huyber.christine@mayo.edu|
22411505|NCT05021133|UMass Chan Medical School|Mayuko Ito Fukunaga|5088561975|mayuko.itofukunaga@umassmed.edu|
22411506|NCT03760510|Vanderbilt University Medical Center|Janna Landsperger|6153223412|janna.landsperger@vumc.org|
22411507|NCT03198988|ART MEDICAL|Mrs Shirly Steinlauf|972-54-5804242|shirly@artmedical.com|
22411508|NCT00871728|Clinical Research Team, Medical Affairs, Medical Dept. Janssen Korea|Clinical Research Associate|+82-2-2094-4879||
22411509|NCT04147715|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
22411510|NCT00235833|Abbott|Medical Information Specialist|800-633-9110||
22411511|NCT01288833|San Francisco VA Medical Center|Dr. Tonya Kaltenbach|415-221-4810|tonya.kaltenbach@va.gov|94121
22411512|NCT00686803|Palatin Technologies, Inc.|Robert Jordan, Executive Director of Clinical Operations|609.495.2200|rjordan@palatin.com|
22411513|NCT00140556|Duke University Medical Center, Dept Radiation Oncology|David Brizel, MD|919 668-5637|david.brizel@duke.edu|
22411514|NCT03867383|Stanford University|Dr. Jessica Ansari|760-845-0328|jansari@stanford.edu|
22411515|NCT00895583|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22411516|NCT04326842|The First Affiliated Hospital of Harbin Medical University|Dr. Hong Zhang|+86 0451-85553952|2315186458@qq.com|
22411517|NCT01078090|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22411518|NCT04535583|Geisel School of Medicine at Dartmouth|Dr. Lisa A. Marsch|603-646-7092|lisa.a.marsch@dartmouth.edu|
22411519|NCT00924066|National Cancer Institute|Antonio Fojo, M.D.|301-496-2631|fojot@mail.nih.gov|
22411520|NCT01748890|Massachusetts General Hospital|Anthony E. Samir|6178523241|asamir@partners.org|
22411521|NCT03035227|Kansas City Heart Rhythm Institute|Dr. Dhanunjaya Lakkireddy|913-449-1297|dhanunjaya.lakkireddy@hcahealthcare.com|
22411522|NCT02100956|Wake Forest University School of Medicine|Professor James C. Eisenach, MD|336-716-4182|jimeisenach@gmail.com|
22411523|NCT03529955|Tulane University|Carole Bitar, MD, FAAD|202-642-8122|cbitar@tulane.edu|
22411524|NCT01986790|Washington University's School of Medicine|Mary C. Politi, PhD|314-747-1968|politim@wudosis.wustl.edu|
22411525|NCT03289234|Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please Email|cti-inq-ml.JP@ml.tanabe-pharma.com|
22411526|NCT03016078|Mölnlycke Health Care|Global Clinical Research Director|+46 31 722 30 00|info@monlycke.com|
22411527|NCT04526899|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
22411528|NCT00416520|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22411529|NCT00449072|sanofi-aventis|Trial Transparency Team||Contact-Us@sanofi.com|
22411530|NCT04630626|NuVasive, Inc.|Nicole Czaplewski, Manager Clinical Affairs|308-660-2021|nczaplewski@nuvasive.com|
22411531|NCT02207309|Ludwigs-Maximilians-Universtity of Munich|Lars Lindner|0049894400|Lars.Lindner@med.uni-muenchen.de|74768
22411532|NCT00795665|University of California Davis|Analyst|916-734-8053|nlogihara@ucdavis.eduu|
22411533|NCT02140957|St. Michael's Hospital|Dr. Jonathon Maguire|(416) 919-3462|jonathon.maguire@utoronto.ca|
22411534|NCT01612000|Protein Sciences Corproation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
22439883|NCT02958917|National Jewish Health|Dr. Evans Fernández|303-388-4461|fernandezevans@njheallth.org|
22439884|NCT00717574|Department of Anesthesia. OUHSC|Dr. Mehmet Ozcan, MD|405-271-4351|mehmet-ozcan@ouhsc.edu|
22439885|NCT01775501|Massachusetts General Hospital|Dr. Lipika Goyal|617-724-4000|LGOYAL@PARTNERS.ORG|
22439886|NCT03037385|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22439887|NCT02318706|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|1-908-992-6400|CTRinfo@dsi.com|
22439888|NCT04328077|Terns, Inc.|Study Director|+1 650-525-5535|clinicaltrials@ternspharma.com|101
22439889|NCT01456039|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
22439890|NCT04936945|Soahg University|Dr. Magdy Mohamed Amien|0934602963|portal@med.sohag.edu.eg|
22439891|NCT04273737|Columbia University Irving Medical Center|Dr. Heakyung Kim|212-305-9416|hk2641@cumc.columbia.edu|
22439892|NCT01702311|Emory University|Guillermo Umpierrez, MD|404-778-1663|geumpie@emory.edu|
22439893|NCT02170376|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22439894|NCT00578539|Baylor College of Medicine|Robert Krance, MD|832-824-4661|rakrance@txch.org|
22439895|NCT04106557|Ovid Therapeutics|Todd F. Baumgartner, M.D., MPH|802-752-5168|tbaumgartner@ovidrx.com|
22439896|NCT00313014|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333||
22439897|NCT03937570|Division of Cardiac Surgery, Department of Surgery - University of Verona|Marzia Lilliu, MD, PhD|+39 3281383539|marzialilliu@gmail.com|
22439898|NCT03714672|Grünenthal GmbH|Clinical Trial Helpdesk|+49 241 569|clinical-trials@grunenthal.com|3223
22411535|NCT03425331|Dana-Farber Cancer Institute|Mark Awad, MD, PhD|(617) 632-3468|mark_awad@dfci.harvard.edu|
22439899|NCT03629535|NYU Langone Health|Greta Piper, MD|212-263-4778|Greta.Piper@nyulangone.org|
22379798|NCT03853317|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
22379799|NCT01306175|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22379800|NCT02649322|Orlando Health|Daryl C. Osbahr, MD|321.843.4800|Daryl.Osbahr@orlandohealth.com|
22379801|NCT01752413|Memorial Blood Centers|Jed B Gorlin MD, MBA|651-332-7284|Jed.Gorlin@innovativeblood.org|
22379802|NCT01182727|Maryland Psychiatric Research Center|Dr. Robert Buchanan, M.D.|410-402-7876|rwbuchanan@mprc.umaryland.edu|
22379803|NCT01551303|Massachusetts General Hospital|Dr. Elizabeth Hoge|617-724-0859|ehoge@partners.org|
22379804|NCT02141659|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22379805|NCT01927731|The University of Texas MD Anderson Cancer Center|Uday Popat, M.D. / Stem Cell Transplantation|713-792-8750|upopat@mdanderson.org|
22379806|NCT00886262|Medical University of South Carolina|Dr. Scott Reeves|843-792-5699|reevess@musc.edu|
22379807|NCT00305864|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
22379808|NCT02065570|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22379809|NCT02743793|DAIT/NIAID|Director, Clinical Research Operations Program|13015947669|DAITClinicalTrialsGov@niaid.nih.gov|
22379810|NCT02589392|Galderma|Stéphanie Leclerc|+33492386706|stephanie.leclerc@galderma.com|
22379811|NCT02965144|Rigshospitalet|Karin Piil|0045612078067|Karin.Piil@regionh.dk|
22379812|NCT00322374|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22379813|NCT03382600|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22379814|NCT02269943|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
22379815|NCT04642469|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22379816|NCT02733042|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22379817|NCT00787722|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
22379818|NCT01088529|Janssen R&D US|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
22379819|NCT03056859|University of New Mexico Anesthesiology Department|Research Officer|505-272-2610|HSC-Anesthesiology@salud.unm.edu|
22379820|NCT02838628|Almirall S.A.|Head of Global Clinical Development|+34932913000|rd@almirall.com|
22379821|NCT04193293|Secura Bio, Inc.|Beth Gregory, PharmD, MBA|1-702-254-0011|bgregory@securabio.com|
22379822|NCT04396535|Mayo Clinic|Dr. Konstantinos Leventakos|507-284-2511|leventakos.konstantinos@mayo.edu|
22379823|NCT02066532|Columbia University Irving Medical Center|Dawn Hershman, MD|212-305-5098|dlh23@cumc.columbia.edu|
22379824|NCT02303626|BioCryst Pharmaceuticals, Inc|VP Clinical Development|(+1) 919 859 1302|clinicaltrials@biocryst.com|
22379825|NCT05832437|Columbia University School of Nursing|Maureen George|212-305-1175|mg3656@cumc.columbia.edu|
22379826|NCT00337662|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22379827|NCT00882921|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22379828|NCT03662360|Clinica Luganese Moncucco|Dr. Med. Pio Fontana|0041919608712|pioeugenio.fontana@moncucco.ch|
22379829|NCT00715741|University of Utah|Harriet Hopf, MD|801-205-1013|Harriet.Hopf@hsc.utah.edu|
22379830|NCT01722318|Synergy Pharmaceuticals Inc.|Dr. Patrick H. Griffin|212-297-0020||
22379831|NCT01233609|Foundation Fighting Blindness Clinical Research Institute|Chief Drug Development Officer|410 423 0581|pzilliox@blindness.org|
22379832|NCT03391960|3M|Helen Han|651-737-9234|mhan3@mmm.com|
22379833|NCT03677128|Duke University|Kristin Schroeder, MD MPH|919-668-6288|kristin.schroeder@duke.edu|
22379834|NCT00581113|Virginia Commonwealth University|Martha D. Wellons|804-628-1939|mwellons@vcu.edu|
22379835|NCT04834362|National Institute of Neurosciences and Hospital, Dhaka|Dr. Mashfiqul Hasan|+8801816268746|mashfiqul.hasan@nins.gov.bd|
22379836|NCT01868789|Orthopedic Foot and Ankle Center|Dr. Gregory Berlet|6148958747|ofacresearch@orthofootankle.com|
22379837|NCT00329719|Mayo Clinic|Kurt A. Jaeckle, M.D.|5072842511|jaeckle.kurt@mayo.edu|
22379838|NCT06017999|Xgene Pharmaceutical|Director of Clinical Trials|+886-2-2528-0580|emily.chen@xgenepharm.com|
22379839|NCT01155388|AMAG Pharmaceuticals, Inc.|Medical Information||CTInterest@covispharma.com|
22379840|NCT03943589|Hansa Biopharma AB|Vice President Research and Development|+4646165670|info@hansabiopharma.com|
22379841|NCT04329104|National Institute of Allergy and Infectious Diseases (NIAID)|Dr. Peter Crompton|301-761-5042|pcrompton@niaid.nih.gov|
22379842|NCT01702428|GlaxoSmithKline|GSK Response Center|866-435-7343||
22379843|NCT02091869|University of Arkansas for Medical Sciences|Dr. Tamara T. Perry|501-364-1538|perrytamarat@uams.edu|41538
22379844|NCT02821832|National Institute of Allergy and Infectious Diseases|Dr. Clif E. Barry 3rd|301-693-4665|cbarry@niaid.nih.gov|
22379845|NCT03685708|National Institutes of Health (NIH) / The National Heart, Lung, and Blood Institute (NHLBI)|Christopher Pleyer, M.D. Principal Investigator, NIH, NHLBI|510.709.6649|christopher.pleyer@nih.gov|
22379846|NCT02682498|UC Irvine Health|Joseph Rinehart|714-456-5059|jrinehar@uci.edu|
22379847|NCT02771210|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22379848|NCT01311362|University of Heidelberg|Prof. Dr. med. Gerd Mikus|4966215639197|gerd.mikus@med.uni-heidelberg.de|
22379849|NCT04397523|Institute for Transfusion Medicine of RNM|Assoc. Prof. Dr. Rada M. Grubovic Rastvorceva, MD MSci PhD, CMO|+38923226923|drgrubovic@gmail.com|
22379850|NCT01275196|Novartis Pharmaceuticals|Study Director|862-778-8300||
22379851|NCT03230864|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
22379852|NCT00832338|Emory University|Jane Meisel, MD|404-778-1900|jane.l.meisel@emory.edu|
22379853|NCT00227760|Princess Margaret Cancer Centre - University Health Network|Dr. Srikala Sridhar|416-946-2249|srikala.sridhar@uhn.ca|
22379854|NCT01744496|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22379855|NCT01284140|University of Iowa|Brian K. Gehlbach, MD|319-356-3603|brian-gehlbach@uiowa.edu|
22379856|NCT01927718|UT MD Anderson Cancer Center|Qaiser Bashir, MD/Associate Professor, Stem Cell Transplantation|713-792-7734|QBashir@mdanderson.org|
22379857|NCT01896115|Boston Scientific|Stephen Carcieri, PhD|661-949-4756|Stephen.Carcieri@bsci.com|
22379858|NCT02029040|UT Southwestern Medical Center|Mohamed Badawy, MD|2144567106|Mohamed.Badawy@UTsouthwestern.edu|
22379859|NCT02512510|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
22379860|NCT02917577|UCalgary|Heinrike Schmeling|4039553194|schmelingresearch@albertahealthservices.ca|
22439900|NCT03081117|Johns Hopkins University|Dr. Leah Rubin, Associate Professor of Neurology, Psychiatry, and Epidemiology|410-955-7311|lrubin@jhu.edu|
22379861|NCT05033080|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22379862|NCT05376371|University or Wisconsin-Madison|Ryan Westergaard|6082657927|rpw@medicine.wisc.edu|
22379863|NCT04159415|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22379864|NCT03560245|Neurotropebioscience, Inc|Alan J. Tuchman, MD, Acting Chief Medical Officer|973-242-0005|atuchman@neurotrope.com|
22379865|NCT02400437|Dana-Farber Cancer Institute|Jorge Castillo|617-632-2681|jorgej_castillo@dfci.harvard.edu|
22379866|NCT02088632|Jefferson Headache Center|Clinical research manager|2159552680|mary.hopkins@jefferson.edu|
22379867|NCT02913521|Egeen|Kalev Kask|16504690600|kalev.kask@egeeninc.com|
22379868|NCT01468532|Barbara Ann Karmanos Cancer Institute|Ulka N. Vaishampayan|313-576-8718|vaishamu@karmanos.org|
22379869|NCT00960752|UT MD Anderson Cancer Center|Michael Davis, PHD., Chair, Melanoma Medical Oncology|713-792-3454|mdavies@mdanderson.org|
22379870|NCT05259774|Relife Srl|Lia Fabbri|05556809528|lfabbri@relifecompany.it|
22379871|NCT00459303|National Taiwan University Hospital|Fung-Rong Hu|+886223123456|fungronghu@ntuh.gov.tw|2131
22379872|NCT02058290|Pacira Pharmaceuticals, Inc.|Erol Onel, MD|858-625-2424|erol.onel@pacira.com|
22379873|NCT01238549|VAORD|Dr. Ann Spungen|718-584-9000|ann.spungen@va.gov|5814
22379874|NCT03295266|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22379875|NCT00105586|Washington University in St. Louis|Eric Lenze|314-362-1671|lenzee@wustl.edu|
22379876|NCT00675415|Cleveland Clinic|Dr. John Vargo|(216) 445-5012|vargoj@ccf.org|
22379877|NCT02262260|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22379878|NCT01794117|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|Dr. Edward W. Cowen|301-827-2328|cowene@mail.nih.gov|
22379879|NCT03406702|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
22379880|NCT00601003|Beat Childhood Cancer|Giselle Sholler, MD|704-381-9900|Giselle.Saulniersholler@atriumhealth.org|
22379881|NCT04394247|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22379882|NCT00735644|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22379883|NCT00514046|National Cancer Institute|Dr. Brigitte Widemann|240-760-6203|widemanb@nih.gov|
22379884|NCT00655551|UCB, Inc|UCB Clinical Trial Call Center|+1 877 822 9493||
22439901|NCT00809185|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Anjali Advani|216-445-9354|advania@ccf.org|
22439902|NCT00874510|Center for Health Incentives and Behavioral Economics|Kevin Volpp, MD, PhD|215.573-0270|volpp70@exchange.upenn.edu|
22439903|NCT03007966|Wake Forest University Health Sciences|Christopher Edwards|336-716-4498|chedward@wakehealth.edu|
22439904|NCT00474487|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@Novartis.com|
22439905|NCT00419393|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22439906|NCT03904017|University of Colorado|Layne Dylla|303-724-1716|layne.dylla@cuanschutz.edu|
22439907|NCT00248625|University of Pittsburgh|Robert H. Squires, Jr.|412-692-8648|squiresr@upmc.edu|
22439908|NCT00904943|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22439909|NCT03284710|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22439910|NCT02994238|Northwestern University|Kathy Boon- Clinical Research Associate|312-503-4687|kathy.boon@northwestern.edu|
22439911|NCT05176314|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22379885|NCT00591123|UCLA GI Oncology Program, David Geffen School of Medicine at UCLA|Zev Wainberg, MD|310-829-5471|zwainberg@mednet.ucla.edu|
22379886|NCT02855164|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22379887|NCT00383240|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22379888|NCT02049710|Carnegie Mellon University, Social and Decision Sciences|Mandy Lanyon, Research Associate II|4122683249|mandy@cmu.edu|
22379889|NCT06385483|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22379890|NCT04858295|University of Pennsylvania|Dr. Sarah Schrauben|267-324-7588|sarahsch@upenn.edu|
22379891|NCT06211296|Pi-Cardia|Hadas Givon, VP CA/RA|+972-8-9484800|hadas@pi-cardia.net|
22379892|NCT01818141|Hartford Hospital|Dr. David P. Nicolau, PharmD, FCCP, FIDSA|860-972-3941|david.nicolau@hhchealth.org|
22379893|NCT01554982|Keryx|Lisa Loram|919-434-6195|lisa.loram@keryx.com|
22379894|NCT00678444|UPittsburgh|Dr. Jerry Lowder|314-747-1402|lowderj@wudosis.wustl.edu|
22379895|NCT04781647|Assembly BioSciences Inc.|Director of Clinical Operations|415-366-5172|psalstrand@assemblybio.com|
22379896|NCT00739583|Johns Hopkins University|Simon C Mears|410-550-0101|smears1@jhmi.edu|
22379897|NCT01668147|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
22379898|NCT02662244|UCSD|Dr. Arisa Ortiz|858-657-1697|dermstudies@ucsd.edu|
22379899|NCT00315627|University of Miami Miller School of Medicine|Dr. Rodolfo Alejandro|305 243-5324|ralejand@med.miami.edu|
22379900|NCT00224133|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com|
22379901|NCT02802020|Boston Scientific Corporation|Brian Vatcher|+1-508-683-5274|brian.vatcher@bsci.com|
22379902|NCT01238575|Emory University|Lawrence Scahill, MSN, PhD||lawrence.scahill@emory.edu|
22379903|NCT02516579|Addmedica|Medical director|+33172690186|corinne.duguet@addmedica.com|
22379904|NCT00593554|IndianaU|Dr. Sherif Farag|317-278-0460|ssfarag@iu.edu|
22379905|NCT03796689|University of California, San Fransico|Dr. Mark Pletcher, Professor|415-514-8008|mark.pletcher@ucsf.edu|
22379906|NCT00795132|University of Utah|Dr. Michael Pulsipher|801-588-2680|michael.pulsipher@hsc.utah.edu|
22379907|NCT04764929|Columbia University|Patrick Wilson, MD|212-305-8458|ptw2107@cumc.columbia.edu|
22379908|NCT02338713|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22379909|NCT00883103|Baystate Medical Center|Oz Harmanli, MD|4137945608|oz.harmanli@baystatehealth.org|
22379910|NCT00358150|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
22379911|NCT02173535|Johnson & Johnson Vision Care Inc.|Charis Lau, Pharm.D., O.D., FAAO|(904) 443-1293|MLau87@ITS.JNJ.com|
22379912|NCT04254679|McGill University|Dr. Julio F. Fiore Jr|514 934-1934|julio.fiorejunior@mcgill.ca|35655
22379913|NCT03954158|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22379914|NCT03875495|Genenta Science|Chief Medical Officer|+39 02 2643 3982|info-trial@genenta.com|
22379915|NCT04800757|The University of Texas Health Science Center at Houston|Maria Eugenia Fernandez-Esquer|(713) 500-9657|Maria.E.Fernandez-Esquer@uth.tmc.edu|
22379916|NCT04076020|University of Pittsburgh|Dr. Jared Magnani|(412)383-0611|magnanij@pitt.edu|
22379917|NCT05022602|Seno Medical, Inc.|Shaan Schaeffer|6106983259|sschaeffer@senomedical.com|
22379918|NCT05462652|Big Health, Inc.|Jessica Lake|(510) 244-3753‬|research@bighealth.com|
22379919|NCT03410914|Sunnybrook Health Sciences Centre|Dr. Paul Karanicolas|4164806100|paul.karanicolas@sunnybrook.ca|4774
22379920|NCT00859508|Synthes USA HQ, Inc.|Heidi Hausner, Clinical Research Manager|610-719-5707|hausner.heidi@synthes.com|
22379921|NCT00654329|Children's National Medical Center|Julia C. Finkel, MD|202-476-4867|jfinkel@cnmc.org|4867
22379922|NCT04241575|The Chinese University of Hong Kong|Dr Vincent Wong|+85235054205|wongv@cuhk.edu.hk|
22379923|NCT00479037|Nycomed|Clinical Trial Operations|+45 4677 1111|clinicaltrials@nycomed.com|
22379924|NCT01861756|Aristotle University Thessaloniki|Dr. Apostolos Tsapas||atsapas@auth.gr|
22411536|NCT03433274|Abbott|Kayla Dellefratte, Senior Manager Clinical Project Management|+16692149748|kayla.dellefratte@abbott.com|
22379925|NCT00502996|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22379926|NCT01729728|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|Clinical-Trials@grunenthal.com|
22379927|NCT01316692|Vanderbilt-Ingram Cancer Center|Jeff Sosman, MD|615-875-8359|jeff.sosman@vanderbilt.edu|
22379928|NCT00178620|The University of Texas Health Science Center at Houston|Dr. Richard W. Smalling|713-500-6559|richard.w.smalling@uth.tmc.edu|
22379929|NCT02368002|University of Minnesota|Nancy Sherwood|612-625-4567|sherw005@umn.edu|
22379930|NCT02132533|UT Southwestern Medical Center|Chet Edward Wells, MD|214-648-2316|dawn.wilson@utsouthwestern.edu|
22379931|NCT02001974|Dompé Farmaceutici|Pieradelchi Ruffini, MD|+39 (0)2 583831|info@dompe.it|
22379932|NCT00993317|Korea Otsuka Pharmaceutical|Eun Young Cho, Clinical Trial Manager|+82-2-3287-9233|hyerim@otsuka.co.kr|
22379933|NCT00672958|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22379934|NCT01380990|UCL Institute of Child Health|Dr Claire Booth|+44207 905 2198|C.Booth@ucl.ac.uk|
22379935|NCT04422639|University of Arkansas for Medical Sciences|Assistant Director of Cancer Clinical Trials|501-686-8274|bscanlan@uams.edu|
22379936|NCT01964521|The Norfolk & Norwich University Hospitals NHS Foundation Trust|Dr Ketan Dhatariya|+44 1603 286286|ketan.dhatariya@nnuh.nhs.uk|
22379937|NCT02374593|Riley Hospital for Children|Dr. Erica Eugster|317 944-3889|eeugster@iu.edu|
22379938|NCT03121534|The University of Texas MD Anderson Cancer Center|Philip Thompson MD.|713-745-5732|PAThompson2@mdanderson.org|
22379939|NCT01463293|Fonterra Research Centre|Dr James Dekker|+64 6 350 6323|james.dekker@fonterra.com|
22379940|NCT02796963|UNC Project-China|Dr. Weiming Tang|+86-21-83755824|weimingtangscience@gmail.com|
22379941|NCT03192215|Columbia University|Mitchell S.V. Elkind, MD, MS, FAHA/ Randolph S. Marshall, MD, MS (trial investigators)|212-305-1710/ 212-305-8389|mse13@cumc.columbia.edu, rsm2@cumc.columbia.edu|
22379942|NCT02593032|University of Pennsylvania|Dr. Nalaka Gooneratne|215 573 2048|ngoonera@pennmedicine.upenn.edu|
22379943|NCT04844918|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22379944|NCT00110513|GTC Biotherapeutics|Denise Tilton, RN, MHA, Director Clinical Affairs|508-370-5257|denise.tilton@gtc-bio.com|
22379945|NCT01990820|NorthShore University HealthSystem|Dr. Mark Gerber|847-504-3300|mgerber@northshore.org|
22379946|NCT01009047|Janssen Research & Development, LLC|Senior Director, Clinical Leader|+1-609-730-2436||
22379947|NCT01716208|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
22379948|NCT04110366|Imperial College London|Dr Ryan Thwaites|(0044) 0203 3125730|r.thwaites@imperial.ac.uk|
22379949|NCT03119571|University of Minnesota|Demetri Yannopoulos, MD|6126261382|yanno001@umn.edu|
22379950|NCT01146574|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
22379951|NCT03299062|University of Arkansas for Medical Sciences|Rohit Dhall, MD|6025033193|rdhall@uams.edu|
22379952|NCT04485546|Dompé Farmaceutici S.p.A|Sarah Wilting, OD MS|833-366-7387|usmedinfo@dompe.com|
22379953|NCT00876460|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22379954|NCT02956434|VA Boston Healthcare System|Dr. Johanna Thompson-Hollands|857-364-2311|johanna.thompson-hollands@va.gov|
22379955|NCT01404611|Laboratorios SALVAT|Enrique Jimenez, Medical Director|+34933946470|ejimenezv@salvatbiotech.com|
22379956|NCT01216293|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22379957|NCT00799643|Joslin Diabetes Center|Allison B.Goldfine|617-309-2400|allison.goldfine@joslin.harvard.edu|
22411537|NCT00441584|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22379958|NCT05819619|Hackensack Meridian Health|Melissa M. Figueroa, MD, MPH, FACOG|551-996-8400|melissa.figueroa@hmhn.org|
22379959|NCT01040780|Cancer Hospital, Chinese Academy of Medical Sciences|Yan Sun, M.D.|0086-010-87788519|zhangheping@csco.org.cn|
22379960|NCT03681639|Zimmer Biomet|Esther Foo|+41792894930|esther.foo@zimmerbiomet.com|
22379961|NCT00654940|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22379962|NCT02169830|Saint Louis University|Dr. Anthony A Mikulec|314-977-8884|anthony.mikulec@health.slu.edu|
22379963|NCT03204695|Coherex Medical, Inc.|Senior Director Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22379964|NCT01682538|Swedish Orphan Biovitrum|Medical Director|+4686972000|erik.brouwer@sobi.com|
22379965|NCT00968838|The University of Texas M D Anderson Cancer Center|Dr. Emil J. Freireich MD/Professor|713-792-2660|eharriso@mdanderson.org|
22379966|NCT00777803|Merz Pharmaceuticals GmbH|Matthias Zerm|+49 69 1503|matthias.zerm@merz.de|865
22379967|NCT01755689|GlaxoSmithKline|GSK Response Center|866-435-7343||
22379968|NCT04448236|Haven of Hope hospital, Hospital Authority|Dr. Lau Chung Wai|27038888|lcw431@ha.org.hk|
22379969|NCT02930122|University of Kentucky|Dr. Cale Jacobs|859-218-3065|cale.jacobs@uky.edu|
22379970|NCT01995357|Coloplast A/S|MD, Medical Director|+45 4911 1395|dkbir@coloplast.com|
22379971|NCT02609659|AbbVie|Global Medical Services|800-633-9110||
22379972|NCT01432015|Gynecologic Oncology Associates|John P. Micha, M.D.|949-642-5165|Research@gynoncology.com|
22379973|NCT01004250|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22379974|NCT01853254|Hoffmann-La Roche|Medical Communications|800 821-8590||
22379975|NCT02462083|Bausch Health Americas, Inc.|Director of Clinical Operations|1-510-259-5284|aloncaric@bauschhealth.com|
22379976|NCT02435511|University of Chicago|Dr. Stacy Lindau|7738348986|slindau@bsd.uchicago.edu|
22379977|NCT02711995|Weill Cornell Medicine|Katerina Andreadis|646-962-9883|kaa2055@med.cornell.edu|
22379978|NCT00377741|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22379979|NCT01809210|AstraZeneca|Dr Gabriella Mariani , MD|+44 (0)207 6048000|ClinicalTrialTransparency@astrazeneca.com|
22379980|NCT01115998|University of Oklahoma Health Sciences Cetner|Director of Sponsored Programs|405-271--2090|mary-cotter@ouhsc.edu|
22379981|NCT00827944|Derriford Hospital, Department of Surgery|Pr. Andrew KINGSNORTH|+44 175 276 3017|Andrew.Kingsnorth@phnt.swest.nhs.uk|
22379982|NCT01861301|University of Chicago|Hedy Kindler, MD|773-702-0360|hkindler@medicine.bsd.uchicago.edu|
22379983|NCT03905811|University of Iowa|Jordan Schultz|3193849388|jordan-schultz@uiowa.edu|
22379984|NCT01383993|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22379985|NCT04975789|University of Wisconsin - Madison, School of Nursing|Maichou Lor, PhD, RN|608-265-4248|mlor2@wisc.edu|
22379986|NCT01489020|Roxall Medicina España S.A.|Dr. M Cruz Gómez project manager of Roxall Medicina España S.A.|+34 944438000|maricruz.gomez@roxall.es|
22379987|NCT03685747|Thomas Jefferson University|Walter Kraft|2159559077|walter.kraft@jefferson.edu|
22379988|NCT00415493|ASTHMA Inc.|Principal Investigator|(510) 620-5714|dennis.shusterman@cdph.ca.gov|
22379989|NCT00262743|Mayo Clinic|Dr. Tait Shanafelt||shanafelt.tait@mayo.edu|
22379990|NCT02485353|IndianaU|Hamid Sayar, MD|317-948-7576|ssayar@iu.edu|
22379991|NCT05584657|Iterum Therapeutics|Senior Vice President and Head of Clinical Development|8606614035|saronin@iterumtx.com|
22379992|NCT05454449|National Yang-Ming Chiao-Tung University|Yi-Fen Shih, Ph.D Department of Physical Therapy and Assistive Technology|+886-2-28267340|yfshih@nycu.edu.tw|
22379993|NCT01950273|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22379994|NCT04430335|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-716-9055|megreen@wakehealth.edu|
22379995|NCT00179010|Vanderbilt University|Italo Biaggioni, MD., Professor of Medicine and Pharmacology|(615) 936-3420|italo.biaggioni@vanderbilt.edu|
22379996|NCT03748979|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
22379997|NCT04747275|Children's Mercy|Max Feldt|816-960-8892|mmfeldt@cmh.edu|
22379998|NCT02360774|Beth Israel Deaconess Medical Center|Jody Dushay|6176671996|jdushay@bidmc.harvard.edu|
22379999|NCT00531011|Abbott Vascular, Italy|Maria Jose' M. Lopera|+39-02-516251|mariajose.lopera@av.abbott.com|
22380000|NCT03268590|Case Western Reserve University|Michael John Decker, PhD|216-368-2467|mjd6@case.edu|
22380001|NCT05719285|Cleveland Clinic Foundation|Dr. Lauren Gleich|701-330-1669|LAURENGLEICHDO@GMAIL.COM|
22380002|NCT02823964|Anthera Pharmaceuticals|Nicole Ramza|510-856-5600|info@anthera.com|
22380003|NCT02694640|University of South Carolina|Dr. Bernardine Pinto|8037779272|pintob@mailbox.sc.edu|
22380004|NCT03537261|Massachusetts General Hospital Lurie Center|Lisa Nowinski, PhD|781-860-1700|lnowinski@mgh.harvard.edu|
22380005|NCT00610675|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22380006|NCT01458249|Eisai Co., Ltd.|Sun Asami|+81-3-3817-5252||5252
22380007|NCT01824082|University of California San Diego|Brian M. Ilfeld|858-822-0776|bilfled@health.ucsd.edu|
22380008|NCT02056119|Rush University Medical Center|David Vines, PhD, RRT|3129424408|david_vines@rush.edu|
22380009|NCT01348854|Abbott Medical Optics|Carrie Garufis|714-247-8200|carrie.garufis@amo.abbott.com|
22380010|NCT04524104|Univeristy of Illinois, Chicago|Nan Lv, PhD, Research Scientist|312-802-1072|lvn2017@uic.edu|
22380011|NCT00983619|MedImmune, LLC|Shahram Rahimian|800-236-9933|information.center@astrazeneca.com|
22380012|NCT02731313|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22380013|NCT02443103|IndianaU|Dr. Kathy Miller|317-948-3855|kathmill@iu.edu|
22380014|NCT01017653|Preston Robert Tisch Brain Tumor Center|Annick Desjardins||annick.desjardins@dm.duke.edu|
22380015|NCT02366936|Duke University Health System|Dr. William Malcolm|919-681-4913|william.malcolm@duke.edu|
22426248|NCT04754542|University of Colorado Denver|Eric Engebretson|3037244518|eric.engebretson@cuanschutz.edu|
22380016|NCT02878213|EPD Solutions|Chen Sagy Bross|+972-50-5560073|chensb@epd-medical.com|
22426249|NCT04570709|University of North Carolina Lineberger Comprehensive Cancer Center|Melahat Canter|9199620000|Melahat_Canter@med.unc.edu|
22380017|NCT01558674|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22380018|NCT00656916|UT MD Anderson Cancer Center|Lara Bashoura, MD / Assistant Professor||CR_Study_Registration@mdanderson.org|
22380019|NCT01555021|Massachusetts General Hospital, Boston, MA|John D. Matthews, M.D., M.Sc.|617-643-9095|jmatthews@partners.org|
22380020|NCT01313923|UC Irvine Dermatology Research Center|Sergei A. Grando, MD, PhD, DSc|9498242713|sgrando@uci.edu|
22380021|NCT01388530|David Geffen School of Medicine at UCLA|James McGough, M.D.|310-794-7841|jmcgough@mednet.ucla.edu|
22380022|NCT02420327|University of Maryland School of Medicine|Dr. Britta Hahn|410-402-6112|bhahn@som.umaryland.edu|
22380023|NCT02204293|Helios Fachklinik Vogelsang-Gommern GmbH, Germany|Prof. Dr Eugen Feist|+49 30 450 513 192|eugen.feist@charite.de|
22380024|NCT00614198|Center for Autisme|Lennart Pedersen|44982355|lpe@centerforautisme.dk|
22380025|NCT01225835|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22380026|NCT01266993|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22380027|NCT03051659|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|(877) 442-3324|Sara_Tolaney@dfci.harvard.edu|
22380028|NCT04779242|Paratek Pharmaceuticals Inc|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
22380029|NCT01757067|University of Maryland Medical Center|Dr. Timm-Michael Dickfeld|410-328-7801|Tdickfel@som.umaryland.edu|
22380030|NCT02643979|Icahn School of Medicine at Mount Sinai|Dr. Daniel Katz|212-241-7475|daniel.katz@mountsinai.org|
22380031|NCT00849680|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||clinicaltrialsdisclosure@merck.com|
22380032|NCT02559609|UConn Health|Sheia Alessi|860-679-1849|salessi@uchc.edu|
22380033|NCT00003458|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22380034|NCT04714216|Emory University|Dr. Francisco J. Pasquel|404-778-1695|fpasque@emory.edu|
22380035|NCT01349829|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
22380036|NCT02555371|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22380037|NCT03095599|IVAC|Le Van Be|(+84 90) 3501529|ivaclevabe@dng.vnn.vn|
22380038|NCT00299689|James Graham Brown Cancer Center, University of Louisville|Dr. Jason Chesney|502/852-3679|jaches03@exchange.louisville.edu|
22380039|NCT00513019|University of Minnesota|Jon E. Grant|612-273-9800|grant045@umn.edu|
22380040|NCT00742885|GlaxoSmithKline|GSK Response Center|866-435-7343||
22380041|NCT00528190|Ottawa Hospital Research Institute|Shawn Aaron|613-737-8259|saaron@ohri.ca|
22380042|NCT04129580|Penn State Milton S. Hershey Medical Center|Dr Sarah Kawasaki|7175311000|skawasaki@pennstatehealth.psu.edu|
22380043|NCT03615482|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22380044|NCT00322868|Case Western Reserve University|Michael W Konstan, MD|2168443267|michael.konstan@case.edu|
22380045|NCT04006795|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22380046|NCT01852162|University of Florida|Dominick Angiolillo, MD, PhD|904-244-3933|dominick.angiolillo@jax.ufl.edu|
22380047|NCT03248570|University of California, San Francisco|Dr. David Oh, MD|(415) 476-1000|David.Oh@ucsf.edu|
22380048|NCT01500226|Tesaro|Martin Huber, M.D., Senior Vice President and Chief Medical Officer|781-257-2536|mhuber@tesarobio.com|
22380049|NCT02955277|Assuta Hospital Systems|Dr. Zvi Buckman|+97237462520|Bukman_tz@mac.org.il|
22380050|NCT04404257|William Beaumont Hospitals|Dr. Simon Dixon, MD|248-898-4198|simon.dixon@beaumont.edu|
22380051|NCT04212169|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22380052|NCT02176928|University of Miami|Shirin Shafazand, MD, MS|305-243-7888|sshafazand@med.miami.edu|
22380053|NCT00225420|Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
22380054|NCT00360555|Sprout Pharmaceuticals|Scientific Program Director|9198820850|clinicaltrials@sproutpharma.com|
22380055|NCT02018861|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22380056|NCT01642186|Memorial Sloan Kettering Cancer Center|Dr. Ghassan Abou-Alfa, MD|646-824-6566|abou-alg@mskcc.org|
22380057|NCT00163215|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22380058|NCT02466126|Department of Veterans Affairs, Micheal E. DeBakey VAMC|Dr. Jeffrey Cully|713-794-8526|Jeffrey.Cully@va.gov|
22380059|NCT00590980|University of Illinois at Chicago|Sepideh Amin-Hanjani, MD|312-996-4842|hanjani@uic.edu|
22380060|NCT00504348|Tokyo Medical and Dental University|Kazuki Takada, M.D.|81-3-3813-6111|takada.rheu@tmd.ac.jp|
22380061|NCT00709891|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22380062|NCT01023308|Novartis Pharmaceuticals|Study Director|862-778-8300||
22380063|NCT01646320|AstraZeneca Pharmaceuticals|Eva Johnsson, Clinical Science Lead|+46 31 7762484|Eva.Johnsson@astrazeneca.com|762 484
22380064|NCT02137538|Stanford University|E Kirk Neely|650-723-5791|neely@stanford.edu|
22380065|NCT02451930|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22380066|NCT00962585|Ausio Pharmaceuticals, LLC|Rick Schwen, PhD, DABT, RAC / Vice President of Regulatory Affairs|513-731-0222|rick@ausiopharma.com|
22380067|NCT05258747|Sandoz|Sandoz Disclosure Office|+49 8024 / 908 0|sandoz.disclosure@sandoz.com|
22380068|NCT02254421|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22380069|NCT02701582|NYU School of Medicine|Marc Bloom, MD, PHD|305 689-2388|mbloom@miami.edu|
22426250|NCT03429348|University of Arizona|Jeff Burgess, MD., MS, MPH, Assoc Dean of Research|520-626-4918|jburgess@email.arizona.edu|
22380070|NCT03092960|Stanford University|Lisa Goldman Rosas|(650) 721-8415|lgrosas@stanford.edu|
22380071|NCT01406860|University of Iowa Hospitals and Clinics|Brett Faine|3193108067|brett-faine@uiowa.edu|
22380072|NCT02722941|Moffitt Cancer Center|Taiga Nishihori, MD|813-745-8156|Taiga.Nishihori@moffitt.org|
22380073|NCT01080196|University of Utah|Dr Paul LaStayo|8019719298|paul.lastayo@health.utah.edu|
22380074|NCT03988374|Church & Dwight Co., Inc|Dr. Annahita Ghassemi, PhD|6098061200|annhita.ghassemi@churchdwight.com|
22380075|NCT03249376|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646-440-9333|ITCIClinicalTrials@itci-inc.com|
22411538|NCT00542386|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22411539|NCT04864405|The Ottawa Hospital Cancer Centre|Marie-France Savard, MD|613-737-7700|msavard@toh.ca|70170
22411540|NCT00506441|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22411541|NCT04969939|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22411542|NCT03843359|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22411543|NCT03075527|Dana-Farber Cancer Institute|Mark Awad, MD, PhD|6176323468|mark_awad@dfci.harvard.edu|
22411544|NCT02811432|London Sch Hygiene & Trop Medicine -|Professor Joy Lawn|+44 (0)20 7636 8636|joy.lawn@lshtm.ac.uk|
22411545|NCT02667067|NuVasive, Inc.|Nicole Czaplewski|308-660-2021|nczaplewski@nuvasive.com|
22411546|NCT05359003|Wake Forest University School of Medicine|Halley Alexander, MD, MS, FACNS|336-716-6898|halley.alexander@advocatehealth.org|
22411547|NCT06230848|Loyola University Chicago|Dr. Thao Griffith|464-220-9825|tgriffith1@luc.edu|
22411548|NCT06202521|Senhwa Biosciences|Becky Lin, Project Manager of Clinical Department|+886-2-8911-9856|beckylin@senhwabio.com|
22411549|NCT06064617|The Ohio State University|Ann Morrison|614-247-0010|morrison.421@osu.edu|
22411550|NCT02717611|Acerta Pharma|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22411551|NCT04980378|Globus Medical|Jessica Fulwider, Lead Clinical Project Manager|703-772-1455|jfulwider@globusmedical.com|
22411552|NCT00616928|GlaxoSmithKline|GSK Response Center|866-435-7343||
22411553|NCT01149616|Beth Israel Deaconess Medical Center|Dr Lauren Fisher|6176671853|lauren_fisher@dmgaz.org|
22411554|NCT05182606|University of Pittsburgh|Dr. Jessica Merlin|(412) 383-0617|merlinjs@upmc.edu|
22411555|NCT01357356|Serenity Pharmaceuticals|Chief Medical Officer|8456396760|sfein@serenitypharma.com|17
22411556|NCT02669264|ADC Therapeutics|ADC Therapeutics|954-903-7994|clinical.trials@adctherapeutics.com|
22411557|NCT00500682|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22411558|NCT01680159|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22411559|NCT04128696|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22411560|NCT00772382|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22411561|NCT01512849|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22411562|NCT05576012|Lipum AB|Peter Hovstadius, Chief Medical Officer|0046708893335|peter.hovstadius@lipum.se|
22411563|NCT00821821|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22411564|NCT03020472|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
22411565|NCT03731182|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22411566|NCT01711021|Noven Pharmaceuticals, Inc.|Study Director|(305) 253-5099|ClinicalTrials@noven.com|
22411567|NCT02442856|University of Pennsylvania|Michael Mullen|215-662-3339|mmullen@pennmedicine.upenn.edu|
22411568|NCT02833415|University of Texas Southwestern Medical Center|Ian J. Neeland MD|214-645-1267|ian.neeland@utsouthwestern.edu|
22411569|NCT01769209|Stanford University Medical Center|Michaela Liedtke, MD|650-498-6000|mliedtke@stanford.edu|
22411570|NCT03036579|University of Michigan|Dennis J. Fasbinder, DDS|7346474450|djfas@umich.edu|
22411571|NCT02352337|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
22411572|NCT04488575|Evelo Biosciences Inc|Duncan McHale, MBBS, MRCP, PhD|+447500128938|duncan@evelobio.com|
22411573|NCT02458638|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22411574|NCT01908127|Tehran University of Medical Sciences|Dr. Mehrsa Paryab|00989121091675|drmparyab@yahoo.com|
22411575|NCT03495648|University of Kentucky|Ann Koempel|(859) 257-3800|ann.koempel@uky.edu|
22411576|NCT02324972|Aquinox Pharmaceuticals (Canada) Inc.|Clinical|+1 604-629-9223|clinical@aqxpharma.com|
22411577|NCT02236338|Virginia Commonwealth University|Dr. Malcolm Sydnor|(804) 828-0534|malcolm.sydnor@vcuhealth.org|
22411578|NCT02401542|Rainier Therapeutics|Chief Medical Officer|510-878-2486|Sabella@RainierRx.com|
22411579|NCT00576901|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22411580|NCT02398188|Neothetics, Inc.|Neothetics Clinical|858-550-1900||
22411581|NCT01259869|Canadian Cancer Trials Group|Lesley Seymour|6135336430|lseymour@ctg.queensu.ca|
22411582|NCT05245617|Orthofix s.r.l.|Clinical Affairs Operations team|+39 045 6719000|clinicalaffairs@orthofix.it|
22439912|NCT04441138|Rush University Medical Center|Dr. Gaurav Marwaha|3129424399|Gaurav_Marwaha@Rush.edu|
22439913|NCT02118584|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22439914|NCT01231984|Becton Dickinson|Laurence Hirsch, MD|201-847-6513|Laurence_Hirsch@bd.com|
22439915|NCT04204447|University at Buffalo|Andrew Talal|7168884737|ahtalal@buffalo.edu|
22439916|NCT00322855|University of New Mexico|Christine M. Gan, Ph.D|5059250387|cgan@salud.unm.edu|
22439917|NCT02968134|The University of Queensland|Prof. Jason Roberts|+61 7 3646 4108|j.roberts2@uq.edu.au|
22439918|NCT01350947|Huntsman Cancer Institute|Mark Wade|801-213-5746|mark.wade@hci.utah.edu|
22439919|NCT00537394|ACTG Network Coordinating Center, Social & Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301)628-3313|ACTGCT.Gov@s-3.com|
22439920|NCT01283139|MedImmune, LLC|Gabor Illei, MD, Senior Director, Clinical Development|301-398-0000|IlleiG@Medimmune.com|
22439921|NCT01969708|The Emmes Corporation|Principal Investigator of the SCORE2 Data Coordinating Center|301-251-1161|score2@emmes.com|
22439922|NCT04267380|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22439923|NCT00004563|University of Texas Health Science Center at Houston|Maureen Mayes, MD|+1 (713) 500-6900|Maureen.D.Mayes@uth.tmc.edu|
22411583|NCT00620763|United States Department of Agriculture Grand Forks Human Nutrition Research Center|Brenda Ling|701-795-8300|brenda.ling@ars.usda.gov|
22411584|NCT00729859|University of Washington|Stephanie T. Page, MD, PhD|206-616-0483|page@u.washington.edu|
22380076|NCT01335308|University of Michigan|Ken Resnicow|734 647 0212|kresnic@umich.edu|
22380077|NCT00627042|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22380078|NCT04204772|University of Minnesota, Department of Medicine|Armin Rashidi, MD, PhD|612-624-0123|arashidi@umn.edu|
22380079|NCT00794820|University of Texas (UT) MD Anderson Cancer Center|Susan O'Brien, MD/ Leukemia|1-877-632-6789|CR_Study_Registration@mdanderson.org|
22380080|NCT04496414|Integra LifeSciences (Shanghai) Co., Ltd.|Dr. Hua Tang|0086 21 63179772|hua.tang@integralife.com|
22380081|NCT00855868|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22380082|NCT00432679|GlaxoSmithKline|GSK Response Center|866-435-7343||
22380083|NCT00906503|Barbara Ann Karmanos Cancer Institute|Barbara Ann Karmanos Cancer Institute|313-576-9370|davisv@karmanos.org|
22380084|NCT03405662|University of California, San Francisco & San Francisco VA Health Care System|Dr. Linda Chao|415-221-4810|linda.chao@ucsf.edu|24386
22380085|NCT00280293|UT Southwestern Medical Center|Dr. E. Sherwood Brown|214-645-6950|sherwood.brown@utsouthwestern.edu|
22380086|NCT01177813|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22380087|NCT00581256|University of Michigan Cancer Center|Dr. Lori Pierce, M.D.|734-764-9922|ljpierce@umich.edu|
22380088|NCT03220737|Emergent BioSolutions Canada Inc.|David Cassie, Scientist, Clinical Research|204-275-4589|dcassie@ebsi.com|
22380089|NCT00176865|Masonic Cancer Center, University of Minnesota|Dr. Angela Smith|612-626-2778|smith719@umn.edu|
22380090|NCT00684983|Mayo Clinic|Paul Haluska Jr MD PhD|507-284-1159|haluska.paul@mayo.edu|
22380091|NCT04011384|University of Pennsylvania|Dr. Laura Gibson|215-898-7093|gibla@pennmedicine.upenn.edu|
22380092|NCT04716881|Go Medical Industries, Pty Ltd|Director of Operations|61(8) 9388 1700|ctc@gomedical.com.au|
22380093|NCT01630590|UT MD Anderson Cancer Center|Dr. Paul Corn, Chair Ad Interim, Genitourinary Medical Oncology|(713) 563-7208|pcorn@mdanderson.org|
22380094|NCT01751113|GlaxoSmithKline|GSK Response Center|866-435-7343||
22380095|NCT00363896|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
22380096|NCT04147260|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22380097|NCT01079143|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22380098|NCT02708238|"Department of Translational Medical Sciences, Section of Pediatrics, University of Naples Federico II"|Annamaria Staiano|00390817462679|staiano@unina.it|
22380099|NCT02471404|AstraZeneca|Eva Johnsson, MD, PhD|+46 (0)31776 24 84|ClinicalTrialTransparency@astrazeneca.com|
22380100|NCT02207374|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)||clinicaltrials@novonordisk.com|
22380101|NCT02087150|Acclarent|Patricia Chen|949-453-6408|pchen126@its.jnj.com|
22380102|NCT00785538|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22380103|NCT00683449|MediciNova, Inc.|Kazuko Matsuda, MD PhD MPH, Vice President, Clinical Development|858-373-1500|matsuda@medicinova.com|132
22380104|NCT03897205|Hansa Biopharma AB|Vice President Research and Development|+4646165670|info@hansabiopharma.com|
22380105|NCT00925782|University of Kansas Medical Center|Omar Aljitawi, M.D., Assistant Professor of Medicine|913-588-6029|oaljitawi@kumc.edu|
22380106|NCT01272882|ChristianaCHS|Gerard Fulda|302-733-4260|gfulda@christianacare.org|
22380107|NCT01000376|Eisai|Dr. Peter Tarassoff|888-422-4743||
22380108|NCT00507026|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22380109|NCT04230980|Weill Cornell Medical College|Grace Tan, Clinical Research Coordinator|212-746-3208|grt2008@med.cornell.edu|
22380110|NCT04285229|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22380111|NCT02768558|RTOG Foundation|Wendy Seiferheld|215-574-3208|wseiferheld@acr.org|
22380112|NCT01603940|Hospital Universitario Pedro Ernesto (UERJ)|Ronaldo Altenburg Gismondi, MD, PhD|+5521996092383|ronaldogismondi@gmail.com|
22380113|NCT03367962|Stanford University|Dr. Robert Negrin|6507230822|negrs@stanford.edu|
22380114|NCT02748564|Cancer Institute of New Jersey|Adam Berger, MD|215-235-8079|ab2047@cinj.rutgers.edu|
22380115|NCT03114995|Cardiovascular Center, Seoul National University Bundang Hospital|Dr. Tae-Jin Youn|+82-31-787-7031|ytjmd@snubh.org|
22380116|NCT04223154|Wake Forest University School of medicine|Colleen A. Hanlon, Ph.D.|336-716-5465|chanlon@wakehealth.edu|
22380117|NCT02819479|Norton Neuroscience Institute|Shervin R. Dashti, MD, PhD, Principal Investigator|502-394-6390|shervin.dashti@nortonhealthcare.org|
22380118|NCT02968940|NYU Langone Health - Perlmutter Cancer Center|Sylvia Kurz, MD, PhD|212-731-6267|Sylvia.Kurz@nyulangone.org|
22380119|NCT02718417|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22380120|NCT00506285|Psychiatry Research Clinic|Barrie K. Marchant|801 585-6663|barriemarchant@aol.com|
22380121|NCT01305356|Wright Medical|Justin Moss|615-236-4984|Justin.Moss@wright.com|
22380122|NCT00551213|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22380123|NCT01890967|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22380124|NCT02892409|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22380125|NCT02766673|Children's Hospital of Philadelphia|Natalie Napolitano, MPH, RRT-NPS, FAARC|215-590-1708|napolitanon@email.chop.edu|
22380126|NCT02774343|The University of Texas Health Science Center at Houston|Joy M. Schmitz, PhD|713-486-2867|Joy.M.Schmitz@uth.tmc.edu|
22380127|NCT01154036|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22380128|NCT02264574|Pharmacyclics LLC, An AbbVie Company|Lori Styles|(408) 215-3770|lstyles@pcyc.com|
22380129|NCT02080520|Atherosclerosis Research Unit, University of Southern California|Howard N. Hodis, M.D.|323-442-1478|athero@usc.edu|
22380130|NCT00390455|Dana-Farber Cancer Institue|Harold Burstein, M.D.||hburstein@partners.org|
22380131|NCT03039543|Seoul National University Bundang Hospital|Dr. Junghee Ryu, Associate Professor|82-31-787-7497|jinaryu74@gmail.com|
22426251|NCT03627832|University of Missouri|Dr. Mary Beth Miller|573-882-1813|millmary@health.missouri.edu|
22380132|NCT00634322|BTG International (Protherics)|VP Clinical Development, BTG International|610-943-3632|janet.rush@btgplc.com|
22380133|NCT01591460|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22380134|NCT03679013|Inova Fairfax Hospital|Ramesh Singh, MD|(703)776-8025|ramesh.singh@inova.org|
22380135|NCT01930643|Mackay Memorial Hospital|Dr. Kuang-Hua Cheng|+886-975837711|jeff01@mmh.org.tw|
22380136|NCT04102540|University of Colorado College of Nursing|Dr. Samantha Stonbraker|3037248281|Samantha.Stonbraker@CUAnschutz.edu|
22380137|NCT01720797|University of Florida|Calogero Dolce, DDS, PhD|352-273-5700|cdolce@dental.ufl.edu|
22380138|NCT02379117|UNottingham|Dr Gordon Moran|44 [0]115 9249924|Gordon.Moran@nottingham.ac.uk|70608
22380139|NCT01686932|Novartis|Study Director|862-778-8300||
22380140|NCT01183650|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22380141|NCT04827134|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22380142|NCT01048606|Université de Sherbrooke|Pr Isabelle Dionne, Ph.D., vice-dean to research and graduate studies|1-819-821-8000|isabelle.dionne@usherbrooke.ca|63327
22380143|NCT03657264|Guerbet|Jing Hao, MD|+33145915000|jing.hao@guerbet.com|
22380144|NCT01598428|Shandong University|Dr.Yang Gao|0086-543-89268587|pinkapples@126.com|
22380145|NCT00924469|Janssen Research & Development, LLC 10990 Wilshire Blvd, Suite 1200 Los Angeles, CA 90024|Senior Director, Clinical Research|(310) 914-2917||
22380146|NCT01651936|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinialTrialsDisclosure@merck.com|
22380147|NCT03044353|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22380148|NCT03358329|Intersect ENT, Inc.|James Stambaugh, Vice President of Clinical & Medical Affairs|650-641-2103|jstambaugh@intersectent.com|
22380149|NCT01448525|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22380150|NCT03875911|UCLA Jules Stein Eye Institute|Dr. Joseph Caprioli|310-825-6323|caprioli@jsei.ucla.edu|
22380151|NCT05284019|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
22380152|NCT01990300|Takeda (Note: This product was divested to Teijin Pharma Limited in 2023)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22380153|NCT01231503|GlaxoSmithKline|GSK Response Center|866-435-7343||
22380154|NCT02293837|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22380155|NCT01076088|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22380156|NCT03285113|China Medical University Hospital (in Taiwan)|Dr. Yeong-Ray Wen (Department of Anaesthesia)|+886 4 2205-2121|yray.wen@gmail.com|
22380157|NCT03053492|Medical University of South Carolina|Michelle Woodbury|843-792-1671|woodbuml@musc.edu|
22380158|NCT05515679|Hopeful Aging|Michael Skrajner|4404777881|info@hopefulaging.com|
22380159|NCT04267575|Jerome Canady Research Institute for Advanced Biological and Technological Sciences|Jerome Canady, M.D.|301-270-0147|drjcanady@gwu.edu|
22380160|NCT01448044|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22380161|NCT01952301|Perio Health Professionals, PLLC|Dr. Michael K. McGuire|713-783-5442|mkmperio@swbell.net|
22380162|NCT03018106|Emory University|Gina Northington, MD|(404) 778-5770|gina.northington@emory.edu|
22380163|NCT01994720|AstraZeneca R&D|Brilinta Global Clinical Lead|+46 31 776 10 00||
22380164|NCT02216422|AbbVie|Global Medical Services|800-633-9110||
22380165|NCT01010217|UT MD Anderson Cancer Center|Dr. Stefan O Ciurea, Associate Profeddor of Stem Cell Transplantation|713-745-0146|sciurea@mdanderson.org|
22380166|NCT02213055|The Deirdre Imus Environmental Health Center at HackensackUMC|Project Manager, Environmental Research|551-996-8071|dimuscenter@hackensackumc.org|
22380167|NCT02061761|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22380168|NCT01024751|Bausch & Lomb Incorporated|William Reindel, OD, MS|(585) 338-8129|william.reindel@bausch.com|
22380169|NCT00955903|Wake Forest School of Medicine|Jamy Ard, MD|3367169837|jard@wakehealth.edu|
22380170|NCT04033991|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22380171|NCT00577720|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22380172|NCT03246672|William S Middleton Memorial Veterans Hospital|Dr. Corrine Voils|608-262-9636|corrine.voils@va.gov|
22380173|NCT03260504|University of Washington|Scott Tykodi, MD, PhD|206-606-7763|stykodi@fredhutch.org|
22380174|NCT00967018|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
22380175|NCT03542175|Memorial Sloan Kettering Cancer Center|Dr. Atif Khan, MD|848-225-6334|khana7@mskcc.org|
22380176|NCT05868954|Wake Forest University Health Sciences|Julio Mateus Nino, MD, PhD|704-355-8248|julio.mateusnino@advocatehealth.org|
22380177|NCT03216902|Santen Inc|R&D Quality Manager|+1 415 268 9199|clinicaltrials@santen.com|
22380178|NCT01381952|Karolinska University Hospital|Dr. Söderman|+46851774037|michael.soderman@karolinska.se|
22380179|NCT01850082|VA Boston Healthcare System|Marco Zenati, M.D.|857-203-6815|Marco.Zenati@va.gov|
22380180|NCT01680458|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22380181|NCT02138747|Astellas Pharma US, Inc.|Clinical Trial Disclosure||Astellas.resultsdisclosure@astellas.com|
22380182|NCT02302066|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22380183|NCT00183443|Stanford University|Dr. Patricia Suppes|6504935000|tsuppes@Stanford.edu|62567
22380184|NCT03777865|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22380185|NCT04793464|University of Oregon|Dr. Leslie Leve|541-346-9528|leve@uoregon.edu|
22380186|NCT00401102|Iona College|Dr. Colleen Jacobsonn|646-207-3563|cjacobson@iona.edu|
22380187|NCT00405704|UNC Chapel Hill|Dr. Myra Carpenter, Senior Investigator|919-962-3245|myra_carpenter@unc.edu|
22380188|NCT02696902|MedImmune, LLC|Mark Esser|+1 301 3986849|information.center@astrazeneca.com|
22380189|NCT02452866|Symbiomix Therapeutics|VP Clinical Operations|609-722-7250|nadetoro@symbiomix.com|112
22380190|NCT00762021|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22380191|NCT00845871|Novartis pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22380192|NCT01857622|Daiichi Sankyo.,LTD|Kenichi Sakakura, Manager|81-90-1885-0271|sakakura.kenichi.ef@daiichisankyo.co.jp|
22380193|NCT03729024|RxSight|Jeffrey Ha, Senior Director of Clinical Research|949-521-7870|jha@rxsight.com|
22380194|NCT03380780|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22380195|NCT01291225|Center for Injury Research and Policy|Dr. Gary Smith|614-355-5850|Gary.Smith@Nationwidechildrens.org|
22380196|NCT01734434|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22380197|NCT00867490|Novartis Pharmaceuticals|Study Director|862 778-8300||
22380198|NCT02406261|Eli Lilly and Company|Chief Medical Officer|800-545-5079||
22380199|NCT01567163|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22439924|NCT01056822|Pharmaceuticals|Novartis|+1 (862) 778-8300||
22380200|NCT02571439|Maimonides Medical Center|Dr Kalpana Tyagaraj|7182836000|KTyagaraj@maimonidesmed.org|
22380201|NCT02501135|Nationwide Children's Hospital|Clinical Research Coordinator|6147222997|heather.dellinger@nationwidechildrens.org|
22380202|NCT00393094|National Cancer Institute, National Institutes of Health|Howard A. Fine, M.D.|301-402-6383|hfine@mail.nih.gov|
22380203|NCT02019602|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22380204|NCT00780442|Medical University of South Carolina|Dr. Kimber L. Price|843-792-4847|pricekl@musc.edu|
22380205|NCT03207711|University of California, San Francisco|Frederick Hecht, MD|(415) 353-9743|rick.hecht@ucsf.edu|
22380206|NCT01600950|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22380207|NCT02372058|Albert Einstein Medical Center located in Philadelphia, Pennsylvania, USA|Dr. David L. Schutzman|215-456-6698|schutzmand@einstein.edu|
22380208|NCT00549822|Massachusetts General Hospital|Dr. Paul Goss|617-724-3118|pgoss@mgh.harvard.edu|
22380209|NCT00658736|Cleveland Clinic|Dr. Tyler Stevens|216 445-1996|stevent@ccf.org|
22380210|NCT02788006|Fédération Francophone de Cancérologie Digestive|Karine Le Malicot|+33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
22380211|NCT00318149|GlaxoSmithKline|GSK Response Center|866-435-7343||
22380212|NCT00570258|University of Arkansas for Medical Sciences|Beth Scanlan|501-686-8274|bscanlan@uams.edu|
22380213|NCT03541642|Temple University|Dr. Sarah Bass|215-204-5110|sbass@temple.edu|
22380214|NCT02682563|AmsterdamUMC|Erik van Bommel|+31 20 444 2264|e.vanbommel@amsterdamumc.nl|
22380215|NCT03088137|IVFarma LLC|Mikhail Polzikov (PhD)|+74996455342|mikhail.polzikov@ivfarma.ru|1
22380216|NCT03050398|Novartis Pharmaceuticals|Study Director|888-669-6682|Novartis.email@novartis.com|
22380217|NCT05108649|University of Pennsylvania|Valentina Goren, MRA Project Manager|215-746-3602|vsoup@pennmedicine.upenn.edu|
22380218|NCT03523871|NYU Langone Health|Luis Angel, MD|646-501-0119|Luis.Angel@nyulangone.org|
22380219|NCT01083160|Abbott|Global Medical Services|1-800-633-9110||
22380220|NCT00918749|Warner Chilcott|Grexan Wulff, Manager, Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22380221|NCT01951092|Alpert Medical School of Brown University/The Miriam Hospital|Aadia Rana, MD|401-793-4680|arana@lifespan.org|
22380222|NCT01712789|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22380223|NCT00219141|Novartis Pharmaceuticals|Study Director|862 778-8300||
22380224|NCT00972179|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22380225|NCT03055832|TearFilm Innovations, Inc.|Rob Thornhill|844-458-9776|rthornhill@tearfilm.com|
22380226|NCT00136916|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22380227|NCT01991197|Clinical Research Centre, St Vincent's University Hospital, Dublin, Ireland|Dr Maeve Lynch||maeve.lynch2@hse.ie|
22380228|NCT01012973|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22380229|NCT01932996|University of Minnesota|Rebekah Pratt|612-625-1196|rjpratt@umn.edu|
22380230|NCT02923895|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22380231|NCT00846742|St. Jude Children's Research Hospital|Matt Ehrhardt, MD, MS|(901) 595-5913|matt.ehrhardt@stjude.org|
22380232|NCT03051997|Medcial University of South Carolina|Professor|843-876-1840|cunninpb@musc.edu|
22380233|NCT02341144|Johns Hopkins All Children's Hospital|Nicole Chandler|7277674170|nicole.chandler@jhmi.edu|727
22380234|NCT01435798|Translational Pain Research, Brigham and Women's Hospital|Christine N. Sang, MD, MPH|617-525-7246|paintrials@partners.org|
22380235|NCT01586000|Premier Research|Kimberly Myer, Sr. Program Director, NIH|984-238-1297|Kimberly.Myer@premier-research.com|
22380236|NCT03257995|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22380237|NCT03228017|NYU Langone|Dr. Michael Garshick|212-263-0855|michael.garshick@nyulangone.org|
22380238|NCT02969031|Dana-Farber Cancer Institute|Julie Goldman|617-632-5563|Julie_Goldman@dfci.harvard.edu|
22380239|NCT04170296|Endo Pharmaceuticals|David Hernandez, MD|800-462-3636|clinicaltrials@endo.com|
22380240|NCT03567993|UMass Chan Medical School|Dr. Rajani Sadasivam|508-456-8923|rajani.sadasivam@umassmed.edu|
22380241|NCT01378520|Dartmouth-Hitchcock|Donald A. Mahler, M.D.|603 650-5533|Donald.a.mahler@hitchcock.org|
22380242|NCT00547105|UT Southwestern Medical Center|Director of Clinical Trial||ClinicalTrials@utsouthwestern.edu|
22380243|NCT00903786|Eisai Inc.|Eisai Medical Services Inc.|1-888-422-4743|esi_medinfo@eisai.com|
22380244|NCT02285595|Sonendo, Inc.|Director of Clinical Research|9496678036|clinical@sonendo.com|
22380245|NCT01960790|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22380246|NCT01374802|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22380247|NCT04318093|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22380248|NCT01370603|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22380249|NCT02133924|Icahn School of Medicine at Mount Sinai|Dr. John Levine|212-241-3429|john.levine@mssm.edu|
22380250|NCT02413190|Kennedy Krieger Institute|Dr. Kathryn Wagner|443-923-9525|wagnerk@kennedykrieger.org|
22380251|NCT01644474|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22380252|NCT00050089|VAMC Bronx|Dr. Sheldon Brown|(718) 584-9000|sheldon.brown@va.gov|6666
22380253|NCT04039503|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22380254|NCT01097460|Merrimack Pharmaceuticals|Dr. Victor Moyo|1-617-441-1094|vmoyo@merrimackpharma.com|
22380255|NCT01163747|Hoffman-LaRoche|Medical Communications|800-821-8590||
22380256|NCT01823614|Central Research Institute for Epidemiology|Dmitry Kireev|+74959749646|dmitry.kireev@pcr.ru|2227
22380257|NCT02044458|Aurora Health Care, Inc.|Jessica J F Kram, MPH|414-219-5594|jessica.kram@aurora.org|
22380258|NCT02218203|Translational Pain Research, Brigham and Women's Hospital|Christine N. Sang, MD, MPH|617-525-7246|paintrials@partners.org|
22380259|NCT01919996|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22380260|NCT02924389|Emory University|Cecile Lahiri, MD|404-616-6306|cdelill@emory.edu|
22380261|NCT05567952|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22380262|NCT05220501|Sunnybrook Health Sciences Centre|Dr. Laurence Klotz|+1. 416 480 4673|Laurence.Klotz@sunnybrook.ca|
22380263|NCT02692235|AWFiS|Robert Olek|+48 58 5547392|robol@awf.gda.pl|
22380264|NCT00802841|Novartis|Study Director|862-778-1873||
22380265|NCT01268059|MedImmune, LLC|Mohammed Dar, MD, Vice President & Head, Clinical Development, Oncology|+1 301-398-0000|information.center@astrazeneca.com|
22380266|NCT03660943|Centrexion Therapeutics, Inc.|Director of Clinical Operations|617-837-6911|info@centrexion.com|
22380267|NCT03699124|Bavarian Nordic A/S|Bavarian Nordic Call Center|1-844-422-8274|medical.information_us@bavarian-nordic.com|
22380268|NCT03294213|Ambu A/S|Anna Lundgaard|+4529643748|aclu@ambu.com|
22380269|NCT04411940|Cycle Pharmaceuticals|Head of Global Regulatory Affairs & Clinical Development|+441223803635|claudia.percivalle@cyclepharma.com|
22380270|NCT00472186|Dupage Chidlren's ENT & Allergy|Manali Amin, MD|630-785-0367|manali.amin@gmail.com|
22380271|NCT00997243|Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center|Alison Walker, MD|614-293-3196|Alison.Walker@osumc.edu|
22380272|NCT02472314|Wayne State University School of Medicine and Cleveland Clinic Florida|Vani J. Sabesan, MD|131375138489|sabes001@gmail.com|
22380273|NCT05794997|Brigham and Women's Hospital|Rishi J Desai, PhD|6172780932|rdesai@bwh.harvard.edu|
22380274|NCT02086552|Mayo Clinic|Francis K Buadi, MD|507/284-2511|Kumar.Shaji@mayo.edu|
22380275|NCT05641077|Cleveland Clinic|Lannah Lua-Mailland|216-314-2163|lual@ccf.org|
22380276|NCT00724061|Northwestern University|Dr. Timothy Kuzel|312-695-6180|cancertrials@northwestern.edu|
22380277|NCT04655313|Arcutis Biotherapeutics|Arcutis Medical Information|+1 (844) 692-6729|medinfo@arcutis.com|
22380278|NCT03781960|University of Pennsylvania Hospital|Thomas Karasic, MD|215-614-1858|thomas.karasic@pennmedicine.upenn.edu|
22380279|NCT00594932|Oklahoma Medical Research Foundation|Joan T Merrill M.D.|405 271 7805|joan-merrill@omrf.org|
22380280|NCT01536145|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22380281|NCT02444234|University of Southern California|Paul M Beringer, Pharm.D.|323-442-1402|beringer@usc.edu|
22380282|NCT00688259|VA Greater Los Angeles Healthcare System at West Los Angeles|Shirley M. Glynn, Ph.D.|3102683939|shirley.glynn@va.gov|
22380283|NCT02162992|H. Germans Trias i Pujol|Dr. Roger Villuendas|+34 4978398|rogervilluendas@hotmail.com|
22380284|NCT02982720|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317.921.2050|jsmith@hoosiercancer.org|
22380285|NCT02144519|University of South Carolina|Michael W Beets|8037773003|beets@mailbox.sc.edu|
22380286|NCT02343575|Stanford University|Yelizaveta Sher, MD|650-736-0459|ysher@stanford.edu|
22380287|NCT01734850|CSL Behring|Trial Registration Coordinator|484-878-4000|clinicaltrials@cslbehring.com|
22380288|NCT03824938|Columbia University Irving Medical Center|Victoria M. Leavitt, MD|212-342-1351|vl3227@cumc.columbia.edu|
22380289|NCT05126459|Loma Linda University Health|Dr. Jung-Wei Chen|909 558 1000|JWChen@llu.edu|
22380290|NCT00287469|Armed Forces Research Institute of Medical Services|Mrigendra P. Shrestha MD|662-644-4888|shrestham@afrims.org|
22380291|NCT01058863|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22380292|NCT00681187|Ipsen|Medical Director, Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22380293|NCT03653416|Icahn School of Medicine at Mount Sinai|Poonam Pai B. H|347-569-4816|poonam.paibantwalhebbalasankatte@mountsinai.org|
22380294|NCT03619174|Viveve|Vice President, Clinical & Medical Affairs|720-696-8173|clinicalaffairs@viveve.com|
22380295|NCT03190083|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Nidhi Sharma|+1 216-444-9014|sharman2@ccf.org|
22380296|NCT01872949|CHF Solutions, Inc.|Audrey Singh|952-345-4217|audrey.singh@chf-solutions.com|
22380297|NCT01556763|EnVivo Pharmaceuticals, Inc.|Maria Gawryl, Ph.D., Vice President, Regulatory Affairs & Drug Development|617-225-4264|mgawryl@envivopharma.com|
22380298|NCT02258464|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22380299|NCT00932646|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22380300|NCT00776100|Mayo Clinic|Steven E. Schild, M.D.|507-538-1760|sschild@mayo.edu|
22380301|NCT03786094|Spexis AG|Christian Zwingelstein|+41 61 567 16 00|info@spexisbio.com|
22380302|NCT05480722|University of Delaware|William B Farquhar|302-831-6168|wbf@udel.edu|
22380303|NCT04759885|NTC srl|Alessandro Colombo|+390243850490|alessandro.colombo@ntcpharma.com|
22380304|NCT00195715|Abbott|Global Medical Services|1-800-633-9110||
22380305|NCT03844321|Massachusetts General Hospital|Andrew Nierenberg|617-512-2641|anierenberg@mgh.harvard.edu|
22380306|NCT03421496|Radius Health|Bruce Mitlak, MD; Head of Discovery Science and Chief Medical Officer|617-444-1943|bmitlak@radiuspharm.com|
22380307|NCT05822921|Virginia Tech|Dr. Angela Scarpa|540-231-2615|ascarpa@vt.edu|
22380308|NCT01414426|UChicago|Dr. Alexander Pearson|855-702-8222|apearson5@medicine.bsd.uchicago.edu|
22380309|NCT01267253|NRG Oncology|Linda Gedeon for Wei Deng,PhD|716-845-1169|lgedeon@gogstats.org|
22380310|NCT00996580|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22380311|NCT00064025|Gynecologic Oncology Group Statistical and Data Center|Jessalyn Reboy|716-845-7738|reboyj@norgoncology.org|
22380312|NCT02468934|SPR Therapeautics|Clinical Affairs|216-378-9108|support@SPRTherapeutics.com|
22380313|NCT02397265|Imperial College London|Nick Oliver|020 7594 2460|nick.oliver@imperial.ac.uk|
22380314|NCT01234766|Dartmouth-Hitchcock Medical Center|Frederick Lansigan, MD|603-650-4628|Frederick.Lansigan@hitchcock.org|
22380315|NCT02036515|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22380316|NCT00518713|Lundbeck LLC|Email contact via H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
22380317|NCT01515345|Kaiser Franz Josef Hospital|Univ.Prof. Dr Günter Christ|+43160191|guenter.christ@wienkav.at|2508
22380318|NCT02218489|Kala Pharmaceuticals, Inc|VP, Clinical Development|781-996-5252|Results003@kalarx.com|
22380319|NCT00547911|National Institutes of Health|Dr. David Goldstein|301-496-1115|goldsteind@ninds.nih.gov|
22380320|NCT02601937|Epizyme, Inc.|Medical Lead or Designee|(855) 500-1011|clinicaltrials@epizyme.com|
22380321|NCT04145349|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22380322|NCT02385721|Boryung Pharmaceutical Co., Ltd|Myung Sook Hong|82-2-708-8238|mshong@boryung.co.kr|
22380323|NCT03280563|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22380324|NCT03038672|Mayo Clinic|Stephen Ansell|(507)284-5096|ansell.stephen@mayo.edu|
22380325|NCT04423393|Vir Biotechnology, Inc.|Study Inquiry|(415) 906-4324|clinicaltrials@vir.bio|
22380326|NCT00432159|Depuy Synthes|Lynn Wilson|508-880-8109|lwilso45@its.jnj.com|
22380327|NCT05160025|Rutgers University|Dr. John Palmieri, Study Coordinator|9733562378|john.palmieri@rutgers.edu|
22380328|NCT01929993|Fundação Oswaldo Cruz|Dr Fábio Russomano|55 21 25541815|fabiorussomano@gmail.com|
22411585|NCT00760383|Human Physiology, University of Oregon|Hans C. Dreyer, PT, PhD|541-346-5775|hcdreyer@uoregon.edu|
22380329|NCT00107380|SWOG Statistical Center|Study Statistician|206-667-4623||
22380330|NCT03673098|Massachusetts General Hospital|Dr. Christina Psaros|617-726-7458|cpsaros@mgh.harvard.edu|
22380331|NCT03850444|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22380332|NCT03595683|University of Chicago|Dr. Randy Sweis|773-834-3094|rsweis@uchicago.edu|
22380333|NCT01021878|Pontifícia Universidade Católica do Paraná|Dr. Roberto Pecoits-Filho and Dr. Thyago P. Moraes|554132713150|r.pecoits@pucpr.br|
22380334|NCT04569058|Massachusetts General Hospital|T. Atilla Ceranoglu, MD|617-726-1291|aceranoglu@mgh.harvard.edu|
22380335|NCT03158948|INOTREM SA|Executive VP Research and Medical Sciences|30 62 86 51|jjg@inotrem.com|+33 (0)6
22380336|NCT02774265|University of Maryland Medical Center|Dr. Bryce Haac|410-328-3495|bhaac@som.umaryland.edu|
22380337|NCT03468426|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22380338|NCT03123263|TTUHSC-El Paso|Sumit Gaur|9152155200|sumit.gaur@ttuhsc.edu|
22380339|NCT05876351|European Clinical Trial Information|Alexion Pharmaceuticals Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
22380340|NCT03415022|New York State Psychiatric Institue|Dr. Franklin Schneier|646-774-8041|Franklin.Schneier@nyspi.columbia.edu|
22380341|NCT02206152|University of Minenesota|Elizabeth Seaquist, MD|612-624-9176|chape044@umn.edu|
22380342|NCT00478608|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22380343|NCT01349907|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22380344|NCT04963764|Ann & Robert H. Lurie Children's Hospital of Chicago|Dr. Todd Florin|312-227-6080|edpneumoniaresearch@luriechildrens.org|
22380345|NCT00344370|Kowa Research Institute|Bill Arana|919 433-1600|barana@kowaus.com|
22380346|NCT03226457|University of Dundee|Dr Natalie Mordi (Principle Investigator)|+ 44 (0) 1382 383 667|n.a.mordi@dundee.ac.uk|
22380347|NCT03583541|Washington University in St. Louis|Fred Ssewamala|3149358521|fms1@wustl.edu|
22380348|NCT00884286|Pharma Mar, S.A.|Clinical Development Department of PharmaMar´s Oncology,Business Unit.,|+34 918466000|clinicaltrials@pharmamar.com|
22380349|NCT04463615|City of Hope Medical Center|Dr. Christiane Querfeld|6263598111|cquerfeld@coh.org|
22380350|NCT00088205|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22380351|NCT05199233|Mayo Clinic Rochester|Dr. Ivana T. Croghan|507 284-2511|gimresearchstudies@mayo.edu|
22380352|NCT00736073|DUMC|Dr. Martin Poleski|9196841817|martin.poleski@dm.duke.edu|
22380353|NCT02563834|Indiana University|Dr. Kieren J Mather|317-278-7826|kmather@iu.edu|
22380354|NCT02491892|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22380355|NCT00065468|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22380356|NCT02117544|Alcon Research, Ltd|Clinical Project Lead, Vision Care, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
22380357|NCT00792428|Beth Israel Deaconess Medical Center|Gottfried Schlaug, MD, PhD|617-632-8917|gschlaug@bidmc.harvard.edu|
22380358|NCT03553940|Saint Louis University|Daniel F. Hoft, MD, PhD|314-977-5500|daniel.hoft@health.slu.edu|
22380359|NCT00231894|Nathan Kline Institute ofr Psychiatric research|Robert C. Smith MD|845-398-6531|rsmith@nki.rfmh.org|
22380360|NCT04675242|Nicox Ophthalmics, Inc.|Doug Hubatsch|832-360-3022|hubatsch@nicox.com|
22380361|NCT02448719|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22411586|NCT01336894|Boston Medical Center|Hiran C. Fernando, MD|617-638-5600|hiran.fernando@bmc.org|
22411587|NCT05034731|Advanced Bionics|Ankur Kaushal, VP of Global Regulatory Affairs|6613621400|clinicalresearch@advancedbionics.com|
22411588|NCT00868309|Instituto Bioclon S.A. de C.V.|Walter Garcia|+52 (55)54883700|wgarcia@silanes.com.mx|3785
22411589|NCT00963157|Group Health Research Institute|Lisa Jackson, MD, MPH|206-442-5216||
22380362|NCT02410161|Université de Sherbrooke|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
22411590|NCT01725451|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22380363|NCT04707391|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22380364|NCT01848834|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22380365|NCT01342029|Cedars-Sinai Medical Center|C.Noel Bairey Merz, MD|310-423-9680|merz@cshs.org|
22380366|NCT01406717|SPIL|Clinical Trials|912266455645|clinical.trials@sparcmail.com|
22380367|NCT02040090|Kamada|Eran Schenker, VP Medical Director|+972-8-9406472|Erans@kamada.com|
22380368|NCT02554435|California State Polytechnic University, Pomona|Dr. Zakkoyya Lewis|5628819950|drkoyyalewis@gmail.com|
22380369|NCT02275533|University of Chicago|Theodore Karrison|708-925-6771|tkarrison@health.bsd.uchicago.edu|
22380370|NCT01570868|The University of Texas (UT) MD Anderson Cancer Center|Jorge Cortes, MD/Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
22380371|NCT03370276|Moffitt Cancer Center|Christine Chung, MD|813-745-5061|Christine.Chung@moffitt.org|
22380372|NCT01614574|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22380373|NCT02875561|University of Colorado|Dr. Saketh Guntupalli|303-724-2024|saketh.guntupalli@cuanschutz.edu|
22380374|NCT01168674|Tufts Medical Center|Dr. Nassir Ghaemi|6176365735|nghaemi@tuftsmedicalcenter.org|
22380375|NCT02584855|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22380376|NCT00653263|UArkansas|Michael J Mancino|501-526-8442|mjmancino@uams.edu|
22380377|NCT00895843|University of Manchester|Mr Sin L Yong|01612756806|sin.l.yong@manchester.ac.uk|
22380378|NCT02611830|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22380379|NCT02329600|Faculty of Oral and Dental Medicine Cairo University|Dr. Noha Ayman Ghallab|+201005263365|noha.ghallab@dentistry.cu.edu.eg|
22380380|NCT03687450|Brigham and Women's Hospital|Julia Loewenthal, MD|6177325500|jloewenthal@bwh.harvard.edu|
22380381|NCT04963062|University of Wisconsin School of Medicine and Public Health|Shuang Li|608.263.8336|lis@urology.wisc.edu|
22380382|NCT03997851|University of Miami|Leigh Nattkemper|3055889734|Lxn202@med.miami.edu|
22380383|NCT01518257|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22380384|NCT03985098|University of Houston|Susan Abughosh|832-842-8395|smabughosh@uh.edu|
22380385|NCT02708641|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR, Regulatory Supervisor, CRS|412-647-5554|stadtermanbm@upmc.edu|
22380386|NCT01155726|Alcon Research|Director of Clinical Trials|1-800-241-7629||
22380387|NCT02054247|Eskisehir Osmangazi University|Dr. Onur Armagan|00902222392979|dronurarmagan@hotmail.com|
22380388|NCT05257837|The Ohio State University|Dr. Brad Bushman|614-688-8779|bushman.20@osu.edu|
22380389|NCT01330043|Stanford University|Dr. Sean P. David|401-265-2275|spdavid@stanford.edu|
22380390|NCT05675709|Oregon Health & Science University|Susan Flocke|503 494 4404|fmresrch@ohsu.edu|
22380391|NCT04758403|BIDMC|Adnan Majid|617-632-8386|tsipresearchstaff@bidmc.harvard.edu|
22380392|NCT01033773|MedStar Health Research Institute|Dr Michelle Magee|2028772383|michelle.f.magee@medstar.net|
22380393|NCT01254565|Amgen, Inc|Study Director|866-572-6436||
22380394|NCT02367014|Stealth BioTherapeutics Inc.|Jim Carr PharmD Chief Clinical Development Officer|617-600-6888|jim.carr@stealthbt.com|
22380395|NCT02726399|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian, MD|646-888-4186|janjigiy@mskcc.org|
22380396|NCT01300559|Duke University Medical Center|Steven E. Hill, M.D.|681-6614|hill0012@mc.duke.edu|
22380397|NCT01440049|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22380398|NCT02268552|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22380399|NCT00447330|Duke University Medical Center|Brant Hamel|919-668-1861|brant.hamel@duke.edu|
22380400|NCT04168385|Mirum Pharmaceuticals, Inc.|Mirum Clinical Trials|16506674085|medinfo@mirumpharma.com|
22380401|NCT02139982|The Second Affiliated Hospital & Yuying Children hospital of Wenzhou Medical University|Dr. Ting Li|008613587876896|liting1021@aliyun.com|
22380402|NCT02971891|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
22380403|NCT02748512|Axiom|Kelley Collins-Winters, RTR, BS, MBA|469-667-6655|kelleyc@axiom.cc|
22380404|NCT00787943|Northwestern University|Amy Paller, MD|312-695-3721|apaller@northwestern.edu|
22380405|NCT04990687|UAB|Samantha White|205-934-1989|swwhite@uabmc.edu|
22380406|NCT02900781|Texas Tech University Health Sciences Center|Nancy Swinford CCRC|8067432569|nancy.swinford@ttuhsc.edu|
22380407|NCT01754779|UT Southwestern Medical Center|Dr. Naim Maalouf|214/648-2954|naim.maalouf@utsouthwestern.edu|
22380408|NCT05818540|Bleep, LLC|Stuart Heathington|919-619-7170|stuart@bleepsleep.com|
22380409|NCT02339389|Brigham and Women's Hospital|Bhavani Kodali|6175258449|bkodali@partners.org|
22380410|NCT01196104|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
22380411|NCT01041508|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
22380412|NCT00409240|Providence VAMC|Wen-Chih Wu, MD|401-273-7100|wen-chih.wu@va.gov|6237
22380413|NCT01094171|GlaxoSmithKline|GSK Response Center|866-435-7343||
22380414|NCT01310868|University College London|GALA-5 Trial Coorinator|0207 679 9898|ctc.sponsor@ucl.ac.uk|
22380415|NCT04496167|Endo Pharmaceuticals|Clinical Operations|800-462-3636|clinicaltrials@endo.com|
22380416|NCT00598481|Fondazione Telethon|Fondazione Telethon||cvezzali@telethon.it|
22380417|NCT04612049|University of Montreal|Dr Danielle Levac|5148639108|danielle.levac@umontreal.ca|
22380418|NCT01708187|Orthopedic Foot and Ankle Center|Gregory Berlet, MD|614-895-8747|ofacresearch@orthofootankle.com|
22380419|NCT02501759|OHSU Knight Cancer Institute|Fegus Coakley|503-494-2333|coakleyf@ohsu.edu|
22380420|NCT02408549|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22380421|NCT02025205|Pulmonx|Narinder Shargill, Vice President, Global Medical and Clinical Affairs|650-216-0108|nshargill@pulmonx.com|
22380422|NCT01833117|Alcon Research, Ltd.|Michela Montecchi-Palmer, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22380423|NCT01232556|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22380424|NCT04172987|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22380425|NCT03020095|Ascletis Pharmaceticals Co., Ltd|Clinical Trial Disclosures|86057187707910|xin.li@ascletis.com|
22380426|NCT03785340|Ocugen|Vijay Tammara, VP, Strategic regulatory Operations|484-328-4751|Vijay.tammara@ocugen.com|
22380427|NCT02500316|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
22380428|NCT02337478|Wake Forest University Health Sciences|Timothy Pardee, MD, Ph.D.|336-716-5440|tpardee@wakehealth.edu|
22380429|NCT04374500|Umeå University, Umeå, Sweden|Stefan Söderberg|+46 70 319 38 03|stefan.soderberg@umu.se|
22380430|NCT01607411|GlaxoSmithKline|GSK Response Center|866-435-7343||
22380431|NCT01513967|Regenera Pharma Ltd|Dr Konstatin Adamsky|+972 8 9316306|kostia@Regenerapharma.com|
22380432|NCT01987830|Massachusetts General Hospital|Dr. Elizabeth Gerstner|(617) 726-2000|EGERSTNER@mgh.harvard.edu|
22380433|NCT05294419|Genomics Ltd|Seamus Harrison|+44 1865 981600|seamus.harrison@genomics.com|
22380434|NCT00544544|McLean Hospital|Brian P. Brennan, M.D.|617-855-2911|bbrennan@partners.org|
22380435|NCT02076074|Washington University School of Medicine|Imran Zoberi, M.D.|314-362-8610|izoberi@wustl.edu|
22380436|NCT03277378|Abbott|Robyn Capobianco, PhD|+1 512 286 4274|robyn.capobianco@abbott.com|
22380437|NCT00442286|CVRx|Vice President of Clinical Research|763-416-2876|lgalle@cvrx.com|
22380438|NCT05221749|Alexandria University|Nour Ammar|4868066|nour.ammar@alexu.edu.eg|201
22380439|NCT03428815|University of Pittsburgh|Dr. Goeran Fiedler|14126246475|gfiedler@pitt.edu|
22380440|NCT02102464|TearScience, Inc.|VP Clinical and Regulatory Affairs|919-467-4007|regulatory@tearscience.com|
22380441|NCT01700348|Philips Oral Healthcare, Inc|Marcia Delaurenti, Clinical Project Manager|425-908-1212|marcia.delaurenti@philips.com|
22380442|NCT01053637|BAYLOR COLLEGE OF MEDICINE|Corrie E. Chumpitazi|832 824-1353|corriec@bcm.edu|
22380443|NCT04140890|Wayne State University|Dr. Yi-Ling Hu|3142039991|ha1124@wayne.edu|
22380444|NCT02404493|Johnson & Johnson Consumer, Inc|Amisha Parikh-Das, PhD/Study Director|973-255-8701 USA EST|AParikh1@its.jnj.com|
22380445|NCT02388074|bioAffinity Technologies Inc.|Bijal Karia, PhD Director of Research|2107485287|bk@bioaffinitytech.com|
22380446|NCT00915902|Nemours Alfred I. duPont Hospital for Children|Research Coordinator|302-651-6686|cprosper@nemours.org|
22380447|NCT01778062|Novartis Pharmaceuticals|Study Director|862-778-8300||
22380448|NCT00950937|Hospital de Clínicas de Porto Alegre|Pedro Dall'Ago|555133038751|pdallago@pq.cnpq.br|
22380449|NCT03958630|National Institute of Mental Health|Innis, Robert|+1 301 594 1368|robert.innis@nih.gov|
22380450|NCT01736358|Montefiore Medical Center|Dr.David Hoenig||dhoenig@montefiore.org|
22380451|NCT02413684|Duke Asthma, Airway and Allergy Center|Njira Lugogo|919-613-5707|njira.lugogo@duke.edu|
22380452|NCT04701593|Virginia Tech|Dr Vishak John|(540) 855-5100|vishakjohn@vt.edu|
22380453|NCT03317379|New York State Psychiatric Institute|Lisa Ranzenhofer, PhD|240 671 9040|lr2840@cumc.columbia.edu|
22380454|NCT04157686|Medytox Inc.|Young Ryu|+82-2-6901-5424|aab005@medytox.com|
22380455|NCT04445155|University of South Florida|Dr. Ukamaka Oruche|813-396-2524|orucheu@usf.edu|
22380456|NCT02018315|University of Texas Southwestern Medical Center|Juan Pascual, M.D., Ph.D.|214-648-3550|juan.pascual@utsouthwestern.edu|
22380457|NCT04191135|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22380458|NCT02107274|Ministry of Health of Malaysia|Dr. Albert Iruthiaraj L. Anthony|+60174633410|albert5409@yahoo.com|
22380459|NCT03251144|University of California Los Angeles|Theodoros Kelesidis|3108257875|tkelesidis@mednet.ucla.edu|
22380460|NCT05305040|AlloVir, Inc.|Kevin Anderson|617-433-2605|kanderson@allovir.com|
22380461|NCT02206685|Baylor College of Medicine|Kim P. Nguyen, MD, Principal Investigator|832-824-5907|kpnguyen@texaschildrens.org|
22380462|NCT01195675|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22380463|NCT02424344|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
22380464|NCT04730947|Mayo Clinic|Dr. Barry A. Borlaug|507-293-2762|borlaug.barry@mayo.edu|
22380465|NCT01174550|Duke University Medical Center|Dr. Pamela Douglas|919-668-8700|pamela.douglas@duke.edu|
22380466|NCT02123966|Dana-Farber Cancer Institute|Nathaniel S. Treister, DMD, DMSc|617-632-2806|ntreister@partners.org|
22380467|NCT01536262|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22380468|NCT00412516|PATH|Anthony A Marfin, Director Japanese Encephalitis Vaccine Introduction and Sustainability Project|2062853500|aamarfin@path.org|
22380469|NCT01460381|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22380470|NCT01097655|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
22380471|NCT02561455|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
22380472|NCT03639675|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
22380473|NCT01021332|Astellas Pharma Europe B.V.|Medical Director, Global Medical Science||astellas.resultsdisclosure@astellas.com|
22380474|NCT00826280|Astellas Pharma Global Development|Senior Medical Director||clinicaltrials@us.astellas.com|
22380475|NCT04731714|Washington University School of Medicine|Kevin J. Black, M.D.|314-362-5041|kevin@wustl.edu|
22380476|NCT05343455|Journey Medical Corporation|Dr. Srinivas Sidgiddi|9084585362|ssidgiddi@jmcderm.com|
22380477|NCT02307916|Massachusetts Eye and Ear|Dr. Brad Welling|617-573-4075|brad_welling@meei.harvard.edu|
22380478|NCT03354637|Aclaris Therapeutics, Inc.|Marco Cardillo, Clinical Trial Manager|484-540-6299|mcardillo@aclaristx.com|
22380479|NCT04006366|Perelman School of Medicine at the University of Pennsylvania|Kelly C. Allison, PhD|2158982823|kca@pennmedicine.upenn.edu|
22380480|NCT02033993|Canadian Cancer Trials Group|Dr. Wendy Parulekar|613-533-6430|wparulekar@ctg.queenus.ca|
22380481|NCT01123161|Cedars-Sinai Medical Center|Dr. Patrick Lyden|310-423-5166|lydenp@cshs.org|
22380482|NCT00873093|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22380483|NCT00788255|Stanford University School of Medicine|Dr. Alexander Butwick|(650) 736-8513|ajbut@stanford.edu|
22380484|NCT01152554|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22380485|NCT01008722|University of California, San Diego|Dr. Sanjiv Narayan (Professor of Medicine, Principal Investigator)|(650) 498-8161|sanjiv1@stanford.edu|
22380486|NCT00146640|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center,|496151725200|service@merckgroup.com|
22380487|NCT03486899|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22380488|NCT01439711|Duke University Medical Center|E. Shelley Hwang MD MPH|919-684-6849|shelley.hwang@duke.edu|
22380489|NCT04242875|Carolina Eyecare Physicians|Director of Research|8438813937|hsandoval@cepmd.com|
22380490|NCT02397460|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22380491|NCT02511561|Otonomy|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
22380492|NCT01723826|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22380493|NCT01767129|Avanir Pharmaceuticals|Avanir Medical Information|855-572-2722|medinfo@avanir.com|
22380494|NCT01146808|Columbia University Medical Center|Robert S. Brown Jr., MD, MPH|(212) 305-3839|tt2103@columbia.edu|
22380495|NCT02225275|The University of Texas MD Anderson Cancer Center|Dr. Alessandra Ferrajoli MD/ Professor|173-792-2063|aferrajo@mdanderson.org|
22380496|NCT00597870|Lundquist Institute of BioMedical Studies|Rodney A. White, MD|3109635230|rawhite@ucla.edu|
22380497|NCT01603121|Eastern Virginia Medical School|Dr. David Lieb, Principal Investigator|7574465910|liebdc@evms.edu|
22380498|NCT00738530|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22380499|NCT01656759|Rush University|Sean Kearns|708-236-2664|sean_m_kearns@rush.edu|
22380500|NCT01628510|Washington University|Roberta Pineda|314-286-1304|pineda_r@kids.wustl.edu|
22380501|NCT04179461|Cincinnati Children's Hospital Medical Center|Theresa Guilbert, MD, MS|(513) 636-6771|Theresa.Guilbert@cchmc.org|
22380502|NCT04374565|University of Virginia|Dr. Jeffrey Sturek|434-284-1776|JMS3HK@hscmail.mcc.virginia.edu|
22380503|NCT02859597|Montefiore Medical Center|Dr.Jay Berger|7189204316|jberger@montefiore.org|
22380504|NCT02916862|Florida International University|Cristina Palacios|3053483235|crpalaci@fiu.edu|
22380505|NCT03160079|University of California, San Diego, Moores Cancer Center|Dr. James Mangan|858-822-6600|jmangan@health.ucsd.edu|
22380506|NCT01107730|Attikon Hospital|Ioannis K. Toumpoulis|00306977243942|toumpoul@otenet.gr|
22380507|NCT00813111|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
22380508|NCT04648891|Mayo Clinic|David G. Lott, M.D.|480-342-2983|Lott.David@mayo.edu|
22380509|NCT03259373|Harvard Pilgrim Health Care|Richard Platt, MD|(617) 867-4912|Richard_Platt@harvardpilgrim.org|
22380510|NCT03262701|Loma Linda University School of Dentistry|Yoon Jeong Kim|(909) 558-4610|yjkim02d2@llu.edu|
22380511|NCT01706965|New York State Psychiatric Insititute|Marlene Carlson|646-774-8436|marlene.carlson@nyspi.columbia.edu|
22380512|NCT05764239|Synlogic|Clinical Operations|(617) 401-9975|info@synlogictx.com|
22380513|NCT03698864|Processa Pharmaceuticals|Mary G. Nyberg, VP Clinical Operations|443-776-3133|mnyberg@processapharmaceuticals.com|
22380514|NCT01591161|Bausch Health|Study Director||susan.harris@bauschhealth.com|
22380515|NCT00057811|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22380516|NCT00556374|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22380517|NCT04131907|Laborie Medical Technologies|Jill Moland|800-522-6743|jmoland@laborie.com|
22380518|NCT00847301|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22380519|NCT00641186|Baylor College of Medicine|Christine Hunter|713-798-3951|chunter@bcm.edu|
22380520|NCT02922985|University of Texas Medical Branch|Emily Hadley|4022028626|ehadley15@gmail.com|
22380521|NCT00462644|Wake Forest University, Department of Surgery|Amy N. Hildreth, MD||ahildret@gmail.com|
22380522|NCT01388543|"University of Colorado | Skaggs School of Pharmacy and Pharmaceutical Sciences"|Dr. Peter Anderson|3037246128|peter.anderson@cuanschutz.edu|
22380523|NCT03363659|Advocate Aurora Health|Manager of Oncology research|414 778 4345|karen.cheek@aah.org|
22380524|NCT00904150|Centre for Neuroscience and Trauma, Queen Mary, University of London|Professor Anne MacGregor|+44 7774 868628|e.macgregor@qmul.ac.uk|
22380525|NCT01671748|Cardiff and Vale University Health Board|Dr Judith White|02920744771|judith.white3@wales.nhs.uk|
22380526|NCT03872388|MD Anderson Cancer Center|Carlos Barcenas, MD|(713) 794-5098|chbarcenas@mdanderson.org|
22380527|NCT00394095|University of Cincinnati|Melissa DelBello, MD|513-558-4489|melissa.delbello@uc.edu|
22380528|NCT04213846|University of Washington|Christine Lee, Ph.D.|206-543-6574|leecm@uw.edu|
22380529|NCT05737550|Kontigo Care AB|Markku Hämälainen, CSO|+46 (0)76 947 3132|markku.hamalainen@kontigocare.com|
22380530|NCT01866475|Teleflex|Tatiana Puga|2104451794|tatiana.puga@teleflex.com|
22380531|NCT02823990|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
22380532|NCT01036087|UT MD Anderson Cancer Center|Dr. Naoto Ueno, Professor, Breast Medical Oncology|(713) 792-8754|nueno@mdanderson.org|
22380533|NCT03527277|University of California, Davis|Kimber Stanhope|5302190914|klstanhope@ucdavis.edu|
22380534|NCT01781611|Oklahoma Medical Research Foundation|Joan T. Merrill, M.D.|405-822-2336|joan-merrill@omrf.org|
22380535|NCT04351750|National Cheng Kung University|Dr. Kuan-Yin Lin|+88662353535|10802003@gs.ncku.edu.tw|5931
22411591|NCT00358826|Tallikut Pharmaceuticals, Inc.|Brian Cunningham, MD|312-505-0420|brian@baycitycapital.com|
22411592|NCT00283686|Emory University|Dr. Arlene Chapman|(404) 712-1993|abchapm@emory.edu|
22411593|NCT03267030|NOPHO|Dr Birgitte Klug Albertsen|+45 20224643|biralber@rm.dk|
22411594|NCT00696709|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22411595|NCT00310856|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
22411596|NCT01306253|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
22380536|NCT01333943|Hospital for Special Surgery|David H. Kim, MD|(212) 606-1206|KimD@HSS.EDU|
22380537|NCT01421771|University of New Mexico Health Sciences Center|Samiha Mateen|505-272-6057|smateen@salud.unm.edu|
22380538|NCT02091063|Columbia University|Jennifer Amengual, MD|212-305-0591|jea2149@cumc.columbia.edu|
22380539|NCT02459587|Veterans Health Administration|Dr. Mark Ilgen|7349366266|mark.ilgen@va.gov|
22380540|NCT03861728|University of Miami|Wendy Lee|305-326-6434|wlee@miami.edu|
22380541|NCT02652130|Mesoblast, Inc.|Christopher James, VP, Head of Clinical Operations|212-880-2060|Christopher.James@Mesoblast.com|7925
22380542|NCT02028884|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22380543|NCT00354029|Baerum Hospital|Ulrich J Spreng|004798499184|ulispreng@hotmail.com|
22380544|NCT05176353|University of Michigan|Owen Albin, MD|734.232.1871|oalbin@med.umich.edu|
22380545|NCT01600703|University Health Network|Dr. Gary Lewis|416-340-4270|gary.lewis@uhn.ca|
22380546|NCT02633891|BVAMC|Dr. Lindsay Zilliox|410-328-3100|lzilliox@som.umaryland.edu|
22380547|NCT00108524|Durham VAMC|William S Yancy, Jr. MD, MHSc|919-286-0411|william.yancy2@va.gov|7770
22380548|NCT04466618|Mayo Clinic|Dr Adrian Vella|5072843754|vella.adrian@mayo.edu|
22380549|NCT02800928|Yale School of Medicine|Sherry McKee PhD|203-737-3529|sherry.mckee@yale.edu|
22380550|NCT01853163|Navitas Life Sciences GmbH|Managing Director|+49 (0) 69-66 80 30-0|marty.boom@navitaslifesciences.com|
22380551|NCT01969162|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22380552|NCT02096081|Merz North America, Inc.|Michelle Widmann|919-582-8238|Michelle.Widmann@merz.com|
22380553|NCT02886728|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22380554|NCT00109928|SWOG Statistical Center|Study Statistician|206-667-4623||
22380555|NCT04830514|University of Arkansas for Medical Sciences|David D. Church, Ph.D., Assistant Professor|5015265709|dchurch@uams.edu|
22380556|NCT01364727|Stanford University Medical Center|Heather A Wakelee, MD|650-736-7221|hwakelee@stanford.edu|
22380557|NCT01676220|Sanofi|Trial Transparency Team||Contact --US@sanofi.com|
22380558|NCT02411591|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22380559|NCT00445263|SAMU 93|Pr Frédéric Lapostolle|0033148964454|frederic.lapostolle@avc.aphp.fr|
22380560|NCT00750893|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22380561|NCT01405794|University of Utah|Dr. Mark Munger|801-581-6165|mmunger@hsc.utah.edu|
22380562|NCT00305682|Masonic Cancer Center, University of Minnesota|Dr.Claudio G. Brunstein MD, PhD|612-625-3918|bruns072@umn.edu|
22380563|NCT00661258|Boston University Center for Global Health and Development|Dr. Lora Sabin|617-414-1272|lsabin@bu.edu|
22380564|NCT01628874|Children's Hospital Colorado|Dr. Ryan Caltagirone|303-521-8563|ryan.caltagirone@childrenscolorado.org|
22380565|NCT01473420|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22380566|NCT02760862|Ain-Shams University Hospitals|Dr. Ibrahim Mamdouh Esmat|01001241928|ibrahim_mamdouh@med.asu.edu.eg|
22380567|NCT03171168|Montefiore Medical Center|Matthew Bartels|(914) 597-2332|MBARTELS@montefiore.org|
22380568|NCT00670982|Dana-Farber Cancer Institute|Harold J. Burstein, MD|617-632-2335|hal_burstein@dfci.harvard.edu|
22380569|NCT02906202|bluebird bio, Inc|Study Medical Director|339-499-9300|medinfo@bluebirdbio.com|
22380570|NCT01133860|IRCCS Policlinico San Matteo Foundation|Prof. Carlo Balduini|0039.0382.502580|c.balduini@smatteo.pv.it|
22380571|NCT03990363|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22380572|NCT01500746|Northwestern University|Dr. Elliot Hirsch|312-695-6022|elliot-hirsch@md.northwestern.edu|
22380573|NCT02406209|Aldeyra Therapeutics, Inc.|Sr. Director, Clinical Operations|781-257-3063|bcavanagh@aldeyra.com|
22380574|NCT01563978|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44-1625-512415|dave.goldstraw@astrazeneca.com|
22380575|NCT04630756|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22380576|NCT04178551|VA Connecticut Healthcare System|William C. Becker, MD|203-932-5711|william.becker4@va.gov|2427
22380577|NCT03796013|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22380578|NCT01824472|University of Pennsylvania|Dr. Nalaka Gooneratne|215 573 2048|ngoonera@upenn.edu|
22411597|NCT01261325|UCB Clinical Trial Call Center|Study Director|+1 887 822 9493||
22380579|NCT01815736|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22380580|NCT04436796|Sansum Diabetes Research Institute|Jordan Pinsker|805-682-7640|jpinsker@sansum.org|
22380581|NCT03387514|UW School of Medicine and Public Health|Steve Cho, MD|608-263-5585|cho85@wisc.edu|
22380582|NCT03040687|Johns Hopkins University|Kawsar Talaat|410-502-9627|ktalaat@jhu.edu|
22380583|NCT02846558|Johns Hopkins Department of Neurology|Dr. Ellen Mowry, M.D., M.C.R.|410-502-0675|emowry1@jhmi.edu|
22380584|NCT00107744|Tulane University|Jiang He, MD, PhD, Chair of Epidemiology|504-988-5165|jhe@tulane.edu|
22380585|NCT01556243|Mayo Clinic|Judy Boughey|507-266-9997|Boughey.Judy@mayo.edu|
22380586|NCT04684914|Altimmune|Randy Brown|3179003335|rbrown@altimmune.com|
22380587|NCT02353832|University of Texas Southwestern|Michael Folkert, M.D., Ph.D.|214-645-8525|Michael.Folkert@utsouthwestern.edu|
22380588|NCT04471792|Kansas State University|Dr. Judy Delp|3522269535|mullerdelp@vet.k-state.edu|
22380589|NCT03374072|Boston University|Dr. Gael Orsmond|(617)353-2703|gorsmond@bu.edu|
22380590|NCT01672983|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
22380591|NCT02174198|Columbia University|Nurit Bittner, DDS, MS, Dip.ABP|212-342-2763|nb2203@cumc.columbia.edu|
22380592|NCT05516342|Hopeful Aging|Michael Skrajner|4404777881|mike@hopefulaging.com|
22380593|NCT04096365|AtaCor Medical, Inc.|Alan Marcovecchio, Vice President, Clinical Affairs|949 391 2252|alan@atacor.com|
22380594|NCT00920374|GlaxoSmithKline|GSK Response Center|866-435-7343||
22380595|NCT02401529|King Fahd General Hospital|Dr Faris Ahmed Bahammam|00966554699544|dr_farisbahammam@yahoo.com|
22380596|NCT01414036|Boston Medical Center|Karen E. Lasser|617-414-6688|karen.lasser@bmc.org|
22380597|NCT01939158|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22380598|NCT05310084|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22380599|NCT05373901|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22380600|NCT02065245|University of Miami, Miller School of Medicine - Interdisciplinary Stem Cell Institute (ISCI)|Joshua M Hare, MD|305-243-5579|JHare@med.miami.edu|
22380601|NCT00924664|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22380602|NCT01598987|Novartis Pharmaceuticals|Study Director|862-778-8300||
22380603|NCT03531905|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
22380604|NCT03961256|Mayo Clinic|Mark D. Stegall, M.D.|507-266-2812|Stegall.Mark@mayo.edu|
22380605|NCT01616563|Metabolic Syndrome Canada|Rupinder Dhaliwal|613 484 3830|rupinder.dhaliwal@metsc.ca|
22380606|NCT00072475|University of Minnesota|Pankaj Gupta, M.D.||gupta013@umn.edu|
22380607|NCT05153174|University of Rochester Medical Center|Dr Thu H. Le, MD, FAHA - Chief of Nephrology|585-273-4259|thu_le@urmc.rochester.edu|
22380608|NCT03303105|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22380609|NCT01824446|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22380610|NCT02023944|Bedford Veterans Hospital|Maureen K. O'Connor|781-687-2830|maureen.oconnor@va.gov|
22380611|NCT01033643|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22380612|NCT05559047|Bleep, LLC|Stuart Heatherington|919-619-7170|stuart@bleepsleep.com|
22380613|NCT00839917|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22380614|NCT02297503|Galderma|Maria Norberg|+46184891267|maria.norberg@galderma.com|
22380615|NCT00765362|DJO Surgical|Manager of Clinical Affairs|512-832-9500|jane.jacob@djosurgical.com|1323
22380616|NCT02037061|Cleveland Clinic|Dr. Cecile Unger|216-444-0542|ungerc@ccf.org|
22380617|NCT00519779|The Ohio State University|Dr. Janice Kiecolt-Glaser|614-293-3499|Janice.Kiecolt-Glaser@osumc.edu|
22380618|NCT00765661|Veloxis|Christina Sylvest, Sr VP Global Clinical Development & Operations|45 20553877|csy@veloxis.com|
22380619|NCT05570747|Bleep, LLC|Stuart Heatherington, Founder and Executive Chairman of Bleep|(919) 619-7170|stuart@bleepsleep.com|
22380620|NCT02029703|Cleveland Clinic|M. Elaine Husni, MD, MPH|216-445-1853|HUSNIE@CCF.ORG|
22380621|NCT00180687|Imperial College London|Dr. Nawar Alkhamesi|442033121110|n.alkhamesi@imperial.ac.uk|
22380622|NCT00839982|FCHRC|Elihu Estey, MD, Director of AML Program|206-288-7176|eestey@seattlecca.org|
22380623|NCT01275053|Beth Israel Deaconess Medical Center|Dr. Christos Mantzoros|6176678633|cmantzor@bidmc.harvard.edu|
22380624|NCT02724020|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22380625|NCT02179918|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22380626|NCT00939796|Acclarent|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com|
22380627|NCT02954575|Octapharma AG|Cristina Solomon|+41 (0)55 451 21 89|Cristina.Solomon@octapharma.com|
22380628|NCT03413605|Center for Asian Health, Lewis Katz School of Medicine, TempleUniversity|Dr. Grace X. Ma|215-707-6493|grace.ma@temple.edu|
22380629|NCT00570661|Italfarmaco SpA|Maurizio Caserini, MD|+39 0264431|m.caserini@italfarmaco.com|
22380630|NCT01700673|Johns Hopkins University School of Medicine, Division of Hematologic Malignancies|Jonathan Webster, MD|4106149106|jwebst17@jhmi.edu|
22380631|NCT01734382|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22380632|NCT04537949|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
22380633|NCT01112696|Medtronic|Scott Lee M.D.|818-576-4204|scott.w.lee@medtronic.com|
22380634|NCT01349660|Sarah Cannon Development Innovations|Charles Davis, RAC||Charles.Davis2@scri-innovations.com|
22380635|NCT05593211|Anthem Biotechnologies|Jeremy D. Ollerenshaw, Ph.D.|770.337.2390|ollerenj@anthembiotech.com|
22380636|NCT03225846|Wave Life Sciences|Medical Director|855-215-4687|clinicaltrials@wavelifesci.com|
22380637|NCT04248465|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22380638|NCT00859131|Medical University of South Carolina|Kenneth Chavin, MD, PhD|843-792-3368|chavinkd@musc.edu|
22380639|NCT01728805|Kyowa Kirin Inc|Fiona Herr, Associate Director, Medical Communications|1 (908) 234-1096|medinfo-US@kyowakirin.com|
22380640|NCT01875861|Central Arkansas Veterans Healthcare System|Dr. Richard Owen|(501) 257-1710|Richard.Owen2@va.gov|
22380641|NCT00810641|KONOS|Treatment of apogeotropic HC BPPV|82 10 5538 6565|ohsun@jbnu.ac.kr|
22380642|NCT03703206|University of Pennsylvania|Nabil Elkassbany, MD|2158236700|nabil.elkassabany@uphs.upenn.edu|
22380643|NCT02359019|Barbara Ann Karmanos Cancer Institute|Dr. Ammar Sukari|313-576-8778|sukaria@karamanos.org|
22380644|NCT01213173|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com|
22380645|NCT02253316|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8323|rvij@wustl.edu|
22380646|NCT02684903|University of Oregon|Dr. Elizabeth Skowron|541-346-9329|eskowron@uoregon.edu|
22380647|NCT03824535|Stanford University|Dr. Carina Mari Aparici|650-497 9280|drmari@stanford.edu|
22380648|NCT02841267|Hugo W. Moser Research Institute at Kennedy Krieger Inc.|Dr. Kathryn R. Wagner|443-923-9525|wagnerk@kennedykrieger.org|
22380649|NCT06403605|ETS Wound Care, LLC|Donald Buck, MD|410-490-5998|dbuck@etswoundcare.com|
22380650|NCT07083843|OmanMOH|Amal Salim AlSahi|96103040|amalalsahi@gmail.com|968
22380651|NCT02941146|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
22380652|NCT02651103|Nationwide Children's Hospital|Clinical Research Coordinator|6147222997|heather.dellinger@nationwidechildrens.org|
22380653|NCT02153788|Duke University Medical Center|Andrew Krystal, MD|919-681-8742|andrew.krystal@duke.edu|
22380654|NCT01106287|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22411598|NCT02668302|Collin County ENT|Keith E Matheny, MD (Principal Investigator)|(972) 596-4005|kmatheny618@gmail.com|
22411599|NCT05576987|Afyonkarahisar Health Science University|Dr. Cahide ÇEVİK|+90 505 518 92 44|cahide.cevik@afsu.edu.tr|
22411600|NCT02948426|National Cancer Institute|Dr. Stanley Lipkowitz|240-760-6129|lipkowis@navemed.nci.nih.gov|
22411601|NCT01995058|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
22411602|NCT03664544|Tanabe Pharma Europe Ltd|General Information|Please e-mail|Regulatory.eu@mb.tanabe-pharma.com|
22411603|NCT03611309|Stanford University|Karl Lorenz, MD MSHS|650-498-9822|kalorenz@stanford.edu|
22411604|NCT01983020|Beth Israel Medical Center|Ronald Kaplan, MD||rkaplan@chpnet.org|
22411605|NCT03280537|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22411606|NCT01588106|GWT-TUD GmbH|Dr. Carsta Köhler|+49 (0) 351 25933 100|contact@gwtonline.de|
22411607|NCT03083132|University of Arkansas for Medical Sciences|Dr. Tuhin Virmani|501-686-7235|tvirmani@uams.edu|
22411608|NCT03118739|AstraZeneca R&D|Fredrik Erlandsson, Global Clinical Lead|+46317762365|Fredrik.Erlandsson@astrazeneca.com|
22411609|NCT02995837|University of Miami|Ignacio Tapia, MD|3052439885|itapia@miami.edu|
22411610|NCT05771545|Hebrew University of Jerusalem|Adam Rose|+972-55-500-1040|adam.rose@mail.huji.ac.il|
22411611|NCT03996005|Hôpitaux Universitaires de Strasbourg|Dr TRICARD Thibault|03 69 55 04 61|thibault.tricard@chru-strasbourg.fr|
22411612|NCT06268730|University of North Carolina at Chapel Hill|Keri Heilman, PhD|913-802-2168|keri_heilman@med.unc.edu|
22411613|NCT01022112|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22411614|NCT00289458|University of Saskatchewan|Dr. Cathy M. Arnold|306 966 6588|cathy.arnold@usask.ca|
22411615|NCT04274192|University of Arkansas for Medical Sciences|Dr. Sherry Courtney|501-364-1028|SECourtney@uams.edu|
22411616|NCT07174544|College of Nursing, The Catholic University of Korea|Hyunjoo Na, Associate professor, PI|+82-2-3147-8442|hjna@catholic.ac.kr|
22411617|NCT03419234|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22411618|NCT05918952|Duke University School of Nursing|Dr. Schenita Randolph|919-684-3786|schenita.randolph@duke.edu|
22411619|NCT01104207|VA Portland Medical Center|Robert L. Folmer, Ph.D.|503-220-8262|Robert.Folmer@va.gov|51868
22411620|NCT03355742|Clinical Affairs, Abbott Vascular|Siok Hwee Tan, PhD, Principal Clinical Research Scientist|+1 408-845-3581|siokhwee.tan@abbott.com|
22411621|NCT02207621|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director of Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
22411622|NCT02623959|UT MD Anderson Cancer Center|Ost,David,M.D. / DOST@MDANDERSON.ORG|713-745-8775|DOst@mdanderson.org|
22411623|NCT00135707|Dept of Obstetrics and Gynecology, University of Pittsburgh|Dr. James Roberts|412-641-1427|RSIJMR@mwri.magee.edu|
22411624|NCT01681030|Ethicon, Inc|Richard Kocharian, MD, PhD|+1-908-218-2013|rkochar1@its.jnj.com|
22411625|NCT00812253|The Ohio State University|Kathleen Dungan|6146853333|kathleen.dungan@osumc.edu|
22411626|NCT04903288|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22411627|NCT02909140|Wilmer Eye Institute|Dr. Fasika Woreta|(410) 955-5650|fworeta1@jhmi.edu|
22411628|NCT01176448|University of Virginia Dept of Otolaryngology Head and Neck Surgery|J. Jared Christophel MD|434-243-9391|jjchristop@gmail.com|
22439925|NCT00784563|Veterans Affairs Medical Center of Iowa City|Ergun Y. Uc, MD|319-356-8753|ergun-uc@uiowa.edu|
22411629|NCT02627742|Baxter Healthcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
22411630|NCT02363907|Dexcom|Eileen Casal, RN, MSN|8588759774|ecasal@dexcom.com|
22411631|NCT00634907|University of Utah|Dr. Gwen McMillin/Principal Investigator|801-583-2787|gwen.mcmillin@aruplab.com|2671
22411632|NCT03291509|University of Kansas Medical Center|Dr. Lauren Ptomey|913-588-7983|lptomey@kumc.edu|
22411633|NCT01645306|advanceCOR GmbH|Prof. Dr. Götz Münch, CRP & CEO|+4989200020410|muench@advancecor.com|
22411634|NCT02584140|UCSD Medical Center, Antiviral Research Center|Jill Blumenthal, MD|(619) 471-3913|jblumenthal@health.ucsd.edu|
22411635|NCT03445195|Entasis Therapeutics|Chief Medical Officer|781-810-8940|Enquiries@entasistx.com|
22411636|NCT01180244|Department of Mechanical Engineering, Kettering University|Dr. Jeffrey B. Hargrove||jhargrov@kettering.edu|
22411637|NCT00906425|Institut Straumann|Michael Hotze, PhD|+4161965|michael.hotze@straumann.com|1235
22411638|NCT02498522|AinShamsU|Dr. Ahmed kotb|1008681999|ahmedmkotp@hotmail.com|+20
22411639|NCT01595009|Novartis Pharmaceuticals|Study Director|862-778-1873||
22411640|NCT03463525|AstraZeneca|Global Clinical Lead|+1 877-240-9479|information.center@astrazeneca.com|
22411641|NCT03172780|Mylan Pharmaceuticals Pvt Ltd.|Dr. Prasanna C Ganapathi, Associate Vice President, Global Clinical Sciences|08066728952|PrasannaC.Ganapathi@mylan.in|28952
22411642|NCT01111110|University of Florida|Dr.Sreekala Prabhakaran. Clinical Assistant Professor Pediatrics|352-273-8381|sprabhakaran@peds.ufl.edu|
22439926|NCT00762164|Bronx VA Medical Center|Dr. Lawrence Baruch|718-584-9000|lawrence.baruch@va.gov|6776
22439927|NCT01938079|Columbia University|Amy L. Dzierba, Pharm.D., BCPS, BCCCP, FCCM|212-305-5852|ald9012@nyp.org|
22380655|NCT02331940|University of Crete|Director of Clinical Trials|2810394824|izolthi@gmail.com|0030
22380656|NCT01450943|VA Northern California Health Care System|Sara Dahle, D.P.M., M.P.H.|916-843-7151|Sara.dahle@va.gov|
22380657|NCT00557505|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22380658|NCT01244763|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441||
22380659|NCT05205941|MMV|Benoit Bestgen|+41797651868|bestgenb@mmv.org|
22380660|NCT00550732|Merck Sharp & Dohme Corp.|Senior Vice President, Globalo Clinical Development||ClinicalTrialsDisclosure@merck.com|
22380661|NCT01323660|GlaxoSmithKline|GSK Response Center|866-435-7343||
22380662|NCT02664220|McGovern Medical School, University of Texas Health Sciences Center at Houston|Dr. Kuojen Tsao|713-500-7300|Kuojen.Tsao@uth.tmc.edu|
22380663|NCT01330355|Valeant Pharmaceuticals|Johnson Varughese|908-541-2179|Johnson.Varughese@valeant.com|
22380664|NCT03189134|Boston Children's Hospital|Aditya K. Kaza, MD|617-355-7932|aditya.kaza@cardio.chboston.org|
22411643|NCT02623829|Icahn School of Medicine at Mount Sinai|Dr. Daniel Bernstein|212-731-3311|daniel.bernstein@mountsinai.org|
22411644|NCT00681863|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22411645|NCT03119064|Brown University Oncology Research Group|Heinrich Elinzano, MD|401-863-3000|BrUOG@BROWN.EDU|
22411646|NCT00804609|Stanford University|Brendan Carvalho|650-861-8607|bcarvalho@stanford.edu|
22411647|NCT01388647|Vector Oncology|Vice President of Scientific Affairs|901-435-5550|mwalker@vectoroncology.com|1759
22411648|NCT01006707|Stanford University School of Medicine|Dr. Larry Chu|(650) 723-6632|lchu@stanford.edu|
22411649|NCT02659202|Mayo Clinic|Dr. Bruce Johnson|507-284-4375|johnson.bruce@mayo.edu|
22411650|NCT00710203|UC Davis, Department of Dermatology|Daniel Eisen, M.D.|916-734-6479|dbeisen@ucdavis.edu|
22411651|NCT00622908|Bausch & Lomb Incorporated|Timothy Comstock|(585) 338-6631|timothy.comstock@bausch.com|
22411652|NCT03937466|Wake Forest University School of Medicine|Nancy Avis, PhD|336-716-6974|navis@wakehealth.edu|
22411653|NCT00455663|UTHSCSA|Dawn I. Velligan|210-567-5508|velligand@uthscsa.edu|
22411654|NCT01851590|Department of Cardiac Surgery, Heart and Lung Centre, Helsinki University Hospital, Finland|Janne Jokinen, MD, PhD, Consultant Cardiothoracic Surgeon|50 554 8103|janne.jokinen@helsinki.fi|+358
22411655|NCT02462070|Bausch Health|Study Director||anya.loncaric@bauschhealth.com|
22411656|NCT00321711|Amgen Inc.|Study Director|866-572-6436||
22411657|NCT00543439|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22411658|NCT02354378|Boston Children's Hospital|Keira Mason, MD|6173552339|keira.mason@childrens.harvard.edu|
22411659|NCT03264066|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22411660|NCT01484028|Vistakon, Johnson and Johnson Vision Care|Dr. Michael Mayers, O.D., FAAO, Senior Research Optometrist|1 904 443 3252|mmayers@its.jnj.com|
22411661|NCT02400710|Center for Integrated Healthcare, Syracuse Veterans Affairs Medical Center|Kyle Possemato, Ph.D.|315-425-4400|kyle.possmato@va.gov|53551
22411662|NCT02922959|University of Cincinnati Addiction Sciences Division|Theresa Winhusen|5135858292|winhust@ucmail.uc.edu|
22411663|NCT03187080|University of Wisconsin School of Medicine and Public Health|Venkat Rao, MD, MBA|(608) 263-1223|rao@surgery.wisc.edu|
22411664|NCT03872700|Montefiore Medical Center|Dr. Benjamin W Friedman|718-920-6626|befriedm@montefiore.org|
22411665|NCT00492206|University of Pittsburgh Cancer Institute|Ahmad Tarhini, MD|412-648-6507|tarhiniaa@upmc.edu|
22411666|NCT00146770|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
22411667|NCT00722111|VAHSRD|Dr. JoAnne Robbins|608-256-1901|bert.landreth@va.gov|11697
22439928|NCT01844765|NovartisPharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22439929|NCT02025179|Northwestern University|Dr. Thomas Schnitzer|312-503-2315|tjs@northwestern.edu|
22439930|NCT00556075|Repros Therapeutics Inc.|Jennifer L. Wike|2817193402|jwike@reprosrx.com|
22439931|NCT00601835|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22439932|NCT01927497|Academic medical center|prof. dr. P.J. Tanis|0031205669111|g.d.musters@amc.nl|
22439933|NCT00395746|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22439934|NCT04528641|Reithera|Medical Director|06 99775|roberto.camerini@reithera.com|352
22439935|NCT03914417|Icahn School of Medicine at Mount Sinai|Dr. Sharon Rose|212-241-3288|sharone.rose@gmail.com|
22439936|NCT02747186|University of North Carolina at Chapel Hill|Raymond P. White Jr., DDS, PhD|919-537-3944|ray_white@unc.edu|
22439937|NCT01897025|National University Hospital|Dr Effie Chew|65-67726198|effie_chew@nuhs.edu.sg|
22439938|NCT00517296|Vanderbilt University Medical Center|David A. Schwartz, MD|615-322-4643|david.a.schwartz@vanderbilt.edu|
22439939|NCT00310765|retired|Dr. Ann Silverman||anngimd@icloud.com|
22439940|NCT04764162|Virginia Tech|Dr. Kevin Davy|(540)231-3487|kdavy@vt.edu|
22439941|NCT00791934|Acclarent, Inc.|Clinical Director|650-687-5888|lenglan1@its.jnj.com|
22439942|NCT01300728|Sutter Neurology Medical Group|Shawn Kile, MD|(916) 454-6850|KileS@sutterhealth.org|
22439943|NCT00506350|GlaxoSmithKline|GSK Response Center|866-435-7343||
22439944|NCT00945009|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22439945|NCT04388683|Tufts Medical Center|Dr. Marvin Konstam|617-636-6293|mkonstam@tuftsmedicalcenter.org|
22411668|NCT02826603|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
22411669|NCT00905489|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22411670|NCT00583596|St. Jude Medical Formally AGA Medical Corporation|Jeffrey Mifek|6517565586|jmifek@sjm.com|
22411671|NCT03558997|Regeneron Pharmaceuticals, Inc|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
22411672|NCT02619682|Fred Hutchinson Cancer Care Center|Dr Leona A Holmberg|206-667-6447|lholmber@fredhutch.org|
22411673|NCT03944785|Supernus Pharmacueticals|Gianpiera Ceresoli-Borroni|301-838-2521|gceresoliborroni@supernus.com|
22411674|NCT01861522|Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml.JP@ml.tanabe-pharma.com|
22411675|NCT00526890|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22411676|NCT02473991|ain shams university maternity hospital|prof Dr khaled ebrahim abdalla|00201023220701|drkhaled_abdallah@med.asu.edu.eg|
22411677|NCT01859702|Alcon Research, Ltd.|Abayomi Ogundele, Global Medical Affairs Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22411678|NCT01893138|Cook MyoSite, Inc.|Ron Jankowski, PhD|412-963-7380|Ron.Jankowski@CookMyosite.com|
22411679|NCT03123549|NuVasive, Inc.|Jessica Fulwider|7037721455|jfulwider@nuvasive.com|
22411680|NCT01326026|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22411681|NCT01170260|University of New Mexico Health Sciences|Hadya Khawaja|505-272-7028|hkhawaja@salud.unm.edu|
22439946|NCT04972162|WSAUDAS|Dr. Veronika Littmann|+4991313080|veronika.littmann@wsa.com|
22439947|NCT00781768|Loyola University Medical Center|Patrick Stiff, M.D.|708-327-3148|pstiff@lumc.edu|
22411682|NCT04567615|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1-855-907-3286|Clinical.Trials@bms.com|
22411683|NCT04317053|NYU Langone Health|Kelly Doran, MD, MHS|212-263-5850|Kelly.Doran@nyulangone.org|
22426252|NCT01950299|Virginia Commonwealth University|Antonio Abbate, MD, PhD|804-828-0513|antonio.abbate@vcuhealth.org|
22426253|NCT00815997|NPO International TRI Network|Sigeru Saito, MD, Principal Investigator|+81-467-461717|saito@shonankamakura.or.jp|10490
22426254|NCT04110314|UCLA|Principal Investigator|310-206-6328|pszilagyi@mednet.ucla.edu|
22426255|NCT04685993|Lipocine Inc|Senior Director of Clinical Development|801.994.7383|admin@lipocine.com|
22426256|NCT04658797|CooperVision, Inc|Jose Vega, OD, MSc, FAAO|9256213761|JVega2@coopervision.com|
22426257|NCT00737100|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22426258|NCT05270980|NYU Langone Health|Dr. Joshua Chodosh|212-263-6768|Joshua.Chodosh@nyulangone.org|
22426259|NCT01607593|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22426260|NCT00115778|Columbia University Medical Cetner|Selim Arcasoy, MD|212-305-7771|sa2059@columbia.edu|
22426261|NCT00500578|UT MD Anderson Cancer Center|Roy F Chemaly, MD/MPH, MBA /Associate Professor|713-745-1116|rfchemaly@mdanderson.org|
22426262|NCT04428385|Duke University|Wendy Prudhomme - O'Meara, PhD|919-613-4406|wendy.omeara@duke.edu|
22426263|NCT03713684|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22426264|NCT00528424|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22426265|NCT02515630|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22426266|NCT03870334|NImmune|Project Management|(540) 944-4545|pm@nimmun.com|
22426267|NCT02595502|Johnson & Johnson Vision Care Inc.|Brian Pall, O.D., M.S., F.A.A.O - Senrior Principal Research Optometrist|904-443-1290|BPALL@its.jnj.com|
22426268|NCT00974311|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22426269|NCT04553666|University of Rochester Medical Center|Dr. Nikesha Gilmore, Assistant Professor|1-585-275-1275|nikesha_gilmore@urmc.rochester.edu|
22426270|NCT03286218|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979|ClinicalTrials.gov@lilly.com|
22426271|NCT00458003|Northwestern University|Paul Fitzgerald|312-6951064|p-fitzgerald2@northwestern.edu|
22426272|NCT04556760|AstraZeneca Clinical Study Information Center|Global Clinical Head|1-877-240-94 79|information.center@astrazeneca.com|
22426273|NCT02513550|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22426274|NCT02849743|The Children's Hospital of Philadelphia|Dr. Shana McCormack|(215) 590-3174|mccormacks1@chop.edu|
22426275|NCT03677635|King's College London|Dr Clementine Edwards|07557866053|clementine.edwards@kcl.ac.uk|
22426276|NCT02168491|Medical University Vienna, Austria|Prof. Dr. Michael Krebs|+ 43 1 40400|michael.krebs@meduniwien.ac.at|43120
22426277|NCT00809445|Columbia University, Mailman School of Public Health|Dr. Lisa Metsch|212-305-3577|lm2892@columbia.edu|
22426278|NCT04919317|Temple University Hospital|George Taylor, MD, MS; surgical resident|2678150512|George.Taylor@tuhs.temple.edu|
22426279|NCT01566604|Novartis|Study Director|862-778-8300||
22426280|NCT00972959|"Department of Clinical Therapeutics, University of Athens School of Medicine, Alexandra General Hospital of Athens,"|Prof. M. A. Dimopoulos|0030 210 3381511|mdimop@med.uoa.gr|
22426281|NCT02895035|Penn State Hershey Eye Center|Seth Pantanelli|717-531-5690|spantanelli@pennstatehealth.psu.edu|
22426282|NCT02572453|Dana-Farber Cancer Institute|Jillian Foreman|1-877-338-7425|jillianM_foreman@dfci.harvard.edu|
22426283|NCT01443858|Duke Center for Smoking Cessation|Dr. Jed E. Rose|919-668-5055|jed.rose@duke.edu|
22426284|NCT06060496|University of Kentucky|Gopalkumar Rakesh, MD|8592579402|gopalkumar.rakesh@uky.edu|
22426285|NCT03861091|Wake Forest Baptist Comprehensive Cancer Center|Biostatistician|336-716-5440|blevine@wakehealth.edu|
22426286|NCT00321906|The University of Chicago|Edward Garrity, MD|(773) 834-1119|egarrity@uchicago.edu|
22426287|NCT02221648|Yale University School of Medicine|Bahman Jabbari M.D, , Professor of Neurology|203-737-2464|bahman.jabbari@yale.edu|
22426288|NCT03626701|AVITA Medical|Elizabeth Kirshner|661-877-6869|ekirshner@avitamedical.com|
22426289|NCT00149396|Medigene|Associate Director Regulatory Affairs|858-586-2252|p.larson@medigeneusa.com|
22426290|NCT00810069|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22426291|NCT00719160|Yale University|Karl L. Insogna, M.D.|203-737-2871|Karl.insogna@yale.edu|
22426292|NCT00426764|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22426293|NCT01922258|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development||DT-inquiry@otsuka.jp|
22426294|NCT03113968|Department of Psychiatry, Mass General Brigham, and Harvard Medical School|Dr. Amit Anand|6177266421|aanand7@bwh.harvard.edu|
22426295|NCT00901342|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@Dendreon.com|
22426296|NCT02782741|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22426297|NCT05116202|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22426298|NCT00594230|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|ASKSARAH@scresearch.net|
22426299|NCT01121939|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22426300|NCT02686164|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22426301|NCT01242241|Baylor College of Medicine|Dr. Olutoyin A. Olutoye|832-824-5800|oao@bcm.edu|
22426302|NCT01827592|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22426303|NCT02324361|Partners Healthcare|Study Project Manager|4259856430|szan@mail.harvard.edu|
22426304|NCT01481558|University of Sao Paulo|Claudia Kimie Suemoto|551130618249|cksuemoto@usp.br|
22426305|NCT01105312|Mayo Clinic|Winston Tan MD|507-284-1159|tan.winston@mayo.edu|
22426306|NCT02541409|Johns Hopkins University Bloomberg School of Public Health|Dr. Shruti Mehta|443-287-3837|smehta@jhu.edu|
22426307|NCT02329327|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
22426308|NCT03560869|University of Delaware|William B. Farquhar|302-831-6178|wbf@udel.edu|
22439948|NCT02458313|University of Colorado School of Medicine|Dr. Kristina Legget|3037245809|kristian.legget@cuanschutz.edu|
22439949|NCT04671017|Valneva Austria GmbH|Clinical Strategy Manager|+43 1 206 20|office@valneva.com|0
22439950|NCT00199381|Kyowa Hakko Kirin Pharma, Inc.|Director of Clinical Trials|609-919-1100|mcantillon@kyowa-kirin-pharma.com|
22439951|NCT00603408|Washington University School of Medicine|Rebecca Aft, M.D., Ph.D.|314-747-0063|aftr@wudosis.wustl.edu|
22439952|NCT00385671|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22439953|NCT02608684|Cedars-Sinai Medical Center|Bobbie J. Rimel, MD|310-423-1126|Bobbie.Rimel@cshs.org|
22439954|NCT00751296|University Health Network - Princess Margaret Cancer Centre|Dr. Christine Chen|416-946-2827|Christine.Chen@uhn.ca|
22439955|NCT01972217|AstraZeneca|Medical Director|+13028851180|ClinicalTrialTransparency@astrazeneca.com|
22439956|NCT00181168|Johns Hopkins Univ|Paul W. Ladenson, MD, Professor and PI|4109553663|ladenson@jhmi.edu|
22439957|NCT03453164|Fukushima medical university of medicine|Prof. Koji Kono|+81245471259|kojikono@fmu.ac.jp|
22439958|NCT01428258|University of Wisconsin-Madison|Dr. Denise M Ney|608-262-4386|ney@nutrisci.wisc.edu|
22439959|NCT03566511|Albert Einstein College of Medicine|Dr. Meredith Hawkins|718-839-7975|meredith.hawkins@einsteinmed.edu|
22439960|NCT02878343|UPenn|Dr. Karen Glanz||kglanz@pennmedicine.upenn.edu|
22439961|NCT02939287|Rush University Medical Center|Danielle Murphy, PharmD, BCOP, BCPS|3129472401|danielle_murphy@rush.edu|
22439962|NCT04026113|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22439963|NCT01709721|CTI Clinical Trial and Consulting Services|Heather Kapushoc, Sr. Biostatistician|571-315-2574|hkapushoc@ctifacts.com|
22439964|NCT04614363|Houston Methodist|Dr. Brian Miles|713-441-8113|bjmiles@houstonmethodist.org|
22439965|NCT02558894|AstraZeneca|Global Clinical Lead|+1 301-398-0000|ClinicalTrialTransparency@astrazeneca.com|
22439966|NCT03288103|Cincinnati Childrens Hospital Medical Center|Dr. Philippe Backeljauw, MD|15136368444|Philippe.backlejauw@cchmc.org|
22439967|NCT05236270|University of Oklahoma Health Sciences|Dr. Amanda Janitz|405-271-2229|amanda-janitz@ouhsc.edu|48081
22439968|NCT02476617|AbbVie|Global Medical Services|800-633-9110||
22439969|NCT01383928|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22439970|NCT03486912|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
22439971|NCT02491684|AstraZeneca|Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22439972|NCT01149096|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22439973|NCT01263769|UT MD Anderson Cancer Center|Dr. Jose Karam, MD, Associate Professor, Urology|(713) 745-0374|jakaram@mdanderson.org|
22439974|NCT03267277|National Institute of Environmental Health Sciences|Dr. Adam Schiffenbauer|+1 301 451 6270|adam.schiffenbauer@nih.gov|
22439975|NCT01451606|University of Maryland, Baltimore|Dr. Joel Greenspan|4107067090|jgreenspan@umaryland.edu|
22439976|NCT00468169|University of Chicago|Everett E Vokes, MD|(773) 702-9306|evokes@medicine.bsd.uchicago.edu|
22439977|NCT04372017|Sanford Health|Dr. Susan Hoover|605-328-8120|Susan.Hoover@sanfordhealth.org|
22439978|NCT01126749|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
22439979|NCT03668873|Cleveland Clinic Foundation|Cynthia R. Johnson, PhD|216 448-6440|johnsoc@ccf.org|
22439980|NCT02183675|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22439981|NCT01521117|Oregon Health & Science University|Amie Hiller, MD|503 721 1091|peterami@ohsu.edu|
22439982|NCT01569191|Aston University|Prof James Wolffsohn|+44(0)1212044140|j.s.w.wolffsohn@aston.ac.uk|
22439983|NCT00568022|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22439984|NCT03896438|University of Minnesota|Melanie Stimac|612-301-2449|stima011@umn.edu|
22439985|NCT03025282|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22439986|NCT02657889|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22439987|NCT00392392|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|ASKSARAH@scresearch.net|
22439988|NCT01377584|University of Pittsburgh|Faith Luyster, PhD|412-624-7910|fsl3@pitt.edu|
22439989|NCT00464698|Massachusetts General Hospital|Darin D. Dougherty, MD|617-724-6300|ddougherty@partners.org|
22439990|NCT03050801|National Institutes of Health|Dr. Eric Wassermann|301-496-0151|wassermanne@ninds.nih.gov|
22439991|NCT01576341|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|0049 80244760|biopharma.clinicaltrials@sandoz.com|
22439992|NCT03836625|Vanderbilt University|Kate Clouse|(615) 343-5351|kate.clouse@vanderbilt.edu|
22439993|NCT03361137|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22439994|NCT00829738|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com|
22439995|NCT03413891|University Hospitals Leuven|Mrs. Barbara Debaveye|003216 341463|barbara.debaveye@uzleuven.be|
22439996|NCT05358366|University of North Carolina at Chapel Hill|Natalia Villegas Rodriguez, PhD|919-966-4260|navilleg@email.unc.edu|
22439997|NCT02103309|Alcon Japan, Ltd.|Director of Clinical Trials|1-888-451-3937|alcon.medinfo@alcon.com|
22439998|NCT03077542|National Heart, Lung, and Blood Institute at National Institutes of Health|Courtney Fitzhugh, M.D.|301.402.6496|fitzhughc@nhlbi.nih.gov|
22439999|NCT00795704|University of Mississippi Medical Center|Daniel Riche|601-984-2640|driche@umc.edu|
22440000|NCT00301808|Barbara Ann Karmanos Cancer Institute|Shrish Gadgeel, M.D.|(313) 556-8820|sgadgee1@hfhs.org|
22440001|NCT00844844|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals Inc.||clinicaltrials@alxn.com|
22440002|NCT03905096|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22440003|NCT01943344|Vivasure Medical|Dr Chris Martin|+353 9 395 440|chris.martin@vsuremed.com|
22440004|NCT05460754|Montana State University|Dr. Mary P Miles|406 994-6678|mmiles@montana.edu|
22440005|NCT05305443|University of Illinois Urbana Champaign|Dr. Liliane Windsor|217-300-1782|lwindsor@illinois.edu|
22440006|NCT02977403|Eunice Kennedy Shriver National Institute of Health, NIH|Dr. Jack Yanovski|301-496-0858|jy15i@nih.gov|
22440007|NCT04659044|Perlmutter Cancer Center at NYU Langone Health|Catherine Diefenbach M.D.|(212) 731-5670|Catherine.diefenbach@nyulangone.org|
22440008|NCT02891447|University of M D Anderson Cancer Center|Dr. Brian Badgwell|713-745-7351|bbadgwell@mdanderson.org|
22440009|NCT04966013|EmitBio Inc|Chief Medical Officer|919.321.1734|info@emitbio.com|
22440010|NCT01740713|Consorzio per Valutazioni Biologiche e Farmacologiche|Clinical Research Coordinator|0039 0382 25075|mariagraziafelisi@cvbf.net|
22440011|NCT04875975|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22440012|NCT01910298|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22440013|NCT05086705|The Ohio State University Comprehensive Cancer Center|Dr. Sagar Sardesai|614-293-6401|sagar.sardesai@osumc.edu|
22426309|NCT03718429|University of Florida|Dominick Angiolillo, MD,PhD|904-244-3378|dominick.angiolillo@jax.ufl.edu|
22426310|NCT02346877|Amgen Inc.|Study Director|866-572-6436||
22426311|NCT01545141|Roswell Park Cancer Institute|Kris Attwood|716-845-2300|Kristopher.attwood@roswellpark.org|
22426312|NCT02049983|Levita Magnetics International Corp|Alberto Rodriguez-Navarro, MD|6506557625|info@levita.com|
22426313|NCT00691652|OHSU Knight Cancer Institute|Dr. Craig Okada|503-494-1080|Okadac@ohsu.edu|
22426314|NCT01386606|Repros Therapeutics Inc.|Jennifer L. Wike|281-719-3402|jwike@reprosrx.com|
22426315|NCT01334086|Princess Margaret Cancer Centre|Dr. Karen Yee, Hematology and Medical Oncology Site Group Lead|416-946-4501|Karen.Yee@uhn.ca|4495
22426316|NCT00593814|W.L. Gore and Associates|Tab Bonny|928 864 4275|tbonny@wlgore.com|
22426317|NCT00500448|University of Michigan|Riann Palmieri-Smith|7346153154|riannp@umich.edu|
22426318|NCT02723188|Tel Aviv University|Yair Bar-Haim|97236406393|yair1@post.tau.ac.il|
22426319|NCT00991081|Stanford University|Sean P. David, MD, SM, DPhil|650-498-4687|spdavid@stanford.edu|
22426320|NCT03110354|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22426321|NCT01204736|Rehabilitation Institute of Chicago|Dr. Wendy Murray|3122386965|w-murray@northwestern.edu|
22426322|NCT02787499|Massachusetts General Hospital/Harvard Medical School|Mark Siedner|6177264686|msiedner@mgh.harvard.edu|
22426323|NCT02026141|University of Saskatchewan-Department of Anesthesia|Dr. Ian Chan|306-717-8028|iac549@mail.usask.ca|
22426324|NCT02169505|UT MD Anderson Cancer Center|Ahmed,Sairah,MD / Stem Cell Transplantation|713-792-7734|sahmed3@mdanderson.org|
22426325|NCT02735980|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22426326|NCT02539992|Stryker European Operations BV|Dr. Eric Garling, Director Medical & Scientific Affairs Europe|+31 20 219 2660|eric.garling@stryker.com|
22426327|NCT00917124|University Hospital Center Zagreb|Zeljko Colak|00385915624189|zcolak2000@yahoo.com|
22426328|NCT00723827|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22426329|NCT02185417|Boston VAHCS|Dr. Sarah Leatherman|857-364-4201|sarah.leatherman@va.gov|
22426330|NCT03131167|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22426331|NCT05439421|Wake Forest University Health Sciences|Erin L. Sutfin, PhD|336.713.5282|esutfin@wakehealth.edu|
22426332|NCT01167569|Rutgers RWJMS|Alan Spotnitz, MD|732-235-9806|spotnitz@rwjms.rutgers.edu|
22426333|NCT00126594|University of Texas (UT) MD Anderson Cancer Center|Eric Jonasch, MD/Associate Professor, Genitourinary Medical Oncology|713-792-2830|CR_Study_Registration@mdanderson.org|
22426334|NCT03843372|Sleep Center, Chang Gung Memorial Hospital, Keelung, Taiwan|Dr. Chung-Chieh Yu|886+22432-9292|terminatorchieh@yahoo.com.tw|2658
22426335|NCT01477762|Emory University|Dr. Tanja Jovanovic|(404) 778-1485|tjovano@emory.edu|
22426336|NCT00243919|Duke University|Pamela W. Duncan, PT, PhD, FAHA, FAPTA|919-681-2060|pamela.duncan@duke.edu|
22426337|NCT02157519|Massachusetts General Hospital Cancer Center|Joseph Greer, PhD|617-643-2143|jgreer2@mgh.harvard.edu|
22426338|NCT01656395|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22426339|NCT03871153|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22426340|NCT03225170|NHGRI|Dr. Lori Erby|301-443-2635|lori.erby@nih.gov|
22426341|NCT03107208|"University of Colorado Denver | Anschutz"|Rebecca Ohman, MD|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
22426342|NCT01272908|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22426343|NCT01168921|The University of Texas MD Anderson Cancer Center|William Wierda MD/Professor|713-745-0428|wwierda@mdanderson.org|
22426344|NCT03675360|Tulane University School of Public Health and Tropical Medicine|Dr. Kirsten Dorans, Assistant Professor, Department of Epidemiology|15049880883|kdorans@tulane.edu|
22426345|NCT00687908|Galderma|Clinical Project Manager|+33 492 95 29 21|jean-charles.dhuin@galderma.com|
22426346|NCT02716779|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22426347|NCT02600923|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22426348|NCT01156805|Hospital General de Granollers|Dr. Esteve Llargues|938425000|ellargues@fhag.es|2675
22426349|NCT01431339|Durata Therapeutics|Michael Zelasky|203-871-4616|mzelasky@duratatx.com|
22426350|NCT05918406|Oyster Point Pharma Inc|Marian Macsai, MD|312-259-2477|marian.macsai@viatris.com|
22426351|NCT01497067|Alcon Research|Sr. Clinical Trial Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
22426352|NCT04058028|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22426353|NCT02227784|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22426354|NCT01705977|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22426355|NCT01275144|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22426356|NCT00828113|University of Wisconsin School of Medicine and Public Health|Douglas E. Jorenby, Ph.D.|6082627527|dej@ctri.medicine.wisc.edu|
22440014|NCT02429830|Torax Medical, Inc|Senior Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22440015|NCT03960541|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22426357|NCT01852513|The University of Chicago|Dr. Jayant Pinto, PI|773-702-6727|jpinto@surgery.bsd.uchicago.edu|
22440016|NCT01395797|New York State Psychiatric Institute|Sandra Comer PhD|646 774-6146|sdc10@columbia.edu|
22440017|NCT04944992|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22440018|NCT04295720|University of Arizona|Phillip H. Kuo, MD, PhD|520-626-1957|pkuo@arizona.edu|
22440019|NCT02798627|University of Pennsylvania Perelman School of Medicine|Kyle Kampman, MD|2157462764|kampman@pennemdicine.upenn.edu|
22440020|NCT05024032|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22440021|NCT00939393|Acclarent, Inc.|Clinical Director|650-687-5888|lenglan1@its.jnj.com|
22440022|NCT02364700|New York University|Grace Kim PhD, OTR/L|121-998-5846|gjk207@nyu.edu|
22440023|NCT00681044|Boston Medical Center|Dr. Vaishali Sanchorawala, Director of Stem Cell Transplant Program|617-637-7017|vaishali.sanchorawala@bmc.org|
22440024|NCT02844569|University of North Carolina at Chapel Hill|Dr. Thiago Morelli|919-537-3727|thiago_morelli@unc.edu|
22440025|NCT00744497|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22440026|NCT02770014|Dana-Farber Cancer Institute|Geoffrey Oxnard, MD|617-632-6049|geoffrey_oxnard@dfci.harvard.edu|
22440027|NCT01074502|UNC Chapel Hill|Aida Lugo-Somolinos MD-PI|919-843-9447|alugosom@med.unc.edu|
22440028|NCT03459079|University of Florida|Kenneth Cusi|352-505-9060|kcusi@ufl.edu|
22440029|NCT01691534|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|212-227-7540|Dan.Everitt@tballiance.org|
22440030|NCT00674817|GlaxoSmithKline|GSK Response Center|866-435-7343||
22440031|NCT00976183|Gynecologic Oncology Associates|John P. Micha, M.D.|949-642-5165|Research@gynoncology.com|
22440032|NCT00834977|TEVA Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22440033|NCT04945733|Janssen Pharmaceutical K.K.|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22440034|NCT05660577|Bausch & Lomb|Study Director|5102595284|aloncaric@bausch.com|
22440035|NCT04723056|Stanford University|Linda Nguyen|650-736-0431|nguyenlb@stanford.edu|
22440036|NCT05106894|Children's Hospital Los Angeles|Dr. Beth A. Smith|3233614670|bsmith@chla.usc.edu|
22440037|NCT03363841|Scynexis|David Angulo|201-884-5471|David.Angulo@scynexis.com|
22440038|NCT01968447|LUMC|Albert Dahan|+31 71 52 62301|a.dahan@lumc.nl|
22440039|NCT00821795|Lexington VAMC|Dennis G Karounos, MD Principal investigator|859 233-4511|dennis.karounos@va.gov|4430
22440040|NCT02156076|Bristol-Myers Squibb|Study Director||Clinical.Trials@bms.com|
22440041|NCT03431285|King Fahd University Hospital- Imam Abdulrahman Bin Faisal University|Dr. Muhammed Alshahrani|+966138966666|msshahrani@iau.edu.sa|2002
22440042|NCT01827137|Sellas Life Sciences|Dragan Cicic|646-200-5278|info@sellaslife.com|
22440043|NCT04196777|Iowa City VA Health Care System|Daniel Livorsi|319-688-3871|daniel.livorsi@va.gov|
22440044|NCT00981656|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22440045|NCT00687596|Taiho Oncology, Inc.|Taiho Central|+1 844-878-2446|medicalinformation@taihooncology.com|
22440046|NCT01527149|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
22440047|NCT03402217|Ci3 at the University of Chicago|Ellen McCammon|773-834-8462|emccammon@bsd.uchicago.edu|
22440048|NCT02005549|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22440049|NCT02230410|Mayo Clinic|Dr. Kenneth K. Wang|507-293-7911|wang.kenneth@mayo.edu|
22440050|NCT02135861|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22440051|NCT02992288|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
22440052|NCT00499486|The Sidney Kimmel Comprehensive Cancer Centre at Johns Hopkins|Dr. Hidalgo||mhidalgo@cnio.es|
22440053|NCT00656513|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22440054|NCT01440959|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
22440055|NCT03796728|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22440056|NCT00333775|Hoffmann-La Roche|Medical Communications|800 821-8590||
22440057|NCT03165617|Seqirus|Seqirus Clinical Trial Manager|1-855-358-8966|seqirus.clinicaltrials@Seqirus.com|
22440058|NCT03926208|Rush University Medical Center|Dr. Daniel D. Bohl|414.640.7245|danielbohl@gmail.com|
22440059|NCT00412984|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22440060|NCT02199184|The University of Texas MD Andeerson Cancer Center|Elias Joseph Jabbour|713-792-4764|ejabbout@mdanderson.org|
22440061|NCT03651765|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
22440062|NCT04218240|University of Pennsylvania|Kyle M. Kampman, MD|2157462764|kampman@pennmedicine.upenn.edu|
22440063|NCT05467007|The George Washington University|Dr. Andrew C. Meltzer|202-741-2952|Ameltzer@mfa.gwu.edu|
22440064|NCT04097678|Twin Cities Spine Center|Clinical Research Director|612-775-6222|jmdawson@tcspine.com|
22440065|NCT03694678|Massachusetts General Hospital|Ana-Maria Vranceanu|6178931664|avranceanu@mgh.harvard.edu|
22440066|NCT02435212|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|novartis.email@novartis.com|
22380665|NCT04227340|St. Jude Children's Research Hospital|Belinda Mandrell, PhD, RN|(901) 595-4209|belinda.mandrell@stjude.org|
22380666|NCT00401817|Weill Cornell Medicine|John Leonard, MD|646.962.2064|amr2017@med.cornell.edu|
22380667|NCT02015663|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
22380668|NCT02059161|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22380669|NCT00958009|EMD Serono, Inc.|Fernando Dangond, MD|781-681-2348|Fernando.dangond@emdserono.com|
22380670|NCT04183192|U.S. Food and Drug Administration|David Strauss, MD, PhD|3017966323|David.Strauss@fda.hhs.gov|
22440067|NCT02453737|Mayo Clinic|Dr. Robert W. Mutter|507-284-3191|Mutter.Robert@mayo.edu|
22440068|NCT04711850|Hansa Biopharma AB|Vice President Research and Development|+4646165670|info@hansabiopharma.com|
22440069|NCT01346358|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22426358|NCT04786691|University of Arkansas for Medical Sciences|Jessica Yeh|(501) 686-6114|jyeh@uams.edu|
22426359|NCT01871077|Laboratorios Sophia|PhD. Ricardo Llamas|+52 (33) 3001 4200|drricardollamas@gmail.com|1259
22426360|NCT04457362|NYU Langone Health|Nader Paksima|2122632193|Nader.Paksima@nyulangone.org|
22426361|NCT02864407|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22426362|NCT00096538|Memorial Sloan Kettering Cancer Center|Dr. Ariela Noy|212-639-7423|noya@mskcc.org|
22426363|NCT02992119|MORU|Lorenz von Seidlein|662036663|Lorenz@tropmedres.ac|
22426364|NCT00401518|Globus Medical|Director of Clinical Affairs|610-930-1800|jmyer@globusmedical.com|
22426365|NCT02731300|Department of Physiology; Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.|Paradee Auvichayapat|66896222624|aparad@kku.ac.th|
22426366|NCT02465164|Central Clinical Trials Office|Central Clinical Trials Office|3139537454|smarl1@hfhs.org|
22426367|NCT03110133|Finch Therapeutics|Dr. Shrish Budree|(857) 322-4646|sbudree@finchtherapeutics.com|646
22426368|NCT03030625|Hospital Universitario de La Princesa|Dr. Almudena Zapatero Laborda|+34 915 20 22 00|almudena.zapatero@salud.madrid.org|
22426369|NCT02223351|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
22426370|NCT00003471|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22426371|NCT03571724|22nd Century Group, Inc.|Karen E. Delaney|716-270-1523|kdelaney@xxiicentury.com|
22426372|NCT00715403|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22426373|NCT00101868|University of Illinois|James F. Graumlich, MD, Professor of Medicine|309-655-7734|jfg@uic.edu|
22426374|NCT04001803|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22426375|NCT01733745|Alcon Research, Ltd.|Abayomi Ogundele, Pharm.D, Global Brand Medical Affairs Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22426376|NCT01931397|Oregon Health & Science University|Dr. Amira Al-Uzri , Professor of Pediatrics|503-494-6956|aluzria@ohsu.edu|
22426377|NCT00520039|West Virginia School of Osteopathic Medicine|Dr. Karen Steele|(304)667-4255|ksteele@osteo.wvsom.edu|
22426378|NCT02472262|Washington University School of Medicine in St. Louis|Mark Manary|3144542178|manarymj@wustl.edu|
22426379|NCT02493517|Ipsen|Medical Director, Oncology||clinical.trials@ipsen.com|
22426380|NCT01367249|Bausch & Lomb Incorporated|James Gow|949-788-6000|james.gow@bausch.com|
22426381|NCT05404711|University of Pittsburgh School of Medicine|Mary Ellen Vajravelu, MD,MSHP|412-692-6533|vajravelume@upmc.edu|
22426382|NCT00325819|Group Health Research Institute|Lisa Jackson, MD, MPH|206-442-5216|jackson.L@ghc.org|
22426383|NCT01683604|HoffmannLaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22426384|NCT01548599|University of California, San Francisco|Sheri Weiser|(415) 314-0665|Sheri.Weiser@ucsf.edu|
22426385|NCT02188160|Kala Pharmaceuticals, Inc.|VP, Clinical Development|781-996-5252|results002@kalarx.com|
22426386|NCT00916578|UT MD Anderson Cancer Center|Woodward,Wendy,M.D., PH.D.|713-792-7734|CR_Study_Registration@mdanderson.org|
22426387|NCT00934375|Eisai Inc.|Anita Murthy, Study Director|201-692-1100||
22426388|NCT02674503|Birmingham VA - GRECC Director; Professor at UAB|Dr. Alayne Markland|205-558-7067|alayne.markland@va.gov|
22426389|NCT00945243|DePuy Synthes Spine|Mark Lotito|508-880-8045|mlotito@its.jnj.com|
22426390|NCT02371616|GlaxoSmithKline|GSK Response Center|866-435-7343||
22426391|NCT02576899|VISN 1 MIRECC|Megan M. Kelly, Ph.D.|781-687-3317|Megan.Kelly1@va.gov|
22426392|NCT00754741|Henry Ford Health System|L. Keoki Williams, MD, MPH|313-874-5454|chphsr@hfhs.org|
22426393|NCT04152200|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
22426394|NCT04969289|Columbia University|Lauren Chernick, MD, MSc|212-305-9825|lc2243@columbia.edu|
22426395|NCT02699996|Rutgers Cancer Inst. of NJ|Dr. Katie Devine|7322357549|katie.devine@rutgers.edu|
22426396|NCT04069715|KGK Science Inc.|Malkanthi Evans (Ph.D.), Chief Scientific officer|5194389374|mevans@kgkscience.com|239
22426397|NCT01198002|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22426398|NCT02063672|Lutonix|Heidi Ronhovde|7634632900|heidi.ronhovde@crbard.com|
22426399|NCT00313729|UCSF Neuro-Oncology|Susan Chang MD|415-353-2966|Susan.Chang@ucsf.edu|
22426400|NCT01307787|UMCG|G.Breedland||g.breedland@cvr.umcg.nl|
22426401|NCT01547715|Novartis Vaccines and Diagnostics SRL|Posting Director||RegistryContactVaccinesUS@novartis.com|
22380671|NCT02308501|Ora|Caitlin Pearson|978-685-8900|cpearson@oraclinical.com|
22380672|NCT00087490|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22380673|NCT00628628|The University of Texas (UT) MD Anderson Cancer Center|Saroj Vadhan-Raj, MD / Professor||CR_Study_Registration@mdanderson.org|
22380674|NCT02839681|National Cancer Institute|Dr. Raffit Hassan|240-760-6232|raffit_hassan@nih.gov|
22380675|NCT02300311|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
22380676|NCT00848211|Thymon LLC|Gideon Goldstein, MD, PhD|(973) 467-9558|gidgold@gmail.com|
22380677|NCT00772928|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22380678|NCT02165124|Johns Hopkins Univesity|Dr. Clifford Weiss|4106141046|cweiss@jhmi.edu|
22380679|NCT00768599|AmDerma Pharmaceuticals|Candis Edwards|631-974-7949|cedwards@amderma.com|
22380680|NCT01347645|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
22380681|NCT00388362|Stanford University|Laura Johnston, MD|650-723-0822|janices1@stanford.edu|
22380682|NCT01141660|Eastern Virginia Medical School|Cristina Baldassari|7576689853|baldassc@yahoo.com|
22380683|NCT01438229|St. Jude Medical|Steven Madej|651-756-2230|smadej@sjm.com|
22380684|NCT00209027|Emory University|Erica Duncan|404-321-6111|erica.duncan@va.gov|7532
22380685|NCT02335268|GMIHO Gesellschaft für Medizinische Innovation - Hämatologie und Onkologie mbH|Dr. Carsta Köhler|+49 351 25933|info@gmiho.de|100
22426402|NCT03353792|Associate Professor of Medicine|Raimund Herzog, MD, MHS|(877) 925-3637|raimund.herzog@yale.edu|
22426403|NCT01965327|Children's Hospital of Philadelphia|David Lynch, MD, PhD|215-590-1719|lynch@email.chop.edu|
22426404|NCT01294423|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
22426405|NCT01241279|Valeant Pharmaceuticals/Bausch & Lomb|Johnson Varughese|908-927-1162|Johnson.Varughese@valeant.com|
22426406|NCT00710931|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22426407|NCT01484951|Alcon Global Medical Affairs|Abayomi Ogundele, Pharm.D|1-888-451-3937||
22426408|NCT02452047|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22426409|NCT01657617|University of Kentucky|Ronald McGarry|859 323 6486|rcmcga2@email.uky.edu|
22426410|NCT01248455|National Cancer Institute|Dr. Dickran Kazandijian|301-480-0532|kazandjiandg@mail.nih.gov|
22426411|NCT02147613|Arizona State University - Downtown Phoenix Campus|Siddhartha S. Angadi, PhD., FACSM|6028272254|sangadi@asu.edu|
22426412|NCT02654639|Levine Cancer Institute-Concord|Mohamed Salem, MD|704-403-1370|mohamed.salem@lcic.edu|
22426413|NCT04821063|Italfarmaco SpA|Maurizio Caserini, MD|+39 02 6443 2575|m.caserini@italfarmacogroup.com|
22426414|NCT02631941|Zambon S.p.A.|Isabella Salerio, PhD|+3902665241|clinicaltrials@zambongroup.com|
22426415|NCT00597818|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
22426416|NCT04176939|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22426417|NCT02318849|University of Hawaii|Cheryl Albright, PhD, Prinicipal Investigator|808-956-9716|cherylal@hawaii.edu|
22426418|NCT00230048|Wayne State University|Steven J. Ondersma|313-577-6680|s.ondersma@wayne.edu|
22426419|NCT00676403|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22426420|NCT01204203|University of Alabama at Birmingham|Francisco Robert, MD|205-934-5077|pacorobertuab@cs.com|
22426421|NCT00661089|The Rehabilitation Institute of Chicago|Dr. Christina Marciniak|312-238-1000|cmarciniak@ric.org|
22426422|NCT00983372|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22426423|NCT05635045|Columbia University Medical Center|Mathew Maurer|2123058274|msm10@cumc.columbia.edu|
22426424|NCT05044429|GWUniversity|Principal Investigator|202-823-4259|eheinz@mfa.gwu.edu|
22426425|NCT02937623|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22426426|NCT00971867|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials.@bms.com|
22426427|NCT02541864|Kaohsiung Veterans General Hospital|Dr. Feng-Woei Tsay|+886-7-3422121|fwchaie@vghks.gov.tw|8233
22426428|NCT03727841|National Cancer Institute|Dr. Mark Gilbert|240-760-6023|mark.gilbert@nih.gov|
22426429|NCT02247739|Pharming Group NV|VP Clinical Research & Medical Affairs||a.relan@pharming.com|
22440070|NCT02839096|University of Missouri School of Medicine|Research Success Core|(573) 817-3386|obgynresearchsuccesscore@health.missouri.edu|
22426430|NCT02533934|University of California San Francisco|Rodney Rogers|+14155951226|Rodney.Rogers@ucsf.edu|
22426431|NCT00905424|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22440071|NCT04819945|GATT Technologies B.V.|Dr Stuart Head, MD, PhD, Chief Medical Officer|+31645306042|s.head@gatt-tech.com|
22440072|NCT00135226|Nuffield Department of Population Health|Prof Jane Armitage|+44 (0)1865 743743|ascend@ndph.ox.ac.uk|
22440073|NCT00965354|Imperial College|Openshaw, Peter J M|07973 820 801|p.openshaw@imperial.ac.uk|
22440074|NCT02380573|University of Texas Health Science Center at San Antonio|Dr. Peter Fox|210-567-8150|fox@uthscsa.edu|
22440075|NCT00074165|OHSU Knight Cancer Institute|Dr. Edward Neuwelt|503-494-5626|neuwelte@ohsu.edu|
22440076|NCT05379179|University of Arizona|Jessica Winters|520-780-1882|jwinters1@arizona.edu|
22440077|NCT04531176|The Cleveland Clinic Foundation|Kim Jenkins|216-445-4791|jenkink@ccf.org|
22440078|NCT02151487|UT Southwestern Medical Center|Dawood Nasir|214-590-5352|Dawood.Nasir@UTSouthwestern.edu|
22440079|NCT00561652|Minneapolis VA Medical Center|Dr. Howard Fink|612-467-3304|howard.fink@va.gov|
22440080|NCT00214045|University of Wisconsin School of Medicine and Public Health|Dr. Stephen Nakada|(608)263-1359|nakada@urology.wisc.edu|
22440081|NCT04484961|Houston Methodist Hospital|Bradley Lambert, PhD|8326872483|bslambert@houstonmethodist.org|
22440082|NCT00685165|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
22440083|NCT03155724|BIOTRONIK|Clinical Studies Engineer Manager|800-547-0394|crystal.miller@biotronik.com|
22440084|NCT04875013|DR. EYTAN A. DAVID, MD, Otolaryngologist|Dr. Eytan David|(604) 988-0598|dr.david@shaw.ca|
22440085|NCT02485691|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
22440086|NCT02392806|Saint Louis University|Noah Hillman|3145779292|noah.hillman@health.slu.edu|
22440087|NCT03518086|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22440088|NCT02336282|St. Jude Children's Research Hospital|Kevin Krull, PhD|(901) 595-5891|kevin.krull@stjude.org|
22440089|NCT04163341|University of Alabama at Birmingham|Dr. Michael Mugavero|202-966-5822|mmugavero@uab.edu|
22440090|NCT04567628|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22440091|NCT00079417|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org|
22440092|NCT01615939|Northwestern University, Feinberg School of Medicine|Antoun Nader|312-695-3045|a-nader2@northwestern.edu|
22440093|NCT01586364|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
22440094|NCT02121535|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
22440095|NCT05366738|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-7428|medicalinformation@phathompharma.com|
22440096|NCT03821402|Revance Therapeutics, Inc.|Todd Gross, PhD, VP, Clinical Development & Data Science|510-742-3400|tgross@revance.com|
22440097|NCT02208310|University of Michigan|Peter Higgins|7346472964|phiggins@umich.edu|
22426432|NCT01655719|University of Michigan|Tim Muth|734-615-8914|tmuth@med.umich.edu|
22440098|NCT01054885|GlaxoSmithKline|GSK Response Center|866-435-7343||
22440099|NCT00804908|AbbVie|Global Medical Information|800-633-9110||
22440100|NCT01280903|University of Pittsburgh|Elizabeth A. Schlenk|412-624-4103|els100@pitt.edu|
22440101|NCT01533207|NRG Oncology|Linda Gedeon on behalf of Danielle Enserro, PhD|716-845-1169|linda.gedeon@roswellpark.org|
22440102|NCT03829228|USANA Health Science|Dr. Junqiang Tian|8019547462|jeremy.tian@usanainc.com|
22440103|NCT02177695|SWOG Statistics and Data Management Center|Genitourinary Committee Statistician|2066674623|mplets@fredhutch.org|
22426433|NCT00379899|Amgen Inc.|Study Director|866-572-6436||
22426434|NCT01569126|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22426435|NCT01585246|Michigan State University|Dr. Gwen Wyatt|517-884-4630|gwyatt@msu.edu|
22426436|NCT04396626|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22426437|NCT02111174|Johns Hopkins SKCCC|Thomas Smith, M.D.|410-955-2091|tsmit136@jhmi.edu|
22426438|NCT04552132|Saint Louis University|Dr. David Bingham|208-851-0618|davidbingham1623@gmail.com|
22426439|NCT01657162|Radius Health, Inc.|Radius Head of Clinical Operations|(617) 551-4700||
22426440|NCT04907214|Vanderbilt University Medical Center|Dr. Mona Mashayekhi|615-936-1760|mona.mashayekhi@vumc.org|
22426441|NCT03758157|Wello, Inc.|Alan C. Heller|469-522-5200|allen.heller@welloinc.com|
22426442|NCT01005576|Washington University School of Medicine|Dr. Shalini Shenoy|314-454-6018|shalinishenoy@wustl.edu|
22426443|NCT02421419|Penn State Milton S. Hershey Medical Center|Kenneth Taylor, M.D.|(717) 531-5638|ktaylor2@pennstatehealth.psu.edu|
22426444|NCT00726180|Universtiy of Michigan|Anne F. Schott, MD|734-936-6000|aschott@umich.edu|
22426445|NCT01747499|Washington University School of Medicine|Mark A. Schroeder, M.D.|314-454-8304|markschroeder@wustl.edu|
22426446|NCT01676701|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22426447|NCT00196105|Cook|Scott Snyder|765-463-7537|ssnyder@medinst.com|
22426448|NCT05117112|UAMS|David Church|5015265769|dchurch@uams.edu|
22426449|NCT00248651|Mayo Clinic|Dr. Yuri A. Saito Loftus|507-266-9094|saito.yuri@mayo.edu|
22426450|NCT02108977|Health Services Research & Development, Durham VAMC|Dr. Santanu Datta, Health Sciences Research Specialist, HSR&D|(919) 286-0411|Santanu.Datta@va.gov|7580
22426451|NCT01365130|BrUOG|Howard Safran, MD|4018633000|Hsafran@lifespan.org|
22426452|NCT00909064|UC Davis|Gavin Pereira|916-534-0919|gcpereira@ucdavis.edu|
22426453|NCT05607576|Cincinnati Children's Hospital Medical Center|Deborah Elder; Associate Professor|5136364744|Deborah.Elder@cchmc.org|
22426454|NCT05616013|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22426455|NCT00870467|Abbott|Global Medical Services|800-633-9110||
22426456|NCT03430856|Biocon Research limited|Dr. Subramanian L|080-28082808|subramanian.l101@biocon.com|1323
22426457|NCT00962078|Schoen Klinik Berchtesgadener Land, Schoenau am Koenigssee, Germany|Dr. Rainer Gloeckl|+49 8652 931630|rgloeckl@schoen-klinik.de|
22426458|NCT02481050|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22426459|NCT04159714|Mayo Clinic|Dr. Robert Hyde|507-255-4137|Hyde.Robert1@mayo.edu|
22426460|NCT02357459|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
22426461|NCT01022203|Southeast Louisiana Veterans Health Care System (SLVHCS)|Frederic Sautter, Ph.D.|504-988-3026|Fsautter@tulane.edu|
22426462|NCT04350593|Saint Luke's Hospital of Kansas City|DARE-19 Global Project Manager|816-932-9858|DARE-19@saint-lukes.org|
22426463|NCT03638128|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22426464|NCT03163446|ContraFect|Medical Director|914-207-2300|clinicalstudies@contrafect.com|
22426465|NCT00611806|Massachusetts General Hospital|Joshua L. Roffman, MD|617-724-1920|jroffman@partners.org|
22426466|NCT00587067|Memorial Sloan Kettering Cancer Center|Dr. William Jarnagin, MD|212-639-3624|jarnagiw@mskcc.org|
22426467|NCT00903201|GlaxoSmithKline|GSK Response Center|866-435-7343||
22426468|NCT01094288|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22426469|NCT00563290|The Ohio State University Comprehensive Cancer Center|Thomas Olencki, DO|614-293-2886|Thomas.Olencki@osumc.edu|
22426470|NCT02611882|University of California, San Francisco|Dr. Thomas Hope, MD|(415) 221-4810|Thomas.Hope@ucsf.edu|2264
22426471|NCT01228591|Johnson & Johnson Vision Care|Brian Pall, O.D., M.S., F.A.A.O. Principal Research Optometrist|1 904 443-1290|bpall@its.jnj.com|
22426472|NCT01389232|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22426473|NCT01317940|Children's Hospital Los Angeles|Dr. Etan Orgel|3233612672|eorgel@chla.usc.edu|
22426474|NCT04678284|Hennepin Healthcare|Dr. Katherine Diaz Vickery|612-873-6852|katherine.vickery@hcmed.org|
22426475|NCT01921517|University of Pennsylvania Perelman School of Medicine|Felix W. Wehrli, Principal Investigator|215-662-7951|felix.wehrli@pennmedicine.upenn.edu|
22426476|NCT03205150|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22426477|NCT01095835|Hoffmann-La Roche|Medical Communications|800-821-8590||
22426478|NCT00871624|Tufts Medical Center|Russel Roberts, PharmD|617-636-4576|rroberts@tuftsmedicalcenter.org|
22426479|NCT02486692|Ralph H. Johnson VAMC|Anouk Grubaugh|843-532-6672|grubaugh@musc.edu|
22426480|NCT03028142|Verona Pharma plc|Brian Maurer|+19147675037|brian.maurer@veronapharma.com|9147675037
22426481|NCT00001322|National Institute of Mental Health|Schmidt, Peter|+1 301 496 6120|peterschmidt@mail.nih.gov|
22426482|NCT01640548|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22426483|NCT00116688|Amgen Inc.|Study Director|866-572-6436||
22440104|NCT03027609|Aridis Pharmaceutical Inc|Lynne Deans|001-925200|deansl@aridispharma.com|3089
22426484|NCT02864069|UCSD|Dr. Amy Jak|8586423742|ajak@ucsd.edu|
22426485|NCT03593200|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
22426486|NCT01775670|Massachusetts General Hospital|Taylor Pong||tpong1@partners.org|
22426487|NCT01298700|Allergan, Inc|Michael Robinson, MD|714-246-4500|clinicaltrials@allergan.com|
22426488|NCT00129441|University of Pittsburgh|David A. Lewis, MD|(412) 246-6010|lewisda@upmc.edu|
22426489|NCT04006145|Albireo AB|Patrick Horn, MD, PhD|+1 (857) 378- 2035|medinfo@albireopharma.com|
22440105|NCT02443688|Celtaxsys, Inc.|Director, Clincal Operations|4702060153|sbirnbaum@celtaxsys.com|123
22440106|NCT03182374|Zimmer Biomet|Clinical Project Lead|+41791522905|miguelcorreatapia@zimmerbiomet.com|
22426490|NCT01053156|MIND Institute, University of California Davis Medical Center|Randi J. Hagerman MD, Medical Director of the MIND Institute|916-703-0247|randi.hagerman@ucdmc.ucdavis.edu|
22426491|NCT01001429|Rutgers New Jersey Medical School|Anuradha Patel, MD|973 972-1886|patelan@njms.rutgers.edu|
22426492|NCT00010257|ECOG Statistical Office|Study Statistician|617-632-3012||
22426493|NCT02812186|Stony Brook University|Dr. Ruchir Gupta|917-443-1263|gupta2005@yahoo.com|
22426494|NCT02169440|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22426495|NCT00643760|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
22426496|NCT00857506|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
22426497|NCT00789321|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
22426498|NCT00104052|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22426499|NCT01162343|Vanderbilt University Medical Center|Dr. Jin Han, MD|615-936-0253|jin.h.han@vanderbilt.edu|
22426500|NCT03652818|Nevakar, Inc.|Eric Lang, MD|(908) 367-7400|Clinicaltrials@nevakar.com|
22426501|NCT04789304|Boehringer Ingelheim, Call Centre|Boehringer Ingelheim|018002430127|clintriage.rdg@boehringer-ingelheim.com|
22426502|NCT01783743|Johns Hopkins University|Sheila K West|410 955 2606|shwest@jhmi.edu|
22426503|NCT02771275|Edwards Lifesciences, LLC|Sabrina Hundt, Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Sabrina_Hundt@edwards.com|
22426504|NCT03322293|University of California San Francisco Dept. of Dermatology|Dr. Sarah Arron, MD, PhD|415-353-9684|sarah.arron@ucsf.edu|
22426505|NCT01421498|Shire (Note: Lifitegrast was divested to Novartis in 2019)|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22426506|NCT01239797|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22426507|NCT00853762|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22426508|NCT03059914|Loma Linda University Health|Sarat Ummethala|909 558 4983|saratdoc@yahoo.com|
22426509|NCT01418339|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22426510|NCT02219685|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22426511|NCT02869789|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22426512|NCT03506048|Emory University|Dr. Taofeek Owonikoko|412-647-9975|owonikokotk2@upmc.edu|
22426513|NCT00297648|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
22426514|NCT01746862|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22426515|NCT04742673|Vanderbilt University Medical Center|Christopher Hughes|615-322-5000|christopher.hughes@vumc.org|
22426516|NCT03243305|Evofem, Inc.|Chief Medical Officer|858 550 1900|kculwell@evofem.com|
22426517|NCT02689804|Columbia University|Carolyn L. Westhoff, MD|212-305-4805|clw3@columbia.edu|
22426518|NCT00227539|University of Washington|Renato G. Martins|206-288-6680|rgmart@uw.edu|
22426519|NCT00673257|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22426520|NCT00570401|Memorial Sloan Kettering Cancer Center|Dr. Gregory Riely|646-888-4199|rielyg@mskcc.org|
22426521|NCT00910845|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22426522|NCT00792909|GlaxoSmithKline|GSK Response Center|866-435-7343||
22426523|NCT04157088|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22426524|NCT00810199|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22426525|NCT00992017|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|919-405-1429|mallen@fhi360.org|
22440107|NCT01462370|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22440108|NCT03651479|Eastern Mediterranean University|Asst. Prof. Dr. Gozde Iyigun|+903926303011|gozde.iyigun@emu.edu.tr|
22440109|NCT00473564|University of Alabama at Birmingham|William Carroll, MD|205-934-9767|wcarroll@uabmc.edu|
22440110|NCT02135432|University of Alabama at Birmingham|Steven M. Rowe|205-975-6385|smrowe@uab.edu|
22440111|NCT00914316|William Beaumont Hospital|Barbara Higgins, RN|248 551-1535|Barbara.Higgins@beaumont.org|
22440112|NCT04135417|Humacyte Inc.|Shamik Parikh, Chief Medical Officer|919-313-9633|sparikh@humacyte.com|130
22440113|NCT01391546|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22440114|NCT00726063|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
22440115|NCT02007096|Division of General Surgery, Department of Surgery, The Mount Sinai Medical Center|Dr. Celia M Divino|212-241-5499|Celia.Divino@mountsinai.org|
22440116|NCT06271993|Covalon Technologies Inc.|Director of Regulatory Affairs|888-236-4944|customerservice@covalon.com|
22440117|NCT02988466|University of Minnesota, Masonic Cancer Center|Mark Juckett, MD|(612) 626-5654|juck0001@umn.edu|
22440118|NCT00989911|Ahamanson/UCLA ACHDC|Dr. Jamil Aboulhosn|3108255950|jaboulhosn@mednet.ucla.edu|
22426526|NCT01691378|Rocky Mountain MIRECC|Lisa Brenner|720-723-6488|lisa.brenner@va.gov|
22426527|NCT02951312|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
22426528|NCT01107925|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22426529|NCT04235504|Medtronic Diabetes|Javier Castaneda|+31 433566566|javier.castaneda@medtronic.com|
22426530|NCT04877990|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22426531|NCT01514383|Medline Industries, Inc|Ed Drower, Clinical Project Director|847-643-3874|edrower@medline.com|
22440119|NCT00837434|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22426532|NCT01817075|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22426533|NCT04888494|Northwestern University|A. Vania Apkarian|+1 312 503 0404|a-apkarian@northwestern.edu|
22426534|NCT06236113|North Memorial Health Robbinsdale Hospital|Michaela A West, MD, PhD|763-581-3704|Michaela.West@NorthMemorial.com|
22426535|NCT04940156|Oxford University Hospitals NHS Trust|Dr Richard Varini|01865220256|richard.varini@ouh.nhs.uk|
22426536|NCT02067858|University of Pittsburgh|Karen Holeva|412-623-1275|holevakd@upmc.edu|
22426537|NCT01699750|Alcon Research, Ltd.|Jessie Lemp, DrPH|1-888-451-3937|alcon.medinfo@alcon.com|
22426538|NCT01959113|University of California, San Diego|Director of Clinical Trials Unit|858-657-8390|dermstudies@ucsd.edu|
22426539|NCT05310877|The Miriam Hospital|Emily Gathright, PhD|401-793-8271|Emily.Gathright@lifespan.org|
22426540|NCT01868646|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical Research and Medical Information Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
22426541|NCT01831427|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22426542|NCT01878799|National Institute of Allergy and Infectious Diseases|Dr. Shyam Kottilil|+1 301 435 0936|skottilil@niaid.nih.gov|
22426543|NCT01249417|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22426544|NCT01854697|AbbVie|Global Medical Information|800-633-9110||
22426545|NCT00565461|Valneva Austria GmbH|Head Clinical Development|0043120620|info@valneva.com|0
22426546|NCT05556148|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
22426547|NCT01171898|Aragon Pharmaceuticals, Inc.|Senior Medical Director, WC Clinical Oncology Department|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22426548|NCT03191799|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22426549|NCT00468585|Memorial Sloan Kettering Cancer Center|Dr. Tiffany Traina|646-888-4558|trainat@mskcc.org|
22426550|NCT03769649|InMode|Maria Shusterman|855.411.2639|marias@inmodemd.com|
22426551|NCT01607658|Acerus Pharmaceuticals Corporation|Dr. Nathan Bryson, Chief Scientific Officer|1-416-679-0776|nbryson@aceruspharma.com|
22426552|NCT02000921|University of Minnesota|Dorothy Hatsukami|612 626-2121|hatsu001@umn.edu|
22426553|NCT00915590|Massachusetts Eye and Ear Infirmary|Reza Dana, MD, MPH, MSc|617-573-3313|Cornea_Research@meei.harvard.edu|
22426554|NCT03933449|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22426555|NCT00501631|Alkermes, Inc.|Bernard L. Silverman, MD|1-781-609-6000|bernard.silverman@alkermes.com|
22426556|NCT02087774|Marshall University|Rebecca Hayes, M.D.|3046173570|hayes79@live.marshall.edu|
22426557|NCT00719901|Mayo Clinic|A. Keith Stewart|480-301-4411|stewart.keith@mayo.edu|
22426558|NCT02858401|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22426559|NCT02059239|Weill Cornell Medicine|Dr. Tsiporah Shore|646-962-7950|tbs2001@med.cornell.edu|
22426560|NCT00193453|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|askSarah@scresearch.net|
22426561|NCT01408706|Wheaton Franciscan Healthcare - All Saints|Dr. James Taylor|262-687-5000|james.taylor@wfhc.org|
22426562|NCT01268267|Ascensia Diabetes Care|Carmine Greene|574-257-3040|carmine.greene@ascensia.com|
22426563|NCT01307956|University of Nebraska Medical Center|Jean L Grem|402-559-5166|jgrem@unmc.edu|
22426564|NCT02204917|Children's Hospital of Philadelphia|Dr. Kassa Darge, MD, PhD, Radiologist-in-Chief|267-425-7110|DARGE@email.chop.edu|
22426565|NCT01575080|Ascensia Diabetes Care|Carmine Greene|574-257-3040|carmine.greene@ascensia.com|
22426566|NCT01529606|UTHSC|Professor|901-448-2369|lhong2@uthsc.edu|
22426567|NCT02233530|University of Ibadan, Ibadan, Nigeria|Dr Adesola Ogunniyi|+2348038094173|aogunniyi892@gmail.com|
22426568|NCT00490035|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22426569|NCT02577640|Ohio State University|Casey McClurkin|614-293-6255|casey.mclurkin@osumc.edu|
22426570|NCT00731822|GlaxoSmithKline|GSK Response Center|866-435-7343||
22426571|NCT06290089|Scandinavian Biopharma Holding AB / Etvax|Head of Clinical Development|004684705600|info@scandinavianbiopharma.se|
22426572|NCT05209880|Brigham and Women's Hospital|Kei Ouchi, MD, MPH|6175257771|kouchi@bwh.harvard.edu|
22426573|NCT03834493|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22426574|NCT05017272|Q2i LLC Telephone: 646-660-2151 Email: sjenkins@q2i-group.com|Steve Jenkins|646-660-2151|sjenkins@q2i-group.com|
22426575|NCT05796791|Medical University of South Carolina|Emily Amador|916-279-6481|emmcamador@gmail.com|
22426576|NCT05276973|NRG Oncology|Helen Huang on behalf of Wei Deng, PhD.|(716) 845-1300|huangh@nrgoncology.org|2318
22426577|NCT03180736|EMN|Sarah Lonergan, Trial lead|+44 7767565020|sarah.lonergan@emn.life|
22426578|NCT04073303|AbbVie|ABBVIE CALL CENTER|844-663-3742|abbvieclinicaltrials@abbvie.com|
22426579|NCT03258593|National Cancer Institute|Dr. Raju Chelluri|240-858-3700|raju.chelluri@nih.gov|
22426580|NCT06228703|Rush University|Jie Li|3125634643|Jie_Li@rush.edu|
22426581|NCT03437694|University of North Texas Health Science Center|Crystal Hodge|8177350131|crystal.hodge@unthsc.edu|
22426582|NCT04144322|University of Michigan|Dr. Tae-Ju Oh|7346473320|taejuoh@umich.edu|
22426583|NCT02277028|now at Northwestern University, Department of PM&R|Mary Ellen Stoykov|312-503-3106|mstoykov@sralab.org|
22426584|NCT02718911|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22426585|NCT04817332|University of Dundee, UK|Professor James D Chalmers|01382660111|jchalmers@dundee.ac.uk|
22426586|NCT01368263|Washington University School of Medicine|Timothy Pluard, M.D.|314-362-5645|tpluard@saint-lukes.org|
22426587|NCT01982695|Nationwide Children's Hopsital|Dr. Jerry R. Mendell|(614) 722-5615|Jerry.Mendell@NationwideChildrens.org|
22426588|NCT01867008|Cochlear Americas|Clinical Project Manager|303-264-2340|knix@cochlear.com|
22426589|NCT01447888|Allina Health|John Mrachek, MD|612-871-7639|John.Mrachek@allina.com|
22426590|NCT02036931|Zimmer Biomet|Oliver Marti|+41 79 576 31 98|oliver.marti1@zimmerbiomet.com|
22426591|NCT01898403|Stanford University Medical Center|Dana T Lin, MD; Clinical Assistant Professor|650-498-6000|danalin@stanford.edu|
22440120|NCT01980017|University of Ottawa Heart Institute|Dr. Robert Reid|6136967393|breid@ottawaheart.ca|
22426592|NCT05457257|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22426593|NCT01158261|Ethicon, Inc|Director of Clinical Development|908-218-2492|jbatill2@its.jnj.com|
22426594|NCT03143101|MedImmune, LLC|Raburn Mallory|+1-301-398-5799|information.center@astrazeneca.com|
22426595|NCT05227118|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22426596|NCT01435759|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22426597|NCT01601496|Getinge Group|Elizabeth Bulger|603 880 1433 ext 5368|Elizabeth.Bulger@getinge.com|
22426598|NCT03126786|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
22426599|NCT00289094|DePuy Orthopaedics, Inc.|Tammy O'Dell, EMT, CCRA|574-372-7104|TOdell2@its.jnj.com|
22426600|NCT01710020|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22426601|NCT00427908|GlaxoSmithKline|GSK Response Center|866-435-7343||
22426602|NCT04865029|Tulane University|Franck Mauvais-Jarvis|504-259-1139|fmauvais@tulane.edu|
22426603|NCT03377270|Northwestern University|Dr. Bonnie Martin-Harris|847-467-0407|bonnie.martinharris@northwestern.edu|
22426604|NCT05067972|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22426605|NCT02981914|University of Chicago|Theodore Karrison (Research Professor)|773-702-9326|karrisont@nrgoncology.org|
22426606|NCT04391842|Medical Pain Consultants|Dr. Ralph Ortiz|(607) 844-9979|drortizmpc@gmail.com|
22426607|NCT00808067|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22426608|NCT04157517|Takeda (Note: This product was divested to Teva Pharmaceuticals in 2025)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22426609|NCT01900847|University of Arizona|Jaiva Larsen|5039396612|jlarsen@aemrc.arizona.edu|
22426610|NCT02002871|Philips GmbH Innovative Technologies Aachen|Prof. Dr. Matthias Born|+491735321764|matthias.born@philips.com|
22426611|NCT00565604|Lake Washington Vascular Surgery|Daniel Pepper, MD|(425) 453-1772||
22426612|NCT04579380|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22426613|NCT05814419|UCHealth|Gary J Luckasen, MD|970-624-1680|gary.luckasen@uchealth.org|
22426614|NCT04113694|Medtronic Diabetes|Emma Pham, MSHS (Clinical Study Manager)|818 576 4878|emma.pham@medtronic.com|
22426615|NCT00464685|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22426616|NCT05630196|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22426617|NCT03438266|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22426618|NCT03973996|Ohio State University|Dr. Richard Bruno|8603358494|bruno.27@osu.edu|
22426619|NCT04070989|JnJ MedTech|Mary Panozzo|+15744049398|MPanozzo@its.jnj.com|
22426620|NCT06088784|HPI, Inc.|Sr. Director, Clinical Development Operations|301-738-3980|mary.bearkland@hanall.com|
22426621|NCT03635333|Yale University School of Medicine|Danielle Davis|2039747607|danielle.davis@yale.edu|
22426622|NCT00830219|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22426623|NCT01130272|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22426624|NCT00641056|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22426625|NCT03041441|Duke University Dept of Radiology|Research Coordiantor|(919) 684-7732|christopher.vallanat@duke.edu|
22426626|NCT00239720|University of Chicago|Marcus Clark, MD|773-702-0202|mclark@medicine.bsd.uchicago.edu|
22426627|NCT01811732|Melinta Therapeutics, Inc.|Sue Cammarata (Chief Medical Officer)|1-844-MELINTA (1-844-635-4682)|clinicaltrials@melinta.com|
22426628|NCT01405560|Merck Sharp & Dohme Corp|Vice President, Late Stage Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22426629|NCT04773223|University Clinical Centre of Serbia|Petar Zlatanovic|+381644961020|petar91goldy@gmail.com|
22426630|NCT00896493|Stanford University Medical Center|Wen-Kai Weng, Associate Professor of Medicine|650-723-7689|wkweng@stanford.edu|
22426631|NCT00536510|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22426632|NCT02035553|ACADIA Pharmaceuticals Inc.|James Youakim, Vice President, Clinical Development|609-250-6900|jyouakim@acadia-pharm.com|
22426633|NCT04539964|SetPoint Medical|VP of Clinical Affairs|661.750.6140|info@setpointmedical.com|
22426634|NCT01674725|AbbVie|Global Medical Information|800-633-9110||
22426635|NCT03102762|Cairo University|Dr. Hussein Ghanem, Directer of this clinical trial|01001176111|hmhghanem@gmail.com|
22426636|NCT02709746|H. Lundbeck A/S|Email contact via|+45 36301311|LundbeckClinicalTrials@Lundbeck.com|
22426637|NCT03074695|Duke University|Ashraf Habib, M.D.|919-681-4544|ashraf.habib@duke.edu|
22426638|NCT00902577|ACRIN|Donna Harfeil, Director of Protocol Management|215-717-2765|dhartfeil@acr.org|
22426639|NCT01232790|Yale University School of Medicine, Department of Psychiatry|Cenk Tek MD, Associate Professor of Psychiatry; Director, Psychosis Program, CMHC|(203) 974-7484|cenk.tek@yale.edu|
22426640|NCT00083915|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990|pettynathanm@uams.edu|2461
22426641|NCT00956085|Stanford University|Carolyn Rodriguez, MD, PhD, Assistant Professor|6507236158|cr2163@stanford.edu|
22426642|NCT03836586|University of Florida|Dr. Ellen Terry|352-273-6441|elterry@ufl.edu|
22426643|NCT04456686|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22426644|NCT02532036|University of Oxford|Professor Helen McShane|+44 (0)1865 617606|helen.mcshane@ndm.ox.ac.uk|
22426645|NCT03722576|Mayo Clinic|Elizabeth J. Carey, M.D.|480-342-1094|Carey.Elizabeth@mayo.edu|
22426646|NCT00685516|UCLA|Susanne Henning, Ph.D., Principal Investigator|310-825-9345|shenning@mednet.ucla.edu|
22426647|NCT01039467|Fuwai Hospital|Dr. Shu Zhang|861088398833|zsfuwai@vip.163.com|
22426648|NCT02048722|Northwestern University|Mary Mulcahy, MD|312 695 4440|m-mulcahy@northwestern.edu|
22426649|NCT03575702|R-Pharm|Georgiy Sharvadze, Medical Advisor|0074959567937|sharvadze@rpharm.ru|1175
22426650|NCT04074265|University of California, Los Angeles|Rachel Thompson|8472200324|rathompson@mednet.ucla.edu|
22426651|NCT04585919|Harvard TH Chan School of Public Health|James Daly|617-384-8915|jdaly@hsph.harvard.edu|
22426652|NCT03519009|Johns Hopkins University|Professor|4436176051|ksilverm@jhmi.edu|
22426653|NCT02127658|Indiana University|Dr. Paul Musey|(317) 880-3900|pmusey@iu.edu|
22426654|NCT05559905|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22426655|NCT04003103|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22426656|NCT01764841|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22426657|NCT02115607|Sidney Kimmel Cancer Center at Thomas Jefferson University|Flemming Forsberg, PhD|215-955-4870|flemming.forsberg@jefferson.edu|
22426658|NCT04863872|Kaiser Permanente Washington Health Research Institute|James Ralston, MD, MPH|206-287-2076|James.D.Ralston@kp.org|
22426659|NCT00549549|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22426660|NCT02155699|Northwestern University|Dr. Vijay A Mittal|847-467-3880|vijay.mittal@northwestern.edu|
22426661|NCT05547386|Mayo Clinic|Geoffrey Johnson, M.D., Ph.D.|507-284-4104|johnson.geoffrey@mayo.edu|
22426662|NCT00441285|Universidad Peruana Cayetano Heredia|Hector H. Garcia, MD, PhD|+511 3287360|hgarcia@jhsph.edu|
22426663|NCT02573259|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22426664|NCT00952315|IU Health Physicians Urology|James Lingeman, MD|317-962-3700||
22426665|NCT00751140|H. Lee Moffitt Cancer Center and Research Institute|Philippe E. Spiess, M.D.|813-745-8343|philippe.spies@moffitt.org|
22426666|NCT01815502|MUSC|Dr. Andrew M Atz|843-876-1698|atzam@musc.edu|
22426667|NCT02895295|Stanford University|Dr. M. Kate Bundorf|6507250067|bundorf@stanford.edu|
22426668|NCT02249104|Galderma Laboratories L.P.|Dr. Jay Mashburn|817 961 5027|jay.mashburn@galderma.com|
22426669|NCT05254340|Indiana University|Dr. Huiping Xu|317-278-6735|huipxu@iu.edu|
22426670|NCT04000438|Dilafor AB|Gunvor Ekman-Ordeberg|+467060833111|gunvor.ekman-ordeberg@dilafor.com|
22426671|NCT00223665|University of Washington|Celestia Higano, MD|206-606-1187|mjcampbe@seattlecca.org|
22426672|NCT00418028|GEICAM (Grupo Español de Investigación en Cancer de Mama)|The Oncologist 2015;20:1-2 http://www.theoncologist.com/ Scientific Director and CEO|+34916592870|geicam@geicam.org|
22426673|NCT01945944|Rainbow Babies and Children's Hospital|Steven Shein, MD|216-844-3310|drstevenshein@gmail.com|
22426674|NCT00816777|Generic Devices Consulting, Inc|John Greenbaum|772-353-5301|genericd@bellsouth.net|
22426675|NCT04376515|University of California, Irvine|Dr. Dominic Ugarte|949-508-0135|dugarte@hs.uci.edu|
22426676|NCT03811821|Mayo Clinic|Adil Bharucha, M.B.B.S., M.D.|507-266-6931|bharucha.adil@mayo.edu|
22426677|NCT03574974|Yale University|Ilan Harpaz-Rotem Professor|203-937-4760|ilan.harpaz-rotem@yale.edu|
22426678|NCT03433898|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22426679|NCT04369833|Pusan national university hospital|Dr. Sang Soo Kim|+82-51-240-7837|drsskim7@gmail.com|
22426680|NCT06729177|University of Tennessee, Knoxville|Leala Holcomb|415-307-6410|lholcom5@utk.edu|
22426681|NCT01395810|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
22426682|NCT03574038|Study's principal investigator|Dr. Mersedeh Bahr-Hosseini|3107941195|MBahrHosseini@mednet.ucla.edu|
22426683|NCT05069259|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22426684|NCT01496976|Moffitt Cancer Center|Celeste M. Bello, MD|813-745-8623|Celeste.Bello@moffitt.org|
22426685|NCT05556616|Takeda (Note: This product was divested to Teva Pharmaceuticals in 2025)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22426686|NCT03256578|Leiden University Medical Center|Dr. Arjan te Pas|+31 71 5265839|a.b.te_pas@lumc.nl|
22426687|NCT05428436|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
22426688|NCT03964207|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22426689|NCT05252858|UPMC|Amy Monroe|412-623-6382|monroeal@upmc.edu|
22426690|NCT02337062|Acacia Pharma Ltd|Dr Gabriel Fox|44-(0)1223-919764|GabrielFox@acaciapharma.com|
22426691|NCT00001566|National Cancer Institute (NCI), National Institutes of Health (NIH)|Crystal Mackall, M.D.|301-402-5940|mackallc@mail.nih.gov|
22426692|NCT01290718|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22426693|NCT00578903|Baylor College of Medicine|Kathryn Leung|832-824-4269|kleung@bcm.edu|
22426694|NCT01222104|St Jude Medical|Andrew Campbell|651-756-5538|acampbell2@sjm.com|
22426695|NCT00888654|Barbara Ann Karmanos Cancer Institute|Elisabeth Heath, M.D.|313-576-8715|heathe@karmanos.org|
22426696|NCT03250689|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22426697|NCT03669549|Millendo Therapeutics|Clinical Trial Information|+1 734-845-9000|millendo@millendo.com|
22426698|NCT04023578|Ossur Iceland ehf|Kristleifur Kristleifsson|6641112|kkristjansson@ossur.com|+354
22426699|NCT00705757|Summa Health System ( at the time of the trial)|Deepak P. Edward, MD|330-780-0399|deepak.edward@gmail.com|
22426700|NCT02425306|University of Virginia|Craig Slingluff, MD, Professor of Surgery|434-924-9311|cls8h@virginia.edu|
22426701|NCT02265965|University of California, San Francisco|Jennifer Lucero, MD|415-476-5535|jennifer.lucero@ucsf.edu|
22426702|NCT05953363|Becton, Dickinson and Company|Gloria Viti/Clinical Project Manager|00393452237718|gloria.viti@bd.com|
22426703|NCT01701674|H. Lee Moffitt Cancer Center and Research Institute|Dr. Amod Sarnaik|813-745-8581|amod.sarnaik@moffitt.org|
22426704|NCT03387267|Nestlé Health Science|Kemuel Reyes|(908) 333-9379|Kemuel.Reyes@us.nestle.com|
22426705|NCT05696392|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22426706|NCT02783898|NHS Lothian|Dr Matt Reed|+44 131 242 1448|Matthew.Reed@nhslothian.scot.nhs.uk|
22426707|NCT00359203|Medtronic Italia SpA|Silvia Giuli|003932814224|silvia.giuli@medtronic.com|
22426708|NCT04464707|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
22426709|NCT02131064|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22426710|NCT01062893|Wake Forest University School of Medicine|Peter H. Pan, MD|336-718-8278|ppan@wakehealth.edu|
22426711|NCT02554760|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|Kerrie.Jiang@allergan.com|
22426712|NCT00593918|University of Wisconsin-Madison|Theresa Guilbert, MD|608-263-9608|tguilbert@wisc.edu|
22426713|NCT02638974|University of Manchester|Dr Kerry Gutridge, Trial Manager|0161-306-7931|kerry.gutridge@manchester.ac.uk|
22426714|NCT04663685|UBC/Arthritis Research Canada|Ellen Wang|2266980999|ewang@arthritisresearch.ca|
22426715|NCT00394888|Medical College of Wisconsin|Dr. Beth Drolet|414-266-1569|bdrolet@mcw.edu|
22426716|NCT02078193|East Carolina University, Division of Nephrology|Austin Rice|252-744-1904|riceau15@ecu.edu|
22426717|NCT04458675|Vibrant LTD|Tal Malina / Clinical trials manager|+972 046663322|tal.m@vibrantgastro.com|
22426718|NCT01579513|Medical University of South Carolina|Eric Graham, MD|843-792-9570|grahamem@musc.edu|
22426719|NCT00936455|University of California San Diego|Dr Brett Meyer|619-543-7760|bcmeyer@ucsd.edu|
22426720|NCT00871234|Indiana University School of Medicine|Samir K. Gupta, MD, MS|317-274-7926|sgupta1@iupui.edu|
22426721|NCT00866905|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22426722|NCT04202497|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22426723|NCT04344301|Dartmouth College|Dr. Paul Barr|+1-603-653-0863|paul.j.barr@dartmouth.edu|
22426724|NCT00072410|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22426725|NCT02903446|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Angelo Gaffo, MD; Associate Professor|205-996-6086|agaffo@uab.edu|
22426726|NCT05590377|Takeda (Note: This product was divested to Teva Pharmaceuticals in 2025)|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22426727|NCT03389620|Duke University|Timothy J. Amrhein, M.D.|919-684-1909|timothy.amrhein@duke.edu|
22426728|NCT02201342|Mezzion Pharmaceuticals|Won Geun Kim|3128980292|wg.kim@mezzion.com|
22426729|NCT04782180|University of Miami|Hansel Tookes, Professor of Medicine|305-689-7030|hetookes@miami.edu|
22426730|NCT05852353|Stanford University|Kathleen Kan, MD|(650) 497-8000|kkan@stanford.edu|
22426731|NCT01005745|H. Lee Moffitt Cancer Center and Research Institute|Amod Sarnaik, M.D.|813-745-8581|amod.sarnaik@moffitt.org|
22426732|NCT06077773|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22426733|NCT03834506|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22426734|NCT02499146|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22426735|NCT04325828|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22426736|NCT05115630|University of Texas MD Anderson Cancer Center|Jeremy Ramdial, MD./ Stem Cell Transplantation Department|713-745-0146|JLRamdial@mdanderson.org|
22426737|NCT02287038|Ralph H. Johnson VA Medical Center|Dr. Zhewu Wang|8437897949|zhewu.wang@va.gov|
22426738|NCT03160716|Q-Med AB|Reception|+46184749000|reception.seupp@galderma.com|
22426739|NCT01628848|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6131-7366||
22426740|NCT01377636|New York University Langone Medical Center, Anesthesiology|Patrick Linton, MD, Director of Adult Off-Site Anesthesia Services|212-263-5072|Patrick.Linton@nyumc.org|
22426741|NCT00689338|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22426742|NCT01939314|Indiana University School of Medicine|Jason Schaffer, MD|317-962-8026|jtschaff@iupui.edu|
22426743|NCT00735007|Merck Serono International, S.A., an affiliate of Merck KGaA, Darmstadt, Germany|Elisabetta Verdun di Cantogno|+41 22 414 4887|elisabetta.verdun@merckserono.net|
22426744|NCT00078286|Duke University|Dr. Ranga Krishnan|919-668-3647|krish001@mc.duke.edu|
22426745|NCT00969228|GlaxoSmithKline|GSK Response Center|866-435-7343||
22426746|NCT02371876|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com|
22426747|NCT02284386|Pacira|James B. Jones, MD, PharmD|(973) 254-3560|jim.jones@pacira.com|
22426748|NCT03311945|Hospital Clinic of Barcelona|Esteban Martínez|+34 93 227 54 00|estebanm@clinic.cat|
22426749|NCT01619878|Novartis Pharmaceuticals|Study Director|862-778-8300||
22426750|NCT03839394|Duke University|Nwora Lance Okeke, MD, MPH|919-684-2579|lance.okeke@duke.edu|
22426751|NCT00922636|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22426752|NCT00870727|Indiana University|Christopher J. McDougle, MD|781-860-1783|cmcdougle@partners.org|
22426753|NCT00557466|Novartis Pharmaceuticals|Study Director|862-778-8300||
22426754|NCT01712516|Novartis Pharmaceuticals|Study Director|862-778-8300||
22426755|NCT01251952|Barbara Ann Karmanos Cancer Institute|Zaid Al-Kadhimi, M.D.|(313) 576-8022|alkadhiz@karmanos.org|
22426756|NCT00496769|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22426757|NCT02308046|Curatek Pharmaceuticals|Vice President|847-806-7680|info@curatek.com|
22426758|NCT00869414|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
22426759|NCT00607243|Seoul National University Hospital|Myoung-don Oh, M.D.|+82-2-2072-2945|mdohmd@snu.ac.kr|
22426760|NCT02224625|Bioscience Labs|C Beausoleil|406-587-5735|cbeausoleil@bioscience.com|
22426761|NCT01181167|Daiichi Sankyo Co., Ltd.|Masayuki Fukuzawa, Associate Director|81-90-5584-2197|fukuzawa.masayuki.gn@daiichisankyo.co.jp|
22426762|NCT01996371|OhioU|Shelby Miracle|614-366-1648|shelby.miracle@osumc.edu|
22426763|NCT01573000|GlaxoSmithKline|GSK Response Center|866-435-7343||
22426764|NCT01125098|Department of Oncology Haematology and Respiratory Diseases|Leonardo Fabbri|+39 059422|leonardo.fabbri@unimore.it|4227
22426765|NCT03342001|University of Maryland School of Medicine|Dr. Kashif Munir|443-682-6873|kmunir@som.umaryland.edu|
22426766|NCT00729521|Medical College of Wisconsin|Peter Layde, MD, MSc|414-955-8113|playde@mcw.edu|
22440121|NCT03044106|University of North Carolina at Chapel Hill|Nicholas Wise, DC|(864) 494-1001|nicholas_wise@med.unc.edu|
22426767|NCT01384877|BC Cancer|Dr. Philippa Hawley|604-877-6000|phawley@bccancer.bc.ca|67-2752
22426768|NCT01003106|Wilmer Eye Institute, Johns Hopkins University School of Medicine|Peter A. Campochiaro, MD|(410) 955-5106|pcampo@jhmi.edu|
22426769|NCT01968421|Peking Union Medical College Hospital|Dr. Jinming Gao, Director of Clinical Trials|8610691550549|gjinming@yahoo.com|
22426770|NCT01930539|University of Nebraska Medical Center|Lynn Mack|402-559-6276|lmack@unmc.edu|
22426771|NCT01548404|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
22426772|NCT01962675|Shepherd Center|Edelle Field-Fote|404-603-4274|edelle_field-fote@shepherd.org|
22426773|NCT04040439|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22426774|NCT00426270|Octapharma USA|Michael Eppolito|201 604-1155|michael.eppolito@octapharma.com|
22426775|NCT01117870|McMaster University/ St. Joseph's Healthcare Hamilton|Dr. Harsha Shanthanna|905-522-1155|harshamd@gmail.com|
22426776|NCT01450813|Fletcher Allen Health Care at The University of Vermont|Donald Mathews, M.D.|(802) 847-2415|Donald.Mathews@vtmednet.org|
22426777|NCT00896064|GlaxoSmithKline|GSK Response Center|866-435-7343||
22426778|NCT01309386|Neuroscience department, Clinical science department, R&D in Janssen, Chiyodaku, Tokyo 101-0065, Japan|Manager|+81-3-4411-5509||
22426779|NCT02062437|Tornier SAS|Nathalie Trétout|+33 4 76 71 35 00|nathalie.tretout@tornier.com|
22426780|NCT02779491|Bournemouth University|Prof. Katherine Appleton|+441202965985|k.appleton@bournemouth.ac.uk|
22426781|NCT00752089|GlaxoSmithKline|GSK Response Center|866-435-7343||
22426782|NCT01774981|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22426783|NCT01324102|VA Boston Healthcare System|Jennifer Moye|774-826-3721|jennifer.moye@va.gov|
22426784|NCT03362944|Frohlich Lab - University of North Carolina at Chapel HIll|Trevor McPherson|919-966-4755|trevor_mcpherson@med.unc.edu|
22426785|NCT01235065|R Adams Cowley Shock Trauma Center|Dale Yeatts, Principal Investigator|443-909-0648|djyeatts@gmail.com|
22426786|NCT00728494|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22426787|NCT00975416|National Institute on Drug Abuse|Mary R. Lee, M.D.|301-825-0545|leemary@mail.nih.gov|
22426788|NCT02915835|University of Michigan|Dr. Cathie Spino|7346155469|spino@umich.edu|
22426789|NCT00433836|Novartis Pharmaceuticals|Study Director|862-778-8300||
22426790|NCT00748241|Astra Tech AB|Head of Clinical Research Area Dental|+46317763000||
22426791|NCT01240382|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
22426792|NCT02456727|Albert Einstein College of Medicine|Diane McKee|718-430-2952|Diane.Mckee@einstein.yu.edu|
22426793|NCT02643693|Philip Morris Products S.A.|Christelle Haziza, PhD|+41 (58) 242 11 11|ClinicalTrials.PMI@pmi.com|
22426794|NCT01319565|National Cancer Institute|Dr. Steven A. Rosenberg|240-858-3080|sar@mail.nih.gov|
22426795|NCT00113607|Janssen R&D US|Director Clinical Research Medical Leader|908 704 5779||
22426796|NCT00685815|Luitpold Pharmaceuticals, Inc.|Angie Butcher|610-650-4200|abutcher@lpicrd.com|
22426797|NCT00909844|Ipsen Pharma|Medical Director, Endocrinology||clinical.trials@ipsen.com|
22426798|NCT00698815|Massachusetts General Hospital|Rebecca S. Heist, MD||rheist@partners.org|
22426799|NCT02974868|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22426800|NCT00706004|University of Arkansas for Medical Sciences|Catherine O'Brien|501-364-1828|obriencatherinee@uams.edu|
22426801|NCT02674516|Nanyang Technological University|Dr. Olivia Choy|(65) 65921522|oliviachoy@ntu.edu.sg|
22426802|NCT01064479|UT MD Anderson Cancer Center|Dr. Xiuning Le, MD, Assistant Professor, Thoracic-Head & Neck Med Onc|(713) 792-6980|xle1@mdanderson.org|
22426803|NCT01535118|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22426804|NCT00749398|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22426805|NCT02634073|GlaxoSmithKline|GSK Response Center|866-435-7343||
22426806|NCT01639352|University of Miami|Lynn Feun, M.D.|305-243-4909|lfeun@med.miami.edu|
22426807|NCT01663402|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1
22426808|NCT01211145|AstraZeneca|Jamie Mullen, Medical Science Director|781-472-5032|jamie.mullen@astrazeneca.com|
22426809|NCT04195061|Massachusetts General Hospital|Melanie S. Haines, MD|617-726-3870|mshaines@mgh.harvard.edu|
22426810|NCT04252625|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
22426811|NCT01720316|McLean Hospital|Dr. Deborah L. Levy|617-855-2854|dlevy@mclean.harvard.edu|
22426812|NCT04577794|Galapagos NV|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
22426813|NCT02713178|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
22426814|NCT01298167|Yale University|David Leffell, MD|203 785 7999|david.leffell@yale.edu|
22426815|NCT02864732|University of Pittsburgh|Research Assistant|412 4822283|mza7@pitt.edu|
22426816|NCT02667301|StratejikYG|Murat Haluk Ozkul|0905327777842|kbbhaluk@gmail.com|
22426817|NCT01645059|Hospital San Pedro Alcántara|Dr. Santiago González Santiago||santidatvs@hotmail.com|
22426818|NCT00846586|Novartis Pharmaceuticals|Study Director|862 778-8300||
22426819|NCT02104895|Radiation-Oncology Unit, AOU Careggi, Florence University, Florence, Italy|Dr. Icro Meattini|+39055794|icro.meattini@unifi.it|7719
22426820|NCT05770713|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22426821|NCT01883895|UW Madison|Nalini Sehgal|608-263-8639|sehgal@rehab.wisc.edu|
22426822|NCT04414787|Duke University|Christopher Cox|919-681-7232|christopher.cox@duke.edu|
22426823|NCT05093933|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22426824|NCT02532283|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22426825|NCT01249131|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22426826|NCT00473083|BC Cancer Agency|Dr. Barbara Melosky, Principal Investigator|604-877-6000|BMelosky@bccancer.bc.ca|
22426827|NCT01184872|Novartis Pharmaceutical|Study Director|862 778 8300||
22426828|NCT03426345|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
22426829|NCT02431598|Duke University Medical Center|Dr. Mustafa Bashir|919-684-8111|mustafa.bashir@duke.edu|
22426830|NCT02446691|GlaxoSmithKline|GSK Response Center|866-435-7343|sss42438@gsk.com|
22426831|NCT00192114|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22426832|NCT00492297|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22426833|NCT03885908|Memorial Sloan Kettering Cancer Center|Dr. Armin Shahrokni, MD, MPH|646-888-3651|shahroka@mskcc.org|
22426834|NCT03817606|Riverside Medical Center|Cynthia Koehn, Clinical Research Nurse|815-933-1671|ckoehn@rhc.net|
22426835|NCT00466817|University of Alabama in Birmingham|David Kimberlin, MD|205-934-2424|dkimberlin@peds.uab.edu|
22426836|NCT03194334|University Ghent|Prof. Wim Derave|+32/9/2646326|wim.derave@ugent.be|
22426837|NCT00678418|Alkermes, Inc.|Bernard L. Silverman, MD|1-781-609-6000|bernard.silverman@alkermes.com|
22426838|NCT03924323|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22426839|NCT03903172|Wright State University|Sheela Barhan, MD|937-208-2850|sheela.barhan@wright.edu|
22426840|NCT01545388|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22426841|NCT01900444|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22426842|NCT00072384|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22426843|NCT01380366|Northwestern University|Dr. Jonathan Fryer, MD|312-695-2125|jfryer@nmh.org|
22426844|NCT06058390|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22426845|NCT02495389|Loyola University Chicago|Alan Wolfe, Ph.D.|708-216-5814|awolfe@luc.edu|
22426846|NCT03585270|Idorsia Pharmaceutical Ltd|Idorsia Clinical Trial Information|+1 856 661 3721|idorsiaclinicaltrials@idorsia.com|
22426847|NCT03292016|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
22426848|NCT02184208|Boston Children's Hospital|Brian Kendall Walsh|617-919-3692|brian.walsh@childrens.harvard.edu|
22426849|NCT01802385|University of Minnesota|Joshua Rhein|612-624-1966|joshua.rhein@gmail.com|
22426850|NCT02756910|Peking Union Medical College Hospital|Lijian Pei|＋86 10 69152020|hazelbeijing@vip.163.com|
22426851|NCT00323063|Rutgers Cancer Institute of|Deborah Toppmeyer, MD|732-235-6789|toppmede@cinj.rutgers.edu|
22426852|NCT03904693|Actelion Pharmaceuticals Ltd.|Clinical Scientific Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22426853|NCT04195594|TRCGEN+ (managed by Trans Russian Co)|Nikolaos Tzenios|+447583902071|Nicolas@trccolleges.com|
22426854|NCT01172873|New York State Psychiatric Institute/Columbia University|Moira A. Rynn, M.D.|646-774-5805|RynnM@nyspi.columbia.edu|
22426855|NCT05518539|Newsom Eye|T Hunter Newsom|813-908-2020|hunter@newsomeye.net|
22426856|NCT03077893|Regenesis Biomedical|Heather M Vander Ploeg|602-428-7041|heather.vanderploeg@regenesisbio.com|
22426857|NCT01218542|Emory University|Dr. Hui-Kuo Shu|404-778-2161|hgshu@emory.edu|
22426858|NCT03569397|University of Alabama at Birmingham|Adam Sturdivant, MPH|205-934-4042|Adamsturdivant@uabmc.edu|
22426859|NCT04613518|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22426860|NCT03589807|Emory Children's Center|Evan J. Anderson, MD|404-727-5642|evanderson@emory.edu|
22426861|NCT01076543|University of Chicago|Dr. Sonali Smith, Professor of Medicine|773-834-2895|smsmith@medicine.bsd.uchicago.edu|
22426862|NCT00338741|EMD Serono|Liz Gedney/Clinical Trial Leader|+781 681-2179||
22426863|NCT01534273|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22426864|NCT01619865|University of Iowa Holden Comprehensive Cancer Center|Sue O'Dorisio, MD, PhD|319-356-7873|sue-odorisio@uiowa.edu|
22426865|NCT03586050|ETHICON|Jaclyn Calia Stanziola|908-808-6380|jcalia@its.jnj.com|
22426866|NCT01494818|Alcon Research, Ltd.|Renee Garofalo, OD, FAAO|1-888-451-3937|alcon.medinfo@alcon.com|
22426867|NCT04831138|UT Southwestern Medical Center|Dr. Ananth Madhuranthakam|214-648-7737|ananth.madhuranthakam@utsouthwestern.edu|
22426868|NCT00791999|Medical Advisor of the Clinical Trial|Dr. Kazuhiko Yamamoto, Medical Advisor of the Clinical Trial|+81 3 5800 8825|yamamoto-tky@umin.ac.jp|
22426869|NCT01787006|Department of Radiation Oncology, University of Lübeck, Germany|Prof. Dr. med. Dirk Rades|0049 451 500|dirk.rades@uksh.de|45401
22426870|NCT02688933|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22426871|NCT03509467|Moffitt Cancer Center|Peter Kanetsky, PhD, MPH|813-745-3988|Peter.Kanetsky@moffitt.org|
22426872|NCT04379921|Stanford University|Corinna Zygourakis, MD|(650) 723-6469|corinnaz@stanford.edu|
22426873|NCT04275973|University of Wisconsin - Madison|Peter Adamczyk|(608) 263-3231|peter.adamczyk@wisc.edu|
22426874|NCT06110754|Emory University|Soumitri Sil, PhD|404-727-2712|soumitri.sil@emory.edu|
22426875|NCT03383874|University of Texas Southwestern Medical Center|Dr. E. Sherwood Brown|214-645-6950|sherwood.brown@utsouthwestern.edu|
22426876|NCT00791219|Mayne Pharma|Stuart Mudge, VP Scientific Affairs|+613 8614 7704|stuart.mudge@maynepharma.com|
22426877|NCT00767572|UCSF|Dr. Doreen DeFaria Yeh|617-643-7024|ddefariayeh@partners.org|
22426878|NCT04037358|Johns Hopkins University School of Medicine|Dr. Ana P. Kiess|443-287-7528|akiess1@jhmi.edu|
22426879|NCT04112368|University of Illinois Chicago|Tory Eisenlohr-Moul|859-317-0503|temo@uic.edu|
22426880|NCT01949142|Otonomy, Inc|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
22426881|NCT05027815|University of California, San Francisco|Jonathan Esensten MD, PhD|415-502-3785|Jonathan.Esensten@ucsf.edu|
22426882|NCT00674206|Emory University|Dr. Amelia Zelnak|404-778-1900|amelia.zelnak@emoryhealthcare.org|
22426883|NCT04802161|University of North Carolina, Lineberger Comprehensive Cancer Center|Dr. Joshua F. Zeidner|919-962-5164|Joshua_Zeidner@med.unc.edu|
22426884|NCT06831344|Phathom Pharmaceuticals, Inc.|Phathom Medical Information|1-888-775-7428|medicalinformation@phathompharma.com|
22426885|NCT00447902|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22426886|NCT02873689|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22426887|NCT00350545|Stanford University|David B. Miklos|650 725-4959|dmiklos@stanford.edu|650
22426888|NCT01794702|The University of Texas MD Anderson Cancer Center|Nitin Jain, MD./Associate Professor|713-745-6080|njain@mdanderson.org|
22426889|NCT00434252|Genentech, Inc.|Medical Communications|800-821-8590||
22426890|NCT00641563|University Hospital Bern, Switzerland|Dr. M. Hänggi|0316323029|matthias.haenggi@insel.ch|
22426891|NCT00352118|Masonic Cancer Center, University of Minnesota|Frank Ondrey, M.D.|612-625-3200|ondre002@umn.edu|
22426892|NCT02997163|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22426893|NCT02337764|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22426894|NCT02990000|University of Massachusetts Amherst|Dr. Michael J. Constantino|4135451388|mconstantino@psych.umass.edu|
22426895|NCT01446705|Center for Health Information and Communication, Roudebush VA Medical Center|Dr. David A. Haggstrom|317-988-2067|dahaggst@iu.edu|
22426896|NCT03653741|Weill Cornell Medical College|David Chuang, MD|212-746-5519|dtc9002@med.cornell.edu|
22426897|NCT02349438|Johnson & Johnson Vision Care Inc.|Chantal Coles-Brennan, PRINCIPAL RESEARCH OPTOMETRIST|904-443-3449|CColesb@ITS.JNJ.com|
22426898|NCT01949545|Amgen, Inc.|Study Director|866-572-6436||
22426899|NCT01831219|Think Surgical|Senior Manager of Clinical Applications|510-249-2339|nnetravali@thinksurgical.com|
22426900|NCT03268343|Achieve Life Sciences|Daniel Cain, Senior Director Clinical Research|425.686.1546|dcain@achievelifesciences.com|
22426901|NCT02810418|National Cancer Institute|Dr. Christine C. Alewine|240-760-6146|christine.alewine@nih.gov|
22426902|NCT03103503|BIOTRONIK|Clinical Studies Engineer Manager|800-547-0394|crystal.miller@biotronik.com|
22426903|NCT05088772|University of Toronto|Dr. Connor Brenna|416 340 3598|connor.brenna@mail.utoronto.ca|
22426904|NCT00452374|The University of Texas M. D. Anderson Cancer Center|William Wierda, M.D./Associate Professor|713-745-0428|eharriso@mdanderson.org|
22426905|NCT01433159|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
22426906|NCT01100853|University of Pennsylvania|Dr. Helen Pettinati|215-222-3200|helenp@mail.med.upenn.edu|139
22426907|NCT04161391|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
22426908|NCT01507181|Mood and Anxiety Disorders Program, Department of Psychiatry, Icahn School of Medicine at Mount Sinai|Dr. J. W. Murrough|212-241-7574|james.murrough@mssm.edu|
22426909|NCT00702780|Seoul National University Hospital|Young Min Choe|82-2-2072-1730|howlow44@daum.net|
22426910|NCT01863771|Janssen Pharmaceutical K.K.|Senior Director Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
22426911|NCT00386334|Sepracor Inc.|Lunesta Medical Director|1-866-503-6351||
22426912|NCT02089347|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22426913|NCT00458237|Beth Israel Deaconess Medical Center|Gerburg Wulf|(617) 667-1910|gwulf@bidmc.harvard.edu|
22426914|NCT02914834|University of Illinois Chicago|Judith Schlaeger, PhD|3124134669|jschlaeg@uic.edu|
22426915|NCT03060473|University of Texas Medical Branch|Dr. Nkechinyere Emezienna|4097476651|nkemezie@utmb.edu|
22426916|NCT01225549|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22426917|NCT02730962|University of Minnesota|Dr. Alexander Khoruts|612-624-2101|khoru001@umn.edu|
22426918|NCT00286182|Columbia University|Mathew Maurer, MD, Professor of Medicine at the Columbia University Medical Center|212-305-9808|msm10@cumc.columbia.edu|
22426919|NCT00289211|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22426920|NCT02666222|Envoy Medical Corp.|Elizabeth Anderson, PhD|651-361-8080|landerson@envoymedical.com|
22426921|NCT01825200|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
22426922|NCT01474486|Phoenix VA Health Care System|Diane J. Parrington|602-277-5551|diane.parrington@va.gov|7532
22426923|NCT01255163|National Institute on Aging (NIA/NIH)|Dimitrios Kapogiannis, Clinical Investigator|410-350-3953|kapogiannisd@mail.nih.gov|
22426924|NCT00898937|Georgetown University Medical Center - Lombardi Comprehensive Cancer Center|Claudine Isaacs|202-444-3677|isaacsc@georgetown.edu|
22426925|NCT04219189|Virginia Commonwealth University|Dr. Caroline Cobb|(804) 827-3562|cobbco@vcu.edu|
22426926|NCT03863353|University of Michigan|Dr. Terri Voepel-Lewis|734-6466803|terriv@umich.edu|
22426927|NCT00966433|Wake Forest University Health Sciences|Dr. Thomas Templeton, MD|336-716-4285|ttemplet@wakehealth.edu|
22426928|NCT04079790|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22426929|NCT01297283|Medtronic|Latifa Foudali|+33 631992144|latifa.foudali@medtronic.com|
22426930|NCT01924533|AstraZeneca|Gershon Locker Global Clinical Lead (GCL)||gershon.locker@astrazeneca.com|
22426931|NCT05817669|Argenx|Regulatory manager|Please email:|regulatory@argenx.com|
22426932|NCT04233879|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22426933|NCT03918811|Hospitalsantojanni|Professor Mauro Andreu|+541168788298|mfandreu@gmail.com|
22426934|NCT03055936|Orion Corporation, Orion Pharma|Clinical Study Director|+358104264184|clinicaltrials@orionpharma.com|
22426935|NCT03041636|The University of Texas MD Anderson Cancer Center|Zeev Extrov MD./Professor|713-794-1675|zestrov@mdanderson.org|
22426936|NCT02115984|Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences|Dr. Sergey S. Bogachev|+7-963-946-57-69|labmolbiol@mail.ru|
22426937|NCT05002972|University of Kentucky|Dawn Brewer|859-257-1661|dawn.brewer@uky.edu|
22426938|NCT01664091|Dana-Farber Cancer Institute|Julia Wong, MD|617-632-3591|JWONG@LROC.HARVARD.EDU|
22426939|NCT02240667|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22426940|NCT01578772|UCLA|Dr. Jordan Lake|310-557-2273|jlake@mednet.ucla.edu|
22426941|NCT00086190|University of Rochester Medical Center|Irene H. Richard, MD|585-341-7500|irene_richard@urmc.rochester.edu|
22426942|NCT00249834|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22440122|NCT01207414|Novartis Pharmaceuticals|Study Director|862-778-8300||
22440123|NCT01748292|Retina Consultants of Houston|Charles C. Wykoff, MD, PhD|713-524-3434|ccwmd@houstonretina.com|
22426943|NCT01217827|VA Palo Alto HCS|Paul Heidenreich|650-849-1205|paul.heidenreich@va.gov|
22426944|NCT05502302|University of Minnesota, Masonic Cancer Center|Dr. Rachel Vogel|612-624-6928|isak0023@umn.edu|
22426945|NCT02998151|Cincinnati Children's Hospital Medical Center|Dr. Craig Erickson|513-636-0523|craig.erickson@cchmc.org|
22426946|NCT03301636|Lumos Pharma Inc. (Formerly NewLink Genetics)|Lumos Pharma|515-598-2921|clinical.trials@lumos-pharma.com|
22426947|NCT03459625|Loma Linda University|Cameron Leigh Neece|909 558 4000|cneece@llu.edu|
22426948|NCT01204671|GlaxoSmithKline|GSK Response Center|866-435-7343||
22426949|NCT02700048|University of Minnesota|Amir Moheet|6126249990|mohee002@umn.edu|
22426950|NCT02530437|University of Texas MD Anderson Cancer Center|Dr. Jaffer Ajani|(713) 792-2828|jajani@mdanderson.org|
22426951|NCT04541355|University of California, San Francisco|Dr. Hyunseok Kang, MD|(888) 689-8273|hyunseok.kang@ucsf.edu|
22426952|NCT05047536|Kezar Life Sciences, Inc.|Regulatory Affairs|650-822-5600|clinicaltrials@kezarbio.com|
22426953|NCT01121263|Icahn School of Medicine at Mount Sinai|Deborah Ascheim, MD|212-659-9567|deborah.ascheim@mssm.edu|
22426954|NCT01655901|CHEO Research Institute|Dr. Jean-Philippe Chaput|613-737-7600|jpchaput@cheo.on.ca|3683
22426955|NCT00194129|UHCMC Mood Disorders Program|David Kemp, MD|216-844-2865|David.Kemp@UHhospitals.org|
22426956|NCT00623181|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22426957|NCT01929889|Northwestern University|Dr. John Csernansky|312-503-9096|jcsernan@nmff.org|
22426958|NCT01669434|University of Nebraska Medical Center|Dr. Jason Shiffermiller|402-559-7299|jshiffermiller@unmc.edu|
22426959|NCT02860988|University of Kentucky|Dr. Joseph Calvert|(859) 323-5771|joe.calvert@uky.edu|
22426960|NCT02579629|Emory University|Katherine Egan|404-727-8463|kfegan@emory.edu|
22426961|NCT01190891|Madigan Army Medical Center|Troy Patience, Research Operations Service|(253) 968-1160|usarmy.jblm.medcom-mamc.mbx.dci@mail.mil|
22426962|NCT00737048|JANSSEN PHARMACEUTICAL. K.K. , Neuroscience Department, Clinical Science Division|Medical Director|+81-3-4411-5509||
22426963|NCT00301834|University of California San Francisco|Dr. Morton Cowan|4154762188|mcowan@peds.ucsf.edu|
22426964|NCT02737358|Medical University of South Carolina|Erin A. McClure, Ph.D.|843-792-7192|mccluree@musc.edu|
22426965|NCT00744939|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22426966|NCT01739335|Bronx VA Medical Center|Dr. Julia Golier; Chief of Psychiatry|718-584-9000|julia.golier@va.gov|6587
22426967|NCT03657069|Stanford University|Dung Nguyen, MD, PharmD, FACS|(650) 498-6004|nguyendh@stanford.edu|
22426968|NCT00183430|VA Puget Sound HCS|Murray A. Raskind, MD|206-277-3797|Murray.Raskind@va.gov|
22426969|NCT00843349|University of Miami|Dr. Myles Wolf, Associate Professor of Medicine, Chief-Division of Nephrology and Hypertension|305-243-7745|mwolf@med.miami.edu|
22426970|NCT00883181|Amgen Inc.|Study Director|866-572-6436||
22426971|NCT01218308|GlaxoSmithKline|GSK Response Center|866-435-7343||
22426972|NCT00526474|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22426973|NCT03845894|Wake Forest School of Medicine|Jonathan Doug Jaffe DO|336-716-4498|jjaffe@wakehealth.edu|
22426974|NCT03238417|VA Greater Los Angeles Healthcare System|Elizabeth M. Yano, PhD, MSPH|818-891-7711|elizabeth.yano@va.gov|36031
22426975|NCT03108482|Esteve Pharmaceuticals, S.A.|Dr. Neus Gascon|+34934446000|ngascon@esteve.com|
22426976|NCT00106002|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
22426977|NCT04896216|University of Minnesota|Kumi Smith|612.301.3051|smi00831@umn.edu|
22426978|NCT04753034|Aditum Bio|VP, Clinical Operations|(510) 227-2102|Chris.resburg@aditumbio.com|
22426979|NCT01122173|Auris Health, Inc.|Emir Deljkich/Sr. Director, Clinical Affairs|650-397-2677|emir.deljkich@aurisrobotics.com|
22426980|NCT00379145|NRG Oncology|Angela Kuras on behalf of James Kauderer|716-845-5702|kurasa@nrgoncology.org|
22426981|NCT04210986|Vice President of Operations|Suzanne Liv Page|970-401-8770|spage@sprivail.org|
22426982|NCT01774591|University of Chicago|George L. Bakris, MD|773-702-7936|bbrisky@medicine.bsd.uchicago.edu|
22426983|NCT03504917|www.roche.com/about_roche/roche_worldwide.htm|Reference Study ID Number: WN39434|888-662-6728 (U.S. Only)|global-roche-genentech-trials@gene.com|
22426984|NCT03810183|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22426985|NCT04275336|Children's Hospital of Fudan University|Ms.Yu Zhuowen|18017591126|yzw100@126.com|
22426986|NCT04664205|University of North Carolina at Chapel Hill|Abbie Smith-Ryan, PhD|919-962-2574|abbsmith@email.unc.edu|
22426987|NCT02053493|Duke Clinical Research Insitute|Dr. Adrian Hernandez|919-668-7515|Adrian.Hernandez@duke.edu|
22426988|NCT01909804|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22426989|NCT05057221|University of Michigan|Lena M. Napolitano MD|734-615-4775|lenan@med.umich.edu|
22426990|NCT05222880|Johnson & Johnson Vision Care, Inc. (JJVC)|Thomas R. Karkkainen|(904)254-0152|TKarkkai@its.jnj.com|
22426991|NCT05401565|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22426992|NCT00904007|Veterans Affairs Boston Healthcare System|Dr. B. Price Kerfoot|7742869230|price.kerfoot@gmail.com|
22426993|NCT00617357|LifeCell|Dr Michael Franz|908 947 1100|mfranz@lifecell.com|
22426994|NCT03976752|Emory University|Dr. Colleen Kelley|404-712-1823|colleen.kelley@emory.edu|
22426995|NCT00549393|Johns Hopkins University|Dr. Aaron Milstone|4106143917|amilsto1@jhmi.edu|
22426996|NCT02153918|National Cancer Institute|Dr. Peter Pinto|301-496-6353|pintop@nih.gov|
22426997|NCT03327324|NYU Langone Health|Joshua Chodosh, MD, MSHS|(212) 263-6768|Joshua.Chodosh@nyulangone.org|
22426998|NCT01791985|Imperial College London|Michael Seckl|+44 (0)20 3311 1421|m.seckl@imperial.ac.uk|
22426999|NCT01103323|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22427000|NCT04406714|University of North Carolina Lineberger Comprehensive Cancer Center|Alexis Moore|+1 919-962-5409|alexis.moore@unc.edu|
22427001|NCT04536701|Ohio State University|Dr. Karen Rose|614-292-4844|rose.1482@osu.edu|
22427002|NCT01946204|Janssen Research & Development, LLC|Senior Medical Director, WC Clinical Oncology Department|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22427003|NCT03797898|Seattle Children's|Tumaini R. Coker, MD, MBA|206-884-0559|Tumaini.Coker@seattlechildrens.org|
22427004|NCT00485069|GlaxoSmithKline|GSK Response Center|866-435-7343||
22427005|NCT03217591|Akebia Therapeutics|Akebia Therapeutics|6178446128|trials@akebia.com|
22427006|NCT05324306|Medical University of South Carolina|Dr. Konrad Rajab|843-792-1414|tkrajab@uams.edu|
22427007|NCT00535652|University of Ulm|Prof. Dr. Henne-Bruns, PI|++4973150053500|doris.henne-bruns@uniklinik-ulm.de|
22427008|NCT00596271|Valneva Austria GmbH|Katrin Dubischar-Kastner|+43 1 206 20|info@valneva.com|0
22427009|NCT00402727|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22427010|NCT04460326|Boston Medical Center|Sara M Alexanian, MD|617-638-8545|sara.alexanian@bmc.org|
22427011|NCT00577317|NRG Oncology|Linda Gedeon for Helen Huang, MS.|716-845-1169|Linda.gedeon@roswellpark.org|
22427012|NCT03372798|Oxford University Hospitals NHS Foundation Trust|Dr Tim Betts|0044 01865 220256|ep.doctors@ouh.nhs.uk|
22427013|NCT01687218|Division of Infectious Diseases - UPMC|Ross D. Cranston, MD, FRCP|412-383-2054|rdc27@pitt.edu|
22427014|NCT01835912|BrockU|Panagiota Klentrou|19056885550|nklentrou@brocku.ca|4538
22427015|NCT02421354|The University of Texas MD Anderson Cancer Center|Dr. Srdan Verstovsek, MD. Professor|713-745-3429|sverstov@mdanderson.org|
22427016|NCT02084511|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22427017|NCT00461734|Princess Alexandra Hospital|Dr. Gerald Kaye|07 3176 2111|gerald.kaye@health.qld.gov.au|
22427018|NCT03528551|Novo Nordisk A/S|Clinical Transparency Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22427019|NCT02236000|NSABP Foundation, Inc.|Judy Langer, Director of Regulatory Affairs|412-339-5300|judy.langer@nsabp.org|
22427020|NCT03204643|Atrium Health|Dr. Jason Roberge|704-355-0268|Jason.Roberge@AtriumHealth.org|
22427021|NCT00875810|MedtronicSpineECA|Cristina Faria|+41 21 802 70 00|cristina.faria@medtronic.com|
22427022|NCT01085643|Cedars-Sinai Medical Center|Edy Soffer, MD|(310) 423-6143|edy.soffer@cshs.org|
22427023|NCT00944710|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
22427024|NCT01789047|Rush University Medical Center|Director of Clinical Research|312 942 8002|Teresa_Chmura@rush.edu|
22427025|NCT03644017|Merit Medical Systems, Inc.|Casey Holland, Senior Director Clinical Operations|+1 (617) 842-0251|casey.holland@merit.com|
22427026|NCT02175225|Beth Israel Deaconess Medical Center|Magdy Selim, MD, PhD|617-632-8913|mselim@bidmc.harvard.edu|
22427027|NCT02340000|Albany Medical College|Paul Sorum, MD|5182627500|sorump@mail.amc.edu|
22427028|NCT03106077|UT MD Anderson Cancer Center|Stacy Moulder, Professor, Breast Medical Oncology|(713) 792-2817|smoulder@mdanderson.org|
22427029|NCT02668640|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22427030|NCT06034457|Cleveland Clinic|Dr. Leslie Heinberg, Vice Chair for Psychology, Department of Psychiatry and Psychology|216 445-1986|heinbel@ccf.org|
22427031|NCT04344028|University of Wisconsin - Madison|Dr. C. Shawn Green|(608) 263-4868|csgreen2@wisc.edu|
22427032|NCT00919633|Medtronic, Inc.|Study Trial Manager|763-505-4594|sarah.mische@medtronic.com|
22427033|NCT01526785|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22440124|NCT02057250|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22440125|NCT00771277|VA Medical Center Memphis|Dr. Linda O. Nichols|901 523-8990|linda.nichols@va.gov|5082
22440126|NCT03199976|Helsinki University Central Hospital|Dr Anne Kotaniemi-Syrjänen|+35894711|anne.kotaniemi-syrjanen@hus.fi|
22440127|NCT03367793|Ohio State University College of Optometry|Dr. Heather Anderson, Study PI|614-247-5825|anderson.3881@osu.edu|
22440128|NCT03962491|Virginia Commonwealth University|Kathryn Polak, PhD|(804) 827-1184|polakkm@vcu.edu|
22440129|NCT02967991|University Hospitals Case Western Reserve|Shaffer Mok|4404065500|Shaffer.Mok@UHHospitals.org|
22440130|NCT05058365|The University of Hong Kong|Professor Lam Shui-fong|85239172388|lamsf@hku.hk|
22440131|NCT00702702|Repros Therapeutics Inc.|Jennifer L. Wike|281-719-3402|jwike@reprosrx.com|
22440132|NCT04393935|Emory University|Natalie Crawford, PhD|404-712-9445|ndcrawford@emory.edu|
22440133|NCT03844997|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|Sudipto Mukherjee, MD, PhD|866-223-8100|TaussigResearch@ccf.org|
22440134|NCT04689139|Petrovsky NRCS|Dr. Artem Gubko|+79684241490|gubko@artvig.ru|
22440135|NCT04552301|Icahn School of Medicine at Mount Sinai|Dr. Juan Wisnivesky|(212) 241-2125|juan.wisnivesky@mountsinai.org|
22440136|NCT02893293|Stanford University|Heike Daldrup-Link, MD|(650) 725-2548|mairead@stanford.edu|
22440137|NCT02738801|Galapagos NV|Evelyn Fox|003215342900|evelyn.fox@glpg.com|3215342900
22440138|NCT03279081|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22440139|NCT00771914|University of Rochester Division of Epidemiology, Department of Community and Preventive Medicine|Robert Block, MD, MPH, FACP|585-275-3356|robert_block@urmc.rochester.edu|
22440140|NCT00573508|Astellas Pharma Global Development|Astellas Medical Monitor||clinicaltrials@us.astellas.com|
22440141|NCT01260493|Vårdalinstitute, University of Gothenburg|Professor Synneve Dahlin-Ivanoff ( Research leader)|+46 31 7865733|synneve.dahlin-ivanoff@gu.se|
22440142|NCT02989493|University of Wisconsin|John Curtin|608-262-0387|jjcurtin@wisc.edu|
22440143|NCT04643808|Medical Univesristy of South Carolina|Dr Dorothea Jenkins|843-792-2112|jenkd@musc.edu|
22440144|NCT00388349|Stanford University|Dr. Sally Arai|650-723-0822|sarai1@stanford.edu|
22440145|NCT01063049|Gastroenterology Services|Dr. David Gerard|630 969 1167|davidpgerard@comcast.net|
22440146|NCT03656939|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22440147|NCT01667900|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22440148|NCT01283555|PATH|Jessica Cohen|206-285-3500|jcohen@path.org|
22440149|NCT00231816|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22440150|NCT00774046|University of Chicago|Dr. Lucy A. Godley|773-702-4140|lgodley@medicine.bsd.uchicago.edu|
22440151|NCT00976274|Department of Family Medicine, Yonsei University College of Medicine|Dr. Jae-Yong Shim|(+82) 2-2019-3480|hope@yuhs.ac|
22440152|NCT05328102|Xencor, Inc|Michael Chiarella|858-945-2415|mchiarella@xencor.com|
22440153|NCT01614249|University of Nairobi|Mrs. Rose Okoyo Opiyo|+254 020 2726300|roseopiyo@uonbi.ac.ke|43481
22440154|NCT02954536|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian,MD|646-888-4186|janjigiy@mskcc.org|
22440155|NCT05498649|Scripps Optometric Group|Dr Keith Wan|858-530-2800|keithmwan@gmail.com|
22440156|NCT02946580|Massachusetts General Hospital|Dr. Kyle Staller|617-724-7556|kstaller@mgh.harvard.edu|
22440157|NCT03094416|IBSA|Claudia Scarsi|+41583601000|claudia.scarsi@ibsa.ch|
22440158|NCT03638453|Dana Farber Cancer Institute/Boston Children's Hospital|Dr. Kira Bona, MD, MPH|617-632-4688|kira.bona@childrens.harvard.edu|
22440159|NCT00321789|Veterans Affairs Medical Center|Corrine I. Voils|919-286-0411|corrine.voils@va.gov|5196
22440160|NCT00005780|National Cancer Institute|Dr. Christopher J. Melani|240-760-6057|christopher.melani@nih.gov|
22440161|NCT00374140|University of Pittsburgh|Ahmad Tarhini, MD, PhD|(412) 648-6578|tarhiniaa@upmc.edu|
22440162|NCT02651675|Regenxbio Inc.|Clinical Development Lead|240-552-8968|srastogi@regenxbio.com|
22440163|NCT02246530|University of Alabama at Birmingham|Dr. Breanna Willeford, DO|205-934-4131|breannawilleford@uabmc.edu|
22440164|NCT05712460|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22440165|NCT03529669|Oxford University Hospitals NHS Trust|Dr Somnath Mukherjee|01865 617018|Somnath.Mukherjee@ouh.nhs.uk|
22440166|NCT04292535|Michigan State University|Matthew B. Pontifex|517-432-5105|pontifex@msu.edu|
22440167|NCT01420861|Oncternal Therapeutics|Mary Breitmeyer|8582092082|mbreitmeyer@oncternal.com|208
22440168|NCT04084171|University of Virginia Center for Diabetes Technology|Marc Breton, PhD|434-982-6484|mb6nt@virginia.edu|
22440169|NCT03563209|İzmir Katip Çelebi University, Faculty of Medicine|ilker şengül|05337333698|ilkrsngl@gmail.com|
22440170|NCT01404039|Spaulding Rehabilitation Hospital|Felipe Fregni|6179526156|felipe.fregni@ppcr.hms.harvard.edu|
22440171|NCT00303069|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com|
22440172|NCT00092417|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22440173|NCT00425269|University of Oslo|Victoria Telle Hjellset|0047 22 85 06 12|t.v.t.hjellset@medisin.uio.no|
22440174|NCT00758667|Vanderbilt University|R. Bruce Shack, MD|615-936-0160|bruce.shack@vanderbilt.edu|
22440175|NCT01084655|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22440176|NCT00335777|Jefferson Headache Center|Stephen D. Silberstein, MD|215-955-2243|stephen.silberstein@jefferson.edu|
22440177|NCT00992108|UCLA Neurology|Marisa Chang, MD|310-794-1870|marisachang@mednet.ucla.edu|
22440178|NCT04639245|Fred Hutchinson Cancer Center|Dr. Damian Green|(855) 557-0555|dgreen@fredhutch.org|
22440179|NCT02189317|Emory University|John W Xerogeanes, MD|404-778-7202|jxeroge@emory.edu|
22440180|NCT01112917|BRIGHT Research Partners|Andrea Fenton Abbs - Study Director|612-298-7460|andrea@brightresearchpartners.com|
22440181|NCT05101122|Apnimed|Clinical Trials|6015008880|clinicaltrials@apnimed.com|
22440182|NCT03131219|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22440183|NCT01635504|University of British Columbia|Dr. Shannon Humphrey|(604) 714-0222|shannon@carruthers-humphrey.com|
22440184|NCT00616759|Loma Linda University|Ronald L. Warnell, M.D.|909-558-9551|rwarnell@llu.edu|
22440185|NCT01528332|Philips Consumer Lifestyle|Dr. Elke Naujokat|+31 (0) 631974213|elke.naujokat@philips.com|
22440186|NCT02399163|GlaxoSmithKline|GSK Response Center|866-435-7343||
22440187|NCT03163303|University of California, San Francisco|Dr. Derek Satre|(415) 476-7382|derek.satre@ucsf.edu|
22440188|NCT00600080|Johnson & Johnson Vision Care|Kurt Moody, OD|+1 904 443-3088|kmoody1@its.jnj.com|
22440189|NCT02177123|InnFocus, Inc.|Sharon Herbert, Associate Director of Clinical Operations|(415) 268-9059|sharon.herbert@santen.com|
22440190|NCT04613362|Richard L. Roudebush VA Medical Center|Dr. Teresa Damush|317-988-4277|teresa.damush@va.gov|
22440191|NCT00074711|Creighton University|Robert P Heaney, MD|402 280 4029|rpheaney@creighton.edu|
22440192|NCT03466658|Penn State Health|Dr. Hyunmin Kim|717-531-4826|hkim2@pennstatehealth.psu.edu|
22440193|NCT00886379|Brigham and Women's Hospital|Dr. Janet Rich-Edwards|617-525-7929|jr33@partners.org|
22440194|NCT01684917|Imperial College London|Professor Gary Frost|+44 (0)20 7594 0959|g.frost@imperial.ac.uk|
22440195|NCT03520998|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
22440196|NCT01435382|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22440197|NCT00910650|University of California at Los Angeles, Jonsson Comprehensive Cancer Center|Ignacio Baselga|310 206-2090|ibaselga@mednet.ucla.edu|
22440198|NCT02392637|UT MD Anderson Cancer Center|Dr. Milind Javle, Professor, GI Medical Oncology|(713) 792-5434|mjavle@mdanderson.org|
22440199|NCT00260533|University of California San Diego|Murray B. Stein MD, MPH|858-534-6400|mstein@ucsd.edu|
22440200|NCT01761877|Stony Brook University|Dr. Alison T Stopeck|5206476982|Alison.Stopeck@stonybrookmedicine.edu|
22440201|NCT03542877|University of Colorado|Dr. Wells Messersmith|303-724-0747|wells.messersmith@cuanschutz.edu|
22440202|NCT01310777|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
22440203|NCT01780506|Gilead Sciences|Gilead Clinical Study Information Center||GileadClinicalTrials@gilead.com|
22440204|NCT01096875|Ankara University Medical Faculty, Department of Cardiovascular Surgery|Prof. A. Ruchan Akar MD., FRCS(CTh).|+90 533 646 06 84|akarruchan@gmail.com|
22440205|NCT01867671|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22440206|NCT04852302|National Cancer Institute|Dr. Kevin Camphausen|240-760-6205|camphauk@mail.nih.gov|
22440207|NCT05249582|Palo Alto University|Erick Kim|(510) 457-1584|ekim@paloaltou.edu|
22440208|NCT01743469|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22440209|NCT00317473|USAMRU-K|Mark A. Withers, MD PhD|+254-722-449-357|aodika@wrp-ksm.org|
22440210|NCT02285855|UT MD Anderson Cancer Center|Stephen Chun/Assistant Professor, Radiation Oncology|713- 563-9600|sgchun@mdanderson.org|
22440211|NCT03253796|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22440212|NCT00528112|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
22440213|NCT02516696|Weill Cornell Medicine|Multiple Myeloma Program Manager|646.962.9376|hyk4001@med.cornell.edu|
22440214|NCT02718898|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22440215|NCT02163538|University Louisville|Dr. Resad Pasic|502-561-7465|resad.pasic@louisville.edu|
22440216|NCT01345240|GlaxoSmithKline|GSK Response Center|866-435-7343||
22440217|NCT01468558|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
22440218|NCT01259063|Memorial Sloan Kettering Cancer Center|Dr. Guido Dalbagni|646-422-4394|dalbagng@mskcc.org|
22440219|NCT00599014|Emory University|Dr. Javed Butler|404-778-5136|jbutle4@emory.edu|
22440220|NCT02158442|Osprey Medical|Michele Shepard|952.955.8236|mshepard@ospreymed.com|
22440221|NCT02855281|Hospital Bethanien Solingen, Clinic of Pneumology and Allergology, Center for Sleep Medicine and Respiratory Care, Solingen, Germany|Dr. Lars Hagmeyer|0212636004|institut@klinik-bethanien.de|
22440222|NCT00617734|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22440223|NCT05560425|University of North Carolina at Chapel Hill|Elena Vidrascu, PhD, MSc|919-843-9193|elena91@live.unc.edu|
22440224|NCT05135767|Brown University|Hayley Treloar Padovano, PhD|4018636623|hayley_treloar@brown.edu|
22440225|NCT02694185|Rocky Mountain Regional VA Medical Center|Elizabeth Cheng|720-857-5101|elizabeth.cheng@va.gov|
22440226|NCT05082857|Wake Forest University School of Medicine|Anna Miller-Fitzwater, MD, MPH|336-713-0630|amillerf@wakehealth.edu|
22440227|NCT04366349|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22440228|NCT03341299|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
22440229|NCT01235897|University of California, San Francisco|Jo Chien, MD|415-885-7577|crss@ucsf.edu|
22440230|NCT05421624|Boston University|Franchino Porciuncula, EdD, PT, DScPT|(617) 353-7525|fporciun@bu.edu|
22440231|NCT03755206|Johns Hopkins Center for Indigenous Health|Dr. Emily E. Haroz, Associate Professor|4109556931|eharoz1@jhu.edu|
22440232|NCT04905134|Duke University|Walter T. Lee, MD, MHS|919-613-6407|walter.lee@duke.edu|
22440233|NCT03009058|Immodulon Therapeutics Ltd|Chief Medical Odfficer|+44 (0)20 3137 6346|info@immodulon.com|
22440234|NCT05556265|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22440235|NCT03137992|Lupin Research Inc|Dr. Mark Lepore|(443) 740-9323|marklepore@lupin.com|
22440236|NCT04359810|Columbia University Irving Medical Center|Max O'Donnell, MD|212-305-5794|mo2130@columbia.edu|
22440237|NCT03221556|Boston Medical Center|Caroline Kistin, MD MSc|(617) 414-3638|caroline_kistin@brown.edu|
22440238|NCT04760782|University of Vermont|Dr. David Lunardini|(802) 847-2663|david.lunardini@uvmhealth.org|
22440239|NCT05737069|HALEON|Haleon Response Center|+441932959500|ww.clinical-trial-register@haleon.com|
22440240|NCT01486966|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22440241|NCT02331134|University of Colorado Hospital|Antonio Jimeno, MD, PhD|3037242478|antonio.jimeno@cuanschutz.edu|
22440242|NCT05010707|Washington University in St. Louis, School of Medicine|Thomas Baranski, MD, PhD|314-747-3997|baranski@wustl.edu|
22440243|NCT04825574|Blueprint Medicines|Blueprint Medicines Medical Information|1-888-258-7768|medinfo@blueprintmedicines.com|
22440244|NCT05967260|Oregon Health & Science University|Clara Mosquera-Lopez|503--418-4129|mosquera@ohsu.edu|
22440245|NCT05565742|Eli Lilly and Company|Chief Medical Officer|08005455979|ClinicalTrials.gov@lilly.com|
22440246|NCT00668148|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22440247|NCT01243190|The university of Texas MD Anderson Cancer Center|William Wierda MD./Professor|713-745-0428|wwierda@mdanderson.org|
22440248|NCT05472090|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 799-8599|greg.sullivan@tonixpharma.com|
22440249|NCT01601236|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
22440250|NCT02419001|Synthetic Biologics Inc.|Michael Kaleko|(240) 238-3862|mkaleko@syntheticbiologics.com|
22440251|NCT01074814|Translational Drug Development|Linda Vocila, Executive Director Clinical Strategy|6023588311|lvocila@td2inc.com|
22440252|NCT02166346|Johns Hopkins University|Michael Levy, Principal Investigator|443-287-4412|mlevy@jhmi.edu|
22440253|NCT01209689|Hoffmann-La Roche|Medical Communications|800 821-8590||
22440254|NCT02231086|Amsterdam UMC|Prof. dr. P.J. Tanis|+31-20-4444444|p.j.tanis@amsterdamumc.nl|
22440255|NCT03780244|QMedAB|Clinical Project Manager|817-961-5000|aestheticclinicaltrials@galderma.com|
22440256|NCT01083771|Brown University Oncology Research Group (BrUOG)|Anthony Mega, MD|4018633000|kayla_rosati@brown.edu|
22440257|NCT03175367|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|8447346643|clinicaltrials@regeneron.com|
22440258|NCT02851615|Cincinnati Children's Hospital Medical Center|Dr. Lori Crosby|513-636-5380|Lori.Crosby@cchmc.org|
22440259|NCT01843621|Dept of Pediatrics, Pharmongkutklao Hospital, Bankok, Thailand|Sriluck Simasathien, MD|66-2-644-8971|ssriluck@yahoo.com|
22440260|NCT02345070|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
22440261|NCT02151058|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
22440262|NCT01181349|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22440263|NCT00321620|Amgen Inc.|Study Director|866-572-6436||
22440264|NCT03337477|AstraZeneca Clinical|Study Information Center|+1 877 240 9479|information.center@astrazeneca.com|
22440265|NCT01698333|Therapeutics Inc.|Clinical Research|858-571-1800|clinicalresearch@therapeuticsinc.com|
22440266|NCT01747876|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22440267|NCT03198715|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22440268|NCT00853307|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22440269|NCT00242502|University of Texas MD Anderson Cancer Center|Ahmed Kaseb, MD/ Professor||MJLim@mdanderson.org|
22440270|NCT02437344|NYSPI|Linda Sherman|6467747158|lsherma@nyspi.columbia.edu|
22440271|NCT04538989|Rezolute|Chief Medical Officer (Dr. Brian Roberts)|650-206-4507|brian@rezolutebio.com|
22440272|NCT04225897|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22440273|NCT05172128|Duke University Medical Center|Dr. P. Murali Doraiswamy|9196845933|murali.doraiswamy@duke.edu|
22440274|NCT02584686|Department of Andrlolgy, Sexology & STDs, Cairo University|Prof. Dr. Hussein Ghanem, Chairman of Andrology Department|00201001176111|hmhghanem@gmail.com|
22440275|NCT01537666|Savara Inc.|Taneli Jouhikainen, MD, MBA; Chief Operating Officer|(888) 302-4876|info@savarapharma.com|
22440276|NCT02703597|University of Florida|Assistant Professor|3526279467|gkhalil@ufl.edu|
22440277|NCT00481832|Stanford University School of Med|Wen-Kai Weng, MD; Associate Professor of Medicine|650-723-7689|wkweng@stanford.edu|
22440278|NCT00456846|Celgene Corporation|Anne McClain|888-260-1599|clinicaltrialdisclosure@celgene.com|
22440279|NCT00581308|W. L. Gore & Associates|Jay Donosky|(800) 437-8181|jdonosky@wlgore.com|
22440280|NCT03416985|University of California Los Angeles|Joan Pi Anfruns, DMD|310-825-0834|jpianfruns@dentistry.ucla.edu|
22440281|NCT02006472|Prilenia|Prilenia|+972 775558|info@prilenia.com|482
22440282|NCT03219723|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22440283|NCT04558125|Cedars-Sinai Medical Center|Victor Tapson, MD|919-971-6441|Victor.Tapson@cshs.org|
22440284|NCT03137381|Concert Pharmaceuticals, Inc.|Colleen E. Hamilton|781-860-0045|AAclinicaltrial_inquiries@concertpharma.com|
22440285|NCT00459316|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22440286|NCT01614886|Novartis Pharmaceuticals|Study Director|862-778-8300||
22440287|NCT03848325|University of Pittsburgh|Sanjay R. Patel MD, MS|412-383-0607|patelsr2@upmc.edu|
22440288|NCT04843007|NanoAlvand|Dr. Hamidreza kafi|9129232594|Kafi.h@orchidpharmed.com|+98
22440289|NCT03379818|University of Birmingham|Dr Andrea Krott|+44 (0)121 414 4903|a.krott@bham.ac.uk|
22440290|NCT00423579|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22440291|NCT03913455|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22440292|NCT04004988|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22440293|NCT03873116|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
22440294|NCT00003475|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22440295|NCT04682366|Wake Forest|Majid Mirzazadeh|336-716-4131|mmirzaza@wakehealth.edu|
22440296|NCT03020667|Uwatoko Clinic|Kunihiko Uwatoko, MD|+81-52-991-4602|uwatoko.clinic@gmail.com|
22440297|NCT03697252|Karuna Therapeutics, Inc.|Stephen Brannan|857-449-2234|sbrannan@karunatx.com|
22440298|NCT03125395|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
22440299|NCT02531802|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
22440300|NCT00106704|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22440301|NCT00643864|CarolinasHS|Dr. Mark Hirsch, Senior Scientist|704 355 7673|mark.hirsch@carolinashealthcare.org|
22440302|NCT00482053|Stanford University Medical Center|Wen-Kai Weng, Assistant Professor of Medicine|650-723-7689|wkweng@stanford.edu|
22440303|NCT01028820|The University of North Carolina at Chapel Hill|Linmarie Sikich, M.D.|(919) 972-7499|lsikich@med.unc.edu|
22440304|NCT03292926|Hospital for Special Surgery, Anesthesiology|Dr. Jonathan Beathe|2126061036|beatheJ@hss.edu|
22440305|NCT04842747|Veru|Gary Barnette PhD CSO|800-606-9382|veruclinicaltrials@verupharma.com|
22440306|NCT01590264|Washington University in Saint Louis|Dr. Jay F. Piccirillo|314-362-8641|piccirilloj@ent.wustl.edu|
22440307|NCT02559622|Novartis Pharmaceuticals|Study Director|862--778--8300||
22440308|NCT01710345|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
22440309|NCT01766440|Galderma|Michael Graeber|(817)961-5000|michael.graeber@galderma.com|
22440310|NCT04011540|University of Pennsylvania|Lauren Southwick|267-428-0125|lauren.southwick@pennmedicine.upenn.edu|
22440311|NCT01033019|Novartis|Study Director|862-778-8300||
22440312|NCT01339832|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
22440313|NCT02731469|Biocad|Yulia Linkova Medical Director|+7 (495) 992 66 28|linkova@biocad.ru|930
22440314|NCT00979940|Indiana University School of Medicine|Dr. Rolf Kreutz|3179620500|rkreutz@iu.edu|
22440315|NCT01668784|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22440316|NCT02761330|Washington Universtiy School of Medicine|Alyssa Labonte|314-273-7338|alabonte@wustl.edu|
22440317|NCT05386329|Massachusetts General Hospital, Department of Psychiatry|Director, Center for OCD and Related Disorders|617-724-6146|swilhelm@mgh.harvard.edu|
22440318|NCT03183869|Lawson Health Research Institute|Chantelle Graf, RN|519-685-8500|chantelle.graf@sjhc.london.on.ca|35352
22440319|NCT03043313|Seagen Inc.|Chief Medical Officer|(855) 473-2436|medinfo@seagen.com|
22440320|NCT01292135|Pharmacyclics|Thorsten Graef, MD|855.427.8846|medinfo@pcyc.com|
22440321|NCT04973449|AstraZeneca Clinical study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
22440322|NCT01506596|Vector Oncology LLC|Dr. Mark Walker, VP of Scientific Affairs|901-435-5570|mwalker@vectoroncology.com|
22440323|NCT03816696|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22440324|NCT04408989|mabxience Research SL|Susana Millan|+3491771500|susana.millan@mabxience.com|
22440325|NCT04798183|Pusan National University Yangsan Hospital|Sungchul huh, M.D., Ph.D.||dr.huhsc@gmail.com|0553604250
22440326|NCT03475004|University of Colorado|Dr. Christopher Lieu|303-724-6390|christopher.lieu@cuanschutz.edu|
22440327|NCT03645122|VA Pittsburgh Healthcare System|Assistant Director for Clinical and Regulatory Affairs|412-822-3669|Nikitha.Deepak@va.gov|
22440328|NCT04756427|Washington University|Darla Shores|314-454-6173|shores@wustl.edu|
22440329|NCT00311766|RegeneRx Biopharmaceuticals, Inc.|Study Director, David R. Crockford|617-285-5588|dcrockford@regenerx.com|
22440330|NCT02260934|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22440331|NCT01436526|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22440332|NCT04609319|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22440333|NCT01001975|Merck Sharpe & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22440334|NCT04272242|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22440335|NCT04053036|University of Chicago|Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
22440336|NCT01520506|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com|
22440337|NCT00906204|Wright State University Boonshoft School of Medicine, Dayton, Ohio, USA|Dr. R. Brian Stevens, MD, PhD, FACS|937-545-4817|rbstevens1@icloud.com|
22440338|NCT00696072|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22440339|NCT00535496|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22440340|NCT00371150|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22440341|NCT00124943|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22440342|NCT03181932|Savara Inc|Raymond D Pratt, Chief Medical Officer|+1 512 784 8757|ray.pratt@savarapharma.com|
22440343|NCT03304626|University of Cincinnati|Khurram Bari|513-558-2898|khurram.bari@uc.edu|
22440344|NCT01887327|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|ClinicalTrials@mnk.com|5
22440345|NCT03298035|The University of Texas Health Science Center at Houston|Catherine C. Beaullieu, MD|(713) 500-6044|Catherine.C.Beaullieu@uth.tmc.edu|
22440346|NCT00874094|NY Eye & Ear Infirmary|Anthony P Sclafani, MD|212-979-4200|asclafani@nyee.edu|
22440347|NCT00408317|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
22440348|NCT02092610|Radboud University Hospital Nijmegen Medical Centre|Dr. Myrthe Hol|(024) 36 14934|Myrthe.Hol@radboudumc.nl|
22440349|NCT02379728|Global Innovations for Reproductive Health & Life|Dr. Allan Kember, Director of Programs|+1-902-580-8385|allan.kember@mail.utoronto.ca|
22440350|NCT01921205|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22440351|NCT03331315|University of Tennessee - West Cancer Center|Michael Ulm|404-281-9480|mulm@westclinic.com|
22440352|NCT00360230|GlaxoSmithKline|GSK Response Center|866-435-7343||
22440353|NCT05179785|University of Pittsburgh|Mary Phillips|4123838206|fmristudies@upmc.edu|
22440354|NCT01052493|Imperial College London|Dr Tricia Tan|020 83838038|t.tan@imperial.ac.uk|
22440355|NCT02105740|Universidade de Brasília|Gil Montenegro|556181487323|prof.gilmontenegro@gmail.com|
22440356|NCT03931941|Clinical Development|Clinical Development|651-705-8778|US8-Studyinfo@ferring.com|
22440357|NCT03431259|Massachusetts General Hospital|Marilyn Heng, Principal Investigator|6176430149|mheng@mgh.harvard.edu|
22440358|NCT01069003|Medtronic|Sidney Cohen, Sr. Clinical Medical Advisor|707-591-7277|sidney.a.cohen@medtonic.com|
22440359|NCT01075243|GlaxoSmithKline|GSK Response Center|866-435-7343||
22440360|NCT00627393|New England Research Institutes, Inc.|Susan Assmann, PhD|617-972-3048|sassmann@neriscience.com|
22440361|NCT00347022|GUERBET|Corinne DUBOURDIEU|+33.1.45.91.50.00|corinne.dubourdieu@guerbet-group.com|
22440362|NCT00551642|Mallinckrodt|Medical Information Call Center|800-556-3314|medinfo@mnk.com|
22440363|NCT03337308|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
22440364|NCT03593902|Northwestern University|Kathleen Quigley|312-695-8192|kathleen.quigley@nm.org|
22440365|NCT00129246|Associate Professor of Psychiatry and Program Director, Smoking Cessation Service at Smilow Cancer Hospital at Yale-New Haven|Benjamin A. Toll, PhD|(203) 974 5767|benjamin.toll@yale.edu|
22440366|NCT00283296|Human Engineering Research Laboratories|Rory Cooper, PhD|412-822-3700|rcooper@pitt.edu|
22440367|NCT03558737|University of Utah|Bradley Yoder|801-581-7052|bradley.yoder@hsc.utah.edu|
22440368|NCT01294553|GlaxoSmithKline|GSK Response Center|866-435-7343||
22440369|NCT01217229|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
22440370|NCT00888134|Massachusetts General Hospital|Donald P. Lawrence|617-643-3614|dplawrence@mgh.harvard.edu|
22440371|NCT03994081|University of North Carolina at Chapel Hill|Tobias Schwippel, MD|919-966-9929|tobias_schwippel@unc.edu|
22440372|NCT03783078|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22440373|NCT00286728|VAHSRD|Christine Timko|650-617-2746|Christine.Timko@va.gov|
22440374|NCT01903460|Mirum|Study Physician|+1 650-667-4085|medinfo@mirumpharma.com|
22440375|NCT03104868|Northwestern University|Dr. Michael Wolf|312-503-5592|mswolf@northwestern.edu|
22440376|NCT02758210|Emory University|Mikhael El Chami, MD|404-686-2504|melcham@emory.edu|
22440377|NCT02620774|Center for Anti-infective Research and Development|David Nicolau|860-972-3941|david.nicolau@hhchealth.org|
22440378|NCT02059278|Point Guard Partners LLC|Jeremy Brace|727-458-2823|jbrace@pointguardllc.com|
22440379|NCT00888173|NRG Oncology|Linda Gedeon For Michael Sill, PhD.|716-845-1169|lgedeon@gogstats.org|
22440380|NCT01488890|Sanofi Pasteur|Medical Director||Contact-US@sanofi.com|
22440381|NCT00829426|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22440382|NCT02628873|Wright State University|Steven Lindheim|858-740-1083|doclalalindheim@gmail.com|
22440383|NCT00537134|Centre Hospitalier de l'Université de Montréal (CHUM)|Ruby Klink|(514) 890-8000|ruby.klink.chum@ssss.gouv.qc.ca|27235
22440384|NCT03597347|Savara Inc|Raymond D Pratt, Chief Medical Officer|+1 512 784 8757|ray.pratt@savarapharma.com|
22440385|NCT04606134|University of Rochester Medical Center|Mara Weinstein MD|(585) 275-7546|Mara_Weinsteinvelez@URMC.Rochester.edu|
22440386|NCT00107653|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22440387|NCT02961894|Rex Medical|Colin Valentis|610-629-6051|cvalentis@rexmedical.com|
22440388|NCT01099267|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
22440389|NCT04986904|University of Virginia|Dr. Kelly Shaffer|434-982-1022|kshaffer@virginia.edu|
22440390|NCT02532517|Cerenovus|Christopher Hendricks|415-656-6565|CHendric@its.jnj.com|
22440391|NCT02234843|Therapeutic Area Head|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22440392|NCT01319981|The University of Texas MD Anderson Cancer Center|Elias Joseph Jabbour, MD./ Professor|713-792-4764|ejabbour@mdanderson.org|
22440393|NCT00584948|University of California, Davis Medical Center|Randi J Hagerman, MD|916-703-0247|randi.hagerman@ucdmc.ucdavis.edu|
22440394|NCT00938704|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
22440395|NCT01652235|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
22440396|NCT05138653|Cerevel Therapeutics|Cerevel Central Contact|8572500977|info@cerevel.com|
22440397|NCT03205709|Columbia University Medical Center|D.P. Devanand, M.D.|774-8658|dpd3@cumc.columbia.edu|646
22440398|NCT03735875|The University of Texas MD Anderson Cancer Center|Naval Daver, MD./Professor|713-794-4392|NDaver@mdanderson.org|
22440399|NCT02711891|Rush University Medical Center|Kathleen C. Heneghan, RN, PhD|3123395943|kheneghan@facs.org|
22440400|NCT05856422|Clinimark|Associate Researcher|833 373 0998|Carolyn.Cohen@element.com|1
22440401|NCT03204188|National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI)|Adrian Wiestner, M.D., Ph.D., Principal Investigator|301-594-6855|wiestnea@nhlbi.nih.gov|
22440402|NCT00091949|Yale School of Medicine|Walter N. Kernan|203-764-7000|walter.kernan@yale.edu|
22440403|NCT02786394|The University Of British Columbia|Associate Professor MC Ashe|604-675-2574|maureen.ashe@ubc.ca|
22440404|NCT03531112|University of North Carolina at Chapel Hill|Rachel Goode, PhD|919-962-6429|rwgoode@email.unc.edu|
22440405|NCT01256788|Steadman Hawkins Clinic of the Carolinas/Greenville Health System|Dr. Douglas Wyland|864-454-7422|dwyland@ghs.org|
22440406|NCT04828343|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22440407|NCT01148979|McLean Hospital|J. Alexander Bodkin, MD|617-855-3186|abodkin@mclean.harvard.edu|
22440408|NCT00777153|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
22440409|NCT01597596|Sanofi|Trial Transparency Team||Contact -US@sanofi.com|
22440410|NCT00732030|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
22440411|NCT04743778|University of Michigan, School of Social Work|Dr. Jaclynn Hawkins|(734) 615-2817|jachawk@umich.edu|
22440412|NCT00565084|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22440413|NCT03252431|Generon/Evive Biotech|Christina Tay|1-908-540-0816|christina.tay@evivebiotech.com|
22440414|NCT02812342|Yale Dermatology - Middlebury|Brett King, MD, PhD, BA, Associate Professor of Dermatology|(203) 737-4825|brett.king@yale.edu|
22440415|NCT03824769|University of Connecticut|Zeely Denmat|860-455-3842|zeely.denmat@uconn.edu|
22440416|NCT02266888|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22440417|NCT01550224|Stanford University Medical Center|Steven Edward Coutre, MD; Professor of Medicine (Hematology)|650-725-4040|coutre@stanford.edu|
22440418|NCT03611829|McGill University|Mallory Frayn, PhD (c)|514-398-1399|mallory.frayn@mail.mcgill.ca|
22440419|NCT02224560|GW Research Ltd|Medical Enquiries||medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
22440420|NCT00728689|Siga Technologies, Inc.|Annie Frimm, Vice President, Regulatory Affairs|951-303-8797|afrimm@siga.com|
22440421|NCT01523366|AstraZeneca|Tomas LG Andersson, MD, PhD|1-800-236-9933|ClinicalTrialTransparency@astrazeneca.com|
22440422|NCT02461758|University of Wisconsin School of Medicine and Public Health|FREDDY CALDERA, ASST PROFESSOR , GASTROENTEROLOGY|(608) 263-1995|fcaldera@medicine.wisc.edu|
22440423|NCT04454918|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22440424|NCT04543279|Washington University School of Medicine|Dr. Amy Zhou|314-362-8814|a.zhou@wustl.edu|
22440425|NCT02871934|VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA|Dr. Jason Vassy|857-364-2561|jvassy@partners.org|
22440426|NCT00929695|Fred Hutchinson Cancer Research Center|Marco Mielcarek|206-667-2827|mmielcar@fhcrc.org|
22440427|NCT04030143|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
22440428|NCT03216226|Zealand Pharma A/S|Kim Mark Knudsen|+45 50603780|KMKnudsen@zealandpharma.com|
22440429|NCT00425802|Memorial Sloan Kettering Cancer Center|Hugo Castro-Malaspina, MD|212-639-8197|castro-h@mskcc.org|
22440430|NCT01352715|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22440431|NCT05966142|Duke University|Hrishikesh Chakraborty, PhD|919-668-1238|hrishikesh.chakraborty@duke.edu|
22440432|NCT04849364|Hoosier Cancer Research Network|Fauzia Sharmin|317-921-2050|fsharmin@hoosiercancer.org|
22440433|NCT00894803|University of Cincinnati|Dr Arthur Pancioli|513-558-8087|arthur.pancioli@uc.edu|
22440434|NCT04006288|University of Florida|Dr. Dominick J Angiolillo. Professor of med University of Florida College of Medicine-Jacksonville|904-244-3378|dominick.angiolillo@jax.ufl.edu|
22440435|NCT00449696|Seikagaku Corporation|Clinical Development Dept.|81-3-5220-8950|hiroyuki.hosokawa@seikagaku.co.jp|
22440436|NCT01808755|Divisione Urologia IRCCS Policlinico San Matteo Pavia, Italy|D. Porru|39-0382-503868/503872|danieleporru@tin.it|
22440437|NCT02673372|Maimonides Medical Center|Sergey Motov, Director of Research|718-283-8693|smotov@maimonidesmed.org|
22440438|NCT00307801|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22440439|NCT02323217|Imperial College London|Dr Robin J Tyacke|(0)20 7594 7096|r.tyacke@imperial.ac.uk|+44
22440440|NCT02784548|VA San Diego Healthcare System|Dr. Thomas Rutledge|8585528585|thomas.rutledge@va.gov|7273
22440441|NCT00577889|Mayo Clinic Cancer Center|Robert McWilliams, M.D.||McWilliams.robert@mayo.edu|
22440442|NCT03094325|NYU Langone Health|Daniel Swistel, MD|646-754-7217|Daniel.Swistel@nyulangone.org|
22440443|NCT01523756|Coloplast A7S|Marianne Raff|+45 4911 2562|dkmr@oloplast.com|
22440444|NCT03224819|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22440445|NCT00795535|University of Miami|Kenneth Proctor, PhD, Professor of Surgery|305-355-4960|kproctor@med.miami.edu|
22440446|NCT03955146|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|zephyrus@fibrogen.com|
22440447|NCT04363320|University of Wisconsin - Madison|Todd Molfenter, PhD|608-262-1685|tdmolfenter@wisc.edu|
22440448|NCT00604565|Rockwell Medical|Ajay Gupta, MD|248-960-9009|rd@rockwellmed.com|
22440449|NCT03605667|Biohaven Pharmaceuticals, Inc|Chief Medical Officer|+1 203-404-0410|clinicaltrials@biohavenpharma.com|
22440450|NCT05632211|Alvotech Swiss AG|Clinical Development and Medical Lead|+41 78 659 89 89|alvotech.clinical@alvotech.com|
22440451|NCT00541658|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22440452|NCT03373240|Yale University|Dr. Arielle Baskin-Sommers|203-432-9257|arielle.baskin-sommers@yale.edu|
22440453|NCT02867436|Motol University Hospital|Zdeněk Šumník, PI|+420702000087|zdenek.sumnik@lfmotol.cuni.cz|
22440454|NCT04029883|Cedars-Sinai Medical Center|Dr. Joseph Ebinger|424-315-2284|cda-research@cshs.org|
22440455|NCT04080505|Columbia University|Jennifer Kuo, MD|212-305-6969|jhk2029@cumc.columbia.edu|
22440456|NCT03175679|BeijingYouanH|Dr. LJUN|861366138148|lujun98@ccmu.edu.cn|
22440457|NCT05194124|Rhythm Pharmaceuticals, Inc.|Rhythm Clinical Trials|857-264-4280|clinicaltrials@rhythmtx.com|
22440458|NCT04876521|All India Institute of Medical Sciences|Dr. Biswa Ranjan Mishra|09438884220|psych_biswa@aiimsbhubaneswar.edu.in|
22440459|NCT05494385|Indiana University School of Medicine|Dr. Anna Guanzon|2197651884|amguanzon89@gmail.com|
22440460|NCT05408429|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22440461|NCT03642873|Reckitt Benckiser, Inc|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
22440462|NCT03108131|The University of Texas MD Anderson Cancer Center|Dr. Kanwal Raghav|(917) 733-0356|kpraghav@mdanderson.org|
22440463|NCT01253291|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22440464|NCT02920632|Amsterdam UMC, Vrije Universiteit|Dr. Chris Vriend|+31625694912|c.vriend@amsterdamumc.nl|
22440465|NCT03312231|Kaiser Permanente Washington Health Research Institute|Lisa A. Jackson, MD, MPH|206-442-5216|lisa.a.jackson@kp.org|
22440466|NCT05178173|University of North Carolina at Chapel Hill|Laura Jacox, DMD, PhD|919-966-9731|ljacox@live.unc.edu|
22440467|NCT03157830|Providence Health & Services|Director of PBSI /WC Clinical Research Program|(503) 216-1012|Chiayi.Chen@providence.org|
22440468|NCT02195518|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22440469|NCT03694353|BioMarin Pharmaceutical Inc|Debra Lounsbury/Sr. Director, Clinical Sciences|415-506-6348|Dlounsbury@bmrn.com|
22440470|NCT04370873|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22440471|NCT03804528|University of Miami|Joyce Gomes-Osman|305-284-2632|j.gomes@miami.edu|
22440472|NCT04309396|Mayo Clinic Arizona|Dr. Jay Pasricha|(480)301-4279|pasricha.jay@mayo.edu|
22440473|NCT00651742|Taiho Oncology, Inc|Taiho|+1 844-878-2446|medicalinformation@taihooncology.com|
22440474|NCT01074970|Hoosier Cancer Research Network|Director of Clinical Data Management|317-634-5842|jsmith@hoosiercancer.org|41
22440475|NCT02086175|Dana-Farber Cancer Institute|Caron A. Jacobson, MD|617-632-6404|cajacobson@partners.org|
22440476|NCT00734149|Duke University Medical Center|Cristina Gasparetto, MD|919-668-1017|gaspa001@mc.duke.edu|
22440477|NCT04314284|Washington University School of Medicine|Mary Politi, Ph.D.|314-747-1967|mpoliti@wustl.edu|
22440478|NCT03312634|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
22440479|NCT04610281|Ullo World|Dr. Brigitte Laurent|+33782096875|brigitte@ullo.fr|
22440480|NCT01942837|Dana-Farber Cancer Institute|Mary-Ellen Taplin, MD|617-582-7221|mtaplin@partners.org|
22440481|NCT01298648|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22440482|NCT02648919|University of Hawaii Cancer Center|Stacy Mercado, IIT/ Education Manager|8084404561|smercado@cc.hawaii.edu|
22440483|NCT05887388|University of North Carolina at Chapel Hill|Mark Toles, PhD|919-966-5684|mtoles@email.unc.edu|
22440484|NCT01424215|Maimonides|Danny Sherwinter|7182837952|dsherwinter@maimonidesmed.org|
22440485|NCT01458392|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22440486|NCT02038933|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22440487|NCT01116986|UWisconsin|Stevens Smith|608-262-7563|sss@ctri.medicine.wisc.edu|
22440488|NCT03250273|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Nilofer Azad, MD|410-614-9169|nazad2@jhmi.edu|
22440489|NCT04154904|Oregon Health and Science University|Jessica Castle|1503-494-7072|castleje@ohsu.edu|
22440490|NCT00936715|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22440491|NCT00267059|The University of Texas M. D. Anderson Cancer Center|Alessandra Ferrajoli, MD, BS / Associate Professor|713-792-2063|eharriso@mdanderson.org|
22440492|NCT03040336|Pittsburgh VA Healthcare System, CHERP|Dr. Daniel E Hall|4123602016|daniel.hall2@va.gov|
22440493|NCT02000440|GlaxoSmithKline|GSK Response Center|866-435-7343||
22440494|NCT02416206|The Blood and Marrow Transplant Group of Georgia|Dr. Scott Solomon|404-255-1930|ssolomon@bmtga.com|
22440495|NCT02383576|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22440496|NCT00871975|LABORIE|Clinical Research Administrator|905 612 1170|acampbell@laborie.com|2274
22440497|NCT01436149|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22440498|NCT01690143|University of Alabama at Birmingham|Luciano J Costa, Principal Investigator|205-209-6038|ljcosta@uabmc.edu|
22440499|NCT01643668|Massachusetts General Hospital|Yi-Bin Chen, MD|617-726-0187|YCHEN6@PARTNERS.ORG|
22440500|NCT01409707|University of Mississippi Medical Center|Dr. Scott Coffey|601-815-5588|scoffey@umc.edu|
22440501|NCT00632229|University of South Florida|Dr. Eric Storch|727-767-8230|estorch@health.usf.edu|
22440502|NCT01716234|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22440503|NCT01467960|Villa Melitta|Sarah Dassati|+39 0471 471|sarahdassati@yahoo.it|471
22440504|NCT00474812|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Charles Nock MD|216-844-3862|charles.nock@uhhospitals.org|
22440505|NCT05810740|Pierre Fabre Médicament|Ana Catarina Pinto, Responsible Medical Officer|5 3450 6059|ana.catarina.pinto@pierre-fabre.com|
22440506|NCT03542487|Office of Evaluation Sciences, General Services Administration|Mattie Toma|859-621-0517|mattie.toma@gsa.gov|
22440507|NCT00737672|W.L. Gore and Associates, Inc.|Clinical Project Manager|928-864-3771|cavery@wlgore.com|
22440508|NCT01539824|Immodulon Therapeutics Ltd|Chief Medical Officer|+44 (0)20 3137 6346|info@immodulon.com|
22440509|NCT02735863|ABIVAX|Sharon Skare|+33153830961|sharon.skare@abivax.com|
22440510|NCT02002598|Columbia University|Suzanne Lentzsch, MD|646-317-4840|sl3440@cumc.columbia.edu|
22440511|NCT02560038|The University of Texas Health Science Center at Houston|Marka Lyons, Research Manager|713-500-6919|Marka.Lyons@uth.tmc.edu|
22440512|NCT02018562|Johns Hopkins University|Vinciya Pandian PhD, MSN, RN, ACNP-BC, FAAN|4436553482|vpandia1@jhu.edu|
22440513|NCT01838395|BioLineRx Ltd.|VP Clinical & Medical Affairs|+972-8-642-9100|clinicaltrials@biolinerx.com|
22440514|NCT00453895|University of Würzburg|Prof. Dr. Martin Fassnacht|+49-931-201-39201|fassnacht_m@medizin.uni-wuerzburg.de|
22440515|NCT01723384|San Francisco Department of Public Healt|Dr. Glenn-Milo Santos|415-437-6231|glenn-milo.santos@ucsf.edu|
22440516|NCT05378672|Zealand Pharma A/S|Clinical Operations|+45 88 77 36 00|clinicaltrials@zealandpharma.com|
22440517|NCT05720897|Indiana University|Stuart Schrader|3172781409|sschrade@iu.edu|
22440518|NCT00400179|Taiho Pharma USA, Inc.|Taiho|+1 844-878-2446|medicalinformation@taihooncology.com|
22440519|NCT04780061|Patterson Institute for Integrative Oncology Research|Clinical Trial Coordinator|6137921222|mlegacy@thechi.ca|1
22440520|NCT02344108|Mass General Brigham|Matthew E Stenerson, MS, Clinical Research Project Manager|7155721100|matthew_stenerson@meei.harvard.edu|
22440521|NCT04050553|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22440522|NCT01535040|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
22440523|NCT00498940|Columbia University Medical Center|Santos Cabreriza/ Associate Scientist|212-305-9515|sc45@cumc.columbia.edu|
22440524|NCT03353688|University of Alabama at Birmingham|Program Manger|(205) 934-0683|clg17@uab.edu|
22440525|NCT02023086|Université de Montréal|Langis Michaud|5149166312|langis.michaud@umontreal.ca|
22440526|NCT04607005|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22440527|NCT04760613|NYU Langone health|Stephen Ross, MD|212-263-6289|Stephen.ross@nyulangone.org|
22440528|NCT03589859|VA Northeast Ohio Healthcare System|Dr. Mark Walker|216-791-3800|mark.walker5@va.gov|65229
22440529|NCT03111121|West Virginia University|Pavithra Ranganathan Ellison, MD|3045984122|pavithra.ellison@hsc.wvu.edu|
22440530|NCT03043794|Johns Hopkins University, Department of Radiation Oncology|Dana Baker Kaplin, MPH|410-614-3950|dkaplin1@jhmi.edu|
22440531|NCT04671901|Memorial Sloan Kettering Cancer Center|Dr. Michael Ortiz MD|212-639-6057|ortizm2@mskcc.org|
22440532|NCT00626106|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22440533|NCT03472885|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22440534|NCT05417438|UMass Chan Medical School|Reem Najjar|7742750890|Reem.najjar@umassmed.edu|
22440535|NCT02845297|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Ivana Gojo|410-502-8775|igojo1@jhmi.edu|
22440536|NCT01664975|Zhengzhou University|Mingzhi Zhang|0371-66295564|mingzhi_zhang@126.com|
22440537|NCT02201953|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22440538|NCT02937116|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+8613382419112|jessica.yi@innoventbio.com|
22440539|NCT02079246|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
22440540|NCT03666663|UCSF|Dr.Nina Riggins|7028064831|Nina.Riggins7@gmail.com|
22440541|NCT02505919|PROCEPT BioRobotics Corporation|Angela Lee|6502327215|a.lee@procept-biorobotics.com|
22440542|NCT03124342|VANDERBILT UNIVERSITY MEDICAL CENTER|Matthew W. Semler, MD, MSc|(615) 322-3412|matthew.w.semler@vumc.org|
22440543|NCT01712399|MedImmune, LLC.|Marius Albulescu, MD|301-398-0000|clinicaltrialenquiries@medimmune.com|
22440544|NCT02201394|Atherothrombosis Research Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai|Dr. Juan J. Badimon||Juan.Badimon@mssm.edu|
22440545|NCT01803607|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22440546|NCT03077412|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22440547|NCT00632814|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22440548|NCT04939714|Emory University|Carolyn Clevenger, DMP, APRN|404-712-2394|carolyn.clevenger@emory.edu|
22440549|NCT03762993|Purdue University|Preeti Sivasankar|765-494-3788|preeti@purdue.edu|
22440550|NCT02993107|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
22440551|NCT03038100|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22440552|NCT00918255|Abbott|Global Medical Services|800-633-9110||
22440553|NCT02392624|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22440554|NCT04441892|Mayo Clinic|Dr. Michael J. Ackerman|507-284-8900|ackerman.michael@mayo.edu|
22440555|NCT03841604|Zambon SpA|Elena Tiberio, BSc|+39 02665241|clinicaltrials@zambongroup.com|
22440556|NCT01337960|VA Maryland Health Care System|Larry Forrester, PhD|410-637-3241|Larry.Forrester@va.gov|
22440557|NCT03877510|Impax Laboratories, LLC|Pamela Fitzpatrick, Senior Director, Specialty Regulatory Affairs|631-633-2104|pfitzpatrick@amneal.com|
22440558|NCT03763877|Poxel|Director, Medical Operations|+33 (0)4 37 37 20 10|carole.thang@poxelpharma.com|
22440559|NCT00842335|Jubilant Clinsys Inc.|Jane Fisher, Senior Manager, Regulatory Affairs|+1 (919) 518-8786|jfisher@clinsys.com|
22440560|NCT00832299|Beth Israel Medical Center|Peter Kozuch, MD||pkozuch@chpnet.org|
22440561|NCT02930824|University of Florida|Dr. Larisa Cavallari|(352) 273-8245|LCavallari@cop.ufl.edu|
22440562|NCT02086500|University of Pittsburgh|Dr. Jason Sperry MD, MPH|4128028270|sperryjl@upmc.edu|
22440563|NCT01524796|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22440564|NCT03938259|Baylor College of Medicine7|Dr. Adam Adler|832-824-5801|Adam.adler@bcm.edu|
22440565|NCT02121158|VA Cooperative Studies Program Coordinating Center, West Haven, CT|Michael T. Wininger, Ph.D., Study Biostatistician|203-932-5711|michael.wininger@va.gov|3262
22440566|NCT02435992|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
22440567|NCT03879772|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22440568|NCT02989597|Montefiore Medical Center|Dr. Andrew J. Kobets|718-920-7400|akobets@montefiore.org|
22440569|NCT03856788|Icahn School of Medicine at Mount Sinai|Christina Jeng, MD, FASA|212) 241-6426|christina.jeng@mountsinai.org|
22440570|NCT03415685|Lutronic|Alexander Denis, Global Manager of Clinical Research|9788959206|adenis@lutronic.com|
22440571|NCT01834911|New York Medical College|Dr. Robert Fekete|9143451313|robert_fekete@nymc.edu|
22440572|NCT03941288|Mayo Clinic|Michael Camilleri, MD|507-266-2305|camilleri.michael@mayo.edu|
22440573|NCT00389610|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Daniel Laheru, MD|410-955-8974|laherda@jhmi.edu|
22440574|NCT00887809|Memorial Sloan Kettering Cancer Center|Dr. William Tap|646-888-4163|tapw@mskcc.org|
22440575|NCT00765206|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22440576|NCT05131308|Kansas City Heart Rhythm Institute|Dhanunjaya Lakkireddy|913-449-1297|dhanunjaya.lakkireddy@hcahealthcare.com|
22440577|NCT02698215|University of California Los Angeles|Lara Ray, PhD|310-794-5383|lararay@psych.ucla.edu|
22440578|NCT04757766|Servier|olga linnik|8-495-93707-00|olga.linnik@servier.com|
22440579|NCT04771455|Northwestern University|Dr. Andrea Graham|312-503-5266|andrea.graham@northwestern.edu|
22440580|NCT01210313|ABCSG (Austrian Breast & Colorectal Cancer Study Group)|Trial Office Director|+43 1 4089230|info@abcsg.at|
22440581|NCT03982355|IMperial COllege London|Dr SImon Dryden|+447828464949|simon.dryden@imperial.ac.uk|
22440582|NCT02226367|VA Puget Sound Health Care System|Murray Raskind, MD|(206) 277-3797|Murray.Raskind@va.gov|
22440583|NCT03773978|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22440584|NCT03113487|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
22440585|NCT03777982|Dana Farber/Mass General Brigham Cancer Care|Anthony D'Amico|857-215-1489|adamico@bwh.harvard.edu|
22440586|NCT00870740|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22440587|NCT04916587|University of Colorado, Denver|Dr. Monica Perez Jolles|303-724-0829|monica.jolles@cuanschutz.edu|
22440588|NCT04475081|Louisiana State University Health - New Orleans|Associate Dean for Research|9858693445|pfidel@lsuhsc.edu|
22440589|NCT01502293|OncoSec Medical Incorporated|Kellie Malloy, Chief Clinical Development Officer|858-375-9989|kmalloy@oncosec.com|
22440590|NCT03710187|University of Tennessee Medical Center|Pharm D, Pharmacist Specialist, Critical Care|865-305-9134|swinters@utmck.edu|
22440591|NCT01318577|Bausch Health|Study Director|585-338-6399|robert.steffen@bausch.com|
22440592|NCT03944577|University of Nebraska Medical Center|Douglas Stoller|402-559-0815|douglas.stoller@unmc.edu|
22440593|NCT00391586|Dana Farber Cancer Institute|Dennie Jones, MD|617-632-6478|DennieV_Jones@DFCI.HARVARD.EDU|
22440594|NCT03011099|UT health PM&R|Chang, Shuo-Hsiu, PT, PhD|713-799-7016|Shuo-Hsiu.Chang@uth.tmc.edu|
22440595|NCT03058146|University of California, San Diego|Dr. Zvinka Zlatar|858-822-7737|zzlatar@health.ucsd.edu|
22440596|NCT03041181|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317-643-5842|jsmith@hoosiercancer.org|41
22440597|NCT02667119|UConn Health|Kristyn Zajac, PhD|860-679-8572|zajac@uchc.edu|
22440598|NCT03536572|VA San Diego Healthcare System|Carl J. Stepnowky, Deputy ACOS R&D|858-642-3269|carl.stepnowsky@va.gov|
22440599|NCT00521079|EnteroMedics Inc|Senior Vice President of Clinical|651-634-3209|ktweden@enteromedics.com|
22440600|NCT05452486|University of Arkansas for Medical Sciences|Dr. Caitlin Price|(501) 686-8125|CEPrice@uams.edu|
22440601|NCT04123470|Lokon Pharma|Angelica Loskog CEO|+46 18-50 74 44|angelica.loskog@lokonpharma.com|
22440602|NCT03435211|Masimo|Chelsea Frank|(949) 297-7000|studies@masimo.com|
22440603|NCT05972993|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22440604|NCT00723736|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22440605|NCT03818256|Corcept Therapeutics Incorporated|Medical Director|650-327-3270|info@corcept.com|
22440606|NCT02749422|NYU Langone Health|Anli Liu|929-455-2340|Anli.Liu@nyulangone.org|
22440607|NCT00911170|Amgen Inc.|Study Director|866-572-6436||
22440608|NCT02681523|Imperial College London|Laura Kenny|+44 (0)20 7594 2806|l.kenny@imperial.ac.uk|
22440609|NCT02677493|IL-YANG PHARM.|Clinical Research Manager|+82-70-7165-7316|hlpark@ilyang.co.kr|7316
22440610|NCT03641937|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
22440611|NCT00554216|Vivus, Inc.|Wesley W. Day PhD|650-934-5200|day@vivus.com|
22440612|NCT01347112|Mayo Clinic|Dr. Richard Hurt|507-284-7313|rhurt@mayo.edu|
22440613|NCT01679314|electroCore LLC|Annelie Andersson|+46 721 803076|annelie.andersson@electrocorellc.com|
22440614|NCT01615120|Oncternal|Mary Breitmeyer|858-434-1113|MBreitmeyer@oncternal.com|
22440615|NCT05462756|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22440616|NCT03591406|Vifor (International) Inc.|VIT-IRON-2011-004 Clinical Study Team|+41 58 851 80 00|VIT-IRON-2011-004.study@viforpharma.com|
22440617|NCT01389596|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22440618|NCT01709084|Janssen R&D US|Director, R&D, Medical Departement||ClinicalTrialDisclosure@its.jnj.com|
22440619|NCT00214201|UW Madison|Director of Clinical Trials|608-263-2565||
22440620|NCT04082819|SE Health|SE Research Centre|N/A|research@sehc.com|
22440621|NCT00463567|Novartis Pharmaceuticals|Study Director|862-778-8300||
22440622|NCT01432730|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22440623|NCT00641667|Janssen Research & Development, L.L.C. USA|Director, Clinical Research|1 609 730-3387||
22440624|NCT01235741|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
22440625|NCT01705509|Cardiovascular Institute of the South|Agostino Ingraldi, MD, FACC|337-988-1585|Agostino.Ingraldi@cardio.com|
22440626|NCT00904033|University of Rochester|Luke J Peppone, PhD, MPH|585-275-7827|Luke_Peppone@urmc.rochester.edu|
22440627|NCT01213316|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22440628|NCT03906448|University of Florida|David Tran, MD, PhD|352-273-9000|david.tran@neurosurgery.ufl.edu|
22440629|NCT01774721|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22440630|NCT00779155|Pico-Tesla Magnetic Therapies, LLC|Allen S. Braswell CEO|303-795-3222|abraswell@pico-tesla.com|
22440631|NCT00118417|Massachusetts General Hospital|Naomi M. Simon, MD|617-726-7913|nsimon@partners.org|
22440632|NCT02978781|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22440633|NCT01383356|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22440634|NCT02035267|Allergan, Inc|Beta Bowen|1-714-246-4446|Bowen_Beta@allergan.com|
22440635|NCT04827680|Venus Concept|Director of Clinical Affairs|888-907-0115|mgronski@venusconcept.com|
22440636|NCT02054104|National Cancer Institute|Dr. David Schrump|240-858-7000|schrumpd@mail.nih.gov|
22440637|NCT03134703|Johns Hopkins All Children's Hospital|Sandra Brooks, MD|727-767-4313|sbrook36@jhmi.edu|
22440638|NCT00084136|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22440639|NCT03543878|Georgia Institute of Technology|Annabelle C. Singer, PhD|510-501-9659|asinger@gatech.edu|
22440640|NCT00080535|National Cancer Institute, National Institutes of Health|Robert J. Kreitman, M.D.|301-496-6947|kreitmar@mail.nih.gov|
22440641|NCT01374438|Metabolic Solutions Development Company|Dr. Jerry Colca|269.343.8732|jcolca@msdrx.com|
22440642|NCT00836693|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22440643|NCT02004041|Vanda Pharmaceuticals Inc.|Vanda Pharmaceuticals Inc.|202-734-3400|clinicaltrials@vandapharma.com|
22440644|NCT02633306|University of Minenesota|Stephen Haines, MD|612 624-6666|shaines@umn.edu|
22440645|NCT01657019|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22440646|NCT01213472|GlaxoSmithKline|GSK Clinical Trials|877-379-3718|GSKClinicalSupportHD@gsk.com|
22440647|NCT01122238|UWisconsin|Stevens Smith|608-262-7563|sss@ctri.medicine.wisc.edu|
22440648|NCT00129402|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22440649|NCT02131259|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22440650|NCT02191111|University of Mississippi|Dr. Meagen Rosenthal|662-915-2475|mmrosent@olemiss.edu|
22440651|NCT00089752|University of Pennsylvania School of Nursing|Terri E. Weaver, PhD, RN, FAAN|215-898-2992|tew@nursing.upenn.edu|
22440652|NCT01472289|TotipotentSC|Dr. Venkatesh Ponemone|+91-124-4976860|venkatesh.ponemone@totipotentsc.com|
22440653|NCT00907335|Valeant Pharmaceuticals International, Inc|David Lineberry, Associate Director, Clinical Operations|949-973-1153|David.Lineberry@valeant.com|
22440654|NCT03131570|ROCKEFELLER UNIVERSITY|Dr. James G. Krueger|2123277409|KRUEGEJ@MAIL.ROCKEFELLER.EDU|
22440655|NCT04596267|Boston Medical Center|Dr. Eric Devine|617-418-7888|eric.devine@bmc.org|
22440656|NCT00071058|National Cancer Institute, National Institutes of Health|Antonio Fojo, M.D.|301-496-2631|FojoT@mail.nih.gov|
22440657|NCT05261386|ADS Therapeutics LLC|Dr. Rong Yang|9496798408|rong_yang@cloudbreaktherapeutics.com|
22380686|NCT05049616|The University of Texas Health Science Center at Houston|Michal Fishel Bartal, MD|(713) 500-6421|michal.f.bartal@uth.tmc.edu|
22380687|NCT05893797|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22380688|NCT04770220|Alzheon|Aidan Power|(508) 861-7709|aidan.power@alzheon.com|
22380689|NCT05087095|Virginia Commonwealth University|Ashlee Loughan, PhD, LCP|804-828-9815|ashlee.loughan@vcuhealth.org|
22380690|NCT04894903|Vanderbilt University Medical Center|William Martinez, MD, MS|615-936-1010|william.martinez@vumc.org|
22380691|NCT01923428|Ardelyx|Chief Development Officer|510 745 1752|drosenbaum@ardelyx.com|
22380692|NCT01822353|Helsinki University Hospital, Helsinki, Finland|Paula Kauppi, Chief Specialist|+358504286802|paula.kauppi@hus.fi|
22380693|NCT02550873|Promedior Inc.|Renu Gupta, MD, Chief Medical Officer|856-722-9824|rgupta@promedior.com|
22380694|NCT04320615|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22380695|NCT00850720|Children's Healthcare of Atlanta|Kiran Hebbar, MBBS|404-785-1600|kiran.hebbar@choa.org|
22380696|NCT03873246|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
22380697|NCT00885495|University of Cincinnati College of Medicine|Dr. Carl J. Fichtenbaum|513-584-6361|carl.fichtenbaum@uc.edu|
22380698|NCT02107443|University of Rochester, Medical Center|Dr. Supriya Mohile, Professor of Medicine|585-275-0394|URCC_COACH@URMC.Rochester.edu|
22380699|NCT00946647|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22380700|NCT01368211|Transfusion Service Rigshospitalet - Dept of Immunology, Copenhagen Denmark|Dr. Pär Johansson|+45 35452030|per.johansson@rh.regionh.dk|
22380701|NCT04387162|Atlanta VA Medical Center|Amy Rodriguez|404-321-6111|amy.rodriguez@va.gov|
22380702|NCT02334527|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22380703|NCT05708846|vitalera (FollowHealth SL)|Data Scientist of vitalera|+34644499760|dheart@humanitcare.com|
22380704|NCT03621982|ADC Therapeutics|Yvan LeBruchec|+41799110551|Yvan.LeBruchec@adctherapeutics.com|
22380705|NCT00238420|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22380706|NCT01254890|University of Texas (UT) MD Anderson Cancer Center|Farhad Ravandi-Kashani, Professor, Leukemia Department||CR_Study_Registration@mdanderson.org|
22380707|NCT01159535|University of Washington|Dr. Sarah Bowen|(206) 543-3452|swbowen@uw.edu|
22380708|NCT04069221|Medicines for Malaria Venture|Dr Myriam El Gaaloul, PharmD|+41 22 555 0377|elgaaloulm@mmv.org|
22440658|NCT04189952|University of Miami|Craig Moskowitz, MD|305-243-9009|chm78@med.miami.edu|
22440659|NCT01498068|Janssen Belgium|Compound Development Team Leader|32 14 64 13 70||
22440660|NCT04266717|University of Delaware|Michele A. Lobo|302-831-8526|malobo@udel.edu|
22440661|NCT02596867|TTUHSC-EP|Zeina Nahleh|9152155195|zeina.nahleh@ttuhsc.edu|
22440662|NCT00361296|Johns Hopkins University|Doug Smith, MD|4102872935|smithdo@jhmi.edu|
22440663|NCT00198822|Center for Human Nutrition, Department of International Health, Johns Hopkins Bloomberg School of Public Health|Prof. Keith P West, Jr., Principal Investigator|410-955-2061|kwest@jhsph.edu|
22440664|NCT02968758|GenePOC|Dr Keith Chiasson, PhD|418-650-3535|keith.chiasson@genepoc.ca|322
22440665|NCT01032538|Martina Hansens Hospital|Tor Kjetil Nerhus|+47 93409934|kjnerhus@gmail.com|
22440666|NCT00453206|Wake Forest University Health Sciences|David Hurd, MD|336-716-2843|dhurd@wakehealth.edu|
22440667|NCT02180100|Peking University Shenzhen Hospital|Prof. Shangrong Fan|86755-83923333|fanshangrong@163.com|5502
22440668|NCT04672239|Recovery Research Institute, Department of Psychiatry, Massachusetts General Hospital|Bettina B. Hoeppner, Ph.D., MS|617-643-1988|bhoeppner@mgh.harvard.edu|
22440669|NCT01551186|Washington University School of Medicine, St. Louis, Missouri|Dr. Erik Dubberke, MD, MSPH|314-454-8354|edubberk@wustl.edu|
22440670|NCT03866577|Momenta Pharmaceuticals, Inc.|Senior Director Clinical Development Head Rheumatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22440671|NCT04825678|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22440672|NCT01342211|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22440673|NCT05430854|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22440674|NCT04223479|The University of Jordan|Lana M. Agraib|+962|lanamg2007@yahoo.com|00000
22440675|NCT01824836|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22440676|NCT03253393|University of New South Wales|Dr Jacqueline Tan|+612 9385 6551|jacqueline.tan@unsw.edu.au|
22440677|NCT03593044|The Ohio State University College of Optometry|Dr. Jeffrey Walline|(614) 247-6840|walline.1@osu.edu|
22440678|NCT01582477|St. Elizabeth's Medical Center|Andrew Sternlicht, MD|617-789-2777|andrew.sternlicht@steward.org|
22440679|NCT01987453|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22440680|NCT02118441|Department of Anesthesia, St. Paul's Hospital|S. K. W. Schwarz, MD, PhD|604-806-8337|stephan.schwarz@ubc.ca|
22440681|NCT05291520|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22440682|NCT04375085|Elixir Medical Corp|Candace Elek, EVP Clinical Research|4086362000|celek@elixirmedical.com|
22440683|NCT02409277|University of Utah|Flory Nkoy|801-662-3660|flory.nkoy@hsc.utah.edu|
22440684|NCT01354899|Molnlycke Health Care AB|Tina Kjellen|+46317223098|tina.kjellen@molnlycke.com|
22440685|NCT00420771|NYSPI|John J. Mariani, MD|212-543-5987|jm2330@columbia.edu|
22440686|NCT03881852|Axsome Therapeutics, Inc.|Caroline Streicher, Executive Director, Clinical Operations|212-332-5061|cstreicher@axsome.com|
22440687|NCT01421719|Stanford University|Rodney U. Anderson, MD|6504984240|rua@stanford.edu|
22440688|NCT01124006|DePuy Synthes Spine|Mark Lotito|508-880-8045|Mlotito@its.jnj.com|
22440689|NCT02696967|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22440690|NCT00847509|Certus International, Inc.|Edward M. Aten, M.D.|603.627.1212|eaten@certusintl.com|
22440691|NCT02653417|Radius Pharmaceuticals, Inc.|Clinical Operations|617-551-4000|clinopsinfo@radiuspharm.com|
22440692|NCT01357850|GlaxoSmithKline|GSK Response Center|866-435-7343||
22440693|NCT02736890|Icahn School of Medicine at Mount Sinai|Dr. Thomas Bryce|212-241-6321|thomas.bryce@mountsinai.org|
22440694|NCT02351856|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22440695|NCT02904954|Weill Cornell Medicine|Cathy Spinelli, RN BSN|212-746-3328|caf2007@med.cornell.edu|
22440696|NCT01198795|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|58124
22440697|NCT00753506|Sheppard Pratt|Dr. Faith Dickerson|410-938-4359|fdickerson@sheppardpratt.org|
22440698|NCT03819114|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22440699|NCT04226742|University of California, Irvine|Stephen Schueller|949-824-3850|s.schueller@uci.edu|
22440700|NCT01635439|NWAFH|Ahmed Abdelaziz|0096644411088|webmaster@nwafh.med.sa|
22440701|NCT04591353|University of Alabama at Birmingham|Promil Kukreja|205-934-4042|Pkukreja@uab.edu|
22440702|NCT01647217|Tissuetech Inc|Hosam El Sheha, MD, PhD|305-274-1299|hsheha@tissuetechinc.com|
22440703|NCT01936870|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22440704|NCT01047358|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22440705|NCT04790916|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22440706|NCT00248040|Dompé farmaceutici s.p.a.|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22440707|NCT02494323|Bet-Loewenstein|Dr.Yaron Sacher|97297709918|ysacher@clalit.org.il|
22440708|NCT03847896|Avillion LLP|Chief Medical Officer|+44 (0)203 764 9530|avillion@avillionllp.com|
22440709|NCT02395471|Medtronic MITG Gastrointestinal & Hepatology|Dr.Jaime Kean|303-882-6759|Jaime.M.Kean@medtronic.com|
22440710|NCT04803396|Dompé farmaceutici SpA|dr. Mauro P. Ferrari|+39 02 583831|clinops@pec.dompe.it|
22440711|NCT03038880|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22440712|NCT02885025|VA Greater Los Angeles Healthcare System|Joseph Yusin Chief division Allergy Immunology|3104783711|joseph.yusin2@va.gov|40230
22440713|NCT03926611|Novartis Pharmaceuticals|Study Director|(862) 778-8300|novartis.email@novartis.com|
22440714|NCT02612779|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22440715|NCT03041038|Northwestern University|Dr. Amy Paller|3126953721|NUderm-research@northwestern.edu|
22440716|NCT00763035|Wake Forest University Health Sciences|Gregory Hundley|+1 (336) 716-0607|ghundley@wakehealth.edu|336
22440717|NCT02796170|Tulane University|Dragana Lovre|(504)988-9928|dlovre@tulane.edu|
22440718|NCT01527370|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22440719|NCT01271946|Arstasis|Debra Cogan, Director of Quality, Regulatory and Clinical|650-261-8073|dcogan@arstasis.com|
22440720|NCT02177032|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
22440721|NCT00930046|Boston Children's Hospital|Dr. Navil Sethna|781-216-1650|navil.sethna@childrens.harvard.edu|
22440722|NCT01598532|Spaulding Rehabilitation Hospital|Ross D. Zafonte, DO|617-952-5227|rzafonte@partners.org|
22440723|NCT00912808|Oregon Health & Science University|Kathryn Chung, MD|503 220 8262|chungka@ohsu.edu|51091
22440724|NCT00702221|BTG International Inc.|SVP, Clinical Development|610-278-1660|thomas.king@btgplc.com|
22440725|NCT02900378|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22440726|NCT03769519|Duke|Isaretta L. Riley, MD, MPH|919-286-0411|isaretta.riley@duke.edu|
22440727|NCT01134055|GlaxoSmithKline|GSK Response Center|866-435-7343||
22440728|NCT00767364|Wayne State University School of Medicine, Children's Hospital of Michigan|Eric McGrath, MD|313-745-5863|emcgrath@med.wayne.edu|
22440729|NCT03345784|University Health Network, Princess Margaret Cancer Centre|Dr. Stephanie Lheureux, PI|416-946-2818|stephanie.lheureux@uhnresearch.ca|
22440730|NCT03429270|Laborie|Stephanie Gallone, Clinical Research Manager|9056121170|sgallone@laborie.com|1755
22440731|NCT04798196|UW-Madison|Gina Landucci|(608) 890-1440|gina.landucci@wisc.edu|
22440732|NCT00571493|University of Nebraska Medical Center|Julie M Vose|402-559-3848|jmvose@unmc.edu|
22440733|NCT01249261|Warner Chilcott|Grexan J. Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22440734|NCT03114683|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+8613382419112|jessica.yi@innoventbio.com|
22440735|NCT03066947|BriaCell Therapeutics Corporation|Dr. William Williams|1-888-485-6340|williams@briacell.com|
22440736|NCT01615484|University of North Carolina at Chapel Hill|Thomas Egan, MD, MSc, FACS|919-966-3381|thomas_egan@med.unc.edu|
22440737|NCT00497081|San Francisco Department of Public Health|Glenn-Milo Santos, MPH|415.437.6231|glenn-milo.santos@sfdph.org|
22440738|NCT01967940|Gilead Sciences|Gilead Clinical Study Information Center||GileadClinicalTrials@gilead.com|
22440739|NCT01550003|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22440740|NCT05567783|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
22440741|NCT05005182|Mayo Clinic|Abhishek Mangaonkar|507-538-0173|Mangaonkar.Abhishek@mayo.edu|
22440742|NCT03675126|Sarepta Therapeutics, Inc.|Medical Director|1-888-727-3782|SareptAlly@sarepta.com|
22440743|NCT00001959|NIDDK, NIH|Jeffrey B Kopp, MD|3015943403|jbkopp@nih.gov|
22440744|NCT02958995|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
22440745|NCT03755934|AstraZeneca Clinical Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
22440746|NCT00940771|Bill Holt Clinic, Phoenix Children's Hospital|Janice Piatt, MD, Medical Director|602-933-0955|jpiatt@phoenixchildrens.com|
22440747|NCT00904982|University of Pennsylvania Perelman School of Medicine|Stephen E. Kimmel, MD, MSCE/Director, Clinical Epidemiology|(215) 898-1740|stevek@mail.med.upenn.edu|
22440748|NCT00963859|The University of Texas (UT) MD Anderson Cancer Center|John W. Davis, MD / Assistant Professor||CR_Study_Registration@mdanderson.org|
22440749|NCT02252666|University of Wisconsin - Madison|Dr. Mitchell Tyler|(608) 262-5112|metyler1@wisc.edu|
22440750|NCT02594124|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22440751|NCT05523089|Cidara Therapeutics, Inc.|Chief Medical Officer|858-888-7868|clinicaltrialinfo@cidara.com|
22440752|NCT05530252|BeijingSHCMU|Dr.Nannan Han|15701545851|qhddenver@126.com|
22440753|NCT01350999|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22440754|NCT01833247|Stanford University Department of Neurology|Robert S. Fisher, MD, PhD|650-7215289|robert.fisher@stanford.edu|
22440755|NCT02230995|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22440756|NCT04040933|Johnson & Johnson Consumer Inc. (J&JCI)|Robin Mathew|908-904-5034|rmathew1@its.jnj.com|
22440757|NCT02066181|Memorial Sloan-Kettering Cancer Center|Mrinal Murugesan Gounder M.D.|646-888-4167|gounderm@mskcc.org|
22440758|NCT00354978|UT MD Anderson Cancer Center|Scott Kopetz, MD Associate Professor|713-792-2828|mjlim@mdanderson.org|
22440759|NCT05764785|University of Massachusetts Boston|Dr. Jean Rhodes|(617) 620-9147‬|jean.rhodes@umb.edu|
22440760|NCT02141295|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22440761|NCT02536976|Struthers Parkinson's Center|Dr. Sotirios Parashos|001-952-993-5495|sotirios.parashos@parknicolet.com|
22440762|NCT00071890|INSERM U897 Bordeaux FRANCE|Pr G. Chene|557571392|genevieve.chene@isped.u-bordeaux2.fr|+33
22440763|NCT01671319|University of Wisconsin Carbone Cancer Center|Dr. Amyé Tevaarwerk|608-262-2837|at4@medicine.wisc.edu|
22440764|NCT02144610|AnGes USA, Inc.|Dr. Susan Pitman Lowenthal|240-780-9025|spitmanlowenthal@anges-usa.com|
22440765|NCT02169427|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22440766|NCT00959985|Massachusetts General Hospital|Dr. Alphonse G Taghian, MD PhD|617-726-6050|ataghian@partners.org|24369
22440767|NCT00706238|GlaxoSmithKline|GSK Response Center|866-435-7343||
22440768|NCT01193244|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22440769|NCT00628108|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
22440770|NCT03848832|GW Research Ltd|Medical Enquiries|1-833-424-6724|medinfo@gbio.com|
22440771|NCT00865566|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
22440772|NCT01039376|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
22440773|NCT00785785|Novartis Pharmaceuticals|Study Director|862-778-8300||
22440774|NCT02453321|University of Pittsburgh Medical Center|Kevin King, DO - Clinical Asst. Professor|412 748-5589|kingkk@upmc.edu|
22440775|NCT03252925|The First Affiliated Hospital of Soochow University|Yue Han|13901551669|hanyue@suda.edu.cn|
22440776|NCT01244893|Johnson & Johnson Vision Care|Brian Pall, O.D., M.S., F.A.A.O. Senior Research Optometrist|(904) 443-1290|BPALL@its.jnj.com|
22440777|NCT00357552|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
22440778|NCT00976404|Northwestern University|Baiba Berzins, MPH|312-695-5012|baiba@northwestern.edu|
22440779|NCT00521404|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22440780|NCT03089281|Boston Scientific|Clinical Trial Manager|1-800-227-3422|Sara.Veraghtert@bsci.com|
22440781|NCT04555616|University of Kentucky|Elizabeth Rhodus|859-257-5567|elizabeth.rhodus@uky.edu|
22440782|NCT00882557|Cubist Pharmaceuticals, Inc.|Ed Campanaro/Vice President, Clinical Operations|781-860-8318|ed.campanaro@cubist.com|
22440783|NCT02282605|Destiny Pharma|Director of Projects|+44 (0) 1273 704440|medinfo@destinypharma.com|
22440784|NCT00711191|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22440785|NCT02404025|Novartis Pharmaceuticals|Study Director|1-888-669-6682|novartis.email@novartis.com|
22440786|NCT00955916|H. Lee Moffitt Cancer Center and Research Institute|Rami Komrokji, M.D.|813-745-4291|rami.komrokji@moffitt.org|
22440787|NCT02230670|Conatus Pharmaceuticals|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com|
22440788|NCT01943903|HeartFlow|VP, Clinical|408-314-2335|smullen@heartflow.com|
22440789|NCT01907854|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22440790|NCT01744977|Durham Veterans Affairs Medical Center|Hayden Bosworth, PhD|919-286-6936|hayden.bosworth@va.gov|
22440791|NCT01101867|The Ohio State University|Dr. Kathleen Dungan|614-685-3333|kathleen.dungan@osumc.edu|
22440792|NCT01750229|Medtronic Neuromodulation|Neuro Clinical Trials||medtronicneurotrials@medtronic.com|
22440793|NCT03774576|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22440794|NCT01746901|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22440795|NCT03594110|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22440796|NCT02968004|OPKO Health, Inc.|OPKO Health, Inc.|3055754100|contact@opko.com|
22440797|NCT00217399|Georgetown University|Dr. Claudine Isaacs|202-444-3677|isaacsc@georgetown.edu|
22440798|NCT00803569|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22440799|NCT04298697|Emory University|Colleen Kelley, MD, MPH|404-712-1823|colleen.kelley@emory.edu|
22440800|NCT03995368|VA Greater Los Angeles Healthcare System|Dr. Jonathan K. Wynn|3104783711|Jonathan.Wynn@va.gov|44957
22440801|NCT03592186|Brown University School of Public Health|Sara Becker, Ph.D, Principal Investigator|4018636604|sara_becker@brown.edu|
22440802|NCT02593006|Hackensack University Medical Center|Yukiko Kimura MD|551-996-5306|yukiko.kimura@hackensackmeridian.org|
22440803|NCT02072668|University of Tennessee Center for the Heath Sciences|Dr. Kenneth Ataga|901.448.3181|kataga@uthsc.edu|
22440804|NCT01353898|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22440805|NCT02431637|Medicines for Malaria Venture|Dr. Jörg J. Möhrle|+41 22 555 0369|moehrlej@mmv.org|
22440806|NCT01352793|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22440807|NCT00656448|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes M.D./Professor|713/794-5783|eharriso@mdanderson.org|
22440808|NCT04322526|University of Pittsburgh|Dr. Marta Pecina|734-945-2473|pecinam@upmc.edu|
22440809|NCT00993967|Santhera Pharmaceuticals|Thomas Meier, PhD|+41 61 906 89 50|thomas.meier@santhera.com <Thomas.Meier@santhera.com>|
22440810|NCT03714880|University of Pittsburgh|Suji Uhm, MD, MPH|412-641-4590|uhms@upmc.edu|
22440811|NCT03352609|MUSC|Dr Friedrich|843-792-9888|friedric@musc.edu|
22440812|NCT03507569|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22440813|NCT03815929|Principle Investigator|Dr. Ekta Kapoor|507 538-7103|kapoor.ekta@mayo.edu|
22440814|NCT03313037|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22440815|NCT02760498|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22440816|NCT02205736|Levine Cancer Institute at Carolinas Healthcare System|Dr. James Symanowski|9804422371|james.symanowski@carolinashealthcare.org|
22440817|NCT01198977|Rehabilitation Care Services; MS Center of Excellence (MSCOE), VA Puget Sound Health Care System|Aaron Turner, PhD, Director, Rehabilitation Psychology; Asst Director Research, MSCOE|206-277-6134|Aaron.Turner@med.va.gov|
22440818|NCT03205423|New York State Psychiatric Institute|Jermaine Jones|7577533212|jermaine.jones@NYSPI.Columbia.edu|
22440819|NCT00595088|Bnai Zion Medical Center|Dr. Sarel Halachmi|+97248359542|sarel.halachmi@b-zion.org.il|
22440820|NCT00735436|Duke University Medical Center|Annick Desjardins, MD, FRCPC||annick.desjardins@dm.duke.edu|
22440821|NCT04323124|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22440822|NCT04586205|University of Pennsylvania|Yvette Sheline|215-573-0082|sheline@pennmedicine.upenn.edu|
22440823|NCT06904586|Duzce University|Assistant Professor|+905059313588|gizem123demir@hotmail.com|
22440824|NCT04684836|Vanderrbilt University|Jessica Ancker, MS, PhD|(615) 322-5000|jessica.s.ancker@vumc.org|
22440825|NCT02393378|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22440826|NCT00775190|Beaumont Health System|Evie Russell, RN|248-898-5388|Evie.Russell@beaumont.org|
22440827|NCT01710501|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22440828|NCT01376804|Hoffman-LaRoche|Medical Communications|800-821-8590||
22440829|NCT01281124|The Ohio State University Comprehensive Cancer Center|Greg Otterson|614-293-2887|Greg.Otterson@osumc.edu|
22440830|NCT05097963|Mayo Clinic|Vinay Chandrasekhara, M.D.|507-284-2687|Chandrasekhara.Vinay@mayo.edu|
22440831|NCT02492763|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22440832|NCT02446899|AstraZeneca AB|Global Clinical Lead|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
22440833|NCT01002339|Hospital Universitario de Canarias. Universidad de La Laguna. Spain|Dr. Armando Torres Ramírez|+34630989515|atorres@ull.es|
22440834|NCT02215252|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22440835|NCT00892099|Massachusetts General Hospital|Dr. Ishir Bhan|617-726-3934|ibhan@mgh.harvard.edu|
22440836|NCT03910244|Cleveland Clinic|Keith McCrae, MD|216-445-7809|mccraek@ccf.org|
22440837|NCT01106690|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
22440838|NCT04455815|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
22440839|NCT03977818|Institut Bergonié|Pr Antoine Italiano|33 5 56 33 33 33|a.italiano@bordeaux.unicancer.fr|
22440840|NCT02683577|Ipsen Pharma|Medical Director||clinical.trials@ipsen.com|
22440841|NCT03219528|University of Michigan|Allen Lee|734-936-4785|allenlee@med.umich.edu|
22440842|NCT03809104|Ci-Shan Hospital, Health and Welfare of Minister, Taiwan|Ms. Chia-Yu Wei|+886-7-6615523|ivywei@chis.mohw.gov.tw|1729
22440843|NCT00790842|PrECOG|PrECOG Statistician|978-835-3516|jbmanola@gmail.com|
22440844|NCT02504151|Yale|Dr. Mohini Ranganathan|(203)932-5711|mohini.ranganathan@yale.edu|2546
22440845|NCT00538902|Abbott|Global Medical Services|800-633-9110||
22440846|NCT01454102|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22440847|NCT02148874|The Ohio State University Wexner Medical Center|Lisa Christian, PhD|614-293-0936|lisa.christian@osumc.edu|
22440848|NCT00705016|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22440849|NCT00942604|LEO Pharma|Dr. Torsten Skov|+4520736294|torsten.skov@leo-pharma.com|
22440850|NCT01188343|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22440851|NCT04109547|Novo Nordisk A/S|Clinical Reporting Office (2834)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22440852|NCT00817843|UMC Utrecht|Professor F.L.J. Visseren, MD PhD|0031-88-7555555|f.l.j.visseren@umcutrecht.nl|
22440853|NCT01499355|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
22440854|NCT02668653|Daiichi Sankyo Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22440855|NCT03129568|Okayama University Hospital|Dr. Hidemasa Oh|086-235-6506|hidemasa@okayama-u.ac.jp|6506
22440856|NCT00686712|Charles R. Drew University of Medicine and Science|Stanley H. Hsia, MD|323-357-3633|stanleyhsia@cdrewu.edu|
22440857|NCT01318915|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22440858|NCT03987503|University of California, San Francisco|Dr. Meghan D. Morris, Associate Professor|415-574-0651|meghan.morris@ucsf.edu|
22440859|NCT04119414|University of Miami|Stephen Weiss|7862108684|sweiss2@med.miami.edu|
22440860|NCT02054689|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MSCCR, CCRP, Clinical Research Manager|4126475554|stadtermanbm@upmc.edu|
22440861|NCT00999102|NY Presbyterian Hospital - Weill Cornell Medical Center|Dr. Samuel Mann, PI|212-746-2200|sjmann@med.cornell.edu|
22440862|NCT03678493|University of Minnesota, Masonic Cancer Center|Armin Rashidi, MD, PhD|(612) 273-8383|arashidi@umn.edu|
22440863|NCT03000608|Santalis Pharmaceuticals|Dr. Paul Castella|2103992316|paulc@santalispharmaceuticals.com|101
22440864|NCT01929317|GlaxoSmithKline|GSK Response Center|866-435-7343||
22440865|NCT01808456|Inova Fairfax Hospital|Dr. Ravinder Wali|7037764001|ravinder.wali@inova.org|
22440866|NCT03146585|University Hospital Hradec Kralove|Dr. David Astapenko|+420608177374|astapenko.d@seznam.cz|
22440867|NCT01624350|Medtronic|Medtronic (Sponsor)|508.452.4095|michelle.v.disalvo@medtronic.com|
22440868|NCT02546388|University of Pennslyvania|Paco Bravo, MD|1-215-220-9494|Paco.Bravo@pennmedicine.upenn.edu|
22440869|NCT03801408|University of Arkansas for Medical Sciences|Sara Jones, Principal Investigator|501-526-7846|sljones@uams.edu|
22440870|NCT01662765|Bahcesehir University, School of Medicine|Dr. Mehmet Kaplan|+905056268899|dr.kaplan27@gmail.com|
22440871|NCT05069948|The University of Edinburgh and NHS Lothian|Aimun Jamjoom|0131 536 1000|v1ajamjo@ed.ac.uk|
22440872|NCT04792645|University of Chicago|Dr. Jon Grant|773-834-3778|jongrant@uchicago.edu|
22440873|NCT04410367|Blue Earth Diagnostics, Ltd.|Chief Medical Officer|+44 (0)1865 784 186|contact@blueearthDx.com|
22440874|NCT01899521|Atlanta VA Medical Center|Dr. Ashish Mehta|404-321-6111|Ashish.Mehta@va.gov|207133
22440875|NCT01588522|BPGbio Inc.|Bing Nie|617-588-1002|bing.nie@bpgbio.com|
22440876|NCT04504253|University of Utah|Brent Kious, MD|8015851418|brent.kious@hsc.utah.edu|
22440877|NCT04377659|Memorial Sloan Kettering Cancer Center|Dr. Boglarka Gyurkocza, MD|646-608-3768|gyurkocb@mskcc.org|
22440878|NCT02855125|Taiho Oncology, Inc.|Taiho Central|+1 844-878-2446|medicalinformation@taihooncology.com|
22440879|NCT00664443|Ottawa Hospital Research Institute|Manya Charette|613-798-5555|mancharette@ohri.ca|17758
22440880|NCT01899040|Scion NeuroStim, Inc|Robert Black|919-260-5528|bacllc@earthlink.net|
22440881|NCT03712358|Istari Oncology|Lisa Franklin|919-245-7662|lfranklin@istarioncology.com|
22440882|NCT02638220|Travere Therapeutics, Inc.|Cheryl Wong Po Foo/Director, Clinical Development|8889697879|cheryl.wongpofoo@travere.com|
22440883|NCT04051996|Yale University|Dr. Amer Zeidan|(203) 200-4363|amer.zeidan@yale.edu|
22440884|NCT01350258|Thomas Jefferson University|Dolores Grosso, CRNP, DNP|215-955-8874|Dolores.Grosso@jefferson.edu|
22440885|NCT02153632|Osmotica Pharmaceuticals|George Wagner, VP of Regulatory Affairs|9088091357|gwagner@osmotica.ccom|
22440886|NCT02083354|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22440887|NCT01646125|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22440888|NCT02105662|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22440889|NCT00214890|UCSD|Sheldon Morris|6195438080|shmorris@ucsd.edu|
22440890|NCT01417377|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22440891|NCT02113982|Stemline Therapeutics, Inc.|Ira Gupta, MD|877-332-7967|clinicaltrials@menarinistemline.com|
22440892|NCT00384670|Department of Pediatrics, Pharamongkutklao Hospital|Sriluck Simasathien ; Infectious Disease Consultant|66-2-644-8971||
22440893|NCT01772316|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22440894|NCT02085161|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22440895|NCT01394003|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22440896|NCT03537404|R-Pharm|Emiliya Krasavina, Medical Adviser|0074959567937|krasavina@rpharm.ru|
22440897|NCT00068692|ECOG-ACRIN statistical office|Statistician||eatrials@jimmy.harvard.edu|
22440898|NCT01222689|university of california san francisco|Dr. Andrew Ko, MD|415-353-7286|Andrew.Ko@ucsf.edu|
22440899|NCT01600716|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22440900|NCT03481595|Cleveland Clinic Florida|Carlos Higuera|9546595430|higuerc@ccf.org|
22440901|NCT03557034|Cleveland Clinic|Khaldoun Tarakji, MD, MPH|216-445-9225|TARAKJK@ccf.org|
22440902|NCT02540629|Seoul National University Hospital|Dr. Jeong Ho Park|+821035426282|timthe@gmail.com|
22440903|NCT03349034|Icahn School of Medicine at Mount Sinai|Dr. Brett Miles|(212) 241-9410|brett.miles@mountsinai.org|
22440904|NCT00123422|Edward Hines Jr. ,VA Hospital|Eileen Collins|708-202-3525|eileen.collins@va.gov|
22440905|NCT02301416|Wake Forest School of Medicine|Jamy Ard|336-716-9837|jard@wakehealth.edu|
22440906|NCT04816552|Johns Hopkins School of Public Health|Dr. Christine Marie George|(202) 657-5798|cmgeorge@jhu.edu|
22440907|NCT00602472|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22440908|NCT01938716|UT MD Anderson Cancer Center|Dr. Gauri R Varadhachary,Professor, GI Medical Oncology|713-792-2828|gvaradha@mdanderson.org|
22440909|NCT01908803|Alcon Research, Ltd.|Sr Clinical Project Lead, GCRA, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
22440910|NCT00823615|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
22440911|NCT00098813|Memorial Sloan-Kettering Cancer Center|Dr. David Pfister|646-888-4237|pfisterd@mskcc.org|
22440912|NCT05488535|Advanced Bionics|Emily Cardenas, Au.D.|16616785405|Emily.Cardenas@advancedbionics.com|
22440913|NCT00433004|University of Pennsylvania|Arden McAllister|215-662-3532|arden.mcallister@uphs.upenn.edu|267
22440914|NCT01051518|Medtronic|M. Hollander|+31620534428|maarten.hollander@medtronic.com|
22440915|NCT04730271|DePuy Synthes|Ian Leslie|N/A|ileslie1@its.jnj.com|
22440916|NCT00998296|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22440917|NCT02350296|Dompé farmaceutici SpA|Clinical Development & Operations|+39 02 583831|clinical.trials@dompe.com|
22440918|NCT04396639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22440919|NCT02106390|GlaxoSmithKline|GSK Response Center|866-435-7343||
22440920|NCT05029362|The University of Texas Health Science Center at Houston|Irene Tami-Maury, DMD, MSc, DrPH|(713) 500-9234|Irene.M.Tami-Maury@uth.tmc.edu|
22440921|NCT03734692|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, CCRP|4126475554|stadtermanbm@upmc.edu|
22440922|NCT05571605|University of North Texas|Dr. Justin Sprick|940-565-2226|justin.sprick@unt.edu|
22440923|NCT00419952|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22440924|NCT05050227|VA Greater Los Angeles Healthcare System, UCLA David Geffen School of Medicine|Lucinda B. Leung, MD, PhD, MPH|310-478-3711|lleung@mednet.ucla.edu|
22440925|NCT04288661|1st Propaedeutic Surgery Department,Hippocration Hospital,University of Athens, Greece|Dr Maria Malvina Eleftheriou|+30 6945176503|malvina_el@hotmail.com|
22440926|NCT03126591|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22440927|NCT02115048|Translational Research In Oncology (TRIO)|Director, Project Management|+33 1 58 10 09 09|TRIO020.contact@trioncology.org|
22440928|NCT03722238|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22440929|NCT02085460|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
22440930|NCT01285323|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22440931|NCT02606643|Saint Louis University|Gary Furhman|314-977-2090|jathompson@slu.edu|
22440932|NCT00093041|Genmab A/S|VP Clinical Operations Eva Järlid Westerberg|+45 7020 2728|E.Westerberg@genmab.com|
22440933|NCT02158546|Alkermes|Eva Stroynowski|781-609-7000|eva.stroynowski@alkermes.com|
22440934|NCT02376998|University Magna Graecia of Catanzaro|Prof. Raffaele Serra|+3909613647380|rserra@unicz.it|
22440935|NCT02351817|Coloplast A/S|Medical Director|+45 4911 1395|dkbir@coloplast.com|
22440936|NCT01194856|Cleveland Clinic|Marisa Tungsiripat|2164442037|tungsim@ccf.org|
22440937|NCT01011894|Memorial Sloan Kettering Cancer Center|Dr. Renier Brentjens|212-639-7053|brentjer@mskcc.org|
22440938|NCT03418714|Johns Hopkins University|Frederick Barrett|4105509777|fbarret2@jhmi.edu|
22440939|NCT00561925|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22440940|NCT00417417|NHLBI/NIH|Richard O. Cannon III, MD|301-496-9895|cannonr@nih.gov|
22440941|NCT00684021|UT-Houston School of Public Health|Lemuel Moye, MD, PhD|713-500-9518|Lemmoye@msn.com|
22440942|NCT00891904|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22440943|NCT01208207|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22440944|NCT03122509|Memorial Sloan Kettering Cancer Center|Dr. Neil Segal, MD, PhD|646-888-4187|segaln@mskcc.org|
22440945|NCT04041414|University of Southern California|Jeremy Goldbach, PhD, LMSW|(213) 821-6460|goldbach@usc.edu|
22440946|NCT00665652|Dartmouth Hitchcock Medical Center|Elijah Stommel|603-650-5104|elijah.w.stommel@hitchcock.org|
22440947|NCT01749215|University of California, San Francisco/San Francisco VA Healthcare System|Dr. Steven L. Batki|415-221-4810|steven.batki@ucsf.edu|23671
22440948|NCT02382705|University of British Columbia|Dr. Robert Enns|604 688 6332|cgalorport@gmail.com|
22440949|NCT02556177|GE Healthcare|John Strohmeyer|609-865-7423|john.strohmeyer@ge.com|
22440950|NCT01526577|LG Life Sciences|Dong Yeop Shin|82 2 6924 3114|dongyeopshin@lgls.com|
22440951|NCT04320316|University of Alabama at Birmingham|M.D|12056389107|hdabdullatif@uabmc.edu|
22440952|NCT01807624|Jean Brown Research Center|Dr. Derek Muse|(801) 261-2000|participate@jeanbrownresearch.com|
22440953|NCT02512783|Children's Hospitals and Clinics of Minnesota|Angela Doucette|6128137144|angela.doucette@childrensmn.org|
22440954|NCT03060096|Wake Forest NCORP Research Base|Dr. Emily Dressler|336-716-0891|NCORP@wakehealth.edu|
22440955|NCT01055197|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
22440956|NCT00734539|Duke Univiersity Medical Center|Daniel K. Benjamin Jr|919-668-7081|danny.benjamin@dm.duke.edu|
22440957|NCT01782378|VA Boston Healthcare System, Jamaica Plain Campus, Boston, MA|Margaret Naeser, PhD|857-364-4030|Margaret.Naeser@va.gov; mnaeser@bu.edu|
22440958|NCT00830440|GI Dynamics, Inc.|Manager of Clinical Affairs|781.357.3263|kwoessner@gidynamics.com|
22440959|NCT02233517|VAORD|Elizabeth Van Voorhees|(919) 286-0411|elizabeth.vanvoorhees@va.gov|6435
22440960|NCT01663103|University of Colorado Anschutz Medical Campus|Dr. Kristen Nowak|303-724-4842|Kristen.Nowak@ucdenver.edu|
22440961|NCT04008745|University of Sao Paulo|Isabel de Camargo Neves Sacco|+551130918426|icnsacco@usp.br|
22440962|NCT03102437|Impulse Dynamics|Angela Stagg|18453592389|astagg@impulsedynamics.com|
22440963|NCT01721044|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22440964|NCT04351334|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22440965|NCT04355169|Shionogi Inc.|Shionogi Clinical Trials Administrator Clinical Support Help Line|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
22440966|NCT02048670|Mayo Clinic|Dr. Devin L. McCaslin|507-284-3410|mccaslin.devin@mayo.edu|
22440967|NCT00722072|OHSU Knight Cancer Institute|Dr. Stephen Chui|503-494-8534|chuis@ohsu.edu|
22440968|NCT02420821|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22440969|NCT04467905|Milestone Pharmaceuticals Inc.|Leonid Kokovin-Sher|1 450-912-6783|lkokovin-sher@milestonepharma.com|
22440970|NCT02202759|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22440971|NCT01590888|Prana Biotechnology|Dr Caroline Herd|+61393494906|info@pranabio.com|
22440972|NCT04953728|University of Michigan|Jiande Chen|734-764-3880|cjiande@med.umich.edu|
22440973|NCT02331277|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22440974|NCT02042274|University of Guelph|Dr. David Mutch, Associate Professor|519-824-4120|dmutch@uoguelph.ca|53322
22440975|NCT01071798|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22440976|NCT01732718|University of North Carolina at Chapel Hill|Kenneth Ataga, MD|901-448-2813|kataga@uthsc.edu|
22440977|NCT01759446|Acura Pharma|Dr. Al Brzeczko|847-705-7709|abrzeczko@acurapharm.com|
22440978|NCT01760733|Telemark Hospital Trust|MD, PhD Kristian Heldal|+4790018417|hkri@ous-hf.no|
22440979|NCT03403283|University of Alabama at Birmingham|maria grant|13528714314|mariagrant@uabmc.edu|
22440980|NCT00815659|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22440981|NCT00719472|Genentech, Inc.|Medical Communications|800-821-8590||
22440982|NCT00842296|Medtronic|Stephanie Brucato, Principal Clinical Research Specialist|508-261-8000|stephanie.m.brucato@medtronic.com|
22440983|NCT01908062|Oregon Health & Science University|Todd Korthuis|503-494-8044|korthuis@ohsu.edu|
22440984|NCT03584789|HealthPartners Institute|D. Brad Rindal, DDS, Associate Dental Director Research|952-967-5026|donald.b.rindal@healthpartners.com|
22440985|NCT01357525|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR, Regulatory Supervisor, CRS|412-647-5554|stadtermanbm@upmc.edu|
22440986|NCT04646044|Nektar Therapeutics|Study Director|855-482-8676|StudyInquiry@nektar.com|
22440987|NCT00742235|Massachusetts General Hospital|Principal Investigator|617-726-3934|ibhan@partners.org|
22440988|NCT04287036|Johnson & Johnson Vision Care|Meredith Bishop OD, MS, FAAO|1-800-843-2020|mbishop4@its.jnj.com|
22440989|NCT02346721|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22440990|NCT01544335|Massachusetts General Hospital|Associate Director, Lymphedema Research Program|6177240127|cbrunelle@mgh.harvard.edu|
22440991|NCT04211909|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22440992|NCT00124514|cincinnatichildrens|Hermine Brunner|5136367982|hermine.brunner@cchmc.org|
22440993|NCT02488915|Neuravi Ltd|Mairsíl Claffey|0035391394123|mclaffey@neuravi.com|
22440994|NCT01532986|VA Greater Los Angeles Healthcare System|Eric M Cheng|3102067671|echeng@mednet.ucla.edu|
22440995|NCT03216512|Duke University|Dr Scott Kollins|919-681-0014|scott.kollins@duke.edu|
22440996|NCT03408392|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22440997|NCT00885170|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22440998|NCT03771664|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22440999|NCT02120898|Teva Pharmaceuticals Inc. USA|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
22441000|NCT01046396|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
22441001|NCT02551887|Indiana University|Dr. Gregory Zimet|317-274-8812|gzimet@iu.edu|
22441002|NCT02161016|RTI Surgical|Robin Waite|386-418-8888|rwaite@rtix.com|
22441003|NCT03818321|TriHealth|Dr. Rachel Pauls|513-463-4300|Rachel_Pauls@trihealth.com|
22441004|NCT00275509|New York University Langone Transplant Institute|Robert Montgomery, MD|646-501-2418|Robert.Montgomery@nyumc.org|
22441005|NCT01441076|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Grayson, Peter|+1 301 827 9187|peter.grayson@nih.gov|
22441006|NCT02210039|Massachusetts General Hospital|Guillermo Tearney, PI|617-724-2979|gtearney@partners.org|
22441007|NCT00380367|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22441008|NCT01605799|San Francisco VA Medical Center|Dr. Shira Maguen|415-221-4810|shira.maguen@va.gov|22511
22441009|NCT01385293|Duke University|Andrew J. Armstrong, MD ScM FACP|919 668 4667|andrew.armstrong@duke.edu|
22441010|NCT00499083|University of Nebraska Medical Center|Elizabeth Reed|402-559-5166|ereed@unmc.edu|
22441011|NCT01278212|Medical University of South Carolin|Harriet Eldredge-Hindy|8437926382|eldredge@musc.edu|
22441012|NCT01559857|Stanford University|Dr. Natalie Rasgon|6507249694|natalie.rasgon@stanford.edu|
22441013|NCT00477386|IndianaU|Daniela Matai, MD|317-944-0920|dmatai@iupui.edu|
22441014|NCT01254422|Sanofi Pasteur SA|Director||Contact-US@sanofi.com|
22441015|NCT00643162|Cedars Sinai Medical Center|Felicia Mayes|310-423-0825|mayesf@cshs.org|
22441016|NCT04587661|University of Pittsburgh|Dr. Charles Jonassaint|+14125869850|cjonassaint@pitt.edu|
22441017|NCT02415608|Stanford University Medical Center|Jason Robert Gotlib, MD; Professor of Medicine (Hematology)|650-498-6000|C.Langford@stanford.edu|
22441018|NCT00847210|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
22441019|NCT01812252|Fred Hutch Cancer Center|Bart Lee Scott M.D.|(206)909-0977|bscott@fredhutch.org|
22441020|NCT01656408|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22441021|NCT05465317|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|001
22441022|NCT04634253|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22441023|NCT01457703|University of Colorado Denver|Clinical Research Regulatory Manager|303-724-6501|Chanel.mansfield@ucdenver.edu|
22441024|NCT01658436|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|trialandresults.registries@novartis.com|
22441025|NCT00926237|University of Arkansas for Medical Sciences|Dr Mark Mennemeier|205 410 2413|msmennemeier@uams.edu|
22441026|NCT03133793|Sponsored Programs Adminstration (SPA)|Dr. Mario Medina, Director of Sponsored Programs Administration|913-588-5724|mmedina3@kumc.edu|
22441027|NCT03486834|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22441028|NCT00888940|Cubist Pharmaceuticals, Inc.|Alistair Wheeler, MD MFPM, Senior Director Clinical Research|781-860-8660|awheeler@cubist.com|
22441029|NCT00432172|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
22441030|NCT00515619|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
22441031|NCT02379091|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22441032|NCT02053376|UPMC Hillman Cancer Center|Barbara Stadterman, Regulatory Supervisor|412-647-5554|stadtermanbm@upmc.edu|
22441033|NCT03326713|Rutgers Cancer Institute|Anita Y. Kinney, PhD|(732) 865-3375|anita.kinney@rutgers.edu|
22441034|NCT00771758|Ortho-McNeil Janssen Scientific Affair, LLC.|Senior Director of Clinical Development, Pain|(908)927-5465||
22441035|NCT03067077|Stanford University School of Medcine|Edward E. Manche|6507255765|edward.manche@stanford.edu|
22441036|NCT02529072|Duke University Medical Center|Principal Investigator|9196845301|dukebrain1@duke.edu|
22441037|NCT00935584|VA san Diego Healthcare System|Dr. Zia Agha|8586421295|zia.agha@va.gov|
22441038|NCT00687193|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22441039|NCT05370495|Seinda|Jing-Feng Huang, Ph.D.|1.858.254.9188|jfhuang@SeindaPharm.com|
22441040|NCT02514083|National Heart Lung and Blood Institute (NHLBI)|Inhye Ahn, M.D.|301-827-1203|inhye.ahn@nih.gov|
22441041|NCT02017405|Entera Health, Inc.|Audrey L. Shaw, Ph.D.|919 971 8000|audrey.shaw@enterahealth.com|
22441042|NCT03894124|Chelsea and Westminster NHS Foundation Trust|Research Operations Manager|+442033156825|chelwest.research@nhs.net|
22441043|NCT01350401|Adaptimmune|Clinical Trials Management||clinicaltrials@adaptimmune.com|
22441044|NCT02273596|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
22441045|NCT01404936|UT MD Anderson Cancer Center|Anas Younes, MD / Professor||CR_Study_Registration@mdanderson.org|
22441046|NCT02139592|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22441047|NCT01014351|SCRI Development Innovations LLC|John D. Hainsworth, M.D.|615-329-7274|asksarah@scresearch.net|
22441048|NCT00921895|Rapid Pathogen Screening, Inc.|Robert Sambusky, MD|941-556-1853|sambursky@rpsdetectors.com|
22441049|NCT06131476|Johnson & Johnson Vision Care|Principal Research Optometrist, Clinical Sciences|1 800-843-2020|njoshi30@its.jnj.com|
22441050|NCT02873702|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22441051|NCT01177397|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
22441052|NCT01528969|Kuwait University, Faculty of Dentistry|Prof. Eino Honkala|+965 65638938|eino.honkala@hsc.edu.kw|
22441053|NCT03085797|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22441054|NCT00194532|University Of Washington|Ann Stapleton, MD|206-616-4121|stapl@uw.edu|
22441055|NCT01765972|Johnson & Johnson Vision Care Inc.|Katherine Osborn Lorenz, OD, MS|614 459-9477|KOSBORN@its.jnj.com|
22441056|NCT04050202|University of California, San Francisco|Danielle Roubinov, PhD|919-843-5898|danielle.roubinov@ucsf.edu|
22441057|NCT01554241|University of California, San Francisco|Janice B.Schwartz, M.D., Professor of Medicine|(415) 406-1573|janice.schwartz@ucsf.edu|
22441058|NCT05661409|Emory University|Dr. Matthew K. Whalin|404-616-5014|mwhalin@emory.edu|
22441059|NCT03198507|Redhill Biopharma Inc.|June Almenoff, Chief Scientific Officer|(984) 444 7010|jalmenoff@redhillus.com|
22441060|NCT00724698|Schering-Plough|Head, Clinical Trials Registry & Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com|
22441061|NCT02690948|Stanford University|Anne Lynn S. Chang, Associate Professor of Dermatology|650-721-7151|alschang@stanford.edu|
22441062|NCT01411891|University of Wisconsin School of Medicine and Public Health, Department of Anesthesiology|Dr. Kristopher Schroeder|608-263-8100|kmschro1@wisc.edu|
22441063|NCT04614974|UPMC Children's Hospital of Pittsburgh|Dr. Amber Shaffer|412-692-6874|shafferad@upmc.edu|
22441064|NCT00831480|Baylor College of Medicine|Dr. Gilad E. Amiel|713-798-4079|lhiggins@bcm.edu|
22441065|NCT00658359|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22441066|NCT01075685|Inpes|Juliette Guillemont|+331 49 33 22 55|juliette.guillemont@inpes.sante.fr|
22441067|NCT03449667|University of California San Diego|Brian M. Ilfeld, MD, MS|(858) 822-0776|bilfeld@health.ucsd.edu|
22441068|NCT03196349|Duke University|Dr. Thomas Ortel|919-684-5350 ext 3|thomas.ortel@duke.edu|
22441069|NCT01963078|MUSC|Dr. Megan Moran-Santa Maria|843-817-6233|moranm@musc.edu|
22441070|NCT03388164|Laureate Institute for Brain Research|Teresa Victor|918-502-5108|tvictor@laureateinstitute.org|
22441071|NCT03023397|University of North Carolina at Chapel Hill|Allison Burbank, MD|919-962-5136|allison_burbank@med.unc.edu|
22441072|NCT00363480|GlaxoSmithKline|GSK Response Center|866-435-7343||
22441073|NCT01151189|Aeras|Product Director; Bernard Landry|301-547-2919|blandry@aeras.org|
22441074|NCT02911844|University of Pennsylvania|Dr. Steven Kawut|215-573-0258|kawut@upenn.edu|
22441075|NCT00454324|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22441076|NCT02535806|Children's Mercy Hospital|Dr. Keith August|816-302-6808|kjaugust@cmh.edu|
22441077|NCT02129699|European Thoracic Oncology Platform|European Thoracic Oncology Platform|+41 31389 93 91|SPLENDOUR@etop-eu.org|
22441078|NCT01394016|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22441079|NCT03534804|Research Compliance Office, Huntsman Cancer Institute|IIT Data Management Team|801-213-6215|IITDataManagement@hci.utah.edu|
22441080|NCT02530515|UT MD Anderson Cancer Center|Dr. Chitra Hosing / Stem Cell Transplantation|(713) 745-3219|cmhosing@mdanderson.org|
22441081|NCT04161157|University of Kentucky|Dr. Laurie McLouth|859-562-2526|laurie.mclouth@uky.edu|
22441082|NCT03752567|Farmacia La Regina|Dr. Raffaele La Regina|+393389066138|raffaele.laregina@gmail.com|
22441083|NCT04858035|Montclair State University|Elaine R. Hitchcock|9732293797|hitchcocke@montclair.edu|
22441084|NCT06482125|Universitas Pelita Harapan|Dr. Corry Quando Yahya|2181383190900|corry.yahya@lecturer.uph.edu|
22441085|NCT05353777|Levita Magnetics|Vivian Soto|+56958360507|VSoto@Levita.com|
22441086|NCT05174416|Peking Union Medical College Hospital|Prof. Shuyang Zhang|+86 13911667211|shuyangzhang103@163.com|
22441087|NCT02833233|Memorial Sloan Kettering Cancer Center|Dr. Elizabeth Comen|646-888-4525|comene@mskcc.org|
22441088|NCT02991768|University of Kansas Medical Center|Clinical Research Coordinator|913-588-3520|edelaney2@kumc.edu|
22441089|NCT04701762|Cleveland Clinic|Kurt Ruetzler|216 407-4108|ruetzlk@ccf.org|
22441090|NCT05786651|Lehigh University|Nancy Carlisle|610-758-5122|nbc415@lehigh.edu|
22441091|NCT05030129|Rush University Medical Center|Elizabeth Berry-Kravis, MD PhD|312-942-4036|Elizabeth_Berry-Kravis@rush.edu|
22441092|NCT02538510|University of Washington|Cristina Rodriguez|2066066748|rodrigcr@uw.edu|
22441093|NCT03397966|Vanderbilt University Medical Center|Alp Ikizler, Catherine McLaughlin Hakim Chair in Vascular Biology, Professor of Medicine|615-343-7592|alp.ikizler@vumc.org|
22441094|NCT01442103|Molnlycke Health Care|Joan wilson|+1 706-650-1012|joan.wilson@molnlycke.com|
22441095|NCT02042872|James J. Peters VA Medical Center|William A. Bauman, M.D.|718-584-9000|william.bauman@va.gov|5428
22441096|NCT02605122|Cempra Pharmeuticals, a wholly owned subsidary of Melinta Therapeutics, Inc.|Melissa Allaband|9199140822|mallaband@melinta.com|
22441097|NCT01213199|GALDERMA|Fabien AUDIBERT, CPM|+ 33 4 92 95 29 21|fabien.audibert@galderma.com|
22441098|NCT00807001|Idenix Pharmaceuticals, Inc.|John Z. Sullivan-Bolyai, MD, MPH|877-433-6491||
22441099|NCT00842751|University of Washington, Dept. of Medicine|John Amory, MD|(206) 616-1727|jamory@u.washington.edu|
22441100|NCT01399372|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
22441101|NCT00590772|Penn State University|Timothy Craig|717-531-6525|tcraig@psu.edu|
22441102|NCT03284307|University of Sydney|Robert Sanders, MBBS, PhD, FRCA|02 9036 3136|robert.sanders@sydney.edu.au|
22441103|NCT01027273|Icahn School of Medicine at Mount Sinai|Carol R Horowitz, MD, MPH|212-659-9567|carol.horowitz@mountsinai.org|
22441104|NCT04313244|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22441105|NCT00043979|National Cancer Institute, National Institutes of Health|Dr. Terry Fry|301-402-0215|fryt@mail.nih.gov|
22441106|NCT04069702|Duke University|Sarah Kelleher, PhD|9194163405|sarah.kelleher@duke.edu|
22441107|NCT03096288|University of Florida College of Medicine - Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3378|dominick.angiolillo@jax.ufl.edu|
22441108|NCT02560558|Emory University|Dr. Idelberto Badell|404-712-6562|ibadell@emory.edu|
22441109|NCT02819804|Northwestern University|Shira Dinner, MD|312-695-6180|shira.dinner@nm.org|
22441110|NCT03967444|Galderma Research & Development, Aesthetics|Director of Clinical Operations|817-961-5655|aestheticclinicaltrials@galderma.com|
22441111|NCT02858362|Summit Therapeutics|Clinical Disclosure|Please Email|clinicaltrials@summitplc.com|
22441112|NCT02369796|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22441113|NCT01821118|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
22441114|NCT00686686|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22441115|NCT00131248|UT Houston Medical School|Kathleen A. Kennedy, MD, MPH|713 500-6708|kathleen.a.kennedy@uth.tmc.edu|
22441116|NCT01052701|Johns Hopkins School of Medicine|Associate Director, Drug Development Unit|(410) 614-8762|ejfuchs@jhmi.edu|
22441117|NCT01187355|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
22441118|NCT00318643|Halozyme Therapeutics|Chief Medical Officer|855-495-3639|halozyme@EVERSANA.com|
22441119|NCT05038982|Johns Hopkins University|Shawn Kwatra|410-502-7546|skwatra1@jhmi.edu|
22441120|NCT01942694|Division of Endocrinology, Diabetes, and Metabolism, Tufts Medical Center|Dr. Anastassios Pittas|617-636-3232|apittas@tuftsmedicalcenter.org|
22441121|NCT02691507|Johnson & Johnson Consumer, Inc|Amisha Parikh-Das, PhD/Study Director|973-255-8701 USA EST|AParikh1@its.jnj.com|
22441122|NCT00472576|Experimental Therapeutics and Pathophysiology Branch, DIRP, NIMH|Dr. Carlos Zarate|301-451-0861|zaratec@mail.nih.gov|
22441123|NCT04170608|FARAPULSE|Christopher Schneider|617-686-7661|kschneider@farapulse.com|
22441124|NCT01378871|Albert Einstein College of Medicine|Dr, Amit Verma||amit.verma@einsteinmed.edu|
22441125|NCT04355143|University of California Los Angeles|Reza Ardehali, MD, PhD|310-825-5280|rardehali@mednet.ucla.edu|
22441126|NCT03739203|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22441127|NCT02387502|Govt. Medical College, Haldwani.|Dr. Geeta Bhandari|8958267145|bhandari_geetantl@rediff.com|
22441128|NCT01519921|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22441129|NCT01216189|Karolinska Institutet|Professor Anna Martling|+46851770000|anna.martling@ki.se|
22441130|NCT01143246|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22441131|NCT01146795|Columbia University|Jason Wright, MD|212-305-3410|jw2459@cumc.columbia.edu|
22441132|NCT05375760|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22441133|NCT03853109|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22441134|NCT00385216|Columbia University|Pamela Flood, MD|212-305-2008|pdf3@columbia.edu|
22441135|NCT04032093|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22441136|NCT01356277|McGill University Health Centre|Dr. Bethany Foster|514-412-4461|bethany.foster@mcgill.ca|
22441137|NCT02565108|GW Research Ltd.|Medical Enquiries||medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
22441138|NCT01310075|UT MD Anderson Cancer Center|Dr. Mark W Clemens, Associate Professor, Plastic Surgery|713-794-1247|mwclemens@mdanderson.org|
22441139|NCT00646048|Boston Scientific|Colleen Holthe, Clinical Project Manager|651-581-4632|Colleen.Holthe@bsci.com|
22441140|NCT00702299|University of Arizona|Dr. Setsuko Chambers|520/626.0950|schambers@azcc.arizona.edu|
22441141|NCT02708186|Axovant Sciences GMBH|Senior Director of Clinical Research|1-833-296-8268|clinicaltrials@axovant.com|
22441142|NCT02745119|Hoffmann-La Roche|Medical Communications|616878333|global.trial_information@roche.com|+41
22441143|NCT00960999|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
22441144|NCT02536963|Rebiscan|CEO|857-600-0982|jgshaka@rebiscan.com|
22441145|NCT02425943|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
22441146|NCT02141204|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22441147|NCT01209325|University of California, San Francisco|Dr. Joel M. Palefsky|415-476-1574|jpalefsky@medicine.ucsf.edu|
22441148|NCT02582775|University of Minnesota, Masonic Cancer Center|Dr. Christen Ebens|(612) 626-5654|ebens012@umn.edu|
22441149|NCT03529422|UNC Lineberger Comprehensive Cancer Center|Melahat Canter|919-962-0000|Melahat_Canter@med.unc.edu|
22441150|NCT02484391|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-716-7970|bpowell@wakehealth.edu|
22441151|NCT04922216|University of North Carolina at Chapel Hill|Brooke Nezami, PhD|919-966-5852|bnezami@unc.edu|
22441152|NCT02064582|UT Southwestern Medical Center|Kevin Courtney, MD|214-648-4180|Kevin.Courtney@utsouthwestern.edu|
22441153|NCT01136980|EndoGastric Solutions|Adrain Lobontiu|+16504749259|alobontiu@endogastricsolutions.com|
22441154|NCT03207763|Emory University|Evan Anderson, MD|404-727-1746|evanderson@emory.edu|
22441155|NCT02102204|Amgen Inc.|Study Director|866-572-6436||
22441156|NCT03751657|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1)866-867-7178|clinicaltrials@novonordisk.com|
22441157|NCT00990704|Abbott|Global Medical Services|800-633-9110||
22441158|NCT04603027|Evelo Biosciences, Inc.|Duncan McHale, MBBS, MRCP, PhD|+447500128938|duncan@evelobio.com|
22441159|NCT03894813|Peking University Shenzhen Hospital|Prof. Shangrong Fan|86-0755-83923333|fanshangrong@163.com|
22441160|NCT02248246|Ethicon|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
22441161|NCT02269267|Medical College of Wisconsin|Ehab Atallah, MD|414-805-4600|eatallah@mcw.edu|
22441162|NCT03773796|Medical University of Innsbruck|Prof. Klaus Seppi|004351250481553|klaus.seppi@tirol-kliniken.at|
22441163|NCT03805659|Medical College of Wisconsin|Peter Kraegel|414-955-0657|pkraegel@mcw.edu|
22441164|NCT01745822|French National Research Institute for Sustainable Development (IRD)|Gonzague Jourdain|+66818830065|gonzague.jourdain@ird.fr|
22441165|NCT00145158|Ludwig Institute for Cancer Research|Jonathan Skipper PhD|12124501539|jskipper@lcr.org|
22441166|NCT02741518|Brigham and Women's Hospital|Dr. Jessica Allegretti|617-732-5500|jallegretti@bwh.harvard.edu|
22441167|NCT00476008|Charles E. Schmidt College of Medicine, Florida Atlantic University|Peter Holland, MD|561-297-0164|holland@fau.edu|
22441168|NCT01788358|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22441169|NCT01227018|Vanderbilt-Ingram Cancer Center|Dr. Dana Cardin|615-936-8580|dana.cardin@vanderbilt.edu|
22441170|NCT03249116|Tufts University|Dr. Megan K Mueller|508-887-4543|megan.mueller@tufts.edu|
22441171|NCT03762317|Hennepin County Medical Center|Dr. Kunal Gupta|6128732677|kunal.gupta@hcmed.org|
22441172|NCT00221117|Toronto RI Institute|Dr. Milos Popovic|416-597-3422|milos.popovic@utoronto.ca|6305
22441173|NCT00499616|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22441174|NCT00659737|Drexel university|Michael Green|215-762-1524|micheal.green@drexelmed.edu|
22441175|NCT00808080|UC San Diego Moores Cancer Center|Dr. Thomas Lane, Stem Cell Lab Director|858-822-5364|jreiner@Ucsd.edu|
22441176|NCT01189409|BC Cancer|Dr. Philippa Hawley|607-877-6000|PHawley@bccancer.bc.ca|67-2707
22441177|NCT02803580|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22441178|NCT01837823|Mount Sinai Hospital and Icahn School of Medicine at Mount Sinai|Dr. Annapoorna Kini|212-241-4181|annapoorna.kini@mountsinai.org|
22441179|NCT03052400|Charles R. Drew University of Medicine and Science|Stanley H. Hsia, MD|323-357-3633|stanleyhsia@cdrewu.edu|
22441180|NCT01358721|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
22441181|NCT00867815|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22441182|NCT00001213|National Institutes of Health|Rachel J. Bishop, MD, Principal Investigator, National Eye Institute|301-402-3771|bishopra@nei.nih.gov|
22441183|NCT02636595|AbbVie|Global Medical Services|800-633-9110||
22441184|NCT02297373|Ottawa Hospital|Dr Gregoire Le Gal|613-737-8899|glegal@toh.ca|
22441185|NCT05782179|MinervaX|Cornelia Oostvogels/Chief Medical Officer (CMO)|00491515092821|lio@minervax.com|
22441186|NCT04954833|Johnson & Johnson Vision Care, Inc. (JJVC)|Xu Cheng|1-800-843-2020|xcheng6@its.jnj.com|
22441187|NCT00831181|Beth Israel Medical Center|Dr Peter Kozuch|212 844-8282|pkozuch@chpnet.org|
22441188|NCT04048356|University of New Mexico|Peter Jeppson, site contact for study|505-967-8428|pjeppson@salud.unm.edu|
22441189|NCT05021978|Praxis Precision Medicines|Charmaine Manilay|2243996121|cmanilay@praxismedicines.com|
22441190|NCT00196313|Duramed Research|Duramed Research Protocol Chair|215-293-7279|role_medical_affairs@tevapharm.com|
22441191|NCT04639258|Medtronic Structural Heart & Aortic|Robert Waltonen|763-526-0424|robert.waltonen@medtronic.com|
22441192|NCT04592887|Varian, a Siemens Healthineers Company|Senior Manager, Clinical Trials|437-991-3496|ClinOps@varian.com|
22441193|NCT00414596|NEMA Research, Inc|Jospeph V Pergolizzi, MD|239-597-3564|nemaresearch@aol.com|
22441194|NCT01924949|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22441195|NCT01635153|Dartmouth-Hitchcock|Dr C Fordham von Reyn|6036507167|fvr@dartmouth.edu|
22441196|NCT02754440|Terumo BCT, Inc.|Heather Pidcoke, MD, PhD|(303) 231-4805|Heather.Pidcoke@terumobct.com|
22441197|NCT02558296|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
22441198|NCT00533117|NYSPI|Barbara Stanley|6467747582|bhs2@columbia.edu|
22441199|NCT01189032|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
22441200|NCT03588884|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
22441201|NCT01995838|Eisai Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
22441202|NCT01967576|National Cancer Institute|Dr. Andrea Apolo|301-480-0536|apoloab@nih.gov|
22441203|NCT00345358|GlaxoSmithKline|GSK Response Center|866-435-7343||
22441204|NCT02592798|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22441205|NCT01696188|Sidney Kimmel Medical College at Thomas Jefferson University|Dr. Eric Schwenk|215-955-6161|Eric.Schwenk@jefferson.edu|
22441206|NCT02668393|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22441207|NCT02139007|UAB|Jeff Foster|205-996-6086|pjfoster@uabmc.edu|
22441208|NCT00174187|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22441209|NCT01285557|Taiho Oncology, Inc.|Taiho|+1 844-878-2446|medicalinformation@taihooncology.com|
22441210|NCT02000115|Abbott Structural Heart|Daniella Corporan|779-220-7309|daniella.corporan@abbott.com|
22441211|NCT04815824|VA Eastern Colorado Health Care System|Dr. Sarah Wherry|303-704-8054|sarah.wherry@va.gov|
22441212|NCT03278249|University of Cincinnati Cancer Center|Rekha Chaudhary, MD, Adjunct-Associate Professor of Medicine|513-558-2119|Rekha.chaudhary@uc.edu|
22441213|NCT02656693|Brigham and Women's Hospital|Heather J. Baer, ScD|617-525-7503|hbaer@bwh.harvard.edu|
22441214|NCT02565784|Q-Med AB|Clinical Project Manager|+46184749000|reception.seupp@galderma.com|
22441215|NCT02223702|Kocaeli University|Chair and Associate Professor of Periodontology|+902623442222|esragd@yahoo.com|5102
22441216|NCT01373671|Siemens Medical Solutions USA, Inc.|Director of Clinical Affairs|610-448-6468|lesley.ewing@siemens.com|
22441217|NCT04657094|City of Hope Medical Center|Dr. Alexey Danilov|6263598111|adanilov@coh.org|
22441218|NCT02948634|UT Southwestern|Jason Zafereo|14-648-1002|jason.zafereo@utsouthwestern.edu|2146481002
22441219|NCT03007225|Ain Shams University|Dr Iman Montasser, Assistant professor of Tropical Medicine member of HCC clinic and group , Ain Sha|0020201065065333|imanfawzy2@gmail.com|
22441220|NCT01079299|Center for Curative and Palliative Wound Care Calvary Hospital|Oscar M. Alvarez / Principal Investigator|718-518-2577|oalvarez@calvaryhospital.org|
22441221|NCT00753649|GlaxoSmithKline|GSK Response Center|866-435-7343||
22441222|NCT03108469|Clinvest Research|Jim Sly|4178413673|jsly@clinvest.com|
22441223|NCT05844007|Montana State University|Dr. Lauren Davis|828-773-6328|lauren.davis6@montana.edu|
22441224|NCT01039519|Synta Pharmaceuticals|VP Clinical Research|781-541-7156|aoneill@syntapharma.com|
22441225|NCT03062540|Tonix Pharmaceuticals|Gregory Sullivan, MD|(862) 904-0355|greg.sullivan@tonixpharma.com|
22441226|NCT01255436|University of the Philippines Manila|Dr. Lia M. Palileo|6325679740|liapalileo@gmail.com|
22441227|NCT04816669|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
22441228|NCT01229267|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22441229|NCT00333762|VA Pittsburgh Healthcare System|Dana Sinciline|412-822-3683|dana.sinciline@va.gov|
22441230|NCT02223858|Veterans Affairs Pittsburgh Healthcare System|Dr. Leslie R.M. Hausmann|412-360-2112|leslie.hausmann@va.gov|
22441231|NCT00241839|University of Florida|Mark S. Segal, MD, PhD; Assistant Professor and Chief, Division of Nephrology|352-273-8821|Mark.Segal@medicine.ufl.edu|
22441232|NCT06170242|Enanta Pharmaceuticals, Inc.|Medical Monitor|+1 6176070800|enquiries@enanta.com|
22441233|NCT02976038|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
22441234|NCT02832115|Aultman Hospital|Dr. Prabhakaran Gopalakrishnan|3304548076|prab.gopalakrishnan@aultman.com|
22441235|NCT02919995|Verona Pharma plc|Brian Maurer|+19147675037|brian.maurer@veronapharma.com|
22441236|NCT01059435|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22441237|NCT02245217|Huntsman Cancer Institute|Josiah Hawks|8015850601|Josiah.Hawks@hci.utah.edu|
22441238|NCT01263197|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22441239|NCT02577718|MD Anderson Cancer Center|Dr. A M Chaftari|7137923491|achaftar@mdanderson.org|
22441240|NCT02194985|Amicus Therapeutics|Medical Affairs|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
22441241|NCT03281200|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22441242|NCT00225732|Cumberland Pharmaceuticals Inc.|Amy Rock, Ph.D.|615-255-0068|arock@cumberlandpharma.com|
22441243|NCT00346697|Johns Hopkins University|Dr Todd Brown, Associate Professor of Medicine and Epidemiology|410-502-2327|tbrown27@jhmi.edu|
22441244|NCT01012440|University of Chicago|Dr. Kirti Kulkarni|(773) 702-2781|kkulkarni@radiology.bsd.uchicago.edu|
22441245|NCT00594815|Memorial Sloan Kettering Cancer Center|Dr. Antonio Omuro|212-639-7523|omuroa@mskcc.org|
22441246|NCT02557139|Kadmon Corporation, LLC|Olivier Schueller, Senior Vice President, CMC & Clinical Pharmacology|833-900-5366|olivier.schueller@kadmon.com|
22441247|NCT02284243|Recro Pharma|Randall Mack|484-395-2470|rmack@recropharma.com|2406
22441248|NCT01227993|National Eye Institute|Catherine Meyerle, MD|301-435-7821|meyerlec@nei.nih.gov|
22441249|NCT01932437|Elusys Therapeutics, Inc.|Senior Director of Regulatory|973-808-0222|cdillon@elusys.com|
22441250|NCT04269889|National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH)|David J. Young, MD, PhD|301.827.7823|david.young2@nih.gov|
22441251|NCT04987333|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22441252|NCT00949702|Hoffmann-La Roche|Medical Communications|800-821-8590||
22441253|NCT01654302|Northwestern University|Julia Marks, CRC|312-503-1215|julia.marks@northwestern.edu|
22441254|NCT01569607|Emory University|Dr. Cathrin Buetefisch|404-712-5507|cathrin.buetefisch@emory.edu|
22441255|NCT02699749|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22441256|NCT01167504|Institute of Food Research|Professor Peter Wilde|+441603255258|peter.wilde@ifr.ac.uk|
22441257|NCT02377817|Global Innovations for Reproductive Health & Life|Dr. Allan Kember, Director of Programs|+1-902-580-8385|allan.kember@mail.utoronto.ca|
22441258|NCT04139018|Washington University School of Medicine Department of Otolaryngology - Head and Neck Surgery|Jay Piccirillo, M.D., Vice Chair for Research|314-362-8641|piccirij@wustl.edu|
22441259|NCT02364570|The Ohio State University|Richard Bruno, PhD, RD|6142925522|bruno.27@osu.edu|
22441260|NCT03614156|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
22441261|NCT01094119|Cleveland Clinc|Daniel Sessler|216-444-4900|DS@OR.org|
22441262|NCT03810105|Memorial Sloan Kettering Cancer Center|Dr. Karen Autio, MD|646-422-4632|autiok@mskcc.org|
22441263|NCT05503823|University of Manitoba|Dr. Zahra Moussavi|204 474-7023|zahra.moussavi@umanitoba.ca|
22441264|NCT01106248|Eisai|Dr. Peter Tarassoff|888-422-4743||
22441265|NCT00357903|Amgen Inc.|Study Director|866-572-6436||
22441266|NCT00606593|Actelion Pharmaceuticals Ltd|Pascal Charef/Clinical Trial Leader|+41 61 565 65 65||
22441267|NCT01160822|Novartis Pharmaceuticals|Study Director|862-778-8300||
22441268|NCT01607255|VA Northern California Healthcare Systems - Mather|Joseph W. Leung, MD, Chief of Gastroenterology|916-366-5339|Joseph.Leung2@va.gov|
22441269|NCT03529695|USC Center for Economic and Social Research|Kayla De La Haye, PhD, Research Scientist|323-442-8228|delahaye@usc.edu|
22441270|NCT00759941|Alcon Research, Ltd.|Head, Global Medical Affairs|800-862-5266|medinfo@alconlabs.com|
22441271|NCT00354432|Wake Forest University School of Medicine|Dr. Doug Case|(336) 716-5425|dcase@wakehealth.edu|
22441272|NCT03863080|Immunovant, Inc|Central Study Contact|1-800-797-0414|clinicaltrials@immunovant.com|
22441273|NCT04194437|TransMedics, Inc.|VP Cliinical Affairs|978-552-0900|ldamme@transmedics.com|
22441274|NCT01967238|Stanford University|Taia Wang|5103873941|taiawang@stanford.edu|
22441275|NCT03493464|Bracco Diagnostics Inc.|Giordana Marioni, Clinical Trial Assistant|609-514-2282|giordana.marioni@diag.bracco.com|
22441276|NCT03123731|University of California, San Diego|Dr. Brook Henry|619-543-4737|blhenry@ucsd.edu|
22441277|NCT04949490|BioNTech SE|BioNTech clinical trials patient information|+49 6131 9084|patients@biontech.de|0
22441278|NCT00811590|Huntsman Cancer Institute|Dr. Randall Burt|801-585-3281|randall.burt@hci.utah.edu|
22441279|NCT02864394|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22441280|NCT05232682|Brown University|Mollie Monnig, PhD|4018633491|mollie_monnig@brown.edu|
22441281|NCT05358353|Reflow Medical|Carolyn Mascho|949-481-0399|cmascho@reflowmedical.com|
22441282|NCT01284335|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22441283|NCT02604160|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22441284|NCT01596062|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22441285|NCT01069900|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
22441286|NCT03180840|Protalix Ltd.|Sari Alon|+972-4-9028100|sari@protalix.com|215
22441287|NCT02933450|Emergency Department, Baylor College of Medicine|Dr Zubaid Rafiue|7138732626|zubaidrafique@gmail.com|
22441288|NCT01812668|Barbara Ann Karmanos Cancer Institute|Dr. Elisabeth Heath|313-576-8734|heathe@karmanos.org|
22441289|NCT01168219|Washington University School of Medicine|Ravi Vij, MD||rvij@im.wustl.edu|
22441290|NCT05801341|UW School of Medicine and Public Health|Ellen Wald, MD|(608) 263-8558|erwald@pediatrics.wisc.edu|
22441291|NCT02405442|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22441292|NCT01742117|Mayo Clinic|Dr. Naveen L. Pereira|507-284-4441|Pereira.Naveen@mayo.edu|
22441293|NCT00337675|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
22441294|NCT00859456|Columbia University|Robert Taub, MD||rntaubipod@gmail.com|
22441295|NCT00880919|University of Minnesota|Dr. S. Charles Schulz, MD|612-273-9820|scs@umn.edu|
22441296|NCT01576809|Novartis Consumer Health|Clinical project Leader|41223633111||
22441297|NCT02015637|Melinta Therapeutics, Inc.|Susan K. Cammarata, M.D. (Chief Medical Officer)|1-844-MELINTA (1-844-635-4682)|clinicaltrials@melinta.com|
22441298|NCT01695304|Centers for Disease Control and Prevention|Ciara O'Reilly, PhD|404-639-1953|bwf1@cdc.gov|
22441299|NCT00921518|Wilkes University|Judith Kristeller|570-408-4272|judith.kristeller@wilkes.edu|
22441300|NCT00927953|MacroGenics, Inc.|Medical Officer||info@macrogenics.com|
22441301|NCT02863419|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22441302|NCT01219881|The Ohio State University|Dr. Joseph Werner|614-293-8487|Joseph.Werner@osumc.edu|
22441303|NCT01491607|Emergent BioSolutions|Dr. Robert Hopkins|(301) 944-0136|hopkinsr@ebsi.com|
22441304|NCT01317277|UCSD HIV Neurobehavioral Research Program (HNRP)|Dr. David J Moore, Professor of Psychiatry|619-543-5093|djmoore@ucsd.edu|
22441305|NCT02688777|North Florida/South Georgia Veteran's Health System|Dr. Dorian Rose|352-376-1611|dorian.rose@va.gov|105238
22441306|NCT02549365|Imperial College London|Dr Paul Turner|+44 20 3312 7754|p.turner@imperial.ac.uk|
22441307|NCT00912795|Center for Innovative Public Health Research|Dr. Michele Ybarra|877-302-6858|michele@innovativepublichealth.org|1 - 801#
22441308|NCT00297258|GlaxoSmithKline|GSK Response Center|866-435-7343||
22441309|NCT02454517|Fred Hutchinson Cancer Center|Jeannette M. Schenk, PhD|206-667-6860|jschenk@fredhutch.org|
22441310|NCT00473382|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
22441311|NCT02999672|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22441312|NCT03565497|Boston University|Dr. Michael Otto|617-306-1836|mwotto@bu.edu|
22441313|NCT01470326|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22441314|NCT01166282|AbbVie|Global Medical Information|800-633-9110||
22441315|NCT00531661|CardioMEMS, Inc.|Jordan Bauman|4043458235|jbauman@cardiomems.com|
22441316|NCT01155518|suny buffalo|sandeep dhindsa||sandhindsa@yahoo.com|
22441317|NCT02561832|AstraZeneca Pharmaceuticals LP|Carsten Goessl MD|+1 2404490654|Carsten.Goessl@astrazeneca.com|
22441318|NCT02892448|The Ottawa Hospital Research Institute|Dr. Paul E Beaule|613-737-8899|pbeaule@toh.ca|73265
22441319|NCT03214666|GT Biopharma, Inc.|Dr. Gregory Berk|925-719-3531|gb@gtbiopharma.com|
22441320|NCT03048578|NYU Langone Health - Weight Management Program|Holly F. Lofton, MD|(212) 263-3166|Holly.Lofton@nyulangone.org|
22441321|NCT02921841|Rhode Island Hospital|Larry K. Brown, MD|(401) 793 - 8808|lkbrown@lifespan.org|
22441322|NCT01497496|Moffitt Cancer Center|Celeste Bello, MD|813-745-8623|Celeste.Bello@moffitt.org|
22441323|NCT02902237|Department of Medicine A, University Hospital Muenster, Germany|Prof. Dr. Wolfgang Berdel, Professor of Medicine|+49 251 835|berdel@uni-muenster.de|2672
22441324|NCT02023697|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22441325|NCT00541385|Medicines for Malaria Venture (MMV)|Stephan Duparc, MD, Chief Medical Officer|+41 22 555 0300|duparcs@mmv.org|351
22441326|NCT01469377|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22441327|NCT01733680|SUNy Upstate Medical University|Gail P DePalma|3154643260|depalmag@upstate.edu|
22441328|NCT03937999|Montefiore Medical Center|Paul Riska, MD|718-920-6494|priska@montefiore.org|
22441329|NCT04139798|Bausch & Lomb|Daniel Donatello|5853385306|Daniel.Donatello@bausch.com|
22441330|NCT02839200|Idorsia Pharmaceuticals|Clinical Trial Disclosure Desk|+41 588 441977|clinical-trials-disclosure@idorsia.com|
22441331|NCT02952820|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
22441332|NCT00734500|Duke University|Michael Cohen-Wolkowiez|9196688812|michael.cohenwolkowiez@duke.edu|
22441333|NCT03857867|Stanford|Peter Tass|650-304-8849|ptass@stanford.edu|
22441334|NCT03070964|Pharma Mar, S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|+34 918466000|clinicaltrials@pharmamar.com|
22441335|NCT01286480|University of Alberta|Dr. Andrew Mackie|780-407-8361|andrew.mackie@ualberta.ca|
22441336|NCT00834093|Dana-Farber Cancer Institute|Dr. Glenn Hanna|617.632.6799|GJHANNA@PARTNERS.ORG|
22441337|NCT00885534|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|646-888-4162|chapmanp@mskcc.org|
22441338|NCT02453711|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22441339|NCT01587924|GlaxoSmithKline|GSK Response Center|866-435-7343||
22441340|NCT01578486|UMass Medical School|Xiaoduo Fan, MD, MPH|508-856-3881|xiaoduo.fan@umassmed.edu|
22441341|NCT03181529|Johns Hopkins University|Dr. Roland Griffiths|410-550-0034|rgriff@jhmi.edu|
22441342|NCT00607373|Genzyme Corporation|Genzyme Medical Information|617-252-7832||
22441343|NCT01918306|Vanderbilt-Ingram Cancer Center|Dr. Vandana Abramson|800-811-8480|vandana.abramson@vanderbilt.edu|
22441344|NCT02773576|Braeburn Inc|Christine Kampf|6104678728|ckampf@braeburnrx.com|
22441345|NCT01237197|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu|
22441346|NCT04772560|University of Houston|Kathryn Richdale OD, PhD|713-743-1974|richdale@uh.edu|
22441347|NCT01319552|Columbia University|Dr. Steven Spitalnik|2123425648|eldad.hod@gmail.com|
22441348|NCT00314795|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22441349|NCT02015910|Georgetown University Medical Center|Paul J. Kim, DPM, Director of Research|202-444-3059|Paul.J.Kim@gunet.georgetown.edu|
22441350|NCT04546672|Oregon Health & Science University|Dr. Brandon Togioka|503-494-4572|togioka@ohsu.edu|
22441351|NCT01397968|SK Life Science|Chief Medical Officer|201-421-3830|mkamin@sklsi.com|
22441352|NCT02908672|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22441353|NCT01424072|University of São Paulo|Leonice Fumiko Sato Kurebayashi|5511 991126023|fumie_ibez@yahoo.com.br|
22441354|NCT02876601|Medical University of Vienna|Univ.Prof. Dr. Bernd Jilma|+4314040029810|bernd.jilma@meduniwien.ac.at|
22441355|NCT01781728|Johns Hopkins University, Department of Radiation Oncology|Dr. Amol Narang|410-913-3559|anarang2@jhmi.edu|
22441356|NCT00802945|Nektar|Alison Hannah, MD||AHannah@nektar.com|
22441357|NCT05307692|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22441358|NCT01648751|University of PIttsburgh|Pamela Moalli MD PHD|412-641-6052|moalpa@upmc.edu|
22441359|NCT03467750|Emory University|Dr. Laura Gilbertson|404-785-6670|laura.gilbertson@emory.edu|
22441360|NCT05673876|Genentech Inc|Medical Communications|800 821-8590|genentech@druginfo.com|
22441361|NCT03052829|Medical College of Wisconsin|Amberly Anger|414-955-6708|aanger@mcw.edu|
22441362|NCT05006573|AstraZeneca|Global Clinical Head|1-877-240-9479|information.center@astrazeneca.com|
22441363|NCT04400643|Hamilton Medical AG|Jean Michel Arnal|+33 1 84 04 97 58|jarnal@hamilton-medical.com|
22441364|NCT01077050|SciBase|Director of Clinical Operations|+46841062001|per.svedenhag@scibase.se|
22441365|NCT00684060|UT-Houston School of Public Health|Lemuel Moye, MD, PhD|713-500-9518|Lemmoye@msn.com|
22441366|NCT00702715|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22441367|NCT02641561|Cooper University Hospital|Shaffer R. S. Mok, M.D., M.B.S.|6099804564|mok.shaffer@gmail.com|
22441368|NCT00689260|EMD Serono, Inc.|Sanja Dragnic, MD|781-681-2337|sanja.dragnic@emdserono.com|
22441369|NCT05780424|University of Minnesota|Greg Grandits|651-528-9491|greg-g@ccbr.umn.edu|
22441370|NCT01170247|University of Iowa|Brett Faine|319-310-8067|brett-faine@uiowa.edu|
22441371|NCT01934647|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22441372|NCT00662298|Imperial College London|Professor Fan Chung|00442075947954|f.chung@imperial.ac.uk|
22441373|NCT03126344|Shanghai ninth people's hospital|Sun Yu|13611895542|dr_sunyu@163.com|+86
22441374|NCT01715857|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22441375|NCT02563067|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
22441376|NCT03544333|University Hospital of Psychiatry Zurich, Switzerland|Stephanie Homan, PhD|0041 44 384|stephanie.homan@bli.uzh.ch|28 02
22441377|NCT00774267|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22441378|NCT00826462|University of Oslo|Professor Morten Lindbaek|+47-22850646|morten.lindbak@medisin.uio.no|
22441379|NCT00475306|Montefiore Medical Center|Dr. BW Friedman|718-920-6626|befriedm@montefiore.org|
22441380|NCT01237899|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22441381|NCT00790088|Medtronic Int. Trading SaRL|Dr Odile Carrette|+41218038119|odile.osullivan@medtronic.com|
22441382|NCT02910986|Mayo Clinic|Celine M. Vachon, Ph.D.|507 293-3247|Vachon.Celine@mayo.edu|
22441383|NCT04141839|University of Arizona|Mary Koss|5204818610|mpk@arizona.edu|
22441384|NCT03682770|Regeneron Pharmaceuticals, Inc|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22441385|NCT02304367|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|Medinfo@ultragenyx.com|
22441386|NCT01262989|GlaxoSmithKline|GSK Response Center|866-435-7343||
22441387|NCT03599089|Concentric Analgesics|Head of Clinical Operations|14154847921|nancy@concentricanalgesics.com|
22441388|NCT00272311|Florida Atlantic University|Charles H. Hennekens, M.D.||chenneke@fau.edu|
22441389|NCT00459186|Dana-Farber Cancer Institute|Dr. Mary-Ellen Taplin|617-632-3237|Mary_Taplin@dfci.harvard.edu|
22441390|NCT00573144|Mayo Clinic|Dr. Horng H. Chen|507-284-1644|chen.horng@mayo.edu|
22441391|NCT03417154|University of Minnesota, Masonic Cancer Center|Dr. Joseph Maakaron|(612) 626-5654|maaka001@umn.edu|
22441392|NCT02500797|Memorial Sloan-Kettering Cancer Center|Sandra P. D'Angelo, M.D.|646-888-4159|dangelos@mskcc.org|
22441393|NCT03511937|University of North Carolina at Chapel Hill|Anna Grummon, PhD|(617) 495-2021|agrummon@hsph.harvard.edu|
22441394|NCT02983552|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
22441395|NCT00357006|Monash Alfred Psychiatry Research Centre|Prof Jayashri Kulkarni|+61 390766924|j.kulkarni@alfred.org.au|66924
22441396|NCT03710161|University of Nebraska Medical Center|Dr. Laura Graeff-Armas|402-559-6310|laura.armas@unmc.edu|
22441397|NCT02637037|AstraZeneca AB|Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
22441398|NCT00074490|National Cancer Institute|Dr. Steven Pavletic|301-402-4899|steven_pavletic@nih.gov|
22441399|NCT01526733|Halozyme Therapeutics, Inc|Vice President, Endocrinology Clinical Development|858-794-8889||
22441400|NCT04539795|University of Alabama at Birmingham (UAB)|Dr. Wells (Study PI)|205-934-5555|LungHealth@uabmc.edu|
22441401|NCT03613519|Boston University School of Public Health|Lynn Rosenberg, ScD|617.734.6006|lrosenbe@bu.edu|
22441402|NCT01869764|Wake Forest University Health Sciences|Edward Levine, MD|336-716-5440|elevine@wakehealth.edu|
22441403|NCT02175030|University of Utah|David Turok, MD, PI|801-581-5160|david.turok@hsc.utah.edu|
22441404|NCT02037230|University of Michigan Rogel Cancer Center|Theodore Lawrence, M.D., Ph.D.|734-647-9955|tsl@umich.edu|
22441405|NCT01292629|Hoya Surgical Optics, Inc.|Kees den Besten, Vice President Global Quality, Regulatory Affairs, and Clinical Research|+65 6681 0025|kees.denbesten@HOYA.com|
22441406|NCT00068419|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22441407|NCT03519711|PTC Therapeutics, Inc.|Medical Information|1-866-562-4620|medinfo@ptcbio.com|
22441408|NCT01600170|University of Pennsylvania School of Medicine|Ronald G Collman|215-898-0913|collmanr@pennmedicine.upenn.edu|
22441409|NCT02506244|Scripps Research Translational Institute|Steven R. Steinhul, MD, Prinicipal Investigator|858-554-5757|steinhub@scripps.edu|
22441410|NCT03962062|Medicines Development for Global Health|Sally Kinrade, Vice President, Project Leader, Onchocerciasis & Lymphatic Filariasis|+61 3 9912 2400|sally.kinrade@medicinesdevelopment.com|
22441411|NCT02170077|BIAL - Portela & Cª, SA|Head of Clinical Research|+351 22 9866100|clinical.trials@bial.com|
22441412|NCT01780974|Oregon Health & Science University|Lynne Shinto, ND, MPH|503-494-5035|shintol@ohsu.edu|
22441413|NCT02970162|Catalyst Pharmaceuticals, Inc.|Gary Ingenito|305-420-3200|gingenito@catalystpharma.com|
22441414|NCT02447003|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22441415|NCT00750438|Imperial College London|Prof Gary Frost|+44 (0)20 7594 0959|g.frost@imperial.ac.uk|
22441416|NCT03848728|University of California, San Francisco|Douglas Black|4158063016|douglas.black@ucsf.edu|
22441417|NCT00658385|Memorial Sloan Kettering Cancer Center|Dr. Farid Boulad|212-639-6684|bouladf@mskcc.org|
22441418|NCT00670748|National Cancer Institute|Dr. Steven A. Rosenberg|301-496-4164|sar@mail.nih.gov|
22441419|NCT01185080|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22441420|NCT03959176|Wake Forest University School of Medicine|Keith Walter, MD|336-716-2144|kwalter@wakehealth.edu|
22441421|NCT02736578|Stanford University|Eben Rosenthal|650-723-2967|elr@stanford.edu|
22441422|NCT01322945|Barrow Neurological Institute|Andrew S. Little, MD|602-406-3181|heidi.jahnke@dignityhealth.org|
22441423|NCT05615922|NYU Langone Health|Leigh Charvet, PhD|929-455-5141|Leigh.Charvet@nyulangone.org|
22441424|NCT06083506|WestVirginiaU|Arif Salman Abdul Shakore|304-293-5831|arifsalman.abdulshakore@hsc.wvu.edu|
22441425|NCT04500158|Virginia Commonwealth University|Dr. Caroline Carrico|(804) 828-8328|ckcarrico@vcu.edu|
22441426|NCT04364867|Orthopedic Institute, Norton Healthcare|Ryan Krupp MD|502-394-6341|Ryan.Krupp@nortonhealthcare.org|
22441427|NCT02587637|Abbott|Robyn Capobianco|+1 512 286 4274|robyn.capobianco@abbott.com|
22441428|NCT00905164|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22441429|NCT04730804|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
22441430|NCT05475483|SOM Innovation Biotech SA|Chief Medical Officer|+41 79 552 15 78|medori@sombiotech.com|
22441431|NCT01193257|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22441432|NCT01089517|Ophthotech|Jeffrey Nau|646-573-7045|jeff.nau@ophthotech.com|
22441433|NCT03059355|University of Miami, Miller School of Medicine - Interdisciplinary Stem Cell Institute (ISCI)|Joshua M Hare, MD|305 243 5579|JHare@med.miami.edu|
22441434|NCT00839319|University of Washington|Mara Roth, MD|206-221-0519|mylang@u.washington.edu|
22441435|NCT01330108|University of Alabama at Birmingham|Robert C Bourge|205-934-3624|bbourge@uab.edu|
22441436|NCT02810509|Ilsan Paik Hospital Inje University|Keun-Sik Hong, MD, PhD, Prof|82-31-910-7680|nrhks@paik.ac.kr|
22441437|NCT00423917|Mayo Clinic|Winston Tan MD|507/284-1159|tan.winston@mayo.edu|
22441438|NCT00555061|GlaxoSmithKline|GSK Response Center|866-435-7343||
22441439|NCT01175083|GlaxoSmithKline|GSK Response Center|866-435-7343||
22441440|NCT02881567|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
22441441|NCT02950467|UCSF|Michelle Matvey|4152214810|michelle.matvey@ucsf.edu|24117
22441442|NCT00373113|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22441443|NCT00673738|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D.|813-745-3050|alberto.chiappori@moffitt.org|
22441444|NCT03830892|Virginia Commonwealth University|Dr. Andrew J. Barnes|804-827-4361|abarnes3@vcu.edu|
22441445|NCT01499277|AstraZeneca-PPD|Yunxia Lu|910-558-4197|Yunxia.Lu@ppdi.com|
22441446|NCT00975689|National Institute of Child Health and Human Development; NIH|Dr. Forbes D Porter, Senior Investigator|(301) 435-4432|fdporter@mail.nih.gov|
22441447|NCT01614392|Jean Mayer USDA HNRCA, Tufts University|Dr. Roger Fielding|6175563083|Roger.Fielding@tufts.edu|
22441448|NCT00372593|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22441449|NCT02974543|University of Michigan|Susan Shore, Professor of Otolaryngology|734 647-2116|sushore@umich.edu|
22441450|NCT03534180|City of Hope|Dr. Jasmine Zain, MD|6263598111|jazain@coh.org|
22441451|NCT00220636|NY State Psychiatric Institute|David Hellerstein MD|6467748000|hellers@nyspi.columbia.edu|
22441452|NCT00330967|Phoenix VA Health Care System|Charles Oh|602-277-5551|charles.oh@va.gov|1-5127
22441453|NCT00539942|University of Alabama at Birmingham|Warner K. Huh, MD|205-996-4662|warner.huh@ccc.uab.edu|
22441454|NCT04902924|Rehabilitation and Exercise Science Laboratory (RESlab), University of Applied Sciences and Arts of Southern Switzerland (SUPSI)|Vanessa Wellauer|0041 81 300 01 78|vanessa.wellauer@supsi.ch|
22441455|NCT01662102|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
22441456|NCT02586207|Sanford Health|Steven F. Powell, MD|605-328-8000|Steven.Powell@sanfordhealth.org|
22441457|NCT00343460|Heron Therapeutics|Robert Geller, M.D.|650-366-2626|rgeller@herontx.com|
22441458|NCT02362282|North Florida/South Georgia Gainesville VA Medical Center|Janis J Daly, Ph.D., Director Brain Rehabilitation Research Center|352-548-6000|Janis.Daly@va.gov|6603
22441459|NCT02004093|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
22441460|NCT04085289|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22441461|NCT00774566|Stardtisches Klinikum Karlsruhe, Medizinische Klinik IV|Dr. Armin Luik|0049-721974|armin.luik@klinikum-karlsruhe.de|2901
22441462|NCT04896073|National Cancer Institute|Dr. Anish Thomas|240-760-7343|anish.thomas@nih.gov|
22441463|NCT00439517|Merck KGaA|Merck KGaA Communication Center|+49-6151-75-5200|service@merckgroup.com|
22441464|NCT02058303|Ochsner Health System|Ken Bode|504.842.1936|ken.bode@ochsner.org|
22441465|NCT03527732|Swiss Tropical and Public Health Institute|Prof. Dr. Jennifer Keiser|+41 (61) 284 8218|jennifer.keiser@swisstph.ch|
22441466|NCT00470275|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
22441467|NCT02207088|AbbVie|Global Medical Services|800-633-9110||
22441468|NCT04853017|Elicio Therapeutics, Inc.|Study Director|(857) 209-0050|info@elicio.com|
22441469|NCT06404021|University of Calabria|Antonio Curcio|+390984681889|antonio.curcio.cardio@unical.it|
22441470|NCT02981446|Santen Inc|Director of R&D Quality Management|15106851794|evelyn.chikere@santen.com|
22441471|NCT04411667|Sharp HealthCare|Matthew Geriak, PharmD / Research Pharmacist|8589393717|matthew.geriak@sharp.com|
22441472|NCT03239106|Washington University School of Medicine|Brian Kim, Associate Professor of Medicine|314-273-1376|briankim@wustl.edu|
22441473|NCT03399552|Memorial Sloan Kettering Cancer Center|Dr. Andreas Rimner, MD|646-608-2449|Rimnera@MSKCC.ORG|
22441474|NCT00411684|HRA Pharma|Paul Carter - Chief Scientific Officer|+33 1 40 33 11 30|p.carter@hra-pharma.com|
22441475|NCT00638014|Duke University|Elliott Bennett-Guerrero|9196819660|benne011@mc.duke.edu|
22441476|NCT02109497|Prana Biotechnology|Dr Caroline Herd|+6133494906|info@pranabio.com|
22441477|NCT01147874|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22441478|NCT02991040|Prollenium Medical Technologies Inc.|Mr. Ario Khoshbin|+1 (905) 508-1469|ario@prollenium.com|
22441479|NCT04287517|Istanbul University Faculty of Medicine Sports Medicine Department|Dr. Sergen Devran, Residency in Istanbul University Sports Medicine Department|00905377782594|sergendevran@gmail.com|
22441480|NCT04150861|Ferring Pharmaceuticals|Global Clinical Compliance|-|DK0-Disclosure@ferring.com|
22441481|NCT02533453|Astrazeneca, Korea|Hyun Jung Kang / Local Study Leader|82 2 2188 0846|hyunjung.kang@astrazeneca.com|0846
22441482|NCT01273519|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22441483|NCT01974635|AMES Technology Inc.|Paul Cordo|15039706129|pcordo@amesdevices.com|
22441484|NCT00396253|Genentech, Inc.|Medical Communications|800-821-8590||
22441485|NCT00092443|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22441486|NCT04717336|The National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH)|Georg Aue, MD|301.451.7141|aueg@nhlbi.nih.gov|
22441487|NCT01721837|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22441488|NCT01951963|Health Partners|Dr. Aaron Burnett|651-254-5304|Aaron.M.Burnett@HealthPartners.Com|
22441489|NCT01724346|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22441490|NCT05720312|Stanford University|Gregory Sahlem, MD|(650) 434-7844|gsahlem@stanford.edu|
22441491|NCT00536744|SANUWAVE, Inc.|Dr. Daniel Jorgensen, MD|678-578-0116|daniel.jorgensen@sanuwave.com|
22441492|NCT00787644|University of Vermont|Dr. Anne Dixon|802 656 3525|anne.dixon@uvm.edu|
22441493|NCT02264249|Cleveland Clinic Florida|Dr. Alison Schneider|954-659-5646|schneia2@ccf.org|
22441494|NCT01642589|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
22441495|NCT00298558|New England Research Institutes|Sharon L. Tennstedt, PhD|617-972-3362|stennstedt@neriscience.com|
22441496|NCT01108185|Abbott|Global Medical Services|1-800-633-9110||
22441497|NCT01393392|Rutgers Robert Wood Johnson Medical School|Dr. Nina Cooperman|732-235-8569|cooperna@rwjms.rutgers.edu|
22441498|NCT02110069|Boston Children's Hospital|Dr. Denise M. Adans|617-919-6407|adamsdm@chop.edu|
22441499|NCT04774094|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22441500|NCT02374450|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22441501|NCT06714682|Ain Shams university|Dr. Mohamed Ibrahim , Lecturer of anesthesia|01115560811|T.majestic@hotmail.com|002
22442253|NCT02692391|Ohio State University|Georgios Papachristou, MD PhD|6142836255|georgios.papachristou@osumc.edu|
22442254|NCT02762370|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
22442255|NCT00268853|Institut de Recherches Internationales Servier|Anton Egorov, Associate Project Director Clinical Development|+33 1 55 72 31 94|anton.egorov@servier.com|
22442256|NCT03632954|Integra LifeSciences|Allison Matthews|(443) 766-3869|allison.matthews@integralife.com|
22442257|NCT01708902|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22442258|NCT01442844|Massachusetts General Hospital|Dr. Alexandra Kimball|617-726-5066|harvardskinstudies@partners.org|
22442259|NCT01430169|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
22442260|NCT01136785|The University of Chicago|Dr. Eve Van Cauter/Dr. Babak Mokhlesi|773-702-0169 or 773-702-2181|evcauter@medicine.bsd.uchicago.edu; bmokhles@medicine.bsd.uchicago.edu|
22442261|NCT02873429|University of Pittsburgh|Carol M. Greco, Associate Professor of Psychiatry|412-623-6873|grecocm@upmc.edu|
22442262|NCT00612807|Duke University Medical Center|Jill Compton, Ph.D.|919-416-2089|compton@duke.edu|
22442263|NCT01516034|Dr David Friedman Laser & Skin Center|David J. Friedman, Principal Investigator|+972-2-5635673|drfriedmanlaser@gmail.com|
22442264|NCT05073432|University of Rochester|Dr. Allison Magnuson|585-602-5085|allison_magnuson@urmc.rochester.edu|
22442265|NCT01881828|Jaeb Center for Health Research|Kellee Miller|15310 Amberly Drive|t1dstats@jaeb.org|
22442266|NCT00472030|University of Iowa|Janet Fairley, M.D.|319-384-8560|janet-fairley@uiowa.edu|
22442267|NCT00829504|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
22442268|NCT05564052|Janssen Research & Development, LLC|Sr. Director Clinical Sciences Onc|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22442269|NCT01224145|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
22442270|NCT04507373|UT Southwestern Medical Center|Dr. Zahid Ahmad|214/648-2377|ZAHID.AHMAD@UTSouthwestern.edu|
22442271|NCT03745820|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
22442272|NCT02151773|Takeda|Takeda Study Registration Call Center|+1-877-825-3327|medicalinformation@tpna.com|
22442273|NCT03680742|Cerus Endovascular|Lori E Adels, Ph.D.|510-651-4000|lori.adels@cerusendo.com|109
22442274|NCT01248104|Loma Linda University Medical Center|Dr. Jason Gatling|909-558-4475|jgatling@llu.edu|44475
22442275|NCT02894502|University of Rome Tor vergata, Rome, Italy|Dr. Ercole Vellone|+393387491811|ercole.vellone@uniroma2.it|
22442276|NCT01410357|Case Western Reserve University School of Medicine and Neurological Institute|Dr. Martha Sajatovic|216-844-2808|martha.sajatovic@uhhospitals.org|
22442277|NCT01651806|Rush University Medical Center|Brett Levine, MD|708.236.2664|levine.research@rushortho.com|
22442278|NCT01790243|Becton Dickinson|Anna Lovas|7634452382|anna.lovas@bd.com|
22442279|NCT04250077|We The Village|Jane Macky, CEO|9176844267|jane@wethevillage.co|
22442280|NCT03700684|University of Massachusetts Amherst|Kelly Richardson|413-545-2007|krichardson@umass.edu|
22442281|NCT02471612|Tata Main Hospital|Dr.Deb Sanjay Nag|+91-7763807101|debsanjay@gmail.com|
22442282|NCT01999517|Mount Sinai Medical Center|Gervasio Lamas, MD|305-674-2162|gervasiolamas@gmail.com|
22442283|NCT01598129|Oncos Therapeutics|Director, Clinical Operations||info@oncos.com|
22442284|NCT00647270|Abbott|Global Medical Services|800-633-9110||
22442285|NCT03615040|University of Leicester|Professor Chris Brightling|+44 116 250 2704|ceb17@le.ac.uk|
22442286|NCT02420015|Duke University School of Medicine|Angela Kirby|919-286-0411|angela.kirby@duke.edu|175526
22442287|NCT01024309|OrthoCarolina Research Institute|Dr. Susan Odum|704.323.2265|Susan.Odum@OrthoCarolina.com|
22442288|NCT03236155|Rush University Medical Center|Anne DeBenedetti, CRC|3124322468|anne.debenedetti@rushortho.com|
22442289|NCT00435045|GlaxoSmithKline|GSK Response Center|866-435-7343||
22442290|NCT01743001|Actelion Pharmaceuticals Ltd|Clinical Trial Disclosure Desk||clinical-trials-disclosure@actelion.com|
22442291|NCT03052426|West Virginia University|Dr. Brandy Brown|304-293-1955|bkenned2@hsc.wvu.edu|
22442292|NCT05387434|University of Kansas Medical Center|Dr. Anna Gorczyca|913-588-9077|agorczyca@kumc.edu|
22442293|NCT01090323|Novartis Pharmaceuticals|Study Director|862-778-8300||
22442294|NCT05498701|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22442295|NCT01864005|Astrazeneca|Judith Hsia|1-301-398-0102|judithhsia@astrazeneca.com|
22442296|NCT02424578|Iroko Pharmaceuticals|SVP Medical Affairs, Pharmacovigilance and Medical Information|2675463003|eoimagosie@iroko.com|3182
22441502|NCT01006291|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22441503|NCT01677377|Indivior, Inc.|Global Director, Clinical Development|804-379-1090||
22441504|NCT02260180|Aclaris Therapeutics, Inc.|Judith Schnyder, Senior Director of Clinical Operations|1-484-329-2144|jschnyder@aclaristx.com|
22441505|NCT01760785|Denver Research Institute|Dr. Thomas Beresford|303-399-8020|thomas.beresford@ucdenver.edu|3732
22441506|NCT00943072|Regeneron Pharmaceuticals|Clinical Trials Administrator|914 847 5385|clinicaltrials@regeneron.com|
22441507|NCT03275350|Oregon Health & Science University|Dr. Todd Korthuis|503-494-8044|korthuis@ohsu.edu|
22441508|NCT00905645|Sientra|Chief Technology Officer|(805) 562-3500|denise.dajles@sientra.com|
22441509|NCT01386970|"University of Colorado | Skaggs School of Pharmacy and Pharmaceutical Sciences"|Dr. Peter Anderson|3037246128|peter.anderson@cuanschutz.edu|
22441510|NCT04439136|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
22441511|NCT00408200|University of Pennsylvania|Anthony Killian|215-615-5299|tony.killian@uphs.upenn.edu|
22441512|NCT00578292|Baylor College of Medicine/Texas Children's Hospital|Dr. Tami D. John|832-824-4723|tdjohn@texaschildrens.org|
22441513|NCT04849559|Vanda Pharmaceuticals|Vanda Pharmaceuticals|202-734-3400|clinicaltrials@vandapharma.com|
22441514|NCT03901469|Zenith Epigenetics|Zenith Study Team|587-390-7865|ZEN003694-004@zenithepigenetics.com|
22441515|NCT03217058|University of California San Francisco|Dr. Derek Satre, Principal Investigator|415-476-7382|Derek.Satre@ucsf.edu|
22441516|NCT00614432|University of Hawaii|Investigator|808-203-6500|whrc@hawaii.edu|
22441517|NCT04103749|Boston Scientific Corporation|Victoria Lazzari|508-382-9132|victoria.lazzari@bsci.com|
22441518|NCT01543633|Neuroscience Statistics Research Laboratory, Massachusetts General Hospital|Dr. Emery N. Brown|(617) 726-8786|enb@neurostat.mit.edu|
22441519|NCT03306173|Fralin Biomedical Research Institute at VTC|Dr. Roberta Freitas-Lemos|540 526 2106|rflemos@vtc.vt.edu|
22441520|NCT01077076|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22441521|NCT02289157|UTSW Medical Center|Dr. Scott Roberts|214-648-3113|scott.roberts@utsouthwestern.edu|
22441522|NCT00060840|Mallinckrodt|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
22441523|NCT01388335|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22441524|NCT01415882|Mayo Clinic|Shaji Kumar|507-284-5096|Kumar.Shaji@mayo.edu|
22441525|NCT00976560|GlaxoSmithKline|GSK Response Center|866-435-7343||
22441526|NCT03210337|Aclaris Therapeutics|Executive Director, Clinical Operations|4843292144|jschnyder@aclaristx.com|
22441527|NCT00125164|Ipsen|Medical Director, Pediatric Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
22441528|NCT00670306|AEterna Zentaris|Daniel Croteau, Medical Manager|418-652-7669|DCroteau@aezsinc.com|272
22441529|NCT01470118|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22441530|NCT01339052|Dana-Farber Cancer Institute|Patrick Y. Wen, MD, Director, DFCI Center for Neuro-Oncology|617-632-2166|pwen@partners.org|
22441531|NCT03339219|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22441532|NCT03702283|VANDERBILT UNIVERSITY MEDICAL CENTER|Cosby A Stone, Jr. MD, MPH|6153223412|Cosby.a.stone@vumc.org|
22441533|NCT01243580|Agile Therapeutics|Lisa Flood|609-683-1880|lflood@agiletherapeutics.com|
22441534|NCT01301027|University of Utah|Srinivansan Beddhu, M.D.|801-585-3810|srinivansan.beddhu@hsc.utah.edu|
22441535|NCT05126953|Bausch + Lomb Incorporated|Schafer, Jill|0000000|Jill.Schafer@bausch.com|
22441536|NCT04950816|The University of Texas Health Science Center at Houston|Diane Santa Maria, DrPH|713-500-2187|diane.m.santamaria@uth.tmc.edu|
22441537|NCT04939415|Krupp Center for Integrative Research, University of California San Diego|Gordon Saxe, M.D./Ph.D.|6195435765|gsaxe@health.ucsd.edu|
22441538|NCT03155841|University of Pennsylvania|Jose Bauermeister|215-898-9993|bjose@upenn.edu|
22441539|NCT04308291|Medtronic Diabetes|Fabio Di Piazza|+393456172157|fabio.di.piazza@medtronic.com|
22441540|NCT00003469|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22441541|NCT00523302|Medical University of South Carolina|Edward B. Short|8437923295|shortb@musc.edu|
22441542|NCT02481219|Given Imaging (a Medtronic company)|Liron Bar Yaakov|+97249097946|liron.bar-yaakov@covidien.com|
22441543|NCT00714870|St. Elizabeth's Medical Center|Dr. Shirley Gonzalez|617-926-0114|shirleyg2008@gmail.com|
22441544|NCT02357368|Emory University|Lisa Haddad, MD|404-778-1385|lisa.haddad@emory.edu|
22441545|NCT03895840|University of Kansas Medical Center|Neil Segal, MD|9135740961|segal-research@kumc.edu|
22441546|NCT01931566|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
22441547|NCT01599637|Novartis Pharmaceuticals|Study Director|862-778-8300||
22441548|NCT00611026|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22441549|NCT00760617|GlaxoSmithKline|GSK Response Center|866-435-7343||
22441550|NCT04625101|Neurocrine Biosciences|Neurocrine Medical Information|+1 877-641-3461|medinfo@neurocrine.com|
22441551|NCT01436435|Boston Scientific|DeeAnn Tinjum, Clinical Trial Manager|763-494-1927|deeann.tinjum@bsci.com|
22441552|NCT01192191|GlaxoSmithKline|GSK Response Center|866-435-7343||
22441553|NCT00467753|UMDNJ|Sherie Novotny, MD|(732) @35-4119|novotnsl@rutgers.edu|
22441554|NCT01047553|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22441555|NCT01072643|The Children's Hospital of Philadelphia|Dr. Aruna T. Nathan|215-590-1858|aruna.nathan@gmail.com|
22441556|NCT02817464|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
22441557|NCT03008369|Mayo Clinic|Ashish Vitthalrao Chintakuntlawar, MBBS, Ph.D.|5072930504|Chintakuntlawar.Ashish@mayo.edu|
22441558|NCT04292899|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22441559|NCT00948441|University of Pittsburgh|Judith M. Martin, MD|412-692-7028|judy.martin@chp.edu|
22441560|NCT03695367|Heron Therapeutics, Inc.|Vice President, Clinical Operations|858-251-7232|svisonneau@herontx.com|
22441561|NCT01493167|Helsinki University Hospital|Dr Nina Linfors|358 9 4711|nina.c.lindfors@hus.fi|
22441562|NCT02039843|Tennesse Valley HCS|Joan Richerson|615-574-8198|joan.richerson@va.gov|
22441563|NCT01958164|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22441564|NCT00740857|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22441565|NCT02963506|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
22441566|NCT02581410|GlaxoSmithKline|GSK Response Center|866-435-7343||
22441567|NCT05978713|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22441568|NCT02807402|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22441569|NCT02819011|Baylor College of Medicine|Prof.Bijan Najafi|17137987536|bijan.najafi@bcm.edu|
22441570|NCT02685267|PCCTC|Jake Vinson|646-422-4383|vinsonj@mskcc.org|
22441571|NCT01865552|Samsung Bioepis|Director of Clinical Development|+82 31 8061 4534|sbregistry@samsung.com|
22441572|NCT01027806|School of Medicine, University of Missouri Health|Leila Kheirandish-Gozal, M.D., M.Sc.|(573) 884-3229|gozall@health.missouri.edu|
22441573|NCT03079102|Baylor College of Medicine|Cameron Dezfulian|832-826-6210|cameron.dezfulian@bcm.edu|
22441574|NCT02923921|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22441575|NCT03083873|Iovance|Sr. Medical Director, Rana Fiaz|661-645-3572|rana.fiaz@iovance.com|
22441576|NCT00479687|Bioventus LLC|Regulatory and Clinical Affairs|18003964325|CT.gov@bioventusglobal.com|
22441577|NCT01264705|UT Southwestern Medical Center|Adam Yopp, MD|214-648-5870|adam.yopp@utsouthwestern.edu|
22441578|NCT00854113|Theracos|Yuan-Di Halvorsen|617-726-4236|yhalvorsen@ccib.mgh.harvard.edu|
22441579|NCT00796419|Emory University|Greg Martin, MD, MSc|404-616-0148|greg.martin@emory.edu|
22441580|NCT00611403|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22441581|NCT00539864|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
22441582|NCT01250145|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22441583|NCT04683887|Azienda Unità Sanitaria Locale di Piacenza|Massimo Guasconi|+39-0523-303853|m.guasconi2@ausl.pc.it|
22441584|NCT02840799|University of Pennsylvania|Hannah Maynard|215-662-7580|hannah.maynard@pennmedicine.upenn.edu|
22441585|NCT00578734|Penn State Children's Hospital|Dr. Neal J. Thomas|717-531-5337|nthomas@hmc.psu.edu|
22441586|NCT04990804|Vanderbilt University Medical Center|Research Coordinator|615-936-7107|kennadie.long@vumc.org|
22441587|NCT04202419|Miami Dermatology and Laser Institute|Dr. Jill Waibel|(305) 615-2393|info@miamidermlaser.com|
22441588|NCT02642315|University of Missouri Columbia|Pradeep Sahota MD|573-882-6402|sahotap@missouri.edu|
22441589|NCT02687191|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22441590|NCT01349049|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
22441591|NCT03887702|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|adarke@fredhutch.org|
22441592|NCT01643772|Mundipharma (China) Pharmaceutical Co.Ltd|Ms. Dan Zhu, Clinical operation and quality lead of the study|+8610 6563 6891|dan.zhu@mundipharma.com.cn|
22441593|NCT03860818|Ralph H. Johnson VA Healthcare System|Dr. David J. Taber|843.789.6624|David.Taber2@va.gov|
22441594|NCT00505778|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
22441595|NCT03436082|Yale School of Medicine|Joseph Ross, MD, MHS|203-785-2987|joseph.ross@yale.edu|
22441596|NCT02917642|University of São Paulo|Dr. Ericka T. Pinheiro|551126488293|erickapinheiro@usp.br|
22441597|NCT01864603|University of California, San Francisco|Tamara Clark|628-206-8790|Tamara.Clark@ucsf.edu|
22441598|NCT02173509|University Aveiro|Teresa Herdeiro|+351234370200|teresaherdeiro@ua.pt|
22441599|NCT04661579|PATH|Christian F. Ockenhouse, MD, PhD|1 (206) 285-3500|cockenhouse@path.org|
22441600|NCT03656562|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22441601|NCT04335136|APEIRON Biologics AG|Dr. Romana Gugenberger|+4366488506236|romana.gugenberger@apeiron-biologics.com|
22441602|NCT01396447|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22441603|NCT01402102|Clinical trial center for Functional Food in Chonbuk Nat'l University Hospital|Dr. Dal-Sik Kim|82-63-250-1793|dskim@chonbuk.ac.kr|
22441604|NCT02423902|Alaunos Therapeutics|Jaymes Holland|6502732627|jholland@alaunos.com|
22441605|NCT02136069|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22441606|NCT04269265|University of Minnesota|Kevin Escandon, MD MS|612-626-9344|escan012@umn.edu|
22441607|NCT04693234|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
22441608|NCT05814367|Johnson & Johnson Vision Care, Inc. (JJVC)|Nabin Joshi|1-800-843-2020|njoshi30@its.jnj.com|
22441609|NCT04838626|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
22441610|NCT02578706|Icahn School of Medicine at Mount Sinai|Dr. Meagan O'Brien||Meagan.O'Brien@mssm.edu|
22441611|NCT00176917|Masonic Cancer Center, University of Minnesota|Paul J. Orchard, M.D.|612-626-2313|orcha001@umn.edu|
22441612|NCT00811018|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22441613|NCT00392769|UT MD Anderson Cancer Center|Judith Wolff, MD / Professor||CR_Study_Registration@mdanderson.org|
22441614|NCT04154189|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22441615|NCT01056016|Cincinnati Children's Hospital Medical Center|Jeff Epstein, Ph.D.|5136368296|jeff.epstein@cchmc.org|
22441616|NCT00067002|UT MD Anderson Cancer Center|Simrit Parmar, MD/Associate Professor, Stem Cell Transplantation|713-792-7734|SParmar@mdanderson.org|
22441617|NCT03350672|Philadelphia FIGHT Community Health Centers|Linden Lalley-Chareczko|2155258695|lchareczko@fight.org|
22441618|NCT00478023|Grunenthal GmbH|Claudia Leinweber|49 241 569 2509|claudia.leinweber@grunenthal.com|
22441619|NCT01004991|Weill Cornell Medicine|Peter Martin, MD|646.962.2064|amr2017@med.cornell.edu|
22441620|NCT01847027|University of North Texas Health Science Center|Meharvan Singh, PhD|8177355429|meharvan.singh@unthsc.edu|
22441621|NCT01026324|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617-632-5053|stephen_hodi@dfci.harvard.edu|
22441622|NCT04674761|Albireo AB|Albireo AB|medinfo@albireopharma.com|medinfo@albireopharma.com|
22441623|NCT02469870|Trifoia|Dr. Jordan Pennefather|1-877-874-3642|jordanp@trifoia.com|
22441624|NCT01627288|Duke University Health System|Jennifer Mewshaw, MS RN|(919) 668-5211|Jennifer.Mewshaw@duke.edu|
22441625|NCT05340478|Michael E. DeBakey VA Medical Center|Dr. Ellen Teng|713 791-1414|Ellen.Teng@va.gov|
22441626|NCT01594216|Abramson Cancer Center|Angela DeMichele, MD|215-615-5329|Angela.DeMichele@pennmedicine.upenn.edu|
22441627|NCT01032889|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
22441628|NCT01500720|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22441629|NCT02624986|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22441630|NCT03830307|University of Pittsburgh|Dr. Grace Lim|412-641-4260|limkg2@upmc.edu|
22441631|NCT03532451|ECOG Stats Center|Xiangying Chu|3472770190|xchu@ds.dfci.harvard.edu|
22441632|NCT02116205|WRAIR Clinical Trials Center|Dr. Kristin Mills, Principal Investigator|301-319- 2039|Kristin.t.mills.ctr@mail.mil|
22441633|NCT03710577|Univerisity of Wisconsin-Madison|Dr. Kelli Koltyn|608-262-4234|koltyn@education.wisc.edu|
22441634|NCT00525161|University of Kentucky|Dr. Suleiman Massarweh|8593238043|massarweh@uky.edu|
22441635|NCT01076361|Medtronic|4968 Clinical Trial Leader||medtroniccrmtrials@medtronic.com|
22441636|NCT02561338|Hua Medicine|Yi Zhang|+86-21-58869997|yzhang@huamedicine.com|3269
22441637|NCT02284035|Hospital Clinic of Barcelona|Dr. Esteban Martínez|+34 93 227 54 00|ESTEBANM@clinic.cat|
22441638|NCT04845568|Washington University|Ellen Fitzsimmons-Craft|3142862074|fitzsimmonse@wustl.edu|
22441639|NCT00630838|University of Michigan|Daniel Teitelabum|734-936-8464|dttlbm@umich.edu|
22441640|NCT00928408|Amgen Inc.|Study Director|866-572-6436||
22441641|NCT01369888|National Cancer Institute|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
22441642|NCT00256997|Janssen Inc. Toronto, Ontario, Canada|Director Medical Affairs - CNS|+1-416-382-5094||
22441643|NCT06139887|White River Junction VA Medical Center|Dr. Natalie Riblet|1-802-295-9363|natalie.riblet@va.gov|5893
22441644|NCT02538354|Universy Medical Center Groningen|dr. J.Z.H. von Martels|0031503616161|j.z.h.von.martels@umcg.nl|
22441645|NCT04672655|Stanford University|Molly Tanenbaum, PhD|(650) 725-3955|mollyt@stanford.edu|
22441646|NCT01326104|University of Florida|Kristine Wynne|352-273-9727|kristine.wynne@neurosurgery.ufl.edu|
22441647|NCT01287741|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22441648|NCT02930018|NoNO Inc.|Michael Tymianski, MD PhD|4165831687|mtymianski@nonoinc.ca|
22441649|NCT02433366|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
22441650|NCT01170533|University of Florida-Jacksonville|Dominick J. Angiolillo, MD, PhD|904-244-3933|dominick.angiolillo@jax.ufl.edu|
22441651|NCT00662675|Johnson & Johnson Pharmaceutical Research & Development, LLC|Director, Clinical Team Leader|609-730-3158||
22441652|NCT01717053|Duke University|Dr. Bridget Koontz|919-668-5213|bridget.koontz@duke.edu|
22441653|NCT01256294|Novartis Pharmaceuticals|Study Director|862-778-8300||
22441654|NCT04681352|Merz Aesthetics|Public Disclosure Manager|+1 984-301-3095|Aesthetic.Trials@merz.com|
22441655|NCT04432727|Tactile Medical|Michelle Wetherby|612-230-4576|mwetherby@tactilemedical.com|
22441656|NCT01675544|Creighton University School of Medicine|Dr. Venkata M. Alla|(402) 280-4292|venkataalla@creighton.edu|
22441657|NCT02600819|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22441658|NCT02631590|Moffitt Cancer Center|Richard Kim, MD, Principal Investigator|813-745-1277|Richard.Kim@moffitt.org|
22441659|NCT01621802|GlaxoSmithKline|GSK Response Center|866-435-7343||
22441660|NCT01149148|UmichiganHS|Dr. Wei C. Lau|734 9369479|weiclau@med.umich.edu|
22441661|NCT03565328|National Heart Lung and Blood Institute (NHLBI)|Michael Sack, M.D. Principal Investigator, NIH, NHLBI|301.402.9259|sackm@nhlbi.nih.gov|
22441662|NCT04605991|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22441663|NCT01743859|University of Colorado|Dr. Daniel Pollyea||daniel.pollyea@ucdenver.edu|
22441664|NCT01727024|Novartis Pharmaceuticals|Study Director|862-778-8300||
22441665|NCT02920242|Novartis Pharmaceuticals|Study Director|862-778-1873|novartisemail@novartis.com|
22441666|NCT02028208|Allerdern (dba) SmartPractice|Kathryn Shannon|602 225 0595|kshannon@smarthealth.com|7208
22441667|NCT03021343|Khalidi Hospital & Medical Center|Dr. Ramzi Tabbalat|00962795535522|ramzi_md@yahoo.com|
22441668|NCT04995419|Astellas Pharma China, Inc.|Clinical Transparency|+86-(0)10-85216666|astellas.resultsdisclosure@astellas.com|
22441669|NCT02948088|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
22441670|NCT00634101|Johnson & Johnson Vision|DIR CLINICAL NEW PRODUCT DEVELOPMENT|1-800-843-2020|KMoody1@its.jnj.com|
22441671|NCT00139477|Nemours Children's Clinic|Dr. Nelly Mauras, Chief, Division of Endocrinology|904-697-3674|nmauras@nemours.org|
22441672|NCT00845897|Washington University School of Medicine|Mary Hastings PT, DPT, ATC|314 286 1433|hastingsmk@wustl.edu|
22441673|NCT01814241|University of North Carolina at Chapel Hill|Dr. Edwin Kim, Director of the UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
22441674|NCT02722499|Medical College of Wisconsin|Jennifer A. Campbell|414-955-8829|jacampbell@mcw.edu|
22441675|NCT04999852|Indiana University|Clarissa Tokash|(812) 855-7686|catokash@iu.edu|
22441676|NCT05626322|Pfizer Inc.|Pfizer CT.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22441677|NCT03776812|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
22441678|NCT04758637|University of Southern California|Jason Doctor|213.821.8142|jdoctor@usc.edu|
22441679|NCT03610269|Masimo|Vikram Ramakanth|949-297-7416|clinicalresearchdept@masimo.com|
22380709|NCT02419755|St. Jude Children's Research Hospital|Tanja A. Gruber, MD, PhD|901-595-2252|tanja.gruber@stjude.org|
22441680|NCT01354314|The Johns Hopkins University|Dr. Ned Sacktor|410-550-1045|sacktor@jhmi.edu|
22441681|NCT00369265|Philadelphia ENT Associates|Robert T. Sataloff, M.D., D.M.A., FACS|215-545-3322|rtsataloff@phillyent.com|
22441682|NCT05019521|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22441683|NCT02721966|Novartis Pharma AG|Study Director|1-888-669-6682|novartis.email@novartis.com|
22441684|NCT00828204|Biogen Idec Inc.|Biogen Idec Medical Director||clinicaltrials@biogenidec.com|
22441685|NCT02840461|Teva Pharmaceuticals Inc. USA|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
22441686|NCT03843541|Zambon S.p.A.|Valentina Zanin|+39026652441|valentina.zanin@zambongroup.com|
22441687|NCT03217071|University of California, San Francisco|Dr. Sue Yom, MD, PhD|(415) 353-9893|Sue.Yom@ucsf.edu|
22441688|NCT04163016|Cares|UCB|001 844 599 2273|UCBCares@ucb.com|
22441689|NCT00427765|UT MD Anderson Cancer Center|Partow Kebriaei, MD/Associate Professor||celsaenz@mdanderson.org|
22441690|NCT01104311|Asan Medical Center, University of Ulsan|Sun U. Kwon, MD, PhD, Prof|82-2-3010-3960|sukwon@amc.seoul.kr|
22441691|NCT04983680|Massachusetts General Hospital/Harvard Medical School|Dr. Christina Luberto|617-643-9453|cluberto@mgh.harvard.edu|
22441692|NCT04434937|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
22441693|NCT02633059|Mayo Clinic|Dr. Shaji Kumar|507-284-5096|Kumar.Shaji@mayo.edu|
22441694|NCT04193189|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
22441695|NCT04549545|Aerin Medical|Tien Dang Sr. Clinical Affairs Manager|669-256-6596|tdang@aerinmedical.com|
22441696|NCT03036215|HealthPartners Institute|James Fricton, DDS, Senior Research Investigator|6126191678|james.r.fricton@healthpartners.com|
22441697|NCT04075812|The Ohio State University|Marcia Bockbrader MD PhD|6142933127|bockbrader.13@osu.edu|
22441698|NCT00295880|Masonic Cancer Center, University of Minnesota Blood and Marrow Transplant Program|John E. Wagner, M.D.|612-626-2961|wagne002@umn.edu|
22441699|NCT01474239|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22441700|NCT01243242|Alcobra|Dr Yaron Daniely CEO|972-072-2204662|yaron@alcobra-pharma.com|
22441701|NCT03983317|TheraNova, LLC|Vice President of Research and Development|415-926-8616|clinicalstudy@theranova.com|
22441702|NCT00792571|Lung Biotechnology PBC|Lung Biotechnology PBC Study Director|301-608-9292||
22441703|NCT04857320|LANGFORD RESEARCH INSTITUTE|Managing Director|5614296429|KKirby@Langfordresearch.org|150
22441704|NCT03790696|Washington University School of Medicine|Jennifer Harper / Clinical Research Coordinator|314-286-2697|jenniferharper@wustl.edu|
22441705|NCT04896086|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|VRC Clinical Trials Program Leadership|301-451-8715|ctpleadership@mail.nih.gov|
22441706|NCT02249832|Feinstein Institutes for Medical Research|Bruce T. Volpe, MD|(516) 562-3384|bvolpe1@northwell.edu|
22441707|NCT03848182|Montefiore Medical Center; 1695 Eastchester Road|Dr. Jennifer Chuy, Co-Investigator, Assistant Professor (Oncology)|718-405-8505|jchuy@montefiore.org|
22441708|NCT03291964|Oregon Health and Science university|David Sheridan Assistant Prof|5034941691|sheridda@ohsu.edu|
22441709|NCT02936648|Department of Veterans Affairs, CHOIR and BridgeQUERI|Vera Yakovchenko|781.687.3374|vera.yakovchenko@va.gov|
22441710|NCT02914301|George Washington University School of Medicine & Health Sciences- Department of Emergency Medicine|Dr. Andrew C. Meltzer|202-741-2952|ameltzer@mfa.gwu.edu|
22441711|NCT00485134|US Army Medical Materiel Development Activity (USAMMDA)|Division of Regulated Activies and Compliance|301-619-0317|usarmy.detrick.medcom-usammda.mbx.usamrmc-regulatory-affairs@mail.mil|
22441712|NCT00970684|Case Comprehensive Cancer Center|Nathan Pennell MD|216-445-9285|penneln@ccf.org|
22441713|NCT00481091|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22441714|NCT04294680|Campbell Clinic|Principal Investigator|9017595522|tbrolin@campbellclinic.com|
22441715|NCT03010488|New York State Psychiatric Institute|David Hellerstein|646-774-8069|david.hellerstein@nyspi.columbia.edu|
22441716|NCT02078960|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
22441717|NCT01056302|Department of Veterans Affairs|Dr. Rebeka Silva|415-221-4810|rebeka.silva@va.gov|22784
22441718|NCT04881942|Altria|Jeffery Edmiston, Functional Director Clinical Research|8043352366|Jeffery.S.Edmiston@altria.com|
22441719|NCT00859638|McMaster University|Dr. Julie Richardson|(905) 525-9140|jrichard@mcmaster.ca|27811
22441720|NCT01147627|The Third Affiliated Hospital of Sun Yat-sen University|Dr. Jianping Weng|86-20-85253162|wjianp@mail.sysu.edu.cn|
22441721|NCT00771953|University of Maryland Baltimore Greenebaum Cancer Center|Michelle Medeiros|410-328-1160|mmedeiros@umm.edu|
22441722|NCT03328208|Hypnalgesics, LLC|Elvira V. Lang, MD, CEO|6177349087|drevlang@comforttalk.com|
22441723|NCT00947193|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
22441724|NCT04364984|Medical Practice Prof D.Ivanov|Prof Dmytro Ivanov|0504448788|drivanovdd@gmail.com|+38
22441725|NCT01349959|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Clinical Research Office|410-955-8866|jhcccro@jhmi.edu|
22441726|NCT02675634|Scientific and Regulatory affairs|Sara Gosk|+45 49113568|dksargo@coloplast.com|
22441727|NCT01652534|Northwestern University|Dr. Tanya Simuni|312-503-2970|tsimuni@nm.org|
22441728|NCT02722304|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
22441729|NCT03656380|University of North Carolina at Chapel Hill|Lindsay Cortright, MA|919-445-4911|lindsay_cortright@med.unc.edu|
22441730|NCT00393861|IndianaU|Lawrence H. Einhorn, M.D.|(317) 944-0920|leinhorn@iu.edu|
22441731|NCT05300763|Johnson & Johnson Vision Care, Inc.|John R. Buch, Senior Principal Research Optometrist|1-800-843-2020|jbuch@its.jnj.com|
22441732|NCT01485172|GlaxoSmithKline|GSK Response Center|866-435-7343||
22441733|NCT01587014|Medical Center of the Rockies|Dr. Julie Dunn|970-624-1680|julie.dunn@uchealth.org|
22441734|NCT01409811|City of Hope|Carolyn Behrendt, Ph.D.|626-218-1148|cbehrendt@coh.org|
22441735|NCT00441064|Novartis Pharmaceuticals|Study Director|862-778-8300||
22441736|NCT03051178|University of Florida|Dr. Aysegul Gunduz|3522736877|agunduz@bme.ufl.edu|
22441737|NCT00953056|Merck Sharp and Dohme|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
22441738|NCT03111628|JohnsHopkinsU|Sarbjit S. Saini|410550-2129|ssaini@jhmi.edu|
22441739|NCT02879812|Emory University|Dr. Rachel Patzer|404-727-6047|rpatzer@emory.edu|
22441740|NCT02442804|Brown University|John Bellone, Ph.D.|4012737100|john_bellone@brown.edu|6168
22441741|NCT03523988|University of Washington|Lead Investigator|4254668544|akeith@uw.edu|
22441742|NCT03433040|University of South Florida|Wendy Duncan, QA/QI Research Compliance Manager|8139747454|wduncan3@usf.edu|
22441743|NCT02527421|Prosoft Clinical|Robert Babilon President|484 320 2068|b.babilon@prosoftclinical.com|
22441744|NCT04200352|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
22441745|NCT02541604|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
22441746|NCT00993148|Northwestern University|Dr. Babafemi Taiwo|312-695-5085|b-taiwo@northwestern.edu|
22441747|NCT00806819|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22441748|NCT02373683|Case Western Reserve University|Katherine Slain|12168443310|katherine.slain@uhhospitals.org|
22441749|NCT00912197|Imperial College London|Prof Gary Frost|+44 (0)20 7594 0959|g.frost@imperial.ac.uk|
22441750|NCT02267837|Shaughnessy Orthodontics|Dr. Timothy Shaughnessy|770-495-9590|staff@straightteethdoc.com|
22441751|NCT00756613|VA|Tamara Paine|7082028387|tamara.paine@va.gov|25785
22441752|NCT03304249|University of Kansas Medical Center|Megan Olalde|913-588-2042|molalde@kumc.edu|
22441753|NCT03801044|Sisli Hamidiye Etfal Training and Research Hospital|Mustafa Sevinc|00905309291239|musevinc@hotmail.com|
22441754|NCT04901715|University of North Carolina at Chapel Hill|Kelli Sullivan, MPH|919-962-9786|kelli_sullivan@med.unc.edu|
22441755|NCT05036733|University of Michigan|Yvonne J Huang MD|734-936-5047|yvjhuang@med.umich.edu|
22441756|NCT02285439|Children's Hospital Los Angeles|Dr. Nathan Robison|323.361.2121|mek162@chla.usc.edu|
22441757|NCT04693767|Penumbra Inc.|Brooke Lawson|+15109952183|blawson@penumbrainc.com|
22441758|NCT05522153|Virtua Medical Group, PA|Sean McMillan|908-812-7542|smcmillan@virtua.org|
22441759|NCT04301193|University of Maryland|Division Chief of Obstetric Anesthesiology|(410) 328-4229|bkodali@som.umaryland.edu|
22441760|NCT00147069|Imperial College London|Professor Louise Donnelly|+44 (0)20 7594 7895|l.donnelly@imperial.ac.uk|
22441761|NCT00459732|Children's Hospital & Research Center, Oakland|Ellen Fung, PhD RD CCD|510-428-3885|efung@mail.cho.org|4939
22441762|NCT02082119|Humanitas Cancer Center|Dr. Marta Scorsetti|+390282248524|marta.scorsetti@hunimed.eu|
22441763|NCT00552188|Tallikut Pharmaceuticals, Inc.|Brian Cunningham, MD|312-505-0420|brian@baycitycapital.com|
22441764|NCT00588159|Mayo Clinic|Dr. Michelle A. O. Kinney|507-266-9877|kinney.michelle@mayo.edu|
22441765|NCT01368562|Bausch Health Companies|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
22441766|NCT02491944|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
22441767|NCT00727441|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Daniel Laheru|410-955-8974|laherda@jhmi.edu|
22441768|NCT04216264|Duke University|Dr. Charles Wood|919-620-4772|charles.wood@duke.edu|
22441769|NCT00243269|University of Rochester|Joseph Roscoe PhD|585 275-9962|joseph_roscoe@urmc.rochester.edu|
22441770|NCT01421472|Merrimack Pharmaceuticals|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
22441771|NCT01296672|UT Health|Jonathan Gelfond|210 567-0836|gelfondjal@uthscsa.edu|
22441772|NCT01311024|head of Clinical Research Unit, National Institute for Health and Welfare|Arto Palmu, MD, PhD Research manager,|+358295247910|arto.palmu@thl.fi|
22441773|NCT00856518|North Florida/South Georgia Veterans Health System|Dr. Janis Daly|352-376-1611|janis.daly@neurology.ufl.edu|5223
22441774|NCT02867384|Dana-Farber Cancer Institute|Corey Cutler, MD|6176323470|corey_cutler@dfci.harvard.edu|
22441775|NCT01941186|Child Health Institute of New Jersey|Manuel Jimenez, MD, MS|732-235-6230|jimenema@rwjms.rutgers.edu|
22441776|NCT02105961|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22441777|NCT01976091|Sarepta Therapeutics, Inc|Medical Information|1-800-690-2003|SareptAlly@sarepta.com|
22441778|NCT00934362|University of North Carolina at Chapel Hill|Dr. Scott Donaldson|919-966-9198|scott_donaldson@med.unc.edu|
22441779|NCT02566369|Galderma S.A.|Anne Fulton|+1 817-961-5203|anne.fulton@galderma.com|
22441780|NCT01092117|Endologix|Manager, Clinical Affairs|864-270-8524|nsmith@endologix.com|
22441781|NCT04380519|R-Pharm|Sergey Grishin, Head of Scientific Affairs Department|0074959567937|sa.grishin@rpharm.ru|1506
22441782|NCT04173494|Sierra Oncology LLC - a GSK company|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22441783|NCT01623050|SinuSys Corporation|Janie Mandrusov, Director of Pre-Clinical and Clinical Development|4084104411|emandrusov@sinusys.com|
22441784|NCT02283827|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
22441785|NCT02147561|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22441786|NCT00526071|Medical Affairs|Amicus Therapeutics|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
22441787|NCT01191762|Kenneth R. Phelps, M.D.|Kenneth R. Phelps, M.D.|518-626-5641|kenneth.phelps@va.gov|
22441788|NCT03898557|University of Pennsylvania|Alison M. Buttenheim, PhD MBA|215.573.5314|abutt@nursing.upenn.edu|
22441789|NCT00078897|University of Arizona|Dr. Elizabeth Jacobs|(520) 626-0341|jacobse@email.arizona.edu|
22441790|NCT02622178|Wills Eye Hospital, Glaucoma Research Center|Dr. L. Jay Katz|215-928-3123|ljkatz@willseye.org|
22441791|NCT00659789|Bionor Pharma ASA|Maja Sommerfelt|+4723010960|ms@bionorpharma.com|
22441792|NCT00048074|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
22441793|NCT04476797|Galera Therapeutics|Judy Schnyder|484-870-9625|jschnyder@galeratx.com|
22441794|NCT02395081|Brigham and Women's Hospital|Dr. Janet Rich-Edwards|617-525-8264|jr33@partners.org|
22441795|NCT01583296|Ferkauf Graduate School of Psychology, Yeshiva University|Jonathan M. Feldman|6465924508|jonathan.feldman@einstein.yu.edu|
22441796|NCT01063283|Inova|Michael Maitland, MD, PhD|571-472-4724|Michael.Maitland@inova.org|
22441797|NCT00356304|VA New Jersey Healthcare System|Alejandro Interian, Principal Investigator|908-647-0180|alejandro.interian@va.gov|4617
22441798|NCT02504216|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
22441799|NCT00223080|Department of Disease Control, Ministry of Public Health|Dr. Supachai Rerks-Ngarm|66-2-590-3006|supachai@health.moph.go.th|
22441800|NCT02598583|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22441801|NCT03237286|University of Pittsburgh|Dr. Rebecca Price|412-383-2150|pricerb@upmc.edu|
22441802|NCT03193593|Bonti|Wajdie Ahmad|9493796569|wajdie@bonti.com|
22441803|NCT02792829|Eisai Inc.|Eisai Medical Research Inc.|1-888-422-4743|esi_medinfo@eisai.com|
22441804|NCT01262820|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
22441805|NCT04473469|University of Michigan|Timothy Bruns|(734) 647-8727|bruns@umich.edu|
22441806|NCT01151904|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
22441807|NCT05220436|South London & Maudsley NHS Foundation Trust|Dr Emilie Bourke|07702686322|emilie.bourke@slam.nhs.uk|
22441808|NCT01737502|Mayo Clinic in Florida|Yanyan Lou, MD|904-953-0315|lou.yanyan@mayo.edu|
22441809|NCT05307965|John Radcliffe Hospital|Giovanni Luigi De Maria|+441865228364|GiovanniLuigi.DeMaria@ouh.nhs.uk|
22441810|NCT04421027|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
22441811|NCT06019611|Mayo Clinic|Dr. Kristin Zhao, Director of the Assistive and Restorative Technologies Laboratory|507-284-8942|zhao.kristin@mayo.edu|
22441812|NCT02219659|MemorialCare Long Beach|Division of Pulmonary and Critical Care|(562) 933-2000|mtanios@yahoo.com|
22441813|NCT00560352|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22441814|NCT00487461|University of Illinois at Chicago|Ali Alaraj, MD|312-996-4842|alaraj@uic.edu|
22441815|NCT03568461|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
22441816|NCT03387085|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@immunitybio.com|
22441817|NCT03390114|Indiana University School of Medicine|Samir K. Gupta, MD, MS|3172747926|sgupta1@iu.edu|
22441818|NCT01395524|AstraZeneca|Mark Sostek||aztrial_results_posting@astrazeneca.com|
22441819|NCT01574183|MUSC|Aimee McRae-Clark, PharmD|843-792-5216|mcraeal@musc.edu|
22441820|NCT02609113|Wake Forest Baptist Health|Vanessa Baute, MD|336-716-8140|vbaute@wakehealth.edu|
22441821|NCT04458090|University of Colorado Anschutz Medical Campus|Dr. Channing Tate, Assistant Professor|3037248985|channing.tate@cuanschutz.edu|
22441822|NCT02175199|Alcon Research, Ltd.|Global Brand Lead, GCRA, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22441823|NCT00122980|Baylor College of Medicine|Russell E. Ware, MD, PhD, Director, Texas Children's Hematology Center|(832) 824-1368|reware@bcm.edu|
22441824|NCT01124864|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22441825|NCT03093662|Brooke Army Medical Center|Dr. Derek Brown|2109160808|Derek.J.Brown1.mil@mail.mil|
22441826|NCT00798759|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
22441827|NCT00724711|Gilead Sciences|Dara Wambach, MA, Associate Director, Regulatory Affairs|650 522 5163|Dara.Wambach@gilead.com|
22441828|NCT03387111|ImmunityBio|Sandeep Bobby Reddy, Chief Medical Officer|855-797-9277|Bobby.Reddy@Immunitybio.com|
22441829|NCT01239992|University Munich|Klaus G. Parhofer|+49-89-7095-3010|klaus.parhofer@med.uni-muenchen.de|
22441830|NCT00535288|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22441831|NCT02810444|Biotest AG|Dr. med. Andrea Wartenbrg-Demand|+49 6103 801|andrea.wartenberg-demand@biotest.com|0
22441832|NCT03390101|BIOCAD|Nikiforova Aleksandra|+7(812) 380 49 33|nikiforovaan@biocad.ru|6254
22441833|NCT00857714|IndianaU|Sunil Badve, MD|317-491-6417|sbadve@iupui.edu|
22441834|NCT00545272|Novartis Pharmaceuticals|Study Director|862-778-8300||
22441835|NCT02934503|NYU Langone|Dr. Joshua Sabari|212-731-6363|Joshua.Sabari@nyulangone.org|
22441836|NCT00724867|GlaxoSmithKline|GSK Response Center|866-435-7343||
22441837|NCT00436345|GlaxoSmithKline|GSK Response Center|866-435-7343||
22441838|NCT04027608|University at Buffalo|Jennifer Temple, Principle Investigator|7168295593|jltemple@buffalo.edu|
22441839|NCT00856232|UMDNJ|Dr. Boris Veysman|732-235-8717|veysmabo@umdnj.edu|
22441840|NCT04248491|Beaumont Health|Director Urology Research|2485511488|bernadette.zwaans@Corewellhealth.org|
22441841|NCT01068964|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22441842|NCT00787618|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
22441843|NCT00621348|AIIMS|Rakesh Lodha|91 11 26593621|rakesh_lodha@hotmail.com|
22441844|NCT02910505|Cutera|Margot Doucette|415-656-9612|mdoucette@cutera.com|
22441845|NCT04643158|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22441846|NCT04329806|Vanderbilt University Medical Center|Dr. Alfredo Gamboa|615 875 1003|alfredo.gamboa@vumc.org|
22441847|NCT02197078|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22441848|NCT00622440|University of California, San Francisco|Naomi Jay, PhD|415-353-7443|Naomi.Jay@ucsf.edu|
22441849|NCT02223377|Department of Anesthesia, McMaster University, Canada|Dr. Thuvaraha Vanniyasingam|(905) 525-9140|tvanniya@stjosham.on.ca|21736
22441850|NCT04726969|Swiss Tropical and Public Health Institute|Prof Dr Jennifer Keiser|+41 61 284 82 18|jennifer.keiser@swisstph.ch|
22441851|NCT02474069|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
22441852|NCT06026124|Purdue University|Dr. Patricia Deevy, Research Associate|765-496-1821|deevy@purdue.edu|
22441853|NCT03023813|Cleveland Clinic|Glen Taksler PhD|216-445-7499|taksleg@ccf.org|
22441854|NCT03710083|Medtronic Minimed|Vivian Chen, Statistician|8185763309|vivian.chen@medtronic.com|
22441855|NCT02283762|Bayer|Therapeutic Area Head|+1 888-8422937|clinical-trials-contact@bayer.com|
22441856|NCT00974480|Innovaderm Research Inc|Annie Levesque|514-521-4285|alevesque@innovaderm.ca|222
22441857|NCT00202878|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22441858|NCT02416622|AGTC|Dr. Matt Feinsod|386-462-2204|mfeinsod@agtc.com|7202
22441859|NCT01491984|IWK Health Centre|Dr. Ronald George|902-470-6627|rbgeorge@dal.ca|
22441860|NCT01594528|Centre Hospitalier Esquirol|Dr Murielle Girard|0033555431028|murielle.girard@ch-esquirol-limoges.fr|
22441861|NCT00975780|Yale University School of Medicine|Vincent James Quagliarello MD, Professor of Medicine (Infectious Diseases); Clinical Chief, Infectio|(203) 785-7571|vincent.quagliarello@yale.edu|
22441862|NCT02813577|Becton Dickinson|Anna Lovas|763-445-2385|anna.lovas@bd.com|
22441863|NCT00035932|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
22441864|NCT01976741|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
22441865|NCT00889720|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22441866|NCT01620216|OHSU|Dr. Stephen Spurgeon|5034948950|spurgeos@ohsu.edu|
22441867|NCT03865381|Verily Life Sciences|Head of Clinical Science|(650) 253-0000|info@verily.com|
22441868|NCT02873377|University of Miami|Taghrid Asfar|305-243-3826|tasfar@med.miami.edu|
22441869|NCT00104520|Gilead Sciences, Inc.|Mark Bresnik, MD, Director, Clinical Research|(650) 522-5934|mark.bresnik@gilead.com|
22441870|NCT00452361|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
22441871|NCT02282514|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
22441872|NCT03043105|Peking Union Medical College Hospital|Dr. Jian Li|86-010-69155027|lijian@pumch.cn|
22441873|NCT00233064|MedImmune, LLC|Hasan S. Jafri, MD|301-398-0000||
22441874|NCT02302339|Celldex Therapeutics|Head of Regulatory Affairs|844-723-9363|info@celldex.com|
22441875|NCT03564678|The University of Texas MD Anderson Cancer Center|Elias Jabbour MD/Professor|713-792-4764|ejabbour@mdanderson.org|
22441876|NCT00826202|Nathan Kline Institute|Daniel Javitt MD, PhD|845-398-6534|javitt@nki.rfmh.org|
22441877|NCT00494676|Schepens Eye Research Institute|Alex Bowers|617-912-2512|alex_bowers@meei.harvard.edu|
22441878|NCT04073225|Johns Hopkins University|Michelle Carlson|(410) 790-8205|mcarlso2@jhu.edu|
22441879|NCT05186805|Organon and Co|Clinical Lead, Late-Stage Clinical Development|551-430-6000|pdrl@organon.com|
22441880|NCT04238819|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22441881|NCT03892967|Mayo Clinic|Andrea L. Cheville, MD|507-284-1402|Cheville.Andrea@mayo.edu|
22441882|NCT04917757|University Hospital Würzburg|Prof Dr. Martin Fassnacht|4993120139021|fassnacht_m@ukw.de|
22441883|NCT05767749|Weill Cornell Medicine|Dr. Kira Minkis|(646) 962-3376|kim9036@med.cornell.edu|
22441884|NCT03760718|Oregon Health & Science University|Brandon Togioka, MD|503-494-4572|togioka@ohsu.edu|
22441885|NCT03704389|Northwestern University|Stephen D. Persell, MD, MPH, FACP|312-503-6464|spersell@nm.org|
22441886|NCT05603312|MeiraGTx, LLC|Program Manager|646-860-7982|patients@meiragtx.com|
22441887|NCT04236141|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22441888|NCT01657461|Medtronic|Manish Gupta, Sr. Director of Medical Affairs|949 297 5494|manish.s.gupta@medtronic.com|
22441889|NCT05480111|The University of Texas Health Science Center at Houston|Randa J Jalloul, MD|713-566-5749|Randa.J.Jalloul@uth.tmc.edu|
22441890|NCT01322841|Indiana University School of Medicine|Aaron Carroll|3172789616|aaecarro@iu.edu|
22441891|NCT01754727|AbbVie|Global Medical Information|800-633-9110||
22441892|NCT04540510|Nuvance Health (formerly Western Connecticut Health Network)|Joann Petrini|203-739-6882|Joann.Petrini@wchn.org|
22441893|NCT02848729|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
22441894|NCT04838977|University of Utah|Heather Keenan|8015877567|heather.keenan@hsc.utah.edu|
22441895|NCT05367492|Massachusetts General Hospital|A. Eden Evins, MD, MPH|617-643-4679|aeevins@mgh.harvard.edu|
22441896|NCT00353470|Albert Einstein College of Medicine|Barbara Milrod, M.D., PI|212-595-0806|bmilrod@montefiore.org|
22441897|NCT00950859|ViiV Healthcare|GSK Response Center|866-435-7343||
22441898|NCT00265148|GlaxoSmithKline|GSK Response Center|866-435-7343||
22441899|NCT01463007|BrUOG-Brown University Oncology Research Group|Dr. Jaroslaw Hepel|4018633000|kristen_mitchell@brown.edu|
22441900|NCT03583385|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22441901|NCT04780919|Charles University, 2nd Faculty of Medicine|Jakub Katolicky|+420 739 081 676|jakub@katolicky.eu|
22441902|NCT03539549|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
22441903|NCT01737593|UCLA|Dr. Wendy Ren|310.267.8678|wren@mednet.ucla.edu|
22441904|NCT01652469|European Thoracic Oncology Platform (ETOP)|Heidi Roschitzki-Voser, Lead Trial Activities|+41 31 511 94 18|Heidi.Roschitzki@etop-eu.org|
22441905|NCT02123472|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22441906|NCT00918736|Veterans General Hospital, Kaohsiung, Taiwan|Shu-Fen Sun|886-73422121|sfsun.tw@yahoo.com.tw|4210
22441907|NCT01474018|Baylor Endocrine Center|Dr. Erin D. Roe|214-820-3466|edr@roemd.com|
22441908|NCT03801031|University of Iowa|David Bender, MD|319-356-2015|david-bender@uiowa.edu|
22441909|NCT01942733|Email contact via H. Ludbeck A/S|Study director||LundbeckClinicalTrials@lundbeck.com|
22441910|NCT00838513|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals Inc||clinicaltrials@alxn.com|
22441911|NCT00126490|H. Lee Moffitt Cancer Center and Research Institute|Mayer Fishman, M.D., Ph.D.|813-745-8311|mayer.fishman@moffitt.org|
22441912|NCT04625517|UT Southwestern Medical Center|Kelli Key, Ph.D.|214-648-8152|Kelli.Key@UTSouthwestern.edu|
22441913|NCT03462511|Columbia University School of Nursing|Arlene Smaldone, PhD, RN|212-342-3048|ams130@columbia.edu|
22441914|NCT02925416|Melinta Therapeutics|Study Director|1-844-633-6568|medinfo@melinta.com|
22441915|NCT02625909|The Kirby Institute|Pip Marks, Clinical Trials Manager|+61 2 9385 0886|pmarks@kirby.unsw.edu.au|
22441916|NCT01598506|Emory University|Dr. Grant Lynde|404-778-3900|glynde@emory.edu|
22441917|NCT03962504|National Center for PTSD at VA Boston Healthcare System|Dr. Denise Sloan|857-364-6333|denise.sloan@va.gov|
22441918|NCT02367833|Penn State University|Dr. Mary Jane De Souza|8148630045|mjd34@psu.edu|
22441919|NCT03001817|Kowa Research Institute, Inc.|Director, Clinical Operations|919-433-1600|CTGResults@KowaUS.com|
22441920|NCT02167139|Samsung Bioepis|Director, Clinical Development|+82 31 8061 4534|dh01.shin@samsung.com|
22442297|NCT03679754|Alaunos Therapeutics|Jaymes Holland|6502732627|jholland@alaunos.com|
22441921|NCT02067676|Enteric Disease Department, Naval Medical Research Center|Ramiro Gutierrez, MD|301-319-3193|ramiro.l.gutierrez.mil@mail.mil|
22441922|NCT00996333|Columbia University|Paul Oberstein|212-305-0592|po2178@cumc.columbia.edu|
22441923|NCT00476229|UT MD Anderson Cancer Center|Chitra M. Hosing, MD/Associate Professor||gmccormi@mdanderson.org|
22441924|NCT04296448|Johns Hopkins University Department o Peidaitrics Division of Pediatric Emergency Medicne|Dr. Therese Canares|(410) 955-6146‬|therese.canares@jhmi.edu|
22441925|NCT02100696|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22441926|NCT02471326|National Institute of Allergy and Infectious Diseases|Sneller, Michael|+1 301 496 0491|MSNELLER@niaid.nih.gov|
22441927|NCT01009619|Katholieke Universiteit Leuven and University Hospital Leuven|Prof. Dr. GM Verleden|+32 16 34 68 08|geert.verleden@uzleuven.be|
22441928|NCT03566485|Vanderbilt-Ingram Cancer Center|Teresa Melton|6159367423|teresa.melton@vumc.org|
22441929|NCT05110872|Fralin Biomedical Research Institute at Virginia Tech Carilion|Dr. Freitas-Lemos|540-526-2106|rflemos@vtc.vt.edu|
22441930|NCT04059159|Spinal Singularity|Derek Herrera|949-436-7974|dherrera@urodevmedical.com|
22441931|NCT04518358|Guiding Technologies Corp.|John Nosek|609-605-9273|john.nosek@guidingtechnologies.com|
22441932|NCT02797613|Memorial University|Peter Daley|7097250240|pkd336@mun.ca|
22441933|NCT03849118|Telix Pharmaceuticals (Innovations) Pty Ltd|Dr. Kavita Vadali, Sr. Clinical Project Manager|+1 919-924-8887|kavita.vadali@telixpharma.com|
22441934|NCT01640834|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22441935|NCT01387542|Janssen-Cilag Ltd.: 106 Moo 4 Lad Krabang Industrial Estate, Chalongkrung Rd., Lamplatew, Lad Krabang, Bangkok 10520|Medical Affairs Director|+66 2 7397200||5888
22441936|NCT01010867|Columbia University Medical Center|Monica Bhatia, MD|2123055808|mb2476@cumc.columbia.edu|
22441937|NCT03601117|Stanford University|Dr Nolan Williams|(650)800-6920|nolanw@stanford.edu|
22441938|NCT01668589|Amgen Inc.|Study Director|866-572-6436||
22441939|NCT02954172|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+86 13382419112|jessica.yi@innoventbio.com|
22441940|NCT04420325|UZ Leuven|Lennert Minten|+32496397568|lennert.minten@gmail.com|
22441941|NCT01827956|Institut Bergonié|Simone Mathoulin-Pélissier, Director of Clinical Trials Unit|+33556333333|s.mathoulin@bordeaux.unicancer.fr|
22441942|NCT04393454|Albert Einstein College of Medicine|Dr. Chaoyuan Kuang|718-430-3516|chaoyuan.kuang@einsteinmed.edu|
22441943|NCT02752165|University of Rochester|Jill Halterman|5852755798|jill_halterman@urmc.rochester.edu|
22441944|NCT01120964|Asklepion Pharmaceuticals, LLC|Gurdyal Kalsi, MD, MFPM (Hon)|+1 410.736.3750|gurdyal.kalsi@asklepionpharm.com|
22441945|NCT01003769|Mayo Clinic|Asher Alban Chanan-Khan, M.D.|(716) 845-3221|chanan-khan.asher@mayo.edu|
22441946|NCT01704599|Dept. Dermatology Wayne StateUniversity|Peter J. Aronson, MD|(313)_745-7845|paronson@med.wayne.edu|
22441947|NCT05064358|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22441948|NCT04022499|Denver Health and Hospital Authority|Rocio Pereira, Medical Director, Community Integrated Health Care|303-436-6000|rocio.pereira@dhha.org|
22441949|NCT04976192|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
22441950|NCT02621151|NYU Langone Health|Minas Economides, MD|2127315413|minas.economides@nyulangone.org|
22441951|NCT05407064|Mind Medicine Inc|Medical Affairs|1-332-245-4732|MedAffairs@mindmed.co|
22441952|NCT00924027|National Cancer Institute|Dr. Deborah E. Citrin|240-760-6206|citrind@mail.nih.gov|
22441953|NCT01761162|Biotronik, Inc.|Clinical Studies Engineer|503-927-7230|justin.michalski@biotronik.com|
22441954|NCT01077921|Duke University Medical Center|Laura De Castro, MD, MHSc|(412) 623-7026|laura.decastro@dm.duke.edu|
22441955|NCT01505764|Department of Veterans Affairs|Jose M Garcia MD, PhD, Clinician Investigator|206-7642984|jose.garcia@va.gov|
22441956|NCT02160899|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
22441957|NCT04129151|Dana-Farber Cancer Institute|David S Shulman, MD|617-632-6670|david_shulman@dfci.harvard.edu|
22441958|NCT04473235|Universidade Federal de Minas Gerais|Elisa de Paula França Resende|+55 31 3307 9417|elisa.resende@gbhi.org|
22441959|NCT02726542|Massachusetts General Hospital|Takara Stanley, MD|617-726-5312|tstanley@mgh.harvard.edu|
22441960|NCT01945710|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_medinfo@eisai.com|
22441961|NCT02730195|Emory University|William Blum, MD|404-778-1900|william.g.blum@emory.edu|
22441962|NCT00745849|University of Texas Southwestern|Ganesh Shanmugam, MD|9797036112|ganesh01@yahoo.com|
22441963|NCT01139008|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
22441964|NCT02785770|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22441965|NCT03968939|UMissouri - Missouri Orthopaedic Institute|Vicki L Jones|573-882-7583|jonesvicki@health.missouri.edu|
22441966|NCT01303003|Steward St. Elizabeth's Medical Center|Meghan Cashman, IRB Manager|617-789-2804|meghan.cashman@steward.org|2804
22441967|NCT00813943|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22441968|NCT01088048|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22441969|NCT04978454|Duke University Medical Center|Christopher Woods|919-684-7916|chris.woods@duke.edu|
22441970|NCT01320137|GlaxoSmithKline|GSK Response Center|866-435-7343||
22441971|NCT01049009|Emory University School of Medicine|Dr. Arshed A. Quyyumi|404-727-3655|aquyyum@emory.edu|
22441972|NCT03760731|Rocky Mountain Regional VA Medical Center|Lauren Michelle Borges, PhD|303-916-0128|lauren.borges2@va.gov|
22441973|NCT01092546|GE Healthcare|Paul Sherwin, M.D.|609-514-6820|Paul.Sherwin@ge.com|
22441974|NCT01970358|Dana-Farber Cancer Institute|Patrick Ott, MD PhD|6176325990|patrick_ott@dfci.harvard.edu|
22441975|NCT02644109|Nutrition and Food Technology Institute, University of Chile|Dr. Sandra Hirsch|+56229781495|shirsch@inta.uchile.cl|
22441976|NCT00536913|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22441977|NCT01519869|University of Kentucky|Rachel Miller|859-323-2169|raware00@uky.edu|
22441978|NCT02209532|Novadaq Technologies|Alicia Wilton|416-949-4992|alicia.wilton@stryker.com|
22441979|NCT04075734|Rutgers Cancer Institute of NJ|Dr. Katie Devine|7322357549|katie.devine@rutgers.edu|
22441980|NCT01421355|Brigham and Women's Hospital|Joshua Beckman, MD|617-732-6320|jbeckman@partners.org|
22441981|NCT02433080|University College London|Dr Anne Lanceley|+442076796807|a.lanceley@ucl.ac.uk|
22441982|NCT03563183|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
22441983|NCT03855059|University of Arizona/Deptartment of Anesthesiology|Peter Lichtenthal, MD|5206267221|plich@arizona.edu|
22441984|NCT02268175|Dana-Farber Cancer Institute|Mary-Ellen Taplin, MD|617-582-7221|mary_taplin@dfci.harvard.edu|
22441985|NCT04080167|St. Jude Children's Research Hospital|Jane Hankins, MD|(901) 595-4974|jane.hankins@stjude.org|
22441986|NCT04927364|VA Palo Alto Healthcare System|Claudia Padula|650-849-1211|padula@stanford.edu|
22441987|NCT05487196|UPMC Magee Women's Hospital|Dr. Grace Lim, MD, MSc|412-641-1778|limkg2@upmc.edu|
22441988|NCT05188053|Mayo Clinic|Gabriel Schouten - Clinical Research Coordinator|507-266-5895|schouten.gabriel@mayo.edu|
22441989|NCT00794313|Oregon Health & Science Universtiy|Kathyrn Chung MD|503 721 - 1091|chungka@ohsu.edu|
22441990|NCT01761240|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
22441991|NCT05422638|VA San Diego Healthcare System|Ariel J Lang, PhD, MPH|858-552-8585|ariel.lang@va.gov|5953
22441992|NCT04016623|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
22441993|NCT02529553|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22441994|NCT06013176|Abramson Cancer Center|Dr. Samuel Takvorian|267-438-8269|Samuel.takvorian@pennmedicine.upenn.edu|
22441995|NCT05126225|University of California Los Angeles, Joe. C Wen School of Nursing|Dr. Wei-Ti Chen|310-206-8539|wchen@sonnet.ucla.edu|
22441996|NCT00114517|University of Southern California|Howard N. Hodis, M.D., Director, Atherosclerosis Research Unit|323-442-1478|athero@usc.edu|
22441997|NCT04695977|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
22441998|NCT02635425|Ain Shams university|Dr. Ahmad Hussieny Salama|00201223114626|ahmdhsf@hotmail.com|
22441999|NCT03278067|GlaxoSmithKline|GSK Response Center|866-435-7343|emily.p.lu@gsk.com|
22442000|NCT01868542|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
22442001|NCT00130247|Case Western Reserve University, Tuberculosis Research Unit|John L. Johnson, M.D., Principal Investigator|(216) 368-1949|jlj@case.edu|
22442002|NCT03844945|Aerie Pharmaceuticals Ireland Limited, Japan Branch|Clinical Research, Japan|+81-3-6860-8410|JapanCS208@aeriepharma.com|
22442003|NCT05111301|Tandem Diabetes Care|Supervisor, Clinical Operations|(877) 801-6901|clinicalaffairs@tandemdiabetes.com|
22442004|NCT00220779|Talecris Biotherapeutics|Ralph Kantor, PhD|1-800-520-2807|ralph.kantor@talecris.com|
22442005|NCT04518995|Concert Pharmaceuticals, Inc.|Colleen E. Hamilton|781-860-0045|AAclinicaltrial_inquiries@concertpharma.com|
22442006|NCT04590248|AstraZeneca Clinical Study Information Centre|Global Clinical Head|+1-877-240-94 79|information.center@astrazeneca.com|
22442007|NCT02052414|The Center for Clinical Research|James M. North MD|3367656181|jnorth1@ccrpain.com|
22442008|NCT01816711|Aarhus University Hospital|Mette Abildgaard Pedersen|31411180|meabpe@rm.dk|
22442009|NCT05011279|Dana-Farber Cancer Institute|Catherine Marinac|617-632-4703|CatherineR_Marinac@dfci.harvard.edu|
22442010|NCT01971086|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22442011|NCT01343693|Zimmer Biomet Spine|Zimmer Biomet Spine Clinical Affairs|303-501-8571|spinemedinfo@zimmerbiomet.com|
22442012|NCT01235598|UCB|UCB Clinical Trials Call Center|+1 877 822 9493||
22442013|NCT00395343|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22442014|NCT01536067|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
22442015|NCT00606905|University of Chicago|Mary D. Stephenson, M.D. MSc|773 834-1167|mstephen@babies.bsd.uchicago.edu|
22442016|NCT04657666|Jazz Pharmaceuticals|Clinical Trial Disclosure & Transparency|215-832-3750|ClinicalTrialDisclosure@JazzPharma.com|
22442017|NCT05043142|Yuria-Pharm|Tetiana Sprynsian|+380665134849|Tetiana.Sprynsian.pm@pharmaxi.com.ua|
22442018|NCT02386189|Iowa City VA Health Care System|Dr. Carolyn Turvey|319 358 9501|carolyn.turvey@va.gov|7714
22442019|NCT03120351|ClevelandCF|Bruce Vrooman|216-444-2200|vroomab@ccf.org|
22442020|NCT01558128|Weill Cornell Medicine, Department of Anesthesiology|Michele Steinkamp, Research Nurse Specialist|212-746-2953|mls9004@med.cornell.edu|
22442021|NCT04931888|Yale University|Julia Rosenberg, MD MHS|2037777411|julia.rosenberg@yale.edu|
22442022|NCT04693052|Northwestern University|Dr. Jeffrey Rado, MD,MPH,FAPA|312-695-5060|jeffrey.rado@nm.org|
22442023|NCT02969408|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
22442024|NCT02350478|Medical University of Graz|Assoz.-Prof. Dr. Harald Sourij|+43316385|ha.sourij@medunigraz.at|81310
22442025|NCT01667419|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
22442026|NCT03330002|Essential Medical, a wholly owned subsidiary of Teleflex, Inc.|Darra Bigelow, Clinical Trials Manager|610-331-7299|darra.bigelow@teleflex.com|
22442027|NCT03869216|Xavier University of Louisiana|Margarita Echeverri, Professor of Social and Behavioral Sciences|504-520-6719|mechever@xula.edu|
22442028|NCT04915950|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
22442029|NCT03860259|University of Pittsburgh Medical Center Department of Anesthesiology and Perioperative Medicine|Jacques E. Chelly, MD, PhD, MBA|412-623-6382|chelje@anes.upmc.edu|
22442030|NCT01068600|Novartis Pharmaceuticals|Study Director|862-778-8300||
22442031|NCT00332722|Pain Management Center of Paducah|Dr. Laxmaiah Manchikanti, MD|2705548373|drlm@thepainmd.com|101
22442032|NCT01209702|Hoffman-LaRoche|Medical Communications|800-821-8590||
22442033|NCT00486291|Vivus, Inc|Wesley W. Day, PhD|650-934-5200|day@vivus.com|
22442034|NCT00528450|Memorial Sloan Kettering Cancer Center|Dr. Peter Maslak|212-639-5518|maslakp@mskcc.org|
22442035|NCT04036292|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
22442036|NCT01015638|GlaxoSmithKline|GSK Response Center|88-435-7343||
22442037|NCT00984620|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22442038|NCT02164461|Advaxis, Inc.|Sumitra Sheeri|609-423-2528|Sheeri@advaxis.com|
22442039|NCT00947167|Stanford University School of Medicine|Pamela L. Kunz, MD, Leader GI Oncology Research Group|650-725-8738|pkunz@stanford.edu|
22442040|NCT00324961|GlaxoSmithKline|GSK Response Center|866-435-7343||
22442041|NCT00344487|University of Maryland Institute of Human Virology|Charles E. Davis, Jr. MD|410-706-1684|cdavis@ihv.umaryland.edu|
22442042|NCT06011759|VA Ann Arbor Health Care System|Paul Pfeiffer, MD, MS, Corresponding Principal Investigator|N/A|paul.pfeiffer@va.gov|
22442043|NCT05321784|OHSU Knight Cancer Institute|Khoa Nguyen|503-418-9314|nguyekho@ohsu.edu|
22442044|NCT02355184|CytoDyn|Joseph Meidling|(360) 980-8524|jmeidling@cytodyn.com|
22442045|NCT06173063|Rockfield Medical Devices Ltd.|Edel Keaveney, Senior Research Manager|(+353) (0)91 763 000|edel@rockfieldmd.com|
22442046|NCT02578095|Viking Therapeutics, Inc|Scott Stubbe, Vice President Clinical Operations|8587044685|sstubbe@vikingtherapeutics.com|
22442047|NCT01925131|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|amoseley@fredhutch.org|
22442048|NCT03320824|QMedAB|Clinical Project Manager|(817) 961-5000|aestheticclinicaltrials@galderma.com|
22442049|NCT00109590|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
22442050|NCT00588861|Biomet Manufacturing|Nick Higdon, Clinical Research Specialist|1-800-348-9500|nicholas.higdon@biomet.com|3047
22442051|NCT02438358|Lumicell|Jorge Ferrer, Ph.D.|617-571-0592|jmferrer@lumicell.com|
22442052|NCT00923949|National Cancer Institute|Giuseppe Giaccone M.D.|301-496-4916|giacconeg@mail.nih.gov|
22442053|NCT00490529|Stanford University|Ronald Levy|650-725-6452|levy@stanford.edu|
22442054|NCT03254459|Insys Therapeutics, Inc.|Director, Clinical Development|4805003105|gdecastro@insysrx.com|
22442055|NCT01129583|Columbia University Medical Center|TTC research fellow|212-305-3912|ttc@gmail.com|
22442056|NCT01328405|University of Wisconsin School of Medicine and Public Health|Dr. Kristopher Schroeder|608-263-8100|kmschro1@wisc.edu|
22442057|NCT04672954|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22442058|NCT02165839|Stanford University|Oxana Palesh, Associate Professor of Psychiatry and Behavioral Sciences|(650) 725-7011|oxana.palesh@stanford.edu|
22442059|NCT01904773|AstraZeneca Pharmaceuticals LP, Neuroscience Innovative Medicines Unit|Joel Posener, MD - Head, Early Clinical Development||ClinicalTrialTransparency@astrazeneca.net|
22442060|NCT04565327|University of California, San Francisco|Dr. Zhen Wang, MD|(415) 476-3767|Zheng.Wang@ucsf.edu|
22442061|NCT01511055|Mayo Clinic|Sean C. Dowdy, M.D.|507-266-0225|Dowdy.Sean@mayo.edu|
22442062|NCT00395057|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22442063|NCT01109056|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
22442064|NCT02891070|Baxter Healtcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
22442065|NCT02516969|UPMC Hillman Cancer Center|Barbara M. Stadterman, MPH, MSCR, CCRP|412-647-5554|stadtermanbm@upmc.edu|
22442066|NCT02704143|Changhai Hospital affiliated to Navy Medical University|Dr. Huojun Zhang|86-021-31162207|chyyzhj@163.com|
22442067|NCT01588418|University of Texas Health Science Center at San Antonio|Dr. Ralph DeFronzo|210-567-6691|defronzo@uthscsa.edu|
22442068|NCT02551991|Ipsen Bioscience, Inc.|Medical Director|see email|clinical.trials@ipsen.com|
22442069|NCT02507960|University of Maryland Medical Center|Elizabeth Nichols|4103287586|enichols1@umm.edu|
22442070|NCT05525078|Medical University of South Carolina|Tracy Smith, PhD|843 792 5164|smithtra@musc.edu|
22442071|NCT00942994|Novartis Pharmaceuticals|Study Director|862-778-8300||
22442072|NCT00387790|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org|
22442073|NCT01874340|Novartis|Study Director|862-778-8300||
22442074|NCT04126278|NYU Langone Health|Mehul Shah|616-501-7223|Mehul.Shah@nyulangone.org|
22442075|NCT03029988|Navidea Biopharmaceuticals|Bonnie Abbruzzese Senior Director|614.793.7500|babbruzzese@navidea.com|147
22442076|NCT01716052|UTHSCSA @CTRC|Dr. Kenneth Kist|210-450-5600|KIST@UTHSCSA.EDU|
22442077|NCT01290913|Boston Children's Hospital|Clinical Coordinator|6173556127|sara.little@childrens.harvard.edu|
22442078|NCT00093379|The University of Texas (UT) MD Anderson Cancer Center|Cathy Eng, MD/ Professor||CR_Study_Registration@mdanderson.org|
22442079|NCT02864862|The University of Texas Health Science Center at Houston|Chun-Teh Lee|713-486-4384|Chun-Teh.Lee@uth.tmc.edu|
22442080|NCT02191865|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
22442081|NCT01523275|University of California, San Francisco|Jolie Chang|415-353-2203|jolie.chang@ucsf.edu|
22442082|NCT03598114|Washington University School of Medicine|Sarah Moreland-Russell, Ph.D., MPH|314-935-8382|smoreland-russell@wustl.edu|
22442083|NCT02527200|Novo Nordisk A/S|Clinical Transparency and Medical Writing Office (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
22442084|NCT00689117|GlaxoSmithKline|GSK Response Center|866-435-7343||
22442085|NCT02204124|Washington University School of Medicine|William Hawkins, M.D.|314-286-0702|hawkinsw@wustl.edu|
22442086|NCT00444678|NYU Langone Health|Deirdre Cohen, MD|212-731-5656|Deirdre.Cohen@nyulangone.org|
22442087|NCT01022398|Creighton University|Cardiology Research Manager|402-280-4566|tammyburns@creighton.edu|
22442088|NCT01317550|MD Anderson Cancer Center|Dr. Zhongxing Liao, MD/Professor, Radiation Oncology Department|713-563-2300|zliao@mdanderson.org|
22442089|NCT02888119|NYU Langone Health|Dr. Ravinder Regatte|(212) 263-4857|Ravinder.Regatte@nyulangone.org|
22442090|NCT03364270|Cedars-Sinai Medical Center|Balaji Tamarappoo, MD|3104232219|Balaji.Tamarappoo@cshs.org|
22442091|NCT03646123|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22442092|NCT02280408|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22442093|NCT01584544|Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College|Dr. Jing Jin|8601087788122|jingjin1025@163.com|
22442094|NCT02745145|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
22442095|NCT01980589|Amgen, Inc.|Study Director|866-572-6436||
22442096|NCT02577445|Livanova|Clinical Project Manager|0032498644704|renske.dezwaef@livanova.com|
22442097|NCT01297491|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22442098|NCT00518089|Allergan, Inc.|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com|
22442099|NCT04413617|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22442100|NCT00775593|GIMEMA|Edoardo La Sala|+39 06 70390524|e.lasala@gimema.it|
22442101|NCT00312195|Purdue Pharma L.P.|Clinical Leader, Executive Medical Director|800-733-1333||
22442102|NCT03152929|Spectrum Health|Marianne Melnik|616-486-6333|marianne.melnik@corewellhealth.org|
22442103|NCT04145219|ALK-Abelló A/S|Vice President, Clinical Operations Strategy|+45 4574 7576|clinicaltrials@alk.net|
22442104|NCT01838980|Motus GI Medical Technologies Ltd.|Medical Consultant|+972-4-6214446|rose@motusgi.com|104
22442105|NCT01719744|Princess Margaret Cancer Centre|Dr. ALBIRUNI RAZAK|416-586-4800|Albiruni.Razak@uhn.ca|5371
22442106|NCT02902484|UT Southwestern Medical Center|Dr. Salwan Al Mutar|214-648-4008|salwan.almutar@utsouthwestern.edu|
22442107|NCT05854784|CLINUVEL UK LTD|Director, Global Clinical Affairs|+4401372860765|mail@clinuvel.com|
22442108|NCT01703754|Alaunos Therapeutics|Jaymes Holland|6502732627|jholland@alaunos.com|
22442109|NCT05871450|German University of Health and Sports|Wolfgang Ruf|+49 (030) 577 97 37 370|wolfgang.ruf@dhgs-hochschule.de|
22442110|NCT00947882|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22442111|NCT02379637|Novartis|Dr Marianna Armogida Director Clinical Research Innovation|+41223635182|marianna.armogida@novartis.com|
22442112|NCT02447302|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
22442113|NCT03686007|City of Hope Medical Center|Dr. Virginia Sun|626-359-8111|VSun@coh.org|
22442114|NCT06057727|University of Pennsylvania|Dr. Shivan Mehta|2679726027|shivan.mehta@pennmedicine.upenn.edu|
22442115|NCT01561313|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
22442116|NCT04449263|CooperVision, Inc|Jose Vega, OD, MSc, FAAO|9256402964|javega2@coopervision.com|
22442117|NCT01742286|Study Director|Study Director|862-778-8300|novartis.email@novartis.com|
22442118|NCT01233232|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
22442119|NCT04198714|MetroHealth Medical Center|Dr. Jeffrey Mangel|216-778-5595|jmangel@metrohealth.org|
22442120|NCT01031836|AstraZeneca|Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
22442121|NCT05091567|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
22442122|NCT01217307|University Medical Center Groningen|Dr. I.C.C. van der Horst||i.c.c.van.der.horst@umcg.nl|
22442123|NCT03054129|Dr. İsmail Atabek Physical Therapy and Rehabilitation Center|Ertan Şahinoğlu, PT, PhD|+90 5326478653|ertan.sahinoglu@hotmail.com|
22442124|NCT00843284|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22442125|NCT01696929|Georgia Regents University|Dr. Brian Miller|706-721-4445|brmiller@gru.edu|
22442126|NCT02603666|Karolinska University Hospital, Huddinge, 141 86 Stockholm|Ferenc Karpati M.D., Ph.D., Senior Consultant|+46858580000|ferenc.karpati@karolinska.se|81656
22442127|NCT01794338|Carolinas HelathCare System|Research Director|704-355-3168|Amy.Lincourt@carolinashealthcare.org|
22442128|NCT01282463|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22442129|NCT02051933|CarolinasHS|Christine Churchill|704-355-6947|christine.churchill@carolinashealthcare.org|
22442130|NCT01954927|St. Jude Children's Research Hospital|Doralina Anghelescu, MD|(901) 595-4034|doralina.anghelescu@stjude.org|
22442131|NCT02156271|Duke University Medical Center|Dr. Andrew Krystal|919-681-8742|andrew.krystal@duke.edu|
22442132|NCT02617485|Mabion S.A.|Adam Tuszyner|+48504441105|a.tuszyner@mabion.eu|
22442133|NCT03861988|Stanford University|Boris Heifets, MD, PhD|(650) 497-8057|bheifets@stanford.edu|
22442134|NCT00791076|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
22442135|NCT00480987|The University of Texas M. D. Anderson Cancer Center|Gautam Borthakur, MBBS / Assistant Professor|713-792-7305|eharriso@mdanderson.org|
22442136|NCT00669409|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22442137|NCT03101111|Themis Bioscience|Christiane Thomasser|01 236 7151|christiane.thomasser@themisbio.com|
22442138|NCT00095940|Pediatric Brain Tumor Consortium|Assistant Director Operations and Biostatistics Center|901-595-2617|dana.wallace@stjude.org|
22442139|NCT04491604|Krystal Biotech|Dr. Hubert Chen, MD, Senior Vice President of Clinical Development|(412) 586-5830|inquiries@krystalbio.com|
22442140|NCT00296296|Stanford University|Stephan Busque, MD|650-498-6189|sbsuque@stanford.edu|
22442141|NCT00641641|University of New South Wales|Sean Emery|9385 0900|semery@kirby.unsw.edu.au|
22442142|NCT03241030|Baylor College of Medicine|Nidhi Singh, MD|832-824-2771|nidhi.singh@bcm.edu|
22442143|NCT03263702|Icahn School of Medicine at Mount Sinai|Sam Cammack|212-824-8931|sam.cammack@mountsinai.org|
22442144|NCT00966875|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22442145|NCT02453347|Audie L. Murphy Veterans Administration Hospital|Dr. Carlos Jaramillo|210-617-5300|jaramilloc3@uthscsa.edu|15773
22380710|NCT02325713|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22380711|NCT00852137|LEO Pharma|Dr. Torsten Skov|+4520736294|torsten.skov@leo-pharma.com|
22380712|NCT04988477|Hennepin Healthcare Research Institute|Dr. Sandra Japuntich|6128736856|sandra.japuntich@hcmed.org|
22380713|NCT02699190|The Children's Hospital of Philadelphia|Dr. Adeline Vanderver|215-590-1719|vandervera@chop.edu|
22380714|NCT04034238|National cancer Institute|Dr. Christine C. Alewine|240-760-6146|christine.alewine@nih.gov|
22380715|NCT04822298|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22380716|NCT00465361|Children's Mercy Hospitals and Clinics|Sarah S. Nyp|816-234-3000|ssnyp@cmh.edu|
22380717|NCT01625338|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
22380718|NCT01789203|Methodist Hospital|Samir Patel|267-808-0577|spatel2@houstonmethodist.org|
22380719|NCT00951561|Another Way Products|Charles Tepper|917-538-6894|charles_tepper@yahoo.com|
22380720|NCT02092987|Columbia University Medical Center|Jose Luchsinger|212-305-4730|jal94@cumc.columbia.edu|
22380721|NCT00515086|Novartis Pharmaceuticals|Study Director|862-778-8300||
22380722|NCT02967016|Rutgers SUNJ|Dr. Antonio Gonzalez|4133869415|ajantoni@gmail.com|
22380723|NCT02068729|Stryker Spine|Marissa Conrad, Senior Director of Clinical and Medical Affairs|201-749-8162|marissa.conrad@stryker.com|
22380724|NCT01447914|University of Texas (UT) MD Anderson Cancer Center|Robert Orlowski, MD, PhD / Professor, Department of Lymphoma/Myeloma|713-792-2860|ROrlowski@mdanderson.org|
22380725|NCT03487666|Georgetown University|Candace Mainor, MD|202-444-2223|Candace.Mainor@gunet.georgetown.edu|
22380726|NCT03201757|Alkermes|Global Clinical Services|888-253-8008|clinicaltrials@alkermes.com|
22380727|NCT05967442|Advocate Christ Medical Center|Marc McDowell|708684800|marc.mcdowell@aah.org|
22380728|NCT03930186|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22380729|NCT04569240|Cleveland Clinc|Andrea Parianos|216-445-8354|debsa@ccf.org|
22380730|NCT04365413|University of Oklahoma Health Sciences Center, Stephenson Cancer Center|Lacey McNally|405-325-0789|lacey-mcnally@ouhsc.edu|
22380731|NCT03019458|Sunshine Care Foundation|Dr. Patrick Acuna|+63 947 959-1851|patrick_acuna@hotmail.com|
22380732|NCT00031447|Collaborative Antiviral Study Group|Penelope M Jester|205-934-2424|pjester@peds.uab.edu|
22380733|NCT01161160|GlaxoSmithKline|GSK Response Center|866-435-7343||
22380734|NCT02271594|BD|Dr. Ken Strauss|32475380454|kenneth.strauss@bd.com|
22380735|NCT02521259|Seoul National University Bundang Hospital|Dr. YEA JI LEE|+821086307701|ladydaisy82@naver.com|
22380736|NCT03330119|Main Line Health System|Dr. Norman Brest|484-476-2325|brestn@mlhs.org|
22380737|NCT01561079|Johns Hopkins University School of Medicine|Dr. Lauren M Jansson|410-550-5438|ljansson@jhmi.edu|
22380738|NCT02062905|Ocular Therapeutix, Inc.|Director, Clinical Affairs|781-357-4000|dmulani@ocutx.com|
22380739|NCT00715390|The Children's Hospital of Philadelphia|Ronald Litman, DO|215-590-5091|litmanr@email.chop.edu|
22380740|NCT03835546|Fundació Lluita contra la SIDA|Jose A. Muñoz-Moreno|+34 93 497 84 14|jmunoz@flsida.org|
22380741|NCT02435901|Northwell Health System Cohen Children's Medical Center of NY|Indira Sahdev, MD|7184703460|isahdev@northwell.edu|
22380742|NCT03311854|Sobi AG|Veronica Asnaghi, MD|+41 61 201 13 20|veronica.asnaghi@sobi.com|
22380743|NCT01403987|Boston Medical Center|Brian Jacobson, MD, Principal Investigator|617-6386563|brian.jacobson@bmc.org|
22380744|NCT01207934|Washington University School of Medicine|Samuel Klein, MD|3143628708|sklein@wustl.edu|
22380745|NCT00751790|Debiopharm S.A.|Eija Lundström|+41 21 3210111|elundstrom@debiopharm.com|
22380746|NCT01276535|Westlake Dermatology|Gregory A. Nikolaidis, MD|512-328-3376|karen@westlakedermatology.com|
22380747|NCT00180674|Imperial College London|Prof Mark Thursz|+44 (0)20 3312 1903|m.thursz@imperial.ac.uk|
22380748|NCT03302910|Indiana University School of Medicine|Peter S. Pang|317-880-3900|ppang@iu.edu|
22380749|NCT01106976|VAAAHS|Nicolaas Bohnen|7349988400|Nicolaas.Bohnen@va.gov|
22380750|NCT02949518|Hospital for Special Surgery|Dr. Ellen Soffin|212-606-1206|soffine@hss.edu|
22380751|NCT01477749|Dendreon Pharmaceuticals, Inc.|Lynn Ngo|206-274-6763|lngo@dendreon.com|
22380752|NCT03566680|The University of Alabama at Birmingham|Dr. Andrew Pucker|920-579-2900|apucker@uab.edu|
22380753|NCT01066156|Cambridge Health Alliance|Igor Elman|(617) 665-1000|ielman@challiance.org|
22380754|NCT04003974|Fulcrum Therapeutics|Call Center|617-651-8853|clinicaltrials@fulcrumtx.com|
22380755|NCT02400307|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22380756|NCT03248440|Senju USA, Inc.|Takahiro Ogawa, PhD|+1 818 719 7190|ogawataka@senju-usa.com|
22380757|NCT04081298|Fred Hutchinson Cancer Center|Heather Greenlee|206-667-4502|hgreenlee@fredhutch.org|
22380758|NCT03389893|DAIT/NIAID|Director, Clinical Research Operations Program|240-669-5064|DAITClinicalTrialsGov@niaid.nih.gov|
22380759|NCT00525057|UT MD Anderson Cancer Center|Patrick Lin, MD/Professor, Orthopaedic Oncology|(713) 745-0088|plin@mdanderson.org|
22380760|NCT02150044|Acclarent, Inc.|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com|
22380761|NCT01719861|Stanford University Medical Center|Joel Neal, MD, PhD; Assistant Professor of Medicine|650-725-3081|jwneal@stanford.edu|
22380762|NCT04305236|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
22380763|NCT01925170|Mayo Clinic|Dr. Deborah Rhodes|507-284-7971|rhodes.deborah@mayo.edu|
22380764|NCT02186938|MUSC|Dr Hand|843-792-5442|handw@musc.edu|
22380765|NCT01077024|University of Cincinnati Addiction Sciences Division|Dr. Theresa Winhusen|513-585-8227|winhust@ucmail.uc.edu|
22380766|NCT02034435|Vanderbilt University Medical Center|Dr. James M. Luther, MD|(615) 936-3420|james.luther@vumc.org|
22380767|NCT03862482|Université de Montréal|Dr. Aldo Joseph Camarda|514-343-7124|aj.camarda@umontreal.ca|
22380768|NCT03100838|USFDA|Dr. Minori Kinjo|240-40269118|minori.kinjo@fda.hhs.gov|
22380769|NCT00801242|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
22380770|NCT00184028|USC/Norris Comrpehensive Cancer Center|Barbara Gitlitz, MD|323-865-3906|Gitlitz@usc.edu|
22380771|NCT00994279|Wake Forest NCI NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
22380772|NCT01606189|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
22380773|NCT01857323|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com|
22380774|NCT01400893|CytoPherx, Inc|H. David Humes|734-997-7055|dhumes@cytopherx.com|302
22380775|NCT00519636|GlaxoSmithKline|GSK Response Center|866-435-7343||
22380776|NCT04504916|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22380777|NCT03057834|Wake Forest University School of Medicine|Candace Parker-Autry, MD|336-716-3779|candace.parkerautry@wfusm.edu|
22380778|NCT01638468|Boston Scientific|Angela Schutt|763-494-2166|angela.schutt@bsci.com|
22380779|NCT00003509|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
22380780|NCT03803774|National Cancer Institute|Dr. Vassiliki Saloura|240-760-6352|vassiliki.saloura@nih.gov|
22380781|NCT03749460|University of Washington|Cristina Rodriguez|2066066748|rodrigcr@uw.edu|
22380782|NCT04343222|University of Wisconsin - Madison|Maxwell Wingelaar|231-233-6051|mwingelaar@uwhealth.org|
22380783|NCT03077620|Washington University in St Louis School of Medicine|Dr. Brendan Lucey|314-747-3805|luceyb@wustl.edu|
22380784|NCT00118144|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
22380785|NCT00245011|Sidney Kimmel Comprehensive Cancer Center|David M. Loeb, M.D., Ph.D., Director, Musculoskeletal Tumor Program|410.502.7247|loebda@jhmi.edu|
22380786|NCT00550173|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22380787|NCT01345292|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
22380788|NCT01207908|Cincinnati Children's Hospital Medical Center|Dr. Meilan Rutter|513-636-4744|meilan.rutter@cchmc.org|
22380789|NCT01385280|University of Arizona Cancer Center|Program Coordinator|520-626-0301|aselegue@email.arizona.edu|
22380790|NCT01893320|The University of Texas MD Anderson Cancer Center|Naval Daver MD, Associate Professor|713-794-4392|NDaver@mdanderson.org|
22380791|NCT05406791|University of Illinois at Chicago|Colleen Stiles-Shields, PhD|312-413-1128|ecss@uic.edu|
22380792|NCT02403674|Merck Sharp & Dohme LLC|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@msd.com|
22380793|NCT01254305|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|8124
22380794|NCT01636362|Molnlycke Health Care AB|Joan Wilson|706 504 8997|joan.wilson@molnlycke.com|
22380795|NCT00926393|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
22380796|NCT02307123|Tampere University Hospital|Toni Pakkanen, MD|358408227209|toni.pakkanen@icloud.com|
22380797|NCT00707863|Indiana Uiniveristy|Amit Anand MD|3172747422|aanand@iupui.edu|
22380798|NCT02223689|Medline Industries, Inc.|Lori Rotolo|8476434640|lrotolo@medline.com|
22380799|NCT03560141|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
22380800|NCT05677867|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22380801|NCT01521949|University of Colorado Cancer Center|Elaine Lam, MD|7208480273|elaine.lam@ucdenver.edu|
22380802|NCT01094743|Johnson & Johnson Vision Care|Huan Sheng, MD, PhD|1-904-443-3440|HSheng2@its.jnj.com|
22380803|NCT02851511|University of Florida|Adam Woods, Ph.D.|352-294-5842|ajwoods@phhp.ufl.edu|
22380804|NCT02988375|Henry Ford Health|Dr. Christopher Drake|(248) 344-6672|cdrake1@hfhs.org|
22380805|NCT04004208|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22380806|NCT01902901|Kaiser Permanente Center for Health Research|Katrina Goddard|503-335-6353|katrina.ab.goddard@kpchr.org|
22380807|NCT00402883|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
22380808|NCT01528124|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22380809|NCT00276250|Emory University|Nicole Turgeon, MD|404-727-3257|nturgeo@emory.edu|
22380810|NCT02118714|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
22380811|NCT01328587|National Heart Lung and Blood Institute|Dunbar, Cynthia|+1 301 827 1164|dunbarc@nhlbi.nih.gov|
22380812|NCT02071095|Icahn School of Medicine at Mount Sinai|Dr. Nina Bhardwaj|212-824-8427|nina.bhardwaj@mssm.edu|
22380813|NCT03023332|Case Western Reserve University|Jaclene Zauszniewski, PhD|216.368.3612|jaz@case.edu|
22380814|NCT02412761|The University of Texas Health Science Center at Houston|Joyce P. Samuel, MD, MS|(713) 500-5670|Joyce.P.Samuel@uth.tmc.edu|
22380815|NCT01818700|Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University school of medicine, Seoul Korea|Dr. Whan Eoh|82-2-3410-3491|w.eoh@samsung.com|
22380816|NCT01272011|Malcom Randall VAMC|Dr. Nicole Tester|352-376-1611|ntester@phhp.ufl.edu|7507
22380817|NCT02013687|Fraunhofer USA Center for Molecular Biotechnology|Dr. Jessica Chichester, Senior Scientist Immunology|302-369-3635|jessica.chichester@fhcmb.org|
22380818|NCT01627340|GlaxoSmithKline|GSK Response Center|866-435-7343||
22380819|NCT06096181|Cedars-Sinai Medical Center|Glenn Tan, MD|310-423-5841|Glenn.Tan@cshs.org|
22380820|NCT02240680|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
22380821|NCT01657032|The Medical University of Warsaw|Hanna Szajewska, Malgorzata Pieścik-Lech|+48-22-45-23-309|hania@ipgate.pl|
22380822|NCT01782326|Novartis Pharmaceuticals|Study Director|862-778-8300||
22380823|NCT05968482|Amzell BV|Chief Executive Officer|+31235560460|amzell-disclosure@amzell.com|
22380824|NCT02987829|Tracon Pharmaceuticals Inc.|Charles Theuer, MD PhD|8585500780|ctheuer@traconpharma.com|
22380825|NCT02559817|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
22380826|NCT03379233|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
22380827|NCT00965484|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22380828|NCT02687919|University of Iowa|Amanda Irish||amanda.k.irish@gmail.com|
22380829|NCT00419003|Baylor College of Medicine|Dr. Sanjay Mathew|7137985439|sjmathew@bcm.edu|
22380830|NCT02531438|Paratek Pharmaceuticals, Inc.|Dr. Paul McGovern; Vice President, Clinical Affairs|484-751-4935|Paul.Mcgovern@paratekpharma.com|
22380831|NCT01653847|Northwestern University|Lorenzo Gallon, MD|312-695-4457|l-gallon@northwestern.edu|
22380832|NCT01653743|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
22380833|NCT01845636|New York State Psychiatric Institute|Dr. Davangere Devanand|646-774-8658|dpd3@cumc.columbia.edu|
22380834|NCT02015195|Division of Emergency Medicine, Department of Surgery, Stanford University School of Medicine|Paul Auerbach, MD|650.725.9445|auerbach@stanford.edu|
22380835|NCT02554513|VASLCHCS|Dr. Shannon Mauszycki|801-582-1565|shannon.mauszycki@utah.edu|
22380836|NCT00483262|Dana-Farber Cancer Institute|Irene Ghobrial, MD|617-632-4198|irene_ghobrial@dfci.harvard.edu|
22380837|NCT00832260|Hospital Universitari i politecnic La Fe|Dr. José Olagüe|+34 961 24 40 00|jolague@terra.com|
22380838|NCT02303574|AstraZeneca|Bengt Larsson|+46 766 346712|clinicaltrialtransparency@astrazeneca.com|
22380839|NCT01359410|Washington University School of Medicine|William Hawkins, M.D.|314-362-7046|hawkinsw@wustl.edu|
22380840|NCT05590910|UT Health San Antonio-Faculty; Texas Woman's University-Student|Jorgie Ann Contreras|2107235319|contrerasj6@uthscsa.edu|
22380841|NCT00859014|University of Texas Health Science Center|Dr. Sean I. Savitz, Professor and Director of Stroke|713.500.7083|sean.i.savitz@uth.tmc.edu|
22380842|NCT00162942|Otsuka America Pharmaceutical, Inc|Tao Wang|240-683-3213|tao.wang@otsuka-us.com|
22380843|NCT04796935|Elevate Clinical Consulting|Keri Urwin|919-247-8845|kurwin@elevateclinicalconsulting.com|
22380844|NCT00429702|SunCoast CCOP Research Base|SunCoast CCOP Research Base Lead Biostatistician|18009091242|ccop@epi.usf.edu|
22380845|NCT00783718|Millennium Pharmaceuticals Inc|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
22380846|NCT01192295|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
22380847|NCT00630539|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
22380848|NCT01253980|Poisons Information Centre, Red Cross War Memorial Children's Hospital and University of Cape Town|Dr Kate Balme|+27 21 658 5308|kate.balme@uct.ac.za|
22380849|NCT01051778|Cairo university|Usama .M .Fouda|+20123595106|umfrfouda@yahoo.com|
22380850|NCT02929108|Washington University School of Medicine|Debra Oliver, Ph.D.|314-747-5361|oliverd@wustl.edu|
22380851|NCT01027871|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
22380852|NCT00052962|National Cancer Institute, National Institutes of Health|Marybeth Hughes, M.D.|301-594-9341|hughesm@mail.nih.gov|
22380853|NCT01414166|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22380854|NCT03782727|Cardiff and Vale University Health Board|Dr Rachel Abbott|02920743181|rachel.abbott@wales.nhs.uk|
22380855|NCT03658811|Toyos Clinic|Dillon O'Brien|6153274015|dobrien@toyosclinic.com|6
22380856|NCT04209790|Geisinger|Regulatory Project Manager|570-214-2462|khassanzadeh@geisinger.edu|
22380857|NCT04060680|Medtronic|Drew Turk, Clinical Research Specialist|7633580375|drew.turk@medtronic.com|
22380858|NCT00940017|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
22380859|NCT05458102|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22380860|NCT05336123|Brown University|Dr. Lauren Weinstock|401-455-6304|Lauren_Weinstock@brown.edu|
22380861|NCT00852475|Baltimore VAMC and University of Maryland Medical Center|Michael Miller, MD|4103286299|mmiller@medicine.umaryland.edu|
22380862|NCT02373813|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
22380863|NCT01511536|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22380864|NCT02021461|BIAL - Portela & Cª, S.A.|Director R&D|351-22-9866100|clinical.trials@bial.com|
22380865|NCT02703532|Emory University|Sarah Blanton, PT, DPT, NCS, FNAP|404-712-2222|sblanto@emory.edu|
22380866|NCT00495469|GlaxoSmithKline|GSK Response Center|866-435-7343||
22380867|NCT00051311|National Cancer Institute|Dr. Ronald Gress|240-760-6167|Ronald_Gress@nih.gov|
22380868|NCT04170023|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|+1 855-752-2356|clinicaltrials@alexion.com|
22380869|NCT04990440|Janssen Research & Development, LLC|Director Clinical Research Dermatology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
22380870|NCT03712098|SUNY Buffalo|Rebecca Ashare|7168296273|rlashare@buffalo.edu|
22380871|NCT02256969|Massachusetts Eye and Ear Infirmary|Assistant Professor of Ophthalmology|617-573-6060|ophthalmologyclinicalresearch@meei.harvard.edu|6060
22380872|NCT00372567|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
22380873|NCT00953160|Cutera Inc.|Ayse Turley, Clinical Development Researcher|415-657-5665|aturley@cutera.com|
22380874|NCT02537444|Acerta Pharma, LLC|Priti Patel, MD, Executive Director - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
22380875|NCT03836664|University of Kansas Medical Center|Dr Dipika Aggarwal, Clinical Assistant Professor|9139459926|daggarwal@kumc.edu|
22380876|NCT01427907|Fresenius Medical Care, North America|Mayuri Thakuria MD (MBBS), MPH|781-699-4645|mayuri.thakuria@fmc-na.com|
22380877|NCT03825393|Tokat State Hospital|Dr.Sevil Okan|5308211797|doctorsevil@yahoo.com|
22380878|NCT00425503|Baylor College of Medicine|Dr. Teresa Hayes - Associate Professor|713-794-7368|thayes@bcm.edu|
22380879|NCT01169519|Duke University Medical Center|Dr. Kevin Hill|919-668-8305|kevin.hill@duke.edu|
22380880|NCT03278028|Aclaris Therapeutics|Executive Director, Clinical Operations|+1(484) 329-2144|jschnyder@aclaristx.com|
22380881|NCT00229619|NIH National Heart, Lung and Blood Institute|Adrian Wiestner MD, NHLBI|301-594-6855|wiestnera@nhlbi.nih.gov|
22380882|NCT03890120|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
22380883|NCT01052662|University of Massachusetts Medical School|Gerardo Gonzalez, MD|508 856 6480|gerardo.gonzalez@umassmed.edu|
22380884|NCT00479674|Duke University Medical Center|Dr. Kimberly Blackwell|919-668-1748|black034@duke.edu|
22380885|NCT01054911|University of Alabama in Birmingham, Comprehensive Cancer Center|Dr. James Posey, MD|205-934-0916|jposey@uabmc.edu|
22380886|NCT02478359|Kaiser Permanente|Huong Q2 Nguyen, Research Scientist|626-564-3935|huong.q2.nguyen@kp.org|
22380887|NCT00905060|University of California, Davis|Dr. Orin Bloch, MD||obloch@ucdavis.edu|
22380888|NCT03293485|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22380889|NCT01852955|Northwestern University|Gildasio De Oliveira, M.D.|312-695-4858|gjr@northwestern.edu|
22380890|NCT03633903|Laureate Institute for Brain Research|Namik Kirlic, PhD|918-502-5747|nkirlic@laureateinstitute.org|
22380891|NCT01813422|Amgen Inc.|Study Director|866-572-6436||
22380892|NCT02874846|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director of Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
22380893|NCT00487721|University of Colorado, Denver|Dr. Thomas Flaig|(720) 848 0655|Thomas.Flaig@ucdenver.edu|
22380894|NCT04992442|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22380895|NCT00410384|GlaxoSmithKline|GSK Response Center|866-435-7343||
22380896|NCT02953548|GW Research Ltd|Medical Enquires|+44 01223 238170; 1877886281|medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
22380897|NCT01023178|Stanford University|Sejal Shah MD|6507235791|sshah2@stanford.edu|
22380898|NCT03610633|Medical University of South Carolina|Laura Lohnes|843-792-7709|lohnes@musc.edu|
22380899|NCT03453385|Medical University of South Carolina (MUSC)|Dr. Matthew Carpenter|843-876-2436|carpente@musc.edu|
22380900|NCT00577629|Duke University Medical Center|Anne Beaven, MD|919-684-8964|anne.beaven@duke.edu|
22380901|NCT05489224|CELLTRION, Inc.|Head of Clinical Planning Department 3|+82-32-850-4167|jeehye.suh@celltrion.com|
22380902|NCT04887285|Northwestern University|Steven P. Cohen|312-695-2500|steven.cohen@northwestern.edu|
22380903|NCT04640571|University of Maryland, Baltimore|James Polli|410-465-3466|jpolli@rx.umaryland.edu|
22380904|NCT06268301|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
22380905|NCT01688102|The Rockefeller University|Dr. Manish Ponda|212-327-7631|mponda@rockefeller.edu|
22380906|NCT00832780|University of New Mexico Comprehensive Cancer Center|Ben Liem, MD|505-272-0086|BLiem@salud.unm.edu|
22380907|NCT05705167|Pharma Mar, S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|+34 918466000|clinicaltrials@pharmamar.com|
22380908|NCT05768945|Brigham and Women's Hospital|Rishi J Desai, PhD|617-278-0932|rdesai@bwh.harvard.edu|
22380909|NCT01670500|DFCI|Project Manager|617-632-2257|CTOPM@dfci.harvard.edu|
22380910|NCT04955626|BioNTech clinical trials patient information|BioNTech SE|+49 6131 90840|patients@biontech.de|
22380911|NCT03473756|Bayer AG|Bayer Clinical Trials Contact|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
22380912|NCT03714022|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
22380913|NCT05121675|Perelman School of Medicine|Dr. Heather Nuske|2153495537|Heather.Nuske@Pennmedicine.upenn.edu|
22380914|NCT03864133|Wake Forest University Health Sciences|Keith Walter, MD|336-716-3937|kwalter@wakehealth.edu|
22380915|NCT02668432|University of Texas Health San Antonio|Bethany Kalich, PharmD|210-883-1177|kalich@uiwtx.edu|
22380916|NCT02487446|Novartis Pharmaceuticals|Study Director|862-778-1873||
22380917|NCT02234310|Bioverativ, a Sanofi company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6
22380918|NCT03289455|Autolus Ltd|Clinical Project Manager|+44 1483 920748|clinicaltrials@autolus.com|
22380919|NCT04951479|UPMC|Anish Ghodadra, MD|4126470104|ghodadraa@upmc.edu|
22380920|NCT03706690|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
22380921|NCT05617040|Barinthus Biotherapeutics|Chief Medical Officer|+44 1865 818808|enquiries@barinthusbio.com|
22380922|NCT02711826|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
22380923|NCT00729690|Rush University|Asokumar Buvanendran|(312) 942-3685|asokumar@aol.com|
22380924|NCT02169219|Massachusetts General Hospital, Division of Rheumatology|Dr. John Stone|617-643-2140|adfernandes@mgh.harvard.edu|
22380925|NCT04482855|University of Pennsylvania School of Nursing|Dr. Jie Deng|2155734729|jiedeng@nursing.upenn.edu|
22380926|NCT02044419|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|857-242-5142|alison.long@aegerion.com|
22380927|NCT02507219|Laureate Institute for Brain Research|Dr. Martin Paulus|918-502-5120|mpaulus@laureateinstitute.org|
22380928|NCT02886936|University of Pennsylvania|Jessica Kenia, Research Coordinator|215-893-2678|jessica.kenia@pennmedicine.upenn.edu|
22380929|NCT04562779|Denver Health & Hospital Authority|Dr. Dale Terasaki|303-602-6922|dale.terasaki@dhha.org|
22380930|NCT02320721|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
22380931|NCT03173248|Institut de Recherches Internationales Servier (I.R.I.S.)|Clinical Studies Department|+33155726000|scientificinformation@servier.com|
22380932|NCT01544582|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
22380933|NCT00075803|NHLBI|Nancy DiFronzo, PhD|301-435-0065|difronozon@nhlbi.nih.gov|
22380934|NCT03015740|M D Anderson Cancer Center|Dr. Pavlos Msaouel|713-563-4585|PMsaouel@mdanderson.org|
22380935|NCT00929305|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com|
22380936|NCT05927480|HealthPartners Institute|Sandy Vang, Director of Research Administration at Regions Hospital|1-651-254-6961|sandy.x.vang@healthpartners.com|
22380937|NCT05194735|Alaunos Therapeutics, Inc.|Jaymes Holland|6502732627|jholland@alaunos.com|
22380938|NCT00731042|3M Company|Chou Eyberg|651-737-0934|cieyberg1@mmm.com|
22380939|NCT02624778|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
22380940|NCT05541497|Yale School of Medicine|Lisa Fucito, PhD: Associate Professor of Psychiatry; Director, Tobacco Treatment Service, Psychiatry|(203) 688-1878|lisa.fucito@yale.edu|
22380941|NCT04091672|AVITA Medical|SVP Global Clinical Research|1-833-462-8482|ekirshner@avitamedical.com|
22380942|NCT01256476|Kowa Research Institute, Inc.|Roger Morgan, MD, FACS|919-433-1600|RMorgan@KowaUS.com|
22380943|NCT05296629|Journey Medical Corporation|Dr. Srinivas Sidgiddi|9084585362|ssidgiddi@jmcderm.com|
22380944|NCT01796665|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
22380945|NCT02600429|clinical operation|Director of clinical operation||swkang@regentreellc.com|
22380946|NCT00231179|Children's Hospital of Philadelphia|Jerilynn Radcliffe, PhD|215-590-7446|Radcliffe@email.chop.edu|
22380947|NCT02491411|SKCCC at JHU|Samuel Denmeade|410-955-8875|denmesa@jhmi.edu|
22380948|NCT01955382|NIAID/NIH|Dr. Rick M. Fairhurst, Principal Investigator|301-761-5077|rfairhurst@niaid.nih.gov|
22380949|NCT04610684|Hoosier Cancer Research Network|Clinical Data Analyst|3179212050|amajumdar@hoosiercancer.org|
22380950|NCT02395185|Shriners Hospital for Children|Rebecca Davis|859-268-5705|rfdavis@shrinenet.org|
